Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" A1CF "ACF, ACF64, ACF65, APOBEC1CF, ASP" ENSG00000148584 "APOBEC1 complementation factor" Q9NQ94 10 50799409-50885675 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 32.5;liver: 99.7" "Cell type enhanced" "Detected in many" 17 "Cholangiocytes: 107.0;Enterocytes: 90.6;Hepatocytes: 295.0;Intestinal endocrine cells: 111.9;Paneth cells: 71.9;Proximal tubular cells: 93.2" "Cancer enriched" "Detected in some" 6 "liver cancer: 18.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "basophil: 1.6" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.6" "Group enriched" "Detected in some" 23 "CACO-2: 13.8;Hep G2: 35.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037779, HPA044079" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA037779: AB_10670529, HPA044079: AB_2678800" "unprognostic (3.87e-3)" "unprognostic (7.86e-2)" "unprognostic (2.34e-1)" "unprognostic (2.21e-3)" "unprognostic (2.73e-1)" "unprognostic (4.61e-3)" "unprognostic (1.71e-1)" "unprognostic (7.38e-3)" "unprognostic (1.30e-2)" "unprognostic (2.46e-2)" "unprognostic (1.20e-1)" "unprognostic (1.90e-3)" "unprognostic (1.97e-2)" "unprognostic (2.77e-1)" "unprognostic (2.19e-2)" "unprognostic (8.50e-4)" 0.1 0.1 0.1 1.7 0.1 0.0 0.1 0.1 0.1 0.1 14.4 0.0 0.0 8.7 0.1 0.6 0.1 0.1 3.0 0.1 0.1 0.1 9.5 99.7 0.1 0.0 0.1 0.0 0.1 5.6 0.0 0.1 0.0 0.1 0.1 3.8 0.0 0.1 0.0 0.1 0.1 32.5 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 1.6 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 35.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 9.1 0.0 0.0 0.4 0.4 107.0 0.0 0.0 3.5 2.0 0.0 8.3 0.8 0.0 0.0 90.6 0.0 9.5 0.0 0.0 0.0 0.0 295.0 0.0 0.0 111.9 7.4 6.4 0.0 0.0 0.0 0.0 0.0 49.6 0.0 15.6 71.9 0.0 93.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 25.9 0.1 AAMDC "C11orf67, CK067, FLJ21035, PTD015" ENSG00000087884 "Adipogenesis associated Mth938 domain containing" Q9H7C9 11 77821109-77918432 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 155.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 73.6" "Low region specificity" "Detected in all" "HPA037918, HPA037919" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA037918: AB_2675737, HPA037919: AB_2675738" "unprognostic (3.10e-2)" "unprognostic (9.04e-3)" "unprognostic (6.02e-2)" "unprognostic (4.67e-1)" "unprognostic (1.27e-1)" "unprognostic (3.51e-2)" "unprognostic (3.00e-1)" "unprognostic (1.44e-1)" "unprognostic (1.08e-1)" "unprognostic (1.07e-2)" "unprognostic (1.23e-1)" "unprognostic (7.08e-2)" "unprognostic (1.90e-1)" "unprognostic (2.08e-1)" "unprognostic (1.35e-1)" "unprognostic (1.37e-1)" "unprognostic (3.84e-2)" 18.8 42.2 7.5 7.5 11.4 5.2 16.2 10.9 8.6 13.8 15.8 9.5 16.9 10.1 18.0 9.5 12.4 13.4 11.8 35.0 7.5 6.4 12.8 15.5 11.8 3.5 13.0 6.8 14.3 18.1 6.9 11.1 7.9 9.9 12.6 8.3 10.0 16.7 14.5 155.8 13.0 13.6 21.0 15.3 7.4 14.2 14.4 13.1 6.5 14.1 15.7 5.0 14.4 17.0 8.1 13.2 43.3 11.9 13.7 18.0 6.4 7.8 6.4 10.0 7.1 29.3 20.4 2.7 13.0 8.9 11.8 14.8 73.6 11.9 5.3 12.7 21.8 11.7 4.4 15.0 8.7 14.1 12.2 12.1 5.1 11.1 13.5 14.4 2.8 4.6 27.1 6.0 12.4 6.6 11.0 35.0 7.1 5.8 8.6 24.9 9.2 6.0 11.4 4.7 22.0 11.0 5.8 17.2 5.1 15.6 4.7 3.5 13.4 16.5 7.2 9.2 15.6 11.1 5.7 36.4 12.5 6.8 23.6 4.3 9.3 14.5 9.7 4.8 4.7 6.9 43.3 11.9 12.3 6.1 6.6 7.8 7.0 11.9 10.0 12.7 8.1 10.4 7.8 6.9 13.7 6.4 13.2 18.0 6.4 7.5 11.4 10.9 8.6 7.5 6.4 13.0 6.8 9.9 13.1 77.4 23.1 12.7 70.3 57.1 10.1 103.7 63.7 44.2 25.0 75.0 3.9 21.7 122.7 56.1 47.2 50.1 92.1 0.0 64.0 37.5 60.8 57.8 40.4 94.8 39.9 11.1 21.8 93.9 31.4 27.5 63.3 28.7 79.2 82.0 49.3 57.0 62.2 98.2 60.5 133.6 12.6 45.3 59.7 89.5 53.2 88.1 13.2 17.5 57.2 63.6 AATF "BFR2, CHE-1, CHE1, DED" ENSG00000275700 "Apoptosis antagonizing transcription factor" Q9NY61 17 36948875-37056871 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Syncytiotrophoblasts: 137.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004940, HPA075963" Uncertain Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA004940: AB_1078075, HPA075963: " "unprognostic (1.10e-1)" "unprognostic (5.46e-3)" "unprognostic (1.30e-3)" "unprognostic (2.30e-3)" "unprognostic (5.54e-2)" "unprognostic (1.94e-2)" "prognostic unfavorable (6.62e-5)" "unprognostic (3.06e-2)" "unprognostic (4.10e-2)" "unprognostic (2.84e-1)" "unprognostic (2.48e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (4.14e-5)" "unprognostic (2.18e-2)" "unprognostic (1.51e-1)" "unprognostic (7.53e-3)" "unprognostic (3.21e-3)" 8.2 6.8 5.7 11.4 9.8 14.4 7.1 7.5 6.9 7.5 8.8 9.2 7.5 6.2 9.7 6.3 7.6 8.2 7.5 9.8 5.9 7.6 8.7 6.8 11.0 10.1 4.5 11.1 8.8 8.5 5.2 11.1 8.3 7.1 8.6 4.6 6.7 9.2 13.0 8.3 8.5 8.5 7.9 11.2 7.0 8.7 10.2 18.5 9.5 7.2 13.1 10.4 13.5 19.4 18.8 32.1 27.3 20.5 27.2 19.0 20.8 33.7 7.3 14.7 9.9 11.5 13.5 13.4 9.8 15.3 13.6 23.1 14.6 37.7 17.1 11.6 24.6 18.4 27.7 15.4 20.7 19.1 20.7 17.5 13.3 16.1 12.1 28.1 14.9 10.1 27.7 19.7 17.6 13.6 11.0 18.4 24.2 11.3 13.2 15.2 30.9 21.3 9.3 12.0 12.9 20.0 22.1 20.2 12.7 18.4 15.9 6.9 19.7 8.1 18.0 16.8 14.1 14.5 12.3 11.8 20.0 25.0 42.0 12.8 18.2 28.4 14.7 21.0 20.8 14.2 20.2 32.1 23.9 27.3 23.5 18.0 21.5 25.0 18.8 19.4 19.6 19.6 26.1 20.5 25.9 17.4 27.2 19.0 20.8 28.8 32.8 36.7 38.8 12.4 16.1 28.1 36.1 40.9 24.4 21.6 62.0 8.3 31.9 21.4 24.3 32.8 23.3 41.6 49.6 22.2 22.9 46.2 13.9 41.7 17.5 15.4 8.6 24.5 50.0 21.9 36.5 27.0 64.9 22.6 26.9 40.2 25.9 21.9 36.9 22.5 32.3 37.3 47.2 30.2 38.3 137.1 42.4 29.3 33.1 ABCA1 "ABC1, HDLDT1, TGD" ENSG00000165029 "ATP binding cassette subfamily A member 1" O95477 9 104781002-104928237 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport" Translocase "Atherosclerosis, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 98.3;Hepatocytes: 162.2;Kupffer cells: 103.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 11.6;neutrophil: 10.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 11.6" "Cell line enhanced" "Detected in many" "HSkMC: 17.0;U-87 MG: 39.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057283, CAB069889" Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB069889: AB_10002789, HPA057283: AB_2683396" "unprognostic (1.58e-2)" "unprognostic (2.54e-1)" "unprognostic (1.46e-1)" "unprognostic (2.80e-1)" "unprognostic (7.47e-3)" "unprognostic (1.85e-1)" "unprognostic (9.22e-2)" "unprognostic (9.80e-2)" "unprognostic (2.04e-1)" "unprognostic (7.28e-3)" "unprognostic (2.14e-1)" "unprognostic (4.78e-2)" "unprognostic (1.04e-2)" "unprognostic (2.00e-3)" "unprognostic (2.51e-2)" "unprognostic (6.71e-2)" "unprognostic (2.57e-1)" 25.7 38.1 6.3 9.8 13.1 15.8 23.0 2.3 8.5 8.2 14.8 8.0 6.5 4.4 7.8 9.6 7.0 7.9 13.6 10.7 7.5 3.7 7.1 33.3 12.7 29.4 18.9 2.3 8.7 5.4 1.8 3.3 20.1 10.2 9.4 9.4 7.7 6.3 8.7 21.3 12.1 8.1 25.2 16.1 12.8 7.3 8.8 8.0 16.9 5.8 2.2 5.0 16.4 20.0 1.8 0.2 11.6 1.5 0.1 0.6 0.1 0.0 2.7 2.2 0.0 6.5 2.5 2.0 2.8 10.9 0.9 1.0 0.4 0.4 3.8 3.1 2.8 10.7 0.0 1.2 0.1 0.8 0.0 0.0 0.4 0.9 9.5 11.8 0.0 6.7 17.0 0.7 11.1 0.2 10.6 1.0 0.3 0.0 9.8 0.2 0.3 2.3 5.2 3.1 0.5 0.8 0.0 0.0 0.2 1.8 1.8 0.3 0.1 2.9 0.5 0.6 4.5 0.0 1.9 1.0 3.0 0.2 3.9 3.1 3.8 1.8 2.3 39.0 0.0 0.0 2.2 0.8 11.6 0.2 1.0 0.2 1.2 0.3 0.0 0.2 1.8 0.6 0.0 10.6 0.1 1.5 0.1 0.1 0.1 6.3 13.1 2.3 4.0 7.5 3.7 18.9 2.3 10.2 8.0 98.3 9.4 5.1 4.8 26.4 11.9 7.8 12.7 2.7 9.1 10.4 45.2 21.2 0.0 3.8 1.5 9.3 3.2 0.0 1.4 4.6 28.8 3.1 46.1 162.2 63.2 0.0 8.7 25.2 103.3 0.7 28.7 31.4 25.3 2.8 2.4 0.1 4.9 3.5 26.5 17.0 5.5 45.3 16.4 1.2 0.7 16.9 7.4 4.4 2.3 8.9 ABCA3 "ABC-C, ABC3, EST111653, LBM180" ENSG00000167972 "ATP binding cassette subfamily A member 3" Q99758 16 2275881-2340746 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.8;lung: 75.8" "Cell type enriched" "Detected in many" 6 "Alveolar cells type 2: 382.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 15.1;HDLM-2: 15.2;SCLC-21H: 21.2;SH-SY5Y: 15.3;T-47d: 34.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007884 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA007884: AB_1078077" "unprognostic (2.64e-1)" "unprognostic (2.19e-2)" "unprognostic (6.09e-3)" "unprognostic (2.61e-3)" "unprognostic (2.20e-1)" "unprognostic (1.35e-1)" "unprognostic (2.90e-2)" "unprognostic (1.86e-1)" "unprognostic (6.58e-3)" "unprognostic (3.67e-2)" "unprognostic (1.71e-3)" "unprognostic (2.22e-2)" "unprognostic (5.33e-2)" "unprognostic (3.32e-2)" "unprognostic (7.85e-2)" "unprognostic (2.91e-1)" "unprognostic (1.30e-1)" 6.3 6.2 12.9 3.4 15.3 1.6 7.0 21.9 30.8 3.0 3.8 13.1 1.8 2.7 3.2 4.2 3.6 4.9 3.3 5.6 14.6 13.8 3.9 1.5 75.8 3.9 11.4 13.1 3.2 9.6 14.8 6.0 4.7 18.3 5.3 2.1 4.9 8.5 5.0 5.0 4.2 2.5 5.0 11.3 3.7 3.0 7.2 6.1 5.6 16.2 0.5 6.4 3.0 1.3 0.2 0.5 0.0 0.6 2.0 1.5 0.4 0.3 9.7 1.8 15.1 0.4 0.0 0.1 2.6 0.6 1.0 1.1 1.3 1.5 0.1 3.8 1.2 0.9 0.2 8.7 0.1 0.3 15.2 5.8 1.0 1.1 0.2 1.3 0.1 1.6 0.1 0.2 0.1 0.5 6.2 14.7 0.1 10.4 0.0 0.0 12.9 0.0 1.0 2.0 2.3 4.7 2.4 0.3 1.7 8.7 0.3 21.2 15.3 1.8 10.7 0.2 0.8 34.9 0.9 4.2 0.1 0.5 4.1 4.3 2.8 1.2 0.0 2.1 5.2 0.1 0.0 0.1 0.0 1.5 0.1 0.8 0.2 0.6 1.4 0.5 0.1 0.6 1.5 0.0 2.0 0.6 0.0 0.3 0.4 12.9 15.3 21.9 30.8 14.6 13.8 11.4 13.1 18.3 6.1 65.5 382.0 0.0 0.4 0.6 16.5 5.1 2.5 4.0 17.0 17.4 11.8 0.0 0.0 4.6 7.7 4.2 0.2 0.0 3.3 0.0 1.4 1.9 27.8 0.9 0.9 17.5 5.2 2.5 2.7 2.7 1.7 1.6 1.7 2.8 0.7 6.9 2.4 0.0 3.2 1.5 9.5 6.5 3.1 1.9 14.0 1.4 0.0 2.5 0.6 0.1 ABCA5 EST90625 ENSG00000154265 "ATP binding cassette subfamily A member 5" Q8WWZ7 17 69244311-69327244 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 52.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SiHa: 16.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022032, HPA062904" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA022032: AB_1844427, HPA062904: AB_2732692" "unprognostic (1.24e-2)" "unprognostic (1.49e-2)" "unprognostic (1.62e-3)" "unprognostic (7.17e-2)" "unprognostic (8.05e-4)" "unprognostic (3.05e-2)" "unprognostic (2.38e-2)" "unprognostic (2.32e-3)" "unprognostic (1.10e-1)" "unprognostic (1.52e-1)" "prognostic favorable (9.97e-5)" "unprognostic (3.60e-2)" "unprognostic (1.09e-3)" "unprognostic (1.07e-1)" "unprognostic (1.65e-1)" "unprognostic (2.55e-1)" "unprognostic (8.52e-2)" 10.5 8.6 6.7 3.8 9.8 6.0 12.7 35.6 12.4 8.8 9.6 4.3 13.5 9.7 6.0 7.7 8.6 6.6 4.6 5.2 5.3 6.2 7.9 21.7 4.9 3.3 4.1 7.9 6.9 20.3 13.0 35.9 5.3 13.6 7.4 10.6 15.5 8.2 11.4 52.8 24.0 15.5 3.4 7.6 4.3 8.9 9.0 3.9 1.7 7.9 10.3 5.9 5.5 8.1 4.2 3.9 4.5 0.7 3.0 4.2 1.2 4.2 2.0 1.6 2.5 7.9 5.7 0.5 4.5 4.9 4.7 7.0 0.6 1.6 0.0 2.4 3.9 3.7 6.4 1.0 3.7 5.3 0.1 3.0 0.0 4.8 3.0 10.5 0.0 2.7 5.6 4.6 2.0 5.4 1.0 10.2 1.6 0.0 1.7 0.4 3.7 2.6 0.0 1.6 1.6 3.0 0.3 0.1 0.4 0.9 7.2 8.9 1.4 16.1 7.4 4.6 1.5 7.6 2.7 7.4 5.3 1.5 4.9 0.9 9.2 0.2 0.3 2.2 0.0 4.8 0.7 0.7 4.5 3.1 0.2 4.2 2.4 4.0 3.4 0.5 4.2 2.1 3.4 1.9 3.0 0.1 3.9 2.4 1.2 6.7 9.8 35.6 12.4 5.3 6.2 4.1 7.9 13.6 3.9 17.9 16.9 10.2 30.0 58.2 127.4 22.1 28.1 49.5 14.8 36.6 110.0 11.6 5.0 9.2 14.9 17.1 72.6 0.0 8.6 4.9 18.8 32.6 13.9 89.4 6.2 100.1 108.2 18.4 4.8 9.5 59.0 8.9 96.2 47.7 65.8 49.9 12.8 38.6 43.2 10.2 117.6 90.5 24.0 103.0 47.0 46.9 19.8 13.8 26.6 34.4 ABCA6 EST155051 ENSG00000154262 "ATP binding cassette subfamily A member 6" Q8N139 17 69078702-69141888 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 53.9" "Group enriched" "Detected in many" 4 "Fibroblasts: 27.1;Hepatocytes: 95.4;Leydig cells: 47.5" "Cancer enriched" "Detected in some" 7 "liver cancer: 4.8" "Group enriched" "Detected in many" 5 "basal ganglia: 6.6;midbrain: 10.9;pons and medulla: 11.2;thalamus: 9.3" "Cell type enhanced" "Detected in some" "classical monocyte: 1.0;plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 20.7;ASC TERT1: 30.0;HSkMC: 13.1;HUVEC TERT2: 27.9;RT4: 7.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA064878, HPA067180" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA064878: AB_2685380, HPA067180: AB_2685797" "unprognostic (7.76e-2)" "unprognostic (6.80e-2)" "unprognostic (2.12e-1)" "unprognostic (8.01e-2)" "unprognostic (8.47e-2)" "unprognostic (9.82e-3)" "prognostic favorable (3.29e-4)" "unprognostic (1.35e-1)" "unprognostic (6.60e-2)" "unprognostic (3.00e-2)" "unprognostic (2.94e-1)" "unprognostic (1.02e-1)" "unprognostic (7.96e-4)" "unprognostic (1.61e-4)" "unprognostic (2.10e-2)" "unprognostic (3.03e-2)" "unprognostic (1.69e-1)" 31.4 4.3 1.4 2.0 6.6 0.4 12.1 0.7 1.9 12.3 9.9 4.7 2.9 1.8 7.9 6.9 10.5 4.9 7.2 13.2 1.5 0.9 3.0 53.9 9.3 3.6 10.9 0.2 22.0 1.9 1.1 6.0 1.8 11.2 8.0 3.4 4.2 7.1 1.9 6.6 5.0 3.9 9.8 21.0 1.8 4.4 5.0 9.3 0.0 6.7 6.6 2.5 16.6 11.7 0.0 1.2 0.0 1.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 20.7 30.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 13.1 0.0 1.6 0.4 0.8 27.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 1.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.2 1.2 0.0 0.3 1.4 6.6 0.7 1.9 1.5 0.9 10.9 0.2 11.2 9.3 0.0 0.0 2.7 0.9 2.7 13.9 4.8 0.0 0.0 1.2 3.5 5.9 0.0 0.0 0.2 2.9 2.2 0.5 0.0 0.2 0.0 27.1 0.1 0.0 95.4 1.2 0.0 2.4 2.5 1.8 2.2 47.5 2.8 5.0 1.0 0.1 3.9 0.5 0.0 11.3 0.6 13.8 0.0 1.7 0.9 1.0 2.5 0.0 0.0 0.0 0.3 ABCA8 KIAA0822 ENSG00000141338 "ATP binding cassette subfamily A member 8" O94911 17 68867292-68955392 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Leydig cells: 465.4;Muller glia cells: 138.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC diff: 16.6;ASC TERT1: 37.0;HSkMC: 27.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044914 Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044914: AB_10964859" "unprognostic (2.58e-2)" "unprognostic (2.76e-2)" "unprognostic (1.89e-1)" "unprognostic (1.65e-1)" "unprognostic (3.04e-1)" "unprognostic (6.84e-2)" "unprognostic (1.47e-2)" "unprognostic (1.33e-2)" "unprognostic (1.19e-1)" "unprognostic (5.22e-2)" "unprognostic (6.68e-2)" "unprognostic (8.76e-2)" "unprognostic (1.42e-3)" "unprognostic (3.52e-3)" "unprognostic (1.88e-1)" "unprognostic (3.29e-1)" "unprognostic (6.14e-3)" 29.1 25.2 10.0 3.4 27.2 0.5 15.1 3.2 15.4 7.3 12.8 29.9 3.9 5.4 10.2 13.0 12.4 17.6 14.3 30.0 12.5 5.5 8.1 26.6 15.2 1.3 37.8 9.2 44.7 5.1 4.5 14.8 7.6 22.2 10.3 14.3 16.4 9.8 7.9 8.9 4.9 9.9 7.1 28.2 9.9 11.5 15.8 42.7 0.0 13.0 14.2 2.8 13.6 20.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 16.6 37.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 6.1 0.0 0.0 27.9 0.0 0.4 0.0 0.2 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 10.0 27.2 3.2 15.4 12.5 5.5 37.8 9.2 22.2 42.7 47.6 0.6 0.0 1.3 5.4 1.4 12.5 0.0 0.0 7.9 0.0 2.0 0.1 0.0 0.0 4.2 4.2 0.0 0.0 0.0 0.1 35.3 0.3 1.1 35.8 0.9 4.8 0.0 7.4 1.9 4.3 465.4 1.8 1.7 0.0 0.0 138.5 0.0 0.0 66.1 0.0 2.1 38.8 6.2 1.1 1.2 4.1 0.2 0.0 0.0 0.2 ABCB1 "ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1" ENSG00000085563 "ATP binding cassette subfamily B member 1" P08183 7 87503633-87713323 "Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Translocase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 57.8;intestine: 49.6" "Cell type enhanced" "Detected in many" 13 "Cholangiocytes: 104.4;Enterocytes: 174.5;Paneth cells: 77.2" "Cancer enhanced" "Detected in many" "renal cancer: 14.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 19.2" "Group enriched" "Detected in many" 8 "NK-cells: 11.4;T-cells: 19.2" "Cell line enhanced" "Detected in some" "CACO-2: 30.1;HEK 293: 9.3;HEL: 16.7;Hep G2: 8.2;RPTEC TERT1: 11.5;SH-SY5Y: 36.8" "CAB001716, HPA002199, HPA074614" Enhanced Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA "Nucleoplasm, Plasma membrane" "Focal adhesion sites" "CAB001716: , HPA002199: AB_1844428, HPA074614: " "unprognostic (5.38e-3)" "unprognostic (2.45e-2)" "unprognostic (1.42e-1)" "unprognostic (1.06e-1)" "unprognostic (2.25e-2)" "unprognostic (9.99e-5)" "unprognostic (2.23e-3)" "unprognostic (5.65e-3)" "unprognostic (1.14e-1)" "unprognostic (5.17e-2)" "prognostic favorable (3.33e-4)" "unprognostic (5.19e-1)" "prognostic favorable (2.95e-4)" "unprognostic (2.06e-1)" "unprognostic (1.50e-1)" "unprognostic (3.83e-1)" "unprognostic (6.12e-2)" 2.6 57.8 9.4 3.2 11.5 1.2 3.4 5.1 10.5 5.5 22.7 3.8 2.0 14.4 9.4 3.5 2.0 3.2 9.0 1.8 9.2 6.6 19.1 15.6 3.8 2.2 9.4 5.7 2.2 1.5 1.7 1.3 3.1 11.1 2.7 10.7 7.6 1.5 2.1 1.1 1.3 49.6 5.7 9.0 2.4 1.7 1.3 8.6 0.1 2.4 1.4 2.2 2.6 5.9 1.9 0.0 0.1 0.0 11.4 19.2 1.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 9.3 16.7 1.9 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 11.5 0.1 0.4 36.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.4 3.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 7.8 0.0 19.2 0.4 2.0 4.7 0.0 1.9 1.2 4.8 0.1 11.4 0.0 0.0 0.0 1.5 9.4 11.5 5.1 10.5 9.2 6.6 9.4 5.7 11.1 8.6 0.0 4.8 5.9 0.1 0.7 0.6 2.8 104.4 1.4 1.2 47.1 0.0 5.0 5.0 10.2 21.6 23.1 174.5 23.3 1.6 0.1 0.5 0.1 3.5 32.6 0.4 0.0 0.0 3.7 1.2 2.5 0.9 0.8 0.0 0.0 8.9 0.0 11.4 77.2 0.0 44.0 0.9 0.0 0.8 0.5 0.4 0.5 8.2 27.3 1.7 0.1 ABCB11 "ABC16, BSEP, PFIC-2, PFIC2, PGY4, SPGP" ENSG00000073734 "ATP binding cassette subfamily B member 11" O95342 2 168922938-169031322 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport Translocase "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "liver: 47.4" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 1: 38.7;Alveolar cells type 2: 58.1;Club cells: 35.2;granulocytes: 22.1;Hepatocytes: 17.9" "Cancer enriched" "Detected in single" 87 "liver cancer: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 1.0;NB-4: 1.7;PC-3: 1.0;THP-1: 2.6;TIME: 1.8;U-2197: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA019035 Enhanced Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA019035: AB_1844429" "unprognostic (7.78e-2)" "unprognostic (3.92e-1)" "unprognostic (8.31e-2)" "unprognostic (2.56e-1)" "unprognostic (1.13e-1)" "unprognostic (5.10e-2)" "unprognostic (1.00e-2)" "unprognostic (9.71e-2)" "unprognostic (1.18e-1)" "unprognostic (1.72e-2)" "unprognostic (5.64e-3)" "unprognostic (3.71e-1)" "unprognostic (5.26e-6)" "unprognostic (7.12e-2)" "unprognostic (1.82e-1)" "unprognostic (1.94e-1)" 1.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.0 0.0 0.4 0.0 0.0 0.0 0.0 1.7 0.1 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.8 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 38.7 58.1 0.0 0.0 0.0 0.0 0.3 0.0 16.0 35.2 0.0 0.0 0.0 0.0 0.1 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.1 17.9 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.7 ABCB4 "GBD1, MDR2, MDR3, PFIC-3, PGY3" ENSG00000005471 "ATP binding cassette subfamily B member 4" P21439 7 87401697-87480435 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 93.2" "Cell type enriched" "Detected in some" 6 "Hepatocytes: 235.3" "Cancer enriched" "Detected in some" 11 "liver cancer: 16.3" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 6 "memory B-cell: 4.9;naive B-cell: 11.4" "Lineage enriched" "Detected in many" 8 "B-cells: 11.4" "Group enriched" "Detected in some" 5 "SH-SY5Y: 12.0;WM-115: 22.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA049395, HPA053288" Enhanced Approved "Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites" NA NA "Nucleoplasm, Plasma membrane, Actin filaments" "Focal adhesion sites" "HPA049395: AB_2680745, HPA053288: AB_2682102" "unprognostic (7.92e-2)" "unprognostic (8.87e-2)" "unprognostic (1.97e-1)" "unprognostic (1.90e-1)" "unprognostic (8.95e-2)" "unprognostic (1.06e-2)" "unprognostic (2.35e-3)" "unprognostic (9.91e-2)" "unprognostic (3.53e-1)" "unprognostic (1.19e-1)" "unprognostic (2.44e-3)" "unprognostic (8.43e-2)" "unprognostic (2.83e-2)" "unprognostic (8.01e-3)" "unprognostic (7.12e-2)" "unprognostic (2.11e-2)" "unprognostic (2.47e-1)" 0.5 4.1 0.2 4.3 0.2 0.2 0.3 0.1 1.1 0.2 0.6 0.4 0.0 0.0 0.1 0.2 0.6 0.1 0.3 4.0 0.3 0.2 0.4 93.2 0.1 4.1 0.3 0.2 0.3 0.1 0.0 0.5 0.0 0.3 0.3 0.4 0.8 0.4 0.1 2.9 0.6 1.2 1.6 0.5 5.2 0.2 0.5 0.4 0.1 0.4 4.2 3.2 0.6 0.5 11.4 1.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.3 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 12.0 0.0 0.6 2.2 0.5 0.2 0.5 0.0 0.2 1.6 0.1 0.0 0.0 0.0 2.8 0.2 0.0 22.9 0.0 0.0 0.0 0.0 0.0 0.1 4.9 0.0 0.1 1.4 11.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.2 0.1 1.1 0.3 0.2 0.3 0.2 0.3 0.4 0.0 0.3 23.1 0.0 0.9 0.0 9.3 0.0 0.0 0.0 1.8 0.0 0.9 0.0 0.1 0.6 0.8 0.1 0.0 0.0 0.2 1.5 0.0 0.0 235.3 0.5 36.5 0.0 5.5 5.4 0.2 0.0 0.0 10.1 0.0 0.0 0.0 0.1 0.0 0.4 0.5 0.0 0.0 0.9 0.5 0.1 0.4 0.1 0.0 0.0 0.0 ABCB6 "EST45597, MTABC3, umat" ENSG00000115657 "ATP binding cassette subfamily B member 6 (Langereis blood group)" Q9NP58 2 219209766-219219017 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation, Dyskeratosis congenita, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 4.0;Club cells: 2.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 27.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046723, HPA058011" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane,Mitochondria,Cytosol" NA NA 22000 "Golgi apparatus" "Nucleoplasm, Plasma membrane, Mitochondria, Cytosol" "HPA046723: AB_10960288, HPA058011: AB_2683578" "unprognostic (8.04e-2)" "unprognostic (3.22e-2)" "unprognostic (4.53e-3)" "unprognostic (3.19e-2)" "unprognostic (2.55e-1)" "unprognostic (9.11e-2)" "prognostic unfavorable (9.45e-7)" "unprognostic (2.26e-1)" "unprognostic (3.62e-2)" "unprognostic (1.53e-1)" "unprognostic (1.18e-4)" "unprognostic (3.02e-3)" "prognostic unfavorable (1.52e-7)" "unprognostic (1.51e-1)" "unprognostic (9.55e-2)" "unprognostic (7.75e-2)" "unprognostic (2.30e-1)" 10.1 8.4 8.2 3.9 13.5 10.2 9.2 7.6 9.1 6.9 7.6 5.4 8.3 8.1 7.1 10.1 9.0 8.4 8.5 9.5 5.6 8.2 6.9 16.2 7.2 4.9 9.8 7.6 13.1 7.1 8.0 6.0 3.7 9.2 9.2 4.2 6.0 5.6 11.3 24.0 5.5 8.0 9.5 9.2 3.2 6.8 19.5 7.7 0.8 9.9 11.3 4.7 14.8 6.0 2.8 5.6 1.3 1.1 1.2 3.2 2.4 0.1 9.9 2.0 12.5 14.0 5.0 12.3 3.7 3.4 4.1 4.1 15.2 2.1 0.1 19.1 3.6 2.2 21.4 0.2 1.5 1.3 6.3 2.2 15.5 10.9 27.9 16.9 0.0 5.2 7.3 1.8 2.7 0.0 6.1 7.1 2.1 13.1 1.9 2.7 5.1 1.0 0.1 3.1 23.0 4.1 5.2 6.3 0.6 2.2 0.2 7.4 7.9 7.7 18.3 8.1 8.0 5.5 0.3 3.2 5.5 0.2 7.4 4.3 5.0 4.0 0.0 6.2 0.1 7.3 1.3 1.1 0.0 1.7 0.9 0.5 2.8 1.3 0.7 0.9 2.3 3.2 2.1 0.0 1.2 0.8 5.6 1.1 2.4 8.2 13.5 7.6 9.1 5.6 8.2 9.8 7.6 9.2 7.7 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 4.0 2.3 0.0 0.0 0.2 0.0 0.6 1.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.5 0.3 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.4 0.0 0.7 0.0 0.2 0.9 0.2 0.3 0.2 0.0 0.0 0.0 ABCB8 "EST328128, M-ABC1, MABC1" ENSG00000197150 "ATP binding cassette subfamily B member 8" Q9NUT2 7 151028422-151047782 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 68.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045187 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA045187: AB_10964281" "unprognostic (5.29e-2)" "unprognostic (9.17e-3)" "unprognostic (8.28e-2)" "unprognostic (8.32e-2)" "unprognostic (8.63e-3)" "prognostic favorable (5.91e-4)" "unprognostic (4.76e-2)" "unprognostic (3.75e-1)" "unprognostic (1.55e-1)" "unprognostic (2.43e-2)" "prognostic favorable (3.34e-4)" "unprognostic (2.26e-1)" "prognostic favorable (5.88e-4)" "unprognostic (7.52e-3)" "unprognostic (1.76e-1)" "unprognostic (1.64e-2)" "unprognostic (1.23e-1)" 12.6 22.8 14.4 13.8 22.0 12.2 8.5 24.9 24.8 16.3 12.3 22.2 10.4 19.3 16.5 14.9 17.6 12.9 11.5 13.0 14.5 12.8 14.5 33.5 11.7 13.3 19.1 17.9 13.3 12.6 15.4 20.1 23.6 15.9 12.3 9.5 12.5 11.1 12.8 11.2 13.7 14.7 12.7 13.3 11.5 13.1 13.6 19.5 14.0 18.4 11.7 10.6 9.6 10.4 4.4 10.4 10.3 6.7 4.0 7.5 3.6 12.5 19.8 5.1 16.1 8.1 4.7 10.2 6.6 6.9 10.6 11.2 7.9 21.1 6.6 8.9 7.0 12.8 13.3 7.4 13.8 4.7 8.2 8.1 5.2 7.9 9.4 5.3 4.0 13.1 8.1 10.5 12.6 5.2 3.9 10.6 14.7 27.4 9.1 7.9 28.1 15.3 7.6 3.4 9.5 22.6 7.3 3.2 23.5 7.1 5.4 4.9 9.9 7.1 20.2 6.4 4.1 8.0 5.3 6.5 9.9 2.6 7.1 9.9 9.2 4.6 4.7 14.0 9.7 10.1 10.3 4.5 3.4 7.5 6.7 5.2 4.4 5.3 6.1 6.3 3.5 4.9 6.9 1.1 4.0 4.7 10.4 5.6 3.6 14.4 22.0 24.9 24.8 14.5 12.8 19.1 17.9 15.9 19.5 11.9 0.6 11.7 5.2 3.3 22.7 6.7 12.7 1.4 1.2 10.4 35.3 32.5 3.3 13.7 1.8 3.4 24.1 0.0 17.6 18.5 6.5 7.1 50.6 21.2 25.1 28.6 0.0 5.5 8.1 1.9 6.1 5.9 8.5 11.8 8.7 11.2 17.7 7.8 11.7 12.8 32.9 25.8 5.9 8.8 15.4 6.5 68.4 7.5 10.6 5.1 ABCC5 "EST277145, MOAT-C, MRP5, SMRP" ENSG00000114770 "ATP binding cassette subfamily C member 5" O15440 3 183919934-184018015 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 184.6;Rod photoreceptor cells: 122.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 48.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044067, HPA052295" Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "HPA044067: AB_2678797, HPA052295: AB_2681789" "unprognostic (9.39e-2)" "unprognostic (6.23e-3)" "unprognostic (3.83e-2)" "unprognostic (1.10e-3)" "unprognostic (2.28e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (6.78e-8)" "unprognostic (4.46e-2)" "unprognostic (6.07e-3)" "unprognostic (1.02e-1)" "unprognostic (5.91e-3)" "prognostic unfavorable (3.40e-4)" "unprognostic (1.10e-1)" "unprognostic (9.05e-3)" "unprognostic (1.64e-1)" "unprognostic (3.33e-2)" "unprognostic (1.24e-2)" 7.9 11.2 24.7 9.6 26.2 12.0 6.7 42.8 28.6 7.7 11.4 12.0 13.4 6.8 14.1 7.0 17.1 6.1 11.6 16.0 19.1 13.7 12.8 3.6 9.4 7.3 20.5 18.5 11.8 4.9 22.4 20.5 10.8 21.7 10.6 14.4 31.1 7.4 9.3 41.0 14.5 8.5 10.5 12.9 16.3 48.5 9.4 20.9 9.3 5.5 7.3 7.4 18.1 12.7 4.2 3.5 15.8 4.5 5.0 7.0 4.5 7.3 4.1 9.4 11.2 9.4 10.7 14.6 6.0 4.7 5.4 5.9 6.3 5.7 8.0 14.1 5.7 8.2 29.9 11.6 6.6 7.1 8.7 11.2 16.9 10.3 5.7 3.9 5.1 13.2 17.0 6.7 5.8 3.8 11.1 6.3 23.7 15.7 11.1 9.2 19.5 14.1 5.9 9.7 13.4 7.9 9.8 3.1 4.7 19.6 48.0 17.2 10.2 6.1 33.9 10.1 12.7 20.5 1.6 7.2 6.3 6.2 8.0 8.2 4.3 8.3 7.4 4.6 10.3 6.4 10.7 4.5 7.7 7.0 2.1 4.5 3.2 4.0 3.1 3.5 4.2 4.6 6.3 15.8 5.0 3.5 1.3 5.0 4.5 24.7 26.2 42.8 28.6 19.1 13.7 20.5 18.5 21.7 20.9 8.9 4.0 1.9 12.9 7.9 34.3 31.9 2.5 56.2 46.6 41.8 184.6 2.7 6.6 5.0 4.8 6.7 9.5 0.0 4.0 3.9 8.0 10.9 4.7 2.4 39.9 31.8 56.9 5.5 27.9 2.2 7.5 11.2 11.8 6.4 6.3 9.4 6.1 9.3 7.4 2.7 122.3 0.0 8.6 3.1 14.7 10.7 3.8 5.0 7.2 50.3 ABCC6 "ARA, EST349056, MLP1, MRP6, PXE, URG7" ENSG00000091262 "ATP binding cassette subfamily C member 6" O95255 16 16148928-16223522 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Transport, Vision" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 27.4" "Cell type enhanced" "Detected in many" 14 "Distal tubular cells: 38.1;Hepatocytes: 56.7;Proximal tubular cells: 117.8" "Cancer enhanced" "Detected in many" "liver cancer: 16.7" "Cell type enriched" "Detected in some" 5 "classical monocyte: 7.3" "Lineage enriched" "Detected in many" 5 "monocytes: 7.3" "Cell line enriched" "Detected in some" 8 "Hep G2: 38.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA038105 Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA038105: AB_2675835" "unprognostic (1.32e-1)" "unprognostic (1.11e-1)" "unprognostic (5.98e-2)" "unprognostic (3.15e-2)" "unprognostic (1.59e-1)" "unprognostic (3.09e-1)" "prognostic favorable (3.82e-4)" "unprognostic (6.54e-3)" "unprognostic (3.64e-1)" "unprognostic (9.10e-2)" "unprognostic (1.30e-1)" "unprognostic (1.65e-1)" "unprognostic (1.12e-3)" "unprognostic (3.42e-1)" "unprognostic (2.00e-1)" "unprognostic (4.91e-2)" "unprognostic (1.41e-1)" 2.3 1.4 0.2 0.0 0.2 0.0 1.1 0.0 0.0 0.1 1.5 7.0 0.0 0.0 0.0 0.3 1.2 0.8 0.1 0.1 9.0 27.4 2.8 0.0 0.2 0.1 6.7 0.5 0.1 0.0 0.7 1.2 6.7 0.2 1.7 0.0 3.7 0.0 0.2 0.1 2.2 0.0 2.2 0.0 0.0 0.0 0.2 0.9 1.3 7.3 0.6 0.1 1.2 0.0 0.9 0.4 0.0 0.0 0.5 1.1 0.0 0.2 0.6 0.9 3.8 1.5 0.0 0.5 0.0 0.1 0.0 0.4 0.0 0.3 0.0 0.4 1.1 0.1 38.6 0.2 0.0 0.2 1.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.2 0.4 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.6 0.1 0.5 0.1 0.2 4.9 3.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 7.3 0.3 0.0 1.0 0.0 0.0 0.1 0.0 0.9 0.2 0.1 0.1 1.3 0.6 0.1 0.1 0.0 1.2 26.8 26.9 3.6 0.7 0.1 0.3 2.4 20.4 18.7 9.1 8.7 0.0 0.0 38.1 1.6 0.2 0.6 19.1 0.0 7.1 0.0 1.0 1.6 1.1 56.7 1.1 0.0 2.9 1.8 4.1 0.4 1.4 1.5 1.7 1.0 13.4 1.3 2.9 3.5 5.3 117.8 0.7 0.0 0.5 0.1 0.2 0.6 0.0 0.0 13.3 0.4 ABCC9 "CMD1O, SUR2" ENSG00000069431 "ATP binding cassette subfamily C member 9" O60706 12 21797401-21942529 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" Transport Receptor "Atrial fibrillation, Cardiomyopathy, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 2: 47.6;Hepatocytes: 84.7;Sertoli cells: 129.4;Smooth muscle cells: 47.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 17.6;BJ hTERT+: 10.1;CACO-2: 16.0;HSkMC: 21.0;U-138 MG: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007279 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA007279: AB_1844435" "unprognostic (4.82e-2)" "unprognostic (3.62e-2)" "unprognostic (5.51e-4)" "unprognostic (1.09e-1)" "unprognostic (1.09e-1)" "unprognostic (8.30e-2)" "unprognostic (3.17e-2)" "unprognostic (1.50e-2)" "unprognostic (2.47e-2)" "unprognostic (8.72e-2)" "unprognostic (2.51e-2)" "unprognostic (3.57e-1)" "prognostic unfavorable (1.85e-5)" "unprognostic (2.66e-2)" "unprognostic (1.21e-2)" "unprognostic (3.10e-3)" "unprognostic (8.22e-5)" 21.6 4.7 5.5 2.6 5.4 1.2 25.8 1.5 8.6 12.4 6.8 4.8 5.1 3.0 15.3 6.3 9.1 9.5 9.6 26.2 5.7 2.6 5.6 31.1 6.2 2.7 2.9 4.2 11.8 5.8 1.7 2.7 2.8 5.5 7.0 1.6 10.8 4.8 8.4 33.2 3.3 4.1 17.1 4.9 3.5 9.1 3.4 4.2 0.1 6.3 14.5 1.2 9.5 8.4 1.6 0.9 1.8 0.8 0.5 0.9 0.0 0.6 0.1 7.5 0.2 17.6 8.0 0.2 4.1 10.1 4.5 2.3 16.0 0.7 0.3 0.8 0.4 0.5 0.2 0.0 0.0 4.7 0.2 0.1 0.3 0.5 0.2 0.0 0.3 0.4 21.0 0.0 4.5 1.7 0.3 0.0 0.3 0.2 0.9 0.2 0.9 0.2 0.2 1.0 0.8 0.4 0.3 0.2 0.2 0.0 0.8 0.3 1.2 0.2 0.4 0.1 1.2 0.8 0.2 0.2 17.5 1.3 1.5 5.3 0.8 0.8 0.3 4.3 0.2 0.3 0.9 0.5 0.4 0.9 0.4 0.6 0.7 0.7 0.7 0.2 1.6 0.6 0.8 1.8 0.5 0.8 0.9 0.4 0.0 5.5 5.4 1.5 8.6 5.7 2.6 2.9 4.2 5.5 4.2 32.8 47.6 0.0 1.0 3.1 0.4 27.8 0.0 36.1 39.8 0.0 0.0 0.2 0.0 0.0 0.2 4.9 0.0 0.0 0.2 0.1 10.6 0.4 22.1 84.7 0.1 1.6 0.0 11.1 3.3 0.0 0.3 2.1 10.1 0.0 0.0 13.1 0.1 0.0 0.4 0.0 1.1 129.4 47.2 0.5 0.7 1.9 0.2 0.0 0.0 1.4 ABCG2 "ABCP, BCRP, CD338, EST157481, MXR" ENSG00000118777 "ATP binding cassette subfamily G member 2 (Junior blood group)" Q9UNQ0 4 88090264-88231322 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" Transport Translocase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 49.6;intestine: 56.6;seminal vesicle: 61.0" "Cell type enhanced" "Detected in many" 15 "Enterocytes: 135.7;Extravillous trophoblasts: 47.1;Hofbauer cells: 105.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 5.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 18.8;BEWO: 32.9;OE19: 25.5;RPMI-8226: 16.5;SuSa: 12.7" "CAB037299, HPA054719" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB037299: AB_476804, HPA054719: " "unprognostic (5.04e-1)" "unprognostic (3.05e-2)" "unprognostic (2.01e-1)" "unprognostic (1.10e-1)" "unprognostic (1.01e-3)" "unprognostic (9.19e-2)" "unprognostic (1.09e-1)" "unprognostic (1.30e-1)" "unprognostic (9.14e-2)" "unprognostic (1.37e-1)" "unprognostic (3.01e-3)" "unprognostic (4.52e-2)" "unprognostic (1.67e-3)" "unprognostic (8.82e-3)" "unprognostic (7.04e-2)" "unprognostic (1.30e-1)" "unprognostic (1.92e-1)" 2.8 2.5 11.6 0.8 14.8 1.2 2.4 4.3 9.7 13.6 12.5 8.4 49.6 24.9 14.4 4.2 1.5 6.1 3.3 2.0 16.0 12.2 2.3 19.7 3.0 0.8 17.6 5.6 5.6 0.6 3.2 7.0 12.3 17.0 5.5 8.1 6.9 2.9 61.0 0.4 0.6 56.6 11.8 15.7 0.9 1.2 1.9 5.5 0.0 3.8 0.8 1.3 2.0 3.1 1.2 0.5 0.0 0.2 2.4 5.7 0.7 0.6 18.8 5.6 0.0 0.2 0.0 32.9 0.7 0.6 1.0 1.6 4.1 0.2 0.0 0.2 0.1 2.4 5.5 0.1 0.5 1.4 5.3 0.8 0.2 0.1 5.6 0.0 0.2 0.0 0.1 2.3 2.2 0.1 0.5 1.7 0.4 0.4 0.0 0.6 10.9 2.6 0.0 1.9 25.5 0.0 1.2 0.0 16.5 0.0 4.0 0.0 0.2 3.9 0.4 0.5 12.7 0.1 0.0 0.0 0.7 0.7 0.2 0.0 5.2 1.9 0.0 1.4 0.0 0.8 0.0 0.0 0.0 1.9 0.0 5.7 0.1 0.7 0.6 0.0 1.2 0.7 0.3 0.0 2.4 0.2 0.5 1.7 0.7 11.6 14.8 4.3 9.7 16.0 12.2 17.6 5.6 17.0 5.5 3.0 1.4 0.5 0.2 3.4 0.0 1.1 0.0 1.4 0.0 0.0 0.0 14.3 1.7 0.0 2.6 9.0 135.7 0.0 0.2 47.1 2.1 0.2 5.7 25.0 105.8 0.0 2.9 13.5 1.0 0.4 1.1 1.1 5.0 0.0 2.9 0.9 0.1 35.1 0.4 4.5 0.2 0.0 1.4 0.9 3.4 0.4 31.5 0.8 0.8 0.1 ABHD12B "BEM46L3, C14orf29" ENSG00000131969 "Abhydrolase domain containing 12B" Q7Z5M8 14 50872160-50904970 "Predicted intracellular proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 10.0;retina: 10.0;skin 1: 21.6" "Cell type enriched" "Detected in some" 8 "Muller glia cells: 136.7" "Cancer enriched" "Detected in many" 5 "testis cancer: 7.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 2.3;neutrophil: 5.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 5.4" "Cell line enhanced" "Detected in some" "HEK 293: 1.3;Hep G2: 1.4;NB-4: 2.4;NTERA-2: 1.6;RH-30: 2.0;SH-SY5Y: 1.3;SuSa: 2.9;T-47d: 1.3;THP-1: 1.9" "Region enriched" "Detected in single" 5 "thalamus: 2.3" "Low region specificity" "Detected in many" HPA002873 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA002873: AB_2220573" "unprognostic (6.61e-2)" "unprognostic (3.49e-2)" "unprognostic (2.92e-3)" "unprognostic (1.99e-3)" "unprognostic (4.63e-2)" "unprognostic (1.17e-2)" "unprognostic (1.62e-2)" "unprognostic (2.09e-1)" "unprognostic (4.31e-2)" "unprognostic (6.27e-2)" "unprognostic (3.30e-1)" "unprognostic (3.35e-1)" "unprognostic (1.70e-3)" "unprognostic (3.16e-2)" "unprognostic (9.62e-2)" "unprognostic (3.18e-3)" "unprognostic (1.68e-1)" 1.1 0.2 2.4 0.4 10.0 2.4 2.8 0.3 5.2 0.2 1.5 5.4 0.3 0.2 0.8 0.4 0.7 2.0 0.4 0.5 1.4 1.2 0.6 0.2 0.8 0.4 2.2 2.7 0.3 1.1 1.3 0.3 0.4 2.2 0.3 2.4 10.0 0.2 0.2 0.2 21.6 0.3 0.2 0.7 0.2 0.2 1.2 3.9 0.0 0.4 0.0 0.3 0.2 0.2 0.0 0.1 5.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.4 0.5 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 1.6 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 2.9 1.3 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.9 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.4 0.0 0.1 0.0 0.0 0.0 2.4 10.0 0.3 5.2 1.4 1.2 2.2 2.7 2.2 3.9 0.0 0.0 0.0 0.0 0.3 3.3 1.4 0.0 14.7 0.0 1.8 2.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 2.8 1.1 0.0 0.0 0.0 0.9 136.7 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.2 0.2 1.3 0.2 0.0 1.6 0.1 ABHD14B "CIB, MGC15429" ENSG00000114779 "Abhydrolase domain containing 14B" Q96IU4 3 51968510-51983409 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Proximal tubular cells: 216.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 52.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036444, HPA036642" Supported Approved Nucleoplasm,Nucleoli,Cytosol NA NA 2600000 Nucleoli "Nucleoplasm, Cytosol" "HPA036444: AB_10672221, HPA036642: AB_10672225" "unprognostic (8.97e-2)" "prognostic favorable (6.92e-5)" "unprognostic (1.84e-1)" "prognostic favorable (5.42e-5)" "unprognostic (1.07e-1)" "unprognostic (2.21e-2)" "unprognostic (2.06e-3)" "unprognostic (1.35e-3)" "unprognostic (3.95e-1)" "unprognostic (1.80e-1)" "unprognostic (1.20e-1)" "unprognostic (2.95e-2)" "prognostic favorable (2.93e-5)" "unprognostic (1.16e-1)" "unprognostic (3.55e-1)" "unprognostic (9.70e-2)" "unprognostic (3.70e-2)" 40.0 34.2 6.2 19.8 7.5 11.4 25.2 10.7 7.0 21.9 33.6 8.6 32.1 30.3 19.6 21.7 27.7 22.0 32.9 12.2 6.2 5.8 42.6 78.4 21.5 35.1 7.8 7.3 29.5 45.0 14.2 15.2 11.4 6.7 30.9 20.2 29.1 39.4 35.0 11.7 16.0 58.7 22.6 8.9 23.3 18.7 11.2 6.2 26.0 35.3 15.2 32.5 24.6 16.9 24.9 15.5 12.5 9.4 9.9 27.2 14.0 10.3 8.8 0.7 10.4 28.8 25.7 2.7 4.1 4.8 7.6 8.9 6.5 20.5 11.6 3.3 14.3 3.5 5.2 6.4 5.9 5.8 15.8 6.9 18.3 7.7 25.5 15.5 10.2 18.9 33.2 20.4 7.7 10.5 11.7 9.2 17.7 10.6 18.6 14.7 10.1 4.5 7.8 1.0 11.3 22.6 11.6 1.4 52.4 13.8 4.2 4.4 4.7 10.4 19.4 33.0 1.6 27.9 7.0 8.7 4.0 19.1 9.1 2.4 23.7 11.1 4.8 8.8 32.8 7.0 12.5 9.4 4.2 18.3 7.6 27.2 24.9 23.0 22.4 15.5 18.7 23.4 21.3 0.8 9.9 4.8 11.3 16.3 14.0 6.2 7.5 10.7 7.0 6.2 5.8 7.8 7.3 6.7 6.2 6.0 25.8 75.9 43.7 26.9 12.4 3.2 56.0 24.1 9.1 66.3 13.7 13.4 124.3 28.2 1.4 33.6 100.6 0.0 40.7 15.9 35.2 36.3 50.7 104.1 49.3 7.9 72.9 30.7 50.2 0.5 60.1 36.2 52.3 32.5 83.5 7.7 25.4 66.2 43.9 216.2 37.1 38.8 41.0 0.5 3.4 26.6 9.8 59.8 107.0 52.8 ABHD15 ENSG00000168792 "Abhydrolase domain containing 15" Q6UXT9 17 29560547-29567137 "Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 25.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 11.1;MAIT T-cell: 5.0;NK-cell: 7.2;plasmacytoid DC: 17.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA014470 Approved Approved Nucleoplasm,Cytosol "Secreted in other tissues" NA NA "Nucleoplasm, Cytosol" "HPA014470: AB_1852993" "unprognostic (1.79e-1)" "unprognostic (4.00e-2)" "unprognostic (1.38e-1)" "unprognostic (8.60e-3)" "unprognostic (1.91e-1)" "unprognostic (1.62e-1)" "unprognostic (4.61e-1)" "unprognostic (1.87e-1)" "unprognostic (1.85e-1)" "unprognostic (9.76e-2)" "unprognostic (1.76e-3)" "unprognostic (3.00e-2)" "unprognostic (3.58e-2)" "unprognostic (1.70e-1)" "unprognostic (1.71e-1)" "unprognostic (3.46e-1)" "unprognostic (5.45e-2)" 22.6 3.5 4.9 6.0 3.2 5.4 21.6 2.9 4.1 3.8 8.8 4.2 4.4 8.5 4.2 3.1 4.1 4.3 7.8 6.6 2.1 1.9 8.4 21.2 5.6 12.7 2.7 3.9 2.8 10.9 8.8 8.5 3.2 4.3 4.0 5.0 3.6 4.5 4.6 2.1 3.4 12.7 5.5 3.3 9.1 6.3 1.4 4.6 1.6 5.2 2.7 6.0 5.6 9.1 2.0 17.0 11.1 0.4 7.2 5.0 0.7 3.8 15.0 1.9 5.3 20.6 9.0 7.9 5.3 5.9 5.3 4.9 3.4 2.0 5.7 3.9 5.7 9.4 10.6 6.6 2.3 2.9 17.7 5.0 2.3 7.4 4.3 6.3 5.9 10.7 6.7 6.2 5.1 0.9 3.9 3.8 3.4 3.0 5.5 2.8 5.2 5.6 6.9 0.4 13.0 4.5 13.1 7.3 13.2 9.5 5.9 1.3 2.2 8.0 3.6 2.0 2.1 9.1 13.7 4.7 3.1 3.9 7.7 4.6 9.3 6.2 3.0 6.1 3.7 6.5 11.1 0.4 1.8 1.9 0.2 5.0 1.0 1.0 1.7 1.0 2.0 0.3 1.0 0.5 7.2 0.2 17.0 0.9 0.7 4.9 3.2 2.9 4.1 2.1 1.9 2.7 3.9 4.3 4.6 3.0 5.5 5.6 1.1 1.1 0.0 2.0 5.1 5.3 4.5 7.0 0.0 0.9 0.0 2.8 0.2 1.4 8.3 0.0 6.6 1.0 3.8 1.2 2.3 25.3 6.6 1.6 6.9 3.7 6.7 0.2 4.4 8.2 5.0 3.6 6.3 0.9 4.8 0.0 4.2 5.4 0.7 0.0 2.0 0.5 0.4 2.0 0.2 14.4 6.3 1.1 ABHD16B "C20orf135, dJ591C20.1" ENSG00000183260 "Abhydrolase domain containing 16B" Q9H3Z7 20 63861498-63862988 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 58 "Early spermatids: 120.3;Late spermatids: 172.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "eosinophil: 6.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 13.6;PC-3: 16.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA059272, HPA075886" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059272: AB_2683963, HPA075886: " 4.3 3.6 3.0 5.3 3.8 2.0 1.1 0.6 3.0 1.3 1.9 4.1 2.3 0.0 2.9 2.2 0.9 2.2 1.9 2.0 2.6 2.0 2.2 3.4 1.5 2.3 4.8 0.0 3.2 1.3 2.9 0.0 3.6 0.0 3.1 2.4 3.4 0.0 1.2 7.4 5.0 9.0 2.0 0.0 1.4 1.5 1.8 1.6 6.3 1.8 0.4 2.0 1.6 4.1 2.7 0.5 1.1 0.0 0.0 6.3 4.9 0.0 0.0 0.0 13.6 5.4 3.8 4.0 0.0 1.2 10.6 0.0 0.0 0.0 2.6 3.3 2.4 4.7 9.8 0.0 1.4 6.9 0.0 0.0 0.0 0.0 0.2 0.0 2.9 4.6 4.5 0.0 7.1 2.2 4.0 1.2 0.5 16.3 4.8 0.6 1.4 0.0 2.8 2.0 1.6 4.6 2.7 0.6 0.2 5.4 0.6 1.7 2.9 5.1 1.5 2.0 3.7 2.1 2.5 2.1 1.5 2.1 0.3 1.8 6.3 1.9 1.2 1.2 0.8 0.7 1.5 1.5 1.8 1.5 1.1 0.8 0.4 0.8 1.6 2.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 120.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 172.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 ABHD2 LABH2 ENSG00000140526 "Abhydrolase domain containing 2" P08910 15 89087459-89202360 "Enzymes, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 303.3;Hepatocytes: 272.0;Late spermatids: 360.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 29.0;neutrophil: 22.7" "Lineage enriched" "Detected in all" 4 "granulocytes: 29.0" "Cell line enriched" "Detected in all" 4 "HEL: 85.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005999 Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA005999: AB_1078080" "unprognostic (6.60e-2)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (3.00e-2)" "unprognostic (2.16e-1)" "unprognostic (1.56e-1)" "unprognostic (2.26e-1)" "unprognostic (1.67e-1)" "unprognostic (3.34e-1)" "unprognostic (3.67e-3)" "unprognostic (3.41e-3)" "unprognostic (1.80e-1)" "prognostic favorable (2.18e-7)" "unprognostic (4.17e-1)" "unprognostic (3.07e-2)" "unprognostic (1.34e-2)" "unprognostic (1.60e-1)" 13.2 24.8 14.8 9.5 19.3 15.6 11.7 25.2 23.4 10.7 16.1 12.0 6.5 23.4 18.2 34.7 9.0 12.1 32.2 24.5 12.2 11.3 11.8 76.4 22.2 11.2 11.1 14.8 13.1 28.3 11.2 18.1 5.6 19.8 22.9 9.6 22.6 11.8 10.0 19.3 7.5 18.5 11.4 8.3 14.2 35.8 42.9 7.6 7.7 8.6 8.1 12.1 13.5 10.4 1.1 3.0 29.0 7.0 4.7 3.5 2.5 8.1 15.8 3.9 4.2 7.7 10.4 2.1 5.5 16.5 5.3 5.0 3.9 14.2 2.3 6.4 6.9 14.6 10.9 8.6 6.7 7.5 12.2 3.8 85.1 3.7 3.0 3.9 5.8 20.0 5.3 4.8 18.8 12.1 8.7 6.4 5.3 7.5 7.3 14.5 3.4 3.6 1.4 1.7 19.2 4.7 5.2 8.2 17.7 7.1 12.9 6.7 10.1 10.5 4.9 8.8 3.7 5.5 4.6 9.8 18.6 6.3 6.7 13.8 6.0 11.9 2.8 15.2 5.4 14.4 3.1 5.6 29.0 1.6 4.8 0.9 1.1 1.5 1.5 3.0 1.1 1.4 1.5 22.7 4.7 7.0 2.4 3.5 2.5 14.8 19.3 25.2 23.4 12.2 11.3 11.1 14.8 19.8 7.6 89.3 113.5 3.0 42.1 16.6 23.6 42.1 163.1 95.0 100.1 40.1 17.7 3.6 1.7 43.2 303.3 25.9 52.7 23.3 74.0 6.2 25.7 185.3 57.9 272.0 39.6 19.1 46.9 22.7 53.9 360.0 30.5 37.9 55.6 12.6 45.6 51.3 79.4 31.3 56.3 11.3 14.4 77.6 50.5 77.4 9.8 15.3 2.2 22.5 31.7 70.1 ABHD3 LABH3 ENSG00000158201 "Abhydrolase domain containing 3" Q8WU67 18 21650897-21704805 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Phospholipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 54.7;RPMI-8226: 60.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010729 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" Vesicles "HPA010729: AB_1844449" "unprognostic (1.46e-1)" "unprognostic (4.61e-2)" "unprognostic (2.37e-2)" "unprognostic (3.52e-1)" "unprognostic (8.46e-2)" "unprognostic (3.14e-3)" "unprognostic (3.54e-3)" "unprognostic (1.52e-1)" "prognostic unfavorable (8.52e-4)" "unprognostic (6.21e-2)" "unprognostic (1.98e-1)" "unprognostic (6.37e-2)" "unprognostic (1.73e-1)" "unprognostic (2.15e-2)" "unprognostic (1.00e-1)" "unprognostic (3.98e-2)" "unprognostic (4.58e-2)" 9.2 5.4 12.0 14.2 10.7 8.6 20.7 19.5 11.1 6.4 34.2 4.8 5.1 23.8 6.0 5.4 12.7 7.8 13.5 7.1 8.8 8.5 8.7 21.7 12.8 21.3 11.5 5.0 9.4 8.8 10.7 11.8 10.8 16.6 6.9 37.1 14.7 10.3 4.1 10.1 3.8 45.3 5.5 12.3 17.9 19.0 4.4 10.8 20.9 12.9 6.7 13.7 9.2 25.5 7.1 6.1 33.0 23.3 7.1 17.6 9.1 7.5 5.5 5.4 3.4 3.4 2.3 0.0 5.0 2.0 3.5 4.8 5.7 7.8 21.7 9.1 1.6 16.0 25.1 8.7 4.1 5.0 13.6 6.0 2.3 9.3 9.8 5.2 10.2 7.9 2.0 4.8 5.2 2.4 1.8 2.3 7.5 6.0 12.9 3.1 3.0 9.9 11.4 2.6 24.2 12.9 54.7 4.1 60.9 9.8 7.3 4.5 2.0 11.3 10.1 2.8 6.1 3.1 18.1 1.8 3.5 5.0 6.1 7.6 14.6 9.4 22.3 4.4 13.4 7.9 29.1 10.2 11.4 11.1 17.9 8.5 7.1 10.0 10.6 6.1 5.1 8.2 10.3 33.0 7.1 23.3 4.2 17.6 9.1 12.0 10.7 19.5 11.1 8.8 8.5 11.5 5.0 16.6 10.8 8.9 9.4 22.4 33.1 29.8 13.4 3.6 45.9 16.0 7.9 3.5 45.2 23.7 1.7 47.1 3.1 9.6 90.1 0.0 24.3 19.9 15.1 42.5 11.5 26.1 56.1 0.0 34.9 12.3 24.7 1.1 6.9 28.6 30.4 17.2 46.9 9.4 35.8 46.5 6.0 7.7 13.6 12.9 15.9 3.5 8.5 13.2 78.8 38.3 23.5 28.7 ABHD4 FLJ12816 ENSG00000100439 "Abhydrolase domain containing 4" Q8TB40 14 22598237-22613215 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 44.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000600 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA000600: AB_1078081" "unprognostic (5.04e-2)" "unprognostic (5.15e-2)" "unprognostic (2.68e-3)" "unprognostic (8.17e-2)" "unprognostic (1.17e-1)" "unprognostic (5.24e-2)" "unprognostic (1.19e-3)" "unprognostic (3.69e-2)" "unprognostic (1.28e-1)" "unprognostic (5.72e-2)" "unprognostic (1.32e-3)" "unprognostic (3.73e-1)" "unprognostic (1.56e-2)" "unprognostic (5.18e-2)" "unprognostic (1.37e-1)" "unprognostic (4.51e-2)" "unprognostic (1.03e-2)" 17.2 24.9 12.8 6.4 14.5 10.0 20.5 12.3 13.9 19.4 14.7 21.4 37.5 13.4 26.0 26.2 28.6 14.4 22.4 16.4 14.1 10.4 23.9 17.0 13.6 8.7 18.9 12.9 15.4 11.4 14.8 12.2 15.9 15.5 19.3 12.8 22.2 13.9 35.5 17.9 14.2 26.3 22.8 18.5 11.9 18.5 45.0 16.4 5.1 25.1 11.1 14.7 23.2 20.7 3.8 2.8 18.6 4.2 4.4 6.0 3.4 7.8 13.2 5.4 4.9 44.0 16.0 5.2 3.5 18.2 8.9 16.7 8.0 12.6 0.7 9.4 15.5 9.6 15.4 3.4 9.2 7.3 5.8 1.2 2.9 9.2 26.3 20.1 0.4 10.7 20.3 7.2 11.7 10.0 18.7 9.2 5.5 2.1 14.4 8.2 4.3 0.2 0.4 6.6 32.1 9.7 2.1 4.8 3.2 10.4 8.4 0.3 1.1 23.9 8.5 9.1 11.3 3.3 0.8 6.5 3.9 5.4 6.3 1.4 15.6 8.1 0.2 2.9 0.6 3.1 18.6 4.2 6.6 6.0 3.2 5.0 3.8 3.9 3.9 2.8 2.4 1.3 2.6 17.4 4.4 2.9 0.4 2.3 3.4 12.8 14.5 12.3 13.0 14.1 10.4 18.9 12.9 15.5 16.4 11.9 3.5 3.2 5.8 2.9 3.0 5.2 15.3 0.0 2.3 3.5 3.9 5.0 8.3 10.7 3.2 5.9 9.8 0.0 10.3 1.5 5.0 6.9 4.7 7.3 6.4 7.9 5.8 8.6 4.7 3.2 5.2 3.8 1.7 13.6 6.1 7.5 8.8 10.5 7.8 4.2 3.1 6.5 6.2 0.7 0.5 2.4 22.4 5.3 2.8 9.3 ABHD5 "CGI-58, NCIE2" ENSG00000011198 "Abhydrolase domain containing 5" Q8WTS1 3 43690108-43734371 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Differentiation, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Cataract, Deafness, Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 70.3" "Cell type enhanced" "Detected in many" 7 "Syncytiotrophoblasts: 171.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 26.1;classical monocyte: 7.6;neutrophil: 21.0" "Group enriched" "Detected in many" 5 "granulocytes: 26.1;monocytes: 7.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020685, HPA035851, HPA035852" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA "Vesicles, Cytosol" Nucleoplasm "CAB020685: , HPA035851: AB_10671942, HPA035852: AB_10672073" "unprognostic (2.58e-1)" "unprognostic (2.73e-1)" "prognostic favorable (8.89e-4)" "unprognostic (1.07e-1)" "unprognostic (1.75e-2)" "unprognostic (2.26e-1)" "unprognostic (6.13e-2)" "unprognostic (2.40e-2)" "unprognostic (5.33e-2)" "unprognostic (3.50e-3)" "unprognostic (2.56e-2)" "unprognostic (4.13e-3)" "prognostic favorable (9.17e-5)" "unprognostic (2.48e-1)" "unprognostic (8.87e-2)" "unprognostic (4.18e-2)" "unprognostic (4.18e-2)" 26.5 10.5 5.2 7.4 12.2 32.2 70.3 8.5 10.3 7.6 10.2 10.5 5.9 7.4 4.6 4.0 22.7 3.7 10.4 9.8 7.4 4.5 10.1 18.4 14.1 8.7 18.5 4.6 4.2 12.8 9.1 8.6 20.2 14.9 5.8 6.7 4.4 21.1 7.4 10.4 24.8 15.1 8.1 19.0 7.0 8.9 8.1 12.5 3.3 13.2 9.9 6.7 11.2 16.0 1.7 3.6 26.1 7.6 0.9 2.4 2.5 8.5 3.0 3.6 3.8 15.2 5.8 7.5 34.9 13.9 9.6 7.2 4.7 3.0 7.1 4.8 10.9 8.5 2.8 5.7 8.5 9.8 25.8 5.5 18.2 11.6 3.2 7.6 4.1 5.9 6.4 29.5 16.1 13.8 8.4 16.0 4.8 10.8 5.4 21.3 4.6 2.9 2.9 9.7 6.8 9.8 1.3 10.4 4.1 12.4 17.0 4.4 6.0 15.3 8.3 3.6 4.0 8.9 3.5 8.8 8.5 6.7 15.7 15.1 4.9 13.6 3.4 9.0 7.5 6.6 26.1 7.6 4.4 1.2 3.7 1.0 1.7 0.9 1.4 3.6 1.2 0.8 1.3 21.0 0.9 2.7 0.9 2.4 2.5 5.2 12.2 8.5 10.3 7.4 4.5 18.5 4.6 14.9 12.5 23.8 43.8 8.5 23.5 35.4 11.3 9.7 15.3 17.4 25.0 26.2 25.5 13.3 28.2 49.4 13.5 16.9 64.4 23.3 53.5 21.2 16.2 21.6 16.1 11.3 16.6 3.2 34.9 14.7 26.6 12.9 4.9 30.4 6.8 16.2 17.1 12.4 61.4 24.6 5.3 31.4 14.7 0.0 26.8 35.6 43.9 35.8 171.7 15.8 18.2 41.1 ABHD6 ENSG00000163686 "Abhydrolase domain containing 6" Q9BV23 3 58237506-58295693 "Enzymes, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 43.4" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 53.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017283, HPA073225" Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA017283: AB_1844452, HPA073225: AB_2686583" "unprognostic (4.20e-2)" "unprognostic (7.92e-2)" "prognostic favorable (1.13e-4)" "unprognostic (2.35e-2)" "unprognostic (1.16e-2)" "unprognostic (3.00e-1)" "unprognostic (5.45e-2)" "unprognostic (1.15e-2)" "unprognostic (9.54e-2)" "unprognostic (1.11e-3)" "unprognostic (1.34e-2)" "unprognostic (1.94e-1)" "prognostic favorable (1.11e-11)" "unprognostic (1.94e-1)" "unprognostic (2.41e-1)" "unprognostic (2.72e-1)" "unprognostic (6.31e-2)" 8.3 10.0 11.6 4.6 14.0 1.0 5.8 17.7 22.5 3.7 8.1 30.0 10.3 26.3 4.7 10.8 4.8 6.9 4.4 4.1 19.0 9.2 24.3 43.4 6.3 5.2 18.6 12.2 4.1 2.4 4.8 15.2 4.8 19.0 4.4 8.1 10.5 3.0 12.9 3.1 17.2 33.5 6.8 24.0 22.8 9.0 3.1 14.3 2.0 6.6 2.1 5.4 4.6 4.1 3.9 7.0 2.1 9.3 0.7 2.6 1.1 2.0 7.7 1.1 5.0 14.5 2.6 13.4 5.4 4.8 5.7 7.7 4.0 2.8 3.9 0.5 2.9 17.6 6.0 5.2 2.4 5.1 6.6 2.6 3.3 5.2 5.5 4.9 1.0 17.6 2.5 11.1 5.2 2.5 6.7 3.2 6.5 3.9 9.0 4.6 1.5 6.7 0.4 3.7 16.7 17.0 2.5 2.3 8.7 8.7 2.8 6.7 2.7 5.9 3.3 11.1 2.3 2.2 2.7 3.4 4.1 4.5 10.1 6.4 2.6 7.6 0.1 10.5 9.9 5.6 0.0 2.8 2.1 2.1 9.3 2.0 3.9 1.2 2.6 4.6 3.0 1.2 1.5 0.0 0.7 6.2 7.0 1.4 1.1 11.6 14.0 17.7 22.5 19.0 9.2 18.6 12.2 19.0 14.3 0.0 2.6 8.8 2.6 7.7 13.8 4.8 0.0 17.4 5.7 3.5 3.9 2.2 1.7 2.9 0.8 7.8 13.6 0.0 1.6 0.4 2.1 1.3 10.5 53.3 8.1 14.3 0.0 26.4 14.6 0.4 6.4 9.6 3.3 14.4 2.2 10.8 1.6 0.0 7.8 15.4 3.0 0.0 3.5 0.5 2.3 21.5 0.5 3.2 4.5 2.0 ABHD8 "FLJ11743, MGC14280, MGC2512" ENSG00000127220 "Abhydrolase domain containing 8" Q96I13 19 17292131-17310236 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.0" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 114.8;Horizontal cells: 68.3;Late spermatids: 221.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 28.4;U-266/70: 21.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037658, HPA058209" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA037658: AB_10672602, HPA058209: AB_2683638" "unprognostic (4.71e-3)" "unprognostic (5.06e-2)" "prognostic unfavorable (5.25e-4)" "unprognostic (7.45e-3)" "unprognostic (7.09e-2)" "unprognostic (1.96e-2)" "unprognostic (5.61e-2)" "unprognostic (9.62e-3)" "unprognostic (1.25e-1)" "unprognostic (1.07e-1)" "prognostic favorable (3.04e-5)" "unprognostic (3.77e-1)" "unprognostic (6.36e-3)" "unprognostic (1.56e-1)" "unprognostic (3.14e-1)" "unprognostic (1.50e-1)" "unprognostic (9.24e-2)" 5.4 14.7 24.7 6.0 23.6 6.4 3.7 20.3 34.0 4.6 5.4 4.1 6.1 4.6 5.9 3.7 3.9 6.2 5.4 6.8 22.0 17.5 6.1 12.4 7.3 6.5 12.3 17.1 9.3 11.0 11.4 9.1 8.9 9.0 7.9 1.6 8.5 12.6 11.6 11.4 6.8 3.6 4.6 4.6 7.7 6.5 19.6 6.9 4.8 6.6 3.2 3.8 4.8 4.6 1.3 6.0 5.6 4.8 3.2 3.6 1.7 11.4 3.3 1.7 6.7 2.2 0.7 18.1 2.3 3.2 2.5 3.3 2.9 7.9 0.8 3.2 1.8 4.0 1.6 1.6 4.0 0.5 13.5 11.1 3.7 5.0 4.9 7.3 0.2 5.3 2.1 2.5 4.3 0.5 4.0 1.9 6.6 3.3 6.6 1.0 0.6 4.5 0.6 3.2 1.9 28.4 6.8 5.3 3.3 2.2 1.1 2.1 11.3 5.2 1.7 7.2 1.5 7.2 6.6 1.1 2.4 5.2 12.0 4.1 21.7 16.3 4.1 8.0 4.5 2.1 0.1 4.8 5.6 2.5 3.7 1.7 0.7 3.6 2.1 6.0 1.3 2.9 2.6 3.0 3.2 4.0 2.9 2.5 1.7 24.7 23.6 20.3 34.0 22.0 17.5 12.3 17.1 9.0 6.9 0.0 2.2 3.0 4.6 3.4 51.4 1.8 7.6 0.0 3.4 7.0 17.7 15.8 6.6 12.4 114.8 3.6 0.5 0.0 7.5 7.4 7.3 5.2 4.6 12.5 19.9 68.3 6.9 1.8 7.6 221.4 11.5 6.0 1.7 26.2 3.1 27.9 7.4 2.9 24.1 7.8 30.3 6.5 3.5 18.4 1.4 3.6 20.7 3.8 1.4 2.8 ABI2 "ABI-2, ABI2B, AblBP3, AIP-1, argBPIA, SSH3BP2" ENSG00000138443 "Abl interactor 2" Q9NYB9 2 203328219-203447723 "Predicted intracellular proteins" "Host-virus interaction, Neurogenesis" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070567 Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA070567: AB_2686281" "unprognostic (5.26e-3)" "unprognostic (5.26e-3)" "unprognostic (1.86e-1)" "unprognostic (4.11e-3)" "unprognostic (2.13e-1)" "unprognostic (1.97e-2)" "unprognostic (1.81e-3)" "unprognostic (7.05e-2)" "unprognostic (8.03e-2)" "unprognostic (8.56e-3)" "unprognostic (6.19e-3)" "unprognostic (1.95e-1)" "unprognostic (4.47e-2)" "unprognostic (4.24e-2)" "unprognostic (2.94e-1)" "unprognostic (9.21e-2)" "unprognostic (1.73e-1)" 8.6 11.6 28.8 7.7 41.8 2.8 12.8 24.4 50.7 17.2 11.5 18.7 8.4 5.1 23.3 16.1 10.5 19.4 11.4 25.1 26.0 24.0 17.8 6.3 13.4 6.4 19.1 30.2 24.3 6.5 18.6 21.5 15.9 17.6 16.4 9.5 11.7 7.1 20.3 5.9 6.4 6.9 21.2 18.8 10.2 6.9 22.2 16.8 11.6 22.2 3.2 7.3 10.2 8.4 1.7 13.8 0.4 3.7 3.9 5.3 3.4 7.2 11.2 40.2 25.3 9.5 16.4 8.8 12.6 11.2 11.0 12.7 10.3 13.7 0.0 8.7 14.8 15.3 8.0 18.2 13.3 21.9 3.6 10.4 18.2 12.0 8.0 14.6 7.8 8.3 11.6 6.4 20.0 15.6 31.8 20.3 20.9 12.8 16.3 19.3 13.1 19.5 7.4 20.8 6.8 25.0 12.9 20.3 1.3 11.3 7.5 16.1 21.2 2.4 7.4 14.0 31.7 9.7 9.1 15.1 20.2 17.1 10.8 13.7 11.5 10.5 10.0 21.8 3.2 12.8 0.2 1.5 0.0 3.8 1.7 4.1 1.7 4.3 4.4 4.3 1.7 5.3 4.5 0.4 3.9 3.7 13.8 4.6 3.4 28.8 41.8 24.4 45.2 26.0 24.0 19.1 30.2 17.6 16.8 50.6 24.5 13.0 49.7 26.8 105.5 50.4 25.5 83.0 35.2 50.6 153.2 18.7 28.2 19.2 102.1 33.4 9.5 0.0 11.6 14.1 50.4 34.8 15.1 9.8 14.0 96.9 47.3 57.7 11.1 62.2 43.1 22.6 47.2 22.6 8.6 78.1 13.9 17.5 59.4 28.0 93.6 25.8 56.7 71.0 49.9 22.8 16.5 17.5 18.0 32.3 ABL1 "ABL, c-ABL, JTK7, p150" ENSG00000097007 "ABL proto-oncogene 1, non-receptor tyrosine kinase" P00519 9 130713946-130887675 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Autophagy, Cell adhesion, DNA damage, DNA repair, Endocytosis" "DNA-binding, Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002686, HPA027251, HPA027280, HPA028409" Supported Enhanced "Nucleoplasm,Nuclear bodies" Yes No Nucleoplasm "Nuclear bodies" "CAB002686: , HPA027251: AB_1844453, HPA027280: AB_1844454, HPA028409: AB_10601011" "unprognostic (4.82e-2)" "unprognostic (3.99e-2)" "unprognostic (5.55e-2)" "unprognostic (4.72e-2)" "unprognostic (1.16e-1)" "unprognostic (1.46e-1)" "unprognostic (3.75e-3)" "unprognostic (1.89e-3)" "unprognostic (2.34e-1)" "unprognostic (2.54e-2)" "unprognostic (1.09e-2)" "unprognostic (1.48e-1)" "unprognostic (3.96e-3)" "unprognostic (1.10e-2)" "unprognostic (1.47e-1)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" 20.1 11.6 12.4 15.0 18.1 10.7 22.0 6.7 16.0 28.9 34.3 29.1 12.1 11.9 26.6 16.9 21.4 20.8 30.9 14.2 10.3 8.4 9.9 6.7 13.8 8.7 24.1 9.4 24.2 12.2 27.7 14.5 13.6 17.1 27.3 15.8 19.4 14.6 18.0 10.8 14.2 17.0 66.6 14.3 10.8 21.9 9.8 21.2 5.8 19.5 11.4 9.1 35.8 31.9 3.1 3.1 1.1 5.0 2.4 2.6 1.6 7.2 16.1 17.2 20.8 25.3 30.9 6.3 12.7 19.9 14.9 12.6 12.6 9.4 11.9 7.3 16.8 15.3 14.0 8.7 11.7 11.0 7.4 5.4 7.8 27.4 10.7 17.3 11.9 10.9 22.5 12.9 26.6 16.5 20.8 20.6 15.4 43.5 9.5 18.1 13.7 15.1 9.8 19.1 11.3 11.9 17.5 22.3 12.8 15.1 8.5 16.1 20.1 21.3 8.3 10.2 10.5 16.2 11.0 23.6 57.2 14.8 21.8 19.9 2.9 6.8 15.9 23.5 9.9 18.1 0.2 2.1 1.1 2.0 1.2 2.6 3.1 2.0 1.9 2.0 1.4 1.9 1.7 0.2 2.4 5.0 3.1 0.9 1.6 12.4 18.1 6.7 16.0 10.3 8.4 24.1 9.4 17.1 21.2 8.9 9.9 4.2 6.4 8.1 6.2 5.8 12.7 5.3 5.7 14.0 11.8 11.3 1.7 12.6 3.1 14.3 15.4 0.0 9.5 3.5 27.8 8.1 2.3 13.4 13.7 9.5 21.2 20.3 13.7 7.4 25.9 6.5 5.0 3.6 15.7 15.7 14.3 20.3 24.1 8.4 9.7 19.4 21.0 11.9 13.6 5.9 12.7 7.9 19.1 6.4 ABL2 "ABLL, ARG" ENSG00000143322 "ABL proto-oncogene 2, non-receptor tyrosine kinase" P42684 1 179099327-179229684 "Cancer-related genes, Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Cell adhesion" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 157.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 32.3;TIME: 30.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001866, CAB017106, HPA072754" Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB017106: , HPA001866: AB_1078082, HPA072754: AB_2732212" "unprognostic (3.05e-1)" "prognostic unfavorable (3.50e-4)" "unprognostic (1.07e-1)" "unprognostic (4.71e-2)" "unprognostic (9.45e-2)" "unprognostic (8.23e-3)" "unprognostic (1.91e-2)" "unprognostic (4.81e-3)" "unprognostic (1.26e-1)" "unprognostic (6.98e-2)" "unprognostic (1.12e-1)" "unprognostic (3.73e-1)" "prognostic unfavorable (1.78e-7)" "unprognostic (4.76e-2)" "unprognostic (4.14e-2)" "unprognostic (6.08e-2)" "prognostic unfavorable (8.40e-4)" 14.3 5.2 8.6 7.4 13.7 3.7 8.3 14.9 10.6 9.2 6.6 5.8 4.5 4.0 5.4 4.7 3.9 4.3 18.8 6.8 9.7 3.9 4.9 4.3 11.5 3.7 6.5 6.1 5.6 8.4 9.2 8.4 6.1 8.1 5.1 5.2 5.8 4.5 4.4 5.2 6.6 3.7 6.9 6.2 3.9 4.7 9.2 8.6 3.6 5.8 3.1 3.6 6.7 11.2 2.8 2.0 3.8 1.2 1.8 2.2 0.6 10.1 5.6 3.7 2.5 3.2 7.4 2.3 11.3 9.3 13.9 10.1 4.1 3.1 5.9 8.4 8.0 9.6 5.1 5.4 3.8 19.8 3.7 4.9 2.8 5.1 2.0 5.9 3.1 0.9 6.8 5.0 19.8 32.3 6.0 15.4 3.0 6.7 1.7 18.1 2.7 2.5 1.7 3.6 2.0 1.8 3.7 6.3 2.9 4.7 1.6 2.3 5.2 9.4 3.0 23.2 5.9 2.7 2.6 30.1 14.5 10.8 6.9 18.1 3.1 3.9 6.1 6.8 1.8 13.9 3.8 1.2 0.4 2.2 0.4 1.0 1.8 1.4 1.4 0.9 2.8 1.9 2.0 2.6 1.8 0.5 2.0 0.8 0.6 8.6 13.7 14.9 10.6 9.7 3.9 6.5 6.1 8.1 8.6 20.8 26.6 12.4 33.8 41.7 36.0 7.0 17.8 6.7 10.3 10.4 157.1 7.7 10.0 12.7 14.0 46.7 9.7 0.0 11.9 6.7 36.0 32.7 16.2 14.5 21.0 23.8 25.9 33.7 32.7 21.4 14.1 36.5 65.8 12.6 9.6 9.8 30.1 14.4 12.7 8.4 34.1 6.5 29.3 18.2 26.3 33.5 8.7 10.1 13.9 20.7 ABLIM2 KIAA1808 ENSG00000163995 "Actin binding LIM protein family member 2" Q6H8Q1 4 7965310-8158832 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0;skeletal muscle: 71.8" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 11.1;Intestinal endocrine cells: 10.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.0" "Lineage enriched" "Detected in single" 4 "T-cells: 3.0" "Group enriched" "Detected in some" 5 "SCLC-21H: 13.2;SiHa: 5.8;U-2197: 20.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035808 Uncertain Uncertain Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA035808: AB_10601962" "unprognostic (7.57e-2)" "unprognostic (3.24e-3)" "unprognostic (7.78e-2)" "unprognostic (3.33e-1)" "unprognostic (2.86e-2)" "unprognostic (6.09e-2)" "unprognostic (1.49e-2)" "unprognostic (5.54e-2)" "unprognostic (1.46e-1)" "unprognostic (5.01e-3)" "unprognostic (2.04e-2)" "unprognostic (3.61e-1)" "unprognostic (1.48e-1)" "unprognostic (4.32e-2)" "unprognostic (5.15e-2)" "unprognostic (1.45e-1)" "unprognostic (2.45e-2)" 4.0 3.8 8.2 1.9 19.1 0.8 2.1 4.0 26.0 1.4 2.1 2.3 0.0 1.1 1.2 1.3 10.5 1.4 1.7 5.7 3.4 5.1 2.5 1.2 1.8 1.4 2.8 7.6 1.1 3.3 2.4 6.1 1.2 9.9 1.8 2.1 1.3 2.6 1.2 71.8 3.8 1.8 2.1 1.8 14.8 1.8 1.5 4.0 0.0 2.4 1.9 2.3 1.5 1.7 0.7 0.5 0.0 0.2 0.0 3.0 0.2 1.0 0.0 0.2 1.5 0.4 0.1 0.4 0.0 0.0 0.1 0.0 0.0 1.3 2.9 0.3 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.7 0.0 0.0 0.1 1.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.6 1.9 0.1 0.0 1.2 2.7 0.9 0.1 1.0 0.6 0.2 0.0 13.2 1.0 5.8 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.4 20.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 1.0 0.1 3.0 0.0 2.5 0.0 0.5 0.7 1.2 0.9 0.0 0.0 0.2 0.0 1.2 0.2 8.2 19.1 4.0 26.0 3.4 5.1 2.8 7.6 9.9 4.0 0.0 1.4 0.0 0.1 2.3 5.1 3.6 0.0 2.7 0.0 3.5 0.0 0.0 0.0 3.0 1.7 2.7 7.5 0.0 3.8 0.5 0.4 0.3 2.3 0.4 0.1 11.1 10.3 1.3 0.3 4.2 0.0 0.0 0.0 0.0 3.0 2.7 3.4 4.5 3.5 0.3 2.9 6.5 4.2 0.0 1.5 5.5 0.0 0.0 5.2 0.1 ABLIM3 KIAA0843 ENSG00000173210 "Actin binding LIM protein family member 3" O94929 5 149141483-149260542 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 58.4" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 57.0;Hepatocytes: 97.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 2.2" "Lineage enhanced" "Detected in single" "granulocytes: 2.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 25.1;HHSteC: 25.7;HSkMC: 29.6;hTERT-HME1: 29.6;hTERT-RPE1: 24.8;TIME: 32.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003245 Approved Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Nucleoplasm, Plasma membrane" "Cell Junctions" "HPA003245: AB_1078083" "unprognostic (1.07e-1)" "unprognostic (1.31e-1)" "unprognostic (9.87e-2)" "unprognostic (1.75e-1)" "unprognostic (8.74e-2)" "unprognostic (4.19e-2)" "unprognostic (9.48e-3)" "unprognostic (4.37e-3)" "unprognostic (1.05e-1)" "unprognostic (1.09e-2)" "unprognostic (4.17e-3)" "unprognostic (2.42e-1)" "prognostic unfavorable (1.28e-4)" "unprognostic (3.12e-2)" "unprognostic (8.10e-2)" "unprognostic (2.45e-3)" "unprognostic (1.20e-1)" 45.9 6.0 7.9 3.5 9.8 1.2 35.0 29.7 12.5 9.1 4.7 11.6 7.0 2.9 4.9 8.9 15.6 5.8 6.1 58.4 8.5 10.2 17.0 48.1 9.1 4.8 9.9 5.9 2.6 2.4 39.3 3.1 26.1 14.3 6.5 4.7 7.7 3.0 9.9 24.3 3.5 3.7 8.7 14.0 5.0 2.7 2.3 3.3 0.1 4.2 8.9 4.5 8.8 14.6 0.0 0.6 2.2 0.3 0.0 0.0 6.8 7.2 1.5 0.0 0.0 13.1 25.1 0.0 5.1 14.3 2.9 5.1 0.0 5.1 0.0 0.8 6.4 15.6 0.1 0.0 5.9 5.8 0.0 0.0 0.0 0.3 0.1 25.7 0.0 0.0 29.6 1.6 10.5 29.6 24.8 13.1 0.0 0.0 2.3 17.0 2.8 0.0 0.0 0.0 0.4 20.1 0.0 0.0 0.0 16.4 5.0 2.0 0.0 1.0 0.3 2.7 0.4 0.4 0.0 32.8 6.2 1.4 6.4 8.6 0.0 0.0 0.0 10.8 0.0 17.6 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.6 0.0 6.8 7.9 9.8 29.7 12.5 8.5 10.2 9.9 5.9 14.3 3.3 0.0 3.0 4.7 1.0 1.3 1.1 57.0 28.1 4.0 1.2 0.0 0.0 0.1 5.0 6.8 1.8 20.2 0.0 0.0 3.0 0.6 2.1 2.2 1.1 97.0 9.3 27.0 0.0 20.3 11.9 0.0 0.3 0.8 5.0 0.0 0.0 19.7 14.9 0.0 0.7 18.3 21.8 0.0 2.3 1.7 2.3 1.4 0.3 0.0 0.0 4.9 ABR MDB ENSG00000159842 "Active BCR-related" Q12979 17 1003518-1229021 "Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 43.6" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 112.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 9 "basophil: 8.9" "Lineage enriched" "Detected in single" 10 "granulocytes: 8.9" "Cell line enhanced" "Detected in some" "Daudi: 18.8;hTERT-RPE1: 20.2;LHCN-M2: 12.6;RPMI-8226: 10.8;TIME: 20.9;U-251 MG: 21.0;U-698: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053618, HPA054824" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA053618: AB_2682208, HPA054824: AB_2682616" "unprognostic (1.69e-1)" "prognostic favorable (4.03e-4)" "unprognostic (1.58e-1)" "unprognostic (1.94e-3)" "unprognostic (1.12e-1)" "unprognostic (2.20e-2)" "unprognostic (4.99e-2)" "unprognostic (7.53e-2)" "unprognostic (1.91e-1)" "unprognostic (9.61e-2)" "unprognostic (7.20e-3)" "unprognostic (4.43e-3)" "prognostic favorable (2.21e-4)" "unprognostic (2.27e-3)" "unprognostic (1.61e-1)" "unprognostic (2.46e-1)" "unprognostic (1.74e-2)" 12.9 5.8 31.8 18.0 28.7 6.0 5.8 7.0 43.6 6.6 19.9 12.0 2.3 9.4 7.9 4.0 11.0 6.1 6.7 26.6 24.0 16.9 6.8 4.0 9.3 6.9 14.1 27.0 3.9 5.0 8.3 6.0 7.2 11.3 4.6 21.6 19.4 23.7 3.4 2.9 5.9 11.9 25.1 8.1 8.1 13.6 3.8 11.3 2.9 7.0 2.3 18.0 7.2 7.4 0.3 0.7 8.9 0.8 0.0 0.8 0.0 0.5 0.6 0.2 0.0 0.9 0.1 0.5 0.1 0.1 0.0 0.0 0.4 0.0 18.8 0.3 0.1 0.8 0.0 2.0 0.0 0.4 5.8 10.2 0.0 0.2 0.0 0.4 2.3 6.7 0.2 0.0 0.1 6.7 20.2 0.0 0.0 0.0 0.0 12.6 0.7 0.0 2.5 0.1 0.4 0.1 0.1 0.0 10.8 0.1 0.2 0.2 0.3 0.0 0.0 1.0 0.0 5.9 2.9 20.9 0.1 0.2 2.1 21.0 0.0 0.2 15.4 1.0 4.1 0.4 8.9 0.3 1.0 0.2 0.8 0.4 0.1 0.3 0.0 0.7 0.3 0.0 0.3 0.9 0.0 0.4 0.0 0.8 0.0 31.8 28.7 7.0 43.6 24.0 16.9 14.1 27.0 11.3 11.3 29.8 21.1 7.8 15.2 15.1 60.3 21.8 25.5 10.7 17.0 1.8 2.0 1.9 0.0 15.6 33.8 21.5 39.3 0.0 5.5 2.5 13.4 17.6 18.5 0.8 27.7 11.1 14.5 18.4 24.0 112.5 12.7 28.3 18.6 18.0 35.9 29.4 29.8 25.9 8.9 5.8 18.0 38.8 21.7 1.9 7.5 14.8 1.8 13.8 49.9 22.6 ABRACL "C6orf115, Costars, HSPC280, PRO2013" ENSG00000146386 "ABRA C-terminal like" Q9P1F3 6 139028682-139043302 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 82.9" "Cell type enhanced" "Detected in many" 4 "Hofbauer cells: 308.6;Proximal tubular cells: 337.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 77.9;U-937: 75.7" "Low region specificity" "Detected in all" HPA030217 Enhanced Approved Nucleoplasm,Cytosol NA NA 7400000 Nucleoplasm Cytosol "HPA030217: AB_10602335" "unprognostic (1.10e-2)" "unprognostic (1.63e-1)" "unprognostic (9.30e-2)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (1.72e-1)" "unprognostic (7.93e-3)" "unprognostic (1.37e-1)" "unprognostic (1.50e-1)" "unprognostic (2.21e-1)" "unprognostic (8.17e-2)" "unprognostic (2.16e-1)" "unprognostic (3.07e-3)" "unprognostic (5.90e-3)" "unprognostic (3.63e-2)" "unprognostic (3.29e-2)" "prognostic favorable (1.65e-6)" 12.2 4.2 12.0 25.5 10.1 23.1 22.1 1.8 19.0 6.5 28.4 2.4 10.6 22.6 10.3 43.8 23.5 6.0 10.9 7.9 15.1 7.1 29.0 26.8 14.0 39.0 5.5 10.3 5.1 9.5 10.3 9.3 12.9 4.8 8.2 26.9 4.3 19.9 9.7 2.3 12.8 35.5 7.1 5.1 45.6 13.7 20.1 5.0 60.2 13.2 19.2 26.0 23.0 9.0 17.1 37.2 30.5 82.9 24.6 48.8 51.8 11.2 6.0 15.5 14.4 6.2 9.7 17.0 9.0 6.4 6.8 14.0 13.4 13.2 0.0 16.4 8.8 29.4 17.1 13.6 19.4 7.9 29.9 25.1 43.9 3.4 4.6 9.0 73.2 20.2 8.7 16.4 9.1 7.5 12.3 35.5 31.0 5.5 15.4 19.4 23.6 45.6 77.9 18.5 17.6 11.8 29.5 9.5 3.5 18.2 33.4 34.7 3.8 6.1 17.2 28.0 22.9 6.8 55.0 26.4 4.3 3.7 9.0 15.9 8.4 23.8 3.0 5.5 75.7 12.8 30.5 31.7 18.9 29.8 55.8 46.1 15.3 48.8 38.1 33.8 17.1 47.7 44.3 8.6 24.6 82.9 37.2 43.5 51.8 12.0 10.1 1.8 19.0 15.1 7.1 5.5 10.3 4.8 5.0 17.9 26.9 128.7 58.7 124.0 0.2 2.8 30.6 20.1 22.7 41.8 0.0 69.4 51.4 124.4 2.6 35.9 215.0 0.0 127.3 176.9 29.2 47.3 79.5 178.9 308.6 0.0 41.3 49.1 193.8 9.4 4.4 118.3 82.7 71.3 101.8 34.9 147.3 167.5 12.0 337.1 1.3 32.3 17.4 1.4 2.1 78.7 40.6 137.1 116.5 103.7 ABTB2 "ABTB2A, BTBD22, DKFZP586C1619" ENSG00000166016 "Ankyrin repeat and BTB domain containing 2" Q8N961 11 34150988-34358008 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 31.6" "Cell type enhanced" "Detected in many" 7 "monocytes: 16.2;Syncytiotrophoblasts: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "eosinophil: 8.1;plasmacytoid DC: 2.8" "Group enriched" "Detected in many" 13 "dendritic cells: 2.8;granulocytes: 8.1" "Cell line enhanced" "Detected in many" "SK-BR-3: 18.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020065, HPA030699" Approved Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA020065: AB_1844459, HPA030699: AB_2673576" "unprognostic (3.00e-1)" "prognostic unfavorable (5.70e-5)" "unprognostic (2.61e-1)" "unprognostic (9.09e-2)" "unprognostic (3.17e-2)" "unprognostic (2.40e-2)" "unprognostic (1.34e-1)" "unprognostic (1.23e-2)" "unprognostic (2.04e-1)" "unprognostic (2.09e-1)" "unprognostic (1.24e-3)" "unprognostic (2.86e-1)" "prognostic favorable (3.51e-5)" "unprognostic (1.50e-1)" "unprognostic (1.42e-1)" "unprognostic (3.81e-2)" "unprognostic (6.58e-2)" 3.1 13.7 4.8 2.7 6.7 3.2 2.2 5.0 5.8 8.0 8.5 10.6 18.2 11.7 7.4 6.3 4.4 4.1 3.2 13.0 4.7 3.9 8.4 8.0 2.9 2.7 9.0 1.5 2.8 2.2 0.3 2.8 8.1 15.8 4.5 3.6 7.5 8.7 31.6 19.4 5.6 20.2 3.6 20.2 1.2 3.0 3.1 7.7 6.4 2.1 3.5 2.8 3.4 5.0 0.0 2.8 8.1 0.4 0.0 0.1 0.1 4.0 12.0 4.9 1.3 1.3 0.1 4.9 2.4 1.9 2.1 4.1 2.9 3.0 0.1 4.1 3.0 12.7 7.8 2.7 2.7 1.7 0.1 6.6 0.0 7.1 12.7 0.7 6.4 0.9 0.7 1.5 4.2 1.8 7.8 0.0 0.5 1.3 0.3 1.3 10.1 0.2 7.8 6.1 6.0 6.6 1.2 2.9 4.5 7.6 9.7 6.2 5.1 6.0 18.7 4.7 3.4 4.0 2.8 0.6 2.4 0.4 7.4 4.3 0.7 0.3 0.1 5.5 1.8 7.3 0.0 0.1 8.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 2.8 0.1 0.1 4.8 6.7 5.0 5.6 4.7 3.9 9.0 1.5 15.8 7.7 0.0 2.9 0.8 2.3 4.1 2.8 7.4 5.1 0.0 0.0 12.2 0.0 1.9 5.0 4.5 0.8 0.6 10.3 0.0 3.9 0.9 5.5 5.8 1.1 5.7 0.7 0.0 6.9 0.0 1.0 0.0 1.1 0.8 1.7 16.2 1.6 6.2 7.3 0.8 5.6 1.1 0.3 0.0 3.3 0.5 0.6 4.3 23.7 0.0 1.3 6.0 AC003006.1 ENSG00000269026 19 57682045-57753575 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BJ: 2.1;HEK 293: 2.8;HL-60: 3.5;RT4: 2.8;U-266/84: 5.4;U-698: 2.0" HPA068553 Approved Nucleoplasm NA NA Nucleoplasm "HPA068553: AB_2686002" "unprognostic (2.74e-1)" "unprognostic (1.47e-1)" "unprognostic (1.63e-1)" "unprognostic (1.54e-2)" "unprognostic (3.50e-1)" "unprognostic (1.43e-2)" "unprognostic (3.61e-1)" "unprognostic (4.82e-2)" "unprognostic (1.46e-1)" 2.4 1.3 1.3 3.2 1.9 1.7 2.3 7.7 1.6 1.8 2.0 2.4 3.4 3.0 3.0 2.0 1.4 2.3 2.1 2.0 1.5 1.2 1.3 1.9 1.5 4.4 1.3 0.7 5.2 4.4 1.2 2.3 1.7 1.5 1.6 1.2 2.2 4.5 3.5 3.4 2.0 1.4 2.5 1.9 2.8 3.4 8.1 1.9 5.6 2.5 1.6 4.2 2.8 2.0 1.6 1.1 1.7 1.3 4.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.1 0.0 0.7 0.0 1.6 0.0 0.4 0.6 0.0 0.0 0.0 0.7 0.7 0.0 0.8 2.8 0.7 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.8 1.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.3 0.0 5.4 2.0 0.0 0.0 0.0 0.3 1.3 0.6 0.4 0.0 1.3 1.6 0.7 1.5 0.5 1.0 1.1 0.5 1.7 4.0 0.2 1.1 0.6 0.2 1.3 1.9 7.7 1.6 1.5 1.2 1.3 0.7 1.5 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC004593.3 ENSG00000285162 "Beta-chimaerin isoform 3 " 7 29122340-29514667 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 6.3;brain: 16.3" "Group enriched" "Detected in some" 11 "Collecting duct cells: 1.8;Early spermatids: 1.0;granulocytes: 1.1;Hepatocytes: 2.4;Late spermatids: 1.1" "Group enriched" "Detected in some" 34 "classical monocyte: 6.2;intermediate monocyte: 5.1;myeloid DC: 6.3;non-classical monocyte: 2.5" "Group enriched" "Detected in many" 59 "dendritic cells: 6.3;monocytes: 6.2" "Cell line enhanced" "Detected in some" "EFO-21: 2.7;GAMG: 3.3;HaCaT: 3.5;HEL: 2.5;U-266/84: 4.1" HPA019026 Uncertain "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA019026: " 0.1 0.3 0.1 0.2 0.1 0.2 0.1 16.3 0.1 0.1 0.2 0.1 0.1 2.6 0.4 0.1 0.1 0.0 0.4 1.2 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.5 0.7 0.1 0.0 0.1 0.1 0.1 0.1 0.0 2.0 0.1 0.1 0.5 1.9 2.9 0.1 0.1 1.7 0.1 0.1 0.1 0.1 0.0 6.3 0.1 6.2 0.0 0.0 2.2 0.0 0.2 0.7 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.3 1.5 0.0 2.7 0.0 3.3 3.5 0.1 0.0 0.0 0.1 1.2 2.5 0.8 1.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 1.2 0.0 1.6 1.3 0.7 0.0 0.2 0.0 0.3 0.6 0.2 0.1 0.8 1.2 0.9 1.6 0.4 0.1 0.7 0.6 0.0 0.0 0.1 0.3 4.1 0.0 0.0 0.0 1.7 0.0 6.2 0.0 0.0 5.1 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.1 0.0 2.5 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC004754.1 ENSG00000269881 16 249547-269943 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "intestine: 15.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 2.4;ASC TERT1: 2.4;EFO-21: 5.1;HHSteC: 2.5;hTERT-RPE1: 2.9" "HPA011651, HPA071871" Uncertain Uncertain Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA011651: , HPA071871: AB_2732188" "unprognostic (1.22e-1)" "unprognostic (2.09e-2)" "unprognostic (2.26e-1)" "unprognostic (1.75e-2)" "unprognostic (5.40e-2)" "unprognostic (2.56e-1)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" "unprognostic (3.37e-2)" "unprognostic (5.06e-2)" "unprognostic (5.24e-3)" "unprognostic (4.66e-2)" "unprognostic (7.84e-2)" "unprognostic (1.10e-1)" "unprognostic (1.32e-1)" "unprognostic (1.69e-1)" "unprognostic (2.95e-2)" 0.5 0.0 0.7 0.0 1.1 0.0 0.0 0.3 0.6 0.6 0.2 15.3 0.3 0.3 0.1 0.2 0.0 0.9 0.4 1.4 0.3 0.1 0.0 0.0 0.7 0.1 1.7 0.0 0.2 0.0 0.2 0.0 0.0 0.3 1.0 0.1 7.4 0.2 0.7 0.0 0.1 0.9 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.8 0.4 1.8 2.4 2.4 0.5 0.0 1.2 0.0 0.1 0.3 0.1 0.0 5.1 1.1 0.8 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 2.5 0.0 0.0 1.0 0.0 0.2 1.0 2.9 0.7 0.1 0.0 0.3 0.0 2.1 0.0 0.2 1.2 0.6 0.0 1.3 0.0 0.0 0.9 0.0 0.3 1.0 0.0 0.0 0.4 0.2 1.0 0.6 0.0 0.4 0.0 1.0 0.0 0.1 0.2 0.1 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.8 0.0 0.5 1.5 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC005726.1 ENSG00000258472 17 28455752-28614197 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 16.8" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 10.4;Ciliated cells: 10.7;Club cells: 10.3;Collecting duct cells: 3.5;granulocytes: 5.8;Proximal tubular cells: 9.0;Syncytiotrophoblasts: 4.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.5;CACO-2: 2.1;Karpas-707: 3.5;PC-3: 3.2;THP-1: 3.5" HPA046590 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA046590: AB_2679710" "unprognostic (1.26e-2)" "unprognostic (1.82e-1)" "unprognostic (6.04e-3)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "unprognostic (2.23e-3)" "unprognostic (2.76e-3)" "unprognostic (7.25e-2)" "unprognostic (5.96e-2)" "unprognostic (4.58e-2)" "unprognostic (9.22e-3)" "unprognostic (3.17e-3)" "unprognostic (1.49e-4)" "unprognostic (1.25e-1)" "unprognostic (2.65e-1)" "unprognostic (7.50e-2)" "unprognostic (3.79e-4)" 0.5 0.6 6.3 0.4 16.4 1.6 0.5 3.5 16.8 2.8 0.9 0.0 0.0 1.6 1.3 0.6 1.4 2.3 2.4 1.0 5.1 3.6 0.9 1.5 3.6 0.5 1.6 6.6 0.8 3.6 0.2 3.1 0.4 6.9 1.0 0.2 3.6 0.5 0.2 0.6 0.5 0.5 0.8 1.1 0.5 1.0 0.6 2.1 0.0 2.6 0.0 1.3 3.5 0.5 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 6.5 0.2 0.8 0.0 0.0 0.2 0.3 0.0 0.2 0.0 2.1 0.0 0.0 0.1 0.0 0.1 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.5 3.5 0.0 0.5 0.0 1.0 0.0 0.0 3.2 0.3 0.0 0.0 0.2 1.3 0.0 0.4 0.3 0.9 0.0 0.0 0.6 3.5 0.0 0.8 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 6.3 16.4 3.5 16.8 5.1 3.6 1.6 6.6 6.9 2.1 8.9 10.4 0.0 0.0 0.0 0.0 0.0 0.0 10.7 10.3 3.5 0.0 1.3 1.7 1.1 0.0 0.0 0.0 0.0 1.7 0.7 0.0 0.0 5.8 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.0 0.0 0.0 0.8 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 AC007325.2 ENSG00000277196 Unmapped 138082-161852 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 12.8;skin 1: 12.6" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 5.1;Distal tubular cells: 6.6" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.4" "Lineage enhanced" "Detected in single" "T-cells: 1.4" "Group enriched" "Detected in some" 13 "OE19: 84.6;RPTEC TERT1: 44.7" HPA020361 Uncertain Approved Nucleoplasm,Vesicles,Mitochondria NA NA Mitochondria "Nucleoplasm, Vesicles" "HPA020361: AB_10963116" 0.0 0.0 0.0 0.0 0.6 6.4 0.0 0.0 11.1 0.0 0.0 2.1 0.0 0.0 2.8 4.5 1.6 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.0 12.6 12.8 0.0 0.0 0.0 0.0 1.1 1.8 0.5 0.0 0.7 0.0 0.0 0.0 1.4 0.0 0.0 2.0 0.0 0.6 1.2 0.0 0.4 0.0 0.0 0.0 0.0 1.2 0.4 0.0 0.1 0.0 0.0 2.4 4.5 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.9 0.0 0.0 0.1 4.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.2 84.6 0.0 0.0 0.0 0.0 44.7 0.1 0.1 0.1 0.0 1.7 0.3 4.8 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 AC008560.1 ENSG00000253251 "Uncharacterized protein FLJ26957 " Q6ZNX1 5 65624765-65630891 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 28 "Alveolar cells type 2: 1.4;Ciliated cells: 1.4;Club cells: 2.3;Cytotrophoblasts: 3.3;Extravillous trophoblasts: 3.7;Hofbauer cells: 3.1;Syncytiotrophoblasts: 4.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA066071, HPA068764" Approved Supported Nucleoplasm,Nucleoli No No Nucleoplasm Nucleoli "HPA066071: AB_2685609, HPA068764: AB_2686028" "unprognostic (7.87e-2)" "unprognostic (1.56e-1)" "unprognostic (1.34e-1)" "unprognostic (1.82e-1)" "unprognostic (1.29e-1)" "unprognostic (9.52e-2)" "unprognostic (5.58e-4)" "unprognostic (2.20e-2)" "unprognostic (1.38e-2)" "unprognostic (7.24e-3)" "unprognostic (5.09e-4)" "unprognostic (2.12e-2)" "unprognostic (1.68e-2)" "unprognostic (1.49e-1)" "unprognostic (1.37e-1)" "unprognostic (1.94e-1)" "prognostic favorable (1.17e-4)" 5.8 7.1 7.3 6.5 13.1 31.5 10.0 8.7 13.3 5.4 6.6 7.1 5.5 7.0 5.9 7.4 6.3 5.3 6.1 4.9 8.2 7.9 11.6 9.7 6.2 9.9 9.9 8.0 5.9 8.7 3.8 13.1 6.5 11.3 10.7 7.6 5.7 6.4 6.6 6.6 7.0 7.6 7.8 9.1 8.9 6.0 7.5 8.6 10.4 6.9 6.4 8.3 5.3 5.0 5.0 4.4 13.4 4.1 6.3 8.8 2.9 2.7 3.7 5.7 11.9 3.3 3.8 6.8 4.3 3.8 6.0 7.7 6.4 8.7 5.0 4.9 5.0 7.1 3.6 5.5 5.2 9.2 6.7 6.9 4.6 9.6 8.5 2.6 5.0 7.9 2.3 7.3 6.4 6.8 1.8 4.1 8.5 6.5 11.9 5.0 7.1 7.1 7.3 4.5 1.6 2.2 4.9 5.4 7.9 5.0 6.0 7.7 5.8 3.8 3.5 10.8 3.9 4.2 4.5 3.1 5.7 7.5 4.4 6.8 7.5 13.8 11.2 4.2 6.2 5.2 13.4 4.1 7.5 5.4 3.7 5.7 5.0 6.5 5.6 3.7 4.9 8.8 8.1 4.3 6.3 4.1 4.4 7.9 2.9 7.3 13.1 8.7 13.3 8.2 7.9 9.9 8.0 11.3 8.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.3 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 AC008758.5 ENSG00000268870 19 12391949-12441082 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RH-30: 7.6;RT4: 6.1" "HPA003150, HPA018683" Uncertain Uncertain "Nucleoplasm,Centriolar satellite" NA NA Nucleoplasm "Centriolar satellite" "HPA003150: AB_1080725, HPA018683: AB_2669920" 2.1 1.3 1.3 4.3 1.4 1.4 3.3 6.5 2.3 3.3 3.6 0.2 10.8 1.2 2.7 1.4 1.7 0.8 1.5 1.1 1.4 0.7 4.9 3.0 1.7 3.1 1.5 0.7 1.4 2.3 0.3 1.3 3.0 1.8 2.9 2.5 0.1 3.5 6.2 1.9 1.8 4.0 1.0 2.3 1.6 1.3 1.6 1.4 8.4 2.0 1.1 1.2 3.4 4.4 2.5 1.6 0.6 0.4 1.1 2.6 1.2 1.6 0.0 1.1 2.4 0.2 0.0 3.7 1.2 0.0 0.3 0.0 1.5 0.1 1.1 3.7 1.0 1.0 0.0 0.0 0.9 0.0 0.0 0.7 3.6 0.0 2.3 0.0 2.0 3.9 0.0 1.6 1.9 0.0 0.0 1.4 1.7 1.5 0.0 0.0 0.2 1.8 0.6 1.9 3.5 0.0 0.9 7.6 0.0 0.0 6.1 0.0 1.1 0.1 0.7 0.0 2.9 3.5 2.6 0.6 0.4 0.4 3.0 0.3 0.0 1.0 2.0 0.8 0.2 1.1 0.0 0.4 0.6 1.7 0.2 2.6 2.5 2.2 1.9 1.6 1.7 2.5 0.1 0.3 1.1 0.1 0.3 2.2 1.2 1.3 1.4 6.5 2.3 1.4 0.7 1.5 0.7 1.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008770.2 ENSG00000267179 19 11925075-11979290 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.1;HHSteC: 2.8;PC-3: 1.8;U-266/70: 2.6;U-937: 2.0" HPA047845 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA047845: AB_2680178" "unprognostic (2.46e-3)" "unprognostic (9.75e-5)" "unprognostic (1.14e-2)" "unprognostic (1.80e-1)" "unprognostic (2.37e-2)" "unprognostic (2.38e-3)" "unprognostic (1.26e-1)" "unprognostic (1.58e-3)" "unprognostic (4.30e-2)" "unprognostic (3.97e-2)" "unprognostic (4.82e-3)" "unprognostic (2.69e-2)" "unprognostic (5.04e-3)" "unprognostic (2.24e-2)" "unprognostic (9.29e-2)" "unprognostic (1.67e-1)" "unprognostic (8.13e-2)" 3.8 4.6 2.3 7.9 2.7 2.1 7.7 3.0 3.3 2.5 3.4 1.2 4.4 1.4 3.7 4.0 2.4 1.8 4.5 2.1 2.3 2.0 2.8 2.9 4.4 4.9 2.3 1.0 3.6 8.5 1.4 3.9 2.9 1.8 2.8 2.7 1.8 5.3 3.5 2.3 3.6 2.2 4.7 2.0 2.7 2.4 5.9 2.3 3.0 2.3 1.6 4.0 3.2 4.3 1.5 1.5 1.4 1.3 1.1 1.9 0.8 0.6 0.0 0.7 0.0 0.0 0.8 0.0 1.3 2.1 0.9 1.0 0.0 0.4 0.8 0.1 0.0 0.3 0.5 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 2.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.0 0.7 0.8 0.0 0.0 0.5 0.2 1.8 1.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.6 2.6 1.2 1.7 0.4 2.0 0.0 0.0 0.5 1.4 0.7 0.6 1.9 0.7 1.1 0.6 1.5 1.5 0.3 0.6 1.0 1.1 1.3 0.6 0.2 0.8 2.3 2.7 3.0 2.5 2.3 2.0 2.3 1.0 1.8 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC010487.3 ENSG00000283088 19 52880663-52962768 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 22.4" HPA062474 Uncertain "Nucleoplasm,Cytoplasmic bodies" NA NA Nucleoplasm "Cytoplasmic bodies" "HPA062474: AB_2732685" 2.4 0.1 1.7 3.3 3.5 1.1 2.9 1.6 2.6 4.5 2.5 1.5 5.7 2.2 4.7 4.4 3.5 4.1 4.3 2.2 1.7 4.1 0.3 2.8 2.3 4.6 0.8 5.6 1.6 9.7 5.3 4.9 2.3 7.3 3.0 1.5 2.9 4.3 1.1 0.0 2.9 3.3 3.9 4.9 1.9 1.9 3.8 9.1 4.5 2.1 2.6 6.2 4.1 1.0 2.2 2.8 2.2 4.6 2.6 1.4 2.0 0.0 3.7 3.9 0.2 0.0 2.2 2.0 1.7 1.9 3.2 1.3 0.5 2.4 1.5 1.2 1.9 0.3 0.0 0.8 1.2 0.0 0.5 1.5 3.4 0.0 2.1 0.0 1.8 0.7 0.0 2.1 0.8 1.7 2.3 0.9 1.9 0.0 2.3 0.0 2.5 0.0 3.9 0.0 2.3 2.0 2.5 1.5 0.3 22.4 1.8 4.7 0.0 0.7 0.0 6.1 2.2 0.1 1.3 1.0 1.8 0.2 1.9 1.5 6.5 1.6 0.0 0.0 2.2 2.8 0.7 0.8 1.9 1.6 2.0 0.5 1.4 1.1 1.8 1.0 2.6 0.8 0.3 4.6 2.2 2.2 0.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC011455.2 ENSG00000269547 19 38915404-38949855 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 2.6;ovary: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 3.7;A549: 5.2;AN3-CA: 2.8;T-47d: 4.4;U-251 MG: 6.4" "HPA052730, HPA056957" Uncertain Uncertain Nucleoplasm,Vesicles,Mitochondria NA NA "Nucleoplasm, Mitochondria" Vesicles "HPA052730: AB_2681929, HPA056957: AB_2683286" "unprognostic (6.10e-2)" "unprognostic (3.79e-2)" 1.3 2.6 0.3 1.7 0.3 0.0 0.1 0.4 1.1 0.3 0.1 0.0 1.2 0.5 0.1 0.4 0.8 1.1 0.1 0.1 1.6 1.1 0.2 0.0 0.2 3.0 0.6 0.0 0.1 0.5 0.2 0.0 0.1 0.0 0.2 0.2 0.2 0.0 0.3 0.1 0.1 0.5 0.1 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.7 5.2 0.0 2.8 0.9 0.0 0.5 0.0 0.3 0.4 0.0 0.0 0.0 0.0 1.8 0.0 0.3 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.1 0.0 0.5 0.3 1.2 0.5 0.5 0.0 1.2 0.3 2.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 4.4 0.2 0.0 1.4 1.4 0.0 6.4 0.0 0.6 0.0 2.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC012184.2 ENSG00000260537 16 70299194-70372582 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in single" 27 "Ciliated cells: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 22.6;U-698: 22.3" "HPA046380, HPA066668" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA046380: AB_2679645, HPA066668: " 12.9 11.6 2.6 10.2 4.7 10.4 7.2 12.9 6.3 4.8 7.4 5.6 5.2 9.8 5.7 5.2 9.8 4.2 7.1 10.8 2.9 2.7 7.2 14.6 6.6 8.8 3.6 3.7 4.5 13.7 0.8 7.1 4.3 4.9 4.7 7.5 7.7 8.7 5.8 23.5 15.9 7.0 6.0 3.2 7.0 7.3 2.6 4.5 6.8 8.0 6.6 13.3 13.4 5.2 8.8 14.7 12.3 16.0 12.0 17.9 11.1 1.4 4.9 4.2 9.8 0.0 4.7 8.2 4.6 5.5 7.9 8.4 9.0 12.6 8.3 5.8 4.7 1.5 5.0 0.0 3.4 6.2 2.5 6.2 5.4 4.1 0.6 5.1 8.2 4.4 3.0 0.8 8.2 0.0 2.0 5.6 2.3 3.1 2.2 3.3 3.7 0.1 0.0 5.1 0.7 1.1 22.6 1.7 15.2 2.5 6.3 5.3 5.1 11.7 2.1 2.3 1.3 4.3 2.0 5.2 5.4 5.6 2.2 2.9 7.7 5.1 22.3 0.7 5.2 9.7 12.3 13.0 9.2 13.5 16.0 11.2 8.8 11.9 13.2 14.7 8.3 10.2 9.9 1.8 12.0 11.5 3.0 17.9 11.1 2.6 4.7 12.9 6.3 2.9 2.7 3.6 3.7 4.9 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC023509.3 ENSG00000267281 12 53506688-53625979 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 2: 3.0;Club cells: 3.4;Collecting duct cells: 1.8;granulocytes: 1.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 4.5" HPA003384 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA003384: AB_1078234" "unprognostic (1.14e-1)" "unprognostic (1.72e-1)" "unprognostic (2.11e-2)" "unprognostic (1.38e-2)" "unprognostic (1.94e-1)" "unprognostic (8.37e-4)" "unprognostic (6.25e-2)" "unprognostic (7.90e-2)" "unprognostic (1.53e-2)" "unprognostic (1.94e-1)" "unprognostic (1.08e-5)" "unprognostic (1.91e-2)" "unprognostic (2.26e-7)" "unprognostic (9.21e-2)" "unprognostic (2.50e-1)" "unprognostic (3.72e-1)" "unprognostic (9.77e-3)" 4.5 2.4 3.9 2.0 6.0 4.5 4.6 14.9 5.2 3.3 2.7 7.8 2.1 1.4 4.5 1.8 3.2 3.6 3.8 3.7 4.4 2.8 2.4 3.8 7.0 3.6 6.8 2.3 5.1 3.5 1.4 3.6 2.9 5.1 3.3 3.5 3.1 3.0 4.3 4.5 3.4 2.4 5.7 4.7 2.9 3.1 4.7 6.6 1.9 2.4 1.7 4.1 5.9 2.5 0.7 1.4 2.9 2.2 0.2 2.5 0.5 0.6 4.5 0.0 0.5 1.8 2.3 0.0 0.0 1.5 1.6 0.3 0.5 0.7 1.7 0.4 0.0 0.0 1.4 0.3 1.2 1.3 1.8 0.9 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.5 0.9 0.0 0.0 2.0 1.9 0.0 1.8 0.0 0.0 0.0 0.2 0.8 0.2 0.7 0.3 0.0 0.5 0.0 0.2 0.0 1.4 0.0 0.0 0.3 1.3 2.3 1.8 0.0 0.6 0.6 0.0 0.3 0.0 0.6 1.5 0.8 0.9 0.0 2.9 1.7 0.5 2.5 2.2 0.5 0.2 0.2 0.4 0.9 0.7 0.0 0.4 2.4 0.2 0.0 1.4 0.3 0.5 3.9 6.0 14.9 5.2 4.4 2.8 6.8 2.3 5.1 6.6 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 1.8 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 AC058822.1 ENSG00000282278 4 53377839-54295272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 19.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.4;fHDF/TERT166: 12.7;HDLM-2: 3.4;NTERA-2: 2.9;U-2197: 2.9" HPA058202 Supported Nucleoplasm NA NA Nucleoplasm "HPA058202: AB_2683636" 4.3 2.6 3.6 9.5 5.0 2.7 3.4 4.3 19.1 4.7 4.6 3.4 2.6 2.6 5.5 2.6 3.2 2.6 2.6 4.5 2.6 3.0 3.3 5.4 3.9 3.6 5.1 7.8 6.6 2.6 5.3 5.3 3.8 4.0 2.8 2.6 3.0 3.1 3.2 2.6 7.1 6.5 3.3 4.7 4.1 4.7 4.2 9.3 4.3 3.0 4.2 4.5 3.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.1 2.0 0.0 0.2 5.4 0.0 0.1 1.0 0.0 0.0 0.0 12.7 0.0 0.0 1.1 0.0 0.1 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 1.5 0.0 2.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC073610.3 ENSG00000272822 12 48903503-48957365 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 27.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 7.9;hTERT-RPE1: 8.0" HPA068942 Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA068942: AB_2732124" "unprognostic (7.48e-2)" "unprognostic (6.47e-2)" "unprognostic (7.52e-2)" "unprognostic (1.05e-1)" "unprognostic (1.64e-1)" "unprognostic (2.57e-3)" "unprognostic (1.26e-1)" "unprognostic (7.66e-2)" "unprognostic (7.25e-2)" "unprognostic (1.01e-2)" "unprognostic (6.24e-2)" "unprognostic (5.78e-2)" "unprognostic (1.01e-12)" "unprognostic (1.92e-2)" "unprognostic (1.33e-1)" "unprognostic (2.84e-1)" "unprognostic (9.06e-2)" 6.8 3.4 10.5 2.2 20.7 3.6 4.6 7.7 27.5 6.4 4.9 6.3 2.6 2.2 9.7 7.3 5.1 4.7 7.6 7.2 8.8 7.2 5.0 4.1 5.5 5.5 5.7 13.7 6.1 7.4 2.2 5.3 3.3 10.6 5.4 4.6 3.5 4.8 4.5 3.4 4.4 4.2 10.6 4.6 4.7 4.0 8.4 4.3 3.3 5.0 2.3 4.4 4.9 3.9 0.8 1.8 1.1 1.1 1.3 3.2 2.0 1.0 0.4 3.8 2.9 4.1 1.6 0.0 1.6 7.9 2.3 1.0 0.0 1.1 1.1 2.4 1.4 2.5 0.4 1.4 0.0 2.1 5.1 0.6 1.1 0.6 0.0 2.8 0.0 1.1 0.4 2.0 0.6 1.3 8.0 1.0 1.9 0.1 1.4 1.3 0.4 0.2 0.6 0.0 2.1 1.1 2.2 0.6 0.2 0.2 0.3 1.9 0.5 0.9 0.7 0.8 0.7 0.2 0.5 4.3 0.7 0.5 0.2 0.5 2.0 0.3 0.7 1.8 1.1 0.4 0.9 1.1 0.3 2.7 0.4 3.2 0.6 0.9 1.8 0.9 0.8 2.3 2.6 1.1 1.3 0.4 1.8 0.5 2.0 10.5 20.7 7.7 27.5 8.8 7.2 5.7 13.7 10.6 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 AC073896.1 ENSG00000144785 12 56285916-56316059 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "Club cells: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 25.7" "HPA038466, HPA068007" Uncertain Approved "Nucleoplasm,Centriolar satellite" NA NA "Nucleoplasm, Centriolar satellite" "HPA038466: AB_10672646, HPA068007: " "unprognostic (3.07e-2)" "unprognostic (9.89e-3)" "unprognostic (8.23e-2)" "unprognostic (3.45e-2)" "unprognostic (8.20e-3)" "unprognostic (1.63e-1)" "unprognostic (2.13e-1)" "unprognostic (1.38e-1)" "unprognostic (3.74e-3)" "unprognostic (2.83e-1)" "unprognostic (1.04e-1)" "unprognostic (9.26e-4)" "unprognostic (2.22e-1)" "unprognostic (3.01e-1)" "unprognostic (1.93e-1)" 6.4 12.2 6.7 7.8 7.4 4.5 5.4 12.4 13.6 7.2 20.3 7.2 13.3 15.3 6.5 10.9 6.9 5.7 5.9 8.3 5.0 5.5 8.5 18.1 5.3 5.1 6.4 6.6 8.5 20.5 6.9 12.5 13.2 6.6 7.1 4.8 5.6 15.5 10.9 8.6 5.9 8.3 2.9 7.5 10.6 10.0 5.8 6.1 3.4 12.5 4.3 4.6 5.4 4.8 22.5 19.3 7.9 13.2 9.7 12.5 18.8 6.5 3.8 4.9 6.7 3.0 1.9 5.1 9.7 3.1 3.3 1.8 0.8 5.6 3.0 22.7 2.3 2.1 14.4 6.3 1.0 2.0 7.8 4.3 1.0 4.4 2.9 0.2 7.5 11.8 3.4 0.4 2.4 0.2 3.9 4.0 6.4 2.8 3.3 1.6 1.8 4.1 4.1 14.4 1.6 11.3 18.6 7.0 4.8 0.6 1.8 8.5 11.3 2.8 9.6 9.4 1.2 5.1 15.4 0.0 9.0 5.8 5.0 14.3 11.0 25.7 7.7 15.2 6.5 11.1 7.9 7.6 4.1 12.4 13.2 10.0 22.5 7.7 12.5 15.1 19.0 9.0 11.8 1.6 9.7 6.6 19.3 11.4 18.8 6.7 7.4 12.4 8.3 5.0 5.5 6.4 6.6 6.6 6.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC093668.1 ENSG00000270249 7 102541501-102592444 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "parathyroid gland: 6.9" "Cell type enriched" "Detected in single" 12 "Club cells: 1.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 3.7;hTERT-RPE1: 3.4;Karpas-707: 4.0" HPA046970 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA046970: AB_2679882" 0.4 0.7 0.6 0.8 0.6 0.7 0.4 3.1 1.1 1.0 1.0 2.5 0.9 2.5 0.4 0.6 0.0 0.3 0.6 0.5 1.4 0.1 0.7 0.5 0.3 0.7 1.2 6.9 2.9 0.4 0.5 0.6 1.1 0.2 5.4 1.7 1.4 0.0 0.3 1.3 1.1 0.2 0.3 0.1 0.4 0.7 4.0 3.5 1.3 1.0 0.7 5.3 1.2 0.1 0.0 1.0 0.2 0.2 3.7 0.5 1.1 0.7 0.6 0.0 0.0 2.1 2.3 0.7 1.6 0.4 0.8 0.0 0.0 0.0 0.7 0.0 1.3 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.4 0.0 1.2 0.0 4.0 0.0 0.4 2.6 1.3 0.5 2.3 1.0 1.4 0.0 0.5 0.3 0.8 1.5 1.2 0.0 0.0 0.2 1.7 0.5 0.0 0.0 0.0 0.1 0.3 0.0 1.8 1.5 0.4 0.4 1.0 0.0 0.0 0.7 0.4 2.9 0.9 4.1 4.0 3.8 2.9 1.7 3.1 5.3 3.0 1.3 0.7 1.0 3.5 5.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC116366.3 ENSG00000283782 5 132410832-132646079 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 7.5;Ciliated cells: 22.7;Club cells: 11.4;monocytes: 10.8" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA052291 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA052291: AB_2681786" 4.8 4.8 2.6 11.9 4.4 1.9 5.3 4.2 6.0 6.3 6.3 4.0 6.0 5.6 4.2 7.0 3.2 4.9 7.4 4.0 3.2 5.8 6.5 10.4 9.8 4.1 2.8 8.6 3.4 5.7 6.3 3.5 3.9 5.6 4.7 6.2 4.3 5.8 4.7 1.7 8.0 6.1 4.4 9.3 4.6 1.9 4.7 7.6 5.7 2.4 9.6 4.4 8.3 5.0 3.5 7.4 3.1 5.1 9.0 3.7 3.3 0.2 1.0 1.5 8.4 8.7 4.5 3.5 3.4 6.4 6.1 0.2 7.2 2.9 2.0 4.2 11.2 2.3 4.7 0.9 5.7 6.1 0.7 4.1 0.9 0.7 12.3 2.5 2.6 4.9 1.8 4.4 9.3 6.4 4.5 3.2 0.7 7.8 7.4 0.1 7.7 3.0 2.1 2.2 1.2 7.2 3.6 9.8 1.8 0.6 1.5 1.5 2.2 1.7 3.0 2.4 0.2 3.4 5.7 2.9 1.8 2.0 1.9 11.0 5.7 3.6 3.5 8.1 1.6 3.8 1.9 7.4 9.0 3.1 5.0 5.0 4.9 6.4 1.1 5.0 5.4 6.2 4.9 5.1 2.8 3.5 5.7 3.7 20.8 7.5 0.0 0.0 0.0 0.0 0.0 0.0 22.7 11.4 3.5 0.0 0.0 1.7 2.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 10.8 0.0 0.0 1.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC118549.1 ENSG00000036549 "ZZ-type zinc finger-containing protein 3 " Q8IYH5 1 77562416-77683419 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 19.0;Proximal tubular cells: 15.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053663, HPA054913, HPA066197" Uncertain Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA053663: AB_2682222, HPA054913: AB_2682640, HPA066197: AB_2685635" "unprognostic (1.30e-1)" "unprognostic (4.78e-2)" "unprognostic (2.73e-2)" "unprognostic (2.13e-3)" "unprognostic (5.38e-3)" "unprognostic (8.77e-2)" "prognostic unfavorable (6.96e-5)" "unprognostic (2.91e-1)" "unprognostic (9.67e-2)" "unprognostic (1.35e-1)" "unprognostic (2.83e-1)" "unprognostic (1.91e-1)" "unprognostic (1.71e-1)" "unprognostic (3.96e-1)" "unprognostic (1.95e-1)" "unprognostic (3.05e-2)" "unprognostic (1.43e-1)" 17.8 17.4 20.8 14.1 23.6 11.6 21.6 20.4 20.3 18.1 16.2 16.1 18.3 12.1 18.3 14.3 14.5 15.3 12.1 13.7 16.9 11.7 18.8 20.0 12.3 15.8 24.1 17.8 24.1 14.5 19.0 28.2 13.9 14.4 16.0 13.0 10.5 15.2 16.8 19.0 16.9 12.4 17.0 16.2 11.5 13.5 9.9 23.6 17.9 26.5 8.6 16.0 20.1 14.9 7.9 7.4 5.6 5.1 7.4 10.4 5.0 13.4 6.9 12.7 9.7 11.1 17.7 13.4 17.2 15.9 15.9 17.5 7.7 7.2 17.6 15.5 14.4 18.0 12.4 16.7 11.1 24.1 13.8 13.2 21.8 13.9 9.5 17.1 22.5 6.2 13.5 17.2 17.6 34.4 15.4 16.1 12.2 21.1 13.7 15.4 6.3 11.2 7.0 18.8 7.4 15.7 13.2 21.7 9.0 11.1 14.3 15.9 13.4 10.3 11.8 30.3 9.1 7.1 12.4 13.2 13.8 17.0 22.3 22.1 10.3 14.4 18.7 13.6 19.7 10.5 0.1 4.6 5.6 6.9 5.1 10.4 7.9 8.2 8.1 7.4 7.9 10.2 9.2 0.9 7.4 4.7 5.0 10.4 5.0 20.8 23.6 20.4 20.3 16.9 11.7 24.1 17.8 14.4 23.6 11.9 19.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 12.5 10.4 0.0 11.4 10.0 13.1 0.0 0.0 0.0 0.0 11.1 10.1 0.0 0.0 5.8 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 13.6 0.0 0.0 11.8 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 AC126755.2 ENSG00000233024 "Nuclear pore complex-interacting protein family member A5 isoform 2 " 16 18358086-18379331 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.5" "Group enriched" "Detected in some" 7 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 6.7;Ciliated cells: 10.7;granulocytes: 10.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 4.7" "Group enriched" "Detected in many" 6 "B-cells: 4.7;T-cells: 1.8" "Low cell line specificity" "Detected in all" HPA053611 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (9.10e-2)" "unprognostic (6.00e-3)" "unprognostic (1.66e-1)" "unprognostic (5.77e-2)" "unprognostic (8.31e-2)" "unprognostic (6.34e-2)" "unprognostic (6.34e-2)" "unprognostic (6.76e-2)" "unprognostic (1.30e-3)" "unprognostic (5.87e-2)" "unprognostic (5.79e-3)" "unprognostic (1.60e-2)" "unprognostic (1.25e-5)" "unprognostic (1.96e-1)" "unprognostic (1.90e-2)" "unprognostic (5.38e-2)" "unprognostic (6.45e-3)" 4.1 5.4 5.2 3.3 5.5 3.3 6.0 46.5 10.1 5.4 6.9 3.4 9.5 10.0 4.7 6.3 4.4 3.3 6.4 6.4 3.5 4.6 5.4 4.2 3.3 11.5 6.6 14.3 27.8 2.8 5.4 6.3 3.7 7.0 17.5 9.8 4.5 7.6 2.8 4.9 4.0 4.6 6.5 3.6 4.6 3.8 4.7 0.5 0.5 0.5 0.3 1.8 0.5 7.0 4.7 26.0 21.2 22.3 20.8 6.1 27.2 9.9 13.4 20.0 4.6 4.2 9.8 10.6 23.9 7.9 12.8 8.0 7.3 16.4 8.3 7.7 26.2 22.7 22.6 22.7 12.4 60.1 21.3 33.3 16.8 22.6 28.3 6.5 12.2 6.0 19.7 13.4 10.8 20.3 27.2 11.0 7.0 5.9 29.2 6.4 9.8 13.3 13.4 7.4 11.6 17.1 10.8 14.6 10.4 9.9 14.9 12.4 18.1 8.0 15.2 8.3 14.9 11.6 15.0 8.1 17.3 9.3 0.0 0.5 0.5 1.8 0.1 0.6 4.7 1.2 0.9 0.2 1.1 1.0 0.4 0.0 0.3 0.3 0.5 0.4 0.5 3.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 10.7 1.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC131097.2 ENSG00000216921 2 241893985-241902551 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 7 "pancreas: 27.6;tongue: 59.2" "Cell type enriched" "Detected in some" 4 "Exocrine glandular cells: 7.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 3.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 4.1;MCF7: 1.8;REH: 6.3;SCLC-21H: 4.1" HPA073342 Approved Nucleoplasm NA NA Nucleoplasm "HPA073342: " "unprognostic (9.31e-2)" "unprognostic (4.59e-2)" "unprognostic (1.61e-2)" "unprognostic (1.10e-1)" "unprognostic (7.48e-2)" "unprognostic (3.12e-1)" "unprognostic (2.93e-2)" "unprognostic (4.75e-2)" "unprognostic (1.76e-1)" "unprognostic (1.50e-1)" "unprognostic (2.04e-2)" "unprognostic (5.12e-2)" "unprognostic (5.44e-2)" "unprognostic (8.45e-2)" "unprognostic (2.44e-1)" "unprognostic (3.29e-1)" 2.7 0.3 4.9 0.6 4.4 0.2 1.6 1.7 2.4 0.8 0.6 0.6 0.6 0.1 0.6 0.6 3.8 0.5 0.9 0.6 2.1 2.3 0.6 0.6 0.6 0.6 3.9 0.6 1.4 27.6 0.0 0.6 0.6 0.6 2.6 0.0 0.6 4.4 4.0 3.7 2.6 0.6 0.6 0.6 0.6 0.1 0.8 0.6 1.1 6.4 59.2 2.6 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.5 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.5 0.6 0.0 1.8 1.4 0.2 0.5 0.0 0.0 6.3 0.0 0.6 0.0 0.0 4.1 0.1 0.0 0.6 0.0 0.9 0.0 0.9 1.2 0.0 0.2 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 4.4 1.7 2.4 2.1 2.3 3.9 0.6 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC138696.1 ENSG00000264668 8 143247110-143276403 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 4.8" "HPA047232, HPA056268" Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Plasma membrane" "HPA047232: , HPA056268: AB_2683082" "unprognostic (2.24e-2)" "unprognostic (2.10e-1)" "unprognostic (3.56e-3)" "unprognostic (1.87e-1)" "unprognostic (8.68e-3)" "unprognostic (1.14e-1)" "unprognostic (1.51e-1)" "unprognostic (9.80e-2)" "unprognostic (4.20e-1)" "unprognostic (3.27e-2)" "unprognostic (1.34e-1)" "unprognostic (1.03e-2)" "unprognostic (2.20e-2)" "unprognostic (3.99e-1)" "unprognostic (2.59e-2)" "unprognostic (4.06e-1)" 3.6 4.8 6.2 2.5 4.4 1.5 2.5 5.8 7.3 3.3 3.8 4.7 2.5 2.6 5.7 2.7 2.8 7.8 2.0 2.7 6.2 4.8 2.6 1.9 2.7 2.5 4.8 3.0 5.8 6.8 4.6 4.5 2.2 4.2 3.0 2.2 3.8 3.6 3.9 4.7 1.8 3.1 3.2 3.7 2.7 2.7 3.5 3.6 1.5 2.7 1.5 2.6 3.6 4.4 0.6 0.6 0.0 0.2 0.9 2.1 0.1 1.4 0.0 0.0 0.8 4.8 0.3 0.5 1.4 3.0 1.6 0.6 0.0 1.9 0.2 0.8 0.3 0.3 0.7 0.0 0.6 0.5 0.0 1.4 0.3 0.0 0.0 0.0 0.3 0.7 2.8 1.3 0.0 1.0 0.5 0.9 1.1 0.0 0.1 0.0 0.0 3.3 0.0 3.0 0.4 0.9 1.6 2.8 0.2 0.0 0.0 0.0 2.1 0.0 0.0 0.7 0.0 1.0 0.9 0.0 0.0 0.7 3.0 0.1 2.3 0.8 1.6 1.1 0.3 0.4 0.0 0.0 0.0 0.1 0.0 2.1 0.2 0.0 0.1 0.0 0.6 0.3 0.0 0.0 0.9 0.2 0.6 0.3 0.1 6.2 4.4 5.8 7.3 6.2 4.8 4.8 3.0 4.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC138894.1 ENSG00000261832 16 28456371-28492098 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 3.5;Ciliated cells: 9.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.0;BEWO: 1.3;hTCEpi: 3.4;NB-4: 1.4;REH: 1.0" HPA053611 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (2.93e-3)" "unprognostic (8.88e-3)" "unprognostic (4.33e-3)" "unprognostic (2.66e-1)" "unprognostic (3.59e-1)" "unprognostic (9.85e-2)" "unprognostic (3.82e-4)" "unprognostic (3.25e-2)" "unprognostic (3.44e-2)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (1.59e-1)" "unprognostic (1.03e-1)" "unprognostic (6.85e-2)" "unprognostic (1.40e-1)" "unprognostic (2.37e-1)" "unprognostic (3.74e-1)" 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.6 0.0 0.8 0.3 0.5 0.0 0.1 0.0 0.3 0.2 0.1 0.3 0.3 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 3.4 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.0 0.0 1.4 0.4 0.0 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.6 0.1 0.0 0.0 0.3 0.0 0.1 0.2 0.2 0.5 0.3 0.3 0.0 0.0 0.2 0.0 6.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 9.4 1.2 0.0 0.0 0.8 1.7 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 AC138969.1 ENSG00000183889 "Nuclear pore complex-interacting protein family member A5 isoform 2 " 16 16317444-16350590 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 3.0;Ciliated cells: 5.3;Club cells: 7.9;granulocytes: 8.1;monocytes: 2.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 4.3;T-cells: 2.7" "Cell line enhanced" "Detected in all" "HMC-1: 64.2" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (2.91e-1)" "unprognostic (3.88e-1)" "unprognostic (1.09e-1)" "unprognostic (2.18e-2)" "unprognostic (1.92e-1)" "unprognostic (8.96e-2)" "unprognostic (2.31e-2)" "unprognostic (3.69e-3)" "unprognostic (1.27e-1)" "unprognostic (1.32e-1)" "unprognostic (5.45e-7)" "unprognostic (1.22e-2)" "unprognostic (5.04e-6)" "unprognostic (6.04e-2)" "unprognostic (9.80e-2)" "unprognostic (1.79e-1)" "unprognostic (2.22e-3)" 5.2 6.4 9.8 2.9 7.1 6.5 5.5 35.6 12.6 4.6 9.3 2.7 11.3 17.9 7.0 10.9 9.9 5.5 11.0 9.0 4.6 4.5 6.3 5.3 5.9 16.4 5.6 12.2 17.9 3.3 7.4 11.0 5.4 8.5 10.1 19.0 5.0 12.5 4.4 6.2 5.0 7.4 6.6 7.3 4.4 4.9 4.3 0.8 0.4 0.7 0.2 2.7 0.7 7.9 5.7 15.7 14.8 22.5 21.4 11.0 16.3 8.0 8.6 11.5 3.9 4.8 6.5 15.6 17.9 7.0 14.1 9.9 6.7 13.1 2.6 9.4 15.1 39.2 25.9 23.1 9.5 64.2 19.8 43.1 13.5 22.7 16.9 5.6 12.2 5.5 21.9 12.6 13.5 15.4 35.4 7.2 7.4 3.9 18.7 6.5 6.6 13.7 26.7 9.9 10.3 8.0 12.0 26.0 11.9 12.8 29.2 3.8 13.6 8.1 8.4 6.1 10.1 18.2 12.4 7.7 10.3 7.0 0.0 0.7 0.4 2.7 0.1 0.8 4.3 2.0 2.3 0.1 1.1 1.5 0.6 0.0 0.2 0.6 0.8 1.1 0.7 3.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 5.3 7.9 0.0 0.0 0.6 0.0 1.1 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 8.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC240274.1 ENSG00000271254 Unmapped 4612-29626 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Spermatocytes: 132.8;Spermatogonia: 61.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " 1.1 5.4 0.7 0.5 1.0 1.0 1.6 3.1 2.3 2.6 1.7 0.8 2.9 1.4 0.3 2.0 0.4 1.4 0.0 5.4 0.0 7.0 1.8 1.3 3.5 1.0 0.8 0.7 1.1 3.9 2.3 1.2 0.5 6.9 1.3 0.2 0.7 2.1 1.4 2.7 2.1 6.4 3.1 0.9 11.0 14.8 16.7 11.8 5.6 6.2 3.8 16.8 10.2 15.7 13.3 5.3 4.3 8.8 1.3 15.4 5.4 6.3 6.4 3.1 21.3 5.8 13.2 2.4 8.1 7.3 7.6 7.5 5.2 4.0 4.6 8.9 7.2 10.2 4.4 14.5 10.5 3.0 6.1 15.2 9.2 3.2 2.6 1.6 35.8 16.7 10.7 1.2 3.8 6.2 12.5 20.3 16.6 14.0 6.9 5.1 12.6 2.3 5.9 9.7 10.0 24.1 7.5 3.6 12.0 7.4 2.4 11.6 3.4 2.7 1.7 2.7 1.7 2.1 3.1 1.5 1.0 1.1 0.7 2.1 1.8 1.9 2.0 6.4 1.5 1.4 0.1 0.9 20.8 12.3 0.0 1.7 0.0 2.0 0.0 0.0 20.1 7.9 0.0 3.9 7.3 1.7 2.1 15.2 0.1 1.6 0.0 2.3 13.2 0.9 0.8 14.0 2.4 5.8 0.0 0.0 2.5 2.5 4.3 15.5 2.9 0.0 1.8 5.5 2.2 2.2 3.5 17.3 1.5 1.3 6.5 0.0 132.8 61.7 0.0 2.2 0.0 4.5 0.9 ACADS "ACAD3, SCAD" ENSG00000122971 "Acyl-CoA dehydrogenase short chain" P16219 12 120725735-120740008 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 58.4;skeletal muscle: 50.7" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 312.7;Hepatocytes: 154.5;Paneth cells: 154.3;Undifferentiated cells: 144.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 23.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004799, CAB019284, HPA022271" Enhanced Enhanced Nucleoplasm,Centrosome,Mitochondria NA NA 15000 Mitochondria "Nucleoplasm, Centrosome" "CAB019284: , HPA004799: AB_1844471, HPA022271: AB_1844472" "unprognostic (7.14e-2)" "unprognostic (3.03e-3)" "unprognostic (8.15e-2)" "prognostic favorable (5.05e-4)" "unprognostic (1.11e-3)" "unprognostic (5.75e-2)" "prognostic favorable (2.43e-4)" "unprognostic (5.65e-2)" "unprognostic (1.22e-1)" "unprognostic (2.14e-1)" "unprognostic (2.69e-2)" "unprognostic (4.04e-2)" "prognostic favorable (3.33e-6)" "unprognostic (1.23e-2)" "unprognostic (1.81e-1)" "unprognostic (1.21e-1)" "prognostic favorable (6.34e-5)" 19.5 14.5 5.7 10.0 5.2 5.3 18.0 2.3 4.6 2.9 26.2 4.7 4.5 35.8 2.8 5.3 5.0 2.9 9.1 32.6 3.7 3.3 13.2 58.4 5.6 7.8 5.0 4.1 2.3 14.4 3.0 2.4 4.3 3.8 4.1 9.0 5.6 8.9 4.6 50.7 3.4 35.3 6.5 3.8 8.6 9.5 10.7 5.4 4.0 8.1 16.8 4.3 5.0 3.2 6.8 11.4 7.2 14.0 15.3 14.7 10.0 2.0 7.2 0.4 6.3 8.6 3.4 7.2 3.0 3.0 3.9 2.9 5.6 5.1 0.2 7.8 2.5 1.8 3.3 4.2 1.3 0.5 10.5 5.3 5.2 2.2 11.9 6.2 0.4 23.6 10.3 2.0 1.7 0.1 1.2 3.9 13.3 4.2 0.0 1.7 4.2 7.2 12.0 1.3 6.6 3.0 5.3 2.7 1.4 7.3 11.5 0.7 4.0 6.2 0.0 9.8 0.6 5.0 8.2 4.4 0.1 3.1 3.0 0.5 10.0 5.6 2.5 6.7 4.4 2.6 7.2 13.0 6.4 12.4 14.0 8.8 5.9 11.3 13.0 11.4 6.8 14.7 13.2 1.3 15.3 8.7 9.5 11.9 10.0 5.7 5.2 2.3 4.6 3.7 3.3 5.0 4.1 3.8 5.4 11.9 10.7 10.2 10.2 6.0 1.1 32.5 30.6 2.7 5.7 17.4 0.0 60.7 43.1 26.8 15.8 14.2 312.7 23.3 28.4 26.2 16.9 7.1 19.5 154.5 47.4 1.6 43.8 12.9 27.2 26.3 19.8 11.1 16.9 32.5 94.5 13.0 25.9 154.3 17.0 74.9 0.7 6.5 13.0 29.1 8.3 4.0 63.2 20.3 144.6 9.0 ACADVL "ACAD6, LCACD, VLCAD" ENSG00000072778 "Acyl-CoA dehydrogenase very long chain" P49748 17 7217125-7225273 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019006, HPA020595" Enhanced Supported Nucleoplasm,Nucleoli,Mitochondria NA NA 19000000 Mitochondria "Nucleoplasm, Nucleoli" "HPA019006: AB_1844478, HPA020595: AB_1844479" "unprognostic (4.81e-2)" "unprognostic (2.86e-1)" "unprognostic (2.21e-2)" "unprognostic (1.09e-2)" "unprognostic (6.63e-3)" "unprognostic (1.51e-1)" "unprognostic (1.89e-2)" "unprognostic (1.39e-1)" "unprognostic (1.07e-1)" "unprognostic (3.21e-1)" "prognostic favorable (6.87e-4)" "unprognostic (3.55e-2)" "unprognostic (1.20e-1)" "unprognostic (1.34e-1)" "unprognostic (1.58e-1)" "unprognostic (4.01e-1)" "unprognostic (2.84e-3)" 32.7 69.2 22.8 18.2 21.1 15.1 24.1 19.8 18.4 21.1 44.0 16.5 26.7 51.7 17.4 19.7 31.5 14.2 24.4 118.2 20.2 12.2 35.2 90.0 17.3 9.8 18.5 16.8 15.5 67.8 31.5 32.3 40.2 20.9 22.1 24.2 20.0 27.4 29.0 132.3 20.3 51.2 25.0 15.7 21.9 28.7 11.5 18.6 14.6 29.6 36.9 21.2 22.4 31.8 8.3 32.0 37.9 29.0 11.6 14.9 20.0 33.5 32.1 13.2 18.1 57.0 21.0 25.0 24.7 34.4 28.1 17.5 12.9 30.3 18.0 20.6 51.7 10.1 25.9 8.8 27.0 24.9 56.9 9.1 9.6 22.8 19.7 27.4 9.1 25.0 23.3 24.7 23.5 37.1 43.6 25.3 22.1 12.3 21.9 45.1 12.7 9.4 11.0 6.2 35.2 12.7 13.2 14.6 42.6 62.6 30.6 3.5 8.7 34.8 44.3 20.2 12.9 20.3 14.0 25.1 24.9 18.7 12.6 24.1 20.6 9.6 0.9 45.9 16.1 18.1 6.8 29.0 37.9 13.5 18.0 12.4 8.3 10.9 14.9 32.0 7.6 8.3 10.2 6.3 11.6 12.0 26.0 9.7 20.0 22.8 21.1 19.8 18.4 20.2 12.2 18.5 16.8 20.9 18.6 56.6 73.4 64.0 249.7 77.5 39.6 397.7 150.3 17.4 43.3 191.9 58.9 369.3 157.5 241.9 107.0 71.4 453.8 23.3 66.5 164.5 100.7 311.9 89.7 297.9 171.6 31.8 172.2 51.5 68.0 184.1 115.3 93.1 77.6 423.8 144.6 37.1 129.2 196.4 124.8 276.8 38.8 103.5 102.3 100.5 34.7 76.5 554.7 68.2 215.2 275.4 ACAP3 "CENTB5, KIAA1716" ENSG00000131584 "ArfGAP with coiled-coil, ankyrin repeat and PH domains 3" Q96P50 1 1292376-1309609 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.0" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 148.4;Cone photoreceptor cells: 98.2;Rod photoreceptor cells: 208.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049317, HPA058381" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA049317: AB_2680710, HPA058381: AB_2683699" "unprognostic (5.92e-2)" "unprognostic (1.55e-1)" "unprognostic (4.60e-3)" "unprognostic (5.26e-2)" "unprognostic (7.94e-2)" "unprognostic (3.77e-3)" "unprognostic (2.98e-3)" "unprognostic (1.01e-3)" "unprognostic (1.29e-2)" "unprognostic (8.05e-2)" "unprognostic (1.56e-3)" "unprognostic (5.35e-3)" "unprognostic (3.70e-2)" "unprognostic (6.76e-3)" "unprognostic (3.45e-1)" "unprognostic (1.51e-1)" "unprognostic (6.35e-2)" 8.7 7.8 16.4 4.2 24.5 10.4 7.3 42.0 23.6 6.4 6.4 11.5 4.3 7.9 5.9 4.2 10.6 3.7 5.1 7.9 19.5 8.7 4.8 4.9 4.7 4.0 13.0 15.4 5.5 8.2 5.1 11.2 4.3 10.4 5.8 3.4 5.6 14.6 7.7 14.2 26.5 7.7 11.8 8.1 6.0 8.0 3.1 12.8 3.1 2.7 4.5 3.5 5.6 6.4 0.9 1.2 1.5 2.0 0.0 1.4 0.7 5.3 6.0 2.8 4.8 7.1 4.9 3.0 13.5 4.4 3.9 3.0 7.6 4.6 5.9 7.0 7.5 3.9 12.3 2.7 3.6 0.9 6.6 12.0 2.5 22.3 14.3 4.9 5.0 6.2 3.4 2.9 3.3 2.1 3.6 1.8 7.0 6.8 8.2 4.4 7.4 10.5 7.2 2.9 7.2 14.0 10.2 6.4 22.7 2.3 2.9 21.4 15.1 8.1 5.0 12.7 2.6 5.4 3.9 5.9 7.3 5.1 5.8 4.7 6.6 4.7 5.1 10.1 13.3 3.1 0.0 1.4 1.5 1.3 2.0 0.0 0.9 1.0 0.6 1.2 0.8 1.4 1.2 0.2 0.0 1.4 1.0 0.5 0.7 16.4 24.5 42.0 22.1 19.5 8.7 13.0 15.4 10.4 12.8 0.0 6.6 10.0 5.2 28.5 148.4 22.4 17.8 2.7 1.2 1.8 98.2 7.4 3.3 8.2 1.9 6.3 12.4 0.0 4.3 6.8 9.1 4.9 0.0 12.1 6.2 50.9 31.0 14.1 19.0 5.8 14.1 8.3 8.5 1.0 11.9 23.8 9.6 9.5 12.4 5.9 208.8 6.5 14.3 4.2 9.5 29.9 8.5 10.2 10.9 8.1 ACAT2 ENSG00000120437 "Acetyl-CoA acetyltransferase 2" Q9BWD1 6 159760328-159779055 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 20.4;liver: 31.0" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 168.5;Exocrine glandular cells: 155.7" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 48.1" "Low region specificity" "Detected in all" "CAB021106, HPA025736, HPA025765, HPA025811" Enhanced Approved Nucleoplasm,Cytosol NA NA 16000000 Cytosol Nucleoplasm "CAB021106: AB_10058215, HPA025736: AB_1844487, HPA025765: AB_1844485, HPA025811: AB_1844488" "unprognostic (3.31e-1)" "unprognostic (2.44e-2)" "prognostic favorable (1.12e-4)" "prognostic unfavorable (7.25e-4)" "unprognostic (1.38e-1)" "unprognostic (2.03e-1)" "unprognostic (9.25e-2)" "unprognostic (4.76e-2)" "unprognostic (1.43e-1)" "unprognostic (2.58e-1)" "unprognostic (1.21e-1)" "unprognostic (1.59e-1)" "prognostic unfavorable (7.38e-4)" "unprognostic (1.39e-1)" "unprognostic (1.50e-2)" "unprognostic (8.56e-2)" "unprognostic (2.54e-2)" 1.6 2.6 2.7 1.5 1.7 1.6 2.2 2.2 6.3 2.1 4.3 3.2 1.4 4.8 5.7 1.0 0.7 0.7 2.9 3.6 3.0 31.0 1.8 2.5 2.9 2.1 0.7 1.3 1.2 0.9 4.2 3.9 2.3 0.5 0.1 2.4 1.6 1.4 5.1 1.1 1.7 6.6 0.9 4.2 1.1 2.6 13.3 9.5 12.3 8.4 10.0 20.4 12.2 6.7 6.3 42.7 16.3 6.1 11.3 1.4 5.9 7.1 14.1 24.4 24.5 8.6 5.6 3.0 4.7 48.1 6.5 17.7 46.2 16.7 3.3 18.1 13.1 10.2 40.6 6.1 7.6 3.5 6.1 3.4 23.3 10.0 2.1 6.9 16.0 14.1 9.6 8.5 11.9 13.0 12.1 14.3 6.7 4.6 8.1 9.6 17.4 32.9 8.7 11.4 6.5 6.9 4.5 2.4 2.0 8.5 15.1 4.3 5.2 4.5 7.3 15.2 4.6 8.4 13.8 1.5 14.9 7.8 6.1 7.1 12.3 13.9 8.4 13.7 13.3 15.9 13.8 9.5 13.3 16.0 12.3 3.2 10.0 5.6 8.7 20.4 12.2 11.9 35.5 24.6 29.0 23.2 14.0 1.2 40.8 20.1 21.6 19.2 2.0 44.4 59.7 47.3 168.5 10.9 23.5 0.0 155.7 84.2 22.6 31.4 12.7 55.7 46.8 12.7 16.4 12.9 10.5 110.0 12.7 23.1 28.7 92.8 21.4 21.8 47.0 17.5 18.0 33.8 19.6 0.0 34.0 14.7 48.7 18.3 29.4 26.6 23.3 27.6 ACBD4 FLJ13322 ENSG00000181513 "Acyl-CoA binding domain containing 4" Q8NC06 17 45132600-45144181 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 43.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051772 Approved Approved Nucleoplasm,Vesicles Yes No "Nucleoplasm, Vesicles" "HPA051772: AB_2681603" "unprognostic (1.57e-2)" "unprognostic (1.45e-1)" "unprognostic (2.59e-2)" "unprognostic (1.54e-1)" "unprognostic (5.33e-3)" "unprognostic (1.60e-2)" "prognostic favorable (4.76e-4)" "unprognostic (2.27e-2)" "unprognostic (9.06e-2)" "unprognostic (4.86e-2)" "prognostic favorable (4.64e-4)" "unprognostic (8.24e-2)" "unprognostic (2.04e-3)" "unprognostic (1.97e-1)" "unprognostic (2.12e-1)" "unprognostic (1.27e-1)" "prognostic favorable (6.53e-4)" 7.5 9.5 8.1 8.5 15.3 3.5 6.7 10.8 10.9 8.6 19.6 4.9 14.4 25.9 9.2 6.8 8.3 10.1 10.7 6.2 8.1 6.8 12.3 43.1 6.3 8.0 6.1 11.1 10.4 14.2 13.6 8.5 5.4 6.3 11.1 5.4 9.9 12.3 13.6 5.4 7.5 29.0 10.3 4.8 8.3 7.3 2.5 6.3 3.9 11.3 4.4 7.3 8.5 7.2 8.8 3.5 5.6 4.3 6.3 7.7 5.4 5.9 11.6 1.5 3.3 2.7 5.2 4.1 2.2 4.7 3.7 7.3 4.5 8.4 6.3 5.8 3.2 2.2 5.7 2.0 3.8 1.5 9.1 4.6 3.1 7.5 8.9 6.1 1.2 8.7 5.1 3.6 1.3 1.9 12.7 3.6 5.9 2.0 10.2 1.8 4.0 4.4 1.6 0.2 6.3 3.2 3.7 0.3 14.0 9.2 3.8 2.5 1.1 1.6 2.4 6.4 0.8 15.6 2.2 1.3 0.9 2.9 1.4 1.4 16.0 4.4 1.9 5.4 1.6 1.6 5.5 3.8 5.6 5.3 4.3 5.7 6.8 6.2 5.9 3.5 8.8 6.7 7.7 1.0 6.3 2.8 2.2 7.1 5.4 8.1 15.3 10.8 10.9 8.1 6.8 6.1 11.1 6.3 6.3 3.0 4.8 2.9 5.7 1.6 14.6 8.0 17.8 1.4 0.0 3.5 21.6 5.5 6.6 5.7 1.3 5.3 10.5 0.0 6.3 1.0 4.3 3.8 8.1 20.8 4.6 11.1 5.8 4.9 1.6 2.7 6.4 1.7 3.3 5.4 5.8 12.3 5.2 10.5 7.1 15.1 15.8 6.5 7.2 0.7 3.8 1.6 5.3 4.4 7.0 1.7 ACBD6 MGC2404 ENSG00000230124 "Acyl-CoA binding domain containing 6" Q9BR61 1 180269653-180502954 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 143.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028179, HPA028457" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA028179: AB_10601788, HPA028457: " "unprognostic (3.12e-1)" "unprognostic (4.38e-2)" "unprognostic (1.66e-1)" "unprognostic (7.66e-2)" "unprognostic (1.48e-1)" "unprognostic (1.66e-1)" "unprognostic (2.93e-3)" "unprognostic (1.75e-2)" "unprognostic (2.03e-2)" "unprognostic (2.73e-2)" "unprognostic (7.05e-2)" "unprognostic (2.11e-1)" "prognostic unfavorable (4.02e-7)" "unprognostic (1.26e-1)" "unprognostic (1.74e-1)" "unprognostic (1.21e-1)" "unprognostic (2.51e-1)" 6.5 7.5 7.3 9.7 7.7 9.1 7.1 17.4 8.1 8.0 5.2 6.5 9.6 5.8 8.6 7.6 5.4 6.0 7.1 8.9 6.6 6.8 5.5 6.8 11.2 6.1 7.9 10.5 9.7 6.8 10.5 11.3 5.8 6.8 5.0 6.5 7.2 7.6 9.5 6.3 5.2 7.8 4.0 6.8 6.1 18.2 7.3 8.1 8.1 7.7 7.1 7.6 6.9 11.5 14.5 2.7 13.3 16.4 10.9 7.7 21.2 15.8 13.6 10.0 9.5 16.6 28.5 9.8 19.7 17.1 15.5 22.3 15.6 18.8 20.3 9.6 8.4 15.3 10.0 18.1 10.9 14.2 19.5 14.8 14.3 12.7 24.5 25.3 13.4 15.0 25.9 10.6 16.7 15.0 19.0 15.3 23.2 15.3 13.7 19.3 21.6 23.9 15.0 14.5 7.5 21.8 11.3 35.9 14.5 11.1 21.4 27.4 13.1 22.0 13.1 14.2 23.1 18.9 15.3 12.8 15.4 15.6 21.1 32.4 16.7 42.7 14.0 15.6 15.1 1.9 8.4 2.7 9.3 13.3 10.7 11.5 8.0 7.9 14.5 8.8 10.0 10.9 0.6 16.4 10.0 11.8 7.4 7.7 29.8 24.1 29.2 23.8 18.9 50.3 40.9 17.8 34.8 39.8 15.7 37.3 143.2 34.9 32.0 69.5 28.1 4.2 0.0 36.3 31.1 30.4 19.4 18.6 11.6 38.5 49.3 18.7 20.9 11.1 43.0 47.5 25.5 35.4 34.3 18.7 36.3 29.4 14.0 47.7 38.9 5.8 58.2 26.4 104.2 59.8 19.6 70.6 22.5 24.7 15.2 ACIN1 "ACINUS, fSAP152, KIAA0670" ENSG00000100813 "Apoptotic chromatin condensation inducer 1" Q9UKV3 14 23058564-23095614 "Plasma proteins, Predicted intracellular proteins, Transporters" "Apoptosis, mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000657 Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA000657: AB_1078091" "unprognostic (2.54e-3)" "unprognostic (1.99e-1)" "unprognostic (1.38e-2)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (4.89e-3)" "prognostic unfavorable (4.88e-5)" "unprognostic (1.49e-3)" "unprognostic (9.70e-2)" "unprognostic (4.11e-2)" "unprognostic (1.00e-2)" "unprognostic (6.64e-3)" "unprognostic (1.35e-3)" "unprognostic (4.34e-2)" "unprognostic (2.78e-2)" "unprognostic (2.28e-2)" "unprognostic (7.33e-2)" 32.4 44.4 34.6 46.6 36.2 57.6 32.5 45.7 41.8 36.6 30.1 39.1 35.2 28.5 52.9 32.2 39.3 34.6 33.3 29.7 33.1 28.3 34.9 35.5 28.8 41.1 34.4 27.7 43.9 34.5 51.1 48.3 37.0 33.7 35.4 34.6 31.5 33.0 38.3 43.8 38.1 35.1 40.1 35.0 52.9 34.0 34.5 40.6 44.2 38.5 27.1 45.9 30.5 47.8 6.9 6.8 13.4 4.9 9.7 5.5 2.7 23.7 24.5 38.7 31.3 24.2 19.5 38.9 26.5 18.7 32.1 26.2 32.4 27.9 44.1 15.7 21.9 21.1 26.2 53.4 30.3 33.0 31.0 23.7 38.8 25.9 44.6 13.9 42.0 34.5 22.8 18.7 32.8 27.7 26.3 28.0 32.9 35.7 17.7 24.1 29.7 47.6 41.5 43.5 26.4 23.4 43.2 30.1 23.5 26.6 42.0 25.8 19.0 35.2 23.0 20.9 29.4 18.9 34.0 28.6 22.0 22.0 20.8 24.4 18.8 21.1 45.7 19.5 31.9 23.8 4.1 4.9 5.6 5.5 4.5 4.4 4.4 3.7 4.2 4.1 6.9 5.1 4.6 13.4 9.7 3.7 6.8 3.8 2.7 34.6 36.2 45.7 41.8 33.1 28.3 34.4 27.7 33.7 40.6 65.5 108.5 33.5 28.5 33.2 38.0 57.7 30.6 109.7 78.5 33.2 25.5 48.1 14.9 45.8 27.6 44.3 40.8 46.7 42.7 55.4 35.5 30.5 120.8 24.7 40.9 14.3 55.9 32.5 26.9 5.0 42.6 35.7 25.3 52.3 37.3 25.9 52.1 42.1 36.0 14.1 42.2 6.5 39.6 35.1 34.6 40.7 57.9 36.3 40.7 34.1 ACKR2 "CCBP2, CCR10, CCR9, CMKBR9, D6" ENSG00000144648 "Atypical chemokine receptor 2" O00590 3 42804752-42887974 "G-protein coupled receptors, Predicted membrane proteins" "Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "placenta: 96.2;salivary gland: 74.8" "Group enriched" "Detected in many" 10 "Cytotrophoblasts: 26.5;Extravillous trophoblasts: 87.8;Syncytiotrophoblasts: 61.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "eosinophil: 7.3;NK-cell: 2.2" "Group enriched" "Detected in many" 5 "granulocytes: 7.3;NK-cells: 2.2" "Cell line enhanced" "Detected in some" "BEWO: 32.2;HEL: 10.3;SK-BR-3: 17.2;U-937: 6.5" "Group enriched" "Detected in many" 9 "amygdala: 2.3;basal ganglia: 7.0;cerebral cortex: 5.0;hippocampal formation: 2.6" "Not detected" "Not detected" "HPA013819, HPA073493" Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA "Vesicles, Cytosol" Nucleoplasm "HPA013819: AB_1846126, HPA073493: AB_2686610" "unprognostic (1.12e-1)" "unprognostic (2.51e-1)" "unprognostic (1.90e-2)" "unprognostic (8.15e-2)" "unprognostic (7.51e-2)" "unprognostic (1.54e-2)" "unprognostic (1.21e-3)" "unprognostic (1.74e-1)" "unprognostic (2.99e-1)" "unprognostic (6.20e-2)" "unprognostic (8.47e-2)" "unprognostic (8.45e-2)" "unprognostic (1.13e-4)" "unprognostic (5.13e-3)" "unprognostic (3.22e-1)" "unprognostic (5.58e-3)" "unprognostic (6.09e-2)" 10.4 0.9 0.4 0.7 0.5 0.4 5.3 0.2 0.4 2.9 1.8 0.1 0.6 0.7 2.0 5.2 2.5 2.4 1.2 1.0 0.5 0.4 1.1 14.5 1.5 1.0 0.5 0.2 0.9 0.7 0.3 0.6 96.2 0.2 1.1 2.0 0.3 74.8 0.4 2.1 2.5 1.0 3.2 0.7 1.1 0.9 1.5 0.1 0.4 3.8 2.3 2.0 3.2 4.1 0.8 0.4 7.3 0.6 2.2 0.4 0.3 0.1 0.0 0.1 0.2 1.5 0.1 32.2 0.0 0.0 0.0 0.0 0.3 0.1 0.7 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.1 10.3 0.2 1.8 0.0 0.1 1.2 0.3 0.3 0.0 0.0 0.0 0.0 0.3 1.3 0.2 0.2 0.2 0.0 0.1 0.0 0.4 0.1 0.1 0.0 0.0 0.4 4.5 0.1 0.1 0.8 17.2 0.0 1.9 1.7 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.1 0.0 0.0 6.5 0.1 0.7 0.2 7.3 0.4 0.5 0.1 0.2 0.1 0.2 0.4 0.8 0.3 0.3 1.0 2.2 0.6 0.3 0.1 0.3 0.4 0.5 0.2 0.4 0.5 0.4 0.5 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.6 0.6 2.5 1.4 0.0 0.0 2.0 26.5 1.7 0.0 1.9 1.4 2.0 0.0 0.0 87.8 1.8 0.4 2.3 5.8 4.6 1.6 1.7 3.7 0.3 1.1 0.3 0.2 0.0 0.0 0.1 2.5 0.6 0.0 1.1 0.3 0.9 0.0 0.0 4.5 3.3 0.0 61.6 0.5 0.4 0.1 ACLY "ACL, ATPCL, CLATP" ENSG00000131473 "ATP citrate lyase" P53396 17 41866908-41930542 "Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007783, HPA022434, HPA022953, HPA022959, HPA028758" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" No No 2100000 "Plasma membrane, Cytosol" Nucleoplasm "CAB007783: AB_562242, HPA022434: AB_1844513, HPA022953: AB_1844514, HPA022959: AB_1844515, HPA028758: AB_10603575" "unprognostic (2.21e-2)" "prognostic unfavorable (1.79e-4)" "unprognostic (1.41e-1)" "unprognostic (1.21e-2)" "unprognostic (2.83e-1)" "unprognostic (8.94e-3)" "prognostic unfavorable (3.66e-4)" "unprognostic (3.38e-3)" "unprognostic (4.11e-2)" "unprognostic (5.94e-3)" "unprognostic (2.13e-2)" "unprognostic (3.01e-2)" "unprognostic (3.88e-3)" "unprognostic (1.66e-1)" "unprognostic (9.36e-2)" "unprognostic (3.90e-2)" "unprognostic (4.67e-3)" 38.3 24.0 16.7 26.2 22.9 19.1 35.7 21.5 29.1 22.9 22.2 25.1 18.0 30.7 27.0 24.9 23.2 23.7 28.2 18.4 18.3 33.7 37.8 22.2 23.3 27.4 23.1 17.9 19.0 30.6 27.1 19.5 26.7 49.0 41.3 23.2 15.6 25.4 19.6 10.9 19.6 29.6 27.2 26.2 24.5 24.6 20.7 21.4 32.0 21.3 18.2 24.6 20.3 21.3 16.1 23.9 25.2 26.3 16.0 23.9 21.4 23.4 80.1 37.8 32.6 58.5 54.9 34.8 33.1 36.2 41.7 52.4 40.6 27.1 38.2 21.3 46.4 39.2 37.4 48.7 56.7 34.9 34.4 46.6 21.8 46.1 42.2 27.2 35.3 28.6 43.6 17.1 73.2 14.8 27.4 43.9 29.6 26.9 30.5 34.5 23.9 58.1 19.8 24.6 15.8 14.5 38.1 45.7 49.0 42.7 41.9 71.2 39.1 23.6 73.9 25.3 34.1 44.1 33.8 47.2 32.6 26.8 32.7 54.3 17.9 22.7 36.3 55.0 27.4 26.4 18.9 20.7 25.2 23.8 22.1 22.5 16.1 19.0 21.3 23.9 13.8 14.6 16.1 10.7 16.0 26.3 13.9 23.9 21.4 16.7 22.9 21.5 27.7 18.3 33.7 23.1 17.9 49.0 21.4 26.8 22.1 18.5 8.0 22.1 9.0 9.6 40.8 18.7 15.9 22.7 3.9 19.9 10.0 29.9 66.2 28.7 23.4 0.0 29.7 39.3 29.9 33.0 14.0 24.6 27.1 17.5 63.4 40.5 40.5 11.4 57.2 21.6 30.4 31.5 46.6 7.0 34.4 17.3 48.1 71.1 6.5 12.9 16.5 21.4 33.8 28.9 18.5 21.3 19.8 12.0 ACOT12 "Cach, STARD15, THEAL" ENSG00000172497 "Acyl-CoA thioesterase 12" Q8WYK0 5 81330005-81394179 "Enzymes, Predicted intracellular proteins, Transporters" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 38 "liver: 49.6" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 37.1" "Cancer enriched" "Detected in single" 76 "liver cancer: 13.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.0;CACO-2: 2.5;Karpas-707: 1.8;SK-MEL-30: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA037723, HPA037724" Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA037723: AB_10672606, HPA037724: AB_2675631" "unprognostic (6.06e-2)" "unprognostic (1.39e-1)" "prognostic favorable (5.30e-4)" "unprognostic (7.68e-2)" "unprognostic (8.22e-2)" "unprognostic (5.68e-3)" "unprognostic (2.46e-1)" "unprognostic (6.86e-2)" "unprognostic (1.46e-2)" "unprognostic (3.07e-1)" "unprognostic (1.06e-1)" 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 1.2 49.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.7 0.0 0.5 0.1 0.0 0.1 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.3 0.0 0.4 0.0 1.8 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 5.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.1 0.4 0.0 0.0 0.6 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 ACOT7 "ACH1, ACT, BACH, CTE-II, hBACH, LACH1, MGC1126" ENSG00000097021 "Acyl-CoA thioesterase 7" O00154 1 6264269-6394391 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 50.0" "Cell type enhanced" "Detected in many" 8 "granulocytes: 137.0;Late spermatids: 118.5;Proximal tubular cells: 214.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "NK-cell: 20.5;plasmacytoid DC: 19.4" "Group enriched" "Detected in many" 4 "dendritic cells: 19.4;NK-cells: 20.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025735, HPA025762" Enhanced Supported Nucleoplasm,Cytosol No No 29000 Cytosol Nucleoplasm "HPA025735: AB_1844523, HPA025762: AB_1844524" "unprognostic (3.94e-2)" "unprognostic (1.74e-1)" "unprognostic (7.09e-2)" "unprognostic (4.33e-2)" "unprognostic (4.10e-2)" "unprognostic (5.06e-2)" "prognostic unfavorable (2.31e-5)" "prognostic unfavorable (1.29e-4)" "unprognostic (2.35e-2)" "unprognostic (4.05e-2)" "unprognostic (1.15e-1)" "unprognostic (1.73e-1)" "prognostic unfavorable (2.55e-6)" "unprognostic (2.68e-2)" "unprognostic (1.45e-1)" "unprognostic (9.06e-2)" "unprognostic (3.72e-2)" 4.7 13.3 25.8 10.8 29.8 7.7 3.9 23.9 50.0 4.4 18.3 11.3 0.5 33.2 5.1 3.8 14.3 4.4 5.3 6.3 27.8 43.9 29.4 9.1 8.6 12.3 36.0 20.7 5.3 4.0 1.9 18.5 7.4 49.9 5.6 13.5 6.6 4.1 4.9 1.5 9.4 33.2 14.3 14.2 8.9 6.2 13.1 6.9 9.0 2.3 6.5 11.6 9.1 6.6 1.0 19.4 0.4 0.6 20.5 4.4 2.8 23.7 20.7 20.4 22.0 4.7 7.8 7.7 20.5 10.6 30.4 18.2 71.4 7.7 29.1 15.1 16.6 23.5 23.5 32.9 54.7 11.4 25.5 28.7 15.3 16.4 25.3 19.3 17.9 12.7 6.9 10.5 25.1 29.8 8.1 17.0 36.5 12.4 6.3 16.0 27.7 37.3 19.0 10.2 23.9 48.0 44.6 23.5 19.7 17.1 9.1 11.2 31.7 18.4 28.3 65.2 10.5 10.1 8.4 27.5 27.7 16.2 27.4 32.3 5.3 21.6 40.9 17.5 31.3 16.8 0.0 0.1 0.1 4.1 0.6 1.0 1.0 3.4 3.6 2.9 0.4 1.2 2.3 0.4 20.5 0.5 19.4 4.4 2.8 25.8 29.8 23.9 50.0 27.8 43.9 36.0 20.7 49.9 6.9 6.0 25.5 13.7 13.3 28.2 33.6 8.1 12.7 1.4 7.9 8.7 9.8 15.1 13.3 19.1 73.6 15.6 70.9 0.0 6.2 23.1 14.2 7.0 137.0 13.4 26.8 44.5 4.6 5.5 4.0 118.5 3.4 16.9 37.1 25.2 88.8 10.6 16.5 29.1 6.7 214.2 15.6 0.0 6.2 38.2 26.7 25.7 14.4 21.4 48.7 19.5 ACOT9 "ACATE2, CGI-16, MT-ACT48" ENSG00000123130 "Acyl-CoA thioesterase 9" Q9Y305 X 23702253-23766475 "Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "monocytes: 296.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035533 Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA035533: AB_10696506" "unprognostic (5.69e-2)" "unprognostic (6.34e-2)" "unprognostic (1.59e-1)" "unprognostic (2.09e-1)" "unprognostic (1.53e-2)" "unprognostic (1.27e-2)" "prognostic unfavorable (3.23e-4)" "unprognostic (1.12e-1)" "unprognostic (1.89e-1)" "unprognostic (2.50e-1)" "unprognostic (9.75e-3)" "unprognostic (3.49e-2)" "unprognostic (2.15e-3)" "unprognostic (6.53e-2)" "unprognostic (1.68e-1)" "unprognostic (1.44e-1)" "unprognostic (1.14e-1)" 19.1 15.9 6.3 14.1 7.7 10.5 29.2 6.5 13.6 15.4 16.3 5.4 17.6 11.5 21.2 16.1 12.0 14.5 15.5 35.7 5.7 7.7 12.8 15.5 23.6 36.0 7.3 8.6 13.4 16.6 9.1 7.8 13.3 12.7 12.8 12.7 13.9 16.3 23.0 28.8 10.4 12.5 35.7 13.8 15.8 15.0 7.1 4.5 3.8 15.1 11.4 9.7 15.9 14.4 5.5 16.4 11.1 26.5 6.0 10.0 8.4 26.1 17.9 7.8 17.1 12.8 14.7 3.9 20.8 18.0 20.6 20.0 15.8 23.7 1.3 13.3 23.1 27.8 16.0 9.8 26.4 28.7 6.1 14.9 8.9 18.7 11.4 17.3 3.4 11.3 12.9 18.1 24.1 27.5 13.5 30.1 0.2 5.6 9.0 22.2 9.1 4.8 8.4 11.3 10.3 21.8 5.1 29.7 11.1 24.4 9.7 1.5 7.5 22.6 9.5 13.3 30.2 10.7 4.6 27.9 17.2 11.4 24.9 11.3 2.2 5.1 0.1 12.7 3.4 14.5 9.1 16.1 11.1 5.6 22.2 7.6 5.5 7.0 6.3 16.4 4.6 2.3 5.3 8.4 6.0 26.5 2.8 10.0 8.4 6.3 7.7 6.5 13.6 5.7 7.7 7.3 8.6 12.7 4.5 44.7 33.0 11.4 38.4 17.9 4.3 37.2 15.3 28.1 35.2 15.7 23.6 3.6 5.0 60.6 0.7 35.1 10.5 0.0 45.6 9.3 28.3 31.5 35.9 11.3 39.9 4.8 2.4 35.6 33.3 0.0 16.7 63.3 32.1 296.6 8.7 10.0 62.9 11.8 24.1 25.0 9.3 25.8 20.3 1.8 9.6 9.4 2.5 22.3 9.4 32.8 ACP1 "HAAP, LMW-PTP, LMWPTP" ENSG00000143727 "Acid phosphatase 1" P24666 2 264140-278283 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 913.9;Late spermatids: 1666.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016754 Approved Approved Nucleoplasm,Cytosol NA NA 3700000 Nucleoplasm Cytosol "HPA016754: AB_1844505" "unprognostic (1.15e-1)" "unprognostic (1.36e-1)" "unprognostic (1.37e-2)" "unprognostic (6.25e-3)" "unprognostic (1.06e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (6.67e-6)" "unprognostic (2.45e-1)" "prognostic unfavorable (3.04e-4)" "unprognostic (9.72e-3)" "unprognostic (4.89e-2)" "unprognostic (2.71e-2)" "unprognostic (7.10e-2)" "unprognostic (2.88e-2)" "unprognostic (3.39e-2)" "unprognostic (1.92e-1)" "unprognostic (2.44e-2)" 22.3 59.7 38.0 20.8 40.3 38.0 33.0 27.9 43.7 23.1 29.7 27.4 24.4 31.1 25.2 36.2 24.8 29.5 26.9 27.4 34.6 33.7 42.1 54.8 24.7 29.4 31.5 34.6 33.7 53.0 28.4 43.9 39.7 39.7 27.0 32.8 28.5 46.0 23.8 35.4 21.6 34.5 24.2 28.6 28.1 34.2 38.3 21.2 33.0 32.5 32.8 29.8 22.7 20.3 33.9 20.3 17.3 23.0 35.3 41.0 33.1 17.8 26.6 41.5 22.8 18.8 18.8 33.7 21.7 23.1 21.7 19.2 36.5 18.0 11.2 16.9 20.3 28.5 17.5 40.3 23.6 19.6 27.3 41.0 32.8 24.1 79.8 26.1 37.2 18.9 19.2 21.5 20.3 25.2 23.0 24.6 42.0 33.1 21.9 25.6 24.2 40.0 36.0 50.1 47.2 30.0 26.6 42.1 25.6 33.9 25.5 45.3 44.8 13.5 32.0 43.4 28.3 18.9 19.9 20.3 23.9 15.9 19.7 32.7 29.8 59.1 34.9 28.3 32.2 28.1 17.3 19.8 17.1 30.1 22.7 39.7 33.9 34.3 34.4 17.7 31.1 41.0 39.7 3.5 35.3 23.0 20.3 35.6 33.1 38.0 40.3 27.9 43.7 34.6 33.7 31.5 34.6 39.7 21.2 41.7 88.5 101.3 80.3 70.3 51.3 74.2 109.5 129.8 67.1 64.6 7.9 179.7 228.8 194.3 913.9 64.7 84.9 163.5 146.5 234.8 71.9 111.0 68.2 112.0 123.7 27.0 79.2 50.3 57.7 1666.6 87.5 74.7 77.6 116.4 107.9 64.8 155.5 108.7 86.7 241.7 43.6 90.5 79.3 111.8 121.7 79.7 157.0 93.8 114.3 108.3 ACRBP "CT23, OY-TES-1, SP32" ENSG00000111644 "Acrosin binding protein" Q8NEB7 12 6638075-6647460 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 170.4" "Group enriched" "Detected in many" 6 "Early spermatids: 884.1;Late spermatids: 605.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 4 "classical monocyte: 7.7;intermediate monocyte: 9.8;myeloid DC: 11.0;non-classical monocyte: 17.6" "Group enriched" "Detected in many" 8 "dendritic cells: 11.0;monocytes: 17.6" "Cell line enhanced" "Detected in some" "HEL: 5.5;HMC-1: 7.3;U-266/70: 16.3;U-266/84: 10.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039081, HPA039082" Enhanced Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Nucleoplasm, Vesicles" "HPA039081: AB_10670920, HPA039082: AB_10671036" "unprognostic (7.76e-3)" "unprognostic (2.27e-1)" "unprognostic (3.41e-3)" "unprognostic (2.31e-2)" "unprognostic (3.65e-2)" "unprognostic (2.13e-2)" "unprognostic (2.42e-1)" "unprognostic (3.40e-3)" "unprognostic (2.85e-1)" "unprognostic (5.47e-3)" "unprognostic (1.17e-2)" "unprognostic (1.43e-1)" "unprognostic (9.41e-3)" "unprognostic (1.25e-1)" "unprognostic (2.56e-1)" "unprognostic (1.44e-1)" "unprognostic (2.80e-4)" 0.8 0.4 0.3 0.9 0.8 2.5 0.5 1.3 0.6 0.4 1.6 0.6 0.5 2.2 0.4 4.2 0.5 0.6 1.7 1.0 0.6 0.3 0.9 0.7 0.8 3.6 0.4 0.3 0.4 1.5 0.0 0.5 0.4 0.8 0.7 0.4 0.8 0.5 0.1 0.3 0.4 3.3 0.6 0.6 2.3 0.6 170.4 0.3 0.5 3.9 0.3 0.8 0.7 0.5 1.2 11.0 1.6 17.6 0.3 0.1 6.5 0.2 0.1 0.9 2.7 1.0 1.3 1.4 0.0 0.0 0.1 0.1 0.0 1.9 0.3 0.9 0.2 0.1 0.0 0.5 0.0 0.2 0.6 0.0 5.5 0.6 0.0 2.1 0.1 7.3 0.1 3.7 1.0 0.1 0.7 0.6 1.9 3.6 0.0 0.1 0.4 0.2 1.9 1.7 4.5 0.0 0.3 0.1 0.3 0.6 0.1 1.1 0.2 0.0 0.7 1.2 1.4 0.0 2.0 0.8 0.1 0.8 0.6 0.0 16.3 10.7 0.5 0.6 2.0 0.0 0.9 7.7 0.7 0.1 9.8 0.0 0.8 0.0 0.0 11.0 1.2 0.1 0.1 1.6 0.3 17.6 2.8 0.0 6.5 0.3 0.8 1.3 0.6 0.6 0.3 0.4 0.3 0.8 0.3 0.0 2.2 0.0 0.2 0.1 1.4 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 884.1 0.5 1.2 0.0 0.4 0.2 0.4 0.0 5.8 0.0 9.0 0.0 0.0 2.5 11.7 605.9 7.5 3.9 0.0 0.0 0.9 1.0 0.2 0.9 4.2 0.8 1.5 6.5 0.1 127.7 7.2 0.0 0.1 0.0 0.9 0.1 ACSF2 "ACSMW, FLJ20920" ENSG00000167107 "Acyl-CoA synthetase family member 2" Q96CM8 17 50426158-50474845 "Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 60.0" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 70.1;Proximal tubular cells: 99.5;Syncytiotrophoblasts: 67.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 37.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024693 Enhanced Uncertain Nucleoplasm,Microtubules,Cytosol NA NA "Nucleoplasm, Microtubules, Cytosol" "HPA024693: AB_2671654" "unprognostic (1.40e-2)" "unprognostic (1.34e-1)" "unprognostic (2.58e-1)" "unprognostic (1.53e-1)" "unprognostic (1.06e-1)" "unprognostic (2.11e-1)" "unprognostic (8.48e-2)" "unprognostic (1.14e-2)" "unprognostic (6.49e-2)" "unprognostic (7.83e-2)" "unprognostic (2.41e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (2.17e-4)" "unprognostic (1.72e-2)" "unprognostic (1.11e-1)" "unprognostic (2.45e-2)" "prognostic favorable (2.41e-4)" 13.2 37.6 4.8 7.7 4.4 1.1 16.3 2.0 4.0 8.4 19.1 4.0 30.3 9.2 3.5 15.4 6.7 4.3 7.2 12.9 5.6 2.0 60.0 15.0 9.0 3.7 3.7 2.8 9.4 3.4 2.6 1.7 14.1 3.9 12.4 7.4 7.6 10.1 33.3 28.4 9.7 22.4 4.5 3.5 4.5 8.0 4.5 3.6 3.5 30.6 6.6 5.9 13.0 7.6 7.8 13.8 11.9 6.2 1.2 4.3 2.1 9.6 3.1 2.6 6.2 27.5 5.0 15.3 2.3 3.4 5.0 9.9 12.3 18.5 6.0 5.1 2.8 4.6 5.8 1.8 11.4 6.0 7.5 4.4 10.3 1.5 21.8 4.6 1.3 9.6 22.2 17.5 6.4 0.8 18.0 6.8 7.9 1.2 3.4 5.4 11.6 3.1 4.1 0.4 18.2 4.6 7.8 1.9 15.2 1.6 37.7 8.5 4.6 4.5 6.9 4.7 5.5 6.0 8.8 5.1 9.2 2.9 1.3 0.7 6.1 1.2 3.1 3.8 6.5 0.5 0.0 2.5 11.9 1.8 6.2 1.6 7.8 1.3 1.8 13.8 1.9 0.6 0.8 0.4 1.2 5.4 5.2 4.3 2.1 4.8 4.4 2.0 4.0 5.6 2.0 3.7 2.8 3.9 3.6 26.8 22.4 2.4 22.9 5.4 0.0 17.3 10.2 12.0 17.0 3.5 0.0 70.1 10.0 10.9 0.2 5.2 47.0 0.0 3.9 9.5 5.9 3.5 21.9 34.1 19.9 0.0 9.8 4.3 8.8 1.3 24.7 11.5 3.3 15.4 19.9 6.6 4.5 35.1 13.4 99.5 0.2 0.0 3.9 0.0 2.7 6.0 67.7 5.7 18.3 10.6 ACSL1 "ACS1, FACL1, FACL2, LACS, LACS1, LACS2" ENSG00000151726 "Acyl-CoA synthetase long chain family member 1" P33121 4 184755595-184826818 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 105.0;liver: 190.9" "Group enriched" "Detected in many" 4 "Early spermatids: 359.4;Hepatocytes: 1018.8;Late spermatids: 335.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "neutrophil: 80.2" "Lineage enriched" "Detected in many" 9 "granulocytes: 80.2" "Cell line enhanced" "Detected in many" "ASC diff: 151.2;ASC TERT1: 36.7;HSkMC: 80.3;RPTEC TERT1: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011316, HPA011964" Enhanced Uncertain Nucleoplasm,Mitochondria,Cytosol NA NA Nucleoplasm "Mitochondria, Cytosol" "HPA011316: AB_1844536, HPA011964: AB_1844537" "unprognostic (1.10e-2)" "unprognostic (3.19e-1)" "unprognostic (1.04e-1)" "unprognostic (1.64e-3)" "unprognostic (2.93e-2)" "unprognostic (1.21e-2)" "unprognostic (1.82e-3)" "unprognostic (2.75e-2)" "unprognostic (1.79e-1)" "unprognostic (5.89e-2)" "unprognostic (9.83e-2)" "unprognostic (3.15e-1)" "prognostic favorable (1.25e-5)" "unprognostic (2.77e-1)" "unprognostic (4.38e-2)" "unprognostic (6.25e-3)" "unprognostic (3.13e-2)" 105.0 6.7 4.2 14.1 13.5 46.0 54.4 3.2 9.6 7.2 12.2 16.4 5.5 4.9 5.7 12.7 8.8 6.4 5.7 24.3 6.4 4.1 32.8 190.9 20.7 18.9 24.0 3.8 4.2 7.3 5.9 8.7 4.4 11.6 14.2 2.6 9.1 17.9 4.8 89.1 20.4 4.5 6.4 18.2 16.9 6.5 6.4 15.9 2.1 8.3 10.1 5.8 7.6 11.0 0.5 2.2 80.2 8.9 0.7 0.7 2.9 6.1 1.9 1.2 3.1 151.2 36.7 1.0 3.4 1.7 2.0 1.4 0.4 1.7 2.5 0.3 4.0 4.9 3.8 5.4 2.2 1.7 12.4 1.9 1.8 1.7 5.0 24.3 4.9 4.6 80.3 18.6 1.7 8.7 3.6 2.6 0.4 0.8 7.8 9.8 3.2 0.3 6.8 0.2 4.1 2.7 0.9 1.0 3.2 47.8 17.5 4.6 4.3 3.1 9.4 10.5 0.5 3.4 5.0 2.8 1.8 2.1 4.3 1.0 3.0 1.5 1.1 5.8 6.9 2.8 2.3 8.9 2.8 0.5 5.2 0.5 0.5 0.4 0.2 2.2 0.5 0.4 0.3 80.2 0.7 3.6 0.4 0.7 2.9 4.2 13.5 3.2 9.6 6.4 4.1 24.0 3.8 11.6 15.9 23.8 107.2 14.5 16.5 18.7 5.8 89.7 28.1 13.4 21.6 29.6 17.7 8.6 79.6 3.9 359.4 5.6 2.6 0.0 11.0 1.9 9.1 56.1 23.1 1018.8 39.4 3.2 0.0 19.0 136.2 335.5 17.8 64.1 30.4 24.4 4.2 3.3 9.0 0.9 15.6 75.0 10.3 12.9 12.0 8.1 16.7 35.9 2.9 10.0 1.7 21.4 ACSL5 "ACS2, ACS5, FACL5" ENSG00000197142 "Acyl-CoA synthetase long chain family member 5" Q9ULC5 10 112374018-112428380 "Enzymes, Plasma proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 278.7" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 266.6;Paneth cells: 93.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 43.3;RT4: 44.2;U-937: 21.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007162, CAB035986, CAB062546" Enhanced Supported Nucleoplasm,Mitochondria NA NA 22000 Mitochondria Nucleoplasm "CAB035986: AB_941506, CAB062546: AB_2665614, HPA007162: AB_2667761" "unprognostic (5.75e-3)" "unprognostic (2.06e-1)" "unprognostic (3.08e-2)" "prognostic favorable (1.13e-4)" "unprognostic (2.45e-1)" "unprognostic (2.13e-2)" "unprognostic (4.92e-2)" "unprognostic (5.90e-2)" "unprognostic (1.67e-1)" "unprognostic (4.06e-2)" "unprognostic (4.18e-3)" "unprognostic (7.40e-2)" "unprognostic (5.25e-3)" "unprognostic (2.11e-1)" "unprognostic (1.10e-1)" "unprognostic (5.92e-3)" "unprognostic (1.08e-3)" 10.0 1.4 3.1 12.7 3.5 2.2 6.4 1.2 3.1 9.3 84.6 1.6 3.8 64.5 8.7 41.8 4.2 8.0 11.2 3.1 3.3 3.1 3.2 56.5 10.8 7.1 4.0 1.2 5.0 1.6 0.1 1.2 2.1 3.9 7.0 21.5 8.4 2.4 4.0 2.6 1.3 278.7 2.6 3.8 12.4 7.7 2.3 2.5 6.3 3.1 2.7 7.2 17.4 6.7 10.8 19.4 16.3 17.0 16.2 25.1 11.7 11.6 0.3 0.2 0.0 0.8 0.1 1.0 0.3 2.3 0.0 0.2 10.6 43.3 14.2 2.6 0.6 2.1 0.1 0.0 0.0 0.2 11.9 0.0 11.1 0.4 18.5 2.8 17.2 18.8 1.9 0.0 0.2 0.0 0.8 0.8 0.0 0.0 6.5 0.0 0.0 0.0 7.9 0.0 9.8 0.4 3.9 0.0 8.7 1.2 44.2 0.0 0.3 17.3 6.6 0.0 0.0 0.0 9.7 12.5 0.1 0.1 0.7 0.7 4.7 0.0 6.9 0.4 21.6 0.0 14.5 9.3 16.3 16.7 17.0 16.6 10.8 13.7 18.4 19.4 8.2 9.5 14.5 2.5 16.2 15.9 6.2 25.1 11.7 3.1 3.5 1.2 3.1 3.3 3.1 4.0 1.2 3.9 2.5 11.9 43.5 21.6 7.4 3.4 0.0 1.4 12.7 5.3 33.0 0.0 3.9 1.6 0.0 12.0 65.8 24.5 266.6 0.0 5.6 1.9 1.7 5.7 17.3 79.9 16.7 0.0 39.2 16.0 19.2 29.7 14.7 23.5 3.3 4.6 84.3 0.0 29.0 93.1 11.3 0.0 1.2 0.0 1.4 1.7 1.4 1.5 0.6 14.9 90.6 41.4 ACSS2 "ACAS2, AceCS, ACS, ACSA, dJ1161H23.1" ENSG00000131069 "Acyl-CoA synthetase short chain family member 2" Q9NR19 20 34872146-34927962 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 63.4" "Cell type enhanced" "Detected in all" 5 "Enterocytes: 98.3;Mucus-secreting cells: 80.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.0" "Group enriched" "Detected in many" 5 "dendritic cells: 12.6;granulocytes: 17.0;monocytes: 11.6" "Cell line enhanced" "Detected in many" "RPMI-8226: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004141 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA004141: AB_1078094" "unprognostic (1.97e-2)" "unprognostic (1.33e-1)" "unprognostic (1.70e-1)" "unprognostic (2.25e-2)" "unprognostic (1.84e-2)" "unprognostic (1.86e-1)" "unprognostic (1.42e-1)" "unprognostic (5.45e-2)" "unprognostic (1.13e-1)" "unprognostic (3.92e-2)" "unprognostic (1.66e-1)" "unprognostic (1.42e-2)" "prognostic favorable (2.04e-4)" "unprognostic (2.72e-1)" "unprognostic (2.32e-1)" "unprognostic (3.08e-1)" "unprognostic (2.54e-1)" 30.3 12.6 2.8 9.2 7.0 1.9 12.4 5.6 7.0 6.8 21.0 10.6 8.3 21.4 6.6 7.0 8.1 4.5 7.7 24.8 2.9 2.5 11.2 15.7 11.7 3.2 6.8 3.2 5.1 3.2 4.7 2.5 4.6 5.5 3.4 10.4 3.5 9.8 6.8 63.4 6.8 24.1 3.0 6.1 2.7 13.4 3.1 7.1 1.1 3.9 7.3 3.0 6.5 6.1 0.7 12.6 17.0 11.6 0.3 3.0 4.7 11.9 1.6 1.2 1.6 8.5 9.0 12.4 7.1 5.5 2.0 3.5 4.3 6.6 0.0 8.1 3.1 7.7 9.0 2.9 17.9 1.5 0.1 2.8 16.6 0.8 2.0 6.2 1.6 9.1 6.1 3.9 2.9 2.8 2.9 3.1 1.2 10.5 1.3 2.7 1.4 0.5 7.3 0.8 3.6 20.3 4.4 7.8 26.2 6.8 1.2 1.1 5.4 8.7 6.4 6.9 3.4 3.1 3.6 11.7 2.4 3.3 4.3 2.3 11.3 8.2 3.8 6.7 2.6 1.9 17.0 11.6 3.0 0.6 7.2 0.5 0.4 1.6 0.7 12.6 0.7 3.0 1.5 6.5 0.3 3.4 2.1 1.1 4.7 2.8 7.0 5.6 7.0 2.9 2.5 6.8 3.2 5.5 7.1 11.9 40.9 3.0 8.5 6.9 6.0 70.4 25.5 5.3 13.6 10.4 5.9 13.6 10.0 16.5 7.2 13.2 98.3 23.3 29.5 8.5 8.9 8.8 9.2 44.8 14.7 7.9 7.5 10.4 17.2 6.0 10.6 13.8 13.5 19.8 80.6 8.8 18.1 60.0 4.2 51.2 3.4 12.9 9.9 11.6 7.3 9.5 17.5 5.0 60.0 8.9 ACTL6A "Actl6, Arp4, BAF53A, INO80K" ENSG00000136518 "Actin like 6A" O96019 3 179562880-179588408 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Growth regulation, Neurogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 197.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012188, HPA018671, HPA063149" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB012188: AB_304125, HPA018671: AB_2669914, HPA063149: " "unprognostic (2.13e-1)" "unprognostic (5.33e-2)" "unprognostic (1.54e-2)" "unprognostic (2.24e-3)" "unprognostic (7.79e-3)" "unprognostic (1.51e-2)" "prognostic unfavorable (1.89e-5)" "unprognostic (3.36e-2)" "unprognostic (1.09e-3)" "unprognostic (2.13e-2)" "prognostic unfavorable (5.44e-5)" "unprognostic (1.03e-2)" "prognostic unfavorable (4.80e-5)" "unprognostic (4.21e-2)" "unprognostic (1.96e-1)" "unprognostic (4.21e-3)" "unprognostic (5.20e-2)" 18.8 17.9 9.9 23.4 16.8 8.7 21.3 8.7 9.6 16.8 21.3 15.3 15.6 14.5 24.8 16.4 23.2 16.3 14.9 24.2 8.7 7.4 19.6 18.6 14.6 17.4 16.7 5.4 24.8 20.9 13.7 23.4 20.1 13.7 17.7 23.5 10.4 19.0 17.4 12.8 19.4 19.8 16.1 14.8 19.3 16.7 47.5 17.0 46.1 21.9 20.4 23.8 18.7 22.7 17.5 19.8 8.0 16.1 14.5 22.4 13.8 46.2 14.0 34.9 18.4 13.4 14.7 27.4 18.7 14.6 34.9 29.6 31.6 22.8 36.2 33.6 17.5 40.6 21.4 30.5 23.0 43.5 35.8 25.4 29.6 15.5 23.9 15.3 36.7 18.6 10.2 23.6 22.5 19.0 11.0 19.8 21.9 23.0 20.7 25.1 31.6 32.1 22.7 31.0 42.0 31.4 30.2 29.2 66.9 27.6 18.7 28.7 20.5 28.8 28.8 28.8 18.2 56.2 30.3 14.9 24.9 21.5 25.5 56.3 13.5 20.1 55.5 13.8 39.1 27.4 3.3 11.3 8.0 15.1 14.3 20.0 17.5 17.5 17.4 19.8 13.7 19.2 19.4 1.5 14.5 16.1 11.2 22.4 13.8 9.9 16.8 8.7 9.6 8.7 7.4 16.7 5.4 13.7 17.0 20.8 23.9 24.3 37.3 41.9 4.8 6.0 28.1 30.8 23.9 26.2 7.9 42.0 29.9 42.1 15.5 20.7 13.0 0.0 39.2 57.0 28.9 28.3 13.9 14.0 30.6 0.0 29.2 12.3 18.6 11.4 30.0 16.7 28.7 33.3 24.6 16.3 32.2 17.5 28.3 17.9 12.3 25.8 23.6 197.2 97.8 40.1 25.6 19.2 36.2 35.1 ACTR8 INO80N ENSG00000113812 "ARP8 actin related protein 8 homolog" Q9H981 3 53867066-53882202 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 71.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 28.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065236 Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA065236: AB_2685442" "unprognostic (9.05e-2)" "unprognostic (2.06e-1)" "prognostic favorable (2.21e-4)" "unprognostic (2.97e-1)" "unprognostic (5.67e-2)" "unprognostic (1.88e-1)" "prognostic unfavorable (5.11e-6)" "unprognostic (2.24e-2)" "unprognostic (4.68e-2)" "unprognostic (1.02e-1)" "unprognostic (2.82e-1)" "unprognostic (5.68e-2)" "prognostic favorable (7.88e-9)" "unprognostic (3.68e-1)" "unprognostic (3.35e-1)" "unprognostic (2.84e-1)" "unprognostic (1.15e-1)" 13.2 11.2 19.8 12.6 20.0 11.3 12.9 25.6 24.5 13.7 12.4 13.9 10.5 9.9 14.1 14.3 14.1 12.8 11.3 24.3 18.2 13.7 17.9 11.8 12.4 17.0 17.7 15.5 15.0 15.8 21.9 22.0 14.8 16.0 13.0 16.8 12.5 14.2 12.6 20.1 14.5 11.9 15.3 16.1 14.4 12.6 27.5 19.9 19.9 16.8 10.5 19.2 16.1 11.8 6.1 6.3 28.8 7.1 8.6 8.5 4.4 6.5 8.1 15.9 13.1 13.1 16.5 11.9 15.5 19.8 21.0 16.8 12.6 8.0 20.0 4.6 21.3 15.5 5.6 11.9 10.7 20.0 8.1 4.9 19.9 12.6 13.4 15.5 21.1 17.9 12.9 11.0 21.7 13.7 16.3 16.2 10.7 8.9 7.0 21.1 7.6 7.0 12.6 14.8 9.5 12.9 9.3 9.9 12.0 15.9 18.4 4.7 13.7 10.1 8.8 8.9 15.7 5.7 11.8 11.0 16.1 10.5 14.7 14.0 19.6 24.9 20.5 11.9 15.5 10.0 28.8 4.7 5.8 5.8 7.1 5.8 6.1 5.4 5.5 6.3 3.8 5.7 6.1 2.4 8.6 4.2 4.6 8.5 4.4 19.8 20.0 25.6 24.5 18.2 13.7 17.7 15.5 16.0 19.9 3.0 7.7 7.8 6.1 6.9 6.5 17.8 10.2 2.7 4.5 3.5 3.9 10.4 18.3 13.2 35.7 7.7 5.2 0.0 13.7 9.4 7.1 5.7 5.7 4.7 10.2 1.6 10.4 7.4 6.3 71.4 10.0 8.2 5.0 13.6 9.0 7.0 11.6 2.9 9.2 15.9 4.7 0.0 9.2 17.6 15.4 5.6 8.6 12.2 5.7 5.4 ACTRT3 ARPM1 ENSG00000184378 "Actin related protein T3" Q9BYD9 3 169766921-169769895 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "testis: 57.4" "Cell type enriched" "Detected in many" 9 "Early spermatids: 728.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.4" "Group enriched" "Detected in many" 4 "B-cells: 1.2;T-cells: 3.4" "Cell line enhanced" "Detected in many" "ASC diff: 16.0;HSkMC: 10.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA035817, HPA035818" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA035817: AB_10671938, HPA035818: AB_2674801" "unprognostic (2.35e-1)" "unprognostic (9.39e-2)" "unprognostic (2.10e-2)" "prognostic unfavorable (4.11e-4)" "unprognostic (1.89e-2)" "unprognostic (1.75e-1)" "unprognostic (3.29e-1)" "unprognostic (1.24e-1)" "unprognostic (7.31e-4)" "unprognostic (2.64e-1)" "unprognostic (9.16e-2)" "unprognostic (4.41e-2)" "unprognostic (8.03e-2)" "unprognostic (8.49e-2)" "unprognostic (1.63e-1)" "unprognostic (8.25e-3)" "unprognostic (2.22e-1)" 1.0 0.7 0.9 0.4 1.1 0.5 1.5 2.4 1.3 1.0 0.5 0.5 1.3 0.7 0.7 1.4 0.6 1.4 0.5 0.7 0.7 0.9 1.8 1.7 0.7 0.6 1.0 0.4 1.1 0.3 0.8 1.0 0.7 1.1 1.0 0.4 0.6 0.5 1.3 0.7 0.3 0.5 1.0 0.6 0.1 0.8 57.4 0.7 0.2 1.0 0.1 0.5 1.5 3.1 1.2 0.5 0.0 0.0 0.0 3.4 0.4 3.6 2.2 0.2 1.1 16.0 5.2 0.0 4.4 2.6 2.7 2.3 0.0 4.6 0.0 6.1 4.9 1.8 2.3 1.2 2.1 2.8 2.7 1.6 8.4 1.9 0.4 2.6 0.9 0.7 10.3 0.5 3.3 0.6 1.8 4.9 1.0 0.0 0.0 4.8 1.8 0.3 0.1 3.9 3.1 4.6 0.7 0.0 0.1 2.9 0.9 2.9 2.0 5.2 1.3 0.1 0.5 2.2 3.6 2.2 0.0 0.0 2.2 0.0 0.5 0.2 0.2 1.1 0.0 0.5 0.0 0.0 0.0 0.7 0.0 3.4 1.2 0.0 1.1 0.5 1.1 0.4 0.4 0.0 0.0 0.0 0.5 0.0 0.4 0.9 1.1 2.4 1.3 0.7 0.9 1.0 0.4 1.1 0.7 0.0 1.0 0.0 0.7 0.3 1.0 0.6 0.0 2.7 2.3 0.0 2.0 1.4 1.7 2.0 728.6 0.7 0.0 0.0 1.8 1.1 1.4 0.4 1.1 1.7 1.4 3.2 0.0 1.8 0.6 82.5 8.9 0.6 1.7 0.0 0.1 1.4 1.3 0.0 5.3 2.5 1.1 12.9 1.9 5.5 4.0 0.0 0.7 0.0 0.4 0.3 ACVR2B ActR-IIB ENSG00000114739 "Activin A receptor type 2B" Q13705 3 38453851-38493142 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Heterotaxy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 16.4;NTERA-2: 20.3;SuSa: 12.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007398, CAB025115, HPA040384" Approved Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" No No Cytosol "Nucleoplasm, Nuclear bodies" "CAB025115: , HPA007398: AB_2667822, HPA040384: AB_2732484" "unprognostic (5.11e-2)" "unprognostic (1.54e-1)" "unprognostic (3.47e-1)" "unprognostic (8.73e-2)" "unprognostic (9.24e-2)" "unprognostic (2.21e-1)" "unprognostic (1.32e-2)" "unprognostic (1.25e-2)" "unprognostic (1.88e-1)" "unprognostic (1.53e-2)" "unprognostic (5.14e-2)" "unprognostic (1.30e-1)" "unprognostic (4.08e-3)" "unprognostic (1.64e-1)" "unprognostic (1.98e-1)" "unprognostic (1.83e-1)" "unprognostic (4.75e-1)" 2.8 7.4 5.5 4.6 7.9 1.1 5.5 13.2 7.5 5.2 3.4 7.2 4.5 2.8 4.7 5.1 2.5 5.6 3.3 3.9 5.9 5.4 5.3 5.4 6.9 2.2 5.9 5.4 8.3 6.1 11.3 5.1 16.0 6.5 3.9 3.6 5.0 4.6 4.2 15.9 2.4 2.8 4.6 4.7 3.1 4.0 9.1 9.1 12.8 4.8 1.7 2.2 4.2 10.3 0.3 0.3 0.5 0.2 0.5 1.6 0.3 0.8 1.4 16.4 1.4 0.6 0.4 8.8 0.3 0.5 0.3 0.7 2.3 1.1 0.1 1.2 0.3 0.5 1.0 6.3 1.0 0.9 2.4 4.1 4.2 2.5 3.5 0.8 2.9 1.6 0.7 0.9 0.5 1.8 1.0 1.1 6.2 6.9 1.4 0.3 1.3 5.1 1.9 20.3 0.8 0.7 1.7 5.5 1.0 1.0 1.9 3.8 6.7 0.4 2.5 2.2 12.2 1.3 3.9 0.9 0.5 2.7 0.4 1.4 3.9 5.4 0.9 0.6 2.5 1.1 0.5 0.1 0.1 0.4 0.2 0.6 0.2 1.0 0.5 0.0 0.3 1.6 1.5 0.3 0.5 0.2 0.3 0.7 0.3 5.5 7.9 13.2 7.0 5.9 5.4 5.9 5.4 6.5 9.1 6.0 6.7 0.5 3.6 3.5 20.7 11.6 5.1 6.7 4.5 0.0 21.6 6.7 0.0 3.2 9.1 6.1 2.9 0.0 3.3 5.8 3.1 3.2 1.1 7.5 2.2 20.6 6.9 4.9 2.1 12.6 10.9 3.2 6.8 0.0 3.2 9.6 3.8 2.5 7.4 2.8 25.5 0.0 5.6 8.1 19.0 3.4 5.1 2.5 4.7 3.3 ACYP1 ENSG00000119640 "Acylphosphatase 1" P07311 14 75053221-75069483 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034944 Approved Approved Nucleoplasm,Cytosol NA NA 92000 Cytosol Nucleoplasm "HPA034944: AB_10669898" "prognostic favorable (1.17e-4)" "unprognostic (3.83e-3)" "unprognostic (1.92e-1)" "unprognostic (5.90e-2)" "unprognostic (1.26e-1)" "unprognostic (1.85e-1)" "prognostic unfavorable (6.14e-7)" "unprognostic (5.48e-2)" "unprognostic (4.40e-1)" "unprognostic (1.64e-2)" "unprognostic (1.37e-3)" "unprognostic (3.56e-2)" "unprognostic (4.74e-2)" "unprognostic (6.69e-3)" "unprognostic (9.39e-2)" "unprognostic (1.07e-1)" "unprognostic (5.32e-3)" 8.7 27.4 23.0 13.9 20.4 12.7 16.2 24.0 25.2 10.6 14.9 14.8 14.3 11.3 10.2 26.9 11.6 21.4 7.1 10.8 19.9 30.2 12.2 5.2 10.9 17.6 28.7 19.3 9.1 7.0 8.9 38.2 10.4 24.4 10.0 19.8 9.4 9.7 12.9 22.3 24.4 11.3 11.4 27.5 10.9 14.0 16.7 22.9 8.3 20.2 10.3 19.0 7.5 12.0 10.6 7.6 12.3 6.6 10.0 17.8 5.1 24.8 13.7 19.8 12.1 8.0 9.4 11.0 14.3 5.6 14.6 20.8 13.8 28.1 27.5 8.8 5.9 8.7 22.4 13.0 6.3 23.9 39.9 16.0 17.8 36.1 9.7 4.8 11.2 18.7 5.2 9.1 20.1 10.4 9.4 19.1 26.1 14.0 33.2 19.1 17.0 25.1 20.9 6.0 21.8 13.8 20.2 26.1 12.8 20.5 13.2 36.3 14.7 9.8 6.7 22.2 9.8 14.8 11.1 9.0 10.0 18.5 20.1 15.3 7.9 16.0 28.8 15.3 13.2 10.7 3.9 2.2 12.3 8.6 4.3 9.7 10.0 14.5 9.9 3.8 10.6 12.2 11.3 0.9 10.0 6.6 7.6 17.8 5.1 23.0 20.4 24.0 25.2 19.9 30.2 28.7 19.3 24.4 22.9 6.0 7.8 18.2 36.9 25.4 31.8 17.9 35.7 80.3 19.4 62.8 11.8 19.4 33.2 16.7 18.7 25.1 15.8 70.0 16.2 27.5 20.2 16.2 11.5 4.3 19.1 41.3 28.9 6.7 3.8 7.0 15.5 11.7 37.1 10.0 22.3 16.1 18.0 20.1 15.6 17.3 29.9 25.8 25.8 90.7 15.8 21.0 11.4 22.3 32.3 31.1 ACYP2 ENSG00000170634 "Acylphosphatase 2" P14621 2 53970838-54305300 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 116.4" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 159.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035301 Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA035301: AB_10670291" "unprognostic (1.19e-1)" "unprognostic (2.84e-2)" "unprognostic (3.40e-1)" "unprognostic (2.16e-1)" "unprognostic (6.90e-3)" "unprognostic (6.21e-2)" "unprognostic (2.03e-3)" "unprognostic (3.17e-1)" "unprognostic (5.22e-2)" "unprognostic (7.83e-3)" "unprognostic (3.64e-3)" "unprognostic (1.16e-1)" "unprognostic (6.66e-2)" "unprognostic (2.13e-1)" "unprognostic (1.97e-1)" "unprognostic (3.24e-1)" "unprognostic (2.24e-2)" 12.9 24.0 31.0 4.6 33.9 5.6 10.1 15.5 29.3 6.7 6.2 19.4 4.4 6.2 6.7 10.5 6.6 7.1 7.3 39.6 29.1 28.4 8.8 18.7 7.2 7.5 35.7 18.2 5.7 10.3 9.1 9.7 5.9 28.1 10.4 4.8 6.3 11.5 8.4 116.4 6.6 5.6 6.9 35.7 7.8 7.5 6.5 22.7 3.5 8.2 22.9 6.4 8.2 4.1 20.9 23.7 24.1 10.2 12.6 15.9 8.9 7.7 4.3 4.6 3.8 16.8 13.3 4.2 9.3 7.0 5.8 5.1 1.0 5.6 15.1 24.7 9.2 5.8 6.6 2.5 7.8 5.4 13.0 10.3 11.6 4.7 11.5 6.9 9.7 5.6 9.6 14.6 4.1 6.9 11.8 2.6 7.8 4.8 8.1 12.2 4.9 6.0 12.0 5.2 6.1 5.4 4.8 4.4 8.5 13.6 7.1 13.3 8.8 11.3 7.1 4.2 1.8 2.6 8.9 9.3 8.2 7.9 3.6 8.6 17.1 9.4 8.4 11.9 16.6 9.0 24.1 10.2 19.8 13.4 9.0 11.9 20.9 13.4 12.7 14.7 19.7 15.9 13.4 8.5 12.6 8.8 23.7 11.6 8.9 31.0 33.9 15.5 29.3 29.1 28.4 35.7 18.2 28.1 22.7 14.9 13.2 27.4 34.8 18.2 14.8 159.9 25.5 25.4 21.6 17.4 9.8 12.0 53.0 19.2 60.2 23.2 19.1 23.3 33.4 5.0 14.9 30.3 19.6 58.0 27.9 27.0 29.4 26.4 35.8 48.4 12.4 30.9 21.9 21.6 25.3 53.2 29.4 17.5 29.0 36.5 28.8 51.8 26.4 19.2 9.7 18.6 8.6 17.0 18.0 35.7 ADAL ENSG00000168803 "Adenosine deaminase like" Q6DHV7 15 43330657-43354555 "Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 76.6;Rod photoreceptor cells: 77.1;Spermatogonia: 66.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039879, HPA048175, HPA058795" Approved Approved "Nucleoplasm,Nuclear speckles,Vesicles" NA NA Nucleoplasm "Nuclear speckles, Vesicles" "HPA039879: , HPA048175: AB_2680298, HPA058795: " "unprognostic (1.65e-2)" "unprognostic (1.53e-3)" "unprognostic (9.80e-2)" "unprognostic (3.15e-3)" "unprognostic (2.46e-3)" "unprognostic (1.86e-1)" "unprognostic (2.00e-1)" "unprognostic (5.83e-2)" "unprognostic (5.90e-2)" "unprognostic (2.68e-1)" "unprognostic (6.85e-3)" "unprognostic (1.69e-1)" "prognostic favorable (7.64e-9)" "unprognostic (2.37e-3)" "unprognostic (8.77e-2)" "unprognostic (5.31e-2)" "unprognostic (2.44e-2)" 6.9 7.9 10.0 4.6 12.4 4.7 7.1 9.0 11.3 4.0 6.2 9.9 4.2 6.9 6.8 11.0 5.1 4.3 4.7 23.8 9.3 10.3 14.1 10.6 4.2 5.2 10.5 9.0 4.6 5.2 15.6 10.6 3.4 10.7 7.7 5.9 11.8 4.9 8.0 20.9 3.5 8.6 8.8 14.0 4.7 4.7 12.5 9.2 4.4 13.0 9.7 5.6 6.1 3.6 5.0 7.3 8.8 4.6 5.0 8.7 3.0 4.7 2.5 9.8 10.5 4.1 5.5 4.5 5.5 5.8 8.9 13.9 9.8 2.4 5.8 9.5 6.2 11.9 5.2 0.0 4.0 8.0 5.6 6.5 13.5 16.2 8.0 5.8 0.0 10.3 7.1 7.9 6.5 6.8 5.8 1.9 13.4 14.3 11.3 9.7 3.3 8.3 6.7 3.9 5.2 3.6 10.9 14.3 8.5 8.3 2.9 12.5 8.4 9.4 8.3 8.4 5.5 8.8 9.4 2.4 15.8 7.4 12.0 11.6 11.9 19.7 2.3 8.9 14.5 12.9 8.8 3.3 7.7 5.9 4.6 4.7 5.0 5.5 5.0 4.5 5.0 5.8 7.0 2.3 5.0 3.9 7.3 8.7 3.0 10.0 12.4 9.0 11.3 9.3 10.3 10.5 9.0 10.7 9.2 8.9 9.3 12.5 7.9 6.3 39.1 42.8 10.2 12.0 5.7 17.4 76.6 6.4 49.7 7.8 9.3 6.9 8.7 0.0 7.3 5.5 7.6 7.8 7.0 27.2 7.5 39.7 7.5 10.4 5.4 9.6 8.9 11.2 8.5 3.6 7.3 33.0 5.4 0.0 8.1 24.8 77.1 6.5 8.0 33.7 66.1 3.9 2.2 9.2 9.9 2.4 ADAM10 "CD156c, HsT18717, kuz, MADM" ENSG00000137845 "ADAM metallopeptidase domain 10" O14672 15 58588807-58749978 "Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Notch signaling pathway" "Hydrolase, Metalloprotease, Protease" "Alzheimer disease, Amyloidosis, Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 77.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001709, HPA050670" Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 8200000 "Plasma membrane" "Nucleoplasm, Vesicles" "CAB001709: , HPA050670: " "unprognostic (1.43e-1)" "unprognostic (1.38e-1)" "unprognostic (2.77e-1)" "unprognostic (5.04e-2)" "unprognostic (3.09e-1)" "unprognostic (2.70e-3)" "unprognostic (7.48e-2)" "prognostic unfavorable (8.46e-5)" "unprognostic (3.99e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (6.69e-2)" "unprognostic (2.57e-2)" "unprognostic (2.57e-3)" "unprognostic (9.14e-2)" "unprognostic (2.09e-2)" "unprognostic (1.60e-2)" 25.9 11.1 15.5 17.1 17.7 15.6 20.0 25.2 17.6 18.6 20.1 15.7 12.7 13.9 19.9 11.8 17.1 13.8 18.0 18.8 17.6 13.7 20.8 14.8 25.0 26.1 23.1 12.4 13.9 13.1 10.9 11.6 36.1 14.5 23.6 16.7 14.6 12.4 19.1 8.9 15.4 15.6 12.8 30.4 40.4 18.4 8.5 18.9 38.5 27.3 9.2 14.9 30.0 19.1 6.2 12.7 26.9 23.7 9.8 12.2 12.8 12.1 27.4 7.5 8.1 9.6 13.9 18.9 10.4 31.0 7.7 10.7 12.6 16.1 5.6 32.2 9.3 13.5 24.8 4.5 11.0 10.2 8.4 5.8 9.6 10.0 11.7 10.7 6.8 27.7 12.1 8.1 5.4 7.9 11.2 14.9 12.2 6.0 15.3 13.5 4.5 22.4 7.7 10.2 4.0 3.9 9.3 24.5 14.4 17.9 32.7 8.1 5.3 11.3 13.2 18.0 17.1 7.8 13.6 10.5 10.1 11.3 77.5 10.0 8.6 18.5 6.1 14.1 13.1 17.6 12.9 18.8 10.4 8.1 21.5 12.2 5.3 8.0 7.1 12.7 6.2 8.4 7.0 26.9 9.8 23.7 5.8 10.3 12.8 15.5 17.7 25.2 16.9 17.6 13.7 23.1 12.4 14.5 18.9 77.4 49.8 30.6 25.8 23.7 20.2 29.7 30.6 30.8 35.2 76.8 25.5 27.4 1.7 45.7 21.6 61.6 39.3 0.0 27.7 46.7 28.8 75.5 27.9 30.4 56.9 42.9 34.7 76.1 87.0 16.2 16.7 64.0 43.9 13.6 45.8 27.0 37.3 43.2 15.9 20.3 32.7 12.9 28.3 13.6 16.2 19.4 22.2 43.6 33.7 59.6 ADAM32 ENSG00000197140 "ADAM metallopeptidase domain 32" Q8TC27 8 39106990-39284911 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 47.0" "Cell type enhanced" "Detected in many" 27 "Early spermatids: 134.9;Late spermatids: 35.0;Spermatocytes: 21.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "U-2 OS: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA044156, HPA062151" Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA044156: AB_10796798, HPA062151: AB_2684699" "unprognostic (2.13e-1)" "unprognostic (6.92e-2)" "unprognostic (4.63e-3)" "unprognostic (8.99e-2)" "unprognostic (1.48e-1)" "unprognostic (1.52e-2)" "unprognostic (5.66e-3)" "unprognostic (1.49e-1)" "unprognostic (2.05e-1)" "unprognostic (1.12e-1)" "unprognostic (2.50e-1)" "unprognostic (3.38e-2)" "unprognostic (1.13e-7)" "unprognostic (3.42e-1)" "unprognostic (4.90e-2)" "unprognostic (8.34e-3)" "unprognostic (7.82e-2)" 0.6 0.6 0.3 0.2 0.4 0.4 0.6 0.3 0.5 0.6 0.3 0.2 0.2 0.0 0.3 0.8 0.2 0.3 0.5 0.4 0.3 0.7 0.2 0.2 0.2 0.2 0.3 0.6 0.5 1.2 0.1 0.2 0.2 0.4 0.3 0.4 0.4 0.2 0.7 0.2 0.8 0.3 0.2 0.2 0.5 0.1 47.0 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.9 0.2 1.5 0.4 2.6 0.9 0.0 0.7 0.3 0.1 0.4 2.0 0.2 0.2 1.3 0.4 1.2 0.4 0.1 2.6 0.0 0.5 2.4 0.1 0.2 0.5 0.0 1.5 0.1 0.3 0.0 2.2 0.3 0.3 0.2 0.8 2.7 0.2 0.1 0.0 1.9 0.1 0.3 0.2 0.5 1.3 2.8 0.4 0.6 0.0 1.4 0.0 0.2 0.1 0.0 0.1 0.3 1.0 0.4 0.2 0.4 0.0 0.3 1.1 0.0 0.0 2.6 3.8 0.1 1.4 0.0 0.4 0.1 0.9 0.1 0.7 1.5 0.4 0.2 0.7 0.4 0.3 0.9 0.6 0.9 0.1 0.8 0.7 0.8 1.0 2.6 0.4 0.2 0.2 0.0 0.3 0.4 0.3 0.5 0.3 0.7 0.3 0.6 0.4 0.2 0.0 0.0 0.0 1.0 0.8 8.0 1.4 0.0 1.4 0.0 1.8 17.7 0.2 0.0 0.2 134.9 1.0 0.0 0.0 1.2 0.1 1.9 1.3 0.0 0.4 0.4 0.0 4.1 0.6 0.0 35.0 2.6 0.0 0.0 0.0 0.7 1.1 2.0 0.0 2.8 0.0 4.2 0.0 0.7 21.9 1.8 0.0 0.1 0.0 1.1 1.0 ADAMTS16 ADAMTS16s ENSG00000145536 "ADAM metallopeptidase with thrombospondin type 1 motif 16" Q8TE57 5 5140330-5320304 "Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.4;ovary: 16.3" "Cell type enriched" "Detected in some" 6 "Collecting duct cells: 7.0" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "cerebellum: 20.4;cerebral cortex: 5.2" "Cell type enriched" "Detected in single" 10 "NK-cell: 3.6" "Lineage enriched" "Detected in single" 10 "NK-cells: 3.6" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 6.1;SuSa: 5.6;U-2 OS: 4.8;U-2197: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA067668 Approved "Nucleoplasm,Nuclear membrane,Midbody ring,Mitochondria" "Secreted to extracellular matrix" Yes No "Nuclear membrane, Mitochondria" "Nucleoplasm, Midbody ring" "HPA067668: " "unprognostic (8.48e-2)" "unprognostic (1.19e-1)" "unprognostic (2.86e-2)" "unprognostic (1.98e-4)" "unprognostic (1.91e-2)" "unprognostic (5.04e-2)" "unprognostic (7.64e-2)" "unprognostic (7.80e-3)" "unprognostic (2.12e-2)" "unprognostic (5.44e-2)" "unprognostic (1.51e-2)" "unprognostic (2.18e-1)" "prognostic favorable (3.29e-5)" "unprognostic (1.20e-4)" "unprognostic (1.46e-1)" "unprognostic (4.59e-3)" "unprognostic (2.86e-3)" 7.4 0.4 1.8 0.5 2.8 0.6 1.0 20.4 5.2 2.6 0.9 0.1 3.7 0.6 2.3 11.0 1.9 1.1 8.8 0.9 1.7 0.5 5.4 0.6 0.9 0.2 0.5 1.9 16.3 6.3 0.0 0.5 0.2 2.2 0.7 0.4 0.0 0.4 0.8 0.5 0.5 0.6 10.4 0.6 0.4 0.6 0.8 0.0 0.0 0.8 0.0 0.1 3.4 1.5 0.2 0.1 0.3 0.0 3.6 0.2 0.0 2.5 2.7 2.7 0.1 0.2 0.6 0.2 0.1 0.1 0.6 0.9 0.1 2.4 0.1 3.3 0.0 4.7 0.2 0.0 0.0 0.8 0.1 1.6 0.1 3.8 0.0 0.0 0.3 0.1 0.0 0.0 6.1 0.2 0.7 0.0 0.3 0.8 0.4 1.1 0.1 0.1 0.3 1.7 0.1 2.5 0.5 3.2 0.1 0.1 0.0 1.1 0.1 0.1 0.1 0.2 5.6 0.1 0.2 0.1 3.2 4.8 8.9 2.1 0.5 0.2 0.1 4.6 0.1 0.4 0.3 0.0 0.1 0.2 0.0 0.2 0.0 0.2 0.1 0.1 0.2 0.2 0.1 0.3 3.6 0.0 0.0 0.0 0.0 1.8 2.8 20.4 5.2 1.7 0.5 0.5 1.9 2.2 0.0 0.0 1.1 0.0 0.0 0.0 1.2 0.4 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADAMTS17 "FLJ16363, FLJ32769" ENSG00000140470 "ADAM metallopeptidase with thrombospondin type 1 motif 17" Q8TE56 15 99971589-100342005 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Deafness, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.1" "Cell type enhanced" "Detected in some" 26 "Early spermatids: 111.4;Horizontal cells: 20.6;Late spermatids: 51.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.4" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "HEK 293: 7.4;JURKAT: 25.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA062487 Approved Nucleoplasm "Secreted to extracellular matrix" NA NA Nucleoplasm "HPA062487: AB_2684780" "unprognostic (7.73e-2)" "unprognostic (2.38e-2)" "unprognostic (1.79e-2)" "unprognostic (9.03e-3)" "unprognostic (2.56e-1)" "unprognostic (9.90e-3)" "unprognostic (5.78e-2)" "unprognostic (1.18e-3)" "unprognostic (5.03e-3)" "unprognostic (4.70e-2)" "unprognostic (2.93e-1)" "unprognostic (1.27e-1)" "unprognostic (3.35e-2)" "unprognostic (8.48e-2)" "unprognostic (1.21e-1)" "unprognostic (7.43e-3)" "unprognostic (6.43e-2)" 1.2 2.0 3.6 2.7 3.1 1.5 1.9 0.7 4.5 1.9 2.1 2.9 6.4 2.5 4.9 1.9 5.1 2.9 1.9 2.2 3.4 1.6 2.2 15.7 10.5 2.0 1.6 1.0 3.0 12.2 0.3 3.5 1.6 1.7 1.9 2.1 2.7 8.3 4.7 13.5 5.0 2.8 6.6 2.1 2.5 3.6 4.0 2.0 20.1 1.9 2.7 2.1 2.7 2.1 0.1 0.0 1.4 0.1 0.2 0.8 0.1 0.0 0.0 0.0 0.4 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.1 1.3 0.2 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 25.8 0.0 0.1 0.1 0.6 2.2 0.4 0.2 1.2 1.1 0.0 0.6 2.8 0.0 0.3 2.3 0.4 0.3 2.8 3.7 0.6 0.0 0.4 0.4 0.0 0.9 0.7 0.0 0.4 0.0 0.0 0.0 0.5 3.4 1.4 0.0 0.0 0.1 0.0 0.5 0.0 0.8 0.2 0.0 0.1 0.5 0.5 0.4 0.2 0.1 0.0 0.0 0.1 3.6 3.1 0.7 4.5 3.4 1.6 1.6 1.0 1.7 2.0 0.0 0.0 0.0 0.6 0.9 0.9 3.4 0.0 0.0 1.2 0.0 0.0 0.0 1.7 0.0 111.4 0.7 0.1 0.0 0.7 0.0 0.8 1.7 0.0 3.9 6.1 20.6 0.0 0.0 0.6 51.8 2.0 0.0 0.0 0.0 0.3 2.3 0.4 0.0 0.0 0.0 0.5 0.0 0.1 0.9 1.4 0.5 0.1 1.3 0.3 0.8 ADAMTS5 "ADAMTS11, ADMP-2" ENSG00000154736 "ADAM metallopeptidase with thrombospondin type 1 motif 5" Q9UNA0 21 26917912-26966513 "Cancer-related genes, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 21.2;placenta: 20.9" "Cell type enhanced" "Detected in many" 16 "Fibroblasts: 51.0;Leydig cells: 58.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 6 "classical monocyte: 1.5" "Lineage enriched" "Detected in single" 6 "monocytes: 1.5" "Cell line enhanced" "Detected in some" "ASC diff: 23.9;ASC TERT1: 10.1;fHDF/TERT166: 9.5;RH-30: 25.2;U-87 MG: 9.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA005661, CAB025996, HPA030906, HPA030908" Approved Supported Nucleoplasm "Secreted to extracellular matrix" NA NA 18000 Nucleoplasm "CAB025996: , HPA005661: AB_1078101, HPA030906: AB_2673654, HPA030908: AB_2673655" "unprognostic (1.97e-1)" "unprognostic (2.88e-3)" "unprognostic (2.69e-2)" "unprognostic (4.01e-2)" "unprognostic (4.67e-1)" "unprognostic (2.10e-2)" "unprognostic (4.38e-8)" "unprognostic (1.11e-3)" "unprognostic (7.66e-2)" "unprognostic (6.17e-2)" "unprognostic (8.13e-2)" "unprognostic (7.76e-2)" "prognostic unfavorable (2.46e-4)" "unprognostic (6.69e-3)" "unprognostic (3.01e-1)" "prognostic unfavorable (8.54e-4)" "unprognostic (1.15e-1)" 14.1 0.4 1.0 1.6 0.6 0.0 21.2 2.5 0.9 5.5 2.3 0.4 7.2 0.3 10.7 8.2 1.2 3.3 1.0 6.9 1.0 0.0 1.6 0.8 1.2 0.4 1.1 0.4 14.9 0.4 0.1 0.4 20.9 1.5 2.2 0.8 2.3 1.8 9.7 11.0 3.3 2.4 6.2 1.1 6.4 1.8 2.3 0.4 0.6 5.3 1.5 0.6 2.8 3.1 0.0 0.2 0.0 1.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 23.9 10.1 0.0 1.3 0.2 1.4 0.5 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 2.1 0.0 0.9 0.0 0.3 0.0 2.5 0.1 0.0 5.5 0.0 1.0 0.2 0.2 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 25.2 0.0 2.2 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 6.4 0.3 1.3 0.6 0.0 0.0 0.0 9.1 0.1 1.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.6 2.5 0.9 1.0 0.0 1.1 0.4 1.5 0.4 0.0 0.3 0.0 0.1 2.6 1.9 2.6 0.0 0.0 1.2 3.5 0.0 0.8 0.0 0.0 4.8 7.1 0.0 0.0 0.2 1.4 51.0 0.2 0.0 0.0 1.8 0.0 1.7 2.5 0.0 0.8 58.1 0.8 3.3 0.0 0.0 0.0 0.0 0.0 8.5 2.2 0.0 12.9 13.7 0.0 0.5 2.6 2.3 0.0 0.0 0.1 ADAR "ADAR1, G1P1, IFI4" ENSG00000160710 "Adenosine deaminase, RNA specific" P55265 1 154582062-154627999 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, mRNA processing, RNA-mediated gene silencing" "DNA-binding, Hydrolase, RNA-binding" "Aicardi-Goutieres syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003890, HPA051519, CAB056157" Enhanced Enhanced Nucleoplasm,Nucleoli No No Nucleoli Nucleoplasm "CAB056157: AB_2665578, HPA003890: AB_1078103, HPA051519: AB_2681520" "unprognostic (3.46e-1)" "unprognostic (8.11e-2)" "unprognostic (1.42e-1)" "unprognostic (1.83e-2)" "unprognostic (2.38e-1)" "unprognostic (9.37e-2)" "unprognostic (2.07e-2)" "unprognostic (6.97e-2)" "unprognostic (2.03e-1)" "unprognostic (2.90e-1)" "unprognostic (4.13e-2)" "unprognostic (7.16e-2)" "prognostic unfavorable (7.30e-5)" "unprognostic (3.44e-1)" "unprognostic (1.49e-1)" "unprognostic (9.00e-2)" "unprognostic (3.94e-2)" 36.1 33.1 30.3 36.6 44.4 43.1 29.7 41.4 50.8 30.7 28.2 33.3 19.9 31.4 38.0 26.5 27.7 32.9 28.9 24.0 25.7 38.1 31.5 36.0 34.7 41.3 27.3 32.6 39.2 29.5 46.2 38.4 33.9 39.8 28.8 31.1 32.2 36.7 30.2 14.0 27.0 40.6 36.3 24.4 47.7 29.1 21.9 26.9 57.6 32.8 16.7 41.9 29.7 27.6 7.8 6.1 25.1 8.6 6.4 9.7 5.6 26.6 30.9 26.5 32.6 26.8 27.8 31.5 18.4 36.9 61.6 53.5 26.6 26.2 48.0 29.7 29.3 34.2 25.9 33.8 34.9 31.4 46.6 16.9 25.0 21.9 15.0 29.2 35.3 27.8 27.0 25.5 31.5 32.3 25.2 31.5 34.7 23.6 37.0 21.5 32.5 42.6 18.2 43.7 35.7 23.3 40.8 21.8 38.6 21.1 29.7 26.4 31.5 31.7 51.3 37.6 41.3 34.5 43.5 28.7 22.1 21.8 18.2 21.2 43.8 48.0 51.6 21.5 23.3 24.9 6.9 6.6 12.0 9.4 8.3 8.8 7.8 9.4 9.7 6.1 6.2 8.8 8.6 25.1 6.4 8.6 5.5 7.1 5.6 30.3 44.4 41.4 50.8 25.7 38.1 27.3 32.6 39.8 26.9 77.4 46.4 72.2 33.2 29.7 90.3 15.5 33.1 41.5 43.3 45.4 90.3 33.7 8.3 43.8 3.6 83.1 68.1 23.3 58.0 42.0 39.5 47.9 61.1 78.8 46.9 158.9 60.6 78.0 80.2 9.5 68.1 57.4 18.6 68.5 54.5 46.8 58.0 53.7 55.5 36.0 81.7 51.8 36.9 11.7 23.2 35.3 26.3 58.3 48.2 41.3 ADARB1 "ADAR2, ADAR2a, ADAR2a-L1, ADAR2a-L2, ADAR2a-L3, ADAR2b, ADAR2c, ADAR2d, ADAR2g, DRABA2, DRADA2, hRED1, RED1" ENSG00000197381 "Adenosine deaminase, RNA specific B1" P78563 21 45073853-45226560 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, mRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 59.9" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 52.9;Horizontal cells: 65.2;Muller glia cells: 34.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 27.9;HHSteC: 32.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029645 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029645: AB_10602106" "unprognostic (2.69e-1)" "unprognostic (7.65e-2)" "prognostic unfavorable (8.16e-5)" "unprognostic (1.82e-2)" "unprognostic (1.07e-2)" "unprognostic (9.07e-2)" "unprognostic (3.29e-2)" "unprognostic (6.97e-2)" "unprognostic (3.82e-2)" "unprognostic (1.23e-2)" "unprognostic (1.28e-1)" "unprognostic (3.44e-1)" "prognostic unfavorable (3.56e-4)" "unprognostic (4.57e-2)" "unprognostic (3.06e-1)" "unprognostic (2.73e-2)" "unprognostic (2.38e-2)" 12.2 5.3 7.1 10.4 8.4 4.5 8.9 33.1 11.6 11.7 17.2 2.5 5.6 2.9 13.4 6.6 14.0 8.8 11.1 6.7 7.3 8.1 4.6 4.0 19.9 11.8 7.4 8.1 5.3 4.7 19.0 3.7 12.0 13.6 14.7 5.0 11.0 4.6 8.7 11.8 10.8 5.9 59.9 3.5 10.5 11.7 3.8 4.0 3.9 3.8 4.5 8.4 34.6 20.3 6.1 2.1 4.8 0.6 0.5 2.6 0.5 3.1 0.4 2.5 2.9 3.1 2.1 3.4 2.1 3.5 6.9 4.4 5.0 0.5 1.0 5.8 10.5 3.8 0.3 3.7 8.9 7.6 0.7 3.3 6.9 27.9 3.3 32.3 4.7 3.4 11.6 3.9 2.4 7.2 2.6 7.2 9.6 1.6 0.4 20.0 2.3 3.1 4.5 4.0 1.6 4.8 0.9 2.4 3.2 1.5 1.0 14.7 3.9 17.1 0.7 5.4 4.3 1.6 3.8 7.6 2.3 2.8 9.2 8.0 3.1 1.4 0.8 2.0 11.1 12.1 1.3 0.2 4.8 1.1 0.6 1.8 2.4 2.6 1.6 0.0 6.1 1.8 1.4 0.2 0.5 0.3 2.1 1.6 0.5 7.1 8.4 33.1 11.6 7.3 8.1 7.4 8.1 13.6 4.0 0.0 0.6 3.2 2.5 9.8 52.9 17.1 0.0 0.0 2.3 0.0 11.8 0.4 0.0 1.3 2.0 13.5 0.4 0.0 0.4 0.9 11.0 4.9 8.1 5.9 6.1 65.2 0.0 14.7 3.4 1.9 3.4 2.9 5.0 7.2 0.7 34.4 1.0 0.0 5.3 2.2 15.5 0.0 18.6 4.1 11.5 6.4 0.8 6.9 1.2 2.0 ADAT1 ENSG00000065457 "Adenosine deaminase, tRNA specific 1" Q9BUB4 16 75596981-75623300 "Enzymes, Predicted intracellular proteins" "tRNA processing" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 80.3;Late spermatids: 160.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040713, HPA040903" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA040713: AB_10795371, HPA040903: AB_10794071" "unprognostic (7.71e-3)" "unprognostic (5.35e-2)" "unprognostic (7.62e-2)" "unprognostic (9.00e-2)" "unprognostic (9.99e-2)" "unprognostic (4.69e-2)" "unprognostic (4.54e-2)" "unprognostic (6.65e-3)" "unprognostic (3.38e-1)" "unprognostic (1.14e-2)" "unprognostic (9.75e-2)" "unprognostic (2.97e-1)" "unprognostic (4.60e-3)" "unprognostic (7.21e-2)" "unprognostic (4.92e-1)" "unprognostic (5.58e-3)" "unprognostic (8.27e-2)" 14.8 17.1 12.5 12.6 18.2 13.0 15.1 11.0 23.3 13.5 12.4 21.4 11.8 10.1 15.1 24.4 12.0 12.6 15.8 10.4 17.2 15.1 17.2 17.8 12.8 21.2 16.7 20.5 11.1 15.3 33.5 16.7 14.0 22.3 15.3 15.1 11.8 12.2 14.2 9.0 21.2 13.6 12.6 16.0 21.3 11.7 51.8 16.8 19.4 20.6 9.2 16.7 17.1 11.3 12.5 8.6 15.0 13.0 12.1 20.5 8.3 14.1 23.2 14.0 14.5 21.1 17.3 13.1 15.7 18.0 21.4 17.1 19.2 21.7 16.8 16.7 14.2 12.1 16.1 12.9 20.2 21.3 11.0 7.6 7.4 16.1 13.5 15.5 14.3 16.7 19.1 15.9 31.8 26.0 6.7 17.9 20.7 12.4 7.6 18.8 53.0 16.6 13.5 11.5 14.5 10.0 19.7 12.0 20.8 20.9 21.8 19.8 20.5 35.5 11.1 9.7 12.9 23.0 9.5 13.0 34.4 14.2 13.8 15.0 16.1 22.6 46.9 14.9 15.3 28.4 9.6 7.2 15.0 14.7 8.4 20.5 12.5 13.8 20.0 8.0 11.8 8.5 12.0 9.5 12.1 13.0 8.6 14.0 8.3 12.5 18.2 11.0 23.3 17.2 15.1 16.7 20.5 22.3 16.8 8.9 4.3 7.6 4.6 4.0 13.4 4.8 5.1 9.4 4.5 7.0 25.5 11.0 14.9 7.4 80.3 8.5 5.9 23.3 6.7 7.7 5.4 7.1 8.1 8.7 8.8 12.7 13.8 6.7 10.4 160.0 9.2 10.2 3.3 10.8 5.3 7.2 8.0 3.5 7.4 8.6 18.9 6.5 5.7 14.0 11.7 4.6 8.1 9.6 8.0 6.5 ADAT2 "DEADC1, dJ20N2.1, TAD2" ENSG00000189007 "Adenosine deaminase, tRNA specific 2" Q7Z6V5 6 143422832-143450673 "Enzymes, Predicted intracellular proteins" "tRNA processing" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035479 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA035479: AB_10611672" "unprognostic (2.24e-1)" "unprognostic (3.07e-3)" "unprognostic (1.55e-1)" "unprognostic (8.20e-2)" "unprognostic (3.05e-2)" "unprognostic (8.58e-2)" "unprognostic (1.07e-3)" "unprognostic (3.31e-2)" "unprognostic (1.34e-1)" "unprognostic (7.30e-2)" "unprognostic (1.27e-1)" "unprognostic (1.25e-2)" "unprognostic (9.28e-5)" "unprognostic (4.88e-2)" "unprognostic (6.96e-2)" "unprognostic (7.29e-2)" "unprognostic (4.08e-2)" 7.3 9.5 6.6 15.1 9.4 17.1 8.6 7.7 8.8 6.6 9.5 4.9 4.7 9.9 8.3 5.3 12.0 7.9 7.6 4.2 5.2 3.8 7.5 13.2 11.3 17.6 4.9 8.0 7.5 13.3 7.1 9.6 4.0 7.3 8.6 13.3 6.0 10.1 6.2 13.3 17.1 10.0 6.5 6.7 13.1 10.8 4.1 5.3 8.6 10.8 10.1 13.5 6.6 8.7 2.8 3.2 0.4 1.4 1.9 6.6 2.3 2.9 2.5 3.1 10.6 2.6 8.5 4.7 4.2 1.9 2.9 4.1 6.7 7.5 10.5 4.6 2.8 3.3 8.6 5.8 5.9 5.7 5.5 13.0 14.8 10.5 13.5 3.3 20.8 7.4 2.9 8.7 5.7 9.1 2.5 6.2 9.7 16.1 9.1 4.4 4.2 8.0 11.7 4.0 4.0 4.8 9.8 9.2 8.5 4.5 3.3 6.9 4.7 3.5 9.5 2.8 1.7 4.0 7.6 4.8 4.3 3.6 8.8 8.0 9.4 6.6 7.9 4.0 17.5 4.9 0.0 0.9 0.0 3.2 1.4 4.7 2.8 3.0 2.9 3.2 2.0 3.4 5.1 0.4 1.9 0.2 3.0 6.6 2.3 6.6 9.4 7.7 8.8 5.2 3.8 4.9 8.0 7.3 5.3 6.0 11.7 0.8 3.4 6.0 3.6 2.7 0.0 2.7 4.5 1.8 0.0 2.0 3.3 3.4 1.0 4.7 1.8 23.3 3.4 2.1 4.4 2.9 7.0 4.0 4.1 1.6 4.1 4.3 5.1 1.1 6.4 2.8 5.0 0.0 5.6 2.0 4.8 0.0 3.2 0.7 3.1 0.0 4.9 1.8 5.4 8.2 0.7 6.9 7.8 3.8 ADAT3 TAD3 ENSG00000213638 "Adenosine deaminase, tRNA specific 3" 19 1905378-1913447 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 5.5;Suprabasal keratinocytes: 9.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 14.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 12.9" "Low region specificity" "Detected in all" HPA058899 Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA058899: AB_2683847" "unprognostic (1.79e-1)" "unprognostic (7.99e-2)" "unprognostic (1.57e-1)" "unprognostic (3.61e-3)" "unprognostic (4.43e-2)" "prognostic favorable (6.13e-4)" "unprognostic (1.48e-4)" "unprognostic (2.18e-1)" "unprognostic (1.63e-1)" "unprognostic (1.38e-1)" "unprognostic (4.78e-3)" "unprognostic (5.27e-2)" "unprognostic (2.21e-2)" "prognostic favorable (6.98e-4)" "unprognostic (2.48e-1)" "unprognostic (1.05e-1)" "unprognostic (9.55e-3)" 6.5 7.4 4.7 5.6 7.9 5.0 6.5 7.3 10.6 4.5 12.4 18.2 7.7 31.0 6.0 7.4 12.1 7.3 7.1 4.4 4.8 3.7 9.4 7.8 6.2 4.4 8.1 4.9 8.7 7.5 3.4 8.6 9.0 10.4 8.3 5.3 7.8 16.1 7.0 5.4 18.3 20.5 3.0 12.5 8.9 15.6 5.5 7.3 3.1 8.8 3.3 6.5 3.2 7.7 2.2 14.0 0.3 1.3 4.9 2.6 0.7 4.8 1.3 0.7 1.0 0.4 0.0 6.2 1.8 0.3 0.7 1.0 2.0 1.5 2.9 0.7 0.2 0.4 3.2 0.2 0.2 0.0 7.0 12.9 0.7 2.9 2.6 0.3 1.3 9.2 0.0 0.2 0.8 0.0 0.1 0.6 0.8 8.0 1.6 0.4 1.0 2.3 4.2 6.8 0.2 8.8 7.8 1.2 4.7 0.8 1.3 2.8 6.7 2.2 5.2 2.4 0.3 4.0 1.0 1.6 0.7 2.9 2.6 3.8 2.8 2.6 2.5 0.6 1.3 1.6 0.3 1.3 0.0 1.6 0.6 1.6 1.0 2.3 2.5 1.8 2.2 1.7 2.6 0.3 4.9 1.1 14.0 2.3 0.7 4.7 7.9 7.3 10.6 4.8 3.7 8.1 4.9 10.4 7.3 0.0 1.0 1.5 1.1 5.5 0.0 0.6 2.5 2.7 0.0 0.0 0.0 1.3 1.7 1.0 0.0 0.6 3.5 0.0 0.6 1.9 1.0 0.2 0.0 0.8 1.6 0.0 1.2 3.1 1.2 0.2 0.0 0.9 0.0 1.0 0.9 0.0 0.5 3.5 0.7 2.9 0.0 0.0 0.3 0.9 1.6 9.7 3.8 0.0 1.5 0.7 ADCK1 FLJ39600 ENSG00000063761 "AarF domain containing kinase 1" Q86TW2 14 77800083-77935012 "Enzymes, Predicted secreted proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 19.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051012, HPA055014" Uncertain Uncertain Nucleoplasm "Secreted - unknown location" NA NA Nucleoplasm "HPA051012: AB_2681310, HPA055014: AB_2682672" "unprognostic (6.36e-2)" "unprognostic (7.09e-2)" "unprognostic (6.00e-2)" "unprognostic (1.76e-1)" "unprognostic (2.24e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (1.70e-4)" "prognostic favorable (4.11e-5)" "unprognostic (2.33e-1)" "unprognostic (1.64e-1)" "unprognostic (4.57e-3)" "unprognostic (1.38e-1)" "prognostic favorable (5.82e-6)" "unprognostic (6.30e-3)" "unprognostic (2.06e-1)" "unprognostic (9.57e-2)" "unprognostic (4.06e-1)" 7.2 11.0 11.0 7.0 15.2 7.4 6.9 6.8 20.5 5.6 10.3 19.0 7.7 11.2 7.7 10.3 7.7 7.1 9.1 11.1 12.4 10.4 8.8 10.5 6.2 6.0 13.5 9.4 6.6 9.8 11.3 11.3 7.8 15.0 8.2 10.3 13.8 10.6 8.9 13.7 8.5 8.5 10.5 10.6 9.7 7.5 5.5 11.5 10.8 9.1 7.8 7.5 6.9 5.0 4.0 8.9 1.4 7.2 3.4 5.3 3.1 3.3 5.4 3.3 10.8 8.1 4.6 4.3 3.4 5.7 3.1 3.8 3.0 8.0 7.3 5.5 6.0 5.7 6.4 17.8 5.4 2.0 4.2 5.6 1.9 3.4 4.9 8.3 2.8 4.1 5.8 10.1 1.2 3.9 3.2 4.4 6.4 7.0 4.5 4.0 16.8 3.4 5.6 6.4 12.3 6.4 5.6 0.5 5.8 4.4 8.5 7.2 4.0 6.6 9.3 4.0 5.1 13.3 6.2 3.9 2.9 2.3 5.9 3.1 4.6 5.0 4.2 4.4 4.9 3.8 1.4 4.7 1.3 5.3 7.2 3.5 1.7 2.2 3.1 8.9 4.0 2.5 4.6 0.4 3.4 2.8 7.0 3.7 3.1 11.0 15.2 6.8 20.5 12.4 10.4 13.5 9.4 15.0 11.5 0.0 3.0 0.8 1.8 0.8 5.0 4.8 0.0 1.4 1.2 0.0 19.6 6.8 3.3 3.6 1.2 1.2 2.1 0.0 4.3 3.6 2.0 1.3 1.1 5.8 8.2 7.9 1.7 1.8 5.1 0.4 1.4 5.4 0.0 1.0 3.6 3.2 3.0 0.0 1.8 3.3 8.8 0.0 1.9 1.7 9.7 1.3 4.5 1.8 4.9 0.9 ADD1 ENSG00000087274 "Adducin 1" P35611 4 2843857-2930076 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 379.0;Rod photoreceptor cells: 557.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009794, HPA035873, HPA035874" Enhanced Enhanced "Nucleoplasm,Plasma membrane" NA NA 1400000 "Plasma membrane" Nucleoplasm "CAB009794: AB_633663, HPA035873: AB_2674836, HPA035874: AB_2674837" "unprognostic (1.79e-1)" "unprognostic (1.37e-1)" "unprognostic (1.66e-2)" "unprognostic (5.40e-3)" "unprognostic (1.90e-1)" "unprognostic (2.66e-2)" "unprognostic (5.07e-3)" "unprognostic (1.68e-2)" "unprognostic (3.52e-1)" "unprognostic (2.50e-1)" "prognostic favorable (3.94e-4)" "unprognostic (5.22e-2)" "prognostic favorable (1.29e-7)" "unprognostic (2.61e-2)" "unprognostic (1.12e-1)" "unprognostic (7.38e-2)" "unprognostic (4.03e-3)" 44.0 31.7 43.1 27.9 52.1 26.7 35.6 46.3 66.6 37.5 43.3 47.2 27.3 30.8 47.9 29.2 35.1 43.0 33.1 41.1 39.5 34.1 36.8 23.4 38.0 27.9 40.5 46.7 65.3 25.0 31.3 28.4 31.2 44.7 43.1 30.7 36.3 26.2 54.9 69.5 25.5 33.6 58.1 33.8 34.9 32.6 25.2 37.0 25.5 27.9 19.6 28.5 45.3 34.9 21.3 16.2 21.5 6.5 16.4 12.9 9.1 18.5 15.6 37.1 19.1 55.0 41.2 13.9 31.5 37.9 32.9 27.9 22.9 23.6 9.7 16.6 54.0 38.6 11.9 27.7 26.5 27.6 12.4 12.7 27.5 13.5 22.0 26.9 16.3 19.6 40.6 24.9 28.9 11.6 34.3 40.9 18.5 28.5 23.6 37.5 10.9 50.2 22.8 20.8 17.1 22.2 22.3 20.6 11.4 24.1 41.3 22.2 28.9 22.8 9.3 19.5 29.4 21.8 15.5 49.4 27.0 13.9 22.1 26.0 19.0 15.4 12.4 26.0 20.3 26.0 11.0 4.8 21.5 12.9 4.5 11.8 16.1 7.2 10.8 7.5 21.3 6.8 8.1 6.7 16.4 6.5 16.2 9.2 9.1 43.1 52.1 46.3 66.6 39.5 34.1 40.5 46.7 44.7 37.0 65.5 42.1 48.2 25.8 23.9 91.0 71.2 40.8 34.8 51.2 57.6 379.0 29.9 13.3 33.6 44.3 61.8 38.1 0.0 39.8 26.5 52.3 36.5 35.9 41.0 35.3 104.9 55.5 59.5 43.4 29.2 71.9 38.1 33.7 57.7 42.6 228.9 44.9 31.6 114.5 36.3 557.2 97.0 52.0 40.7 36.8 32.0 30.6 55.8 35.2 27.7 ADD2 ADDB ENSG00000075340 "Adducin 2" P35612 2 70607618-70768225 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "bone marrow: 53.6;brain: 35.0" "Cell type enhanced" "Detected in some" 22 "Early spermatids: 28.5;Erythroid cells: 70.0;Horizontal cells: 131.9" "Cancer enhanced" "Detected in many" "testis cancer: 11.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 4.7;non-classical monocyte: 4.4" "Group enriched" "Detected in many" 20 "B-cells: 4.7;monocytes: 4.4;T-cells: 1.9" "Cell line enhanced" "Detected in many" "HAP1: 14.3;JURKAT: 13.9;K-562: 18.7;NTERA-2: 36.9;RPMI-8226: 17.6;SCLC-21H: 18.4;U-251 MG: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009796, HPA034509, HPA034510" Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 66000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB009796: AB_2223572, HPA034509: AB_2674201, HPA034510: AB_2674202" "unprognostic (3.58e-2)" "unprognostic (2.68e-4)" "unprognostic (3.83e-2)" "unprognostic (3.01e-4)" "unprognostic (1.94e-1)" "unprognostic (2.25e-3)" "unprognostic (1.35e-1)" "unprognostic (3.26e-1)" "unprognostic (3.49e-1)" "unprognostic (1.48e-1)" "unprognostic (1.20e-2)" "unprognostic (8.93e-2)" "unprognostic (4.47e-7)" "unprognostic (2.81e-4)" "unprognostic (1.77e-1)" "unprognostic (1.71e-3)" "unprognostic (1.31e-3)" 1.9 2.6 14.0 2.6 17.9 53.6 1.5 29.7 35.0 1.3 1.3 1.2 0.0 1.0 1.3 1.2 2.3 1.4 1.2 1.5 14.1 10.7 0.9 0.9 1.8 3.1 6.0 19.7 1.0 2.1 1.3 2.8 1.6 14.0 1.3 1.2 1.7 1.1 1.1 1.6 1.2 1.2 1.9 6.0 1.9 1.1 2.9 2.7 0.0 2.3 0.0 2.9 1.5 0.5 4.7 0.1 0.1 4.4 0.0 1.9 0.6 7.1 8.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 1.1 5.3 0.0 14.3 0.0 0.0 0.0 8.4 0.7 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 3.4 0.0 13.9 18.7 0.0 0.0 0.0 0.1 0.6 36.9 0.0 0.2 0.0 0.2 17.6 2.4 0.0 18.4 8.3 9.1 0.0 0.0 4.2 0.0 4.4 0.3 0.0 0.4 0.0 19.4 6.0 7.0 0.0 0.3 2.9 3.3 0.1 0.1 0.0 0.0 2.4 0.1 4.7 0.0 0.0 0.1 4.0 1.9 1.0 0.1 0.0 4.4 0.0 0.0 0.6 14.0 17.9 29.7 35.0 14.1 10.7 6.0 19.7 14.0 2.7 0.0 0.3 3.4 0.1 0.1 19.8 2.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 28.5 2.9 0.0 70.0 0.9 0.2 1.0 0.7 0.0 0.0 0.2 131.9 0.0 1.3 0.3 24.0 0.9 0.0 1.7 1.0 0.0 0.5 0.5 0.0 0.7 0.0 9.4 0.0 0.0 0.7 3.2 0.1 0.2 0.0 0.0 0.6 ADGB "C6orf103, CAPN16, dJ408K24.1, FLJ23121" ENSG00000118492 Androglobin Q8N7X0 6 146598965-146815462 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.9;epididymis: 13.1;testis: 30.6" "Cell type enhanced" "Detected in some" 26 "Ciliated cells: 121.8;Early spermatids: 236.9;Late spermatids: 53.2" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 6.6;pons and medulla: 20.9" "Cell type enriched" "Detected in single" 10 "myeloid DC: 2.6" "Lineage enriched" "Detected in single" 10 "dendritic cells: 2.6" "Cell line enriched" "Detected in single" 25 "HDLM-2: 17.9" "Low region specificity" "Detected in all" "HPA036340, HPA036341" Enhanced Uncertain Nucleoplasm,Mitochondria No NA Mitochondria Nucleoplasm "HPA036340: AB_2675071, HPA036341: AB_10672241" "unprognostic (4.15e-3)" "unprognostic (1.23e-2)" "unprognostic (9.30e-3)" "unprognostic (1.09e-1)" "unprognostic (2.07e-2)" "unprognostic (3.11e-2)" "unprognostic (5.05e-1)" "unprognostic (2.34e-1)" "unprognostic (4.83e-3)" "unprognostic (1.05e-1)" "unprognostic (1.93e-1)" "unprognostic (1.77e-2)" "unprognostic (3.66e-2)" "unprognostic (2.68e-1)" 0.1 0.1 1.6 0.1 6.6 0.1 0.2 0.0 0.2 1.0 0.5 5.1 0.0 0.1 0.4 13.1 0.2 9.8 0.1 0.1 2.2 2.7 0.2 0.2 4.8 0.2 0.0 0.0 4.3 0.1 0.3 0.8 0.2 20.9 0.2 0.4 0.0 0.1 0.3 0.1 0.3 0.1 0.1 0.4 0.1 0.2 30.6 1.2 0.0 0.2 0.1 0.2 0.1 0.0 0.0 2.6 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 6.6 0.0 0.1 2.2 2.7 0.0 0.0 20.9 1.2 3.0 1.0 0.0 0.0 0.0 0.0 0.8 0.0 121.8 14.8 0.0 3.9 0.0 0.0 0.0 236.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 53.2 2.6 1.2 0.0 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.0 19.2 3.0 0.0 0.0 0.0 0.0 0.0 ADGRD1 "DKFZp434B1272, GPR133, PGR25" ENSG00000111452 "Adhesion G protein-coupled receptor D1" Q6QNK2 12 130953907-131141469 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 66.1" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 29.1;Cardiomyocytes: 39.1;Fibroblasts: 20.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 4.1;intermediate monocyte: 4.9;myeloid DC: 2.4;non-classical monocyte: 3.6" "Group enriched" "Detected in many" 6 "dendritic cells: 2.4;monocytes: 4.9" "Cell line enhanced" "Detected in some" "BJ: 5.1;fHDF/TERT166: 5.8;HeLa: 10.5;HHSteC: 6.7;HMC-1: 14.5;U-2 OS: 7.1" "Region enhanced" "Detected in some" "basal ganglia: 5.3" "Low region specificity" "Detected in all" "HPA042395, HPA076279" Uncertain Supported "Nucleoplasm,Plasma membrane" NA NA 600000 "Plasma membrane" Nucleoplasm "HPA042395: AB_10796906, HPA076279: " "unprognostic (3.21e-1)" "unprognostic (1.49e-4)" "unprognostic (1.32e-2)" "unprognostic (1.63e-1)" "unprognostic (4.40e-3)" "unprognostic (1.28e-1)" "prognostic unfavorable (9.27e-4)" "unprognostic (2.55e-3)" "unprognostic (1.63e-2)" "unprognostic (6.94e-2)" "unprognostic (1.11e-2)" "unprognostic (3.98e-2)" "unprognostic (4.79e-5)" "unprognostic (1.31e-3)" "unprognostic (4.58e-1)" "unprognostic (2.15e-2)" "unprognostic (1.77e-3)" 12.7 2.1 2.0 3.2 3.1 0.5 8.9 1.1 3.9 11.2 5.5 2.2 3.9 2.2 13.3 14.0 6.8 8.8 45.6 34.8 1.9 1.5 1.6 5.2 18.6 0.6 4.2 2.2 12.5 11.8 0.3 3.5 26.6 2.4 13.3 2.4 13.0 1.6 2.3 11.6 3.8 6.4 66.1 6.4 1.9 10.2 3.8 2.6 0.0 6.3 7.1 2.1 29.5 30.8 0.2 2.4 0.0 4.9 0.5 0.0 1.2 0.0 0.7 0.0 2.6 0.1 0.0 0.1 5.1 0.0 0.0 0.4 0.0 0.0 0.3 0.0 5.8 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10.5 0.0 6.7 0.0 14.5 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.9 0.0 0.1 0.2 2.2 0.5 0.6 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 3.3 0.0 0.4 0.0 0.5 7.1 1.9 0.1 0.1 1.8 0.9 0.1 0.0 0.0 0.0 4.1 0.0 0.0 4.9 0.0 0.0 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.5 3.6 0.0 0.0 1.2 2.0 3.1 1.1 3.9 1.9 1.5 4.2 2.2 2.4 2.6 20.8 29.1 0.0 0.0 0.0 0.0 39.1 0.0 4.0 9.1 1.8 0.0 0.9 0.0 0.0 14.7 1.0 0.0 0.0 0.3 0.6 20.1 0.1 1.1 2.6 2.3 0.0 0.0 3.1 2.4 14.7 12.7 0.7 0.0 1.8 0.0 0.0 0.5 0.0 14.9 0.0 0.7 6.5 0.9 2.6 5.7 0.0 0.8 0.0 0.0 0.3 ADGRG5 "GPR114, PGR27" ENSG00000159618 "Adhesion G protein-coupled receptor G5" Q8IZF4 16 57542421-57591681 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 37.7;lymphoid tissue: 25.6" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 2: 2.2;Kupffer cells: 1.2;monocytes: 1.8;T-cells: 5.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 37.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "HMC-1: 28.1;OE19: 9.2" "Region enhanced" "Detected in single" "thalamus: 0.4" "Not detected" "Not detected" HPA007133 Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" Nucleoplasm "HPA007133: AB_1849253" "unprognostic (6.11e-3)" "prognostic favorable (4.25e-4)" "unprognostic (2.70e-1)" "unprognostic (2.27e-2)" "unprognostic (6.14e-2)" "unprognostic (1.14e-2)" "unprognostic (6.43e-2)" "unprognostic (1.42e-2)" "unprognostic (8.09e-4)" "unprognostic (3.80e-3)" "unprognostic (3.02e-3)" "unprognostic (1.91e-1)" "unprognostic (4.37e-3)" "unprognostic (7.69e-3)" "unprognostic (4.52e-1)" "unprognostic (1.62e-3)" "unprognostic (6.32e-3)" 0.7 0.6 2.4 20.2 2.7 1.4 0.8 0.6 2.1 0.6 2.1 2.5 0.0 4.3 0.5 0.2 1.7 0.8 0.8 0.5 1.6 1.1 0.5 0.6 2.9 12.1 2.6 0.9 0.5 0.4 0.2 0.8 0.0 2.9 1.2 1.7 0.5 4.6 0.8 0.4 0.7 7.5 0.3 3.5 12.8 0.5 1.2 3.5 3.4 1.1 0.2 25.6 2.8 0.9 4.0 21.9 37.7 0.0 8.8 11.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 28.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.4 2.6 9.2 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 37.7 11.1 0.0 5.6 4.0 1.6 6.4 0.7 2.8 0.4 4.0 0.1 8.8 0.0 21.9 0.0 2.3 2.4 2.7 0.6 2.1 1.6 1.1 2.6 0.9 2.9 3.5 0.0 2.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 5.7 0.4 0.0 ADH4 ADH-2 ENSG00000198099 "Alcohol dehydrogenase 4 (class II), pi polypeptide" P08319 4 99123657-99157792 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "liver: 345.2" "Cell type enriched" "Detected in some" 34 "Hepatocytes: 802.6" "Cancer enriched" "Detected in some" 60 "liver cancer: 230.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 11 "Hep G2: 22.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA020525 Enhanced Uncertain Nucleoplasm,Cytosol NA NA 5300000 "Nucleoplasm, Cytosol" "HPA020525: AB_1844609" "unprognostic (2.75e-1)" "unprognostic (1.69e-2)" "unprognostic (1.85e-2)" "unprognostic (5.54e-3)" "unprognostic (2.14e-2)" "unprognostic (1.33e-2)" "prognostic favorable (7.08e-6)" "unprognostic (1.49e-1)" "unprognostic (1.39e-2)" "unprognostic (6.91e-2)" "unprognostic (1.88e-1)" "unprognostic (2.34e-2)" "unprognostic (7.16e-3)" "unprognostic (2.20e-1)" "unprognostic (5.89e-3)" 0.3 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.2 3.6 0.0 0.1 11.0 0.0 0.1 0.7 0.0 0.0 0.1 0.0 0.0 0.2 345.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.1 0.4 0.1 4.5 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.8 0.1 0.1 0.5 1.2 0.7 2.8 0.5 0.4 0.9 0.1 0.3 0.3 0.2 0.3 0.5 0.1 0.2 0.2 0.0 0.0 0.0 0.2 0.2 0.5 0.3 0.0 0.2 0.3 0.0 0.2 0.4 0.3 0.1 0.6 0.8 22.4 0.1 1.8 0.5 0.3 0.0 0.2 0.2 0.2 0.1 0.2 0.4 1.0 0.1 0.3 0.3 0.6 0.4 0.0 0.2 0.2 1.8 0.5 0.2 0.4 0.2 0.3 2.0 0.3 0.0 0.3 0.5 0.0 0.4 0.5 0.2 0.5 0.1 0.6 0.4 0.7 0.1 0.7 0.1 2.8 0.4 0.5 0.9 0.5 0.8 0.4 0.5 0.5 0.1 1.2 0.8 0.8 1.0 0.4 0.5 0.7 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.2 15.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 21.9 0.0 0.0 23.3 0.5 0.0 0.0 0.0 0.0 802.6 0.0 0.0 0.0 13.5 20.9 2.6 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 ADI1 "APL1, ARD, FLJ10913, HMFT1638, MTCBP-1, mtnD, SIPL" ENSG00000182551 "Acireductone dioxygenase 1" Q9BV57 2 3497361-3519736 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 127.7" "Cell type enhanced" "Detected in all" 7 "Distal tubular cells: 752.7;Hepatocytes: 1079.9;Proximal tubular cells: 1041.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035403, HPA035404" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA035403: AB_10603576, HPA035404: AB_2674611" "unprognostic (2.19e-2)" "unprognostic (1.68e-2)" "unprognostic (2.60e-2)" "unprognostic (1.75e-1)" "unprognostic (3.65e-2)" "unprognostic (1.12e-1)" "unprognostic (1.16e-3)" "unprognostic (4.23e-3)" "unprognostic (2.36e-3)" "unprognostic (4.00e-3)" "unprognostic (2.97e-2)" "unprognostic (1.50e-1)" "unprognostic (1.90e-2)" "unprognostic (1.56e-1)" "unprognostic (9.94e-2)" "unprognostic (6.76e-2)" "unprognostic (8.74e-2)" 13.5 19.1 10.8 9.0 11.5 6.4 15.1 5.2 9.2 12.5 60.6 9.3 29.9 27.3 11.7 17.8 16.3 11.4 35.5 49.5 9.0 7.9 42.6 127.7 10.8 12.4 11.3 9.4 12.8 14.7 9.2 8.4 18.7 9.6 24.5 11.8 10.7 22.7 27.0 43.1 7.9 38.9 17.3 11.7 16.6 18.3 8.0 7.9 4.9 12.9 18.9 10.4 14.7 17.9 14.2 37.8 64.7 26.5 10.1 17.7 32.2 12.0 14.7 13.3 10.6 46.7 22.8 24.9 25.2 32.6 27.4 19.9 20.9 13.8 5.7 39.9 26.7 4.6 11.0 15.7 11.8 14.1 10.2 35.1 17.6 9.5 33.8 39.1 18.2 39.5 25.2 15.7 12.8 16.0 9.7 17.2 8.4 13.1 10.0 21.5 27.1 6.1 32.1 11.6 27.4 23.0 6.5 8.5 32.4 19.0 18.0 14.9 15.0 13.9 14.7 9.6 8.2 15.6 19.3 14.3 18.9 7.7 9.2 14.1 9.9 23.9 23.4 13.9 28.3 9.9 14.2 26.5 64.7 6.3 25.2 6.8 14.2 14.9 5.9 25.6 11.2 17.7 5.9 12.3 10.1 22.0 37.8 13.8 32.2 10.8 11.5 5.2 9.2 9.0 7.9 11.3 9.4 9.6 7.9 62.5 87.9 109.0 118.8 67.5 8.0 255.0 285.3 33.5 56.9 144.8 13.7 343.4 752.7 121.5 6.7 56.4 182.2 46.7 76.6 194.2 104.6 159.8 40.5 1079.9 211.6 7.9 54.8 164.5 143.1 16.8 126.8 60.1 194.0 117.2 123.2 123.6 76.7 181.4 197.7 1041.1 13.1 161.7 119.7 4.6 8.9 67.1 319.0 55.1 135.6 117.6 ADIRF "AFRO, APM2, C10orf116" ENSG00000148671 "Adipogenesis regulatory factor" Q15847 10 86968192-86983934 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 1712.2;Smooth muscle cells: 2588.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 2.0;naive CD4 T-cell: 3.9;naive CD8 T-cell: 2.8" "Lineage enriched" "Detected in single" 11 "T-cells: 3.9" "Cell line enhanced" "Detected in many" "A-431: 25.7;HaCaT: 66.5;PC-3: 36.3;RT4: 46.2" "Low region specificity" "Detected in many" HPA026810 Approved Supported Nucleoplasm,Cytosol NA NA 580000 "Nucleoplasm, Cytosol" "HPA026810: AB_2672003" 123.4 9.5 15.7 21.4 6.1 1.5 109.7 1.6 8.4 44.3 65.3 6.8 21.6 66.2 25.3 34.6 24.3 34.7 29.9 24.8 17.3 6.1 20.3 10.3 32.5 5.4 10.5 9.3 54.7 12.6 7.2 11.7 8.7 7.2 38.6 7.0 23.6 41.5 38.8 30.5 23.7 69.5 19.8 9.6 10.0 12.2 12.5 9.9 1.2 29.7 38.6 8.3 39.5 41.6 0.0 0.3 0.0 0.3 0.0 3.9 0.6 25.7 0.3 0.0 0.0 2.1 12.7 1.8 9.0 9.7 0.0 0.0 0.9 3.3 0.0 0.3 11.0 0.6 66.5 0.0 2.1 0.1 0.9 0.0 0.0 2.7 0.2 1.2 0.0 0.4 0.3 4.1 0.0 5.9 0.9 3.6 0.3 0.1 3.6 0.3 3.2 0.1 0.7 0.1 0.5 36.3 0.1 0.0 0.3 0.4 46.2 1.6 0.1 3.0 13.8 0.1 0.0 17.0 0.3 9.8 0.3 2.1 1.7 0.0 0.5 0.4 0.0 0.7 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.4 0.0 2.0 0.0 0.3 0.0 3.9 2.8 0.0 0.0 0.0 0.0 0.2 0.6 15.7 6.1 1.6 7.9 17.3 6.1 10.5 9.3 7.2 9.9 1712.2 356.0 16.7 133.5 469.5 4.8 0.0 50.9 125.8 883.8 177.9 2.0 235.3 1145.6 5.7 8.2 494.5 1530.9 23.3 240.4 10.7 324.4 500.6 48.4 93.5 24.0 0.0 28.8 792.4 7.8 23.6 1212.4 52.8 578.6 174.1 95.1 265.3 201.2 1122.8 441.6 716.9 13.2 1448.7 2588.8 2.5 4.4 383.4 139.5 13.1 194.6 684.0 ADK AK ENSG00000156110 "Adenosine kinase" P55263 10 74151185-74709303 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Purine salvage" "Kinase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 71.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032876, HPA038391, HPA038409, HPA075222" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 320000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB032876: AB_2242229, HPA038391: AB_2675990, HPA038409: AB_10675798, HPA075222: " "unprognostic (1.55e-3)" "unprognostic (1.09e-1)" "unprognostic (1.88e-1)" "unprognostic (2.62e-2)" "unprognostic (2.52e-2)" "prognostic unfavorable (1.93e-4)" "prognostic favorable (9.91e-4)" "unprognostic (2.64e-1)" "unprognostic (2.88e-1)" "unprognostic (1.55e-1)" "unprognostic (8.15e-3)" "unprognostic (2.51e-1)" "unprognostic (1.89e-3)" "unprognostic (2.03e-1)" "unprognostic (2.88e-2)" "unprognostic (4.97e-3)" "unprognostic (2.95e-2)" 13.8 10.7 11.8 13.6 25.4 12.1 14.5 11.2 11.8 9.5 9.3 9.0 9.6 8.8 6.6 10.6 29.4 8.9 6.3 15.7 9.8 11.1 19.0 71.9 15.1 17.9 12.3 9.3 5.2 12.6 15.1 23.5 43.2 11.6 8.7 10.8 8.5 13.1 11.4 18.1 20.8 6.4 8.3 13.2 11.3 7.4 11.9 10.3 13.4 20.8 24.1 21.9 12.6 14.7 49.3 23.0 5.4 21.6 6.5 15.7 9.8 38.1 8.6 9.1 12.2 9.2 14.2 21.0 33.2 26.3 25.7 28.9 24.1 39.8 20.0 8.3 13.3 12.1 34.9 10.7 35.3 41.2 13.4 12.3 12.7 14.1 25.9 10.5 20.3 5.2 13.0 23.3 18.7 46.6 19.0 22.3 9.3 10.1 6.5 19.3 21.3 23.9 27.5 2.6 17.8 60.9 23.1 15.8 17.2 28.1 21.0 7.2 8.5 14.6 56.7 11.0 8.5 37.7 15.4 19.1 8.5 15.7 22.7 27.3 9.4 10.6 22.6 16.1 29.3 5.2 1.3 10.1 1.4 4.5 18.0 10.0 29.7 9.5 8.2 23.0 49.3 7.9 6.5 5.4 6.5 21.6 16.7 15.7 9.8 11.8 25.4 11.2 11.8 9.8 11.1 12.3 9.3 11.6 10.3 77.4 57.2 37.1 62.9 83.7 14.5 53.3 35.7 34.8 76.2 29.6 53.0 120.6 77.9 60.0 55.9 14.7 5.9 0.0 58.9 113.1 27.2 33.9 19.8 112.8 36.3 11.1 10.4 14.7 21.4 22.9 15.5 40.6 45.5 31.5 11.5 10.0 45.7 14.0 11.3 48.3 27.9 6.5 32.8 13.3 12.2 84.8 89.7 20.3 19.9 57.0 ADNP "ADNP1, KIAA0784" ENSG00000101126 "Activity dependent neuroprotector homeobox" Q9H2P0 20 50888916-50931421 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Autism spectrum disorder, Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006371 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA006371: AB_1078105" "unprognostic (3.40e-2)" "unprognostic (6.81e-2)" "unprognostic (1.21e-1)" "unprognostic (1.06e-2)" "unprognostic (1.68e-1)" "unprognostic (6.68e-2)" "prognostic unfavorable (1.65e-5)" "unprognostic (1.73e-1)" "unprognostic (1.80e-1)" "unprognostic (4.38e-2)" "unprognostic (3.11e-1)" "unprognostic (1.39e-2)" "unprognostic (1.29e-1)" "unprognostic (4.91e-2)" "unprognostic (3.63e-1)" "unprognostic (1.90e-2)" "unprognostic (1.08e-1)" 23.7 26.5 32.2 28.1 29.3 21.3 32.4 46.0 35.4 26.3 24.2 23.0 34.2 18.4 32.6 38.7 27.8 28.4 25.5 19.9 27.2 21.1 23.7 22.7 27.9 29.0 29.0 28.5 38.8 21.7 49.2 32.4 23.5 25.6 27.4 22.4 26.1 25.3 30.6 31.8 28.6 25.6 28.6 23.9 28.6 24.9 33.4 28.2 50.2 28.4 17.4 31.1 32.1 33.1 16.4 28.7 15.0 24.6 15.1 30.9 8.1 20.9 19.8 37.6 19.8 18.8 18.5 16.2 15.6 17.7 30.8 22.6 28.4 16.5 27.4 20.5 18.7 16.1 24.0 31.6 29.9 36.3 13.1 11.3 19.6 22.1 21.8 18.2 31.1 17.0 17.5 37.2 18.8 34.0 22.4 20.4 16.9 25.8 19.4 19.4 21.2 30.6 20.7 18.8 18.2 15.9 28.6 20.9 20.0 18.0 28.3 31.3 23.6 35.8 51.5 26.3 25.6 24.5 29.2 17.3 27.4 29.6 20.7 16.8 14.1 16.4 46.6 15.4 18.3 18.7 15.0 12.3 10.6 20.8 18.5 22.5 13.6 23.4 19.0 13.9 16.4 23.4 30.9 6.3 15.1 24.6 28.7 15.4 8.1 32.2 29.3 46.0 35.4 27.2 21.1 29.0 28.5 25.6 28.2 8.9 19.5 18.0 29.5 53.2 39.0 30.7 40.8 10.7 23.9 14.0 23.6 26.4 14.9 19.0 21.4 29.2 18.0 0.0 19.0 18.1 29.3 29.1 17.3 25.9 19.0 36.5 35.6 25.8 22.4 24.8 29.1 18.3 38.8 14.4 31.8 27.7 23.4 21.0 37.4 17.3 33.7 38.8 27.6 26.7 26.4 45.5 18.5 27.7 32.0 34.4 ADPRH ARH1 ENSG00000144843 "ADP-ribosylarginine hydrolase" P54922 3 119579268-119589945 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 16.0;HEL: 11.5;HMC-1: 13.0;Karpas-707: 17.6;U-266/70: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001701, HPA036961" Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "CAB001701: , HPA036961: AB_2675405" "prognostic favorable (2.42e-4)" "unprognostic (2.29e-1)" "unprognostic (4.77e-1)" "unprognostic (2.39e-2)" "unprognostic (3.38e-2)" "unprognostic (2.65e-1)" "unprognostic (3.06e-2)" "unprognostic (2.63e-1)" "unprognostic (4.24e-2)" "unprognostic (3.31e-3)" "unprognostic (1.88e-1)" "unprognostic (1.71e-1)" "unprognostic (6.04e-2)" "unprognostic (2.60e-3)" "unprognostic (8.87e-2)" "unprognostic (2.03e-1)" "unprognostic (4.35e-2)" 14.3 8.5 2.3 10.9 4.6 2.5 14.8 1.2 2.4 7.1 6.2 4.7 14.6 1.9 7.9 6.2 5.0 5.4 6.6 8.4 2.3 2.4 5.1 5.5 17.4 18.9 3.7 2.7 3.6 11.9 8.1 2.8 23.0 4.0 6.3 3.9 6.8 6.5 14.5 19.7 3.1 6.4 8.8 4.7 13.6 5.1 4.1 3.6 5.3 7.4 5.8 12.0 7.1 6.9 8.2 8.0 13.3 13.0 3.4 9.6 4.9 1.6 2.0 0.5 0.0 1.7 1.9 0.0 1.4 0.3 1.2 1.6 0.6 1.3 0.4 0.6 2.1 0.0 0.1 1.4 0.0 1.2 16.0 0.1 11.5 0.2 0.0 2.8 0.0 13.0 2.8 0.0 0.6 0.0 0.5 5.0 0.0 1.0 17.6 7.6 0.5 0.0 2.7 4.8 0.1 4.0 0.0 5.7 0.7 0.7 0.6 0.3 0.0 0.0 0.1 4.3 0.7 3.1 7.2 4.1 0.0 0.8 3.2 0.3 17.2 3.8 0.0 2.1 0.0 3.1 7.8 13.0 13.3 0.6 12.0 0.6 8.2 1.4 1.3 8.0 4.9 0.2 0.6 0.4 3.4 9.2 7.0 9.6 4.9 2.3 4.6 1.2 2.4 2.3 2.4 3.7 2.7 4.0 3.6 8.9 7.5 4.5 0.7 0.7 0.6 4.1 2.5 2.7 4.5 3.5 3.9 4.8 1.7 2.2 0.8 8.4 0.0 0.0 2.9 3.2 1.1 0.9 10.4 1.3 8.4 0.0 0.0 5.5 9.4 0.4 0.3 10.6 1.7 7.2 0.1 0.8 2.4 0.0 2.8 0.8 4.6 0.0 2.9 0.5 0.2 0.6 9.8 1.3 0.0 0.1 ADPRHL1 ARH2 ENSG00000153531 "ADP-ribosylhydrolase like 1" Q8NDY3 13 113399610-113453524 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 89.6;skeletal muscle: 68.1" "Cell type enriched" "Detected in many" 15 "Cardiomyocytes: 122.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 14.7;T-47d: 26.4" "Region enhanced" "Detected in single" "cerebellum: 2.6" "Not detected" "Not detected" "HPA066478, HPA072123" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA066478: AB_2685673, HPA072123: " "unprognostic (3.03e-1)" "unprognostic (1.38e-2)" "unprognostic (2.31e-1)" "unprognostic (8.88e-3)" "unprognostic (1.50e-1)" "prognostic unfavorable (4.88e-4)" "prognostic unfavorable (2.55e-5)" "unprognostic (1.57e-1)" "unprognostic (1.63e-1)" "unprognostic (2.35e-1)" "unprognostic (2.56e-1)" "unprognostic (1.58e-1)" "unprognostic (1.62e-1)" "unprognostic (2.14e-2)" "unprognostic (1.53e-2)" "unprognostic (4.99e-3)" "unprognostic (1.02e-1)" 1.8 1.0 0.6 0.2 1.1 0.0 0.8 0.5 3.0 0.4 1.4 0.3 0.0 0.9 0.4 4.0 2.2 1.9 0.7 89.6 0.5 0.8 0.2 0.4 0.5 0.1 0.7 1.1 0.5 1.5 0.0 1.8 1.4 0.3 0.9 0.5 0.0 1.9 0.1 68.1 0.9 3.0 0.2 0.5 0.3 1.0 1.3 0.0 0.1 0.7 21.8 0.6 0.3 0.5 1.9 2.8 1.7 1.6 1.1 2.5 1.0 4.0 9.6 1.0 3.0 3.1 5.0 2.7 1.5 0.7 0.5 0.4 2.7 9.9 1.4 5.7 1.7 2.8 2.2 3.8 0.2 0.4 1.4 1.6 4.1 2.3 0.7 1.0 0.3 1.7 1.7 2.3 3.2 0.4 0.4 0.1 3.6 1.2 0.4 4.0 8.7 0.6 2.4 2.2 10.4 5.1 6.3 2.5 3.6 1.0 0.4 14.7 3.4 1.0 4.8 1.2 1.2 26.4 0.5 0.3 0.1 1.8 4.4 0.5 1.4 1.1 4.7 2.9 0.8 2.1 0.4 1.2 0.1 0.1 1.6 1.8 1.9 0.8 2.5 2.8 0.8 1.4 1.5 1.7 1.1 1.3 0.5 1.3 1.0 0.6 1.1 0.5 3.0 0.5 0.8 0.7 1.1 0.3 0.0 0.0 5.8 0.0 1.9 1.1 1.3 122.4 0.0 8.1 4.5 0.0 0.0 3.2 0.0 2.8 1.1 1.6 3.8 0.0 2.9 2.2 1.5 2.3 0.0 1.0 0.5 1.6 4.1 1.3 0.3 1.3 0.0 0.5 1.7 0.0 5.1 2.1 1.4 5.8 1.4 0.3 1.7 0.0 0.5 1.8 2.6 2.3 2.1 0.0 3.2 2.8 ADPRHL2 "ARH3, FLJ20446" ENSG00000116863 "ADP-ribosylhydrolase like 2" Q9NX46 1 36088875-36093932 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" Hydrolase "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026641, HPA027104, HPA027141" Approved Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA026641: , HPA027104: AB_10601330, HPA027141: AB_1844619" "unprognostic (3.22e-3)" "unprognostic (5.10e-2)" "unprognostic (2.95e-2)" "unprognostic (1.61e-2)" "unprognostic (5.98e-2)" "unprognostic (2.09e-1)" "prognostic unfavorable (2.10e-7)" "unprognostic (3.71e-2)" "unprognostic (2.63e-1)" "unprognostic (5.34e-2)" "unprognostic (3.17e-2)" "unprognostic (7.80e-2)" "prognostic unfavorable (3.71e-4)" "unprognostic (4.37e-2)" "unprognostic (9.31e-2)" "unprognostic (3.65e-2)" "unprognostic (4.74e-2)" 15.5 27.6 17.4 15.2 17.4 16.9 20.0 16.5 22.7 15.9 17.3 30.3 17.7 15.6 14.3 17.8 26.3 28.4 13.5 15.1 19.1 18.9 19.8 16.5 20.7 19.1 25.8 18.5 19.7 27.6 15.1 14.0 20.9 19.7 16.6 12.9 12.2 21.9 20.2 26.4 24.4 17.7 22.2 23.5 18.0 14.1 25.1 20.0 21.2 21.2 22.3 19.7 16.1 15.9 27.7 38.9 34.1 38.8 23.5 29.3 29.2 25.7 10.9 13.0 18.3 12.0 8.8 18.6 19.2 16.2 31.1 30.7 12.9 23.4 18.4 18.8 19.1 16.1 16.1 16.4 29.5 18.7 13.1 20.6 16.7 13.2 17.3 22.7 19.0 9.9 10.3 22.6 28.1 12.3 23.7 19.6 17.8 14.4 15.3 14.5 12.4 19.2 28.8 28.0 15.3 22.7 15.7 13.7 18.5 27.8 21.2 16.0 25.4 14.1 14.8 31.3 18.0 15.2 16.5 13.4 18.0 18.6 24.9 25.4 19.9 19.0 16.3 26.0 18.9 11.0 18.2 32.4 34.1 25.5 38.7 24.0 23.6 27.9 29.3 38.9 27.7 28.3 24.0 31.4 23.5 38.8 24.6 22.8 29.2 17.4 17.4 16.5 22.7 19.1 18.9 25.8 18.5 19.7 20.0 29.8 10.0 22.9 24.4 34.9 17.7 7.3 15.3 30.8 14.8 21.0 5.9 67.9 29.9 47.4 6.6 17.1 20.1 0.0 30.7 33.5 19.7 18.0 14.9 6.0 46.0 9.5 16.7 11.1 11.2 7.9 15.3 22.0 25.3 45.1 12.5 24.3 38.3 15.0 17.0 36.1 15.8 25.8 17.9 24.4 46.2 35.8 59.0 19.2 19.8 22.7 ADRA1A "ADRA1C, ADRA1L1" ENSG00000120907 "Adrenoceptor alpha 1A" P35348 8 26748150-26867273 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 45.1" "Group enriched" "Detected in some" 15 "Early spermatids: 50.8;Hepatocytes: 14.0;Late spermatids: 20.6" "Cancer enhanced" "Detected in some" "liver cancer: 0.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC diff: 1.3;HAP1: 1.7;JURKAT: 2.0;NTERA-2: 2.3;U-2 OS: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029678, HPA029679, HPA076693" Approved Supported Supported Nucleoplasm,Vesicles,Cytosol NA NA Cytosol "Nucleoplasm, Vesicles" "HPA029678: AB_10602108, HPA029679: AB_2673143, HPA076693: " "unprognostic (1.27e-1)" "unprognostic (1.68e-2)" "unprognostic (1.99e-1)" "unprognostic (3.57e-1)" "unprognostic (5.04e-4)" "unprognostic (1.97e-1)" "unprognostic (9.55e-2)" "unprognostic (3.08e-1)" "unprognostic (1.58e-2)" "unprognostic (7.47e-2)" "unprognostic (1.71e-2)" "unprognostic (6.06e-3)" "unprognostic (7.41e-2)" "unprognostic (1.52e-2)" "unprognostic (1.30e-1)" 14.5 0.7 7.1 1.1 3.9 0.3 3.4 6.2 4.9 0.9 1.5 5.9 4.9 1.0 1.8 2.0 0.9 0.6 0.5 10.1 11.6 2.0 0.8 45.1 3.9 1.4 4.7 4.7 1.0 0.5 0.3 0.6 0.3 3.8 10.2 0.7 0.6 4.6 11.2 0.6 0.9 1.3 2.4 1.9 7.0 1.2 0.5 4.2 0.0 0.6 0.1 0.6 0.6 0.7 0.3 0.0 0.3 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.3 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 7.1 3.9 6.2 4.9 11.6 2.0 4.7 4.7 3.8 4.2 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 1.3 0.0 20.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 ADRM1 "ARM1, GP110, Rpn13" ENSG00000130706 "Adhesion regulating molecule 1" Q16186 20 62302093-62308862 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 11 "Late spermatids: 1352.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 113.5" "Low region specificity" "Detected in all" HPA042266 Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042266: AB_10794044" "unprognostic (5.49e-2)" "unprognostic (5.14e-3)" "unprognostic (7.34e-2)" "unprognostic (6.16e-2)" "unprognostic (2.06e-2)" "unprognostic (1.06e-1)" "unprognostic (1.77e-3)" "unprognostic (2.14e-2)" "unprognostic (3.56e-2)" "unprognostic (2.13e-3)" "unprognostic (8.98e-2)" "unprognostic (3.50e-1)" "prognostic unfavorable (9.02e-6)" "unprognostic (4.15e-2)" "unprognostic (1.09e-1)" "unprognostic (3.22e-1)" "unprognostic (8.47e-2)" 22.9 22.9 14.8 23.4 16.8 30.5 17.0 24.1 29.3 14.7 16.9 18.8 12.4 24.0 19.9 15.3 23.9 14.0 20.4 24.6 14.6 15.1 21.7 54.5 15.7 22.1 15.5 13.4 17.2 34.9 9.5 13.4 27.6 21.4 14.8 7.9 14.8 21.0 18.3 86.6 26.4 19.5 17.3 15.4 23.5 20.1 30.0 10.1 23.8 16.4 29.1 29.4 17.3 14.6 79.2 67.2 69.4 78.0 51.7 77.6 70.9 33.9 38.1 10.7 22.8 10.2 7.5 29.1 22.5 15.3 42.2 16.9 113.5 36.0 18.3 41.1 12.8 24.1 38.4 13.4 33.0 13.0 21.3 27.5 44.4 27.6 59.8 17.3 22.9 42.4 9.5 20.3 27.5 11.0 7.0 16.3 18.2 32.4 20.0 9.7 45.7 28.7 44.9 36.2 16.5 56.9 23.1 18.8 29.0 11.3 25.6 19.2 23.9 24.2 38.5 27.0 7.6 26.8 25.3 23.9 42.2 44.7 41.1 45.0 42.7 33.6 24.4 44.4 23.1 30.5 48.3 66.3 69.4 66.0 78.0 58.9 79.2 59.8 62.7 67.2 75.5 45.1 51.4 62.2 51.7 65.0 62.7 77.6 70.9 14.8 16.8 24.1 29.3 14.6 15.1 15.5 13.4 21.4 10.1 32.8 25.1 83.4 87.4 131.7 31.3 16.5 53.5 32.1 30.7 62.8 17.7 212.4 97.8 167.4 291.0 91.6 138.0 46.7 184.0 146.0 94.9 83.7 41.5 89.8 134.3 31.8 55.5 94.5 71.8 1352.6 67.0 102.8 92.8 165.1 52.2 58.4 189.2 105.2 81.7 101.6 22.8 64.7 95.7 129.4 168.8 129.5 353.8 81.2 63.5 120.7 AEBP1 ACLP ENSG00000106624 "AE binding protein 1" Q8IUX7 7 44104361-44114562 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Transcription, Transcription regulation" "Calmodulin-binding, DNA-binding, Repressor" "Disease mutation, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 177.1" "Cell type enhanced" "Detected in many" 19 "Fibroblasts: 159.0;Leydig cells: 140.4;Peritubular cells: 478.4;Smooth muscle cells: 174.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 10.5" "Lineage enriched" "Detected in many" 5 "dendritic cells: 10.5" "Cell line enhanced" "Detected in many" "ASC diff: 34.9;BJ: 45.9;BJ hTERT+: 30.3;fHDF/TERT166: 49.3;JURKAT: 34.8;WM-115: 28.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB009966, HPA047724, HPA063595, HPA064970" Supported Supported Nucleoplasm,Vesicles,Cytosol "Secreted - unknown location" NA NA 2300000 Vesicles "Nucleoplasm, Cytosol" "CAB009966: AB_2225690, HPA047724: AB_2680132, HPA063595: AB_2685052, HPA064970: AB_2685394" "unprognostic (1.70e-2)" "unprognostic (5.42e-2)" "unprognostic (1.66e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (1.60e-4)" "unprognostic (1.13e-1)" "unprognostic (7.00e-2)" "unprognostic (8.79e-2)" "unprognostic (2.52e-1)" "unprognostic (3.27e-2)" "unprognostic (1.26e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (9.31e-9)" "unprognostic (2.88e-3)" "unprognostic (9.58e-2)" "unprognostic (1.17e-2)" "unprognostic (6.28e-3)" 46.5 19.0 8.9 23.9 9.5 3.1 90.9 1.7 5.4 78.1 20.5 17.9 15.8 5.8 73.7 39.4 20.7 43.7 47.9 35.4 12.7 6.4 19.6 6.3 35.5 13.0 12.5 10.8 84.8 8.8 2.7 10.9 26.7 17.2 46.1 7.9 33.3 11.9 70.2 11.4 19.7 16.9 42.6 43.7 16.6 17.6 30.6 9.6 48.0 19.6 12.3 7.5 58.2 177.1 2.3 10.5 0.0 0.0 0.2 1.4 0.4 0.1 0.0 10.8 0.0 34.9 12.4 0.2 45.9 30.3 5.2 1.1 0.0 0.0 1.2 5.1 49.3 0.0 0.0 0.5 0.8 2.2 0.1 0.0 3.1 0.0 0.0 9.8 0.0 0.0 18.8 0.0 17.7 0.0 0.2 2.3 34.8 1.9 0.0 0.0 0.0 19.9 3.7 4.6 0.0 0.0 16.5 0.4 0.3 1.2 0.0 1.1 6.1 0.0 0.0 20.1 10.6 0.1 3.3 8.0 0.0 21.3 0.1 0.0 0.2 0.2 24.2 0.1 0.0 28.2 0.0 0.0 0.0 0.4 0.0 0.3 2.1 0.4 0.0 0.0 2.3 1.4 0.8 0.0 0.2 0.0 10.5 0.0 0.4 8.9 9.5 1.7 5.4 12.7 6.4 12.5 10.8 17.2 9.6 0.0 4.5 6.7 5.4 30.7 0.2 15.5 0.0 4.0 2.3 7.0 0.0 1.7 0.0 0.8 2.0 14.4 0.0 0.0 0.0 2.6 159.0 2.4 2.3 0.0 3.1 0.0 0.0 38.6 1.9 9.5 140.4 3.8 81.0 1.0 0.0 0.1 0.7 0.0 478.4 0.6 0.6 38.8 174.1 2.4 4.5 24.0 2.9 0.7 0.0 2.0 AEBP2 MGC17922 ENSG00000139154 "AE binding protein 2" Q6ZN18 12 19404045-19720801 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020893, HPA022282" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA020893: AB_2670528, HPA022282: AB_2670931" "unprognostic (3.28e-1)" "unprognostic (1.77e-1)" "unprognostic (2.29e-1)" "unprognostic (3.16e-2)" "unprognostic (2.74e-1)" "unprognostic (5.17e-2)" "prognostic unfavorable (3.24e-4)" "unprognostic (9.15e-2)" "unprognostic (4.56e-2)" "unprognostic (5.19e-3)" "unprognostic (1.87e-1)" "unprognostic (3.45e-2)" "unprognostic (1.68e-1)" "unprognostic (7.92e-2)" "unprognostic (1.71e-1)" "unprognostic (3.02e-1)" "unprognostic (1.47e-1)" 20.9 27.6 26.8 23.6 24.0 13.8 19.1 31.9 32.4 28.2 19.6 13.3 14.6 11.8 25.7 16.2 27.0 20.4 20.2 16.9 21.4 13.5 21.1 14.8 16.3 19.0 14.1 25.0 26.5 14.2 30.5 19.0 40.2 15.6 25.1 15.9 18.2 21.8 24.5 15.8 28.7 15.8 25.2 16.6 16.4 15.3 15.8 19.2 19.6 23.7 11.5 22.5 28.9 28.7 5.2 4.0 6.0 4.4 9.6 9.9 1.9 9.3 12.3 12.7 6.6 9.7 12.3 33.8 8.8 10.8 13.6 14.5 14.1 17.0 15.4 7.3 11.9 8.9 11.7 27.7 10.6 21.5 43.5 10.5 13.9 18.1 9.4 11.9 17.3 9.6 10.8 11.6 11.2 16.7 16.3 11.0 10.9 7.7 0.7 12.8 10.9 19.0 25.3 26.6 7.9 5.8 15.2 27.2 10.5 10.0 19.9 3.3 7.6 18.5 7.3 9.2 30.5 10.2 11.1 12.0 12.8 9.8 3.9 13.2 4.2 7.7 33.0 9.6 7.9 9.4 6.0 4.4 4.0 7.3 4.3 7.3 3.7 7.3 6.3 3.1 5.2 6.4 9.9 5.0 9.6 3.3 4.0 7.0 1.9 26.8 24.0 31.9 32.4 21.4 13.5 14.1 25.0 15.6 19.2 23.8 11.0 14.3 21.7 66.7 28.8 19.8 10.2 25.4 28.4 12.2 41.2 51.8 14.9 10.5 1.1 20.4 7.9 0.0 10.4 21.2 32.2 20.9 26.6 11.4 13.3 49.3 21.8 13.5 19.0 1.4 22.7 10.5 27.0 15.4 10.2 17.4 9.7 8.6 27.3 14.6 15.6 19.4 61.4 11.7 23.0 66.5 69.5 17.9 10.8 23.7 AEN "FLJ12484, FLJ12562, ISG20L1" ENSG00000181026 "Apoptosis enhancing nuclease" Q8WTP8 15 88621296-88632282 "Predicted intracellular proteins" "Apoptosis, DNA damage" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048599 Supported "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA "Nucleoplasm, Nucleoli" "Nuclear membrane" "HPA048599: AB_2756313" "unprognostic (8.64e-2)" "unprognostic (1.94e-1)" "unprognostic (2.16e-2)" "prognostic favorable (1.72e-4)" "unprognostic (1.52e-2)" "unprognostic (4.40e-2)" "unprognostic (4.08e-2)" "unprognostic (9.42e-2)" "unprognostic (4.28e-2)" "unprognostic (1.17e-2)" "unprognostic (9.00e-2)" "unprognostic (7.88e-2)" "unprognostic (8.58e-3)" "unprognostic (3.39e-2)" "unprognostic (2.73e-1)" "unprognostic (8.71e-2)" "unprognostic (6.10e-2)" 9.4 10.4 6.5 10.2 7.2 14.8 11.2 2.8 5.0 8.0 7.8 4.9 13.4 5.0 9.3 10.2 8.9 7.0 23.0 8.2 4.7 8.5 7.9 17.4 9.1 15.4 13.1 3.1 11.2 18.8 6.7 21.3 11.0 7.8 11.6 9.1 4.3 14.5 9.1 18.8 5.9 8.0 10.6 9.3 14.2 11.1 14.3 4.6 14.0 16.6 10.9 13.7 12.5 5.4 9.3 4.1 0.6 3.6 3.0 15.0 7.6 4.9 22.1 13.8 11.8 6.1 7.4 29.3 17.7 16.2 13.6 16.8 18.1 9.7 21.3 5.7 9.6 12.3 7.1 50.8 14.3 11.5 5.2 20.0 11.4 8.9 29.9 15.1 9.4 11.5 9.1 12.7 17.0 14.0 4.9 11.4 7.1 17.9 12.1 16.6 11.5 11.6 7.9 33.3 10.3 12.8 15.3 9.8 15.7 5.7 10.7 10.9 10.0 7.1 8.2 13.6 33.0 6.8 10.9 10.3 13.9 19.4 5.6 23.8 23.5 15.7 18.2 12.8 10.6 27.2 0.0 1.8 0.6 5.3 3.1 10.0 9.3 9.1 6.9 4.1 9.3 10.0 8.8 0.4 3.0 3.6 2.4 15.0 7.6 6.5 7.2 2.8 5.0 4.7 8.5 13.1 3.1 7.8 4.6 6.0 7.2 11.2 18.2 16.6 0.4 3.4 10.2 2.7 12.5 1.8 0.0 3.4 3.3 12.4 19.8 4.4 2.9 0.0 6.4 13.5 6.7 23.7 2.3 5.0 4.1 1.6 8.6 1.8 5.9 39.3 4.0 5.1 13.5 20.8 5.8 2.3 9.5 5.8 2.5 5.0 0.8 12.9 17.0 6.3 15.0 24.7 5.1 7.2 6.0 24.5 AES "GRG5, TLE5" ENSG00000104964 "Amino-terminal enhancer of split" Q08117 19 3052910-3063107 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "B-cells: 15.8;T-cells: 49.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049499 Supported Nucleoplasm NA NA Nucleoplasm "HPA049499: AB_2680795" "unprognostic (1.08e-1)" "unprognostic (3.32e-3)" "unprognostic (7.15e-2)" "prognostic favorable (3.89e-4)" "unprognostic (1.45e-1)" "unprognostic (4.07e-3)" "unprognostic (3.00e-2)" "unprognostic (1.26e-2)" "unprognostic (3.58e-1)" "unprognostic (7.58e-2)" "unprognostic (1.38e-3)" "unprognostic (2.15e-1)" "prognostic favorable (7.74e-4)" "unprognostic (7.17e-3)" "unprognostic (2.60e-1)" "unprognostic (2.08e-2)" "unprognostic (1.78e-3)" 43.9 64.7 83.7 31.4 62.1 30.7 71.9 115.4 95.8 49.7 61.4 23.4 46.9 30.3 51.6 30.9 58.3 52.5 52.1 131.7 70.9 56.0 38.9 35.4 53.9 66.7 56.7 47.7 63.1 66.5 44.1 42.2 64.1 55.1 52.9 32.3 47.7 102.4 73.2 162.7 43.8 34.4 69.9 39.7 56.4 46.9 25.6 26.2 59.2 61.4 49.8 40.3 64.2 55.7 15.8 6.0 6.7 2.3 8.1 49.4 17.6 27.6 32.6 22.6 43.6 27.9 30.7 17.9 34.6 47.5 44.8 39.2 13.7 28.1 40.8 39.8 44.3 15.9 23.8 26.7 51.3 22.3 68.7 12.3 15.1 32.7 24.9 49.9 21.9 20.6 34.2 40.9 21.4 20.1 47.7 41.7 20.9 53.0 20.7 37.3 28.0 54.3 23.9 20.5 18.9 32.4 57.8 26.0 29.6 53.1 57.4 59.3 62.3 33.1 43.8 34.7 11.6 32.8 28.8 58.7 38.8 26.0 33.6 32.5 1.1 0.2 57.2 35.6 36.1 35.6 6.7 1.4 3.6 28.5 2.3 21.9 13.0 37.5 29.7 2.6 15.8 49.4 32.3 1.0 8.1 1.8 6.0 48.5 17.6 83.7 62.1 115.4 95.8 70.9 56.0 56.7 47.7 55.1 26.2 53.6 54.2 112.4 200.3 74.8 153.7 4.5 119.8 33.5 39.8 118.7 45.2 21.8 99.5 139.0 6.8 93.1 241.4 0.0 124.8 329.2 65.0 157.5 39.2 101.0 72.4 50.9 240.5 116.0 102.1 7.0 218.3 69.7 91.1 113.6 195.4 95.4 169.1 172.3 245.8 60.7 51.8 38.8 87.6 2.8 11.5 56.7 78.6 182.7 134.1 286.4 AFDN "AF-6, AF6, MLLT4" ENSG00000130396 "Afadin, adherens junction formation factor" P55196 6 167826922-167972023 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Cell adhesion" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 157.8;Alveolar cells type 2: 72.9;Ciliated cells: 85.6;Club cells: 75.1;Collecting duct cells: 90.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013496, HPA030212, HPA030213, HPA030214, HPA030215, HPA049868" Approved Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "CAB013496: , HPA030212: AB_10599291, HPA030213: AB_10601340, HPA030214: AB_10601005, HPA030215: AB_10601556, HPA049868: AB_2680924" "prognostic unfavorable (7.43e-5)" "unprognostic (2.66e-3)" "unprognostic (2.07e-2)" "unprognostic (2.61e-1)" "unprognostic (1.13e-1)" "unprognostic (9.06e-2)" "unprognostic (4.12e-1)" "unprognostic (3.12e-2)" "unprognostic (4.12e-1)" "unprognostic (1.09e-3)" "unprognostic (1.75e-1)" "unprognostic (1.73e-2)" "unprognostic (5.56e-2)" "unprognostic (5.43e-3)" "unprognostic (1.59e-1)" "unprognostic (4.72e-2)" "unprognostic (5.68e-2)" 17.0 7.4 14.9 13.0 17.2 1.8 23.5 17.8 19.3 19.6 26.3 16.1 25.5 22.2 15.8 17.7 59.5 27.9 18.2 13.9 15.6 7.2 20.6 29.3 26.3 5.1 17.1 12.5 16.2 29.7 16.4 27.4 18.7 16.1 20.9 27.2 15.3 38.6 18.6 12.7 24.8 42.3 17.4 13.0 13.5 21.1 16.3 15.2 2.1 25.7 13.7 24.5 16.3 27.9 3.5 0.6 2.9 0.5 0.0 1.2 0.0 18.9 5.9 41.5 14.8 4.0 3.4 30.9 7.7 4.0 6.7 8.3 25.3 11.9 3.4 14.3 4.6 10.5 9.1 17.2 15.8 12.0 21.4 17.8 0.1 2.5 19.1 6.1 2.1 9.1 2.4 10.7 11.2 26.5 10.7 12.3 7.4 38.0 13.3 4.3 8.1 0.2 0.1 10.1 27.1 2.7 12.3 10.9 14.4 12.2 9.3 19.2 11.7 7.8 29.8 11.8 40.5 3.5 0.8 18.0 3.1 15.1 13.4 12.7 0.2 16.1 6.9 9.3 4.4 27.2 0.0 0.5 0.0 1.0 0.5 0.6 3.5 1.2 0.4 0.6 2.7 0.0 0.5 2.9 0.0 0.3 0.0 0.6 0.0 14.9 17.2 17.8 19.3 15.6 7.2 17.1 12.5 16.1 15.2 157.8 72.9 0.0 0.0 0.0 0.0 0.0 0.0 85.6 75.1 90.7 0.0 27.0 18.3 58.2 0.0 0.0 0.0 0.0 34.2 28.5 0.0 0.0 8.1 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 19.0 0.0 0.0 52.1 0.0 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 35.2 0.0 0.0 0.0 AFF1 "AF-4, AF4, MLLT2, PBM1" ENSG00000172493 "AF4/FMR2 family member 1" P51825 4 86935002-87141054 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 121.7" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 212.1;Rod photoreceptor cells: 150.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069947 Approved Nucleoplasm,Mitochondria No No "Nucleoplasm, Mitochondria" "HPA069947: AB_2686219" "unprognostic (1.01e-1)" "unprognostic (7.56e-2)" "unprognostic (2.57e-3)" "unprognostic (1.53e-1)" "unprognostic (1.33e-1)" "unprognostic (1.55e-2)" "unprognostic (1.79e-1)" "unprognostic (6.23e-2)" "unprognostic (6.09e-2)" "unprognostic (7.13e-2)" "unprognostic (1.24e-1)" "unprognostic (8.32e-3)" "unprognostic (5.86e-2)" "unprognostic (1.33e-2)" "unprognostic (4.41e-1)" "unprognostic (2.55e-1)" "unprognostic (2.71e-2)" 33.7 16.6 8.0 11.8 9.5 19.5 26.5 6.5 12.2 20.2 21.0 10.5 18.9 11.1 27.4 16.6 15.8 18.6 15.3 22.4 10.3 5.3 27.6 15.5 18.4 12.9 9.3 5.5 24.7 19.0 28.6 18.5 121.7 9.5 16.8 14.3 27.0 16.0 25.6 58.8 18.6 16.2 20.3 11.5 13.9 15.0 6.7 10.3 17.0 38.8 21.1 13.9 19.5 26.5 11.3 14.6 21.1 5.4 5.1 8.8 2.8 7.9 7.3 6.1 6.4 10.1 12.1 8.6 8.0 11.8 6.1 9.2 7.7 14.8 9.0 11.0 9.8 7.8 3.6 9.6 12.1 8.5 15.4 3.8 18.8 19.1 6.4 7.8 18.0 14.9 9.8 8.8 10.5 9.3 8.9 22.5 7.6 11.5 25.6 2.6 2.1 16.2 5.2 8.1 13.3 2.6 12.9 3.6 11.5 18.1 7.6 13.9 2.5 12.3 8.1 3.9 13.4 4.8 15.1 11.3 11.4 10.4 6.9 4.4 22.2 12.3 15.6 9.4 20.8 4.1 3.5 5.4 11.7 6.7 4.1 7.4 8.0 8.8 6.6 6.0 11.3 4.7 4.4 21.1 5.1 2.2 14.6 7.5 2.8 8.0 9.5 6.5 12.2 10.3 5.3 9.3 5.5 9.5 10.3 38.7 57.2 25.4 12.5 21.4 44.7 96.4 40.8 40.2 31.8 87.2 212.1 0.9 3.3 11.6 6.6 38.8 30.8 46.7 10.9 3.8 14.6 24.9 23.3 27.7 11.3 17.5 31.0 65.1 43.0 5.4 27.0 25.6 21.9 8.2 40.8 22.0 11.1 31.7 26.9 40.9 150.1 25.8 15.6 3.5 6.4 27.7 27.5 15.2 25.3 14.4 AFF3 "LAF4, MLLT2-like" ENSG00000144218 "AF4/FMR2 family member 3" P51826 2 99545419-100142739 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 43.6" "Cell type enhanced" "Detected in many" 10 "B-cells: 79.7;Horizontal cells: 44.5" "Cancer enhanced" "Detected in many" "breast cancer: 11.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 16.2;naive B-cell: 27.5;plasmacytoid DC: 12.8" "Group enriched" "Detected in many" 16 "B-cells: 27.5;dendritic cells: 12.8" "Cell line enhanced" "Detected in many" "Daudi: 23.7;U-698: 35.1" "Low region specificity" "Detected in all" "HPA044512, HPA053379" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044512: AB_10795984, HPA053379: AB_2682133" "unprognostic (1.05e-2)" "unprognostic (3.01e-2)" "unprognostic (2.30e-1)" "unprognostic (4.88e-3)" "unprognostic (1.02e-1)" "unprognostic (4.98e-5)" "unprognostic (1.11e-3)" "unprognostic (3.04e-2)" "unprognostic (8.75e-2)" "unprognostic (3.07e-1)" "unprognostic (1.95e-3)" "unprognostic (7.57e-2)" "prognostic unfavorable (5.64e-4)" "unprognostic (6.40e-3)" "unprognostic (6.79e-2)" "unprognostic (3.69e-2)" "unprognostic (7.87e-3)" 3.2 2.4 6.0 40.2 6.1 10.3 16.6 20.5 9.9 4.2 4.2 1.8 0.8 1.2 8.9 1.7 4.1 4.1 2.3 4.9 6.3 6.2 1.8 2.4 7.6 23.3 5.4 6.8 7.5 1.1 0.3 5.2 6.9 4.4 18.9 2.3 5.5 6.6 3.3 1.0 1.0 5.9 8.6 6.6 43.6 4.8 6.0 2.5 34.7 1.7 0.7 42.0 7.4 2.7 27.5 12.8 0.2 0.2 0.9 1.2 0.4 0.1 0.0 10.0 3.5 0.0 0.4 0.0 1.4 0.3 3.0 1.0 0.0 0.0 23.7 0.1 1.5 7.6 0.1 0.2 0.0 1.8 6.0 2.9 0.0 0.1 0.0 0.2 0.1 6.8 0.6 0.0 6.2 0.1 7.7 0.0 1.3 0.1 0.0 0.0 0.1 1.9 0.3 1.3 0.0 1.6 3.2 0.0 0.1 0.0 0.0 9.9 3.5 0.1 0.1 6.4 1.3 11.9 10.9 3.9 9.5 2.6 0.3 1.5 0.2 0.0 35.1 8.8 0.8 0.8 0.2 0.2 0.0 0.0 0.2 0.2 16.2 0.1 0.0 2.9 27.5 1.2 0.0 0.1 0.9 0.2 12.8 0.0 0.4 6.0 6.1 20.5 9.9 6.3 6.2 5.4 6.8 4.4 2.5 6.0 29.7 79.7 0.4 1.5 15.0 9.6 0.0 0.0 6.8 0.0 11.8 0.2 0.0 0.0 25.7 1.2 0.0 0.0 0.0 0.1 4.7 14.7 0.0 0.8 1.4 44.5 22.0 0.6 7.0 28.0 10.0 12.9 13.5 0.0 0.3 8.9 0.0 0.0 19.8 0.8 1.4 0.0 6.9 5.1 7.0 1.1 0.1 2.2 0.0 0.1 AFF4 "AF5Q31, MCEF" ENSG00000072364 "AF4/FMR2 family member 4" Q9UHB7 5 132875379-132963634 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Disease mutation, Dwarfism, Obesity, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023690, HPA029634" Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA023690: AB_1844633, HPA029634: AB_2673129" "unprognostic (3.24e-2)" "unprognostic (1.86e-2)" "unprognostic (6.17e-3)" "unprognostic (1.45e-1)" "unprognostic (1.99e-1)" "unprognostic (1.10e-1)" "unprognostic (2.56e-2)" "unprognostic (7.37e-2)" "unprognostic (1.18e-1)" "unprognostic (6.13e-2)" "unprognostic (4.94e-2)" "unprognostic (3.52e-1)" "unprognostic (1.16e-2)" "unprognostic (2.77e-2)" "unprognostic (3.25e-2)" "prognostic unfavorable (6.44e-4)" "unprognostic (1.69e-1)" 22.9 29.6 22.8 19.1 38.7 38.3 23.6 37.8 25.6 26.2 21.8 25.2 22.1 14.6 27.6 19.5 29.8 20.8 26.8 21.3 18.7 18.7 25.7 24.2 24.8 19.6 19.0 19.7 34.0 24.9 48.8 40.1 20.4 18.3 26.7 18.5 27.5 25.2 25.1 32.1 22.2 17.8 24.4 18.8 17.3 24.8 17.6 24.4 26.6 33.9 15.7 19.2 26.3 24.7 8.7 5.2 12.2 4.9 3.8 5.5 1.5 16.8 13.6 18.7 20.7 14.4 17.5 14.7 18.2 19.6 16.8 21.5 20.0 11.1 8.5 21.7 23.8 20.4 8.4 15.0 22.5 28.2 6.1 9.7 10.6 18.5 7.1 18.5 3.7 11.0 20.4 15.1 29.1 29.6 18.1 16.1 7.8 7.5 7.3 20.9 6.4 10.2 3.9 7.2 5.0 5.5 6.8 18.3 3.2 14.6 23.7 14.6 15.4 20.7 5.1 20.6 27.0 10.7 6.0 22.6 20.2 17.2 17.8 19.3 10.1 17.2 7.8 19.0 6.9 13.8 12.2 2.4 3.8 5.5 2.0 4.1 7.7 5.1 3.7 2.9 8.7 5.3 4.6 5.2 3.8 4.9 5.2 2.5 1.5 22.8 38.7 37.8 25.6 18.7 18.7 19.0 19.7 18.3 24.4 74.5 31.6 45.5 71.7 70.7 71.8 55.7 68.8 48.2 73.9 55.8 149.2 32.2 6.6 46.4 222.1 55.8 54.9 0.0 40.0 37.0 72.8 98.0 41.6 20.2 36.3 74.7 93.7 57.1 46.7 140.8 64.2 53.7 65.8 30.7 46.2 72.9 61.9 60.4 63.3 26.2 136.3 77.6 56.1 34.9 20.1 75.7 58.5 51.1 37.9 92.8 AGAP2 CENTG1 ENSG00000135439 "ArfGAP with GTPase domain, ankyrin repeat and PH domain 2" Q99490 12 57723761-57742157 "Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 55.9;lymphoid tissue: 18.8" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 7.5;Horizontal cells: 7.9;Sertoli cells: 32.3;T-cells: 12.1" "Cancer enriched" "Detected in many" 12 "glioma: 20.6" "Group enriched" "Detected in many" 4 "amygdala: 34.3;basal ganglia: 40.2;cerebellum: 48.2;cerebral cortex: 35.4;hippocampal formation: 37.6" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 18.0;Karpas-707: 17.5;RH-30: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023474, HPA075831" Enhanced Supported "Nucleoplasm,Midbody ring,Cytosol" NA NA "Nucleoplasm, Cytosol" "Midbody ring" "HPA023474: AB_1855378, HPA075831: " "unprognostic (1.87e-1)" "unprognostic (2.46e-3)" "unprognostic (9.26e-2)" "unprognostic (5.56e-4)" "unprognostic (3.95e-1)" "unprognostic (1.14e-2)" "unprognostic (5.00e-2)" "unprognostic (2.36e-2)" "unprognostic (3.39e-1)" "unprognostic (2.80e-1)" "unprognostic (1.93e-3)" "unprognostic (4.18e-1)" "unprognostic (4.81e-9)" "unprognostic (3.30e-1)" "unprognostic (2.72e-2)" "unprognostic (3.07e-1)" "unprognostic (5.75e-2)" 3.8 1.8 34.3 11.8 40.2 8.1 0.7 48.2 55.9 0.6 2.1 1.2 0.0 2.0 1.5 0.9 1.6 0.8 2.8 4.3 37.6 8.9 1.2 0.8 2.2 13.5 6.3 3.1 1.2 2.4 1.7 1.2 1.7 2.5 1.0 1.2 0.7 4.5 0.9 8.3 2.1 2.2 0.8 2.1 10.0 2.1 0.9 0.7 18.8 0.9 1.5 16.6 2.9 0.6 1.9 1.4 6.3 1.2 2.3 6.3 1.7 3.0 4.5 8.7 2.5 0.0 0.0 5.0 2.1 0.4 0.0 0.2 0.5 2.9 7.9 0.6 0.0 1.6 1.9 0.0 0.0 0.0 8.6 1.3 8.7 0.7 1.4 0.0 8.9 18.0 0.0 0.0 0.0 0.0 3.7 0.0 9.3 0.0 17.5 0.0 5.3 15.7 5.7 1.4 0.9 4.6 6.5 43.8 5.7 0.0 2.6 2.5 9.1 1.1 1.6 1.8 0.0 1.1 6.3 4.8 2.4 4.1 4.6 1.5 7.4 4.4 3.9 4.4 5.9 4.1 6.0 0.8 1.0 4.8 1.2 5.1 1.9 4.8 5.1 1.4 1.6 2.0 3.0 6.3 2.3 0.7 1.2 6.3 1.7 34.3 40.2 48.2 35.4 37.6 8.9 6.3 3.1 2.5 0.7 3.0 0.6 4.1 0.2 0.0 7.5 2.2 2.5 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.2 0.4 0.2 2.3 0.0 1.4 7.9 0.0 0.6 0.6 0.7 0.0 1.6 0.0 3.6 0.3 0.1 0.1 0.0 0.7 0.0 1.9 32.3 1.2 0.7 0.4 0.4 0.0 12.1 0.1 0.0 AGL ENSG00000162688 "Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase" P35573 1 99850084-99924023 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycogen biosynthesis" "Glycosidase, Glycosyltransferase, Hydrolase, Multifunctional enzyme, Transferase" "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "liver: 23.1;skeletal muscle: 85.6;tongue: 34.4" "Cell type enhanced" "Detected in all" 6 "Muller glia cells: 151.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028498, HPA054340" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 16000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA028498: AB_10600975, HPA054340: AB_2682455" "unprognostic (2.90e-1)" "unprognostic (5.34e-2)" "unprognostic (3.99e-3)" "unprognostic (2.18e-2)" "unprognostic (6.46e-3)" "unprognostic (5.13e-2)" "unprognostic (1.12e-1)" "unprognostic (1.92e-2)" "unprognostic (9.37e-3)" "unprognostic (1.11e-1)" "unprognostic (8.10e-3)" "unprognostic (7.61e-2)" "prognostic favorable (1.73e-10)" "unprognostic (6.38e-2)" "unprognostic (2.89e-1)" "unprognostic (1.15e-1)" "unprognostic (7.13e-2)" 5.0 4.5 2.5 4.7 3.6 2.0 4.2 5.4 6.1 3.4 4.5 2.1 5.4 3.3 4.8 4.2 9.1 4.1 2.6 8.2 2.2 2.3 5.8 23.1 4.2 5.3 2.4 4.2 3.8 3.6 8.7 4.7 4.8 2.9 5.5 4.2 3.9 5.1 8.7 85.6 3.7 4.0 5.4 2.8 4.8 4.4 2.9 1.2 7.1 4.3 34.4 3.4 6.7 3.6 3.0 2.3 3.5 1.6 6.1 4.3 2.1 12.1 3.6 4.3 7.0 7.1 6.8 14.5 3.8 5.7 3.4 6.0 13.5 4.1 15.9 7.4 6.5 3.0 6.9 25.1 7.5 6.4 8.4 7.9 9.2 12.4 7.5 4.7 8.2 5.6 8.2 4.9 4.7 3.9 4.8 5.3 5.6 15.2 1.1 3.5 3.8 9.6 2.6 6.8 5.4 4.6 0.0 1.4 0.8 10.3 16.4 10.7 7.4 11.1 10.7 6.0 8.4 7.7 5.5 5.4 4.1 5.9 5.5 3.7 4.5 3.6 18.4 7.2 2.2 2.1 0.1 1.3 3.5 4.3 1.6 4.1 3.0 3.2 2.9 2.3 2.9 3.2 3.2 1.5 6.1 0.9 2.1 3.3 2.1 2.5 3.6 5.4 6.1 2.2 2.3 2.4 4.2 2.9 1.2 20.8 23.2 15.3 15.5 9.4 36.9 94.9 20.4 29.4 29.6 15.7 51.1 77.6 19.9 11.9 1.1 10.8 15.8 23.3 11.2 17.2 13.6 9.9 10.4 84.7 15.8 49.3 16.1 16.0 16.2 1.1 9.5 9.2 15.1 10.8 18.2 151.6 14.2 10.5 20.1 16.3 47.8 6.5 14.2 8.1 11.7 8.2 24.4 15.0 17.4 16.6 AGO3 "EIF2C3, FLJ12765, hAGO3" ENSG00000126070 "Argonaute 3, RISC catalytic component" Q9H9G7 1 35930718-36072500 "Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" "Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048342, HPA067849, HPA075436" Uncertain Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA "Cytoplasmic bodies" "Nucleoplasm, Cytosol" "HPA048342: AB_2680365, HPA067849: , HPA075436: AB_2686750" "unprognostic (4.10e-2)" "unprognostic (7.10e-2)" "unprognostic (4.94e-2)" "prognostic unfavorable (5.70e-4)" "unprognostic (1.89e-2)" "unprognostic (2.12e-2)" "unprognostic (4.39e-4)" "unprognostic (5.14e-2)" "unprognostic (2.37e-3)" "unprognostic (1.30e-1)" "unprognostic (4.97e-2)" "unprognostic (2.96e-2)" "unprognostic (9.28e-3)" "unprognostic (1.61e-1)" "unprognostic (4.45e-2)" "unprognostic (9.06e-2)" "unprognostic (1.81e-1)" 9.8 8.1 8.8 16.2 11.7 20.6 9.6 12.8 9.6 9.4 7.4 13.8 10.4 4.6 9.5 10.9 7.8 7.4 8.8 9.5 8.0 7.4 8.2 11.3 9.6 9.3 11.5 6.1 10.8 9.7 13.3 28.0 11.0 9.1 9.8 7.1 8.7 7.7 14.1 8.3 12.5 7.3 12.0 10.9 8.3 8.0 21.4 13.5 14.4 9.7 4.7 10.1 8.4 13.9 6.5 5.1 14.0 6.0 6.0 5.5 2.3 6.6 4.6 5.9 4.6 8.3 5.0 7.1 5.5 5.8 8.5 9.1 5.0 7.5 7.4 6.8 5.6 9.8 5.6 6.3 4.0 11.4 10.2 3.9 9.0 8.0 3.8 4.4 8.7 7.6 2.4 3.6 12.2 7.7 3.4 7.2 7.8 9.7 10.8 7.4 2.5 6.3 4.7 10.2 3.5 8.1 7.7 7.9 7.3 2.7 6.5 7.2 4.5 9.8 2.5 3.4 9.4 3.7 3.6 5.6 5.9 15.1 5.2 5.9 6.0 10.3 10.3 3.0 5.6 5.7 8.5 4.7 13.2 5.5 4.2 3.5 6.2 3.6 3.9 5.1 6.5 5.0 5.0 14.0 6.0 6.0 4.5 3.4 2.3 8.8 11.7 12.8 9.6 8.0 7.4 11.5 6.1 9.1 13.5 80.4 42.9 19.0 30.7 34.5 67.6 16.7 7.6 12.0 26.1 24.4 106.0 9.2 0.0 13.1 43.3 29.9 12.7 0.0 10.6 11.0 30.1 30.9 56.4 20.3 14.3 39.7 44.9 31.3 28.4 54.4 35.1 34.5 21.9 14.4 14.3 46.3 13.7 7.0 38.9 6.7 82.2 19.4 33.0 33.1 19.8 29.4 10.8 27.7 16.3 25.0 AHCYL2 KIAA0828 ENSG00000158467 "Adenosylhomocysteinase like 2" Q96HN2 7 129225023-129430211 "Enzymes, Predicted intracellular proteins" "One-carbon metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 72.4" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 75.8;Enterocytes: 114.1;Muller glia cells: 87.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in all" 8 "HDLM-2: 73.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053128 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA053128: AB_2682050" "unprognostic (1.57e-1)" "unprognostic (2.91e-1)" "unprognostic (8.52e-3)" "unprognostic (1.71e-3)" "unprognostic (7.44e-3)" "prognostic favorable (4.17e-4)" "unprognostic (8.85e-2)" "unprognostic (1.43e-1)" "unprognostic (3.35e-1)" "unprognostic (2.74e-1)" "unprognostic (1.63e-1)" "unprognostic (6.79e-3)" "prognostic favorable (1.08e-7)" "unprognostic (4.70e-3)" "unprognostic (2.46e-1)" "unprognostic (7.21e-2)" "unprognostic (2.62e-1)" 4.3 6.6 12.8 5.9 20.3 1.5 4.3 7.2 16.9 7.1 61.8 13.3 5.1 23.1 6.1 3.3 5.7 4.4 22.7 3.4 16.5 9.6 11.9 3.4 26.1 4.2 10.7 14.9 5.7 5.8 9.1 12.8 5.1 19.8 5.0 72.4 24.3 15.0 3.3 20.7 9.8 15.0 5.3 11.4 2.9 16.5 8.1 9.6 4.6 24.1 4.0 4.0 5.4 4.7 0.9 1.3 2.0 2.5 3.3 5.0 0.5 2.7 4.3 8.3 4.9 2.2 3.3 1.7 2.1 3.0 2.4 2.2 2.5 1.8 1.6 2.2 2.3 5.2 1.9 4.1 3.4 2.7 73.5 5.1 3.9 4.8 2.0 1.3 2.8 5.0 3.0 4.4 1.9 3.0 4.1 4.8 3.2 1.7 9.3 3.1 2.5 4.2 3.7 4.1 2.7 3.0 2.8 2.2 4.4 4.9 3.6 3.8 2.4 4.9 2.1 2.9 7.2 2.0 2.1 2.7 2.1 1.2 5.5 2.2 3.9 4.4 2.2 5.4 3.1 3.2 0.1 1.2 2.0 0.9 2.5 1.2 0.9 1.5 0.7 1.3 0.5 1.3 0.5 0.4 3.3 1.2 0.4 5.0 0.5 12.8 20.3 7.2 16.9 16.5 9.6 10.7 14.9 19.8 9.6 56.6 75.8 3.4 4.5 13.9 9.4 4.5 17.8 5.3 19.4 5.2 5.9 8.4 10.0 3.6 61.0 3.9 114.1 0.0 4.9 2.2 3.1 6.2 5.7 4.9 3.9 4.8 8.7 4.3 8.3 20.3 3.7 5.1 23.6 7.2 29.7 87.7 4.5 30.8 6.3 15.7 5.0 6.5 1.2 4.6 2.4 8.5 12.7 3.2 32.7 13.9 AHDC1 "DJ159A19.3, RP1-159A19.1" ENSG00000126705 "AT-hook DNA binding motif containing 1" Q5TGY3 1 27534035-27604431 "Disease related genes, Predicted intracellular proteins" DNA-binding "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Peritubular cells: 59.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 22.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028648, HPA028685, HPA028691" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA028648: AB_10599276, HPA028685: , HPA028691: AB_10601781" "unprognostic (1.96e-1)" "unprognostic (1.73e-1)" "unprognostic (6.93e-2)" "prognostic unfavorable (1.20e-4)" "unprognostic (4.43e-1)" "prognostic favorable (2.68e-4)" "unprognostic (9.20e-2)" "unprognostic (3.05e-1)" "unprognostic (2.56e-1)" "prognostic unfavorable (4.92e-4)" "unprognostic (5.21e-3)" "unprognostic (3.96e-1)" "unprognostic (1.76e-1)" "unprognostic (1.46e-1)" "unprognostic (2.30e-1)" "unprognostic (1.02e-1)" "unprognostic (1.03e-1)" 10.2 17.6 16.9 6.7 12.9 4.6 7.7 40.3 21.7 15.3 8.7 5.8 6.7 5.2 16.8 6.6 20.4 13.5 7.5 9.9 15.2 7.4 7.2 5.6 6.6 5.7 8.2 12.7 19.0 7.5 4.3 16.0 8.4 13.7 8.0 3.0 8.8 15.4 13.1 41.5 21.3 5.6 11.0 14.6 18.2 9.3 8.9 12.9 9.1 12.8 10.9 10.6 9.8 14.0 0.6 1.6 0.9 0.7 2.0 1.4 0.7 7.6 7.0 9.9 5.3 3.2 5.3 10.1 7.2 5.2 5.0 4.2 2.7 7.2 1.1 5.3 4.8 3.0 7.7 1.0 9.4 1.4 2.8 3.8 6.0 6.3 3.6 3.0 1.6 3.1 5.0 3.9 3.5 2.2 5.1 2.6 3.6 7.2 0.9 8.3 3.7 5.1 8.6 7.3 1.9 8.7 22.9 11.9 0.6 3.3 1.0 17.1 6.5 5.0 8.3 2.0 3.5 4.1 1.3 4.8 8.7 7.2 6.4 2.2 2.5 1.7 1.2 7.4 4.8 4.9 0.9 0.4 0.5 1.2 0.6 0.7 0.5 1.0 1.2 0.4 0.6 1.4 1.0 0.7 2.0 0.7 1.6 1.1 0.7 16.9 12.9 40.3 21.7 15.2 7.4 8.2 12.7 13.7 12.9 6.0 6.9 8.2 7.7 44.0 32.7 14.2 2.5 5.3 9.1 17.4 0.0 9.1 3.3 9.3 0.6 11.9 5.6 0.0 11.8 4.0 19.6 9.7 0.0 9.7 11.2 33.4 9.4 14.7 2.1 1.9 48.1 4.1 15.1 2.8 6.1 11.7 12.9 5.8 59.8 4.4 1.8 38.8 15.6 2.6 4.3 49.1 4.7 4.5 6.3 11.3 AHR bHLHe76 ENSG00000106546 "Aryl hydrocarbon receptor" P35869 7 16916359-17346152 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Cancer-related genes, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 69.6" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 140.0;granulocytes: 130.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 28.0;hTERT-HME1: 29.2;RT4: 24.0" "CAB005072, HPA029722, HPA029723" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB005072: AB_633731, HPA029722: AB_10599189, HPA029723: AB_10599025" "unprognostic (1.29e-2)" "unprognostic (1.21e-2)" "unprognostic (2.13e-1)" "unprognostic (1.39e-2)" "unprognostic (7.28e-2)" "unprognostic (1.22e-1)" "unprognostic (1.44e-1)" "unprognostic (3.39e-1)" "unprognostic (4.32e-2)" "unprognostic (9.98e-2)" "unprognostic (1.24e-3)" "unprognostic (2.89e-1)" "unprognostic (7.53e-3)" "unprognostic (2.00e-1)" "unprognostic (2.82e-3)" "unprognostic (3.25e-2)" "unprognostic (9.45e-2)" 23.1 12.2 2.5 13.2 3.5 19.8 19.1 1.6 3.5 14.6 14.0 5.7 8.7 8.5 11.9 10.1 14.2 11.2 22.2 14.8 3.2 2.2 7.3 23.9 26.4 20.0 6.5 2.5 21.3 6.8 4.5 3.8 69.6 3.7 21.4 8.9 10.9 11.1 8.5 5.2 16.6 13.7 12.1 4.8 15.6 13.3 6.8 4.0 7.1 12.4 7.9 12.3 26.7 26.6 1.1 9.3 5.6 7.6 3.1 2.9 2.0 3.0 2.5 1.0 0.0 7.7 5.3 0.4 6.3 9.1 2.9 4.3 3.0 6.8 0.0 1.9 9.2 11.6 8.4 0.6 5.7 7.7 0.1 1.4 1.8 3.2 2.7 14.3 3.0 4.5 7.2 28.0 11.1 29.2 13.3 9.7 0.0 0.2 0.0 13.2 1.5 0.0 4.8 0.8 23.0 4.0 0.0 0.0 0.1 9.3 24.0 0.9 0.0 4.7 5.1 4.6 7.7 3.6 1.0 1.6 1.2 0.0 15.9 0.0 1.3 0.0 0.0 20.4 11.7 20.0 0.7 7.6 5.6 0.7 3.6 1.1 0.8 2.6 1.4 9.3 1.1 1.5 1.1 0.8 3.1 1.3 2.2 2.9 2.0 2.5 3.5 1.6 3.5 3.2 2.2 6.5 2.5 3.7 4.0 140.0 72.8 9.4 40.0 66.9 34.6 12.9 43.3 42.8 75.1 7.0 7.9 3.1 0.0 15.8 4.8 55.4 13.6 0.0 13.4 1.2 31.0 42.7 130.4 40.0 24.3 41.3 5.2 44.2 75.1 2.4 3.4 73.2 67.4 36.9 10.6 0.5 24.6 16.9 2.5 5.6 5.7 6.5 41.1 2.4 2.3 78.0 18.0 7.5 12.6 90.1 AHRR "AHH, AHHR, bHLHe77, KIAA1234" ENSG00000063438 "Aryl-hydrocarbon receptor repressor" A9YTQ3 5 304176-438291 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 44.3" "Group enriched" "Detected in some" 8 "Early spermatids: 233.3;Late spermatids: 118.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 23.8;HMC-1: 35.8;NB-4: 43.1;WM-115: 25.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA021483 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA021483: AB_1855110" "unprognostic (2.06e-4)" "unprognostic (3.48e-2)" "unprognostic (8.71e-3)" "unprognostic (2.23e-1)" "unprognostic (1.09e-1)" "unprognostic (9.33e-4)" "unprognostic (4.08e-2)" "unprognostic (1.06e-1)" "unprognostic (1.17e-1)" "unprognostic (1.02e-5)" "unprognostic (1.87e-1)" "unprognostic (5.07e-2)" "unprognostic (1.65e-6)" "unprognostic (1.70e-1)" "unprognostic (1.94e-1)" "unprognostic (1.20e-1)" "unprognostic (3.55e-2)" 0.8 0.4 1.0 4.6 0.8 0.2 2.4 0.4 1.4 2.4 1.2 0.7 1.4 0.7 1.6 0.9 1.4 0.5 4.4 0.3 1.2 1.0 0.6 0.4 6.2 0.4 0.3 0.0 2.1 1.0 0.1 1.3 2.1 0.9 0.6 1.2 2.7 0.9 0.3 0.6 5.8 1.7 0.9 0.3 4.7 0.7 44.3 0.3 0.1 0.9 1.8 4.2 2.0 3.6 0.9 2.3 1.0 0.5 0.0 1.0 0.3 0.1 4.0 0.6 0.5 2.2 4.6 4.7 8.5 11.5 4.8 9.5 0.1 3.2 0.3 4.4 15.4 1.3 0.2 0.7 0.2 2.1 0.6 1.7 4.0 23.8 0.1 1.6 1.2 35.8 0.9 0.3 3.3 0.4 6.4 1.7 1.0 0.6 0.3 5.1 0.3 0.3 43.1 0.1 1.0 4.0 0.6 0.2 0.4 0.1 0.0 5.6 0.2 11.3 2.1 5.8 0.1 0.2 14.7 2.1 8.9 1.1 10.0 0.3 1.3 2.1 0.3 3.8 0.3 25.2 0.0 0.5 1.0 0.3 0.0 0.1 0.2 0.6 0.3 0.0 0.9 0.1 0.1 0.5 0.0 0.1 2.3 1.0 0.3 1.0 0.8 0.4 1.4 1.2 1.0 0.3 0.0 0.9 0.3 0.0 0.0 0.0 0.0 1.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 233.3 1.0 0.0 0.0 0.2 4.3 3.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 118.4 3.1 2.2 18.6 10.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 6.5 1.4 21.3 7.0 1.3 0.7 0.0 0.0 0.1 AIM2 PYHIN4 ENSG00000163568 "Absent in melanoma 2" O14862 1 159062484-159147096 "Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" DNA-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 44.7;lymphoid tissue: 43.8" "Group enriched" "Detected in some" 6 "B-cells: 18.9;Early spermatids: 19.7;Late spermatids: 24.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 6 "memory B-cell: 44.7;naive B-cell: 14.3" "Lineage enriched" "Detected in many" 9 "B-cells: 44.7" "Cell line enhanced" "Detected in some" "Daudi: 31.8;HDLM-2: 44.3;Karpas-707: 17.6;U-266/70: 14.8;U-266/84: 11.1;U-87 MG: 13.7" "Low region specificity" "Detected in all" "HPA031365, HPA040309" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA031365: AB_10601332, HPA040309: AB_2676925" "unprognostic (6.05e-2)" "unprognostic (7.68e-2)" "unprognostic (4.24e-3)" "unprognostic (2.08e-2)" "unprognostic (6.94e-2)" "unprognostic (3.44e-1)" "unprognostic (3.20e-1)" "unprognostic (1.35e-1)" "unprognostic (4.27e-2)" "unprognostic (1.28e-3)" "unprognostic (7.10e-3)" "unprognostic (1.13e-1)" "unprognostic (1.23e-12)" "unprognostic (1.01e-1)" "unprognostic (3.91e-2)" "unprognostic (2.28e-1)" "unprognostic (2.32e-3)" 0.7 0.3 1.3 28.2 0.9 0.4 0.6 0.5 0.6 0.4 1.9 0.1 0.0 0.7 0.2 0.2 4.1 0.5 1.1 0.5 1.2 0.6 0.9 0.8 2.0 24.1 0.5 0.2 0.6 0.3 0.0 8.8 0.4 0.5 0.7 1.0 0.5 1.9 0.0 0.2 0.3 12.8 0.2 2.6 43.8 1.3 1.4 1.4 1.4 0.7 0.6 25.9 4.0 0.5 44.7 1.2 4.7 2.4 0.0 3.3 1.4 5.3 0.0 0.3 0.0 0.0 4.4 0.0 0.0 0.5 0.4 0.3 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 44.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 2.9 0.0 2.8 3.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.3 0.1 14.8 11.1 0.3 13.7 1.2 2.3 4.2 2.4 0.0 0.6 2.1 1.7 44.7 1.6 1.1 1.2 14.3 0.1 0.4 4.7 0.0 2.2 0.0 3.3 1.4 1.3 0.9 0.5 0.6 1.2 0.6 0.5 0.2 0.5 1.4 0.0 0.0 18.9 0.1 0.0 0.7 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 19.7 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.9 24.1 0.3 1.0 3.3 1.0 0.0 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 2.1 0.0 0.4 AIPL1 LCA4 ENSG00000129221 "Aryl hydrocarbon receptor interacting protein like 1" Q9NZN9 17 6393693-6435199 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Disease mutation, Leber congenital amaurosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "retina: 123.7" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 388.8;Rod photoreceptor cells: 1307.2" "Cancer enriched" "Detected in single" 12 "testis cancer: 0.5" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 4.1;OE19: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA026578 Enhanced Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA026578: AB_2671905" "unprognostic (2.42e-2)" "unprognostic (1.17e-1)" "unprognostic (2.02e-2)" "unprognostic (1.68e-3)" "unprognostic (3.24e-1)" "unprognostic (1.13e-3)" "unprognostic (3.76e-1)" "unprognostic (5.35e-2)" 0.1 0.1 1.4 0.4 0.3 2.9 0.1 0.5 0.8 0.2 0.1 0.1 0.1 0.0 0.1 0.3 1.1 0.0 0.3 0.1 0.6 0.5 0.1 0.1 0.2 0.1 0.5 0.1 0.2 0.1 0.0 0.8 0.1 0.1 0.1 0.0 123.7 2.3 0.1 0.1 2.4 0.1 0.1 0.1 1.0 0.2 3.3 0.1 0.2 0.4 0.1 0.2 0.1 0.1 1.0 1.1 2.2 0.7 1.1 0.6 0.0 0.1 1.5 0.5 0.1 0.1 0.0 0.4 0.0 0.3 0.1 0.5 0.1 0.1 0.3 0.1 0.0 0.1 4.1 0.1 0.2 0.2 0.2 0.3 0.4 1.7 0.4 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.8 0.0 0.4 0.2 0.1 0.8 7.6 1.3 0.1 0.0 0.0 0.1 1.0 0.2 0.2 0.9 0.3 0.0 0.3 0.2 0.0 0.0 0.3 0.2 0.4 0.3 0.3 0.1 0.1 0.6 0.5 0.2 0.9 0.7 0.6 0.6 0.3 0.3 0.6 0.3 0.1 0.3 1.0 0.3 0.4 2.2 1.1 0.5 1.1 0.4 0.0 1.4 0.3 0.5 0.5 0.6 0.5 0.5 0.1 0.1 0.1 3.0 0.6 0.0 1.0 0.7 109.4 0.6 0.0 0.0 2.3 0.0 388.8 0.1 0.0 0.0 7.5 0.3 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.1 62.0 0.0 2.5 0.0 1.0 0.0 0.3 1.7 0.0 0.0 135.1 0.1 0.0 0.4 0.0 1307.2 0.0 0.1 0.2 0.0 0.4 0.2 0.0 0.0 2.0 AJUBA "JUB, MGC15563" ENSG00000129474 "Ajuba LIM protein" Q96IF1 14 22971174-22982642 "Cancer-related genes, Predicted intracellular proteins" "Cell adhesion, Cell cycle, RNA-mediated gene silencing, Transcription, Transcription regulation" Repressor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 55.0" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 42.2;Sertoli cells: 32.3;Suprabasal keratinocytes: 43.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 49.9;hTCEpi: 52.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA006171 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA006171: AB_1852044" "unprognostic (1.15e-1)" "unprognostic (2.99e-2)" "unprognostic (2.39e-1)" "unprognostic (1.24e-3)" "unprognostic (9.81e-2)" "unprognostic (1.49e-1)" "unprognostic (1.80e-3)" "unprognostic (2.73e-1)" "unprognostic (1.39e-1)" "unprognostic (1.86e-1)" "prognostic unfavorable (5.67e-4)" "unprognostic (1.47e-1)" "unprognostic (3.19e-3)" "unprognostic (2.94e-1)" "unprognostic (2.68e-1)" "unprognostic (9.35e-3)" "unprognostic (2.07e-1)" 2.9 2.0 1.1 2.4 1.8 0.0 4.1 1.1 1.6 11.1 2.0 1.6 4.9 0.5 8.8 4.4 12.3 4.7 7.9 3.2 2.3 0.6 15.6 55.0 8.5 2.2 1.5 1.3 8.2 5.6 5.5 1.4 12.5 2.6 9.2 1.1 7.1 5.5 11.0 1.5 31.3 1.7 4.3 0.5 2.9 2.6 4.1 1.3 7.1 15.4 5.3 6.6 3.7 10.0 1.3 1.0 2.6 1.2 2.9 2.5 0.6 10.4 12.4 16.6 6.4 1.6 2.9 13.3 10.3 13.6 24.2 21.7 26.4 10.9 0.2 10.8 21.2 16.7 34.0 12.7 49.9 29.6 1.0 1.1 0.8 20.1 29.7 19.0 1.1 0.7 9.3 52.3 10.1 39.0 17.2 9.2 1.9 0.4 0.6 22.3 8.4 1.0 1.2 1.0 19.6 17.1 2.8 13.8 0.2 24.2 16.3 0.0 1.4 31.1 9.2 2.0 14.1 12.8 1.0 8.2 10.5 21.2 1.7 9.8 0.1 0.3 0.1 1.6 0.9 4.7 2.2 1.2 0.5 1.4 0.5 0.5 0.4 1.2 2.5 0.4 1.3 1.5 0.9 2.6 2.9 0.8 1.0 0.2 0.6 1.1 1.8 1.1 1.6 2.3 0.6 1.5 1.3 2.6 1.3 17.9 5.4 0.0 12.1 42.2 0.0 4.0 15.3 4.0 9.1 7.0 0.0 8.2 5.0 13.1 4.3 5.0 0.0 0.0 12.9 9.4 5.4 3.4 0.0 14.0 1.5 0.0 0.0 1.8 0.0 3.8 3.4 0.7 3.3 0.0 0.3 7.7 24.1 0.0 0.7 17.8 0.0 32.3 12.7 6.0 2.5 43.3 3.3 0.0 0.9 4.3 AK9 "AKD1, AKD2, C6orf199, C6orf224, dJ70A9.1, FLJ25791, FLJ42177, MGC26954" ENSG00000155085 "Adenylate kinase 9" Q5TCS8 6 109492856-109691217 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Nucleotide metabolism" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 165.9;Spermatocytes: 116.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA030804, HPA030805, HPA031779, HPA031781, HPA036324, HPA036711" Enhanced Enhanced "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA030804: AB_2673617, HPA030805: AB_2673618, HPA031779: AB_10603674, HPA031781: AB_2674044, HPA036324: AB_2675060, HPA036711: AB_2675265" "unprognostic (9.68e-3)" "unprognostic (2.15e-1)" "unprognostic (1.66e-2)" "unprognostic (2.36e-2)" "unprognostic (3.42e-1)" "unprognostic (7.28e-2)" "unprognostic (1.41e-3)" "unprognostic (6.76e-3)" "unprognostic (1.89e-1)" "unprognostic (3.50e-2)" "unprognostic (1.67e-4)" "unprognostic (2.58e-1)" "unprognostic (2.98e-2)" "unprognostic (1.24e-1)" "unprognostic (1.30e-1)" "unprognostic (8.39e-2)" "unprognostic (5.56e-2)" 4.6 4.7 7.7 5.6 8.4 4.7 8.3 13.5 8.7 5.0 6.5 8.5 4.1 5.0 6.3 11.1 6.2 11.3 5.2 6.9 9.1 10.3 7.6 4.5 6.7 5.5 9.4 4.9 6.7 4.6 15.4 33.3 4.4 11.5 5.9 6.7 3.7 7.0 6.3 6.1 5.5 6.2 5.7 11.7 6.5 6.1 22.0 7.7 20.5 11.4 4.1 5.0 5.9 4.4 11.2 2.9 15.1 4.1 4.9 6.4 1.6 2.5 1.8 7.6 13.5 7.1 4.5 5.7 4.0 5.0 4.2 5.7 2.9 5.3 5.5 2.1 3.7 9.2 4.5 2.2 4.3 8.9 11.7 4.7 4.2 4.4 2.9 5.8 5.3 2.6 3.6 8.4 7.7 10.1 10.3 5.5 8.4 3.9 4.6 3.1 5.2 4.6 3.5 1.7 5.8 2.9 6.1 4.2 5.1 6.1 5.0 9.2 7.9 4.8 4.6 6.6 4.5 6.0 6.4 5.8 4.0 2.7 5.8 2.6 2.4 2.1 3.2 8.1 6.7 2.2 15.1 2.8 6.5 5.1 1.5 4.4 10.5 5.1 6.1 2.0 11.2 6.4 5.5 5.4 4.9 4.1 2.9 3.6 1.6 7.7 8.4 13.5 8.7 9.1 10.3 9.4 4.9 11.5 7.7 26.8 18.8 6.6 7.7 2.4 14.6 16.1 2.5 165.9 18.2 8.7 13.7 3.3 0.0 7.0 55.8 11.3 10.5 0.0 3.9 1.2 3.5 4.8 20.9 1.8 3.0 19.1 19.0 5.5 4.6 32.1 6.9 5.3 5.0 1.8 14.3 15.2 6.1 7.8 6.0 5.6 48.9 25.8 5.2 116.9 28.5 2.3 4.7 12.8 9.9 7.5 AKAP5 "AKAP75, AKAP79" ENSG00000179841 "A-kinase anchoring protein 5" P24588 14 64465499-64474503 "Plasma proteins, Predicted intracellular proteins, Transporters" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 39.1" "Group enriched" "Detected in many" 4 "granulocytes: 63.8;Mucus-secreting cells: 24.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "basophil: 5.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 5.7" "Cell line enhanced" "Detected in many" "CACO-2: 14.1" "Group enriched" "Detected in all" 5 "amygdala: 34.7;basal ganglia: 98.5;cerebral cortex: 52.2;hippocampal formation: 56.3" "CAB004308, HPA053891" Enhanced Supported Approved Nucleoplasm NA NA Nucleoplasm "CAB004308: AB_626655, HPA053891: AB_2682294" "unprognostic (4.29e-2)" "unprognostic (5.89e-3)" "unprognostic (3.44e-4)" "unprognostic (2.30e-1)" "unprognostic (1.73e-1)" "unprognostic (2.24e-3)" "unprognostic (1.08e-1)" "unprognostic (3.57e-1)" "unprognostic (6.92e-2)" "unprognostic (3.02e-3)" "unprognostic (8.23e-2)" "unprognostic (1.42e-1)" "unprognostic (5.44e-2)" "unprognostic (4.49e-4)" "unprognostic (2.11e-1)" "unprognostic (2.42e-1)" "unprognostic (7.45e-2)" 0.7 0.8 17.3 2.2 39.1 1.0 1.1 2.9 21.8 0.7 5.9 0.2 0.0 1.1 2.3 0.6 1.0 0.8 1.6 0.6 9.9 1.4 2.4 1.2 3.0 2.9 1.3 9.2 0.7 0.5 1.5 1.3 1.8 0.9 1.0 6.1 0.0 0.7 1.0 0.6 1.0 2.4 2.2 0.7 2.0 1.1 0.7 1.3 0.1 1.1 0.0 2.5 1.4 0.7 0.7 0.4 5.7 0.3 0.9 1.0 0.2 1.7 1.4 1.7 1.0 0.6 0.1 5.7 1.3 0.6 1.6 2.1 14.1 4.4 1.3 2.7 1.0 0.2 0.6 3.7 0.3 1.6 2.6 3.1 4.3 2.6 1.2 0.1 0.5 0.6 0.6 0.1 1.1 0.0 2.9 0.6 3.2 0.5 1.0 1.0 1.0 3.4 0.3 1.3 0.2 0.7 4.2 0.8 0.3 2.6 1.6 4.4 2.0 1.5 0.1 0.4 5.5 1.3 0.3 0.8 1.9 5.8 0.2 2.2 3.0 3.3 3.2 1.3 0.5 0.3 5.7 0.3 0.2 1.0 0.1 0.2 0.5 0.3 0.9 0.2 0.7 0.4 0.5 0.7 0.9 0.1 0.4 0.1 0.2 17.3 39.1 2.9 19.9 9.9 1.4 1.3 9.2 0.9 1.3 6.0 3.7 0.5 1.3 0.8 7.0 0.9 2.5 0.0 0.0 0.0 7.9 0.5 0.0 0.5 1.6 0.8 0.9 0.0 0.2 1.4 1.5 1.0 63.8 0.8 0.4 7.9 0.0 0.6 0.8 0.5 0.0 1.3 1.7 0.0 24.0 0.5 0.6 0.0 0.0 0.7 7.9 0.0 0.4 0.5 4.3 0.6 0.6 10.2 4.6 0.7 AKAP8 "AKAP95, DKFZp586B1222" ENSG00000105127 "A-kinase anchoring protein 8" O43823 19 15353385-15379798 "Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity, Protein transport, Transcription, Transcription regulation, Transport" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004776 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA004776: AB_1078122" "unprognostic (9.04e-3)" "unprognostic (3.67e-3)" "unprognostic (1.03e-1)" "unprognostic (4.17e-2)" "unprognostic (8.03e-2)" "unprognostic (1.77e-2)" "unprognostic (4.13e-2)" "unprognostic (3.17e-2)" "unprognostic (3.34e-3)" "unprognostic (1.27e-1)" "unprognostic (2.82e-1)" "unprognostic (1.78e-3)" "unprognostic (5.04e-3)" "unprognostic (1.22e-2)" "unprognostic (3.57e-1)" "unprognostic (6.06e-2)" "unprognostic (3.83e-2)" 17.7 12.1 7.0 14.0 11.9 32.8 13.9 15.7 10.9 14.8 11.5 11.6 7.9 18.0 14.9 14.9 13.4 12.9 10.9 10.8 7.6 5.8 12.9 14.2 11.7 12.9 10.9 5.9 13.5 13.7 11.4 9.4 17.8 9.3 11.8 7.7 13.7 13.5 15.8 25.7 16.1 14.5 14.9 9.3 16.0 13.3 12.4 11.1 15.2 12.3 12.1 16.0 13.6 11.4 7.2 9.7 2.3 9.3 5.6 7.9 4.9 14.4 10.5 10.5 9.5 3.6 5.2 12.7 8.8 7.6 8.9 8.1 15.8 18.0 14.4 9.3 8.6 5.8 11.0 7.8 11.0 5.8 13.8 11.5 16.4 12.0 14.5 4.2 22.1 13.4 7.5 5.9 7.6 2.5 3.6 7.6 9.7 11.8 9.8 6.0 18.4 13.3 10.0 15.6 9.5 13.9 14.2 9.4 15.3 4.6 18.7 9.7 10.2 9.3 13.6 10.4 5.3 7.7 9.4 14.6 13.4 8.2 12.9 17.1 13.0 10.5 16.6 9.9 15.4 10.8 0.0 6.7 2.3 7.6 7.3 7.9 7.2 6.5 7.8 9.7 6.4 5.9 6.2 0.9 5.6 9.3 7.8 7.9 4.9 7.0 11.9 15.7 10.9 7.6 5.8 10.9 5.9 9.3 11.1 11.9 25.5 29.7 17.0 17.1 14.3 15.0 7.6 26.8 27.3 12.2 25.5 24.6 5.0 13.6 1.9 18.6 13.8 23.3 18.7 23.1 13.9 14.2 29.0 11.9 11.5 20.6 10.4 9.8 12.7 2.1 17.5 16.3 11.8 20.8 16.1 16.7 14.7 11.5 13.1 7.9 18.1 6.5 21.3 16.3 24.3 14.1 33.6 20.2 18.0 16.9 AKIP1 "BCA3, C11orf17" ENSG00000166452 "A-kinase interacting protein 1" Q9NQ31 11 8911139-8920084 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061391 Supported Nucleoplasm NA NA Nucleoplasm "HPA061391: AB_2684499" "unprognostic (7.79e-3)" "unprognostic (5.65e-2)" "unprognostic (1.60e-1)" "prognostic favorable (5.15e-4)" "unprognostic (6.58e-2)" "unprognostic (7.81e-2)" "prognostic unfavorable (6.24e-9)" "unprognostic (1.03e-1)" "unprognostic (5.97e-2)" "unprognostic (5.77e-2)" "unprognostic (6.63e-2)" "unprognostic (8.88e-2)" "unprognostic (6.74e-3)" "unprognostic (1.15e-2)" "unprognostic (1.64e-1)" "unprognostic (1.71e-3)" "unprognostic (1.19e-1)" 13.2 26.4 18.8 12.0 19.6 10.2 11.7 16.3 19.7 13.2 14.8 16.6 13.5 14.4 19.8 19.4 23.9 14.0 17.4 26.9 16.7 17.7 15.7 13.6 16.2 10.5 17.6 22.6 17.6 14.0 14.5 14.8 17.0 15.4 17.5 12.3 15.8 16.8 16.9 35.2 9.6 16.0 22.3 16.5 20.2 12.7 22.1 11.2 12.5 20.9 13.5 10.7 15.5 14.6 4.5 20.8 1.2 15.6 5.8 25.9 8.6 32.3 30.1 13.3 12.7 12.9 16.0 10.5 23.9 19.3 14.8 14.5 16.1 20.0 5.9 19.2 17.3 16.4 21.8 6.4 11.6 10.3 28.8 16.9 10.3 16.7 14.2 15.0 13.6 12.3 13.9 16.1 7.3 26.8 11.7 13.3 12.4 20.8 6.3 27.1 10.7 10.8 12.5 10.9 16.1 23.1 11.4 9.6 7.4 15.1 13.8 9.3 9.0 27.6 12.3 12.9 8.9 14.1 11.3 21.7 20.8 18.8 35.3 23.3 9.7 24.1 1.4 21.4 16.4 21.9 1.2 15.6 0.6 7.8 13.4 8.1 4.5 9.1 8.6 19.7 4.5 6.2 10.8 0.9 5.8 6.5 20.8 25.9 8.6 18.8 19.6 16.3 19.7 16.7 17.7 17.6 22.6 15.4 11.2 17.9 6.9 4.9 12.3 9.5 14.5 11.6 15.3 16.0 12.5 19.2 9.8 35.6 21.6 35.4 43.6 20.4 5.7 0.0 31.6 34.9 17.3 8.5 48.5 11.9 57.1 23.8 2.4 19.0 20.9 16.4 20.4 20.6 15.1 45.9 8.6 27.2 29.4 17.5 45.3 15.3 14.0 19.4 19.1 37.0 32.5 6.1 9.8 14.4 14.5 7.8 AKIRIN1 "C1orf108, FLJ12666" ENSG00000174574 "Akirin 1" Q9H9L7 1 38991223-39006059 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 9 "Early spermatids: 1447.5;Late spermatids: 943.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051871 Approved Approved "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA051871: AB_2681646" "unprognostic (1.16e-1)" "unprognostic (2.13e-2)" "unprognostic (1.05e-1)" "unprognostic (5.35e-3)" "unprognostic (1.40e-1)" "unprognostic (1.39e-3)" "prognostic unfavorable (5.39e-7)" "unprognostic (3.53e-1)" "unprognostic (1.44e-1)" "unprognostic (2.51e-2)" "unprognostic (9.49e-3)" "unprognostic (1.47e-2)" "unprognostic (3.89e-2)" "unprognostic (1.22e-1)" "unprognostic (7.13e-2)" "unprognostic (3.77e-3)" "unprognostic (5.17e-2)" 30.2 20.8 28.3 21.1 29.4 43.1 16.8 17.6 30.3 16.2 23.3 35.0 20.4 15.9 20.6 29.5 19.8 19.5 28.6 40.8 30.1 34.0 29.2 35.0 19.8 25.5 32.1 21.0 17.0 18.2 25.9 34.5 19.5 31.3 25.5 25.0 20.3 18.2 25.7 20.7 12.0 19.2 28.2 41.8 20.5 24.3 68.0 23.6 25.6 24.5 11.2 27.1 22.6 22.4 14.8 22.7 43.1 15.8 29.3 28.6 20.1 16.4 7.7 33.2 27.0 16.2 19.3 23.5 19.4 20.4 19.6 20.1 19.6 13.8 13.1 18.1 18.4 14.1 11.6 32.0 17.4 31.7 19.5 16.0 38.8 11.7 24.9 21.5 36.8 21.3 19.8 22.8 25.5 21.1 17.6 18.1 17.2 26.3 13.1 24.5 6.7 15.6 15.9 69.9 12.5 12.9 25.0 24.1 13.0 21.8 20.3 22.9 15.7 21.5 11.4 42.0 54.3 10.6 19.1 16.0 12.0 19.5 13.0 19.6 19.0 24.4 28.1 20.7 21.9 20.4 12.2 15.8 33.2 14.6 13.5 22.4 14.8 24.1 22.6 22.7 13.0 28.6 18.3 43.1 29.3 15.0 17.1 21.7 20.1 28.3 29.4 17.6 30.3 30.1 34.0 32.1 21.0 31.3 23.6 59.6 44.0 57.9 73.6 122.5 43.4 42.7 28.1 25.4 40.9 36.6 45.2 66.3 79.6 41.6 1447.5 35.9 34.6 46.7 35.5 58.5 56.4 57.9 47.3 31.4 40.1 52.4 90.8 28.8 40.3 943.7 40.9 47.8 40.5 101.0 32.3 47.2 39.9 31.7 42.8 28.4 42.1 51.8 47.4 71.1 89.7 121.1 140.1 47.3 28.1 70.7 AKIRIN2 "C6orf166, dJ486L4.2, FLJ10342" ENSG00000135334 "Akirin 2" Q53H80 6 87675072-87702209 "Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Urothelial cells: 178.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064239 Supported Nucleoplasm No Yes Nucleoplasm "HPA064239: AB_2685222" "unprognostic (9.65e-2)" "unprognostic (2.56e-1)" "unprognostic (8.25e-2)" "unprognostic (8.09e-2)" "unprognostic (3.58e-1)" "unprognostic (1.87e-2)" "unprognostic (1.07e-1)" "unprognostic (5.38e-2)" "unprognostic (6.17e-2)" "unprognostic (6.60e-3)" "unprognostic (1.62e-2)" "unprognostic (2.56e-1)" "unprognostic (1.48e-2)" "unprognostic (9.62e-2)" "unprognostic (9.55e-2)" "unprognostic (2.23e-3)" "unprognostic (1.02e-1)" 27.9 24.1 23.7 19.9 27.0 53.4 22.0 19.3 27.8 13.7 14.1 17.5 10.3 11.4 16.3 22.5 20.5 16.2 14.4 20.1 22.1 21.1 14.8 27.8 21.9 34.5 19.3 18.6 20.7 8.5 12.0 15.5 16.7 17.3 13.4 11.9 21.3 15.5 11.6 54.2 12.9 13.6 15.9 20.2 35.7 12.1 20.7 14.7 45.0 14.1 14.8 26.1 21.4 14.9 15.4 27.0 51.9 25.6 12.5 13.6 11.1 10.4 11.4 32.7 18.5 20.8 14.4 19.2 18.7 12.0 15.7 15.5 18.0 8.2 27.8 20.3 19.3 25.8 16.2 18.2 13.6 18.1 35.3 22.6 16.1 10.3 40.2 22.7 13.7 13.9 16.6 14.1 19.2 19.2 15.2 17.1 11.2 31.2 19.4 20.2 13.8 4.3 28.3 23.2 9.1 17.8 17.2 23.3 11.3 19.4 9.4 24.6 23.4 11.4 6.7 18.2 19.6 8.2 32.8 21.7 12.9 8.7 10.8 24.2 18.8 20.9 17.6 14.1 18.1 20.5 23.1 20.6 21.7 10.7 25.6 11.0 15.4 10.5 10.3 19.5 12.6 8.3 8.7 51.9 12.5 24.6 27.0 13.6 11.1 23.7 27.0 19.3 24.5 22.1 21.1 19.3 18.6 17.3 14.7 23.8 16.6 44.6 173.9 85.7 12.9 18.5 28.1 4.0 19.4 17.4 7.9 40.7 38.1 26.5 41.2 28.6 13.7 23.3 12.9 57.9 48.3 99.6 32.4 25.8 69.7 11.1 11.6 38.6 81.5 82.9 33.1 86.1 70.9 25.2 8.3 53.7 23.7 10.5 26.5 40.8 14.2 6.5 48.6 61.8 46.9 81.2 114.2 55.8 10.9 178.8 AKNA KIAA1968 ENSG00000106948 "AT-hook transcription factor" Q7Z591 9 114334156-114394405 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 71.2" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 139.4;Rod photoreceptor cells: 137.4;T-cells: 94.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 32.0;MOLT-4: 30.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA052367, HPA063993" Supported Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA052367: AB_2681801, HPA063993: AB_2685169" "unprognostic (5.19e-3)" "prognostic favorable (1.22e-4)" "unprognostic (5.38e-3)" "prognostic favorable (2.14e-5)" "unprognostic (3.12e-1)" "prognostic favorable (1.25e-4)" "unprognostic (1.88e-1)" "unprognostic (3.28e-2)" "unprognostic (4.13e-2)" "unprognostic (6.62e-2)" "unprognostic (5.85e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (2.55e-5)" "unprognostic (1.19e-2)" "unprognostic (6.61e-3)" "unprognostic (2.93e-1)" "prognostic favorable (2.29e-4)" 7.2 2.8 4.6 41.8 4.9 17.5 6.1 2.0 4.5 13.9 7.3 5.9 2.4 5.7 13.4 4.5 3.3 11.4 12.9 2.8 4.9 3.8 3.9 5.6 11.2 30.4 4.9 3.3 9.9 3.4 0.8 3.6 2.8 4.9 5.3 4.7 7.1 10.2 4.2 1.6 2.5 18.4 8.8 3.6 43.1 7.3 3.9 4.8 71.2 4.0 4.5 42.9 6.1 6.4 7.2 8.8 16.6 6.1 11.9 16.6 6.4 1.4 1.5 1.8 1.3 12.8 1.5 8.0 1.6 1.9 1.5 1.2 2.7 1.6 17.5 1.6 1.4 2.8 3.4 1.2 0.4 0.5 32.0 0.7 1.8 0.7 1.8 15.4 16.9 19.2 2.6 2.8 1.3 1.4 2.2 2.7 15.8 1.7 21.2 0.6 2.5 30.4 22.0 6.9 3.4 1.8 18.9 0.3 4.0 14.6 0.8 0.9 1.7 0.4 1.4 4.7 2.4 4.0 9.3 4.4 0.8 1.7 0.3 1.4 4.4 4.9 14.8 1.0 8.6 0.7 8.0 6.1 9.6 16.6 4.6 13.1 6.5 8.9 14.1 4.1 7.2 7.9 10.6 16.6 11.9 4.1 8.8 7.0 6.4 4.6 4.9 2.0 4.5 4.9 3.8 4.9 3.3 4.9 4.8 11.9 28.1 43.3 5.9 4.6 25.8 3.1 0.0 29.4 12.5 22.7 139.4 7.7 0.0 3.4 16.1 6.3 6.7 0.0 7.0 5.7 8.0 6.2 31.3 8.5 16.0 4.8 12.2 13.5 41.0 20.2 13.6 31.2 5.0 26.2 19.5 6.5 5.0 10.5 6.3 0.9 137.4 0.0 10.8 0.6 0.7 3.0 2.9 94.4 12.9 7.5 AKR1A1 "ALR, DD3" ENSG00000117448 "Aldo-keto reductase family 1 member A1" P14550 1 45550543-45570049 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Proximal tubular cells: 1001.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006246, HPA017919, HPA019649, HPA027734" Approved Supported Nucleoplasm,Cytosol NA NA 8100000 Cytosol Nucleoplasm "CAB006246: AB_425840, HPA017919: AB_1844695, HPA019649: AB_1844696, HPA027734: AB_10600976" "unprognostic (1.73e-1)" "prognostic favorable (2.66e-6)" "unprognostic (4.03e-1)" "prognostic favorable (2.92e-4)" "unprognostic (1.17e-1)" "unprognostic (1.77e-2)" "unprognostic (6.54e-3)" "unprognostic (1.31e-3)" "unprognostic (2.52e-1)" "unprognostic (1.24e-1)" "unprognostic (1.83e-1)" "unprognostic (8.43e-2)" "unprognostic (4.51e-2)" "unprognostic (1.56e-2)" "unprognostic (2.46e-1)" "unprognostic (2.89e-2)" "unprognostic (4.57e-2)" 20.0 20.4 12.0 27.9 13.9 9.7 31.8 11.5 23.6 21.7 39.6 18.7 20.0 43.6 18.5 31.7 39.0 21.8 31.7 18.5 11.2 12.0 79.6 80.4 26.0 33.8 15.0 13.9 18.3 44.2 11.3 27.5 20.2 13.1 19.4 28.9 16.7 59.8 24.1 13.4 18.2 69.7 19.4 16.3 25.6 27.7 10.5 13.1 24.8 24.6 31.3 33.2 17.4 18.6 23.3 46.8 26.8 56.3 13.8 18.7 38.4 16.4 23.8 21.8 16.8 47.4 34.4 15.4 19.5 45.7 17.1 34.5 9.9 12.7 40.6 15.7 22.3 17.9 21.1 22.9 28.5 16.1 16.3 20.6 23.5 20.2 43.3 39.6 30.3 26.4 38.0 25.8 21.6 40.2 32.3 39.4 29.6 12.0 32.5 20.0 11.9 32.4 13.2 23.7 53.3 16.3 37.4 26.1 47.1 48.6 22.5 26.0 15.0 16.9 67.5 24.7 31.3 18.9 17.4 24.0 7.9 17.6 27.4 11.6 22.4 29.9 19.1 15.5 39.5 6.7 26.8 56.3 10.5 16.3 51.8 17.8 23.3 15.3 16.0 46.8 22.7 13.1 13.5 2.6 13.8 38.1 40.8 18.7 38.4 12.0 13.9 11.5 23.6 11.2 12.0 15.0 13.9 13.1 13.1 44.7 49.4 132.5 80.9 43.7 20.8 32.3 96.8 60.2 53.4 75.0 35.3 93.6 154.2 163.4 4.1 51.7 130.2 0.0 136.9 121.2 79.9 92.3 108.6 269.4 347.1 15.9 113.6 74.9 110.8 5.9 63.3 159.5 77.6 161.5 133.1 26.5 118.5 151.9 52.6 1001.5 34.9 6.5 49.5 3.2 27.2 41.0 56.8 53.3 166.2 98.2 AKR1B1 "ALDR1, AR" ENSG00000085662 "Aldo-keto reductase family 1 member B" P15121 7 134442350-134459284 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "adrenal gland: 302.2;seminal vesicle: 109.3" "Cell type enhanced" "Detected in many" 13 "Collecting duct cells: 615.9;Cytotrophoblasts: 969.9;Extravillous trophoblasts: 1080.2;Syncytiotrophoblasts: 1691.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 122.4;BJ hTERT+: 224.5;RPTEC TERT1: 106.2;U-87 MG: 101.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026425, CAB027391, CAB047353, HPA052751" Enhanced Supported Nucleoplasm,Cytosol No No 1700000 Cytosol Nucleoplasm "CAB027391: , CAB047353: , HPA026425: AB_10601563, HPA052751: AB_2681935" "unprognostic (2.76e-2)" "unprognostic (2.84e-2)" "unprognostic (2.02e-2)" "unprognostic (1.37e-2)" "unprognostic (6.81e-2)" "unprognostic (2.26e-1)" "unprognostic (4.18e-2)" "unprognostic (5.09e-2)" "unprognostic (2.51e-3)" "unprognostic (2.47e-1)" "unprognostic (2.98e-2)" "unprognostic (8.78e-2)" "unprognostic (2.81e-2)" "prognostic unfavorable (2.44e-5)" "unprognostic (2.03e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (7.00e-4)" 5.9 302.2 7.5 4.7 13.7 2.5 9.5 6.9 10.9 4.4 3.9 8.2 50.4 2.7 4.6 6.1 4.2 4.6 5.2 24.2 7.3 8.4 17.7 2.5 6.9 10.0 9.5 9.0 8.2 7.2 9.4 8.0 24.8 11.9 5.5 4.1 5.8 4.4 109.3 37.6 2.8 4.8 5.6 7.9 6.7 5.0 5.2 5.9 7.3 6.0 10.3 7.6 7.1 3.7 31.4 34.8 22.5 26.0 26.3 42.7 47.2 13.5 122.4 13.8 19.5 59.5 16.2 36.8 13.1 224.5 19.3 25.0 5.6 12.4 0.0 6.1 21.9 85.2 5.7 15.0 13.1 15.4 4.8 13.7 6.9 18.4 16.6 85.3 0.0 0.0 15.1 9.8 27.6 7.3 18.9 27.2 13.6 0.0 4.6 21.3 0.2 20.3 9.3 22.9 0.9 0.1 21.2 8.8 10.2 106.2 66.2 10.3 22.9 91.9 0.1 9.6 9.4 0.0 10.3 21.4 19.1 8.9 1.7 14.2 12.6 13.9 34.2 101.0 0.0 11.4 22.5 26.0 1.2 37.9 17.0 34.0 31.4 32.4 36.7 34.8 28.5 42.7 41.1 2.1 26.3 8.9 4.9 22.0 47.2 7.5 13.7 6.9 10.9 7.3 8.4 9.5 9.0 11.9 5.9 11.9 23.7 50.6 46.4 18.3 34.0 127.0 30.6 24.1 23.9 615.9 7.9 969.9 139.3 102.5 3.0 53.2 0.7 0.0 35.6 1080.2 76.5 15.6 52.0 1.3 331.4 68.3 29.7 89.6 135.4 11.5 73.4 69.6 28.7 93.8 13.6 46.3 62.2 5.8 72.9 43.7 20.2 58.2 30.9 20.7 70.9 10.2 1691.2 45.4 5.0 37.4 AKR1C2 "BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD" ENSG00000151632 "Aldo-keto reductase family 1 member C2" P52895 10 4987400-5018031 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 71.9;liver: 122.7;tongue: 111.8" "Cell type enhanced" "Detected in many" 14 "Cholangiocytes: 135.0;Hepatocytes: 341.7;Pancreatic endocrine cells: 140.7" "Group enriched" "Detected in many" 6 "cervical cancer: 21.7;head and neck cancer: 31.5;liver cancer: 50.2;lung cancer: 69.0;urothelial cancer: 35.7" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.4" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.4" "Group enriched" "Detected in some" 4 "A549: 130.6;ASC diff: 162.1;Hep G2: 243.7;OE19: 168.2;RT4: 74.6" "CAB047304, HPA068265" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nucleoli fibrillar center, Endoplasmic reticulum" "CAB047304: , HPA068265: AB_2685966" "unprognostic (6.77e-2)" "unprognostic (8.88e-3)" "unprognostic (3.02e-2)" "unprognostic (2.24e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (2.86e-2)" "unprognostic (8.65e-2)" "unprognostic (5.03e-2)" "unprognostic (2.58e-1)" "unprognostic (1.02e-1)" "unprognostic (6.25e-3)" "unprognostic (8.58e-2)" "unprognostic (1.09e-2)" "unprognostic (8.60e-3)" "unprognostic (1.46e-2)" "unprognostic (8.30e-2)" 60.4 4.0 1.8 2.0 3.3 0.0 71.9 2.5 2.1 1.3 2.9 1.0 1.2 5.5 1.0 3.0 17.4 1.5 19.4 9.3 1.7 2.3 4.8 122.7 5.9 1.1 4.7 0.9 1.9 2.4 0.0 1.8 0.1 4.2 8.1 2.4 2.0 12.0 2.4 19.8 4.2 2.4 4.4 3.9 0.6 26.2 2.3 2.6 0.1 4.2 111.8 5.5 25.3 11.9 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 130.6 0.1 13.8 162.1 5.6 0.0 0.0 0.5 0.0 0.1 0.5 0.0 0.0 0.7 0.9 0.6 3.6 0.0 0.6 0.0 0.0 0.0 0.0 36.8 243.7 0.3 0.0 0.0 14.5 8.2 0.6 0.6 0.0 0.0 0.0 5.0 0.0 1.3 0.2 0.0 0.0 0.0 168.2 0.0 0.0 0.0 2.1 1.2 74.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.5 0.3 0.1 4.8 0.0 0.0 0.0 0.0 1.7 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.8 3.3 2.5 2.1 1.7 2.3 4.7 0.9 4.2 2.6 11.9 3.2 0.0 3.2 10.5 1.8 3.7 135.0 18.7 19.4 0.0 0.0 0.0 0.0 12.3 18.3 8.7 9.3 0.0 93.5 0.1 15.0 4.5 0.0 341.7 0.1 3.2 1.7 12.3 13.7 5.6 73.4 1.1 8.5 1.0 2.8 33.8 140.7 7.0 73.9 2.6 2.6 0.0 7.6 0.3 0.3 11.8 0.0 1.3 7.4 79.1 AKR1C3 "DDX, HAKRB, HSD17B5, KIAA0119, PGFS" ENSG00000196139 "Aldo-keto reductase family 1 member C3" P42330 10 5035354-5107686 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 50.1;intestine: 52.3" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 261.7;Exocrine glandular cells: 644.1;Pancreatic endocrine cells: 362.8;Proximal tubular cells: 434.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 50.1;gdT-cell: 26.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 115.0;ASC diff: 66.2;Hep G2: 48.3;OE19: 226.4;RT4: 45.4" "CAB010874, HPA068265" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" NA NA 11000000 "Nucleoplasm, Cytosol" "Nucleoli fibrillar center, Endoplasmic reticulum" "CAB010874: AB_476751, HPA068265: AB_2685966" "unprognostic (4.20e-3)" "unprognostic (2.70e-2)" "unprognostic (8.92e-2)" "unprognostic (1.53e-1)" "unprognostic (1.05e-1)" "unprognostic (1.81e-3)" "prognostic unfavorable (1.96e-4)" "unprognostic (1.41e-1)" "unprognostic (6.74e-2)" "unprognostic (5.08e-2)" "unprognostic (1.31e-1)" "unprognostic (4.33e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (4.45e-1)" "unprognostic (3.70e-2)" "unprognostic (1.79e-3)" "unprognostic (4.24e-3)" 16.6 6.6 3.2 3.2 3.9 3.5 12.8 3.2 3.9 3.2 17.3 3.2 3.2 52.3 3.2 3.2 6.0 4.5 32.2 4.8 4.4 1.0 20.1 34.4 5.5 3.2 3.2 3.2 3.2 4.2 1.8 3.2 3.2 4.2 3.2 11.4 3.2 4.4 3.2 13.0 2.6 31.1 4.2 3.2 3.2 28.6 3.2 3.2 3.2 3.2 3.2 3.2 12.3 3.2 0.1 9.6 50.1 0.7 4.6 26.7 9.7 0.0 115.0 0.0 33.6 66.2 23.8 0.0 0.0 1.6 0.0 0.1 3.4 1.9 0.0 6.2 1.5 3.4 0.9 0.1 2.3 0.0 0.2 0.0 0.2 35.6 48.3 0.3 0.0 0.0 13.2 4.7 1.5 0.0 1.9 2.2 0.2 0.7 0.0 3.0 0.2 0.7 0.1 0.0 226.4 0.3 0.2 0.7 3.4 11.3 45.4 0.0 0.2 16.5 0.0 0.0 0.0 0.0 0.0 16.0 0.3 0.3 6.9 0.2 0.0 0.0 0.0 3.8 4.5 0.3 50.1 0.7 1.1 26.7 0.2 1.7 0.0 5.0 4.8 0.5 0.1 3.2 2.4 1.9 4.6 0.3 9.6 4.9 9.7 3.2 3.9 3.2 3.9 4.4 1.0 3.2 3.2 4.2 3.2 41.7 4.0 1.5 1.1 10.6 1.7 3.6 0.0 88.3 61.4 34.9 0.0 0.1 36.5 85.3 2.9 61.2 261.7 0.0 644.1 0.0 13.8 0.7 5.7 0.0 1.6 1.6 18.4 0.0 0.0 2.1 72.5 19.0 20.3 5.4 31.0 121.7 362.8 121.1 100.4 434.1 3.6 25.8 8.0 0.3 0.7 9.4 0.0 0.0 103.0 27.3 AKR1C4 "3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581" ENSG00000198610 "Aldo-keto reductase family 1 member C4" P17516 10 5195462-5218949 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "liver: 127.0" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 437.4" "Cancer enriched" "Detected in some" 86 "liver cancer: 108.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basophil: 1.2;gdT-cell: 1.1" "Group enriched" "Detected in many" 6 "granulocytes: 1.2;T-cells: 1.1" "Group enriched" "Detected in some" 4 "HDLM-2: 11.6;OE19: 5.1" "HPA044720, HPA068265" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" NA NA 1800000 "Nucleoplasm, Cytosol" "Nucleoli fibrillar center, Endoplasmic reticulum" "HPA044720: AB_2679058, HPA068265: AB_2685966" "unprognostic (2.21e-1)" "unprognostic (3.04e-1)" "unprognostic (5.15e-2)" "unprognostic (1.25e-1)" "unprognostic (5.99e-2)" "unprognostic (9.40e-2)" "unprognostic (2.32e-1)" "unprognostic (1.26e-1)" "unprognostic (1.52e-2)" "unprognostic (1.29e-1)" "unprognostic (3.31e-1)" "unprognostic (7.34e-2)" "unprognostic (1.45e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 127.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 1.1 0.1 0.0 1.5 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.5 0.3 1.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 5.1 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 1.2 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.2 45.9 2.7 1.2 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 23.3 0.6 0.0 0.0 0.0 0.0 437.4 0.0 0.0 0.0 14.1 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.6 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 AKR1D1 SRD5B1 ENSG00000122787 "Aldo-keto reductase family 1 member D1" P51857 7 138002324-138117986 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism" Oxidoreductase "Disease mutation, FDA approved drug targets, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 38 "liver: 103.2" "Group enriched" "Detected in some" 41 "Early spermatids: 50.2;Hepatocytes: 96.2;Late spermatids: 85.4" "Cancer enriched" "Detected in single" 77 "liver cancer: 20.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 20 "Hep G2: 16.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA057002 Enhanced Approved Nucleoplasm,Cytosol No NA Nucleoplasm Cytosol "HPA057002: AB_2683308" "unprognostic (2.38e-1)" "unprognostic (1.65e-2)" "unprognostic (1.02e-2)" "unprognostic (1.52e-2)" "prognostic favorable (9.91e-5)" "unprognostic (6.11e-2)" "unprognostic (2.31e-1)" "unprognostic (1.30e-1)" "unprognostic (6.87e-2)" "unprognostic (2.94e-1)" "unprognostic (9.68e-3)" "unprognostic (2.90e-1)" "unprognostic (5.80e-2)" "unprognostic (3.11e-1)" "unprognostic (1.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 103.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 2.7 0.5 0.7 0.7 0.2 0.2 0.0 0.2 0.2 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.8 0.3 0.2 0.1 0.0 0.6 0.3 0.0 0.0 0.2 0.3 0.1 0.4 0.3 16.9 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.3 0.2 0.1 0.0 0.2 0.1 0.4 0.0 0.3 0.0 0.2 0.2 0.2 0.1 0.1 0.1 0.2 0.4 0.3 0.2 0.1 0.3 0.2 0.3 0.3 0.2 0.2 0.3 0.3 2.7 0.5 0.6 0.4 0.4 0.3 0.6 0.4 0.4 0.3 1.1 0.5 0.7 1.8 0.7 0.5 0.5 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 50.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 96.2 0.4 0.0 0.0 1.3 1.9 85.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.2 0.0 0.0 0.1 AKR1E2 "AKR1CL2, AKRDC1, MGC10612" ENSG00000165568 "Aldo-keto reductase family 1 member E2" Q96JD6 10 4786629-4848062 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "testis: 35.0" "Group enriched" "Detected in some" 5 "Early spermatids: 126.7;Late spermatids: 125.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 3.2;myeloid DC: 1.6;naive CD4 T-cell: 1.4;plasmacytoid DC: 1.8" "Group enriched" "Detected in many" 5 "dendritic cells: 1.8;granulocytes: 3.2;T-cells: 1.4" "Cell line enhanced" "Detected in many" "JURKAT: 11.3;RT4: 9.4;U-2197: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA037821, HPA037822" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA037821: AB_2675687, HPA037822: AB_10671722" "unprognostic (2.33e-2)" "unprognostic (2.59e-2)" "unprognostic (1.68e-2)" "unprognostic (8.27e-2)" "unprognostic (7.33e-2)" "unprognostic (1.99e-1)" "unprognostic (1.44e-1)" "unprognostic (7.42e-3)" "unprognostic (7.47e-2)" "unprognostic (2.77e-2)" "unprognostic (1.32e-1)" "unprognostic (1.53e-1)" "unprognostic (3.06e-2)" "unprognostic (2.74e-1)" "unprognostic (2.04e-2)" "unprognostic (1.62e-4)" "unprognostic (5.62e-2)" 3.3 1.6 1.8 3.2 2.6 2.4 4.2 1.4 2.5 2.6 2.3 0.7 3.4 1.8 5.0 1.7 1.9 1.4 5.0 2.7 1.5 1.5 1.8 1.1 4.4 2.8 1.4 2.1 1.5 2.7 3.7 1.2 2.6 1.9 1.7 1.7 5.0 1.9 2.6 2.3 2.0 1.7 2.9 2.1 1.5 2.1 35.0 0.9 0.8 4.5 2.0 0.6 1.7 2.9 0.1 1.8 3.2 0.4 0.0 1.4 0.3 0.4 5.1 2.0 0.9 0.0 0.0 0.1 2.0 0.1 0.1 0.0 8.0 0.8 0.0 0.0 5.2 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 1.0 5.5 1.0 0.0 0.0 5.9 11.3 4.5 0.0 0.0 4.8 0.6 0.0 2.1 7.2 3.8 0.0 0.0 0.0 1.4 9.4 0.0 4.4 7.5 2.1 4.0 2.2 4.0 2.2 3.5 0.0 1.8 17.8 0.0 2.4 0.0 0.0 0.1 0.0 1.4 3.2 0.4 0.3 0.1 0.2 0.0 0.1 0.4 0.2 1.6 0.0 1.4 0.4 0.1 0.0 0.0 1.8 0.0 0.3 1.8 2.6 1.4 2.5 1.5 1.5 1.4 2.1 1.9 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.1 126.7 1.4 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 1.1 1.6 0.0 1.8 0.6 125.1 2.6 0.5 3.3 1.0 0.0 0.3 0.1 0.0 1.4 0.3 1.1 0.0 0.9 23.0 4.7 0.1 0.0 0.0 0.0 0.1 AKT1 "AKT, PKB, PRKBA, RAC" ENSG00000142208 "AKT serine/threonine kinase 1" P31749 14 104769349-104795751 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Neurogenesis, Sugar transport, Translation regulation, Transport" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 30.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 30.7" "Cell line enhanced" "Detected in all" "MCF7: 115.3" "Low region specificity" "Detected in all" "HPA002891, CAB003765" Supported Supported Nucleoplasm,Microtubules NA NA Nucleoplasm Microtubules "CAB003765: AB_562035, HPA002891: AB_1078123" "unprognostic (3.30e-2)" "unprognostic (4.27e-2)" "unprognostic (1.98e-1)" "unprognostic (1.84e-1)" "unprognostic (3.70e-1)" "unprognostic (9.17e-3)" "unprognostic (1.55e-3)" "unprognostic (1.21e-1)" "unprognostic (1.47e-1)" "prognostic favorable (4.83e-4)" "unprognostic (3.58e-2)" "unprognostic (1.90e-2)" "prognostic favorable (2.12e-4)" "unprognostic (7.14e-2)" "unprognostic (1.28e-1)" "unprognostic (1.06e-1)" "unprognostic (2.41e-1)" 31.7 45.4 22.9 24.2 23.6 20.3 40.0 20.9 29.5 24.7 32.6 20.0 30.8 22.5 27.0 21.5 33.0 25.5 30.3 47.7 22.9 19.1 26.3 49.2 31.3 21.0 22.1 14.7 25.9 43.0 20.3 16.7 28.4 21.5 31.1 18.2 25.3 30.4 36.1 23.8 20.4 24.0 40.5 17.5 35.4 32.6 16.2 18.8 26.3 32.7 22.4 29.3 36.7 35.9 3.2 5.2 30.7 5.8 5.7 6.2 3.0 15.4 30.8 25.5 37.9 19.7 20.5 28.5 28.4 34.6 42.0 33.7 20.2 18.7 18.7 21.9 38.9 21.4 20.1 18.0 26.4 18.3 42.6 7.3 14.1 18.4 21.7 21.9 23.0 36.9 29.3 22.3 21.0 14.0 20.2 31.4 18.4 12.3 20.8 26.9 115.3 28.9 29.4 6.6 30.3 22.1 27.3 23.6 12.7 19.4 38.4 29.3 24.3 23.7 31.0 17.8 11.9 40.6 34.3 25.0 28.2 13.5 40.1 28.5 22.6 10.9 16.1 23.8 19.5 33.9 3.3 5.3 30.7 5.4 5.2 4.0 2.9 4.8 6.2 3.6 3.2 2.5 5.7 11.8 5.7 5.8 5.2 4.7 3.0 22.9 23.6 20.9 29.5 22.9 19.1 22.1 14.7 21.5 18.8 14.9 24.3 13.4 13.8 11.0 24.3 13.8 40.8 5.3 11.4 21.0 11.8 15.1 11.6 21.0 1.2 19.6 22.2 0.0 30.3 25.7 18.8 34.2 2.3 38.4 20.2 39.7 28.8 24.5 23.7 3.1 26.4 18.1 10.1 17.2 36.1 35.8 43.4 17.3 29.0 13.9 24.0 25.8 11.8 0.9 5.1 12.2 19.6 18.1 26.9 30.8 AKT2 ENSG00000105221 "AKT serine/threonine kinase 2" P31751 19 40230317-40285536 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Sugar transport, Translation regulation, Transport" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Diabetes mellitus, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 109.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004204, HPA064521" Uncertain Supported Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles, Cytosol" "CAB004204: AB_626659, HPA064521: AB_2685278" "unprognostic (6.13e-2)" "unprognostic (2.21e-1)" "unprognostic (1.56e-1)" "prognostic unfavorable (1.05e-6)" "unprognostic (2.85e-1)" "unprognostic (6.40e-3)" "unprognostic (9.59e-2)" "unprognostic (1.22e-2)" "unprognostic (2.98e-2)" "unprognostic (2.49e-2)" "unprognostic (3.02e-1)" "prognostic unfavorable (4.74e-4)" "unprognostic (1.30e-2)" "unprognostic (1.89e-1)" "unprognostic (3.28e-1)" "unprognostic (6.16e-2)" "unprognostic (2.00e-1)" 31.1 20.3 15.4 17.6 15.2 21.3 18.2 46.3 18.2 23.3 18.2 23.4 21.2 12.3 22.8 28.0 22.1 22.7 14.0 23.1 15.4 10.0 23.0 62.5 14.6 17.8 17.9 13.3 27.8 24.5 21.1 24.0 17.5 14.7 19.7 12.3 26.8 18.5 24.3 48.5 18.3 17.1 20.0 16.8 18.7 15.5 21.3 15.7 26.6 52.6 29.5 23.6 19.6 19.9 6.3 8.8 7.7 4.4 3.2 4.9 2.4 22.8 56.3 21.5 22.1 26.8 32.8 11.9 15.3 22.6 31.7 28.3 24.8 21.3 23.3 13.6 33.6 13.3 10.0 23.8 31.8 20.4 22.3 27.1 15.3 35.7 15.5 16.8 17.5 18.4 30.2 19.1 21.5 20.4 25.1 6.9 25.7 19.6 24.5 17.6 19.0 27.8 8.5 11.6 25.4 15.1 18.5 11.7 16.8 24.7 37.4 29.6 18.1 15.7 26.8 12.7 23.0 21.2 22.6 6.8 19.4 19.2 17.3 23.9 22.8 19.5 19.1 18.9 20.8 15.8 7.6 4.4 3.6 4.5 2.0 4.5 3.9 3.6 3.0 3.0 6.3 3.5 4.9 7.7 3.2 2.6 8.8 2.7 2.4 15.4 15.2 46.3 18.2 15.4 10.0 17.9 13.3 14.7 15.7 14.9 12.8 36.4 20.9 21.2 67.1 26.8 28.1 12.0 10.3 57.6 39.3 25.4 18.3 18.1 2.9 17.0 18.8 0.0 26.0 20.6 22.1 24.5 13.9 74.6 19.3 57.2 18.5 12.9 19.7 7.4 39.7 13.5 21.9 19.8 19.0 52.5 20.4 19.2 25.1 18.3 109.8 19.4 23.3 11.6 16.2 24.0 32.4 17.1 20.1 24.4 AL031777.3 ENSG00000282988 6 26195595-26199293 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 10 "lymphoid tissue: 184.8" "Cell type enhanced" "Detected in some" 22 "Cytotrophoblasts: 4.4;Extravillous trophoblasts: 4.1;granulocytes: 3.5;Hofbauer cells: 7.2;Syncytiotrophoblasts: 17.3" "Cell type enriched" "Detected in many" 4 "neutrophil: 18.7" "Lineage enriched" "Detected in many" 7 "granulocytes: 18.7" "Cell line enhanced" "Detected in some" "K-562: 7.9;SiHa: 7.5;U-2 OS: 5.7;U-266/70: 9.5;U-266/84: 6.3" HPA041189 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" 1.3 1.3 0.1 10.9 0.2 13.1 4.8 0.3 0.7 3.9 3.4 0.0 2.2 0.7 1.0 2.2 7.1 1.2 1.9 4.2 0.0 1.0 1.1 3.5 12.7 0.0 0.1 2.4 1.2 0.7 0.0 3.4 0.4 2.9 0.9 0.9 1.1 3.2 0.7 0.7 3.2 1.5 2.6 8.5 1.7 4.3 0.1 184.8 0.9 3.9 11.4 4.0 0.0 2.7 1.1 18.7 1.0 0.6 1.1 0.7 0.8 0.5 0.2 0.7 0.2 0.1 0.0 0.7 0.1 1.5 0.4 0.6 0.9 0.8 2.4 0.0 0.2 1.2 0.3 0.0 0.0 2.6 0.3 0.7 2.5 1.5 0.0 0.2 0.8 1.2 0.0 0.8 0.5 0.1 0.2 0.4 7.9 1.6 0.0 1.1 2.9 1.7 0.2 2.5 2.4 0.7 0.2 4.4 0.0 0.0 0.9 0.2 7.5 0.0 0.5 0.0 4.8 0.0 0.8 0.8 5.7 0.0 0.2 9.5 6.3 0.9 0.6 2.2 0.3 4.3 0.0 1.2 0.3 0.3 0.4 0.9 0.6 0.6 0.4 2.7 0.5 0.8 18.7 0.6 1.0 1.1 1.1 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 1.6 0.0 0.0 0.0 0.0 0.2 4.1 0.0 0.0 3.5 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 AL139011.2 ENSG00000258465 1 160217464-160285130 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 14 "Alveolar cells type 2: 1.6;Club cells: 3.4;granulocytes: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 6.7;BJ hTERT+: 5.9;EFO-21: 6.6;HDLM-2: 6.0" "HPA027218, HPA027381, HPA044837" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "HPA027218: AB_10602586, HPA027381: AB_1858808, HPA044837: AB_10962496" "unprognostic (4.71e-2)" "unprognostic (1.75e-1)" "unprognostic (2.21e-2)" "unprognostic (1.75e-2)" "unprognostic (2.41e-1)" "unprognostic (8.04e-4)" "unprognostic (4.70e-2)" "unprognostic (1.51e-2)" "unprognostic (2.53e-1)" "unprognostic (1.18e-1)" "unprognostic (2.08e-1)" "unprognostic (1.61e-1)" "unprognostic (1.87e-3)" "unprognostic (2.92e-1)" "unprognostic (5.29e-1)" "unprognostic (1.06e-1)" "unprognostic (5.18e-3)" 8.6 4.0 3.7 3.0 10.2 2.0 4.4 15.4 11.4 4.8 4.7 8.6 2.5 3.5 6.3 4.2 5.3 6.4 4.6 16.7 3.8 3.9 6.2 10.8 4.1 3.2 3.6 5.9 7.6 4.0 6.7 4.1 5.0 9.1 5.5 3.5 6.1 5.5 3.0 14.6 4.0 4.2 7.8 4.1 3.7 4.3 4.8 4.1 2.5 7.9 3.8 3.4 5.8 4.7 5.8 8.9 6.7 6.5 8.0 5.0 8.0 0.1 2.1 0.3 0.5 6.7 1.9 0.6 0.9 5.9 3.3 0.8 0.0 0.8 0.2 6.6 1.0 5.2 0.8 1.1 0.2 0.0 6.0 0.0 0.3 0.7 0.2 3.4 0.0 0.3 3.2 0.2 3.0 3.4 3.5 0.5 0.8 1.0 4.7 0.5 0.3 1.1 0.0 0.3 0.6 0.6 0.5 0.0 0.3 0.3 0.8 0.6 0.8 0.2 1.4 0.0 1.0 2.8 5.6 0.0 0.8 0.8 0.0 0.2 0.8 3.4 0.5 0.4 0.3 0.3 6.4 6.3 6.2 3.6 6.5 5.0 5.8 4.4 4.7 8.9 3.9 2.5 3.2 6.7 8.0 6.3 2.5 4.9 8.0 3.7 10.2 15.4 11.4 3.8 3.9 3.6 5.9 9.1 4.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 AL139260.3 ENSG00000274944 1 38864501-38881617 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 7.3;testis: 15.5" "Cell type enriched" "Detected in some" 5 "Ciliated cells: 8.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 7.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA041188, HPA078331" Uncertain Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA041188: AB_10794405, HPA078331: AB_2686882" "unprognostic (8.00e-2)" "unprognostic (3.86e-2)" "unprognostic (2.54e-1)" "unprognostic (2.00e-1)" "unprognostic (9.72e-3)" "unprognostic (4.27e-4)" "unprognostic (4.64e-7)" "unprognostic (2.59e-2)" "unprognostic (4.01e-2)" "unprognostic (1.22e-1)" "unprognostic (6.52e-2)" "unprognostic (9.54e-3)" "unprognostic (6.09e-6)" "unprognostic (1.30e-2)" "unprognostic (3.69e-1)" "unprognostic (1.27e-1)" "unprognostic (2.32e-3)" 1.2 0.0 0.4 1.3 0.9 0.0 0.4 0.4 1.0 0.4 3.3 0.6 0.4 2.0 0.4 0.4 3.0 0.0 0.4 0.4 0.4 0.5 1.5 0.4 2.7 0.4 0.4 0.4 0.4 0.0 0.4 0.8 0.6 0.4 2.3 1.8 2.3 0.4 0.4 1.5 2.1 0.4 0.4 0.4 2.4 15.5 0.4 0.4 0.4 0.4 0.4 0.4 0.4 3.0 7.3 2.8 4.0 0.0 1.7 0.0 12.4 1.3 3.3 0.0 0.6 0.0 3.6 0.4 0.0 0.0 0.5 6.7 13.3 2.4 11.3 0.2 0.5 9.2 0.0 0.9 0.0 7.9 2.1 2.8 2.5 2.2 0.0 17.0 5.0 0.0 0.0 1.6 1.1 1.5 2.0 0.5 6.4 4.6 1.7 3.3 6.8 16.1 6.5 9.8 7.7 7.9 8.0 12.6 0.0 7.0 6.3 3.4 7.7 7.3 1.5 3.6 4.2 5.2 5.8 2.3 6.5 6.3 11.5 1.5 11.7 9.4 5.7 7.4 2.6 0.0 1.3 0.2 0.5 1.9 1.1 3.0 0.2 0.5 4.2 2.0 0.4 0.4 2.8 0.0 4.0 7.3 1.7 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 8.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AL139300.1 ENSG00000256500 14 103562962-103685924 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 37.2" "Cell type enhanced" "Detected in some" 28 "Ciliated cells: 1.4;granulocytes: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA044617, HPA052450" Uncertain Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA044617: AB_2679024, HPA052450: AB_2681838" "unprognostic (1.56e-1)" 10.2 7.5 16.6 7.8 20.3 2.8 15.5 21.9 25.1 5.9 4.8 3.2 5.1 2.0 5.5 4.6 5.8 3.9 4.2 20.0 17.2 17.2 5.3 5.6 4.2 7.7 17.3 6.2 5.0 15.8 9.9 5.8 4.2 5.2 5.0 2.9 2.7 7.7 6.3 37.2 2.0 4.2 8.5 22.6 2.9 2.8 18.5 4.0 2.2 7.8 9.2 5.4 6.6 6.9 4.2 4.9 4.2 5.1 2.3 4.4 1.3 6.3 12.0 13.2 1.2 7.3 9.0 5.8 18.5 14.3 20.9 13.2 7.3 9.7 16.2 12.1 13.4 14.1 6.3 8.8 10.6 13.3 5.4 1.0 6.2 6.3 6.8 9.7 8.5 3.7 7.0 2.9 10.0 11.4 11.8 11.9 10.7 8.3 4.2 15.0 12.1 13.3 3.1 9.1 14.3 15.1 5.9 10.4 8.7 10.7 7.4 17.3 10.6 11.0 4.6 10.3 5.5 10.2 4.9 8.4 9.2 7.3 14.7 8.7 5.4 6.3 18.5 15.5 3.5 8.3 0.7 3.2 4.2 2.8 4.3 2.9 1.9 3.4 4.1 1.9 4.2 4.4 1.9 2.8 2.3 5.1 4.9 4.2 1.3 16.6 20.3 21.9 25.1 17.2 17.2 17.3 6.2 5.2 4.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL162417.1 ENSG00000285245 9 133098121-133163914 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 6.8;HUVEC TERT2: 2.1;K-562: 1.5;REH: 2.4;TIME: 2.3;U-937: 1.5" HPA025961 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA025961: AB_2671795" 2.4 1.8 2.0 5.1 1.5 3.4 6.0 2.6 2.4 1.6 1.5 1.8 1.0 3.2 2.0 1.5 1.9 0.9 2.0 2.0 2.1 1.2 0.9 2.9 8.2 1.2 0.9 6.5 4.6 0.8 0.9 7.9 2.9 2.7 1.1 6.5 2.2 2.6 1.3 1.3 1.0 3.7 2.2 3.0 1.4 0.9 1.5 0.0 2.6 0.4 4.1 2.0 3.0 0.0 0.0 0.0 0.2 0.0 0.1 1.6 0.0 0.6 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 2.1 0.1 1.5 0.5 0.0 0.0 0.6 0.5 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 2.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL358113.1 ENSG00000285130 9 69035750-69255187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.9;Ciliated cells: 2.7;Club cells: 1.2" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 11 "dendritic cells: 1.3;monocytes: 2.8;T-cells: 2.6" "Cell line enhanced" "Detected in some" "HaCaT: 2.9;HUVEC TERT2: 2.2;REH: 9.8;U-2 OS: 2.2" "HPA001813, HPA068304, HPA070714" Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Nucleoplasm, Plasma membrane, Cell Junctions" "HPA001813: AB_1080764, HPA068304: AB_2685970, HPA070714: AB_2732161" 1.6 4.3 2.5 1.9 2.1 2.6 2.8 3.6 2.5 1.6 2.8 3.0 2.7 1.6 2.2 1.6 1.6 3.4 1.6 5.8 1.3 2.1 8.8 2.1 3.2 2.8 1.7 3.7 9.4 1.6 1.7 1.6 2.4 4.0 1.6 2.9 2.8 3.2 7.5 1.6 3.0 4.5 1.6 3.1 3.1 3.4 2.1 0.0 2.6 2.0 2.1 2.4 1.3 0.1 1.3 0.1 2.8 0.0 2.6 0.4 0.4 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 1.7 0.3 0.0 2.9 0.2 1.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 2.2 1.5 0.1 0.0 0.2 0.0 1.2 0.2 0.8 0.0 0.1 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.4 0.0 0.4 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.2 2.6 0.2 0.1 1.3 0.1 1.0 0.1 0.6 0.3 0.1 0.0 2.8 1.3 2.6 0.4 3.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 AL512785.2 ENSG00000254706 1 162365407-162383531 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 10.3;U-266/70: 5.7" HPA074060 Approved Nucleoplasm NA NA Nucleoplasm "HPA074060: " "unprognostic (1.41e-2)" "unprognostic (2.12e-1)" "unprognostic (4.50e-1)" "unprognostic (9.12e-3)" "unprognostic (6.73e-2)" "unprognostic (2.09e-2)" "unprognostic (3.57e-1)" "unprognostic (3.42e-1)" "unprognostic (4.63e-2)" "unprognostic (2.96e-1)" "unprognostic (7.61e-3)" "unprognostic (6.07e-2)" "unprognostic (1.19e-2)" "unprognostic (6.10e-2)" 0.9 1.0 0.0 0.2 0.0 1.3 2.7 0.6 0.0 2.6 2.8 2.3 1.5 0.0 1.1 1.4 2.7 0.7 0.1 0.1 2.0 4.6 0.6 0.1 0.3 0.2 4.3 0.0 0.4 0.6 1.3 0.2 5.5 6.3 0.2 1.5 1.2 0.6 0.9 0.0 3.5 2.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.6 4.7 0.0 4.0 3.3 0.3 0.0 0.0 0.2 0.6 0.2 0.0 2.5 2.4 0.0 5.0 0.0 1.4 0.5 0.0 0.8 0.0 0.0 3.7 10.3 0.1 4.1 0.2 0.4 0.0 0.9 0.3 0.0 0.3 1.0 0.4 1.1 1.2 0.2 0.2 3.4 0.1 0.0 1.1 2.7 3.6 0.4 0.0 0.0 2.2 3.5 2.1 2.1 1.7 0.6 2.4 0.8 5.1 0.0 3.0 0.1 0.9 0.0 1.8 5.7 0.0 0.0 0.5 0.2 0.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALAS1 "ALAS, ALAS3" ENSG00000023330 "5'-aminolevulinate synthase 1" P13196 3 52198086-52214327 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Heme biosynthesis" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 167.6;liver: 136.4" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 210.5;Syncytiotrophoblasts: 258.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 55.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 55.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017498, HPA035860" Enhanced Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB017498: AB_2225629, HPA035860: AB_10672992" "unprognostic (1.17e-1)" "unprognostic (1.65e-1)" "unprognostic (1.50e-1)" "unprognostic (7.09e-2)" "unprognostic (2.33e-1)" "unprognostic (6.21e-2)" "prognostic favorable (1.82e-5)" "unprognostic (3.98e-2)" "unprognostic (1.26e-1)" "unprognostic (2.31e-2)" "unprognostic (9.86e-2)" "unprognostic (5.64e-2)" "prognostic favorable (6.06e-7)" "unprognostic (8.45e-2)" "unprognostic (3.91e-2)" "unprognostic (1.07e-1)" "unprognostic (1.75e-2)" 9.2 167.6 7.8 6.7 10.6 39.1 8.9 17.0 15.4 6.0 11.0 12.0 15.3 11.4 6.3 11.8 10.5 4.7 8.7 24.8 8.8 7.0 14.1 136.4 13.5 10.0 7.6 9.9 5.8 6.1 8.5 5.8 13.4 12.2 7.3 11.1 8.3 15.7 16.9 24.6 6.8 17.4 6.5 7.3 6.3 12.2 9.7 5.0 7.5 7.4 11.4 9.6 12.1 7.6 6.8 8.4 55.0 12.2 8.8 11.3 6.3 10.3 16.1 11.4 10.5 17.8 13.3 31.0 15.2 14.1 20.4 19.8 21.4 19.6 9.7 3.8 10.6 41.4 6.1 16.3 12.5 16.7 18.8 6.4 12.4 12.7 16.2 25.2 20.1 25.0 16.5 11.7 32.4 10.8 7.5 18.6 17.0 7.3 8.0 18.5 8.4 9.5 30.7 9.8 11.9 27.9 5.7 7.1 15.3 17.9 62.7 6.0 4.0 24.6 12.1 13.7 9.6 6.9 28.7 13.3 11.4 11.3 23.5 21.9 11.9 20.5 14.6 12.7 21.9 18.1 55.0 9.2 27.8 6.9 12.2 11.3 6.8 7.2 7.7 8.4 6.0 6.5 7.0 14.2 8.8 10.2 4.8 9.7 6.3 7.8 10.6 17.0 15.4 8.8 7.0 7.6 9.9 12.2 5.0 32.8 47.6 4.5 16.4 15.3 15.1 88.4 35.7 38.8 27.3 22.7 3.9 67.2 48.0 28.5 9.7 25.9 35.4 0.0 27.6 21.7 19.9 18.1 89.4 210.5 62.6 11.1 33.3 25.2 14.6 3.1 12.4 23.3 5.0 73.9 18.6 9.1 33.4 18.7 15.6 25.9 6.8 12.9 27.3 23.7 19.0 14.2 258.6 17.3 16.1 24.3 ALDH1A3 "ALDH6, RALDH3" ENSG00000184254 "Aldehyde dehydrogenase 1 family member A3" P47895 15 100877714-100916626 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 14 "Glandular cells: 329.1;Leydig cells: 180.1;Peritubular cells: 127.3;Urothelial cells: 421.1" "Group enriched" "Detected in many" 7 "melanoma: 16.8;prostate cancer: 80.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 1.0;eosinophil: 2.1;plasmacytoid DC: 1.5" "Group enriched" "Detected in many" 5 "dendritic cells: 1.5;granulocytes: 2.1" "Cell line enhanced" "Detected in many" "A-431: 42.6;HaCaT: 53.0;HBEC3-KT: 131.3;hTERT-RPE1: 43.5;U-2197: 75.5;U-87 MG: 60.0;WM-115: 62.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA046271, HPA064749" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA046271: AB_10965992, HPA064749: AB_2685344" "unprognostic (6.87e-2)" "unprognostic (2.23e-1)" "unprognostic (6.20e-3)" "unprognostic (1.21e-3)" "unprognostic (1.76e-2)" "unprognostic (1.14e-1)" "unprognostic (6.28e-2)" "unprognostic (5.46e-2)" "unprognostic (9.62e-2)" "unprognostic (4.53e-2)" "unprognostic (3.64e-2)" "unprognostic (2.56e-1)" "unprognostic (1.25e-2)" "unprognostic (2.61e-2)" "unprognostic (2.12e-1)" "unprognostic (7.34e-2)" "unprognostic (6.07e-3)" 30.3 5.7 2.3 14.9 1.6 0.0 11.1 4.1 2.6 14.2 11.5 1.6 10.5 5.2 5.9 37.9 10.5 11.5 15.0 6.1 2.1 2.0 3.7 1.7 4.2 5.5 2.6 1.7 9.0 7.4 3.2 13.2 5.1 3.9 51.9 3.2 49.9 41.5 19.2 6.1 1.7 15.6 14.2 6.4 1.5 5.3 15.9 0.7 0.6 0.9 15.2 18.9 18.0 9.8 0.3 1.5 2.1 0.2 0.0 0.0 0.1 42.6 5.7 0.0 0.0 9.4 4.2 0.1 0.3 0.3 0.2 0.1 0.1 34.1 0.3 0.5 11.5 6.8 53.0 1.0 131.3 0.8 0.0 0.2 0.2 2.3 0.0 3.2 0.1 0.2 3.0 3.6 2.9 0.5 43.5 0.4 0.0 0.0 0.3 0.2 0.4 0.0 0.2 1.1 1.1 34.7 0.0 0.5 0.2 0.0 35.8 0.0 3.0 13.2 11.7 4.0 0.4 1.1 0.3 6.7 0.0 0.1 75.5 1.6 0.0 0.4 0.2 60.0 0.0 62.0 1.0 0.2 2.1 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.1 2.3 1.6 4.1 2.6 2.1 2.0 2.6 1.7 3.9 0.7 14.9 7.5 0.0 119.5 0.6 0.0 1.2 0.0 38.8 62.6 97.7 0.0 7.4 3.3 68.6 0.8 5.6 0.2 0.0 1.2 0.3 4.7 329.1 5.7 0.0 1.0 0.0 3.4 1.3 0.0 2.5 180.1 1.3 0.0 1.0 1.5 0.0 18.3 0.0 127.3 0.5 0.0 12.9 0.9 0.5 0.7 1.4 4.1 0.0 0.2 421.1 ALDH1B1 "ALDH5, ALDHX" ENSG00000137124 "Aldehyde dehydrogenase 1 family member B1" P30837 9 38392664-38398661 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 113.9" "Group enriched" "Detected in many" 5 "Cholangiocytes: 117.2;Ductal cells: 60.1;Extravillous trophoblasts: 40.0;Hepatocytes: 113.4;Proximal tubular cells: 118.8;Undifferentiated cells: 68.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 55.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021037, HPA077080" Enhanced Supported Nucleoplasm,Vesicles,Mitochondria,Cytosol NA NA 210000 Mitochondria "Nucleoplasm, Vesicles, Cytosol" "HPA021037: AB_1844724, HPA077080: " "unprognostic (4.16e-1)" "unprognostic (1.98e-2)" "unprognostic (5.84e-2)" "unprognostic (1.55e-3)" "unprognostic (2.47e-2)" "unprognostic (4.48e-3)" "unprognostic (2.84e-3)" "unprognostic (2.70e-2)" "unprognostic (1.91e-1)" "unprognostic (1.35e-1)" "unprognostic (2.09e-1)" "unprognostic (1.00e-1)" "prognostic favorable (2.05e-4)" "unprognostic (1.04e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (1.17e-5)" "unprognostic (2.89e-2)" 7.4 4.9 2.1 16.8 2.1 0.6 5.4 1.1 5.4 5.8 25.4 1.7 6.1 7.0 27.3 10.7 21.6 16.7 30.8 11.6 3.1 2.0 18.0 55.2 3.5 5.9 2.4 2.0 12.2 14.6 1.4 1.4 1.6 3.0 22.7 11.5 5.2 5.9 18.2 19.4 3.0 11.2 113.9 2.7 2.8 15.8 7.8 1.7 1.6 6.3 7.0 2.0 54.5 8.3 5.9 9.4 1.2 10.5 7.5 10.2 5.1 21.5 20.1 6.2 9.9 8.8 10.5 5.0 10.3 5.2 8.7 9.0 13.4 4.2 13.6 6.2 14.5 13.2 3.0 20.4 21.9 8.7 15.2 8.8 6.7 14.8 39.8 6.4 10.7 7.6 12.5 4.8 7.1 6.2 17.9 8.3 3.3 19.4 13.4 13.2 8.2 0.0 4.3 18.4 55.5 9.0 4.4 37.6 10.4 7.8 9.7 13.6 6.3 7.9 5.2 6.0 6.8 4.9 8.4 5.6 10.1 16.7 8.4 12.9 2.0 3.9 5.4 5.2 11.0 6.8 0.2 4.2 0.2 7.3 9.1 10.2 5.9 7.0 6.6 9.4 3.1 5.8 6.8 1.2 7.5 10.5 1.3 4.8 5.1 2.1 2.1 1.1 5.4 3.1 2.0 2.4 2.0 3.0 1.7 8.9 1.7 3.6 3.8 0.9 1.3 5.6 117.2 0.0 3.4 15.7 2.0 1.3 14.9 60.1 0.5 3.8 7.0 0.0 5.9 40.0 6.2 2.9 9.2 113.4 6.5 0.0 15.0 9.8 3.8 1.3 6.1 4.0 0.0 7.2 16.9 1.3 14.2 3.5 6.3 118.8 0.3 0.0 9.5 0.3 0.6 0.9 1.5 2.9 68.9 2.6 ALDH3A1 ALDH3 ENSG00000108602 "Aldehyde dehydrogenase 3 family member A1" P30838 17 19737984-19748943 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 88.2;lymphoid tissue: 70.3;stomach 1: 49.9;tongue: 106.6" "Cell type enhanced" "Detected in many" 15 "Basal keratinocytes: 39.2;Ciliated cells: 100.4;Club cells: 55.7;Suprabasal keratinocytes: 28.0;Urothelial cells: 32.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "pons and medulla: 1.8" "Cell type enhanced" "Detected in some" "NK-cell: 2.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 22 "A549: 261.5;OE19: 326.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB045957, HPA051150, HPA063783" Enhanced Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "Nucleoplasm, Vesicles" "CAB045957: AB_11127164, HPA051150: AB_2681364, HPA063783: AB_2685122" "unprognostic (3.11e-5)" "unprognostic (1.20e-2)" "unprognostic (1.08e-1)" "unprognostic (7.04e-3)" "unprognostic (4.36e-3)" "prognostic favorable (7.55e-5)" "unprognostic (3.12e-1)" "unprognostic (3.84e-1)" "unprognostic (2.10e-1)" "unprognostic (1.67e-1)" "unprognostic (2.69e-3)" "unprognostic (5.54e-2)" "unprognostic (1.72e-1)" "unprognostic (3.84e-2)" "unprognostic (1.83e-1)" "unprognostic (2.88e-2)" "unprognostic (7.23e-2)" 0.7 0.1 0.2 0.8 0.4 0.0 0.5 0.2 0.3 1.3 0.9 0.8 0.3 1.3 0.2 0.4 88.2 1.2 3.8 0.2 0.4 0.0 0.4 0.4 26.0 0.2 0.2 0.3 0.6 0.2 0.0 0.3 0.2 1.8 0.5 0.6 0.5 26.7 0.3 0.4 16.2 0.6 0.3 0.3 0.3 49.9 0.3 0.2 0.2 0.2 106.6 70.3 1.6 3.9 1.1 0.3 0.0 0.0 2.4 0.7 0.1 0.0 261.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 13.1 0.0 0.1 0.0 0.1 1.5 0.0 0.6 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 326.9 1.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.3 1.1 0.0 0.7 0.0 2.4 0.0 0.0 0.0 0.1 0.2 0.4 0.2 0.3 0.4 0.0 0.2 0.3 1.8 0.2 3.0 5.6 0.0 23.3 39.2 0.0 0.4 2.5 100.4 55.7 0.0 0.0 0.0 0.0 0.8 1.3 0.4 3.3 0.0 0.4 0.0 0.6 2.6 2.3 0.0 0.2 0.0 1.7 0.6 0.8 1.9 0.9 1.1 0.0 0.0 4.2 1.9 5.8 5.9 1.8 4.4 0.1 0.0 0.3 0.7 7.3 28.0 0.0 0.0 7.5 32.1 ALDH8A1 ALDH12 ENSG00000118514 "Aldehyde dehydrogenase 8 family member A1" Q9H2A2 6 134917390-134950122 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "kidney: 26.2;liver: 90.1" "Cell type enhanced" "Detected in some" 22 "Collecting duct cells: 29.6;Hepatocytes: 129.5;Proximal tubular cells: 94.1" "Group enriched" "Detected in some" 7 "liver cancer: 26.3;renal cancer: 17.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 5.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 5.6;RPTEC TERT1: 6.4;U-266/70: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA026292, HPA055414" Enhanced Approved Nucleoplasm,Centrosome NA NA 24000 Centrosome Nucleoplasm "HPA026292: AB_1844741, HPA055414: AB_2682810" "unprognostic (1.12e-1)" "unprognostic (1.48e-1)" "unprognostic (1.88e-1)" "unprognostic (1.75e-1)" "unprognostic (2.70e-2)" "unprognostic (6.32e-2)" "unprognostic (4.30e-3)" "unprognostic (1.12e-1)" "unprognostic (3.98e-2)" "unprognostic (1.64e-1)" "unprognostic (2.39e-2)" "unprognostic (3.99e-2)" "prognostic favorable (9.87e-4)" "unprognostic (1.25e-2)" "unprognostic (1.36e-1)" "unprognostic (2.36e-2)" "unprognostic (5.86e-5)" 0.3 0.3 0.8 0.3 1.0 0.6 0.3 1.9 0.9 0.3 0.6 0.3 0.3 0.2 0.3 0.6 0.3 0.1 0.3 0.3 1.4 0.6 26.2 90.1 0.3 0.3 1.1 0.4 0.3 0.3 0.2 0.3 0.4 0.3 0.3 0.2 0.3 0.3 0.3 1.0 0.5 0.3 0.3 0.8 0.3 0.1 0.3 0.3 0.4 0.4 0.3 0.3 0.3 0.3 1.5 1.1 5.9 0.9 2.3 1.3 0.6 0.2 1.1 1.6 0.8 0.5 0.2 1.4 0.4 0.5 0.1 1.0 0.5 0.7 0.4 0.6 0.0 0.4 1.1 1.1 0.1 0.9 1.2 5.6 3.7 3.9 5.3 0.6 1.5 2.0 1.6 1.8 0.4 0.9 1.2 0.4 1.8 5.4 2.2 0.2 0.1 1.8 2.4 0.3 0.4 1.1 0.1 0.5 0.5 6.4 0.8 1.7 0.6 0.3 0.1 1.3 0.5 0.9 0.3 0.4 0.8 3.2 1.3 1.5 5.6 1.7 0.9 0.7 1.4 0.5 5.9 0.9 0.9 1.3 0.3 0.5 1.0 1.2 0.7 0.1 1.5 1.1 0.9 2.4 2.3 0.4 1.1 1.2 0.6 0.8 1.0 1.9 0.9 1.4 0.6 1.1 0.4 0.3 0.3 3.0 1.1 2.2 0.2 0.0 1.8 0.3 2.5 0.0 1.2 29.6 0.0 0.2 16.6 0.1 0.0 0.2 0.0 0.0 0.0 1.2 0.4 0.1 0.0 129.5 0.1 3.2 0.0 3.1 1.3 0.0 0.0 0.1 0.0 1.0 0.0 0.3 0.0 0.0 0.0 94.1 1.6 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 ALDOC ENSG00000109107 "Aldolase, fructose-bisphosphate C" P09972 17 28573115-28577264 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis Lyase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 166.7;heart muscle: 56.9" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 100.1;Horizontal cells: 259.0;Rod photoreceptor cells: 259.1" "Cancer enriched" "Detected in all" 6 "glioma: 128.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 63.4;U-266/70: 43.8;U-87 MG: 28.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003282, CAB020828, HPA067442" Enhanced Supported Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" Yes No 280000000 "Nucleoplasm, Nucleoli fibrillar center" "Vesicles, Cytosol" "CAB020828: , HPA003282: AB_1078130, HPA067442: " "unprognostic (2.90e-1)" "unprognostic (4.45e-3)" "unprognostic (5.69e-3)" "unprognostic (1.43e-1)" "unprognostic (3.56e-1)" "prognostic unfavorable (9.80e-4)" "unprognostic (1.03e-1)" "unprognostic (1.70e-1)" "unprognostic (1.30e-1)" "unprognostic (6.03e-3)" "unprognostic (3.90e-1)" "unprognostic (3.24e-2)" "prognostic unfavorable (1.29e-7)" "unprognostic (1.28e-1)" "unprognostic (2.00e-1)" "unprognostic (2.74e-2)" "unprognostic (1.23e-1)" 26.0 9.4 86.7 4.8 78.9 7.5 9.8 100.1 166.7 3.8 5.3 17.4 0.3 7.0 4.4 4.6 7.1 3.9 4.4 56.9 64.6 54.3 3.3 26.2 4.6 6.5 69.9 51.4 12.8 1.6 4.7 2.3 2.1 98.1 6.0 5.6 16.5 4.2 6.1 1.7 12.5 15.0 4.6 34.4 6.7 8.7 4.6 23.4 0.0 2.1 0.5 10.0 3.4 3.5 12.2 4.6 8.8 4.1 13.7 20.5 8.8 7.5 0.5 3.5 14.7 7.4 7.6 0.7 3.9 8.8 3.0 18.5 4.4 0.7 3.5 4.6 3.4 0.8 9.9 2.4 24.1 5.6 3.1 2.3 6.8 2.8 7.5 6.9 2.5 8.0 7.0 3.4 0.3 6.0 0.4 1.3 7.3 4.6 19.1 2.6 3.6 2.9 8.3 5.5 1.6 3.9 2.4 0.4 63.4 0.4 1.0 9.4 16.7 2.2 18.1 0.1 5.8 9.8 5.6 0.9 0.3 1.4 0.5 0.6 43.8 12.5 2.6 28.6 7.1 0.5 0.1 3.5 1.4 11.4 4.1 16.2 12.2 15.6 9.2 4.6 11.5 20.5 15.1 8.8 13.7 2.3 2.2 19.5 8.8 86.7 78.9 100.1 78.5 64.6 54.3 69.9 51.4 98.1 23.4 0.0 12.0 9.3 17.7 6.6 72.2 19.0 5.1 0.0 7.9 7.0 100.1 1.2 3.3 14.2 0.8 8.4 22.7 0.0 8.9 3.9 7.1 4.4 12.7 50.8 4.4 259.0 20.7 16.5 4.7 0.8 8.6 3.7 23.6 58.7 8.7 81.4 11.6 14.0 9.6 1.6 259.1 12.9 17.6 0.4 3.2 9.5 1.3 17.0 3.3 8.0 ALG14 MGC19780 ENSG00000172339 "ALG14, UDP-N-acetylglucosaminyltransferase subunit" Q96F25 1 94974407-95072945 "Disease related genes, Predicted membrane proteins" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031829 Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA031829: AB_2674062" "unprognostic (7.79e-2)" "unprognostic (3.59e-2)" "unprognostic (1.51e-3)" "unprognostic (1.75e-3)" "unprognostic (1.36e-1)" "unprognostic (6.56e-2)" "unprognostic (4.00e-1)" "unprognostic (2.17e-2)" "unprognostic (3.18e-1)" "unprognostic (2.01e-1)" "unprognostic (7.79e-2)" "unprognostic (1.15e-1)" "unprognostic (1.24e-1)" "unprognostic (9.55e-2)" "unprognostic (6.01e-2)" "unprognostic (4.99e-2)" "unprognostic (1.93e-1)" 5.8 13.2 6.8 4.1 8.5 4.6 6.8 5.6 8.0 5.5 7.5 8.5 7.0 8.5 5.4 11.3 5.7 4.8 6.1 6.3 7.0 7.2 8.9 15.1 5.3 7.5 8.2 4.7 5.3 12.6 5.8 6.6 6.3 8.4 5.1 8.7 6.9 14.5 9.8 7.2 5.0 9.2 4.4 9.4 5.8 6.0 10.0 4.2 3.7 8.5 6.2 5.3 4.8 4.2 4.9 5.8 3.1 3.9 2.8 3.8 1.9 5.2 3.3 2.8 2.5 2.2 3.8 2.5 3.8 4.1 3.9 3.3 3.9 1.8 2.7 4.0 4.7 4.7 3.6 3.2 3.6 4.7 5.7 5.5 1.5 3.6 5.9 3.6 3.6 1.0 4.1 3.7 2.9 2.9 3.2 3.3 3.6 2.9 3.6 3.7 2.5 3.8 2.3 1.7 5.2 4.8 2.4 5.7 2.9 4.4 3.0 2.5 3.2 2.1 7.2 6.3 2.2 3.2 3.1 2.6 2.5 2.8 4.4 7.9 2.3 2.2 2.4 1.8 1.8 2.0 3.1 3.2 1.1 2.5 3.9 2.4 4.9 3.1 3.1 4.5 4.4 2.9 3.0 2.7 2.8 1.9 5.8 3.8 1.9 6.8 8.5 5.6 8.0 7.0 7.2 8.2 4.7 8.4 4.2 0.0 12.6 5.2 10.9 10.4 14.8 7.3 10.2 8.1 11.4 15.7 5.9 28.7 16.6 21.4 5.4 8.0 19.2 23.3 46.6 23.6 21.1 9.2 1.1 30.6 17.2 7.9 4.1 14.7 6.3 6.5 13.3 10.8 30.4 11.8 11.1 28.5 21.0 25.9 9.6 34.3 12.9 32.3 12.5 33.6 22.6 7.5 21.1 4.4 24.9 9.1 ALG8 MGC2840 ENSG00000159063 "ALG8, alpha-1,3-glucosyltransferase" Q9BVK2 11 78100936-78139660 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 115.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051898 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA051898: AB_2681656" "unprognostic (1.37e-1)" "unprognostic (9.24e-2)" "unprognostic (4.60e-2)" "unprognostic (2.69e-2)" "unprognostic (2.65e-1)" "unprognostic (6.49e-2)" "unprognostic (5.38e-3)" "unprognostic (5.91e-2)" "unprognostic (1.39e-1)" "unprognostic (1.10e-3)" "unprognostic (5.29e-2)" "unprognostic (1.20e-1)" "unprognostic (1.35e-2)" "unprognostic (1.19e-1)" "unprognostic (2.34e-1)" "unprognostic (3.78e-2)" "unprognostic (6.37e-2)" 20.2 24.5 18.0 11.2 22.3 9.7 23.7 13.8 17.9 16.5 15.0 20.7 23.9 10.3 14.5 30.9 13.3 18.4 12.3 13.0 15.9 16.0 24.9 40.8 12.8 15.7 16.0 11.6 22.9 23.4 24.2 23.6 21.7 17.1 15.5 19.0 17.6 23.2 19.5 8.2 13.3 13.3 14.8 17.6 13.8 13.1 38.9 16.5 18.2 29.7 13.1 17.4 13.2 11.2 21.9 19.4 3.0 20.3 18.2 19.0 14.9 8.9 24.6 23.6 20.2 20.5 14.4 12.7 13.1 19.7 22.5 21.8 46.6 32.7 20.9 24.3 15.7 29.5 25.7 27.5 18.9 36.4 15.0 16.5 25.2 21.7 20.9 13.3 24.0 16.8 11.5 12.2 26.3 13.1 12.9 16.3 19.0 31.2 21.6 30.1 13.0 20.0 27.1 26.3 60.1 12.9 21.4 10.9 49.8 22.6 13.8 6.9 17.4 18.9 30.7 9.5 22.5 34.3 19.0 10.0 15.3 17.8 34.4 11.3 15.5 30.1 30.9 8.5 23.6 26.4 0.3 17.5 3.0 15.7 19.5 17.5 21.9 16.0 16.1 19.4 16.6 19.0 17.2 1.1 18.2 20.3 18.7 13.0 14.9 18.0 22.3 13.8 17.9 15.9 16.0 16.0 11.6 17.1 16.5 11.9 12.3 25.2 20.6 9.3 13.9 6.3 25.5 10.7 13.6 19.2 17.7 44.1 5.0 18.7 10.7 14.3 6.0 0.0 22.1 52.0 15.3 15.6 11.5 36.4 27.9 15.9 7.5 11.1 14.0 9.8 16.7 17.3 25.3 4.6 15.5 8.2 16.4 5.8 14.9 14.6 12.9 0.0 15.2 115.0 39.1 7.9 27.3 14.9 14.0 15.7 ALKBH1 "ABH, alkB, ALKBH, hABH" ENSG00000100601 "AlkB homolog 1, histone H2A dioxygenase" Q13686 14 77672404-77708020 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, RNA repair, Translation regulation" "Dioxygenase, Lyase, Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044087, HPA060061" Approved Supported "Nucleoplasm,Endoplasmic reticulum" "Intracellular and membrane" NA NA Nucleoplasm "Endoplasmic reticulum" "HPA044087: AB_2678803, HPA060061: " "unprognostic (1.92e-2)" "unprognostic (8.38e-2)" "unprognostic (1.32e-1)" "unprognostic (1.37e-3)" "unprognostic (3.41e-2)" "unprognostic (5.03e-2)" "unprognostic (3.74e-3)" "unprognostic (7.45e-3)" "unprognostic (2.68e-2)" "unprognostic (3.95e-2)" "unprognostic (5.05e-3)" "unprognostic (2.16e-2)" "prognostic favorable (1.80e-4)" "unprognostic (1.65e-3)" "unprognostic (1.46e-1)" "unprognostic (2.63e-1)" "unprognostic (2.44e-2)" 8.2 8.5 6.2 6.7 8.6 2.7 9.7 9.6 8.8 9.7 9.1 8.2 4.5 6.5 7.0 5.9 7.1 8.0 5.8 11.1 5.4 5.7 7.9 9.4 5.9 8.3 6.5 3.7 8.3 7.9 8.4 11.2 10.2 6.4 9.3 9.1 9.9 7.2 8.7 16.5 8.2 6.7 7.8 5.5 8.3 7.8 9.9 6.6 12.7 8.8 6.5 10.3 8.5 9.4 5.4 4.9 11.4 5.7 5.2 5.3 3.2 5.3 8.0 6.5 4.4 7.0 7.7 8.2 5.6 7.3 12.4 14.0 8.1 3.3 8.3 3.2 5.1 5.8 4.9 14.2 6.1 14.7 5.6 5.6 4.4 4.7 6.8 9.9 4.6 2.9 6.5 10.1 7.3 11.6 5.5 10.1 6.5 6.8 4.8 6.6 8.5 6.2 6.0 7.2 8.1 10.3 6.2 6.6 5.5 7.1 4.8 8.4 6.3 4.6 4.8 6.1 5.6 11.8 4.8 4.6 5.2 5.3 5.7 4.5 6.0 9.5 8.1 3.5 6.7 5.1 11.4 5.0 2.2 5.0 5.7 4.3 5.4 4.7 5.0 4.9 4.9 5.0 3.9 1.4 5.2 3.8 2.6 5.3 3.2 6.2 8.6 9.6 8.8 5.4 5.7 6.5 3.7 6.4 6.6 0.0 4.6 3.7 4.9 7.4 4.0 6.5 0.0 5.3 3.4 1.8 2.0 8.9 8.3 5.3 3.3 4.1 4.2 0.0 6.1 6.7 6.0 3.8 9.2 3.0 6.5 0.0 2.4 3.1 4.6 3.1 6.1 5.6 5.0 5.4 4.6 7.3 5.7 0.0 4.9 5.1 4.9 6.5 5.2 15.8 14.9 4.6 10.2 4.4 4.2 3.0 ALKBH2 "ABH2, MGC90512" ENSG00000189046 "AlkB homolog 2, alpha-ketoglutarate dependent dioxygenase" Q6NS38 12 109088188-109093631 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011198, HPA045392, HPA051976" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB011198: AB_261971, HPA045392: AB_2679309, HPA051976: AB_2681680" "prognostic favorable (6.67e-5)" "unprognostic (3.66e-3)" "unprognostic (1.08e-1)" "unprognostic (4.64e-2)" "unprognostic (4.55e-2)" "unprognostic (4.71e-2)" "unprognostic (1.69e-1)" "unprognostic (9.60e-2)" "unprognostic (3.63e-1)" "unprognostic (1.85e-1)" "unprognostic (6.39e-2)" "unprognostic (6.43e-3)" "prognostic unfavorable (1.41e-5)" "unprognostic (1.01e-2)" "unprognostic (7.88e-2)" "unprognostic (6.24e-2)" "prognostic favorable (8.67e-4)" 16.1 12.3 13.6 16.9 13.4 8.2 22.3 12.7 20.5 12.9 11.7 15.2 14.6 9.0 18.0 14.2 14.1 18.3 12.2 12.3 13.5 12.3 12.0 25.6 9.8 17.0 14.3 8.9 23.1 18.5 7.1 7.8 8.1 15.7 15.0 10.7 10.8 18.9 18.5 20.0 25.0 10.7 15.9 15.4 12.3 12.6 14.3 13.5 11.3 13.9 19.7 16.5 15.5 13.8 16.9 13.1 1.1 6.7 9.0 18.2 6.9 13.0 22.4 12.8 28.6 9.0 12.3 20.4 8.7 5.8 9.2 10.3 23.5 9.4 20.1 8.7 5.0 4.3 9.5 21.5 8.7 5.4 17.9 19.2 10.0 12.7 21.4 12.0 13.8 9.4 12.6 19.0 8.7 22.4 11.4 3.5 19.4 14.8 12.0 6.1 23.0 12.7 27.8 17.7 13.8 22.8 11.3 12.5 21.6 12.2 18.2 13.2 22.8 9.2 30.0 18.2 5.0 18.4 8.5 3.6 10.3 11.2 9.7 12.8 16.9 19.6 43.8 8.8 12.0 16.4 1.1 5.1 0.7 8.0 6.7 14.1 16.2 12.1 11.2 5.1 16.9 18.2 10.7 0.9 9.0 4.3 13.1 9.0 6.9 13.6 13.4 12.7 20.5 13.5 12.3 14.3 8.9 15.7 13.5 8.9 4.6 11.9 40.0 45.2 4.3 5.9 10.2 13.4 18.2 8.7 2.0 14.2 13.3 16.1 10.1 14.7 2.6 0.0 20.7 22.0 18.8 11.8 5.8 19.2 9.1 4.8 8.1 4.9 7.1 4.9 24.7 7.4 25.3 3.6 10.2 10.0 18.9 2.9 16.3 14.6 6.4 0.0 27.8 8.8 28.1 52.4 4.2 11.5 14.5 23.5 ALKBH3 DEPC-1 ENSG00000166199 "AlkB homolog 3, alpha-ketoglutaratedependent dioxygenase" Q96Q83 11 43880811-43920266 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 78.8;Late spermatids: 69.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA009674, HPA046489" Approved Supported Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA009674: AB_1850460, HPA046489: AB_2679671" "unprognostic (3.53e-1)" "unprognostic (2.41e-1)" "unprognostic (7.43e-3)" "unprognostic (4.70e-2)" "unprognostic (6.94e-3)" "unprognostic (1.89e-1)" "unprognostic (7.71e-2)" "unprognostic (5.42e-2)" "unprognostic (8.56e-2)" "unprognostic (4.62e-1)" "unprognostic (5.87e-2)" "unprognostic (7.02e-2)" "unprognostic (2.09e-2)" "unprognostic (1.22e-1)" "unprognostic (2.31e-1)" "unprognostic (2.76e-1)" "unprognostic (1.35e-2)" 17.6 14.2 14.3 13.2 16.7 8.6 26.5 21.2 22.7 19.1 15.7 19.5 12.8 13.2 22.6 31.2 16.2 20.0 16.4 12.5 14.3 13.4 15.6 25.8 15.1 17.3 15.0 14.4 21.8 23.5 22.1 16.6 9.1 15.6 19.1 16.6 19.5 25.5 19.1 29.1 20.2 15.0 18.3 14.8 17.8 17.0 17.3 12.1 14.5 16.4 21.4 22.2 15.2 17.4 14.9 18.5 21.2 21.0 17.1 21.3 13.8 7.4 13.0 5.2 0.0 10.1 13.0 0.0 9.1 20.2 18.3 18.0 6.1 5.8 1.1 5.8 13.7 9.9 10.2 7.1 15.7 17.0 0.0 24.9 10.9 8.8 12.8 25.1 20.0 14.6 13.7 27.3 8.1 39.4 7.6 13.1 21.5 15.4 11.9 9.0 8.9 17.9 10.3 9.5 7.9 19.1 5.2 11.2 14.0 11.0 11.7 9.7 7.8 7.0 11.1 16.7 4.8 16.1 12.3 9.2 10.4 5.8 17.0 13.0 10.8 11.3 12.1 15.5 8.5 8.5 21.2 12.9 7.1 17.0 14.1 16.2 14.4 17.4 15.1 18.5 14.9 21.3 18.9 2.3 17.1 21.0 16.3 16.2 13.8 14.3 16.7 21.2 22.7 14.3 13.4 15.0 14.4 15.6 12.1 14.9 10.4 11.1 9.1 9.2 10.0 5.6 12.7 16.0 10.3 15.7 3.9 3.1 26.6 17.0 78.8 13.7 9.2 0.0 28.4 4.0 9.7 6.6 7.0 11.3 16.7 9.5 9.1 14.7 10.7 69.5 15.0 13.1 16.9 15.4 12.7 17.2 23.0 7.0 9.9 14.1 10.5 6.5 19.6 18.7 9.5 6.1 1.8 14.9 13.1 5.0 ALKBH5 "FLJ20308, OFOXD1" ENSG00000091542 "AlkB homolog 5, RNA demethylase" Q6P6C2 17 18183078-18209954 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 130.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007196 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA007196: AB_1850461" "unprognostic (1.07e-1)" "unprognostic (1.51e-1)" "unprognostic (2.23e-2)" "unprognostic (1.48e-2)" "unprognostic (1.80e-2)" "unprognostic (1.24e-1)" "unprognostic (2.23e-1)" "unprognostic (2.64e-1)" "unprognostic (1.34e-1)" "unprognostic (1.94e-2)" "prognostic favorable (3.75e-4)" "unprognostic (6.54e-2)" "unprognostic (3.99e-2)" "unprognostic (2.88e-2)" "unprognostic (3.22e-2)" "unprognostic (4.68e-3)" "prognostic unfavorable (5.69e-4)" 18.0 19.5 17.1 14.6 21.9 19.1 26.2 23.4 25.3 18.2 21.8 20.1 18.8 15.1 22.1 12.1 17.3 30.5 18.7 45.8 16.5 18.9 16.0 24.2 14.7 16.9 19.0 16.9 20.9 25.0 22.7 20.2 14.8 15.4 19.4 8.9 19.9 23.7 21.1 130.4 12.7 16.9 20.4 15.3 18.8 16.2 29.7 17.6 26.8 23.5 19.5 13.7 26.8 44.8 11.5 8.9 17.6 10.6 7.6 17.0 5.7 33.1 32.0 13.0 23.4 19.1 13.3 11.3 16.0 19.8 26.3 24.5 36.1 8.8 21.0 23.7 17.6 13.9 21.9 19.6 16.9 13.6 23.9 26.7 15.4 18.2 20.1 17.8 11.1 20.7 12.7 11.5 19.7 11.7 16.7 15.2 16.4 16.7 9.6 14.6 24.6 23.9 12.4 11.0 13.9 16.4 21.7 25.7 36.8 7.7 11.4 13.4 17.7 20.0 13.9 18.2 42.7 14.0 9.6 15.4 25.4 17.7 37.2 31.3 11.2 8.5 12.7 46.1 18.2 16.6 4.3 7.2 17.6 15.1 7.4 14.0 7.9 13.6 17.0 8.9 11.5 10.9 11.0 4.6 7.6 10.6 6.6 7.9 5.7 17.1 21.9 23.4 25.3 16.5 18.9 19.0 16.9 15.4 17.6 32.8 25.7 39.8 24.5 57.5 79.0 78.7 25.5 28.1 18.2 26.2 37.3 28.1 71.3 24.0 48.1 37.6 35.4 46.7 27.3 36.7 47.3 36.0 41.4 52.9 29.7 112.8 58.5 27.6 39.9 29.1 38.0 25.6 47.2 17.2 41.8 72.5 28.5 42.4 48.8 81.8 52.8 19.4 44.3 106.7 98.2 48.9 26.3 48.4 31.6 21.6 ALKBH6 MGC15677 ENSG00000239382 "AlkB homolog 6" Q3KRA9 19 36009120-36014239 "Cancer-related genes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA073835, HPA074340" Approved Supported "Nucleoplasm,Focal adhesion sites" NA NA Nucleoplasm "Focal adhesion sites" "HPA073835: AB_2686637, HPA074340: AB_2686680" "unprognostic (1.90e-3)" "unprognostic (1.82e-1)" "unprognostic (5.16e-3)" "unprognostic (1.12e-2)" "unprognostic (1.24e-1)" "unprognostic (5.86e-5)" "unprognostic (6.21e-2)" "unprognostic (4.53e-2)" "unprognostic (3.95e-1)" "unprognostic (3.56e-2)" "unprognostic (8.78e-4)" "unprognostic (1.77e-2)" "unprognostic (2.31e-5)" "unprognostic (9.34e-2)" "unprognostic (2.15e-1)" "unprognostic (3.82e-1)" "unprognostic (1.05e-3)" 8.4 7.0 14.1 6.4 15.2 6.8 6.3 7.8 18.9 5.8 8.2 7.8 2.5 6.6 6.5 6.6 6.5 8.2 7.7 9.2 13.0 14.9 5.7 12.6 6.8 8.7 14.8 12.5 5.4 3.4 8.2 8.5 6.2 19.5 9.7 4.6 6.5 8.7 9.9 6.3 5.8 6.4 8.5 10.5 8.9 9.6 4.2 4.9 5.7 6.2 3.7 8.4 7.2 4.7 18.1 13.5 29.5 15.0 15.7 19.5 9.4 10.3 11.1 4.2 6.2 6.6 4.0 7.1 10.3 6.9 12.1 12.3 4.6 5.5 9.1 16.5 5.7 6.3 4.1 4.4 11.9 6.4 14.3 8.0 5.2 4.2 4.9 7.5 4.5 16.0 6.0 8.6 10.0 3.4 4.2 8.2 13.9 8.1 6.9 6.5 10.8 10.8 5.9 3.3 10.8 7.2 6.9 5.8 6.5 8.7 4.6 5.1 5.3 7.0 8.5 8.6 6.2 6.7 10.2 3.5 6.3 9.3 14.3 10.0 13.0 7.7 6.4 13.7 5.1 6.7 29.5 11.4 27.3 17.1 15.0 13.0 18.1 15.5 16.1 9.6 14.6 13.2 12.8 9.6 15.7 11.7 13.5 19.5 9.4 14.1 15.2 7.8 18.9 13.0 14.9 14.8 12.5 19.5 4.9 3.0 1.7 11.5 10.4 6.1 6.0 1.4 10.2 0.0 1.2 17.4 0.0 16.3 5.0 9.6 4.7 4.7 7.7 23.3 8.1 13.8 6.9 7.1 0.0 12.9 9.3 9.5 12.6 8.0 4.9 4.0 10.3 7.9 8.5 19.8 9.6 4.9 10.7 14.0 4.2 8.7 3.3 6.5 9.6 3.1 2.5 4.4 15.9 15.8 8.0 8.8 ALKBH8 "MGC10235, TRM9, TRMT9A" ENSG00000137760 "AlkB homolog 8, tRNA methyltransferase" Q96BT7 11 107502726-107565746 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Multifunctional enzyme, Oxidoreductase, RNA-binding, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038724, HPA038725, HPA061514" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA038724: AB_2676176, HPA038725: AB_10674838, HPA061514: AB_2684547" "unprognostic (2.66e-2)" "unprognostic (3.82e-1)" "unprognostic (8.19e-2)" "unprognostic (3.76e-1)" "unprognostic (4.04e-2)" "unprognostic (2.97e-1)" "unprognostic (1.22e-2)" "unprognostic (1.95e-1)" "unprognostic (4.45e-2)" "unprognostic (7.67e-2)" "unprognostic (1.89e-2)" "unprognostic (7.95e-2)" "unprognostic (2.81e-1)" "unprognostic (2.03e-1)" "unprognostic (2.04e-1)" "unprognostic (2.34e-3)" "unprognostic (1.01e-1)" 9.7 6.7 7.2 14.1 12.6 6.1 11.3 9.9 11.7 8.6 7.4 7.6 9.4 6.7 9.5 7.1 9.8 7.4 6.0 12.4 7.4 7.6 9.2 9.5 7.5 11.5 7.2 5.5 9.9 7.0 13.4 10.0 6.9 7.9 8.9 7.9 8.1 7.7 7.5 12.6 9.7 7.8 9.0 7.0 10.8 6.8 5.8 5.8 9.2 11.1 5.7 12.0 8.9 8.1 3.7 3.3 0.5 4.1 4.8 6.2 2.2 4.9 6.0 6.3 6.8 3.5 7.8 5.2 9.6 7.1 7.1 7.7 11.1 9.1 11.6 5.5 9.1 9.7 8.9 9.3 7.7 9.2 10.3 6.2 9.7 2.4 5.1 5.2 12.3 12.0 4.8 8.8 9.1 11.6 3.6 8.7 9.1 13.7 3.9 5.6 4.4 11.1 6.2 8.3 9.6 10.0 10.2 9.7 8.0 5.6 5.4 5.7 6.4 5.5 4.1 4.0 3.9 6.8 3.7 8.2 15.4 9.2 5.0 11.8 3.6 3.9 9.1 4.3 8.3 15.1 0.0 2.0 0.5 4.5 4.1 4.3 1.9 3.3 3.9 3.3 3.7 6.2 5.2 0.0 4.8 2.7 2.0 3.5 2.2 7.2 12.6 9.9 11.7 7.4 7.6 7.2 5.5 7.9 5.8 0.0 4.0 2.9 1.7 1.8 5.9 10.0 7.6 0.0 4.5 1.8 5.9 1.8 0.0 1.8 0.2 2.2 1.1 0.0 2.9 2.3 3.4 1.1 9.3 6.4 2.4 1.6 1.2 4.3 2.5 0.0 2.6 2.2 3.3 3.6 3.0 2.5 1.9 4.0 3.9 2.6 3.5 0.0 2.3 1.7 2.9 3.6 0.7 5.0 3.8 0.6 ALMS1 KIAA0328 ENSG00000116127 "ALMS1, centrosome and basal body associated protein" 2 73385758-73610793 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 23.2" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 55.4;Late spermatids: 63.9;Rod photoreceptor cells: 38.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "RH-30: 24.2" "Low region specificity" "Detected in all" "HPA035276, HPA043200" Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Centrosome, Cytosol" Nucleoplasm "HPA035276: , HPA043200: AB_10796689" "unprognostic (2.86e-1)" "unprognostic (9.67e-2)" "unprognostic (2.58e-2)" "unprognostic (4.50e-3)" "unprognostic (1.36e-1)" "unprognostic (6.39e-2)" "unprognostic (2.91e-3)" "unprognostic (7.73e-2)" "unprognostic (1.02e-1)" "unprognostic (8.58e-2)" "unprognostic (4.78e-2)" "unprognostic (1.84e-1)" "unprognostic (3.43e-2)" "unprognostic (1.63e-1)" "unprognostic (7.85e-2)" "unprognostic (2.13e-1)" "unprognostic (1.94e-1)" 3.4 1.7 3.0 6.5 5.5 6.3 3.9 5.5 4.5 6.0 4.0 5.4 4.3 2.0 7.4 3.9 2.2 7.9 4.3 1.6 3.4 3.5 2.1 2.7 2.5 2.0 5.0 11.0 4.0 6.1 6.6 3.2 3.6 3.6 3.3 4.7 2.3 5.8 2.3 1.8 2.4 4.2 3.2 2.1 2.8 23.2 3.4 6.7 5.1 1.9 3.2 2.9 4.1 0.8 1.3 1.3 0.4 0.5 1.2 0.0 8.5 3.4 6.3 4.6 2.5 4.1 3.9 2.9 3.2 4.8 3.6 3.7 1.2 8.1 1.8 4.9 6.4 3.8 10.6 3.3 7.3 4.8 2.9 5.3 3.7 3.0 2.1 7.4 2.6 3.1 2.0 6.7 3.3 2.3 4.3 7.5 6.0 4.3 4.0 2.5 7.0 3.4 8.1 2.4 3.1 7.8 24.2 3.4 1.2 3.1 5.1 6.1 6.7 1.1 2.7 5.1 1.4 1.8 2.7 6.8 7.1 5.4 7.0 5.0 2.5 8.6 2.6 4.2 3.0 0.0 0.1 1.3 1.2 0.2 0.3 0.2 0.6 0.1 0.1 0.8 0.4 0.6 0.0 0.5 0.4 1.3 0.1 0.0 6.0 9.3 0.0 2.6 2.2 23.1 5.8 2.5 21.4 12.5 10.4 23.6 2.6 0.0 3.9 55.4 8.6 3.8 0.0 3.0 2.2 4.8 3.9 4.7 2.1 2.8 20.6 7.0 0.6 3.0 63.9 7.5 3.1 3.3 2.8 5.6 5.7 2.9 0.0 8.5 1.1 38.5 6.5 3.9 25.2 24.4 2.9 1.6 2.5 4.6 1.8 ALOX5 5-LOX ENSG00000012779 "Arachidonate 5-lipoxygenase" P09917 10 45374176-45446119 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Leukotriene biosynthesis" "Dioxygenase, Hydrolase, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 45.2;bone marrow: 39.9;lymphoid tissue: 41.8" "Cell type enhanced" "Detected in many" 13 "granulocytes: 194.3;Hofbauer cells: 78.7;Kupffer cells: 81.6;Macrophages: 81.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 7.9;CAPAN-2: 6.1;Daudi: 22.3;HMC-1: 16.0;Karpas-707: 7.0;RT4: 10.5;U-266/70: 10.5;U-698: 7.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA071285 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA071285: AB_2686379" "unprognostic (2.57e-2)" "unprognostic (2.81e-1)" "unprognostic (4.82e-2)" "unprognostic (1.75e-2)" "unprognostic (7.98e-3)" "unprognostic (1.26e-1)" "unprognostic (5.32e-2)" "unprognostic (8.69e-2)" "unprognostic (1.86e-2)" "unprognostic (6.91e-2)" "unprognostic (5.04e-2)" "unprognostic (3.42e-1)" "prognostic unfavorable (1.80e-5)" "unprognostic (5.59e-3)" "unprognostic (4.22e-2)" "unprognostic (1.53e-1)" "prognostic favorable (7.18e-4)" 7.4 3.9 2.9 18.3 7.4 39.9 5.8 13.2 3.2 3.4 6.5 6.4 1.0 4.5 3.2 4.7 4.9 5.4 8.0 6.1 3.9 2.6 4.8 2.6 34.7 36.9 9.0 1.7 2.6 10.0 1.3 1.7 11.2 6.1 7.8 3.4 3.2 6.6 3.4 1.1 2.9 14.4 7.8 8.4 41.8 4.5 2.0 6.2 2.4 3.0 1.4 16.7 27.2 10.5 14.8 11.1 45.2 21.3 0.0 0.5 9.5 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 6.1 22.3 0.8 0.0 0.0 0.3 0.2 0.0 0.0 0.4 0.2 4.3 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 7.0 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.1 0.0 0.8 0.3 10.5 0.5 0.0 0.0 0.2 0.0 0.1 0.1 0.5 0.0 0.0 1.2 0.0 0.0 10.5 1.9 7.4 0.0 0.1 0.0 36.7 21.3 27.0 0.0 20.0 0.1 14.8 0.5 0.2 11.1 10.4 0.0 0.0 45.2 0.0 19.6 0.3 0.1 9.5 2.9 7.4 13.2 3.2 3.9 2.6 9.0 1.7 6.1 6.2 14.9 58.3 34.9 5.4 1.0 0.8 2.0 15.3 4.0 12.5 8.7 2.0 0.5 0.0 19.2 0.4 0.7 2.1 0.0 18.9 1.4 0.6 3.3 194.3 0.6 78.7 0.0 6.8 2.5 81.6 1.1 0.3 81.2 0.0 18.0 0.7 0.3 17.8 0.0 0.0 0.0 0.2 12.9 0.7 0.4 0.8 1.3 3.4 1.3 0.4 35.5 ALPK3 "KIAA1330, MAK, Midori" ENSG00000136383 "Alpha kinase 3" Q96L96 15 84816680-84873482 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 18.4;skeletal muscle: 47.6" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 52.4;Cholangiocytes: 20.4;Exocrine glandular cells: 17.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 9.5;HDLM-2: 7.1;HUVEC TERT2: 10.2;LHCN-M2: 13.9;NTERA-2: 8.5;RH-30: 25.0;THP-1: 6.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA026558 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA026558: AB_1844774" "unprognostic (2.69e-2)" "unprognostic (1.42e-1)" "unprognostic (2.71e-2)" "unprognostic (4.61e-2)" "unprognostic (2.08e-1)" "unprognostic (6.53e-2)" "unprognostic (1.44e-3)" "unprognostic (1.42e-1)" "unprognostic (1.68e-2)" "unprognostic (1.82e-1)" "unprognostic (1.74e-3)" "unprognostic (1.23e-1)" "prognostic favorable (3.95e-7)" "unprognostic (1.76e-2)" "unprognostic (1.77e-1)" "unprognostic (2.96e-2)" "unprognostic (4.87e-2)" 3.7 1.8 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.5 1.4 0.0 0.1 1.7 0.8 0.2 0.3 18.4 0.0 0.6 1.6 1.3 1.0 0.0 0.1 0.0 2.1 8.8 6.9 0.6 0.4 0.0 0.4 0.2 47.6 0.0 0.2 0.8 0.0 0.0 1.2 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.1 0.1 0.1 0.2 0.0 9.5 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.3 0.0 0.1 0.7 0.0 0.0 0.0 7.1 1.1 1.1 0.2 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.1 10.2 0.0 0.0 0.0 13.9 0.5 0.0 0.1 8.5 0.2 0.0 0.0 25.0 0.1 0.0 2.6 0.0 0.1 0.0 1.3 0.0 1.3 0.0 6.1 0.2 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 6.0 2.4 0.5 0.0 0.8 3.1 52.4 20.4 0.0 1.2 8.7 15.7 0.2 0.0 3.1 0.1 4.5 0.0 0.0 17.3 0.6 1.5 0.5 1.1 1.5 7.9 0.0 8.7 2.5 0.3 0.0 0.0 1.9 3.3 8.2 0.3 0.9 13.6 0.2 0.0 1.7 3.0 0.0 8.3 0.2 3.1 0.1 0.6 0.0 0.3 0.8 ALX1 CART1 ENSG00000180318 "ALX homeobox 1" Q15699 12 85280107-85301784 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 13.9" "Cell type enriched" "Detected in some" 6 "Melanocytes: 30.4" "Cancer enriched" "Detected in some" 10 "melanoma: 16.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 6.9;HEK 293: 15.4;HUVEC TERT2: 11.3;SK-MEL-30: 18.7;THP-1: 12.2;WM-115: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001598, HPA018905" Uncertain Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Nuclear bodies" "Nucleoplasm, Golgi apparatus" "HPA001598: AB_1078400, HPA018905: AB_1844783" "unprognostic (4.92e-3)" "unprognostic (8.09e-2)" "unprognostic (1.09e-3)" "unprognostic (1.84e-1)" "unprognostic (6.24e-2)" "unprognostic (2.05e-2)" "unprognostic (9.27e-2)" "unprognostic (1.22e-1)" "unprognostic (3.57e-1)" "unprognostic (2.01e-1)" "unprognostic (1.55e-5)" "unprognostic (8.97e-2)" "unprognostic (1.43e-1)" 1.9 0.0 0.1 0.0 0.2 0.0 4.8 0.0 0.2 5.4 0.1 0.0 0.8 0.0 5.4 8.5 0.1 4.7 0.0 0.1 0.2 0.2 8.3 0.0 0.1 0.0 0.2 0.0 3.6 0.1 0.0 1.6 0.1 0.0 1.6 0.0 13.9 3.8 2.0 0.4 3.3 0.1 1.1 0.0 0.0 0.1 1.5 0.0 0.0 0.2 4.0 0.0 2.4 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.5 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 2.5 0.0 6.9 0.3 0.0 0.0 15.4 0.0 2.7 0.0 0.2 0.0 0.0 0.0 0.0 2.1 0.0 6.3 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 1.8 4.0 0.0 0.0 18.7 2.9 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.3 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 1.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 30.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 ALX4 "FPP, KIAA1788, PFM, PFM2" ENSG00000052850 "ALX homeobox 4" Q9H161 11 44260444-44310166 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 10.5;retina: 14.4" "Group enriched" "Detected in some" 15 "Cardiomyocytes: 17.1;Leydig cells: 4.4" "Cancer enhanced" "Detected in some" "testis cancer: 1.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 5.4;BJ: 4.5;HAP1: 6.3;HEK 293: 6.5;HEL: 8.8;K-562: 4.1;SiHa: 9.4" "Region enriched" "Detected in single" 8 "olfactory region: 11.1" "Region enriched" "Detected in single" 34 "olfactory region: 27.7" HPA001903 Supported Nucleoplasm NA NA Nucleoplasm "HPA001903: AB_2666495" "unprognostic (7.56e-5)" "unprognostic (1.69e-1)" "unprognostic (5.40e-2)" "unprognostic (2.74e-1)" "unprognostic (7.24e-3)" "unprognostic (2.63e-4)" "unprognostic (1.95e-1)" "unprognostic (2.89e-2)" "unprognostic (2.33e-4)" "unprognostic (5.13e-2)" "unprognostic (1.25e-1)" "unprognostic (1.55e-1)" "unprognostic (1.34e-6)" "unprognostic (3.62e-2)" "unprognostic (2.85e-1)" "unprognostic (2.02e-3)" "unprognostic (2.03e-1)" 1.6 0.1 0.6 0.0 1.6 0.0 10.5 0.7 1.6 2.0 0.1 1.4 0.0 0.0 2.4 2.4 0.5 0.8 0.3 0.9 1.3 0.7 0.3 0.0 0.5 0.0 0.4 2.2 0.2 0.1 0.2 0.3 0.0 0.3 2.0 0.0 14.4 5.6 0.1 3.1 2.8 0.0 1.1 0.2 0.1 0.1 2.5 0.5 0.0 0.4 4.2 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 5.4 0.0 0.0 0.0 4.5 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 6.3 0.0 0.0 1.3 6.5 8.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.6 0.7 1.6 1.3 0.7 0.4 2.2 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 AMBN ENSG00000178522 Ameloblastin Q9NP70 4 70592256-70607288 "Disease related genes, Predicted secreted proteins" Biomineralization "Amelogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 10.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "cervical cancer: 2.6;endometrial cancer: 2.9" "Region enriched" "Detected in some" 5 "basal ganglia: 10.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "HEK 293: 12.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036099 Approved Nucleoplasm,Vesicles "Secreted in other tissues" NA NA Vesicles Nucleoplasm "HPA036099: " "unprognostic (3.22e-1)" 0.2 0.0 0.0 0.0 10.6 0.0 0.0 0.0 2.4 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.4 0.1 0.0 1.2 0.2 1.2 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 10.6 0.0 2.0 0.0 0.4 0.1 0.0 0.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AMD1 SAMDC ENSG00000123505 "Adenosylmethionine decarboxylase 1" P17707 6 110874770-110895713 "Enzymes, Predicted intracellular proteins" "Polyamine biosynthesis, Spermidine biosynthesis" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 104.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029281, HPA029282" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA029281: AB_10600101, HPA029282: AB_10599965" "prognostic unfavorable (3.87e-4)" "unprognostic (4.68e-2)" "unprognostic (1.85e-3)" "unprognostic (1.01e-1)" "unprognostic (2.01e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (1.91e-6)" "unprognostic (1.18e-1)" "unprognostic (2.03e-2)" "unprognostic (6.50e-2)" "unprognostic (2.25e-1)" "unprognostic (4.20e-1)" "prognostic favorable (4.28e-4)" "unprognostic (8.62e-3)" "unprognostic (1.55e-1)" "unprognostic (4.41e-2)" "unprognostic (7.71e-2)" 16.7 15.2 29.7 16.9 35.6 38.1 17.8 27.3 34.2 18.6 18.6 45.7 12.5 14.9 18.9 14.2 28.9 14.7 17.5 18.5 32.5 21.5 25.2 16.9 16.9 18.5 39.0 22.0 16.9 20.2 21.8 26.2 33.8 32.7 104.7 19.4 12.8 17.5 19.2 15.3 14.5 13.5 18.4 38.3 16.7 18.4 15.8 46.0 19.4 25.5 20.1 24.6 12.6 16.8 6.6 12.9 42.0 14.0 6.1 9.2 6.5 20.8 14.3 17.5 33.1 26.5 16.9 22.9 30.1 33.4 23.5 27.7 22.7 13.2 36.9 14.6 19.0 25.0 14.4 41.3 27.2 32.4 21.6 23.9 38.2 13.0 23.8 15.8 32.9 22.9 11.3 25.2 16.2 32.8 8.2 20.4 19.0 28.5 32.2 39.5 12.6 43.7 25.3 21.5 20.8 13.1 24.1 17.6 21.9 26.6 28.0 22.5 16.0 18.3 23.3 26.5 14.9 15.0 28.2 13.4 15.6 11.8 83.0 32.4 8.8 14.3 37.7 18.0 26.4 20.0 15.0 9.8 14.7 7.6 11.6 8.9 6.3 7.6 8.7 12.9 6.6 9.2 9.0 42.0 6.1 14.0 5.8 8.8 6.5 29.7 35.6 27.3 34.2 32.5 21.5 39.0 22.0 32.7 46.0 35.7 72.7 96.8 225.1 280.1 92.0 87.2 86.6 30.8 108.1 52.4 56.9 32.2 124.3 65.9 25.2 75.1 78.4 70.0 59.9 125.5 124.4 304.0 93.3 52.5 68.2 73.1 119.2 47.9 101.7 37.7 40.6 70.6 124.9 74.9 52.0 241.3 72.3 49.3 47.0 70.8 99.1 19.4 119.5 83.5 72.8 251.9 45.7 59.8 63.1 119.5 AMDHD1 MGC35366 ENSG00000139344 "Amidohydrolase domain containing 1" Q96NU7 12 95943293-95968716 "Enzymes, Predicted intracellular proteins" "Histidine metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "liver: 99.0" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 125.2" "Cancer enriched" "Detected in many" 14 "liver cancer: 23.4" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 19.5;HMC-1: 21.5;Karpas-707: 26.6;SiHa: 17.8;SK-BR-3: 20.0;U-266/70: 21.5;U-266/84: 25.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA039720, HPA040149" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" No NA 410000 Cytosol "Nucleoplasm, Plasma membrane" "HPA039720: AB_10672967, HPA040149: " "unprognostic (4.81e-2)" "unprognostic (2.91e-1)" "unprognostic (1.53e-1)" "unprognostic (2.09e-2)" "unprognostic (1.80e-2)" "unprognostic (2.88e-2)" "unprognostic (2.33e-2)" "unprognostic (6.62e-3)" "unprognostic (1.06e-1)" "unprognostic (7.01e-2)" "unprognostic (3.35e-3)" "unprognostic (1.17e-1)" "unprognostic (4.63e-3)" "unprognostic (3.98e-2)" "unprognostic (1.70e-1)" "unprognostic (4.08e-3)" "unprognostic (2.61e-1)" 1.1 5.7 0.5 2.4 0.8 2.0 0.9 0.5 1.3 0.7 0.7 0.6 0.4 1.9 0.9 0.5 0.8 0.5 0.7 1.1 0.6 0.5 4.4 99.0 1.3 1.4 0.5 0.4 0.7 1.1 0.0 1.2 0.6 1.0 0.7 0.0 0.8 1.3 0.7 11.3 2.2 1.9 0.6 0.6 2.9 1.9 6.2 0.5 0.7 0.6 0.7 0.7 0.8 0.9 1.5 1.2 3.7 3.8 5.7 1.6 1.4 19.5 4.3 0.3 2.8 0.1 0.0 4.4 0.6 0.2 0.3 0.6 1.9 2.5 1.7 1.9 0.0 1.1 3.7 0.1 0.0 0.1 6.8 0.7 1.9 3.0 3.8 0.0 2.5 21.5 0.0 0.1 0.3 0.0 0.1 0.1 1.7 1.3 26.6 0.0 3.0 1.6 4.8 2.0 0.7 1.0 3.5 0.1 2.2 0.0 1.8 2.2 3.2 17.8 20.0 2.3 0.0 2.1 3.6 0.0 2.8 9.7 3.5 2.4 21.5 25.2 2.7 1.9 5.2 3.1 0.3 1.6 3.7 1.2 1.4 1.1 1.5 0.6 1.6 1.2 1.0 1.0 1.1 1.2 5.7 3.8 0.6 0.3 1.4 0.5 0.8 0.5 0.6 0.6 0.5 0.5 0.4 1.0 0.5 0.0 0.3 2.2 0.2 0.3 0.0 0.4 0.0 0.0 1.2 3.5 0.0 0.5 3.3 0.1 0.6 0.3 0.0 0.0 1.0 0.1 0.3 0.0 0.0 125.2 4.1 1.6 1.7 11.1 3.7 0.0 0.3 1.1 3.3 0.0 0.0 1.9 0.3 0.0 0.0 23.2 0.0 0.0 0.0 1.2 1.9 0.3 0.2 2.9 0.0 0.1 AMER3 "FAM123C, FLJ38377" ENSG00000178171 "APC membrane recruitment protein 3" Q8N944 2 130755435-130768134 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 30.1" "Cell type enhanced" "Detected in some" 23 "Bipolar cells: 6.2;Horizontal cells: 3.2;Intestinal endocrine cells: 14.6;Rod photoreceptor cells: 5.0" "Cancer enhanced" "Detected in single" "pancreatic cancer: 0.5" "Region enhanced" "Detected in many" "cerebellum: 30.1" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.5" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 15.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045593, HPA054230" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA045593: AB_10965021, HPA054230: AB_2682423" "unprognostic (6.68e-2)" "unprognostic (3.73e-1)" "unprognostic (2.17e-2)" "unprognostic (1.83e-1)" "unprognostic (2.71e-1)" "unprognostic (5.33e-3)" "unprognostic (1.51e-1)" "unprognostic (2.71e-1)" "unprognostic (1.02e-1)" "unprognostic (6.46e-3)" 0.5 2.4 4.8 0.7 6.0 0.8 0.5 30.1 13.9 0.5 0.8 0.0 0.0 2.0 0.6 0.5 0.5 0.5 0.5 0.5 2.7 4.3 0.5 0.5 0.5 0.6 1.8 5.6 0.6 3.3 0.4 3.4 0.5 3.0 0.6 0.8 0.7 0.5 0.5 0.5 0.7 1.2 0.5 0.8 0.6 2.5 1.6 0.7 0.0 0.6 0.0 0.5 0.5 0.1 0.3 0.3 1.5 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.1 0.0 0.2 0.1 0.0 0.3 0.1 0.2 1.5 0.2 0.1 0.3 0.1 0.0 4.8 6.0 30.1 10.3 2.7 4.3 1.8 5.6 3.0 0.7 0.0 0.0 0.0 0.0 0.0 6.2 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 14.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 AMHR2 "MISR2, MISRII" ENSG00000135409 "Anti-Mullerian hormone receptor type 2" Q16671 12 53423855-53431534 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease mutation, Pseudohermaphroditism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 27.1;ovary: 38.2;testis: 15.2" "Group enriched" "Detected in some" 4 "granulocytes: 25.4;Ito cells: 12.3" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "HEL: 28.3;K-562: 15.3" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 10 "hippocampal formation: 14.3" "HPA060228, HPA069636" Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA060228: AB_2684227, HPA069636: AB_2686163" "unprognostic (5.79e-2)" "unprognostic (3.65e-1)" "unprognostic (3.98e-1)" "unprognostic (1.71e-1)" "unprognostic (1.14e-1)" "unprognostic (4.61e-3)" "unprognostic (2.33e-1)" "unprognostic (1.44e-2)" "unprognostic (2.91e-1)" "unprognostic (4.98e-2)" "unprognostic (1.35e-1)" "unprognostic (2.32e-1)" "unprognostic (2.15e-2)" "unprognostic (3.34e-2)" "unprognostic (1.42e-1)" "unprognostic (2.04e-1)" "unprognostic (1.97e-1)" 0.3 27.1 0.2 0.2 0.4 0.0 0.2 0.2 0.2 0.2 0.3 0.3 0.2 0.0 0.3 0.6 0.4 0.2 0.4 0.8 0.2 0.0 0.2 1.1 0.3 0.2 0.2 0.2 38.2 8.8 0.1 0.2 0.2 0.3 0.4 0.0 0.2 0.2 0.2 2.5 0.0 0.4 0.5 0.2 3.7 0.3 15.2 0.2 0.2 0.2 0.5 0.3 0.3 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 28.3 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.8 2.4 0.0 0.0 0.0 1.8 0.0 0.0 0.1 25.4 0.0 0.1 0.0 0.0 12.3 2.2 1.3 4.6 0.0 0.0 0.0 0.0 0.0 4.6 0.0 3.9 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.2 0.0 0.0 0.0 AMIGO1 "AMIGO, KIAA1163" ENSG00000181754 "Adhesion molecule with Ig like domain 1" Q86WK6 1 109504175-109509738 "Predicted membrane proteins, Transporters" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.9" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 27.9;Rod photoreceptor cells: 8.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 15 "gdT-cell: 1.5;MAIT T-cell: 1.6;memory CD4 T-cell: 2.2;memory CD8 T-cell: 2.5;naive CD4 T-cell: 5.4;naive CD8 T-cell: 3.9;NK-cell: 1.9;T-reg: 1.5" "Group enriched" "Detected in many" 21 "NK-cells: 1.9;T-cells: 5.4" "Cell line enhanced" "Detected in many" "SCLC-21H: 9.6;SK-BR-3: 12.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046152 Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA046152: AB_2679559" "unprognostic (1.35e-1)" "unprognostic (3.94e-1)" "unprognostic (2.32e-2)" "unprognostic (4.78e-1)" "unprognostic (1.13e-1)" "unprognostic (1.12e-2)" "prognostic unfavorable (1.21e-4)" "unprognostic (2.44e-2)" "unprognostic (9.91e-2)" "unprognostic (1.55e-2)" "unprognostic (6.16e-3)" "unprognostic (3.11e-1)" "unprognostic (9.06e-3)" "unprognostic (1.82e-1)" "unprognostic (1.43e-1)" "unprognostic (2.10e-1)" "unprognostic (1.97e-1)" 5.3 14.8 11.8 3.7 19.1 1.0 4.7 23.4 33.9 4.8 6.6 4.8 4.0 3.2 5.7 16.4 4.1 4.9 4.3 11.0 12.2 14.3 7.6 3.5 6.4 5.2 9.9 15.0 12.8 9.2 21.1 8.1 3.0 15.6 9.2 3.7 10.3 9.6 11.1 22.4 3.3 4.1 6.5 6.0 4.6 5.0 4.1 5.3 1.7 9.1 1.9 4.6 4.5 3.8 0.1 0.0 0.0 0.1 1.9 5.4 0.9 2.6 1.2 2.7 9.5 3.6 1.5 3.4 4.4 2.2 5.1 2.4 0.5 0.1 0.2 1.2 2.8 1.2 1.4 7.3 0.3 4.3 1.0 0.6 0.0 1.7 0.8 2.9 2.1 5.4 0.7 3.2 1.7 0.0 0.5 1.2 1.5 2.1 0.0 0.1 4.4 0.4 4.4 1.7 2.2 3.0 0.7 0.0 0.4 5.9 1.3 9.6 3.2 1.0 12.6 3.5 1.2 3.6 3.1 1.1 0.2 5.9 3.4 1.8 0.2 0.0 0.0 1.9 0.0 2.7 0.0 0.0 0.0 1.5 0.1 1.6 0.1 2.2 2.5 0.0 0.0 5.4 3.9 0.0 1.9 0.0 0.0 1.5 0.9 11.8 19.1 23.4 33.9 12.2 14.3 9.9 15.0 15.6 5.3 3.0 1.3 0.0 0.4 0.6 27.9 6.7 2.5 0.0 0.0 3.5 3.9 1.0 0.0 1.0 0.0 0.8 1.0 0.0 0.8 0.1 0.6 1.1 0.0 0.8 0.2 4.8 4.6 0.6 0.0 0.0 2.0 0.0 0.0 1.0 0.7 7.1 0.7 0.9 5.3 0.5 8.8 0.0 1.0 0.7 0.9 0.4 0.2 0.0 1.5 0.3 AMMECR1 ENSG00000101935 "Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1" Q9Y4X0 X 110194186-110440233 "Disease related genes, Predicted intracellular proteins" "Alport syndrome, Deafness, Disease mutation, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 70.0;Rod photoreceptor cells: 93.5;Syncytiotrophoblasts: 72.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA000590, HPA051762" Uncertain Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA000590: AB_2666037, HPA051762: AB_2681596" "unprognostic (7.77e-2)" "unprognostic (1.93e-1)" "unprognostic (2.06e-1)" "unprognostic (5.17e-2)" "unprognostic (1.25e-1)" "unprognostic (6.87e-2)" "unprognostic (1.66e-3)" "unprognostic (6.55e-2)" "unprognostic (5.98e-2)" "prognostic favorable (6.62e-5)" "unprognostic (3.61e-2)" "unprognostic (3.96e-2)" "unprognostic (2.43e-3)" "unprognostic (3.33e-1)" "unprognostic (1.02e-1)" "prognostic favorable (8.44e-4)" "unprognostic (7.82e-2)" 7.2 6.6 2.4 10.1 4.5 17.0 5.3 2.9 6.5 6.3 6.2 3.9 5.0 4.6 5.3 6.0 15.9 6.3 6.5 3.0 3.1 2.9 7.5 8.5 5.9 5.8 2.6 3.2 12.4 7.4 5.0 9.5 22.7 6.6 4.3 6.1 9.7 6.5 7.0 3.2 14.2 7.8 4.5 2.4 9.7 5.8 4.0 2.3 12.5 6.0 11.1 11.3 6.8 8.9 4.3 2.9 1.5 4.8 1.2 6.7 1.9 11.3 5.6 4.1 2.0 4.7 7.0 4.5 7.9 7.1 6.5 9.6 8.9 8.3 6.7 3.8 10.4 5.2 5.4 13.1 8.9 6.7 4.7 5.9 9.3 12.9 1.8 11.9 7.4 3.9 3.9 15.9 7.4 13.3 3.5 5.1 3.3 25.9 20.2 4.9 9.5 3.5 2.6 18.9 9.7 11.0 7.7 4.4 11.9 11.0 9.6 6.6 3.2 13.3 13.1 11.1 5.2 3.2 7.4 2.3 4.5 2.8 13.3 7.1 4.2 4.7 10.8 6.9 15.5 15.0 1.3 1.9 1.5 3.4 1.3 4.6 3.3 6.7 5.4 2.9 4.3 4.6 3.9 1.3 1.2 4.8 1.3 4.6 1.9 2.4 4.5 2.9 6.5 3.1 2.9 2.6 3.2 6.6 2.3 0.0 9.8 8.2 3.8 8.5 29.6 3.8 5.1 5.3 3.4 3.5 49.1 19.3 19.9 8.0 0.4 4.2 7.9 70.0 10.4 9.3 11.3 5.9 2.3 6.0 6.1 1.6 14.5 25.2 7.8 0.8 11.8 4.0 3.3 7.2 10.2 5.8 9.8 0.0 16.3 8.2 93.5 12.9 4.7 1.8 6.9 23.3 72.3 10.0 9.9 11.5 AMMECR1L MGC4268 ENSG00000144233 "AMMECR1 like" Q6DCA0 2 127861630-127885922 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "retina: 45.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000590, HPA057234" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA000590: AB_2666037, HPA057234: AB_2683376" "unprognostic (1.34e-1)" "unprognostic (1.29e-3)" "unprognostic (8.95e-2)" "prognostic unfavorable (6.10e-4)" "unprognostic (1.92e-1)" "unprognostic (9.10e-2)" "unprognostic (2.66e-2)" "unprognostic (1.19e-2)" "unprognostic (2.70e-1)" "unprognostic (1.11e-1)" "unprognostic (4.98e-2)" "unprognostic (2.27e-2)" "unprognostic (4.06e-3)" "unprognostic (7.75e-2)" "unprognostic (4.54e-1)" "unprognostic (1.12e-2)" "unprognostic (8.91e-2)" 7.8 6.4 5.2 5.2 5.2 5.0 7.1 5.7 5.2 7.6 5.5 5.2 5.2 4.6 8.7 5.2 6.4 6.9 5.9 5.2 5.2 3.3 5.2 7.7 5.6 5.2 5.2 5.2 7.6 8.8 7.6 5.2 7.3 5.2 6.4 5.7 45.9 5.9 5.2 5.2 7.2 5.8 7.5 5.2 6.8 6.1 7.9 5.2 5.2 6.1 5.2 5.4 5.8 7.3 4.2 5.4 9.0 3.7 3.5 6.1 3.2 12.3 8.3 17.1 14.0 16.2 13.2 16.2 14.6 13.3 16.1 14.6 18.4 9.3 12.1 9.8 14.4 7.6 12.3 16.5 12.2 17.8 14.2 12.1 15.2 12.3 10.4 19.4 15.1 15.7 14.6 26.7 19.8 26.7 15.5 16.9 12.4 13.9 12.1 13.0 8.7 14.0 14.6 13.5 9.5 15.3 14.8 13.7 6.8 12.8 10.8 11.3 12.8 12.1 18.9 29.4 14.6 8.8 10.5 16.7 20.0 18.7 9.3 11.0 10.2 15.0 12.4 9.6 9.7 13.2 1.6 3.2 9.0 4.7 3.7 6.1 3.6 4.5 4.1 4.8 4.2 4.1 3.8 4.3 3.5 3.7 5.4 4.2 3.2 5.2 5.2 5.7 5.2 5.2 3.3 5.2 5.2 5.2 5.2 17.9 7.2 8.2 7.4 16.0 5.1 11.2 7.6 18.7 11.4 3.5 5.9 4.4 0.0 5.2 10.1 6.7 6.3 0.0 4.9 5.8 11.0 10.9 6.9 14.3 3.9 1.6 5.2 8.0 6.6 12.4 6.4 6.1 5.0 1.8 11.6 4.3 7.3 7.0 7.8 4.1 5.5 0.0 8.0 6.3 10.4 13.8 6.4 2.5 9.1 12.5 AMOT KIAA1071 ENSG00000126016 Angiomotin Q4VCS5 X 112774503-112840815 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 40.0;epididymis: 102.0" "Cell type enhanced" "Detected in many" 8 "Collecting duct cells: 27.9;Cytotrophoblasts: 35.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 15.6;HAP1: 16.7;OE19: 13.4;SuSa: 24.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067290, HPA067853" Enhanced Supported "Nucleoplasm,Cell Junctions" NA NA "Cell Junctions" Nucleoplasm "HPA067290: AB_2685819, HPA067853: AB_2732773" "unprognostic (1.08e-2)" "unprognostic (5.51e-2)" "unprognostic (2.38e-2)" "unprognostic (3.36e-1)" "unprognostic (3.20e-1)" "unprognostic (8.95e-2)" "unprognostic (3.82e-2)" "prognostic favorable (3.94e-4)" "unprognostic (4.46e-2)" "unprognostic (3.79e-1)" "unprognostic (2.17e-1)" "unprognostic (5.60e-2)" "prognostic favorable (4.21e-9)" "unprognostic (9.54e-2)" "unprognostic (2.59e-2)" "unprognostic (4.50e-2)" "unprognostic (6.44e-2)" 3.7 2.3 18.4 2.0 17.9 1.3 5.5 3.0 14.0 8.1 3.5 13.9 40.0 3.1 4.7 102.0 3.8 9.7 3.1 3.7 15.4 10.9 8.2 2.5 3.0 1.6 14.4 10.3 5.4 2.7 8.4 7.0 14.9 18.0 5.6 4.3 1.2 6.9 27.6 25.2 2.7 3.6 3.5 15.7 2.1 3.3 2.7 13.5 0.1 3.8 9.3 1.8 3.2 4.3 0.5 0.2 0.0 0.6 1.9 1.5 0.2 2.7 0.0 15.6 0.6 0.3 0.3 5.7 0.5 0.0 0.0 0.0 6.5 0.5 0.3 3.2 2.4 0.0 5.6 16.7 0.0 0.0 0.0 4.0 0.0 0.0 0.1 0.1 0.0 0.7 0.1 0.0 3.5 0.4 3.2 0.1 0.3 0.0 0.0 0.3 0.2 4.2 0.2 6.9 13.4 0.1 5.4 4.8 0.1 7.2 7.1 0.0 5.3 0.0 0.0 6.0 24.5 0.5 0.1 0.1 1.9 4.6 0.0 6.2 0.4 0.0 0.0 0.7 0.0 4.0 0.0 0.0 0.0 1.1 0.4 1.5 0.5 0.7 1.0 0.2 0.2 0.7 0.6 0.0 1.9 0.6 0.2 1.0 0.2 18.4 17.9 3.0 14.0 15.4 10.9 14.4 10.3 18.0 13.5 3.0 1.3 0.0 2.1 1.5 1.0 1.2 0.0 8.1 6.8 27.9 0.0 35.2 1.7 3.4 0.1 3.0 4.6 0.0 1.8 2.6 3.8 8.2 0.0 3.6 5.2 0.0 15.2 3.7 1.5 0.0 6.4 0.6 3.3 2.8 9.2 4.5 2.2 3.5 6.0 14.4 0.4 6.5 3.1 0.5 2.1 1.0 13.3 0.0 6.3 2.2 AMT "GCST, NKH" ENSG00000145020 Aminomethyltransferase P48728 3 49416775-49422753 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Aminotransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 10.4;Hep G2: 29.9;NTERA-2: 5.4;SH-SY5Y: 7.9;SuSa: 7.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005566 Supported Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA005566: AB_1844811" "unprognostic (2.10e-2)" "unprognostic (1.65e-2)" "unprognostic (1.82e-1)" "unprognostic (9.14e-3)" "unprognostic (4.04e-1)" "unprognostic (1.11e-2)" "unprognostic (2.81e-1)" "unprognostic (2.17e-3)" "unprognostic (1.94e-1)" "unprognostic (3.29e-1)" "unprognostic (7.17e-3)" "unprognostic (1.88e-1)" "prognostic favorable (3.90e-8)" "unprognostic (4.40e-1)" "unprognostic (1.91e-1)" "unprognostic (3.60e-1)" "unprognostic (1.98e-3)" 4.7 10.9 6.6 8.0 8.8 6.0 6.6 16.7 10.4 8.4 10.0 7.4 21.3 10.9 9.2 11.1 3.4 9.7 13.0 16.6 7.4 2.0 21.4 41.2 5.6 2.3 7.6 8.3 14.5 18.5 16.3 10.4 2.5 10.7 9.1 10.1 12.2 9.8 20.0 3.8 5.4 11.0 7.1 5.8 7.9 8.1 2.6 7.4 1.7 8.7 0.4 1.8 6.2 8.1 0.7 5.4 4.7 3.2 8.9 1.6 2.3 0.1 0.5 0.7 0.1 0.4 0.0 10.4 0.0 0.2 0.1 0.2 0.3 0.2 0.0 0.1 0.2 0.0 0.2 0.1 0.4 0.1 0.2 0.2 0.0 0.3 29.9 1.1 0.0 0.1 0.3 0.7 0.0 0.4 1.1 0.1 0.2 0.0 0.0 0.1 0.3 0.2 0.2 5.4 0.0 0.1 0.0 0.1 0.2 0.7 0.2 0.0 7.9 0.1 0.0 0.6 7.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.1 0.0 0.0 3.2 4.7 0.0 1.9 0.1 0.6 0.0 0.0 5.4 0.7 1.6 1.5 0.3 8.9 0.7 0.5 0.0 2.3 6.6 8.8 16.7 10.4 7.4 2.0 7.6 8.3 10.7 7.4 3.0 11.6 3.7 11.4 2.5 17.2 18.3 17.8 6.7 7.9 0.0 19.6 22.7 0.0 0.7 1.7 2.7 19.7 0.0 0.6 6.5 4.7 10.1 7.0 37.3 4.4 7.9 12.2 3.1 2.7 1.6 9.8 3.5 5.0 0.0 16.2 21.5 0.5 14.0 6.0 0.7 17.7 6.5 4.3 1.4 0.4 2.4 8.6 5.7 31.1 8.6 AMZ2 ENSG00000196704 "Archaelysin family metallopeptidase 2" Q86W34 17 68247574-68257164 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 585.3;Late spermatids: 1307.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023299, HPA052406" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA023299: AB_2226909, HPA052406: AB_2681818" "unprognostic (3.04e-1)" "unprognostic (3.68e-2)" "unprognostic (3.93e-2)" "unprognostic (3.27e-3)" "unprognostic (3.32e-1)" "unprognostic (1.79e-2)" "prognostic unfavorable (1.32e-5)" "unprognostic (2.43e-1)" "unprognostic (3.92e-2)" "unprognostic (2.83e-3)" "unprognostic (3.59e-3)" "unprognostic (3.37e-1)" "prognostic unfavorable (3.14e-4)" "unprognostic (2.37e-1)" "unprognostic (2.95e-1)" "unprognostic (3.28e-1)" "unprognostic (7.62e-2)" 22.3 21.3 29.3 13.7 43.3 14.2 20.8 29.2 35.8 19.8 19.8 20.3 19.6 11.9 19.0 25.3 22.3 24.6 17.7 33.6 26.8 23.7 26.8 16.6 14.1 22.4 26.0 27.0 23.4 20.4 29.4 25.4 18.9 28.3 21.1 15.0 19.0 17.9 25.1 39.9 15.5 13.5 19.3 27.8 16.6 15.7 77.2 20.5 15.5 28.4 20.6 22.4 20.2 14.9 20.9 17.2 31.4 21.1 34.8 31.2 19.7 23.4 26.1 22.1 18.7 17.0 29.6 34.8 17.0 23.0 29.6 24.9 10.7 15.1 35.1 19.2 26.3 27.9 11.6 18.0 50.1 38.9 12.4 17.0 12.9 11.6 20.8 32.2 11.7 22.3 25.2 56.3 27.5 51.3 29.3 29.9 30.2 13.2 22.5 37.4 17.4 26.4 10.9 10.4 12.5 24.4 10.1 60.2 26.3 17.8 12.4 22.3 17.5 15.8 32.6 31.7 47.6 25.7 8.1 15.5 39.9 19.0 14.3 18.4 31.6 29.0 60.6 28.1 16.7 20.1 31.4 14.4 19.6 22.1 16.6 28.6 17.4 27.3 29.0 17.2 20.9 24.4 26.3 25.2 34.8 21.1 15.7 31.2 19.7 29.3 43.3 29.2 35.8 26.8 23.7 26.0 27.0 28.3 20.5 11.9 14.1 28.3 32.0 16.6 13.3 73.2 22.9 57.6 21.6 22.7 7.9 54.0 92.9 25.1 585.3 25.4 8.9 0.0 22.9 56.9 31.5 18.0 32.4 13.7 37.1 17.5 20.3 22.7 19.9 1307.8 33.4 36.7 54.0 56.9 16.8 56.2 24.4 12.9 30.8 48.5 11.6 19.4 27.2 187.0 54.0 19.7 28.6 51.1 15.8 15.9 ANAPC10 "APC10, DKFZP564L0562, DOC1" ENSG00000164162 "Anaphase promoting complex subunit 10" Q9UM13 4 144831908-145098541 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 111.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044547 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA044547: AB_2678979" "unprognostic (2.96e-2)" "unprognostic (1.59e-1)" "unprognostic (1.19e-1)" "unprognostic (3.04e-1)" "unprognostic (5.88e-2)" "unprognostic (2.66e-3)" "unprognostic (1.02e-2)" "unprognostic (6.69e-2)" "prognostic unfavorable (8.22e-4)" "unprognostic (2.80e-2)" "unprognostic (1.46e-1)" "unprognostic (4.00e-2)" "unprognostic (1.27e-1)" "unprognostic (2.99e-1)" "unprognostic (7.81e-2)" "unprognostic (1.70e-1)" "unprognostic (5.55e-2)" 19.0 15.6 16.4 11.9 22.1 14.0 23.4 29.8 24.6 19.3 14.4 16.6 10.6 7.1 19.3 21.3 13.8 17.5 12.5 21.4 17.2 17.6 21.2 21.0 15.8 15.0 18.1 16.2 19.9 14.2 15.1 28.6 19.6 25.9 15.4 16.7 15.9 14.5 15.5 23.8 13.7 11.7 19.4 20.2 14.8 13.1 27.3 20.5 20.4 19.2 13.3 16.7 15.4 15.5 13.5 13.9 18.2 8.4 14.1 15.1 6.7 9.1 5.2 14.0 5.2 13.3 14.3 9.1 11.1 11.8 15.0 10.8 11.6 12.7 14.4 7.3 8.4 10.6 5.7 11.7 15.8 15.3 12.2 9.2 7.7 4.0 9.5 16.9 15.8 9.0 11.8 10.9 12.0 19.1 11.9 12.0 15.9 21.2 18.9 15.0 6.8 27.1 19.0 9.2 11.0 11.7 12.8 11.7 8.3 16.2 6.0 9.5 7.8 8.0 6.5 14.3 13.3 6.1 13.2 9.6 9.4 6.2 9.1 14.9 15.7 17.2 21.8 13.1 20.1 12.6 18.2 6.8 8.6 11.9 8.4 12.0 13.5 12.8 12.2 9.4 10.9 13.0 12.9 2.0 14.1 8.2 13.9 15.1 6.7 16.4 22.1 29.8 24.6 17.2 17.6 18.1 16.2 25.9 20.5 11.9 13.4 18.6 19.9 14.4 8.3 14.1 5.1 22.7 19.4 14.0 0.0 32.6 39.7 20.4 45.0 20.2 7.7 0.0 22.8 30.5 14.3 19.9 25.4 15.3 31.0 4.8 2.9 19.0 11.1 14.9 31.4 20.5 10.1 33.3 12.0 15.4 22.4 12.4 25.5 37.2 8.8 32.3 20.6 111.9 38.5 17.3 24.7 20.8 12.1 22.2 ANAPC11 "APC11, Apc11p, HSPC214, MGC882" ENSG00000141552 "Anaphase promoting complex subunit 11" Q9NYG5 17 81890790-81900991 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Late spermatids: 944.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA021989, HPA027838" Approved Enhanced Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA021989: AB_1844915, HPA027838: AB_10600978" "unprognostic (9.00e-3)" "unprognostic (1.24e-2)" "unprognostic (3.76e-1)" "unprognostic (4.93e-2)" "unprognostic (8.76e-2)" "unprognostic (1.67e-1)" "unprognostic (5.13e-2)" "unprognostic (8.20e-2)" "unprognostic (1.65e-1)" "unprognostic (2.17e-3)" "unprognostic (2.22e-2)" "unprognostic (1.08e-1)" "unprognostic (4.76e-2)" "unprognostic (8.07e-2)" "unprognostic (9.08e-2)" "unprognostic (2.51e-2)" "unprognostic (3.16e-1)" 29.3 26.1 44.9 21.9 34.1 39.6 27.2 19.5 31.8 19.4 26.3 14.8 30.3 26.1 19.2 27.5 31.7 24.6 26.0 63.6 32.9 26.7 25.9 38.4 18.5 26.7 35.2 31.8 17.2 40.3 12.6 20.6 25.7 29.8 25.4 12.2 18.1 48.8 24.0 94.2 21.6 24.8 25.4 27.6 18.9 25.9 42.2 27.3 18.5 32.5 45.7 17.0 23.5 25.5 54.9 107.5 74.0 80.1 43.1 52.8 80.4 41.4 97.5 23.2 34.3 18.5 21.1 26.6 20.1 15.8 18.3 20.9 40.0 36.6 13.1 22.5 17.7 20.2 24.2 9.3 25.7 6.6 19.2 70.6 19.6 43.3 60.3 20.8 14.6 17.4 23.4 23.5 18.7 15.3 11.9 29.3 17.9 26.7 38.2 18.9 74.7 35.5 24.2 21.9 40.3 72.8 14.8 22.1 26.3 16.7 37.3 29.2 47.4 21.7 34.3 39.4 16.7 41.9 35.6 17.4 35.6 28.5 38.1 37.7 18.7 7.8 16.5 37.4 22.3 28.4 70.1 80.1 74.0 45.3 63.7 42.8 54.9 46.4 49.5 64.6 51.6 45.2 43.5 40.5 43.1 59.3 107.5 52.8 80.4 44.9 34.1 19.5 31.8 32.9 26.7 35.2 31.8 29.8 27.3 119.1 121.6 108.7 168.5 132.0 55.6 277.3 203.8 155.2 153.6 188.5 19.6 436.4 442.7 236.1 329.1 152.3 247.2 186.9 293.4 435.1 217.2 291.4 105.2 427.2 386.6 31.8 182.7 139.3 155.4 944.1 168.2 179.2 248.0 315.6 205.6 112.3 274.1 235.0 154.9 400.2 53.7 103.5 220.7 379.1 245.5 163.2 425.4 121.6 237.2 254.5 ANAPC15 "APC15, C11orf51, DKFZP564M082, HSPC020" ENSG00000110200 "Anaphase promoting complex subunit 15" P60006 11 72106378-72112780 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036596 Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA036596: AB_10671961" "unprognostic (1.17e-1)" "unprognostic (5.83e-2)" "unprognostic (4.23e-2)" "unprognostic (3.05e-2)" "unprognostic (1.86e-2)" "unprognostic (2.09e-2)" "prognostic unfavorable (4.37e-4)" "unprognostic (9.18e-2)" "unprognostic (3.35e-2)" "prognostic favorable (2.55e-4)" "unprognostic (9.34e-3)" "unprognostic (1.76e-1)" "unprognostic (1.26e-3)" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "unprognostic (2.77e-1)" "unprognostic (9.08e-2)" 10.7 14.9 29.5 13.8 30.1 40.3 14.0 9.1 32.5 9.9 20.0 13.7 13.2 14.9 15.3 19.9 17.2 13.4 13.3 22.2 23.6 19.8 16.0 16.9 12.2 19.5 25.2 20.6 8.0 16.6 9.4 11.7 12.7 19.3 17.4 20.5 11.6 18.2 20.6 41.5 14.1 14.8 21.8 17.7 14.4 15.1 22.1 12.6 22.5 21.6 23.1 20.9 12.8 9.4 27.0 45.6 39.9 52.7 20.5 44.0 35.5 19.6 29.7 24.4 15.4 7.2 11.8 11.5 21.0 19.3 33.9 22.6 34.7 21.5 26.6 20.5 29.9 16.5 33.5 36.7 39.3 32.1 17.0 17.4 30.2 34.0 22.4 8.6 29.3 28.3 12.3 15.6 19.2 25.8 12.8 22.2 37.5 21.8 18.5 22.0 33.8 56.3 27.3 19.7 41.7 17.2 23.9 60.6 18.0 29.1 13.7 17.3 15.1 21.5 21.2 33.3 13.7 24.8 15.7 20.0 15.6 20.6 30.8 22.1 19.0 18.4 33.9 9.6 23.6 8.7 7.5 52.7 39.9 24.0 33.4 25.4 27.0 30.9 27.9 45.6 19.9 37.1 33.9 21.7 20.5 30.4 36.6 44.0 35.5 29.5 30.1 9.1 32.5 23.6 19.8 25.2 20.6 19.3 12.6 14.9 13.9 33.5 62.0 37.2 30.5 2.8 12.7 40.2 35.2 22.7 25.5 72.2 104.5 44.3 13.8 19.6 61.2 0.0 89.5 62.0 19.8 46.4 30.0 37.8 71.7 12.7 47.5 19.0 44.0 9.1 6.4 47.5 25.3 51.3 52.0 22.6 43.9 54.5 21.5 83.0 32.0 19.4 29.7 92.2 129.0 35.9 39.0 41.5 65.5 51.5 ANAPC2 "APC2, KIAA1406" ENSG00000176248 "Anaphase promoting complex subunit 2" Q9UJX6 9 137174784-137188549 "Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018692, HPA066539" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB018692: AB_2258285, HPA066539: AB_2685688" "unprognostic (5.20e-2)" "unprognostic (8.86e-3)" "unprognostic (1.43e-2)" "prognostic favorable (8.91e-5)" "unprognostic (2.29e-1)" "unprognostic (2.38e-2)" "unprognostic (4.46e-1)" "unprognostic (4.84e-2)" "unprognostic (1.07e-1)" "unprognostic (3.36e-1)" "prognostic favorable (1.07e-7)" "unprognostic (7.41e-2)" "prognostic favorable (3.67e-4)" "prognostic favorable (2.87e-4)" "unprognostic (1.35e-1)" "unprognostic (8.46e-2)" "unprognostic (9.88e-2)" 14.6 15.5 13.3 15.3 17.9 19.0 14.1 21.8 26.9 12.2 11.8 28.5 17.7 17.1 15.1 12.3 13.6 13.8 16.4 14.1 12.5 10.2 12.3 19.1 13.1 19.1 22.4 14.5 15.4 23.7 10.6 12.6 11.0 16.2 15.2 5.0 15.5 25.7 14.5 20.0 25.0 16.2 9.4 13.3 19.3 16.2 31.6 13.4 14.0 14.4 11.7 15.2 13.2 11.7 1.4 2.3 0.6 3.2 1.1 2.4 3.3 10.2 22.8 5.5 9.1 6.7 4.0 17.4 9.2 5.9 8.8 6.8 13.7 10.7 11.1 10.9 6.1 8.2 21.2 6.6 7.1 1.3 14.1 11.3 6.6 26.6 12.4 7.9 10.1 11.6 8.0 5.7 5.9 3.2 4.4 10.7 10.3 9.7 13.7 4.1 28.9 12.1 14.3 11.2 13.7 17.4 14.5 13.6 20.6 6.8 9.1 7.3 11.0 14.0 19.1 5.8 2.8 20.3 13.9 11.2 13.1 10.4 15.5 8.3 6.7 9.8 12.0 10.5 7.0 9.4 0.3 2.3 0.4 2.4 2.4 1.4 1.4 1.2 1.9 1.9 1.4 1.4 1.5 0.6 1.1 3.2 2.3 1.2 3.3 13.3 17.9 21.8 26.9 12.5 10.2 22.4 14.5 16.2 13.4 0.0 0.3 6.5 7.4 8.2 4.7 3.1 7.6 0.0 1.2 10.4 3.9 22.6 11.6 9.4 31.6 5.7 18.6 0.0 9.4 9.5 8.5 6.4 11.5 10.4 13.6 1.6 9.8 12.3 9.5 40.9 10.3 6.6 13.5 16.2 14.6 3.5 6.9 7.0 8.9 13.4 4.3 0.0 9.9 30.0 24.3 8.3 20.5 10.2 11.3 6.3 ANAPC5 APC5 ENSG00000089053 "Anaphase promoting complex subunit 5" Q9UJX4 12 121308245-121399896 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039457, HPA039801" Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA039457: AB_10795676, HPA039801: AB_2676687" "unprognostic (3.41e-1)" "unprognostic (1.16e-3)" "unprognostic (5.37e-2)" "unprognostic (7.24e-3)" "unprognostic (5.35e-3)" "unprognostic (1.18e-2)" "prognostic unfavorable (2.31e-5)" "unprognostic (1.63e-1)" "unprognostic (6.91e-2)" "unprognostic (7.85e-2)" "unprognostic (1.93e-3)" "unprognostic (4.94e-2)" "prognostic unfavorable (2.01e-9)" "unprognostic (1.79e-1)" "unprognostic (1.79e-1)" "unprognostic (6.87e-2)" "unprognostic (3.28e-1)" 28.9 26.9 23.2 24.1 37.3 29.3 31.3 34.1 38.1 28.2 26.3 57.0 21.8 22.3 33.7 28.4 26.0 34.2 20.8 24.8 25.4 21.6 23.6 33.5 22.2 31.6 53.8 25.1 30.0 40.1 27.4 34.1 22.3 34.3 22.9 29.6 24.9 47.3 24.7 48.6 29.2 23.9 26.1 36.5 30.0 27.6 18.2 45.5 36.5 27.5 32.1 37.7 26.3 25.9 30.7 36.4 27.0 32.1 34.9 38.7 42.0 27.7 39.3 17.7 12.6 31.2 34.6 31.2 27.0 30.9 31.5 28.3 31.3 14.4 37.9 27.9 39.3 12.9 23.9 41.0 26.6 25.2 32.6 45.6 34.5 25.6 35.8 34.2 49.9 34.5 34.6 25.4 32.2 25.8 29.2 39.7 33.7 43.5 23.0 25.3 39.9 43.1 49.0 28.0 27.5 43.3 38.4 25.9 48.9 22.9 28.9 22.5 22.6 40.2 16.8 27.4 21.5 40.2 47.8 24.9 21.3 15.3 14.5 22.1 29.7 30.0 44.5 28.0 37.7 26.2 18.6 30.7 27.0 26.6 32.1 32.4 30.7 30.3 32.5 36.4 23.9 30.6 29.0 7.5 34.9 27.3 24.2 38.7 42.0 23.2 37.3 34.1 38.1 25.4 21.6 53.8 25.1 34.3 45.5 38.7 59.2 66.3 57.9 58.3 59.3 43.2 20.4 104.4 66.0 52.4 53.0 76.6 59.7 42.2 18.2 53.7 39.2 70.0 77.0 87.6 63.3 47.3 65.9 57.2 49.3 73.1 81.8 41.7 46.3 27.6 74.2 48.5 45.5 86.6 46.8 37.6 53.3 38.6 59.8 55.9 55.9 51.8 61.8 48.6 79.0 56.7 68.5 76.2 66.1 44.7 ANAPC7 APC7 ENSG00000196510 "Anaphase promoting complex subunit 7" Q9UJX3 12 110372900-110403730 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 79.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009567 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB009567: AB_2227137" "unprognostic (2.49e-1)" "unprognostic (1.42e-3)" "unprognostic (1.69e-2)" "unprognostic (2.36e-2)" "unprognostic (2.02e-2)" "unprognostic (4.35e-2)" "prognostic unfavorable (1.54e-6)" "unprognostic (3.20e-1)" "unprognostic (7.08e-2)" "unprognostic (1.48e-1)" "unprognostic (1.04e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (4.36e-10)" "unprognostic (1.45e-1)" "unprognostic (9.92e-2)" "unprognostic (3.08e-2)" "unprognostic (1.58e-2)" 15.6 20.3 17.8 14.7 25.1 12.2 19.9 24.8 25.1 20.6 16.2 16.8 12.2 11.9 21.4 19.8 34.2 20.9 15.6 18.8 19.1 18.5 21.4 16.8 16.6 20.8 16.2 22.1 18.1 16.7 26.6 14.9 9.6 17.6 21.8 18.9 16.4 19.7 21.3 29.7 16.0 13.3 24.0 17.1 16.8 14.9 36.3 16.3 25.8 23.2 24.5 22.2 19.2 22.5 14.9 17.7 17.6 15.1 20.1 22.4 12.5 18.7 25.9 18.9 16.1 19.9 10.1 10.8 13.2 12.0 24.4 17.0 26.4 12.1 30.0 13.4 17.7 14.1 19.1 28.2 18.1 24.9 16.0 22.7 26.5 19.2 21.8 14.5 23.7 12.6 11.0 13.0 21.1 14.1 17.4 23.6 21.6 41.6 6.2 19.1 20.1 35.8 17.7 16.5 18.4 22.6 27.7 18.8 35.7 16.5 24.1 24.7 14.2 20.6 16.3 21.6 17.5 34.4 21.5 14.8 14.6 13.7 12.9 15.5 10.9 22.1 40.5 16.3 20.3 16.8 14.3 10.5 17.6 17.2 15.1 20.2 13.3 18.5 16.5 17.7 14.9 15.5 16.5 8.3 20.1 13.1 9.7 22.4 12.5 17.8 25.1 24.8 25.1 19.1 18.5 16.2 22.1 17.6 16.3 14.9 13.6 11.2 18.2 9.0 18.1 15.9 12.7 14.7 25.0 12.2 19.6 10.3 10.0 15.4 5.7 13.5 7.4 0.0 13.1 8.1 9.4 15.1 15.1 13.5 19.4 20.6 10.4 11.6 15.9 8.5 17.0 10.3 16.9 9.0 10.2 16.7 13.1 7.0 20.5 11.9 22.2 12.9 11.2 79.8 34.1 11.7 6.1 15.2 14.5 15.5 ANGEL1 "Ccr4e, KIAA0759" ENSG00000013523 "Angel homolog 1" Q9UNK9 14 76786178-76826246 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 45.0;Late spermatids: 52.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000948 Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA000948: AB_2227189" "unprognostic (4.81e-2)" "unprognostic (2.37e-2)" "unprognostic (2.67e-1)" "unprognostic (2.46e-3)" "unprognostic (1.42e-1)" "unprognostic (3.15e-1)" "unprognostic (7.33e-2)" "prognostic favorable (3.43e-4)" "unprognostic (9.24e-2)" "unprognostic (1.01e-1)" "prognostic favorable (5.46e-4)" "unprognostic (3.03e-1)" "unprognostic (6.92e-3)" "unprognostic (1.42e-1)" "unprognostic (2.22e-1)" "unprognostic (1.53e-1)" "unprognostic (6.32e-2)" 7.2 13.0 14.7 8.1 16.4 4.3 9.0 10.0 16.6 7.2 7.1 17.9 3.3 6.6 11.0 18.8 5.1 9.1 8.0 11.6 15.1 10.8 7.0 11.3 10.5 8.6 22.5 11.7 15.2 35.8 13.1 18.9 7.7 14.5 6.7 8.2 11.7 10.7 6.7 8.1 4.7 6.3 9.2 16.5 18.6 11.5 27.5 14.9 6.1 9.3 4.6 7.8 7.2 5.3 9.0 9.3 1.9 8.3 6.6 10.2 6.7 9.5 10.4 11.6 10.4 9.5 8.7 10.8 5.7 8.3 6.0 7.7 9.9 13.6 17.5 8.5 5.0 8.2 12.1 11.0 10.3 10.1 7.3 9.9 10.5 6.5 7.6 6.2 5.6 6.7 9.2 12.9 5.6 11.1 8.6 15.1 18.7 10.4 4.6 6.2 18.6 10.1 8.5 13.3 15.3 13.9 12.3 7.9 10.3 9.1 13.6 16.5 7.3 8.7 12.0 5.4 11.0 23.5 5.9 7.2 7.0 6.2 5.2 4.7 12.0 9.0 10.8 6.0 9.9 8.7 0.7 5.9 1.9 7.9 6.7 9.6 9.0 7.1 7.4 9.3 7.7 10.2 7.5 1.8 6.6 8.3 6.2 5.7 6.7 14.7 16.4 10.0 15.0 15.1 10.8 22.5 11.7 14.5 14.9 6.0 10.9 4.5 1.4 1.0 2.2 6.1 10.2 0.0 2.3 3.5 9.8 1.3 0.0 2.9 45.0 5.8 1.3 0.0 2.8 2.3 1.9 2.3 1.1 8.1 6.4 0.0 4.1 6.2 4.7 52.1 2.0 4.3 1.7 0.0 4.1 4.3 2.5 0.0 4.6 1.0 8.0 6.5 1.4 17.4 3.2 0.4 1.0 2.5 3.7 1.0 ANGEL2 "Ccr4d, FLJ12793, KIAA0759L" ENSG00000174606 "Angel homolog 2" Q5VTE6 1 212992182-213015826 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030795, HPA030796" Uncertain Approved "Nucleoplasm,Nuclear bodies,Mitochondria" NA NA Nucleoplasm "Nuclear bodies, Mitochondria" "HPA030795: , HPA030796: AB_10600979" "unprognostic (1.26e-1)" "unprognostic (2.02e-1)" "unprognostic (8.73e-2)" "unprognostic (2.76e-1)" "unprognostic (2.04e-2)" "unprognostic (1.93e-2)" "unprognostic (1.50e-1)" "unprognostic (4.98e-2)" "unprognostic (1.33e-2)" "unprognostic (2.92e-1)" "unprognostic (2.70e-3)" "unprognostic (6.46e-2)" "prognostic unfavorable (8.39e-6)" "unprognostic (9.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.44e-1)" "prognostic favorable (1.20e-4)" 11.4 11.7 18.0 10.8 32.6 9.5 17.8 21.6 22.7 14.5 9.3 16.9 8.6 8.6 14.8 14.2 10.2 12.2 10.4 9.2 17.4 13.8 13.3 13.0 11.0 15.8 17.0 13.9 19.1 10.5 15.5 14.8 10.8 13.8 14.5 11.0 12.3 9.8 11.2 11.0 15.1 10.7 12.2 14.9 15.5 10.5 9.0 15.9 19.5 14.0 7.9 14.9 10.8 9.7 7.8 7.2 7.6 5.9 14.1 11.3 6.7 8.7 7.0 11.4 9.7 8.7 12.9 10.2 7.2 12.0 11.5 11.5 4.7 6.5 8.5 6.6 7.1 6.4 6.9 13.1 6.9 11.7 15.9 7.9 8.5 5.6 4.6 9.6 8.4 10.2 7.9 8.9 9.0 9.3 9.8 9.7 7.7 9.8 8.8 13.2 2.9 9.6 5.7 26.9 4.8 5.1 4.9 20.5 8.9 9.0 5.9 5.6 16.3 8.6 11.7 13.3 12.7 9.0 6.2 7.2 9.5 5.1 11.7 10.9 6.5 6.2 5.7 10.7 6.3 8.7 7.4 5.9 7.6 7.4 5.5 9.1 7.8 9.2 7.6 7.2 5.3 9.8 8.1 4.0 14.1 4.4 4.4 11.3 6.7 18.0 32.6 21.6 22.7 17.4 13.8 17.0 13.9 13.8 15.9 44.7 9.8 14.6 7.5 6.2 21.3 12.6 17.8 28.1 15.9 12.2 9.8 12.8 10.0 8.7 1.2 11.3 6.7 0.0 9.2 12.6 10.6 8.8 16.2 11.5 10.5 27.0 6.4 11.6 19.2 1.5 14.4 11.3 3.3 10.8 9.2 13.4 8.4 7.0 13.1 13.5 17.6 19.4 9.0 7.4 16.2 6.0 9.2 18.1 8.8 6.2 ANGPTL4 "ARP4, FIAF, HFARP, NL2, PGAR, pp1158" ENSG00000167772 "Angiopoietin like 4" Q9BY76 19 8363289-8374373 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 55.5;liver: 68.4;pancreas: 51.7" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 145.0;Pancreatic endocrine cells: 173.2;Peritubular cells: 123.8" "Cancer enhanced" "Detected in all" "renal cancer: 212.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 5.8;neutrophil: 2.3" "Lineage enriched" "Detected in single" 7 "granulocytes: 5.8" "Cell line enhanced" "Detected in many" "ASC diff: 16.4;HBEC3-KT: 65.4;LHCN-M2: 17.7;TIME: 33.0;U-138 MG: 19.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA007879, CAB033770" Approved Approved Nucleoplasm,Vesicles "Secreted to blood" NA NA 7750000 1500000 "Nucleoplasm, Vesicles" "CAB033770: AB_2057427, HPA007879: AB_1078158" "unprognostic (1.26e-1)" "unprognostic (5.29e-3)" "prognostic unfavorable (7.53e-4)" "unprognostic (1.88e-2)" "unprognostic (7.68e-3)" "unprognostic (3.58e-1)" "unprognostic (1.03e-2)" "prognostic unfavorable (9.50e-4)" "unprognostic (3.18e-1)" "unprognostic (3.90e-3)" "unprognostic (9.69e-3)" "unprognostic (2.87e-1)" "prognostic unfavorable (1.34e-5)" "unprognostic (1.18e-3)" "unprognostic (3.04e-1)" "unprognostic (7.68e-2)" "unprognostic (2.00e-2)" 55.5 9.6 23.3 13.5 24.7 2.3 33.0 5.1 37.6 3.3 11.8 9.2 0.3 10.6 5.9 1.5 11.8 3.2 8.8 11.4 17.1 5.5 9.4 68.4 9.0 2.7 21.4 3.1 2.9 51.7 2.3 3.3 21.4 36.8 6.7 2.1 2.5 3.9 3.7 5.9 6.5 23.5 6.0 20.6 2.5 4.4 3.7 27.7 0.0 7.1 2.5 3.5 10.7 6.0 0.5 0.3 5.8 0.4 0.8 0.6 0.2 0.0 0.6 0.3 0.9 16.4 3.6 0.1 1.2 0.1 0.2 0.0 0.0 6.0 0.0 9.0 2.5 1.3 0.8 0.0 65.4 0.1 0.5 0.1 0.1 0.2 0.1 0.3 0.0 0.0 1.7 0.2 10.0 0.2 1.8 5.0 0.1 0.3 0.2 17.7 0.5 0.0 0.5 0.1 0.0 0.5 0.3 0.0 0.2 3.2 1.2 0.0 0.1 7.5 0.8 1.1 0.4 1.9 0.1 33.0 19.4 0.1 9.8 0.0 0.0 0.0 0.0 13.3 0.0 3.6 5.8 0.4 0.9 0.4 0.2 0.3 0.5 0.5 0.4 0.2 0.4 0.3 0.3 2.3 0.8 0.2 0.3 0.6 0.2 23.3 24.7 5.1 37.6 17.1 5.5 21.4 3.1 36.8 27.7 35.7 4.3 0.5 32.6 12.5 0.1 3.6 2.5 4.0 10.3 14.0 0.0 5.4 0.0 91.5 0.5 17.6 26.4 0.0 15.3 96.9 44.0 38.8 2.3 145.0 7.4 0.0 0.0 20.9 1.6 0.4 81.4 6.1 8.5 3.6 8.6 4.1 173.2 7.0 123.8 3.7 0.0 32.3 98.2 0.0 0.9 10.0 33.5 1.9 1.7 72.4 ANGPTL8 "C19orf80, RIFL, TD26" ENSG00000130173 "Angiopoietin like 8" Q6UXH0 19 11237450-11241943 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Lipid metabolism" Hormone "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "liver: 81.0" "Cell type enriched" "Detected in some" 14 "Hepatocytes: 96.9" "Cancer enriched" "Detected in some" 37 "liver cancer: 84.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 27 "Hep G2: 26.8;MCF7: 15.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA042131 Approved "Nucleoplasm,Golgi apparatus" "Secreted to blood" NA NA 836000 320000 "Golgi apparatus" Nucleoplasm "HPA042131: AB_10794413" "unprognostic (2.37e-2)" "unprognostic (1.86e-1)" "unprognostic (1.15e-1)" "unprognostic (1.31e-2)" "unprognostic (1.17e-1)" "unprognostic (1.00e-1)" "unprognostic (3.73e-1)" "unprognostic (2.80e-1)" "unprognostic (3.49e-1)" "unprognostic (1.02e-1)" "unprognostic (9.67e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (1.84e-6)" "unprognostic (1.09e-1)" "unprognostic (3.55e-1)" "unprognostic (4.57e-1)" "unprognostic (1.75e-2)" 8.0 0.1 0.0 0.6 0.0 0.0 5.1 0.0 0.1 0.1 5.7 0.0 0.0 0.2 0.1 0.8 0.1 0.1 1.0 0.6 0.0 0.0 1.5 81.0 0.1 3.0 0.2 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 4.8 0.1 0.7 0.3 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.3 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.2 0.7 26.8 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 15.5 0.0 0.5 0.1 0.0 0.0 0.1 0.3 0.7 0.0 0.2 0.0 0.2 0.3 0.7 0.0 0.3 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.2 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 96.9 0.1 0.0 0.0 6.7 5.9 1.3 0.9 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 ANKAR FLJ25415 ENSG00000151687 "Ankyrin and armadillo repeat containing" Q7Z5J8 2 189674290-189761193 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 2.3;testis: 9.0" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 63.4;Late spermatids: 36.4;Rod photoreceptor cells: 48.1" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "naive B-cell: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "TIME: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036168 Uncertain Approved "Nucleoplasm,Centriolar satellite" NA NA "Centriolar satellite" Nucleoplasm "HPA036168: AB_10673345" "unprognostic (2.12e-2)" "unprognostic (1.23e-1)" "unprognostic (1.06e-2)" "unprognostic (5.41e-2)" "unprognostic (3.14e-1)" "unprognostic (1.95e-2)" "unprognostic (1.64e-1)" "unprognostic (1.10e-1)" "unprognostic (2.65e-2)" "unprognostic (5.03e-3)" "unprognostic (2.89e-1)" "unprognostic (2.65e-2)" "unprognostic (6.34e-4)" "unprognostic (2.43e-1)" "unprognostic (1.27e-1)" "unprognostic (1.97e-1)" "unprognostic (2.47e-2)" 0.2 0.4 0.2 0.0 0.2 0.0 0.4 0.2 0.2 0.2 0.2 0.0 0.3 0.7 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.4 0.2 0.5 0.2 0.2 0.2 1.2 0.3 0.1 0.5 0.3 0.4 0.0 0.2 0.2 0.3 0.0 0.2 0.2 0.6 9.0 0.6 0.1 0.2 0.2 2.3 0.3 0.5 0.4 0.0 0.6 0.1 0.6 0.5 0.4 0.5 0.4 1.1 0.0 0.0 0.7 0.2 0.5 0.9 1.1 0.3 0.3 1.0 0.1 0.8 0.7 0.0 0.3 1.0 0.6 0.6 0.5 1.3 0.0 1.8 0.2 1.3 0.2 0.3 1.4 0.2 0.0 0.0 0.1 0.9 0.3 0.4 0.0 0.5 0.0 0.8 0.7 0.3 0.4 0.0 0.6 2.3 0.0 0.0 0.5 0.3 0.8 0.1 2.4 1.8 2.7 0.8 1.1 0.0 0.0 1.1 0.4 0.1 0.5 0.1 0.2 0.0 0.0 0.5 0.6 0.4 0.1 0.6 0.3 0.1 0.1 2.3 0.2 0.5 0.0 0.0 0.3 0.3 0.0 0.1 3.0 5.1 0.5 5.6 1.1 12.0 4.1 2.5 1.4 3.4 10.4 13.7 1.2 1.7 3.0 63.4 6.8 3.4 0.0 3.7 0.9 4.6 3.6 0.0 2.1 2.1 3.2 0.0 3.7 1.3 36.4 20.1 4.0 6.8 1.0 4.5 8.9 3.5 5.5 13.1 2.1 48.1 6.5 3.3 11.1 4.7 1.1 0.1 4.4 3.8 3.5 ANKDD1A FLJ25870 ENSG00000166839 "Ankyrin repeat and death domain containing 1A" Q495B1 15 64911902-64958700 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Leydig cells: 57.2;Muller glia cells: 36.1;Peritubular cells: 73.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 19.2;RT4: 14.4;U-266/84: 18.6" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 6 "cerebellum: 29.1" HPA040757 Approved Approved Nucleoplasm "Secreted - unknown location" NA NA Nucleoplasm "HPA040757: AB_10960566" "unprognostic (3.72e-4)" "unprognostic (1.86e-1)" "unprognostic (6.07e-3)" "unprognostic (3.25e-2)" "unprognostic (4.78e-1)" "unprognostic (2.49e-1)" "unprognostic (1.14e-1)" "unprognostic (1.22e-3)" "unprognostic (5.11e-3)" "unprognostic (5.57e-2)" "unprognostic (4.37e-2)" "unprognostic (1.60e-1)" "unprognostic (3.15e-7)" "unprognostic (1.06e-1)" "unprognostic (1.98e-1)" "unprognostic (8.04e-3)" "unprognostic (1.64e-2)" 3.9 12.4 7.9 3.7 9.5 3.2 2.3 7.9 9.4 4.3 2.2 0.6 3.5 1.9 4.7 7.6 5.1 5.9 3.9 3.6 8.3 3.9 2.0 1.3 4.4 6.3 4.2 9.8 5.8 7.6 3.5 4.4 5.4 3.5 3.3 0.5 2.4 3.3 4.2 1.5 4.9 2.4 6.5 3.0 14.2 2.6 8.6 1.1 0.0 3.8 0.9 1.6 5.1 4.0 1.0 1.5 1.4 1.9 6.8 4.0 0.8 1.0 2.9 1.4 1.3 2.2 1.7 5.7 1.3 3.5 1.4 2.0 1.6 1.4 1.3 1.5 2.9 1.2 1.4 2.9 0.2 1.1 0.7 0.8 1.4 3.0 1.1 1.6 1.1 2.3 1.3 0.4 0.9 0.5 0.8 1.0 1.3 0.2 19.2 0.4 2.7 0.5 2.1 1.7 0.5 1.3 0.8 0.8 9.1 0.1 14.4 2.9 3.5 0.7 1.0 1.3 1.3 1.1 1.1 1.4 2.6 2.7 2.3 1.3 5.3 18.6 1.0 2.9 2.6 0.8 1.0 0.9 0.1 2.1 1.9 0.8 1.0 1.1 3.2 1.5 0.7 0.8 0.8 1.4 6.8 1.8 0.0 4.0 0.8 7.9 9.5 7.9 9.4 8.3 3.9 4.2 9.8 3.5 1.1 0.0 2.2 0.0 4.9 4.9 9.4 1.2 0.0 0.0 1.2 0.0 11.8 2.7 0.0 0.7 0.8 8.0 0.0 0.0 1.9 4.6 7.0 2.2 5.7 0.0 4.9 3.2 1.2 1.3 5.4 0.9 57.2 7.9 10.1 0.0 0.0 36.1 4.2 0.0 73.9 0.0 6.6 12.9 13.9 1.4 1.1 3.1 1.8 4.1 0.0 4.1 ANKFN1 FLJ38335 ENSG00000153930 "Ankyrin repeat and fibronectin type III domain containing 1" Q8N957 17 55882301-56511659 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.8;cervix, uterine: 19.9;fallopian tube: 10.9" "Cell type enhanced" "Detected in some" 22 "Ciliated cells: 34.8;Early spermatids: 13.6;Late spermatids: 7.4;Sertoli cells: 6.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 8.1;MOLT-4: 16.8;T-47d: 5.8;U-2197: 5.6" "Low region specificity" "Detected in many" "HPA021566, HPA022538, HPA048953" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA021566: AB_1844828, HPA022538: AB_1844829, HPA048953: " "unprognostic (6.64e-2)" "unprognostic (1.29e-1)" "unprognostic (3.52e-2)" "unprognostic (9.38e-5)" "unprognostic (2.39e-1)" "unprognostic (2.31e-3)" "unprognostic (3.84e-2)" "unprognostic (1.68e-1)" "unprognostic (3.31e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-2)" "unprognostic (6.81e-3)" "unprognostic (3.44e-8)" "unprognostic (1.24e-1)" "unprognostic (1.69e-1)" "unprognostic (4.93e-2)" "unprognostic (9.51e-2)" 3.9 1.0 5.5 0.5 10.2 0.5 1.2 2.6 4.7 19.9 0.7 11.4 0.5 0.7 0.8 3.4 0.7 10.9 0.9 0.5 6.8 4.6 0.7 0.6 2.0 0.6 6.3 3.7 0.5 0.5 0.5 1.0 2.1 11.8 0.9 0.8 0.0 0.7 0.8 0.6 5.2 0.8 0.5 7.5 0.6 1.1 3.6 10.0 0.0 0.6 0.0 0.5 3.2 5.3 0.2 0.5 0.1 0.1 0.3 0.4 0.0 0.0 0.0 0.1 0.0 1.3 0.2 0.3 0.0 2.9 0.2 0.3 0.0 0.1 0.3 0.2 0.7 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 8.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 2.2 0.1 0.4 16.8 0.0 0.0 0.9 0.7 0.1 0.0 0.1 0.0 0.1 1.5 0.0 1.7 0.0 0.3 0.1 5.8 0.0 0.0 0.0 0.4 5.6 0.1 1.5 0.3 0.0 0.8 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.2 0.0 0.3 0.1 0.3 0.1 0.5 0.0 0.0 5.5 10.2 2.6 4.7 6.8 4.6 6.3 3.7 11.8 10.0 0.0 0.6 0.0 0.1 0.5 0.0 0.6 0.0 34.8 0.0 0.0 0.0 0.3 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.7 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.6 0.0 1.7 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 6.5 0.3 5.9 2.1 0.4 2.4 0.0 0.0 0.9 ANKLE1 "ANKRD41, FLJ39369, LEMD6" ENSG00000160117 "Ankyrin repeat and LEM domain containing 1" Q8NAG6 19 17281645-17287646 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 22.6;brain: 8.3;lymphoid tissue: 12.9" "Group enriched" "Detected in some" 7 "Erythroid cells: 23.3;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 8.3" "Cell type enhanced" "Detected in many" "intermediate monocyte: 4.3" "Group enriched" "Detected in many" 4 "B-cells: 3.0;dendritic cells: 2.2;monocytes: 4.3" "Cell line enhanced" "Detected in many" "Daudi: 30.8;HEL: 12.6;HL-60: 13.5;NB-4: 17.4;U-937: 24.2" "Low region specificity" "Detected in all" "HPA026789, HPA073498" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA026789: AB_10611675, HPA073498: AB_2686612" "unprognostic (5.66e-2)" "unprognostic (2.21e-1)" "unprognostic (6.90e-2)" "prognostic unfavorable (4.86e-5)" "unprognostic (2.73e-1)" "unprognostic (1.72e-3)" "unprognostic (2.19e-2)" "unprognostic (2.09e-2)" "unprognostic (1.31e-2)" "unprognostic (2.28e-1)" "unprognostic (7.89e-4)" "unprognostic (5.86e-2)" "unprognostic (0.00e+0)" "unprognostic (2.03e-1)" "unprognostic (1.61e-1)" "unprognostic (2.00e-3)" "unprognostic (4.30e-2)" 0.6 0.5 1.0 12.9 3.1 22.6 0.6 8.3 1.4 0.7 0.7 0.6 0.2 0.3 0.9 1.3 0.5 0.8 0.5 0.2 1.0 1.2 0.5 0.5 1.3 3.7 1.6 0.7 1.7 0.2 0.6 0.9 1.1 1.4 1.0 0.5 0.4 0.7 0.6 0.9 1.4 1.2 0.9 1.2 5.7 0.3 1.0 0.5 8.9 0.6 0.2 5.3 1.0 0.7 3.0 2.2 0.7 4.3 0.0 0.4 0.8 0.1 0.3 1.5 0.8 0.0 0.3 1.5 0.5 0.1 0.3 0.2 7.0 0.4 30.8 0.3 0.1 0.0 0.6 11.9 0.1 0.3 9.3 1.6 12.6 4.9 0.0 0.1 13.5 5.2 0.1 0.4 1.2 0.0 0.3 0.2 2.6 1.6 3.6 0.1 0.2 9.3 17.4 3.8 0.1 1.1 7.5 0.0 3.1 0.1 0.1 0.4 2.7 3.0 0.2 0.2 0.3 0.0 8.9 0.6 0.1 0.5 0.6 0.3 0.3 0.3 10.9 0.1 24.2 0.6 0.0 1.8 0.7 0.0 4.3 0.0 3.0 0.0 0.4 2.2 1.7 0.1 0.0 0.0 0.0 3.1 1.1 0.0 0.8 1.0 3.1 8.3 1.4 1.0 1.2 1.6 0.7 1.4 0.5 0.0 0.3 0.8 0.8 0.7 2.0 0.8 0.0 1.4 0.0 0.0 0.0 1.5 0.0 0.1 0.1 0.2 0.0 23.3 0.2 0.4 0.4 0.3 1.1 0.0 0.7 0.0 0.0 0.0 0.8 0.0 1.7 1.2 0.0 1.0 0.7 0.2 0.4 0.0 1.4 0.0 1.5 6.5 0.4 0.5 0.9 0.4 0.3 0.0 0.0 0.1 ANKMY1 "FLJ20499, ZMYND13" ENSG00000144504 "Ankyrin repeat and MYND domain containing 1" Q9P2S6 2 240479422-240569209 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 45.0" "Group enriched" "Detected in many" 5 "Early spermatids: 147.5;Late spermatids: 162.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA026620, HPA048869" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA026620: AB_1844834, HPA048869: " "unprognostic (2.89e-3)" "unprognostic (1.03e-1)" "unprognostic (3.83e-2)" "unprognostic (3.22e-3)" "unprognostic (3.46e-1)" "unprognostic (3.97e-5)" "unprognostic (8.32e-2)" "unprognostic (1.19e-1)" "unprognostic (4.40e-3)" "unprognostic (1.50e-2)" "unprognostic (1.90e-1)" "unprognostic (2.36e-2)" "unprognostic (2.59e-5)" "unprognostic (2.01e-1)" "unprognostic (1.80e-1)" "unprognostic (2.42e-2)" "prognostic favorable (3.20e-4)" 4.5 4.3 5.2 9.0 7.9 9.8 5.8 6.4 7.3 7.2 5.7 10.3 10.8 5.8 6.6 9.0 5.3 21.8 9.2 3.6 6.1 4.3 5.1 5.1 6.3 7.2 8.7 4.8 7.3 8.0 6.6 5.4 6.4 6.4 5.8 5.1 5.1 6.9 13.6 5.0 7.2 6.2 5.8 6.3 7.3 8.4 45.0 6.7 6.0 6.0 3.4 10.7 5.8 6.0 7.4 4.2 6.9 3.4 2.0 7.5 3.4 5.3 11.7 2.5 4.7 2.3 3.3 10.6 2.5 3.9 2.1 2.9 3.7 11.0 5.3 0.5 2.8 3.2 5.8 4.9 6.0 2.5 9.8 4.0 10.5 5.7 9.8 1.9 5.8 10.1 5.3 14.7 2.0 14.1 6.5 2.2 8.5 9.7 6.8 3.6 5.1 5.3 9.6 2.1 9.2 7.0 15.2 7.7 8.4 3.3 11.5 6.0 4.4 2.1 5.6 7.8 3.2 4.8 9.0 2.7 8.0 2.7 3.1 4.4 15.8 3.9 5.1 4.5 8.9 6.1 0.1 3.3 6.9 7.5 2.6 4.3 4.7 4.8 4.7 4.2 7.4 7.1 5.1 1.3 2.0 3.4 2.8 1.5 3.4 5.2 7.9 6.4 7.3 6.1 4.3 8.7 4.8 6.4 6.7 0.0 7.2 2.7 1.6 0.8 3.4 1.8 2.5 30.8 10.3 3.5 3.9 2.8 1.7 2.2 147.5 2.8 4.3 0.0 3.7 1.6 1.5 2.0 5.7 5.5 2.5 3.2 4.1 3.1 7.0 162.8 3.7 4.0 0.0 4.6 4.6 1.9 2.5 0.0 2.8 2.6 3.5 0.0 1.3 14.7 8.8 1.9 2.4 4.4 4.9 1.4 ANKMY2 "DKFZP564O043, ZMYND20" ENSG00000106524 "Ankyrin repeat and MYND domain containing 2" Q8IV38 7 16599776-16645817 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067100 Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA067100: AB_2685777" "unprognostic (3.07e-1)" "unprognostic (4.20e-1)" "unprognostic (2.05e-1)" "unprognostic (1.55e-1)" "unprognostic (1.99e-3)" "unprognostic (2.40e-1)" "unprognostic (1.17e-2)" "unprognostic (1.70e-2)" "unprognostic (3.53e-2)" "unprognostic (1.81e-1)" "unprognostic (9.11e-2)" "unprognostic (3.00e-2)" "prognostic favorable (1.05e-7)" "unprognostic (5.75e-2)" "unprognostic (9.07e-2)" "unprognostic (1.55e-1)" "unprognostic (3.85e-2)" 9.6 10.3 14.5 6.6 30.1 10.0 11.8 14.6 28.7 12.4 13.6 9.0 13.3 12.2 10.8 10.4 9.4 13.1 11.1 30.2 18.5 12.7 13.3 8.9 9.4 6.7 12.7 21.2 21.5 9.6 13.2 14.9 7.3 20.4 11.3 14.1 11.8 11.4 16.3 17.3 8.5 13.5 14.4 11.9 8.8 19.1 8.0 7.8 8.9 17.7 7.5 7.1 14.6 11.6 6.7 4.9 18.5 8.9 10.6 10.2 5.2 10.5 9.0 12.3 12.2 11.7 12.3 6.6 12.9 15.8 10.0 15.4 15.0 16.2 2.1 15.1 13.5 20.9 11.1 8.3 4.9 15.0 4.7 5.7 19.1 10.8 6.7 7.6 14.2 7.4 10.6 2.6 10.0 10.1 13.9 9.0 13.0 19.6 3.5 14.1 2.8 6.0 9.9 8.2 32.7 10.7 9.9 11.1 5.1 15.5 9.2 7.8 4.7 8.7 6.4 5.2 12.0 7.6 12.8 5.5 7.7 6.9 17.2 8.8 12.9 9.4 3.3 11.9 11.7 12.3 18.5 3.2 14.3 10.0 4.3 9.6 6.7 8.2 10.2 4.9 6.7 6.9 8.2 2.7 10.6 8.9 4.7 8.3 5.2 14.5 30.1 14.6 28.7 18.5 12.7 12.7 21.2 20.4 7.8 3.0 10.8 3.7 9.1 4.1 13.2 33.4 12.7 40.2 19.4 10.4 5.9 11.7 18.3 5.8 18.4 5.8 14.9 0.0 8.0 9.4 11.8 5.1 5.8 5.0 8.0 7.9 18.5 3.7 4.8 26.3 11.8 5.0 13.5 7.2 14.1 16.0 4.9 10.5 12.7 9.7 18.2 25.8 14.6 3.7 4.1 3.6 14.2 6.2 15.0 5.4 ANKRA2 ENSG00000164331 "Ankyrin repeat family A member 2" Q9H9E1 5 73552335-73565686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003968, HPA065263" Approved Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA003968: , HPA065263: AB_2685449" "unprognostic (1.75e-1)" "unprognostic (5.78e-2)" "unprognostic (1.40e-1)" "unprognostic (1.86e-1)" "unprognostic (3.31e-1)" "unprognostic (3.89e-2)" "unprognostic (5.68e-2)" "unprognostic (6.19e-2)" "unprognostic (3.47e-2)" "unprognostic (1.09e-1)" "unprognostic (1.06e-2)" "unprognostic (1.79e-1)" "unprognostic (9.80e-3)" "unprognostic (3.36e-1)" "unprognostic (3.31e-1)" "unprognostic (6.65e-2)" "unprognostic (1.13e-3)" 13.0 19.4 11.9 9.2 17.1 18.7 20.9 22.8 18.3 15.7 13.5 16.6 13.1 15.0 20.0 21.0 13.3 18.5 15.0 12.2 18.1 15.8 9.6 15.9 20.7 13.9 20.6 12.3 23.3 19.7 11.4 30.2 15.4 23.1 19.8 16.4 17.5 19.0 14.3 14.5 13.4 15.3 17.8 30.7 13.0 16.2 10.3 15.8 18.1 22.2 4.5 14.7 14.9 13.3 10.7 5.9 16.9 7.4 7.0 15.5 7.3 5.1 3.9 5.8 6.1 10.6 16.2 17.7 7.1 10.6 6.2 9.3 1.2 8.0 4.8 5.7 7.0 7.0 3.7 2.7 12.6 8.9 10.1 4.8 4.2 3.0 5.5 8.3 2.5 8.3 16.7 17.1 7.4 7.7 11.6 6.9 6.4 4.1 8.1 7.1 3.1 4.3 6.5 3.1 1.9 2.9 2.6 6.2 6.6 4.8 6.4 7.8 6.1 5.4 4.3 8.4 9.3 6.5 4.2 8.6 2.5 3.0 4.0 5.1 16.0 11.5 4.1 6.2 4.1 7.2 16.9 5.7 11.3 8.7 4.6 10.5 10.7 10.2 12.1 4.9 8.4 15.5 14.2 9.0 7.0 7.4 5.9 11.7 7.3 11.9 17.1 22.8 18.3 18.1 15.8 20.6 12.3 23.1 15.8 3.0 8.6 26.7 25.9 14.1 25.6 7.7 35.7 16.0 12.5 17.4 9.8 22.6 23.2 10.6 0.9 12.1 16.1 23.3 14.6 18.8 13.1 25.9 18.5 19.5 9.2 22.3 23.2 16.0 16.2 1.7 30.2 11.1 11.8 12.6 19.4 15.6 14.7 18.4 27.3 14.0 21.5 25.8 14.4 23.0 15.1 10.8 40.8 18.1 16.2 31.3 ANKRD1 "ALRP, C-193, CARP, CVARP, MCARP" ENSG00000148677 "Ankyrin repeat domain 1" Q15327 10 90912096-90921276 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 81 "heart muscle: 398.9;skeletal muscle: 333.3" "Cell type enriched" "Detected in some" 15 "Cardiomyocytes: 12578.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 7.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "EFO-21: 104.9;hTERT-RPE1: 57.1;LHCN-M2: 128.8;SuSa: 41.0;TIME: 179.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA038736 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" NA Yes "Nucleoli fibrillar center" Nucleoplasm "HPA038736: AB_2676184" "unprognostic (2.45e-1)" "unprognostic (6.14e-3)" "unprognostic (2.24e-1)" "unprognostic (4.39e-1)" "unprognostic (9.14e-3)" "prognostic unfavorable (1.95e-4)" "unprognostic (1.28e-2)" "unprognostic (6.63e-3)" "unprognostic (2.19e-1)" "unprognostic (3.27e-1)" "unprognostic (4.51e-2)" "unprognostic (3.40e-1)" "unprognostic (2.72e-5)" "unprognostic (3.40e-2)" "unprognostic (2.79e-1)" "unprognostic (7.22e-2)" "unprognostic (3.16e-3)" 1.5 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 2.1 1.5 0.1 0.1 398.9 0.0 0.0 0.1 0.1 4.5 0.2 0.0 0.0 0.1 0.4 0.1 0.1 0.7 0.1 0.9 0.1 0.0 0.8 0.1 333.3 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 2.9 1.6 0.5 0.3 0.0 0.4 0.5 1.9 0.6 0.9 0.4 0.2 2.9 0.8 0.5 0.0 0.4 0.5 0.0 1.7 0.1 0.5 0.9 38.0 1.4 0.0 104.9 0.1 4.0 1.0 0.1 0.2 1.3 0.1 0.1 0.0 0.2 11.7 2.3 0.0 0.0 3.7 0.0 0.7 1.8 57.1 35.8 0.0 0.0 0.0 128.8 0.0 0.0 0.0 0.1 0.2 0.0 0.0 8.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 41.0 0.0 0.1 179.4 0.3 13.8 0.2 14.1 0.0 0.0 0.2 0.0 0.0 0.0 1.9 0.2 0.5 0.2 0.3 0.3 0.3 0.2 0.2 0.2 0.4 0.4 0.3 0.7 0.9 0.6 0.5 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 848.6 37.7 0.0 1.3 0.0 0.0 12578.5 10.2 1.4 9.1 0.0 0.0 0.1 0.0 19.0 2.0 0.0 0.0 0.0 0.2 0.2 0.2 0.4 3.5 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.5 0.0 0.0 0.1 ANKRD11 "LZ16, T13" ENSG00000167522 "Ankyrin repeat domain 11" Q6UB99 16 89267619-89490561 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019288, HPA041593, HPA049470" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB019288: , HPA041593: AB_2677567, HPA049470: AB_2680780" "unprognostic (7.31e-2)" "unprognostic (6.35e-2)" "unprognostic (1.85e-1)" "unprognostic (3.53e-3)" "unprognostic (1.82e-1)" "unprognostic (1.69e-1)" "prognostic unfavorable (6.39e-4)" "unprognostic (1.81e-1)" "unprognostic (1.83e-2)" "unprognostic (1.78e-1)" "unprognostic (4.81e-2)" "prognostic unfavorable (7.67e-4)" "unprognostic (1.56e-3)" "unprognostic (1.79e-1)" "unprognostic (7.93e-2)" "unprognostic (5.78e-3)" "unprognostic (2.16e-1)" 24.2 23.3 22.8 25.6 23.1 48.7 41.4 32.3 31.7 22.0 24.1 22.9 22.0 22.4 26.9 18.9 25.0 23.4 23.4 22.2 24.6 20.0 17.8 15.1 32.3 33.8 20.8 21.0 32.6 27.9 33.7 31.5 18.8 19.3 20.5 14.9 23.3 21.4 25.8 27.0 35.8 24.1 26.7 20.3 26.1 22.6 21.3 22.1 26.1 21.6 19.3 19.6 23.4 34.4 4.2 7.2 11.7 5.9 9.8 4.5 1.8 21.9 27.5 27.7 21.2 17.1 17.7 26.8 25.1 16.9 15.2 10.8 32.0 23.6 20.4 17.4 18.2 17.1 22.3 18.9 23.1 17.2 10.1 22.6 16.1 19.1 25.6 25.9 11.8 18.3 19.6 23.5 19.9 25.8 22.1 18.2 34.3 34.5 16.3 19.0 20.8 19.5 29.8 24.3 11.4 25.4 40.4 32.0 17.0 15.8 18.5 16.3 20.0 36.2 7.6 26.0 14.7 17.8 18.6 33.6 32.1 30.0 17.7 27.5 29.8 10.4 25.4 25.8 19.6 17.3 7.5 3.9 3.7 3.8 4.0 4.3 3.1 4.3 4.5 2.1 4.2 3.8 3.5 11.7 9.8 5.9 7.2 4.2 1.8 22.8 23.1 32.3 31.7 24.6 20.0 20.8 21.0 19.3 22.1 122.1 96.0 57.0 118.7 103.5 174.0 224.2 89.2 33.5 56.9 68.0 149.2 36.4 26.6 65.7 85.7 83.9 67.5 46.7 62.6 29.3 87.3 94.1 53.2 57.8 42.6 147.8 102.5 75.5 58.0 27.9 96.1 74.6 45.5 95.6 51.2 90.0 94.9 50.7 99.7 28.0 102.5 38.8 89.3 78.8 102.6 106.9 32.4 71.0 51.7 144.5 ANKRD12 "FLJ20053, GAC-1, KIAA0874" ENSG00000101745 "Ankyrin repeat domain 12" Q6UB98 18 9136228-9285985 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 46.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040705 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040705: AB_10673301" "unprognostic (2.20e-1)" "unprognostic (1.14e-1)" "unprognostic (3.59e-1)" "unprognostic (1.37e-1)" "unprognostic (1.46e-1)" "unprognostic (3.41e-3)" "unprognostic (7.25e-2)" "unprognostic (6.17e-2)" "prognostic unfavorable (6.71e-4)" "unprognostic (1.24e-2)" "unprognostic (1.55e-1)" "unprognostic (3.38e-1)" "unprognostic (2.39e-2)" "unprognostic (4.62e-1)" "unprognostic (1.56e-1)" "unprognostic (3.03e-1)" "unprognostic (1.03e-2)" 17.0 10.9 22.2 23.1 26.1 19.6 15.4 48.1 25.4 17.8 18.8 10.1 18.2 13.7 14.6 15.4 16.1 12.1 16.1 12.3 19.9 13.5 14.7 16.5 14.6 22.1 20.2 18.3 16.3 16.7 15.5 16.4 19.2 17.4 15.9 13.6 9.5 15.7 20.6 25.8 21.8 18.1 17.2 21.3 20.3 15.3 29.3 23.8 11.4 18.2 13.0 19.5 24.2 22.6 18.7 19.2 51.2 10.7 8.8 19.0 5.2 4.2 2.9 4.0 2.6 6.4 6.6 3.2 6.6 6.2 2.4 3.3 2.6 3.3 5.9 3.9 4.5 7.3 3.9 2.9 2.6 6.5 6.2 3.6 2.7 2.1 3.8 4.7 6.3 8.7 3.4 5.8 3.4 5.5 5.4 4.0 3.5 6.1 46.8 5.8 2.4 4.2 4.3 1.5 10.5 3.0 3.8 5.6 21.5 3.1 6.8 9.3 3.4 6.5 3.2 4.7 3.7 4.0 5.3 8.6 17.7 8.2 14.1 6.1 13.7 21.1 11.0 8.7 3.4 6.6 27.4 8.7 25.5 14.5 7.7 16.1 18.7 18.7 13.9 5.9 17.3 19.0 14.8 51.2 8.8 10.7 19.2 13.0 5.2 22.2 26.1 48.1 25.4 19.9 13.5 20.2 18.3 17.4 23.8 259.1 252.1 212.5 167.3 96.2 295.2 122.2 76.5 112.4 180.9 64.6 492.8 36.1 16.6 83.3 150.6 136.7 122.5 70.0 72.2 31.7 114.1 175.8 178.3 57.2 58.3 270.1 88.9 119.7 80.5 178.4 124.8 126.0 86.0 167.7 80.4 131.0 84.0 75.9 133.0 29.3 294.9 109.9 138.1 215.6 153.7 83.9 65.3 191.8 63.5 140.5 ANKRD13D ENSG00000172932 "Ankyrin repeat domain 13D" Q6ZTN6 11 67288547-67302485 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 80.8" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 70.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 49.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039950 Approved Approved Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA039950: AB_10796337" "unprognostic (1.10e-1)" "unprognostic (1.18e-3)" "unprognostic (1.37e-3)" "unprognostic (4.19e-2)" "unprognostic (9.83e-3)" "unprognostic (1.58e-1)" "unprognostic (4.87e-3)" "unprognostic (3.72e-2)" "unprognostic (1.44e-1)" "unprognostic (1.16e-2)" "unprognostic (5.06e-3)" "unprognostic (3.71e-2)" "prognostic unfavorable (5.73e-10)" "unprognostic (1.62e-1)" "unprognostic (1.80e-1)" "unprognostic (4.01e-2)" "unprognostic (6.74e-2)" 9.1 9.1 18.2 18.1 17.6 80.8 18.9 20.2 18.7 9.0 7.6 7.7 13.7 8.0 9.0 10.4 14.6 10.2 11.9 8.8 20.2 14.0 8.3 4.5 12.4 20.8 12.4 11.4 9.4 7.7 6.0 17.0 9.2 10.7 12.7 4.5 10.9 17.5 12.0 4.2 28.1 8.6 9.9 9.6 24.1 8.9 6.8 12.0 9.6 6.4 6.2 14.4 14.3 13.4 2.6 8.1 11.4 4.6 3.8 6.7 1.9 6.3 4.5 3.4 8.1 5.2 5.1 6.4 3.9 3.8 4.6 2.9 5.3 7.0 6.9 6.6 4.4 6.2 10.6 2.5 5.0 0.7 9.7 3.0 5.8 6.8 3.0 8.1 6.4 23.5 5.5 7.9 4.1 5.3 6.9 4.3 7.0 4.1 8.4 4.0 10.3 8.6 49.8 3.9 9.8 5.7 21.6 3.7 4.8 6.5 8.7 4.0 6.8 3.4 10.2 27.2 2.7 10.5 18.3 5.5 7.3 4.7 7.4 5.1 8.5 6.1 4.1 9.6 18.0 4.7 7.2 3.3 11.4 6.7 4.6 4.4 2.6 3.8 5.4 1.9 2.4 2.4 5.8 10.8 3.8 3.8 8.1 2.8 1.9 18.2 17.6 20.2 18.7 20.2 14.0 12.4 11.4 10.7 12.0 0.0 22.6 9.3 10.5 12.6 49.4 4.5 2.5 18.7 10.3 15.7 70.7 6.9 1.7 7.8 17.6 14.2 2.6 0.0 6.0 6.4 13.6 15.3 24.3 2.4 17.5 39.7 10.4 25.2 48.3 5.1 20.4 28.1 11.8 14.4 6.2 25.2 7.9 2.9 15.9 1.4 45.9 12.9 12.1 2.8 5.5 22.0 6.3 29.9 6.9 15.7 ANKRD17 "FLJ22206, GTAR, KIAA0697, MASK2, NY-BR-16" ENSG00000132466 "Ankyrin repeat domain 17" O75179 4 73073376-73258798 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045024, HPA063731" Approved Supported "Nucleoplasm,Nuclear membrane" No No Nucleoplasm "Nuclear membrane" "HPA045024: AB_10964778, HPA063731: AB_2685106" "unprognostic (3.86e-3)" "unprognostic (3.59e-2)" "unprognostic (1.70e-2)" "unprognostic (1.26e-1)" "unprognostic (1.73e-2)" "unprognostic (1.39e-1)" "unprognostic (1.63e-3)" "unprognostic (3.29e-2)" "unprognostic (3.10e-2)" "unprognostic (1.78e-1)" "unprognostic (8.79e-2)" "unprognostic (2.92e-2)" "unprognostic (3.98e-3)" "unprognostic (9.06e-2)" "unprognostic (2.13e-1)" "unprognostic (4.00e-2)" "unprognostic (4.07e-1)" 19.6 20.2 28.9 23.2 32.4 10.3 24.8 41.2 29.9 22.8 19.4 21.2 19.5 18.2 19.3 24.2 22.2 23.5 18.8 20.4 23.4 21.6 25.3 25.3 18.0 17.4 22.3 19.4 23.4 22.8 40.2 34.6 23.2 31.8 19.7 24.2 21.5 23.1 23.1 32.7 22.2 18.5 20.7 18.0 17.7 19.2 13.5 25.1 22.3 22.7 15.9 21.1 21.1 18.9 4.5 7.6 3.2 2.8 9.3 5.3 1.7 12.3 13.6 21.7 17.1 24.5 21.6 11.9 18.2 21.5 16.4 15.9 16.5 16.3 33.6 15.2 18.6 8.7 10.4 27.1 16.1 22.8 13.0 11.5 22.8 14.8 23.9 13.1 29.8 14.1 18.2 17.6 23.5 18.8 17.1 21.8 13.8 31.9 12.4 19.6 11.4 24.4 10.6 14.1 16.0 13.8 19.5 23.9 13.9 17.5 18.7 21.1 14.3 17.6 19.9 9.5 17.7 10.7 11.8 26.2 17.4 16.7 15.5 14.2 10.4 5.2 25.7 14.1 13.1 17.7 2.3 2.8 3.0 5.3 1.8 2.7 3.0 3.3 3.6 2.3 4.5 3.2 3.6 3.2 9.3 2.1 7.6 2.0 1.7 28.9 32.4 41.2 29.9 23.4 21.6 22.3 19.4 31.8 25.1 44.7 48.2 16.6 32.2 67.7 55.9 71.9 33.1 22.7 48.9 38.4 115.8 24.2 6.6 26.7 4.0 47.7 39.9 0.0 25.0 20.0 36.8 36.1 30.1 45.3 23.8 65.2 43.4 40.5 26.7 4.2 32.5 26.4 27.0 22.6 40.3 32.1 25.1 17.3 35.3 19.8 77.0 19.4 28.2 24.7 28.7 71.0 28.3 24.9 41.9 42.2 ANKRD20A1 "ANKRD20A, DKFZp434A171" ENSG00000260691 "Ankyrin repeat domain 20 family member A1" Q5TYW2 9 67859147-67902094 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.3;testis: 6.5" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 3.0;Cardiomyocytes: 2.6;Ciliated cells: 4.0;Spermatocytes: 6.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "eosinophil: 2.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.3" "Cell line enhanced" "Detected in some" "Karpas-707: 7.1;U-266/70: 11.7;U-266/84: 3.9" "HPA043239, HPA047112, HPA047167, HPA047766, HPA051753, HPA054389" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592, HPA054389: " "unprognostic (4.92e-1)" "unprognostic (4.31e-3)" "unprognostic (3.97e-1)" "unprognostic (2.30e-2)" "unprognostic (5.94e-2)" "unprognostic (2.26e-2)" "unprognostic (1.31e-1)" "unprognostic (1.35e-2)" "unprognostic (2.32e-2)" "unprognostic (7.17e-2)" "unprognostic (1.70e-1)" "unprognostic (5.45e-2)" 0.1 0.0 0.0 0.3 0.1 0.8 0.3 0.2 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.9 0.2 0.1 0.0 0.4 0.1 0.3 0.8 0.0 6.5 0.5 0.0 0.0 0.0 0.0 2.3 0.1 0.1 0.3 0.0 0.2 0.4 1.4 0.6 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.3 1.8 0.0 0.0 0.4 0.9 1.0 0.4 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.1 0.2 1.8 0.4 7.1 0.0 0.0 1.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 2.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.3 0.6 1.0 11.7 3.9 0.0 0.5 0.0 1.9 0.0 0.0 2.3 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 3.0 1.3 0.0 0.0 0.0 0.0 2.6 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 1.1 0.0 1.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 6.3 1.9 0.0 0.0 0.0 0.9 0.0 ANKRD20A2 ENSG00000183148 "Ankyrin repeat domain 20 family member A2" Q5SQ80 9 40223285-40266392 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 4 "testis: 7.6" "Cell type enhanced" "Detected in some" 15 "Distal tubular cells: 1.7;granulocytes: 1.1;Spermatocytes: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 16.7;U-266/70: 2.8;U-266/84: 5.0" "HPA043239, HPA047112, HPA047167, HPA047766, HPA051753, HPA054389" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592, HPA054389: " "unprognostic (4.24e-3)" "unprognostic (9.19e-2)" 0.1 0.1 0.4 0.0 1.4 0.2 0.3 1.0 1.2 0.1 0.4 0.0 0.0 0.5 1.2 0.7 0.1 1.9 0.7 0.7 0.3 0.2 1.2 0.0 0.4 0.0 1.4 1.1 0.8 0.0 0.4 1.1 1.1 0.4 0.3 0.2 0.1 0.0 0.1 1.5 0.0 7.6 0.5 0.0 0.0 0.3 0.1 0.9 0.9 0.0 0.0 0.6 0.0 0.2 1.3 1.6 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.8 1.6 16.7 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.1 2.8 5.0 0.0 0.0 0.0 0.8 0.1 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.2 0.0 0.0 0.1 ANKRD20A3 ENSG00000276203 "Ankyrin repeat domain 20 family member A3" Q5VUR7 9 66106815-66153135 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "esophagus: 1.1;lung: 1.3;testis: 2.0" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 5.3;Horizontal cells: 4.8;Spermatocytes: 16.4;Spermatogonia: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.6;HDLM-2: 5.2;RPTEC TERT1: 1.4;WM-115: 1.3" "HPA043239, HPA047112, HPA047167, HPA047766, HPA051753, HPA054389" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592, HPA054389: " "unprognostic (4.27e-2)" 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.5 0.0 0.1 0.1 0.0 5.2 0.0 0.6 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.5 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.1 0.2 0.8 1.8 0.0 5.3 0.0 0.0 3.9 0.0 0.0 0.0 2.0 0.0 1.0 0.0 0.9 0.0 0.0 0.6 3.5 0.0 0.1 4.8 0.0 0.6 1.3 1.8 0.3 0.0 0.0 0.0 0.4 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.1 16.4 6.5 0.1 0.0 0.0 0.2 1.0 ANKRD20A4 ENSG00000172014 "Ankyrin repeat domain 20 family member A4" Q4UJ75 9 64369394-64413142 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 7 "Spermatocytes: 40.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 1.7;plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 4.4;Karpas-707: 4.3" "HPA043239, HPA047112, HPA047167, HPA047766, HPA051753, HPA054389" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592, HPA054389: " "unprognostic (3.40e-2)" "unprognostic (1.02e-1)" "unprognostic (2.69e-2)" "unprognostic (2.56e-1)" "unprognostic (9.24e-2)" "unprognostic (1.11e-2)" "unprognostic (3.97e-3)" "unprognostic (8.99e-2)" "unprognostic (2.88e-1)" "unprognostic (4.12e-1)" "unprognostic (4.01e-2)" "unprognostic (1.82e-2)" "unprognostic (1.16e-1)" "unprognostic (8.10e-2)" "unprognostic (5.84e-2)" 1.5 1.0 0.7 0.2 1.6 3.9 0.9 2.3 1.9 0.3 0.9 0.6 0.5 0.2 1.7 0.5 0.2 1.7 0.8 1.0 0.7 0.1 1.1 0.1 0.6 1.4 2.4 0.0 0.9 1.0 0.4 1.4 0.9 0.0 0.4 0.6 1.2 0.0 0.3 1.0 0.9 2.1 0.7 0.0 0.3 0.6 0.0 1.4 1.7 0.0 0.0 0.8 0.0 0.7 0.4 2.3 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 2.8 0.2 0.0 1.0 0.3 1.9 0.2 0.0 4.4 1.4 1.3 0.4 0.7 0.0 1.0 2.0 0.0 0.0 0.1 0.1 0.5 0.6 2.8 3.0 4.3 0.1 0.3 0.8 0.2 0.3 2.5 0.9 0.0 1.0 0.6 0.8 0.5 1.9 0.6 0.2 0.1 2.0 0.5 1.9 0.2 0.9 0.0 1.8 0.5 0.1 0.9 0.6 1.0 0.4 0.0 0.4 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.4 0.0 0.0 3.0 0.0 0.0 0.8 0.5 1.5 5.5 0.0 2.7 0.0 0.0 2.0 0.3 0.0 0.1 2.3 0.4 5.9 0.0 3.2 0.1 0.4 0.4 1.1 0.0 0.0 1.6 2.9 0.6 1.2 0.8 0.0 0.7 0.0 0.0 2.5 0.6 0.8 3.5 1.1 0.1 0.3 0.0 0.9 40.3 2.7 0.5 0.2 1.7 1.7 2.3 ANKRD20A8P ANKRD20B ENSG00000229089 "Ankyrin repeat domain 20 family member A8, pseudogene" Q5CZ79 2 94811046-94857282 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 3.2;thyroid gland: 5.0" "Cell type enhanced" "Detected in some" 22 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 1.7;Cardiomyocytes: 3.0;Club cells: 9.1;granulocytes: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "RT4: 2.8;U-2 OS: 9.8" "HPA043239, HPA047112, HPA047167, HPA047766, HPA051753, HPA054389" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592, HPA054389: " "unprognostic (3.08e-1)" "unprognostic (3.86e-1)" "unprognostic (3.79e-2)" "unprognostic (1.30e-4)" "unprognostic (2.29e-1)" "unprognostic (1.55e-1)" "unprognostic (6.38e-2)" 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 5.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.3 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.7 0.0 0.0 0.0 0.0 3.0 0.0 1.4 9.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANKRD22 MGC22805 ENSG00000152766 "Ankyrin repeat domain 22" Q5VYY1 10 88822132-88851818 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 40.2;stomach 1: 27.6;tongue: 29.0" "Cell type enhanced" "Detected in many" 16 "Basal keratinocytes: 33.1;Suprabasal keratinocytes: 89.8;Urothelial cells: 29.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 15.4" "Group enriched" "Detected in many" 13 "granulocytes: 15.4;monocytes: 6.8" "Cell line enhanced" "Detected in some" "A-431: 8.5;CAPAN-2: 27.2;HL-60: 8.0;OE19: 20.7;RT4: 18.4;T-47d: 12.5;U-937: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA012922 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA012922: AB_1844838" "unprognostic (1.86e-1)" "unprognostic (1.48e-3)" "unprognostic (9.73e-3)" "prognostic favorable (8.73e-6)" "unprognostic (1.18e-1)" "unprognostic (2.81e-2)" "unprognostic (2.39e-2)" "unprognostic (1.50e-1)" "unprognostic (4.57e-2)" "unprognostic (7.21e-3)" "prognostic unfavorable (6.15e-4)" "unprognostic (1.09e-3)" "unprognostic (1.05e-2)" "unprognostic (4.87e-3)" "unprognostic (4.17e-2)" "unprognostic (3.18e-3)" "unprognostic (1.01e-3)" 0.4 0.5 2.3 8.4 3.6 5.3 2.3 0.3 3.2 6.7 6.7 0.5 0.0 2.0 0.3 0.2 21.9 0.3 4.3 1.1 4.0 0.6 6.0 1.6 1.3 6.1 3.6 0.2 0.3 40.2 0.1 1.6 0.2 2.7 2.0 7.2 0.1 3.7 0.0 0.3 18.5 2.1 1.3 7.4 8.8 27.6 0.3 1.4 7.9 0.3 29.0 14.6 4.4 8.6 0.1 0.4 15.4 6.8 0.5 0.8 1.2 8.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.2 0.1 0.1 0.0 0.0 6.7 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 8.0 0.0 0.0 0.5 0.0 0.1 0.4 0.0 0.8 0.0 0.0 0.0 0.1 0.7 6.4 0.1 20.7 0.1 0.0 0.0 0.0 0.1 18.4 0.0 0.0 0.0 1.3 0.0 0.0 12.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 7.3 0.1 0.1 4.8 2.5 0.1 6.8 0.0 0.0 0.4 0.1 0.4 0.1 0.8 0.2 15.4 0.5 1.2 0.4 0.0 1.2 2.3 3.6 0.3 3.2 4.0 0.6 3.6 0.2 2.7 1.4 0.0 3.0 0.0 16.2 33.1 0.0 0.1 10.2 0.0 1.2 7.0 0.0 0.0 0.0 2.6 0.0 0.0 6.4 0.0 5.2 0.0 0.7 10.4 0.0 0.0 2.4 0.0 1.7 0.0 7.2 0.0 0.3 12.3 1.7 1.0 11.8 0.0 4.5 20.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 89.8 0.0 0.7 11.2 29.8 ANKRD23 "DARP, FLJ32449, MARP3" ENSG00000163126 "Ankyrin repeat domain 23" Q86SG2 2 96824526-96857934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skeletal muscle: 184.5" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 10.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "gdT-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "Karpas-707: 29.7" "Not detected" "Not detected" HPA036201 Approved Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA "Nucleoplasm, Cytosol" "Actin filaments" "HPA036201: AB_10673347" "unprognostic (2.48e-1)" "unprognostic (7.83e-4)" "unprognostic (4.93e-4)" "unprognostic (1.21e-2)" "unprognostic (4.28e-1)" "unprognostic (3.28e-1)" "unprognostic (3.27e-2)" "unprognostic (6.66e-2)" "unprognostic (2.46e-2)" "unprognostic (3.59e-2)" "unprognostic (1.81e-4)" "unprognostic (1.43e-1)" "unprognostic (2.04e-6)" "unprognostic (2.70e-1)" "unprognostic (1.39e-1)" "unprognostic (1.54e-1)" "unprognostic (2.70e-4)" 0.4 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.8 0.1 0.1 2.6 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.1 0.1 0.1 0.7 0.0 0.1 2.2 0.1 184.5 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 12.2 0.9 0.1 0.1 0.4 0.2 0.5 0.0 0.9 1.2 0.4 0.3 0.5 0.3 0.6 0.0 0.2 0.8 0.2 0.0 0.2 0.1 0.0 0.1 0.3 0.1 0.0 0.2 0.2 0.2 0.2 0.1 0.8 0.7 0.4 0.4 0.1 0.1 0.6 1.4 0.2 0.3 0.4 0.0 0.1 0.1 1.1 0.6 29.7 0.2 0.7 0.3 0.6 0.3 0.1 0.2 1.0 0.0 3.7 0.1 0.7 1.1 0.1 0.2 0.5 0.0 0.1 0.8 0.0 0.2 0.3 0.5 0.5 0.0 1.3 0.5 0.2 0.3 0.8 0.3 0.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.1 0.0 0.9 0.0 0.2 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 1.4 0.0 0.6 0.7 2.1 2.5 0.0 10.7 2.3 0.0 2.0 0.3 0.0 0.3 3.0 0.6 0.4 0.0 0.9 0.1 0.9 0.4 1.1 1.0 0.2 1.6 0.0 2.5 0.8 1.5 1.4 0.0 0.0 0.0 1.1 1.8 0.1 0.0 2.8 0.0 3.6 0.0 1.9 1.0 0.4 1.1 0.2 0.0 0.6 0.1 ANKRD29 FLJ25053 ENSG00000154065 "Ankyrin repeat domain 29" Q8N6D5 18 23598926-23662885 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 17 "Alveolar cells type 1: 202.5;Cone photoreceptor cells: 62.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 1.1;plasmacytoid DC: 1.6" "Group enriched" "Detected in many" 14 "dendritic cells: 1.6;T-cells: 1.1" "Cell line enhanced" "Detected in many" "ASC TERT1: 12.7;BJ hTERT+: 12.1;hTCEpi: 12.0;PC-3: 11.5;U-2197: 15.0;U-87 MG: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041272, HPA049419" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA041272: AB_2677387, HPA049419: AB_2680757" "unprognostic (4.52e-3)" "unprognostic (8.37e-2)" "unprognostic (7.04e-2)" "unprognostic (1.78e-1)" "unprognostic (2.01e-3)" "prognostic favorable (1.92e-5)" "unprognostic (3.29e-2)" "prognostic favorable (5.98e-5)" "unprognostic (1.11e-1)" "unprognostic (1.93e-2)" "unprognostic (3.83e-2)" "unprognostic (3.54e-1)" "prognostic favorable (7.20e-5)" "unprognostic (1.10e-2)" "unprognostic (9.46e-2)" "unprognostic (7.36e-2)" "unprognostic (1.64e-5)" 11.8 6.1 8.9 6.6 6.6 0.2 9.9 1.9 15.1 8.4 3.0 3.7 3.0 1.2 13.1 6.4 6.5 9.6 4.4 4.9 9.8 5.3 2.5 1.6 25.2 14.6 8.7 6.2 12.4 0.8 18.4 6.0 0.3 17.9 7.0 1.8 4.3 5.1 7.5 3.2 3.2 4.5 9.8 3.2 2.0 11.7 2.9 3.1 1.6 2.3 5.5 11.1 4.8 9.1 0.0 1.6 0.0 0.0 0.0 1.1 0.0 1.6 4.8 0.0 0.0 1.2 12.7 0.1 4.8 12.1 1.9 2.4 2.2 0.4 0.0 0.7 2.2 9.5 2.4 0.0 6.3 0.4 0.1 4.4 0.0 3.1 0.1 0.2 0.0 0.3 3.3 12.0 1.9 3.2 1.8 1.2 0.0 0.0 0.2 3.2 0.5 0.0 0.0 0.8 4.0 11.5 0.0 0.3 1.1 3.0 1.7 0.7 5.9 1.2 0.2 0.1 0.2 1.4 0.0 2.8 0.3 1.7 15.0 4.2 0.0 0.0 0.0 15.6 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 8.9 6.6 1.9 15.1 9.8 5.3 8.7 6.2 17.9 3.1 202.5 27.6 0.0 7.4 4.5 4.2 7.1 5.1 2.7 10.3 1.8 62.8 0.0 5.0 1.8 30.7 19.4 0.4 0.0 1.0 0.0 2.0 4.4 3.5 0.9 2.3 39.7 1.7 9.2 0.6 20.2 6.6 2.4 6.8 0.0 0.5 0.9 6.8 0.2 19.1 8.6 3.7 12.9 38.7 2.7 2.0 2.5 0.0 0.0 0.9 2.7 ANKRD34B DP58 ENSG00000189127 "Ankyrin repeat domain 34B" A5PLL1 5 80556755-80570488 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 31.0" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 2.0;Collecting duct cells: 3.5;Intestinal endocrine cells: 1.7;Kupffer cells: 3.2" "Cancer enhanced" "Detected in some" "prostate cancer: 2.3" "Region enriched" "Detected in many" 6 "basal ganglia: 31.0" "Cell type enriched" "Detected in some" 5 "neutrophil: 7.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 7.2" "Cell line enriched" "Detected in some" 29 "RPTEC TERT1: 46.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043327 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA043327: AB_10794180" "unprognostic (1.05e-1)" "unprognostic (4.16e-6)" "unprognostic (2.07e-4)" "unprognostic (1.05e-1)" "unprognostic (3.03e-1)" "unprognostic (8.25e-4)" "unprognostic (6.44e-2)" "unprognostic (1.80e-1)" "unprognostic (9.41e-2)" "unprognostic (6.52e-3)" "unprognostic (1.93e-1)" "unprognostic (4.28e-2)" "unprognostic (1.02e-1)" "unprognostic (2.33e-1)" "unprognostic (2.94e-2)" 0.1 0.3 0.9 1.5 31.0 5.7 0.3 0.0 0.9 0.5 0.1 0.4 0.3 0.1 0.2 0.2 0.1 0.1 0.2 0.1 1.0 4.1 2.8 0.1 0.2 3.0 1.2 0.2 0.0 0.0 0.0 0.0 0.4 0.7 0.5 0.2 0.0 0.3 0.2 0.0 0.1 0.1 0.2 0.4 1.0 0.1 1.0 5.1 0.0 0.1 0.0 4.6 0.1 0.0 0.0 0.0 7.2 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 46.9 0.0 0.1 0.2 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.3 0.9 31.0 0.0 0.9 1.0 4.1 1.2 0.2 0.7 5.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 1.7 0.0 3.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 ANKRD35 FLJ25124 ENSG00000198483 "Ankyrin repeat domain 35" Q8N283 1 145866560-145885866 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 42.4" "Cell type enhanced" "Detected in many" 9 "Leydig cells: 33.6;Muller glia cells: 39.3;Peritubular cells: 47.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 5.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 11.0;THP-1: 7.4;TIME: 9.4;U-87 MG: 9.4;U-937: 8.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA035453 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA035453: AB_10672864" "prognostic favorable (9.35e-4)" "prognostic favorable (2.90e-4)" "unprognostic (2.07e-1)" "unprognostic (7.39e-3)" "unprognostic (1.77e-2)" "unprognostic (1.02e-2)" "unprognostic (3.27e-1)" "unprognostic (3.58e-2)" "unprognostic (3.03e-1)" "unprognostic (1.79e-1)" "unprognostic (2.98e-1)" "unprognostic (5.86e-2)" "unprognostic (9.29e-10)" "unprognostic (8.80e-3)" "unprognostic (2.18e-1)" "unprognostic (5.92e-2)" "unprognostic (8.69e-3)" 2.1 1.2 3.3 1.0 3.7 0.4 3.6 12.1 7.4 16.1 1.7 0.8 0.3 0.5 2.1 1.3 11.4 2.5 1.1 0.8 3.4 3.6 0.4 1.4 0.8 0.5 3.7 3.4 2.8 0.5 0.2 0.3 0.3 8.0 2.5 0.8 0.3 4.2 2.3 5.2 42.4 0.7 1.8 2.0 0.4 1.2 0.8 0.3 0.7 0.3 14.9 13.6 2.3 7.7 0.0 1.3 0.3 5.5 1.5 2.9 1.9 0.1 0.0 0.0 0.0 2.5 11.0 0.3 1.6 4.0 0.5 1.3 0.4 0.0 0.0 0.3 1.3 0.0 0.2 0.0 0.0 0.2 0.0 0.0 3.2 0.0 0.0 1.3 3.1 0.1 3.8 0.5 0.3 0.1 0.1 0.5 0.0 0.0 0.0 2.4 0.0 0.0 4.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 7.4 9.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 9.4 8.2 0.0 0.0 5.5 0.0 2.0 2.0 0.3 0.0 0.8 2.9 0.7 0.0 0.6 1.9 0.3 1.5 0.4 1.3 1.5 1.9 3.3 3.7 12.1 7.4 3.4 3.6 3.7 3.4 8.0 0.3 0.0 0.0 0.0 14.7 4.0 1.5 1.2 2.5 4.0 1.2 1.8 0.0 0.1 0.0 0.0 3.6 1.0 0.0 0.0 0.4 0.1 20.2 8.0 19.5 8.6 8.7 0.0 0.0 1.8 1.6 4.7 33.6 1.1 5.0 0.0 0.0 39.3 0.1 0.0 47.7 0.0 1.4 0.0 5.2 0.0 0.9 10.8 0.2 7.5 0.0 12.9 ANKRD36 UNQ2430 ENSG00000135976 "Ankyrin repeat domain 36" A6QL64 2 97113496-97264521 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 70.7;Rod photoreceptor cells: 71.9;Spermatocytes: 72.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 13.9" "HPA051757, HPA057661" Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA051757: AB_2681594, HPA057661: AB_2683494" "unprognostic (4.24e-3)" "unprognostic (7.59e-2)" "unprognostic (6.15e-3)" "unprognostic (9.86e-2)" "unprognostic (9.83e-3)" "unprognostic (5.25e-3)" "unprognostic (5.65e-2)" "unprognostic (1.49e-2)" "unprognostic (4.37e-2)" "unprognostic (1.94e-1)" "unprognostic (1.00e-1)" "unprognostic (2.51e-2)" "unprognostic (9.14e-7)" "unprognostic (1.67e-2)" "unprognostic (2.23e-1)" "unprognostic (2.64e-2)" "unprognostic (1.75e-1)" 5.1 3.3 8.8 6.0 14.5 22.0 6.8 20.5 10.2 5.6 4.6 4.8 2.2 3.0 8.5 7.7 2.4 6.0 3.8 3.9 7.6 3.3 3.2 1.8 5.0 5.0 4.0 11.3 8.9 5.1 5.3 9.2 2.3 6.8 4.8 5.2 4.7 4.3 3.1 2.2 5.9 4.3 4.7 3.7 5.9 5.1 13.3 8.2 5.6 5.4 2.1 3.7 4.0 4.9 9.9 11.7 9.3 3.3 4.9 9.2 1.7 6.2 1.5 5.1 3.2 1.1 2.6 2.4 2.4 1.7 1.9 1.9 1.6 3.2 8.0 1.6 2.3 1.5 3.1 1.9 2.1 1.6 3.8 2.8 6.0 6.8 2.9 0.5 4.4 2.6 1.7 1.4 1.4 2.4 3.0 3.4 11.2 4.1 13.9 0.8 1.1 5.5 5.8 1.2 0.5 2.9 5.3 2.1 2.2 1.4 3.0 3.6 2.6 2.5 1.5 0.8 2.9 1.6 2.5 5.2 5.4 5.3 6.2 2.8 8.2 3.5 6.5 3.1 6.4 1.8 9.3 2.6 3.5 9.2 1.2 9.1 9.9 8.4 7.3 1.2 9.9 8.6 9.2 3.9 4.9 3.3 11.7 7.0 1.7 8.8 14.5 20.5 10.2 7.6 3.3 4.0 11.3 6.8 8.2 41.7 27.2 12.9 8.0 14.0 47.0 19.1 0.0 44.2 27.3 7.0 70.7 0.9 0.0 5.7 53.0 19.6 2.0 0.0 15.9 4.8 14.4 5.5 25.5 0.8 4.5 20.6 13.2 9.8 4.6 5.3 24.2 17.3 37.1 4.6 6.8 13.0 9.3 3.4 17.0 1.4 71.9 0.0 23.1 72.1 11.9 8.2 0.3 25.4 8.5 12.9 ANKRD36B "FLJ21281, KIAA1641" ENSG00000196912 "Ankyrin repeat domain 36B" Q8N2N9 2 97492663-97589965 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 16.4" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 49.5" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA051757, HPA057661" Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA051757: AB_2681594, HPA057661: AB_2683494" "unprognostic (2.07e-1)" "unprognostic (9.96e-2)" "unprognostic (1.53e-1)" "unprognostic (2.05e-2)" "unprognostic (2.92e-1)" "unprognostic (1.30e-1)" "unprognostic (2.85e-1)" "unprognostic (8.72e-3)" "unprognostic (5.03e-2)" "unprognostic (7.17e-3)" "unprognostic (4.20e-2)" "unprognostic (4.00e-2)" "unprognostic (2.13e-6)" "unprognostic (1.07e-1)" "unprognostic (2.54e-1)" "unprognostic (7.71e-3)" "unprognostic (6.98e-2)" 1.0 1.5 2.0 2.8 7.0 16.4 3.3 6.8 6.7 1.4 1.7 1.6 0.2 1.3 3.8 2.0 0.5 2.0 2.1 0.8 3.1 1.1 0.4 2.2 2.3 4.3 6.2 3.8 1.7 1.8 3.3 0.7 3.9 1.8 2.7 1.0 2.6 3.0 0.7 3.6 2.1 1.9 1.9 1.7 1.7 7.5 4.0 4.2 1.3 2.8 2.1 1.2 0.8 3.5 2.6 3.4 0.7 2.6 3.0 0.3 3.6 2.3 2.7 2.3 1.6 3.6 1.7 2.6 1.7 1.7 1.9 2.2 4.5 5.2 1.4 2.1 1.6 1.7 1.7 1.2 1.8 1.5 4.2 4.1 4.7 1.6 1.2 3.2 2.4 2.4 2.1 2.1 3.5 4.0 2.2 10.7 5.5 4.4 2.0 0.9 4.0 5.8 1.3 0.8 2.7 5.0 1.3 1.8 1.8 2.3 3.0 4.3 1.9 1.6 1.4 3.6 2.6 3.0 3.3 3.0 3.5 3.5 3.4 6.1 7.7 4.8 1.8 4.3 1.5 3.4 0.7 0.9 2.2 0.3 2.0 2.2 2.6 1.8 0.3 3.5 3.0 2.3 0.5 2.6 0.2 2.6 1.3 0.3 11.9 16.7 6.2 6.2 0.0 34.4 12.2 2.5 30.8 31.8 8.7 19.6 1.3 0.0 6.9 39.2 6.8 2.6 0.0 11.9 3.0 2.6 4.5 22.0 0.6 2.9 15.9 13.8 3.1 2.7 3.6 11.8 3.9 0.0 10.0 9.0 9.5 8.7 4.0 7.1 0.5 35.1 6.5 1.4 49.5 6.8 0.0 0.1 13.8 5.8 10.4 ANKRD36C DKFZp667P0924 ENSG00000174501 "Ankyrin repeat domain 36C" Q5JPF3 2 95836919-95991831 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 19.6" "Cell type enhanced" "Detected in many" 9 "Exocrine glandular cells: 514.5;Pancreatic endocrine cells: 319.5;Urothelial cells: 431.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 25.5" "HPA051757, HPA057661" Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA051757: AB_2681594, HPA057661: AB_2683494" "unprognostic (2.21e-1)" "unprognostic (5.39e-2)" "unprognostic (6.32e-2)" "unprognostic (2.50e-1)" "unprognostic (1.83e-1)" "unprognostic (3.79e-3)" "unprognostic (1.29e-1)" "unprognostic (5.57e-2)" "unprognostic (1.57e-1)" "unprognostic (2.03e-1)" "unprognostic (1.44e-2)" "unprognostic (5.29e-3)" "unprognostic (5.35e-6)" "unprognostic (9.99e-2)" "unprognostic (2.47e-1)" "unprognostic (3.44e-2)" "unprognostic (1.79e-1)" 2.2 1.0 4.2 1.8 4.1 13.2 5.3 8.0 5.8 3.1 3.1 0.5 2.8 0.7 3.2 1.9 1.8 2.6 4.0 1.5 3.3 1.8 1.2 0.8 2.0 2.7 1.6 1.7 5.6 3.1 1.2 3.9 0.9 3.1 1.6 2.1 2.1 9.2 1.5 0.9 2.9 2.6 1.5 1.9 2.4 4.5 10.1 1.1 2.8 1.6 2.4 4.0 2.5 2.2 11.1 19.6 18.1 2.0 7.2 12.5 0.7 6.6 1.3 2.8 1.9 1.8 4.9 1.0 1.6 1.1 2.1 2.7 1.5 1.5 6.6 2.1 1.1 2.1 1.5 2.5 1.2 2.7 3.8 3.3 2.7 3.2 1.9 0.4 7.8 2.0 1.4 1.0 1.6 0.8 2.1 3.5 9.6 2.6 8.4 2.3 0.9 6.0 2.9 0.6 0.3 25.5 3.2 2.1 2.7 1.0 1.3 2.5 2.2 1.0 1.7 1.1 1.1 0.8 1.9 3.9 2.6 2.9 2.0 1.9 3.2 2.6 7.2 0.7 5.4 1.0 18.1 2.0 1.5 12.5 0.3 8.1 9.2 10.0 8.1 1.4 11.1 8.7 8.5 0.1 7.2 0.5 19.6 8.3 0.7 4.2 4.1 8.0 5.8 3.3 1.8 1.6 1.7 3.1 1.1 35.7 24.0 8.3 28.7 9.5 80.2 21.4 5.1 61.6 79.6 8.7 74.6 0.2 0.0 187.2 85.1 14.3 7.4 23.3 514.5 0.7 15.0 147.9 31.4 1.3 6.9 31.8 20.2 8.0 6.7 8.4 30.2 13.0 13.5 40.5 53.0 17.5 319.5 7.4 34.3 0.3 74.8 19.4 17.0 86.7 12.4 6.5 0.2 28.8 13.0 431.0 ANKRD37 Lrp2bp ENSG00000186352 "Ankyrin repeat domain 37" Q7Z713 4 185396021-185400628 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Melanocytes: 135.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036626, HPA058127" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "HPA036626: AB_10671963, HPA058127: AB_2683614" "unprognostic (9.08e-2)" "unprognostic (2.85e-3)" "unprognostic (3.89e-2)" "unprognostic (2.36e-3)" "unprognostic (1.19e-1)" "unprognostic (2.27e-1)" "unprognostic (7.51e-2)" "unprognostic (9.12e-2)" "unprognostic (1.74e-1)" "unprognostic (1.09e-1)" "unprognostic (7.36e-2)" "unprognostic (9.69e-3)" "unprognostic (2.81e-2)" "unprognostic (1.38e-1)" "unprognostic (1.41e-1)" "unprognostic (6.45e-3)" "unprognostic (1.08e-1)" 7.7 8.9 11.0 3.9 15.2 3.3 10.9 9.9 20.9 17.2 7.5 6.0 5.4 4.8 4.9 4.1 35.8 8.0 4.8 13.6 12.0 9.6 6.4 14.2 12.4 3.0 12.3 5.8 14.8 13.5 1.7 11.7 10.7 16.8 24.1 7.0 8.4 35.4 21.9 22.1 7.3 4.9 5.0 16.1 4.6 5.2 8.7 14.2 1.5 14.2 18.6 12.2 14.3 22.8 7.7 4.2 10.2 3.9 3.2 8.1 3.0 6.2 0.9 0.7 3.6 4.9 3.1 3.4 2.9 2.2 2.1 4.7 1.5 1.8 3.0 1.2 5.3 4.4 2.4 3.4 3.7 2.7 8.5 0.9 2.0 3.2 4.5 2.1 1.9 4.7 0.6 4.0 2.0 2.8 15.7 2.7 2.0 3.1 5.1 5.9 1.6 1.6 7.5 1.0 0.6 5.0 0.5 1.0 8.2 2.6 0.5 5.0 8.9 2.0 2.0 8.6 2.7 1.8 1.2 3.5 4.6 3.7 2.6 3.3 9.6 2.8 1.3 13.1 1.4 5.3 0.4 3.8 10.2 5.5 3.5 4.7 7.6 4.3 8.1 2.6 7.7 3.3 4.7 2.0 3.2 3.9 4.2 5.1 3.0 11.0 15.2 9.9 20.9 12.0 9.6 12.3 5.8 16.8 14.2 20.8 23.7 16.6 23.8 52.8 24.8 1.2 0.0 101.7 22.7 8.7 27.5 15.7 21.6 17.9 3.7 11.7 61.7 23.3 20.0 36.6 28.6 40.4 63.2 20.4 13.8 9.5 115.1 10.4 6.7 2.0 8.6 24.5 135.0 28.9 93.8 89.4 40.5 35.1 11.0 15.7 103.2 6.5 35.0 13.3 15.1 42.0 70.6 11.7 31.3 16.2 ANKRD39 MGC41816 ENSG00000213337 "Ankyrin repeat domain 39" Q53RE8 2 96836611-96858095 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 73.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042678 Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA042678: AB_10794532" "unprognostic (6.26e-2)" "unprognostic (1.32e-1)" "prognostic unfavorable (2.26e-4)" "unprognostic (9.53e-2)" "unprognostic (2.28e-2)" "unprognostic (2.09e-1)" "unprognostic (4.03e-2)" "unprognostic (1.68e-1)" "unprognostic (9.25e-2)" "unprognostic (3.12e-3)" "prognostic favorable (6.12e-5)" "unprognostic (6.15e-2)" "prognostic unfavorable (6.78e-9)" "unprognostic (3.16e-1)" "unprognostic (1.14e-1)" "unprognostic (5.03e-2)" "prognostic favorable (5.21e-4)" 8.9 16.2 17.1 9.2 19.2 12.0 6.9 29.4 20.8 7.4 8.3 15.0 7.2 11.2 11.7 5.9 7.6 10.9 7.9 17.6 14.8 14.7 6.5 12.6 7.6 13.0 13.5 14.0 7.3 11.2 11.7 14.2 7.4 13.4 10.4 5.6 10.3 9.5 10.1 6.3 10.9 8.4 9.5 10.7 8.9 7.9 3.7 13.0 5.4 6.3 4.3 8.7 9.0 5.8 15.5 29.0 7.1 9.0 14.4 27.8 8.7 6.4 4.2 2.4 5.3 0.8 1.6 5.9 5.0 2.3 6.3 4.8 10.4 2.7 4.1 7.4 3.6 5.0 2.8 3.1 4.7 1.4 4.7 9.3 2.9 3.8 14.1 4.2 6.6 7.2 3.1 2.8 5.7 2.2 2.3 4.5 8.6 6.1 73.5 2.3 10.1 6.2 5.2 3.1 2.2 9.8 4.7 1.7 23.0 3.2 3.3 5.6 3.7 3.6 8.5 6.3 2.3 2.5 3.6 2.2 3.9 3.9 4.4 8.8 3.8 4.1 6.7 4.0 7.6 4.1 7.1 6.9 5.3 19.6 8.3 16.4 15.5 19.4 17.2 6.8 13.6 10.8 13.3 3.5 14.4 9.0 29.0 27.8 8.7 17.1 19.2 29.4 20.8 14.8 14.7 13.5 14.0 13.4 13.0 6.0 6.2 15.2 17.4 8.4 22.4 15.9 22.9 45.5 11.4 8.7 3.9 39.8 21.6 26.0 4.0 12.0 12.9 0.0 27.9 33.6 16.9 10.0 12.7 24.6 26.7 31.8 17.9 9.8 9.9 2.0 11.5 10.8 27.0 8.2 17.9 14.6 32.4 8.6 13.8 20.7 27.7 25.8 24.0 12.5 17.8 15.6 18.1 24.9 16.8 13.6 ANKRD42 "FLJ37874, PPP1R79, SARP" ENSG00000137494 "Ankyrin repeat domain 42" Q8N9B4 11 83193739-83260694 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 41.8" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 73.6;Early spermatids: 123.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039917 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" No No "Nucleoplasm, Cytosol" "Plasma membrane" "HPA039917: AB_10672894" "unprognostic (6.59e-2)" "unprognostic (9.00e-2)" "unprognostic (1.00e-1)" "unprognostic (1.31e-3)" "unprognostic (9.12e-2)" "unprognostic (3.78e-1)" "unprognostic (1.67e-2)" "unprognostic (1.03e-1)" "unprognostic (1.11e-1)" "unprognostic (2.11e-1)" "unprognostic (2.99e-2)" "unprognostic (1.59e-1)" "unprognostic (1.09e-2)" "unprognostic (3.10e-3)" "unprognostic (1.79e-1)" "unprognostic (4.25e-1)" "unprognostic (1.90e-1)" 5.6 14.5 13.9 5.4 22.1 8.3 7.1 4.8 15.1 8.2 5.4 3.0 11.6 5.8 6.9 22.2 5.6 17.2 8.7 5.4 18.1 13.4 12.3 5.2 7.4 4.5 8.2 12.4 9.9 8.6 16.8 17.9 4.5 13.1 8.4 4.8 6.5 6.7 10.3 6.1 6.2 5.3 6.7 8.7 4.8 6.4 41.8 5.3 1.0 13.0 1.5 4.5 6.8 16.1 7.1 4.8 7.9 11.1 5.8 4.3 2.1 3.9 6.9 3.3 6.8 10.7 11.2 3.0 8.1 6.3 4.8 3.0 4.2 4.8 1.7 10.5 7.2 9.7 8.5 3.5 5.5 4.0 2.2 2.8 2.8 9.4 2.7 7.4 7.8 6.6 6.6 6.6 12.1 6.5 9.4 4.9 2.8 8.1 1.6 6.9 5.8 1.1 8.6 2.8 6.1 4.4 1.9 5.0 2.0 16.0 4.7 2.7 3.5 10.5 6.6 2.1 4.6 9.9 4.4 7.1 7.5 5.2 27.2 3.7 2.1 4.7 3.3 5.9 4.9 3.1 7.9 3.6 4.3 4.1 4.1 2.8 7.1 3.7 4.3 4.8 5.2 1.9 3.0 3.0 5.8 11.1 2.0 1.4 2.1 13.9 22.1 4.8 15.1 18.1 13.4 8.2 12.4 13.1 5.3 8.9 13.6 3.2 17.5 10.0 3.0 6.7 7.6 73.6 7.9 7.0 37.3 2.7 8.3 6.6 123.0 7.1 3.6 0.0 5.8 2.7 8.7 10.0 12.8 3.8 4.4 1.6 2.9 9.2 8.2 53.0 8.1 9.0 6.8 6.4 3.2 6.7 5.4 3.6 9.9 11.4 21.3 12.9 8.7 38.6 18.1 13.4 4.6 7.0 3.1 11.2 ANKRD49 "FGIF, FLJ20189, GBIF" ENSG00000168876 "Ankyrin repeat domain 49" Q8WVL7 11 94493629-94499583 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040273, HPA048137" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA040273: AB_10674991, HPA048137: AB_2680279" "unprognostic (1.52e-2)" "unprognostic (2.76e-2)" "unprognostic (1.92e-1)" "unprognostic (5.22e-3)" "unprognostic (1.71e-2)" "unprognostic (1.30e-1)" "unprognostic (9.06e-3)" "unprognostic (1.46e-2)" "unprognostic (7.21e-3)" "unprognostic (1.36e-1)" "unprognostic (1.23e-1)" "unprognostic (4.21e-3)" "prognostic unfavorable (9.96e-4)" "unprognostic (6.32e-3)" "unprognostic (2.82e-1)" "unprognostic (3.40e-2)" "prognostic favorable (6.16e-4)" 9.8 9.0 10.2 10.7 10.8 19.6 12.7 18.6 10.9 15.6 14.8 4.5 9.5 11.2 15.1 19.6 13.2 8.2 7.9 5.7 9.5 6.9 13.3 11.0 10.4 17.5 7.2 8.5 12.3 15.6 9.1 27.9 16.3 7.7 12.6 13.1 7.7 12.1 10.7 7.9 8.8 19.2 9.6 12.5 21.3 12.1 5.3 8.5 22.6 18.0 9.9 19.2 11.9 9.3 20.5 17.7 34.7 15.1 17.3 19.6 10.5 6.4 2.9 7.6 6.5 7.5 9.6 9.2 10.2 9.1 10.7 12.7 14.2 12.7 17.0 15.7 7.2 9.3 14.1 9.2 6.9 8.6 13.3 7.4 14.7 11.4 4.8 8.6 12.9 11.8 6.7 17.4 8.2 11.5 7.9 8.4 15.1 13.9 10.1 7.0 4.4 13.7 23.4 4.4 12.2 7.3 11.1 8.5 8.5 10.1 6.8 7.5 7.8 7.0 7.0 6.3 14.2 14.2 8.7 5.2 9.7 6.8 10.6 5.1 5.9 13.6 18.1 3.2 15.6 5.5 34.7 15.1 12.6 14.9 12.5 16.3 20.5 15.9 13.1 11.4 19.6 19.6 17.9 27.1 17.3 9.3 17.7 19.1 10.5 10.2 10.8 18.6 10.9 9.5 6.9 7.2 8.5 7.7 8.5 11.9 9.4 31.8 9.7 4.9 15.9 5.3 17.8 8.1 17.0 24.4 13.7 25.3 18.3 16.9 4.4 13.5 27.1 46.7 20.0 13.5 13.3 9.6 19.8 16.6 12.2 11.1 12.9 16.0 28.9 1.5 33.1 17.8 10.1 13.6 20.3 20.2 18.8 30.3 22.3 12.6 14.5 25.8 11.8 22.3 18.8 5.9 23.5 35.0 21.1 5.1 ANKRD50 KIAA1223 ENSG00000151458 "Ankyrin repeat domain 50" Q9ULJ7 4 124664052-124712732 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 45.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.8" "Group enriched" "Detected in many" 5 "dendritic cells: 2.4;monocytes: 3.8" "Cell line enhanced" "Detected in many" "hTERT-HME1: 22.2;HUVEC TERT2: 22.1;TIME: 55.6" "Low region specificity" "Detected in all" HPA044008 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA044008: AB_10961996" "unprognostic (7.82e-2)" "unprognostic (1.68e-2)" "unprognostic (6.85e-3)" "unprognostic (5.90e-1)" "unprognostic (9.77e-2)" "unprognostic (1.19e-1)" "unprognostic (2.72e-1)" "unprognostic (7.26e-2)" "unprognostic (1.63e-1)" "unprognostic (3.02e-1)" "prognostic unfavorable (3.28e-4)" "unprognostic (1.67e-1)" "unprognostic (8.25e-2)" "unprognostic (5.55e-3)" "unprognostic (4.82e-2)" "unprognostic (8.23e-2)" "unprognostic (8.16e-3)" 10.1 4.8 6.6 8.2 6.8 4.7 7.6 4.0 8.3 17.1 10.0 4.3 8.7 3.7 17.5 7.4 11.4 5.9 10.2 7.3 6.2 6.5 9.8 6.9 13.4 5.4 5.5 6.5 9.0 5.2 12.5 3.9 17.1 6.2 19.1 6.9 6.7 7.7 7.9 3.2 12.9 7.9 14.2 4.8 7.1 8.2 16.8 4.8 15.4 9.2 5.8 4.4 16.5 10.9 0.1 2.4 0.5 3.8 0.4 0.1 0.4 2.3 4.3 12.3 5.7 9.8 6.3 1.2 6.0 5.1 3.1 2.0 1.9 3.0 0.0 1.9 8.5 2.8 2.1 8.1 4.6 5.5 0.0 1.7 1.9 5.6 1.8 7.0 3.2 2.5 6.3 6.3 4.9 22.2 5.9 22.1 2.2 3.5 4.2 5.9 5.3 4.0 1.1 2.5 3.4 6.4 3.3 3.8 0.5 3.9 9.6 3.5 4.4 4.1 2.6 4.8 5.3 2.8 2.7 55.6 6.7 5.2 3.2 5.1 3.1 0.0 0.8 3.0 1.4 7.6 0.0 1.5 0.5 0.0 3.8 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.1 0.0 0.4 2.3 0.9 0.0 0.4 6.6 6.8 4.0 8.3 6.2 6.5 5.5 6.5 6.2 4.8 29.8 18.2 0.5 15.0 35.8 2.8 8.4 15.3 8.1 6.8 5.2 0.0 1.9 0.0 8.8 35.0 14.5 3.8 0.0 17.2 23.7 15.5 12.9 4.7 6.8 4.8 20.6 8.1 31.9 10.0 45.7 6.4 8.7 10.1 2.8 3.1 2.9 13.7 2.9 11.3 3.3 1.0 0.0 18.6 16.8 9.7 26.8 3.4 0.0 4.5 15.8 ANKRD52 "FLJ34236, PP6-ARS-C" ENSG00000139645 "Ankyrin repeat domain 52" Q8NB46 12 56237807-56258391 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043815 Uncertain Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA043815: AB_10961762" "unprognostic (6.25e-3)" "unprognostic (6.45e-2)" "unprognostic (1.19e-1)" "unprognostic (2.67e-2)" "unprognostic (1.79e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (3.33e-4)" "unprognostic (9.84e-2)" "unprognostic (9.46e-2)" "unprognostic (5.43e-2)" "unprognostic (3.97e-3)" "unprognostic (1.24e-1)" "unprognostic (1.36e-1)" "unprognostic (1.61e-3)" "unprognostic (1.27e-1)" "unprognostic (3.70e-2)" "unprognostic (6.31e-2)" 10.7 23.2 12.3 13.2 19.6 12.1 10.8 23.1 23.5 10.8 11.6 15.6 9.1 11.9 13.8 8.9 10.9 11.5 12.7 12.0 12.7 13.4 13.2 8.3 9.8 12.3 13.3 14.7 14.6 14.1 28.4 14.5 12.6 22.8 11.9 12.1 14.8 11.6 13.6 30.8 15.8 13.0 15.8 8.8 11.9 10.9 8.5 13.5 10.5 12.4 11.4 13.4 12.3 11.8 1.1 1.1 2.4 0.6 0.3 1.2 0.5 11.7 29.2 13.0 23.5 10.6 8.4 9.2 23.6 10.5 21.2 9.6 18.9 6.6 12.6 15.1 23.0 7.4 15.4 14.3 10.3 12.3 12.1 14.5 22.6 19.0 7.2 7.3 17.7 13.2 8.6 11.7 19.7 10.0 15.6 12.3 10.4 9.2 6.9 19.8 16.4 14.2 5.9 5.4 7.7 13.5 11.2 9.0 5.0 14.0 15.1 9.9 9.0 25.7 16.5 9.4 10.5 13.3 6.9 16.9 22.2 19.5 12.4 14.7 6.4 8.4 6.2 22.8 5.9 14.4 2.4 0.6 0.9 1.2 0.1 1.0 0.8 0.4 0.7 0.3 1.1 0.6 0.7 0.3 0.3 0.4 1.1 0.3 0.5 12.3 19.6 23.1 23.5 12.7 13.4 13.3 14.7 22.8 13.5 6.0 4.0 4.7 2.9 10.0 4.7 5.6 2.5 0.0 0.0 12.2 25.5 5.1 0.0 8.4 0.3 4.8 8.3 0.0 8.0 6.2 5.3 4.5 1.1 6.0 6.2 7.9 9.2 6.2 6.5 0.8 5.8 3.9 10.1 4.6 6.8 3.7 12.4 9.0 4.6 5.8 6.1 0.0 5.2 6.7 8.1 9.5 3.1 4.8 7.3 3.7 ANKRD54 LIAR ENSG00000100124 "Ankyrin repeat domain 54" Q6NXT1 22 37830855-37849327 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071287 Approved Approved Nucleoplasm,Microtubules,Midbody Yes No "Microtubules, Midbody" Nucleoplasm "HPA071287: AB_2686380" "unprognostic (5.36e-2)" "prognostic favorable (2.06e-4)" "unprognostic (1.02e-1)" "prognostic favorable (7.38e-5)" "unprognostic (1.14e-1)" "unprognostic (1.50e-1)" "unprognostic (1.65e-2)" "unprognostic (1.77e-2)" "unprognostic (1.06e-1)" "unprognostic (3.41e-2)" "prognostic favorable (6.16e-4)" "unprognostic (2.53e-1)" "unprognostic (6.33e-2)" "unprognostic (1.13e-1)" "unprognostic (5.07e-2)" "unprognostic (1.89e-1)" "unprognostic (3.02e-3)" 7.8 14.8 18.4 7.9 15.8 7.5 9.1 20.0 19.5 13.5 11.9 14.1 17.4 9.8 11.2 14.9 13.6 33.5 11.4 8.9 17.1 20.6 13.0 11.9 9.3 8.1 14.2 12.1 19.0 24.6 15.3 16.4 7.9 14.8 13.1 9.4 13.4 19.1 16.3 9.3 11.8 9.5 13.5 11.7 7.5 8.9 23.7 11.0 12.3 18.2 8.7 9.8 11.6 13.9 6.2 6.7 3.5 10.0 12.8 6.9 3.8 10.9 11.1 9.4 13.8 12.7 7.1 5.0 15.2 11.7 25.8 15.8 7.0 4.3 10.6 6.3 9.9 8.3 9.8 12.0 8.4 12.5 8.5 24.2 5.3 10.1 16.7 11.3 10.5 12.8 6.4 8.8 13.9 8.2 6.3 15.7 7.9 7.0 7.4 11.7 11.5 10.2 12.1 2.7 14.7 10.2 11.9 11.5 6.6 14.2 3.6 16.4 8.8 12.7 11.3 18.0 4.4 11.6 16.7 9.1 15.0 16.2 7.8 11.1 8.3 6.7 8.4 12.5 9.0 10.8 2.6 5.4 2.4 6.8 6.4 6.8 4.5 6.6 5.2 6.7 6.2 6.9 3.4 3.5 12.8 10.0 6.7 2.8 3.8 18.4 15.8 20.0 19.5 17.1 20.6 14.2 12.1 14.8 11.0 11.9 16.4 13.9 9.0 14.1 17.4 7.1 22.9 33.5 11.4 17.4 27.5 18.3 33.2 14.5 5.0 9.0 15.5 0.0 12.7 15.1 10.4 8.9 9.2 9.6 11.6 25.4 8.6 11.1 8.1 6.0 16.7 9.5 10.1 8.2 12.6 16.9 11.3 15.2 20.1 14.7 22.1 6.5 14.4 54.6 39.2 15.4 14.1 16.0 14.4 8.8 ANKRD55 FLJ11795 ENSG00000164512 "Ankyrin repeat domain 55" Q3KP44 5 56099678-56233359 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 14.3;brain: 20.0;liver: 5.7;lymphoid tissue: 6.1;testis: 16.7" "Group enriched" "Detected in some" 7 "Early spermatids: 143.8;Ito cells: 52.8" "Cancer enriched" "Detected in single" 6 "testis cancer: 1.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 12.6;eosinophil: 13.1;naive CD4 T-cell: 14.3" "Group enriched" "Detected in many" 67 "granulocytes: 13.1;T-cells: 14.3" "Group enriched" "Detected in some" 6 "HEL: 24.5;HMC-1: 12.7;NB-4: 16.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA051049, HPA061649" Uncertain Approved "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "HPA051049: AB_2681326, HPA061649: " "unprognostic (1.00e-4)" "unprognostic (1.58e-4)" "unprognostic (2.63e-1)" "unprognostic (1.93e-1)" "unprognostic (7.78e-4)" "unprognostic (1.46e-3)" "unprognostic (1.47e-1)" "unprognostic (1.33e-2)" "unprognostic (1.47e-1)" "unprognostic (1.16e-1)" "unprognostic (1.33e-1)" "unprognostic (1.40e-1)" "unprognostic (7.19e-6)" "unprognostic (2.56e-2)" "unprognostic (1.48e-1)" "unprognostic (3.25e-2)" "unprognostic (1.01e-1)" 0.9 0.5 3.3 1.3 20.0 1.4 0.5 0.5 6.7 0.3 0.5 1.5 0.0 0.5 0.3 0.2 0.6 0.6 0.8 0.4 4.3 7.8 1.1 5.7 0.6 6.1 2.3 3.5 0.5 0.3 0.2 0.5 1.4 9.9 0.3 0.7 0.7 2.1 0.3 0.3 0.9 2.4 0.5 4.1 3.0 0.7 16.7 1.8 0.0 0.4 0.0 3.8 1.0 0.3 0.0 0.0 13.1 0.2 0.0 14.3 2.1 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 24.5 0.1 0.9 0.0 1.1 12.7 0.0 0.0 0.0 0.0 0.0 3.0 0.0 2.0 0.8 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 1.3 0.0 1.6 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 1.4 0.3 12.6 0.2 13.1 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 14.3 0.5 1.2 0.0 0.0 0.0 0.6 2.1 3.3 20.0 0.5 6.7 4.3 7.8 2.3 3.5 9.9 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 143.8 1.0 0.0 0.0 0.2 0.3 0.6 0.0 2.3 0.5 0.6 0.0 0.0 52.8 4.1 14.1 0.6 0.0 1.7 0.0 0.0 0.8 0.0 0.0 0.7 0.2 0.0 0.0 0.0 3.2 0.5 0.0 1.0 2.2 0.0 0.1 ANKRD61 ENSG00000157999 "Ankyrin repeat domain 61" A6NGH8 7 6031376-6036386 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "bone marrow: 8.7;testis: 9.1" "Group enriched" "Detected in some" 19 "Early spermatids: 44.1;Late spermatids: 19.5" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 12.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA029511, HPA050732" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA029511: AB_10602430, HPA050732: " "unprognostic (1.40e-1)" "unprognostic (1.03e-3)" "unprognostic (9.32e-2)" "unprognostic (5.67e-2)" "unprognostic (1.73e-1)" "unprognostic (2.56e-2)" "unprognostic (6.76e-2)" "unprognostic (2.65e-1)" "unprognostic (8.44e-2)" "unprognostic (8.46e-2)" "unprognostic (1.98e-1)" "unprognostic (6.68e-2)" "unprognostic (2.73e-2)" "unprognostic (5.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.55e-2)" "unprognostic (2.63e-1)" 0.5 0.5 0.0 0.7 0.2 8.7 0.7 0.5 0.9 0.4 0.3 0.6 0.6 0.0 0.4 0.5 0.2 0.6 0.1 0.1 0.3 0.5 0.5 1.1 0.0 0.8 1.0 0.1 0.5 0.4 0.4 0.0 0.9 0.0 0.6 2.1 0.8 0.0 0.2 0.9 0.9 9.1 0.9 0.0 0.5 0.5 0.6 1.5 0.9 1.1 0.0 0.8 0.3 2.2 6.0 1.8 2.8 0.3 0.3 2.6 1.4 0.4 0.6 0.6 3.0 5.6 1.1 0.6 0.2 2.6 2.2 1.0 0.0 0.7 0.3 0.8 1.5 12.7 0.4 0.2 1.7 2.6 0.4 1.2 0.5 1.1 1.3 0.5 1.7 2.0 1.8 0.7 3.8 0.3 1.8 0.9 0.4 0.7 1.6 0.5 0.3 0.5 2.9 1.4 2.5 1.4 1.6 0.2 2.9 3.0 1.1 1.2 2.4 4.9 2.9 1.8 1.6 1.8 0.9 0.7 1.4 1.5 0.9 1.1 0.0 0.1 1.1 0.0 0.0 0.0 0.8 1.5 0.6 0.1 0.5 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 44.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 ANKRD65 ENSG00000235098 "Ankyrin repeat domain 65" E5RJM6 1 1418420-1421769 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.8;fallopian tube: 33.6" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 56.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 14 "myeloid DC: 4.8;plasmacytoid DC: 10.4" "Lineage enriched" "Detected in single" 20 "dendritic cells: 10.4" "Group enriched" "Detected in some" 7 "Hep G2: 20.3;RT4: 20.0;SCLC-21H: 27.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA065720 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA065720: AB_2685545" "unprognostic (2.17e-2)" "unprognostic (2.52e-2)" "unprognostic (1.21e-1)" "unprognostic (2.77e-1)" "unprognostic (1.48e-1)" "unprognostic (1.69e-2)" "unprognostic (1.59e-1)" "prognostic favorable (1.08e-5)" "unprognostic (1.64e-1)" "unprognostic (4.39e-1)" "unprognostic (1.16e-1)" "unprognostic (4.43e-2)" "unprognostic (5.14e-2)" "unprognostic (3.02e-3)" "unprognostic (1.81e-2)" "unprognostic (8.04e-2)" "unprognostic (2.76e-2)" 4.6 1.1 12.4 2.8 20.8 0.4 4.2 8.0 13.3 6.7 4.8 21.0 3.7 2.2 4.0 5.6 6.7 33.6 2.7 2.2 12.0 8.6 1.9 0.9 9.9 7.1 37.8 8.2 6.9 13.3 1.1 0.6 6.3 13.7 8.9 1.8 2.1 14.0 21.2 2.8 4.8 2.1 3.8 16.7 1.4 4.3 3.1 28.0 4.2 1.8 1.0 6.3 13.2 3.3 0.5 10.4 0.3 0.3 0.0 0.4 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.5 0.0 2.6 0.2 2.5 0.0 0.3 0.2 0.0 0.0 20.3 0.5 0.0 0.0 0.2 3.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 2.7 0.0 0.0 20.0 27.7 0.2 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.0 4.8 0.5 0.1 0.4 0.0 0.0 0.0 10.4 0.0 0.2 12.4 20.8 8.0 13.3 12.0 8.6 37.8 8.2 13.7 28.0 20.8 25.3 0.0 11.4 1.9 8.4 0.6 12.7 56.2 20.5 1.8 0.0 21.2 8.3 12.9 0.0 5.0 0.0 0.0 27.8 0.4 3.8 7.3 8.1 0.6 2.0 7.9 1.7 1.8 0.6 0.0 19.2 2.9 3.3 1.8 0.0 16.0 12.0 0.0 27.3 0.3 2.2 0.0 2.6 0.4 0.3 2.8 14.1 0.0 0.0 7.9 ANKRD7 TSA806 ENSG00000106013 "Ankyrin repeat domain 7" Q92527 7 118214669-118496171 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 58 "testis: 184.1" "Group enriched" "Detected in some" 4 "Early spermatids: 2368.8;Spermatocytes: 2786.2" "Cancer enhanced" "Detected in some" "testis cancer: 1.9" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "memory B-cell: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 5.2;JURKAT: 5.8;SCLC-21H: 9.8;U-266/70: 12.7;WM-115: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA043489, HPA052941" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA043489: AB_10959304, HPA052941: " "unprognostic (1.29e-1)" "unprognostic (7.22e-4)" "unprognostic (3.13e-3)" "unprognostic (6.16e-2)" "unprognostic (8.49e-2)" "unprognostic (1.69e-1)" "unprognostic (5.51e-1)" "unprognostic (9.46e-2)" "unprognostic (1.44e-1)" "unprognostic (2.63e-3)" "unprognostic (1.45e-2)" "unprognostic (1.55e-2)" "unprognostic (3.35e-2)" "unprognostic (3.57e-4)" "unprognostic (3.32e-2)" 0.1 0.1 0.5 0.0 0.8 0.0 0.1 0.1 1.0 0.1 0.1 0.0 0.0 0.1 0.1 1.3 0.1 0.1 0.0 0.1 0.4 0.1 0.2 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.9 0.0 1.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 184.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 3.1 0.4 1.0 0.0 0.0 0.8 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 5.2 1.6 0.0 3.1 0.0 0.1 0.3 0.1 1.4 1.0 0.0 0.0 0.0 1.9 0.0 0.0 2.3 0.4 0.7 0.0 0.4 0.0 5.8 0.0 2.2 1.4 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 2.4 0.0 0.0 1.9 0.0 0.0 1.2 0.4 0.0 1.1 0.3 0.0 12.7 0.6 0.5 1.8 0.0 4.0 0.0 0.0 1.0 0.4 0.0 0.3 3.1 0.2 0.6 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.4 0.0 0.1 0.5 0.8 0.1 1.0 0.4 0.1 0.1 0.3 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.4 2.5 0.0 0.0 0.0 0.0 0.1 5.0 0.1 2368.8 0.3 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.1 3.2 0.0 0.0 0.0 635.0 36.5 0.0 1.7 0.0 0.0 1.2 0.1 0.0 27.6 1.4 0.0 25.8 0.1 2786.2 17.7 0.1 0.0 0.0 0.0 0.0 ANKS1A "ANKS1, KIAA0229" ENSG00000064999 "Ankyrin repeat and sterile alpha motif domain containing 1A" Q92625 6 34889265-35091413 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 74.5;Cone photoreceptor cells: 60.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SCLC-21H: 32.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036768, HPA036769" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036768: AB_10670923, HPA036769: AB_10672473" "unprognostic (3.75e-2)" "unprognostic (2.67e-1)" "unprognostic (2.59e-2)" "unprognostic (7.79e-3)" "unprognostic (5.73e-2)" "prognostic favorable (7.48e-4)" "unprognostic (1.18e-3)" "unprognostic (3.51e-3)" "unprognostic (1.62e-1)" "unprognostic (2.18e-1)" "unprognostic (1.42e-1)" "unprognostic (1.38e-2)" "prognostic favorable (8.05e-5)" "unprognostic (1.76e-1)" "unprognostic (9.71e-2)" "unprognostic (2.23e-2)" "unprognostic (7.80e-2)" 13.6 15.6 11.8 10.5 20.7 5.0 11.5 19.2 19.9 8.8 20.3 11.6 33.9 9.8 10.2 11.0 15.4 19.8 9.9 14.8 11.7 8.0 10.3 11.6 14.5 8.0 15.0 8.8 14.6 11.0 13.9 12.8 27.3 12.8 9.3 8.7 19.7 8.5 30.4 14.8 11.6 10.9 13.9 10.6 18.6 12.3 23.6 13.9 9.5 11.3 4.2 9.1 22.7 9.9 1.3 3.4 2.4 4.3 0.5 1.5 1.1 8.1 3.6 8.4 8.1 3.8 3.5 12.9 3.4 3.8 3.8 5.0 10.1 4.9 5.4 5.4 3.3 7.3 8.3 9.7 9.1 4.2 4.3 11.4 3.9 4.7 7.6 2.3 6.2 3.9 4.3 8.4 4.9 6.2 4.4 9.1 6.0 6.7 2.5 3.6 5.4 3.7 7.0 6.1 10.5 4.4 4.8 4.4 5.8 8.3 15.7 32.8 8.2 4.9 8.0 25.0 11.0 6.1 7.2 7.9 4.1 5.2 4.2 4.9 3.8 5.8 2.6 3.2 9.4 11.4 0.0 2.0 1.2 0.9 2.9 1.2 1.3 0.8 1.5 1.5 0.5 1.0 0.8 2.4 0.5 4.3 3.4 1.0 1.1 11.8 20.7 19.2 19.9 11.7 8.0 15.0 8.8 12.8 13.9 74.5 10.7 4.6 6.7 10.8 27.5 21.2 12.7 29.4 9.1 12.2 60.9 7.4 0.0 6.6 11.3 34.4 11.8 0.0 5.1 6.3 8.5 9.5 2.3 4.9 9.8 7.9 12.7 50.3 26.9 8.1 11.8 10.1 5.0 4.6 11.3 21.8 8.6 5.8 28.3 5.6 44.8 19.4 8.9 5.8 4.9 17.9 10.4 2.5 7.7 11.5 ANKS3 "FLJ32345, FLJ32767, KIAA1977" ENSG00000168096 "Ankyrin repeat and sterile alpha motif domain containing 3" Q6ZW76 16 4696510-4734378 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 104.1;Rod photoreceptor cells: 98.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041409, HPA041482" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041409: AB_10794375, HPA041482: AB_10795594" "unprognostic (3.02e-1)" "unprognostic (2.19e-1)" "unprognostic (3.06e-2)" "unprognostic (2.55e-2)" "unprognostic (5.44e-2)" "unprognostic (1.31e-3)" "unprognostic (1.05e-2)" "unprognostic (8.65e-2)" "unprognostic (3.75e-1)" "unprognostic (4.42e-2)" "unprognostic (7.36e-3)" "unprognostic (1.77e-2)" "unprognostic (1.10e-1)" "unprognostic (2.19e-1)" "unprognostic (2.66e-1)" "unprognostic (9.96e-2)" "unprognostic (1.57e-3)" 6.9 10.1 7.4 6.4 12.0 4.2 8.9 14.5 11.1 8.1 9.3 8.2 5.0 6.2 8.7 6.7 8.2 9.3 6.8 5.6 8.3 8.5 10.5 5.0 5.8 8.6 10.0 10.9 15.7 16.5 6.8 14.2 5.6 9.7 9.1 3.2 10.9 14.4 10.2 7.7 8.3 4.8 11.7 7.0 5.2 6.1 8.0 7.5 3.2 9.4 3.4 4.7 7.6 7.5 3.3 5.3 0.0 1.6 1.3 3.8 1.1 1.9 23.2 3.0 6.6 5.9 4.9 7.0 8.7 7.1 8.1 7.3 12.0 4.9 4.4 11.0 5.8 3.2 3.9 6.5 4.7 3.6 5.7 12.5 4.0 10.8 2.9 6.4 2.1 3.6 3.0 5.1 7.8 7.5 4.9 1.5 2.9 9.4 1.4 4.8 7.1 4.2 7.9 8.1 2.9 4.5 6.8 7.5 7.9 6.2 2.4 9.8 9.5 4.5 6.6 3.7 1.8 6.6 2.8 2.7 6.0 8.1 11.1 4.4 6.9 12.3 6.6 3.2 2.3 6.8 0.0 1.1 0.0 2.4 1.6 2.9 3.3 2.7 1.7 1.9 3.3 3.8 2.5 0.0 1.3 1.4 5.3 1.7 1.1 7.4 12.0 14.5 11.1 8.3 8.5 10.0 10.9 9.7 7.5 6.0 14.7 4.7 12.4 6.8 42.9 3.2 10.2 12.0 9.1 21.0 104.1 9.6 16.6 15.3 5.5 7.5 7.8 0.0 7.4 7.2 11.0 10.5 0.0 5.7 6.9 47.7 8.6 8.6 2.1 4.2 25.0 6.0 10.1 15.4 10.4 12.4 9.9 14.8 26.5 11.3 98.5 6.5 13.5 24.1 25.8 8.4 5.6 13.1 10.7 6.2 ANKS4B "FLJ38819, HARP" ENSG00000175311 "Ankyrin repeat and sterile alpha motif domain containing 4B" Q8N8V4 16 21233665-21253845 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 64.5;kidney: 16.2;liver: 15.0" "Group enriched" "Detected in some" 14 "Enterocytes: 78.6;Hepatocytes: 24.1;Intestinal endocrine cells: 24.1;Mucus-secreting cells: 34.5;Paneth cells: 31.7;Proximal tubular cells: 28.1;Undifferentiated cells: 21.9" "Group enriched" "Detected in many" 8 "colorectal cancer: 12.2;liver cancer: 5.1;pancreatic cancer: 3.2;renal cancer: 3.3;stomach cancer: 5.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 2.1;HDLM-2: 5.4;Hep G2: 12.8;OE19: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043523, HPA061125" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043523: AB_10966687, HPA061125: " "unprognostic (1.35e-1)" "unprognostic (4.96e-2)" "unprognostic (2.73e-2)" "unprognostic (3.32e-2)" "unprognostic (8.42e-3)" "unprognostic (8.61e-2)" "unprognostic (2.36e-1)" "unprognostic (9.48e-2)" "unprognostic (2.04e-1)" "unprognostic (4.08e-1)" "unprognostic (1.08e-1)" "unprognostic (9.75e-4)" "unprognostic (5.15e-3)" "unprognostic (1.88e-1)" "unprognostic (4.77e-2)" "unprognostic (4.34e-3)" 0.1 0.1 0.1 4.3 0.2 0.0 0.1 0.9 0.1 0.1 26.9 0.0 0.0 9.3 0.1 1.5 0.1 0.1 9.2 0.1 0.1 0.1 16.2 15.0 0.1 0.0 0.1 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.1 7.6 0.0 0.1 0.0 0.5 0.1 64.5 0.1 0.1 0.1 1.6 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.8 0.6 2.0 0.4 1.1 0.4 0.1 0.0 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.4 0.1 0.0 0.1 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.1 3.3 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 1.5 0.4 0.4 0.3 0.3 0.2 0.5 0.3 0.2 0.1 0.8 0.4 0.4 2.0 1.1 0.2 0.6 0.3 0.1 0.1 0.2 0.9 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.2 0.6 2.5 0.0 1.2 1.8 0.0 0.0 0.0 0.0 0.7 0.1 78.6 0.0 1.5 0.0 0.0 0.3 1.1 24.1 0.0 0.0 24.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 34.5 1.2 1.2 31.7 0.0 28.1 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.5 21.9 0.3 ANKS6 "ANKRD14, FLJ36928, NPHP16, SAMD6" ENSG00000165138 "Ankyrin repeat and sterile alpha motif domain containing 6" Q68DC2 9 98731329-98796965 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Joubert syndrome, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 31.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA008355 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA008355: AB_2058277" "unprognostic (1.66e-1)" "unprognostic (1.46e-1)" "unprognostic (9.31e-2)" "unprognostic (9.15e-3)" "unprognostic (6.90e-3)" "unprognostic (1.22e-1)" "unprognostic (4.29e-3)" "unprognostic (4.10e-2)" "unprognostic (1.48e-1)" "unprognostic (3.46e-3)" "unprognostic (1.00e-1)" "unprognostic (5.94e-2)" "prognostic favorable (3.44e-5)" "unprognostic (1.40e-1)" "unprognostic (1.02e-1)" "unprognostic (3.95e-2)" "unprognostic (2.68e-1)" 5.0 3.7 5.8 4.3 9.9 1.8 4.8 31.2 9.5 7.3 6.5 9.4 2.6 5.9 6.0 7.4 7.5 7.8 7.7 2.9 6.9 6.1 7.7 1.8 7.2 3.4 10.1 4.4 9.6 18.1 10.0 2.8 2.8 11.4 3.6 7.3 4.2 3.1 3.5 3.3 4.4 5.4 8.9 6.1 2.5 7.7 6.1 9.2 1.8 13.4 2.4 4.5 5.4 6.4 0.9 0.0 0.0 0.1 0.0 2.1 0.2 5.2 7.9 7.3 12.8 6.1 5.0 4.9 3.8 6.6 4.3 5.2 4.3 3.8 9.7 2.9 5.4 6.2 15.6 5.3 6.4 2.3 13.5 5.5 2.3 4.7 1.8 6.0 1.2 1.6 6.1 8.1 5.9 6.0 5.3 4.9 9.0 16.3 2.3 3.3 8.7 0.5 2.5 11.5 23.5 8.6 6.5 18.1 0.7 7.7 3.3 4.7 5.4 1.6 9.4 4.3 6.2 0.0 2.7 4.9 4.5 4.9 12.2 3.7 4.5 7.6 1.6 6.3 4.4 6.4 0.0 0.1 0.0 1.3 0.0 0.7 0.9 0.7 2.1 0.0 0.6 1.8 0.9 0.0 0.0 0.0 0.0 1.1 0.2 5.8 9.9 31.2 9.5 6.9 6.1 10.1 4.4 11.4 9.2 6.0 8.0 2.4 0.7 1.5 6.1 4.4 12.7 5.3 4.5 12.2 7.9 2.3 3.3 3.6 2.9 3.1 4.2 0.0 7.7 2.5 3.4 3.4 1.1 1.5 1.6 0.0 4.7 1.8 1.5 4.9 2.6 1.1 0.0 1.0 6.8 1.4 7.0 3.5 4.2 5.0 0.6 0.0 2.3 4.2 4.9 1.0 0.9 2.1 7.6 2.4 ANKZF1 "FLJ10415, ZNF744" ENSG00000163516 "Ankyrin repeat and zinc finger domain containing 1" Q9H8Y5 2 219229757-219236669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035208 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA035208: AB_10602229" "unprognostic (5.23e-2)" "unprognostic (2.23e-1)" "unprognostic (1.12e-3)" "unprognostic (8.27e-2)" "unprognostic (3.38e-1)" "unprognostic (7.95e-3)" "prognostic unfavorable (3.09e-5)" "unprognostic (3.87e-2)" "unprognostic (9.68e-3)" "unprognostic (7.82e-3)" "unprognostic (1.24e-2)" "unprognostic (3.26e-3)" "prognostic unfavorable (2.01e-6)" "unprognostic (1.49e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-1)" "unprognostic (2.88e-3)" 10.1 11.1 14.8 19.0 19.8 13.7 12.9 38.4 25.9 13.8 15.4 17.5 21.7 17.5 14.3 14.7 17.1 21.1 11.7 13.8 12.7 9.6 15.2 15.8 13.2 23.2 19.6 13.5 19.6 19.0 12.3 22.7 11.3 16.4 16.6 10.4 13.6 18.2 22.7 18.9 21.7 19.5 9.5 18.5 21.0 15.1 8.7 18.8 18.7 14.0 8.8 19.8 16.8 16.2 11.7 8.3 10.7 10.6 20.6 17.8 11.0 19.5 3.9 5.2 7.6 7.2 5.9 20.5 6.5 6.5 9.0 11.4 9.5 8.3 4.1 11.6 2.7 9.9 14.4 6.9 11.0 6.6 8.6 7.1 9.1 11.6 8.8 7.1 5.6 9.0 6.0 21.9 6.7 10.6 14.8 6.1 10.8 15.3 9.5 4.5 8.6 8.7 14.7 8.5 8.0 7.1 8.9 6.2 13.2 4.9 5.0 6.7 6.2 6.6 15.6 12.5 13.5 4.0 13.7 6.5 7.4 5.7 5.9 8.1 20.9 11.8 7.4 12.6 8.5 3.2 8.4 7.7 8.8 14.6 7.5 15.4 11.0 14.7 14.4 7.8 11.7 17.8 16.3 10.7 20.6 10.6 8.3 14.0 11.0 14.8 19.8 38.4 25.9 12.7 9.6 19.6 13.5 16.4 18.8 14.9 15.0 12.3 13.1 8.2 34.6 8.1 10.2 54.9 22.7 12.2 29.5 8.7 11.6 17.4 3.8 7.9 16.3 23.3 10.9 18.1 7.4 12.2 21.8 10.9 6.6 30.2 9.2 6.2 10.0 3.1 22.2 9.3 10.1 12.6 19.3 22.3 13.7 17.5 15.6 9.6 53.8 6.5 6.4 9.6 15.9 8.7 9.7 31.9 16.6 9.2 ANLN "ANILLIN, scra, Scraps" ENSG00000011426 "Anillin actin binding protein" Q9NQW6 7 36389806-36453791 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Actin-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.4;lymphoid tissue: 32.7" "Cell type enhanced" "Detected in many" 21 "Early spermatids: 106.8;Late spermatids: 41.2;Spermatocytes: 20.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HBF TERT88: 100.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005680, CAB033902, HPA050556, CAB062547, CAB068175" Enhanced Enhanced Nucleoplasm,Midbody Yes Yes Nucleoplasm Midbody "CAB033902: AB_2058302, CAB062547: AB_2665622, CAB068175: AB_2665623, HPA005680: AB_2667388, HPA050556: AB_2681175" "unprognostic (4.23e-2)" "unprognostic (1.59e-3)" "unprognostic (1.49e-1)" "prognostic unfavorable (1.73e-4)" "unprognostic (1.67e-2)" "unprognostic (3.44e-2)" "prognostic unfavorable (5.97e-7)" "prognostic unfavorable (6.99e-5)" "unprognostic (2.69e-2)" "unprognostic (3.66e-2)" "prognostic unfavorable (2.00e-6)" "unprognostic (3.13e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (5.29e-2)" "unprognostic (1.34e-1)" "unprognostic (2.94e-2)" "unprognostic (4.04e-3)" 1.7 0.6 13.9 7.2 10.5 20.9 1.3 1.8 36.7 1.9 3.9 1.6 0.0 2.9 1.3 2.4 12.8 0.6 1.4 0.6 24.0 12.1 0.7 0.8 3.3 4.2 30.5 2.5 0.9 0.4 0.3 0.3 12.9 9.7 0.7 5.5 0.0 0.9 0.3 0.4 8.9 3.4 9.4 63.4 1.6 3.3 9.2 12.5 32.7 0.6 17.7 6.7 2.6 1.3 0.0 0.3 0.6 0.9 0.0 1.7 2.0 68.4 14.4 12.0 9.1 1.6 4.2 12.9 43.2 25.3 52.2 39.2 9.8 21.2 3.4 12.5 21.8 27.8 35.3 9.4 25.2 100.3 2.3 6.8 4.7 16.2 8.1 0.2 6.7 5.5 0.9 1.1 34.0 22.4 6.2 16.2 4.6 9.8 7.3 42.5 10.3 5.7 7.8 13.3 10.5 15.2 4.2 36.0 2.3 11.5 11.2 5.1 6.0 22.7 26.4 3.9 17.4 17.8 7.7 15.3 32.7 36.8 19.2 50.4 3.0 4.8 6.4 11.1 10.9 68.6 0.0 0.9 0.1 0.0 0.2 0.0 0.0 0.9 0.5 0.3 0.0 0.6 0.0 0.6 0.0 0.3 0.2 1.7 2.0 13.9 10.5 1.8 7.7 24.0 12.1 30.5 2.5 9.7 12.5 0.0 0.6 0.0 1.0 12.6 0.0 0.6 0.0 2.7 1.2 0.0 0.0 2.5 0.0 0.5 106.8 0.1 0.9 0.0 0.2 20.2 3.5 1.3 0.0 0.0 8.0 0.0 0.0 1.8 1.5 41.2 1.1 2.6 0.0 0.0 2.2 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.4 20.9 14.9 8.2 2.4 1.5 1.6 1.4 ANO1 "DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A" ENSG00000131620 "Anoctamin 1" Q5XXA6 11 70078302-70189528 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Developmental protein, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "ductus deferens: 142.4;epididymis: 38.5;salivary gland: 122.9;seminal vesicle: 93.6" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 56.2;Hepatocytes: 117.3;Late spermatids: 50.1;Sertoli cells: 45.3;Smooth muscle cells: 42.3;Suprabasal keratinocytes: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A-431: 32.9;CAPAN-2: 50.5;HaCaT: 61.6;OE19: 43.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA032148, HPA057356" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA032148: AB_2674180, HPA057356: AB_2732610" "unprognostic (2.73e-1)" "unprognostic (7.91e-2)" "unprognostic (3.66e-2)" "prognostic favorable (4.58e-6)" "unprognostic (1.90e-1)" "prognostic unfavorable (7.28e-5)" "unprognostic (1.16e-3)" "prognostic unfavorable (2.40e-4)" "unprognostic (2.13e-2)" "unprognostic (3.51e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.21e-1)" "prognostic unfavorable (4.09e-6)" "unprognostic (1.56e-1)" "unprognostic (1.06e-1)" "unprognostic (8.85e-3)" "unprognostic (1.81e-1)" 6.9 0.4 1.1 2.1 1.1 0.0 17.2 1.6 1.4 9.7 5.3 1.1 142.4 0.2 14.2 38.5 3.6 11.7 10.6 6.9 1.1 0.2 2.6 24.4 4.4 1.5 1.0 1.0 3.9 4.5 0.5 2.0 6.2 1.5 7.2 1.7 1.7 122.9 93.6 3.4 19.1 1.8 5.7 1.0 1.1 9.5 7.6 0.9 1.1 8.9 8.1 3.8 4.5 5.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 32.9 1.3 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 50.5 0.0 0.6 0.0 0.0 61.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 43.3 4.8 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 10.5 0.2 0.3 3.9 0.1 0.1 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.1 1.6 1.4 1.1 0.2 1.0 1.0 1.5 0.9 0.0 0.0 0.0 18.1 15.8 0.0 2.8 25.5 0.0 1.2 0.0 0.0 1.1 0.0 2.9 56.2 2.2 0.0 0.0 0.0 0.6 3.5 9.1 4.6 117.3 0.2 0.0 0.0 4.9 1.6 50.1 1.7 0.9 5.0 0.0 11.4 1.0 0.6 0.0 1.4 0.4 0.3 45.3 42.3 1.4 1.5 40.8 3.4 0.0 0.2 17.8 ANO2 "C12orf3, TMEM16B" ENSG00000047617 "Anoctamin 2" Q9NQ90 12 5531869-5946232 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "placenta: 46.9;retina: 30.6;testis: 13.4" "Group enriched" "Detected in many" 12 "Cone photoreceptor cells: 76.6;Early spermatids: 58.6;Late spermatids: 219.4;Rod photoreceptor cells: 168.7" "Cancer enhanced" "Detected in some" "testis cancer: 2.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "basophil: 5.1" "Lineage enriched" "Detected in single" 51 "granulocytes: 5.1" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.6;HUVEC TERT2: 8.5;U-2 OS: 22.5" "Region enriched" "Detected in some" 4 "basal ganglia: 20.0" "HPA036276, HPA057499" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA036276: AB_10670713, HPA057499: AB_2732613" "unprognostic (6.32e-2)" "unprognostic (1.01e-1)" "unprognostic (3.77e-1)" "unprognostic (1.25e-2)" "unprognostic (1.55e-1)" "unprognostic (4.05e-3)" "unprognostic (2.86e-1)" "unprognostic (2.62e-1)" "unprognostic (1.11e-2)" "unprognostic (1.90e-1)" "unprognostic (1.84e-3)" "unprognostic (3.78e-3)" "unprognostic (1.04e-2)" "unprognostic (1.10e-2)" "unprognostic (9.93e-2)" "unprognostic (2.27e-1)" "unprognostic (2.17e-1)" 5.8 0.1 1.0 1.3 2.3 0.0 4.3 1.2 1.3 3.3 1.0 1.6 0.9 0.8 1.8 2.1 0.9 1.9 1.5 3.9 1.9 0.9 1.2 0.9 4.7 0.9 1.6 2.0 0.9 0.9 1.4 0.9 46.9 1.2 1.4 0.7 30.6 0.9 1.6 2.3 0.6 0.9 2.1 1.1 1.9 1.0 13.4 0.9 0.9 1.6 1.3 0.9 1.3 2.3 0.0 0.0 5.1 0.0 0.0 0.0 0.2 2.2 0.0 4.0 0.0 0.0 0.2 1.9 0.0 8.6 0.4 0.9 0.0 0.1 0.1 0.2 0.0 0.1 0.3 0.0 0.1 0.6 0.2 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.5 0.0 0.0 1.7 0.0 0.8 0.0 0.0 4.1 2.0 0.0 1.7 0.0 0.9 0.1 0.1 0.0 0.0 2.1 1.4 0.0 3.7 1.2 0.0 0.2 0.0 22.5 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 1.0 2.3 1.2 1.3 1.9 0.9 1.6 2.0 1.2 0.9 0.0 0.0 0.0 0.0 0.0 7.4 1.1 0.0 0.0 0.0 0.0 76.6 1.1 0.0 0.0 58.6 3.6 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.2 9.5 0.0 1.8 0.0 219.4 0.3 0.0 0.0 0.0 0.0 10.6 0.0 0.0 1.4 0.0 168.7 0.0 0.4 1.5 1.3 0.1 2.1 0.0 0.0 0.0 ANP32A "C15orf1, I1PP2A, LANP, MAPM, mapmodulin, PHAPI, PP32" ENSG00000140350 "Acidic nuclear phosphoprotein 32 family member A" P39687 15 68778535-68820897 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB005231, HPA063133, HPA067561" Supported Enhanced Nucleoplasm,Centrosome,Cytosol NA NA 740000 "Nucleoplasm, Centrosome" Cytosol "CAB005231: AB_2289588, HPA063133: AB_2684947, HPA067561: AB_2685861" "unprognostic (1.41e-2)" "unprognostic (1.91e-1)" "unprognostic (2.46e-1)" "unprognostic (3.03e-1)" "unprognostic (6.96e-2)" "unprognostic (2.29e-2)" "unprognostic (1.04e-2)" "unprognostic (4.44e-2)" "unprognostic (4.00e-2)" "unprognostic (3.74e-2)" "unprognostic (1.20e-1)" "unprognostic (7.83e-2)" "unprognostic (4.16e-2)" "unprognostic (3.24e-2)" "unprognostic (2.38e-2)" "unprognostic (1.42e-1)" "unprognostic (1.17e-1)" 25.8 20.4 32.7 32.0 40.1 46.0 28.2 50.7 33.7 24.5 30.7 40.5 16.0 27.0 26.8 21.7 28.8 30.0 23.4 47.8 32.3 23.6 30.0 29.6 27.2 55.0 33.9 30.0 26.7 25.6 24.2 18.3 38.6 26.6 30.4 35.4 27.2 23.6 27.8 41.7 18.9 28.9 30.5 42.7 40.1 29.8 9.4 36.7 75.0 29.0 18.5 52.4 35.7 27.6 12.7 19.8 27.7 19.9 18.1 12.3 9.6 26.4 32.5 42.8 36.9 15.0 13.2 28.4 14.0 18.7 27.4 23.2 26.8 49.9 85.9 26.2 15.7 16.2 38.9 98.9 28.6 33.0 38.7 33.7 65.0 27.5 33.5 9.3 51.1 35.2 10.5 20.2 15.0 30.0 18.0 39.8 41.7 47.2 33.6 23.5 18.5 51.3 42.0 37.9 26.2 16.5 72.0 39.7 51.0 24.1 41.9 56.8 35.2 21.3 24.0 39.3 44.7 31.9 67.1 17.8 28.5 45.3 19.6 37.3 20.4 56.6 99.5 18.9 86.1 26.0 8.1 17.6 27.7 11.9 19.9 10.0 12.7 9.8 12.3 19.8 12.7 12.1 10.6 18.1 18.1 16.8 17.6 11.2 9.6 32.7 40.1 50.7 33.7 32.3 23.6 33.9 30.0 26.6 36.7 101.3 93.6 54.3 58.8 57.6 85.2 68.1 48.4 129.8 100.1 66.3 33.4 225.4 91.2 95.6 3.6 76.3 57.2 70.0 83.9 137.0 53.5 48.8 89.1 75.9 163.6 62.0 75.3 58.3 145.4 4.0 32.2 112.8 74.2 132.6 83.9 86.2 70.3 56.1 28.0 115.7 65.9 25.8 68.0 7.7 13.8 30.6 194.4 102.2 82.6 46.3 ANP32B "APRIL, PHAPI2, SSP29" ENSG00000136938 "Acidic nuclear phosphoprotein 32 family member B" Q92688 9 97983361-98015943 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063133, HPA067561, HPA069657" Supported Enhanced Nucleoplasm,Centrosome,Cytosol NA NA 290000 Nucleoplasm "Centrosome, Cytosol" "HPA063133: AB_2684947, HPA067561: AB_2685861, HPA069657: " "unprognostic (2.82e-1)" "unprognostic (2.05e-2)" "unprognostic (4.57e-2)" "unprognostic (6.74e-2)" "unprognostic (1.85e-1)" "unprognostic (5.52e-2)" "prognostic unfavorable (1.98e-7)" "unprognostic (6.76e-3)" "unprognostic (5.70e-2)" "unprognostic (7.16e-2)" "unprognostic (3.50e-1)" "unprognostic (6.39e-2)" "unprognostic (9.22e-3)" "unprognostic (5.20e-2)" "unprognostic (2.36e-1)" "unprognostic (3.67e-2)" "unprognostic (1.78e-2)" 43.0 24.6 37.9 46.5 55.5 105.7 37.7 15.6 30.1 43.2 38.9 81.0 24.6 32.7 46.3 38.4 40.4 28.4 39.2 27.0 41.8 32.0 26.0 35.9 35.0 70.4 55.7 21.7 51.1 46.0 29.3 20.7 37.5 41.8 38.9 42.3 26.2 32.5 29.7 29.4 38.6 34.9 45.3 88.3 38.6 36.7 19.0 47.6 85.9 37.0 31.9 81.8 64.5 58.6 34.8 32.6 36.8 44.6 22.7 51.3 25.1 71.5 38.7 43.2 36.0 24.3 43.0 39.4 37.2 33.0 40.0 33.7 48.5 35.2 87.8 22.3 24.9 30.5 47.4 58.1 42.0 45.9 56.9 32.8 76.0 33.2 52.3 31.3 130.1 44.3 32.5 30.7 32.1 66.3 32.6 34.7 78.8 146.1 62.2 30.8 95.5 98.2 115.7 16.8 70.3 38.5 58.7 67.3 41.7 26.1 30.0 34.9 30.5 43.6 42.7 38.1 22.2 24.1 48.7 42.0 26.1 42.3 32.8 39.0 56.5 63.8 53.0 24.2 52.3 48.6 23.1 27.2 36.8 22.7 30.9 31.3 34.8 42.7 31.9 32.6 29.6 51.3 38.7 11.3 22.7 44.6 31.8 50.8 25.1 37.9 55.5 15.6 30.1 41.8 32.0 55.7 21.7 41.8 47.6 80.4 91.7 174.3 178.4 160.5 57.6 74.9 101.9 53.5 93.3 71.5 23.6 273.1 82.9 105.6 102.1 109.0 128.4 327.1 148.0 437.2 99.8 129.7 116.6 84.4 250.6 112.8 144.0 112.3 244.5 70.6 135.4 174.1 121.4 164.1 222.6 53.5 126.7 126.7 136.5 75.6 33.5 148.8 133.5 138.6 318.8 134.8 278.6 173.4 278.8 183.9 ANP32D PP32R2 ENSG00000139223 "Acidic nuclear phosphoprotein 32 family member D" O95626 12 48472665-48473624 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in single" "Cell type enriched" "Detected in single" 6 "Cardiomyocytes: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.3;REH: 1.2" "HPA063133, HPA067561" Uncertain Enhanced Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Centrosome" Cytosol "HPA063133: AB_2684947, HPA067561: AB_2685861" "unprognostic (2.20e-1)" "unprognostic (3.75e-1)" "unprognostic (3.18e-1)" "unprognostic (3.23e-2)" "unprognostic (5.11e-2)" "unprognostic (1.72e-3)" "unprognostic (2.30e-2)" "unprognostic (3.62e-3)" "unprognostic (2.76e-2)" "unprognostic (3.48e-1)" 0.1 0.9 0.3 0.0 0.2 0.1 0.2 0.2 0.6 0.0 0.5 0.0 0.6 0.8 0.2 0.1 0.2 0.0 0.1 0.2 0.1 0.1 0.7 0.0 0.2 1.1 0.1 0.0 0.2 0.5 0.3 0.2 0.4 0.3 0.2 0.0 0.1 0.2 0.2 0.5 0.2 0.9 0.8 0.0 0.4 0.1 0.1 0.1 0.6 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.5 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.7 0.4 0.4 0.0 0.0 0.0 0.2 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.6 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 ANP32E "LANP-L, LANPL, MGC5350" ENSG00000143401 "Acidic nuclear phosphoprotein 32 family member E" Q9BTT0 1 150218417-150236156 "Predicted intracellular proteins" "Chaperone, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021114, HPA063133, HPA067561" Supported Enhanced Nucleoplasm,Centrosome,Cytosol NA NA 18000 "Nucleoplasm, Centrosome" Cytosol "CAB021114: AB_10057407, HPA063133: AB_2684947, HPA067561: AB_2685861" "unprognostic (1.04e-1)" "unprognostic (2.40e-1)" "unprognostic (2.51e-1)" "unprognostic (8.95e-2)" "unprognostic (1.69e-2)" "unprognostic (1.47e-3)" "prognostic unfavorable (4.50e-5)" "unprognostic (1.64e-1)" "unprognostic (6.58e-2)" "unprognostic (3.91e-2)" "unprognostic (7.73e-3)" "unprognostic (2.47e-1)" "prognostic unfavorable (3.82e-8)" "unprognostic (1.76e-2)" "unprognostic (1.60e-1)" "unprognostic (1.77e-1)" "unprognostic (3.52e-1)" 11.5 18.3 31.2 21.0 30.9 38.4 10.6 50.3 20.6 14.3 11.3 18.3 13.5 12.9 16.5 21.0 12.8 12.8 11.9 19.8 22.9 25.9 18.6 16.8 13.3 38.4 26.5 19.5 19.1 6.9 20.1 14.7 12.3 21.2 14.2 10.9 20.1 9.2 20.9 25.5 12.5 14.5 25.2 32.7 20.3 9.9 6.0 17.8 52.2 18.1 13.6 34.7 20.6 12.1 24.5 8.2 20.7 10.5 14.6 27.0 15.7 34.3 22.2 46.4 23.0 3.6 5.4 17.7 18.5 10.5 17.9 17.2 16.4 24.4 62.6 16.5 10.6 10.6 12.0 26.1 11.5 25.7 71.6 15.8 43.3 27.6 23.6 3.4 87.0 22.0 4.4 1.8 16.7 15.4 8.8 13.2 30.5 41.4 37.1 16.3 35.6 35.5 22.7 46.8 11.2 10.2 37.8 25.8 32.9 12.7 13.8 15.2 26.2 38.6 6.2 10.8 21.5 16.8 44.5 13.6 9.2 25.9 9.4 36.9 47.9 48.1 61.3 10.4 62.8 16.7 20.7 10.5 16.3 18.0 7.3 27.0 24.5 24.2 19.7 8.2 17.0 17.4 21.6 7.2 14.6 8.8 5.7 25.7 15.7 31.2 30.9 50.3 20.6 22.9 25.9 26.5 19.5 21.2 17.8 11.9 78.4 61.4 38.4 86.4 117.9 90.4 22.9 60.2 30.7 69.8 31.4 37.5 72.9 27.5 1.1 45.4 12.3 140.2 23.2 113.7 65.8 16.5 60.2 48.9 46.0 60.4 13.8 39.9 41.9 1.4 28.1 57.2 64.1 62.3 11.5 131.8 20.8 17.5 31.5 44.8 110.8 25.8 85.5 9.3 21.8 86.1 34.0 89.3 28.0 19.3 ANXA1 "ANX1, LPC1" ENSG00000135046 "Annexin A1" P04083 9 73151757-73170393 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Adaptive immunity, Immunity, Inflammatory response, Innate immunity" "Phospholipase A2 inhibitor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 432.6;tongue: 235.4" "Cell type enhanced" "Detected in many" 10 "granulocytes: 2387.0;Syncytiotrophoblasts: 5914.0;Urothelial cells: 4139.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011271, HPA011272, CAB013023, CAB035987, CAB058693" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" NA Yes 77000000 "Plasma membrane, Cytosol" Nucleoplasm "CAB013023: AB_2533983, CAB035987: , CAB058693: AB_2665585, HPA011271: AB_1844883, HPA011272: AB_1844884" "unprognostic (2.53e-2)" "unprognostic (1.31e-1)" "unprognostic (9.08e-2)" "prognostic favorable (5.71e-5)" "unprognostic (1.53e-2)" "unprognostic (4.28e-2)" "unprognostic (1.82e-2)" "unprognostic (1.30e-2)" "unprognostic (1.30e-1)" "unprognostic (1.14e-1)" "unprognostic (2.54e-3)" "unprognostic (1.47e-1)" "unprognostic (9.82e-3)" "unprognostic (1.13e-1)" "unprognostic (8.55e-2)" "prognostic favorable (4.57e-5)" "prognostic unfavorable (6.19e-6)" 52.7 3.5 2.7 11.5 3.3 81.4 45.9 0.9 2.5 61.5 8.5 3.6 5.5 2.4 6.9 11.2 432.6 11.9 14.9 8.9 3.2 2.5 9.1 2.1 37.3 7.6 4.3 1.9 11.7 2.4 0.5 6.3 149.5 13.5 12.9 4.4 6.4 93.0 7.2 7.9 11.6 6.4 12.3 6.5 5.9 5.9 5.6 3.1 3.9 21.7 235.4 153.3 18.0 83.1 0.7 98.9 146.2 79.1 27.3 52.5 102.8 66.2 104.7 4.7 4.9 66.8 63.6 0.3 114.8 71.8 47.5 32.2 3.0 59.9 0.1 38.0 100.1 105.0 81.6 10.1 69.5 37.7 37.5 0.7 5.1 31.1 0.1 53.3 11.0 2.5 36.6 57.6 48.0 94.4 44.0 67.3 6.0 21.0 2.8 58.5 0.2 19.5 6.0 5.9 26.5 42.6 0.0 26.7 0.2 106.8 14.0 0.0 0.0 39.5 1.0 26.5 65.5 0.2 1.7 83.1 55.7 35.1 76.5 58.9 0.4 0.1 0.2 128.7 10.3 83.8 146.2 79.1 141.1 52.2 21.5 52.5 0.7 47.0 45.9 98.9 0.2 13.7 25.4 8.6 27.3 19.3 3.5 8.3 102.8 2.7 3.3 0.9 2.5 3.2 2.5 4.3 1.9 13.5 3.1 541.9 512.9 7.3 2232.0 752.1 0.0 11.9 17.8 1060.0 889.5 59.3 0.0 1215.0 0.0 156.6 6.3 398.1 0.8 0.0 20.0 1352.9 735.1 1709.3 2387.0 2.5 570.9 0.0 5.1 113.5 449.6 2.3 206.0 1058.5 291.8 475.3 1.8 0.2 431.7 0.0 8.9 3.1 0.0 64.7 275.6 0.7 2.9 522.6 5914.0 282.4 0.5 4139.3 ANXA10 ANX14 ENSG00000109511 "Annexin A10" Q9UJ72 4 168092515-168187690 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "gallbladder: 33.5;stomach 1: 105.3" "Group enriched" "Detected in some" 14 "Exocrine glandular cells: 153.7;Hepatocytes: 62.3;Pancreatic endocrine cells: 198.3" "Group enriched" "Detected in many" 5 "pancreatic cancer: 62.4;stomach cancer: 42.2;urothelial cancer: 19.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "OE19: 72.5;PC-3: 32.8;RT4: 44.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA005469, HPA074650" Enhanced Approved Nucleoplasm,Nucleoli,Vesicles NA NA "Nucleoplasm, Nucleoli" Vesicles "HPA005469: AB_1844849, HPA074650: " "unprognostic (2.29e-2)" "unprognostic (8.71e-3)" "unprognostic (2.48e-2)" "unprognostic (1.71e-1)" "unprognostic (4.69e-1)" "unprognostic (2.29e-2)" "prognostic favorable (3.64e-6)" "unprognostic (1.18e-3)" "unprognostic (2.88e-1)" "unprognostic (8.61e-4)" "unprognostic (3.43e-2)" "unprognostic (1.84e-1)" "unprognostic (1.69e-3)" "unprognostic (8.41e-2)" "unprognostic (4.01e-1)" "unprognostic (2.04e-1)" "unprognostic (8.89e-3)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 1.4 0.1 4.2 0.1 0.1 0.5 0.0 33.5 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 1.5 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.4 0.1 0.1 105.3 0.1 0.1 0.1 0.1 0.1 0.1 11.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.5 32.8 0.0 0.1 0.0 0.0 44.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 10.2 0.0 2.3 0.0 2.0 0.0 0.0 3.5 7.3 0.0 0.0 0.0 153.7 0.0 0.0 0.6 0.0 62.3 0.0 0.0 0.0 1.3 2.7 0.0 0.0 0.0 0.0 1.0 0.4 0.0 198.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 ANXA11 ANX11 ENSG00000122359 "Annexin A11" P50995 10 80150889-80205572 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004851, HPA027545" Supported Supported Nucleoplasm,Cytosol NA NA 530000 Nucleoplasm Cytosol "CAB004851: AB_626682, HPA027545: AB_1844851" "unprognostic (1.85e-2)" "unprognostic (2.85e-2)" "unprognostic (5.35e-3)" "unprognostic (5.06e-2)" "unprognostic (8.18e-3)" "unprognostic (1.99e-1)" "unprognostic (4.01e-3)" "unprognostic (6.28e-2)" "unprognostic (2.32e-2)" "unprognostic (4.88e-2)" "unprognostic (3.46e-2)" "unprognostic (2.56e-2)" "prognostic favorable (6.69e-8)" "unprognostic (2.69e-3)" "unprognostic (1.84e-1)" "unprognostic (6.79e-2)" "unprognostic (2.02e-1)" 44.1 7.3 19.4 27.8 23.8 37.0 61.1 22.8 24.4 26.4 34.4 8.6 18.4 28.6 20.2 36.4 49.5 23.9 47.5 57.1 17.2 8.3 39.1 21.9 35.1 38.1 10.8 14.2 27.3 24.0 26.2 9.7 35.0 7.5 28.9 27.6 16.7 20.2 27.8 39.5 18.6 44.1 28.1 11.2 22.9 29.3 15.1 6.6 45.7 18.9 39.2 31.8 34.9 39.6 12.7 14.4 77.9 12.1 11.6 21.9 13.0 35.1 30.8 1.8 9.2 39.5 39.0 19.7 26.3 67.8 16.4 17.0 27.9 55.0 2.3 19.1 39.3 1.3 46.1 7.9 22.0 10.0 59.8 14.0 14.4 18.3 21.6 23.2 15.8 35.8 41.2 13.3 9.1 7.0 32.5 23.3 19.0 14.1 26.7 12.9 20.9 19.2 34.9 3.3 35.4 65.5 14.7 2.7 53.3 27.7 32.7 0.8 6.4 11.3 45.5 25.7 16.1 13.5 19.4 28.0 11.5 17.3 26.3 13.8 16.3 22.2 15.2 12.0 26.4 7.6 22.6 12.1 77.9 14.5 9.6 15.3 12.7 18.3 20.3 9.1 10.9 17.3 14.9 43.8 11.6 10.7 14.4 21.9 13.0 19.4 23.8 22.8 24.4 17.2 8.3 10.8 14.2 7.5 6.6 89.3 65.4 74.2 217.3 45.4 1.2 269.2 201.2 96.4 109.2 209.3 0.0 234.0 281.8 337.9 2.4 74.8 352.8 0.0 309.2 260.9 113.9 251.0 115.3 34.3 206.7 3.2 74.5 82.9 136.2 4.7 86.0 136.1 86.0 249.7 151.8 36.1 317.7 312.1 87.0 110.5 2.3 90.5 126.4 2.8 34.1 36.8 155.2 122.2 162.8 514.6 ANXA13 ANX13 ENSG00000104537 "Annexin A13" P27216 8 123680794-123737407 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ductus deferens: 41.9;gallbladder: 38.7;intestine: 108.6" "Cell type enhanced" "Detected in some" 20 "Cholangiocytes: 180.9;Intestinal endocrine cells: 43.0;Mucus-secreting cells: 139.9" "Group enriched" "Detected in many" 13 "colorectal cancer: 7.8;liver cancer: 8.5;pancreatic cancer: 6.1;renal cancer: 7.0;stomach cancer: 7.3" "Region enhanced" "Detected in single" "midbrain: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "A549: 23.8;HDLM-2: 12.3" "Low region specificity" "Detected in all" "HPA018535, HPA019569, HPA019650, CAB025135" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB025135: , HPA018535: AB_1844854, HPA019569: AB_1844855, HPA019650: AB_1844856" "unprognostic (6.47e-3)" "unprognostic (1.95e-1)" "unprognostic (3.50e-2)" "unprognostic (1.83e-1)" "unprognostic (5.66e-2)" "unprognostic (4.05e-2)" "unprognostic (5.48e-2)" "unprognostic (2.86e-3)" "unprognostic (2.06e-1)" "unprognostic (9.11e-2)" "unprognostic (2.48e-2)" "unprognostic (2.01e-1)" "unprognostic (1.57e-2)" "unprognostic (1.49e-1)" "unprognostic (1.03e-1)" "unprognostic (5.79e-2)" "unprognostic (4.79e-2)" 0.2 0.1 0.3 0.7 0.5 0.0 0.4 0.1 0.4 0.2 30.3 0.4 41.9 66.5 1.1 2.6 0.2 13.3 38.7 0.1 0.5 0.6 2.1 4.3 0.1 0.1 3.0 0.1 0.9 0.3 0.0 0.1 0.1 0.7 1.1 8.1 0.2 0.2 20.7 0.1 0.1 108.6 0.4 8.0 0.1 0.7 2.3 0.3 0.1 0.1 0.1 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.5 0.0 0.0 0.0 1.4 1.4 0.0 0.1 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.1 0.4 0.5 0.6 3.0 0.1 0.7 0.3 0.0 0.0 0.0 0.2 0.9 0.0 0.3 180.9 5.3 0.0 0.0 0.0 0.0 3.3 0.0 0.9 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 43.0 0.0 0.0 1.0 1.1 0.0 0.0 0.0 139.9 0.0 0.1 18.7 0.0 18.5 9.5 0.0 0.0 0.0 0.1 0.5 0.0 0.0 20.0 0.0 ANXA2R "AXIIR, C5orf39" ENSG00000177721 "Annexin A2 receptor" Q3ZCQ2 5 43039081-43043170 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.9;lymphoid tissue: 25.1" "Cell type enhanced" "Detected in many" 13 "B-cells: 27.5;Ito cells: 22.1;Kupffer cells: 18.7;T-cells: 60.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 10.1;JURKAT: 12.3;MOLT-4: 10.8;REH: 11.3;U-937: 41.9" HPA051482 Uncertain Approved "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA Nucleoplasm "Cytosol, Cytoplasmic bodies" "HPA051482: AB_2681500" "unprognostic (3.38e-2)" "unprognostic (2.00e-3)" "unprognostic (1.21e-2)" "unprognostic (1.92e-2)" "unprognostic (1.40e-2)" "unprognostic (3.92e-3)" "unprognostic (5.65e-3)" "unprognostic (1.03e-1)" "unprognostic (1.87e-1)" "unprognostic (8.14e-2)" "unprognostic (2.13e-2)" "unprognostic (4.34e-1)" "prognostic unfavorable (6.36e-8)" "unprognostic (2.68e-1)" "unprognostic (2.77e-1)" "unprognostic (2.68e-1)" "unprognostic (1.68e-1)" 5.5 1.6 1.3 8.8 4.1 13.1 8.6 1.0 1.5 5.7 4.1 2.0 1.8 2.5 3.6 3.9 4.6 3.7 2.9 2.2 1.7 1.3 2.4 1.4 7.2 19.0 2.6 0.5 2.0 1.1 0.7 1.8 2.6 1.4 5.7 2.2 2.1 2.9 1.9 4.4 2.2 7.5 3.2 1.9 14.9 2.4 2.3 2.0 25.1 3.1 1.8 13.4 5.2 5.6 8.9 1.4 1.5 2.1 6.5 28.9 7.7 0.7 0.7 0.6 0.4 1.1 3.0 0.2 0.2 0.1 0.1 0.3 1.4 0.9 2.8 2.5 0.5 0.8 0.3 1.8 0.2 0.1 4.6 1.4 0.9 1.9 0.6 1.5 1.0 0.4 10.1 0.1 0.8 0.1 0.0 5.6 12.3 0.6 3.6 0.7 1.0 10.8 1.5 0.0 0.6 5.5 11.3 1.4 1.6 0.3 0.4 2.2 0.0 1.0 0.2 0.2 0.1 0.3 1.9 3.5 0.2 0.0 0.3 0.9 1.6 2.3 1.1 1.3 41.9 0.5 1.5 1.1 0.5 16.0 0.7 18.6 8.7 16.6 17.5 1.0 8.9 28.9 21.2 0.9 6.5 2.1 1.4 17.7 7.7 1.3 4.1 1.0 1.5 1.7 1.3 2.6 0.5 1.4 2.0 0.0 16.4 27.5 1.6 3.3 0.0 1.2 2.5 2.7 2.3 0.0 0.0 0.4 0.0 0.2 3.0 15.4 0.2 0.0 0.0 0.9 4.1 1.2 14.0 0.8 7.6 0.0 1.7 22.1 18.7 1.3 1.4 6.9 6.8 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 2.8 0.7 0.8 1.9 0.3 60.4 0.5 0.9 ANXA7 ANX7 ENSG00000138279 "Annexin A7" P20073 10 73375101-73414076 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "monocytes: 438.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 124.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004312, HPA064290" Approved Approved Nucleoplasm,Cytosol NA NA 540000 Nucleoplasm Cytosol "CAB004312: AB_626681, HPA064290: AB_2685233" "unprognostic (1.48e-1)" "unprognostic (4.70e-2)" "unprognostic (1.90e-1)" "unprognostic (2.23e-1)" "unprognostic (1.48e-1)" "unprognostic (1.66e-1)" "unprognostic (1.54e-1)" "unprognostic (2.08e-1)" "unprognostic (2.06e-2)" "unprognostic (1.17e-1)" "unprognostic (1.47e-1)" "unprognostic (2.67e-1)" "prognostic favorable (1.98e-4)" "unprognostic (1.63e-1)" "unprognostic (8.37e-2)" "unprognostic (6.93e-2)" "unprognostic (3.06e-2)" 27.4 27.1 28.0 18.5 28.7 24.1 29.3 23.5 33.1 25.2 21.1 25.0 15.5 13.0 25.1 28.2 24.7 19.7 20.7 36.6 27.2 26.8 39.4 40.8 21.5 33.0 26.0 28.8 26.2 24.2 103.3 28.1 23.3 24.9 24.1 25.4 22.8 26.0 25.3 75.4 21.5 17.3 32.3 25.4 21.3 18.0 11.7 15.5 17.1 30.2 28.2 26.7 27.6 20.5 35.3 36.4 53.0 34.9 33.0 44.4 42.5 24.7 17.9 7.0 17.1 27.5 27.1 15.3 16.6 43.7 21.7 18.4 26.2 29.4 9.9 16.9 31.2 14.3 20.8 13.0 19.6 21.6 24.4 9.7 14.0 9.0 23.2 24.3 19.9 6.4 16.8 19.1 27.1 48.7 19.1 19.2 10.8 18.1 28.2 27.6 19.8 11.2 12.8 7.8 14.8 124.5 9.3 20.0 18.0 37.6 15.2 5.6 7.8 18.6 43.1 15.6 10.3 26.9 10.6 17.9 8.9 16.1 26.8 21.3 18.3 25.9 14.0 21.0 25.8 6.8 53.0 34.9 45.1 22.2 26.2 30.1 35.3 34.4 27.7 36.4 24.0 31.5 27.7 35.4 33.0 25.6 15.6 44.4 42.5 28.0 28.7 23.5 33.1 27.2 26.8 26.0 28.8 24.9 15.5 62.5 47.8 60.3 122.2 76.5 30.6 118.6 63.7 88.3 48.9 89.0 13.7 182.8 164.2 134.1 6.4 80.4 61.4 23.3 132.0 94.9 102.4 102.2 105.2 113.2 105.4 9.5 184.2 56.4 82.6 3.6 126.8 86.9 81.0 438.2 73.6 57.2 111.8 42.1 164.1 200.8 21.6 25.8 92.7 20.5 33.6 80.8 148.3 76.1 67.3 127.8 ANXA8 ANX8 ENSG00000265190 "Annexin A8" P13928 10 47460162-47484158 "Predicted intracellular proteins" "Blood coagulation, Hemostasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 41.6;skin 1: 60.7" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 92.3;Ciliated cells: 25.4;Club cells: 73.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 16.1" "Cell type enhanced" "Detected in some" "myeloid DC: 5.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 73.7;HBEC3-KT: 107.5;hTCEpi: 60.8;hTERT-HME1: 23.2;RT4: 27.0" "HPA045246, HPA047451" Approved Nucleoplasm NA NA Nucleoplasm "HPA045246: AB_2679271, HPA047451: AB_2680052" "unprognostic (8.32e-4)" "unprognostic (2.52e-1)" "unprognostic (2.44e-1)" "unprognostic (6.15e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (6.07e-4)" "unprognostic (5.94e-2)" "unprognostic (2.88e-2)" "unprognostic (2.40e-1)" "unprognostic (1.50e-2)" "prognostic unfavorable (2.68e-4)" "unprognostic (1.19e-1)" "unprognostic (7.55e-15)" "unprognostic (1.04e-2)" "unprognostic (9.94e-2)" "unprognostic (1.65e-1)" "unprognostic (1.39e-1)" 0.1 0.0 0.1 3.7 0.1 0.0 2.3 0.1 0.1 2.9 0.4 0.1 0.1 0.0 0.1 1.3 41.6 0.2 0.1 0.1 0.1 0.1 0.1 2.4 0.1 0.1 0.1 0.4 0.1 0.0 0.1 7.7 0.1 1.2 0.0 0.3 0.1 1.8 0.1 60.7 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 2.5 9.5 10.2 0.1 0.0 5.5 1.1 2.1 0.7 0.0 0.5 20.5 2.6 0.0 0.0 0.0 0.0 6.1 0.4 0.0 0.0 0.0 1.3 5.9 0.0 0.4 0.1 0.3 73.7 0.0 107.5 0.0 4.7 0.0 0.0 6.7 0.0 4.4 0.0 0.2 0.0 60.8 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 10.7 3.1 0.0 1.6 0.0 0.5 0.0 0.0 6.4 0.1 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 92.3 8.2 0.0 9.1 1.0 0.0 1.6 5.1 25.4 73.9 3.5 0.0 5.7 0.0 3.2 0.4 0.4 0.7 0.0 0.4 7.2 0.5 1.1 1.1 0.0 0.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.5 1.8 5.1 0.0 0.0 15.7 ANXA8L1 "ANXA8L2, bA145E20.2, bA301J7.3" ENSG00000264230 "Annexin A8 like 1" Q5VT79 10 46375627-46391784 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 35.9;skin 1: 75.4;tongue: 34.2" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 26.8;Cholangiocytes: 17.8;Ciliated cells: 20.1;Club cells: 36.4;Extravillous trophoblasts: 14.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 3.2;myeloid DC: 5.0" "Group enriched" "Detected in many" 5 "dendritic cells: 5.0;monocytes: 3.2" "Cell line enhanced" "Detected in some" "HaCaT: 72.8;HBEC3-KT: 110.8;hTCEpi: 29.4;SiHa: 26.2" "HPA045246, HPA047451" Approved Nucleoplasm NA NA Nucleoplasm "HPA045246: AB_2679271, HPA047451: AB_2680052" "unprognostic (3.67e-3)" "unprognostic (4.56e-3)" "unprognostic (9.14e-3)" "unprognostic (3.92e-2)" "unprognostic (1.63e-1)" "unprognostic (1.64e-3)" "unprognostic (1.27e-2)" "unprognostic (1.08e-2)" "unprognostic (8.05e-2)" "unprognostic (6.94e-3)" "unprognostic (8.33e-5)" "unprognostic (3.43e-1)" "unprognostic (8.26e-10)" "unprognostic (1.39e-1)" "unprognostic (1.95e-1)" "unprognostic (1.52e-1)" "unprognostic (1.32e-1)" 0.0 0.0 0.0 1.5 0.0 0.0 4.8 0.0 0.0 5.6 0.3 0.0 0.0 0.0 0.7 1.2 35.9 1.2 0.0 0.9 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 12.4 0.0 0.9 0.0 0.0 1.1 0.7 0.0 75.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 34.2 13.3 6.9 0.6 0.0 5.0 0.8 3.2 0.5 0.0 0.5 14.5 3.7 0.0 0.0 0.0 0.0 5.3 0.2 0.0 0.0 0.0 0.3 2.6 0.0 0.1 0.0 0.1 72.8 0.0 110.8 0.0 6.2 0.0 0.0 7.1 0.0 2.6 0.0 0.1 0.0 29.4 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 16.9 0.0 0.0 26.2 2.3 0.0 1.4 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 26.8 1.4 0.0 3.1 0.0 0.0 3.0 17.8 20.1 36.4 0.0 0.0 7.2 0.0 0.7 0.1 0.0 2.0 0.0 0.2 14.1 0.8 1.7 0.0 0.0 0.6 0.0 0.0 0.6 0.0 1.3 0.3 0.0 0.0 0.0 0.1 0.1 5.6 0.3 0.0 0.0 0.0 12.9 0.0 0.2 1.0 1.0 5.3 0.0 0.1 3.0 AP2A2 "ADTAB, CLAPA2, DKFZP564D1864, HIP9, HYPJ, KIAA0899" ENSG00000183020 "Adaptor related protein complex 2 alpha 2 subunit" O94973 11 924894-1012245 "Plasma proteins, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017514, HPA043040" Supported Supported Nucleoplasm,Vesicles NA NA 93000 Vesicles Nucleoplasm "CAB017514: AB_2056344, HPA043040: AB_2678283" "unprognostic (1.90e-1)" "unprognostic (1.54e-1)" "unprognostic (2.20e-1)" "unprognostic (2.09e-2)" "unprognostic (1.28e-2)" "unprognostic (5.72e-2)" "prognostic unfavorable (9.27e-5)" "unprognostic (1.34e-2)" "unprognostic (4.09e-1)" "unprognostic (1.70e-1)" "prognostic favorable (4.57e-4)" "unprognostic (2.41e-1)" "unprognostic (2.86e-3)" "unprognostic (1.05e-1)" "unprognostic (1.58e-1)" "unprognostic (1.40e-1)" "unprognostic (2.08e-2)" 21.9 11.1 20.2 8.7 20.7 18.4 23.2 50.9 32.4 17.5 13.9 9.5 10.4 16.8 16.3 8.5 12.2 21.5 10.1 14.7 22.6 20.0 19.4 16.3 13.3 18.1 16.1 21.1 11.2 14.7 7.8 15.5 16.3 16.9 15.5 16.3 11.5 21.7 14.7 13.3 16.5 12.0 18.5 18.1 34.5 17.0 16.4 6.7 12.4 12.1 5.0 9.1 10.5 10.5 3.4 3.7 6.8 4.6 3.4 5.4 1.7 5.5 2.5 3.0 8.8 11.4 11.7 7.4 8.0 2.7 4.9 4.0 0.9 6.0 5.8 7.0 9.5 4.6 7.3 7.0 4.4 3.2 4.2 18.3 1.7 7.7 3.1 4.5 2.2 4.2 13.8 4.8 2.4 4.9 12.0 6.8 3.9 5.9 4.5 5.0 0.5 2.0 2.5 1.7 7.1 14.3 3.6 2.0 6.3 7.4 5.1 9.5 8.1 8.9 7.3 1.1 5.3 4.3 0.8 10.6 1.6 1.9 2.2 4.0 3.6 2.9 4.3 3.0 2.9 2.4 3.3 4.6 3.8 3.1 4.6 1.8 1.7 3.2 1.8 3.7 3.4 3.4 3.5 6.8 3.4 3.8 3.7 5.4 1.7 20.2 20.7 50.9 32.4 22.6 20.0 16.1 21.1 16.9 6.7 35.7 17.9 12.7 10.5 12.7 45.7 11.3 22.9 20.1 14.8 59.3 56.9 33.3 33.2 32.3 35.0 28.7 39.6 23.3 15.9 35.6 25.3 20.9 26.5 52.5 68.3 95.3 33.7 81.0 78.2 20.9 31.9 26.9 8.5 30.7 27.3 29.4 24.3 20.1 26.2 42.7 64.8 25.8 14.4 46.9 25.1 9.9 23.8 20.8 32.0 9.7 AP3B1 "ADTB3A, HPS2" ENSG00000132842 "Adaptor related protein complex 3 beta 1 subunit" O00203 5 78000525-78294755 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Albinism, Disease mutation, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038737, HPA045458" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA038737: AB_10670788, HPA045458: AB_2679333" "unprognostic (9.14e-2)" "unprognostic (2.02e-1)" "prognostic favorable (1.37e-5)" "unprognostic (8.17e-2)" "unprognostic (2.95e-2)" "unprognostic (2.14e-1)" "unprognostic (1.18e-3)" "unprognostic (7.47e-3)" "unprognostic (4.51e-1)" "unprognostic (9.05e-3)" "unprognostic (1.01e-1)" "unprognostic (6.97e-2)" "prognostic favorable (7.97e-6)" "unprognostic (1.65e-1)" "unprognostic (1.35e-1)" "unprognostic (1.98e-1)" "unprognostic (3.39e-2)" 30.1 19.9 16.5 23.1 20.7 16.5 19.0 15.2 16.6 21.7 20.8 17.4 21.1 17.0 21.2 50.3 26.5 14.6 14.2 16.6 15.6 15.1 28.3 13.7 16.1 27.1 22.2 11.4 18.3 22.0 29.4 36.1 20.1 17.4 18.8 25.6 15.0 23.3 18.8 12.9 18.9 24.8 18.1 20.2 25.5 19.1 13.0 20.9 38.0 24.0 18.6 22.9 19.4 18.2 26.2 10.1 9.0 9.2 5.2 6.7 4.5 20.0 16.2 18.8 25.8 22.6 27.2 16.5 22.8 26.6 20.5 28.0 12.4 17.8 21.2 13.5 28.0 17.2 14.9 18.1 38.2 26.4 24.1 12.8 14.9 14.8 22.6 13.3 13.0 19.5 19.7 14.2 17.4 17.6 19.9 26.0 4.4 10.4 14.0 35.7 12.4 16.8 21.2 9.9 15.1 9.7 17.6 33.0 29.4 30.6 19.3 6.6 10.6 21.0 13.7 19.6 16.2 16.6 22.4 26.2 15.5 12.3 18.7 22.8 10.8 16.6 14.5 20.2 19.4 19.6 8.5 7.3 6.3 6.0 7.5 6.7 18.5 5.1 6.2 10.1 26.2 4.4 5.6 9.0 5.2 9.2 8.6 6.0 4.5 16.5 20.7 15.2 16.6 15.6 15.1 22.2 11.4 17.4 20.9 41.7 28.9 51.7 18.1 14.1 16.2 22.4 5.1 30.8 37.5 29.6 21.6 26.3 21.6 28.5 9.1 22.8 29.0 0.0 33.1 32.1 20.5 19.7 31.3 14.8 34.9 19.1 18.4 24.5 36.5 15.6 14.7 33.9 25.3 57.7 31.0 25.3 34.9 23.0 15.6 19.4 27.1 25.8 15.5 11.4 9.6 20.6 24.9 18.7 25.2 18.2 AP3B2 NAPTB ENSG00000103723 "Adaptor related protein complex 3 beta 2 subunit" Q13367 15 82659281-82709914 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.8" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 17.0;Cone photoreceptor cells: 25.5;Horizontal cells: 12.7;Intestinal endocrine cells: 13.4;Rod photoreceptor cells: 56.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RT4: 11.8;SCLC-21H: 19.3;SH-SY5Y: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039467, HPA039818" Enhanced Supported Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039467: AB_10795143, HPA039818: AB_10795299" "unprognostic (3.17e-1)" "unprognostic (9.40e-2)" "unprognostic (5.33e-2)" "unprognostic (1.48e-6)" "unprognostic (8.44e-2)" "unprognostic (7.62e-2)" "unprognostic (5.82e-2)" "unprognostic (2.32e-1)" "unprognostic (3.85e-1)" "unprognostic (1.63e-1)" "unprognostic (3.57e-3)" "unprognostic (1.12e-1)" "unprognostic (8.66e-2)" "unprognostic (4.95e-2)" "unprognostic (3.21e-2)" "unprognostic (7.52e-2)" "unprognostic (1.43e-2)" 1.5 5.4 17.0 2.0 15.5 2.4 1.6 32.3 35.8 1.6 1.6 2.7 0.0 1.8 2.0 2.2 1.6 1.4 1.4 1.1 12.1 11.0 1.3 1.2 1.3 1.6 5.7 18.6 1.8 2.7 8.3 12.3 1.4 16.0 1.7 1.5 3.5 1.7 2.0 1.1 1.8 1.5 1.8 3.7 1.3 2.1 2.6 2.7 0.0 1.7 0.0 1.9 1.8 0.6 1.0 0.5 3.2 1.0 1.1 0.9 0.2 0.2 0.2 5.2 2.0 0.5 0.1 4.6 0.3 0.0 0.6 0.1 0.5 0.5 0.5 3.5 0.1 1.1 0.7 0.5 0.0 0.1 1.6 0.5 0.3 0.5 0.2 0.3 0.4 1.2 0.5 0.6 0.1 0.2 0.3 0.1 1.9 0.6 0.5 0.1 0.8 0.3 0.4 6.0 0.1 0.2 0.3 0.1 0.1 0.0 11.8 19.3 14.9 2.9 0.8 1.3 0.6 0.2 1.0 0.3 0.4 0.8 0.3 1.0 1.0 5.7 0.5 1.4 0.3 0.9 0.7 1.0 0.5 0.6 0.4 0.3 0.6 0.5 0.3 0.1 1.0 0.9 0.5 3.2 1.1 0.6 0.5 0.3 0.2 17.0 15.5 32.3 25.6 12.1 11.0 5.7 18.6 16.0 2.7 0.0 0.6 0.0 1.9 0.3 17.0 0.8 0.0 0.0 0.0 0.0 25.5 0.0 0.0 0.1 5.7 0.0 0.0 0.0 0.3 0.1 0.4 0.8 0.0 0.0 0.1 12.7 13.4 0.0 0.0 5.7 0.9 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.4 0.5 56.5 0.0 0.4 8.1 3.0 0.1 0.0 0.0 0.0 0.8 AP5B1 "AP-5, DKFZp761E198, PP1030" ENSG00000254470 "Adaptor related protein complex 5 beta 1 subunit" Q2VPB7 11 65775893-65780802 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 48.6" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 16 "neutrophil: 22.5" "Lineage enriched" "Detected in many" 16 "granulocytes: 22.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065739, HPA067880" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Vesicles" "Golgi apparatus" "HPA065739: AB_2685550, HPA067880: AB_2685914" "unprognostic (3.64e-1)" "unprognostic (9.40e-2)" "unprognostic (4.37e-3)" "unprognostic (1.45e-2)" "unprognostic (5.56e-3)" "unprognostic (1.09e-2)" "unprognostic (1.29e-2)" "unprognostic (3.26e-2)" "unprognostic (1.73e-1)" "unprognostic (1.62e-2)" "unprognostic (1.25e-1)" "unprognostic (2.15e-1)" "prognostic favorable (2.31e-5)" "unprognostic (2.03e-2)" "unprognostic (2.15e-2)" "unprognostic (2.45e-1)" "unprognostic (1.67e-1)" 11.2 6.8 5.3 10.2 8.2 48.6 10.3 10.7 9.1 6.3 6.7 4.0 6.9 9.6 9.8 6.8 13.2 7.2 8.2 6.6 5.7 3.5 7.7 9.3 11.3 13.3 6.0 5.5 4.5 16.1 9.9 5.5 14.8 5.3 6.4 4.2 8.0 10.9 10.7 11.9 10.3 9.5 5.1 5.6 13.0 7.9 3.1 6.2 9.2 7.9 7.4 7.8 11.0 6.5 0.2 0.3 22.5 1.3 0.3 0.4 0.5 10.1 7.9 1.8 10.3 4.9 2.5 14.8 4.3 4.1 4.5 3.6 6.8 4.7 5.8 8.3 3.7 8.4 12.1 5.0 3.3 1.4 9.2 8.7 5.3 8.9 3.3 4.0 6.8 11.1 4.8 6.2 3.1 1.6 3.5 3.5 10.1 11.9 7.6 2.3 7.0 4.3 6.8 3.6 2.4 8.9 13.9 0.3 12.7 3.3 11.5 2.4 4.3 3.2 2.0 19.3 2.1 3.9 10.0 5.5 8.3 7.5 10.6 4.4 7.8 7.9 5.8 5.9 5.8 8.0 0.6 1.3 0.5 0.4 0.8 0.2 0.2 0.2 0.2 0.3 0.2 0.3 0.2 22.5 0.3 1.0 0.2 0.1 0.5 5.3 8.2 10.7 9.1 5.7 3.5 6.0 5.5 5.3 6.2 0.0 9.1 5.2 10.1 2.2 5.2 1.4 5.1 1.4 0.0 7.0 13.7 6.1 1.7 7.4 1.1 2.2 9.5 0.0 11.6 14.8 2.6 4.8 2.3 5.8 13.4 11.1 2.9 1.8 8.1 0.0 0.6 6.1 6.8 7.2 2.2 3.9 8.7 6.2 3.5 6.9 9.6 0.0 3.7 0.2 3.6 1.9 29.2 4.4 3.0 9.5 AP5S1 "C20orf29, FLJ11168" ENSG00000125843 "Adaptor related protein complex 5 sigma 1 subunit" Q9NUS5 20 3820524-3828837 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034200, HPA043533, HPA048244" Uncertain Enhanced Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "CAB034200: AB_1564201, HPA043533: AB_2732507, HPA048244: AB_2680328" "unprognostic (1.07e-2)" "unprognostic (1.43e-1)" "unprognostic (8.52e-2)" "unprognostic (2.74e-2)" "unprognostic (1.34e-1)" "unprognostic (2.05e-2)" "unprognostic (5.49e-2)" "unprognostic (7.76e-2)" "unprognostic (1.33e-1)" "unprognostic (8.91e-2)" "unprognostic (5.15e-3)" "unprognostic (8.17e-2)" "prognostic favorable (5.53e-5)" "unprognostic (2.92e-1)" "unprognostic (1.62e-1)" "unprognostic (6.09e-3)" "unprognostic (5.08e-2)" 9.4 14.9 10.1 8.6 13.4 10.7 6.8 7.9 15.3 6.7 10.6 12.0 13.9 10.4 7.1 11.8 8.5 8.2 10.6 13.2 10.2 9.3 12.4 18.9 7.9 19.3 8.9 10.7 8.1 16.9 12.1 9.4 13.0 7.1 8.2 7.5 13.4 13.8 7.0 27.2 7.3 9.9 6.7 8.2 10.2 9.9 19.9 6.3 11.2 13.2 11.2 8.3 7.0 5.8 7.8 10.8 4.7 12.9 6.5 11.9 6.6 11.0 21.2 3.0 2.0 4.1 5.3 3.6 6.7 5.5 6.7 5.3 17.9 11.9 6.4 7.3 7.1 12.7 9.9 2.5 10.9 2.3 3.5 7.0 10.6 6.2 15.4 7.0 7.3 6.5 9.0 6.2 8.3 6.6 4.5 7.8 7.8 7.5 12.6 8.8 18.1 16.9 6.4 2.6 8.0 17.3 7.2 5.0 6.6 7.5 9.0 9.1 3.6 6.7 20.5 11.1 2.1 10.1 3.7 10.6 14.1 6.7 7.2 12.7 6.8 7.5 3.5 4.9 6.6 12.0 1.7 8.3 4.7 11.9 12.9 9.2 6.1 10.1 9.9 10.8 7.8 9.4 8.7 2.1 6.5 7.0 8.7 10.3 6.6 10.1 13.4 7.9 15.3 10.2 9.3 8.9 10.7 7.1 6.3 0.0 8.8 3.7 4.0 1.4 14.4 10.1 10.2 5.3 4.5 3.5 9.8 17.2 10.0 8.7 2.6 6.7 8.5 0.0 11.0 12.0 4.2 4.0 13.9 7.4 13.6 23.8 12.1 6.7 5.1 2.5 5.5 6.2 5.0 13.6 5.9 12.3 9.1 7.4 3.9 6.2 19.6 12.9 3.9 14.9 8.5 0.9 15.4 4.9 5.2 2.7 AP5Z1 "KIAA0415, SPG48, zeta" ENSG00000242802 "Adaptor related protein complex 5 zeta 1 subunit" O43299 7 4775622-4794312 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Protein transport, Transport" "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035693 Supported Supported "Nucleoplasm,Nuclear speckles" NA NA "Nuclear speckles" Nucleoplasm "HPA035693: AB_10960687" "unprognostic (1.64e-1)" "unprognostic (5.22e-2)" "unprognostic (3.01e-3)" "unprognostic (4.24e-2)" "unprognostic (2.43e-3)" "unprognostic (5.19e-1)" "prognostic unfavorable (1.35e-5)" "unprognostic (1.50e-1)" "unprognostic (2.03e-1)" "unprognostic (1.04e-1)" "unprognostic (1.10e-3)" "unprognostic (1.26e-2)" "unprognostic (5.32e-3)" "unprognostic (8.28e-2)" "unprognostic (1.71e-1)" "unprognostic (1.95e-2)" "unprognostic (2.22e-1)" 15.2 18.6 9.5 19.2 11.1 20.8 11.3 14.3 14.9 10.7 12.6 13.5 6.3 22.2 14.0 11.0 10.8 10.6 9.9 8.0 8.6 6.8 9.9 9.2 12.6 18.6 10.9 9.7 12.6 16.9 5.6 11.5 9.6 10.3 11.6 4.6 13.1 15.0 12.8 8.4 21.8 19.1 13.0 8.5 23.4 17.1 10.1 12.6 18.2 11.3 6.6 16.9 13.2 10.6 11.7 11.3 15.7 17.0 12.3 13.4 9.8 10.7 4.8 1.2 8.6 5.4 3.9 11.9 8.5 4.9 6.7 5.5 9.3 10.0 7.4 5.1 5.6 22.6 12.9 1.1 5.3 0.7 5.6 5.2 5.5 11.4 6.7 18.0 9.6 15.7 7.9 4.2 5.6 2.2 2.0 4.4 5.6 9.5 8.1 2.8 11.5 2.8 21.7 8.0 2.8 11.8 7.0 4.2 6.9 2.1 10.3 4.9 9.1 7.2 11.4 8.2 1.1 10.1 15.5 11.1 7.1 8.3 14.1 6.4 17.1 11.0 4.4 10.5 11.9 14.2 1.7 12.9 15.7 13.4 17.0 10.7 10.5 9.2 11.8 11.3 11.7 10.1 8.4 13.5 12.3 14.2 10.2 8.6 9.8 9.5 11.1 14.3 14.9 8.6 6.8 10.9 9.7 10.3 12.6 8.9 12.9 9.3 2.7 6.2 11.1 3.6 17.8 5.3 1.2 10.4 3.9 10.2 0.0 11.8 1.9 7.1 14.0 0.0 11.8 6.6 8.9 4.7 16.2 7.5 24.2 17.5 11.5 13.5 11.9 1.1 12.4 11.0 13.5 28.9 11.5 8.0 16.0 12.2 10.3 5.9 8.5 0.0 8.2 5.6 9.7 9.7 13.8 13.6 10.1 3.1 APAF1 "APAF-1, CED4" ENSG00000120868 "Apoptotic peptidase activating factor 1" O14727 12 98645141-98735433 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 39.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 33.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031373, CAB069399" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "CAB069399: AB_1611908, HPA031373: AB_10602230" "unprognostic (1.32e-1)" "unprognostic (5.12e-2)" "prognostic favorable (5.90e-4)" "unprognostic (2.21e-1)" "unprognostic (3.94e-1)" "unprognostic (8.21e-3)" "unprognostic (2.03e-3)" "unprognostic (1.35e-1)" "unprognostic (2.26e-2)" "unprognostic (5.92e-3)" "unprognostic (5.63e-2)" "unprognostic (6.04e-2)" "unprognostic (9.93e-3)" "unprognostic (3.47e-2)" "unprognostic (2.53e-1)" "unprognostic (3.53e-2)" "unprognostic (3.07e-2)" 10.5 4.7 10.3 11.0 11.0 36.1 8.8 13.4 11.5 10.8 11.6 8.2 5.5 7.0 10.6 7.5 6.2 6.3 11.6 5.8 10.2 8.6 5.8 6.8 11.8 11.2 8.8 6.7 10.8 7.4 5.7 6.2 10.1 8.2 9.1 12.9 8.5 8.2 6.4 6.0 7.5 14.9 7.2 10.9 15.9 8.6 6.1 9.3 15.7 7.0 3.9 14.2 9.5 9.0 2.8 6.3 33.0 8.7 1.1 1.9 1.5 4.4 6.6 20.4 7.8 7.0 12.4 5.6 11.2 8.3 8.5 8.6 4.3 3.2 6.7 3.2 9.3 3.2 7.3 14.2 8.1 10.7 4.7 5.7 12.2 6.3 5.3 2.4 11.8 15.7 5.1 2.5 8.6 4.5 9.4 14.5 4.7 5.6 3.4 12.4 1.3 6.3 12.4 5.6 5.0 3.9 7.9 16.3 2.1 5.0 7.9 3.0 5.1 8.7 3.7 3.2 13.1 6.4 17.8 11.2 5.8 4.5 6.5 3.6 2.3 4.4 7.4 2.2 16.7 7.6 6.2 8.7 7.2 1.9 3.6 1.5 2.4 1.4 1.1 6.3 2.8 1.4 0.9 33.0 1.1 3.6 4.6 0.9 1.5 10.3 11.0 13.4 11.5 10.2 8.6 8.8 6.7 8.2 9.3 11.9 8.0 5.9 4.8 3.4 6.4 1.4 2.5 5.3 4.5 7.0 13.7 3.3 0.0 7.6 0.6 9.2 14.4 0.0 7.0 6.6 8.2 7.3 5.8 5.5 10.5 4.8 11.5 14.1 39.2 0.8 5.5 26.0 10.1 6.4 16.4 2.5 14.3 19.2 4.9 1.5 10.2 0.0 5.2 3.9 11.1 2.9 1.6 9.6 11.5 9.0 APC "DP2, DP2.5, DP3, PPP1R46" ENSG00000134982 "APC, WNT signaling pathway regulator" P25054 5 112707498-112846239 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.9" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 169.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013349, HPA013362" Supported Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA013349: AB_1844913, HPA013362: " "unprognostic (4.80e-2)" "unprognostic (1.19e-1)" "unprognostic (3.72e-2)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (7.09e-3)" "unprognostic (1.62e-1)" "unprognostic (8.10e-3)" "unprognostic (2.35e-1)" "unprognostic (4.85e-3)" "unprognostic (1.27e-1)" "unprognostic (4.18e-2)" "unprognostic (1.02e-2)" "unprognostic (1.07e-1)" "unprognostic (3.35e-1)" "unprognostic (2.23e-2)" "unprognostic (1.96e-1)" 7.2 5.4 40.9 6.4 21.7 8.5 6.3 19.1 39.7 6.8 7.1 10.3 2.0 6.6 6.3 3.9 8.4 5.0 5.5 7.4 37.9 12.9 6.9 6.2 6.7 5.6 23.6 20.7 7.6 4.6 13.8 7.2 5.5 39.1 5.9 6.9 4.0 4.0 4.9 7.0 6.1 8.8 8.1 19.1 6.2 5.4 5.3 20.6 3.6 6.5 2.7 6.2 6.2 3.9 3.8 3.0 12.9 2.9 3.0 3.4 1.1 8.3 7.7 12.9 9.4 10.6 8.9 5.3 13.6 6.5 7.6 9.0 6.1 6.8 16.2 13.2 17.3 11.7 6.9 13.2 11.1 12.5 9.7 9.0 12.3 11.2 4.7 5.2 6.2 6.7 7.4 7.7 12.8 8.5 5.3 10.5 7.8 15.1 5.6 10.9 5.8 7.1 3.1 4.6 4.6 2.8 6.0 16.0 7.9 7.0 10.7 13.1 7.9 12.9 5.0 5.5 5.5 7.0 5.1 16.7 15.4 7.4 15.1 10.3 4.4 6.6 6.4 8.5 11.5 8.6 10.4 2.9 5.0 3.4 1.4 2.9 3.1 1.8 2.1 2.3 3.8 2.9 2.8 12.9 3.0 2.5 3.0 1.6 1.1 40.9 21.7 19.1 31.4 37.9 12.9 23.6 20.7 39.1 20.6 47.6 17.6 10.8 8.3 10.0 169.9 48.4 12.7 20.1 26.1 0.0 62.8 4.4 0.0 16.7 6.3 21.0 24.6 0.0 17.0 5.3 10.2 10.3 18.5 12.1 13.8 74.7 26.4 28.8 14.9 4.4 16.4 14.8 16.9 19.0 15.5 21.8 16.3 25.9 18.4 4.2 37.9 38.8 14.3 14.9 26.7 10.2 2.4 10.7 14.2 7.6 APEX1 "APE, APE-1, APEN, APEX, APX, HAP1, REF-1, REF1" ENSG00000100823 "Apurinic/apyrimidinic endodeoxyribonuclease 1" P27695 14 20455191-20457772 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Activator, DNA-binding, Endonuclease, Exonuclease, Hydrolase, Nuclease, Repressor, RNA-binding" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000956, HPA002564, CAB004294, CAB047307" Supported Supported Nucleoplasm Yes No 98000 Nucleoplasm "CAB004294: AB_626685, CAB047307: , HPA000956: AB_2666158, HPA002564: AB_1078174" "unprognostic (2.80e-3)" "unprognostic (1.39e-1)" "unprognostic (1.55e-2)" "unprognostic (4.74e-3)" "unprognostic (1.97e-2)" "unprognostic (5.88e-2)" "prognostic unfavorable (7.82e-5)" "unprognostic (4.21e-2)" "unprognostic (3.14e-2)" "unprognostic (2.46e-2)" "unprognostic (2.42e-2)" "unprognostic (1.68e-1)" "unprognostic (1.38e-1)" "unprognostic (1.22e-1)" "unprognostic (1.83e-2)" "unprognostic (2.54e-1)" "unprognostic (7.08e-2)" 43.9 52.8 30.6 33.2 32.5 55.6 43.6 24.1 44.9 38.5 41.9 37.3 28.4 44.1 53.2 30.1 40.7 42.9 46.4 34.4 28.0 27.4 44.4 61.3 31.8 44.5 30.2 31.1 64.7 48.4 31.8 21.7 29.4 34.4 36.1 39.8 36.0 35.5 38.9 53.2 41.2 37.6 40.9 30.1 51.0 41.7 20.9 28.3 73.2 51.2 38.5 48.4 41.8 32.7 35.0 53.0 1.5 23.7 20.6 32.5 38.4 44.6 54.9 49.3 45.4 34.7 50.1 42.5 42.0 45.2 62.6 54.3 40.0 44.4 86.3 37.5 32.0 33.5 47.9 58.6 44.4 58.2 38.5 25.0 34.9 32.5 66.7 36.5 110.9 36.3 51.7 49.0 40.7 40.4 50.2 52.2 35.7 40.5 28.4 50.1 43.5 71.0 46.7 48.5 50.7 49.7 79.0 55.4 36.2 52.5 60.3 59.5 37.8 45.5 56.8 45.1 36.3 34.5 50.2 33.7 33.0 55.4 33.2 39.1 38.2 66.1 58.2 14.8 70.5 41.7 0.1 23.7 1.5 19.0 20.5 25.9 35.0 23.8 22.6 46.8 31.4 32.5 28.3 1.5 20.6 12.4 53.0 14.1 38.4 30.6 32.5 24.1 44.9 28.0 27.4 30.2 31.1 34.4 28.3 59.6 45.2 101.2 74.7 94.4 52.3 42.8 86.6 72.3 79.6 64.6 39.3 161.9 127.6 119.2 16.8 57.5 33.9 0.0 91.3 165.4 86.9 49.2 78.7 65.2 158.8 27.0 115.1 39.3 80.7 4.0 74.5 109.4 60.8 100.0 78.8 68.5 83.2 73.7 60.5 126.7 45.4 51.8 136.6 6.3 43.7 84.8 84.9 76.1 136.8 42.5 APEX2 "APE2, APEXL2, XTH2, ZGRF2" ENSG00000169188 "Apurinic/apyrimidinic endodeoxyribonuclease 2" Q9UBZ4 X 55000357-55009057 "Enzymes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair" "DNA-binding, Endonuclease, Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048577 Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" NA Yes "Nucleoplasm, Nucleoli fibrillar center" Vesicles "HPA048577: AB_2680448" "unprognostic (2.90e-2)" "prognostic favorable (6.17e-4)" "unprognostic (4.32e-2)" "unprognostic (2.39e-1)" "unprognostic (1.62e-1)" "unprognostic (5.62e-2)" "prognostic unfavorable (6.13e-7)" "unprognostic (5.89e-2)" "unprognostic (4.87e-2)" "prognostic favorable (5.21e-4)" "unprognostic (7.46e-2)" "unprognostic (3.16e-1)" "unprognostic (6.86e-2)" "unprognostic (1.03e-2)" "unprognostic (3.17e-2)" "unprognostic (1.40e-1)" "prognostic favorable (6.63e-4)" 11.1 12.8 8.6 12.0 12.3 11.9 10.2 8.7 11.8 10.0 12.3 13.7 8.2 12.3 11.5 12.6 20.8 10.7 13.9 10.6 8.7 7.2 15.4 18.5 10.3 14.2 9.7 6.0 14.4 10.7 10.7 12.7 17.8 8.8 11.0 15.1 9.1 10.4 10.0 10.3 16.7 18.7 10.0 9.9 18.0 10.8 7.7 8.9 21.9 10.6 10.2 27.4 11.6 12.7 6.7 9.4 9.2 9.9 26.6 7.5 6.3 22.0 19.9 7.9 11.4 11.5 7.7 13.4 9.1 12.3 17.7 17.3 10.8 18.6 14.6 14.3 8.6 20.9 16.6 18.0 17.3 13.4 11.8 13.7 17.8 19.8 11.0 7.4 10.9 16.8 7.6 14.2 24.9 9.0 8.4 14.0 15.6 9.1 9.9 13.1 21.5 14.7 14.3 15.6 10.5 24.0 13.1 13.1 15.9 9.5 11.1 7.3 8.0 17.2 20.9 8.8 18.8 16.5 8.5 8.1 10.5 15.3 21.1 11.8 10.4 13.3 12.1 11.2 18.7 12.4 9.2 7.8 8.5 7.5 9.9 6.2 6.1 7.1 7.4 9.4 6.7 6.4 6.2 2.9 26.6 8.3 5.1 7.5 6.3 8.6 12.3 8.7 11.8 8.7 7.2 9.7 6.0 8.8 8.9 3.0 16.9 15.2 10.8 11.4 3.2 4.7 10.2 12.0 9.1 10.4 0.0 43.2 13.3 21.7 0.2 7.7 13.7 70.0 13.2 28.4 7.0 7.8 8.1 10.2 21.2 6.4 5.8 8.6 8.6 0.8 5.5 13.5 0.0 29.7 11.1 5.8 15.0 14.8 8.1 15.8 2.1 19.4 4.4 1.0 10.8 11.0 39.8 15.8 11.3 10.0 APIP "APIP2, CGI-29, Mmrp19" ENSG00000149089 "APAF1 interacting protein" Q96GX9 11 34853094-34916499 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Apoptosis, Methionine biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Distal tubular cells: 159.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021188, HPA024131" Approved Approved Nucleoplasm,Cytosol NA NA 77000 Nucleoplasm Cytosol "HPA021188: AB_10610977, HPA024131: AB_10602171" "unprognostic (2.80e-1)" "unprognostic (7.68e-2)" "unprognostic (5.30e-2)" "unprognostic (3.68e-3)" "unprognostic (4.22e-2)" "unprognostic (1.76e-1)" "prognostic unfavorable (1.99e-4)" "unprognostic (2.74e-2)" "unprognostic (3.84e-2)" "unprognostic (9.16e-2)" "unprognostic (2.45e-2)" "unprognostic (1.68e-1)" "unprognostic (1.51e-1)" "unprognostic (3.23e-1)" "unprognostic (5.48e-2)" "unprognostic (7.44e-2)" "unprognostic (1.58e-2)" 23.2 29.8 12.0 13.7 18.7 9.6 15.8 7.6 12.6 12.7 13.8 17.9 16.8 10.5 15.3 10.8 12.2 13.9 12.1 15.4 14.5 11.7 24.8 21.8 16.2 14.4 21.5 11.7 13.2 19.7 13.4 10.3 12.5 21.1 14.1 12.6 10.4 18.5 20.4 48.7 6.8 13.9 16.0 27.8 13.9 19.1 9.7 21.1 23.9 19.0 12.9 11.5 19.0 16.1 14.2 25.6 14.9 19.8 17.5 15.8 10.6 8.6 9.3 11.0 2.6 9.0 9.0 4.9 12.8 12.3 12.6 14.4 5.5 7.6 26.6 7.8 4.7 13.0 10.4 20.1 8.6 16.3 16.3 19.1 13.7 9.9 13.9 13.9 38.0 10.5 8.8 6.4 8.0 13.2 5.6 10.3 15.5 32.2 16.4 8.7 8.3 18.1 17.5 8.8 11.8 22.0 11.7 32.3 9.1 13.0 12.5 9.3 4.5 16.1 12.9 15.7 5.5 13.5 11.8 8.6 9.5 9.6 24.3 3.1 16.1 12.0 30.0 11.8 8.1 12.1 4.7 16.9 14.9 11.0 17.5 13.6 14.2 13.4 11.9 25.6 13.4 13.8 11.7 4.1 17.5 19.8 16.5 15.8 10.6 12.0 18.7 7.6 12.6 14.5 11.7 21.5 11.7 21.1 21.1 32.8 26.7 21.4 29.7 22.1 22.7 19.8 40.8 48.2 28.4 17.4 3.9 31.1 159.2 23.6 5.4 20.4 30.7 23.3 28.4 20.1 20.0 35.6 19.7 21.2 67.0 17.5 34.1 22.1 46.7 7.4 22.2 39.5 20.3 66.7 30.2 16.6 21.6 24.6 23.3 70.8 21.9 38.8 25.8 22.8 24.0 23.1 22.1 24.1 38.3 41.1 APLF "C2orf13, MGC47799, Xip1, ZCCHH1" ENSG00000169621 "Aprataxin and PNKP like factor" Q8IW19 2 68467561-68655862 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 19 "Early spermatids: 110.5;Late spermatids: 132.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.3" "Lineage enriched" "Detected in all" 4 "granulocytes: 9.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029396, HPA034642, HPA034643" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA029396: AB_10610285, HPA034642: AB_2674259, HPA034643: AB_10602431" "unprognostic (9.37e-2)" "unprognostic (1.04e-1)" "unprognostic (2.14e-1)" "unprognostic (4.29e-3)" "unprognostic (5.18e-3)" "unprognostic (2.39e-3)" "unprognostic (3.24e-1)" "unprognostic (1.46e-1)" "unprognostic (4.00e-2)" "unprognostic (2.78e-1)" "unprognostic (1.25e-3)" "unprognostic (3.28e-1)" "unprognostic (5.02e-3)" "unprognostic (8.44e-2)" "unprognostic (5.95e-2)" "unprognostic (1.35e-2)" "unprognostic (1.85e-3)" 5.2 4.4 3.8 7.3 6.5 2.8 8.2 1.1 5.0 8.0 5.7 3.1 3.8 2.6 8.8 4.0 10.6 3.3 4.1 3.8 4.7 2.0 3.7 5.1 3.4 5.8 3.6 2.1 4.3 3.8 4.1 5.1 6.2 3.2 8.5 2.7 2.3 6.4 4.8 5.4 9.2 3.3 9.2 5.6 5.7 3.6 4.1 6.1 5.1 4.4 7.5 5.8 6.9 6.9 1.1 1.4 9.3 1.2 1.5 2.2 0.9 3.6 0.9 4.1 4.1 5.5 7.4 2.1 3.2 5.8 1.9 2.4 2.3 3.0 6.7 2.6 2.6 4.5 1.2 0.5 4.4 4.6 6.2 0.8 5.5 0.8 1.4 2.6 1.9 4.9 4.1 3.7 2.7 4.1 4.9 1.4 4.2 1.1 4.8 1.9 0.6 2.7 5.0 2.3 3.6 1.6 3.6 1.4 3.0 3.8 2.0 1.2 2.7 3.2 0.4 3.8 6.0 0.3 1.1 3.6 6.7 1.5 3.4 2.5 4.4 2.4 5.2 2.9 2.7 4.4 9.3 0.9 3.1 0.9 1.2 1.0 1.1 1.4 1.3 1.3 1.0 1.5 0.8 0.0 1.5 0.9 1.4 2.2 0.9 3.8 6.5 1.1 5.0 4.7 2.0 3.6 2.1 3.2 6.1 3.0 1.6 0.9 2.2 2.2 0.1 2.6 0.0 1.4 3.4 0.0 2.0 5.3 0.0 2.7 110.5 2.5 0.0 0.0 1.7 2.0 2.3 1.5 0.0 0.8 1.9 3.2 3.4 2.5 0.3 132.8 4.0 1.7 0.0 6.4 0.5 0.5 0.9 0.0 1.8 1.9 0.3 0.0 2.7 5.0 3.9 2.9 4.1 0.0 0.7 1.3 APLP1 APLP ENSG00000105290 "Amyloid beta precursor like protein 1" P51693 19 35867899-35879791 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion, Endocytosis" Heparin-binding Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 147.5" "Group enriched" "Detected in many" 4 "Bipolar cells: 142.9;Horizontal cells: 152.6" "Cancer enhanced" "Detected in many" "glioma: 63.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 25.4;AN3-CA: 47.1;EFO-21: 24.9;HMC-1: 24.3;SCLC-21H: 27.4;SH-SY5Y: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028970, HPA028971" Enhanced Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA 3900000 "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA028970: AB_2672847, HPA028971: AB_10601334" "unprognostic (1.33e-2)" "unprognostic (2.07e-1)" "unprognostic (9.36e-3)" "prognostic unfavorable (3.87e-4)" "unprognostic (7.32e-3)" "unprognostic (1.26e-2)" "unprognostic (1.04e-3)" "unprognostic (2.24e-2)" "unprognostic (4.98e-2)" "unprognostic (6.16e-2)" "unprognostic (2.35e-2)" "unprognostic (1.13e-1)" "unprognostic (2.57e-11)" "unprognostic (1.38e-3)" "unprognostic (7.12e-2)" "unprognostic (5.43e-2)" "prognostic unfavorable (2.65e-5)" 2.6 15.6 37.0 2.9 47.9 1.6 1.6 13.1 147.5 2.4 2.6 91.6 0.0 2.0 2.3 2.1 2.2 2.3 4.3 6.0 53.2 37.4 2.4 1.5 2.4 2.1 54.6 24.6 1.9 32.1 5.6 17.6 1.9 38.4 2.3 2.6 3.3 2.4 2.4 1.5 2.0 2.4 2.9 118.2 1.7 9.6 5.7 36.9 0.0 2.2 0.0 2.2 2.1 0.1 1.5 0.4 2.2 0.7 3.0 0.6 0.2 1.4 10.6 25.4 47.1 2.4 1.0 3.3 2.2 1.1 2.5 0.3 2.5 1.4 0.2 24.9 5.5 8.2 0.7 7.8 0.5 1.7 17.7 0.9 0.1 3.1 1.4 0.7 0.0 24.3 1.1 0.6 1.0 0.0 9.4 0.8 1.8 0.9 0.4 7.2 2.3 0.0 0.0 1.2 4.3 6.2 2.4 0.1 0.3 0.4 0.3 27.4 27.8 8.2 1.1 0.3 7.2 6.1 1.3 0.6 17.1 9.8 9.6 1.4 1.1 0.4 0.1 11.2 0.3 8.6 2.2 0.7 0.4 0.4 0.5 0.3 0.7 0.4 0.6 0.2 1.5 0.5 0.6 2.1 3.0 0.7 0.4 0.2 0.2 37.0 47.9 13.1 54.6 53.2 37.4 54.6 24.6 38.4 36.9 6.0 0.0 0.0 2.4 1.1 142.9 4.8 0.0 0.0 0.0 0.0 11.8 0.3 0.0 2.1 25.2 2.8 0.0 0.0 3.8 4.1 2.1 1.8 0.0 0.0 0.4 152.6 33.6 1.3 0.3 8.5 1.1 0.5 5.0 0.0 0.0 11.9 4.4 0.0 0.0 0.0 24.2 0.0 1.7 9.7 22.2 0.5 0.3 0.0 0.0 1.2 APOBEC3A "ARP3, PHRBN" ENSG00000128383 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3A" P31941 22 38952741-38992778 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 113.5;bone marrow: 42.7;lymphoid tissue: 31.5" "Cell type enriched" "Detected in many" 5 "Urothelial cells: 223.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 15.8" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "intermediate monocyte: 113.5" "Lineage enriched" "Detected in many" 7 "monocytes: 113.5" "Cell line enhanced" "Detected in some" "Karpas-707: 3.5" "HPA043237, HPA056980, HPA066719" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA043237: AB_10795980, HPA056980: AB_2683298, HPA066719: AB_2685711" "unprognostic (6.45e-3)" "unprognostic (1.44e-2)" "unprognostic (1.12e-1)" "unprognostic (5.21e-3)" "unprognostic (1.31e-1)" "unprognostic (2.72e-2)" "unprognostic (1.91e-1)" "unprognostic (1.91e-1)" "unprognostic (3.52e-1)" "unprognostic (2.59e-3)" "unprognostic (9.01e-3)" "unprognostic (2.00e-1)" "unprognostic (1.13e-2)" "unprognostic (1.76e-1)" "unprognostic (4.98e-2)" "unprognostic (3.41e-1)" "unprognostic (1.91e-1)" 4.3 0.2 0.3 11.0 0.4 42.7 0.5 0.2 0.7 1.7 0.8 0.2 0.0 0.6 1.3 1.4 7.2 3.3 3.4 0.9 0.2 0.3 0.7 1.3 16.0 15.8 1.9 0.5 0.7 0.7 0.1 0.3 4.9 0.7 0.3 0.2 2.0 5.9 0.0 1.2 0.3 0.8 0.8 1.7 31.5 0.8 0.4 0.2 1.4 0.7 22.3 29.0 2.7 6.4 0.2 1.2 15.3 113.5 0.1 0.1 15.2 0.7 0.3 0.5 2.5 0.2 0.4 1.1 0.3 0.0 0.0 0.1 0.2 1.6 0.6 1.7 0.2 0.3 2.1 0.6 0.4 0.0 0.8 0.2 0.2 1.7 0.2 0.2 0.3 1.1 0.2 0.9 0.3 0.2 0.3 0.1 0.5 0.3 3.5 0.1 1.3 0.5 0.5 1.1 0.5 0.2 0.9 0.5 0.7 0.6 1.3 1.2 0.6 0.4 1.4 0.2 0.3 1.1 0.1 1.5 1.1 0.9 0.4 0.4 0.5 0.8 1.0 1.4 2.5 1.2 3.5 26.8 0.9 0.0 113.5 0.1 0.2 0.0 0.0 1.2 0.1 0.0 0.0 15.3 0.1 31.1 0.1 0.1 15.2 0.3 0.4 0.2 0.7 0.2 0.3 1.9 0.5 0.7 0.2 26.8 47.2 0.0 9.0 1.1 0.5 0.0 0.0 14.7 33.0 1.8 3.9 0.2 0.0 0.0 0.5 0.1 4.3 23.3 0.2 0.2 0.5 4.8 24.4 0.0 15.6 0.0 0.0 0.6 18.0 0.0 0.3 11.3 15.1 0.0 0.0 0.8 0.8 0.0 0.4 0.0 0.8 0.0 0.9 0.1 0.5 5.9 0.2 1.0 0.0 223.8 APOBEC3B "FLJ21201, PHRBNL" ENSG00000179750 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3B" Q9UH17 22 38982347-38992804 "Cancer-related genes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Hydrolase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 20.1" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 4.7;Ductal cells: 7.3;Melanocytes: 6.8;Pancreatic endocrine cells: 5.7;Urothelial cells: 9.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "memory B-cell: 10.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 60.7;Karpas-707: 68.8" "HPA056980, HPA066719" Approved Nucleoplasm NA NA Nucleoplasm "HPA056980: AB_2683298, HPA066719: AB_2685711" "unprognostic (2.92e-2)" "prognostic favorable (2.58e-5)" "unprognostic (4.29e-2)" "unprognostic (1.19e-1)" "unprognostic (2.50e-1)" "unprognostic (1.35e-1)" "unprognostic (1.69e-2)" "unprognostic (2.18e-1)" "unprognostic (1.35e-1)" "unprognostic (6.36e-2)" "unprognostic (1.08e-2)" "unprognostic (5.88e-2)" "prognostic unfavorable (2.78e-4)" "unprognostic (8.47e-2)" "unprognostic (2.98e-2)" "unprognostic (2.70e-1)" "unprognostic (1.04e-1)" 1.6 2.3 0.3 4.4 2.2 20.1 1.4 0.3 1.2 2.3 9.9 0.7 0.3 5.8 2.0 2.4 4.6 1.2 2.2 1.6 0.6 0.2 3.6 0.9 2.5 4.3 0.3 0.3 1.7 5.7 0.4 0.3 6.4 0.8 2.1 10.0 1.3 4.8 0.3 4.1 1.9 8.8 1.0 0.7 10.4 3.8 2.0 0.3 5.9 3.3 0.3 12.0 2.0 2.4 10.2 0.8 1.7 5.8 2.2 3.8 5.9 60.7 6.8 2.6 16.4 0.3 1.5 4.5 5.6 4.9 10.8 14.2 13.0 11.1 0.6 5.1 5.6 15.9 26.1 0.3 1.1 10.9 21.9 0.6 17.5 1.5 3.4 0.1 14.5 10.6 0.6 0.1 11.2 0.5 2.2 4.1 0.0 9.8 68.8 16.6 1.6 0.0 8.1 0.0 5.8 6.1 0.4 26.3 21.8 2.2 10.2 0.4 0.0 0.0 0.0 3.7 0.4 8.1 4.2 2.5 11.9 20.8 1.8 0.1 15.3 4.2 0.0 8.5 16.2 24.1 0.5 1.3 0.0 0.3 5.8 0.0 10.2 0.8 0.5 0.8 3.2 0.0 0.4 1.7 2.2 1.8 0.1 3.8 5.9 0.3 2.2 0.3 1.2 0.6 0.2 0.3 0.3 0.8 0.3 0.0 1.7 0.8 2.2 4.7 0.0 0.2 0.0 1.4 2.3 0.0 0.0 0.3 0.0 7.3 0.0 0.0 0.5 0.0 1.6 1.9 0.4 1.2 0.0 0.0 1.8 0.0 0.0 0.0 1.6 0.0 0.0 1.6 6.8 1.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.9 0.7 0.0 0.6 9.5 APOBEC3F "ARP8, BK150C2.4.MRNA, KA6" ENSG00000128394 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3F" Q8IUX4 22 39040604-39053910 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cholangiocytes: 10.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 17.7" HPA073637 Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA073637: " "unprognostic (1.38e-3)" "unprognostic (1.28e-3)" "unprognostic (4.63e-2)" "unprognostic (1.63e-2)" "unprognostic (6.16e-2)" "unprognostic (3.51e-2)" "unprognostic (3.90e-2)" "unprognostic (1.42e-1)" "unprognostic (6.03e-2)" "unprognostic (1.34e-2)" "unprognostic (1.57e-1)" "unprognostic (1.88e-1)" "unprognostic (2.06e-3)" "unprognostic (9.36e-2)" "unprognostic (3.21e-2)" "unprognostic (1.49e-1)" "prognostic favorable (8.28e-4)" 6.9 9.0 1.9 7.9 2.3 2.5 3.1 0.7 2.0 9.6 5.4 3.9 14.5 3.1 8.2 5.6 5.6 8.1 3.1 6.7 2.4 1.7 5.9 4.5 5.4 13.1 1.8 1.2 14.1 5.5 3.9 4.9 1.7 2.6 6.4 2.4 6.6 6.4 16.3 3.2 1.6 5.0 3.9 3.6 14.3 4.3 11.9 1.9 7.3 4.2 2.5 15.9 5.4 4.5 23.2 4.3 5.9 9.1 9.3 6.9 4.7 4.4 3.5 1.4 5.5 4.1 6.1 2.0 3.4 6.3 8.1 12.9 3.0 8.0 10.6 3.6 7.1 6.7 5.6 1.3 5.3 3.2 10.0 4.4 14.3 0.0 1.5 8.1 1.5 6.0 8.0 2.3 4.1 1.4 4.4 7.4 2.8 1.0 17.7 4.0 3.2 3.2 1.9 0.6 0.0 0.5 5.3 0.5 2.3 6.7 5.9 0.7 1.1 4.1 1.1 2.2 3.3 4.2 1.2 1.9 1.7 4.7 0.2 1.5 3.1 1.6 0.5 4.9 1.4 2.6 1.4 3.3 5.9 6.1 6.6 6.9 16.4 4.0 6.2 4.3 23.2 2.5 3.9 1.5 9.3 9.1 3.7 5.4 4.7 1.9 2.3 0.7 2.0 2.4 1.7 1.8 1.2 2.6 1.9 0.0 0.3 5.2 4.0 0.8 0.0 4.4 10.2 2.7 0.0 0.0 0.0 1.4 1.7 7.1 2.1 1.5 0.5 0.0 3.5 1.2 2.2 3.4 2.3 0.9 5.0 0.0 1.2 4.3 2.1 3.3 4.6 1.9 5.0 6.4 2.1 2.0 4.6 2.8 6.0 2.8 0.3 0.0 1.9 0.3 0.2 0.6 1.4 5.3 1.5 6.2 APOBEC3G "bK150C2.7, CEM15, dJ494G10.1, FLJ12740, MDS019" ENSG00000239713 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3G" Q9HC16 22 39077005-39087743 "Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 64.4" "Cell type enhanced" "Detected in many" 10 "B-cells: 66.5;monocytes: 92.8;T-cells: 124.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 14.8;Daudi: 20.0;HDLM-2: 16.7;Karpas-707: 23.0" "HPA001812, HPA073637" Enhanced Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA001812: AB_1078175, HPA073637: " "prognostic favorable (4.78e-4)" "prognostic favorable (4.70e-4)" "unprognostic (8.18e-3)" "prognostic favorable (6.03e-5)" "unprognostic (2.37e-1)" "unprognostic (3.43e-1)" "unprognostic (7.77e-2)" "unprognostic (2.33e-1)" "unprognostic (4.23e-1)" "unprognostic (4.13e-3)" "unprognostic (9.13e-3)" "unprognostic (1.81e-1)" "prognostic unfavorable (8.66e-13)" "unprognostic (3.41e-2)" "unprognostic (5.83e-2)" "unprognostic (2.91e-2)" "prognostic favorable (6.30e-4)" 6.0 6.1 1.9 8.0 2.2 4.8 3.8 1.4 1.8 6.4 4.2 2.8 8.0 1.7 6.1 4.3 3.7 8.8 7.2 4.6 2.4 1.7 4.1 4.1 5.1 16.0 2.5 1.3 12.4 0.9 2.0 3.4 3.4 2.5 5.0 3.3 4.8 3.8 28.0 3.3 1.2 5.6 3.6 3.1 18.9 3.5 15.6 1.4 6.5 3.8 2.6 15.2 7.4 6.0 16.1 8.6 5.9 17.5 35.5 64.4 39.1 1.9 0.0 0.0 0.0 2.5 4.9 0.1 0.4 8.2 9.6 14.8 0.7 11.9 20.0 0.2 3.4 6.1 0.0 0.1 0.6 2.8 16.7 0.0 10.3 0.0 0.1 11.1 3.4 4.9 7.4 0.2 5.2 1.1 0.0 1.3 0.6 0.9 23.0 1.4 0.0 3.8 3.4 0.3 0.0 0.7 7.7 0.0 12.7 0.0 8.8 0.0 0.0 0.2 0.0 1.1 0.9 0.0 6.5 0.0 1.5 0.1 0.0 0.0 0.0 1.9 0.2 1.7 3.1 2.5 4.0 6.8 4.5 64.4 15.1 37.7 16.1 20.2 49.8 8.6 11.6 6.9 30.3 5.9 35.5 17.5 5.5 15.8 39.1 1.9 2.2 1.4 1.8 2.4 1.7 2.5 1.3 2.5 1.4 3.0 12.8 66.5 12.9 1.5 0.2 2.2 2.5 8.1 12.5 0.0 2.0 2.9 5.0 8.7 39.3 8.7 0.0 23.3 2.1 1.2 7.7 7.9 11.6 0.8 27.1 0.0 5.8 10.4 18.7 11.7 17.5 15.2 6.8 92.8 1.7 7.8 2.3 1.5 8.5 1.0 1.0 19.4 8.0 0.7 1.1 1.1 0.8 124.6 1.1 18.5 APOBEC3H ARP10 ENSG00000100298 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3H" Q6NTF7 22 39097224-39104067 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 15.7;ductus deferens: 14.1" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 2: 6.2;monocytes: 18.0;T-cells: 23.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 10 "gdT-cell: 15.7;MAIT T-cell: 6.6;memory CD4 T-cell: 8.6;memory CD8 T-cell: 13.2;naive CD8 T-cell: 6.4;NK-cell: 11.8;T-reg: 7.5" "Group enriched" "Detected in many" 14 "NK-cells: 11.8;T-cells: 15.7" "Cell line enhanced" "Detected in some" "Daudi: 4.4;HDLM-2: 4.3;Karpas-707: 11.3;U-266/70: 7.5" "HPA021492, HPA058565" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021492: AB_10964888, HPA058565: " "unprognostic (7.09e-3)" "prognostic favorable (1.20e-4)" "unprognostic (1.05e-1)" "unprognostic (6.81e-4)" "unprognostic (3.40e-1)" "unprognostic (1.54e-3)" "unprognostic (2.30e-2)" "unprognostic (1.36e-2)" "unprognostic (2.17e-1)" "unprognostic (3.83e-2)" "unprognostic (5.07e-2)" "unprognostic (5.36e-2)" "prognostic unfavorable (8.73e-12)" "unprognostic (1.05e-1)" "unprognostic (1.03e-1)" "unprognostic (6.55e-3)" "prognostic favorable (8.43e-7)" 1.7 2.2 0.7 6.2 1.2 4.9 1.0 0.8 0.9 1.5 2.3 0.9 14.1 0.4 1.7 6.4 1.5 1.9 2.7 5.9 0.7 0.7 2.3 1.3 4.2 5.3 2.0 1.0 0.9 3.8 0.8 2.0 1.3 1.2 1.6 5.6 1.1 3.3 3.6 2.7 0.5 2.7 1.6 2.1 7.5 2.0 4.0 0.3 3.7 1.8 1.2 5.5 3.1 1.5 1.0 0.1 0.0 1.0 11.8 15.7 2.9 0.0 0.7 0.1 0.0 0.0 0.4 3.2 0.0 0.2 0.3 0.1 0.0 0.4 4.4 1.7 0.4 0.0 0.2 0.0 0.9 0.0 4.3 0.5 1.0 0.2 0.1 0.4 0.0 3.3 2.9 2.5 0.3 0.4 0.3 0.0 0.2 0.0 11.3 1.3 1.3 2.0 0.4 0.0 0.1 0.0 2.4 0.0 0.3 0.0 2.0 0.0 0.0 0.2 0.0 0.0 1.7 0.1 0.7 0.0 0.0 0.2 0.0 0.0 7.5 1.0 0.2 0.3 1.9 0.1 0.0 0.2 0.0 15.7 0.3 6.6 1.0 8.6 13.2 0.1 0.3 0.5 6.4 0.0 11.8 1.0 0.0 7.5 2.9 0.7 1.2 0.8 0.9 0.7 0.7 2.0 1.0 1.2 0.3 0.0 6.2 0.8 0.5 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 5.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 3.5 0.0 3.8 0.0 0.0 0.6 0.6 0.0 0.0 0.8 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.3 23.2 0.0 0.6 APOC3 ENSG00000110245 "Apolipoprotein C3" P02656 11 116829706-116833072 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism, Lipid transport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 714.1" "Cell type enriched" "Detected in some" 60 "Hepatocytes: 64257.6" "Cancer enriched" "Detected in many" 643 "liver cancer: 4021.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "CACO-2: 28.5;Hep G2: 77.0" "Not detected" "Not detected" "HPA065365, HPA073918" Supported Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Secreted to blood" NA NA 106000000000 97000000000 Nucleoplasm "Nucleoli, Cell Junctions" "HPA065365: AB_2732733, HPA073918: " "prognostic favorable (3.77e-4)" "unprognostic (2.33e-1)" "prognostic unfavorable (6.87e-5)" "unprognostic (1.60e-2)" "unprognostic (5.21e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 38.7 0.1 0.1 31.7 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.4 714.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 91.3 0.1 0.1 0.3 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 28.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 77.0 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.7 0.9 0.0 0.0 0.3 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 100.1 0.0 0.0 0.0 0.0 858.6 0.0 0.0 0.0 0.0 0.0 3.3 0.0 3.8 0.0 0.0 1074.6 0.4 0.3 0.0 0.0 0.0 64257.6 1.0 0.0 0.0 825.6 1072.7 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 3.2 0.0 0.0 APOL6 "APOL-VI, APOLVI" ENSG00000221963 "Apolipoprotein L6" Q9BWW8 22 35648395-35668409 "Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 105.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB028574, HPA029165, HPA029167" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "CAB028574: , HPA029165: AB_10670037, HPA029167: AB_10670832" "unprognostic (7.25e-3)" "unprognostic (2.67e-2)" "unprognostic (1.09e-2)" "unprognostic (1.07e-1)" "unprognostic (2.76e-1)" "unprognostic (1.55e-1)" "unprognostic (2.32e-2)" "unprognostic (8.29e-2)" "unprognostic (3.76e-2)" "unprognostic (6.26e-3)" "unprognostic (1.46e-3)" "unprognostic (1.46e-1)" "unprognostic (6.65e-3)" "unprognostic (2.49e-2)" "unprognostic (4.17e-2)" "unprognostic (1.71e-2)" "prognostic favorable (6.61e-4)" 40.6 9.2 4.8 18.8 5.5 10.1 32.3 1.9 4.2 7.4 17.9 4.1 5.0 14.0 8.8 9.5 9.8 5.9 12.5 9.3 4.0 4.3 15.4 36.9 15.8 17.0 4.6 2.2 17.0 4.7 3.7 5.1 8.9 5.9 11.7 8.9 6.4 10.1 5.6 7.4 3.6 36.6 6.4 7.6 19.5 10.1 2.5 4.5 12.7 24.8 7.7 13.4 8.5 14.1 1.2 2.8 9.2 9.0 5.9 9.1 4.2 7.2 2.3 0.2 0.9 18.1 9.1 10.2 3.1 8.2 10.2 12.9 1.1 8.2 10.0 1.5 8.0 7.5 9.4 0.0 5.0 2.7 18.9 0.1 4.2 1.5 2.3 14.3 5.8 7.4 11.6 3.4 3.5 2.0 2.3 2.1 4.6 0.4 18.3 1.9 0.7 8.1 1.8 0.3 0.5 3.1 3.4 4.0 4.8 4.5 16.6 0.2 0.1 4.9 4.2 5.6 0.7 0.7 6.8 2.2 2.5 1.5 1.7 1.6 9.7 7.7 1.0 4.8 9.3 3.6 6.4 5.6 2.9 9.1 8.9 7.7 1.2 6.1 7.2 2.8 1.0 6.0 6.7 9.2 5.9 9.0 0.3 6.3 4.2 4.8 5.5 1.9 4.2 4.0 4.3 4.6 2.2 5.9 4.5 65.5 29.3 17.5 9.9 7.1 0.1 6.6 38.2 40.2 40.9 12.2 0.0 6.7 8.3 30.0 10.4 23.9 70.1 0.0 36.3 26.7 19.5 29.2 36.8 105.8 31.4 0.0 45.4 41.7 43.9 4.6 24.2 30.8 8.5 23.4 48.8 3.1 38.3 42.1 17.7 23.8 0.0 0.0 13.4 0.2 0.2 4.5 2.1 51.7 25.8 43.1 APOLD1 "DKFZP434F0318, FLJ25138" ENSG00000178878 "Apolipoprotein L domain containing 1" Q96LR9 12 12725917-12829975 "Predicted membrane proteins" "Angiogenesis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 109.5" "Cell type enhanced" "Detected in many" 9 "Endothelial cells: 140.0;Erythroid cells: 70.0;Ito cells: 65.7;Muller glia cells: 64.4;Sertoli cells: 109.9;Smooth muscle cells: 101.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 26.2;HDLM-2: 13.2;hTERT-RPE1: 10.9" "Group enriched" "Detected in many" 5 "basal ganglia: 5.8;olfactory region: 24.7" "Low region specificity" "Detected in all" "HPA052462, HPA058882" Approved Approved "Nucleoplasm,Plasma membrane" No No "Nucleoplasm, Plasma membrane" "HPA052462: AB_2681841, HPA058882: AB_2683844" "unprognostic (1.98e-1)" "unprognostic (8.36e-3)" "unprognostic (5.28e-2)" "unprognostic (1.28e-3)" "unprognostic (1.37e-1)" "unprognostic (1.16e-2)" "unprognostic (5.58e-3)" "unprognostic (8.07e-2)" "unprognostic (3.46e-1)" "unprognostic (4.23e-2)" "unprognostic (1.35e-1)" "unprognostic (3.23e-2)" "unprognostic (4.30e-3)" "unprognostic (3.42e-3)" "unprognostic (1.81e-1)" "unprognostic (6.18e-2)" "unprognostic (1.15e-2)" 109.5 8.8 11.2 9.2 17.7 0.6 34.4 9.8 17.5 25.5 9.0 7.7 2.9 2.5 7.1 7.0 18.8 14.0 18.7 22.3 13.0 11.8 7.4 9.3 7.1 3.4 16.6 3.3 10.0 12.8 17.2 4.7 44.8 16.7 7.2 7.1 8.1 4.4 3.7 16.6 7.4 6.0 28.0 13.9 4.7 5.3 5.4 12.4 5.7 34.4 9.9 3.3 10.9 7.1 2.3 1.7 4.8 0.9 0.8 2.7 0.3 4.3 0.1 26.2 0.8 0.8 1.5 0.2 4.2 7.0 4.3 6.3 1.7 4.6 1.3 0.4 1.6 1.5 1.4 1.0 0.2 7.3 13.2 1.0 0.4 1.3 0.0 1.6 0.6 0.4 1.0 1.2 1.5 3.4 10.9 3.2 2.4 0.4 1.8 2.2 0.9 0.7 0.7 0.1 1.0 0.8 2.0 0.5 0.6 0.5 0.4 2.3 2.4 4.0 0.4 9.6 0.4 0.1 2.1 3.9 1.0 1.4 5.8 3.8 1.3 0.6 1.0 1.5 2.8 4.9 4.8 0.9 0.7 0.9 0.4 1.1 2.2 2.0 1.3 0.6 2.3 1.6 1.0 4.4 0.8 0.6 1.7 2.7 0.3 11.2 17.7 9.8 17.5 13.0 11.8 16.6 3.3 16.7 12.4 6.0 4.0 21.4 2.2 16.1 4.2 7.0 7.6 8.1 9.1 0.0 3.9 1.5 0.0 0.9 1.6 140.0 1.1 70.0 0.4 1.1 8.4 3.7 7.0 1.6 5.1 3.2 3.5 65.7 14.5 1.1 4.0 5.7 27.0 3.6 4.7 64.4 0.8 0.0 0.4 0.3 3.3 109.9 101.3 3.2 0.7 13.6 0.8 20.8 6.3 2.8 APPBP2 "Hs.84084, KIAA0228, PAT1" ENSG00000062725 "Amyloid beta precursor protein binding protein 2" Q92624 17 60443149-60526219 "Cancer-related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 317.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 48.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066852, HPA078370" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA066852: , HPA078370: " "unprognostic (1.43e-1)" "unprognostic (1.89e-1)" "unprognostic (1.40e-3)" "unprognostic (2.97e-2)" "unprognostic (2.93e-2)" "unprognostic (4.53e-2)" "prognostic unfavorable (3.65e-4)" "unprognostic (7.67e-2)" "unprognostic (9.24e-2)" "unprognostic (2.39e-1)" "unprognostic (2.90e-3)" "unprognostic (6.87e-2)" "unprognostic (5.07e-2)" "unprognostic (1.03e-1)" "unprognostic (3.84e-1)" "unprognostic (1.31e-1)" "unprognostic (9.36e-2)" 18.8 16.0 16.1 13.2 22.6 5.3 15.9 28.1 27.3 17.5 13.9 25.4 12.9 10.1 18.5 13.8 14.5 14.5 16.1 10.1 16.6 16.0 18.4 15.0 16.4 10.9 20.8 15.4 27.9 17.1 23.4 20.4 24.3 25.1 19.4 12.8 13.4 13.0 15.0 14.5 12.6 10.8 16.7 18.5 15.4 14.5 30.8 21.2 17.9 17.8 7.2 11.0 15.8 15.3 12.7 12.0 15.7 14.2 15.6 16.7 9.3 7.0 9.7 10.2 8.5 10.9 11.6 5.7 11.2 7.8 6.3 8.0 4.7 6.2 7.4 18.9 9.4 10.8 6.1 7.2 3.9 11.1 6.6 5.5 9.4 9.1 9.6 11.7 7.7 10.4 11.3 5.2 6.6 6.4 9.8 9.7 4.6 7.0 8.6 9.1 48.1 10.8 3.9 2.2 7.8 4.3 7.2 17.0 8.6 9.7 11.7 11.1 9.5 9.7 1.6 8.0 5.9 13.6 5.3 12.5 14.2 17.4 9.7 8.5 9.3 29.2 6.2 9.4 4.6 10.0 13.5 12.0 15.0 10.2 8.7 11.7 9.7 12.0 11.2 12.0 12.7 16.7 12.2 15.7 15.6 14.2 7.2 11.5 9.3 16.1 22.6 28.1 24.1 16.6 16.0 20.8 15.4 25.1 21.2 26.8 20.0 19.3 13.1 16.0 57.6 22.2 15.3 12.0 18.2 14.0 17.7 21.5 16.6 15.5 317.9 26.3 12.3 0.0 14.7 7.2 23.0 21.2 23.0 17.1 16.8 35.0 31.8 39.3 19.2 94.9 32.8 14.8 16.9 17.2 22.0 40.8 15.2 14.4 36.7 27.2 33.4 38.8 23.1 33.4 25.1 16.2 52.9 20.6 18.9 15.3 APRT ENSG00000198931 "Adenine phosphoribosyltransferase" P07741 16 88809339-88811944 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Purine salvage" "Glycosyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026681 Approved Approved Nucleoplasm,Cytosol NA NA 1200000 "Nucleoplasm, Cytosol" "HPA026681: AB_1844964" "unprognostic (5.87e-2)" "unprognostic (5.10e-2)" "unprognostic (1.98e-1)" "unprognostic (3.67e-2)" "unprognostic (1.78e-1)" "unprognostic (2.50e-3)" "unprognostic (1.72e-3)" "unprognostic (6.90e-2)" "unprognostic (1.71e-1)" "unprognostic (1.82e-1)" "unprognostic (6.78e-2)" "unprognostic (8.74e-2)" "unprognostic (9.58e-3)" "unprognostic (1.14e-1)" "unprognostic (2.51e-1)" "unprognostic (4.75e-2)" "unprognostic (1.48e-2)" 22.9 37.1 10.9 33.6 13.2 32.9 31.6 10.1 15.3 22.7 31.1 10.7 33.6 27.1 19.9 28.3 50.7 21.0 30.4 22.5 9.1 8.2 27.7 60.4 30.6 94.2 14.8 10.7 17.9 58.2 19.4 15.6 19.3 11.0 25.1 15.1 13.9 48.2 37.4 26.2 49.8 24.3 18.4 12.1 30.4 27.5 16.0 12.2 37.9 29.5 49.7 35.8 18.5 32.8 65.4 92.1 24.2 70.2 58.2 83.7 104.7 25.6 37.7 7.4 33.3 9.1 18.1 39.4 19.4 17.3 22.9 8.9 38.8 31.2 23.9 38.1 11.0 10.9 27.5 12.1 31.9 4.6 16.8 72.1 20.3 17.8 40.5 28.8 13.9 16.7 19.3 34.6 18.3 23.2 10.6 28.6 40.7 42.7 17.9 11.6 94.5 39.2 41.1 28.5 26.7 49.4 42.3 11.5 56.5 25.3 17.5 36.8 22.6 37.0 21.7 20.9 7.2 71.5 27.7 18.5 20.7 18.1 16.7 19.1 35.2 29.5 65.7 30.5 37.0 18.3 8.5 70.2 24.2 63.0 57.7 83.7 63.2 81.9 67.5 71.6 65.4 75.9 64.3 4.3 58.2 37.1 92.1 66.1 104.7 10.9 13.2 10.1 15.3 9.1 8.2 14.8 10.7 11.0 12.2 107.2 125.0 285.8 232.8 283.3 20.2 39.3 252.3 87.0 112.6 87.2 5.9 238.4 344.8 378.2 9.5 147.6 262.7 70.0 383.2 347.1 184.5 203.2 130.3 282.7 315.2 14.3 202.5 130.8 259.2 24.9 222.1 260.5 281.7 449.1 262.5 57.6 343.1 185.9 127.3 427.1 16.1 38.8 137.7 8.1 99.7 432.5 144.4 269.7 340.7 292.1 APTX "AOA, AOA1, AXA1, EAOH, EOAHA, FLJ20157" ENSG00000137074 Aprataxin Q7Z2E3 9 32972606-33025168 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Hydrolase" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064930 Supported Supported Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA064930: AB_2685386" "unprognostic (9.18e-2)" "unprognostic (2.65e-2)" "unprognostic (3.61e-2)" "unprognostic (1.73e-2)" "unprognostic (4.04e-1)" "unprognostic (8.16e-2)" "unprognostic (2.26e-2)" "unprognostic (1.00e-1)" "unprognostic (1.32e-2)" "unprognostic (2.78e-3)" "unprognostic (3.48e-3)" "unprognostic (3.49e-2)" "prognostic favorable (6.01e-5)" "unprognostic (7.87e-2)" "unprognostic (1.34e-1)" "unprognostic (1.13e-1)" "unprognostic (6.50e-2)" 12.9 20.3 17.5 11.2 18.4 19.9 16.5 15.1 21.7 12.0 15.2 19.3 9.3 11.7 14.7 12.9 19.1 14.7 8.0 11.9 13.3 13.9 17.9 23.4 12.6 11.8 16.4 16.5 11.8 14.3 15.8 14.3 12.1 20.2 12.1 18.1 14.6 12.5 11.9 14.1 20.6 13.8 14.6 15.7 11.7 12.5 18.2 14.5 8.8 10.5 12.6 16.1 13.4 12.1 17.1 18.4 16.1 20.8 26.4 19.4 15.0 21.6 16.4 12.5 10.8 12.8 11.2 16.6 14.5 15.1 17.7 19.6 21.8 7.7 16.9 8.7 12.1 11.0 11.5 20.3 19.4 22.0 22.8 8.3 10.0 23.5 22.2 14.8 16.1 9.6 15.0 23.8 20.3 26.4 11.3 16.9 13.1 15.1 16.9 16.5 9.3 14.4 23.7 19.1 14.2 17.7 13.1 8.7 12.0 14.5 13.2 8.7 7.3 13.3 11.9 9.7 12.1 13.5 6.6 10.4 9.9 13.2 17.1 14.9 7.3 12.0 16.9 14.7 13.2 7.9 9.1 17.7 14.9 13.4 16.3 17.6 17.0 15.2 15.5 18.4 17.1 18.0 14.6 16.1 26.4 20.8 17.9 19.4 15.0 17.5 18.4 15.1 21.7 13.3 13.9 16.4 16.5 20.2 14.5 17.9 31.9 15.7 18.7 14.8 13.6 12.9 28.1 25.4 19.4 8.7 9.8 23.7 24.9 20.4 49.1 11.9 11.6 0.0 24.6 22.8 12.6 16.4 16.1 17.4 16.5 12.7 16.1 6.7 15.2 35.4 12.4 14.5 13.5 20.8 12.6 17.8 24.5 3.5 9.9 24.1 16.2 12.9 12.2 35.9 27.0 18.4 23.3 14.1 15.1 20.4 AQP11 ENSG00000178301 "Aquaporin 11" Q8NBQ7 11 77589391-77610355 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 60.1" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 30.5;Late spermatids: 51.4;Muller glia cells: 29.1;Spermatocytes: 35.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "B-cells: 2.0;NK-cells: 2.0;T-cells: 2.3" "Cell line enhanced" "Detected in many" "CACO-2: 7.8;GAMG: 12.3;Hep G2: 13.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042879 Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA042879: AB_10794919" "unprognostic (4.95e-2)" "unprognostic (7.61e-2)" "unprognostic (2.15e-2)" "unprognostic (9.62e-5)" "unprognostic (2.42e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-1)" "unprognostic (3.48e-2)" "unprognostic (2.65e-1)" "prognostic favorable (9.89e-4)" "unprognostic (1.16e-1)" "unprognostic (1.00e-1)" "unprognostic (1.73e-1)" "unprognostic (1.73e-2)" "unprognostic (2.44e-1)" "unprognostic (6.46e-2)" "unprognostic (1.66e-3)" 1.0 14.5 4.2 0.8 3.5 0.6 1.1 5.0 4.8 0.6 22.4 2.1 0.7 24.7 0.8 1.2 0.5 0.9 2.4 0.7 2.5 4.5 5.2 13.9 0.6 0.9 3.4 3.4 9.3 3.6 0.9 1.8 3.5 3.4 3.9 2.1 3.8 0.8 0.7 1.0 1.0 60.1 0.6 1.5 1.0 2.3 7.4 1.7 0.0 1.6 0.2 0.4 0.8 0.6 2.0 0.1 0.3 0.1 2.0 2.3 0.8 1.0 3.3 1.4 2.2 3.2 0.8 1.4 1.7 0.8 1.6 0.7 7.8 1.6 1.6 0.8 0.7 12.3 1.0 0.5 0.1 0.8 4.8 1.3 1.3 1.1 13.0 1.0 2.7 1.5 0.8 0.3 0.9 0.2 1.9 0.3 0.4 0.8 1.0 1.8 1.6 1.0 1.8 1.4 7.5 3.0 1.4 3.5 0.6 0.9 1.2 1.4 1.0 2.1 0.4 0.8 1.1 1.6 0.4 0.9 1.3 4.1 2.5 1.1 1.1 0.8 1.3 0.4 0.2 1.8 0.0 0.0 0.3 1.9 0.0 1.3 0.3 0.8 1.5 0.1 2.0 2.3 0.7 0.0 2.0 0.1 0.1 0.1 0.8 4.2 3.5 5.0 4.8 2.5 4.5 3.4 3.4 3.4 1.7 0.0 0.0 0.0 0.7 0.1 7.5 0.4 7.6 0.0 0.0 1.8 0.0 6.6 0.0 1.2 30.5 0.3 15.8 0.0 3.4 10.1 0.9 1.2 4.6 21.5 1.0 0.0 4.1 0.0 0.3 51.4 14.4 0.0 1.7 0.0 3.1 29.1 3.7 3.1 10.6 15.3 5.0 0.0 0.7 35.9 5.8 0.1 13.3 0.0 5.6 0.1 AQP3 GIL ENSG00000165272 "Aquaporin 3 (Gill blood group)" Q92482 9 33441154-33447633 "Blood group antigen proteins, Plasma proteins, Predicted membrane proteins" Transport "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 179.6;lymphoid tissue: 156.1;salivary gland: 194.2;tongue: 132.4" "Group enriched" "Detected in many" 6 "Basal glandular cells: 608.6;Basal keratinocytes: 1708.5;Collecting duct cells: 1526.7;Glandular cells: 959.6;Suprabasal keratinocytes: 2172.4;Urothelial cells: 2008.6" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 5 "hippocampal formation: 2.1;pons and medulla: 6.7" "Group enriched" "Detected in many" 6 "MAIT T-cell: 41.1;memory CD4 T-cell: 39.2;memory CD8 T-cell: 12.0;naive CD4 T-cell: 22.7;naive CD8 T-cell: 10.8;T-reg: 42.1" "Lineage enriched" "Detected in many" 16 "T-cells: 42.1" "Cell line enhanced" "Detected in many" "HaCaT: 28.1;HeLa: 51.2;JURKAT: 28.8;RT4: 47.6;SK-BR-3: 32.9;U-266/70: 34.1;U-266/84: 44.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA014924 Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA014924: AB_2669120" "unprognostic (4.29e-2)" "prognostic favorable (5.31e-4)" "unprognostic (1.15e-1)" "unprognostic (3.26e-2)" "unprognostic (1.84e-2)" "unprognostic (1.11e-2)" "unprognostic (9.95e-2)" "unprognostic (1.64e-1)" "unprognostic (3.46e-1)" "unprognostic (9.06e-2)" "unprognostic (4.87e-2)" "unprognostic (1.25e-1)" "unprognostic (1.54e-2)" "unprognostic (1.16e-2)" "unprognostic (2.59e-1)" "unprognostic (3.73e-2)" "unprognostic (4.51e-2)" 1.3 0.4 0.4 2.7 0.2 1.9 5.2 0.9 0.3 29.7 26.7 0.1 1.7 9.9 5.5 3.2 179.6 3.3 2.0 6.0 2.1 0.4 23.9 44.0 16.5 5.7 0.5 0.3 3.6 5.7 0.0 0.7 5.3 6.7 15.5 1.2 0.4 194.2 5.5 0.9 65.2 33.2 5.1 0.3 17.2 3.9 1.2 0.0 70.6 0.6 132.4 156.1 37.6 60.2 2.6 2.4 0.5 0.1 0.5 42.1 10.3 0.1 8.4 0.4 0.0 15.6 2.8 0.2 0.0 0.2 0.2 0.2 4.4 2.6 0.1 2.0 0.0 0.1 28.1 1.3 0.1 0.0 13.4 1.3 0.9 51.2 0.4 0.0 0.2 0.3 0.4 1.4 0.1 0.0 0.0 0.1 28.8 14.3 13.0 1.5 6.2 12.8 5.0 1.1 19.2 0.1 0.2 21.3 2.3 0.2 47.6 0.4 1.1 7.1 32.9 0.0 1.9 0.2 2.2 0.2 0.0 0.2 0.0 0.0 34.1 44.2 3.2 0.1 0.0 0.0 0.3 0.1 0.0 4.5 0.0 41.1 2.6 39.2 12.0 0.0 0.5 22.7 10.8 0.5 0.5 0.1 2.4 42.1 10.3 0.4 0.2 0.9 0.3 2.1 0.4 0.5 0.3 6.7 0.0 35.7 265.4 2.2 608.6 1708.5 1.4 2.1 104.4 136.5 215.0 1526.7 2.0 0.6 0.0 27.2 1.3 40.5 4.2 93.5 41.7 1.3 46.3 959.6 19.7 111.7 2.2 0.0 7.9 16.0 3.8 0.0 30.8 32.1 150.1 1.0 63.7 0.3 32.0 2.9 1.1 28.8 0.4 0.0 42.2 0.0 1.0 2172.4 42.0 43.3 3.5 2008.6 AQR "fSAP164, IBP160, KIAA0560" ENSG00000021776 "Aquarius intron-binding spliceosomal factor" O60306 15 34851782-34969839 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 108.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040624, HPA055647" Enhanced Nucleoplasm No No Nucleoplasm "HPA040624: AB_2677050, HPA055647: AB_2682874" "unprognostic (1.73e-1)" "unprognostic (3.71e-2)" "unprognostic (2.97e-1)" "unprognostic (1.32e-2)" "unprognostic (1.03e-1)" "unprognostic (9.04e-2)" "unprognostic (4.25e-2)" "unprognostic (1.90e-1)" "unprognostic (5.95e-2)" "unprognostic (2.65e-1)" "unprognostic (1.14e-2)" "unprognostic (1.48e-1)" "prognostic favorable (4.83e-4)" "unprognostic (2.97e-1)" "unprognostic (2.47e-1)" "unprognostic (3.84e-1)" "unprognostic (3.13e-2)" 15.5 15.8 8.0 14.0 12.4 9.7 16.1 11.2 14.3 16.6 11.2 11.8 8.7 9.2 18.5 11.8 18.3 12.3 8.7 9.9 8.4 7.5 14.4 11.2 10.7 12.6 8.7 6.9 15.5 13.6 16.8 13.2 15.3 13.2 12.0 11.8 12.4 15.1 11.3 8.7 14.2 13.0 14.3 8.3 16.8 12.9 15.8 9.2 27.9 14.8 8.5 16.5 15.7 14.9 5.9 5.5 7.1 5.1 4.5 6.5 2.9 5.0 13.1 8.7 9.1 11.8 11.0 4.5 6.2 7.9 8.3 7.5 5.9 3.1 4.1 4.0 10.5 5.5 8.0 14.6 8.9 9.2 5.8 5.9 13.2 11.6 5.4 6.7 10.7 6.2 8.5 5.9 6.5 6.9 7.8 7.0 3.3 9.3 4.1 8.2 3.4 6.2 7.2 8.6 11.7 5.4 8.5 15.0 4.1 8.4 8.9 9.5 7.4 10.1 9.7 2.2 8.0 6.8 8.4 9.1 6.2 3.4 4.2 5.5 5.0 6.1 8.4 7.7 9.3 6.2 7.1 4.7 2.7 6.5 5.1 5.7 4.0 5.7 6.2 3.8 5.9 5.8 6.4 2.3 4.5 3.0 5.5 4.6 2.9 8.0 12.4 11.2 13.4 8.4 7.5 8.7 6.9 13.2 9.2 11.9 27.0 11.9 11.9 8.5 25.3 14.6 20.4 29.4 36.4 14.0 108.0 13.3 3.3 11.5 36.0 17.9 15.5 0.0 12.3 12.0 10.6 12.5 23.1 17.1 13.1 23.8 12.7 31.9 17.0 6.9 19.2 12.7 15.1 13.6 17.7 17.4 15.9 14.0 17.3 10.3 38.7 6.5 9.8 19.3 20.1 8.4 11.1 20.8 19.1 11.2 ARAF ARAF1 ENSG00000078061 "A-Raf proto-oncogene, serine/threonine kinase" P10398 X 47561100-47571920 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046188, HPA066326" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA046188: AB_2679578, HPA066326: AB_2685659" "unprognostic (1.21e-1)" "unprognostic (5.69e-3)" "unprognostic (2.47e-2)" "unprognostic (2.10e-2)" "unprognostic (7.63e-2)" "unprognostic (9.35e-2)" "unprognostic (1.79e-2)" "unprognostic (1.07e-1)" "unprognostic (3.76e-2)" "unprognostic (1.61e-1)" "unprognostic (6.75e-2)" "unprognostic (8.65e-2)" "prognostic favorable (1.45e-6)" "unprognostic (1.97e-1)" "unprognostic (2.01e-1)" "unprognostic (6.37e-2)" "unprognostic (4.71e-2)" 22.2 24.2 10.9 16.5 15.5 41.9 19.5 16.0 13.7 18.0 23.2 21.1 24.1 17.8 21.3 18.4 19.4 18.7 21.0 28.6 12.8 7.3 28.0 49.6 21.8 20.2 16.4 9.5 23.4 35.1 28.1 16.9 25.3 13.5 23.5 15.8 25.4 22.1 18.5 60.8 18.9 23.8 18.6 11.2 27.4 24.2 10.2 16.3 27.7 23.1 23.9 27.3 20.2 16.9 23.9 34.3 36.1 38.4 22.4 29.1 27.5 20.3 29.3 12.6 20.2 19.2 15.3 17.0 17.2 18.2 25.7 23.7 23.9 25.0 12.1 14.1 23.0 21.6 28.7 22.2 23.7 14.8 22.3 26.1 12.1 31.1 12.3 27.0 24.0 37.2 20.1 24.2 24.5 21.5 17.0 19.7 15.4 22.5 23.9 17.4 34.4 17.4 25.9 18.1 17.2 32.8 16.2 16.4 27.3 14.7 19.5 14.3 11.0 18.5 17.1 10.1 20.8 32.2 18.2 18.7 16.7 18.8 33.3 17.3 31.0 19.8 9.4 22.2 27.2 13.3 23.9 29.0 36.1 29.1 35.4 26.9 21.4 25.5 26.7 34.3 23.9 22.7 26.7 23.6 22.4 38.4 24.7 25.1 27.5 10.9 15.5 16.0 13.7 12.8 7.3 16.4 9.5 13.5 16.3 14.9 36.4 18.8 19.6 14.0 4.0 23.6 30.6 8.1 10.3 17.4 9.8 27.3 19.9 24.2 1.1 17.9 37.6 0.0 29.9 25.3 15.5 19.0 16.1 35.8 24.8 12.7 30.5 22.7 22.7 3.0 16.1 21.7 32.1 55.1 36.8 13.3 23.6 40.2 16.6 22.1 8.2 19.4 18.6 5.6 10.2 14.2 37.3 27.4 26.6 21.6 ARAP1 CENTD2 ENSG00000186635 "ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1" Q96P48 11 72685069-72793599 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 49.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020703, HPA070383" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA 39000 "Nucleoplasm, Plasma membrane" "Vesicles, Cytosol" "CAB020703: , HPA070383: AB_2686262" "unprognostic (3.60e-2)" "unprognostic (7.68e-2)" "unprognostic (6.19e-2)" "unprognostic (5.98e-2)" "unprognostic (5.76e-2)" "unprognostic (1.64e-2)" "prognostic unfavorable (6.45e-4)" "unprognostic (4.01e-2)" "unprognostic (4.07e-1)" "unprognostic (5.95e-2)" "prognostic favorable (2.04e-5)" "unprognostic (1.84e-1)" "unprognostic (1.05e-3)" "unprognostic (6.93e-2)" "unprognostic (2.57e-2)" "prognostic favorable (6.41e-4)" "unprognostic (7.56e-3)" 19.2 29.6 28.8 32.9 29.1 51.1 17.9 34.0 37.5 19.6 16.8 26.6 20.0 17.4 23.7 20.0 21.1 30.3 26.1 20.3 27.7 14.4 20.9 16.6 35.5 27.8 27.5 17.8 28.8 18.9 14.3 31.0 20.9 23.0 21.3 11.2 18.1 19.9 19.0 12.9 27.5 23.6 17.1 25.6 53.8 16.2 23.5 32.3 18.8 24.7 14.0 18.6 28.4 19.6 3.3 7.4 24.0 22.5 6.1 4.4 6.4 7.2 15.5 5.9 7.2 25.3 17.2 8.9 10.0 18.1 11.4 11.4 21.1 19.4 16.2 20.2 16.8 15.5 24.6 9.0 23.9 4.9 19.0 10.6 13.7 14.6 29.1 17.5 9.3 38.5 18.3 25.5 18.7 9.0 14.3 12.1 11.9 11.4 6.5 5.3 15.0 14.1 32.4 3.7 13.1 10.0 13.8 9.0 7.9 10.7 23.2 6.2 12.5 7.3 10.9 32.3 7.9 9.5 21.2 14.3 16.2 11.3 16.4 6.1 10.5 5.1 8.5 8.6 13.9 8.6 7.5 11.0 13.3 4.4 18.7 2.6 3.3 2.9 3.3 7.4 2.6 2.3 2.7 24.0 6.1 22.5 2.5 3.1 6.4 28.8 29.1 34.0 37.5 27.7 14.4 27.5 17.8 23.0 32.3 26.8 28.8 11.5 8.0 6.5 4.1 2.0 5.1 8.1 3.4 15.7 31.4 7.0 8.3 13.1 49.1 4.4 11.6 0.0 6.4 7.7 16.7 4.7 10.4 10.2 37.8 0.0 22.3 12.9 43.1 4.4 19.2 39.0 8.5 10.8 13.9 8.6 10.7 7.0 14.2 4.7 2.9 0.0 6.1 0.3 2.5 4.6 4.1 6.7 12.1 6.7 ARFGEF1 "ARFGEP1, BIG1, DKFZP434L057, p200" ENSG00000066777 "ADP ribosylation factor guanine nucleotide exchange factor 1" Q9Y6D6 8 67173511-67343677 "Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 131.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023399, HPA023822" Supported Supported Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA023399: AB_1844981, HPA023822: AB_1844982" "prognostic unfavorable (8.76e-4)" "unprognostic (1.62e-1)" "unprognostic (4.60e-2)" "unprognostic (1.01e-2)" "unprognostic (1.11e-1)" "unprognostic (5.49e-2)" "unprognostic (1.52e-2)" "unprognostic (4.52e-1)" "unprognostic (5.38e-2)" "unprognostic (4.67e-2)" "unprognostic (2.13e-3)" "unprognostic (1.31e-1)" "prognostic favorable (2.48e-4)" "unprognostic (1.13e-1)" "unprognostic (2.84e-1)" "unprognostic (1.62e-1)" "unprognostic (1.61e-2)" 17.0 17.1 14.5 24.3 15.6 24.9 14.0 20.4 16.3 17.7 24.7 9.5 24.7 16.8 15.4 20.3 23.8 13.1 16.0 12.0 11.3 11.7 23.9 15.3 18.6 22.7 11.4 9.5 15.1 21.4 38.6 21.8 17.4 16.7 15.8 17.7 13.2 20.7 29.4 20.9 18.4 26.9 13.8 12.0 20.1 19.5 27.1 12.6 36.7 22.9 15.7 16.8 22.9 17.7 2.1 3.7 8.4 3.7 3.7 6.1 1.3 15.8 10.3 10.1 3.7 11.7 16.0 11.9 11.2 12.5 11.4 11.6 6.3 15.5 12.0 4.9 14.0 13.9 11.4 12.1 15.7 14.0 15.4 8.5 20.2 6.3 6.8 10.1 10.3 20.2 9.8 11.3 10.2 17.5 11.8 16.2 12.7 12.4 13.1 13.1 3.5 24.2 4.9 22.1 17.4 9.5 11.9 7.2 2.4 18.9 29.5 4.0 7.8 7.2 17.5 9.8 16.1 30.2 9.2 19.7 7.9 10.5 10.3 8.3 11.5 12.5 9.0 12.4 10.6 7.3 8.0 2.6 6.6 4.8 3.7 6.1 2.1 3.2 3.9 2.6 2.1 5.3 4.5 8.4 3.7 1.5 3.7 5.9 1.3 14.5 15.6 20.4 16.3 11.3 11.7 11.4 9.5 16.7 12.6 41.7 17.2 18.8 23.7 21.1 35.4 28.2 20.4 30.8 26.1 36.6 131.6 16.1 10.0 24.5 19.5 24.8 32.5 0.0 22.1 13.2 15.8 30.7 15.0 17.8 14.2 41.3 28.3 22.1 29.5 23.4 37.2 23.8 16.9 27.9 29.9 21.4 31.5 23.0 28.3 21.0 94.9 6.5 17.5 49.4 48.5 25.7 20.8 23.0 22.7 61.6 ARFIP1 HSU52521 ENSG00000164144 "ADP ribosylation factor interacting protein 1" P53367 4 152779937-152918463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005080, HPA037375, HPA063759" Enhanced Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "CAB005080: AB_2058797, HPA037375: AB_2675440, HPA063759: AB_2685114" "unprognostic (1.06e-1)" "unprognostic (1.19e-1)" "prognostic favorable (5.75e-5)" "unprognostic (1.49e-3)" "unprognostic (4.32e-1)" "unprognostic (1.24e-1)" "unprognostic (3.54e-2)" "unprognostic (5.34e-1)" "unprognostic (1.03e-2)" "unprognostic (3.56e-1)" "unprognostic (3.60e-2)" "unprognostic (1.82e-2)" "prognostic favorable (2.83e-10)" "unprognostic (1.83e-1)" "unprognostic (1.32e-1)" "unprognostic (7.02e-2)" "unprognostic (4.22e-3)" 17.8 15.6 12.2 22.6 13.2 2.8 22.3 15.7 12.3 22.8 25.3 17.5 25.6 20.9 21.1 23.8 23.4 17.6 20.8 11.9 12.6 13.2 23.6 15.3 20.3 14.9 16.1 9.5 22.9 18.8 20.4 22.5 29.0 13.5 23.8 26.4 19.1 19.6 23.9 12.7 19.1 29.9 18.5 18.3 18.5 20.2 12.7 13.9 14.7 23.9 10.2 17.9 24.3 20.4 8.4 10.9 35.7 13.8 12.3 7.6 7.7 13.2 9.9 13.8 13.5 21.8 22.3 17.1 15.9 22.5 16.1 15.4 11.5 27.8 10.6 5.3 22.1 12.4 9.5 14.3 16.1 20.1 8.9 8.9 10.5 10.1 11.4 15.4 19.7 22.2 15.7 17.9 13.7 13.6 17.5 14.8 6.2 12.3 23.0 22.5 15.4 11.0 11.0 11.6 16.6 10.1 6.4 7.8 9.8 29.1 17.8 17.5 14.4 12.0 22.7 15.8 14.1 20.3 10.6 9.1 15.6 11.1 15.1 11.2 25.3 20.8 14.5 19.8 19.8 21.5 12.1 12.0 17.9 6.7 13.8 6.7 8.4 5.3 5.5 10.9 7.7 4.1 5.5 35.7 12.3 12.6 1.3 7.6 7.7 12.2 13.2 15.7 12.3 12.6 13.2 16.1 9.5 13.5 13.9 6.0 25.6 10.4 15.8 26.3 17.3 8.1 28.1 25.4 21.6 36.6 0.0 24.5 23.2 23.7 30.8 19.9 26.4 0.0 15.9 21.2 22.4 21.3 22.0 17.8 19.1 17.5 37.3 19.0 22.2 19.7 20.8 18.5 20.3 5.4 34.5 32.0 19.3 24.6 20.5 24.5 23.6 32.3 18.9 25.5 31.9 29.6 36.7 11.4 29.7 29.4 ARFIP2 POR1 ENSG00000132254 "ADP ribosylation factor interacting protein 2" P53365 11 6474683-6481479 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032985, HPA038156" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Nucleoplasm, Nucleoli fibrillar center, Golgi apparatus" "CAB032985: AB_2058811, HPA038156: AB_10697243" "unprognostic (2.32e-1)" "unprognostic (2.75e-1)" "unprognostic (2.97e-2)" "prognostic favorable (2.00e-5)" "unprognostic (8.44e-2)" "unprognostic (1.25e-1)" "unprognostic (4.05e-3)" "unprognostic (2.50e-1)" "unprognostic (2.96e-1)" "unprognostic (1.76e-1)" "unprognostic (5.70e-3)" "unprognostic (3.11e-1)" "prognostic favorable (9.53e-4)" "unprognostic (2.05e-1)" "unprognostic (2.41e-1)" "unprognostic (2.32e-2)" "unprognostic (9.48e-3)" 13.3 20.5 19.7 15.2 19.4 12.6 33.0 24.0 32.0 24.5 22.9 16.4 29.5 20.2 17.5 23.1 22.0 25.5 21.5 13.2 16.5 17.2 21.3 32.7 17.5 13.0 15.5 22.0 20.3 36.0 36.1 29.9 27.3 16.8 30.9 31.2 18.6 46.6 29.4 12.1 21.6 23.5 17.8 14.9 15.0 31.2 14.9 16.0 12.3 28.4 16.3 24.2 16.0 19.8 11.5 17.4 7.8 12.7 15.6 15.5 10.8 14.2 19.0 11.6 11.8 18.2 17.1 16.6 11.5 31.4 25.9 31.0 17.9 23.9 11.5 4.9 23.2 14.5 20.3 14.7 24.6 21.7 8.9 26.0 6.2 25.2 17.1 22.0 10.0 12.8 18.1 19.7 12.5 30.3 19.0 16.4 11.0 9.8 13.6 16.8 28.0 11.8 11.4 19.6 32.1 21.6 9.1 6.5 10.9 18.0 14.8 15.4 18.7 14.0 62.6 7.2 11.1 25.8 9.3 10.4 11.1 10.7 11.5 8.5 20.4 9.1 7.0 19.9 6.2 12.6 7.4 12.7 7.8 15.5 8.8 15.2 10.7 14.6 12.7 17.4 11.5 14.5 14.8 5.3 15.6 5.4 13.6 14.7 10.8 19.7 19.4 24.0 32.0 16.5 17.2 15.5 22.0 16.8 16.0 6.0 5.4 21.6 37.4 24.8 31.5 3.9 28.1 10.7 7.9 12.2 27.5 68.9 49.7 42.8 17.9 17.9 60.6 0.0 74.5 52.8 24.9 63.7 32.2 17.1 24.8 20.6 60.5 20.3 9.1 30.2 19.0 15.7 23.6 33.3 78.2 31.3 48.5 52.6 23.0 26.0 27.9 25.8 17.5 32.9 16.4 28.1 94.1 16.2 40.6 54.8 ARGLU1 FLJ10154 ENSG00000134884 "Arginine and glutamate rich 1" Q9NWB6 13 106541673-106568164 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 91.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034962, HPA056792" Supported Enhanced Nucleoplasm,Mitochondria,Cytosol No No Nucleoplasm "Mitochondria, Cytosol" "HPA034962: AB_10611676, HPA056792: AB_2683236" "unprognostic (1.66e-2)" "unprognostic (3.10e-2)" "unprognostic (2.24e-1)" "unprognostic (2.82e-1)" "unprognostic (3.97e-2)" "unprognostic (3.00e-2)" "unprognostic (1.11e-3)" "unprognostic (3.21e-2)" "unprognostic (9.00e-2)" "unprognostic (1.52e-1)" "prognostic favorable (3.92e-5)" "unprognostic (1.43e-3)" "prognostic unfavorable (1.09e-4)" "unprognostic (2.91e-3)" "unprognostic (2.65e-1)" "unprognostic (2.87e-1)" "prognostic favorable (7.34e-5)" 43.5 31.8 59.1 46.5 63.6 67.5 46.1 82.1 72.8 37.9 41.7 44.9 33.5 35.2 62.2 50.9 38.1 50.2 55.0 40.4 55.7 20.6 30.5 24.4 65.3 75.7 62.5 44.5 65.2 34.1 24.0 61.1 48.3 44.0 38.9 48.6 35.5 46.8 48.2 34.1 53.0 54.3 43.3 51.8 50.4 42.8 25.9 67.2 40.2 45.5 22.0 61.0 44.0 44.9 23.7 23.2 34.7 18.0 16.5 18.6 10.9 26.6 14.8 67.4 15.1 10.7 18.6 15.0 29.7 9.0 10.0 15.2 30.2 38.8 32.4 10.2 11.6 11.7 30.2 14.2 12.2 18.8 42.1 15.1 37.2 91.5 15.5 9.5 60.0 24.8 16.6 16.1 9.1 12.3 25.0 12.7 22.5 13.4 25.2 12.8 9.4 23.7 31.9 17.8 19.6 5.6 40.9 16.9 15.4 11.2 31.1 17.6 25.3 14.0 22.5 6.7 27.9 17.7 31.1 23.0 13.4 13.4 14.9 16.6 28.3 23.3 38.8 27.7 38.5 15.3 34.7 18.0 16.7 18.6 14.6 17.2 20.7 13.8 11.6 14.4 23.7 15.8 13.8 30.3 16.5 13.4 23.2 15.5 10.9 59.1 63.6 82.1 72.8 55.7 20.6 62.5 44.5 44.0 67.2 131.0 200.7 147.3 175.2 232.4 221.8 78.3 101.9 224.9 215.0 108.2 127.6 118.5 84.6 100.9 28.5 282.9 157.6 93.5 97.9 120.4 173.1 219.9 158.9 69.6 87.5 287.6 180.1 188.4 85.6 18.1 236.2 133.0 121.4 162.3 134.2 304.1 112.4 133.3 204.7 39.4 283.1 213.4 189.5 194.6 112.8 229.2 154.9 147.4 126.3 268.6 ARHGAP10 "FLJ20896, FLJ41791, GRAF2" ENSG00000071205 "Rho GTPase activating protein 10" A1A4S6 4 147732063-148072780 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Leydig cells: 127.4;monocytes: 96.4;Peritubular cells: 113.8;Rod photoreceptor cells: 129.8;Sertoli cells: 142.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 14.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 9 "cerebellum: 154.3" HPA039589 Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA039589: " "unprognostic (8.57e-3)" "unprognostic (1.34e-1)" "unprognostic (3.45e-2)" "unprognostic (1.38e-2)" "unprognostic (2.79e-1)" "unprognostic (3.41e-3)" "unprognostic (2.62e-2)" "prognostic unfavorable (2.23e-4)" "unprognostic (2.40e-2)" "unprognostic (2.00e-1)" "unprognostic (1.06e-1)" "unprognostic (2.57e-2)" "prognostic favorable (8.15e-5)" "prognostic unfavorable (6.26e-4)" "unprognostic (1.54e-1)" "unprognostic (1.02e-3)" "unprognostic (1.09e-2)" 31.2 7.9 2.3 11.3 3.2 2.0 27.8 1.8 3.7 20.1 23.9 1.9 13.2 3.4 15.4 17.6 25.2 17.6 20.3 20.0 2.8 1.6 9.6 4.8 11.8 8.3 3.8 1.9 19.9 7.8 20.8 4.7 7.5 9.9 19.8 6.0 16.0 6.7 17.0 37.5 12.3 8.9 58.0 5.2 9.7 15.9 11.2 2.5 8.7 9.9 12.4 7.9 28.7 24.9 0.0 2.6 14.0 1.5 4.1 9.7 2.1 9.8 4.0 2.2 4.5 16.7 22.8 22.7 13.7 11.4 8.8 6.9 10.3 5.7 0.0 2.3 11.6 7.4 4.9 7.9 11.2 10.7 5.4 5.3 3.3 3.1 0.3 25.8 3.3 4.0 11.8 8.8 11.0 9.4 11.2 10.6 2.9 0.5 18.7 15.7 12.0 2.0 0.0 2.0 6.6 2.0 3.8 6.2 11.5 6.1 9.1 5.3 2.5 3.6 14.4 3.8 9.8 1.8 0.3 10.6 8.3 6.4 5.0 6.5 7.0 0.8 0.0 12.7 0.4 7.3 0.0 1.5 14.0 5.2 0.0 9.7 0.0 3.9 5.7 2.6 0.0 1.1 5.7 0.2 4.1 0.0 0.0 4.6 2.1 2.3 3.2 1.8 3.7 2.8 1.6 3.8 1.9 9.9 2.5 3.0 2.6 0.0 6.9 12.8 3.8 58.3 5.1 0.0 2.3 1.8 41.2 24.2 0.0 4.2 7.8 9.0 0.0 0.0 13.5 41.5 17.5 3.3 1.1 11.3 20.5 3.2 0.0 6.2 3.9 6.2 127.4 12.8 5.0 96.4 0.0 7.7 14.2 0.0 113.8 11.7 129.8 142.3 59.0 3.9 16.1 8.9 10.6 12.5 1.1 2.4 ARHGAP15 BM046 ENSG00000075884 "Rho GTPase activating protein 15" Q53QZ3 2 143091362-143768352 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 52.0;bone marrow: 33.5;lymphoid tissue: 94.4" "Cell type enhanced" "Detected in many" 8 "B-cells: 62.8;Early spermatids: 89.3;granulocytes: 83.5;T-cells: 90.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 18.2;HEL: 25.4;HL-60: 35.8;MOLT-4: 23.7;NB-4: 27.8;THP-1: 37.8;U-698: 28.4;U-937: 19.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA032125 Uncertain "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA032125: AB_10671370" "unprognostic (1.59e-2)" "unprognostic (2.40e-3)" "unprognostic (8.63e-2)" "unprognostic (2.19e-2)" "unprognostic (2.99e-1)" "unprognostic (6.62e-3)" "unprognostic (6.14e-2)" "unprognostic (2.18e-3)" "unprognostic (1.32e-2)" "unprognostic (3.58e-2)" "unprognostic (2.13e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (6.95e-5)" "unprognostic (4.40e-2)" "unprognostic (2.12e-2)" "unprognostic (4.58e-2)" "unprognostic (6.94e-2)" 5.5 2.7 3.6 36.6 4.6 33.5 3.7 0.6 2.9 2.4 4.3 1.5 2.1 2.7 2.1 4.3 3.6 2.4 4.9 5.0 3.8 2.1 4.5 4.8 9.1 36.9 7.8 1.7 1.5 1.2 0.4 1.3 1.6 4.6 3.9 3.3 1.0 8.1 2.2 1.1 1.7 12.2 1.6 11.3 51.8 3.0 3.5 5.9 94.4 4.2 2.2 21.7 6.0 3.9 25.2 14.5 52.0 9.6 28.7 46.0 23.2 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.5 0.0 25.4 0.1 0.0 0.0 35.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.1 1.2 0.0 0.0 23.7 27.8 0.1 0.0 0.0 13.3 0.1 6.7 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 1.2 37.8 0.1 0.1 0.9 0.0 0.0 0.3 0.1 28.4 0.2 19.0 1.1 38.6 8.6 34.9 26.6 8.8 42.3 25.2 46.0 33.3 14.5 22.5 33.9 28.4 52.0 28.7 9.6 14.4 36.5 23.2 3.6 4.6 0.6 2.9 3.8 2.1 7.8 1.7 4.6 5.9 0.0 14.8 62.8 0.0 4.9 0.0 2.0 0.0 4.0 4.5 0.0 0.0 0.1 0.0 0.0 89.3 2.6 0.0 0.0 0.0 0.3 11.5 0.2 83.5 0.4 19.7 1.6 0.0 6.7 31.4 5.3 13.8 38.9 8.5 19.8 0.0 0.2 0.0 0.0 3.2 0.3 0.2 45.3 28.6 7.1 1.0 4.0 0.2 90.6 0.0 0.1 ARHGAP17 "FLJ10308, FLJ13219, NADRIN, RICH1, WBP15" ENSG00000140750 "Rho GTPase activating protein 17" Q68EM7 16 24919385-25015666 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041703 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041703: AB_10794304" "unprognostic (1.79e-1)" "unprognostic (8.98e-2)" "unprognostic (8.11e-2)" "prognostic favorable (3.59e-4)" "unprognostic (4.42e-2)" "unprognostic (3.49e-2)" "prognostic unfavorable (4.95e-4)" "unprognostic (3.02e-2)" "unprognostic (6.62e-2)" "unprognostic (8.81e-3)" "unprognostic (4.99e-2)" "unprognostic (3.45e-2)" "unprognostic (1.38e-2)" "unprognostic (1.94e-1)" "unprognostic (3.91e-2)" "unprognostic (1.26e-1)" "prognostic unfavorable (3.76e-4)" 25.0 23.2 12.3 22.5 21.7 10.1 20.6 12.2 15.8 15.1 15.8 22.9 6.8 14.3 21.4 12.4 19.1 16.8 15.4 18.9 13.4 5.4 15.0 12.6 17.8 28.7 28.0 8.7 15.1 14.0 17.0 20.5 62.6 16.3 13.7 16.0 19.3 16.4 10.9 22.0 19.2 25.5 15.1 19.6 40.8 16.5 18.6 24.8 16.9 17.1 12.4 29.6 13.4 16.8 25.7 24.6 8.0 17.2 5.7 7.2 6.8 20.5 11.8 15.8 16.7 16.3 17.2 17.8 14.6 13.9 15.5 15.0 18.3 8.2 9.6 9.7 25.6 14.5 5.8 15.7 9.2 16.3 14.9 21.7 8.5 28.0 30.0 18.6 11.1 7.9 21.9 5.5 16.5 11.9 10.9 25.5 8.4 10.4 0.0 16.9 14.4 10.3 13.9 19.0 5.6 10.8 48.5 13.4 3.7 18.7 4.5 11.0 11.5 14.4 14.7 5.5 13.3 8.1 28.1 34.9 11.6 9.4 25.8 11.0 9.9 12.3 5.6 14.1 16.4 10.1 3.5 9.0 8.0 6.3 17.2 5.7 25.7 5.6 6.4 13.9 24.0 6.4 6.2 4.7 5.7 14.0 24.6 7.2 6.8 12.3 21.7 12.2 15.8 13.4 5.4 28.0 8.7 16.3 24.8 8.9 11.2 6.4 5.7 12.9 5.5 22.7 12.7 6.7 7.9 5.2 9.8 9.2 3.3 11.9 4.5 28.4 31.3 0.0 13.8 16.2 9.9 8.7 6.9 5.8 23.1 9.5 20.2 28.3 25.4 7.3 12.4 15.9 15.1 6.4 22.2 6.1 15.0 28.3 11.0 3.8 7.2 25.8 24.7 4.4 14.9 21.0 13.2 13.6 15.3 11.3 ARHGAP22 RhoGAP2 ENSG00000128805 "Rho GTPase activating protein 22" Q7Z5H3 10 48446034-48656265 "Predicted intracellular proteins" "Angiogenesis, Differentiation, Transcription, Transcription regulation" "Developmental protein, GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 32.3" "Group enriched" "Detected in many" 5 "Early spermatids: 51.6;Late spermatids: 92.5;monocytes: 23.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 3.2;myeloid DC: 2.9;naive B-cell: 2.6" "Group enriched" "Detected in many" 29 "B-cells: 2.6;dendritic cells: 2.9;monocytes: 3.2" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 28.1;LHCN-M2: 25.4;TIME: 26.9;U-87 MG: 33.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB020696, HPA040391, HPA064439" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB020696: , HPA040391: AB_2676957, HPA064439: AB_2685266" "unprognostic (1.87e-1)" "unprognostic (3.98e-2)" "unprognostic (2.38e-2)" "unprognostic (2.62e-1)" "unprognostic (1.07e-1)" "unprognostic (6.74e-3)" "unprognostic (4.81e-3)" "unprognostic (2.78e-1)" "unprognostic (1.66e-1)" "unprognostic (3.03e-1)" "unprognostic (1.12e-1)" "unprognostic (1.02e-1)" "prognostic unfavorable (2.16e-8)" "unprognostic (7.40e-2)" "unprognostic (1.60e-1)" "unprognostic (9.39e-2)" "unprognostic (3.66e-2)" 2.6 3.1 10.2 6.7 12.5 3.0 2.0 7.3 12.2 1.8 2.7 32.3 1.0 1.7 2.1 1.9 1.6 2.2 4.4 3.3 12.5 9.6 1.2 0.8 2.9 6.0 18.3 6.6 7.7 1.5 2.7 1.8 2.2 24.6 3.2 2.8 1.6 3.4 3.2 3.9 3.4 2.5 3.4 27.3 6.2 2.3 4.6 18.4 2.0 6.0 0.4 5.4 3.1 1.9 2.6 2.9 0.0 3.2 0.0 0.0 0.9 2.4 0.5 0.1 0.0 2.1 8.6 1.7 13.1 6.0 1.2 1.7 2.7 0.3 0.0 0.5 5.1 0.9 4.8 0.1 4.4 2.1 0.2 4.5 6.9 0.0 0.0 1.1 0.7 0.8 2.0 4.5 15.0 1.2 28.1 8.2 0.0 6.5 1.2 25.4 0.1 0.1 0.0 2.8 0.0 0.2 0.0 0.0 3.1 2.5 0.2 0.4 2.6 0.6 0.0 0.2 0.2 0.1 0.1 26.9 12.3 0.1 1.6 9.1 0.0 0.0 0.0 33.5 0.1 1.9 0.0 3.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.9 2.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 10.2 12.5 7.3 9.2 12.5 9.6 18.3 6.6 24.6 18.4 0.0 1.7 1.3 4.2 3.1 1.0 2.4 0.0 6.7 4.5 0.0 2.0 9.2 0.0 2.5 51.6 1.4 0.0 0.0 3.9 0.2 2.6 1.0 0.0 0.0 10.4 0.0 0.0 2.5 9.5 92.5 2.6 11.0 1.7 23.4 0.0 1.5 2.0 0.0 5.6 0.0 1.4 0.0 0.5 1.4 4.2 0.5 0.8 0.0 0.0 0.5 ARHGAP23 KIAA1501 ENSG00000275832 "Rho GTPase activating protein 23" Q9P227 17 38419280-38512392 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.4" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 56.6;Ito cells: 51.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 77.1;RT4: 30.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019818, HPA047291" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "HPA019818: AB_1844993, HPA047291: AB_2680012" "unprognostic (3.35e-1)" "unprognostic (5.11e-2)" "unprognostic (6.43e-2)" "prognostic unfavorable (6.87e-5)" "unprognostic (9.53e-2)" "unprognostic (1.46e-1)" "unprognostic (1.80e-1)" "unprognostic (1.99e-1)" "unprognostic (5.56e-2)" "unprognostic (1.50e-3)" "prognostic unfavorable (3.24e-4)" "unprognostic (3.67e-2)" "prognostic unfavorable (5.38e-5)" "unprognostic (8.36e-2)" "unprognostic (5.83e-2)" "unprognostic (4.57e-2)" "unprognostic (2.25e-1)" 4.3 2.7 11.7 3.5 32.1 4.2 1.7 3.6 20.1 4.4 1.4 52.4 0.0 1.0 5.1 1.5 13.3 4.0 3.6 7.8 12.6 1.6 0.5 5.7 1.3 42.3 12.6 6.1 0.8 1.5 0.0 9.5 20.2 3.7 0.9 0.9 0.7 6.6 2.1 16.3 1.1 5.5 16.3 10.5 0.5 5.2 39.0 1.4 0.9 0.5 5.0 11.6 2.3 0.0 0.8 0.0 0.1 0.0 0.1 0.1 8.2 4.4 4.0 1.3 2.5 8.5 5.0 11.3 12.8 10.0 5.8 14.7 14.5 0.1 9.4 26.3 5.0 77.1 0.4 16.0 7.1 0.9 0.8 0.0 14.1 0.1 12.8 0.8 0.0 4.9 3.1 7.2 4.6 8.2 10.2 1.5 0.1 2.2 5.6 0.0 2.4 1.5 2.4 0.3 1.7 4.3 8.7 2.7 4.2 30.0 0.9 2.3 6.8 0.0 0.1 5.9 1.7 1.9 14.8 16.9 5.9 3.4 3.0 1.7 1.7 0.4 4.2 2.0 14.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 11.9 1.0 0.0 14.3 8.9 56.6 16.3 2.5 1.4 15.9 3.5 0.0 20.8 0.0 2.6 6.7 24.5 0.0 23.3 1.2 2.1 14.3 5.3 0.0 0.2 4.2 25.4 0.0 51.5 3.7 15.8 8.3 0.9 1.7 0.0 0.2 7.5 4.4 0.0 6.7 0.0 3.3 0.0 7.2 17.6 1.9 22.6 13.8 0.0 0.0 35.6 ARHGAP25 KIAA0053 ENSG00000163219 "Rho GTPase activating protein 25" P42331 2 68679601-68826833 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 94.2;lymphoid tissue: 48.7" "Cell type enhanced" "Detected in many" 19 "B-cells: 49.9;granulocytes: 196.2;T-cells: 57.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 94.2" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 4 "HMC-1: 75.2" "Group enriched" "Detected in many" 4 "amygdala: 3.2;basal ganglia: 7.8;cerebral cortex: 8.5;hippocampal formation: 6.4" "Low region specificity" "Detected in many" "HPA035346, HPA061395" Enhanced Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA035346: AB_10601116, HPA061395: AB_2684501" "unprognostic (1.13e-3)" "prognostic favorable (7.72e-4)" "unprognostic (2.45e-2)" "unprognostic (4.44e-3)" "unprognostic (8.07e-2)" "unprognostic (1.36e-2)" "unprognostic (1.13e-1)" "unprognostic (6.16e-3)" "unprognostic (2.67e-2)" "unprognostic (3.51e-2)" "unprognostic (1.00e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (1.93e-4)" "unprognostic (3.10e-1)" "unprognostic (4.26e-2)" "unprognostic (3.61e-1)" "unprognostic (4.49e-2)" 7.4 3.5 2.6 33.1 3.6 14.6 5.7 0.9 3.2 3.1 4.9 6.7 1.6 2.5 4.0 10.5 3.5 3.5 7.2 4.3 2.8 2.3 5.7 4.6 12.9 39.0 5.9 1.9 8.1 2.2 0.6 3.1 4.5 4.2 3.7 4.2 3.1 5.7 1.5 2.0 3.3 14.3 3.5 6.3 48.7 3.4 2.2 3.3 20.9 4.0 2.3 40.6 6.1 4.7 23.6 7.5 94.2 12.5 22.8 26.3 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.8 0.1 0.0 0.0 0.7 0.0 5.8 0.0 0.6 0.0 18.7 0.0 0.0 0.3 4.1 75.2 0.0 0.7 0.1 2.4 0.0 0.0 6.4 0.1 6.8 0.0 0.0 4.7 13.1 0.3 0.0 0.0 5.2 1.2 0.2 0.0 1.5 1.2 0.1 0.0 0.0 0.4 0.4 0.0 3.4 1.0 0.0 0.2 0.0 0.1 14.9 7.9 4.7 0.0 9.3 0.1 27.5 8.7 72.8 26.3 10.9 16.4 23.6 11.8 22.7 5.3 14.5 8.5 15.0 94.2 22.8 12.5 7.5 14.2 15.7 2.6 3.6 0.9 3.2 2.8 2.3 5.9 1.9 4.2 3.3 3.0 19.6 49.9 9.3 4.9 0.6 1.4 2.5 9.4 3.4 0.0 0.0 0.3 1.7 0.0 1.5 14.1 0.0 0.0 0.2 0.2 0.9 1.0 196.2 0.6 39.1 0.0 2.9 12.9 22.8 2.2 1.4 21.0 1.7 38.7 0.3 0.3 0.0 0.0 2.5 0.0 0.0 6.5 1.9 0.7 1.3 1.3 0.2 57.3 0.0 2.4 ARHGAP27 "CAMGAP1, FLJ43547, SH3D20, SH3P20" ENSG00000159314 "Rho GTPase activating protein 27" Q6ZUM4 17 45393902-45434421 "Predicted intracellular proteins" Endocytosis "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 38.8" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 60.1;Paneth cells: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 12.4;HMC-1: 11.6;OE19: 14.6;RT4: 18.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA023919, HPA053053" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA023919: AB_2059402, HPA053053: AB_2682027" "unprognostic (9.80e-2)" "unprognostic (1.36e-1)" "unprognostic (7.34e-2)" "unprognostic (4.89e-3)" "unprognostic (4.66e-1)" "unprognostic (2.69e-2)" "unprognostic (7.69e-2)" "unprognostic (6.89e-2)" "unprognostic (2.26e-1)" "unprognostic (2.33e-1)" "unprognostic (1.49e-2)" "unprognostic (1.96e-3)" "unprognostic (5.54e-2)" "unprognostic (3.10e-2)" "unprognostic (1.10e-1)" "unprognostic (2.92e-2)" "prognostic favorable (3.21e-4)" 6.0 3.1 4.9 21.9 8.7 15.0 5.5 5.2 6.3 9.3 23.1 6.4 2.7 14.9 3.2 7.8 35.0 4.5 17.4 7.0 7.5 3.2 11.0 2.4 10.5 24.1 8.2 2.4 2.4 3.5 4.3 4.0 9.7 7.5 6.1 13.0 3.8 13.6 9.1 2.6 11.6 38.8 3.8 10.2 28.6 8.8 2.9 8.0 29.4 6.3 5.8 34.1 8.0 15.0 4.1 7.8 10.4 11.2 1.9 3.1 3.5 4.3 4.3 0.1 1.3 0.6 0.3 12.4 0.0 0.2 0.3 0.1 3.8 8.7 4.0 8.5 0.3 1.9 2.8 0.5 0.8 0.2 8.0 2.7 0.2 1.6 2.4 0.1 0.0 11.6 0.6 3.5 0.0 1.3 0.4 2.6 4.3 1.0 7.2 0.3 3.0 3.7 1.3 0.2 14.6 3.6 3.1 0.2 1.3 2.8 18.8 0.6 0.4 0.5 3.7 0.2 1.5 2.9 7.3 4.1 0.0 1.1 0.0 0.4 9.0 5.8 0.8 0.2 1.1 0.0 1.0 4.7 4.2 2.8 9.3 1.8 4.1 1.7 3.1 4.5 3.4 1.4 1.4 10.4 1.9 11.2 7.8 2.3 3.5 4.9 8.7 5.2 6.3 7.5 3.2 8.2 2.4 7.5 8.0 6.0 19.1 20.6 15.4 9.2 2.6 9.8 17.8 2.7 7.9 17.4 3.9 6.4 3.3 4.9 0.8 20.2 60.1 0.0 3.0 8.9 2.5 21.5 4.6 1.5 13.3 1.6 18.4 16.5 38.7 0.9 0.3 16.4 6.8 1.0 29.2 1.2 11.8 59.6 0.0 5.0 1.4 0.0 3.1 2.3 1.9 7.5 11.8 14.9 32.0 47.8 ARHGAP29 PARG1 ENSG00000137962 "Rho GTPase activating protein 29" Q52LW3 1 94148988-94275068 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Endothelial cells: 271.0;Glandular cells: 419.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 27 "classical monocyte: 1.6;intermediate monocyte: 2.6;non-classical monocyte: 3.7" "Lineage enriched" "Detected in single" 38 "monocytes: 3.7" "Cell line enhanced" "Detected in many" "A-431: 48.5;hTERT-HME1: 43.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026534 Approved Approved "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" NA NA "Nucleoplasm, Centrosome" "Plasma membrane, Cytosol" "HPA026534: AB_1844998" "unprognostic (2.49e-1)" "unprognostic (1.52e-3)" "unprognostic (3.16e-2)" "prognostic unfavorable (6.26e-5)" "unprognostic (8.53e-2)" "unprognostic (2.94e-2)" "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (8.02e-2)" "unprognostic (2.89e-2)" "prognostic unfavorable (9.63e-4)" "unprognostic (4.42e-1)" "unprognostic (2.36e-2)" "unprognostic (3.81e-3)" "unprognostic (1.94e-1)" "unprognostic (1.13e-1)" "unprognostic (4.61e-3)" 28.1 3.2 7.2 6.8 10.6 0.3 24.4 34.9 11.5 11.9 7.4 2.3 9.0 2.8 10.3 8.1 6.9 8.2 9.1 15.9 7.8 5.2 27.7 21.1 23.0 8.2 6.7 3.6 11.5 6.5 12.8 7.4 22.9 10.0 12.2 4.7 11.7 20.7 10.4 10.3 13.5 5.4 8.0 6.4 26.0 8.8 7.7 7.0 2.2 22.7 8.9 3.8 10.6 14.8 0.0 0.0 0.0 3.7 0.0 0.0 0.3 48.5 2.0 3.0 0.0 10.6 25.2 10.8 16.3 26.5 13.8 20.2 5.8 2.4 0.0 36.7 32.6 15.8 10.4 0.1 11.1 28.5 0.0 1.6 0.2 2.8 2.6 1.0 0.0 0.0 4.9 2.0 10.5 43.7 16.3 37.2 0.0 0.0 0.0 13.7 1.6 0.9 0.0 3.9 0.2 33.4 0.6 2.5 0.0 29.1 4.3 0.0 0.6 10.0 7.8 0.7 12.2 2.3 0.1 33.3 8.4 11.5 12.9 12.5 0.0 0.0 0.0 1.6 0.0 0.4 0.0 1.6 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.3 7.2 10.6 34.9 11.5 7.8 5.2 6.7 3.6 10.0 7.0 47.6 17.3 2.9 135.8 20.8 9.7 19.9 25.5 9.4 33.0 123.9 17.7 21.9 46.4 71.3 49.8 271.0 0.0 0.0 14.7 90.4 34.4 419.1 3.5 51.3 2.6 87.4 0.0 176.8 18.6 16.2 22.7 5.6 25.3 0.0 0.9 95.2 37.1 0.0 20.5 47.5 80.7 187.5 197.8 66.2 123.5 15.1 11.8 4.3 0.4 45.2 ARHGAP32 "GC-GAP, GRIT, KIAA0712, MGC1892, RICS" ENSG00000134909 "Rho GTPase activating protein 32" A7KAX9 11 128965060-129279324 "Cancer-related genes, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.9" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 115.8;Muller glia cells: 120.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 21.2;SK-BR-3: 23.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038382, HPA038389, HPA061505" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli fibrillar center" "HPA038382: AB_2675984, HPA038389: AB_10670972, HPA061505: AB_2684544" "unprognostic (1.17e-1)" "unprognostic (3.58e-2)" "unprognostic (2.54e-2)" "unprognostic (1.82e-1)" "unprognostic (3.89e-2)" "unprognostic (5.64e-2)" "unprognostic (1.52e-1)" "unprognostic (5.97e-2)" "unprognostic (7.32e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (6.64e-4)" "unprognostic (1.47e-1)" "unprognostic (6.17e-3)" "unprognostic (1.17e-1)" "unprognostic (4.01e-1)" "unprognostic (5.80e-2)" "unprognostic (1.64e-2)" 4.0 5.9 22.1 3.4 32.8 1.7 9.4 4.7 46.9 8.2 12.3 5.1 1.5 18.4 7.3 8.4 21.9 12.2 6.8 3.8 9.9 6.8 6.5 4.5 5.2 1.5 6.4 21.7 10.2 13.3 14.9 5.3 7.5 5.4 6.0 14.3 4.5 13.4 4.1 6.2 16.0 19.0 5.5 4.3 2.6 10.8 9.2 8.4 5.8 3.6 12.8 12.9 8.0 13.1 1.3 1.6 0.7 2.1 3.0 1.2 0.6 6.4 3.4 10.8 0.0 3.5 3.6 7.8 2.4 3.4 1.5 1.9 7.9 13.4 0.0 3.7 4.7 7.8 14.7 4.9 6.1 3.0 0.0 1.7 0.1 1.7 2.9 1.7 0.0 0.0 3.4 8.0 1.5 9.1 3.4 1.9 5.5 0.3 0.1 2.7 5.0 5.3 0.1 2.9 19.4 3.7 13.1 3.2 1.3 1.7 21.2 10.7 4.3 3.7 23.1 4.4 4.3 12.0 2.0 3.5 5.5 2.9 3.2 4.7 0.1 0.0 0.0 2.4 14.7 3.4 0.0 0.4 0.0 0.3 2.1 1.2 0.0 0.4 0.6 1.0 1.3 0.8 0.2 0.7 3.0 0.7 1.6 0.4 0.6 22.1 32.8 4.7 46.9 9.9 6.8 6.4 21.7 5.4 8.4 6.0 12.6 0.5 10.9 16.3 25.3 3.9 12.7 41.5 28.4 10.4 115.8 17.3 1.7 6.9 12.7 4.9 46.1 0.0 23.7 3.3 11.9 19.8 1.1 13.6 5.4 17.5 39.1 6.2 4.6 10.4 6.4 3.4 15.1 0.0 61.0 120.0 20.3 45.6 12.4 8.6 31.5 19.4 5.9 8.6 5.6 27.1 23.8 1.3 46.4 48.2 ARHGAP36 FLJ30058 ENSG00000147256 "Rho GTPase activating protein 36" Q6ZRI8 X 131058242-131089883 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 58.4;brain: 25.5;pituitary gland: 50.3" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 21 "thyroid cancer: 62.5" "Region enriched" "Detected in many" 5 "hypothalamus: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 164 "SH-SY5Y: 64.4" "Region enhanced" "Detected in many" "hypothalamus: 104.3" "Group enriched" "Detected in many" 5 "basal ganglia: 19.8;hypothalamus: 57.8;midbrain: 27.1;pons and medulla: 20.1" "HPA002064, HPA076209" Enhanced Approved "Nucleoplasm,Vesicles,Plasma membrane" Yes NA Nucleoplasm "Vesicles, Plasma membrane" "HPA002064: AB_1078891, HPA076209: " "unprognostic (2.92e-2)" "unprognostic (7.71e-9)" "unprognostic (2.19e-1)" "unprognostic (8.15e-2)" "unprognostic (1.67e-1)" "unprognostic (1.78e-1)" "unprognostic (2.73e-1)" "unprognostic (1.40e-2)" "unprognostic (1.34e-2)" "unprognostic (2.31e-1)" 6.9 58.4 1.4 0.2 3.6 0.1 1.0 0.0 2.7 0.5 0.2 0.0 0.0 0.1 0.1 2.0 0.3 0.2 0.2 0.1 1.0 25.5 0.1 0.1 0.1 0.1 0.5 0.0 0.1 0.1 0.1 50.3 0.3 5.4 0.3 0.2 0.6 0.2 0.2 13.7 0.1 0.1 0.1 0.8 0.1 0.2 0.6 0.0 0.5 0.5 4.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 64.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 3.6 0.0 0.4 1.0 25.5 0.5 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 ARHGAP39 "CrGAP, KIAA1688, Vilse" ENSG00000147799 "Rho GTPase activating protein 39" Q9C0H5 8 144529179-144605816 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 12.8" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 20.1;Cone photoreceptor cells: 19.6;Rod photoreceptor cells: 23.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044491 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Yes NA Cytosol "Nucleoplasm, Microtubules, Cytokinetic bridge" "HPA044491: AB_10794775" "unprognostic (3.42e-2)" "unprognostic (2.65e-2)" "unprognostic (9.85e-2)" "unprognostic (4.17e-1)" "unprognostic (1.53e-1)" "unprognostic (2.49e-1)" "unprognostic (1.74e-7)" "unprognostic (1.89e-2)" "unprognostic (3.00e-1)" "unprognostic (2.02e-1)" "unprognostic (6.90e-3)" "unprognostic (1.53e-1)" "unprognostic (5.19e-2)" "unprognostic (1.26e-2)" "unprognostic (1.42e-1)" "unprognostic (1.27e-1)" "unprognostic (9.97e-2)" 1.1 1.9 3.6 1.0 3.5 0.0 1.2 6.2 7.0 2.0 2.0 2.4 1.7 1.2 1.4 7.0 0.9 0.4 5.3 4.4 1.8 0.2 1.5 0.3 3.3 0.9 2.9 2.0 4.0 0.9 2.1 0.9 3.5 2.3 0.6 2.6 2.4 0.6 7.2 0.9 1.2 12.8 2.8 0.1 0.5 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.0 7.6 7.6 3.6 5.6 0.7 0.6 7.0 2.0 0.6 2.5 1.6 4.9 4.5 0.8 5.2 0.8 2.6 6.5 1.8 1.9 0.5 0.0 6.8 0.1 5.0 3.1 1.2 0.0 0.8 0.5 3.1 3.2 1.3 1.3 0.8 0.3 7.0 0.0 1.0 12.4 4.2 0.0 3.8 3.1 10.9 3.9 2.9 2.9 2.0 3.9 10.5 7.4 5.8 2.0 3.4 1.4 8.6 1.1 1.9 1.9 0.1 6.3 4.1 0.0 0.1 0.3 3.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.0 2.9 0.0 0.5 3.3 7.1 1.6 0.0 20.1 3.4 3.5 19.6 0.4 0.0 2.2 2.1 0.7 3.9 0.0 2.1 0.7 1.3 1.1 0.0 1.3 0.4 3.2 0.0 1.3 0.0 2.5 2.0 0.0 5.0 0.0 3.6 3.5 1.1 8.6 7.8 1.4 23.7 6.5 1.5 8.1 7.7 2.6 0.5 0.0 4.3 0.6 ARHGAP4 "C1, KIAA0131, p115, RhoGAP4, SrGAP4" ENSG00000089820 "Rho GTPase activating protein 4" P98171 X 153907367-153934999 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 44.8;lymphoid tissue: 48.4" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 71.1;Kupffer cells: 73.8;Macrophages: 43.6;T-cells: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 26.2;Karpas-707: 26.9;MOLT-4: 25.3;RPMI-8226: 49.8;THP-1: 24.3;U-698: 23.2;U-937: 21.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001012, HPA001083" Enhanced Approved "Nucleoplasm,Focal adhesion sites" NA NA "Focal adhesion sites" Nucleoplasm "HPA001012: AB_1078201, HPA001083: AB_1078199" "unprognostic (3.54e-2)" "prognostic favorable (3.94e-5)" "prognostic unfavorable (1.97e-5)" "unprognostic (5.79e-2)" "unprognostic (9.42e-2)" "prognostic favorable (3.31e-4)" "unprognostic (5.72e-3)" "unprognostic (1.39e-1)" "unprognostic (3.27e-1)" "unprognostic (1.37e-1)" "unprognostic (7.81e-3)" "unprognostic (1.45e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (8.47e-3)" "unprognostic (2.01e-1)" "unprognostic (1.03e-1)" "unprognostic (1.99e-1)" 7.0 4.8 5.3 24.3 5.8 44.8 5.0 4.5 3.2 3.1 6.5 5.2 2.1 6.0 3.9 7.0 4.4 5.2 6.5 4.2 4.5 3.2 7.4 4.9 13.4 29.1 5.2 0.9 2.6 2.3 0.9 3.5 9.0 4.8 4.2 3.0 5.7 7.5 1.8 1.6 1.8 18.0 3.9 5.9 48.4 4.9 3.6 4.2 43.2 4.2 1.6 29.0 7.1 3.6 10.8 17.7 18.7 30.5 8.5 15.7 12.6 0.4 0.1 0.2 1.7 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.1 12.5 26.2 1.6 0.0 0.2 0.2 1.3 0.0 0.0 7.1 1.0 10.2 0.1 0.5 1.1 18.6 17.3 0.0 0.1 0.0 0.1 0.1 2.6 6.6 0.0 26.9 0.1 1.3 25.3 0.3 0.8 0.1 0.0 12.0 3.5 49.8 0.1 0.2 2.4 3.6 0.2 0.6 0.2 0.3 5.9 24.3 0.5 0.1 0.3 0.2 0.1 16.3 13.9 23.2 0.2 21.7 0.0 5.1 14.1 18.7 15.7 23.1 10.9 10.8 11.2 12.4 14.1 10.4 10.1 10.1 12.0 8.5 30.5 17.7 12.6 12.6 5.3 5.8 4.5 3.2 4.5 3.2 5.2 0.9 4.8 4.2 8.9 33.9 40.2 0.5 3.1 9.8 30.4 2.5 13.4 4.5 17.4 3.9 1.7 5.0 0.7 0.1 10.6 3.9 0.0 0.6 1.2 2.1 0.4 33.5 0.5 71.1 3.2 4.6 4.3 73.8 0.0 0.9 43.6 10.1 12.6 2.1 1.3 0.1 0.0 0.0 0.6 4.4 0.0 0.9 0.5 4.9 1.5 1.1 48.4 3.9 0.4 ARHGAP40 "C20orf95, dJ1100H13.4" ENSG00000124143 "Rho GTPase activating protein 40" Q5TG30 20 38601934-38651035 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "breast: 18.6;epididymis: 38.0;skin 1: 26.7" "Cell type enhanced" "Detected in some" 12 "Collecting duct cells: 3.5;Early spermatids: 3.2;Late spermatids: 2.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.7;HBEC3-KT: 12.2;RPTEC TERT1: 10.8;SK-BR-3: 11.6;T-47d: 14.0" "Not detected" "Not detected" "HPA042636, HPA042840" Uncertain Supported "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" No NA "Plasma membrane, Cytosol" "Nucleoplasm, Centrosome" "HPA042636: AB_10962149, HPA042840: AB_10963929" "unprognostic (9.89e-3)" "unprognostic (2.57e-1)" "unprognostic (1.93e-1)" "unprognostic (1.24e-3)" "unprognostic (3.11e-2)" "unprognostic (1.89e-1)" "unprognostic (2.50e-3)" "unprognostic (1.69e-1)" "unprognostic (3.09e-2)" "unprognostic (4.35e-2)" "unprognostic (5.63e-3)" "unprognostic (2.52e-1)" "prognostic unfavorable (2.89e-4)" "unprognostic (2.24e-1)" "unprognostic (7.42e-2)" "unprognostic (1.26e-1)" "unprognostic (1.54e-1)" 0.3 0.0 0.3 0.3 0.3 0.0 18.6 0.3 0.5 1.6 0.3 0.4 5.2 0.8 0.6 38.0 15.8 0.0 0.9 0.3 0.3 0.1 4.1 0.3 1.8 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.4 0.3 3.0 0.0 0.3 1.9 5.1 0.3 26.7 0.3 0.7 0.3 0.3 2.6 1.2 0.6 0.3 0.3 5.2 6.6 3.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 7.7 0.1 0.0 0.0 0.1 0.1 0.8 0.0 3.4 0.0 0.0 0.0 0.0 12.2 0.2 0.0 0.0 0.1 0.0 3.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 11.6 0.0 1.5 14.0 0.4 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.5 0.3 0.1 0.3 0.3 0.3 0.6 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 3.5 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.2 ARHGAP8 "BPGAP1, FLJ20185" ENSG00000241484 "Rho GTPase activating protein 8" P85298 22 44752558-44862788 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 29.3" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 18.6;Ductal cells: 23.6;Pancreatic endocrine cells: 23.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "T-reg: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 12.4;BEWO: 23.4;CACO-2: 14.8;HEK 293: 20.2;MCF7: 20.9;SK-BR-3: 20.2" HPA069694 Approved Approved Nucleoplasm Yes No Nucleoplasm "HPA069694: AB_2686173" "unprognostic (4.14e-1)" "unprognostic (1.21e-2)" "unprognostic (6.88e-2)" "unprognostic (8.07e-2)" "unprognostic (1.24e-1)" "unprognostic (1.19e-1)" "unprognostic (6.49e-2)" "unprognostic (5.51e-2)" "unprognostic (2.88e-1)" "unprognostic (1.50e-1)" "unprognostic (8.78e-3)" "unprognostic (9.58e-2)" "unprognostic (7.65e-6)" "unprognostic (8.59e-2)" "unprognostic (3.29e-1)" "unprognostic (2.32e-2)" "unprognostic (2.22e-2)" 0.5 0.1 1.7 5.6 0.4 0.2 7.5 0.3 0.4 2.2 10.6 0.6 29.3 1.2 2.6 13.0 5.7 6.1 11.5 0.3 0.3 0.4 18.2 0.9 3.9 0.3 0.3 0.3 0.9 14.6 4.5 5.2 22.4 1.2 10.0 5.7 1.9 28.4 24.8 0.3 1.4 3.6 1.2 0.3 6.7 4.3 3.0 0.3 0.7 15.2 2.4 4.9 2.0 1.8 0.2 0.7 0.2 0.4 0.1 2.2 0.3 12.4 0.1 0.2 0.1 0.0 0.2 23.4 0.1 1.5 0.0 0.1 14.8 6.7 0.1 0.8 0.0 0.2 9.3 4.4 10.7 0.1 0.0 20.2 0.0 0.3 0.1 0.0 0.0 0.2 0.1 4.7 0.1 0.2 0.3 0.0 0.2 0.4 0.3 0.0 20.9 0.0 0.0 3.1 9.4 0.0 0.0 0.0 0.2 5.7 8.5 1.3 0.0 0.0 20.2 0.4 5.3 8.7 0.1 0.1 0.0 0.7 0.1 0.1 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.1 0.0 0.6 0.0 0.0 0.2 0.1 0.3 0.2 0.1 0.0 0.7 2.2 0.3 1.7 0.4 0.3 0.4 0.3 0.4 0.3 0.3 1.2 0.3 3.0 12.2 0.0 18.6 0.6 0.4 0.8 5.1 4.0 6.8 17.4 3.9 16.5 0.0 23.6 2.3 1.0 2.6 0.0 9.4 0.9 1.3 16.8 0.0 0.0 2.7 0.0 6.9 0.0 0.6 2.5 0.3 0.0 0.0 0.0 7.6 0.5 23.2 3.5 0.4 1.4 0.3 0.0 0.7 0.0 3.9 0.3 5.8 1.0 12.3 15.6 ARHGEF10 "Gef10, KIAA0294" ENSG00000104728 "Rho guanine nucleotide exchange factor 10" O15013 8 1823976-1958641 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.4" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024649 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA024649: AB_1845002" "unprognostic (2.51e-1)" "unprognostic (3.60e-2)" "unprognostic (2.39e-1)" "unprognostic (1.08e-2)" "unprognostic (1.02e-1)" "unprognostic (3.57e-1)" "unprognostic (1.44e-1)" "unprognostic (7.27e-2)" "unprognostic (1.69e-1)" "unprognostic (1.07e-1)" "unprognostic (2.43e-2)" "unprognostic (9.29e-2)" "unprognostic (3.37e-2)" "unprognostic (1.81e-2)" "unprognostic (4.42e-1)" "unprognostic (3.18e-2)" "unprognostic (4.46e-2)" 13.5 8.2 11.1 6.9 18.4 1.8 9.7 3.5 14.2 11.6 10.8 20.4 9.3 3.2 19.5 7.1 7.2 8.9 8.0 19.0 13.5 7.9 6.5 2.3 17.7 5.4 17.0 8.6 9.6 5.8 4.9 4.6 9.9 13.4 9.3 5.7 10.2 7.5 10.4 3.8 14.2 5.3 15.0 18.0 5.7 8.4 19.1 21.0 1.6 8.4 4.4 4.1 10.2 19.9 0.0 0.0 0.0 0.0 1.4 0.7 0.1 6.4 8.2 7.9 3.3 6.6 9.8 1.7 8.5 7.2 6.7 7.3 2.6 3.0 0.0 1.3 11.8 11.1 4.9 7.1 10.7 8.4 0.0 2.8 2.8 7.2 0.0 6.3 0.0 1.8 7.1 6.1 6.8 6.2 10.2 12.7 2.2 3.1 0.0 7.6 3.5 4.1 0.8 6.0 4.8 4.4 0.3 7.4 0.0 4.9 2.3 1.4 1.8 6.7 0.2 4.2 10.3 3.4 1.6 15.2 6.6 3.8 0.1 8.2 0.0 2.7 0.0 5.1 6.2 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.0 1.4 0.0 0.0 0.2 0.1 11.1 18.4 3.5 14.2 13.5 7.9 17.0 8.6 13.4 21.0 3.0 5.5 0.0 10.3 34.1 5.3 11.8 12.7 1.4 4.5 7.0 9.8 0.5 0.0 6.9 13.7 23.5 0.5 0.0 1.7 0.8 29.2 17.0 0.0 0.9 1.4 20.6 1.2 16.5 0.6 16.5 32.5 2.7 21.9 0.0 4.1 15.5 8.6 0.0 24.8 0.3 9.9 0.0 22.7 32.7 18.3 13.2 0.2 1.3 1.9 4.1 ARHGEF11 "GTRAP48, KIAA0380, PDZ-RHOGEF" ENSG00000132694 "Rho guanine nucleotide exchange factor 11" O15085 1 156934840-157045370 "Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 47.5;Cone photoreceptor cells: 88.4;Rod photoreceptor cells: 54.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "WM-115: 37.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011026, HPA012037, HPA014658" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA011026: AB_1850426, HPA012037: AB_1850430, HPA014658: AB_1850428" "unprognostic (2.19e-1)" "unprognostic (9.10e-2)" "unprognostic (1.91e-1)" "unprognostic (2.17e-1)" "unprognostic (2.00e-1)" "unprognostic (4.94e-3)" "unprognostic (3.30e-2)" "unprognostic (9.40e-2)" "unprognostic (1.21e-1)" "unprognostic (1.58e-1)" "prognostic favorable (1.72e-4)" "unprognostic (3.38e-1)" "unprognostic (2.41e-2)" "unprognostic (5.11e-2)" "unprognostic (1.58e-1)" "unprognostic (1.08e-1)" "unprognostic (4.73e-2)" 11.9 13.0 17.5 11.6 13.4 4.3 12.3 28.8 22.4 12.3 13.2 9.2 22.0 14.4 14.7 11.9 13.1 12.2 14.3 13.2 13.6 16.0 10.9 7.6 12.7 8.0 13.9 13.7 15.6 11.0 31.7 15.4 12.3 13.1 11.4 12.9 14.5 9.3 25.1 14.7 11.2 23.3 15.2 9.1 9.8 11.9 20.9 9.9 1.0 14.9 5.3 6.3 13.2 12.6 0.4 0.9 3.3 2.8 0.0 1.0 0.7 7.0 14.0 12.0 9.1 16.0 8.3 13.7 7.0 10.5 11.0 8.1 9.4 7.5 0.9 12.3 12.3 8.4 7.7 8.1 7.3 6.1 10.1 5.0 3.5 8.3 6.1 9.3 7.1 12.5 12.7 8.0 10.1 7.9 8.3 7.9 3.1 5.7 0.6 7.3 9.2 1.8 3.9 14.9 11.2 8.6 0.2 5.9 3.9 5.4 11.6 2.3 13.7 15.1 12.2 12.8 10.9 10.9 16.2 11.8 11.3 7.2 9.9 7.2 10.1 6.2 0.7 7.2 0.9 37.4 0.0 1.4 0.0 0.0 2.8 0.0 0.4 0.6 0.0 0.9 0.0 0.6 1.0 3.3 0.0 1.5 0.0 0.3 0.7 17.5 13.4 28.8 22.4 13.6 16.0 13.9 13.7 13.1 9.9 3.0 3.4 0.8 2.3 1.0 47.5 11.8 0.0 1.4 2.3 1.8 88.4 1.5 1.7 1.0 5.3 3.5 14.6 0.0 1.4 0.5 3.0 3.2 9.2 4.9 3.6 20.6 5.2 2.5 7.5 6.7 4.4 4.0 1.7 0.0 4.0 12.3 1.1 5.1 4.2 0.8 54.7 0.0 4.1 3.0 4.8 1.8 1.3 0.0 3.9 2.2 ARHGEF12 "KIAA0382, LARG" ENSG00000196914 "Rho guanine nucleotide exchange factor 12" Q9NZN5 11 120336914-120489936 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.2" "Group enriched" "Detected in many" 5 "granulocytes: 2.2;NK-cells: 1.5;T-cells: 1.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018911, CAB025581" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "CAB025581: , HPA018911: AB_1845003" "unprognostic (1.55e-1)" "unprognostic (1.29e-1)" "unprognostic (6.91e-3)" "unprognostic (1.28e-1)" "unprognostic (7.28e-2)" "unprognostic (5.39e-2)" "unprognostic (1.56e-1)" "unprognostic (5.55e-2)" "unprognostic (4.79e-2)" "unprognostic (7.77e-2)" "unprognostic (4.34e-3)" "unprognostic (4.78e-2)" "prognostic favorable (5.43e-6)" "unprognostic (1.29e-1)" "unprognostic (4.38e-2)" "unprognostic (2.13e-1)" "unprognostic (1.48e-1)" 17.6 19.2 27.6 8.3 32.5 5.9 19.6 40.4 41.5 21.7 16.4 12.4 15.7 14.9 17.5 15.9 17.8 18.6 17.3 23.4 21.8 17.7 41.2 38.8 24.1 6.5 15.8 26.3 16.3 16.9 55.8 17.2 25.4 21.1 16.8 17.8 20.7 16.7 20.0 24.1 29.0 14.8 18.6 10.8 12.4 19.0 6.7 13.0 3.0 31.3 15.0 10.9 19.4 22.9 0.3 0.3 2.2 0.1 1.5 1.0 0.4 13.2 11.1 14.9 14.3 20.2 20.2 6.2 15.6 17.7 9.5 12.1 13.0 9.7 1.1 19.2 27.8 16.8 9.9 19.1 19.7 18.6 10.9 9.4 21.5 12.0 9.9 18.1 0.0 16.0 19.3 14.3 20.8 23.2 21.0 28.7 11.7 18.1 44.1 23.9 9.2 0.0 0.0 4.1 17.1 9.6 4.7 17.1 4.2 23.3 23.0 11.0 13.6 21.8 18.3 5.7 9.3 15.6 1.7 28.4 21.1 9.0 13.7 11.3 13.0 5.2 7.3 8.7 2.8 15.9 2.2 0.0 0.0 1.0 0.1 0.2 0.3 0.6 0.6 0.0 0.3 0.0 0.5 0.0 1.5 0.1 0.3 0.7 0.4 27.6 32.5 40.4 41.5 21.8 17.7 15.8 26.3 21.1 13.0 68.5 79.7 12.3 48.8 80.4 124.2 79.1 58.6 52.2 67.1 92.5 174.7 13.7 29.9 34.0 5.0 74.1 47.9 23.3 43.8 8.3 45.2 80.8 10.5 105.8 6.1 85.8 36.4 81.0 27.2 11.5 27.6 17.4 49.0 10.8 44.1 42.4 44.6 49.0 31.5 60.7 84.8 25.8 70.9 13.5 11.9 74.4 24.0 17.5 34.8 95.3 ARHGEF26 "DKFZP434D146, SGEF" ENSG00000114790 "Rho guanine nucleotide exchange factor 26" Q96DR7 3 154121003-154257827 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Alveolar cells type 1: 315.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RH-30: 10.0;U-251 MG: 18.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017722, HPA049195" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA017722: AB_1856800, HPA049195: AB_2680671" "unprognostic (1.41e-1)" "unprognostic (1.43e-3)" "unprognostic (3.55e-1)" "unprognostic (7.99e-3)" "unprognostic (2.82e-1)" "unprognostic (9.42e-3)" "prognostic favorable (9.74e-4)" "unprognostic (7.06e-2)" "unprognostic (1.16e-1)" "unprognostic (6.01e-5)" "unprognostic (1.44e-3)" "unprognostic (4.36e-2)" "unprognostic (2.22e-1)" "unprognostic (5.53e-3)" "unprognostic (3.11e-1)" "unprognostic (1.07e-1)" "unprognostic (5.24e-3)" 11.2 4.0 9.1 5.8 8.7 1.0 9.8 5.6 17.8 9.2 20.0 6.5 3.3 10.3 5.9 3.1 12.0 8.3 17.6 4.1 8.7 4.6 3.1 22.0 18.6 1.0 5.4 6.3 5.3 27.1 13.9 2.9 4.7 12.2 5.3 3.7 4.4 4.1 5.5 1.5 7.0 11.5 12.7 9.7 1.6 12.3 7.4 5.5 0.0 4.1 2.5 2.0 7.4 11.4 0.0 0.3 0.0 0.5 0.0 0.1 0.0 5.3 3.1 6.1 4.2 2.7 0.4 0.1 0.3 0.0 1.6 1.8 2.5 0.4 2.5 0.4 0.1 2.8 6.3 3.1 1.5 2.8 0.0 8.1 0.0 2.3 0.8 2.5 0.8 0.1 0.9 0.1 1.9 0.3 0.9 0.1 2.6 0.0 0.0 1.0 6.2 1.1 0.1 3.9 1.2 2.7 0.0 10.0 0.0 0.5 3.5 2.3 0.7 0.7 8.8 1.3 3.3 5.4 0.4 0.0 0.9 4.0 0.0 18.1 2.6 0.4 0.0 1.6 0.0 6.2 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.1 8.7 5.6 10.1 8.7 4.6 5.4 6.3 12.2 5.5 315.6 29.8 0.9 7.9 17.3 9.4 1.2 20.4 21.4 17.0 3.5 3.9 1.4 0.0 1.9 9.1 3.0 2.6 0.0 2.2 1.0 8.1 6.7 4.7 44.5 0.6 4.8 0.0 8.6 2.8 1.7 9.8 0.9 3.3 1.8 4.5 70.3 1.7 2.9 17.7 0.0 50.2 0.0 4.2 2.9 32.4 20.7 5.1 5.7 1.7 5.3 ARHGEF33 ENSG00000214694 "Rho guanine nucleotide exchange factor 33" A8MVX0 2 38889841-38975449 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 42.5" "Group enriched" "Detected in some" 5 "Early spermatids: 25.0;Late spermatids: 21.2;Spermatocytes: 30.7;Spermatogonia: 34.3" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 5 "cerebellum: 42.5" "Cell type enriched" "Detected in single" 8 "eosinophil: 6.7" "Lineage enriched" "Detected in single" 8 "granulocytes: 6.7" "Group enriched" "Detected in some" 4 "BEWO: 9.0;HeLa: 4.0;SiHa: 11.2" "Region enriched" "Detected in single" 32 "cerebellum: 314.4" "Region enriched" "Detected in all" 11 "cerebellum: 47.0" "HPA034661, HPA041051" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA034661: AB_10669679, HPA041051: AB_2677274" "unprognostic (8.38e-2)" "unprognostic (7.05e-4)" "unprognostic (1.95e-1)" "unprognostic (4.67e-2)" "unprognostic (1.35e-1)" "unprognostic (1.49e-3)" "unprognostic (1.49e-1)" "unprognostic (3.66e-1)" "unprognostic (3.37e-1)" "unprognostic (5.82e-2)" "unprognostic (2.05e-3)" "unprognostic (4.99e-1)" "unprognostic (4.12e-2)" "unprognostic (6.14e-2)" "unprognostic (1.56e-1)" "unprognostic (2.42e-1)" "unprognostic (1.99e-1)" 0.3 4.0 3.7 1.0 8.6 0.0 1.7 42.5 3.4 2.3 0.7 0.6 0.7 0.1 2.8 5.1 0.7 2.2 1.4 0.8 3.3 3.6 1.4 0.2 1.2 0.5 2.0 2.9 6.8 0.2 2.2 3.5 0.8 3.2 1.7 0.6 0.8 0.4 1.2 0.4 1.3 0.6 1.0 1.5 0.5 0.9 10.1 2.4 0.2 1.4 0.2 0.4 1.2 0.6 0.2 0.1 6.7 0.8 0.0 0.2 0.1 0.3 0.0 0.4 0.2 0.2 0.2 9.0 0.8 0.0 0.0 0.0 0.1 0.2 0.5 0.1 0.8 0.0 0.0 0.0 0.0 0.0 1.9 1.0 0.3 4.0 0.3 0.7 0.4 0.3 0.8 1.0 0.5 0.0 0.5 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.4 0.5 0.3 11.2 0.4 0.0 1.1 0.0 0.3 0.6 0.2 1.5 0.0 0.1 0.5 0.2 0.0 0.2 0.2 0.1 0.0 0.6 6.7 0.0 0.8 0.1 0.1 0.0 0.2 0.1 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 3.7 8.6 42.5 3.4 3.3 3.6 2.0 2.9 3.2 2.4 0.0 1.0 0.0 0.1 0.0 2.5 0.4 0.0 5.3 1.2 0.0 0.0 0.8 0.0 0.1 25.0 0.3 0.0 0.0 0.0 1.3 1.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 21.2 1.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 3.2 0.2 3.1 0.0 0.7 30.7 34.3 0.1 0.5 0.0 0.0 0.2 ARHGEF38 FLJ20184 ENSG00000236699 "Rho guanine nucleotide exchange factor 38" Q9NXL2 4 105552620-105708093 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 35.5" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 2: 33.6;Ciliated cells: 45.5;Club cells: 18.2" "Cancer enhanced" "Detected in many" "prostate cancer: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 3.0;RPTEC TERT1: 16.4;SK-BR-3: 9.0;T-47d: 9.3" "Low region specificity" "Detected in all" "HPA036510, HPA045484" Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA036510: AB_10672357, HPA045484: AB_2679345" "unprognostic (1.49e-1)" "unprognostic (1.01e-1)" "unprognostic (1.62e-1)" "unprognostic (6.19e-3)" "unprognostic (2.09e-2)" "unprognostic (2.24e-3)" "unprognostic (1.85e-1)" "unprognostic (5.47e-3)" "unprognostic (2.79e-1)" "unprognostic (6.14e-5)" "unprognostic (1.17e-1)" "unprognostic (3.53e-3)" "unprognostic (3.16e-8)" "unprognostic (2.33e-3)" "unprognostic (6.16e-2)" "unprognostic (3.19e-3)" "unprognostic (6.45e-3)" 0.2 0.2 0.2 3.2 0.2 0.0 10.8 0.2 0.2 3.5 7.6 0.0 1.6 2.3 1.4 15.7 0.4 1.1 11.7 0.2 0.2 0.2 13.8 0.4 16.1 0.0 0.2 0.0 1.3 12.9 0.0 35.5 0.4 0.0 14.6 5.6 0.2 13.9 0.5 0.2 1.0 9.6 0.0 0.2 0.2 4.1 0.6 0.0 0.0 8.0 0.7 2.0 0.5 0.4 0.0 0.0 0.1 0.2 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 3.0 0.3 0.0 0.0 0.1 16.4 0.0 0.0 0.0 0.0 9.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.1 0.2 0.1 0.0 0.3 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 6.0 33.6 0.0 0.9 0.0 0.0 1.4 2.5 45.5 18.2 12.2 0.0 0.1 8.3 4.2 1.2 0.0 4.1 0.0 5.0 0.1 0.0 13.9 0.0 0.0 0.1 0.0 8.1 0.0 0.0 0.0 0.0 0.0 3.3 0.0 7.7 0.0 3.3 5.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 7.0 0.4 ARHGEF5 "GEF5, P60, TIM, TIM1" ENSG00000050327 "Rho guanine nucleotide exchange factor 5" Q12774 7 144355288-144380632 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 44.1;Paneth cells: 42.1;Urothelial cells: 36.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 11 "B-cells: 3.1;granulocytes: 1.1;T-cells: 4.2" "Cell line enhanced" "Detected in many" "A-431: 20.7;CAPAN-2: 14.1;hTCEpi: 15.6;WM-115: 15.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA020980, HPA029504, HPA044188, HPA045619, HPA045699" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA020980: AB_1845007, HPA029504: AB_10602231, HPA044188: AB_2678850, HPA045619: AB_2679393, HPA045699: AB_2679423" "unprognostic (1.45e-1)" "unprognostic (2.05e-1)" "unprognostic (1.87e-2)" "unprognostic (1.94e-1)" "unprognostic (9.45e-2)" "unprognostic (2.69e-2)" "unprognostic (9.95e-3)" "unprognostic (9.21e-2)" "unprognostic (1.05e-2)" "unprognostic (2.27e-1)" "unprognostic (3.67e-2)" "unprognostic (2.12e-1)" "prognostic favorable (3.28e-7)" "unprognostic (4.67e-2)" "unprognostic (4.86e-1)" "unprognostic (2.36e-1)" "unprognostic (7.76e-2)" 2.3 1.0 1.2 5.2 1.8 0.9 7.6 1.2 1.2 4.6 7.7 1.2 7.4 8.5 3.4 7.8 16.6 2.5 8.4 1.3 1.2 0.4 9.0 6.7 4.8 3.2 1.2 1.2 3.0 8.8 7.7 4.3 14.3 2.6 6.6 4.6 4.0 17.7 9.4 1.2 21.1 16.7 2.2 1.7 2.4 6.5 1.4 1.2 1.5 11.6 10.0 4.5 3.4 6.9 3.1 0.2 1.1 0.1 0.0 4.2 0.4 20.7 2.0 0.0 0.0 0.0 0.0 7.1 2.2 1.5 1.0 1.3 7.0 14.1 0.0 6.8 0.9 1.7 9.7 0.8 9.6 1.0 0.0 2.9 0.0 3.2 1.1 2.3 0.0 0.0 3.6 15.6 0.7 7.2 3.2 0.2 0.0 0.0 0.0 0.9 8.6 0.0 0.0 4.5 9.3 3.8 0.8 0.0 0.2 11.5 7.1 0.0 0.0 8.8 8.6 3.7 2.6 5.3 1.3 0.2 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.7 0.0 15.3 0.0 0.0 0.0 0.8 0.1 1.3 1.8 2.7 2.1 0.1 3.1 2.7 0.7 1.1 0.0 0.0 0.2 4.2 0.4 1.2 1.8 1.2 1.2 1.2 0.4 1.2 1.2 2.6 1.2 6.0 15.0 0.8 31.5 16.5 0.0 1.1 7.6 18.7 12.5 21.0 3.9 9.2 5.0 12.2 1.3 0.8 44.1 0.0 14.5 11.9 2.3 16.5 0.0 5.9 1.5 0.0 9.2 1.3 0.0 0.4 1.4 0.0 5.0 0.0 15.4 3.4 19.5 42.1 1.4 3.4 2.4 0.0 1.6 0.4 0.9 14.6 11.9 0.5 15.6 36.6 ARID1A "B120, BAF250, BAF250a, C10rf4, C1orf4, P270, SMARCF1" ENSG00000117713 "AT-rich interaction domain 1A" O14497 1 26693236-26782110 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005456, CAB016334" Supported Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB016334: AB_673396, HPA005456: AB_1078205" "unprognostic (2.83e-1)" "unprognostic (1.81e-1)" "unprognostic (7.48e-2)" "unprognostic (1.41e-1)" "unprognostic (2.44e-1)" "unprognostic (1.89e-2)" "prognostic unfavorable (4.18e-4)" "unprognostic (3.02e-1)" "unprognostic (3.66e-2)" "unprognostic (1.34e-1)" "unprognostic (9.69e-2)" "unprognostic (7.76e-2)" "unprognostic (1.01e-2)" "unprognostic (1.62e-2)" "unprognostic (6.05e-2)" "unprognostic (2.66e-1)" "unprognostic (6.54e-2)" 18.6 18.4 17.4 24.9 17.0 33.8 27.8 23.6 19.1 20.3 23.7 21.7 23.9 15.8 24.1 17.3 23.2 20.6 21.9 15.5 14.8 12.8 13.7 15.9 18.8 35.6 20.3 19.2 24.1 23.9 27.5 15.8 19.3 17.2 16.5 16.4 18.9 21.4 23.1 22.6 20.6 20.7 18.4 15.4 25.9 19.5 16.5 19.8 57.3 24.8 14.2 24.5 24.4 20.4 4.3 5.3 7.4 3.3 4.7 5.1 3.5 19.2 18.3 25.9 27.0 7.5 7.2 12.2 9.0 7.9 12.4 8.8 13.3 13.0 27.2 7.9 11.7 7.8 11.7 22.5 10.0 14.5 33.6 8.8 23.1 11.9 8.9 6.2 34.2 7.4 8.3 7.1 14.6 10.5 6.9 10.6 19.7 27.6 30.5 8.0 9.1 28.8 13.3 27.4 12.5 8.5 30.1 17.1 15.4 7.7 13.0 24.3 20.0 15.8 13.4 10.9 15.0 3.9 19.4 18.7 13.3 12.9 12.4 14.6 14.5 19.1 12.5 8.1 21.9 11.7 0.4 3.3 2.9 4.0 2.9 5.1 4.3 3.2 4.9 3.1 4.3 4.0 4.4 7.4 4.7 2.8 5.3 1.5 3.5 17.4 17.0 23.6 19.1 14.8 12.8 20.3 19.2 17.2 19.8 56.6 36.8 33.6 18.1 65.3 60.2 31.1 28.1 25.4 28.4 36.6 49.1 31.8 1.7 31.8 14.2 37.2 28.4 0.0 32.5 32.1 42.6 39.3 56.9 53.9 43.0 69.9 45.7 51.0 93.5 7.5 35.6 45.4 38.8 34.3 56.1 31.2 40.3 31.6 39.3 14.5 37.1 51.8 27.2 46.0 55.3 82.4 30.7 41.2 46.0 27.7 ARID1B "6A3-5, BAF250b, DAN15, ELD/OSA1, KIAA1235, p250R" ENSG00000049618 "AT-rich interaction domain 1B" Q8NFD5 6 156777374-157210779 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016511, HPA075291" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA016511: AB_1845008, HPA075291: AB_2686743" "prognostic unfavorable (1.04e-4)" "unprognostic (9.82e-2)" "unprognostic (1.73e-1)" "unprognostic (5.42e-2)" "unprognostic (7.47e-2)" "unprognostic (1.40e-2)" "unprognostic (2.73e-2)" "unprognostic (2.89e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (4.16e-4)" "unprognostic (2.53e-1)" "unprognostic (5.33e-2)" "unprognostic (1.07e-3)" "unprognostic (2.46e-1)" "unprognostic (1.80e-1)" "unprognostic (3.53e-1)" "unprognostic (1.16e-1)" 18.3 15.0 20.2 18.8 20.9 25.8 19.3 42.1 32.8 20.0 17.4 26.3 21.7 15.3 23.0 14.2 18.6 20.7 15.9 16.8 20.4 11.3 14.2 10.6 17.0 18.3 19.4 16.7 30.2 18.5 47.4 29.2 12.2 17.7 17.7 13.3 24.0 20.0 20.2 30.6 27.3 17.8 21.7 14.9 21.1 15.0 10.7 24.6 24.0 23.8 13.3 26.3 23.5 21.0 9.5 11.9 5.6 3.0 2.7 5.6 1.6 7.2 11.1 16.4 22.3 13.5 12.4 11.2 7.7 10.1 10.0 10.0 9.8 10.5 22.8 4.8 13.0 12.3 9.2 14.0 12.5 9.9 22.9 9.8 16.5 11.2 11.6 9.5 13.7 12.1 14.0 10.1 15.2 13.6 10.9 13.8 14.9 19.4 17.8 7.1 8.5 15.9 15.5 8.3 9.6 5.9 36.3 7.0 12.3 6.9 13.4 15.0 19.2 15.4 16.2 9.0 9.0 10.9 21.6 14.2 12.6 13.4 11.6 15.0 12.3 11.0 29.2 11.0 16.5 16.9 5.6 3.0 2.5 5.4 2.4 5.0 6.8 4.7 3.8 2.3 9.5 4.0 5.6 5.5 2.7 2.6 11.9 4.6 1.6 20.2 20.9 42.1 32.8 20.4 11.3 19.4 16.7 17.7 24.6 44.7 46.7 59.6 18.3 42.2 35.6 27.8 28.1 28.1 36.4 120.4 27.5 10.8 6.6 33.6 12.1 27.8 19.2 0.0 29.8 6.4 27.7 23.2 38.1 23.3 12.3 44.5 39.2 37.4 29.2 13.0 52.6 28.8 28.7 72.1 38.0 23.8 39.9 21.0 59.1 12.2 30.1 45.3 28.2 6.3 14.9 48.7 14.6 23.2 34.9 20.2 ARID2 "BAF200, DKFZp686G052, FLJ30619, KIAA1557" ENSG00000189079 "AT-rich interaction domain 2" Q68CP9 12 45729665-45908040 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Early spermatids: 522.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063044 Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA063044: AB_2684929" "unprognostic (8.41e-2)" "unprognostic (1.03e-1)" "unprognostic (4.02e-2)" "unprognostic (3.94e-2)" "unprognostic (4.15e-2)" "prognostic favorable (5.75e-4)" "unprognostic (1.26e-2)" "unprognostic (9.71e-2)" "unprognostic (9.04e-2)" "unprognostic (5.57e-2)" "unprognostic (1.34e-1)" "unprognostic (2.47e-1)" "unprognostic (1.12e-2)" "unprognostic (9.21e-2)" "unprognostic (3.02e-1)" "unprognostic (2.00e-1)" "unprognostic (6.53e-2)" 9.0 7.9 7.1 14.6 7.2 14.0 11.8 15.7 8.8 10.2 11.4 8.2 17.9 6.4 12.2 10.7 11.5 8.8 10.6 8.2 7.4 5.8 8.7 6.9 10.2 13.0 9.6 3.8 12.2 10.7 18.4 15.1 10.3 7.5 9.9 8.1 10.1 9.7 20.6 8.6 13.5 12.6 12.5 7.3 10.2 9.0 30.9 11.0 33.3 11.5 8.2 11.2 10.0 10.0 2.1 5.3 10.5 4.9 3.1 4.4 1.3 5.4 7.8 14.0 6.1 6.0 4.2 7.6 3.8 5.4 5.3 5.0 11.1 5.6 10.5 7.1 5.2 3.9 6.6 11.3 6.5 7.7 4.6 5.4 13.9 8.6 5.4 4.1 10.9 6.4 3.4 4.9 6.7 10.8 7.5 5.4 15.9 11.7 10.9 4.7 7.1 15.6 7.8 8.4 0.0 4.2 12.1 10.0 10.1 5.1 9.1 7.6 9.7 6.2 7.2 6.0 8.4 11.0 21.9 6.4 5.7 6.9 3.8 4.9 7.3 6.1 29.4 4.4 28.8 4.0 10.5 1.7 4.2 4.1 2.2 4.3 1.7 3.7 4.4 2.4 2.1 3.6 3.3 2.4 3.1 4.9 5.3 3.1 1.3 7.1 7.2 15.7 8.8 7.4 5.8 9.6 3.8 7.5 11.0 26.8 27.9 10.2 11.5 30.0 49.0 12.6 5.1 9.4 12.5 27.9 64.8 11.9 6.6 11.2 522.0 21.5 15.0 0.0 8.7 8.9 17.5 17.9 20.9 13.1 9.9 30.2 20.2 16.5 27.5 122.6 23.0 20.0 13.5 12.6 19.9 19.7 15.6 24.6 21.2 6.9 67.9 25.8 22.7 61.7 16.5 36.1 19.6 24.5 16.0 16.5 ARID3A "BRIGHT, DRIL1" ENSG00000116017 "AT-rich interaction domain 3A" Q99856 19 925781-975934 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 38.3" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 156.8;Extravillous trophoblasts: 418.2;Syncytiotrophoblasts: 433.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 9.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 64.0;CACO-2: 21.6;K-562: 27.8;THP-1: 19.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA004793, HPA076330" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA004793: AB_1847870, HPA076330: AB_2732309" "unprognostic (1.34e-1)" "unprognostic (2.62e-3)" "unprognostic (4.08e-2)" "unprognostic (1.15e-1)" "unprognostic (1.31e-3)" "unprognostic (5.67e-2)" "unprognostic (3.40e-3)" "unprognostic (1.38e-1)" "unprognostic (5.22e-2)" "unprognostic (2.54e-1)" "prognostic favorable (1.95e-5)" "unprognostic (4.00e-1)" "prognostic unfavorable (3.22e-4)" "unprognostic (3.29e-1)" "unprognostic (2.67e-3)" "unprognostic (1.30e-1)" "unprognostic (8.95e-2)" 4.0 2.3 1.7 6.2 2.3 11.5 4.4 4.8 3.8 3.6 5.0 1.6 3.3 4.2 2.9 2.9 4.1 2.7 3.2 2.1 2.2 1.5 4.4 2.6 6.1 7.8 2.8 2.0 1.6 5.5 3.4 4.1 38.3 2.1 2.3 1.8 2.6 2.8 5.6 2.0 3.3 5.0 2.6 2.4 8.3 3.4 17.8 2.5 6.6 2.1 2.1 4.6 4.0 6.9 1.5 9.2 6.4 2.9 1.9 0.5 0.8 1.1 1.5 5.3 1.3 2.2 1.7 64.0 5.0 3.2 2.7 1.8 21.6 0.1 0.4 1.2 1.7 0.6 0.4 2.1 1.1 1.2 6.6 1.5 2.1 1.9 19.4 0.9 7.4 5.5 2.4 1.7 1.7 0.4 0.4 0.9 1.7 27.8 6.2 0.7 1.7 2.8 8.4 5.1 0.8 0.3 6.5 1.6 4.1 0.3 1.1 2.5 4.9 1.6 1.3 0.9 12.3 2.3 19.9 1.5 1.8 2.4 2.5 0.5 14.6 13.0 3.8 1.1 4.3 1.2 0.8 2.4 1.6 0.5 2.1 0.5 1.5 0.3 0.4 1.5 0.9 0.5 0.2 6.4 1.9 2.9 9.2 0.3 0.8 1.7 2.3 4.8 3.8 2.2 1.5 2.8 2.0 2.1 2.5 6.0 3.2 27.9 7.8 13.2 8.8 6.5 0.0 0.0 1.2 14.0 7.9 156.8 8.3 4.8 29.9 7.8 3.2 23.3 2.8 418.2 16.2 7.5 3.5 6.7 78.2 6.4 45.1 9.8 34.1 2.0 6.6 32.5 15.1 35.1 11.2 2.3 9.8 0.0 6.0 4.5 3.3 0.0 12.8 0.6 8.5 13.4 433.4 10.9 4.3 1.8 ARID3B "BDP, DRIL2" ENSG00000179361 "AT-rich interaction domain 3B" Q8IVW6 15 74541177-74598131 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 41.2;Late spermatids: 48.5;Rod photoreceptor cells: 50.3;Syncytiotrophoblasts: 53.5" "Cancer enhanced" "Detected in all" "testis cancer: 10.9" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 33.1;SuSa: 38.1;U-266/70: 20.2" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 7 "cerebellum: 67.3" HPA050320 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA050320: AB_2681085" "unprognostic (2.97e-1)" "unprognostic (5.91e-2)" "unprognostic (6.41e-2)" "unprognostic (8.15e-2)" "unprognostic (8.42e-2)" "unprognostic (1.13e-1)" "unprognostic (3.33e-3)" "unprognostic (3.95e-1)" "unprognostic (1.41e-1)" "unprognostic (2.60e-1)" "unprognostic (1.27e-2)" "unprognostic (1.64e-2)" "unprognostic (1.42e-2)" "unprognostic (4.71e-2)" "unprognostic (3.52e-2)" "unprognostic (9.45e-3)" "unprognostic (2.20e-1)" 2.5 2.0 2.5 5.8 2.4 21.1 2.4 8.0 4.0 3.2 5.2 2.6 5.2 4.4 2.7 2.1 5.5 2.4 8.4 3.9 2.0 2.8 3.1 3.6 6.7 11.0 2.0 0.2 1.5 5.7 1.8 8.3 17.5 3.6 4.3 4.1 9.1 5.6 6.9 6.1 2.7 6.4 1.8 2.5 9.2 7.0 19.5 2.1 7.2 3.7 1.8 10.4 3.2 8.2 3.7 2.1 14.4 2.2 4.3 6.0 3.2 2.7 1.1 15.5 3.3 0.6 0.3 16.6 0.7 0.7 0.9 1.0 18.3 1.3 0.2 0.8 0.7 5.5 3.3 18.7 2.5 0.8 17.3 4.3 10.7 1.9 4.9 0.4 1.7 7.0 0.4 1.1 1.6 1.6 0.7 1.6 4.3 9.3 6.3 0.2 0.6 4.6 5.7 33.1 1.1 1.0 2.0 0.6 4.4 0.9 2.9 3.9 7.0 0.8 1.7 3.2 38.1 2.2 3.1 1.0 1.3 1.6 1.0 2.0 20.2 12.7 1.9 0.7 2.7 0.5 2.8 2.0 7.5 6.0 1.7 3.5 3.7 3.5 4.4 1.5 1.8 2.7 3.4 14.4 4.3 2.2 2.1 4.8 3.2 2.5 2.4 8.0 4.0 2.0 2.8 2.0 0.2 3.6 2.1 3.0 6.4 12.4 4.2 4.6 20.4 1.2 0.0 1.4 1.2 0.0 41.2 29.5 0.0 2.5 34.7 2.8 6.3 0.0 2.9 15.3 3.6 6.1 2.3 2.4 7.0 11.1 5.2 3.7 7.9 48.5 2.6 7.4 3.3 3.6 6.1 5.7 4.9 7.0 2.8 1.3 50.3 0.0 1.4 17.7 13.0 2.9 53.5 10.2 4.1 6.7 ARID4A "RBBP1, RBP-1, RBP1" ENSG00000032219 "AT-rich interaction domain 4A" P29374 14 58298385-58373887 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048899 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA048899: " "unprognostic (1.57e-1)" "unprognostic (9.39e-2)" "unprognostic (5.17e-2)" "unprognostic (2.69e-1)" "unprognostic (3.70e-2)" "prognostic favorable (1.91e-4)" "unprognostic (2.71e-1)" "prognostic favorable (7.82e-4)" "unprognostic (2.08e-2)" "unprognostic (6.92e-2)" "unprognostic (3.27e-1)" "unprognostic (3.72e-2)" "unprognostic (9.32e-2)" "unprognostic (2.32e-1)" "unprognostic (2.64e-1)" "unprognostic (4.11e-2)" "unprognostic (3.52e-2)" 15.1 8.5 17.3 15.1 22.2 34.5 13.4 45.9 27.0 12.8 12.0 7.9 12.7 10.2 11.6 9.7 10.1 10.7 10.7 10.0 13.3 11.5 11.3 21.7 12.0 15.8 9.6 18.7 15.3 11.4 17.2 22.9 11.3 17.3 10.8 10.6 6.4 10.8 13.5 10.6 13.2 12.3 12.5 11.0 15.3 10.2 7.9 15.0 15.0 12.6 4.5 12.8 13.8 11.9 15.1 7.5 42.7 14.1 10.7 11.1 3.6 6.7 5.7 16.0 7.9 7.9 9.6 8.1 8.1 6.9 5.5 8.7 6.7 10.7 16.3 8.6 6.8 5.3 7.8 7.0 3.9 8.1 11.4 4.5 7.4 6.4 6.4 4.8 15.5 10.7 7.2 4.3 5.3 5.5 8.8 8.7 9.5 8.3 13.5 5.8 9.1 11.2 14.0 3.1 6.6 6.9 11.6 13.8 4.8 5.9 12.0 13.8 11.9 13.7 6.9 9.6 8.2 11.8 14.3 12.3 9.4 7.4 7.5 3.7 4.4 3.3 15.0 5.6 9.9 4.7 19.3 7.6 21.7 8.5 7.8 9.5 11.6 10.3 8.8 5.6 15.1 11.1 10.8 42.7 10.7 14.1 7.5 7.2 3.6 17.3 22.2 45.9 27.0 13.3 11.5 9.6 18.7 17.3 15.0 77.4 85.3 20.4 20.9 34.1 91.9 45.6 15.3 8.1 40.9 26.2 49.1 16.0 16.6 19.0 13.5 41.6 29.5 23.3 19.0 18.3 27.2 20.2 63.6 37.6 29.9 106.5 21.9 33.2 40.4 5.3 33.6 50.9 25.3 68.5 30.9 64.2 20.9 36.8 33.9 11.9 63.2 19.4 25.5 37.6 24.7 29.2 17.0 54.9 29.8 15.5 ARID4B "BCAA, BRCAA1, RBP1L1, SAP180" ENSG00000054267 "AT-rich interaction domain 4B" Q4LE39 1 235131634-235328219 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027205, HPA027333" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" Nucleoplasm "HPA027205: , HPA027333: AB_1845013" "unprognostic (2.62e-1)" "unprognostic (2.38e-1)" "unprognostic (1.67e-1)" "unprognostic (1.32e-1)" "unprognostic (1.87e-3)" "unprognostic (7.75e-2)" "unprognostic (1.27e-1)" "unprognostic (4.16e-2)" "unprognostic (1.30e-2)" "unprognostic (1.03e-1)" "unprognostic (5.69e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (2.23e-4)" "unprognostic (1.42e-2)" "unprognostic (1.25e-1)" "unprognostic (3.52e-2)" "unprognostic (8.84e-3)" 15.3 13.8 14.9 19.0 22.5 34.1 15.9 32.8 17.6 19.7 13.4 19.2 18.2 9.1 18.7 18.1 12.0 15.0 15.2 10.6 15.2 14.5 13.1 14.0 15.5 22.3 26.9 13.9 21.8 16.8 23.8 25.7 14.7 20.3 17.9 10.7 12.0 16.7 17.0 12.3 12.3 14.2 14.6 19.8 19.8 14.7 19.5 23.4 33.7 20.2 8.2 18.9 18.2 18.6 17.1 11.7 35.9 11.8 16.6 17.0 6.0 12.2 9.2 16.2 12.5 11.9 12.5 13.3 14.0 12.3 9.7 9.5 9.5 13.1 14.4 16.3 10.5 6.9 10.9 13.1 5.9 14.1 18.5 14.2 11.6 11.1 7.9 9.1 12.4 17.1 8.4 8.0 11.9 10.2 12.7 13.1 9.2 15.0 20.7 9.1 5.5 18.5 11.3 14.8 8.8 6.1 6.9 11.5 12.0 10.6 10.3 13.2 18.3 17.8 14.8 13.8 4.9 15.6 20.1 18.0 12.0 9.1 14.6 13.6 20.2 16.0 14.4 8.2 9.1 16.0 24.6 7.1 19.5 16.1 7.6 14.7 15.6 17.0 13.7 6.8 17.1 16.9 14.4 35.9 16.6 11.8 11.7 13.6 6.0 14.9 22.5 32.8 17.6 15.2 14.5 26.9 13.9 20.3 23.4 95.3 99.9 54.7 68.9 110.4 111.2 62.2 35.7 91.0 101.2 29.6 113.9 55.7 16.6 62.0 329.6 108.9 41.9 46.7 41.8 58.1 114.7 81.5 105.3 23.1 39.4 106.5 86.4 65.7 52.4 349.2 93.7 99.4 79.2 108.2 45.8 77.7 57.3 49.9 72.9 15.0 150.5 45.3 129.6 212.6 167.8 93.1 131.0 129.6 39.6 111.5 ARID5A "MRF-1, RP11-363D14" ENSG00000196843 "AT-rich interaction domain 5A" Q03989 2 96536743-96552638 "Predicted intracellular proteins, Transcription factors" "Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Smooth muscle cells: 294.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 5 "HDLM-2: 73.1;RPMI-8226: 32.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA002860, HPA023879" Approved Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA002860: , HPA023879: AB_1845014" "prognostic favorable (2.05e-6)" "unprognostic (1.08e-3)" "unprognostic (1.69e-2)" "unprognostic (3.89e-3)" "unprognostic (1.90e-2)" "unprognostic (3.38e-2)" "unprognostic (3.03e-1)" "unprognostic (1.17e-1)" "unprognostic (1.24e-3)" "unprognostic (2.46e-1)" "unprognostic (1.56e-3)" "unprognostic (1.17e-1)" "prognostic unfavorable (4.24e-8)" "unprognostic (2.74e-2)" "unprognostic (9.79e-2)" "unprognostic (1.06e-1)" "unprognostic (5.13e-2)" 20.1 4.1 6.8 24.5 8.7 14.6 26.2 3.1 8.8 10.5 14.6 4.9 4.1 7.2 17.5 16.1 9.1 11.5 16.8 17.8 7.0 5.5 5.4 7.2 26.0 29.0 10.7 3.1 11.4 9.8 3.8 6.6 13.0 17.4 14.7 3.7 11.4 8.2 5.1 26.1 7.3 12.3 33.1 13.6 14.9 10.1 5.4 6.2 12.4 8.2 7.7 15.7 19.5 12.0 5.2 12.8 21.4 5.3 17.7 11.5 8.8 0.8 0.3 0.4 1.5 0.8 0.9 2.2 1.4 4.9 1.7 1.5 0.8 0.2 0.2 1.0 0.8 2.6 1.3 0.4 0.0 0.5 73.1 1.1 1.8 0.3 1.7 1.0 1.2 1.4 0.6 1.6 1.4 0.2 1.5 1.5 2.2 1.5 11.1 0.6 0.8 2.4 4.3 0.9 0.4 0.0 3.3 3.0 32.2 0.2 0.7 0.6 0.3 0.1 0.1 1.1 0.4 0.0 2.7 1.4 1.5 1.9 1.7 1.2 6.8 5.3 0.9 0.8 3.0 1.4 7.2 5.3 21.4 11.5 4.8 11.1 4.4 9.7 10.7 7.1 5.2 10.8 10.5 15.3 17.7 3.3 12.8 11.0 8.8 6.8 8.7 3.1 8.8 7.0 5.5 10.7 3.1 17.4 6.2 3.0 28.9 11.8 34.4 46.5 17.4 12.2 5.1 10.7 11.4 3.5 29.5 3.6 3.3 29.9 14.9 43.6 3.2 0.0 27.0 7.0 17.5 22.9 58.0 22.2 62.8 0.0 0.0 22.1 29.8 23.3 3.4 64.4 55.6 95.6 5.4 6.2 24.8 5.3 6.0 5.0 24.7 45.3 294.5 2.7 17.6 28.4 3.3 91.4 2.6 17.8 ARID5B "FLJ21150, MRF2" ENSG00000150347 "AT-rich interaction domain 5B" Q14865 10 61901300-62096944 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 88.6" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 860.1;Smooth muscle cells: 627.3;Syncytiotrophoblasts: 769.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 45.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015037 Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Endoplasmic reticulum" "Nucleoplasm, Plasma membrane, Cytosol" "HPA015037: AB_1845015" "unprognostic (3.31e-1)" "unprognostic (1.99e-2)" "unprognostic (2.94e-2)" "unprognostic (1.86e-1)" "unprognostic (1.17e-1)" "unprognostic (5.60e-2)" "unprognostic (1.50e-2)" "unprognostic (4.90e-2)" "unprognostic (3.90e-1)" "unprognostic (6.03e-2)" "unprognostic (1.97e-1)" "unprognostic (5.75e-1)" "unprognostic (1.20e-2)" "unprognostic (1.15e-1)" "unprognostic (2.58e-1)" "unprognostic (1.94e-1)" "unprognostic (3.93e-2)" 43.3 5.6 7.8 13.8 9.9 4.2 22.6 3.3 11.5 27.5 14.0 9.5 4.4 6.8 29.4 10.4 14.0 15.6 27.2 16.0 5.9 5.1 14.6 5.7 14.6 14.4 11.8 6.5 18.6 4.3 14.7 11.4 22.4 9.4 16.6 8.2 6.9 14.5 7.3 88.6 15.0 12.1 29.4 10.4 12.7 9.4 7.7 10.5 8.6 7.5 11.7 18.0 22.5 17.1 21.2 1.0 4.3 3.6 5.7 14.7 2.6 0.8 0.3 2.3 5.9 5.2 14.0 0.4 16.9 45.7 12.1 9.5 20.5 0.9 1.4 4.1 16.2 1.7 5.6 8.1 2.5 14.6 5.3 2.4 0.8 4.1 5.1 9.7 0.2 10.1 17.6 1.3 7.1 8.1 10.4 1.4 2.9 0.7 2.3 3.9 2.9 5.5 0.4 0.4 3.9 5.4 6.7 3.9 0.4 7.9 9.2 1.3 1.7 7.5 4.1 4.9 5.5 3.5 0.2 1.3 6.7 9.1 10.1 4.2 0.1 0.0 4.4 5.8 0.3 2.1 4.3 0.6 0.4 7.3 1.4 0.9 19.0 10.5 6.3 1.0 21.2 6.9 4.5 1.2 5.7 3.6 0.5 14.7 2.6 7.8 9.9 3.3 11.5 5.9 5.1 11.8 6.5 9.4 10.5 122.1 57.7 77.2 286.1 860.1 43.7 59.7 12.7 50.9 120.6 48.8 0.0 138.5 84.6 43.9 23.9 62.4 4.7 23.3 12.8 104.6 292.5 224.3 23.2 5.1 46.6 69.9 34.9 106.8 33.2 10.0 140.4 39.6 131.6 60.5 13.2 19.3 30.6 20.9 57.0 145.5 2.8 129.4 627.3 5.7 0.5 417.5 769.7 77.6 30.2 122.9 ARIH1 "ARI, HARI, HHARI, UBCH7BP" ENSG00000166233 "Ariadne RBR E3 ubiquitin protein ligase 1" Q9Y4X5 15 72474326-72602985 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003295, HPA073245" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA003295: AB_1845017, HPA073245: AB_2686587" "unprognostic (3.31e-2)" "unprognostic (1.92e-1)" "unprognostic (2.25e-1)" "unprognostic (3.18e-2)" "unprognostic (8.21e-2)" "unprognostic (5.45e-2)" "unprognostic (1.73e-1)" "unprognostic (9.43e-2)" "unprognostic (7.92e-2)" "unprognostic (1.37e-1)" "unprognostic (4.96e-2)" "unprognostic (9.19e-2)" "unprognostic (1.78e-1)" "unprognostic (2.93e-1)" "unprognostic (3.19e-1)" "unprognostic (1.04e-1)" "unprognostic (5.70e-2)" 15.3 15.6 11.4 17.4 15.5 24.6 13.3 20.4 21.5 15.8 14.5 10.4 14.0 17.0 21.1 11.2 14.2 12.3 14.4 19.7 10.5 10.5 10.9 10.5 13.7 9.3 10.1 15.0 17.3 13.5 12.9 14.0 15.4 12.6 14.0 7.6 13.0 13.2 13.1 68.3 16.3 13.5 15.8 10.7 11.4 12.5 55.2 10.0 16.9 11.7 13.0 12.7 18.4 20.4 1.9 1.1 4.6 1.5 2.1 2.5 0.3 9.4 9.9 9.8 5.7 5.1 3.6 11.5 10.6 3.9 4.8 3.3 10.0 8.1 9.2 16.0 4.5 17.0 13.5 10.0 5.5 2.7 16.4 6.9 7.0 12.2 6.6 3.6 10.4 8.1 4.2 1.9 5.3 6.9 4.6 3.5 6.8 7.3 11.0 4.7 6.1 10.0 4.0 10.6 3.4 3.6 11.4 11.9 5.2 2.7 15.8 9.2 10.5 13.8 6.2 16.3 13.5 5.0 12.0 9.1 8.0 11.1 30.7 14.8 11.6 23.2 10.8 5.3 9.5 8.4 4.6 1.0 2.2 1.7 1.5 1.5 0.7 1.3 1.1 0.7 1.9 1.6 1.5 3.4 2.1 0.7 1.1 2.5 0.3 11.4 15.5 20.4 14.0 10.5 10.5 10.1 15.0 12.6 10.0 17.9 30.7 20.4 42.7 58.8 62.5 41.5 20.4 29.4 30.7 17.4 86.4 15.9 3.3 17.2 84.9 33.4 23.6 0.0 16.2 16.9 29.1 45.9 43.7 24.7 16.7 58.8 44.6 41.1 23.7 41.4 26.4 21.3 15.1 10.0 22.7 24.7 20.6 20.1 25.8 12.2 60.6 19.4 46.1 40.7 29.7 52.2 34.1 30.5 20.9 52.0 ARIH2 TRIAD1 ENSG00000177479 "Ariadne RBR E3 ubiquitin protein ligase 2" O95376 3 48918821-48986382 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067381, HPA069715, HPA070963" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA067381: AB_2685827, HPA069715: AB_2686182, HPA070963: AB_2686329" "unprognostic (7.24e-2)" "unprognostic (1.08e-1)" "unprognostic (1.26e-1)" "unprognostic (2.74e-1)" "unprognostic (2.55e-1)" "unprognostic (4.79e-3)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.90e-2)" "unprognostic (4.01e-2)" "unprognostic (5.01e-2)" "prognostic favorable (7.31e-4)" "unprognostic (5.01e-3)" "prognostic favorable (6.60e-4)" "unprognostic (1.15e-1)" "unprognostic (7.04e-2)" "unprognostic (1.27e-2)" "unprognostic (1.39e-2)" 15.0 16.2 14.1 12.8 20.6 16.0 19.2 22.7 22.5 14.1 18.6 25.4 13.9 10.0 18.7 29.2 14.9 16.2 12.8 38.5 15.8 14.9 14.3 17.2 14.5 17.8 24.7 18.3 18.3 20.5 23.1 19.8 15.3 19.7 16.5 15.5 19.2 13.2 19.5 71.3 11.4 14.4 23.0 18.8 17.5 15.7 27.5 21.4 17.7 18.7 15.2 17.2 16.4 14.1 20.6 21.7 27.6 24.5 15.8 32.6 25.3 14.3 14.5 14.0 19.8 20.7 11.4 19.0 16.9 19.8 21.2 23.5 15.2 12.8 29.3 7.9 18.1 30.8 8.6 28.8 17.3 26.0 19.7 17.5 30.2 19.1 12.4 18.8 22.3 14.6 12.2 26.2 26.4 35.9 12.1 15.9 14.1 23.8 20.1 18.7 9.9 22.5 9.2 23.8 15.5 22.0 8.4 16.0 24.4 12.4 19.4 6.1 16.6 16.6 20.9 16.2 17.3 10.6 15.9 15.1 12.9 18.7 19.2 26.5 26.3 50.8 37.1 14.1 18.7 16.1 27.6 24.5 26.2 32.6 21.6 22.1 19.5 20.9 26.7 21.7 20.6 21.6 27.8 17.2 15.8 13.5 18.7 22.9 25.3 14.1 20.6 22.7 22.5 15.8 14.9 24.7 18.3 19.7 21.4 32.8 22.3 31.1 35.9 45.2 56.4 60.0 30.6 37.5 58.0 27.9 82.5 31.2 24.9 23.6 8.2 33.8 20.3 23.3 37.3 30.6 28.0 46.9 42.9 36.5 23.8 54.0 16.0 35.0 26.4 4.7 38.6 33.2 28.7 41.5 22.9 39.7 33.1 22.9 40.7 25.6 73.6 25.8 35.4 140.0 77.3 47.2 44.6 50.1 26.5 58.6 ARL14EP "ARF7EP, C11orf46, FLJ38968" ENSG00000152219 "ADP ribosylation factor like GTPase 14 effector protein" Q8N8R7 11 30323051-30338227 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039634, HPA048127" Approved Supported "Nucleoplasm,Vesicles,Focal adhesion sites,Cytosol" NA NA "Vesicles, Focal adhesion sites, Cytosol" Nucleoplasm "HPA039634: AB_2676606, HPA048127: AB_2680277" "prognostic favorable (2.50e-5)" "unprognostic (8.93e-2)" "unprognostic (6.19e-3)" "unprognostic (1.34e-1)" "unprognostic (1.67e-1)" "unprognostic (3.09e-1)" "prognostic unfavorable (5.26e-4)" "unprognostic (2.50e-2)" "unprognostic (6.50e-3)" "unprognostic (5.76e-2)" "unprognostic (8.86e-2)" "unprognostic (1.04e-1)" "unprognostic (8.57e-3)" "unprognostic (1.60e-1)" "unprognostic (3.47e-1)" "unprognostic (4.50e-2)" "prognostic favorable (7.49e-4)" 13.9 21.5 24.5 12.9 29.1 6.3 18.7 22.7 23.4 17.0 14.5 8.0 22.4 8.7 18.1 22.7 11.1 15.8 12.4 20.5 17.7 15.5 16.5 17.6 10.3 23.5 15.5 20.5 20.1 15.0 33.4 28.6 10.6 15.1 19.0 10.3 9.0 17.0 19.9 28.0 11.6 12.5 18.3 16.0 18.2 14.4 14.5 15.0 11.6 23.3 13.9 19.1 16.1 15.1 17.6 12.7 5.5 9.6 24.4 28.7 11.2 5.8 8.5 9.5 8.3 15.6 17.0 4.8 11.5 14.5 10.4 11.6 4.7 2.2 23.8 7.9 8.2 11.6 9.9 13.8 9.7 14.8 18.9 17.1 7.2 6.7 8.2 24.6 12.8 8.3 17.6 19.6 4.9 18.7 15.2 11.4 9.9 11.3 13.0 18.1 5.6 11.6 10.6 11.0 13.1 11.9 10.2 23.2 9.7 13.9 8.1 10.9 11.6 8.9 12.0 14.1 8.9 12.7 7.3 10.0 12.0 6.4 23.5 10.9 20.4 11.6 15.5 11.4 8.0 11.4 5.5 9.6 3.0 12.1 9.4 28.7 17.6 14.8 13.4 12.7 14.0 13.7 13.1 1.7 24.4 7.0 9.1 9.5 11.2 24.5 29.1 22.7 23.4 17.7 15.5 15.5 20.5 15.1 15.0 26.8 28.1 30.5 38.1 11.0 32.2 57.0 17.8 34.8 20.5 24.4 13.7 14.7 64.6 23.3 99.1 24.8 6.3 0.0 19.6 10.7 22.3 27.7 26.6 24.2 22.8 30.2 13.9 12.9 24.3 44.0 25.3 30.9 25.3 43.3 10.0 34.4 19.0 9.7 23.7 27.2 28.6 12.9 24.1 60.6 33.2 9.7 9.3 28.9 10.4 24.4 ARL2 ARFL2 ENSG00000213465 "ADP ribosylation factor like GTPase 2" P36404 11 65014113-65022184 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Late spermatids: 847.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA044610 Supported Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Focal adhesion sites,Cytosol" NA NA Nucleoplasm "Nucleoli, Golgi apparatus, Focal adhesion sites, Cytosol" "HPA044610: AB_10964207" "unprognostic (9.23e-2)" "unprognostic (3.66e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (4.58e-4)" "unprognostic (1.61e-1)" "unprognostic (5.08e-2)" "unprognostic (1.07e-3)" "unprognostic (2.34e-1)" "unprognostic (9.85e-3)" "unprognostic (6.43e-2)" "unprognostic (6.87e-3)" "prognostic favorable (7.70e-4)" "unprognostic (2.15e-2)" "unprognostic (1.85e-1)" "unprognostic (1.60e-1)" "unprognostic (4.39e-1)" "unprognostic (1.24e-2)" 39.6 32.0 37.3 17.7 78.7 19.8 26.8 16.1 46.5 21.2 23.5 34.7 13.4 23.9 26.8 20.2 23.7 35.2 22.4 52.6 34.8 32.7 33.8 6.6 23.1 14.8 36.1 38.2 27.2 29.9 22.5 15.4 25.5 32.7 25.3 15.5 30.3 26.9 33.1 78.3 19.6 23.4 28.2 44.9 16.7 18.9 31.4 28.7 7.9 26.3 23.6 12.9 24.7 22.8 43.7 37.8 18.7 21.8 21.0 40.7 34.7 36.1 57.7 17.9 26.4 48.6 36.9 16.3 17.8 41.3 25.6 25.3 16.3 25.0 14.0 34.1 25.1 39.0 23.3 18.8 31.4 12.2 14.6 29.5 14.1 26.0 24.6 37.2 17.1 12.8 29.0 26.3 21.3 47.8 37.4 34.0 16.9 33.2 26.1 17.2 42.8 14.1 38.5 28.0 17.2 47.1 7.5 19.6 33.6 27.5 15.8 33.3 18.8 15.3 15.9 50.2 17.6 16.6 21.0 25.6 48.3 16.3 38.3 18.4 9.0 12.6 8.6 22.8 24.7 39.2 10.2 21.8 18.7 34.8 21.2 37.6 43.7 32.2 33.6 27.6 37.3 36.8 40.7 2.8 21.0 12.4 37.8 20.6 34.7 37.3 78.7 16.1 46.5 34.8 32.7 36.1 38.2 32.7 28.7 20.8 35.8 37.0 78.1 72.4 72.3 89.8 50.9 32.1 52.4 78.5 27.5 165.9 227.1 118.2 362.1 147.4 126.8 46.7 66.9 164.2 116.5 55.8 93.5 17.1 87.0 65.2 80.0 119.1 47.3 847.8 66.4 70.8 168.7 138.9 56.4 119.5 81.6 95.1 66.8 340.4 40.2 64.7 111.8 98.4 65.3 72.4 89.7 39.2 87.9 60.9 ARL3 ARFL3 ENSG00000138175 "ADP ribosylation factor like GTPase 3" P36405 10 102673731-102714407 "Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transport" "Ciliopathy, Disease mutation, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036292, HPA063596" Approved Supported Nucleoplasm,Centrosome NA NA 17000 Centrosome Nucleoplasm "HPA036292: AB_10673618, HPA063596: AB_2685053" "unprognostic (1.36e-1)" "unprognostic (2.89e-3)" "unprognostic (4.19e-2)" "unprognostic (7.58e-2)" "unprognostic (2.98e-2)" "unprognostic (3.24e-2)" "unprognostic (2.45e-2)" "unprognostic (7.69e-2)" "unprognostic (4.00e-2)" "unprognostic (3.21e-1)" "unprognostic (3.99e-3)" "unprognostic (5.58e-2)" "prognostic favorable (1.71e-6)" "unprognostic (5.62e-2)" "unprognostic (3.09e-2)" "unprognostic (4.21e-2)" "unprognostic (1.03e-1)" 8.8 13.8 24.8 6.6 29.4 2.9 11.4 24.1 32.9 14.1 8.9 9.6 8.2 6.8 17.1 16.7 10.2 23.0 8.3 29.9 19.9 21.4 22.7 8.1 9.6 5.5 20.2 16.0 25.2 9.9 18.9 21.0 7.7 17.6 12.1 7.7 21.5 8.8 14.5 7.9 7.9 6.4 13.4 14.2 5.3 9.0 13.6 9.3 4.1 17.3 5.5 7.2 16.0 13.8 5.0 7.8 14.9 8.1 4.5 11.1 5.8 8.4 14.6 20.1 14.7 9.4 14.0 3.5 6.7 10.3 8.2 9.0 5.0 4.4 3.5 6.5 10.8 9.9 6.3 7.6 9.0 10.3 9.2 7.9 5.7 10.4 4.7 10.1 2.6 5.8 7.1 7.6 11.3 6.7 21.9 9.3 7.1 2.5 3.6 13.6 8.7 5.4 4.2 7.7 5.4 5.8 4.5 14.9 3.1 10.9 4.5 7.1 15.5 5.1 1.1 7.9 11.6 26.8 2.6 5.3 5.6 7.9 11.3 9.2 2.5 5.0 6.5 14.8 7.9 4.8 2.3 8.1 2.7 4.5 6.5 11.1 5.0 7.8 6.5 7.8 3.5 4.8 5.7 14.9 4.5 5.5 5.7 5.2 5.8 24.8 29.4 24.1 25.6 19.9 21.4 20.2 16.0 17.6 9.3 50.6 35.3 24.6 62.4 28.5 163.4 124.2 25.5 234.2 69.4 59.3 110.0 37.6 198.9 63.3 31.0 37.3 8.7 0.0 38.5 31.6 63.5 46.4 32.3 23.7 54.8 92.2 71.9 38.1 15.3 15.4 56.1 32.0 72.6 102.8 28.8 161.1 29.6 11.5 97.9 174.9 241.8 25.8 102.0 184.2 20.1 27.7 27.0 20.1 26.6 42.6 ARL4A ARL4 ENSG00000122644 "ADP ribosylation factor like GTPase 4A" P40617 7 12686856-12690934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 71.2" "Group enriched" "Detected in all" 6 "Early spermatids: 1213.7;Late spermatids: 2876.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 61.8;K-562: 73.5" "Low region specificity" "Detected in all" HPA064513 Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA064513: AB_2685276" "unprognostic (8.29e-2)" "unprognostic (1.34e-1)" "unprognostic (3.94e-1)" "unprognostic (4.97e-2)" "unprognostic (3.88e-2)" "unprognostic (7.43e-2)" "unprognostic (1.34e-2)" "unprognostic (6.56e-2)" "unprognostic (9.97e-2)" "unprognostic (2.23e-1)" "unprognostic (3.02e-2)" "unprognostic (3.57e-2)" "unprognostic (7.27e-3)" "unprognostic (1.74e-1)" "unprognostic (9.29e-2)" "unprognostic (9.42e-3)" "unprognostic (9.49e-3)" 22.6 3.6 12.3 6.7 6.7 30.8 21.5 3.0 15.8 16.9 19.4 3.2 7.4 11.3 13.6 9.9 23.5 11.0 7.5 7.0 6.0 4.6 5.2 6.6 8.6 9.5 10.3 11.0 5.2 3.5 1.8 5.6 19.2 8.5 12.0 13.7 4.0 39.0 6.8 4.2 34.9 44.6 12.8 6.5 9.5 10.3 71.2 6.7 3.7 8.8 9.2 6.5 10.5 25.0 22.8 7.4 3.3 15.4 6.5 17.6 7.3 10.1 10.9 29.0 61.8 4.7 7.8 0.0 4.1 3.8 6.8 4.1 9.6 7.7 0.0 1.8 5.8 17.5 2.9 6.4 5.3 6.9 2.2 4.8 2.1 14.2 8.9 9.7 8.9 3.8 3.5 21.1 4.0 17.9 4.3 16.3 4.1 73.5 10.0 6.9 4.4 0.4 12.6 10.5 29.7 12.5 0.0 10.1 4.7 9.0 4.9 5.3 5.0 6.9 7.3 1.4 7.8 3.6 7.3 5.6 2.7 9.7 10.3 16.7 4.6 6.0 2.3 7.1 3.7 10.9 3.3 7.8 0.3 6.3 13.0 17.6 21.4 15.0 9.7 7.4 22.8 7.4 6.1 1.1 6.5 15.4 6.6 8.9 7.3 12.3 6.7 3.0 15.8 6.0 4.6 10.3 11.0 8.5 6.7 20.8 20.7 36.3 179.9 301.7 21.4 12.9 40.8 100.4 60.3 19.2 80.5 129.5 23.2 34.7 1213.7 160.4 353.7 23.3 25.7 18.5 63.5 47.1 78.5 18.7 55.4 3.2 60.0 103.2 124.4 2876.1 63.9 134.7 114.7 54.1 63.0 9.4 39.9 112.2 25.1 13.0 114.7 12.9 42.2 236.6 53.4 205.1 371.3 38.3 56.5 52.6 ARL6 "BBS3, RP55" ENSG00000113966 "ADP ribosylation factor like GTPase 6" Q9H0F7 3 97764521-97801242 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision" "Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Mental retardation, Obesity, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 22.7;Cone photoreceptor cells: 25.5;Rod photoreceptor cells: 54.6;Spermatocytes: 30.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 22.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019361 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA019361: AB_1845028" "unprognostic (1.31e-1)" "unprognostic (2.82e-2)" "unprognostic (7.12e-2)" "unprognostic (4.66e-2)" "unprognostic (2.08e-1)" "unprognostic (1.02e-1)" "unprognostic (8.78e-3)" "unprognostic (2.88e-2)" "unprognostic (5.55e-3)" "unprognostic (9.43e-2)" "unprognostic (1.19e-1)" "unprognostic (3.31e-1)" "prognostic favorable (2.53e-7)" "unprognostic (9.49e-2)" "unprognostic (1.67e-1)" "unprognostic (2.16e-2)" "unprognostic (2.97e-1)" 5.5 9.2 8.8 3.6 18.6 1.6 6.0 10.0 17.7 6.5 4.9 5.0 7.3 2.7 7.9 7.3 5.3 11.9 6.2 5.9 17.1 11.0 13.2 4.4 8.4 3.9 8.9 14.1 6.4 5.6 22.6 22.3 5.0 12.9 7.1 4.6 7.3 9.1 6.5 2.9 5.2 3.2 7.2 8.0 4.7 5.0 10.9 9.0 4.2 9.1 2.0 3.8 5.6 5.1 2.7 1.0 0.5 1.0 4.1 4.8 1.6 7.7 4.4 4.0 3.3 10.1 7.1 1.0 5.1 4.8 4.5 5.8 1.6 3.1 4.2 4.9 2.4 7.4 3.8 5.1 5.8 9.2 5.2 3.1 1.2 3.3 1.7 4.9 5.3 2.8 3.6 4.2 6.0 1.5 4.0 4.4 5.5 1.4 0.8 7.2 2.8 3.0 2.6 5.0 4.1 5.0 1.5 4.2 2.5 5.1 2.2 22.0 11.7 4.4 3.0 9.2 2.8 3.6 2.1 3.3 4.5 3.9 3.9 6.8 3.5 4.2 4.9 8.3 2.9 5.4 0.5 0.5 0.2 2.4 0.7 4.8 1.9 2.1 2.5 0.9 2.7 3.6 3.0 0.0 4.1 1.0 1.0 3.6 1.6 8.8 18.6 10.0 17.7 17.1 11.0 8.9 14.1 12.9 9.0 3.0 2.2 0.5 2.8 2.9 11.0 1.8 0.0 22.7 5.7 8.7 25.5 1.1 3.3 3.4 15.0 2.9 0.0 0.0 2.2 1.7 2.3 1.7 0.0 2.6 1.6 4.8 2.4 4.9 1.3 3.7 3.7 0.8 1.7 0.0 1.3 6.5 2.0 2.0 3.9 8.2 54.6 6.5 3.3 30.4 5.3 1.8 0.6 1.5 1.2 1.4 ARL6IP4 "SFRS20, SR-25, SRp25, SRrp37" ENSG00000182196 "ADP ribosylation factor like GTPase 6 interacting protein 4" Q66PJ3 12 122980060-122982913 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA052098 Approved Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA052098: AB_2681724" "unprognostic (1.10e-1)" "unprognostic (4.01e-2)" "unprognostic (8.42e-3)" "unprognostic (1.86e-1)" "unprognostic (4.23e-2)" "unprognostic (2.04e-3)" "unprognostic (6.48e-4)" "unprognostic (1.06e-2)" "unprognostic (1.38e-1)" "unprognostic (8.62e-2)" "unprognostic (3.03e-5)" "unprognostic (4.01e-2)" "unprognostic (8.41e-8)" "unprognostic (6.84e-2)" "unprognostic (2.16e-1)" "unprognostic (1.43e-2)" "prognostic favorable (1.08e-4)" 42.1 59.6 63.3 35.7 46.8 55.3 40.3 36.9 55.9 36.7 43.0 32.2 38.9 43.7 33.8 30.7 38.9 42.9 40.1 57.0 42.8 40.9 45.2 59.1 33.9 51.6 45.2 38.3 50.0 94.4 30.0 34.7 29.7 35.1 38.9 24.7 39.7 59.7 41.2 131.1 30.7 44.9 64.3 36.1 38.1 41.6 35.2 27.7 35.5 39.1 43.4 39.9 39.5 39.9 54.4 72.4 58.1 81.5 46.5 59.6 61.3 49.0 53.6 35.3 23.6 24.8 32.9 27.7 28.3 34.1 42.6 32.4 26.4 20.9 46.9 35.6 35.8 19.9 26.0 28.1 45.9 19.0 41.5 29.3 77.9 47.5 51.8 47.8 42.4 34.4 34.0 37.1 32.7 43.1 46.8 46.8 37.9 34.5 22.8 34.0 57.9 49.3 77.2 27.7 29.7 34.0 37.6 38.8 55.4 36.8 41.9 34.3 41.1 26.7 44.8 65.1 16.1 58.7 55.3 41.8 24.7 45.0 23.5 35.2 49.0 23.6 53.4 35.6 49.8 30.8 32.9 58.4 58.1 47.4 72.2 51.0 54.4 57.0 52.5 72.4 50.6 55.1 49.4 16.1 46.5 81.5 49.3 59.6 61.3 63.3 46.8 36.9 55.9 42.8 40.9 45.2 38.3 35.1 27.7 86.4 116.6 229.3 258.2 181.7 102.3 0.0 173.3 87.0 80.8 200.7 41.2 248.7 437.7 251.9 151.9 255.7 444.9 46.7 552.1 221.9 252.2 285.2 160.8 400.6 340.2 92.2 214.5 213.6 390.7 256.2 206.0 341.0 357.7 480.7 268.3 146.1 343.4 291.0 170.1 721.8 106.3 174.6 249.2 209.1 156.8 177.7 200.9 256.7 288.4 330.8 ARMC12 "C6orf81, FLJ25390" ENSG00000157343 "Armadillo repeat containing 12" Q5T9G4 6 35737032-35749079 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 60.2" "Group enriched" "Detected in some" 65 "Early spermatids: 374.1;Late spermatids: 785.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 3.2;plasmacytoid DC: 2.9" "Group enriched" "Detected in many" 11 "dendritic cells: 2.9;monocytes: 1.0;T-cells: 3.2" "Cell line enhanced" "Detected in many" "ASC diff: 7.3;HSkMC: 9.7;MOLT-4: 6.6;U-698: 7.2" "Not detected" "Not detected" "HPA030895, HPA075457, HPA075777" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA030895: AB_10602114, HPA075457: , HPA075777: " "unprognostic (1.94e-4)" "unprognostic (2.21e-1)" "unprognostic (3.24e-1)" "unprognostic (1.32e-2)" "unprognostic (2.34e-1)" "unprognostic (1.19e-1)" "unprognostic (2.52e-1)" "unprognostic (2.12e-1)" "unprognostic (4.48e-1)" "unprognostic (3.52e-2)" "unprognostic (6.36e-4)" "unprognostic (8.99e-2)" "unprognostic (1.17e-12)" "unprognostic (6.53e-2)" "unprognostic (1.82e-1)" "unprognostic (1.49e-1)" "unprognostic (2.09e-1)" 0.5 0.4 0.9 0.5 1.2 0.7 0.7 0.5 0.9 0.6 0.5 0.5 0.5 0.0 0.5 5.8 0.5 0.6 0.8 0.5 0.7 0.9 0.5 1.4 0.5 1.1 0.7 0.5 1.0 0.5 0.1 4.8 0.5 0.5 1.1 0.3 0.6 0.5 1.0 0.5 0.5 0.5 0.6 0.5 0.8 0.1 60.2 0.5 0.5 0.7 0.5 0.6 0.5 0.5 0.1 2.9 0.0 1.0 0.2 3.2 0.4 0.0 0.5 3.2 3.8 7.3 3.4 0.0 0.1 0.2 0.3 0.4 0.1 0.2 0.7 0.1 0.1 1.1 0.1 1.1 0.2 0.2 1.6 0.9 0.4 0.1 0.1 3.8 0.0 0.0 9.7 2.3 0.1 1.3 3.7 0.7 2.8 0.1 4.5 1.1 0.4 6.6 0.8 0.5 0.0 0.2 3.0 0.0 0.0 0.8 0.0 0.9 3.2 0.0 0.0 0.5 1.5 2.0 0.3 0.0 0.6 0.3 0.1 0.0 1.0 0.3 7.2 0.3 4.0 0.3 0.0 1.0 0.0 0.1 0.0 1.2 0.0 1.2 0.5 0.7 0.1 0.7 3.2 0.0 0.2 0.1 2.9 0.0 0.4 0.9 1.2 0.5 0.6 0.7 0.9 0.7 0.5 0.5 0.5 0.0 0.0 0.0 1.7 0.8 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 374.1 0.6 0.0 0.0 0.0 0.0 0.4 0.5 0.0 2.4 0.0 0.0 0.0 0.0 1.6 785.6 7.8 0.0 0.0 0.0 0.1 0.8 0.0 0.0 3.9 0.1 0.1 0.0 0.5 8.9 5.4 0.1 0.0 0.0 0.0 0.3 ARMC2 "bA787I22.1, DKFZp434P0714" ENSG00000118690 "Armadillo repeat containing 2" Q8NEN0 6 108848416-108974472 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 31.8" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 88.3;Early spermatids: 89.1;Late spermatids: 112.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA025809, HPA053696" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA025809: AB_1845032, HPA053696: AB_2682233" "unprognostic (4.42e-2)" "unprognostic (9.64e-2)" "unprognostic (1.12e-1)" "unprognostic (2.09e-2)" "unprognostic (1.45e-2)" "unprognostic (2.11e-1)" "unprognostic (4.00e-4)" "unprognostic (1.13e-2)" "unprognostic (3.74e-2)" "unprognostic (5.71e-2)" "unprognostic (5.19e-5)" "unprognostic (7.55e-2)" "unprognostic (1.55e-3)" "unprognostic (9.38e-2)" "unprognostic (6.44e-2)" "unprognostic (4.65e-2)" "unprognostic (2.28e-1)" 6.0 5.2 13.3 5.6 19.6 7.8 7.3 9.6 14.7 7.4 4.2 7.9 2.1 2.0 8.2 11.9 3.7 21.5 5.4 9.4 12.2 7.0 4.6 2.8 8.8 4.0 4.0 11.8 6.1 3.3 9.9 20.0 7.0 16.7 4.4 4.9 5.7 3.8 5.2 3.7 5.3 3.5 4.4 6.3 5.8 4.9 31.8 7.1 2.4 11.0 2.8 4.3 4.0 5.0 2.7 4.6 9.5 4.7 4.8 7.0 1.6 3.4 2.1 10.3 6.5 5.1 6.4 2.3 2.1 2.9 5.4 7.2 3.1 3.1 5.4 2.7 3.4 8.3 3.0 5.6 4.2 9.4 1.5 4.8 5.1 4.7 3.2 2.8 7.8 2.3 7.3 5.9 6.2 1.8 7.2 5.0 16.6 2.1 8.4 5.5 2.6 6.7 7.1 3.2 3.3 2.6 7.7 8.5 4.4 4.9 4.1 14.4 5.3 7.3 1.9 5.1 6.0 3.7 4.0 2.5 4.6 2.4 3.8 2.8 3.9 5.2 4.6 7.8 5.5 5.7 4.3 3.5 0.9 3.4 4.7 3.2 1.4 2.7 3.7 2.8 2.7 1.6 3.9 9.5 4.8 3.7 4.6 7.0 1.6 13.3 19.6 9.6 14.7 12.2 7.0 4.0 11.8 16.7 7.1 8.9 3.0 0.0 1.1 0.9 1.5 4.3 2.5 88.3 18.2 0.0 0.0 1.3 0.0 0.8 89.1 1.2 0.0 0.0 0.8 1.7 1.3 0.8 0.0 0.2 3.2 1.6 1.7 0.6 3.7 112.4 6.4 1.3 5.0 0.0 0.3 1.8 0.7 0.0 9.6 1.2 5.2 0.0 2.3 27.6 5.5 1.3 0.5 2.9 0.5 0.7 ARMC5 FLJ13063 ENSG00000140691 "Armadillo repeat containing 5" Q96C12 16 31458080-31467166 "Disease related genes, Predicted intracellular proteins" "Cushing syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 23.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 35.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041524, HPA063706" Approved Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Intracellular and membrane" NA NA "Nucleoplasm, Cytosol" "Focal adhesion sites" "HPA041524: AB_10796676, HPA063706: AB_2685098" "unprognostic (1.37e-1)" "unprognostic (1.68e-3)" "unprognostic (8.22e-3)" "unprognostic (9.96e-2)" "unprognostic (2.59e-1)" "unprognostic (2.94e-3)" "unprognostic (4.09e-2)" "unprognostic (6.14e-3)" "unprognostic (2.37e-1)" "unprognostic (1.11e-1)" "prognostic favorable (1.97e-6)" "unprognostic (4.70e-2)" "unprognostic (3.60e-2)" "unprognostic (1.99e-2)" "unprognostic (2.34e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" 8.3 8.1 6.6 8.1 11.6 35.3 8.4 13.1 13.6 5.3 5.7 7.8 5.5 9.7 9.1 6.0 8.4 7.1 4.9 6.6 8.4 7.5 6.7 16.1 8.4 7.3 8.9 5.4 8.6 9.3 9.2 9.4 7.3 9.1 7.2 2.9 6.5 10.4 5.8 14.2 13.2 8.3 4.5 5.9 8.6 8.0 6.0 8.9 6.8 9.9 6.8 5.3 5.1 16.8 4.0 10.0 2.8 3.1 9.8 4.9 3.2 2.9 4.7 2.1 3.0 1.3 1.0 5.3 3.9 1.7 2.3 1.9 4.4 3.1 2.9 8.2 2.2 2.3 4.5 2.4 3.5 0.4 4.1 6.0 1.3 7.1 10.1 2.5 8.8 8.9 2.4 4.0 2.3 0.6 2.6 3.5 4.9 6.5 7.1 1.6 7.4 3.3 35.4 3.3 1.3 3.0 5.9 3.0 10.8 1.7 3.5 6.7 5.9 3.6 4.9 2.7 1.3 3.2 10.5 6.5 5.0 3.7 2.0 3.2 6.5 5.6 1.8 3.3 7.4 3.5 2.8 3.1 0.9 4.9 1.6 4.1 4.0 3.8 3.8 4.1 3.5 3.4 3.8 1.8 9.8 1.7 10.0 4.6 3.2 6.6 11.6 13.1 13.6 8.4 7.5 8.9 5.4 9.1 8.9 6.0 14.7 4.5 7.9 5.8 3.9 5.6 10.2 1.4 7.9 0.0 5.9 6.2 3.3 4.7 1.0 8.5 10.3 0.0 4.0 4.6 5.8 5.6 9.2 23.6 5.3 12.7 7.5 6.2 4.8 0.0 4.0 3.0 1.7 2.8 5.2 6.8 3.3 3.6 5.3 3.7 5.2 0.0 6.4 3.9 6.1 5.5 9.6 5.0 3.8 4.8 ARMC8 "DKFZP434A043, GID5, HSPC056, VID28" ENSG00000114098 "Armadillo repeat containing 8" Q8IUR7 3 138187248-138298389 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036996, HPA044869" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA036996: AB_10672786, HPA044869: AB_2679123" "unprognostic (2.04e-1)" "unprognostic (1.60e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (2.05e-4)" "unprognostic (3.51e-2)" "unprognostic (2.39e-2)" "prognostic unfavorable (8.90e-5)" "unprognostic (1.96e-1)" "unprognostic (2.04e-2)" "unprognostic (7.48e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (2.15e-4)" "unprognostic (3.27e-2)" "unprognostic (2.03e-1)" "unprognostic (4.06e-2)" "unprognostic (5.51e-2)" "unprognostic (1.18e-1)" 19.4 13.5 16.9 14.3 21.9 43.5 14.5 52.6 26.4 17.1 14.4 16.8 9.4 9.9 15.2 10.8 18.0 13.7 13.0 14.4 16.9 20.9 16.6 13.8 13.9 16.3 17.6 16.1 14.3 11.9 20.5 26.1 16.3 26.3 14.5 15.9 12.5 11.9 15.8 34.6 11.8 13.1 20.6 18.7 16.7 14.2 14.7 19.1 21.3 18.2 12.1 18.4 16.9 12.9 25.6 25.4 40.1 23.8 25.3 26.5 19.3 20.4 10.0 13.2 10.7 16.7 14.8 17.8 15.9 15.4 21.8 21.4 15.7 10.9 19.4 16.4 13.6 25.6 10.8 17.0 15.5 27.0 13.0 12.0 34.5 6.6 10.6 21.2 26.7 38.7 22.0 9.9 14.0 20.2 11.9 17.0 17.0 12.8 11.0 27.0 18.0 18.7 12.6 18.3 15.5 8.8 14.7 21.3 15.4 14.3 19.1 15.4 11.2 22.8 7.9 13.2 18.0 15.7 14.1 18.4 11.7 9.5 15.4 11.6 21.2 16.2 29.7 10.5 12.8 11.5 32.3 22.1 40.1 22.8 23.8 26.0 25.6 21.0 24.0 25.4 22.0 24.6 24.4 15.6 25.3 23.5 11.2 26.5 19.3 16.9 21.9 52.6 26.4 16.9 20.9 17.6 16.1 26.3 19.1 26.8 13.1 26.2 26.3 27.5 36.5 20.9 20.4 10.7 29.6 12.2 31.4 25.9 10.0 17.4 5.7 22.2 15.9 70.0 12.8 23.2 20.3 19.7 33.6 21.2 20.1 41.3 22.5 23.4 25.0 5.8 28.1 27.7 18.6 15.4 15.1 24.5 11.5 20.4 20.8 23.7 42.0 12.9 28.9 44.1 30.6 24.8 28.5 26.1 16.1 24.0 ARMCX1 "ALEX1, GASP7" ENSG00000126947 "Armadillo repeat containing, X-linked 1" Q9P291 X 101550531-101554700 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 9.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 26.9;ASC TERT1: 24.2;BJ hTERT+ SV40 Large T+ RasG12V: 27.8;LHCN-M2: 24.4;RH-30: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000268, HPA005685, CAB020695" Supported Supported Nucleoplasm,Mitochondria,Cytosol No No Mitochondria "Nucleoplasm, Cytosol" "CAB020695: , HPA000268: , HPA005685: AB_10600781" "unprognostic (2.31e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (2.65e-2)" "unprognostic (2.32e-2)" "unprognostic (2.25e-2)" "unprognostic (2.39e-1)" "unprognostic (2.18e-3)" "unprognostic (2.13e-1)" "unprognostic (1.23e-1)" "unprognostic (1.02e-1)" "prognostic favorable (7.32e-5)" "unprognostic (1.02e-1)" "unprognostic (2.85e-2)" "unprognostic (2.20e-3)" "unprognostic (8.77e-2)" "unprognostic (2.12e-2)" "unprognostic (1.09e-2)" 17.5 29.8 13.6 7.4 16.5 2.7 18.9 13.4 21.5 24.4 18.7 9.6 15.9 6.2 27.3 19.0 12.3 16.3 14.8 26.6 13.3 18.4 12.1 3.8 11.6 4.4 13.7 14.6 42.6 10.2 20.1 18.0 12.5 16.4 25.8 7.0 13.0 12.0 21.1 22.7 8.1 7.6 26.3 9.1 11.4 10.0 8.1 10.5 3.5 14.0 11.6 3.3 26.8 29.7 0.2 9.9 0.5 4.3 2.1 3.7 2.1 0.7 0.2 5.6 0.0 26.9 24.2 0.0 8.7 17.2 11.0 27.8 0.0 0.1 0.0 7.5 13.4 12.1 0.7 0.0 1.2 6.2 0.0 0.0 5.0 1.7 0.0 14.2 0.0 0.0 20.2 1.7 8.3 0.0 9.1 6.6 0.0 0.1 0.1 24.4 0.3 0.0 0.0 8.0 0.0 0.0 0.0 30.8 0.0 7.5 0.0 5.5 4.6 0.0 0.1 15.0 1.6 0.9 3.7 8.7 6.7 3.5 19.4 0.1 0.0 0.1 0.0 6.5 0.0 4.1 0.0 4.3 0.5 0.0 3.9 0.7 0.0 0.6 0.3 9.9 0.2 1.5 3.7 0.1 2.1 1.1 5.1 0.9 2.1 13.6 16.5 13.4 19.9 13.3 18.4 13.7 14.6 16.4 10.5 23.8 6.1 0.0 23.8 29.5 26.3 54.8 7.6 5.3 5.7 22.7 5.9 1.4 11.6 14.6 0.3 23.2 0.5 0.0 6.0 2.1 52.1 21.0 24.2 0.4 23.6 20.6 5.2 17.8 9.4 0.9 43.7 11.0 55.6 6.4 1.0 31.1 7.5 0.0 41.8 11.4 13.3 45.3 48.4 1.7 0.7 19.1 2.2 1.0 0.6 7.4 ARMCX2 "ALEX2, GASP9, KIAA0512" ENSG00000184867 "Armadillo repeat containing, X-linked 2" Q7L311 X 101655281-101659891 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 92.7" "Cell type enhanced" "Detected in many" 7 "Sertoli cells: 58.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 48.1;NTERA-2: 34.7;RH-30: 26.6;SuSa: 27.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005761 Enhanced Approved Nucleoplasm,Mitochondria Yes No Mitochondria Nucleoplasm "HPA005761: AB_10600782" "unprognostic (1.33e-1)" "unprognostic (2.26e-2)" "unprognostic (4.25e-2)" "unprognostic (1.48e-1)" "unprognostic (9.59e-2)" "unprognostic (6.96e-2)" "unprognostic (5.00e-2)" "unprognostic (1.87e-1)" "unprognostic (7.17e-2)" "unprognostic (3.41e-2)" "prognostic favorable (3.45e-5)" "unprognostic (9.06e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (2.69e-4)" "unprognostic (1.12e-1)" "unprognostic (6.73e-2)" "unprognostic (1.25e-1)" 7.7 21.5 12.5 6.7 19.9 1.0 14.2 17.6 17.5 17.1 11.4 8.2 38.8 3.7 18.4 92.7 6.2 16.7 12.5 18.8 13.2 17.1 13.3 2.6 8.3 4.9 11.8 13.3 28.8 9.8 34.1 38.9 15.4 12.4 17.6 5.3 9.7 23.6 41.8 3.8 3.2 6.2 19.3 9.0 10.9 8.3 6.3 10.7 1.4 35.1 3.6 4.3 13.9 18.9 7.6 1.6 0.0 1.4 4.3 4.4 1.9 0.0 0.0 14.9 0.1 13.3 12.1 0.1 16.3 20.5 0.4 0.4 0.0 6.3 0.0 0.0 21.4 0.0 0.4 0.0 0.3 0.1 0.0 0.5 0.0 17.5 0.0 14.1 0.1 0.0 19.1 5.2 12.8 0.1 20.2 17.3 0.0 0.0 0.1 48.1 0.0 0.0 0.2 34.7 0.9 0.1 4.0 26.6 0.0 0.8 0.0 6.0 11.1 0.0 0.0 0.4 27.9 7.6 0.0 3.8 18.4 19.6 11.5 0.1 0.0 0.0 0.0 16.8 0.0 0.3 0.0 0.7 0.0 1.6 1.4 0.7 5.1 1.5 1.5 1.1 7.6 4.2 4.4 0.0 4.3 0.9 1.6 0.9 1.9 12.5 19.9 17.6 17.5 13.2 17.1 11.8 13.3 12.4 10.7 14.9 5.4 4.4 13.8 3.8 11.2 22.2 7.6 2.7 15.9 31.4 7.9 1.0 3.3 8.0 0.1 13.0 0.0 0.0 1.8 0.4 20.2 13.8 2.3 0.4 3.6 1.6 8.7 16.0 2.1 0.4 22.5 4.0 5.0 11.8 2.2 7.0 3.1 0.0 23.0 4.2 9.7 58.2 26.4 1.4 1.1 2.6 4.2 2.5 1.2 6.2 ARMCX3 "ALEX3, GASP6" ENSG00000102401 "Armadillo repeat containing, X-linked 3" Q9UH62 X 101622797-101627843 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000325, HPA000967, HPA001530" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA000325: AB_1078206, HPA000967: AB_1078208, HPA001530: AB_2666349" "unprognostic (1.67e-1)" "unprognostic (2.14e-1)" "unprognostic (5.23e-2)" "unprognostic (8.69e-3)" "unprognostic (1.73e-2)" "unprognostic (1.47e-2)" "unprognostic (9.72e-3)" "unprognostic (2.19e-2)" "unprognostic (4.77e-2)" "unprognostic (6.80e-2)" "unprognostic (3.38e-3)" "unprognostic (2.12e-2)" "prognostic favorable (1.55e-5)" "unprognostic (3.29e-2)" "unprognostic (3.13e-1)" "unprognostic (1.07e-2)" "unprognostic (1.55e-2)" 21.0 39.2 26.6 14.8 32.9 8.5 20.5 20.5 36.9 30.6 18.8 21.0 37.1 13.3 26.9 67.8 12.7 17.1 22.0 31.7 28.0 26.6 24.0 17.8 19.1 12.7 27.8 29.6 26.7 38.2 62.0 37.9 28.5 35.4 29.1 14.8 13.6 34.8 31.6 25.5 7.9 13.8 24.6 25.7 24.1 19.0 9.2 22.8 8.2 31.9 17.1 13.7 21.4 21.3 11.6 18.8 25.2 11.8 10.2 14.8 9.4 8.8 6.0 16.4 9.1 37.8 42.2 3.7 19.5 18.8 8.6 24.9 7.1 8.2 3.4 11.2 22.7 17.5 1.7 12.3 7.1 10.5 6.7 7.8 6.3 20.4 10.2 30.0 6.1 15.0 23.3 9.6 10.3 11.1 21.6 16.2 3.8 4.8 30.2 23.3 3.9 5.0 0.2 8.3 16.2 1.3 6.4 21.4 3.0 12.0 3.7 7.6 6.5 9.4 0.6 20.2 23.8 7.1 6.3 22.7 11.4 7.4 25.7 3.8 24.5 6.6 0.0 17.3 4.9 9.6 25.2 11.2 9.5 10.9 11.3 14.8 11.6 10.8 9.5 11.3 7.9 12.2 8.5 4.1 10.2 11.8 18.8 6.6 9.4 26.6 32.9 20.5 36.9 28.0 26.6 27.8 29.6 35.4 22.8 41.7 29.7 51.4 69.7 33.7 60.9 87.7 56.0 14.7 34.2 71.5 55.0 47.1 31.5 41.8 0.5 61.9 17.9 46.7 26.6 17.4 93.4 96.0 76.3 43.1 44.4 58.8 78.9 51.5 46.4 1.1 59.8 60.8 92.8 22.6 46.0 98.2 30.2 24.6 68.2 33.5 12.2 32.3 93.7 1.9 0.4 18.7 96.1 34.6 28.6 71.5 ARMCX4 "CXorf35, GASP4, MGC40053" ENSG00000196440 "Armadillo repeat containing, X-linked 4" X 101418287-101533459 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "parathyroid gland: 10.8" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 24.7;Collecting duct cells: 26.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 9.0;hTEC/SVTERT24-B: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000429, HPA051930" Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA000429: AB_1078210, HPA051930: AB_2681665" "unprognostic (1.92e-1)" "unprognostic (1.91e-1)" "unprognostic (1.07e-2)" "unprognostic (1.10e-2)" "unprognostic (6.91e-3)" "unprognostic (2.81e-3)" "unprognostic (7.28e-2)" "unprognostic (3.67e-4)" "unprognostic (2.33e-2)" "unprognostic (4.29e-1)" "prognostic favorable (8.20e-5)" "unprognostic (1.94e-2)" "unprognostic (1.40e-2)" "unprognostic (6.94e-3)" "unprognostic (1.69e-1)" "unprognostic (1.88e-1)" "unprognostic (4.92e-2)" 1.5 4.6 1.9 0.8 2.7 0.3 2.9 3.2 5.7 2.4 1.7 0.6 4.0 2.8 0.7 2.8 1.1 1.2 2.0 2.9 1.2 0.5 1.5 0.5 1.9 8.5 1.4 10.8 4.3 1.6 4.1 1.6 1.2 5.7 1.6 2.1 1.5 2.8 1.4 1.3 1.3 0.4 2.4 0.5 2.1 1.4 0.0 0.1 0.0 0.0 0.0 0.5 0.0 2.3 0.6 8.2 0.0 4.0 4.2 0.8 5.6 4.4 4.6 9.0 1.9 0.8 0.0 2.2 8.3 0.1 1.0 0.0 0.1 7.6 0.0 0.9 0.6 2.3 0.0 2.3 0.0 3.1 2.6 0.4 10.0 0.0 0.0 8.0 0.0 0.0 0.7 2.0 0.0 0.3 0.3 6.0 0.8 0.0 0.4 6.8 0.0 1.2 1.4 5.6 5.1 0.8 0.0 3.0 1.4 0.6 1.2 3.0 2.1 1.3 6.4 0.0 0.0 0.0 0.0 3.9 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.0 3.0 5.0 0.5 6.3 2.2 24.7 8.7 0.0 14.7 11.4 26.2 7.9 1.4 14.9 2.2 0.2 7.7 2.6 0.0 2.0 0.6 7.0 8.5 3.5 2.1 2.0 22.3 2.9 4.3 4.6 0.4 9.8 2.0 16.9 2.8 2.7 10.8 2.1 3.5 11.7 4.4 7.4 0.0 11.4 1.0 1.2 3.0 1.3 1.8 3.6 3.9 ARMCX6 "FLJ20811, GASP10" ENSG00000198960 "Armadillo repeat containing, X-linked 6" Q7L4S7 X 101615118-101618001 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043030, HPA048125" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Nuclear membrane" "HPA043030: AB_2678277, HPA048125: AB_2680275" "unprognostic (1.20e-1)" "unprognostic (2.80e-1)" "unprognostic (8.82e-3)" "unprognostic (1.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.80e-2)" "unprognostic (1.73e-3)" "unprognostic (1.92e-3)" "unprognostic (4.13e-2)" "unprognostic (1.07e-1)" "unprognostic (2.26e-2)" "unprognostic (3.31e-1)" "unprognostic (3.74e-1)" "unprognostic (1.51e-1)" "unprognostic (2.85e-1)" "unprognostic (7.82e-3)" "unprognostic (2.38e-2)" 15.1 17.2 11.7 12.1 12.1 7.6 12.7 10.9 12.1 18.7 12.0 15.4 22.6 6.7 17.3 25.9 17.3 14.1 12.4 15.6 11.3 12.6 14.1 12.2 11.2 12.1 13.1 10.3 21.3 27.2 23.4 21.0 16.3 13.1 17.7 9.0 11.8 39.2 23.5 6.5 11.3 10.4 17.1 16.7 22.6 10.6 9.0 11.4 17.9 17.3 9.7 19.3 18.8 13.7 12.8 14.1 10.0 7.0 8.1 8.7 6.4 6.6 7.9 12.4 7.0 25.4 15.1 2.4 14.1 13.7 12.6 24.7 4.8 6.5 7.1 14.4 13.2 13.2 7.0 12.0 5.7 9.9 6.1 7.3 6.7 11.0 6.3 11.7 6.5 8.4 9.4 5.8 7.7 4.0 17.6 12.8 3.7 5.5 9.2 18.9 16.4 9.5 0.0 8.9 8.7 1.6 9.8 16.6 2.6 9.1 0.9 6.8 6.4 8.2 0.0 10.5 9.9 5.8 3.1 9.9 15.4 6.9 21.4 3.2 11.4 6.1 0.0 4.6 1.7 5.0 10.0 3.8 6.3 6.5 7.0 8.7 12.8 7.0 7.3 8.1 9.1 8.4 7.8 0.5 8.1 5.0 14.1 3.9 6.4 11.7 12.1 10.9 12.1 11.3 12.6 13.1 10.3 13.1 11.4 8.9 7.8 28.4 14.8 11.8 4.8 8.1 12.7 1.4 6.8 29.6 15.7 31.9 19.9 36.6 0.4 25.1 3.1 0.0 24.2 14.6 30.1 15.7 13.9 13.4 60.4 9.5 15.7 23.4 19.6 1.3 17.3 28.6 35.4 30.7 15.5 28.2 25.6 14.0 18.7 17.2 4.1 25.8 15.6 2.6 2.2 14.1 28.8 33.1 13.8 15.9 ARMT1 "C6orf211, FLJ12910" ENSG00000146476 "Acidic residue methyltransferase 1" Q9H993 6 151452258-151470101 "Predicted intracellular proteins" "DNA damage" "Hydrolase, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003004, HPA005819" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 3200000 "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA003004: AB_1078358, HPA005819: AB_1845741" "unprognostic (5.16e-3)" "prognostic unfavorable (7.09e-4)" "prognostic favorable (4.14e-4)" "unprognostic (6.39e-2)" "unprognostic (1.91e-1)" "unprognostic (1.33e-2)" "unprognostic (1.37e-2)" "unprognostic (9.47e-2)" "unprognostic (2.33e-2)" "unprognostic (2.16e-1)" "unprognostic (2.24e-1)" "unprognostic (3.28e-1)" "unprognostic (3.16e-2)" "unprognostic (1.49e-1)" "unprognostic (9.78e-2)" "unprognostic (4.12e-1)" "unprognostic (1.22e-1)" 15.5 15.8 10.7 11.5 16.2 3.9 20.5 17.5 18.2 13.7 12.8 7.5 9.9 14.7 13.0 13.4 11.5 10.6 9.0 13.4 11.4 13.0 34.7 33.2 15.4 15.0 10.9 8.6 15.3 7.7 7.7 13.8 26.7 18.6 11.6 14.2 9.2 8.8 10.6 14.9 7.0 16.2 11.8 10.6 16.2 10.9 10.8 9.4 13.2 26.5 11.9 14.0 14.1 10.6 9.6 12.3 26.9 18.6 10.8 13.2 10.8 8.2 6.3 13.3 11.9 10.9 17.2 21.5 15.5 13.5 13.0 17.3 16.4 6.8 12.3 10.4 10.9 11.9 8.4 39.3 11.6 22.0 13.6 12.3 8.9 7.5 19.0 13.6 16.6 11.2 13.8 8.2 17.4 10.3 10.8 18.4 9.3 12.7 15.9 16.2 34.3 10.4 16.0 22.7 8.1 5.3 13.8 11.5 9.7 39.8 10.5 5.5 3.6 12.9 12.2 7.9 24.9 34.6 13.1 15.2 6.4 8.9 23.5 12.3 7.4 9.3 14.7 11.3 20.6 7.4 22.8 14.7 26.9 7.8 18.6 10.3 9.6 10.2 8.3 12.3 7.1 9.5 8.7 12.2 10.8 16.6 4.6 13.2 10.8 10.7 16.2 17.5 18.2 11.4 13.0 10.9 8.6 18.6 9.4 23.8 36.8 8.9 7.0 0.0 8.9 16.5 7.6 20.1 11.4 22.7 7.9 26.6 38.1 17.4 0.9 7.7 12.9 23.3 15.6 32.5 8.4 5.6 3.5 43.3 30.5 7.9 4.7 17.2 35.4 2.3 17.8 24.7 0.0 31.5 10.6 14.5 16.3 7.0 13.8 56.4 19.8 0.0 13.7 18.9 17.0 0.0 30.1 12.8 13.8 8.4 ARNT "bHLHe2, HIF-1beta" ENSG00000143437 "Aryl hydrocarbon receptor nuclear translocator" P27540 1 150809705-150876768 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 7 "U-698: 97.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001759, CAB004318" Supported Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB004318: AB_626698, HPA001759: AB_1078213" "unprognostic (1.81e-1)" "unprognostic (8.14e-2)" "unprognostic (6.87e-2)" "unprognostic (5.76e-2)" "unprognostic (1.86e-1)" "unprognostic (4.10e-2)" "unprognostic (9.43e-2)" "unprognostic (5.27e-3)" "unprognostic (5.05e-1)" "unprognostic (3.42e-2)" "unprognostic (1.22e-1)" "unprognostic (9.52e-2)" "unprognostic (1.85e-3)" "unprognostic (2.68e-1)" "unprognostic (4.67e-1)" "unprognostic (6.45e-2)" "unprognostic (6.92e-2)" 23.5 20.8 12.1 14.5 12.6 11.3 25.1 25.4 14.4 28.0 17.2 18.7 12.8 10.9 26.1 14.4 16.6 20.4 17.9 20.0 10.2 8.2 14.4 32.2 21.6 12.0 11.6 9.5 31.8 22.4 16.5 22.9 31.7 12.3 18.2 16.4 28.3 15.2 16.3 25.5 21.9 15.2 22.6 14.0 19.2 16.5 14.9 12.3 18.8 16.1 13.9 18.0 23.0 24.4 6.6 12.7 23.9 15.6 8.0 8.8 9.7 4.0 4.2 6.4 4.8 13.7 13.2 8.6 4.6 9.2 6.4 5.8 3.6 4.2 4.3 4.2 8.3 3.1 4.7 5.8 5.2 5.6 6.9 3.5 5.2 7.2 4.2 7.9 6.1 6.1 10.3 4.9 7.7 6.8 7.7 7.8 5.9 6.6 8.7 6.5 8.0 4.9 3.4 5.2 7.4 3.3 6.2 7.7 6.1 5.0 4.2 4.2 6.3 9.0 6.2 3.6 9.0 7.8 13.4 5.5 5.3 4.8 4.2 4.0 9.9 7.2 97.0 6.5 0.2 3.6 23.9 15.6 13.9 8.8 14.7 7.9 6.2 7.2 8.4 12.7 6.6 7.0 7.1 8.1 8.0 14.7 5.2 7.2 9.7 12.1 12.6 25.4 14.4 10.2 8.2 11.6 9.5 12.3 12.3 11.9 9.3 9.7 7.8 12.6 20.9 10.6 22.9 6.7 11.4 10.4 51.1 20.7 3.3 8.1 4.2 11.7 8.6 0.0 8.5 31.6 20.3 7.2 3.5 36.0 17.1 6.4 19.5 31.9 35.9 2.1 30.0 15.7 10.1 14.4 15.1 7.7 8.6 7.0 30.8 9.3 37.6 12.9 15.0 18.6 15.7 13.4 24.7 10.1 8.0 8.6 ARNT2 "bHLHe1, KIAA0307" ENSG00000172379 "Aryl hydrocarbon receptor nuclear translocator 2" Q9HBZ2 15 80404350-80597937 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 73.2" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 29.2;Intestinal endocrine cells: 22.0;Late spermatids: 28.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 15.9;BJ hTERT+ SV40 Large T+ RasG12V: 16.0;hTERT-RPE1: 16.7;LHCN-M2: 14.3;SK-MEL-30: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001056, CAB005081" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB005081: AB_2243005, HPA001056: AB_1845042" "unprognostic (2.04e-3)" "unprognostic (8.32e-2)" "unprognostic (2.10e-1)" "unprognostic (1.95e-1)" "unprognostic (1.11e-1)" "unprognostic (5.65e-2)" "unprognostic (2.61e-2)" "unprognostic (1.48e-1)" "unprognostic (2.74e-2)" "unprognostic (3.00e-1)" "prognostic favorable (1.46e-6)" "unprognostic (2.20e-1)" "prognostic favorable (7.51e-4)" "unprognostic (2.53e-1)" "unprognostic (2.31e-1)" "unprognostic (3.39e-1)" "unprognostic (3.62e-2)" 1.4 2.3 30.6 2.3 35.5 1.0 1.8 9.1 73.2 4.2 2.4 14.3 0.0 2.0 5.3 7.2 2.3 4.9 2.7 3.7 32.8 17.4 11.5 1.0 4.4 2.3 19.2 23.4 9.3 3.2 4.2 3.6 1.7 11.9 5.1 2.4 2.0 1.5 4.8 7.0 2.3 2.5 3.7 13.2 3.2 3.9 8.0 12.7 0.0 6.0 0.0 2.9 2.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.8 15.9 0.0 0.1 2.0 0.0 6.7 9.5 7.8 16.0 0.0 0.0 0.0 1.7 8.0 4.1 0.2 5.8 0.3 10.1 0.0 1.6 0.2 0.0 0.5 0.5 0.0 4.0 7.6 0.3 3.4 0.1 16.7 0.0 0.0 0.0 0.1 14.3 7.5 0.0 0.0 3.1 0.0 0.1 0.0 0.2 0.0 3.4 11.2 8.4 11.6 0.8 0.1 17.1 1.0 0.3 0.0 0.0 12.5 2.5 0.3 7.9 0.0 0.0 0.0 4.8 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 35.5 9.1 36.0 32.8 17.4 19.2 23.4 11.9 12.7 0.0 2.9 0.0 1.1 1.1 15.4 5.9 0.0 2.7 7.9 3.5 7.9 0.1 11.6 6.4 29.2 0.8 0.0 0.0 0.2 3.3 0.9 1.9 2.3 0.0 0.2 1.6 22.0 0.6 0.0 28.4 0.6 0.6 6.8 0.0 0.9 5.7 3.0 2.8 2.8 0.6 9.2 6.5 2.8 1.1 1.5 0.3 2.3 0.0 0.8 1.1 ARNTL "bHLHe5, BMAL1, JAP3, MOP3, PASD3" ENSG00000133794 "Aryl hydrocarbon receptor nuclear translocator like" O00327 11 13276652-13387266 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB045962, HPA050938" Supported Supported Nucleoplasm,Vesicles "Intracellular and membrane" NA NA Nucleoplasm Vesicles "CAB045962: AB_11124144, HPA050938: AB_2681282" "unprognostic (1.89e-1)" "unprognostic (1.95e-1)" "unprognostic (1.95e-2)" "unprognostic (1.63e-1)" "unprognostic (9.00e-2)" "unprognostic (1.77e-1)" "unprognostic (3.72e-1)" "unprognostic (3.76e-2)" "unprognostic (8.92e-2)" "unprognostic (2.86e-2)" "unprognostic (3.16e-1)" "unprognostic (7.80e-2)" "unprognostic (1.34e-2)" "unprognostic (2.10e-1)" "unprognostic (2.77e-2)" "unprognostic (3.11e-2)" "unprognostic (7.08e-2)" 12.3 28.5 13.4 10.3 13.3 13.4 18.2 24.4 25.2 16.4 10.3 5.7 10.6 11.8 10.4 6.5 9.3 9.7 9.4 8.1 11.5 7.5 11.1 17.3 12.1 15.0 6.7 13.1 21.1 9.8 6.1 17.8 9.2 9.3 7.5 8.9 8.6 11.2 8.2 19.2 27.2 10.9 11.7 9.6 10.4 9.6 16.2 9.3 29.2 17.6 0.7 12.2 8.1 17.0 2.8 6.1 20.0 7.8 9.8 19.7 7.3 6.9 6.7 6.2 4.2 11.9 7.7 4.9 7.0 7.5 6.8 8.1 3.4 10.1 0.1 2.2 5.2 9.9 2.7 4.8 8.4 5.9 11.8 5.1 3.2 5.5 1.7 21.3 1.4 13.2 9.6 22.0 2.5 18.4 5.0 4.9 13.6 1.9 12.4 6.9 3.7 3.3 0.7 1.7 6.0 3.7 4.2 7.8 3.4 6.7 1.6 1.3 12.0 5.8 2.0 6.7 7.0 4.5 5.9 9.5 7.2 5.6 17.0 4.0 3.6 9.5 0.0 7.1 3.7 6.2 4.4 6.7 13.7 14.3 6.9 19.7 2.4 13.4 12.9 6.1 2.8 7.8 9.1 20.0 9.8 7.8 1.1 8.5 7.3 13.4 13.3 24.4 25.2 11.5 7.5 6.7 13.1 9.3 9.3 23.8 16.0 4.2 11.8 27.4 25.4 7.2 10.2 4.0 13.6 1.8 15.7 13.7 14.9 6.0 1.2 6.3 10.2 0.0 5.8 1.7 9.3 5.8 2.3 18.7 7.2 28.6 1.2 12.9 15.1 2.5 11.8 10.5 3.3 9.0 4.7 16.9 5.7 5.9 18.7 7.8 29.1 12.9 8.2 4.1 3.8 28.2 5.3 18.1 3.4 12.1 ARNTL2 "bHLHe6, BMAL2, CLIF, MOP9, PASD9" ENSG00000029153 "Aryl hydrocarbon receptor nuclear translocator like 2" Q8WYA1 12 27332854-27425289 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 30.0" "Cell type enhanced" "Detected in many" 15 "Glandular cells: 33.6;Pancreatic endocrine cells: 57.8;Urothelial cells: 126.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 4.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 35.3;U-2197: 48.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059074 Uncertain Supported Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA059074: AB_2683897" "unprognostic (6.86e-2)" "unprognostic (6.16e-2)" "unprognostic (5.88e-3)" "unprognostic (1.01e-2)" "unprognostic (3.34e-2)" "unprognostic (1.34e-1)" "unprognostic (2.84e-3)" "unprognostic (2.97e-3)" "unprognostic (1.49e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (5.29e-6)" "unprognostic (5.26e-2)" "prognostic unfavorable (1.56e-5)" "unprognostic (7.81e-3)" "unprognostic (2.77e-1)" "unprognostic (1.21e-1)" "unprognostic (2.79e-1)" 3.5 1.3 5.7 9.8 5.9 2.2 3.3 3.6 10.6 6.8 3.1 1.1 0.0 2.9 1.5 0.5 30.0 1.5 3.9 1.9 9.1 2.8 1.6 10.3 2.7 5.0 2.1 6.8 0.9 2.3 2.4 1.5 14.7 2.6 1.9 3.5 0.0 9.2 0.9 1.0 7.7 2.8 4.7 2.0 1.2 10.9 2.8 1.3 3.8 1.2 15.4 21.1 5.9 12.5 0.6 1.4 4.5 0.5 0.5 1.5 0.2 21.9 5.6 1.2 0.4 1.1 3.4 17.7 7.8 10.3 5.1 8.0 5.3 17.1 0.2 4.4 3.7 15.8 9.1 3.6 27.4 13.1 35.3 4.7 4.2 3.7 4.4 1.5 8.5 1.8 1.2 2.4 17.8 14.0 8.8 23.9 5.3 2.1 9.0 5.8 2.6 4.6 4.6 9.7 7.5 19.7 8.6 20.7 1.3 4.3 12.6 4.1 0.7 4.0 0.6 0.1 3.1 0.8 2.8 16.2 16.6 9.6 48.3 32.2 1.3 2.4 0.0 14.3 6.9 3.2 4.5 0.5 0.5 0.2 0.3 0.2 0.5 0.2 0.2 1.4 0.6 0.2 0.3 2.4 0.5 0.2 0.3 1.5 0.2 5.7 5.9 3.6 10.6 9.1 2.8 2.1 6.8 2.6 1.3 3.0 2.2 0.0 32.7 0.7 1.1 0.8 17.8 0.0 7.9 8.7 0.0 1.3 0.0 22.0 3.3 4.2 0.7 0.0 23.8 3.5 2.3 33.6 0.0 4.2 1.3 0.0 1.2 3.1 2.8 3.0 0.0 5.0 1.7 26.2 2.7 0.0 57.8 0.0 0.0 0.6 0.0 0.0 2.1 3.4 4.9 1.9 3.5 0.0 0.6 126.8 ARPC2 "ARC34, p34-Arc" ENSG00000163466 "Actin related protein 2/3 complex subunit 2" O15144 2 218217094-218254356 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "monocytes: 1874.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001994, HPA008352, HPA052703" Approved Supported Nucleoplasm NA NA 24000000 Nucleoplasm "CAB001994: , HPA008352: AB_1854887, HPA052703: " "unprognostic (7.42e-2)" "unprognostic (4.07e-1)" "unprognostic (1.50e-1)" "unprognostic (3.28e-3)" "unprognostic (2.77e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (3.63e-5)" "unprognostic (3.23e-2)" "unprognostic (1.90e-2)" "unprognostic (4.07e-2)" "unprognostic (3.95e-3)" "unprognostic (6.25e-2)" "prognostic unfavorable (1.07e-7)" "unprognostic (1.97e-1)" "unprognostic (1.04e-1)" "unprognostic (1.01e-2)" "unprognostic (7.41e-2)" 46.9 28.8 32.6 78.6 37.9 79.5 67.1 19.3 31.4 34.1 42.5 19.9 26.3 34.0 37.2 35.8 103.4 30.2 51.2 52.3 40.7 25.0 38.2 35.1 71.8 118.3 26.4 27.8 30.7 31.2 18.9 23.0 67.1 26.8 35.6 48.6 23.7 39.0 32.7 60.1 56.2 59.2 69.1 23.9 73.7 43.8 36.5 22.3 59.0 27.2 72.7 102.5 58.5 49.7 60.6 101.2 167.7 145.0 50.0 76.2 149.4 47.6 20.9 30.1 22.4 40.4 54.4 56.0 74.6 72.0 63.0 63.4 64.8 50.8 39.0 40.7 84.7 45.6 55.6 40.7 110.3 74.3 32.4 29.0 39.6 31.6 35.5 45.3 82.5 111.9 36.1 89.3 63.0 52.3 59.3 82.2 33.4 18.7 77.1 96.5 33.0 44.8 96.8 35.8 55.1 20.4 34.1 26.6 53.0 63.4 87.0 17.7 32.3 27.2 30.2 64.0 65.2 21.8 76.0 71.5 82.1 31.5 36.8 55.8 42.0 44.4 68.0 59.5 51.9 61.7 106.1 97.2 143.7 75.0 131.3 50.2 60.6 58.9 72.7 101.2 47.6 42.1 62.0 167.7 50.0 145.0 56.1 76.2 149.4 32.6 37.9 19.3 31.4 40.7 25.0 26.4 27.8 26.8 22.3 265.0 262.5 474.2 568.5 824.8 84.9 120.6 224.2 202.1 246.9 164.0 53.0 815.9 290.1 578.5 498.2 333.2 468.4 23.3 579.0 1225.3 410.2 308.1 398.0 92.5 1003.6 55.6 306.9 268.2 655.6 636.8 198.2 927.3 393.1 1874.7 258.1 106.0 656.4 469.9 306.9 244.6 80.4 297.5 339.0 278.1 210.5 848.4 874.6 601.9 267.4 1012.4 ARPC3 "ARC21, p21-Arc" ENSG00000111229 "Actin related protein 2/3 complex subunit 3" O15145 12 110434825-110450422 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006550 Approved Uncertain Nucleoplasm NA NA 38000000 Nucleoplasm "HPA006550: AB_1854869" "unprognostic (1.83e-1)" "unprognostic (4.21e-3)" "unprognostic (4.15e-1)" "unprognostic (4.26e-3)" "unprognostic (2.89e-1)" "unprognostic (1.11e-3)" "unprognostic (1.10e-2)" "unprognostic (6.71e-2)" "unprognostic (2.89e-2)" "unprognostic (1.84e-2)" "prognostic unfavorable (4.67e-4)" "unprognostic (9.96e-2)" "prognostic unfavorable (2.22e-11)" "unprognostic (3.00e-1)" "unprognostic (5.83e-2)" "unprognostic (2.05e-2)" "unprognostic (1.79e-3)" 47.9 50.5 47.4 65.2 50.0 123.1 65.3 21.3 61.0 40.2 58.9 29.4 31.4 47.2 35.9 56.9 88.1 32.4 49.4 39.7 44.6 39.1 64.3 54.0 86.0 143.3 41.1 38.0 27.6 51.5 23.8 41.9 58.4 34.4 34.4 63.9 23.1 51.2 37.6 23.9 35.5 52.2 40.1 49.6 93.9 47.8 29.3 35.0 65.7 38.6 49.8 99.3 61.6 47.2 59.7 83.9 136.8 111.0 33.9 50.9 102.9 48.8 39.2 35.1 21.9 36.5 69.6 46.4 55.6 60.8 66.7 65.6 42.1 39.1 70.9 41.6 61.1 41.2 38.3 37.8 57.0 72.8 40.9 46.1 61.3 17.4 40.7 59.9 60.5 96.3 48.8 61.9 42.2 39.2 83.7 82.9 49.1 38.8 19.4 82.2 38.6 72.2 149.3 34.1 57.1 47.3 56.4 20.3 60.1 115.7 62.7 39.1 39.0 37.4 52.7 46.2 53.7 85.2 102.4 69.8 40.2 22.6 35.4 38.0 38.5 55.4 99.6 52.7 61.4 47.3 89.4 83.8 134.8 32.1 97.9 29.0 59.7 32.9 35.7 83.9 52.2 24.8 32.1 136.8 33.9 111.0 53.8 50.9 102.9 47.4 50.0 21.3 61.0 44.6 39.1 41.1 38.0 34.4 35.0 175.7 264.9 449.7 241.0 141.6 37.6 43.7 229.3 270.4 177.5 254.7 11.8 446.1 490.7 567.2 84.2 191.2 402.9 140.2 470.4 667.1 173.4 288.5 473.1 161.8 1260.7 50.9 263.3 228.9 810.9 28.3 159.6 1039.3 227.7 769.2 436.5 125.5 569.7 627.8 148.2 609.1 28.3 245.8 164.8 185.1 179.4 150.3 603.5 401.3 343.1 512.2 ARRB1 ARR1 ENSG00000137486 "Arrestin beta 1" P49407 11 75264182-75351705 "Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Transport" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 43.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 37.5" "Group enriched" "Detected in many" 5 "dendritic cells: 12.7;granulocytes: 14.7;monocytes: 37.5" "Cell line enhanced" "Detected in many" "HEL: 49.9;RH-30: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003763, HPA049318, HPA070249" Approved Supported Nucleoplasm NA NA 2100000 Nucleoplasm "CAB003763: AB_562248, HPA049318: AB_2680711, HPA070249: AB_2732151" "unprognostic (3.40e-1)" "unprognostic (8.37e-2)" "unprognostic (1.63e-1)" "unprognostic (1.88e-1)" "unprognostic (2.35e-1)" "unprognostic (3.27e-3)" "unprognostic (1.33e-2)" "unprognostic (1.15e-2)" "unprognostic (1.23e-2)" "unprognostic (1.35e-1)" "unprognostic (2.73e-1)" "unprognostic (9.35e-2)" "unprognostic (2.34e-2)" "unprognostic (2.29e-1)" "unprognostic (7.10e-2)" "unprognostic (3.90e-1)" "unprognostic (1.26e-1)" 20.9 5.4 27.7 14.7 31.7 9.6 15.9 24.4 36.7 6.9 17.8 11.2 2.0 15.4 7.6 4.5 13.8 12.1 9.2 12.2 25.0 16.0 9.1 7.4 37.3 9.7 19.1 25.7 12.5 28.8 1.8 3.3 17.7 21.8 12.0 16.9 10.1 8.5 7.5 7.2 11.6 18.5 15.9 6.4 26.5 23.1 3.1 19.0 3.8 6.4 3.9 7.2 13.2 7.9 0.1 12.7 14.7 37.5 3.9 3.6 10.9 1.5 7.0 7.3 3.5 6.4 5.5 15.1 1.5 5.2 1.9 1.3 10.3 7.2 0.6 18.0 1.4 1.4 0.3 2.9 0.0 0.7 0.0 1.6 49.9 0.9 6.1 1.6 1.4 19.3 2.7 0.3 3.2 0.0 2.3 21.6 1.8 24.2 0.0 3.7 4.0 0.9 16.8 5.4 21.0 2.1 5.5 34.8 1.9 7.7 6.2 3.8 4.0 2.6 18.5 4.5 16.2 13.6 8.1 18.0 1.4 1.9 5.8 0.1 0.0 0.0 0.0 1.0 23.3 1.7 8.3 19.8 13.0 3.6 31.3 1.3 0.1 1.7 2.0 12.7 0.0 1.5 2.1 14.7 3.9 37.5 0.2 1.5 10.9 27.7 31.7 24.4 36.7 25.0 16.0 19.1 25.7 21.8 19.0 26.8 15.0 2.7 1.7 1.6 1.8 4.0 5.1 5.3 5.7 3.5 5.9 36.0 1.7 4.3 1.6 14.3 24.1 0.0 7.4 1.2 6.0 4.6 23.1 1.8 34.3 0.0 5.2 22.7 43.2 11.6 14.7 20.6 3.3 21.6 8.2 0.2 7.3 17.5 15.6 0.0 0.9 12.9 5.3 0.0 0.6 2.6 28.1 6.9 20.0 2.6 ARRB2 "ARR2, BARR2, DKFZp686L0365" ENSG00000141480 "Arrestin beta 2" P32121 17 4710489-4721499 "Predicted intracellular proteins" "Protein transport, Transport" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 102.8;lymphoid tissue: 66.6" "Cell type enhanced" "Detected in many" 11 "Hofbauer cells: 226.1;Kupffer cells: 213.1;Macrophages: 203.0;monocytes: 348.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 42.4;HMC-1: 71.5;NB-4: 43.0;U-937: 61.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075177 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA075177: " "unprognostic (1.12e-1)" "prognostic favorable (2.93e-5)" "unprognostic (1.09e-1)" "unprognostic (1.47e-1)" "unprognostic (7.43e-2)" "unprognostic (3.37e-2)" "unprognostic (2.62e-3)" "unprognostic (3.85e-2)" "unprognostic (3.05e-2)" "unprognostic (2.58e-1)" "unprognostic (1.66e-3)" "prognostic unfavorable (2.61e-5)" "unprognostic (1.32e-2)" "unprognostic (8.61e-2)" "unprognostic (4.92e-2)" "unprognostic (1.49e-1)" "unprognostic (1.88e-1)" 21.6 15.6 23.7 47.8 18.3 102.8 10.0 28.1 26.3 8.7 16.1 20.4 1.9 23.0 7.4 7.8 7.1 10.8 14.8 10.2 27.3 20.9 10.5 15.6 35.0 31.3 20.1 19.6 8.7 8.3 6.6 10.2 16.0 19.7 7.4 13.2 10.7 8.7 6.2 5.5 5.8 21.0 13.7 21.7 66.6 12.5 5.0 18.3 23.5 6.4 3.2 17.0 15.7 7.1 2.2 18.0 52.9 32.8 5.9 11.4 16.0 3.7 19.9 7.8 7.5 1.5 2.2 4.1 2.9 4.0 8.7 10.9 6.8 3.1 10.4 2.7 2.2 4.2 6.3 12.9 4.1 9.0 24.8 18.8 42.4 10.1 12.0 2.3 18.8 71.5 2.0 5.3 10.7 4.3 5.7 6.6 19.7 2.8 10.5 1.9 6.6 18.8 43.0 4.2 10.0 4.1 22.2 6.9 11.6 3.0 2.0 8.1 11.2 6.6 11.5 5.1 3.4 5.5 8.9 5.7 3.3 6.6 5.6 11.1 4.4 5.9 5.9 8.7 61.3 4.8 22.6 30.4 52.5 11.0 31.5 7.8 2.2 7.1 11.4 18.0 1.9 6.8 9.0 52.9 5.9 32.8 4.4 6.0 16.0 23.7 18.3 28.1 26.3 27.3 20.9 20.1 19.6 19.7 18.3 20.8 44.9 18.5 7.0 10.2 17.4 8.1 10.2 8.1 18.2 3.5 2.0 4.8 13.3 8.8 0.4 9.2 10.3 0.0 6.2 9.4 8.1 3.9 91.4 12.1 226.1 20.6 8.1 19.6 213.1 1.8 4.6 203.0 10.1 348.1 14.3 4.7 7.6 17.3 4.6 12.9 7.5 19.4 5.4 0.5 11.8 7.3 5.0 76.9 11.9 10.5 ARRDC2 "CLONE24945, PP2703" ENSG00000105643 "Arrestin domain containing 2" Q8TBH0 19 18001132-18014102 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 60.7" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 53.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 28.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053788, HPA074216" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA053788: AB_2682262, HPA074216: " "unprognostic (8.10e-2)" "prognostic favorable (5.93e-4)" "unprognostic (2.20e-3)" "unprognostic (8.67e-2)" "unprognostic (4.81e-3)" "unprognostic (4.26e-3)" "unprognostic (1.82e-1)" "unprognostic (1.06e-1)" "unprognostic (4.40e-2)" "prognostic unfavorable (5.84e-4)" "unprognostic (1.16e-1)" "unprognostic (8.37e-2)" "unprognostic (4.87e-3)" "unprognostic (7.26e-2)" "unprognostic (1.01e-1)" "prognostic favorable (6.91e-4)" "prognostic favorable (2.92e-4)" 26.7 5.3 10.4 12.5 34.6 39.3 27.7 3.2 19.5 10.9 9.6 28.3 7.3 6.9 7.6 4.7 8.1 8.5 13.1 8.5 14.1 8.2 10.7 9.8 22.6 19.0 47.5 9.0 4.9 6.2 18.7 5.7 8.1 20.1 10.1 7.2 6.0 15.3 11.6 60.7 9.4 13.3 6.7 16.8 18.7 12.1 3.2 32.9 10.5 14.3 4.9 19.1 9.3 11.3 5.9 3.1 3.7 6.3 7.2 16.0 4.7 5.8 10.7 0.2 5.4 4.5 4.1 4.2 3.4 9.8 2.9 2.9 2.4 11.6 11.0 9.8 2.9 4.7 4.0 4.3 3.1 2.3 7.1 6.3 8.4 8.3 3.3 4.1 6.3 12.4 4.4 5.0 3.3 5.1 5.4 4.9 7.1 9.6 0.3 2.7 9.1 4.8 17.5 1.3 13.2 17.7 28.3 0.1 8.2 4.2 5.5 2.6 2.6 5.6 5.7 5.7 0.9 3.4 16.3 10.4 5.0 3.9 16.9 4.3 0.8 0.0 12.4 8.1 24.2 3.9 3.7 6.3 3.7 4.0 5.2 2.8 3.9 6.7 5.1 3.1 5.9 16.0 8.4 2.4 7.2 5.4 2.0 5.0 4.7 10.4 34.6 3.2 19.5 14.1 8.2 47.5 9.0 20.1 32.9 14.9 16.2 24.9 14.4 5.7 0.4 6.2 53.5 16.0 7.9 8.7 0.0 0.6 1.7 8.3 0.7 27.0 6.6 0.0 5.6 7.1 7.8 19.7 26.5 5.4 16.7 0.0 17.7 15.4 24.0 1.0 4.4 39.6 5.0 8.2 8.7 0.9 10.8 7.8 7.1 0.3 0.4 12.9 14.6 0.5 3.7 6.1 1.0 20.8 5.2 23.1 ARSK "DKFZp313G1735, TSULF" ENSG00000164291 "Arylsulfatase family member K" Q6UWY0 5 95555074-95605064 "Plasma proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Extravillous trophoblasts: 43.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042384 Approved Approved Nucleoplasm,Vesicles "Secreted in other tissues" NA NA Vesicles Nucleoplasm "HPA042384: AB_10795703" "unprognostic (9.50e-2)" "unprognostic (1.37e-1)" "unprognostic (2.03e-3)" "unprognostic (2.39e-1)" "unprognostic (3.33e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (2.59e-4)" "unprognostic (3.39e-1)" "unprognostic (1.37e-1)" "unprognostic (5.19e-2)" "unprognostic (7.61e-2)" "unprognostic (2.07e-1)" "unprognostic (3.74e-2)" "unprognostic (1.91e-2)" "unprognostic (2.32e-1)" "unprognostic (8.20e-2)" "unprognostic (1.06e-2)" 8.5 10.2 6.9 4.8 7.6 4.7 7.6 14.2 12.3 8.9 8.6 4.3 9.6 5.1 8.5 9.6 6.7 7.4 6.9 8.5 7.9 7.1 11.5 9.7 7.4 5.6 8.4 9.9 12.8 11.7 29.3 14.5 11.2 7.2 10.7 5.9 7.3 6.7 11.2 5.5 8.4 5.4 6.7 8.8 5.5 9.7 4.5 7.5 10.6 15.8 2.8 4.5 9.2 14.0 6.7 2.7 10.0 1.6 3.9 9.2 2.3 3.4 2.2 4.6 4.6 23.2 12.1 6.7 10.9 6.3 4.3 8.8 2.8 5.4 4.7 5.7 3.7 7.7 3.3 4.0 6.9 9.4 5.0 5.9 3.7 5.5 4.5 6.8 2.0 3.0 8.9 6.2 6.5 4.2 9.0 6.9 6.4 3.7 5.1 9.4 1.6 5.6 3.9 6.0 1.1 10.5 3.5 7.4 7.4 9.8 0.8 3.3 3.3 6.7 2.2 6.5 6.7 6.2 2.2 12.4 6.8 5.5 10.5 6.6 4.4 7.4 5.6 6.8 5.5 25.2 10.0 1.6 2.5 5.3 1.5 6.1 5.3 6.0 6.7 0.8 6.7 9.2 6.9 1.5 3.9 1.0 2.7 4.5 2.3 6.9 7.6 14.2 12.3 7.9 7.1 8.4 9.9 7.2 7.5 3.0 2.1 2.7 7.4 3.9 8.1 3.9 2.5 5.3 2.3 7.0 11.8 9.0 3.3 3.0 6.3 5.4 2.5 0.0 2.2 43.9 10.4 4.5 23.0 12.1 3.9 9.5 2.9 3.7 3.1 1.8 10.0 5.2 5.0 6.4 1.8 13.2 1.9 3.5 11.0 4.5 9.1 0.0 8.3 2.2 7.9 6.0 4.2 9.6 3.0 1.6 ASAP3 "CENTB6, DDEFL1, FLJ20199, UPLC1" ENSG00000088280 "ArfGAP with SH3 domain, ankyrin repeat and PH domain 3" Q8TDY4 1 23428563-23484568 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.6" "Lineage enhanced" "Detected in single" "monocytes: 1.6" "Cell line enhanced" "Detected in many" "ASC diff: 19.6;ASC TERT1: 18.6;HSkMC: 23.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020537, HPA020546" Approved Supported Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA020537: AB_2670467, HPA020546: AB_2670470" "unprognostic (2.51e-1)" "unprognostic (2.70e-2)" "unprognostic (4.35e-3)" "prognostic unfavorable (5.56e-4)" "unprognostic (3.87e-1)" "unprognostic (2.24e-2)" "unprognostic (1.19e-3)" "prognostic favorable (2.80e-4)" "unprognostic (1.88e-2)" "prognostic unfavorable (8.30e-4)" "unprognostic (2.24e-1)" "unprognostic (1.18e-1)" "prognostic favorable (5.12e-5)" "unprognostic (3.39e-3)" "unprognostic (3.92e-2)" "unprognostic (2.02e-2)" "unprognostic (7.27e-2)" 10.6 15.5 8.7 5.9 9.9 0.7 15.2 2.6 8.3 11.0 8.9 6.6 13.5 2.4 7.9 7.7 12.9 8.7 7.8 20.7 6.9 5.1 10.7 7.4 7.9 2.3 9.2 6.1 29.6 13.7 13.7 7.4 12.4 16.3 12.0 6.8 8.2 14.6 25.5 24.2 32.5 3.7 9.9 15.4 1.9 8.9 9.4 6.7 0.2 12.0 12.0 6.2 7.0 17.7 0.1 0.0 0.0 1.6 0.0 0.4 0.4 1.0 1.0 10.6 6.9 19.6 18.6 13.1 1.9 2.3 3.0 3.8 0.7 0.0 5.4 2.2 3.7 1.7 5.0 7.3 1.7 1.7 0.2 0.9 0.3 2.8 6.8 10.6 0.0 0.5 23.7 2.7 4.7 4.3 8.9 2.3 0.8 3.6 0.0 1.8 2.2 0.7 0.0 1.8 2.9 2.5 2.8 1.1 0.0 2.0 2.1 0.4 3.6 8.3 2.1 2.1 5.5 7.9 0.0 0.8 1.2 3.2 3.6 0.1 2.3 2.3 0.6 0.5 0.0 0.7 0.0 0.2 0.0 0.0 0.7 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.6 0.0 0.0 0.4 8.7 9.9 2.6 8.3 6.9 5.1 9.2 6.1 16.3 6.7 8.9 7.0 0.0 1.7 1.8 1.0 11.6 0.0 2.7 2.3 3.5 0.0 1.6 3.3 4.0 3.5 3.1 2.1 0.0 5.2 32.0 6.7 3.3 1.1 3.4 1.6 0.0 1.2 3.7 0.0 5.6 11.5 0.4 0.0 0.0 7.0 7.5 4.0 0.0 12.7 4.9 0.5 0.0 1.9 6.0 8.1 3.8 1.1 0.0 3.7 1.1 ASB1 ASB-1 ENSG00000065802 "Ankyrin repeat and SOCS box containing 1" Q9Y576 2 238426742-238452250 "Predicted intracellular proteins" "Ubl conjugation pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003508 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA003508: AB_1845065" "unprognostic (1.02e-1)" "unprognostic (5.30e-2)" "unprognostic (9.58e-2)" "prognostic unfavorable (4.89e-5)" "unprognostic (4.04e-1)" "unprognostic (2.29e-1)" "prognostic unfavorable (5.37e-4)" "unprognostic (3.49e-2)" "unprognostic (5.81e-2)" "unprognostic (1.50e-2)" "prognostic favorable (1.56e-4)" "unprognostic (3.70e-2)" "unprognostic (2.36e-2)" "unprognostic (2.92e-1)" "unprognostic (1.07e-1)" "unprognostic (1.43e-1)" "unprognostic (2.19e-1)" 9.2 8.4 17.0 10.9 19.7 3.8 7.7 9.3 18.4 7.1 8.7 16.2 7.8 5.8 12.0 5.9 7.5 9.3 7.8 22.0 16.1 14.7 8.0 6.2 7.6 10.5 18.0 12.7 15.3 6.6 15.1 8.8 4.9 15.6 9.8 7.2 9.3 5.4 12.1 26.2 8.3 7.8 11.8 18.8 7.8 7.6 14.0 11.3 9.0 8.2 9.3 11.7 7.1 6.5 5.5 4.2 1.4 1.1 3.0 6.7 1.9 4.9 7.1 9.8 7.8 6.3 6.6 7.9 13.6 9.0 8.1 9.2 3.4 3.5 4.3 1.9 12.7 18.3 5.4 9.6 21.5 13.0 10.8 7.9 5.4 6.4 8.5 14.6 7.4 7.2 7.0 9.9 23.9 32.5 12.9 3.5 7.6 11.3 2.9 15.0 3.3 4.0 7.8 10.4 4.3 6.1 5.8 19.9 2.8 5.9 6.7 7.9 10.7 4.2 3.1 7.0 6.1 2.3 7.9 7.5 14.9 9.7 11.6 26.9 10.6 6.5 7.4 23.4 2.3 7.4 0.0 0.8 1.4 6.7 1.1 3.5 5.5 4.7 6.5 0.9 3.3 4.1 4.9 0.3 3.0 0.6 4.2 5.5 1.9 17.0 19.7 9.3 18.4 16.1 14.7 18.0 12.7 15.6 11.3 8.9 3.0 14.1 23.6 7.0 10.6 40.0 20.4 14.7 6.8 8.7 3.9 11.2 1.7 15.7 27.1 3.8 5.1 23.3 18.1 23.0 14.5 14.7 16.1 9.9 23.2 9.5 12.2 4.9 14.2 15.0 7.2 9.5 6.8 14.4 5.2 8.0 22.5 17.3 13.8 10.2 5.7 25.8 12.7 37.9 35.5 5.9 4.8 15.8 6.0 11.6 ASB13 "FLJ13134, MGC19879" ENSG00000196372 "Ankyrin repeat and SOCS box containing 13" Q8WXK3 10 5638867-5666595 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 44.9;Hepatocytes: 52.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 30.0;RPMI-8226: 31.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048293, HPA061742" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA048293: AB_2680344, HPA061742: AB_2684599" "unprognostic (3.64e-2)" "unprognostic (3.60e-1)" "unprognostic (7.39e-2)" "unprognostic (2.21e-2)" "unprognostic (4.83e-2)" "unprognostic (2.77e-2)" "unprognostic (1.74e-1)" "unprognostic (2.47e-1)" "unprognostic (2.90e-2)" "unprognostic (2.87e-1)" "unprognostic (6.93e-2)" "unprognostic (3.42e-2)" "unprognostic (4.58e-3)" "unprognostic (1.16e-2)" "unprognostic (3.03e-1)" "unprognostic (2.87e-2)" "unprognostic (1.40e-2)" 7.7 14.0 5.8 5.8 7.3 2.7 10.8 12.2 18.2 7.4 23.7 7.3 6.9 21.6 6.5 11.0 7.5 11.8 9.6 7.9 5.3 5.8 18.4 28.5 5.4 14.7 5.8 5.5 13.6 8.4 2.8 5.9 3.3 8.7 6.7 5.9 41.1 6.1 6.3 8.1 8.1 26.4 5.1 5.1 7.0 6.9 4.7 4.9 2.1 4.6 7.0 11.7 9.3 8.6 2.3 10.8 0.4 9.5 0.8 3.5 5.2 4.7 6.1 2.7 11.8 11.5 3.1 4.7 0.8 2.2 2.7 3.5 5.2 9.1 30.0 7.4 1.8 1.1 7.5 6.2 6.2 0.5 1.4 10.5 4.3 3.8 4.0 7.3 3.9 0.4 5.0 10.0 1.7 2.3 3.3 2.5 8.0 5.3 0.6 0.8 3.4 4.6 3.6 5.6 14.2 3.7 1.9 0.2 31.9 3.8 7.7 5.3 12.4 5.8 3.9 9.4 0.8 12.3 5.0 0.6 1.7 2.9 7.0 2.5 1.4 3.7 20.1 5.2 10.1 1.3 0.0 9.5 0.2 1.2 6.7 2.1 1.5 3.5 1.5 10.8 2.3 3.5 1.6 0.4 0.8 5.0 0.3 0.9 5.2 5.8 7.3 12.2 18.2 5.3 5.8 5.8 5.5 8.7 4.9 0.0 7.2 0.0 1.5 1.4 44.9 6.9 7.6 6.7 5.7 1.8 17.7 4.6 5.0 4.6 0.6 3.7 18.4 0.0 4.0 1.2 5.8 2.3 3.5 52.1 6.5 15.9 4.1 3.7 11.9 0.0 12.4 4.5 8.5 1.8 6.5 8.5 3.8 11.2 20.1 25.4 11.4 6.5 8.1 0.2 2.2 1.5 1.7 2.5 11.7 1.0 ASB2 ASB-2 ENSG00000100628 "Ankyrin repeat and SOCS box containing 2" Q96Q27 14 93934153-93976791 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 96.9" "Cell type enhanced" "Detected in some" 17 "Cardiomyocytes: 40.8;Early spermatids: 26.4;Late spermatids: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in many" 8 "eosinophil: 23.1" "Lineage enriched" "Detected in many" 8 "granulocytes: 23.1" "Cell line enhanced" "Detected in some" "Karpas-707: 8.8;RPMI-8226: 8.0;U-266/70: 24.0;U-266/84: 5.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA001546 Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA001546: AB_1078224" "unprognostic (5.65e-4)" "unprognostic (8.19e-2)" "unprognostic (1.31e-1)" "prognostic favorable (3.62e-6)" "unprognostic (4.11e-2)" "unprognostic (1.61e-1)" "unprognostic (5.29e-2)" "unprognostic (1.05e-3)" "unprognostic (4.25e-2)" "unprognostic (1.48e-2)" "unprognostic (2.51e-2)" "unprognostic (1.89e-1)" "unprognostic (2.49e-7)" "unprognostic (2.51e-3)" "unprognostic (2.12e-1)" "unprognostic (2.01e-2)" "unprognostic (2.27e-1)" 3.1 0.5 0.2 7.9 0.8 0.4 0.5 0.2 1.7 7.4 14.0 0.0 4.6 2.2 11.9 5.7 7.2 6.5 7.7 17.2 0.2 0.2 0.3 0.3 0.8 2.3 0.3 0.6 2.3 0.3 0.3 0.2 0.3 0.5 8.5 1.5 1.5 1.6 5.8 96.9 0.5 4.4 24.4 0.3 1.5 5.0 0.3 0.0 0.0 0.7 25.7 4.7 14.3 4.5 0.9 2.6 23.1 3.0 0.0 1.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 24.0 5.3 0.8 0.2 2.5 0.5 0.0 0.0 23.1 0.8 1.0 0.1 0.9 0.8 1.7 2.6 0.2 0.1 0.2 0.0 0.0 3.0 0.1 1.1 0.5 0.2 0.8 0.2 1.7 0.2 0.2 0.3 0.6 0.5 0.0 0.0 0.0 1.4 0.0 0.3 0.0 40.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 26.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 20.6 0.3 1.0 1.7 9.0 0.0 0.9 0.3 0.0 0.4 0.0 1.1 0.0 3.1 0.9 5.9 0.1 2.4 6.9 0.0 0.1 ASB7 ENSG00000183475 "Ankyrin repeat and SOCS box containing 7" Q9H672 15 100602534-100651705 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003300 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA003300: AB_1845071" "unprognostic (1.38e-1)" "unprognostic (3.48e-2)" "unprognostic (3.91e-2)" "unprognostic (4.65e-2)" "unprognostic (1.37e-1)" "unprognostic (1.82e-1)" "unprognostic (1.20e-1)" "unprognostic (5.55e-2)" "unprognostic (1.34e-1)" "unprognostic (1.55e-2)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" "unprognostic (2.18e-2)" "unprognostic (3.09e-2)" "unprognostic (1.10e-1)" "unprognostic (2.17e-1)" "unprognostic (1.46e-2)" 8.6 8.9 8.9 15.5 11.9 20.2 10.2 12.7 10.2 10.3 12.1 8.1 13.5 8.3 11.6 12.5 10.0 10.9 9.5 7.0 10.4 8.3 12.5 12.1 8.8 12.9 10.6 6.7 11.2 11.0 13.7 11.8 14.0 9.4 10.1 11.8 7.6 10.3 11.3 8.0 9.5 15.5 11.2 9.7 10.4 8.3 13.8 9.2 21.2 11.5 9.6 11.1 11.6 9.2 6.6 7.0 13.6 8.0 5.5 9.4 6.3 6.2 14.0 6.4 7.7 8.6 9.3 7.5 7.0 12.6 11.6 12.2 8.4 12.8 10.3 6.4 8.9 11.5 14.1 8.9 9.0 12.2 7.2 9.6 13.7 9.3 8.3 13.0 8.0 12.1 8.9 10.1 9.5 15.7 11.2 10.7 11.4 8.0 8.7 6.6 6.8 6.2 8.1 6.1 14.1 6.8 8.5 14.0 8.5 11.5 14.2 6.4 9.2 10.7 10.5 14.4 12.8 7.4 10.1 8.1 10.3 9.6 7.1 9.7 10.5 21.6 9.9 7.9 7.4 8.0 1.7 8.0 13.6 7.6 6.5 6.1 6.3 6.7 9.3 7.0 6.6 9.4 6.7 7.3 5.5 4.1 4.5 7.7 6.3 8.9 11.9 12.7 10.2 10.4 8.3 10.6 6.7 9.4 9.2 0.0 4.8 3.2 2.1 5.8 4.0 3.4 10.2 9.4 6.8 3.5 5.9 3.1 1.7 5.3 1.7 3.7 8.4 0.0 4.3 2.1 3.3 4.3 10.4 6.8 5.0 12.7 8.1 6.2 6.3 1.7 4.6 4.8 3.3 2.8 6.6 3.3 4.6 8.2 4.9 6.2 4.6 0.0 3.5 8.9 6.1 4.0 4.9 6.1 5.5 4.7 ASCC1 "ASC1p50, CGI-18, Em:AC022392.3" ENSG00000138303 "Activating signal cointegrator 1 complex subunit 1" Q8N9N2 10 72096032-72217134 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038038, HPA057567" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038038: AB_10674544, HPA057567: " "unprognostic (1.96e-1)" "unprognostic (2.79e-2)" "unprognostic (5.36e-2)" "unprognostic (1.03e-2)" "unprognostic (2.92e-3)" "unprognostic (2.34e-2)" "prognostic unfavorable (3.52e-4)" "unprognostic (1.22e-2)" "unprognostic (8.30e-3)" "unprognostic (3.22e-1)" "prognostic unfavorable (2.00e-4)" "unprognostic (1.52e-1)" "unprognostic (1.39e-1)" "unprognostic (4.34e-2)" "unprognostic (1.74e-1)" "unprognostic (2.66e-1)" "unprognostic (6.64e-2)" 17.2 23.3 23.2 13.3 25.9 10.9 20.9 27.4 23.8 21.2 12.4 25.7 19.6 9.5 16.9 21.3 16.4 17.2 16.0 26.4 24.7 21.6 18.6 24.3 12.7 19.8 35.2 14.9 21.9 24.8 19.3 22.0 14.5 28.2 15.4 12.9 13.1 11.9 19.5 25.7 14.8 12.5 18.0 35.4 16.9 13.7 20.9 34.5 20.8 17.8 9.4 20.9 18.0 15.7 24.9 22.9 25.4 14.9 19.7 24.2 14.6 13.4 17.7 13.5 25.5 18.7 19.6 10.3 8.2 17.6 14.0 17.3 19.2 48.6 18.2 16.9 11.9 10.2 17.5 10.8 16.5 15.2 12.8 9.6 11.4 14.6 17.7 16.9 12.5 12.1 18.4 36.2 15.0 21.1 19.4 17.1 20.1 15.8 22.7 14.9 12.8 16.4 17.3 7.1 9.8 4.3 9.3 10.9 13.3 24.1 9.1 12.8 9.2 11.4 29.4 22.2 12.0 10.1 8.5 16.2 7.1 13.5 5.6 8.6 14.1 18.2 22.0 11.4 28.6 5.5 16.5 14.9 25.4 14.5 14.7 14.4 24.3 17.2 15.2 15.1 24.9 24.2 21.9 9.4 19.7 11.5 22.9 21.6 14.6 23.2 25.9 27.4 23.8 24.7 21.6 35.2 14.9 28.2 34.5 8.9 4.3 18.4 13.0 5.6 11.5 19.7 5.1 5.3 7.9 12.2 13.7 14.9 19.9 17.7 22.1 10.8 4.5 23.3 17.8 16.4 12.8 6.0 12.7 17.7 15.8 23.8 3.5 7.4 28.5 10.0 19.0 7.9 18.6 27.9 4.9 17.7 13.3 4.5 19.4 9.2 13.9 12.9 17.9 28.9 20.6 6.0 12.7 16.6 4.7 8.2 ASCC2 "ASC1p100, DKFZp586O0223, FLJ21588" ENSG00000100325 "Activating signal cointegrator 1 complex subunit 2" Q9H1I8 22 29788608-29838304 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 128.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001439, HPA052879" Approved Approved "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA "Focal adhesion sites, Cytosol" Nucleoplasm "HPA001439: AB_1078229, HPA052879: AB_2732577" "unprognostic (1.70e-1)" "unprognostic (1.02e-2)" "unprognostic (8.58e-2)" "unprognostic (3.83e-3)" "unprognostic (1.84e-1)" "unprognostic (2.45e-3)" "unprognostic (3.01e-3)" "unprognostic (1.16e-1)" "unprognostic (1.35e-1)" "unprognostic (5.39e-2)" "unprognostic (1.56e-2)" "unprognostic (1.24e-1)" "unprognostic (3.97e-3)" "unprognostic (5.19e-2)" "unprognostic (7.53e-2)" "unprognostic (3.81e-1)" "unprognostic (2.05e-3)" 19.5 24.2 13.1 22.1 15.1 32.3 23.1 13.4 14.0 16.8 16.9 17.9 22.5 16.5 17.1 17.7 31.1 14.6 19.0 17.7 10.8 8.2 15.8 35.3 19.2 20.2 15.4 9.1 16.2 18.4 17.5 20.6 23.2 12.5 20.1 17.8 17.6 22.2 30.9 50.0 21.7 22.3 14.2 12.9 22.7 25.8 41.0 13.0 28.9 21.9 25.0 26.6 19.1 21.2 11.3 21.1 28.5 27.6 17.3 18.8 10.9 19.7 11.5 12.5 16.9 18.8 16.7 18.0 20.6 15.9 21.4 21.5 13.4 10.7 19.7 14.9 19.8 13.6 24.0 16.0 23.4 18.1 25.2 28.0 16.9 14.6 16.0 23.6 30.3 51.5 17.9 21.3 24.3 22.4 12.6 18.7 13.3 17.4 19.2 19.3 24.4 18.5 16.0 9.1 27.9 15.7 22.4 15.4 20.6 13.1 32.7 19.4 17.1 19.1 21.1 15.3 13.4 15.0 15.9 18.4 30.0 5.1 18.1 20.3 23.0 17.5 23.4 17.5 17.0 21.6 18.2 16.7 28.5 18.8 27.6 16.8 11.3 14.2 15.8 21.1 8.9 14.7 14.8 5.1 17.3 22.5 12.0 16.4 10.9 13.1 15.1 13.4 14.0 10.8 8.2 15.4 9.1 12.5 13.0 17.9 14.3 24.0 18.4 26.7 9.0 16.5 25.5 18.7 18.2 38.4 3.9 37.6 10.0 24.0 92.7 20.5 38.5 23.3 21.6 52.8 23.3 15.9 34.6 23.2 27.5 4.8 14.9 17.8 24.8 128.4 28.7 33.0 27.0 22.6 17.2 11.8 22.4 24.6 23.3 15.2 13.6 19.4 16.0 39.1 19.2 34.4 37.1 35.9 20.3 30.8 ASCL1 "ASH1, bHLHa46, HASH1" ENSG00000139352 "Achaete-scute family bHLH transcription factor 1" P50553 12 102957686-102960516 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.3;liver: 23.0;pituitary gland: 29.4" "Cell type enriched" "Detected in some" 7 "Intestinal endocrine cells: 34.9" "Group enriched" "Detected in many" 6 "glioma: 21.4;lung cancer: 11.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "SCLC-21H: 33.4;SH-SY5Y: 18.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA029217, HPA076307" Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA029217: AB_10669595, HPA076307: " "unprognostic (7.92e-2)" "unprognostic (4.37e-3)" "unprognostic (4.55e-2)" "unprognostic (5.02e-2)" "unprognostic (3.12e-1)" "unprognostic (1.22e-2)" "unprognostic (1.56e-1)" "unprognostic (2.09e-1)" "unprognostic (4.84e-2)" "unprognostic (1.31e-2)" "unprognostic (1.31e-1)" "unprognostic (7.10e-6)" "unprognostic (3.40e-1)" "unprognostic (2.17e-1)" "unprognostic (3.76e-1)" "unprognostic (5.52e-2)" 0.9 2.8 11.1 0.7 6.9 0.7 0.7 3.3 19.3 1.3 0.9 6.6 0.0 0.9 1.0 0.8 0.7 2.2 0.8 0.7 8.5 5.8 0.8 23.0 1.7 1.4 7.6 4.7 1.6 0.9 0.7 29.4 0.8 13.9 1.1 1.0 0.0 0.7 0.8 0.8 0.7 0.8 0.9 18.7 0.7 3.2 0.9 7.3 6.0 1.0 0.0 0.8 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.4 18.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 6.9 3.3 10.7 8.5 5.8 7.6 4.7 13.9 7.3 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.1 4.8 34.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.3 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 ASF1A "CIA, DKFZP547E2110" ENSG00000111875 "Anti-silencing function 1A histone chaperone" Q9Y294 6 118894220-118909167 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chaperone, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Erythroid cells: 116.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030502, HPA071495" Enhanced Nucleoplasm No No Nucleoplasm "HPA030502: AB_2673504, HPA071495: AB_2686404" "unprognostic (7.09e-2)" "unprognostic (1.33e-1)" "unprognostic (4.78e-2)" "unprognostic (1.35e-1)" "unprognostic (3.95e-3)" "unprognostic (2.09e-1)" "prognostic unfavorable (5.02e-7)" "unprognostic (8.28e-2)" "unprognostic (8.42e-2)" "unprognostic (8.37e-3)" "unprognostic (3.28e-2)" "unprognostic (4.95e-1)" "unprognostic (9.07e-3)" "unprognostic (2.90e-2)" "unprognostic (7.37e-2)" "unprognostic (1.42e-2)" "unprognostic (5.09e-3)" 7.8 14.1 21.5 9.1 23.8 7.9 14.4 20.3 17.5 12.9 10.4 12.6 16.1 8.5 12.3 15.6 13.7 12.3 9.0 14.6 18.1 19.2 14.4 13.3 15.0 16.3 21.6 14.9 20.9 10.8 25.7 12.9 9.5 15.2 12.0 12.5 9.1 11.6 15.4 16.6 12.9 11.7 11.6 21.4 15.2 11.8 10.5 14.8 36.9 20.2 14.9 16.4 13.3 12.2 13.4 12.8 12.2 7.9 12.1 30.8 17.6 6.0 3.9 13.8 9.2 11.9 7.0 11.1 8.3 8.3 10.9 12.3 4.8 5.3 10.2 13.7 5.9 9.5 6.7 11.9 10.6 13.9 7.3 11.0 15.0 9.4 30.9 8.3 25.3 7.8 6.1 10.8 9.4 14.4 14.6 14.4 32.7 23.2 27.4 12.8 6.4 29.5 20.0 5.7 9.1 13.5 16.2 5.6 12.7 14.5 7.9 8.9 6.8 8.4 8.5 9.7 4.5 4.9 23.7 12.3 5.1 7.5 7.0 12.7 8.5 14.1 14.9 13.3 20.2 10.9 6.6 6.0 12.2 16.3 6.3 22.7 13.4 26.6 20.9 12.8 8.1 29.1 23.8 1.0 12.1 7.9 9.7 30.8 17.6 21.5 23.8 20.3 17.5 18.1 19.2 21.6 14.9 15.2 14.8 14.9 19.9 35.3 13.8 26.2 15.4 23.4 12.7 24.1 15.9 8.7 3.9 59.8 53.0 28.9 26.4 23.7 8.5 116.8 20.7 67.2 19.7 9.5 22.0 13.9 21.7 23.8 28.4 14.1 16.8 7.8 23.6 19.0 15.1 26.2 10.5 22.6 19.3 10.5 21.9 22.6 12.5 12.9 29.7 26.5 40.0 28.9 39.0 47.3 16.7 11.1 ASF1B FLJ10604 ENSG00000105011 "Anti-silencing function 1B histone chaperone" Q9NVP2 19 14119509-14136956 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Chaperone, Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 39.2;lymphoid tissue: 45.1;testis: 45.2" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 35.5;Extravillous trophoblasts: 30.7;Spermatocytes: 54.1;Spermatogonia: 88.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in many" 7 "neutrophil: 39.2" "Lineage enriched" "Detected in many" 7 "granulocytes: 39.2" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA054036, HPA069385" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "HPA054036: AB_2682350, HPA069385: " "unprognostic (3.14e-1)" "prognostic favorable (4.45e-5)" "unprognostic (2.41e-3)" "unprognostic (2.40e-1)" "unprognostic (2.15e-1)" "unprognostic (2.27e-2)" "prognostic unfavorable (2.03e-4)" "unprognostic (2.87e-2)" "unprognostic (1.33e-3)" "unprognostic (1.52e-1)" "prognostic unfavorable (1.98e-4)" "unprognostic (8.48e-3)" "prognostic unfavorable (2.22e-16)" "prognostic favorable (2.49e-4)" "unprognostic (1.27e-1)" "unprognostic (3.92e-2)" "unprognostic (4.31e-2)" 1.3 1.6 0.7 15.1 1.3 10.0 0.9 0.3 0.8 2.0 7.2 0.8 1.1 4.9 0.9 1.9 9.3 0.7 3.0 1.2 0.6 0.4 1.5 1.4 3.1 11.5 0.9 0.3 1.0 0.8 0.0 0.9 3.8 0.9 0.9 7.6 0.7 2.0 0.3 0.7 2.9 5.2 1.5 1.0 6.4 3.1 45.2 0.6 45.1 0.7 6.4 14.0 1.9 2.9 0.8 0.8 39.2 5.2 1.0 3.3 2.0 28.6 11.1 17.5 13.3 1.7 1.6 7.6 15.2 12.5 28.6 36.2 11.5 14.1 27.4 14.0 7.7 12.1 17.6 18.6 10.6 22.5 24.3 13.4 25.9 23.5 8.0 0.1 17.4 16.2 0.3 0.7 16.0 5.5 3.2 11.1 20.0 22.3 38.4 14.0 32.6 35.3 14.8 8.0 30.2 27.1 34.1 25.9 22.6 8.9 12.4 21.4 7.8 18.0 13.3 7.6 4.9 10.0 18.0 5.4 16.6 10.3 41.9 25.1 20.6 20.8 35.0 13.2 32.0 16.1 0.4 4.0 1.0 1.4 5.2 0.8 0.8 1.2 1.5 0.8 0.8 0.7 1.3 39.2 1.0 5.1 0.3 3.3 2.0 0.7 1.3 0.3 0.8 0.6 0.4 0.9 0.3 0.9 0.6 0.0 1.1 4.5 2.3 2.3 0.0 0.4 2.5 0.0 1.2 0.0 0.0 9.2 0.0 1.3 35.5 0.1 2.9 23.3 1.1 30.7 0.4 0.8 4.6 0.0 17.8 0.0 1.2 0.6 7.1 22.9 0.0 4.2 1.7 1.8 3.4 0.4 0.8 2.9 0.7 0.0 0.7 0.0 0.2 54.1 88.8 1.0 8.7 4.4 7.1 0.9 ASH1L "ASH1, ASH1L1, huASH1, KMT2H" ENSG00000116539 "ASH1 like histone lysine methyltransferase" Q9NR48 1 155335268-155562807 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Methyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004806 Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA004806: AB_1845087" "unprognostic (2.98e-1)" "unprognostic (3.15e-2)" "unprognostic (1.10e-1)" "unprognostic (1.70e-2)" "unprognostic (2.05e-2)" "unprognostic (4.75e-2)" "unprognostic (1.42e-1)" "unprognostic (1.87e-2)" "unprognostic (1.46e-1)" "unprognostic (1.59e-1)" "unprognostic (1.07e-1)" "unprognostic (6.84e-2)" "prognostic favorable (3.80e-4)" "unprognostic (2.95e-1)" "unprognostic (1.62e-1)" "unprognostic (2.45e-2)" "unprognostic (1.94e-1)" 20.1 10.1 12.1 17.7 14.5 12.3 14.5 23.6 15.5 15.4 17.7 15.5 20.4 8.2 18.7 12.5 12.5 12.2 10.0 11.0 11.8 10.6 13.0 8.9 10.6 9.4 16.6 11.5 23.5 10.0 24.4 22.6 12.9 13.2 18.9 10.7 10.7 11.8 22.2 21.8 12.8 12.8 17.4 14.5 8.6 10.4 7.8 14.3 15.6 16.8 7.1 10.6 17.8 19.9 11.0 5.7 16.5 5.3 8.6 10.7 1.7 13.6 11.7 7.7 6.6 17.4 18.7 8.7 11.1 11.6 7.6 6.4 8.7 9.1 6.1 11.2 14.5 5.8 14.2 12.1 9.7 12.0 6.0 7.8 7.5 11.6 4.7 8.4 8.3 5.9 11.5 10.8 12.7 12.5 11.5 9.0 6.0 10.7 9.2 12.6 10.7 5.6 4.5 7.3 17.0 11.4 5.2 15.9 7.0 8.4 15.1 7.9 11.7 17.5 15.8 8.6 8.4 12.7 18.2 13.8 11.7 12.6 11.1 13.6 8.6 4.9 9.7 9.1 6.3 10.1 16.5 5.3 11.0 8.3 3.2 7.9 10.0 7.8 6.3 2.5 11.0 10.7 5.5 12.8 8.6 3.5 5.7 8.6 1.7 12.1 14.5 23.6 15.2 11.8 10.6 16.6 11.5 13.2 14.3 56.6 88.1 42.2 92.1 92.3 138.8 87.3 43.3 45.5 96.7 48.8 190.5 40.3 14.9 37.0 14.5 82.3 61.6 23.3 34.5 22.1 98.4 94.0 78.6 28.8 21.6 108.1 64.8 59.5 40.8 12.1 94.6 55.1 50.6 62.3 49.5 77.4 31.8 59.1 111.7 23.9 119.9 97.0 97.6 85.7 46.2 97.9 63.7 68.9 46.6 109.1 ASH2L "ASH2, ASH2L1, ASH2L2, Bre2" ENSG00000129691 "ASH2 like histone lysine methyltransferase complex subunit" Q9UBL3 8 38105242-38144076 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 65.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042289 Approved Supported "Nucleoplasm,Plasma membrane" Yes No Nucleoplasm "Plasma membrane" "HPA042289: AB_10795608" "unprognostic (9.39e-2)" "unprognostic (5.58e-3)" "unprognostic (2.67e-3)" "unprognostic (5.40e-3)" "unprognostic (2.87e-1)" "unprognostic (2.66e-2)" "unprognostic (4.04e-1)" "unprognostic (9.15e-2)" "unprognostic (1.30e-1)" "unprognostic (1.12e-1)" "unprognostic (5.10e-2)" "unprognostic (9.73e-3)" "prognostic favorable (4.25e-4)" "unprognostic (9.95e-2)" "unprognostic (1.27e-1)" "unprognostic (7.69e-3)" "unprognostic (2.54e-1)" 22.3 17.0 24.2 16.7 26.7 24.0 19.7 26.1 28.2 20.9 20.0 21.9 14.7 14.5 20.8 16.1 21.6 18.2 19.6 20.6 21.0 23.4 21.0 20.6 16.0 21.4 20.3 26.8 24.1 30.1 28.3 13.9 24.3 23.1 19.4 20.9 16.0 18.1 20.0 31.8 18.8 23.0 21.8 20.1 20.3 18.8 41.7 16.0 36.2 19.5 15.3 24.1 20.1 17.4 12.6 17.0 33.9 16.6 16.6 13.2 11.4 14.1 7.5 12.6 12.6 9.1 11.4 16.2 14.4 15.2 18.2 16.1 8.0 6.4 16.0 12.3 12.1 9.1 8.5 16.2 8.1 17.3 6.2 7.3 65.0 8.0 16.9 13.2 10.5 13.2 9.8 7.7 8.4 9.4 9.2 14.2 15.0 43.5 12.4 17.7 8.2 27.7 13.1 16.4 12.6 4.8 11.5 14.0 6.9 9.4 10.7 5.8 10.4 10.7 7.0 11.6 13.1 8.5 12.3 11.1 11.3 11.4 16.0 11.4 11.8 14.8 14.2 11.5 13.7 15.5 18.2 13.9 33.9 11.1 16.6 11.8 12.5 12.5 13.1 17.0 12.6 13.2 12.1 11.8 16.6 15.0 9.7 13.0 11.4 24.2 26.7 26.1 28.2 21.0 23.4 20.3 26.8 23.1 16.0 11.9 18.6 12.7 7.9 6.2 12.1 15.3 10.2 25.4 17.0 12.2 9.8 31.2 6.6 17.1 6.6 11.3 10.6 0.0 25.1 31.4 12.7 5.3 18.5 10.2 20.4 6.4 10.4 13.5 18.9 11.2 21.6 14.8 21.9 29.7 10.5 14.8 16.9 7.0 19.4 13.2 14.9 12.9 9.5 30.1 32.2 5.9 25.9 15.0 11.4 6.5 ASIC3 "ACCN3, DRASIC, TNaC1" ENSG00000213199 "Acid sensing ion channel subunit 3" Q9UHC3 7 151048292-151052756 "Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.1" "Cell type enhanced" "Detected in some" 18 "Cone photoreceptor cells: 11.8;Early spermatids: 11.6;Late spermatids: 43.6" "Cancer enhanced" "Detected in many" "testis cancer: 7.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-266/70: 17.2;U-266/84: 9.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA049155, HPA054805" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA049155: AB_2680657, HPA054805: AB_2732588" "unprognostic (8.71e-3)" "unprognostic (1.09e-1)" "unprognostic (1.92e-4)" "unprognostic (2.73e-1)" "unprognostic (7.06e-2)" "unprognostic (2.02e-2)" "unprognostic (2.34e-1)" "unprognostic (3.75e-2)" "unprognostic (2.42e-1)" "unprognostic (4.45e-2)" "unprognostic (8.64e-3)" "unprognostic (1.67e-2)" "unprognostic (1.33e-12)" "unprognostic (1.49e-2)" "unprognostic (7.38e-2)" "unprognostic (1.65e-2)" "unprognostic (5.31e-3)" 2.6 2.4 6.8 0.9 27.1 1.5 1.3 20.1 15.4 3.6 2.3 0.9 0.5 2.9 4.9 3.5 0.6 2.4 1.9 2.4 6.5 5.3 1.5 1.3 2.7 1.9 4.2 9.9 3.0 1.4 1.4 7.1 1.8 6.2 1.9 1.8 0.7 1.7 1.4 9.0 3.5 2.7 2.4 6.0 2.1 2.8 10.2 2.2 0.5 1.1 0.5 1.9 0.9 1.2 0.0 0.0 0.0 0.8 0.0 0.7 0.0 1.3 3.6 1.7 2.4 3.3 0.0 7.4 0.4 0.0 0.3 0.4 0.7 1.6 0.9 0.4 0.2 1.6 2.3 0.9 0.0 0.7 7.8 4.2 1.6 2.7 0.0 0.0 0.1 3.9 0.5 0.5 0.2 0.0 2.6 0.1 0.9 3.8 6.4 0.5 6.0 0.3 0.4 1.7 0.1 2.8 2.9 1.6 0.5 0.3 1.3 2.2 8.6 0.6 0.4 4.1 4.6 1.7 0.4 0.1 1.5 2.2 4.0 1.0 17.2 9.1 0.1 2.1 5.7 1.4 0.0 0.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.8 27.1 20.1 15.4 6.5 5.3 4.2 9.9 6.2 2.2 0.0 0.3 0.0 0.0 0.6 8.6 1.6 0.0 0.0 0.0 0.0 11.8 0.1 0.0 0.2 11.6 0.3 0.3 0.0 0.3 0.1 0.5 0.2 9.2 0.6 0.6 6.4 0.0 0.0 0.6 43.6 1.4 0.3 0.0 1.0 0.0 1.9 0.3 0.0 1.8 0.3 5.0 0.0 0.0 9.2 5.1 0.6 0.6 0.0 0.2 0.1 ASIC4 "ACCN4, BNAC4" ENSG00000072182 "Acid sensing ion channel subunit family member 4" Q96FT7 2 219514170-219538772 "Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.7;pituitary gland: 20.6" "Group enriched" "Detected in some" 10 "Bipolar cells: 200.8;Cone photoreceptor cells: 163.0" "Cancer enriched" "Detected in single" 38 "glioma: 8.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 30 "HEL: 19.1;HMC-1: 5.8;K-562: 10.9;SH-SY5Y: 5.2" "Region enhanced" "Detected in many" "basal ganglia: 65.5" "Low region specificity" "Detected in many" "HPA036042, HPA057078" Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Centriolar satellite" NA NA "Golgi apparatus, Centriolar satellite" "Nucleoplasm, Plasma membrane" "HPA036042: AB_10672998, HPA057078: " "unprognostic (3.48e-1)" "unprognostic (1.44e-1)" "unprognostic (2.55e-1)" "unprognostic (1.61e-2)" "unprognostic (2.62e-1)" "unprognostic (8.74e-2)" "unprognostic (3.04e-2)" "unprognostic (2.54e-1)" "unprognostic (6.53e-2)" "unprognostic (1.90e-2)" "unprognostic (9.46e-3)" "unprognostic (1.88e-1)" "unprognostic (7.80e-8)" "unprognostic (3.82e-2)" "unprognostic (2.30e-1)" "unprognostic (5.51e-1)" "unprognostic (2.48e-2)" 0.8 3.3 4.9 0.6 4.7 0.5 0.6 6.9 17.7 1.0 0.5 1.6 0.0 0.5 0.8 0.6 0.5 0.6 0.6 0.6 3.9 4.5 0.5 0.6 0.9 0.6 4.8 2.9 0.5 0.5 0.5 20.6 0.6 3.0 0.6 0.5 4.9 0.6 0.8 0.5 0.6 0.5 0.7 1.9 0.6 0.7 1.6 3.1 0.0 0.5 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.2 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 4.7 6.9 4.9 3.9 4.5 4.8 2.9 3.0 3.1 0.0 0.0 0.0 1.6 0.1 200.8 0.8 0.0 0.0 0.0 0.0 163.0 1.8 0.0 0.0 2.8 0.1 0.3 0.0 0.3 0.7 0.7 0.5 18.4 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 8.4 0.0 2.9 0.4 0.0 9.5 0.0 0.4 0.2 0.6 0.3 2.4 0.0 0.4 0.3 ASNA1 "ARSA-I, GET3, TRC40" ENSG00000198356 "ArsA arsenite transporter, ATP-binding, homolog 1 (bacterial)" O43681 19 12737139-12748323 "Predicted intracellular proteins, Transporters" Transport Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045951, HPA048087" Approved Enhanced Nucleoplasm,Nucleoli NA NA 52000 Nucleoli Nucleoplasm "HPA045951: AB_2679511, HPA048087: AB_2680258" "unprognostic (2.87e-1)" "prognostic favorable (9.53e-4)" "unprognostic (1.01e-1)" "unprognostic (2.16e-1)" "unprognostic (2.05e-2)" "unprognostic (5.70e-2)" "unprognostic (2.01e-2)" "unprognostic (1.33e-2)" "unprognostic (3.34e-1)" "unprognostic (3.08e-2)" "unprognostic (1.85e-1)" "unprognostic (4.39e-2)" "prognostic favorable (4.27e-5)" "unprognostic (6.11e-2)" "unprognostic (5.77e-2)" "unprognostic (2.32e-3)" "prognostic unfavorable (8.47e-4)" 22.3 33.9 32.3 23.1 32.8 35.1 22.2 28.2 51.9 23.5 27.2 26.1 23.6 24.7 24.8 30.3 33.3 30.7 28.9 48.0 30.5 27.9 46.9 28.5 21.2 26.6 29.2 26.5 24.2 30.3 23.8 25.2 32.0 27.3 21.8 18.3 30.9 26.7 21.5 35.7 28.9 24.7 21.3 24.5 26.5 24.2 30.9 18.5 25.8 40.7 28.0 23.5 28.7 20.6 12.5 27.1 16.0 26.9 9.3 20.2 19.4 33.6 27.8 14.9 32.1 29.7 18.3 18.4 17.5 24.2 34.0 26.8 21.7 16.8 15.5 27.4 22.7 39.0 18.1 20.6 23.4 16.3 23.8 32.3 13.4 21.0 24.6 31.8 19.8 26.1 21.1 20.6 27.4 16.3 22.0 24.0 18.4 16.6 21.1 26.5 75.3 26.1 15.9 37.7 21.7 52.4 19.4 23.2 30.3 31.7 28.8 27.7 23.5 23.7 31.9 28.0 13.3 26.3 19.1 20.4 48.1 16.3 53.2 40.6 38.0 63.9 14.3 33.7 32.4 26.4 16.0 26.9 15.0 16.1 20.4 13.7 12.5 14.4 14.2 27.1 10.6 10.4 12.8 9.6 9.3 23.7 17.8 20.2 19.4 32.3 32.8 28.2 51.9 30.5 27.9 29.2 26.5 27.3 18.5 3.0 6.5 44.7 52.5 61.4 33.5 7.4 66.2 9.4 5.7 52.4 15.7 89.1 112.7 135.7 88.0 42.9 87.6 46.7 116.1 66.8 58.1 46.3 34.5 24.5 125.2 27.0 53.9 36.8 50.0 143.9 44.5 54.1 77.6 138.9 56.6 59.9 93.6 94.7 53.0 177.7 23.1 32.3 54.5 52.9 128.0 69.5 92.6 59.8 57.4 54.0 ASPDH ENSG00000204653 "Aspartate dehydrogenase domain containing" A6ND91 19 50511600-50514690 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 26.9;kidney: 24.7;liver: 59.8" "Group enriched" "Detected in some" 8 "Hepatocytes: 137.5;Proximal tubular cells: 442.0" "Cancer enriched" "Detected in some" 13 "liver cancer: 24.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 13.6;MOLT-4: 15.9;SH-SY5Y: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA042631, HPA042654" Approved Approved Nucleoplasm,Cytosol Yes NA 51000 Nucleoplasm Cytosol "HPA042631: AB_10794530, HPA042654: AB_10794383" "unprognostic (5.79e-2)" "unprognostic (9.47e-2)" "unprognostic (8.97e-3)" "unprognostic (6.13e-3)" "unprognostic (5.13e-1)" "unprognostic (3.64e-2)" "unprognostic (3.15e-3)" "unprognostic (3.32e-2)" "unprognostic (2.87e-2)" "unprognostic (2.09e-2)" "unprognostic (2.87e-3)" "unprognostic (6.70e-3)" "unprognostic (9.65e-3)" "unprognostic (3.36e-2)" "unprognostic (1.07e-1)" "unprognostic (5.31e-4)" "unprognostic (1.99e-3)" 1.3 3.2 11.7 1.6 16.2 1.3 0.9 7.4 26.9 0.9 1.0 8.9 0.0 6.9 1.1 0.9 1.2 0.9 2.3 1.2 12.9 8.3 24.7 59.8 1.1 1.6 9.2 9.8 0.9 1.5 0.9 7.7 0.9 4.1 1.2 0.9 1.0 2.3 0.9 1.1 1.8 2.9 0.9 5.1 1.4 1.1 1.1 6.6 1.3 1.7 0.0 0.9 1.1 0.0 0.0 0.4 0.0 0.5 0.0 0.2 0.0 0.1 2.3 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 13.6 0.0 0.6 3.8 0.0 1.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 1.6 0.0 1.6 15.9 0.1 0.0 0.5 0.3 0.3 0.3 1.1 0.0 0.2 1.8 9.5 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 3.7 0.7 2.0 0.2 2.4 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 11.7 16.2 7.4 26.9 12.9 8.3 9.2 9.8 4.1 6.6 0.0 0.0 0.9 0.0 0.0 22.8 0.3 2.5 0.0 0.0 8.7 3.9 0.0 38.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 137.5 0.0 0.0 6.8 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 442.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ASPN "FLJ20129, PLAP-1, SLRR1C" ENSG00000106819 Asporin Q9BXN1 9 92456205-92482506 "Disease related genes, Plasma proteins, Predicted secreted proteins" Biomineralization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 62.1" "Cell type enhanced" "Detected in some" 11 "Basal keratinocytes: 59.6;Fibroblasts: 60.7;Ito cells: 22.7;Sertoli cells: 38.8;Smooth muscle cells: 29.5;Suprabasal keratinocytes: 23.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "basophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 14.7;BJ hTERT+: 5.0;HHSteC: 21.0;HSkMC: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007894, HPA008435, HPA024230" Approved Uncertain Nucleoplasm,Cytosol "Secreted to extracellular matrix" NA NA 33000 Nucleoplasm Cytosol "HPA007894: , HPA008435: AB_1845112, HPA024230: AB_1845113" "unprognostic (2.40e-1)" "unprognostic (1.02e-2)" "unprognostic (8.13e-3)" "unprognostic (3.51e-2)" "unprognostic (1.22e-1)" "unprognostic (1.01e-2)" "unprognostic (9.50e-3)" "unprognostic (1.17e-1)" "unprognostic (2.74e-3)" "unprognostic (6.38e-2)" "unprognostic (3.70e-2)" "unprognostic (4.70e-2)" "prognostic unfavorable (1.64e-7)" "unprognostic (1.42e-3)" "unprognostic (3.04e-2)" "unprognostic (6.27e-3)" "unprognostic (2.48e-2)" 13.4 2.2 0.5 5.2 1.7 0.0 4.8 0.4 0.7 40.2 14.6 0.6 8.1 2.8 62.1 26.7 15.3 9.9 26.4 31.6 0.6 0.6 3.5 21.9 10.3 0.7 0.9 1.4 7.8 4.7 0.8 1.9 3.7 1.0 12.2 3.6 1.6 2.0 3.6 10.8 3.7 19.7 37.1 0.8 0.8 8.8 6.7 0.4 1.5 7.1 27.7 2.2 24.2 3.8 0.4 0.2 1.9 0.7 0.1 0.2 0.0 0.0 0.0 0.0 0.0 1.3 14.7 0.0 2.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 4.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.4 0.2 0.1 0.2 0.1 0.7 0.2 0.0 0.0 0.5 1.7 0.4 0.7 0.6 0.6 0.9 1.4 1.0 0.4 0.0 1.4 0.0 0.0 59.6 0.5 3.6 0.0 1.4 1.2 0.0 0.0 0.1 0.0 0.0 0.3 5.8 0.0 0.0 0.0 0.0 60.7 0.0 1.1 0.4 0.2 0.0 0.0 22.7 0.0 0.2 5.5 0.5 13.5 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.6 38.8 29.5 0.0 0.0 23.6 0.0 0.0 0.0 0.0 ASPSCR1 "ASPL, ASPS, TUG, UBXD9, UBXN9" ENSG00000169696 "ASPSCR1, UBX domain containing tether for SLC2A4" Q9BZE9 17 81976807-82017406 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 151.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "Hep G2: 82.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026749 Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" NA NA Nucleoplasm "Vesicles, Plasma membrane" "HPA026749: AB_1845114" "unprognostic (5.01e-2)" "unprognostic (1.19e-3)" "unprognostic (7.61e-2)" "unprognostic (1.34e-1)" "unprognostic (1.36e-1)" "prognostic favorable (8.55e-4)" "unprognostic (2.02e-1)" "unprognostic (2.07e-2)" "unprognostic (3.43e-1)" "unprognostic (1.71e-3)" "prognostic favorable (2.67e-4)" "unprognostic (1.13e-1)" "prognostic unfavorable (1.26e-4)" "unprognostic (3.16e-2)" "unprognostic (1.13e-1)" "unprognostic (2.27e-1)" "unprognostic (1.01e-2)" 10.3 12.6 14.3 12.6 14.5 16.8 10.6 16.5 20.8 9.9 12.9 16.7 11.8 17.5 10.1 15.8 11.9 9.3 15.1 11.5 13.1 12.6 15.8 31.9 14.1 14.8 18.9 12.9 8.8 17.8 17.0 19.7 21.8 14.8 13.2 7.1 14.4 22.6 9.9 25.1 15.5 14.4 9.1 12.6 13.2 13.0 16.9 14.6 9.8 16.4 12.9 13.0 9.7 8.3 8.1 14.6 15.7 11.3 7.2 10.5 5.2 5.1 9.0 3.5 5.1 2.2 2.8 15.3 4.9 3.7 5.9 5.8 5.2 5.9 5.2 5.0 3.5 4.5 2.5 3.8 3.7 1.8 3.6 11.5 5.8 7.3 82.6 7.3 5.1 8.5 3.2 4.0 2.9 2.1 3.1 5.6 4.4 5.8 7.5 3.3 17.3 4.7 11.1 4.4 9.5 6.6 5.2 5.1 10.6 5.7 4.7 9.4 9.6 3.9 12.6 9.0 4.2 7.5 12.2 4.6 10.1 7.0 7.4 6.1 5.4 3.2 5.8 5.4 5.2 6.0 15.7 11.3 8.0 6.7 7.6 4.0 7.9 10.5 9.0 14.6 8.1 8.0 6.0 2.9 7.2 9.3 9.1 4.9 5.2 14.3 14.5 16.5 20.8 13.1 12.6 18.9 12.9 14.8 14.6 8.9 46.0 18.6 20.7 11.8 21.4 11.4 17.8 10.7 9.1 14.0 39.3 64.7 33.2 21.2 40.2 16.0 26.7 0.0 22.9 151.3 16.6 19.3 20.8 45.6 39.1 47.7 24.0 15.4 16.6 63.2 10.9 17.1 18.6 18.0 24.4 56.7 16.2 20.1 16.6 44.0 32.8 12.9 15.3 43.6 48.7 12.5 49.7 23.6 23.8 19.7 ASRGL1 "ALP, ALP1, FLJ22316" ENSG00000162174 "Asparaginase like 1" Q7L266 11 62337448-62393412 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 52.4;cervix, uterine: 68.7;testis: 57.6" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 275.4;Late spermatids: 421.8;Spermatocytes: 320.2" "Cancer enhanced" "Detected in all" "endometrial cancer: 53.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 51.4;eosinophil: 52.4" "Group enriched" "Detected in many" 4 "granulocytes: 52.4;monocytes: 14.2" "Cell line enhanced" "Detected in many" "EFO-21: 30.5;HAP1: 29.4;RPTEC TERT1: 26.0;SCLC-21H: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029725, HPA055572, CAB070192" Enhanced Approved "Nucleoplasm,Microtubules,Cytokinetic bridge" NA NA Microtubules "Nucleoplasm, Cytokinetic bridge" "CAB070192: AB_2665720, HPA029725: AB_10602328, HPA055572: AB_2682854" "unprognostic (1.14e-1)" "unprognostic (8.38e-3)" "prognostic favorable (6.14e-4)" "prognostic favorable (1.56e-5)" "unprognostic (5.35e-2)" "unprognostic (8.19e-2)" "prognostic unfavorable (9.46e-4)" "unprognostic (8.67e-2)" "unprognostic (1.85e-1)" "unprognostic (3.54e-2)" "unprognostic (2.71e-1)" "unprognostic (4.44e-1)" "prognostic favorable (4.32e-7)" "unprognostic (2.28e-2)" "unprognostic (1.53e-1)" "unprognostic (5.43e-3)" "unprognostic (1.40e-1)" 3.6 2.6 27.8 3.8 37.0 7.1 4.6 12.3 22.3 68.7 7.9 9.9 2.0 4.1 15.3 7.9 1.4 36.8 9.5 1.7 19.5 19.0 23.8 2.4 6.6 3.3 30.8 11.8 1.6 5.1 1.5 5.7 2.3 16.4 8.6 9.9 4.9 6.4 4.8 2.3 1.2 3.1 3.0 9.6 2.4 5.6 57.6 11.3 2.8 3.7 0.0 3.0 2.9 1.0 0.5 8.2 52.4 14.2 2.5 0.7 4.9 0.8 6.7 7.4 9.6 0.0 0.0 5.8 0.8 0.3 1.3 1.2 11.0 3.0 0.7 30.5 0.1 3.3 0.6 29.4 0.3 1.5 1.1 12.1 0.4 9.1 8.0 0.2 8.1 11.0 0.3 0.1 0.6 0.1 0.4 13.8 16.7 8.2 7.6 0.3 12.8 21.8 5.4 10.1 4.6 5.3 8.9 4.4 4.1 26.0 2.1 40.1 5.7 5.7 9.9 4.9 8.0 5.3 4.1 0.7 0.1 5.6 0.4 3.3 11.7 11.1 1.0 0.3 4.2 3.4 51.4 14.2 52.4 0.6 10.3 0.4 0.5 0.2 0.7 8.2 0.4 0.5 0.7 3.3 2.5 7.2 1.4 0.1 4.9 27.8 37.0 12.3 22.3 19.5 19.0 30.8 11.8 16.4 11.3 6.0 26.7 10.4 1.9 3.1 21.7 1.6 53.5 1.4 3.4 21.0 31.4 1.4 112.7 25.5 275.4 23.3 4.1 0.0 19.3 1.8 3.8 54.4 76.5 2.6 22.5 15.9 45.3 31.9 9.1 421.8 8.1 27.7 1.7 0.0 35.8 78.6 8.8 5.8 6.7 99.6 37.4 12.9 2.3 320.2 48.6 1.1 0.7 6.9 26.0 5.3 ASS1 "ASS, CTLN1" ENSG00000130707 "Argininosuccinate synthase 1" P00966 9 130444929-130501274 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle" Ligase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 121.5;liver: 309.9" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 457.5;Hepatocytes: 809.9;Proximal tubular cells: 889.6;Urothelial cells: 385.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 15 "plasmacytoid DC: 4.6" "Lineage enriched" "Detected in single" 46 "dendritic cells: 4.6" "Cell line enhanced" "Detected in many" "BJ hTERT+: 87.4;HaCaT: 82.8;hTCEpi: 80.5;RPMI-8226: 134.1;THP-1: 100.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA020896, HPA020934" Enhanced Approved Nucleoplasm,Cytosol No No 4500000 Cytosol Nucleoplasm "HPA020896: AB_1845117, HPA020934: AB_1845118" "unprognostic (3.73e-2)" "unprognostic (1.77e-2)" "unprognostic (2.78e-1)" "prognostic unfavorable (8.14e-9)" "unprognostic (3.06e-1)" "unprognostic (1.05e-2)" "unprognostic (2.93e-2)" "unprognostic (3.71e-2)" "unprognostic (3.27e-2)" "unprognostic (1.22e-1)" "unprognostic (4.02e-2)" "unprognostic (4.24e-2)" "unprognostic (2.92e-3)" "unprognostic (1.41e-2)" "unprognostic (1.05e-1)" "unprognostic (3.14e-1)" "unprognostic (4.72e-3)" 20.6 15.4 4.6 7.1 4.1 0.0 15.7 2.3 5.4 8.3 18.5 3.5 33.9 11.9 12.0 12.6 9.4 16.6 14.0 11.4 3.8 5.7 121.5 309.9 8.0 2.2 3.2 4.3 11.4 7.9 0.5 4.6 8.7 4.5 12.1 16.8 10.7 26.3 40.6 7.4 12.5 26.8 5.9 3.4 2.7 5.2 8.7 2.2 0.8 17.5 7.0 4.5 17.7 8.6 0.0 4.6 0.0 0.0 0.0 0.0 0.0 11.7 1.1 1.3 2.2 8.9 22.7 4.3 14.0 87.4 2.8 8.5 5.0 3.3 0.0 9.5 28.9 0.8 82.8 5.8 0.5 1.9 2.0 2.6 0.0 1.8 12.8 31.0 1.7 0.1 15.0 80.5 4.5 8.1 0.0 0.1 37.6 0.4 52.2 2.8 58.1 0.6 24.5 1.8 60.2 2.6 0.1 1.5 134.1 7.6 5.8 33.8 0.5 50.0 52.7 3.9 5.4 36.2 100.4 0.0 1.1 7.0 0.2 1.2 8.7 8.3 2.9 22.0 13.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 4.6 4.1 2.3 5.4 3.8 5.7 3.2 4.3 4.5 2.2 23.8 25.8 33.7 45.3 62.6 0.0 5.0 94.3 20.1 50.0 45.4 0.0 159.6 112.7 79.7 0.8 23.2 457.5 0.0 98.3 5.0 15.7 85.0 5.7 809.9 12.7 0.0 11.5 35.0 18.0 2.7 28.7 2.6 3.3 2.8 129.1 4.8 73.5 143.8 117.4 889.6 0.3 0.0 10.8 1.1 2.0 15.3 120.5 12.5 77.1 385.2 ASTN2 KIAA0634 ENSG00000148219 "Astrotactin 2" O75129 9 116425225-117415070 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 7 "Early spermatids: 119.3;Late spermatids: 157.4" "Cancer enhanced" "Detected in all" "prostate cancer: 15.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 24.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027035 Uncertain Approved Nucleoplasm,Cytosol No No Cytosol Nucleoplasm "HPA027035: AB_1845122" "unprognostic (3.25e-2)" "unprognostic (2.70e-2)" "unprognostic (7.41e-3)" "unprognostic (5.42e-3)" "unprognostic (1.89e-1)" "unprognostic (2.67e-2)" "unprognostic (1.55e-1)" "unprognostic (1.02e-2)" "unprognostic (2.94e-1)" "unprognostic (2.80e-1)" "unprognostic (3.40e-2)" "unprognostic (2.93e-1)" "prognostic favorable (6.66e-16)" "unprognostic (3.28e-1)" "unprognostic (2.01e-1)" "unprognostic (1.63e-1)" "unprognostic (1.57e-1)" 4.1 11.9 13.0 3.3 14.9 4.4 5.3 17.2 25.5 5.6 4.6 20.0 5.5 4.6 3.8 5.3 3.2 9.6 3.4 18.6 13.5 16.3 5.5 5.2 3.0 3.0 15.4 19.4 4.0 7.4 5.6 10.7 2.6 16.1 29.2 4.2 6.7 6.1 13.6 7.7 3.5 5.2 3.6 11.3 3.1 4.1 16.7 16.9 1.9 2.4 0.9 2.4 3.6 3.0 2.3 1.3 2.5 0.7 7.8 10.3 1.3 2.5 7.8 3.1 4.7 5.2 4.8 10.4 3.8 1.5 1.7 1.9 5.4 3.0 5.8 4.5 2.5 6.3 0.9 7.6 0.4 2.1 3.1 2.0 2.2 3.7 11.1 2.0 1.4 4.2 6.5 0.7 5.2 0.4 3.7 1.2 6.9 2.7 4.3 5.2 2.6 2.7 1.1 9.1 6.9 4.7 3.3 18.4 1.7 5.3 8.3 4.3 24.9 4.6 1.5 3.2 10.5 10.4 0.9 2.4 4.0 6.5 3.9 3.3 6.3 3.6 5.5 7.1 1.4 16.9 2.5 0.6 0.6 3.9 0.4 4.8 2.0 4.2 3.2 0.3 2.3 4.0 3.3 2.4 7.8 0.7 1.3 10.3 1.3 13.0 14.9 17.2 23.2 13.5 16.3 15.4 19.4 16.1 16.9 6.0 6.2 0.0 3.6 1.1 2.1 19.3 2.5 17.4 7.9 1.8 9.8 0.4 3.3 0.7 119.3 0.7 0.7 0.0 1.0 0.3 3.6 12.1 5.8 1.8 2.5 9.5 12.1 0.6 0.0 157.4 2.6 0.3 0.0 0.0 0.9 3.3 0.7 2.6 5.3 5.7 4.7 0.0 3.8 5.1 13.0 0.5 0.2 2.5 1.7 2.0 ASXL1 KIAA0978 ENSG00000171456 "Additional sex combs like 1, transcriptional regulator" Q8IXJ9 20 32358330-32439319 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Repressor" "Cancer-related genes, Craniosynostosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064156 Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA064156: AB_2685200" "unprognostic (1.49e-1)" "unprognostic (5.97e-2)" "unprognostic (8.36e-2)" "prognostic unfavorable (2.86e-4)" "unprognostic (6.69e-2)" "prognostic favorable (9.16e-4)" "unprognostic (2.01e-3)" "unprognostic (2.89e-1)" "unprognostic (1.49e-1)" "unprognostic (1.38e-1)" "unprognostic (4.32e-2)" "unprognostic (3.21e-2)" "unprognostic (1.84e-3)" "unprognostic (5.47e-2)" "unprognostic (1.90e-1)" "unprognostic (4.82e-2)" "unprognostic (1.06e-1)" 24.3 19.6 19.0 35.0 18.2 39.0 24.7 28.3 23.8 32.4 22.7 17.7 16.9 15.6 32.4 22.2 14.3 20.5 21.6 17.9 19.7 10.7 21.2 25.2 27.3 26.7 20.3 14.7 28.1 27.1 21.2 16.3 19.8 18.2 20.6 16.4 16.6 17.4 23.3 25.5 18.2 21.8 21.8 12.2 28.2 19.7 32.1 23.0 47.4 26.8 15.8 29.0 23.2 35.3 9.8 3.1 1.3 0.8 1.7 14.6 1.9 22.9 13.3 20.9 11.6 9.6 12.0 18.2 15.4 13.2 26.9 19.9 39.6 14.8 21.7 9.9 19.0 25.6 16.0 17.6 14.8 22.0 32.5 9.6 34.6 21.1 21.6 8.6 14.4 14.4 13.3 9.9 18.7 14.1 13.3 14.8 17.9 16.7 11.8 12.5 7.0 19.7 11.6 5.0 10.7 15.4 11.5 25.1 9.4 11.0 11.1 9.6 15.1 27.9 9.3 12.2 11.6 13.3 10.2 15.3 28.6 25.0 13.2 17.1 13.8 14.7 16.0 14.5 38.4 10.9 0.0 0.8 1.3 4.4 0.7 3.5 9.8 5.2 5.6 0.7 5.8 5.8 5.9 0.9 1.7 0.7 3.1 14.6 1.9 19.0 18.2 28.3 23.8 19.7 10.7 20.3 14.7 18.2 23.0 47.6 38.1 41.7 41.8 35.5 18.7 18.5 15.3 21.4 25.0 26.2 49.1 16.2 21.6 12.4 73.4 61.8 21.2 0.0 10.8 12.8 37.0 40.7 17.4 29.3 18.3 17.5 6.9 34.4 16.8 61.5 23.6 23.6 74.2 10.0 12.1 12.6 14.1 11.5 13.8 22.1 30.4 6.5 44.0 25.6 13.5 26.7 4.9 41.5 15.5 32.6 ASXL2 "ASXH2, FLJ10898, KIAA1685" ENSG00000143970 "Additional sex combs like 2, transcriptional regulator" Q76L83 2 25733753-25878516 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034646, HPA058040" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA034646: AB_2674261, HPA058040: AB_2683586" "unprognostic (4.78e-2)" "unprognostic (3.41e-2)" "unprognostic (2.23e-2)" "unprognostic (1.09e-2)" "unprognostic (1.01e-1)" "unprognostic (2.88e-2)" "unprognostic (2.98e-2)" "unprognostic (2.80e-1)" "unprognostic (2.68e-3)" "unprognostic (3.17e-2)" "unprognostic (1.39e-2)" "unprognostic (1.29e-1)" "unprognostic (1.33e-3)" "unprognostic (1.82e-1)" "unprognostic (1.58e-1)" "unprognostic (2.31e-1)" "unprognostic (3.75e-2)" 15.0 14.9 14.5 14.1 16.5 10.4 13.1 23.0 16.1 14.4 13.9 15.7 13.0 9.8 14.7 9.9 17.5 12.1 10.0 14.2 15.2 8.9 14.7 10.2 13.1 15.3 14.3 8.5 11.4 12.1 28.0 17.4 17.4 13.9 10.5 14.2 12.6 15.3 14.1 20.5 14.2 12.9 13.3 12.3 15.4 12.1 20.7 18.0 26.2 16.5 10.7 17.0 16.7 13.5 3.0 3.7 4.7 2.7 1.8 4.5 1.3 15.7 9.5 7.3 5.2 7.3 10.3 9.4 8.7 13.6 8.5 7.7 10.5 8.6 9.8 5.1 9.8 10.0 9.8 14.4 10.6 12.3 9.8 6.6 17.4 8.5 11.5 6.2 19.2 17.4 5.1 11.1 13.0 10.3 7.6 10.9 6.2 15.1 7.9 9.0 6.4 9.0 6.4 10.3 9.2 6.7 10.1 25.0 7.9 7.9 10.7 8.0 9.0 10.5 10.0 8.8 7.5 5.6 8.2 14.4 12.1 13.8 10.4 12.5 16.1 15.8 20.5 11.3 16.2 8.6 2.1 2.4 3.7 4.5 2.7 3.6 2.7 3.5 3.9 2.3 3.0 3.0 3.6 4.7 1.8 2.4 3.7 2.5 1.3 14.5 16.5 23.0 16.1 15.2 8.9 14.3 8.5 13.9 18.0 23.8 17.9 16.0 8.0 28.7 21.5 25.8 10.2 38.8 15.9 8.7 23.6 9.0 13.3 13.9 36.9 22.2 10.5 0.0 12.4 7.4 14.5 11.0 23.1 13.9 16.0 23.8 9.9 26.4 25.3 19.7 18.1 21.6 21.9 15.4 16.7 13.6 14.9 14.0 12.4 12.9 24.1 38.8 11.0 30.5 24.7 35.9 12.2 28.8 15.6 13.8 ASZ1 "ALP1, ANKL1, C7orf7, CT1.19, GASZ, Orf3" ENSG00000154438 "Ankyrin repeat, SAM and basic leucine zipper domain containing 1" Q8WWH4 7 117363222-117428123 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "testis: 15.7" "Cell type enriched" "Detected in some" 4 "Spermatocytes: 87.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 24 "Daudi: 4.0;U-266/70: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA020558 Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA020558: AB_1845123" "unprognostic (4.30e-1)" "unprognostic (1.87e-1)" "unprognostic (1.42e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 0.0 87.1 20.1 0.0 0.0 0.0 0.0 0.1 ATAD2 "ANCCA, CT137, DKFZp667N1320, MGC29843, MGC5254, PRO2000" ENSG00000156802 "ATPase family, AAA domain containing 2" Q6PL18 8 123319850-123416350 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 53.8" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 74.6;Spermatogonia: 90.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 75.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029424, CAB056158" Enhanced Enhanced Nucleoplasm Yes Yes Nucleoplasm "CAB056158: AB_2665580, HPA029424: AB_10611680" "unprognostic (1.56e-1)" "unprognostic (4.55e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.08e-1)" "unprognostic (4.44e-2)" "unprognostic (2.98e-2)" "unprognostic (2.74e-3)" "unprognostic (2.02e-3)" "unprognostic (5.62e-2)" "unprognostic (1.19e-2)" "unprognostic (4.98e-2)" "prognostic unfavorable (8.33e-15)" "unprognostic (1.15e-2)" "unprognostic (1.82e-1)" "unprognostic (4.84e-2)" "unprognostic (6.17e-2)" 4.1 4.9 4.6 12.6 9.2 22.8 7.2 5.6 6.9 14.0 8.6 1.5 13.4 5.3 4.7 5.0 10.7 4.7 3.5 13.7 4.2 6.3 2.2 10.1 9.8 13.7 4.0 4.3 9.9 3.9 3.5 18.7 5.2 4.0 11.4 7.5 2.4 6.8 15.4 13.8 7.2 6.6 5.5 4.1 8.8 6.9 20.2 3.4 53.8 4.8 6.3 12.7 9.9 5.9 4.3 2.3 7.2 2.8 4.0 7.4 1.8 25.5 9.9 14.2 4.8 2.5 3.2 6.2 20.0 6.9 17.3 19.3 7.5 11.1 16.7 6.1 6.3 6.8 12.2 18.9 6.4 27.8 23.2 10.1 30.0 10.7 15.2 1.0 10.9 14.9 1.0 1.0 16.4 5.4 3.7 5.2 9.8 14.0 17.0 12.8 26.4 31.4 8.2 2.5 19.3 9.9 16.4 16.9 9.0 6.1 11.7 18.2 7.9 29.0 75.6 5.1 6.0 15.4 10.4 3.2 13.1 18.1 10.3 24.0 5.5 9.8 15.5 8.6 18.4 10.2 7.2 1.5 5.4 2.9 1.3 4.0 4.3 4.2 4.8 2.3 2.8 2.8 3.0 0.4 4.0 2.8 0.3 7.4 1.8 4.6 9.2 5.6 6.9 4.2 6.3 4.0 4.3 4.0 3.4 6.0 8.3 14.2 19.9 14.1 2.5 22.9 2.5 5.3 11.4 3.5 3.9 8.2 1.7 2.4 46.2 6.7 2.2 23.3 1.9 21.2 7.3 19.9 13.9 14.0 9.7 1.6 1.2 9.2 11.1 17.9 6.9 6.6 1.7 5.4 4.4 5.2 2.7 3.5 13.1 0.9 2.1 0.0 8.6 74.6 90.7 10.7 11.3 15.3 12.8 24.8 ATAD2B KIAA1240 ENSG00000119778 "ATPase family, AAA domain containing 2B" Q9ULI0 2 23748664-23927114 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034555 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA034555: AB_10601665" "unprognostic (2.40e-1)" "unprognostic (4.36e-2)" "unprognostic (2.58e-1)" "unprognostic (2.16e-1)" "unprognostic (1.62e-2)" "unprognostic (5.93e-3)" "unprognostic (5.57e-3)" "unprognostic (2.22e-2)" "unprognostic (1.85e-2)" "unprognostic (1.23e-1)" "unprognostic (9.14e-2)" "unprognostic (7.56e-3)" "prognostic unfavorable (2.35e-5)" "unprognostic (2.46e-1)" "unprognostic (2.68e-1)" "unprognostic (2.67e-2)" "unprognostic (1.98e-1)" 9.5 6.0 10.8 13.9 11.7 16.7 12.2 17.1 8.1 8.9 6.8 7.0 7.5 9.8 10.1 5.6 11.3 8.1 7.8 7.2 9.2 4.9 6.2 8.0 13.9 13.0 8.7 5.2 11.9 8.8 10.6 14.0 7.9 7.9 8.5 8.7 8.8 9.5 5.1 17.1 15.9 9.6 13.4 8.0 9.4 7.6 8.1 10.5 25.3 10.5 6.1 12.5 7.5 13.3 7.6 11.5 13.2 8.8 6.0 5.9 1.8 3.7 3.2 10.4 4.8 3.0 3.3 8.2 2.5 2.1 3.3 2.3 5.0 1.8 12.3 2.3 2.3 1.5 5.0 8.0 2.8 2.8 8.0 3.9 10.4 4.0 6.0 3.3 9.2 7.8 2.6 4.9 2.0 3.3 2.8 4.5 7.0 11.0 5.5 2.6 6.4 8.6 10.8 6.1 6.3 1.8 9.8 11.3 2.8 3.7 8.4 4.8 8.0 6.9 8.5 3.7 6.0 4.2 9.2 4.3 3.4 3.9 2.8 2.9 5.7 2.6 9.3 1.8 10.6 3.1 12.4 8.8 5.1 4.5 5.1 4.9 7.6 4.1 3.9 7.9 7.6 5.9 4.8 13.2 6.0 6.1 11.5 3.5 1.8 10.8 11.7 17.1 8.1 9.2 4.9 8.7 5.2 7.9 10.5 3.0 13.6 5.9 7.4 9.5 25.2 7.3 7.6 9.4 13.6 8.7 45.2 6.8 0.0 5.9 48.6 10.5 13.7 0.0 10.4 6.3 8.6 8.4 12.7 8.3 7.2 9.5 15.0 14.1 15.1 22.9 11.5 15.7 3.3 22.6 9.8 16.3 7.9 17.3 10.3 1.7 44.5 6.5 9.2 14.4 11.8 15.3 9.2 12.1 8.1 10.7 ATAD5 "C17orf41, ELG1, FLJ12735, FRAG1" ENSG00000176208 "ATPase family, AAA domain containing 5" Q96QE3 17 30831970-30895869 "Predicted intracellular proteins" "DNA damage" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 19.0;lymphoid tissue: 29.9" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 32.2;Spermatogonia: 35.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA066823 Approved "Nucleoplasm,Cytokinetic bridge,Centriolar satellite,Cytosol" "Intracellular and membrane" Yes No Nucleoplasm "Cytokinetic bridge, Centriolar satellite, Cytosol" "HPA066823: " "unprognostic (3.12e-1)" "unprognostic (7.36e-2)" "unprognostic (1.12e-2)" "unprognostic (1.36e-3)" "unprognostic (3.33e-1)" "unprognostic (1.05e-2)" "unprognostic (1.28e-4)" "unprognostic (1.77e-1)" "unprognostic (1.79e-3)" "unprognostic (7.24e-2)" "unprognostic (2.78e-1)" "unprognostic (3.19e-3)" "unprognostic (6.30e-10)" "unprognostic (3.10e-2)" "unprognostic (1.19e-1)" "unprognostic (3.42e-1)" "unprognostic (1.38e-1)" 2.0 1.2 1.1 8.1 3.8 19.0 2.4 9.6 3.2 2.7 3.3 1.2 0.7 2.8 2.1 2.5 4.0 2.0 1.7 1.4 1.8 1.3 1.9 1.4 2.3 6.4 1.9 2.7 3.0 1.7 1.3 3.1 5.3 2.3 1.8 3.1 0.6 2.1 1.2 1.3 4.5 3.4 1.5 1.5 6.3 2.2 4.0 2.6 29.9 1.8 2.7 5.3 1.8 2.7 2.3 2.1 3.1 1.3 3.0 1.6 0.3 4.8 4.0 9.6 9.1 0.2 1.0 3.8 4.2 2.2 4.7 6.8 4.4 3.4 12.9 4.1 2.0 3.2 8.8 6.2 3.2 8.6 2.9 5.4 7.8 5.2 3.0 0.1 15.2 6.4 0.4 0.4 7.0 2.4 0.9 2.4 12.7 12.1 10.9 3.1 2.8 16.9 7.5 5.6 3.5 1.9 11.6 18.2 6.2 1.2 5.1 5.6 5.0 4.8 2.7 2.5 5.5 5.2 6.8 1.9 5.9 7.9 8.3 7.6 3.6 3.8 16.3 2.6 7.2 5.7 1.2 1.0 1.4 1.6 1.3 0.9 1.2 0.9 1.2 0.7 2.3 1.1 1.2 3.1 3.0 0.6 2.1 1.4 0.3 1.1 3.8 9.6 3.2 1.8 1.3 1.9 2.7 2.3 2.6 3.0 2.6 13.3 3.2 4.1 18.5 2.7 0.0 4.0 3.4 3.5 0.0 13.2 0.0 2.7 12.9 2.9 2.2 0.0 2.5 20.4 3.9 1.6 3.5 0.5 7.3 11.1 0.0 2.5 3.2 4.6 3.4 7.2 6.8 10.8 4.5 3.9 2.9 2.9 2.1 0.3 19.9 0.0 6.2 32.2 35.1 4.0 6.6 5.3 9.3 1.4 ATE1 ENSG00000107669 "Arginyltransferase 1" O95260 10 121740421-121928801 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 62.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038444, HPA057549" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA038444: AB_10672745, HPA057549: AB_2683463" "unprognostic (1.37e-1)" "unprognostic (5.19e-2)" "unprognostic (2.75e-3)" "unprognostic (2.40e-1)" "unprognostic (4.67e-2)" "unprognostic (6.65e-3)" "unprognostic (1.85e-1)" "unprognostic (1.42e-1)" "unprognostic (1.71e-1)" "unprognostic (1.00e-1)" "unprognostic (2.52e-1)" "unprognostic (5.69e-2)" "prognostic favorable (2.67e-4)" "unprognostic (3.20e-1)" "unprognostic (8.08e-2)" "unprognostic (2.16e-1)" "unprognostic (1.02e-1)" 15.4 16.9 14.6 16.8 18.8 14.7 16.9 23.1 20.8 17.4 18.8 17.6 12.6 13.5 14.4 14.3 15.7 13.6 14.4 27.5 15.0 18.4 23.1 23.0 14.0 11.7 17.6 14.0 14.4 13.4 23.6 22.5 15.0 15.4 16.5 20.0 19.0 14.1 16.6 33.6 12.0 16.2 25.8 15.6 12.9 12.0 18.1 14.6 21.4 22.0 11.2 14.3 22.8 15.2 14.0 14.4 17.1 11.5 9.9 16.0 8.5 10.0 17.1 13.3 11.2 9.2 11.0 9.1 8.8 15.9 10.6 11.2 22.2 12.5 12.4 7.3 10.1 7.1 10.3 12.3 8.8 10.3 20.4 10.9 4.4 7.5 17.9 9.4 18.9 10.4 8.0 8.2 11.0 23.3 12.5 11.5 8.2 6.8 25.7 8.4 6.3 10.2 7.8 6.8 10.9 8.2 10.0 14.0 7.2 13.4 8.6 3.8 12.4 12.0 8.5 18.2 8.9 6.2 4.8 14.1 6.1 6.0 9.1 15.7 22.4 30.8 15.1 9.5 13.2 5.1 17.1 11.1 14.7 16.0 11.1 15.5 13.0 13.9 13.7 9.4 14.0 15.7 14.3 8.1 9.9 11.5 14.4 13.6 8.5 14.6 18.8 23.1 20.8 15.0 18.4 17.6 14.0 15.4 14.6 8.9 15.8 7.4 11.5 7.4 21.9 62.1 7.6 12.0 14.8 19.2 11.8 6.1 14.9 9.2 5.3 13.6 18.8 0.0 11.6 8.0 10.8 18.1 11.6 23.8 8.5 22.3 21.2 26.4 14.8 5.8 19.0 10.5 13.5 6.4 14.8 18.4 12.5 14.4 24.4 29.3 31.4 0.0 11.7 23.5 33.8 15.3 7.2 10.4 15.0 14.6 ATF1 TREB36 ENSG00000123268 "Activating transcription factor 1" P18846 12 50763710-50821122 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016222, HPA055069, HPA055406" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB016222: AB_2290030, HPA055069: AB_2682688, HPA055406: AB_2682807" "unprognostic (1.71e-1)" "unprognostic (1.50e-3)" "unprognostic (1.50e-1)" "unprognostic (9.05e-2)" "unprognostic (6.68e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (1.53e-5)" "unprognostic (3.65e-1)" "unprognostic (8.17e-3)" "unprognostic (5.94e-2)" "unprognostic (4.31e-3)" "unprognostic (5.52e-2)" "unprognostic (1.73e-1)" "unprognostic (2.74e-2)" "unprognostic (2.46e-1)" "unprognostic (2.27e-1)" "unprognostic (8.75e-2)" 24.4 20.7 9.8 13.7 9.5 10.2 16.2 28.1 10.6 22.4 19.7 8.1 14.6 12.3 19.2 14.2 16.2 15.5 13.4 20.0 10.8 8.0 17.7 19.8 15.1 15.8 12.2 6.0 24.7 11.8 18.1 15.2 36.1 11.9 20.7 15.1 12.5 16.3 14.2 37.9 12.9 18.8 13.4 12.3 22.9 12.7 9.3 13.9 34.4 30.8 16.3 16.2 21.6 20.0 13.3 13.6 26.3 12.3 12.2 18.8 11.6 13.5 9.8 10.4 10.6 15.0 16.0 25.9 14.4 24.8 22.8 18.0 20.1 21.5 18.7 23.8 16.6 10.0 11.3 12.3 14.8 24.4 18.4 12.7 20.6 22.2 10.7 28.8 29.6 19.8 17.0 23.5 16.3 26.8 23.8 11.0 13.2 25.1 18.1 16.9 20.1 18.6 18.8 15.1 15.7 15.7 17.9 16.2 22.1 17.3 9.3 14.0 7.6 30.5 13.3 21.7 14.9 18.5 18.1 7.6 16.1 19.5 13.5 11.4 10.0 11.8 29.9 15.5 16.7 7.6 4.2 11.5 26.3 13.9 12.3 15.8 13.0 15.1 16.4 13.6 13.3 18.8 14.3 7.3 12.2 7.7 6.2 17.9 11.6 9.8 9.5 28.1 10.6 10.8 8.0 12.2 6.0 11.9 13.9 50.6 14.4 34.4 42.6 66.9 12.0 12.9 10.2 18.7 23.9 12.2 0.0 27.2 44.7 20.3 6.5 18.6 17.3 70.0 18.5 60.0 36.0 33.7 9.3 15.7 24.6 12.7 5.8 15.4 21.9 4.9 29.7 29.4 21.9 18.0 13.9 12.9 18.2 14.0 26.2 25.4 6.9 38.8 32.0 9.3 10.2 47.7 67.4 30.9 21.2 30.7 ATF2 "CRE-BP1, CREB2, HB16, TREB7" ENSG00000115966 "Activating transcription factor 2" P15336 2 175072250-175168382 "Enzymes, Predicted intracellular proteins, Transcription factors" "DNA damage, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 100.8;Late spermatids: 111.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003769, HPA022134" Supported Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB003769: AB_562241, HPA022134: AB_1845138" "unprognostic (1.11e-1)" "unprognostic (2.01e-1)" "unprognostic (9.81e-2)" "unprognostic (1.93e-1)" "unprognostic (9.29e-3)" "unprognostic (2.56e-1)" "prognostic unfavorable (7.08e-5)" "unprognostic (2.28e-2)" "unprognostic (3.70e-2)" "unprognostic (6.47e-2)" "unprognostic (7.17e-2)" "unprognostic (4.02e-2)" "unprognostic (4.40e-3)" "unprognostic (1.15e-2)" "unprognostic (1.50e-1)" "unprognostic (7.21e-3)" "unprognostic (6.70e-2)" 25.3 21.0 25.3 14.3 29.3 14.3 19.7 39.6 33.4 27.5 15.9 18.0 15.7 12.8 22.4 22.6 16.0 19.5 17.9 14.1 25.1 28.0 23.0 26.8 15.2 17.6 23.2 18.4 27.3 19.0 24.0 33.0 19.9 29.6 19.0 16.0 14.9 16.8 19.1 13.9 10.1 13.2 18.3 22.9 17.5 13.8 19.9 18.9 34.6 32.6 10.2 20.1 21.7 16.7 15.0 18.7 24.2 14.8 15.3 22.0 14.3 7.3 6.5 19.4 12.5 17.3 18.5 8.9 12.1 20.8 14.7 21.4 14.0 13.8 11.1 13.3 14.2 17.4 7.2 14.7 7.4 23.1 13.8 8.5 15.7 11.9 30.5 19.4 14.5 16.5 13.8 16.5 18.9 22.6 19.5 20.2 10.5 12.7 17.4 16.4 5.6 23.4 18.1 18.0 12.6 14.8 20.4 8.9 17.2 21.5 6.5 16.1 13.3 15.2 4.7 17.8 16.3 10.5 16.2 12.7 17.2 9.0 9.1 7.2 16.6 25.0 14.2 13.5 13.9 11.6 24.2 14.4 16.8 18.2 12.8 22.0 15.0 15.7 18.8 18.7 12.7 18.3 19.9 9.3 15.3 14.8 10.5 19.8 14.3 25.3 29.3 39.6 33.4 25.1 28.0 23.2 18.4 29.6 18.9 14.9 10.4 18.4 14.2 29.3 20.8 18.7 20.4 21.4 14.8 22.7 9.8 11.7 11.6 12.1 100.8 23.3 13.2 0.0 6.1 9.9 28.8 16.7 28.9 24.6 16.4 38.1 15.6 18.4 26.8 111.2 30.2 20.4 28.7 10.0 14.8 24.9 12.5 8.6 26.9 14.9 24.6 12.9 38.1 32.4 11.7 22.1 5.3 24.5 13.6 9.5 ATF3 ENSG00000162772 "Activating transcription factor 3" P18847 1 212565334-212620777 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 138.4" "Cell type enhanced" "Detected in many" 5 "Glandular cells: 644.1;Intestinal endocrine cells: 855.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 6.1;intermediate monocyte: 5.5;myeloid DC: 2.2;non-classical monocyte: 8.1" "Group enriched" "Detected in many" 12 "dendritic cells: 2.2;granulocytes: 6.1;monocytes: 8.1" "Cell line enhanced" "Detected in many" "BEWO: 39.9;SuSa: 49.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" HPA001562 Approved Supported Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "HPA001562: AB_1078233" "unprognostic (2.66e-2)" "unprognostic (1.52e-2)" "unprognostic (2.80e-1)" "unprognostic (4.27e-3)" "unprognostic (3.29e-1)" "unprognostic (1.46e-1)" "unprognostic (1.31e-1)" "unprognostic (1.73e-1)" "unprognostic (9.31e-2)" "unprognostic (8.65e-3)" "unprognostic (8.75e-2)" "unprognostic (1.52e-1)" "unprognostic (6.97e-2)" "unprognostic (3.31e-2)" "unprognostic (1.10e-1)" "unprognostic (2.04e-2)" "unprognostic (2.08e-2)" 41.5 21.5 9.5 41.0 7.1 9.4 30.2 3.0 8.0 30.0 16.2 15.3 36.4 5.0 34.9 28.6 31.4 38.1 33.4 31.8 6.5 6.9 19.4 36.1 42.8 4.6 13.5 6.5 23.1 16.0 15.1 12.4 65.1 9.4 30.4 15.0 8.1 12.1 138.4 13.2 39.5 11.4 76.1 13.0 5.4 31.6 10.7 12.4 1.5 45.5 37.3 7.4 38.3 33.8 0.3 2.2 6.1 8.1 0.0 0.4 0.8 6.1 0.3 12.3 2.6 1.2 3.2 39.9 4.4 3.5 3.8 9.1 8.1 4.6 0.1 2.0 0.2 20.8 3.4 7.3 1.1 6.3 29.1 7.1 0.4 3.6 2.9 22.6 2.6 6.9 5.5 19.8 10.6 24.7 0.7 0.7 7.1 2.8 23.2 0.5 0.8 7.9 1.6 8.8 3.3 2.6 2.3 8.2 5.2 0.5 0.9 5.5 5.6 5.7 10.3 17.3 49.4 6.0 1.9 0.7 1.1 5.9 3.7 2.0 18.3 7.7 2.1 3.6 1.4 3.2 6.1 0.9 0.0 0.4 5.5 0.4 0.1 0.1 0.0 2.2 0.3 0.0 0.0 0.3 0.0 8.1 1.1 0.0 0.8 9.5 7.1 3.0 8.0 6.5 6.9 13.5 6.5 9.4 12.4 393.1 144.2 7.7 234.8 180.1 3.7 604.8 73.9 128.5 135.4 52.4 0.0 136.7 1.7 158.3 2.8 136.2 500.9 0.0 108.1 256.8 236.1 644.1 77.3 21.2 99.6 1.6 855.0 28.8 13.4 2.5 16.1 211.8 165.4 55.1 427.3 12.1 155.6 312.1 1.1 1.2 2.5 97.0 421.2 0.3 2.1 177.2 351.7 6.9 216.0 169.1 ATF5 ENSG00000169136 "Activating transcription factor 5" Q9Y2D1 19 49928702-49933935 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 24 "liver: 470.7" "Cell type enhanced" "Detected in all" 19 "Hepatocytes: 1071.5;monocytes: 428.4" "Cancer enriched" "Detected in all" 7 "liver cancer: 200.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 11.9;intermediate monocyte: 11.7;myeloid DC: 7.5;plasmacytoid DC: 18.7" "Group enriched" "Detected in all" 7 "dendritic cells: 18.7;monocytes: 11.9" "Cell line enhanced" "Detected in all" "HDLM-2: 45.9;Karpas-707: 79.8;THP-1: 66.5;U-266/84: 101.3;U-698: 47.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030187 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030187: AB_10601666" "unprognostic (2.09e-2)" "prognostic favorable (1.14e-4)" "unprognostic (9.38e-3)" "prognostic unfavorable (1.16e-4)" "unprognostic (1.18e-1)" "unprognostic (1.03e-2)" "unprognostic (2.52e-1)" "unprognostic (6.70e-2)" "unprognostic (3.11e-2)" "unprognostic (2.36e-1)" "unprognostic (4.83e-2)" "unprognostic (2.96e-3)" "prognostic unfavorable (3.39e-7)" "unprognostic (3.06e-2)" "unprognostic (8.06e-2)" "unprognostic (1.19e-1)" "unprognostic (2.51e-1)" 4.6 6.6 2.1 5.0 2.7 2.9 7.0 1.3 2.2 2.4 2.9 2.4 3.9 4.6 2.3 4.0 3.4 2.6 3.1 4.2 2.1 2.1 3.0 470.7 2.8 5.0 2.2 1.4 2.6 3.8 1.4 1.9 4.4 2.1 2.8 1.6 2.6 3.1 2.5 4.3 2.1 4.2 2.5 2.6 3.3 2.8 5.3 1.9 3.8 20.0 3.3 5.5 5.6 7.1 1.1 18.7 2.2 11.9 1.5 1.3 2.5 10.0 7.0 2.7 1.8 2.8 2.4 2.7 7.4 6.2 7.6 4.6 5.3 5.5 9.0 3.7 4.2 5.2 3.6 3.4 3.0 3.6 45.9 3.4 6.1 2.2 4.0 1.9 23.7 17.5 17.0 4.8 5.5 1.3 1.9 3.2 20.1 5.5 79.8 3.7 9.4 3.4 5.2 1.3 2.7 9.5 28.5 2.9 3.6 8.6 13.6 4.3 3.1 17.0 7.3 5.1 1.0 6.0 66.5 5.5 14.8 9.4 1.7 7.5 2.1 101.3 47.6 11.6 9.5 5.5 0.3 11.9 0.7 0.7 11.7 1.3 1.1 0.9 0.9 7.5 0.7 0.7 0.9 2.2 1.5 3.0 18.7 0.9 2.5 2.1 2.7 1.3 2.2 2.1 2.1 2.2 1.4 2.1 1.9 11.9 11.0 53.7 10.0 20.0 3.2 6.9 48.4 9.4 5.7 15.7 5.9 27.8 11.6 11.4 203.6 16.7 30.2 46.7 25.7 13.8 18.6 21.5 5.8 1071.5 79.6 87.4 20.6 44.2 56.2 107.0 12.4 56.5 38.8 428.4 16.5 9.5 17.3 14.4 15.6 28.4 7.2 12.9 15.1 6.2 5.7 21.0 29.7 10.2 18.3 15.5 ATF6B "CREBL1, G13" ENSG00000213676 "Activating transcription factor 6 beta" Q99941 6 32115264-32128253 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046871 Uncertain Approved Nucleoplasm,Nucleoli NA NA 31000000 Nucleoplasm Nucleoli "HPA046871: AB_10963542" "unprognostic (2.93e-3)" "unprognostic (1.56e-1)" "unprognostic (5.50e-2)" "unprognostic (1.82e-2)" "unprognostic (1.13e-1)" "unprognostic (4.37e-2)" "unprognostic (9.80e-3)" "unprognostic (1.55e-1)" "unprognostic (3.15e-1)" "unprognostic (3.68e-2)" "unprognostic (9.03e-2)" "unprognostic (3.66e-2)" "unprognostic (4.04e-3)" "unprognostic (1.75e-2)" "unprognostic (1.76e-1)" "unprognostic (3.86e-1)" "unprognostic (1.10e-2)" 11.7 19.4 23.1 13.7 29.4 24.9 14.3 20.2 19.1 17.8 20.2 15.4 9.8 11.2 19.2 32.7 20.0 27.7 15.4 11.0 19.4 11.4 13.5 14.0 15.6 17.0 20.6 16.5 22.6 18.4 38.1 16.1 21.1 16.9 16.8 18.8 14.1 16.2 14.0 7.1 17.8 15.9 9.4 12.8 22.8 20.2 19.5 17.0 21.7 21.2 11.8 21.0 18.0 16.4 4.4 5.7 6.6 4.1 5.6 4.9 4.4 0.7 2.9 8.1 3.0 6.0 6.8 2.9 3.3 3.1 7.3 9.1 9.4 15.7 14.3 11.5 29.1 10.5 4.6 10.9 21.8 5.3 2.9 12.0 1.0 15.1 10.0 19.9 1.1 17.4 11.4 9.7 1.3 20.2 18.4 19.7 26.9 18.9 19.0 18.5 7.4 10.0 7.0 2.4 14.0 0.5 0.7 3.5 6.4 6.5 1.4 0.5 0.8 14.2 7.7 19.2 3.7 24.2 1.8 8.5 4.0 4.4 6.4 9.8 19.1 8.2 6.7 9.2 6.6 9.8 6.6 2.2 1.9 4.9 4.1 4.7 4.4 2.8 2.3 5.7 3.4 1.8 3.5 2.5 5.6 3.7 3.8 4.5 4.4 23.1 29.4 20.2 19.1 19.4 11.4 20.6 16.5 16.9 17.0 11.9 14.6 95.8 29.3 22.0 84.7 1.7 45.9 28.1 10.3 52.4 90.3 71.4 5.0 39.2 2.4 30.3 49.8 0.0 37.3 41.1 28.7 30.1 16.1 18.3 46.0 41.3 51.5 37.4 39.0 3.2 65.6 45.4 30.4 53.3 48.7 43.1 31.4 49.1 48.8 11.3 83.5 58.2 28.4 71.1 55.1 22.1 74.6 74.8 52.7 35.4 ATF7 ATFA ENSG00000170653 "Activating transcription factor 7" P17544 12 53507856-53626410 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003384 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA003384: AB_1078234" "unprognostic (2.20e-2)" "unprognostic (3.10e-2)" "unprognostic (2.48e-2)" "unprognostic (7.96e-2)" "unprognostic (2.54e-1)" "unprognostic (4.73e-2)" "unprognostic (1.54e-2)" "unprognostic (9.16e-3)" "unprognostic (3.59e-3)" "unprognostic (8.03e-2)" "unprognostic (1.76e-3)" "unprognostic (2.59e-1)" "unprognostic (3.28e-3)" "prognostic unfavorable (2.10e-4)" "unprognostic (2.51e-1)" "unprognostic (3.37e-1)" "unprognostic (1.17e-1)" 22.6 12.2 18.3 14.6 25.3 11.4 21.5 56.1 22.9 17.8 17.7 31.6 12.1 10.5 21.5 13.0 19.7 14.6 15.6 18.8 20.1 9.5 15.1 12.3 18.0 10.3 28.2 12.9 23.5 15.6 15.3 17.3 15.4 22.2 17.1 18.6 15.6 21.9 13.4 23.1 20.9 12.2 24.5 22.3 11.4 16.1 12.4 27.5 11.4 15.2 10.8 13.1 18.1 18.4 11.5 11.4 14.2 19.5 15.5 11.5 9.3 10.0 19.5 10.4 11.4 19.9 25.5 6.9 12.1 12.6 13.5 9.0 14.0 15.7 15.8 16.1 14.9 5.5 12.6 8.1 13.4 12.4 15.2 10.3 13.6 22.5 14.9 13.4 17.4 10.2 19.9 17.6 16.8 19.1 22.5 26.4 8.6 15.5 14.6 20.1 18.6 10.4 12.2 10.3 11.4 10.6 13.9 12.5 15.2 20.3 13.0 8.7 9.3 18.5 13.7 19.2 10.6 18.3 10.8 19.4 16.1 11.4 12.8 10.9 7.2 8.6 10.1 13.2 16.5 14.7 12.9 14.8 14.2 8.6 19.5 8.7 10.8 11.5 8.4 11.4 11.5 8.5 9.9 9.3 15.5 14.3 7.8 10.8 9.3 18.3 25.3 56.1 22.9 20.1 9.5 28.2 12.9 22.2 27.5 11.9 15.9 15.9 19.8 19.7 8.2 13.6 25.5 13.4 10.3 14.0 23.6 19.3 31.5 26.8 29.2 25.1 15.8 0.0 27.5 19.6 17.7 30.9 28.8 12.5 22.3 9.5 17.9 27.6 21.9 26.4 25.0 17.3 23.6 16.2 19.1 22.1 21.8 14.0 23.0 37.9 9.6 25.8 23.7 8.1 16.3 25.2 23.3 17.9 19.9 24.1 ATF7IP "FLJ10688, p621" ENSG00000171681 "Activating transcription factor 7 interacting protein" Q6VMQ6 12 14365632-14502935 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016578, HPA023505" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA016578: AB_1845147, HPA023505: AB_1845148" "unprognostic (2.06e-2)" "unprognostic (3.12e-2)" "unprognostic (1.25e-1)" "unprognostic (6.25e-3)" "unprognostic (1.20e-3)" "unprognostic (2.48e-2)" "unprognostic (5.84e-2)" "unprognostic (8.56e-3)" "unprognostic (7.36e-2)" "unprognostic (3.05e-2)" "unprognostic (3.62e-2)" "unprognostic (1.86e-1)" "unprognostic (7.90e-3)" "unprognostic (2.88e-1)" "unprognostic (7.64e-2)" "unprognostic (1.14e-2)" "unprognostic (3.78e-2)" 17.5 15.0 11.1 36.4 15.3 25.2 16.6 29.4 12.7 18.0 12.9 14.1 16.0 7.3 16.1 14.5 20.2 13.0 15.2 18.3 11.7 8.3 11.3 14.0 16.2 25.2 13.8 10.7 19.5 13.0 23.3 23.3 22.4 11.9 15.7 12.3 14.4 21.7 18.0 25.4 15.6 16.6 15.4 12.3 23.9 12.5 30.1 13.6 38.8 20.2 12.6 24.5 17.2 27.3 25.0 9.9 15.9 9.7 8.6 13.4 6.6 10.9 6.5 27.1 15.7 14.3 18.3 5.9 11.5 6.7 9.3 14.4 15.0 11.8 18.3 8.1 8.1 17.1 11.1 16.8 10.9 21.2 13.1 9.8 12.3 11.2 3.2 8.4 8.3 7.3 9.8 9.1 11.5 12.0 14.8 20.3 6.7 7.2 10.0 14.7 10.4 11.9 7.3 17.3 5.7 6.2 24.9 29.9 9.9 8.1 21.6 8.7 7.2 13.5 7.9 7.6 23.0 8.0 9.8 9.3 13.2 8.5 7.5 9.8 6.5 6.3 26.0 8.4 7.9 14.1 15.9 8.1 13.6 12.9 6.3 13.4 16.9 11.0 12.5 7.2 25.0 8.9 12.2 13.5 8.6 9.7 9.9 13.4 6.6 11.1 15.3 29.4 12.7 11.7 8.3 13.8 10.7 11.9 13.6 62.5 34.4 42.4 10.8 6.0 51.5 58.1 15.3 32.1 38.7 33.2 64.8 13.8 6.6 13.0 53.7 33.7 9.3 23.3 10.6 7.7 14.3 12.4 24.4 25.9 17.2 60.4 27.0 27.6 42.9 13.3 27.0 26.9 5.0 26.2 21.6 26.7 13.6 10.5 27.6 14.0 38.8 12.9 11.3 42.6 23.5 5.8 12.9 45.7 19.5 9.1 ATG10 "APG10L, DKFZP586I0418, FLJ13954" ENSG00000152348 "Autophagy related 10" Q9H0Y0 5 81972025-82276857 "Predicted intracellular proteins" "Autophagy, Protein transport, Transport, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 69.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044163 Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA044163: AB_2678842" "unprognostic (1.20e-1)" "unprognostic (7.96e-2)" "unprognostic (1.07e-2)" "unprognostic (2.51e-2)" "unprognostic (3.18e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (3.22e-5)" "unprognostic (5.60e-3)" "unprognostic (2.96e-2)" "unprognostic (1.92e-2)" "unprognostic (2.48e-1)" "unprognostic (1.21e-1)" "unprognostic (9.62e-2)" "unprognostic (1.67e-1)" "unprognostic (2.10e-1)" "unprognostic (1.30e-3)" "unprognostic (4.43e-1)" 8.2 9.2 8.4 6.3 13.6 8.4 11.7 11.3 15.4 7.2 8.9 14.7 7.5 5.5 12.0 13.7 10.9 7.2 7.3 8.0 8.4 7.9 9.3 10.4 7.1 8.3 10.3 13.5 5.8 9.9 23.0 9.5 7.9 11.3 9.6 10.2 12.4 8.6 9.6 10.3 10.9 6.0 9.1 10.4 6.7 7.1 27.0 8.9 22.8 11.7 4.6 9.9 9.2 8.2 7.6 11.4 12.2 9.3 9.2 8.9 6.0 3.4 9.2 6.0 17.0 4.0 7.7 15.3 4.0 3.2 2.9 4.5 2.7 12.5 6.0 3.4 6.4 22.4 2.0 4.3 8.9 3.9 10.2 3.1 6.6 8.7 2.8 3.9 3.4 5.5 7.1 6.1 4.3 3.6 4.5 5.5 13.0 7.9 5.2 10.6 6.9 7.8 4.0 8.5 2.5 6.0 5.9 8.6 14.4 7.5 4.8 8.9 12.8 6.5 3.6 7.4 10.7 7.0 6.5 4.3 5.6 5.2 2.8 8.3 7.0 11.7 8.3 7.4 8.3 8.9 3.3 9.3 12.2 8.4 8.8 7.9 5.9 7.5 7.7 11.4 7.6 7.2 8.9 12.1 9.2 6.5 8.8 7.4 6.0 8.4 13.6 11.3 15.4 8.4 7.9 10.3 13.5 11.3 8.9 14.9 14.1 6.0 15.3 22.0 16.1 7.0 12.7 9.4 18.2 12.2 9.8 22.1 13.3 13.4 56.8 11.3 7.8 0.0 16.0 38.5 13.5 10.0 10.5 11.9 15.9 17.5 9.2 9.2 11.9 69.6 6.4 17.8 30.4 20.8 7.6 11.4 14.5 9.9 9.6 13.5 14.7 0.0 13.4 45.1 18.1 28.0 17.6 15.2 10.9 11.2 ATG13 KIAA0652 ENSG00000175224 "Autophagy related 13" O75143 11 46617527-46674818 "Cancer-related genes, Predicted intracellular proteins, Transporters" Autophagy "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039350 Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA039350: AB_10673142" "unprognostic (3.66e-1)" "unprognostic (1.14e-1)" "unprognostic (1.51e-1)" "unprognostic (1.65e-1)" "unprognostic (5.36e-2)" "unprognostic (2.31e-1)" "prognostic unfavorable (8.59e-5)" "unprognostic (1.05e-1)" "unprognostic (1.10e-1)" "unprognostic (1.27e-1)" "unprognostic (1.35e-1)" "unprognostic (7.57e-2)" "unprognostic (2.44e-2)" "unprognostic (2.41e-1)" "unprognostic (2.14e-1)" "unprognostic (7.68e-2)" "unprognostic (3.47e-1)" 13.8 15.8 20.2 11.9 27.3 25.8 12.5 32.8 37.0 13.2 12.6 39.5 9.2 14.3 12.9 16.8 14.9 16.6 14.5 17.8 19.5 16.3 14.3 21.1 11.5 13.6 31.8 18.2 15.6 19.7 24.4 23.1 13.5 27.2 12.8 12.0 21.3 17.0 13.5 20.9 16.3 12.4 12.3 15.7 16.2 16.5 60.6 34.9 14.8 18.6 8.8 15.8 12.5 13.0 15.8 20.0 38.9 24.0 17.0 24.7 20.3 13.8 25.5 19.6 11.5 27.3 32.1 19.8 16.2 28.7 20.0 25.7 17.3 13.9 13.0 11.5 24.4 26.0 17.0 18.8 21.9 20.3 24.6 35.9 14.0 17.8 30.4 30.7 18.6 24.3 38.6 26.2 13.8 30.5 28.6 19.7 30.4 24.4 29.8 17.9 20.8 18.5 27.6 24.5 25.5 22.1 17.7 25.4 22.8 13.4 15.3 18.7 18.8 22.4 18.0 23.9 19.7 25.7 38.5 19.4 24.7 15.1 22.7 17.6 27.2 30.1 16.5 30.6 16.9 18.1 21.2 20.7 26.9 21.3 24.0 17.2 15.8 19.2 16.8 20.0 12.7 16.6 18.3 38.9 17.0 18.7 14.9 24.7 20.3 20.2 27.3 32.8 37.0 19.5 16.3 31.8 18.2 27.2 34.9 14.9 15.2 10.4 10.0 8.2 22.0 12.4 5.1 2.7 10.3 12.2 37.3 8.7 6.6 16.3 35.8 11.7 19.0 46.7 28.1 18.9 8.4 17.1 8.1 19.4 13.5 31.8 17.2 12.9 15.2 36.4 10.6 13.5 11.8 22.6 19.5 15.2 26.0 12.2 10.6 11.2 29.7 12.9 13.7 31.1 10.4 10.0 22.1 10.9 10.4 14.3 ATG16L2 "ATG16B, FLJ00012, WDR80" ENSG00000168010 "Autophagy related 16 like 2" Q8NAA4 11 72814308-72843674 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 60.9;lymphoid tissue: 52.0" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 45.9;Macrophages: 38.5;Paneth cells: 43.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 28.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045444, HPA050312" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA045444: AB_2679324, HPA050312: AB_2681082" "unprognostic (7.20e-3)" "unprognostic (1.16e-1)" "unprognostic (1.54e-1)" "unprognostic (4.26e-2)" "unprognostic (2.12e-1)" "unprognostic (1.31e-3)" "unprognostic (1.61e-2)" "unprognostic (4.74e-3)" "unprognostic (1.89e-1)" "unprognostic (1.90e-1)" "prognostic favorable (7.06e-4)" "unprognostic (2.49e-2)" "prognostic unfavorable (3.39e-4)" "unprognostic (1.74e-1)" "unprognostic (4.38e-2)" "unprognostic (1.08e-1)" "unprognostic (4.83e-2)" 7.8 6.6 7.1 20.7 8.0 60.9 7.2 7.4 6.2 9.5 9.7 10.5 7.6 5.5 11.9 7.5 10.2 8.3 11.6 5.8 7.4 4.8 7.2 6.5 16.3 16.4 10.7 7.0 10.1 8.0 5.7 11.5 5.2 8.6 7.3 8.9 11.3 10.1 5.5 3.6 35.7 13.1 10.4 7.9 52.0 6.6 2.6 8.3 3.2 6.5 8.0 19.6 8.5 8.5 2.0 4.7 28.5 7.1 2.4 2.6 1.4 1.4 1.3 4.1 3.2 4.9 4.0 2.6 3.2 3.2 1.6 2.5 1.6 3.5 9.6 2.1 4.1 2.9 2.9 0.5 10.8 2.8 7.6 1.6 7.5 6.9 2.7 3.6 9.8 31.3 3.9 1.5 3.6 4.5 17.9 4.9 17.6 1.0 13.2 1.8 4.7 11.3 16.9 0.6 6.4 1.5 5.6 2.9 4.2 5.3 4.9 3.1 2.4 1.3 7.2 3.0 3.4 3.6 13.5 6.8 4.4 1.6 7.9 2.5 6.0 1.5 4.2 1.9 8.8 2.4 2.4 7.1 18.1 1.3 3.9 1.3 1.2 1.9 2.6 4.7 2.0 1.0 1.2 28.5 2.4 4.7 0.8 1.7 1.4 7.1 8.0 7.4 6.2 7.4 4.8 10.7 7.0 8.6 8.3 6.0 18.4 16.7 5.1 14.8 2.6 4.4 5.1 6.7 3.4 5.2 2.0 6.8 0.0 3.7 0.5 7.9 8.0 0.0 0.9 3.1 5.6 2.8 23.0 2.9 15.2 4.8 12.6 12.9 45.9 0.4 9.5 38.5 3.3 16.2 9.0 4.0 2.3 43.6 7.4 1.6 3.7 0.0 6.6 1.6 7.7 15.2 10.3 23.5 10.4 4.2 ATG2A KIAA0404 ENSG00000110046 "Autophagy related 2A" Q2TAZ0 11 64894546-64917248 "Predicted intracellular proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 63.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 16.5" "Lineage enriched" "Detected in all" 6 "granulocytes: 16.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038715 Uncertain Supported Nucleoplasm,Vesicles "Intracellular and membrane" NA NA Vesicles Nucleoplasm "HPA038715: AB_10673474" "unprognostic (3.05e-2)" "unprognostic (2.33e-1)" "unprognostic (7.55e-2)" "unprognostic (1.18e-1)" "unprognostic (3.42e-1)" "unprognostic (9.23e-3)" "unprognostic (1.88e-2)" "unprognostic (1.12e-1)" "unprognostic (1.37e-1)" "unprognostic (2.68e-2)" "unprognostic (1.05e-1)" "unprognostic (1.66e-2)" "prognostic favorable (4.79e-5)" "unprognostic (2.92e-2)" "unprognostic (2.69e-1)" "unprognostic (3.37e-1)" "unprognostic (1.15e-1)" 8.4 8.3 6.0 8.4 10.4 63.7 7.1 12.2 14.3 7.2 9.2 11.6 8.2 10.0 9.5 5.5 6.1 7.7 8.9 6.4 7.0 6.4 9.0 33.2 9.3 7.7 7.5 7.5 11.8 11.7 7.6 8.7 8.9 9.0 8.5 4.3 12.1 9.3 8.4 12.4 15.9 11.4 9.7 6.7 11.1 9.2 8.0 8.2 13.2 8.4 7.8 9.4 7.9 6.2 1.0 2.3 16.5 2.0 1.5 2.6 0.9 9.9 9.7 3.6 9.6 4.7 3.3 9.5 5.5 8.3 7.6 5.6 8.6 7.9 7.2 11.7 4.8 9.8 8.6 3.6 6.6 2.0 6.7 12.4 6.4 14.5 7.7 6.7 5.0 14.9 9.1 5.8 9.6 5.1 4.4 6.3 7.3 12.1 5.9 3.3 16.2 6.0 17.0 4.1 2.8 10.8 6.7 5.6 10.4 4.1 8.6 13.1 5.1 8.1 11.8 10.2 2.8 11.4 6.4 8.0 7.2 7.1 14.2 4.2 11.5 4.0 5.1 10.6 4.0 4.5 2.8 2.0 2.0 2.6 1.9 2.2 0.8 1.7 2.2 1.3 1.0 1.4 2.5 16.5 1.5 1.5 2.3 0.9 0.9 6.0 10.4 12.2 14.3 7.0 6.4 7.5 7.5 9.0 8.2 8.9 14.4 11.8 7.7 25.6 17.0 5.6 2.5 10.7 10.3 8.7 31.4 11.2 1.7 8.3 1.7 9.0 26.4 0.0 8.9 4.7 14.6 10.6 9.2 17.5 9.7 12.7 34.4 8.6 14.6 2.5 11.8 16.9 28.7 10.8 12.8 10.3 12.5 16.1 9.6 5.2 25.4 12.9 10.7 6.2 5.5 33.5 56.0 39.2 15.6 13.5 ATG2B "C14orf103, FLJ10242" ENSG00000066739 "Autophagy related 2B" Q96BY7 14 96279202-96363870 "Predicted intracellular proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000880, HPA001427, HPA019665" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA000880: AB_1078888, HPA001427: AB_1845551, HPA019665: AB_2274278" "unprognostic (9.39e-2)" "unprognostic (1.01e-1)" "unprognostic (7.28e-2)" "unprognostic (1.07e-1)" "unprognostic (1.02e-1)" "unprognostic (6.01e-2)" "unprognostic (3.19e-1)" "unprognostic (9.29e-3)" "unprognostic (1.47e-1)" "unprognostic (1.21e-1)" "unprognostic (3.75e-3)" "unprognostic (1.45e-2)" "unprognostic (7.60e-3)" "unprognostic (6.66e-2)" "unprognostic (3.08e-1)" "unprognostic (3.90e-2)" "unprognostic (8.49e-2)" 3.6 3.4 2.6 2.5 4.1 4.4 5.2 9.2 4.5 3.9 3.2 3.1 4.9 4.4 2.9 4.0 3.0 2.7 3.2 3.3 4.5 6.0 3.4 3.1 3.0 5.1 8.1 9.7 4.1 2.7 4.0 3.2 3.1 3.1 5.2 9.3 4.3 3.8 2.7 3.9 3.6 6.5 4.9 3.5 3.3 3.6 1.5 1.6 2.1 1.0 2.5 3.0 0.7 4.1 5.2 6.5 5.1 11.3 10.5 5.2 6.1 8.7 6.7 7.6 2.8 2.8 9.2 5.8 9.9 4.5 5.7 8.8 6.0 10.8 8.5 4.5 4.0 5.7 2.5 7.4 7.3 4.4 8.8 6.1 9.0 7.2 7.1 8.4 7.0 4.6 8.3 5.3 6.6 6.6 6.3 3.1 4.8 5.4 6.1 14.6 6.2 7.5 5.1 6.4 7.2 9.2 3.8 4.4 7.0 6.0 4.2 11.2 3.7 1.7 9.0 3.9 8.4 6.9 8.6 7.6 5.1 3.6 0.6 1.0 1.7 1.6 0.6 3.0 1.5 1.8 1.7 1.3 1.5 1.9 2.0 2.1 2.5 1.0 1.6 2.7 0.7 11.9 10.5 7.5 2.8 12.2 24.5 11.2 7.6 2.7 6.8 8.7 25.5 4.4 3.3 5.2 31.1 9.8 8.2 0.0 5.2 2.7 7.8 11.1 6.9 23.2 3.6 30.2 7.9 13.5 10.5 36.0 11.8 8.9 1.7 3.6 11.8 8.5 4.9 10.5 9.9 6.8 19.0 6.5 8.5 15.6 13.8 24.6 13.2 6.5 8.7 3.1 ATG4B "Apg4B, AUTL1, DKFZp586D1822, KIAA0943" ENSG00000168397 "Autophagy related 4B cysteine peptidase" Q9Y4P1 2 241637213-241673857 "Enzymes, Predicted intracellular proteins, Transporters" "Autophagy, Protein transport, Transport, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037195, HPA069803" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB037195: AB_1078237, HPA069803: AB_2686200" "unprognostic (1.51e-1)" "unprognostic (8.80e-2)" "prognostic unfavorable (6.85e-4)" "unprognostic (1.51e-1)" "unprognostic (2.43e-2)" "unprognostic (2.67e-3)" "unprognostic (1.07e-3)" "unprognostic (1.06e-1)" "unprognostic (1.61e-1)" "unprognostic (1.58e-1)" "unprognostic (1.15e-3)" "unprognostic (3.02e-2)" "prognostic unfavorable (2.79e-4)" "unprognostic (2.60e-1)" "unprognostic (6.63e-2)" "unprognostic (1.66e-1)" "prognostic favorable (9.64e-4)" 10.9 16.5 19.6 16.6 21.3 31.3 15.1 34.8 25.7 13.5 18.7 21.7 23.2 14.6 33.5 24.0 26.7 17.7 18.8 19.5 20.5 21.5 17.2 15.5 15.8 19.4 29.2 19.7 17.3 19.2 18.7 27.4 15.4 20.3 20.5 18.9 20.8 22.8 14.2 17.2 26.6 21.1 18.9 23.1 18.7 15.5 28.0 21.4 21.2 18.2 7.3 21.9 15.3 14.4 16.5 20.3 18.9 18.6 11.4 19.6 16.8 8.7 13.6 19.5 15.0 19.5 14.2 19.3 12.8 14.0 16.6 13.8 14.9 15.5 6.7 5.8 23.0 13.4 12.9 18.5 24.4 16.1 14.3 18.8 19.8 22.0 32.2 25.4 11.4 11.1 14.1 17.0 18.6 18.0 17.7 17.1 26.1 16.8 10.3 18.8 21.4 20.4 20.1 22.7 15.7 14.5 35.2 17.9 10.1 13.0 28.3 19.5 13.5 10.9 14.5 15.3 16.6 16.0 16.8 18.6 15.8 10.8 10.5 13.8 11.6 12.1 25.7 19.2 14.2 14.8 4.6 18.6 18.9 18.7 15.5 15.5 15.7 15.2 16.5 20.3 16.5 19.6 14.7 14.8 11.4 16.2 16.3 19.3 16.8 19.6 21.3 34.8 25.7 20.5 21.5 29.2 19.7 20.3 21.4 29.8 35.6 22.7 23.7 21.6 21.6 14.1 33.1 10.7 13.6 26.2 31.4 31.0 16.6 32.4 12.9 23.6 57.6 23.3 34.9 23.5 23.5 30.3 18.5 24.9 29.3 39.7 34.4 24.5 27.8 19.8 20.4 31.5 27.0 64.1 34.3 30.2 33.1 28.1 23.3 18.2 25.2 19.4 23.4 44.0 53.5 22.2 45.1 33.0 27.0 27.5 ATG4C "APG4C, AUTL1, AUTL3, FLJ14867" ENSG00000125703 "Autophagy related 4C cysteine peptidase" Q96DT6 1 62784135-62865513 "Enzymes, Predicted intracellular proteins" "Autophagy, Protein transport, Transport, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007049 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA007049: AB_1845159" "unprognostic (1.28e-1)" "unprognostic (2.69e-1)" "prognostic favorable (9.83e-4)" "unprognostic (7.43e-2)" "unprognostic (1.17e-1)" "unprognostic (1.70e-1)" "unprognostic (3.76e-2)" "unprognostic (8.36e-2)" "unprognostic (1.83e-2)" "unprognostic (1.30e-1)" "unprognostic (3.77e-1)" "unprognostic (1.93e-1)" "unprognostic (5.66e-2)" "unprognostic (1.81e-1)" "unprognostic (4.17e-2)" "unprognostic (3.26e-2)" "unprognostic (1.19e-1)" 8.8 9.8 19.4 11.3 32.8 6.0 9.2 16.7 23.4 10.6 9.5 29.8 7.2 7.7 9.6 7.2 8.6 8.0 10.4 7.2 23.7 15.5 13.5 12.6 9.2 13.7 42.6 16.5 10.3 11.2 15.5 11.3 15.0 22.4 8.0 10.6 4.9 10.8 8.0 6.4 6.3 7.8 11.2 26.5 13.3 8.6 8.9 40.4 11.0 12.0 3.7 12.4 13.4 6.8 20.6 19.4 16.0 10.9 7.0 9.4 6.7 7.6 6.1 9.5 8.3 12.5 13.5 9.5 11.5 7.8 11.1 12.5 4.5 6.1 16.3 8.9 5.8 13.0 5.9 11.3 8.7 16.1 12.2 10.4 18.3 6.5 5.8 8.9 14.8 12.3 11.1 6.2 11.8 5.6 10.8 13.3 18.0 15.5 13.3 9.3 3.6 14.9 5.7 13.9 11.0 10.1 17.9 22.8 11.5 8.0 5.6 12.9 6.5 7.6 14.4 14.8 17.2 7.0 7.0 5.2 8.9 8.7 15.0 12.6 11.6 15.6 13.3 10.2 14.7 10.7 16.0 10.9 8.5 4.8 8.8 6.6 20.6 6.6 5.6 19.4 19.1 9.4 7.7 1.6 7.0 5.0 11.6 5.7 6.7 19.4 32.8 16.7 23.4 23.7 15.5 42.6 16.5 22.4 40.4 6.0 8.8 28.4 6.2 4.4 5.1 8.1 10.2 1.4 9.1 7.0 2.0 33.2 16.6 6.4 1.3 11.6 3.6 0.0 7.3 24.5 8.4 4.1 11.5 8.9 31.5 4.8 5.8 13.5 18.6 1.4 8.1 20.5 8.5 30.7 4.4 9.7 4.5 4.5 9.2 19.9 5.1 6.5 7.6 30.5 13.3 3.4 24.3 9.6 6.6 2.7 ATG4D "APG4-D, APG4D, AUTL4" ENSG00000130734 "Autophagy related 4D cysteine peptidase" Q86TL0 19 10543895-10553418 "Enzymes, Predicted intracellular proteins, Transporters" "Apoptosis, Autophagy, Protein transport, Transport, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 90.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA067683 Approved Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA067683: AB_2685886" "unprognostic (2.85e-1)" "prognostic favorable (3.18e-5)" "unprognostic (2.73e-1)" "unprognostic (3.67e-1)" "unprognostic (2.18e-1)" "unprognostic (1.15e-2)" "unprognostic (3.52e-2)" "unprognostic (1.23e-1)" "unprognostic (4.28e-2)" "unprognostic (7.30e-2)" "prognostic favorable (9.95e-4)" "unprognostic (1.52e-1)" "prognostic favorable (2.39e-7)" "prognostic favorable (5.03e-4)" "unprognostic (3.78e-2)" "unprognostic (2.29e-1)" "unprognostic (3.18e-3)" 6.4 10.8 5.1 9.2 7.8 35.0 6.3 15.6 14.9 6.2 18.4 9.8 8.1 26.0 6.1 7.2 18.4 5.5 7.6 15.4 4.6 4.9 14.5 8.8 7.3 9.8 9.6 6.4 7.0 16.1 8.2 12.1 6.9 7.3 9.7 7.3 7.8 11.5 8.5 31.5 17.7 27.3 4.0 4.5 12.0 10.5 29.0 8.8 19.9 9.8 16.4 10.5 7.5 9.6 2.0 7.6 5.7 1.6 2.2 3.6 1.4 7.0 4.7 6.6 8.9 1.2 1.0 5.1 4.3 4.3 6.2 6.8 7.9 2.3 4.5 8.2 0.5 4.7 11.1 4.1 3.7 0.8 4.4 10.7 12.0 11.5 4.4 4.1 4.8 12.3 1.0 7.7 5.3 1.9 1.6 1.8 9.9 8.9 11.0 1.9 11.3 14.1 29.3 10.0 3.2 12.9 10.4 4.1 8.0 3.5 9.5 24.8 9.6 6.4 12.5 4.9 1.2 7.7 11.8 3.4 9.5 6.0 19.0 9.6 9.8 6.6 5.3 8.1 9.3 10.7 3.0 1.6 5.7 2.1 1.5 3.1 2.0 2.5 2.3 1.1 1.0 2.5 3.4 0.5 2.2 0.7 7.6 3.6 1.4 5.1 7.8 15.6 14.9 4.6 4.9 9.6 6.4 7.3 8.8 8.9 10.0 8.8 18.9 27.1 15.0 0.4 17.8 2.7 1.2 1.8 13.7 23.7 11.6 14.3 51.1 4.1 90.5 23.3 14.4 5.4 10.1 17.3 6.9 9.7 11.7 27.0 21.4 5.5 12.0 6.8 8.1 8.7 11.8 19.0 28.4 10.6 16.6 38.2 4.2 16.8 17.6 12.9 16.0 63.1 19.6 27.4 30.6 21.3 23.3 29.3 ATG7 "APG7L, DKFZp434N0735, GSA7" ENSG00000197548 "Autophagy related 7" O95352 3 11272309-11557665 "Predicted intracellular proteins, Transporters" "Autophagy, Biological rhythms, Protein transport, Transport, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 78.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 13.1;classical monocyte: 39.7;eosinophil: 24.5;intermediate monocyte: 22.9;myeloid DC: 23.8;neutrophil: 31.3;non-classical monocyte: 16.3" "Group enriched" "Detected in all" 5 "dendritic cells: 23.8;granulocytes: 31.3;monocytes: 39.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007639, CAB018771" Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 13000 Cytosol "Nucleoplasm, Plasma membrane" "CAB018771: AB_2062165, HPA007639: AB_1845162" "unprognostic (3.97e-2)" "unprognostic (2.83e-2)" "prognostic favorable (9.66e-4)" "unprognostic (1.18e-2)" "unprognostic (2.79e-1)" "unprognostic (5.19e-2)" "prognostic unfavorable (1.41e-4)" "unprognostic (1.82e-1)" "unprognostic (2.40e-1)" "unprognostic (1.80e-3)" "unprognostic (2.30e-2)" "unprognostic (2.67e-1)" "prognostic favorable (9.55e-4)" "unprognostic (1.61e-1)" "unprognostic (3.65e-2)" "unprognostic (1.16e-1)" "unprognostic (1.50e-1)" 27.0 18.6 14.8 21.1 21.9 37.5 16.6 14.1 29.2 16.4 15.2 26.2 13.4 11.6 28.9 15.9 18.9 17.4 15.1 12.3 14.0 13.1 13.1 11.8 18.4 18.8 14.8 17.1 15.5 13.1 18.7 23.0 18.7 21.6 12.9 17.8 19.3 16.6 11.6 15.8 22.2 16.9 18.3 16.6 19.7 13.1 19.7 13.9 17.7 12.7 12.2 21.6 16.5 15.2 4.0 23.8 31.3 39.7 5.9 4.8 14.2 18.4 14.6 6.5 3.4 11.5 15.2 32.4 17.4 22.7 17.4 20.3 6.2 16.8 8.5 10.6 15.4 18.1 5.7 7.2 24.4 30.0 7.5 9.1 6.1 14.1 7.4 15.2 17.6 20.3 15.6 11.3 33.7 21.2 18.0 24.0 5.4 9.0 7.0 24.1 12.0 5.0 8.2 5.1 8.5 18.9 6.3 7.8 7.5 13.1 13.3 5.8 5.7 12.4 10.5 6.7 8.4 11.4 17.2 16.3 14.3 10.4 9.4 24.3 4.5 11.7 14.3 23.2 16.6 19.3 13.1 39.7 24.5 4.8 22.9 3.7 4.0 4.0 4.5 23.8 3.7 3.5 4.2 31.3 5.9 16.3 4.2 3.4 14.2 14.8 21.9 14.1 29.2 14.0 13.1 14.8 17.1 21.6 13.9 0.0 9.8 6.1 6.1 9.8 11.1 3.9 0.0 12.0 5.7 7.0 17.7 13.7 6.6 10.0 41.0 10.5 6.9 23.3 11.3 14.0 8.9 5.5 14.9 7.8 50.1 19.1 10.9 20.9 20.3 78.6 9.5 19.9 3.3 9.0 7.0 9.3 12.7 7.0 9.2 5.4 12.5 6.5 5.1 19.5 11.5 6.8 16.0 10.0 7.3 7.3 ATM "ATA, ATC, ATD, ATDC, TEL1, TELO1" ENSG00000149311 "ATM serine/threonine kinase" Q13315 11 108222484-108369102 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, DNA damage" "DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Neurodegeneration, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 198.3;Rod photoreceptor cells: 196.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 48.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000102, HPA067142" Supported Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB000102: , HPA067142: AB_2685789" "unprognostic (9.77e-2)" "unprognostic (1.47e-1)" "unprognostic (3.04e-1)" "unprognostic (2.36e-1)" "unprognostic (5.70e-2)" "unprognostic (2.86e-2)" "unprognostic (6.32e-3)" "unprognostic (1.05e-1)" "unprognostic (8.19e-2)" "unprognostic (1.63e-1)" "unprognostic (7.68e-2)" "unprognostic (6.16e-2)" "unprognostic (2.17e-3)" "unprognostic (3.10e-1)" "unprognostic (7.87e-2)" "unprognostic (1.21e-1)" "unprognostic (2.81e-1)" 8.3 10.9 12.7 26.5 19.3 16.8 9.4 17.7 14.4 10.9 8.5 10.9 8.8 6.0 11.2 11.4 6.9 9.5 9.2 9.6 12.4 8.5 7.7 9.5 10.1 33.4 19.6 6.7 20.5 20.7 15.7 29.2 8.8 14.5 9.1 7.9 7.2 15.1 9.8 6.2 8.4 16.5 10.6 23.4 22.6 8.9 6.1 17.9 19.5 10.7 5.1 26.9 10.7 10.7 13.7 6.1 13.5 12.5 7.6 18.5 4.4 2.7 3.9 7.7 4.1 10.0 14.6 2.0 6.1 6.8 3.5 5.9 4.8 6.5 9.6 9.1 4.9 5.6 4.1 5.8 5.1 5.5 7.7 3.4 8.7 4.8 4.8 5.3 10.5 9.4 9.4 3.2 5.4 10.4 7.7 7.4 8.2 8.4 6.6 6.9 2.0 7.1 9.7 6.3 4.1 3.9 5.6 5.3 15.1 4.0 5.5 5.2 6.4 7.1 3.3 10.5 7.1 5.0 5.9 11.5 8.8 4.9 5.0 5.7 4.4 4.6 48.5 5.8 11.5 9.8 13.5 5.7 3.8 14.9 5.3 10.4 11.1 10.5 11.3 2.7 13.7 18.5 17.9 10.8 7.6 12.5 6.1 5.3 4.4 12.7 19.3 17.7 14.4 12.4 8.5 19.6 6.7 14.5 17.9 35.7 21.0 122.7 17.4 11.2 101.7 35.4 10.2 13.4 19.4 21.0 198.3 14.8 5.0 7.7 12.8 18.8 4.9 0.0 10.6 10.5 26.4 9.5 12.7 21.2 26.0 57.2 19.5 36.8 82.2 2.7 36.5 48.1 25.3 9.0 15.9 35.9 7.6 10.5 26.2 10.3 196.6 25.8 17.3 18.7 33.6 10.8 3.5 111.7 11.7 9.9 ATN1 "B37, D12S755E, DRPLA" ENSG00000111676 "Atrophin 1" P54259 12 6924463-6942321 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease mutation, Epilepsy, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031619 Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA031619: AB_10601667" "unprognostic (3.86e-3)" "unprognostic (2.07e-1)" "unprognostic (1.80e-3)" "unprognostic (5.82e-2)" "unprognostic (1.37e-1)" "unprognostic (1.95e-1)" "prognostic unfavorable (7.20e-4)" "unprognostic (1.44e-1)" "unprognostic (6.90e-2)" "unprognostic (8.42e-3)" "unprognostic (1.86e-2)" "unprognostic (3.19e-1)" "unprognostic (7.43e-2)" "unprognostic (5.46e-2)" "unprognostic (9.49e-2)" "unprognostic (3.95e-1)" "unprognostic (7.35e-2)" 37.6 38.6 34.6 20.1 28.1 4.3 25.9 57.5 45.5 33.7 30.5 27.0 38.3 22.8 35.7 17.2 21.2 34.7 28.0 25.6 32.8 22.4 21.6 8.8 26.3 11.9 24.4 33.8 72.0 28.7 37.4 43.8 27.6 29.2 28.9 14.2 29.2 44.0 40.9 26.5 28.3 20.5 33.4 29.5 19.3 22.3 8.8 29.4 2.3 42.0 7.3 9.1 30.0 57.6 2.6 2.1 2.5 0.5 0.5 2.5 0.7 15.5 20.3 22.0 44.2 20.8 18.8 36.7 18.6 16.0 19.1 13.6 20.5 18.6 4.2 5.9 22.9 15.7 10.4 13.4 18.2 10.1 49.4 13.3 19.8 18.8 9.7 32.2 4.0 30.2 30.4 13.4 23.9 18.8 33.0 18.7 6.4 16.7 8.6 16.9 22.3 8.7 3.7 45.0 7.2 8.6 18.2 11.9 3.1 14.0 22.0 6.8 21.9 19.0 22.2 13.3 22.5 8.4 11.2 24.2 22.5 29.0 17.7 28.4 6.6 2.2 2.9 17.5 5.2 23.5 1.9 0.5 2.5 2.5 0.3 2.2 2.6 1.1 1.4 0.6 2.3 1.4 1.9 0.0 0.5 0.1 2.1 1.2 0.7 34.6 28.1 57.5 45.5 32.8 22.4 24.4 33.8 29.2 29.4 14.9 18.8 2.4 11.1 26.9 27.8 12.2 15.3 10.7 21.6 27.9 17.7 23.4 13.3 16.4 1.7 28.0 25.9 0.0 26.2 12.8 25.2 15.6 9.3 7.2 10.2 23.8 20.8 27.6 11.9 2.6 59.0 9.4 20.3 7.2 23.5 15.7 23.6 19.8 49.5 9.9 25.4 19.4 22.1 5.8 7.1 21.8 31.0 7.2 18.8 15.2 ATOH1 "bHLHa14, HATH1, MATH-1, Math1" ENSG00000172238 "Atonal bHLH transcription factor 1" Q92858 4 93828753-93830964 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "intestine: 29.5" "Cell type enriched" "Detected in some" 36 "Mucus-secreting cells: 198.8" "Cancer enhanced" "Detected in some" "colorectal cancer: 9.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.7;HL-60: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA049400 Approved Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA049400: " "prognostic favorable (3.26e-5)" "unprognostic (5.20e-1)" "unprognostic (2.69e-1)" "unprognostic (1.26e-1)" "unprognostic (2.70e-1)" 0.0 0.0 0.1 6.4 0.1 0.0 0.1 0.1 0.1 0.1 22.5 0.0 0.0 8.8 0.1 0.0 0.1 0.1 2.7 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 15.0 0.0 0.1 0.0 0.0 0.1 29.5 0.2 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 2.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.8 0.2 0.5 0.0 0.2 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 198.8 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 ATOH8 "bHLHa21, FLJ14708, HATH6" ENSG00000168874 "Atonal bHLH transcription factor 8" Q96SQ7 2 85751344-85788066 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "thyroid gland: 41.8" "Cell type enhanced" "Detected in many" 7 "Club cells: 22.7;Hepatocytes: 31.6;Late spermatids: 19.8;Muller glia cells: 25.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 15.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 2.9;MAIT T-cell: 1.7" "Group enriched" "Detected in many" 12 "monocytes: 2.9;T-cells: 1.7" "Cell line enhanced" "Detected in many" "AN3-CA: 11.4;RH-30: 19.2;RT4: 12.3;TIME: 18.1;U-2197: 12.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA028406 Supported Nucleoplasm NA NA Nucleoplasm "HPA028406: AB_2672587" "unprognostic (7.70e-2)" "unprognostic (1.82e-2)" "unprognostic (1.49e-1)" "unprognostic (1.19e-1)" "unprognostic (2.84e-3)" "unprognostic (2.01e-1)" "unprognostic (2.50e-2)" "unprognostic (1.78e-1)" "unprognostic (6.28e-3)" "unprognostic (1.56e-1)" "prognostic favorable (8.98e-6)" "unprognostic (3.32e-2)" "prognostic favorable (3.80e-5)" "unprognostic (1.36e-1)" "unprognostic (2.45e-1)" "unprognostic (1.96e-1)" "unprognostic (1.91e-2)" 36.4 2.4 3.7 2.4 4.3 0.8 19.9 2.9 4.9 10.5 4.0 4.3 4.5 2.7 11.5 2.2 5.0 7.6 5.7 12.9 5.0 2.0 3.6 30.8 21.1 4.5 6.3 2.1 9.7 4.3 1.0 2.3 3.2 5.4 9.0 1.3 6.4 3.5 12.1 25.2 8.4 3.2 5.8 4.1 8.1 4.4 2.0 4.6 0.3 41.8 4.2 1.1 10.4 24.5 0.0 0.2 0.0 2.9 0.0 1.7 0.4 0.0 3.6 5.1 11.4 5.0 0.3 0.1 9.5 1.0 2.9 1.3 0.0 0.0 0.0 3.6 7.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 8.5 0.5 3.3 0.0 0.0 3.7 0.0 0.0 0.0 6.0 1.9 0.0 0.0 0.0 7.8 0.1 0.0 0.0 0.1 2.5 0.1 0.0 19.2 0.1 0.0 12.3 8.5 1.8 1.8 0.0 0.6 0.0 0.0 0.0 18.1 4.5 0.2 12.5 0.0 0.0 0.0 0.0 1.5 0.0 8.9 0.0 2.9 0.0 0.0 0.3 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 3.7 4.3 2.9 4.9 5.0 2.0 6.3 2.1 5.4 4.6 8.9 16.5 0.0 6.2 2.3 0.2 11.5 7.6 2.7 22.7 1.8 0.0 0.1 0.0 7.5 11.2 11.7 0.0 0.0 2.0 0.5 9.0 5.6 1.1 31.6 2.4 0.0 4.1 5.5 2.4 19.8 3.1 3.3 1.7 0.0 1.9 25.7 0.9 0.0 0.4 0.3 0.3 0.0 9.4 1.1 0.7 1.3 0.2 0.0 0.8 1.1 ATOX1 HAH1 ENSG00000177556 "Antioxidant 1 copper chaperone" O00244 5 151742316-151772532 "Predicted intracellular proteins" "Copper transport, Ion transport, Transport" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Hepatocytes: 744.7;Proximal tubular cells: 898.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055036 Approved "Nucleoplasm,Plasma membrane" NA NA 27000 Nucleoplasm "Plasma membrane" "HPA055036: " "unprognostic (5.55e-2)" "unprognostic (1.60e-1)" "unprognostic (3.84e-1)" "unprognostic (1.82e-1)" "unprognostic (8.11e-2)" "unprognostic (3.34e-2)" "unprognostic (2.33e-1)" "unprognostic (8.60e-2)" "unprognostic (3.58e-2)" "unprognostic (2.53e-2)" "prognostic favorable (9.57e-4)" "unprognostic (2.72e-1)" "unprognostic (7.15e-2)" "unprognostic (8.18e-2)" "unprognostic (2.57e-2)" "unprognostic (1.87e-1)" "unprognostic (2.22e-1)" 27.0 37.2 43.1 25.6 40.4 23.4 39.1 22.8 38.5 29.0 23.9 29.7 32.3 30.2 21.4 37.6 28.4 24.5 33.4 27.7 37.5 45.7 50.5 96.1 21.3 48.9 54.3 37.0 16.2 29.0 31.5 23.0 25.6 35.2 25.7 24.4 25.0 34.7 29.8 12.8 26.3 31.6 28.1 46.5 34.1 21.0 28.7 33.8 24.5 36.3 29.7 44.8 27.2 22.1 22.5 49.9 43.3 54.8 20.1 22.8 24.2 14.1 23.3 13.7 9.5 36.6 30.0 18.1 25.6 29.0 25.8 35.2 31.5 30.6 28.5 31.2 43.8 57.9 13.2 16.6 64.1 21.2 18.3 28.4 12.5 15.1 32.0 34.1 17.2 14.3 38.7 13.5 32.3 21.3 19.1 37.7 17.9 10.3 84.2 39.0 34.7 12.7 38.2 7.8 31.7 48.9 7.8 15.8 44.0 24.7 12.3 18.0 10.6 21.9 62.6 95.4 16.2 30.6 21.1 42.2 26.8 21.3 32.6 44.3 69.6 61.1 17.0 36.3 11.7 110.2 27.5 48.7 43.3 18.3 54.8 16.7 22.5 16.6 15.8 39.1 16.2 13.2 14.3 36.4 20.1 37.4 49.9 22.8 24.2 43.1 40.4 22.8 38.5 37.5 45.7 54.3 37.0 35.2 33.8 53.6 54.1 119.1 60.7 60.1 20.6 93.1 175.8 60.2 37.5 200.7 13.7 132.7 459.3 179.7 119.0 146.1 314.3 70.0 138.4 184.0 143.5 107.5 72.6 744.7 575.7 23.8 144.8 249.2 183.4 241.2 76.8 138.6 226.0 621.2 138.5 98.0 246.1 221.7 97.2 898.1 22.2 90.5 140.1 71.6 147.1 93.1 99.3 57.9 140.1 99.5 ATP10D "ATPVD, KIAA1487" ENSG00000145246 "ATPase phospholipid transporting 10D (putative)" Q9P241 4 47485288-47593486 "Enzymes, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 55.7" "Cell type enhanced" "Detected in many" 11 "Leydig cells: 57.5;Syncytiotrophoblasts: 147.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "basophil: 31.5" "Lineage enriched" "Detected in many" 9 "granulocytes: 31.5" "Cell line enhanced" "Detected in many" "HAP1: 24.4" HPA050808 Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA050808: AB_2681242" "unprognostic (1.62e-1)" "unprognostic (2.97e-1)" "unprognostic (4.93e-2)" "unprognostic (1.47e-2)" "unprognostic (1.16e-1)" "unprognostic (4.23e-2)" "unprognostic (1.65e-2)" "unprognostic (8.05e-2)" "unprognostic (3.48e-2)" "unprognostic (3.54e-2)" "unprognostic (3.04e-1)" "unprognostic (2.43e-1)" "prognostic favorable (5.00e-8)" "unprognostic (3.97e-2)" "unprognostic (4.47e-3)" "unprognostic (1.11e-2)" "unprognostic (3.37e-2)" 8.1 9.7 7.6 6.8 8.0 1.4 6.9 3.9 7.5 10.2 7.4 5.2 10.4 4.5 12.9 10.1 15.2 6.7 8.6 7.4 7.3 4.0 14.5 5.8 9.4 6.7 7.0 4.8 10.0 6.2 16.9 18.6 55.7 8.1 8.1 4.5 7.7 7.5 11.5 2.8 14.8 6.0 11.4 8.9 12.7 7.6 3.9 7.3 3.6 10.7 5.4 9.2 9.9 13.1 3.6 1.8 31.5 2.9 1.0 0.9 0.6 1.4 1.0 2.3 1.6 6.7 7.3 0.4 10.4 12.6 5.0 9.0 5.4 9.0 4.6 3.9 16.8 8.5 2.7 24.4 8.7 7.7 1.8 1.9 3.7 1.7 0.3 6.0 1.1 2.3 6.3 6.7 9.8 6.5 16.5 8.4 2.3 0.0 2.5 13.6 0.5 2.4 0.7 0.8 0.0 1.3 2.8 5.3 0.0 9.1 1.8 1.5 2.9 4.8 1.2 3.1 5.4 2.2 1.2 12.7 12.4 2.5 1.1 4.5 1.1 0.8 0.0 6.1 6.9 3.9 31.5 1.4 0.1 0.6 2.3 0.9 1.3 0.2 0.3 1.8 3.6 0.0 0.4 0.7 1.0 2.9 1.1 0.3 0.6 7.6 8.0 3.9 7.5 7.3 4.0 7.0 4.8 8.1 7.3 8.9 6.9 15.0 7.9 17.1 10.9 3.6 0.0 2.7 2.3 15.7 29.5 27.1 1.7 4.3 1.6 14.0 1.6 0.0 4.1 7.4 11.8 5.8 2.3 4.9 11.7 12.7 9.2 17.8 16.1 0.6 57.5 9.1 6.8 7.2 4.3 28.8 2.7 2.5 23.7 9.1 8.9 25.8 9.8 0.4 2.7 23.6 147.8 11.5 3.7 6.5 ATP13A4 "DKFZp761I1011, FLJ37958" ENSG00000127249 "ATPase 13A4" Q4VNC1 3 193402077-193593111 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 46.4;parathyroid gland: 52.5;thyroid gland: 51.2" "Cell type enhanced" "Detected in many" 19 "Alveolar cells type 1: 59.6;Alveolar cells type 2: 19.6;Cholangiocytes: 12.7;Ciliated cells: 13.4;Club cells: 22.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 23.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA051932 Approved Nucleoplasm NA NA Nucleoplasm "HPA051932: " "unprognostic (4.97e-2)" "unprognostic (1.50e-3)" "unprognostic (4.86e-3)" "unprognostic (2.52e-3)" "unprognostic (2.72e-2)" "prognostic favorable (3.91e-4)" "unprognostic (1.55e-1)" "unprognostic (3.99e-3)" "unprognostic (2.65e-1)" "unprognostic (1.36e-1)" "unprognostic (4.39e-2)" "unprognostic (1.34e-1)" "unprognostic (4.29e-5)" "unprognostic (1.91e-1)" "unprognostic (1.70e-1)" "unprognostic (5.75e-3)" "unprognostic (2.00e-1)" 0.6 0.7 11.2 0.6 11.1 0.6 17.8 2.6 10.1 1.8 2.2 8.4 9.0 0.9 0.6 46.4 11.8 2.7 4.3 0.6 11.1 5.1 0.8 0.7 22.0 0.8 7.5 7.7 0.8 3.9 52.5 3.5 0.6 9.0 0.6 3.2 0.5 4.5 16.7 0.6 11.2 0.6 0.7 6.1 0.7 7.6 0.8 7.5 0.0 51.2 7.8 9.5 0.6 3.7 0.4 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.1 0.6 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.0 1.2 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 9.4 0.2 0.1 1.1 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 1.9 1.0 1.5 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 11.2 11.1 2.6 10.1 11.1 5.1 7.5 7.7 9.0 7.5 59.6 19.6 0.0 0.0 0.1 1.9 0.4 12.7 13.4 22.7 0.0 0.0 0.8 0.0 2.1 0.3 0.0 0.0 0.0 0.2 0.1 0.2 0.0 1.1 0.0 0.2 1.6 0.0 1.8 0.8 0.8 0.0 0.6 1.7 0.0 1.5 0.6 1.2 1.7 0.4 0.2 0.9 0.0 0.0 0.7 1.2 1.4 0.6 0.8 1.7 0.0 ATP5S "ATPW, HSU79253" ENSG00000125375 "ATP synthase, H+ transporting, mitochondrial Fo complex subunit s (factor B)" Q99766 14 50312326-50335558 "Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 234.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046967, HPA062690" Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA046967: AB_2679880, HPA062690: AB_2684836" "unprognostic (2.24e-2)" "unprognostic (3.44e-3)" "unprognostic (7.85e-2)" "unprognostic (1.71e-1)" "unprognostic (8.53e-3)" "unprognostic (2.92e-2)" "unprognostic (2.21e-1)" "prognostic favorable (5.53e-4)" "unprognostic (5.73e-2)" "unprognostic (2.98e-1)" "unprognostic (1.02e-3)" "unprognostic (1.91e-1)" "prognostic favorable (2.37e-8)" "unprognostic (5.64e-2)" "unprognostic (1.67e-1)" "unprognostic (1.72e-1)" "unprognostic (2.95e-1)" 5.5 5.0 8.4 6.0 12.5 10.0 7.0 5.6 11.0 5.9 5.2 13.9 7.9 9.4 7.0 7.6 7.9 6.0 5.7 9.0 8.8 9.0 6.8 5.0 5.4 6.6 10.0 10.5 6.3 7.3 3.3 11.2 3.5 10.1 5.6 4.6 8.3 5.6 4.7 11.6 11.7 6.5 3.6 12.4 5.4 5.4 19.8 10.3 5.1 10.1 8.0 6.1 5.1 5.1 17.0 14.2 15.4 14.1 9.2 12.9 9.6 7.9 2.0 3.8 2.1 4.7 8.5 12.0 2.9 3.7 5.0 7.3 3.3 6.0 9.1 2.7 4.7 3.4 4.9 1.3 2.7 3.1 5.2 2.4 4.8 4.1 13.9 1.1 7.1 7.4 7.6 6.7 0.7 1.4 2.1 3.6 6.7 1.6 16.1 3.4 7.2 1.7 5.3 2.5 6.3 4.2 5.2 5.6 4.7 2.4 11.4 5.5 3.5 2.4 7.6 5.4 1.6 8.1 3.7 2.2 6.4 9.1 3.9 3.0 8.1 5.3 5.3 1.0 5.4 5.1 9.8 10.4 15.4 11.4 11.4 10.0 17.0 9.4 11.0 7.7 14.1 11.9 12.9 1.1 9.2 14.1 14.2 10.8 9.6 8.4 12.5 5.6 11.0 8.8 9.0 10.0 10.5 10.1 10.3 20.8 20.5 18.2 24.5 13.6 25.6 57.7 17.8 37.5 22.7 24.4 21.6 30.9 28.2 25.5 234.6 18.6 18.0 23.3 37.3 20.1 16.7 20.9 40.5 21.2 25.1 35.0 23.7 16.5 23.7 98.5 24.7 26.0 15.1 31.5 21.0 27.3 25.0 14.4 15.6 28.9 61.8 19.4 18.6 38.2 20.6 17.9 34.9 23.2 26.8 30.3 ATP6V1A "ATP6A1, ATP6V1A1, VA68, Vma1, VPP2" ENSG00000114573 "ATPase H+ transporting V1 subunit A" P38606 3 113747019-113812056 "Disease related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" Translocase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 467.9;Late spermatids: 569.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 33.6" "Group enriched" "Detected in all" 6 "dendritic cells: 16.4;granulocytes: 33.6;monocytes: 15.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006910, HPA035084" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA 2700000 "Vesicles, Cytosol" Nucleoplasm "CAB006910: , HPA035084: AB_2674454" "unprognostic (1.32e-1)" "unprognostic (8.68e-2)" "unprognostic (5.87e-2)" "unprognostic (4.70e-2)" "unprognostic (1.36e-1)" "unprognostic (2.00e-1)" "unprognostic (3.43e-2)" "unprognostic (2.90e-2)" "unprognostic (1.42e-1)" "unprognostic (2.25e-1)" "unprognostic (1.36e-2)" "unprognostic (5.19e-3)" "prognostic favorable (3.82e-12)" "unprognostic (8.82e-2)" "unprognostic (2.46e-3)" "unprognostic (2.43e-1)" "unprognostic (1.52e-2)" 12.8 19.8 24.1 10.4 33.2 7.4 12.7 34.8 52.8 14.0 11.1 10.3 5.6 9.3 7.5 8.2 13.2 10.0 10.8 4.7 26.2 38.2 47.9 18.2 12.3 11.4 25.4 25.0 6.2 10.5 39.3 13.5 12.3 52.0 11.2 11.8 14.7 18.0 8.4 4.5 12.6 7.9 8.2 13.6 13.7 10.9 8.9 8.3 9.6 21.0 5.7 13.6 10.2 8.2 3.8 16.4 33.6 15.4 3.8 3.4 6.0 25.4 11.6 14.6 12.7 30.9 13.8 15.6 13.8 21.1 14.5 20.1 21.8 20.5 20.9 32.9 20.1 16.1 16.6 33.0 18.2 19.1 9.5 9.1 18.5 18.0 16.8 25.5 13.6 21.7 18.6 12.6 18.8 13.2 22.6 23.6 10.6 21.1 15.8 21.5 16.7 9.9 6.1 18.3 17.8 14.6 8.6 10.6 23.7 39.8 24.3 28.3 10.4 24.2 16.5 18.1 21.0 25.0 11.0 21.7 13.6 10.1 9.3 8.2 16.6 17.8 19.3 26.6 17.2 15.0 9.2 15.4 5.2 2.8 11.7 2.6 3.8 2.6 2.7 16.4 2.9 2.5 2.9 33.6 3.8 9.5 4.6 3.4 6.0 24.1 33.2 34.8 52.8 26.2 38.2 25.4 25.0 52.0 8.3 26.8 28.3 28.9 13.2 27.0 92.7 7.9 33.1 14.7 19.4 94.2 39.3 18.1 69.6 25.2 467.9 26.0 24.0 0.0 23.9 18.8 17.8 28.2 10.4 64.4 67.8 95.3 53.6 36.2 95.4 569.6 16.7 67.0 43.9 49.5 25.8 42.1 22.3 24.6 21.5 62.8 37.3 6.5 14.6 25.3 14.3 41.9 36.7 17.1 21.3 21.1 ATP6V1B1 "ATP6B1, RTA1B, VATB, Vma2, VPP3" ENSG00000116039 "ATPase H+ transporting V1 subunit B1" P15313 2 70935868-70965431 "Disease related genes, Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" Hydrolase "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 37.9;placenta: 29.0;salivary gland: 106.9" "Cell type enhanced" "Detected in some" 21 "Cytotrophoblasts: 143.1;Distal tubular cells: 41.4;Extravillous trophoblasts: 41.7;Melanocytes: 28.7;Syncytiotrophoblasts: 54.2" "Group enriched" "Detected in many" 5 "ovarian cancer: 94.7;renal cancer: 23.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.0;non-classical monocyte: 1.4" "Group enriched" "Detected in many" 12 "monocytes: 1.4;T-cells: 1.0" "Group enriched" "Detected in some" 9 "BEWO: 13.8;HaCaT: 12.7;SK-BR-3: 31.3" "Not detected" "Not detected" "CAB009523, HPA031847" Enhanced Approved "Nucleoplasm,Nuclear membrane" No NA "Nucleoplasm, Nuclear membrane" "CAB009523: AB_677577, HPA031847: AB_2674072" "unprognostic (2.28e-2)" "unprognostic (6.02e-2)" "unprognostic (2.20e-5)" "unprognostic (1.15e-2)" "unprognostic (3.96e-1)" "unprognostic (1.31e-1)" "unprognostic (2.22e-2)" "unprognostic (2.17e-1)" "unprognostic (1.19e-2)" "unprognostic (1.48e-1)" "unprognostic (2.94e-2)" "unprognostic (1.40e-1)" "unprognostic (1.33e-3)" "unprognostic (1.03e-1)" "unprognostic (2.70e-1)" "unprognostic (3.63e-5)" "unprognostic (1.97e-2)" 0.6 0.0 0.1 0.1 0.1 0.0 4.4 0.8 0.2 12.2 0.1 0.1 6.9 0.1 0.5 0.4 0.5 5.0 0.1 0.3 0.1 0.0 37.9 0.1 2.1 0.1 0.1 0.1 2.0 1.1 0.0 1.7 29.0 0.1 0.6 0.0 7.4 106.9 1.1 0.1 11.8 0.1 0.2 0.1 0.1 0.0 0.3 0.1 0.3 0.1 1.6 1.1 0.1 0.2 0.0 0.0 0.0 1.4 0.0 1.0 0.0 0.2 0.2 0.4 0.8 1.7 2.0 13.8 0.2 0.1 0.0 0.0 0.0 1.3 0.0 0.1 0.8 0.0 12.7 0.4 0.0 0.0 0.3 0.4 0.0 0.2 0.2 0.0 0.0 0.0 1.0 0.1 0.0 0.2 2.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.1 0.3 0.9 0.4 31.3 0.0 1.8 0.3 0.0 0.3 0.4 0.1 0.6 0.3 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.1 0.8 0.2 0.1 0.0 0.1 0.1 0.1 0.1 3.0 0.0 0.0 1.8 0.1 0.8 0.4 0.0 1.4 1.2 0.0 7.9 143.1 41.4 0.0 0.6 0.6 0.0 0.0 0.5 41.7 0.7 0.7 0.0 0.0 10.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 28.7 0.0 0.0 0.3 0.5 0.0 1.1 0.0 3.4 0.0 0.3 0.4 1.3 0.4 54.2 0.0 0.0 0.6 ATP6V1C1 "ATP6C, ATP6D, VATC, Vma5" ENSG00000155097 "ATPase H+ transporting V1 subunit C1" P21283 8 103021063-103073051 "FDA approved drug targets, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023943, HPA057297" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA023943: AB_1845197, HPA057297: AB_2683402" "unprognostic (5.73e-3)" "unprognostic (3.30e-1)" "unprognostic (1.09e-2)" "unprognostic (1.93e-2)" "unprognostic (1.52e-2)" "unprognostic (3.35e-2)" "prognostic unfavorable (8.82e-4)" "unprognostic (3.29e-2)" "unprognostic (3.87e-1)" "unprognostic (5.62e-2)" "unprognostic (1.19e-1)" "unprognostic (5.59e-2)" "unprognostic (3.98e-2)" "unprognostic (1.23e-1)" "unprognostic (3.85e-1)" "unprognostic (3.88e-1)" "unprognostic (2.83e-1)" 17.1 23.1 25.1 16.8 36.7 6.5 15.7 26.2 58.8 13.6 11.1 11.4 7.6 12.1 14.1 10.9 10.6 12.2 13.7 19.0 28.5 28.0 35.0 18.1 12.9 15.9 23.2 33.3 14.4 12.9 21.3 29.2 20.2 45.1 13.2 13.7 11.5 10.4 12.2 11.7 8.5 12.8 14.5 15.0 14.3 12.1 13.0 12.5 10.7 26.9 8.4 15.6 15.5 10.7 10.6 16.3 27.9 24.3 10.0 12.5 10.8 29.1 17.5 9.3 6.9 24.4 15.8 11.5 21.9 21.8 24.6 29.1 12.9 29.6 18.8 25.1 17.4 39.3 11.8 18.3 17.0 35.2 12.3 14.1 18.3 13.3 15.3 26.0 9.8 22.1 15.1 22.2 33.0 15.9 14.8 18.5 12.2 23.3 15.4 27.3 13.2 18.3 7.2 8.1 26.5 17.0 10.6 16.4 14.2 27.5 21.0 11.9 10.2 12.3 11.7 38.3 17.3 24.5 11.6 22.0 14.3 14.5 31.7 15.3 20.2 7.3 17.9 27.7 20.4 13.8 8.4 17.4 20.6 9.1 24.3 10.2 10.6 7.7 8.9 16.3 10.2 9.0 9.7 27.9 10.0 22.1 8.8 12.5 10.8 25.1 36.7 26.2 58.8 28.5 28.0 23.2 33.3 45.1 12.5 29.8 23.7 18.1 27.2 31.0 29.7 39.1 12.7 41.5 18.2 29.6 15.7 32.6 54.7 34.3 128.0 23.1 13.6 23.3 27.3 30.1 23.0 29.4 23.1 15.3 87.3 35.0 15.0 18.4 45.4 117.5 22.5 45.4 18.6 26.2 12.6 31.4 26.9 14.4 17.3 112.2 20.4 19.4 32.5 10.5 20.2 28.7 62.6 17.5 13.4 25.0 ATP6V1D "ATP6M, VATD, VMA8" ENSG00000100554 "ATPase H+ transporting V1 subunit D" Q9Y5K8 14 67294371-67360265 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031515, HPA057316" Enhanced Approved Nucleoplasm Yes No Nucleoplasm "HPA031515: AB_10600785, HPA057316: AB_2683409" "unprognostic (1.10e-1)" "unprognostic (7.35e-2)" "unprognostic (1.59e-1)" "unprognostic (7.10e-3)" "unprognostic (1.52e-1)" "unprognostic (7.64e-2)" "unprognostic (7.78e-3)" "unprognostic (1.19e-1)" "unprognostic (2.32e-1)" "unprognostic (3.05e-2)" "unprognostic (1.13e-2)" "unprognostic (3.08e-2)" "prognostic favorable (7.60e-13)" "unprognostic (2.78e-1)" "unprognostic (3.18e-2)" "unprognostic (1.41e-2)" "unprognostic (1.44e-2)" 18.2 51.9 43.9 13.8 47.7 9.9 15.9 23.6 54.1 13.1 19.9 13.5 20.9 16.2 13.8 30.2 33.6 17.9 14.8 52.6 39.8 45.2 52.0 19.9 14.5 11.8 39.7 44.9 10.4 12.4 21.8 28.8 17.2 39.6 21.4 20.3 10.8 15.7 18.1 31.8 14.7 16.8 16.1 29.4 9.7 17.8 14.0 23.0 14.7 34.1 25.2 15.3 16.6 17.0 14.7 35.0 39.2 34.5 17.9 28.5 23.9 62.0 12.9 26.5 16.6 17.7 18.8 18.7 48.0 22.1 29.4 24.6 14.8 21.9 5.1 20.1 28.7 28.2 23.4 14.4 22.4 39.8 22.1 9.9 5.4 17.9 12.0 32.5 5.3 19.8 13.5 16.4 20.6 15.6 32.5 18.4 13.6 11.9 15.7 42.2 15.0 15.4 12.0 19.1 22.6 15.5 12.0 22.0 8.1 39.1 24.6 33.2 14.6 30.9 20.1 41.3 25.0 28.5 15.7 29.6 44.2 32.3 21.1 30.7 16.8 12.1 7.2 44.2 10.8 24.5 32.2 34.5 37.3 18.6 33.6 15.7 14.7 20.1 20.0 35.0 14.5 15.1 16.8 39.2 17.9 33.3 26.7 28.5 23.9 43.9 47.7 23.6 54.1 39.8 45.2 39.7 44.9 39.6 23.0 50.6 50.0 34.2 59.3 85.5 56.9 137.6 43.3 182.0 63.7 78.5 51.1 84.1 310.0 120.5 149.9 33.7 68.6 93.5 42.7 73.5 53.9 61.4 40.4 40.0 114.2 82.6 52.2 20.3 37.5 68.5 30.5 59.4 75.9 57.7 39.8 86.6 96.8 63.1 47.7 271.8 92.4 12.9 27.8 77.2 60.9 120.9 172.2 35.9 33.7 102.9 ATP6V1E1 "ATP6E, ATP6E2, ATP6V1E, P31, Vma4" ENSG00000131100 "ATPase H+ transporting V1 subunit E1" P36543 22 17592136-17628818 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Distal tubular cells: 391.3;Syncytiotrophoblasts: 400.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009528, CAB018699, HPA029196" Enhanced Approved Nucleoplasm NA NA 61000 Nucleoplasm "CAB009528: AB_2062678, CAB018699: AB_781534, HPA029196: AB_2672944" "unprognostic (1.53e-3)" "unprognostic (5.78e-3)" "unprognostic (1.31e-2)" "unprognostic (1.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.24e-3)" "prognostic unfavorable (1.56e-5)" "unprognostic (2.17e-1)" "unprognostic (2.09e-1)" "unprognostic (3.37e-2)" "unprognostic (7.72e-3)" "prognostic favorable (4.18e-4)" "prognostic favorable (7.66e-8)" "unprognostic (3.81e-2)" "unprognostic (1.28e-1)" "unprognostic (2.58e-2)" "unprognostic (2.75e-1)" 32.8 45.9 59.5 20.4 69.0 24.9 31.5 48.9 90.3 30.2 26.7 34.5 25.2 17.6 27.7 44.4 37.5 26.7 26.7 67.4 58.9 55.4 71.7 26.1 31.7 24.5 54.5 52.3 27.0 15.8 48.3 29.6 46.2 69.8 31.1 32.0 24.1 21.5 42.1 48.5 26.9 19.1 38.1 53.7 23.9 23.8 20.2 32.4 17.5 31.9 26.1 32.5 32.1 22.0 24.2 26.3 55.3 34.8 22.6 29.4 30.1 21.7 19.8 18.0 17.4 59.9 32.4 19.7 29.1 38.8 37.0 43.0 24.6 18.0 13.6 25.0 38.8 47.5 34.5 28.0 25.5 33.1 26.1 31.7 24.5 19.8 32.9 87.7 28.2 42.5 40.6 50.1 35.7 26.1 41.6 31.2 17.4 30.6 28.0 63.0 22.6 24.4 20.5 13.1 48.7 28.0 14.3 26.2 8.1 61.4 34.5 13.2 23.0 26.6 18.9 62.6 36.7 18.3 32.7 26.6 26.1 13.8 32.5 21.5 27.4 48.1 17.3 42.0 13.8 35.0 45.2 32.9 55.3 21.4 30.8 20.8 24.2 21.9 20.5 26.3 19.0 20.8 21.5 44.3 22.6 34.8 25.4 29.4 30.1 59.5 69.0 48.9 90.3 58.9 55.4 54.5 52.3 69.8 32.4 71.5 74.4 66.3 65.8 37.3 53.1 103.3 86.6 80.3 53.4 130.9 25.5 202.2 391.3 124.1 6.9 68.0 66.0 23.3 104.7 118.4 63.5 55.0 86.8 40.9 161.1 50.9 40.3 70.0 71.1 12.5 87.2 106.2 75.9 170.5 45.1 93.9 121.5 73.7 91.9 264.4 32.5 58.2 83.4 71.0 67.3 45.0 400.7 65.0 28.6 80.6 ATP6V1G1 "ATP6G, ATP6G1, ATP6GL, ATP6J, DKFZp547P234, Vma10" ENSG00000136888 "ATPase H+ transporting V1 subunit G1" O75348 9 114587746-114598373 "Plasma proteins, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004615, HPA042898" Supported Approved Nucleoplasm,Nucleoli NA NA 150000 Nucleoli Nucleoplasm "CAB004615: AB_2258908, HPA042898: AB_2678217" "unprognostic (3.85e-1)" "unprognostic (1.71e-1)" "unprognostic (2.03e-1)" "unprognostic (1.24e-1)" "unprognostic (2.23e-1)" "unprognostic (1.84e-3)" "unprognostic (2.49e-1)" "unprognostic (1.51e-1)" "unprognostic (2.28e-1)" "unprognostic (3.47e-3)" "unprognostic (9.40e-3)" "unprognostic (4.13e-2)" "prognostic favorable (1.73e-7)" "unprognostic (2.44e-2)" "unprognostic (1.50e-1)" "unprognostic (9.11e-2)" "unprognostic (3.92e-2)" 34.8 66.4 41.5 36.7 38.0 56.6 56.6 37.5 49.4 45.2 34.2 23.4 42.3 26.7 43.7 91.0 57.5 32.3 39.2 45.4 40.8 52.5 84.9 65.9 45.3 50.0 52.2 39.5 49.2 55.9 39.5 79.4 77.8 44.7 65.3 33.2 49.2 63.2 45.1 54.9 40.8 33.2 31.7 35.6 66.5 52.7 58.3 25.6 51.7 65.2 53.5 53.4 45.8 40.1 99.9 81.6 96.6 67.9 50.0 85.1 121.6 18.2 17.6 36.2 8.8 30.1 21.8 33.6 28.5 22.6 23.6 17.0 23.6 22.0 17.7 24.9 20.3 44.1 41.4 27.0 21.5 19.9 14.0 18.6 17.0 22.3 34.2 42.1 37.8 31.5 27.9 57.9 18.9 23.6 24.8 22.3 28.7 32.5 37.6 32.2 39.6 36.4 23.9 42.8 52.2 33.2 35.4 23.2 28.3 48.4 31.4 27.3 34.9 38.4 67.2 101.2 36.5 54.4 44.9 29.7 19.3 15.3 30.0 31.9 50.7 99.4 30.9 24.8 22.7 26.4 78.3 67.9 96.6 46.7 63.9 57.9 99.9 65.6 56.0 50.9 94.2 85.1 67.1 87.3 50.0 65.8 81.6 76.5 121.6 41.5 38.0 37.5 49.4 40.8 52.5 52.2 39.5 44.7 25.6 148.9 142.4 298.6 409.4 461.0 169.7 124.8 155.4 207.5 149.0 314.0 39.3 304.8 822.3 322.2 78.2 218.7 155.2 93.5 229.3 273.5 294.0 644.3 261.0 292.4 487.8 155.7 346.4 198.9 353.7 42.3 283.3 376.1 469.0 820.6 271.3 242.1 355.1 164.9 235.8 828.3 125.3 232.8 269.9 334.2 301.9 504.0 633.4 276.3 162.4 656.9 ATP8A2 "ATPIB, ML-1" ENSG00000132932 "ATPase phospholipid transporting 8A2" Q9NTI2 13 25372071-26025851 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 34.9;pituitary gland: 37.0;testis: 10.4" "Cell type enhanced" "Detected in many" 13 "Cone photoreceptor cells: 90.3;Early spermatids: 29.4;Rod photoreceptor cells: 86.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.3;naive CD8 T-cell: 3.3" "Lineage enriched" "Detected in single" 12 "T-cells: 3.3" "Group enriched" "Detected in some" 4 "HMC-1: 21.6;JURKAT: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039926, HPA040033" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA039926: AB_10794205, HPA040033: AB_2676809" "unprognostic (3.79e-2)" "unprognostic (4.28e-2)" "unprognostic (3.32e-2)" "unprognostic (1.95e-4)" "unprognostic (3.57e-2)" "unprognostic (1.89e-1)" "unprognostic (1.31e-2)" "unprognostic (2.97e-3)" "unprognostic (2.77e-1)" "unprognostic (3.66e-1)" "unprognostic (4.96e-4)" "unprognostic (1.24e-1)" "unprognostic (1.18e-2)" "unprognostic (4.20e-5)" "unprognostic (9.10e-2)" "unprognostic (2.95e-1)" "unprognostic (7.22e-2)" 1.1 4.9 11.2 1.4 11.4 0.8 2.2 34.9 30.2 1.1 1.3 1.3 0.0 1.4 2.1 4.8 0.9 0.9 1.0 1.0 9.4 11.8 1.3 0.8 2.3 1.9 6.7 10.4 1.2 1.9 0.9 37.0 1.2 19.8 1.1 1.3 3.1 1.0 1.0 1.3 0.9 1.5 1.0 3.5 1.3 1.8 10.4 1.4 0.0 1.0 0.0 1.2 1.2 0.3 0.0 0.0 0.2 0.0 0.2 3.3 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 1.0 0.0 0.0 0.6 1.4 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 21.6 0.2 0.0 0.0 0.0 0.6 0.5 9.6 0.0 0.0 1.7 0.3 3.7 0.0 2.0 0.0 0.7 0.0 2.7 1.0 0.2 0.1 3.3 0.0 0.1 0.3 0.1 0.4 0.0 0.4 0.2 0.1 1.1 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.8 0.6 0.0 0.0 2.3 3.3 0.2 0.2 0.0 0.0 0.7 0.6 11.2 11.4 34.9 18.4 9.4 11.8 6.7 10.4 19.8 1.4 0.0 9.8 0.9 0.1 0.9 20.0 2.2 2.5 0.0 0.0 0.0 90.3 1.2 0.0 0.3 29.4 1.5 0.0 0.0 0.0 0.3 0.4 0.2 4.7 0.0 2.4 20.6 0.0 0.0 0.0 24.5 0.9 0.0 0.0 0.0 0.0 4.5 0.0 0.0 1.1 0.6 86.2 12.9 0.0 12.9 9.9 0.4 0.9 0.5 0.0 0.0 ATP8B1 "ATPIC, BRIC, FIC1, PFIC, PFIC1" ENSG00000081923 "ATPase phospholipid transporting 8B1" O43520 18 57646426-57803101 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hearing, Lipid transport, Transport" Translocase "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 21.3" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 198.4;Mucus-secreting cells: 179.9;Undifferentiated cells: 138.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 27.5;HBF TERT88: 24.7;RT4: 58.5" "Low region specificity" "Detected in many" "HPA018673, HPA018674" Enhanced Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA018673: AB_1845207, HPA018674: AB_1845208" "unprognostic (1.83e-1)" "unprognostic (1.32e-1)" "prognostic favorable (2.60e-4)" "unprognostic (8.81e-2)" "unprognostic (1.32e-3)" "unprognostic (2.06e-1)" "unprognostic (1.39e-1)" "unprognostic (1.02e-1)" "unprognostic (9.62e-3)" "unprognostic (1.97e-1)" "unprognostic (3.30e-3)" "unprognostic (4.55e-3)" "prognostic favorable (6.35e-4)" "unprognostic (1.88e-1)" "unprognostic (2.22e-1)" "unprognostic (3.25e-1)" "unprognostic (8.60e-3)" 3.8 2.3 0.0 1.8 0.0 0.0 3.4 0.0 0.3 4.5 21.3 8.9 2.4 0.8 6.7 2.6 4.8 1.8 0.2 0.0 2.1 3.0 3.6 0.0 0.1 0.7 10.7 2.7 1.1 1.3 6.0 19.3 5.8 2.8 0.4 3.6 11.1 2.0 0.2 1.2 13.3 0.0 5.7 0.2 12.8 5.4 6.0 2.0 4.7 2.1 0.7 1.3 0.3 10.2 3.5 0.1 0.1 3.6 6.6 5.0 19.9 19.4 21.0 13.1 2.6 8.9 0.7 6.0 27.5 8.3 15.2 0.1 4.2 24.7 0.2 0.4 0.1 0.9 0.9 1.1 0.2 0.1 1.0 3.8 6.3 11.1 15.5 11.0 0.2 0.1 0.4 12.1 4.9 0.2 0.2 0.2 11.0 1.0 0.1 0.1 0.2 2.9 58.5 0.4 0.3 0.4 12.3 0.1 0.5 3.8 0.6 12.6 17.1 0.6 2.7 4.6 0.2 0.1 0.2 0.4 0.2 0.9 0.8 2.1 0.5 1.3 0.9 1.0 2.7 1.0 0.7 0.5 6.0 0.9 1.0 4.7 0.7 1.2 2.0 0.4 0.3 17.9 18.2 4.5 44.8 6.9 0.7 4.0 33.1 40.2 48.9 38.4 0.0 17.1 0.0 20.8 2.0 26.8 198.4 0.0 45.9 1.9 5.1 74.4 4.6 16.8 2.3 6.4 65.7 30.1 3.8 0.0 0.3 1.3 6.8 1.0 179.9 0.2 33.7 74.8 0.0 0.1 1.1 12.9 17.6 0.3 1.2 14.3 9.2 1.5 138.5 100.6 ATP8B4 "ATPIM, KIAA1939" ENSG00000104043 "ATPase phospholipid transporting 8B4 (putative)" Q8TF62 15 49858238-50182817 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 28.1;cervix, uterine: 26.0;endometrium 1: 18.2" "Group enriched" "Detected in many" 4 "Early spermatids: 23.4;granulocytes: 19.6;Hofbauer cells: 12.9;Kupffer cells: 29.9;Late spermatids: 19.9;Macrophages: 17.3;T-cells: 8.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 6.9;NK-cell: 10.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 19.1;NB-4: 7.3;THP-1: 12.3;U-937: 38.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040254 Approved Uncertain Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA040254: AB_10673028" "unprognostic (6.45e-3)" "unprognostic (3.83e-2)" "unprognostic (5.39e-2)" "unprognostic (2.96e-3)" "unprognostic (3.25e-1)" "unprognostic (6.51e-3)" "unprognostic (1.03e-1)" "unprognostic (4.87e-3)" "unprognostic (1.64e-2)" "unprognostic (5.11e-2)" "unprognostic (1.20e-1)" "unprognostic (3.74e-2)" "unprognostic (5.99e-2)" "unprognostic (5.12e-2)" "unprognostic (1.20e-2)" "unprognostic (1.53e-1)" "unprognostic (2.08e-1)" 2.3 1.2 1.6 1.5 2.1 28.1 1.0 0.6 0.9 26.0 1.5 1.7 1.6 0.4 18.2 3.5 0.6 9.5 3.1 0.8 2.5 0.9 1.0 1.2 3.2 0.7 2.7 0.1 3.9 0.4 0.2 1.1 2.9 2.1 0.7 1.2 0.8 0.9 0.6 0.4 0.5 1.1 2.7 3.1 2.3 0.6 0.9 4.6 0.8 0.5 0.8 2.1 1.3 1.5 0.0 2.2 6.9 1.7 10.6 0.5 0.8 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 5.2 0.0 3.0 0.6 0.0 0.0 5.3 19.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 7.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.4 38.5 0.0 6.9 1.7 2.4 0.5 0.8 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.8 10.6 0.3 0.0 0.0 0.8 1.6 2.1 0.6 0.9 2.5 0.9 2.7 0.1 2.1 4.6 0.0 3.4 1.3 0.1 1.3 0.2 1.2 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 23.4 0.5 0.4 0.0 0.0 1.6 3.3 0.5 19.6 2.8 12.9 0.0 0.0 1.8 29.9 19.9 1.7 17.3 1.7 1.0 0.3 0.5 0.0 0.0 0.7 0.8 0.0 0.0 4.3 0.4 0.6 0.3 2.4 8.6 0.0 0.1 ATR "FRP1, MEC1, SCKL, SCKL1" ENSG00000175054 "ATR serine/threonine kinase" Q13535 3 142449235-142578826 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 35.3;Spermatocytes: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054320 Supported "Nucleoplasm,Golgi apparatus" No No Nucleoplasm "Golgi apparatus" "HPA054320: AB_2682448" "unprognostic (1.47e-1)" "unprognostic (8.90e-2)" "unprognostic (2.90e-1)" "unprognostic (4.23e-2)" "unprognostic (2.25e-2)" "unprognostic (6.42e-2)" "prognostic unfavorable (8.39e-5)" "unprognostic (3.44e-1)" "unprognostic (1.67e-1)" "unprognostic (3.02e-1)" "prognostic unfavorable (1.23e-5)" "unprognostic (1.94e-1)" "unprognostic (5.61e-2)" "unprognostic (1.06e-1)" "unprognostic (3.55e-1)" "unprognostic (1.69e-2)" "unprognostic (1.43e-1)" 10.5 24.3 7.7 11.4 15.9 10.1 14.8 11.3 14.6 10.1 8.5 10.0 10.4 6.0 14.7 16.8 9.4 12.1 9.3 8.8 9.8 7.1 9.6 12.0 10.3 16.0 10.0 8.1 12.3 13.6 18.0 22.5 8.8 12.5 11.0 11.2 9.5 12.5 10.8 7.7 11.2 10.9 9.8 8.8 14.2 9.0 15.3 9.7 19.0 13.8 7.7 15.1 10.9 10.6 5.8 2.8 2.2 4.0 6.7 6.0 0.8 22.7 11.2 7.5 8.5 10.7 11.8 8.9 12.6 7.1 9.4 9.7 5.2 7.3 18.6 13.0 8.9 12.3 14.8 11.0 11.6 14.2 5.9 7.2 10.2 8.5 5.1 4.7 17.1 5.7 9.2 6.4 8.9 10.6 6.4 9.7 9.7 7.1 8.4 9.6 10.0 12.9 7.1 7.2 14.9 8.0 10.7 10.9 13.5 9.5 10.6 5.3 5.4 23.2 8.4 8.2 7.1 12.2 6.9 12.5 9.6 4.8 12.4 13.5 11.0 6.5 17.3 12.5 6.7 7.6 0.7 2.7 2.2 4.4 4.0 6.0 3.1 3.2 4.2 2.8 5.8 4.1 4.0 1.7 6.7 2.5 2.5 2.4 0.8 7.7 15.9 11.3 14.6 9.8 7.1 10.0 8.1 12.5 9.7 6.0 8.8 13.4 6.5 3.5 14.7 7.1 7.6 18.7 6.8 3.5 35.3 6.6 0.0 5.3 12.0 7.1 2.1 0.0 4.3 3.3 4.8 6.7 1.1 6.0 5.7 7.9 7.5 8.6 9.1 6.9 6.1 6.9 10.1 4.6 5.4 4.8 6.2 0.0 6.7 4.1 23.4 0.0 6.4 42.3 15.8 4.0 4.2 5.1 7.0 5.2 ATRIP "FLJ12343, MGC20625, MGC21482, MGC26740" ENSG00000164053 "ATR interacting protein" Q8WXE1 3 48446710-48467645 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 38.3" "Cell type enhanced" "Detected in some" 7 "Ciliated cells: 5.3;Exocrine glandular cells: 3.3;Pancreatic endocrine cells: 3.5;Suprabasal keratinocytes: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033109, HPA047590" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB033109: AB_634993, HPA047590: AB_2680094" "unprognostic (5.43e-3)" "unprognostic (1.29e-1)" "unprognostic (2.85e-1)" "unprognostic (8.87e-2)" "unprognostic (2.34e-1)" "unprognostic (4.79e-3)" "unprognostic (4.72e-2)" "unprognostic (8.88e-3)" "unprognostic (2.66e-1)" "unprognostic (7.94e-2)" "unprognostic (2.53e-2)" "unprognostic (7.05e-2)" "unprognostic (2.01e-1)" "unprognostic (8.89e-2)" "unprognostic (2.59e-1)" "unprognostic (1.40e-2)" "unprognostic (8.52e-2)" 6.1 5.3 4.9 6.2 5.5 7.1 6.5 9.4 6.4 7.0 5.2 7.2 5.1 3.8 8.2 5.1 7.0 5.7 5.0 5.4 3.5 2.8 5.4 5.4 6.0 5.5 4.8 3.6 6.8 5.3 5.3 5.5 9.2 3.8 6.2 6.0 6.5 5.1 7.2 7.3 8.0 4.6 5.4 3.4 6.3 5.2 38.3 4.6 13.4 9.3 6.6 9.0 5.5 6.2 0.9 2.9 1.0 1.4 1.4 3.4 1.5 7.0 2.9 8.2 6.2 5.0 8.5 8.7 10.7 5.0 13.3 11.1 4.3 5.0 15.7 5.1 4.5 6.2 7.3 9.2 8.4 13.0 9.3 4.7 12.2 13.1 2.9 2.7 11.8 7.8 3.6 2.7 7.1 3.4 2.9 5.8 5.9 9.7 8.1 12.4 3.9 9.9 4.2 6.4 3.6 8.8 6.7 7.5 11.5 4.5 3.5 4.0 5.8 8.6 8.7 3.4 7.7 7.4 4.5 6.5 8.9 5.8 10.7 12.4 9.6 15.3 10.8 4.7 8.9 4.9 0.7 1.4 0.0 3.3 0.8 0.5 0.9 3.0 1.7 0.9 0.5 2.1 3.3 1.0 1.4 1.0 2.9 3.4 1.5 4.9 5.5 9.4 6.4 3.5 2.8 4.8 3.6 3.8 4.6 0.0 1.0 0.0 0.0 2.6 0.8 1.3 0.0 5.3 2.3 0.0 2.0 0.1 0.0 3.0 0.0 0.7 0.0 0.0 3.3 0.1 0.2 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 1.9 0.0 2.8 0.0 0.6 3.5 0.0 0.0 1.5 2.0 0.0 0.9 0.0 0.0 3.3 0.1 0.0 0.0 0.0 ATRNL1 "ALP, FLJ45344, KIAA0534" ENSG00000107518 "Attractin like 1" Q5VV63 10 115093365-115948992 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0" "Cell type enhanced" "Detected in some" 10 "Bipolar cells: 40.4;Early spermatids: 37.4;Ito cells: 32.5;Late spermatids: 28.8;Spermatocytes: 41.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "memory B-cell: 2.0" "Lineage enriched" "Detected in single" 20 "B-cells: 2.0" "Cell line enhanced" "Detected in many" "AN3-CA: 20.5;RH-30: 13.7;U-266/70: 11.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038070 Uncertain Approved Nucleoplasm,Mitochondria NA NA 33000000 "Nucleoplasm, Mitochondria" "HPA038070: AB_10697237" "unprognostic (3.85e-2)" "unprognostic (1.89e-1)" "unprognostic (5.88e-2)" "unprognostic (3.20e-3)" "unprognostic (1.57e-2)" "unprognostic (3.33e-1)" "unprognostic (1.11e-1)" "unprognostic (1.88e-2)" "unprognostic (5.17e-2)" "unprognostic (4.06e-2)" "unprognostic (2.18e-2)" "unprognostic (2.50e-2)" "unprognostic (1.04e-3)" "unprognostic (3.10e-2)" "unprognostic (2.76e-2)" "unprognostic (1.88e-2)" "unprognostic (2.08e-3)" 0.9 11.7 8.6 0.7 15.9 0.3 2.1 2.2 26.0 0.9 2.3 2.1 1.1 0.8 12.0 1.1 1.5 1.0 0.8 2.9 9.3 5.8 4.8 2.9 0.6 1.0 4.0 15.7 17.5 2.3 0.3 11.1 3.3 8.4 6.9 0.9 2.0 1.8 8.3 3.8 0.6 1.0 13.4 2.0 0.8 0.9 13.0 2.5 0.0 2.0 0.0 0.9 1.1 1.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.2 20.5 0.0 0.0 0.0 0.1 0.4 3.0 4.4 0.1 0.1 0.0 1.4 0.5 4.2 0.0 1.1 0.0 3.5 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.1 8.6 0.0 8.6 0.0 6.9 9.4 0.2 8.0 0.0 6.7 0.0 0.1 5.9 13.7 8.9 3.1 0.0 3.4 9.9 0.0 0.0 0.2 3.8 1.2 0.0 0.0 0.0 2.5 0.0 2.9 11.3 0.0 3.3 0.1 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 15.9 2.2 26.0 9.3 5.8 4.0 15.7 8.4 2.5 0.0 0.0 0.0 0.1 0.6 40.4 1.7 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.6 37.4 0.0 0.0 0.0 0.3 0.0 1.1 0.1 0.0 0.0 2.2 9.5 0.0 32.5 3.2 28.8 1.4 0.0 0.0 0.0 0.0 4.0 0.5 0.0 0.7 0.3 4.4 0.0 0.4 41.3 5.3 0.1 0.2 0.0 0.0 0.0 ATXN1 "ATX1, D6S504E, SCA1" ENSG00000124788 "Ataxin 1" P54253 6 16299112-16761491 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 108.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 24.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008335, HPA070756" Approved Supported Nucleoplasm,Nucleoli,Cytosol Yes No Nucleoplasm "Nucleoli, Cytosol" "HPA008335: AB_1845129, HPA070756: AB_2686306" "unprognostic (1.01e-1)" "unprognostic (4.77e-2)" "unprognostic (1.23e-1)" "unprognostic (5.64e-3)" "unprognostic (4.54e-1)" "unprognostic (1.95e-2)" "unprognostic (7.74e-2)" "unprognostic (4.51e-2)" "unprognostic (4.06e-1)" "unprognostic (1.11e-2)" "unprognostic (3.87e-2)" "unprognostic (2.69e-2)" "unprognostic (1.41e-3)" "unprognostic (1.67e-3)" "unprognostic (2.33e-1)" "unprognostic (1.06e-1)" "unprognostic (3.29e-3)" 8.1 9.1 17.7 11.9 25.1 5.5 9.1 33.7 29.5 14.8 13.5 12.9 10.3 8.2 20.5 9.8 11.1 11.0 12.1 11.8 18.0 11.0 9.1 10.1 14.8 11.6 21.1 17.7 10.7 10.3 18.4 11.6 10.3 16.4 14.2 8.5 9.8 8.4 14.0 26.3 12.0 8.3 19.1 16.1 11.4 10.3 8.1 25.6 4.6 11.8 12.5 7.4 11.7 11.3 0.4 0.8 4.4 1.7 0.1 2.5 0.8 3.4 2.0 0.7 0.0 3.5 4.8 4.6 3.7 8.7 2.3 2.7 2.1 2.2 0.1 5.0 7.1 3.0 3.2 0.2 2.3 3.3 1.9 3.6 0.5 3.2 6.7 5.7 3.2 5.6 3.7 4.5 4.8 4.1 8.9 4.6 0.7 0.0 4.1 1.9 1.7 0.2 3.6 0.7 1.1 3.3 0.2 4.6 3.0 3.1 5.8 0.2 2.0 3.4 4.3 7.0 7.0 2.8 5.5 7.0 3.2 4.9 3.7 3.3 24.3 13.9 0.1 2.0 3.3 7.8 0.7 1.7 0.4 2.5 1.3 1.9 0.4 1.7 2.4 0.8 0.1 0.2 1.5 4.4 0.1 0.7 0.4 1.3 0.8 17.7 25.1 33.7 29.5 18.0 11.0 21.1 17.7 16.4 25.6 44.7 20.4 14.9 54.4 81.3 39.6 30.2 25.5 22.7 26.1 10.4 94.2 0.3 6.6 15.9 3.6 15.7 12.5 0.0 7.4 3.0 26.7 57.3 38.1 25.3 20.8 36.5 1.2 20.3 33.9 1.8 9.8 33.2 30.4 28.9 12.3 24.2 22.2 13.5 26.5 7.7 108.3 51.8 35.3 0.9 1.3 42.7 0.3 44.9 6.8 52.7 ATXN1L BOAT1 ENSG00000224470 "Ataxin 1 like" P0C7T5 16 71845991-71885268 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Late spermatids: 197.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062596, HPA062789" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA062596: AB_2684802, HPA062789: AB_2684868" "unprognostic (1.51e-1)" "unprognostic (1.73e-2)" "unprognostic (1.39e-1)" "unprognostic (1.67e-1)" "unprognostic (3.01e-2)" "unprognostic (1.01e-1)" "unprognostic (1.68e-1)" "unprognostic (1.14e-1)" "unprognostic (1.00e-1)" "unprognostic (1.04e-1)" "unprognostic (8.13e-2)" "unprognostic (1.99e-1)" "prognostic favorable (5.33e-8)" "unprognostic (1.61e-1)" "unprognostic (1.42e-1)" "unprognostic (5.30e-2)" "prognostic unfavorable (8.42e-4)" 19.2 12.0 17.1 14.2 15.9 41.3 16.2 11.9 20.9 15.0 15.4 22.7 9.1 10.2 19.4 9.8 14.7 14.2 14.5 11.9 13.5 10.9 23.4 10.0 14.9 11.4 14.7 13.1 16.7 16.3 29.3 10.3 14.6 14.7 14.4 11.9 14.2 14.4 14.0 15.9 18.6 14.9 16.3 14.5 13.8 16.0 25.3 16.9 10.9 15.1 8.2 12.9 16.2 18.5 1.8 1.3 3.2 2.1 2.0 3.0 1.4 8.5 11.6 11.8 8.6 13.9 6.9 13.9 7.2 8.1 13.2 10.1 16.5 9.6 9.6 11.4 11.3 6.0 15.1 10.0 11.0 14.4 2.6 8.8 7.0 12.1 11.5 10.4 8.5 14.4 9.9 14.1 14.9 10.8 8.7 11.9 12.7 7.9 7.7 7.7 24.3 14.3 8.4 10.8 6.7 5.5 15.4 12.0 11.4 9.1 12.0 6.3 10.8 14.4 7.7 8.8 13.0 11.9 9.1 14.3 14.5 15.3 9.1 9.7 17.4 14.6 22.9 9.0 5.8 12.2 3.2 1.5 1.7 2.3 2.1 1.6 1.8 1.7 2.0 1.3 1.5 3.0 2.7 2.2 2.0 0.9 0.8 3.0 1.4 17.1 15.9 11.9 20.9 13.5 10.9 14.7 13.1 14.7 16.9 0.0 8.8 10.7 13.3 20.3 11.2 11.0 7.6 5.3 5.7 14.0 13.7 7.2 14.9 10.6 37.1 15.7 13.6 0.0 10.3 6.3 10.5 13.0 12.7 10.6 7.5 14.3 7.5 13.5 8.8 197.6 13.8 11.3 11.8 15.4 7.5 8.0 12.2 16.4 12.0 14.0 15.5 12.9 14.4 20.4 17.9 21.8 9.6 23.5 8.5 23.8 ATXN3 "ATX3, JOS, MJD, SCA3" ENSG00000066427 "Ataxin 3" P54252 14 92044496-92106625 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB021976, HPA024123, HPA069338" Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "CAB021976: , HPA024123: AB_1845133, HPA069338: AB_2686124" "unprognostic (1.06e-2)" "unprognostic (2.93e-1)" "unprognostic (1.22e-1)" "unprognostic (3.67e-2)" "unprognostic (5.76e-2)" "unprognostic (1.57e-1)" "unprognostic (1.42e-1)" "unprognostic (9.85e-3)" "unprognostic (1.69e-1)" "unprognostic (6.75e-2)" "unprognostic (1.04e-2)" "unprognostic (3.06e-2)" "unprognostic (2.03e-2)" "unprognostic (8.94e-3)" "unprognostic (4.22e-1)" "unprognostic (1.64e-1)" "unprognostic (1.11e-1)" 17.8 10.3 10.2 9.1 11.6 14.3 12.8 18.7 12.1 16.0 11.8 12.2 11.9 6.4 17.9 12.4 17.7 9.5 11.2 10.4 9.0 9.9 9.9 16.0 12.3 11.6 16.3 9.5 14.0 10.3 11.9 17.2 11.7 13.8 15.8 11.7 8.6 11.4 10.2 6.1 21.0 8.7 20.6 16.5 12.6 9.0 14.8 14.3 16.2 11.5 12.0 15.6 15.4 13.6 9.8 14.5 11.4 18.8 7.0 8.5 5.3 5.6 11.1 10.1 9.3 14.7 14.4 19.7 6.4 10.5 8.2 11.5 8.1 15.7 11.5 12.8 10.5 9.7 9.9 7.7 14.1 18.2 13.1 2.3 4.9 5.4 11.8 12.1 8.6 8.8 11.6 12.6 14.3 15.0 11.0 12.6 12.9 6.5 8.6 12.4 22.0 9.0 7.8 7.1 18.8 9.2 7.2 18.5 6.5 10.5 12.8 3.4 6.0 15.6 6.6 8.8 14.1 12.3 6.1 6.7 8.1 11.9 5.2 3.4 7.5 12.5 10.6 6.0 8.5 4.7 11.4 13.4 9.4 5.9 14.5 7.0 7.1 6.9 6.5 14.5 9.8 7.6 8.5 11.3 7.0 18.8 8.4 6.8 5.3 10.2 11.6 18.7 12.1 9.0 9.9 16.3 9.5 13.8 14.3 14.9 14.3 18.1 26.1 22.6 32.4 17.3 17.8 12.0 12.5 40.1 47.1 17.4 13.3 17.7 18.3 43.4 11.7 0.0 15.0 23.8 25.4 29.1 23.2 19.1 20.8 25.4 15.4 39.3 27.2 18.5 62.7 31.8 21.9 30.7 16.0 20.6 17.6 17.5 61.2 14.6 45.6 45.3 35.8 30.5 60.9 26.5 21.2 23.0 19.4 25.1 ATXN7 "ADCAII, OPCA3, SCA7" ENSG00000163635 "Ataxin 7" O15265 3 63898399-64003453 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 55.4" "Cell type enriched" "Detected in some" 4 "Syncytiotrophoblasts: 51.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 11.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA034989 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA034989: AB_10602596" "unprognostic (1.51e-2)" "unprognostic (2.44e-1)" "unprognostic (5.98e-2)" "unprognostic (2.18e-1)" "unprognostic (1.92e-1)" "prognostic favorable (1.22e-4)" "unprognostic (9.65e-2)" "unprognostic (2.76e-2)" "unprognostic (2.46e-1)" "unprognostic (2.12e-1)" "unprognostic (7.82e-2)" "unprognostic (9.77e-3)" "unprognostic (2.56e-1)" "unprognostic (8.04e-2)" "unprognostic (1.74e-1)" "unprognostic (9.19e-2)" "unprognostic (3.45e-2)" 8.8 6.4 4.9 14.5 7.4 19.7 8.9 10.2 6.5 9.5 10.7 4.9 6.7 8.0 10.9 9.2 9.2 7.5 11.4 7.5 5.0 4.3 6.3 8.2 10.2 19.9 6.1 3.1 12.4 21.7 15.3 10.9 15.1 6.0 8.2 8.1 15.1 12.2 7.8 9.6 10.6 12.5 9.2 5.7 11.1 7.2 14.6 6.7 55.4 8.8 8.5 24.2 8.4 10.2 0.9 0.5 11.1 0.5 2.6 5.9 1.1 6.0 4.9 5.0 4.1 5.8 6.6 6.6 3.5 6.5 7.5 6.1 6.9 5.9 5.8 2.1 6.8 8.1 4.0 6.4 6.6 8.0 15.2 2.6 10.1 5.8 2.1 2.9 4.2 12.2 6.3 3.6 11.1 12.4 5.6 5.6 9.6 3.8 17.7 4.6 14.4 8.9 3.5 3.4 4.1 2.2 3.8 4.6 7.0 3.7 7.2 2.0 3.7 7.8 5.2 7.1 4.2 3.6 6.1 7.7 6.5 8.9 9.5 8.1 8.0 8.1 6.4 7.7 7.1 6.2 11.1 0.3 0.9 3.2 0.5 2.6 0.0 5.9 3.4 0.1 0.9 5.7 3.7 1.2 2.6 0.1 0.5 4.7 1.1 4.9 7.4 10.2 6.5 5.0 4.3 6.1 3.1 6.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.1 0.0 0.0 0.0 ATXN7 "ADCAII, OPCA3, SCA7" ENSG00000285258 "Ataxin 7" O15265 3 63864557-64003462 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 8.9" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 96.2;Rod photoreceptor cells: 72.4" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA034989 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034989: AB_10602596" 0.4 0.0 1.5 2.8 1.3 0.0 2.0 0.7 0.0 2.0 2.0 0.0 0.9 0.8 0.0 1.0 0.9 0.9 2.1 0.5 1.0 3.0 1.9 0.9 0.9 0.5 0.6 0.3 3.1 0.8 0.3 1.5 1.0 0.0 0.8 1.8 0.1 4.9 3.6 8.9 1.9 2.5 4.3 0.7 2.4 0.1 3.5 3.3 3.3 6.1 3.3 3.0 2.5 4.1 5.6 1.5 3.2 6.9 1.1 2.1 4.8 2.8 3.4 2.3 4.9 6.6 2.6 6.3 4.3 2.5 4.6 4.6 5.8 1.9 6.9 5.2 6.8 4.2 2.9 3.9 2.3 9.8 2.9 13.2 3.0 4.0 2.2 1.6 0.8 5.8 2.9 2.5 2.6 3.4 1.1 1.7 6.0 4.9 3.9 2.9 1.4 6.7 4.0 6.1 3.3 3.6 4.7 5.4 4.8 4.3 2.4 4.8 3.6 5.7 1.9 2.7 2.5 1.2 2.9 4.9 2.9 2.4 1.6 4.3 3.5 2.5 8.9 2.5 1.4 3.6 4.3 0.7 8.9 7.8 5.7 20.9 38.7 67.5 0.0 33.1 8.1 5.7 5.2 96.2 0.0 0.0 2.5 11.6 15.5 24.4 0.0 3.7 0.0 4.1 20.9 14.9 17.4 0.0 23.8 25.3 33.7 34.3 6.2 11.8 10.2 11.8 8.2 19.4 28.6 2.0 27.1 12.4 0.3 72.4 0.0 19.6 12.5 15.3 40.4 0.0 40.6 18.2 34.4 ATXN7L1 "ATXN7L4, KIAA1218, MGC33190" ENSG00000146776 "Ataxin 7 like 1" Q9ULK2 7 105605067-105876604 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 68.4;Late spermatids: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021448 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021448: AB_1845213" "unprognostic (1.60e-1)" "unprognostic (1.53e-1)" "unprognostic (4.36e-2)" "unprognostic (1.01e-2)" "unprognostic (2.84e-1)" "unprognostic (8.20e-3)" "unprognostic (3.69e-1)" "unprognostic (2.51e-2)" "unprognostic (8.71e-2)" "unprognostic (1.02e-1)" "unprognostic (1.41e-1)" "unprognostic (8.65e-2)" "unprognostic (2.22e-1)" "unprognostic (3.79e-1)" "unprognostic (5.75e-2)" "unprognostic (1.07e-1)" "unprognostic (2.01e-1)" 10.8 10.7 10.3 12.1 16.6 7.7 10.6 24.7 13.4 13.3 11.7 9.7 12.3 7.9 9.2 9.1 9.6 11.7 8.4 6.4 8.5 6.2 14.1 12.3 7.8 15.6 7.1 7.3 13.3 7.2 11.2 17.8 10.8 6.9 10.1 11.6 8.3 11.4 12.1 5.2 12.2 10.9 9.7 6.9 10.4 9.8 20.8 9.9 12.4 11.8 4.6 17.9 11.3 11.7 3.9 3.1 4.3 4.8 4.2 14.5 3.4 2.9 3.9 8.4 3.9 5.2 6.1 2.6 5.2 5.2 4.7 4.4 3.8 5.6 1.2 4.1 5.4 4.1 2.7 4.7 5.3 3.4 16.1 3.1 3.9 2.9 3.6 3.1 6.3 13.0 4.2 4.4 3.1 3.1 3.4 4.2 2.8 4.6 2.6 3.8 6.9 3.4 3.5 15.5 8.0 3.9 3.4 2.8 0.8 3.5 2.9 5.2 3.5 3.7 7.3 7.3 8.6 3.8 6.4 10.5 7.3 3.4 6.0 2.0 0.6 0.0 0.1 4.6 9.8 7.3 2.3 4.2 4.3 2.9 4.8 2.1 3.9 7.5 6.4 3.1 3.6 8.2 4.7 1.4 4.2 2.8 2.1 14.5 3.4 10.3 16.6 24.7 13.4 8.5 6.2 7.1 7.3 6.9 9.9 0.0 4.6 3.6 4.7 4.5 8.2 2.4 2.5 16.0 2.3 5.2 2.0 5.6 5.0 3.3 68.4 3.6 10.8 0.0 2.3 3.1 4.9 5.1 4.7 13.4 6.5 7.9 5.2 6.7 10.3 39.7 6.1 6.3 8.5 7.2 8.2 2.0 3.7 10.5 4.2 29.8 0.6 6.5 4.2 7.9 1.7 3.4 4.5 8.7 8.1 3.3 ATXN7L3B lnc-SCA7 ENSG00000253719 "Ataxin 7 like 3B" Q96GX2 12 74537827-74545430 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 170.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056612 Approved Nucleoplasm NA NA Nucleoplasm "HPA056612: AB_2683190" "unprognostic (3.43e-3)" "unprognostic (1.07e-1)" "unprognostic (4.76e-2)" "unprognostic (3.20e-2)" "unprognostic (3.68e-1)" "unprognostic (9.26e-2)" "unprognostic (1.81e-3)" "unprognostic (7.12e-2)" "unprognostic (9.55e-2)" "unprognostic (6.06e-2)" "unprognostic (2.08e-1)" "unprognostic (1.49e-1)" "prognostic favorable (2.25e-6)" "unprognostic (2.07e-1)" "unprognostic (1.27e-1)" "unprognostic (1.16e-2)" "unprognostic (1.15e-2)" 12.4 17.9 29.7 13.1 34.2 15.6 20.9 44.1 52.1 18.2 15.8 20.6 12.9 18.5 19.9 24.3 14.8 31.6 14.7 16.1 27.6 35.0 22.2 18.6 15.3 17.6 26.0 32.2 31.5 20.9 23.3 18.3 20.8 31.2 21.6 18.1 22.3 20.4 21.0 18.1 16.4 16.9 17.0 20.0 17.2 34.2 8.1 18.5 27.8 23.1 9.5 20.2 14.8 13.2 5.6 9.1 13.7 11.5 8.2 14.8 8.4 9.4 7.5 25.1 15.8 15.9 15.0 10.7 9.1 9.1 10.8 8.5 8.6 5.3 13.8 7.2 9.0 7.2 9.6 12.9 8.8 9.0 12.7 10.2 18.4 7.7 13.0 15.2 18.2 3.9 17.2 20.5 8.2 13.6 18.9 12.4 16.1 22.7 7.0 8.8 13.7 20.1 13.0 14.2 13.1 7.2 15.8 13.5 12.4 9.9 15.6 39.5 24.9 10.3 12.2 14.3 16.9 28.8 12.0 10.6 10.4 9.2 6.1 5.6 8.3 7.7 18.0 4.5 6.7 10.4 13.7 9.5 12.5 5.6 9.0 6.7 4.4 8.5 6.2 9.1 5.6 14.8 8.0 2.7 8.2 11.5 5.1 6.1 8.4 29.7 34.2 44.1 52.1 27.6 35.0 26.0 32.2 31.2 18.5 68.5 31.6 13.7 33.4 16.4 86.9 46.2 45.9 170.0 66.0 36.6 31.4 47.5 26.6 34.8 0.6 33.8 24.5 23.3 28.4 31.6 25.2 38.1 44.0 25.2 19.3 49.3 34.8 29.4 20.7 1.3 34.8 19.8 20.3 19.0 36.4 95.6 46.1 17.5 35.3 27.2 75.5 19.4 16.7 11.8 14.9 19.9 37.6 21.8 32.8 34.3 AUP1 ENSG00000115307 "AUP1, lipid droplet regulating VLDL assembly factor" Q9Y679 2 74526645-74529939 "Predicted membrane proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007674 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA007674: AB_1078251" "unprognostic (1.09e-1)" "unprognostic (2.95e-2)" "unprognostic (1.97e-2)" "unprognostic (2.11e-2)" "unprognostic (5.97e-2)" "unprognostic (2.96e-3)" "prognostic unfavorable (2.29e-4)" "unprognostic (2.00e-1)" "unprognostic (2.73e-1)" "unprognostic (3.79e-2)" "unprognostic (2.77e-1)" "unprognostic (3.65e-1)" "prognostic unfavorable (2.97e-9)" "unprognostic (9.68e-2)" "unprognostic (1.59e-1)" "unprognostic (3.35e-1)" "unprognostic (3.96e-2)" 18.8 21.7 13.9 15.5 16.9 9.4 24.2 18.0 16.7 25.7 28.2 14.6 18.4 14.0 14.6 17.8 25.6 15.4 12.5 14.1 11.8 11.2 19.2 44.5 14.4 21.1 18.4 8.0 11.8 44.2 26.4 14.1 20.6 15.1 13.6 25.9 13.5 29.8 17.6 34.6 25.2 31.3 18.0 12.2 18.2 26.0 10.6 14.4 13.5 19.0 11.7 19.9 16.7 13.5 26.3 38.0 30.6 46.3 20.7 31.6 36.4 15.1 22.7 5.8 9.9 34.7 17.3 16.0 11.0 25.3 20.4 10.7 35.4 10.9 15.5 7.8 21.4 38.8 18.6 25.0 19.3 14.5 13.3 23.8 23.0 11.6 29.5 36.7 12.0 11.9 22.9 42.6 30.8 28.6 11.8 21.3 20.2 30.3 21.5 21.7 21.8 12.4 14.4 15.0 58.5 19.5 16.0 24.0 45.5 22.8 12.9 9.3 10.5 10.9 33.7 26.1 9.9 14.8 19.1 8.1 16.5 10.2 4.0 17.4 5.4 8.7 19.0 19.8 16.2 29.1 28.4 39.3 30.6 25.0 46.3 30.2 24.3 26.4 27.3 38.0 26.3 22.1 24.7 19.1 20.7 40.4 35.8 31.6 36.4 13.9 16.9 18.0 16.7 11.8 11.2 18.4 8.0 15.1 14.4 62.5 39.4 71.5 92.4 65.0 32.0 29.5 63.7 32.1 45.5 64.6 13.7 119.5 19.9 114.5 16.9 64.6 148.5 23.3 181.0 166.6 79.4 112.4 86.7 93.6 145.8 35.0 70.9 41.7 72.1 22.0 41.1 89.5 92.8 62.3 95.5 74.6 135.1 112.2 35.7 52.8 33.4 58.2 59.8 85.0 60.7 68.8 187.2 80.9 105.4 119.9 AURKA "AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7" ENSG00000087586 "Aurora kinase A" O14965 20 56369389-56392337 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "lymphoid tissue: 32.3;testis: 41.1" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 70.0;Extravillous trophoblasts: 59.5;granulocytes: 55.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB001454, HPA002636" Enhanced Approved Nucleoplasm,Centrosome,Cytosol Yes Yes "Nucleoplasm, Centrosome, Cytosol" "CAB001454: AB_563420, HPA002636: AB_1845217" "unprognostic (7.73e-2)" "unprognostic (2.46e-2)" "unprognostic (2.76e-2)" "prognostic unfavorable (9.40e-5)" "unprognostic (1.92e-1)" "unprognostic (2.11e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (4.69e-3)" "unprognostic (2.42e-1)" "unprognostic (6.88e-2)" "prognostic unfavorable (6.13e-4)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.47e-8)" "unprognostic (1.67e-1)" "unprognostic (6.83e-2)" "unprognostic (9.00e-2)" "unprognostic (5.14e-2)" 3.7 2.3 1.5 12.7 1.3 8.3 3.0 1.3 1.8 1.4 6.7 1.3 0.8 7.3 1.8 1.2 7.7 1.1 3.7 4.1 1.1 1.1 2.4 5.1 2.9 12.3 1.6 0.9 8.3 1.4 0.3 0.7 6.1 1.5 1.0 8.3 1.5 2.7 0.5 6.9 2.1 7.2 2.7 1.3 7.4 4.3 41.1 1.1 32.3 1.2 5.9 13.3 2.4 2.4 3.9 5.2 6.0 8.7 2.0 6.6 2.6 33.0 24.4 16.3 11.5 0.9 2.1 20.7 27.1 12.7 65.7 27.7 68.2 23.2 10.8 18.7 11.1 34.1 26.7 29.0 18.2 70.0 9.8 11.1 19.3 25.0 42.5 0.5 25.8 27.2 1.0 1.9 22.7 20.4 5.2 15.3 17.7 21.9 8.6 27.9 33.7 15.4 20.0 14.9 27.1 25.1 11.7 31.5 12.0 10.5 8.7 14.1 7.6 37.9 43.6 18.2 15.6 25.8 16.1 8.8 28.6 28.3 15.8 38.2 12.1 14.0 18.8 15.4 15.0 23.6 0.2 5.3 6.0 1.9 8.7 2.9 3.9 3.3 1.9 5.2 1.4 1.5 1.5 3.7 2.0 4.8 1.2 6.6 2.6 1.5 1.3 1.3 1.8 1.1 1.1 1.6 0.9 1.5 1.1 0.0 3.2 4.5 1.1 1.0 1.0 3.4 2.5 1.4 2.3 3.5 2.0 9.8 1.7 3.9 16.9 1.6 5.3 70.0 4.2 59.5 3.8 0.7 55.2 2.4 14.8 1.6 5.8 3.1 2.4 9.5 1.4 5.5 0.0 18.0 5.7 3.5 3.6 3.5 0.4 1.9 2.5 6.5 2.1 16.2 31.6 1.0 6.9 4.9 9.8 1.4 AURKAIP1 "AIP, AKIP, FLJ20608" ENSG00000175756 "Aurora kinase A interacting protein 1" Q9NWT8 1 1373730-1375495 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 9 "Late spermatids: 2457.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031821 Approved Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA031821: AB_10601458" "unprognostic (9.54e-2)" "unprognostic (1.86e-2)" "unprognostic (2.77e-1)" "unprognostic (4.77e-2)" "unprognostic (2.68e-1)" "unprognostic (2.98e-2)" "unprognostic (3.31e-1)" "unprognostic (9.52e-2)" "unprognostic (2.76e-1)" "unprognostic (9.91e-2)" "unprognostic (3.39e-2)" "unprognostic (3.34e-1)" "prognostic favorable (8.11e-4)" "unprognostic (1.01e-1)" "unprognostic (1.09e-1)" "unprognostic (7.18e-2)" "unprognostic (1.84e-1)" 26.6 29.3 30.3 19.6 30.5 20.9 16.3 17.8 40.5 14.1 27.9 18.7 18.3 33.5 14.3 18.3 25.0 14.5 22.9 55.2 25.3 23.4 35.0 59.1 14.4 17.6 29.0 23.0 14.8 41.2 16.8 18.7 23.6 21.9 17.2 13.6 20.0 35.8 20.4 115.9 20.2 29.5 15.9 18.5 16.9 24.7 73.8 12.6 16.0 27.1 41.4 20.7 18.2 15.2 53.4 81.9 82.5 67.5 36.1 61.6 59.2 38.9 23.7 13.0 23.3 11.5 14.6 24.0 23.7 15.8 37.6 26.8 41.5 36.2 20.6 35.4 16.0 18.9 28.9 17.8 31.4 10.9 24.7 50.3 16.6 31.0 38.3 22.7 21.4 22.6 19.1 14.2 26.3 10.7 11.0 20.4 19.7 32.7 28.5 21.8 29.7 26.2 76.5 24.6 24.6 67.5 30.7 16.0 44.2 29.7 10.4 41.8 31.3 17.0 59.4 56.3 8.3 25.7 50.1 15.2 23.3 29.9 27.7 34.9 37.3 34.0 43.2 32.5 31.7 15.7 60.8 67.5 70.6 51.1 53.6 48.4 53.1 53.9 53.7 58.0 53.4 50.7 49.3 82.5 36.1 46.0 81.9 61.6 59.2 30.3 30.5 17.8 40.5 25.3 23.4 29.0 23.0 21.9 12.6 44.7 60.9 130.3 137.2 144.1 107.1 195.9 180.9 89.7 56.9 157.1 60.9 351.3 573.6 261.8 1001.4 114.7 553.0 116.8 362.4 394.1 140.0 198.9 86.5 355.2 260.5 98.5 195.6 106.2 140.4 2457.2 126.0 155.3 205.8 225.4 267.9 199.3 331.2 287.5 111.4 527.2 88.0 155.2 136.5 419.6 143.7 172.8 366.4 100.2 314.0 225.6 AURKB "Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5" ENSG00000178999 "Aurora kinase B" Q96GD4 17 8204733-8210600 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 19.7;lymphoid tissue: 59.9" "Group enriched" "Detected in many" 6 "Erythroid cells: 46.7;Extravillous trophoblasts: 76.2;Hofbauer cells: 23.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 10.9" "Lineage enriched" "Detected in many" 5 "T-cells: 10.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB005862, HPA037708" Enhanced Enhanced Nucleoplasm,Midbody Yes Yes Nucleoplasm Midbody "CAB005862: AB_449204, HPA037708: AB_2675623" "unprognostic (4.76e-2)" "unprognostic (3.61e-3)" "unprognostic (2.25e-1)" "unprognostic (3.14e-2)" "unprognostic (2.27e-1)" "unprognostic (6.05e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (1.99e-3)" "unprognostic (9.41e-3)" "unprognostic (3.47e-2)" "unprognostic (4.61e-3)" "unprognostic (1.01e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.77e-2)" "unprognostic (2.93e-1)" "unprognostic (6.76e-2)" "unprognostic (3.77e-1)" 1.2 1.3 0.4 22.1 0.6 19.7 2.0 0.6 0.6 2.6 5.8 0.5 0.9 5.9 0.9 1.3 17.1 0.3 2.2 1.0 0.4 0.2 1.4 1.8 2.4 17.8 0.4 0.4 0.8 0.6 0.0 0.4 3.8 0.8 0.9 5.5 0.7 2.7 0.4 2.1 5.0 8.1 1.3 0.7 11.2 4.2 1.2 0.4 59.9 0.5 8.0 19.1 2.1 5.0 2.3 0.8 1.2 0.6 0.5 10.9 1.4 41.6 28.6 42.7 20.5 0.9 1.4 16.4 20.0 10.8 41.5 38.3 37.0 12.6 41.6 10.4 7.9 17.3 30.7 30.9 13.7 34.3 18.2 50.8 24.8 16.4 31.2 0.1 13.0 24.4 0.7 0.6 24.3 15.2 4.1 19.0 27.4 15.4 16.1 18.1 19.8 47.5 18.6 26.5 13.7 12.7 32.2 39.3 17.2 9.0 8.2 9.3 13.2 17.8 8.0 13.6 13.3 14.0 8.8 7.4 16.6 17.1 14.9 52.0 11.8 7.8 31.3 8.0 19.9 33.6 0.0 0.6 0.9 0.6 0.4 0.2 1.6 1.9 3.1 0.8 2.3 0.2 1.0 1.2 0.5 0.3 0.2 10.9 1.4 0.4 0.6 0.6 0.6 0.4 0.2 0.4 0.4 0.8 0.4 0.0 0.3 2.2 0.3 3.9 0.0 1.1 0.0 0.0 3.4 0.0 0.0 5.1 0.0 0.2 0.0 0.0 1.4 46.7 0.0 76.2 4.7 0.4 4.6 0.6 23.9 0.0 0.0 4.9 6.3 0.0 0.6 4.4 1.7 0.0 4.2 0.0 0.2 2.9 0.0 0.0 0.0 0.0 0.3 0.7 2.0 2.0 7.6 2.5 6.3 1.4 AUTS2 "FBRSL2, KIAA0442" ENSG00000158321 "AUTS2, activator of transcription and developmental regulator" Q8WXX7 7 69598296-70793495 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Autism, Autism spectrum disorder, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 60.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 8.6;naive B-cell: 11.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 28.1;REH: 27.4;SCLC-21H: 38.5;SH-SY5Y: 20.9;T-47d: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000390 Approved Approved Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA000390: AB_1845218" "unprognostic (8.73e-3)" "unprognostic (2.24e-1)" "unprognostic (4.62e-2)" "unprognostic (8.78e-2)" "unprognostic (2.44e-2)" "unprognostic (1.04e-1)" "unprognostic (1.65e-2)" "unprognostic (2.68e-2)" "unprognostic (1.07e-3)" "unprognostic (3.33e-2)" "unprognostic (3.52e-2)" "unprognostic (8.46e-2)" "unprognostic (3.29e-3)" "unprognostic (1.76e-2)" "unprognostic (2.47e-1)" "unprognostic (3.04e-1)" "unprognostic (7.33e-2)" 10.3 7.3 29.3 11.6 30.3 9.3 20.3 14.3 19.1 10.5 14.0 17.3 4.1 8.9 10.5 12.4 13.7 8.0 16.6 5.6 22.2 12.9 14.6 19.7 14.7 6.1 14.8 12.3 17.2 6.0 9.9 17.4 5.7 18.9 14.6 13.1 9.9 52.1 8.3 14.9 23.3 18.8 13.6 10.2 8.2 11.3 10.0 20.6 10.5 6.7 7.9 8.9 13.0 10.8 11.6 3.2 0.8 0.2 1.5 2.2 0.7 0.1 2.5 28.1 1.5 1.8 1.1 0.3 1.7 0.0 0.1 0.1 9.5 0.1 4.1 0.6 1.7 0.1 9.1 3.4 3.8 0.8 18.6 7.5 2.0 2.6 0.1 0.8 0.0 0.1 2.9 5.2 4.2 1.0 1.0 0.0 4.5 0.1 2.2 2.4 1.6 0.4 0.8 20.0 6.2 0.0 27.4 13.7 11.6 0.0 4.1 38.5 20.9 1.8 3.1 0.0 12.7 26.3 0.0 0.0 0.1 9.4 3.0 17.2 0.0 0.0 14.2 0.0 0.0 0.0 0.8 0.2 0.2 1.6 0.1 2.2 8.6 1.1 1.5 0.7 11.6 0.2 0.9 0.5 1.5 0.1 3.2 0.2 0.7 29.3 30.3 14.3 19.1 22.2 12.9 14.8 12.3 18.9 20.6 17.9 31.0 10.7 17.8 25.3 35.0 19.0 10.2 12.0 19.4 8.7 15.7 1.0 5.0 9.8 26.8 8.3 16.3 0.0 1.1 0.1 11.3 21.3 0.0 24.5 0.7 60.4 27.7 16.0 3.1 14.8 14.7 4.3 16.9 1.0 20.8 14.3 2.6 14.0 13.8 9.8 22.5 25.8 7.4 11.3 15.4 14.1 1.1 19.2 22.7 20.3 AVPI1 "PP5395, VIP32, VIT32" ENSG00000119986 "Arginine vasopressin induced 1" Q5T686 10 97677424-97687323 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 211.2;Syncytiotrophoblasts: 162.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 29.0;HHSteC: 30.0;hTCEpi: 56.5;SK-MEL-30: 45.6;U-2197: 33.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037649 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA037649: AB_10671879" "unprognostic (4.57e-2)" "unprognostic (3.28e-2)" "unprognostic (3.04e-2)" "unprognostic (4.79e-2)" "unprognostic (2.73e-1)" "unprognostic (1.25e-1)" "unprognostic (4.37e-3)" "unprognostic (4.60e-2)" "unprognostic (7.34e-3)" "unprognostic (8.56e-3)" "unprognostic (2.29e-3)" "unprognostic (1.23e-1)" "unprognostic (3.91e-3)" "unprognostic (4.04e-1)" "unprognostic (2.03e-1)" "unprognostic (8.66e-2)" "unprognostic (3.83e-3)" 21.5 27.4 5.1 4.7 8.5 3.3 11.0 6.3 17.7 13.0 18.6 3.6 4.8 10.7 5.8 8.2 16.3 6.5 19.9 8.5 5.5 5.8 5.6 29.9 17.1 1.7 7.3 5.6 43.3 10.8 4.1 7.2 19.3 8.0 15.3 15.0 13.6 10.7 13.8 8.3 35.5 15.3 8.5 12.6 11.9 12.7 8.4 2.5 1.3 8.2 9.7 7.6 22.0 16.6 3.5 12.4 2.3 7.1 2.0 5.0 3.0 9.0 23.9 0.1 3.5 5.0 2.3 4.9 4.4 24.4 6.1 9.3 4.4 11.4 0.2 3.2 2.5 4.4 9.6 1.8 7.7 2.3 0.2 2.1 0.6 29.0 12.3 30.0 0.6 0.7 3.6 56.5 4.6 12.1 5.6 0.8 0.8 1.3 0.5 3.3 7.8 0.4 0.7 0.8 2.5 2.2 0.3 2.7 0.3 6.0 5.0 0.4 1.0 15.4 5.5 45.6 0.8 4.2 0.7 1.3 1.5 2.9 33.0 1.1 1.1 0.7 0.1 5.5 1.9 0.9 0.0 7.1 2.3 5.0 6.1 2.3 3.5 3.3 3.7 12.4 2.2 3.6 4.4 0.7 2.0 0.5 2.4 2.9 3.0 5.1 8.5 6.3 17.7 5.5 5.8 7.3 5.6 8.0 2.5 17.9 14.7 1.4 58.4 85.3 9.6 6.7 30.6 13.4 17.0 36.6 5.9 126.4 36.5 16.0 51.3 6.0 96.5 0.0 21.5 57.2 30.8 25.7 5.8 38.1 39.2 12.7 30.5 22.7 16.7 211.2 9.5 40.5 79.2 9.0 38.3 125.0 29.4 66.6 13.8 9.1 12.7 6.5 29.8 2.7 1.6 94.7 162.8 9.6 58.7 83.6 AXIN2 "DKFZp781B0869, MGC126582" ENSG00000168646 "Axin 2" Q9Y2T1 17 65528563-65561647 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Extravillous trophoblasts: 87.1" "Cancer enhanced" "Detected in all" "colorectal cancer: 33.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 5.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 11.8;CACO-2: 22.1;Hep G2: 32.9;OE19: 36.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012283, CAB017783" Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "CAB012283: AB_2290204, CAB017783: " "unprognostic (1.31e-2)" "unprognostic (1.29e-1)" "unprognostic (1.05e-2)" "unprognostic (3.45e-3)" "unprognostic (4.48e-1)" "unprognostic (9.81e-2)" "unprognostic (1.12e-2)" "unprognostic (1.82e-1)" "unprognostic (4.57e-2)" "unprognostic (8.84e-3)" "prognostic favorable (6.58e-4)" "unprognostic (1.98e-1)" "unprognostic (1.42e-1)" "unprognostic (3.45e-2)" "unprognostic (2.10e-1)" "unprognostic (2.74e-1)" "unprognostic (1.25e-1)" 7.4 10.1 9.0 7.0 8.9 0.9 5.2 8.2 13.1 16.5 12.2 8.7 10.5 7.2 29.0 7.7 6.5 18.6 6.9 7.3 7.9 5.7 3.5 2.5 15.2 3.4 5.3 10.3 14.7 3.9 3.2 5.8 18.2 10.6 14.8 15.2 7.8 4.6 9.8 12.4 14.9 7.5 18.0 4.8 6.9 14.6 6.8 9.0 27.6 11.3 3.6 3.8 11.8 8.7 4.1 0.0 4.4 0.0 1.9 5.1 0.8 0.0 5.9 11.8 0.2 4.3 1.8 5.2 0.1 0.5 0.4 0.7 22.1 2.1 0.4 0.7 3.4 0.4 0.1 2.4 0.0 0.8 1.0 1.3 0.0 1.0 32.9 0.4 0.0 0.0 1.0 0.9 0.9 0.2 0.7 1.0 2.2 0.0 0.5 0.6 0.1 5.7 0.0 2.3 36.5 0.2 4.1 0.6 0.0 1.1 0.1 3.7 2.4 0.2 0.1 2.0 9.1 0.4 0.1 2.6 2.3 4.3 3.3 0.7 0.0 1.2 1.5 1.1 0.2 1.1 4.4 0.0 0.0 0.3 0.0 0.8 1.0 2.3 0.4 0.0 4.1 5.1 0.8 0.0 1.9 0.0 0.0 0.0 0.8 9.0 8.9 8.2 13.1 7.9 5.7 5.3 10.3 10.6 9.0 0.0 7.0 0.0 1.2 10.0 3.8 8.1 2.5 1.4 10.3 0.0 3.9 14.3 0.0 1.0 27.8 3.8 2.8 0.0 0.7 87.1 17.5 4.1 0.0 1.9 3.3 1.6 5.2 1.3 0.0 11.2 6.1 0.3 16.9 1.8 18.7 3.5 0.7 3.5 10.3 0.6 1.9 12.9 5.9 5.4 12.6 4.8 11.9 0.0 16.8 1.1 AZGP1 "ZA2G, ZAG" ENSG00000160862 "Alpha-2-glycoprotein 1, zinc-binding" P25311 7 99966720-99976157 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 158.8;salivary gland: 270.5" "Group enriched" "Detected in many" 6 "Glandular cells: 2272.6;Hepatocytes: 3981.0" "Group enriched" "Detected in many" 12 "breast cancer: 412.6;liver cancer: 273.6;prostate cancer: 469.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 16.8;Karpas-707: 9.6;OE19: 49.6;RPMI-8226: 38.9;T-47d: 13.0" "Region enriched" "Detected in single" 4 "olfactory region: 0.9" "HPA012582, HPA012876, CAB016087, CAB032276" Enhanced Approved Nucleoplasm,Vesicles "Secreted to blood" NA NA 55200000000 160000000000 Vesicles Nucleoplasm "CAB016087: AB_667849, CAB032276: AB_2062580, HPA012582: AB_1845226, HPA012876: " "unprognostic (8.14e-2)" "unprognostic (1.50e-1)" "unprognostic (3.41e-1)" "unprognostic (5.42e-3)" "unprognostic (4.98e-2)" "unprognostic (5.74e-3)" "prognostic favorable (2.90e-4)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (2.19e-1)" "unprognostic (2.35e-2)" "unprognostic (1.79e-1)" "prognostic favorable (1.53e-4)" "unprognostic (2.18e-1)" "unprognostic (2.08e-2)" "unprognostic (9.80e-2)" "unprognostic (3.51e-3)" 6.4 0.0 1.1 1.3 1.7 0.0 64.1 1.1 1.4 1.1 1.4 1.5 0.9 1.4 0.9 1.2 1.3 0.0 2.2 9.0 1.2 0.4 18.0 158.8 3.0 0.9 2.7 1.2 1.0 55.3 0.0 0.9 1.0 1.3 62.4 0.0 1.6 270.5 2.5 1.0 11.5 1.5 0.9 1.1 0.9 14.4 1.2 1.7 0.9 1.0 3.0 3.2 1.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.2 4.3 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 1.6 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 1.4 0.0 49.6 0.0 0.0 0.5 38.9 0.0 0.0 0.0 0.6 0.2 7.9 3.8 0.0 13.0 0.0 0.0 0.1 0.0 0.6 0.3 0.6 0.2 0.1 0.0 0.1 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 1.7 1.1 1.4 1.2 0.4 2.7 1.2 1.3 1.7 20.8 187.7 32.0 321.8 3.8 0.0 94.8 420.4 5.3 50.0 5.2 2.0 0.0 39.7 11.0 1.3 0.4 8.5 46.7 221.1 0.0 0.2 2272.6 3.5 3981.0 0.0 0.0 11.9 58.3 79.1 3.1 0.9 0.3 59.1 3.6 5.4 22.6 173.5 5.8 0.0 512.3 0.2 0.0 1.1 4.3 0.4 8.4 0.0 15.2 6.3 497.4 B3GALNT2 MGC39558 ENSG00000162885 "Beta-1,3-N-acetylgalactosaminyltransferase 2" Q8NCR0 1 235449923-235504481 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 35.7" "Cell type enriched" "Detected in many" 7 "Cone photoreceptor cells: 237.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012502, HPA050662" Approved Approved "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA Nucleoplasm "Golgi apparatus" "HPA012502: AB_1845228, HPA050662: AB_2681209" "unprognostic (5.50e-2)" "unprognostic (3.16e-3)" "unprognostic (6.60e-2)" "unprognostic (1.63e-1)" "unprognostic (1.36e-2)" "unprognostic (1.28e-1)" "unprognostic (7.59e-3)" "unprognostic (1.96e-2)" "unprognostic (3.39e-2)" "unprognostic (3.38e-1)" "unprognostic (7.19e-3)" "unprognostic (2.89e-1)" "unprognostic (1.99e-1)" "unprognostic (5.52e-2)" "unprognostic (3.40e-1)" "unprognostic (3.53e-3)" "unprognostic (8.34e-3)" 5.0 6.3 3.9 4.3 5.1 1.3 8.4 4.7 4.5 5.4 7.6 3.5 5.1 3.3 8.0 8.7 10.3 6.1 9.7 7.9 2.8 2.9 3.7 4.6 3.7 3.1 3.0 3.2 5.9 35.7 9.8 8.9 4.5 4.7 8.3 5.8 8.5 8.7 7.3 21.6 6.1 6.9 16.9 2.5 3.3 9.2 5.8 3.9 4.7 7.1 7.0 5.0 9.7 5.9 1.5 5.7 2.4 2.7 1.9 1.9 1.3 9.9 6.5 7.2 10.7 11.7 9.9 17.4 8.7 7.9 6.6 6.1 5.0 8.9 5.2 11.5 9.9 4.3 12.6 14.0 10.2 8.2 10.2 9.7 3.3 8.3 5.7 7.4 10.7 3.7 7.1 6.6 6.8 16.5 5.0 10.1 14.1 8.0 7.0 6.2 4.7 6.7 3.9 10.3 6.3 3.7 7.4 12.0 13.2 4.2 11.8 9.3 11.9 15.1 5.7 7.5 3.1 11.0 10.9 9.9 5.8 9.6 9.8 11.6 10.2 8.4 3.2 3.8 7.7 13.4 2.4 2.3 1.1 1.1 2.7 1.7 1.5 0.8 1.9 5.7 1.1 1.0 1.3 0.2 1.9 2.5 3.1 0.5 1.3 3.9 5.1 4.7 4.5 2.8 2.9 3.0 3.2 4.7 3.9 8.9 5.3 6.4 25.1 27.7 18.9 5.4 2.5 5.3 4.5 5.2 237.6 17.0 0.0 5.8 13.0 6.7 7.3 0.0 6.1 5.6 8.1 23.5 5.7 4.4 3.5 27.0 8.6 4.3 3.1 4.5 9.8 7.9 1.7 9.0 4.6 7.8 7.6 4.3 15.2 0.8 17.3 0.0 14.4 16.6 34.1 26.0 18.8 5.3 5.2 31.0 B4GALNT4 "FLJ25045, NGalNAc-T1" ENSG00000182272 "Beta-1,4-N-acetyl-galactosaminyltransferase 4" Q76KP1 11 369796-382116 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.1;ovary: 18.6" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 17.5;Cardiomyocytes: 11.2;Horizontal cells: 31.8;Muller glia cells: 40.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 20.2;NTERA-2: 18.0;SCLC-21H: 22.4;SH-SY5Y: 27.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043276, HPA053126" Uncertain Uncertain Nucleoplasm,Vesicles,Cytosol "Intracellular and membrane" NA No "Nucleoplasm, Cytosol" Vesicles "HPA043276: , HPA053126: AB_2682049" "unprognostic (6.11e-2)" "unprognostic (7.82e-2)" "unprognostic (1.79e-1)" "unprognostic (6.92e-3)" "unprognostic (5.36e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" "unprognostic (2.72e-2)" "unprognostic (1.33e-1)" "unprognostic (1.53e-1)" "unprognostic (1.69e-3)" "unprognostic (4.99e-3)" "unprognostic (1.52e-10)" "unprognostic (9.01e-2)" "unprognostic (2.56e-1)" "unprognostic (2.92e-4)" "unprognostic (1.25e-1)" 1.6 2.5 20.6 2.8 16.7 1.2 3.5 26.5 35.1 5.9 2.0 8.6 0.8 2.4 8.6 2.4 1.8 8.7 2.1 1.4 17.6 16.8 1.2 1.1 1.3 1.6 11.5 14.9 18.6 1.8 6.3 6.1 1.1 13.0 3.8 1.6 2.3 4.0 3.7 1.1 3.8 2.9 3.1 8.3 1.5 1.5 1.8 11.0 0.0 1.1 0.0 1.7 1.3 1.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.6 20.2 11.5 0.0 0.0 4.7 3.6 0.9 1.6 0.5 2.0 0.0 0.0 2.7 0.4 3.2 0.7 2.7 4.8 0.5 0.0 6.8 0.0 6.4 6.2 0.2 0.0 4.9 0.4 2.9 0.1 2.2 7.3 0.2 1.0 6.1 0.0 0.0 5.9 0.2 0.0 18.0 0.3 7.9 0.0 0.0 2.6 0.2 0.0 22.4 27.3 1.3 1.0 0.2 2.2 7.9 0.0 4.9 1.1 6.4 1.9 0.2 0.0 0.9 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.6 16.7 26.5 21.2 17.6 16.8 11.5 14.9 13.0 11.0 0.0 0.0 0.0 1.3 0.7 17.5 11.2 0.0 0.0 0.0 1.8 3.9 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.2 31.8 1.7 0.0 0.0 0.0 2.8 0.0 3.3 0.0 0.0 40.9 0.3 0.0 1.1 0.0 8.1 0.0 0.2 0.0 0.2 0.3 0.2 0.0 0.0 0.4 BAALC ENSG00000164929 "BAALC, MAP3K1 and KLF4 binding" Q8WXS3 8 103140710-103230305 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 121.3" "Cell type enhanced" "Detected in many" 16 "Ito cells: 27.0;Muller glia cells: 94.5" "Cancer enriched" "Detected in many" 8 "glioma: 139.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "NK-cell: 6.9" "Lineage enriched" "Detected in single" 25 "NK-cells: 6.9" "Cell line enhanced" "Detected in some" "AF22: 24.9;BJ hTERT+: 8.7;SCLC-21H: 13.6;SH-SY5Y: 10.0;U-87 MG: 37.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027132, HPA068307" Approved Supported Nucleoplasm,Cytosol No NA Cytosol Nucleoplasm "HPA027132: AB_10600985, HPA068307: AB_2685971" "unprognostic (1.68e-1)" "unprognostic (9.17e-3)" "unprognostic (1.40e-2)" "unprognostic (4.62e-4)" "unprognostic (1.75e-2)" "unprognostic (2.84e-2)" "unprognostic (1.39e-1)" "unprognostic (7.87e-2)" "unprognostic (2.00e-1)" "unprognostic (4.99e-2)" "unprognostic (4.17e-2)" "unprognostic (2.18e-2)" "unprognostic (7.58e-2)" "unprognostic (2.51e-3)" "unprognostic (2.76e-2)" "unprognostic (1.70e-1)" "unprognostic (9.27e-3)" 7.8 11.1 42.3 3.2 51.9 3.9 3.0 12.5 121.3 2.8 2.9 18.9 0.0 2.3 3.0 2.0 2.2 4.6 2.9 3.2 38.1 34.5 2.8 3.4 4.9 2.6 48.3 25.1 2.7 2.6 1.9 5.2 5.7 41.4 2.0 2.9 0.0 2.1 2.4 3.0 2.7 2.8 3.1 51.2 8.8 2.4 2.6 24.6 0.0 2.8 0.0 2.2 2.8 0.3 0.2 0.1 0.0 0.0 6.9 0.1 0.4 0.2 1.4 24.9 0.2 0.2 7.4 0.0 1.3 8.7 0.0 0.1 0.2 0.0 0.1 0.2 4.7 0.1 0.4 0.4 0.0 0.0 0.0 1.5 0.2 0.3 0.0 0.6 0.0 0.5 1.5 1.4 0.3 0.0 1.3 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.6 0.1 0.5 0.1 0.1 0.5 0.0 0.0 13.6 10.0 0.3 0.0 0.0 2.3 0.1 0.1 1.4 7.9 0.5 0.2 0.5 0.0 0.1 0.1 37.1 0.1 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.9 0.0 0.1 0.0 0.4 42.3 51.9 12.5 43.6 38.1 34.5 48.3 25.1 41.4 24.6 0.0 2.6 0.0 0.7 4.8 2.5 0.6 12.7 17.4 1.2 0.0 0.0 0.0 6.6 17.6 3.0 18.8 0.0 0.0 21.5 0.0 2.6 0.4 0.0 0.5 1.0 0.0 17.0 27.0 2.2 5.6 1.4 0.7 13.5 8.2 0.0 94.5 6.5 0.0 0.0 0.0 2.9 0.0 3.0 0.0 0.1 3.4 0.0 1.7 0.0 0.8 BABAM1 "C19orf62, FLJ20571, HSPC142, MERIT40, NBA1" ENSG00000105393 "BRISC and BRCA1 A complex member 1" Q9NWV8 19 17267350-17281249 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA054386, HPA068786, HPA077609" Approved Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" No No "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA054386: AB_2682471, HPA068786: AB_2686034, HPA077609: " "unprognostic (5.60e-2)" "unprognostic (1.08e-3)" "unprognostic (6.77e-2)" "unprognostic (1.06e-1)" "unprognostic (1.44e-1)" "unprognostic (2.18e-2)" "unprognostic (9.45e-3)" "unprognostic (2.05e-2)" "unprognostic (7.30e-2)" "unprognostic (2.03e-2)" "unprognostic (5.12e-2)" "unprognostic (7.21e-2)" "unprognostic (3.31e-3)" "unprognostic (1.74e-2)" "unprognostic (1.63e-1)" "unprognostic (3.79e-1)" "unprognostic (5.74e-2)" 23.2 26.7 39.8 24.2 33.6 37.3 23.7 32.5 50.0 25.6 25.6 24.5 18.7 25.5 24.9 20.5 26.3 22.0 26.8 36.8 35.2 33.3 24.0 31.2 21.6 30.7 34.4 33.8 23.6 29.2 22.2 15.7 31.9 25.8 22.7 23.8 20.8 30.5 25.5 72.7 25.0 23.4 23.9 23.3 29.1 24.5 24.6 22.2 34.5 19.2 33.5 31.3 21.4 19.8 44.7 51.6 51.6 50.1 33.2 55.2 59.7 35.4 19.9 20.1 19.1 22.5 16.0 45.9 21.3 28.4 43.1 43.0 22.8 42.5 25.2 50.9 29.5 19.2 17.7 23.6 29.5 27.7 36.1 37.6 22.1 26.4 27.6 18.3 39.7 28.3 24.2 20.6 28.5 17.0 23.6 36.2 36.1 36.8 29.6 31.1 29.0 39.9 37.7 52.6 29.9 42.9 26.9 26.6 33.2 31.6 17.5 19.5 35.4 25.8 27.0 23.3 24.1 23.7 32.1 26.0 26.2 16.6 32.0 35.4 39.7 47.5 33.1 37.2 52.6 24.6 50.0 50.1 51.6 45.4 46.0 43.4 44.7 42.0 43.8 51.6 43.3 39.2 38.6 12.6 33.2 43.4 42.8 55.2 59.7 39.8 33.6 32.5 50.0 35.2 33.3 34.4 33.8 25.8 22.2 11.9 33.8 59.1 31.8 31.0 19.2 29.8 35.7 16.0 21.6 33.2 13.7 144.3 86.2 64.8 47.6 38.0 52.1 23.3 63.0 136.2 53.0 40.9 45.1 42.0 86.6 15.9 42.1 35.6 36.2 68.8 33.9 46.9 62.4 98.2 53.3 27.8 60.0 57.5 41.8 72.1 12.0 38.8 52.6 40.7 69.5 36.1 132.2 58.6 59.6 34.3 BACH1 "BACH-1, BTBD24" ENSG00000156273 "BTB domain and CNC homolog 1" O14867 21 29194071-29630751 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 165.1;Late spermatids: 300.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 46.7" "Group enriched" "Detected in all" 4 "granulocytes: 46.7;monocytes: 15.2" "Cell line enhanced" "Detected in all" "Karpas-707: 48.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034949 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034949: AB_2674376" "unprognostic (1.57e-1)" "unprognostic (8.08e-3)" "unprognostic (2.64e-1)" "unprognostic (2.33e-2)" "unprognostic (6.00e-2)" "unprognostic (2.99e-1)" "unprognostic (9.84e-3)" "unprognostic (1.20e-3)" "unprognostic (5.76e-2)" "unprognostic (5.79e-3)" "prognostic unfavorable (3.11e-5)" "unprognostic (5.63e-2)" "prognostic unfavorable (7.14e-4)" "unprognostic (2.59e-1)" "unprognostic (1.60e-1)" "unprognostic (4.19e-2)" "unprognostic (8.70e-2)" 23.3 7.8 7.9 15.5 13.1 44.7 10.3 4.7 8.8 13.5 12.8 9.6 6.7 9.9 16.0 10.0 18.6 8.9 15.6 10.7 8.0 5.8 11.7 17.6 25.2 21.9 10.8 5.5 9.5 12.5 5.3 9.2 28.8 11.1 14.9 7.8 9.2 12.2 5.3 30.7 22.9 17.9 15.9 16.0 22.9 9.5 20.6 11.1 14.3 11.3 12.6 14.0 19.4 15.8 4.0 7.6 46.7 15.2 2.1 4.4 4.0 7.6 3.1 9.7 2.5 7.6 22.2 6.1 8.4 20.1 8.1 9.1 6.4 10.6 9.1 6.8 7.6 8.5 4.0 5.8 11.2 14.4 7.5 4.8 28.0 6.5 6.6 10.1 8.0 10.5 11.4 17.2 15.9 23.8 9.6 4.2 5.0 14.1 48.1 11.1 2.7 6.8 4.7 14.9 3.0 3.2 7.0 23.0 11.7 4.3 6.0 4.0 4.6 4.5 8.6 10.6 10.1 6.3 9.8 10.7 8.0 11.1 8.6 4.2 27.9 17.8 9.8 6.5 10.0 23.9 17.9 15.2 11.3 1.6 12.4 1.3 3.2 2.7 1.4 7.6 4.0 3.9 1.9 46.7 2.1 13.3 1.8 4.4 4.0 7.9 13.1 4.7 8.8 8.0 5.8 10.8 5.5 11.1 11.1 26.8 15.4 19.9 36.3 52.4 17.0 19.0 17.8 16.0 27.3 14.0 17.7 11.1 6.6 16.3 165.1 28.5 21.5 0.0 14.0 13.5 23.3 45.2 45.3 15.7 19.4 12.7 29.6 28.8 52.8 300.7 12.4 74.4 20.3 39.7 16.5 10.6 22.1 14.0 13.4 9.8 11.9 32.3 23.6 21.8 17.9 50.7 33.2 13.8 9.3 37.3 BACH2 BTBD25 ENSG00000112182 "BTB domain and CNC homolog 2" Q9BYV9 6 89926529-90296908 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 29.8" "Cell type enriched" "Detected in many" 4 "Horizontal cells: 187.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "naive B-cell: 15.4" "Lineage enriched" "Detected in many" 4 "B-cells: 15.4" "Group enriched" "Detected in some" 6 "Daudi: 52.7;U-698: 30.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA051384, HPA058384" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051384: AB_2681462, HPA058384: AB_2683700" "unprognostic (4.00e-3)" "unprognostic (3.17e-2)" "unprognostic (1.07e-1)" "unprognostic (2.47e-4)" "unprognostic (1.49e-1)" "unprognostic (2.29e-1)" "unprognostic (3.42e-2)" "unprognostic (8.92e-2)" "unprognostic (2.36e-1)" "unprognostic (1.06e-2)" "unprognostic (3.12e-3)" "unprognostic (4.22e-1)" "unprognostic (9.87e-3)" "unprognostic (2.10e-2)" "unprognostic (1.83e-1)" "unprognostic (2.03e-1)" "unprognostic (3.87e-4)" 2.9 2.1 5.3 29.8 5.6 18.5 4.1 11.4 6.9 5.4 2.2 6.3 1.0 1.3 6.8 2.1 1.9 3.0 2.3 2.6 5.2 2.9 1.7 5.8 5.8 26.7 5.2 4.0 6.3 4.0 5.8 1.9 2.4 4.9 3.7 1.7 0.9 5.2 2.2 7.9 5.4 6.5 2.8 5.2 7.6 1.8 3.4 6.9 26.9 2.0 2.4 20.6 4.8 3.3 15.4 0.2 1.8 0.0 1.5 3.7 0.4 0.3 0.0 1.9 0.1 0.1 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.0 52.7 0.0 0.0 0.0 0.0 0.3 0.6 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 1.2 0.0 0.0 3.4 2.1 4.6 0.0 0.1 1.0 0.0 0.5 0.0 0.4 7.2 1.3 0.9 0.0 0.1 1.7 4.9 0.1 0.0 0.3 0.6 0.0 0.0 0.1 0.0 0.7 0.0 0.0 3.5 0.1 30.9 0.2 0.5 0.4 1.8 0.0 0.7 0.4 0.0 0.8 2.1 0.8 0.7 0.2 15.4 3.7 2.4 0.0 1.5 0.0 0.2 0.1 0.4 5.3 5.6 11.4 6.9 5.2 2.9 5.2 4.0 4.9 6.9 0.0 0.3 43.2 8.5 6.6 5.6 2.0 0.0 0.0 3.4 3.5 39.3 0.1 0.0 4.4 17.2 1.1 0.0 0.0 2.4 0.2 5.3 14.0 0.0 2.4 0.5 187.5 0.0 2.5 0.3 5.3 5.5 0.9 3.3 0.0 0.1 0.6 3.8 0.0 4.2 0.0 1.9 0.0 1.7 0.0 1.5 6.8 0.0 5.1 0.0 3.1 BAG1 ENSG00000107262 "BCL2 associated athanogene 1" Q99933 9 33247820-33264720 "Cancer-related genes, Predicted intracellular proteins" Apoptosis Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 11 "Early spermatids: 1003.4;Late spermatids: 2167.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 82.4;NB-4: 78.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002486, HPA018121" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB002486: AB_563422, HPA018121: AB_1845255" "unprognostic (4.49e-3)" "unprognostic (4.52e-2)" "unprognostic (2.33e-2)" "unprognostic (1.32e-3)" "unprognostic (5.46e-2)" "unprognostic (3.67e-3)" "unprognostic (2.10e-1)" "unprognostic (1.34e-2)" "unprognostic (4.62e-2)" "unprognostic (7.21e-2)" "unprognostic (4.24e-1)" "unprognostic (2.23e-1)" "prognostic favorable (2.22e-16)" "unprognostic (4.45e-2)" "unprognostic (4.03e-1)" "unprognostic (7.64e-3)" "unprognostic (1.07e-2)" 21.5 22.1 30.0 14.6 34.3 25.2 28.6 21.2 25.0 21.4 32.0 18.3 19.5 20.8 15.5 20.4 26.9 17.4 34.8 48.6 25.0 24.3 41.9 34.5 21.2 14.1 33.8 20.1 14.4 43.2 40.9 24.9 16.6 20.0 24.7 27.7 18.2 38.5 26.4 93.2 26.7 27.2 22.2 27.7 21.4 32.5 46.0 20.5 14.9 29.7 41.9 21.2 30.8 27.3 10.2 18.8 29.4 11.6 8.2 9.0 5.1 10.6 10.6 9.0 19.8 13.8 8.1 12.6 8.6 12.3 13.3 13.6 7.4 10.3 35.2 6.5 8.7 4.7 13.4 10.4 7.1 8.8 17.8 9.9 17.5 82.4 11.5 11.7 40.0 21.4 8.2 39.9 6.2 15.0 6.2 15.7 9.1 20.2 17.7 11.0 16.6 27.3 78.8 17.5 13.8 15.5 14.4 12.9 22.6 16.8 31.0 28.9 17.4 38.5 33.9 8.7 3.7 15.4 48.9 8.3 5.9 7.6 17.4 15.0 14.1 21.8 19.1 5.0 21.7 3.3 12.2 11.5 29.4 5.8 11.6 5.2 6.8 6.6 6.9 14.0 10.2 9.0 5.4 7.0 8.2 11.2 18.8 7.8 5.1 30.0 34.3 21.2 25.0 25.0 24.3 33.8 20.1 20.0 20.5 83.4 68.2 64.1 244.9 381.9 70.1 123.1 117.2 45.5 85.3 207.6 55.0 122.0 336.5 113.1 1003.4 65.4 200.5 23.3 167.5 46.5 81.3 398.0 41.5 69.3 91.7 36.5 190.1 49.7 67.4 2167.8 79.4 97.7 155.3 55.1 184.6 65.3 112.7 159.6 83.4 221.7 93.8 97.0 133.9 99.2 59.6 490.8 205.6 67.3 143.0 386.9 BAG6 "BAT3, D6S52E, G3" ENSG00000204463 "BCL2 associated athanogene 6" P46379 6 31639028-31652705 "Predicted intracellular proteins" "Apoptosis, Differentiation, Immunity, Spermatogenesis, Transport" "Chaperone, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Late spermatids: 339.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020704, HPA045116, HPA053291" Enhanced Enhanced Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 2000000 "Nucleoplasm, Cytosol" "CAB020704: , HPA045116: AB_2679220, HPA053291: AB_2682103" "unprognostic (7.32e-2)" "unprognostic (2.96e-2)" "unprognostic (3.43e-1)" "unprognostic (7.67e-3)" "unprognostic (2.61e-1)" "unprognostic (6.00e-2)" "unprognostic (1.07e-3)" "unprognostic (2.14e-1)" "unprognostic (4.46e-1)" "unprognostic (1.34e-1)" "unprognostic (2.88e-2)" "unprognostic (9.98e-2)" "unprognostic (1.08e-3)" "unprognostic (2.04e-1)" "unprognostic (1.82e-2)" "unprognostic (6.05e-2)" "unprognostic (8.16e-2)" 20.8 30.1 16.1 18.4 21.7 16.9 18.1 22.1 31.2 23.9 23.8 22.3 17.9 38.2 25.1 38.6 19.9 23.8 21.4 25.5 15.1 14.1 20.6 41.8 25.7 18.1 15.9 15.6 22.0 22.2 6.6 20.7 27.0 17.5 20.5 30.7 24.4 20.9 19.6 50.5 22.3 31.0 17.3 13.2 23.7 26.1 101.8 16.2 39.9 22.9 30.4 27.1 18.3 19.3 4.8 8.4 8.2 7.5 3.2 6.3 3.1 1.9 14.4 16.8 3.4 8.4 13.0 3.8 3.4 2.7 3.3 3.6 35.8 1.6 2.5 26.0 27.8 20.7 2.4 2.0 29.5 5.4 4.1 39.5 11.1 1.8 22.7 12.6 3.3 33.0 10.4 11.9 2.9 3.9 15.0 9.7 20.4 21.0 11.6 24.1 5.6 2.0 19.6 2.1 3.2 2.6 4.9 2.3 4.6 14.4 5.2 2.4 4.5 1.3 4.1 3.3 4.3 30.2 27.7 1.9 11.4 8.7 2.0 3.3 15.2 20.0 22.1 15.5 2.7 3.6 8.2 5.7 6.6 6.3 7.5 5.0 4.4 4.4 4.1 4.5 4.8 3.5 4.2 5.8 3.2 6.8 8.4 3.0 3.1 16.1 21.7 22.1 31.2 15.1 14.1 15.9 15.6 17.5 16.2 44.7 36.5 27.4 30.3 28.5 26.7 70.2 43.3 36.1 39.8 34.9 17.7 53.0 26.6 57.4 195.1 37.0 85.3 23.3 43.3 57.5 32.9 30.2 48.4 36.0 49.4 47.7 73.6 38.1 38.8 339.6 30.8 35.7 27.0 30.7 49.7 29.6 55.0 57.5 37.1 40.2 39.7 38.8 37.2 93.9 52.8 31.0 99.9 35.4 49.8 33.1 BAHD1 KIAA0945 ENSG00000140320 "Bromo adjacent homology domain containing 1" Q8TBE0 15 40439721-40468242 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041196 Supported Nucleoplasm NA NA Nucleoplasm "HPA041196: AB_10803999" "prognostic unfavorable (1.55e-4)" "unprognostic (4.08e-1)" "unprognostic (3.00e-2)" "unprognostic (1.56e-2)" "unprognostic (1.35e-2)" "unprognostic (1.04e-1)" "unprognostic (7.19e-2)" "unprognostic (1.12e-2)" "unprognostic (2.06e-2)" "unprognostic (2.00e-2)" "unprognostic (3.49e-3)" "unprognostic (4.81e-2)" "prognostic favorable (1.29e-10)" "unprognostic (4.95e-2)" "unprognostic (1.15e-1)" "unprognostic (1.70e-1)" "unprognostic (1.11e-1)" 12.7 24.3 11.8 15.7 13.8 10.1 19.5 11.3 16.1 12.1 12.5 10.6 19.1 13.0 15.0 15.6 13.1 15.8 13.2 12.8 12.7 8.7 13.8 13.8 14.8 13.5 12.9 13.2 26.1 16.6 19.6 15.6 14.4 10.9 13.6 8.7 10.2 14.1 16.1 13.5 13.4 13.0 11.3 9.1 14.5 13.8 21.7 12.2 18.4 23.9 8.0 12.9 15.7 22.5 2.4 1.8 3.8 3.2 3.9 4.1 1.2 10.0 5.1 9.2 15.1 7.5 5.8 20.1 8.2 6.0 9.0 8.9 14.1 4.8 7.6 11.1 7.3 11.0 20.2 14.9 6.2 5.1 14.5 9.5 19.9 8.0 6.8 7.1 8.6 15.1 7.7 6.4 5.5 5.5 8.1 7.8 9.7 19.5 6.4 5.3 9.5 9.5 13.0 9.1 11.9 9.7 16.4 10.4 6.2 10.0 12.0 14.4 8.8 5.0 26.7 5.8 6.0 21.3 13.9 9.0 9.9 11.1 13.9 8.5 9.8 10.8 8.7 10.3 13.3 6.6 1.9 0.9 3.8 4.1 1.8 2.2 1.7 2.9 2.3 1.0 2.4 3.8 3.3 1.0 3.9 3.2 1.8 0.9 1.2 11.8 13.8 11.3 16.1 12.7 8.7 12.9 13.2 10.9 12.2 17.9 6.5 2.7 3.3 7.3 3.3 9.6 7.6 2.7 9.1 10.4 2.0 4.1 1.7 4.9 0.7 6.7 10.3 0.0 6.3 5.9 4.8 4.5 9.2 10.6 4.8 15.9 7.5 9.8 7.6 2.2 9.5 3.7 0.0 2.8 8.3 4.8 5.5 10.5 5.3 4.2 3.7 6.5 3.6 6.0 10.2 6.8 3.4 4.4 6.6 3.8 BANF1 BAF ENSG00000175334 "Barrier to autointegration factor 1" O75531 11 66002079-66004149 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB032896, HPA039242" Enhanced Supported Nucleoplasm,Cytosol NA NA 77000 Nucleoplasm Cytosol "CAB032896: AB_2061090, HPA039242: AB_2676409" "unprognostic (1.69e-1)" "unprognostic (4.46e-3)" "unprognostic (2.04e-1)" "unprognostic (9.59e-3)" "unprognostic (1.23e-1)" "unprognostic (3.70e-3)" "unprognostic (6.16e-3)" "unprognostic (8.39e-3)" "unprognostic (2.31e-1)" "unprognostic (5.07e-2)" "unprognostic (1.76e-2)" "unprognostic (4.57e-1)" "unprognostic (7.36e-3)" "unprognostic (3.06e-2)" "unprognostic (1.01e-1)" "unprognostic (1.83e-3)" "unprognostic (6.39e-2)" 31.2 39.7 38.2 31.6 33.9 24.0 33.5 30.8 38.1 40.7 32.4 33.2 26.5 25.0 38.8 44.4 43.8 58.4 33.4 51.0 35.4 32.5 38.6 61.0 24.6 35.7 33.8 24.7 60.0 40.8 33.5 27.3 40.1 27.5 52.6 33.1 31.1 38.0 38.8 112.7 25.5 29.9 38.9 35.8 39.7 26.8 44.2 27.8 57.6 71.5 54.5 43.8 36.4 45.8 40.0 44.6 14.7 42.8 32.5 30.4 43.8 63.9 64.7 43.6 42.3 22.3 29.7 22.1 35.6 33.2 66.5 42.1 37.5 51.6 55.4 65.8 47.0 54.2 45.1 57.3 59.3 48.9 43.5 34.3 64.4 41.0 46.6 27.3 46.6 49.8 27.6 38.2 42.4 37.4 41.6 48.4 53.5 51.3 44.5 64.1 103.7 52.2 91.7 49.3 41.0 45.4 49.1 43.2 125.7 59.7 32.5 35.3 45.4 38.5 63.8 44.1 33.8 71.1 36.0 33.5 51.0 56.5 57.6 49.7 32.7 59.0 69.4 44.8 39.8 46.2 14.7 41.6 13.9 29.2 41.7 27.6 40.0 24.5 28.3 44.6 37.8 28.3 30.4 4.4 32.5 42.8 40.0 20.6 43.8 38.2 33.9 30.8 38.1 35.4 32.5 33.8 24.7 27.5 27.8 50.6 37.0 151.2 131.4 112.6 49.6 28.6 114.7 113.8 61.4 186.7 23.6 256.8 276.8 168.3 13.4 125.9 55.0 0.0 153.9 288.2 139.3 117.6 138.4 109.1 284.8 47.7 137.2 73.1 75.3 32.5 131.5 149.4 177.2 175.9 138.1 83.5 151.2 91.2 116.3 188.4 42.8 71.1 136.7 219.1 317.9 103.3 146.1 124.6 162.6 122.5 BANK1 "BANK, FLJ20706" ENSG00000153064 "B cell scaffold protein with ankyrin repeats 1" Q8NDB2 4 101411286-102074812 "Disease related genes, Predicted intracellular proteins" "B-cell activation" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 61.4;intestine: 18.0;lymphoid tissue: 67.0" "Cell type enriched" "Detected in many" 6 "B-cells: 268.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 15 "memory B-cell: 61.4;naive B-cell: 46.2" "Lineage enriched" "Detected in many" 17 "B-cells: 61.4" "Cell line enhanced" "Detected in some" "Daudi: 10.4;HEL: 8.1;HL-60: 7.3;U-266/70: 25.0" "Low region specificity" "Detected in many" HPA037002 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA037002: AB_10672383" "unprognostic (1.59e-2)" "unprognostic (2.08e-2)" "unprognostic (6.43e-2)" "unprognostic (1.60e-1)" "unprognostic (1.28e-3)" "unprognostic (1.73e-2)" "unprognostic (4.89e-2)" "unprognostic (1.62e-2)" "unprognostic (1.01e-1)" "unprognostic (9.97e-2)" "unprognostic (4.25e-2)" "unprognostic (7.89e-2)" "unprognostic (2.80e-1)" "unprognostic (2.18e-1)" "unprognostic (2.75e-2)" "unprognostic (6.09e-3)" "unprognostic (1.75e-1)" 3.3 2.9 0.7 45.4 0.9 2.0 1.9 2.1 0.7 0.7 1.3 0.7 1.4 0.7 0.4 1.2 6.0 1.0 1.6 0.9 0.8 0.7 2.0 0.5 4.9 30.3 0.7 0.2 0.9 0.6 0.0 3.7 0.5 0.6 2.2 1.1 0.5 7.7 1.8 0.4 0.6 18.0 0.3 0.8 67.0 2.5 1.3 0.7 4.8 5.5 0.4 42.3 6.5 1.1 61.4 2.0 3.6 0.3 0.2 0.0 2.1 0.0 2.3 0.0 0.0 2.7 1.1 0.0 0.1 0.0 0.3 0.5 0.0 3.6 10.4 1.0 0.0 0.0 0.1 0.1 1.1 0.3 0.0 0.0 8.1 2.1 0.0 0.1 7.3 0.0 0.5 0.3 0.0 0.0 0.9 0.1 0.0 0.0 3.1 0.5 0.4 0.0 0.4 0.0 0.3 4.4 0.1 0.5 0.0 0.3 4.8 2.1 0.0 0.2 0.1 0.0 0.0 0.4 1.9 1.0 0.0 0.5 0.0 0.0 25.0 0.0 1.7 0.1 4.1 0.0 1.5 0.3 3.6 0.0 0.1 0.0 61.4 0.0 0.0 2.0 46.2 0.0 0.0 0.1 0.2 0.0 1.0 0.0 2.1 0.7 0.9 2.1 0.7 0.8 0.7 0.7 0.2 0.6 0.7 41.7 21.9 268.2 2.1 0.1 0.2 0.4 0.0 2.7 17.0 3.5 0.0 1.8 0.0 0.2 1.9 0.4 0.0 0.0 0.2 0.6 1.0 5.2 1.1 0.0 1.2 0.0 0.0 0.0 2.7 1.8 0.0 7.7 5.0 0.0 0.0 1.1 2.5 0.2 0.4 2.4 0.0 0.0 0.0 1.4 3.2 1.0 0.2 2.5 0.4 4.0 BANP "BEND1, DKFZp761H172, FLJ10177, FLJ20538, SMAR1, SMARBP1" ENSG00000172530 "BTG3 associated nuclear protein" Q8N9N5 16 87949244-88077318 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, DNA-binding, Repressor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047164 Approved Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA047164: AB_2679964" "unprognostic (1.82e-1)" "unprognostic (7.84e-3)" "unprognostic (4.73e-2)" "unprognostic (2.14e-1)" "unprognostic (1.55e-1)" "unprognostic (3.35e-2)" "unprognostic (4.95e-2)" "unprognostic (1.47e-1)" "unprognostic (1.19e-1)" "unprognostic (8.17e-2)" "unprognostic (3.53e-3)" "unprognostic (1.68e-3)" "unprognostic (4.98e-2)" "unprognostic (2.05e-1)" "unprognostic (1.70e-1)" "unprognostic (1.62e-2)" "unprognostic (5.89e-2)" 11.9 14.2 17.0 19.4 20.7 21.1 15.4 35.8 21.5 13.6 11.3 11.8 22.0 10.1 14.3 7.2 10.7 13.5 10.0 10.9 13.2 9.0 10.9 17.6 13.4 17.1 24.4 8.9 18.2 12.7 16.5 15.2 14.9 18.3 12.9 7.5 11.7 12.4 17.7 13.6 12.2 12.4 9.0 16.3 17.7 10.3 19.0 23.3 23.2 13.8 8.0 13.0 12.1 27.5 14.4 16.4 36.0 11.4 12.8 15.2 10.2 9.0 14.5 7.2 10.8 6.4 7.9 24.4 11.0 5.6 10.9 7.4 15.8 12.6 12.2 14.9 2.6 9.9 10.5 10.8 5.0 3.9 9.4 11.6 7.6 9.0 13.0 5.5 8.0 6.3 2.3 8.1 6.6 4.8 9.8 6.6 8.1 12.7 7.0 6.5 10.5 11.0 10.5 12.5 7.0 17.6 11.9 8.4 8.8 6.5 4.3 10.7 8.8 13.9 8.2 10.1 11.2 10.1 10.4 8.1 11.7 8.2 6.9 10.8 5.8 9.8 18.9 7.0 12.5 11.3 12.1 11.2 21.7 13.3 9.9 11.0 14.4 14.0 11.6 13.7 13.2 15.2 13.4 36.0 12.8 11.4 16.4 12.3 10.2 17.0 20.7 35.8 21.5 13.2 9.0 24.4 8.9 18.3 23.3 8.9 8.8 12.4 10.8 13.3 15.2 4.4 15.3 5.3 2.3 15.7 3.9 16.6 3.3 10.4 4.2 10.5 8.4 23.3 7.0 22.2 15.6 12.7 8.1 7.3 11.2 25.4 11.6 4.9 11.1 6.4 10.0 14.6 18.6 11.8 8.3 14.3 9.7 7.0 10.3 6.8 16.5 12.9 36.4 29.5 21.6 18.6 47.4 13.8 7.7 10.5 BAP1 "hucep-6, KIAA0272, UCHL2" ENSG00000163930 "BRCA1 associated protein 1" Q92560 3 52401013-52410350 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Chromatin regulator, Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 81.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004322, HPA028814, HPA028815, HPA055560" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004322: AB_626723, HPA028814: AB_10602393, HPA028815: AB_2672785, HPA055560: AB_2682850" "unprognostic (1.52e-1)" "unprognostic (7.96e-2)" "unprognostic (1.96e-2)" "unprognostic (6.04e-2)" "unprognostic (1.74e-1)" "unprognostic (2.55e-2)" "unprognostic (9.41e-3)" "unprognostic (8.53e-3)" "unprognostic (1.33e-1)" "unprognostic (3.15e-1)" "unprognostic (4.64e-3)" "unprognostic (3.30e-3)" "prognostic favorable (3.29e-7)" "unprognostic (6.37e-2)" "unprognostic (1.91e-1)" "unprognostic (5.54e-2)" "unprognostic (2.92e-1)" 13.8 17.6 35.6 14.7 33.3 37.3 13.5 21.8 50.4 12.5 17.0 16.3 11.5 12.4 14.7 14.6 21.2 12.1 15.7 16.4 41.5 15.5 16.6 19.0 14.9 15.2 19.4 27.6 16.9 16.3 30.0 11.1 14.8 19.6 14.4 14.9 15.6 17.9 14.6 24.8 40.5 13.9 14.5 10.0 16.1 13.3 37.3 14.7 18.6 15.3 12.9 16.0 14.1 11.7 5.5 8.4 11.3 5.0 3.0 8.5 3.9 14.8 16.9 20.6 17.4 19.9 12.8 23.2 14.7 19.1 24.0 18.6 20.5 13.9 21.4 7.4 20.5 27.1 12.1 21.6 23.8 15.3 21.1 20.5 26.4 35.8 21.2 18.5 24.8 23.5 19.1 31.9 26.5 14.2 13.2 19.1 41.2 22.6 18.9 18.0 12.9 29.4 34.0 23.2 11.8 20.6 12.7 16.7 21.1 14.8 24.1 7.8 25.3 18.1 5.3 21.5 12.1 14.8 34.3 20.4 21.7 20.0 26.0 27.3 28.7 37.7 30.6 23.7 26.2 25.6 3.4 5.0 7.4 8.5 3.9 4.0 5.0 6.8 6.9 3.3 5.5 4.9 6.4 11.3 3.0 3.1 8.4 6.0 3.9 35.6 33.3 21.8 50.4 41.5 15.5 19.4 27.6 19.6 14.7 0.0 13.6 15.0 8.8 28.0 15.3 19.3 10.2 5.3 9.1 24.4 0.0 12.2 10.0 12.0 81.1 12.4 17.6 0.0 14.3 13.1 11.8 9.7 20.7 25.8 11.0 9.5 10.4 15.4 19.3 32.6 9.5 10.2 11.8 11.8 12.9 9.9 12.6 15.3 11.0 14.6 11.3 19.4 13.2 30.9 12.4 20.6 10.1 11.3 16.4 8.5 BARX1 ENSG00000131668 "BARX homeobox 1" Q9HBU1 9 93951622-93955372 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "stomach 1: 59.7" "Cell type enhanced" "Detected in single" 23 "Early spermatids: 2.6" "Cancer enhanced" "Detected in many" "stomach cancer: 19.3" "Region enhanced" "Detected in single" "hippocampal formation: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AN3-CA: 15.6;HMC-1: 37.3;NTERA-2: 11.0;THP-1: 14.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA055858 Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA055858: AB_2682947" "unprognostic (6.19e-4)" "unprognostic (4.81e-2)" "unprognostic (1.58e-2)" "prognostic unfavorable (8.16e-6)" "unprognostic (4.96e-3)" "prognostic unfavorable (1.02e-4)" "unprognostic (1.46e-2)" "unprognostic (5.20e-3)" "unprognostic (1.23e-2)" "unprognostic (8.75e-2)" "unprognostic (1.02e-1)" "unprognostic (3.33e-1)" "unprognostic (9.68e-13)" "unprognostic (7.02e-2)" "unprognostic (1.59e-1)" "unprognostic (2.60e-1)" "unprognostic (2.16e-2)" 4.3 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.6 0.2 2.4 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.1 0.4 1.5 0.0 0.2 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 59.7 5.6 0.0 0.0 0.5 12.3 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 37.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 11.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 3.2 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 BARX2 ENSG00000043039 "BARX homeobox 2" Q9UMQ3 11 129375940-129452279 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 49.8;lymphoid tissue: 36.4;salivary gland: 78.3;tongue: 40.7;vagina: 22.0" "Cell type enhanced" "Detected in many" 10 "Basal glandular cells: 99.1;Suprabasal keratinocytes: 72.1;Urothelial cells: 102.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "pons and medulla: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HDLM-2: 60.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB033311, HPA064966, HPA068414" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "CAB033311: AB_781574, HPA064966: , HPA068414: AB_2685984" "unprognostic (4.25e-2)" "unprognostic (2.89e-1)" "unprognostic (2.46e-1)" "unprognostic (1.22e-5)" "unprognostic (3.85e-2)" "unprognostic (9.29e-2)" "unprognostic (1.57e-1)" "unprognostic (1.43e-3)" "unprognostic (4.80e-1)" "unprognostic (1.71e-2)" "unprognostic (4.35e-3)" "unprognostic (1.15e-1)" "unprognostic (8.39e-2)" "unprognostic (3.48e-1)" "unprognostic (8.37e-2)" "unprognostic (2.14e-2)" "prognostic unfavorable (3.06e-4)" 0.1 0.0 0.3 1.6 0.5 0.0 6.0 0.6 0.9 8.7 4.4 1.4 0.3 7.1 0.6 1.8 49.8 6.8 5.0 0.1 0.5 0.4 1.9 0.1 0.5 0.1 0.7 0.2 1.0 6.9 0.0 0.6 1.5 4.1 1.5 1.9 0.0 78.3 0.7 1.0 11.2 7.9 0.0 1.6 0.0 2.6 1.2 0.2 0.4 0.5 40.7 36.4 0.2 22.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.4 7.8 0.0 1.9 0.0 60.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.7 0.0 1.5 0.0 2.3 0.0 0.0 0.0 7.7 0.3 0.0 0.0 14.7 0.0 0.1 0.1 0.0 0.0 7.4 0.0 0.1 1.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.6 0.9 0.5 0.4 0.7 0.2 4.1 0.2 0.0 1.4 0.0 99.1 38.2 0.4 0.4 2.5 6.7 6.8 0.0 0.0 10.6 6.6 18.2 6.5 0.3 27.5 0.0 0.6 6.4 2.3 15.2 0.0 0.0 1.6 0.0 1.7 0.0 0.0 1.3 0.0 0.8 10.1 0.0 12.2 0.8 5.0 22.1 0.4 1.4 0.2 0.0 0.7 0.0 1.1 72.1 3.5 0.0 15.8 102.1 BATF "B-ATF, BATF1, SFA-2" ENSG00000156127 "Basic leucine zipper ATF-like transcription factor" Q16520 14 75522425-75547015 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 41.1;lymphoid tissue: 26.6" "Cell type enhanced" "Detected in many" 18 "granulocytes: 226.5;T-cells: 75.6;Urothelial cells: 57.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Lineage enriched" "Detected in all" 5 "T-cells: 41.1" "Cell line enhanced" "Detected in some" "HDLM-2: 82.7;MCF7: 31.1;RT4: 19.5;SK-BR-3: 15.9;U-937: 23.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA059588, HPA064962" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059588: AB_2684074, HPA064962: AB_2685392" "unprognostic (3.33e-3)" "unprognostic (4.87e-3)" "prognostic unfavorable (8.30e-4)" "prognostic favorable (5.35e-6)" "unprognostic (3.02e-2)" "prognostic favorable (7.91e-5)" "unprognostic (1.14e-2)" "unprognostic (1.39e-1)" "unprognostic (2.94e-1)" "unprognostic (6.72e-2)" "unprognostic (7.17e-2)" "unprognostic (8.90e-2)" "prognostic unfavorable (3.74e-9)" "unprognostic (4.74e-2)" "unprognostic (1.90e-1)" "unprognostic (1.41e-1)" "prognostic favorable (4.30e-4)" 4.9 1.3 0.9 15.8 4.7 13.8 7.6 0.2 1.9 2.8 2.8 0.2 1.0 2.0 1.3 1.4 2.6 1.9 7.0 3.1 1.0 0.7 1.9 3.0 7.9 20.2 2.1 0.2 1.6 1.6 0.5 1.2 3.7 1.9 5.2 1.1 1.0 6.0 8.3 0.9 2.8 8.0 2.6 2.7 26.6 5.7 0.7 1.9 6.2 2.7 3.4 23.1 10.4 7.3 7.1 9.0 5.0 8.9 6.4 41.1 8.4 1.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 82.7 0.0 1.8 0.0 0.3 2.7 2.2 8.6 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.4 2.4 0.0 31.1 1.0 6.7 0.0 13.0 0.0 0.2 0.0 1.4 0.0 19.5 0.0 0.0 0.0 15.9 0.6 0.0 1.4 4.3 0.0 0.0 0.0 1.0 0.0 7.7 8.2 0.0 0.0 23.0 0.0 1.2 8.9 2.7 19.6 4.9 15.4 7.1 21.4 25.1 9.0 5.2 8.6 18.1 5.0 6.4 4.2 1.0 41.1 8.4 0.9 4.7 0.2 1.9 1.0 0.7 2.1 0.2 1.9 1.9 8.9 43.8 23.6 46.3 4.7 0.0 0.2 2.5 9.4 13.6 3.5 0.0 0.3 0.0 0.3 0.5 0.7 0.0 0.0 2.3 0.2 3.3 20.8 226.5 0.8 49.2 0.0 0.0 3.1 16.0 0.2 0.0 19.3 5.0 9.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 3.0 0.9 75.6 0.0 57.9 BATF3 "JDP1, JUNDM1, SNFT" ENSG00000123685 "Basic leucine zipper ATF-like transcription factor 3" Q9NR55 1 212686418-212699985 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 26.8" "Group enriched" "Detected in many" 4 "Extravillous trophoblasts: 36.2;Macrophages: 24.9;monocytes: 98.2;Smooth muscle cells: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "intermediate monocyte: 18.0;myeloid DC: 16.5;non-classical monocyte: 26.8" "Group enriched" "Detected in many" 36 "dendritic cells: 16.5;monocytes: 26.8" "Cell line enriched" "Detected in some" 12 "HDLM-2: 93.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA075858 Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA075858: " "unprognostic (3.87e-2)" "unprognostic (2.10e-2)" "unprognostic (4.29e-2)" "unprognostic (6.85e-2)" "unprognostic (6.33e-2)" "unprognostic (3.15e-2)" "unprognostic (3.84e-2)" "unprognostic (6.59e-2)" "unprognostic (3.08e-1)" "unprognostic (6.47e-2)" "unprognostic (1.28e-2)" "unprognostic (1.75e-1)" "unprognostic (6.43e-10)" "unprognostic (9.88e-2)" "unprognostic (5.19e-2)" "unprognostic (3.90e-1)" "unprognostic (7.08e-2)" 10.4 1.3 6.7 6.3 9.4 5.4 3.5 0.4 5.2 2.0 2.4 3.3 0.2 1.4 1.8 0.4 1.8 2.6 3.8 4.1 5.5 2.1 2.6 2.3 7.2 8.7 9.5 2.8 3.1 3.2 1.2 1.3 4.6 4.3 2.3 1.6 0.5 2.2 1.2 1.5 1.1 4.3 3.7 4.7 9.5 3.2 1.1 7.1 5.0 2.1 2.6 4.9 3.0 6.0 0.2 16.5 0.6 26.8 0.3 0.4 2.4 0.3 0.9 0.1 0.0 0.0 0.6 0.7 0.5 1.1 1.1 1.2 0.0 0.3 0.0 0.2 0.0 1.8 0.0 1.1 0.2 0.8 93.1 2.2 0.0 0.3 0.0 0.2 4.2 0.6 0.1 0.0 2.2 0.3 0.1 0.0 7.7 0.1 1.1 0.2 0.0 3.2 1.7 0.4 0.0 1.5 0.6 0.4 0.0 1.0 0.0 0.2 0.1 0.3 0.0 0.0 0.4 0.0 3.0 0.0 0.5 2.1 0.1 2.4 0.1 0.2 0.5 1.5 3.8 1.1 0.0 4.1 0.0 0.0 18.0 0.0 0.2 0.0 0.0 16.5 0.0 0.0 0.0 0.6 0.3 26.8 0.0 0.4 2.4 6.7 9.4 0.4 5.2 5.5 2.1 9.5 2.8 4.3 7.1 3.0 1.1 0.5 2.2 5.0 0.1 0.3 0.0 4.0 2.3 0.0 0.0 0.8 0.0 0.7 0.3 5.8 0.0 0.0 0.3 36.2 8.5 6.6 4.7 0.2 4.6 0.0 0.0 6.2 10.5 0.8 0.9 24.9 1.7 98.2 0.0 0.2 1.3 0.0 0.0 0.5 0.4 0.0 25.8 1.1 4.3 2.5 3.8 1.0 0.0 0.9 BAZ2B WALp4 ENSG00000123636 "Bromodomain adjacent to zinc finger domain 2B" Q9UIF8 2 159318979-159616692 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Cone photoreceptor cells: 292.6;Rod photoreceptor cells: 350.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 24.1;neutrophil: 54.6" "Lineage enriched" "Detected in all" 8 "granulocytes: 54.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019819, HPA059292" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA019819: AB_1845282, HPA059292: AB_2683968" "unprognostic (2.27e-1)" "unprognostic (1.67e-1)" "unprognostic (5.24e-2)" "unprognostic (1.23e-1)" "unprognostic (1.37e-2)" "unprognostic (4.94e-3)" "unprognostic (1.19e-1)" "unprognostic (5.64e-2)" "unprognostic (5.49e-3)" "unprognostic (9.01e-2)" "unprognostic (2.29e-1)" "unprognostic (1.44e-1)" "unprognostic (1.27e-1)" "unprognostic (2.14e-1)" "unprognostic (3.30e-1)" "unprognostic (1.06e-2)" "unprognostic (2.14e-2)" 16.7 20.7 22.1 12.7 37.7 23.5 16.5 30.3 28.5 25.8 18.3 30.0 19.4 12.4 25.4 17.7 16.6 19.2 19.3 13.4 26.1 13.1 13.3 12.3 18.1 9.8 37.2 20.4 33.4 16.4 27.1 45.4 14.9 29.5 17.1 12.4 13.0 19.0 24.6 19.2 12.7 14.5 20.0 42.3 14.4 14.4 18.6 48.9 6.5 19.0 9.1 9.6 18.6 19.2 2.4 5.9 54.6 7.0 4.7 2.7 1.4 3.6 7.3 25.2 15.2 7.6 12.2 4.4 7.8 9.6 4.3 5.1 11.1 10.2 6.3 13.4 7.6 4.3 8.5 10.0 10.6 6.8 2.1 5.7 11.5 12.7 1.5 5.0 7.8 8.0 9.5 11.7 10.7 11.8 15.8 22.1 3.9 12.5 1.2 6.8 4.3 2.7 4.8 8.3 0.7 6.4 6.4 8.1 4.3 8.7 13.3 16.7 14.6 15.4 1.9 9.1 13.5 2.9 21.5 21.8 7.8 15.8 3.2 5.2 4.7 0.4 7.0 7.2 8.5 4.9 24.1 7.0 8.8 2.7 3.0 2.2 1.5 1.6 2.7 4.4 2.4 1.1 1.7 54.6 4.7 2.6 5.9 1.7 1.4 22.1 37.7 30.3 28.5 26.1 13.1 37.2 20.4 29.5 48.9 92.3 148.1 29.6 60.8 29.0 86.6 49.4 58.6 93.7 85.3 64.6 292.6 16.0 8.3 42.8 118.0 64.1 41.6 23.3 33.7 5.4 30.0 44.2 69.6 25.9 22.6 89.0 95.8 58.9 53.8 22.7 55.0 50.5 13.5 59.5 45.4 116.6 43.6 49.2 32.9 7.5 350.6 12.9 23.6 123.2 15.1 32.9 22.3 30.5 40.3 81.3 BBOF1 "C14orf45, CCDC176" ENSG00000119636 "Basal body orientation factor 1" Q8ND07 14 74019353-74082863 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 37.7" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 326.6;Early spermatids: 164.7;Late spermatids: 84.6;Spermatocytes: 82.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA003090, HPA003136, HPA075108" Approved Approved "Nucleoplasm,Plasma membrane,Centriolar satellite" NA NA "Nucleoplasm, Plasma membrane" "Centriolar satellite" "HPA003090: AB_1845571, HPA003136: AB_1078330, HPA075108: " "unprognostic (1.84e-2)" "unprognostic (1.31e-1)" "unprognostic (5.71e-2)" "prognostic favorable (6.34e-4)" "unprognostic (1.11e-2)" "unprognostic (1.29e-2)" "unprognostic (1.28e-2)" "unprognostic (2.08e-1)" "unprognostic (1.85e-1)" "unprognostic (4.62e-2)" "unprognostic (1.01e-1)" "unprognostic (3.89e-1)" "unprognostic (1.40e-3)" "unprognostic (6.14e-2)" "unprognostic (2.57e-1)" "unprognostic (7.93e-2)" "unprognostic (6.04e-3)" 5.3 3.5 9.4 4.1 12.5 6.0 8.4 4.3 12.5 7.7 6.5 4.4 8.5 2.5 8.2 16.4 6.1 24.1 6.6 4.8 11.5 8.2 10.6 2.8 7.6 2.2 7.3 9.2 5.8 3.2 6.1 17.4 3.0 22.3 6.4 4.2 5.8 4.4 8.9 5.3 3.7 2.7 7.7 13.8 1.8 3.9 37.7 6.7 2.5 14.5 2.6 2.6 7.0 3.4 1.5 5.0 2.4 0.1 2.1 4.2 3.0 4.8 2.8 1.2 8.0 5.4 12.0 1.0 4.2 6.0 4.3 4.1 1.0 3.3 4.7 1.2 5.1 1.8 1.2 1.6 0.7 4.9 0.7 0.9 0.5 2.7 1.0 4.6 2.3 0.3 5.7 4.0 9.6 1.2 6.8 1.5 8.9 2.5 0.9 3.1 3.8 7.4 1.2 0.4 0.4 2.0 2.7 3.1 0.8 7.4 1.2 4.9 3.1 8.2 3.3 2.2 1.3 8.5 0.2 3.5 5.3 3.8 7.1 1.2 1.8 4.2 2.9 15.7 0.3 1.5 2.4 0.1 0.2 3.4 0.0 4.0 1.3 3.2 2.2 0.2 1.5 4.2 3.4 2.4 2.1 0.0 5.0 0.6 3.0 9.4 12.5 4.3 12.5 11.5 8.2 7.3 9.2 22.3 6.7 11.9 7.2 0.0 4.2 0.0 7.2 0.0 5.1 326.6 55.7 3.5 27.5 1.6 13.3 7.3 164.7 2.2 0.4 23.3 3.1 2.2 3.0 3.9 1.1 2.5 2.0 6.4 2.4 4.9 0.6 84.6 10.0 1.7 0.0 1.0 3.2 5.7 2.4 0.0 5.6 14.4 27.4 0.0 0.0 82.2 13.0 0.0 0.8 3.2 0.8 2.8 BBX "HBP2, HSPC339, MDS001" ENSG00000114439 "BBX, HMG-box containing" Q8WY36 3 107522936-107811324 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 761.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006049, HPA050646" Enhanced Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA006049: AB_2667504, HPA050646: AB_2681200" "unprognostic (7.57e-3)" "unprognostic (1.49e-2)" "unprognostic (8.73e-2)" "unprognostic (3.77e-2)" "unprognostic (1.63e-1)" "unprognostic (3.49e-1)" "unprognostic (2.32e-2)" "unprognostic (2.12e-2)" "unprognostic (1.91e-1)" "unprognostic (9.84e-2)" "unprognostic (4.81e-2)" "unprognostic (8.62e-2)" "unprognostic (1.11e-3)" "unprognostic (7.22e-2)" "unprognostic (2.24e-1)" "unprognostic (3.28e-1)" "unprognostic (3.02e-1)" 10.6 22.6 13.1 11.0 20.6 11.2 10.8 12.8 15.1 14.3 13.2 15.4 27.8 6.7 15.1 28.3 10.2 13.2 12.7 11.5 14.8 11.6 14.9 7.3 10.8 10.4 24.5 9.0 21.0 9.0 35.7 39.6 17.8 17.5 17.4 7.3 9.1 11.8 25.1 8.5 7.5 9.4 14.0 26.7 14.1 9.6 43.9 25.5 13.5 19.3 8.0 10.1 15.9 15.6 33.7 16.3 25.2 17.5 25.2 26.1 11.4 18.6 17.3 14.9 22.3 13.3 19.4 12.2 17.7 18.3 16.1 17.9 1.9 15.2 9.7 22.2 11.2 18.4 13.0 16.7 21.5 24.4 12.5 7.8 14.5 14.0 4.1 15.8 19.9 9.0 16.2 15.8 16.2 32.6 22.7 13.5 11.7 6.7 14.6 13.6 6.2 11.2 2.0 7.3 0.2 14.7 15.9 14.1 11.0 10.2 14.1 10.7 10.9 31.3 3.1 15.4 16.0 12.4 4.5 17.7 19.8 14.7 7.3 12.6 6.2 4.1 11.0 17.9 10.3 11.5 25.2 9.1 21.6 22.6 9.2 26.1 32.8 20.3 22.8 12.7 33.7 25.7 21.1 14.9 25.2 17.5 16.3 13.4 11.4 13.1 20.6 12.8 15.1 14.8 11.6 24.5 9.0 17.5 25.5 59.6 69.7 91.3 125.6 75.7 90.3 93.6 76.5 44.2 45.5 90.7 60.9 172.5 41.4 69.4 761.4 73.0 16.6 46.7 65.1 74.7 80.3 95.3 31.2 27.6 41.9 162.1 63.8 57.1 54.0 372.5 144.7 68.9 64.1 36.1 33.3 141.5 56.6 43.5 193.7 88.0 61.1 142.3 128.8 73.5 118.0 66.0 165.9 68.7 36.0 108.0 BCCIP "BCCIPalpha, TOK-1" ENSG00000107949 "BRCA2 and CDKN1A interacting protein" Q9P287 10 125823546-125853695 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 132.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038011 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038011: AB_2675784" "unprognostic (1.05e-1)" "unprognostic (2.38e-2)" "unprognostic (2.29e-1)" "unprognostic (2.96e-2)" "unprognostic (3.54e-2)" "unprognostic (1.38e-2)" "unprognostic (1.93e-3)" "unprognostic (2.51e-1)" "unprognostic (3.04e-2)" "unprognostic (6.62e-3)" "unprognostic (1.88e-1)" "unprognostic (1.30e-3)" "unprognostic (1.90e-3)" "unprognostic (4.75e-2)" "unprognostic (1.58e-1)" "unprognostic (7.39e-2)" "unprognostic (9.91e-2)" 24.0 25.0 27.9 28.8 28.0 32.3 33.4 28.0 30.2 20.8 23.0 15.0 27.8 19.7 21.1 35.9 27.6 21.3 17.9 28.7 28.7 21.3 35.0 45.9 19.0 27.6 23.6 22.0 28.0 29.2 19.8 27.6 19.8 33.5 27.3 26.3 14.4 34.7 26.7 132.7 19.3 23.5 29.7 35.6 27.2 28.2 28.6 24.1 24.6 26.0 32.0 28.7 24.0 47.9 30.9 30.7 16.1 35.4 26.0 33.8 19.0 54.8 28.5 32.4 35.8 18.5 20.4 27.1 29.5 28.3 36.5 34.0 46.6 36.9 38.6 18.6 27.0 27.5 30.5 55.3 41.8 51.2 35.5 37.5 38.8 24.6 51.4 23.4 53.2 24.7 20.9 25.3 43.5 46.1 27.8 34.7 36.5 42.8 19.8 30.9 32.8 34.4 53.8 25.0 46.3 43.1 33.0 34.1 23.1 32.3 26.4 17.2 17.6 22.0 36.2 36.2 27.6 19.5 23.7 23.2 17.1 30.1 25.1 53.1 20.3 22.6 57.4 33.5 27.8 13.1 12.4 28.7 16.1 24.6 34.7 33.8 30.9 28.2 26.8 30.7 28.9 31.9 28.6 4.7 26.0 35.4 26.5 29.7 19.0 27.9 28.0 28.0 30.2 28.7 21.3 23.6 22.0 33.5 24.1 59.6 61.1 29.0 39.2 59.4 23.5 74.2 22.9 92.3 78.5 22.7 21.6 35.7 66.3 28.3 8.2 26.2 18.0 23.3 38.0 30.2 29.3 38.3 25.5 42.9 32.0 15.9 24.8 24.5 28.9 7.7 34.2 29.8 21.9 35.1 20.2 25.8 38.2 14.0 29.4 48.8 23.1 25.8 31.5 79.8 108.7 45.7 28.3 24.9 31.1 42.9 BCDIN3D ENSG00000186666 "BCDIN3 domain containing RNA methyltransferase" Q7Z5W3 12 49836039-49843129 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 29.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039911 Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA039911: AB_10673021" "unprognostic (2.21e-2)" "unprognostic (6.64e-2)" "unprognostic (2.70e-3)" "unprognostic (1.73e-2)" "unprognostic (1.68e-1)" "unprognostic (2.84e-2)" "unprognostic (9.96e-3)" "prognostic favorable (3.24e-4)" "unprognostic (2.30e-3)" "unprognostic (1.62e-3)" "unprognostic (2.12e-3)" "unprognostic (1.84e-1)" "prognostic favorable (1.03e-5)" "unprognostic (2.31e-2)" "unprognostic (3.15e-2)" "unprognostic (1.06e-1)" "prognostic favorable (1.06e-4)" 5.6 9.3 6.9 6.0 8.4 2.6 7.8 8.9 9.0 6.1 6.0 7.2 6.9 4.9 8.3 7.5 9.1 7.7 4.9 5.3 5.9 4.5 7.3 10.5 4.5 8.3 9.8 4.8 8.5 11.9 8.4 12.7 6.5 6.6 8.7 5.7 5.2 15.4 6.9 32.8 7.6 8.4 5.3 7.6 9.3 8.4 5.3 7.7 15.2 9.9 4.2 10.8 7.4 6.0 9.9 5.0 5.9 6.6 6.2 10.3 4.6 3.4 4.9 4.7 7.3 9.9 5.8 4.9 4.7 6.2 5.0 5.2 2.6 9.0 3.0 5.4 2.1 3.8 4.6 4.7 2.8 2.8 10.4 6.3 4.2 3.8 1.6 7.9 4.8 4.2 3.1 11.2 3.5 5.0 6.3 2.3 6.5 7.5 8.3 3.1 8.6 5.3 7.7 4.7 7.5 8.7 5.6 4.4 5.9 4.9 3.1 6.5 9.1 5.6 9.1 6.7 3.9 11.4 5.3 2.6 4.2 3.2 6.3 2.5 7.9 6.8 5.7 4.5 3.5 2.8 5.9 5.4 2.8 7.6 6.5 10.1 9.9 9.4 7.2 5.0 9.1 10.3 9.7 4.6 6.2 6.6 3.0 7.8 4.6 6.9 8.4 8.9 9.0 5.9 4.5 9.8 4.8 6.6 7.7 29.8 23.5 12.6 7.6 1.9 6.7 2.4 2.5 18.7 11.4 1.8 0.0 11.0 11.6 8.2 1.7 2.9 4.3 0.0 8.5 6.0 5.0 5.7 10.4 6.4 5.0 4.8 1.7 4.3 4.9 0.7 7.8 4.8 0.0 1.0 5.5 7.1 5.8 6.0 6.0 6.7 5.8 0.0 4.1 8.2 10.0 2.8 6.4 10.0 5.0 2.0 BCL11A "BCL11A-L, BCL11A-S, BCL11A-XL, CTIP1, EVI9, HBFQTL5, ZNF856" ENSG00000119866 "B cell CLL/lymphoma 11A" Q9H165 2 60450520-60555154 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 107.1" "Cell type enhanced" "Detected in many" 8 "B-cells: 89.5;Erythroid cells: 93.5;Horizontal cells: 49.3;Suprabasal keratinocytes: 61.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "memory B-cell: 39.6;naive B-cell: 53.7;plasmacytoid DC: 107.1" "Group enriched" "Detected in many" 16 "B-cells: 53.7;dendritic cells: 107.1" "Cell line enhanced" "Detected in many" "Daudi: 20.7;MOLT-4: 19.1;REH: 19.5;U-698: 42.7;U-937: 13.7" "Group enriched" "Detected in all" 5 "amygdala: 42.3;basal ganglia: 57.1;cerebral cortex: 62.7;hippocampal formation: 65.3;olfactory region: 101.8" "Group enriched" "Detected in all" 4 "basal ganglia: 58.3;cerebral cortex: 93.2;hippocampal formation: 97.2;olfactory region: 128.9" "CAB014891, HPA029003, HPA075941" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "CAB014891: , HPA029003: AB_2672863, HPA075941: " "unprognostic (4.10e-3)" "unprognostic (6.72e-2)" "unprognostic (4.50e-2)" "unprognostic (9.41e-3)" "unprognostic (2.37e-1)" "unprognostic (4.47e-3)" "unprognostic (2.53e-2)" "unprognostic (1.68e-2)" "unprognostic (1.02e-1)" "unprognostic (2.45e-1)" "unprognostic (4.27e-4)" "unprognostic (1.23e-2)" "unprognostic (2.35e-2)" "unprognostic (3.59e-2)" "unprognostic (2.26e-1)" "unprognostic (4.40e-2)" "unprognostic (2.99e-2)" 1.5 2.4 6.6 13.9 14.6 17.0 5.5 1.8 34.5 3.9 8.6 0.2 0.1 7.6 1.8 1.4 13.6 4.8 2.2 4.7 14.5 3.4 1.7 1.5 3.0 21.2 3.5 14.4 1.6 11.3 1.2 3.9 0.9 9.6 4.8 5.1 0.0 11.4 2.0 1.4 24.9 11.4 2.9 2.0 13.5 3.3 2.0 2.6 20.9 2.4 4.0 30.4 3.6 7.8 53.7 107.1 1.3 5.1 1.0 0.1 1.2 0.2 0.0 1.7 0.0 0.3 0.3 0.1 0.6 0.0 0.0 0.0 0.0 0.0 20.7 0.1 0.0 0.0 4.2 6.4 3.0 0.0 0.3 6.2 0.0 0.2 0.1 0.0 7.4 0.0 0.7 1.7 0.0 1.0 1.7 1.0 7.0 0.3 0.1 0.0 0.0 19.1 7.6 11.8 3.0 0.1 19.5 0.5 7.9 0.0 0.3 8.4 2.0 0.1 0.1 0.1 3.5 0.1 3.6 0.5 0.1 4.9 0.1 0.0 0.3 0.0 42.7 0.0 13.7 0.6 0.4 2.9 0.5 0.0 5.1 0.1 39.6 0.0 0.0 10.7 53.7 0.1 0.1 1.3 1.0 3.7 107.1 0.1 1.2 6.6 14.6 1.8 34.5 14.5 3.4 3.5 14.4 9.6 2.6 0.0 9.0 89.5 14.8 41.1 0.5 12.2 5.1 5.3 7.9 1.8 0.0 0.5 5.0 7.7 9.4 1.2 8.4 93.5 5.6 0.7 5.1 4.2 9.3 0.0 32.9 49.3 19.0 0.6 8.2 3.6 0.3 17.9 15.1 6.4 11.7 0.1 5.4 13.6 0.0 0.3 0.1 0.0 1.3 1.6 5.9 61.1 0.7 0.0 24.2 4.1 BCL11B "CTIP-2, CTIP2, hRIT1-alpha, ZNF856B" ENSG00000127152 "B cell CLL/lymphoma 11B" Q9C0K0 14 99169287-99271524 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Cancer-related genes, Disease mutation, Mental retardation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.7;lymphoid tissue: 25.4;skin 1: 17.6" "Group enriched" "Detected in many" 8 "Basal keratinocytes: 55.8;Suprabasal keratinocytes: 62.4;T-cells: 48.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 13.7" "Group enriched" "Detected in many" 8 "gdT-cell: 3.3;MAIT T-cell: 3.0;memory CD4 T-cell: 4.5;memory CD8 T-cell: 3.7;naive CD4 T-cell: 7.4;naive CD8 T-cell: 4.9;T-reg: 3.0" "Lineage enriched" "Detected in single" 14 "T-cells: 7.4" "Group enriched" "Detected in some" 6 "JURKAT: 24.7;MOLT-4: 29.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA049117 Enhanced Supported Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA049117: AB_2680639" "unprognostic (1.64e-5)" "unprognostic (4.66e-2)" "unprognostic (2.35e-2)" "unprognostic (1.87e-2)" "unprognostic (9.37e-2)" "unprognostic (5.97e-2)" "unprognostic (4.75e-2)" "unprognostic (6.07e-2)" "unprognostic (1.74e-1)" "unprognostic (1.40e-2)" "unprognostic (1.90e-1)" "unprognostic (1.12e-1)" "unprognostic (1.60e-6)" "unprognostic (1.07e-3)" "unprognostic (1.61e-1)" "unprognostic (3.31e-3)" "prognostic favorable (7.48e-4)" 0.3 0.4 4.4 6.6 13.7 5.2 1.3 0.3 3.8 0.8 1.3 0.1 0.0 2.3 1.9 0.8 3.9 0.3 3.0 0.8 4.8 1.0 0.3 0.5 1.1 10.8 0.8 2.6 0.2 0.1 0.0 0.1 0.0 0.6 0.6 1.7 0.3 5.0 0.7 0.1 17.6 3.0 0.2 0.7 4.9 2.1 0.4 1.6 25.4 0.9 1.5 8.8 2.0 2.3 0.0 0.0 0.1 0.0 0.5 7.4 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.1 0.0 0.0 24.7 0.0 2.8 0.0 1.6 29.5 0.4 0.3 2.2 0.0 4.6 0.0 0.0 0.0 1.6 2.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.1 0.0 1.8 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.1 3.3 0.0 3.0 0.0 4.5 3.7 0.0 0.0 7.4 4.9 0.0 0.5 0.0 0.0 3.0 1.1 4.4 13.7 0.3 3.8 4.8 1.0 0.8 2.6 0.6 1.6 3.0 0.0 2.7 1.6 55.8 0.1 3.1 5.1 0.0 1.2 0.0 0.0 0.1 1.7 0.3 0.0 0.1 4.3 0.0 0.4 0.0 1.1 0.2 4.7 0.0 0.2 0.0 1.2 4.3 1.2 0.2 0.6 0.7 5.0 0.0 2.6 0.0 0.7 4.3 0.0 0.3 0.0 0.0 3.3 0.7 4.9 62.4 0.0 48.4 6.9 0.6 BCL2 "Bcl-2, PPP1R50" ENSG00000171791 "BCL2, apoptosis regulator" P10415 18 63123346-63320128 "Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "gdT-cell: 2.3;MAIT T-cell: 7.6;memory B-cell: 5.2;memory CD4 T-cell: 6.3;memory CD8 T-cell: 3.8;naive B-cell: 4.1;naive CD4 T-cell: 5.1;naive CD8 T-cell: 4.5;T-reg: 6.7" "Group enriched" "Detected in many" 8 "B-cells: 5.2;T-cells: 7.6" "Cell line enhanced" "Detected in many" "Karpas-707: 22.8;U-266/70: 79.4" "Low region specificity" "Detected in all" "CAB000003, HPA055295" Enhanced Supported "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "CAB000003: AB_2064429, HPA055295: AB_2682776" "unprognostic (1.11e-3)" "prognostic favorable (5.13e-5)" "unprognostic (5.49e-2)" "unprognostic (1.19e-1)" "unprognostic (1.89e-1)" "unprognostic (3.05e-3)" "unprognostic (2.88e-1)" "unprognostic (1.93e-3)" "unprognostic (4.78e-2)" "unprognostic (2.08e-1)" "unprognostic (2.23e-2)" "unprognostic (8.51e-2)" "prognostic favorable (1.29e-8)" "unprognostic (6.67e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.47e-4)" "unprognostic (2.63e-1)" 12.9 3.0 10.1 15.7 9.4 5.3 24.6 4.7 8.4 14.8 7.8 7.4 9.1 5.0 17.1 9.3 4.7 12.2 9.2 6.5 10.0 8.1 8.5 2.3 5.0 14.6 10.8 5.6 18.2 2.9 19.6 7.0 22.4 9.2 8.4 5.9 10.8 5.4 15.7 20.0 6.3 10.5 8.6 9.3 17.8 5.4 3.5 10.5 21.0 35.6 2.9 13.4 7.9 16.4 5.2 0.3 0.7 0.2 0.7 7.6 1.9 0.5 0.1 2.3 1.8 2.8 0.4 0.8 0.2 0.2 0.8 0.5 1.1 0.1 0.0 0.4 0.2 1.5 0.1 2.1 0.3 0.4 13.6 0.4 0.1 0.6 0.2 0.5 12.4 1.8 0.5 0.2 0.9 1.9 0.3 0.2 1.4 0.2 22.8 0.4 0.4 2.6 5.4 0.5 0.2 0.4 11.7 0.5 8.8 3.9 1.9 1.9 1.8 0.0 0.0 2.8 0.5 0.1 10.5 0.1 3.0 1.0 0.3 1.5 79.4 10.4 0.9 0.5 8.8 1.7 0.7 0.0 0.0 2.3 0.0 7.6 5.2 6.3 3.8 0.1 4.1 5.1 4.5 0.1 0.7 0.2 0.3 6.7 1.9 10.1 9.4 4.7 8.4 10.0 8.1 10.8 5.6 9.2 10.5 0.0 0.6 41.9 30.2 17.3 1.0 15.4 17.8 0.0 3.4 7.0 0.0 8.5 13.3 2.5 0.2 3.5 0.8 0.0 0.0 0.9 10.3 31.5 15.1 1.5 8.3 0.0 5.2 3.7 10.4 2.1 8.1 16.9 43.9 29.7 9.9 18.9 0.3 0.0 13.1 13.5 0.5 25.8 10.8 0.3 0.6 15.4 41.1 28.7 10.6 39.2 BCL2L2 "BCL-W, KIAA0271, PPP1R51" ENSG00000129473 "BCL2 like 2" Q92843 14 23298790-23311759 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB040539, HPA048740" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "CAB040539: , HPA048740: " "unprognostic (8.23e-3)" "unprognostic (9.85e-2)" "unprognostic (1.71e-2)" "unprognostic (6.08e-2)" "unprognostic (2.04e-1)" "unprognostic (1.64e-1)" "unprognostic (3.47e-3)" "unprognostic (1.53e-2)" "unprognostic (1.78e-1)" "unprognostic (2.91e-3)" "unprognostic (1.50e-3)" "unprognostic (2.60e-1)" "prognostic favorable (1.99e-6)" "unprognostic (2.44e-1)" "unprognostic (2.00e-1)" "unprognostic (6.60e-2)" "unprognostic (5.38e-2)" 29.9 22.8 38.2 15.6 33.6 7.4 25.1 27.3 44.8 13.7 32.3 27.4 21.9 19.4 19.0 20.6 32.8 16.6 17.6 23.8 36.2 32.9 22.3 9.0 18.6 8.6 43.3 39.5 17.5 30.6 34.1 16.5 15.1 32.8 31.8 20.4 15.0 36.5 31.9 10.6 29.2 19.0 34.8 40.9 11.3 22.3 14.9 28.1 1.2 25.6 11.8 10.1 23.0 23.2 1.3 1.8 0.6 1.8 0.1 0.3 1.3 11.8 12.8 11.6 8.5 22.4 19.6 10.6 21.5 13.2 10.7 11.8 7.8 18.9 7.7 7.7 11.8 13.6 22.1 7.2 13.5 13.5 3.9 6.8 8.5 17.1 15.4 14.0 9.2 15.1 15.1 26.6 8.0 13.0 13.7 9.0 1.4 8.3 7.6 12.7 8.9 0.7 6.2 4.5 16.4 25.0 5.5 14.3 3.5 9.4 20.3 15.4 9.2 9.7 15.5 17.5 7.5 9.8 7.4 17.5 19.1 12.0 12.9 11.0 9.8 5.8 1.1 12.1 7.6 21.6 0.0 1.8 0.4 0.3 1.8 0.2 1.3 0.0 0.2 1.8 1.0 0.3 0.0 0.6 0.1 1.0 0.9 0.1 1.3 38.2 33.6 27.3 44.8 36.2 32.9 43.3 39.5 32.8 28.1 8.9 13.3 0.5 6.8 7.7 17.1 25.0 2.5 9.4 12.5 5.2 23.6 4.4 11.6 7.4 17.7 9.0 10.1 0.0 15.7 3.4 6.7 14.5 5.7 6.4 4.9 19.1 17.9 9.8 7.3 3.3 10.3 4.0 6.8 4.6 15.5 6.8 18.7 10.5 20.1 7.5 12.0 6.5 16.0 0.0 0.2 9.7 4.7 1.8 9.7 15.2 BCL2L2-PABPN1 ENSG00000258643 "BCL2L2-PABPN1 readthrough" Q92843 14 23306835-23325369 "Cancer-related genes, Predicted intracellular proteins, Transporters" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 34 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 3.8;Ciliated cells: 8.1;Club cells: 2.3;granulocytes: 2.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 21.5;BJ hTERT+ SV40 Large T+ RasG12V: 23.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA000637, HPA048740" Approved Uncertain "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA000637: AB_1079553, HPA048740: " "unprognostic (1.32e-2)" "unprognostic (8.74e-2)" "unprognostic (1.21e-1)" "unprognostic (1.32e-3)" "unprognostic (9.82e-3)" "unprognostic (2.85e-2)" "unprognostic (1.05e-6)" "unprognostic (4.39e-2)" "unprognostic (1.67e-1)" "unprognostic (1.84e-3)" "unprognostic (7.61e-2)" "unprognostic (3.47e-2)" "unprognostic (1.72e-7)" "unprognostic (3.13e-2)" "unprognostic (8.77e-2)" "unprognostic (3.46e-3)" "unprognostic (4.95e-2)" 11.4 5.3 14.2 5.8 17.7 12.0 17.7 16.4 24.2 17.9 21.0 14.4 11.4 4.5 13.7 6.9 14.4 16.1 16.0 11.2 17.8 9.5 7.1 6.9 10.3 6.4 13.1 21.2 8.0 21.4 29.1 11.4 18.0 17.5 16.3 5.6 7.5 22.1 37.7 7.0 14.5 7.7 18.6 20.2 9.7 13.0 15.0 14.8 0.0 14.4 5.7 5.4 16.6 12.1 1.9 1.1 2.1 4.4 3.5 0.3 1.1 5.1 6.6 4.2 3.4 0.3 9.6 3.3 1.4 13.8 21.5 23.4 5.4 16.8 1.7 1.2 7.2 5.2 7.3 4.8 6.6 5.6 3.5 5.3 0.4 0.9 8.7 2.9 1.8 10.4 8.7 12.2 7.9 1.5 1.7 5.1 0.1 1.6 5.1 6.5 7.9 0.2 1.1 5.3 1.0 4.2 3.2 0.1 1.1 3.7 2.1 7.0 2.8 2.1 7.1 1.9 0.7 3.8 2.8 1.9 5.6 4.4 5.5 3.6 2.8 2.6 0.5 2.3 3.8 8.6 2.1 4.4 0.3 0.2 1.6 0.2 1.4 0.0 0.0 0.6 1.9 0.3 0.1 0.8 3.5 2.6 1.1 0.0 1.1 14.2 17.7 16.4 24.2 17.8 9.5 13.1 21.2 17.5 14.8 3.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 8.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 BCL3 "BCL4, D19S37" ENSG00000069399 "B cell CLL/lymphoma 3" P20749 19 44747705-44760044 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 16.5" "Lineage enriched" "Detected in all" 6 "granulocytes: 16.5" "Cell line enhanced" "Detected in many" "HDLM-2: 27.0;Karpas-707: 22.4;SiHa: 28.7;U-266/70: 21.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB002051, HPA047514" Approved Supported Nucleoplasm,Vesicles,Midbody Yes No Nucleoplasm "Vesicles, Midbody" "CAB002051: AB_563428, HPA047514: AB_2680074" "prognostic favorable (9.67e-4)" "unprognostic (8.82e-2)" "unprognostic (2.81e-1)" "unprognostic (7.54e-2)" "prognostic unfavorable (4.01e-4)" "unprognostic (3.49e-2)" "unprognostic (2.34e-3)" "unprognostic (2.79e-1)" "prognostic favorable (3.74e-4)" "unprognostic (2.09e-2)" "unprognostic (9.23e-2)" "unprognostic (1.81e-1)" "prognostic unfavorable (3.13e-14)" "unprognostic (8.24e-2)" "unprognostic (1.36e-1)" "unprognostic (3.77e-2)" "unprognostic (3.04e-2)" 17.7 13.0 4.0 21.1 5.6 35.2 18.7 1.4 4.7 11.7 14.9 2.4 5.9 24.5 10.4 9.7 27.1 12.5 22.7 20.1 3.9 2.0 17.8 52.1 36.4 20.5 4.3 0.5 26.5 13.2 2.4 9.2 9.5 5.6 16.0 8.0 8.8 13.7 13.7 20.2 9.0 35.5 11.5 6.5 41.6 15.0 8.3 4.0 6.5 13.9 22.9 37.0 18.7 11.9 1.3 2.6 16.5 2.4 1.8 1.5 0.7 3.9 13.6 0.3 7.2 2.6 5.5 0.7 2.4 2.6 1.5 2.2 2.8 7.2 3.9 5.6 4.8 8.0 4.4 0.9 4.1 1.0 27.0 0.2 0.5 7.1 3.6 6.3 0.3 11.6 9.6 3.2 3.4 4.3 7.1 4.1 0.0 0.5 22.4 0.9 3.3 0.0 3.0 0.3 6.0 5.7 1.8 2.7 1.4 6.9 8.2 0.0 0.4 28.7 14.7 0.7 0.5 5.1 3.0 6.9 4.9 5.1 7.6 0.9 21.3 8.3 4.0 9.1 0.5 3.7 0.2 2.4 4.2 0.7 1.6 1.0 1.3 0.9 1.1 2.1 1.1 0.5 0.6 16.5 1.8 0.9 2.6 1.5 0.7 4.0 5.6 1.4 4.7 3.9 2.0 4.3 0.5 5.6 4.0 17.9 53.0 18.6 32.7 41.4 1.7 2.4 25.5 18.7 31.8 12.2 0.0 0.3 8.3 26.4 9.3 39.0 55.4 0.0 58.8 5.9 33.8 37.5 36.9 31.7 13.9 7.9 20.6 35.6 31.1 1.3 12.4 45.8 38.8 36.9 31.6 2.3 42.1 35.1 4.2 17.7 0.5 6.5 57.5 0.5 1.2 53.3 1.1 14.6 22.9 44.4 BCL6 "BCL5, BCL6A, LAZ3, ZBTB27, ZNF51" ENSG00000113916 "B cell CLL/lymphoma 6" P41182 3 187721377-187745727 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Immunity, Inflammatory response, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 114.3" "Cell type enhanced" "Detected in many" 5 "Smooth muscle cells: 96.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 63.4" "Lineage enriched" "Detected in many" 4 "granulocytes: 63.4" "Cell line enhanced" "Detected in many" "ASC diff: 27.3;Daudi: 42.9;HSkMC: 31.1;U-698: 59.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000307, HPA004899, HPA050645" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB000307: AB_2063451, HPA004899: AB_1078273, HPA050645: AB_2681199" "unprognostic (5.36e-2)" "unprognostic (3.29e-2)" "unprognostic (1.63e-3)" "unprognostic (2.49e-1)" "unprognostic (2.85e-1)" "unprognostic (6.34e-3)" "unprognostic (2.62e-2)" "unprognostic (3.33e-3)" "unprognostic (8.75e-2)" "unprognostic (2.04e-2)" "unprognostic (1.63e-3)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.27e-9)" "unprognostic (5.22e-2)" "unprognostic (7.82e-2)" "unprognostic (5.67e-2)" "unprognostic (2.58e-2)" 47.1 14.3 21.8 23.2 25.9 50.6 48.0 58.7 23.7 21.2 21.2 19.2 11.5 4.1 17.7 8.8 20.9 28.3 22.3 18.6 21.5 8.0 10.1 20.1 26.3 24.5 31.6 9.3 20.2 15.6 9.1 23.3 7.5 28.5 17.3 5.8 15.9 19.1 11.8 114.3 36.4 8.1 24.4 50.1 27.2 16.1 10.2 26.6 18.9 14.8 10.4 22.4 24.9 20.0 3.9 5.6 63.4 15.4 0.9 1.3 5.2 1.2 3.6 3.6 0.8 27.3 21.8 3.9 4.3 10.5 5.0 5.3 2.6 2.0 42.9 3.1 5.4 3.1 2.1 1.2 2.8 4.3 9.0 1.4 0.0 1.8 6.1 14.2 0.5 0.2 31.1 18.2 6.1 9.4 16.3 2.8 1.1 0.4 7.4 4.8 1.4 1.4 0.3 0.3 0.7 2.7 11.9 1.8 0.2 3.5 6.3 0.8 0.0 5.0 2.1 2.8 8.3 9.4 1.5 5.6 12.1 1.9 4.4 2.0 5.5 1.8 59.6 6.6 1.6 8.5 1.6 6.9 4.1 1.3 8.7 1.3 1.4 0.8 1.2 5.6 3.9 0.5 0.6 63.4 0.9 15.4 0.9 0.6 5.2 21.8 25.9 58.7 23.7 21.5 8.0 31.6 9.3 28.5 26.6 17.9 76.9 6.5 13.3 42.0 11.0 60.5 17.8 25.4 22.7 15.7 19.6 1.1 0.0 9.2 12.3 27.7 1.6 0.0 10.6 2.0 36.2 28.7 10.5 44.4 11.2 0.0 4.6 9.8 56.3 6.2 26.7 26.7 33.7 3.6 1.1 40.1 8.7 0.0 17.7 1.1 9.6 32.3 96.4 0.4 0.7 53.8 3.4 10.7 1.9 21.9 BCL7A BCL7 ENSG00000110987 "BCL tumor suppressor 7A" Q4VC05 12 122019422-122062044 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 101.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 8.4;plasmacytoid DC: 9.7" "Group enriched" "Detected in many" 10 "B-cells: 8.4;dendritic cells: 9.7" "Cell line enhanced" "Detected in many" "Daudi: 26.2;MOLT-4: 19.2;U-698: 30.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019762 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA019762: AB_10962489" "unprognostic (3.27e-1)" "unprognostic (2.97e-2)" "prognostic unfavorable (6.81e-4)" "unprognostic (1.35e-1)" "unprognostic (1.46e-1)" "unprognostic (1.23e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (5.18e-1)" "unprognostic (5.13e-2)" "unprognostic (1.06e-2)" "unprognostic (3.13e-1)" "unprognostic (3.11e-1)" "prognostic favorable (1.54e-6)" "unprognostic (4.86e-2)" "unprognostic (8.56e-2)" "unprognostic (6.16e-3)" "unprognostic (1.51e-2)" 3.8 3.7 13.0 9.8 14.5 9.9 6.5 19.8 18.2 6.7 4.2 6.8 3.3 3.6 6.0 7.4 3.3 10.3 4.3 9.4 9.5 7.5 10.7 5.3 5.1 19.4 6.6 15.9 4.9 11.7 8.3 6.1 2.8 6.8 6.3 3.8 3.8 8.2 7.2 12.8 8.2 3.4 4.1 5.1 6.5 4.4 3.1 7.9 26.4 11.1 3.5 15.8 6.9 5.4 8.4 9.7 0.1 0.1 0.5 0.9 0.6 1.7 2.4 8.0 5.6 0.5 0.3 1.7 1.0 1.1 1.7 1.5 1.0 0.7 26.2 2.9 0.8 1.0 2.3 5.8 5.5 1.5 0.0 9.5 1.3 0.2 1.4 1.7 4.0 2.3 1.3 5.3 1.2 7.2 2.0 2.1 12.3 5.9 0.0 1.0 3.6 19.2 0.3 2.9 2.4 4.1 10.6 2.8 0.3 3.2 4.5 8.0 9.0 1.3 0.3 3.3 2.0 5.4 3.3 1.9 0.3 1.7 3.0 1.7 2.7 1.8 30.3 0.5 2.6 1.8 0.1 0.0 0.0 0.1 0.0 0.0 2.9 0.2 0.2 2.2 8.4 0.9 0.6 0.1 0.5 0.1 9.7 0.0 0.6 13.0 14.5 19.8 18.0 9.5 7.5 6.6 15.9 6.8 7.9 20.8 8.6 37.2 47.6 31.9 38.8 25.8 38.2 14.7 22.7 36.6 17.7 1.0 49.7 25.7 6.1 3.1 1.7 0.0 9.5 0.8 8.7 26.5 10.4 16.8 3.2 101.7 20.6 4.3 3.5 9.8 13.0 8.5 11.8 5.4 8.0 5.6 10.5 7.0 7.4 18.9 13.5 6.5 15.6 0.5 4.3 26.3 0.5 0.0 11.4 26.0 BCL7B ENSG00000106635 "BCL tumor suppressor 7B" Q9BQE9 7 73536356-73558002 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Differentiation, Wnt signaling pathway" "Allergen, Williams-Beuren syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049943, HPA058069" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA049943: AB_2680963, HPA058069: AB_2683594" "unprognostic (2.79e-2)" "unprognostic (2.87e-1)" "unprognostic (1.93e-2)" "unprognostic (1.04e-1)" "unprognostic (3.54e-3)" "unprognostic (1.12e-1)" "unprognostic (2.91e-2)" "unprognostic (4.84e-2)" "unprognostic (1.35e-1)" "unprognostic (2.73e-1)" "unprognostic (5.37e-2)" "unprognostic (9.43e-2)" "prognostic favorable (4.38e-4)" "unprognostic (4.09e-1)" "unprognostic (3.55e-1)" "unprognostic (5.41e-2)" "unprognostic (1.32e-1)" 24.3 13.6 19.2 10.3 21.7 44.1 21.2 10.2 24.2 10.8 21.4 10.3 12.5 11.2 12.1 12.2 13.1 9.7 12.2 28.7 17.6 14.0 15.2 16.6 15.9 11.5 12.8 13.7 7.9 9.9 13.9 16.1 15.3 13.1 11.7 10.7 14.9 10.4 14.9 43.2 7.7 16.5 20.8 9.3 14.2 15.2 15.8 10.6 11.9 13.7 9.3 11.6 16.4 12.5 13.2 14.6 14.4 15.4 17.1 12.8 5.7 18.5 9.4 5.4 11.0 4.4 6.0 9.6 20.6 14.7 14.7 11.7 10.4 16.4 19.3 4.3 13.1 17.3 7.7 4.9 9.4 12.3 19.2 9.4 10.0 5.8 5.5 11.1 14.3 25.7 4.5 8.1 13.2 13.2 5.5 9.1 6.9 14.9 13.7 8.2 15.4 26.1 15.8 12.8 10.5 23.9 13.5 7.1 17.4 9.8 12.9 15.4 16.1 16.2 15.9 13.0 3.3 11.1 15.0 12.6 17.6 14.6 10.3 21.2 12.8 10.7 28.9 16.2 19.7 18.4 10.3 12.0 14.4 10.1 13.6 12.0 10.2 11.5 12.8 11.8 13.2 12.0 10.6 7.0 17.1 15.4 14.6 9.1 5.7 19.2 21.7 10.2 24.2 17.6 14.0 12.8 13.7 13.1 10.6 29.8 16.5 31.6 71.7 57.5 27.0 27.7 17.8 12.0 15.9 15.7 5.9 59.7 46.4 37.9 5.2 31.9 47.7 0.0 40.1 35.9 32.0 54.5 32.3 17.1 45.7 39.7 33.1 25.8 22.4 5.9 23.9 39.6 30.4 45.1 29.3 22.9 49.1 49.1 28.7 33.5 15.3 45.3 46.7 60.8 68.5 50.4 85.1 55.4 35.3 58.1 BCL7C ENSG00000099385 "BCL tumor suppressor 7C" Q8WUZ0 16 30833626-30894960 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Distal tubular cells: 184.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018676, HPA052654" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA018676: AB_1845322, HPA052654: AB_2681903" "unprognostic (2.27e-2)" "prognostic favorable (4.23e-4)" "unprognostic (2.95e-1)" "unprognostic (1.49e-1)" "unprognostic (1.21e-1)" "unprognostic (3.60e-1)" "unprognostic (3.18e-3)" "unprognostic (4.91e-3)" "unprognostic (2.44e-1)" "unprognostic (3.41e-2)" "unprognostic (3.84e-2)" "unprognostic (9.22e-2)" "unprognostic (2.05e-2)" "unprognostic (2.45e-1)" "unprognostic (2.97e-1)" "unprognostic (2.07e-2)" "unprognostic (2.85e-1)" 18.5 13.5 14.2 19.1 16.2 21.3 24.8 16.1 12.4 24.1 22.1 13.3 21.6 14.3 21.2 18.9 23.2 19.0 27.5 24.4 13.1 14.4 22.3 12.6 13.2 19.6 17.1 9.3 28.2 14.1 11.1 15.9 17.1 17.1 25.4 10.7 19.3 20.3 22.3 23.4 21.7 20.2 31.3 13.7 15.0 16.8 24.9 13.6 10.5 26.5 17.7 20.5 20.5 32.0 7.2 6.6 7.0 5.2 5.7 10.2 3.7 21.2 12.5 14.2 32.8 10.8 17.3 8.5 16.8 14.2 16.8 12.3 10.6 13.9 1.4 19.9 21.0 9.9 11.5 7.2 14.7 11.4 14.9 25.3 5.0 10.3 17.7 16.1 9.0 11.3 18.7 19.5 12.5 6.8 9.4 16.6 11.0 11.8 8.9 15.8 28.1 9.3 23.4 7.3 12.2 20.3 20.6 14.4 19.1 8.9 7.9 9.2 14.9 15.6 13.1 10.4 9.1 21.5 13.8 11.4 23.2 23.1 14.5 13.7 8.3 7.5 9.7 15.5 15.3 17.1 6.2 5.2 7.0 9.2 3.5 10.2 7.2 7.9 10.1 4.5 7.1 7.1 8.4 4.2 5.7 3.7 6.6 8.2 3.7 14.2 16.2 16.1 12.4 13.1 14.4 17.1 9.3 17.1 13.6 11.9 10.7 24.5 65.4 35.1 10.0 15.1 33.1 9.4 13.6 68.0 5.9 44.4 184.1 29.8 17.9 44.4 33.8 23.3 30.9 46.1 66.6 43.2 2.3 20.2 50.4 12.7 35.8 35.0 23.5 19.6 51.8 41.0 52.3 89.2 34.6 29.6 38.8 17.5 48.4 62.8 9.8 19.4 38.9 2.6 3.4 37.3 20.9 41.5 53.7 57.0 BCL9 ENSG00000116128 "B cell CLL/lymphoma 9" O00512 1 147541412-147626216 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Intestinal endocrine cells: 27.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "NTERA-2: 24.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020274 Approved Approved "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA020274: AB_2670400" "unprognostic (2.31e-1)" "unprognostic (1.52e-2)" "unprognostic (5.32e-2)" "unprognostic (1.38e-1)" "unprognostic (1.04e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (6.74e-4)" "unprognostic (1.03e-1)" "unprognostic (2.78e-1)" "unprognostic (2.29e-1)" "unprognostic (4.78e-3)" "unprognostic (3.92e-2)" "unprognostic (1.64e-3)" "unprognostic (2.58e-1)" "unprognostic (2.20e-1)" "unprognostic (1.37e-1)" "unprognostic (1.60e-2)" 4.5 7.8 10.2 5.9 9.2 3.1 4.8 22.3 12.6 18.2 9.4 8.1 10.9 5.3 23.9 15.9 6.8 18.9 5.2 8.3 8.0 7.4 9.6 4.3 5.0 4.0 5.9 8.7 17.0 6.1 14.6 10.6 4.5 6.8 10.5 7.9 11.8 8.1 13.2 7.9 7.8 5.5 15.7 5.4 3.8 7.6 6.1 6.5 22.4 7.8 8.0 6.0 9.6 8.0 0.4 0.0 0.6 0.3 0.1 2.6 1.0 2.9 2.9 20.6 15.3 2.3 2.8 4.0 2.4 3.9 2.7 2.6 3.8 4.5 2.8 5.5 2.3 4.5 2.4 13.0 4.4 2.5 6.7 3.6 1.3 3.1 2.5 2.0 0.8 4.1 2.7 3.8 3.2 2.3 4.8 4.1 9.4 2.6 4.6 2.3 6.7 7.0 0.6 24.3 6.0 6.4 7.5 5.2 5.5 10.4 3.3 5.6 12.2 2.7 5.1 4.7 19.8 6.4 1.3 3.0 1.9 9.0 5.3 3.8 20.9 5.3 5.4 4.8 0.8 9.1 0.0 0.3 0.6 1.0 0.0 0.9 0.2 1.2 1.2 0.0 0.4 2.6 1.6 0.2 0.1 0.1 0.0 0.9 1.0 10.2 9.2 22.3 12.6 8.0 7.4 5.9 8.7 6.8 6.5 0.0 2.1 0.0 5.2 2.7 7.9 4.7 7.6 2.7 2.3 12.2 2.0 1.8 10.0 3.4 9.0 2.8 1.8 0.0 4.0 2.0 4.6 7.6 8.1 2.6 1.1 6.4 27.2 6.2 2.8 4.2 8.9 0.4 0.0 1.0 10.9 4.3 3.8 0.0 7.4 4.9 2.8 0.0 3.8 3.2 6.8 3.1 1.7 0.5 6.9 2.7 BCL9L DLNB11 ENSG00000186174 "B cell CLL/lymphoma 9 like" Q86UU0 11 118893875-118925608 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049370, HPA053421" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA049370: AB_2680732, HPA053421: AB_2682145" "unprognostic (1.67e-2)" "unprognostic (1.48e-2)" "unprognostic (1.20e-1)" "unprognostic (2.71e-1)" "unprognostic (2.87e-1)" "unprognostic (1.90e-1)" "unprognostic (6.61e-3)" "unprognostic (1.17e-3)" "unprognostic (1.03e-1)" "unprognostic (4.61e-2)" "unprognostic (4.66e-3)" "unprognostic (1.39e-1)" "unprognostic (2.83e-3)" "unprognostic (4.85e-3)" "unprognostic (2.24e-2)" "unprognostic (2.14e-1)" "unprognostic (2.90e-3)" 18.4 18.9 10.2 17.2 10.0 13.3 23.8 31.7 9.9 27.4 16.4 6.7 15.8 13.2 22.3 12.8 18.9 22.2 21.2 15.6 9.0 4.1 10.9 9.0 17.1 13.8 9.5 7.7 22.2 16.4 9.0 6.5 31.9 9.1 16.1 4.1 14.5 21.5 14.7 19.1 19.9 14.6 22.8 7.9 13.9 14.0 9.0 8.6 13.0 12.2 11.9 16.7 21.9 25.6 0.6 0.6 1.1 0.5 0.7 2.2 0.8 12.3 22.5 3.2 5.9 10.5 10.2 20.7 17.1 13.2 5.4 3.2 23.9 24.7 3.4 22.9 17.9 22.2 24.0 1.5 31.4 1.4 4.1 0.8 3.3 12.6 8.2 11.9 1.1 3.2 12.9 19.6 6.5 13.1 10.5 4.8 2.0 4.3 3.9 3.7 20.8 2.5 0.9 3.8 7.4 13.0 5.3 1.4 2.3 5.7 8.6 1.7 2.6 24.1 36.6 3.4 6.0 28.8 1.4 16.0 17.5 13.3 5.2 14.5 0.8 0.0 1.0 9.4 3.9 9.9 0.0 0.5 0.0 2.2 0.0 1.5 0.3 1.2 1.3 0.1 0.6 1.9 1.5 1.1 0.7 0.0 0.6 0.2 0.8 10.2 10.0 31.7 9.9 9.0 4.1 9.5 7.7 9.1 8.6 14.9 11.5 2.4 8.8 34.5 18.4 2.0 15.3 4.0 11.4 7.0 3.9 9.8 0.0 11.8 0.1 10.1 8.0 0.0 12.7 7.0 11.6 18.2 2.3 10.0 3.8 12.7 5.2 11.1 5.2 0.0 13.6 2.6 6.8 19.8 5.0 6.9 20.3 7.0 13.4 2.2 2.8 25.8 14.7 0.5 1.0 39.5 29.6 11.8 6.3 9.1 BCLAF3 CXorf23 ENSG00000173681 "BCLAF1 and THRAP3 family member 3" A2AJT9 X 19912860-19970298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 14.2;Club cells: 13.6;Collecting duct cells: 8.7" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027215 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA027215: AB_1847358" "unprognostic (2.46e-1)" "unprognostic (1.96e-1)" "unprognostic (3.15e-1)" "unprognostic (2.24e-1)" "unprognostic (2.27e-2)" "unprognostic (2.48e-2)" "unprognostic (3.72e-2)" "prognostic favorable (5.42e-4)" "unprognostic (1.82e-2)" "unprognostic (1.10e-1)" "unprognostic (1.43e-1)" "unprognostic (4.83e-2)" "unprognostic (2.03e-2)" "unprognostic (2.21e-1)" "unprognostic (9.38e-2)" "unprognostic (2.30e-2)" "prognostic favorable (5.56e-4)" 4.3 2.4 3.7 2.8 3.4 2.5 4.6 8.1 3.4 3.4 4.5 2.6 5.0 8.1 2.8 3.6 3.6 2.7 4.0 3.2 3.8 2.0 3.8 3.2 3.7 5.1 3.2 7.1 3.3 2.5 4.6 5.4 3.1 4.9 3.9 5.3 4.1 3.4 4.2 4.1 3.1 1.8 4.2 3.3 4.2 3.9 2.8 2.3 4.8 1.4 1.4 1.6 0.3 5.6 4.5 6.3 10.5 5.6 8.0 3.5 5.3 4.4 3.4 4.8 4.1 6.2 5.8 3.2 6.2 6.1 4.2 5.5 3.9 6.6 3.8 4.5 3.8 4.8 4.0 8.0 5.1 6.5 7.1 6.1 3.8 5.2 8.0 3.9 4.7 2.7 13.9 3.9 4.3 3.6 3.4 5.5 5.4 5.8 1.5 6.3 7.7 9.1 5.7 3.9 5.9 6.6 5.6 5.3 12.1 6.7 4.6 7.2 5.8 2.9 13.9 3.8 4.4 3.4 4.8 5.0 2.9 5.0 4.1 0.9 1.8 1.5 1.2 1.6 1.2 1.2 1.5 0.7 2.8 1.2 1.4 4.8 1.4 1.4 2.3 0.5 0.3 14.9 14.2 0.0 0.0 0.0 0.0 0.0 0.0 8.1 13.6 8.7 0.0 3.3 1.7 5.5 0.0 0.0 0.0 0.0 3.1 3.2 0.0 0.0 5.8 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 2.8 0.0 0.0 5.7 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 BCOR "FLJ20285, KIAA1575" ENSG00000183337 "BCL6 corepressor" Q6W2J9 X 40049815-40177329 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes, Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056308, HPA073591" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA056308: AB_2683095, HPA073591: AB_2732227" "unprognostic (2.75e-2)" "unprognostic (2.83e-1)" "unprognostic (2.45e-1)" "unprognostic (9.26e-2)" "unprognostic (1.55e-1)" "unprognostic (9.80e-3)" "prognostic unfavorable (1.30e-5)" "unprognostic (3.82e-3)" "unprognostic (6.86e-2)" "unprognostic (1.86e-1)" "unprognostic (4.08e-2)" "unprognostic (1.18e-1)" "unprognostic (3.91e-3)" "unprognostic (6.83e-2)" "unprognostic (9.57e-2)" "unprognostic (2.63e-1)" "unprognostic (1.55e-1)" 9.1 12.8 8.7 8.7 10.5 20.6 13.3 11.5 12.0 10.0 12.6 22.7 11.9 7.8 11.1 13.9 13.6 10.4 8.6 13.0 7.1 5.4 11.2 13.3 11.4 15.2 12.9 8.4 19.8 13.6 19.7 11.9 12.5 10.7 13.2 8.2 13.7 11.1 16.5 28.8 13.6 10.3 12.9 8.6 11.4 11.5 9.8 15.8 18.4 16.0 11.4 13.5 13.8 25.5 6.5 7.3 7.6 7.1 8.2 6.8 11.8 13.1 8.7 17.8 21.7 2.0 1.6 3.1 4.5 7.1 5.7 4.7 3.7 5.3 12.0 5.3 8.3 3.7 12.4 29.0 3.8 5.1 20.9 26.4 13.4 13.4 14.4 3.4 10.8 7.7 2.6 5.6 6.3 3.6 8.4 7.7 7.9 34.3 29.0 7.0 8.4 24.4 22.6 17.5 6.2 13.6 11.9 18.4 13.5 10.5 8.3 12.8 23.1 9.4 8.3 7.0 9.1 8.9 23.8 6.4 6.2 7.8 9.1 5.0 17.2 13.3 12.5 5.4 9.9 9.5 7.6 5.0 4.5 6.8 6.1 4.3 6.5 4.7 3.9 7.3 5.5 4.7 4.8 1.1 8.2 7.1 3.1 5.5 11.8 8.7 10.5 11.5 12.0 7.1 5.4 12.9 8.4 10.7 15.8 20.8 23.2 12.3 3.2 13.1 34.2 7.6 10.2 6.7 5.7 10.4 11.8 3.7 1.7 4.5 2.1 17.4 4.9 0.0 9.1 5.5 13.6 7.9 23.2 9.5 6.4 14.3 15.6 19.0 11.0 2.1 9.8 8.6 5.0 7.2 11.7 7.7 6.6 0.0 7.4 4.0 22.0 0.0 26.4 1.1 13.5 12.2 1.7 7.5 7.6 2.6 BCORL1 "CXorf10, FLJ11362" ENSG00000085185 "BCL6 corepressor like 1" Q5H9F3 X 129981107-130058083 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "Syncytiotrophoblasts: 78.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 20.4;HAP1: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031775, HPA031777, HPA068568" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA031775: AB_10602332, HPA031777: AB_10671578, HPA068568: AB_2686007" "unprognostic (8.07e-2)" "unprognostic (2.78e-2)" "unprognostic (7.09e-2)" "prognostic unfavorable (2.20e-5)" "unprognostic (4.58e-1)" "unprognostic (1.68e-3)" "unprognostic (1.96e-3)" "unprognostic (5.56e-3)" "unprognostic (2.39e-1)" "unprognostic (8.02e-2)" "unprognostic (4.46e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (5.00e-4)" "unprognostic (9.18e-2)" "unprognostic (2.60e-2)" "unprognostic (3.09e-1)" "unprognostic (1.41e-2)" 7.5 7.9 7.7 5.2 9.1 9.8 9.1 19.8 10.5 8.7 8.3 10.7 8.1 5.4 9.2 5.4 5.8 9.3 4.2 6.9 8.4 4.5 7.5 4.7 6.7 5.3 7.6 5.9 11.4 8.9 13.4 15.0 28.9 7.5 8.1 4.5 6.0 6.5 8.4 6.0 6.5 6.0 8.8 5.3 7.7 6.6 26.1 8.1 6.8 10.3 2.2 5.1 6.7 8.5 1.2 1.6 3.5 1.3 0.8 1.3 0.7 2.2 5.5 12.9 20.4 7.6 5.5 3.6 3.0 3.5 3.9 4.5 6.6 1.4 1.0 6.7 6.0 3.7 1.3 30.8 1.2 3.7 2.2 4.5 10.6 2.7 2.2 3.8 2.6 3.1 3.4 2.5 7.7 0.4 5.8 4.7 3.5 5.1 10.8 2.5 1.3 3.9 8.0 3.5 1.8 3.9 8.3 5.2 1.4 2.2 0.3 2.1 7.3 1.6 0.4 2.0 7.2 4.5 4.0 3.9 3.2 4.1 3.8 2.9 3.5 6.3 1.6 2.1 5.4 1.5 0.1 1.3 2.8 1.3 0.2 1.0 1.2 0.9 0.8 1.6 1.0 0.6 0.7 3.5 0.8 0.5 0.7 0.2 0.7 7.7 9.1 19.8 10.5 8.4 4.5 7.6 5.9 7.5 8.1 0.0 3.2 0.0 2.3 10.5 1.8 6.4 5.1 2.7 1.2 7.0 0.0 10.7 0.0 3.2 0.4 7.1 2.7 0.0 0.9 4.2 5.8 2.9 6.9 3.0 2.8 7.9 11.5 3.1 2.6 1.0 4.4 1.8 6.8 1.0 1.7 3.1 2.3 0.0 3.5 2.2 1.0 6.5 4.5 3.5 5.3 10.0 78.1 1.5 2.8 2.5 BCR "ALL, BCR1, CML, D22S11, D22S662, PHL" ENSG00000186716 "BCR, RhoGEF and GTPase activating protein" P11274 22 23179704-23318037 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ito cells: 62.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 44.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010421, CAB018545, HPA038337" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "CAB010421: AB_2274682, CAB018545: AB_2063918, HPA038337: AB_10675795" "unprognostic (7.46e-3)" "unprognostic (2.43e-2)" "unprognostic (2.15e-3)" "unprognostic (1.16e-1)" "unprognostic (5.35e-2)" "unprognostic (1.45e-1)" "unprognostic (5.08e-2)" "unprognostic (1.44e-1)" "unprognostic (7.55e-2)" "unprognostic (1.81e-1)" "unprognostic (9.46e-2)" "unprognostic (2.39e-2)" "prognostic favorable (9.15e-10)" "unprognostic (1.47e-1)" "unprognostic (7.10e-2)" "unprognostic (4.10e-2)" "unprognostic (7.43e-2)" 14.5 8.4 24.0 9.1 41.2 26.7 10.5 14.2 26.5 13.6 9.7 10.3 10.6 8.7 9.2 13.9 19.3 10.8 8.3 7.8 20.9 13.0 16.3 8.3 11.3 10.9 16.0 15.6 8.8 12.9 14.5 14.9 15.7 14.2 7.0 6.8 8.3 15.5 9.7 3.4 12.8 8.7 9.0 9.5 9.1 14.0 9.6 15.4 11.8 16.6 5.5 9.2 9.2 8.8 1.5 0.8 1.2 1.0 2.8 6.6 2.5 19.0 8.2 12.7 13.0 7.6 5.2 19.2 6.9 6.5 6.4 5.2 14.4 7.7 13.3 12.9 5.9 6.2 19.6 1.3 19.2 1.8 25.4 13.2 11.6 11.3 11.4 9.9 10.7 6.1 4.4 13.0 9.5 8.4 11.4 22.3 9.6 44.4 6.3 2.9 12.5 10.0 8.4 10.7 15.1 8.1 13.2 5.1 8.7 9.9 12.1 11.7 11.1 12.6 10.9 5.2 8.5 6.9 8.8 25.1 3.8 0.4 6.2 5.7 1.4 5.8 4.7 9.9 8.1 5.9 0.0 1.0 0.0 6.6 0.4 2.3 1.4 3.3 3.3 0.8 1.5 2.6 3.6 1.2 2.8 1.0 0.8 1.6 2.5 24.0 41.2 14.2 24.9 20.9 13.0 16.0 15.6 14.2 15.4 8.9 11.5 3.0 9.5 13.7 24.0 7.3 20.4 2.7 19.4 17.4 21.6 10.5 8.3 12.4 3.9 22.4 11.1 0.0 14.1 5.9 7.3 10.2 10.4 18.4 6.0 22.3 19.1 62.0 10.8 7.7 8.1 5.4 5.0 6.4 12.0 13.4 21.8 5.8 5.3 14.3 8.0 0.0 8.6 1.6 6.8 13.8 9.0 9.2 11.2 11.5 BDP1 "HSA238520, KIAA1241, KIAA1689, TAF3B1, TFC5, TFIIIB150, TFIIIB90, TFNR" ENSG00000145734 "B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB" A6H8Y1 5 71455615-71567820 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 7.3;TIME: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064166, HPA077984" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA064166: , HPA077984: " "unprognostic (4.96e-2)" "unprognostic (2.19e-1)" "unprognostic (6.65e-2)" "unprognostic (3.01e-1)" "unprognostic (3.47e-2)" "unprognostic (1.44e-2)" "unprognostic (7.72e-2)" "unprognostic (2.02e-1)" "unprognostic (9.59e-3)" "unprognostic (8.20e-2)" "unprognostic (2.85e-1)" "unprognostic (1.23e-1)" "unprognostic (3.86e-2)" "unprognostic (1.52e-1)" "unprognostic (7.83e-2)" "unprognostic (2.50e-2)" "unprognostic (5.86e-2)" 7.8 8.7 6.1 4.4 9.0 3.3 7.9 13.1 9.8 5.9 4.4 2.5 3.3 1.5 6.1 3.3 5.0 7.8 5.2 4.0 6.6 3.4 6.5 4.2 3.7 3.5 6.3 5.6 5.0 10.7 1.5 10.0 3.7 5.7 4.9 4.1 1.9 4.9 6.1 10.0 6.5 4.1 6.1 4.1 4.7 3.6 4.9 7.5 6.7 7.9 2.5 3.0 5.7 3.7 2.5 1.4 1.8 0.4 1.9 1.3 0.1 0.2 2.3 4.4 1.1 0.1 0.5 4.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.3 1.6 5.0 0.0 0.1 0.0 3.5 0.0 0.0 0.1 5.6 1.0 2.7 0.6 0.0 0.0 0.0 0.0 0.7 2.4 4.1 0.0 7.3 0.0 1.8 2.4 0.0 0.4 0.0 0.3 4.8 4.7 0.0 4.0 1.9 1.7 0.0 6.1 0.0 0.9 3.6 2.6 0.0 0.0 9.7 4.7 0.1 1.6 0.0 1.5 3.8 0.0 0.0 0.4 5.2 0.0 0.1 1.8 1.3 0.4 0.6 0.9 0.6 0.5 0.6 2.5 1.3 0.9 0.5 1.9 0.0 1.4 0.4 0.1 6.1 9.0 13.1 9.8 6.6 3.4 6.3 5.6 5.7 7.5 56.6 88.2 43.6 51.4 39.5 73.1 98.6 45.9 57.6 83.0 33.2 96.2 32.1 1.7 38.7 21.8 53.7 20.2 46.7 31.3 41.0 40.7 42.1 55.6 24.1 27.5 89.0 56.2 22.1 17.5 16.8 54.4 37.3 27.0 55.1 25.9 46.5 39.7 23.0 51.2 8.2 121.3 51.8 48.6 64.7 53.0 37.9 40.3 55.4 32.3 59.9 BEAN1 SCA31 ENSG00000166546 "Brain expressed associated with NEDD4 1" Q3B7T3 16 66427297-66493529 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.6" "Cell type enhanced" "Detected in some" 9 "Cytotrophoblasts: 4.8;Early spermatids: 8.4;Extravillous trophoblasts: 8.9;Late spermatids: 8.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "eosinophil: 1.9;neutrophil: 5.2;plasmacytoid DC: 2.4" "Group enriched" "Detected in many" 7 "dendritic cells: 2.4;granulocytes: 5.2" "Cell line enhanced" "Detected in some" "AN3-CA: 9.7;BEWO: 4.9;RPTEC TERT1: 8.6;U-87 MG: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053851 Uncertain Uncertain Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA053851: AB_2682280" "unprognostic (1.92e-1)" "unprognostic (5.79e-4)" "unprognostic (3.83e-2)" "unprognostic (3.38e-3)" "unprognostic (1.01e-1)" "unprognostic (4.04e-2)" "unprognostic (2.16e-1)" "unprognostic (1.13e-1)" "unprognostic (4.89e-1)" "unprognostic (1.59e-1)" "unprognostic (2.13e-3)" "unprognostic (4.18e-2)" "unprognostic (3.38e-2)" "unprognostic (1.63e-1)" "unprognostic (3.10e-2)" "unprognostic (1.98e-1)" "unprognostic (2.10e-2)" 1.2 1.2 2.9 1.1 2.5 2.9 1.2 6.9 9.6 1.2 0.7 0.1 0.0 0.6 1.2 1.9 1.8 1.9 1.4 3.0 4.6 4.1 0.9 1.1 1.4 0.9 2.3 3.2 1.4 1.9 0.1 0.4 4.5 11.6 1.0 0.9 5.0 1.9 0.4 3.6 3.2 0.8 0.8 1.7 1.2 1.2 3.1 0.2 0.0 1.9 3.1 0.9 1.0 1.0 0.3 2.4 5.2 0.5 0.4 0.2 0.1 0.8 1.0 1.0 9.7 0.3 0.1 4.9 0.3 0.0 0.1 0.1 0.0 1.0 0.1 0.6 0.3 0.6 0.2 0.1 0.1 0.3 0.0 0.7 0.0 0.2 0.7 0.7 0.1 0.0 0.7 1.9 0.6 0.3 1.4 0.0 0.2 0.1 0.3 0.2 0.5 0.0 0.4 0.3 0.1 0.6 0.1 0.2 0.5 8.6 0.6 0.1 0.2 0.2 0.2 1.4 0.7 0.2 0.1 0.3 0.4 2.7 0.1 0.4 0.5 0.1 0.1 5.6 0.2 1.4 0.4 0.5 1.9 0.2 0.1 0.1 0.2 0.1 0.1 0.3 0.3 0.2 0.1 5.2 0.4 0.2 2.4 0.1 0.1 2.9 2.5 6.9 9.6 4.6 4.1 2.3 3.2 11.6 0.2 0.0 0.0 0.0 0.2 0.1 0.4 1.2 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.2 8.4 0.3 0.0 0.0 0.0 8.9 0.6 1.0 0.0 0.0 0.9 0.0 0.0 1.3 0.0 8.0 0.3 0.0 3.3 0.0 0.0 0.0 1.0 0.0 2.1 0.0 0.9 0.0 0.5 2.9 0.3 0.1 2.4 0.0 0.0 0.3 BEGAIN KIAA1446 ENSG00000183092 "Brain enriched guanylate kinase associated" Q9BUH8 14 100537147-100587413 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.9" "Cell type enriched" "Detected in many" 15 "Horizontal cells: 135.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "eosinophil: 6.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.8" "Group enriched" "Detected in some" 7 "HeLa: 21.8;SH-SY5Y: 53.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002899 Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA002899: AB_1078277" "unprognostic (2.98e-4)" "unprognostic (2.75e-3)" "unprognostic (2.66e-2)" "unprognostic (2.66e-4)" "unprognostic (2.77e-3)" "unprognostic (1.93e-2)" "unprognostic (5.16e-2)" "unprognostic (6.35e-2)" "unprognostic (3.83e-1)" "unprognostic (4.33e-2)" "unprognostic (4.15e-2)" "unprognostic (5.47e-2)" "unprognostic (1.59e-1)" "unprognostic (9.01e-2)" "unprognostic (3.11e-1)" "unprognostic (2.75e-1)" "unprognostic (2.60e-1)" 1.8 5.5 16.4 1.1 10.8 6.4 1.5 24.9 21.6 1.3 1.3 0.9 0.0 4.6 2.0 1.8 1.4 3.0 2.5 1.5 15.3 7.1 0.9 0.8 1.0 1.3 4.4 6.0 3.5 13.0 2.3 8.2 3.1 3.6 2.6 0.9 2.1 2.8 2.7 0.9 1.3 3.0 1.7 2.0 3.3 1.0 2.6 1.4 5.4 1.0 0.4 1.3 0.8 0.6 0.6 1.0 6.8 1.5 0.0 0.4 0.1 0.3 1.3 0.7 4.5 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.4 0.1 0.2 0.2 1.0 0.1 0.2 0.0 0.0 0.0 0.4 2.0 21.8 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.5 0.0 0.0 0.3 0.2 0.0 0.0 1.7 0.1 0.6 0.5 0.1 0.7 0.0 0.1 2.7 0.0 0.0 1.2 53.1 1.2 0.0 1.2 0.0 0.3 5.4 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 3.8 1.0 0.1 1.3 0.1 6.8 0.0 1.5 0.0 0.6 0.4 0.0 0.0 0.2 0.1 0.0 0.6 0.0 1.4 1.0 0.0 0.1 16.4 10.8 24.9 17.3 15.3 7.1 4.4 6.0 3.6 1.4 0.0 1.1 0.0 1.4 2.2 1.5 1.4 0.0 0.0 1.2 0.0 0.0 0.1 0.0 1.0 0.3 0.6 0.7 0.0 6.9 0.2 1.4 0.5 9.2 0.0 0.2 135.1 0.0 0.0 0.0 0.6 1.7 0.7 1.7 1.8 0.0 0.7 4.1 0.0 6.3 0.0 2.4 0.0 0.3 0.9 0.4 1.8 0.1 0.0 0.2 0.3 BEND3 KIAA1553 ENSG00000178409 "BEN domain containing 3" Q5T5X7 6 107065182-107115269 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 12.6" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 5.9;Late spermatids: 5.2" "Cancer enhanced" "Detected in all" "testis cancer: 12.0" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017891, HPA062067" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA017891: AB_2064595, HPA062067: AB_2684675" "unprognostic (2.86e-2)" "unprognostic (3.16e-1)" "unprognostic (9.47e-3)" "unprognostic (4.25e-3)" "unprognostic (1.04e-1)" "unprognostic (2.43e-2)" "unprognostic (8.37e-8)" "unprognostic (1.59e-1)" "unprognostic (9.71e-2)" "unprognostic (3.99e-2)" "unprognostic (2.71e-2)" "unprognostic (6.89e-2)" "unprognostic (1.12e-2)" "unprognostic (8.65e-2)" "unprognostic (3.49e-1)" "unprognostic (1.09e-1)" "unprognostic (4.37e-1)" 1.8 1.9 1.4 1.8 2.5 1.8 5.6 4.0 2.2 1.6 3.6 1.3 0.8 3.0 2.4 4.2 2.5 2.3 3.6 3.8 1.1 1.3 3.1 4.4 2.0 1.5 1.8 0.8 1.9 12.6 1.8 2.3 1.5 3.3 2.6 3.9 1.3 3.4 1.0 5.0 1.4 4.1 2.5 1.8 2.8 5.0 4.6 1.5 2.4 1.9 3.9 3.6 2.2 1.2 1.5 1.3 2.0 1.0 0.8 1.7 0.4 2.8 4.1 11.3 6.4 1.3 1.0 9.3 1.1 1.5 1.5 1.8 4.6 2.1 8.4 2.9 2.9 2.6 2.8 12.2 6.3 2.5 3.3 6.1 2.3 3.0 5.1 1.1 6.0 3.0 2.5 2.6 2.2 3.2 1.2 1.9 4.0 6.3 3.5 1.9 5.7 5.1 4.6 15.8 7.1 2.6 7.0 3.3 5.5 2.4 8.4 11.5 5.6 3.6 6.1 2.3 6.0 3.6 4.8 2.2 4.1 3.9 1.9 5.4 2.4 3.2 8.6 1.4 4.7 3.2 2.0 0.8 1.5 1.2 1.0 0.9 1.5 1.1 1.1 0.5 1.1 0.8 1.7 1.6 0.8 1.0 1.3 1.2 0.4 1.4 2.5 4.0 1.8 1.1 1.3 1.8 0.8 3.3 1.5 3.0 2.4 0.0 0.8 2.6 1.4 2.8 0.0 1.4 2.3 0.0 5.9 0.8 0.0 0.8 4.2 0.8 0.4 0.0 1.5 1.2 0.6 1.0 0.0 0.6 0.6 0.0 1.2 0.0 1.0 5.2 0.9 0.5 0.0 0.0 2.2 0.2 0.9 0.0 0.0 0.8 1.4 0.0 2.1 0.6 2.5 2.6 0.7 0.0 3.0 0.7 BEND4 "CCDC4, FLJ35632, FLJ43965" ENSG00000188848 "BEN domain containing 4" Q6ZU67 4 42110938-42152878 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 26.7" "Group enriched" "Detected in some" 7 "Muller glia cells: 10.2;Spermatogonia: 35.8" "Group enriched" "Detected in some" 43 "prostate cancer: 6.3;testis cancer: 5.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "memory B-cell: 1.1;naive B-cell: 3.3" "Lineage enriched" "Detected in single" 12 "B-cells: 3.3" "Cell line enhanced" "Detected in some" "HAP1: 23.9;HEK 293: 5.8;HEL: 14.6;MOLT-4: 8.9;SuSa: 11.8;U-698: 9.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA036850 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA036850: AB_10600787" "unprognostic (3.62e-4)" "unprognostic (3.82e-1)" "unprognostic (4.82e-2)" "unprognostic (5.96e-3)" "unprognostic (2.97e-3)" "unprognostic (1.10e-1)" "unprognostic (3.81e-2)" "unprognostic (4.00e-1)" "unprognostic (2.97e-1)" "unprognostic (5.58e-2)" "unprognostic (6.71e-3)" "unprognostic (1.68e-1)" "unprognostic (1.54e-5)" "unprognostic (3.48e-1)" "unprognostic (1.49e-1)" "unprognostic (4.58e-3)" "unprognostic (4.24e-1)" 0.4 0.3 3.9 5.0 1.0 1.6 0.3 0.2 2.6 0.2 0.6 0.0 0.0 0.5 0.4 0.2 0.3 0.2 0.4 0.3 2.8 1.9 0.3 0.5 1.0 3.7 2.8 1.1 0.6 0.3 0.1 3.8 0.8 1.8 6.4 0.7 0.2 0.8 0.2 0.2 0.2 2.8 0.4 0.4 4.8 0.5 26.7 0.3 4.8 0.3 0.0 3.0 0.7 2.3 3.3 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 23.9 0.0 0.0 0.0 5.8 14.6 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 0.0 4.9 0.0 0.0 0.0 0.0 8.9 0.0 4.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 3.4 0.6 0.0 0.0 0.0 11.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.2 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 3.9 1.0 0.2 2.6 2.8 1.9 2.8 1.1 1.8 0.3 0.0 0.0 0.9 0.1 0.0 0.6 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 3.2 0.0 1.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 35.8 0.0 0.0 0.0 0.0 0.0 BEND6 "bA203B9.1, C6orf65, FLJ30162" ENSG00000151917 "BEN domain containing 6" Q5SZJ8 6 56955126-57027342 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.0" "Group enriched" "Detected in many" 8 "Bipolar cells: 68.2;Horizontal cells: 39.7" "Cancer enriched" "Detected in many" 6 "glioma: 4.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 11.1" "Lineage enriched" "Detected in many" 5 "dendritic cells: 11.1" "Cell line enhanced" "Detected in many" "ASC TERT1: 20.2;fHDF/TERT166: 18.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031605, HPA052973" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA031605: AB_10602395, HPA052973: AB_2682002" "unprognostic (4.27e-1)" "unprognostic (7.05e-2)" "unprognostic (4.42e-2)" "unprognostic (1.18e-6)" "unprognostic (2.44e-1)" "unprognostic (2.10e-1)" "unprognostic (1.17e-1)" "unprognostic (1.77e-2)" "unprognostic (9.41e-3)" "unprognostic (1.57e-1)" "unprognostic (8.82e-2)" "unprognostic (1.94e-2)" "unprognostic (9.84e-6)" "unprognostic (9.27e-3)" "unprognostic (1.51e-1)" "unprognostic (4.79e-2)" "unprognostic (2.98e-3)" 1.5 3.1 12.0 2.0 10.7 1.0 1.1 29.2 29.7 5.8 1.7 2.5 0.6 0.8 3.2 1.3 1.8 1.1 5.2 3.1 11.2 10.0 1.0 0.5 1.0 1.2 11.3 8.6 2.9 0.8 2.8 1.1 2.7 33.0 3.4 2.2 0.2 1.0 3.4 4.3 1.5 1.2 4.8 7.2 1.2 1.3 1.5 4.1 0.0 1.3 0.0 1.3 3.9 1.6 0.0 11.1 0.0 0.0 2.1 0.0 0.1 3.4 1.5 0.8 0.4 12.1 20.2 3.3 10.4 10.1 4.7 5.4 0.1 1.6 0.0 3.4 18.4 6.5 0.4 1.2 0.5 5.9 1.5 0.6 2.2 4.9 0.2 3.2 6.3 0.1 8.7 2.9 6.4 2.9 8.0 3.1 8.7 2.8 6.0 9.4 3.5 3.8 1.6 2.9 0.1 0.8 0.0 0.1 1.6 1.7 3.4 4.1 4.1 6.9 0.9 0.8 4.2 0.2 3.8 3.9 14.2 0.4 9.6 2.2 8.3 9.1 2.7 8.3 4.4 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 2.1 0.0 11.1 0.0 0.1 12.0 10.7 29.2 20.8 11.2 10.0 11.3 8.6 33.0 4.1 0.0 0.0 0.0 0.2 0.8 68.2 3.6 0.0 0.0 1.2 0.0 3.9 0.4 0.0 0.2 0.4 0.0 0.0 0.0 0.3 1.2 6.9 0.6 0.0 0.0 0.1 39.7 0.0 1.8 0.0 0.6 1.7 2.1 3.3 0.0 0.0 3.7 0.3 0.0 2.8 0.3 4.1 0.0 1.9 0.5 4.1 0.9 0.0 0.0 0.0 0.0 BEND7 "C10orf30, FLJ40283" ENSG00000165626 "BEN domain containing 7" Q8N7W2 10 13438484-13528974 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 129.1;Late spermatids: 176.1" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "neutrophil: 2.7" "Lineage enriched" "Detected in single" 24 "granulocytes: 2.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 14.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037835 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles" Yes No "Nucleoplasm, Nucleoli fibrillar center, Vesicles" "HPA037835: AB_10669722" "unprognostic (6.22e-2)" "unprognostic (1.80e-1)" "unprognostic (1.89e-1)" "unprognostic (1.33e-2)" "unprognostic (1.18e-2)" "unprognostic (4.62e-3)" "unprognostic (3.24e-3)" "unprognostic (3.52e-2)" "unprognostic (1.26e-1)" "unprognostic (5.02e-2)" "unprognostic (1.12e-1)" "unprognostic (1.06e-1)" "unprognostic (4.19e-3)" "unprognostic (1.57e-1)" "unprognostic (1.60e-1)" "unprognostic (1.58e-1)" "unprognostic (5.20e-3)" 2.3 1.7 1.1 0.3 1.3 0.0 3.0 5.4 0.8 3.0 3.6 7.4 2.9 6.2 0.5 5.7 2.6 1.5 0.8 1.4 8.4 3.6 3.3 0.0 1.2 3.3 5.4 9.8 4.4 1.5 2.1 2.6 5.3 2.6 4.5 0.8 8.7 2.4 0.6 0.9 3.5 8.1 11.2 0.0 2.1 1.4 0.0 0.0 2.7 0.0 0.1 0.0 0.0 7.6 4.4 5.6 2.4 0.1 0.0 7.3 2.9 0.1 8.5 5.0 3.5 14.4 0.0 4.1 6.4 4.2 0.4 8.0 2.2 7.3 0.0 7.2 0.1 0.0 10.8 3.2 0.0 0.0 0.2 5.0 1.3 0.0 13.7 8.1 1.4 4.4 0.0 7.4 5.7 0.1 0.0 2.5 0.1 1.0 0.0 4.0 0.0 6.0 1.3 0.5 4.3 8.7 0.0 0.2 7.7 0.2 3.6 6.7 1.7 11.2 10.4 4.0 0.0 0.0 0.0 2.7 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 20.8 12.3 2.2 15.3 3.1 14.2 8.9 28.1 14.7 15.9 19.2 7.9 1.9 3.3 11.2 129.1 9.8 8.7 0.0 14.1 2.1 5.8 19.6 5.8 8.2 2.4 1.6 7.5 16.0 7.9 176.1 4.6 2.1 3.3 1.8 10.4 19.0 17.4 6.2 5.6 41.7 31.7 0.0 7.5 15.3 17.8 1.6 2.1 5.7 9.0 26.7 BET1L "GOLIM3, GS15" ENSG00000177951 "Bet1 golgi vesicular membrane trafficking protein like" Q9NYM9 11 167784-207428 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 91.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039819 Approved Supported "Nucleoplasm,Golgi apparatus" No No "Golgi apparatus" Nucleoplasm "HPA039819: AB_10673020" "unprognostic (1.68e-1)" "unprognostic (2.07e-1)" "unprognostic (2.14e-3)" "unprognostic (2.56e-3)" "prognostic unfavorable (9.80e-4)" "unprognostic (1.18e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (1.82e-1)" "unprognostic (1.52e-1)" "unprognostic (3.08e-2)" "unprognostic (2.65e-1)" "unprognostic (2.08e-1)" "unprognostic (1.03e-1)" "unprognostic (9.10e-2)" "unprognostic (1.69e-1)" "unprognostic (3.75e-2)" "unprognostic (8.49e-2)" 18.6 20.3 11.4 23.4 15.2 9.2 19.2 14.4 19.8 22.3 18.0 21.0 34.1 17.0 23.4 28.6 16.2 21.7 25.3 18.7 11.6 12.6 21.4 30.3 20.4 20.4 14.9 13.7 33.8 62.2 29.3 31.4 17.3 15.8 27.3 18.0 24.4 35.1 28.0 11.6 18.6 22.4 26.1 13.4 22.3 21.8 27.4 10.5 18.4 27.0 15.6 22.4 25.8 21.0 18.1 12.3 34.3 15.1 15.1 22.5 15.9 18.5 15.5 9.2 11.4 28.7 25.4 13.4 19.9 26.2 21.4 22.0 19.3 18.0 16.5 9.7 35.9 15.4 17.4 10.6 18.2 16.4 12.7 11.5 15.2 8.2 19.4 26.6 17.2 29.7 28.5 24.5 12.6 33.9 24.9 14.4 11.7 22.1 17.3 13.6 10.1 12.5 10.9 14.1 27.1 17.6 13.1 13.7 11.1 17.6 8.3 10.1 12.2 17.7 28.7 19.3 13.9 14.7 13.6 15.9 16.6 7.7 6.7 9.7 30.5 13.9 14.5 22.5 14.5 15.1 27.0 10.4 34.3 16.7 15.1 20.0 18.1 19.3 17.0 10.5 15.1 22.5 17.3 24.5 15.1 13.2 12.3 14.6 15.9 11.4 15.2 14.4 19.8 11.6 12.6 14.9 13.7 15.8 10.5 11.9 14.2 6.7 14.7 8.2 6.4 14.0 12.7 6.7 4.5 14.0 7.9 13.5 18.3 11.3 46.5 9.2 28.5 0.0 20.3 20.8 15.4 22.9 36.9 33.1 20.4 3.2 7.5 17.8 18.0 91.1 20.4 14.6 6.8 12.6 19.3 8.2 16.7 23.0 17.7 24.5 8.9 6.5 11.7 41.4 14.9 10.2 22.0 15.8 13.3 19.3 BEX4 "BEXL1, FLJ10097" ENSG00000102409 "Brain expressed X-linked 4" Q9NWD9 X 103215092-103217246 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 304.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 37.9;HMC-1: 45.9;K-562: 53.1" "Low region specificity" "Detected in all" "HPA045105, HPA051935" Uncertain Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA045105: AB_10966792, HPA051935: AB_2681667" "unprognostic (1.45e-1)" "unprognostic (2.12e-1)" "unprognostic (1.01e-2)" "unprognostic (2.55e-3)" "unprognostic (1.75e-3)" "unprognostic (3.69e-1)" "unprognostic (1.52e-1)" "unprognostic (1.06e-3)" "unprognostic (3.03e-1)" "unprognostic (6.33e-2)" "prognostic favorable (9.41e-4)" "unprognostic (1.62e-2)" "prognostic favorable (2.54e-14)" "unprognostic (1.62e-3)" "unprognostic (2.60e-2)" "unprognostic (1.13e-1)" "unprognostic (5.33e-2)" 9.8 36.8 63.8 8.6 71.4 21.5 20.8 53.6 68.8 20.7 14.3 29.5 11.5 6.4 25.5 99.8 17.7 24.5 14.8 35.1 61.6 77.6 34.9 5.1 15.8 10.7 54.3 54.7 38.8 12.6 40.7 34.1 29.4 50.5 30.1 10.1 18.0 27.1 32.1 2.5 7.5 8.7 20.9 51.2 23.1 9.6 16.2 24.4 8.6 47.8 3.5 12.3 14.1 11.5 12.9 28.3 36.7 10.4 34.0 25.7 15.0 0.0 0.0 23.5 0.0 6.0 4.1 21.0 5.5 4.7 10.4 19.2 0.0 0.3 0.0 9.3 3.8 8.8 0.1 9.4 1.2 11.5 0.0 8.8 37.9 0.0 0.0 18.4 28.4 45.9 15.5 3.1 5.4 0.0 11.6 12.0 14.8 53.1 0.1 3.1 0.1 19.8 0.2 28.4 0.0 1.6 0.0 6.8 0.1 9.5 0.5 17.5 26.8 1.9 0.3 1.1 23.9 0.9 0.3 0.3 1.3 8.4 0.2 0.0 3.0 1.3 0.0 3.9 0.0 1.1 36.7 8.6 14.8 12.1 10.4 10.1 12.9 14.7 12.2 18.2 12.6 25.7 20.2 1.9 34.0 8.5 28.3 13.5 15.0 63.8 71.4 53.6 68.8 61.6 77.6 54.3 54.7 50.5 24.4 32.8 30.2 36.0 116.3 24.3 176.9 67.8 43.3 36.1 56.9 94.2 23.6 266.1 253.7 53.3 2.2 46.6 6.3 0.0 12.2 138.8 44.1 99.1 108.3 0.8 81.6 209.7 60.6 49.1 47.6 6.7 58.7 61.3 109.6 191.2 37.7 161.0 15.3 24.6 57.7 144.4 67.7 51.8 44.8 22.8 14.5 21.1 304.7 33.2 28.0 91.2 BHLHA15 "bHLHa15, BHLHB8, MIST1" ENSG00000180535 "Basic helix-loop-helix family member a15" Q7RTS1 7 98211427-98212979 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "pancreas: 145.8;salivary gland: 95.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "prostate cancer: 16.2" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "memory B-cell: 1.7" "Lineage enriched" "Detected in single" 7 "B-cells: 1.7" "Group enriched" "Detected in some" 8 "Karpas-707: 17.1;RPMI-8226: 31.7;U-266/70: 37.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB034083, HPA047834" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "CAB034083: AB_2065216, HPA047834: AB_2680172" "unprognostic (2.80e-2)" "unprognostic (9.45e-3)" "unprognostic (8.10e-2)" "unprognostic (6.66e-2)" "unprognostic (4.33e-3)" "unprognostic (1.10e-2)" "unprognostic (4.05e-2)" "unprognostic (1.37e-1)" "unprognostic (3.60e-1)" "unprognostic (4.28e-2)" "unprognostic (1.46e-1)" "unprognostic (1.88e-1)" "unprognostic (3.70e-4)" "unprognostic (3.36e-1)" "unprognostic (1.94e-1)" "unprognostic (2.95e-1)" "unprognostic (8.25e-3)" 0.1 0.1 0.2 0.8 0.2 0.0 0.1 0.1 0.2 0.3 1.2 0.0 3.5 0.9 0.1 0.1 0.4 0.1 0.8 0.1 0.3 0.2 0.3 4.7 0.5 1.8 0.1 0.0 0.0 145.8 0.0 0.4 0.0 0.0 1.6 0.1 0.0 95.2 6.8 0.4 0.2 0.8 0.0 0.1 1.9 6.2 0.1 0.0 0.0 0.2 1.2 2.7 0.4 0.1 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 1.7 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 17.1 0.0 0.3 0.0 0.0 0.5 1.2 0.5 0.2 0.0 31.7 0.0 0.0 1.9 0.7 0.0 3.6 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 37.9 2.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BHLHB9 "GASP3, KIAA1701, p60TRP" ENSG00000198908 "Basic helix-loop-helix family member b9" Q6PI77 X 102720688-102753540 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 21.1" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 11.3;Cone photoreceptor cells: 11.8;Muller glia cells: 11.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 5.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000887 Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA000887: AB_2666130" "unprognostic (4.07e-2)" "unprognostic (4.15e-2)" "unprognostic (4.87e-2)" "unprognostic (1.70e-3)" "unprognostic (6.42e-3)" "unprognostic (2.36e-1)" "unprognostic (2.40e-3)" "unprognostic (5.06e-3)" "unprognostic (2.65e-1)" "unprognostic (7.65e-2)" "unprognostic (2.74e-2)" "unprognostic (4.27e-2)" "unprognostic (1.29e-3)" "unprognostic (1.43e-1)" "unprognostic (7.46e-2)" "unprognostic (4.95e-2)" "unprognostic (8.88e-2)" 2.8 6.4 8.6 1.6 13.0 2.7 3.7 15.3 20.6 5.5 3.4 8.7 2.3 2.1 7.5 5.8 2.9 4.5 3.0 4.9 8.9 12.5 6.3 3.8 2.6 1.5 7.2 12.7 9.9 3.6 9.1 7.1 4.8 21.1 7.2 2.9 3.9 3.6 8.2 4.8 3.4 2.5 7.2 6.3 2.7 2.5 4.4 7.3 1.7 6.6 1.2 2.0 4.1 3.4 0.7 0.3 0.9 0.2 5.3 2.0 0.5 0.5 4.0 13.1 3.9 4.2 2.5 5.3 3.5 4.7 5.8 11.1 3.4 2.4 0.0 3.7 3.9 3.8 2.8 7.2 3.8 6.5 0.0 4.3 1.0 3.3 0.7 6.7 0.7 1.3 4.4 3.4 2.6 0.3 5.3 5.8 0.2 3.0 3.6 5.0 2.2 2.6 0.4 7.6 1.4 3.0 1.4 3.8 0.0 3.8 5.8 5.8 5.5 3.8 1.1 0.4 4.9 3.3 1.8 5.9 1.5 4.0 2.2 3.3 1.9 4.8 0.0 3.6 0.9 2.4 0.9 0.2 0.2 1.0 0.1 0.9 0.4 1.1 2.0 0.1 0.7 1.3 1.7 0.7 5.3 0.1 0.3 1.6 0.5 8.6 13.0 15.3 20.6 8.9 12.5 7.2 12.7 21.1 7.3 6.0 1.0 0.0 1.0 1.5 11.3 7.0 2.5 0.0 1.2 3.5 11.8 3.3 6.6 1.2 0.0 2.1 0.5 0.0 0.7 0.8 2.5 1.7 0.0 1.0 1.1 3.2 4.6 3.7 2.1 0.4 2.6 0.0 0.0 1.0 0.6 11.0 0.2 0.0 2.5 1.7 6.0 6.5 1.0 3.9 6.5 1.0 1.1 0.0 1.1 0.6 BHLHE41 "BHLHB3, bHLHe41, DEC2, SHARP-1, SHARP1" ENSG00000123095 "Basic helix-loop-helix family member e41" Q9C0J9 12 26120026-26125127 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 58.9" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 333.3;Cone photoreceptor cells: 172.8;Horizontal cells: 236.8;Muller glia cells: 283.4;Rod photoreceptor cells: 289.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 35 "memory B-cell: 5.3;naive B-cell: 1.6" "Lineage enriched" "Detected in single" 54 "B-cells: 5.3" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 33.8;Karpas-707: 14.3;RT4: 44.7;U-266/70: 19.2;U-87 MG: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056035, HPA077617" Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA056035: AB_2683017, HPA077617: " "unprognostic (1.57e-3)" "unprognostic (1.57e-2)" "unprognostic (2.32e-2)" "unprognostic (6.62e-2)" "unprognostic (2.18e-1)" "unprognostic (2.29e-1)" "unprognostic (5.86e-2)" "unprognostic (2.59e-1)" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "unprognostic (1.16e-1)" "unprognostic (2.96e-2)" "prognostic unfavorable (8.73e-5)" "unprognostic (5.23e-2)" "unprognostic (1.65e-1)" "unprognostic (5.61e-3)" "prognostic favorable (1.09e-4)" 7.0 11.7 23.8 5.8 32.3 1.2 10.7 22.9 26.9 30.6 7.6 33.3 3.0 2.8 6.9 15.6 3.2 34.5 14.1 14.7 25.9 19.6 3.8 1.4 9.1 6.0 38.9 14.0 10.9 6.4 6.2 11.2 8.3 28.3 8.2 9.1 19.0 13.4 11.7 58.9 3.8 4.3 4.3 49.6 6.2 4.4 4.0 44.0 0.9 43.6 6.4 13.3 16.5 6.7 5.3 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.1 0.0 7.6 3.5 1.7 0.8 1.3 0.1 0.5 0.0 4.8 0.0 0.7 1.5 11.4 4.0 0.1 0.6 0.4 0.0 0.6 0.3 0.0 0.0 0.3 1.9 0.1 0.5 0.4 2.8 5.5 33.8 0.0 0.0 0.0 14.3 0.8 0.4 0.0 1.3 3.7 1.3 2.8 0.0 0.6 10.9 1.8 44.7 0.0 0.0 0.5 0.2 10.1 0.2 0.0 0.0 2.3 2.6 3.1 0.3 2.0 19.2 11.0 0.0 16.5 1.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 32.3 22.9 26.9 25.9 19.6 38.9 14.0 28.3 44.0 0.0 0.6 22.9 50.0 5.4 333.3 33.5 33.1 42.8 10.3 27.9 172.8 22.2 0.0 35.8 0.2 4.8 10.8 0.0 19.8 2.4 18.8 38.9 5.7 0.0 71.2 236.8 12.6 3.1 2.7 0.4 27.9 35.2 13.5 47.7 3.0 283.4 13.9 5.7 25.1 2.1 289.4 6.5 6.6 0.5 0.4 2.9 5.9 0.0 3.3 52.5 BHMG1 HMGDC ENSG00000237452 "Basic helix-loop-helix and HMG-box containing 1" C9JSJ3 19 45733251-45764534 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 33 "testis: 17.8" "Group enriched" "Detected in some" 15 "Spermatocytes: 24.2;Spermatogonia: 22.0" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Daudi: 3.5;K-562: 8.3" "Not detected" "Not detected" HPA049521 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA049521: AB_2680803" "unprognostic (4.15e-2)" "unprognostic (2.97e-2)" "unprognostic (2.64e-1)" "unprognostic (1.53e-1)" "unprognostic (8.33e-2)" "unprognostic (6.29e-2)" "unprognostic (1.70e-3)" "unprognostic (3.31e-2)" "unprognostic (3.34e-1)" "unprognostic (1.15e-2)" "unprognostic (1.08e-1)" "unprognostic (6.53e-12)" "unprognostic (2.29e-1)" "unprognostic (1.07e-1)" "unprognostic (6.11e-3)" "unprognostic (1.87e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.3 0.0 3.5 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 8.3 0.3 0.0 1.3 0.0 0.4 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.3 0.9 0.4 0.2 0.4 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 24.2 22.0 0.0 0.0 0.0 0.0 0.0 BICDL1 "BICDR-1, CCDC64, FLJ26450" ENSG00000135127 "BICD family like cargo adaptor 1" Q6ZP65 12 119989869-120094494 "Predicted intracellular proteins" "Neurogenesis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 29.9;skin 1: 20.5" "Group enriched" "Detected in some" 6 "Collecting duct cells: 12.2;Distal tubular cells: 19.9;Proximal tubular cells: 20.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTCEpi: 27.4;MCF7: 14.8;SCLC-21H: 17.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061116 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA061116: AB_2684433" "unprognostic (2.17e-1)" "prognostic favorable (6.50e-4)" "unprognostic (1.68e-3)" "unprognostic (3.05e-2)" "unprognostic (6.81e-4)" "prognostic favorable (3.15e-4)" "prognostic unfavorable (6.84e-4)" "unprognostic (5.11e-2)" "unprognostic (3.18e-2)" "unprognostic (4.63e-2)" "unprognostic (3.31e-3)" "unprognostic (7.26e-2)" "prognostic favorable (3.93e-5)" "prognostic favorable (1.21e-5)" "unprognostic (1.36e-1)" "unprognostic (1.03e-1)" "unprognostic (2.15e-1)" 4.0 0.8 2.7 3.8 2.3 0.7 0.9 11.9 6.5 0.8 0.9 1.3 0.0 16.5 7.5 0.7 1.4 0.0 3.1 5.1 29.9 0.5 0.7 8.7 1.5 0.0 1.1 1.2 18.4 0.1 0.9 1.0 1.4 0.1 0.0 20.5 1.1 0.0 0.7 2.3 8.6 8.0 6.3 6.0 1.2 3.5 0.5 0.1 0.9 0.8 0.2 3.4 0.7 1.8 5.7 0.3 0.0 0.5 0.0 7.0 0.0 0.0 0.0 0.0 5.1 3.2 9.0 2.4 0.0 5.1 4.3 0.7 0.9 0.0 0.6 0.9 0.0 2.5 9.8 0.0 1.1 9.5 0.0 27.4 0.0 0.3 0.0 0.0 7.8 0.3 1.1 0.0 14.8 6.4 0.1 11.7 13.6 2.7 0.7 0.5 2.4 3.5 4.6 17.3 1.2 2.0 5.4 1.4 3.0 12.4 4.5 0.0 0.1 1.6 0.0 0.1 2.3 8.7 3.5 0.3 1.3 0.9 0.9 0.0 0.0 3.4 0.0 1.3 0.5 3.4 2.9 0.0 0.5 2.6 2.0 0.0 0.2 0.8 0.1 0.6 0.7 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 12.2 0.0 0.5 19.9 0.8 0.0 0.0 0.0 0.0 2.9 0.6 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.7 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 BICRA GLTSCR1 ENSG00000063169 "BRD4 interacting chromatin remodeling complex associated protein" Q9NZM4 19 47608196-47703277 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 6.2;Collecting duct cells: 7.0;Syncytiotrophoblasts: 4.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056211 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA056211: AB_2683068" "unprognostic (2.36e-1)" "unprognostic (1.27e-1)" "unprognostic (1.41e-2)" "unprognostic (9.58e-2)" "unprognostic (7.75e-2)" "prognostic favorable (1.34e-4)" "unprognostic (8.38e-2)" "unprognostic (1.36e-1)" "unprognostic (1.42e-1)" "unprognostic (1.47e-2)" "unprognostic (1.56e-3)" "unprognostic (2.21e-3)" "prognostic unfavorable (1.82e-4)" "unprognostic (9.72e-2)" "unprognostic (7.98e-2)" "unprognostic (1.61e-1)" "prognostic favorable (9.34e-4)" 12.6 8.5 11.3 14.0 12.4 12.0 10.8 19.6 13.1 13.7 12.5 16.7 8.2 15.2 17.0 7.9 10.8 14.4 10.1 9.9 11.4 5.9 7.2 7.6 10.6 11.5 13.8 12.4 16.5 7.6 17.4 9.5 12.7 9.3 13.0 10.4 8.7 11.0 12.8 30.4 14.0 12.1 15.4 11.5 10.5 9.9 7.1 12.7 12.4 11.9 4.2 9.6 14.9 13.8 0.6 1.6 1.8 0.6 0.1 0.9 0.1 7.4 8.1 16.2 11.9 8.6 8.8 8.0 6.8 6.8 9.0 6.3 8.7 4.8 8.5 3.6 9.4 7.0 7.6 10.7 5.3 9.7 8.1 6.8 5.2 5.8 4.2 10.8 6.2 8.7 7.2 7.9 9.9 8.9 7.3 9.1 7.8 7.8 10.9 5.5 5.9 9.9 15.1 10.6 11.0 6.4 10.4 5.5 2.3 3.6 5.4 9.1 11.3 17.4 10.1 4.5 14.3 4.2 4.8 9.8 7.0 12.8 5.2 9.4 7.5 14.1 8.8 1.3 4.2 9.6 0.2 0.6 1.6 0.3 0.0 0.1 0.1 0.2 0.2 0.6 0.6 0.9 0.2 1.8 0.1 0.2 1.6 0.2 0.1 11.3 12.4 19.6 13.1 11.4 5.9 13.8 12.4 9.3 12.7 8.9 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 7.0 0.0 3.7 0.0 2.8 0.0 0.0 0.0 0.0 3.3 3.1 0.0 0.0 1.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 2.8 0.0 0.0 3.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 BICRAL "GLTSCR1L, KIAA0240" ENSG00000112624 "BRD4 interacting chromatin remodeling complex associated protein like" Q6AI39 6 42746958-42868560 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 6.5;Ciliated cells: 5.3;Club cells: 7.9;Hofbauer cells: 4.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029390, HPA029391" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA029390: AB_10599730, HPA029391: AB_10599949" "unprognostic (2.30e-1)" "unprognostic (1.76e-1)" "unprognostic (2.15e-2)" "unprognostic (3.46e-2)" "unprognostic (9.25e-2)" "prognostic favorable (5.47e-4)" "unprognostic (2.74e-1)" "unprognostic (6.17e-2)" "unprognostic (1.52e-1)" "unprognostic (2.04e-2)" "unprognostic (1.55e-1)" "unprognostic (7.24e-2)" "unprognostic (1.54e-3)" "unprognostic (4.71e-2)" "unprognostic (2.60e-1)" "unprognostic (1.29e-1)" "unprognostic (6.54e-2)" 12.7 7.1 9.8 11.0 10.9 8.3 12.1 39.6 14.4 12.6 10.6 16.3 10.0 7.2 14.6 9.8 8.0 13.0 8.8 8.4 8.5 9.2 7.7 6.8 9.3 17.5 9.1 12.0 20.9 9.8 17.5 16.2 6.2 10.7 11.8 11.9 17.1 10.6 10.7 9.8 12.8 10.1 12.1 9.6 12.2 9.0 10.5 10.3 17.1 14.0 6.3 14.6 13.4 11.4 2.8 1.4 7.5 1.6 2.9 4.5 1.1 5.0 4.0 3.6 5.8 7.5 8.8 3.2 4.5 4.6 4.0 3.1 1.8 3.6 11.7 4.1 7.5 6.2 4.0 3.5 4.6 6.6 8.7 2.2 8.2 4.0 5.1 4.0 6.9 7.5 5.3 9.0 3.9 7.2 7.6 4.1 7.0 7.8 10.5 4.7 6.0 1.1 4.0 4.0 19.8 2.5 7.2 2.1 11.6 4.0 3.3 12.4 6.6 5.0 7.3 5.1 3.7 6.4 8.2 4.7 5.6 5.6 3.6 4.4 9.6 5.5 18.0 3.3 8.9 3.9 3.9 1.1 5.1 4.5 0.8 4.0 2.5 2.8 4.4 0.9 2.8 2.7 3.3 7.5 2.9 1.6 1.4 3.1 1.1 9.8 10.9 39.6 14.4 8.5 9.2 9.1 12.0 10.7 10.3 8.9 6.5 0.0 0.0 0.0 0.0 0.0 0.0 5.3 7.9 3.5 0.0 1.5 0.0 3.3 0.0 0.0 0.0 0.0 3.3 1.6 0.0 0.0 1.1 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 2.8 0.0 0.0 3.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 BIRC2 "API1, c-IAP1, cIAP1, hiap-2, MIHB, RNF48" ENSG00000110330 "Baculoviral IAP repeat containing 2" Q13490 11 102347211-102378670 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA005513, CAB020661" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center, Cytosol" Nucleoplasm "CAB020661: , HPA005513: AB_1846746" "unprognostic (1.36e-1)" "unprognostic (3.29e-1)" "unprognostic (9.52e-3)" "unprognostic (1.62e-1)" "unprognostic (1.37e-1)" "unprognostic (7.02e-2)" "unprognostic (2.72e-2)" "unprognostic (1.04e-2)" "unprognostic (1.17e-2)" "unprognostic (9.59e-2)" "unprognostic (1.05e-2)" "unprognostic (3.02e-2)" "unprognostic (1.84e-2)" "unprognostic (1.07e-1)" "unprognostic (9.20e-2)" "unprognostic (5.00e-2)" "unprognostic (1.64e-2)" 20.9 25.8 19.1 23.3 24.1 25.9 57.0 20.5 28.5 25.1 22.2 18.4 18.7 19.3 24.6 31.1 18.6 17.0 21.1 39.2 19.1 18.3 24.3 36.8 34.0 47.2 23.3 15.8 21.5 40.8 22.0 27.3 24.3 22.3 19.6 22.2 14.3 21.9 22.1 38.8 17.3 24.4 23.8 26.3 27.6 19.0 19.7 15.5 51.2 18.9 17.3 21.9 22.2 20.2 5.8 12.6 37.5 16.6 12.2 12.0 9.8 9.8 7.3 11.3 8.8 14.3 19.9 7.2 38.3 14.6 22.0 13.4 9.1 24.6 10.9 37.9 17.5 12.3 10.9 7.3 10.1 26.4 14.5 3.7 10.9 5.4 11.0 14.6 6.6 7.0 12.7 19.7 12.5 16.1 20.3 15.0 6.6 9.8 0.0 39.5 3.1 6.9 5.8 5.4 11.8 7.1 3.5 14.7 7.2 17.0 11.4 4.7 6.2 13.3 8.1 11.4 18.1 12.8 8.0 24.6 46.5 10.5 14.0 24.6 4.5 6.1 7.4 10.0 8.3 33.8 31.7 16.6 37.5 9.1 15.2 7.5 5.8 8.7 8.4 12.6 5.6 11.3 11.3 25.5 12.2 16.3 7.6 12.0 9.8 19.1 24.1 20.5 28.5 19.1 18.3 23.3 15.8 22.3 15.5 38.7 40.9 33.3 88.5 59.6 24.1 51.6 63.7 60.2 44.3 61.1 27.5 32.6 36.5 42.3 11.1 49.4 69.1 23.3 63.8 22.6 51.4 66.2 61.2 138.2 36.5 19.1 46.6 67.5 96.7 7.4 33.6 60.1 49.0 85.6 48.7 27.5 44.2 49.9 27.3 66.5 29.1 25.8 53.9 31.1 41.3 54.8 29.4 45.8 37.3 65.0 BIRC3 "API2, c-IAP2, cIAP2, hiap-1, MALT2, MIHC, RNF49" ENSG00000023445 "Baculoviral IAP repeat containing 3" Q13489 11 102317450-102339403 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 46.0;lymphoid tissue: 46.3" "Cell type enhanced" "Detected in many" 16 "granulocytes: 530.1;monocytes: 1925.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory B-cell: 32.9;naive B-cell: 32.9" "Group enriched" "Detected in many" 10 "B-cells: 32.9;T-cells: 17.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 38.4;Daudi: 33.7;HDLM-2: 31.9;hTERT-HME1: 33.6;U-266/70: 22.5;U-266/84: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002317 Enhanced Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA002317: AB_1846748" "prognostic favorable (3.60e-4)" "unprognostic (2.89e-1)" "prognostic favorable (9.35e-4)" "unprognostic (3.28e-2)" "prognostic unfavorable (7.28e-4)" "unprognostic (5.83e-3)" "unprognostic (2.23e-1)" "unprognostic (3.88e-3)" "unprognostic (9.62e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (3.03e-4)" "unprognostic (3.21e-1)" "prognostic unfavorable (6.66e-6)" "unprognostic (6.42e-2)" "unprognostic (6.23e-3)" "unprognostic (1.00e-1)" "unprognostic (3.85e-2)" 6.9 3.3 1.4 43.9 2.3 5.1 5.4 0.5 2.0 5.3 13.1 0.5 2.8 6.8 2.9 3.7 8.4 3.9 13.9 6.0 2.2 1.3 10.8 12.5 21.8 46.3 2.8 1.2 3.4 7.0 1.1 14.5 0.9 2.2 8.7 6.2 1.1 9.2 4.7 2.2 5.5 46.0 7.3 3.0 34.9 15.9 3.2 2.7 34.2 3.0 4.1 34.0 12.6 6.2 32.9 0.8 2.0 2.6 2.5 17.1 2.8 6.5 5.3 0.0 0.1 0.1 0.7 0.6 0.5 4.4 0.6 0.7 0.9 38.4 33.7 17.4 0.3 5.5 3.6 0.0 0.9 2.1 31.9 0.1 0.1 1.6 0.2 6.6 0.5 0.7 0.7 4.7 2.1 33.6 1.2 0.1 2.7 0.1 0.0 0.8 0.0 2.3 0.3 0.1 3.1 0.2 0.0 0.3 1.7 8.7 3.4 0.0 0.1 0.5 0.6 0.3 0.2 1.7 0.3 1.7 7.3 0.8 0.4 6.7 22.5 19.2 11.9 1.3 1.9 0.9 2.0 0.9 0.4 1.4 2.2 2.5 32.9 10.7 3.5 0.8 32.9 7.5 2.2 0.5 2.5 2.6 0.3 17.1 2.8 1.4 2.3 0.5 2.0 2.2 1.3 2.8 1.2 2.2 2.7 134.0 68.1 285.1 318.0 89.9 0.3 12.0 76.5 30.8 73.9 38.4 0.0 1.7 6.6 193.4 1.3 50.1 284.0 46.7 153.8 0.5 71.9 371.3 530.1 3.4 11.1 0.0 14.5 7.4 18.1 1.3 4.6 71.9 182.2 1925.2 27.1 0.1 190.8 361.2 2.1 8.8 0.0 0.0 133.5 0.5 0.4 73.9 0.5 89.3 29.9 164.7 BIRC7 "KIAP, ML-IAP, mliap, RNF50" ENSG00000101197 "Baculoviral IAP repeat containing 7" Q96CA5 20 63235883-63240507 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Protease inhibitor, Thiol protease inhibitor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 14.4;placenta: 13.6;retina: 21.1" "Group enriched" "Detected in some" 5 "Hofbauer cells: 56.9;Melanocytes: 25.3;Muller glia cells: 46.0" "Cancer enriched" "Detected in many" 10 "melanoma: 73.7" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 9 "T-cells: 2.0" "Cell line enriched" "Detected in some" 4 "SK-MEL-30: 63.7" "Not detected" "Not detected" "HPA047850, HPA061283" Enhanced Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA047850: AB_2680181, HPA061283: " "unprognostic (3.60e-1)" "unprognostic (7.94e-2)" "unprognostic (2.70e-2)" "unprognostic (1.78e-3)" "unprognostic (1.15e-1)" "unprognostic (8.11e-2)" "unprognostic (1.69e-2)" "unprognostic (1.12e-1)" "unprognostic (1.62e-3)" "unprognostic (1.24e-2)" "unprognostic (6.90e-2)" "unprognostic (2.27e-1)" "unprognostic (8.82e-3)" "unprognostic (1.22e-2)" "unprognostic (4.77e-2)" "unprognostic (2.55e-2)" "unprognostic (4.84e-2)" 1.6 1.3 1.0 0.7 1.0 0.3 0.7 0.1 2.2 3.0 1.3 0.5 0.1 0.4 0.8 14.4 0.3 0.3 0.5 2.8 0.9 1.1 2.6 0.8 2.3 2.2 4.9 1.0 0.2 0.1 0.1 0.6 13.6 1.5 0.4 0.3 21.1 0.8 0.1 0.1 4.9 0.3 0.2 4.3 1.6 0.3 0.4 0.3 0.3 0.3 1.0 0.5 0.4 1.8 0.0 0.0 0.0 0.2 0.0 2.0 0.1 0.1 1.4 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 2.2 0.4 0.0 6.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 63.7 1.6 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 1.0 0.1 2.2 0.9 1.1 4.9 1.0 1.5 0.3 0.0 0.6 0.0 0.0 1.1 0.0 0.6 0.0 0.0 0.0 1.8 0.0 1.4 0.0 0.6 0.1 0.0 0.0 0.0 0.6 8.2 0.5 0.0 2.3 0.0 56.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.3 0.0 0.0 46.0 2.3 0.0 0.0 1.1 0.8 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 BIVM FLJ20159 ENSG00000134897 "Basic, immunoglobulin-like variable motif containing" Q86UB2 13 102799049-102841535 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 3.6;NK-cells: 6.3;T-cells: 4.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050126 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA050126: AB_2681027" "unprognostic (8.86e-2)" "unprognostic (1.02e-1)" "unprognostic (3.55e-1)" "unprognostic (2.77e-1)" "unprognostic (1.19e-2)" "unprognostic (1.83e-3)" "unprognostic (1.37e-1)" "unprognostic (1.00e-1)" "unprognostic (1.91e-2)" "unprognostic (1.30e-1)" "unprognostic (6.89e-3)" "unprognostic (6.66e-2)" "unprognostic (1.97e-1)" "unprognostic (2.79e-2)" "unprognostic (2.73e-1)" "unprognostic (7.29e-2)" "unprognostic (3.33e-2)" 6.8 7.6 10.8 3.3 15.6 3.4 9.6 32.3 16.9 9.2 6.9 6.9 10.5 6.8 10.1 14.3 5.6 7.7 6.9 18.7 10.9 8.4 17.7 17.6 6.4 4.5 9.3 10.8 10.1 10.3 6.4 10.7 7.4 10.4 8.7 8.2 6.3 6.7 9.8 16.9 8.3 6.7 8.8 7.1 7.0 8.9 2.2 9.8 4.3 8.4 7.4 3.6 6.7 6.3 0.6 1.2 3.6 0.4 6.3 4.9 0.9 7.5 2.4 9.0 10.4 11.6 17.9 2.1 9.1 9.2 5.7 6.4 2.7 3.4 0.0 4.1 8.7 4.3 5.2 7.3 7.2 8.1 6.9 9.1 6.4 6.8 4.6 10.4 7.2 11.2 14.4 9.2 3.1 10.2 13.8 8.6 10.4 6.9 0.0 11.7 1.6 8.2 9.4 2.1 10.6 6.4 0.0 4.3 3.2 26.3 3.2 14.0 12.1 3.7 4.3 5.9 3.7 6.9 9.9 6.2 7.3 1.9 5.4 5.5 6.0 2.7 0.0 9.3 0.0 12.7 3.6 0.4 0.8 2.4 0.2 4.9 0.5 1.4 3.1 1.2 0.6 0.9 2.1 0.4 6.3 0.1 0.5 1.2 0.9 10.8 15.6 32.3 16.9 10.9 8.4 9.3 10.8 10.4 9.8 8.9 10.9 3.0 3.0 3.3 15.7 24.6 12.7 8.1 13.6 17.4 13.7 6.3 24.9 4.5 0.2 11.7 5.2 0.0 4.8 5.9 11.4 4.1 5.8 26.7 5.7 22.3 20.9 19.6 5.2 0.2 12.7 4.2 3.3 1.0 16.5 7.7 4.7 10.5 10.6 25.2 11.5 19.4 9.5 0.5 8.7 4.3 2.1 10.1 15.1 2.6 BIVM-ERCC5 ENSG00000270181 "BIVM-ERCC5 readthrough" 13 102799110-102875994 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 10.6" "Group enriched" "Detected in some" 28 "Alveolar cells type 2: 2.9;Ciliated cells: 1.4;Club cells: 4.5;granulocytes: 2.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "MAIT T-cell: 2.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 3.0;HEK 293: 12.2;HeLa: 5.2;PC-3: 6.7;SCLC-21H: 3.4" "HPA045845, HPA050126, HPA050374" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA045845: AB_2679471, HPA050126: AB_2681027, HPA050374: AB_2681106" "unprognostic (6.01e-2)" 1.0 1.0 2.7 3.7 4.5 1.1 1.4 10.6 5.7 1.0 2.9 1.3 2.6 1.0 2.1 1.1 1.0 2.6 1.0 1.9 2.7 3.2 2.4 2.3 1.5 2.2 2.7 1.0 1.9 1.0 2.7 1.3 2.6 2.0 1.0 1.1 1.0 2.7 1.0 1.0 1.0 2.6 0.6 1.8 2.6 1.2 2.3 0.3 1.7 1.5 1.0 1.0 1.0 0.0 2.8 0.0 1.4 1.3 2.9 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.7 0.0 0.1 0.6 0.0 3.0 0.3 0.0 0.0 0.0 12.2 0.0 5.2 0.0 0.5 2.5 0.0 0.0 0.4 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.4 0.1 3.4 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.4 0.8 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.1 0.6 2.9 0.0 0.7 1.0 2.8 0.0 0.2 0.1 0.0 1.3 0.0 0.0 0.3 1.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 1.4 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BLK MGC10442 ENSG00000136573 "BLK proto-oncogene, Src family tyrosine kinase" P51451 8 11486894-11564604 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "blood: 47.8;intestine: 23.5;lymphoid tissue: 39.8" "Cell type enriched" "Detected in some" 52 "B-cells: 93.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory B-cell: 47.8;naive B-cell: 33.9" "Lineage enriched" "Detected in many" 5 "B-cells: 47.8" "Cell line enhanced" "Detected in some" "Daudi: 44.0;REH: 11.9;RPMI-8226: 14.5;U-698: 21.5;U-87 MG: 9.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB005093, HPA069571" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "CAB005093: AB_2274756, HPA069571: AB_2732137" "unprognostic (6.50e-5)" "unprognostic (4.22e-3)" "unprognostic (5.64e-2)" "unprognostic (1.42e-1)" "unprognostic (3.45e-1)" "unprognostic (5.98e-6)" "unprognostic (1.59e-2)" "unprognostic (8.94e-4)" "unprognostic (1.02e-3)" "unprognostic (9.83e-3)" "unprognostic (1.22e-2)" "unprognostic (4.66e-2)" "unprognostic (9.05e-6)" "unprognostic (5.62e-2)" "unprognostic (5.43e-2)" "unprognostic (2.19e-1)" "unprognostic (1.16e-1)" 0.5 0.2 0.1 32.3 0.1 1.7 0.2 0.1 0.1 0.1 1.2 0.0 0.0 0.3 0.1 0.0 1.9 0.2 0.4 0.3 0.1 0.1 1.3 0.5 0.6 27.6 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.4 0.4 0.3 2.4 0.0 0.1 0.1 23.5 0.0 0.1 31.9 1.4 0.2 0.0 3.9 0.7 0.4 39.8 2.5 0.4 47.8 4.3 0.1 0.0 0.0 9.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 11.9 0.0 14.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.3 3.8 21.5 9.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 9.8 47.8 0.3 1.1 0.0 33.9 0.2 0.1 0.1 0.0 0.0 4.3 0.4 1.9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 93.8 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BLM "BS, RECQ2, RECQL3" ENSG00000197299 "Bloom syndrome RecQ like helicase" P54132 15 90717327-90816165 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 36.7" "Cell type enhanced" "Detected in many" 6 "B-cells: 18.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005689 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005689: AB_1845372" "unprognostic (2.77e-1)" "unprognostic (3.82e-3)" "unprognostic (4.03e-2)" "unprognostic (2.98e-2)" "unprognostic (4.75e-2)" "unprognostic (9.89e-2)" "unprognostic (6.12e-5)" "unprognostic (2.82e-2)" "unprognostic (4.55e-3)" "unprognostic (5.24e-3)" "unprognostic (1.80e-3)" "unprognostic (9.12e-2)" "unprognostic (1.55e-15)" "unprognostic (6.53e-3)" "unprognostic (6.55e-2)" "unprognostic (2.43e-1)" "unprognostic (1.83e-2)" 1.8 0.4 3.1 11.4 1.5 5.5 0.6 4.7 2.6 0.7 1.9 0.9 0.5 1.4 1.2 1.1 2.9 0.4 1.3 1.0 2.3 2.4 0.9 0.5 2.0 7.7 2.8 0.2 0.9 0.4 0.0 1.2 3.6 0.5 0.7 2.5 0.7 7.8 0.0 1.7 0.6 2.8 0.5 1.9 6.7 1.4 4.9 0.5 36.7 0.6 3.1 9.3 1.4 0.7 7.4 1.2 4.3 1.6 4.6 5.0 1.6 5.5 7.8 8.8 5.1 0.0 0.4 5.5 4.1 1.2 4.7 5.1 6.9 3.9 14.2 2.6 1.1 5.9 9.2 13.5 3.7 6.1 8.6 10.0 14.9 8.5 2.2 0.0 14.3 7.4 0.0 0.0 4.7 2.4 0.6 3.3 7.7 12.8 4.4 4.9 3.4 10.7 7.8 9.3 12.1 1.7 10.9 16.5 5.5 1.1 9.9 6.5 6.1 3.3 4.5 2.6 8.6 3.1 11.7 1.8 3.4 6.3 3.5 8.8 3.3 13.2 14.8 1.9 10.1 5.9 2.5 1.0 4.3 3.1 1.2 4.8 7.4 2.8 3.8 1.2 4.3 2.0 2.2 0.8 4.6 1.6 1.2 5.0 1.6 3.1 1.5 4.7 1.7 2.3 2.4 2.8 0.2 0.5 0.5 3.0 12.8 18.6 0.5 0.2 2.9 8.4 0.0 9.4 6.8 0.0 2.0 1.8 1.7 0.9 2.0 0.7 0.0 0.0 0.6 6.5 1.5 0.6 12.7 0.5 4.8 0.0 0.0 2.5 9.7 1.6 0.0 3.8 0.0 1.0 1.2 1.2 0.8 0.0 0.4 0.0 6.5 0.0 0.4 12.0 11.8 0.5 0.8 8.7 2.3 0.3 BLMH BH ENSG00000108578 "Bleomycin hydrolase" Q13867 17 30248195-30292056 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 67.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039548, HPA064307" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No 59000000 "Nucleoplasm, Nuclear bodies, Cytosol" "HPA039548: AB_10805479, HPA064307: AB_2685241" "unprognostic (6.85e-2)" "unprognostic (2.79e-1)" "unprognostic (1.48e-1)" "unprognostic (2.46e-1)" "unprognostic (1.76e-1)" "unprognostic (2.54e-2)" "unprognostic (3.91e-3)" "unprognostic (2.07e-1)" "unprognostic (2.05e-3)" "unprognostic (6.69e-3)" "unprognostic (1.95e-3)" "unprognostic (2.14e-2)" "unprognostic (2.14e-2)" "unprognostic (1.22e-3)" "unprognostic (1.05e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-1)" 11.2 8.3 9.0 17.1 10.2 8.5 14.2 12.1 14.5 10.5 9.8 8.5 9.6 6.7 13.1 12.2 15.7 8.4 10.1 9.7 7.5 7.2 13.6 7.5 13.6 20.3 9.5 8.5 8.8 15.3 15.0 8.3 14.6 9.2 8.4 8.5 7.3 12.8 9.5 15.0 67.5 10.0 15.7 11.1 13.2 9.2 12.4 8.6 24.7 9.3 15.5 13.6 10.8 11.7 4.6 6.6 0.9 5.7 9.8 17.3 6.3 10.2 16.2 15.6 10.8 10.7 11.5 7.6 9.5 5.9 15.1 13.0 23.7 3.0 30.4 17.0 7.7 6.8 7.1 33.8 13.0 12.8 8.0 26.6 18.6 14.5 20.1 15.7 33.9 11.5 13.6 0.9 11.8 6.8 12.4 22.1 25.5 39.7 12.4 6.2 7.7 42.0 24.8 15.0 0.0 7.6 36.4 40.6 20.1 12.0 9.1 36.1 12.9 8.4 16.5 10.4 28.2 11.2 17.5 14.0 9.3 18.8 4.1 16.8 15.0 30.9 41.1 7.1 0.0 12.4 0.0 5.7 0.9 10.5 3.9 17.3 4.6 12.6 13.7 6.5 4.2 11.6 12.3 0.7 9.8 1.9 6.6 12.4 6.3 9.0 10.2 12.1 14.5 7.5 7.2 9.5 8.5 9.2 8.6 3.0 13.0 12.3 14.0 14.2 18.2 16.5 12.7 6.7 2.3 10.4 11.8 41.1 6.6 14.9 8.2 17.9 8.9 0.0 12.2 31.7 13.3 8.5 43.8 6.6 22.1 12.7 17.2 28.3 21.8 5.2 15.0 10.4 10.1 10.0 7.6 10.9 8.9 8.6 23.3 17.0 16.0 6.5 15.3 9.7 16.7 11.0 23.0 18.7 10.7 5.9 BLVRB "FLR, SDR43U1" ENSG00000090013 "Biliverdin reductase B" P30043 19 40447765-40465840 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 137.6" "Cell type enhanced" "Detected in all" 13 "Erythroid cells: 2523.0;Hofbauer cells: 895.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "classical monocyte: 73.4" "Group enriched" "Detected in all" 7 "dendritic cells: 54.8;monocytes: 73.4" "Cell line enhanced" "Detected in many" "A549: 81.2;K-562: 73.7;OE19: 64.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041698, HPA041937" Enhanced Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" No No 440000000 Cytosol "Nucleoplasm, Vesicles, Plasma membrane" "HPA041698: AB_10796781, HPA041937: AB_10794308" "unprognostic (1.86e-1)" "unprognostic (1.14e-2)" "unprognostic (4.23e-1)" "unprognostic (1.50e-1)" "unprognostic (2.08e-1)" "unprognostic (2.46e-1)" "unprognostic (9.92e-2)" "unprognostic (1.20e-2)" "unprognostic (8.56e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (3.90e-4)" "unprognostic (2.30e-1)" "unprognostic (2.70e-1)" "unprognostic (2.02e-1)" "unprognostic (5.11e-2)" "unprognostic (1.25e-1)" "unprognostic (3.92e-2)" 36.9 17.9 10.9 12.8 12.2 137.6 28.9 3.5 10.9 17.0 26.7 7.7 18.5 20.9 14.1 19.6 45.3 14.6 19.0 31.0 8.2 8.6 31.8 72.4 37.3 30.0 11.7 9.6 21.3 19.4 5.7 5.6 32.2 13.8 22.9 7.7 17.5 27.1 22.1 43.4 16.7 26.4 22.1 9.7 47.1 31.1 7.6 7.9 6.6 24.3 42.9 24.4 29.9 22.1 8.6 54.8 9.1 73.4 4.0 5.3 34.4 34.2 81.2 1.1 12.1 11.3 10.9 9.6 4.3 12.7 5.9 11.5 15.9 31.1 11.5 33.5 7.7 19.2 11.0 4.1 9.4 1.2 19.5 3.5 17.5 12.2 9.6 26.1 0.2 5.1 10.6 17.9 7.9 4.4 6.0 6.2 4.3 73.7 20.9 6.9 53.2 0.9 1.0 0.3 64.3 22.7 8.1 3.8 18.6 7.4 23.1 0.0 1.8 13.1 34.7 13.2 1.6 33.7 2.6 6.7 15.8 16.9 24.2 2.3 11.4 13.4 4.3 41.1 6.9 6.1 5.0 73.4 2.6 4.6 33.7 4.4 8.6 4.0 4.0 54.8 5.4 4.2 3.3 9.1 4.0 16.9 11.5 5.3 34.4 10.9 12.2 3.5 10.9 8.2 8.6 11.7 9.6 13.8 7.9 205.4 126.9 50.2 283.1 114.9 10.9 116.8 180.9 95.0 73.9 92.5 5.9 76.7 225.5 197.9 7.2 54.2 483.6 2523.0 231.2 82.2 103.0 212.9 41.6 520.7 895.0 9.5 43.0 55.9 549.4 16.6 115.1 152.9 136.7 94.6 130.3 62.8 228.4 480.5 88.4 302.1 11.3 32.3 73.1 2.1 3.6 114.0 62.5 43.7 144.8 253.2 BLZF1 JEM-1 ENSG00000117475 "Basic leucine zipper nuclear factor 1" Q9H2G9 1 169367970-169396540 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 111.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025703, HPA027331, HPA067113" Supported Supported "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA025703: AB_1845379, HPA027331: AB_1845380, HPA067113: AB_2685781" "unprognostic (5.25e-2)" "unprognostic (9.03e-2)" "unprognostic (9.31e-3)" "unprognostic (1.48e-2)" "unprognostic (4.66e-1)" "unprognostic (4.00e-1)" "unprognostic (2.34e-2)" "unprognostic (4.52e-3)" "unprognostic (1.07e-1)" "unprognostic (8.72e-2)" "unprognostic (1.81e-3)" "unprognostic (4.86e-2)" "prognostic unfavorable (2.33e-4)" "unprognostic (3.28e-1)" "unprognostic (3.06e-2)" "unprognostic (7.53e-2)" "unprognostic (2.18e-1)" 17.5 13.5 15.7 12.2 18.6 19.7 17.3 21.0 24.1 19.6 14.3 7.8 12.7 10.5 14.4 13.2 29.3 11.8 14.5 14.7 13.8 11.6 19.6 13.1 11.3 9.4 14.0 18.0 17.4 12.0 15.5 30.3 16.9 20.5 19.9 14.1 7.5 16.0 15.2 13.5 15.7 17.3 18.8 16.7 10.9 12.4 35.6 15.8 19.1 19.1 17.5 13.6 22.1 20.8 5.2 5.1 31.4 7.5 8.9 10.9 5.1 24.9 8.0 8.0 6.9 12.2 18.9 13.0 22.3 15.7 23.7 26.2 9.3 16.4 3.7 12.6 14.8 15.0 18.3 7.8 13.9 18.7 7.7 7.7 6.7 9.9 6.5 12.8 12.8 9.5 13.8 17.9 17.7 16.1 13.3 12.4 7.4 11.6 10.1 21.7 5.3 5.5 5.9 9.7 18.0 12.0 3.3 12.6 7.8 22.8 8.5 5.0 15.1 14.6 19.8 16.6 14.2 22.0 9.2 14.8 14.1 11.0 13.1 18.0 10.2 12.1 9.4 10.9 5.9 21.7 31.4 5.9 23.2 6.2 7.5 7.9 5.2 7.7 7.0 5.1 4.8 6.9 7.4 12.0 8.9 7.0 3.9 10.9 5.1 15.7 18.6 21.0 24.1 13.8 11.6 14.0 18.0 20.5 15.8 20.8 16.0 8.1 38.5 16.4 14.4 27.9 12.7 36.1 22.7 10.4 13.7 15.4 19.9 21.3 111.7 10.3 14.0 0.0 11.6 14.4 16.6 14.2 25.4 4.3 12.2 31.8 12.1 8.6 10.2 53.5 13.6 11.1 13.5 6.4 10.5 15.1 24.8 11.5 16.6 16.7 25.7 0.0 20.2 33.9 22.8 13.7 16.8 15.0 8.5 70.2 BMF FLJ00065 ENSG00000104081 "Bcl2 modifying factor" Q96LC9 15 40087890-40108892 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 81.0" "Cell type enhanced" "Detected in many" 5 "Exocrine glandular cells: 12.7;monocytes: 14.4;Pancreatic endocrine cells: 13.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 19.8;HMC-1: 22.4;hTERT-RPE1: 29.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010120 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA010120: AB_1845385" "unprognostic (2.94e-1)" "unprognostic (4.92e-3)" "unprognostic (7.63e-2)" "unprognostic (4.44e-1)" "unprognostic (1.89e-1)" "prognostic favorable (1.83e-4)" "prognostic unfavorable (6.32e-4)" "unprognostic (1.42e-2)" "unprognostic (4.26e-1)" "unprognostic (3.75e-1)" "unprognostic (5.15e-2)" "unprognostic (1.55e-1)" "unprognostic (7.06e-2)" "unprognostic (6.66e-2)" "unprognostic (1.26e-1)" "unprognostic (2.34e-2)" "unprognostic (2.35e-2)" 5.3 2.9 1.3 13.5 1.9 15.8 6.1 2.3 2.0 10.9 9.9 2.1 13.0 11.9 12.4 4.7 2.8 8.3 6.7 3.4 1.3 1.6 6.5 3.9 7.7 18.4 2.8 0.9 8.9 8.1 1.8 2.8 5.7 2.5 7.0 4.5 7.2 9.2 10.8 4.6 4.0 23.2 5.8 3.0 18.1 6.7 4.1 2.1 81.0 18.6 3.1 15.0 7.5 3.7 5.1 3.3 5.2 6.0 0.0 1.4 0.9 0.4 0.6 11.5 2.5 0.3 0.5 7.8 0.0 1.8 0.2 0.5 11.5 0.8 3.3 3.7 0.5 3.5 2.4 2.8 0.0 0.0 7.9 2.3 1.7 19.8 2.6 1.1 0.3 22.4 5.8 0.6 0.2 0.2 29.0 3.0 2.4 0.9 1.4 1.0 0.6 1.1 8.4 3.1 5.7 0.4 2.1 2.6 9.5 0.5 2.6 6.1 5.0 2.2 5.8 5.1 12.9 3.4 6.7 2.3 0.4 1.6 0.3 0.1 14.2 13.3 2.0 0.8 1.6 1.3 0.1 4.2 3.6 0.2 4.9 0.4 5.1 0.4 1.4 2.7 1.8 0.7 0.1 5.2 0.0 6.0 3.3 1.2 0.9 1.3 1.9 2.3 2.0 1.3 1.6 2.8 0.9 2.5 2.1 3.0 2.1 10.0 1.0 1.0 0.0 1.6 7.6 0.0 5.7 0.0 0.0 0.6 0.0 8.9 1.0 2.1 5.1 0.0 12.7 1.1 1.9 2.6 0.0 0.9 7.6 0.0 1.2 1.8 10.8 0.0 1.7 6.1 0.0 14.4 1.5 0.3 13.9 0.3 0.7 2.2 0.4 0.0 0.8 0.2 1.1 0.5 1.5 0.7 1.3 0.9 BMI1 "PCGF4, RNF51" ENSG00000168283 "BMI1 proto-oncogene, polycomb ring finger" P35226 10 22321211-22331484 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 132.9;Late spermatids: 118.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 89.1;U-937: 104.6" "CAB011120, HPA030471, HPA030472" Supported Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" "Nucleoli, Cytosol" "CAB011120: , HPA030471: AB_2673491, HPA030472: AB_10601090" "unprognostic (5.44e-1)" "unprognostic (2.98e-1)" "unprognostic (4.24e-2)" "unprognostic (4.37e-2)" "unprognostic (2.76e-3)" "unprognostic (6.93e-2)" "prognostic unfavorable (2.60e-8)" "unprognostic (9.43e-2)" "unprognostic (7.95e-2)" "unprognostic (7.84e-2)" "unprognostic (8.23e-2)" "unprognostic (1.56e-1)" "unprognostic (7.44e-2)" "unprognostic (9.73e-2)" "unprognostic (8.56e-2)" "unprognostic (7.91e-3)" "unprognostic (3.41e-2)" 19.7 23.5 28.0 17.0 35.0 13.3 26.5 26.1 33.7 21.6 22.3 26.3 11.6 14.1 23.9 22.8 16.0 17.0 17.4 15.1 28.3 24.2 19.2 25.5 16.7 17.9 42.3 27.7 18.8 18.6 40.0 37.6 20.6 24.8 25.5 16.0 16.5 15.7 20.3 28.5 10.3 14.6 26.3 34.8 24.6 16.5 24.3 40.7 12.9 17.6 10.6 18.8 21.5 25.9 5.0 1.8 13.0 3.4 6.2 8.4 2.4 13.0 6.3 7.3 2.2 12.8 10.3 7.3 8.8 4.0 6.7 8.0 6.6 16.3 6.7 6.0 8.0 7.5 4.6 10.5 6.2 8.4 89.1 13.1 18.4 5.4 7.4 7.6 6.8 10.2 6.6 10.9 7.4 8.2 8.5 4.7 10.8 18.2 11.3 8.9 5.2 18.2 2.0 1.7 6.1 15.1 13.6 10.4 6.4 6.4 4.2 6.1 12.1 5.8 7.6 9.8 3.3 6.9 27.3 10.1 7.5 22.7 18.1 11.8 14.0 18.2 14.7 10.7 104.6 4.9 13.0 1.5 2.5 6.1 3.4 8.4 5.0 6.4 5.8 1.0 2.6 5.5 5.2 0.6 6.2 2.1 1.8 4.3 2.4 28.0 35.0 26.1 33.7 28.3 24.2 42.3 27.7 24.8 40.7 23.8 20.0 13.4 18.4 14.2 21.3 16.1 10.2 16.0 25.0 12.2 7.9 10.9 11.6 14.2 132.9 25.3 4.2 0.0 15.8 17.8 14.4 26.4 11.5 25.2 8.6 28.6 12.7 28.3 19.0 118.0 33.4 13.9 35.4 17.2 12.0 12.6 17.8 5.8 34.3 7.6 13.9 19.4 37.7 10.4 24.3 12.8 5.6 18.3 9.5 17.6 BMP7 OP-1 ENSG00000101144 "Bone morphogenetic protein 7" P18075 20 57168748-57266629 "Predicted intracellular proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 37.0;thyroid gland: 44.3" "Cell type enhanced" "Detected in many" 16 "Cytotrophoblasts: 108.5;Muller glia cells: 38.0;Syncytiotrophoblasts: 47.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "basophil: 2.4" "Lineage enriched" "Detected in single" 13 "granulocytes: 2.4" "Cell line enhanced" "Detected in some" "Daudi: 42.0;MCF7: 48.6;OE19: 22.8;RPMI-8226: 18.6;SK-BR-3: 31.7;U-698: 57.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057757 Approved Nucleoplasm,Nucleoli,Vesicles "Secreted to blood" NA NA 248000 Vesicles "Nucleoplasm, Nucleoli" "HPA057757: AB_2683518" "unprognostic (1.67e-1)" "unprognostic (9.72e-3)" "unprognostic (9.67e-2)" "prognostic unfavorable (2.91e-4)" "unprognostic (2.62e-1)" "unprognostic (1.60e-1)" "unprognostic (1.16e-1)" "unprognostic (1.01e-1)" "unprognostic (6.78e-2)" "unprognostic (4.63e-3)" "unprognostic (4.03e-2)" "unprognostic (1.09e-2)" "unprognostic (3.82e-2)" "unprognostic (4.30e-2)" "unprognostic (1.21e-1)" "unprognostic (5.42e-2)" "unprognostic (1.59e-1)" 1.5 7.2 16.8 2.4 17.5 0.7 2.1 3.8 19.7 9.2 2.3 23.6 6.0 2.7 1.9 17.7 17.2 10.0 1.2 8.5 13.9 9.9 4.5 0.7 1.8 1.6 14.3 11.2 0.8 1.0 0.8 1.9 24.4 12.2 5.0 2.4 37.0 2.6 10.3 1.0 15.5 2.4 1.0 13.8 1.3 4.1 1.4 13.4 1.8 44.3 5.7 4.9 7.8 7.0 0.1 0.1 2.4 0.0 0.0 0.1 0.0 0.0 0.1 5.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 1.7 42.0 10.8 0.0 2.2 12.2 1.3 0.0 0.0 0.1 4.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 48.6 0.0 0.0 3.0 22.8 0.0 0.0 0.0 18.6 0.0 0.0 0.1 4.6 1.3 31.7 0.1 4.0 0.2 0.1 0.1 0.0 2.9 0.0 0.0 0.0 0.0 57.4 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 16.8 17.5 3.8 12.5 13.9 9.9 14.3 11.2 12.2 13.4 6.0 2.1 0.0 11.4 12.2 3.8 12.4 0.0 2.7 2.3 1.8 0.0 108.5 0.0 0.0 3.9 1.5 0.0 0.0 0.0 14.4 10.8 4.9 21.8 0.0 9.3 1.6 2.4 0.0 0.0 3.3 0.3 0.0 3.3 0.0 0.0 38.0 0.0 0.0 0.4 1.6 2.4 0.0 0.9 1.4 1.4 8.4 47.6 0.5 0.2 10.6 BMPR2 "BMPR-II, BMPR3, BRK-3, PPH1, T-ALK" ENSG00000204217 "Bone morphogenetic protein receptor type 2" Q13873 2 202376936-202567751 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017385, HPA049014" Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA017385: AB_1845397, HPA049014: AB_2680599" "unprognostic (2.17e-1)" "unprognostic (9.00e-2)" "unprognostic (2.35e-1)" "unprognostic (2.73e-1)" "unprognostic (1.67e-1)" "unprognostic (2.55e-1)" "unprognostic (4.30e-2)" "unprognostic (1.11e-1)" "unprognostic (3.18e-2)" "unprognostic (1.10e-2)" "unprognostic (2.13e-2)" "unprognostic (1.97e-1)" "unprognostic (1.29e-2)" "unprognostic (1.21e-3)" "unprognostic (9.20e-2)" "unprognostic (1.18e-1)" "unprognostic (3.40e-1)" 18.1 15.0 12.1 9.8 14.2 1.1 10.2 9.5 17.1 15.7 11.7 8.2 6.5 5.5 12.9 10.2 10.6 10.3 13.2 14.6 10.8 13.5 10.7 11.5 24.9 4.4 10.4 14.5 12.0 7.0 15.5 6.1 21.7 10.8 11.0 7.7 11.4 7.1 9.1 10.6 7.2 8.1 15.3 7.5 8.9 7.2 12.9 3.8 3.9 11.6 5.2 5.4 11.1 8.9 1.6 2.6 0.9 2.7 1.1 3.6 0.9 5.7 5.4 5.6 8.8 14.0 13.6 10.8 12.0 12.1 10.5 10.5 4.7 8.7 2.0 14.0 24.2 9.0 10.9 7.3 9.3 16.5 6.0 5.0 6.1 5.8 7.3 9.7 1.7 4.8 9.9 8.8 7.7 10.3 16.2 30.2 2.5 3.9 10.0 12.9 10.8 1.4 1.6 3.1 2.8 5.0 3.9 11.0 3.0 8.9 12.3 5.7 5.7 12.8 7.6 14.1 14.3 5.9 4.0 33.3 21.4 11.4 7.3 7.2 1.4 1.7 0.6 5.1 3.9 6.2 0.5 2.0 0.9 3.4 1.8 2.5 1.5 1.3 2.2 2.3 1.6 2.7 1.4 0.6 1.1 2.7 2.6 3.6 0.9 12.1 14.2 9.5 17.1 10.8 13.5 10.4 14.5 10.8 3.8 98.3 38.9 17.1 16.1 29.8 51.7 46.4 12.7 21.4 39.8 19.2 76.6 14.0 1.7 27.3 2.4 119.4 12.7 0.0 24.7 19.4 40.9 19.9 23.1 15.5 16.2 33.4 24.1 109.2 20.0 2.3 31.4 17.4 40.5 15.4 16.3 38.7 36.3 20.9 40.3 10.7 29.9 64.7 45.7 17.7 11.1 31.5 16.7 13.8 13.4 22.7 BMS1 "BMS1L, KIAA0187" ENSG00000165733 "BMS1, ribosome biogenesis factor" Q14692 10 42782801-42834937 "Disease related genes, Predicted intracellular proteins" "Ribosome biogenesis" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036589, HPA043081" Uncertain Enhanced "Nucleoplasm,Nucleoli,Mitotic chromosome" Yes No "Nucleoplasm, Nucleoli, Mitotic chromosome" "HPA036589: AB_10601460, HPA043081: AB_2678305" "unprognostic (1.46e-2)" "unprognostic (4.31e-1)" "unprognostic (7.09e-2)" "unprognostic (3.56e-2)" "unprognostic (3.11e-2)" "unprognostic (7.25e-3)" "prognostic unfavorable (1.06e-6)" "unprognostic (1.47e-1)" "unprognostic (1.20e-1)" "unprognostic (1.89e-2)" "unprognostic (3.81e-3)" "unprognostic (1.32e-2)" "unprognostic (2.16e-3)" "unprognostic (7.03e-2)" "unprognostic (1.80e-1)" "unprognostic (3.43e-1)" "unprognostic (4.82e-2)" 17.8 15.3 10.4 15.8 19.7 17.4 16.2 22.5 20.6 15.5 12.9 13.7 11.2 11.8 23.1 13.4 17.8 14.0 10.0 14.4 10.8 13.3 17.8 16.8 14.1 17.2 12.6 15.4 17.5 16.2 24.7 28.0 15.3 22.8 14.1 15.4 12.3 18.8 14.0 29.9 18.1 13.8 14.7 15.0 18.3 13.5 14.8 13.4 20.7 14.0 17.2 19.2 14.4 15.9 9.8 8.4 3.4 9.1 6.2 11.6 5.6 16.8 14.4 14.0 15.9 10.6 8.8 13.6 14.2 15.0 16.8 14.5 19.8 13.3 9.0 10.1 12.2 9.4 14.8 22.8 18.3 22.1 13.1 16.0 12.0 11.2 16.8 9.2 32.4 11.4 7.9 9.4 18.1 17.6 9.4 12.7 10.5 21.0 9.7 11.9 14.2 18.0 10.7 17.7 11.7 15.3 16.6 14.7 9.6 9.3 14.9 10.7 11.4 12.3 13.8 11.7 15.3 16.7 9.4 15.3 7.9 28.3 15.7 23.0 7.8 9.6 26.3 11.5 24.0 6.0 3.4 5.1 2.9 8.6 9.1 10.2 9.8 10.6 9.3 8.4 7.4 11.6 10.0 0.7 6.2 7.4 4.4 7.5 5.6 10.4 19.7 22.5 20.6 10.8 13.3 12.6 15.4 22.8 13.4 29.8 24.9 24.6 24.5 20.4 21.0 41.4 22.9 68.3 44.3 22.7 9.8 24.5 18.3 25.0 12.0 26.4 7.9 0.0 30.5 25.1 21.9 17.4 20.9 17.1 17.5 20.6 16.1 23.9 18.6 8.1 21.9 21.0 32.1 41.5 10.4 11.4 29.2 7.0 15.6 23.2 25.6 19.4 20.3 35.2 53.5 22.2 20.8 20.0 16.8 36.0 BMX "ETK, PSCTK3" ENSG00000102010 "BMX non-receptor tyrosine kinase" P51813 X 15464246-15556529 "Enzymes, Predicted intracellular proteins" "Apoptosis, Cell adhesion, Stress response" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "epididymis: 57.1" "Group enriched" "Detected in some" 9 "Endothelial cells: 18.5;Ito cells: 51.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 17 "neutrophil: 10.5" "Lineage enriched" "Detected in single" 105 "granulocytes: 10.5" "Cell line enriched" "Detected in single" 121 "HUVEC TERT2: 90.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001048, CAB032495" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB032495: AB_2290760, HPA001048: AB_1078289" "unprognostic (7.80e-2)" "unprognostic (4.92e-3)" "unprognostic (1.16e-2)" "unprognostic (4.07e-3)" "unprognostic (2.69e-1)" "unprognostic (2.14e-1)" "unprognostic (1.06e-3)" "unprognostic (2.36e-1)" "unprognostic (1.87e-1)" "unprognostic (1.21e-1)" "unprognostic (1.78e-1)" "unprognostic (1.06e-1)" "unprognostic (1.26e-2)" "unprognostic (1.84e-2)" "unprognostic (3.64e-2)" "unprognostic (1.26e-1)" "unprognostic (2.81e-2)" 8.2 0.3 0.1 1.0 0.7 3.6 5.4 0.1 0.3 2.2 5.5 0.1 4.6 2.4 2.6 57.1 1.5 2.5 2.6 10.5 0.5 0.0 0.2 0.9 3.7 6.5 0.4 0.0 1.4 0.9 0.2 0.6 2.6 0.7 2.2 1.4 0.5 1.5 0.6 4.2 1.6 5.5 2.2 0.4 2.4 1.5 1.9 0.1 0.2 2.2 1.1 0.8 2.8 2.4 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.1 0.3 0.5 0.0 0.4 0.0 0.7 0.1 0.0 1.4 0.0 0.5 0.3 0.0 1.2 0.0 1.4 0.0 1.8 0.0 0.0 0.0 0.0 0.0 18.5 0.0 0.0 0.2 0.0 0.5 0.4 0.0 0.2 0.1 0.0 4.1 51.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 BNC1 "BNC, HsT19447" ENSG00000169594 "Basonuclin 1" Q01954 15 83255903-83284714 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" DNA-binding "Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 13.4;testis: 27.5;tongue: 20.2" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 78.8;Early spermatids: 37.3;Late spermatids: 74.8;Suprabasal keratinocytes: 51.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 25.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 16.3;HBEC3-KT: 37.1;hTCEpi: 41.7;hTERT-HME1: 40.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA063183, HPA066947, HPA077428" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063183: AB_2684957, HPA066947: AB_2685752, HPA077428: AB_2732345" "unprognostic (1.86e-3)" "unprognostic (1.08e-1)" "unprognostic (7.89e-3)" "unprognostic (5.55e-2)" "unprognostic (4.06e-2)" "unprognostic (2.47e-2)" "unprognostic (2.45e-2)" "unprognostic (7.91e-2)" "unprognostic (8.89e-4)" "unprognostic (6.94e-2)" "unprognostic (4.13e-1)" "unprognostic (3.85e-3)" "unprognostic (8.46e-3)" "unprognostic (2.20e-1)" "unprognostic (2.95e-3)" "unprognostic (1.01e-2)" 12.7 0.1 0.0 1.6 0.1 0.0 0.9 0.0 0.4 2.7 1.5 0.1 0.0 0.0 0.4 10.8 13.4 0.8 0.1 1.4 0.1 0.0 0.1 0.1 0.7 1.3 0.2 0.2 0.6 0.0 0.0 0.0 1.9 0.5 0.4 0.0 0.7 1.7 0.2 0.1 7.9 0.2 0.3 0.3 0.1 0.0 27.5 0.0 6.0 0.2 20.2 3.7 0.2 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 1.4 2.1 0.0 0.6 0.1 7.1 10.0 0.0 0.1 0.0 0.3 4.3 0.0 16.3 0.8 37.1 12.9 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 1.8 41.7 6.3 40.7 1.5 6.9 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 3.7 0.0 0.0 4.8 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.2 0.2 0.5 0.0 0.0 0.0 0.0 9.7 78.8 0.0 0.4 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 37.3 0.5 0.0 0.0 0.0 0.0 2.4 0.6 0.0 0.0 0.1 0.0 0.0 1.3 0.0 74.8 0.6 0.5 8.5 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.2 16.3 5.9 51.1 0.0 0.0 0.0 4.6 BNC2 "BSN2, FLJ20043" ENSG00000173068 "Basonuclin 2" Q6ZN30 9 16409503-16870843 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 35.8;ovary: 37.0" "Group enriched" "Detected in many" 4 "granulocytes: 21.9;Leydig cells: 83.4;Peritubular cells: 63.6;Proximal tubular cells: 31.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 5 "gdT-cell: 5.8" "Lineage enriched" "Detected in many" 5 "T-cells: 5.8" "Cell line enhanced" "Detected in many" "HSkMC: 18.5;Karpas-707: 22.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA018525, HPA059419" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA018525: AB_1845402, HPA059419: AB_2732637" "unprognostic (2.68e-1)" "unprognostic (2.89e-1)" "unprognostic (3.64e-2)" "unprognostic (1.14e-2)" "unprognostic (1.56e-2)" "unprognostic (5.07e-2)" "unprognostic (2.81e-2)" "unprognostic (2.50e-1)" "unprognostic (1.94e-2)" "unprognostic (6.05e-2)" "unprognostic (5.99e-2)" "unprognostic (3.87e-1)" "unprognostic (1.15e-1)" "unprognostic (1.36e-2)" "unprognostic (1.62e-1)" "unprognostic (6.74e-2)" "unprognostic (1.14e-3)" 4.3 1.0 0.5 5.1 0.7 0.3 4.3 0.5 0.7 19.8 7.6 1.8 2.9 0.8 35.8 5.5 3.8 14.3 9.3 3.8 1.2 0.5 7.6 0.4 2.6 0.9 0.9 0.5 37.0 0.5 2.7 1.5 2.2 2.3 6.4 2.1 11.0 1.3 4.8 7.6 2.9 2.8 23.1 2.0 0.5 3.0 4.7 1.0 0.9 1.7 3.6 1.3 8.5 9.0 0.1 0.0 0.0 0.0 1.0 5.8 3.2 0.1 0.9 0.7 0.0 10.1 12.5 1.6 6.2 10.9 4.5 3.7 0.0 0.0 0.0 2.1 4.2 3.3 0.0 2.9 0.0 4.6 0.1 1.2 0.1 2.9 0.0 7.8 0.0 0.2 18.5 0.0 9.5 0.0 7.8 10.0 0.0 0.0 22.5 6.3 0.0 0.0 1.5 3.7 0.0 5.7 0.0 7.1 15.0 3.4 0.2 0.1 0.5 0.0 0.0 10.6 4.9 0.0 0.0 9.8 10.5 7.8 8.5 11.4 0.1 0.0 0.1 4.3 1.4 1.4 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.8 0.0 1.0 0.0 0.0 0.0 3.2 0.5 0.7 0.5 0.7 1.2 0.5 0.9 0.5 2.3 1.0 0.0 2.1 0.0 0.6 9.0 2.1 4.3 0.0 1.4 1.2 0.0 0.0 2.4 0.0 0.5 5.0 6.8 0.3 0.0 0.3 1.6 11.6 0.1 21.9 0.0 6.1 0.0 0.0 11.6 2.1 1.8 83.4 2.2 10.1 0.0 0.0 2.3 0.1 0.0 63.6 31.8 0.2 6.5 7.4 0.7 5.1 4.8 1.0 1.5 0.0 0.0 BOC CDON2 ENSG00000144857 "BOC cell adhesion associated, oncogene regulated" Q9BWV1 3 113211003-113287459 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 17 "Basal keratinocytes: 18.8;Leydig cells: 78.6;Peritubular cells: 44.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "memory B-cell: 1.3" "Lineage enriched" "Detected in single" 8 "B-cells: 1.3" "Cell line enhanced" "Detected in many" "AN3-CA: 31.2;ASC diff: 46.2;BJ hTERT+: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB025806 Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" "Intracellular and membrane" NA No 4500000 "Nuclear bodies, Plasma membrane" Nucleoplasm "CAB025806: " "unprognostic (6.89e-3)" "unprognostic (1.34e-2)" "unprognostic (2.62e-3)" "unprognostic (1.03e-2)" "unprognostic (5.03e-3)" "prognostic favorable (4.89e-4)" "unprognostic (8.66e-5)" "unprognostic (1.10e-1)" "unprognostic (1.19e-2)" "unprognostic (4.78e-3)" "unprognostic (3.42e-2)" "unprognostic (1.10e-1)" "unprognostic (3.65e-3)" "unprognostic (4.94e-3)" "unprognostic (1.11e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (1.18e-5)" 19.4 4.8 5.3 10.4 8.1 0.4 21.6 4.2 6.0 26.6 23.8 5.4 10.6 3.9 25.8 25.3 19.6 33.2 14.5 20.3 13.3 2.9 4.7 1.0 3.6 3.6 5.5 2.2 26.1 12.0 1.9 12.5 1.9 26.2 21.2 3.9 45.6 17.9 17.4 4.6 25.7 9.6 35.2 36.7 3.5 11.8 9.2 7.6 1.2 13.4 12.9 4.9 28.4 25.0 1.3 0.1 0.0 0.0 0.0 0.1 0.3 0.0 2.9 11.0 31.2 46.2 2.4 0.3 5.0 16.5 1.2 1.1 0.0 0.0 0.0 3.1 8.4 0.7 0.0 2.2 1.0 0.4 0.0 1.3 0.0 1.0 0.0 0.2 0.1 0.1 8.0 0.7 0.7 0.1 10.3 0.0 0.0 0.0 0.0 0.2 0.8 0.1 0.5 2.8 0.0 2.7 0.0 4.9 0.0 0.3 0.0 3.3 4.7 0.0 0.2 0.1 3.4 1.3 0.1 0.0 1.8 2.9 0.0 1.6 0.0 0.0 0.0 3.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 5.3 8.1 4.2 6.0 13.3 2.9 5.5 2.2 26.2 7.6 0.0 0.3 0.0 2.3 18.8 0.4 0.8 0.0 0.0 1.2 5.2 0.0 4.4 0.0 0.0 1.3 3.3 0.0 0.0 0.0 4.0 12.4 2.8 0.0 0.0 0.7 0.0 1.7 2.5 0.0 1.1 78.6 0.9 10.1 0.0 0.0 14.1 0.5 0.0 44.9 0.0 0.5 0.0 8.3 1.1 3.0 9.7 1.6 0.0 0.0 0.3 BOD1L1 "BOD1L, FAM44A, FLJ33215, KIAA1327" ENSG00000038219 "Biorientation of chromosomes in cell division 1 like 1" Q8NFC6 4 13568738-13627723 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Rod photoreceptor cells: 187.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 12.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 12.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036943, HPA037362, HPA041290" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA036943: AB_2675397, HPA037362: AB_10670380, HPA041290: AB_2677393" "unprognostic (1.07e-1)" "unprognostic (3.27e-2)" "unprognostic (7.73e-2)" "unprognostic (2.29e-2)" "unprognostic (5.94e-2)" "unprognostic (6.15e-2)" "unprognostic (6.39e-2)" "unprognostic (2.10e-1)" "unprognostic (2.13e-2)" "unprognostic (3.19e-1)" "unprognostic (9.02e-2)" "unprognostic (1.72e-1)" "prognostic favorable (3.48e-6)" "unprognostic (2.03e-1)" "unprognostic (1.16e-1)" "unprognostic (1.02e-2)" "unprognostic (6.60e-2)" 17.5 12.6 18.9 23.8 24.3 40.2 18.3 30.4 34.9 21.5 16.8 10.4 18.2 12.1 20.5 19.8 15.2 16.9 14.1 13.6 18.4 12.4 14.2 12.6 22.8 22.0 20.1 21.7 26.8 16.0 28.6 16.0 18.3 21.1 15.4 14.5 7.1 17.1 27.3 13.2 19.5 20.9 18.2 21.1 26.9 16.1 18.0 21.6 23.4 16.4 11.7 22.3 16.5 16.2 2.2 2.5 12.2 1.4 0.7 1.6 0.5 10.2 13.8 13.8 9.9 16.8 17.8 10.6 11.9 12.6 9.9 11.2 10.3 11.2 13.8 5.4 13.0 18.5 7.0 11.2 11.8 19.2 9.5 6.5 19.4 17.4 12.6 10.4 29.1 16.1 14.2 13.5 20.5 15.9 13.7 10.2 9.8 13.6 16.6 12.4 6.1 15.0 19.5 17.7 6.6 12.0 11.5 20.5 5.5 18.5 10.4 8.2 15.1 13.1 4.6 10.6 15.5 5.4 11.3 23.1 15.4 8.1 9.5 15.6 19.7 11.5 17.5 15.2 13.8 12.2 2.5 1.4 2.8 1.6 1.4 1.3 1.7 1.0 1.1 0.9 2.2 1.5 1.1 12.2 0.7 0.9 2.5 0.9 0.5 18.9 24.3 30.4 34.9 18.4 12.4 20.1 21.7 21.1 21.6 77.4 85.8 51.3 16.8 23.4 156.0 80.3 53.5 52.2 75.1 34.9 84.4 13.6 3.3 26.0 15.3 42.2 24.0 23.3 21.8 14.9 25.9 20.4 60.2 30.4 18.6 152.6 33.4 33.7 36.5 13.5 46.6 34.3 23.6 21.6 26.0 103.2 26.0 21.0 54.5 4.5 187.0 45.3 24.0 75.4 15.2 25.2 15.6 37.3 21.0 22.8 BOLA2 "BOLA2A, My016" ENSG00000183336 "BolA family member 2" Q9H3K6 16 29443056-29454964 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.6" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 2: 2.4;Ciliated cells: 1.4;Club cells: 2.3;granulocytes: 1.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA045380, HPA046696" Supported Uncertain Nucleoplasm NA NA 180000 Nucleoplasm "HPA045380: AB_2679301, HPA046696: AB_2679757" 2.3 3.6 3.6 9.0 3.6 9.5 2.2 1.3 2.0 1.4 5.6 13.5 1.6 0.0 4.6 1.2 1.5 3.1 3.3 2.7 3.2 3.5 2.7 6.6 3.4 0.6 7.2 0.7 3.6 2.9 1.8 0.8 7.1 1.2 4.6 2.5 10.7 0.5 3.6 6.0 7.2 5.5 1.8 1.2 2.3 2.3 25.6 21.4 15.8 20.7 10.4 20.1 18.1 14.2 23.4 3.9 8.4 1.5 2.2 12.4 4.7 2.3 4.5 5.9 10.7 12.9 5.2 14.8 1.4 7.2 8.3 1.9 7.8 0.3 14.6 35.6 11.8 8.9 23.5 3.8 7.7 12.8 1.9 4.4 9.2 2.6 0.9 5.0 17.2 5.3 12.3 2.5 28.7 9.7 13.3 10.7 7.6 21.8 18.0 5.8 25.8 3.8 5.8 10.0 11.1 2.6 23.2 4.4 0.8 7.5 5.5 5.0 9.2 5.8 10.2 9.9 22.6 12.0 9.4 10.4 10.8 9.9 8.2 19.3 15.8 16.5 20.7 16.0 25.6 15.6 16.7 14.8 20.6 11.9 13.7 3.7 10.4 17.4 21.4 20.1 18.1 0.0 2.4 0.0 0.2 0.1 0.0 0.0 0.0 1.4 2.3 0.0 0.0 0.2 0.0 0.4 0.5 0.0 0.5 0.0 0.7 0.1 0.0 0.1 1.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.2 0.0 0.2 0.3 BOLA2B ENSG00000169627 "BolA family member 2B" Q9H3K6 16 30192934-30194306 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 47.7" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 89.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 80.0;Hep G2: 72.9;MCF7: 69.2" "HPA045380, HPA046696" Supported Uncertain Nucleoplasm NA NA 180000 Nucleoplasm "HPA045380: AB_2679301, HPA046696: AB_2679757" "unprognostic (2.49e-1)" "unprognostic (4.60e-3)" "unprognostic (8.49e-2)" "unprognostic (3.02e-3)" "unprognostic (9.80e-4)" "unprognostic (1.22e-1)" "unprognostic (3.75e-2)" "unprognostic (1.25e-1)" "unprognostic (3.08e-2)" "unprognostic (2.24e-2)" "unprognostic (1.26e-1)" "unprognostic (5.75e-2)" "unprognostic (1.70e-1)" "unprognostic (2.94e-1)" "unprognostic (5.29e-1)" "unprognostic (2.21e-2)" "unprognostic (4.91e-3)" 5.3 6.2 10.0 8.5 8.3 17.6 4.5 6.7 8.8 5.1 13.8 6.1 3.9 14.7 5.8 5.6 9.7 3.3 6.7 11.9 8.2 6.1 7.4 5.4 4.9 15.6 8.9 3.9 5.2 8.3 1.8 6.5 5.5 4.7 4.1 8.5 5.0 7.9 3.9 5.9 7.4 11.2 4.2 8.5 10.8 9.2 7.8 5.6 9.2 3.9 7.7 13.7 7.8 24.9 47.7 32.4 24.8 33.5 25.6 33.6 26.2 15.2 49.2 4.8 11.7 1.6 1.9 15.7 3.7 2.3 3.5 4.9 29.3 15.9 4.6 18.2 1.0 6.3 8.3 2.7 7.1 0.6 14.3 80.0 9.9 28.1 72.9 3.5 6.3 13.1 1.1 4.7 6.0 2.4 1.2 6.1 14.7 6.5 15.5 3.1 69.2 17.8 18.6 14.5 7.0 51.6 15.6 7.1 34.0 4.6 24.8 14.7 14.6 2.0 21.3 4.9 1.5 9.6 9.2 4.8 8.1 6.5 14.0 14.0 26.0 16.1 16.2 11.7 16.9 12.0 14.3 25.5 24.8 28.6 33.5 29.7 47.7 30.3 31.7 21.4 38.1 22.2 31.8 4.3 25.6 29.2 32.4 33.6 26.2 10.0 8.3 6.7 8.8 8.2 6.1 8.9 3.9 4.7 5.6 14.9 16.3 3.7 2.1 5.6 0.8 89.6 33.1 42.8 39.8 22.7 2.0 6.5 39.7 11.7 27.2 8.0 36.6 0.0 21.1 4.3 5.6 3.1 27.9 18.1 10.1 1.6 27.7 15.4 27.7 21.6 2.3 10.1 6.8 13.6 24.2 4.1 21.3 25.4 1.4 21.3 2.0 6.5 5.1 4.3 6.8 9.8 3.2 17.5 23.3 3.3 BOP1 KIAA0124 ENSG00000261236 "Block of proliferation 1" Q14137 8 144262102-144291370 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 60.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 67.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047869, HPA066764" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "HPA047869: AB_2680193, HPA066764: AB_2685716" "unprognostic (6.92e-2)" "unprognostic (5.03e-3)" "unprognostic (6.78e-2)" "unprognostic (2.06e-3)" "unprognostic (3.32e-1)" "unprognostic (2.16e-2)" "prognostic unfavorable (3.35e-5)" "unprognostic (2.25e-2)" "unprognostic (4.14e-1)" "unprognostic (3.31e-1)" "unprognostic (2.26e-2)" "unprognostic (7.00e-2)" "prognostic unfavorable (2.23e-7)" "unprognostic (7.83e-2)" "unprognostic (4.33e-1)" "unprognostic (8.49e-2)" "unprognostic (4.06e-3)" 4.8 4.3 5.7 7.7 5.9 7.8 6.4 6.3 6.9 2.0 3.9 1.6 2.0 5.1 2.7 1.5 6.8 2.6 4.8 5.1 5.5 2.8 6.2 2.3 6.6 4.1 6.7 2.7 17.5 5.1 2.2 3.2 4.3 2.9 1.5 1.5 5.8 3.0 19.0 7.4 4.5 4.9 2.0 4.8 4.4 8.3 3.3 6.3 3.9 6.7 4.5 3.5 6.9 5.2 6.4 2.5 4.7 3.5 5.7 2.5 12.5 24.6 3.4 14.5 2.0 2.3 12.6 8.7 1.8 8.8 5.5 18.6 7.3 15.3 14.9 3.3 3.3 10.1 6.2 10.3 2.0 13.4 24.8 19.2 14.9 14.1 4.6 8.5 10.6 4.5 5.1 7.4 6.7 1.7 5.5 14.2 19.3 5.1 3.4 32.0 22.8 10.9 8.3 12.9 67.8 17.5 5.1 23.3 3.6 8.4 19.1 7.6 9.3 12.1 5.9 1.7 8.9 8.1 10.3 8.1 25.0 10.9 24.9 4.9 3.1 12.8 6.0 13.8 10.6 0.0 4.7 2.5 4.4 4.7 4.8 5.2 4.9 5.7 6.4 4.5 4.4 4.1 0.2 3.5 4.0 4.1 4.2 2.5 8.9 6.1 13.4 13.8 0.5 10.2 6.7 10.2 2.7 6.8 10.4 0.0 21.5 5.0 24.4 8.9 8.7 7.0 0.0 18.7 35.1 9.3 10.0 10.3 13.1 19.1 14.3 25.8 3.7 6.4 15.5 9.8 7.5 0.0 11.8 9.2 13.7 20.3 8.6 9.2 13.6 4.2 12.9 4.3 10.4 60.5 0.1 14.9 8.7 21.6 11.6 BORA "C13orf34, FLJ22624" ENSG00000136122 "Bora, aurora kinase A activator" Q6PGQ7 13 72727749-72756198 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.5" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 9.8;Sertoli cells: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040866 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA Yes "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA040866: AB_10794868" "unprognostic (9.93e-2)" "unprognostic (7.18e-2)" "unprognostic (4.57e-2)" "unprognostic (7.09e-2)" "unprognostic (1.49e-1)" "unprognostic (1.47e-2)" "unprognostic (1.37e-4)" "unprognostic (2.65e-2)" "unprognostic (2.82e-3)" "unprognostic (6.18e-2)" "unprognostic (1.08e-2)" "unprognostic (2.11e-2)" "unprognostic (5.32e-12)" "unprognostic (7.04e-3)" "unprognostic (2.88e-1)" "unprognostic (9.93e-2)" "unprognostic (2.28e-2)" 3.7 3.0 2.3 10.9 3.2 10.9 6.8 5.8 4.2 3.3 9.0 1.8 6.3 6.9 3.1 5.9 7.1 3.2 3.2 2.3 2.6 2.2 4.3 4.3 7.7 11.8 4.3 1.5 3.1 5.6 0.8 6.3 6.8 4.4 4.0 9.1 2.2 4.6 6.7 2.1 6.1 10.6 3.5 5.3 8.9 5.5 7.0 4.6 26.5 5.0 5.8 12.4 5.6 4.5 5.0 5.7 7.2 5.4 4.6 8.3 3.7 22.3 3.9 12.7 8.6 1.6 1.6 9.0 7.5 6.7 11.8 12.9 10.3 12.9 14.6 4.3 4.3 6.9 9.6 11.4 7.3 15.7 13.5 6.3 18.0 6.3 8.4 1.5 33.9 11.7 1.3 1.9 5.3 11.6 2.6 9.8 15.5 8.2 6.3 8.5 5.2 15.2 9.8 5.6 23.3 4.6 11.1 7.5 6.5 4.0 5.8 3.4 4.0 7.5 7.3 5.4 10.1 4.9 12.4 3.5 3.3 7.5 5.7 9.5 5.4 4.9 10.5 9.2 16.1 8.2 7.2 3.1 1.6 6.6 5.4 5.8 4.6 5.7 6.4 5.7 5.0 4.7 8.3 0.7 4.6 3.3 3.2 5.9 3.7 2.3 3.2 5.8 4.2 2.6 2.2 4.3 1.5 4.4 4.6 3.0 3.2 2.4 1.3 0.6 1.9 0.2 0.0 2.7 2.3 1.8 2.0 3.9 0.0 1.5 1.0 0.2 2.3 0.0 2.2 9.8 0.7 1.4 1.1 0.0 3.8 7.9 0.0 3.1 5.1 0.8 0.9 2.9 0.0 1.8 1.9 1.0 1.4 2.6 1.1 0.5 2.1 12.9 1.9 1.2 4.7 1.0 2.4 2.5 4.0 1.3 BORCS8 MEF2BNB ENSG00000254901 "BLOC-1 related complex subunit 8" Q96FH0 19 19176903-19192591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045700 Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA045700: AB_10968570" "unprognostic (4.23e-3)" "unprognostic (1.61e-2)" "unprognostic (2.75e-1)" "unprognostic (3.58e-2)" "unprognostic (2.28e-1)" "unprognostic (3.01e-2)" "unprognostic (5.51e-2)" "unprognostic (5.81e-3)" "unprognostic (1.78e-2)" "unprognostic (6.82e-2)" "prognostic favorable (4.05e-5)" "unprognostic (6.20e-2)" "unprognostic (1.76e-1)" "unprognostic (1.22e-1)" "unprognostic (3.16e-1)" "unprognostic (1.38e-2)" "unprognostic (3.00e-2)" 11.3 17.0 25.0 12.9 26.8 12.2 13.3 19.3 31.0 10.1 13.5 17.3 14.5 15.5 12.9 15.8 13.8 14.0 14.8 17.9 23.9 30.0 16.0 14.1 12.0 14.0 26.3 12.2 10.5 10.1 11.7 20.1 11.3 15.6 10.9 15.3 13.6 12.4 15.5 12.0 9.6 9.5 13.0 13.9 11.9 11.2 11.1 12.9 12.4 13.0 11.1 13.8 10.9 8.5 8.7 9.8 25.6 14.6 5.0 7.1 6.7 9.7 5.5 9.1 7.4 9.9 5.4 9.1 10.3 8.7 16.2 15.0 9.6 9.6 7.2 14.4 11.9 12.7 6.4 9.8 12.6 7.7 3.9 12.5 5.4 12.5 10.2 8.1 3.9 7.7 6.5 9.4 12.4 6.2 7.3 14.2 12.4 9.7 10.5 17.1 17.6 14.8 9.1 4.9 11.7 12.1 7.1 3.6 8.2 14.0 6.0 18.5 10.2 9.4 6.2 7.6 7.3 6.8 7.6 7.2 5.6 8.3 19.0 15.5 6.6 7.8 8.3 11.1 6.7 11.4 10.6 9.6 16.0 4.9 13.7 4.8 8.7 5.7 5.6 7.4 6.3 4.7 5.2 25.6 5.0 14.6 9.8 7.1 6.7 25.0 26.8 19.3 31.0 23.9 30.0 26.3 12.2 15.6 12.9 11.9 22.9 13.7 12.0 0.0 15.5 0.0 28.1 24.1 13.6 14.0 9.8 27.4 36.5 34.2 2.6 9.7 16.6 0.0 28.6 29.2 3.1 15.0 9.3 15.3 35.2 17.5 10.5 12.9 26.3 4.5 7.2 17.5 0.0 43.3 12.4 10.6 32.6 10.5 6.3 29.8 13.3 0.0 0.0 32.2 21.5 0.0 33.1 15.0 12.5 15.3 BORCS8-MEF2B MEF2BNB-MEF2B ENSG00000064489 "BORCS8-MEF2B readthrough" 19 19145567-19192158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in single" 19 "Club cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "PC-3: 11.1;U-266/70: 11.2" HPA004734 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cytosol" "Cell Junctions" "HPA004734: AB_10963939" "unprognostic (2.74e-1)" "unprognostic (5.77e-3)" "unprognostic (8.67e-2)" "unprognostic (3.88e-1)" "unprognostic (1.46e-4)" "unprognostic (1.88e-1)" "unprognostic (1.04e-2)" "unprognostic (1.66e-1)" "unprognostic (1.98e-1)" "unprognostic (3.75e-2)" "unprognostic (1.66e-1)" "unprognostic (7.20e-2)" "unprognostic (6.23e-2)" "unprognostic (1.25e-1)" "unprognostic (2.33e-1)" "unprognostic (7.78e-2)" "unprognostic (5.29e-2)" 4.8 3.5 7.0 5.8 7.4 7.4 4.6 5.6 8.6 5.4 5.4 8.1 6.7 3.2 6.7 7.4 5.4 10.5 7.2 3.4 6.8 6.2 7.5 5.9 4.8 7.1 8.0 5.5 9.8 7.8 5.5 4.9 5.0 7.3 5.7 5.5 6.2 5.6 7.2 5.3 8.8 4.0 8.9 5.9 5.8 5.0 5.5 5.8 5.6 5.9 4.9 7.5 5.8 5.8 0.0 0.4 0.6 0.1 0.0 0.3 0.0 1.6 0.0 0.7 1.2 1.0 2.5 1.3 1.1 1.0 1.5 1.5 0.0 3.1 3.4 0.5 0.0 0.5 0.6 0.7 0.6 0.3 0.5 2.5 1.1 0.1 0.3 2.3 0.0 0.2 0.0 2.3 0.7 3.7 0.6 0.4 3.2 0.2 2.0 0.6 3.1 0.7 0.4 0.0 0.0 11.1 3.3 0.9 0.9 0.0 0.2 0.0 1.1 2.0 0.0 0.9 0.1 0.3 0.6 0.3 0.7 1.2 5.7 0.4 11.2 1.7 5.6 2.4 2.7 0.2 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.6 0.0 0.1 0.2 0.1 0.0 7.0 7.4 5.6 8.6 6.8 6.2 8.0 5.5 7.3 5.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 BPGM ENSG00000172331 "Bisphosphoglycerate mutase" P07738 7 134646808-134679813 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Congenital erythrocytosis, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "placenta: 184.7" "Group enriched" "Detected in all" 5 "Distal tubular cells: 109.5;Erythroid cells: 303.7;Syncytiotrophoblasts: 308.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 38.0;RT4: 61.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016493, HPA028735" Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA 69000000 "Nucleoli, Nucleoli rim" Nucleoplasm "HPA016493: AB_1845414, HPA028735: AB_10600791" "unprognostic (2.56e-1)" "prognostic favorable (7.95e-4)" "unprognostic (3.19e-1)" "unprognostic (3.94e-1)" "unprognostic (1.78e-1)" "unprognostic (5.22e-2)" "unprognostic (3.81e-3)" "unprognostic (1.96e-1)" "unprognostic (7.74e-2)" "unprognostic (4.67e-3)" "unprognostic (7.42e-2)" "unprognostic (5.69e-2)" "prognostic favorable (1.54e-8)" "unprognostic (2.18e-1)" "unprognostic (1.35e-1)" "unprognostic (2.73e-1)" "unprognostic (3.78e-2)" 6.1 7.3 13.6 4.5 11.1 37.7 6.9 11.7 11.6 7.1 6.9 9.1 6.1 4.3 5.4 10.2 14.6 4.7 6.9 7.3 12.5 14.2 19.1 8.1 8.0 5.2 13.9 7.8 5.7 5.4 16.5 14.4 184.7 12.4 7.5 5.4 6.7 10.6 10.3 17.7 5.5 6.0 6.6 15.9 8.6 6.8 7.4 8.8 8.5 7.5 22.2 13.3 24.9 9.5 11.6 10.2 28.2 12.8 9.8 14.5 12.8 4.5 5.5 7.4 9.9 8.5 5.0 7.4 13.7 16.6 5.3 8.0 2.2 6.1 5.5 4.1 7.6 10.6 3.7 7.8 7.5 9.4 38.0 6.8 3.2 5.1 2.5 5.8 6.0 4.2 4.9 6.9 10.0 5.5 8.2 19.3 7.0 9.2 7.0 12.6 2.2 9.8 8.4 7.6 9.3 5.3 7.5 5.3 4.0 12.1 61.1 6.3 10.7 6.3 7.7 6.8 8.2 5.1 3.9 14.7 8.5 2.0 11.4 11.1 11.5 13.2 6.9 14.7 5.8 14.5 28.2 9.8 27.6 14.5 12.8 10.4 11.6 9.5 12.7 10.2 10.5 13.2 13.4 18.0 9.8 12.5 6.7 12.0 12.8 13.6 11.1 11.7 11.6 12.5 14.2 13.9 7.8 12.4 8.8 8.9 26.7 14.4 18.4 34.7 20.3 20.5 15.3 29.4 14.8 26.2 2.0 35.3 109.5 38.4 2.2 11.9 5.1 303.7 15.9 28.0 17.1 21.1 24.3 4.3 13.3 19.1 12.6 8.0 7.3 5.1 9.5 11.3 21.9 19.8 3.8 18.6 36.1 3.5 11.3 47.1 11.6 6.5 24.7 27.9 22.5 11.5 308.5 21.5 4.5 13.7 BPTF "FAC1, FALZ, NURF301" ENSG00000171634 "Bromodomain PHD finger transcription factor" Q12830 17 67825524-67984378 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029069, HPA048289" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA029069: AB_10602597, HPA048289: AB_2680342" "unprognostic (1.22e-1)" "unprognostic (6.53e-2)" "unprognostic (2.41e-2)" "unprognostic (3.74e-2)" "unprognostic (4.43e-2)" "unprognostic (1.10e-1)" "unprognostic (1.02e-2)" "unprognostic (2.30e-1)" "unprognostic (8.97e-2)" "unprognostic (1.54e-1)" "unprognostic (4.07e-2)" "unprognostic (9.24e-2)" "prognostic favorable (8.46e-4)" "unprognostic (1.05e-1)" "unprognostic (2.85e-1)" "unprognostic (3.01e-2)" "unprognostic (1.56e-1)" 16.1 16.2 28.0 28.6 28.7 22.3 19.5 61.9 35.3 20.7 18.5 18.9 17.0 12.1 20.1 24.0 17.9 17.8 17.4 13.9 26.6 17.7 17.1 14.7 24.1 31.7 31.6 22.2 27.1 16.3 31.3 29.7 17.2 26.0 17.3 18.0 14.5 16.9 18.4 17.9 29.5 18.2 16.5 18.4 21.1 17.4 23.6 33.5 41.4 19.0 12.3 30.1 16.7 32.5 12.6 10.4 15.1 4.8 9.7 7.3 1.4 13.3 17.5 25.7 13.0 14.3 13.7 14.1 10.5 9.8 12.6 11.0 16.1 9.6 54.9 7.8 11.7 10.0 10.5 25.1 11.3 20.6 7.7 24.2 21.1 16.8 22.0 6.8 30.7 17.0 10.0 12.8 12.6 9.6 11.5 23.6 17.6 23.8 15.8 10.9 20.5 31.3 15.3 19.6 12.5 16.0 22.6 31.1 10.8 11.1 16.8 19.4 22.2 14.4 38.9 14.8 32.6 16.4 17.8 16.5 19.3 15.1 7.0 12.9 13.0 13.0 32.6 9.1 14.9 7.4 15.1 3.9 7.5 7.3 2.2 5.9 5.7 5.9 5.7 2.8 12.6 6.2 6.4 8.9 9.7 4.8 10.4 4.2 1.4 28.0 28.7 61.9 35.3 26.6 17.7 31.6 22.2 26.0 33.5 107.2 124.1 51.4 47.2 66.7 204.4 114.1 56.0 96.4 130.8 55.8 135.5 32.0 6.6 51.8 19.7 85.7 44.6 46.7 54.5 27.7 63.0 50.8 115.8 38.4 36.7 187.5 121.0 64.4 50.9 14.5 100.7 50.8 60.8 45.1 58.7 132.3 54.5 60.4 104.7 15.3 196.3 64.7 58.2 135.4 80.7 66.0 32.4 81.2 68.6 50.4 BRAT1 "BAAT1, C7orf27, MGC22916" ENSG00000106009 "BRCA1 associated ATM activator 1" Q6PJG6 7 2537877-2555727 "Disease related genes, Predicted intracellular proteins" "DNA damage" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029455, HPA076508" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA029455: AB_10600761, HPA076508: AB_2686803" "unprognostic (2.53e-1)" "unprognostic (2.24e-1)" "unprognostic (1.19e-2)" "unprognostic (7.04e-3)" "unprognostic (6.07e-3)" "unprognostic (8.95e-2)" "prognostic unfavorable (8.02e-4)" "unprognostic (2.03e-1)" "unprognostic (1.76e-1)" "unprognostic (2.46e-1)" "unprognostic (1.10e-3)" "unprognostic (4.69e-2)" "prognostic unfavorable (3.90e-4)" "unprognostic (5.37e-2)" "unprognostic (3.12e-2)" "unprognostic (8.88e-2)" "unprognostic (3.71e-2)" 16.1 19.2 12.2 13.0 14.3 12.1 10.1 20.4 12.9 11.4 9.6 14.3 9.4 16.5 12.2 11.7 10.3 11.4 15.8 8.1 13.4 9.1 9.1 13.7 15.9 11.6 14.7 9.8 13.8 17.0 9.9 12.5 11.0 8.9 14.0 3.1 12.9 20.0 13.7 12.0 19.0 13.8 8.8 11.3 14.6 14.5 17.0 10.6 19.2 14.5 5.8 12.3 10.2 10.8 14.2 23.1 18.7 22.2 10.2 17.1 14.6 15.0 13.8 3.2 12.0 3.1 2.8 11.0 5.2 2.9 4.5 3.9 9.8 9.3 11.4 8.3 3.4 8.6 15.3 3.9 5.9 0.7 4.4 20.1 5.2 10.1 6.2 4.0 7.0 8.1 4.9 4.2 4.6 1.3 2.6 5.2 8.9 16.7 4.1 3.1 21.5 4.9 33.2 15.8 3.7 21.2 12.2 9.9 10.9 2.8 4.8 8.8 13.5 7.8 13.0 5.3 1.5 11.7 14.5 5.1 6.1 19.7 12.7 9.9 9.2 7.1 8.1 6.9 14.2 14.5 3.6 22.2 12.3 16.8 20.2 14.7 14.2 15.2 17.1 23.1 12.6 12.8 13.7 18.7 10.2 17.4 16.4 13.0 14.6 12.2 14.3 20.4 12.9 13.4 9.1 14.7 9.8 8.9 10.6 11.9 5.4 8.2 16.1 6.9 10.7 5.7 15.3 5.3 12.5 8.7 11.8 18.4 13.3 9.5 15.3 10.5 12.9 0.0 11.8 11.3 10.3 7.4 13.9 12.9 27.9 3.2 10.9 18.4 13.2 6.1 21.0 12.4 6.8 18.0 12.9 11.2 11.0 13.3 20.8 13.6 10.8 6.5 9.5 27.0 39.0 5.9 12.2 13.4 13.4 7.6 BRCA1 "BRCC1, FANCS, PPP1R53, RNF53" ENSG00000012048 "BRCA1, DNA repair associated" P38398 17 43044295-43170245 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, DNA-binding, Transferase" "Cancer-related genes, Disease mutation, Fanconi anemia, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Spermatocytes: 64.7;Spermatogonia: 61.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "dendritic cells: 9.1;granulocytes: 9.7;monocytes: 12.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB001946, HPA004840, HPA034966, HPA057371" Approved Supported "Nucleoplasm,Nuclear bodies" NA Yes "Nucleoplasm, Nuclear bodies" "CAB001946: , HPA004840: , HPA034966: AB_10795287, HPA057371: AB_2732611" "unprognostic (7.87e-3)" "unprognostic (6.97e-2)" "unprognostic (3.53e-3)" "unprognostic (2.39e-1)" "unprognostic (5.42e-2)" "unprognostic (7.07e-3)" "unprognostic (1.56e-3)" "unprognostic (4.14e-3)" "unprognostic (9.62e-3)" "unprognostic (2.47e-1)" "unprognostic (5.53e-3)" "unprognostic (1.28e-1)" "unprognostic (1.08e-4)" "unprognostic (1.08e-3)" "unprognostic (1.48e-1)" "unprognostic (2.12e-1)" "unprognostic (8.31e-2)" 4.8 4.3 6.0 9.6 11.3 15.3 5.1 12.9 10.6 5.4 9.2 3.4 6.8 4.3 5.4 5.5 9.1 5.5 3.3 6.5 6.6 5.3 4.2 7.7 4.9 13.0 7.5 5.9 5.1 4.7 4.2 11.0 5.3 10.5 4.1 10.4 3.7 5.4 7.4 7.3 8.3 6.7 5.5 9.2 5.9 5.1 17.6 7.0 10.9 15.6 7.3 14.6 5.5 5.6 2.0 9.1 9.7 12.7 1.4 1.3 10.7 15.7 25.6 14.1 11.2 2.3 5.2 13.8 18.6 8.0 15.6 14.9 15.5 12.3 36.4 3.4 7.1 18.5 18.3 19.1 10.4 26.2 16.6 14.0 17.1 20.1 13.4 0.5 30.5 14.9 1.4 1.7 23.5 7.5 4.0 8.1 17.0 25.8 15.6 14.7 10.5 25.5 10.1 7.7 10.6 6.8 17.6 29.7 14.9 5.8 15.3 9.7 10.4 14.3 4.7 7.0 10.0 12.6 14.1 5.2 14.0 11.4 18.1 19.3 7.3 17.8 28.0 11.3 18.1 14.6 4.6 12.7 1.8 1.3 4.0 1.3 1.1 1.3 1.0 9.1 2.0 1.2 1.3 9.7 1.4 1.5 1.4 0.4 10.7 6.0 11.3 12.9 10.6 6.6 5.3 7.5 5.9 10.5 7.0 0.0 3.2 5.2 3.8 2.6 8.3 10.4 7.6 13.4 5.7 1.8 21.6 7.0 0.0 2.6 11.1 2.9 1.0 0.0 1.0 17.5 2.9 2.4 8.1 16.1 8.6 11.1 0.0 5.5 4.0 5.2 2.3 5.3 0.0 3.6 3.7 2.8 1.6 3.1 1.4 0.8 21.1 6.5 1.4 64.7 61.1 1.9 3.3 2.5 3.5 2.5 BRCA2 "BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, XRCC11" ENSG00000139618 "BRCA2, DNA repair associated" P51587 13 32315474-32400266 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Disease mutation, Fanconi anemia, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 23.2;testis: 16.9" "Group enriched" "Detected in many" 4 "Erythroid cells: 23.3;monocytes: 31.5;Spermatocytes: 75.1;Spermatogonia: 82.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA026815 Uncertain Supported Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA026815: AB_10602692" "unprognostic (9.36e-2)" "unprognostic (2.50e-1)" "unprognostic (4.50e-3)" "unprognostic (1.06e-2)" "unprognostic (5.40e-2)" "unprognostic (2.26e-2)" "unprognostic (1.37e-2)" "unprognostic (1.15e-1)" "unprognostic (1.60e-2)" "unprognostic (2.01e-1)" "unprognostic (6.97e-3)" "unprognostic (4.06e-2)" "unprognostic (3.07e-9)" "unprognostic (2.36e-2)" "unprognostic (1.18e-1)" "unprognostic (1.88e-1)" "unprognostic (1.32e-1)" 2.4 1.0 0.6 13.8 0.6 11.6 3.2 0.6 0.6 1.8 4.0 0.2 0.2 1.4 1.5 2.7 3.0 1.0 0.7 2.1 0.6 0.7 1.0 1.4 3.5 5.3 0.7 0.5 1.4 3.3 0.4 0.7 7.0 0.8 0.9 2.0 0.1 1.8 0.3 3.3 1.8 3.2 0.8 2.1 6.6 1.5 16.9 0.1 23.2 0.9 4.8 4.2 1.3 1.7 1.3 1.9 0.4 0.2 1.5 0.8 0.0 4.0 3.5 6.1 4.6 0.6 1.6 6.2 4.3 2.7 5.0 4.6 8.3 5.3 14.2 2.9 2.1 6.9 5.4 5.0 2.5 9.7 9.2 2.7 9.0 2.2 3.2 0.2 12.8 4.5 0.4 0.3 9.2 6.4 0.5 4.1 7.2 5.9 4.9 5.7 4.6 10.3 7.6 7.2 4.6 1.9 10.1 15.7 2.7 1.3 4.3 2.3 4.4 5.2 2.3 2.1 2.2 2.7 6.4 3.2 5.8 6.2 6.4 6.0 1.9 2.9 7.3 3.0 5.1 5.5 0.1 0.2 0.2 0.3 0.2 0.1 0.9 0.4 0.2 0.2 1.3 0.6 0.8 0.4 1.5 0.2 1.9 0.4 0.0 0.6 0.6 0.6 0.6 0.6 0.7 0.7 0.5 0.8 0.1 8.9 1.6 1.9 2.8 2.3 0.0 1.6 0.0 4.0 2.3 0.0 0.0 9.1 0.0 1.8 4.3 3.6 1.0 23.3 1.4 9.1 3.5 0.6 3.5 0.8 8.2 0.0 1.2 2.5 6.7 2.5 2.0 13.2 3.3 31.5 3.0 0.2 1.1 1.5 1.1 0.6 0.0 12.9 2.0 75.1 82.4 1.1 4.6 3.8 5.3 1.4 BRCC3 "BRCC36, C6.1A, CXorf53" ENSG00000185515 "BRCA1/BRCA2-containing complex subunit 3" P46736 X 155071420-155123074 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway" "Chromatin regulator, Hydrolase, Metalloprotease, Protease" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048737 Supported Nucleoplasm NA NA Nucleoplasm "HPA048737: AB_2680504" "unprognostic (1.16e-2)" "unprognostic (2.40e-2)" "unprognostic (5.99e-2)" "unprognostic (1.53e-1)" "unprognostic (1.43e-1)" "unprognostic (2.88e-2)" "unprognostic (4.48e-2)" "unprognostic (6.47e-3)" "unprognostic (1.33e-1)" "unprognostic (9.68e-2)" "unprognostic (1.35e-3)" "unprognostic (3.72e-2)" "unprognostic (3.71e-3)" "unprognostic (7.14e-3)" "unprognostic (1.57e-1)" "unprognostic (1.17e-1)" "unprognostic (1.90e-1)" 12.9 14.8 11.3 11.2 16.5 14.0 12.9 20.0 18.6 11.8 19.5 9.1 15.2 16.7 9.4 11.8 20.4 12.1 8.3 10.3 10.3 12.1 18.3 12.3 9.4 12.5 10.4 10.5 10.7 12.2 14.3 11.8 14.2 15.3 12.2 19.5 8.7 15.5 12.6 21.3 10.0 19.2 13.1 8.9 11.1 13.7 3.9 12.9 10.2 13.9 13.7 12.7 11.4 11.6 13.4 16.2 25.0 17.8 21.0 19.0 12.3 31.2 19.3 8.2 6.4 6.1 5.1 13.5 12.8 8.1 7.9 17.3 17.5 13.7 30.0 23.4 8.1 12.1 12.2 21.0 11.4 11.4 17.4 16.7 6.0 30.5 14.4 5.4 21.3 9.4 6.2 5.2 12.8 10.9 7.8 10.8 12.0 9.8 8.9 6.3 13.2 8.1 7.6 7.2 32.2 13.8 12.8 14.0 12.5 9.4 14.8 13.4 5.7 8.4 13.5 7.6 10.2 9.4 7.2 12.0 7.0 10.8 10.3 19.2 11.4 18.6 39.0 10.2 19.9 8.2 22.6 14.7 25.0 16.2 17.8 19.0 13.4 16.0 14.8 16.2 11.8 12.5 14.0 8.0 21.0 16.9 10.4 18.6 12.3 11.3 16.5 20.0 18.6 10.3 12.1 10.4 10.5 15.3 12.9 29.8 15.1 9.3 5.8 4.8 12.7 24.6 10.2 38.8 42.1 7.0 13.7 22.3 16.6 19.5 0.4 7.8 14.7 0.0 17.5 21.1 9.1 7.6 25.5 7.6 15.5 7.9 9.2 6.2 8.3 0.8 5.5 10.9 5.0 19.8 21.3 12.9 11.9 17.3 11.3 13.5 13.5 19.4 7.1 0.6 1.3 5.6 11.3 11.8 26.0 7.5 BRD4 "CAP, HUNK1, HUNKI, MCAP" ENSG00000141867 "Bromodomain containing 4" O60885 19 15235519-15332545 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015055, HPA061646, CAB068177, CAB068178" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB068177: AB_2665685, CAB068178: AB_2665686, HPA015055: AB_1845435, HPA061646: AB_2684575" "unprognostic (2.83e-3)" "unprognostic (2.39e-2)" "unprognostic (6.37e-3)" "unprognostic (3.38e-2)" "unprognostic (2.15e-1)" "unprognostic (9.53e-3)" "unprognostic (3.03e-3)" "unprognostic (6.13e-2)" "unprognostic (7.63e-2)" "unprognostic (2.72e-2)" "unprognostic (3.98e-2)" "unprognostic (5.26e-2)" "unprognostic (1.83e-3)" "unprognostic (2.43e-1)" "unprognostic (2.73e-1)" "unprognostic (1.28e-1)" "unprognostic (1.22e-1)" 23.0 20.7 27.8 25.6 30.1 25.2 20.4 32.1 29.9 20.8 19.6 17.2 18.9 17.6 23.4 12.5 22.9 18.6 15.8 21.3 20.3 12.4 18.1 25.3 22.5 22.7 14.8 17.6 27.3 31.3 19.1 18.8 34.0 17.6 20.8 10.7 18.9 22.0 19.3 47.7 27.3 21.0 20.3 13.9 26.8 20.2 20.1 16.8 34.2 21.5 11.6 23.7 20.9 24.8 6.9 4.3 11.6 4.4 4.9 3.5 2.0 20.4 20.7 12.9 24.3 12.3 8.7 15.6 15.1 12.3 11.9 12.6 21.8 30.9 25.7 25.0 16.4 11.7 20.5 15.0 14.2 10.4 25.7 9.9 24.3 18.1 19.0 18.8 24.0 27.1 12.8 14.7 14.8 29.2 7.9 11.5 17.3 41.1 26.1 7.6 26.5 22.5 17.3 26.3 9.4 24.3 28.3 13.6 16.1 9.5 22.1 15.6 14.1 19.9 14.6 17.0 11.0 14.6 16.4 18.3 31.2 14.9 27.7 23.7 21.3 18.8 13.1 17.2 19.5 24.2 5.2 3.6 3.9 3.5 4.4 2.7 5.4 3.1 2.9 2.1 6.9 3.1 2.9 11.6 4.9 3.9 4.3 2.2 2.0 27.8 30.1 32.1 29.9 20.3 12.4 14.8 17.6 17.6 16.8 59.6 53.2 59.1 104.0 104.5 62.2 73.0 56.0 22.7 28.4 24.4 78.5 177.3 21.6 46.6 107.0 73.3 66.9 93.5 57.8 59.0 72.1 110.7 34.8 77.4 51.9 74.7 109.2 55.3 67.7 148.2 71.7 51.2 42.2 43.3 47.3 38.6 55.1 44.4 75.0 28.3 85.9 71.1 85.8 52.5 37.5 125.2 212.7 56.7 51.5 128.6 BRD7 "BP75, CELTIX1" ENSG00000166164 "Bromodomain containing 7" Q9NPI1 16 50313487-50368934 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042389, CAB046458, HPA060171" Enhanced Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB046458: AB_2066024, HPA042389: AB_2677974, HPA060171: AB_2684214" "unprognostic (2.10e-2)" "unprognostic (9.52e-3)" "unprognostic (7.06e-2)" "unprognostic (3.39e-2)" "unprognostic (7.27e-2)" "unprognostic (1.62e-1)" "unprognostic (4.85e-3)" "unprognostic (1.08e-1)" "prognostic unfavorable (5.38e-4)" "unprognostic (2.15e-1)" "unprognostic (8.97e-2)" "unprognostic (9.46e-2)" "prognostic favorable (1.55e-4)" "unprognostic (1.13e-1)" "unprognostic (4.38e-2)" "unprognostic (3.59e-2)" "unprognostic (6.34e-2)" 23.5 26.9 38.8 33.7 39.0 42.2 39.1 34.5 35.9 24.5 30.7 32.4 26.4 23.4 29.0 38.1 37.3 27.1 24.4 41.2 35.3 31.9 29.9 22.9 27.9 32.1 38.4 26.9 26.8 36.5 53.3 35.1 37.9 42.6 29.5 30.3 22.2 26.9 30.7 37.9 31.2 31.1 27.2 48.1 32.1 29.0 41.5 36.4 46.1 31.2 26.5 36.4 24.5 40.0 8.8 11.2 9.6 6.8 12.3 12.1 3.7 22.3 19.7 34.7 20.6 14.7 14.6 22.9 18.4 18.2 29.1 13.2 33.1 22.8 33.4 19.3 16.3 18.1 20.7 31.7 18.5 33.6 15.1 26.3 22.6 15.8 45.7 17.3 31.1 25.0 10.6 27.9 14.9 25.8 17.7 19.3 33.2 32.6 10.7 17.7 14.5 35.2 42.0 27.2 23.6 18.8 43.4 32.6 24.2 25.4 15.8 27.0 21.9 22.3 21.7 15.0 31.0 13.0 28.3 19.4 18.5 22.5 15.2 17.8 5.1 1.9 57.1 14.5 22.7 18.3 8.2 6.8 9.6 8.8 5.7 6.8 8.0 8.9 8.1 5.4 8.8 10.1 12.1 4.0 12.3 5.1 11.2 8.5 3.7 38.8 39.0 34.5 35.9 35.3 31.9 38.4 26.9 42.6 36.4 35.7 59.7 42.5 27.5 45.1 90.5 31.9 48.4 50.9 36.4 47.1 62.8 63.5 91.2 20.0 32.8 31.4 37.2 46.7 19.9 40.7 28.7 42.0 15.0 35.5 26.0 85.8 34.5 23.9 27.0 15.6 30.2 35.5 25.3 14.4 38.2 74.8 20.8 37.0 26.5 46.0 113.1 51.8 22.1 155.1 163.9 55.3 60.5 24.9 35.5 64.3 BRD8 "p120, SMAP" ENSG00000112983 "Bromodomain containing 8" Q9H0E9 5 138139766-138178986 "Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Spermatocytes: 193.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001841 Supported Supported Nucleoplasm,Mitochondria NA Yes Nucleoplasm Mitochondria "HPA001841: AB_1845438" "unprognostic (1.25e-1)" "unprognostic (1.20e-1)" "unprognostic (2.81e-3)" "unprognostic (2.31e-2)" "unprognostic (9.01e-2)" "unprognostic (3.56e-2)" "prognostic unfavorable (1.09e-6)" "unprognostic (1.73e-1)" "unprognostic (7.01e-2)" "unprognostic (6.06e-2)" "unprognostic (1.51e-2)" "unprognostic (4.87e-2)" "prognostic unfavorable (7.80e-4)" "unprognostic (4.29e-1)" "unprognostic (1.28e-1)" "unprognostic (2.22e-1)" "unprognostic (2.07e-2)" 11.9 14.1 21.0 10.4 22.1 14.0 18.2 28.9 24.8 17.1 15.7 21.1 14.4 11.1 20.0 31.2 13.8 18.9 12.0 11.6 16.5 16.6 15.5 14.2 14.0 13.5 18.5 16.8 24.9 17.8 19.8 37.0 17.7 22.1 17.2 18.4 15.4 14.7 18.5 15.3 16.8 12.8 18.7 16.6 16.4 14.3 54.6 20.7 25.5 20.5 7.7 15.3 14.3 14.0 9.7 10.6 17.8 9.6 20.7 15.3 8.3 11.4 15.0 26.5 42.4 19.3 18.2 24.0 17.8 19.8 25.9 27.3 22.5 25.8 11.5 17.9 16.5 26.6 13.5 27.9 17.2 28.0 20.1 20.7 15.6 35.7 15.2 10.8 9.4 16.5 13.5 11.4 20.5 18.7 20.9 16.4 21.6 13.9 14.9 17.2 12.8 19.1 15.1 11.9 13.3 7.8 18.7 21.9 14.0 17.4 16.9 23.5 11.8 21.3 9.3 16.2 37.5 16.0 17.5 10.2 12.8 14.9 8.8 15.4 13.3 14.7 15.9 9.8 14.0 11.8 12.7 9.6 11.9 14.1 6.9 14.8 9.7 12.0 12.4 10.6 9.6 15.3 15.1 17.8 20.7 7.1 7.4 11.0 8.3 21.0 22.1 28.9 24.8 16.5 16.6 18.5 16.8 22.1 20.7 23.8 28.1 13.4 8.4 6.2 29.9 31.6 12.7 40.2 37.5 26.2 35.3 22.4 16.6 14.7 69.4 21.5 13.6 23.3 10.8 10.9 16.2 15.0 22.1 15.1 10.3 28.6 30.0 11.6 14.2 29.1 29.1 15.4 23.6 36.1 19.4 28.9 14.4 14.4 22.6 9.2 33.8 25.8 10.3 193.0 44.5 6.0 21.2 15.2 18.3 6.7 BRD9 FLJ13441 ENSG00000028310 "Bromodomain containing 9" Q9H8M2 5 850291-892824 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 43.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021465, HPA023197" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021465: AB_1845441, HPA023197: AB_2671106" "unprognostic (3.10e-2)" "unprognostic (1.76e-1)" "unprognostic (1.45e-3)" "unprognostic (4.61e-2)" "unprognostic (5.89e-2)" "unprognostic (2.59e-2)" "prognostic unfavorable (5.88e-7)" "unprognostic (6.28e-2)" "unprognostic (7.53e-3)" "unprognostic (3.84e-2)" "unprognostic (8.82e-2)" "unprognostic (2.28e-2)" "prognostic unfavorable (2.37e-6)" "unprognostic (6.64e-2)" "unprognostic (1.07e-1)" "unprognostic (6.62e-3)" "unprognostic (1.02e-2)" 13.7 12.3 14.5 15.2 23.8 12.7 12.9 31.8 22.0 13.0 13.0 16.1 10.9 11.7 17.9 10.0 12.8 14.9 9.1 15.3 16.2 10.9 9.1 8.5 11.9 14.3 15.1 15.0 16.3 14.6 13.2 18.2 10.9 14.4 11.2 11.1 11.1 14.7 14.7 25.8 13.1 12.5 12.7 13.9 12.5 13.6 18.5 21.1 16.8 13.3 12.0 15.9 15.6 14.4 6.5 3.1 6.2 4.7 2.7 4.8 1.1 6.2 3.8 12.0 11.9 4.3 8.8 13.7 12.5 7.3 12.5 9.2 7.9 8.5 8.0 19.3 11.8 13.3 5.8 8.1 11.3 10.5 43.9 5.5 10.4 13.8 3.9 9.4 15.0 8.9 6.6 3.3 8.8 7.7 8.8 12.2 14.3 12.7 5.7 9.4 6.4 17.3 8.6 7.2 5.7 6.5 11.0 7.3 6.8 6.3 8.2 7.1 12.6 23.9 8.4 4.4 6.6 7.5 13.2 12.1 11.2 7.5 5.8 12.1 9.2 4.2 14.2 9.4 14.4 13.6 6.2 4.7 5.4 3.5 2.4 4.6 6.5 4.2 4.8 3.1 4.9 4.8 3.0 4.1 2.7 3.1 1.8 4.5 1.1 14.5 23.8 31.8 22.0 16.2 10.9 15.1 15.0 14.4 21.1 17.9 15.6 25.2 12.1 22.6 66.5 21.2 25.5 2.7 14.8 22.7 43.2 15.1 19.9 21.0 76.4 21.8 20.0 0.0 17.1 26.0 16.9 10.8 18.5 18.4 18.2 95.3 15.6 33.7 23.0 43.5 21.0 16.9 13.5 24.4 24.0 25.2 23.6 21.6 18.4 12.6 85.2 25.8 16.5 33.9 61.3 17.8 16.5 29.9 21.8 11.5 BRF1 "BRF, GTF3B, hBRF, TAF3B2, TAF3C, TFIIIB90" ENSG00000185024 "BRF1, RNA polymerase III transcription initiation factor subunit" Q92994 14 105209286-105315589 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051918, HPA074990" Approved Approved "Nucleoplasm,Nuclear bodies" Yes No Nucleoplasm "Nuclear bodies" "HPA051918: AB_2681663, HPA074990: " "unprognostic (1.98e-1)" "unprognostic (4.45e-2)" "unprognostic (1.46e-2)" "unprognostic (2.51e-2)" "unprognostic (1.07e-1)" "unprognostic (7.52e-2)" "unprognostic (1.52e-4)" "unprognostic (2.67e-2)" "unprognostic (3.25e-1)" "unprognostic (2.26e-1)" "prognostic favorable (7.25e-6)" "unprognostic (8.83e-2)" "prognostic favorable (1.13e-4)" "unprognostic (1.85e-1)" "unprognostic (2.70e-1)" "unprognostic (5.39e-2)" "unprognostic (2.52e-1)" 12.1 11.8 15.2 11.0 15.9 9.2 8.2 21.7 25.9 10.4 9.6 24.7 11.0 11.8 11.0 7.0 9.1 15.4 10.5 10.6 16.4 19.1 10.0 9.8 11.3 11.2 19.1 14.5 14.4 20.8 18.0 16.6 9.3 18.3 12.1 6.9 13.2 15.8 11.0 21.8 12.4 12.3 12.5 21.2 12.0 10.5 11.1 14.8 9.9 9.7 6.1 9.5 8.9 7.6 3.3 6.4 4.0 7.4 4.9 3.6 2.8 7.3 16.6 7.1 15.6 6.4 7.2 7.5 11.1 6.8 9.5 7.7 11.7 11.3 5.8 10.9 7.2 4.6 15.0 8.5 7.1 5.2 15.7 9.4 6.8 8.6 5.4 7.2 8.1 15.0 6.9 5.9 5.7 7.0 4.8 6.8 11.8 8.1 4.4 4.6 22.9 9.5 10.3 5.4 12.2 17.9 17.1 5.0 5.7 4.7 17.9 23.1 17.2 11.1 8.8 9.4 3.5 20.2 11.3 10.0 7.4 6.4 13.9 8.5 8.9 6.7 5.3 8.9 6.7 10.0 0.7 2.3 4.0 3.6 2.2 2.5 3.2 2.5 3.5 2.5 3.3 3.4 2.9 1.0 4.9 7.4 6.4 3.1 2.8 15.2 15.9 21.7 25.9 16.4 19.1 19.1 14.5 18.3 14.8 3.0 5.1 5.9 5.9 6.6 16.4 7.2 2.5 12.0 6.8 3.5 15.7 10.2 3.3 5.0 1.9 6.8 8.6 0.0 6.0 7.4 6.6 6.4 2.3 10.2 6.1 28.6 9.2 9.8 5.4 0.7 6.1 6.4 8.5 4.6 10.2 8.3 4.2 7.0 4.2 5.6 18.4 0.0 7.3 7.0 13.6 7.8 7.8 10.7 9.0 4.1 BRI3BP "BNAS1, HCCR-2, HCCRBP-3, KG19" ENSG00000184992 "BRI3 binding protein" Q8WY22 12 124993700-125031231 "Predicted membrane proteins, Transporters" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 128.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 38.1;U-698: 46.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014957 Approved Approved Nucleoplasm,Mitochondria NA Yes "Nucleoplasm, Mitochondria" "HPA014957: AB_1845447" "unprognostic (1.62e-2)" "unprognostic (6.82e-2)" "unprognostic (1.53e-2)" "unprognostic (9.95e-2)" "unprognostic (4.66e-2)" "unprognostic (1.20e-2)" "prognostic unfavorable (6.87e-4)" "unprognostic (7.65e-3)" "unprognostic (2.84e-2)" "unprognostic (3.47e-3)" "unprognostic (7.40e-2)" "unprognostic (4.82e-2)" "unprognostic (2.72e-3)" "unprognostic (1.44e-3)" "unprognostic (2.20e-1)" "unprognostic (9.20e-2)" "unprognostic (1.55e-1)" 3.8 3.2 10.8 12.6 13.7 4.7 6.8 13.4 16.0 3.8 16.8 8.8 2.4 22.5 2.9 3.0 10.7 5.0 9.8 3.0 11.0 10.8 8.3 7.5 3.4 14.2 10.9 10.3 2.2 11.2 9.8 4.0 2.6 10.5 3.8 17.8 4.7 4.1 3.1 2.0 8.0 21.8 3.3 12.6 7.3 9.0 2.6 7.7 11.1 5.4 4.5 17.8 3.6 4.3 2.4 5.7 9.5 2.5 1.5 1.2 0.7 9.4 12.5 4.6 4.3 4.0 2.1 5.0 6.7 1.5 4.0 1.9 7.9 6.5 38.1 7.9 1.7 2.8 11.7 10.8 6.0 3.9 7.0 5.9 17.5 5.6 7.1 0.7 25.4 22.0 0.9 3.5 4.7 2.6 1.9 1.7 13.9 6.0 2.2 4.2 10.1 13.0 11.4 2.5 10.3 4.9 8.3 7.7 8.3 6.2 14.5 6.2 4.0 8.2 9.0 3.0 1.6 16.0 21.0 2.0 3.6 3.8 3.8 6.7 7.4 13.3 46.8 3.8 9.5 9.8 4.5 2.5 9.5 1.2 1.7 1.1 1.8 0.9 0.9 2.4 2.4 0.8 1.2 3.8 1.5 1.6 5.7 0.8 0.7 10.8 13.7 13.4 16.0 11.0 10.8 10.9 10.3 10.5 7.7 8.9 7.2 26.7 7.9 10.9 35.5 6.3 45.9 8.1 5.7 8.7 13.7 8.8 3.3 9.0 23.9 3.0 55.2 0.0 9.2 18.3 5.5 8.0 18.4 25.2 17.3 23.8 7.5 3.7 28.3 128.6 1.1 15.5 10.1 3.6 39.6 13.2 14.1 35.1 3.9 10.9 25.6 0.0 5.9 0.9 8.1 15.9 4.3 8.7 67.9 7.8 BRICD5 "C16orf79, MGC21830" ENSG00000182685 "BRICHOS domain containing 5" Q6PL45 16 2209253-2211950 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 29.7;testis: 42.8" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 10.7;Cone photoreceptor cells: 23.6;Rod photoreceptor cells: 11.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 29.7" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA063522 Approved "Nucleoplasm,Actin filaments" NA NA "Actin filaments" Nucleoplasm "HPA063522: AB_2685029" "prognostic favorable (9.74e-4)" "unprognostic (7.12e-3)" "unprognostic (1.25e-2)" "unprognostic (1.04e-1)" "unprognostic (1.18e-1)" "unprognostic (1.93e-3)" "unprognostic (2.02e-1)" "unprognostic (4.62e-2)" "unprognostic (4.34e-3)" "unprognostic (7.56e-2)" "prognostic favorable (7.01e-4)" "unprognostic (9.84e-3)" "unprognostic (2.65e-2)" "unprognostic (9.79e-2)" "unprognostic (2.88e-1)" "unprognostic (3.57e-1)" "prognostic favorable (8.06e-5)" 2.0 4.0 3.2 3.7 4.9 3.0 2.0 29.7 5.3 2.0 2.0 2.0 2.0 5.4 2.8 2.0 2.0 1.6 2.0 2.9 3.5 4.4 2.9 2.0 2.1 4.6 3.1 2.8 2.0 3.0 2.2 3.6 2.9 2.5 2.4 0.5 9.9 3.7 4.0 9.1 2.7 5.2 2.0 3.3 6.3 2.7 42.8 2.0 2.4 6.1 2.0 2.0 2.0 2.0 0.8 0.6 2.3 0.8 0.8 1.7 0.4 2.8 5.6 7.7 4.4 1.2 1.3 14.1 2.7 0.5 1.5 2.3 7.1 7.0 1.6 1.8 0.5 1.8 7.6 1.0 1.0 1.1 5.2 3.4 1.7 13.4 1.8 0.7 0.7 4.4 1.5 2.1 2.3 0.5 2.3 0.9 6.4 1.9 4.0 0.6 7.6 4.8 10.8 7.5 0.9 3.2 14.8 5.8 5.0 1.7 2.2 5.4 4.9 2.7 3.4 2.6 3.7 3.4 4.0 2.2 7.4 6.0 6.4 2.3 12.1 5.2 4.0 1.4 4.5 3.5 0.4 0.7 2.2 0.6 0.8 0.3 0.3 0.3 0.1 0.6 0.8 1.7 0.4 2.3 0.8 0.2 0.4 0.4 0.4 3.2 4.9 29.7 5.3 3.5 4.4 3.1 2.8 2.5 2.0 3.0 4.1 0.0 0.5 0.3 10.7 0.4 0.0 4.0 0.0 5.2 23.6 1.6 0.0 0.8 2.1 1.1 1.8 0.0 0.5 0.7 1.0 0.8 4.6 1.0 1.1 4.8 1.2 1.8 2.2 5.9 1.1 2.5 1.7 1.0 1.2 4.3 0.7 0.0 2.5 0.3 11.0 0.0 0.5 3.9 1.9 1.0 0.7 0.0 2.3 0.4 BRIP1 "BACH1, FANCJ, OF" ENSG00000136492 "BRCA1 interacting protein C-terminal helicase 1" Q9BX63 17 61681266-61863521 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Helicase, Hydrolase" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 30.1" "Group enriched" "Detected in many" 11 "Early spermatids: 136.2;Late spermatids: 148.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.2;granulocytes: 2.1;T-cells: 3.7" "Cell line enhanced" "Detected in many" "MCF7: 42.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005474 Approved Supported "Nucleoplasm,Nuclear membrane" NA Yes "Nucleoplasm, Nuclear membrane" "HPA005474: AB_2667333" "unprognostic (1.88e-1)" "unprognostic (1.55e-2)" "prognostic favorable (3.45e-5)" "unprognostic (6.85e-4)" "unprognostic (3.09e-1)" "prognostic favorable (3.62e-4)" "unprognostic (2.60e-3)" "unprognostic (5.60e-2)" "unprognostic (5.66e-3)" "unprognostic (6.71e-2)" "unprognostic (1.50e-3)" "unprognostic (2.75e-2)" "unprognostic (3.41e-12)" "unprognostic (1.19e-2)" "unprognostic (2.25e-1)" "unprognostic (3.96e-2)" "unprognostic (3.62e-3)" 1.0 0.9 0.7 6.3 3.5 9.1 1.1 0.6 1.4 1.4 2.6 0.2 0.6 2.8 1.5 1.2 3.7 0.8 1.8 0.4 0.5 0.5 0.6 2.3 1.3 4.0 0.5 0.9 2.1 1.3 0.1 0.4 1.7 0.7 1.0 2.8 0.4 1.4 0.0 0.4 2.7 5.5 1.0 0.5 2.3 1.3 10.8 0.4 30.1 0.4 2.0 6.6 1.3 1.7 2.2 0.5 2.1 0.3 0.6 3.7 0.5 12.5 4.3 12.4 7.1 0.4 1.1 2.7 11.6 6.8 12.4 16.1 4.4 4.0 7.5 2.7 2.4 3.6 4.5 6.4 2.4 16.8 1.9 7.8 7.6 6.8 5.4 0.1 9.8 4.5 0.2 0.1 9.9 2.6 1.7 2.7 7.4 5.3 5.1 7.8 42.2 15.5 3.4 2.7 3.0 3.7 9.7 23.9 3.6 1.7 5.7 5.0 12.9 4.5 1.6 1.8 4.9 4.2 3.8 2.3 18.3 13.4 6.7 13.3 3.2 6.1 8.0 3.7 4.7 4.5 2.1 0.3 1.5 0.5 0.2 0.6 2.2 1.2 0.6 0.4 1.8 1.8 0.9 1.0 0.6 0.2 0.5 3.7 0.5 0.7 3.5 0.6 1.4 0.5 0.5 0.5 0.9 0.7 0.4 0.0 0.3 1.5 1.3 2.1 0.1 0.5 0.0 1.4 6.8 0.0 0.0 0.7 0.0 0.3 136.2 0.3 0.9 0.0 0.2 2.5 0.6 0.1 0.0 3.0 1.4 0.0 0.0 0.6 0.3 148.4 1.1 0.4 3.3 1.0 1.5 0.3 0.5 0.0 1.1 0.0 0.2 0.0 0.9 13.3 4.5 0.4 0.2 0.8 2.5 0.3 BRMS1L "BRMS1, FLJ39177, MGC11296" ENSG00000100916 "Breast cancer metastasis-suppressor 1 like" Q5PSV4 14 35826318-35932325 "Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046623 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA046623: AB_2679724" "prognostic unfavorable (5.78e-4)" "unprognostic (1.86e-1)" "unprognostic (2.03e-1)" "unprognostic (1.69e-3)" "unprognostic (2.66e-2)" "unprognostic (2.27e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (2.56e-2)" "unprognostic (2.02e-2)" "unprognostic (8.04e-2)" "unprognostic (6.50e-2)" "unprognostic (1.66e-1)" "prognostic favorable (6.55e-5)" "unprognostic (2.06e-2)" "unprognostic (1.98e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (6.87e-6)" 8.4 14.3 15.5 5.0 18.6 3.0 8.7 18.6 21.4 8.7 6.0 7.2 5.9 4.5 9.0 8.1 9.0 6.7 5.9 15.4 13.2 13.3 12.3 8.3 6.7 3.9 11.5 16.7 10.4 4.3 14.9 7.8 9.9 15.9 9.4 5.3 3.9 5.6 9.2 16.3 8.0 3.9 9.8 11.0 4.7 5.6 7.1 11.0 2.2 10.1 5.8 5.2 7.3 9.6 2.1 2.3 0.8 3.4 1.0 4.0 2.2 7.0 7.2 12.6 7.2 11.4 14.5 18.7 7.4 7.2 11.5 11.3 4.6 6.0 5.7 7.6 10.3 5.4 9.1 9.9 13.5 16.6 6.3 12.2 5.2 7.3 20.1 8.1 2.6 4.4 10.1 9.2 8.9 7.6 6.0 8.2 3.3 2.5 4.6 12.9 9.4 3.0 4.2 5.0 10.0 10.7 3.1 13.9 4.3 9.3 8.1 3.7 9.6 8.5 10.0 8.4 10.0 11.4 3.7 5.0 11.1 6.7 6.2 7.2 4.3 5.6 3.5 2.7 5.7 6.7 0.1 1.4 0.8 2.8 3.2 2.4 2.1 3.0 3.7 0.9 1.5 4.0 3.6 0.1 1.0 3.4 2.3 3.4 2.2 15.5 18.6 18.6 17.5 13.2 13.3 11.5 16.7 15.9 11.0 8.9 8.6 6.9 7.6 16.6 16.8 16.5 2.5 6.7 12.5 7.0 3.9 16.9 6.6 4.3 2.8 10.2 1.3 0.0 6.1 13.7 12.5 9.3 14.9 3.9 4.4 15.9 4.6 4.9 1.8 1.7 10.3 3.6 8.5 9.0 3.6 16.9 4.5 3.5 9.2 16.2 16.3 19.4 18.6 4.9 16.2 14.2 18.8 7.0 3.7 4.7 BROX "C1orf58, FLJ32421" ENSG00000162819 "BRO1 domain and CAAX motif containing" Q5VW32 1 222712553-222735196 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031445 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 190000 "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA031445: AB_10602697" "unprognostic (1.27e-1)" "unprognostic (4.32e-1)" "unprognostic (3.43e-2)" "unprognostic (4.60e-2)" "unprognostic (1.30e-1)" "unprognostic (5.02e-1)" "unprognostic (3.31e-2)" "unprognostic (2.83e-2)" "unprognostic (2.52e-2)" "unprognostic (6.72e-2)" "unprognostic (4.27e-2)" "unprognostic (2.53e-2)" "unprognostic (4.84e-2)" "unprognostic (1.09e-1)" "unprognostic (6.56e-2)" "unprognostic (1.83e-2)" "unprognostic (2.50e-2)" 24.0 21.1 22.7 15.7 25.3 33.0 22.2 21.6 24.9 17.8 23.6 22.0 13.8 19.8 18.2 15.6 30.1 17.7 18.3 14.9 22.5 20.2 22.6 21.0 18.5 22.7 30.2 22.7 21.4 16.2 28.3 21.8 28.1 29.6 17.0 23.7 11.8 21.3 17.9 23.7 23.5 33.0 16.8 27.5 22.9 23.2 12.6 30.1 24.4 25.0 22.5 19.7 21.1 19.8 8.8 13.4 30.9 21.7 14.2 15.3 8.5 25.6 15.4 9.5 8.3 13.9 14.8 18.5 17.6 22.1 14.5 16.7 8.6 33.6 8.5 21.2 21.8 7.9 22.6 10.6 16.9 22.2 10.6 9.5 12.7 17.2 8.5 15.7 14.5 12.1 13.0 16.7 18.1 21.6 16.6 13.1 5.6 19.2 11.7 17.8 7.7 6.1 7.5 12.0 21.1 18.4 6.4 28.9 19.1 17.2 25.6 10.7 16.9 19.3 22.2 13.1 9.5 26.9 14.9 18.9 20.0 11.6 20.6 19.9 8.8 14.7 7.7 16.2 12.3 18.2 30.9 15.8 18.3 12.0 21.7 13.3 8.8 15.3 12.0 13.4 8.3 10.3 13.0 27.3 14.2 21.0 7.5 13.8 8.5 22.7 25.3 21.6 24.9 22.5 20.2 30.2 22.7 29.6 30.1 68.5 33.2 19.3 26.5 43.0 16.4 34.1 30.6 77.6 30.7 48.8 7.9 23.9 48.0 33.6 16.0 24.8 34.2 46.7 28.3 27.0 25.7 39.8 15.1 22.1 32.3 33.4 30.6 33.7 50.9 16.7 22.5 40.8 47.2 35.1 45.9 31.0 43.0 40.3 30.1 41.6 19.5 51.8 26.8 21.8 22.2 40.8 43.1 43.7 38.4 39.3 BRPF3 KIAA1286 ENSG00000096070 "Bromodomain and PHD finger containing 3" Q9ULD4 6 36196744-36232790 "Plasma proteins, Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022787 Uncertain Approved Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA022787: AB_1845454" "unprognostic (1.44e-1)" "unprognostic (2.24e-1)" "unprognostic (5.52e-2)" "unprognostic (2.15e-2)" "unprognostic (2.98e-1)" "unprognostic (9.51e-2)" "unprognostic (5.33e-2)" "unprognostic (3.78e-1)" "unprognostic (3.02e-2)" "unprognostic (1.07e-1)" "unprognostic (7.98e-2)" "unprognostic (3.74e-1)" "unprognostic (3.59e-2)" "unprognostic (3.29e-2)" "unprognostic (1.67e-1)" "unprognostic (1.28e-1)" "unprognostic (1.28e-1)" 9.6 21.8 11.9 12.3 11.7 12.3 25.8 22.4 16.7 11.9 15.2 10.9 28.3 13.5 16.0 13.4 9.5 10.8 10.6 10.9 10.3 9.1 15.9 16.5 9.6 7.7 10.4 11.7 15.2 20.8 18.1 18.8 8.7 7.4 15.2 15.3 8.0 16.5 31.0 22.9 14.5 17.0 12.2 9.8 9.8 12.4 22.9 11.8 11.8 18.3 4.4 7.1 13.9 22.3 0.8 0.5 3.0 0.2 0.1 2.0 0.6 6.7 6.5 16.4 12.8 9.1 7.7 14.0 10.2 10.8 14.4 11.4 19.0 6.4 10.5 11.0 10.0 18.2 6.6 14.4 7.3 12.7 9.9 8.9 7.4 6.0 11.2 9.6 5.7 10.4 9.8 6.3 17.1 8.6 10.5 10.7 5.1 15.4 9.7 7.8 9.6 6.5 2.5 8.2 8.3 5.6 19.1 6.7 3.2 4.7 13.9 23.5 7.4 8.3 9.1 8.7 10.6 10.2 15.9 11.2 15.1 12.9 4.1 11.8 8.0 10.3 7.9 2.5 9.2 17.7 3.0 0.2 1.4 1.9 0.2 2.0 0.8 0.5 0.6 0.2 0.4 0.9 0.6 1.5 0.1 0.1 0.5 1.2 0.6 11.9 11.7 22.4 16.7 10.3 9.1 10.4 11.7 7.4 11.8 6.0 10.1 2.9 6.8 8.5 10.1 10.9 12.7 2.7 5.7 5.2 5.9 4.2 0.0 4.7 13.2 7.1 15.1 0.0 9.2 3.7 9.5 10.3 2.3 16.6 3.7 0.0 18.9 11.6 5.0 10.4 10.3 2.5 6.8 5.4 26.5 4.3 10.0 10.5 8.9 11.4 6.7 0.0 6.2 17.9 12.2 9.9 6.9 4.3 13.9 8.4 BRSK1 KIAA1811 ENSG00000160469 "BR serine/threonine kinase 1" Q8TDC3 19 55282072-55312533 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, DNA damage, Neurogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 65.0" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 30.8;Enterocytes: 12.3;Horizontal cells: 36.5" "Cancer enhanced" "Detected in all" "glioma: 12.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 26.2;SH-SY5Y: 23.6;WM-115: 21.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021212, HPA061719" Enhanced Supported "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA021212: AB_1845455, HPA061719: AB_2684593" "unprognostic (1.42e-3)" "unprognostic (2.92e-2)" "unprognostic (1.20e-1)" "unprognostic (6.69e-3)" "unprognostic (2.71e-1)" "unprognostic (4.21e-2)" "unprognostic (3.06e-6)" "unprognostic (4.24e-1)" "unprognostic (2.06e-2)" "unprognostic (3.04e-1)" "prognostic favorable (1.02e-4)" "unprognostic (3.00e-1)" "prognostic unfavorable (7.98e-6)" "unprognostic (1.16e-1)" "unprognostic (6.61e-3)" "unprognostic (1.34e-1)" "unprognostic (2.09e-1)" 1.4 9.8 28.6 3.2 23.6 1.0 1.6 26.7 65.0 1.8 2.2 7.9 0.1 3.3 5.4 3.7 3.0 2.3 3.9 6.5 33.4 20.0 1.4 0.8 1.7 2.4 20.4 14.8 2.4 2.6 12.4 11.0 1.5 13.3 3.8 1.9 2.8 2.5 4.6 1.0 1.1 2.6 4.9 9.2 1.5 1.9 4.4 7.2 0.0 3.0 0.0 1.6 3.2 0.7 0.0 0.3 0.0 0.9 0.1 0.8 0.2 0.3 1.3 15.5 8.2 0.0 0.6 0.1 2.4 3.4 3.3 4.9 5.9 2.7 3.1 1.7 2.8 3.1 0.1 3.2 0.1 3.1 14.6 12.8 2.0 1.6 0.6 3.3 0.6 6.0 2.2 0.3 3.4 0.0 12.9 0.1 8.2 2.8 19.1 3.0 0.8 3.7 0.7 11.2 0.3 1.0 8.5 3.9 0.5 0.2 0.0 26.2 23.6 0.0 0.4 5.7 4.6 1.3 1.7 0.0 6.4 6.8 3.5 4.6 15.8 11.6 7.1 6.5 1.4 21.4 0.0 0.9 0.0 0.1 0.4 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.2 28.6 23.6 26.7 40.2 33.4 20.0 20.4 14.8 13.3 7.2 0.0 2.2 0.0 1.0 0.1 30.8 0.8 0.0 0.0 1.2 1.8 2.0 0.0 0.0 0.3 0.8 0.3 12.3 0.0 0.0 0.0 0.5 0.8 0.0 0.0 1.4 36.5 3.4 0.0 7.8 0.0 0.6 0.4 0.0 0.0 1.0 3.2 0.2 0.0 4.6 0.8 10.2 0.0 1.0 3.9 6.5 0.0 0.0 0.8 1.2 0.1 BRWD1 "C21orf107, DCAF19, FLJ11315, N143, WDR9" ENSG00000185658 "Bromodomain and WD repeat domain containing 1" Q9NSI6 21 39184176-39321559 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030943, HPA030944, HPA030945, CAB034184" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "CAB034184: AB_2243666, HPA030943: AB_2673666, HPA030944: AB_2673667, HPA030945: AB_10670161" "unprognostic (6.00e-2)" "unprognostic (1.35e-1)" "unprognostic (1.96e-1)" "unprognostic (1.31e-1)" "unprognostic (1.27e-1)" "unprognostic (8.39e-3)" "unprognostic (4.94e-2)" "unprognostic (5.01e-2)" "unprognostic (8.90e-2)" "unprognostic (2.26e-1)" "unprognostic (4.82e-3)" "unprognostic (5.45e-2)" "unprognostic (2.58e-3)" "unprognostic (6.48e-2)" "unprognostic (1.19e-1)" "unprognostic (3.88e-2)" "unprognostic (2.56e-2)" 10.9 16.7 33.0 15.4 36.8 13.4 16.3 15.5 40.2 12.3 12.0 14.3 10.5 8.8 13.0 21.1 10.2 11.8 9.9 12.9 29.1 32.9 13.9 21.8 10.0 12.9 24.3 17.7 16.2 17.2 12.8 12.0 15.2 13.4 13.2 11.5 13.0 9.3 11.8 14.6 11.9 9.6 13.1 16.1 9.6 9.9 17.2 10.5 22.4 17.7 9.3 13.2 12.1 11.6 8.5 7.2 11.6 6.1 10.2 11.1 3.8 10.2 4.1 10.1 5.6 6.5 9.8 10.4 5.9 6.9 4.6 5.4 3.9 7.0 32.9 6.2 8.0 5.5 5.1 9.4 6.8 7.3 7.6 7.7 22.3 7.2 7.1 8.2 12.3 6.3 6.7 11.2 6.3 16.0 10.7 6.8 21.0 16.5 16.6 6.4 7.9 8.4 14.5 10.6 12.4 5.8 14.9 7.8 10.4 5.6 6.6 8.0 10.3 12.6 15.2 8.7 3.9 12.9 17.2 7.5 6.1 2.9 3.5 4.4 18.5 12.7 16.0 7.3 13.2 4.8 4.4 5.2 11.6 10.7 6.1 8.3 8.5 9.2 11.0 7.2 6.3 11.1 9.0 5.7 10.2 3.8 6.8 10.3 3.8 33.0 36.8 15.5 40.0 29.1 32.9 24.3 17.7 13.4 10.5 44.7 40.4 19.5 36.5 56.1 63.7 54.9 17.8 49.5 39.8 17.4 110.0 50.0 38.1 24.8 41.9 37.6 30.2 23.3 30.0 38.8 37.9 51.4 31.3 31.6 22.1 69.9 34.0 33.2 35.6 16.8 40.0 27.5 28.7 23.4 35.9 35.9 32.0 28.1 42.1 28.1 103.4 25.8 37.3 85.4 77.1 61.5 83.5 38.9 34.2 55.4 BRWD3 "FLJ38568, MRX93" ENSG00000165288 "Bromodomain and WD repeat domain containing 3" Q6RI45 X 80670854-80809688 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 58.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012802 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA012802: AB_2066662" "unprognostic (1.13e-2)" "unprognostic (2.14e-1)" "unprognostic (2.85e-1)" "unprognostic (3.17e-3)" "unprognostic (7.04e-3)" "unprognostic (2.00e-1)" "unprognostic (1.50e-1)" "unprognostic (7.18e-2)" "unprognostic (7.44e-2)" "unprognostic (2.75e-1)" "unprognostic (7.18e-2)" "unprognostic (1.62e-2)" "unprognostic (1.41e-2)" "unprognostic (2.23e-2)" "unprognostic (1.54e-1)" "unprognostic (1.01e-1)" "unprognostic (3.35e-1)" 7.7 5.7 7.5 9.1 7.7 10.5 13.0 20.9 8.5 9.3 8.2 5.6 8.6 8.5 8.0 6.2 10.8 8.1 6.3 5.0 7.4 4.6 5.6 7.5 12.7 9.3 5.3 5.5 11.9 7.8 7.3 12.5 8.6 6.5 6.7 8.1 7.7 8.2 11.3 3.7 14.0 10.3 5.8 12.7 8.9 7.3 9.3 7.1 10.1 9.0 6.0 9.1 10.7 12.7 1.1 0.7 2.8 1.1 0.5 1.2 0.5 4.6 5.1 7.7 5.1 3.1 3.9 5.6 2.7 2.4 3.5 4.8 2.3 6.5 5.0 6.4 2.5 4.3 8.3 11.8 4.6 4.7 4.3 4.8 10.2 8.2 3.5 2.3 5.8 6.9 2.6 3.2 4.0 5.5 5.1 5.3 4.5 7.4 12.7 4.0 0.8 3.3 5.4 11.8 5.1 2.1 3.0 13.5 2.9 4.0 4.0 1.8 4.4 6.6 3.6 2.9 15.1 1.6 5.7 4.8 4.1 5.2 3.8 2.9 5.6 5.9 6.0 3.3 11.8 2.7 0.5 1.1 0.7 0.8 0.9 0.8 0.7 0.8 0.7 0.6 1.1 0.6 1.2 2.8 0.5 0.8 0.7 0.6 0.5 7.5 7.7 20.9 8.5 7.4 4.6 5.3 5.5 6.5 7.1 11.9 11.2 7.5 6.9 15.5 23.2 7.7 15.3 4.0 18.2 5.2 15.7 4.9 0.0 5.3 0.9 10.5 12.9 0.0 5.2 6.5 8.2 9.4 10.5 5.8 4.7 58.8 6.9 5.5 10.3 3.0 9.2 12.7 1.7 1.8 10.2 10.8 8.4 21.0 9.6 3.1 21.0 6.5 7.6 6.6 8.3 18.2 6.4 10.0 10.2 19.5 BSPRY FLJ20150 ENSG00000119411 "B-box and SPRY domain containing" Q5W0U4 9 113349541-113371233 "Predicted intracellular proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 67.7;salivary gland: 68.2" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 59.2;Exocrine glandular cells: 58.0;Pancreatic endocrine cells: 56.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "basal ganglia: 20.8" "Cell type enriched" "Detected in single" 20 "plasmacytoid DC: 8.0" "Lineage enriched" "Detected in single" 20 "dendritic cells: 8.0" "Cell line enhanced" "Detected in some" "A-431: 18.1;CAPAN-2: 11.6;MCF7: 27.0;OE19: 31.4;RPMI-8226: 14.1;SK-BR-3: 13.6;T-47d: 13.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042889, HPA077485" Approved Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042889: AB_10795515, HPA077485: " "unprognostic (1.32e-1)" "unprognostic (3.09e-2)" "unprognostic (1.18e-1)" "unprognostic (2.20e-3)" "unprognostic (1.68e-1)" "unprognostic (2.10e-3)" "unprognostic (4.29e-1)" "unprognostic (1.67e-1)" "unprognostic (1.17e-1)" "unprognostic (2.71e-1)" "unprognostic (2.28e-1)" "unprognostic (1.95e-2)" "prognostic favorable (4.56e-14)" "unprognostic (1.15e-3)" "unprognostic (2.36e-1)" "unprognostic (1.38e-1)" "unprognostic (1.70e-1)" 0.2 1.6 1.0 4.6 20.8 2.1 6.1 4.1 1.4 2.9 5.4 0.4 7.9 3.6 1.0 6.4 14.2 1.9 8.5 1.4 0.6 0.7 9.3 0.4 4.1 0.6 0.7 1.3 0.3 37.8 67.7 10.1 1.7 0.6 2.4 4.5 2.7 68.2 4.8 0.1 12.4 6.8 0.4 0.3 0.3 10.4 2.1 1.8 1.2 28.2 10.7 5.4 1.5 3.2 0.0 8.0 0.0 0.0 0.0 0.4 0.1 18.1 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 3.8 11.6 0.0 0.2 0.0 0.0 1.6 0.1 0.0 0.0 2.0 1.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 9.4 0.1 0.0 0.0 27.0 0.3 0.0 0.4 31.4 0.0 0.4 0.0 14.1 1.8 3.9 6.2 0.0 0.0 13.6 0.0 0.8 13.7 1.9 0.0 0.0 0.0 0.0 0.0 4.4 5.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.0 0.0 0.1 1.0 20.8 4.1 1.4 0.6 0.7 0.7 1.3 0.6 1.8 6.0 5.8 2.4 1.7 0.9 0.6 1.6 15.3 2.7 4.5 26.2 5.9 8.1 33.2 59.2 0.1 0.1 12.9 0.0 58.0 0.7 0.4 15.4 3.5 0.8 1.2 0.0 19.7 0.0 0.0 0.2 0.0 0.1 10.1 1.8 19.3 0.3 56.5 14.0 0.0 15.3 9.1 0.0 0.0 0.5 2.3 12.4 5.6 0.5 24.3 13.9 BTAF1 "MOT1, TAF-172, TAF(II)170, TAF172, TAFII170" ENSG00000095564 "B-TFIID TATA-box binding protein associated factor 1" O14981 10 91923769-92030325 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070682 Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA070682: AB_2686294" "unprognostic (2.41e-1)" "unprognostic (1.29e-1)" "unprognostic (5.39e-2)" "unprognostic (1.20e-1)" "unprognostic (3.92e-1)" "prognostic favorable (5.07e-4)" "unprognostic (2.72e-1)" "unprognostic (9.28e-2)" "unprognostic (1.16e-1)" "unprognostic (7.34e-2)" "unprognostic (9.70e-3)" "unprognostic (4.27e-2)" "prognostic unfavorable (4.04e-5)" "unprognostic (6.45e-2)" "unprognostic (1.10e-1)" "unprognostic (4.79e-2)" "unprognostic (1.98e-1)" 21.8 13.7 15.1 20.2 23.1 26.7 20.8 19.9 21.6 20.8 19.7 18.3 17.4 15.9 24.3 22.0 19.4 26.2 15.5 15.9 16.0 7.0 13.8 15.5 20.1 29.3 22.2 13.4 30.4 19.7 21.1 22.3 13.8 16.5 18.2 16.4 18.1 21.0 18.3 15.8 48.6 23.4 22.1 22.4 22.4 19.6 21.2 23.8 29.0 19.5 10.8 25.8 24.3 21.2 6.9 9.6 6.8 6.3 4.4 5.3 2.6 16.8 8.2 19.4 23.5 10.3 16.3 9.7 9.9 11.8 9.8 14.7 11.3 10.3 18.2 6.4 9.7 6.1 18.3 13.0 8.8 14.8 12.4 14.0 12.9 19.3 11.8 10.6 19.3 13.5 11.5 11.4 14.9 21.8 21.2 9.4 15.6 10.5 21.0 10.0 7.3 14.9 12.3 8.8 4.9 6.5 12.1 12.1 8.4 9.2 10.4 7.5 8.8 9.5 4.8 12.2 13.4 9.8 12.9 10.1 8.9 7.1 11.9 14.0 24.4 11.2 15.0 13.9 17.9 2.3 6.8 5.5 2.9 5.3 3.7 4.6 5.1 3.9 3.6 4.0 6.9 4.9 3.7 3.9 4.4 6.3 9.6 3.1 2.6 15.1 23.1 19.9 21.6 16.0 7.0 22.2 13.4 16.5 23.8 17.9 26.9 9.3 10.2 19.3 24.2 12.6 2.5 30.8 17.0 19.2 43.2 5.5 1.7 5.6 6.5 12.7 7.3 0.0 5.7 8.6 10.8 12.3 23.1 7.8 6.3 17.5 15.5 8.0 8.9 3.6 10.9 15.4 5.0 7.2 6.4 12.8 5.8 5.8 11.0 2.2 37.4 6.5 18.6 18.7 8.5 26.1 12.2 13.8 7.8 14.0 BTBD1 ENSG00000064726 "BTB domain containing 1" Q9H0C5 15 83016422-83067354 "Predicted intracellular proteins" "Differentiation, Myogenesis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 96.2" "Cell type enhanced" "Detected in all" 5 "Cardiomyocytes: 78.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024263, HPA067671" Enhanced Supported "Nucleoplasm,Cytoplasmic bodies" NA NA "Cytoplasmic bodies" Nucleoplasm "HPA024263: , HPA067671: AB_2685882" "unprognostic (1.63e-1)" "unprognostic (4.61e-2)" "unprognostic (1.35e-1)" "unprognostic (5.54e-2)" "unprognostic (1.80e-1)" "unprognostic (3.17e-2)" "unprognostic (4.80e-2)" "unprognostic (1.65e-1)" "unprognostic (1.85e-1)" "unprognostic (1.44e-1)" "unprognostic (2.73e-1)" "unprognostic (1.07e-1)" "prognostic favorable (6.21e-7)" "unprognostic (8.94e-3)" "unprognostic (8.27e-2)" "unprognostic (7.71e-2)" "unprognostic (1.89e-2)" 11.6 9.4 17.6 7.9 17.3 10.4 10.0 11.9 22.5 9.2 11.0 13.8 4.7 10.8 8.5 9.8 10.4 10.9 9.8 35.0 17.0 14.3 13.0 11.3 8.1 11.1 17.0 11.5 8.5 6.1 12.8 10.0 8.0 18.0 10.6 12.3 6.9 8.7 8.7 96.2 6.6 10.6 9.3 18.2 9.2 7.9 18.4 11.5 10.5 12.7 21.3 11.0 9.8 7.4 4.6 8.8 9.3 6.7 3.9 7.2 2.1 15.4 14.9 13.2 12.9 20.8 35.9 6.9 22.5 30.8 19.5 21.7 9.4 16.1 31.1 28.0 25.2 16.2 19.6 28.8 18.0 23.1 24.8 23.5 26.4 22.3 13.4 24.5 24.9 29.5 29.2 16.3 13.2 19.8 25.3 28.6 12.2 23.4 17.5 41.0 8.1 18.9 13.0 18.4 13.6 16.5 19.3 33.5 15.4 19.6 36.8 23.1 16.6 26.1 21.7 36.9 18.8 16.3 21.0 28.7 22.1 16.5 30.4 31.1 18.0 27.7 30.3 23.9 42.3 15.3 2.2 4.9 9.3 5.5 5.4 4.9 4.5 5.2 7.2 8.8 4.6 5.9 5.8 2.9 3.9 6.7 3.8 4.8 2.1 17.6 17.3 11.9 22.5 17.0 14.3 17.0 11.5 18.0 11.5 14.9 4.3 16.8 11.9 13.5 8.9 78.3 7.6 30.8 21.6 10.4 5.9 7.1 14.9 12.7 24.1 14.7 14.8 23.3 9.1 11.1 13.3 10.4 17.3 9.2 16.1 11.1 22.3 14.7 23.0 20.5 8.1 19.5 11.8 19.0 11.5 7.3 12.1 17.3 10.6 12.1 7.8 6.5 13.2 44.2 14.9 10.7 6.8 15.8 16.5 15.9 BTBD10 "GMRP-1, GMRP1, MGC13007" ENSG00000148925 "BTB domain containing 10" Q9BSF8 11 13388001-13463297 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 111.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046777 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA046777: AB_2679801" "unprognostic (2.38e-1)" "unprognostic (4.25e-1)" "unprognostic (1.75e-1)" "unprognostic (9.76e-2)" "unprognostic (1.59e-1)" "unprognostic (1.84e-2)" "prognostic unfavorable (1.37e-4)" "unprognostic (1.07e-1)" "unprognostic (2.52e-1)" "unprognostic (3.00e-1)" "unprognostic (1.29e-3)" "unprognostic (1.15e-2)" "unprognostic (1.43e-1)" "unprognostic (1.32e-1)" "unprognostic (2.02e-1)" "unprognostic (6.98e-2)" "unprognostic (1.27e-1)" 11.0 10.3 18.7 10.5 36.3 9.3 11.0 17.7 33.2 13.0 14.2 9.4 12.7 10.5 13.5 9.8 23.3 9.8 12.1 13.6 17.0 18.8 9.2 7.7 10.2 11.0 14.6 17.4 11.8 7.1 16.4 13.3 19.1 23.7 12.5 16.8 7.1 9.2 14.9 10.5 10.4 9.1 17.2 13.3 9.4 13.8 28.8 12.4 8.9 10.8 10.2 13.4 18.6 16.3 9.4 14.5 33.1 23.3 12.1 11.5 8.4 22.1 15.8 14.3 9.5 12.9 12.7 18.2 23.4 13.7 18.2 16.6 15.2 26.2 15.4 11.2 17.4 18.6 18.1 10.8 25.1 21.5 15.2 11.4 8.2 6.0 9.0 20.1 11.0 19.0 11.0 28.1 10.5 24.2 13.9 36.7 11.1 4.6 15.8 18.7 13.5 11.1 6.0 6.1 20.3 14.4 9.9 12.2 9.4 28.8 18.0 6.2 8.7 14.0 11.4 7.9 17.1 8.1 5.9 33.2 18.7 15.4 18.0 13.4 5.9 20.6 10.3 12.9 9.4 15.9 18.1 12.6 18.4 9.7 19.3 11.5 9.4 9.2 10.6 14.5 9.0 10.5 10.4 33.1 12.1 23.3 6.3 11.3 8.4 18.7 36.3 17.7 33.2 17.0 18.8 14.6 17.4 23.7 12.4 14.9 6.5 9.3 25.5 25.0 12.0 12.2 17.8 20.1 11.4 5.2 3.9 20.6 5.0 31.2 66.5 18.8 9.1 0.0 22.0 47.0 13.2 25.4 22.0 5.4 19.6 7.9 15.6 11.6 14.6 18.9 9.2 12.1 16.9 27.9 12.6 7.7 36.2 11.5 17.3 7.9 12.1 6.5 16.1 111.4 48.7 31.2 51.9 16.0 12.8 50.9 BTBD11 "ABTB2B, FLJ33957" ENSG00000151136 "BTB domain containing 11" A6QL63 12 107318413-107659642 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 61.8" "Cell type enhanced" "Detected in some" 7 "Basal keratinocytes: 4.6;Peritubular cells: 3.9;Suprabasal keratinocytes: 6.8;Urothelial cells: 3.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 7.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 19.3;Hep G2: 10.2;MOLT-4: 12.9;PC-3: 9.1;RT4: 8.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055898, HPA061334" Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA055898: AB_2682964, HPA061334: " "unprognostic (3.40e-2)" "unprognostic (4.06e-1)" "unprognostic (2.37e-1)" "unprognostic (7.85e-2)" "unprognostic (8.78e-3)" "unprognostic (4.82e-2)" "unprognostic (3.52e-1)" "unprognostic (2.12e-1)" "unprognostic (1.52e-1)" "unprognostic (5.92e-2)" "unprognostic (5.33e-2)" "unprognostic (1.78e-1)" "unprognostic (4.92e-8)" "unprognostic (2.66e-1)" "unprognostic (1.55e-1)" "unprognostic (3.33e-2)" "unprognostic (9.07e-3)" 0.9 1.1 3.7 2.4 6.6 3.3 2.7 4.6 10.2 6.8 1.0 2.2 3.2 1.1 1.3 1.5 24.1 0.8 1.2 1.0 2.9 9.4 3.7 1.4 1.0 4.0 8.3 3.0 0.6 1.2 61.8 3.2 2.0 19.0 3.1 1.0 1.7 6.2 1.6 0.9 8.4 1.6 1.0 4.9 1.5 1.0 1.1 1.2 24.8 14.4 9.5 9.0 2.3 7.9 0.3 1.3 2.8 0.8 0.3 7.2 1.2 0.1 19.3 3.9 0.0 1.5 0.4 0.0 0.4 0.0 0.2 0.0 0.2 3.1 0.0 4.8 0.1 1.8 7.0 3.9 7.3 0.2 0.0 1.2 0.0 0.1 10.2 0.0 0.1 0.0 1.6 3.1 0.0 2.3 3.0 0.5 8.0 0.0 0.0 0.1 0.6 12.9 1.5 4.0 0.4 9.1 0.0 6.2 0.0 0.0 8.7 5.0 1.9 0.0 0.2 0.0 0.4 0.4 0.5 0.8 0.0 0.2 0.0 1.5 0.0 0.0 0.0 5.1 2.0 0.0 1.3 0.8 1.1 2.1 0.3 7.2 0.1 2.4 1.4 1.3 0.3 3.0 2.7 2.8 0.3 0.6 0.2 1.1 1.2 3.7 6.6 4.6 10.2 2.9 9.4 8.3 3.0 19.0 1.2 0.0 0.0 0.0 3.1 4.6 1.0 1.7 0.0 0.0 3.4 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.8 0.0 0.5 0.3 1.6 3.4 0.0 0.8 0.0 0.6 2.0 0.0 0.0 0.0 0.3 0.2 0.0 3.9 0.6 0.3 0.0 1.1 0.0 0.0 6.8 0.3 0.0 0.0 3.8 BTBD6 BDPL ENSG00000184887 "BTB domain containing 6" Q96KE9 14 105248490-105251093 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 73.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031355 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA031355: AB_10611812" "prognostic favorable (1.11e-4)" "unprognostic (2.01e-2)" "unprognostic (2.65e-1)" "unprognostic (1.97e-2)" "unprognostic (2.69e-1)" "unprognostic (2.58e-1)" "unprognostic (2.23e-2)" "unprognostic (4.83e-2)" "unprognostic (2.58e-1)" "unprognostic (1.44e-1)" "prognostic favorable (2.25e-4)" "unprognostic (8.48e-3)" "prognostic favorable (6.51e-5)" "unprognostic (6.55e-2)" "unprognostic (3.22e-1)" "unprognostic (6.86e-2)" "unprognostic (9.85e-2)" 25.9 9.4 19.9 9.4 17.7 11.8 53.4 18.1 27.0 13.6 14.6 5.4 15.2 14.1 9.9 14.7 17.4 11.4 13.6 19.8 17.9 12.9 9.7 12.3 17.7 11.3 11.3 15.9 13.1 5.6 7.7 12.4 7.7 9.5 13.1 11.7 11.6 20.5 12.6 73.0 19.4 14.3 14.4 6.1 9.3 13.7 24.7 6.2 8.2 9.3 31.3 10.6 11.5 22.3 2.4 2.7 4.6 1.6 0.6 8.1 1.1 17.7 14.3 7.8 20.7 25.2 17.6 0.0 16.5 15.0 25.6 17.5 11.1 16.4 5.6 10.1 24.0 5.3 24.0 15.0 15.9 12.7 14.5 12.2 4.1 20.8 0.0 17.3 12.5 8.0 18.2 22.0 11.8 9.6 10.0 20.4 19.0 0.0 0.1 13.6 25.3 13.1 5.1 3.3 16.9 24.7 14.2 0.0 5.2 9.7 19.7 12.9 5.5 15.5 12.5 12.2 5.7 25.6 16.1 13.6 20.7 0.5 30.2 20.4 3.7 5.0 2.7 21.3 5.8 16.0 0.6 1.1 4.6 4.1 1.6 4.0 2.4 4.3 4.2 1.1 1.3 3.3 2.3 0.7 0.6 1.2 2.7 8.1 1.1 19.9 17.7 18.1 27.0 17.9 12.9 11.3 15.9 9.5 6.2 23.8 18.7 1.5 22.6 10.4 23.3 21.0 17.8 20.1 21.6 10.4 5.9 2.2 18.3 5.1 9.8 13.5 20.8 0.0 0.0 3.1 9.6 22.7 24.3 12.8 6.7 19.1 19.5 9.8 7.6 25.6 8.6 8.9 11.8 2.8 24.7 14.8 0.8 14.4 7.1 7.8 16.4 12.9 8.2 8.9 7.9 11.0 1.8 7.5 16.9 20.0 BTBD8 ENSG00000189195 "BTB domain containing 8" Q5XKL5 1 92080305-92184725 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 42.3" "Cell type enhanced" "Detected in many" 6 "Rod photoreceptor cells: 16.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.2" "Low region specificity" "Detected in all" "HPA024216, HPA035311" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA024216: AB_1852385, HPA035311: AB_10671933" "unprognostic (2.94e-1)" "unprognostic (2.97e-2)" "unprognostic (1.99e-1)" "unprognostic (3.06e-2)" "unprognostic (1.83e-1)" "unprognostic (3.17e-2)" "unprognostic (2.72e-2)" "unprognostic (7.56e-2)" "unprognostic (1.36e-2)" "unprognostic (2.97e-1)" "unprognostic (2.82e-2)" "unprognostic (8.42e-2)" "unprognostic (3.73e-3)" "unprognostic (5.04e-2)" "unprognostic (9.49e-2)" "unprognostic (2.39e-2)" "unprognostic (3.15e-1)" 3.4 4.6 11.7 1.2 27.3 0.7 3.3 20.3 42.3 2.3 2.4 4.0 0.6 1.7 3.4 4.7 2.0 3.3 2.3 2.8 7.8 2.1 2.4 1.9 2.5 1.4 4.5 23.3 5.0 2.7 5.1 6.0 2.5 16.4 3.3 2.5 1.2 2.8 2.7 2.3 1.8 2.1 2.0 6.6 1.8 2.4 8.3 9.9 0.2 3.7 0.0 1.1 4.7 2.7 0.5 0.8 0.6 0.7 0.9 2.3 0.4 2.7 2.2 1.6 0.0 5.0 10.2 5.5 1.8 2.5 1.5 1.8 0.5 3.2 1.2 6.5 1.6 6.0 0.8 1.2 3.2 2.3 2.8 1.8 2.1 0.6 0.9 1.1 1.1 1.2 6.0 2.7 0.9 1.8 6.8 1.5 2.9 2.5 0.8 2.8 1.7 0.8 2.1 1.7 3.8 1.7 1.8 1.6 0.2 3.2 2.0 0.9 1.5 2.9 1.4 1.4 3.0 2.3 1.6 1.0 1.9 1.2 1.1 0.7 2.1 0.9 0.0 1.5 0.2 0.4 0.0 0.6 0.0 2.3 0.1 0.5 0.5 1.0 0.9 0.0 0.5 1.8 1.4 0.6 0.9 0.7 0.8 0.9 0.4 11.7 27.3 20.3 42.3 7.8 2.1 4.5 23.3 16.4 9.9 0.0 2.6 0.0 1.0 0.3 8.7 0.7 5.1 5.3 5.7 5.2 5.9 1.9 1.7 3.1 4.5 0.6 1.7 0.0 2.5 0.9 1.1 1.8 0.0 0.8 0.6 3.2 0.0 1.3 2.4 0.5 5.5 1.3 1.7 1.8 2.3 6.5 3.2 2.9 3.5 1.1 16.7 0.0 0.5 3.7 8.2 0.5 1.1 0.5 2.3 0.9 BTBD9 "dJ322I12.1, KIAA1880" ENSG00000183826 "BTB domain containing 9" Q96Q07 6 38168451-38640148 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041930 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA041930: AB_10795270" "unprognostic (4.40e-1)" "unprognostic (1.74e-1)" "unprognostic (1.75e-3)" "unprognostic (1.64e-2)" "unprognostic (6.59e-2)" "unprognostic (3.94e-2)" "unprognostic (1.48e-1)" "unprognostic (1.76e-3)" "unprognostic (5.44e-2)" "unprognostic (6.13e-2)" "unprognostic (1.92e-2)" "unprognostic (2.74e-1)" "prognostic favorable (4.20e-13)" "unprognostic (1.35e-1)" "unprognostic (6.56e-2)" "unprognostic (8.67e-2)" "unprognostic (1.15e-2)" 5.3 6.6 17.9 5.4 23.9 9.1 5.1 9.8 20.4 5.7 6.6 7.8 7.1 6.3 7.2 5.4 7.8 13.0 7.5 9.2 15.6 11.5 8.4 3.8 12.5 7.4 8.9 13.7 11.5 4.8 28.6 12.9 5.6 10.5 6.8 7.8 7.0 5.3 6.4 7.8 7.4 8.7 6.8 6.1 5.3 5.7 10.2 7.7 4.1 8.5 3.0 7.6 7.5 5.2 5.2 3.9 12.7 5.5 5.0 5.6 2.6 5.9 5.1 8.1 10.1 6.0 8.4 5.8 6.4 8.4 7.0 7.5 6.0 3.5 3.7 4.2 9.6 9.5 4.3 4.4 9.1 8.3 10.3 8.7 7.8 5.2 2.6 4.7 7.9 16.2 6.4 6.9 9.5 9.0 6.4 12.0 6.7 3.8 6.1 7.0 3.7 5.6 2.8 2.1 6.1 4.4 3.3 5.7 7.0 6.7 15.1 10.3 7.3 6.0 5.9 5.8 6.0 6.2 5.4 7.8 6.9 4.3 7.5 6.6 3.6 3.0 4.3 5.4 4.9 7.4 12.7 2.7 4.5 3.8 3.8 5.3 3.9 3.8 3.4 2.5 5.2 4.8 4.3 6.7 5.0 5.5 3.9 5.6 2.6 17.9 23.9 9.8 20.4 15.6 11.5 8.9 13.7 10.5 7.7 3.0 13.2 1.4 2.0 4.0 11.6 10.3 10.2 2.7 9.1 8.7 7.9 2.5 5.0 3.6 14.3 3.6 11.7 0.0 5.1 1.3 3.2 2.5 0.0 2.1 2.2 4.8 4.7 9.8 3.5 18.9 2.8 3.5 1.7 0.0 4.5 5.2 4.9 3.7 3.2 5.1 5.1 0.0 3.8 2.2 2.7 5.1 3.9 5.0 5.1 2.7 BTF3L4 MGC23908 ENSG00000134717 "Basic transcription factor 3 like 4" Q96K17 1 52056125-52090716 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067026 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA067026: AB_2685765" "unprognostic (6.12e-2)" "unprognostic (6.33e-2)" "unprognostic (5.09e-2)" "unprognostic (8.83e-3)" "unprognostic (1.42e-2)" "unprognostic (5.63e-2)" "prognostic unfavorable (6.73e-8)" "unprognostic (8.85e-2)" "unprognostic (5.59e-2)" "unprognostic (1.71e-3)" "unprognostic (2.61e-1)" "unprognostic (2.85e-1)" "prognostic unfavorable (4.43e-6)" "unprognostic (1.62e-1)" "unprognostic (2.56e-1)" "unprognostic (1.68e-1)" "unprognostic (8.56e-2)" 22.3 29.1 20.6 14.8 22.1 26.7 26.2 25.5 52.3 17.5 12.8 17.2 8.4 7.1 19.5 16.7 20.3 19.6 12.5 28.4 23.7 22.4 18.5 20.8 19.6 38.8 20.4 23.8 29.2 47.6 21.0 24.3 19.1 16.7 15.7 12.6 16.5 26.4 13.5 36.9 19.3 9.8 22.4 23.1 14.1 14.2 19.2 14.6 20.7 22.9 13.6 20.4 19.0 16.2 23.2 34.1 32.2 36.0 21.3 28.2 27.9 28.0 6.8 33.5 17.5 18.1 23.3 34.7 27.8 28.0 31.9 34.4 12.4 14.7 26.2 28.0 19.5 37.7 16.4 32.3 21.7 40.9 18.1 22.6 30.0 12.5 18.5 49.6 33.2 20.8 23.9 30.0 29.5 41.7 26.5 25.2 21.7 22.6 16.7 28.6 12.0 22.9 19.7 59.6 21.8 15.0 15.2 39.0 30.8 30.8 22.6 26.4 29.9 32.5 30.1 40.0 38.8 27.2 35.6 18.4 18.0 19.5 23.2 32.7 29.3 48.3 25.6 15.6 25.9 22.6 24.1 35.4 32.2 15.0 36.0 20.1 23.2 21.7 15.4 34.1 22.1 25.4 19.4 15.1 21.3 31.0 16.1 28.2 27.9 20.6 22.1 25.5 52.3 23.7 22.4 20.4 23.8 16.7 14.6 32.8 18.2 57.0 77.6 95.7 41.1 40.3 43.3 40.2 31.8 66.3 31.4 99.7 142.6 93.1 81.2 49.3 16.0 93.5 69.0 113.3 65.9 74.4 22.0 66.1 115.8 36.5 50.2 45.4 117.9 13.6 67.0 77.6 74.2 55.9 28.5 42.6 74.2 28.1 52.3 110.7 28.6 58.2 77.3 111.6 14.3 140.0 122.0 50.7 33.3 87.5 BTG1 APRO2 ENSG00000133639 "BTG anti-proliferation factor 1" P62324 12 92140278-92145897 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 190.7" "Cell type enhanced" "Detected in all" 5 "Basal keratinocytes: 2444.1;Suprabasal keratinocytes: 2626.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 66.8" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC TERT1: 50.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005972 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005972: AB_1078303" "prognostic favorable (4.36e-5)" "unprognostic (1.43e-1)" "unprognostic (2.32e-1)" "unprognostic (1.37e-2)" "unprognostic (1.07e-1)" "unprognostic (3.61e-3)" "unprognostic (1.10e-1)" "unprognostic (5.51e-2)" "unprognostic (1.46e-1)" "unprognostic (1.34e-2)" "unprognostic (2.50e-1)" "unprognostic (4.94e-2)" "prognostic unfavorable (1.95e-7)" "unprognostic (1.14e-1)" "unprognostic (1.56e-1)" "unprognostic (5.79e-2)" "unprognostic (9.81e-2)" 52.0 22.1 11.5 58.3 13.4 126.9 114.4 66.8 10.4 41.7 40.1 5.5 21.9 15.5 30.1 22.0 28.7 27.9 39.9 49.2 11.9 8.1 22.2 58.1 85.6 190.7 10.4 8.2 29.1 64.2 17.6 17.1 23.4 13.3 28.7 18.1 21.0 19.0 25.9 31.6 70.6 34.3 26.0 24.6 77.1 26.4 19.0 8.9 148.9 15.7 14.3 58.2 54.2 35.2 58.3 6.6 94.3 14.0 47.1 95.2 26.1 7.0 8.8 9.7 1.1 36.3 50.4 4.2 7.9 17.4 5.3 5.3 5.2 2.4 7.5 1.6 8.3 8.4 4.8 3.2 8.8 9.9 9.0 6.8 1.5 6.1 2.7 36.8 5.5 2.6 43.0 26.7 12.1 37.5 23.5 10.6 5.0 5.2 10.0 6.0 7.2 3.9 17.7 2.3 7.7 10.0 13.4 5.4 2.3 16.3 14.6 5.4 10.8 9.8 7.6 25.5 7.8 32.0 12.8 3.4 6.0 1.8 4.6 4.8 13.8 7.4 12.5 4.7 4.4 6.7 22.3 13.6 94.3 17.0 10.6 20.1 44.5 34.3 29.8 6.6 58.3 95.2 39.1 52.3 47.1 14.0 6.2 39.2 26.1 11.5 13.4 66.8 10.4 11.9 8.1 10.4 8.2 13.3 8.9 89.3 164.0 1133.8 898.4 2444.1 509.3 99.7 695.5 18.7 63.7 165.7 184.6 344.9 271.9 357.5 306.7 258.8 666.0 140.2 222.2 261.3 225.7 728.6 288.8 235.3 359.2 400.5 434.2 206.2 468.4 134.9 265.8 682.9 933.0 1485.2 192.1 767.8 308.3 596.2 227.4 96.3 342.5 530.3 1116.5 68.9 113.5 2626.0 1122.8 1563.2 226.0 1040.3 BTG2 "APRO1, MGC126063, MGC126064, PC3, TIS21" ENSG00000159388 "BTG anti-proliferation factor 2" P78543 1 203305491-203309602 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Intestinal endocrine cells: 927.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 37.5;HMC-1: 39.2;RT4: 30.5;U-266/70: 60.7;U-266/84: 30.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002355 Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA002355: AB_1078304" "prognostic favorable (8.53e-4)" "unprognostic (1.54e-1)" "unprognostic (4.63e-2)" "unprognostic (4.81e-3)" "unprognostic (5.91e-2)" "unprognostic (1.46e-1)" "unprognostic (2.47e-1)" "unprognostic (7.87e-3)" "unprognostic (4.72e-1)" "unprognostic (1.71e-1)" "unprognostic (1.61e-1)" "unprognostic (1.18e-2)" "unprognostic (4.46e-2)" "unprognostic (6.22e-2)" "unprognostic (4.34e-1)" "unprognostic (1.17e-1)" "unprognostic (2.86e-3)" 61.6 45.9 10.1 61.4 20.6 46.9 27.8 13.0 10.4 23.0 53.3 27.8 27.0 15.2 27.1 24.6 55.7 103.7 76.1 65.3 10.4 10.0 22.3 4.3 40.7 20.0 12.2 5.5 102.0 117.6 7.0 52.2 42.7 28.3 61.0 38.5 30.4 18.1 104.1 98.9 30.5 36.6 50.8 22.7 32.7 67.1 11.5 9.9 82.9 36.7 45.2 49.0 64.7 21.5 14.1 17.3 34.5 14.2 5.7 8.5 7.1 0.9 1.4 2.6 1.0 3.3 2.4 22.1 2.6 5.1 0.7 2.5 1.9 0.4 37.5 1.8 0.8 0.4 16.5 9.5 10.0 1.3 2.4 4.6 19.6 2.7 4.3 7.3 0.1 39.2 2.5 18.6 2.5 4.6 2.3 13.7 1.9 9.1 26.0 6.8 0.8 4.1 1.2 1.1 0.4 0.2 2.6 8.9 18.8 1.3 30.5 0.4 2.7 2.0 0.8 0.3 20.6 2.2 2.3 3.4 0.0 4.4 0.6 0.1 60.7 30.6 24.0 0.5 0.9 1.5 3.2 8.1 9.9 4.7 12.1 7.1 14.1 5.3 4.8 5.1 13.1 8.5 5.9 34.5 5.7 14.2 17.3 4.9 7.1 10.1 20.6 13.0 10.4 10.4 10.0 12.2 5.5 28.3 9.9 145.9 242.1 142.2 203.8 204.5 25.9 219.9 10.2 57.6 52.4 177.9 27.5 38.6 13.3 59.7 0.8 123.6 335.6 23.3 145.5 16.4 143.3 218.8 358.2 1.6 99.0 3.2 927.5 46.6 65.9 1.7 67.3 167.7 114.7 31.5 370.7 221.0 58.8 329.8 51.9 10.8 21.5 122.9 223.5 0.9 0.6 391.6 115.4 202.7 212.8 200.1 BTRC "beta-TrCP1, betaTrCP, bTrCP, bTrCP1, FBXW1A, Fwd1" ENSG00000166167 "Beta-transducin repeat containing E3 ubiquitin protein ligase" Q9Y297 10 101354033-101557321 "Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031156, CAB032986" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "CAB032986: AB_2243598, HPA031156: AB_2673764" "unprognostic (1.43e-1)" "unprognostic (2.35e-2)" "unprognostic (8.88e-2)" "unprognostic (2.09e-1)" "unprognostic (3.55e-1)" "unprognostic (2.73e-1)" "unprognostic (2.41e-2)" "unprognostic (9.25e-2)" "unprognostic (3.22e-1)" "unprognostic (1.59e-2)" "unprognostic (8.80e-3)" "unprognostic (5.05e-1)" "unprognostic (2.81e-3)" "unprognostic (1.33e-1)" "unprognostic (2.95e-2)" "unprognostic (3.07e-2)" "unprognostic (2.23e-1)" 6.6 11.2 16.0 7.3 23.1 3.6 11.8 16.2 28.0 10.2 6.6 10.7 13.7 5.4 8.8 14.5 11.5 10.8 8.1 18.6 15.7 18.3 11.6 7.1 6.8 5.3 14.3 15.3 15.5 8.6 21.5 17.3 10.4 13.5 12.2 7.0 11.9 9.0 8.7 14.1 9.0 5.4 9.7 10.2 7.5 6.4 17.9 9.0 6.3 11.4 7.1 7.5 7.3 9.8 5.2 4.8 3.9 3.7 5.1 8.1 3.4 6.3 9.7 13.7 15.8 13.4 11.7 4.9 9.1 14.8 9.6 8.0 6.8 5.0 10.4 9.3 7.8 9.9 9.9 11.2 9.9 10.4 6.8 8.9 7.5 6.1 8.8 7.1 11.0 4.1 7.1 11.6 8.2 14.7 19.0 11.8 9.7 8.1 3.5 9.2 5.4 7.4 5.5 6.3 7.1 7.7 9.3 19.2 2.1 8.8 4.1 10.2 8.7 6.0 2.7 8.5 16.6 7.4 3.8 9.9 5.1 8.0 6.5 6.4 5.8 12.6 6.6 5.0 5.5 3.4 3.8 3.7 3.9 6.1 3.1 6.1 5.2 6.5 5.5 4.8 4.4 8.1 6.5 2.4 5.1 3.1 2.4 5.6 3.4 16.0 23.1 16.2 23.3 15.7 18.3 14.3 15.3 13.5 9.0 3.0 10.3 4.2 3.6 4.9 29.4 27.1 10.2 12.0 10.3 3.5 27.5 9.5 6.6 8.4 26.8 6.6 4.5 0.0 6.3 6.2 8.2 6.1 12.8 4.9 4.9 15.9 2.9 5.5 2.8 14.1 8.3 3.3 1.7 3.6 4.1 14.1 7.2 3.5 9.9 8.0 24.9 6.5 3.1 31.8 17.1 6.1 10.4 5.1 4.5 5.9 BUB1 "BUB1A, BUB1L, hBUB1" ENSG00000169679 "BUB1 mitotic checkpoint serine/threonine kinase" O43683 2 110637698-110678114 "Enzymes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 56.5;testis: 30.9" "Cell type enriched" "Detected in many" 5 "Spermatocytes: 68.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "T-reg: 6.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 68.1" "Not detected" "Not detected" HPA006123 Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA006123: AB_1845498" "unprognostic (7.74e-2)" "unprognostic (3.45e-2)" "unprognostic (9.72e-3)" "prognostic unfavorable (3.65e-4)" "unprognostic (1.61e-1)" "unprognostic (5.62e-3)" "prognostic unfavorable (1.03e-5)" "prognostic unfavorable (3.94e-4)" "unprognostic (1.26e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (2.37e-5)" "unprognostic (1.76e-1)" "unprognostic (0.00e+0)" "unprognostic (2.45e-2)" "unprognostic (3.64e-1)" "unprognostic (5.01e-2)" "unprognostic (1.28e-1)" 1.1 0.9 0.5 15.8 1.0 8.9 0.6 0.3 1.0 1.2 2.8 0.4 0.0 2.4 0.7 2.3 5.8 0.5 1.0 1.1 0.5 0.5 0.9 0.8 2.1 11.6 0.6 0.2 1.0 0.7 0.0 0.4 2.4 0.5 0.7 4.3 0.4 1.4 0.0 0.5 1.8 3.1 1.4 1.3 7.9 1.8 30.9 0.1 56.5 0.6 5.7 12.1 2.5 2.0 1.8 2.4 3.0 0.2 1.4 6.1 1.1 30.3 8.9 23.4 14.7 1.0 1.7 12.4 15.8 10.4 27.5 20.8 18.7 17.5 20.6 9.8 9.1 25.8 13.3 29.9 11.5 34.2 16.3 14.6 68.1 9.5 14.9 0.2 19.6 19.3 0.4 0.7 21.2 10.5 3.9 16.1 23.1 29.8 43.0 22.5 10.0 32.8 16.4 22.6 10.8 16.9 21.8 20.0 31.4 5.6 9.6 15.7 6.8 11.2 9.6 8.5 14.9 7.5 16.6 6.6 12.5 20.5 9.4 21.9 22.5 21.1 25.3 8.5 15.2 22.0 3.0 0.0 0.7 0.6 0.2 0.9 1.8 2.5 1.0 0.8 1.4 1.6 1.5 0.0 1.4 0.1 2.4 6.1 1.1 0.5 1.0 0.3 1.0 0.5 0.5 0.6 0.2 0.5 0.1 0.0 1.0 7.8 0.2 0.5 0.0 0.8 0.0 1.4 2.3 0.0 0.0 1.3 0.0 0.2 8.3 0.0 0.0 0.0 0.0 8.1 0.3 0.2 0.0 0.2 6.6 0.0 0.0 1.3 1.3 4.7 0.3 1.7 0.0 1.0 0.9 0.0 0.1 0.0 0.4 0.0 0.0 6.5 0.0 68.0 14.1 0.4 0.6 2.5 2.0 0.9 BUB1B-PAK6 ENSG00000259288 "BUB1B-PAK6 readthrough" 15 40217428-40276396 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA031124 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Cell Junctions" NA NA "Nucleoplasm, Nucleoli fibrillar center" "Cell Junctions" "HPA031124: AB_10601044" "unprognostic (1.83e-1)" "unprognostic (1.29e-3)" "unprognostic (1.32e-1)" "unprognostic (9.23e-2)" "unprognostic (1.12e-1)" "unprognostic (1.88e-1)" "unprognostic (9.48e-2)" 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BUB3 BUB3L ENSG00000154473 "BUB3, mitotic checkpoint protein" O43684 10 123154277-123170467 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003601, CAB037075" Supported Supported Nucleoplasm NA Yes 100000000 Nucleoplasm "CAB037075: AB_1078310, HPA003601: AB_1078309" "unprognostic (7.82e-2)" "prognostic favorable (2.04e-4)" "unprognostic (9.07e-2)" "unprognostic (1.83e-1)" "unprognostic (7.93e-2)" "unprognostic (8.60e-2)" "prognostic unfavorable (4.45e-5)" "unprognostic (6.04e-3)" "unprognostic (9.41e-2)" "unprognostic (6.30e-3)" "unprognostic (2.69e-2)" "unprognostic (1.37e-2)" "prognostic unfavorable (3.81e-7)" "unprognostic (8.80e-2)" "unprognostic (7.64e-2)" "unprognostic (1.51e-1)" "unprognostic (7.71e-2)" 23.8 35.1 21.1 35.3 26.6 51.0 27.9 30.4 28.3 20.2 27.7 31.3 22.3 24.5 24.5 22.7 38.2 22.1 20.7 19.6 19.8 28.3 24.1 25.1 22.4 51.8 33.3 23.6 27.4 20.5 20.7 37.3 22.6 31.3 21.8 29.6 16.8 26.5 21.4 23.4 28.9 30.3 22.2 29.1 38.8 24.4 35.4 28.2 67.8 28.1 22.8 49.0 30.3 26.5 43.0 25.8 32.7 24.3 45.6 71.6 52.4 51.7 52.2 33.7 37.3 19.2 18.2 29.1 54.2 58.0 60.4 48.1 45.3 35.8 46.6 20.3 24.7 28.8 33.6 49.8 58.7 63.5 37.8 49.7 29.3 63.3 49.6 20.0 57.1 36.4 15.1 23.1 53.6 69.0 32.6 40.5 39.8 35.5 46.9 54.1 44.6 46.9 35.4 20.7 26.9 49.3 64.4 16.8 29.9 27.5 57.5 25.2 25.5 30.6 20.7 25.9 14.6 23.5 29.6 31.7 47.5 29.1 29.8 79.8 25.1 35.4 72.5 25.9 56.8 20.0 32.7 23.6 32.4 53.5 24.3 48.1 43.0 49.1 54.2 24.2 37.5 52.9 55.7 11.7 45.6 21.2 25.8 71.6 52.4 21.1 26.6 30.4 28.3 19.8 28.3 33.3 23.6 31.3 28.2 23.8 35.1 84.1 58.3 116.0 25.8 36.7 38.2 37.5 25.0 36.6 9.8 71.6 59.7 62.8 111.8 69.4 34.1 23.3 51.2 112.6 68.6 51.7 49.7 36.7 69.7 9.5 39.1 44.8 49.9 110.6 41.7 56.4 91.1 199.2 46.1 52.8 54.3 35.1 43.5 60.0 21.6 103.5 63.6 136.5 153.0 116.6 54.3 139.0 54.0 50.5 BUD13 "Cwc26, fSAP71, MGC13125" ENSG00000137656 "BUD13 homolog" Q9BRD0 11 116748170-116772988 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Spermatocytes: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038340, HPA038341" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA038340: AB_2675967, HPA038341: AB_10671528" "unprognostic (1.89e-1)" "unprognostic (1.73e-1)" "unprognostic (1.01e-2)" "unprognostic (2.77e-2)" "unprognostic (1.05e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (5.07e-5)" "unprognostic (1.77e-1)" "unprognostic (8.39e-2)" "unprognostic (1.46e-1)" "unprognostic (4.23e-2)" "unprognostic (9.10e-2)" "unprognostic (1.81e-1)" "unprognostic (4.53e-2)" "unprognostic (1.41e-1)" "unprognostic (1.86e-2)" "unprognostic (1.63e-1)" 15.1 10.0 9.7 20.4 12.4 12.9 16.1 19.0 15.5 21.2 20.6 16.1 11.6 12.8 19.4 13.8 16.3 16.8 13.7 13.2 9.5 9.4 12.4 11.3 14.4 17.5 10.8 7.8 20.4 13.8 15.7 13.3 18.0 11.0 17.1 16.3 13.5 14.7 13.4 18.5 15.1 20.8 15.5 12.4 18.1 14.7 29.8 11.9 37.9 18.1 14.0 21.2 16.6 22.6 10.8 8.5 20.1 8.7 7.1 11.9 5.7 11.0 6.1 17.2 10.3 5.5 6.6 8.6 10.9 12.2 12.6 12.3 14.3 16.8 23.5 13.9 9.0 13.2 15.6 13.8 8.5 13.9 13.7 5.6 27.4 4.4 10.8 6.7 23.0 16.4 6.0 10.0 10.6 10.9 8.1 12.2 23.4 17.5 11.7 10.3 8.7 28.0 20.4 10.3 15.8 9.7 21.2 14.8 18.1 8.9 12.8 10.2 13.6 12.8 9.4 5.0 11.4 12.9 15.3 6.9 14.5 9.2 7.3 14.5 4.8 6.0 19.4 4.7 21.3 12.8 14.3 7.8 20.1 10.9 7.8 11.9 10.8 9.4 8.6 8.5 8.8 10.8 8.8 9.5 7.1 8.7 7.5 8.0 5.7 9.7 12.4 19.0 15.5 9.5 9.4 10.8 7.8 11.0 11.9 8.9 3.5 6.9 10.0 6.8 6.6 3.7 2.5 12.0 5.7 8.7 11.8 7.2 6.6 6.8 7.7 6.6 10.2 23.3 7.2 9.4 5.1 5.1 10.5 5.4 7.0 3.2 9.2 6.7 7.9 3.2 8.3 8.1 6.8 4.6 6.4 6.9 5.1 6.8 10.3 3.9 6.5 6.5 3.6 33.2 21.3 4.3 8.2 10.0 9.7 5.8 BUD23 "MERM1, MGC19709, MGC2022, MGC5140, PP3381, WBMT, WBSCR22" ENSG00000071462 "BUD23, rRNA methyltransferase and ribosome maturation factor" O43709 7 73683025-73705161 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 144.6;Exocrine glandular cells: 122.2;Pancreatic endocrine cells: 97.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 113.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052185 Approved Supported Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "HPA052185: AB_2681753" "unprognostic (2.49e-1)" "unprognostic (1.87e-1)" "unprognostic (2.67e-2)" "unprognostic (4.79e-2)" "unprognostic (3.62e-3)" "unprognostic (8.54e-2)" "prognostic unfavorable (9.92e-4)" "unprognostic (1.17e-1)" "unprognostic (9.16e-2)" "unprognostic (9.20e-2)" "unprognostic (6.71e-2)" "unprognostic (4.20e-2)" "prognostic unfavorable (1.46e-4)" "unprognostic (5.15e-2)" "unprognostic (1.55e-1)" "unprognostic (1.46e-1)" "unprognostic (3.13e-3)" 16.6 23.4 16.3 15.0 18.8 19.6 18.3 12.3 20.6 17.5 19.3 17.9 19.5 18.3 19.1 30.6 17.5 24.1 23.1 34.2 16.0 17.5 28.1 36.3 16.1 18.3 25.3 17.5 19.3 27.9 14.3 21.8 22.1 16.4 16.5 19.8 20.3 25.1 25.6 52.2 19.3 21.6 21.2 18.7 18.7 18.9 97.0 16.5 22.1 25.8 22.6 22.7 18.7 14.8 43.9 49.0 14.4 18.3 30.1 37.6 31.4 22.2 24.6 9.0 71.4 12.4 11.1 15.0 15.4 13.9 19.9 16.3 34.0 30.1 26.0 8.1 16.5 34.3 16.0 20.7 14.9 18.4 18.2 24.0 11.3 28.7 13.7 15.7 31.7 16.6 10.0 17.2 17.5 15.9 10.1 12.8 21.5 44.7 48.2 17.2 35.1 19.9 43.6 21.5 51.7 28.3 17.8 17.6 113.3 22.0 16.1 27.3 20.5 20.6 55.0 22.8 9.3 34.6 25.4 13.7 17.2 21.9 21.7 32.9 16.7 29.2 43.7 39.4 24.2 35.9 11.5 17.1 14.4 30.7 18.3 34.3 43.9 35.5 33.6 31.5 38.0 37.6 34.4 3.2 30.1 16.2 49.0 37.3 31.4 16.3 18.8 12.3 20.6 16.0 17.5 25.3 17.5 16.4 16.5 41.7 53.9 0.0 0.0 0.0 0.0 0.0 0.0 144.6 78.5 43.6 0.0 64.0 82.9 81.2 0.0 0.0 0.0 0.0 122.2 66.3 0.0 0.0 43.0 0.0 62.2 0.0 0.0 0.0 0.0 0.0 0.0 25.8 0.0 36.9 0.0 0.0 97.5 0.0 0.0 82.3 0.0 0.0 0.0 0.0 0.0 0.0 89.2 0.0 0.0 0.0 BUD31 "Cwc14, EDG-2, EDG2, fSAP17, G10, YCR063W" ENSG00000106245 "BUD31 homolog" P41223 7 99408641-99419616 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028943 Approved Approved Nucleoplasm,Microtubules,Centrosome NA NA Nucleoplasm "Microtubules, Centrosome" "HPA028943: AB_10602396" "unprognostic (1.68e-1)" "unprognostic (2.73e-2)" "unprognostic (2.89e-2)" "unprognostic (2.63e-2)" "unprognostic (5.29e-2)" "unprognostic (2.38e-2)" "unprognostic (2.02e-3)" "unprognostic (2.16e-2)" "unprognostic (4.02e-2)" "unprognostic (1.46e-2)" "unprognostic (8.71e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (9.66e-4)" "unprognostic (1.42e-1)" "unprognostic (4.10e-2)" "unprognostic (1.55e-1)" "unprognostic (1.71e-1)" 26.4 31.9 43.6 26.1 44.8 66.6 29.5 28.3 36.4 25.6 31.3 25.6 31.6 27.0 25.1 32.2 35.2 35.7 28.1 30.8 39.2 36.3 37.9 33.2 26.2 34.5 39.5 27.4 28.8 31.4 21.0 35.2 33.7 32.3 27.3 22.7 22.0 31.5 28.9 20.7 23.5 31.2 25.4 34.5 29.1 26.7 51.2 27.0 24.1 40.1 29.0 31.6 35.3 26.5 39.1 32.2 91.2 42.7 34.1 37.6 56.6 25.2 29.8 16.7 37.4 16.8 18.9 16.2 24.3 23.4 27.9 30.7 34.8 25.2 19.4 29.7 23.4 30.4 15.1 18.4 22.2 23.5 23.4 24.9 14.1 21.2 22.8 35.0 24.0 18.7 18.4 27.5 25.4 48.1 16.3 21.7 20.4 34.6 44.5 25.6 66.3 31.5 65.1 36.7 27.0 37.4 16.5 16.9 33.5 24.4 20.2 29.4 35.4 24.0 27.7 50.5 11.3 17.4 30.3 17.7 26.6 33.9 52.7 37.9 28.0 46.9 51.7 23.5 35.9 48.1 59.1 39.3 91.2 34.1 40.5 31.9 39.1 32.8 33.0 32.2 36.6 27.9 29.2 83.0 34.1 42.7 31.1 37.6 56.6 43.6 44.8 28.3 36.4 39.2 36.3 39.5 27.4 32.3 27.0 77.4 75.2 90.6 127.0 171.3 30.4 11.1 68.8 149.9 61.4 87.2 9.8 144.5 202.2 156.4 106.4 90.4 143.8 23.3 162.5 137.0 129.0 115.9 89.0 77.4 132.0 15.9 140.8 71.8 86.2 82.8 75.9 103.3 129.9 174.1 105.3 65.9 188.4 119.3 69.6 168.4 26.3 58.2 153.3 197.9 133.6 160.7 152.5 126.4 87.3 146.8 BYSL Enp1 ENSG00000112578 "Bystin like" Q13895 6 41921188-41933046 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031217, HPA031219" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA031217: AB_10599488, HPA031219: AB_10601989" "unprognostic (6.12e-3)" "unprognostic (6.97e-2)" "unprognostic (2.90e-1)" "unprognostic (2.33e-3)" "unprognostic (4.38e-2)" "unprognostic (2.73e-3)" "prognostic unfavorable (6.43e-4)" "unprognostic (2.09e-2)" "unprognostic (2.51e-1)" "unprognostic (6.38e-2)" "unprognostic (1.30e-1)" "unprognostic (2.03e-1)" "prognostic unfavorable (2.15e-8)" "unprognostic (4.39e-2)" "unprognostic (2.18e-1)" "unprognostic (2.79e-3)" "unprognostic (5.99e-2)" 11.5 13.4 6.0 11.5 7.2 6.0 17.5 5.0 8.9 7.8 7.9 4.6 5.3 4.0 11.0 5.4 11.7 9.3 10.0 17.6 5.9 6.8 8.0 18.6 7.1 7.4 5.8 6.5 11.8 15.9 10.6 5.4 11.3 7.4 8.0 6.8 4.8 9.6 7.9 31.7 9.2 5.0 12.6 6.3 9.9 7.3 8.9 4.6 20.1 7.1 11.9 12.9 7.3 10.1 4.0 9.3 0.9 3.4 4.5 5.5 2.2 11.9 14.8 8.2 11.6 6.1 6.9 16.8 12.2 6.4 19.3 14.1 20.4 3.1 22.0 11.1 9.1 13.2 7.9 24.9 17.8 15.2 7.9 27.1 20.5 10.4 22.9 10.6 14.6 9.0 8.9 11.6 18.0 16.4 4.2 13.2 12.9 26.0 4.9 12.7 20.4 15.3 14.7 6.4 37.3 15.6 18.3 11.2 14.0 10.7 10.2 16.5 10.0 8.1 7.4 14.2 6.6 8.6 12.9 10.2 11.2 13.3 7.6 17.7 5.7 7.4 47.6 3.8 14.8 11.7 0.0 3.4 0.9 3.9 3.4 5.5 3.8 2.5 3.1 5.4 4.0 1.3 3.0 0.3 4.5 3.1 9.3 3.1 2.2 6.0 7.2 5.0 8.9 5.9 6.8 5.8 6.5 7.4 4.6 0.0 3.8 8.9 21.5 27.5 2.5 2.5 5.1 4.0 5.7 1.8 3.9 19.5 3.3 20.9 6.2 7.1 1.4 0.0 14.8 19.5 10.6 9.6 2.3 6.6 10.6 0.0 5.2 4.3 1.0 3.4 7.5 5.3 8.5 7.2 5.5 3.4 18.6 0.0 6.7 8.4 2.8 6.5 17.3 6.5 26.9 22.1 24.4 5.0 9.9 23.5 C10orf55 bA417O11.3 ENSG00000222047 "Chromosome 10 open reading frame 55" Q5SWW7 10 73909969-73922777 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 14.0" "Cell type enhanced" "Detected in some" 13 "Basal glandular cells: 6.4;Distal tubular cells: 6.6;Early spermatids: 11.8;Sertoli cells: 6.5;Urothelial cells: 5.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 5.1;CAPAN-2: 4.8;HaCaT: 4.9;hTERT-RPE1: 3.4;RPTEC TERT1: 7.6;U-251 MG: 3.3" HPA045739 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA045739: AB_10961861" "unprognostic (5.50e-2)" "unprognostic (1.82e-1)" "unprognostic (1.84e-2)" "unprognostic (2.25e-2)" "unprognostic (4.42e-2)" "unprognostic (2.71e-2)" "unprognostic (9.68e-3)" "unprognostic (5.61e-3)" "unprognostic (4.99e-2)" "unprognostic (8.84e-2)" "unprognostic (3.62e-3)" "unprognostic (1.30e-1)" "unprognostic (2.15e-3)" "unprognostic (1.27e-1)" "unprognostic (3.90e-2)" "unprognostic (5.94e-3)" "unprognostic (3.13e-2)" 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 1.1 0.5 1.0 0.0 0.0 0.0 0.1 0.0 14.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.1 0.3 0.0 0.0 0.0 0.1 0.0 0.3 1.6 0.4 0.3 0.0 4.8 0.0 0.3 0.2 1.5 4.9 0.0 0.8 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.4 0.6 1.0 3.4 0.1 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 2.1 0.0 7.6 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 2.1 0.0 0.0 0.4 3.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.5 11.8 0.0 0.0 0.0 0.6 0.0 0.2 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 1.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 6.5 0.3 0.0 0.2 0.1 0.0 0.0 0.0 5.4 C10orf62 bA548K23.1 ENSG00000203942 "Chromosome 10 open reading frame 62" Q5T681 10 97589727-97590934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 60 "testis: 81.1" "Cell type enriched" "Detected in some" 5 "Late spermatids: 7737.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.3;Hep G2: 2.9;T-47d: 2.1" HPA072947 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA Cytosol "Nucleoplasm, Vesicles" "HPA072947: AB_2686562" "unprognostic (3.66e-2)" "unprognostic (3.97e-2)" "unprognostic (2.81e-1)" "unprognostic (5.36e-2)" "unprognostic (3.62e-1)" "unprognostic (1.20e-1)" "unprognostic (3.63e-2)" "unprognostic (2.53e-2)" "unprognostic (2.04e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.8 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.5 2.9 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1574.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7737.3 36.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.0 0.3 0.0 6.5 0.0 33.1 18.8 0.0 0.0 0.0 0.0 0.0 C10orf71 FLJ45913 ENSG00000177354 "Chromosome 10 open reading frame 71" Q711Q0 10 49299193-49327487 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "skeletal muscle: 104.2;tongue: 35.0" "Cell type enriched" "Detected in single" 478 "Cardiomyocytes: 47.8" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 21 "K-562: 9.2;RH-30: 14.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA057556 Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA057556: AB_2683467" "unprognostic (1.25e-2)" "unprognostic (3.97e-2)" "unprognostic (4.16e-2)" "unprognostic (5.58e-2)" "unprognostic (1.66e-1)" "unprognostic (1.17e-1)" "unprognostic (1.81e-1)" 2.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 2.0 1.7 0.1 0.0 13.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 3.3 15.3 0.1 0.0 0.0 0.3 0.0 0.0 1.1 0.0 104.2 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.5 35.0 3.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C10orf90 "bA422P15.2, FATS, FLJ32938" ENSG00000154493 "Chromosome 10 open reading frame 90" Q96M02 10 126424997-126670446 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 30.9;breast: 9.2;salivary gland: 18.6;testis: 12.3" "Group enriched" "Detected in some" 27 "Early spermatids: 96.0;Late spermatids: 93.2" "Cancer enriched" "Detected in some" 5 "melanoma: 4.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "MAIT T-cell: 2.7" "Lineage enriched" "Detected in single" 28 "T-cells: 2.7" "Cell line enhanced" "Detected in some" "SK-MEL-30: 49.5;U-2197: 15.1;U-266/84: 10.6;U-87 MG: 15.7;WM-115: 12.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038648, HPA075229" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA038648: AB_10672721, HPA075229: " "unprognostic (1.21e-2)" "unprognostic (3.34e-1)" "unprognostic (7.50e-2)" "unprognostic (2.05e-2)" "unprognostic (1.66e-1)" "unprognostic (9.30e-2)" "unprognostic (1.98e-3)" "unprognostic (5.06e-2)" "unprognostic (9.34e-3)" "unprognostic (3.73e-2)" "unprognostic (9.52e-2)" "unprognostic (1.22e-1)" "unprognostic (5.06e-11)" "unprognostic (2.69e-3)" "unprognostic (9.91e-3)" "unprognostic (1.26e-1)" "unprognostic (2.88e-1)" 1.9 0.8 7.5 1.0 21.5 0.8 9.2 1.4 18.7 0.9 0.9 30.9 0.0 0.7 0.8 0.8 0.9 0.7 1.1 0.8 10.8 5.9 0.9 0.8 0.8 0.7 26.0 5.9 0.9 1.1 0.7 0.5 1.3 14.4 0.9 1.0 1.7 18.6 0.7 0.9 1.9 0.8 0.8 17.2 0.8 0.7 12.3 28.0 0.0 1.3 0.0 2.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 49.5 0.0 0.0 0.1 0.0 2.0 0.0 15.1 0.3 0.0 10.6 0.0 15.7 0.0 12.4 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 21.5 1.4 11.3 10.8 5.9 26.0 5.9 14.4 28.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 96.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 93.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.4 0.0 3.5 0.0 0.0 0.0 C11orf1 FLJ23499 ENSG00000137720 "Chromosome 11 open reading frame 1" Q9H5F2 11 111878935-111885975 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 16 "Early spermatids: 375.8;Late spermatids: 825.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038410, HPA057519" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA038410: AB_10672591, HPA057519: AB_2683454" "unprognostic (1.33e-2)" "unprognostic (1.61e-1)" "unprognostic (1.96e-1)" "prognostic favorable (9.32e-4)" "unprognostic (1.30e-1)" "unprognostic (1.42e-2)" "unprognostic (1.10e-1)" "unprognostic (1.14e-1)" "unprognostic (9.26e-2)" "unprognostic (3.23e-2)" "unprognostic (1.41e-2)" "unprognostic (2.86e-2)" "prognostic favorable (1.39e-4)" "unprognostic (3.76e-2)" "unprognostic (2.12e-1)" "unprognostic (1.97e-1)" "unprognostic (2.08e-1)" 11.5 21.2 20.3 12.5 34.8 8.9 29.2 8.3 13.9 12.6 15.8 11.2 21.0 11.8 10.4 39.3 17.7 17.0 19.8 20.8 16.6 18.2 40.1 31.2 15.8 12.4 20.2 12.0 17.1 47.6 19.9 18.9 8.3 14.3 16.6 15.8 12.7 22.6 29.5 8.3 16.9 15.5 10.2 17.4 10.0 15.6 31.4 12.2 10.6 24.2 15.0 10.2 14.2 9.5 14.8 19.0 5.0 8.2 9.5 22.0 6.3 8.0 10.4 13.6 15.0 15.7 12.1 14.1 4.5 11.5 3.7 4.7 17.3 15.1 29.6 21.5 7.6 10.6 9.5 5.4 16.5 5.8 13.1 7.7 10.0 2.2 13.4 9.9 14.6 7.1 22.1 26.0 13.1 25.3 16.6 4.5 31.9 14.3 22.4 12.4 7.9 19.7 23.0 15.5 28.2 15.9 10.2 14.1 41.2 22.9 14.9 12.2 11.7 2.8 10.6 9.6 13.6 21.2 10.3 3.9 13.7 9.8 6.0 6.2 13.1 19.1 44.2 7.0 17.4 8.3 3.3 4.4 5.0 8.2 8.2 15.4 14.8 13.7 10.4 6.4 10.2 22.0 16.4 1.1 9.5 5.5 19.0 9.7 6.3 20.3 34.8 8.3 13.9 16.6 18.2 20.2 12.0 14.3 12.2 23.8 17.5 18.4 55.8 21.1 6.9 48.4 20.4 42.8 31.8 33.2 5.9 24.6 170.8 16.9 375.8 13.5 15.8 46.7 23.8 20.6 13.9 36.9 28.8 31.0 21.2 14.3 25.3 9.2 7.3 825.1 25.3 19.0 23.6 19.0 36.6 26.8 21.3 17.5 23.0 138.3 12.9 19.4 12.7 47.1 30.9 25.7 17.6 12.7 46.6 52.8 C11orf21 ENSG00000110665 "Chromosome 11 open reading frame 21" Q9P2W6 11 2295645-2303049 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 29.5;bone marrow: 30.4;lymphoid tissue: 16.0" "Cell type enhanced" "Detected in some" 23 "Cardiomyocytes: 60.5;granulocytes: 15.1;Kupffer cells: 14.3;Macrophages: 12.4;T-cells: 17.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 30.8;HL-60: 11.6;NB-4: 10.7;THP-1: 7.5;U-937: 13.1" HPA037607 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA037607: AB_10672909" "unprognostic (5.25e-3)" "unprognostic (2.65e-4)" "unprognostic (1.35e-1)" "unprognostic (4.61e-3)" "unprognostic (4.32e-2)" "unprognostic (3.58e-4)" "unprognostic (8.98e-4)" "unprognostic (2.37e-3)" "unprognostic (1.87e-1)" "unprognostic (1.15e-2)" "unprognostic (1.60e-1)" "unprognostic (1.22e-1)" "unprognostic (8.84e-4)" "unprognostic (8.50e-2)" "unprognostic (9.54e-2)" "unprognostic (3.55e-1)" "unprognostic (4.07e-2)" 1.5 0.4 0.7 8.7 0.5 30.4 0.7 0.2 0.7 1.5 0.8 1.7 0.8 0.2 1.6 1.3 0.7 1.0 5.4 15.6 0.4 0.4 1.0 1.3 5.2 8.5 2.2 0.9 0.7 0.6 0.0 0.8 0.8 1.0 0.8 0.8 1.4 9.3 0.1 0.4 0.8 3.3 0.6 1.4 16.0 2.0 0.9 1.0 6.4 1.1 2.7 11.5 1.0 0.9 2.6 7.3 29.5 23.2 9.5 10.6 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 30.8 0.0 0.1 0.3 11.6 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 13.1 0.0 29.5 6.3 18.7 10.6 13.1 7.3 2.0 3.6 8.4 7.3 2.6 5.4 7.5 5.5 9.5 23.2 0.7 2.6 6.4 0.7 0.5 0.2 0.7 0.4 0.4 2.2 0.9 1.0 1.0 0.0 6.2 1.9 0.0 0.3 0.0 60.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 15.1 0.0 3.4 0.0 0.0 1.3 14.3 0.0 0.0 12.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 17.5 0.0 0.0 C11orf24 DM4E3 ENSG00000171067 "Chromosome 11 open reading frame 24" Q96F05 11 68261335-68272001 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 65.7" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 99.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 63.4" "HPA012411, HPA012748" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus" Vesicles "HPA012411: , HPA012748: AB_1845526" "unprognostic (1.13e-2)" "unprognostic (2.03e-2)" "unprognostic (1.19e-1)" "unprognostic (8.22e-2)" "prognostic unfavorable (7.38e-4)" "unprognostic (2.31e-2)" "unprognostic (7.91e-2)" "prognostic unfavorable (6.05e-4)" "unprognostic (1.56e-1)" "unprognostic (2.68e-2)" "unprognostic (4.99e-2)" "unprognostic (1.55e-1)" "prognostic unfavorable (1.60e-9)" "unprognostic (2.18e-2)" "unprognostic (1.61e-1)" "unprognostic (2.21e-1)" "unprognostic (8.67e-3)" 12.9 9.3 6.6 12.9 10.6 2.7 14.7 6.7 13.7 14.1 32.6 23.3 8.4 35.2 21.8 12.3 8.6 12.2 19.2 19.1 9.1 6.5 10.0 44.3 12.6 14.4 10.3 8.1 14.1 17.5 5.8 8.1 12.6 14.5 12.2 11.8 14.7 22.1 12.6 6.9 8.9 65.7 21.5 13.8 11.3 13.5 7.8 10.3 3.4 9.2 11.4 18.8 14.6 10.5 23.7 16.4 9.3 11.0 5.5 9.2 6.9 12.5 13.0 7.7 15.0 18.7 19.0 9.0 30.3 19.7 15.3 15.8 27.4 7.8 5.7 9.4 37.6 13.9 14.2 11.4 13.6 9.9 6.2 6.7 6.0 13.2 18.3 15.1 5.1 20.3 15.7 10.2 23.2 9.5 9.2 6.1 3.0 10.5 9.4 12.9 15.6 1.2 7.4 12.9 20.4 15.8 2.3 13.2 29.3 6.9 6.0 5.1 9.5 9.9 7.9 63.4 6.7 7.4 4.3 6.7 24.1 14.9 30.3 13.3 11.6 11.3 5.3 19.3 4.0 23.1 9.3 7.2 7.5 9.2 11.0 6.2 17.3 5.3 5.7 12.0 23.7 5.0 5.3 1.1 5.5 8.1 16.4 4.8 6.9 6.6 10.6 6.7 13.7 9.1 6.5 10.3 8.1 14.5 10.3 8.9 2.2 11.5 8.0 12.5 3.7 8.5 12.7 10.7 4.5 8.7 2.0 12.7 1.7 14.5 2.8 6.4 37.3 0.0 27.1 24.7 18.1 10.2 43.9 99.7 14.5 0.0 4.6 9.2 12.1 5.6 13.0 12.4 27.0 21.6 33.5 6.6 21.8 12.4 15.2 8.8 2.9 12.9 17.9 12.7 20.6 9.8 8.8 4.9 12.8 7.9 C11orf53 MGC50104 ENSG00000150750 "Chromosome 11 open reading frame 53" Q8IXP5 11 111245805-111286401 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 7.6" "Cell type enriched" "Detected in some" 5 "Exocrine glandular cells: 51.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "OE19: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA056128, HPA073101" Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA056128: AB_2683046, HPA073101: " "unprognostic (3.51e-2)" "unprognostic (3.60e-2)" "unprognostic (4.84e-2)" "unprognostic (5.84e-2)" "unprognostic (1.94e-1)" "unprognostic (8.07e-3)" "unprognostic (5.60e-3)" "unprognostic (3.09e-1)" "unprognostic (2.50e-1)" "unprognostic (9.95e-2)" "unprognostic (8.66e-2)" "unprognostic (3.52e-2)" 1.4 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.1 2.6 1.2 1.6 0.0 0.0 1.8 2.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.9 0.8 0.0 0.6 1.2 0.4 2.4 4.1 0.0 3.2 0.0 3.0 0.0 0.0 0.0 4.5 7.6 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 1.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 7.6 0.0 0.0 0.0 0.0 0.0 0.0 1.5 11.2 0.0 2.1 0.0 51.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.5 0.0 0.0 6.6 0.3 0.0 0.0 0.0 2.5 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.0 1.7 3.5 C11orf54 PTD012 ENSG00000182919 "Chromosome 11 open reading frame 54" Q9H0W9 11 93741591-93764749 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 123.3;liver: 55.9" "Group enriched" "Detected in all" 5 "Cholangiocytes: 165.6;Distal tubular cells: 150.9;Hepatocytes: 260.8;Proximal tubular cells: 596.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040088, HPA040511" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA 640000 "Nuclear bodies" Nucleoplasm "HPA040088: AB_10795518, HPA040511: AB_10795369" "unprognostic (3.32e-2)" "unprognostic (3.51e-1)" "unprognostic (1.67e-3)" "unprognostic (2.62e-2)" "unprognostic (1.82e-2)" "unprognostic (1.90e-2)" "unprognostic (2.81e-2)" "unprognostic (1.01e-1)" "unprognostic (2.46e-2)" "unprognostic (2.87e-1)" "unprognostic (2.10e-3)" "unprognostic (1.58e-1)" "prognostic favorable (5.06e-6)" "unprognostic (2.19e-1)" "unprognostic (6.10e-2)" "unprognostic (2.41e-2)" "unprognostic (6.53e-3)" 6.0 10.2 5.0 4.3 7.6 1.8 7.2 6.7 6.0 5.9 12.0 7.7 7.8 12.2 6.4 7.3 6.8 7.5 10.6 8.5 5.3 5.0 123.3 55.9 8.0 4.6 8.4 5.1 8.5 13.9 5.6 11.6 5.7 7.3 9.7 10.0 8.9 8.3 6.5 14.2 5.2 20.0 6.7 9.3 5.2 8.4 5.1 7.8 8.9 11.3 5.3 5.3 6.9 4.9 10.6 12.4 37.6 11.7 9.3 11.9 7.2 3.8 5.5 12.7 7.8 9.9 11.4 14.8 5.3 8.8 5.4 7.5 2.1 21.6 15.7 35.4 10.2 6.0 9.0 14.6 3.9 7.5 15.8 5.0 8.6 12.8 10.1 11.3 7.2 4.6 10.6 7.5 10.0 7.2 14.6 8.7 10.9 11.3 11.0 5.5 3.0 13.1 10.0 4.6 25.6 8.8 12.5 16.5 24.8 30.9 7.4 6.5 8.3 9.7 12.2 11.7 9.9 27.1 5.7 5.7 5.5 4.4 9.6 2.8 4.9 14.3 15.5 4.2 11.9 9.4 23.7 11.7 27.3 9.0 8.5 9.3 10.6 9.3 10.2 8.9 9.5 11.5 10.1 37.6 9.3 7.4 12.4 11.9 7.2 5.0 7.6 6.7 6.0 5.3 5.0 8.4 5.1 7.3 7.8 59.6 41.2 13.2 10.0 4.8 16.3 31.1 165.6 41.5 40.9 45.4 15.7 42.4 150.9 13.7 7.6 15.8 55.5 23.3 12.2 12.2 12.6 30.6 15.0 260.8 15.3 14.3 21.4 22.7 28.8 4.7 23.9 10.6 8.5 13.6 34.5 17.1 11.1 37.0 21.5 596.3 16.8 6.5 7.2 31.1 12.4 8.7 51.8 10.2 31.6 13.7 C11orf58 SMAP ENSG00000110696 "Chromosome 11 open reading frame 58" O00193 11 16613132-16756881 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036591, HPA076406" Uncertain Approved "Nucleoplasm,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" Nucleoplasm "HPA036591: AB_10669909, HPA076406: AB_2686798" "unprognostic (8.09e-2)" "unprognostic (1.19e-1)" "unprognostic (1.20e-1)" "unprognostic (4.31e-2)" "unprognostic (2.88e-1)" "unprognostic (9.19e-2)" "prognostic unfavorable (5.84e-5)" "unprognostic (1.30e-1)" "unprognostic (7.84e-2)" "unprognostic (9.45e-3)" "unprognostic (1.76e-1)" "unprognostic (2.06e-1)" "unprognostic (4.41e-2)" "unprognostic (7.30e-2)" "unprognostic (9.77e-2)" "unprognostic (1.39e-1)" "unprognostic (1.50e-1)" 44.5 47.1 34.7 37.8 49.0 34.7 40.5 59.7 43.0 40.3 42.1 32.3 29.7 27.3 54.1 35.3 51.6 36.3 34.0 55.1 32.4 33.3 42.6 56.4 41.6 43.0 36.5 38.9 54.2 39.6 35.8 53.7 58.9 35.7 42.0 23.6 30.6 40.1 36.3 69.5 36.4 28.4 43.0 38.9 41.1 35.1 27.5 33.9 50.6 47.6 32.6 36.5 52.0 39.2 97.7 91.8 87.4 74.8 67.4 91.1 123.2 66.2 53.4 63.9 31.5 35.6 32.5 45.0 66.0 34.4 44.0 40.3 50.5 63.0 57.3 53.1 40.0 49.6 38.8 43.0 31.1 47.7 75.2 46.0 50.6 46.1 45.6 44.1 72.4 45.6 32.1 43.6 26.1 57.7 36.2 30.7 36.5 63.3 40.0 37.7 38.8 77.6 35.3 47.3 31.9 30.5 63.2 64.5 30.1 34.1 38.0 43.9 45.0 57.7 43.9 78.4 39.6 39.0 50.3 57.2 55.2 45.2 66.0 62.3 26.8 99.0 79.7 48.1 42.3 50.4 78.3 65.8 87.4 72.2 72.9 83.0 97.7 80.2 75.8 71.4 89.3 91.1 78.9 31.3 67.4 74.8 91.8 81.5 123.2 34.7 49.0 59.7 43.0 32.4 33.3 36.5 38.9 35.7 33.9 229.3 197.2 206.1 231.6 228.4 159.6 184.4 135.0 259.6 228.6 190.1 141.4 273.3 363.1 215.1 28.5 242.4 57.2 116.8 199.0 283.9 266.4 215.5 227.9 146.0 198.9 135.1 152.8 152.9 158.4 25.1 190.7 234.1 217.6 267.9 113.4 201.7 195.9 92.6 192.0 246.7 201.4 155.2 279.5 283.4 219.5 241.8 379.3 210.4 107.6 232.0 C11orf68 "BLES03, P5326" ENSG00000175573 "Chromosome 11 open reading frame 68" Q9H3H3 11 65916808-65919117 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045938 Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim" No Yes "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA045938: AB_10961633" "unprognostic (3.18e-1)" "unprognostic (3.35e-2)" "unprognostic (2.38e-2)" "unprognostic (4.48e-2)" "unprognostic (1.23e-1)" "unprognostic (9.25e-2)" "unprognostic (1.15e-2)" "unprognostic (9.88e-2)" "unprognostic (5.98e-2)" "unprognostic (9.88e-2)" "unprognostic (2.73e-1)" "unprognostic (1.50e-3)" "prognostic favorable (5.02e-6)" "unprognostic (2.16e-1)" "unprognostic (3.55e-1)" "unprognostic (3.07e-2)" "unprognostic (1.18e-1)" 20.1 13.1 23.5 11.0 23.5 6.9 15.4 44.0 42.9 24.5 19.7 20.0 16.6 13.6 26.3 33.0 19.0 25.3 16.4 24.5 22.9 18.8 13.7 12.1 15.4 17.3 18.3 23.7 32.9 17.6 20.6 11.0 19.5 18.6 23.3 12.9 14.8 24.2 27.5 37.0 19.6 13.1 22.2 15.5 19.0 14.1 21.5 18.5 23.0 21.5 13.1 16.4 22.3 23.1 6.6 3.6 12.6 5.2 4.9 7.5 2.8 20.4 9.2 5.7 6.2 20.2 19.6 4.9 16.4 25.2 21.0 12.9 3.4 23.3 4.2 11.5 24.6 33.7 6.7 4.4 10.1 11.4 6.5 4.4 5.0 6.2 8.9 16.1 3.9 6.7 18.1 15.2 15.2 16.9 21.9 15.6 7.2 6.6 10.6 38.1 9.3 5.2 9.6 5.7 4.5 46.3 7.7 6.5 11.8 11.1 3.9 3.9 6.1 6.3 8.4 15.8 6.2 10.8 3.8 16.8 33.6 16.4 45.6 8.3 7.1 3.1 3.5 19.9 3.0 26.1 8.7 3.5 4.9 7.4 5.2 5.2 4.2 4.8 6.1 2.6 6.6 7.4 7.5 12.6 4.9 2.6 3.6 5.6 2.8 23.5 23.5 44.0 42.9 22.9 18.8 18.3 23.7 18.6 18.5 14.9 6.1 6.7 24.0 13.6 10.2 13.7 15.3 0.0 1.2 15.7 9.8 13.0 6.6 11.6 6.3 10.5 10.0 0.0 10.0 13.3 15.8 19.5 3.5 9.6 12.3 15.9 4.6 16.0 11.5 19.9 19.8 6.6 10.1 14.4 11.6 22.3 13.9 0.0 33.2 5.1 7.2 19.4 12.5 13.9 14.3 11.2 18.3 8.7 8.4 22.4 C11orf71 FLJ20010 ENSG00000180425 "Chromosome 11 open reading frame 71" Q6IPW1 11 114391443-114400511 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in all" 5 "testis: 83.2" "Group enriched" "Detected in many" 15 "Early spermatids: 502.7;Late spermatids: 1567.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 19.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA063943, HPA074787" Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA063943: AB_2685157, HPA074787: AB_2686712" "unprognostic (1.24e-1)" "unprognostic (2.53e-2)" "unprognostic (1.42e-2)" "prognostic favorable (6.94e-4)" "unprognostic (7.35e-2)" "unprognostic (4.53e-2)" "unprognostic (1.83e-1)" "unprognostic (2.30e-3)" "unprognostic (1.58e-1)" "unprognostic (3.04e-3)" "unprognostic (1.39e-2)" "unprognostic (2.85e-2)" "prognostic favorable (7.01e-9)" "unprognostic (5.68e-2)" "unprognostic (5.43e-2)" "unprognostic (1.87e-1)" "unprognostic (1.17e-2)" 3.9 7.3 5.7 3.4 12.1 2.2 5.7 4.1 8.1 4.2 4.9 10.2 5.6 5.5 3.7 18.0 3.2 5.4 3.9 5.4 6.9 6.1 10.6 15.0 3.9 4.3 10.3 4.7 5.0 6.9 8.7 6.9 2.5 6.7 5.6 4.6 5.7 7.2 5.0 9.9 5.6 5.1 2.1 5.7 5.4 5.2 83.2 12.2 6.4 9.5 4.7 3.2 3.1 3.1 10.5 13.6 14.5 17.7 13.2 11.9 11.3 1.2 3.3 3.5 11.1 5.3 3.1 2.5 0.5 1.4 1.4 1.3 2.7 19.9 5.3 7.1 0.8 6.9 5.1 2.3 2.3 1.7 6.1 1.4 4.0 2.4 5.3 5.0 2.3 4.5 5.0 2.6 1.8 5.6 1.6 1.7 8.9 4.1 5.0 2.6 4.5 4.2 3.5 1.8 4.4 2.1 3.1 2.8 13.6 3.1 2.4 9.6 3.8 12.5 1.4 1.9 3.8 9.4 1.3 1.7 0.3 5.2 3.9 0.9 4.9 7.9 4.1 0.7 5.5 1.4 11.7 17.7 11.1 10.3 11.1 6.3 7.0 7.0 7.1 10.6 10.5 11.4 11.9 14.5 13.2 12.2 13.6 7.7 11.3 5.7 12.1 4.1 8.1 6.9 6.1 10.3 4.7 6.7 12.2 3.0 11.2 1.5 13.8 2.4 9.8 18.7 0.0 24.1 5.7 5.2 3.9 14.3 69.6 12.0 502.7 7.0 13.5 0.0 16.8 2.2 3.7 14.4 5.8 0.0 10.1 12.7 17.4 0.0 0.0 1567.4 12.0 9.1 5.0 10.0 19.0 23.4 11.0 17.5 8.5 59.7 12.5 6.5 4.1 23.4 8.8 2.3 12.2 1.7 15.1 9.5 C11orf96 AG2 ENSG00000187479 "Chromosome 11 open reading frame 96" 11 43942505-43944338 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ovary: 152.0" "Cell type enhanced" "Detected in many" 19 "Peritubular cells: 445.9;Sertoli cells: 297.5;Smooth muscle cells: 1129.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "SH-SY5Y: 65.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038843 Uncertain Approved "Nucleoplasm,Focal adhesion sites,Cytosol" No NA "Nucleoplasm, Focal adhesion sites, Cytosol" "HPA038843: AB_10673296" "unprognostic (1.55e-1)" "unprognostic (1.33e-1)" "unprognostic (1.28e-2)" "unprognostic (8.15e-3)" "unprognostic (5.49e-2)" "unprognostic (3.42e-3)" "unprognostic (8.11e-3)" "unprognostic (1.15e-2)" "unprognostic (2.46e-2)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (5.98e-2)" "prognostic unfavorable (2.34e-5)" "unprognostic (2.65e-2)" "unprognostic (2.07e-1)" "unprognostic (1.18e-2)" "unprognostic (3.19e-2)" 68.2 81.2 4.9 23.4 17.4 3.4 42.6 2.6 10.5 39.7 32.2 3.3 6.6 12.4 35.1 41.5 16.3 69.3 70.0 34.3 8.8 7.9 17.9 67.7 61.9 4.9 7.6 4.7 152.0 18.1 3.8 14.2 14.6 32.8 28.6 6.2 7.6 2.3 12.8 38.2 10.1 17.2 22.9 15.3 12.7 31.3 41.7 4.2 0.0 16.7 14.0 2.3 62.9 32.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.7 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.9 2.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.4 0.6 0.7 0.0 0.0 0.0 0.7 0.8 0.5 0.0 0.3 3.3 0.2 1.4 0.0 0.0 0.7 65.3 0.0 0.0 6.0 1.9 0.0 0.7 0.9 3.1 1.3 0.8 0.0 7.6 0.0 1.0 2.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 17.4 2.6 7.1 8.8 7.9 7.6 4.7 32.8 4.2 6.0 166.6 0.0 14.6 82.5 15.3 5.3 0.0 1.4 2.3 0.0 2.0 1.1 0.0 2.2 3.5 30.5 0.0 0.0 0.5 3.5 142.9 42.4 12.8 2.5 3.3 1.6 0.0 114.8 6.9 5.8 199.6 9.5 165.4 0.0 0.0 2.3 2.8 0.0 445.9 0.0 7.6 297.5 1129.9 1.6 1.4 77.3 2.6 2.5 0.0 35.8 C12orf10 "Gamm1, MYG, MYG1" ENSG00000139637 "Chromosome 12 open reading frame 10" Q9HB07 12 53299686-53307177 "Predicted intracellular proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 85.6" "Group enriched" "Detected in all" 6 "Early spermatids: 413.5;Late spermatids: 787.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038626, HPA038627" Approved Supported Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA038626: AB_10674692, HPA038627: AB_2676123" "unprognostic (5.33e-2)" "unprognostic (4.41e-2)" "unprognostic (6.77e-2)" "unprognostic (2.44e-2)" "unprognostic (3.59e-1)" "unprognostic (7.56e-2)" "unprognostic (1.61e-3)" "unprognostic (2.73e-1)" "unprognostic (1.97e-1)" "unprognostic (3.58e-2)" "unprognostic (2.71e-2)" "unprognostic (1.39e-1)" "unprognostic (2.81e-1)" "unprognostic (6.41e-2)" "unprognostic (2.18e-1)" "unprognostic (2.16e-1)" "unprognostic (1.61e-1)" 16.1 18.7 21.5 13.0 18.4 13.7 17.8 18.4 32.2 17.9 15.1 14.0 18.7 14.3 17.7 18.3 15.9 28.4 16.6 20.2 19.7 21.3 18.8 15.7 13.0 23.6 25.0 23.9 33.3 27.6 20.6 15.7 11.7 27.7 14.6 11.9 14.3 19.4 19.7 22.4 15.7 13.1 17.7 14.3 12.1 16.2 85.6 12.9 19.4 24.1 18.3 15.0 17.3 15.0 26.1 31.1 12.2 27.4 19.2 33.3 23.2 13.2 30.5 10.8 17.2 11.7 17.7 1.3 8.8 14.2 20.1 14.6 27.6 14.4 12.7 20.9 12.2 11.2 15.0 15.1 19.1 11.0 10.6 29.6 13.2 25.2 32.0 27.4 13.6 8.9 17.6 14.6 18.5 18.9 20.2 17.9 15.1 0.7 26.4 13.5 62.3 18.3 22.4 18.0 13.6 29.5 17.2 10.3 29.7 17.3 14.8 21.8 21.0 9.9 19.5 21.4 6.6 30.6 13.0 11.6 19.7 18.6 14.1 13.8 23.9 24.8 14.1 25.0 11.6 15.1 7.8 27.4 12.2 18.3 20.6 27.5 26.1 24.6 18.4 31.1 22.0 25.9 23.4 6.9 19.2 15.4 19.4 33.3 23.2 21.5 18.4 18.4 32.2 19.7 21.3 25.0 23.9 27.7 12.9 20.8 13.4 38.4 38.3 34.7 24.1 14.2 33.1 28.1 13.6 29.6 11.8 30.6 66.3 54.6 413.5 33.7 29.6 23.3 80.2 49.2 43.7 27.1 13.9 21.5 61.3 9.5 48.4 28.3 41.7 787.6 47.5 41.2 32.1 34.3 43.5 34.6 50.7 40.7 42.8 99.0 31.7 38.8 57.5 104.3 80.3 34.9 21.6 34.8 48.6 26.8 C12orf45 MGC40397 ENSG00000151131 "Chromosome 12 open reading frame 45" Q8N5I9 12 104986310-105074197 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 82.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 82.3" "Lineage enriched" "Detected in all" 13 "dendritic cells: 82.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038722 Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA038722: AB_10673118" "unprognostic (1.27e-2)" "unprognostic (9.98e-2)" "unprognostic (2.52e-1)" "unprognostic (2.02e-2)" "unprognostic (4.75e-3)" "unprognostic (1.44e-2)" "unprognostic (1.10e-1)" "unprognostic (2.26e-1)" "unprognostic (4.31e-2)" "unprognostic (2.34e-1)" "unprognostic (5.20e-2)" "unprognostic (2.56e-1)" "prognostic unfavorable (4.58e-10)" "unprognostic (1.46e-1)" "unprognostic (8.71e-2)" "unprognostic (2.42e-2)" "unprognostic (2.19e-2)" 12.1 11.4 14.1 14.4 14.4 15.9 10.8 6.5 15.4 9.0 13.6 9.4 12.4 14.9 9.6 10.0 11.1 7.3 7.1 9.2 12.3 11.5 8.0 18.8 7.7 14.6 11.4 11.0 10.2 35.3 2.7 10.8 7.9 16.0 10.3 11.7 7.5 21.6 13.8 7.7 10.6 10.6 9.7 9.6 12.3 14.1 8.1 9.7 11.0 12.1 8.5 15.4 9.0 11.1 5.9 82.3 1.2 6.2 4.7 5.5 3.5 9.4 13.5 6.5 16.6 5.5 5.6 30.2 8.5 2.1 5.2 2.9 13.5 4.8 18.1 8.6 3.8 13.1 6.3 5.4 12.9 5.8 5.1 9.7 12.0 6.9 18.5 8.1 17.9 9.5 8.3 5.5 7.8 8.5 8.7 8.4 15.2 10.0 4.7 5.0 15.8 11.8 30.7 12.7 14.2 19.6 15.9 7.9 40.8 7.0 12.4 8.4 6.1 8.2 17.7 12.7 12.4 14.7 7.3 4.0 13.1 8.5 11.1 12.9 9.9 11.2 19.1 6.1 12.6 12.3 1.2 6.2 0.1 2.6 5.2 3.2 5.9 3.5 3.2 18.7 4.4 3.6 3.4 0.7 4.7 2.9 82.3 5.5 3.5 14.1 14.4 6.5 15.4 12.3 11.5 11.4 11.0 16.0 9.7 6.0 33.1 19.3 31.8 34.7 9.6 34.4 28.1 25.4 31.8 31.4 23.6 29.8 23.2 25.1 16.4 17.7 9.1 0.0 47.4 53.7 16.7 19.3 19.7 42.3 33.7 3.2 12.0 10.4 20.2 8.5 14.1 56.0 37.1 52.3 18.7 15.6 38.0 18.4 9.6 32.1 11.1 0.0 28.3 17.2 30.2 28.5 18.4 20.8 25.3 32.5 C12orf60 MGC47869 ENSG00000182993 "Chromosome 12 open reading frame 60" Q5U649 12 14803572-14906586 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 22.5" "Cell type enriched" "Detected in many" 7 "Early spermatids: 342.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043911 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043911: AB_10963941" "unprognostic (3.71e-2)" "unprognostic (7.02e-2)" "unprognostic (1.72e-1)" "unprognostic (6.39e-2)" "unprognostic (4.01e-1)" "unprognostic (1.21e-1)" "unprognostic (1.72e-1)" "unprognostic (3.09e-2)" "unprognostic (8.56e-2)" "unprognostic (1.18e-1)" "unprognostic (8.25e-3)" "unprognostic (9.42e-2)" "unprognostic (2.17e-1)" "unprognostic (7.09e-2)" "unprognostic (1.85e-1)" "unprognostic (1.97e-2)" "unprognostic (2.75e-2)" 1.7 8.9 2.6 2.3 9.9 1.7 1.8 1.9 4.7 1.5 1.3 4.8 1.6 0.7 1.1 2.9 1.3 2.9 1.8 5.4 3.7 2.0 4.8 8.7 2.0 3.2 6.3 4.7 1.5 2.1 1.7 3.8 1.6 7.2 2.1 1.2 5.1 1.9 1.4 2.5 1.3 1.4 0.8 9.2 5.5 1.9 22.5 4.9 1.7 3.3 1.0 2.0 1.5 1.7 3.9 1.1 3.6 1.4 3.3 4.5 1.2 2.5 2.8 2.8 8.1 3.1 2.2 2.5 1.9 1.0 2.0 2.4 1.2 2.8 2.2 2.3 0.6 3.0 2.9 3.1 6.2 2.7 5.0 3.1 1.7 0.8 1.9 2.5 2.6 0.9 1.1 3.8 2.0 4.2 2.7 3.8 3.6 2.8 0.5 2.7 0.8 1.0 1.5 9.6 3.8 1.6 3.1 4.8 3.3 3.6 0.8 2.0 2.5 4.1 1.0 3.6 8.6 3.2 1.2 2.9 1.8 2.0 1.4 2.1 1.4 0.9 7.3 2.2 2.4 2.5 0.3 1.3 3.6 2.3 1.4 3.7 3.9 1.9 3.3 1.1 2.6 4.5 3.8 0.3 3.3 0.8 1.0 3.6 1.2 2.6 9.9 1.9 4.7 3.7 2.0 6.3 4.7 7.2 4.9 0.0 0.0 7.5 0.4 0.2 3.3 3.3 0.0 5.3 2.3 5.2 19.6 1.4 6.6 1.3 342.1 2.3 0.0 0.0 1.0 1.7 1.2 0.4 0.0 0.8 1.0 1.6 0.0 0.0 1.2 51.4 2.8 1.1 0.0 3.6 0.1 2.5 0.6 0.0 2.5 2.9 16.1 19.4 1.0 10.5 7.9 0.9 0.2 2.5 0.3 0.3 C12orf65 "FLJ38663, SPG55" ENSG00000130921 "Chromosome 12 open reading frame 65" Q9H3J6 12 123232916-123257959 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 80.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057595 Approved Approved Nucleoplasm,Mitochondria,Cytosol No Yes "Nucleoplasm, Cytosol" Mitochondria "HPA057595: " "unprognostic (9.07e-3)" "unprognostic (1.51e-2)" "unprognostic (5.30e-2)" "unprognostic (8.19e-3)" "unprognostic (1.23e-1)" "unprognostic (2.58e-1)" "prognostic unfavorable (4.29e-9)" "unprognostic (9.33e-3)" "unprognostic (2.39e-1)" "unprognostic (2.50e-2)" "unprognostic (6.33e-3)" "unprognostic (1.20e-2)" "unprognostic (2.01e-2)" "unprognostic (3.89e-2)" "unprognostic (3.19e-2)" "unprognostic (9.83e-3)" "prognostic favorable (7.82e-5)" 7.8 15.7 13.2 11.3 15.1 9.6 9.0 21.6 18.2 14.1 10.8 12.3 11.6 13.8 14.9 16.5 10.7 11.7 11.1 17.4 13.2 15.2 12.1 15.6 10.6 18.8 11.5 13.2 21.3 12.4 8.8 24.6 9.2 15.0 15.1 9.7 13.1 21.2 10.8 14.3 17.7 12.6 10.5 14.2 14.7 11.7 17.3 12.2 80.9 15.3 7.9 15.5 14.3 13.7 23.6 10.0 22.6 4.6 17.1 28.9 10.0 14.2 9.9 11.2 21.9 5.6 6.0 6.8 11.9 7.6 12.1 8.9 10.6 8.5 17.8 10.3 3.8 12.3 10.5 12.1 6.5 11.6 13.3 10.8 21.0 9.7 9.2 12.6 9.7 10.6 6.3 15.8 8.8 18.2 18.7 7.8 25.5 22.1 7.4 8.0 6.2 23.3 18.0 8.5 12.1 15.2 17.4 13.3 16.5 11.3 8.2 23.8 10.3 13.3 6.8 12.4 8.4 10.8 11.4 8.8 13.2 15.8 11.9 12.0 12.2 14.0 16.3 8.6 12.9 17.2 22.6 3.5 14.0 15.9 3.8 19.8 23.6 22.0 21.1 6.0 20.2 28.9 24.7 3.7 17.1 4.6 10.0 18.5 10.0 13.2 15.1 21.6 18.2 13.2 15.2 11.5 13.2 15.0 12.2 38.7 45.0 27.9 34.0 40.3 32.8 41.3 15.3 17.4 20.5 24.4 13.7 36.6 51.4 17.6 17.3 20.3 14.7 23.3 9.4 19.4 29.7 17.7 14.0 27.0 12.6 42.9 9.2 16.5 7.5 5.0 35.1 13.2 23.6 37.9 16.9 33.9 12.4 13.3 39.6 23.9 34.3 12.9 33.9 63.0 26.2 31.6 9.0 44.9 20.0 7.1 C12orf74 ENSG00000214215 "Chromosome 12 open reading frame 74" Q32Q52 12 92702843-92708549 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 6.9;lung: 6.6;lymphoid tissue: 12.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "memory B-cell: 3.7;naive B-cell: 3.1" "Lineage enriched" "Detected in single" 21 "B-cells: 3.7" "Cell line enhanced" "Detected in some" "RPMI-8226: 2.7;RT4: 2.5;SK-BR-3: 2.8" HPA062856 Approved "Nucleoplasm,Nuclear bodies,Aggresome" NA NA Nucleoplasm "Nuclear bodies, Aggresome" "HPA062856: " "unprognostic (2.75e-2)" "unprognostic (4.33e-2)" "unprognostic (2.28e-3)" "unprognostic (4.55e-3)" "unprognostic (7.95e-4)" "unprognostic (2.23e-1)" "unprognostic (2.57e-1)" "unprognostic (1.63e-1)" "unprognostic (2.15e-1)" "unprognostic (5.84e-2)" "unprognostic (5.83e-4)" "unprognostic (3.03e-1)" "unprognostic (5.89e-2)" "unprognostic (1.42e-2)" 0.2 0.1 0.1 12.3 0.1 0.0 0.2 0.1 0.1 2.1 0.7 0.0 3.6 0.3 0.7 6.9 1.7 4.5 0.3 0.2 0.1 0.1 1.3 0.5 6.6 1.9 0.1 0.0 1.0 1.1 0.0 0.2 0.0 0.0 0.6 0.3 0.0 0.9 0.9 0.1 0.2 1.8 0.0 0.1 2.6 2.1 0.5 0.0 0.1 0.2 0.0 10.5 2.5 1.4 3.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.5 2.5 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C14orf39 SIX6OS1 ENSG00000179008 "Chromosome 14 open reading frame 39" Q8N1H7 14 60396469-60515543 "Plasma proteins, Predicted intracellular proteins" "DNA recombination, Meiosis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 16.9;salivary gland: 6.7;testis: 14.9" "Cell type enriched" "Detected in some" 6 "Spermatocytes: 70.5" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in single" "hypothalamus: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 4.7;JURKAT: 21.7;MOLT-4: 17.6;RH-30: 4.8;U-2 OS: 9.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA059518 Uncertain Approved Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "HPA059518: AB_2684049" "unprognostic (6.17e-2)" "unprognostic (1.73e-3)" "unprognostic (3.00e-6)" "unprognostic (2.78e-1)" "unprognostic (6.97e-2)" "unprognostic (7.55e-4)" "unprognostic (2.12e-1)" "unprognostic (1.71e-1)" "unprognostic (2.17e-1)" "unprognostic (1.78e-1)" "unprognostic (7.46e-2)" "unprognostic (4.35e-1)" "unprognostic (1.50e-1)" "unprognostic (2.09e-1)" 1.0 2.7 0.0 0.6 0.2 0.0 0.1 0.0 0.5 0.5 0.8 0.0 0.0 0.3 0.6 0.0 0.7 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.4 1.7 0.0 0.6 16.9 0.0 0.2 1.6 0.0 1.6 6.7 0.1 3.8 0.0 0.3 0.1 0.5 0.0 0.6 14.9 0.0 0.0 0.4 1.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.6 4.7 0.0 0.0 0.0 0.0 0.3 3.6 0.0 0.6 0.0 0.1 0.0 21.7 0.0 0.0 1.6 0.0 17.6 0.2 2.3 0.0 1.1 0.0 4.8 0.0 0.3 1.2 0.0 2.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 1.4 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.6 0.0 1.4 5.7 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.0 0.0 3.2 0.0 0.0 0.0 5.1 0.3 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.7 0.0 1.0 0.0 0.0 70.5 6.1 0.0 0.0 0.0 0.0 0.1 C14orf93 "FLJ12154, RTFC" ENSG00000100802 "Chromosome 14 open reading frame 93" Q9H972 14 22985908-23010166 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Intestinal endocrine cells: 15.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002569 Approved Approved "Nucleoplasm,Plasma membrane" "Secreted - unknown location" NA NA "Nucleoplasm, Plasma membrane" "HPA002569: AB_1078334" "prognostic favorable (5.05e-4)" "unprognostic (1.31e-2)" "unprognostic (2.97e-2)" "unprognostic (2.23e-3)" "unprognostic (2.30e-2)" "unprognostic (1.30e-1)" "unprognostic (1.24e-2)" "unprognostic (1.02e-1)" "unprognostic (1.88e-1)" "unprognostic (1.29e-1)" "unprognostic (4.86e-3)" "unprognostic (7.45e-2)" "unprognostic (2.01e-3)" "unprognostic (1.10e-1)" "unprognostic (2.49e-1)" "unprognostic (2.14e-1)" "unprognostic (7.11e-2)" 10.4 6.1 10.2 11.8 7.3 12.4 9.8 14.3 7.9 12.0 12.2 8.3 16.7 8.1 10.8 13.5 10.3 11.1 10.3 7.2 9.6 4.6 10.3 9.7 8.7 10.3 6.8 5.9 12.2 15.9 12.9 18.9 5.4 7.4 11.0 10.9 9.1 9.8 10.2 7.3 20.3 9.4 8.4 11.0 12.9 9.5 5.8 9.0 22.7 16.3 7.8 14.6 11.6 9.5 9.7 8.8 21.3 11.3 8.8 12.4 6.6 3.9 7.4 6.3 8.8 10.2 22.9 8.8 4.6 7.2 3.7 4.9 4.6 11.7 11.1 4.4 4.2 5.2 8.4 3.8 11.7 3.5 4.3 2.7 7.0 9.0 10.5 8.9 5.0 6.0 16.5 9.2 5.5 7.0 13.5 6.8 7.2 7.5 2.4 3.8 11.1 6.4 9.4 2.1 8.5 5.2 10.4 6.0 6.7 4.8 6.0 23.0 10.0 6.2 6.0 6.3 7.1 9.3 8.9 3.8 7.0 9.3 3.1 4.6 8.6 2.3 7.6 4.8 6.3 7.1 11.7 7.5 21.3 8.3 6.9 7.3 9.7 6.8 8.6 8.8 9.4 10.2 9.8 10.7 8.8 11.3 6.2 12.4 6.6 10.2 7.3 14.3 7.9 9.6 4.6 6.8 5.9 7.4 9.0 8.9 0.6 4.7 4.8 2.7 1.2 2.8 2.5 5.3 1.2 0.0 3.9 3.0 6.6 2.8 0.5 2.9 2.9 0.0 2.6 4.3 2.4 2.0 6.9 1.1 3.3 0.0 15.1 1.3 2.7 1.0 4.0 3.4 5.0 0.0 5.2 2.9 3.4 7.0 3.9 3.0 1.9 6.5 3.1 1.5 7.9 1.4 2.5 4.3 4.9 1.4 C15orf40 MGC29937 ENSG00000169609 "Chromosome 15 open reading frame 40" Q8WUR7 15 82988441-83011641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042980 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA042980: AB_10964298" "unprognostic (8.30e-3)" "unprognostic (2.56e-2)" "unprognostic (3.96e-2)" "unprognostic (1.31e-1)" "unprognostic (3.58e-1)" "unprognostic (2.02e-2)" "unprognostic (1.17e-2)" "unprognostic (3.04e-2)" "unprognostic (8.65e-2)" "unprognostic (2.20e-2)" "unprognostic (8.55e-3)" "unprognostic (7.71e-2)" "prognostic favorable (4.35e-4)" "unprognostic (2.83e-1)" "unprognostic (1.84e-1)" "unprognostic (1.33e-1)" "unprognostic (2.51e-2)" 13.5 16.3 14.3 11.1 15.4 15.1 13.5 15.9 15.8 10.9 13.9 15.0 16.3 16.3 9.6 24.2 10.8 10.6 10.1 9.0 13.1 9.1 17.2 16.3 9.2 16.0 13.2 13.8 13.9 16.7 12.3 14.1 9.0 12.7 10.3 10.0 11.9 13.8 12.1 13.4 18.2 16.8 10.6 10.5 13.8 11.3 14.3 10.3 14.3 16.0 11.9 12.5 9.9 10.4 27.9 18.8 27.0 14.1 26.5 24.7 12.2 9.1 11.6 7.6 10.4 9.7 9.0 7.3 6.0 9.8 5.9 6.8 8.4 16.3 10.0 8.4 4.6 14.8 17.8 16.9 12.5 6.8 19.0 11.8 9.4 15.6 9.6 9.6 15.6 10.0 7.9 17.6 9.9 11.3 8.0 10.3 26.4 12.8 16.6 5.7 9.4 13.3 8.5 13.4 14.2 7.9 17.9 10.8 13.3 10.2 14.4 18.7 11.4 16.0 11.5 22.6 10.3 14.5 9.3 6.6 12.9 18.1 9.7 10.8 15.4 23.4 18.9 16.2 16.1 14.0 27.0 14.1 18.8 19.3 13.6 21.1 27.9 20.5 19.9 13.2 24.4 24.1 20.7 15.1 26.5 12.6 18.8 24.7 12.2 14.3 15.4 15.9 15.8 13.1 9.1 13.2 13.8 12.7 10.3 26.8 23.8 25.3 23.3 10.6 26.7 10.1 43.3 62.9 50.0 24.4 11.8 40.7 79.6 40.9 25.5 18.5 46.7 23.3 48.5 24.2 18.6 24.2 25.6 32.6 26.7 28.6 27.6 20.9 27.8 25.0 30.8 31.9 25.3 40.5 29.1 29.3 50.2 27.1 33.9 93.6 27.5 19.4 15.3 101.2 55.6 13.4 29.7 32.4 31.5 21.3 C15orf41 "FLJ22851, HH114, MGC11326" ENSG00000186073 "Chromosome 15 open reading frame 41" Q9Y2V0 15 36579611-36810248 "Disease related genes, Predicted intracellular proteins" "Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "heart muscle: 79.9" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 94.8;Early spermatids: 108.6;Late spermatids: 112.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061023 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA061023: AB_2684417" "unprognostic (1.82e-1)" "unprognostic (1.14e-1)" "unprognostic (1.10e-2)" "unprognostic (4.92e-2)" "unprognostic (2.93e-3)" "unprognostic (2.27e-2)" "unprognostic (2.37e-2)" "unprognostic (2.02e-2)" "unprognostic (3.40e-2)" "unprognostic (3.29e-2)" "unprognostic (2.59e-3)" "unprognostic (9.14e-2)" "unprognostic (3.74e-6)" "unprognostic (1.22e-2)" "unprognostic (4.54e-2)" "unprognostic (1.62e-4)" "unprognostic (1.58e-1)" 2.3 4.1 3.4 4.1 8.9 0.8 2.4 4.2 4.1 5.5 4.0 2.8 3.5 4.9 8.8 2.7 7.0 3.3 4.7 79.9 2.5 2.4 2.3 2.8 2.9 1.9 3.1 2.3 3.6 1.9 2.7 3.5 1.8 2.8 5.4 2.7 2.7 3.5 5.3 7.9 4.2 3.0 16.0 3.4 2.0 2.8 4.9 3.7 2.8 2.2 7.2 3.9 7.7 6.2 3.6 2.4 0.4 2.1 4.9 7.8 2.0 13.2 7.1 9.0 3.4 9.9 12.1 3.7 6.4 3.2 8.1 6.7 9.8 5.3 2.1 6.5 15.6 6.0 24.4 9.3 5.5 9.4 1.0 6.5 6.9 6.6 7.1 9.0 6.0 5.2 9.0 6.1 6.9 3.8 6.2 7.7 6.8 8.8 2.2 11.1 6.0 1.8 3.4 4.9 6.1 3.6 5.5 2.5 1.4 5.2 18.2 5.2 3.3 4.3 4.3 3.4 7.0 4.0 9.2 5.4 8.0 4.4 5.3 1.7 5.4 7.4 9.8 10.1 10.5 7.3 0.0 0.8 0.4 4.3 2.1 3.9 3.6 3.4 4.2 2.4 3.5 4.1 3.5 0.1 4.9 0.8 1.8 7.8 2.0 3.4 8.9 4.2 4.1 2.5 2.4 3.1 2.3 2.8 3.7 0.0 0.6 0.8 16.5 9.6 7.7 94.8 5.1 2.7 2.3 0.0 31.4 6.8 5.0 3.4 108.6 4.5 1.3 0.0 1.2 5.6 4.6 5.1 0.0 2.1 1.7 7.9 1.2 4.9 2.2 112.4 2.8 1.3 1.7 0.0 2.0 2.7 3.9 0.0 3.5 1.4 15.6 0.0 6.2 4.4 4.7 8.5 9.0 2.2 2.4 22.3 C15orf59 "INSYN1, LOC388135, MGC131524" ENSG00000205363 "Chromosome 15 open reading frame 59" Q2T9L4 15 73735431-73752747 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 24.1;heart muscle: 16.2" "Group enriched" "Detected in some" 4 "Bipolar cells: 8.5;Cardiomyocytes: 12.5;Muller glia cells: 6.8" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 11.6;fHDF/TERT166: 7.7;HEK 293: 7.9;NTERA-2: 4.9;SK-BR-3: 6.9;U-2 OS: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041563 Approved Approved Nucleoplasm,Cytosol No NA "Nucleoplasm, Cytosol" "HPA041563: AB_10794670" "unprognostic (2.28e-2)" "unprognostic (2.47e-2)" "unprognostic (4.85e-2)" "unprognostic (2.36e-1)" "unprognostic (1.71e-1)" "unprognostic (9.36e-2)" "unprognostic (3.37e-2)" "unprognostic (1.02e-2)" "unprognostic (1.60e-1)" "unprognostic (8.36e-2)" "unprognostic (2.67e-4)" "unprognostic (2.67e-2)" "prognostic favorable (5.38e-9)" "unprognostic (4.98e-2)" "unprognostic (5.19e-2)" "unprognostic (2.46e-4)" "unprognostic (1.20e-3)" 1.2 1.9 9.3 0.4 9.7 0.0 0.9 5.5 24.1 2.2 0.7 0.3 1.0 2.4 9.4 6.5 1.5 16.2 9.1 8.3 3.5 0.0 1.7 0.0 14.4 4.8 1.0 0.0 0.7 0.2 4.5 0.2 0.7 10.1 1.4 8.4 1.0 2.1 4.2 0.0 0.8 1.9 0.4 0.4 1.6 3.8 0.8 0.6 1.5 0.5 0.8 0.5 0.0 0.0 0.5 2.9 1.8 11.6 0.2 0.0 1.5 0.0 1.0 0.0 0.0 0.0 0.1 1.0 7.7 1.6 3.0 2.5 0.0 0.0 0.0 7.9 0.4 0.0 0.0 0.9 0.0 0.2 0.9 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.7 1.0 0.0 0.2 4.9 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.7 0.6 6.9 0.7 1.8 3.1 0.2 0.1 1.9 6.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.5 0.3 0.4 0.2 0.3 0.3 0.3 0.4 0.1 0.8 0.5 0.5 1.5 0.8 0.3 0.6 0.3 0.0 0.0 0.3 0.0 0.4 0.0 8.5 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 6.8 0.0 0.0 2.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C15orf65 FLJ27352 ENSG00000261652 "Chromosome 15 open reading frame 65" H3BRN8 15 55408548-55418764 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 27.6" "Group enriched" "Detected in many" 6 "Ciliated cells: 50.9;Early spermatids: 140.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 6.5" "Group enriched" "Detected in many" 5 "B-cells: 2.3;granulocytes: 6.5;monocytes: 1.6" "Cell line enhanced" "Detected in many" "hTCEpi: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA067189 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA067189: AB_2685800" "unprognostic (2.77e-2)" "unprognostic (7.42e-2)" "unprognostic (7.50e-2)" "prognostic favorable (3.18e-7)" "unprognostic (1.59e-1)" "unprognostic (9.56e-3)" "unprognostic (1.16e-3)" "unprognostic (6.69e-2)" "unprognostic (2.54e-1)" "unprognostic (1.51e-1)" "unprognostic (2.25e-1)" "unprognostic (8.89e-2)" "unprognostic (1.84e-3)" "unprognostic (2.09e-1)" "unprognostic (1.81e-1)" "unprognostic (1.42e-1)" "unprognostic (1.80e-1)" 3.4 3.1 6.5 0.9 7.4 0.8 5.4 2.4 6.7 7.7 5.2 3.7 5.4 2.9 3.7 11.2 3.4 13.7 5.3 7.0 6.0 7.6 11.2 1.9 3.8 2.2 5.2 6.8 4.6 11.0 6.2 17.2 1.2 12.0 5.8 6.2 2.8 27.6 5.3 8.7 2.4 2.5 3.7 3.4 1.9 7.8 11.3 4.6 1.7 7.1 0.6 1.8 3.6 1.5 2.3 0.6 6.5 1.6 0.0 0.7 0.4 0.8 1.7 2.9 1.8 4.5 6.7 0.5 1.6 2.2 1.4 2.8 0.0 1.5 1.3 4.4 5.2 3.5 1.3 0.0 2.7 0.5 2.4 2.0 1.2 10.1 0.4 8.8 2.9 1.6 2.8 14.9 4.2 1.2 7.8 2.7 0.0 2.3 4.3 6.2 2.2 0.1 9.3 0.9 5.3 3.3 0.5 0.0 11.2 7.6 0.0 7.9 4.8 2.0 3.4 12.8 1.6 6.9 2.8 1.9 2.4 0.9 2.5 0.9 1.9 5.0 1.2 6.2 7.2 1.2 6.5 1.1 3.9 0.5 1.6 0.0 1.9 0.1 0.7 0.6 2.3 0.1 0.0 2.1 0.0 0.8 0.2 0.0 0.4 6.5 7.4 2.4 6.7 6.0 7.6 5.2 6.8 12.0 4.6 3.0 0.6 0.8 3.6 1.1 0.8 7.3 2.5 50.9 4.5 5.2 0.0 1.0 14.9 7.1 140.3 3.6 2.1 0.0 9.6 1.1 3.1 4.5 4.6 1.0 2.5 3.2 3.5 3.1 1.9 6.8 4.0 0.2 3.3 1.0 16.7 3.6 7.0 11.5 5.3 16.8 7.5 6.5 2.8 5.8 2.8 1.5 0.0 0.0 4.6 1.7 C16orf45 FLJ32618 ENSG00000166780 "Chromosome 16 open reading frame 45" Q96MC5 16 15434295-15625028 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 72.3" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 125.3;Late spermatids: 336.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 11.1" "Lineage enriched" "Detected in many" 4 "T-cells: 11.1" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 33.1;U-2197: 24.0;U-87 MG: 41.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041114, HPA063757" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA041114: AB_10794542, HPA063757: " "unprognostic (1.02e-1)" "unprognostic (2.22e-1)" "unprognostic (1.67e-2)" "unprognostic (6.96e-2)" "unprognostic (3.79e-2)" "unprognostic (1.21e-1)" "prognostic favorable (1.53e-4)" "unprognostic (3.23e-2)" "unprognostic (1.90e-2)" "unprognostic (1.16e-2)" "unprognostic (3.64e-2)" "unprognostic (5.28e-2)" "prognostic favorable (1.75e-4)" "unprognostic (3.79e-3)" "unprognostic (8.31e-2)" "unprognostic (1.71e-1)" "unprognostic (1.58e-1)" 11.5 10.2 38.8 6.8 27.6 1.3 8.4 30.6 72.3 28.4 10.4 10.1 3.8 5.9 21.3 12.7 14.2 12.3 14.6 28.7 39.2 30.4 9.4 12.9 6.0 4.1 21.8 33.8 26.1 5.6 2.2 11.3 1.4 61.3 15.0 6.2 8.5 6.5 17.8 25.5 4.9 4.4 21.5 12.5 5.3 7.6 13.8 12.0 0.0 5.7 4.4 3.0 14.2 10.7 2.7 0.5 0.6 0.1 0.2 11.1 1.5 0.4 10.7 4.5 0.4 20.2 17.2 0.0 5.8 20.1 5.2 2.9 0.0 0.2 0.0 1.3 33.1 12.7 0.0 1.2 1.6 2.7 0.2 0.2 2.5 4.1 0.3 6.6 0.0 4.4 8.4 1.7 11.6 0.2 8.6 8.0 4.7 0.1 0.1 7.7 6.4 1.4 0.2 5.7 0.1 4.1 0.3 6.1 0.0 2.8 1.8 8.9 8.7 0.3 2.9 1.8 0.8 0.1 0.1 4.6 11.7 6.0 24.0 2.9 2.0 4.6 0.0 41.3 0.0 2.8 0.1 0.1 0.2 11.1 0.0 2.0 2.7 2.1 6.2 0.5 1.6 2.0 3.3 0.6 0.2 0.1 0.3 2.7 1.5 38.8 27.6 30.6 52.4 39.2 30.4 21.8 33.8 61.3 12.0 0.0 0.3 0.0 14.8 7.9 42.1 49.5 5.1 17.4 12.5 1.8 13.7 0.0 26.6 13.2 125.3 26.0 0.0 0.0 72.8 0.0 29.8 4.3 11.5 11.9 0.8 17.5 15.6 17.8 3.2 336.0 18.4 10.9 13.5 18.0 0.0 7.6 41.6 0.0 45.3 7.0 15.7 12.9 42.0 35.1 15.8 5.1 0.1 1.8 0.0 8.8 C16orf46 FLJ32702 ENSG00000166455 "Chromosome 16 open reading frame 46" Q6P387 16 81053497-81077267 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 25.2" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 80.6;Late spermatids: 78.6;Spermatocytes: 32.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA041136, HPA041379" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041136: AB_10795535, HPA041379: AB_10794666" "unprognostic (7.73e-2)" "unprognostic (2.17e-1)" "unprognostic (2.59e-1)" "unprognostic (1.02e-2)" "unprognostic (1.83e-1)" "unprognostic (9.93e-2)" "unprognostic (1.81e-2)" "unprognostic (2.32e-3)" "unprognostic (5.11e-2)" "unprognostic (1.93e-1)" "unprognostic (8.06e-2)" "unprognostic (1.86e-1)" "unprognostic (8.54e-2)" "unprognostic (1.58e-1)" "unprognostic (3.53e-1)" "unprognostic (7.06e-3)" "unprognostic (8.72e-2)" 2.0 2.5 5.2 1.8 6.8 2.2 3.1 3.3 8.6 2.8 1.4 3.5 1.3 1.3 2.8 4.4 1.7 8.6 2.0 1.4 5.8 5.8 2.4 3.0 2.2 1.1 5.9 6.0 1.7 2.6 2.9 14.4 3.2 8.6 3.0 1.4 3.5 2.0 2.4 2.5 1.0 1.0 1.9 4.2 1.1 1.1 25.2 2.5 1.5 8.9 0.5 1.3 1.9 1.3 0.2 0.4 1.1 0.4 0.0 2.0 0.0 2.8 0.5 1.1 0.5 5.2 1.0 2.6 0.6 3.6 2.0 1.2 0.6 4.0 0.7 1.8 0.7 2.5 1.0 1.1 2.0 3.6 0.6 0.7 0.8 2.3 2.7 3.1 1.0 2.2 2.1 1.6 4.7 2.9 2.2 1.7 1.4 1.7 1.4 1.6 2.0 0.3 5.5 1.3 1.0 0.6 2.2 0.3 0.4 3.5 1.7 1.5 1.4 4.0 1.3 0.7 1.7 1.2 1.4 1.4 0.9 0.4 0.8 0.7 1.5 2.1 1.6 1.8 1.4 1.0 0.0 0.4 1.1 0.2 0.0 2.0 0.2 0.1 0.2 0.3 0.2 0.1 0.2 0.0 0.0 0.2 0.4 0.0 0.0 5.2 6.8 3.3 8.6 5.8 5.8 5.9 6.0 8.6 2.5 0.0 2.9 0.0 8.1 1.6 2.1 2.0 0.0 20.1 3.4 0.0 3.9 6.3 5.0 0.8 80.6 1.6 0.0 0.0 0.4 13.6 2.3 6.0 0.0 2.9 2.8 0.0 1.2 1.3 1.2 78.6 7.5 1.0 5.0 0.0 1.2 2.9 0.4 0.0 7.1 3.1 7.0 0.0 2.0 32.0 4.9 2.4 5.3 0.0 0.9 5.5 C16orf58 FLJ13868 ENSG00000140688 "Chromosome 16 open reading frame 58" Q96GQ5 16 31489471-31509309 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024406 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles,Cytosol" NA NA "Nucleoli, Golgi apparatus, Vesicles" "Nucleoplasm, Cytosol" "HPA024406: AB_1845580" "unprognostic (1.46e-2)" "unprognostic (2.52e-2)" "unprognostic (2.25e-2)" "unprognostic (4.22e-1)" "unprognostic (6.21e-2)" "unprognostic (3.05e-2)" "unprognostic (2.44e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-1)" "unprognostic (9.89e-2)" "unprognostic (3.20e-1)" "unprognostic (1.58e-1)" "unprognostic (6.34e-3)" "unprognostic (1.14e-1)" "unprognostic (1.22e-1)" "unprognostic (5.69e-2)" "unprognostic (2.24e-2)" 13.5 17.7 15.9 15.3 22.3 11.0 15.7 17.9 30.8 22.6 17.5 16.6 34.2 18.6 24.2 21.4 16.8 21.0 20.0 16.7 12.9 15.3 19.1 51.0 13.9 15.7 13.8 16.4 29.5 49.1 30.7 27.6 23.1 13.1 22.0 11.6 22.9 36.9 26.7 4.8 14.1 22.2 15.6 9.1 12.9 19.7 11.9 14.3 15.1 26.4 14.2 19.3 15.9 17.4 8.9 12.0 8.8 9.8 10.8 11.3 8.4 11.6 15.4 9.7 16.8 22.5 15.0 18.0 14.0 23.9 10.9 13.0 4.6 20.5 10.0 29.7 20.6 14.1 16.3 9.6 12.9 5.1 14.5 9.6 10.1 8.8 11.6 32.7 11.9 12.2 18.2 14.1 14.3 29.5 21.5 10.5 16.1 14.9 17.3 10.6 22.0 5.5 8.0 7.5 17.1 10.1 12.7 14.5 30.2 12.4 7.3 10.6 16.3 10.5 27.7 21.8 9.6 23.9 17.6 9.1 19.1 10.7 12.2 9.1 25.2 14.7 7.5 24.4 18.4 26.2 3.8 6.9 8.8 10.3 9.8 9.6 8.9 10.7 10.2 12.0 8.5 10.8 9.3 1.2 10.8 9.6 11.0 11.3 8.4 15.9 22.3 17.9 30.8 12.9 15.3 13.8 16.4 13.1 14.3 6.0 14.2 9.0 7.9 5.5 22.6 0.8 10.2 6.7 9.1 15.7 2.0 18.1 5.0 17.5 1.5 6.3 17.7 0.0 18.6 17.9 13.1 13.9 18.4 21.9 12.9 12.7 14.3 7.4 8.4 2.5 20.1 6.4 16.9 6.4 20.7 12.4 12.0 10.5 15.2 6.8 22.3 25.8 9.2 13.4 11.7 4.1 18.7 8.3 17.8 7.9 C16orf72 "FLJ41272, PRO0149" ENSG00000182831 "Chromosome 16 open reading frame 72" Q14CZ0 16 9091648-9121640 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 187.0;Late spermatids: 474.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041568, HPA067492" Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA041568: AB_10796677, HPA067492: AB_2685850" "unprognostic (3.98e-2)" "unprognostic (4.74e-2)" "unprognostic (5.87e-3)" "unprognostic (1.35e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (1.37e-1)" "unprognostic (3.17e-2)" "unprognostic (1.76e-1)" "unprognostic (1.79e-1)" "unprognostic (6.74e-2)" "unprognostic (8.64e-2)" "unprognostic (7.92e-3)" "unprognostic (2.03e-1)" "unprognostic (1.29e-2)" "unprognostic (6.64e-3)" "unprognostic (6.51e-2)" 20.1 16.5 15.4 15.8 22.5 80.1 17.7 15.2 25.5 20.1 19.5 18.3 17.4 13.5 17.3 16.7 24.0 14.9 22.6 24.9 13.6 14.4 17.2 23.7 19.3 20.1 14.3 19.3 17.3 16.8 31.3 14.0 20.5 19.0 16.5 14.3 17.8 16.6 16.3 34.5 19.2 17.3 16.7 14.1 19.4 16.6 20.2 12.6 20.1 17.5 20.6 21.2 17.7 21.5 4.1 3.8 14.3 4.1 3.0 5.8 1.9 9.1 10.2 16.3 14.8 19.5 15.3 8.6 18.0 15.0 10.4 10.8 8.5 11.9 16.4 10.4 20.7 8.2 10.8 15.0 15.9 22.0 10.7 8.4 11.0 14.2 17.9 25.2 13.8 12.9 23.0 25.1 17.4 25.1 16.8 18.0 17.2 16.5 25.1 18.4 13.2 12.2 12.3 19.8 9.4 9.0 21.0 20.0 17.5 13.6 16.8 10.6 11.9 21.6 15.3 18.1 15.9 17.6 14.1 20.6 20.5 13.5 26.2 11.5 28.7 24.6 23.3 18.2 12.4 16.5 5.5 3.8 4.0 5.1 4.0 5.8 3.5 4.4 3.6 2.8 4.1 5.1 4.5 14.3 3.0 4.1 3.8 3.4 1.9 15.4 22.5 15.2 25.5 13.6 14.4 14.3 19.3 19.0 12.6 44.7 39.9 33.3 37.4 68.3 43.2 33.4 22.9 9.4 20.5 21.0 82.5 23.7 16.6 24.0 187.0 26.3 30.0 0.0 25.3 28.8 34.7 42.7 17.4 52.9 28.8 41.3 46.4 38.6 79.4 474.2 22.7 35.5 30.4 19.8 35.5 37.0 32.5 38.6 25.5 29.8 48.0 32.3 42.3 35.2 21.5 56.2 47.7 31.5 34.3 57.2 C16orf87 ENSG00000155330 "Chromosome 16 open reading frame 87" Q6PH81 16 46796607-46831411 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 167.5;Spermatogonia: 106.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041179 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA041179: AB_10795002" "unprognostic (2.44e-1)" "unprognostic (4.21e-1)" "unprognostic (2.91e-1)" "unprognostic (1.80e-1)" "unprognostic (1.63e-2)" "prognostic unfavorable (7.95e-5)" "unprognostic (1.74e-1)" "unprognostic (3.13e-2)" "unprognostic (3.21e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (6.57e-4)" "unprognostic (9.90e-2)" "unprognostic (1.35e-2)" "unprognostic (2.08e-2)" "unprognostic (2.66e-1)" "unprognostic (6.61e-3)" "unprognostic (1.84e-2)" 5.4 7.7 10.9 7.7 22.1 23.3 8.2 6.3 13.9 5.8 6.7 3.9 5.9 5.1 6.9 5.2 7.2 5.0 6.4 10.3 7.4 6.2 14.2 19.7 6.1 12.7 5.5 10.6 5.3 4.2 22.0 9.6 8.7 6.5 6.2 5.0 4.3 5.5 4.4 18.2 5.6 11.8 7.6 6.5 7.8 4.6 28.5 8.0 10.6 5.0 6.1 9.0 8.7 6.4 13.6 10.9 9.1 9.8 3.8 15.4 4.8 8.7 3.8 13.8 7.5 3.8 3.5 12.9 10.1 6.2 6.9 4.2 6.0 6.3 13.2 11.4 5.4 3.8 6.8 13.0 4.7 9.2 10.8 8.8 8.1 5.9 7.4 8.5 9.4 11.7 5.4 5.6 8.8 8.6 10.1 5.9 12.9 9.0 2.5 7.3 5.1 13.6 14.1 12.8 4.4 7.1 20.6 21.3 8.9 11.2 5.5 8.4 9.5 12.6 12.2 4.7 25.4 5.2 10.9 6.7 8.2 6.7 8.4 5.1 11.5 12.2 35.6 3.8 8.2 7.7 3.0 7.8 9.1 5.5 9.8 3.0 13.6 7.8 6.8 10.9 8.1 7.4 5.3 1.1 3.8 9.0 6.0 15.4 4.8 10.9 22.1 6.3 13.9 7.4 6.2 5.5 10.6 6.5 8.0 14.9 11.5 27.0 14.9 41.9 8.2 30.5 22.9 4.0 7.9 15.7 21.6 61.1 26.6 17.6 34.8 10.8 9.8 0.0 10.6 46.5 31.9 16.3 13.9 34.4 20.5 28.6 18.3 14.1 20.8 12.1 15.8 35.1 32.1 20.8 10.8 18.6 12.2 8.6 13.4 66.8 10.7 32.3 21.2 167.5 106.7 36.6 28.7 16.0 12.0 13.2 C17orf100 LOC388327 ENSG00000256806 "Chromosome 17 open reading frame 100" 17 6651718-6693202 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 18.4" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 26.3;Late spermatids: 35.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 11.6;SH-SY5Y: 11.5" HPA046824 Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes No Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA046824: AB_2679825" "unprognostic (9.24e-3)" "unprognostic (1.79e-1)" "unprognostic (3.16e-1)" "unprognostic (6.37e-3)" "unprognostic (1.56e-1)" "unprognostic (1.90e-2)" "unprognostic (1.19e-1)" "unprognostic (8.99e-2)" "unprognostic (2.69e-1)" "unprognostic (2.02e-3)" "unprognostic (2.58e-3)" "unprognostic (4.72e-2)" "unprognostic (5.54e-3)" "unprognostic (4.52e-2)" "unprognostic (9.68e-2)" "unprognostic (9.44e-2)" "unprognostic (7.65e-2)" 0.8 1.5 1.4 1.6 3.3 0.1 1.4 3.8 5.6 2.3 2.4 4.0 1.2 3.6 1.5 2.8 2.1 1.7 1.5 0.3 1.5 2.2 18.4 1.2 3.5 1.3 2.5 1.1 8.5 2.5 9.1 0.6 3.0 2.2 1.6 0.8 5.2 1.1 0.3 9.3 4.3 0.7 1.6 2.2 2.8 3.6 2.3 1.6 3.3 0.2 1.1 1.7 0.5 5.7 3.1 7.5 2.4 2.5 5.5 1.9 1.3 2.5 5.7 1.8 0.8 1.6 2.7 0.7 4.1 1.7 3.4 3.8 1.8 1.5 2.9 1.3 4.4 4.9 1.1 2.6 2.5 6.5 7.5 1.4 2.6 11.6 2.0 0.2 3.9 2.3 2.5 0.8 1.8 5.0 1.0 8.0 1.8 1.5 2.2 2.8 1.6 2.4 0.8 2.3 1.7 3.1 0.9 2.3 3.4 1.1 5.9 11.5 3.4 0.4 3.9 1.8 3.0 0.4 1.5 1.6 3.3 0.9 1.3 2.1 1.4 1.0 1.4 0.5 3.7 5.7 1.9 7.5 2.5 2.4 3.4 4.3 4.6 2.9 3.1 5.7 5.5 3.0 1.8 2.5 2.3 1.0 3.0 1.9 0.0 1.7 0.0 4.6 2.5 3.7 0.3 0.0 2.7 5.7 0.0 2.0 1.3 1.7 3.4 26.3 1.0 5.9 0.0 2.9 1.4 1.5 3.9 9.2 0.0 1.1 1.6 7.5 0.0 0.0 35.6 0.9 1.0 1.7 1.0 5.4 5.2 2.8 3.5 1.8 2.1 5.2 6.5 2.5 11.1 4.2 2.6 1.3 0.5 3.0 4.7 C17orf107 ENSG00000205710 "Chromosome 17 open reading frame 107" Q6ZR85 17 4899418-4902932 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pituitary gland: 25.7;salivary gland: 26.0" "Group enriched" "Detected in many" 11 "Early spermatids: 54.2;Late spermatids: 207.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "neutrophil: 6.7" "Lineage enriched" "Detected in single" 7 "granulocytes: 6.7" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 5.5;HMC-1: 7.3;hTCEpi: 6.7" "Not detected" "Not detected" HPA069713 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA069713: AB_2686181" "prognostic favorable (5.06e-5)" "unprognostic (1.63e-1)" "unprognostic (2.43e-1)" "unprognostic (1.51e-2)" "unprognostic (5.83e-2)" "unprognostic (1.13e-3)" "unprognostic (9.61e-2)" "unprognostic (5.03e-2)" "unprognostic (4.15e-1)" "unprognostic (2.05e-1)" "prognostic favorable (8.61e-4)" "unprognostic (1.17e-1)" "prognostic favorable (2.68e-4)" "unprognostic (9.29e-2)" "unprognostic (2.65e-1)" "unprognostic (2.71e-1)" "unprognostic (3.12e-1)" 2.4 3.7 5.0 2.3 5.1 4.2 3.0 7.7 8.7 3.9 1.4 0.2 5.9 2.1 1.9 5.9 1.3 1.8 3.3 15.3 3.8 4.3 2.2 8.8 2.9 1.0 1.6 4.2 6.4 7.7 6.2 25.7 1.5 1.7 4.5 0.9 2.1 26.0 6.4 0.6 3.3 1.6 1.2 2.2 2.1 4.6 4.7 0.6 0.1 1.9 0.6 2.7 3.3 1.9 0.0 0.0 6.7 0.2 0.0 0.9 0.1 0.7 0.8 1.0 0.3 2.2 1.7 1.5 3.9 0.5 0.2 0.6 0.7 0.7 0.4 0.6 5.5 0.0 1.4 0.1 0.5 0.3 0.1 0.8 2.1 0.6 0.8 3.1 0.0 7.3 1.8 6.7 0.1 0.4 0.2 0.2 0.2 0.1 0.1 0.1 0.7 0.1 0.6 0.3 1.9 0.8 0.3 0.2 2.9 0.3 0.3 0.1 0.5 0.6 2.3 0.3 0.5 0.7 1.1 0.5 0.3 0.7 0.6 0.5 0.6 0.6 0.1 0.5 0.1 0.3 0.0 0.2 0.8 0.2 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.8 6.7 0.0 0.1 0.0 0.0 0.1 5.0 5.1 7.7 8.7 3.8 4.3 1.6 4.2 1.7 0.6 0.0 2.2 0.9 2.5 1.5 0.5 12.3 0.0 0.0 1.2 0.0 0.0 0.3 1.7 0.3 54.2 0.7 0.0 0.0 1.1 1.6 2.2 2.2 11.5 3.4 0.9 4.8 0.0 0.6 1.5 207.3 1.4 4.3 1.7 0.0 1.6 0.0 0.8 0.0 1.1 1.6 0.6 0.0 3.1 1.0 1.1 1.1 4.3 0.7 0.2 0.9 C17orf49 "BAP18, HEPIS, MGC49942" ENSG00000258315 "Chromosome 17 open reading frame 49" Q8IXM2 17 7014495-7017525 "Predicted intracellular proteins" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "monocytes: 100.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022961, HPA024457" Supported Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA022961: AB_1845592, HPA024457: AB_1845593" "unprognostic (1.48e-2)" "unprognostic (1.67e-3)" "unprognostic (9.09e-2)" "unprognostic (5.15e-2)" "unprognostic (4.54e-1)" "unprognostic (3.27e-2)" "unprognostic (2.38e-1)" "unprognostic (7.62e-2)" "unprognostic (2.27e-2)" "unprognostic (4.06e-2)" "unprognostic (2.25e-2)" "unprognostic (1.49e-2)" "unprognostic (1.06e-9)" "unprognostic (5.68e-2)" "unprognostic (1.74e-1)" "unprognostic (1.41e-2)" "unprognostic (4.62e-2)" 28.3 21.9 32.7 30.7 29.1 55.4 25.8 24.9 32.1 21.4 20.7 20.9 13.9 18.5 19.1 29.9 29.7 27.2 25.6 25.6 28.4 24.5 23.3 34.3 30.4 45.2 25.9 21.1 19.0 25.1 20.8 20.9 29.7 19.7 20.4 23.2 22.5 22.7 16.8 32.7 30.2 19.2 18.4 23.1 44.6 18.4 21.8 17.9 60.4 31.4 30.7 53.7 25.7 18.8 52.3 78.9 48.8 49.8 82.3 48.3 40.4 18.3 24.5 38.8 30.0 27.7 39.4 13.3 10.0 16.4 20.1 16.5 12.0 15.2 17.7 27.7 23.9 6.5 15.3 9.6 19.4 15.4 61.7 25.6 15.9 7.8 23.1 20.8 10.1 21.3 24.7 26.2 15.0 30.4 14.5 31.4 14.4 5.8 50.6 24.5 21.0 16.6 33.9 12.9 21.1 14.4 10.4 11.4 25.6 22.7 12.3 10.6 30.1 17.6 9.1 17.7 14.6 11.5 13.1 17.1 11.7 14.5 19.7 25.4 18.2 10.3 5.9 18.3 15.1 16.7 48.8 37.6 34.4 47.0 49.8 29.8 52.3 48.3 47.0 57.6 50.6 32.3 35.7 34.3 82.3 37.1 78.9 47.9 40.4 32.7 29.1 24.9 32.1 28.4 24.5 25.9 21.1 19.7 17.9 3.0 10.1 19.8 5.3 9.3 1.0 0.4 0.0 4.0 7.9 1.8 0.0 9.5 14.9 15.3 0.1 9.3 5.6 0.0 20.0 13.6 6.9 2.7 17.4 1.5 9.7 0.0 29.4 8.0 8.7 1.0 3.7 18.0 23.6 100.0 10.0 2.0 18.7 13.6 1.4 3.7 3.9 6.5 15.5 4.6 18.8 10.3 8.7 20.8 16.0 4.6 C17orf50 ENSG00000270806 "Chromosome 17 open reading frame 50" Q8WW18 17 35760897-35765079 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 63.6" "Group enriched" "Detected in some" 88 "Early spermatids: 590.0;Late spermatids: 956.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 2.3;dendritic cells: 3.5;T-cells: 3.7" "Cell line enriched" "Detected in some" 5 "HaCaT: 10.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA043184, HPA063464" Supported Nucleoplasm Yes NA Nucleoplasm "HPA043184: AB_2678358, HPA063464: " "unprognostic (2.21e-1)" "unprognostic (1.07e-1)" "unprognostic (4.36e-2)" "unprognostic (4.01e-2)" "unprognostic (5.84e-2)" "unprognostic (5.12e-3)" "unprognostic (2.04e-2)" "unprognostic (1.97e-2)" "unprognostic (7.94e-2)" "unprognostic (5.36e-2)" "unprognostic (1.14e-2)" "unprognostic (2.71e-1)" "unprognostic (6.68e-2)" "unprognostic (4.67e-2)" "unprognostic (1.54e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 63.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 3.5 0.0 0.6 0.2 3.7 0.6 0.0 0.4 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 1.2 0.1 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.9 2.2 0.1 0.0 0.6 0.0 0.3 0.0 0.5 0.1 0.5 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.6 1.9 2.3 2.0 1.2 0.0 1.9 3.5 3.7 0.0 0.2 0.0 3.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 590.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.2 0.0 0.0 956.8 7.8 0.0 0.0 0.0 0.6 1.0 0.0 0.0 5.3 0.5 0.0 6.5 0.0 8.4 6.1 0.0 0.0 0.0 0.6 0.1 C17orf51 "FLJ12977, FLJ31874, FLJ33618" ENSG00000212719 "Chromosome 17 open reading frame 51" A8MQB3 17 21524790-21574458 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 41.2" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 20.9;Early spermatids: 18.9;Horizontal cells: 23.8;Rod photoreceptor cells: 28.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA052106 Enhanced Approved "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Nucleoplasm, Nuclear bodies" Vesicles "HPA052106: AB_2681728" "unprognostic (1.99e-1)" "unprognostic (5.29e-2)" "unprognostic (6.35e-3)" "unprognostic (2.78e-3)" "unprognostic (3.72e-1)" "unprognostic (4.09e-2)" "unprognostic (4.36e-3)" "unprognostic (5.80e-2)" "unprognostic (2.55e-1)" "unprognostic (1.53e-1)" "unprognostic (2.51e-3)" "unprognostic (7.42e-3)" "unprognostic (2.29e-2)" "unprognostic (1.23e-1)" "unprognostic (3.17e-1)" "unprognostic (6.42e-5)" "unprognostic (9.05e-3)" 6.1 7.2 8.0 4.2 8.4 0.8 3.0 41.2 20.5 5.3 4.5 5.2 3.1 3.2 8.3 10.1 3.2 6.7 3.6 6.5 8.6 7.3 4.0 3.8 3.0 3.0 5.9 8.1 5.9 6.6 7.8 8.9 2.1 5.5 6.3 3.2 3.8 5.0 7.0 7.3 3.0 2.4 6.6 5.0 3.3 4.1 9.2 5.9 1.2 2.9 2.2 3.0 4.0 4.7 4.2 4.1 1.2 3.9 2.6 6.0 1.8 2.6 6.2 2.3 8.0 7.4 7.0 2.2 7.2 3.6 5.2 6.0 12.2 0.4 3.5 4.1 3.9 6.4 0.3 9.9 3.8 8.7 11.1 15.4 0.7 5.7 5.1 13.8 0.9 3.9 6.6 3.4 10.6 11.6 1.9 3.7 9.5 1.9 0.8 4.4 0.0 7.7 0.4 4.4 3.3 5.2 7.5 4.9 0.5 1.9 0.5 5.2 0.9 6.7 0.2 5.3 8.7 0.1 0.3 6.7 6.2 6.3 14.7 8.6 2.3 2.8 13.7 7.4 1.3 7.2 0.0 3.9 0.0 4.0 1.8 3.1 2.2 1.9 1.8 1.9 4.2 6.0 5.1 1.2 2.6 1.0 4.1 1.7 1.8 8.0 8.4 41.2 14.5 8.6 7.3 5.9 8.1 5.5 5.9 0.0 0.6 1.5 4.4 4.4 20.9 3.3 0.0 4.0 2.3 1.8 15.7 0.4 5.0 1.8 18.9 2.8 0.0 0.0 3.1 1.5 6.1 2.9 0.0 2.6 1.1 23.8 1.2 1.3 0.3 11.5 5.8 1.3 5.0 0.0 1.3 5.2 1.6 0.0 7.8 2.1 28.0 0.0 7.9 13.0 6.5 1.9 0.2 0.9 0.9 1.2 C17orf53 MGC3130 ENSG00000125319 "Chromosome 17 open reading frame 53" Q8N3J3 17 44141906-44162476 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, DNA synthesis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 13.4;lymphoid tissue: 8.2;testis: 32.1" "Cell type enhanced" "Detected in some" 12 "Extravillous trophoblasts: 7.0;Late spermatids: 5.5;Spermatocytes: 8.9;Spermatogonia: 13.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA023004, HPA023393, HPA024430" Uncertain Approved Nucleoplasm,Cytosol NA Yes "Nucleoplasm, Cytosol" "HPA023004: AB_1853877, HPA023393: AB_1853878, HPA024430: AB_1853879" "unprognostic (1.72e-1)" "unprognostic (5.95e-2)" "unprognostic (2.43e-2)" "prognostic unfavorable (8.08e-4)" "unprognostic (1.59e-1)" "unprognostic (7.37e-2)" "prognostic unfavorable (3.46e-4)" "prognostic unfavorable (9.39e-4)" "unprognostic (1.90e-1)" "unprognostic (2.89e-1)" "unprognostic (3.66e-4)" "unprognostic (2.86e-1)" "unprognostic (0.00e+0)" "unprognostic (3.06e-2)" "unprognostic (5.88e-2)" "unprognostic (3.65e-2)" "unprognostic (8.40e-2)" 2.0 0.7 0.5 3.5 0.4 13.4 2.0 2.8 1.4 1.2 1.5 0.6 0.5 1.4 1.3 1.1 4.0 0.9 1.4 1.9 0.8 0.7 0.8 0.8 1.3 2.4 0.5 0.2 1.3 1.2 0.7 0.7 2.3 1.0 1.0 1.7 0.6 1.1 1.1 1.8 2.4 2.2 1.1 0.5 1.9 1.0 32.1 0.4 8.2 0.5 1.5 4.8 0.8 1.7 1.4 3.7 0.9 1.1 0.3 2.0 0.6 7.5 9.5 7.5 6.7 0.6 2.1 8.9 5.9 5.2 11.5 12.6 9.7 4.7 8.1 5.3 5.2 12.0 6.6 9.7 9.4 10.2 9.1 12.2 5.2 8.7 6.5 0.3 5.7 6.5 1.7 1.4 14.2 7.1 1.5 4.8 8.9 11.7 10.6 5.6 5.6 13.5 8.5 5.1 3.5 9.3 8.5 12.0 10.0 2.7 6.1 4.7 2.7 3.6 3.6 2.9 8.9 7.2 6.6 2.2 11.1 8.7 7.5 8.6 6.1 10.2 7.0 5.2 4.4 6.3 0.0 1.1 0.9 1.1 0.8 0.4 0.8 0.8 0.2 0.4 1.4 0.6 0.4 0.0 0.3 0.4 3.7 2.0 0.6 0.5 0.4 2.8 1.4 0.8 0.7 0.5 0.2 1.0 0.4 0.0 0.0 0.5 0.6 1.6 0.2 0.8 0.0 0.0 1.2 0.0 0.0 1.6 0.0 0.5 2.5 0.1 0.0 0.0 0.2 7.0 0.7 0.3 0.0 0.2 2.5 0.0 0.0 0.0 0.0 5.5 0.3 0.0 0.0 0.0 0.2 0.5 0.7 0.0 1.1 0.2 0.0 0.0 0.3 8.9 13.0 1.0 1.5 0.0 0.6 0.3 C17orf64 ENSG00000141371 "Chromosome 17 open reading frame 64" Q86WR6 17 60392429-60431421 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 74.5" "Cell type enhanced" "Detected in some" 30 "Early spermatids: 846.4;Late spermatids: 397.1;Spermatocytes: 173.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 5.8" "Group enriched" "Detected in many" 4 "dendritic cells: 5.8;granulocytes: 2.5" "Cell line enhanced" "Detected in some" "JURKAT: 2.4;MCF7: 11.0;THP-1: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA044415 Enhanced Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA044415: AB_10797148" "unprognostic (3.00e-1)" "unprognostic (2.60e-2)" "unprognostic (2.36e-1)" "unprognostic (6.50e-2)" "unprognostic (1.77e-1)" "unprognostic (1.51e-2)" "unprognostic (2.30e-2)" "unprognostic (3.24e-1)" "unprognostic (1.43e-1)" "unprognostic (1.80e-1)" "unprognostic (6.85e-2)" "unprognostic (1.68e-6)" "unprognostic (3.30e-1)" "unprognostic (2.77e-1)" "unprognostic (2.80e-2)" "unprognostic (5.46e-2)" 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 74.5 0.1 0.2 0.0 0.1 0.1 0.0 0.0 1.0 5.8 2.5 0.6 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.1 1.3 0.0 0.0 0.0 0.6 0.7 0.0 1.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 1.7 0.2 0.5 1.7 0.0 0.1 0.0 0.0 0.0 2.4 0.0 0.6 0.0 11.0 0.3 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.2 0.0 0.0 2.7 0.3 0.0 0.1 0.1 0.0 1.7 1.3 0.2 0.0 1.5 0.0 0.0 0.6 0.0 0.1 0.5 0.0 1.0 0.3 0.0 1.8 0.2 0.0 0.6 2.5 0.0 0.0 5.8 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 846.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 397.1 8.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 173.7 15.3 0.1 0.0 0.0 0.0 0.0 C17orf80 "FLJ20721, HLC-8, MIG3, SPEP1" ENSG00000141219 "Chromosome 17 open reading frame 80" Q9BSJ5 17 73232233-73248947 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 128.4;Late spermatids: 75.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012896 Uncertain Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA012896: AB_1850766" "unprognostic (9.22e-2)" "unprognostic (1.62e-1)" "prognostic favorable (1.43e-4)" "unprognostic (5.55e-3)" "unprognostic (8.58e-2)" "unprognostic (2.66e-1)" "prognostic unfavorable (9.02e-6)" "unprognostic (1.08e-1)" "unprognostic (1.00e-3)" "unprognostic (1.84e-2)" "unprognostic (1.20e-3)" "unprognostic (6.09e-2)" "unprognostic (1.21e-2)" "unprognostic (1.45e-1)" "unprognostic (1.52e-1)" "unprognostic (2.36e-3)" "unprognostic (1.37e-1)" 8.0 10.5 12.8 8.5 13.2 2.4 10.6 27.8 15.4 11.3 11.7 8.4 5.3 9.1 13.1 9.0 10.8 11.2 7.8 13.5 13.8 10.0 11.5 8.6 10.2 11.0 11.8 12.7 16.0 10.1 17.2 24.9 10.9 11.8 11.6 9.0 9.4 9.0 11.2 22.2 7.5 10.4 12.4 14.4 9.9 9.7 32.5 11.3 16.1 14.6 8.3 10.3 10.3 13.3 6.5 7.1 14.6 5.0 5.2 8.7 3.9 9.9 10.5 14.6 8.9 10.7 9.2 14.2 13.1 11.4 18.6 17.7 9.9 8.2 18.9 9.3 6.7 12.7 10.0 20.2 7.5 21.8 6.8 13.7 17.4 11.0 11.6 9.4 18.3 10.3 7.2 9.4 12.3 10.2 9.3 15.9 12.8 18.7 11.3 12.3 5.7 21.1 8.7 11.5 11.0 11.3 12.8 40.2 9.6 9.7 7.5 17.9 16.1 6.9 12.8 15.2 24.1 14.0 11.5 8.7 19.5 18.0 6.3 12.4 12.9 15.3 18.3 7.8 8.3 12.3 14.6 4.0 5.7 8.5 5.0 8.7 6.5 6.3 7.5 4.6 5.8 6.0 8.6 1.9 5.2 4.7 7.1 8.6 3.9 12.8 13.2 27.8 15.4 13.8 10.0 11.8 12.7 11.8 11.3 6.0 10.8 3.4 1.6 4.4 8.2 17.9 7.6 25.4 11.4 5.2 19.6 7.3 8.3 4.8 128.4 7.1 5.1 0.0 3.4 4.8 4.1 1.7 7.0 3.9 4.1 7.9 5.2 4.3 5.3 75.5 4.9 5.4 1.7 5.4 3.0 9.8 4.2 4.0 7.1 5.3 14.7 0.0 4.7 23.5 12.3 3.9 14.1 4.1 4.4 1.3 C18orf25 "ARKL1, MGC12909, RNF111L1" ENSG00000152242 "Chromosome 18 open reading frame 25" Q96B23 18 46173553-46266991 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 54.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051314, HPA051899" Approved Approved Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA051314: AB_2681438, HPA051899: AB_2681657" "unprognostic (1.44e-2)" "unprognostic (2.32e-1)" "unprognostic (2.08e-2)" "unprognostic (5.77e-3)" "unprognostic (4.46e-1)" "unprognostic (7.78e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (3.97e-1)" "unprognostic (7.46e-2)" "unprognostic (1.00e-1)" "unprognostic (1.43e-1)" "unprognostic (5.80e-2)" "unprognostic (3.27e-2)" "unprognostic (1.24e-1)" "unprognostic (2.96e-1)" "unprognostic (1.23e-1)" "unprognostic (1.52e-1)" 5.3 4.9 5.8 6.4 8.2 18.6 6.5 10.1 10.1 6.1 4.9 5.5 6.5 4.4 7.7 5.3 54.0 6.2 3.8 11.4 4.8 4.9 5.4 6.2 5.9 6.8 5.3 6.5 5.9 5.0 15.3 6.3 7.3 8.3 5.2 5.7 9.5 11.3 4.8 13.1 6.2 5.5 5.7 4.7 6.3 5.1 7.8 5.7 8.2 7.4 10.2 11.8 7.2 12.7 8.1 11.0 19.0 11.0 2.8 11.1 5.5 11.2 11.3 9.5 10.8 6.8 6.2 12.2 16.4 8.7 17.6 15.0 8.7 13.0 8.7 15.7 11.1 6.3 25.8 17.6 11.1 19.2 14.5 5.6 7.6 9.7 6.5 11.8 14.3 10.4 5.7 13.1 20.5 17.1 10.3 6.9 8.2 8.5 10.4 9.7 8.5 10.8 7.3 8.4 3.9 4.5 9.9 11.3 12.8 16.9 20.4 13.4 7.0 12.0 8.6 8.5 12.1 5.6 8.9 10.1 16.1 11.5 3.9 15.1 13.7 11.6 14.1 8.3 15.2 17.2 4.2 7.5 15.4 5.7 8.4 9.9 5.9 11.1 8.6 7.4 8.1 8.0 6.3 19.0 2.8 11.0 11.0 7.1 5.5 5.8 8.2 10.1 10.1 4.8 4.9 5.3 6.5 8.3 5.7 11.9 10.8 11.5 9.5 22.3 13.2 26.0 10.2 8.1 4.5 14.0 19.6 5.7 1.7 7.4 2.1 15.5 9.5 0.0 5.7 8.3 10.4 10.0 15.0 12.5 7.9 12.7 11.5 8.0 10.4 2.5 7.5 11.4 6.8 4.6 8.3 9.8 14.0 10.5 9.9 6.5 29.9 19.4 10.8 16.7 12.4 27.9 20.4 11.7 9.2 16.9 C18orf32 FLJ23458 ENSG00000177576 "Chromosome 18 open reading frame 32" Q8TCD1 18 49477250-49487252 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 217.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040921 Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA040921: AB_10795423" "unprognostic (5.83e-2)" "unprognostic (5.48e-2)" "unprognostic (5.54e-2)" "unprognostic (3.13e-2)" "unprognostic (4.19e-2)" "unprognostic (1.44e-1)" "unprognostic (1.72e-1)" "unprognostic (2.80e-2)" "unprognostic (6.36e-2)" "unprognostic (4.36e-3)" "unprognostic (2.58e-3)" "unprognostic (2.76e-2)" "prognostic favorable (8.89e-9)" "unprognostic (1.02e-1)" "unprognostic (7.42e-2)" "unprognostic (1.28e-2)" "unprognostic (4.36e-2)" 17.1 16.5 67.0 7.1 59.0 19.1 25.5 27.4 48.4 22.2 24.2 29.5 16.1 10.7 12.7 35.0 13.6 17.2 19.4 25.1 57.5 49.8 42.2 38.6 19.6 14.8 67.8 28.3 16.5 20.1 23.8 20.5 15.7 47.0 21.3 22.4 17.0 21.6 18.9 10.8 10.2 14.2 14.9 78.5 13.6 23.4 15.5 25.2 8.3 28.8 8.0 12.7 19.4 9.6 16.1 21.4 57.2 22.1 9.8 15.4 21.0 7.7 9.0 17.0 10.5 15.4 13.7 19.5 11.8 13.1 11.5 9.8 1.7 3.5 7.0 29.8 10.0 7.6 9.1 3.9 13.3 9.9 22.5 8.0 6.3 6.0 10.8 24.6 12.4 13.6 11.9 29.7 7.7 11.5 15.7 15.4 14.3 7.2 13.5 23.8 4.8 7.8 6.4 4.7 10.9 9.0 7.4 5.9 14.1 30.7 15.3 19.6 33.7 7.7 6.1 16.0 20.8 8.7 4.5 16.4 11.9 10.1 3.4 12.7 41.3 24.5 7.6 9.4 8.4 11.1 36.3 17.1 43.2 13.9 19.3 15.4 16.1 13.7 14.3 14.1 12.8 11.7 15.4 57.2 9.8 22.1 21.4 14.6 21.0 67.0 59.0 27.4 48.4 57.5 49.8 67.8 28.3 47.0 25.2 41.7 20.3 28.9 4.1 4.8 34.9 4.3 25.5 52.2 20.5 22.7 41.2 17.0 33.2 73.7 217.6 11.1 72.2 0.0 72.4 14.3 10.6 4.9 43.9 39.5 19.7 17.5 91.7 22.1 40.2 140.1 15.8 19.2 21.9 101.8 54.1 24.7 79.0 66.6 9.6 38.9 33.0 19.4 7.6 11.7 13.0 6.8 32.4 19.1 36.5 4.6 C18orf54 "LAS2, MGC33382" ENSG00000166845 "Chromosome 18 open reading frame 54" Q8IYD9 18 54357917-54385218 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 21.4;testis: 25.2" "Cell type enhanced" "Detected in many" 18 "Early spermatids: 73.3;Extravillous trophoblasts: 22.1;Late spermatids: 23.0;Spermatocytes: 34.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040704 Approved Nucleoplasm "Secreted in male reproductive system" NA NA Nucleoplasm "HPA040704: AB_10959454" "unprognostic (2.96e-1)" "unprognostic (5.58e-2)" "unprognostic (5.29e-2)" "unprognostic (8.63e-3)" "unprognostic (2.40e-1)" "unprognostic (1.05e-1)" "unprognostic (5.60e-6)" "unprognostic (1.11e-2)" "unprognostic (7.85e-3)" "unprognostic (2.55e-2)" "unprognostic (5.91e-3)" "unprognostic (1.13e-2)" "unprognostic (3.06e-5)" "unprognostic (2.29e-1)" "unprognostic (4.21e-1)" "unprognostic (1.28e-2)" "unprognostic (7.05e-2)" 2.9 1.3 2.8 4.8 7.7 2.0 2.1 4.5 4.3 4.1 2.4 3.8 1.0 1.3 3.6 1.1 2.0 1.9 2.1 2.0 3.3 2.2 1.6 0.9 2.5 4.0 10.0 3.4 2.5 1.1 1.9 1.0 21.4 5.7 1.8 2.3 0.7 1.4 1.6 1.0 1.8 2.0 2.7 5.8 4.3 1.5 25.2 6.7 9.3 1.9 1.2 4.0 2.1 3.2 1.4 0.6 1.9 4.1 0.8 2.1 0.6 5.8 3.4 14.6 6.9 3.6 6.3 4.9 9.7 4.2 9.8 12.6 2.2 3.1 4.3 2.7 3.2 4.3 6.3 10.1 5.3 12.8 14.4 3.2 4.2 3.7 3.7 0.8 4.8 4.6 2.1 1.1 13.3 6.2 4.2 11.7 5.7 4.4 9.4 14.0 1.8 5.2 3.0 7.2 1.1 6.7 4.0 10.8 3.0 4.8 4.0 8.1 4.6 4.0 1.7 2.2 8.7 2.5 4.1 10.5 18.2 8.0 3.0 5.3 5.7 6.4 6.4 4.8 8.2 12.8 1.9 0.7 0.3 1.3 0.8 1.2 0.9 1.1 0.9 0.6 1.4 1.0 1.2 0.0 0.8 4.1 0.3 2.1 0.6 2.8 7.7 4.5 4.3 3.3 2.2 10.0 3.4 5.7 6.7 0.0 1.1 0.0 0.6 0.3 1.6 1.2 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.1 73.3 2.6 0.1 0.0 0.2 22.1 1.5 0.3 0.0 0.0 2.1 0.0 0.0 4.9 2.8 23.0 1.4 1.7 1.7 1.8 0.6 2.3 0.3 0.0 0.7 0.2 0.7 0.0 1.4 34.4 16.0 0.4 1.7 0.7 0.8 0.7 C19orf33 "H2RSP, IMUP, IMUP-1, IMUP-2" ENSG00000167644 "Chromosome 19 open reading frame 33" Q9GZP8 19 38304161-38305009 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 88.4;intestine: 105.8;tongue: 78.5" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 1588.2;Exocrine glandular cells: 683.1;Mucus-secreting cells: 800.2;Pancreatic endocrine cells: 1532.5;Paneth cells: 1006.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 11 "myeloid DC: 15.1" "Lineage enriched" "Detected in many" 11 "dendritic cells: 15.1" "Cell line enhanced" "Detected in some" "A-431: 70.1;A549: 108.2;CAPAN-2: 66.8;HBEC3-KT: 64.8;hTCEpi: 67.9;OE19: 57.5;PC-3: 61.8" "HPA054406, HPA059696" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" No No "Nucleoplasm, Cytosol" "Plasma membrane" "HPA054406: AB_2682478, HPA059696: AB_2684105" "unprognostic (9.31e-2)" "unprognostic (2.06e-1)" "unprognostic (4.34e-2)" "unprognostic (1.44e-2)" "unprognostic (3.92e-3)" "unprognostic (2.37e-2)" "unprognostic (9.49e-2)" "prognostic unfavorable (5.42e-4)" "unprognostic (2.09e-1)" "unprognostic (1.74e-2)" "prognostic unfavorable (5.05e-4)" "unprognostic (6.92e-2)" "unprognostic (5.50e-2)" "unprognostic (4.82e-2)" "unprognostic (1.61e-1)" "unprognostic (3.63e-2)" "unprognostic (6.01e-2)" 6.9 0.6 0.5 16.4 0.7 0.3 5.0 0.5 0.8 14.5 58.8 0.6 3.5 34.6 3.9 4.3 88.4 18.2 45.2 9.9 0.8 0.3 5.8 1.0 34.8 0.6 0.7 1.4 4.9 0.8 0.0 2.0 10.0 1.7 10.3 18.2 1.2 21.5 6.8 2.8 53.3 105.8 2.9 3.1 1.9 28.7 1.5 0.5 1.5 4.4 78.5 39.2 16.2 35.1 0.1 15.1 1.4 0.6 0.3 0.4 14.6 70.1 108.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 66.8 0.0 40.1 0.0 0.0 26.3 0.0 64.8 0.0 0.0 0.0 0.0 22.7 1.8 0.5 0.0 0.0 0.0 67.9 0.0 43.6 0.1 1.1 0.0 0.0 0.0 0.0 18.1 0.0 0.1 0.1 57.5 61.8 0.0 0.0 0.0 41.0 20.8 0.1 0.0 41.0 29.7 0.0 0.1 9.2 0.2 14.6 0.0 20.4 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 1.1 0.6 1.4 0.3 0.0 0.3 0.1 0.2 0.1 15.1 0.1 0.4 0.3 0.9 0.3 0.0 0.9 0.0 14.6 0.5 0.7 0.5 0.8 0.8 0.3 0.7 1.4 1.7 0.5 497.3 155.5 7.0 25.1 200.2 0.0 1.4 298.1 195.4 353.8 52.4 0.0 5.2 1.7 144.5 0.4 9.8 1588.2 0.0 683.1 1.0 5.6 22.7 39.1 0.0 1.3 0.0 73.3 4.9 1.6 2.8 3.7 8.2 1.7 4.6 800.2 0.0 1532.5 1006.5 0.0 21.6 0.0 0.0 5.0 1.4 1.9 304.5 2.6 0.0 506.3 112.5 C19orf44 FLJ21742 ENSG00000105072 "Chromosome 19 open reading frame 44" Q9H6X5 19 16496311-16521352 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 37.3;Late spermatids: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041683, HPA049414" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA041683: AB_10793929, HPA049414: AB_2680754" "unprognostic (2.16e-1)" "unprognostic (2.16e-2)" "unprognostic (1.25e-1)" "unprognostic (8.52e-2)" "unprognostic (2.05e-1)" "unprognostic (8.38e-3)" "unprognostic (1.83e-1)" "unprognostic (4.19e-2)" "unprognostic (6.45e-2)" "unprognostic (1.36e-1)" "unprognostic (2.32e-3)" "unprognostic (3.73e-1)" "unprognostic (1.04e-1)" "unprognostic (7.02e-2)" "unprognostic (7.88e-2)" "unprognostic (1.06e-1)" "unprognostic (1.90e-1)" 5.0 4.6 8.1 3.6 8.1 6.1 5.6 11.2 8.8 9.9 7.7 7.4 10.2 3.9 12.7 5.8 5.1 11.5 7.6 5.9 6.3 5.1 6.9 4.3 4.5 3.8 4.0 3.8 13.2 8.1 14.9 19.7 4.1 5.9 11.0 2.9 11.2 10.6 9.9 6.9 7.7 3.8 8.2 5.9 3.9 5.3 19.7 5.8 4.1 9.1 3.1 4.3 6.4 6.1 3.5 1.6 5.7 1.7 1.5 2.7 1.0 5.5 6.3 5.4 7.7 3.5 8.8 7.2 4.7 4.5 5.9 8.6 3.8 6.9 4.8 8.4 3.7 4.2 3.9 4.6 4.1 4.6 2.8 11.3 2.3 9.0 4.9 6.3 2.6 2.5 4.5 4.1 7.8 5.8 10.5 3.2 6.4 6.7 1.5 3.2 7.6 4.2 6.8 3.4 6.3 8.3 3.1 2.7 6.6 6.2 2.5 6.4 3.9 4.6 6.8 4.1 5.1 5.9 2.8 6.4 8.0 3.8 5.6 6.4 4.8 3.4 2.7 5.7 2.5 6.7 5.7 1.5 0.5 1.6 0.7 0.4 3.5 1.5 0.7 0.6 3.4 1.7 2.7 3.3 1.5 1.7 1.6 0.6 1.0 8.1 8.1 11.2 8.8 6.3 5.1 4.0 3.8 5.9 5.8 0.0 6.4 0.0 0.8 0.3 3.5 3.6 5.1 6.7 7.9 7.0 11.8 1.5 0.0 1.3 37.3 1.6 0.4 0.0 1.0 1.6 1.7 0.5 0.0 1.0 0.6 0.0 6.9 1.3 0.3 52.0 2.8 1.2 0.0 1.8 0.9 2.5 1.2 0.9 4.9 2.7 7.4 0.0 2.1 7.2 2.1 0.4 0.5 0.0 1.1 0.2 C19orf47 FLJ36888 ENSG00000160392 "Chromosome 19 open reading frame 47" Q8N9M1 19 40319536-40348527 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 35.4;skeletal muscle: 118.0" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 39.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 20.2" "Lineage enriched" "Detected in all" 8 "granulocytes: 20.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041843, HPA046309" Enhanced Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA041843: AB_10959886, HPA046309: AB_10960266" "prognostic favorable (6.50e-4)" "unprognostic (1.35e-3)" "unprognostic (1.80e-1)" "prognostic unfavorable (7.10e-5)" "unprognostic (2.75e-1)" "unprognostic (4.73e-2)" "prognostic unfavorable (1.41e-4)" "unprognostic (2.26e-1)" "unprognostic (1.59e-1)" "unprognostic (1.63e-1)" "unprognostic (1.47e-2)" "unprognostic (3.25e-2)" "unprognostic (6.23e-2)" "unprognostic (1.62e-2)" "unprognostic (5.28e-2)" "unprognostic (2.77e-1)" "unprognostic (3.28e-2)" 3.2 2.9 4.5 4.2 5.7 4.7 4.4 5.8 9.1 3.5 3.3 9.2 3.6 3.8 3.8 3.1 7.4 2.8 3.5 35.4 4.2 3.8 2.9 4.4 3.4 4.5 6.2 5.0 3.6 3.8 3.7 3.7 4.8 5.6 4.5 2.5 3.6 4.9 4.6 118.0 5.2 3.6 3.7 4.8 3.7 3.0 10.0 5.3 5.0 3.8 6.4 4.7 4.1 5.0 2.1 1.6 20.2 1.6 1.7 2.3 1.3 12.9 19.9 8.4 9.1 5.0 4.5 11.6 13.4 6.2 12.7 15.4 16.5 5.4 15.1 7.5 6.3 6.7 6.5 10.2 12.3 5.3 18.5 12.5 12.3 12.4 12.5 3.7 12.4 8.0 4.5 7.3 17.1 6.1 3.4 7.7 14.1 15.0 8.9 10.7 12.6 18.5 7.0 5.4 10.4 7.6 18.4 13.8 7.6 4.1 11.4 10.8 8.8 14.4 13.6 5.2 5.2 8.1 10.3 10.1 16.0 11.2 10.8 18.3 10.7 14.7 15.0 6.8 11.9 11.0 20.2 1.6 4.7 1.3 1.4 1.6 1.6 2.3 2.1 1.6 2.1 1.6 1.2 5.7 1.7 1.6 1.6 1.6 1.3 4.5 5.7 5.8 9.1 4.2 3.8 6.2 5.0 5.6 5.3 3.0 3.2 0.0 2.4 4.2 2.9 39.1 2.5 1.4 2.3 0.0 2.0 9.1 0.0 3.2 8.0 3.7 2.9 0.0 3.9 11.7 4.7 1.6 4.6 3.8 5.8 3.2 3.5 5.5 5.6 17.1 1.7 2.6 5.0 2.8 2.8 2.9 3.3 0.0 6.3 2.4 1.8 6.5 2.1 14.9 5.5 6.0 13.3 2.2 2.3 1.4 C19orf53 "HSPC023, LYDG10" ENSG00000104979 "Chromosome 19 open reading frame 53" Q9UNZ5 19 13774168-13778462 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059928, HPA061291" Approved Approved Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA059928: AB_2684165, HPA061291: AB_2684469" "unprognostic (3.94e-2)" "unprognostic (2.70e-3)" "unprognostic (6.53e-2)" "unprognostic (3.12e-1)" "unprognostic (1.99e-2)" "unprognostic (8.93e-2)" "unprognostic (2.93e-3)" "unprognostic (2.77e-2)" "unprognostic (1.32e-1)" "unprognostic (2.96e-2)" "unprognostic (1.67e-1)" "unprognostic (6.31e-2)" "unprognostic (1.60e-3)" "unprognostic (5.21e-2)" "unprognostic (4.06e-2)" "unprognostic (2.69e-3)" "unprognostic (1.85e-2)" 37.3 41.5 55.6 31.1 53.7 42.1 33.1 22.0 41.7 40.4 35.7 27.0 34.2 28.0 33.9 55.6 43.1 44.0 39.3 67.0 46.2 44.8 42.8 68.4 35.5 42.4 47.2 34.7 49.9 46.9 27.4 41.8 27.2 37.3 39.2 26.4 30.1 45.9 35.7 90.7 31.5 29.2 39.6 37.0 34.8 31.3 34.1 30.0 59.6 53.5 47.7 41.6 43.1 43.1 67.9 63.0 57.3 49.6 36.3 75.8 92.4 35.4 50.6 25.2 21.0 35.8 40.5 16.7 33.4 29.7 41.6 41.5 46.9 17.3 18.9 41.7 40.4 30.6 19.0 23.3 50.5 21.5 22.6 73.5 17.7 54.7 50.9 37.1 27.7 23.5 49.4 36.5 38.5 21.8 26.5 35.6 28.2 27.4 32.6 32.4 79.9 39.1 28.7 32.1 27.2 89.7 21.5 19.2 32.7 36.9 44.0 23.0 27.7 23.4 27.8 33.9 19.5 25.3 28.5 23.7 47.3 18.9 50.6 45.7 36.5 46.4 28.2 28.7 31.5 25.6 48.1 48.8 57.3 49.0 49.6 55.5 67.9 63.4 57.0 44.2 63.3 75.8 68.0 23.7 36.3 43.1 63.0 69.4 92.4 55.6 53.7 22.0 41.7 46.2 44.8 47.2 34.7 37.3 30.0 107.2 86.2 241.2 221.7 258.6 46.5 224.1 198.7 117.8 97.8 254.7 21.6 202.0 532.2 215.9 134.2 206.4 254.0 163.5 291.0 335.7 214.9 274.6 125.8 284.8 320.6 33.4 218.2 154.1 231.7 499.2 202.5 228.8 219.4 359.7 182.1 129.2 247.0 245.4 171.5 582.8 48.4 90.5 205.0 94.7 135.7 304.6 178.2 221.8 197.3 276.6 C19orf57 MGC11271 ENSG00000132016 "Chromosome 19 open reading frame 57" Q0VDD7 19 13882348-13906452 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 22.9" "Cell type enhanced" "Detected in many" 10 "Rod photoreceptor cells: 7.7;Spermatocytes: 16.3;Spermatogonia: 10.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 4.9" "Group enriched" "Detected in many" 5 "dendritic cells: 2.6;T-cells: 4.9" "Low cell line specificity" "Detected in many" "HPA044012, HPA054615" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA044012: AB_10964782, HPA054615: AB_2682543" "unprognostic (1.71e-1)" "unprognostic (3.48e-3)" "unprognostic (1.84e-1)" "prognostic unfavorable (3.38e-4)" "unprognostic (2.12e-1)" "prognostic favorable (5.14e-4)" "unprognostic (5.01e-2)" "unprognostic (2.30e-1)" "unprognostic (1.06e-1)" "unprognostic (1.36e-1)" "unprognostic (7.60e-2)" "unprognostic (4.43e-2)" "unprognostic (1.57e-4)" "unprognostic (1.21e-3)" "unprognostic (2.46e-1)" "unprognostic (1.39e-1)" "unprognostic (5.73e-2)" 2.5 0.9 4.6 1.9 5.5 4.0 4.2 12.8 9.1 2.6 6.9 5.8 0.8 7.7 1.8 3.7 6.2 5.6 1.9 1.1 5.4 3.1 1.3 2.2 1.6 1.9 7.2 3.7 2.8 10.8 3.3 1.6 0.9 6.3 2.4 3.0 1.4 4.4 1.9 1.3 14.2 5.6 1.2 5.9 1.8 2.9 22.9 4.1 2.3 1.4 0.5 1.8 2.1 4.5 0.1 2.6 0.0 0.2 0.6 4.9 1.1 9.4 0.3 7.2 4.0 2.1 0.4 4.8 2.7 1.1 3.2 3.1 5.9 1.4 10.5 14.8 1.1 1.9 4.8 2.1 0.9 1.1 1.5 4.6 4.4 3.9 0.1 0.6 2.2 9.8 0.4 0.7 2.0 0.3 0.5 0.7 5.9 3.0 4.2 1.0 3.1 8.4 4.9 1.0 3.3 7.2 9.3 2.7 0.6 1.2 2.2 6.3 2.4 10.4 1.9 3.0 0.6 2.0 2.1 0.0 5.9 3.2 13.4 0.7 7.6 1.6 5.3 3.6 7.2 9.0 0.0 0.1 0.0 4.9 0.0 0.5 0.0 0.2 1.1 0.0 0.1 0.4 2.5 0.0 0.6 0.2 2.6 0.0 1.1 4.6 5.5 12.8 9.1 5.4 3.1 7.2 3.7 6.3 4.1 0.0 0.0 0.0 2.6 1.4 1.9 1.2 0.0 0.0 1.2 0.0 2.0 0.4 3.3 0.4 0.5 0.5 1.8 0.0 1.0 0.3 0.8 0.5 0.0 0.0 0.5 1.6 0.0 0.6 0.8 1.4 2.6 0.0 1.7 1.0 2.5 1.4 0.4 5.8 1.8 0.0 7.7 0.0 1.4 16.3 10.0 2.6 0.7 0.0 2.5 1.8 C19orf66 "FLJ11286, IRAV, RyDEN" ENSG00000130813 "Chromosome 19 open reading frame 66" Q9NUL5 19 10086122-10093252 "Predicted intracellular proteins" "Antiviral defense" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 55.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 24.9;BJ hTERT+ SV40 Large T+ RasG12V: 26.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042001 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042001: AB_10794167" "prognostic favorable (4.04e-4)" "unprognostic (1.21e-2)" "unprognostic (2.39e-3)" "unprognostic (2.03e-1)" "unprognostic (2.19e-2)" "unprognostic (2.00e-2)" "unprognostic (1.46e-1)" "unprognostic (3.93e-1)" "unprognostic (6.57e-2)" "unprognostic (4.22e-3)" "unprognostic (2.34e-1)" "unprognostic (1.88e-1)" "prognostic unfavorable (8.96e-11)" "unprognostic (5.92e-2)" "unprognostic (1.81e-1)" "unprognostic (4.41e-3)" "prognostic favorable (1.35e-4)" 9.8 13.8 13.7 17.6 12.1 9.0 9.9 10.6 16.9 14.5 11.2 8.4 10.3 9.6 12.6 14.1 8.9 16.4 15.5 6.9 11.0 13.9 11.5 55.8 11.6 14.4 9.0 13.5 14.5 10.0 14.1 12.8 9.8 10.0 12.4 6.1 11.6 13.0 15.8 3.7 7.6 14.2 9.7 8.6 14.0 8.3 3.7 8.6 9.8 11.9 5.4 13.0 12.9 10.1 8.8 6.7 11.6 12.0 17.5 21.2 10.0 2.8 1.6 1.7 1.3 6.6 8.9 0.7 3.3 18.4 24.9 26.4 0.2 2.4 1.7 1.0 8.7 7.5 1.2 0.8 6.2 0.4 12.0 0.0 5.2 1.2 4.1 12.9 1.8 2.9 16.0 4.6 3.9 0.6 8.3 7.1 7.2 0.7 6.9 5.0 2.3 5.9 3.5 0.4 2.6 2.5 5.4 0.0 3.2 3.7 4.4 0.2 1.5 4.8 0.4 14.1 0.1 0.2 4.7 5.2 2.1 1.0 2.8 0.4 8.4 2.6 0.4 5.7 1.6 4.2 11.1 8.3 11.6 15.9 7.4 21.2 8.8 13.5 17.1 6.7 6.9 11.5 12.1 10.8 17.5 12.0 1.3 13.9 10.0 13.7 12.1 10.6 16.9 11.0 13.9 9.0 13.5 10.0 8.6 20.8 26.6 27.2 22.7 13.4 62.6 2.5 22.9 16.0 37.5 26.2 35.3 4.8 14.9 28.5 8.9 40.5 24.0 0.0 30.6 5.1 30.4 24.7 31.1 94.1 28.7 52.4 17.9 46.1 23.4 23.8 37.7 26.6 16.9 57.7 15.9 33.5 32.5 20.1 35.7 11.1 32.9 71.1 26.4 1.6 3.2 13.2 2.2 64.3 11.5 18.6 C19orf70 "MIC13, P117, QIL1" ENSG00000174917 "Chromosome 19 open reading frame 70" Q5XKP0 19 5678421-5680896 "Predicted intracellular proteins" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 13 "Late spermatids: 2933.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042672 Approved Supported Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA Mitochondria Nucleoplasm "HPA042672: AB_10794531" "unprognostic (9.54e-2)" "unprognostic (4.90e-3)" "unprognostic (3.04e-1)" "unprognostic (3.21e-3)" "unprognostic (1.52e-2)" "unprognostic (1.80e-1)" "unprognostic (1.65e-1)" "unprognostic (2.53e-3)" "unprognostic (2.14e-2)" "unprognostic (9.32e-2)" "unprognostic (2.50e-2)" "unprognostic (1.57e-1)" "prognostic favorable (7.60e-5)" "unprognostic (1.08e-1)" "unprognostic (5.94e-2)" "unprognostic (2.27e-1)" "unprognostic (5.47e-2)" 20.2 23.6 32.9 14.5 28.4 13.2 16.0 11.0 29.8 13.0 22.2 13.5 17.8 25.4 12.2 26.8 22.7 16.7 24.0 70.2 27.2 26.5 30.5 38.4 12.7 21.1 32.1 21.1 13.5 24.2 13.2 15.6 12.4 16.9 16.6 11.7 13.6 28.7 22.7 79.1 17.6 20.7 14.7 20.9 14.1 18.2 33.4 12.3 11.6 20.3 45.0 12.6 15.4 11.8 43.6 48.2 11.6 42.2 27.4 39.5 40.7 24.2 20.1 7.0 13.4 16.5 17.1 9.1 16.1 15.3 18.6 15.4 16.0 12.7 10.6 26.2 14.0 9.9 18.1 3.6 22.8 5.3 17.4 38.4 10.3 14.0 17.8 23.3 14.1 13.0 20.0 20.6 10.0 13.9 11.7 13.3 16.3 15.9 33.1 14.0 21.9 21.3 16.8 7.4 17.8 64.4 11.7 8.5 38.7 20.3 15.3 16.4 20.9 4.9 31.8 22.5 4.7 19.4 17.4 13.5 18.3 7.8 33.4 22.7 50.0 33.1 8.4 27.3 22.6 18.5 8.9 35.5 11.6 33.6 42.2 39.5 43.6 38.6 37.2 41.2 35.6 38.1 35.9 5.6 27.4 35.6 48.2 30.9 40.7 32.9 28.4 11.0 29.8 27.2 26.5 32.1 21.1 16.9 12.3 65.5 61.7 101.3 135.8 87.3 47.7 288.5 122.3 167.3 76.2 150.1 25.5 132.2 623.4 178.9 798.0 106.8 325.2 46.7 265.1 165.3 137.3 120.3 92.3 251.0 214.9 17.5 154.8 98.8 146.2 2933.3 115.3 157.0 163.6 263.3 176.9 49.5 211.4 214.0 112.8 383.4 42.2 109.9 170.0 106.7 73.5 109.3 105.3 94.8 219.4 109.5 C19orf73 FLJ10490 ENSG00000221916 "Chromosome 19 open reading frame 73" Q9NVV2 19 49118397-49119140 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Basal glandular cells: 8.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 12.7" HPA062719 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA062719: AB_2684847" "unprognostic (3.02e-1)" "unprognostic (3.75e-2)" "unprognostic (2.25e-1)" "unprognostic (5.53e-2)" "unprognostic (2.04e-2)" "unprognostic (4.39e-3)" "unprognostic (2.10e-2)" "unprognostic (1.74e-1)" "unprognostic (2.92e-1)" "unprognostic (1.97e-3)" "prognostic favorable (1.58e-4)" "unprognostic (3.05e-1)" "unprognostic (9.00e-5)" "unprognostic (1.19e-1)" "unprognostic (6.70e-2)" "unprognostic (1.91e-1)" "unprognostic (5.13e-3)" 2.5 3.4 5.0 2.3 6.7 1.0 3.7 10.2 8.7 1.4 3.9 4.1 3.1 7.7 1.3 5.6 2.6 1.4 2.1 3.5 4.9 4.5 2.5 4.8 1.5 2.3 9.2 4.9 0.7 12.9 3.3 5.4 1.4 5.0 2.5 2.9 1.8 6.3 2.1 3.6 4.1 4.4 1.3 4.7 3.6 2.9 2.1 5.6 1.1 3.1 1.2 1.7 1.5 1.4 6.2 5.5 0.7 4.1 7.9 4.6 2.3 2.4 3.1 1.2 6.0 2.0 0.4 1.3 0.7 0.4 1.3 0.9 0.2 1.4 1.8 0.7 0.5 1.9 1.6 1.6 0.2 0.2 3.5 12.7 1.5 1.9 2.0 2.0 0.0 0.7 0.2 4.1 0.9 3.4 1.0 0.4 6.2 2.8 2.9 0.6 2.6 1.9 1.8 0.9 2.6 0.6 1.8 2.4 2.3 2.3 1.0 6.3 2.9 1.2 1.5 2.3 0.9 1.5 0.6 1.2 1.6 2.7 0.5 0.6 1.8 3.4 2.0 1.1 2.1 1.8 0.0 3.3 0.7 2.9 1.9 4.6 2.7 2.2 2.6 5.5 6.2 4.3 3.2 0.1 7.9 4.1 4.2 1.9 2.3 5.0 6.7 10.2 8.7 4.9 4.5 9.2 4.9 5.0 5.6 0.0 0.0 4.5 8.9 1.9 3.6 0.7 5.1 1.4 1.2 3.5 0.0 0.7 3.3 2.2 0.4 0.5 3.3 0.0 1.7 0.8 1.4 6.4 0.0 3.9 1.2 1.6 2.9 1.8 1.2 0.7 0.0 1.3 3.3 0.0 4.2 3.4 1.9 0.0 1.4 7.0 4.3 0.0 1.1 0.4 3.4 2.3 0.3 1.8 4.7 3.5 C1D "LRP1, Rrp47, SUN-CoR, SUNCOR" ENSG00000197223 "C1D nuclear receptor corepressor" Q13901 2 68041130-68110948 "Predicted intracellular proteins" "Apoptosis, rRNA processing, Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037413, HPA037588" Approved Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA037413: AB_2675463, HPA037588: AB_10672907" "unprognostic (1.84e-1)" "unprognostic (1.85e-1)" "unprognostic (1.06e-1)" "unprognostic (3.71e-3)" "unprognostic (2.03e-1)" "unprognostic (1.49e-2)" "unprognostic (4.01e-3)" "unprognostic (1.46e-1)" "unprognostic (1.26e-1)" "unprognostic (1.98e-1)" "unprognostic (3.90e-2)" "unprognostic (1.29e-2)" "unprognostic (4.24e-3)" "unprognostic (6.18e-2)" "unprognostic (2.50e-1)" "unprognostic (8.80e-2)" "unprognostic (1.01e-1)" 17.1 20.1 15.9 13.3 17.9 31.5 17.2 13.9 26.5 15.4 16.3 12.4 15.4 14.7 14.9 14.6 13.8 13.9 12.4 15.8 14.9 15.6 28.4 29.8 14.4 21.0 14.8 16.8 14.9 27.3 12.5 25.3 18.6 17.0 14.8 13.9 8.6 13.5 14.0 29.4 11.7 19.2 12.2 17.2 16.4 15.1 13.8 18.6 17.4 18.0 16.4 14.7 13.2 20.0 20.0 16.1 32.1 19.6 22.6 19.7 9.4 21.9 12.3 15.4 12.9 15.6 19.8 20.5 28.5 19.7 20.0 16.5 21.5 24.7 27.7 17.4 19.0 21.2 10.8 18.1 13.3 31.2 29.5 21.8 32.5 10.5 24.6 15.8 40.3 34.5 16.3 22.4 15.0 14.3 24.4 15.3 26.2 25.8 24.2 18.3 11.1 26.8 34.9 16.5 20.4 15.3 16.9 18.3 21.8 18.1 15.9 13.5 15.5 10.4 18.2 28.2 18.6 13.3 27.4 17.0 17.3 19.9 21.1 25.0 23.2 25.8 35.0 22.0 25.1 19.6 28.1 14.3 32.1 15.9 18.5 18.7 20.0 18.0 13.2 16.1 17.2 19.6 19.7 29.0 22.6 19.6 15.0 19.0 9.4 15.9 17.9 13.9 26.5 14.9 15.6 14.8 16.8 17.0 18.6 71.5 36.3 61.4 75.3 75.6 34.8 30.5 61.1 75.0 45.5 61.1 21.6 86.5 198.9 74.3 40.6 40.9 39.1 23.3 52.1 69.0 56.7 67.4 42.8 75.7 76.6 33.4 49.7 40.5 54.7 18.1 51.5 56.0 54.0 76.7 38.4 39.8 54.5 63.3 55.5 180.4 29.5 97.0 44.0 91.4 84.7 75.4 90.2 57.5 31.5 88.7 C1orf100 ENSG00000173728 "Chromosome 1 open reading frame 100" Q5SVJ3 1 244352635-244389663 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 66 "testis: 65.3" "Group enriched" "Detected in some" 119 "Early spermatids: 1095.9;Late spermatids: 535.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 51 "K-562: 11.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA031179, HPA031180" Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA031179: AB_10599995, HPA031180: AB_10599026" "unprognostic (9.84e-2)" "unprognostic (2.14e-3)" "unprognostic (3.37e-2)" "unprognostic (9.07e-2)" "unprognostic (6.63e-2)" "unprognostic (1.49e-2)" "unprognostic (5.45e-3)" "unprognostic (2.17e-2)" "unprognostic (4.00e-2)" "unprognostic (3.44e-1)" "unprognostic (9.67e-5)" "unprognostic (1.85e-2)" "unprognostic (2.08e-3)" "unprognostic (2.53e-2)" "unprognostic (1.79e-1)" "unprognostic (2.85e-1)" "unprognostic (1.27e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1095.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 535.2 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 6.9 1.6 0.0 0.0 0.0 0.0 0.0 C1orf109 FLJ20508 ENSG00000116922 "Chromosome 1 open reading frame 109" Q9NX04 1 37681570-37692249 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 44.6;Suprabasal keratinocytes: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027110, HPA027127" Supported Supported Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA027110: AB_10611813, HPA027127: AB_1845628" "unprognostic (1.37e-1)" "unprognostic (3.65e-2)" "unprognostic (2.43e-1)" "unprognostic (3.30e-3)" "unprognostic (1.71e-2)" "unprognostic (7.13e-3)" "prognostic unfavorable (1.76e-7)" "unprognostic (1.93e-1)" "unprognostic (1.48e-2)" "unprognostic (8.38e-2)" "unprognostic (1.73e-1)" "unprognostic (3.79e-3)" "unprognostic (9.96e-2)" "unprognostic (1.66e-2)" "unprognostic (2.25e-1)" "unprognostic (7.96e-3)" "unprognostic (1.69e-1)" 13.8 15.1 12.0 9.3 15.0 9.3 14.5 17.9 20.5 12.9 11.1 11.4 16.2 11.0 15.9 14.3 13.7 13.9 10.5 11.1 13.1 12.9 12.8 12.0 8.8 14.1 13.6 15.0 19.7 19.6 20.5 10.9 14.6 15.9 15.0 7.8 12.9 20.3 14.8 15.2 14.9 8.5 11.6 9.9 10.1 11.1 11.2 12.2 13.1 15.7 9.1 12.6 13.7 12.8 11.4 27.5 3.3 5.0 12.2 16.2 7.5 8.3 9.6 8.3 13.6 7.3 5.2 18.9 10.0 7.1 15.2 11.2 14.6 10.1 11.9 12.1 4.4 7.0 12.2 15.3 10.2 15.6 18.9 17.2 13.5 9.7 9.1 14.1 14.7 8.9 7.1 12.6 14.9 19.5 6.6 7.6 10.5 26.5 14.5 8.6 5.7 14.2 6.5 25.8 8.6 18.5 14.2 17.4 32.5 8.0 7.2 25.1 12.1 8.8 13.7 20.3 8.7 7.7 6.6 5.1 15.3 9.6 12.3 20.3 11.8 13.1 24.3 7.6 14.4 16.0 1.7 5.0 3.3 10.3 3.9 16.1 11.4 12.4 9.9 5.9 10.3 16.2 13.8 0.9 12.2 4.2 27.5 6.2 7.5 12.0 15.0 17.9 20.5 13.1 12.9 13.6 15.0 15.9 12.2 6.0 6.4 16.6 16.0 44.6 9.7 4.5 7.6 6.7 15.9 3.5 9.8 11.8 11.6 8.2 1.2 10.5 4.0 23.3 6.3 11.6 13.5 9.8 11.5 4.9 4.9 15.9 4.1 5.5 4.3 0.2 9.2 4.9 11.8 7.2 4.5 10.1 8.1 7.0 13.1 6.8 12.2 0.0 10.3 10.1 26.6 54.3 6.6 13.8 7.3 9.6 C1orf162 MGC24133 ENSG00000143110 "Chromosome 1 open reading frame 162" Q8NEQ5 1 111473792-111478512 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 119.1;lymphoid tissue: 86.6" "Cell type enhanced" "Detected in many" 18 "granulocytes: 175.8;Hofbauer cells: 198.4;Kupffer cells: 675.1;Macrophages: 367.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 7 "HDLM-2: 45.4;HL-60: 22.1;NB-4: 12.3;THP-1: 17.5;U-937: 36.7" HPA026988 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA026988: AB_10600887" "unprognostic (8.79e-2)" "unprognostic (5.18e-3)" "unprognostic (1.14e-2)" "unprognostic (2.11e-1)" "unprognostic (5.20e-2)" "unprognostic (5.96e-2)" "unprognostic (1.61e-1)" "unprognostic (5.66e-2)" "unprognostic (1.11e-1)" "unprognostic (4.69e-2)" "unprognostic (1.86e-1)" "unprognostic (1.80e-1)" "prognostic unfavorable (3.14e-6)" "unprognostic (1.29e-2)" "unprognostic (3.15e-2)" "unprognostic (1.53e-1)" "unprognostic (2.74e-1)" 39.8 9.3 9.2 25.1 17.9 37.5 20.1 4.6 9.3 5.2 6.3 4.9 0.8 2.7 5.4 7.4 4.9 10.2 11.7 14.8 13.4 4.7 17.3 14.8 40.1 86.6 17.5 1.9 5.8 4.5 1.3 9.7 5.6 15.3 5.0 6.9 5.0 5.9 2.5 7.2 3.6 8.3 13.5 31.0 78.1 5.8 6.1 13.9 10.6 6.2 1.1 20.0 7.2 6.7 24.7 83.3 98.7 119.1 40.1 27.8 74.8 0.1 0.0 0.1 0.3 0.1 0.2 0.2 0.3 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.2 45.4 0.1 0.1 0.1 0.0 0.2 22.1 3.7 0.0 0.9 0.3 0.3 0.3 0.6 0.2 0.2 0.1 0.1 0.1 0.1 12.3 0.0 0.2 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.2 0.1 17.5 0.0 0.2 0.3 0.2 0.2 0.2 0.0 0.2 0.1 36.7 0.5 68.4 82.5 98.7 14.2 119.1 4.1 17.5 17.7 8.2 83.3 24.7 27.8 16.8 11.4 40.1 86.3 24.9 5.0 74.8 9.2 17.9 4.6 9.3 13.4 4.7 17.5 1.9 15.3 13.9 20.8 66.7 71.8 0.5 7.0 3.7 3.1 12.7 1.4 7.9 7.0 2.0 1.1 0.0 0.2 33.3 3.7 0.6 0.0 0.2 1.2 5.8 0.7 175.8 6.4 198.4 0.0 1.7 17.8 675.1 60.1 2.6 367.2 11.8 1.0 0.0 0.3 0.2 0.0 0.7 0.6 3.9 32.3 4.2 1.8 1.7 5.6 1.4 95.6 0.6 0.3 C1orf174 RP13-531C17.2 ENSG00000198912 "Chromosome 1 open reading frame 174" Q8IYL3 1 3889125-3900293 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 104.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008270, HPA065778" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA008270: AB_1845633, HPA065778: AB_2685557" "unprognostic (4.91e-3)" "unprognostic (1.13e-1)" "unprognostic (1.62e-1)" "unprognostic (1.75e-1)" "unprognostic (3.38e-1)" "unprognostic (1.49e-2)" "prognostic unfavorable (5.84e-4)" "unprognostic (2.52e-1)" "prognostic unfavorable (7.62e-4)" "unprognostic (7.24e-2)" "unprognostic (5.36e-2)" "unprognostic (7.02e-2)" "prognostic unfavorable (2.73e-6)" "unprognostic (3.71e-2)" "unprognostic (3.95e-1)" "unprognostic (8.05e-2)" "unprognostic (1.46e-2)" 17.6 17.4 15.0 18.8 16.5 24.0 17.8 16.3 19.2 15.4 16.9 21.3 11.6 15.6 19.4 20.1 19.3 19.7 21.1 13.4 15.3 15.4 18.1 24.8 14.5 20.2 15.8 17.1 19.6 20.0 5.4 13.3 24.4 16.7 18.9 15.6 16.5 15.9 17.2 22.9 15.6 16.5 20.1 13.7 22.4 16.5 18.9 15.3 26.9 21.9 19.7 22.4 19.5 15.0 16.5 18.7 30.4 28.8 16.1 27.6 13.6 14.3 8.4 13.3 11.2 11.2 7.0 9.4 13.2 7.4 11.8 12.1 12.2 22.8 11.4 14.9 9.7 16.5 13.9 14.0 9.0 13.3 19.3 13.6 29.4 8.6 17.9 6.9 20.9 15.3 7.4 5.9 12.4 10.0 9.2 9.4 14.1 22.9 11.7 8.2 10.7 21.6 16.1 15.1 19.2 17.8 16.4 22.2 10.7 8.0 8.7 12.8 10.6 12.0 18.0 18.1 12.8 7.5 12.8 10.2 17.1 12.8 28.3 12.5 4.5 4.3 21.9 8.3 23.3 5.6 27.7 16.1 30.4 27.6 28.8 24.0 16.5 18.7 20.9 18.7 15.2 17.9 22.7 13.3 16.1 18.8 10.3 19.3 13.6 15.0 16.5 16.3 19.2 15.3 15.4 15.8 17.1 16.7 15.3 8.9 4.8 14.9 10.8 19.5 9.8 3.4 7.6 12.0 14.8 5.2 7.9 52.5 23.2 19.2 104.9 12.3 10.9 0.0 16.9 53.1 17.4 9.5 36.8 11.6 27.7 11.1 10.9 9.8 14.0 14.5 15.8 18.9 13.5 16.2 13.6 11.7 14.8 14.0 18.0 17.2 10.5 12.9 12.3 20.1 26.0 15.4 22.3 24.5 15.6 9.9 C1orf189 ENSG00000163263 "Chromosome 1 open reading frame 189" Q5VU69 1 154199372-154206333 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "epididymis: 11.9;fallopian tube: 41.8;testis: 21.0" "Cell type enhanced" "Detected in some" 31 "Ciliated cells: 28.1;Early spermatids: 63.9;Late spermatids: 12.8" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.2" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA045779 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Nucleoplasm, Golgi apparatus, Plasma membrane" "HPA045779: AB_2679448" "unprognostic (8.23e-3)" "unprognostic (5.55e-3)" "unprognostic (2.39e-2)" "unprognostic (2.01e-3)" "unprognostic (2.50e-3)" "unprognostic (2.02e-1)" "unprognostic (8.15e-2)" "unprognostic (1.62e-1)" "unprognostic (2.24e-2)" "unprognostic (8.78e-3)" "unprognostic (1.36e-2)" "unprognostic (7.40e-2)" "unprognostic (3.20e-2)" "unprognostic (3.75e-2)" "unprognostic (2.06e-1)" "unprognostic (9.79e-2)" "unprognostic (3.05e-2)" 0.1 0.0 0.4 0.1 0.6 0.5 0.1 0.1 0.2 2.2 0.1 0.8 0.1 0.0 0.7 11.9 0.1 41.8 0.1 0.1 0.8 1.1 0.1 0.3 5.6 0.1 0.1 0.1 4.2 0.1 0.0 0.1 0.1 0.9 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 21.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.8 0.3 3.2 1.0 0.0 1.6 0.3 0.1 0.0 1.8 0.0 1.4 0.0 1.0 0.6 0.8 2.1 0.0 3.4 0.9 1.3 0.4 0.0 0.2 0.5 1.4 2.3 0.0 1.4 2.1 0.8 2.7 2.3 2.1 0.6 0.8 2.6 1.9 0.8 0.0 0.0 0.0 1.4 1.2 0.4 1.0 3.7 0.8 0.3 3.3 1.3 3.8 0.4 1.5 0.9 0.0 0.0 0.9 0.0 0.0 0.0 2.7 0.3 2.5 0.0 1.9 0.0 2.0 1.3 1.2 2.3 2.3 0.5 0.4 0.5 0.0 0.0 0.1 1.5 0.2 1.0 0.0 0.2 0.1 0.4 0.3 0.8 0.2 1.6 3.2 0.0 0.5 0.0 0.4 0.3 0.4 0.6 0.1 0.2 0.8 1.1 0.1 0.1 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.1 0.0 0.0 0.0 0.0 0.0 0.0 63.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 C1orf21 PIG13 ENSG00000116667 "Chromosome 1 open reading frame 21" Q9H246 1 184387058-184629020 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 238.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 11.4;memory CD8 T-cell: 5.9;naive CD8 T-cell: 5.9;NK-cell: 7.5" "Group enriched" "Detected in many" 12 "NK-cells: 7.5;T-cells: 11.4" "Cell line enhanced" "Detected in many" "HDLM-2: 23.3;Karpas-707: 17.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026831 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA026831: AB_1845636" "unprognostic (8.27e-2)" "unprognostic (7.45e-2)" "unprognostic (2.44e-1)" "unprognostic (1.70e-1)" "unprognostic (5.07e-2)" "unprognostic (1.18e-2)" "unprognostic (1.92e-3)" "unprognostic (5.44e-2)" "unprognostic (2.18e-1)" "unprognostic (1.40e-1)" "unprognostic (1.11e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (3.35e-8)" "unprognostic (1.81e-2)" "unprognostic (1.46e-1)" "unprognostic (3.03e-1)" "unprognostic (3.60e-2)" 12.0 15.9 16.8 7.5 9.5 2.1 25.2 17.5 18.8 20.2 18.5 4.4 16.7 8.7 17.3 14.2 14.1 10.1 9.2 20.0 12.5 8.8 4.1 7.5 12.2 3.5 8.3 13.3 13.9 4.7 12.6 7.6 5.7 11.8 17.8 13.1 10.7 5.1 18.9 51.7 30.1 15.8 25.2 7.6 8.2 10.7 4.1 5.4 1.5 4.4 13.6 3.9 22.0 23.5 0.0 0.7 0.2 0.1 7.5 11.4 2.1 0.6 0.1 3.6 0.3 11.4 9.4 6.1 3.2 3.1 2.0 1.8 0.0 0.3 0.0 0.0 3.6 0.7 2.0 2.3 2.6 1.9 23.3 3.7 0.1 1.0 0.0 4.5 2.0 1.0 11.3 7.7 2.3 2.0 8.2 2.4 3.5 0.0 17.7 3.1 2.4 2.3 0.6 5.4 4.8 0.6 3.0 3.8 3.5 0.0 1.2 2.1 5.4 1.6 1.4 6.6 3.4 0.2 0.2 2.3 4.1 2.1 6.2 3.9 11.0 5.1 0.0 4.1 3.3 4.7 0.0 0.1 0.0 11.4 0.0 1.1 0.0 1.9 5.9 0.7 0.0 0.6 5.9 0.2 7.5 0.0 0.2 0.0 2.1 16.8 9.5 17.5 15.9 12.5 8.8 8.3 13.3 11.8 5.4 35.7 88.4 1.5 208.9 135.5 27.4 78.1 28.1 17.4 53.4 1.8 0.0 92.1 6.6 5.0 34.6 101.3 150.2 0.0 16.6 76.1 45.1 118.1 9.3 55.0 34.1 25.4 18.4 81.6 6.3 26.6 70.8 10.1 60.8 32.5 59.7 30.7 19.0 164.9 18.0 5.7 8.7 19.4 53.8 2.3 16.6 127.2 238.0 44.5 61.0 172.9 C1orf216 FLJ38984 ENSG00000142686 "Chromosome 1 open reading frame 216" Q8TAB5 1 35713875-35719472 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.1" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 22.3;Rod photoreceptor cells: 26.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028299, HPA031343" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA028299: AB_10601122, HPA031343: AB_2673834" "unprognostic (1.17e-1)" "unprognostic (2.43e-2)" "unprognostic (9.84e-2)" "unprognostic (1.51e-2)" "unprognostic (1.83e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (2.15e-4)" "unprognostic (2.23e-1)" "unprognostic (3.81e-1)" "unprognostic (2.07e-1)" "unprognostic (4.67e-3)" "unprognostic (1.86e-1)" "prognostic unfavorable (7.68e-10)" "unprognostic (3.31e-1)" "unprognostic (3.08e-1)" "unprognostic (2.48e-1)" "unprognostic (5.93e-2)" 4.3 4.4 12.5 2.1 10.5 1.1 2.4 5.0 22.1 4.7 3.5 1.0 4.1 5.0 2.1 2.5 3.0 4.0 12.1 9.7 0.7 1.8 3.1 2.4 7.0 3.5 1.2 2.0 1.8 1.6 3.1 2.0 1.1 4.4 5.1 2.9 1.2 7.0 5.2 2.2 1.2 3.4 1.4 2.5 2.4 1.4 2.5 3.2 0.1 3.7 0.8 7.3 3.0 3.4 8.0 4.4 5.7 20.1 14.8 2.9 9.8 11.5 14.5 13.9 4.7 7.3 4.3 7.1 14.3 11.9 3.3 10.9 6.4 12.5 14.0 5.2 25.7 11.7 1.3 7.6 12.7 17.0 15.1 8.2 10.4 3.3 10.7 9.4 3.2 10.2 11.6 15.5 5.6 5.1 10.9 6.4 3.7 6.8 3.4 5.8 3.5 5.0 4.0 5.9 5.9 9.3 1.9 19.0 2.7 3.6 5.7 11.2 11.8 9.4 8.8 10.1 3.5 8.7 3.2 11.8 12.3 18.4 0.0 3.2 0.1 5.9 3.7 1.9 2.5 4.7 7.3 3.2 1.4 1.1 4.4 0.1 0.8 2.7 0.7 1.6 3.0 0.0 2.1 0.0 2.9 5.4 18.4 6.4 0.0 0.0 1.2 1.8 13.7 2.0 0.0 5.5 10.2 6.0 0.0 0.0 2.4 1.2 4.7 1.8 4.6 1.7 6.9 22.3 1.7 5.5 4.0 6.8 7.8 5.4 15.1 8.2 0.0 16.2 2.2 0.0 19.4 0.7 26.6 0.0 6.9 2.8 2.2 4.0 0.9 5.0 0.3 1.4 C1orf226 FLJ13137 ENSG00000239887 "Chromosome 1 open reading frame 226" A1L170 1 162366908-162386818 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 28.6" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 27.5;Early spermatids: 20.6;Hepatocytes: 22.6;Late spermatids: 30.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 13.2;HEL: 16.9" "Low region specificity" "Detected in all" "HPA052251, HPA074060" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA052251: AB_2681775, HPA074060: " "prognostic favorable (2.60e-4)" "unprognostic (1.30e-1)" "unprognostic (2.69e-2)" "unprognostic (1.59e-2)" "unprognostic (6.71e-3)" "unprognostic (9.80e-2)" "unprognostic (8.55e-2)" "unprognostic (1.65e-1)" "unprognostic (2.05e-1)" "unprognostic (4.48e-2)" "unprognostic (1.57e-1)" "unprognostic (1.24e-3)" "prognostic favorable (4.44e-5)" "unprognostic (9.34e-3)" "unprognostic (1.06e-1)" "unprognostic (1.51e-1)" "prognostic favorable (1.13e-4)" 1.5 8.2 1.5 3.4 1.5 1.2 7.1 4.8 2.0 3.7 18.0 1.5 1.5 4.9 1.9 1.6 4.4 2.5 3.2 1.5 1.6 2.4 5.2 15.2 3.0 1.5 1.8 1.5 2.0 3.5 1.4 6.9 18.9 1.5 3.2 8.3 2.0 8.2 7.6 1.5 3.3 28.6 2.4 2.3 2.2 5.8 2.7 1.5 1.5 1.5 7.4 5.1 2.2 1.5 0.0 0.0 0.8 0.7 0.0 0.0 0.2 13.2 0.7 10.9 8.3 0.3 0.0 0.2 1.2 1.1 0.8 0.4 1.5 6.1 0.0 9.1 0.2 4.0 9.7 3.2 0.7 0.5 0.2 4.4 16.9 0.5 7.4 0.2 0.0 0.1 1.2 0.8 0.0 0.6 3.0 3.3 1.8 1.4 0.1 0.2 4.3 0.6 0.0 6.8 11.9 6.1 0.2 1.7 0.0 9.3 5.4 4.7 3.2 4.5 1.2 2.6 4.2 4.9 0.7 2.3 0.0 1.4 0.2 3.3 6.3 0.0 0.0 1.6 0.2 0.7 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 1.5 1.5 4.8 2.0 1.6 2.4 1.8 1.5 1.5 1.5 3.0 1.6 0.0 1.4 0.7 0.7 3.3 2.5 1.4 1.2 14.0 27.5 0.0 0.0 0.8 20.6 1.1 8.0 0.0 2.0 0.1 0.6 3.7 0.0 22.6 0.1 6.4 2.4 3.7 1.0 30.4 2.0 0.0 0.0 0.0 10.3 6.5 1.7 3.5 1.8 0.0 0.3 0.0 0.2 0.7 0.7 1.3 0.1 0.0 5.6 2.0 C1orf52 "FLJ44982, gm117" ENSG00000162642 "Chromosome 1 open reading frame 52" Q8N6N3 1 85249953-85259672 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036072, HPA061790" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA036072: AB_10602696, HPA061790: AB_2684610" "unprognostic (1.59e-1)" "unprognostic (2.30e-1)" "unprognostic (5.97e-2)" "unprognostic (1.13e-2)" "unprognostic (4.06e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (5.37e-5)" "unprognostic (6.67e-3)" "unprognostic (2.95e-2)" "unprognostic (3.73e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (4.93e-4)" "prognostic unfavorable (1.17e-7)" "unprognostic (8.01e-2)" "unprognostic (2.54e-1)" "unprognostic (4.14e-1)" "unprognostic (2.05e-2)" 14.4 13.5 22.4 13.4 30.1 42.9 17.4 13.8 25.8 11.8 12.3 19.1 9.4 11.3 14.2 16.9 12.0 11.3 12.2 13.0 25.4 19.3 9.9 13.3 14.6 20.3 20.6 19.9 13.9 14.2 11.0 15.6 21.0 17.9 13.1 11.9 8.8 11.5 11.8 18.0 19.8 10.7 12.0 18.7 14.1 12.0 17.0 20.3 12.4 11.4 8.8 14.3 11.2 12.3 27.3 20.8 25.6 21.4 15.5 23.6 16.7 13.4 6.1 11.9 9.9 13.0 9.9 20.7 13.7 8.3 15.1 14.8 8.7 7.2 12.4 12.9 12.0 13.5 9.0 24.0 7.8 15.2 12.8 15.0 16.7 10.7 10.9 11.5 17.2 7.8 7.9 11.1 13.2 10.1 10.6 9.5 18.7 19.7 13.7 8.8 3.7 13.1 14.0 36.7 6.5 8.8 14.5 13.8 5.3 15.0 8.4 7.3 11.4 3.8 10.7 20.2 15.7 6.1 28.0 9.1 8.3 12.4 15.2 16.8 13.0 21.7 18.9 4.9 13.2 9.3 25.6 15.1 22.8 16.4 21.4 17.6 27.3 15.6 14.2 19.4 16.7 23.6 22.9 23.6 15.5 17.6 20.8 12.9 16.7 22.4 30.1 13.8 25.8 25.4 19.3 20.6 19.9 17.9 20.3 41.7 26.4 35.3 50.1 129.1 22.6 21.3 7.6 30.8 33.0 15.7 21.6 54.0 16.6 32.5 28.7 43.0 21.5 23.3 24.1 49.7 56.0 31.9 49.7 14.7 32.0 14.3 37.2 25.8 27.0 8.0 33.9 37.1 30.4 16.2 18.9 25.6 27.3 23.5 23.0 17.3 25.6 38.8 54.2 91.6 55.3 112.7 56.8 36.3 22.0 60.4 C1orf94 MGC15882 ENSG00000142698 "Chromosome 1 open reading frame 94" Q6P1W5 1 34166883-34219131 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 24.6" "Cell type enhanced" "Detected in some" 29 "Early spermatids: 53.5;Late spermatids: 24.4;Spermatocytes: 12.2" "Cancer enriched" "Detected in single" 10 "glioma: 1.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "NTERA-2: 11.4;U-87 MG: 33.0" "Low region specificity" "Detected in many" HPA045805 Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA045805: AB_10969626" "unprognostic (1.17e-1)" "unprognostic (1.38e-1)" "unprognostic (9.77e-2)" "unprognostic (4.09e-2)" "unprognostic (1.65e-2)" "unprognostic (2.31e-1)" 0.0 0.1 0.6 0.0 0.8 0.0 0.0 1.2 1.8 0.0 0.1 3.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 24.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.6 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 33.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 1.2 1.8 0.5 0.7 0.5 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 53.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 12.2 0.5 0.0 0.0 0.0 0.0 0.0 C1QTNF1 "CTRP1, FLJ90694, GIP, ZSIG37" ENSG00000173918 "C1q and TNF related 1" Q9BXJ1 17 79022814-79049788 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 77.5" "Group enriched" "Detected in many" 5 "Ito cells: 145.5;Sertoli cells: 103.5;Smooth muscle cells: 105.0;Syncytiotrophoblasts: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 1.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 84.6;BJ hTERT+: 19.8;HHSteC: 32.0;HSkMC: 17.0;U-87 MG: 20.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB025429, HPA051101" Uncertain Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA 314000000 30000 "Nucleoplasm, Cytosol" "CAB025429: , HPA051101: AB_2681343" "unprognostic (2.58e-1)" "prognostic unfavorable (2.95e-4)" "unprognostic (1.20e-1)" "unprognostic (3.48e-1)" "unprognostic (1.12e-2)" "unprognostic (7.11e-2)" "unprognostic (3.18e-1)" "unprognostic (1.07e-2)" "unprognostic (1.23e-2)" "unprognostic (7.48e-2)" "unprognostic (9.81e-3)" "unprognostic (5.83e-2)" "prognostic unfavorable (9.09e-9)" "unprognostic (1.93e-2)" "unprognostic (2.19e-1)" "unprognostic (4.04e-2)" "unprognostic (1.95e-2)" 62.4 18.3 1.7 7.4 4.3 0.4 60.5 1.3 5.1 14.3 10.3 5.2 30.8 2.5 11.0 14.2 10.2 14.4 19.1 77.5 2.0 4.1 9.5 19.4 9.7 16.6 4.8 2.5 25.2 7.5 10.1 4.2 34.0 7.6 13.3 3.3 19.6 13.8 51.8 11.9 8.6 6.1 6.9 2.5 14.3 6.1 8.8 2.8 1.3 26.9 13.3 5.0 14.8 27.5 0.5 0.3 1.9 0.3 1.2 0.4 0.0 0.0 8.2 0.0 0.0 84.6 7.6 0.0 4.2 19.8 1.8 3.5 0.6 4.0 0.0 0.4 1.2 5.2 0.2 0.2 0.1 1.3 0.0 0.9 0.0 3.1 0.4 32.0 0.0 0.0 17.0 0.0 3.8 0.2 2.6 2.4 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.9 8.6 0.0 5.5 0.1 0.0 0.1 0.3 1.6 2.7 0.4 7.9 0.3 0.0 0.0 0.3 9.0 0.2 1.0 1.2 0.0 0.0 0.0 20.0 0.0 0.8 1.9 0.3 0.5 0.3 0.2 0.2 0.2 0.4 0.2 0.1 0.5 0.2 0.4 0.4 1.2 0.2 0.3 0.0 0.0 1.7 4.3 1.3 4.2 2.0 4.1 4.8 2.5 7.6 2.8 0.0 1.1 0.0 0.6 5.8 0.0 9.4 10.2 0.0 0.0 1.8 0.0 17.3 0.0 13.9 0.1 10.5 1.3 0.0 5.3 1.2 14.4 1.2 0.0 1.5 2.3 0.0 4.6 145.5 10.5 0.0 9.8 0.7 3.3 19.0 6.8 0.5 3.2 2.9 3.2 0.0 0.3 103.5 105.0 0.0 0.7 4.0 39.6 0.5 4.5 0.5 C1QTNF6 "CTRP6, ZACRP6" ENSG00000133466 "C1q and TNF related 6" Q9BXI9 22 37180167-37199385 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "endometrium 1: 23.7;placenta: 79.5" "Cell type enriched" "Detected in many" 12 "Extravillous trophoblasts: 349.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 45.0;RT4: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002042 Enhanced Approved Nucleoplasm "Secreted to blood" No No 354000000 Nucleoplasm "HPA002042: AB_1078342" "unprognostic (9.65e-2)" "unprognostic (1.21e-2)" "unprognostic (2.32e-1)" "unprognostic (2.23e-3)" "unprognostic (1.25e-3)" "unprognostic (3.01e-2)" "unprognostic (3.17e-2)" "prognostic unfavorable (9.60e-6)" "unprognostic (6.96e-2)" "unprognostic (5.11e-2)" "unprognostic (2.61e-2)" "unprognostic (1.72e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.61e-2)" "unprognostic (5.36e-2)" "unprognostic (1.08e-3)" "unprognostic (1.52e-2)" 3.3 4.4 1.2 4.2 1.6 0.8 2.5 1.2 1.8 7.8 2.5 1.3 1.6 1.0 23.7 7.2 1.6 5.2 6.2 3.1 1.4 0.7 3.9 7.9 9.2 3.1 1.2 1.3 5.9 2.3 1.4 1.4 79.5 1.7 4.3 2.5 4.4 2.2 3.4 1.5 3.1 3.2 5.7 1.8 4.6 1.8 3.5 1.2 1.6 2.4 1.7 1.8 5.1 2.7 2.4 1.1 1.8 0.5 4.0 3.8 1.0 6.7 8.4 4.4 1.5 0.8 8.9 13.4 1.4 2.8 1.1 0.8 1.5 9.9 0.0 5.7 2.3 0.6 14.0 0.1 3.4 0.5 1.9 1.1 1.1 3.2 1.5 3.1 0.0 0.9 12.3 1.9 0.9 0.2 3.0 10.6 0.3 0.0 3.1 0.4 45.0 0.0 0.2 2.8 1.0 0.1 0.1 0.0 1.1 10.2 20.8 0.7 5.7 0.4 8.1 1.1 2.4 2.8 0.2 3.6 0.4 2.3 0.1 0.0 6.5 0.1 0.0 0.9 0.8 1.2 1.0 0.5 1.5 0.7 0.5 0.8 0.8 1.3 1.0 0.5 2.4 2.9 2.2 1.8 4.0 0.3 1.1 3.8 1.0 1.2 1.6 1.2 1.8 1.4 0.7 1.2 1.3 1.7 1.2 0.0 0.0 3.0 1.4 1.3 0.9 1.1 2.5 4.0 2.3 1.8 0.0 4.2 1.7 1.9 1.7 1.4 2.6 0.0 1.0 349.8 8.9 0.6 1.1 5.0 8.4 0.0 0.0 11.6 1.0 6.2 0.6 0.9 5.0 1.0 2.1 4.2 2.0 3.5 0.4 1.3 0.7 0.0 3.3 7.0 4.0 0.3 28.8 2.5 3.9 1.0 C1R ENSG00000159403 "Complement C1r" P00736 12 7080209-7092607 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Disease mutation, Ehlers-Danlos syndrome, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 370.2" "Group enriched" "Detected in many" 5 "Fibroblasts: 462.9;Hepatocytes: 1385.8;Leydig cells: 1057.9;Peritubular cells: 364.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 2.0;gdT-cell: 1.6;MAIT T-cell: 2.0;memory CD4 T-cell: 1.4;memory CD8 T-cell: 3.4;naive CD4 T-cell: 2.8;naive CD8 T-cell: 2.9;neutrophil: 2.5;NK-cell: 3.2;T-reg: 1.4" "Group enriched" "Detected in many" 6 "granulocytes: 2.5;NK-cells: 3.2;T-cells: 3.4" "Cell line enhanced" "Detected in many" "ASC diff: 181.7;ASC TERT1: 92.7;BJ hTERT+: 80.0;BJ hTERT+ SV40 Large T+ RasG12V: 49.3;HSkMC: 107.4" "Low region specificity" "Detected in all" "HPA001251, HPA001551" Uncertain Uncertain Nucleoplasm,Cytosol "Secreted to blood" NA NA 14000000000 "Nucleoplasm, Cytosol" "HPA001251: AB_2666252, HPA001551: AB_10754818" "unprognostic (1.55e-2)" "unprognostic (8.97e-2)" "unprognostic (3.46e-2)" "unprognostic (1.92e-1)" "unprognostic (1.47e-2)" "unprognostic (2.66e-2)" "unprognostic (1.94e-2)" "unprognostic (2.05e-1)" "unprognostic (2.50e-1)" "unprognostic (1.72e-1)" "unprognostic (1.21e-1)" "unprognostic (4.16e-2)" "prognostic unfavorable (1.94e-14)" "unprognostic (3.54e-2)" "unprognostic (2.25e-2)" "unprognostic (6.13e-2)" "unprognostic (2.59e-2)" 45.8 17.4 2.6 18.1 3.8 0.0 82.0 1.4 2.8 36.7 24.5 2.4 11.2 5.0 27.2 66.8 38.1 33.3 46.7 49.5 1.9 1.8 27.5 370.2 25.3 46.8 3.5 2.0 103.5 11.4 1.4 6.3 10.3 4.6 47.8 15.3 17.7 12.8 13.2 16.0 10.7 14.4 53.2 6.2 35.1 19.8 39.3 1.9 2.3 30.6 20.7 15.1 46.8 83.8 0.4 0.0 2.5 0.4 3.2 3.4 0.8 0.1 1.5 0.1 1.3 181.7 92.7 0.1 20.4 80.0 24.2 49.3 0.2 0.3 0.0 0.6 15.9 1.6 0.3 1.7 0.8 3.4 1.9 0.1 0.0 0.6 0.6 34.9 0.1 0.2 107.4 0.5 11.0 0.8 18.4 0.4 0.1 0.0 2.5 3.1 0.0 0.9 0.1 0.8 0.0 0.1 1.1 0.5 0.1 0.1 0.9 0.0 0.3 14.7 0.4 0.4 0.2 0.0 0.0 0.0 5.8 0.9 26.7 0.1 0.1 0.4 0.0 8.3 0.1 0.8 0.0 0.4 2.0 1.6 0.1 2.0 0.0 1.4 3.4 0.0 0.4 2.8 2.9 2.5 3.2 0.0 0.0 1.4 0.8 2.6 3.8 1.4 2.8 1.9 1.8 3.5 2.0 4.6 1.9 20.8 84.7 28.4 53.6 48.5 0.2 14.6 168.2 6.7 34.2 17.4 2.0 2.9 3.3 164.2 3.5 51.3 0.3 23.3 39.1 4.8 462.9 14.1 9.3 1385.8 10.3 0.0 0.0 128.9 25.4 9.4 1057.9 10.1 50.6 2.8 0.6 15.1 74.1 0.6 364.9 5.0 0.9 168.1 97.8 5.7 4.1 35.0 4.3 13.1 0.7 9.8 C1S ENSG00000182326 "Complement C1s" P09871 12 6988259-7071032 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Disease mutation, Ehlers-Danlos syndrome, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 351.6" "Cell type enhanced" "Detected in many" 21 "Hepatocytes: 2464.3;Leydig cells: 1104.9;Peritubular cells: 601.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "neutrophil: 6.2" "Lineage enriched" "Detected in single" 17 "granulocytes: 6.2" "Cell line enhanced" "Detected in many" "ASC diff: 99.3;ASC TERT1: 132.1;BJ hTERT+: 42.1;HSkMC: 70.1" "Low region specificity" "Detected in all" "CAB016722, HPA018852" Supported Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA 93000000000 13000000000 Nucleoplasm Cytosol "CAB016722: , HPA018852: AB_1847112" "unprognostic (2.72e-3)" "unprognostic (7.31e-2)" "unprognostic (9.37e-2)" "unprognostic (1.39e-2)" "unprognostic (1.05e-2)" "unprognostic (9.63e-2)" "prognostic favorable (7.73e-4)" "unprognostic (6.38e-2)" "unprognostic (1.16e-1)" "unprognostic (6.14e-2)" "unprognostic (1.57e-1)" "unprognostic (1.85e-2)" "prognostic unfavorable (7.44e-15)" "unprognostic (2.02e-2)" "unprognostic (5.68e-3)" "unprognostic (1.19e-2)" "unprognostic (5.39e-2)" 48.7 16.6 3.3 18.7 4.1 0.0 55.7 1.9 3.1 35.3 31.1 2.9 12.7 6.8 32.2 50.0 38.3 46.4 47.2 34.4 2.5 1.1 18.0 351.6 31.4 21.1 6.3 3.2 98.8 15.5 1.9 6.0 8.5 6.5 52.1 18.6 26.1 14.6 12.4 18.2 14.7 19.2 47.6 8.8 32.5 24.6 37.2 2.3 3.2 30.5 22.7 18.8 48.6 73.0 0.2 0.1 6.2 0.3 0.2 0.1 0.0 0.0 2.2 0.1 1.3 99.3 132.1 0.4 17.9 42.1 9.5 17.4 0.0 0.2 0.0 2.4 22.2 2.5 0.1 0.0 0.2 0.8 0.0 0.0 0.0 0.6 4.7 29.9 0.2 0.1 70.1 0.3 7.7 0.5 11.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.1 0.3 0.3 0.0 0.1 10.9 0.2 0.2 2.1 0.0 0.0 0.0 4.4 0.3 16.9 0.0 0.0 0.0 0.1 9.5 0.1 0.2 0.6 0.3 0.2 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.1 6.2 0.2 0.1 0.1 0.0 0.0 3.3 4.1 1.9 3.1 2.5 1.1 6.3 3.2 6.5 2.3 14.9 34.2 18.3 17.5 67.8 0.6 21.4 152.8 6.7 20.5 3.5 0.0 2.9 1.7 170.0 5.7 37.8 0.0 46.7 37.9 3.5 388.0 7.4 4.7 2464.3 7.1 4.8 0.0 105.6 49.3 8.8 1104.9 9.4 84.4 1.8 0.0 15.1 43.6 0.0 601.8 4.1 0.9 135.8 123.7 5.0 4.1 47.0 2.2 4.3 0.0 3.0 C20orf27 FLJ20550 ENSG00000101220 "Chromosome 20 open reading frame 27" Q9GZN8 20 3753508-3768387 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 64.7" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 123.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "basal ganglia: 64.7" "Group enriched" "Detected in many" 5 "classical monocyte: 28.1;intermediate monocyte: 46.6;myeloid DC: 38.5;non-classical monocyte: 42.2" "Group enriched" "Detected in all" 5 "dendritic cells: 38.5;monocytes: 46.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047483 Approved Approved Nucleoplasm,Cytosol NA NA 87000 "Nucleoplasm, Cytosol" "HPA047483: AB_2680064" "unprognostic (1.15e-1)" "unprognostic (1.23e-1)" "unprognostic (8.13e-2)" "unprognostic (3.21e-3)" "unprognostic (2.99e-1)" "unprognostic (2.48e-1)" "prognostic unfavorable (1.69e-5)" "unprognostic (8.36e-2)" "unprognostic (2.07e-1)" "unprognostic (4.53e-2)" "unprognostic (3.54e-3)" "unprognostic (1.84e-1)" "prognostic unfavorable (6.18e-6)" "unprognostic (1.80e-1)" "unprognostic (2.16e-1)" "unprognostic (1.49e-1)" "unprognostic (1.27e-1)" 23.1 9.7 10.2 11.8 64.7 51.9 17.2 4.9 15.8 12.0 22.6 7.7 3.7 10.3 16.9 10.9 14.4 18.7 26.6 7.3 9.2 14.4 5.0 5.4 8.4 13.5 14.5 6.1 20.9 8.5 3.9 5.3 6.7 13.7 18.3 4.9 5.0 9.0 7.1 11.2 9.6 9.4 22.3 5.7 13.4 21.2 6.0 13.2 6.0 5.4 7.9 6.1 27.4 10.3 7.8 38.5 1.1 46.6 5.8 8.5 13.8 34.4 36.4 5.7 24.3 11.9 6.5 9.0 8.9 5.9 16.5 12.1 24.9 13.1 21.6 8.7 10.4 22.0 29.7 15.3 22.3 6.3 5.0 27.4 12.2 7.4 44.4 8.5 17.5 5.4 9.2 9.4 21.0 10.5 5.7 11.1 15.8 21.7 13.6 8.5 48.7 23.1 41.7 24.6 24.1 49.5 17.9 14.0 25.5 10.3 12.6 25.7 11.7 8.1 36.1 17.8 2.7 8.0 22.0 6.8 23.1 16.0 36.6 27.2 10.5 17.5 16.0 6.8 33.3 11.3 0.2 28.1 0.4 5.9 46.6 8.5 7.8 7.0 7.8 38.5 7.3 8.0 7.8 1.1 5.8 42.2 7.3 6.4 13.8 10.2 64.7 4.9 15.8 9.2 14.4 14.5 6.1 13.7 13.2 0.0 3.5 24.6 18.0 21.5 9.4 2.8 7.6 1.4 2.3 10.4 2.0 15.9 24.9 31.1 8.2 25.0 10.5 70.0 26.1 38.9 26.3 9.4 23.0 14.7 123.1 1.6 15.1 13.5 94.5 13.7 30.2 60.1 35.4 4.6 10.2 20.0 28.5 16.4 23.3 27.0 12.7 64.7 66.1 18.7 30.1 28.7 6.1 16.2 30.3 20.0 C21orf58 ENSG00000160298 "Chromosome 21 open reading frame 58" P58505 21 46300181-46323875 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "fallopian tube: 27.2;lymphoid tissue: 22.7;pituitary gland: 25.1" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 203.4;Erythroid cells: 140.2;Intestinal endocrine cells: 66.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 29.3" "HPA035110, HPA035111" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA Yes Nucleoplasm "Nuclear bodies" "HPA035110: AB_10603683, HPA035111: AB_2674468" "unprognostic (2.19e-1)" "unprognostic (6.74e-3)" "unprognostic (2.51e-1)" "unprognostic (6.31e-3)" "unprognostic (1.08e-2)" "prognostic favorable (7.00e-4)" "unprognostic (4.74e-3)" "unprognostic (6.14e-2)" "prognostic unfavorable (7.48e-4)" "unprognostic (1.38e-1)" "prognostic favorable (4.20e-4)" "unprognostic (1.27e-1)" "unprognostic (1.01e-10)" "unprognostic (1.04e-1)" "unprognostic (1.70e-1)" "unprognostic (2.51e-1)" "unprognostic (6.07e-2)" 1.3 1.8 2.2 4.3 5.0 11.1 5.2 3.6 3.1 3.2 3.5 4.6 3.3 4.7 2.2 9.7 3.1 27.2 3.2 2.6 2.9 2.9 1.3 1.3 9.1 5.9 2.9 1.8 8.0 3.2 1.4 25.1 2.1 5.8 2.3 2.7 1.9 2.5 1.7 1.6 5.3 4.3 1.5 1.8 2.8 3.7 5.7 2.2 22.7 1.8 2.1 4.6 1.7 2.1 2.1 1.8 8.2 0.5 0.7 1.8 0.9 12.1 5.6 14.8 9.2 1.5 2.0 8.2 7.5 2.8 5.3 5.2 2.5 9.0 8.8 1.9 2.1 6.2 9.8 3.9 3.2 1.6 9.2 8.6 14.1 14.6 1.4 0.3 4.0 8.1 0.9 0.7 3.7 0.9 1.9 3.3 22.0 8.0 23.5 4.3 5.0 19.8 5.4 6.3 3.4 2.8 29.3 6.7 7.8 1.6 2.3 12.2 7.6 5.6 4.0 1.8 3.3 9.9 8.0 2.2 3.2 9.3 3.2 4.5 9.5 4.2 4.2 5.7 17.5 8.4 8.2 0.5 1.1 0.9 0.3 0.5 0.2 1.1 1.2 0.1 2.1 1.8 1.4 0.7 0.7 0.2 1.8 1.3 0.9 2.2 5.0 3.6 3.1 2.9 2.9 2.9 1.8 5.8 2.2 3.0 1.6 3.0 1.2 0.8 17.1 3.6 0.0 203.4 22.7 1.8 25.5 3.5 0.0 1.9 13.4 1.1 2.3 140.2 0.9 5.4 3.6 1.8 2.3 1.6 3.4 4.8 66.7 3.7 1.8 25.4 4.9 2.7 0.0 1.0 3.5 4.3 1.1 3.5 2.5 0.6 28.6 0.0 2.1 52.4 42.1 1.3 1.1 2.6 5.9 0.7 C22orf23 "EVG1, FLJ32787, LOC84645" ENSG00000128346 "Chromosome 22 open reading frame 23" Q9BZE7 22 37943050-37953669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "testis: 189.0" "Group enriched" "Detected in some" 4 "Early spermatids: 211.4;Late spermatids: 246.7;Spermatocytes: 159.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HaCaT: 17.1;U-138 MG: 17.6;U-87 MG: 26.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000650 Approved Nucleoplasm NA NA Nucleoplasm "HPA000650: AB_2732391" "unprognostic (6.09e-3)" "unprognostic (3.02e-1)" "unprognostic (1.09e-1)" "unprognostic (2.99e-2)" "unprognostic (1.95e-1)" "unprognostic (1.80e-1)" "unprognostic (7.42e-5)" "unprognostic (1.50e-2)" "unprognostic (2.60e-1)" "unprognostic (2.72e-2)" "unprognostic (1.04e-1)" "unprognostic (5.80e-2)" "unprognostic (8.18e-3)" "unprognostic (4.21e-1)" "unprognostic (1.09e-1)" "unprognostic (1.82e-2)" "unprognostic (8.46e-2)" 0.9 0.9 1.3 2.0 1.8 0.7 0.8 1.7 3.3 1.2 4.1 2.8 0.8 0.8 3.7 2.8 6.1 6.0 2.5 1.8 1.7 1.7 1.2 1.1 2.7 1.0 1.9 2.0 2.2 3.4 0.1 2.2 2.0 5.5 1.8 0.0 2.0 4.1 1.4 1.8 11.3 1.2 1.2 3.2 0.8 3.8 189.0 1.2 0.8 3.4 0.9 0.9 5.2 1.6 0.7 0.3 0.9 0.2 0.1 1.4 0.2 3.5 2.8 6.2 5.7 0.1 0.2 7.6 9.8 0.3 0.3 0.4 3.3 3.2 1.8 2.9 0.2 6.4 17.1 0.2 0.1 0.3 3.5 7.3 1.0 2.3 2.3 0.2 2.8 2.5 0.2 0.1 1.1 0.1 8.6 0.0 1.4 1.2 1.1 0.0 2.2 0.1 1.7 0.9 3.5 2.5 3.3 8.8 0.7 0.1 15.6 3.1 2.3 4.6 1.7 5.5 10.4 2.1 3.9 14.9 17.6 5.9 13.7 5.2 2.5 1.1 0.9 26.5 1.3 9.9 0.9 0.1 0.0 1.3 0.2 1.4 0.7 0.3 0.1 0.0 0.7 0.0 0.1 0.2 0.1 0.0 0.3 0.0 0.2 1.3 1.8 1.7 1.8 1.7 1.7 1.9 2.0 5.5 1.2 0.0 3.7 0.0 0.1 0.2 0.1 0.0 0.0 50.9 2.3 0.0 0.0 0.1 1.7 0.3 211.4 0.0 0.0 0.0 0.3 0.1 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 246.7 6.4 0.0 0.0 0.0 0.0 2.0 0.2 0.0 4.9 1.4 0.5 0.0 0.0 159.9 4.3 0.0 0.0 0.0 0.0 0.0 C22orf46 "CTA-216E10.6, FLJ23584" ENSG00000184208 "Chromosome 22 open reading frame 46" C9J442 22 41688939-41698136 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 19.8" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 65.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" HPA052741 Uncertain Approved Nucleoplasm,Nucleoli "Secreted - unknown location" NA NA Nucleoplasm Nucleoli "HPA052741: AB_2681933" "unprognostic (3.76e-2)" "unprognostic (3.13e-2)" "unprognostic (1.45e-2)" "prognostic favorable (4.70e-4)" "unprognostic (1.56e-1)" "unprognostic (6.02e-3)" "unprognostic (2.61e-1)" "unprognostic (5.43e-2)" "unprognostic (2.22e-1)" "unprognostic (8.38e-2)" "unprognostic (3.32e-2)" "unprognostic (7.03e-2)" "unprognostic (1.20e-1)" "unprognostic (3.31e-2)" "unprognostic (1.42e-1)" "unprognostic (1.29e-1)" "unprognostic (1.62e-1)" 3.9 2.0 8.1 3.1 6.8 1.0 3.9 2.2 5.7 2.7 2.4 2.3 3.1 4.5 1.7 2.4 2.7 4.8 8.7 7.5 2.7 2.3 2.2 3.1 12.8 5.2 1.4 8.3 3.5 2.1 3.3 2.8 2.8 3.0 3.3 3.3 2.6 2.9 19.8 2.8 2.4 6.2 3.5 3.1 2.2 1.5 1.1 0.4 0.1 2.6 3.5 1.2 0.7 8.8 4.5 11.1 6.8 8.2 8.7 10.1 7.5 8.1 6.4 8.6 4.5 5.8 5.5 5.5 6.2 6.3 4.1 5.7 5.8 7.7 19.7 5.4 6.1 9.4 3.8 4.8 4.5 12.0 6.9 7.8 10.7 7.6 4.9 1.6 8.6 9.9 8.2 5.6 14.6 3.5 5.5 4.5 13.4 3.5 5.1 9.2 6.1 5.4 6.1 2.7 4.2 8.7 7.9 11.3 8.5 9.0 5.5 4.3 8.4 14.4 4.4 3.9 17.5 17.8 5.1 5.0 5.5 11.4 0.1 0.5 0.0 0.7 0.4 0.9 1.1 1.1 1.1 0.2 0.5 0.9 1.2 0.1 3.5 2.6 0.4 0.7 0.7 11.9 16.5 7.1 3.9 1.9 9.4 18.9 5.1 8.1 11.4 7.0 13.7 8.3 1.7 4.2 65.6 7.1 8.4 0.0 4.2 5.8 4.9 2.0 7.0 4.0 4.2 3.2 2.9 9.2 7.3 8.2 4.9 8.3 1.7 9.0 7.2 9.7 3.7 3.7 6.0 1.3 6.2 0.0 3.5 12.0 11.5 2.3 7.1 15.8 4.0 1.4 C2CD2 "C21orf25, C21orf258, DKFZP586F0422, TMEM24L" ENSG00000157617 "C2 calcium dependent domain containing 2" Q9Y426 21 41885112-41953890 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 56.9" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 51.0;Cone photoreceptor cells: 78.5;Ito cells: 42.4;Rod photoreceptor cells: 35.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 38.7;SK-BR-3: 21.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030922, HPA030924" Enhanced Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA030922: AB_2673660, HPA030924: AB_10669873" "unprognostic (3.02e-3)" "unprognostic (3.69e-2)" "unprognostic (2.21e-2)" "unprognostic (9.63e-2)" "unprognostic (3.15e-3)" "unprognostic (2.93e-2)" "unprognostic (2.39e-2)" "unprognostic (3.44e-2)" "unprognostic (3.00e-2)" "unprognostic (4.39e-2)" "unprognostic (2.43e-1)" "unprognostic (2.38e-1)" "prognostic unfavorable (7.68e-5)" "unprognostic (1.99e-1)" "unprognostic (4.56e-2)" "unprognostic (1.06e-2)" "unprognostic (1.48e-1)" 23.9 56.9 5.4 6.1 8.0 1.1 21.0 2.7 7.0 5.8 5.8 7.6 10.9 3.5 6.3 6.1 5.4 4.9 7.8 3.6 5.9 5.1 5.3 4.2 9.6 9.1 12.8 4.5 11.7 10.7 19.4 3.8 4.2 10.9 8.8 4.3 11.8 8.1 9.4 2.7 10.1 4.4 5.6 11.7 20.7 5.7 2.7 9.1 5.7 4.8 3.9 5.3 7.0 23.9 1.1 1.4 0.9 1.3 1.9 2.8 0.7 6.1 2.6 1.8 4.2 38.7 10.7 7.2 4.3 6.8 2.7 2.5 4.0 7.0 0.1 2.4 8.4 6.7 0.7 6.5 4.5 3.5 0.4 2.9 1.1 3.2 3.2 5.2 0.4 0.0 6.8 4.2 14.5 5.7 6.0 12.8 0.3 3.8 0.0 7.2 0.5 0.9 1.2 10.2 2.6 8.9 0.6 2.7 3.7 4.0 13.0 3.0 1.3 4.7 21.3 3.8 3.8 5.6 2.7 4.4 6.5 0.9 2.1 3.5 2.4 3.5 0.5 19.0 3.6 1.3 0.0 1.3 0.0 1.3 0.8 0.5 0.5 1.2 0.5 1.4 1.1 2.8 1.6 0.9 1.9 0.7 0.2 1.5 0.7 5.4 8.0 2.7 7.0 5.9 5.1 12.8 4.5 10.9 9.1 3.0 13.3 6.4 6.8 3.7 51.0 2.0 5.1 4.0 5.7 3.5 78.5 9.6 0.0 5.0 0.1 12.0 2.3 0.0 7.1 3.7 6.1 12.9 0.0 4.5 3.2 1.6 4.7 42.4 7.8 0.0 3.4 2.9 1.7 0.0 7.3 3.5 7.9 6.8 2.1 2.8 35.1 12.9 15.6 0.0 2.3 2.3 7.8 1.7 7.1 12.4 C2CD2L "KIAA0285, TMEM24" ENSG00000172375 "C2CD2 like" O14523 11 119102198-119118544 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.1" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 35.3;Rod photoreceptor cells: 29.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HMC-1: 29.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011044 Approved Approved "Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol" NA NA "Nucleoplasm, Nucleoli" "Nuclear membrane, Cytosol" "HPA011044: AB_2668414" "unprognostic (3.43e-2)" "unprognostic (2.81e-2)" "unprognostic (1.03e-3)" "prognostic favorable (4.92e-4)" "unprognostic (3.18e-2)" "unprognostic (1.19e-1)" "unprognostic (2.25e-3)" "unprognostic (3.37e-3)" "unprognostic (5.28e-2)" "unprognostic (2.09e-1)" "unprognostic (3.99e-3)" "unprognostic (8.19e-2)" "prognostic unfavorable (1.75e-4)" "unprognostic (8.02e-2)" "unprognostic (8.32e-3)" "unprognostic (4.10e-2)" "unprognostic (2.60e-1)" 5.2 7.0 15.9 7.3 33.1 14.7 4.8 18.2 31.2 5.8 10.3 7.5 8.3 18.7 4.1 6.1 9.4 10.9 6.3 7.9 15.8 13.6 6.3 7.3 8.3 8.5 9.1 12.6 3.9 7.5 7.8 14.2 4.8 11.7 4.8 8.8 5.6 8.7 7.0 8.3 12.5 19.4 6.1 7.3 9.2 5.5 2.6 9.1 7.0 5.5 6.7 6.6 6.6 5.3 0.4 1.1 5.7 4.2 1.7 1.6 1.1 3.4 2.5 3.5 7.2 4.6 1.9 2.2 5.2 4.6 5.2 4.4 4.1 3.6 5.2 13.7 3.6 5.3 7.7 4.4 2.2 2.1 8.1 3.7 20.4 3.3 2.9 6.1 5.8 29.8 2.3 4.6 9.7 3.6 5.7 3.2 7.8 8.4 9.3 4.8 9.1 6.5 14.1 1.3 8.4 6.9 4.1 3.2 5.9 5.1 2.2 11.0 6.2 2.2 11.7 3.3 1.4 20.6 7.8 3.9 4.8 1.6 5.7 9.1 4.1 2.4 2.0 3.0 10.1 5.3 1.1 3.0 5.7 0.6 3.2 1.0 0.4 1.4 1.4 1.1 0.1 1.6 0.8 1.0 1.7 4.2 0.7 1.6 1.1 15.9 33.1 18.2 31.2 15.8 13.6 9.1 12.6 11.7 9.1 6.0 6.2 2.2 1.4 9.5 14.6 2.0 2.5 13.4 4.5 1.8 35.3 0.8 3.3 2.8 2.6 5.0 25.7 0.0 2.4 1.2 2.0 2.9 2.3 4.3 7.9 20.6 1.2 15.4 12.9 1.5 2.0 9.7 6.8 7.2 5.5 4.8 4.2 10.1 1.4 3.3 29.7 6.5 3.1 2.3 1.9 9.5 0.9 8.7 4.5 1.6 C2CD3 DKFZP586P0123 ENSG00000168014 "C2 calcium dependent domain containing 3" Q4AC94 11 74012714-74171210 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 65.5;Alveolar cells type 2: 98.8;Ciliated cells: 88.3;Club cells: 61.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 14.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 39.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038552, HPA038553, HPA040433" Approved Approved "Nucleoplasm,Centriolar satellite" NA NA "Nucleoplasm, Centriolar satellite" "HPA038552: AB_10669542, HPA038553: AB_2676080, HPA040433: AB_2676981" "unprognostic (3.94e-1)" "unprognostic (7.89e-2)" "unprognostic (3.68e-2)" "unprognostic (8.86e-3)" "unprognostic (1.31e-1)" "unprognostic (1.18e-1)" "unprognostic (8.48e-5)" "unprognostic (1.99e-1)" "unprognostic (4.96e-3)" "unprognostic (2.20e-1)" "unprognostic (1.74e-1)" "unprognostic (5.86e-2)" "unprognostic (2.21e-1)" "unprognostic (1.91e-1)" "unprognostic (3.11e-1)" "unprognostic (1.18e-1)" "unprognostic (2.92e-1)" 7.4 11.9 10.5 13.5 11.2 17.3 8.4 14.9 11.8 8.1 6.8 14.3 4.4 6.3 10.9 10.3 7.8 12.5 6.4 8.3 9.6 6.5 8.5 8.4 9.7 8.5 12.0 8.1 10.2 6.9 17.5 15.0 13.5 11.4 8.6 9.0 10.4 8.5 7.9 6.9 9.7 7.3 7.2 11.3 10.0 7.7 19.9 13.2 16.7 13.1 4.2 12.1 8.1 9.7 5.3 2.0 14.8 3.2 3.3 2.6 0.5 5.7 11.3 8.4 10.1 4.9 4.4 3.9 8.4 6.0 11.0 9.6 15.8 4.6 5.9 6.2 5.1 10.4 10.2 9.3 4.0 13.0 9.8 4.7 8.6 12.7 6.2 5.3 9.7 13.5 3.2 3.8 11.5 6.8 3.9 6.9 7.7 8.6 11.6 9.6 5.5 10.4 5.2 5.8 10.3 5.5 8.9 39.4 6.4 3.2 9.2 10.1 6.5 15.9 5.6 12.6 7.8 9.7 5.3 7.4 7.9 12.2 8.3 7.4 9.0 6.2 18.4 2.7 5.8 8.7 14.8 1.9 2.2 2.6 2.2 2.2 2.3 1.5 2.1 1.0 5.3 2.0 1.9 13.1 3.3 3.2 2.0 1.0 0.5 10.5 11.2 14.9 11.8 9.6 6.5 12.0 8.1 11.4 13.2 65.5 98.8 2.7 3.4 4.6 8.1 4.2 2.5 88.3 61.4 8.7 3.9 3.1 0.0 3.3 25.7 5.3 4.3 0.0 2.2 2.1 3.3 4.0 33.7 2.4 4.3 11.1 7.5 6.2 7.8 19.0 4.0 7.4 6.8 3.6 4.5 6.3 3.0 2.9 6.0 1.2 13.8 6.5 4.1 9.9 6.5 4.0 1.9 9.6 5.2 2.3 C2orf16 DKFZp434G118 ENSG00000221843 "Chromosome 2 open reading frame 16" Q68DN1 2 27537386-27582721 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 22.3" "Cell type enriched" "Detected in some" 10 "Early spermatids: 68.8" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "classical monocyte: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SCLC-21H: 6.3;SiHa: 4.5" "Not detected" "Not detected" "HPA052136, HPA056962" Uncertain Approved "Nucleoplasm,Nuclear bodies" No No "Nuclear bodies" Nucleoplasm "HPA052136: AB_2681742, HPA056962: AB_2683290" "unprognostic (4.32e-2)" "unprognostic (1.08e-2)" "unprognostic (8.36e-2)" "unprognostic (3.40e-3)" "unprognostic (6.36e-2)" "unprognostic (6.17e-2)" "unprognostic (6.15e-2)" "unprognostic (3.07e-1)" "unprognostic (9.35e-2)" "unprognostic (3.79e-3)" "unprognostic (4.59e-1)" "unprognostic (2.19e-2)" "unprognostic (8.82e-2)" "unprognostic (8.00e-2)" "unprognostic (1.44e-1)" "unprognostic (1.46e-2)" "unprognostic (8.53e-3)" 0.2 0.5 0.2 0.2 0.2 0.0 0.2 0.2 0.7 0.2 0.2 0.2 0.2 0.2 0.2 1.0 0.5 0.1 0.4 0.5 0.2 0.2 0.2 0.9 0.2 0.2 0.2 0.2 0.4 0.4 0.0 0.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.6 22.3 0.2 0.2 0.7 0.2 0.2 0.4 0.2 0.0 0.3 0.3 1.0 0.0 0.6 0.1 1.6 1.6 2.3 1.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.2 2.1 0.8 2.0 0.0 1.5 0.5 0.0 0.0 0.0 1.4 0.4 3.0 1.2 1.6 0.0 1.7 1.3 0.0 0.0 0.2 0.0 1.1 0.2 0.9 1.2 2.2 0.1 0.4 0.0 0.8 0.4 0.8 0.0 1.2 1.3 0.6 0.0 1.5 6.3 1.1 4.5 1.2 0.6 0.4 1.0 1.1 2.7 1.5 2.1 1.0 1.0 0.4 0.0 1.9 0.5 0.3 2.1 0.0 1.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.3 0.0 0.8 0.2 0.0 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 68.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 6.8 0.6 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.4 0.0 1.7 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 C2orf42 FLJ20558 ENSG00000115998 "Chromosome 2 open reading frame 42" Q9NWW7 2 70149880-70248615 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 41.2" "Cell type enhanced" "Detected in many" 20 "Early spermatids: 194.1;Late spermatids: 86.2;Spermatocytes: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031840, HPA031841, HPA031842" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA031840: AB_2674066, HPA031841: AB_10601124, HPA031842: AB_2674068" "unprognostic (8.49e-2)" "unprognostic (2.09e-1)" "unprognostic (2.52e-1)" "unprognostic (1.03e-1)" "unprognostic (1.51e-1)" "unprognostic (3.41e-1)" "unprognostic (1.92e-1)" "unprognostic (2.20e-3)" "unprognostic (2.26e-1)" "unprognostic (3.73e-1)" "prognostic favorable (5.94e-5)" "unprognostic (4.66e-2)" "unprognostic (9.41e-2)" "unprognostic (2.11e-2)" "unprognostic (1.43e-1)" "unprognostic (2.84e-1)" "unprognostic (2.49e-3)" 6.2 5.9 6.2 4.3 8.7 3.1 6.8 10.7 11.8 6.4 4.5 11.5 6.6 3.2 6.6 8.5 5.0 8.7 5.7 4.2 7.2 6.4 6.3 11.2 4.5 8.2 7.3 6.2 8.3 5.0 8.6 8.2 5.9 6.7 5.0 4.0 7.4 4.6 5.8 4.8 4.9 4.6 5.8 6.1 6.7 4.4 41.2 8.2 9.7 6.2 2.1 8.3 6.2 7.5 12.8 6.6 8.0 6.6 17.9 14.2 9.0 4.9 8.4 8.0 7.2 15.9 9.8 9.0 12.0 8.0 10.1 8.4 6.4 4.6 6.2 7.0 7.5 16.1 7.0 8.1 6.8 10.7 11.0 7.2 7.5 5.9 6.4 14.2 6.2 7.6 11.6 13.0 9.2 11.9 10.5 9.3 8.2 6.3 24.8 12.7 4.7 8.0 8.8 5.6 8.4 9.0 7.7 10.7 11.5 8.2 6.0 6.6 6.6 6.4 11.0 12.1 5.7 4.7 7.5 7.2 8.8 6.1 8.1 9.6 13.3 13.2 6.4 7.2 10.0 7.7 1.9 6.6 8.0 11.2 6.1 14.2 12.8 11.4 13.4 6.6 11.5 13.2 13.7 7.0 17.9 6.1 6.0 12.6 9.0 6.2 8.7 10.7 11.8 7.2 6.4 7.3 6.2 6.7 8.2 0.0 2.1 11.8 2.6 2.3 6.6 2.4 0.0 5.3 1.2 5.2 0.0 7.4 6.6 3.1 194.1 2.6 2.9 0.0 2.1 3.0 4.0 2.7 2.3 5.8 3.8 0.0 1.2 5.5 3.5 86.2 6.9 2.7 3.3 1.0 2.2 7.0 1.7 2.9 7.4 5.4 3.9 0.0 3.1 42.3 11.7 3.8 8.0 6.4 2.1 1.8 C2orf49 "asw, MGC5509" ENSG00000135974 "Chromosome 2 open reading frame 49" Q9BVC5 2 105337359-105349211 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043846, HPA060814" Approved Supported Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA043846: AB_2678698, HPA060814: AB_2684372" "unprognostic (4.19e-2)" "unprognostic (1.49e-1)" "unprognostic (3.06e-1)" "unprognostic (6.16e-3)" "unprognostic (2.57e-3)" "unprognostic (8.75e-3)" "unprognostic (1.89e-3)" "unprognostic (6.51e-2)" "unprognostic (5.01e-2)" "unprognostic (2.07e-1)" "unprognostic (2.56e-1)" "unprognostic (5.94e-2)" "prognostic unfavorable (5.06e-5)" "unprognostic (1.22e-1)" "unprognostic (1.22e-1)" "unprognostic (1.39e-1)" "unprognostic (6.04e-2)" 15.9 14.8 17.2 15.8 20.4 24.3 17.3 25.6 22.4 19.7 15.0 21.9 19.9 13.4 22.0 13.5 18.6 19.0 14.2 21.3 20.0 16.0 13.4 15.0 14.0 16.9 25.3 19.9 30.7 19.3 13.0 12.0 19.2 18.1 17.2 15.1 12.4 15.9 17.2 28.2 14.3 14.8 18.3 22.9 15.3 19.7 19.2 22.1 26.5 18.8 13.1 18.8 18.1 21.2 16.7 18.4 17.9 13.5 8.2 11.7 6.4 13.6 9.8 12.4 12.5 13.9 17.2 22.1 13.8 14.4 12.2 16.8 21.3 13.7 16.2 17.3 11.8 33.0 13.2 16.9 11.7 15.9 21.0 12.9 17.5 8.4 16.4 17.2 14.5 14.5 12.4 20.5 17.2 15.7 17.5 10.9 12.8 24.3 13.4 17.1 10.7 17.6 16.8 16.2 9.2 11.8 11.8 18.2 18.5 13.7 13.2 14.7 11.7 12.2 11.1 16.1 14.4 10.9 16.4 17.9 13.0 18.3 9.2 11.1 17.0 13.8 17.0 13.0 14.8 12.5 10.2 13.5 11.1 9.4 7.9 9.2 14.3 10.5 9.1 8.8 16.7 11.7 9.8 17.9 8.2 10.6 18.4 11.6 6.4 17.2 20.4 25.6 22.4 20.0 16.0 25.3 19.9 18.1 22.1 14.9 11.0 27.3 12.2 25.8 36.0 25.4 12.7 46.8 22.7 24.4 27.5 18.6 21.6 19.7 30.9 16.9 14.7 0.0 15.8 23.4 13.6 10.4 16.1 19.5 14.3 22.3 10.9 14.1 13.6 30.0 25.6 16.2 6.8 13.6 15.0 37.4 19.7 15.2 27.3 14.3 42.6 19.4 15.5 29.7 29.0 21.7 30.8 18.1 13.6 14.8 C2orf54 FLJ22671 ENSG00000172478 "Chromosome 2 open reading frame 54" Q08AI8 2 240886048-240896889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 63.8;lymphoid tissue: 28.6;tongue: 35.5" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 50.6;Intestinal endocrine cells: 48.2;Paneth cells: 56.1;Suprabasal keratinocytes: 22.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "NK-cell: 3.4" "Lineage enriched" "Detected in single" 4 "NK-cells: 3.4" "Group enriched" "Detected in some" 6 "CACO-2: 21.6;HaCaT: 16.2;SK-BR-3: 57.4" "Not detected" "Not detected" HPA052722 Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA052722: " "unprognostic (5.86e-3)" "unprognostic (4.17e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (2.77e-4)" "unprognostic (1.43e-2)" "unprognostic (1.33e-1)" "unprognostic (8.95e-2)" "unprognostic (1.70e-1)" "unprognostic (1.89e-2)" "unprognostic (2.83e-2)" "unprognostic (2.96e-1)" "unprognostic (2.08e-1)" "unprognostic (6.46e-2)" "unprognostic (1.55e-1)" "unprognostic (8.26e-2)" "unprognostic (2.05e-1)" 0.3 0.0 0.3 1.5 0.3 0.0 0.9 0.3 0.3 8.9 3.9 0.3 0.3 6.3 0.7 0.4 63.8 0.3 0.3 0.3 0.3 0.0 2.8 2.8 5.5 0.3 0.3 0.3 0.3 0.4 0.0 0.3 0.7 0.3 0.5 1.1 0.3 7.6 0.3 0.3 18.6 3.6 0.3 0.3 0.3 1.0 0.3 0.3 1.0 0.3 35.5 28.6 0.8 19.1 0.8 0.1 0.7 0.2 3.4 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 21.6 1.4 0.1 0.1 0.0 0.0 16.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.6 0.0 0.0 0.1 3.3 0.0 0.0 0.0 5.3 0.1 3.2 1.0 0.0 0.0 57.4 0.0 0.0 0.4 0.2 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.1 0.2 0.0 0.3 0.5 0.0 0.1 0.8 0.1 0.2 0.1 3.4 0.2 0.0 0.2 0.1 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 50.6 1.7 0.0 0.8 2.5 0.0 0.3 0.0 1.4 10.3 1.8 0.0 1.1 5.0 1.4 0.0 0.0 2.1 0.0 3.2 0.1 0.4 1.3 0.0 3.4 0.0 0.0 48.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 3.5 0.0 10.5 56.1 0.0 12.6 0.0 0.0 0.2 0.0 0.0 22.7 0.2 0.0 1.2 6.3 C2orf66 UNQ6411 ENSG00000187944 "Chromosome 2 open reading frame 66" Q6UXQ4 2 196805002-196810276 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "adipose tissue: 7.0;pituitary gland: 6.4" "Cell type enriched" "Detected in some" 12 "Early spermatids: 27.1" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HEL: 9.4;RT4: 3.5;TIME: 3.9" HPA020869 Uncertain Uncertain Nucleoplasm,Cytosol "Secreted - unknown location" NA NA Nucleoplasm Cytosol "HPA020869: AB_1851545" "unprognostic (1.19e-1)" "unprognostic (4.85e-2)" "unprognostic (6.95e-2)" "unprognostic (1.19e-1)" "unprognostic (3.48e-2)" "unprognostic (1.61e-2)" "unprognostic (6.80e-3)" "unprognostic (3.05e-2)" "unprognostic (1.95e-1)" "unprognostic (4.10e-3)" "unprognostic (4.54e-4)" "unprognostic (1.98e-1)" "unprognostic (1.75e-5)" "unprognostic (1.84e-1)" "unprognostic (2.30e-1)" "unprognostic (1.38e-2)" "unprognostic (1.86e-2)" 7.0 4.0 0.4 0.2 0.7 0.2 1.0 0.1 0.4 0.0 0.2 0.0 0.1 1.2 0.1 1.1 0.4 0.7 0.4 2.8 0.3 0.0 0.2 0.0 0.7 0.3 0.6 0.0 6.4 0.1 0.3 0.4 0.0 0.2 0.0 2.8 0.3 0.1 0.0 0.2 0.0 2.6 0.1 0.2 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.4 0.1 0.1 0.4 1.1 0.5 0.3 0.0 0.5 0.2 0.2 0.3 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.0 1.1 0.2 0.3 0.6 9.4 1.0 0.1 0.0 0.1 0.8 0.7 1.4 0.2 0.2 0.2 0.8 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.2 3.5 0.4 0.2 0.0 0.1 0.1 0.4 0.0 0.0 3.9 0.3 0.3 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 C2orf68 ENSG00000168887 "Chromosome 2 open reading frame 68" Q2NKX9 2 85606654-85612066 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051143 Uncertain Approved "Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria" NA NA "Nucleoplasm, Nuclear membrane, Mitochondria" Nucleoli "HPA051143: AB_2681360" "unprognostic (1.71e-2)" "unprognostic (3.65e-2)" "unprognostic (1.07e-2)" "prognostic unfavorable (1.12e-6)" "unprognostic (9.34e-2)" "unprognostic (2.16e-1)" "prognostic unfavorable (6.76e-6)" "unprognostic (4.24e-3)" "unprognostic (8.41e-2)" "unprognostic (2.34e-1)" "unprognostic (2.88e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (1.11e-6)" "unprognostic (1.18e-1)" "unprognostic (1.76e-1)" "unprognostic (3.70e-2)" "unprognostic (8.81e-3)" 10.7 9.8 7.0 17.4 12.3 11.5 16.5 16.6 9.9 16.5 15.2 17.2 17.7 13.1 17.1 15.0 13.6 14.3 16.2 13.7 7.7 6.6 13.5 16.8 17.5 15.6 16.1 7.2 22.2 25.4 13.3 14.6 21.8 11.4 16.5 14.1 10.8 20.6 20.6 23.3 18.6 18.5 14.8 10.9 17.5 13.4 15.1 12.3 37.1 17.2 20.4 17.6 15.2 17.0 15.4 16.5 36.1 22.7 19.2 20.1 9.5 8.6 8.1 13.3 10.0 13.7 6.8 9.0 4.0 5.3 6.7 8.9 7.3 10.6 11.8 6.1 7.3 6.2 9.6 7.3 8.0 7.2 6.2 15.3 20.2 11.9 7.6 11.3 10.8 10.7 10.4 9.3 5.0 13.3 9.7 10.9 13.2 10.2 13.3 6.4 9.9 12.3 10.6 6.4 10.6 7.0 13.8 25.4 11.6 8.6 9.2 17.1 12.3 6.2 8.3 8.0 8.2 9.4 5.5 6.4 4.8 13.3 5.4 3.8 17.2 12.0 11.0 7.1 11.0 5.8 18.0 22.7 36.1 15.4 15.0 14.5 10.9 14.7 14.5 16.5 15.4 20.1 18.7 36.1 19.2 16.9 10.6 11.9 9.5 7.0 12.3 16.6 9.9 7.7 6.6 16.1 7.2 11.4 12.3 59.6 76.5 21.4 16.8 5.3 17.5 9.3 38.2 25.4 34.2 33.2 33.4 38.5 14.9 14.0 3.3 9.0 23.5 0.0 17.1 14.2 11.3 12.3 32.5 19.2 20.3 23.8 18.5 19.0 31.3 7.0 22.5 24.2 13.5 14.4 15.8 10.8 17.3 10.5 12.7 19.2 23.7 19.4 7.6 37.2 20.6 8.5 20.8 28.0 16.8 17.6 C2orf72 LOC257407 ENSG00000204128 "Chromosome 2 open reading frame 72" A6NCS6 2 231037490-231049719 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 22.5;placenta: 23.9" "Cell type enhanced" "Detected in many" 16 "Cholangiocytes: 33.1;Hepatocytes: 111.5;Paneth cells: 62.8" "Cancer enhanced" "Detected in many" "liver cancer: 40.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 13.1;CACO-2: 3.0;EFO-21: 4.9;OE19: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044962 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA044962: AB_10960863" "unprognostic (4.90e-2)" "unprognostic (7.03e-2)" "unprognostic (2.15e-1)" "unprognostic (7.44e-3)" "unprognostic (2.88e-2)" "unprognostic (6.41e-2)" "unprognostic (3.38e-1)" "unprognostic (6.51e-2)" "unprognostic (6.25e-3)" "unprognostic (1.84e-1)" "prognostic favorable (5.27e-4)" "unprognostic (2.65e-1)" "prognostic unfavorable (4.74e-4)" "unprognostic (2.78e-1)" "unprognostic (7.23e-3)" "unprognostic (2.70e-2)" "unprognostic (5.19e-2)" 1.0 0.9 6.5 0.9 8.4 0.8 1.6 1.7 10.1 0.8 7.8 9.9 0.0 2.3 0.8 1.1 0.9 0.9 1.8 0.8 7.7 4.7 1.4 22.5 1.2 0.8 5.1 7.9 0.8 6.1 1.7 1.7 23.9 8.2 2.0 2.5 0.8 1.0 0.9 0.8 0.8 2.6 1.0 2.2 0.8 4.2 0.9 5.9 0.0 0.8 0.0 0.8 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.0 0.0 13.1 0.0 0.0 0.1 0.0 3.0 0.0 0.0 4.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 5.6 0.1 0.0 0.0 0.3 0.0 0.0 0.1 2.2 0.1 1.5 0.8 0.8 0.9 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 8.4 1.7 10.1 7.7 4.7 5.1 7.9 8.2 5.9 0.0 0.0 1.9 0.0 0.1 0.6 0.3 33.1 0.0 0.0 0.0 0.0 1.4 1.7 2.0 7.3 0.0 15.3 0.0 1.8 9.0 0.0 0.9 0.0 111.5 0.5 0.0 4.7 3.7 2.5 25.8 0.3 0.0 1.7 0.0 13.2 9.7 1.0 62.8 3.9 1.4 0.3 0.0 0.1 0.5 0.9 0.0 4.3 0.0 24.3 0.1 C2orf81 "hCG40743, LOC388963" ENSG00000284308 "Chromosome 2 open reading frame 81" 2 74414176-74421591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 17.9;testis: 20.0" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 17.4;Early spermatids: 35.6;Late spermatids: 23.4;Spermatocytes: 16.4" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 13.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 12.2;RPMI-8226: 11.6;SCLC-21H: 15.2;SH-SY5Y: 16.5" "HPA049564, HPA054835" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA049564: , HPA054835: AB_2682620" 0.4 0.9 2.2 1.2 5.5 0.5 0.9 1.2 3.4 1.3 0.8 2.6 8.2 0.9 2.2 4.9 1.6 17.9 2.0 0.7 2.1 1.9 0.0 2.5 3.0 0.0 2.8 3.2 1.6 4.9 13.7 1.0 1.9 1.8 0.2 3.2 1.3 3.5 0.8 0.3 1.1 0.7 0.0 2.1 1.7 20.0 0.8 5.3 2.1 0.7 1.9 1.9 0.0 6.5 13.2 0.2 1.8 3.1 3.4 1.3 3.5 6.6 2.0 7.4 2.3 1.9 0.7 0.6 2.2 0.6 0.7 0.4 4.1 8.6 1.6 1.0 1.8 1.3 0.1 1.7 0.7 4.8 0.5 0.9 0.5 0.1 1.1 1.8 1.9 1.1 4.4 0.9 0.9 2.6 0.0 4.7 0.3 1.4 1.1 12.2 2.2 4.5 4.0 2.1 1.5 1.1 0.7 11.6 2.6 1.5 15.2 16.5 2.1 3.3 0.9 0.3 3.1 1.6 0.1 0.7 3.3 2.3 1.8 3.2 5.6 2.8 4.6 1.7 1.5 0.1 1.8 0.0 0.6 1.8 0.3 5.7 0.7 0.8 6.2 6.5 3.4 1.5 0.2 3.1 1.4 13.2 0.6 1.3 0.0 3.7 0.0 1.0 0.6 0.6 1.1 2.5 17.4 4.5 3.5 0.0 0.0 5.0 2.9 35.6 1.4 0.1 0.0 1.9 0.0 2.1 0.6 0.0 0.0 0.0 3.2 6.9 2.5 2.1 23.4 3.1 3.0 3.3 9.0 1.6 4.8 2.0 0.0 7.1 4.2 3.5 6.5 3.9 16.4 1.5 0.6 0.0 0.0 1.1 0.2 C2orf91 ENSG00000205086 "Chromosome 2 open reading frame 91" Q6ZV80 2 41935368-41954266 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.1;lung: 4.7" "Cell type enhanced" "Detected in single" 22 "Alveolar cells type 1: 3.0" "Cancer enriched" "Detected in single" 9 "testis cancer: 0.8" "Region enhanced" "Detected in some" "midbrain: 5.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "AN3-CA: 5.2;HDLM-2: 17.9" HPA042517 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center, Cytosol" Nucleoplasm "HPA042517: AB_10795508" "unprognostic (9.49e-3)" "unprognostic (2.24e-2)" "unprognostic (1.73e-1)" "unprognostic (9.61e-2)" "unprognostic (2.58e-1)" "unprognostic (8.04e-2)" "unprognostic (1.01e-1)" "unprognostic (2.13e-2)" "unprognostic (3.37e-1)" "unprognostic (3.92e-2)" "unprognostic (1.16e-1)" "unprognostic (4.79e-2)" "unprognostic (1.08e-2)" "unprognostic (2.91e-2)" "unprognostic (7.61e-2)" "unprognostic (2.78e-2)" "unprognostic (1.47e-1)" 0.3 2.1 0.3 0.3 1.3 1.5 0.3 0.3 0.8 0.4 0.3 0.8 0.2 0.0 0.4 1.0 0.3 0.3 0.3 0.5 0.3 0.4 0.9 0.3 4.7 0.9 5.1 0.2 0.4 0.4 0.4 0.5 0.2 1.9 0.8 0.2 0.8 3.5 0.2 0.2 1.3 0.3 0.2 2.2 0.6 1.3 1.1 0.2 0.2 0.2 0.2 0.6 0.2 0.3 1.2 1.4 2.8 1.2 1.2 0.9 0.3 0.2 0.4 0.7 5.2 0.2 0.1 0.3 0.1 0.1 0.0 0.3 0.4 0.3 0.3 0.3 0.2 0.2 0.2 0.0 0.1 0.1 17.9 0.3 0.2 0.4 0.1 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 1.8 0.1 0.3 0.1 0.1 0.3 0.4 0.1 0.0 0.6 0.1 0.1 0.3 0.2 1.8 0.0 0.0 0.2 0.9 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.5 0.1 0.2 0.2 0.0 0.2 1.3 1.2 1.4 0.6 0.9 0.5 0.6 0.7 0.5 1.4 1.2 0.7 0.9 2.8 1.2 1.0 1.3 0.4 0.3 0.3 1.3 0.3 0.8 0.3 0.4 5.1 0.2 1.9 0.2 3.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.3 0.1 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 C3orf33 "AC3-33, FLJ31139" ENSG00000174928 "Chromosome 3 open reading frame 33" Q6P1S2 3 155762617-155806351 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 17.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037663 Uncertain Approved Nucleoplasm,Cytosol "Secreted - unknown location" NA NA Nucleoplasm Cytosol "HPA037663: AB_10672610" "unprognostic (1.18e-1)" "unprognostic (9.39e-3)" "unprognostic (1.48e-1)" "unprognostic (1.66e-3)" "unprognostic (1.31e-1)" "unprognostic (7.27e-2)" "unprognostic (6.31e-3)" "unprognostic (3.28e-2)" "unprognostic (1.56e-1)" "unprognostic (5.47e-2)" "unprognostic (1.10e-1)" "unprognostic (2.70e-1)" "prognostic favorable (6.48e-7)" "unprognostic (3.19e-1)" "unprognostic (1.79e-1)" "unprognostic (2.24e-2)" "unprognostic (1.56e-1)" 4.3 16.9 6.7 3.1 7.9 2.3 6.8 9.2 9.5 5.0 3.6 6.5 5.0 4.1 6.1 9.7 2.5 5.4 3.5 9.3 7.6 7.9 9.4 4.1 5.2 2.8 5.6 11.0 6.9 19.4 11.7 8.6 2.1 7.9 7.2 3.4 5.5 4.5 6.6 5.6 1.6 2.8 11.1 5.0 2.8 4.3 6.2 6.9 1.7 13.4 2.4 1.7 4.0 6.3 2.3 3.0 3.0 1.8 6.1 7.7 3.4 6.0 8.5 4.0 5.6 0.3 5.1 1.8 2.5 4.0 2.5 6.1 2.9 7.7 1.1 6.2 2.6 3.8 0.9 4.1 0.1 4.6 2.9 6.0 3.7 1.4 7.8 7.1 5.0 1.2 4.0 4.5 2.7 5.3 3.3 4.3 6.3 5.8 2.9 4.3 4.4 5.3 4.5 5.4 5.5 1.9 5.4 2.2 5.9 14.1 2.8 3.1 4.1 5.8 7.8 5.2 2.2 10.7 6.6 2.7 2.9 2.1 6.1 6.5 4.9 4.6 0.0 2.1 4.7 2.9 3.0 1.8 0.2 6.2 1.6 7.7 2.3 4.9 5.5 3.0 2.2 6.2 6.4 0.1 6.1 1.1 2.4 3.2 3.4 6.7 7.9 9.2 9.5 7.6 7.9 5.6 11.0 7.9 6.9 3.0 7.9 0.0 5.1 1.1 7.9 9.8 2.5 5.3 7.9 0.0 5.9 3.0 5.0 3.2 5.2 2.2 1.3 0.0 2.9 2.5 4.6 4.0 6.9 3.0 2.2 6.4 3.5 1.3 0.3 4.2 5.8 1.6 1.7 0.0 3.1 15.6 1.6 3.4 7.4 5.3 7.0 0.0 3.1 11.3 17.2 1.3 3.1 2.5 4.1 2.0 C3orf36 FLJ22173 ENSG00000221972 "Chromosome 3 open reading frame 36" Q3SXR2 3 133928145-133929812 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "lung: 8.2;seminal vesicle: 14.7" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "EFO-21: 6.6;HeLa: 1.7;TIME: 5.2" HPA046432 Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA046432: AB_2679664" "unprognostic (3.56e-1)" "unprognostic (3.28e-2)" "unprognostic (1.87e-1)" "unprognostic (5.29e-3)" "unprognostic (4.64e-4)" "unprognostic (5.05e-3)" "unprognostic (8.18e-5)" "unprognostic (1.22e-1)" "unprognostic (2.74e-2)" "unprognostic (2.03e-2)" "unprognostic (1.15e-2)" "unprognostic (2.22e-1)" "unprognostic (7.85e-2)" "unprognostic (4.79e-3)" "unprognostic (2.08e-1)" "unprognostic (9.09e-2)" "unprognostic (8.27e-3)" 1.1 1.9 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.2 1.3 0.0 0.6 1.1 0.8 0.7 0.0 0.0 1.9 0.0 8.2 0.1 0.0 0.0 0.7 1.6 0.2 0.1 2.3 0.3 0.4 14.7 0.0 0.1 1.4 1.0 0.0 1.5 0.8 0.0 2.7 0.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 6.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C3orf38 MGC26717 ENSG00000179021 "Chromosome 3 open reading frame 38" Q5JPI3 3 88149743-88168729 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 8 "Early spermatids: 252.0;Late spermatids: 238.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 59.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034736, HPA034737" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA034736: AB_2674307, HPA034737: AB_10671505" "unprognostic (1.93e-1)" "unprognostic (1.40e-1)" "unprognostic (3.75e-3)" "unprognostic (1.48e-2)" "unprognostic (1.74e-2)" "unprognostic (2.41e-2)" "unprognostic (2.26e-3)" "unprognostic (1.54e-1)" "unprognostic (1.80e-2)" "prognostic favorable (3.55e-4)" "unprognostic (9.28e-3)" "prognostic unfavorable (4.12e-4)" "unprognostic (1.95e-2)" "unprognostic (2.88e-3)" "unprognostic (1.63e-1)" "unprognostic (4.57e-2)" "unprognostic (3.67e-2)" 12.2 11.7 13.7 12.8 16.1 35.2 12.3 12.9 12.8 11.6 11.9 13.6 8.4 9.5 11.5 10.7 14.6 10.7 9.4 9.7 11.3 11.1 10.2 13.5 10.6 19.2 15.1 9.4 12.1 9.3 7.1 15.8 12.5 11.4 11.2 11.2 9.0 10.6 10.2 9.7 11.6 11.4 10.9 11.3 17.0 10.1 33.2 13.5 29.5 11.6 9.0 17.1 12.4 11.6 20.0 17.7 25.8 24.2 17.1 17.4 15.3 6.4 6.7 13.2 7.0 8.8 8.0 6.1 10.5 12.6 15.7 21.3 7.7 8.9 8.7 9.4 9.7 7.5 4.7 9.5 7.7 13.6 15.6 4.5 10.6 5.2 6.5 12.6 14.5 9.2 11.4 7.8 10.5 9.0 10.3 9.0 9.5 6.7 10.0 17.0 7.5 14.6 6.1 16.0 12.1 7.6 9.2 4.6 8.2 10.4 8.8 4.0 5.8 9.6 5.3 15.8 11.2 10.2 11.1 8.2 9.8 10.7 59.4 11.5 9.2 13.6 12.9 7.6 11.5 9.2 25.8 16.8 17.5 13.5 24.2 17.4 20.0 12.6 13.8 17.7 15.9 12.6 12.8 7.5 17.1 19.7 12.3 15.1 15.3 13.7 16.1 12.9 12.8 11.3 11.1 15.1 9.4 11.4 13.5 17.9 6.9 32.0 16.6 10.4 21.8 5.6 0.0 14.7 11.4 5.2 21.6 19.3 16.6 14.7 252.0 8.7 11.8 0.0 12.0 18.8 15.4 14.2 13.9 7.4 23.4 6.4 15.5 8.6 17.2 238.1 15.3 21.8 15.1 27.1 10.7 22.8 11.6 13.3 14.2 9.8 21.7 12.9 12.2 25.9 12.0 12.3 21.4 28.7 9.0 18.6 C3orf52 "FLJ23186, TTMP" ENSG00000114529 "Chromosome 3 open reading frame 52" Q5BVD1 3 112086335-112131004 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 41.2" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 112.5;Glandular cells: 75.6;Syncytiotrophoblasts: 62.7;Urothelial cells: 119.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 14.9;U-698: 20.8" "HPA007678, HPA008119, HPA011968" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies, Cytosol" "HPA007678: , HPA008119: AB_1848824, HPA011968: AB_1848826" "unprognostic (8.86e-2)" "unprognostic (1.71e-1)" "unprognostic (3.58e-2)" "unprognostic (7.97e-2)" "unprognostic (1.45e-2)" "unprognostic (3.87e-3)" "unprognostic (3.49e-4)" "unprognostic (2.54e-1)" "unprognostic (1.39e-2)" "unprognostic (2.30e-1)" "prognostic unfavorable (3.85e-4)" "unprognostic (2.71e-2)" "unprognostic (3.76e-6)" "unprognostic (3.14e-1)" "unprognostic (2.05e-1)" "unprognostic (1.75e-2)" "unprognostic (9.59e-2)" 1.1 1.0 0.3 5.3 0.7 0.4 1.9 0.3 0.4 1.0 9.1 0.0 6.9 2.8 1.7 1.5 2.7 1.0 12.4 3.0 0.4 0.4 7.1 0.5 6.3 0.8 0.3 0.0 0.6 41.2 0.0 8.7 6.1 0.5 5.4 9.0 0.6 3.9 9.6 1.5 22.3 12.7 4.2 0.3 0.8 10.6 1.0 0.0 20.8 10.7 4.3 3.6 6.1 6.1 0.8 0.8 0.0 0.0 0.0 2.7 1.0 8.7 1.4 2.4 0.0 0.3 0.0 3.2 6.9 2.9 4.0 4.6 14.9 4.7 0.3 1.3 2.0 4.6 6.2 2.8 1.7 7.6 0.0 2.3 6.0 2.0 0.7 1.8 0.0 0.0 0.5 3.5 3.6 6.1 2.8 0.9 0.0 1.5 1.5 3.0 0.6 0.2 0.0 5.2 5.6 1.9 0.2 7.9 0.0 7.1 7.7 0.3 0.6 2.6 2.7 2.5 2.9 4.0 0.0 2.2 1.4 2.4 0.0 0.0 5.5 0.0 20.8 1.2 0.0 1.4 0.0 0.0 0.0 1.3 0.0 0.4 0.8 2.7 1.3 0.5 0.3 1.5 0.6 0.0 0.0 0.0 0.8 0.0 1.0 0.3 0.7 0.3 0.4 0.4 0.4 0.3 0.0 0.5 0.0 14.9 7.7 0.5 112.5 28.8 0.0 1.4 5.1 13.4 22.7 17.4 0.0 15.2 0.0 29.6 24.4 0.3 14.6 0.0 31.2 16.0 1.7 75.6 0.0 0.0 1.6 0.0 11.3 0.6 0.3 18.2 0.3 0.3 1.7 4.6 32.5 0.0 53.5 5.9 0.4 1.7 0.0 0.0 3.3 1.8 5.5 29.4 62.7 0.8 5.4 119.7 C4orf46 "LOC201725, RCDG1" ENSG00000205208 "Chromosome 4 open reading frame 46" Q504U0 4 158666679-158672255 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 26.3" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047287, HPA052670" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047287: AB_2680011, HPA052670: " "unprognostic (2.71e-1)" "unprognostic (2.38e-1)" "unprognostic (1.41e-2)" "unprognostic (2.57e-1)" "unprognostic (2.26e-1)" "unprognostic (6.10e-2)" "unprognostic (6.27e-5)" "unprognostic (1.60e-1)" "unprognostic (4.71e-2)" "unprognostic (4.20e-2)" "unprognostic (1.35e-1)" "unprognostic (5.29e-2)" "unprognostic (4.56e-2)" "unprognostic (5.15e-2)" "unprognostic (1.19e-1)" "unprognostic (5.69e-2)" "unprognostic (9.06e-3)" 4.5 4.6 4.2 5.4 5.6 16.7 4.3 6.4 5.5 5.4 4.5 10.7 2.4 4.2 7.2 5.1 5.5 4.2 4.0 5.1 4.5 3.7 3.9 2.7 4.8 7.7 7.3 3.5 6.4 5.8 2.2 3.1 6.3 5.3 4.1 6.1 7.2 4.1 3.4 2.8 4.1 4.4 5.7 6.6 5.4 4.3 25.5 7.3 26.3 6.1 5.8 7.2 5.3 5.0 4.0 5.1 4.9 4.9 8.6 5.8 3.4 6.9 4.2 10.4 15.3 4.6 4.8 5.2 11.9 8.2 13.8 12.1 3.7 6.3 12.5 1.9 6.0 5.1 3.9 9.0 6.1 18.1 17.0 4.6 18.8 4.8 5.0 1.6 14.3 10.4 2.8 2.2 11.2 4.9 4.6 10.0 12.6 8.2 31.5 18.9 3.7 27.2 12.9 7.1 4.5 5.6 19.8 5.9 5.5 4.2 3.5 5.7 17.3 5.2 4.8 4.3 5.4 4.0 11.5 5.3 21.5 9.8 11.9 9.8 7.2 9.1 15.7 5.4 12.8 8.2 4.9 4.7 4.5 4.9 3.9 3.7 4.0 4.0 4.8 5.1 3.9 5.5 5.8 1.6 8.6 4.9 4.4 4.1 3.4 4.2 5.6 6.4 5.5 4.5 3.7 7.3 3.5 5.3 7.3 3.0 2.6 10.0 5.2 21.4 5.6 3.6 0.0 1.4 0.0 1.8 3.9 7.4 6.6 3.2 0.9 4.5 2.6 0.0 2.6 9.4 12.3 4.9 6.9 2.1 8.0 9.5 7.5 4.3 10.8 1.5 4.4 4.4 18.6 27.1 4.0 4.2 4.0 2.9 5.6 2.1 25.5 6.5 8.2 32.0 14.2 13.7 2.7 7.7 3.6 4.1 C5orf24 FLJ37562 ENSG00000181904 "Chromosome 5 open reading frame 24" Q7Z6I8 5 134845680-134859737 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057749, HPA062502" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA057749: AB_2683515, HPA062502: AB_2684785" "unprognostic (8.10e-2)" "unprognostic (1.59e-1)" "unprognostic (8.33e-3)" "unprognostic (2.03e-1)" "unprognostic (2.72e-2)" "unprognostic (9.45e-2)" "unprognostic (3.27e-2)" "unprognostic (3.31e-2)" "unprognostic (1.72e-2)" "unprognostic (2.04e-1)" "unprognostic (1.54e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (5.86e-4)" "unprognostic (6.55e-2)" "unprognostic (2.37e-1)" "unprognostic (5.04e-2)" "unprognostic (4.75e-2)" 22.8 26.7 24.1 16.7 32.6 20.8 37.7 44.8 38.2 22.0 21.5 19.8 17.0 21.7 29.7 16.7 22.8 18.3 21.5 23.2 24.9 23.8 40.7 41.8 22.6 21.3 22.2 23.0 21.0 14.9 30.2 18.5 27.9 22.7 22.6 19.0 21.4 18.0 20.4 21.0 18.9 20.2 29.8 32.5 20.3 17.6 14.6 22.4 15.4 30.0 12.1 14.2 24.6 18.5 8.4 12.9 11.1 11.3 6.4 9.3 4.4 10.4 8.8 18.2 26.5 22.8 26.8 6.6 22.4 15.9 12.5 15.0 11.7 11.9 9.7 19.6 15.9 15.8 7.1 10.3 15.5 21.7 7.2 14.7 10.9 20.9 13.6 17.3 4.7 13.0 22.0 19.0 17.9 20.6 25.0 22.8 16.2 7.5 12.1 26.9 5.9 10.2 8.2 4.1 6.5 9.1 11.8 17.4 10.9 31.6 9.7 11.4 21.7 23.3 6.2 32.7 8.5 12.8 15.4 25.0 25.2 10.9 18.3 16.0 12.7 9.1 12.0 18.4 13.4 18.6 5.0 11.3 11.1 7.3 8.5 5.9 8.4 4.9 5.8 9.4 8.2 9.3 5.6 2.2 6.4 7.0 12.9 5.7 4.4 24.1 32.6 44.8 38.2 24.9 23.8 22.2 23.0 22.7 22.4 80.4 28.5 30.5 26.6 38.2 47.6 28.9 63.7 25.4 25.0 101.2 35.3 27.3 49.7 45.6 11.7 89.4 26.4 0.0 37.8 30.6 51.2 28.9 20.8 78.4 27.7 65.2 51.8 68.2 24.8 5.4 65.3 35.6 60.8 26.2 29.8 25.5 61.7 35.1 67.1 91.2 43.2 71.1 80.9 50.1 50.3 43.2 18.5 38.9 31.6 21.1 C5orf51 LOC285636 ENSG00000205765 "Chromosome 5 open reading frame 51" A6NDU8 5 41904188-41921636 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043779, HPA063816" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043779: AB_2678666, HPA063816: AB_2685130" "unprognostic (6.64e-2)" "unprognostic (2.24e-2)" "unprognostic (9.92e-2)" "unprognostic (6.92e-3)" "unprognostic (3.93e-2)" "unprognostic (3.41e-2)" "prognostic unfavorable (1.90e-4)" "unprognostic (4.98e-2)" "unprognostic (1.59e-1)" "unprognostic (4.90e-3)" "unprognostic (2.10e-2)" "unprognostic (4.58e-2)" "unprognostic (1.01e-1)" "unprognostic (3.97e-1)" "unprognostic (3.75e-1)" "unprognostic (2.30e-2)" "unprognostic (1.67e-2)" 16.6 12.4 15.9 12.7 21.5 3.4 15.9 20.5 21.3 14.7 12.5 23.5 12.6 10.5 14.9 21.9 16.2 11.4 12.2 12.8 16.0 17.5 15.3 14.0 10.7 13.1 20.6 12.3 22.1 11.9 24.1 18.6 17.2 25.1 16.5 12.6 13.2 12.9 15.4 7.2 14.1 11.9 16.8 22.1 12.8 11.5 9.4 18.5 16.2 19.0 6.9 14.0 18.9 13.5 5.6 6.8 21.0 7.4 5.6 7.4 7.9 7.4 5.7 11.7 24.4 24.0 18.9 12.8 8.8 15.3 12.5 13.4 5.7 7.7 8.0 10.9 9.8 21.8 4.8 15.4 8.3 18.1 10.7 4.7 7.7 17.3 8.5 29.1 9.8 5.9 18.4 12.1 14.6 16.9 8.0 10.7 9.7 13.7 13.8 13.2 7.7 9.2 10.1 11.6 4.5 3.1 8.1 16.2 12.4 8.3 7.2 7.1 11.1 28.1 13.5 14.5 10.9 15.0 10.1 7.7 14.9 8.9 11.2 8.5 7.0 11.3 8.2 16.5 17.3 10.5 21.0 6.9 6.6 4.7 5.6 6.0 5.1 5.5 5.0 6.8 5.6 7.4 4.9 4.7 5.6 7.4 4.1 3.9 7.9 15.9 21.5 20.5 21.3 16.0 17.5 20.6 12.3 25.1 18.5 29.8 8.6 14.5 7.4 8.9 9.2 13.4 12.7 10.7 9.1 14.0 5.9 11.0 8.3 9.8 9.1 9.0 5.1 0.0 6.7 10.7 9.3 9.4 4.7 16.3 12.5 7.9 10.4 8.6 16.1 8.9 8.3 6.7 6.8 10.8 9.2 14.5 7.3 5.8 7.4 10.8 9.0 12.9 11.3 6.6 7.8 11.5 14.1 5.0 7.4 9.1 C5orf67 ENSG00000225940 "Chromosome 5 open reading frame 67" F2Z3F1 5 56511567-56606232 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 17.9;kidney: 9.3;retina: 16.3" "Group enriched" "Detected in some" 4 "Collecting duct cells: 1.8;Distal tubular cells: 1.7;Proximal tubular cells: 1.2" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.9" "Region enriched" "Detected in some" 5 "pons and medulla: 6.1" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Group enriched" "Detected in many" 5 "dendritic cells: 1.5;granulocytes: 3.3;monocytes: 1.9" "Group enriched" "Detected in some" 7 "CACO-2: 3.2;EFO-21: 9.3;U-266/70: 10.4" HPA054214 Approved Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoli "Nucleoplasm, Vesicles" "HPA054214: " "unprognostic (7.28e-2)" "unprognostic (1.41e-1)" "unprognostic (2.55e-1)" "unprognostic (1.35e-1)" "unprognostic (1.12e-3)" "unprognostic (6.58e-2)" "unprognostic (7.93e-2)" "unprognostic (2.91e-1)" "unprognostic (2.18e-1)" "unprognostic (8.69e-2)" "unprognostic (1.35e-1)" "unprognostic (1.83e-1)" "unprognostic (1.64e-1)" "unprognostic (3.62e-2)" 0.4 0.0 0.2 0.2 1.2 0.4 1.0 0.2 0.2 0.4 0.8 0.4 0.2 1.5 0.6 17.9 0.4 0.4 0.2 0.2 0.6 0.2 9.3 0.2 0.4 0.6 0.7 0.2 0.2 0.2 0.0 0.2 0.2 6.1 0.2 0.0 16.3 1.1 0.2 0.2 0.8 1.6 0.2 0.2 1.5 0.1 0.2 0.2 0.2 2.1 0.2 0.2 0.2 0.2 0.1 1.5 3.3 1.9 0.0 0.4 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.3 0.0 9.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.2 0.0 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.5 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.6 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 3.3 0.0 1.9 1.5 0.4 0.1 0.2 1.2 0.2 0.2 0.6 0.2 0.7 0.2 6.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C6orf163 ENSG00000203872 "Chromosome 6 open reading frame 163" Q5TEZ5 6 87344849-87365463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 20.2" "Group enriched" "Detected in some" 26 "Early spermatids: 164.9;Late spermatids: 171.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Region enriched" "Detected in single" 4 "basal ganglia: 1.4" "Low region specificity" "Detected in all" "HPA044797, HPA052927" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA044797: AB_10962365, HPA052927: AB_2681990" "unprognostic (4.98e-2)" "unprognostic (6.42e-2)" "unprognostic (1.65e-1)" "unprognostic (2.33e-2)" "unprognostic (4.18e-2)" "unprognostic (3.49e-2)" "unprognostic (7.55e-3)" "unprognostic (3.96e-3)" "unprognostic (1.37e-1)" "unprognostic (1.95e-2)" "unprognostic (5.60e-4)" "unprognostic (6.66e-2)" "unprognostic (3.77e-3)" "unprognostic (1.46e-1)" "unprognostic (1.93e-2)" "unprognostic (3.19e-1)" "unprognostic (1.42e-2)" 0.7 0.8 0.5 0.5 4.3 3.2 1.3 0.7 1.0 0.8 0.8 1.5 0.5 0.0 1.4 3.0 0.5 2.3 0.5 1.0 0.9 0.4 0.6 0.9 1.7 0.9 0.5 0.5 3.3 1.1 1.7 1.8 0.5 4.6 1.2 1.2 0.5 1.2 0.5 1.5 2.4 1.1 0.5 0.5 1.7 0.8 20.2 1.2 0.5 1.1 0.5 0.8 0.6 0.6 1.4 0.7 3.4 0.9 1.2 1.8 0.4 0.2 0.6 3.0 4.5 0.5 3.3 3.6 0.0 0.0 0.6 1.0 1.3 0.9 1.8 0.5 0.4 1.9 0.8 1.2 2.6 0.0 1.6 1.8 2.3 1.0 1.0 0.0 1.1 0.6 1.6 1.5 0.8 0.8 1.3 0.5 1.9 3.5 1.6 0.4 0.7 0.3 1.5 0.7 0.1 0.2 4.0 1.0 0.1 1.9 2.9 2.3 1.2 0.3 0.5 1.2 3.2 0.6 1.3 1.0 1.8 1.4 0.9 1.4 0.5 0.8 0.3 0.2 2.1 1.1 0.5 0.7 0.3 1.8 0.4 0.9 1.3 1.8 1.2 0.7 1.4 1.7 1.8 3.4 1.2 0.9 0.4 1.0 0.4 0.5 4.3 0.7 1.0 0.9 0.4 0.5 0.5 4.6 1.2 0.0 0.3 0.0 0.3 0.3 0.6 1.7 2.5 1.4 0.0 0.0 0.0 0.4 0.0 0.1 164.9 0.0 0.2 0.0 0.0 0.3 0.4 0.4 0.0 0.2 0.2 0.0 0.0 0.0 1.2 171.0 2.3 0.0 1.7 0.0 0.3 0.0 0.1 0.0 1.8 0.4 0.5 6.5 0.4 2.1 1.6 0.1 0.7 0.0 0.2 0.3 C7orf25 MGC2821 ENSG00000136197 "Chromosome 7 open reading frame 25" Q9BPX7 7 42908726-42912305 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 7 "Collecting duct cells: 3.5;Cone photoreceptor cells: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 20.9;eosinophil: 12.3;neutrophil: 6.4" "Lineage enriched" "Detected in all" 9 "granulocytes: 20.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020120, HPA049635" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA020120: AB_1845755, HPA049635: AB_2680837" "unprognostic (6.29e-2)" "unprognostic (1.55e-1)" "unprognostic (1.56e-2)" "unprognostic (4.83e-2)" "unprognostic (1.13e-3)" "unprognostic (2.23e-2)" "unprognostic (5.23e-2)" "unprognostic (3.29e-1)" "unprognostic (1.66e-2)" "unprognostic (1.73e-1)" "unprognostic (5.25e-2)" "unprognostic (2.34e-1)" "unprognostic (1.26e-2)" "unprognostic (1.26e-1)" "unprognostic (2.66e-1)" "unprognostic (3.87e-2)" "unprognostic (3.05e-3)" 4.8 6.5 7.6 3.8 7.6 2.4 6.1 7.1 11.0 5.0 5.2 6.3 2.6 2.1 5.3 11.0 5.2 6.5 5.9 5.8 9.2 8.6 7.7 5.9 4.8 5.2 10.0 9.1 7.2 5.1 12.6 6.5 5.8 12.2 8.2 3.4 4.0 5.0 9.2 5.7 3.9 5.3 5.8 9.6 5.2 5.3 11.0 5.3 5.8 7.7 4.5 3.8 5.3 4.4 2.1 1.4 20.9 1.9 1.6 2.2 1.1 3.5 9.1 3.3 4.9 4.6 2.5 3.6 7.0 2.6 4.6 4.2 5.9 4.6 9.2 5.4 6.7 6.7 6.0 3.5 6.2 5.3 4.4 8.7 4.8 9.3 3.6 8.4 3.6 3.1 5.1 4.2 4.6 4.7 2.3 3.5 5.9 6.1 2.1 3.8 6.6 1.9 3.5 4.0 3.2 11.8 2.2 3.5 3.8 2.6 8.7 4.1 4.6 10.3 3.1 3.6 4.8 4.1 3.5 9.4 4.6 5.3 5.0 4.4 4.9 10.9 2.8 4.3 4.6 9.9 20.9 1.9 12.3 1.5 1.8 2.2 2.1 1.1 1.4 1.4 1.7 1.6 1.6 6.4 1.6 1.7 0.6 0.8 1.1 7.6 7.6 7.1 11.0 9.2 8.6 10.0 9.1 12.2 5.3 0.0 0.6 0.8 0.4 0.2 1.0 0.5 0.0 1.4 0.0 3.5 3.9 0.6 1.7 0.8 0.0 0.1 0.0 0.0 1.0 0.2 0.3 0.5 0.0 0.6 0.2 0.0 0.0 1.8 0.0 0.0 0.6 0.2 0.0 0.0 0.1 0.3 0.9 0.0 0.7 1.0 0.5 0.0 0.4 1.2 1.2 0.4 0.7 0.0 0.0 0.1 C7orf26 MGC2718 ENSG00000146576 "Chromosome 7 open reading frame 26" Q96N11 7 6590017-6608726 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042899, HPA052175" Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol" NA NA Nucleoplasm "Nucleoli, Intermediate filaments, Cytosol" "HPA042899: AB_2678218, HPA052175: AB_2681750" "unprognostic (4.85e-2)" "unprognostic (6.87e-2)" "unprognostic (4.51e-2)" "unprognostic (2.50e-2)" "unprognostic (2.18e-2)" "unprognostic (5.22e-2)" "unprognostic (4.28e-3)" "unprognostic (1.49e-1)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "prognostic favorable (6.95e-5)" "unprognostic (4.72e-2)" "unprognostic (2.26e-3)" "unprognostic (4.41e-1)" "unprognostic (1.03e-2)" "unprognostic (3.40e-3)" "unprognostic (1.55e-1)" 19.8 17.1 13.4 21.7 17.7 29.2 20.0 20.6 26.9 19.0 17.9 21.1 21.5 19.4 23.0 15.4 14.7 19.9 15.6 12.8 14.4 14.1 15.4 18.4 19.3 24.1 18.8 20.2 20.6 23.9 17.2 16.6 14.0 15.4 21.1 11.5 16.4 21.2 16.6 18.7 21.9 16.4 19.6 13.1 27.3 18.6 16.8 16.1 31.7 18.3 18.5 20.6 17.6 19.6 4.2 6.4 4.6 3.4 3.3 6.1 1.9 11.1 9.4 6.6 15.4 10.7 6.0 8.7 6.7 5.9 9.7 6.0 8.7 4.7 13.3 8.8 5.0 18.5 12.4 8.7 6.2 4.4 5.1 12.6 4.9 5.9 9.2 12.6 11.8 15.9 6.9 9.3 5.8 6.1 5.2 10.6 14.4 12.9 10.1 5.7 18.8 10.2 24.4 13.0 5.6 12.5 20.9 5.2 11.2 6.3 9.8 8.6 16.0 6.5 21.7 9.0 7.1 9.9 17.8 7.6 8.1 26.6 8.8 14.6 12.3 12.1 12.2 5.4 13.1 23.8 1.1 3.4 4.6 4.7 3.3 6.1 4.1 5.7 6.0 2.6 4.2 5.9 4.9 3.4 3.3 3.3 6.4 5.4 1.9 13.4 17.7 20.6 26.9 14.4 14.1 18.8 20.2 15.4 16.1 8.9 7.5 6.1 8.2 13.5 6.1 5.3 10.2 4.0 5.7 1.8 5.9 10.4 0.0 7.5 5.8 9.3 8.4 0.0 8.8 9.1 9.3 8.5 1.1 6.4 11.6 4.8 12.1 14.7 10.3 3.2 7.5 9.8 6.8 4.6 12.3 6.7 9.2 10.5 8.1 6.3 6.1 6.5 13.2 11.2 13.8 11.2 8.1 14.6 10.2 6.0 C7orf31 ENSG00000153790 "Chromosome 7 open reading frame 31" Q8N865 7 25134697-25180356 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 60.9" "Group enriched" "Detected in many" 17 "Early spermatids: 399.0;Late spermatids: 665.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 18.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA020346 Uncertain Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA020346: AB_1845758" "unprognostic (3.35e-2)" "unprognostic (1.03e-1)" "unprognostic (2.01e-1)" "unprognostic (6.90e-3)" "prognostic unfavorable (1.81e-4)" "unprognostic (1.19e-1)" "unprognostic (3.40e-2)" "unprognostic (1.95e-1)" "unprognostic (2.90e-1)" "unprognostic (1.06e-1)" "unprognostic (3.12e-3)" "unprognostic (8.26e-3)" "unprognostic (1.63e-1)" "unprognostic (4.45e-2)" "unprognostic (9.27e-2)" "unprognostic (1.10e-1)" "unprognostic (1.15e-2)" 2.4 6.2 1.5 4.8 3.1 1.3 2.3 4.0 1.6 3.3 5.1 2.9 2.0 3.3 3.3 2.9 2.4 2.6 3.7 3.1 1.9 1.5 2.6 1.2 2.8 7.0 2.0 2.2 4.6 1.8 4.3 2.1 1.1 2.3 3.2 3.6 4.1 6.0 2.3 0.9 1.8 3.9 2.4 2.9 3.7 3.4 60.9 2.4 5.9 4.6 0.9 3.3 3.5 5.1 3.0 5.9 2.3 1.3 2.8 2.8 0.9 2.8 2.0 4.5 5.2 1.8 1.0 2.5 1.2 4.9 3.7 5.6 3.9 2.7 7.2 1.9 2.2 14.6 1.1 5.0 1.4 4.0 3.4 4.9 3.4 0.2 5.2 4.3 5.5 8.3 3.1 3.9 3.0 0.7 2.6 0.7 6.2 5.1 4.0 0.9 0.0 5.6 7.0 1.8 6.6 1.8 7.0 5.2 1.1 2.5 3.6 1.3 3.8 1.2 4.9 4.6 6.6 0.8 9.2 1.0 2.3 6.2 0.0 1.8 18.0 5.7 10.3 0.7 5.3 10.6 1.4 1.3 2.3 1.7 0.6 2.3 3.0 1.1 1.5 1.7 2.1 2.8 2.2 0.1 2.8 0.8 5.9 2.8 0.9 1.5 3.1 4.0 1.6 1.9 1.5 2.0 2.2 2.3 2.4 0.0 5.3 2.9 2.3 1.0 0.9 1.0 2.5 5.3 0.0 0.0 0.0 2.8 3.3 1.0 399.0 2.2 2.5 0.0 3.4 2.1 2.5 0.9 0.0 1.0 2.4 0.0 4.1 1.8 5.0 665.4 6.6 2.9 3.3 4.6 2.8 7.7 3.2 6.5 4.9 0.6 0.5 0.0 2.1 31.4 12.4 0.5 1.9 4.3 6.0 0.9 C7orf50 "MGC11257, YCR016W" ENSG00000146540 "Chromosome 7 open reading frame 50" Q9BRJ6 7 996986-1138260 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Distal tubular cells: 250.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052281 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA052281: AB_2681784" "unprognostic (1.64e-1)" "unprognostic (1.48e-1)" "unprognostic (1.58e-1)" "unprognostic (3.74e-2)" "unprognostic (1.79e-2)" "unprognostic (1.28e-3)" "unprognostic (2.57e-3)" "unprognostic (1.94e-1)" "unprognostic (1.25e-1)" "unprognostic (1.57e-1)" "prognostic favorable (6.20e-6)" "unprognostic (1.57e-1)" "unprognostic (1.37e-2)" "unprognostic (3.37e-2)" "unprognostic (8.14e-2)" "unprognostic (1.58e-1)" "unprognostic (3.33e-2)" 22.5 14.2 37.7 14.9 29.4 9.7 14.9 16.4 32.8 17.0 17.5 15.5 19.4 12.8 20.1 18.8 14.8 21.0 20.3 28.7 28.1 21.4 21.7 14.2 16.1 21.2 22.4 23.0 21.6 79.5 12.3 39.3 13.9 17.3 21.7 7.9 25.9 25.1 28.8 68.4 8.2 13.8 34.5 19.1 19.5 25.1 19.5 9.8 6.0 20.8 18.0 16.6 17.2 10.9 32.3 41.5 76.3 27.0 8.1 20.6 22.7 41.6 26.7 8.9 27.2 4.8 6.9 18.9 18.7 9.3 16.7 14.2 18.8 17.9 12.5 12.4 12.0 21.2 26.5 10.7 22.6 3.3 11.9 21.6 11.4 18.9 25.5 19.7 14.5 7.9 9.8 18.1 15.5 14.3 7.3 11.4 10.6 20.3 12.0 7.4 60.2 6.7 38.9 21.9 18.8 39.7 19.8 3.3 20.7 7.8 11.6 20.6 29.5 15.4 18.3 25.2 6.2 43.9 26.8 13.1 9.7 43.2 28.9 24.5 10.3 13.8 11.4 19.5 24.2 30.6 3.2 27.0 76.3 20.6 26.2 14.6 23.6 16.9 17.4 41.5 32.3 13.2 15.3 3.0 8.1 25.0 12.0 19.7 22.7 37.7 29.4 16.4 32.8 28.1 21.4 22.4 23.0 17.3 9.8 32.8 64.7 92.5 33.2 20.6 74.8 64.4 40.8 56.2 30.7 62.8 17.7 65.3 250.4 73.5 7.0 40.5 17.6 23.3 74.9 70.2 42.1 41.1 54.3 32.5 140.0 54.0 87.1 33.7 63.1 3.4 34.2 61.3 67.4 120.8 45.0 82.9 55.6 17.3 41.8 101.0 58.5 25.8 67.4 18.1 41.5 21.3 38.9 48.4 57.1 30.7 C7orf55-LUC7L2 ENSG00000269955 "C7orf55-LUC7L2 readthrough" 7 139341360-139422599 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 11 "Basal keratinocytes: 80.5;Melanocytes: 75.9;Smooth muscle cells: 39.2;Suprabasal keratinocytes: 78.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA045663, HPA051631" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA045663: AB_2679410, HPA051631: AB_2681558" "unprognostic (2.54e-1)" "unprognostic (5.27e-2)" "unprognostic (3.21e-2)" "unprognostic (1.33e-3)" "unprognostic (1.38e-1)" "unprognostic (2.46e-3)" "unprognostic (1.68e-2)" "unprognostic (4.48e-2)" "unprognostic (2.26e-1)" "unprognostic (1.76e-3)" "unprognostic (1.10e-1)" "unprognostic (3.12e-2)" "unprognostic (6.42e-3)" 14.4 17.5 10.1 9.7 19.2 7.6 11.7 11.2 21.2 9.8 10.6 8.3 17.2 13.4 13.8 14.3 8.1 10.5 11.1 30.3 8.7 6.7 13.3 14.8 8.9 9.1 14.7 11.7 16.5 25.1 6.9 9.1 8.5 13.9 10.9 6.1 8.2 13.9 15.1 57.2 7.8 11.6 9.3 9.5 10.4 13.5 7.4 13.6 6.1 17.5 21.2 6.2 10.7 12.4 18.6 18.3 17.0 14.8 18.8 21.1 12.6 13.4 19.4 24.0 13.8 10.2 7.2 9.1 10.6 7.1 13.3 10.7 15.3 15.2 15.4 19.2 8.0 17.3 10.6 25.4 9.1 4.3 10.3 5.1 20.1 19.6 12.4 10.0 24.4 16.8 6.3 6.8 12.4 8.1 7.4 9.3 8.6 25.1 20.8 8.3 19.8 36.0 4.0 19.4 18.5 4.9 23.5 18.0 20.6 3.0 9.5 20.2 20.8 14.5 11.4 13.9 4.9 8.5 10.5 10.2 9.5 8.9 9.7 16.0 19.3 16.4 28.4 17.7 16.0 17.0 9.7 12.9 17.0 19.0 12.6 17.8 18.6 18.4 19.5 18.3 18.5 21.1 18.8 4.3 18.8 14.8 15.0 19.8 12.6 10.1 19.2 11.2 21.2 8.7 6.7 14.7 11.7 13.9 13.6 6.0 5.8 0.0 0.0 80.5 0.0 22.1 0.0 14.7 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 20.7 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 1.7 75.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.2 0.0 0.0 78.7 0.0 0.0 0.0 0.0 C8orf33 FLJ20989 ENSG00000182307 "Chromosome 8 open reading frame 33" Q9H7E9 8 145052378-145056030 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024812, HPA026104" Approved Uncertain "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA024812: AB_10599490, HPA026104: AB_10600875" "prognostic unfavorable (2.77e-4)" "unprognostic (6.51e-3)" "unprognostic (1.85e-1)" "unprognostic (5.06e-2)" "unprognostic (1.12e-1)" "unprognostic (9.56e-3)" "prognostic unfavorable (8.95e-4)" "unprognostic (4.75e-2)" "unprognostic (3.51e-1)" "unprognostic (2.45e-2)" "unprognostic (5.17e-2)" "unprognostic (2.71e-1)" "unprognostic (1.05e-1)" "unprognostic (5.29e-2)" "unprognostic (1.72e-1)" "unprognostic (1.01e-1)" "unprognostic (1.37e-1)" 14.3 41.8 14.4 8.8 13.5 5.5 23.2 10.7 17.3 25.3 19.3 13.4 11.3 11.3 11.9 15.0 12.1 14.4 13.1 15.0 15.3 12.1 15.5 11.8 9.4 12.4 14.3 12.0 24.3 13.5 32.4 8.5 12.9 18.1 13.9 24.9 11.9 12.5 24.4 21.7 11.5 7.6 9.5 21.8 9.3 10.2 9.3 13.5 9.1 16.6 10.5 8.5 10.1 9.4 8.7 13.7 4.9 12.0 17.9 13.0 11.3 8.3 8.6 3.0 1.4 17.7 6.2 5.8 5.8 12.1 11.2 8.1 1.7 0.7 9.8 19.3 6.8 1.6 2.8 12.2 12.9 8.1 4.4 22.1 12.8 5.2 2.7 16.8 6.6 2.8 13.3 21.8 6.2 11.5 5.5 8.7 12.5 24.2 2.1 5.3 12.1 13.8 3.7 7.2 7.3 22.8 8.6 3.8 11.6 7.5 2.9 7.0 10.7 16.5 1.8 7.5 5.3 1.9 2.6 4.5 2.9 8.6 4.3 7.4 7.0 4.8 20.7 9.5 15.3 5.0 0.3 10.0 4.9 10.3 12.0 13.0 8.7 10.9 11.5 13.7 8.6 12.9 10.3 0.6 17.9 9.4 12.6 7.8 11.3 14.4 13.5 10.7 17.3 15.3 12.1 14.3 12.0 18.1 13.5 26.8 22.7 32.8 25.8 39.4 43.0 15.7 50.9 28.1 38.7 24.4 29.5 32.9 53.0 60.8 2.6 44.6 31.5 0.0 56.0 33.0 30.5 21.9 20.8 57.2 25.9 47.7 33.9 37.4 16.7 3.7 35.1 22.8 15.1 28.9 32.5 47.3 45.2 34.5 36.4 31.4 50.3 25.8 34.4 22.4 38.2 37.5 20.8 24.2 44.8 23.5 C8orf34 "vest-1, VEST1" ENSG00000165084 "Chromosome 8 open reading frame 34" Q49A92 8 68330722-68819022 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 15.3;parathyroid gland: 19.9" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 16.0;Ciliated cells: 28.1;Club cells: 6.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 4.5;HEK 293: 5.8;LHCN-M2: 5.1;RH-30: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044420, HPA053065" Uncertain Supported "Nucleoplasm,Nucleoli,Golgi apparatus" No NA "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA044420: AB_10963791, HPA053065: AB_2682030" "unprognostic (1.75e-1)" "unprognostic (2.20e-1)" "unprognostic (3.30e-2)" "unprognostic (5.59e-3)" "unprognostic (3.07e-1)" "unprognostic (2.85e-2)" "unprognostic (3.35e-1)" "unprognostic (1.19e-1)" "unprognostic (2.80e-1)" "unprognostic (1.74e-1)" "unprognostic (8.55e-2)" "unprognostic (5.86e-2)" "unprognostic (1.80e-4)" "unprognostic (5.21e-2)" "unprognostic (8.87e-2)" "unprognostic (2.84e-4)" "unprognostic (1.33e-1)" 4.2 0.9 7.4 0.8 10.6 1.1 1.5 9.6 8.4 4.0 0.7 9.6 0.2 0.7 1.5 2.5 2.1 15.3 3.2 1.6 8.9 7.0 1.0 0.7 8.3 0.8 3.7 5.0 1.4 2.1 19.9 2.7 0.9 10.4 3.9 0.9 3.5 1.4 2.2 0.9 1.8 0.8 1.7 3.2 0.8 1.7 1.4 6.7 0.0 1.0 1.1 0.7 1.2 1.1 1.8 2.0 2.9 0.7 1.3 1.8 0.5 0.3 0.0 0.8 0.4 1.2 2.3 0.2 1.4 4.5 0.7 0.6 0.3 0.4 0.2 0.9 1.2 0.2 0.3 0.3 0.8 0.2 0.1 5.8 0.7 1.0 0.4 0.3 0.1 0.5 0.1 0.6 0.8 1.6 0.3 0.1 0.7 0.3 1.0 5.1 0.6 0.1 0.5 2.6 0.0 0.1 0.2 5.4 0.1 0.6 0.4 1.1 0.2 0.3 0.3 0.0 0.6 2.6 0.2 0.1 1.0 0.6 3.4 0.2 0.8 0.0 0.1 0.4 0.3 0.8 2.1 0.7 1.2 1.4 0.3 1.1 1.0 1.2 1.1 0.3 1.8 1.5 1.8 2.9 1.3 0.5 2.0 0.8 0.5 7.4 10.6 9.6 8.4 8.9 7.0 3.7 5.0 10.4 6.7 14.9 16.0 0.0 0.6 1.4 1.2 1.2 0.0 28.1 6.8 0.0 0.0 0.3 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.2 0.9 1.2 1.1 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.3 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.6 0.0 1.0 0.2 0.2 0.6 0.3 0.0 0.0 0.4 C8orf44 FLJ11267 ENSG00000213865 "Chromosome 8 open reading frame 44" Q96CB5 8 66667615-66685564 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA043660, HPA054753" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA043660: AB_10794889, HPA054753: AB_2682592" "unprognostic (6.19e-2)" "unprognostic (7.50e-2)" "unprognostic (3.09e-2)" "unprognostic (1.05e-2)" "unprognostic (1.99e-1)" "unprognostic (2.53e-1)" "unprognostic (8.61e-3)" "unprognostic (8.20e-3)" "unprognostic (4.42e-2)" "unprognostic (2.73e-2)" "prognostic favorable (4.21e-4)" "unprognostic (7.35e-2)" "prognostic unfavorable (1.08e-7)" "unprognostic (4.01e-2)" "unprognostic (9.35e-2)" "unprognostic (1.49e-1)" "prognostic favorable (2.68e-6)" 5.8 4.5 15.8 6.1 18.1 8.6 9.6 16.6 14.9 6.6 5.3 10.4 7.2 4.3 8.4 27.7 4.2 7.7 5.6 5.8 10.6 7.7 5.9 4.0 4.7 10.1 11.4 9.0 10.2 4.6 6.8 14.6 5.8 8.6 6.8 8.3 8.9 7.7 7.0 11.6 12.4 5.3 5.9 9.2 7.5 6.4 15.3 11.5 9.4 10.8 3.0 8.0 6.8 6.0 5.8 4.4 5.7 3.1 0.6 3.8 1.5 8.7 3.4 5.8 4.1 3.5 6.9 3.2 2.4 2.3 3.3 3.9 3.5 9.9 9.8 1.6 4.1 4.7 6.0 5.5 2.1 4.6 7.3 5.3 8.3 10.5 7.2 2.8 3.7 5.9 5.8 4.9 4.4 4.8 6.5 4.1 10.9 9.4 6.5 3.3 3.2 4.1 5.1 5.0 6.5 4.3 4.0 1.9 2.0 4.8 1.8 4.7 3.8 2.6 1.7 3.1 4.3 5.8 2.4 5.9 3.5 4.7 3.4 1.5 7.7 2.6 4.0 5.7 4.0 1.8 5.7 3.1 4.0 1.9 2.5 1.4 5.8 2.4 2.2 2.6 4.8 3.8 2.8 3.6 0.6 1.3 4.4 3.4 1.5 15.8 18.1 16.6 14.9 10.6 7.7 11.4 9.0 8.6 11.5 3.0 3.4 3.7 5.3 0.6 8.6 26.0 0.0 5.3 4.5 7.0 7.9 2.7 10.0 2.0 0.9 3.8 2.6 0.0 3.4 1.6 4.4 4.8 3.5 2.4 2.6 1.6 6.3 3.7 4.4 1.3 8.6 4.9 1.7 1.8 3.6 7.0 2.4 4.3 8.5 3.3 6.0 12.9 3.9 16.4 5.7 1.4 1.4 2.9 3.3 3.4 C8orf48 FLJ25402 ENSG00000164743 "Chromosome 8 open reading frame 48" Q96LL4 8 13566843-13568287 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.7;testis: 17.3" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 23.2;Late spermatids: 38.1;Spermatocytes: 9.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 13.1;U-87 MG: 11.2;WM-115: 8.4" "Low region specificity" "Detected in all" "HPA026107, HPA027440" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA026107: AB_10600765, HPA027440: AB_10601678" "unprognostic (1.67e-2)" "unprognostic (1.28e-1)" "unprognostic (5.07e-2)" "unprognostic (9.01e-2)" "unprognostic (2.31e-2)" "unprognostic (1.13e-1)" "unprognostic (4.84e-3)" "unprognostic (7.70e-2)" "unprognostic (1.76e-1)" "unprognostic (1.09e-1)" "unprognostic (1.05e-2)" "unprognostic (1.87e-1)" "unprognostic (1.41e-3)" "unprognostic (7.74e-4)" "unprognostic (1.78e-1)" "unprognostic (8.42e-3)" "unprognostic (8.70e-2)" 2.7 0.7 3.6 1.2 11.7 0.1 3.7 0.8 2.9 3.0 1.3 0.9 0.2 0.9 2.3 6.0 1.4 3.9 2.5 4.0 2.8 1.6 4.1 1.7 2.4 1.2 1.7 3.0 2.1 1.2 0.5 1.5 2.8 2.8 2.2 1.0 2.4 2.2 1.0 0.9 2.7 0.9 1.9 1.1 1.1 1.9 17.3 1.5 0.0 8.9 0.3 0.5 2.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.1 1.7 0.0 5.9 5.9 0.0 5.2 5.8 2.8 4.8 0.0 0.0 0.0 0.0 2.7 13.1 0.6 0.2 1.0 5.5 0.0 0.5 0.5 0.0 0.0 2.1 0.0 0.9 1.9 3.5 3.8 1.0 0.7 3.6 0.0 0.1 0.0 7.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 3.1 0.0 0.2 5.8 2.0 0.0 0.0 1.6 4.9 4.8 5.7 4.6 0.0 0.0 0.0 11.2 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.6 11.7 0.8 2.9 2.8 1.6 1.7 3.0 2.8 1.5 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 1.4 1.2 0.0 2.0 0.0 0.0 2.6 23.2 0.5 0.0 0.0 1.0 0.0 3.1 0.0 0.0 0.5 0.1 0.0 0.0 1.3 0.0 38.1 4.6 0.0 5.0 0.0 0.0 0.9 0.3 0.0 2.8 2.4 4.3 6.5 4.1 9.9 2.0 0.4 0.0 0.0 0.0 0.1 C8orf59 ENSG00000176731 "Chromosome 8 open reading frame 59" Q8N0T1 8 85214076-85220421 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044805, HPA071903" Enhanced Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "HPA044805: AB_2679095, HPA071903: AB_2686469" "unprognostic (1.61e-2)" "unprognostic (2.98e-1)" "unprognostic (4.51e-1)" "unprognostic (1.63e-3)" "unprognostic (2.19e-2)" "unprognostic (1.71e-1)" "unprognostic (1.36e-2)" "unprognostic (1.47e-1)" "unprognostic (1.22e-3)" "unprognostic (1.63e-1)" "unprognostic (1.69e-2)" "unprognostic (2.82e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.03e-2)" "unprognostic (3.16e-2)" "unprognostic (2.29e-1)" "unprognostic (3.84e-3)" 28.1 28.2 25.3 25.3 21.9 33.0 46.1 18.9 26.5 33.0 38.4 12.6 36.3 28.1 32.0 45.5 44.8 28.7 25.8 41.5 20.6 24.1 32.3 47.1 20.8 30.7 26.3 27.2 45.1 35.1 19.5 36.0 27.7 24.4 35.5 27.7 14.7 37.8 36.2 43.9 24.8 37.1 33.7 27.0 32.2 36.9 16.7 25.7 39.1 43.5 53.6 32.0 39.1 35.2 33.3 42.7 21.3 25.3 36.5 38.0 23.9 38.9 19.9 29.6 19.2 18.4 35.7 23.2 26.0 25.0 30.4 30.0 23.2 33.8 9.7 21.5 17.2 28.5 27.2 20.5 28.5 34.3 27.4 22.4 57.6 18.8 34.2 21.8 21.6 26.1 30.2 33.9 19.6 24.8 33.1 25.8 35.0 25.8 24.0 25.2 30.7 47.7 40.6 8.5 88.2 34.8 20.4 24.8 44.2 29.5 25.0 10.0 21.5 19.7 32.4 35.7 37.3 37.3 32.3 19.7 19.4 40.7 21.5 24.6 27.9 32.7 45.8 38.7 27.7 21.5 21.3 20.5 13.4 24.7 25.3 29.5 33.3 32.7 30.1 34.8 29.9 38.0 36.3 5.1 36.5 21.5 42.7 32.1 23.9 25.3 21.9 18.9 26.5 20.6 24.1 26.3 27.2 24.4 25.7 80.4 65.2 124.2 47.1 48.2 25.9 26.3 86.6 147.2 103.5 34.9 9.8 86.5 56.3 152.0 93.6 67.1 76.6 46.7 240.4 102.1 84.3 40.2 75.1 136.0 90.6 22.3 36.9 108.6 132.2 20.6 173.2 92.3 54.0 180.3 112.7 58.4 213.9 84.2 122.0 90.6 33.5 155.2 88.6 128.1 91.8 40.0 64.3 104.7 101.8 39.3 C8orf74 ENSG00000171060 "Chromosome 8 open reading frame 74" Q6P047 8 10672637-10700593 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 30.2" "Group enriched" "Detected in some" 103 "Early spermatids: 154.4;Late spermatids: 281.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "A549: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA027986 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA027986: AB_10600762" "unprognostic (4.24e-2)" "unprognostic (5.62e-2)" "unprognostic (4.68e-2)" "unprognostic (5.54e-2)" "unprognostic (2.37e-2)" "unprognostic (1.56e-4)" "unprognostic (6.82e-2)" "unprognostic (2.20e-2)" 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.6 0.6 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 1.4 0.0 0.1 0.0 0.2 0.1 30.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.5 0.1 0.0 0.6 1.4 0.5 0.9 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.6 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.8 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.3 0.1 0.3 0.0 0.5 0.5 0.3 0.6 0.1 0.0 0.1 0.1 0.0 0.0 0.4 0.8 0.8 0.3 0.3 0.0 0.2 0.1 0.3 0.3 0.0 0.3 0.1 0.2 0.3 0.4 0.5 0.1 0.5 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 154.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 281.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.1 0.9 0.0 0.0 0.0 0.0 0.0 C8orf76 FLJ14825 ENSG00000189376 "Chromosome 8 open reading frame 76" Q96K31 8 123219957-123241398 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Horizontal cells: 128.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 59.8" HPA023708 Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA023708: AB_1845785" "prognostic unfavorable (9.95e-4)" "unprognostic (1.61e-1)" "unprognostic (9.71e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (1.27e-1)" "unprognostic (6.78e-2)" "unprognostic (4.47e-3)" "unprognostic (1.48e-2)" "unprognostic (2.49e-2)" "unprognostic (1.43e-1)" "unprognostic (3.50e-1)" "unprognostic (7.80e-2)" "prognostic unfavorable (5.95e-11)" "unprognostic (1.54e-2)" "unprognostic (1.94e-1)" "unprognostic (3.26e-1)" "unprognostic (2.71e-2)" 11.9 15.4 13.5 11.4 21.8 13.8 14.5 18.5 15.2 12.0 13.5 11.5 27.0 11.8 9.2 16.1 16.4 9.5 11.2 11.1 11.5 11.8 10.1 19.3 10.2 15.9 11.8 10.6 9.8 12.3 8.5 24.0 15.5 10.9 11.5 15.8 12.5 13.9 23.7 16.9 10.0 12.5 10.8 9.4 15.9 10.4 7.4 14.4 18.8 13.9 9.9 18.3 10.3 10.7 12.7 17.2 24.4 18.9 13.4 18.6 11.0 8.5 7.9 7.4 5.2 7.2 6.7 5.0 8.1 7.9 9.5 9.6 7.2 6.3 5.9 8.9 7.7 7.1 6.6 8.4 4.4 10.8 9.3 12.0 6.9 3.6 10.1 13.1 3.6 5.7 4.9 8.6 8.5 7.1 5.7 8.4 9.3 9.8 4.6 7.8 25.0 10.5 8.2 6.0 20.9 13.8 5.6 3.8 6.7 8.1 7.1 9.7 9.1 8.1 59.8 8.5 7.9 7.3 8.8 4.6 5.4 10.4 5.8 6.6 6.1 6.7 6.3 5.8 8.2 5.8 15.9 16.7 24.4 13.3 18.9 13.9 11.2 14.5 16.8 17.2 12.7 13.9 13.7 9.8 13.4 15.3 14.9 18.6 11.0 13.5 21.8 18.5 15.2 11.5 11.8 11.8 10.6 10.9 14.4 11.9 1.3 15.7 15.3 11.9 7.9 4.8 5.1 14.7 5.7 1.8 9.8 23.3 5.0 14.4 2.3 5.8 16.8 0.0 10.4 25.8 12.4 15.5 21.9 9.8 20.4 128.7 23.7 8.0 17.1 3.0 11.8 16.5 13.5 19.0 12.8 10.2 13.7 14.4 7.1 7.9 7.1 19.4 4.5 13.1 19.3 10.0 33.6 13.8 14.0 34.2 C8orf82 MGC70857 ENSG00000213563 "Chromosome 8 open reading frame 82" Q6P1X6 8 144525733-144529132 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 117.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB034331 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB034331: AB_1565393" "unprognostic (3.56e-1)" "unprognostic (1.28e-1)" "unprognostic (1.13e-1)" "unprognostic (1.63e-2)" "unprognostic (8.60e-2)" "unprognostic (6.31e-3)" "unprognostic (1.95e-1)" "unprognostic (4.57e-2)" "unprognostic (3.82e-1)" "unprognostic (1.22e-1)" "unprognostic (3.61e-1)" "unprognostic (4.09e-2)" "prognostic favorable (1.70e-5)" "unprognostic (5.72e-3)" "unprognostic (3.51e-1)" "unprognostic (1.41e-1)" "unprognostic (1.87e-3)" 11.1 11.4 7.9 10.6 8.1 4.2 16.1 8.6 11.6 14.2 19.4 7.8 8.1 16.8 10.2 10.4 13.3 9.3 14.7 16.3 8.1 6.1 12.7 29.1 7.9 8.9 8.8 7.8 13.4 17.5 19.7 10.2 7.1 6.3 32.8 6.4 8.2 18.0 11.4 12.2 8.9 17.7 7.4 5.1 11.0 12.2 12.7 8.0 8.5 14.8 10.3 7.0 12.4 9.6 1.7 1.5 1.7 2.1 0.9 1.2 0.3 3.6 9.4 5.6 4.5 2.3 2.0 4.7 4.0 2.2 2.2 2.2 4.6 6.3 6.5 6.5 2.5 1.9 4.5 1.2 1.3 0.8 4.9 14.6 12.6 5.4 8.5 2.4 1.9 6.1 3.0 3.1 1.4 1.4 3.6 1.5 3.7 10.2 3.3 1.6 19.5 4.7 7.7 3.0 5.5 26.6 5.4 1.9 3.1 3.4 5.6 19.2 15.6 6.1 4.4 3.9 2.0 8.1 3.9 8.1 4.3 16.7 4.7 2.8 2.4 1.5 5.1 5.7 2.4 4.1 0.8 2.1 1.7 0.6 0.8 0.7 1.4 0.2 0.6 0.9 1.7 0.6 0.7 0.0 0.9 1.7 1.5 1.2 0.3 7.9 8.1 8.6 11.6 8.1 6.1 8.8 7.8 6.3 8.0 3.0 8.6 8.8 41.8 14.2 30.4 14.5 15.3 0.0 1.2 15.7 13.7 26.9 117.7 3.8 12.7 6.7 36.0 0.0 6.5 29.6 15.4 46.1 5.7 63.1 16.7 27.0 32.8 8.0 12.0 15.6 22.5 16.8 32.1 2.8 28.3 26.3 6.6 17.3 19.1 83.0 30.6 32.3 25.4 30.2 18.1 18.2 21.1 11.4 31.0 38.8 C9orf116 "MGC29761, PIERCE1, RbEST47" ENSG00000160345 "Chromosome 9 open reading frame 116" Q5BN46 9 135495181-135501734 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 63.3;testis: 47.8" "Group enriched" "Detected in many" 5 "Ciliated cells: 473.8;Early spermatids: 387.4;Late spermatids: 493.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 22.6;T-47d: 23.4;U-2197: 24.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021439, HPA065287" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021439: AB_1845799, HPA065287: AB_2732732" "unprognostic (9.02e-2)" "unprognostic (1.36e-2)" "unprognostic (1.93e-1)" "prognostic favorable (3.53e-5)" "unprognostic (7.43e-2)" "unprognostic (1.24e-1)" "unprognostic (1.12e-1)" "unprognostic (4.23e-1)" "unprognostic (2.58e-1)" "unprognostic (5.30e-2)" "unprognostic (1.94e-1)" "unprognostic (4.88e-2)" "unprognostic (4.23e-3)" "unprognostic (3.86e-2)" "unprognostic (8.75e-2)" "unprognostic (1.03e-1)" "unprognostic (1.02e-1)" 1.5 7.2 8.0 1.0 9.2 1.0 2.2 1.5 6.2 4.1 1.1 6.2 8.2 1.1 3.3 22.1 1.0 63.3 2.7 1.5 9.6 9.3 7.8 1.5 9.8 0.9 4.9 4.9 9.3 4.5 3.3 7.6 1.5 19.9 2.0 1.3 1.7 2.0 5.0 1.4 1.2 1.0 1.3 2.6 1.0 1.8 47.8 2.6 0.1 6.7 0.2 1.2 2.2 0.3 1.7 0.9 0.1 2.6 1.8 4.2 1.1 5.9 10.3 4.5 7.1 2.0 4.3 0.9 4.0 2.9 4.9 3.3 3.9 6.0 1.0 5.4 2.7 2.7 4.1 5.0 2.2 4.2 0.3 4.6 0.0 11.4 11.9 5.6 0.8 2.8 3.0 1.7 2.4 0.8 4.0 2.3 4.8 5.5 0.8 2.3 22.6 3.0 1.0 9.6 9.3 12.1 4.7 2.2 3.7 11.6 4.3 4.4 4.7 5.7 2.4 0.6 2.2 23.4 1.0 1.1 2.8 3.7 24.2 1.5 2.7 6.6 0.9 8.4 0.3 0.8 0.1 2.6 0.0 1.9 1.6 4.2 0.7 1.3 1.4 0.9 1.7 2.4 1.8 0.0 1.8 0.4 0.4 1.6 1.1 8.0 9.2 1.5 6.2 9.6 9.3 4.9 4.9 19.9 2.6 8.9 5.6 0.0 2.5 0.8 4.6 1.4 7.6 473.8 29.6 14.0 13.7 9.7 10.0 23.1 387.4 1.5 0.7 0.0 7.0 1.8 2.7 2.3 1.1 1.6 3.1 3.2 1.2 0.6 1.9 493.5 7.5 1.9 0.0 3.6 1.0 6.5 9.2 1.4 7.1 40.0 15.4 0.0 1.0 87.1 20.2 0.3 3.8 0.0 1.7 1.4 C9orf152 bA470J20.2 ENSG00000188959 "Chromosome 9 open reading frame 152" Q5JTZ5 9 110190048-110208189 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 20.9;salivary gland: 34.3;stomach 1: 20.7" "Cell type enhanced" "Detected in many" 16 "Mucus-secreting cells: 113.3;Undifferentiated cells: 69.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Lineage enriched" "Detected in single" 14 "granulocytes: 1.5" "Cell line enriched" "Detected in some" 8 "OE19: 57.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA050769 Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA050769: AB_2681230" "unprognostic (1.90e-2)" "unprognostic (2.61e-1)" "unprognostic (1.16e-1)" "prognostic favorable (7.22e-5)" "unprognostic (2.28e-1)" "unprognostic (1.79e-3)" "unprognostic (6.86e-2)" "unprognostic (1.34e-1)" "unprognostic (4.84e-2)" "unprognostic (1.71e-1)" "unprognostic (1.14e-1)" "unprognostic (5.09e-2)" "unprognostic (5.46e-3)" "unprognostic (2.64e-1)" "unprognostic (4.57e-1)" "unprognostic (2.49e-1)" "unprognostic (1.06e-2)" 0.4 0.0 0.4 1.7 0.4 0.0 6.1 0.4 0.4 5.3 16.1 0.5 10.5 9.1 1.0 0.4 2.4 1.5 7.1 0.4 0.4 0.0 0.4 0.5 3.6 0.4 0.4 0.4 0.4 3.9 0.0 0.8 0.4 0.4 11.6 20.9 0.4 34.3 17.0 0.4 3.8 7.0 0.4 0.4 0.4 20.7 0.4 0.4 0.4 0.4 1.6 5.2 1.3 0.4 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 57.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 3.7 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 8.9 12.3 0.0 2.5 0.2 0.0 0.2 22.9 5.3 10.3 0.0 0.0 0.0 0.0 4.3 0.0 0.0 7.7 0.0 9.9 0.0 0.2 16.2 0.0 0.9 0.1 0.0 24.9 0.0 0.0 0.0 0.0 0.2 10.1 0.0 113.3 0.0 5.3 28.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 69.7 4.7 C9orf153 bA507D14.1 ENSG00000187753 "Chromosome 9 open reading frame 153" Q5TBE3 9 86220265-86259657 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 24.5" "Group enriched" "Detected in some" 70 "Early spermatids: 170.5;Late spermatids: 185.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTCEpi: 4.5" HPA079466 Approved "Nucleoplasm,Nuclear bodies,Vesicles,Plasma membrane" NA NA "Nuclear bodies, Plasma membrane" "Nucleoplasm, Vesicles" "HPA079466: " "unprognostic (2.03e-1)" "unprognostic (1.79e-1)" "unprognostic (1.13e-2)" "unprognostic (2.33e-2)" "unprognostic (1.78e-1)" "unprognostic (5.30e-3)" "unprognostic (7.49e-2)" "unprognostic (2.75e-2)" "unprognostic (3.37e-1)" "unprognostic (6.85e-2)" "unprognostic (9.70e-2)" "unprognostic (1.49e-1)" "unprognostic (2.01e-6)" "unprognostic (9.43e-2)" "unprognostic (1.92e-1)" "unprognostic (9.64e-2)" "unprognostic (2.10e-1)" 0.1 0.2 0.1 0.1 0.1 2.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.2 0.2 0.4 0.1 0.1 0.1 0.1 0.0 0.6 0.8 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 24.5 0.3 0.1 0.2 0.1 0.1 0.1 0.1 0.4 0.5 0.6 0.2 0.8 1.1 0.0 0.6 2.2 0.0 1.2 0.1 1.3 1.6 1.2 0.0 0.0 0.8 0.0 2.5 2.4 0.9 2.3 1.7 0.5 1.2 2.0 1.6 0.6 1.0 0.1 2.8 0.4 0.1 0.4 1.1 0.3 4.5 1.5 0.0 0.0 1.0 2.8 0.0 1.9 1.7 0.1 0.8 0.4 0.7 0.1 1.6 0.4 0.8 3.0 0.3 0.0 0.3 0.1 0.0 0.0 0.4 1.1 0.0 0.6 0.2 0.9 2.1 0.2 0.8 2.0 0.3 0.7 0.1 0.5 1.0 0.6 0.2 0.1 1.1 0.0 0.4 0.2 0.1 0.0 0.0 0.4 0.8 0.3 0.0 0.8 0.0 0.5 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 170.5 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 185.9 2.6 0.0 1.7 0.0 0.0 0.6 0.1 0.0 0.7 0.0 0.0 0.0 0.2 1.8 1.3 0.1 0.1 0.0 0.0 0.3 C9orf24 "bA573M23.4, CBE1, MGC32921, MGC33614, NYD-SP22, SMRP1" ENSG00000164972 "Chromosome 9 open reading frame 24" Q8NCR6 9 34379019-34397832 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 47.6;fallopian tube: 76.2;testis: 23.7" "Group enriched" "Detected in many" 10 "Ciliated cells: 1197.9;Early spermatids: 656.4;Late spermatids: 2140.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 17.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Hep G2: 4.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA053008 Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA053008: AB_2682015" "unprognostic (3.62e-3)" "unprognostic (9.06e-3)" "unprognostic (1.00e-1)" "prognostic favorable (3.23e-5)" "unprognostic (7.66e-2)" "unprognostic (1.21e-2)" "unprognostic (2.40e-1)" "unprognostic (1.25e-1)" "unprognostic (2.72e-1)" "unprognostic (1.58e-1)" "prognostic favorable (1.75e-4)" "unprognostic (1.33e-1)" "unprognostic (6.39e-3)" "unprognostic (1.50e-1)" "unprognostic (7.43e-3)" "unprognostic (4.72e-2)" "unprognostic (1.90e-2)" 1.5 1.2 12.7 1.0 20.0 0.8 1.0 1.5 10.8 3.3 1.6 12.2 0.0 2.1 1.3 7.2 1.1 76.2 1.0 4.8 11.2 11.0 1.9 1.0 10.3 0.9 5.3 6.4 6.2 1.5 0.8 3.1 0.9 47.6 1.5 1.3 0.0 2.0 1.1 1.6 1.2 4.3 1.2 2.0 0.9 1.4 23.7 3.0 0.0 1.2 0.1 1.0 0.9 0.0 0.6 0.4 0.1 0.1 0.9 3.6 0.5 0.8 0.0 1.6 0.6 0.3 0.0 1.3 0.6 0.6 0.3 1.4 1.4 0.0 0.3 0.6 0.0 0.7 1.2 0.5 0.2 0.0 2.3 1.3 0.0 1.6 4.1 0.0 0.1 2.0 0.3 0.2 0.4 0.0 0.5 0.6 1.0 0.0 0.6 0.2 0.0 1.3 0.9 0.6 1.2 0.9 0.6 0.1 0.1 0.5 0.1 1.6 0.6 0.0 0.4 0.1 0.1 1.1 0.0 0.0 1.3 1.0 0.5 0.9 2.5 1.4 0.4 1.4 0.2 2.5 0.0 0.0 0.0 1.1 0.1 0.0 0.6 1.3 0.4 0.4 0.0 3.6 1.1 0.1 0.9 0.0 0.0 1.7 0.5 12.7 20.0 1.5 10.8 11.2 11.0 5.3 6.4 47.6 3.0 6.0 13.7 0.0 2.6 1.9 1.0 34.3 2.5 1197.9 128.5 7.0 0.0 0.5 61.3 0.5 656.4 1.0 15.5 0.0 1.3 0.2 0.5 2.8 8.1 2.9 0.4 0.0 11.6 1.8 0.3 2140.7 9.8 2.5 0.0 0.0 9.8 1.2 0.3 6.2 6.7 5.7 0.8 32.3 0.3 10.8 3.8 0.9 0.5 0.0 16.4 1.7 C9orf40 FLJ10110 ENSG00000135045 "Chromosome 9 open reading frame 40" Q8IXQ3 9 74946581-74952886 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 31.1" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 43.7;Spermatocytes: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 5.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042167 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA 290000 "Nucleoplasm, Cytosol" Centrosome "HPA042167: AB_10797382" "unprognostic (2.10e-1)" "unprognostic (7.65e-2)" "unprognostic (2.94e-1)" "unprognostic (7.65e-2)" "unprognostic (6.27e-2)" "unprognostic (4.18e-1)" "prognostic unfavorable (3.43e-4)" "unprognostic (6.12e-2)" "unprognostic (1.11e-1)" "unprognostic (7.73e-2)" "unprognostic (1.15e-1)" "unprognostic (6.15e-3)" "unprognostic (6.78e-3)" "unprognostic (3.74e-2)" "unprognostic (4.21e-2)" "unprognostic (5.38e-2)" "unprognostic (2.20e-2)" 6.2 4.0 8.3 9.7 8.0 9.0 18.8 8.1 12.4 5.1 9.9 5.6 2.8 14.3 5.2 3.0 5.2 3.6 5.0 3.6 7.4 8.4 4.1 5.1 2.8 8.4 8.4 5.6 4.2 3.5 6.6 4.4 6.5 6.7 3.9 9.2 2.2 3.0 4.8 4.7 3.5 18.7 4.9 11.2 5.4 3.6 31.1 5.1 10.5 3.0 3.4 8.0 5.0 16.0 1.8 0.9 5.3 0.5 0.0 2.1 0.3 16.8 3.7 9.7 3.9 3.9 5.1 18.1 13.5 4.2 9.4 10.2 1.0 5.3 15.3 4.0 3.3 15.8 5.0 7.6 0.7 15.1 20.6 11.8 8.1 6.8 6.4 3.2 9.7 12.9 2.5 5.1 5.2 3.7 3.8 2.9 11.2 11.4 10.4 12.3 4.7 17.1 11.4 11.4 8.9 11.4 16.0 7.6 3.7 3.9 4.1 10.6 4.7 5.9 5.0 4.0 9.0 6.1 7.5 3.7 8.5 9.6 11.6 11.7 20.0 14.9 9.7 6.5 10.9 9.1 1.8 0.2 5.3 1.0 0.4 0.4 1.8 1.1 1.0 0.2 1.3 2.1 1.3 0.5 0.0 0.5 0.9 1.2 0.3 8.3 8.0 8.1 12.4 7.4 8.4 8.4 5.6 6.7 5.1 3.0 0.3 6.0 3.5 2.2 7.2 43.7 0.0 1.4 0.0 3.5 7.9 15.9 1.7 2.7 9.5 8.6 12.7 0.0 2.7 19.6 4.0 2.4 0.0 3.4 9.3 1.6 1.2 9.2 3.3 1.3 4.0 1.7 1.7 3.6 4.9 4.5 2.9 8.6 4.9 1.4 13.1 0.0 4.2 46.8 10.7 4.5 10.3 3.2 15.2 3.8 C9orf78 "HCA59, HSPC220" ENSG00000136819 "Chromosome 9 open reading frame 78" Q9NZ63 9 129827290-129835863 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021216, HPA021232, HPA021242" Enhanced Enhanced Nucleoplasm No No Nucleoplasm "HPA021216: AB_1845836, HPA021232: AB_1845837, HPA021242: AB_1845838" "unprognostic (1.00e-1)" "unprognostic (4.23e-3)" "unprognostic (1.03e-2)" "unprognostic (1.83e-1)" "unprognostic (3.35e-2)" "unprognostic (7.03e-2)" "unprognostic (3.50e-2)" "unprognostic (6.02e-3)" "unprognostic (1.27e-1)" "unprognostic (1.26e-1)" "unprognostic (1.13e-2)" "unprognostic (1.43e-2)" "prognostic favorable (3.49e-7)" "unprognostic (5.34e-2)" "unprognostic (1.83e-1)" "unprognostic (2.13e-1)" "unprognostic (1.94e-1)" 23.9 29.0 42.7 24.5 44.0 73.8 28.0 37.0 34.5 24.0 24.7 27.6 25.5 21.8 24.1 28.9 26.2 21.5 24.8 28.7 40.3 39.6 44.8 41.7 21.8 35.7 39.5 30.8 31.1 26.3 20.9 26.6 24.5 29.3 27.5 27.6 18.0 26.7 26.4 45.8 27.8 25.9 28.9 38.7 28.1 22.5 32.3 32.8 42.0 33.6 23.5 34.0 32.4 31.3 28.5 22.9 57.6 43.6 37.8 52.8 34.4 9.3 9.3 10.0 15.6 17.9 12.1 12.4 13.6 11.0 12.2 8.9 9.7 9.9 14.6 11.0 15.5 19.2 20.1 13.7 11.6 10.2 14.3 9.8 23.3 16.6 10.2 11.9 33.8 24.1 11.0 20.6 14.9 12.7 12.3 11.1 62.7 58.3 17.9 14.8 22.4 43.3 43.5 14.8 38.1 22.3 12.5 15.4 30.9 12.2 6.4 8.3 15.8 20.5 19.1 16.3 9.9 16.7 23.9 12.5 18.2 13.8 17.8 17.1 8.0 23.2 23.8 15.1 27.5 14.9 36.4 23.3 57.6 44.4 35.3 43.9 28.5 46.4 48.0 19.2 28.1 52.8 48.2 18.0 37.8 43.6 22.9 48.9 34.4 42.7 44.0 37.0 34.5 40.3 39.6 39.5 30.8 29.3 32.8 83.4 75.8 65.1 59.9 69.4 38.3 50.4 61.1 103.1 105.8 54.1 35.3 62.3 106.1 56.0 34.8 56.1 58.8 186.9 78.2 64.8 51.4 57.1 128.5 71.9 59.9 30.2 81.0 35.6 56.4 11.6 54.7 75.9 69.2 90.2 53.5 48.4 55.0 38.6 57.3 121.7 34.8 77.6 67.6 82.1 101.3 74.3 56.5 139.4 52.1 49.2 C9orf85 MGC61599 ENSG00000155621 "Chromosome 9 open reading frame 85" Q96MD7 9 71911510-71986054 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050767, HPA076627" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" No No "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA050767: AB_2681229, HPA076627: " "unprognostic (7.81e-2)" "unprognostic (2.80e-1)" "unprognostic (6.21e-2)" "unprognostic (3.04e-1)" "unprognostic (2.89e-2)" "unprognostic (2.87e-2)" "unprognostic (1.99e-2)" "unprognostic (2.34e-1)" "unprognostic (1.01e-1)" "unprognostic (3.05e-1)" "unprognostic (1.27e-1)" "unprognostic (3.48e-1)" "unprognostic (1.10e-2)" "unprognostic (8.10e-2)" "unprognostic (6.60e-2)" "unprognostic (4.02e-1)" "unprognostic (6.18e-2)" 13.4 12.7 15.5 10.1 26.0 8.9 14.7 11.2 18.8 12.8 12.9 18.2 15.0 19.3 14.1 14.3 18.4 11.6 12.0 10.5 14.9 13.8 12.3 13.1 10.4 13.0 24.5 13.3 16.9 14.7 9.8 16.9 13.9 15.2 13.1 13.7 14.3 14.7 9.8 14.6 18.4 16.3 15.2 21.1 10.7 11.2 9.2 21.9 14.5 14.8 15.9 12.9 18.8 15.5 11.3 13.1 16.1 9.9 17.1 14.6 9.3 7.7 5.1 9.1 7.4 9.6 17.4 9.3 10.0 15.5 8.1 7.9 1.1 4.7 12.7 5.1 8.6 8.5 14.3 9.5 9.5 11.2 8.9 4.7 7.8 7.5 6.4 10.3 11.4 6.4 14.1 13.0 8.1 17.8 12.7 9.9 12.3 9.2 8.6 10.2 4.0 13.7 8.0 8.6 12.5 12.6 8.1 15.8 0.3 11.5 11.3 7.6 10.0 4.9 12.7 16.5 10.4 4.5 6.6 8.7 7.5 9.6 16.9 7.3 8.6 14.1 5.8 10.1 8.7 4.8 16.1 8.9 12.6 13.4 9.9 13.7 10.9 11.5 11.5 9.3 11.3 14.0 14.6 9.9 17.1 8.3 13.1 10.5 9.3 15.5 26.0 11.2 18.8 14.9 13.8 24.5 13.3 15.2 21.9 6.0 14.2 13.0 11.4 6.8 10.6 10.8 5.1 9.4 11.4 5.2 7.9 17.8 18.3 12.3 6.1 11.6 23.0 0.0 17.3 15.9 12.4 13.2 18.4 8.7 12.9 4.8 6.3 16.0 12.4 4.5 19.2 13.3 3.3 11.8 17.8 11.2 14.2 17.5 12.4 15.1 11.5 12.9 12.7 13.0 14.2 8.5 9.0 12.2 16.3 17.9 CA13 "CAXIII, FLJ37995, MGC59868" ENSG00000185015 "Carbonic anhydrase 13" Q8N1Q1 8 85220587-85284073 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 56.7" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 12.5;OE19: 24.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024689, CAB025567" Enhanced Approved Nucleoplasm,Nucleoli,Vesicles NA NA 100000 Nucleoli "Nucleoplasm, Vesicles" "CAB025567: , HPA024689: AB_1846004" "unprognostic (1.12e-2)" "unprognostic (2.20e-1)" "unprognostic (1.75e-1)" "unprognostic (9.16e-5)" "unprognostic (2.21e-2)" "unprognostic (2.08e-1)" "unprognostic (9.39e-2)" "unprognostic (7.90e-3)" "unprognostic (1.97e-1)" "unprognostic (1.34e-2)" "unprognostic (3.58e-2)" "unprognostic (3.13e-1)" "prognostic favorable (9.40e-4)" "unprognostic (7.59e-2)" "unprognostic (1.59e-1)" "unprognostic (1.55e-2)" "unprognostic (3.00e-1)" 2.6 2.6 2.0 1.9 3.1 0.5 2.9 2.4 2.4 3.2 18.2 0.8 0.0 14.2 1.8 1.7 6.7 1.4 25.6 5.8 1.6 1.9 10.4 17.1 9.5 2.4 2.0 0.1 2.2 1.6 9.3 6.5 1.0 5.7 2.6 3.7 1.9 7.0 1.0 1.9 7.1 56.7 1.9 5.2 2.2 7.0 0.9 0.9 0.4 10.3 3.9 5.6 2.9 5.2 0.8 2.1 3.2 2.5 0.5 0.5 1.0 0.2 0.3 0.7 0.1 0.5 0.5 0.3 0.8 0.9 0.1 2.4 5.8 4.5 0.3 0.4 1.0 5.1 1.9 1.8 2.3 0.1 1.3 0.8 12.5 1.6 5.3 1.2 0.2 0.5 1.9 0.4 0.2 1.0 1.5 1.3 0.5 3.1 2.4 2.1 0.0 0.2 0.2 0.3 24.6 0.3 0.2 1.8 0.1 6.7 0.2 0.2 0.0 0.4 0.0 1.3 0.9 0.4 0.6 1.2 2.3 3.3 0.1 1.3 1.0 0.4 1.5 4.8 1.8 2.2 3.2 2.5 1.3 0.4 0.7 0.2 0.2 0.2 0.1 2.1 0.8 0.3 0.5 0.9 0.5 0.8 0.9 0.1 1.0 2.0 3.1 2.4 2.4 1.6 1.9 2.0 0.1 5.7 0.9 3.0 7.7 1.4 2.1 1.5 1.5 5.2 5.1 10.7 12.5 12.2 31.4 0.2 8.3 3.2 9.1 2.1 16.9 0.0 1.4 0.2 3.1 2.1 0.0 4.7 0.9 0.0 4.6 9.8 3.0 10.4 0.0 2.2 5.0 0.0 3.2 2.0 3.1 4.9 0.0 16.1 5.1 0.0 1.0 1.2 2.3 2.8 0.2 1.0 3.4 1.8 CABCOCO1 "bA63A2.1, C10orf107, Em:AC022398.2, MGC44593" ENSG00000183346 "Ciliary associated calcium binding coiled-coil 1" Q8IVU9 10 61662961-61766766 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 33.1;testis: 18.6" "Cell type enriched" "Detected in some" 12 "Ciliated cells: 163.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "MOLT-4: 24.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041398 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA Centrosome "Nucleoplasm, Cytosol" "HPA041398: AB_10794374" "unprognostic (1.89e-3)" "unprognostic (7.37e-2)" "unprognostic (2.23e-1)" "prognostic favorable (1.79e-4)" "prognostic unfavorable (4.88e-4)" "unprognostic (1.02e-1)" "unprognostic (2.55e-1)" "unprognostic (5.52e-2)" "unprognostic (4.43e-2)" "unprognostic (3.31e-1)" "unprognostic (1.16e-1)" "unprognostic (1.26e-2)" "unprognostic (3.46e-1)" "unprognostic (1.52e-3)" "unprognostic (2.48e-1)" "unprognostic (2.90e-2)" "unprognostic (1.33e-2)" 1.5 1.2 6.3 0.7 5.7 0.5 2.1 0.4 6.8 6.1 1.6 9.5 3.0 1.0 5.2 7.6 0.9 33.1 3.8 0.7 8.1 7.3 2.6 0.9 10.3 0.9 8.1 5.8 4.1 1.6 10.0 5.2 1.4 13.7 5.9 1.3 1.5 1.7 3.7 0.6 0.8 0.9 3.0 14.8 1.9 0.9 18.6 5.6 0.0 1.9 0.0 0.6 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 2.4 0.0 0.4 1.6 0.3 0.5 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.2 2.4 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.1 0.1 0.9 0.9 0.5 0.1 0.0 0.1 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 5.4 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 5.7 0.4 6.8 8.1 7.3 8.1 5.8 13.7 5.6 3.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 163.3 13.6 3.5 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 CABIN1 "KIAA0330, PPP3IN" ENSG00000099991 "Calcineurin binding protein 1" Q9Y6J0 22 24011192-24178628 "Plasma proteins, Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 84.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043296 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043296: AB_10794657" "unprognostic (8.52e-2)" "unprognostic (3.16e-1)" "unprognostic (2.74e-2)" "prognostic favorable (9.57e-5)" "unprognostic (3.43e-2)" "unprognostic (3.06e-3)" "unprognostic (1.04e-2)" "unprognostic (2.92e-2)" "unprognostic (6.21e-2)" "unprognostic (3.75e-1)" "unprognostic (3.46e-3)" "unprognostic (1.01e-1)" "prognostic favorable (2.94e-4)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" "unprognostic (8.50e-3)" "unprognostic (7.79e-2)" 14.4 14.6 15.9 18.5 22.9 34.2 13.4 47.2 29.2 17.5 17.3 23.3 22.6 17.6 24.9 17.2 12.4 23.7 16.9 15.4 14.7 13.2 18.2 13.7 19.7 22.4 12.7 17.4 16.6 18.2 24.4 24.9 12.0 17.8 17.6 11.4 19.0 18.6 24.2 10.2 20.7 16.7 18.0 10.9 21.2 18.6 24.4 10.8 22.5 27.0 10.6 19.3 14.1 14.2 4.1 2.7 15.9 3.7 4.8 7.0 2.0 12.5 9.2 12.5 11.0 11.4 13.2 17.7 10.6 9.3 8.6 9.8 11.3 6.2 14.7 5.9 10.6 11.1 12.0 14.9 9.7 7.7 24.5 14.6 12.6 10.4 23.7 5.4 29.0 13.7 11.2 6.3 10.5 7.9 10.3 14.3 13.3 26.1 8.1 4.9 16.2 13.7 31.5 7.8 17.7 6.6 13.4 9.2 18.3 7.8 12.8 16.2 13.9 13.2 9.2 13.4 11.9 8.2 13.1 11.6 19.9 15.6 7.6 7.6 14.2 8.4 8.9 9.3 13.9 8.3 5.9 3.7 12.9 5.5 2.5 6.2 2.5 4.2 7.0 2.3 4.1 5.0 4.6 15.9 4.8 1.7 2.7 3.2 2.0 15.9 22.9 47.2 29.2 14.7 13.2 12.7 17.4 17.8 10.8 20.8 35.7 15.2 7.4 7.3 31.7 10.2 5.1 20.1 6.8 8.7 84.4 11.7 6.6 9.2 12.4 12.9 12.3 0.0 8.3 5.7 12.0 8.0 17.3 8.2 18.8 31.8 14.3 15.4 12.9 11.5 19.8 12.6 10.1 19.8 10.9 13.3 9.9 3.5 18.7 6.2 52.5 19.4 22.6 37.5 30.6 8.3 18.8 34.6 12.1 6.4 CABLES1 "FLJ35924, HsT2563" ENSG00000134508 "Cdk5 and Abl enzyme substrate 1" Q8TDN4 18 23134564-23260467 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 40.6" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 24.3;Cone photoreceptor cells: 27.5;Ito cells: 29.4;Melanocytes: 27.0" "Cancer enriched" "Detected in all" 5 "melanoma: 38.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "NK-cell: 4.2" "Lineage enriched" "Detected in single" 8 "NK-cells: 4.2" "Cell line enhanced" "Detected in many" "SK-MEL-30: 42.9;U-266/70: 62.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073649 Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" NA NA "Nucleoplasm, Nuclear bodies" "HPA073649: AB_2732233" "unprognostic (1.27e-1)" "unprognostic (2.03e-1)" "unprognostic (1.97e-1)" "unprognostic (4.24e-3)" "unprognostic (1.56e-1)" "unprognostic (2.56e-3)" "unprognostic (3.24e-2)" "unprognostic (1.10e-3)" "unprognostic (1.42e-2)" "unprognostic (1.55e-1)" "unprognostic (1.08e-1)" "unprognostic (1.01e-1)" "prognostic favorable (4.71e-6)" "unprognostic (1.00e-1)" "unprognostic (1.60e-1)" "unprognostic (4.80e-2)" "unprognostic (7.81e-2)" 12.0 2.9 22.3 1.6 31.5 1.8 40.6 8.6 23.4 4.7 4.1 3.0 0.0 6.0 7.7 2.7 5.6 9.2 4.2 3.2 13.9 11.9 10.8 8.0 17.0 2.0 17.2 12.9 3.3 2.0 31.3 2.6 8.4 13.6 2.8 4.2 17.1 17.0 3.9 1.1 13.5 5.1 5.7 3.8 2.6 11.6 2.8 9.2 0.3 12.2 0.2 1.8 5.4 7.1 0.3 0.5 0.0 0.2 4.2 0.4 0.0 3.5 4.0 3.3 0.2 2.0 0.1 5.8 0.8 4.9 1.2 0.7 2.6 6.4 0.2 3.8 4.1 12.1 3.2 2.5 0.6 0.9 0.1 5.5 0.2 11.0 10.2 1.8 0.6 0.2 1.2 0.6 1.5 1.7 7.7 13.3 0.6 0.1 4.6 3.3 8.3 0.0 2.4 2.1 17.8 13.2 0.8 12.0 13.7 6.0 8.7 3.2 2.3 7.3 9.2 42.9 2.5 14.8 2.0 22.1 13.8 0.1 0.4 1.0 62.0 23.5 7.5 0.0 5.3 4.6 0.0 0.1 0.0 0.4 0.2 0.0 0.3 0.0 0.1 0.3 0.3 0.0 0.4 0.0 4.2 0.2 0.5 0.1 0.0 22.3 31.5 8.6 23.4 13.9 11.9 17.2 12.9 13.6 9.2 20.8 24.3 3.9 1.7 4.5 1.6 1.4 10.2 2.7 3.4 3.5 27.5 0.7 1.7 1.0 1.4 1.5 4.6 0.0 2.0 0.9 2.7 0.6 0.0 7.8 12.8 0.0 3.4 29.4 3.1 2.8 0.0 3.5 27.0 0.0 3.9 0.7 1.5 4.8 5.6 14.6 17.4 0.0 1.6 0.0 2.5 5.8 0.2 0.0 2.0 1.6 CABLES2 "C20orf150, dJ908M14.2, ik3-2" ENSG00000149679 "Cdk5 and Abl enzyme substrate 2" Q9BTV7 20 62388632-62407285 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 34.9" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 33.1;Late spermatids: 16.4;Spermatocytes: 16.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052138 Approved "Nucleoplasm,Nuclear bodies,Cell Junctions" NA NA "Nuclear bodies" "Nucleoplasm, Cell Junctions" "HPA052138: AB_2681743" "unprognostic (1.08e-1)" "unprognostic (1.36e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (5.26e-5)" "unprognostic (1.45e-2)" "unprognostic (1.51e-1)" "unprognostic (2.71e-2)" "unprognostic (5.07e-2)" "unprognostic (5.37e-3)" "unprognostic (6.05e-2)" "unprognostic (1.40e-3)" "unprognostic (3.09e-2)" "prognostic unfavorable (1.24e-6)" "unprognostic (1.99e-2)" "unprognostic (3.87e-1)" "unprognostic (1.67e-1)" "unprognostic (2.94e-2)" 2.3 3.3 5.9 5.6 5.6 8.3 2.8 15.1 10.2 3.4 4.4 3.6 1.3 3.6 3.7 3.6 3.7 4.7 3.0 10.5 4.3 5.5 2.6 3.6 2.9 5.7 4.9 5.3 4.3 3.7 4.1 5.8 4.3 7.2 4.1 4.1 3.1 3.6 4.2 5.4 5.2 4.9 4.3 3.5 4.1 3.8 34.9 5.4 5.1 5.7 2.6 5.2 4.1 3.2 1.4 1.1 1.0 1.1 1.5 4.1 0.5 9.3 7.0 12.2 12.4 1.9 2.7 1.7 5.3 5.3 14.9 6.9 25.4 5.4 9.4 4.6 3.4 20.4 6.0 7.4 3.5 5.8 4.2 4.1 11.0 3.7 6.1 3.4 4.4 5.7 1.7 4.0 4.3 1.6 2.6 3.4 12.3 2.8 8.3 3.3 11.5 11.6 3.5 4.0 9.4 8.1 16.1 10.3 4.1 2.2 6.2 6.6 10.2 7.8 10.4 2.1 4.8 7.0 6.8 3.5 13.8 4.2 18.1 5.5 8.0 6.5 11.2 12.4 5.1 7.2 0.0 0.9 0.2 2.7 1.1 1.5 1.4 1.9 2.1 1.1 1.1 1.0 1.2 1.0 1.5 1.1 0.9 4.1 0.5 5.9 5.6 15.1 10.2 4.3 5.5 4.9 5.3 7.2 5.4 3.0 1.7 2.2 0.5 0.8 6.4 6.7 0.0 0.0 3.4 0.0 3.9 0.9 1.7 1.7 33.1 1.5 1.5 0.0 2.0 0.5 2.1 0.9 0.0 1.5 1.7 12.7 3.4 1.8 2.4 16.4 1.7 1.5 0.0 0.0 3.3 1.6 1.9 2.9 3.2 0.7 2.9 0.0 0.9 16.7 7.3 1.8 1.9 0.0 2.5 0.5 CABYR "CBP86, CT88, FSP-2" ENSG00000154040 "Calcium binding tyrosine phosphorylation regulated" O75952 18 24138956-24161603 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 91.1" "Group enriched" "Detected in some" 47 "Early spermatids: 2235.7;Late spermatids: 2707.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basophil: 6.3;memory B-cell: 6.6;naive B-cell: 7.1;neutrophil: 2.9" "Group enriched" "Detected in many" 5 "B-cells: 7.1;granulocytes: 6.3" "Cell line enhanced" "Detected in many" "SiHa: 18.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040703, HPA047801" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA040703: AB_2677087, HPA047801: AB_2680159" "unprognostic (1.18e-3)" "unprognostic (4.18e-1)" "unprognostic (1.73e-1)" "unprognostic (2.65e-1)" "unprognostic (5.26e-2)" "unprognostic (9.07e-3)" "prognostic unfavorable (4.75e-4)" "unprognostic (1.46e-1)" "unprognostic (1.45e-1)" "unprognostic (2.37e-2)" "unprognostic (7.24e-3)" "unprognostic (1.58e-1)" "unprognostic (3.21e-4)" "unprognostic (2.52e-2)" "unprognostic (5.96e-2)" "unprognostic (1.21e-1)" "unprognostic (1.67e-1)" 0.8 1.2 3.9 0.7 3.2 0.7 2.3 0.7 4.8 3.0 0.7 3.5 0.0 0.7 1.5 1.2 1.0 1.8 1.0 0.5 3.6 2.1 0.6 0.5 0.6 0.8 3.1 3.0 0.9 0.7 0.4 9.5 0.7 5.4 1.0 0.8 0.6 0.9 1.0 0.6 1.1 0.7 1.7 2.3 0.7 0.8 91.1 2.9 0.0 0.7 0.0 0.7 1.5 0.6 7.1 0.7 6.3 0.5 1.3 1.0 0.4 3.4 9.1 2.5 1.3 2.9 7.1 10.9 6.1 3.9 7.5 8.2 1.8 6.8 0.1 5.0 9.1 0.3 3.3 2.6 5.3 8.1 0.4 4.1 0.2 4.9 2.0 4.0 0.3 0.4 8.6 8.5 9.8 2.6 3.7 2.2 0.4 0.0 0.2 2.0 1.0 0.1 0.3 8.1 0.4 5.3 0.5 0.3 0.1 3.3 4.2 5.3 6.6 18.6 3.8 0.3 1.6 8.6 0.9 1.2 0.6 1.8 2.5 0.1 0.2 0.2 0.0 3.6 0.7 0.3 6.3 0.5 1.0 0.4 0.3 0.2 6.6 0.5 0.5 0.2 7.1 0.4 1.0 2.9 1.3 0.5 0.7 0.2 0.4 3.9 3.2 0.7 4.8 3.6 2.1 3.1 3.0 5.4 2.9 0.0 0.0 0.0 0.8 0.2 1.9 0.3 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.6 2235.7 0.0 0.0 0.0 0.2 0.4 0.4 0.1 0.0 0.0 0.5 0.0 0.0 0.6 0.0 2707.1 21.6 0.0 1.7 0.0 0.0 0.0 0.2 0.2 20.5 0.0 1.8 19.4 0.4 52.7 14.1 0.0 0.0 0.0 0.0 0.1 CACFD1 "C9orf7, D9S2135, flower" ENSG00000160325 "Calcium channel flower domain containing 1" Q9UGQ2 9 133459965-133470848 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 7.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015280 Approved Nucleoplasm NA NA Nucleoplasm "HPA015280: AB_1845833" "unprognostic (3.15e-2)" "unprognostic (4.25e-1)" "unprognostic (1.96e-3)" "unprognostic (4.48e-1)" "unprognostic (2.77e-2)" "unprognostic (1.35e-1)" "unprognostic (1.19e-2)" "unprognostic (5.49e-2)" "unprognostic (3.97e-1)" "unprognostic (3.17e-1)" "unprognostic (1.67e-3)" "unprognostic (3.91e-2)" "prognostic favorable (2.83e-8)" "unprognostic (5.10e-2)" "unprognostic (1.24e-1)" "unprognostic (3.68e-2)" "unprognostic (3.99e-3)" 2.8 7.0 7.2 7.4 6.9 3.5 11.4 8.5 9.4 5.7 14.0 9.4 5.9 18.9 6.7 16.9 8.4 7.3 15.8 9.1 6.5 5.5 19.1 33.7 9.8 8.6 12.3 6.7 7.7 16.6 10.6 12.6 5.3 8.4 8.3 8.3 6.9 9.9 10.3 5.2 3.3 17.9 6.3 8.7 5.0 22.1 13.7 8.6 4.4 13.7 3.7 3.8 8.7 12.6 4.2 1.3 7.6 1.4 2.7 1.0 1.1 0.8 3.7 8.1 5.0 1.7 0.8 5.1 2.5 3.4 2.3 0.8 8.1 6.7 1.0 8.1 3.4 3.9 1.6 2.5 2.0 0.1 1.4 3.0 0.6 5.3 5.6 4.3 0.0 1.0 1.8 5.5 1.8 1.3 6.6 3.0 1.9 1.4 2.7 2.6 9.4 1.0 1.4 4.9 8.2 3.1 2.1 2.1 7.1 4.7 3.6 10.2 11.4 3.2 13.8 2.0 3.3 15.9 1.8 1.4 5.5 5.2 1.5 0.3 4.6 5.5 3.0 2.1 0.6 1.9 3.7 1.4 7.6 0.8 1.1 0.6 3.5 0.7 1.0 1.3 4.2 0.4 0.7 0.2 2.7 0.9 0.5 0.5 1.1 7.2 6.9 8.5 9.4 6.5 5.5 12.3 6.7 8.4 8.6 17.9 15.8 1.4 4.6 2.5 4.4 7.0 28.1 1.4 6.8 19.2 11.8 1.9 3.3 17.8 10.8 2.3 46.4 0.0 28.6 3.0 5.1 9.4 4.6 38.0 2.9 3.2 27.9 6.2 5.6 6.2 7.5 1.8 5.0 4.6 36.5 6.0 22.8 42.1 7.1 14.4 9.7 0.0 4.2 12.5 6.5 1.4 2.4 1.8 12.8 5.5 CACHD1 "KIAA1573, VWCD1" ENSG00000158966 "Cache domain containing 1" 1 64470792-64693058 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 37.5;Club cells: 18.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 11 "naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.1" "Cell line enhanced" "Detected in many" "AF22: 21.4;NTERA-2: 29.3;SuSa: 19.1;U-2197: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017202 Uncertain Uncertain Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA017202: AB_1852423" "unprognostic (2.92e-2)" "unprognostic (2.91e-1)" "unprognostic (1.29e-2)" "unprognostic (1.02e-1)" "unprognostic (3.75e-1)" "unprognostic (1.01e-1)" "unprognostic (4.82e-2)" "unprognostic (4.32e-2)" "unprognostic (6.77e-2)" "unprognostic (1.33e-1)" "unprognostic (8.16e-2)" "unprognostic (1.86e-1)" "unprognostic (1.24e-3)" "unprognostic (2.67e-2)" "unprognostic (3.89e-1)" "unprognostic (3.65e-1)" "unprognostic (2.13e-1)" 5.4 7.6 6.5 0.5 8.4 0.0 4.7 1.2 4.3 7.3 0.8 0.2 6.1 5.2 1.6 8.5 2.1 1.2 3.5 4.2 3.3 0.4 4.7 0.4 2.3 14.2 3.7 5.5 4.5 5.5 4.0 1.0 4.4 4.3 0.8 3.0 0.9 5.3 0.6 1.7 3.3 0.5 2.4 0.2 2.1 4.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.8 21.4 3.1 8.5 3.0 0.0 3.0 3.9 5.1 4.9 12.4 0.1 0.0 8.8 4.8 3.7 1.5 11.9 2.5 5.2 2.3 6.4 4.4 1.3 0.0 0.0 1.9 0.0 2.6 1.7 0.6 3.2 2.9 2.7 3.0 0.0 0.0 0.0 0.3 0.3 0.0 29.3 0.1 2.2 2.3 2.1 0.0 0.0 0.6 0.5 11.2 6.5 0.0 2.6 19.1 0.8 0.2 1.9 0.5 3.8 15.0 2.6 0.0 0.0 0.0 0.4 0.3 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 37.5 0.0 6.1 15.3 12.7 1.4 0.0 13.4 18.2 3.5 0.0 0.0 0.0 2.0 7.7 11.8 0.0 0.0 2.5 0.1 4.1 1.2 2.3 0.9 0.2 0.0 0.0 3.1 0.3 2.3 13.3 1.8 1.7 0.0 0.0 5.2 1.3 0.0 2.8 3.1 1.1 6.5 5.7 0.4 0.4 12.9 0.0 0.0 0.1 4.8 CACNA1H Cav3.2 ENSG00000196557 "Calcium voltage-gated channel subunit alpha1 H" O95180 16 1153121-1221772 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 49.5" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 16.2;Late spermatids: 13.2;Peritubular cells: 24.4;Sertoli cells: 25.8;Smooth muscle cells: 16.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 10.9;AN3-CA: 15.7;MCF7: 28.9;OE19: 9.6;T-47d: 8.6" "Low region specificity" "Detected in many" HPA039125 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA039125: AB_10795578" "unprognostic (1.66e-3)" "unprognostic (2.10e-1)" "unprognostic (4.07e-2)" "unprognostic (1.21e-3)" "unprognostic (1.37e-2)" "unprognostic (2.15e-1)" "unprognostic (4.39e-2)" "unprognostic (2.38e-2)" "unprognostic (1.06e-1)" "unprognostic (3.30e-2)" "prognostic favorable (3.12e-5)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.78e-5)" "unprognostic (1.93e-2)" "unprognostic (4.65e-2)" "unprognostic (1.70e-2)" "unprognostic (5.55e-2)" 5.0 6.8 5.1 4.2 12.0 0.3 3.3 0.3 4.3 17.5 28.1 1.6 10.2 5.4 25.7 5.9 16.3 11.7 26.0 2.2 2.5 2.1 4.7 5.5 3.5 0.7 1.0 2.8 31.8 2.1 6.6 14.8 1.9 2.0 21.0 2.2 4.2 1.7 24.9 2.9 4.8 8.5 49.5 1.1 0.5 9.7 11.7 2.1 0.0 5.2 1.4 0.5 34.6 20.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 10.9 1.9 15.7 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 6.4 0.0 0.0 6.5 1.9 0.0 2.8 0.2 0.0 0.0 0.0 0.0 0.0 1.9 2.9 0.0 0.0 28.9 0.0 0.0 5.9 9.6 2.2 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.0 0.0 0.5 0.7 8.6 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 12.0 0.3 4.3 2.5 2.1 1.0 2.8 2.0 2.1 0.0 0.0 0.0 0.0 1.3 16.2 1.8 2.5 0.0 0.0 0.0 0.0 0.0 0.0 3.1 5.0 1.2 0.0 0.0 0.0 0.0 0.2 3.3 4.6 8.1 0.1 0.0 10.4 0.6 0.0 13.2 7.8 0.0 0.0 0.0 0.3 0.8 0.7 0.0 24.4 0.8 1.0 25.8 16.5 1.8 4.5 3.0 0.0 0.0 0.0 0.5 CACNA2D3 HSA272268 ENSG00000157445 "Calcium voltage-gated channel auxiliary subunit alpha2delta 3" Q8IZS8 3 54122547-55074557 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.2;skeletal muscle: 19.5" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 28.9;Early spermatids: 77.9;Late spermatids: 41.2;Syncytiotrophoblasts: 56.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 6.2;HAP1: 2.8;HeLa: 14.0" "Low region specificity" "Detected in all" HPA030849 Uncertain Nucleoplasm NA NA 49000 Nucleoplasm "HPA030849: " "unprognostic (6.92e-2)" "unprognostic (1.35e-2)" "unprognostic (1.89e-1)" "unprognostic (4.34e-5)" "unprognostic (5.53e-3)" "unprognostic (2.64e-3)" "unprognostic (3.24e-1)" "unprognostic (1.17e-2)" "unprognostic (5.84e-3)" "unprognostic (7.22e-3)" "unprognostic (1.14e-2)" "unprognostic (2.43e-1)" "unprognostic (2.00e-1)" "unprognostic (1.47e-3)" "unprognostic (2.19e-1)" "unprognostic (3.62e-2)" "unprognostic (6.95e-2)" 1.5 10.3 6.4 1.3 21.9 1.0 1.5 2.4 23.2 1.5 2.0 1.4 0.2 1.4 1.4 4.0 2.1 2.1 1.6 5.1 8.9 8.0 3.8 1.1 2.2 2.2 4.8 12.8 6.7 1.2 1.1 2.4 2.1 9.0 3.4 1.7 2.4 1.9 4.4 19.5 1.2 1.7 2.4 1.7 1.6 1.9 3.9 4.2 0.0 2.1 3.6 2.1 1.0 2.1 0.2 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 1.7 0.2 14.0 0.0 0.8 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.2 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 6.4 21.9 2.4 16.1 8.9 8.0 4.8 12.8 9.0 4.2 0.0 0.0 0.0 0.3 0.2 9.8 28.9 0.0 1.4 1.2 0.0 7.9 8.4 6.6 0.0 77.9 0.1 0.0 0.0 0.6 2.3 2.4 0.2 0.0 0.0 5.4 0.0 0.0 0.6 7.9 41.2 2.6 10.3 0.0 0.0 0.0 4.3 0.8 0.0 1.4 0.1 1.3 6.5 1.9 5.0 2.2 0.1 56.9 0.0 0.0 0.4 CACTIN "C19orf29, cactin, fSAPc, NY-REN-24" ENSG00000105298 "Cactin, spliceosome C complex subunit" Q8WUQ7 19 3610641-3626815 "Predicted intracellular proteins" "Immunity, Innate immunity, mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042504, HPA042548" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "HPA042504: AB_10797501, HPA042548: AB_10794760" "unprognostic (1.18e-1)" "unprognostic (7.90e-3)" "unprognostic (1.09e-1)" "prognostic favorable (3.69e-5)" "unprognostic (5.93e-2)" "unprognostic (2.87e-3)" "unprognostic (3.38e-2)" "unprognostic (1.01e-2)" "unprognostic (3.84e-2)" "unprognostic (1.38e-2)" "unprognostic (1.17e-2)" "unprognostic (7.22e-3)" "unprognostic (3.88e-2)" "unprognostic (4.98e-3)" "unprognostic (5.78e-2)" "unprognostic (3.08e-2)" "unprognostic (5.55e-3)" 16.1 14.4 18.3 19.4 17.8 19.8 16.2 19.2 19.9 11.8 12.4 13.1 12.3 14.5 14.2 9.6 11.9 13.0 13.0 10.3 14.2 10.9 11.9 14.8 11.7 16.5 14.3 9.9 21.4 14.9 8.9 11.1 11.3 13.4 13.4 8.5 10.3 15.5 12.8 28.6 22.0 16.2 12.2 9.8 23.0 15.7 14.4 15.0 13.9 12.6 11.9 12.7 11.3 18.5 2.1 4.3 0.8 2.9 0.9 3.7 1.3 14.5 8.4 7.1 12.1 5.2 5.2 10.8 10.5 4.2 6.3 7.0 8.3 6.6 12.2 9.0 6.5 7.4 13.6 7.4 8.7 3.8 12.3 9.8 7.6 11.5 9.9 7.3 10.2 11.1 5.0 8.5 5.8 4.1 3.8 9.0 10.7 16.8 13.7 3.3 8.8 18.3 8.9 15.2 8.9 9.9 19.4 9.2 11.5 5.8 7.4 9.8 13.7 11.7 8.3 8.4 4.0 6.6 11.8 11.6 8.5 10.7 18.5 18.2 21.0 14.0 13.5 10.5 16.5 11.4 0.0 1.2 0.0 3.7 2.9 1.3 2.0 1.8 1.7 1.0 2.1 2.0 2.5 0.8 0.9 0.4 4.3 1.4 1.3 18.3 17.8 19.2 19.1 14.2 10.9 14.3 9.9 13.4 15.0 0.0 2.4 4.2 3.8 5.4 4.8 2.8 10.2 0.0 1.2 1.8 2.0 3.0 0.0 4.6 2.1 3.0 4.6 0.0 4.2 4.4 3.7 4.6 4.6 4.3 4.4 0.0 1.2 3.1 4.1 3.6 5.5 2.8 1.7 9.0 5.6 5.6 4.8 3.5 5.3 2.8 5.6 0.0 4.5 9.1 9.1 6.9 2.7 3.5 5.2 3.5 CACUL1 "C10orf46, CAC1, FLJ40409, MGC33215" ENSG00000151893 "CDK2 associated cullin domain 1" Q86Y37 10 118674167-118755249 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 177.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050611 Approved Nucleoplasm NA NA Nucleoplasm "HPA050611: AB_2797238" "unprognostic (1.48e-1)" "unprognostic (1.15e-2)" "unprognostic (2.83e-1)" "unprognostic (1.69e-1)" "unprognostic (7.45e-2)" "unprognostic (2.38e-1)" "prognostic unfavorable (1.34e-5)" "unprognostic (3.44e-2)" "unprognostic (1.84e-1)" "unprognostic (9.35e-2)" "unprognostic (1.26e-2)" "unprognostic (3.68e-2)" "unprognostic (1.68e-1)" "unprognostic (9.75e-2)" "unprognostic (8.48e-2)" "unprognostic (3.10e-2)" "unprognostic (1.54e-1)" 19.7 20.0 18.4 13.4 19.3 28.8 23.0 13.2 19.9 20.7 20.2 14.9 22.8 13.7 27.2 21.6 20.7 14.6 14.1 17.9 15.6 16.6 15.2 19.0 19.7 11.2 15.3 17.1 14.8 16.1 23.9 18.7 25.3 15.4 22.5 16.4 13.0 15.7 23.1 26.9 17.0 13.5 26.2 15.0 16.7 17.2 23.8 13.0 20.2 15.9 14.2 15.0 25.1 20.4 3.2 6.1 15.7 11.8 3.1 5.2 3.3 11.6 6.9 5.3 9.6 12.6 8.7 5.5 5.1 13.9 7.3 9.3 7.6 9.9 8.3 3.9 8.2 6.0 10.3 10.5 9.0 9.8 3.3 5.8 7.6 7.2 9.5 8.3 7.0 5.1 6.9 10.1 9.4 14.3 11.1 8.2 9.3 3.7 8.6 8.6 9.0 6.6 11.2 5.1 5.0 3.7 3.8 21.9 5.1 10.7 9.0 2.8 9.0 4.8 12.3 15.8 6.0 6.9 5.7 7.8 5.1 5.8 6.3 8.5 7.5 8.0 5.9 6.6 13.8 3.1 15.7 6.8 12.1 4.1 11.2 4.0 3.0 3.9 4.1 6.1 3.2 4.4 5.2 15.2 3.1 11.8 2.9 2.9 3.3 18.4 19.3 13.2 19.9 15.6 16.6 15.3 17.1 15.4 13.0 56.6 20.8 39.6 27.4 66.4 32.2 38.1 33.1 20.1 13.6 34.9 68.7 58.6 19.9 44.7 177.2 36.4 21.5 23.3 51.7 27.2 35.0 40.2 15.1 24.2 42.7 87.4 65.8 29.4 69.8 24.2 27.3 54.5 27.0 31.5 35.7 37.0 45.0 17.3 22.6 31.5 51.1 12.9 24.1 52.9 83.0 68.9 85.6 33.0 36.6 45.6 CACYBP "S100A6BP, SIP" ENSG00000116161 "Calcyclin binding protein" Q9HB71 1 174999163-175011715 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 117.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025753, HPA057038" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 360000 Cytosol Nucleoplasm "HPA025753: AB_1845878, HPA057038: AB_2683318" "unprognostic (4.70e-3)" "unprognostic (9.92e-2)" "unprognostic (5.55e-2)" "unprognostic (2.22e-1)" "unprognostic (1.25e-1)" "unprognostic (8.96e-3)" "prognostic unfavorable (1.12e-6)" "unprognostic (1.50e-2)" "unprognostic (2.03e-2)" "prognostic favorable (1.39e-5)" "unprognostic (4.55e-2)" "unprognostic (1.87e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (1.41e-1)" "unprognostic (4.44e-2)" "unprognostic (1.97e-1)" "unprognostic (6.79e-2)" 15.1 15.9 38.3 20.3 39.7 24.6 36.2 36.1 46.5 16.0 16.7 10.7 12.5 13.3 14.0 22.5 13.9 15.6 12.7 13.0 36.9 39.1 23.4 18.5 13.3 25.2 33.8 22.8 26.5 10.1 21.4 17.2 19.1 33.1 17.0 18.6 7.9 11.8 17.2 29.8 12.6 14.0 14.4 29.0 13.3 11.7 23.3 27.5 16.2 19.1 12.6 23.9 16.6 117.2 26.7 20.1 17.3 30.2 25.3 29.0 25.8 30.3 21.0 30.9 13.2 10.3 11.6 19.9 23.3 13.8 30.2 22.1 21.6 19.0 32.0 24.3 16.5 21.7 16.6 38.5 17.0 31.3 16.9 23.5 24.0 20.7 23.1 7.8 32.2 15.1 7.8 10.5 24.8 15.0 15.6 21.2 28.8 48.0 18.0 21.7 11.3 49.5 29.5 29.4 45.8 9.8 22.4 22.0 36.9 21.5 24.3 21.3 20.5 15.8 27.7 24.0 43.6 21.5 28.2 10.9 17.2 18.4 24.0 37.3 17.4 50.0 71.0 14.4 28.3 19.9 17.3 16.1 15.9 19.0 24.4 22.1 26.7 27.5 23.0 20.1 20.4 29.0 25.7 8.7 25.3 30.2 16.6 28.5 25.8 38.3 39.7 36.1 46.5 36.9 39.1 33.8 22.8 33.1 27.5 80.4 34.1 105.0 107.7 103.9 56.2 89.6 38.2 80.3 52.4 33.2 58.9 184.6 129.3 83.6 75.6 64.3 63.7 23.3 82.6 245.4 120.8 92.6 91.1 35.8 172.4 28.6 114.6 40.5 47.3 21.9 79.7 120.6 102.9 341.8 42.9 55.2 88.9 53.2 69.3 119.5 79.1 32.3 106.6 100.9 149.2 74.9 120.0 115.4 82.3 81.3 CAD GATD4 ENSG00000084774 "Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase" P27708 2 27217390-27243943 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Pyrimidine biosynthesis" "Allosteric enzyme, Hydrolase, Ligase, Multifunctional enzyme, Transferase" "Cancer-related genes, Congenital disorder of glycosylation, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007781, HPA057266, HPA069341" Supported Supported Nucleoplasm No No 26000 Nucleoplasm "CAB007781: AB_562057, HPA057266: AB_2683387, HPA069341: AB_2686125" "unprognostic (1.69e-1)" "unprognostic (7.34e-2)" "unprognostic (1.49e-1)" "unprognostic (4.71e-3)" "unprognostic (2.55e-1)" "unprognostic (1.92e-1)" "prognostic unfavorable (1.72e-11)" "unprognostic (1.25e-1)" "unprognostic (2.22e-1)" "unprognostic (2.37e-1)" "unprognostic (1.01e-1)" "unprognostic (6.11e-2)" "prognostic unfavorable (1.82e-4)" "unprognostic (6.94e-2)" "unprognostic (1.75e-1)" "unprognostic (1.14e-1)" "unprognostic (5.93e-3)" 12.0 11.9 10.1 23.1 12.4 11.1 18.9 13.3 13.1 14.6 12.4 10.9 9.7 12.1 21.0 18.0 16.3 16.6 15.8 9.8 8.6 8.8 13.1 22.9 13.0 27.9 11.8 9.5 24.4 18.1 10.7 16.4 10.6 10.1 12.5 11.6 12.9 11.7 18.3 12.3 26.0 13.2 17.3 12.5 18.7 11.4 21.3 10.8 35.2 13.8 14.1 18.5 12.7 13.1 5.1 4.9 0.8 2.3 3.7 7.9 2.6 25.3 23.0 10.2 20.5 16.7 13.7 8.1 10.8 7.5 13.6 9.7 26.0 10.1 22.7 9.8 9.8 10.5 14.4 30.1 14.3 10.3 14.8 24.3 32.4 17.5 13.5 8.3 25.5 16.4 10.4 11.8 19.8 22.6 6.3 14.6 21.1 22.8 12.7 12.0 25.5 16.2 38.0 24.6 10.7 17.5 28.5 30.7 23.6 10.1 13.0 20.6 10.3 15.0 10.7 12.6 7.9 8.4 10.7 13.1 20.7 17.1 16.1 21.6 26.4 16.9 46.4 8.3 24.6 17.8 0.0 1.2 0.5 4.7 2.3 4.0 5.1 6.5 7.7 2.7 5.0 4.3 4.3 0.8 3.7 1.2 4.9 7.9 2.6 10.1 12.4 13.3 13.1 8.6 8.8 11.8 9.5 10.1 10.8 3.0 3.8 2.2 3.7 3.3 8.9 4.8 15.3 2.7 5.7 1.8 15.7 4.7 0.0 6.1 1.1 3.8 2.5 0.0 3.0 4.7 5.0 2.4 4.6 4.9 6.9 6.4 6.3 4.3 2.4 1.4 5.8 2.2 3.3 5.4 5.2 4.1 5.3 0.0 9.2 1.3 6.2 0.0 5.1 4.9 10.0 3.0 1.8 4.5 6.8 2.0 CADM4 "IGSF4C, Necl-4, SynCAM4, TSLL2" ENSG00000105767 "Cell adhesion molecule 4" Q8NFZ8 19 43622368-43639839 "Predicted membrane proteins" "Cell adhesion" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 68.9" "Cell type enhanced" "Detected in many" 5 "Glandular cells: 19.9;Proximal tubular cells: 22.7" "Cancer enhanced" "Detected in all" "glioma: 108.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 4.7" "Lineage enriched" "Detected in single" 8 "dendritic cells: 4.7" "Cell line enriched" "Detected in many" 5 "WM-115: 112.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012612 Enhanced Approved "Nucleoplasm,Nuclear membrane" NA NA 5900000 "Nuclear membrane" Nucleoplasm "HPA012612: AB_1851530" "unprognostic (8.80e-3)" "unprognostic (2.57e-2)" "unprognostic (3.61e-3)" "unprognostic (3.53e-1)" "unprognostic (2.87e-1)" "unprognostic (9.29e-3)" "unprognostic (1.78e-1)" "unprognostic (1.77e-1)" "unprognostic (2.77e-1)" "unprognostic (5.03e-1)" "unprognostic (3.19e-3)" "unprognostic (3.81e-1)" "prognostic favorable (2.28e-6)" "unprognostic (1.39e-1)" "unprognostic (3.35e-2)" "unprognostic (2.59e-1)" "unprognostic (3.93e-2)" 3.0 12.6 29.7 3.4 31.0 0.9 6.6 22.2 68.9 4.6 5.3 32.8 2.5 3.0 10.4 6.7 10.8 3.0 3.7 5.5 31.2 26.5 13.2 3.4 3.1 1.8 37.2 20.4 5.2 10.9 26.1 7.5 1.1 29.1 13.7 2.8 4.9 13.3 10.8 5.0 10.8 3.0 6.8 47.8 1.9 4.0 1.9 26.4 0.0 3.3 1.7 3.4 2.9 2.9 0.1 4.7 0.6 0.3 0.0 0.0 0.0 8.8 2.5 13.7 17.9 0.0 0.3 0.7 0.4 0.7 1.2 1.9 3.8 1.5 0.0 3.3 0.1 0.7 2.1 3.0 1.8 1.5 0.1 2.4 0.0 0.6 5.6 1.6 0.0 1.4 0.5 4.0 6.6 0.2 6.5 0.8 0.8 0.9 0.1 0.1 1.3 1.3 0.1 1.5 1.8 0.9 7.1 0.1 0.8 1.8 1.8 1.6 8.8 0.9 2.7 3.5 2.1 2.0 0.4 0.3 0.1 21.2 0.1 0.8 1.3 0.8 0.0 1.0 0.1 112.4 0.0 0.2 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 4.7 0.0 0.0 29.7 31.0 22.2 34.0 31.2 26.5 37.2 20.4 29.1 26.4 0.0 1.7 0.0 17.0 4.4 16.4 2.8 5.1 1.4 1.2 7.0 2.0 0.2 5.0 10.4 17.6 1.9 0.0 0.0 2.7 0.1 1.1 19.9 0.0 2.6 0.4 19.1 0.0 4.3 0.0 14.7 0.3 0.0 13.5 0.0 0.3 15.4 4.2 0.0 1.4 22.7 3.7 0.0 4.7 0.5 0.8 7.4 0.0 0.5 1.0 12.8 CADPS2 CAPS2 ENSG00000081803 "Calcium dependent secretion activator 2" Q86UW7 7 122318425-122886759 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 105.4" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 31.6;Collecting duct cells: 38.4;Muller glia cells: 28.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 105.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 20.3;Karpas-707: 26.5;OE19: 29.0" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 325.7" HPA056398 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA056398: AB_2683117" "unprognostic (1.93e-1)" "unprognostic (5.05e-2)" "unprognostic (1.91e-1)" "unprognostic (3.67e-3)" "unprognostic (8.69e-3)" "unprognostic (9.13e-2)" "unprognostic (1.19e-1)" "unprognostic (1.33e-1)" "unprognostic (4.07e-1)" "unprognostic (4.33e-2)" "unprognostic (3.93e-2)" "unprognostic (1.30e-1)" "prognostic favorable (1.01e-7)" "unprognostic (9.93e-2)" "unprognostic (1.37e-1)" "unprognostic (2.71e-2)" "unprognostic (3.45e-2)" 5.1 11.2 5.1 1.9 7.1 0.0 9.5 105.4 21.1 16.5 5.3 1.4 13.3 6.1 16.3 16.4 5.7 5.7 8.0 4.6 6.8 8.8 20.3 6.2 9.0 1.3 14.0 9.3 5.2 13.2 15.4 17.7 2.7 7.0 10.4 5.4 4.7 23.0 11.5 2.6 2.4 4.7 11.2 4.1 3.3 9.8 1.9 1.4 0.4 9.4 2.4 1.6 4.4 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 2.4 2.5 0.1 0.2 6.3 1.4 6.4 0.0 5.9 0.0 0.0 2.9 0.2 0.0 0.2 0.8 0.6 0.0 5.2 2.0 0.0 11.4 8.2 0.0 0.1 2.6 1.1 1.0 0.8 5.7 20.3 0.0 0.0 26.5 0.1 13.9 0.0 0.0 5.9 29.0 10.0 0.0 0.0 10.5 0.3 6.6 10.3 0.0 0.2 11.5 0.5 1.6 4.4 0.0 5.8 2.2 1.5 0.0 4.1 7.9 0.3 0.0 8.7 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 7.1 105.4 21.1 6.8 8.8 14.0 9.3 7.0 1.4 8.9 31.6 0.0 7.7 1.9 0.0 10.1 5.1 8.1 17.0 38.4 0.0 0.2 14.9 4.7 5.5 19.6 4.5 0.0 9.4 0.3 3.8 16.7 1.1 10.2 0.3 3.2 4.6 16.0 2.7 5.3 8.9 1.1 3.3 0.0 11.6 28.4 6.6 2.9 9.6 6.9 1.3 0.0 5.1 0.5 2.5 1.3 0.2 0.0 7.6 7.4 CALHM2 FAM26B ENSG00000138172 "Calcium homeostasis modulator family member 2" Q9HA72 10 103446786-103452402 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 63.7;Hofbauer cells: 47.4;Leydig cells: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 23.8;BJ: 18.8;BJ hTERT+: 19.1;fHDF/TERT166: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA014706 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA014706: AB_2243916" "unprognostic (2.45e-1)" "unprognostic (1.16e-1)" "unprognostic (3.01e-1)" "unprognostic (2.48e-1)" "unprognostic (3.92e-2)" "unprognostic (1.77e-1)" "unprognostic (1.10e-1)" "unprognostic (1.63e-1)" "unprognostic (8.85e-2)" "unprognostic (5.78e-2)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (3.03e-6)" "unprognostic (8.59e-2)" "unprognostic (2.47e-1)" "unprognostic (3.56e-1)" "unprognostic (4.74e-1)" 24.2 10.5 3.7 10.2 3.8 1.8 28.7 1.9 7.1 34.1 9.2 3.9 8.0 5.6 36.0 18.4 13.4 19.7 18.2 17.0 3.9 2.2 5.7 3.7 11.1 15.9 4.8 5.4 32.5 4.5 1.9 4.0 23.6 4.8 18.2 4.0 10.7 7.6 10.0 8.9 8.9 9.0 19.8 5.5 24.4 7.2 14.1 3.1 3.0 11.0 9.2 10.8 19.9 24.1 7.1 36.6 11.2 47.9 14.0 21.5 17.1 5.3 3.8 0.9 1.2 14.3 23.8 4.6 18.8 19.1 5.8 8.2 1.6 2.6 1.6 2.1 21.5 0.3 2.5 1.9 0.0 1.1 0.2 10.8 3.8 1.1 0.3 6.5 0.6 0.3 8.1 0.0 1.7 0.0 10.8 6.8 4.1 0.8 10.0 3.7 12.3 1.4 1.7 2.4 1.1 3.4 4.5 1.5 3.6 0.5 0.4 2.7 1.2 0.7 3.1 1.0 0.4 0.6 1.2 12.1 1.8 2.3 6.4 1.3 1.5 3.5 1.9 15.9 11.8 0.3 11.2 22.7 0.4 21.5 42.2 17.5 7.1 14.8 17.6 36.6 1.5 2.9 11.2 0.9 14.0 47.9 4.2 18.9 17.1 3.7 3.8 1.9 7.1 3.9 2.2 4.8 5.4 4.8 3.1 3.0 1.1 3.4 2.8 4.7 0.0 2.8 2.5 0.0 0.0 3.5 0.0 2.0 0.0 3.1 0.8 20.4 0.0 0.0 0.2 63.7 23.4 0.8 8.1 0.0 47.4 0.0 1.2 28.3 27.5 0.8 42.3 14.7 8.5 1.8 0.0 0.3 0.2 0.0 15.2 0.3 0.0 19.4 29.8 0.7 0.2 3.3 16.0 17.3 0.0 1.0 CALHM3 "bA225H22.7, FAM26A" ENSG00000183128 "Calcium homeostasis modulator 3" Q86XJ0 10 103472804-103479240 "Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Taste, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 1.8;pancreas: 2.8;testis: 2.0" "Cell type enhanced" "Detected in some" 23 "Cardiomyocytes: 1.1;Early spermatids: 2.2;Extravillous trophoblasts: 5.4;Late spermatids: 1.5" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.5" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.8;myeloid DC: 1.5" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "U-266/84: 17.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA018205 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA018205: AB_2069267" "unprognostic (2.88e-1)" "unprognostic (4.00e-1)" "unprognostic (3.48e-2)" "unprognostic (3.26e-4)" "unprognostic (2.87e-1)" "unprognostic (2.06e-1)" "unprognostic (1.25e-2)" "unprognostic (1.88e-1)" "unprognostic (7.42e-3)" "unprognostic (1.44e-1)" "unprognostic (4.89e-2)" "unprognostic (3.07e-1)" "unprognostic (5.05e-2)" "unprognostic (1.53e-1)" 0.2 0.1 0.5 0.0 0.6 0.0 0.0 0.2 0.7 0.3 0.1 0.8 0.3 0.9 0.0 0.3 0.0 0.0 0.2 0.9 0.0 0.0 0.1 0.0 0.0 0.4 2.8 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 2.0 0.0 0.0 0.2 0.4 0.0 1.5 0.0 1.8 0.0 0.7 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.3 3.3 0.4 1.8 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 17.4 0.2 0.2 0.0 0.0 0.0 0.6 0.0 0.0 1.8 0.0 0.0 0.0 0.7 1.5 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.0 0.0 0.2 5.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 CALML4 "MGC4809, NY-BR-20" ENSG00000129007 "Calmodulin like 4" Q96GE6 15 68190705-68206110 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 44.0;gallbladder: 28.4;intestine: 91.6" "Cell type enriched" "Detected in many" 5 "Ciliated cells: 174.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "intermediate monocyte: 39.2;non-classical monocyte: 44.0" "Lineage enriched" "Detected in many" 10 "monocytes: 44.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051109 Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" Yes No "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA051109: AB_2681346" "unprognostic (1.69e-2)" "unprognostic (1.78e-1)" "unprognostic (4.97e-2)" "unprognostic (8.50e-2)" "unprognostic (1.63e-1)" "unprognostic (3.71e-2)" "unprognostic (4.05e-2)" "unprognostic (6.53e-2)" "unprognostic (6.77e-2)" "unprognostic (2.10e-1)" "unprognostic (4.19e-3)" "unprognostic (6.24e-2)" "unprognostic (3.85e-2)" "unprognostic (7.92e-3)" "unprognostic (2.46e-1)" "unprognostic (7.49e-2)" "unprognostic (1.32e-1)" 2.4 2.5 1.8 12.0 1.1 0.8 2.2 2.6 1.0 3.2 40.3 2.2 7.7 34.0 1.5 7.8 5.1 7.3 28.4 1.4 2.6 0.7 12.6 12.3 3.1 2.6 0.9 1.3 2.3 5.3 0.0 3.1 2.1 8.4 4.3 21.8 3.1 1.9 6.7 1.4 1.7 91.6 2.7 1.0 5.3 5.4 2.4 0.6 1.1 1.5 1.3 1.3 1.9 2.0 0.0 4.5 1.8 44.0 0.0 0.0 2.8 2.5 7.8 5.7 3.5 0.6 1.0 4.0 1.6 1.5 2.6 2.6 14.9 16.1 2.5 2.0 1.1 2.3 10.8 12.8 2.3 1.0 2.1 12.4 4.1 13.3 5.2 2.3 3.5 5.5 1.1 3.4 1.5 2.2 2.1 2.9 5.2 3.9 2.9 0.6 7.2 5.7 7.7 4.9 12.0 2.3 8.5 5.6 5.1 0.9 4.3 2.9 3.4 2.5 2.3 6.8 1.8 1.7 3.4 2.5 3.8 3.5 6.6 6.3 10.6 6.3 7.0 2.4 6.9 1.3 0.0 6.5 0.0 0.0 39.2 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 1.8 0.0 44.0 0.2 0.0 2.8 1.8 1.1 2.6 1.0 2.6 0.7 0.9 1.3 8.4 0.6 0.0 1.0 0.9 0.6 1.3 8.8 0.3 15.3 174.0 26.1 3.5 0.0 0.4 0.0 2.0 4.8 1.9 38.6 0.0 3.9 0.4 1.0 1.2 0.0 7.2 3.1 7.9 7.5 6.7 11.9 0.0 3.4 3.4 0.0 0.0 15.0 1.7 1.8 38.6 6.3 5.8 2.2 0.0 0.3 0.0 0.5 1.8 0.1 1.8 18.3 1.1 CAMK1D CKLiK ENSG00000183049 "Calcium/calmodulin dependent protein kinase ID" Q8IU85 10 12349482-12835545 "Enzymes, Plasma proteins, Predicted membrane proteins" "Inflammatory response, Neurogenesis" "Allosteric enzyme, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Bipolar cells: 148.3;Cone photoreceptor cells: 369.1;Rod photoreceptor cells: 206.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 31.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 31.8" "Cell line enhanced" "Detected in many" "HDLM-2: 47.7;U-266/70: 22.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007266 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA007266: AB_1078389" "unprognostic (1.06e-1)" "unprognostic (2.19e-2)" "unprognostic (2.77e-1)" "unprognostic (3.65e-3)" "unprognostic (4.23e-1)" "unprognostic (2.32e-2)" "unprognostic (6.90e-3)" "prognostic favorable (1.67e-4)" "unprognostic (1.06e-1)" "unprognostic (1.49e-2)" "unprognostic (2.95e-1)" "unprognostic (7.40e-2)" "unprognostic (1.35e-2)" "unprognostic (6.55e-2)" "unprognostic (1.65e-1)" "unprognostic (4.66e-2)" "unprognostic (2.56e-3)" 5.1 5.3 20.9 10.5 22.1 6.6 4.0 23.4 33.5 8.3 11.5 4.6 10.0 3.8 3.3 3.3 8.7 4.3 6.8 13.8 18.6 7.2 2.2 11.5 7.6 9.3 5.8 17.8 2.6 17.0 1.3 2.5 3.2 5.0 4.9 12.9 11.9 4.5 15.4 1.7 18.5 5.5 5.6 4.9 10.5 3.4 6.2 6.8 20.8 13.6 2.9 12.5 8.1 7.0 7.1 4.2 31.8 3.7 1.4 2.3 1.3 0.1 2.6 3.0 0.2 1.8 0.6 0.2 0.4 0.9 0.6 0.9 3.6 2.0 1.4 0.3 0.2 1.5 1.4 3.6 0.5 0.5 47.7 1.8 5.7 8.5 0.2 0.5 0.1 5.2 0.1 2.3 1.2 0.1 6.4 0.3 3.1 0.1 0.2 0.7 3.0 11.1 2.3 2.0 0.0 1.2 8.5 1.6 2.6 0.1 2.8 4.6 2.1 5.7 2.1 0.0 0.4 1.5 1.4 0.1 2.5 3.7 7.9 1.7 22.0 6.9 4.8 3.7 3.7 0.0 8.3 2.2 31.8 1.8 3.1 1.9 5.6 1.6 2.3 4.2 7.1 1.9 1.3 13.9 1.4 3.7 1.4 0.5 1.3 20.9 22.1 23.4 33.5 18.6 7.2 5.8 17.8 5.0 6.8 3.0 28.0 44.7 7.2 20.4 148.3 10.3 15.3 20.1 29.6 1.8 369.1 0.2 0.0 7.8 7.2 8.3 8.8 0.0 19.1 0.7 22.0 3.5 22.0 11.0 15.1 42.9 15.4 11.1 39.3 7.4 21.9 37.1 3.3 24.4 26.1 18.0 9.6 35.1 57.3 0.5 206.3 25.8 9.2 3.9 9.6 36.0 0.2 10.2 29.3 16.3 CAMK2N2 CaM-KIIN ENSG00000163888 "Calcium/calmodulin dependent protein kinase II inhibitor 2" Q96S95 3 184259213-184261463 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "adrenal gland: 14.2;brain: 38.3;pancreas: 37.0;pituitary gland: 12.5" "Cell type enriched" "Detected in some" 11 "Horizontal cells: 58.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 11.3;REH: 19.0;SCLC-21H: 20.0;U-138 MG: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050835, HPA075200" Approved Supported Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA050835: AB_2681253, HPA075200: " "unprognostic (7.28e-2)" "prognostic favorable (9.77e-4)" "unprognostic (1.24e-1)" "unprognostic (4.69e-2)" "unprognostic (1.32e-1)" "unprognostic (6.09e-2)" "unprognostic (2.20e-1)" "unprognostic (1.29e-2)" "unprognostic (1.88e-1)" "unprognostic (4.21e-2)" "unprognostic (5.98e-2)" "unprognostic (9.72e-3)" "unprognostic (5.17e-9)" "unprognostic (3.47e-1)" "unprognostic (2.39e-1)" "unprognostic (1.07e-1)" "unprognostic (1.76e-3)" 1.3 14.2 22.2 1.3 9.6 1.1 1.3 29.7 38.3 1.3 1.3 3.2 0.0 1.4 1.2 1.2 1.2 1.3 1.3 1.2 12.3 32.7 1.3 1.7 1.2 1.2 18.0 8.2 1.1 37.0 2.0 12.5 1.3 25.1 1.4 1.3 1.1 1.2 1.4 1.1 1.2 1.4 1.4 9.3 1.2 1.7 1.3 4.5 0.0 1.3 0.0 1.2 1.2 0.0 0.0 0.5 0.0 0.2 0.0 0.3 0.0 11.3 0.2 1.4 0.6 0.4 0.4 1.0 0.3 4.2 2.7 2.8 0.4 0.5 0.4 2.8 0.2 5.5 1.5 0.7 0.5 1.5 9.3 0.4 0.3 0.2 0.4 0.1 0.2 1.4 0.3 0.7 0.4 1.9 0.6 0.0 0.3 0.0 3.3 0.4 6.0 0.1 0.1 8.1 0.2 3.7 19.0 5.5 1.6 0.6 2.2 20.0 4.3 1.8 0.5 0.1 0.1 6.1 0.1 0.0 20.8 9.1 1.9 3.3 2.2 3.3 2.7 4.8 1.2 1.7 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 22.2 9.6 29.7 38.3 12.3 32.7 18.0 8.2 25.1 4.5 0.0 0.0 0.0 0.0 0.0 5.3 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.6 0.0 0.0 0.1 0.0 0.0 0.0 58.8 3.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.8 1.0 0.0 0.0 0.0 4.8 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 CAMK4 CaMK-GR ENSG00000152495 "Calcium/calmodulin dependent protein kinase IV" Q16566 5 111223653-111494886 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Inflammatory response" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.9;lymphoid tissue: 71.7" "Cell type enhanced" "Detected in many" 27 "Bipolar cells: 47.8;Early spermatids: 236.0;Late spermatids: 80.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "MAIT T-cell: 14.1;memory CD4 T-cell: 10.3;memory CD8 T-cell: 7.8;naive CD4 T-cell: 19.8;naive CD8 T-cell: 10.9;T-reg: 11.3" "Lineage enriched" "Detected in single" 26 "T-cells: 19.8" "Cell line enhanced" "Detected in many" "HDLM-2: 39.4;JURKAT: 27.3;MOLT-4: 12.0;SH-SY5Y: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004347, HPA011753, HPA017206" Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "CAB004347: AB_626793, HPA011753: AB_1845950, HPA017206: AB_1845949" "unprognostic (2.99e-5)" "unprognostic (7.19e-2)" "unprognostic (3.43e-3)" "unprognostic (5.11e-2)" "unprognostic (4.75e-3)" "unprognostic (3.48e-2)" "unprognostic (7.66e-4)" "unprognostic (7.22e-3)" "unprognostic (2.49e-1)" "unprognostic (2.92e-1)" "unprognostic (1.09e-1)" "unprognostic (1.46e-1)" "unprognostic (2.23e-5)" "unprognostic (2.42e-2)" "unprognostic (3.01e-2)" "unprognostic (1.66e-1)" "unprognostic (9.99e-3)" 1.1 6.5 9.5 6.4 34.2 4.6 1.0 48.9 16.5 1.8 2.3 1.0 0.0 2.4 1.3 0.8 1.4 0.9 2.7 0.9 5.9 3.2 1.4 2.5 1.9 12.0 2.3 6.8 1.4 0.9 0.3 1.3 0.6 3.4 5.8 2.5 0.1 1.7 2.6 0.8 0.9 3.8 1.5 2.0 4.2 2.6 13.8 6.6 71.7 1.0 0.0 8.1 2.8 1.1 0.7 0.0 0.4 0.0 0.6 19.8 3.4 0.0 0.0 1.4 0.9 0.3 1.1 0.0 0.3 3.0 3.6 3.6 0.0 0.0 0.0 1.9 0.1 2.4 0.1 3.0 0.3 2.6 39.4 2.4 0.5 1.3 0.0 0.1 0.2 0.1 0.1 0.0 7.6 0.8 2.2 0.6 27.3 0.0 1.4 0.2 0.0 12.0 0.0 1.8 0.0 0.1 1.8 2.3 0.1 1.3 0.0 8.6 15.4 0.5 0.0 2.6 0.1 0.0 0.2 0.0 7.5 4.4 0.0 6.6 1.2 0.1 0.0 3.6 0.0 2.8 0.0 0.0 0.0 2.8 0.0 14.1 0.7 10.3 7.8 0.0 0.2 19.8 10.9 0.4 0.6 0.0 0.0 11.3 3.4 9.5 34.2 48.9 15.1 5.9 3.2 2.3 6.8 3.4 6.6 0.0 0.6 4.2 0.2 1.0 47.8 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 236.0 0.7 0.0 0.0 0.0 0.1 1.6 0.4 4.6 0.2 0.2 0.0 0.0 0.6 1.0 80.4 3.7 1.1 0.0 0.0 0.1 2.1 0.8 0.0 1.4 0.0 4.1 0.0 4.5 3.2 6.1 0.9 0.0 29.9 0.0 0.3 CAMKMT "C2orf34, CLNMT" ENSG00000143919 "Calmodulin-lysine N-methyltransferase" Q7Z624 2 44361950-44772592 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067912 Supported Nucleoplasm NA NA Nucleoplasm "HPA067912: AB_2685922" "unprognostic (2.28e-1)" "unprognostic (6.15e-2)" "unprognostic (1.96e-1)" "unprognostic (2.39e-2)" "prognostic favorable (9.10e-4)" "unprognostic (1.03e-1)" "unprognostic (9.58e-3)" "unprognostic (1.46e-3)" "unprognostic (1.85e-1)" "unprognostic (7.42e-2)" "unprognostic (8.76e-2)" "unprognostic (1.37e-1)" "unprognostic (3.33e-1)" "unprognostic (4.82e-2)" "unprognostic (4.66e-2)" "unprognostic (1.70e-1)" "unprognostic (8.57e-2)" 7.1 8.0 13.9 10.8 21.7 13.9 8.2 15.4 13.1 9.8 10.8 8.2 8.7 8.7 11.0 10.5 8.8 8.1 14.8 7.3 11.8 14.8 11.4 7.0 8.2 8.1 14.1 4.3 6.7 17.6 15.7 17.6 5.2 13.7 5.8 10.9 8.4 12.0 6.4 10.9 9.7 10.8 8.2 10.5 8.4 7.8 19.0 12.6 13.7 12.1 8.1 10.7 7.9 10.0 17.7 9.9 9.3 8.5 7.7 17.2 6.9 7.0 4.4 5.4 4.8 5.7 5.8 11.5 5.9 4.1 3.0 3.9 8.1 6.4 6.8 6.6 3.8 3.9 5.9 7.3 9.1 5.3 25.4 10.5 10.0 9.3 15.2 2.2 6.5 7.1 2.4 5.6 4.1 7.8 4.5 4.4 7.3 7.9 12.1 4.9 7.3 11.8 13.2 9.9 16.7 4.7 7.0 6.4 13.6 14.5 7.9 10.5 9.6 5.6 16.8 6.1 5.3 6.1 5.5 6.0 4.1 4.8 4.9 4.3 9.6 8.0 12.3 4.5 11.5 3.1 9.3 8.5 5.9 11.7 6.7 11.7 17.7 11.2 9.7 9.5 13.4 17.2 13.5 5.1 7.7 7.1 9.9 16.0 6.9 13.9 21.7 15.4 13.1 11.8 14.8 14.1 4.3 13.7 12.6 6.0 1.9 6.5 6.4 4.6 4.2 1.5 7.6 0.0 0.0 8.7 0.0 3.2 19.9 10.2 52.0 3.5 4.7 0.0 13.8 4.1 5.1 4.8 5.7 5.1 5.2 1.6 0.0 1.3 1.8 25.7 7.5 4.0 10.1 7.2 4.8 15.5 7.3 6.5 5.3 11.2 2.3 0.0 5.1 18.0 5.4 6.5 2.2 8.7 7.4 5.2 CAMKV "MGC8407, VACAMKL" ENSG00000164076 "CaM kinase like vesicle associated" Q8NCB2 3 49857988-49870222 "Enzymes, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 36 "brain: 77.2" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 2.3;Cone photoreceptor cells: 2.0;Early spermatids: 4.6;Horizontal cells: 3.2;Late spermatids: 6.5" "Group enriched" "Detected in some" 11 "glioma: 4.0;testis cancer: 5.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "AF22: 5.3;HAP1: 7.0;NTERA-2: 25.2;RPMI-8226: 4.8;SCLC-21H: 8.6;SH-SY5Y: 5.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007656, CAB034931" Enhanced Supported Approved "Nucleoplasm,Cytokinetic bridge" NA NA Nucleoplasm "Cytokinetic bridge" "CAB034931: AB_2068550, HPA007656: AB_1078391" "unprognostic (9.47e-4)" "unprognostic (5.65e-3)" "unprognostic (1.42e-1)" "unprognostic (2.70e-7)" "unprognostic (2.76e-1)" "unprognostic (7.95e-4)" "unprognostic (3.09e-2)" "unprognostic (2.61e-1)" "unprognostic (1.48e-1)" "unprognostic (4.30e-3)" "unprognostic (1.72e-1)" "unprognostic (8.11e-2)" "unprognostic (1.00e-3)" "unprognostic (7.61e-2)" "unprognostic (9.51e-2)" "unprognostic (1.67e-3)" 1.2 2.1 20.7 1.2 77.2 1.2 1.2 0.5 62.8 1.2 1.2 1.7 0.0 1.2 1.2 1.2 1.2 1.2 1.2 1.2 33.4 11.7 1.2 1.2 1.2 1.2 3.3 23.5 1.2 1.2 1.2 1.8 1.2 2.1 1.2 1.2 0.0 1.2 1.2 1.2 1.3 1.2 1.2 1.9 1.2 1.3 2.1 6.0 0.0 1.2 0.0 1.2 1.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 5.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.0 0.0 0.1 0.7 0.1 25.2 0.0 0.1 0.8 0.0 4.8 0.0 0.0 8.6 5.5 0.0 0.0 0.0 1.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 20.7 77.2 0.5 34.0 33.4 11.7 3.3 23.5 2.1 6.0 0.0 0.0 0.0 0.0 0.2 2.3 0.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 3.2 1.2 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.7 0.1 0.2 0.0 0.1 0.0 CAMLG "CAML, GET2" ENSG00000164615 "Calcium modulating ligand" P49069 5 134738501-134752160 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 658.5;Late spermatids: 1206.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052636, HPA056472" Approved Approved Nucleoplasm,Nucleoli,Vesicles NA NA Vesicles "Nucleoplasm, Nucleoli" "HPA052636: AB_2681893, HPA056472: AB_2683143" "unprognostic (9.23e-2)" "unprognostic (8.54e-2)" "unprognostic (2.95e-1)" "unprognostic (2.21e-1)" "unprognostic (1.07e-1)" "unprognostic (1.07e-2)" "unprognostic (3.68e-2)" "unprognostic (5.41e-3)" "unprognostic (3.07e-1)" "unprognostic (8.54e-2)" "unprognostic (5.34e-3)" "unprognostic (4.58e-2)" "prognostic unfavorable (1.09e-5)" "unprognostic (3.26e-2)" "unprognostic (1.43e-2)" "unprognostic (2.19e-1)" "unprognostic (3.16e-1)" 24.2 29.0 37.6 14.3 32.4 22.7 29.3 28.2 39.3 33.3 32.7 15.5 20.2 26.1 31.7 45.2 21.4 23.0 21.8 22.3 32.4 38.3 20.1 19.7 18.9 18.4 36.2 22.7 53.0 25.7 14.8 21.9 14.0 22.4 27.5 14.3 21.7 15.9 26.2 32.5 19.7 22.2 30.4 26.0 15.1 17.7 36.6 14.0 21.1 21.6 18.5 19.3 40.3 20.0 25.0 16.1 32.1 23.3 16.6 28.6 17.4 9.6 7.5 12.8 23.8 28.5 44.2 5.8 13.7 19.9 10.2 19.4 13.7 14.7 39.3 20.1 9.5 15.9 12.5 10.5 16.7 14.6 18.3 19.5 10.4 13.6 11.1 21.0 5.5 33.0 35.8 18.2 12.6 21.7 33.9 19.3 17.4 6.6 18.3 15.2 10.7 14.5 23.3 6.6 12.0 7.6 16.4 17.0 15.1 17.5 9.4 19.0 13.3 9.8 6.3 32.7 17.2 17.3 11.5 18.4 10.0 6.2 15.2 12.4 17.2 18.6 15.0 16.8 17.4 5.4 32.1 15.2 32.1 18.3 17.3 24.6 25.0 26.4 22.9 16.1 22.4 27.8 26.8 27.6 16.6 23.3 14.7 28.6 17.4 37.6 32.4 28.2 39.3 32.4 38.3 36.2 22.7 22.4 14.0 35.7 31.3 84.3 104.0 148.5 76.2 38.6 76.5 32.1 48.9 40.1 23.6 43.8 77.9 53.1 658.5 74.5 44.2 0.0 78.9 53.3 107.2 105.7 119.1 66.0 62.6 52.4 60.0 81.6 102.8 1206.3 155.6 92.2 91.1 124.4 64.9 79.0 61.6 59.6 124.5 149.1 63.7 97.0 161.7 114.4 74.5 176.2 61.2 108.0 83.2 90.1 CAMSAP3 "KIAA1543, Nezha, PPP1R80" ENSG00000076826 "Calmodulin regulated spectrin associated protein family member 3" Q9P1Y5 19 7595902-7618304 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 33.9" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 31.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 20.1;Hep G2: 11.4;SK-BR-3: 9.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043830, HPA062149" Enhanced Approved Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA043830: AB_10795879, HPA062149: AB_2684698" "unprognostic (3.83e-2)" "unprognostic (1.18e-1)" "unprognostic (8.67e-2)" "unprognostic (7.90e-3)" "unprognostic (3.66e-1)" "unprognostic (3.87e-3)" "unprognostic (7.00e-2)" "unprognostic (2.80e-2)" "unprognostic (2.02e-1)" "unprognostic (1.64e-1)" "unprognostic (2.30e-2)" "unprognostic (1.41e-1)" "prognostic favorable (7.55e-7)" "unprognostic (2.16e-2)" "unprognostic (3.88e-2)" "unprognostic (3.72e-2)" "unprognostic (1.59e-3)" 0.8 2.8 8.0 1.9 9.2 0.9 4.1 12.0 15.5 4.5 11.4 0.8 13.5 20.9 1.5 8.0 14.7 4.8 7.6 0.9 5.2 4.8 9.7 14.2 4.5 1.1 2.6 6.5 1.0 15.7 4.2 6.2 3.6 7.0 6.7 4.1 8.8 22.1 16.0 1.1 33.9 17.7 1.0 1.0 1.1 14.5 9.1 1.1 0.9 9.6 2.5 5.7 4.1 6.9 0.0 0.1 0.0 0.0 0.0 0.6 0.0 8.4 1.4 0.2 0.7 0.0 0.0 1.6 0.0 0.0 0.0 0.0 20.1 4.5 2.3 3.6 0.0 0.9 7.5 3.3 2.2 0.0 1.5 7.7 0.0 0.3 11.4 0.0 0.0 3.5 0.0 4.3 0.0 0.3 0.3 0.0 3.4 0.7 0.0 0.0 9.6 0.1 0.1 5.2 6.2 3.7 0.5 0.0 2.8 1.5 4.5 6.5 6.9 1.0 9.8 0.0 1.3 8.2 1.3 0.0 0.0 1.6 0.0 0.3 4.0 0.7 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 8.0 9.2 12.0 15.5 5.2 4.8 2.6 6.5 7.0 1.1 8.9 19.2 0.0 2.4 8.8 22.3 0.8 17.8 0.0 4.5 8.7 0.0 0.4 3.3 5.2 4.4 0.6 31.9 0.0 10.2 0.6 0.3 9.0 5.7 20.3 0.2 9.5 12.6 0.6 1.3 2.7 1.4 0.4 0.0 0.0 18.0 1.3 11.5 21.0 0.0 11.3 12.8 0.0 0.7 0.5 1.7 16.6 0.5 0.9 14.0 4.3 CAMTA2 KIAA0909 ENSG00000108509 "Calmodulin binding transcription activator 2" O94983 17 4967992-4987652 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 63.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027835, HPA051147" Supported "Nucleoplasm,Vesicles,Actin filaments,Mitochondria,Cytosol" NA NA Nucleoplasm "Vesicles, Actin filaments, Mitochondria, Cytosol" "HPA027835: , HPA051147: AB_2681362" "unprognostic (2.82e-1)" "unprognostic (3.06e-1)" "unprognostic (1.11e-2)" "unprognostic (1.01e-3)" "unprognostic (1.10e-1)" "unprognostic (3.24e-2)" "unprognostic (2.36e-1)" "unprognostic (4.71e-2)" "unprognostic (2.78e-2)" "unprognostic (7.08e-2)" "prognostic favorable (6.00e-8)" "unprognostic (3.42e-2)" "unprognostic (9.02e-2)" "unprognostic (3.73e-2)" "unprognostic (1.20e-1)" "unprognostic (4.56e-2)" "unprognostic (1.19e-1)" 9.8 6.4 27.0 9.2 25.2 6.4 5.4 63.6 44.9 6.2 8.0 6.4 3.8 7.3 6.2 3.1 8.4 6.8 6.1 8.0 33.8 17.4 5.5 4.2 8.8 6.2 11.7 19.1 6.7 11.7 14.8 21.3 5.1 18.5 6.8 8.0 5.5 8.7 9.1 20.1 8.6 9.0 10.5 6.5 8.7 8.0 9.0 8.8 2.7 6.5 2.9 6.5 6.5 4.7 1.3 2.2 5.7 8.1 1.1 2.7 2.1 8.0 14.4 2.7 3.8 18.1 12.6 5.6 7.8 8.7 7.4 6.6 3.6 2.2 9.5 7.6 12.2 6.3 8.2 10.2 12.2 4.2 13.3 13.2 6.0 7.8 4.0 10.4 3.5 25.8 8.7 15.3 7.0 11.0 9.0 12.3 7.4 9.7 8.7 6.9 5.3 6.2 2.2 0.4 9.6 6.0 5.4 3.0 3.7 8.4 8.5 3.7 3.2 4.9 9.0 2.4 4.8 7.9 3.5 16.3 5.9 3.5 6.2 12.7 4.4 4.7 3.4 14.4 7.0 5.7 1.0 2.2 1.8 2.7 3.0 2.1 1.3 1.2 2.5 1.4 0.9 1.8 2.0 5.7 1.1 8.1 2.2 1.1 2.1 27.0 25.2 63.6 44.9 33.8 17.4 11.7 19.1 18.5 8.8 3.0 13.7 8.3 3.5 6.2 12.1 5.9 15.3 5.3 3.4 10.4 9.8 5.2 1.7 6.8 29.0 6.9 16.3 0.0 9.8 6.8 6.8 5.5 12.7 11.9 7.7 33.4 10.9 14.1 9.2 39.5 9.5 8.0 3.3 8.2 13.1 4.3 9.1 12.4 8.9 10.5 9.6 12.9 12.3 5.2 7.6 9.2 10.4 10.2 9.5 3.4 CAND1 "DKFZp434M1414, KIAA0829, TIP120, TIP120A" ENSG00000111530 "Cullin associated and neddylation dissociated 1" Q86VP6 12 67269281-67319951 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055748, HPA062833, HPA069053" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" No No 4200000 "Nucleoplasm, Golgi apparatus, Cytosol" "HPA055748: AB_2682905, HPA062833: AB_2684876, HPA069053: AB_2686074" "unprognostic (1.50e-2)" "unprognostic (1.60e-1)" "unprognostic (1.39e-3)" "unprognostic (2.31e-1)" "unprognostic (2.19e-1)" "unprognostic (2.61e-1)" "prognostic unfavorable (1.15e-4)" "unprognostic (2.02e-2)" "unprognostic (2.17e-2)" "unprognostic (3.02e-1)" "unprognostic (3.38e-3)" "unprognostic (1.66e-1)" "unprognostic (2.54e-2)" "unprognostic (2.88e-1)" "unprognostic (1.58e-1)" "unprognostic (1.67e-1)" "unprognostic (1.95e-1)" 21.3 26.7 28.7 19.1 38.3 19.6 27.0 34.6 32.6 23.9 20.0 17.5 17.0 19.7 22.8 29.9 26.6 20.6 19.0 15.2 24.8 27.0 25.4 27.7 18.7 25.4 23.3 29.0 29.0 22.1 33.2 27.1 23.3 33.2 24.1 21.7 15.8 19.6 22.0 11.1 29.5 19.5 22.4 21.5 20.2 19.3 26.9 23.8 39.4 27.0 17.0 30.2 21.1 22.1 11.9 7.8 6.1 10.1 14.7 15.2 4.3 22.5 23.2 35.4 25.1 27.2 21.3 23.8 22.4 19.4 23.7 20.9 21.5 12.9 48.7 19.6 22.4 14.9 21.6 38.0 25.5 27.2 18.4 22.8 27.4 18.7 20.3 17.8 32.3 15.6 20.1 19.4 21.6 20.0 29.1 22.0 23.9 21.7 27.3 25.5 22.1 29.2 21.9 37.4 17.4 16.2 28.6 30.4 20.6 21.8 38.5 36.4 18.1 27.9 25.7 18.1 31.1 27.6 14.9 18.7 18.8 12.2 12.9 16.9 9.0 11.0 41.5 22.4 19.2 19.3 6.1 5.0 5.5 11.6 5.9 14.1 8.6 14.2 12.7 7.8 11.9 15.2 12.7 2.2 14.7 10.1 6.6 14.7 4.3 28.7 38.3 34.6 31.8 24.8 27.0 23.3 29.0 33.2 23.8 56.6 27.6 42.6 43.5 51.6 88.5 14.7 45.9 34.8 29.6 41.8 110.0 31.5 11.6 27.1 2.8 38.6 46.3 0.0 24.9 36.0 41.4 44.6 7.0 41.5 27.1 82.6 43.6 38.1 40.0 7.7 63.9 30.4 32.1 52.3 46.0 63.0 29.9 24.6 57.3 27.3 106.8 25.8 34.2 72.7 42.4 55.8 37.3 47.9 38.5 52.1 CAP2 ENSG00000112186 "Cyclase associated actin cytoskeleton regulatory protein 2" P40123 6 17393216-17557792 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 165.7" "Cell type enhanced" "Detected in many" 14 "Cardiomyocytes: 110.1;Ciliated cells: 48.2;Sertoli cells: 32.3;Smooth muscle cells: 40.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "MAIT T-cell: 2.9" "Lineage enriched" "Detected in single" 29 "T-cells: 2.9" "Cell line enhanced" "Detected in many" "LHCN-M2: 32.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050530, HPA054147" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA050530: AB_2681159, HPA054147: AB_2682400" "unprognostic (7.27e-2)" "unprognostic (5.71e-3)" "unprognostic (1.63e-2)" "unprognostic (1.55e-1)" "unprognostic (4.86e-1)" "unprognostic (2.23e-2)" "unprognostic (9.94e-2)" "unprognostic (3.58e-2)" "unprognostic (7.72e-2)" "unprognostic (1.65e-1)" "unprognostic (6.43e-2)" "unprognostic (2.30e-1)" "unprognostic (1.59e-1)" "unprognostic (1.06e-2)" "unprognostic (1.47e-1)" "unprognostic (8.05e-2)" "unprognostic (1.75e-3)" 5.8 4.1 13.8 3.0 20.1 0.7 3.9 7.5 26.4 5.6 7.7 1.9 2.0 1.9 9.2 5.9 7.0 5.8 3.8 31.2 19.9 8.7 3.3 2.0 2.1 1.1 5.3 17.3 2.1 1.6 3.2 1.7 6.2 8.6 8.4 3.6 2.9 2.5 10.1 165.7 0.9 2.6 13.1 2.0 1.6 3.3 1.1 1.3 0.0 2.3 14.5 1.3 4.6 6.4 0.0 0.0 0.0 0.0 0.0 2.9 0.1 5.1 8.1 15.7 18.7 0.1 0.0 3.4 18.5 13.5 15.2 13.9 2.6 2.3 0.0 17.4 19.8 21.3 2.7 6.9 6.9 22.1 0.0 2.6 0.0 5.2 8.8 1.5 0.0 0.0 1.1 3.4 7.7 3.3 24.9 0.7 0.0 0.0 0.0 32.1 8.3 0.0 0.0 5.9 0.2 4.6 1.7 20.8 0.3 8.0 2.1 2.0 3.9 6.2 20.1 10.9 30.1 22.2 3.7 0.0 12.3 11.7 0.3 16.2 0.0 0.0 0.0 4.1 0.0 16.8 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.8 20.1 7.5 26.4 19.9 8.7 5.3 17.3 8.6 1.3 3.0 1.0 0.0 3.5 1.6 13.5 110.1 2.5 48.2 5.7 1.8 3.9 14.9 3.3 2.4 0.1 1.0 0.0 0.0 0.6 10.7 8.2 1.4 0.0 1.8 1.9 7.9 5.8 4.9 0.0 0.0 0.6 0.0 0.0 0.0 1.1 5.0 3.6 2.0 4.6 16.1 2.0 32.3 40.1 0.1 2.1 0.6 31.4 0.0 1.5 0.7 CAPG "AFCP, MCP" ENSG00000042493 "Capping actin protein, gelsolin like" P40121 2 85394748-85418432 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 121.1" "Cell type enhanced" "Detected in many" 10 "granulocytes: 535.8;Hofbauer cells: 1102.8;monocytes: 603.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 79.0;classical monocyte: 97.4;eosinophil: 58.2;intermediate monocyte: 36.4;memory B-cell: 50.1;myeloid DC: 121.1;naive B-cell: 37.1;NK-cell: 48.3;plasmacytoid DC: 84.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 81.3;HMC-1: 116.7;SK-MEL-30: 84.8;U-937: 61.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018843, HPA019080, HPA019092" Enhanced Enhanced Nucleoplasm "Intracellular and membrane" Yes No 6700000 Nucleoplasm "HPA018843: AB_2669948, HPA019080: AB_1845979, HPA019092: AB_1845980" "unprognostic (2.82e-2)" "unprognostic (1.37e-1)" "unprognostic (8.80e-2)" "unprognostic (1.28e-2)" "unprognostic (4.37e-2)" "unprognostic (7.52e-2)" "prognostic unfavorable (3.22e-5)" "unprognostic (8.83e-2)" "unprognostic (3.22e-2)" "unprognostic (1.54e-1)" "unprognostic (5.70e-3)" "unprognostic (1.75e-1)" "prognostic favorable (2.96e-4)" "unprognostic (1.45e-1)" "unprognostic (7.68e-2)" "unprognostic (5.30e-3)" "unprognostic (7.89e-3)" 44.3 4.9 10.1 18.3 10.8 32.4 17.6 3.3 7.6 19.9 13.8 17.6 17.7 6.8 14.0 16.0 52.3 12.9 25.2 4.1 8.5 6.5 35.4 2.9 44.3 26.9 14.7 4.8 10.6 8.9 40.3 5.2 15.6 11.9 15.0 11.0 7.6 22.5 19.3 2.6 39.2 11.5 9.9 17.6 10.9 25.9 8.4 10.0 21.2 31.5 28.1 40.2 27.0 31.1 50.1 121.1 79.0 97.4 48.3 9.7 67.5 22.8 11.0 0.0 1.0 7.8 17.0 11.8 8.7 0.9 8.6 8.5 1.3 81.3 2.9 12.4 16.3 9.1 26.7 0.0 17.1 3.7 17.6 0.6 8.2 20.2 4.8 6.1 4.6 116.7 14.7 13.2 7.8 9.7 0.4 5.6 16.9 0.9 6.8 5.9 19.3 12.3 54.3 3.4 17.1 14.6 12.3 1.3 1.3 32.6 11.4 0.1 0.1 10.9 14.7 84.8 6.3 6.1 58.0 21.6 18.4 4.0 0.6 0.3 0.1 0.6 1.2 41.7 61.9 0.2 79.0 97.4 58.2 1.1 36.4 3.4 50.1 9.7 3.7 121.1 37.1 2.8 1.3 14.1 48.3 10.3 84.1 9.6 67.5 10.1 10.8 3.3 7.6 8.5 6.5 14.7 4.8 11.9 10.0 17.9 29.8 86.2 131.0 107.6 0.5 1.1 63.7 9.4 23.9 300.1 0.0 25.0 179.1 90.0 3.2 5.8 101.1 0.0 81.2 260.0 55.7 64.5 535.8 0.9 1102.8 1.6 27.6 3.1 175.5 12.5 43.4 306.0 140.0 603.3 55.7 37.8 257.6 119.4 21.2 88.5 1.1 12.9 23.5 6.3 40.4 148.2 29.9 59.9 86.5 209.1 CAPN10 ENSG00000142330 "Calpain 10" Q9HC96 2 240586716-240617705 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 46.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004170, HPA056098" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA004170: AB_1078381, HPA056098: AB_2683037" "unprognostic (1.05e-1)" "unprognostic (1.13e-2)" "unprognostic (9.29e-3)" "unprognostic (6.09e-2)" "unprognostic (5.44e-3)" "prognostic favorable (8.47e-5)" "prognostic unfavorable (4.78e-6)" "unprognostic (7.48e-3)" "unprognostic (7.94e-2)" "unprognostic (1.31e-2)" "prognostic favorable (7.94e-5)" "unprognostic (1.46e-1)" "unprognostic (1.11e-2)" "unprognostic (1.19e-1)" "unprognostic (6.88e-2)" "unprognostic (5.76e-2)" "unprognostic (5.58e-3)" 9.2 11.8 16.8 12.9 15.1 10.9 6.6 20.5 15.7 8.3 13.6 12.8 10.0 20.8 11.3 8.0 9.7 9.8 10.2 11.5 15.9 10.7 14.2 9.3 8.4 15.3 11.2 18.1 10.0 13.0 8.6 13.2 7.3 11.1 10.6 12.2 12.4 14.6 10.7 6.5 19.5 16.2 8.3 8.1 21.0 15.0 10.7 13.7 15.1 9.3 5.6 13.2 8.3 7.0 1.5 2.0 7.7 1.8 5.8 2.2 0.8 5.2 7.9 7.8 6.0 3.0 2.5 13.6 6.7 2.8 4.5 4.3 5.8 12.5 4.0 2.3 2.3 6.3 8.9 2.0 4.5 2.3 15.1 13.8 7.3 13.1 10.1 4.9 4.7 10.3 2.2 3.1 4.7 1.9 4.6 3.3 11.5 8.1 5.0 1.8 4.6 10.5 18.0 11.7 6.3 5.5 10.0 5.5 8.4 7.0 6.2 19.7 15.4 4.3 6.1 8.5 2.7 3.1 5.8 5.8 7.7 6.6 6.2 8.0 12.3 2.8 7.1 7.3 8.6 7.2 1.7 1.8 3.3 2.0 1.0 0.5 1.5 1.3 2.0 0.8 1.5 1.2 1.8 7.7 5.8 1.1 2.0 2.2 0.8 16.8 15.1 20.5 15.7 15.9 10.7 11.2 18.1 11.1 13.7 3.0 5.9 3.7 6.1 4.0 12.5 8.1 12.7 4.0 3.4 8.7 13.7 4.1 6.6 11.8 1.3 5.5 7.8 0.0 7.9 4.3 3.7 7.6 23.0 3.0 5.9 46.1 10.9 4.9 3.2 2.0 8.3 7.0 1.7 9.0 4.9 11.6 11.2 3.5 8.9 5.1 16.7 0.0 6.2 12.1 8.0 4.5 4.6 5.0 6.0 6.0 CAPN12 ENSG00000182472 "Calpain 12" Q6ZSI9 19 38730187-38769904 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 24.5;gallbladder: 21.0;liver: 21.8;salivary gland: 34.3" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 27.1;Cholangiocytes: 50.9;T-cells: 25.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "pons and medulla: 2.4" "Group enriched" "Detected in many" 7 "basophil: 24.5;NK-cell: 12.7" "Group enriched" "Detected in many" 7 "granulocytes: 24.5;NK-cells: 12.7" "Cell line enriched" "Detected in some" 5 "HMC-1: 17.6" "Low region specificity" "Detected in single" "Region enhanced" "Detected in single" "hippocampal formation: 3.6" HPA053322 Approved "Nucleoplasm,Focal adhesion sites" NA NA "Focal adhesion sites" Nucleoplasm "HPA053322: AB_2682111" "unprognostic (1.81e-1)" "unprognostic (4.48e-2)" "unprognostic (1.04e-2)" "unprognostic (1.08e-1)" "unprognostic (1.95e-2)" "unprognostic (2.81e-2)" "unprognostic (1.02e-1)" "unprognostic (6.01e-3)" "unprognostic (7.20e-2)" "unprognostic (2.45e-2)" "unprognostic (1.29e-1)" "unprognostic (4.01e-2)" "prognostic unfavorable (5.90e-6)" "unprognostic (7.04e-2)" "unprognostic (4.01e-2)" "unprognostic (3.00e-1)" "unprognostic (4.59e-2)" 0.6 0.4 0.2 4.7 0.2 0.2 0.7 0.2 0.3 4.2 4.1 0.1 5.6 1.2 1.1 1.0 1.2 3.6 21.0 0.7 1.0 0.4 7.1 21.8 2.0 1.8 0.2 0.1 0.4 5.0 0.2 0.7 0.5 2.4 2.2 0.7 0.4 34.3 3.0 0.3 4.5 1.9 0.5 0.4 4.9 1.6 0.6 0.1 0.4 0.4 1.6 5.2 1.5 1.0 1.7 0.0 24.5 0.0 12.7 2.6 0.7 0.2 1.8 0.1 0.0 0.3 0.1 2.2 0.1 0.0 0.0 0.1 3.2 0.1 0.7 0.1 0.0 0.3 1.3 0.0 0.8 0.0 0.1 0.0 0.3 0.7 0.9 0.0 0.0 17.6 0.8 2.5 0.3 0.0 0.0 0.0 0.0 0.5 0.5 0.3 0.3 0.0 0.0 0.5 1.0 0.0 0.0 0.0 0.2 1.9 0.0 0.1 0.0 0.1 0.4 0.1 0.4 0.1 1.4 0.0 0.0 0.1 0.0 0.4 0.9 0.7 0.0 0.1 0.0 0.7 24.5 0.0 1.8 2.6 0.0 2.5 1.5 0.7 1.3 0.0 1.7 0.0 0.6 0.4 12.7 0.0 0.0 0.5 0.7 0.2 0.2 0.2 0.3 1.0 0.4 0.2 0.1 2.4 0.1 11.9 27.1 15.9 8.0 8.4 1.2 0.6 50.9 5.3 5.7 5.2 0.0 1.5 0.0 9.1 0.4 1.8 4.2 0.0 6.3 8.2 1.1 2.3 4.7 12.7 0.9 0.0 3.5 1.3 1.0 0.2 0.6 2.0 3.3 0.0 18.8 1.7 4.0 3.5 0.4 16.5 0.6 0.0 1.7 0.3 2.4 8.3 2.4 25.4 16.4 4.3 CAPN13 FLJ23523 ENSG00000162949 "Calpain 13" Q6MZZ7 2 30722771-30820542 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 67.3;pancreas: 20.4;stomach 1: 17.6" "Cell type enhanced" "Detected in many" 8 "Club cells: 21.6;Enterocytes: 20.8;Intestinal endocrine cells: 14.5;Undifferentiated cells: 17.1;Urothelial cells: 20.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "RT4: 9.0;SK-BR-3: 21.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA029496, HPA029497, HPA030034" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA029496: AB_2673072, HPA029497: AB_2673073, HPA030034: AB_2673281" "unprognostic (7.42e-2)" "unprognostic (1.19e-1)" "unprognostic (7.01e-3)" "unprognostic (1.96e-1)" "unprognostic (8.56e-2)" "unprognostic (1.51e-1)" "unprognostic (1.68e-1)" "unprognostic (1.32e-3)" "unprognostic (2.17e-1)" "unprognostic (2.66e-2)" "unprognostic (1.11e-1)" "unprognostic (2.49e-1)" "unprognostic (1.96e-2)" "unprognostic (3.64e-1)" "unprognostic (3.32e-2)" "unprognostic (5.03e-2)" "unprognostic (4.28e-3)" 0.2 0.0 0.5 0.5 0.4 0.0 4.8 0.2 0.2 6.2 39.6 0.3 0.2 13.0 1.1 0.6 1.1 0.5 7.4 0.2 0.8 0.4 2.0 0.2 9.4 0.2 0.7 0.3 0.4 20.4 0.6 1.2 0.2 0.2 5.2 16.0 0.2 1.0 0.2 0.2 0.1 67.3 1.6 1.0 0.2 17.6 0.2 0.2 0.2 0.2 0.5 1.0 3.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 9.0 0.1 0.4 0.0 21.7 0.0 0.8 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.2 0.2 0.8 0.4 0.7 0.3 0.2 0.2 6.0 1.9 0.0 7.5 0.0 0.0 1.7 0.0 8.1 21.6 1.8 0.0 0.0 0.0 0.7 0.8 0.0 20.8 0.0 4.8 0.0 0.0 1.9 1.1 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 1.5 3.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.1 20.1 CAPN15 SOLH ENSG00000103326 "Calpain 15" O75808 16 527717-554636 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 15.8" "Lineage enriched" "Detected in many" 6 "granulocytes: 15.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011960 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA011960: AB_10610556" "unprognostic (4.11e-2)" "unprognostic (1.63e-1)" "unprognostic (1.14e-1)" "unprognostic (2.66e-1)" "unprognostic (7.18e-2)" "unprognostic (1.12e-2)" "unprognostic (1.54e-3)" "unprognostic (8.31e-3)" "unprognostic (1.32e-1)" "unprognostic (1.24e-1)" "unprognostic (1.86e-1)" "unprognostic (4.02e-2)" "unprognostic (2.53e-3)" "unprognostic (2.54e-3)" "unprognostic (5.91e-2)" "unprognostic (1.83e-1)" "unprognostic (9.23e-3)" 9.2 7.7 7.1 13.1 6.8 12.0 12.0 20.4 10.9 5.6 15.7 5.7 8.6 26.1 7.9 5.4 10.7 7.5 13.4 5.9 9.8 2.9 9.7 14.1 8.6 8.2 5.8 4.7 8.2 20.5 4.3 9.1 6.1 5.0 7.2 4.7 3.7 11.7 6.9 11.4 14.3 24.7 7.0 3.4 16.8 21.9 10.8 4.1 9.7 6.9 6.6 11.8 6.4 11.8 2.7 0.5 15.8 1.1 1.1 0.4 0.2 8.4 11.0 1.6 4.8 0.9 1.8 24.5 9.1 2.4 2.6 1.8 14.4 6.2 12.3 8.8 1.6 2.6 11.3 1.0 3.6 0.9 12.7 19.4 10.2 11.3 8.8 3.9 11.9 14.4 2.0 2.1 2.6 1.2 1.5 2.8 7.6 18.6 3.7 0.8 13.1 13.3 13.1 14.2 4.4 10.5 23.3 4.5 12.1 1.7 5.5 10.3 9.4 6.0 8.4 5.1 1.0 6.9 12.5 13.4 8.1 11.4 8.2 11.3 9.8 5.4 10.5 3.5 7.0 5.0 3.0 1.1 0.7 0.2 0.8 0.1 0.3 0.1 0.4 0.3 2.7 0.1 0.2 15.8 1.1 1.0 0.5 0.2 0.2 7.1 6.8 20.4 10.9 9.8 2.9 5.8 4.7 5.0 4.1 3.0 9.6 6.0 3.8 7.9 11.8 2.5 10.2 1.4 3.4 7.0 15.7 3.1 1.7 6.3 15.0 7.2 31.5 0.0 13.3 3.5 6.7 8.6 6.9 15.3 6.0 19.1 4.1 8.0 13.5 5.3 6.9 4.8 1.7 2.8 24.3 7.8 10.5 24.9 4.2 4.1 11.4 0.0 3.8 4.9 6.4 6.9 2.1 7.5 19.9 11.9 CAPN5 "ADNIV, HTRA3, nCL-3, VRNI" ENSG00000149260 "Calpain 5" O15484 11 77066932-77126155 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 49.5;intestine: 47.8" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 114.7;Mucus-secreting cells: 72.0;Paneth cells: 69.1;Undifferentiated cells: 49.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 4.8" "Lineage enriched" "Detected in single" 5 "T-cells: 4.8" "Cell line enhanced" "Detected in many" "OE19: 44.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033237, HPA072319" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB033237: AB_2069673, HPA072319: AB_2686512" "unprognostic (6.81e-3)" "unprognostic (1.31e-1)" "unprognostic (3.36e-2)" "prognostic unfavorable (2.16e-6)" "unprognostic (3.47e-3)" "unprognostic (1.34e-1)" "unprognostic (1.13e-1)" "unprognostic (5.30e-2)" "unprognostic (2.52e-1)" "unprognostic (2.21e-2)" "unprognostic (5.35e-3)" "unprognostic (4.64e-1)" "unprognostic (3.17e-3)" "unprognostic (8.58e-3)" "unprognostic (3.25e-1)" "unprognostic (2.31e-2)" "unprognostic (2.30e-3)" 3.9 7.1 5.6 19.5 5.4 1.5 3.9 6.3 10.8 7.4 34.1 6.0 4.8 32.7 6.3 8.3 18.3 6.6 49.5 4.4 5.4 4.6 8.7 26.8 2.8 1.2 3.7 7.0 15.4 3.2 0.7 3.3 2.6 10.2 9.3 27.9 7.4 4.7 7.5 1.8 1.9 47.8 9.3 4.1 2.2 29.3 22.0 2.3 0.6 3.1 4.6 7.3 9.8 6.3 0.2 0.7 0.0 0.9 0.0 4.8 2.1 0.3 5.5 3.7 3.6 13.9 13.4 0.3 5.5 9.6 5.7 4.2 3.2 1.6 0.2 4.0 9.6 6.5 0.2 1.5 0.4 2.4 0.3 0.3 1.1 0.1 0.3 3.5 0.1 0.3 6.6 0.6 9.2 2.2 8.0 6.6 2.6 0.1 0.1 10.6 7.7 0.9 0.1 3.1 44.2 4.3 0.8 12.5 0.2 1.9 6.9 0.2 6.7 1.3 1.0 2.5 2.4 0.8 0.0 13.7 11.1 6.6 15.3 0.7 0.4 0.7 0.0 5.7 0.1 2.6 0.0 0.7 0.0 4.8 0.9 0.4 0.0 0.5 1.6 0.7 0.2 2.4 2.5 0.0 0.0 0.2 0.3 0.0 2.1 5.6 5.4 6.3 10.8 5.4 4.6 3.7 7.0 10.2 2.3 0.0 0.3 0.8 0.2 1.4 1.5 1.7 28.1 4.0 7.9 22.7 0.0 0.0 1.7 9.0 0.9 2.1 114.7 0.0 29.7 0.4 6.2 2.3 0.0 37.5 0.8 1.6 21.5 2.5 1.8 1.1 11.5 1.2 6.8 0.0 72.0 6.4 15.2 69.1 4.2 5.9 1.8 0.0 2.2 0.4 2.3 0.6 0.0 0.0 49.0 1.4 CAPN6 "CalpM, CANPX, CAPNX" ENSG00000077274 "Calpain 6" Q9Y6Q1 X 111245103-111270523 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "epididymis: 62.9;placenta: 173.5" "Group enriched" "Detected in some" 4 "Extravillous trophoblasts: 165.5;Syncytiotrophoblasts: 117.5" "Cancer enhanced" "Detected in many" "endometrial cancer: 25.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 1.2;plasmacytoid DC: 2.0" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "HDLM-2: 10.1;NTERA-2: 15.8;SuSa: 14.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA040259 Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA040259: " "unprognostic (1.27e-3)" "unprognostic (2.04e-1)" "unprognostic (2.69e-2)" "unprognostic (5.77e-3)" "unprognostic (2.07e-1)" "unprognostic (9.93e-2)" "unprognostic (8.39e-3)" "unprognostic (1.06e-1)" "unprognostic (2.08e-1)" "unprognostic (9.45e-3)" "unprognostic (5.12e-1)" "unprognostic (6.25e-2)" "unprognostic (7.67e-2)" "unprognostic (6.50e-2)" "unprognostic (5.02e-3)" "unprognostic (2.66e-1)" "unprognostic (6.30e-2)" 1.7 0.0 0.2 1.7 0.2 0.0 6.0 0.3 0.3 3.9 4.2 0.2 23.4 0.2 18.2 62.9 2.4 2.9 2.6 0.4 0.2 0.0 5.1 0.4 0.3 1.1 0.2 0.4 1.9 4.1 0.0 0.2 173.5 0.3 3.6 2.2 2.1 5.6 21.7 1.7 1.0 1.3 2.0 0.3 1.0 7.2 2.8 0.2 0.5 1.7 4.7 2.9 1.4 2.6 0.1 2.0 0.8 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 15.8 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.1 0.3 0.4 0.3 0.0 14.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.2 0.2 0.3 0.3 0.2 0.0 0.2 0.4 0.3 0.2 0.0 0.0 0.0 1.0 0.1 0.0 0.3 10.2 0.0 0.0 7.0 0.0 35.2 3.3 5.0 0.0 0.0 0.0 0.0 0.6 165.5 2.6 0.2 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.3 0.0 2.7 0.0 20.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 117.5 0.0 0.0 0.3 CAPN8 nCL-2 ENSG00000203697 "Calpain 8" A6NHC0 1 223538007-223665734 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 32.0;stomach 1: 85.8" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 2: 123.4;Club cells: 94.4;Mucus-secreting cells: 49.6" "Cancer enhanced" "Detected in many" "pancreatic cancer: 28.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 1.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 13 "OE19: 51.0;RT4: 30.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA073939 Approved "Nucleoplasm,Nuclear membrane,Vesicles" No NA "Nucleoplasm, Nuclear membrane, Vesicles" "HPA073939: AB_2686646" "unprognostic (4.87e-3)" "unprognostic (2.58e-1)" "unprognostic (1.89e-1)" "unprognostic (2.06e-2)" "unprognostic (1.32e-2)" "unprognostic (1.49e-1)" "unprognostic (7.97e-3)" "unprognostic (1.19e-1)" "unprognostic (1.26e-1)" "unprognostic (8.08e-2)" "unprognostic (2.72e-3)" "unprognostic (3.55e-1)" "unprognostic (4.12e-6)" "unprognostic (6.95e-2)" "unprognostic (5.59e-2)" "unprognostic (3.83e-2)" "unprognostic (5.44e-3)" 0.2 0.0 0.5 10.3 0.3 0.0 7.5 0.2 0.3 1.0 7.9 0.6 0.2 2.2 0.3 3.3 0.6 0.4 32.0 0.2 0.2 0.1 2.5 0.2 13.0 0.2 0.2 0.2 0.2 8.0 0.0 0.2 0.8 0.2 4.6 9.9 0.2 4.6 0.3 0.3 1.5 4.0 3.2 0.2 0.2 85.8 0.4 0.2 0.3 0.2 1.5 1.2 15.1 3.9 0.4 0.0 1.1 0.0 0.0 1.4 1.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 1.8 0.0 0.0 0.0 0.1 3.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 51.0 1.6 0.0 0.0 0.0 0.6 30.2 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.9 0.7 0.0 0.0 0.1 1.4 1.1 0.0 0.0 0.0 0.0 1.5 0.5 0.3 0.2 0.3 0.2 0.1 0.2 0.2 0.2 0.2 26.8 123.4 0.0 6.0 0.1 0.0 2.2 15.3 24.1 94.4 24.4 0.0 0.1 0.0 0.4 1.4 0.0 30.0 0.0 19.7 0.0 0.0 3.3 10.4 0.0 0.5 0.0 2.9 0.0 0.0 3.5 1.7 0.4 0.0 0.0 49.6 0.0 21.9 16.9 3.2 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.1 0.0 13.2 15.4 CAPNS1 "30K, CANP, CANPS, CAPN4, CDPS" ENSG00000126247 "Calpain small subunit 1" P04632 19 36139575-36150353 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006872 Approved Approved Nucleoplasm,Cytosol NA NA 50000000 "Nucleoplasm, Cytosol" "HPA006872: AB_1078382" "unprognostic (1.23e-1)" "unprognostic (1.25e-1)" "unprognostic (2.94e-2)" "unprognostic (1.19e-2)" "unprognostic (1.91e-1)" "unprognostic (2.03e-1)" "unprognostic (2.82e-3)" "unprognostic (1.25e-3)" "unprognostic (2.04e-2)" "unprognostic (6.40e-2)" "unprognostic (1.17e-1)" "unprognostic (5.53e-2)" "unprognostic (7.10e-3)" "unprognostic (1.37e-2)" "unprognostic (1.79e-2)" "unprognostic (1.51e-1)" "unprognostic (4.72e-2)" 67.8 59.4 58.7 49.6 53.1 47.1 54.4 29.9 92.0 74.8 87.8 50.8 45.3 61.3 50.1 48.8 111.9 74.9 70.6 137.2 55.7 61.0 104.0 67.5 70.7 74.0 56.6 52.0 63.0 45.1 72.3 48.6 48.1 71.5 59.8 69.6 62.8 61.4 71.8 95.7 30.9 95.6 69.2 47.4 63.6 50.4 49.2 27.8 45.4 71.4 65.9 87.3 56.7 57.9 13.4 25.7 11.3 33.2 9.6 20.3 8.1 40.6 102.1 25.6 36.5 61.8 75.7 5.2 33.3 71.2 68.0 52.8 23.1 60.5 14.6 49.4 110.9 24.2 21.7 30.6 81.6 57.8 61.6 15.0 17.0 30.8 38.9 71.8 16.8 43.0 81.0 50.9 43.9 62.5 83.0 73.8 18.0 20.5 59.0 103.3 53.5 30.1 30.6 14.7 78.2 51.8 15.9 20.7 27.1 127.6 41.0 17.3 21.8 40.1 57.0 15.8 33.7 33.2 27.7 47.7 60.4 45.9 20.1 33.4 21.1 28.0 13.1 68.5 23.1 51.6 8.8 22.5 9.3 20.3 31.4 13.0 12.9 14.3 16.2 19.8 13.4 8.8 11.8 11.3 9.6 33.2 25.7 14.0 8.1 58.7 53.1 29.9 92.0 55.7 61.0 56.6 52.0 71.5 27.8 116.1 91.8 59.6 67.7 27.2 19.1 134.0 140.1 65.6 69.4 155.3 0.0 63.2 53.0 186.3 77.2 116.2 213.8 23.3 219.3 74.8 68.1 79.4 62.3 66.0 137.4 15.9 103.5 152.2 233.3 179.9 86.3 85.5 37.1 193.8 203.5 55.8 195.6 175.4 71.5 84.9 23.3 45.3 70.7 91.6 5.5 25.2 58.6 61.8 108.1 99.3 CAPRIN2 "C1QDC1, caprin-2, EEG1, FLJ11391, FLJ22569, RNG140" ENSG00000110888 "Caprin family member 2" Q6IMN6 12 30709552-30754951 "Predicted intracellular proteins" "Differentiation, Growth regulation" "Protein synthesis inhibitor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039746 Supported Supported Nucleoplasm,Centrosome,Cytosol NA NA Cytosol "Nucleoplasm, Centrosome" "HPA039746: AB_10672902" "unprognostic (7.45e-2)" "unprognostic (6.38e-2)" "unprognostic (2.83e-3)" "unprognostic (1.08e-1)" "unprognostic (5.03e-2)" "unprognostic (1.10e-1)" "unprognostic (2.64e-2)" "unprognostic (1.92e-1)" "unprognostic (8.91e-2)" "unprognostic (9.90e-2)" "unprognostic (3.09e-1)" "unprognostic (3.30e-2)" "prognostic unfavorable (3.50e-5)" "unprognostic (1.91e-1)" "unprognostic (3.49e-2)" "unprognostic (1.82e-1)" "prognostic favorable (8.36e-4)" 5.5 7.8 12.5 5.3 20.6 9.3 5.0 19.9 15.7 7.3 5.3 4.4 9.5 4.0 8.6 10.5 3.6 4.9 6.1 17.4 11.8 19.0 6.5 5.3 6.5 5.4 11.2 11.6 8.3 5.5 22.4 11.0 4.2 18.2 7.4 5.7 6.1 3.1 10.0 5.6 10.6 4.6 8.4 11.5 6.7 6.5 22.3 9.4 4.3 5.7 3.9 5.0 6.1 8.1 4.1 4.2 7.5 1.5 2.6 5.4 0.9 4.5 3.2 6.0 5.1 6.0 6.3 3.6 8.5 7.1 3.7 5.0 1.7 2.9 2.7 7.5 8.8 7.4 3.6 3.2 13.8 6.7 4.0 3.5 11.1 5.2 6.4 3.3 1.7 1.1 7.3 5.5 11.8 9.5 15.4 8.3 4.9 0.7 2.7 8.7 0.9 2.2 2.9 7.1 2.4 9.7 1.0 9.1 1.3 1.6 16.4 7.5 4.6 3.1 2.2 3.6 15.0 2.0 0.5 11.2 7.1 3.9 21.6 15.5 5.2 3.6 2.4 8.6 0.5 4.6 7.5 1.5 1.2 4.4 0.6 5.4 3.7 2.8 4.6 0.6 4.1 3.1 2.8 0.3 2.6 0.7 4.2 1.8 0.9 12.5 20.6 19.9 13.7 11.8 19.0 11.2 11.6 18.2 9.4 20.8 23.0 1.4 4.6 6.4 28.8 21.4 0.0 18.7 9.1 3.5 21.6 6.4 8.3 4.4 7.4 8.5 5.1 0.0 9.6 1.5 5.4 2.6 20.9 5.9 7.7 11.1 16.0 7.4 6.1 10.7 6.4 4.6 3.3 3.6 3.0 12.2 21.7 2.6 8.1 9.5 36.8 6.5 7.7 7.5 23.0 4.0 10.3 5.2 3.2 2.4 CAPS "CAPS1, MGC126562" ENSG00000105519 Calcyphosine 19 5911707-5915877 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.4;fallopian tube: 116.0" "Cell type enriched" "Detected in many" 8 "Ciliated cells: 1030.6" "Cancer enriched" "Detected in all" 5 "endometrial cancer: 171.3" "Region enhanced" "Detected in all" "pons and medulla: 71.4" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 36.6;U-266/70: 10.1" "Low region specificity" "Detected in many" HPA043520 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA043520: AB_10964138" "unprognostic (2.06e-1)" "unprognostic (1.13e-2)" "unprognostic (7.94e-3)" "prognostic favorable (7.63e-5)" "unprognostic (5.18e-1)" "prognostic favorable (8.60e-4)" "unprognostic (7.07e-2)" "unprognostic (2.46e-3)" "unprognostic (1.51e-1)" "unprognostic (1.82e-1)" "unprognostic (4.70e-2)" "unprognostic (9.99e-2)" "unprognostic (4.01e-2)" "unprognostic (8.47e-2)" "unprognostic (3.25e-1)" "unprognostic (6.86e-3)" "unprognostic (5.96e-3)" 2.6 4.1 8.0 4.3 14.7 4.3 2.8 1.4 3.3 12.4 3.3 34.4 15.6 3.1 9.1 49.4 2.8 116.0 13.6 2.0 13.4 6.6 8.9 5.0 25.4 4.4 8.0 7.8 26.7 6.5 2.5 7.5 17.7 71.4 9.4 2.0 3.3 7.7 12.7 2.0 5.7 5.0 2.9 7.5 7.6 9.4 2.1 17.9 0.4 7.8 0.9 2.5 8.8 11.3 4.9 4.0 5.2 2.2 5.3 4.8 2.4 1.1 1.1 0.7 3.5 1.3 1.8 2.2 0.6 0.4 0.2 0.3 0.8 7.5 0.8 2.2 0.9 0.5 1.4 0.3 0.3 0.1 2.4 1.0 0.6 2.2 2.0 1.2 0.6 1.8 2.3 2.1 0.2 0.5 2.5 0.5 2.6 0.5 2.9 0.4 2.1 1.4 2.0 0.6 8.8 5.7 1.7 0.3 2.3 1.0 3.2 0.7 2.6 0.5 36.6 3.7 2.0 2.3 2.3 1.0 0.6 0.4 2.7 9.7 10.1 3.4 0.7 4.3 1.0 1.4 3.3 2.2 1.6 4.8 1.8 2.6 3.1 3.0 3.6 2.1 4.9 2.4 2.0 5.2 5.3 1.6 4.0 3.2 2.4 8.0 14.7 1.4 3.3 13.4 6.6 8.0 7.8 71.4 17.9 11.9 16.8 0.8 29.9 4.2 2.2 1.9 0.0 1030.6 124.0 115.1 3.9 21.6 29.9 26.7 4.7 3.8 3.9 0.0 5.2 16.2 21.6 27.6 5.8 0.0 4.6 6.4 18.4 0.0 0.0 4.0 4.4 4.4 10.1 1.8 19.7 7.2 24.2 2.9 4.6 3.6 3.9 6.5 4.2 0.5 0.4 3.6 17.2 0.0 7.4 100.9 CAPS2 ENSG00000180881 "Calcyphosine 2" Q9BXY5 12 75275979-75390928 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 21.7" "Cell type enriched" "Detected in many" 4 "Ciliated cells: 96.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 1.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 12.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039542, HPA040004" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles,Centrosome Yes No Nucleoli "Nucleoplasm, Vesicles, Centrosome" "HPA039542: , HPA040004: AB_10794758" "unprognostic (1.38e-2)" "unprognostic (1.21e-1)" "unprognostic (7.26e-2)" "unprognostic (5.10e-2)" "unprognostic (3.05e-2)" "unprognostic (1.55e-2)" "unprognostic (2.66e-1)" "unprognostic (2.36e-1)" "unprognostic (9.61e-2)" "unprognostic (1.24e-1)" "unprognostic (2.02e-3)" "unprognostic (1.01e-1)" "unprognostic (1.32e-2)" "unprognostic (3.07e-1)" "unprognostic (1.75e-1)" "unprognostic (4.52e-2)" "unprognostic (2.69e-1)" 2.6 4.2 8.0 1.2 5.8 1.6 3.7 15.5 11.2 3.7 2.5 5.5 2.1 1.8 5.0 8.8 3.6 21.7 3.4 5.4 6.3 6.6 6.6 4.2 5.8 1.3 5.4 5.6 4.5 2.6 7.3 15.8 0.9 7.8 5.1 2.0 4.4 5.5 3.6 3.8 2.6 1.9 2.0 8.7 2.6 3.2 8.0 9.5 1.4 9.3 2.2 1.4 2.6 2.0 0.1 0.6 0.0 0.7 1.1 1.8 0.1 1.3 3.7 1.0 0.3 1.9 1.4 0.1 0.7 0.2 2.0 2.2 0.0 1.7 0.3 3.3 0.5 0.8 0.8 0.0 1.6 1.4 1.2 0.6 1.5 0.6 0.0 0.0 0.2 0.0 0.6 1.0 1.7 0.3 12.1 0.2 1.3 0.3 0.6 2.6 0.0 1.8 1.4 0.5 0.0 0.5 0.0 0.0 0.2 2.6 0.0 2.1 1.0 0.2 0.1 1.2 0.2 1.2 0.5 0.8 1.9 0.8 0.4 0.3 0.2 0.0 0.0 1.6 0.0 1.5 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.7 0.0 0.0 0.1 0.6 0.9 0.0 1.1 0.7 0.6 1.8 0.1 8.0 5.8 15.5 11.2 6.3 6.6 5.4 5.6 7.8 9.5 8.9 3.2 0.0 2.5 1.5 0.7 7.1 2.5 96.4 17.0 5.2 3.9 1.0 5.0 0.8 21.6 1.7 0.0 0.0 1.5 0.5 1.7 1.5 0.0 1.5 0.5 1.6 0.0 2.5 1.8 11.5 5.8 0.9 0.0 0.0 1.7 5.8 0.4 0.0 6.7 2.5 20.8 0.0 1.4 9.1 0.9 0.5 0.2 0.0 0.6 0.5 CAPSL MGC26610 ENSG00000152611 "Calcyphosine like" Q8WWF8 5 35904295-35938779 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 34.9;epididymis: 18.3;fallopian tube: 59.4" "Group enriched" "Detected in some" 5 "Ciliated cells: 455.0;Early spermatids: 136.1;Late spermatids: 117.8" "Group enriched" "Detected in many" 5 "endometrial cancer: 14.1;ovarian cancer: 3.4" "Region enriched" "Detected in many" 7 "pons and medulla: 34.9" "Cell type enriched" "Detected in single" 13 "naive CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Group enriched" "Detected in some" 4 "BJ hTERT+ SV40 Large T+: 7.5;BJ hTERT+ SV40 Large T+ RasG12V: 6.4;HBF TERT88: 4.9;REH: 7.8;U-698: 19.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA046811, HPA058495" Enhanced Approved Nucleoplasm,Microtubules No No "Nucleoplasm, Microtubules" "HPA046811: AB_2679819, HPA058495: AB_2683735" "unprognostic (1.16e-1)" "unprognostic (3.40e-2)" "unprognostic (2.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.20e-2)" "unprognostic (7.35e-2)" "unprognostic (1.29e-1)" "unprognostic (1.92e-3)" "unprognostic (4.42e-1)" "unprognostic (3.62e-4)" "unprognostic (1.46e-1)" "unprognostic (1.36e-2)" "unprognostic (1.52e-1)" 0.1 0.2 3.6 0.1 4.4 0.2 0.2 0.0 0.5 2.4 0.1 4.3 0.4 0.1 1.3 18.3 0.2 59.4 0.2 0.2 5.2 5.3 0.7 0.1 11.8 0.1 0.3 0.0 6.7 0.4 0.1 17.0 0.2 34.9 0.2 0.1 0.0 0.4 0.4 0.2 0.2 0.1 0.2 0.8 0.1 0.2 5.4 0.5 0.5 3.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.8 7.5 6.4 0.0 0.0 2.2 0.0 0.9 0.1 0.0 0.1 0.0 4.9 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 1.4 0.0 0.0 1.3 2.2 0.0 0.5 0.0 0.0 19.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.6 4.4 0.0 0.3 5.2 5.3 0.3 0.0 34.9 0.5 3.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 455.0 51.2 1.8 0.0 0.0 1.7 0.0 136.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.1 0.0 0.1 0.0 0.0 0.0 0.0 117.8 0.9 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.0 0.0 3.2 1.1 0.0 0.0 0.0 0.0 0.0 CAPZB ENSG00000077549 "Capping actin protein of muscle Z-line beta subunit" P47756 1 19338776-19485539 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 11 "Late spermatids: 2817.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031531 Approved Approved Nucleoplasm,Vesicles,Cytosol No No 35000000 "Nucleoplasm, Cytosol" Vesicles "HPA031531: AB_10603556" "unprognostic (7.52e-2)" "unprognostic (2.13e-1)" "unprognostic (5.25e-2)" "unprognostic (1.31e-2)" "unprognostic (1.45e-2)" "unprognostic (2.18e-1)" "prognostic unfavorable (1.85e-4)" "unprognostic (4.55e-2)" "unprognostic (7.70e-2)" "unprognostic (3.08e-1)" "unprognostic (4.15e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (3.57e-4)" "unprognostic (1.18e-1)" "unprognostic (2.41e-1)" "unprognostic (4.00e-1)" "unprognostic (3.78e-1)" 29.6 24.8 57.1 38.4 47.3 27.9 28.1 23.0 39.7 34.8 84.1 34.3 19.3 29.2 40.3 28.2 41.8 29.2 29.3 80.3 53.8 40.7 29.3 37.5 29.7 50.4 53.5 33.6 38.6 24.9 23.7 18.1 36.9 29.5 42.2 43.5 30.4 23.7 35.9 160.5 27.0 43.7 49.5 72.0 42.1 32.6 70.5 22.3 51.2 34.2 35.3 54.3 56.9 32.3 39.8 55.6 155.9 96.3 27.1 57.2 78.0 48.6 29.0 52.2 37.5 71.6 92.3 36.7 82.9 86.5 73.5 75.7 36.1 68.7 33.6 36.2 103.6 44.9 41.4 44.8 57.2 82.8 52.9 31.8 65.9 38.9 56.3 73.5 43.6 108.9 85.1 47.7 62.9 59.6 63.2 66.9 39.9 23.4 48.1 73.4 34.6 48.3 50.8 39.2 64.8 31.4 43.7 36.7 44.2 92.7 28.1 31.8 24.5 48.7 40.8 54.8 49.6 44.8 38.2 68.9 49.5 40.7 81.1 39.4 29.8 35.7 42.4 65.0 57.5 53.4 53.8 54.4 155.9 49.1 79.4 41.8 39.8 51.1 52.3 55.6 29.1 43.1 46.1 87.8 27.1 96.3 30.2 57.2 78.0 57.1 47.3 23.0 39.7 53.8 40.7 53.5 33.6 29.5 22.3 92.3 61.8 162.3 259.9 138.7 89.2 77.5 127.4 100.4 63.7 96.0 39.3 284.3 252.0 312.1 989.2 166.8 227.5 23.3 225.6 329.7 194.7 191.6 142.2 80.4 668.4 73.1 135.5 131.3 269.2 2817.9 215.4 313.1 136.7 740.4 212.2 119.4 260.5 192.9 284.2 184.2 70.1 239.3 175.9 100.8 73.9 159.6 286.2 286.6 157.4 234.8 CARD8 "CARDINAL, Dakar, KIAA0955, NDPP, TUCAN" ENSG00000105483 "Caspase recruitment domain family member 8" Q9Y2G2 19 48180770-48255946 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Kupffer cells: 77.2;T-cells: 77.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 34.1;HUVEC TERT2: 44.3;NB-4: 38.3;TIME: 42.0" "HPA042071, HPA043513" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA042071: AB_2677831, HPA043513: AB_2678522" "unprognostic (3.96e-2)" "unprognostic (1.92e-1)" "unprognostic (7.84e-2)" "unprognostic (1.48e-1)" "unprognostic (3.30e-2)" "unprognostic (1.58e-2)" "unprognostic (6.95e-2)" "unprognostic (2.18e-2)" "unprognostic (9.19e-2)" "unprognostic (7.30e-2)" "unprognostic (3.79e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (1.63e-8)" "unprognostic (1.78e-1)" "unprognostic (1.69e-1)" "unprognostic (9.19e-2)" "prognostic favorable (1.72e-5)" 33.9 10.0 7.9 19.3 11.4 14.9 17.2 7.2 9.5 11.9 8.7 10.1 6.9 8.1 14.0 8.1 7.5 9.4 9.7 10.5 8.6 5.2 8.7 10.1 16.8 25.6 13.3 3.3 8.1 10.5 6.9 11.3 15.0 10.2 9.6 8.0 10.2 8.9 6.2 12.0 6.8 15.1 11.1 16.2 42.1 9.9 9.8 11.7 24.1 11.4 9.2 23.9 12.8 10.1 10.2 12.8 53.6 20.0 8.3 14.1 9.5 4.0 9.3 9.0 2.9 2.9 4.6 3.5 3.7 4.8 6.0 9.3 3.2 5.9 7.8 4.7 3.8 4.1 2.5 5.3 2.8 5.7 12.9 4.5 34.1 4.6 6.6 3.9 16.3 26.2 3.8 2.0 2.9 3.5 5.3 44.3 9.3 4.6 10.3 4.6 2.7 6.7 38.3 2.2 8.6 2.3 11.4 4.0 2.0 3.4 5.1 3.0 4.6 6.1 4.3 5.2 4.8 2.7 14.5 42.0 3.5 4.4 1.4 6.0 9.4 22.8 5.2 1.6 11.7 6.1 25.0 15.2 23.0 10.4 19.9 11.5 10.2 10.2 11.8 12.8 9.6 9.8 10.4 53.6 8.3 20.0 9.0 14.1 9.5 7.9 11.4 7.2 9.5 8.6 5.2 13.3 3.3 10.2 11.7 3.0 33.5 45.1 5.2 8.2 8.3 8.1 12.7 10.7 10.3 12.2 11.8 23.9 5.0 6.7 18.0 55.4 6.2 23.3 9.1 8.9 11.8 3.6 32.4 13.6 36.4 6.4 5.2 68.2 77.2 42.1 7.2 52.8 20.3 10.0 6.2 4.7 9.0 7.0 7.4 9.8 3.8 6.5 11.3 18.7 14.0 6.1 12.9 77.8 6.3 3.5 CARM1 PRMT4 ENSG00000142453 "Coactivator associated arginine methyltransferase 1" Q86X55 19 10871513-10923070 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 64.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032961, HPA043561, HPA048073, HPA069313" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "CAB032961: AB_2068446, HPA043561: AB_2678554, HPA048073: AB_2680250, HPA069313: " "unprognostic (9.46e-2)" "unprognostic (3.61e-1)" "unprognostic (2.94e-2)" "unprognostic (2.23e-1)" "unprognostic (2.69e-2)" "unprognostic (3.13e-2)" "unprognostic (1.66e-3)" "unprognostic (3.76e-2)" "unprognostic (7.81e-2)" "unprognostic (6.18e-2)" "unprognostic (9.31e-2)" "unprognostic (7.25e-2)" "prognostic unfavorable (7.88e-6)" "unprognostic (1.71e-2)" "unprognostic (6.26e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (8.37e-4)" 12.2 8.8 12.3 12.6 16.1 13.2 9.6 12.5 17.7 15.8 14.0 9.3 9.0 11.5 19.6 9.1 20.5 14.8 12.4 14.7 11.2 7.2 9.3 14.5 8.9 12.4 7.8 10.2 13.0 16.9 8.2 6.9 15.3 9.5 12.6 10.2 12.0 11.4 13.2 64.3 12.5 12.0 15.6 6.6 9.8 11.1 17.5 8.6 9.4 10.0 12.7 15.6 15.8 15.9 1.3 1.6 0.3 1.4 0.1 2.6 0.4 22.6 16.9 24.2 32.8 20.2 27.7 23.2 16.3 28.3 24.2 23.3 26.0 8.3 31.2 19.6 28.4 12.2 21.7 24.7 24.5 15.3 34.9 20.1 9.6 11.0 31.5 17.3 14.4 12.5 18.9 16.0 16.5 20.0 13.8 30.6 24.9 22.9 28.1 14.2 40.9 25.1 12.4 29.9 15.2 28.1 35.1 12.4 36.3 14.6 11.7 17.6 16.9 11.6 14.1 15.7 12.6 14.1 12.4 18.3 29.2 16.5 27.7 19.0 27.4 21.6 27.3 19.2 23.2 12.6 0.0 1.4 0.2 1.2 1.4 0.5 1.3 0.9 2.6 1.3 1.3 1.0 0.9 0.3 0.1 0.7 1.6 0.8 0.4 12.3 16.1 12.5 17.7 11.2 7.2 7.8 10.2 9.5 8.6 8.9 13.5 11.5 4.9 6.9 31.0 0.8 17.8 8.1 6.8 8.7 49.1 16.3 6.6 11.8 25.6 5.7 28.0 46.7 16.9 26.3 10.3 10.9 1.1 23.7 22.3 42.9 26.5 11.1 17.8 13.0 26.2 7.5 5.0 28.9 25.6 10.2 20.3 25.9 18.0 7.3 19.9 6.5 9.2 25.8 16.4 6.0 10.1 4.1 21.2 9.0 CARS2 FLJ12118 ENSG00000134905 "Cysteinyl-tRNA synthetase 2, mitochondrial" Q9HA77 13 110641412-110713603 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Late spermatids: 173.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-87 MG: 65.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041776 Uncertain Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA041776: AB_2677666" "unprognostic (2.34e-3)" "unprognostic (9.50e-2)" "unprognostic (6.62e-2)" "prognostic favorable (1.84e-4)" "unprognostic (1.98e-1)" "unprognostic (3.54e-3)" "prognostic unfavorable (1.21e-4)" "unprognostic (1.90e-1)" "unprognostic (1.08e-1)" "unprognostic (7.82e-2)" "unprognostic (2.11e-3)" "unprognostic (5.75e-2)" "prognostic unfavorable (2.49e-5)" "unprognostic (4.73e-2)" "unprognostic (3.42e-1)" "unprognostic (3.21e-1)" "unprognostic (1.71e-2)" 19.6 28.1 11.9 24.8 13.0 25.6 37.1 18.2 14.5 21.8 20.2 17.6 21.2 17.8 18.5 23.0 20.2 16.8 26.9 26.0 9.9 10.3 17.0 21.4 19.9 26.7 11.3 14.1 17.6 31.7 11.5 19.7 12.5 11.7 17.5 15.0 16.6 19.0 21.3 39.7 16.1 20.1 22.1 11.7 19.7 17.9 11.2 11.4 21.8 19.2 18.5 21.9 16.9 16.7 3.4 4.0 3.1 6.8 0.6 2.2 1.7 35.4 11.8 6.8 16.5 18.1 17.0 9.2 15.8 14.5 16.0 19.7 16.6 16.0 16.6 22.2 17.2 24.4 18.9 11.6 19.8 13.1 15.1 19.3 10.3 25.0 18.9 18.5 25.2 12.6 21.2 15.8 13.9 16.8 11.4 11.4 12.6 7.1 5.2 22.5 8.2 11.2 8.2 5.7 27.2 11.7 16.6 5.0 6.8 17.1 10.4 12.1 9.2 12.7 19.7 18.2 7.6 9.5 28.1 10.2 13.4 5.0 16.9 15.8 9.4 10.7 9.6 65.5 15.1 13.2 0.0 4.7 0.7 2.0 5.1 2.2 3.4 0.6 0.8 4.0 1.4 2.0 1.0 3.1 0.6 6.8 3.4 0.7 1.7 11.9 13.0 18.2 14.5 9.9 10.3 11.3 14.1 11.7 11.4 8.9 15.7 17.6 19.1 11.4 22.3 34.3 12.7 2.7 7.9 26.2 23.6 21.5 43.1 14.9 53.5 10.8 19.0 0.0 4.1 25.5 14.3 16.8 16.1 23.1 25.1 22.3 18.0 9.8 26.7 173.5 19.0 29.2 11.8 13.6 17.0 23.0 12.9 7.0 17.0 29.6 24.7 6.5 18.6 7.2 4.7 11.8 14.1 12.9 22.3 18.2 CASC10 "bA418C1.3, C10orf114" ENSG00000204682 "Cancer susceptibility 10" Q5T4H9 10 21492658-21497262 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.8;liver: 13.6" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 5.9;Proximal tubular cells: 10.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 10.3;AF22: 10.4;AN3-CA: 14.4;BEWO: 13.9;SK-BR-3: 9.1" HPA064131 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA064131: AB_2685196" "unprognostic (2.69e-2)" "unprognostic (1.46e-2)" "unprognostic (5.37e-3)" "unprognostic (1.87e-3)" "prognostic unfavorable (8.87e-4)" "unprognostic (3.22e-2)" "unprognostic (1.34e-2)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (2.00e-1)" "unprognostic (8.55e-2)" "unprognostic (1.85e-1)" "unprognostic (4.04e-3)" "unprognostic (1.09e-3)" "unprognostic (1.78e-1)" "unprognostic (5.19e-2)" "prognostic unfavorable (5.86e-4)" 1.8 2.6 8.9 0.9 6.2 0.9 0.9 2.0 8.0 2.5 0.8 6.1 0.1 1.0 1.3 1.1 1.2 2.4 1.7 3.8 11.8 3.8 6.3 13.6 1.5 1.3 3.3 4.2 2.6 1.3 3.7 3.3 7.2 2.7 1.9 0.7 2.0 1.0 1.8 5.0 3.3 0.9 1.5 2.2 0.8 0.9 2.6 5.3 0.1 5.6 0.0 0.8 2.3 1.6 0.6 0.4 2.2 0.3 1.0 0.4 0.2 1.7 10.3 10.4 14.4 1.9 1.0 13.9 0.9 0.4 0.1 0.2 1.6 3.6 0.5 1.5 0.8 1.8 2.2 1.8 0.6 0.1 0.3 1.9 0.1 1.5 2.3 0.5 0.0 0.1 1.3 1.8 0.1 0.2 1.5 0.9 0.6 0.6 0.1 0.1 1.6 0.7 0.6 1.4 0.0 0.9 0.8 0.1 0.0 2.1 1.5 1.4 5.1 4.8 9.1 0.6 3.5 1.7 7.9 2.5 0.9 8.1 0.2 1.1 0.1 0.2 0.1 4.5 0.0 4.5 1.5 0.3 0.3 0.3 0.2 0.2 0.3 0.2 0.1 0.0 0.6 0.2 0.4 2.2 1.0 0.3 0.4 0.2 0.2 8.9 6.2 2.0 8.0 11.8 3.8 3.3 4.2 2.7 5.3 0.0 0.6 0.0 0.4 1.0 2.3 2.2 0.0 2.7 0.0 1.8 0.0 2.0 5.0 0.0 0.2 3.7 0.0 0.0 0.0 2.3 1.9 0.1 0.0 5.9 0.7 4.8 0.0 3.7 0.3 0.0 4.4 0.0 1.7 0.0 0.0 2.9 0.2 0.0 1.8 10.5 0.6 0.0 0.3 0.2 0.2 0.6 3.2 0.0 0.0 0.1 CASD1 "C7orf12, FLJ21213, FLJ21879" ENSG00000127995 "CAS1 domain containing 1" Q96PB1 7 94509219-94557019 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 54.4;Horizontal cells: 63.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044404 Uncertain Approved Nucleoplasm Yes No Nucleoplasm "HPA044404: AB_10964353" "unprognostic (4.02e-2)" "unprognostic (4.16e-2)" "unprognostic (1.43e-1)" "unprognostic (1.82e-1)" "unprognostic (7.04e-2)" "unprognostic (7.90e-2)" "unprognostic (3.66e-2)" "unprognostic (2.18e-2)" "unprognostic (9.83e-2)" "unprognostic (4.74e-2)" "unprognostic (4.95e-3)" "unprognostic (2.16e-2)" "unprognostic (5.24e-2)" "unprognostic (4.01e-3)" "unprognostic (1.93e-1)" "unprognostic (7.07e-2)" "unprognostic (2.59e-3)" 8.6 21.6 16.6 7.1 24.2 4.1 13.2 20.5 24.8 10.0 13.2 10.9 7.5 5.0 11.7 12.5 5.1 9.2 8.1 13.6 25.9 22.2 10.2 7.1 9.0 9.2 13.1 16.6 14.1 7.8 12.7 22.8 9.8 20.0 11.8 15.9 8.4 22.6 8.2 11.3 3.7 6.3 9.7 13.7 8.0 6.0 10.1 11.5 7.3 13.2 2.9 8.3 9.0 6.3 1.8 1.1 0.2 0.7 1.8 4.7 0.7 3.0 5.9 20.3 7.5 6.2 7.5 3.4 4.2 7.4 4.6 6.1 3.7 7.6 7.8 11.0 5.6 8.3 1.7 5.1 1.4 9.2 12.4 4.1 6.9 5.0 6.7 5.3 11.4 0.0 6.8 5.4 4.2 6.1 9.1 7.3 9.2 3.7 17.2 11.4 4.5 15.8 6.5 10.4 4.3 4.7 10.9 16.5 6.0 9.4 8.5 7.7 26.3 6.5 12.1 4.1 15.4 3.1 7.2 3.8 11.6 9.2 9.5 6.0 16.5 15.4 16.3 6.3 2.7 7.5 0.0 0.6 0.2 1.9 0.7 4.7 1.8 2.8 2.3 1.1 1.7 2.9 2.2 0.0 1.8 0.6 1.0 1.7 0.7 16.6 24.2 20.5 24.8 25.9 22.2 13.1 16.6 20.0 11.5 26.8 22.9 6.9 5.2 4.0 54.4 17.1 17.8 18.7 17.0 19.2 17.7 9.7 3.3 4.5 2.7 13.3 12.0 0.0 4.8 4.6 9.3 11.8 10.3 10.9 7.4 63.5 6.9 17.2 11.5 4.7 10.6 5.6 23.6 2.8 27.6 25.0 6.1 8.6 9.2 8.8 28.9 19.4 7.1 6.3 11.9 4.0 14.1 7.2 14.1 3.7 CASK "CAGH39, FGS4, LIN2, TNRC8" ENSG00000147044 "Calcium/calmodulin dependent serine protein kinase" O14936 X 41514934-41923645 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 26.3" "Lineage enriched" "Detected in many" 11 "granulocytes: 26.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001949, HPA023857" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB001949: , HPA023857: AB_1846035" "unprognostic (6.30e-2)" "unprognostic (3.78e-2)" "unprognostic (1.48e-1)" "unprognostic (2.48e-3)" "unprognostic (1.56e-1)" "unprognostic (1.29e-1)" "unprognostic (1.42e-3)" "unprognostic (3.58e-1)" "unprognostic (1.02e-1)" "unprognostic (5.85e-3)" "prognostic unfavorable (6.11e-5)" "unprognostic (1.13e-1)" "unprognostic (1.05e-1)" "unprognostic (8.72e-2)" "unprognostic (1.15e-2)" "unprognostic (2.13e-2)" "unprognostic (2.85e-2)" 9.1 15.9 13.9 18.8 12.7 9.8 13.2 14.2 15.7 11.1 22.1 20.0 7.1 27.1 12.2 13.7 17.2 9.9 16.0 7.0 12.1 12.8 14.6 10.8 10.3 13.6 16.3 8.5 13.9 14.2 11.1 9.8 13.4 11.9 10.7 23.8 10.4 15.9 7.7 5.8 12.8 32.9 12.1 10.1 9.6 16.2 2.9 14.3 30.9 9.3 8.1 14.0 11.8 13.1 0.6 0.3 26.3 0.8 2.4 2.3 0.3 10.9 14.0 13.4 8.0 9.1 7.4 4.3 9.6 8.0 5.6 5.2 30.1 17.9 0.1 4.9 11.9 10.2 22.0 14.7 9.8 9.4 9.7 8.2 0.0 12.6 10.6 9.4 1.7 1.5 8.4 26.9 10.7 13.7 11.3 4.6 6.4 0.8 8.5 12.2 12.8 3.1 0.7 12.3 15.8 9.1 5.1 33.0 5.2 12.7 23.8 12.3 6.5 18.0 7.2 5.5 22.6 7.7 0.3 5.3 10.5 10.7 9.0 5.3 3.3 2.1 3.7 10.3 1.2 6.7 26.3 0.8 4.8 0.5 0.7 0.5 0.4 0.6 0.8 0.2 0.6 0.7 0.7 1.1 2.4 0.4 0.3 2.3 0.3 13.9 12.7 14.2 14.2 12.1 12.8 16.3 8.5 11.9 14.3 11.9 14.8 0.9 33.3 29.0 40.5 6.5 10.2 20.1 14.8 7.0 21.6 1.6 43.1 13.2 0.8 10.8 22.7 0.0 12.7 0.7 17.5 19.6 0.0 13.0 16.2 47.7 13.3 4.9 3.5 0.2 9.2 6.8 10.1 0.0 30.6 11.9 17.9 28.1 8.9 17.0 26.0 19.4 14.4 1.6 1.9 28.4 1.4 12.5 36.5 26.9 CASKIN1 "ANKS5A, KIAA1306" ENSG00000167971 "CASK interacting protein 1" Q8WXD9 16 2177180-2196525 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 30.4" "Cell type enhanced" "Detected in some" 21 "Bipolar cells: 19.0;Cone photoreceptor cells: 7.9;Horizontal cells: 39.7;Muller glia cells: 18.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.6;HDLM-2: 17.0;HEK 293: 3.8;SCLC-21H: 7.8;SH-SY5Y: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055990, HPA076882, CAB079050" Enhanced Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB079050: , HPA055990: AB_2682997, HPA076882: " "unprognostic (4.91e-2)" "unprognostic (2.48e-1)" "unprognostic (4.84e-2)" "unprognostic (1.71e-1)" "unprognostic (9.43e-2)" "unprognostic (2.05e-1)" "unprognostic (2.80e-2)" "unprognostic (8.02e-2)" "unprognostic (6.58e-2)" "unprognostic (4.59e-1)" "unprognostic (2.21e-4)" "unprognostic (2.67e-2)" "unprognostic (2.62e-1)" "unprognostic (9.70e-3)" "unprognostic (1.72e-1)" "unprognostic (7.34e-3)" "unprognostic (3.39e-1)" 1.1 1.8 17.7 1.2 18.1 1.1 1.4 15.0 30.4 1.5 1.2 2.3 0.0 1.2 1.5 1.3 1.2 1.4 1.2 2.5 16.4 12.8 1.3 1.1 1.1 1.1 12.4 11.7 1.2 1.5 1.9 1.4 1.2 11.1 1.8 1.2 1.8 2.5 1.4 1.3 2.2 1.3 1.2 2.8 1.1 1.3 1.8 4.0 0.0 1.6 0.0 1.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.0 4.6 0.0 0.0 2.2 0.0 0.0 0.1 0.0 1.5 0.1 0.0 0.9 0.0 0.0 0.0 1.2 0.3 0.0 17.0 3.8 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.7 1.1 0.1 0.0 1.3 0.0 1.0 0.8 0.0 0.0 0.9 0.0 0.4 0.2 0.0 7.8 3.8 0.1 0.2 0.2 0.2 1.0 0.5 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 18.1 15.0 21.7 16.4 12.8 12.4 11.7 11.1 4.0 0.0 0.0 0.0 0.2 0.3 19.0 2.3 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 39.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 18.6 0.2 0.0 0.0 0.0 5.1 0.0 0.0 0.0 1.7 0.4 0.1 0.0 0.0 0.0 CASP1 "ICE, IL1BC" ENSG00000137752 "Caspase 1" P29466 11 105025443-105035250 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 64.2;lymphoid tissue: 40.7" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 83.5;Kupffer cells: 119.3;Macrophages: 125.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 38.4;HBEC3-KT: 18.2;HHSteC: 20.6;U-937: 45.4" "Region enhanced" "Detected in many" "olfactory region: 22.8" "Low region specificity" "Detected in all" "CAB002685, HPA003056" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB002685: , HPA003056: AB_1846037" "unprognostic (1.21e-3)" "unprognostic (3.02e-1)" "unprognostic (9.47e-3)" "unprognostic (1.43e-1)" "unprognostic (1.47e-1)" "unprognostic (1.21e-1)" "unprognostic (5.24e-2)" "unprognostic (1.97e-1)" "unprognostic (1.66e-1)" "unprognostic (6.67e-2)" "unprognostic (2.75e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (3.11e-4)" "unprognostic (9.03e-2)" "unprognostic (2.30e-2)" "unprognostic (3.18e-1)" "unprognostic (5.19e-2)" 7.4 3.9 6.6 15.1 17.0 8.2 6.9 3.5 7.0 4.1 12.8 2.2 2.9 34.0 3.0 4.2 10.6 4.3 7.3 4.9 9.3 3.0 6.4 5.8 20.5 16.2 16.7 2.6 4.4 3.4 0.2 3.7 8.7 13.3 6.1 13.9 3.7 7.0 3.2 1.6 9.9 37.2 5.2 17.4 40.7 5.6 1.5 11.0 4.1 3.7 5.6 9.0 9.7 13.2 7.3 39.6 40.5 64.2 11.1 34.3 31.2 0.4 0.1 0.0 1.8 2.0 4.3 0.3 1.9 38.4 4.8 13.5 0.0 0.2 6.2 0.8 2.2 8.9 2.7 0.0 18.2 1.1 4.0 0.0 0.3 0.2 0.4 20.6 7.2 0.0 7.3 12.9 3.9 10.6 12.6 2.1 0.1 0.0 0.0 1.1 0.0 0.2 10.1 0.0 0.0 0.1 6.0 0.1 4.9 0.1 3.0 0.1 0.1 5.7 0.4 8.4 0.0 0.4 16.7 2.4 4.4 0.2 0.4 0.5 0.0 1.7 0.0 2.8 45.4 0.9 12.3 42.8 23.2 25.4 64.2 34.3 7.3 18.1 22.0 39.6 6.0 9.9 16.4 40.5 11.1 64.0 1.4 22.2 31.2 6.6 17.0 3.5 7.0 9.3 3.0 16.7 2.6 13.3 11.0 17.9 35.4 32.0 33.0 23.1 0.0 2.6 12.7 12.0 11.4 10.4 0.0 1.3 1.7 15.7 0.0 24.1 33.9 0.0 11.7 1.0 13.1 5.7 15.1 1.7 83.5 0.0 5.8 17.8 119.3 0.2 3.1 125.6 5.0 34.3 32.1 0.0 4.7 49.2 3.2 1.0 0.1 0.0 5.4 0.0 0.0 19.4 0.9 48.4 29.9 41.4 CASP14 "MGC119078, MGC119079, MICE" ENSG00000105141 "Caspase 14" P31944 19 15049384-15058293 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Differentiation "Hydrolase, Protease, Thiol protease" Ichthyosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 109.4" "Cell type enriched" "Detected in some" 5 "Suprabasal keratinocytes: 83.9" "Cancer enhanced" "Detected in many" "cervical cancer: 62.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 7 "hTCEpi: 33.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB010059, HPA027062" Enhanced Approved Nucleoplasm,Mitochondria,Cytosol NA NA 2200000 "Nucleoplasm, Cytosol" Mitochondria "CAB010059: AB_626800, HPA027062: AB_2672101" "unprognostic (1.17e-2)" "unprognostic (6.44e-3)" "unprognostic (6.22e-2)" "unprognostic (2.77e-1)" "prognostic unfavorable (7.59e-4)" "unprognostic (9.42e-2)" "unprognostic (2.19e-2)" "prognostic unfavorable (5.96e-4)" "unprognostic (2.68e-1)" "unprognostic (4.30e-2)" "unprognostic (1.99e-1)" "unprognostic (1.97e-1)" 0.2 0.2 0.2 0.0 0.3 0.0 1.9 0.2 0.3 17.9 0.2 0.0 0.8 0.0 1.1 0.3 1.2 0.1 0.0 0.2 0.3 0.2 0.4 0.3 0.2 0.0 0.2 0.0 0.1 0.3 0.0 0.2 0.5 0.0 7.7 0.0 0.0 0.8 2.7 0.3 109.4 0.2 0.0 0.2 0.1 0.2 1.6 0.0 2.3 0.2 0.9 0.0 0.6 4.0 0.8 0.5 2.3 0.6 0.1 0.6 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.6 0.4 0.4 0.2 0.4 0.3 0.6 0.4 0.1 0.8 0.5 0.4 2.3 0.1 0.2 0.5 0.6 0.0 0.2 0.3 0.2 0.3 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 16.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 83.9 0.6 0.0 0.0 0.1 CASP2 "ICH1, MGC2181, NEDD2, PPP1R57" ENSG00000106144 "Caspase 2" P42575 7 143288215-143307696 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 45.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012175, HPA050678" Approved Approved Nucleoplasm NA NA Nucleoplasm "CAB012175: , HPA050678: AB_2681214" "unprognostic (6.96e-2)" "prognostic favorable (7.38e-4)" "unprognostic (2.74e-2)" "unprognostic (7.51e-2)" "unprognostic (4.24e-2)" "unprognostic (2.39e-2)" "prognostic unfavorable (2.34e-4)" "unprognostic (1.74e-2)" "unprognostic (1.34e-2)" "prognostic favorable (2.89e-4)" "unprognostic (1.91e-2)" "unprognostic (1.64e-1)" "prognostic unfavorable (5.01e-6)" "unprognostic (2.66e-3)" "unprognostic (9.48e-2)" "unprognostic (1.19e-1)" "unprognostic (1.64e-1)" 10.5 6.5 6.6 10.7 6.7 26.8 10.2 9.6 10.9 9.6 8.5 9.0 8.2 8.2 10.8 7.8 14.1 8.4 5.7 6.1 5.7 4.1 7.3 5.8 9.8 15.8 6.9 6.1 8.7 8.1 12.1 6.6 11.3 7.3 7.6 10.2 10.1 11.6 5.8 4.3 14.2 14.0 7.4 6.3 18.6 7.5 8.6 6.9 45.7 8.9 8.0 23.0 7.4 10.2 18.5 11.8 33.2 17.7 13.4 21.4 7.6 10.9 10.3 11.6 20.5 6.5 7.7 6.2 11.2 5.1 10.3 11.3 10.2 12.4 20.8 10.7 7.1 7.9 10.8 11.6 8.9 13.8 18.2 8.9 12.3 16.2 7.0 3.5 23.9 15.4 5.3 7.3 12.5 4.4 4.7 8.8 16.4 10.2 13.3 10.9 10.8 41.6 25.2 14.6 10.7 10.5 30.6 6.0 12.7 6.1 9.3 12.7 14.3 22.3 9.7 7.1 8.3 10.6 9.2 9.8 9.2 6.4 16.5 11.2 11.1 10.9 24.2 10.3 28.5 16.7 33.2 10.8 9.3 14.9 11.9 14.6 15.8 20.6 15.4 9.8 18.5 15.4 17.8 12.3 13.4 17.7 11.8 21.4 7.6 6.6 6.7 9.6 10.9 5.7 4.1 6.9 6.1 7.3 6.9 8.9 8.8 17.9 5.4 13.5 4.7 5.3 25.5 2.7 3.4 7.0 7.9 16.2 3.3 7.7 35.5 13.9 6.5 0.0 6.6 12.8 8.7 5.5 9.3 4.4 8.8 6.4 10.3 14.7 15.4 38.5 10.9 12.1 20.3 11.8 10.3 4.0 7.6 3.5 7.8 3.3 14.0 0.0 8.4 10.1 29.4 12.0 4.8 20.8 13.3 6.0 CASP3 "apopain, CPP32, CPP32B, Yama" ENSG00000164305 "Caspase 3" P42574 4 184627696-184649509 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 76.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 7 "basophil: 76.7;eosinophil: 62.8" "Lineage enriched" "Detected in all" 7 "granulocytes: 76.7" "Cell line enhanced" "Detected in all" "Karpas-707: 74.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000091, HPA002643, CAB008381" Enhanced Approved Nucleoplasm,Mitochondria NA NA 310000 Mitochondria Nucleoplasm "CAB000091: , CAB008381: AB_590737, HPA002643: AB_1846048" "unprognostic (1.38e-1)" "unprognostic (1.06e-1)" "unprognostic (2.21e-2)" "prognostic favorable (2.24e-4)" "unprognostic (2.29e-3)" "unprognostic (3.58e-2)" "unprognostic (9.57e-3)" "unprognostic (5.86e-2)" "unprognostic (3.56e-2)" "unprognostic (1.12e-2)" "unprognostic (1.70e-2)" "unprognostic (2.41e-1)" "prognostic unfavorable (2.30e-5)" "unprognostic (1.41e-2)" "unprognostic (5.74e-3)" "unprognostic (1.30e-1)" "unprognostic (4.05e-3)" 20.7 11.6 10.8 16.9 10.5 16.7 10.0 22.3 9.2 10.4 25.4 12.8 12.5 32.3 13.9 11.5 22.8 8.9 12.0 8.8 10.0 8.8 10.6 18.7 12.4 23.6 10.2 8.5 8.3 10.0 4.6 13.6 29.4 9.7 8.8 20.9 8.2 13.0 10.0 12.6 9.5 49.7 9.3 12.6 26.5 18.7 6.4 10.9 44.7 7.8 13.5 24.3 16.2 11.0 4.2 5.2 76.7 10.6 9.2 9.9 7.0 8.3 4.7 18.7 8.9 11.6 15.5 10.8 25.3 19.2 17.8 10.3 8.5 7.1 11.7 4.0 12.3 8.4 7.2 14.8 9.0 20.3 30.0 8.1 18.7 3.7 19.7 13.9 15.2 17.8 21.1 11.0 11.3 9.1 12.8 22.0 12.1 15.4 74.2 18.3 3.6 24.0 14.2 18.5 9.3 5.9 17.4 8.8 11.3 15.3 13.8 10.7 11.7 10.9 10.0 14.2 19.4 5.4 9.9 14.9 8.1 7.5 6.0 11.7 34.5 32.3 8.0 9.9 10.6 11.5 76.7 4.2 62.8 5.5 6.8 5.7 4.2 5.1 7.8 5.2 3.1 3.9 5.8 5.8 9.2 10.6 4.1 9.9 7.0 10.8 10.5 22.3 9.2 10.0 8.8 10.2 8.5 9.7 10.9 17.9 12.0 18.6 18.8 43.3 17.6 14.1 5.1 25.4 20.5 12.2 0.0 41.4 11.6 16.0 7.6 23.3 28.6 0.0 20.9 27.1 16.9 14.4 17.3 12.9 20.5 12.7 17.3 20.9 25.1 3.2 6.9 17.5 28.7 55.9 34.1 13.8 20.4 19.9 7.1 6.5 10.2 12.9 14.4 7.5 14.2 25.0 43.0 36.2 21.5 31.5 CASP6 MCH2 ENSG00000138794 "Caspase 6" P55212 4 109688622-109703583 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 42.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 39.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003775, HPA011337, HPA024303" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB003775: AB_562064, HPA011337: AB_1846053, HPA024303: AB_1846052" "unprognostic (1.07e-1)" "unprognostic (1.91e-1)" "prognostic favorable (2.64e-5)" "unprognostic (1.45e-2)" "unprognostic (1.90e-1)" "unprognostic (1.46e-1)" "unprognostic (3.03e-3)" "unprognostic (9.87e-2)" "unprognostic (2.73e-2)" "unprognostic (2.59e-3)" "unprognostic (1.15e-2)" "unprognostic (6.78e-2)" "unprognostic (2.44e-1)" "unprognostic (8.74e-3)" "unprognostic (2.18e-1)" "unprognostic (2.41e-1)" "prognostic favorable (9.93e-4)" 8.1 6.1 3.6 6.7 4.3 5.3 14.3 2.8 3.8 6.9 25.5 2.8 4.5 23.4 5.9 4.3 8.7 5.3 11.7 4.9 4.0 2.0 11.0 14.3 5.6 8.5 5.0 1.6 7.0 13.0 2.3 6.4 4.3 4.5 8.1 19.5 3.4 8.0 10.3 3.4 6.5 42.8 14.0 6.6 9.1 9.2 2.7 4.3 14.5 11.2 3.3 8.4 8.2 12.7 4.4 8.0 8.5 7.0 5.6 21.3 8.0 12.6 4.1 8.5 7.7 6.2 6.1 12.6 7.1 4.9 6.4 6.9 6.8 26.1 1.3 8.3 7.3 8.9 5.9 10.1 11.2 5.1 20.1 6.6 11.1 3.7 6.0 5.0 11.1 7.9 6.7 8.4 6.1 1.5 8.6 12.1 15.1 14.4 39.6 10.3 7.1 28.7 7.0 6.5 8.7 7.5 10.0 5.4 6.9 21.0 12.0 9.0 6.7 7.5 13.6 4.2 10.7 5.8 4.1 10.2 7.1 7.5 3.4 8.0 5.8 10.5 1.4 9.2 13.4 3.6 8.5 5.3 6.3 4.9 4.8 5.3 4.1 17.8 9.3 6.0 4.4 21.3 11.8 1.1 5.6 7.0 8.0 16.4 8.0 3.6 4.3 2.8 3.8 4.0 2.0 5.0 1.6 4.5 4.3 14.9 13.4 8.5 9.5 9.6 5.2 3.3 30.6 25.4 20.5 19.2 5.9 16.7 8.3 35.9 2.0 9.2 52.0 0.0 40.5 34.0 12.1 6.6 9.3 17.8 17.1 0.0 56.7 6.2 8.6 1.6 11.8 8.5 1.7 25.2 48.2 12.8 42.5 56.1 9.2 26.3 1.3 6.5 6.9 1.7 8.3 10.2 4.8 12.8 64.3 7.8 CASP8 "Casp-8, FLICE, MACH, MCH5" ENSG00000064012 "Caspase 8" Q14790 2 201233443-201287711 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Host-virus interaction" "Hydrolase, Protease, Thiol protease" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 52.5" "Cell type enhanced" "Detected in many" 5 "T-cells: 55.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001302, CAB002047, HPA005688, HPA006191" Approved Supported Nucleoplasm,Cytosol No No Cytosol Nucleoplasm "CAB002047: AB_563465, HPA001302: AB_1846057, HPA005688: AB_1846056, HPA006191: AB_2667535" "unprognostic (5.21e-3)" "unprognostic (2.10e-1)" "unprognostic (1.83e-2)" "unprognostic (9.69e-3)" "unprognostic (2.09e-1)" "unprognostic (5.60e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (2.10e-1)" "unprognostic (4.79e-2)" "prognostic favorable (1.25e-4)" "unprognostic (7.75e-2)" "unprognostic (5.11e-2)" "prognostic unfavorable (1.27e-6)" "unprognostic (7.67e-3)" "unprognostic (2.43e-1)" "unprognostic (2.53e-1)" "unprognostic (4.53e-3)" 14.1 10.6 2.0 31.6 2.6 27.1 10.2 1.4 1.8 7.9 18.5 3.9 7.0 9.6 9.6 12.0 11.7 9.1 12.1 4.4 2.1 2.3 16.4 14.8 17.1 28.3 3.9 1.1 8.2 7.6 1.8 5.9 12.3 3.2 9.8 8.7 4.4 9.6 8.4 2.7 7.4 34.7 5.1 5.0 37.7 7.4 3.8 2.7 43.7 6.7 10.7 43.4 9.6 7.3 13.8 13.7 52.5 17.0 22.2 26.4 12.0 14.5 12.4 3.6 10.1 10.1 14.8 5.6 6.4 6.3 7.6 12.6 16.6 25.4 1.6 14.1 4.9 13.7 7.4 7.9 7.6 15.1 9.4 7.2 14.2 10.1 15.8 8.2 11.0 15.4 12.8 18.8 14.4 11.3 6.4 7.2 12.3 12.7 31.6 6.9 6.0 14.3 11.6 5.9 8.0 11.1 10.8 7.5 25.9 14.3 16.2 1.1 0.5 8.3 13.8 8.2 3.5 3.6 8.6 9.0 8.2 8.6 4.3 5.0 28.7 12.8 9.9 12.3 14.8 7.7 20.7 13.0 24.9 25.0 17.0 23.1 13.8 20.5 26.4 13.7 7.8 13.3 16.9 52.5 22.2 15.6 6.1 24.0 12.0 2.0 2.6 1.4 1.8 2.1 2.3 3.9 1.1 3.2 2.7 23.8 26.1 34.1 10.1 6.6 1.5 1.6 7.6 16.0 18.2 5.2 9.8 7.5 13.3 9.0 5.6 7.1 19.8 0.0 7.3 10.3 3.8 8.1 23.2 10.4 11.2 0.0 4.1 5.5 25.6 0.7 2.3 21.7 6.8 19.8 13.0 0.1 9.6 12.7 0.7 20.0 0.4 0.0 1.4 0.7 0.4 6.8 2.9 55.4 12.1 12.7 CASQ1 "CASQ, PDIB1" ENSG00000143318 "Calsequestrin 1" P31415 1 160190556-160201886 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Muscle protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "skeletal muscle: 320.9;tongue: 83.5" "Cell type enhanced" "Detected in some" 15 "Cardiomyocytes: 16.7;Rod photoreceptor cells: 13.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "BEWO: 10.6;HDLM-2: 20.2;RT4: 36.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA007845, CAB015170, HPA026823" Enhanced Approved Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA "Nucleoplasm, Mitochondria" "CAB015170: AB_2071451, HPA007845: AB_1078388, HPA026823: AB_10603557" "unprognostic (1.87e-2)" "unprognostic (3.97e-3)" "unprognostic (1.01e-1)" "unprognostic (1.13e-2)" "unprognostic (2.03e-2)" "unprognostic (6.85e-2)" "unprognostic (1.96e-2)" "unprognostic (4.65e-3)" "unprognostic (3.85e-2)" "unprognostic (1.01e-2)" "unprognostic (2.87e-2)" "unprognostic (3.01e-2)" "unprognostic (3.21e-3)" "unprognostic (9.04e-4)" "unprognostic (1.80e-1)" "unprognostic (1.58e-1)" "prognostic favorable (8.93e-5)" 6.1 0.1 0.5 0.0 0.3 0.1 0.2 0.3 2.0 0.1 0.1 0.0 0.1 0.0 0.1 11.9 3.9 0.2 0.1 4.0 0.4 0.3 0.1 0.1 0.1 0.2 0.2 0.0 0.1 0.1 0.0 0.1 0.5 0.0 1.3 0.0 0.2 4.5 0.4 320.9 0.1 0.1 0.6 0.2 0.1 0.1 0.3 0.0 0.0 0.9 83.5 4.7 0.4 0.1 0.9 0.0 0.9 0.7 0.2 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.0 10.6 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 20.2 0.2 0.0 0.0 0.0 0.1 0.3 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.1 0.1 0.0 36.1 0.0 0.0 0.1 0.1 0.0 2.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.4 0.1 0.2 0.0 0.0 0.9 0.7 0.2 0.0 0.1 0.0 0.5 0.1 0.1 0.0 0.9 0.1 0.1 0.9 0.2 0.1 0.0 0.3 0.0 0.5 0.3 0.3 2.0 0.4 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.6 16.7 0.0 1.4 0.0 0.0 2.0 1.6 0.0 0.0 1.5 0.0 0.0 0.0 0.0 3.6 0.0 0.1 3.5 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.4 0.0 13.0 0.0 0.8 1.4 1.0 0.0 3.8 0.0 0.0 0.3 CASZ1 "castor, cst, FLJ20321, SRG, ZNF693" ENSG00000130940 "Castor zinc finger 1" Q86V15 1 10636604-10796650 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 573.3;Rod photoreceptor cells: 490.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 9.7;HDLM-2: 10.5;SCLC-21H: 16.3;SK-BR-3: 15.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028222, HPA029927" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA028222: AB_10600106, HPA029927: AB_10601564" "unprognostic (1.20e-1)" "unprognostic (5.06e-2)" "unprognostic (4.67e-2)" "unprognostic (7.49e-3)" "unprognostic (4.75e-2)" "unprognostic (1.90e-2)" "unprognostic (3.55e-4)" "unprognostic (1.13e-2)" "unprognostic (1.13e-1)" "unprognostic (4.46e-2)" "unprognostic (1.26e-1)" "unprognostic (3.73e-2)" "unprognostic (1.03e-5)" "unprognostic (3.75e-2)" "unprognostic (1.27e-1)" "unprognostic (1.51e-2)" "unprognostic (1.56e-1)" 3.4 0.9 0.3 2.5 1.5 2.8 6.0 0.3 0.7 6.1 20.7 0.5 14.7 8.8 11.0 2.4 9.9 3.4 13.8 9.9 0.2 0.2 4.5 1.4 7.4 0.8 0.8 0.3 1.7 4.4 0.0 4.0 1.2 0.9 12.1 2.4 19.8 17.0 17.4 29.9 25.3 27.1 8.0 0.2 1.2 9.2 1.0 0.8 0.2 1.9 14.4 6.2 7.2 7.2 0.5 3.5 1.9 2.2 1.6 1.6 0.4 9.7 0.8 1.8 1.7 0.0 0.0 0.4 0.3 0.1 0.3 0.4 2.1 2.2 0.4 2.0 0.4 0.8 8.4 1.9 1.9 0.1 10.5 3.3 0.7 1.6 2.2 0.3 1.1 3.1 0.1 7.2 0.1 0.6 0.0 0.3 1.5 0.0 0.0 0.0 5.2 0.6 7.0 0.2 5.1 0.5 0.8 1.2 0.1 1.6 4.0 16.3 1.5 2.5 15.4 0.2 0.7 8.2 1.0 0.1 0.0 1.4 0.8 0.2 0.0 0.0 1.0 0.0 3.0 0.1 1.9 0.2 1.2 1.6 0.4 0.7 0.4 0.6 1.1 0.6 0.5 0.0 0.5 0.4 1.6 2.2 3.5 0.3 0.4 0.3 1.5 0.3 0.7 0.2 0.2 0.8 0.3 0.9 0.8 26.8 20.0 0.0 17.1 29.3 11.2 21.0 10.2 14.7 7.9 14.0 573.3 0.5 3.3 12.2 0.4 11.7 41.1 0.0 7.7 0.8 2.6 37.9 4.6 4.0 1.0 130.3 39.6 6.7 0.3 0.9 0.0 1.8 1.7 10.8 33.5 24.9 13.7 29.1 6.3 1.0 490.7 0.0 7.1 1.7 2.3 53.4 0.6 3.2 22.9 24.5 CATSPERG "C19orf15, DKFZp434A1022, FLJ46353" ENSG00000099338 "Cation channel sperm associated auxiliary subunit gamma" Q6ZRH7 19 38335775-38370943 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 35.7" "Group enriched" "Detected in many" 7 "Early spermatids: 23.9;Enterocytes: 14.0;Late spermatids: 27.8;Spermatocytes: 31.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Group enriched" "Detected in many" 5 "granulocytes: 4.8;monocytes: 1.8" "Cell line enhanced" "Detected in some" "BEWO: 4.2;HMC-1: 5.3;MCF7: 4.3" "Low region specificity" "Detected in all" HPA052777 Approved Nucleoplasm,Nucleoli,Cytosol "Secreted in male reproductive system" NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA052777: " "unprognostic (8.50e-5)" "unprognostic (5.12e-2)" "unprognostic (3.57e-3)" "unprognostic (1.51e-1)" "unprognostic (2.63e-1)" "unprognostic (3.18e-1)" "unprognostic (2.60e-1)" "unprognostic (2.87e-3)" "unprognostic (1.00e-1)" "unprognostic (2.92e-2)" "unprognostic (1.06e-1)" "unprognostic (2.50e-1)" "unprognostic (4.37e-4)" "unprognostic (9.99e-2)" "unprognostic (2.01e-1)" "unprognostic (4.61e-2)" "unprognostic (1.07e-3)" 0.9 0.8 2.9 0.8 7.7 1.1 1.3 4.3 5.8 1.2 1.1 6.5 1.9 1.2 1.2 1.8 0.9 1.4 0.9 0.8 3.9 1.0 1.0 1.0 1.1 1.0 7.4 2.2 1.3 1.0 1.0 1.2 0.8 5.2 1.3 1.0 0.4 2.0 1.1 1.0 2.0 1.1 0.9 3.2 0.9 1.0 35.7 6.5 2.2 1.3 0.0 1.0 0.9 3.3 0.1 0.6 4.8 1.8 0.2 0.5 0.2 0.2 0.5 0.2 1.8 0.8 0.0 4.2 0.2 0.0 0.0 0.0 1.3 0.8 0.3 0.0 0.0 0.7 0.6 0.5 0.1 0.0 0.9 0.2 0.1 0.2 0.0 0.1 0.3 5.3 0.0 0.8 0.0 0.5 0.5 0.1 0.8 0.0 1.4 0.0 4.3 0.0 0.0 0.0 1.1 0.8 0.1 0.0 0.8 2.0 0.1 0.4 0.6 0.4 0.9 0.2 0.7 0.4 0.0 0.3 0.0 1.0 0.7 0.0 0.8 0.9 0.0 0.2 0.2 0.0 0.3 0.8 1.8 0.4 0.9 0.2 0.0 0.1 0.2 0.6 0.1 0.5 0.2 4.8 0.2 1.8 0.4 0.3 0.2 2.9 7.7 4.3 5.8 3.9 1.0 7.4 2.2 5.2 6.5 0.0 2.4 1.7 1.9 2.3 1.1 2.4 2.5 0.0 0.0 1.8 0.0 1.0 0.0 0.8 23.9 1.5 14.0 0.0 0.6 0.2 1.5 1.8 1.1 0.5 2.8 1.6 1.7 1.8 0.8 27.8 1.7 2.6 0.0 1.8 1.5 1.9 0.5 3.5 2.1 1.1 1.1 0.0 1.0 31.9 2.7 1.6 1.1 2.5 2.0 1.4 CATSPERZ "C11orf20, DKFZP566E164, TEX40" ENSG00000219435 "Catsper channel auxiliary subunit zeta" Q9NTU4 11 64300391-64304770 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 105 "testis: 139.5" "Cell type enriched" "Detected in some" 4 "Extravillous trophoblasts: 29.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 5.7;CACO-2: 15.6;PC-3: 9.3;T-47d: 7.6" HPA052822 Approved Nucleoplasm NA NA Nucleoplasm "HPA052822: AB_2797245" "unprognostic (1.89e-1)" "unprognostic (7.81e-2)" "unprognostic (1.88e-1)" "unprognostic (8.23e-2)" "unprognostic (2.18e-1)" "unprognostic (1.11e-1)" "unprognostic (5.66e-4)" "unprognostic (5.96e-2)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" 0.1 0.0 0.5 0.0 0.4 0.0 0.8 0.1 0.9 0.2 0.1 0.1 0.2 0.0 0.1 0.7 0.1 0.0 0.2 0.0 0.5 0.2 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 1.3 0.1 0.3 0.1 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 139.5 0.1 0.0 0.4 0.0 0.1 0.1 0.2 0.5 0.4 0.6 0.6 0.0 0.3 0.0 0.0 4.1 0.3 0.0 0.5 1.0 5.7 0.0 0.3 0.0 0.0 15.6 3.2 0.1 0.2 0.2 0.2 3.4 3.2 0.5 0.1 0.0 0.0 1.5 0.1 1.0 0.1 0.0 0.0 0.1 0.3 1.0 0.0 0.0 0.2 0.0 1.6 0.7 0.2 0.7 0.0 0.7 1.1 4.5 9.3 1.7 0.0 2.0 4.5 1.5 0.1 0.9 1.7 0.5 0.2 0.3 7.6 0.4 0.3 0.2 0.1 2.1 0.0 0.4 0.1 0.5 0.3 0.0 0.1 0.0 0.3 0.0 0.3 0.2 0.1 0.5 0.0 0.2 0.0 0.1 0.1 0.0 0.6 0.0 0.6 0.4 0.0 0.0 0.5 0.4 0.1 0.3 0.5 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 29.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 CAVIN4 "cavin-4, MURC" ENSG00000170681 "Caveolae associated protein 4" Q5BKX8 9 100578079-100587906 "Predicted intracellular proteins" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "skeletal muscle: 83.8;tongue: 52.4" "Cell type enhanced" "Detected in some" 13 "Cytotrophoblasts: 1.2;Pancreatic endocrine cells: 1.0" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "NTERA-2: 10.3;SCLC-21H: 15.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA020973, HPA020987, HPA021021" Enhanced Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA020973: AB_1853079, HPA020987: AB_1853080, HPA021021: AB_1853082" "unprognostic (9.54e-5)" "unprognostic (1.68e-2)" "unprognostic (2.50e-2)" "unprognostic (3.76e-2)" "unprognostic (4.92e-2)" "unprognostic (4.56e-3)" "unprognostic (1.14e-4)" "unprognostic (3.36e-2)" "unprognostic (2.23e-1)" "unprognostic (1.60e-1)" "unprognostic (1.31e-1)" "unprognostic (4.02e-1)" "unprognostic (1.74e-8)" "unprognostic (1.14e-1)" "unprognostic (3.39e-1)" "unprognostic (3.68e-3)" "unprognostic (1.55e-3)" 3.5 0.0 0.3 0.1 0.6 0.0 0.0 0.5 0.3 0.1 0.1 0.0 0.0 0.0 0.2 2.7 1.9 0.0 0.1 16.4 0.5 0.3 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 2.8 0.0 83.8 0.1 0.0 0.1 0.7 0.0 0.1 1.4 0.0 0.1 0.2 52.4 1.6 0.0 0.0 0.4 0.3 1.4 0.4 0.7 0.7 0.0 0.5 0.4 7.4 2.7 1.6 2.4 5.3 1.3 1.0 1.0 1.2 0.0 0.5 0.3 0.3 0.6 2.6 0.3 3.5 0.1 2.1 1.7 2.5 0.0 1.2 0.0 0.5 0.3 0.4 5.9 0.3 1.0 0.6 1.8 1.3 1.8 0.2 0.3 4.6 0.1 2.0 0.3 10.3 1.1 0.8 3.0 6.9 0.0 0.8 0.4 15.8 4.2 0.2 0.3 1.4 5.0 0.2 0.2 1.3 1.8 1.5 1.3 1.1 0.4 1.3 0.7 2.0 0.1 1.3 0.6 0.3 0.2 0.5 0.4 0.2 0.2 0.7 0.5 0.1 0.4 0.5 0.5 1.4 0.7 0.3 0.3 0.2 0.0 0.3 0.6 0.5 0.3 0.5 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 CBARP "BARP, C19orf26, DOS, MGC40084" ENSG00000099625 "CACN beta subunit associated regulatory protein" Q8N350 19 1228287-1238027 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.9;pituitary gland: 13.1" "Cell type enhanced" "Detected in some" 21 "Bipolar cells: 18.9;Early spermatids: 35.1;Late spermatids: 59.2" "Cancer enhanced" "Detected in many" "glioma: 4.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 8.7" HPA012777 Approved Nucleoplasm NA NA Nucleoplasm "HPA012777: AB_2067005" "unprognostic (1.31e-1)" "unprognostic (4.57e-3)" "unprognostic (1.34e-1)" "unprognostic (1.10e-2)" "unprognostic (3.14e-1)" "unprognostic (1.06e-1)" "unprognostic (1.54e-5)" "unprognostic (3.48e-1)" "unprognostic (2.17e-1)" "unprognostic (4.58e-2)" "unprognostic (2.86e-3)" "unprognostic (3.03e-1)" "unprognostic (5.99e-2)" "unprognostic (1.07e-2)" "unprognostic (2.12e-1)" "unprognostic (2.40e-1)" "unprognostic (7.42e-5)" 2.3 8.1 7.2 1.5 12.1 1.0 1.2 3.6 17.9 1.2 1.3 5.2 0.0 1.3 1.8 1.1 1.5 1.1 1.8 1.5 8.5 5.6 1.8 1.5 1.4 1.1 3.3 4.7 2.9 2.1 1.6 13.1 1.4 10.6 1.4 1.0 1.2 1.2 1.5 1.3 4.5 1.1 1.2 6.5 1.2 1.9 3.0 2.2 0.0 1.3 0.0 1.2 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 2.0 5.3 0.2 0.6 1.5 4.4 1.3 0.9 1.0 2.4 0.2 0.0 5.0 1.0 0.5 2.4 0.8 0.9 0.2 0.9 1.1 0.1 1.7 1.4 2.3 0.1 1.8 1.2 0.5 1.1 0.3 0.9 0.7 1.2 2.8 0.1 0.6 4.0 0.0 1.3 3.7 0.3 2.2 4.4 0.8 0.3 0.2 0.6 3.2 8.7 0.0 0.1 4.5 0.2 0.6 0.9 1.7 1.9 5.6 5.2 1.6 0.5 0.5 0.0 1.5 0.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 12.1 3.6 17.9 8.5 5.6 3.3 4.7 10.6 2.2 0.0 0.0 0.0 0.2 0.0 18.9 0.0 0.0 0.0 0.0 0.0 2.0 0.0 1.7 0.2 35.1 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.2 3.2 0.0 1.3 1.0 59.2 1.7 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.4 0.1 1.1 0.0 0.0 9.8 4.1 0.0 0.0 0.0 0.0 0.1 CBFA2T3 "ETO2, MTG16, MTGR2, RUNX1T3, ZMYND4" ENSG00000129993 "CBFA2/RUNX1 translocation partner 3" O75081 16 88874858-88977204 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" Repressor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 75.9" "Cell type enhanced" "Detected in many" 7 "B-cells: 11.5;Mucus-secreting cells: 13.5;Sertoli cells: 19.4;Smooth muscle cells: 11.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 26.0" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 21.4;K-562: 37.4;MCF7: 17.3;MOLT-4: 19.0;NB-4: 23.1;REH: 37.6;T-47d: 17.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA059931, HPA062423, HPA065890" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059931: AB_2684168, HPA062423: AB_2684758, HPA065890: AB_2685575" "unprognostic (2.47e-1)" "unprognostic (2.03e-2)" "unprognostic (9.24e-3)" "unprognostic (2.62e-1)" "unprognostic (1.98e-1)" "prognostic favorable (3.95e-4)" "unprognostic (1.13e-3)" "unprognostic (1.69e-2)" "unprognostic (1.25e-1)" "unprognostic (2.10e-1)" "unprognostic (7.30e-3)" "unprognostic (2.38e-1)" "unprognostic (7.04e-5)" "unprognostic (2.18e-1)" "unprognostic (4.08e-2)" "unprognostic (4.62e-2)" "unprognostic (9.35e-3)" 10.0 1.7 3.6 11.3 7.4 8.2 6.1 26.0 5.4 2.3 3.9 1.3 1.4 3.9 3.2 2.1 2.1 1.9 2.5 6.2 3.0 3.0 0.7 2.0 6.4 9.5 2.0 3.8 0.9 24.9 0.7 2.7 3.8 2.3 3.7 1.5 3.1 4.5 2.9 14.2 2.6 5.5 1.5 1.2 14.7 3.5 3.2 2.2 75.9 2.4 2.0 10.3 3.6 4.8 3.7 11.6 3.6 4.9 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 21.4 0.0 0.0 0.0 5.6 10.6 0.0 0.0 0.0 0.0 0.0 0.0 10.3 37.4 0.2 0.0 17.3 19.0 23.1 0.4 0.0 0.0 37.6 0.3 3.7 0.0 0.0 7.4 1.6 0.8 0.1 0.1 0.1 17.1 6.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 12.4 0.0 6.5 0.0 1.1 2.7 2.7 0.0 3.2 0.0 3.7 0.0 0.0 7.1 2.1 0.0 0.0 3.6 0.1 4.9 11.6 0.0 1.7 3.6 7.4 26.0 5.4 3.0 3.0 2.0 3.8 2.3 2.2 0.0 1.4 11.5 5.1 2.3 7.7 1.6 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.2 0.0 3.6 0.9 0.0 2.4 0.1 1.6 2.5 5.8 5.7 2.4 0.0 3.5 2.5 2.8 0.0 2.0 6.4 0.0 1.0 13.5 0.1 1.4 0.0 0.7 0.5 1.2 19.4 11.2 0.2 4.5 1.9 0.2 1.0 0.8 3.8 CBFB PEBP2B ENSG00000067955 "Core-binding factor beta subunit" Q13951 16 67029116-67101058 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 101.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038852 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA038852: AB_10795358" "unprognostic (1.05e-1)" "unprognostic (1.18e-2)" "unprognostic (1.30e-1)" "unprognostic (3.22e-2)" "unprognostic (4.66e-2)" "unprognostic (3.80e-3)" "prognostic unfavorable (2.83e-4)" "unprognostic (1.63e-2)" "unprognostic (1.47e-1)" "unprognostic (1.11e-1)" "unprognostic (4.46e-3)" "unprognostic (1.88e-2)" "prognostic unfavorable (2.89e-8)" "unprognostic (1.03e-1)" "unprognostic (4.31e-2)" "unprognostic (1.37e-1)" "unprognostic (1.20e-1)" 15.9 10.9 15.9 26.4 25.1 20.5 15.0 9.5 14.3 15.4 10.6 23.3 11.8 8.8 15.3 10.2 20.5 14.3 16.3 21.5 16.2 13.2 12.1 14.4 16.1 32.6 23.6 12.4 17.3 13.6 40.4 18.8 13.2 17.5 14.6 11.1 13.7 19.6 10.3 33.3 14.8 12.2 11.7 22.4 18.2 17.1 7.3 24.2 42.2 17.0 14.8 31.0 15.9 18.8 6.5 9.1 20.5 9.2 14.8 7.0 5.1 15.6 10.5 9.2 14.9 6.7 8.6 14.7 18.2 10.9 17.2 15.2 21.0 18.0 34.7 17.4 15.5 7.2 15.6 16.4 10.2 23.2 11.9 9.4 24.1 9.0 16.7 9.6 31.4 51.9 8.7 7.0 19.2 14.8 9.1 13.9 17.2 25.6 12.4 17.8 11.9 32.3 16.8 9.0 8.3 14.8 65.6 39.7 29.5 12.1 14.0 13.5 12.1 46.7 7.1 18.6 11.3 6.4 22.6 19.3 26.7 18.3 15.1 24.4 17.0 30.2 101.5 20.3 21.6 24.0 20.5 7.4 7.4 6.7 9.2 7.0 6.5 6.6 7.0 9.1 6.4 6.3 5.3 4.6 14.8 6.1 3.3 7.0 5.1 15.9 25.1 9.5 14.3 16.2 13.2 23.6 12.4 17.5 24.2 8.9 19.8 29.2 37.0 49.9 4.5 15.4 15.3 13.4 17.0 38.4 11.8 12.1 23.2 14.4 4.4 17.4 7.3 0.0 24.0 26.0 32.1 38.3 26.6 14.0 33.8 9.5 18.2 27.0 43.0 5.7 22.2 46.5 49.0 10.8 12.4 12.3 47.8 5.8 19.8 9.8 14.2 12.9 24.7 13.4 16.3 55.2 14.2 54.9 11.5 52.5 CBLB "Cbl-b, RNF56" ENSG00000114423 "Cbl proto-oncogene B" Q13191 3 105655461-105869552 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-138 MG: 23.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018327, HPA019880" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA018327: AB_1846097, HPA019880: AB_1846099" "unprognostic (2.65e-1)" "unprognostic (9.42e-2)" "unprognostic (1.72e-2)" "unprognostic (2.38e-1)" "unprognostic (5.89e-3)" "unprognostic (2.80e-2)" "unprognostic (8.18e-2)" "unprognostic (1.10e-1)" "unprognostic (7.05e-2)" "unprognostic (1.66e-1)" "unprognostic (9.29e-2)" "unprognostic (1.50e-2)" "unprognostic (1.43e-2)" "unprognostic (8.21e-2)" "unprognostic (2.83e-1)" "unprognostic (1.20e-2)" "unprognostic (3.09e-2)" 38.4 9.0 3.7 19.5 4.9 15.5 16.3 24.4 3.8 13.7 18.7 5.9 7.7 9.3 13.8 12.2 8.3 12.5 13.4 27.5 3.8 4.8 7.4 6.7 16.3 19.1 4.4 1.9 17.7 6.8 3.4 13.5 25.4 7.9 12.9 8.0 11.6 9.1 6.3 10.3 8.5 13.8 25.6 5.7 16.4 12.4 9.2 5.2 11.6 13.5 7.0 18.0 24.9 24.1 5.1 3.1 2.8 2.1 10.3 9.9 1.6 1.6 2.3 7.7 3.8 8.9 9.0 5.0 5.8 2.9 1.7 2.7 2.9 2.0 3.6 4.0 3.0 2.7 2.9 1.0 1.0 2.1 2.8 2.9 2.0 12.0 1.9 13.1 1.4 1.5 8.6 3.1 4.5 12.3 6.4 5.6 3.7 2.1 11.7 3.6 2.1 2.0 0.9 2.7 2.0 3.3 4.2 2.3 0.6 4.1 7.4 6.0 6.5 6.8 0.8 8.9 5.6 1.7 2.9 3.1 23.9 2.0 3.2 1.4 6.6 0.6 5.7 6.4 1.2 1.5 0.7 1.5 2.8 9.9 0.9 8.8 2.2 5.1 5.6 1.3 5.1 4.4 8.0 1.0 10.3 2.1 3.1 5.6 1.6 3.7 4.9 24.4 3.8 3.8 4.8 4.4 1.9 7.9 5.2 14.9 6.7 21.6 6.8 9.6 44.8 39.9 0.0 10.7 6.8 12.2 25.5 8.9 5.0 6.0 27.4 22.6 8.7 0.0 6.9 53.5 21.6 9.6 8.1 6.7 12.2 3.2 12.1 39.3 11.3 9.0 6.9 10.4 15.1 5.4 16.2 7.4 11.7 7.0 10.3 3.1 27.4 6.5 19.9 9.8 15.8 6.0 38.0 52.3 10.7 3.0 CBLC "CBL-3, CBL-SL, RNF57" ENSG00000142273 "Cbl proto-oncogene C" Q9ULV8 19 44777869-44800634 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 66.8" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 105.9;Pancreatic endocrine cells: 67.6;Paneth cells: 84.2;Undifferentiated cells: 54.6;Urothelial cells: 56.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 19.0;BEWO: 13.1;CACO-2: 12.9;CAPAN-2: 26.3;HaCaT: 18.4;HBEC3-KT: 16.0;hTCEpi: 12.3;OE19: 16.9;RT4: 16.0;SK-BR-3: 14.6;T-47d: 10.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB008087, HPA035266" Approved Approved Nucleoplasm,Aggresome NA NA Nucleoplasm Aggresome "CAB008087: AB_2228531, HPA035266: AB_2674542" "unprognostic (1.58e-1)" "unprognostic (2.25e-1)" "unprognostic (8.21e-3)" "unprognostic (1.55e-1)" "unprognostic (3.04e-2)" "unprognostic (3.91e-2)" "unprognostic (1.67e-1)" "unprognostic (2.13e-2)" "unprognostic (3.82e-1)" "unprognostic (7.39e-2)" "unprognostic (1.06e-2)" "unprognostic (1.85e-1)" "prognostic favorable (3.11e-6)" "unprognostic (3.50e-1)" "unprognostic (8.25e-3)" "unprognostic (2.90e-2)" "unprognostic (2.21e-3)" 0.1 0.0 0.5 8.5 0.2 0.0 4.8 0.1 0.4 4.4 39.5 0.1 3.2 29.5 1.7 1.7 22.0 1.4 18.8 0.1 0.6 0.0 4.9 15.1 1.3 0.1 0.1 0.3 0.8 18.1 0.9 0.7 4.1 0.2 6.9 6.9 0.5 11.4 5.2 0.1 20.8 66.8 0.4 0.1 0.1 10.2 1.6 0.1 0.5 1.9 13.2 15.7 7.6 8.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 19.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 12.9 26.3 0.0 0.0 0.0 0.0 18.4 0.0 16.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 16.9 0.0 0.0 0.0 0.0 0.0 16.0 0.1 0.0 0.0 14.6 0.0 0.1 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.4 0.6 0.0 0.1 0.3 0.2 0.1 0.0 1.6 0.0 28.6 13.4 0.0 0.2 5.1 5.3 11.4 7.0 0.0 4.6 1.7 37.5 0.0 0.1 105.9 0.0 42.7 1.3 0.4 14.4 0.0 8.5 0.3 0.0 16.7 0.0 0.0 0.0 0.0 0.9 0.0 1.0 35.8 0.0 67.6 84.2 0.0 9.9 0.0 0.0 0.4 0.0 1.7 22.5 2.1 0.7 54.6 56.4 CBLN3 ENSG00000139899 "Cerebellin 3 precursor" Q6UW01 14 24426532-24430954 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 105.2" "Cell type enhanced" "Detected in some" 8 "Fibroblasts: 2.3;Leydig cells: 2.3;monocytes: 3.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 23 "cerebellum: 105.2" "Cell type enhanced" "Detected in some" "memory B-cell: 1.5;naive B-cell: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.9;HDLM-2: 12.7;HSkMC: 18.9;Karpas-707: 14.2;U-266/70: 9.9" "Region enriched" "Detected in some" 25 "cerebellum: 481.8" "Region enriched" "Detected in some" 47 "cerebellum: 583.0" HPA041266 Enhanced Supported Approved Nucleoplasm "Secreted in brain" NA NA Nucleoplasm "HPA041266: AB_10674430" "unprognostic (5.02e-2)" "unprognostic (3.26e-1)" "unprognostic (1.43e-3)" "prognostic unfavorable (4.22e-4)" "unprognostic (4.39e-4)" "unprognostic (5.39e-3)" "unprognostic (1.60e-2)" "unprognostic (1.92e-2)" "unprognostic (2.16e-2)" "unprognostic (9.76e-2)" "unprognostic (6.20e-2)" "unprognostic (2.71e-2)" "prognostic unfavorable (6.20e-6)" "unprognostic (2.75e-2)" "unprognostic (2.63e-1)" "unprognostic (1.72e-1)" "unprognostic (9.02e-2)" 2.1 7.7 1.2 4.5 1.3 0.0 1.2 105.2 1.7 1.8 1.1 1.9 1.0 0.6 1.3 4.8 1.0 1.2 3.1 1.6 1.0 1.1 1.2 1.4 1.3 7.9 1.3 1.4 3.3 1.0 1.0 1.3 1.7 4.6 1.2 0.7 1.7 1.6 1.6 1.4 1.6 1.3 1.3 2.0 7.4 1.4 1.6 1.1 1.1 1.2 1.5 5.3 1.9 1.3 2.3 0.3 0.1 0.8 0.0 0.3 0.0 1.1 1.0 0.5 1.9 5.0 10.9 0.3 4.2 8.6 1.7 2.2 0.5 2.0 1.8 0.9 2.6 1.9 0.3 0.6 2.3 1.1 12.7 0.4 0.0 3.5 0.8 2.8 0.3 0.7 18.9 1.0 2.1 1.7 7.0 1.5 0.8 0.5 14.2 2.1 0.6 0.0 0.5 0.1 1.1 1.1 0.0 0.0 1.3 1.0 0.4 0.7 0.4 0.3 0.1 0.6 0.3 0.6 0.4 6.6 6.1 1.2 2.5 0.2 9.9 2.3 2.0 0.3 0.8 1.0 0.0 0.0 0.1 0.0 0.8 0.3 1.5 0.1 0.1 0.0 2.3 0.2 0.0 0.1 0.0 0.1 0.3 0.0 0.0 1.2 1.3 105.2 1.7 1.0 1.1 1.3 1.4 4.6 1.1 0.0 0.0 0.0 0.5 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.5 0.0 1.0 0.5 2.3 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.8 0.0 2.3 0.0 0.0 3.6 0.2 0.8 0.8 0.0 1.4 0.5 0.3 0.0 1.2 0.0 0.1 0.5 0.7 0.0 0.4 0.5 CBR1 "CBR, SDR21C1" ENSG00000159228 "Carbonyl reductase 1" P16152 21 36069941-36073166 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 176.1" "Cell type enhanced" "Detected in all" 8 "Distal tubular cells: 641.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA018433, CAB034291" Enhanced Approved Nucleoplasm,Cytosol NA NA 12000000 Nucleoplasm Cytosol "CAB034291: AB_2070856, HPA018433: AB_1846109" "prognostic favorable (2.18e-4)" "unprognostic (9.78e-2)" "unprognostic (3.25e-2)" "unprognostic (2.14e-1)" "unprognostic (6.47e-3)" "unprognostic (1.69e-1)" "unprognostic (1.19e-1)" "unprognostic (6.37e-2)" "unprognostic (4.56e-2)" "unprognostic (1.28e-1)" "unprognostic (7.20e-2)" "unprognostic (4.00e-1)" "prognostic favorable (4.75e-4)" "unprognostic (2.37e-1)" "unprognostic (2.47e-1)" "unprognostic (6.13e-3)" "unprognostic (2.47e-2)" 9.6 22.9 31.7 8.4 41.6 3.7 8.5 12.0 35.8 14.6 63.4 75.9 6.5 176.1 9.3 17.1 40.2 9.6 15.1 7.8 37.7 24.7 35.2 77.2 11.7 8.5 57.3 25.2 10.4 8.0 8.9 7.9 11.7 51.6 16.7 16.8 10.4 23.1 15.0 8.7 34.4 118.1 11.6 48.1 10.0 41.4 5.7 41.9 3.6 11.3 29.8 14.3 12.4 17.1 17.0 29.9 17.1 51.4 19.1 29.2 37.0 25.3 39.1 4.8 12.3 25.1 25.4 0.2 28.5 20.5 15.6 18.7 14.4 14.9 6.4 18.8 26.5 30.1 18.7 9.8 27.9 12.0 31.5 23.1 19.1 22.8 9.8 14.4 10.6 17.6 12.4 35.2 15.1 6.6 17.9 16.6 0.0 0.0 4.7 14.3 25.1 5.3 11.1 0.0 0.0 28.6 0.0 0.1 17.7 41.4 12.7 14.0 12.5 27.5 40.0 32.4 3.9 18.9 14.8 16.7 17.5 7.4 44.3 20.6 32.0 57.9 0.1 32.1 10.6 25.3 1.8 36.6 17.1 18.1 51.4 15.3 17.0 22.7 16.9 29.9 15.6 29.2 21.4 2.5 19.1 38.6 10.4 22.7 37.0 31.7 41.6 12.0 35.8 37.7 24.7 57.3 25.2 51.6 41.9 113.2 54.7 13.0 59.4 113.9 11.9 19.9 81.5 111.1 96.7 90.7 2.0 102.1 641.6 73.2 5.9 17.8 131.2 46.7 60.9 77.8 54.3 48.6 34.6 203.8 78.0 3.2 37.1 54.6 65.5 2.9 113.6 47.2 86.0 102.8 58.6 65.5 81.3 71.8 124.5 200.8 7.4 25.8 60.8 4.2 11.3 108.0 74.6 30.9 77.6 42.0 CBR3 SDR21C2 ENSG00000159231 "Carbonyl reductase 3" O75828 21 36134912-36146566 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 68.2" "Group enriched" "Detected in many" 4 "Basal glandular cells: 23.4;Basal keratinocytes: 63.1;Glandular cells: 36.1;Leydig cells: 62.7;Melanocytes: 62.4;monocytes: 36.1;Peritubular cells: 71.1;Smooth muscle cells: 20.3;Suprabasal keratinocytes: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 10 "B-cells: 11.9;NK-cells: 4.9;T-cells: 17.9" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 43.6" "Low region specificity" "Detected in all" HPA018434 Uncertain Approved Nucleoplasm,Cytosol Yes NA "Nucleoplasm, Cytosol" "HPA018434: AB_1846110" "unprognostic (3.64e-3)" "unprognostic (2.32e-2)" "unprognostic (1.48e-1)" "unprognostic (1.46e-1)" "unprognostic (2.16e-1)" "unprognostic (1.18e-3)" "unprognostic (1.22e-1)" "unprognostic (2.22e-2)" "unprognostic (6.12e-2)" "unprognostic (2.98e-2)" "unprognostic (3.75e-1)" "unprognostic (9.10e-2)" "prognostic unfavorable (5.95e-6)" "unprognostic (3.13e-1)" "unprognostic (1.80e-1)" "unprognostic (3.99e-3)" "unprognostic (1.94e-1)" 9.2 1.5 5.4 3.0 13.9 0.9 12.2 3.1 4.7 8.6 3.8 1.4 4.1 2.4 5.5 8.8 27.6 4.1 4.9 4.9 3.6 2.9 1.6 0.4 3.5 3.4 3.8 6.1 9.3 1.2 0.3 1.2 2.2 2.5 7.2 2.9 3.3 21.8 4.2 2.4 16.3 2.6 10.5 2.3 1.5 2.7 4.3 2.7 0.9 2.3 68.2 14.1 7.1 8.0 11.9 1.2 0.4 0.5 4.9 17.9 6.2 12.2 3.5 1.5 3.1 12.0 18.6 2.4 13.4 15.9 15.4 12.3 0.1 2.6 0.0 3.9 13.7 5.4 5.7 2.0 2.7 6.2 16.7 6.4 0.5 3.7 0.1 1.0 0.0 0.0 2.6 0.3 10.7 1.4 7.4 9.3 1.4 0.0 0.1 4.5 9.2 1.1 5.4 1.2 3.8 15.5 2.6 2.9 23.9 5.1 5.2 0.8 1.1 10.2 12.5 19.5 0.8 3.7 1.4 6.4 10.0 0.8 11.2 12.9 0.6 0.2 0.0 10.4 0.3 17.9 0.0 0.3 0.0 1.2 0.2 1.5 11.9 13.0 4.0 1.2 10.6 17.9 12.3 0.4 4.9 0.5 0.3 5.1 6.2 5.4 13.9 3.1 4.7 3.6 2.9 3.8 6.1 2.5 2.7 0.0 2.7 0.0 23.4 63.1 0.2 0.2 5.1 5.3 11.4 0.0 0.0 0.9 8.3 3.3 0.5 11.3 1.1 0.0 0.6 0.2 7.7 36.1 5.7 0.0 7.4 0.0 0.0 8.6 3.7 1.1 62.7 5.6 62.4 36.1 8.9 1.4 2.1 1.1 71.1 0.0 0.4 0.0 20.3 0.4 0.2 40.8 0.2 1.3 2.9 11.5 CBX1 "CBX, HP1-BETA, HP1Hs-beta, M31, MOD1" ENSG00000108468 "Chromobox 1" P83916 17 48070052-48101521 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 239.1;Spermatogonia: 235.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" CAB012265 Supported Supported "Nucleoplasm,Nuclear bodies" NA NA 35000 "Nucleoplasm, Nuclear bodies" "CAB012265: AB_297216" "unprognostic (7.50e-2)" "unprognostic (3.33e-1)" "unprognostic (2.02e-1)" "unprognostic (2.58e-2)" "unprognostic (3.15e-1)" "unprognostic (3.04e-1)" "prognostic unfavorable (2.70e-4)" "unprognostic (2.68e-2)" "unprognostic (3.45e-2)" "unprognostic (6.55e-2)" "unprognostic (2.78e-1)" "unprognostic (2.72e-2)" "unprognostic (1.67e-2)" "unprognostic (6.48e-3)" "unprognostic (3.82e-1)" "unprognostic (3.65e-1)" "unprognostic (6.73e-2)" 17.4 19.1 39.4 19.5 40.5 8.6 25.5 40.0 39.7 31.3 18.8 22.0 15.4 11.1 39.6 29.3 18.7 22.5 16.4 18.3 35.0 33.4 22.9 12.5 15.6 18.6 32.2 38.0 47.6 12.4 27.8 20.7 19.9 30.8 23.1 19.9 13.5 15.5 29.3 35.4 16.7 11.8 32.8 41.8 18.5 14.2 39.6 31.8 30.9 23.5 12.9 26.1 20.2 19.6 12.7 7.6 25.0 9.1 6.3 9.5 4.1 38.5 22.1 72.9 34.3 14.8 13.3 40.4 35.9 17.4 35.1 37.7 57.8 15.5 26.6 38.5 28.2 27.0 15.5 26.8 22.7 62.0 49.3 21.6 21.6 22.2 21.2 9.0 20.5 13.4 9.4 12.7 26.1 33.5 27.0 28.6 32.2 26.8 12.4 28.1 24.1 57.3 14.0 27.7 21.1 28.7 43.2 60.4 17.0 20.3 22.2 25.9 64.6 24.8 8.2 12.9 54.8 38.9 14.6 19.9 49.1 45.3 20.8 36.1 17.5 39.6 25.6 13.4 9.1 21.7 2.8 9.1 11.2 9.5 9.1 7.9 11.4 8.6 7.8 7.1 12.7 9.1 7.5 25.0 6.3 6.4 7.6 8.4 4.1 39.4 40.5 40.0 35.1 35.0 33.4 32.2 38.0 30.8 31.8 62.5 22.2 26.7 28.9 38.7 41.3 65.0 12.7 44.2 37.5 40.1 19.6 47.7 29.9 61.5 24.8 37.9 9.6 0.0 25.7 68.8 49.4 25.7 38.2 14.9 56.4 47.7 38.8 20.9 29.1 41.0 74.2 25.3 38.8 51.3 25.2 83.7 31.1 7.0 86.3 22.4 31.7 38.8 34.0 239.1 235.7 31.7 23.2 21.9 28.9 17.7 CBX2 "CDCA6, MGC10561" ENSG00000173894 "Chromobox 2" Q14781 17 79778132-79787983 "Disease related genes, Predicted intracellular proteins" "Differentiation, Sexual differentiation, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.9;testis: 16.5" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 27.9;Late spermatids: 28.1;Spermatogonia: 16.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "REH: 32.1;SH-SY5Y: 24.4;SK-BR-3: 46.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023083 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA023083: AB_2671063" "unprognostic (1.37e-2)" "unprognostic (1.19e-1)" "unprognostic (1.95e-1)" "unprognostic (3.80e-2)" "unprognostic (1.49e-1)" "unprognostic (9.72e-2)" "unprognostic (2.25e-11)" "unprognostic (1.05e-1)" "unprognostic (7.77e-2)" "unprognostic (6.34e-3)" "unprognostic (1.86e-3)" "unprognostic (1.66e-1)" "unprognostic (1.25e-8)" "unprognostic (1.34e-1)" "unprognostic (3.33e-2)" "unprognostic (2.37e-3)" "unprognostic (2.07e-1)" 2.1 0.6 1.6 1.3 2.5 3.4 8.1 0.5 1.5 1.7 0.8 0.6 2.9 0.6 4.0 3.4 6.0 1.7 1.1 3.3 0.8 0.7 1.3 0.9 2.2 2.2 1.8 1.1 4.1 2.2 0.4 0.5 3.9 1.3 1.3 0.4 1.0 2.1 1.5 1.3 3.4 1.0 1.2 0.8 2.5 0.9 16.5 1.8 17.9 1.7 6.8 2.4 1.5 3.5 0.8 0.4 0.0 0.6 0.0 0.4 0.2 2.5 6.9 12.8 23.3 0.1 0.2 4.6 0.9 0.4 0.4 0.8 7.1 0.5 9.9 2.0 0.1 1.6 1.3 14.8 0.4 0.3 1.4 8.0 0.5 7.5 4.7 0.5 3.0 2.1 0.2 0.9 0.2 0.6 0.5 2.6 10.7 6.8 0.8 0.4 10.4 15.5 7.3 12.7 3.4 8.1 32.1 9.6 6.0 0.5 3.5 15.7 24.4 4.0 46.6 2.7 6.4 8.4 4.5 1.8 4.6 13.7 1.4 1.7 3.0 1.5 6.1 0.2 8.1 5.4 0.0 0.1 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.6 0.4 0.0 0.2 1.6 2.5 0.5 1.5 0.8 0.7 1.8 1.1 1.3 1.8 0.0 0.0 0.0 0.2 0.9 0.6 2.0 0.0 0.0 0.0 1.8 2.0 0.2 1.7 3.5 27.9 6.7 0.0 0.0 0.8 1.1 0.8 0.8 0.0 0.5 1.1 0.0 0.0 2.5 0.6 28.1 0.6 0.0 3.3 1.0 0.4 2.3 0.9 0.0 0.7 0.5 0.2 0.0 0.0 1.1 16.1 1.3 0.2 0.0 0.0 0.5 CBX3 HP1Hs-gamma ENSG00000122565 "Chromobox 3" Q13185 7 26201162-26213356 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001973, HPA004902" Supported Supported "Nucleoplasm,Nuclear bodies" NA Yes 40000 Nucleoplasm "Nuclear bodies" "CAB001973: , HPA004902: AB_1850635" "prognostic unfavorable (7.92e-4)" "unprognostic (1.43e-1)" "unprognostic (4.84e-2)" "unprognostic (1.12e-2)" "unprognostic (4.85e-2)" "unprognostic (9.25e-3)" "prognostic unfavorable (2.20e-8)" "unprognostic (2.13e-2)" "unprognostic (3.95e-2)" "unprognostic (3.71e-3)" "prognostic unfavorable (4.00e-4)" "unprognostic (1.16e-1)" "prognostic unfavorable (4.56e-7)" "unprognostic (7.79e-2)" "unprognostic (4.69e-2)" "unprognostic (1.17e-1)" "unprognostic (5.78e-2)" 40.7 49.4 41.2 54.3 38.8 65.8 69.4 37.4 45.9 33.9 38.4 20.3 39.0 49.8 39.5 42.1 36.4 33.9 28.6 43.3 39.0 40.8 51.1 45.8 37.0 68.6 44.9 37.2 45.3 31.8 22.4 27.5 45.4 51.1 30.7 43.7 23.7 35.0 45.6 60.4 27.1 56.4 46.7 66.9 54.0 29.3 45.1 33.7 92.3 32.1 38.2 65.0 39.8 38.1 38.8 37.4 55.2 48.4 39.5 60.7 35.1 50.3 22.3 47.7 47.1 17.2 31.3 37.6 39.6 30.2 30.2 30.7 26.3 42.6 76.6 32.0 26.1 64.7 40.3 39.8 33.0 49.4 21.1 29.7 43.7 29.4 29.3 18.9 69.0 42.5 22.9 29.0 23.8 34.2 37.5 40.7 48.9 69.9 37.9 51.1 28.8 66.5 83.3 60.7 43.8 32.3 43.6 44.3 63.2 44.0 28.3 58.4 64.8 32.8 69.8 36.3 52.9 59.3 62.7 30.2 27.5 49.9 32.0 52.5 56.3 81.1 130.3 23.9 59.5 123.9 47.8 38.4 55.2 34.6 47.6 42.8 38.8 51.7 42.7 37.4 35.8 55.0 54.0 39.3 39.5 48.4 30.5 60.7 35.1 41.2 38.8 37.4 45.9 39.0 40.8 44.9 37.2 51.1 33.7 101.3 77.8 131.1 75.5 127.6 104.6 114.5 129.9 139.2 130.8 61.1 72.6 154.4 119.3 152.3 115.5 136.8 88.3 303.7 123.2 293.9 107.2 64.5 211.9 239.9 127.2 47.7 105.7 149.1 266.0 31.0 126.2 175.5 99.5 110.0 127.3 132.2 139.2 87.7 92.3 112.3 126.4 77.6 91.0 234.4 415.8 94.4 226.4 163.9 186.9 86.2 CBX4 "hPC2, NBP16, PC2" ENSG00000141582 "Chromobox 4" O00257 17 79833156-79839429 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 109.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 39.0;SK-MEL-30: 43.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008228, HPA012021" Approved Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA008228: AB_1078413, HPA012021: AB_2668603" "unprognostic (1.30e-1)" "unprognostic (1.15e-1)" "unprognostic (1.72e-2)" "unprognostic (1.86e-1)" "unprognostic (3.97e-2)" "unprognostic (8.80e-2)" "unprognostic (5.39e-3)" "unprognostic (1.49e-1)" "unprognostic (2.55e-1)" "unprognostic (1.40e-2)" "unprognostic (7.62e-2)" "unprognostic (2.34e-3)" "prognostic unfavorable (8.72e-8)" "unprognostic (7.49e-2)" "unprognostic (2.87e-1)" "unprognostic (3.99e-2)" "unprognostic (1.07e-1)" 7.1 9.9 11.6 11.3 14.8 109.1 7.0 9.0 22.5 5.9 6.2 20.4 6.3 8.3 5.9 6.3 14.8 6.7 10.3 12.0 12.9 12.9 6.5 15.3 9.0 13.9 15.4 10.8 9.3 16.8 16.2 14.8 17.0 13.9 8.9 4.8 14.5 12.9 6.9 3.8 20.6 8.5 5.2 12.6 16.3 10.8 5.5 13.1 29.2 8.3 6.7 19.2 8.6 7.1 3.6 4.2 5.2 1.7 1.0 3.8 1.3 10.8 9.7 3.0 12.7 1.9 1.7 8.3 4.9 2.9 1.8 1.9 7.0 6.1 4.2 7.0 1.9 4.0 5.6 3.2 3.2 1.3 4.5 6.2 2.3 9.3 13.0 9.2 12.4 18.6 2.3 19.3 1.6 3.0 3.0 1.5 12.4 7.2 23.7 1.9 7.8 17.0 12.7 1.6 11.3 9.8 17.7 3.0 18.8 2.5 5.2 3.1 5.9 7.4 39.0 43.4 1.3 9.2 19.9 3.8 10.6 9.4 6.5 6.3 20.5 10.4 11.8 6.7 10.8 14.0 3.9 1.4 4.1 2.4 1.5 1.8 3.3 3.1 3.3 0.9 3.6 3.8 3.5 5.2 1.0 1.7 4.2 0.5 1.3 11.6 14.8 9.0 22.5 12.9 12.9 15.4 10.8 13.9 13.1 3.0 14.9 15.9 2.2 20.7 30.6 37.0 12.7 9.4 9.1 1.8 21.6 27.3 0.0 7.5 0.1 13.5 11.5 23.3 6.4 3.3 11.4 6.6 6.9 13.5 11.7 19.1 50.6 20.3 20.6 0.6 4.0 10.2 16.9 4.6 38.4 26.1 7.5 15.9 5.3 2.6 40.4 6.5 11.0 0.0 2.5 26.8 7.2 16.0 26.7 4.8 CBX5 "HP1, HP1-ALPHA, HP1Hs-alpha" ENSG00000094916 "Chromobox 5" P45973 12 54230940-54280133 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016699, CAB017548" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB017548: AB_2071368, HPA016699: AB_1850627" "unprognostic (1.58e-2)" "unprognostic (7.99e-2)" "unprognostic (1.15e-2)" "unprognostic (5.05e-3)" "unprognostic (3.80e-1)" "unprognostic (4.59e-3)" "unprognostic (2.97e-3)" "unprognostic (6.39e-3)" "unprognostic (2.57e-2)" "unprognostic (1.41e-1)" "unprognostic (4.47e-2)" "unprognostic (1.96e-1)" "unprognostic (2.34e-1)" "unprognostic (1.70e-1)" "unprognostic (1.08e-1)" "unprognostic (6.26e-2)" "unprognostic (8.64e-2)" 9.7 18.2 26.3 16.3 28.4 17.3 16.0 22.3 32.3 13.8 12.0 25.3 10.4 8.7 11.7 18.0 11.2 18.9 10.6 22.0 22.1 28.4 20.8 10.1 11.6 19.8 22.4 18.8 22.2 12.2 42.5 26.8 13.9 20.4 13.9 13.0 19.5 10.5 16.0 14.1 19.5 10.4 12.6 25.3 11.7 11.8 26.8 20.3 37.0 27.4 9.0 23.4 10.0 11.6 11.3 18.4 3.7 6.1 6.2 8.2 3.6 8.8 26.4 41.4 19.1 5.5 12.0 9.6 13.7 9.9 11.6 12.1 10.2 28.4 24.5 18.5 13.5 13.9 7.5 29.3 8.5 19.9 38.8 6.4 21.6 30.0 3.6 4.3 11.4 9.2 5.9 5.8 19.9 17.6 13.2 12.8 22.8 24.5 24.3 19.1 15.3 36.2 11.9 33.1 3.7 3.2 35.9 23.2 13.6 12.1 8.1 20.8 32.1 25.7 5.8 3.0 17.0 22.4 19.3 16.8 19.7 17.0 7.4 16.2 6.1 6.8 47.1 12.5 11.7 20.5 0.8 4.7 3.7 6.2 4.9 5.0 9.4 6.7 5.7 7.8 11.3 6.6 6.1 0.7 6.2 6.1 18.4 8.2 3.6 26.3 28.4 22.3 27.2 22.1 28.4 22.4 18.8 20.4 20.3 35.7 44.5 47.7 38.8 41.1 105.7 135.1 56.0 92.3 52.4 78.5 43.2 45.4 89.5 54.0 84.3 46.6 14.0 70.0 51.5 49.9 48.3 35.9 29.0 27.7 32.9 173.2 25.9 32.5 22.5 38.8 59.8 30.8 33.7 55.1 34.8 65.1 38.7 7.0 75.7 47.7 56.4 32.3 42.9 202.7 89.2 28.5 21.9 35.2 33.3 23.0 CBX6 ENSG00000183741 "Chromobox 6" O95503 22 38861450-38872314 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048653 Uncertain Approved Nucleoplasm,Mitochondria NA Yes "Nucleoplasm, Mitochondria" "HPA048653: AB_2680479" "unprognostic (1.65e-2)" "unprognostic (8.66e-2)" "unprognostic (6.20e-3)" "unprognostic (3.14e-3)" "unprognostic (1.56e-1)" "unprognostic (2.62e-1)" "prognostic unfavorable (8.30e-4)" "unprognostic (2.90e-2)" "unprognostic (3.72e-3)" "unprognostic (5.97e-2)" "prognostic favorable (2.46e-6)" "unprognostic (2.75e-1)" "unprognostic (1.27e-3)" "unprognostic (7.39e-2)" "unprognostic (1.03e-1)" "unprognostic (1.94e-1)" "unprognostic (2.26e-2)" 15.0 15.0 44.7 14.5 35.1 21.7 7.4 27.8 53.8 14.0 19.5 15.3 9.8 6.5 19.3 14.2 12.9 18.8 10.9 14.0 40.6 18.3 12.1 5.9 13.0 12.0 15.8 21.8 23.4 13.1 62.2 15.5 4.7 19.3 16.1 7.4 17.0 12.5 25.4 5.5 7.7 9.2 23.8 12.1 11.2 12.0 5.0 12.0 11.3 13.4 4.5 13.8 16.6 9.5 4.7 26.9 2.6 7.4 5.2 11.7 9.2 16.6 17.7 3.9 13.4 30.4 17.1 1.2 18.2 10.5 9.5 8.9 8.8 15.6 27.3 13.7 12.4 6.6 19.9 7.3 7.7 5.2 26.2 22.9 2.7 7.6 3.0 16.6 13.4 13.6 25.4 3.9 21.6 10.3 13.1 10.7 7.9 6.1 13.9 6.4 18.8 8.2 3.9 3.5 9.6 13.7 12.5 13.2 10.7 13.4 15.8 19.3 4.3 11.7 15.6 9.8 1.4 10.7 8.0 13.8 8.3 25.5 14.3 12.4 14.3 13.7 10.0 16.2 14.1 17.1 1.1 5.5 2.6 11.7 7.4 9.7 4.2 8.1 8.2 5.4 4.7 6.7 8.2 2.3 5.2 6.8 26.9 4.6 9.2 44.7 35.1 27.8 53.8 40.6 18.3 15.8 21.8 19.3 12.0 14.9 14.3 23.1 30.9 30.1 95.1 23.3 38.2 5.3 13.6 69.8 37.3 9.4 29.9 79.7 0.5 30.3 1.3 0.0 43.0 1.9 41.4 21.2 5.8 29.7 17.5 117.6 117.7 33.7 40.3 0.9 68.7 20.0 77.6 119.0 0.7 80.1 41.4 7.0 76.0 41.9 56.5 71.1 86.3 2.1 6.0 29.6 3.9 35.8 0.5 68.7 CBX7 ENSG00000100307 "Chromobox 7" O95931 22 39120167-39152674 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 60.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 24.0;U-266/70: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011574, HPA048677, HPA056480" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB011574: AB_726005, HPA048677: AB_2680490, HPA056480: AB_2683146" "prognostic favorable (6.18e-4)" "prognostic favorable (3.63e-4)" "prognostic unfavorable (3.73e-4)" "unprognostic (9.18e-2)" "unprognostic (2.32e-1)" "unprognostic (1.48e-3)" "unprognostic (4.76e-3)" "unprognostic (1.45e-2)" "unprognostic (3.86e-2)" "unprognostic (1.11e-3)" "prognostic favorable (1.04e-4)" "unprognostic (3.03e-3)" "prognostic favorable (2.45e-5)" "unprognostic (3.90e-1)" "unprognostic (1.26e-1)" "unprognostic (3.10e-1)" "unprognostic (1.63e-2)" 17.6 23.1 26.1 14.2 34.3 4.0 14.0 45.0 44.7 20.1 29.3 17.2 24.1 12.3 27.8 21.9 18.0 24.7 19.1 36.5 23.9 19.5 17.6 6.4 19.1 17.2 18.7 29.5 36.9 15.0 33.4 17.1 6.2 19.7 27.1 10.6 21.1 24.0 44.0 38.6 15.4 15.8 35.9 12.9 22.0 18.8 6.5 19.9 4.5 16.9 10.8 15.1 26.2 21.1 3.7 0.7 5.5 0.9 1.7 5.1 1.6 4.5 1.9 0.9 7.4 9.1 3.5 2.4 4.3 5.3 2.4 2.8 0.9 3.1 0.7 5.1 3.2 4.3 1.7 0.6 2.0 1.8 24.0 2.4 0.1 3.1 0.4 3.1 1.1 9.5 1.7 3.0 1.1 0.5 3.0 0.7 3.7 1.1 12.2 1.8 4.3 1.6 0.5 0.5 5.7 3.3 1.8 1.5 6.5 1.2 1.8 2.4 0.6 2.2 3.2 4.9 1.6 3.9 1.8 1.7 4.0 7.6 4.0 1.9 20.8 11.7 2.8 8.1 1.8 1.7 0.6 0.5 4.8 3.7 0.1 3.8 2.9 4.0 4.0 0.1 3.7 5.1 4.8 5.5 1.7 0.9 0.7 3.8 1.6 26.1 34.3 45.0 44.7 23.9 19.5 18.7 29.5 19.7 19.9 6.0 8.3 29.6 11.6 4.0 49.8 60.2 22.9 4.0 13.6 14.0 33.4 2.9 8.3 2.8 7.4 14.7 7.2 0.0 3.3 1.2 8.4 9.8 10.4 10.9 3.7 57.2 4.1 20.3 12.3 6.4 32.5 5.5 18.6 10.0 8.0 16.2 2.9 3.5 26.2 11.0 57.0 45.3 27.8 3.9 2.7 4.3 3.0 17.5 6.2 6.3 CBX8 "HPC3, PC3, RC1" ENSG00000141570 "Chromobox 8" Q9HC52 17 79792132-79801683 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031462 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA031462: AB_10601252" "unprognostic (4.77e-2)" "unprognostic (2.24e-1)" "unprognostic (1.34e-1)" "unprognostic (8.81e-2)" "unprognostic (3.26e-3)" "unprognostic (1.01e-1)" "prognostic unfavorable (3.94e-6)" "unprognostic (2.92e-2)" "unprognostic (1.29e-1)" "unprognostic (6.26e-2)" "prognostic favorable (3.84e-5)" "unprognostic (4.74e-1)" "prognostic unfavorable (5.39e-7)" "unprognostic (6.99e-3)" "unprognostic (7.18e-2)" "unprognostic (4.51e-1)" "unprognostic (5.99e-2)" 5.0 4.6 6.3 7.5 4.3 3.6 4.6 4.4 7.2 3.8 4.3 5.1 3.9 5.4 3.6 20.5 3.9 13.9 7.3 4.8 5.6 2.7 6.9 7.8 6.2 5.0 4.5 5.0 3.2 7.9 10.0 11.0 4.7 4.7 3.6 1.6 5.9 4.8 6.9 3.9 4.2 4.1 2.2 3.3 4.3 5.5 13.6 5.5 12.8 4.4 1.7 4.0 2.6 2.5 4.9 5.7 14.6 6.8 3.0 3.4 2.1 7.8 16.1 4.3 15.5 2.4 1.5 5.2 4.0 2.9 3.5 2.4 8.8 4.0 5.8 11.4 2.2 3.1 7.4 5.5 1.2 1.5 4.4 7.7 2.1 8.5 9.3 2.8 8.6 18.2 1.3 2.5 2.2 0.7 3.4 0.7 6.9 5.1 2.6 1.0 9.6 9.8 12.8 1.7 5.7 8.8 9.2 3.8 10.6 2.6 5.4 6.3 12.7 5.8 18.5 9.2 1.5 9.7 11.3 1.8 7.3 10.1 2.9 6.3 7.5 2.9 3.7 4.5 8.6 4.0 1.0 5.2 14.6 3.4 6.5 1.2 4.9 1.9 2.0 5.7 2.1 1.9 1.8 6.5 3.0 6.8 4.6 1.9 2.1 6.3 4.3 4.4 7.2 5.6 2.7 4.5 5.0 4.7 5.5 0.0 0.3 1.3 0.7 1.5 5.2 2.1 10.2 1.4 0.0 3.5 7.9 6.1 0.0 4.1 2.7 1.2 3.2 0.0 4.8 2.4 1.5 0.8 5.7 2.6 4.2 7.9 8.7 0.6 2.8 0.0 0.9 1.1 1.7 1.0 6.3 6.8 3.7 4.0 2.1 1.9 10.8 0.0 2.8 0.5 11.4 1.0 2.1 3.8 3.7 0.3 CBY3 ENSG00000204659 "Chibby family member 3" A6NI87 5 179678583-179680974 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 15.8" "Group enriched" "Detected in some" 122 "Early spermatids: 194.9;Late spermatids: 243.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 2.8;BEWO: 1.9;HDLM-2: 5.3;HeLa: 3.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA069037 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA069037: AB_2686069" "unprognostic (1.33e-1)" "unprognostic (1.57e-1)" "unprognostic (1.23e-2)" "unprognostic (1.15e-2)" "unprognostic (1.76e-1)" "unprognostic (8.68e-3)" "unprognostic (7.69e-3)" "unprognostic (5.71e-2)" "unprognostic (1.56e-2)" "unprognostic (9.14e-2)" "unprognostic (6.10e-4)" "unprognostic (2.69e-2)" "unprognostic (1.67e-2)" "unprognostic (9.76e-3)" "unprognostic (7.85e-2)" "unprognostic (5.04e-3)" "unprognostic (4.98e-2)" 0.4 0.6 1.1 0.5 1.3 0.2 0.4 0.8 1.2 0.4 0.4 0.4 0.4 0.6 0.4 0.4 0.4 0.3 0.4 0.4 1.1 1.3 0.4 0.4 0.4 0.8 1.9 0.4 0.9 1.1 0.0 0.6 0.4 0.4 0.5 0.0 0.4 0.4 0.4 1.1 1.6 0.9 0.4 2.1 1.2 0.9 15.8 0.4 0.4 0.9 0.4 0.4 0.4 0.4 2.9 1.2 0.1 1.0 0.4 2.1 0.6 0.0 0.5 0.0 2.8 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 5.3 0.3 0.0 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.4 0.0 1.1 0.1 0.9 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.1 1.4 0.1 0.6 0.1 0.0 0.1 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.3 0.7 0.0 0.5 0.0 2.0 1.0 1.1 1.2 2.1 0.7 1.2 2.9 2.1 1.3 0.1 0.4 0.1 0.9 1.4 0.6 1.1 1.3 0.8 0.5 1.1 1.3 1.9 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 194.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 243.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.7 0.8 0.0 0.0 0.0 0.0 0.0 CC2D1B KIAA1836 ENSG00000154222 "Coiled-coil and C2 domain containing 1B" Q5T0F9 1 52345723-52366193 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027500, HPA031426" Uncertain Supported Nucleoplasm,Vesicles NA NA 140000 Nucleoplasm Vesicles "HPA027500: AB_10600693, HPA031426: AB_2673876" "unprognostic (1.11e-2)" "unprognostic (1.06e-1)" "unprognostic (2.38e-2)" "unprognostic (2.50e-2)" "unprognostic (5.85e-2)" "unprognostic (2.04e-2)" "prognostic unfavorable (1.45e-5)" "unprognostic (3.39e-2)" "unprognostic (4.75e-1)" "unprognostic (1.75e-1)" "unprognostic (1.76e-1)" "unprognostic (1.70e-1)" "unprognostic (1.13e-2)" "unprognostic (2.63e-1)" "unprognostic (1.33e-1)" "unprognostic (1.37e-2)" "unprognostic (1.87e-1)" 14.6 16.0 12.6 14.5 20.0 7.4 11.5 12.9 18.8 9.6 13.0 22.5 10.8 14.3 11.1 15.2 16.5 9.6 13.6 14.9 14.3 14.9 17.7 15.5 17.9 18.7 21.0 17.2 14.1 17.2 15.3 20.0 16.2 20.6 12.7 11.0 17.3 16.1 14.0 25.6 15.6 14.9 11.3 29.2 16.9 14.4 24.3 19.2 17.9 17.1 17.1 15.7 12.8 10.8 2.9 1.7 11.2 1.8 2.7 4.0 1.9 9.3 13.3 5.9 8.7 20.5 7.6 14.5 12.4 18.8 15.0 11.9 9.2 7.3 6.7 10.6 13.0 31.9 6.7 7.3 14.6 6.3 11.0 8.6 7.4 11.2 7.1 15.2 8.4 16.4 11.9 13.6 17.1 12.2 14.0 9.4 9.2 11.3 6.7 15.0 7.1 9.2 6.8 10.9 7.8 13.0 6.2 12.0 7.8 13.9 13.7 7.1 6.1 11.5 17.1 15.6 14.3 6.2 11.1 12.7 19.2 10.7 10.2 13.7 9.8 9.2 7.3 21.4 9.7 19.3 11.2 1.8 4.0 4.0 1.0 3.0 2.9 3.2 2.9 1.7 2.2 2.5 3.4 2.6 2.7 0.8 1.7 2.3 1.9 12.6 20.0 12.9 18.8 14.3 14.9 21.0 17.2 20.6 19.2 8.9 14.9 7.4 3.3 2.9 4.4 4.9 5.1 5.3 9.1 10.4 0.0 7.8 3.3 8.9 2.9 5.8 7.8 0.0 11.0 8.6 4.1 3.9 15.1 6.7 9.9 1.6 5.8 8.6 4.8 1.3 3.1 4.2 1.7 6.4 4.8 6.3 9.9 5.8 6.0 3.7 4.0 0.0 2.1 12.7 5.1 2.8 13.2 7.0 3.6 2.7 CCAR1 "CARP-1, CARP1, FLJ10590" ENSG00000060339 "Cell division cycle and apoptosis regulator 1" Q8IX12 10 68721012-68792377 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Transcription, Transcription regulation" "Activator, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007856, HPA048513" Supported Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA007856: AB_1078415, HPA048513: AB_2680424" "unprognostic (1.71e-1)" "unprognostic (1.22e-1)" "unprognostic (2.34e-2)" "unprognostic (1.86e-1)" "unprognostic (5.15e-3)" "unprognostic (1.71e-2)" "prognostic unfavorable (1.41e-5)" "unprognostic (1.10e-1)" "unprognostic (3.25e-2)" "prognostic favorable (4.05e-5)" "unprognostic (2.89e-2)" "unprognostic (3.21e-3)" "prognostic unfavorable (1.37e-4)" "unprognostic (1.67e-1)" "unprognostic (2.36e-1)" "unprognostic (2.24e-1)" "unprognostic (1.41e-2)" 24.2 28.0 22.6 38.7 27.9 27.8 24.6 36.9 31.7 26.0 28.7 21.5 24.7 22.7 23.9 23.7 26.5 19.7 23.2 21.6 21.3 20.5 27.4 22.3 23.4 37.5 31.7 17.9 32.1 22.9 28.6 44.3 29.2 23.6 25.0 31.1 26.0 26.7 37.9 47.0 32.3 25.4 24.5 30.4 28.6 23.5 18.9 29.9 42.1 28.5 20.6 37.4 28.8 25.0 12.4 18.6 12.3 12.8 8.8 16.0 9.1 26.5 27.9 32.1 21.5 13.9 13.5 25.0 23.8 20.5 26.0 17.8 36.7 21.7 31.3 13.1 16.4 13.0 21.0 33.5 18.9 28.5 21.4 21.1 25.1 19.2 22.7 15.9 39.6 29.5 13.5 23.5 21.9 27.0 16.0 20.8 15.9 34.1 20.3 25.0 19.1 26.4 25.1 32.1 20.7 26.0 30.9 19.2 18.7 22.7 20.2 18.6 16.2 23.4 38.6 23.4 26.3 26.1 24.3 20.3 16.2 20.4 17.4 25.6 14.1 18.4 33.6 13.6 26.7 15.3 4.9 12.8 12.3 15.5 11.5 13.8 12.3 11.0 14.9 18.6 12.4 13.3 14.0 3.1 8.8 12.8 11.8 16.0 9.1 22.6 27.9 36.9 31.7 21.3 20.5 31.7 17.9 23.6 29.9 32.8 82.3 47.7 44.3 32.7 48.9 60.4 50.9 49.5 43.3 43.6 55.0 60.8 19.9 54.9 17.6 45.3 37.7 23.3 68.1 73.7 49.1 41.9 65.8 38.5 43.1 52.4 44.3 42.4 40.5 9.5 49.8 41.4 20.3 55.1 49.6 36.7 64.1 24.6 47.4 16.5 65.5 64.7 40.1 90.4 82.9 32.6 91.5 44.7 56.2 39.6 CCAR2 "DBC-1, DBC1, KIAA1967, NET35" ENSG00000158941 "Cell cycle and apoptosis regulator 2" Q8N163 8 22604632-22621514 "Predicted intracellular proteins" "Apoptosis, Biological rhythms, Cell cycle, DNA damage, mRNA processing, mRNA splicing, Transcription, Transcription regulation, Wnt signaling pathway" "Activator, Metalloenzyme inhibitor, Repressor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019907, HPA019943, CAB072827, CAB072828" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA 5300 "Nucleoplasm, Nuclear bodies" "CAB072827: , CAB072828: , HPA019907: AB_1852452, HPA019943: AB_1852454" "unprognostic (3.42e-2)" "unprognostic (5.78e-3)" "unprognostic (2.46e-3)" "unprognostic (1.33e-2)" "unprognostic (6.87e-2)" "unprognostic (2.23e-2)" "unprognostic (5.13e-2)" "unprognostic (8.56e-2)" "unprognostic (2.97e-1)" "unprognostic (1.77e-1)" "unprognostic (2.32e-2)" "unprognostic (1.54e-2)" "prognostic favorable (5.60e-4)" "unprognostic (1.71e-2)" "unprognostic (2.46e-1)" "unprognostic (7.54e-2)" "unprognostic (1.77e-1)" 28.6 32.7 27.8 35.4 38.3 63.1 29.9 45.0 59.1 26.7 33.0 38.4 28.0 25.7 37.3 24.6 31.7 32.8 30.0 21.9 24.6 25.0 25.2 28.1 29.7 39.7 24.8 36.3 37.8 28.0 34.5 31.5 32.3 33.2 28.8 23.4 27.2 29.1 25.4 44.4 39.8 30.9 25.2 22.4 41.2 29.7 62.4 25.0 63.5 29.4 23.3 37.0 30.6 26.2 13.3 10.7 14.4 21.0 12.2 24.3 14.3 26.7 50.1 48.5 25.2 19.2 16.2 32.3 26.3 26.0 38.9 34.8 44.9 22.2 44.3 33.2 28.7 35.8 33.6 44.5 31.2 28.2 17.9 26.6 52.3 38.7 34.8 17.8 28.6 44.8 16.7 28.1 30.9 19.1 22.6 27.9 40.3 54.6 28.2 28.7 32.0 86.1 30.2 70.6 29.0 18.3 57.7 40.1 23.7 20.1 63.8 24.3 56.7 29.6 34.1 22.7 24.5 31.0 27.1 45.0 28.9 38.3 34.7 34.6 20.8 25.8 52.2 32.5 25.2 44.8 12.9 10.1 14.4 24.3 17.4 20.7 13.3 18.2 18.3 10.7 13.2 18.3 19.0 3.7 12.2 21.0 10.1 20.9 14.3 27.8 38.3 45.0 59.1 24.6 25.0 24.8 36.3 33.2 25.0 14.9 3.4 11.0 8.0 12.4 11.5 7.1 7.6 14.7 5.7 15.7 15.7 21.1 8.3 16.3 3.9 8.7 18.0 0.0 15.6 18.8 9.5 9.9 8.1 10.5 13.4 9.5 21.4 9.8 10.8 5.6 13.8 8.6 11.8 10.8 17.8 14.3 17.7 11.5 11.3 7.7 11.8 19.4 12.2 30.0 21.7 13.4 19.8 14.9 18.3 8.6 CCDC102A MGC10992 ENSG00000135736 "Coiled-coil domain containing 102A" Q96A19 16 57512178-57536599 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Leydig cells: 18.1;Peritubular cells: 32.5;Sertoli cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA040598, HPA040958" Supported Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA040598: AB_10794035, HPA040958: AB_10794156" "unprognostic (3.46e-2)" "unprognostic (3.04e-2)" "unprognostic (1.88e-2)" "unprognostic (1.51e-1)" "unprognostic (1.09e-1)" "unprognostic (1.98e-1)" "unprognostic (2.42e-1)" "unprognostic (4.01e-3)" "unprognostic (7.71e-2)" "unprognostic (1.72e-1)" "unprognostic (1.38e-1)" "unprognostic (5.24e-3)" "unprognostic (8.40e-3)" "unprognostic (4.08e-1)" "unprognostic (2.75e-1)" "unprognostic (2.37e-1)" "unprognostic (8.42e-3)" 5.0 3.7 1.9 7.4 2.1 0.8 12.1 2.0 2.4 12.1 9.7 1.8 8.1 4.5 11.1 7.2 5.5 7.9 8.4 6.4 1.6 1.5 5.6 2.2 9.9 6.2 2.0 2.8 8.2 4.6 3.6 2.4 5.0 4.2 13.5 0.9 5.5 4.6 8.6 2.6 4.3 4.3 17.2 2.9 5.8 4.7 2.9 2.2 7.7 7.2 3.9 5.2 10.6 21.2 2.4 1.0 0.3 0.0 1.6 3.5 0.7 5.7 7.0 2.7 3.9 0.9 1.4 5.7 3.8 2.1 2.2 1.1 2.8 6.8 5.3 15.2 1.2 2.9 4.3 1.4 2.0 0.8 4.3 6.2 0.7 3.2 1.2 3.5 0.4 7.1 3.3 1.3 1.8 0.4 4.9 1.7 1.9 4.0 0.0 0.7 2.3 4.7 4.6 6.6 0.6 13.3 4.2 3.1 2.1 2.8 0.9 0.5 7.2 5.9 1.9 2.7 1.1 4.1 2.6 4.7 4.0 13.6 0.3 3.4 6.4 2.3 2.0 2.3 1.9 6.7 0.0 0.0 0.0 3.1 0.0 2.6 2.4 0.8 3.5 0.0 1.3 1.4 2.4 0.3 1.6 0.0 1.0 0.1 0.7 1.9 2.1 2.0 2.4 1.6 1.5 2.0 2.8 4.2 2.2 0.0 4.0 2.2 7.9 11.4 0.0 2.4 2.5 1.4 3.4 7.0 0.0 1.4 8.3 1.4 0.5 9.0 0.4 0.0 0.8 1.0 13.9 6.2 0.0 0.9 0.3 0.0 0.0 4.3 0.0 0.9 18.1 1.2 1.7 0.0 0.7 3.3 0.9 0.0 32.5 7.9 0.0 19.4 11.2 1.7 5.9 5.0 0.2 7.5 0.8 2.6 CCDC106 HSU79303 ENSG00000173581 "Coiled-coil domain containing 106" Q9BWC9 19 55641062-55653161 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Proximal tubular cells: 41.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 11.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 39.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041925, HPA043219" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041925: AB_2677750, HPA043219: AB_2678368" "unprognostic (5.74e-3)" "unprognostic (1.34e-1)" "unprognostic (1.71e-1)" "unprognostic (5.16e-2)" "unprognostic (9.19e-2)" "unprognostic (2.82e-1)" "unprognostic (8.11e-2)" "unprognostic (1.21e-2)" "unprognostic (4.88e-2)" "unprognostic (8.74e-2)" "prognostic favorable (2.23e-6)" "unprognostic (2.28e-1)" "prognostic favorable (7.54e-11)" "unprognostic (5.03e-2)" "unprognostic (7.88e-2)" "unprognostic (3.26e-1)" "unprognostic (8.69e-2)" 15.9 18.7 31.6 8.7 43.9 4.4 14.5 27.2 29.8 13.9 10.4 14.3 10.5 7.2 13.2 11.2 13.0 12.5 14.2 18.0 32.3 21.2 23.5 19.2 10.4 14.8 20.3 14.4 20.9 13.8 19.2 17.5 8.8 15.2 14.7 5.2 12.4 18.0 19.6 34.1 9.3 8.3 20.0 15.1 15.6 13.0 15.9 10.8 13.7 18.0 6.5 14.1 16.9 10.0 11.1 9.0 0.0 2.4 0.6 3.4 1.5 3.9 15.5 6.8 11.9 4.9 4.7 0.9 3.4 6.0 11.9 10.0 3.3 6.1 11.5 2.7 6.3 0.3 3.4 11.5 7.4 3.4 0.6 39.5 12.2 10.4 5.9 14.7 0.8 7.0 7.5 0.9 2.8 0.6 8.3 3.7 7.5 8.9 7.4 5.8 1.0 7.3 4.8 3.2 0.4 8.6 11.5 3.5 7.9 12.3 0.3 7.5 14.0 2.7 19.4 6.7 4.2 8.4 7.9 4.1 3.7 3.8 0.3 2.5 4.4 1.5 14.9 9.9 3.9 0.2 0.0 2.4 0.0 0.5 1.6 1.5 7.8 0.5 0.7 3.0 11.1 3.4 2.0 0.0 0.6 0.1 9.0 0.3 1.5 31.6 43.9 27.2 29.4 32.3 21.2 20.3 14.4 15.2 10.8 0.0 2.2 8.3 7.6 2.3 21.3 19.5 12.7 0.0 1.2 19.2 3.9 11.2 34.9 16.1 3.0 11.3 5.5 0.0 6.3 12.7 8.9 4.6 9.2 14.9 14.5 35.0 4.7 5.5 7.8 1.5 13.0 7.1 3.3 18.0 7.0 18.8 9.0 5.8 17.7 41.5 7.1 12.9 7.2 5.9 19.6 3.1 7.3 3.8 4.7 2.0 CCDC107 MGC31967 ENSG00000159884 "Coiled-coil domain containing 107" Q8WV48 9 35658290-35661511 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016857, HPA050442" Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "HPA016857: AB_10669751, HPA050442: AB_2681128" "unprognostic (3.70e-3)" "unprognostic (7.07e-3)" "unprognostic (3.60e-2)" "unprognostic (2.63e-2)" "unprognostic (7.77e-2)" "unprognostic (1.34e-1)" "unprognostic (1.86e-1)" "unprognostic (4.09e-2)" "unprognostic (4.13e-1)" "unprognostic (1.72e-2)" "unprognostic (1.32e-2)" "unprognostic (1.26e-1)" "unprognostic (8.33e-2)" "unprognostic (1.89e-1)" "unprognostic (5.15e-1)" "unprognostic (1.96e-1)" "unprognostic (5.75e-2)" 42.1 23.4 11.1 15.4 10.3 5.4 50.3 17.2 12.9 17.5 35.2 8.5 18.1 15.0 24.9 28.6 22.4 18.2 31.5 31.3 10.2 11.0 13.0 15.0 14.0 14.1 9.7 7.9 15.3 80.2 7.6 10.5 10.8 8.4 22.8 13.7 11.5 14.6 24.5 29.3 9.6 16.0 44.8 9.7 13.5 24.2 9.2 8.8 19.3 14.0 8.8 10.9 38.9 24.1 20.7 32.5 7.6 11.0 16.4 46.9 18.3 7.9 7.2 6.0 7.5 30.2 19.4 3.5 13.4 12.2 8.6 8.1 3.3 2.4 5.2 6.0 17.6 22.3 2.6 4.4 6.5 6.4 15.3 7.1 2.4 10.9 8.1 7.1 3.7 9.5 11.4 7.7 9.2 7.2 16.1 6.0 8.8 3.2 10.0 10.8 5.1 4.2 5.6 4.4 5.7 22.2 6.1 1.4 4.1 28.6 4.3 3.9 6.5 6.9 9.7 6.6 4.7 5.1 4.7 7.5 13.9 7.7 10.0 12.2 4.5 6.6 10.3 25.6 6.0 12.1 7.6 10.6 5.1 36.1 11.0 46.9 20.7 31.7 31.4 11.8 20.1 15.5 21.3 2.1 16.4 6.4 32.5 35.2 18.3 11.1 10.3 17.2 12.9 10.2 11.0 9.7 7.9 8.4 8.8 62.5 23.5 48.4 32.4 62.4 31.1 0.6 61.1 25.4 15.9 78.5 7.9 12.3 14.9 64.0 5.7 40.2 115.3 0.0 122.5 55.2 43.7 39.9 34.5 68.4 86.5 30.2 84.6 43.0 48.7 20.1 55.0 66.1 108.0 39.7 73.5 46.8 82.6 80.7 96.2 54.7 32.0 116.4 97.8 27.9 59.2 58.5 11.6 95.8 40.0 23.7 CCDC112 MGC39633 ENSG00000164221 "Coiled-coil domain containing 112" Q8NEF3 5 115267188-115296831 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 40.4" "Cell type enhanced" "Detected in many" 12 "Spermatocytes: 227.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 50.4" "Low region specificity" "Detected in all" "HPA045120, HPA050621" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted in male reproductive system" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA045120: AB_2679222, HPA050621: AB_2681191" "unprognostic (1.88e-2)" "unprognostic (5.10e-2)" "unprognostic (4.63e-2)" "unprognostic (5.60e-3)" "unprognostic (2.95e-1)" "unprognostic (1.21e-1)" "unprognostic (2.32e-6)" "unprognostic (4.30e-2)" "unprognostic (3.24e-1)" "unprognostic (4.41e-2)" "unprognostic (3.33e-1)" "unprognostic (2.64e-1)" "prognostic unfavorable (1.51e-6)" "unprognostic (7.00e-2)" "unprognostic (2.79e-2)" "unprognostic (8.61e-2)" "unprognostic (4.10e-3)" 5.5 4.3 9.7 5.7 13.2 7.0 7.7 12.6 12.8 6.5 9.8 7.0 4.3 8.1 6.6 7.3 6.3 4.9 3.9 6.4 11.0 9.0 3.5 1.7 6.1 4.8 9.7 7.6 2.9 13.2 6.5 12.1 3.0 12.6 7.7 10.6 1.9 6.8 8.6 4.5 5.5 6.8 7.7 14.0 5.3 7.0 40.4 11.8 3.7 4.7 3.2 4.7 7.1 4.8 5.3 11.0 11.6 5.5 3.1 3.8 2.1 5.4 2.7 5.5 8.7 3.5 6.8 1.3 4.9 2.6 3.7 4.3 1.2 3.1 6.7 4.1 3.4 5.5 3.5 5.7 2.8 7.8 5.3 4.4 4.4 4.1 1.7 4.7 5.8 2.3 3.1 3.4 4.8 6.4 4.3 5.7 6.1 1.8 5.5 4.9 4.2 8.7 5.0 6.0 5.1 4.8 9.3 6.8 50.4 3.6 2.0 8.3 10.8 5.3 3.4 14.6 3.9 5.7 8.5 5.6 4.9 3.3 9.3 6.8 6.1 5.9 1.4 3.3 4.6 2.9 0.2 5.5 11.6 3.4 4.4 3.8 3.2 2.6 2.9 5.9 5.3 3.4 2.3 3.6 3.1 5.0 11.0 0.1 2.1 9.7 13.2 12.6 12.8 11.0 9.0 9.7 7.6 12.6 11.8 14.9 12.3 12.3 4.6 12.6 28.3 14.6 2.5 12.0 9.1 5.2 9.8 0.6 5.0 24.4 6.8 8.0 11.9 0.0 22.6 1.7 8.5 6.1 9.2 2.6 28.4 9.5 38.9 6.7 23.9 13.4 3.7 28.0 13.5 42.3 28.0 10.3 27.1 14.0 3.9 2.9 24.3 12.9 13.0 227.3 60.7 19.7 0.5 5.3 31.6 3.4 CCDC117 FLJ33814 ENSG00000159873 "Coiled-coil domain containing 117" Q8IWD4 22 28772674-28789301 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 75.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000826 Uncertain Approved Nucleoplasm,Microtubules,Cytosol NA NA Nucleoplasm "Microtubules, Cytosol" "HPA000826: AB_1078417" "unprognostic (1.71e-1)" "unprognostic (2.04e-2)" "unprognostic (1.61e-3)" "unprognostic (9.07e-2)" "unprognostic (3.84e-2)" "unprognostic (1.26e-1)" "unprognostic (1.62e-1)" "unprognostic (1.35e-2)" "unprognostic (8.43e-2)" "unprognostic (7.74e-2)" "unprognostic (1.08e-1)" "unprognostic (1.65e-1)" "unprognostic (1.96e-2)" "unprognostic (1.02e-1)" "unprognostic (1.34e-1)" "unprognostic (1.10e-3)" "unprognostic (8.25e-2)" 10.7 14.2 12.3 13.6 13.6 19.2 25.2 19.3 12.7 15.9 13.1 9.6 16.6 12.1 15.3 8.9 11.5 10.7 10.0 9.0 12.2 10.6 10.3 26.1 12.5 17.0 14.6 8.3 14.9 13.3 12.4 14.1 20.7 11.9 13.0 11.9 9.5 21.0 16.5 20.2 9.1 10.9 15.2 13.1 13.8 12.3 35.9 15.4 24.2 18.1 7.4 20.1 12.3 31.3 13.4 13.9 14.0 13.9 23.3 15.2 12.6 8.7 7.3 14.9 14.5 9.7 8.5 11.8 8.9 10.9 15.5 13.7 11.0 4.2 27.5 4.0 8.1 6.6 9.2 21.8 3.5 14.8 14.9 14.4 11.2 8.3 16.2 6.6 17.9 14.4 5.8 7.7 8.9 5.5 6.9 10.7 9.1 15.6 12.2 6.9 11.3 10.5 14.5 12.1 15.7 3.5 21.2 23.5 11.9 6.9 3.4 5.7 7.6 13.7 12.9 5.5 18.4 16.0 7.7 6.2 19.5 13.4 6.1 6.8 28.6 29.7 23.1 6.8 9.7 8.2 10.7 13.9 14.0 10.2 12.3 10.5 10.0 8.6 9.9 13.9 13.4 15.2 12.2 6.7 23.3 11.7 12.2 10.7 12.6 12.3 13.6 19.3 12.7 12.2 10.6 14.6 8.3 11.9 15.4 20.8 11.0 24.2 10.8 9.4 7.3 9.2 12.7 13.4 9.1 14.0 13.7 14.4 6.6 8.8 75.2 13.7 8.4 23.3 8.7 15.2 15.8 18.4 17.3 38.0 8.0 3.2 19.7 11.6 16.2 24.0 11.8 9.1 16.9 4.6 12.4 5.4 9.2 11.5 7.4 8.4 14.4 0.0 16.0 44.0 41.7 9.5 20.6 14.9 11.8 16.4 CCDC12 MGC23918 ENSG00000160799 "Coiled-coil domain containing 12" Q8WUD4 3 46921726-46982010 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056814, HPA060530" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA056814: AB_2683241, HPA060530: AB_2684309" "unprognostic (1.47e-2)" "unprognostic (1.79e-3)" "unprognostic (2.27e-1)" "unprognostic (1.32e-3)" "unprognostic (1.65e-1)" "unprognostic (4.24e-2)" "unprognostic (6.15e-2)" "unprognostic (4.27e-3)" "unprognostic (1.88e-1)" "unprognostic (4.35e-2)" "unprognostic (1.50e-2)" "unprognostic (4.08e-2)" "prognostic favorable (1.15e-4)" "unprognostic (2.06e-1)" "unprognostic (2.11e-1)" "unprognostic (8.86e-3)" "unprognostic (4.65e-2)" 11.1 14.0 7.8 10.5 9.2 15.1 8.9 13.0 10.3 17.4 13.0 6.1 35.7 11.8 12.5 14.9 50.9 8.4 23.7 11.3 8.3 7.8 10.0 9.5 15.6 13.8 8.2 6.2 9.9 11.2 5.5 8.2 9.0 7.6 14.4 6.1 7.3 52.0 56.7 48.9 16.5 10.4 10.1 7.9 11.5 13.5 6.6 5.2 6.7 9.8 19.6 27.6 11.6 13.5 54.3 55.7 31.9 39.5 31.3 40.9 29.6 17.4 14.7 17.3 9.0 9.8 8.1 13.3 17.7 9.1 13.4 9.8 19.0 15.1 34.2 16.2 10.6 19.1 9.8 14.7 16.5 5.7 33.5 11.1 37.5 21.6 28.6 13.4 40.2 26.8 10.9 15.7 17.0 15.1 10.7 13.0 22.0 40.0 17.0 6.5 21.1 31.1 38.1 22.6 17.3 12.2 13.2 13.4 21.9 13.8 18.4 9.2 17.9 21.7 18.0 16.8 8.0 13.7 40.1 26.5 9.0 17.7 18.3 28.1 22.3 48.7 42.5 12.6 28.6 12.9 11.1 37.4 31.9 40.9 38.3 32.1 54.3 31.6 35.7 35.0 53.5 27.3 32.2 11.3 31.3 39.5 55.7 38.5 29.6 7.8 9.2 13.0 9.4 8.3 7.8 8.2 6.2 7.6 5.2 74.5 47.8 116.2 114.6 70.3 51.3 44.4 56.0 52.2 50.0 76.8 51.1 113.1 94.5 89.3 3.4 66.6 110.9 23.3 109.2 94.8 57.8 77.8 80.8 48.7 87.8 55.6 76.0 52.8 65.3 6.2 54.1 66.7 43.9 106.4 65.7 64.2 89.4 132.5 45.3 73.9 75.0 38.8 61.4 17.9 50.9 95.1 139.6 102.3 79.7 187.7 CCDC122 FLJ31846 ENSG00000151773 "Coiled-coil domain containing 122" Q5T0U0 13 43823909-43879727 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 11.4;hTERT-HME1: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034233, HPA054995, HPA061456" Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "CAB034233: AB_2228702, HPA054995: AB_2682665, HPA061456: AB_2684527" "unprognostic (1.74e-1)" "unprognostic (6.82e-2)" "unprognostic (1.07e-1)" "unprognostic (1.67e-2)" "unprognostic (1.39e-2)" "unprognostic (1.68e-2)" "unprognostic (1.30e-1)" "unprognostic (1.51e-1)" "unprognostic (5.28e-2)" "unprognostic (2.79e-2)" "unprognostic (1.30e-3)" "unprognostic (2.74e-1)" "unprognostic (1.16e-2)" "unprognostic (2.14e-2)" "unprognostic (3.79e-2)" "unprognostic (1.32e-1)" "unprognostic (6.75e-2)" 4.3 6.7 5.0 8.5 9.5 1.8 7.5 2.4 5.6 5.5 5.5 7.2 8.8 3.3 8.0 10.7 4.5 8.6 5.9 8.3 6.1 5.0 10.4 5.7 5.5 4.6 9.8 5.8 12.2 6.9 8.4 15.6 8.2 6.0 9.8 6.9 3.6 5.7 4.8 3.3 7.8 7.3 9.8 6.4 7.7 5.8 9.7 11.0 5.2 10.9 4.5 4.7 6.2 11.8 3.6 3.0 6.4 2.6 3.6 1.9 1.0 2.2 1.8 0.8 0.0 0.7 4.5 2.3 5.9 6.5 3.0 3.4 3.2 8.0 3.6 3.3 3.5 5.2 3.5 0.8 0.9 4.3 5.8 2.8 1.5 1.0 1.8 8.6 0.9 0.4 11.4 7.2 4.5 11.8 2.6 1.5 1.5 0.0 1.1 4.2 2.7 0.5 0.6 1.0 0.5 1.9 0.8 0.0 1.9 4.7 1.3 2.1 3.1 3.9 0.1 3.5 4.8 0.7 0.6 6.9 0.2 0.8 5.3 0.0 0.0 0.0 1.6 3.0 0.1 3.1 6.4 1.6 2.4 1.3 1.4 1.6 2.4 1.9 1.4 1.2 3.6 1.3 1.4 3.9 3.6 2.6 3.0 1.7 1.0 5.0 9.5 2.4 5.6 6.1 5.0 9.8 5.8 6.0 11.0 8.9 9.4 2.7 7.8 2.7 1.5 11.2 7.6 25.4 11.4 7.0 0.0 14.2 16.6 10.3 2.0 5.8 4.4 0.0 9.0 8.0 6.1 7.9 1.1 3.9 1.8 9.5 17.3 7.4 2.2 0.4 16.4 2.5 1.7 1.0 9.1 12.3 7.2 0.0 7.4 8.7 0.6 0.0 5.1 20.5 23.7 3.3 6.6 1.3 8.1 5.9 CCDC125 KENAE ENSG00000183323 "Coiled-coil domain containing 125" Q86Z20 5 69280175-69332809 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 87.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 5.8;eosinophil: 13.0;neutrophil: 10.9" "Lineage enriched" "Detected in many" 6 "granulocytes: 13.0" "Cell line enhanced" "Detected in many" "T-47d: 19.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA041878 Approved Uncertain "Nucleoplasm,Nuclear membrane,Intermediate filaments" NA NA "Nuclear membrane, Intermediate filaments" Nucleoplasm "HPA041878: AB_10796787" "prognostic unfavorable (8.06e-4)" "unprognostic (1.01e-1)" "unprognostic (2.35e-2)" "prognostic favorable (4.40e-4)" "unprognostic (1.05e-1)" "unprognostic (1.91e-2)" "unprognostic (8.21e-2)" "unprognostic (3.08e-2)" "unprognostic (4.06e-2)" "unprognostic (5.07e-2)" "unprognostic (2.52e-2)" "unprognostic (1.91e-2)" "unprognostic (2.05e-2)" "unprognostic (5.40e-2)" "unprognostic (4.68e-2)" "unprognostic (2.52e-2)" "prognostic favorable (2.51e-4)" 4.3 6.1 4.9 6.1 5.6 13.6 10.0 4.9 4.7 4.1 7.9 5.8 7.8 6.7 5.9 4.0 6.6 5.5 10.0 3.0 4.8 4.9 5.0 17.6 5.8 6.2 6.4 4.9 4.8 14.9 4.2 10.4 5.5 6.7 10.1 7.9 3.6 15.9 12.3 2.8 5.3 10.6 4.5 4.7 5.2 8.3 3.4 4.1 3.1 5.5 4.7 5.5 7.3 5.6 0.9 1.5 13.0 2.3 1.1 1.1 0.8 2.1 3.6 0.7 10.1 1.2 0.7 13.0 1.3 1.9 0.9 0.5 3.2 10.9 3.9 7.6 1.4 0.8 2.8 7.4 3.8 0.8 13.6 5.9 2.5 5.8 6.1 3.1 2.6 1.4 4.2 1.9 4.2 1.3 2.1 1.4 4.7 7.2 1.7 0.7 8.7 3.4 4.3 0.1 2.8 2.3 5.0 0.0 5.3 5.0 2.5 4.2 2.7 2.6 5.9 1.9 0.1 19.4 2.8 1.7 0.8 1.5 2.5 2.0 7.9 12.1 1.5 2.6 14.5 0.4 5.8 1.1 13.0 1.1 0.9 0.9 0.9 1.0 0.8 1.5 0.9 0.9 0.5 10.9 1.1 2.3 1.2 0.7 0.8 4.9 5.6 4.9 4.7 4.8 4.9 6.4 4.9 6.7 4.1 23.8 14.8 4.2 3.6 0.9 4.4 5.5 5.1 87.0 19.4 1.8 2.0 26.8 5.0 10.6 0.8 2.9 9.3 0.0 10.4 6.6 1.3 8.6 15.1 15.3 5.4 3.2 1.2 1.8 4.5 1.5 2.0 3.9 1.7 8.2 12.3 5.4 7.8 13.5 2.1 6.9 7.4 0.0 1.4 1.4 2.3 0.9 10.4 3.1 7.4 4.6 CCDC127 FLJ25701 ENSG00000164366 "Coiled-coil domain containing 127" Q96BQ5 5 196871-218215 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 25.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045052 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA045052: AB_10960630" "prognostic unfavorable (7.01e-4)" "unprognostic (4.26e-2)" "unprognostic (1.93e-2)" "unprognostic (9.18e-2)" "unprognostic (2.78e-3)" "unprognostic (2.65e-2)" "prognostic unfavorable (4.04e-6)" "unprognostic (2.41e-1)" "unprognostic (1.57e-1)" "unprognostic (9.62e-2)" "unprognostic (3.43e-3)" "unprognostic (1.13e-1)" "prognostic unfavorable (5.95e-5)" "unprognostic (2.42e-1)" "unprognostic (9.06e-2)" "unprognostic (1.07e-1)" "unprognostic (2.87e-1)" 10.3 14.3 10.3 7.3 13.0 3.8 9.7 14.0 16.2 10.7 10.0 10.6 8.2 8.7 11.6 7.7 13.4 10.5 12.7 16.3 9.8 11.8 8.1 6.8 6.9 12.4 12.0 9.8 15.3 8.6 5.0 14.9 10.2 13.9 10.5 4.1 10.5 8.1 6.1 18.4 12.4 10.1 8.1 9.5 7.2 9.4 11.1 12.2 9.6 23.5 7.4 5.2 9.9 7.9 9.0 8.1 7.2 5.3 8.6 11.0 5.3 4.0 5.3 6.0 10.9 7.3 5.6 5.9 7.8 4.0 3.5 3.5 5.6 8.5 8.5 11.4 3.6 4.6 5.4 3.7 3.0 3.4 21.6 6.6 3.0 25.0 4.9 4.3 2.4 5.5 4.6 4.9 3.3 2.3 8.4 2.9 4.7 4.9 3.0 3.7 3.2 4.2 4.8 5.1 2.4 6.9 5.0 4.4 6.9 6.6 4.1 6.7 10.5 10.8 7.5 7.1 5.0 9.8 4.5 6.6 9.0 5.3 3.6 3.2 5.0 4.2 5.8 5.8 4.2 5.6 4.6 4.5 7.2 8.1 5.3 8.7 9.0 8.3 9.6 4.5 8.8 9.8 11.0 2.9 8.6 4.7 8.1 6.2 5.3 10.3 13.0 14.0 14.7 9.8 11.8 12.0 9.8 13.9 12.2 14.9 7.2 7.0 12.0 12.6 16.5 23.8 7.6 18.7 9.1 5.2 17.7 27.5 3.3 24.3 5.1 15.1 8.1 0.0 13.3 19.7 13.2 13.4 9.2 11.9 17.2 36.5 8.1 15.4 6.9 6.5 19.2 10.3 8.5 29.7 7.7 29.9 13.9 2.9 18.7 7.5 26.8 12.9 9.5 20.9 31.3 6.9 25.2 12.8 6.8 10.6 CCDC129 FLJ38344 ENSG00000180347 "Coiled-coil domain containing 129" Q6ZRS4 7 31514071-31658720 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 17.2;salivary gland: 10.9" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 8.2;Intestinal endocrine cells: 1.7;Late spermatids: 5.2" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "cerebellum: 7.9;midbrain: 5.0;pons and medulla: 17.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 1.6;CACO-2: 1.3;RH-30: 2.1;T-47d: 2.7;U-2 OS: 5.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA024103 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA024103: AB_1846132" "unprognostic (1.11e-2)" "unprognostic (1.39e-1)" "unprognostic (1.57e-1)" "unprognostic (1.78e-5)" "unprognostic (9.72e-3)" "unprognostic (1.78e-1)" "unprognostic (3.89e-2)" "unprognostic (6.42e-3)" "unprognostic (1.01e-1)" "unprognostic (5.77e-2)" "unprognostic (1.77e-2)" "unprognostic (1.10e-1)" "unprognostic (1.99e-1)" "unprognostic (1.53e-1)" 0.1 0.0 0.1 0.6 2.0 0.1 3.3 7.9 0.3 3.7 0.9 1.2 0.0 2.1 1.1 0.2 0.1 0.1 0.1 0.0 0.4 1.4 0.1 0.0 0.4 0.0 5.0 0.0 0.0 0.2 0.0 0.4 0.9 17.2 0.1 0.2 0.0 10.9 0.0 0.0 4.5 0.9 1.1 0.2 0.0 0.8 2.7 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.8 0.8 1.1 0.0 0.1 1.0 0.1 0.0 0.0 1.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.5 0.8 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.2 0.2 0.1 2.1 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.2 2.7 0.0 0.0 0.0 5.6 0.2 0.3 0.2 0.1 0.2 0.0 0.1 0.0 0.3 0.0 0.1 0.2 0.0 0.1 0.7 0.2 0.1 0.1 0.8 1.0 0.4 1.1 0.1 0.0 0.8 0.0 0.1 0.1 2.0 7.9 0.3 0.4 1.4 5.0 0.0 17.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 5.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 CCDC138 FLJ32745 ENSG00000163006 "Coiled-coil domain containing 138" Q96M89 2 108786757-108885477 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Ciliated cells: 57.6;Early spermatids: 83.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049899, HPA054223" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA049899: AB_2680941, HPA054223: AB_2682420" "unprognostic (2.34e-1)" "unprognostic (3.74e-2)" "unprognostic (3.22e-2)" "unprognostic (3.04e-1)" "unprognostic (2.83e-2)" "unprognostic (1.64e-2)" "unprognostic (2.24e-5)" "unprognostic (2.89e-1)" "unprognostic (1.01e-4)" "unprognostic (2.56e-1)" "unprognostic (1.64e-1)" "unprognostic (5.77e-2)" "unprognostic (7.06e-4)" "unprognostic (7.88e-2)" "unprognostic (4.73e-2)" "unprognostic (2.69e-1)" "unprognostic (8.93e-2)" 2.6 2.5 5.7 5.0 7.0 6.1 4.8 13.5 8.2 3.1 3.9 4.9 1.6 2.1 6.0 2.8 5.5 8.6 3.8 2.3 6.8 5.0 3.6 5.5 2.8 8.1 4.3 5.1 3.7 3.5 2.3 7.4 2.8 8.0 3.1 4.8 1.9 3.3 2.1 2.1 4.8 3.4 3.3 6.4 3.2 3.7 19.4 6.5 19.5 2.3 2.9 7.2 4.3 6.1 5.4 8.1 3.1 2.1 3.2 4.8 2.4 8.3 3.8 13.2 6.8 1.1 1.2 8.4 3.6 1.1 8.7 6.3 12.4 4.9 20.0 5.4 1.1 4.3 7.1 9.5 4.9 7.8 4.6 12.3 9.2 7.2 10.3 1.3 12.6 1.4 0.8 1.5 10.2 3.0 1.3 4.5 8.7 17.5 9.3 4.4 4.6 17.9 8.6 19.6 4.5 4.0 11.9 12.5 12.2 4.8 6.6 9.3 9.1 7.9 4.3 6.3 8.5 4.6 6.1 2.8 5.5 9.7 3.5 7.6 2.9 6.7 20.9 2.3 9.8 5.4 3.1 0.9 1.3 2.1 2.1 3.9 5.1 2.8 4.0 0.9 5.4 4.1 4.8 0.5 3.2 0.8 8.1 4.1 2.4 5.7 7.0 13.5 8.2 6.8 5.0 4.3 5.1 8.0 6.5 0.0 3.5 2.9 3.2 2.2 7.3 0.8 0.0 57.6 12.5 1.8 7.9 3.8 1.7 3.0 83.9 2.2 0.5 0.0 1.2 4.4 3.0 0.9 4.6 1.8 1.9 6.4 5.2 1.3 0.6 22.1 3.4 1.3 1.7 1.0 2.1 1.5 2.7 0.0 1.8 1.7 6.9 0.0 2.3 18.5 21.2 2.5 1.1 4.3 2.6 2.4 CCDC141 "CAMDI, FLJ39502" ENSG00000163492 "Coiled-coil domain containing 141" 2 178829757-179050086 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "heart muscle: 47.5;lung: 17.6" "Cell type enhanced" "Detected in many" 22 "Alveolar cells type 2: 19.8;Cardiomyocytes: 103.0;Early spermatids: 34.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "T-reg: 12.9" "Group enriched" "Detected in many" 9 "B-cells: 7.6;T-cells: 12.9" "Cell line enhanced" "Detected in some" "CACO-2: 6.4;Daudi: 4.1;HEL: 9.5;RH-30: 5.1;U-266/70: 6.1;U-698: 8.5" HPA012718 Approved Nucleoplasm NA NA Nucleoplasm "HPA012718: AB_2072055" "unprognostic (1.58e-1)" "unprognostic (1.85e-2)" "unprognostic (3.10e-2)" "unprognostic (2.37e-1)" "unprognostic (8.62e-3)" "unprognostic (4.25e-2)" "unprognostic (2.98e-2)" "unprognostic (2.51e-1)" "unprognostic (1.40e-1)" "unprognostic (1.74e-2)" "unprognostic (5.33e-2)" "unprognostic (8.03e-3)" "unprognostic (7.71e-8)" "unprognostic (2.50e-2)" "unprognostic (1.52e-1)" "unprognostic (1.95e-1)" "unprognostic (1.53e-1)" 1.6 0.6 0.5 7.5 0.6 0.9 4.9 0.5 0.5 0.7 1.2 0.1 0.5 0.2 0.8 2.2 2.5 0.6 6.3 47.5 0.6 0.6 0.5 0.5 17.6 4.4 0.6 0.0 0.8 3.8 0.2 0.5 0.8 1.1 1.0 0.3 1.8 0.6 0.3 9.3 0.5 0.7 1.7 0.7 1.8 0.6 1.6 0.0 11.0 0.7 2.1 7.4 1.4 1.2 7.6 0.0 0.4 0.0 1.1 12.9 0.4 0.2 0.0 0.1 0.3 0.0 0.1 2.0 0.0 0.1 0.0 0.2 6.4 0.5 4.1 0.1 0.0 0.1 0.2 0.1 0.0 0.0 3.5 0.2 9.5 0.3 0.0 0.0 1.7 0.5 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.1 1.6 0.1 0.1 0.1 0.3 3.4 0.6 0.7 0.2 5.1 1.6 0.0 0.1 0.2 0.2 0.1 0.3 0.1 1.1 0.3 0.4 0.1 0.3 0.2 0.3 0.0 6.1 0.1 8.5 0.3 0.5 0.6 0.3 0.0 0.2 0.3 0.0 0.2 6.6 2.1 1.4 0.0 7.6 6.4 4.8 0.4 1.1 0.0 0.0 12.9 0.4 0.5 0.6 0.5 0.5 0.6 0.6 0.6 0.0 1.1 0.0 6.0 19.8 0.5 0.0 0.1 1.4 103.0 10.2 2.7 1.2 0.0 0.0 0.0 0.0 2.5 34.6 3.6 0.0 0.0 1.2 0.2 0.4 0.0 5.8 0.0 0.0 6.4 0.0 0.0 0.3 12.9 1.1 0.8 1.7 0.0 0.0 3.8 0.2 0.0 1.8 0.0 0.6 6.5 1.4 0.0 0.2 0.1 0.0 5.0 0.0 0.1 CCDC144A "FLJ43983, KIAA0565" ENSG00000170160 "Coiled-coil domain containing 144A" A2RUR9 17 16689537-16777881 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 44.4" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 52.2;Cone photoreceptor cells: 51.1;Early spermatids: 46.7;Rod photoreceptor cells: 51.7;Spermatocytes: 128.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 11.1;TIME: 9.4" "HPA022996, HPA047220, HPA047851, HPA066260" Enhanced Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA022996: AB_1846136, HPA047220: AB_2679989, HPA047851: AB_2680182, HPA066260: " "unprognostic (8.54e-2)" "unprognostic (4.49e-3)" "unprognostic (1.07e-1)" "unprognostic (8.34e-2)" "unprognostic (1.10e-1)" "unprognostic (2.18e-2)" "unprognostic (1.57e-1)" "unprognostic (5.69e-2)" "unprognostic (6.95e-2)" "unprognostic (2.60e-2)" "unprognostic (2.73e-1)" "unprognostic (1.43e-1)" "unprognostic (2.54e-1)" "unprognostic (9.49e-2)" "unprognostic (3.32e-1)" "unprognostic (1.41e-1)" "unprognostic (1.74e-1)" 3.7 1.9 2.5 2.7 3.5 5.5 2.7 12.0 3.6 2.1 3.1 2.8 0.4 0.9 5.4 3.9 1.3 2.6 1.7 2.5 4.7 0.8 1.0 1.5 2.8 2.3 4.3 1.8 7.3 5.4 0.2 16.7 3.7 10.3 3.0 1.4 1.7 2.2 1.5 2.4 3.7 2.0 2.5 4.2 2.4 2.2 44.4 2.8 2.4 1.8 0.4 1.5 2.8 4.9 1.0 0.8 0.8 1.3 1.0 3.8 0.0 0.6 3.9 0.9 2.4 3.5 11.1 0.4 0.2 0.0 0.2 0.2 4.9 0.1 0.5 3.4 6.8 0.3 6.0 5.0 0.3 0.3 3.5 0.3 0.5 0.5 0.4 0.2 0.7 3.2 2.0 0.1 2.3 0.2 1.1 0.1 0.2 0.5 0.3 2.2 0.2 0.1 1.2 0.8 1.0 0.4 1.5 0.2 0.1 0.1 4.7 1.3 1.4 0.7 0.2 1.4 2.0 4.0 0.2 9.4 0.8 0.5 5.3 1.5 6.7 6.9 0.2 0.4 7.0 1.8 0.7 0.6 0.3 2.2 0.5 1.4 1.0 2.1 1.4 0.4 0.5 3.8 1.9 0.8 1.0 1.3 0.8 2.1 0.0 2.5 3.5 12.0 3.6 4.7 0.8 4.3 1.8 10.3 2.8 0.0 9.3 3.0 6.4 3.5 52.2 2.5 2.5 5.3 2.3 0.0 51.1 4.2 0.0 1.6 46.7 6.5 1.3 0.0 0.0 5.8 8.2 6.7 25.4 1.7 3.5 31.8 1.2 3.7 5.1 2.9 6.6 4.9 5.0 0.0 2.0 8.3 2.2 3.4 8.5 0.5 51.7 6.5 5.7 128.1 36.1 3.1 1.6 6.9 1.6 5.1 CCDC144NL MGC87631 ENSG00000205212 "Coiled-coil domain containing 144 family, N-terminal like" Q6NUI1 17 20836447-20896140 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "brain: 13.1;testis: 10.6" "Group enriched" "Detected in some" 4 "Early spermatids: 7.2;Rod photoreceptor cells: 7.5;Spermatocytes: 25.8;Spermatogonia: 7.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.2" "Lineage enriched" "Detected in single" 5 "T-cells: 1.2" "Cell line enriched" "Detected in some" 5 "U-2 OS: 26.7" HPA023457 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA023457: AB_2671217" "unprognostic (1.29e-1)" "unprognostic (6.71e-2)" "unprognostic (1.21e-1)" "unprognostic (3.53e-1)" "unprognostic (7.53e-2)" "unprognostic (5.17e-2)" "unprognostic (6.33e-2)" "unprognostic (1.08e-1)" "unprognostic (1.22e-1)" "unprognostic (2.28e-1)" 0.3 0.9 0.9 0.2 13.1 0.5 1.0 2.4 6.6 0.3 0.4 1.4 0.0 0.5 1.5 0.3 0.3 0.9 0.2 0.5 1.2 1.1 0.3 0.6 0.5 0.5 1.7 1.4 1.3 0.4 0.2 1.2 0.8 4.5 1.6 0.5 0.6 0.3 1.8 0.8 0.3 0.2 1.2 4.5 0.4 0.5 10.6 0.0 0.4 0.4 0.0 0.7 0.9 0.2 0.0 0.1 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 2.4 0.0 0.0 26.7 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.0 1.2 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.9 13.1 2.4 6.6 1.2 1.1 1.7 1.4 4.5 0.0 0.0 0.3 0.0 0.6 0.2 1.7 0.4 0.0 0.0 0.0 0.0 2.0 0.5 0.0 0.0 7.2 0.7 0.0 0.0 0.0 1.6 0.9 0.5 0.0 0.0 0.4 1.6 1.2 0.0 0.0 1.3 2.8 0.3 1.7 0.0 0.0 1.4 0.1 0.0 1.1 0.3 7.5 0.0 0.9 25.8 7.3 0.3 0.1 0.0 0.0 0.4 CCDC148 MGC125588 ENSG00000153237 "Coiled-coil domain containing 148" Q8NFR7 2 158171081-158456753 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 5.9;testis: 6.5" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 40.2;Cone photoreceptor cells: 53.0;Early spermatids: 22.4;Rod photoreceptor cells: 29.6" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 9 "basophil: 1.9" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.1;HBF TERT88: 4.3;hTEC/SVTERT24-B: 2.8;RPTEC TERT1: 3.3;SCLC-21H: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042626 Uncertain Uncertain "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA042626: AB_10806244" "unprognostic (1.88e-1)" "unprognostic (5.90e-2)" "unprognostic (3.31e-2)" "unprognostic (1.94e-4)" "unprognostic (3.29e-1)" "unprognostic (7.65e-2)" "unprognostic (1.23e-1)" "unprognostic (1.32e-1)" "unprognostic (1.09e-1)" "unprognostic (7.98e-2)" "unprognostic (1.84e-1)" "unprognostic (1.18e-1)" "unprognostic (1.42e-2)" "unprognostic (5.77e-2)" "unprognostic (3.35e-2)" "prognostic favorable (2.54e-4)" "unprognostic (6.57e-3)" 0.1 0.5 0.6 0.0 0.8 0.0 1.8 1.9 0.3 1.4 0.0 0.0 0.6 2.4 0.0 3.3 0.4 0.0 0.7 0.8 4.3 0.1 0.6 0.0 0.5 1.3 0.1 5.9 1.9 0.0 0.4 0.0 1.0 0.7 0.0 0.2 0.0 0.0 1.0 0.0 0.0 6.5 1.8 0.0 0.1 0.3 0.0 0.0 1.9 0.0 0.0 0.2 0.0 1.3 0.0 0.8 1.0 0.0 0.0 0.1 0.9 0.0 1.1 2.3 1.1 6.1 0.1 0.1 0.9 0.4 0.5 0.0 0.3 4.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.4 0.4 0.0 0.2 0.0 0.1 0.5 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 3.3 0.4 4.2 0.2 0.3 0.4 0.5 1.3 2.4 0.3 0.0 0.4 0.5 0.1 0.2 0.6 0.7 0.0 1.0 0.0 0.4 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 2.2 0.0 9.1 2.0 0.0 40.2 3.4 7.0 53.0 0.0 11.6 5.6 22.4 0.2 0.0 0.0 1.6 0.0 0.5 0.8 0.0 1.0 0.1 4.8 0.0 1.8 0.0 3.8 0.9 0.0 0.0 1.0 0.0 5.2 3.4 0.0 1.8 4.8 29.6 6.5 0.3 7.5 1.5 0.4 0.0 0.0 0.0 1.6 CCDC150 FLJ39660 ENSG00000144395 "Coiled-coil domain containing 150" Q8NCX0 2 196639554-196763490 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 6.7;testis: 11.9" "Group enriched" "Detected in many" 4 "Early spermatids: 24.9;Late spermatids: 16.8;Melanocytes: 6.8;Proximal tubular cells: 9.8;Spermatocytes: 26.5;Spermatogonia: 13.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 7.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA048104 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA048104: AB_2680264" "unprognostic (1.92e-1)" "unprognostic (3.75e-1)" "unprognostic (2.95e-1)" "unprognostic (2.58e-4)" "unprognostic (9.88e-2)" "unprognostic (1.42e-3)" "unprognostic (1.59e-2)" "unprognostic (1.62e-1)" "unprognostic (5.91e-4)" "unprognostic (2.01e-2)" "unprognostic (3.16e-2)" "unprognostic (9.17e-3)" "unprognostic (5.66e-4)" "unprognostic (7.29e-2)" "unprognostic (1.99e-2)" "unprognostic (4.35e-2)" "unprognostic (2.69e-5)" 0.5 0.4 1.0 2.9 5.2 1.5 0.5 2.6 3.1 0.4 1.0 2.4 0.0 0.6 0.5 0.6 1.6 0.6 0.6 0.5 1.3 0.5 6.7 3.4 0.5 0.8 3.1 0.3 0.5 0.5 0.5 1.0 0.7 2.9 0.4 0.9 0.1 0.4 0.2 0.6 0.6 0.8 1.2 3.1 0.6 0.6 11.9 3.9 3.9 0.4 2.9 2.1 0.6 0.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.6 0.6 7.2 4.6 0.2 0.4 3.2 1.6 0.8 1.3 3.4 2.4 1.5 1.2 0.9 1.3 1.1 2.1 2.9 1.3 3.3 6.6 4.1 2.5 3.5 3.9 0.0 1.3 1.1 0.0 0.2 1.6 0.9 0.4 0.8 2.5 3.2 3.0 0.9 0.7 1.2 2.1 4.1 0.5 1.7 2.7 1.2 0.9 0.5 0.7 7.9 1.4 1.2 0.7 0.3 4.0 1.1 0.8 1.4 2.5 2.1 2.3 1.4 1.3 1.3 2.1 1.0 1.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.0 5.2 2.6 3.1 1.3 0.5 3.1 0.3 2.9 3.9 3.0 1.7 0.8 1.5 1.3 3.9 1.6 0.0 4.0 0.0 0.0 2.0 1.1 1.7 0.3 24.9 1.1 0.0 0.0 0.3 1.7 2.5 1.4 3.5 3.9 1.0 1.6 0.0 1.3 1.0 16.8 1.4 1.5 6.8 0.0 0.7 1.6 0.4 0.2 1.8 9.8 0.7 0.0 0.9 26.5 13.8 0.9 0.6 0.8 1.1 1.1 CCDC151 MGC20983 ENSG00000198003 "Coiled-coil domain containing 151" A5D8V7 19 11420604-11435782 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.7;fallopian tube: 18.2" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 30.8;Distal tubular cells: 24.9;Kupffer cells: 37.0;Muller glia cells: 30.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.3;memory B-cell: 1.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "SCLC-21H: 4.1;T-47d: 9.4;U-87 MG: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA044184, HPA054626" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA044184: AB_10959331, HPA054626: AB_2682547" "unprognostic (1.50e-1)" "unprognostic (6.59e-2)" "unprognostic (2.05e-3)" "unprognostic (4.41e-3)" "unprognostic (1.35e-2)" "unprognostic (6.30e-2)" "unprognostic (4.41e-3)" "unprognostic (2.32e-2)" "unprognostic (2.22e-1)" "unprognostic (5.09e-2)" "unprognostic (6.76e-4)" "unprognostic (3.01e-1)" "unprognostic (2.63e-3)" "unprognostic (4.27e-2)" "unprognostic (1.85e-1)" "unprognostic (2.35e-1)" "unprognostic (2.05e-1)" 0.8 3.1 5.7 0.6 9.9 0.6 0.6 4.4 7.7 1.6 0.6 4.0 1.4 0.6 1.0 2.8 0.6 18.2 0.6 1.2 7.7 4.3 2.0 0.8 2.7 0.6 2.3 4.6 2.5 0.6 9.8 10.4 1.4 12.7 0.8 0.6 0.7 4.0 1.8 0.5 0.5 0.6 0.6 1.7 1.9 0.9 8.5 5.4 0.0 2.1 0.0 0.7 0.6 0.4 1.5 0.7 0.1 2.3 0.0 0.0 0.1 0.5 0.1 1.2 0.1 0.1 0.4 1.0 0.5 0.1 0.6 0.7 0.1 0.0 0.3 0.5 0.2 2.3 0.2 0.9 0.5 0.0 1.0 1.0 0.4 0.6 0.0 0.5 0.0 0.5 0.3 0.0 0.6 0.0 1.0 0.0 0.2 0.0 0.9 0.2 0.8 0.0 0.1 0.5 0.3 2.2 0.4 0.1 1.4 0.7 0.0 4.1 2.7 1.2 0.2 0.1 0.5 9.4 0.4 0.0 1.5 0.3 3.5 0.1 3.4 2.7 0.2 3.7 0.6 0.1 0.0 0.6 0.0 0.0 2.3 0.0 1.5 0.0 0.0 0.7 0.4 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.1 5.7 9.9 4.4 7.7 7.7 4.3 2.3 4.6 12.7 5.4 0.0 0.0 3.0 0.6 0.8 0.9 1.2 2.5 30.8 3.4 12.2 0.0 0.4 24.9 0.2 9.6 0.9 0.0 0.0 0.2 0.4 4.3 0.1 4.6 0.5 4.1 1.6 0.0 12.3 37.0 11.5 2.6 3.0 6.8 0.0 0.0 30.6 0.1 0.0 0.7 0.5 2.7 6.5 5.1 15.3 2.9 0.4 1.0 0.0 0.0 0.3 CCDC152 LOC100129792 ENSG00000198865 "Coiled-coil domain containing 152" Q4G0S7 5 42756801-42802360 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 52.8;pituitary gland: 24.3" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 56.6;Muller glia cells: 33.6;Spermatocytes: 65.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 10.6;JURKAT: 10.6;U-2 OS: 19.2;U-266/84: 12.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA036240 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036240: AB_10671242" "unprognostic (1.83e-1)" "unprognostic (2.00e-2)" "unprognostic (3.14e-2)" "unprognostic (1.44e-3)" "unprognostic (3.24e-3)" "unprognostic (1.71e-2)" "unprognostic (2.88e-1)" "unprognostic (6.25e-3)" "unprognostic (9.08e-2)" "unprognostic (1.16e-1)" "unprognostic (7.29e-2)" "unprognostic (9.13e-2)" "unprognostic (1.02e-1)" "unprognostic (2.33e-3)" "unprognostic (5.40e-2)" "unprognostic (4.63e-2)" "unprognostic (2.14e-3)" 4.0 6.0 7.5 2.5 10.2 1.6 3.0 1.0 8.4 2.1 2.3 4.1 0.5 5.0 2.7 1.9 2.0 1.6 6.1 4.6 7.1 3.2 3.6 52.8 3.2 8.6 4.9 5.5 8.2 2.1 0.0 24.3 2.8 20.9 2.1 0.3 1.9 2.1 0.3 1.5 3.1 12.4 0.6 8.8 6.9 1.9 5.7 8.5 8.5 1.7 0.5 3.0 2.9 3.1 3.6 10.0 0.3 0.7 6.2 6.1 1.3 0.3 0.1 0.8 0.1 2.7 3.5 0.0 4.6 0.1 0.0 0.3 0.0 0.2 0.0 0.3 2.0 3.4 3.6 0.0 0.0 0.4 0.0 0.3 0.2 10.6 4.4 2.7 0.1 0.0 4.4 0.0 1.9 0.0 7.0 1.4 10.6 0.5 1.1 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.3 5.3 0.0 0.1 0.0 4.2 0.4 0.1 0.1 0.2 19.2 4.4 0.1 0.1 12.8 0.1 5.6 0.1 0.1 0.1 0.1 0.1 4.0 0.7 4.9 2.2 3.0 5.0 0.7 3.6 4.0 6.1 0.3 6.2 0.3 10.0 1.9 1.3 7.5 10.2 1.0 8.4 7.1 3.2 4.9 5.5 20.9 8.5 56.6 31.3 4.9 0.2 3.3 13.9 8.1 0.0 6.7 13.6 1.8 0.0 1.3 0.0 0.6 5.7 3.5 2.3 0.0 1.0 1.0 10.4 0.3 9.2 4.0 2.3 31.8 1.2 4.9 10.5 5.3 6.1 2.9 3.3 1.0 2.5 33.6 2.0 2.9 7.1 0.5 2.2 0.0 6.6 65.5 22.6 3.4 1.5 10.9 1.2 0.3 CCDC159 ENSG00000183401 "Coiled-coil domain containing 159" P0C7I6 19 11344684-11354944 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 270.6;Late spermatids: 182.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 21.8" "Low region specificity" "Detected in all" "HPA047126, HPA054655" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA047126: AB_10961722, HPA054655: AB_2682558" "unprognostic (1.46e-1)" "unprognostic (3.05e-3)" "unprognostic (2.35e-3)" "prognostic favorable (1.87e-7)" "unprognostic (5.02e-2)" "unprognostic (1.06e-3)" "unprognostic (9.23e-3)" "unprognostic (2.40e-2)" "unprognostic (6.68e-2)" "prognostic favorable (9.46e-4)" "prognostic favorable (1.42e-4)" "unprognostic (2.89e-1)" "unprognostic (3.97e-2)" "unprognostic (5.09e-2)" "unprognostic (2.46e-1)" "unprognostic (3.00e-2)" "prognostic favorable (8.62e-4)" 7.9 24.6 21.0 13.4 35.1 22.2 10.9 15.5 28.6 14.8 12.9 30.6 28.3 17.8 13.9 21.1 11.8 14.2 19.0 13.6 22.8 11.9 13.4 18.9 12.8 14.7 38.5 22.9 19.2 15.1 34.3 20.8 7.3 28.0 24.7 9.5 17.7 14.5 17.4 6.3 14.6 14.3 12.5 24.2 24.1 16.1 28.2 43.5 7.5 17.8 8.5 11.2 13.7 12.6 9.9 16.5 21.2 28.0 15.7 15.2 11.8 2.2 2.0 1.7 5.2 6.8 9.9 1.7 3.7 3.9 4.4 5.9 0.6 2.4 1.9 9.6 7.0 1.3 1.9 1.0 5.9 2.7 9.2 1.4 4.5 1.6 2.4 12.0 1.7 6.8 11.8 15.6 3.2 4.3 4.6 12.3 3.4 4.0 21.8 2.2 2.8 2.7 3.6 0.9 3.1 7.4 3.0 0.0 12.2 4.0 3.2 0.7 2.8 3.7 4.3 6.8 3.2 6.3 7.5 8.1 3.5 1.0 6.0 3.4 20.0 4.8 3.8 4.7 9.2 5.0 21.2 28.0 19.1 12.1 23.6 11.7 8.1 8.2 11.0 16.5 9.9 7.5 5.9 13.2 15.7 16.4 4.3 15.2 11.8 21.0 35.1 15.5 28.6 22.8 11.9 38.5 22.9 28.0 43.5 14.9 9.9 9.0 13.1 6.6 11.2 9.8 12.7 21.4 14.8 17.4 39.3 4.9 21.6 7.6 270.6 9.1 14.8 0.0 8.4 4.4 8.4 23.8 33.5 9.6 20.4 6.4 10.4 12.9 26.0 182.1 10.6 15.7 11.8 13.6 10.6 14.8 7.5 23.0 12.7 31.6 28.9 0.0 8.2 4.8 3.8 7.0 5.0 21.5 8.1 17.5 CCDC171 "bA536D16.1, bA778P13.1, C9orf93, Em:AL513423.1, FLJ39267, FLJ46740" ENSG00000164989 "Coiled-coil domain containing 171" Q6TFL3 9 15553086-16061663 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 152.4;Late spermatids: 134.7;Rod photoreceptor cells: 44.6;Spermatocytes: 149.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 9.5;HEL: 14.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA019803, HPA019806, HPA024133" Uncertain Approved Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA019803: AB_1845846, HPA019806: AB_1845847, HPA024133: AB_1845848" "unprognostic (1.35e-2)" "unprognostic (2.03e-4)" "unprognostic (7.22e-3)" "unprognostic (1.16e-1)" "unprognostic (1.43e-1)" "unprognostic (1.09e-1)" "unprognostic (1.51e-2)" "unprognostic (2.05e-2)" "unprognostic (2.18e-1)" "unprognostic (6.76e-3)" "unprognostic (5.37e-2)" "unprognostic (1.28e-1)" "unprognostic (2.92e-3)" "unprognostic (7.80e-2)" "unprognostic (4.90e-2)" "unprognostic (1.15e-1)" "unprognostic (6.91e-3)" 2.5 2.5 5.8 5.5 7.5 4.0 3.6 8.2 7.8 4.1 2.4 1.1 6.9 1.9 11.6 5.8 2.4 4.6 3.4 2.6 4.9 4.1 2.8 1.3 2.5 2.4 3.4 7.6 6.3 3.4 4.2 7.8 7.3 6.6 3.4 2.5 2.0 1.9 7.4 2.4 4.9 2.2 7.1 6.1 1.5 3.1 20.4 3.3 20.2 4.3 1.4 2.2 2.5 2.8 1.6 0.7 5.1 0.6 0.4 1.8 0.2 1.7 0.9 2.2 2.1 1.2 2.6 1.4 1.4 1.1 1.4 1.5 0.6 0.8 9.5 0.7 0.8 2.5 0.4 0.9 1.3 1.5 2.0 0.9 14.8 1.5 1.3 1.8 2.1 1.9 1.5 2.6 1.1 2.1 1.0 0.6 5.4 0.4 2.6 1.6 0.7 4.1 1.9 1.7 0.8 2.1 4.9 1.6 0.3 1.0 1.4 3.1 1.5 2.8 1.0 3.6 1.9 1.1 1.5 1.1 2.9 1.6 0.8 0.9 1.4 1.7 6.2 1.2 1.2 2.0 5.1 0.6 0.0 0.8 0.6 1.8 0.7 0.7 0.7 0.7 1.6 0.5 0.9 0.5 0.4 0.4 0.7 0.6 0.2 5.8 7.5 8.2 7.8 4.9 4.1 3.4 7.6 6.6 3.3 0.0 6.9 0.0 5.3 2.5 24.3 7.0 0.0 17.4 9.1 3.5 15.7 4.8 5.0 2.0 152.4 2.6 2.7 0.0 3.1 3.6 1.9 0.5 1.1 0.8 1.6 9.5 1.2 2.5 0.3 134.7 5.5 1.1 0.0 1.8 2.6 11.2 2.0 0.0 5.6 1.4 44.6 12.9 2.1 149.3 27.2 2.9 4.7 0.7 3.6 2.6 CCDC174 "C3orf19, FLJ33839" ENSG00000154781 "Coiled-coil domain containing 174" Q6PII3 3 14651746-14672659 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043468, HPA060129" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA043468: AB_2678493, HPA060129: AB_2684208" "unprognostic (6.10e-2)" "unprognostic (7.96e-2)" "unprognostic (2.92e-1)" "unprognostic (3.26e-2)" "unprognostic (6.58e-3)" "unprognostic (5.06e-2)" "unprognostic (6.48e-3)" "unprognostic (1.13e-1)" "unprognostic (1.52e-1)" "unprognostic (5.29e-2)" "unprognostic (3.86e-2)" "prognostic unfavorable (4.75e-4)" "unprognostic (1.15e-2)" "unprognostic (2.30e-3)" "unprognostic (2.04e-1)" "unprognostic (2.64e-1)" "prognostic favorable (3.81e-5)" 16.8 12.9 15.7 13.4 17.5 27.1 17.1 22.3 18.2 19.2 18.5 17.8 15.2 16.8 24.0 14.5 16.1 15.5 12.9 14.4 13.1 10.9 17.9 15.3 13.0 15.7 17.9 14.8 28.0 18.6 15.7 29.9 15.6 16.9 17.7 13.7 12.6 16.1 15.7 26.9 17.4 20.6 14.9 18.7 20.2 18.2 15.3 19.2 23.1 17.5 9.8 18.4 19.0 17.6 14.7 9.5 21.0 9.9 15.4 16.7 8.4 5.1 5.7 8.8 9.3 12.2 10.1 22.3 7.0 10.0 8.8 6.9 6.4 6.1 10.8 5.1 6.1 6.0 4.6 6.3 5.8 6.9 8.1 7.7 11.0 6.8 6.8 17.7 10.7 12.8 11.6 15.0 11.8 14.6 12.4 7.5 11.6 10.9 9.9 6.5 9.1 11.2 9.5 11.8 8.6 9.4 8.4 8.2 8.8 9.0 9.2 4.3 11.6 8.1 6.4 11.2 10.7 9.7 15.3 6.9 7.1 6.9 6.5 8.0 13.2 11.7 12.6 7.1 8.3 9.6 21.0 9.5 18.4 12.1 9.7 14.1 14.7 15.1 13.9 8.4 13.3 16.7 13.3 18.4 15.4 9.9 9.5 10.3 8.4 15.7 17.5 22.3 18.2 13.1 10.9 17.9 14.8 16.9 19.2 8.9 34.6 52.9 25.1 14.3 31.2 32.7 28.1 36.1 34.2 12.2 19.6 26.1 48.0 29.4 124.0 26.9 26.2 70.0 30.5 21.0 25.8 23.3 50.8 26.6 23.1 14.3 17.7 27.6 22.9 39.8 31.1 28.8 13.5 55.1 21.6 23.3 32.0 31.7 37.8 29.8 23.3 32.3 21.7 47.7 31.1 11.8 54.9 42.1 21.1 27.8 CCDC175 C14orf38 ENSG00000151838 "Coiled-coil domain containing 175" P0C221 14 59504539-59576831 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 17.1;pituitary gland: 6.6;testis: 8.2" "Cell type enhanced" "Detected in some" 13 "Ciliated cells: 13.4;Cone photoreceptor cells: 7.9;Early spermatids: 7.0;Rod photoreceptor cells: 11.8;Spermatocytes: 16.5" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "cerebellum: 17.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.6;SCLC-21H: 1.7" HPA004200 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA004200: AB_1078743" "unprognostic (3.64e-3)" "unprognostic (8.05e-2)" "unprognostic (1.13e-1)" "unprognostic (2.21e-1)" "unprognostic (3.83e-1)" "unprognostic (2.02e-2)" "unprognostic (5.98e-2)" "unprognostic (1.27e-1)" 0.2 0.1 0.9 0.2 2.9 0.5 0.2 17.1 3.3 0.2 0.9 1.2 0.0 0.3 0.2 1.0 0.2 1.3 0.5 0.2 0.8 0.5 0.4 0.2 0.5 0.2 0.8 0.9 0.2 0.1 0.3 6.6 0.1 3.0 0.2 1.8 0.6 0.2 0.2 0.2 0.3 0.9 0.2 0.4 0.4 0.2 8.2 1.5 0.0 0.3 0.0 0.2 0.1 0.1 0.0 0.1 0.5 0.1 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.4 0.9 2.9 17.1 3.3 0.8 0.5 0.8 0.9 3.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 13.4 1.2 0.0 7.9 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 11.8 0.0 0.0 16.5 1.3 0.0 0.0 0.0 2.6 0.0 CCDC18 NY-SAR-41 ENSG00000122483 "Coiled-coil domain containing 18" Q5T9S5 1 93179919-93278730 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.0" "Group enriched" "Detected in many" 4 "Spermatocytes: 128.6;Spermatogonia: 37.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028035 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA028035: AB_10601795" "unprognostic (8.79e-2)" "unprognostic (1.59e-1)" "unprognostic (1.04e-1)" "unprognostic (7.89e-2)" "unprognostic (8.08e-2)" "unprognostic (1.49e-4)" "unprognostic (4.36e-4)" "unprognostic (1.02e-1)" "unprognostic (1.44e-2)" "unprognostic (3.41e-2)" "unprognostic (1.63e-2)" "unprognostic (3.50e-2)" "unprognostic (3.64e-13)" "unprognostic (4.94e-2)" "unprognostic (9.19e-2)" "unprognostic (5.16e-2)" "unprognostic (1.44e-1)" 3.8 2.3 2.7 20.0 4.3 13.4 4.6 3.7 2.7 2.2 3.2 0.4 2.9 2.5 1.8 4.0 3.2 1.8 1.7 2.6 3.4 1.9 2.0 3.0 3.8 11.9 1.7 1.8 2.8 1.5 0.7 4.8 1.9 2.6 1.9 4.1 1.3 2.0 3.1 6.2 3.1 3.4 2.3 3.8 6.0 2.3 12.6 2.5 15.8 2.1 2.8 8.2 2.9 3.3 12.2 11.9 6.0 3.9 1.1 2.7 0.5 15.7 5.3 12.4 3.9 3.0 3.2 6.5 9.8 5.2 10.1 10.3 2.7 5.4 20.4 5.5 5.2 9.9 7.5 5.4 7.7 14.7 10.1 7.1 14.0 11.3 4.8 1.1 14.5 6.5 2.1 0.6 7.6 7.5 2.8 6.5 9.2 14.9 15.8 13.4 2.2 6.9 5.9 11.3 4.3 6.6 9.0 14.8 6.0 4.9 7.1 5.5 3.5 13.9 7.1 4.1 5.8 3.4 8.5 5.0 11.9 8.4 7.6 11.1 6.8 8.8 12.3 2.5 13.0 3.1 3.4 3.8 5.3 2.4 3.9 2.7 8.8 2.2 2.1 1.6 12.2 1.7 2.0 6.0 1.1 3.5 11.9 2.2 0.5 2.7 4.3 3.7 2.7 3.4 1.9 1.7 1.8 2.6 2.5 17.9 11.1 17.6 6.5 3.7 2.4 8.1 0.0 6.7 4.5 3.5 3.9 2.6 0.0 1.9 17.7 3.7 1.7 0.0 2.6 5.8 6.8 3.3 18.5 2.9 7.2 1.6 0.0 4.3 12.4 8.5 5.8 19.5 3.3 9.0 2.5 1.1 1.8 3.5 6.0 1.0 0.6 6.5 5.7 128.6 37.7 6.4 2.4 14.1 3.1 6.4 CCDC188 ENSG00000234409 "Coiled-coil domain containing 188" H7C350 22 20148427-20151065 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 6.1;testis: 23.1" "Group enriched" "Detected in some" 125 "Early spermatids: 318.9;Late spermatids: 769.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 47 "plasmacytoid DC: 4.7" "Lineage enriched" "Detected in single" 47 "dendritic cells: 4.7" "Cell line enhanced" "Detected in some" "AF22: 5.8;SCLC-21H: 8.0;SH-SY5Y: 10.5;TIME: 4.2;U-2 OS: 4.5" "Not detected" "Not detected" HPA049901 Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA049901: AB_2680943" "unprognostic (9.83e-2)" "unprognostic (3.09e-2)" "unprognostic (9.79e-2)" "unprognostic (6.42e-3)" "unprognostic (2.45e-1)" "unprognostic (3.83e-2)" "unprognostic (1.04e-2)" "unprognostic (1.02e-1)" "unprognostic (8.43e-2)" "unprognostic (4.08e-3)" "unprognostic (1.67e-5)" "unprognostic (1.16e-1)" "unprognostic (5.37e-5)" "unprognostic (1.55e-1)" "unprognostic (2.79e-1)" "unprognostic (3.44e-1)" "unprognostic (1.40e-2)" 1.1 0.9 0.4 0.5 0.6 0.5 0.5 1.4 1.2 0.4 0.4 0.4 0.4 1.0 0.6 0.4 0.4 0.4 0.4 0.4 0.4 1.9 0.4 0.4 0.6 0.7 0.5 0.4 0.4 0.4 0.0 6.1 0.8 0.4 0.4 0.0 0.4 0.4 0.4 0.7 1.5 0.5 0.4 0.4 1.8 0.8 23.1 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 5.8 0.3 0.0 0.7 0.0 1.7 0.8 1.4 0.9 0.1 0.1 0.0 0.2 0.8 0.2 0.3 0.0 0.0 0.1 0.2 0.0 1.4 0.2 0.0 0.1 0.0 4.0 0.0 0.0 0.0 0.6 0.0 0.1 0.9 0.2 3.8 1.2 0.5 0.0 0.3 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.1 8.0 10.5 0.5 0.0 0.6 0.1 0.0 0.1 4.2 2.4 4.5 3.0 0.2 0.7 0.1 0.2 3.9 0.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.4 0.6 1.4 0.6 0.4 1.9 0.5 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 318.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 769.4 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 3.2 1.9 0.0 0.0 0.0 0.0 0.0 CCDC198 "C14orf105, FLJ10650" ENSG00000100557 "Coiled-coil domain containing 198" Q9NVL8 14 57469301-57493867 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 25.8;kidney: 75.8;pancreas: 21.8" "Group enriched" "Detected in some" 5 "Collecting duct cells: 54.1;Distal tubular cells: 58.0;Proximal tubular cells: 165.1" "Cancer enhanced" "Detected in many" "renal cancer: 25.1" "Region enhanced" "Detected in single" "pons and medulla: 1.5" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "A549: 9.3;RPTEC TERT1: 27.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA029202 Uncertain Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA029202: AB_10600754" "unprognostic (1.45e-1)" "unprognostic (3.65e-1)" "unprognostic (2.38e-1)" "unprognostic (6.67e-2)" "prognostic unfavorable (5.61e-4)" "unprognostic (1.21e-1)" "unprognostic (5.45e-3)" "unprognostic (1.51e-1)" "prognostic favorable (1.92e-4)" "unprognostic (6.07e-2)" "unprognostic (2.77e-1)" "unprognostic (1.61e-3)" 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.6 0.1 0.6 0.1 0.0 1.6 0.7 0.4 25.8 0.1 15.3 17.7 0.1 0.1 0.2 75.8 17.7 0.1 0.0 0.1 0.0 6.1 21.8 0.0 0.1 0.1 1.5 0.1 0.0 0.0 0.1 0.8 0.1 0.4 0.1 0.0 0.3 0.1 0.2 1.6 0.0 0.0 0.1 0.0 0.0 0.3 0.1 2.7 1.9 4.5 0.9 3.4 5.0 3.6 0.0 9.3 0.0 0.3 0.0 0.5 0.2 0.3 0.0 0.0 0.0 0.9 0.9 0.4 2.6 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.0 0.3 0.3 0.1 0.2 0.1 0.2 0.1 0.0 0.2 27.7 0.4 0.3 0.0 0.1 0.0 0.0 0.3 0.1 0.2 0.3 0.7 0.5 0.1 0.1 0.3 0.4 0.3 1.4 0.3 0.2 3.1 0.9 0.6 2.1 0.4 2.6 2.1 4.2 3.0 0.2 2.7 3.5 5.0 4.5 3.4 0.6 1.9 5.0 3.6 0.1 0.1 0.6 0.1 0.1 0.2 0.1 0.0 1.5 0.0 3.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.1 0.0 0.0 58.0 18.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 165.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC22 "CXorf37, JM1" ENSG00000101997 "Coiled-coil domain containing 22" O60826 X 49235467-49250526 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport, Ubl conjugation pathway" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000229, HPA000888" Uncertain Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA000229: , HPA000888: AB_1078420" "unprognostic (1.24e-2)" "unprognostic (1.96e-2)" "unprognostic (1.98e-2)" "unprognostic (3.45e-1)" "unprognostic (1.36e-1)" "unprognostic (2.80e-2)" "prognostic unfavorable (2.17e-4)" "unprognostic (1.68e-2)" "unprognostic (2.62e-2)" "unprognostic (1.70e-1)" "unprognostic (4.57e-3)" "unprognostic (3.61e-2)" "unprognostic (4.99e-2)" "unprognostic (6.99e-2)" "unprognostic (2.57e-1)" "unprognostic (2.10e-2)" "unprognostic (1.40e-3)" 11.5 15.4 12.1 18.2 14.9 26.0 16.3 20.7 16.5 12.5 11.8 13.7 17.2 16.3 14.8 12.3 15.8 13.7 11.9 12.9 12.2 9.8 13.9 14.2 19.8 24.7 12.2 15.9 13.7 20.3 12.1 13.5 11.0 11.8 15.2 8.6 12.8 19.2 21.3 23.0 15.1 15.3 14.6 12.4 23.9 14.2 4.5 14.1 25.0 13.0 15.5 17.9 12.6 12.3 12.4 23.5 13.9 22.1 6.1 13.9 15.1 10.6 9.3 5.7 19.8 5.3 5.4 12.2 6.4 4.6 7.1 8.2 9.4 9.3 3.9 9.5 5.6 8.5 8.7 6.2 10.4 2.9 10.3 13.8 4.2 8.8 8.8 9.0 11.7 7.4 5.0 9.0 9.4 5.2 3.6 7.0 8.0 8.2 7.0 5.0 33.1 8.6 13.8 6.6 5.4 13.7 12.5 9.3 17.1 5.6 5.4 6.8 5.2 9.7 11.4 8.5 6.1 17.8 11.6 7.7 9.3 10.0 11.3 6.6 12.7 6.9 7.1 10.1 22.1 7.2 5.1 22.1 13.9 12.0 19.2 13.1 12.4 12.5 13.9 23.5 11.6 11.4 12.9 1.8 6.1 15.7 9.3 12.9 15.1 12.1 14.9 20.7 16.5 12.2 9.8 12.2 15.9 11.8 14.1 0.0 4.1 16.0 7.9 4.9 9.9 2.0 15.3 2.7 9.1 10.4 5.9 12.2 13.3 12.2 0.1 7.1 12.3 0.0 6.4 12.3 8.4 6.3 11.5 6.4 27.5 1.6 6.4 9.8 16.7 0.0 7.5 14.7 6.8 16.2 14.4 9.3 7.9 7.2 7.1 10.2 7.6 6.5 10.3 0.0 0.7 5.8 16.9 11.3 12.2 7.4 CCDC25 FLJ10853 ENSG00000147419 "Coiled-coil domain containing 25" Q86WR0 8 27733311-27772653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023256 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA023256: AB_2072067" "unprognostic (1.43e-1)" "unprognostic (5.48e-2)" "unprognostic (3.10e-3)" "unprognostic (1.60e-1)" "unprognostic (4.39e-1)" "unprognostic (6.62e-3)" "unprognostic (2.34e-1)" "unprognostic (2.48e-2)" "unprognostic (1.51e-1)" "unprognostic (8.49e-3)" "unprognostic (3.50e-1)" "unprognostic (2.69e-2)" "prognostic favorable (1.11e-7)" "unprognostic (3.93e-2)" "unprognostic (1.21e-1)" "unprognostic (1.18e-1)" "unprognostic (1.69e-1)" 12.7 25.4 16.8 10.6 22.4 4.0 16.7 14.2 26.1 10.3 26.0 13.1 12.0 32.5 13.2 14.2 13.7 14.6 11.3 11.1 16.5 14.0 21.5 30.4 8.5 12.8 19.9 15.8 10.9 16.0 15.6 12.7 9.9 29.4 11.4 15.1 9.8 14.1 12.4 23.3 10.9 39.7 10.5 19.0 12.1 18.0 12.0 17.2 9.7 17.8 13.8 12.8 13.2 10.5 19.2 18.9 14.9 13.2 13.8 21.8 9.1 24.0 13.1 13.2 12.3 11.8 17.1 8.9 20.2 19.6 12.5 12.3 5.4 8.6 26.0 14.0 10.2 10.7 11.4 11.7 19.7 18.1 9.7 7.8 32.4 12.3 9.4 19.8 11.3 10.5 19.1 13.1 13.5 19.0 14.3 26.8 17.0 15.2 12.5 13.9 8.8 27.5 9.6 18.9 23.9 7.3 9.0 22.4 13.7 16.4 14.1 7.6 21.2 13.6 10.5 20.6 10.4 12.0 6.4 21.6 11.5 18.2 19.6 10.6 13.6 15.9 9.5 17.8 15.1 11.8 14.9 10.4 7.3 14.6 13.2 19.8 19.2 21.2 17.8 12.1 14.0 18.8 20.9 4.0 13.8 12.5 18.9 21.8 9.1 16.8 22.4 14.2 26.1 16.5 14.0 19.9 15.8 29.4 17.2 23.8 29.3 26.0 34.6 19.1 41.2 55.6 56.0 65.6 43.3 50.6 11.8 67.5 92.9 63.1 135.8 56.8 64.2 23.3 117.7 46.6 43.3 42.8 61.3 122.8 39.7 52.4 25.4 48.5 33.2 96.8 43.7 30.4 35.4 50.5 50.8 46.3 68.5 45.6 44.6 91.6 36.5 45.3 35.0 69.9 62.9 19.4 35.5 34.9 50.9 23.7 CCDC27 FLJ32825 ENSG00000162592 "Coiled-coil domain containing 27" Q2M243 1 3746460-3771645 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 81 "testis: 53.3" "Group enriched" "Detected in some" 46 "Early spermatids: 60.7;Late spermatids: 19.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "THP-1: 6.2" HPA044395 Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA044395: AB_10962987" "unprognostic (1.36e-1)" "unprognostic (6.67e-3)" "unprognostic (3.23e-4)" "unprognostic (3.13e-2)" "unprognostic (3.42e-1)" "unprognostic (2.07e-1)" "unprognostic (1.79e-2)" "unprognostic (7.18e-2)" "unprognostic (1.20e-1)" "unprognostic (2.17e-2)" "unprognostic (2.54e-3)" "unprognostic (2.66e-2)" "unprognostic (2.46e-2)" "unprognostic (2.28e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 53.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.6 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 CCDC28A "C6orf80, CCRL1AP, DKFZp586D0623" ENSG00000024862 "Coiled-coil domain containing 28A" Q8IWP9 6 138773509-138793319 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 140.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055125 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA055125: AB_2682705" "unprognostic (1.51e-1)" "unprognostic (6.88e-3)" "unprognostic (2.70e-1)" "unprognostic (6.67e-2)" "unprognostic (7.96e-2)" "unprognostic (9.66e-3)" "unprognostic (1.16e-1)" "unprognostic (2.58e-3)" "unprognostic (3.80e-1)" "unprognostic (8.34e-3)" "unprognostic (4.29e-3)" "unprognostic (1.02e-1)" "prognostic favorable (1.11e-5)" "unprognostic (1.63e-1)" "unprognostic (1.06e-1)" "unprognostic (2.28e-2)" "unprognostic (2.37e-2)" 12.9 30.8 25.4 19.8 28.7 20.9 17.9 22.6 27.9 15.6 17.4 13.3 18.7 18.5 11.5 24.8 12.4 22.6 16.8 11.0 31.4 32.2 36.5 40.5 17.4 19.2 22.2 21.7 14.2 22.2 25.5 19.2 19.3 28.3 16.1 15.4 16.4 31.6 20.8 17.4 11.0 21.3 13.9 16.1 18.3 16.5 15.0 13.4 18.2 33.9 9.3 19.8 19.3 12.5 30.0 29.3 73.5 27.3 30.6 44.5 24.5 3.4 6.2 4.7 8.6 8.9 12.5 9.6 5.7 10.0 7.5 12.4 5.3 6.8 14.8 11.1 5.6 10.7 6.0 7.7 7.9 12.3 17.1 17.2 12.0 7.7 10.6 14.1 20.8 12.7 8.0 10.1 5.4 16.2 15.6 12.3 21.1 12.1 20.8 8.5 7.6 17.0 27.4 4.3 13.9 6.5 10.3 4.7 13.7 9.0 5.1 5.9 9.1 7.5 6.9 16.4 9.8 3.3 23.0 9.4 5.9 6.8 11.0 8.6 27.9 24.6 10.9 6.4 12.9 5.2 33.2 27.3 33.7 26.0 27.0 23.2 30.0 27.6 28.3 29.3 29.7 32.1 29.5 73.5 30.6 22.9 25.8 44.5 24.5 25.4 28.7 22.6 27.9 31.4 32.2 22.2 21.7 28.3 13.4 29.8 34.4 36.3 23.6 11.8 15.2 9.4 15.3 60.2 20.5 34.9 17.7 69.7 104.5 12.9 140.9 19.6 31.3 0.0 27.6 36.9 20.0 38.9 41.6 41.9 35.0 9.5 23.7 28.3 38.3 64.6 15.5 34.4 30.4 35.1 32.2 20.5 17.7 32.0 14.2 100.3 12.5 12.9 12.2 40.2 30.3 13.0 91.1 37.6 22.2 27.7 CCDC3 DKFZp761F241 ENSG00000151468 "Coiled-coil domain containing 3" Q9BQI4 10 12896625-13099652 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 89.3" "Cell type enhanced" "Detected in many" 14 "Basal keratinocytes: 44.5;Peritubular cells: 57.0;Sertoli cells: 32.3;Smooth muscle cells: 95.9;Suprabasal keratinocytes: 32.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 7.5;HAP1: 13.6;HDLM-2: 22.3;hTERT-RPE1: 10.7;U-2 OS: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA062425 Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA Nucleoplasm Cytosol "HPA062425: AB_2684759" "unprognostic (2.26e-1)" "unprognostic (6.65e-3)" "unprognostic (1.70e-1)" "unprognostic (4.30e-3)" "unprognostic (1.72e-1)" "unprognostic (5.08e-2)" "unprognostic (3.11e-2)" "unprognostic (2.99e-2)" "unprognostic (5.56e-3)" "unprognostic (5.41e-2)" "unprognostic (4.25e-3)" "unprognostic (2.22e-2)" "prognostic unfavorable (1.38e-5)" "unprognostic (1.54e-2)" "unprognostic (1.49e-1)" "unprognostic (2.29e-1)" "unprognostic (3.88e-2)" 37.1 5.0 14.0 2.5 9.0 0.2 33.6 4.9 15.0 23.0 4.2 2.9 3.4 2.9 16.2 18.6 26.9 21.8 89.3 11.0 8.0 3.0 4.2 8.5 8.0 12.3 4.3 8.7 39.1 2.9 3.8 4.2 9.6 3.2 14.3 3.4 8.8 2.8 10.3 12.0 55.7 5.5 11.8 3.4 9.8 5.8 11.0 3.1 10.4 8.3 9.6 2.0 12.4 14.2 0.1 0.0 0.0 0.0 0.0 0.9 1.0 0.0 0.2 1.2 6.7 0.0 0.0 0.1 0.0 0.0 0.5 0.0 1.7 0.0 0.0 0.5 0.0 7.5 1.3 13.6 2.5 0.4 22.3 5.7 0.0 0.2 0.0 0.5 0.0 0.0 1.7 1.6 0.3 0.0 10.7 0.6 0.5 0.0 0.1 0.7 0.1 0.0 3.7 1.0 0.0 0.0 0.0 3.0 0.2 0.0 0.0 2.6 1.1 4.9 0.7 0.0 3.3 0.0 0.0 0.0 0.0 14.8 0.8 0.2 0.0 0.0 0.0 0.1 0.0 4.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.0 14.0 9.0 4.9 15.0 8.0 3.0 4.3 8.7 3.2 3.1 0.0 0.0 0.0 6.2 44.5 1.0 4.4 0.0 0.0 1.2 0.0 0.0 0.2 1.7 0.0 0.2 8.3 0.0 0.0 0.0 0.1 9.1 1.9 0.0 0.2 0.3 0.0 0.0 8.0 0.0 1.1 20.8 1.6 13.5 0.0 0.0 0.5 0.1 0.0 57.0 0.3 1.9 32.3 95.9 0.0 3.8 32.5 0.2 0.0 0.0 1.0 CCDC36 "CT74, FLJ25320" ENSG00000173421 "Coiled-coil domain containing 36" Q8IYA8 3 49198428-49258104 "Predicted intracellular proteins" "Differentiation, DNA recombination, Meiosis, Oogenesis, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 35.4" "Group enriched" "Detected in some" 8 "Early spermatids: 51.2;Late spermatids: 32.2;Spermatocytes: 85.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 3.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 3.9;hTEC/SVTERT24-B: 13.3;LHCN-M2: 5.5;U-2197: 7.2;WM-115: 3.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA045690, HPA069534" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA045690: AB_10964634, HPA069534: AB_2686146" "unprognostic (1.54e-1)" "unprognostic (9.53e-3)" "unprognostic (2.16e-1)" "unprognostic (5.05e-2)" "unprognostic (3.84e-2)" "unprognostic (1.86e-2)" "unprognostic (1.36e-2)" "unprognostic (1.49e-2)" "unprognostic (9.94e-3)" "unprognostic (2.62e-1)" "unprognostic (1.38e-1)" "unprognostic (1.36e-2)" "unprognostic (5.51e-4)" "unprognostic (3.11e-2)" "unprognostic (2.95e-1)" "unprognostic (3.59e-2)" "unprognostic (6.33e-2)" 6.5 1.7 0.8 1.8 0.8 0.4 3.6 0.8 0.7 3.7 2.2 0.7 2.1 0.4 6.3 1.2 1.1 1.3 1.4 1.9 0.9 0.4 0.5 0.4 1.4 0.5 1.1 0.1 5.0 0.4 0.2 0.4 1.4 2.0 0.6 0.4 2.6 2.0 0.8 1.6 0.8 0.6 3.9 0.4 0.7 0.6 35.4 0.3 0.0 1.3 0.3 0.6 1.2 0.9 0.9 0.6 3.6 0.3 0.8 0.5 0.2 0.0 0.2 0.1 0.2 2.8 3.1 0.1 2.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 3.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 3.5 0.0 0.2 2.4 0.0 13.3 0.0 0.0 1.7 0.1 0.0 0.3 5.5 0.0 0.0 0.2 3.5 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 2.5 7.2 0.1 0.1 0.1 0.1 0.0 0.2 3.6 2.1 0.3 0.6 0.4 0.2 0.3 0.8 0.4 0.3 0.1 0.9 0.4 0.5 3.6 0.8 0.2 0.6 0.3 0.2 0.8 0.8 0.8 0.7 0.9 0.4 1.1 0.1 2.0 0.3 0.0 1.1 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 1.8 5.9 0.0 0.0 0.0 51.2 2.4 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.0 0.3 0.0 0.0 0.6 0.0 32.2 1.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.9 0.0 0.0 85.6 6.8 0.4 0.1 0.0 0.0 0.0 CCDC51 FLJ12436 ENSG00000164051 "Coiled-coil domain containing 51" Q96ER9 3 48432164-48440456 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010980, HPA011408" Supported Supported Nucleoplasm,Centrosome,Mitochondria NA NA "Nucleoplasm, Mitochondria" Centrosome "HPA010980: AB_1846155, HPA011408: AB_2072212" "unprognostic (1.24e-2)" "unprognostic (5.23e-2)" "unprognostic (5.03e-2)" "unprognostic (1.29e-1)" "unprognostic (1.95e-1)" "unprognostic (3.50e-1)" "unprognostic (2.75e-3)" "unprognostic (4.71e-3)" "unprognostic (1.26e-2)" "unprognostic (3.04e-1)" "unprognostic (3.26e-2)" "unprognostic (7.70e-2)" "unprognostic (1.47e-3)" "unprognostic (6.46e-3)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (1.77e-1)" 9.9 14.9 10.1 7.1 12.7 4.5 9.6 10.4 15.9 8.9 12.8 7.5 12.4 11.6 8.2 11.4 15.9 9.7 8.4 12.3 9.2 8.2 15.2 17.8 7.1 9.0 9.9 15.4 8.7 8.5 9.4 7.4 8.5 10.6 7.7 15.1 9.9 11.0 11.2 16.3 10.9 8.8 11.6 8.8 14.7 7.9 10.7 8.9 10.4 11.3 16.1 12.0 8.8 9.7 19.2 18.2 4.8 10.4 10.6 14.8 9.7 9.7 11.9 7.2 8.4 10.6 11.3 19.7 6.5 6.0 13.1 10.7 18.8 16.4 21.2 9.3 5.1 9.8 14.3 17.6 21.2 8.0 9.9 11.6 18.1 18.9 14.1 16.4 8.8 8.3 8.5 48.2 16.1 17.7 7.1 7.4 12.5 10.0 6.2 12.3 9.3 10.2 11.4 15.7 21.0 19.3 7.1 8.4 16.3 17.7 12.2 5.9 12.5 10.7 11.7 17.4 7.0 12.6 13.7 5.6 7.6 10.3 18.8 12.4 10.0 14.6 11.1 10.1 19.1 7.1 2.0 10.4 4.8 12.0 10.2 12.1 19.2 11.2 14.8 18.2 15.4 11.7 13.4 4.5 10.6 6.1 15.2 13.4 9.7 10.1 12.7 10.4 15.9 9.2 8.2 9.9 15.4 10.6 8.9 11.9 1.6 8.9 3.0 4.1 6.8 7.3 22.9 5.3 5.7 8.7 0.0 35.3 19.9 13.2 2.5 5.3 12.6 0.0 10.8 15.3 10.7 3.7 3.5 11.9 14.1 7.9 5.2 3.1 3.8 2.2 11.2 4.1 13.5 13.6 6.3 10.1 12.4 5.8 12.4 27.0 9.5 6.5 3.1 4.8 17.3 4.1 5.6 4.3 12.4 3.1 CCDC59 "BR22, HSPC128, TAP26" ENSG00000133773 "Coiled-coil domain containing 59" Q9P031 12 82223681-82358805 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038555 Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Plasma membrane" "HPA038555: AB_10669543" "unprognostic (1.61e-1)" "unprognostic (6.28e-3)" "unprognostic (1.27e-1)" "unprognostic (2.11e-2)" "unprognostic (1.13e-1)" "unprognostic (6.73e-2)" "unprognostic (1.42e-3)" "unprognostic (1.50e-2)" "unprognostic (1.86e-2)" "unprognostic (1.22e-2)" "unprognostic (2.62e-1)" "unprognostic (5.56e-2)" "prognostic unfavorable (1.39e-6)" "unprognostic (5.73e-2)" "unprognostic (2.01e-1)" "unprognostic (8.86e-2)" "unprognostic (1.02e-2)" 17.9 10.2 11.3 14.2 16.3 54.9 18.9 14.9 14.7 17.6 16.9 8.9 7.7 7.5 14.8 17.4 17.0 17.2 11.2 14.5 11.5 12.5 16.0 15.4 12.6 13.7 14.8 12.4 18.8 12.5 2.6 18.2 18.7 13.5 18.7 12.5 6.5 12.7 13.3 23.5 12.7 18.9 14.5 16.5 17.3 12.1 18.4 14.9 15.3 19.9 17.9 18.1 21.4 20.9 18.9 18.6 17.9 14.0 13.1 23.6 6.7 11.5 11.0 9.1 6.5 10.1 8.8 14.2 10.5 12.2 18.6 15.2 22.1 6.6 13.6 5.4 10.5 13.1 7.4 41.5 20.1 15.8 14.3 22.1 13.3 6.5 14.6 29.9 17.6 7.7 15.3 17.1 19.6 24.7 15.7 15.2 24.7 25.2 7.0 11.4 20.9 16.2 24.1 14.4 11.0 25.5 12.3 13.6 11.1 9.8 11.6 15.5 7.5 12.1 6.5 15.3 10.6 14.0 23.4 7.1 9.3 7.1 6.5 19.2 11.2 12.5 26.1 6.6 14.1 12.4 12.7 9.3 16.8 11.6 9.6 19.8 15.2 18.6 16.9 9.6 18.9 22.1 17.6 17.9 13.1 14.0 18.6 23.6 6.7 11.3 16.3 14.9 14.7 11.5 12.5 14.8 12.4 13.5 14.9 62.5 48.8 69.0 103.9 76.2 31.5 38.7 38.2 61.6 62.6 41.8 21.6 67.1 109.5 41.0 58.5 55.4 25.5 23.3 49.8 74.4 49.4 61.8 76.2 47.2 50.6 41.3 34.3 57.1 55.3 15.9 49.5 60.8 45.5 44.1 52.3 38.3 47.8 48.0 50.5 57.2 38.9 19.4 54.7 185.8 116.5 78.5 122.8 77.6 53.2 81.7 CCDC61 ENSG00000104983 "Coiled-coil domain containing 61" Q9Y6R9 19 45995461-46021318 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 7.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "NB-4: 35.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040325, HPA061548" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA040325: AB_10672970, HPA061548: AB_2684559" "unprognostic (1.30e-1)" "unprognostic (1.51e-3)" "unprognostic (2.56e-1)" "unprognostic (6.23e-3)" "unprognostic (7.27e-2)" "unprognostic (5.59e-3)" "unprognostic (4.83e-2)" "unprognostic (2.81e-1)" "unprognostic (1.58e-1)" "unprognostic (2.93e-2)" "unprognostic (2.73e-2)" "unprognostic (1.34e-1)" "unprognostic (2.13e-3)" "unprognostic (2.58e-1)" "unprognostic (2.09e-1)" "unprognostic (1.40e-2)" "unprognostic (1.09e-1)" 9.0 10.7 7.8 16.9 8.0 6.3 8.5 10.5 9.3 9.2 12.4 13.1 9.3 9.4 15.2 9.5 9.4 18.3 10.7 7.5 6.0 5.0 10.1 10.6 8.8 11.7 6.6 12.4 12.0 10.2 11.2 12.7 7.3 6.3 11.1 6.0 11.8 10.2 11.3 5.5 15.1 10.2 14.5 6.6 12.6 10.6 22.6 10.1 17.8 13.8 7.0 13.0 11.0 9.4 1.9 0.6 7.8 1.0 0.6 2.0 0.4 8.6 6.3 3.3 5.7 6.3 4.6 5.1 6.2 3.2 3.7 6.3 3.9 7.6 5.4 3.1 4.3 5.2 7.3 3.6 8.3 2.8 10.2 3.4 5.7 5.0 6.2 7.0 5.4 8.0 5.0 11.4 3.2 6.7 6.4 7.5 10.4 6.3 11.2 4.8 2.7 12.4 35.3 1.2 9.2 2.7 8.4 1.1 8.7 6.1 7.2 3.6 3.3 6.1 8.0 4.7 3.4 3.4 7.9 6.3 2.7 1.1 1.3 6.9 6.9 3.3 5.4 6.1 6.1 4.5 7.8 0.9 0.8 2.0 0.8 1.1 1.4 1.0 1.2 0.4 1.9 1.5 1.2 2.8 0.6 1.0 0.6 1.0 0.4 7.8 8.0 10.5 9.3 6.0 5.0 6.6 12.4 6.3 10.1 0.0 4.1 1.4 6.2 5.6 4.4 4.2 2.5 1.4 4.5 10.4 0.0 10.1 8.3 1.3 2.6 4.0 8.5 0.0 1.6 7.0 4.3 3.7 0.0 4.0 6.8 3.2 3.5 3.7 4.4 0.9 4.9 2.1 3.3 0.0 8.4 4.8 1.6 5.8 5.3 6.7 1.5 6.5 4.7 13.4 6.1 4.5 6.5 4.4 8.0 3.1 CCDC62 "CT109, ERAP75, FLJ40344, TSP-NY" ENSG00000130783 "Coiled-coil domain containing 62" Q6P9F0 12 122774327-122827528 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 44.3" "Group enriched" "Detected in some" 7 "Early spermatids: 148.4;Late spermatids: 50.4;Spermatocytes: 78.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "U-2 OS: 7.7" "Low region specificity" "Detected in all" "HPA039021, HPA058741" Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA039021: AB_10673604, HPA058741: AB_2683805" "unprognostic (3.39e-2)" "unprognostic (4.16e-2)" "unprognostic (1.46e-2)" "unprognostic (7.48e-2)" "unprognostic (1.58e-2)" "unprognostic (9.37e-2)" "unprognostic (1.65e-1)" "unprognostic (7.09e-2)" "unprognostic (1.97e-1)" "unprognostic (1.48e-1)" "unprognostic (2.21e-4)" "unprognostic (5.23e-1)" "unprognostic (6.39e-6)" "unprognostic (2.78e-2)" "unprognostic (6.18e-2)" "unprognostic (7.27e-2)" "unprognostic (3.25e-4)" 0.2 0.2 0.3 0.1 0.3 0.1 0.1 0.3 0.7 0.2 0.1 0.1 0.1 0.0 0.1 0.8 0.1 0.0 0.1 0.1 0.7 0.2 0.1 0.3 0.1 0.6 0.1 0.2 0.1 0.1 0.1 0.4 0.1 0.2 0.1 0.0 0.1 0.1 0.5 0.3 0.2 0.1 0.1 0.2 0.3 0.0 44.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.0 1.1 2.4 0.6 0.8 1.9 0.4 0.4 0.5 0.3 1.0 0.1 0.7 0.9 0.2 0.3 0.8 0.3 0.3 0.7 1.6 0.2 0.0 0.4 0.3 0.5 0.2 0.4 0.7 0.7 2.6 0.3 0.2 0.0 1.7 2.1 0.3 1.0 1.1 0.4 0.2 0.1 1.8 0.9 0.8 1.1 0.3 0.2 3.4 0.4 0.1 1.9 2.0 0.8 0.3 0.6 0.3 1.5 0.0 0.3 0.9 1.2 0.6 0.1 1.7 0.4 0.9 7.7 0.4 0.4 1.0 0.7 0.7 0.0 0.7 0.5 1.5 0.6 0.4 0.5 0.3 0.9 0.3 0.3 0.4 0.2 1.0 0.8 0.7 2.4 0.8 0.3 1.1 1.9 0.4 0.3 0.3 0.3 0.7 0.7 0.2 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.5 1.2 0.8 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.1 148.4 0.2 0.0 0.0 0.2 0.4 0.3 0.5 0.0 0.0 0.1 1.6 0.0 0.0 0.3 50.4 2.8 0.0 1.7 0.0 0.0 0.8 0.1 0.0 2.5 0.0 1.1 12.9 0.0 78.8 3.0 0.6 0.0 0.0 0.1 0.1 CCDC63 "FLJ35843, ODA5" ENSG00000173093 "Coiled-coil domain containing 63" Q8NA47 12 110846769-110907535 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 26.2" "Group enriched" "Detected in some" 54 "Early spermatids: 233.1;Late spermatids: 164.1" "Cancer enriched" "Detected in single" 12 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "MCF7: 9.9" "Region enriched" "Detected in single" 9 "cerebellum: 10.3" "Not detected" "Not detected" HPA061568 Approved "Nucleoplasm,Nuclear bodies,Vesicles" No NA "Nucleoplasm, Nuclear bodies" Vesicles "HPA061568: AB_2684561" "unprognostic (1.98e-2)" "unprognostic (1.05e-1)" "unprognostic (1.17e-1)" "unprognostic (2.65e-1)" "unprognostic (5.59e-2)" "unprognostic (1.09e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 233.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 164.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 3.7 3.4 0.0 0.1 0.0 0.0 0.0 CCDC8 "3M3, DKFZp564K0322, PPP1R20" ENSG00000169515 "Coiled-coil domain containing 8" Q9H0W5 19 46410372-46413584 "Disease related genes, Predicted intracellular proteins" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 39.4" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 25.5;Distal tubular cells: 33.2;Leydig cells: 65.6;Peritubular cells: 54.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 9 "neutrophil: 3.6" "Lineage enriched" "Detected in single" 9 "granulocytes: 3.6" "Cell line enhanced" "Detected in many" "AF22: 12.0;AN3-CA: 14.3;HSkMC: 13.1;K-562: 12.5;RH-30: 16.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041993 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA041993: AB_10795388" "unprognostic (3.05e-3)" "unprognostic (2.16e-1)" "unprognostic (2.28e-2)" "unprognostic (1.13e-1)" "unprognostic (1.39e-3)" "unprognostic (3.69e-1)" "unprognostic (6.64e-2)" "unprognostic (5.16e-2)" "unprognostic (7.77e-2)" "unprognostic (1.62e-1)" "unprognostic (1.15e-1)" "unprognostic (5.72e-2)" "prognostic favorable (1.72e-5)" "unprognostic (5.43e-3)" "unprognostic (5.77e-2)" "unprognostic (4.09e-2)" "unprognostic (4.18e-3)" 2.7 13.3 3.0 2.1 3.8 0.6 7.6 0.9 2.3 18.9 2.4 5.1 6.2 0.8 15.5 17.3 2.9 19.0 9.7 18.9 3.1 2.3 7.9 0.7 7.1 0.9 2.4 2.9 39.4 19.2 8.5 9.9 5.6 4.6 12.1 1.1 10.0 8.7 7.5 3.0 2.2 1.6 6.7 2.0 1.8 1.7 9.0 2.6 4.2 11.8 2.6 1.4 4.8 5.8 0.4 0.3 3.6 0.4 0.2 0.2 0.1 1.2 0.1 12.0 14.3 3.2 4.0 5.8 6.1 0.0 1.4 0.6 0.0 0.1 0.1 8.2 4.8 0.2 0.1 0.1 9.5 0.6 0.0 6.0 0.0 0.1 0.6 10.7 0.0 0.1 13.1 0.0 3.4 10.0 0.2 0.0 0.1 12.5 0.0 4.4 0.0 0.0 0.8 8.7 0.0 0.0 0.4 16.2 0.0 10.5 0.0 1.9 0.1 0.0 0.0 0.0 9.7 0.1 2.9 1.1 0.8 3.2 0.2 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.4 0.2 0.2 0.2 0.2 0.4 0.1 0.1 0.1 0.4 0.2 0.2 3.6 0.2 0.3 0.3 0.1 0.1 3.0 3.8 0.9 2.3 3.1 2.3 2.4 2.9 4.6 2.6 0.0 0.6 0.0 5.7 0.8 0.0 25.5 10.2 2.7 6.8 10.4 0.0 5.8 33.2 11.1 0.3 0.4 0.0 0.0 0.9 7.8 9.9 0.5 1.1 0.0 1.5 0.0 0.0 1.3 0.0 1.3 65.6 0.9 1.7 0.0 0.0 13.3 5.9 0.0 54.5 0.8 0.4 12.9 7.2 0.3 4.5 0.1 1.7 0.0 0.0 0.5 CCDC82 FLJ23518 ENSG00000149231 "Coiled-coil domain containing 82" Q8N4S0 11 96352769-96389956 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 343.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038704, HPA070631" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA038704: AB_10674835, HPA070631: " "unprognostic (3.04e-1)" "unprognostic (1.09e-1)" "unprognostic (3.00e-1)" "unprognostic (1.99e-1)" "unprognostic (4.05e-2)" "unprognostic (1.51e-1)" "unprognostic (1.75e-3)" "unprognostic (1.37e-1)" "unprognostic (9.94e-3)" "unprognostic (5.94e-2)" "unprognostic (3.68e-1)" "unprognostic (3.41e-1)" "unprognostic (7.68e-3)" "unprognostic (1.42e-1)" "unprognostic (9.84e-2)" "unprognostic (1.44e-1)" "unprognostic (1.31e-2)" 19.4 12.5 22.8 14.6 32.7 12.1 15.3 34.5 29.6 13.6 12.7 18.3 6.7 9.8 18.4 12.2 9.0 14.9 13.9 10.4 23.7 9.0 13.7 17.8 15.7 17.4 31.9 20.3 16.5 13.5 11.7 22.3 14.3 25.6 12.2 11.6 8.1 11.9 13.7 10.8 10.5 15.5 14.1 26.0 16.5 13.6 19.4 35.5 7.5 15.9 6.2 15.8 15.4 16.9 14.3 12.2 28.6 10.8 22.7 19.2 11.0 5.4 8.2 25.4 9.8 16.9 14.5 9.4 21.2 13.1 13.9 20.4 13.5 19.1 11.3 20.0 11.0 23.0 12.8 9.0 7.7 20.7 19.3 5.5 23.1 17.6 11.5 12.1 18.1 15.4 8.8 4.1 28.1 10.6 13.1 16.6 11.6 13.8 12.3 18.7 0.2 15.3 17.6 5.0 9.6 5.9 10.5 21.6 10.1 10.6 14.2 4.0 10.8 11.7 1.2 10.4 17.8 1.9 9.0 19.2 24.8 13.6 20.6 11.2 4.2 12.6 16.5 7.4 14.3 17.5 28.6 8.3 15.5 16.5 10.2 17.2 14.3 17.6 16.1 8.9 12.1 19.2 18.2 11.6 22.7 10.8 12.2 18.4 11.0 22.8 32.7 34.5 29.6 23.7 9.0 31.9 20.3 25.6 35.5 17.9 35.6 25.2 24.5 27.1 51.9 30.7 12.7 84.3 29.6 29.6 94.2 15.2 23.2 29.3 343.9 53.7 8.0 0.0 15.0 15.4 39.1 12.2 38.3 31.4 21.5 30.2 19.0 33.2 26.0 42.3 40.6 33.9 25.3 42.3 7.7 32.4 24.5 11.5 40.3 27.0 45.9 32.3 28.9 80.2 51.2 17.9 6.9 39.2 8.6 18.0 CCDC83 "CT148, FLJ42119, MGC34732" ENSG00000150676 "Coiled-coil domain containing 83" Q8IWF9 11 85855101-85920021 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 27.7" "Group enriched" "Detected in some" 11 "Early spermatids: 142.1;Late spermatids: 149.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "MCF7: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039707, HPA039882" Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA039707: AB_10795259, HPA039882: AB_10795410" "unprognostic (1.14e-1)" "unprognostic (4.09e-1)" "unprognostic (1.49e-2)" "unprognostic (4.43e-2)" "unprognostic (7.05e-6)" "unprognostic (3.52e-1)" "unprognostic (2.17e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.0 1.8 0.8 0.3 0.6 0.0 0.1 0.0 0.5 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.2 0.3 0.3 0.3 0.0 0.0 0.0 0.1 0.7 0.3 0.3 0.2 0.0 0.2 0.3 0.0 0.1 0.1 0.0 0.3 0.1 0.1 0.3 7.9 0.1 0.4 0.0 1.3 0.0 0.1 0.0 0.1 0.6 0.3 0.1 0.1 0.1 0.5 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.2 0.1 0.4 0.8 0.6 0.3 0.6 0.4 0.4 0.3 0.3 0.3 0.3 0.4 0.3 0.5 1.8 0.3 0.8 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 142.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 149.4 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 13.1 1.3 0.0 0.0 0.0 0.0 0.0 CCDC84 DLNB14 ENSG00000186166 "Coiled-coil domain containing 84" Q86UT8 11 118998142-119015791 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 69.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 18.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039906, HPA071715" Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA039906: AB_2676740, HPA071715: AB_2686436" "unprognostic (5.83e-2)" "unprognostic (2.64e-1)" "unprognostic (1.36e-1)" "unprognostic (8.12e-2)" "unprognostic (1.54e-1)" "unprognostic (4.06e-2)" "unprognostic (1.15e-2)" "unprognostic (1.03e-3)" "unprognostic (3.60e-3)" "unprognostic (3.45e-2)" "unprognostic (4.64e-3)" "unprognostic (1.20e-2)" "prognostic unfavorable (2.93e-5)" "unprognostic (8.14e-2)" "unprognostic (8.24e-2)" "unprognostic (3.15e-1)" "unprognostic (2.09e-3)" 9.3 10.7 10.5 11.0 15.3 15.2 12.5 18.9 17.5 9.8 10.6 19.4 12.1 10.7 16.2 16.6 9.3 8.7 10.4 9.4 11.4 9.0 12.6 15.0 13.2 13.6 15.8 11.7 10.0 10.1 14.1 14.1 9.9 16.7 13.7 9.8 18.7 13.0 16.6 16.7 19.1 11.7 12.8 8.7 18.8 10.8 6.8 12.3 7.6 14.0 9.4 15.1 8.5 10.1 5.8 3.8 4.0 2.1 5.5 8.8 2.5 3.6 3.2 2.7 3.7 2.8 0.9 2.8 3.2 3.4 2.8 1.8 18.2 2.2 1.3 10.7 3.6 4.3 9.6 1.3 1.7 2.9 5.0 2.0 6.1 5.4 5.0 2.6 2.6 3.4 1.1 1.9 2.9 3.3 2.9 1.6 4.1 1.3 4.8 2.7 5.7 6.5 4.6 3.5 5.4 8.3 9.0 5.5 6.2 4.4 5.2 3.8 2.5 8.3 2.5 0.6 4.4 7.5 2.3 1.7 2.8 13.5 3.8 2.1 3.7 3.6 5.6 2.2 4.9 5.2 0.0 2.1 4.0 4.4 1.2 5.2 5.0 5.4 4.7 3.3 5.8 5.0 3.6 3.6 5.5 1.2 3.8 8.8 2.5 10.5 15.3 18.9 17.5 11.4 9.0 15.8 11.7 16.7 12.3 41.7 40.5 7.8 13.8 14.0 43.0 7.3 12.7 12.0 35.2 12.2 45.2 13.1 5.0 7.4 1.3 11.9 7.1 0.0 13.1 3.1 11.3 9.3 25.5 6.4 8.0 17.5 6.3 8.6 7.9 1.4 8.9 11.2 6.8 17.2 6.1 17.1 13.1 8.6 8.9 3.1 69.8 12.9 11.7 9.6 11.7 9.7 6.1 14.9 6.0 7.1 CCDC85C ENSG00000205476 "Coiled-coil domain containing 85C" A6NKD9 14 99500180-99604026 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 58.9;Rod photoreceptor cells: 47.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058346, HPA061922" Uncertain Approved "Nucleoplasm,Nucleoli rim,Nuclear bodies,Mitotic chromosome,Cell Junctions" Yes No "Nucleoli rim, Cell Junctions" "Nucleoplasm, Nuclear bodies, Mitotic chromosome" "HPA058346: AB_2683686, HPA061922: " "unprognostic (7.17e-2)" "unprognostic (2.23e-2)" "unprognostic (3.64e-1)" "prognostic unfavorable (1.44e-4)" "unprognostic (5.70e-2)" "unprognostic (2.61e-1)" "unprognostic (1.68e-3)" "unprognostic (4.80e-2)" "unprognostic (1.45e-2)" "unprognostic (8.75e-2)" "unprognostic (3.30e-1)" "unprognostic (1.68e-3)" "prognostic favorable (2.60e-5)" "unprognostic (4.14e-2)" "unprognostic (1.95e-1)" "unprognostic (8.74e-3)" "unprognostic (9.81e-3)" 3.5 12.0 13.9 3.3 15.5 7.2 6.1 45.2 11.8 11.3 15.3 11.7 16.6 15.4 8.7 12.6 24.0 10.0 13.9 11.4 11.6 7.6 7.8 32.3 6.7 1.9 10.3 5.9 6.9 15.3 10.4 10.0 7.1 9.1 15.8 9.5 19.9 20.8 14.8 15.2 13.6 27.0 15.4 8.4 3.0 10.5 8.1 8.1 2.7 9.5 9.3 8.7 13.7 17.9 0.3 0.1 0.7 0.0 0.4 2.0 0.6 17.5 16.1 20.0 12.0 0.2 0.0 18.6 5.9 6.1 12.0 7.0 19.5 18.7 0.1 23.7 6.7 3.3 23.7 14.7 14.3 7.5 28.8 8.7 0.9 16.0 13.1 1.6 0.2 1.9 0.0 7.6 3.4 9.9 7.1 3.7 10.5 4.2 2.7 1.4 29.4 7.8 2.4 7.3 20.3 16.8 11.7 8.4 3.9 8.5 7.0 9.9 12.5 15.2 8.1 3.7 8.0 17.7 3.6 8.4 2.3 20.0 8.5 5.9 4.2 5.5 0.1 0.4 1.5 1.6 0.7 0.0 0.0 0.6 0.0 0.8 0.2 1.9 1.3 0.0 0.3 2.0 1.1 0.6 0.4 0.0 0.1 2.0 0.6 13.9 15.5 45.2 11.8 11.6 7.6 10.3 5.9 9.1 8.1 20.8 6.4 0.9 7.8 7.8 31.0 2.2 7.6 2.7 9.1 1.8 58.9 5.4 0.0 7.3 2.3 4.2 14.2 0.0 8.1 3.5 2.3 8.5 5.8 15.3 1.6 1.6 9.2 6.2 1.2 0.9 0.6 0.6 8.5 0.0 9.6 28.9 11.9 14.0 0.7 5.1 47.8 0.0 2.3 0.9 1.6 12.3 4.1 0.7 10.9 10.3 CCDC86 MGC2574 ENSG00000110104 "Coiled-coil domain containing 86" Q9H6F5 11 60842071-60851081 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 200.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041117, HPA041540" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA041117: AB_10794984, HPA041540: AB_10794299" "unprognostic (2.93e-1)" "unprognostic (6.59e-2)" "unprognostic (2.38e-1)" "unprognostic (1.47e-3)" "unprognostic (3.64e-1)" "prognostic unfavorable (7.36e-5)" "prognostic unfavorable (1.71e-4)" "unprognostic (1.65e-3)" "unprognostic (9.52e-2)" "unprognostic (1.25e-2)" "unprognostic (6.12e-2)" "unprognostic (4.47e-1)" "unprognostic (3.76e-2)" "unprognostic (7.54e-3)" "unprognostic (2.90e-1)" "unprognostic (2.16e-1)" "unprognostic (6.25e-2)" 13.5 12.4 7.3 8.6 11.0 6.1 11.2 3.3 11.2 5.8 6.7 7.9 3.4 7.4 8.4 5.0 9.3 7.4 8.3 9.3 6.7 6.4 8.1 11.4 5.4 8.2 10.0 6.0 11.3 13.6 200.8 12.7 7.3 8.5 11.9 4.7 6.7 6.4 6.2 20.2 10.4 6.2 7.3 6.7 9.3 7.7 47.8 8.7 10.2 7.9 12.6 6.5 8.6 6.5 6.9 20.0 5.0 19.5 4.2 8.5 6.7 21.0 28.7 7.1 20.5 5.8 9.6 9.7 14.2 11.1 26.1 14.0 24.4 14.2 25.8 27.2 7.7 18.6 19.8 24.0 17.1 12.0 9.1 26.6 13.1 12.7 34.0 19.2 20.5 22.5 10.9 13.0 24.1 15.3 3.8 19.3 14.2 41.9 13.3 12.7 24.9 30.8 31.3 28.7 12.5 41.3 21.0 10.7 64.9 9.1 9.0 16.1 10.4 9.1 21.1 16.6 4.7 21.3 8.2 12.6 26.0 16.0 35.3 30.7 11.2 16.5 27.9 21.3 22.2 31.4 2.6 9.1 5.0 6.5 19.5 6.9 6.9 6.9 6.0 20.0 6.5 8.5 7.4 0.7 4.2 6.3 11.2 6.2 6.7 7.3 11.0 3.3 11.2 6.7 6.4 10.0 6.0 8.5 8.7 0.0 2.1 3.0 15.4 32.7 9.3 0.4 2.5 0.0 4.5 1.8 7.9 15.9 6.6 20.4 19.7 6.8 2.6 0.0 10.4 14.1 9.5 18.2 4.7 2.4 16.0 3.2 6.9 3.7 2.8 10.6 10.6 7.9 15.1 4.6 4.9 3.6 13.7 3.5 5.6 5.4 7.9 19.4 20.2 37.1 19.1 27.0 6.9 6.1 9.7 15.5 CCDC88B "BRLZ, CCDC88, FLJ00354, FLJ37970, GIPIE, HkRP3" ENSG00000168071 "Coiled-coil domain containing 88B" A6NC98 11 64340223-64357534 "Predicted intracellular proteins" "Stress response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.5;brain: 23.7;lymphoid tissue: 29.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 10.1;HMC-1: 40.7;Karpas-707: 10.6;THP-1: 16.2;U-937: 11.7" "Not detected" "Not detected" HPA026652 Approved Approved Nucleoplasm,Centrosome,Cytosol "Intracellular and membrane" NA NA Centrosome "Nucleoplasm, Cytosol" "HPA026652: AB_1846168" "unprognostic (1.18e-2)" "unprognostic (3.33e-3)" "unprognostic (3.65e-1)" "unprognostic (1.58e-2)" "unprognostic (2.36e-1)" "prognostic favorable (1.48e-4)" "unprognostic (2.14e-2)" "unprognostic (1.55e-2)" "unprognostic (5.61e-2)" "unprognostic (1.15e-1)" "unprognostic (2.94e-1)" "unprognostic (7.32e-2)" "prognostic unfavorable (7.65e-5)" "unprognostic (3.77e-2)" "unprognostic (7.38e-2)" "unprognostic (1.90e-1)" "unprognostic (2.83e-2)" 3.5 2.5 5.2 29.5 5.4 32.5 2.7 23.7 2.8 2.6 6.1 4.5 6.9 3.2 2.0 1.3 4.2 2.5 8.5 2.3 4.1 2.6 2.0 1.6 11.4 18.6 8.6 2.2 1.3 2.1 0.7 1.6 1.4 6.5 2.9 2.9 1.7 7.5 8.9 0.8 1.9 11.1 1.3 7.2 26.6 3.3 7.3 6.5 16.8 1.9 2.7 20.8 4.1 2.8 3.0 3.5 11.3 6.5 7.1 4.6 1.6 0.1 0.6 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 1.6 9.3 1.4 0.5 0.2 0.8 0.0 0.2 0.0 10.1 0.0 7.0 1.8 0.5 0.4 4.3 40.7 0.0 0.0 0.1 0.0 0.6 0.2 3.0 0.2 10.6 0.3 0.4 5.8 3.6 0.3 1.7 0.2 5.5 0.1 8.6 0.1 0.1 2.3 0.0 0.0 0.2 0.5 0.0 1.2 16.2 0.0 0.0 0.3 0.0 0.1 2.3 0.7 7.5 0.5 11.7 0.2 3.6 6.5 7.6 4.6 4.7 1.4 2.2 2.7 3.8 2.1 3.0 2.6 3.2 11.3 7.1 3.1 3.5 0.8 1.6 5.2 5.4 23.7 2.8 4.1 2.6 8.6 2.2 6.5 6.5 0.0 12.5 29.6 3.8 2.4 39.7 11.9 0.0 8.1 3.4 8.7 0.0 2.6 0.0 11.0 9.4 4.3 33.2 0.0 24.8 4.1 2.6 3.4 25.5 7.2 12.7 0.0 17.3 8.0 22.4 10.9 1.4 23.3 5.0 22.6 20.8 11.7 25.7 31.7 0.7 2.3 4.4 0.0 2.3 12.5 1.5 1.4 1.1 31.6 17.9 14.8 CCDC88C "DAPLE, HkRP2, KIAA1509, SCA40" ENSG00000015133 "Coiled-coil domain containing 88C" Q9P219 14 91271323-91417844 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Guanine-nucleotide releasing factor" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 34.5" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 127.2;T-cells: 71.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "basal ganglia: 18.7" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 19.6;SCLC-21H: 23.8;U-266/70: 20.9;U-266/84: 29.4" "Low region specificity" "Detected in all" HPA005832 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA005832: AB_1079202" "unprognostic (7.28e-2)" "unprognostic (2.33e-3)" "unprognostic (7.23e-2)" "unprognostic (5.06e-2)" "unprognostic (1.00e-1)" "prognostic favorable (3.47e-4)" "unprognostic (3.07e-2)" "prognostic favorable (2.90e-4)" "unprognostic (1.48e-1)" "unprognostic (2.13e-1)" "unprognostic (4.77e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (2.80e-4)" "unprognostic (7.48e-2)" "unprognostic (2.22e-1)" "unprognostic (2.15e-2)" "unprognostic (4.35e-2)" 3.6 0.9 2.7 31.1 18.7 15.0 6.9 0.9 2.3 3.0 8.9 1.8 15.5 9.6 4.7 4.0 8.9 9.7 11.8 2.2 2.0 2.4 5.0 2.6 11.1 34.5 2.0 0.3 2.0 14.8 6.7 4.0 1.8 1.6 6.4 4.7 4.1 12.1 11.7 1.5 4.5 9.6 6.0 2.9 14.5 8.1 4.8 3.7 18.5 2.5 6.0 27.6 7.1 5.3 2.3 1.8 5.2 3.2 3.1 11.0 2.8 3.1 2.9 3.3 3.9 0.0 0.0 15.1 0.0 0.0 0.0 0.0 3.0 4.7 13.5 2.5 0.0 0.1 0.1 4.8 2.7 0.0 11.3 1.8 3.5 1.9 4.2 0.3 7.0 3.0 0.0 4.0 0.0 0.0 0.2 3.7 19.6 4.1 16.9 0.0 10.2 7.0 9.3 3.3 2.4 4.4 5.8 0.1 4.5 0.8 4.5 23.8 5.3 2.0 6.9 1.6 2.5 3.7 6.5 1.1 0.0 0.0 0.0 0.0 20.9 29.4 6.9 0.0 6.3 0.0 5.2 3.2 1.3 9.0 1.8 8.7 2.3 6.1 9.3 1.8 1.9 3.9 5.8 2.6 3.1 2.5 1.5 11.0 2.8 2.7 18.7 0.9 2.3 2.0 2.4 2.0 0.3 1.6 3.7 3.0 27.4 43.1 14.2 8.2 0.0 18.3 10.2 127.2 21.6 14.0 0.0 2.8 0.0 4.0 6.8 12.6 18.6 0.0 5.1 1.7 4.1 16.5 2.3 1.0 5.4 0.0 23.0 16.5 20.3 14.0 3.7 5.0 1.7 1.0 13.4 7.0 6.2 20.1 2.8 11.5 0.0 0.0 4.4 4.1 22.2 8.3 1.5 71.0 16.1 16.3 CCDC89 FLJ38159 ENSG00000179071 "Coiled-coil domain containing 89" Q8N998 11 85684866-85686277 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 40.6" "Cell type enriched" "Detected in some" 11 "Early spermatids: 332.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 5.4;GAMG: 5.2;LHCN-M2: 6.2;SCLC-21H: 7.3;U-2197: 8.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA040628 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA040628: AB_2677053" "unprognostic (5.81e-2)" "unprognostic (1.93e-1)" "unprognostic (1.99e-1)" "unprognostic (3.04e-2)" "unprognostic (5.37e-2)" "unprognostic (6.38e-2)" "unprognostic (1.40e-1)" "unprognostic (4.92e-2)" "unprognostic (8.22e-2)" "unprognostic (2.87e-1)" "unprognostic (9.16e-2)" "unprognostic (2.00e-1)" "unprognostic (2.41e-3)" "unprognostic (7.75e-3)" "unprognostic (5.10e-2)" "unprognostic (8.47e-2)" "unprognostic (3.52e-1)" 0.7 0.9 0.9 0.1 1.8 0.0 1.3 6.4 1.3 1.5 0.6 2.0 0.9 0.1 2.8 0.9 0.3 10.5 1.1 1.0 1.2 1.2 1.4 0.3 1.2 0.6 0.9 1.2 5.9 0.2 2.7 5.2 0.7 3.7 1.7 0.7 0.9 0.4 1.9 0.7 0.5 0.5 2.6 1.2 0.4 1.1 40.6 0.9 0.1 0.4 0.2 0.0 0.7 0.7 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.1 0.0 0.1 3.8 5.0 0.2 1.4 0.0 0.0 0.1 0.2 0.0 0.1 5.4 4.2 5.2 1.9 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.3 2.6 0.0 0.0 2.8 0.1 4.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.3 0.0 0.0 0.0 0.6 0.0 0.0 4.3 0.0 0.3 2.8 7.3 1.8 0.0 0.9 0.0 0.1 0.6 0.0 0.0 3.7 0.0 8.3 3.4 0.0 3.7 0.0 3.2 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.8 6.4 1.3 1.2 1.2 0.9 1.2 3.7 0.9 0.0 1.1 0.0 0.0 0.2 0.1 0.0 0.0 29.4 1.2 0.0 0.0 0.0 0.0 0.0 332.2 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 1.3 6.4 0.0 0.6 1.2 13.3 2.8 0.0 0.0 0.0 0.0 0.9 0.0 0.0 4.2 1.2 0.5 0.0 0.1 3.4 0.9 0.3 0.0 0.0 0.0 0.1 CCDC91 "DKFZp779L1558, FLJ11088, p56" ENSG00000123106 "Coiled-coil domain containing 91" Q7Z6B0 12 28133249-28581511 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 52 "Early spermatids: 1874.4;Late spermatids: 6111.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038169 Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA038169: AB_10672506" "unprognostic (6.25e-2)" "unprognostic (4.25e-2)" "unprognostic (3.67e-2)" "unprognostic (1.91e-2)" "unprognostic (6.71e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (1.05e-4)" "unprognostic (4.98e-2)" "unprognostic (2.44e-2)" "unprognostic (4.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.74e-1)" "prognostic unfavorable (7.69e-4)" "unprognostic (1.05e-1)" "unprognostic (2.44e-2)" "unprognostic (5.85e-2)" "unprognostic (2.38e-1)" 14.3 16.8 16.3 14.5 20.6 9.4 14.6 14.8 22.5 11.3 12.9 10.8 14.4 10.5 16.3 16.6 14.5 11.3 13.4 26.5 16.1 19.8 18.2 13.4 11.3 13.1 18.2 17.1 16.8 22.9 23.3 26.2 10.6 32.3 14.0 11.5 11.5 14.2 15.6 32.7 9.1 11.9 21.2 21.6 13.9 14.8 36.3 15.3 23.3 22.3 9.7 11.6 21.0 16.1 6.5 4.2 16.0 5.4 7.1 8.5 3.6 10.3 7.4 6.8 0.3 7.1 6.6 12.9 8.8 9.4 7.8 10.0 5.2 14.0 5.4 7.7 10.4 4.8 12.0 6.3 14.2 11.8 15.8 5.1 17.9 14.3 4.2 11.1 17.0 8.9 6.5 14.3 7.7 22.7 14.9 6.2 9.7 16.2 18.2 7.4 3.7 16.8 14.6 14.1 8.0 7.0 10.4 19.9 9.3 12.6 7.1 5.8 10.6 16.7 5.7 26.6 19.7 10.9 13.6 4.6 16.6 11.5 16.3 5.1 23.0 24.9 14.9 14.3 14.0 9.3 16.0 2.4 3.4 5.5 4.6 7.3 6.5 7.1 7.9 3.4 5.5 8.5 7.7 0.8 7.1 5.4 4.2 8.1 3.6 16.3 20.6 14.8 22.5 16.1 19.8 18.2 17.1 32.3 15.3 35.7 37.1 20.6 30.7 31.0 61.0 77.1 15.3 58.9 43.3 21.0 43.2 11.4 36.5 38.7 1874.4 19.1 21.3 0.0 41.1 13.3 17.8 30.2 38.3 22.2 27.2 42.9 36.9 11.6 32.1 6111.6 53.5 32.8 35.4 34.3 20.0 49.2 32.1 23.0 48.8 25.1 69.8 38.8 31.7 64.0 34.0 35.4 13.4 40.6 15.0 26.7 CCDC92 FLJ22471 ENSG00000119242 "Coiled-coil domain containing 92" Q53HC0 12 123918660-123972831 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 64.8;Sertoli cells: 71.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038560, HPA057580" Approved Supported Nucleoplasm,Centrosome NA NA Centrosome Nucleoplasm "HPA038560: AB_10672717, HPA057580: AB_2683476" "unprognostic (4.77e-3)" "unprognostic (1.52e-1)" "unprognostic (1.27e-1)" "prognostic favorable (7.15e-4)" "unprognostic (4.82e-2)" "unprognostic (1.79e-1)" "unprognostic (1.45e-1)" "unprognostic (5.01e-2)" "unprognostic (5.69e-2)" "unprognostic (7.14e-2)" "prognostic favorable (4.59e-5)" "unprognostic (1.24e-1)" "unprognostic (1.39e-1)" "unprognostic (3.08e-2)" "unprognostic (1.88e-1)" "unprognostic (1.07e-3)" "unprognostic (4.99e-2)" 19.3 11.1 35.2 9.4 24.6 3.8 16.3 17.0 34.5 11.4 11.7 16.4 6.0 14.4 11.8 18.6 8.9 12.6 10.6 23.6 33.6 26.5 11.5 11.0 20.1 8.2 27.2 23.0 13.0 11.8 18.3 14.9 17.3 34.2 11.2 7.8 13.6 9.0 12.9 22.3 7.7 14.2 14.2 22.4 9.4 11.1 24.0 13.0 8.0 15.3 4.9 6.6 10.7 12.7 1.7 1.3 4.6 1.3 1.3 3.7 1.8 4.0 4.6 2.3 4.0 15.2 8.4 4.1 6.8 12.9 3.8 4.1 2.4 1.2 1.9 2.4 8.5 2.2 2.8 2.5 1.7 2.6 12.6 5.9 2.5 1.6 1.5 8.1 0.4 9.7 4.7 7.8 4.8 3.0 11.8 10.6 4.4 2.5 0.9 3.4 2.7 2.4 4.4 1.0 1.9 10.1 3.1 1.3 0.5 5.2 4.2 4.4 6.3 3.3 1.7 4.6 5.7 4.8 2.2 10.5 7.7 1.7 4.9 2.3 3.2 1.7 0.6 6.1 3.4 3.2 4.6 1.3 1.9 2.3 0.7 3.7 1.6 3.0 3.5 1.0 1.7 2.3 2.8 1.2 1.3 0.1 1.3 0.5 1.8 35.2 24.6 17.0 34.5 33.6 26.5 27.2 23.0 34.2 13.0 17.9 22.0 4.7 6.2 3.4 17.5 37.2 25.5 9.4 11.4 17.4 13.7 3.8 6.6 12.6 64.8 12.7 8.0 0.0 9.4 2.1 13.8 7.0 19.7 11.9 15.4 20.6 4.6 11.1 8.6 48.4 12.7 9.5 8.5 10.8 7.2 12.8 12.3 2.9 16.3 27.1 12.1 71.1 17.6 44.0 5.3 2.6 4.7 7.9 5.2 6.0 CCDC94 FLJ10374 ENSG00000105248 "Coiled-coil domain containing 94" Q9BW85 19 4247079-4269090 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043606, HPA055675" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA043606: AB_10963431, HPA055675: AB_2682880" "unprognostic (1.75e-2)" "unprognostic (2.11e-3)" "unprognostic (1.81e-2)" "unprognostic (6.91e-3)" "unprognostic (1.96e-1)" "unprognostic (1.28e-3)" "unprognostic (2.91e-1)" "unprognostic (1.11e-2)" "unprognostic (1.33e-1)" "unprognostic (7.53e-2)" "unprognostic (1.01e-2)" "unprognostic (1.72e-1)" "prognostic favorable (6.32e-4)" "prognostic favorable (8.04e-4)" "unprognostic (7.61e-2)" "unprognostic (3.12e-2)" "unprognostic (9.46e-3)" 18.1 14.8 16.1 14.5 17.3 50.5 14.3 22.0 20.3 15.5 16.2 18.4 15.6 17.9 17.2 14.6 16.9 16.8 12.5 12.2 16.2 13.6 18.1 16.7 14.7 20.8 20.4 17.1 23.3 24.7 12.2 10.4 23.2 15.6 15.4 10.9 16.0 19.7 14.5 21.5 19.7 15.2 13.6 17.3 18.7 16.1 16.6 20.0 18.8 20.0 26.3 18.8 14.0 12.5 24.8 19.3 22.6 19.3 16.8 25.0 13.9 17.2 16.8 9.4 7.5 5.6 7.5 9.6 7.0 8.9 13.1 14.6 14.9 10.6 20.1 8.0 10.5 11.3 13.1 15.2 16.6 9.2 11.6 15.0 12.9 10.9 17.4 8.3 16.8 18.1 7.9 10.0 11.5 17.2 8.0 10.6 9.8 18.3 23.5 5.4 23.8 17.7 10.5 22.4 7.9 12.8 10.4 7.9 17.9 12.2 17.0 13.6 14.1 6.2 13.6 12.5 5.7 9.8 15.8 11.8 9.3 9.8 18.7 17.3 25.6 18.1 20.0 13.0 18.0 9.9 15.2 15.2 22.6 21.2 19.3 18.9 23.3 20.5 19.5 18.5 24.8 24.5 20.2 9.4 16.8 13.8 19.3 25.0 13.9 16.1 17.3 22.0 20.3 16.2 13.6 20.4 17.1 15.6 20.0 8.9 19.5 14.3 17.9 9.2 12.1 0.0 7.6 1.4 12.5 0.0 0.0 24.6 0.0 0.0 4.1 9.8 18.8 0.0 0.0 21.7 8.0 10.2 32.3 6.2 17.6 12.7 10.4 9.8 11.4 5.7 11.5 9.3 8.5 0.0 11.8 16.0 0.0 12.2 11.0 0.0 12.1 6.5 7.6 13.5 12.1 8.3 38.2 14.4 16.2 12.8 CCDC97 "FLJ40267, MGC20255" ENSG00000142039 "Coiled-coil domain containing 97" Q96F63 19 41310189-41324883 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043320, HPA043572" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA043320: AB_10964344, HPA043572: AB_10962488" "unprognostic (9.25e-3)" "unprognostic (7.26e-2)" "unprognostic (1.68e-1)" "unprognostic (5.10e-2)" "unprognostic (1.04e-1)" "unprognostic (1.51e-2)" "prognostic unfavorable (1.09e-4)" "unprognostic (8.40e-2)" "unprognostic (1.91e-2)" "unprognostic (2.44e-1)" "unprognostic (5.93e-3)" "unprognostic (4.51e-2)" "unprognostic (2.16e-1)" "unprognostic (2.96e-1)" "unprognostic (4.08e-1)" "unprognostic (7.92e-2)" "unprognostic (1.65e-2)" 20.4 15.3 15.5 20.7 18.8 21.5 16.8 16.1 24.7 21.3 16.7 26.7 17.8 15.1 21.3 26.6 22.9 24.5 15.8 16.4 14.6 14.1 16.5 13.3 15.4 23.2 16.0 16.2 27.4 20.6 20.8 21.9 22.9 18.6 19.0 12.6 20.9 21.1 17.2 28.8 21.5 18.4 15.6 21.0 24.2 17.3 39.9 16.8 27.7 17.9 20.4 27.2 17.7 19.7 13.6 7.6 14.6 13.3 11.5 16.8 8.3 13.1 28.9 15.3 17.8 20.2 16.2 11.1 8.9 7.2 14.1 12.1 17.1 12.7 12.6 9.6 7.4 9.5 9.0 21.0 17.7 10.8 23.0 20.3 11.5 13.0 11.2 15.4 19.0 24.9 15.7 22.8 16.4 13.8 11.6 9.7 13.9 14.6 24.1 13.4 9.6 17.3 4.6 7.1 16.0 10.4 19.6 12.2 9.1 12.9 25.2 13.8 12.2 19.8 21.9 8.7 10.7 14.9 14.5 11.5 12.2 12.3 6.3 14.7 24.8 21.2 12.1 11.6 14.0 16.1 9.0 8.3 9.7 15.3 9.2 16.8 11.3 10.3 10.9 6.8 13.6 11.4 10.0 14.6 11.5 13.3 7.6 8.5 8.3 15.5 18.8 16.1 24.7 14.6 14.1 16.0 16.2 18.6 16.8 11.9 7.9 9.3 10.0 4.0 11.7 5.9 10.2 6.7 3.4 8.7 11.8 9.6 6.6 10.7 2.5 7.5 12.9 0.0 22.5 4.4 7.6 7.8 16.1 4.9 13.4 9.5 11.1 10.4 11.6 7.8 11.8 7.7 1.7 18.0 11.1 6.4 17.7 2.9 10.6 7.2 8.8 0.0 8.3 20.6 11.7 5.1 15.3 16.0 9.6 10.9 CCDC9B "C15orf52, FLJ43339" ENSG00000188549 "Coiled-coil domain containing 9B" Q6ZUT6 15 40331452-40340967 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 7.7;Collecting duct cells: 19.2;Ductal cells: 27.2;Pancreatic endocrine cells: 12.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 6.7" "Lineage enriched" "Detected in single" 7 "granulocytes: 6.7" "Cell line enhanced" "Detected in many" "HaCaT: 37.9;hTERT-RPE1: 35.2;WM-115: 43.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040484, HPA041834" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA040484: AB_10794742, HPA041834: AB_10795643" "unprognostic (5.57e-3)" "unprognostic (1.85e-1)" "unprognostic (2.60e-3)" "unprognostic (2.33e-2)" "unprognostic (1.48e-2)" "unprognostic (2.68e-1)" "unprognostic (1.86e-2)" "unprognostic (1.01e-1)" "unprognostic (1.50e-1)" "unprognostic (7.06e-3)" "unprognostic (1.51e-2)" "unprognostic (2.50e-1)" "unprognostic (1.04e-3)" "unprognostic (1.55e-1)" "unprognostic (3.48e-1)" "unprognostic (1.50e-2)" "unprognostic (9.68e-2)" 2.8 4.8 3.6 9.4 5.8 1.5 4.5 3.4 6.2 9.4 29.6 6.3 38.1 5.7 11.5 14.1 19.8 5.0 12.3 30.5 5.8 3.2 5.1 2.1 6.8 1.7 6.7 4.7 2.6 12.0 9.7 4.8 2.3 5.7 10.3 7.6 12.9 13.9 40.6 35.0 7.7 8.3 16.2 3.6 2.5 11.0 5.3 6.3 0.3 21.3 16.1 6.1 13.0 7.2 0.5 0.5 6.7 0.6 0.9 0.3 0.4 14.9 2.1 0.0 0.1 0.3 1.5 0.8 4.5 4.5 5.1 5.0 0.1 13.9 0.1 6.4 14.6 18.5 37.9 0.0 12.4 4.8 0.0 0.1 4.5 17.7 1.4 2.7 0.0 0.9 1.8 2.8 2.2 6.4 35.2 3.6 0.2 0.0 0.2 8.6 0.0 0.1 0.0 0.1 7.0 4.0 0.0 1.3 0.0 15.3 0.8 0.0 1.1 2.7 6.0 2.6 0.0 0.6 0.7 19.1 9.5 15.2 2.5 11.9 0.0 0.0 0.1 11.5 0.8 43.1 6.7 0.6 0.6 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.5 0.3 0.2 1.2 0.9 0.2 0.5 0.0 0.4 3.6 5.8 3.4 5.3 5.8 3.2 6.7 4.7 5.7 6.3 11.9 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 19.2 0.0 0.0 1.7 27.2 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 CCM2L "C20orf160, dJ310O13.5" ENSG00000101331 "CCM2 like scaffolding protein" Q9NUG4 20 32010450-32032180 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 53.0" "Group enriched" "Detected in some" 4 "Endothelial cells: 22.4;Ito cells: 20.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 10.6;HUVEC TERT2: 12.5;NTERA-2: 6.8;RH-30: 4.7;SCLC-21H: 11.6;TIME: 6.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA008434, HPA071063" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA008434: AB_1845671, HPA071063: AB_2686339" "unprognostic (1.71e-1)" "unprognostic (4.64e-2)" "unprognostic (2.43e-3)" "unprognostic (5.84e-3)" "unprognostic (1.91e-1)" "unprognostic (3.09e-3)" "unprognostic (1.27e-3)" "unprognostic (2.37e-1)" "unprognostic (2.04e-1)" "unprognostic (4.34e-2)" "unprognostic (1.00e-3)" "unprognostic (7.84e-2)" "unprognostic (4.66e-3)" "unprognostic (2.19e-2)" "unprognostic (1.57e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" 7.2 1.8 2.1 1.8 2.0 0.2 15.0 2.1 2.2 4.4 1.4 1.7 2.1 1.2 7.1 2.3 1.9 2.6 2.4 5.4 2.0 1.7 3.1 1.0 15.1 1.3 2.3 1.5 1.8 1.0 1.4 1.4 6.7 2.5 1.9 1.2 4.9 1.4 2.0 3.5 1.5 1.6 3.2 1.4 53.0 1.4 1.6 1.6 0.2 3.0 5.2 1.0 2.0 4.6 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 10.6 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 12.5 1.3 0.0 0.0 0.0 3.5 0.0 0.0 6.8 0.2 0.0 0.8 4.7 0.2 0.0 0.0 11.6 1.3 0.3 0.0 0.0 1.7 3.7 0.0 6.3 0.1 2.0 0.0 0.0 0.2 0.0 0.2 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.1 2.0 2.1 2.2 2.0 1.7 2.3 1.5 2.5 1.6 0.0 0.0 0.0 0.0 0.1 0.5 3.6 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 20.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.5 0.3 0.0 0.0 0.0 0.0 CCNA1 CT146 ENSG00000133101 "Cyclin A1" P78396 13 36431520-36442882 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 24.5;parathyroid gland: 24.2;testis: 50.4" "Group enriched" "Detected in some" 6 "Early spermatids: 98.3;Late spermatids: 70.5;Spermatocytes: 99.1" "Cancer enhanced" "Detected in many" "endometrial cancer: 20.7;ovarian cancer: 18.6" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 108 "basophil: 24.5" "Lineage enriched" "Detected in single" 233 "granulocytes: 24.5" "Cell line enriched" "Detected in some" 4 "HMC-1: 87.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA060646, HPA077614" Enhanced Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA060646: AB_2684336, HPA077614: " "unprognostic (1.92e-3)" "unprognostic (1.21e-1)" "unprognostic (4.69e-3)" "unprognostic (1.89e-3)" "unprognostic (5.46e-2)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.51e-1)" "unprognostic (3.40e-1)" "unprognostic (1.24e-1)" "unprognostic (4.01e-3)" "unprognostic (1.64e-1)" "unprognostic (4.04e-6)" "unprognostic (7.04e-3)" "unprognostic (2.45e-1)" "unprognostic (1.42e-1)" "unprognostic (2.63e-2)" 0.4 0.8 7.3 0.4 6.2 1.3 0.6 0.2 4.7 4.0 0.3 1.6 0.0 0.4 2.6 4.7 0.3 11.1 0.6 0.3 4.5 5.9 0.3 0.2 1.0 1.0 1.9 5.5 1.2 0.5 24.2 4.8 0.2 3.1 0.3 0.3 0.1 0.4 0.2 1.3 0.2 0.3 5.1 1.0 0.3 0.4 50.4 0.4 0.2 0.4 0.0 0.5 0.4 0.6 0.1 0.0 24.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 3.8 0.3 3.1 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 1.8 87.1 0.0 8.5 0.1 0.7 1.4 0.2 0.4 0.0 0.1 0.0 1.0 0.1 17.0 0.6 0.0 2.1 0.0 2.0 0.0 0.6 0.0 0.6 1.4 0.0 2.0 0.0 0.4 0.0 17.0 1.1 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 21.5 0.1 24.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 6.2 0.2 4.7 4.5 5.9 1.9 5.5 3.1 0.4 0.0 1.1 0.0 0.5 0.6 0.2 0.3 0.0 16.0 3.4 0.0 0.0 0.0 0.0 0.1 98.3 0.1 0.0 0.0 0.0 0.6 0.4 0.2 4.7 0.0 0.2 0.0 0.0 0.0 0.0 70.5 2.8 1.0 0.0 0.0 0.0 1.8 0.0 0.0 2.5 0.0 0.8 6.5 0.1 99.1 2.5 0.4 0.2 0.0 0.0 0.7 CCNA2 "CCN1, CCNA" ENSG00000145386 "Cyclin A2" P20248 4 121816444-121823933 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 122.3" "Cell type enhanced" "Detected in many" 13 "Erythroid cells: 70.0;Extravillous trophoblasts: 72.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 6.8" "Group enriched" "Detected in many" 5 "NK-cells: 1.7;T-cells: 6.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "CAB000114, HPA020626" Enhanced Enhanced Nucleoplasm,Cytosol Yes Yes "Nucleoplasm, Cytosol" "CAB000114: AB_563675, HPA020626: AB_1847376" "unprognostic (4.02e-2)" "unprognostic (1.93e-1)" "unprognostic (7.66e-3)" "prognostic unfavorable (8.78e-4)" "unprognostic (1.25e-1)" "unprognostic (1.67e-2)" "prognostic unfavorable (9.17e-5)" "prognostic unfavorable (4.27e-4)" "unprognostic (3.92e-3)" "unprognostic (2.65e-2)" "prognostic unfavorable (4.43e-6)" "unprognostic (8.38e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.65e-1)" "unprognostic (1.82e-1)" "unprognostic (6.07e-2)" "unprognostic (1.59e-1)" 3.2 1.5 1.3 18.6 1.7 21.6 1.8 5.1 1.2 2.5 6.3 1.0 0.8 6.6 2.2 2.1 11.7 1.7 2.4 3.2 1.8 1.8 1.7 1.6 3.4 15.6 1.6 0.8 4.5 0.9 0.5 3.2 12.0 1.3 2.2 7.8 1.0 2.1 0.8 1.1 4.2 7.4 2.4 1.8 8.9 2.9 8.4 0.8 122.3 1.4 18.8 18.4 2.5 5.1 0.3 0.9 0.6 0.3 1.7 6.8 1.9 38.7 10.1 27.7 11.8 1.5 3.8 22.7 27.1 11.9 36.0 26.8 22.0 24.1 35.7 7.3 14.2 12.7 13.1 34.8 15.9 29.7 17.1 16.1 28.6 13.4 21.3 0.3 43.1 20.3 1.0 1.2 14.9 8.9 5.7 21.5 19.0 40.7 35.9 28.5 13.9 54.9 25.0 21.8 24.3 11.3 25.2 53.7 17.4 10.2 7.7 11.8 12.5 14.2 17.4 7.5 21.7 14.5 18.3 12.7 16.9 25.7 17.8 25.8 22.8 24.1 40.9 9.7 43.9 18.7 0.0 0.3 0.6 0.2 0.1 0.1 0.3 2.0 1.4 0.9 0.1 0.0 0.5 0.3 1.7 0.3 0.1 6.8 1.9 1.3 1.7 5.1 1.2 1.8 1.8 1.6 0.8 1.3 0.8 0.0 0.6 0.0 0.7 2.5 1.1 0.7 0.0 2.7 1.2 0.0 11.8 5.7 0.0 0.3 4.8 0.7 1.5 70.0 0.2 72.3 3.3 1.1 0.0 1.5 21.0 0.0 1.2 2.5 7.5 1.5 0.9 2.9 1.7 0.0 3.1 1.3 0.4 1.5 1.1 0.0 14.2 0.0 0.9 6.1 7.9 1.1 7.1 3.2 6.4 1.3 CCNC CycC ENSG00000112237 "Cyclin C" P24863 6 99542380-99568973 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Cyclin, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010499, HPA069322" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB010499: AB_2244021, HPA069322: AB_2686120" "unprognostic (1.48e-2)" "unprognostic (1.21e-2)" "unprognostic (1.85e-3)" "unprognostic (6.34e-2)" "unprognostic (1.92e-2)" "unprognostic (1.95e-3)" "unprognostic (2.09e-1)" "unprognostic (3.86e-1)" "unprognostic (1.10e-1)" "unprognostic (1.64e-2)" "unprognostic (1.92e-1)" "unprognostic (7.10e-2)" "prognostic favorable (8.12e-4)" "unprognostic (1.91e-1)" "unprognostic (1.21e-1)" "unprognostic (1.41e-1)" "unprognostic (3.83e-2)" 18.0 21.1 14.5 16.8 20.4 13.7 23.8 23.2 24.3 15.6 17.3 8.7 21.8 19.8 13.5 28.1 26.5 11.7 24.7 12.0 14.9 16.9 31.5 47.4 16.2 23.4 13.6 12.6 13.5 35.6 20.8 31.8 24.4 17.6 18.2 15.9 12.4 37.0 20.9 13.1 15.4 22.6 17.3 12.1 21.1 20.2 8.6 10.0 27.3 30.7 16.8 21.9 17.5 15.5 20.1 15.0 21.5 13.9 17.7 26.6 18.8 27.3 8.1 15.7 30.6 11.8 16.1 39.4 19.9 23.9 24.1 30.9 31.3 16.1 53.6 21.4 16.4 23.9 17.9 24.0 26.9 38.2 13.5 25.8 33.2 13.6 27.3 21.2 37.1 10.9 15.9 16.4 17.0 21.4 16.7 23.9 29.8 45.0 20.0 21.1 13.9 13.5 27.4 21.0 16.7 13.5 23.3 26.4 21.3 31.2 30.9 23.6 14.4 10.0 22.6 23.2 24.4 13.2 35.5 19.1 13.3 17.7 13.9 29.2 14.2 21.8 46.0 22.4 26.5 16.3 21.5 12.9 10.7 14.2 13.9 26.6 20.1 17.9 14.5 15.0 16.0 20.1 15.7 2.5 17.7 10.4 15.0 18.0 18.8 14.5 20.4 23.2 24.3 14.9 16.9 13.6 12.6 17.6 10.0 41.7 32.8 32.0 84.7 66.6 40.4 13.7 50.9 26.8 37.5 22.7 21.6 96.3 71.3 107.0 19.5 44.4 29.0 0.0 162.8 75.7 39.3 116.5 32.3 46.4 37.2 23.8 41.9 33.7 29.7 33.8 20.8 32.2 55.6 39.7 33.7 45.2 119.1 24.6 23.7 103.7 40.3 19.4 43.4 58.1 15.7 59.0 147.5 37.4 38.8 113.6 CCND1 "BCL1, D11S287E, PRAD1, U21B31" ENSG00000110092 "Cyclin D1" P24385 11 69641087-69654474 "Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, Transcription, Transcription regulation" "Cyclin, Repressor" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 534.1;Pancreatic endocrine cells: 367.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.0;myeloid DC: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 96.3;WM-115: 134.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000024, HPA027802" Uncertain Supported Nucleoplasm Yes No Nucleoplasm "CAB000024: AB_563678, HPA027802: AB_2672390" "unprognostic (4.90e-2)" "unprognostic (1.54e-1)" "unprognostic (7.62e-2)" "unprognostic (1.39e-2)" "unprognostic (2.18e-1)" "prognostic unfavorable (5.51e-4)" "unprognostic (1.38e-1)" "unprognostic (2.53e-2)" "unprognostic (9.46e-2)" "unprognostic (4.84e-3)" "prognostic unfavorable (1.96e-4)" "unprognostic (4.39e-2)" "unprognostic (2.61e-3)" "unprognostic (4.38e-3)" "unprognostic (1.16e-1)" "unprognostic (6.40e-3)" "unprognostic (2.57e-1)" 52.0 11.6 9.7 6.0 9.7 0.7 22.8 3.4 7.7 15.4 8.9 15.4 19.9 8.4 18.8 23.1 37.7 11.8 31.0 23.9 10.8 8.8 14.5 68.1 22.2 3.7 12.4 5.6 6.5 31.5 83.2 16.6 38.1 10.0 30.7 6.8 24.8 25.6 21.7 2.0 43.6 10.4 16.5 12.6 12.9 19.2 4.0 7.5 9.0 17.1 23.1 23.6 21.4 22.1 3.0 3.4 0.8 0.0 0.0 0.9 0.3 48.7 19.5 6.5 0.2 20.0 21.1 14.0 77.2 28.8 9.0 5.3 21.9 37.8 0.0 35.1 40.1 15.1 35.7 0.7 21.0 16.2 0.1 3.9 0.0 4.8 22.2 4.8 0.3 0.7 11.9 4.1 12.7 4.9 21.3 15.4 0.0 0.0 0.1 71.0 20.6 0.0 2.8 11.9 20.2 21.5 0.1 20.6 1.1 41.9 30.1 1.1 25.5 0.9 18.3 48.0 16.5 11.1 1.0 64.4 44.3 12.3 19.2 52.4 96.3 57.5 0.1 37.9 0.6 134.1 0.8 0.0 0.0 0.9 0.0 0.1 3.0 0.4 0.2 3.4 2.5 0.8 0.2 0.2 0.0 0.0 0.0 0.0 0.3 9.7 9.7 3.4 7.7 10.8 8.8 12.4 5.6 10.0 7.5 169.7 99.5 5.9 202.5 179.8 2.2 68.0 124.9 78.9 155.8 118.7 2.0 6.4 26.6 534.1 0.2 134.5 22.2 0.0 128.5 1.1 63.9 195.1 27.8 148.1 60.6 0.0 54.3 108.1 18.0 0.9 3.7 17.9 49.0 3.6 40.4 66.7 367.2 54.7 54.1 42.3 2.0 129.4 220.1 0.2 19.0 306.9 2.1 7.0 62.1 326.2 CCND2 ENSG00000118971 "Cyclin D2" P30279 12 4273772-4305350 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 305.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 32.3;HBEC3-KT: 29.5;HDLM-2: 49.7;Karpas-707: 71.8;RH-30: 47.0;SuSa: 37.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA049138, HPA054196" Approved Enhanced Nucleoplasm Yes Yes Nucleoplasm "HPA049138: AB_2680650, HPA054196: AB_2682412" "unprognostic (2.98e-3)" "unprognostic (1.15e-1)" "unprognostic (7.21e-2)" "unprognostic (1.65e-2)" "unprognostic (1.70e-2)" "unprognostic (4.82e-2)" "unprognostic (4.94e-2)" "unprognostic (2.01e-3)" "unprognostic (3.16e-2)" "unprognostic (1.66e-2)" "prognostic favorable (2.52e-4)" "unprognostic (1.75e-1)" "unprognostic (1.25e-1)" "unprognostic (8.23e-2)" "unprognostic (4.52e-1)" "prognostic favorable (9.76e-5)" "unprognostic (7.06e-2)" 13.7 39.3 20.8 12.0 15.9 23.6 10.4 6.1 22.3 14.4 28.3 8.1 24.3 18.5 21.9 41.9 12.2 16.5 9.1 36.9 17.5 7.3 6.0 5.7 12.8 24.5 7.9 17.0 11.6 18.4 8.3 19.2 23.5 9.3 16.4 24.2 14.1 8.3 22.4 2.0 9.2 19.6 45.5 14.0 16.5 11.1 5.2 8.6 6.2 18.5 6.9 13.6 22.3 16.3 3.9 2.1 4.6 1.0 9.1 14.8 5.4 0.0 0.0 32.3 0.0 5.6 0.8 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.2 0.0 0.0 4.1 0.9 29.5 0.0 49.7 0.8 0.3 0.0 0.2 0.1 12.6 2.7 10.8 4.9 0.0 22.3 0.2 0.0 0.9 3.4 71.8 6.3 0.0 0.0 16.6 13.3 0.2 0.0 0.0 47.0 23.4 0.0 2.8 0.0 0.0 0.0 0.0 0.0 37.8 0.0 0.1 2.3 0.0 9.4 0.0 0.0 1.2 12.2 0.0 0.1 9.1 0.0 4.1 1.0 4.6 9.1 0.2 13.7 3.9 13.0 11.0 2.1 1.5 8.2 9.8 1.5 9.1 0.1 1.0 14.8 5.4 20.8 15.9 6.1 22.3 17.5 7.3 7.9 17.0 9.3 8.6 56.6 49.3 25.1 24.4 94.8 6.8 305.9 0.0 9.4 43.3 12.2 0.0 2.6 0.0 2.5 0.7 38.4 26.9 46.7 59.7 1.7 135.6 5.7 54.3 0.8 12.0 3.2 62.3 17.8 13.3 0.9 48.6 38.9 37.1 6.4 146.6 155.3 32.6 35.1 116.7 1.0 3.7 25.8 50.5 0.7 3.6 34.6 5.3 61.2 109.0 7.0 CCND3 ENSG00000112576 "Cyclin D3" P30281 6 41934933-42050357 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 129.2;lymphoid tissue: 142.5" "Cell type enhanced" "Detected in all" 5 "Syncytiotrophoblasts: 197.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 94.2;REH: 89.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000116, HPA042871" Approved Supported Nucleoplasm NA Yes Nucleoplasm "CAB000116: , HPA042871: " "unprognostic (4.53e-2)" "unprognostic (4.45e-2)" "unprognostic (2.45e-1)" "unprognostic (4.40e-3)" "unprognostic (1.01e-1)" "unprognostic (9.80e-2)" "unprognostic (3.40e-2)" "unprognostic (5.25e-2)" "unprognostic (7.76e-2)" "unprognostic (3.45e-1)" "unprognostic (9.17e-2)" "unprognostic (6.39e-2)" "unprognostic (2.45e-3)" "unprognostic (9.12e-2)" "unprognostic (1.71e-1)" "prognostic favorable (8.08e-6)" "unprognostic (2.11e-1)" 20.2 39.8 16.1 28.9 17.5 74.7 36.0 13.3 19.8 13.3 17.3 11.3 14.1 16.0 10.8 10.4 13.5 13.4 19.0 16.3 15.4 14.5 13.7 8.0 32.1 83.8 14.1 15.5 11.1 10.9 5.0 10.1 21.9 9.3 14.2 11.4 10.2 18.1 14.4 6.5 14.6 22.0 11.7 11.5 51.2 18.0 7.4 10.0 142.5 26.8 9.3 32.8 13.0 16.6 24.1 42.4 129.2 45.8 39.0 52.8 66.2 9.2 33.7 3.5 7.8 6.4 13.2 40.9 10.8 6.2 11.2 8.2 6.3 4.2 39.7 18.4 7.2 10.0 5.7 9.4 13.2 5.8 6.7 6.1 62.9 15.0 5.1 14.1 10.2 55.6 12.5 8.7 10.8 4.1 3.4 13.7 26.7 31.7 3.9 16.0 12.5 94.2 49.4 1.5 28.4 7.2 89.5 13.7 4.4 25.9 6.2 12.0 3.1 9.2 11.8 5.3 4.7 7.3 40.2 22.9 12.5 6.9 10.7 12.1 2.5 2.0 62.1 7.3 21.7 7.5 129.2 30.5 87.7 52.8 35.1 37.0 16.4 36.4 42.5 42.4 24.1 42.8 45.0 42.8 39.0 45.8 27.8 23.2 66.2 16.1 17.5 13.3 19.8 15.4 14.5 14.1 15.5 9.3 10.0 56.6 64.8 78.2 82.2 24.0 9.3 21.8 56.0 16.0 18.2 19.2 5.9 150.0 24.9 17.1 12.1 47.0 34.6 93.5 21.5 66.5 22.6 44.0 25.5 3.9 39.8 11.1 9.2 55.9 111.4 7.4 38.3 68.6 35.4 7.2 16.9 35.9 21.6 28.8 48.8 13.2 14.6 45.3 26.8 1.7 5.7 19.7 197.8 130.7 19.5 56.2 CCNDBP1 "DIP1, GCIP, HHM" ENSG00000166946 "Cyclin D1 binding protein 1" O95273 15 43185118-43197176 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 55.4" "Cell type enhanced" "Detected in all" 12 "Cytotrophoblasts: 313.6;Syncytiotrophoblasts: 883.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 8 "HEL: 16.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020664, HPA041065" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "CAB020664: , HPA041065: AB_2677282" "unprognostic (4.48e-1)" "unprognostic (3.98e-2)" "unprognostic (5.00e-2)" "unprognostic (2.37e-2)" "unprognostic (1.18e-1)" "unprognostic (1.27e-2)" "unprognostic (2.95e-1)" "unprognostic (7.75e-2)" "unprognostic (2.13e-1)" "unprognostic (4.94e-3)" "unprognostic (1.36e-1)" "unprognostic (1.86e-1)" "prognostic favorable (2.06e-4)" "unprognostic (1.40e-2)" "unprognostic (1.87e-1)" "unprognostic (7.95e-2)" "unprognostic (1.68e-2)" 15.6 10.9 3.4 12.6 5.3 55.4 17.5 10.8 9.5 8.8 9.4 5.6 11.5 7.6 11.3 10.7 18.3 10.4 9.6 14.1 3.9 6.9 8.2 8.4 11.6 23.6 6.1 5.6 5.6 13.4 5.2 9.6 24.1 9.3 8.8 9.0 7.7 11.3 12.8 21.1 12.0 12.9 8.2 6.0 12.8 11.8 5.9 5.4 8.3 15.6 5.9 11.0 15.9 11.7 5.4 2.9 16.9 8.0 4.6 7.6 1.6 0.3 0.4 0.6 0.3 1.6 1.1 0.6 0.4 2.0 0.4 0.4 0.5 0.4 0.6 0.5 1.4 0.2 0.6 1.4 0.6 0.3 0.9 1.4 16.9 0.8 0.6 1.2 0.8 1.0 2.0 1.6 0.2 0.6 1.7 1.3 0.3 1.0 0.6 0.6 0.0 0.5 1.9 1.2 0.7 0.5 0.5 0.6 1.5 2.2 0.7 0.8 1.3 0.6 0.5 0.4 0.7 0.1 1.6 1.6 0.5 0.2 1.3 0.3 2.0 0.7 0.3 1.7 1.8 0.5 16.9 1.9 4.9 5.2 3.3 5.4 4.4 5.6 5.1 1.6 5.4 5.9 6.1 6.1 4.6 8.0 2.9 7.6 1.6 3.4 5.3 10.8 9.5 3.9 6.9 6.1 5.6 9.3 5.4 44.7 55.2 77.3 44.9 30.8 27.2 52.0 35.7 92.3 50.0 27.9 19.6 313.6 76.3 59.3 11.5 45.0 55.7 140.2 52.3 67.6 49.5 41.5 54.4 28.2 77.3 42.9 44.4 47.9 82.6 10.0 43.7 59.8 60.8 151.5 49.4 52.2 58.5 56.1 27.6 38.5 63.1 45.3 48.9 65.4 36.8 35.3 883.1 83.0 45.2 73.2 CCNE1 CCNE ENSG00000105173 "Cyclin E1" P24864 19 29811898-29824308 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 23.3;placenta: 46.7" "Cell type enriched" "Detected in many" 14 "Extravillous trophoblasts: 1526.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 81.6" "Low region specificity" "Detected in all" "CAB000308, CAB016682, HPA018169" Approved Enhanced Nucleoplasm Yes Yes Nucleoplasm "CAB000308: , CAB016682: AB_1614564, HPA018169: AB_1847384" "unprognostic (2.90e-3)" "unprognostic (1.33e-2)" "unprognostic (1.47e-3)" "prognostic unfavorable (6.35e-6)" "unprognostic (5.78e-2)" "unprognostic (4.77e-2)" "prognostic unfavorable (3.89e-5)" "unprognostic (1.26e-3)" "unprognostic (3.14e-3)" "prognostic unfavorable (2.97e-4)" "unprognostic (3.29e-2)" "unprognostic (7.07e-2)" "unprognostic (1.11e-16)" "unprognostic (5.61e-2)" "unprognostic (1.92e-1)" "unprognostic (6.63e-2)" "unprognostic (1.46e-1)" 1.6 6.8 2.4 4.5 2.9 23.3 0.6 6.3 3.3 0.8 3.0 1.7 1.1 2.3 1.2 0.6 4.7 0.7 2.2 4.4 2.3 2.8 1.2 0.7 1.1 4.6 1.9 1.9 0.9 1.4 1.7 1.0 46.7 2.8 1.1 3.8 1.5 3.2 1.2 2.2 4.4 2.5 3.0 1.7 4.6 2.0 12.3 1.6 4.1 1.6 2.1 5.9 2.7 2.5 2.7 1.6 1.6 1.9 0.0 1.4 0.5 4.1 8.6 6.6 9.4 1.4 1.6 81.6 6.6 1.4 2.9 3.6 8.7 8.4 3.5 15.7 2.9 3.8 1.3 7.8 3.4 4.2 11.1 4.8 2.9 8.4 9.1 1.1 11.5 7.9 1.7 1.9 4.0 0.5 0.9 3.5 3.5 11.8 1.6 4.4 6.2 6.3 3.3 11.0 9.4 2.0 9.5 7.7 2.6 2.2 6.6 5.6 4.7 9.5 11.7 1.0 10.1 2.6 8.6 2.0 6.9 25.9 4.1 4.4 6.6 4.6 23.9 3.9 1.4 3.7 0.0 0.1 0.0 0.6 1.9 1.1 2.7 0.5 0.4 1.6 0.2 0.1 0.9 1.6 0.0 1.9 0.0 1.4 0.5 2.4 2.9 6.3 3.3 2.3 2.8 1.9 1.9 2.8 1.6 0.0 1.1 0.8 1.0 4.2 2.4 2.8 0.0 0.0 2.3 0.0 0.0 112.5 0.0 0.4 7.1 1.1 1.7 0.0 0.6 1526.8 4.8 1.9 0.0 0.0 37.5 3.2 2.9 1.3 0.3 2.6 1.1 1.1 1.7 0.0 2.7 1.8 1.0 2.9 2.1 0.2 0.8 6.5 3.1 14.1 19.5 5.3 96.8 2.2 3.8 2.4 CCNG1 CCNG ENSG00000113328 "Cyclin G1" P51959 5 163437569-163446151 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB000350 Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB000350: " "unprognostic (2.49e-2)" "unprognostic (1.64e-1)" "prognostic favorable (7.00e-4)" "unprognostic (2.92e-2)" "unprognostic (9.04e-2)" "unprognostic (2.26e-1)" "unprognostic (6.25e-2)" "unprognostic (1.58e-1)" "unprognostic (6.15e-2)" "unprognostic (1.45e-2)" "unprognostic (1.29e-2)" "unprognostic (1.20e-1)" "unprognostic (1.38e-3)" "unprognostic (1.46e-1)" "unprognostic (1.38e-1)" "unprognostic (1.19e-1)" "unprognostic (7.89e-2)" 32.3 24.8 11.1 16.0 14.6 9.6 20.5 9.0 9.7 27.9 43.5 11.0 14.1 41.4 22.3 23.6 24.7 19.4 25.8 29.8 11.5 10.3 40.4 46.6 20.7 26.0 22.5 9.1 44.1 42.5 13.5 12.6 17.9 17.0 39.3 26.9 12.6 25.6 18.1 51.7 10.2 68.7 35.8 27.1 22.7 24.6 17.0 15.8 26.5 38.3 29.7 15.6 48.1 21.4 23.2 23.3 15.9 14.0 15.4 36.5 22.8 9.6 10.8 45.2 25.4 39.1 75.4 47.6 13.4 32.8 13.6 30.9 23.4 19.8 23.7 13.7 17.8 22.5 4.0 24.9 33.5 20.2 11.3 31.5 18.7 14.4 40.6 42.8 8.6 12.7 81.8 19.4 13.5 13.9 41.0 43.8 16.3 16.0 16.9 46.2 6.0 15.1 11.7 20.7 7.1 9.8 13.2 22.2 13.1 33.1 37.5 10.7 12.1 0.0 5.5 27.2 29.9 21.1 27.7 25.4 8.8 19.1 7.4 11.7 15.1 5.9 16.0 15.7 14.6 14.7 15.9 10.3 11.8 15.1 14.0 22.3 23.2 26.6 20.6 23.3 14.5 36.5 29.8 4.2 15.4 13.0 8.9 31.3 22.8 11.1 14.6 9.0 9.7 11.5 10.3 22.5 9.1 17.0 15.8 23.8 18.3 58.8 79.1 50.8 12.2 40.5 30.6 2.7 17.0 34.9 0.0 122.0 137.6 62.2 4.0 45.6 56.4 0.0 103.1 85.5 67.2 98.8 42.7 41.4 51.3 14.3 68.1 60.2 65.1 3.1 70.2 48.0 35.4 50.5 100.4 22.6 102.5 63.1 67.8 185.4 9.0 38.8 59.7 7.2 12.8 38.6 81.4 88.8 179.5 81.8 CCNG2 ENSG00000138764 "Cyclin G2" Q16589 4 77157151-77433388 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 16.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034684 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA034684: AB_10669894" "unprognostic (2.58e-1)" "unprognostic (3.00e-1)" "unprognostic (1.46e-2)" "unprognostic (2.29e-1)" "unprognostic (5.73e-2)" "unprognostic (8.15e-2)" "unprognostic (8.40e-3)" "unprognostic (1.72e-2)" "unprognostic (1.20e-2)" "unprognostic (3.06e-1)" "prognostic unfavorable (8.57e-4)" "unprognostic (2.04e-1)" "prognostic favorable (2.47e-5)" "unprognostic (7.98e-2)" "unprognostic (2.20e-1)" "unprognostic (2.28e-1)" "unprognostic (1.05e-3)" 18.4 8.1 11.3 13.5 15.1 25.9 26.7 53.0 17.2 15.1 12.3 8.9 9.6 8.6 16.4 10.7 45.2 8.0 10.4 6.3 9.6 5.4 23.0 3.4 12.8 21.4 7.3 10.6 12.5 7.2 8.8 7.7 20.0 7.3 26.1 11.0 12.2 18.4 10.5 7.5 12.8 9.8 13.5 7.4 14.2 7.7 8.0 7.8 25.3 17.3 7.2 22.6 20.3 18.6 4.8 2.2 16.0 2.3 1.6 4.6 0.6 10.3 1.3 23.4 12.4 15.5 19.9 15.8 8.7 25.2 6.8 12.8 1.5 15.1 20.9 14.1 8.1 6.5 7.5 6.1 28.9 13.2 14.5 4.1 1.7 6.0 3.0 8.1 3.1 21.9 16.8 14.4 3.2 7.1 22.9 10.2 12.4 1.0 12.8 12.5 4.0 14.2 6.6 2.3 5.0 1.4 8.2 22.8 1.3 43.0 28.8 6.2 19.9 10.3 16.4 6.1 14.6 12.2 4.7 9.5 9.3 9.5 6.7 1.4 9.5 7.2 14.8 6.5 4.9 4.6 11.4 1.5 16.0 0.8 2.0 1.9 2.7 1.2 0.8 1.5 4.8 0.9 0.5 6.5 1.6 2.3 2.2 4.6 0.6 11.3 15.1 53.0 17.2 9.6 5.4 7.3 10.6 7.3 7.8 11.9 10.5 50.6 33.0 33.0 67.4 4.0 5.1 4.0 4.5 52.4 21.6 23.6 72.9 23.7 0.6 35.4 27.6 0.0 17.2 86.4 68.4 86.4 38.1 1.6 26.8 23.8 16.0 31.9 38.3 0.9 25.6 27.7 54.0 67.7 29.5 17.3 37.9 17.5 25.8 40.8 46.6 64.7 34.8 5.2 10.0 23.3 13.2 22.4 13.5 38.8 CCNH "CycH, p34, p37" ENSG00000134480 "Cyclin H" P51946 5 87318416-87413019 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 169.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019416, HPA044138" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB019416: AB_2259936, HPA044138: AB_2678828" "unprognostic (5.65e-2)" "unprognostic (3.94e-3)" "unprognostic (4.01e-3)" "unprognostic (4.12e-1)" "unprognostic (1.10e-1)" "unprognostic (9.30e-2)" "unprognostic (3.93e-2)" "unprognostic (6.43e-2)" "unprognostic (8.79e-2)" "prognostic unfavorable (4.35e-4)" "unprognostic (4.16e-2)" "unprognostic (2.27e-2)" "prognostic unfavorable (3.92e-5)" "unprognostic (1.48e-1)" "unprognostic (2.35e-1)" "unprognostic (1.61e-1)" "unprognostic (9.62e-2)" 32.4 25.8 18.7 16.1 25.2 28.9 25.5 40.9 29.9 16.3 14.7 19.2 16.9 16.0 15.5 23.7 17.4 14.9 23.2 20.3 23.4 19.4 22.6 33.8 21.7 19.6 20.8 21.4 24.3 21.0 24.3 32.5 14.8 27.3 25.3 19.0 16.6 17.9 20.5 24.4 13.7 18.8 15.7 22.1 17.2 16.3 46.9 22.3 28.4 25.7 13.9 23.6 19.7 16.4 19.9 23.1 33.5 25.7 16.7 22.8 19.0 19.3 9.2 9.1 6.0 13.4 9.5 9.3 14.0 18.3 25.0 34.7 15.7 11.0 13.2 4.9 21.8 26.1 9.9 11.5 22.9 23.6 14.4 14.5 23.4 16.7 15.1 24.1 18.8 19.0 13.2 8.5 13.0 31.7 12.8 21.9 12.4 15.5 22.5 20.7 11.6 13.2 15.6 3.7 5.1 36.3 11.0 21.4 19.3 20.9 10.5 9.1 5.8 7.8 7.0 16.9 5.6 17.1 14.8 15.0 24.4 9.3 14.1 12.4 7.2 6.8 19.6 15.6 17.8 10.8 20.1 21.8 33.5 15.3 24.9 22.7 19.9 20.3 20.6 23.1 16.6 21.0 20.1 18.2 16.7 25.7 13.7 22.8 19.0 18.7 25.2 40.9 29.9 23.4 19.4 20.8 21.4 27.3 22.3 32.8 31.8 40.7 55.2 33.2 25.9 12.0 22.9 28.1 20.5 17.4 15.7 17.7 34.9 29.2 169.8 34.1 17.3 70.0 30.3 23.0 26.8 33.8 56.5 16.9 39.8 17.5 23.1 28.3 46.3 18.0 27.3 72.7 45.5 15.4 14.4 42.4 24.8 14.0 23.7 37.5 29.3 51.8 55.5 90.7 54.1 30.2 25.2 99.7 17.4 34.9 CCNI CCNI1 ENSG00000118816 "Cyclin I" Q14094 4 77047158-77076005 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 248.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010206, HPA039853, HPA061470" Uncertain Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Golgi apparatus" "Nucleoplasm, Nuclear bodies" "CAB010206: AB_2073599, HPA039853: AB_2676710, HPA061470: AB_2684533" "unprognostic (3.68e-1)" "unprognostic (2.25e-1)" "unprognostic (7.59e-2)" "unprognostic (1.11e-1)" "unprognostic (4.64e-2)" "unprognostic (1.38e-1)" "unprognostic (8.57e-3)" "unprognostic (3.07e-1)" "unprognostic (1.51e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-1)" "unprognostic (2.16e-1)" "prognostic favorable (2.10e-4)" "unprognostic (3.81e-2)" "unprognostic (2.04e-1)" "unprognostic (2.30e-2)" "unprognostic (2.60e-2)" 49.0 26.6 48.1 47.1 45.8 50.3 121.1 101.3 248.9 66.3 56.8 21.6 36.9 25.6 56.7 69.0 56.2 50.7 45.2 87.7 44.8 34.1 48.2 34.5 64.7 70.1 55.8 33.5 94.9 65.4 36.5 33.1 35.4 46.7 61.4 34.9 32.7 45.5 62.9 64.3 38.5 45.8 61.6 58.1 41.3 42.4 53.0 20.3 55.4 81.2 28.2 60.0 82.7 62.6 49.2 42.9 70.5 39.8 33.6 56.2 24.3 24.6 14.8 48.4 42.2 72.8 66.6 18.5 19.1 46.7 30.2 29.2 18.2 37.6 45.6 29.3 47.8 18.9 12.9 33.0 66.7 48.2 32.3 13.0 27.3 17.3 17.3 71.5 46.8 55.2 52.0 79.9 27.8 68.4 86.9 42.3 24.1 23.3 49.7 42.9 28.4 60.8 44.3 21.2 17.3 9.2 38.2 45.7 19.2 45.0 28.2 61.4 33.6 25.3 38.9 30.8 35.4 22.1 20.0 28.6 37.0 22.1 39.3 25.9 27.6 12.5 48.2 31.3 32.4 23.9 43.1 32.9 70.5 31.7 33.4 44.9 46.6 52.4 47.2 37.3 49.2 56.2 47.4 47.0 33.6 39.8 42.9 44.8 24.3 48.1 45.8 101.3 248.9 44.8 34.1 55.8 33.5 46.7 20.3 160.8 205.6 381.1 554.3 375.7 387.2 381.6 262.4 87.0 102.4 186.7 64.8 225.4 673.1 338.9 56.4 305.8 254.0 186.9 291.0 357.2 371.0 733.0 274.5 108.3 295.2 171.6 395.9 297.7 542.3 122.9 559.2 420.6 381.3 312.8 295.3 254.5 414.7 272.5 929.9 450.1 187.1 543.3 450.1 159.5 349.2 345.0 317.4 433.7 302.4 523.8 CCNI2 FLJ16793 ENSG00000205089 "Cyclin I family member 2" Q6ZMN8 5 132747445-132754403 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 17.4;seminal vesicle: 15.7" "Cell type enhanced" "Detected in some" 6 "Distal tubular cells: 3.3;Mucus-secreting cells: 3.3;Muller glia cells: 4.2;Paneth cells: 2.9;Undifferentiated cells: 3.5" "Cancer enhanced" "Detected in many" "colorectal cancer: 5.4" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "MOLT-4: 24.0" HPA056288 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" Yes NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA056288: AB_2683086" "unprognostic (3.84e-2)" "unprognostic (2.44e-3)" "prognostic favorable (8.21e-4)" "unprognostic (5.97e-2)" "unprognostic (3.39e-1)" "unprognostic (6.71e-3)" "unprognostic (1.21e-1)" "unprognostic (7.49e-2)" "unprognostic (3.03e-1)" "unprognostic (2.50e-1)" "unprognostic (1.96e-2)" "unprognostic (1.07e-1)" "unprognostic (2.62e-1)" "unprognostic (1.77e-1)" "unprognostic (4.95e-1)" "unprognostic (1.71e-7)" "unprognostic (1.58e-1)" 0.3 0.7 3.4 5.6 3.5 0.3 0.3 8.4 4.7 1.2 5.8 3.5 17.4 7.8 0.2 0.7 0.5 0.8 5.2 0.6 3.9 2.6 3.8 0.3 0.7 1.7 3.9 0.5 0.3 7.4 0.4 0.9 0.5 4.1 1.7 6.5 1.5 8.4 15.7 0.7 0.7 8.9 0.4 7.2 0.8 5.5 1.4 3.9 7.0 0.8 0.7 2.1 2.4 0.3 0.3 0.1 0.7 0.1 0.2 2.7 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 3.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.0 0.4 0.0 0.6 24.0 0.1 0.4 1.5 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 1.4 1.0 0.3 0.3 0.0 0.0 0.0 0.0 1.7 3.7 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.3 0.1 2.7 0.3 2.1 2.1 0.0 0.3 1.8 0.9 0.3 0.2 0.1 0.1 2.7 0.3 3.4 3.5 8.4 2.8 3.9 2.6 3.9 0.5 4.1 3.9 0.0 0.3 0.0 0.4 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 3.3 0.4 1.7 0.0 1.7 0.0 1.4 0.1 0.0 0.9 1.1 0.0 0.1 1.6 1.2 0.0 0.0 1.5 0.3 0.0 0.0 0.0 3.3 4.2 1.2 2.9 0.0 0.3 0.0 0.0 0.0 0.2 0.7 0.1 0.0 0.0 3.5 0.6 CCNJ "bA690P14.1, FLJ10895" ENSG00000107443 "Cyclin J" Q5T5M9 10 96043394-96060870 "Predicted intracellular proteins" Cyclin "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 13.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 25.5;AN3-CA: 25.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036531, HPA058151" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA036531: AB_10696656, HPA058151: AB_2683623" "unprognostic (1.32e-2)" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" "unprognostic (1.30e-2)" "unprognostic (4.37e-2)" "unprognostic (1.14e-1)" "unprognostic (8.61e-3)" "unprognostic (1.46e-1)" "unprognostic (2.58e-1)" "unprognostic (1.11e-1)" "unprognostic (6.65e-2)" "unprognostic (4.88e-2)" "unprognostic (1.77e-3)" "unprognostic (3.06e-2)" "unprognostic (2.35e-1)" "unprognostic (1.83e-1)" "unprognostic (1.08e-2)" 7.1 10.5 5.0 8.9 9.2 18.1 7.7 11.4 8.2 6.9 8.6 6.4 9.3 8.1 10.8 8.3 6.7 8.7 8.0 5.3 4.9 5.5 11.4 6.4 8.2 8.2 5.0 3.7 8.7 9.3 11.3 11.0 7.4 6.6 7.1 7.1 9.2 7.6 7.3 7.3 5.3 11.7 7.7 5.0 13.4 7.4 9.9 5.7 16.3 7.2 5.8 8.3 6.8 5.0 1.9 6.9 1.1 4.0 1.2 3.1 2.1 5.1 4.2 25.5 25.4 2.6 2.0 3.7 3.2 3.9 5.0 4.4 10.6 2.3 7.1 3.8 3.1 4.0 3.1 16.9 3.5 6.4 3.4 6.8 6.9 3.1 15.0 6.1 6.9 3.3 3.9 4.8 4.6 11.0 4.5 11.4 6.6 10.0 0.1 3.0 5.0 11.7 7.9 14.1 0.4 3.5 14.1 1.1 0.5 5.6 4.9 3.9 13.6 3.7 1.0 7.0 8.8 5.9 7.6 5.7 3.1 6.8 3.5 7.6 1.4 0.5 6.6 3.6 12.2 2.0 0.3 4.0 1.1 2.3 3.3 3.1 1.8 2.0 1.2 6.9 1.9 2.9 2.6 0.5 1.2 3.2 1.4 1.5 2.1 5.0 9.2 11.4 8.2 4.9 5.5 5.0 3.7 6.6 5.7 6.0 1.9 3.7 2.5 1.6 4.9 2.8 2.5 5.3 2.3 5.2 13.7 1.3 3.3 2.4 2.8 3.3 1.3 0.0 2.4 1.8 2.3 3.0 0.0 1.3 3.2 1.6 4.1 7.4 8.4 5.4 1.7 3.6 1.7 1.0 3.9 3.4 3.5 0.0 1.8 2.1 3.3 0.0 3.1 6.3 4.3 1.3 0.9 1.7 3.1 2.7 CCNK CPR4 ENSG00000090061 "Cyclin K" O75909 14 99481169-99535044 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" Cyclin "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000645, HPA077073" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA000645: AB_1078606, HPA077073: AB_2732331" "unprognostic (8.07e-2)" "unprognostic (9.32e-3)" "unprognostic (9.52e-2)" "unprognostic (1.52e-2)" "unprognostic (5.83e-2)" "unprognostic (6.71e-2)" "unprognostic (9.22e-4)" "unprognostic (1.50e-2)" "unprognostic (2.06e-1)" "unprognostic (1.64e-1)" "unprognostic (4.78e-3)" "unprognostic (8.94e-3)" "unprognostic (7.74e-2)" "unprognostic (3.93e-1)" "unprognostic (2.73e-1)" "unprognostic (1.06e-1)" "unprognostic (6.21e-2)" 21.9 18.4 16.1 20.3 20.6 70.4 16.9 25.0 17.6 20.4 21.0 26.2 15.3 20.4 20.2 16.6 25.2 18.6 15.8 18.4 17.0 13.2 18.7 16.5 21.5 21.4 18.9 11.0 26.0 16.9 12.6 28.7 21.0 16.7 16.2 23.2 20.6 21.6 16.2 36.3 20.6 22.5 16.9 19.0 23.1 20.1 50.5 22.4 35.9 19.1 21.0 29.7 21.0 18.5 6.8 6.0 15.6 7.0 6.0 9.3 3.9 16.3 18.4 19.0 15.9 15.5 16.2 34.9 21.8 19.6 22.8 26.6 26.7 21.9 25.9 15.3 23.5 17.0 18.8 20.2 28.1 32.1 25.3 10.6 23.9 12.5 22.9 20.4 33.6 27.4 17.5 21.8 22.7 26.2 10.9 17.1 26.0 21.6 23.1 19.8 35.2 25.8 13.6 18.7 20.4 16.4 23.3 25.6 13.6 12.7 31.4 15.7 11.7 19.6 10.1 9.0 19.3 27.6 15.3 20.7 8.2 13.2 71.9 19.5 19.7 25.6 31.7 21.1 15.7 16.8 5.8 6.5 13.9 9.3 7.0 8.1 6.8 7.2 8.0 5.6 6.6 8.4 7.6 15.6 6.0 6.8 6.0 7.3 3.9 16.1 20.6 25.0 17.6 17.0 13.2 18.9 11.0 16.7 22.4 11.9 35.2 21.7 34.4 32.6 15.9 8.7 17.8 45.5 42.1 21.0 19.6 20.8 11.6 16.6 34.3 20.7 27.5 23.3 21.3 23.6 19.9 39.1 19.7 17.0 21.5 17.5 18.9 27.6 29.1 13.7 20.8 24.0 16.9 27.1 32.0 14.6 24.2 28.5 17.0 13.7 29.9 0.0 15.1 70.7 62.3 39.5 22.8 28.7 29.2 60.7 CCNL1 ania-6a ENSG00000163660 "Cyclin L1" Q9UK58 3 157146508-157160760 "Predicted intracellular proteins" "Transcription, Transcription regulation" Cyclin Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057911 Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" NA NA "Nucleoplasm, Nuclear bodies" "HPA057911: AB_2683553" "unprognostic (1.03e-2)" "unprognostic (3.66e-2)" "unprognostic (1.38e-1)" "unprognostic (6.90e-3)" "unprognostic (1.79e-1)" "unprognostic (6.58e-2)" "unprognostic (3.16e-3)" "unprognostic (7.50e-2)" "unprognostic (5.54e-3)" "unprognostic (3.37e-1)" "unprognostic (3.06e-1)" "unprognostic (2.40e-2)" "prognostic unfavorable (1.01e-6)" "unprognostic (3.71e-1)" "unprognostic (2.24e-1)" "unprognostic (5.62e-2)" "prognostic favorable (6.96e-7)" 32.0 23.2 12.4 36.1 18.7 60.9 26.5 17.1 15.0 16.8 24.3 13.6 17.0 19.8 15.2 20.0 16.7 21.5 25.8 15.6 11.7 8.7 20.4 29.5 23.2 20.6 20.9 9.8 23.3 24.2 13.5 25.3 17.5 18.7 18.0 10.4 15.9 14.9 26.5 16.1 18.5 28.0 19.2 24.6 27.7 19.8 8.6 18.0 25.9 18.5 17.7 20.8 20.2 22.4 12.3 11.3 24.0 8.5 13.1 15.0 6.7 13.3 8.7 11.8 8.6 12.2 8.0 12.3 8.6 10.0 10.2 9.4 15.2 10.5 15.2 7.7 6.3 7.0 11.4 9.0 10.1 9.3 13.3 11.0 10.1 9.4 12.6 10.0 6.6 5.7 9.6 18.7 9.7 12.9 10.0 8.0 8.0 6.4 8.9 7.3 11.1 12.2 12.1 10.6 10.3 10.5 11.5 10.5 21.8 6.4 8.2 6.9 13.0 7.1 6.2 17.0 9.3 6.2 18.1 6.6 9.4 5.5 10.3 10.9 18.6 15.3 19.3 9.5 9.3 8.9 4.3 8.5 12.5 11.6 7.1 12.2 11.2 10.8 11.9 10.6 12.3 15.0 12.1 24.0 13.1 8.2 11.3 11.9 6.7 12.4 18.7 17.1 15.0 11.7 8.7 20.9 9.8 18.7 18.0 202.5 402.1 106.8 367.8 238.1 68.5 43.3 109.5 174.0 241.1 64.6 125.7 121.6 19.9 124.2 27.5 202.1 397.6 46.7 112.4 131.0 201.5 320.1 214.0 72.5 144.7 38.1 237.5 142.4 220.1 14.0 118.5 210.1 133.3 125.4 150.2 55.6 123.2 199.9 70.7 16.6 185.9 129.4 199.9 42.5 20.4 242.1 174.8 208.8 128.5 426.8 CCNL2 "ania-6b, CCNM, CCNS, HLA-ISO, PCEE, SB138" ENSG00000221978 "Cyclin L2" Q96S94 1 1385711-1399328 "Predicted intracellular proteins" "Transcription, Transcription regulation" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053137 Supported Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA053137: AB_2682053" "unprognostic (3.08e-2)" "unprognostic (2.60e-1)" "unprognostic (1.14e-2)" "unprognostic (1.45e-1)" "unprognostic (8.97e-2)" "unprognostic (1.59e-3)" "unprognostic (2.06e-1)" "unprognostic (3.91e-2)" "unprognostic (1.67e-2)" "unprognostic (1.15e-1)" "unprognostic (7.08e-3)" "unprognostic (2.91e-2)" "prognostic unfavorable (1.12e-6)" "unprognostic (4.61e-2)" "unprognostic (6.17e-2)" "unprognostic (3.71e-1)" "prognostic favorable (1.46e-7)" 22.2 28.4 26.7 22.2 34.5 22.9 26.7 56.3 32.5 29.1 23.8 28.2 27.9 26.7 33.9 24.0 24.1 30.1 26.4 18.7 30.3 10.7 24.5 35.5 22.6 22.8 38.6 27.1 40.7 36.6 30.9 32.1 26.3 26.9 27.9 16.6 24.1 27.5 29.4 23.4 33.4 27.4 28.2 27.7 27.9 26.8 11.1 32.9 19.5 33.5 16.1 23.3 30.2 28.8 14.9 13.7 14.3 12.4 13.7 14.6 4.9 10.6 10.8 28.6 12.7 16.1 25.1 14.5 25.0 12.7 12.3 12.3 13.7 22.4 12.9 14.6 15.8 10.9 25.6 11.6 15.7 9.2 7.9 27.9 14.3 46.0 17.9 18.9 9.4 17.0 31.3 11.4 12.4 18.5 36.7 13.5 15.7 16.8 12.4 14.3 12.2 10.1 28.6 10.5 8.4 19.7 20.2 7.5 14.8 21.2 13.5 18.5 24.1 15.9 24.6 14.3 17.4 18.9 14.3 23.4 27.9 13.5 12.3 9.7 23.9 5.1 21.6 15.1 20.2 7.6 10.4 12.4 14.3 13.1 10.0 10.3 12.7 12.1 14.6 13.7 14.9 13.3 11.9 10.8 13.7 11.8 13.3 6.8 4.9 26.7 34.5 56.3 32.5 30.3 10.7 38.6 27.1 26.9 32.9 32.8 88.6 26.2 31.6 40.4 25.5 31.1 33.1 56.2 52.4 27.9 45.2 35.8 18.3 26.5 16.2 39.6 34.6 46.7 23.1 28.2 41.7 26.2 41.6 32.0 21.6 57.2 48.6 39.3 29.2 12.1 47.5 27.9 30.4 17.2 36.8 46.4 31.4 27.1 30.8 12.2 40.6 58.2 49.5 44.0 31.9 38.5 53.3 30.5 28.1 33.5 CCNQ FAM58A ENSG00000262919 "Cyclin Q" Q8N1B3 X 153587919-153600045 "Disease related genes, Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 61.3;Extravillous trophoblasts: 78.8;Syncytiotrophoblasts: 101.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050137, HPA059843" Uncertain Approved Nucleoplasm,Cytosol Yes No "Nucleoplasm, Cytosol" "HPA050137: AB_2681029, HPA059843: AB_2684140" "unprognostic (3.94e-1)" "unprognostic (1.94e-2)" "unprognostic (7.36e-2)" "unprognostic (2.92e-1)" "unprognostic (5.08e-2)" "unprognostic (1.02e-2)" "unprognostic (1.47e-3)" "unprognostic (2.12e-1)" "unprognostic (8.50e-3)" "unprognostic (2.08e-2)" "unprognostic (1.57e-2)" "unprognostic (1.90e-1)" "unprognostic (1.20e-1)" "unprognostic (8.75e-2)" "unprognostic (2.31e-1)" "unprognostic (2.71e-2)" "unprognostic (5.25e-2)" 3.1 5.7 4.2 6.1 12.8 4.2 9.7 3.7 11.1 4.5 5.2 6.4 4.2 6.1 3.7 10.5 5.1 5.1 4.0 14.7 7.9 6.5 6.3 5.0 10.9 9.5 6.1 4.1 9.5 3.0 6.4 6.4 7.3 5.7 6.1 3.5 8.0 6.8 10.3 4.0 5.0 4.9 6.7 7.3 5.4 2.7 7.4 3.9 4.9 4.2 8.7 5.2 4.5 7.4 1.9 6.8 2.3 1.1 4.8 1.4 19.8 15.5 6.0 21.3 11.0 5.6 9.4 12.0 10.5 11.4 11.7 14.9 7.1 16.1 23.2 12.7 17.2 12.9 19.8 11.4 11.8 9.8 20.1 3.9 9.3 11.4 9.7 13.6 9.4 7.4 10.2 7.7 8.5 5.2 9.7 8.4 4.8 7.8 9.7 23.1 9.5 16.6 7.6 21.5 26.2 10.8 9.7 8.4 8.7 8.5 7.9 10.4 6.2 9.7 14.0 6.4 3.5 12.4 6.9 10.1 14.3 22.3 18.1 11.2 10.6 20.4 9.1 21.2 7.4 0.0 2.3 6.8 4.0 2.1 1.8 7.4 3.7 2.8 1.9 6.2 4.0 2.8 1.4 1.1 1.0 1.9 4.8 1.4 3.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 4.0 5.7 7.0 0.0 36.5 61.3 22.4 0.0 0.0 0.0 0.0 32.2 78.8 0.0 0.0 2.3 0.0 36.1 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 39.7 0.0 0.0 27.4 0.0 0.0 34.6 0.0 0.0 0.0 0.0 0.0 0.0 101.1 0.0 0.0 0.0 CCNT1 "CCNT, CYCT1, HIVE1" ENSG00000129315 "Cyclin T1" O60563 12 48688458-48716998 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Transcription, Transcription regulation" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 95.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004892, CAB009016, HPA072012" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB009016: AB_2073888, HPA004892: AB_1078607, HPA072012: " "unprognostic (1.76e-3)" "unprognostic (3.20e-2)" "unprognostic (1.52e-1)" "unprognostic (1.36e-2)" "unprognostic (1.71e-2)" "unprognostic (3.76e-1)" "unprognostic (1.93e-3)" "unprognostic (1.38e-1)" "unprognostic (5.78e-3)" "unprognostic (1.86e-1)" "unprognostic (2.80e-1)" "unprognostic (1.28e-1)" "unprognostic (3.13e-1)" "unprognostic (3.22e-1)" "unprognostic (3.43e-2)" "unprognostic (4.50e-2)" "unprognostic (1.92e-1)" 16.6 14.9 13.1 12.9 17.4 38.1 15.7 20.9 17.7 13.4 12.6 16.5 10.9 9.9 19.9 13.0 13.8 15.8 10.5 11.8 13.5 8.5 13.0 14.1 15.6 14.9 14.3 13.2 21.5 15.9 18.4 19.6 18.5 14.5 12.8 12.4 12.8 12.6 11.2 18.8 16.4 14.6 13.3 12.1 16.8 13.8 22.6 15.7 22.4 16.5 10.9 15.9 15.3 13.2 5.5 4.4 14.8 2.8 3.7 4.9 0.9 7.6 10.6 10.5 10.4 8.4 9.8 12.8 10.3 8.1 7.8 6.4 13.1 9.4 20.8 13.5 6.6 5.6 9.6 16.7 7.3 11.6 11.6 10.7 21.6 17.1 5.9 9.9 23.8 11.0 7.8 10.9 9.8 13.5 11.3 6.4 12.3 20.7 9.0 9.4 4.9 11.1 11.1 11.4 4.6 8.7 10.8 16.8 8.9 7.8 14.0 11.2 12.7 15.8 8.6 12.6 8.7 11.4 13.7 6.5 9.0 9.2 6.4 9.0 13.9 18.7 18.6 10.2 33.9 5.2 6.8 2.8 7.9 3.6 1.8 4.9 4.3 3.1 3.5 1.7 5.5 4.5 4.0 14.8 3.7 2.0 4.4 1.8 0.9 13.1 17.4 20.9 17.7 13.5 8.5 14.3 13.2 14.5 15.7 14.9 17.6 17.9 16.5 34.2 20.2 11.3 15.3 24.1 14.8 12.2 21.6 11.3 3.3 7.0 95.2 23.3 11.2 0.0 6.0 11.3 13.4 16.0 28.9 12.9 8.8 36.5 11.5 22.7 18.0 21.0 15.5 16.2 20.3 5.4 14.3 16.7 6.5 10.5 13.8 7.9 13.0 6.5 23.7 16.1 13.2 39.3 14.5 24.5 10.9 27.8 CCNT2 ENSG00000082258 "Cyclin T2" O60583 2 134918235-134959342 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Transcription, Transcription regulation" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005559 Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA005559: AB_1078608" "unprognostic (2.49e-2)" "unprognostic (1.19e-1)" "unprognostic (9.57e-2)" "unprognostic (1.25e-1)" "unprognostic (4.92e-2)" "unprognostic (2.65e-3)" "unprognostic (1.85e-2)" "unprognostic (1.00e-2)" "unprognostic (1.61e-2)" "unprognostic (1.21e-2)" "unprognostic (2.79e-1)" "prognostic unfavorable (2.44e-4)" "prognostic unfavorable (1.25e-5)" "unprognostic (2.33e-1)" "unprognostic (8.51e-2)" "unprognostic (9.94e-2)" "prognostic favorable (3.28e-4)" 15.8 14.1 21.0 15.2 19.9 32.5 21.1 30.5 22.2 16.4 14.2 16.9 17.8 17.6 22.6 20.9 15.4 16.1 12.9 14.2 16.1 14.3 12.9 20.8 17.5 18.9 18.6 16.2 22.8 24.0 25.1 29.6 17.9 20.0 18.0 16.7 11.5 16.9 19.4 14.5 20.3 17.2 18.0 17.1 19.8 18.9 15.8 19.1 23.0 18.7 9.4 18.2 18.9 19.5 3.8 4.9 6.9 4.5 6.2 8.4 3.4 6.7 3.4 22.1 8.2 11.0 11.2 16.8 9.3 7.7 8.9 11.1 9.1 7.8 11.1 7.1 7.7 4.3 8.8 13.2 7.0 13.0 5.9 8.9 11.9 8.7 12.8 10.8 10.7 10.6 10.2 14.0 8.7 10.8 11.5 13.0 8.4 9.9 11.4 10.3 4.6 11.8 16.0 17.9 5.6 7.0 11.5 7.9 8.8 13.7 18.7 15.1 12.5 6.9 8.0 10.7 16.8 8.4 13.1 11.8 11.5 12.6 4.9 6.8 8.1 4.9 11.6 7.1 8.6 9.7 6.9 3.7 4.5 4.3 4.5 5.3 3.8 4.8 5.1 4.9 3.1 8.4 6.4 4.8 6.2 2.3 4.5 5.9 3.4 21.0 19.9 30.5 22.2 16.1 14.3 18.6 16.2 20.0 19.1 23.8 24.2 24.6 28.3 13.4 32.7 19.5 17.8 9.4 20.5 14.0 31.4 9.1 6.6 13.6 4.7 18.2 17.4 0.0 13.0 7.4 12.5 26.7 10.5 18.4 8.6 39.7 17.7 20.3 12.9 11.8 13.0 20.9 8.5 14.4 14.5 16.7 12.3 17.5 20.8 4.8 32.8 19.4 11.3 16.8 19.9 15.8 11.4 20.0 14.3 38.3 CCSER2 "FAM190B, KIAA1128" ENSG00000107771 "Coiled-coil serine rich protein 2" Q9H7U1 10 84328558-84518521 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 17 "Early spermatids: 1964.7;Late spermatids: 4316.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037481, HPA037482" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA037481: AB_10672385, HPA037482: AB_10671501" "unprognostic (4.06e-3)" "unprognostic (4.14e-2)" "unprognostic (2.04e-1)" "unprognostic (1.07e-1)" "unprognostic (1.71e-2)" "unprognostic (4.16e-3)" "unprognostic (2.43e-1)" "unprognostic (5.60e-2)" "unprognostic (1.54e-1)" "unprognostic (1.71e-1)" "unprognostic (3.02e-2)" "unprognostic (1.10e-1)" "unprognostic (1.41e-1)" "unprognostic (1.83e-2)" "unprognostic (8.56e-2)" "unprognostic (1.33e-1)" "unprognostic (5.74e-2)" 14.9 8.7 18.5 7.9 18.2 7.3 16.7 22.1 21.8 16.4 18.3 17.9 11.4 9.4 15.7 13.1 22.7 9.2 10.3 42.9 19.6 18.2 9.9 10.5 13.3 9.0 21.7 15.9 11.8 9.9 11.8 8.8 15.3 28.3 12.6 10.4 9.4 10.3 13.5 46.2 13.0 15.5 24.2 22.2 8.2 10.6 45.7 15.2 11.8 19.9 14.6 9.1 17.1 11.9 5.2 4.4 5.2 3.0 14.6 15.0 5.4 8.1 6.3 7.5 16.6 11.1 18.2 5.3 9.8 16.3 6.1 12.0 3.5 8.7 5.4 6.4 18.1 9.8 7.0 5.6 6.2 9.2 17.9 3.5 1.9 3.0 4.4 10.2 2.8 4.1 8.8 9.0 9.9 31.9 15.9 16.7 10.3 2.5 16.6 11.0 5.0 4.9 2.0 3.2 2.8 5.1 5.1 3.8 2.0 5.5 8.7 2.3 4.2 5.4 3.6 16.8 10.9 6.6 1.4 14.9 18.4 8.4 9.1 10.3 16.8 5.6 4.3 11.9 3.7 7.9 2.7 3.0 5.2 14.9 2.8 15.0 5.2 11.1 13.7 2.9 5.0 10.0 10.5 4.2 14.6 2.2 4.4 6.7 5.4 18.5 18.2 22.1 21.8 19.6 18.2 21.7 15.9 28.3 15.2 38.7 32.6 20.4 45.4 31.4 85.2 186.4 7.6 17.4 23.9 15.7 29.5 20.9 31.5 27.4 1964.7 54.3 18.1 0.0 40.4 16.4 42.3 44.4 13.9 19.5 18.3 58.8 15.6 33.2 15.6 4316.6 47.8 31.8 25.3 47.7 24.3 49.5 27.2 14.1 56.3 21.9 51.3 12.9 46.9 67.4 64.1 41.0 57.2 64.8 16.6 56.7 CCT4 Cctd ENSG00000115484 "Chaperonin containing TCP1 subunit 4" P50991 2 61868089-61888804 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029349 Supported Supported Nucleoplasm,Cytosol NA NA 3400000 Cytosol Nucleoplasm "HPA029349: AB_10600800" "prognostic unfavorable (2.03e-4)" "unprognostic (2.80e-2)" "unprognostic (6.46e-2)" "unprognostic (1.74e-3)" "unprognostic (5.03e-2)" "unprognostic (1.40e-2)" "prognostic unfavorable (9.37e-12)" "unprognostic (1.28e-3)" "unprognostic (2.48e-1)" "unprognostic (1.56e-1)" "unprognostic (4.88e-2)" "unprognostic (1.10e-1)" "unprognostic (2.10e-2)" "unprognostic (5.18e-2)" "unprognostic (2.00e-1)" "unprognostic (3.96e-1)" "unprognostic (2.14e-2)" 35.1 42.3 34.8 33.3 38.7 32.4 63.3 41.2 40.6 37.7 36.2 26.0 34.4 26.7 43.1 32.6 47.9 44.6 25.3 49.0 31.4 33.7 43.1 37.6 28.7 54.1 42.1 33.9 66.4 65.9 39.7 32.8 37.7 40.0 37.6 35.4 21.5 32.1 35.9 52.5 37.5 28.1 42.5 39.7 36.2 38.1 49.4 37.7 55.6 50.0 40.8 50.9 39.3 93.4 30.3 31.4 13.7 29.8 31.6 39.1 34.6 42.4 49.6 33.1 30.7 27.5 42.0 55.7 38.9 27.9 56.2 37.8 86.2 30.9 68.5 39.6 27.8 58.7 30.7 64.9 49.8 59.4 33.6 63.8 43.7 25.7 54.1 24.8 53.7 29.3 35.6 34.7 45.2 47.2 43.0 46.9 35.4 62.1 22.1 47.8 38.2 46.3 73.9 59.5 58.0 44.2 52.6 51.8 46.3 39.1 29.3 28.9 24.3 28.2 36.0 50.2 40.7 26.1 39.8 29.4 31.3 45.5 23.2 63.0 33.9 45.3 116.2 31.0 62.2 40.9 13.7 19.0 7.5 27.8 27.2 35.7 30.3 29.6 33.3 31.4 27.5 39.1 38.0 2.7 31.6 29.8 20.3 30.7 34.6 34.8 38.7 41.2 40.6 31.4 33.7 42.1 33.9 40.0 37.7 68.5 48.3 130.2 269.5 135.5 48.5 42.1 68.8 100.4 55.7 69.8 13.7 227.3 114.4 153.0 142.9 101.6 46.8 23.3 113.0 234.5 111.0 163.9 94.6 76.0 145.9 30.2 134.7 81.6 97.3 43.3 81.7 92.2 89.4 124.4 81.3 55.3 126.9 70.2 91.9 129.9 47.9 90.5 130.6 212.4 146.7 132.2 151.0 116.1 119.0 187.2 CCT8 "C21orf112, Cctq, PRED71" ENSG00000156261 "Chaperonin containing TCP1 subunit 8" P50990 21 29055805-29073797 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018520, HPA021051, HPA029426" Enhanced Approved "Nucleoplasm,Intermediate filaments,Cytosol" No No 2700000 "Intermediate filaments" "Nucleoplasm, Cytosol" "HPA018520: AB_1846204, HPA021051: AB_1846205, HPA029426: AB_10601796" "unprognostic (3.41e-3)" "unprognostic (2.75e-2)" "unprognostic (2.40e-3)" "unprognostic (1.62e-1)" "unprognostic (1.25e-1)" "unprognostic (4.25e-3)" "prognostic unfavorable (1.56e-5)" "unprognostic (8.78e-2)" "unprognostic (1.37e-1)" "unprognostic (3.09e-1)" "unprognostic (1.02e-2)" "unprognostic (2.91e-1)" "unprognostic (3.01e-2)" "unprognostic (8.26e-2)" "unprognostic (3.50e-2)" "unprognostic (1.25e-1)" "unprognostic (1.57e-1)" 33.5 62.5 28.9 36.1 43.8 28.2 39.7 47.9 46.4 34.5 33.7 15.7 41.9 29.6 37.4 36.4 47.6 33.6 23.6 43.9 33.0 36.0 43.6 42.1 33.2 48.8 28.8 39.2 39.3 47.2 35.4 42.6 41.0 39.6 30.9 38.3 17.0 34.7 38.6 68.4 35.5 30.1 38.3 29.5 39.8 35.2 30.2 30.2 66.6 36.1 52.0 57.6 38.5 47.8 25.6 41.7 17.5 38.1 22.8 27.2 33.9 50.1 28.5 36.5 26.2 27.0 37.2 40.7 40.2 25.7 45.7 38.2 60.4 31.1 99.2 27.0 27.8 56.9 20.3 75.2 46.5 52.0 41.9 39.1 137.2 34.3 26.9 28.0 67.8 38.4 28.3 28.7 53.8 44.7 33.6 43.6 44.2 105.7 58.0 46.6 26.0 51.0 26.5 65.7 50.2 35.5 45.9 71.9 61.7 46.7 26.4 36.6 26.3 39.5 41.7 34.5 40.6 37.3 59.4 31.5 26.0 73.4 24.4 50.1 37.8 72.8 78.2 30.4 77.1 39.6 17.5 33.7 16.7 18.5 36.9 25.5 25.6 24.0 24.3 41.7 19.2 27.2 24.5 3.7 22.8 38.1 24.6 26.6 33.9 28.9 43.8 47.9 46.4 33.0 36.0 28.8 39.2 39.6 30.2 59.6 50.7 145.9 155.3 127.2 80.5 66.6 81.5 101.7 63.7 71.5 17.7 231.9 122.7 173.0 13.3 94.7 74.3 23.3 120.5 222.9 82.2 111.0 110.8 53.3 152.3 73.1 93.1 52.2 97.5 17.8 77.9 129.4 109.6 186.7 93.1 81.5 121.5 94.7 87.4 163.4 64.8 103.5 99.4 175.3 178.0 114.8 238.6 86.3 148.0 143.1 CD163L1 "CD163B, M160, SCARI2, WC1" ENSG00000177675 "CD163 molecule like 1" Q9NR16 12 7346685-7479897 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 18.4;lymphoid tissue: 31.2" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 6.9;Melanocytes: 13.5;Sertoli cells: 19.4;Smooth muscle cells: 8.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 9.2;HDLM-2: 8.2;HUVEC TERT2: 8.9;TIME: 8.3;U-87 MG: 19.4" HPA015663 Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Intracellular and membrane" NA NA 170000 "Centrosome, Cytosol" Nucleoplasm "HPA015663: AB_2072575" "unprognostic (1.25e-3)" "unprognostic (1.77e-1)" "unprognostic (1.42e-2)" "unprognostic (7.46e-3)" "unprognostic (2.29e-2)" "unprognostic (7.79e-2)" "unprognostic (9.39e-2)" "unprognostic (4.44e-3)" "unprognostic (1.07e-1)" "unprognostic (8.35e-2)" "unprognostic (1.08e-1)" "unprognostic (3.08e-1)" "unprognostic (1.26e-6)" "unprognostic (8.59e-2)" "unprognostic (1.17e-1)" "unprognostic (1.52e-1)" "unprognostic (1.69e-1)" 5.0 1.7 1.2 19.1 1.2 0.0 2.5 0.8 1.6 1.4 9.2 0.3 1.0 5.5 1.2 8.5 1.8 1.3 2.6 3.2 1.2 1.0 1.7 1.5 2.8 14.6 1.1 0.7 1.0 1.0 0.1 1.4 6.8 3.3 1.4 15.1 2.7 2.5 1.4 1.1 1.4 18.4 1.8 1.0 31.2 2.6 4.6 0.2 9.5 1.7 6.4 12.9 4.3 1.2 0.2 0.7 0.7 0.8 0.0 0.0 0.2 0.2 0.4 0.2 0.0 1.0 0.3 0.0 0.8 1.8 0.2 0.8 0.0 1.4 0.0 0.3 0.8 9.2 0.0 0.0 1.1 1.4 8.2 0.0 0.0 0.4 1.2 0.0 0.5 0.0 0.3 0.0 0.2 3.3 0.6 8.9 0.0 0.1 4.7 5.2 0.0 0.0 6.6 0.2 0.0 0.0 1.5 1.5 1.8 0.0 0.0 1.2 5.6 4.3 6.8 0.0 0.3 0.0 5.5 8.3 3.0 2.7 0.3 0.0 0.1 0.1 0.0 19.4 0.4 5.7 0.0 0.8 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 1.2 0.8 1.6 1.2 1.0 1.1 0.7 3.3 0.2 0.0 0.0 0.0 0.0 1.1 2.9 0.7 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.0 2.2 0.7 0.0 0.0 1.2 0.3 0.5 0.1 0.0 0.4 6.9 0.0 0.0 0.0 4.1 1.1 0.0 3.3 13.5 0.0 0.0 1.0 2.0 1.1 0.0 0.0 1.7 19.4 8.0 3.4 0.7 1.1 0.2 0.0 0.0 0.1 CD226 "DNAM-1, DNAM1, PTA1, TLiSA1" ENSG00000150637 "CD226 molecule" Q15762 18 69831158-69961803 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.9;parathyroid gland: 82.5" "Cell type enhanced" "Detected in many" 10 "granulocytes: 12.8;Kupffer cells: 11.2;monocytes: 21.6;T-cells: 25.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "gdT-cell: 19.4;MAIT T-cell: 7.3;memory CD4 T-cell: 16.1;memory CD8 T-cell: 11.8;naive CD4 T-cell: 9.0;naive CD8 T-cell: 9.7;NK-cell: 14.0;T-reg: 5.5" "Group enriched" "Detected in many" 11 "NK-cells: 14.0;T-cells: 19.4" "Group enriched" "Detected in some" 6 "HEL: 45.3;HMC-1: 20.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA015715, HPA015865" Supported Supported "Nucleoplasm,Plasma membrane,Centriolar satellite" NA No 27000000 "Plasma membrane" "Nucleoplasm, Centriolar satellite" "HPA015715: AB_1846278, HPA015865: " "unprognostic (1.42e-4)" "unprognostic (1.30e-3)" "unprognostic (9.01e-3)" "unprognostic (3.49e-5)" "unprognostic (4.15e-1)" "unprognostic (9.52e-4)" "unprognostic (3.68e-3)" "unprognostic (2.93e-2)" "unprognostic (3.43e-1)" "unprognostic (3.31e-3)" "unprognostic (8.36e-2)" "unprognostic (1.43e-1)" "unprognostic (2.72e-3)" "unprognostic (2.20e-1)" "unprognostic (3.91e-2)" "unprognostic (2.27e-1)" "unprognostic (3.58e-2)" 1.2 0.6 1.0 7.5 2.0 1.7 0.8 0.7 0.9 1.5 2.9 0.3 0.1 1.1 1.0 1.4 0.8 0.8 1.4 0.9 1.9 1.3 1.3 3.1 5.2 14.0 1.7 0.0 1.0 0.6 82.5 2.4 0.6 1.3 0.9 1.2 2.4 5.4 0.6 1.1 0.4 6.0 1.3 4.2 31.9 1.4 1.8 0.5 6.4 1.8 2.6 10.1 2.0 1.6 0.4 1.5 0.9 0.6 14.0 19.4 6.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 2.4 0.0 45.3 0.1 0.0 0.0 0.3 20.2 0.0 0.5 0.1 0.3 0.0 0.0 0.4 0.1 4.7 0.2 0.0 0.3 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.1 0.0 0.1 5.5 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.5 19.4 0.4 7.3 0.4 16.1 11.8 1.5 0.1 9.0 9.7 0.9 14.0 0.6 0.1 5.5 6.6 1.0 2.0 0.7 0.9 1.9 1.3 1.7 0.0 1.3 0.5 3.0 5.1 0.8 0.3 0.0 2.4 1.6 0.0 2.7 1.2 0.0 0.0 0.1 0.0 0.0 6.6 0.1 0.0 0.0 0.3 0.0 0.4 0.2 12.8 0.5 1.4 0.0 0.0 2.5 11.2 7.5 0.9 7.8 0.0 21.6 0.0 1.4 0.2 0.0 0.7 0.0 3.7 0.0 0.3 0.3 0.5 0.4 0.0 25.4 0.0 0.1 CD248 "CD164L1, TEM1" ENSG00000174807 "CD248 molecule" Q9HCU0 11 66314487-66317044 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 71.0" "Cell type enhanced" "Detected in many" 14 "Fibroblasts: 70.0;Leydig cells: 69.3;Sertoli cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "naive CD8 T-cell: 17.8" "Lineage enriched" "Detected in single" 122 "T-cells: 17.8" "Cell line enhanced" "Detected in some" "ASC diff: 68.1;ASC TERT1: 67.2;BJ: 29.4;BJ hTERT+: 44.3;fHDF/TERT166: 59.3;HSkMC: 71.6;U-2197: 107.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA051856 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 27000000 "Plasma membrane" Nucleoplasm "HPA051856: AB_2681640" "unprognostic (2.26e-1)" "unprognostic (1.72e-1)" "unprognostic (8.95e-2)" "unprognostic (2.77e-2)" "unprognostic (1.14e-2)" "unprognostic (2.61e-1)" "unprognostic (7.21e-3)" "unprognostic (1.36e-2)" "unprognostic (1.01e-1)" "unprognostic (2.82e-2)" "unprognostic (6.31e-2)" "unprognostic (4.77e-2)" "prognostic unfavorable (2.69e-7)" "unprognostic (1.90e-2)" "unprognostic (2.92e-2)" "unprognostic (1.25e-1)" "unprognostic (1.30e-2)" 59.2 3.5 0.8 14.4 2.5 0.0 55.2 0.6 2.2 21.2 7.6 1.9 6.3 2.7 14.1 22.9 14.8 17.7 12.3 18.2 1.2 0.5 5.3 1.7 9.3 16.2 1.3 1.6 15.6 4.9 1.4 2.3 71.0 2.1 10.6 2.7 11.5 4.6 8.0 6.7 13.3 7.5 27.6 1.2 1.9 7.5 8.0 0.7 4.1 9.4 6.6 4.5 19.5 17.6 0.1 0.0 0.0 0.0 0.0 17.8 1.9 0.0 0.0 0.6 0.0 68.1 67.2 0.0 29.4 44.3 2.2 2.0 0.0 0.0 0.0 0.7 59.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 13.5 0.0 0.0 71.6 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.3 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.1 107.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 2.3 0.0 0.1 2.8 17.8 0.0 0.0 0.0 0.0 0.0 1.9 0.8 2.5 0.6 2.2 1.2 0.5 1.3 1.6 2.1 0.7 0.0 0.0 0.0 0.0 11.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.3 2.5 0.0 0.0 0.0 2.5 70.0 0.0 0.0 0.0 5.5 0.0 0.0 4.3 0.0 0.4 69.3 0.0 11.8 1.0 0.0 3.6 0.4 0.0 19.1 0.0 0.0 32.3 12.2 0.1 0.0 7.2 3.7 0.0 0.0 0.0 CD274 "B7-H, B7-H1, B7H1, PD-L1, PDCD1LG1, PDL1" ENSG00000120217 "CD274 molecule" Q9NZQ7 9 5450503-5470566 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 23.9;placenta: 56.0" "Cell type enhanced" "Detected in many" 14 "granulocytes: 26.7;monocytes: 73.9;Syncytiotrophoblasts: 37.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 8.4" "Group enriched" "Detected in many" 6 "granulocytes: 8.4;T-cells: 2.4" "Cell line enhanced" "Detected in many" "HDLM-2: 34.2;HHSteC: 22.8;U-251 MG: 37.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003528, CAB076385" Enhanced Approved "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" Nucleoplasm "CAB076385: AB_2687655, HPA003528: " "prognostic favorable (8.89e-4)" "unprognostic (4.54e-2)" "prognostic favorable (1.64e-5)" "unprognostic (1.27e-2)" "unprognostic (2.96e-2)" "unprognostic (1.08e-1)" "unprognostic (4.61e-2)" "unprognostic (1.44e-1)" "unprognostic (1.68e-2)" "unprognostic (5.67e-4)" "unprognostic (7.39e-3)" "unprognostic (1.69e-2)" "unprognostic (1.24e-2)" "unprognostic (1.35e-1)" "unprognostic (1.49e-2)" "unprognostic (2.67e-1)" "unprognostic (9.02e-2)" 3.4 2.1 1.7 10.8 3.2 1.4 2.2 2.5 3.3 2.0 2.3 2.5 2.8 2.6 1.7 2.4 3.0 1.9 4.3 9.5 1.4 3.7 3.0 3.6 23.9 6.4 2.3 0.7 1.7 2.7 3.8 7.4 56.0 3.2 2.9 2.2 3.3 1.7 1.6 4.3 1.3 2.7 2.3 2.4 12.8 1.9 1.2 1.0 11.6 3.7 2.1 5.8 3.1 1.9 0.9 0.0 8.4 0.1 0.4 2.4 0.7 5.9 0.1 0.0 0.2 0.0 0.0 0.0 11.9 10.1 3.0 4.2 0.0 1.9 0.0 0.2 0.3 1.5 0.2 0.0 5.2 9.9 34.2 0.0 3.4 0.1 0.0 22.8 0.0 0.0 0.2 0.0 6.3 9.3 3.1 5.9 0.3 0.0 1.1 9.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.7 0.3 0.6 0.1 0.0 0.1 0.1 0.9 0.7 0.9 0.0 0.1 10.9 6.5 2.0 0.2 37.9 0.2 0.1 0.1 2.1 0.1 0.0 8.4 0.1 0.3 1.2 0.1 2.1 0.9 2.4 1.8 0.0 0.2 1.3 0.7 5.7 0.4 0.0 0.0 1.1 0.7 1.7 3.2 2.5 3.3 1.4 3.7 2.3 0.7 3.2 1.0 11.9 10.7 0.5 1.2 4.0 1.4 6.5 0.0 4.0 3.4 0.0 0.0 4.9 0.0 6.4 0.2 6.3 0.8 0.0 3.7 20.2 1.9 0.9 26.7 1.0 4.9 0.0 0.0 10.4 1.9 0.0 0.3 7.7 3.3 73.9 0.1 0.6 12.0 0.0 0.4 0.4 0.1 0.0 0.9 0.5 0.7 2.3 37.2 1.3 0.2 2.2 CD33 "FLJ00391, p67, SIGLEC-3, SIGLEC3" ENSG00000105383 "CD33 molecule" P20138 19 51225064-51243860 "CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 49.3;lymphoid tissue: 45.4" "Group enriched" "Detected in many" 7 "granulocytes: 73.9;Hofbauer cells: 67.4;Kupffer cells: 119.1;Macrophages: 56.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "classical monocyte: 37.6;intermediate monocyte: 27.3;myeloid DC: 49.3;non-classical monocyte: 12.6" "Group enriched" "Detected in many" 9 "dendritic cells: 49.3;monocytes: 37.6" "Cell line enhanced" "Detected in some" "HEL: 28.5;HL-60: 37.9;HMC-1: 28.4;NB-4: 18.1;RPMI-8226: 20.5;THP-1: 22.2;U-937: 28.0" "CAB011442, HPA035832, HPA064807" Approved Approved "Nucleoplasm,Plasma membrane" NA NA 1400000 "Nucleoplasm, Plasma membrane" "CAB011442: , HPA035832: AB_2674808, HPA064807: AB_2685356" "unprognostic (1.18e-2)" "unprognostic (1.45e-2)" "unprognostic (2.80e-2)" "unprognostic (7.14e-2)" "unprognostic (3.71e-1)" "unprognostic (9.43e-2)" "unprognostic (2.59e-1)" "unprognostic (5.90e-3)" "unprognostic (1.76e-1)" "unprognostic (1.56e-1)" "unprognostic (2.53e-1)" "unprognostic (6.28e-2)" "unprognostic (6.88e-4)" "unprognostic (7.79e-2)" "unprognostic (3.35e-2)" "unprognostic (6.49e-2)" "unprognostic (1.67e-1)" 10.2 4.3 3.6 8.4 6.0 23.0 6.5 0.8 3.5 2.6 2.7 4.4 0.3 2.5 2.3 5.2 1.7 3.9 5.3 7.5 3.1 2.5 4.1 6.4 11.6 45.4 6.4 1.8 1.9 1.9 0.5 1.7 5.4 5.2 2.6 3.4 2.6 2.9 2.1 1.2 2.5 4.0 5.6 9.9 31.6 2.8 1.5 5.8 2.5 1.7 0.2 2.7 4.7 2.3 0.1 49.3 4.6 37.6 3.3 0.2 14.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 28.5 0.1 0.0 0.0 37.9 28.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.2 7.2 0.0 0.0 0.0 18.1 0.0 0.0 8.7 0.0 1.5 20.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 22.2 0.2 4.9 0.4 0.6 0.0 0.1 2.4 0.0 3.3 28.0 0.1 3.3 37.6 2.3 0.0 27.3 0.1 0.0 0.0 0.1 49.3 0.1 0.0 0.0 4.6 3.3 12.6 1.4 0.2 14.7 3.6 6.0 0.8 3.5 3.1 2.5 6.4 1.8 5.2 5.8 0.0 10.7 1.4 0.5 1.5 0.1 0.6 0.0 1.4 1.2 0.0 0.0 0.7 0.0 0.0 0.4 1.5 0.0 0.0 0.0 0.4 1.5 0.3 73.9 0.8 67.4 0.0 0.0 8.6 119.1 1.3 0.3 56.4 1.7 2.8 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.7 0.5 0.9 0.7 1.7 0.0 0.3 CD34 ENSG00000174059 "CD34 molecule" P28906 1 207880972-207911402 "CD markers, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Endothelial cells: 214.1;Ito cells: 81.0;Leydig cells: 135.4;Peritubular cells: 115.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 32.6;MOLT-4: 32.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000018, HPA036722, HPA036723" Enhanced Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA 69000000 "Plasma membrane, Cell Junctions" Nucleoplasm "CAB000018: AB_2063006, HPA036722: AB_2675271, HPA036723: AB_2675272" "unprognostic (3.82e-1)" "unprognostic (1.67e-1)" "unprognostic (1.04e-1)" "unprognostic (3.09e-1)" "unprognostic (1.24e-1)" "prognostic favorable (5.93e-5)" "unprognostic (1.25e-2)" "unprognostic (7.74e-2)" "unprognostic (7.65e-2)" "unprognostic (3.53e-1)" "unprognostic (1.37e-3)" "unprognostic (6.95e-2)" "prognostic unfavorable (8.47e-4)" "unprognostic (1.51e-2)" "unprognostic (1.30e-1)" "unprognostic (1.60e-1)" "unprognostic (1.01e-2)" 61.9 8.8 4.6 12.8 7.6 1.9 37.5 3.1 6.7 38.3 15.9 5.2 20.5 5.0 41.4 40.3 33.8 22.3 20.6 51.2 5.4 4.9 18.8 2.2 25.0 11.9 8.1 6.7 20.7 8.6 7.8 3.6 78.9 6.3 21.0 7.4 12.8 12.4 20.5 39.7 21.2 12.1 42.3 4.7 9.2 11.3 23.1 4.7 3.5 25.8 35.9 11.0 33.6 33.1 0.6 1.7 1.6 0.3 0.6 0.5 1.5 0.0 0.0 0.1 0.0 1.6 0.1 0.1 0.2 1.2 0.3 0.9 0.0 0.0 0.0 3.2 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 32.6 0.5 0.0 0.0 0.8 0.0 32.1 0.1 0.2 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.2 1.1 0.0 4.9 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.6 0.2 0.3 0.5 0.2 0.5 0.3 0.3 0.2 0.2 0.6 0.3 0.3 1.1 0.6 0.3 1.7 0.2 1.5 4.6 7.6 3.1 6.7 5.4 4.9 8.1 6.7 6.3 4.7 3.0 8.5 0.0 0.1 14.8 0.4 12.3 2.5 0.0 0.0 3.5 2.0 0.2 0.0 0.2 10.9 214.1 0.0 0.0 0.2 0.3 22.6 0.2 1.1 0.5 0.3 0.0 0.0 81.0 0.3 4.2 135.4 2.2 16.9 0.0 0.0 0.3 0.2 0.0 115.6 0.0 0.0 6.5 4.1 0.7 0.5 11.3 0.1 0.0 0.0 0.3 CD3EAP "ASE-1, CAST, PAF49" ENSG00000117877 "CD3e molecule associated protein" O15446 19 45406209-45410766 "Predicted intracellular proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Basal keratinocytes: 109.3;Suprabasal keratinocytes: 96.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 15.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-251 MG: 65.8" "Low region specificity" "Detected in all" "HPA041664, HPA041734" Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" NA NA "Nucleoplasm, Nucleoli fibrillar center" Mitochondria "HPA041664: AB_10795693, HPA041734: AB_10794489" "unprognostic (1.03e-1)" "unprognostic (8.98e-2)" "unprognostic (9.28e-2)" "unprognostic (1.37e-3)" "unprognostic (2.46e-1)" "unprognostic (4.10e-3)" "prognostic unfavorable (4.79e-9)" "unprognostic (1.62e-3)" "unprognostic (3.21e-1)" "unprognostic (5.01e-2)" "unprognostic (2.99e-2)" "unprognostic (7.26e-2)" "unprognostic (6.29e-9)" "unprognostic (1.02e-1)" "unprognostic (2.81e-1)" "unprognostic (1.38e-2)" "unprognostic (4.53e-2)" 7.3 5.9 7.7 8.4 9.7 4.0 7.1 14.9 9.0 5.6 5.5 6.5 2.9 4.9 6.4 3.0 9.9 7.1 6.4 6.7 7.1 6.4 5.2 6.8 4.5 7.2 8.1 6.0 8.7 18.3 6.6 7.3 5.1 8.0 5.2 4.9 3.1 7.2 4.6 14.2 8.4 4.3 6.6 5.6 5.8 4.3 5.2 9.3 3.6 6.1 7.8 8.5 5.5 5.8 3.5 15.9 1.3 3.7 3.2 4.1 2.1 10.4 10.8 1.7 7.9 2.6 2.1 7.0 5.0 1.7 8.9 5.2 10.6 7.5 16.3 5.3 3.7 7.2 10.1 15.6 14.3 6.3 8.0 10.1 9.0 4.1 7.8 4.4 9.1 3.2 3.2 9.2 12.9 7.1 2.2 6.4 6.0 20.5 3.3 8.6 12.3 6.9 2.6 12.7 11.6 9.1 9.4 6.9 10.7 3.5 7.8 10.8 4.0 10.7 14.3 2.3 3.8 7.2 5.5 6.2 12.7 13.3 7.3 65.8 5.9 23.4 17.3 6.3 13.0 9.1 0.9 2.8 0.3 1.7 3.7 3.4 2.8 2.2 2.4 5.0 3.5 3.1 4.1 1.3 3.2 3.3 15.9 1.2 2.1 7.7 9.7 14.9 9.0 7.1 6.4 8.1 6.0 8.0 9.3 6.0 12.8 10.0 23.3 109.3 4.5 1.2 7.6 6.7 12.5 1.8 9.8 13.7 1.7 15.9 0.2 9.0 1.7 0.0 5.8 19.4 6.6 7.7 5.7 4.2 10.0 11.1 4.6 4.9 2.6 0.5 8.9 7.0 11.8 2.8 4.3 3.5 11.0 0.0 10.6 6.1 5.8 0.0 8.9 0.5 18.9 96.7 6.4 0.0 9.5 11.5 CD70 "CD27L, CD27LG, TNFSF7" ENSG00000125726 "CD70 molecule" P32970 19 6583183-6604103 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" Cytokine "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 23.3;lymphoid tissue: 12.7" "Cell type enriched" "Detected in some" 23 "monocytes: 417.4" "Cancer enhanced" "Detected in many" "renal cancer: 24.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "memory B-cell: 13.9;T-reg: 23.3" "Group enriched" "Detected in many" 38 "B-cells: 13.9;T-cells: 23.3" "Cell line enhanced" "Detected in many" "SiHa: 36.8;THP-1: 30.2;U-251 MG: 44.7;U-266/70: 79.5;U-266/84: 57.5" HPA046582 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA046582: " "unprognostic (8.71e-2)" "unprognostic (9.91e-2)" "unprognostic (1.61e-1)" "unprognostic (2.33e-4)" "unprognostic (1.73e-2)" "unprognostic (1.51e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (6.29e-4)" "unprognostic (1.36e-2)" "unprognostic (1.25e-1)" "unprognostic (1.92e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (3.22e-4)" "unprognostic (2.57e-2)" "unprognostic (1.40e-1)" "unprognostic (2.27e-1)" "unprognostic (2.08e-1)" 5.3 0.2 0.2 9.3 0.2 1.4 2.2 0.9 0.9 1.4 4.1 0.2 0.1 1.0 0.4 1.8 4.0 0.7 0.8 0.4 0.2 0.2 1.7 0.4 1.9 6.1 0.4 0.1 0.3 0.4 0.0 0.3 0.3 0.2 0.9 3.1 0.2 3.1 1.2 1.2 3.3 5.2 0.7 0.5 11.8 1.7 1.9 0.1 3.2 0.8 1.8 12.7 3.1 1.1 13.9 0.1 0.2 0.0 0.4 23.3 0.9 0.2 7.5 0.0 14.8 0.3 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.1 14.2 0.8 0.0 16.3 10.4 9.1 0.7 0.0 0.0 0.3 0.0 11.2 0.0 0.0 0.0 0.4 0.1 0.0 8.7 6.2 2.4 0.0 0.0 0.2 0.4 0.2 0.0 0.2 17.8 0.1 0.0 13.7 3.8 0.0 3.0 4.8 0.0 0.0 0.0 36.8 0.0 0.1 0.0 0.1 30.2 0.2 0.1 6.6 0.0 44.7 79.5 57.5 25.6 8.2 4.5 2.8 0.2 0.0 0.0 1.9 0.0 4.8 13.9 3.2 5.0 0.0 4.0 0.4 1.3 0.1 0.4 0.0 0.1 23.3 0.9 0.2 0.2 0.9 0.9 0.2 0.2 0.4 0.1 0.2 0.1 0.0 0.0 18.2 0.1 5.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.1 1.1 0.0 0.3 0.0 1.7 1.3 0.0 0.0 0.0 1.7 3.3 417.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.2 4.6 0.0 10.2 0.0 0.0 CD72 "CD72b, LYB2" ENSG00000137101 "CD72 molecule" P21854 9 35609533-35646810 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 13 "blood: 75.5;lymphoid tissue: 59.7" "Cell type enriched" "Detected in some" 4 "B-cells: 82.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 16 "memory B-cell: 34.3;naive B-cell: 75.5" "Lineage enriched" "Detected in many" 22 "B-cells: 75.5" "Cell line enhanced" "Detected in some" "Daudi: 12.7;Karpas-707: 8.2;REH: 5.3;U-698: 28.3" "Region enriched" "Detected in single" 7 "basal ganglia: 3.6" "Low region specificity" "Detected in single" "CAB002505, HPA044658" Enhanced Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "CAB002505: AB_563629, HPA044658: AB_2679039" "unprognostic (1.13e-2)" "unprognostic (1.26e-2)" "unprognostic (1.21e-2)" "unprognostic (8.82e-2)" "unprognostic (1.87e-2)" "unprognostic (7.81e-2)" "unprognostic (7.11e-2)" "unprognostic (2.95e-1)" "unprognostic (3.29e-2)" "unprognostic (2.02e-2)" "unprognostic (1.95e-1)" "unprognostic (2.89e-1)" "prognostic unfavorable (2.49e-8)" "unprognostic (1.42e-1)" "unprognostic (2.32e-2)" "unprognostic (1.23e-1)" "unprognostic (3.59e-2)" 1.9 1.2 0.8 16.6 1.1 2.6 1.3 0.6 0.6 0.7 0.9 0.2 0.5 0.3 0.8 2.1 0.8 0.7 1.6 0.6 0.8 0.7 1.5 2.3 2.2 26.8 0.8 0.1 0.5 1.4 0.5 1.6 1.5 1.1 0.9 0.3 1.1 3.4 0.1 0.5 0.8 5.2 0.6 1.8 59.7 0.8 0.8 0.2 1.5 1.4 0.3 22.2 4.9 0.6 75.5 3.4 0.2 0.6 1.7 0.7 2.5 0.1 0.0 0.4 0.2 0.7 3.9 0.1 0.2 0.1 0.3 0.5 0.0 0.1 12.7 0.0 0.2 0.1 0.0 0.0 0.1 0.4 1.2 0.3 0.4 0.0 0.0 0.4 0.2 2.8 1.1 0.0 0.2 0.3 0.6 0.0 2.8 0.0 8.2 0.7 0.0 0.2 1.7 0.1 0.0 0.1 5.3 0.0 3.8 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.5 0.1 0.2 0.0 0.1 0.2 28.3 0.5 0.4 0.0 0.0 0.3 0.0 0.5 0.6 0.7 34.3 0.2 0.3 3.4 75.5 0.1 0.4 0.2 1.7 0.0 1.8 0.3 2.5 0.8 1.1 0.6 0.6 0.8 0.7 0.8 0.1 1.1 0.2 0.0 1.1 82.7 0.3 0.9 0.0 0.6 2.5 1.4 0.0 3.5 0.0 0.1 0.0 0.6 0.1 0.5 0.5 0.0 0.6 0.2 0.6 0.4 0.0 0.0 19.7 0.0 1.7 0.6 16.7 0.0 0.9 8.0 0.0 1.8 0.0 0.5 1.2 0.0 0.4 0.3 0.7 0.0 0.8 0.2 1.2 1.0 0.2 4.9 0.3 0.1 CD79B "B29, IGB" ENSG00000007312 "CD79b molecule" P40259 17 63928740-63932354 "Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins" "Adaptive immunity, Immunity" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 138.8;lymphoid tissue: 56.6" "Cell type enriched" "Detected in many" 8 "B-cells: 486.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory B-cell: 100.6;naive B-cell: 138.8" "Lineage enriched" "Detected in many" 6 "B-cells: 138.8" "Cell line enhanced" "Detected in some" "Daudi: 117.7;REH: 38.7;U-698: 161.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA009178, CAB009751, HPA044107" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "CAB009751: AB_2275844, HPA009178: AB_1078483, HPA044107: " "unprognostic (3.90e-3)" "unprognostic (1.61e-3)" "unprognostic (5.21e-2)" "unprognostic (3.45e-3)" "unprognostic (4.22e-3)" "prognostic favorable (2.35e-4)" "unprognostic (1.82e-1)" "unprognostic (9.25e-3)" "unprognostic (3.89e-2)" "unprognostic (1.48e-1)" "unprognostic (1.04e-1)" "unprognostic (2.87e-2)" "unprognostic (2.50e-3)" "unprognostic (1.89e-1)" "unprognostic (1.44e-1)" "unprognostic (4.28e-2)" "unprognostic (2.75e-1)" 1.7 0.7 0.4 50.6 0.4 11.1 1.2 0.3 0.4 0.6 1.7 0.3 0.3 0.7 0.6 0.5 2.6 0.6 1.4 3.4 0.4 0.2 2.3 1.7 1.3 56.6 0.4 0.3 0.6 1.6 0.0 9.0 0.5 0.3 1.0 1.3 0.8 8.9 0.9 1.2 0.9 22.4 0.5 0.4 56.0 1.8 0.6 0.3 3.7 1.4 1.7 46.6 4.5 0.9 138.8 4.2 0.5 25.0 3.4 9.2 9.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 117.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 6.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 38.7 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 1.8 0.1 0.0 0.4 0.0 0.0 5.9 5.7 161.1 0.0 0.2 0.0 0.5 1.1 0.0 4.2 16.5 4.8 100.6 5.4 2.8 4.2 138.8 3.7 2.2 0.5 3.4 25.0 0.6 9.2 9.0 0.4 0.4 0.3 0.4 0.4 0.2 0.4 0.3 0.3 0.3 0.0 2.2 486.9 0.3 3.9 0.0 0.8 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 7.1 0.0 23.3 0.0 0.4 4.3 0.3 15.0 0.5 4.7 0.0 1.2 62.0 14.1 1.1 1.1 3.5 20.3 1.0 0.0 0.0 0.0 0.0 1.8 0.8 0.0 0.0 3.3 0.7 0.1 2.8 0.3 34.6 0.0 0.1 CDA CDD ENSG00000158825 "Cytidine deaminase" P32320 1 20588948-20618908 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 126.5;bone marrow: 68.0" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 120.2;Hepatocytes: 94.4;Kupffer cells: 118.1;Pancreatic endocrine cells: 70.1;Paneth cells: 48.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 126.5" "Lineage enriched" "Detected in many" 6 "granulocytes: 126.5" "Cell line enhanced" "Detected in many" "A-431: 42.9;CAPAN-2: 28.6;HeLa: 40.6;PC-3: 20.4;SiHa: 51.0;U-937: 18.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA064202 Enhanced Approved Nucleoplasm NA NA 3700000 Nucleoplasm "HPA064202: AB_2685211" "unprognostic (2.38e-1)" "prognostic unfavorable (5.05e-4)" "unprognostic (2.86e-1)" "unprognostic (2.56e-1)" "unprognostic (8.02e-2)" "unprognostic (3.84e-3)" "unprognostic (1.47e-1)" "unprognostic (1.68e-3)" "unprognostic (2.64e-1)" "unprognostic (4.01e-2)" "prognostic unfavorable (8.56e-5)" "unprognostic (2.94e-2)" "unprognostic (5.03e-2)" "unprognostic (8.47e-3)" "unprognostic (2.81e-1)" "unprognostic (3.38e-1)" "unprognostic (1.89e-3)" 4.0 1.4 1.5 4.0 1.5 68.0 2.2 1.1 2.4 19.0 8.6 1.7 2.0 2.6 6.7 3.5 38.3 2.9 1.8 5.9 1.7 1.6 12.5 42.1 8.4 9.1 2.0 1.3 2.9 0.8 1.2 0.7 30.8 3.5 4.2 10.2 4.5 6.9 1.5 3.2 7.0 24.7 4.3 1.9 11.8 1.2 2.9 0.9 0.9 3.0 23.3 10.5 3.1 16.5 0.0 1.3 126.5 21.7 0.0 0.1 7.1 42.9 4.2 0.0 0.0 0.0 1.3 0.0 3.3 0.9 0.8 3.4 0.2 28.6 0.0 1.6 6.8 1.8 15.1 0.8 11.2 2.2 0.0 0.8 0.0 40.6 5.4 0.3 0.0 0.0 1.9 1.8 8.1 0.0 0.1 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 5.0 20.4 0.0 0.0 0.4 0.1 0.0 0.0 0.0 51.0 0.0 0.0 0.5 0.0 1.2 0.7 0.0 1.7 3.9 0.2 0.0 0.0 0.0 0.5 18.0 0.0 16.3 21.7 43.3 0.0 11.4 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 126.5 0.0 9.3 0.2 0.0 7.1 1.5 1.5 1.1 2.4 1.7 1.6 2.0 1.3 3.5 0.9 3.0 1.4 0.9 0.2 1.3 0.1 2.8 2.5 0.0 0.0 5.2 0.0 0.2 36.5 2.4 0.6 4.4 120.2 0.0 1.3 2.7 1.0 0.9 0.0 94.4 6.1 0.0 0.0 28.8 118.1 0.8 0.3 3.7 0.0 0.0 12.5 0.0 70.1 48.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 2.1 1.5 4.9 0.3 CDADC1 NYD-SP15 ENSG00000102543 "Cytidine and dCMP deaminase domain containing 1" Q9BWV3 13 49247925-49293485 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 173.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 10.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047615, HPA058314" Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA047615: AB_2680104, HPA058314: AB_2683677" "unprognostic (2.81e-1)" "unprognostic (2.64e-1)" "unprognostic (2.20e-1)" "unprognostic (2.86e-1)" "unprognostic (2.75e-1)" "unprognostic (1.11e-2)" "unprognostic (1.58e-3)" "prognostic favorable (6.03e-4)" "unprognostic (7.68e-2)" "unprognostic (6.06e-2)" "unprognostic (2.35e-3)" "unprognostic (1.89e-1)" "prognostic favorable (1.19e-5)" "unprognostic (3.35e-2)" "unprognostic (5.92e-3)" "unprognostic (5.40e-2)" "unprognostic (8.27e-3)" 9.3 13.8 11.6 6.5 10.4 11.0 8.6 14.1 12.9 8.4 8.6 7.1 8.4 6.3 9.7 12.5 6.7 7.6 6.7 8.5 9.5 9.7 18.6 15.4 7.0 5.7 9.8 11.2 9.5 5.6 8.8 12.5 4.3 10.7 8.2 6.7 7.6 6.8 9.5 7.9 4.7 6.0 8.4 14.2 8.7 8.0 23.5 8.8 5.5 18.5 7.2 5.2 6.5 7.4 1.0 1.3 10.3 2.7 1.8 3.3 1.4 2.6 3.2 2.8 3.4 14.0 7.7 1.4 6.2 3.9 3.1 3.3 3.2 2.1 3.5 1.3 2.7 3.1 4.4 5.7 2.8 4.0 7.6 4.6 4.0 3.1 3.3 6.1 7.5 2.2 5.3 6.9 3.0 3.8 5.6 4.6 7.0 2.5 2.6 3.9 0.9 7.1 6.2 1.0 4.3 2.8 4.8 3.0 3.5 4.6 0.8 1.6 1.4 4.2 2.7 3.5 1.9 1.9 6.6 3.4 1.7 3.1 4.4 2.8 0.8 2.8 2.2 1.4 8.7 4.6 10.3 1.9 1.5 2.4 1.5 2.6 0.7 1.8 3.3 1.3 1.0 1.6 2.3 2.0 1.8 2.7 1.3 2.5 1.4 11.6 10.4 14.1 12.9 9.5 9.7 9.8 11.2 10.7 8.8 6.0 11.3 3.9 7.2 7.1 12.0 13.6 5.1 24.1 7.9 17.4 11.8 4.0 8.3 4.8 173.6 8.9 5.3 23.3 9.3 7.7 10.8 5.9 24.3 11.5 5.4 3.2 6.4 8.6 9.4 52.5 14.7 8.5 6.8 2.8 7.6 23.8 6.1 5.8 13.4 16.7 12.1 0.0 16.9 32.9 4.1 4.6 2.1 14.4 6.0 5.0 CDC123 "C10orf7, D123" ENSG00000151465 "Cell division cycle 123" O75794 10 12195965-12250589 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037830, HPA057540" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA037830: AB_10671368, HPA057540: AB_2732614" "unprognostic (5.35e-3)" "unprognostic (9.06e-2)" "unprognostic (2.42e-1)" "unprognostic (5.09e-3)" "unprognostic (1.75e-2)" "unprognostic (3.50e-2)" "prognostic unfavorable (3.16e-7)" "unprognostic (2.63e-1)" "unprognostic (2.22e-1)" "unprognostic (3.20e-2)" "unprognostic (2.74e-2)" "unprognostic (8.54e-2)" "prognostic unfavorable (2.42e-6)" "unprognostic (5.35e-2)" "unprognostic (1.40e-1)" "unprognostic (3.88e-2)" "unprognostic (6.19e-2)" 26.1 28.0 30.8 28.8 50.8 35.7 25.5 24.6 35.0 25.8 32.0 24.2 16.3 21.5 26.1 27.2 34.1 25.3 18.4 36.5 28.5 25.1 33.2 45.1 21.5 34.7 25.9 27.6 19.5 26.0 18.4 26.9 28.8 36.6 20.7 31.8 16.1 22.4 22.9 29.2 29.8 24.7 30.2 24.9 36.2 21.8 22.5 24.6 39.0 24.4 20.5 41.9 29.2 23.4 43.7 40.7 66.4 34.0 32.3 38.8 40.6 31.0 41.6 29.7 36.0 28.6 28.2 24.4 27.0 18.8 39.0 42.0 57.5 39.8 53.6 28.5 34.1 25.3 35.0 54.1 49.5 32.6 37.6 42.5 41.8 33.6 52.7 35.3 32.6 36.3 30.1 25.8 49.3 29.2 19.4 42.6 69.8 43.0 25.8 33.9 28.7 41.6 27.4 52.3 47.7 15.6 43.3 24.8 47.6 35.7 18.1 15.3 30.2 28.9 37.6 33.5 27.3 39.2 36.8 45.7 24.1 29.5 36.6 34.1 25.4 46.6 65.8 30.2 31.2 15.6 28.6 28.7 66.4 31.4 32.4 32.4 43.7 35.3 34.6 40.7 42.1 29.0 30.9 64.6 32.3 34.0 33.2 38.8 40.6 30.8 50.8 24.6 35.0 28.5 25.1 25.9 27.6 36.6 24.6 29.8 31.0 35.7 38.0 48.1 27.6 45.3 30.6 52.2 30.7 33.2 5.9 108.7 72.9 73.7 3.9 34.2 23.6 0.0 72.5 115.3 36.6 29.6 47.4 34.5 85.2 25.4 20.1 36.2 19.4 7.0 38.6 50.4 43.9 112.8 26.7 40.1 66.8 37.7 43.2 54.7 26.4 38.8 43.2 42.1 28.9 64.6 64.9 50.3 44.3 45.3 CDC14A "cdc14, Cdc14A1, Cdc14A2, DFNB105" ENSG00000079335 "Cell division cycle 14A" Q9UNH5 1 100345001-100520278 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Hearing" "Hydrolase, Protein phosphatase" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 38.2" "Group enriched" "Detected in many" 6 "Early spermatids: 165.7;Late spermatids: 161.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 30.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023783 Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA023783: AB_1846352" "unprognostic (3.72e-2)" "unprognostic (2.38e-2)" "unprognostic (1.84e-2)" "unprognostic (2.98e-2)" "unprognostic (1.54e-3)" "unprognostic (1.38e-1)" "unprognostic (9.27e-4)" "unprognostic (4.88e-3)" "unprognostic (6.30e-2)" "unprognostic (3.97e-3)" "unprognostic (8.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.79e-3)" "unprognostic (6.29e-2)" "unprognostic (2.04e-1)" "unprognostic (1.49e-2)" "unprognostic (6.66e-2)" 6.2 2.4 5.8 6.5 5.5 13.7 12.2 1.8 6.2 7.7 11.8 4.8 2.2 7.2 15.1 4.8 3.4 13.7 3.6 4.1 8.8 3.5 6.6 2.4 12.3 15.4 3.8 5.4 5.8 6.7 9.8 8.1 7.6 4.6 10.0 6.3 8.3 7.7 3.9 4.3 5.6 22.6 5.0 3.2 9.6 6.0 38.2 4.7 12.0 6.1 3.4 11.3 5.8 8.4 4.8 6.1 11.6 3.7 3.9 13.0 4.1 2.2 1.8 5.9 6.7 2.2 1.6 4.1 2.9 1.9 2.9 2.3 6.2 1.9 1.1 2.1 1.7 2.3 1.7 4.0 1.6 2.9 2.3 9.9 4.0 1.7 2.0 0.8 5.4 7.1 1.3 0.4 3.1 1.0 1.4 5.1 2.4 30.6 3.5 4.2 1.0 4.3 6.0 3.6 1.4 2.3 4.7 7.6 1.1 2.0 5.1 1.1 1.9 3.0 2.9 4.0 3.0 1.3 7.0 2.2 1.6 3.6 2.7 1.7 1.7 0.6 1.7 1.9 5.0 0.9 11.6 3.7 8.4 7.3 3.3 13.0 4.8 11.3 8.4 3.5 3.1 11.0 5.8 5.5 3.9 2.3 6.1 5.6 4.1 5.8 5.5 1.8 6.2 8.8 3.5 3.8 5.4 4.6 4.7 3.0 5.6 2.2 4.2 3.3 0.2 5.3 0.0 28.1 5.7 1.8 3.9 1.7 0.0 2.7 165.7 9.3 12.8 0.0 1.7 0.8 4.7 6.6 14.0 1.5 2.3 0.0 4.6 6.2 4.6 161.3 4.6 4.3 5.0 5.4 4.7 9.1 2.5 8.7 0.7 1.7 3.6 0.0 2.8 1.9 3.0 2.0 1.8 10.2 2.7 2.3 CDC14B "Cdc14B1, Cdc14B2, CDC14B3, hCDC14B" ENSG00000081377 "Cell division cycle 14B" O60729 9 96490241-96619830 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.9" "Lineage enhanced" "Detected in many" "granulocytes: 9.9" "Cell line enhanced" "Detected in many" "ASC diff: 15.2;ASC TERT1: 22.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013312, HPA064747" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA013312: AB_1846354, HPA064747: AB_2732719" "unprognostic (5.69e-2)" "unprognostic (9.09e-2)" "unprognostic (3.50e-2)" "unprognostic (8.08e-3)" "unprognostic (4.24e-1)" "unprognostic (1.19e-2)" "unprognostic (1.11e-2)" "unprognostic (4.49e-2)" "unprognostic (1.63e-2)" "unprognostic (2.27e-2)" "unprognostic (2.35e-1)" "unprognostic (2.75e-1)" "prognostic favorable (2.97e-10)" "unprognostic (2.01e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (2.82e-4)" "unprognostic (7.40e-2)" 7.3 6.2 6.8 3.0 7.5 4.4 15.7 2.4 6.6 5.3 5.0 14.8 7.1 4.5 4.0 3.7 3.5 7.1 5.9 8.2 6.0 4.6 9.1 16.0 4.9 1.8 9.5 4.0 5.8 7.3 17.1 5.2 3.4 7.1 5.7 5.4 8.3 3.8 7.2 2.2 3.3 7.7 4.2 9.3 2.2 9.3 16.9 8.2 0.2 13.6 2.2 2.1 10.4 10.3 1.6 0.0 9.9 0.0 0.1 2.9 0.8 5.2 2.9 3.1 3.2 15.2 22.8 8.5 3.8 5.1 2.5 4.1 9.9 8.3 0.0 3.7 8.0 6.2 5.9 4.4 3.0 3.0 1.3 4.1 0.8 1.0 7.8 2.5 0.0 0.1 9.4 1.5 2.7 2.5 3.0 0.5 0.0 3.0 0.6 3.5 2.5 0.0 0.8 5.8 5.9 2.5 0.0 1.9 0.1 4.0 8.1 0.9 4.9 2.7 0.8 1.5 11.0 0.7 1.7 1.5 2.5 3.0 6.6 2.8 0.1 0.0 0.0 2.7 0.0 6.0 9.9 0.0 3.1 2.9 0.0 1.6 1.6 1.3 2.3 0.0 0.8 2.3 1.4 0.0 0.1 0.0 0.0 1.6 0.8 6.8 7.5 2.4 6.6 6.0 4.6 9.5 4.0 7.1 8.2 6.0 9.1 2.4 7.4 8.0 6.4 14.5 10.2 16.0 14.8 8.7 7.9 5.3 6.6 4.8 28.7 4.7 8.5 0.0 5.7 2.5 9.3 10.2 13.9 27.2 8.6 7.9 2.4 8.0 1.0 27.6 8.3 4.1 8.5 3.6 7.6 10.9 6.9 6.5 11.0 14.1 11.7 25.8 22.0 3.7 5.5 6.8 2.9 5.0 7.2 8.1 CDC20 "CDC20A, p55CDC" ENSG00000117399 "Cell division cycle 20" Q12834 1 43358955-43363203 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 42.0;testis: 73.2" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 97.6;Erythroid cells: 70.0;Extravillous trophoblasts: 127.9;Spermatocytes: 74.9;Spermatogonia: 48.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "memory B-cell: 4.5;memory CD4 T-cell: 3.3;memory CD8 T-cell: 3.6;NK-cell: 9.8;T-reg: 11.2" "Group enriched" "Detected in many" 9 "B-cells: 4.5;NK-cells: 9.8;T-cells: 11.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "CAB004525, HPA045842, HPA055288" Enhanced Enhanced Nucleoplasm,Cytosol Yes Yes "Nucleoplasm, Cytosol" "CAB004525: AB_628089, HPA045842: AB_2679470, HPA055288: AB_2682773" "unprognostic (1.66e-2)" "unprognostic (1.09e-1)" "unprognostic (1.73e-2)" "unprognostic (2.14e-3)" "unprognostic (1.58e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (4.00e-8)" "unprognostic (9.06e-3)" "unprognostic (1.17e-2)" "unprognostic (1.23e-2)" "prognostic unfavorable (1.32e-4)" "unprognostic (8.55e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.84e-2)" "unprognostic (2.28e-1)" "unprognostic (2.01e-1)" "unprognostic (1.29e-2)" 1.3 1.2 0.6 16.6 1.1 20.2 1.8 0.8 1.3 2.1 6.2 2.8 0.4 5.8 1.1 1.6 17.8 0.4 1.9 1.2 0.9 0.5 2.2 1.2 1.8 13.4 1.1 0.7 0.9 0.5 0.0 0.4 3.9 1.2 0.8 7.0 0.4 2.9 0.4 0.6 4.6 6.4 2.8 1.2 7.8 4.4 73.2 0.7 42.0 1.2 11.7 21.7 1.9 4.2 4.5 0.9 0.8 0.1 9.8 11.2 2.7 52.6 25.7 35.9 23.4 1.2 3.2 34.4 24.4 21.9 71.2 38.0 40.3 43.8 30.5 14.3 22.4 25.1 37.1 39.2 46.6 59.5 23.9 29.0 44.6 25.4 24.9 0.3 31.1 16.3 1.0 2.2 49.4 44.8 6.2 30.1 29.3 20.1 21.0 32.2 20.4 29.9 19.1 45.4 25.1 34.6 43.5 49.3 19.3 17.3 14.0 21.2 10.4 43.1 29.2 13.5 28.8 20.5 39.4 15.6 21.3 50.0 23.6 75.6 16.1 14.3 31.6 15.3 38.8 31.7 0.0 0.1 0.0 0.4 0.0 0.0 4.5 3.3 3.6 0.9 0.9 0.1 0.3 0.8 9.8 0.0 0.2 11.2 2.7 0.6 1.1 0.8 1.3 0.9 0.5 1.1 0.7 1.2 0.7 0.0 0.6 16.2 2.0 9.3 0.0 0.7 0.0 2.7 1.2 0.0 0.0 13.4 0.0 2.1 97.6 0.7 3.2 70.0 0.3 127.9 4.1 2.0 0.0 1.0 30.9 0.0 0.0 8.0 5.0 7.0 2.6 5.2 0.0 2.8 2.9 0.2 0.7 0.0 1.8 2.1 2.6 0.0 1.4 74.9 48.1 7.3 8.9 1.3 15.5 2.6 CDC25A ENSG00000164045 "Cell division cycle 25A" P30304 3 48157146-48188402 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.0;lymphoid tissue: 23.0;testis: 19.4" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 106.0" "Cancer enhanced" "Detected in many" "testis cancer: 19.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 1.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005855, HPA008803" Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA005855: AB_1846364, HPA008803: " "unprognostic (1.49e-1)" "unprognostic (8.13e-2)" "unprognostic (1.20e-2)" "unprognostic (1.43e-3)" "unprognostic (2.14e-1)" "unprognostic (9.51e-2)" "unprognostic (7.05e-7)" "unprognostic (1.35e-2)" "unprognostic (4.32e-3)" "unprognostic (8.92e-3)" "unprognostic (4.41e-2)" "unprognostic (9.09e-2)" "unprognostic (4.41e-3)" "unprognostic (1.57e-3)" "unprognostic (1.07e-1)" "unprognostic (1.29e-1)" "unprognostic (2.72e-1)" 0.8 1.2 1.1 5.5 1.1 13.0 0.8 0.7 1.2 1.1 3.3 0.6 1.0 1.8 0.6 0.9 3.9 0.4 2.2 0.7 1.3 2.4 1.2 0.9 0.7 4.1 1.4 0.2 2.1 3.6 0.4 2.3 4.2 1.2 1.0 4.0 1.5 1.8 0.5 0.7 0.8 2.1 0.8 0.7 3.6 1.3 19.4 0.2 23.0 1.6 8.8 7.4 0.8 1.3 1.7 0.9 0.5 0.1 0.0 1.0 0.1 7.6 3.8 18.1 9.7 0.6 1.2 12.5 10.6 4.0 13.4 10.9 16.4 4.0 22.8 4.2 2.8 8.5 5.8 30.9 7.3 14.2 7.4 16.3 29.1 6.9 8.1 0.6 20.5 8.5 0.6 1.1 16.6 7.2 1.6 5.0 17.0 23.1 12.1 7.2 4.1 25.6 16.0 26.4 7.0 8.7 11.5 11.9 12.4 3.4 7.2 8.5 10.6 6.6 7.7 3.4 12.0 4.0 14.6 2.5 6.6 10.2 7.3 14.5 6.1 18.2 35.8 4.9 22.9 5.5 0.0 0.0 0.5 0.4 0.0 0.0 1.7 0.6 0.2 0.9 0.0 0.0 1.0 0.0 0.0 0.1 0.5 0.0 0.1 1.1 1.1 0.7 1.2 1.3 2.4 1.4 0.2 1.2 0.2 0.0 0.0 0.0 0.4 0.3 0.0 106.0 0.0 0.0 0.0 0.0 2.0 1.9 0.0 0.5 14.7 0.1 0.3 0.0 0.8 5.7 0.5 0.4 0.0 0.2 2.5 0.0 1.2 1.3 0.3 22.9 1.4 0.0 0.0 0.0 1.5 0.5 0.9 0.0 1.8 0.2 0.4 0.0 0.4 15.8 13.7 0.0 0.2 0.0 3.2 0.3 CDC26 "ANAPC12, APC12, C9orf17" ENSG00000176386 "Cell division cycle 26" Q8NHZ8 9 113255835-113275589 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044130 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA044130: AB_10963690" "unprognostic (9.21e-2)" "unprognostic (1.04e-1)" "unprognostic (1.47e-2)" "unprognostic (2.60e-1)" "unprognostic (1.48e-1)" "unprognostic (2.59e-2)" "prognostic unfavorable (1.72e-4)" "unprognostic (1.03e-1)" "unprognostic (1.26e-1)" "unprognostic (7.27e-2)" "unprognostic (1.62e-1)" "unprognostic (1.18e-1)" "unprognostic (7.49e-3)" "unprognostic (8.84e-2)" "unprognostic (1.27e-1)" "unprognostic (6.26e-2)" "unprognostic (3.79e-2)" 24.2 21.8 19.1 21.0 25.3 15.8 27.4 20.8 19.8 24.2 27.4 18.0 30.9 19.7 20.1 29.4 22.2 18.6 16.6 37.5 18.1 15.9 27.6 34.9 21.7 24.7 24.9 15.2 23.2 24.2 27.4 23.3 26.7 20.7 23.4 23.2 15.6 31.7 24.6 28.1 21.7 37.1 36.3 29.1 27.7 21.8 13.3 25.7 22.7 34.5 20.1 29.7 31.5 44.6 54.8 30.1 65.2 30.3 44.9 68.5 38.2 14.2 23.4 20.5 10.3 35.2 30.4 9.4 20.9 32.9 22.4 22.2 24.6 17.4 26.7 18.7 18.7 25.3 28.3 17.3 31.9 22.4 24.2 12.6 17.5 23.6 22.8 17.2 30.7 17.7 21.0 22.4 20.7 30.4 23.4 30.0 21.4 26.1 20.1 16.9 29.4 26.0 19.8 33.8 67.2 20.9 22.9 44.0 13.1 23.5 25.1 15.8 15.1 28.1 20.3 15.6 23.6 18.6 13.3 19.7 13.5 12.5 19.9 26.9 13.5 23.3 21.1 18.9 18.2 13.1 48.1 30.0 65.2 46.7 30.3 57.2 54.8 59.4 51.5 30.1 45.3 68.5 53.1 46.0 44.9 28.0 25.5 56.7 38.2 19.1 25.3 20.8 19.8 18.1 15.9 24.9 15.2 20.7 25.7 32.8 39.2 64.1 66.0 69.1 19.1 3.6 33.1 41.5 34.2 21.0 21.6 37.2 96.2 52.8 18.0 69.7 46.7 46.7 52.2 58.4 57.1 55.8 26.5 66.9 53.1 14.3 30.6 50.3 51.1 10.0 74.2 59.9 49.0 69.5 42.9 29.4 51.6 55.4 41.1 133.8 30.6 25.8 44.3 31.4 15.8 79.4 40.0 74.6 45.5 76.1 CDC27 "ANAPC3, APC3, D0S1430E, D17S978E, NUC2" ENSG00000004897 "Cell division cycle 27" P30260 17 47117703-47189422 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Erythroid cells: 163.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016315, HPA028129, HPA052399, HPA065835" Supported Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB016315: AB_627228, HPA028129: AB_10603559, HPA052399: AB_2681814, HPA065835: " "unprognostic (2.34e-2)" "unprognostic (8.83e-3)" "prognostic favorable (1.77e-4)" "unprognostic (4.26e-2)" "unprognostic (7.99e-2)" "unprognostic (8.93e-3)" "prognostic unfavorable (4.38e-4)" "prognostic unfavorable (8.15e-4)" "unprognostic (1.98e-1)" "unprognostic (1.45e-1)" "unprognostic (4.05e-3)" "unprognostic (6.17e-2)" "prognostic unfavorable (6.39e-5)" "unprognostic (2.64e-1)" "unprognostic (1.58e-1)" "unprognostic (7.95e-2)" "unprognostic (3.66e-2)" 29.2 18.9 19.4 18.7 25.2 23.0 23.3 26.0 33.0 23.7 17.2 14.8 13.8 14.4 23.2 19.6 17.6 17.6 18.6 22.8 18.3 22.6 16.8 23.8 20.4 21.3 19.4 23.9 19.5 14.3 27.8 26.8 25.0 31.5 17.6 18.2 14.6 15.7 16.5 31.6 15.5 15.3 24.4 17.7 24.2 16.1 23.5 17.4 25.2 42.8 15.5 22.9 23.6 17.3 9.0 7.7 9.6 10.3 12.8 11.6 5.4 23.6 25.4 21.3 17.1 14.4 22.9 12.7 33.5 30.2 32.0 32.8 16.2 12.5 31.9 22.6 28.0 20.5 11.4 22.9 18.9 44.2 45.8 23.5 37.1 26.8 14.4 15.6 21.7 16.9 16.6 9.3 28.8 22.8 15.5 33.0 18.7 29.5 17.8 26.0 20.1 26.7 9.9 10.1 13.4 20.7 14.4 54.7 14.1 19.3 15.0 14.2 17.3 16.8 5.9 18.6 19.0 17.9 15.4 35.1 33.5 29.1 21.1 24.7 18.2 31.5 28.9 18.5 13.0 23.1 9.6 4.4 6.2 8.1 10.3 7.8 6.0 6.8 8.5 6.0 9.0 6.7 7.6 5.7 12.8 7.4 7.7 11.6 5.4 19.4 25.2 26.0 33.0 18.3 22.6 19.4 23.9 31.5 17.4 8.9 22.9 28.9 16.0 23.1 20.2 34.3 22.9 10.7 28.4 19.2 15.7 24.5 13.3 23.9 23.6 38.7 10.6 163.5 23.1 29.3 36.3 14.9 25.5 25.2 24.1 33.4 13.3 37.4 24.8 22.5 26.2 19.8 6.8 31.5 13.5 19.5 24.1 10.5 28.0 17.4 13.9 19.4 33.0 88.5 35.1 23.5 9.6 21.0 14.3 13.1 CDC34 "E2-CDC34, UBC3, UBE2R1" ENSG00000099804 "Cell division cycle 34" P49427 19 531712-542092 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cell cycle, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 170.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002382, CAB005109, CAB047311, HPA074334" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "CAB005109: AB_2276050, CAB047311: , HPA002382: AB_1846370, HPA074334: " "unprognostic (4.65e-2)" "unprognostic (2.02e-1)" "unprognostic (1.41e-1)" "unprognostic (8.72e-2)" "unprognostic (2.84e-1)" "unprognostic (5.73e-2)" "prognostic unfavorable (7.57e-4)" "unprognostic (2.20e-1)" "unprognostic (3.11e-1)" "unprognostic (3.83e-2)" "unprognostic (2.09e-2)" "unprognostic (3.06e-2)" "unprognostic (3.02e-2)" "unprognostic (8.87e-3)" "unprognostic (9.68e-2)" "unprognostic (7.82e-3)" "unprognostic (3.33e-2)" 16.5 15.9 21.3 11.3 19.1 24.7 20.4 25.7 30.9 16.0 20.5 19.5 10.5 15.4 13.3 13.4 15.6 14.5 13.6 35.6 21.1 18.2 12.1 36.0 13.0 9.9 18.5 19.8 17.0 37.4 11.3 17.0 24.9 16.2 17.2 10.6 15.3 26.4 18.5 63.9 19.0 13.2 18.6 14.3 12.7 15.7 43.6 15.0 12.2 13.1 17.0 8.7 19.2 16.4 2.9 2.8 11.5 4.5 1.5 4.1 1.3 18.7 18.8 24.1 19.8 10.9 10.5 24.1 16.9 13.0 18.2 19.0 29.0 11.5 10.3 17.7 12.0 11.0 13.0 18.9 14.2 9.3 16.9 50.8 9.5 12.4 31.4 27.3 13.4 11.6 13.5 21.3 15.4 16.1 14.3 21.7 14.6 40.8 20.8 12.0 26.9 18.3 17.9 30.4 13.9 18.2 16.9 12.4 17.4 13.7 11.2 31.4 23.3 14.7 15.2 28.0 20.7 12.2 19.8 17.7 13.3 15.9 30.9 22.5 20.7 15.9 13.8 18.2 19.0 13.7 4.5 3.5 6.2 2.3 3.4 1.7 2.9 3.2 4.1 2.8 1.7 2.5 2.4 11.5 1.5 4.5 2.3 3.1 1.3 21.3 19.1 25.7 30.9 21.1 18.2 18.5 19.8 16.2 15.0 0.0 4.8 9.7 16.8 41.6 35.9 25.8 38.2 1.4 1.2 14.0 23.6 38.5 11.6 17.9 55.3 20.2 34.4 0.0 17.3 40.4 28.2 30.2 0.0 35.2 23.7 15.9 12.7 14.7 12.6 170.3 16.7 12.9 18.6 10.0 25.9 67.6 35.7 21.2 14.2 15.9 36.1 12.9 30.1 18.4 52.8 47.8 52.7 10.0 21.2 26.8 CDC40 "EHB3, FLJ10564, PRP17, PRPF17" ENSG00000168438 "Cell division cycle 40" O60508 6 110180141-110254275 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 179.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046620 Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA046620: AB_2679722" "unprognostic (4.19e-3)" "unprognostic (2.41e-2)" "unprognostic (1.23e-2)" "unprognostic (1.10e-2)" "unprognostic (4.25e-2)" "unprognostic (3.64e-2)" "unprognostic (3.42e-2)" "unprognostic (5.24e-1)" "unprognostic (2.82e-1)" "unprognostic (1.08e-1)" "unprognostic (9.27e-2)" "unprognostic (1.92e-1)" "unprognostic (4.68e-2)" "unprognostic (7.36e-2)" "unprognostic (1.09e-1)" "unprognostic (3.01e-1)" "unprognostic (2.09e-1)" 13.1 20.7 13.4 13.9 32.8 36.3 15.3 15.4 34.1 15.0 12.7 12.4 11.7 12.0 13.8 12.1 13.3 12.7 11.7 11.3 18.0 11.0 19.9 19.9 12.0 19.5 12.7 12.5 18.7 14.3 17.1 34.0 11.9 14.7 14.5 13.8 11.4 13.3 11.6 16.4 11.8 14.9 13.1 11.6 21.3 12.4 13.1 13.3 29.1 18.1 12.7 19.8 14.2 12.6 23.6 19.8 18.3 17.3 12.4 14.0 7.7 6.6 6.2 11.2 19.5 11.6 12.0 9.2 13.0 16.1 13.2 16.8 13.6 6.9 22.4 14.6 11.6 14.2 9.6 17.2 10.6 18.9 18.0 13.1 18.4 8.9 7.4 15.1 23.5 24.8 10.9 10.2 13.9 11.3 9.9 13.1 14.7 18.3 13.6 13.2 6.5 17.4 8.9 11.2 9.1 6.8 15.3 13.2 7.7 9.7 14.2 12.0 11.9 9.6 8.5 9.2 10.7 7.9 22.8 14.7 7.2 7.2 16.8 14.4 6.9 9.1 20.3 11.7 19.9 10.4 18.3 15.0 15.3 11.7 15.8 11.3 23.0 11.6 11.9 12.4 23.6 14.0 12.0 16.9 12.4 17.3 19.8 12.7 7.7 13.4 32.8 15.4 34.1 18.0 11.0 12.7 12.5 14.7 13.3 29.8 29.9 51.1 24.2 23.5 87.2 18.1 22.9 29.4 31.8 26.2 41.2 28.3 48.0 32.3 179.7 34.6 21.6 0.0 32.6 26.0 25.8 20.0 48.5 50.8 33.4 89.0 25.3 38.6 28.2 63.6 62.5 41.9 10.1 21.6 26.9 50.0 24.6 31.7 42.5 58.7 77.9 77.6 20.3 18.2 18.8 23.7 24.0 42.6 31.9 17.4 CDC42EP1 "Borg5, CEP1, MSE55" ENSG00000128283 "CDC42 effector protein 1" Q00587 22 37560447-37569405 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ductal cells: 199.1;Exocrine glandular cells: 194.9;Pancreatic endocrine cells: 199.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 9.4;intermediate monocyte: 2.9;myeloid DC: 3.5" "Group enriched" "Detected in many" 10 "dendritic cells: 3.5;monocytes: 9.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006379, HPA076536" Approved Supported "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Plasma membrane" "Nucleoplasm, Actin filaments" "HPA006379: AB_1078486, HPA076536: " "unprognostic (1.32e-1)" "unprognostic (1.81e-1)" "unprognostic (2.44e-1)" "unprognostic (3.79e-3)" "unprognostic (5.82e-2)" "unprognostic (4.06e-2)" "unprognostic (4.38e-2)" "unprognostic (5.57e-2)" "unprognostic (9.45e-2)" "unprognostic (1.63e-1)" "unprognostic (2.06e-2)" "unprognostic (1.53e-1)" "unprognostic (1.86e-2)" "unprognostic (2.85e-2)" "unprognostic (3.85e-2)" "unprognostic (3.81e-2)" "unprognostic (1.09e-3)" 19.1 26.2 12.1 10.6 29.4 1.9 21.9 2.9 27.3 17.2 13.0 68.7 7.2 19.7 21.0 6.2 25.0 20.4 31.9 12.2 18.3 10.1 14.6 57.4 18.6 6.9 41.4 13.1 31.7 80.8 7.4 5.7 24.9 28.7 11.5 9.9 12.0 36.5 16.9 7.2 22.4 13.8 13.2 34.5 9.7 69.5 8.8 34.2 0.4 9.7 14.2 14.2 10.3 19.2 0.6 3.5 0.4 9.4 0.6 0.3 3.5 30.5 8.9 3.9 17.3 6.2 10.6 18.8 17.6 10.4 20.3 14.1 21.8 4.0 0.0 6.2 20.3 6.5 23.9 4.5 8.8 6.8 3.8 15.3 0.1 8.6 13.1 44.4 0.0 0.1 19.7 13.4 16.7 16.0 16.4 15.1 0.0 19.1 0.1 8.3 10.5 0.0 0.1 3.4 23.9 20.1 0.1 7.0 0.6 7.1 0.4 0.1 0.7 12.9 28.7 27.5 5.6 12.8 2.7 23.0 42.7 25.5 20.5 24.3 0.0 0.1 0.0 16.9 0.1 34.4 0.4 9.4 0.0 0.2 2.9 0.2 0.0 0.1 0.1 3.5 0.6 0.1 0.3 0.3 0.6 0.2 0.4 0.0 3.5 12.1 29.4 2.9 27.3 18.3 10.1 41.4 13.1 28.7 34.2 6.0 24.5 3.4 55.6 41.7 0.0 1.6 91.7 1.4 12.5 12.2 0.0 83.5 1.7 199.1 3.2 31.5 19.5 0.0 194.9 83.2 32.7 99.5 2.3 31.4 11.9 1.6 11.1 61.4 2.9 1.2 36.5 3.9 20.3 10.0 60.1 9.5 199.6 49.1 33.2 4.4 0.0 38.8 53.1 2.4 0.2 45.5 93.8 2.6 57.5 135.8 CDC45 "CDC45L, CDC45L2" ENSG00000093009 "Cell division cycle 45" O75419 22 19479459-19520612 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.7;lymphoid tissue: 25.4;testis: 43.5" "Cell type enhanced" "Detected in some" 16 "Early spermatids: 88.0;Erythroid cells: 46.7;Spermatocytes: 23.9;Spermatogonia: 49.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 87.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000614, CAB009459" Enhanced Supported Nucleoplasm,Centrosome,Cytosol NA Yes Nucleoplasm "Centrosome, Cytosol" "CAB009459: AB_2078507, HPA000614: AB_1078487" "unprognostic (5.56e-2)" "unprognostic (6.12e-3)" "unprognostic (1.17e-3)" "unprognostic (3.42e-3)" "unprognostic (3.57e-1)" "unprognostic (7.42e-2)" "prognostic unfavorable (6.95e-6)" "unprognostic (6.01e-3)" "unprognostic (1.85e-3)" "unprognostic (1.47e-2)" "prognostic unfavorable (8.94e-4)" "unprognostic (7.28e-2)" "unprognostic (0.00e+0)" "unprognostic (7.62e-3)" "unprognostic (2.02e-1)" "unprognostic (8.52e-2)" "unprognostic (1.10e-1)" 0.9 0.9 0.3 8.4 0.5 15.7 0.9 0.3 0.6 1.3 3.4 0.3 0.2 2.2 0.6 1.4 6.2 0.4 0.8 1.6 0.7 0.3 0.8 1.4 1.3 7.5 0.4 0.2 0.7 0.5 0.1 0.4 3.5 0.4 0.7 4.3 0.2 1.3 0.2 0.4 2.1 3.1 1.1 0.4 4.2 1.8 43.5 0.2 25.4 0.5 7.2 10.2 1.3 1.9 0.7 0.9 1.6 0.5 1.8 3.2 1.9 13.2 11.1 13.9 10.9 0.6 1.3 5.9 16.4 7.7 18.9 18.8 8.5 7.4 14.8 5.8 4.9 7.5 12.8 14.8 10.8 17.0 18.0 25.0 19.8 12.6 9.3 0.7 28.7 10.9 0.4 0.5 14.5 6.5 1.8 9.5 15.3 87.8 18.7 11.0 17.7 23.3 13.6 4.2 25.7 8.4 19.4 23.1 6.5 4.4 12.7 18.0 9.5 8.9 9.8 2.8 6.5 6.4 12.8 3.6 14.8 23.7 11.2 14.9 6.4 11.8 17.2 7.8 14.4 19.7 0.0 0.2 0.0 2.2 0.0 0.0 0.7 1.4 2.3 0.6 0.0 1.0 0.7 1.6 1.8 0.5 0.9 3.2 1.9 0.3 0.5 0.3 0.6 0.7 0.3 0.4 0.2 0.4 0.2 0.0 0.0 0.8 0.4 2.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.9 88.0 0.3 0.4 46.7 0.0 16.8 1.0 0.2 0.0 0.0 6.2 0.0 0.0 3.7 0.6 6.1 0.6 0.9 0.0 0.0 0.8 0.0 0.1 0.0 0.7 0.0 0.0 6.5 0.9 23.9 49.8 1.6 4.1 1.3 2.5 0.4 CDC5L "CDC5, CEF1, hCDC5, PCDC5RP" ENSG00000096401 "Cell division cycle 5 like" Q99459 6 44387525-44450426 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cell cycle, DNA damage, DNA repair, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 293.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006302, HPA011361, CAB012275" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB012275: , HPA006302: AB_1078488, HPA011361: AB_1846379" "unprognostic (2.67e-1)" "unprognostic (9.31e-2)" "unprognostic (8.26e-3)" "unprognostic (4.17e-3)" "unprognostic (2.01e-2)" "unprognostic (2.17e-1)" "unprognostic (7.96e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (7.02e-5)" "unprognostic (1.01e-2)" "unprognostic (6.31e-2)" "unprognostic (1.63e-1)" "unprognostic (4.33e-2)" "unprognostic (3.08e-2)" "unprognostic (3.37e-2)" "unprognostic (1.31e-1)" "unprognostic (1.46e-1)" 21.3 18.6 17.1 17.4 17.6 24.5 18.3 30.3 22.1 19.4 16.1 12.2 13.9 12.6 18.2 20.5 20.4 15.1 12.0 18.0 17.4 15.3 16.4 24.7 12.8 16.3 16.6 15.0 21.8 15.0 32.4 26.1 20.8 19.2 19.6 15.6 8.6 16.8 13.6 30.8 14.8 15.9 23.2 18.1 17.6 14.3 16.9 19.1 28.4 16.0 17.4 18.1 26.0 16.6 11.5 13.6 21.1 17.6 14.8 14.8 8.2 18.3 7.2 17.8 14.4 7.3 9.6 10.1 13.4 10.5 17.0 18.8 9.4 6.3 17.6 11.2 10.7 13.9 11.7 18.5 10.6 25.6 14.8 16.6 23.4 7.2 12.1 6.7 17.5 12.7 7.3 9.4 16.6 14.4 9.8 11.0 9.1 17.9 10.4 15.4 12.4 16.2 12.0 12.5 44.8 6.7 12.7 20.5 11.3 9.6 11.0 19.8 17.2 10.8 7.3 14.3 11.9 10.3 17.1 10.1 14.7 15.0 11.4 18.9 9.0 10.8 32.3 9.4 15.3 14.7 16.7 13.9 17.4 11.7 16.6 13.3 10.7 11.4 12.9 13.6 11.5 12.2 11.8 21.1 14.8 17.6 11.8 14.8 8.2 17.1 17.6 30.3 22.1 17.4 15.3 16.6 15.0 19.2 19.1 68.5 39.9 34.7 52.2 39.3 32.7 74.2 25.5 104.4 97.8 22.7 29.5 47.5 33.2 43.0 293.7 44.7 17.1 0.0 47.7 42.8 39.4 39.6 69.3 34.7 39.6 30.2 34.7 27.6 35.5 192.5 57.0 42.2 18.6 66.7 34.2 61.8 43.6 34.0 51.9 22.6 35.1 64.7 52.1 39.1 88.8 33.5 60.0 32.0 35.9 49.8 CDC6 CDC18L ENSG00000094804 "Cell division cycle 6" Q99741 17 40287633-40304657 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 30.0" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 23.3;Extravillous trophoblasts: 27.7;Spermatogonia: 23.0;Syncytiotrophoblasts: 14.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 6.2" "Group enriched" "Detected in many" 5 "dendritic cells: 6.2;NK-cells: 2.2;T-cells: 3.4" "Cell line enhanced" "Detected in many" "SK-BR-3: 86.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA050114, HPA065070" Approved Approved "Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes Yes "Nucleoplasm, Cytosol" "Cytokinetic bridge, Mitotic spindle" "HPA050114: AB_2681021, HPA065070: AB_2732729" "unprognostic (1.29e-1)" "unprognostic (7.22e-2)" "unprognostic (1.23e-3)" "unprognostic (7.97e-2)" "unprognostic (7.12e-2)" "unprognostic (2.89e-2)" "prognostic unfavorable (5.96e-8)" "unprognostic (2.31e-3)" "unprognostic (1.46e-3)" "unprognostic (1.41e-1)" "prognostic unfavorable (2.90e-4)" "unprognostic (5.47e-2)" "unprognostic (3.00e-15)" "unprognostic (1.86e-2)" "unprognostic (1.35e-1)" "unprognostic (3.95e-3)" "unprognostic (3.88e-2)" 1.8 2.9 3.1 10.8 2.6 16.8 1.5 2.3 6.0 2.7 5.8 0.8 2.7 5.3 1.9 1.6 9.0 1.3 5.4 1.6 1.9 1.4 1.8 5.1 2.8 10.6 1.0 1.5 1.5 3.6 1.1 1.2 9.4 0.8 1.4 5.6 0.2 3.2 4.1 0.9 2.3 7.9 2.4 1.6 7.7 2.7 14.8 1.2 30.0 1.3 5.0 10.1 4.1 3.0 0.7 6.2 0.2 0.3 2.2 3.4 1.2 25.4 17.6 21.3 15.1 1.1 2.3 19.5 27.8 8.3 24.4 29.5 20.0 11.4 20.6 17.4 5.9 14.1 37.1 18.4 12.6 24.3 10.9 14.5 16.7 21.0 17.9 0.7 22.8 10.3 0.6 0.9 28.2 16.9 2.6 7.3 14.2 30.5 19.3 11.8 13.3 33.1 5.5 17.5 15.1 6.5 24.4 51.9 19.4 4.0 28.7 14.6 13.1 25.3 86.7 8.6 17.4 17.6 19.8 6.1 17.6 25.2 28.8 32.9 8.1 17.5 39.7 15.2 15.1 19.2 0.1 0.3 0.0 1.3 0.0 0.9 0.7 1.2 2.1 1.4 0.7 0.9 2.1 0.2 2.2 0.0 6.2 3.4 1.2 3.1 2.6 2.3 6.0 1.9 1.4 1.0 1.5 0.8 1.2 0.0 1.3 2.2 1.1 3.8 0.0 0.6 0.0 0.0 1.2 0.0 0.0 12.0 0.0 1.2 1.4 0.5 1.1 23.3 0.6 27.7 2.4 1.1 0.0 0.9 6.8 0.0 0.0 1.8 1.3 0.2 2.6 1.3 0.0 0.0 1.7 0.3 1.2 2.9 0.7 0.2 0.3 12.9 1.0 11.4 23.0 1.4 14.0 2.5 4.6 2.0 CDC7 "CDC7L1, HsCdc7, Hsk1, huCdc7" ENSG00000097046 "Cell division cycle 7" O00311 1 91500893-91525764 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 28.3;Spermatocytes: 28.4;Spermatogonia: 20.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002669, HPA035831" Enhanced Supported "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" Yes No Nucleoplasm "Cytokinetic bridge, Mitotic spindle" "CAB002669: , HPA035831: AB_2674807" "unprognostic (6.84e-2)" "unprognostic (6.01e-2)" "unprognostic (4.64e-2)" "unprognostic (7.02e-3)" "unprognostic (5.57e-2)" "unprognostic (3.57e-3)" "prognostic unfavorable (3.15e-6)" "unprognostic (6.52e-2)" "unprognostic (2.23e-2)" "unprognostic (1.36e-3)" "unprognostic (2.04e-2)" "unprognostic (1.75e-2)" "prognostic unfavorable (1.89e-15)" "unprognostic (9.44e-3)" "unprognostic (2.49e-2)" "unprognostic (1.09e-1)" "unprognostic (5.39e-2)" 2.5 3.7 5.7 7.6 8.9 15.4 4.3 19.4 10.3 2.5 4.2 1.4 0.9 4.2 2.8 2.6 4.7 1.7 2.6 1.9 6.8 5.2 3.6 2.3 5.1 11.7 4.0 4.7 3.7 2.4 2.2 12.3 7.9 5.2 2.7 6.8 2.3 2.5 2.3 1.0 6.8 4.9 3.3 5.9 15.1 2.6 21.2 4.7 18.7 2.5 4.5 12.0 4.2 3.0 1.6 3.5 0.1 1.6 2.4 6.5 2.1 14.2 4.2 27.6 7.8 0.6 3.7 8.8 5.4 4.3 10.7 11.7 8.9 5.1 9.9 7.6 3.4 9.3 6.2 18.1 6.1 14.8 16.4 15.5 15.0 12.2 4.1 1.0 16.3 5.5 1.9 1.8 9.8 5.6 1.9 4.1 13.9 19.8 14.5 7.3 5.2 14.0 14.6 22.9 7.8 10.1 17.3 22.9 6.3 4.6 10.7 21.9 8.6 17.1 4.7 9.6 7.1 4.4 8.0 3.4 12.1 10.7 9.4 8.1 5.3 6.7 26.5 4.3 15.9 4.4 0.0 1.6 0.0 5.9 1.2 5.2 1.5 4.5 5.6 3.5 1.6 2.5 5.1 0.1 2.4 0.3 2.1 6.5 2.1 5.7 8.9 19.4 10.3 6.8 5.2 4.0 4.7 5.2 4.7 0.0 0.6 2.2 1.1 5.3 7.6 1.3 0.0 1.4 1.2 1.8 0.0 5.3 3.3 1.1 28.3 2.8 0.2 0.0 2.2 5.1 4.6 0.7 4.6 0.0 2.2 3.2 0.0 3.1 1.8 12.9 0.9 1.0 3.3 1.0 1.3 1.3 1.0 1.1 0.7 0.1 4.7 6.5 3.1 28.4 20.6 3.1 1.8 5.1 2.9 0.9 CDC73 "C1orf28, FIHP, HRPT1, HRPT2, parafibromin" ENSG00000134371 "Cell division cycle 73" Q6P1J9 1 193121997-193253901 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002326, CAB016359, HPA069324" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB016359: AB_628102, HPA002326: , HPA069324: " "unprognostic (4.41e-2)" "unprognostic (6.22e-2)" "unprognostic (1.90e-2)" "unprognostic (5.30e-2)" "unprognostic (2.88e-3)" "unprognostic (3.53e-2)" "unprognostic (2.48e-3)" "unprognostic (5.74e-2)" "unprognostic (1.25e-1)" "unprognostic (1.40e-1)" "unprognostic (7.23e-3)" "unprognostic (2.17e-1)" "unprognostic (5.44e-3)" "unprognostic (3.47e-1)" "unprognostic (2.49e-1)" "unprognostic (6.73e-3)" "unprognostic (2.98e-3)" 23.4 20.0 18.1 16.8 22.9 21.0 20.1 25.6 22.6 20.4 20.1 14.5 16.3 12.0 26.8 15.2 20.6 14.9 16.4 21.4 18.4 15.0 18.8 17.1 17.2 16.6 19.7 15.9 23.3 14.5 27.1 24.8 17.3 19.4 26.9 16.2 13.6 17.3 19.0 44.5 15.0 14.5 25.6 23.9 16.0 15.7 16.3 22.1 20.6 27.1 14.1 15.8 26.8 35.0 6.6 6.7 10.2 7.0 9.0 12.5 5.2 13.4 12.1 16.0 10.3 15.0 14.6 12.3 14.5 14.1 17.6 15.4 8.3 16.0 17.5 10.3 17.8 9.7 13.2 14.5 13.7 21.5 11.1 6.9 12.7 10.9 8.0 14.1 17.2 12.7 11.9 13.3 16.5 15.8 15.6 14.9 10.0 19.2 14.2 23.5 12.4 14.1 8.5 15.4 19.8 4.5 12.6 9.7 16.7 20.6 9.4 4.8 13.2 18.1 22.4 20.7 18.6 19.2 12.5 16.6 17.1 4.0 14.5 14.8 13.3 9.9 14.4 10.3 10.6 29.9 6.6 7.0 10.2 9.3 6.8 12.5 6.6 9.2 9.2 6.7 5.4 8.4 8.7 7.4 9.0 5.7 4.9 9.3 5.2 18.1 22.9 25.6 22.6 18.4 15.0 19.7 15.9 19.4 22.1 32.8 20.1 34.3 31.1 33.1 31.2 36.4 20.4 20.1 19.4 31.4 33.4 21.8 28.2 29.4 11.9 30.1 16.2 23.3 28.5 34.0 29.2 33.5 39.4 14.3 28.0 20.6 10.9 22.1 25.9 6.1 31.1 38.8 27.0 47.7 15.3 33.5 28.2 13.1 33.9 26.4 36.3 25.8 57.1 56.5 32.0 30.6 31.8 29.8 16.1 23.2 CDCA2 "PPP1R81, Repo-Man" ENSG00000184661 "Cell division cycle associated 2" Q69YH5 8 25458997-25507920 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 38.8;testis: 17.7" "Group enriched" "Detected in many" 7 "Cardiomyocytes: 22.0;Early spermatids: 29.6;Extravillous trophoblasts: 12.3;Late spermatids: 14.4;Sertoli cells: 12.9;Spermatocytes: 45.9;Spermatogonia: 28.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 2.6;T-reg: 1.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA026293, HPA030049" Enhanced Supported Nucleoplasm Yes Yes Nucleoplasm "HPA026293: AB_1846384, HPA030049: AB_10600862" "unprognostic (2.12e-1)" "unprognostic (4.75e-3)" "prognostic favorable (9.62e-4)" "unprognostic (2.92e-2)" "unprognostic (9.69e-2)" "unprognostic (3.56e-2)" "unprognostic (2.50e-5)" "unprognostic (1.47e-3)" "unprognostic (6.06e-2)" "unprognostic (2.91e-3)" "unprognostic (1.32e-3)" "unprognostic (1.99e-1)" "prognostic unfavorable (2.30e-14)" "unprognostic (1.36e-2)" "unprognostic (4.02e-1)" "unprognostic (1.91e-1)" "unprognostic (5.30e-2)" 0.8 0.5 0.3 11.3 0.5 5.5 0.6 0.3 0.3 0.7 3.3 0.2 0.0 1.3 0.5 0.2 2.8 0.3 0.1 0.6 0.3 0.3 0.5 0.5 0.6 4.4 0.4 0.2 0.4 0.3 0.0 0.4 3.3 0.3 0.5 2.0 0.1 0.7 0.0 0.4 1.0 3.3 0.6 1.0 3.9 0.8 17.7 0.4 38.8 0.4 3.5 5.9 0.6 1.0 0.7 0.0 0.0 0.0 2.6 1.9 0.8 14.8 14.1 13.1 10.9 1.1 2.0 8.7 16.7 9.9 14.6 14.6 12.0 6.8 17.6 7.2 6.9 15.8 13.6 18.2 8.5 21.6 6.6 5.2 18.0 10.2 6.4 0.3 8.0 8.8 1.1 0.5 10.2 6.9 1.4 10.5 10.6 14.2 20.4 13.3 5.8 22.4 3.8 13.4 10.3 6.2 11.6 14.5 6.4 4.1 8.1 5.5 5.9 14.1 6.8 6.6 6.6 7.5 3.9 7.2 10.9 17.5 20.5 15.4 3.4 6.9 18.7 7.8 10.5 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.1 0.0 0.1 0.1 0.0 0.0 2.6 0.0 0.0 1.9 0.8 0.3 0.5 0.3 0.3 0.3 0.3 0.4 0.2 0.3 0.4 0.0 0.6 0.8 0.5 1.0 0.4 22.0 0.0 1.4 0.0 0.0 0.0 1.3 0.0 0.2 29.6 0.0 0.0 0.0 0.0 12.3 0.4 0.4 0.0 0.0 3.3 0.0 0.0 1.3 1.9 14.4 1.1 1.2 0.0 1.0 0.1 0.0 0.2 0.0 0.0 0.5 0.3 12.9 0.7 45.9 28.1 0.6 1.4 1.9 1.2 0.4 CDCA4 "FLJ20764, Hepp" ENSG00000170779 "Cell division cycle associated 4" Q9BXL8 14 105009573-105021148 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 38.3" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 133.3;Spermatogonia: 64.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA064971 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA Yes Nucleoplasm "Plasma membrane, Cytosol" "HPA064971: AB_2685395" "unprognostic (2.22e-3)" "unprognostic (1.84e-1)" "unprognostic (2.69e-1)" "unprognostic (9.93e-3)" "unprognostic (1.42e-1)" "unprognostic (8.36e-2)" "prognostic unfavorable (4.19e-4)" "prognostic unfavorable (7.94e-4)" "unprognostic (4.20e-2)" "unprognostic (8.54e-2)" "prognostic unfavorable (6.67e-4)" "unprognostic (6.73e-2)" "prognostic unfavorable (1.47e-6)" "unprognostic (2.15e-1)" "unprognostic (1.55e-1)" "unprognostic (7.50e-2)" "unprognostic (1.24e-2)" 4.5 2.6 1.7 11.5 2.6 38.3 4.1 8.3 3.2 8.7 3.7 2.6 4.5 4.1 5.6 4.0 16.6 4.1 4.2 2.4 1.5 1.3 2.8 3.0 5.1 9.1 2.7 1.4 5.0 6.2 1.6 1.9 12.4 3.3 4.6 2.7 3.3 5.3 2.2 1.3 21.8 4.4 3.1 2.3 6.7 3.6 12.8 2.3 24.9 5.1 11.2 15.0 3.7 8.8 7.4 4.2 8.3 4.3 10.6 14.7 5.5 15.2 15.9 18.4 13.9 3.1 5.2 24.1 22.8 7.0 17.9 15.7 19.4 19.5 20.0 12.5 8.0 13.7 24.5 12.8 26.3 10.5 21.9 10.1 12.7 13.6 16.2 3.9 22.4 10.7 3.7 8.2 13.8 13.0 6.0 12.1 17.5 13.9 20.8 12.4 37.4 20.8 15.1 13.6 13.3 36.4 20.2 26.8 7.4 6.0 17.7 10.8 13.3 21.8 8.8 17.5 8.5 17.2 15.1 18.7 15.9 20.2 21.7 30.2 7.7 9.5 20.5 13.3 11.4 26.2 0.9 3.6 8.3 10.9 3.9 13.3 7.4 11.4 14.7 3.9 5.2 6.8 8.0 1.3 10.6 4.3 4.2 8.9 5.5 1.7 2.6 8.3 3.2 1.5 1.3 2.7 1.4 3.3 2.3 0.0 2.1 10.4 19.9 57.1 3.0 0.6 0.0 8.1 3.4 1.8 0.0 53.6 3.3 12.9 6.4 9.0 1.1 23.3 6.2 133.3 12.5 7.7 28.8 2.1 21.5 12.7 2.9 7.4 6.2 4.3 7.8 10.6 16.9 10.8 4.4 3.4 9.1 3.5 5.6 1.4 2.7 6.5 10.3 31.0 64.2 58.6 21.6 17.5 6.0 48.5 CDCA5 ENSG00000146670 "Cell division cycle associated 5" Q96FF9 11 65066300-65084164 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 27.4;lymphoid tissue: 39.9;testis: 27.9" "Group enriched" "Detected in many" 5 "Early spermatids: 41.6;Extravillous trophoblasts: 30.6;Late spermatids: 84.2;Spermatocytes: 40.4;Spermatogonia: 22.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "NK-cell: 5.8;T-reg: 4.2" "Group enriched" "Detected in many" 4 "NK-cells: 5.8;T-cells: 4.2" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA023691, HPA076007" Enhanced Enhanced Nucleoplasm Yes Yes Nucleoplasm "HPA023691: AB_1846392, HPA076007: " "unprognostic (3.14e-2)" "unprognostic (4.20e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.67e-4)" "unprognostic (2.15e-1)" "unprognostic (2.68e-1)" "prognostic unfavorable (8.21e-6)" "unprognostic (1.41e-3)" "unprognostic (7.55e-3)" "unprognostic (6.93e-2)" "prognostic unfavorable (8.72e-6)" "unprognostic (2.16e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.55e-3)" "unprognostic (1.86e-1)" "unprognostic (1.35e-1)" "unprognostic (8.97e-2)" 1.3 1.3 1.1 12.3 1.1 27.4 4.3 1.0 2.8 1.6 3.8 0.6 0.0 3.3 0.9 1.4 7.9 0.7 1.4 1.3 1.1 0.9 1.3 1.3 1.9 9.5 1.1 0.5 0.8 0.7 0.2 0.7 5.5 1.3 0.9 4.7 0.1 1.5 0.1 0.7 2.4 3.6 1.7 0.7 5.7 2.1 27.9 0.2 39.9 0.7 6.6 9.9 1.5 2.3 1.2 0.8 0.3 0.5 5.8 4.2 1.4 30.7 17.6 16.9 14.3 1.1 1.8 14.1 22.0 9.2 25.8 20.6 18.0 18.7 28.0 12.7 7.1 30.4 21.3 27.3 12.1 25.2 28.0 11.9 25.2 12.8 15.1 0.1 26.8 20.4 0.6 1.1 24.1 11.2 2.7 7.8 33.6 28.5 51.8 15.7 25.5 37.8 27.7 26.6 15.2 21.4 33.2 18.7 26.7 5.3 11.8 22.0 16.5 14.1 20.2 14.9 11.0 26.0 13.2 4.9 23.4 24.2 24.6 24.4 26.2 41.5 45.6 9.4 16.6 24.1 0.0 0.2 0.3 0.8 0.0 0.1 0.7 1.1 0.6 0.8 1.2 0.1 0.8 0.1 5.8 0.5 0.7 4.2 1.4 1.1 1.1 1.0 2.8 1.1 0.9 1.1 0.5 1.3 0.2 0.0 0.3 0.8 0.8 3.4 0.8 0.8 0.0 0.0 1.2 0.0 2.0 3.7 1.7 0.9 41.6 0.9 0.9 0.0 0.7 30.6 1.8 0.4 3.5 0.0 9.5 1.6 0.0 1.3 2.8 84.2 2.6 1.9 0.0 3.6 2.3 0.8 0.5 0.0 1.4 0.3 0.2 0.0 0.3 40.4 22.0 0.9 3.1 1.9 2.8 1.0 CDCA7 "FLJ14736, JPO1" ENSG00000144354 "Cell division cycle associated 7" Q9BWT1 2 173354820-173368997 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 71.4" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 40.4;Leydig cells: 49.8;Peritubular cells: 32.5;Undifferentiated cells: 66.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 9.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MOLT-4: 61.8" "Group enriched" "Detected in many" 4 "basal ganglia: 8.3;olfactory region: 21.4" "Low region specificity" "Detected in all" HPA005565 Supported Nucleoplasm,Cytosol No Yes "Nucleoplasm, Cytosol" "HPA005565: AB_2078680" "unprognostic (1.67e-3)" "unprognostic (2.26e-1)" "unprognostic (1.21e-1)" "unprognostic (1.54e-2)" "unprognostic (2.16e-1)" "unprognostic (1.44e-2)" "prognostic unfavorable (4.20e-4)" "unprognostic (7.54e-2)" "prognostic unfavorable (5.50e-4)" "unprognostic (4.96e-2)" "unprognostic (2.83e-1)" "unprognostic (8.97e-3)" "unprognostic (0.00e+0)" "unprognostic (4.53e-3)" "unprognostic (1.96e-1)" "unprognostic (2.04e-1)" "unprognostic (2.47e-2)" 1.1 0.6 1.2 28.0 1.5 9.7 1.8 0.5 1.4 8.3 12.3 2.8 2.6 14.9 7.9 1.7 12.9 2.3 6.6 0.9 2.0 1.4 0.8 0.4 1.3 17.2 1.3 2.2 1.1 2.9 0.0 0.4 7.3 3.4 3.2 14.8 1.1 3.3 0.6 4.3 8.3 16.4 1.5 2.0 2.9 7.6 8.1 2.0 71.4 0.9 10.5 24.0 2.3 8.0 2.6 4.2 0.3 0.7 3.6 9.4 2.7 9.8 7.6 17.9 19.4 0.8 3.3 18.7 6.0 2.1 14.2 16.0 11.7 12.6 27.6 7.6 3.6 5.5 10.3 28.4 10.7 20.7 13.2 15.6 6.2 5.5 14.8 0.9 40.4 5.9 2.7 0.9 7.7 6.5 1.8 6.4 36.5 14.9 6.3 4.1 7.9 61.8 40.7 21.1 23.4 5.3 43.7 13.6 17.5 6.9 8.7 5.2 9.2 9.4 3.1 5.0 16.7 0.0 15.9 2.9 9.3 4.0 3.0 10.9 1.7 3.7 38.8 5.8 22.5 7.8 0.0 0.7 0.0 1.4 0.0 0.5 2.6 3.9 7.6 4.2 0.3 0.3 1.4 0.3 3.6 0.0 0.6 9.4 2.7 1.2 1.5 0.5 1.4 2.0 1.4 1.3 2.2 3.4 2.0 0.0 1.1 1.4 12.6 18.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 40.4 0.0 0.0 0.4 1.1 6.7 0.0 0.2 21.5 2.6 2.4 0.0 0.0 8.9 0.0 11.7 0.0 0.8 1.8 49.8 1.6 3.3 0.0 19.1 0.6 0.7 7.0 32.5 0.0 0.0 0.0 4.3 9.4 30.1 13.9 8.5 6.9 66.1 1.7 CDCA7L "JPO2, R1, RAM2" ENSG00000164649 "Cell division cycle associated 7 like" Q96GN5 7 21900900-21946084 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 47.9" "Cell type enhanced" "Detected in many" 7 "Spermatogonia: 61.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 11.8;memory B-cell: 28.6;naive B-cell: 38.5;naive CD4 T-cell: 9.7;plasmacytoid DC: 21.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Region enriched" "Detected in some" 5 "olfactory region: 22.0" "HPA027169, HPA074623" Approved Supported Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "HPA027169: AB_1856058, HPA074623: " "unprognostic (5.13e-3)" "unprognostic (5.94e-2)" "unprognostic (1.91e-1)" "unprognostic (4.63e-2)" "unprognostic (2.33e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (4.36e-6)" "unprognostic (4.09e-2)" "unprognostic (2.86e-1)" "unprognostic (3.87e-2)" "unprognostic (3.22e-2)" "unprognostic (2.34e-1)" "prognostic unfavorable (1.98e-4)" "unprognostic (2.00e-1)" "unprognostic (1.60e-1)" "unprognostic (1.73e-1)" "unprognostic (2.83e-3)" 6.2 1.2 3.7 19.9 9.6 24.2 8.0 6.5 4.2 8.4 9.0 7.8 3.9 5.2 11.1 3.6 6.0 7.0 5.4 12.5 3.9 2.5 2.7 4.5 7.3 18.7 6.2 4.0 13.9 17.4 1.0 1.6 2.2 3.7 7.6 10.2 5.8 10.5 8.0 2.7 13.6 8.7 6.6 3.0 9.3 12.7 12.6 5.3 47.9 20.0 5.1 16.5 6.0 9.4 38.5 21.8 11.8 1.3 0.8 9.7 3.3 19.7 6.8 6.4 0.1 3.5 4.5 0.0 16.2 13.9 12.6 17.9 2.5 18.0 41.3 5.3 13.9 25.1 12.2 10.1 16.6 25.5 0.0 6.7 9.9 20.1 1.6 4.5 25.9 0.1 8.3 3.0 9.7 28.5 13.0 24.8 32.3 13.6 0.0 9.7 7.4 32.7 9.3 36.5 3.9 8.4 32.9 22.9 27.5 3.5 3.7 23.5 19.2 7.3 4.5 7.4 8.5 11.0 11.7 10.5 13.8 17.0 23.9 19.5 21.3 14.6 53.4 13.2 35.0 13.5 0.3 0.6 11.8 0.6 0.9 0.1 28.6 1.9 0.9 4.3 38.5 9.7 3.9 1.1 0.8 1.3 21.8 2.7 3.3 3.7 9.6 6.5 4.2 3.9 2.5 6.2 4.0 3.7 5.3 17.9 20.3 28.9 22.5 24.2 0.2 26.3 2.5 6.7 31.8 0.0 2.0 0.5 3.3 6.7 2.6 3.7 1.5 0.0 5.3 0.2 4.3 7.7 8.1 3.4 9.6 12.7 10.3 2.5 10.2 3.6 3.7 3.5 8.5 0.0 26.4 2.4 4.9 3.5 2.5 0.0 2.1 12.9 12.3 2.7 61.1 6.8 0.2 2.5 24.4 3.9 CDCA8 "BOR, DasraB, FLJ12042, MESRGP" ENSG00000134690 "Cell division cycle associated 8" Q53HL2 1 37692418-37709719 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 19.0;lymphoid tissue: 51.6;testis: 44.7" "Cell type enhanced" "Detected in many" 16 "Extravillous trophoblasts: 20.9;Spermatocytes: 82.1;Spermatogonia: 41.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA028120, HPA028258, HPA028783, CAB040294" Enhanced Supported "Nucleoplasm,Nucleoli,Cytokinetic bridge" Yes Yes Nucleoli "Nucleoplasm, Cytokinetic bridge" "CAB040294: , HPA028120: AB_10670556, HPA028258: AB_10669864, HPA028783: AB_10671092" "unprognostic (8.36e-2)" "unprognostic (2.00e-1)" "unprognostic (8.39e-2)" "unprognostic (7.75e-3)" "unprognostic (2.34e-1)" "unprognostic (5.42e-2)" "prognostic unfavorable (4.93e-10)" "unprognostic (4.30e-3)" "prognostic unfavorable (6.04e-4)" "unprognostic (3.00e-1)" "prognostic unfavorable (8.32e-4)" "unprognostic (3.78e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (6.39e-3)" "unprognostic (2.99e-1)" "unprognostic (3.18e-1)" "unprognostic (1.67e-1)" 1.2 1.4 0.9 12.9 1.7 19.0 1.7 0.8 1.6 1.8 6.0 1.1 0.7 5.3 1.4 1.3 9.6 0.7 2.4 0.8 0.9 0.9 1.3 1.5 2.0 12.2 1.8 1.3 0.9 1.0 0.1 0.8 3.7 1.3 1.0 7.7 0.7 2.1 1.0 0.9 4.0 5.4 1.6 1.2 5.4 3.5 44.7 1.7 51.6 0.9 6.5 14.6 1.6 2.9 2.8 1.8 4.5 5.0 6.3 8.9 2.5 28.4 12.4 23.5 17.0 1.0 2.0 15.8 21.5 10.8 38.0 27.0 19.4 21.3 34.6 8.7 13.7 15.3 16.2 27.0 14.2 40.4 23.0 12.1 31.1 13.3 15.3 0.2 29.9 16.1 0.8 1.0 21.4 19.0 4.3 16.8 24.9 26.2 37.2 27.4 12.7 27.5 18.4 27.2 16.6 17.2 26.9 32.1 19.8 8.6 11.9 20.9 9.2 23.6 11.1 14.5 21.1 16.3 11.4 10.1 18.7 19.9 10.7 33.5 25.3 32.9 47.2 8.8 27.8 21.4 0.0 1.1 1.8 2.5 2.2 4.5 2.8 5.7 3.3 1.0 2.5 1.9 3.8 4.5 6.3 5.0 1.8 8.9 2.5 0.9 1.7 0.8 1.6 0.9 0.9 1.8 1.3 1.3 1.7 0.0 0.3 9.3 0.8 3.0 1.1 0.4 5.1 8.1 0.0 0.0 0.0 2.2 0.0 1.1 0.8 0.2 4.2 0.0 0.6 20.9 0.9 0.6 0.0 1.0 9.5 1.6 3.5 1.8 3.1 2.2 1.4 4.6 1.7 2.8 5.1 0.0 1.6 4.9 1.1 0.5 0.8 19.4 0.0 82.1 41.4 2.4 2.4 3.2 6.3 0.9 CDH17 "cadherin, HPT-1" ENSG00000079112 "Cadherin 17" Q12864 8 94127171-94217303 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "intestine: 184.4" "Group enriched" "Detected in some" 51 "Enterocytes: 404.8;Intestinal endocrine cells: 104.0;Mucus-secreting cells: 149.4;Paneth cells: 316.3;Undifferentiated cells: 191.5" "Group enriched" "Detected in many" 6 "colorectal cancer: 156.4;stomach cancer: 54.9" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 5 "neutrophil: 12.1" "Lineage enriched" "Detected in many" 8 "granulocytes: 12.1" "Cell line enhanced" "Detected in some" "CACO-2: 21.9;OE19: 94.0;U-266/70: 36.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA023614, HPA023616, CAB025143, HPA026556" Enhanced Supported "Nucleoplasm,Cell Junctions" NA NA 3400000 "Cell Junctions" Nucleoplasm "CAB025143: , HPA023614: AB_1845896, HPA023616: AB_1845895, HPA026556: AB_1845897" "unprognostic (2.08e-1)" "unprognostic (5.00e-2)" "unprognostic (1.05e-1)" "unprognostic (1.09e-1)" "unprognostic (3.02e-1)" "unprognostic (3.06e-2)" "unprognostic (5.60e-2)" "unprognostic (3.38e-3)" "unprognostic (2.11e-1)" "unprognostic (1.74e-1)" "unprognostic (5.47e-2)" "unprognostic (3.74e-2)" "unprognostic (2.36e-1)" "unprognostic (1.29e-1)" "unprognostic (1.31e-1)" "unprognostic (7.33e-2)" "unprognostic (1.46e-2)" 0.3 0.2 0.2 17.6 0.3 0.3 0.3 0.2 0.2 0.3 88.9 0.2 0.2 54.5 0.4 0.3 0.4 0.4 7.0 0.6 0.2 0.3 0.3 0.3 0.3 0.5 0.2 0.2 0.3 0.4 0.0 0.3 0.2 0.2 0.4 44.0 0.2 0.3 0.2 0.3 0.2 184.4 1.4 0.2 0.6 0.3 0.3 0.2 0.3 0.2 0.2 0.5 0.4 0.3 1.5 0.8 12.1 1.0 1.4 0.6 0.1 0.0 4.0 0.2 0.2 0.0 0.1 0.3 0.1 0.0 0.0 0.0 21.9 1.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.3 0.1 0.3 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.4 0.0 0.3 0.1 0.3 0.1 94.0 0.1 0.2 0.0 0.7 0.1 0.0 0.4 0.2 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.2 0.2 0.3 0.1 36.3 0.0 0.1 0.1 0.1 0.2 2.5 1.0 1.2 0.5 0.8 0.3 0.6 0.5 0.4 0.8 1.5 0.5 0.6 12.1 1.4 0.5 0.7 0.5 0.1 0.2 0.3 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.6 0.0 404.8 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 104.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 149.4 0.0 0.0 316.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 191.5 0.0 CDH5 "7B4, CD144" ENSG00000179776 "Cadherin 5" P33151 16 66366622-66404786 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 96.6" "Cell type enhanced" "Detected in many" 15 "Endothelial cells: 155.1;Ito cells: 190.9;Syncytiotrophoblasts: 67.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 113.8;TIME: 97.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB028366, HPA075875" Approved Supported "Nucleoplasm,Nuclear membrane,Plasma membrane" NA NA 1000000000 "Plasma membrane" "Nucleoplasm, Nuclear membrane" "CAB028366: AB_2276033, HPA075875: " "unprognostic (1.05e-1)" "unprognostic (8.13e-2)" "unprognostic (6.11e-2)" "unprognostic (4.89e-2)" "unprognostic (4.96e-2)" "unprognostic (5.50e-3)" "unprognostic (9.38e-2)" "unprognostic (5.28e-2)" "unprognostic (1.32e-1)" "unprognostic (1.46e-1)" "unprognostic (2.33e-2)" "unprognostic (2.32e-1)" "prognostic unfavorable (5.14e-4)" "unprognostic (9.49e-3)" "unprognostic (3.01e-2)" "unprognostic (2.22e-1)" "unprognostic (3.15e-2)" 48.7 5.6 4.0 6.2 5.8 0.6 28.1 2.6 4.8 11.1 6.6 3.4 5.5 3.7 18.7 11.2 8.4 7.2 12.6 21.7 4.5 4.3 7.8 12.7 43.7 9.7 6.5 2.8 7.7 3.6 5.0 3.5 96.6 7.6 9.0 4.8 8.5 5.2 4.4 19.0 7.0 6.8 12.1 5.4 10.8 5.7 6.7 3.3 1.2 16.6 15.7 4.5 11.7 11.3 0.0 0.6 0.4 0.8 0.1 0.1 1.1 0.0 0.0 0.7 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 113.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.3 0.0 0.0 97.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.4 0.1 0.0 0.6 0.1 1.1 4.0 5.8 2.6 4.8 4.5 4.3 6.5 2.8 7.6 3.3 0.0 10.4 0.0 0.0 3.7 0.0 14.6 7.6 0.0 1.2 1.8 0.0 3.3 0.0 0.1 33.0 155.1 0.0 0.0 0.0 40.7 3.1 0.1 3.5 1.5 2.1 0.0 0.0 190.9 29.5 47.7 5.8 2.3 11.8 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 3.1 13.4 0.2 2.6 67.5 0.0 0.0 0.0 CDIP1 "C16orf5, CDIP, LITAFL" ENSG00000089486 "Cell death inducing p53 target 1" Q9H305 16 4510675-4538828 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 75.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 49.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049352 Approved Supported Nucleoplasm,Centrosome NA NA Centrosome Nucleoplasm "HPA049352: AB_2680724" "unprognostic (6.38e-3)" "unprognostic (3.70e-3)" "unprognostic (2.95e-2)" "unprognostic (2.50e-3)" "unprognostic (2.74e-2)" "unprognostic (2.56e-2)" "unprognostic (3.48e-1)" "unprognostic (8.26e-2)" "unprognostic (3.68e-2)" "unprognostic (1.03e-2)" "prognostic favorable (2.14e-5)" "unprognostic (9.05e-2)" "prognostic favorable (1.14e-6)" "unprognostic (1.43e-2)" "unprognostic (3.51e-2)" "unprognostic (9.88e-2)" "unprognostic (4.65e-2)" 17.7 14.2 36.8 6.9 41.6 5.1 8.2 36.4 54.6 13.6 9.5 16.3 2.7 30.0 13.4 4.4 8.0 10.9 9.5 25.0 33.8 37.1 23.7 13.2 9.6 8.2 34.2 38.9 18.7 22.9 10.4 19.3 8.5 26.3 13.2 4.1 7.8 10.8 14.7 34.0 9.1 24.2 8.7 20.7 12.0 9.2 10.1 15.7 13.0 10.6 6.7 6.9 7.8 6.3 8.7 9.2 19.3 19.2 14.3 15.9 7.2 3.8 1.6 5.5 1.6 0.4 0.0 0.1 6.0 0.9 5.9 5.1 9.5 1.6 0.2 6.1 4.9 1.8 0.1 5.0 21.2 1.0 13.4 9.5 18.0 6.4 24.6 4.0 8.6 11.3 5.9 11.0 5.3 0.9 1.1 4.7 8.7 0.3 4.9 6.7 0.4 6.7 11.3 12.2 4.3 4.7 25.5 4.9 49.0 1.2 0.1 16.6 7.2 12.0 0.5 7.5 2.5 2.2 4.8 0.2 3.1 9.0 2.1 0.2 13.1 12.1 18.1 0.1 8.8 2.0 3.2 7.9 19.3 15.9 12.5 8.6 8.7 5.7 8.9 7.6 8.3 11.4 9.7 6.2 14.3 19.2 9.2 9.1 7.2 36.8 41.6 36.4 50.3 33.8 37.1 34.2 38.9 26.3 15.7 14.9 6.5 15.6 20.1 26.3 67.6 23.4 2.5 0.0 6.8 15.7 11.8 1.2 44.7 11.0 75.7 16.0 12.0 0.0 7.9 1.3 12.5 12.9 23.0 15.6 16.4 66.7 9.2 24.5 12.4 17.9 16.7 12.3 13.5 2.8 2.3 40.4 9.9 14.4 15.6 47.3 13.1 6.5 13.7 6.4 19.0 13.0 5.6 23.0 3.3 10.6 CDIPT "PIS, PIS1" ENSG00000103502 "CDP-diacylglycerol--inositol 3-phosphatidyltransferase" O14735 16 29858357-29863736 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056597 Enhanced Approved "Nucleoplasm,Nuclear membrane,Plasma membrane" NA NA "Nucleoplasm, Nuclear membrane, Plasma membrane" "HPA056597: AB_2683182" "unprognostic (7.81e-2)" "prognostic favorable (9.40e-4)" "unprognostic (1.93e-3)" "unprognostic (8.08e-3)" "unprognostic (1.50e-2)" "unprognostic (2.84e-2)" "unprognostic (7.60e-2)" "unprognostic (1.09e-2)" "unprognostic (7.03e-2)" "unprognostic (8.75e-2)" "unprognostic (5.56e-3)" "unprognostic (1.61e-1)" "unprognostic (6.17e-2)" "unprognostic (3.36e-2)" "unprognostic (6.95e-2)" "unprognostic (1.56e-1)" "unprognostic (2.48e-1)" 40.4 40.8 24.3 20.2 28.1 15.3 42.9 50.7 39.5 37.1 37.2 21.5 33.9 24.8 33.4 23.0 39.4 30.1 34.5 44.4 23.1 27.9 34.8 66.3 27.1 22.4 24.1 26.4 52.7 40.0 47.1 24.9 43.7 21.8 36.8 16.1 29.3 42.2 38.8 21.0 29.6 32.6 31.8 21.0 25.6 29.5 20.2 16.4 30.4 47.1 19.9 17.3 41.8 42.8 4.8 6.1 20.6 6.5 8.2 8.4 2.7 12.5 27.3 7.7 15.4 42.0 29.1 22.8 22.1 24.8 15.7 15.7 15.9 24.2 8.4 41.9 25.4 13.9 19.8 12.4 14.3 7.2 21.1 25.0 6.0 20.4 23.2 29.3 8.9 15.7 49.2 25.2 21.1 9.7 24.9 19.6 16.1 9.0 21.9 14.1 40.1 12.1 17.7 18.3 13.2 20.3 23.7 9.6 24.5 20.7 12.1 31.7 17.8 11.7 24.9 17.4 14.1 18.6 24.4 17.0 23.3 7.4 18.9 11.3 16.3 18.4 6.0 25.4 14.5 14.0 7.5 6.5 20.6 6.9 4.6 4.6 4.7 6.4 7.3 3.0 4.8 6.3 5.9 16.4 8.2 5.7 6.1 8.4 2.7 24.3 28.1 50.7 39.5 23.1 27.9 24.1 26.4 21.8 16.4 23.8 21.2 20.5 35.7 36.7 46.6 49.2 30.6 18.7 10.3 43.6 43.2 92.1 34.9 59.1 22.5 43.2 44.6 46.7 62.9 107.9 45.5 34.0 13.8 36.5 56.9 55.6 35.8 33.2 37.3 11.0 71.1 25.7 21.9 47.7 34.8 54.4 41.4 37.1 58.0 30.1 42.9 45.3 43.2 8.6 14.0 44.4 61.2 40.6 37.0 35.3 CDK1 "CDC2, CDC28A" ENSG00000170312 "Cyclin dependent kinase 1" P06493 10 60778331-60794852 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "Apoptosis, Biological rhythms, Cell cycle, Cell division, Host-virus interaction, Mitosis" "Host cell receptor for virus entry, Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 88.4" "Cell type enhanced" "Detected in many" 18 "Erythroid cells: 280.4;Extravillous trophoblasts: 116.8;Spermatocytes: 104.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 6.1;T-reg: 5.7" "Group enriched" "Detected in many" 5 "dendritic cells: 1.7;NK-cells: 6.1;T-cells: 5.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA003387, CAB003799" Enhanced Supported Nucleoplasm,Cytosol NA Yes Cytosol Nucleoplasm "CAB003799: AB_344898, HPA003387: AB_1846356" "unprognostic (6.34e-2)" "prognostic favorable (8.81e-4)" "unprognostic (1.90e-1)" "unprognostic (6.82e-2)" "unprognostic (6.67e-2)" "unprognostic (3.83e-2)" "prognostic unfavorable (1.10e-6)" "prognostic unfavorable (7.88e-4)" "unprognostic (1.30e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (4.15e-6)" "unprognostic (1.80e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.27e-1)" "unprognostic (2.75e-1)" "unprognostic (2.13e-1)" "unprognostic (1.60e-1)" 4.1 2.2 0.8 17.8 2.4 17.8 4.4 0.7 1.6 4.2 6.5 1.1 3.4 6.1 2.9 4.8 19.0 1.5 2.4 2.3 0.9 0.7 3.1 1.7 5.7 15.1 1.7 0.6 2.2 1.0 0.5 4.4 13.3 1.2 1.5 8.3 1.0 3.8 2.9 1.0 4.9 8.3 2.7 2.5 8.3 5.0 13.8 1.2 88.4 1.8 16.7 20.1 3.2 6.9 0.9 1.7 0.0 0.2 6.1 5.7 1.8 48.9 18.6 49.6 19.6 3.2 5.0 20.4 37.0 27.0 45.2 43.6 43.6 43.3 44.9 14.4 10.1 16.6 30.5 33.7 21.5 47.1 31.9 24.6 23.5 18.4 25.3 0.6 36.0 24.3 0.9 2.1 29.2 28.5 10.3 27.1 29.6 35.9 55.3 50.2 13.0 45.3 25.9 21.8 29.6 39.3 39.4 46.2 22.0 17.2 16.3 23.3 20.4 24.9 37.8 19.2 28.1 40.8 22.1 11.1 19.3 41.2 20.3 50.6 21.7 34.8 40.5 16.6 40.4 23.9 0.0 0.0 0.0 0.5 0.2 0.5 0.9 1.5 2.7 0.5 0.5 0.5 1.5 0.0 6.1 0.2 1.7 5.7 1.8 0.8 2.4 0.7 1.6 0.9 0.7 1.7 0.6 1.2 1.2 0.0 2.7 2.2 3.6 35.3 1.0 0.5 0.0 14.7 7.9 17.4 0.0 11.0 3.3 0.7 8.8 4.5 1.7 280.4 0.0 116.8 5.1 1.0 0.0 0.8 46.3 0.0 2.9 9.8 15.3 6.3 2.0 8.8 1.7 1.8 4.0 1.0 0.3 0.0 0.7 2.1 0.5 0.0 1.4 104.2 29.6 16.3 18.4 7.0 5.6 6.0 CDK10 PISSLRE ENSG00000185324 "Cyclin dependent kinase 10" Q15131 16 89680737-89696364 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007451, HPA059634, HPA067060" Uncertain Supported "Nucleoplasm,Midbody,Midbody ring" Yes Yes Nucleoplasm "Midbody, Midbody ring" "HPA007451: AB_2732400, HPA059634: AB_2684090, HPA067060: AB_2685772" "unprognostic (7.89e-2)" "unprognostic (8.08e-2)" "unprognostic (3.74e-3)" "unprognostic (9.87e-2)" "unprognostic (1.76e-1)" "unprognostic (3.44e-2)" "unprognostic (4.53e-1)" "unprognostic (9.06e-2)" "unprognostic (2.99e-1)" "unprognostic (2.13e-1)" "prognostic favorable (2.69e-4)" "unprognostic (2.58e-2)" "unprognostic (2.93e-1)" "unprognostic (3.32e-2)" "unprognostic (1.79e-1)" "unprognostic (6.88e-2)" "prognostic favorable (3.63e-4)" 12.3 19.9 16.8 16.4 23.8 17.3 10.1 14.8 21.9 11.1 18.3 8.1 16.4 23.4 12.1 21.7 14.4 14.4 19.4 8.7 15.3 12.6 22.2 33.9 11.8 14.0 13.3 19.4 11.3 22.2 21.6 27.7 13.6 15.8 13.6 12.6 8.1 17.2 8.9 17.5 14.1 20.7 9.0 10.7 15.9 19.0 8.7 13.6 8.0 27.1 10.1 12.1 10.8 14.5 7.8 14.5 3.4 15.3 15.2 13.3 8.8 14.7 9.6 7.7 3.1 3.2 6.1 8.1 12.2 6.9 8.7 2.9 7.4 11.2 13.1 6.2 10.5 5.4 10.3 3.3 17.0 5.5 2.9 8.1 5.1 10.8 0.8 13.4 8.3 9.4 7.5 5.7 5.5 8.3 5.8 15.1 8.7 13.4 1.8 9.9 19.2 10.0 23.8 15.8 16.0 7.3 14.6 10.5 18.4 15.6 11.7 7.6 16.5 15.3 7.1 3.6 9.1 16.7 13.2 13.4 5.9 15.3 6.1 8.3 6.6 3.6 4.0 9.0 14.3 8.4 3.2 11.7 3.4 12.9 15.3 10.9 6.8 11.4 8.9 14.5 7.8 13.3 10.9 1.5 15.2 11.2 10.0 8.8 8.8 16.8 23.8 14.8 21.9 15.3 12.6 13.3 19.4 15.8 13.6 11.9 28.2 16.7 22.2 13.7 17.3 4.8 45.9 18.7 9.1 26.2 23.6 25.3 36.5 23.6 5.0 17.5 42.9 0.0 11.0 16.4 18.6 26.1 9.2 37.6 16.3 17.5 65.1 19.6 16.7 5.4 22.2 13.0 18.6 14.4 38.5 10.3 14.2 35.1 11.7 45.1 33.8 6.5 11.3 23.1 29.8 13.6 23.3 17.5 50.1 18.6 CDK12 "CRK7, CRKR, CRKRS, KIAA0904" ENSG00000167258 "Cyclin dependent kinase 12" Q9NYV4 17 39461511-39564907 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 87.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008038, HPA073305" Supported Enhanced "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA008038: AB_1078570, HPA073305: " "unprognostic (2.02e-1)" "unprognostic (1.80e-1)" "unprognostic (2.61e-2)" "unprognostic (7.56e-2)" "unprognostic (1.05e-1)" "unprognostic (3.19e-1)" "unprognostic (2.56e-3)" "unprognostic (2.37e-2)" "unprognostic (3.86e-2)" "unprognostic (3.00e-3)" "unprognostic (6.87e-3)" "unprognostic (1.86e-1)" "unprognostic (3.06e-2)" "unprognostic (9.10e-2)" "unprognostic (1.24e-1)" "unprognostic (2.22e-2)" "unprognostic (5.32e-1)" 16.0 13.1 12.4 17.4 9.2 32.4 14.0 23.4 17.8 18.2 17.6 9.6 15.7 11.1 15.7 12.0 16.9 12.2 12.5 11.0 10.1 6.7 10.2 18.5 13.5 15.2 10.9 14.3 17.4 11.3 19.0 12.2 18.4 9.5 12.7 11.7 10.4 15.6 11.1 11.1 17.0 16.5 11.0 10.6 16.3 11.8 18.9 8.3 29.0 15.0 5.4 17.3 16.3 20.5 5.1 4.0 10.4 2.9 6.6 4.0 0.9 8.9 11.1 6.7 6.2 4.9 5.5 6.2 8.1 6.9 11.1 8.3 13.6 5.5 12.7 7.1 8.5 11.3 14.6 13.3 10.2 10.8 8.3 11.4 13.7 7.5 10.5 4.8 18.7 9.6 5.9 7.1 13.5 10.7 4.6 6.7 7.7 23.2 8.4 6.3 4.2 15.3 4.8 7.0 4.4 5.0 10.1 14.4 7.2 4.2 10.7 7.2 4.6 10.3 87.5 7.0 10.1 11.2 8.1 7.2 10.1 8.1 7.0 10.4 6.9 4.9 17.9 7.2 7.9 6.6 10.4 2.9 4.1 4.0 2.2 3.0 2.9 2.5 2.7 1.8 5.1 2.9 2.7 9.7 6.6 1.8 4.0 2.0 0.9 12.4 9.2 23.4 17.8 10.1 6.7 10.9 14.3 9.5 8.3 23.8 26.1 37.7 45.0 57.5 45.4 12.1 35.7 29.4 40.9 36.6 60.9 27.7 11.6 24.4 15.9 29.6 32.0 23.3 23.8 24.7 35.7 62.9 27.8 38.9 23.9 33.4 29.9 27.6 37.0 14.0 34.5 34.5 25.3 27.9 26.9 31.5 36.1 31.6 31.8 12.9 67.7 32.3 33.0 113.1 90.5 60.3 48.7 42.9 28.8 77.9 CDK14 "PFTAIRE1, PFTK1" ENSG00000058091 "Cyclin dependent kinase 14" O94921 7 90466424-91210590 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 44.0;Horizontal cells: 163.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "basophil: 7.5;memory B-cell: 9.8;naive B-cell: 5.3;neutrophil: 5.6" "Group enriched" "Detected in many" 9 "B-cells: 9.8;granulocytes: 7.5" "Cell line enhanced" "Detected in many" "Karpas-707: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015267 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA015267: AB_1855249" "prognostic favorable (5.86e-4)" "unprognostic (3.96e-1)" "unprognostic (1.91e-2)" "unprognostic (2.09e-3)" "unprognostic (1.18e-1)" "unprognostic (3.45e-1)" "unprognostic (1.72e-1)" "unprognostic (4.48e-2)" "unprognostic (3.60e-2)" "unprognostic (3.09e-2)" "unprognostic (2.77e-3)" "unprognostic (2.91e-2)" "unprognostic (2.57e-2)" "prognostic unfavorable (7.79e-4)" "unprognostic (2.46e-1)" "unprognostic (2.86e-1)" "unprognostic (4.39e-3)" 8.2 4.7 19.8 7.1 19.4 6.1 8.3 28.6 34.9 10.6 5.2 3.7 0.6 2.7 8.6 3.2 3.1 12.0 11.9 11.5 25.8 15.5 19.8 12.7 9.2 10.9 17.3 17.4 14.9 14.2 3.8 14.2 5.9 22.8 11.3 3.4 4.3 7.7 7.0 5.4 2.7 3.8 7.4 7.0 7.5 7.4 7.2 4.5 0.9 13.1 1.6 11.9 6.9 6.7 9.8 0.9 7.5 0.7 0.1 0.2 0.6 7.1 0.0 14.3 1.8 13.4 13.7 3.3 6.0 5.7 3.7 4.0 0.1 3.5 25.4 0.7 5.9 5.4 2.1 0.7 8.4 7.1 0.0 3.4 0.0 4.7 0.1 6.2 7.2 0.1 9.7 2.1 10.9 3.9 6.1 4.7 0.1 0.1 31.3 7.4 0.0 0.0 2.8 9.0 0.0 3.9 19.5 19.7 19.3 1.9 1.9 3.2 9.2 15.2 0.0 0.3 6.7 1.9 3.6 11.5 15.9 20.4 13.3 9.2 17.7 13.5 18.1 6.0 9.5 15.5 7.5 0.3 0.5 0.0 0.7 0.0 9.8 0.0 0.0 0.9 5.3 0.0 0.0 5.6 0.1 0.5 0.1 0.2 0.6 19.8 19.4 28.6 34.9 25.8 15.5 17.3 17.4 22.8 4.5 17.9 3.2 27.7 7.4 0.7 5.1 11.1 10.2 4.0 13.6 10.4 0.0 0.2 6.6 9.4 44.0 2.1 0.0 0.0 5.8 0.1 12.5 8.3 0.0 9.6 4.0 163.7 1.7 1.3 5.1 27.0 14.4 4.6 5.0 1.0 0.1 8.8 9.4 0.2 14.9 18.1 9.5 0.0 6.6 3.8 6.5 1.1 0.0 0.5 0.0 2.3 CDK15 "ALS2CR7, PFTAIRE2, PFTK2" ENSG00000138395 "Cyclin dependent kinase 15" Q96Q40 2 201790461-201895550 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 20.2;ovary: 9.8" "Group enriched" "Detected in some" 13 "Early spermatids: 23.2;granulocytes: 76.3;Late spermatids: 28.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 52 "basophil: 3.5;eosinophil: 6.9" "Lineage enriched" "Detected in single" 69 "granulocytes: 6.9" "Cell line enhanced" "Detected in some" "BJ hTERT+: 14.9;BJ hTERT+ SV40 Large T+ RasG12V: 12.2;HBF TERT88: 18.6;HMC-1: 35.2;LHCN-M2: 10.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA015786 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA015786: AB_1844780" "unprognostic (2.51e-1)" "unprognostic (2.73e-1)" "unprognostic (2.84e-2)" "unprognostic (1.30e-2)" "unprognostic (1.42e-1)" "unprognostic (2.94e-1)" "unprognostic (4.79e-2)" "unprognostic (1.07e-1)" "unprognostic (1.52e-1)" "unprognostic (1.52e-2)" "unprognostic (1.64e-2)" "unprognostic (1.80e-2)" "unprognostic (7.38e-2)" "unprognostic (9.99e-5)" "unprognostic (6.31e-2)" "unprognostic (1.48e-2)" "unprognostic (1.05e-2)" 1.3 0.2 0.1 5.2 0.1 0.0 3.7 0.3 0.1 3.4 2.3 0.1 0.1 0.3 4.1 20.2 1.1 1.0 4.2 0.3 0.1 0.0 0.4 0.1 3.3 0.1 0.1 0.1 9.8 0.2 0.0 0.5 0.1 0.1 2.0 0.7 1.4 0.6 0.3 0.7 1.1 3.0 3.9 0.1 0.1 1.1 2.5 0.1 0.1 0.2 1.2 1.2 1.6 1.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 1.7 0.0 3.2 14.9 5.6 12.2 0.0 1.5 0.0 0.0 1.3 0.2 0.0 0.0 0.0 18.6 0.0 0.0 1.0 0.0 0.0 0.2 0.0 35.2 2.1 0.0 1.5 0.8 0.2 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.5 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 2.2 0.0 0.0 0.2 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 76.3 0.0 0.0 0.0 0.0 0.0 0.0 28.0 0.3 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.5 0.0 0.1 0.0 0.0 0.0 0.0 CDK17 "PCTAIRE2, PCTK2" ENSG00000059758 "Cyclin dependent kinase 17" Q00537 12 96278261-96400560 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 44.5;TIME: 53.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015325 Approved Approved Nucleoplasm,Cytosol Yes No "Nucleoplasm, Cytosol" "HPA015325: AB_1855090" "unprognostic (4.35e-1)" "unprognostic (2.79e-1)" "unprognostic (2.70e-1)" "unprognostic (3.56e-1)" "unprognostic (1.50e-1)" "unprognostic (4.96e-3)" "unprognostic (5.22e-3)" "unprognostic (1.23e-1)" "unprognostic (3.23e-2)" "unprognostic (2.75e-2)" "unprognostic (2.44e-1)" "unprognostic (5.96e-2)" "prognostic unfavorable (1.09e-6)" "unprognostic (4.97e-3)" "unprognostic (1.72e-1)" "unprognostic (2.92e-2)" "unprognostic (1.70e-2)" 16.3 9.1 20.6 13.9 47.0 31.5 14.7 17.8 35.7 11.8 12.9 23.6 3.4 9.2 20.7 7.5 11.7 10.9 12.9 9.4 25.3 17.3 9.2 12.4 15.9 15.2 23.8 21.0 12.9 8.0 9.9 7.3 24.3 14.8 11.4 9.8 5.7 7.5 9.3 7.3 9.1 9.3 23.4 19.6 15.8 7.9 19.9 28.0 29.6 9.4 6.1 16.6 11.0 10.7 9.6 5.3 29.1 4.7 16.5 14.8 8.6 4.9 4.2 11.0 2.9 5.4 14.3 7.8 11.1 15.7 9.8 9.3 2.5 2.9 7.4 7.7 8.0 5.3 4.5 6.5 6.9 13.4 7.8 5.0 10.6 2.8 3.5 11.7 5.6 6.1 10.3 7.1 14.5 26.2 17.4 44.5 6.3 7.7 6.0 22.1 3.0 5.3 8.8 4.8 2.4 7.3 9.3 5.9 6.3 11.6 4.2 5.7 3.9 6.5 6.1 8.1 8.7 4.6 5.1 53.3 8.7 3.3 4.6 6.0 8.5 6.5 7.9 3.3 2.4 6.4 29.1 3.4 8.9 12.7 4.7 13.7 9.6 10.4 14.4 5.3 8.8 14.8 12.6 12.8 16.5 4.6 3.9 8.1 8.6 20.6 47.0 17.8 24.6 25.3 17.3 23.8 21.0 14.8 28.0 14.9 6.2 24.4 8.9 23.8 10.8 8.9 5.1 9.4 10.3 8.7 15.7 10.0 0.0 4.6 2.7 42.9 6.0 0.0 3.2 25.8 15.5 10.4 17.4 8.9 10.5 4.8 14.5 35.6 15.3 3.2 9.2 9.4 16.9 7.2 7.4 20.2 5.7 3.5 8.9 6.9 9.2 6.5 27.8 6.5 7.6 22.6 11.4 27.7 5.5 11.8 CDK19 "bA346C16.3, CDC2L6, CDK11, KIAA1028" ENSG00000155111 "Cyclin dependent kinase 19" Q9BWU1 6 110609978-110815958 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 31.1" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 84.5;Late spermatids: 95.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 8.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007053 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA007053: AB_1233803" "unprognostic (1.66e-2)" "unprognostic (1.84e-1)" "unprognostic (3.63e-1)" "unprognostic (3.00e-3)" "unprognostic (1.62e-1)" "unprognostic (2.66e-3)" "prognostic unfavorable (3.56e-4)" "unprognostic (1.47e-2)" "unprognostic (2.96e-2)" "unprognostic (2.00e-3)" "unprognostic (3.94e-1)" "unprognostic (4.04e-1)" "prognostic unfavorable (4.72e-5)" "unprognostic (1.75e-1)" "unprognostic (9.78e-2)" "unprognostic (6.51e-2)" "unprognostic (9.50e-3)" 5.3 3.3 18.1 6.1 29.4 9.7 6.0 13.8 21.3 6.6 6.3 31.1 2.4 4.8 9.6 3.7 7.8 5.3 7.8 4.1 20.8 10.1 6.3 4.6 6.2 8.0 22.1 12.9 9.7 3.1 8.0 4.1 10.5 14.4 25.8 6.1 3.4 4.5 5.9 3.2 7.9 5.9 7.1 20.8 7.0 6.5 16.4 26.3 6.1 5.8 1.3 8.4 5.9 6.4 1.3 1.8 8.5 2.2 1.3 0.8 0.6 3.6 3.9 13.7 16.5 7.4 10.7 7.1 11.9 12.7 4.5 5.9 4.9 4.1 9.3 4.3 8.3 9.0 2.1 5.2 2.5 10.3 11.5 3.0 15.8 5.8 5.7 4.5 6.4 11.9 7.3 5.6 6.1 9.5 11.3 4.4 7.9 4.8 13.0 9.6 5.9 8.6 9.6 1.3 5.2 2.7 9.2 7.0 3.5 5.2 6.7 7.0 13.0 9.0 7.4 10.6 4.8 2.5 23.6 4.9 9.4 5.0 18.9 7.2 1.4 1.9 8.0 9.9 8.7 9.7 3.3 2.2 1.5 0.8 1.2 0.8 1.1 0.7 0.7 1.8 1.3 0.5 0.7 8.5 1.3 0.7 0.9 0.8 0.6 18.1 29.4 13.8 21.3 20.8 10.1 22.1 12.9 14.4 26.3 3.0 16.2 8.1 13.2 8.8 17.3 6.2 12.7 4.0 7.9 15.7 15.7 5.4 1.7 7.5 84.5 11.7 13.8 0.0 4.1 17.1 10.8 49.2 6.9 10.5 14.4 22.3 12.1 14.7 33.3 95.4 10.0 18.4 25.3 3.6 14.2 34.3 6.0 17.5 15.2 5.6 14.1 6.5 8.5 38.1 14.1 14.2 6.6 12.8 12.9 7.4 CDK2 ENSG00000123374 "Cyclin dependent kinase 2" P24941 12 55966769-55972784 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 78.7;Extravillous trophoblasts: 67.5;Melanocytes: 82.7;Syncytiotrophoblasts: 142.8" "Cancer enhanced" "Detected in all" "melanoma: 88.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 107.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB013115, HPA066915" Enhanced Enhanced Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "CAB013115: AB_2536375, HPA066915: AB_2685748" "unprognostic (2.36e-2)" "unprognostic (2.60e-1)" "unprognostic (3.71e-2)" "unprognostic (1.83e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (9.94e-4)" "prognostic unfavorable (8.61e-5)" "unprognostic (3.48e-2)" "unprognostic (1.31e-1)" "unprognostic (4.67e-2)" "unprognostic (5.38e-3)" "unprognostic (4.69e-3)" "prognostic unfavorable (1.46e-10)" "unprognostic (1.05e-1)" "unprognostic (1.76e-1)" "unprognostic (6.16e-2)" "unprognostic (6.75e-2)" 10.7 7.6 4.5 20.8 6.5 18.7 11.5 4.2 4.3 12.6 11.6 3.5 6.0 6.1 10.7 6.4 13.6 10.8 12.6 10.1 5.4 2.2 8.3 16.7 19.5 12.2 6.0 2.0 14.2 8.3 5.2 4.2 49.0 7.3 10.8 9.1 51.2 9.3 9.9 10.8 14.6 9.3 11.8 5.0 12.5 10.1 7.8 5.1 39.3 9.5 10.7 14.7 16.7 10.1 9.3 10.8 5.2 3.9 4.5 7.6 4.3 16.8 9.1 20.1 11.1 4.1 5.3 37.0 21.0 11.0 26.2 24.5 19.2 16.3 16.1 15.8 7.8 10.5 10.8 15.3 9.2 26.6 18.9 15.0 18.5 15.1 7.3 1.3 14.6 13.4 2.8 2.3 17.7 6.1 7.6 13.2 16.7 17.5 14.7 18.1 13.0 30.3 12.4 8.0 11.5 13.6 29.6 19.3 12.1 7.6 16.6 8.3 10.7 24.0 8.8 107.8 12.0 19.0 10.7 7.3 18.1 17.5 13.9 15.3 8.3 9.6 20.0 10.3 10.7 15.6 5.2 3.6 3.1 7.0 3.9 7.0 9.3 3.2 5.0 2.7 6.1 3.0 5.3 1.7 4.5 1.6 10.8 7.6 4.3 4.5 6.5 4.2 4.3 5.4 2.2 6.0 2.0 7.3 5.1 14.9 3.7 5.2 20.1 24.8 0.0 2.6 12.7 5.3 9.1 1.8 0.0 78.7 1.7 10.5 0.4 15.0 2.1 0.0 5.0 67.5 17.6 10.9 10.4 8.9 11.6 1.6 5.2 8.6 4.8 0.2 13.8 6.3 82.7 47.7 6.3 3.8 9.0 0.0 4.2 3.8 3.4 0.0 14.4 2.9 7.7 27.5 142.8 5.7 6.8 18.0 CDK20 "CCRK, p42" ENSG00000156345 "Cyclin dependent kinase 20" Q8IZL9 9 87966441-87974753 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 25.4;Spermatocytes: 25.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 7.2" "Group enriched" "Detected in many" 7 "NK-cells: 7.2;T-cells: 5.0" "Cell line enhanced" "Detected in many" "SCLC-21H: 14.4;THP-1: 21.7" "Low region specificity" "Detected in all" "HPA007666, HPA027379, HPA027401" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA007666: AB_10600002, HPA027379: AB_10599939, HPA027401: AB_10601553" "unprognostic (4.60e-2)" "unprognostic (6.48e-2)" "unprognostic (1.69e-2)" "prognostic favorable (2.59e-4)" "unprognostic (2.32e-1)" "unprognostic (4.33e-3)" "unprognostic (2.81e-4)" "unprognostic (6.33e-2)" "unprognostic (1.45e-1)" "unprognostic (1.34e-1)" "unprognostic (2.83e-3)" "unprognostic (4.04e-2)" "prognostic favorable (2.12e-5)" "unprognostic (8.24e-3)" "unprognostic (5.77e-2)" "unprognostic (3.83e-2)" "unprognostic (1.42e-2)" 2.6 16.2 10.8 2.4 13.0 1.6 4.1 8.7 17.1 8.7 5.0 6.1 5.1 5.3 7.2 6.0 2.8 19.5 5.6 3.0 8.6 10.7 8.2 3.2 4.0 2.0 5.8 14.3 9.5 4.8 7.6 10.8 3.1 9.3 6.1 3.4 7.7 3.6 8.6 2.1 3.6 7.6 5.5 3.1 1.6 3.7 17.7 5.2 0.8 6.8 1.2 1.1 6.3 3.0 0.1 0.8 0.4 0.8 7.2 5.0 1.3 2.4 3.0 2.4 7.6 1.7 2.4 1.0 2.2 4.2 5.9 5.5 0.7 3.6 0.0 3.3 3.6 10.3 3.1 0.0 2.1 2.4 5.9 2.5 0.0 1.9 0.0 7.4 2.8 3.4 1.9 4.4 9.3 3.8 4.6 0.0 5.3 0.3 0.0 1.7 7.1 1.9 0.8 1.9 5.3 1.1 0.0 0.0 0.1 7.4 2.0 14.4 4.1 2.5 3.0 3.6 0.8 3.3 21.7 0.0 2.6 1.0 0.5 2.4 3.8 3.6 0.0 9.3 1.9 2.8 0.0 0.7 0.4 1.3 0.8 0.5 0.0 3.0 1.9 0.7 0.1 5.0 3.2 0.1 7.2 0.7 0.8 2.7 1.3 10.8 13.0 8.7 17.1 8.6 10.7 5.8 14.3 9.3 5.2 3.0 4.1 0.0 1.5 1.9 5.2 2.0 2.5 25.4 5.7 1.8 2.0 3.6 1.7 4.2 4.7 0.5 5.4 0.0 1.3 1.9 3.3 2.5 1.1 0.9 0.9 7.9 0.0 0.6 0.0 1.7 4.0 1.1 0.0 0.0 2.0 4.8 1.5 0.0 6.3 5.3 13.5 6.5 2.3 25.0 2.9 1.9 3.3 0.5 2.9 0.7 CDK2AP1 "doc-1, DOC1, DORC1, p12DOC-1, ST19" ENSG00000111328 "Cyclin dependent kinase 2 associated protein 1" O14519 12 123260971-123272334 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Late spermatids: 109.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 13.0;intermediate monocyte: 40.5;myeloid DC: 14.9;non-classical monocyte: 44.8" "Group enriched" "Detected in many" 6 "dendritic cells: 14.9;monocytes: 44.8" "Low cell line specificity" "Detected in many" "CAB019377, HPA057648, HPA068833" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB019377: , HPA057648: AB_2683488, HPA068833: AB_2686046" "unprognostic (1.56e-1)" "unprognostic (5.94e-2)" "unprognostic (1.83e-2)" "unprognostic (3.04e-2)" "unprognostic (7.77e-2)" "unprognostic (8.89e-2)" "unprognostic (4.21e-3)" "unprognostic (2.86e-2)" "unprognostic (1.24e-1)" "unprognostic (2.70e-2)" "unprognostic (3.32e-2)" "unprognostic (2.22e-1)" "prognostic unfavorable (5.27e-7)" "unprognostic (9.32e-2)" "unprognostic (6.20e-2)" "unprognostic (5.56e-2)" "unprognostic (1.18e-1)" 29.9 28.3 60.4 20.1 55.4 21.0 61.5 27.4 61.6 42.6 22.8 62.8 15.0 13.1 34.5 45.2 30.9 25.5 29.9 30.1 61.0 52.4 20.8 18.2 21.1 22.2 76.4 30.3 16.9 16.4 24.2 22.4 21.4 53.6 33.0 21.9 16.4 51.0 35.4 26.6 21.6 12.6 41.0 96.8 17.7 19.4 22.7 59.9 17.9 16.6 22.1 18.0 36.9 23.4 0.2 14.9 5.1 44.8 0.3 0.5 7.6 16.2 22.9 61.2 65.2 49.6 61.9 11.1 53.0 49.7 42.5 32.7 17.2 15.6 0.0 23.7 81.4 15.8 15.0 64.8 34.6 35.4 10.0 16.2 8.8 14.0 27.2 26.5 13.5 9.5 39.3 36.3 24.6 16.0 38.8 60.2 20.1 11.6 0.1 79.9 31.5 17.8 21.8 40.1 20.2 17.2 68.3 26.5 7.0 34.5 39.5 58.0 67.9 38.9 19.1 52.0 17.0 36.9 13.6 36.8 39.7 20.7 23.2 34.8 2.8 5.3 15.0 21.3 6.5 86.3 3.8 13.0 5.1 0.2 40.5 0.5 0.2 0.2 0.3 14.9 0.0 0.1 0.2 0.7 0.3 44.8 1.4 0.1 7.6 60.4 55.4 27.4 52.2 61.0 52.4 76.4 30.3 53.6 59.9 26.8 31.2 0.0 1.1 1.1 0.2 1.6 7.6 18.7 34.2 12.2 0.0 1.2 1.7 19.8 19.8 5.6 5.1 0.0 14.6 2.8 4.1 0.3 18.5 7.3 5.2 3.2 7.5 13.5 18.0 109.1 12.4 7.2 3.3 10.8 19.8 20.0 19.4 10.5 13.4 2.6 0.2 0.0 1.0 1.5 5.7 2.5 1.1 0.0 18.0 0.8 CDK2AP2 "DOC-1R, p14" ENSG00000167797 "Cyclin dependent kinase 2 associated protein 2" O75956 11 67506497-67508649 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047599 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047599: AB_10963069" "unprognostic (2.44e-1)" "unprognostic (5.01e-2)" "unprognostic (1.42e-1)" "prognostic favorable (8.80e-4)" "unprognostic (6.24e-2)" "unprognostic (2.30e-2)" "unprognostic (8.85e-3)" "unprognostic (1.42e-1)" "unprognostic (5.65e-2)" "unprognostic (3.85e-3)" "unprognostic (4.91e-3)" "unprognostic (2.06e-1)" "prognostic unfavorable (5.20e-4)" "unprognostic (7.58e-2)" "unprognostic (3.11e-1)" "unprognostic (6.96e-2)" "unprognostic (1.73e-3)" 16.2 28.0 16.8 20.4 22.4 17.0 26.2 13.5 15.6 20.5 22.4 13.1 32.3 23.4 16.6 44.8 17.8 16.6 18.6 28.6 16.2 14.8 43.3 45.5 19.6 23.8 21.9 9.2 12.3 41.6 9.0 18.1 19.5 21.3 16.0 14.4 8.1 55.1 24.9 9.6 10.1 20.0 13.8 21.1 19.0 19.7 6.8 21.4 28.3 80.3 10.6 22.9 17.4 35.8 25.9 91.6 27.8 30.0 32.5 37.6 23.3 16.8 11.0 5.9 10.4 8.0 2.5 9.4 6.5 3.1 7.6 7.1 13.9 19.7 12.5 22.1 4.3 9.9 12.1 8.7 11.5 2.2 23.5 8.0 6.7 8.5 9.6 18.4 6.5 10.4 3.0 12.6 5.8 13.5 7.5 8.4 17.7 7.0 26.5 4.0 26.1 32.8 22.3 5.3 32.6 18.4 15.0 3.5 40.3 18.0 4.2 4.5 10.3 8.0 16.3 26.3 5.1 11.7 12.9 7.0 4.9 8.9 12.1 4.8 11.2 6.7 10.7 14.5 8.6 5.5 23.9 17.2 27.8 37.6 27.0 32.5 25.9 29.1 34.0 23.0 24.0 17.1 24.6 11.3 32.5 30.0 91.6 32.6 23.3 16.8 22.4 13.5 15.6 16.2 14.8 21.9 9.2 21.3 21.4 59.6 74.7 108.7 45.0 59.5 27.2 75.3 86.6 68.3 58.0 111.7 29.5 94.6 182.4 73.9 0.9 46.6 169.0 0.0 46.4 142.7 44.3 65.4 73.8 110.5 74.2 31.8 98.5 41.1 36.7 1.6 22.7 61.1 108.0 148.7 60.1 47.9 95.1 91.2 28.7 224.3 19.5 25.8 79.5 7.2 30.9 44.5 162.6 126.6 78.6 49.7 CDK4 PSK-J3 ENSG00000135446 "Cyclin dependent kinase 4" P11802 12 57747727-57756013 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in all" 10 "HBEC3-KT: 128.1;LHCN-M2: 141.4;RH-30: 445.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006024, CAB013116, CAB069405" Supported Supported "Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol" NA NA Cytosol "Nucleoplasm, Nuclear membrane, Nucleoli" "CAB013116: AB_2536376, CAB069405: AB_1613464, HPA006024: AB_2667497" "unprognostic (8.88e-2)" "unprognostic (2.53e-1)" "unprognostic (5.27e-2)" "unprognostic (9.01e-2)" "unprognostic (2.21e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (2.09e-7)" "unprognostic (7.39e-2)" "unprognostic (3.23e-3)" "unprognostic (2.93e-2)" "unprognostic (3.19e-2)" "unprognostic (9.10e-2)" "prognostic unfavorable (3.15e-5)" "unprognostic (3.32e-1)" "unprognostic (1.67e-1)" "unprognostic (3.64e-1)" "unprognostic (1.57e-2)" 32.2 43.1 13.8 22.2 15.7 24.0 45.0 13.1 17.9 36.3 28.2 20.1 22.8 15.2 51.4 28.1 29.9 31.0 32.3 27.4 14.5 12.1 24.0 36.9 26.8 26.4 18.3 13.7 61.4 54.4 18.9 34.2 25.0 16.0 37.2 26.9 26.2 29.3 24.1 27.8 25.6 20.7 34.1 13.5 27.2 23.9 24.6 17.5 29.2 54.3 32.1 27.5 33.6 30.9 29.6 25.5 2.6 19.9 15.8 32.1 22.2 9.5 11.1 14.6 13.0 13.4 11.8 9.8 5.5 18.0 24.4 20.2 15.8 9.1 13.9 10.0 8.6 14.4 7.4 20.2 128.1 18.5 6.8 9.3 13.0 7.5 11.1 15.7 14.7 9.0 11.6 9.4 14.9 17.2 16.6 15.6 13.3 13.8 12.0 141.4 13.9 14.1 12.0 17.2 10.0 11.2 12.6 445.0 12.9 7.6 15.1 13.3 12.4 9.8 7.4 14.7 10.5 9.8 17.9 7.1 11.4 10.8 12.9 11.1 6.0 9.7 21.4 10.5 13.7 13.7 1.7 14.3 2.6 26.2 19.9 27.0 29.6 23.1 23.7 21.0 28.1 32.1 28.5 1.2 15.8 12.0 25.5 16.6 22.2 13.8 15.7 13.1 17.9 14.5 12.1 18.3 13.7 16.0 17.5 20.8 25.0 32.0 62.9 79.7 15.3 0.5 48.4 4.0 23.9 45.4 9.8 64.6 59.7 71.7 10.1 44.2 11.3 23.3 53.6 108.9 77.4 41.8 68.1 32.1 111.7 17.5 43.8 34.4 23.2 6.8 59.2 34.0 50.6 54.1 33.5 51.3 55.4 7.0 59.4 66.3 15.3 32.3 54.2 25.9 40.3 75.3 39.1 34.1 78.3 32.5 CDK5 PSSALRE ENSG00000164885 "Cyclin dependent kinase 5" Q00535 7 151053812-151058530 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Biological rhythms, Cell cycle, Cell division, Neurogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Lissencephaly, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 36.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008909, HPA064535" Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Nucleoplasm, Plasma membrane" "Cell Junctions" "CAB008909: , HPA064535: AB_2685280" "unprognostic (1.21e-1)" "unprognostic (3.23e-2)" "unprognostic (4.22e-2)" "unprognostic (1.43e-1)" "unprognostic (1.10e-1)" "unprognostic (3.48e-1)" "unprognostic (5.67e-3)" "unprognostic (1.05e-2)" "unprognostic (1.22e-1)" "unprognostic (5.78e-3)" "unprognostic (6.25e-3)" "unprognostic (3.35e-1)" "unprognostic (4.47e-2)" "unprognostic (1.46e-2)" "unprognostic (1.77e-1)" "unprognostic (2.88e-1)" "unprognostic (1.11e-1)" 4.5 11.3 24.4 6.9 30.4 6.1 5.3 13.6 36.1 5.3 6.1 6.7 4.5 7.9 4.5 17.4 6.5 5.0 6.2 5.8 25.0 19.7 9.0 7.7 5.3 6.0 15.4 15.4 3.2 5.8 8.9 7.9 5.3 20.8 5.8 6.3 3.2 6.0 6.3 5.7 6.5 6.2 6.0 8.6 5.2 5.7 3.1 7.7 6.8 6.0 3.6 6.9 6.7 3.1 6.6 21.5 9.0 21.7 9.5 14.9 10.6 11.7 14.1 13.2 21.5 14.6 10.7 6.6 7.8 12.8 15.3 12.6 10.0 11.0 11.6 27.9 9.6 22.8 8.4 21.2 11.8 7.0 9.1 12.6 12.7 12.4 9.9 9.6 10.2 23.9 11.6 8.9 12.6 3.9 21.4 10.3 18.2 12.9 8.5 15.3 22.7 27.6 21.0 14.5 18.9 22.3 13.5 5.4 12.9 13.3 8.9 8.4 35.9 11.2 13.8 14.7 12.6 6.4 9.0 8.7 15.1 3.9 11.3 14.5 19.7 21.5 4.5 23.7 14.8 27.0 7.8 19.0 9.0 6.9 21.7 5.4 6.6 6.8 6.8 21.5 5.9 5.1 6.2 2.8 9.5 16.4 12.8 14.9 10.6 24.4 30.4 13.6 36.1 25.0 19.7 15.4 15.4 20.8 7.7 0.0 5.9 11.5 6.4 3.2 11.5 3.2 7.6 8.1 7.9 10.4 2.0 20.0 33.2 19.0 0.6 6.3 7.1 0.0 16.6 10.2 6.6 5.0 31.0 9.6 37.8 0.0 8.6 6.2 21.6 0.9 4.4 14.3 10.1 20.8 9.1 11.5 18.7 14.4 10.6 24.0 4.7 6.5 5.0 2.6 9.7 5.5 7.6 8.5 9.6 7.6 CDK5R1 "Nck5a, p35, p35nck5a" ENSG00000176749 "Cyclin dependent kinase 5 regulatory subunit 1" Q15078 17 32486619-32491256 "Predicted intracellular proteins" "Biological rhythms" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 58.8" "Cell type enhanced" "Detected in many" 15 "Cone photoreceptor cells: 43.2;Early spermatids: 15.1;Late spermatids: 13.7;Muller glia cells: 17.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 32.2;SK-MEL-30: 23.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000252 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA000252: AB_2665953" "unprognostic (1.08e-1)" "unprognostic (9.13e-2)" "unprognostic (1.79e-2)" "unprognostic (3.65e-1)" "unprognostic (1.97e-1)" "unprognostic (8.09e-2)" "unprognostic (2.74e-5)" "unprognostic (1.81e-2)" "unprognostic (3.32e-1)" "unprognostic (2.18e-1)" "unprognostic (5.90e-2)" "unprognostic (5.60e-1)" "unprognostic (6.98e-2)" "unprognostic (1.60e-1)" "unprognostic (7.92e-2)" "unprognostic (8.81e-2)" "unprognostic (1.03e-1)" 1.6 3.3 21.9 6.4 21.1 4.9 1.8 26.0 58.8 1.2 1.6 3.6 0.0 2.0 1.6 1.0 5.5 1.5 1.6 1.6 21.4 17.3 1.5 1.3 1.4 11.5 7.6 24.5 3.2 2.0 1.3 3.0 1.4 7.8 1.4 1.5 0.9 1.2 1.3 1.8 2.2 2.0 1.3 4.1 7.7 2.2 5.2 3.2 1.2 1.1 0.3 12.3 1.7 1.1 0.6 1.8 2.9 0.9 0.7 4.2 1.5 2.0 1.2 5.3 1.7 0.6 1.0 0.6 1.2 0.7 1.5 2.0 3.1 0.5 1.0 1.2 1.1 1.3 1.0 2.0 1.3 2.1 0.4 4.0 0.3 0.5 1.2 0.2 0.6 1.1 0.6 3.2 1.6 1.3 0.6 1.1 3.7 2.0 1.2 3.3 0.8 1.8 0.8 3.4 0.7 1.1 1.5 3.2 3.7 0.7 0.9 32.2 8.7 1.2 0.7 23.1 0.8 1.3 2.4 1.1 2.2 3.3 0.8 3.3 0.6 0.8 1.0 1.9 3.0 5.2 0.0 0.9 1.2 2.3 0.8 1.8 0.6 3.1 1.3 0.2 0.5 4.2 2.6 2.9 0.7 0.4 1.8 0.4 1.5 21.9 21.1 26.0 37.3 21.4 17.3 7.6 24.5 7.8 3.2 0.0 1.0 1.4 0.4 1.3 10.4 2.8 0.0 0.0 0.0 0.0 43.2 0.5 0.0 0.1 15.1 0.6 0.2 0.0 0.5 0.3 0.4 0.9 0.0 0.8 0.8 1.6 0.0 1.3 3.8 13.7 0.0 0.4 3.3 0.0 0.8 17.0 1.1 0.2 0.7 1.2 5.6 0.0 1.4 3.2 5.7 1.1 0.9 4.4 0.9 0.3 CDK6 PLSTIRE ENSG00000105810 "Cyclin dependent kinase 6" Q00534 7 92604921-92836594 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 74.6" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 219.8;Late spermatids: 186.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 93.5;REH: 45.7" "Low region specificity" "Detected in all" "HPA002637, CAB004363" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004363: AB_627242, HPA002637: AB_1846432" "unprognostic (1.29e-1)" "unprognostic (5.98e-3)" "unprognostic (9.07e-2)" "unprognostic (2.78e-3)" "unprognostic (2.56e-2)" "unprognostic (3.24e-2)" "unprognostic (3.39e-1)" "unprognostic (2.42e-3)" "unprognostic (7.19e-2)" "unprognostic (7.78e-3)" "prognostic unfavorable (3.86e-6)" "unprognostic (4.06e-2)" "unprognostic (4.09e-3)" "unprognostic (1.09e-1)" "unprognostic (7.88e-2)" "unprognostic (1.93e-1)" "prognostic unfavorable (2.33e-5)" 6.6 11.3 6.0 9.1 7.5 22.5 5.9 2.4 6.0 7.8 10.0 9.6 5.7 7.5 6.0 5.9 8.5 4.6 7.8 6.6 6.9 4.2 6.5 7.5 7.3 7.4 7.0 5.2 5.0 10.0 25.7 4.2 20.5 7.5 6.1 9.2 4.4 10.9 6.1 2.0 11.6 9.4 9.8 7.5 6.3 10.8 5.4 8.0 74.6 4.3 9.2 10.3 6.7 9.0 3.6 5.6 6.5 4.8 3.9 7.1 2.3 6.2 2.9 8.0 5.1 2.3 2.6 1.7 6.4 4.0 3.2 3.0 7.8 4.8 4.8 3.7 4.3 2.0 3.8 4.4 9.2 7.6 10.5 3.1 12.0 5.5 7.5 1.4 7.4 0.6 2.6 5.0 4.3 20.4 3.0 1.2 19.6 11.5 13.3 5.7 1.2 93.5 0.8 2.5 7.9 2.6 45.7 28.1 8.1 4.4 0.1 4.2 27.3 0.7 2.2 3.7 6.1 0.1 12.3 4.7 10.5 16.5 4.1 12.9 7.1 0.1 6.4 1.5 25.5 13.9 4.9 1.9 6.5 5.2 3.9 5.9 2.0 5.5 5.6 4.0 3.6 7.1 4.0 1.1 3.9 4.8 5.6 2.8 2.3 6.0 7.5 2.4 6.0 6.9 4.2 7.0 5.2 7.5 8.0 23.8 3.0 11.9 19.5 53.5 0.2 14.8 25.5 4.0 27.3 21.0 0.0 42.7 8.3 31.7 219.8 24.1 11.0 0.0 20.1 3.4 21.6 18.1 24.3 18.4 15.0 0.0 16.1 7.4 23.4 186.0 4.6 21.9 18.6 20.8 46.7 0.5 63.1 14.0 3.2 5.1 0.0 6.5 22.1 2.6 46.4 44.2 14.8 20.3 68.3 23.3 CDK7 "CAK, CAK1, CDKN7, MO15, STK1" ENSG00000134058 "Cyclin dependent kinase 7" P50613 5 69234795-69277430 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 97.9;Extravillous trophoblasts: 285.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004364, HPA007932, HPA008453" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Plasma membrane, Cytosol" "CAB004364: AB_627243, HPA007932: AB_1078492, HPA008453: " "unprognostic (3.12e-2)" "unprognostic (1.23e-1)" "unprognostic (4.87e-2)" "unprognostic (4.53e-2)" "unprognostic (3.29e-2)" "unprognostic (4.64e-2)" "unprognostic (2.49e-3)" "unprognostic (1.64e-2)" "unprognostic (7.77e-3)" "unprognostic (1.81e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (3.40e-2)" "prognostic unfavorable (9.42e-7)" "unprognostic (2.61e-1)" "unprognostic (2.38e-1)" "unprognostic (3.86e-2)" "unprognostic (1.55e-2)" 7.9 12.9 10.9 6.2 15.2 44.1 14.0 10.8 14.7 9.4 12.7 6.0 6.3 15.8 9.4 8.6 23.4 18.5 16.5 8.1 11.5 9.3 13.8 10.6 10.1 8.8 7.6 9.7 7.7 9.1 3.3 16.2 22.9 11.2 11.2 14.8 6.6 13.2 6.5 15.9 15.4 9.8 12.1 9.2 7.9 13.9 29.0 7.8 12.1 20.0 15.6 15.5 10.7 11.7 15.6 15.0 22.4 11.3 12.4 15.3 7.8 3.6 7.7 1.8 0.5 2.4 11.6 14.7 6.4 7.7 10.7 17.4 16.6 1.9 2.8 10.1 1.7 12.4 2.5 1.4 2.8 5.8 1.3 7.0 0.4 8.1 7.9 0.4 6.7 3.2 14.3 13.8 9.0 2.8 9.4 13.5 15.6 10.3 4.5 4.9 0.7 4.0 14.7 1.7 3.7 7.4 6.6 0.4 1.1 1.6 1.0 0.6 6.5 1.5 5.8 3.4 6.4 11.6 0.6 2.6 0.0 3.2 0.9 5.1 4.8 8.4 3.7 0.8 4.0 0.8 7.3 10.9 22.4 8.6 11.3 14.8 12.4 12.9 15.3 15.0 15.6 11.1 13.2 10.0 12.4 8.0 11.2 12.8 7.8 10.9 15.2 10.8 12.7 11.5 9.3 7.6 9.7 11.2 7.8 14.9 10.4 2.4 16.5 51.3 6.3 8.9 5.1 48.2 10.3 5.2 11.8 97.9 13.3 21.5 6.2 11.3 9.2 0.0 19.0 285.4 10.2 19.9 15.1 6.6 21.2 1.6 2.9 6.7 8.2 3.6 6.9 10.2 6.8 9.0 11.4 9.0 22.5 14.0 6.7 20.7 8.2 25.8 12.2 25.4 15.8 36.6 54.0 9.6 11.8 28.6 CDK8 K35 ENSG00000132964 "Cyclin dependent kinase 8" P49336 13 26254104-26405238 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Kinase, Repressor, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 55.8;Late spermatids: 83.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044721 Approved Nucleoplasm NA NA Nucleoplasm "HPA044721: AB_2679059" "unprognostic (3.28e-3)" "unprognostic (2.25e-3)" "unprognostic (2.08e-1)" "unprognostic (3.88e-3)" "unprognostic (2.30e-2)" "unprognostic (1.05e-2)" "unprognostic (6.42e-3)" "unprognostic (1.85e-2)" "unprognostic (5.00e-2)" "unprognostic (8.57e-2)" "unprognostic (2.52e-1)" "unprognostic (3.18e-3)" "unprognostic (2.12e-1)" "prognostic favorable (9.23e-4)" "unprognostic (1.43e-2)" "unprognostic (1.88e-1)" "unprognostic (6.37e-2)" 7.6 8.8 10.1 10.4 8.5 5.2 5.6 26.9 11.3 5.9 24.0 6.0 13.8 13.8 11.2 6.5 10.0 7.0 11.2 7.6 8.3 7.3 9.4 10.4 6.7 5.2 7.8 7.9 6.1 12.7 8.4 10.2 10.6 8.2 7.8 11.2 4.6 9.0 19.2 9.7 6.1 15.0 12.7 6.0 6.4 11.7 16.3 9.9 12.8 6.4 6.9 7.2 15.5 11.0 1.9 1.7 3.4 1.6 1.0 2.1 1.3 6.9 5.7 11.6 11.8 6.2 7.6 7.2 13.4 9.2 10.0 7.2 16.6 9.7 7.4 5.9 6.9 8.0 8.6 13.3 9.0 12.6 17.1 7.4 14.1 4.6 5.7 4.3 22.0 8.1 5.5 8.7 7.5 12.7 5.5 7.3 12.1 21.8 0.0 9.0 7.4 16.8 10.3 9.2 10.5 7.1 10.6 11.5 5.1 5.8 6.5 9.9 5.8 5.7 10.9 9.8 9.6 3.9 10.1 7.4 6.4 8.2 11.7 7.3 5.7 10.1 13.6 4.0 9.3 7.6 0.4 0.9 3.4 1.1 1.6 1.9 1.0 1.5 2.1 1.7 1.9 2.1 1.7 0.0 1.0 1.2 1.0 0.6 1.3 10.1 8.5 26.9 11.3 8.3 7.3 7.8 7.9 8.2 9.9 8.9 4.1 4.5 6.7 17.5 19.1 5.0 7.6 0.0 5.7 1.8 23.6 7.2 8.3 8.5 55.8 6.8 9.7 0.0 7.2 8.3 9.3 11.0 0.0 5.4 7.1 17.5 8.1 6.2 7.5 83.1 7.2 6.6 8.5 8.2 7.8 7.1 10.6 11.5 7.8 11.5 16.6 6.5 11.3 27.8 17.5 20.8 8.1 6.9 10.5 9.1 CDK9 "C-2k, CDC2L4, PITALRE, TAK" ENSG00000136807 "Cyclin dependent kinase 9" P50750 9 127785679-127790787 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004216, HPA006738" Supported Approved "Nucleoplasm,Cytoplasmic bodies" NA NA Nucleoplasm "Cytoplasmic bodies" "CAB004216: AB_627245, HPA006738: AB_1078493" "unprognostic (3.60e-1)" "unprognostic (1.71e-1)" "unprognostic (5.44e-3)" "unprognostic (1.04e-3)" "unprognostic (1.93e-1)" "unprognostic (3.97e-2)" "unprognostic (2.07e-1)" "unprognostic (5.84e-2)" "unprognostic (2.66e-1)" "unprognostic (8.36e-2)" "unprognostic (1.24e-3)" "unprognostic (3.11e-2)" "prognostic unfavorable (8.92e-4)" "unprognostic (1.37e-1)" "unprognostic (1.00e-1)" "unprognostic (3.52e-2)" "unprognostic (8.78e-3)" 26.2 27.0 22.8 18.9 22.4 33.9 17.4 31.0 26.8 23.1 21.9 22.9 24.7 16.6 22.5 20.1 22.7 29.1 21.5 22.9 26.3 23.4 18.5 48.7 23.3 26.6 23.4 18.8 43.7 29.1 15.5 28.4 19.8 20.6 20.7 10.8 18.7 20.6 21.6 14.6 26.6 21.4 21.0 17.9 29.0 17.7 22.3 16.1 29.3 25.8 18.3 24.2 17.0 17.6 6.0 8.9 5.1 6.4 18.6 9.9 2.9 9.0 16.4 10.3 11.3 11.7 9.2 13.5 9.3 13.7 9.7 8.8 12.2 10.2 15.9 10.9 10.5 13.4 18.3 6.8 15.2 3.7 14.2 8.1 14.8 17.8 10.0 17.1 14.3 23.8 16.1 18.6 10.3 11.6 12.6 20.0 14.2 12.8 21.3 8.7 23.8 15.6 21.6 22.8 13.7 17.6 45.2 8.8 22.7 14.1 10.1 10.2 12.2 14.0 14.8 8.3 8.4 18.6 13.6 22.9 11.7 13.2 10.0 9.0 38.9 29.9 14.2 10.9 9.8 10.6 3.7 3.4 4.9 9.9 4.5 9.9 3.5 5.6 7.9 4.4 6.0 6.3 7.7 5.1 18.6 6.4 8.9 3.8 2.9 22.8 22.4 31.0 26.8 26.3 23.4 23.4 18.8 20.6 16.1 11.9 14.3 20.4 20.9 21.4 13.1 12.9 15.3 18.7 7.9 10.4 2.0 18.7 13.3 26.6 3.2 26.7 12.9 0.0 32.7 18.8 16.4 18.5 24.3 23.6 20.6 23.8 18.5 31.9 17.0 4.3 18.1 18.9 15.1 64.9 11.8 16.2 30.5 11.8 29.4 12.7 7.5 0.0 22.7 7.5 24.0 19.3 42.9 23.5 13.1 23.1 CDKL1 KKIALRE ENSG00000100490 "Cyclin dependent kinase like 1" Q00532 14 50329404-50416461 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 17.9;Ciliated cells: 34.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059605, HPA065919" Uncertain Enhanced Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA059605: AB_2684080, HPA065919: AB_2685578" "unprognostic (4.12e-3)" "unprognostic (3.22e-1)" "unprognostic (4.54e-2)" "unprognostic (8.04e-2)" "unprognostic (1.64e-2)" "unprognostic (1.02e-1)" "unprognostic (3.23e-3)" "unprognostic (9.36e-3)" "unprognostic (2.63e-1)" "unprognostic (9.99e-2)" "unprognostic (1.20e-1)" "unprognostic (9.36e-2)" "unprognostic (5.53e-8)" "unprognostic (1.21e-1)" "unprognostic (7.96e-2)" "unprognostic (9.39e-3)" "unprognostic (3.31e-3)" 7.1 2.1 7.5 1.8 5.1 0.9 3.0 2.7 20.2 14.1 5.9 1.6 2.5 8.4 12.1 2.3 2.6 16.4 2.6 2.9 7.1 2.4 18.8 1.1 4.3 3.0 2.0 12.3 10.5 2.0 1.4 1.4 4.9 2.9 4.0 5.7 1.6 2.5 8.4 1.7 3.0 3.0 7.7 3.1 3.7 2.0 1.9 1.4 1.3 5.0 6.1 2.1 7.0 5.6 5.7 1.3 6.0 2.5 3.8 6.7 2.6 6.1 4.9 0.6 2.4 6.5 7.9 0.3 2.1 3.9 2.2 2.6 2.0 5.8 0.4 2.6 4.6 2.2 4.2 0.9 0.6 2.5 6.7 2.4 6.5 2.1 1.7 7.4 5.9 3.5 1.7 3.6 4.6 10.1 1.8 8.5 6.2 2.7 2.6 1.0 0.3 1.9 3.1 0.7 1.6 2.3 0.7 2.8 1.9 6.9 2.3 1.1 1.3 2.5 16.7 0.6 0.1 0.2 5.0 2.7 5.7 2.9 5.7 4.7 0.9 0.4 0.4 1.0 6.2 7.0 6.0 2.5 4.4 6.3 2.3 6.2 4.6 4.4 6.7 1.3 5.7 3.4 3.7 1.4 3.8 0.3 1.2 4.1 2.6 7.5 5.1 2.7 20.2 7.1 2.4 2.0 12.3 2.9 1.4 17.9 6.9 1.3 3.2 2.7 0.4 0.4 0.0 34.8 4.5 10.4 0.0 0.1 5.0 0.9 0.3 2.1 4.7 0.0 1.6 0.1 4.7 1.2 1.1 0.2 0.3 0.0 1.7 6.7 1.9 0.9 8.3 1.1 0.0 0.0 2.3 0.8 1.2 3.7 3.2 5.5 0.7 0.0 1.3 0.0 0.2 2.4 0.2 2.5 3.4 1.4 CDKL2 "KKIAMRE, P56" ENSG00000138769 "Cyclin dependent kinase like 2" Q92772 4 75578005-75630716 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 27.7" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 55.4;Ciliated cells: 28.1;Spermatocytes: 46.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.6" "Lineage enhanced" "Detected in single" "T-cells: 1.6" "Cell line enhanced" "Detected in some" "A-431: 5.7;HEK 293: 3.8;HHSteC: 4.4;RPTEC TERT1: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040672 Approved Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA040672: AB_10794744" "unprognostic (2.07e-1)" "unprognostic (9.96e-2)" "unprognostic (6.91e-2)" "unprognostic (3.80e-5)" "unprognostic (3.43e-2)" "unprognostic (2.71e-2)" "unprognostic (1.59e-1)" "unprognostic (8.14e-3)" "unprognostic (1.58e-1)" "unprognostic (1.62e-1)" "unprognostic (5.85e-2)" "unprognostic (1.27e-1)" "prognostic favorable (6.88e-15)" "unprognostic (5.91e-2)" "unprognostic (1.70e-1)" "unprognostic (1.64e-1)" "unprognostic (7.52e-2)" 0.7 2.4 7.1 1.2 11.1 0.7 1.2 7.7 13.2 1.7 2.0 6.2 0.0 1.0 1.7 2.3 2.3 4.1 1.4 1.3 5.1 6.7 11.8 0.7 9.2 1.3 7.1 7.0 3.8 1.6 5.7 8.9 0.7 12.5 2.0 2.4 3.4 1.2 2.0 0.7 0.9 0.9 1.5 7.4 0.9 1.5 27.7 6.1 0.0 6.9 0.0 2.0 1.1 0.9 0.4 0.0 0.2 0.0 0.0 1.6 0.1 5.7 0.7 0.3 0.0 0.3 0.3 0.0 0.3 1.8 2.4 2.0 0.5 1.2 0.1 0.9 0.1 2.3 0.8 0.0 0.5 2.3 0.2 3.8 0.0 0.2 0.0 4.4 0.0 0.1 1.5 2.1 0.4 0.8 1.9 0.1 0.0 0.0 0.4 0.9 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 8.2 0.3 3.1 2.5 0.0 0.0 1.2 2.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 2.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.4 1.6 0.0 0.0 0.6 0.5 0.2 0.0 0.0 0.0 1.2 0.1 7.1 11.1 7.7 13.2 5.1 6.7 7.1 7.0 12.5 6.1 23.8 55.4 0.0 0.4 0.1 16.6 0.8 0.0 28.1 7.9 8.7 3.9 0.0 6.6 2.0 24.5 0.0 0.0 0.0 0.2 0.5 0.2 0.3 1.1 0.0 0.1 9.5 1.7 0.6 0.0 16.4 1.7 0.5 1.7 0.0 0.2 10.4 0.1 0.0 1.1 20.7 19.5 0.0 0.0 46.8 1.7 0.3 0.2 1.0 2.6 0.1 CDKL3 NKIAMRE ENSG00000006837 "Cyclin dependent kinase like 3" Q8IVW4 5 134286350-134371047 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 33.4" "Group enriched" "Detected in many" 8 "Early spermatids: 261.7;Late spermatids: 219.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA027751 Uncertain Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA027751: AB_10601256" "unprognostic (4.70e-2)" "unprognostic (2.15e-2)" "unprognostic (2.35e-1)" "unprognostic (1.48e-1)" "unprognostic (1.43e-1)" "unprognostic (3.98e-2)" "unprognostic (3.43e-3)" "unprognostic (5.93e-2)" "unprognostic (2.12e-3)" "unprognostic (1.49e-1)" "unprognostic (8.47e-4)" "unprognostic (2.82e-1)" "unprognostic (9.85e-4)" "unprognostic (8.33e-2)" "unprognostic (4.88e-2)" "unprognostic (7.10e-3)" "unprognostic (3.43e-3)" 2.5 2.7 7.0 2.2 7.1 1.6 2.5 7.0 8.5 2.6 2.4 5.9 5.5 2.3 3.9 5.3 2.6 3.7 2.6 6.6 6.1 6.5 4.5 2.8 2.2 2.5 8.0 4.3 3.0 2.4 3.2 6.5 2.2 8.6 2.8 2.6 3.9 2.0 3.2 7.5 2.7 2.5 4.6 8.4 2.7 2.2 33.4 9.3 1.3 3.9 2.1 3.0 2.8 2.2 1.5 2.7 1.0 1.1 1.4 4.0 1.3 1.0 2.1 3.1 2.2 5.4 4.6 1.3 2.9 2.6 1.3 3.2 1.9 1.5 2.7 1.8 1.8 6.0 0.9 2.6 1.8 2.6 2.9 2.0 1.4 2.3 3.3 3.3 0.6 0.9 2.2 4.7 3.9 1.2 2.2 1.3 6.5 1.5 1.2 3.5 1.1 2.1 8.0 2.1 0.6 1.0 3.4 1.3 0.8 1.7 0.9 4.8 1.4 2.1 0.5 3.5 3.7 1.8 1.6 0.9 2.6 0.6 3.5 1.0 3.3 4.4 5.2 4.0 2.1 2.0 0.0 0.9 1.0 0.9 1.1 4.0 1.5 1.4 2.5 2.7 1.0 3.8 3.8 0.2 1.4 0.4 1.6 2.3 1.3 7.0 7.1 7.0 8.5 6.1 6.5 8.0 4.3 8.6 9.3 0.0 3.0 0.0 5.7 9.6 12.7 1.6 0.0 5.3 3.4 5.2 3.9 2.4 8.3 2.6 261.7 3.6 0.5 0.0 4.4 1.6 6.9 4.0 3.5 1.8 3.1 6.4 2.9 3.1 0.6 219.5 4.6 4.0 10.1 2.8 0.7 10.0 1.5 0.9 8.5 6.1 9.6 0.0 5.6 30.5 13.2 9.7 3.8 3.2 1.1 3.3 CDKL5 "CFAP247, EIEE2, STK9" ENSG00000008086 "Cyclin dependent kinase like 5" O76039 X 18425583-18653629 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.0" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 76.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 7.7;eosinophil: 2.1;neutrophil: 4.7" "Lineage enriched" "Detected in many" 8 "granulocytes: 7.7" "Cell line enhanced" "Detected in many" "A549: 12.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002847, CAB011577" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB011577: AB_727019, HPA002847: AB_1080107" "unprognostic (7.01e-2)" "unprognostic (4.86e-2)" "unprognostic (1.41e-1)" "unprognostic (1.25e-4)" "unprognostic (1.17e-1)" "unprognostic (1.61e-2)" "unprognostic (1.72e-2)" "unprognostic (1.67e-1)" "unprognostic (2.07e-1)" "unprognostic (9.63e-3)" "unprognostic (2.05e-3)" "unprognostic (1.66e-1)" "prognostic favorable (5.54e-4)" "unprognostic (7.67e-3)" "unprognostic (1.29e-1)" "unprognostic (2.67e-3)" "unprognostic (1.99e-1)" 3.3 3.2 8.0 1.8 24.7 3.2 4.3 3.9 28.0 5.4 2.7 7.7 1.8 1.5 4.5 2.8 5.2 2.8 3.1 5.0 8.0 3.7 6.3 2.2 6.9 1.4 3.5 13.2 6.7 4.5 6.2 5.0 5.4 5.9 6.7 2.2 2.0 3.9 4.4 3.0 3.5 1.9 4.0 5.7 2.3 4.9 14.0 5.7 1.6 5.1 0.8 2.1 5.6 4.6 0.7 1.0 7.7 1.0 0.5 0.6 0.2 1.7 12.3 3.5 3.1 3.3 4.5 2.5 2.0 3.8 2.8 3.2 4.0 2.3 1.9 0.4 1.3 5.5 0.5 4.0 3.0 5.9 0.5 2.6 0.0 7.1 3.2 1.6 0.1 0.8 2.6 3.1 6.8 7.1 1.7 1.3 2.2 0.1 2.0 4.2 1.7 0.8 0.8 7.2 1.6 3.0 0.7 3.8 0.1 2.5 9.0 0.7 4.5 4.5 1.1 2.2 7.4 1.7 0.7 7.3 4.3 1.9 7.9 1.5 0.3 0.1 0.3 2.4 0.5 4.2 7.7 1.0 2.1 0.6 0.6 0.3 0.2 0.4 0.3 0.3 0.7 0.6 0.6 4.7 0.5 0.6 1.0 0.2 0.2 8.0 24.7 3.9 28.0 8.0 3.7 3.5 13.2 5.9 5.7 23.8 19.0 0.0 8.3 0.8 16.1 12.0 5.1 6.7 9.1 7.0 31.4 20.0 6.6 5.7 27.2 4.5 0.0 0.0 8.1 2.5 3.1 18.1 1.1 3.0 3.7 76.3 2.4 4.9 5.3 41.5 5.5 1.8 0.0 2.8 1.9 27.7 6.6 0.0 4.9 7.5 19.5 32.3 4.2 2.3 9.8 1.1 39.6 0.8 1.5 24.3 CDKN1A "CAP20, CDKN1, CIP1, P21, p21CIP1, p21Cip1/Waf1, SDI1, WAF1" ENSG00000124762 "Cyclin dependent kinase inhibitor 1A" P38936 6 36676460-36687339 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle" "Protein kinase inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Smooth muscle cells: 552.0;Suprabasal keratinocytes: 587.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 21.0;non-classical monocyte: 27.7" "Group enriched" "Detected in many" 8 "B-cells: 8.8;dendritic cells: 8.5;monocytes: 27.7" "Cell line enhanced" "Detected in many" "HHSteC: 99.1;HSkMC: 72.8;hTCEpi: 94.2;LHCN-M2: 73.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000064, HPA005946, CAB069401" Supported Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB000064: , CAB069401: AB_1620493, HPA005946: AB_2667477" "unprognostic (7.99e-3)" "unprognostic (4.01e-2)" "unprognostic (1.58e-1)" "prognostic favorable (3.14e-5)" "unprognostic (1.57e-2)" "unprognostic (2.19e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (7.05e-4)" "unprognostic (1.30e-1)" "unprognostic (7.27e-2)" "unprognostic (2.79e-2)" "unprognostic (7.55e-3)" "prognostic favorable (4.95e-5)" "unprognostic (8.32e-2)" "unprognostic (6.52e-2)" "unprognostic (1.12e-1)" "unprognostic (3.21e-2)" 81.2 27.0 8.2 21.9 29.8 22.0 38.0 4.8 13.7 25.2 60.8 13.9 10.2 39.8 17.5 17.7 63.5 49.4 47.3 35.9 22.2 8.4 29.1 102.2 55.8 6.3 16.6 4.9 59.1 45.5 12.8 22.8 38.6 44.1 42.0 40.7 8.8 18.0 11.4 98.6 43.5 144.9 40.2 29.6 13.6 25.2 25.3 10.3 6.6 22.7 42.2 27.4 50.5 44.4 8.8 8.5 1.8 27.7 0.2 1.1 13.3 3.0 12.6 9.8 0.2 34.4 61.5 17.9 51.2 41.5 6.4 24.9 1.1 3.0 2.1 1.8 32.1 5.8 7.1 0.4 56.5 10.3 4.1 2.6 0.3 10.5 15.7 99.1 0.0 15.3 72.8 94.2 58.1 18.3 38.4 33.0 0.1 0.5 14.4 73.5 6.5 0.4 1.3 1.2 13.2 1.8 6.2 8.0 3.6 11.2 23.5 4.4 4.2 11.9 1.0 2.4 24.0 3.8 12.8 18.2 11.1 10.5 0.7 4.1 24.3 4.7 6.2 14.3 1.1 30.8 0.0 9.3 0.2 0.2 21.0 0.3 8.8 0.4 0.3 8.0 5.7 0.1 0.1 1.8 0.2 27.7 8.5 1.1 13.3 8.2 29.8 4.8 13.7 22.2 8.4 16.6 4.9 44.1 10.3 77.4 46.3 55.8 285.6 391.3 0.8 136.8 25.5 111.1 48.9 64.6 0.0 32.4 39.7 181.3 0.8 177.8 381.7 0.0 232.1 45.7 194.3 196.1 100.6 63.5 65.3 0.0 168.6 36.2 64.4 2.7 31.9 187.2 207.5 477.9 174.4 59.3 293.5 115.8 15.6 11.0 1.8 25.8 552.0 0.3 1.7 587.4 129.9 10.2 43.4 488.6 CDKN1B "KIP1, P27KIP1" ENSG00000111276 "Cyclin dependent kinase inhibitor 1B" P46527 12 12715058-12722371 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle" "Protein kinase inhibitor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Muller glia cells: 157.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003691, CAB021888, HPA059086" Approved Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB003691: AB_425362, CAB021888: , HPA059086: AB_2683900" "unprognostic (5.67e-2)" "unprognostic (9.76e-2)" "prognostic favorable (5.15e-4)" "unprognostic (6.90e-3)" "unprognostic (5.84e-3)" "unprognostic (1.03e-2)" "prognostic unfavorable (3.25e-4)" "unprognostic (4.04e-2)" "unprognostic (1.11e-1)" "unprognostic (2.85e-3)" "unprognostic (9.23e-3)" "unprognostic (2.96e-1)" "prognostic unfavorable (8.39e-4)" "unprognostic (1.23e-1)" "unprognostic (8.68e-2)" "unprognostic (2.88e-1)" "unprognostic (1.15e-1)" 29.8 30.9 30.2 25.0 30.0 40.2 45.3 64.5 50.6 31.6 34.4 35.6 19.9 29.2 33.1 19.8 26.0 24.3 24.3 21.2 33.0 29.5 20.8 23.3 29.2 38.5 42.9 25.1 46.2 15.1 22.2 15.9 26.8 26.3 25.1 22.2 31.4 23.5 24.2 48.8 26.1 26.4 19.4 46.0 34.3 19.4 19.2 39.0 43.0 29.4 21.4 25.5 34.1 29.1 6.2 3.3 19.2 4.5 6.2 10.6 2.9 12.4 6.2 33.2 5.8 11.4 6.5 16.3 11.7 18.6 16.2 20.0 17.7 14.1 0.1 4.4 6.6 5.8 11.9 15.5 5.7 14.5 21.1 11.0 9.7 17.1 17.8 15.3 8.2 6.9 7.1 12.4 5.3 15.6 38.1 9.6 18.8 10.4 35.5 5.7 15.9 11.5 11.8 13.3 10.8 5.8 8.5 10.8 20.9 7.8 13.5 12.6 20.7 16.8 12.1 21.9 12.4 6.4 18.5 6.5 8.0 12.8 7.2 11.3 30.8 20.3 11.2 10.0 12.4 7.7 4.5 3.1 6.8 5.4 3.1 5.6 6.2 6.9 6.5 3.2 4.8 7.4 5.2 19.2 6.2 4.5 3.3 10.6 2.9 30.2 30.0 64.5 50.6 33.0 29.5 42.9 25.1 26.3 39.0 41.7 24.0 37.6 14.6 46.8 43.1 37.8 20.4 48.2 27.3 8.7 25.5 36.5 13.3 8.0 57.9 56.5 24.9 23.3 8.0 38.1 31.0 32.5 30.1 26.7 22.7 9.5 43.9 46.6 57.3 37.2 51.8 41.9 70.9 14.4 35.8 157.6 10.4 17.5 25.1 12.1 25.0 90.5 40.9 7.7 4.9 45.9 32.6 76.1 40.2 13.6 CDKN1C "BWCR, BWS, KIP2, P57" ENSG00000129757 "Cyclin dependent kinase inhibitor 1C" P49918 11 2883213-2885773 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle" "Protein kinase inhibitor" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 60.3;placenta: 105.6" "Group enriched" "Detected in many" 6 "Cytotrophoblasts: 482.4;Extravillous trophoblasts: 1267.0;Syncytiotrophoblasts: 1874.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "intermediate monocyte: 26.1;non-classical monocyte: 60.3" "Lineage enriched" "Detected in many" 12 "monocytes: 60.3" "Cell line enhanced" "Detected in many" "EFO-21: 8.4;HeLa: 8.7;RPMI-8226: 11.4;SH-SY5Y: 23.3;SiHa: 16.3;SK-MEL-30: 8.9" HPA002924 Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies, Cytosol" "HPA002924: AB_1079548" "unprognostic (5.49e-3)" "unprognostic (2.62e-1)" "unprognostic (9.82e-3)" "unprognostic (5.79e-3)" "unprognostic (4.15e-1)" "unprognostic (2.84e-2)" "unprognostic (1.95e-2)" "unprognostic (1.85e-1)" "unprognostic (3.13e-1)" "unprognostic (3.15e-1)" "unprognostic (2.95e-1)" "unprognostic (3.39e-2)" "unprognostic (2.15e-1)" "unprognostic (3.31e-2)" "unprognostic (8.53e-2)" "unprognostic (1.93e-1)" "unprognostic (2.94e-1)" 53.6 20.7 3.3 5.4 11.9 3.4 13.0 0.9 9.2 10.6 6.9 18.4 3.9 3.3 8.3 5.2 9.9 8.5 7.7 6.9 8.5 5.4 22.7 3.0 5.1 1.8 28.7 4.9 30.9 7.9 1.5 4.0 105.6 11.5 7.2 1.9 8.3 3.1 5.9 27.6 3.0 7.9 6.3 27.9 7.1 7.4 4.3 14.5 0.3 2.0 7.6 2.1 11.2 9.8 0.0 5.0 1.4 60.3 0.0 0.3 2.5 0.1 0.0 1.1 0.0 0.3 0.3 1.2 0.2 0.4 0.2 0.0 2.2 0.2 0.0 8.4 0.1 0.1 0.3 0.2 0.2 0.1 3.8 0.8 0.1 8.7 0.0 2.3 0.0 1.0 1.7 1.1 0.0 0.1 0.1 0.2 0.0 1.8 0.6 0.3 0.0 0.0 4.0 7.5 0.3 2.7 1.5 0.0 11.4 0.5 0.0 2.5 23.3 16.3 0.2 8.9 0.6 0.1 1.9 0.3 0.0 1.6 0.0 0.0 4.9 0.0 0.0 0.0 1.3 4.6 1.4 0.2 0.2 0.1 26.1 0.3 0.0 0.1 0.1 5.0 0.0 0.2 0.0 0.3 0.0 60.3 0.0 0.1 2.5 3.3 11.9 0.9 5.6 8.5 5.4 28.7 4.9 11.5 14.5 3.0 7.2 0.8 96.5 9.5 7.1 23.0 22.9 5.3 10.3 29.6 5.9 482.4 13.3 9.2 178.7 49.1 4.0 0.0 0.5 1267.0 69.5 86.8 0.0 3.0 79.4 7.9 102.1 54.6 16.1 196.4 68.7 19.6 33.7 1.0 14.2 61.0 3.5 2.5 41.8 39.1 25.4 32.3 35.6 1.4 2.7 10.3 1874.3 3.9 5.2 72.7 CDKN2AIP "CARF, FLJ20036" ENSG00000168564 "CDKN2A interacting protein" Q9NXV6 4 183444591-183448198 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 103.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 60.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041397, HPA062142" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA041397: AB_10794297, HPA062142: AB_2684696" "unprognostic (9.00e-2)" "unprognostic (1.14e-1)" "unprognostic (1.07e-1)" "unprognostic (1.07e-1)" "unprognostic (1.54e-1)" "unprognostic (1.56e-1)" "unprognostic (7.20e-2)" "unprognostic (1.52e-2)" "unprognostic (7.65e-3)" "unprognostic (6.70e-2)" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "prognostic favorable (3.00e-5)" "unprognostic (2.93e-2)" "unprognostic (4.69e-2)" "unprognostic (2.25e-3)" "unprognostic (2.23e-2)" 14.2 14.3 13.9 13.6 15.6 32.3 15.9 20.8 13.8 18.1 18.1 15.0 10.1 18.7 17.1 13.2 27.7 13.0 13.3 15.0 13.0 12.9 18.1 17.2 17.8 17.8 15.4 10.7 24.0 18.4 15.9 21.9 16.4 14.0 21.5 14.2 13.0 15.9 15.2 11.1 14.2 18.0 14.8 13.7 16.0 17.2 20.1 12.2 24.7 23.4 20.6 27.3 16.6 24.1 8.3 4.6 28.5 5.9 8.1 14.7 8.4 5.1 2.9 8.7 6.2 7.3 5.3 6.5 8.7 7.3 9.0 6.0 4.3 5.0 17.3 1.8 5.9 3.7 4.1 7.9 6.4 9.5 7.0 4.7 17.9 14.0 5.5 5.8 13.1 7.2 6.3 6.0 5.3 7.0 4.8 7.1 6.6 8.9 18.7 6.2 2.7 14.8 10.7 6.3 1.9 6.0 12.8 4.2 6.9 60.3 4.9 8.9 7.6 6.3 26.6 10.4 5.9 3.9 11.4 4.0 3.2 4.5 2.9 7.0 9.1 3.7 8.9 5.0 11.3 5.1 28.5 4.8 10.4 9.0 5.6 9.4 7.4 11.1 9.7 4.6 8.3 14.7 13.3 5.7 8.1 5.9 3.1 10.9 8.4 13.9 15.6 20.8 13.8 13.0 12.9 15.4 10.7 14.0 12.2 14.9 30.7 18.2 22.6 31.9 21.9 15.7 22.9 33.5 27.3 15.7 9.8 20.1 14.9 11.0 103.2 21.8 25.7 0.0 13.7 12.2 23.7 35.9 61.1 12.8 13.7 20.6 29.1 17.8 8.8 51.4 19.5 18.9 20.3 11.8 19.1 18.8 13.2 20.1 16.3 10.5 19.8 12.9 21.1 32.3 36.3 34.8 15.7 34.1 17.5 48.5 CDKN2B "CDK4I, INK4B, MTS2, P15, p15INK4b, TP15" ENSG00000147883 "Cyclin dependent kinase inhibitor 2B" P42772 9 22002903-22009363 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 47.0" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 140.1;Pancreatic endocrine cells: 107.4;Urothelial cells: 219.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "classical monocyte: 4.6;intermediate monocyte: 3.9;non-classical monocyte: 10.9" "Lineage enriched" "Detected in single" 16 "monocytes: 10.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 18.7;HaCaT: 16.2;HeLa: 15.3;hTERT-RPE1: 28.4;SiHa: 20.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "CAB000349, HPA052838, HPA063327" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB000349: , HPA052838: , HPA063327: AB_2684987" "unprognostic (2.30e-1)" "unprognostic (9.23e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (4.47e-6)" "unprognostic (2.10e-1)" "unprognostic (7.40e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (2.01e-1)" "unprognostic (3.03e-2)" "unprognostic (3.19e-2)" "unprognostic (1.13e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (1.03e-4)" "unprognostic (9.14e-3)" "unprognostic (1.29e-1)" "unprognostic (2.72e-1)" "unprognostic (7.28e-2)" 22.4 1.4 1.4 7.3 1.1 0.0 25.1 0.8 1.2 6.6 35.4 1.4 1.5 14.1 2.6 0.8 27.0 1.2 1.4 1.4 1.6 0.8 0.5 0.6 9.9 2.3 2.0 0.8 0.8 1.0 3.9 7.8 3.7 3.4 3.1 13.4 0.7 5.1 3.2 6.5 8.6 47.0 3.2 1.0 4.4 3.9 3.3 1.3 1.1 0.8 9.8 12.5 2.8 16.6 0.0 0.6 0.0 10.9 0.0 0.4 1.3 0.0 0.0 0.1 0.9 13.6 18.7 0.3 0.6 0.0 2.1 5.9 1.5 4.1 0.0 1.7 1.0 0.0 16.2 0.3 3.2 2.6 1.1 5.0 0.0 15.3 0.7 6.9 0.4 2.7 3.9 0.0 2.7 12.0 28.4 2.0 0.0 0.0 7.2 3.4 1.2 0.0 0.0 0.7 0.8 9.4 0.0 0.9 0.3 4.6 0.0 2.6 0.0 20.5 5.3 14.7 12.6 1.1 0.0 5.3 0.0 0.3 0.0 0.0 6.9 3.9 0.0 0.0 0.4 0.0 0.0 4.6 0.0 0.1 3.9 0.0 0.0 0.4 0.3 0.6 0.0 0.0 0.1 0.0 0.0 10.9 0.0 0.1 1.3 1.4 1.1 0.8 1.2 1.6 0.8 2.0 0.8 3.4 1.3 62.5 7.9 0.9 16.4 4.7 1.2 2.4 2.5 4.0 3.4 5.2 0.0 0.8 0.0 50.3 4.4 2.5 140.1 0.0 34.0 0.4 7.2 41.1 0.0 0.0 1.2 0.0 7.5 2.5 14.8 1.7 0.6 4.0 3.3 1.8 21.9 3.7 107.4 49.1 1.1 0.0 6.7 0.0 6.3 13.8 3.3 21.1 2.6 0.0 11.2 219.8 CDKN2C "INK4C, p18" ENSG00000123080 "Cyclin dependent kinase inhibitor 2C" P42773 1 50960745-50974633 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 70.0;Sertoli cells: 84.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 53.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB005303, CAB018398, HPA019057, HPA019764" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB005303: AB_2078729, CAB018398: AB_2078731, HPA019057: AB_1854865, HPA019764: AB_1854866" "unprognostic (4.07e-2)" "unprognostic (1.47e-3)" "unprognostic (2.89e-1)" "unprognostic (4.86e-2)" "unprognostic (6.70e-2)" "unprognostic (4.76e-3)" "prognostic unfavorable (1.58e-4)" "unprognostic (1.59e-2)" "unprognostic (1.59e-1)" "unprognostic (1.71e-1)" "unprognostic (2.28e-1)" "unprognostic (2.38e-1)" "prognostic unfavorable (1.70e-10)" "unprognostic (2.55e-2)" "unprognostic (2.12e-1)" "unprognostic (6.45e-2)" "unprognostic (1.24e-1)" 42.1 12.6 5.9 10.7 7.9 14.9 31.7 4.3 5.7 13.1 13.0 8.7 7.7 6.6 17.1 13.9 11.5 8.4 13.7 20.1 5.7 3.1 7.4 3.3 7.9 11.0 13.7 5.3 22.5 9.4 23.1 5.7 3.1 3.9 10.3 5.7 6.0 5.4 12.2 9.2 8.5 7.9 15.1 7.5 8.5 5.3 5.3 8.9 54.2 8.0 4.9 9.8 17.4 21.7 3.4 7.4 12.2 2.5 6.0 14.1 3.8 14.0 5.8 1.1 19.4 20.0 2.9 0.2 13.4 13.6 22.5 19.8 0.3 4.8 27.6 12.1 11.4 8.2 1.7 13.0 1.7 11.1 16.7 17.5 20.9 44.3 3.5 1.0 14.5 9.6 1.0 0.3 6.1 2.6 8.5 5.9 22.9 9.4 0.0 13.0 3.5 18.7 7.0 0.0 5.3 14.2 22.3 18.3 0.0 7.1 5.9 9.8 23.0 18.3 12.8 4.3 0.1 6.3 49.3 4.7 25.8 10.0 15.6 0.2 28.3 26.9 22.7 0.0 53.0 22.8 12.2 2.5 11.0 5.2 1.4 6.0 3.4 7.7 6.8 6.1 1.9 4.3 4.1 0.2 6.0 0.6 7.4 14.1 3.8 5.9 7.9 4.3 5.7 5.7 3.1 13.7 5.3 3.9 8.9 0.0 4.6 5.3 2.5 9.0 4.2 12.5 2.5 2.7 2.3 3.5 15.7 1.1 14.9 3.3 3.6 5.3 3.9 70.0 3.1 11.0 20.6 2.5 16.1 6.0 22.5 4.8 8.1 17.2 19.7 5.3 36.5 11.2 6.8 24.4 4.8 27.8 4.0 4.0 44.9 26.6 9.7 84.1 18.6 5.1 6.8 9.8 1.6 33.8 3.9 1.0 CDKN2D "INK4D, p19" ENSG00000129355 "Cyclin dependent kinase inhibitor 2D" P55273 19 10566462-10569059 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.1;bone marrow: 119.4" "Cell type enhanced" "Detected in all" 6 "Spermatocytes: 111.8;Spermatogonia: 87.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 32.8;MOLT-4: 40.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011201, HPA043546" Enhanced Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "CAB011201: AB_261049, HPA043546: AB_2678545" "unprognostic (3.08e-1)" "prognostic favorable (1.02e-4)" "unprognostic (3.57e-2)" "unprognostic (1.49e-2)" "unprognostic (3.29e-2)" "unprognostic (1.37e-2)" "prognostic unfavorable (4.82e-4)" "unprognostic (2.08e-1)" "unprognostic (1.08e-2)" "unprognostic (6.55e-2)" "unprognostic (3.28e-1)" "unprognostic (1.50e-1)" "unprognostic (3.27e-3)" "unprognostic (9.90e-2)" "unprognostic (4.52e-1)" "unprognostic (4.43e-2)" "unprognostic (1.40e-1)" 5.5 4.7 27.9 6.8 24.2 119.4 4.1 14.3 28.7 2.6 3.9 4.2 0.5 3.9 2.4 2.5 3.8 3.0 4.0 8.4 22.9 17.9 2.7 2.1 6.6 11.1 14.3 14.3 2.8 2.8 2.6 3.4 4.8 11.8 2.5 3.6 2.4 3.2 3.0 6.3 6.0 3.5 4.6 5.7 9.7 2.8 10.9 3.6 18.6 1.8 2.8 8.4 4.2 2.4 17.3 16.0 44.1 10.7 11.9 11.3 9.5 11.0 1.7 5.7 3.7 3.0 4.7 1.4 7.3 8.6 8.1 7.1 2.2 2.7 3.1 2.4 7.7 8.2 2.3 1.9 1.8 2.9 12.3 4.6 32.8 2.0 3.6 3.5 3.3 26.6 1.9 6.1 4.1 3.1 6.7 2.2 19.5 1.3 27.0 8.0 1.5 40.4 17.3 1.1 8.5 8.5 6.6 5.5 1.8 3.6 0.9 8.0 4.2 5.1 3.9 5.6 1.1 3.5 8.7 1.7 9.6 4.9 15.8 10.8 16.9 5.7 5.7 10.1 5.6 6.8 35.9 5.6 23.5 10.0 6.8 8.0 17.3 8.3 11.3 5.4 15.9 7.9 9.4 44.1 11.9 10.7 16.0 6.7 9.5 27.9 24.2 14.3 28.7 22.9 17.9 14.3 14.3 11.8 3.6 6.0 9.5 48.4 13.8 20.6 28.1 8.5 2.5 5.3 3.4 5.2 11.8 2.4 8.3 6.0 15.3 15.3 5.8 46.7 4.3 7.1 11.0 10.0 20.7 3.0 8.7 44.5 6.9 20.3 36.0 8.5 6.6 24.1 28.7 10.8 5.8 17.7 9.9 10.5 5.6 3.4 29.5 19.4 30.3 111.8 87.1 29.0 4.1 44.9 3.6 23.8 CDO1 ENSG00000129596 "Cysteine dioxygenase type 1" Q16878 5 115804733-115816954 "Enzymes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 142.1;seminal vesicle: 53.7" "Cell type enhanced" "Detected in many" 19 "Cytotrophoblasts: 255.3;Hepatocytes: 126.0;Syncytiotrophoblasts: 403.0" "Group enriched" "Detected in many" 6 "glioma: 33.6;liver cancer: 74.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 20 "memory CD4 T-cell: 4.1;T-reg: 1.2" "Lineage enriched" "Detected in single" 41 "T-cells: 4.1" "Cell line enhanced" "Detected in some" "AF22: 23.0;ASC diff: 28.4;ASC TERT1: 11.0;GAMG: 8.3;HAP1: 8.1;NTERA-2: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036573, HPA057503" Enhanced Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036573: AB_10696658, HPA057503: AB_2683451" "unprognostic (2.34e-2)" "unprognostic (3.31e-2)" "unprognostic (1.45e-2)" "unprognostic (2.11e-1)" "unprognostic (1.77e-1)" "unprognostic (1.32e-1)" "prognostic favorable (1.91e-5)" "unprognostic (1.14e-3)" "unprognostic (2.63e-1)" "unprognostic (7.23e-2)" "unprognostic (9.28e-3)" "unprognostic (6.69e-2)" "unprognostic (1.58e-1)" "unprognostic (2.74e-3)" "unprognostic (3.06e-2)" "unprognostic (3.70e-1)" "unprognostic (2.06e-2)" 31.9 6.2 9.3 1.7 11.2 0.8 9.9 7.6 9.4 3.4 1.5 3.7 36.4 1.0 3.1 42.6 1.8 4.9 3.7 7.6 7.3 9.0 1.7 142.1 3.9 2.3 6.5 5.5 8.7 4.7 1.0 6.5 17.7 14.5 4.0 1.3 19.2 2.8 53.7 3.5 1.1 1.1 2.6 5.3 1.8 1.2 5.0 4.3 0.0 2.8 2.5 1.6 2.4 2.1 0.0 0.0 0.0 0.0 0.0 4.1 0.1 0.0 0.0 23.0 0.0 28.4 11.0 0.1 0.6 0.2 2.2 2.2 0.0 0.0 0.0 0.0 0.2 8.3 0.0 8.1 0.0 3.2 0.0 4.0 0.7 0.0 0.6 0.1 0.0 0.0 4.1 0.0 0.3 0.0 0.6 2.9 0.0 0.0 0.0 2.6 0.0 0.5 0.1 8.5 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 2.0 0.0 2.5 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 9.3 11.2 7.6 9.4 7.3 9.0 6.5 5.5 14.5 4.3 0.0 2.2 0.0 0.5 0.7 16.3 1.6 0.0 0.0 0.0 1.8 5.9 255.3 0.0 6.0 5.8 3.2 0.0 0.0 0.2 7.4 16.4 1.0 0.0 126.0 20.1 1.6 1.7 21.5 4.9 8.9 84.3 0.2 1.7 1.0 0.0 31.8 0.5 0.0 35.3 0.6 2.9 12.9 3.3 1.5 0.2 1.1 403.0 0.0 0.0 0.1 CDPF1 "C22orf40, LOC150383" ENSG00000205643 "Cysteine rich DPF motif domain containing 1" Q6NVV7 22 46244011-46250679 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018823 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA018823: AB_1853018" "unprognostic (1.98e-2)" "unprognostic (5.06e-3)" "unprognostic (1.42e-2)" "prognostic favorable (3.13e-5)" "unprognostic (2.20e-1)" "unprognostic (1.51e-1)" "unprognostic (1.85e-3)" "unprognostic (1.83e-3)" "unprognostic (2.09e-1)" "unprognostic (2.56e-3)" "unprognostic (4.69e-3)" "unprognostic (2.24e-1)" "unprognostic (1.31e-1)" "unprognostic (1.04e-1)" "unprognostic (2.73e-1)" "unprognostic (1.16e-1)" "unprognostic (1.06e-1)" 7.3 12.7 10.4 9.4 10.9 5.3 7.8 10.6 12.4 10.1 11.4 11.4 5.3 7.0 12.4 11.8 6.0 11.9 8.3 14.1 10.4 6.8 9.4 8.5 9.4 9.0 10.7 9.5 11.2 8.5 8.0 11.1 7.9 10.9 11.0 6.0 10.3 15.5 11.8 12.3 7.7 9.4 8.2 8.7 11.6 9.9 4.0 10.9 12.9 11.2 5.2 9.6 8.1 12.2 8.9 11.6 11.0 8.5 8.3 11.6 7.3 5.5 4.1 6.6 9.6 4.2 7.3 5.5 3.0 4.4 6.1 5.7 0.7 5.7 5.6 3.2 2.2 3.5 6.4 3.0 1.0 3.7 5.3 10.5 3.0 6.2 6.2 7.6 8.1 4.5 7.9 5.9 4.5 5.5 5.0 4.5 10.5 5.8 7.1 4.3 4.0 10.0 5.8 5.1 7.9 4.0 6.4 2.7 12.1 4.6 1.8 3.3 8.0 3.7 6.6 6.3 2.7 7.1 3.4 3.5 11.5 7.3 6.4 3.7 7.0 3.3 4.4 5.3 5.9 11.2 1.5 6.5 11.0 10.1 8.0 9.5 7.3 9.9 8.9 5.5 8.9 11.6 8.4 1.7 8.3 8.5 11.6 7.4 7.3 10.4 10.9 10.6 12.4 10.4 6.8 10.7 9.5 10.9 10.9 6.0 3.8 10.4 2.2 1.5 4.5 4.7 5.1 8.1 2.3 7.0 0.0 11.4 6.6 8.3 0.8 7.1 2.0 0.0 9.8 8.3 4.9 4.0 13.9 4.3 8.2 0.0 4.1 4.3 3.7 0.2 4.6 4.0 5.0 11.8 3.3 4.4 6.3 0.0 7.4 5.4 4.8 12.9 7.3 2.4 7.0 1.8 3.8 7.2 4.9 1.8 CDR1 "CDR, CDR34, CDR62A" ENSG00000184258 "Cerebellar degeneration related protein 1" P51861 X 140782405-140784871 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 56.2" "Cell type enhanced" "Detected in some" 21 "Bipolar cells: 139.0;Horizontal cells: 33.4;Muller glia cells: 111.9;Rod photoreceptor cells: 30.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.4;BJ: 6.6;MOLT-4: 4.2;U-87 MG: 24.4" "Low region specificity" "Detected in all" HPA073147 Approved "Nucleoplasm,Golgi apparatus,Centrosome" NA NA "Nucleoplasm, Golgi apparatus, Centrosome" "HPA073147: AB_2686574" "unprognostic (7.10e-2)" "unprognostic (2.87e-2)" "unprognostic (2.85e-1)" "unprognostic (3.49e-2)" "unprognostic (1.44e-1)" "unprognostic (1.03e-2)" "unprognostic (2.41e-3)" "unprognostic (1.46e-4)" "unprognostic (1.55e-1)" "unprognostic (1.84e-1)" 3.2 1.3 9.1 0.5 26.3 0.0 0.0 56.2 28.7 0.0 0.1 0.2 0.4 0.0 0.6 0.2 1.5 1.5 9.2 2.8 0.1 0.0 0.6 0.1 3.7 0.1 3.9 0.0 7.1 0.4 0.1 0.0 0.6 0.0 0.2 9.4 0.1 0.0 3.6 0.9 0.5 0.1 0.7 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.6 3.4 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.2 0.0 0.8 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.0 1.4 0.0 0.0 0.0 1.4 0.0 1.2 0.0 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 139.0 0.0 0.0 0.0 0.0 0.0 11.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 33.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 111.9 0.0 0.0 0.0 0.0 30.0 0.0 0.0 0.0 0.0 2.8 0.2 0.0 0.0 0.0 CDR2 "CDR62, Yo" ENSG00000140743 "Cerebellar degeneration related protein 2" Q01850 16 22345936-22437165 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 57.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018151, HPA023870" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA018151: AB_1846457, HPA023870: AB_1846459" "unprognostic (7.89e-2)" "unprognostic (1.55e-1)" "unprognostic (5.23e-2)" "unprognostic (3.09e-1)" "unprognostic (6.59e-2)" "unprognostic (1.27e-2)" "unprognostic (5.76e-2)" "unprognostic (2.75e-1)" "unprognostic (2.55e-1)" "unprognostic (1.06e-1)" "unprognostic (9.86e-2)" "unprognostic (3.04e-1)" "unprognostic (2.04e-2)" "unprognostic (3.34e-3)" "unprognostic (1.38e-2)" "unprognostic (5.78e-2)" "unprognostic (1.67e-3)" 10.6 7.2 6.9 14.3 14.2 12.0 13.3 12.0 9.1 16.6 24.6 2.2 14.2 15.9 10.4 11.7 13.2 8.9 13.4 13.1 5.6 8.0 14.7 14.1 20.1 20.3 5.4 4.9 18.3 11.3 9.0 27.4 9.0 9.2 22.9 11.6 37.1 16.9 15.2 5.3 6.5 24.5 40.5 4.2 13.7 11.7 42.9 3.4 17.9 38.2 5.8 14.7 39.8 43.4 1.4 1.5 5.9 1.1 3.1 8.4 2.0 15.4 10.9 9.7 10.4 24.6 21.3 10.2 15.5 24.3 15.9 21.3 14.2 11.1 13.7 8.0 26.4 9.6 15.3 20.9 8.9 18.9 10.3 10.9 10.2 12.0 45.1 28.6 11.3 20.9 15.7 8.2 15.9 17.7 20.4 19.8 18.2 10.1 22.2 15.2 11.4 10.7 8.2 13.6 13.5 9.4 16.1 12.7 20.2 20.1 9.9 7.6 5.3 10.4 22.2 15.4 11.7 6.6 5.5 12.4 15.5 9.9 14.7 13.2 12.0 18.7 18.4 10.2 11.3 13.3 5.9 1.1 1.5 2.4 0.9 5.1 1.4 7.6 4.8 1.1 0.9 6.0 5.0 1.0 3.1 1.1 1.5 8.4 2.0 6.9 14.2 12.0 9.1 5.6 8.0 5.4 4.9 9.2 3.4 3.0 6.1 3.7 14.4 30.2 7.7 2.8 12.7 4.0 9.1 8.7 13.7 1.4 1.7 7.7 23.9 9.0 19.5 23.3 6.1 9.4 14.1 16.6 0.0 8.2 8.0 7.9 6.3 9.2 4.1 4.7 6.4 5.4 10.1 4.6 11.6 7.2 12.0 9.3 10.3 11.2 57.8 6.5 16.5 26.0 17.0 21.2 1.1 14.1 7.5 13.2 CDRT1 "FBXW10B, FBXW10P1, HREP, SM25H2" ENSG00000241322 "CMT1A duplicated region transcript 1" O95170 17 15565483-15619512 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 9.8;testis: 12.8" "Cell type enhanced" "Detected in some" 24 "Ciliated cells: 4.0;Early spermatids: 18.5;Late spermatids: 8.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "T-reg: 2.1" "Lineage enriched" "Detected in single" 5 "T-cells: 2.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 15.6;HaCaT: 28.6;HeLa: 9.7;OE19: 7.1" "HPA013332, HPA047457" Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA013332: AB_1848471, HPA047457: " "unprognostic (2.25e-1)" "unprognostic (2.78e-1)" "unprognostic (7.03e-2)" "unprognostic (3.95e-2)" "unprognostic (1.15e-2)" "unprognostic (1.90e-2)" "unprognostic (1.45e-2)" "unprognostic (5.93e-2)" "unprognostic (5.04e-1)" "unprognostic (1.44e-1)" "unprognostic (1.17e-1)" "unprognostic (3.38e-1)" "unprognostic (9.31e-8)" "unprognostic (1.55e-1)" "unprognostic (1.22e-1)" "unprognostic (5.49e-2)" "unprognostic (1.86e-1)" 1.1 1.8 0.0 0.9 0.0 0.0 0.7 0.2 0.0 2.4 0.3 2.9 0.0 0.8 9.8 0.3 0.7 0.7 0.0 0.0 0.1 0.5 0.9 0.7 0.0 0.0 0.0 0.0 0.1 1.8 0.3 0.6 2.6 0.1 2.1 4.4 1.3 0.0 0.0 0.2 2.6 12.8 1.6 3.0 2.0 4.1 0.4 0.1 0.0 0.3 0.1 2.1 0.0 2.4 6.8 0.2 2.0 0.2 0.7 0.2 0.5 1.5 0.2 0.7 5.1 15.6 0.1 0.4 1.3 1.6 28.6 0.4 0.3 0.4 2.4 0.3 0.1 9.7 0.2 0.2 0.0 0.1 0.3 0.9 0.6 0.4 0.1 0.1 0.4 0.0 1.2 0.8 0.1 0.4 0.2 0.2 7.1 0.8 0.0 0.4 0.0 1.9 3.7 0.1 0.2 2.3 2.0 0.1 0.8 0.1 0.1 1.2 0.5 1.4 0.0 0.4 0.6 2.9 0.0 1.7 0.1 0.8 0.0 0.2 0.0 0.2 0.3 0.1 0.1 0.2 0.0 0.1 0.4 0.1 0.2 0.0 0.1 0.1 0.0 2.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.4 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.2 18.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.5 0.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.4 0.0 0.0 0.0 0.0 0.3 CDS1 ENSG00000163624 "CDP-diacylglycerol synthase 1" Q92903 4 84582979-84651338 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 48.0" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 105.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "myeloid DC: 2.1" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 20.5;hTCEpi: 25.6;OE19: 19.7;SK-BR-3: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036187, HPA064546" Enhanced Approved "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA036187: AB_10601797, HPA064546: AB_2732714" "unprognostic (8.74e-2)" "unprognostic (7.11e-2)" "prognostic favorable (5.22e-4)" "unprognostic (2.73e-3)" "unprognostic (1.45e-2)" "unprognostic (1.73e-1)" "unprognostic (3.10e-3)" "unprognostic (3.11e-1)" "unprognostic (2.62e-1)" "unprognostic (1.35e-1)" "unprognostic (1.16e-1)" "unprognostic (6.67e-2)" "prognostic favorable (0.00e+0)" "unprognostic (2.23e-1)" "unprognostic (1.78e-1)" "unprognostic (3.06e-1)" "unprognostic (2.06e-1)" 0.9 4.6 7.4 2.5 10.4 0.4 6.7 13.3 12.9 4.3 16.7 3.3 9.3 24.8 2.0 19.1 17.4 20.5 8.8 0.5 7.4 8.4 11.9 0.6 10.6 0.8 6.4 4.7 5.5 4.5 19.3 7.1 19.7 14.1 6.1 13.6 4.2 11.2 4.3 0.2 12.9 48.0 0.8 2.4 1.0 11.5 5.1 2.3 0.9 19.3 7.9 6.1 3.5 7.4 0.0 2.1 0.0 0.0 0.0 0.4 0.0 11.4 0.2 0.6 0.1 0.0 0.0 12.0 0.0 0.1 0.3 0.2 4.8 20.5 0.0 0.9 0.0 2.4 12.1 3.7 10.2 0.1 0.8 5.7 0.0 1.8 1.1 0.0 0.3 0.8 0.1 25.6 0.0 3.7 0.4 0.0 0.7 0.0 0.0 0.0 8.1 0.1 0.0 1.7 19.7 0.8 0.0 0.0 2.4 5.7 8.7 4.8 0.1 1.3 27.8 0.0 2.3 8.5 0.2 0.0 0.0 0.6 1.2 1.5 0.0 0.0 0.0 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.4 10.4 13.3 12.9 7.4 8.4 6.4 4.7 14.1 2.3 14.9 36.5 0.5 24.3 25.8 16.5 1.6 17.8 105.7 27.3 38.4 9.8 49.0 3.3 23.6 5.9 2.1 44.6 0.0 20.1 9.6 1.5 29.0 0.0 0.0 10.4 20.6 21.5 1.8 2.2 3.1 0.6 5.6 0.0 1.0 45.1 28.4 30.8 31.6 0.4 14.7 28.1 0.0 1.3 2.3 3.8 47.3 47.9 0.0 47.2 32.3 CDT1 "DUP, RIS2" ENSG00000167513 "Chromatin licensing and DNA replication factor 1" Q9H211 16 88803213-88809258 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" "Disease mutation, Dwarfism, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 25.2;esophagus: 7.1" "Cell type enhanced" "Detected in many" 12 "Erythroid cells: 46.7;Extravillous trophoblasts: 78.3;Spermatogonia: 28.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 39.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA017224 Approved Supported "Nucleoplasm,Nuclear bodies" NA Yes Nucleoplasm "Nuclear bodies" "HPA017224: AB_1846468" "unprognostic (1.33e-1)" "unprognostic (2.04e-2)" "unprognostic (7.32e-2)" "unprognostic (2.67e-1)" "unprognostic (4.34e-1)" "unprognostic (1.98e-1)" "prognostic unfavorable (2.12e-6)" "unprognostic (3.44e-3)" "unprognostic (2.81e-2)" "unprognostic (4.59e-2)" "unprognostic (1.21e-1)" "unprognostic (9.34e-2)" "prognostic unfavorable (2.69e-6)" "unprognostic (7.72e-3)" "unprognostic (5.79e-2)" "unprognostic (2.80e-2)" "unprognostic (8.54e-2)" 0.4 0.4 0.7 2.7 0.9 25.2 0.4 0.0 1.2 1.2 2.5 2.9 0.3 0.0 7.1 0.3 0.0 0.1 0.6 2.2 0.5 0.6 0.9 3.2 1.7 0.0 0.4 0.9 2.1 2.0 0.3 1.0 0.8 0.1 0.0 3.3 3.2 0.3 0.8 3.1 1.7 3.3 0.1 2.1 0.2 1.9 3.7 2.1 3.5 0.9 1.7 4.0 0.7 9.7 10.2 4.4 7.5 0.2 0.9 17.9 6.6 1.8 5.2 3.3 20.8 10.0 14.4 7.4 1.4 3.5 12.6 5.6 4.5 1.7 5.1 23.9 13.5 9.0 17.4 0.0 7.6 5.9 0.4 0.3 5.3 1.1 0.4 1.6 18.6 21.9 4.8 1.9 24.1 31.3 39.6 11.5 3.0 8.2 33.5 6.0 12.6 1.1 7.4 10.7 7.9 11.5 3.6 5.0 2.0 11.4 15.7 1.7 7.3 11.7 11.0 9.7 17.9 15.5 19.8 5.4 19.5 8.8 0.5 0.9 3.5 2.7 0.5 1.1 1.2 2.7 2.7 1.0 3.7 4.0 2.4 2.1 1.7 0.7 2.1 3.0 0.7 0.0 0.6 7.5 3.4 10.0 0.2 1.6 2.5 2.7 2.3 1.8 0.0 24.8 1.7 1.0 0.2 1.2 2.1 46.7 0.0 78.3 1.3 1.7 0.0 0.9 16.4 0.0 2.4 0.6 4.1 0.7 0.3 2.5 1.7 2.8 9.3 1.1 0.5 0.0 0.4 1.0 1.8 0.0 2.0 2.7 28.5 6.1 20.7 3.2 18.0 3.4 CDX2 CDX3 ENSG00000165556 "Caudal type homeobox 2" Q99626 13 27962137-27971139 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "intestine: 21.2" "Group enriched" "Detected in some" 7 "Enterocytes: 190.4;Intestinal endocrine cells: 60.0;Mucus-secreting cells: 200.2;Paneth cells: 129.8;Undifferentiated cells: 183.4" "Cancer enriched" "Detected in many" 6 "colorectal cancer: 63.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CACO-2: 14.7;CAPAN-2: 4.9;HEK 293: 8.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002221, HPA045669, HPA049580" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB002221: AB_563649, HPA045669: AB_2679413, HPA049580: AB_2680823" "unprognostic (1.42e-1)" "unprognostic (2.41e-1)" "unprognostic (2.92e-1)" "unprognostic (8.11e-3)" "unprognostic (4.19e-6)" "unprognostic (1.73e-4)" "unprognostic (1.71e-1)" "unprognostic (1.58e-1)" "unprognostic (5.51e-2)" "unprognostic (6.07e-3)" "unprognostic (1.13e-1)" "unprognostic (1.09e-1)" 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 21.2 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 14.3 0.0 0.0 0.0 0.0 16.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 14.7 4.9 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 8.1 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 20.8 0.0 0.0 190.4 0.0 0.6 0.3 0.0 0.2 0.0 0.0 0.4 0.0 60.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 200.2 0.0 1.1 129.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 183.4 0.1 CDX4 ENSG00000131264 "Caudal type homeobox 4" O14627 X 73447254-73455245 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "skin 1: 5.3;testis: 3.3" "Cell type enhanced" "Detected in some" 22 "Spermatogonia: 1.4;Suprabasal keratinocytes: 1.0" "Cancer enriched" "Detected in single" 11 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HEK 293: 2.0;SuSa: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA043714, HPA056528" Uncertain Approved "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "HPA043714: , HPA056528: AB_2683166" "unprognostic (1.97e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.3 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 1.4 1.0 0.0 0.0 0.0 0.0 CEACAM19 CEAL1 ENSG00000186567 "Carcinoembryonic antigen related cell adhesion molecule 19" Q7Z692 19 44662278-44684359 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 10.7;RPTEC TERT1: 13.7;TIME: 17.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA014462, HPA052865" Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" Nucleoplasm "HPA014462: AB_2669006, HPA052865: AB_2681976" "unprognostic (2.91e-1)" "unprognostic (5.29e-3)" "unprognostic (6.96e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-2)" "unprognostic (8.43e-2)" "unprognostic (5.22e-2)" "unprognostic (1.15e-2)" "unprognostic (9.98e-2)" "unprognostic (1.14e-1)" "unprognostic (1.78e-3)" "unprognostic (1.77e-1)" "unprognostic (3.26e-9)" "unprognostic (8.01e-3)" "unprognostic (9.62e-2)" "unprognostic (1.31e-1)" "unprognostic (2.70e-1)" 1.6 2.9 1.1 0.8 1.9 1.0 2.4 4.3 1.7 3.1 2.4 2.7 2.7 1.4 2.4 4.3 2.1 4.1 1.2 1.8 3.3 4.3 3.8 0.6 0.6 4.0 4.7 1.2 3.9 1.8 4.1 3.3 2.9 3.0 12.5 10.8 2.9 3.0 0.9 1.8 2.0 3.0 3.4 1.7 1.0 4.4 1.7 0.5 1.7 1.0 1.0 0.7 0.6 4.2 8.8 1.3 0.9 3.1 3.6 3.3 2.4 3.6 0.8 1.6 0.3 1.0 0.1 0.8 3.2 0.9 5.3 2.2 0.9 0.7 1.2 5.0 0.1 4.6 1.4 3.2 0.2 0.8 1.1 8.7 2.2 5.4 10.7 2.0 0.6 0.3 0.2 1.2 1.0 0.0 0.5 0.8 1.1 1.0 0.0 1.6 0.2 13.7 1.0 1.7 0.4 0.9 0.9 0.8 1.3 1.2 0.3 17.7 0.3 6.1 1.3 0.7 0.1 0.3 0.0 0.4 1.7 1.4 1.7 1.0 0.6 0.6 0.4 0.3 0.5 0.3 0.6 0.2 1.7 0.4 0.7 1.6 1.0 0.5 0.5 0.3 0.6 3.0 2.1 0.0 0.9 1.8 2.6 4.1 2.5 1.4 2.3 0.0 0.0 0.0 0.0 1.6 0.7 3.1 1.7 0.0 2.9 0.1 0.9 1.3 0.0 1.9 0.2 0.0 1.7 4.9 1.2 0.2 2.8 0.5 0.0 0.0 2.6 0.1 3.5 3.5 2.5 0.2 0.5 0.0 2.8 3.2 0.4 5.3 0.0 0.0 2.2 0.9 CEBPA "C/EBP-alpha, CEBP" ENSG00000245848 "CCAAT/enhancer binding protein alpha" P49715 19 33299934-33302564 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 52.3;liver: 44.3" "Cell type enhanced" "Detected in many" 10 "Hepatocytes: 84.7;Hofbauer cells: 76.1;Suprabasal keratinocytes: 150.2;Syncytiotrophoblasts: 177.5" "Cancer enhanced" "Detected in all" "liver cancer: 70.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 11.0;non-classical monocyte: 11.8" "Group enriched" "Detected in many" 13 "dendritic cells: 4.1;granulocytes: 11.0;monocytes: 11.8" "Cell line enhanced" "Detected in some" "BEWO: 43.5;Hep G2: 23.3;NB-4: 24.0;THP-1: 86.8;U-937: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA052734, HPA065037, HPA067937" Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA052734: AB_2681931, HPA065037: AB_2685410, HPA067937: AB_2685927" "unprognostic (1.80e-1)" "unprognostic (7.62e-3)" "unprognostic (2.09e-3)" "unprognostic (2.21e-2)" "unprognostic (3.38e-1)" "unprognostic (3.99e-2)" "unprognostic (1.94e-1)" "unprognostic (2.43e-3)" "unprognostic (5.95e-2)" "unprognostic (3.96e-2)" "unprognostic (3.09e-1)" "unprognostic (9.45e-2)" "unprognostic (8.02e-3)" "unprognostic (2.19e-1)" "unprognostic (1.98e-1)" "unprognostic (2.49e-2)" "unprognostic (2.72e-2)" 40.7 1.5 2.3 7.6 4.6 8.4 52.3 2.1 4.0 3.5 9.0 5.2 1.1 9.0 2.2 2.1 6.1 2.4 6.4 6.6 3.9 2.4 2.0 44.3 39.9 10.3 4.1 3.1 1.3 9.0 4.5 1.7 17.4 2.7 3.8 5.1 1.9 5.6 1.6 15.4 23.7 12.7 2.9 6.6 3.0 3.5 1.2 2.6 2.2 2.5 10.7 3.5 5.4 7.9 0.1 4.1 11.0 11.8 0.0 0.6 1.5 0.5 1.1 0.0 1.5 12.5 0.0 43.5 0.0 0.3 0.0 0.0 5.3 0.0 0.0 0.6 0.0 0.2 2.0 1.2 0.1 0.0 7.5 1.5 0.0 0.0 23.3 0.2 7.6 9.3 0.5 5.6 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 2.6 0.0 24.0 1.1 13.1 0.6 0.0 0.0 0.2 0.0 3.8 0.0 0.3 0.1 0.1 0.1 1.4 3.0 86.8 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 27.8 0.0 11.0 6.0 0.0 0.6 9.4 0.6 0.0 0.1 0.4 4.1 0.1 0.2 0.4 2.1 0.0 11.8 0.2 0.0 1.5 2.3 4.6 2.1 4.0 3.9 2.4 4.1 3.1 2.7 2.6 14.9 27.8 1.4 20.5 33.2 0.7 0.4 25.5 6.7 5.7 0.0 0.0 27.5 3.3 0.6 0.0 0.6 62.2 0.0 5.0 35.2 6.1 11.7 1.1 84.7 76.1 0.0 4.1 1.3 21.4 0.0 2.8 23.2 5.0 1.0 22.1 8.0 2.1 31.3 1.4 3.7 0.3 0.0 4.1 0.2 0.7 150.2 177.5 1.0 26.9 9.5 CEBPB "C/EBP-beta, CRP2, IL6DBP, LAP, NFIL6, TCF5" ENSG00000172216 "CCAAT/enhancer binding protein beta" P17676 20 50190734-50192689 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 121.9" "Cell type enhanced" "Detected in many" 7 "Smooth muscle cells: 658.6;Suprabasal keratinocytes: 699.3;Syncytiotrophoblasts: 1179.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.6" "Group enriched" "Detected in many" 8 "granulocytes: 13.6;monocytes: 6.1" "Cell line enhanced" "Detected in many" "SK-MEL-30: 45.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB004213, HPA061355, HPA062267" Supported Enhanced Nucleoplasm Yes No Nucleoplasm "CAB004213: AB_626772, HPA061355: AB_2684487, HPA062267: AB_2684731" "unprognostic (2.30e-2)" "unprognostic (2.64e-1)" "unprognostic (1.24e-2)" "unprognostic (1.09e-2)" "unprognostic (9.48e-2)" "unprognostic (2.24e-2)" "unprognostic (1.32e-1)" "unprognostic (1.40e-3)" "unprognostic (1.79e-2)" "unprognostic (9.85e-3)" "unprognostic (9.26e-3)" "unprognostic (6.55e-2)" "prognostic unfavorable (2.44e-12)" "unprognostic (7.29e-2)" "unprognostic (1.43e-1)" "unprognostic (2.45e-2)" "unprognostic (7.63e-2)" 56.9 54.7 7.0 35.9 9.9 21.1 34.4 1.8 6.2 22.8 25.2 6.4 8.0 8.0 19.4 11.2 19.2 21.7 20.2 33.6 8.4 4.4 15.3 92.5 51.3 20.4 9.5 3.0 33.6 18.6 4.1 7.4 75.1 7.7 21.1 5.0 14.0 14.6 11.7 121.9 23.9 19.4 12.6 9.5 40.3 15.3 14.3 8.1 1.5 46.1 25.3 10.7 30.8 30.6 0.4 1.2 13.6 6.1 0.4 0.5 0.5 7.4 3.4 0.3 4.1 19.3 7.6 33.5 10.1 16.0 7.0 6.2 3.4 6.9 4.9 19.4 4.1 34.4 10.2 1.0 9.9 4.7 3.5 2.5 1.5 4.4 5.0 23.8 2.4 9.8 8.1 26.3 8.9 15.8 14.6 0.9 5.1 7.1 9.1 4.3 2.8 1.1 5.3 2.1 7.1 9.9 3.5 1.0 5.5 2.3 1.8 2.0 1.3 8.4 20.9 45.0 2.3 5.5 13.8 1.3 14.6 11.1 12.4 9.7 19.4 8.0 4.3 26.6 5.6 6.3 5.9 3.0 9.1 0.4 5.3 0.1 0.4 0.4 0.5 1.2 0.3 0.3 0.2 13.6 0.4 6.1 0.0 0.2 0.5 7.0 9.9 1.8 6.2 8.4 4.4 9.5 3.0 7.7 8.1 32.8 78.5 51.8 281.2 643.3 2.2 40.0 84.1 21.4 31.8 43.6 0.0 157.2 26.6 27.6 4.6 30.6 66.5 0.0 11.5 550.7 468.0 220.5 50.7 350.5 326.4 3.2 64.1 81.0 362.0 5.0 120.0 403.2 205.8 1.8 77.9 46.2 16.6 52.6 90.5 50.0 3.3 155.2 658.6 0.7 9.1 699.3 1179.1 63.8 45.7 245.2 CEBPD "C/EBP-delta, CELF, CRP3, NF-IL6-beta" ENSG00000221869 "CCAAT/enhancer binding protein delta" P49716 8 47736909-47739086 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 1062.9;Glandular cells: 1104.9;Smooth muscle cells: 1847.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 20.9" "Group enriched" "Detected in many" 5 "granulocytes: 20.9;monocytes: 7.8" "Cell line enhanced" "Detected in many" "BEWO: 13.5;HHSteC: 17.5;HSkMC: 17.3;NB-4: 36.7;SiHa: 15.1" "Low region specificity" "Detected in many" HPA067581 Approved Nucleoplasm NA NA Nucleoplasm "HPA067581: AB_2685865" "prognostic favorable (2.28e-5)" "unprognostic (1.43e-1)" "unprognostic (2.99e-2)" "unprognostic (1.74e-2)" "unprognostic (2.14e-2)" "unprognostic (6.35e-3)" "unprognostic (1.52e-2)" "unprognostic (2.12e-1)" "unprognostic (6.81e-2)" "unprognostic (5.16e-2)" "unprognostic (5.47e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.87e-7)" "unprognostic (1.21e-2)" "unprognostic (1.60e-1)" "unprognostic (4.62e-2)" "unprognostic (3.40e-2)" 27.3 14.9 4.7 14.3 4.7 6.5 12.3 4.7 7.7 7.3 9.5 4.7 4.7 6.1 5.8 4.7 5.4 12.6 4.7 9.5 4.7 1.3 8.2 25.7 10.5 4.7 4.7 4.7 21.5 7.3 0.6 8.4 11.3 4.7 11.0 2.6 7.5 6.4 4.7 9.1 6.8 9.6 4.7 4.7 13.5 8.8 9.4 4.7 4.7 7.1 14.1 4.7 11.7 9.4 0.1 2.7 20.9 7.8 1.3 2.4 0.9 2.3 1.8 0.1 0.0 10.8 11.2 13.5 6.2 4.7 1.7 3.7 3.6 3.8 0.0 4.5 1.6 1.5 2.5 0.4 3.2 0.5 0.0 0.9 0.1 1.5 1.5 17.5 1.0 0.0 17.3 8.4 0.4 4.1 1.1 0.3 0.1 1.0 1.9 0.6 0.7 0.0 36.7 0.7 1.5 0.6 0.0 1.3 0.1 5.1 1.9 0.7 0.2 15.1 2.0 1.5 0.7 1.6 8.4 1.5 0.4 1.1 4.1 0.4 0.0 0.0 0.0 2.0 0.0 0.0 0.9 7.8 3.6 0.8 3.0 2.4 0.0 0.1 0.4 2.7 0.1 0.0 0.0 20.9 1.3 1.1 0.0 0.1 0.9 4.7 4.7 4.7 7.7 4.7 1.3 4.7 4.7 4.7 4.7 95.3 155.3 27.0 1062.9 589.5 4.9 66.7 96.8 56.2 94.4 212.9 5.9 176.8 184.1 42.0 2.5 382.1 63.9 0.0 65.1 327.7 527.3 1104.9 4.7 125.8 194.7 1.6 22.4 138.7 301.2 7.0 403.3 397.2 254.8 5.4 35.9 259.0 72.6 40.7 136.2 287.1 12.7 459.2 1847.8 2.1 3.7 714.5 294.3 115.1 47.7 772.4 CEBPE CRP1 ENSG00000092067 "CCAAT/enhancer binding protein epsilon" Q15744 14 23117304-23119616 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 87.1;bone marrow: 29.4" "Cell type enriched" "Detected in some" 4 "Hofbauer cells: 6.4" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 1.3" "Cell type enriched" "Detected in single" 201 "eosinophil: 87.1" "Lineage enriched" "Detected in single" 237 "granulocytes: 87.1" "Group enriched" "Detected in some" 4 "HL-60: 59.4;NB-4: 30.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA002928, CAB005113" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB005113: AB_631240, HPA002928: AB_1078494" "unprognostic (1.33e-2)" "unprognostic (4.76e-2)" "unprognostic (4.19e-2)" "unprognostic (2.04e-1)" "unprognostic (5.01e-2)" "unprognostic (1.66e-3)" "unprognostic (2.84e-1)" "unprognostic (1.49e-2)" "unprognostic (3.33e-2)" "unprognostic (5.69e-2)" "unprognostic (9.03e-2)" "unprognostic (2.22e-1)" "unprognostic (3.80e-3)" "unprognostic (1.42e-1)" "unprognostic (1.12e-2)" "unprognostic (2.57e-2)" "unprognostic (8.19e-2)" 0.3 0.0 0.1 0.8 0.2 29.4 0.1 0.1 1.3 0.1 0.1 0.1 0.1 1.4 0.1 0.1 0.1 0.3 0.1 2.2 0.1 0.1 0.1 0.2 2.7 0.2 0.3 0.1 0.1 0.1 0.0 0.1 2.2 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.0 1.9 0.1 0.3 7.7 0.4 0.1 0.1 2.6 0.1 0.1 0.8 0.2 0.1 0.0 0.1 87.1 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.4 10.6 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.2 30.7 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.3 87.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.2 0.4 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.1 1.3 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.6 1.6 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 CEBPG "GPE1BP, IG/EBP-1" ENSG00000153879 "CCAAT/enhancer binding protein gamma" P53567 19 33373330-33382686 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012024 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA012024: AB_1846503" "unprognostic (5.56e-2)" "unprognostic (1.35e-1)" "unprognostic (3.29e-3)" "prognostic unfavorable (7.97e-5)" "unprognostic (8.12e-2)" "unprognostic (2.35e-2)" "unprognostic (2.13e-1)" "unprognostic (5.42e-2)" "unprognostic (1.19e-2)" "unprognostic (2.10e-2)" "unprognostic (1.29e-1)" "unprognostic (2.74e-2)" "prognostic unfavorable (7.23e-4)" "unprognostic (1.16e-1)" "unprognostic (5.25e-2)" "unprognostic (8.87e-2)" "unprognostic (2.01e-2)" 16.8 7.2 13.0 10.3 14.3 12.4 21.3 17.9 14.2 9.6 22.6 7.3 6.5 25.2 10.6 7.5 16.4 9.4 8.9 11.3 12.5 14.5 10.0 35.8 13.3 8.8 13.2 9.7 12.2 21.7 10.7 15.7 14.5 13.0 9.6 22.5 6.7 15.2 7.8 34.5 21.0 42.8 13.7 20.9 9.6 14.8 10.7 11.4 9.7 20.0 19.1 11.0 12.3 34.6 8.5 17.1 9.6 20.8 5.4 10.4 9.3 11.9 12.8 10.8 10.9 5.3 7.8 15.1 9.1 7.7 7.6 9.3 12.4 6.1 18.3 7.9 4.5 9.6 6.0 18.9 9.0 13.4 34.3 8.8 9.7 5.4 13.5 17.6 16.1 11.1 10.2 42.8 9.6 33.1 4.2 9.4 15.3 13.4 21.2 6.2 7.5 11.6 10.2 6.1 33.2 7.4 13.1 7.4 7.2 4.8 7.5 21.5 12.9 9.2 9.3 21.5 8.3 7.9 32.8 9.0 7.9 11.1 8.7 13.6 12.8 9.5 12.0 8.3 18.1 10.8 9.6 16.8 7.3 8.0 19.0 7.8 8.5 8.6 9.0 17.1 6.4 8.4 8.3 2.0 5.4 20.8 5.9 10.4 9.3 13.0 14.3 17.9 14.2 12.5 14.5 13.2 9.7 13.0 11.4 17.9 10.4 28.9 79.8 110.4 10.8 14.5 20.4 58.9 21.6 14.0 7.9 35.7 16.6 33.7 60.3 48.8 104.1 0.0 46.7 59.8 28.6 57.1 25.4 60.4 41.6 3.2 33.9 20.3 38.3 57.1 6.4 41.2 27.0 57.7 71.4 25.6 56.4 67.7 8.5 23.7 12.9 6.5 48.7 53.1 45.3 136.1 62.6 25.4 55.6 99.7 CEBPZ "CBF2, CTF2" ENSG00000115816 "CCAAT/enhancer binding protein zeta" Q03701 2 37201612-37231713 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052065 Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA052065: AB_2681715" "unprognostic (1.64e-2)" "unprognostic (1.20e-1)" "unprognostic (3.00e-3)" "prognostic unfavorable (5.07e-4)" "unprognostic (2.88e-1)" "unprognostic (1.72e-2)" "prognostic unfavorable (2.94e-5)" "unprognostic (8.84e-2)" "unprognostic (3.85e-3)" "unprognostic (2.66e-1)" "prognostic unfavorable (8.13e-4)" "unprognostic (2.65e-2)" "unprognostic (5.36e-2)" "unprognostic (4.19e-2)" "unprognostic (8.76e-2)" "unprognostic (2.05e-1)" "unprognostic (8.01e-2)" 21.3 23.0 13.1 23.7 14.4 20.0 21.7 17.0 16.4 22.4 17.8 8.4 17.2 12.8 17.2 16.6 18.6 17.4 12.6 19.4 12.0 12.9 30.5 22.6 15.4 16.7 13.2 12.9 24.2 17.2 18.8 27.3 18.2 16.5 20.4 15.5 8.2 15.5 17.9 88.0 14.0 19.1 19.5 15.4 23.1 15.5 27.3 14.1 19.5 22.5 18.7 17.5 30.1 41.0 20.8 17.4 17.2 14.7 17.0 23.1 9.2 19.8 15.5 16.0 8.8 15.8 17.1 13.6 19.0 13.2 16.1 17.5 24.5 15.1 36.6 17.0 11.2 22.1 17.1 41.3 19.5 20.8 23.3 18.2 34.0 16.0 19.9 12.5 34.1 15.4 13.0 19.3 21.4 21.9 10.7 14.5 9.3 37.0 16.9 16.4 10.3 19.8 26.8 52.1 26.6 14.6 15.9 26.0 27.6 15.5 18.8 17.1 27.7 15.8 19.5 21.4 24.2 14.1 15.0 11.8 15.8 18.0 14.0 26.0 19.0 19.9 29.7 14.1 31.6 17.3 17.2 11.7 10.6 17.2 14.7 21.7 20.3 18.2 16.6 11.8 20.8 23.1 19.1 4.2 17.0 14.3 17.4 14.0 9.2 13.1 14.4 17.0 16.4 12.0 12.9 13.2 12.9 16.5 14.1 80.4 74.1 56.7 60.0 95.1 42.9 29.1 56.0 68.3 106.9 47.1 41.2 45.8 91.2 46.1 195.9 50.1 23.4 46.7 53.9 30.2 41.0 51.4 70.6 63.1 30.5 41.3 42.4 44.8 35.3 23.2 56.4 35.5 20.3 47.7 48.2 52.7 48.9 24.6 47.7 55.4 87.8 51.8 44.3 132.2 95.3 88.3 37.6 59.7 48.5 54.3 CEBPZOS CEBPZ-AS1 ENSG00000218739 "CEBPZ opposite strand" A8MTT3 2 37196488-37216193 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA053866 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA053866: AB_2682283" "unprognostic (2.13e-1)" "unprognostic (1.47e-1)" "unprognostic (1.20e-1)" "unprognostic (1.27e-1)" "unprognostic (1.33e-1)" "unprognostic (8.05e-3)" "prognostic unfavorable (1.72e-6)" "unprognostic (2.34e-2)" "unprognostic (2.40e-2)" "unprognostic (5.93e-2)" "unprognostic (3.14e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (3.46e-7)" "unprognostic (3.69e-2)" "unprognostic (4.49e-2)" "unprognostic (2.03e-1)" "unprognostic (1.33e-2)" 16.5 31.3 29.5 16.2 25.4 17.9 18.5 21.0 30.2 16.9 19.8 16.3 19.1 19.0 25.9 33.0 19.3 19.5 14.4 24.5 43.8 23.8 21.5 18.2 13.8 16.5 23.6 31.3 22.8 14.9 18.6 30.2 22.1 25.4 22.3 18.9 16.1 23.9 16.7 38.4 19.0 22.0 17.1 19.4 13.8 15.3 20.3 12.7 12.9 23.7 19.8 15.1 19.4 14.0 20.9 29.4 15.3 15.3 13.1 25.2 13.7 26.2 8.8 18.9 15.3 20.1 21.9 18.3 19.5 17.6 12.7 9.3 8.2 12.0 9.1 10.5 19.4 16.5 15.5 10.3 14.8 15.6 24.6 21.3 24.5 10.2 12.8 17.4 30.5 13.7 23.2 20.5 17.1 19.1 17.2 20.2 9.8 18.4 13.7 20.6 5.3 7.6 30.0 27.8 21.2 13.6 22.8 26.0 20.9 22.3 7.2 20.3 19.9 14.9 24.9 19.0 10.8 11.1 18.6 17.8 13.7 16.9 20.0 16.8 24.6 0.2 19.8 25.5 18.4 19.5 15.3 14.1 12.1 17.7 15.3 20.4 20.9 20.1 18.5 13.5 18.0 25.2 22.4 5.7 13.1 11.5 29.4 13.7 13.7 29.5 25.4 21.0 30.2 43.8 23.8 23.6 31.3 25.4 12.7 50.6 39.2 29.4 42.0 0.0 44.4 41.1 7.6 49.5 38.7 36.6 17.7 70.8 77.9 36.3 30.8 23.3 27.4 0.0 29.4 42.0 27.8 39.9 16.2 24.1 37.6 30.2 16.8 22.1 25.3 9.5 43.7 33.7 0.0 37.9 27.6 46.1 36.7 28.8 41.8 51.9 51.6 45.3 28.5 119.8 51.1 0.0 57.8 34.5 27.5 38.8 CECR2 KIAA1740 ENSG00000099954 "CECR2, histone acetyl-lysine reader" Q9BXF3 22 17359949-17558149 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.1;skeletal muscle: 30.6" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 159.0;Rod photoreceptor cells: 94.7" "Cancer enriched" "Detected in many" 6 "testis cancer: 8.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.8;HAP1: 11.7;K-562: 6.4;NTERA-2: 18.7;SCLC-21H: 8.4;SuSa: 7.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA002943 Approved Approved Nucleoplasm,Vesicles No No Nucleoplasm Vesicles "HPA002943: AB_1078496" "unprognostic (2.46e-2)" "unprognostic (4.10e-2)" "unprognostic (7.99e-2)" "unprognostic (1.92e-3)" "unprognostic (7.48e-3)" "unprognostic (2.46e-3)" "unprognostic (2.49e-1)" "unprognostic (6.67e-2)" "unprognostic (8.18e-2)" "unprognostic (3.94e-1)" "unprognostic (5.36e-2)" "unprognostic (1.25e-1)" "unprognostic (8.13e-6)" "unprognostic (1.13e-1)" "unprognostic (1.59e-1)" "unprognostic (6.56e-2)" "unprognostic (1.94e-2)" 1.8 1.3 4.6 1.0 8.8 1.5 2.0 25.1 8.4 1.1 1.2 10.6 0.8 1.0 4.3 1.7 1.4 2.5 1.0 4.4 6.1 2.8 1.9 6.5 4.1 0.9 8.0 4.0 5.4 5.6 0.8 8.4 4.7 5.8 2.3 1.1 4.9 1.9 1.1 30.6 1.6 1.2 2.2 5.7 1.4 1.1 6.0 8.0 0.0 2.7 2.2 0.9 2.3 2.5 0.2 0.1 0.9 0.8 0.5 0.1 0.0 0.1 0.0 12.8 4.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.6 0.0 11.7 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 6.4 0.0 0.0 0.1 0.0 0.4 18.7 0.0 0.0 1.4 0.8 0.0 0.0 4.1 8.4 0.0 0.0 0.1 0.7 7.8 1.3 2.0 0.1 0.1 2.8 0.0 0.0 4.8 1.1 1.0 0.0 0.0 0.1 0.3 0.8 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.1 0.9 0.5 0.1 0.0 0.0 0.0 4.6 8.8 25.1 5.0 6.1 2.8 8.0 4.0 5.8 8.0 6.0 8.8 0.0 0.8 0.0 21.9 10.0 0.0 1.4 1.2 1.8 159.0 7.6 0.0 0.0 3.1 1.9 0.0 0.0 0.2 2.0 0.3 1.6 0.0 9.7 0.6 4.8 0.0 3.7 0.0 3.2 1.1 0.0 0.0 0.0 0.0 22.4 0.2 0.0 1.1 1.1 94.7 6.5 1.0 1.5 15.5 0.1 27.6 0.0 0.0 3.7 CELF1 "BRUNOL2, CUG-BP, CUGBP, CUGBP1, EDEN-BP, hNab50, NAB50, NAPOR" ENSG00000149187 "CUGBP Elav-like family member 1" Q92879 11 47465933-47565569 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016114, HPA044597, CAB069989" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB016114: AB_627319, CAB069989: AB_2086153, HPA044597: AB_2679012" "unprognostic (1.05e-1)" "unprognostic (7.54e-2)" "unprognostic (3.24e-2)" "unprognostic (7.64e-2)" "unprognostic (2.69e-1)" "unprognostic (4.08e-2)" "prognostic unfavorable (7.55e-4)" "unprognostic (3.84e-2)" "unprognostic (3.41e-2)" "unprognostic (1.59e-1)" "unprognostic (2.75e-1)" "unprognostic (4.24e-2)" "unprognostic (1.24e-1)" "unprognostic (4.81e-2)" "unprognostic (2.68e-1)" "unprognostic (9.58e-2)" "unprognostic (3.34e-2)" 18.4 22.8 28.3 19.9 30.8 25.8 22.7 49.5 29.8 17.8 20.7 16.6 22.9 14.7 22.9 20.1 21.5 19.0 16.5 19.3 18.7 14.1 18.5 36.5 21.0 24.0 12.8 20.2 18.9 19.2 54.3 19.6 18.2 14.6 16.3 17.7 18.4 18.0 19.7 45.4 20.1 20.1 31.4 11.9 22.3 17.9 20.4 17.7 15.8 19.5 17.0 24.6 20.6 23.8 15.4 12.4 20.6 15.5 7.0 16.1 8.0 17.9 32.0 26.6 27.3 20.9 22.4 22.7 19.3 20.1 24.4 25.6 27.1 21.4 47.5 13.5 20.8 29.5 26.9 41.1 27.4 41.2 19.8 17.9 14.6 42.0 19.4 20.4 22.8 16.2 17.1 16.9 26.5 32.3 17.3 22.2 20.6 27.3 19.4 15.6 24.0 23.5 18.3 37.2 22.4 18.9 24.3 21.3 18.6 21.0 32.2 25.0 21.1 25.7 23.9 15.7 28.5 33.7 15.1 25.5 28.0 27.6 26.7 26.1 16.7 15.1 37.9 22.6 10.9 22.7 10.9 10.8 20.6 12.8 9.6 16.1 14.6 13.5 14.5 12.4 15.4 14.7 12.1 14.6 7.0 15.5 7.7 9.2 8.0 28.3 30.8 49.5 29.8 18.7 14.1 12.8 20.2 14.6 17.7 50.6 34.1 56.8 64.7 95.7 73.0 45.8 86.6 37.5 29.6 75.0 90.3 45.7 18.3 52.0 15.0 60.9 41.1 46.7 48.3 42.8 47.4 90.8 20.8 179.6 61.2 120.8 82.1 87.2 102.7 7.0 48.9 83.5 40.5 34.3 52.3 66.2 69.1 45.6 51.9 31.8 44.1 51.8 57.1 53.7 63.4 95.4 30.1 57.3 64.3 86.4 CELF2 "BRUNOL3, CUGBP2, Etr-3, NAPOR-2" ENSG00000048740 "CUGBP Elav-like family member 2" O95319 10 10798397-11336675 "Predicted intracellular proteins" "mRNA processing" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 242.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 52.8;HMC-1: 51.4;REH: 22.8" "Low region specificity" "Detected in all" "CAB016395, HPA035813" Enhanced Supported "Nucleoplasm,Vesicles,Midbody ring" Yes No Nucleoplasm "Vesicles, Midbody ring" "CAB016395: AB_2086271, HPA035813: AB_2674797" "unprognostic (1.62e-2)" "unprognostic (1.52e-2)" "unprognostic (1.90e-2)" "unprognostic (3.55e-2)" "unprognostic (9.00e-2)" "prognostic favorable (7.61e-4)" "unprognostic (1.57e-1)" "unprognostic (3.77e-2)" "unprognostic (4.20e-2)" "unprognostic (5.22e-2)" "unprognostic (2.60e-3)" "unprognostic (2.83e-2)" "unprognostic (2.14e-1)" "unprognostic (1.44e-1)" "unprognostic (1.84e-1)" "unprognostic (2.31e-2)" "unprognostic (1.45e-1)" 27.0 4.9 26.5 21.0 35.2 49.5 14.6 23.6 35.7 11.7 12.2 10.1 4.5 7.1 11.6 5.1 16.3 10.6 12.9 26.8 24.0 14.9 3.8 3.6 20.8 31.4 11.0 20.0 35.7 3.8 2.2 6.7 6.6 11.6 11.2 13.8 8.5 9.1 10.0 14.8 6.5 18.9 17.3 15.8 22.7 9.4 5.9 15.0 36.9 6.8 6.3 20.9 13.0 11.0 22.7 23.1 51.0 27.2 30.6 31.9 22.9 0.0 0.0 13.0 0.0 2.0 0.7 1.4 1.9 0.0 0.3 0.0 0.0 0.0 0.0 1.4 1.6 0.0 0.0 1.8 0.0 0.1 10.6 3.2 52.8 0.2 0.0 0.5 15.1 51.4 0.8 0.1 0.1 0.0 0.2 1.8 19.0 2.4 22.0 16.2 0.0 18.6 11.0 5.2 0.0 0.0 22.8 13.9 4.7 0.9 0.0 1.9 0.1 0.0 0.0 13.8 4.4 0.0 10.3 0.0 2.4 0.7 8.1 0.0 8.4 7.6 2.5 0.8 18.3 5.8 25.4 18.1 37.8 25.3 24.9 31.9 21.5 25.2 27.7 23.1 22.7 26.6 24.7 51.0 30.6 27.2 16.4 25.8 22.9 26.5 35.2 23.6 33.9 24.0 14.9 11.0 20.0 11.6 15.0 148.9 136.7 93.8 3.2 17.6 71.9 103.5 7.6 6.7 34.2 12.2 96.2 1.0 13.3 1.4 110.6 43.2 3.5 0.0 1.8 0.7 43.6 7.5 123.7 2.4 77.4 127.1 57.0 17.2 242.8 76.2 103.3 121.5 109.6 224.6 40.3 91.1 1.8 14.0 84.1 0.4 90.1 51.8 23.0 3.4 12.1 12.7 1.6 176.6 20.4 1.4 CELF3 "BRUNOL1, CAGH4, ERDA4, MGC57297, TNRC4" ENSG00000159409 "CUGBP Elav-like family member 3" Q5SZQ8 1 151702404-151716814 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 16.8;brain: 44.0;pituitary gland: 31.2" "Cell type enhanced" "Detected in some" 21 "Bipolar cells: 93.5;Cone photoreceptor cells: 37.3;Horizontal cells: 19.1;Intestinal endocrine cells: 50.7" "Group enriched" "Detected in many" 5 "glioma: 4.4;pancreatic cancer: 4.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "SCLC-21H: 28.6;SH-SY5Y: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006292 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA006292: AB_10602250" "unprognostic (2.01e-1)" "unprognostic (1.79e-1)" "unprognostic (7.67e-2)" "unprognostic (1.96e-1)" "unprognostic (1.75e-1)" "unprognostic (6.64e-2)" "unprognostic (1.38e-1)" "unprognostic (3.02e-2)" "unprognostic (3.12e-1)" "unprognostic (3.48e-3)" "unprognostic (3.49e-3)" "unprognostic (6.90e-2)" "unprognostic (1.82e-8)" "unprognostic (8.50e-2)" "unprognostic (9.01e-2)" "unprognostic (2.41e-1)" "unprognostic (3.05e-2)" 1.1 16.8 21.4 1.4 28.9 1.1 1.0 29.2 44.0 1.0 2.1 2.0 0.0 5.0 1.0 1.0 1.1 2.1 1.0 1.0 19.5 16.2 1.1 1.0 1.1 1.0 5.3 15.3 1.0 8.8 1.0 31.2 1.2 3.7 1.1 2.1 3.7 1.0 1.0 1.0 1.0 3.8 1.2 1.5 1.0 8.5 2.0 4.4 0.0 1.1 0.0 1.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 28.6 20.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 28.9 29.2 29.1 19.5 16.2 5.3 15.3 3.7 4.4 0.0 0.0 0.0 0.0 0.0 93.5 0.8 0.0 0.0 0.0 0.0 37.3 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 19.1 50.7 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.6 2.3 0.1 0.0 0.0 0.3 4.8 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 CELF4 BRUNOL4 ENSG00000101489 "CUGBP Elav-like family member 4" Q9BZC1 18 37243047-37566037 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 69.1" "Group enriched" "Detected in many" 5 "Bipolar cells: 75.9;Horizontal cells: 278.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013322, HPA037986" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA013322: , HPA037986: AB_10673035" "unprognostic (7.87e-3)" "unprognostic (2.31e-2)" "unprognostic (4.31e-3)" "unprognostic (3.42e-7)" "unprognostic (2.95e-2)" "unprognostic (2.95e-2)" "unprognostic (3.72e-3)" "unprognostic (2.06e-1)" "unprognostic (2.74e-1)" "unprognostic (2.87e-3)" "unprognostic (1.92e-2)" "unprognostic (1.00e-2)" "unprognostic (3.49e-1)" "unprognostic (1.69e-2)" "unprognostic (2.48e-1)" "unprognostic (8.32e-3)" "unprognostic (6.13e-2)" 1.4 10.7 40.2 1.7 25.2 1.1 1.3 45.3 69.1 1.1 1.6 0.9 0.0 1.6 1.3 1.5 1.4 1.3 2.0 1.7 27.0 26.3 1.4 1.3 1.4 1.6 13.5 26.3 2.0 4.2 1.2 8.1 1.7 13.1 1.5 1.3 0.5 2.5 1.1 8.3 2.0 1.9 1.3 3.7 1.7 1.6 3.9 5.6 0.0 2.3 0.0 1.0 1.2 0.0 0.7 0.5 2.4 0.9 0.9 0.9 0.4 0.1 0.1 0.5 0.5 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.3 0.2 0.7 0.0 0.1 0.4 0.0 0.1 0.0 0.5 0.3 0.0 1.2 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.6 0.0 0.2 0.1 0.4 1.1 0.0 0.2 0.1 0.0 1.4 0.0 0.1 31.7 7.7 0.8 0.2 0.0 0.2 0.2 0.1 0.0 1.0 0.4 0.2 0.1 2.0 0.3 0.1 0.1 0.1 0.1 2.4 0.5 0.5 0.7 0.6 0.7 0.7 0.4 0.4 0.3 0.7 0.8 0.9 1.3 0.9 0.9 0.5 0.6 0.4 40.2 25.2 45.3 31.1 27.0 26.3 13.5 26.3 13.1 5.6 0.0 0.0 0.0 1.4 0.3 75.9 1.5 0.0 0.0 0.0 0.0 39.3 0.2 0.0 0.2 37.5 0.6 0.3 0.0 0.9 0.1 0.7 2.1 0.0 0.0 6.4 278.1 12.2 1.3 0.0 19.6 0.6 0.0 0.0 0.0 0.0 6.0 4.1 0.0 4.9 1.3 20.9 0.0 0.0 10.0 4.3 0.5 0.2 0.0 0.1 0.8 CELSR1 "ADGRC1, CDHF9, FMI2, HFMI2, ME2" ENSG00000075275 "Cadherin EGF LAG seven-pass G-type receptor 1" Q9NYQ6 22 46360834-46537170 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 38.7;Ciliated cells: 33.5;Club cells: 27.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 4 "memory B-cell: 3.0;naive B-cell: 3.0" "Lineage enriched" "Detected in single" 4 "B-cells: 3.0" "Cell line enhanced" "Detected in many" "A549: 24.1;HaCaT: 15.2;T-47d: 17.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA052976, HPA060521" Enhanced "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA052976: AB_2682004, HPA060521: AB_2684303" "unprognostic (5.62e-2)" "unprognostic (4.93e-2)" "unprognostic (4.22e-2)" "unprognostic (1.54e-3)" "unprognostic (2.71e-1)" "unprognostic (1.83e-1)" "unprognostic (3.66e-1)" "unprognostic (3.36e-1)" "unprognostic (5.31e-2)" "unprognostic (1.05e-2)" "unprognostic (1.18e-2)" "unprognostic (8.59e-2)" "unprognostic (2.44e-2)" "unprognostic (1.17e-1)" "unprognostic (2.67e-2)" "unprognostic (1.13e-1)" "unprognostic (1.07e-1)" 3.4 0.5 0.6 5.0 1.4 0.3 4.1 0.4 0.3 8.7 1.3 0.9 3.6 0.3 5.7 7.5 14.2 11.1 5.3 4.6 0.7 0.7 16.2 0.8 19.3 4.2 0.4 0.0 6.0 2.6 7.5 3.8 3.4 2.2 7.2 0.4 3.8 22.6 3.0 0.3 13.9 2.3 3.1 0.4 1.8 3.6 2.8 0.0 1.8 5.7 12.7 12.8 3.1 5.0 3.0 0.2 0.0 0.0 0.7 0.1 0.0 8.7 24.1 4.6 3.9 0.0 0.0 2.2 0.7 1.5 1.4 0.3 5.7 6.8 0.0 11.9 0.1 9.3 15.2 3.8 11.5 0.5 0.0 4.6 0.0 9.7 0.2 0.2 1.5 0.6 0.0 10.8 0.0 9.6 9.1 0.0 0.6 0.0 0.0 0.0 10.9 0.0 1.7 1.7 2.8 3.8 0.0 0.0 2.8 6.4 5.4 0.2 0.3 7.5 6.0 1.2 1.9 17.3 5.1 0.3 0.0 0.1 0.0 0.1 4.6 0.2 2.4 6.0 0.0 5.2 0.0 0.0 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.6 1.4 0.4 0.3 0.7 0.7 0.4 0.0 2.2 0.0 38.7 16.8 1.3 3.3 15.1 0.0 10.2 0.0 33.5 27.3 5.2 0.0 1.0 0.0 1.4 1.2 5.5 0.0 0.0 0.6 1.7 1.7 3.6 0.0 1.6 2.4 0.0 1.2 1.3 0.0 5.0 0.0 1.3 5.0 1.8 2.0 1.3 2.6 0.0 0.0 11.0 0.3 0.0 1.0 0.2 0.2 13.7 0.7 0.0 1.5 4.7 CEMP1 CP-23 ENSG00000205923 "Cementum protein 1" Q6PRD7 16 2530035-2531417 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 24 "Ciliated cells: 2.7;Early spermatids: 2.6;granulocytes: 1.1;Late spermatids: 6.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 4.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 8.7;REH: 9.3" "HPA057658, HPA075926" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA057658: AB_2683492, HPA075926: " 0.7 4.1 5.8 1.6 3.3 0.6 0.5 3.6 3.7 1.2 0.7 1.7 1.1 0.0 3.3 0.6 2.6 3.3 4.5 2.4 3.6 2.5 1.6 5.4 3.0 2.1 0.8 0.8 0.9 1.3 1.0 0.0 5.5 0.6 1.9 8.0 4.6 0.0 2.4 3.4 0.9 1.0 2.4 0.0 4.6 0.6 0.6 1.2 4.2 0.0 0.7 1.8 0.0 1.2 0.9 1.1 6.0 0.0 0.0 3.1 0.3 0.0 0.0 0.0 0.9 5.3 0.0 0.7 0.0 2.3 1.9 0.0 0.0 0.0 0.7 8.7 0.7 0.0 3.0 0.0 0.7 4.2 0.0 0.0 0.0 0.0 1.3 0.0 3.6 2.1 2.0 0.0 3.6 1.0 3.0 2.4 0.5 1.8 9.3 0.6 0.1 0.0 1.8 5.0 1.8 1.4 6.5 6.4 0.3 7.4 0.8 0.4 2.3 2.0 2.9 1.3 1.0 1.7 2.1 2.8 4.3 1.2 4.2 0.0 3.5 0.3 0.0 0.6 0.6 0.6 1.1 0.0 0.4 0.2 0.9 0.0 0.7 0.0 1.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 6.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 CENPA "CenH3, CENP-A" ENSG00000115163 "Centromere protein A" P49450 2 26764289-26801067 "Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 53.7" "Cell type enhanced" "Detected in many" 13 "Extravillous trophoblasts: 27.3;Hofbauer cells: 12.7;Spermatogonia: 18.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.6" "Lineage enriched" "Detected in single" 16 "T-cells: 1.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB008371, HPA073086" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "CAB008371: AB_591074, HPA073086: AB_2686569" "unprognostic (3.94e-2)" "unprognostic (1.38e-1)" "unprognostic (2.29e-2)" "prognostic unfavorable (2.38e-4)" "unprognostic (1.13e-1)" "unprognostic (2.89e-2)" "prognostic unfavorable (2.88e-8)" "prognostic unfavorable (3.70e-4)" "unprognostic (1.69e-3)" "unprognostic (7.80e-2)" "prognostic unfavorable (1.30e-4)" "unprognostic (4.21e-3)" "unprognostic (0.00e+0)" "unprognostic (5.74e-2)" "unprognostic (1.33e-1)" "unprognostic (7.68e-2)" "unprognostic (2.07e-1)" 1.2 0.9 0.2 12.1 0.2 3.5 3.0 0.2 0.2 1.3 3.5 0.4 0.3 5.3 0.9 1.5 8.5 0.1 1.2 1.5 0.2 0.3 0.8 0.7 1.4 8.2 0.3 0.0 0.5 0.7 0.0 0.3 3.1 0.3 0.5 3.2 0.1 1.7 0.0 0.3 4.5 3.6 0.8 0.3 4.9 1.8 7.8 0.0 53.7 0.4 9.2 10.0 1.3 2.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 31.2 7.2 11.2 6.2 0.9 1.8 9.3 9.7 7.4 13.1 11.3 5.2 10.2 9.4 6.3 3.5 15.4 9.2 10.0 5.1 13.0 27.9 9.8 15.9 3.3 8.7 0.3 9.2 17.8 0.1 0.6 5.2 7.2 2.0 6.7 11.6 12.8 19.5 10.3 10.5 13.3 14.2 10.0 10.4 13.3 15.9 20.0 10.4 5.7 1.4 9.6 9.7 9.3 10.4 7.6 4.0 6.2 9.9 4.8 8.1 20.6 9.6 16.0 19.4 19.2 38.4 3.9 19.0 15.3 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.5 5.6 0.0 2.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.4 0.0 0.4 0.0 0.2 27.3 1.0 0.9 0.0 0.0 12.7 0.0 4.1 2.5 1.6 0.0 0.9 1.8 1.7 0.0 3.2 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 7.1 18.1 4.5 2.9 1.7 3.7 2.1 CENPB ENSG00000125817 "Centromere protein B" P07199 20 3783851-3786690 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011626, HPA053507, HPA054405" Approved Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "CAB011626: AB_726801, HPA053507: AB_2682173, HPA054405: AB_2682477" "unprognostic (2.01e-1)" "unprognostic (8.47e-3)" "unprognostic (2.61e-1)" "unprognostic (1.12e-2)" "unprognostic (1.75e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (6.09e-4)" "unprognostic (2.40e-2)" "unprognostic (3.27e-2)" "unprognostic (3.57e-1)" "unprognostic (1.48e-3)" "unprognostic (7.93e-2)" "unprognostic (2.78e-2)" "unprognostic (1.39e-1)" "unprognostic (2.68e-1)" "unprognostic (1.34e-1)" "unprognostic (2.46e-1)" 30.4 18.9 41.2 18.0 41.6 11.9 22.9 13.0 28.9 22.4 23.0 41.1 18.7 19.6 18.4 19.8 22.3 18.1 27.3 26.9 41.9 29.1 19.8 20.3 20.0 16.0 48.0 14.7 25.0 23.9 22.7 12.1 15.2 22.0 18.6 12.3 13.0 27.6 24.3 58.3 32.6 19.9 20.1 55.8 19.8 21.9 9.0 21.9 19.6 21.7 26.4 14.9 20.7 28.0 3.7 4.2 1.4 4.5 3.9 5.0 2.5 32.0 41.4 8.1 17.3 17.3 13.8 5.2 23.1 16.9 14.9 12.1 16.8 23.2 11.2 7.2 21.4 23.3 26.0 6.4 26.3 7.5 15.9 11.0 23.8 14.9 14.8 20.2 7.7 8.0 15.6 14.1 21.3 13.7 11.7 12.7 14.6 15.3 7.1 12.6 52.9 23.0 17.8 10.2 18.2 49.4 19.2 1.0 8.2 15.5 19.9 20.0 14.9 19.1 26.9 18.0 3.8 16.9 17.2 21.5 25.9 14.0 22.3 35.2 8.6 12.4 6.6 9.0 27.8 16.9 0.1 4.5 1.4 5.0 4.0 3.5 2.5 3.6 3.1 3.2 3.7 3.3 3.8 0.6 3.9 2.6 4.2 1.0 2.5 41.2 41.6 13.0 28.9 41.9 29.1 48.0 14.7 22.0 21.9 6.0 17.9 1.5 4.7 12.4 16.8 13.6 33.1 10.7 10.3 14.0 9.8 4.5 3.3 16.2 0.8 17.9 29.0 0.0 25.4 6.4 12.7 10.4 7.0 22.2 19.3 20.6 19.7 17.8 20.8 3.9 20.1 13.0 16.9 10.8 24.3 28.3 24.5 20.4 24.4 6.5 12.2 12.9 13.7 1.2 1.3 12.3 3.8 6.4 21.0 6.2 CENPC "CENP-C, CENPC1, hcp-4, MIF2" ENSG00000145241 "Centromere protein C" Q03188 4 67468748-67545606 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049740, HPA058252" Supported "Nucleoplasm,Nuclear bodies,Midbody" NA NA "Nuclear bodies" "Nucleoplasm, Midbody" "HPA049740: , HPA058252: AB_2683654" "unprognostic (4.35e-1)" "unprognostic (6.41e-3)" "unprognostic (4.31e-3)" "unprognostic (7.85e-2)" "unprognostic (6.31e-2)" "unprognostic (3.85e-3)" "unprognostic (6.40e-2)" "prognostic favorable (9.67e-4)" "unprognostic (3.22e-2)" "unprognostic (7.13e-2)" "unprognostic (8.35e-2)" "unprognostic (4.32e-2)" "prognostic favorable (5.63e-4)" "unprognostic (2.40e-1)" "unprognostic (1.92e-1)" "unprognostic (1.15e-1)" "unprognostic (1.92e-3)" 9.4 8.6 9.3 11.9 14.6 12.9 13.5 26.9 12.2 12.6 7.3 4.6 6.2 5.6 12.6 10.1 9.1 10.1 6.6 6.9 8.0 5.8 9.0 6.6 8.7 7.7 11.8 7.7 20.9 16.4 8.0 21.2 6.3 9.1 12.3 6.0 5.0 10.2 13.4 5.3 9.8 9.1 10.3 13.4 10.5 9.5 7.5 12.6 17.7 13.0 9.1 6.8 10.2 10.4 5.1 2.4 2.8 1.5 1.6 5.0 1.2 0.8 1.0 2.9 1.6 3.4 2.1 1.6 1.0 0.9 1.3 1.1 1.2 2.3 4.5 1.6 1.3 0.7 1.5 3.7 1.7 2.0 1.7 0.7 3.5 1.8 1.6 1.2 6.3 1.5 2.5 0.6 1.0 2.2 2.2 0.7 3.1 5.0 3.1 1.9 1.5 8.6 5.8 3.1 1.6 0.7 4.2 7.0 1.5 1.7 1.5 4.8 2.4 2.2 4.2 1.2 3.0 1.4 2.4 1.0 1.8 1.3 1.3 0.9 2.3 1.0 4.8 2.1 3.7 1.1 2.7 1.3 2.8 3.2 1.5 1.9 3.3 3.6 3.4 1.1 5.1 5.0 3.7 1.0 1.6 1.1 2.4 2.0 1.2 9.3 14.6 26.9 12.2 8.0 5.8 11.8 7.7 9.1 12.6 29.8 31.5 29.9 25.5 13.5 51.4 20.0 15.3 36.1 38.7 15.7 13.7 15.9 10.0 9.7 3.1 19.2 14.8 23.3 14.6 11.7 14.6 15.2 25.5 13.2 11.0 49.3 12.6 19.0 16.4 4.2 32.2 15.1 15.1 15.4 15.8 42.4 12.3 11.5 24.1 13.9 28.4 19.4 15.5 33.5 46.1 8.2 15.3 44.5 14.3 20.9 CENPE "KIF10, PPP1R61" ENSG00000138778 "Centromere protein E" Q02224 4 103105806-103198409 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Developmental protein, Motor protein" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 11.3;lymphoid tissue: 25.1" "Cell type enhanced" "Detected in many" 14 "Erythroid cells: 93.5;Spermatocytes: 69.2;Spermatogonia: 47.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 5.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA042294 Enhanced Approved Nucleoplasm,Microtubules,Cytosol NA Yes "Microtubules, Cytosol" Nucleoplasm "HPA042294: AB_10797386" "unprognostic (1.62e-1)" "unprognostic (1.03e-1)" "unprognostic (5.64e-3)" "unprognostic (2.55e-2)" "unprognostic (1.65e-1)" "unprognostic (3.44e-2)" "unprognostic (2.40e-8)" "unprognostic (2.49e-3)" "unprognostic (1.59e-2)" "unprognostic (3.38e-1)" "unprognostic (4.88e-5)" "unprognostic (1.15e-2)" "unprognostic (0.00e+0)" "unprognostic (9.95e-3)" "unprognostic (2.49e-1)" "unprognostic (1.05e-1)" "unprognostic (2.37e-1)" 2.7 0.9 0.6 9.4 1.5 11.3 0.7 0.2 1.3 1.0 2.1 0.5 0.0 1.9 0.7 1.9 5.9 0.5 0.8 2.5 2.0 0.8 1.3 0.6 1.4 7.3 1.9 0.6 0.7 0.5 0.1 0.4 3.1 1.4 0.7 2.7 0.2 2.2 0.8 0.4 2.2 2.4 1.4 1.3 3.3 1.6 6.6 0.6 25.1 0.6 5.9 6.4 1.5 1.9 0.6 0.5 5.7 3.0 0.8 1.4 0.2 20.9 6.0 21.9 10.6 1.5 3.4 4.3 19.1 9.6 14.3 9.5 9.5 11.4 14.2 4.9 7.0 10.0 9.4 15.7 7.7 22.6 17.7 5.8 16.7 12.6 6.9 0.2 19.8 9.7 1.0 0.6 11.4 9.6 3.2 12.0 13.0 17.3 17.0 18.3 7.6 15.6 8.9 7.0 8.5 9.4 10.5 20.5 4.7 4.0 4.2 10.1 6.0 16.9 11.8 4.6 8.8 6.7 7.0 13.0 13.8 14.5 14.3 19.5 8.3 14.2 14.8 7.7 11.1 14.6 5.7 0.1 0.7 0.2 0.6 0.0 0.6 0.4 0.4 0.2 0.2 0.1 0.3 0.1 0.8 3.0 0.5 1.4 0.2 0.6 1.5 0.2 1.3 2.0 0.8 1.9 0.6 1.4 0.6 3.0 2.1 0.0 1.0 3.2 7.1 1.4 0.0 0.0 1.2 0.0 7.9 2.4 0.0 0.4 3.4 2.8 0.5 93.5 0.0 22.1 1.5 1.3 6.9 0.8 11.2 0.0 1.2 4.3 7.3 0.7 0.9 5.5 0.0 8.2 1.4 1.4 1.3 0.6 2.5 0.0 2.5 0.0 2.5 69.2 47.7 2.5 3.0 2.5 4.7 0.6 CENPF hcp-1 ENSG00000117724 "Centromere protein F" P49454 1 214603195-214664588 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, DNA synthesis, Mitosis, Myogenesis" "Developmental protein" "Cancer-related genes, Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 19.5;lymphoid tissue: 67.5" "Cell type enhanced" "Detected in many" 20 "Erythroid cells: 303.7;Extravillous trophoblasts: 74.0;Spermatogonia: 88.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052382, HPA064308, CAB070134" Enhanced Supported Nucleoplasm Yes Yes Nucleoplasm "CAB070134: AB_2229328, HPA052382: AB_2681808, HPA064308: AB_2732711" "unprognostic (2.80e-1)" "unprognostic (2.16e-1)" "unprognostic (2.65e-1)" "unprognostic (5.30e-2)" "unprognostic (1.73e-1)" "unprognostic (2.40e-2)" "prognostic unfavorable (2.29e-5)" "unprognostic (1.13e-2)" "unprognostic (2.58e-3)" "unprognostic (1.11e-1)" "prognostic unfavorable (1.39e-4)" "unprognostic (1.58e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.92e-2)" "unprognostic (1.71e-1)" "unprognostic (1.89e-2)" "unprognostic (4.12e-1)" 1.6 1.5 1.0 10.7 1.3 19.5 1.1 0.4 0.9 2.1 5.6 0.3 0.0 4.6 1.2 1.7 9.4 0.8 0.4 1.7 0.6 0.6 1.0 0.8 3.2 6.2 0.6 0.5 1.4 0.6 0.0 0.4 6.4 0.8 0.7 4.5 0.4 1.9 0.0 0.5 4.7 6.4 1.6 1.5 3.8 2.3 9.4 0.6 67.5 0.6 7.6 7.6 1.4 2.9 0.3 0.3 0.0 0.0 0.7 1.9 0.2 32.6 18.5 39.9 20.8 1.5 2.0 15.6 20.2 8.3 12.2 12.0 14.7 20.2 31.1 12.0 11.2 11.0 20.3 24.6 13.2 20.7 27.1 15.4 25.5 28.4 20.9 0.2 36.1 14.0 0.7 1.0 17.5 20.2 3.5 12.7 14.3 23.0 18.6 21.7 12.4 21.3 14.4 35.3 9.8 8.2 22.7 56.4 10.2 11.9 8.1 18.7 25.5 27.3 18.2 10.5 22.2 21.7 13.8 16.7 22.1 26.0 18.3 41.7 14.3 15.4 29.9 9.6 26.1 19.5 0.0 0.0 0.0 0.4 0.0 0.1 0.2 1.4 0.4 0.3 0.3 1.9 0.8 0.0 0.7 0.0 0.3 1.7 0.2 1.0 1.3 0.4 0.9 0.6 0.6 0.6 0.5 0.8 0.6 0.0 1.9 40.2 1.2 8.2 3.2 1.9 2.5 26.8 14.8 0.0 0.0 9.1 0.0 1.8 32.4 2.8 1.3 303.7 0.4 74.0 7.7 1.0 1.1 1.9 26.4 1.6 0.0 9.8 11.2 9.4 1.1 9.9 1.7 0.0 5.3 1.1 0.5 0.0 2.8 0.0 2.8 0.0 0.3 20.9 88.3 4.8 4.2 10.9 15.5 0.9 CENPH ENSG00000153044 "Centromere protein H" Q9H3R5 5 69189548-69210357 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.8;testis: 37.3" "Cell type enhanced" "Detected in many" 15 "Erythroid cells: 70.0;Spermatocytes: 122.1;Spermatogonia: 250.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA036494 Approved Supported "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoplasm, Nucleoli rim" "Mitotic chromosome" "HPA036494: AB_10673354" "unprognostic (1.49e-1)" "prognostic favorable (6.86e-4)" "unprognostic (1.73e-2)" "unprognostic (3.16e-2)" "unprognostic (2.32e-1)" "unprognostic (3.87e-2)" "prognostic unfavorable (5.22e-5)" "unprognostic (6.14e-3)" "unprognostic (6.85e-2)" "prognostic favorable (2.50e-4)" "unprognostic (4.21e-2)" "unprognostic (8.80e-2)" "prognostic unfavorable (5.11e-15)" "unprognostic (1.17e-1)" "unprognostic (3.94e-1)" "unprognostic (2.58e-1)" "unprognostic (2.20e-1)" 4.0 1.9 2.9 15.2 3.1 19.1 5.5 2.1 3.0 3.9 4.7 1.2 0.7 4.2 2.9 3.1 7.7 2.5 2.8 4.4 2.7 2.1 1.9 2.2 3.6 11.1 2.6 3.7 3.6 1.6 1.6 2.7 6.8 1.8 2.4 5.5 1.6 3.0 1.5 3.6 6.0 4.0 2.4 2.6 6.2 2.5 37.3 1.8 31.8 1.8 10.2 12.2 3.1 4.3 12.1 6.1 2.5 3.6 7.5 9.8 4.2 18.4 5.7 26.8 20.9 1.7 5.6 14.3 9.1 9.7 20.3 22.0 7.8 23.5 39.7 10.9 5.3 11.8 13.8 17.5 21.0 26.0 12.0 12.0 9.2 9.8 7.7 0.6 13.3 9.5 2.2 4.3 13.2 14.6 5.8 6.8 21.7 16.3 15.8 15.6 10.3 42.8 19.1 23.2 6.0 4.9 26.7 35.3 30.6 6.4 6.8 18.5 24.7 10.0 6.8 8.0 15.2 9.5 9.0 3.3 10.1 17.0 13.4 22.6 19.5 29.5 31.8 15.6 27.0 19.1 0.6 1.8 2.5 4.5 3.0 7.3 11.8 7.6 5.7 2.8 12.1 9.8 8.3 0.4 7.5 3.6 6.1 8.7 4.2 2.9 3.1 2.1 3.0 2.7 2.1 2.6 3.7 1.8 1.8 0.0 1.6 22.3 12.1 32.5 3.6 2.2 5.1 13.4 6.8 0.0 0.0 23.0 0.0 5.8 21.9 5.7 1.2 70.0 7.9 41.3 7.8 4.5 4.7 0.8 15.0 0.0 1.2 5.5 5.6 22.4 3.4 11.0 8.5 5.4 7.2 5.2 5.5 2.9 4.6 2.9 3.0 19.4 6.6 122.1 250.2 16.8 8.4 13.1 13.0 6.2 CENPJ "BM032, CPAP, LAP, LIP1, MCPH6, Sas-4, SASS4, SCKL4" ENSG00000151849 "Centromere protein J" Q9HC77 13 24882284-24922889 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Dwarfism, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 115.8;Spermatocytes: 61.7;Spermatogonia: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" HPA060426 Approved "Nucleoplasm,Plasma membrane,Centrosome" NA NA "Nucleoplasm, Plasma membrane, Centrosome" "HPA060426: AB_2684278" "unprognostic (2.69e-1)" "unprognostic (3.17e-1)" "unprognostic (2.68e-1)" "unprognostic (1.01e-2)" "unprognostic (9.39e-2)" "unprognostic (1.17e-2)" "unprognostic (2.15e-5)" "unprognostic (7.41e-2)" "unprognostic (1.50e-2)" "unprognostic (9.83e-2)" "unprognostic (2.44e-1)" "unprognostic (3.48e-2)" "prognostic unfavorable (1.75e-5)" "unprognostic (7.36e-2)" "unprognostic (5.51e-2)" "unprognostic (2.15e-1)" "unprognostic (1.13e-1)" 5.0 3.5 6.6 6.7 11.9 10.2 6.2 18.4 6.4 10.3 7.6 5.0 7.2 7.5 8.8 4.8 6.6 6.0 3.3 4.2 5.4 4.4 3.9 2.9 4.9 8.5 9.7 3.8 8.1 3.2 2.1 4.6 7.6 7.2 6.3 8.8 2.4 4.6 12.0 3.6 7.6 9.0 9.1 11.6 7.4 4.6 24.3 10.1 14.6 20.8 5.7 7.8 7.9 7.8 4.3 2.4 3.8 1.3 2.2 2.1 0.7 5.3 5.2 17.7 16.5 2.5 3.6 10.0 12.5 5.7 7.8 7.3 6.7 9.5 9.7 3.7 4.5 5.6 13.0 13.3 7.0 12.0 8.9 6.6 35.2 12.3 5.6 1.2 16.1 11.6 2.2 2.0 6.8 3.8 3.6 5.9 9.3 9.9 18.1 8.1 5.1 11.0 22.0 10.0 14.2 4.0 12.3 12.3 5.0 3.1 6.0 9.0 8.4 6.3 6.8 5.1 16.3 3.4 11.0 5.5 9.2 6.3 12.7 8.2 5.0 9.1 10.5 4.3 11.8 14.2 1.9 0.8 3.8 2.1 1.3 0.9 4.3 1.4 1.6 0.9 4.1 1.8 0.9 0.4 2.2 0.9 2.4 1.5 0.7 6.6 11.9 18.4 6.4 5.4 4.4 9.7 3.8 7.2 10.1 3.0 8.0 3.0 3.6 1.8 7.2 5.3 0.0 9.4 14.8 3.5 3.9 5.6 0.0 1.5 115.8 5.3 5.2 0.0 2.6 11.2 2.7 2.0 4.7 1.5 3.7 3.2 0.0 1.3 2.4 17.0 6.1 4.6 0.0 9.0 2.5 2.6 1.7 6.2 5.3 0.8 2.0 6.5 7.2 61.7 32.4 1.1 2.4 6.9 3.3 1.4 CENPN "BM039, C16orf60, FLJ13607, FLJ22660" ENSG00000166451 "Centromere protein N" Q96H22 16 81006498-81033114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 70.0;Extravillous trophoblasts: 78.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052870 Supported Nucleoplasm NA NA Nucleoplasm "HPA052870: AB_2681978" "unprognostic (1.23e-2)" "unprognostic (2.40e-1)" "unprognostic (1.15e-1)" "unprognostic (1.76e-2)" "unprognostic (2.15e-1)" "unprognostic (1.76e-2)" "unprognostic (3.69e-3)" "prognostic unfavorable (6.49e-4)" "unprognostic (1.90e-1)" "unprognostic (2.36e-3)" "prognostic unfavorable (1.46e-5)" "unprognostic (3.02e-2)" "prognostic unfavorable (4.86e-4)" "unprognostic (2.34e-2)" "unprognostic (7.42e-2)" "unprognostic (1.41e-2)" "unprognostic (7.99e-2)" 4.2 4.9 4.8 8.2 5.0 26.9 3.2 2.4 5.4 2.7 6.6 5.9 4.8 6.4 2.6 6.8 9.9 2.1 3.7 7.3 5.0 4.6 6.5 21.0 5.2 8.9 6.0 4.5 2.4 3.9 12.0 2.5 8.8 5.1 25.3 7.0 1.5 3.7 4.7 5.6 3.5 7.7 5.6 6.1 5.9 5.1 11.8 5.6 24.6 4.2 12.6 10.2 4.2 3.8 6.6 8.5 2.9 3.7 4.0 10.1 2.7 23.2 22.4 19.4 17.2 5.3 4.3 23.3 23.9 16.9 38.9 17.3 40.7 18.8 13.2 13.8 14.0 18.3 19.9 15.6 17.3 50.6 7.9 13.3 11.6 18.2 27.2 2.6 16.9 22.9 3.8 1.8 35.4 12.5 5.4 17.7 16.8 21.2 19.0 19.9 42.7 21.6 21.7 20.6 10.7 12.3 25.4 18.4 14.2 7.0 15.8 12.4 11.3 36.2 9.1 10.8 12.0 21.4 9.7 9.3 28.7 29.1 18.9 26.8 13.3 29.2 50.1 13.5 12.1 24.9 0.0 1.7 2.9 2.5 3.3 2.3 1.9 3.9 2.1 8.5 6.6 1.9 2.0 1.4 4.0 3.7 2.7 10.1 2.7 4.8 5.0 2.4 5.4 5.0 4.6 6.0 4.5 5.1 5.6 0.0 4.5 1.5 14.2 21.3 1.0 3.4 7.6 1.4 4.5 3.5 0.0 29.0 0.0 4.8 34.5 2.9 4.3 70.0 5.7 78.1 10.5 11.7 5.8 3.9 23.1 0.0 1.2 5.5 8.8 31.4 2.6 8.4 6.8 4.6 7.7 0.8 4.7 2.9 3.2 6.7 0.0 0.0 8.3 40.2 40.3 14.3 22.8 15.4 12.7 11.9 CENPO "CENP-O, MGC11266" ENSG00000138092 "Centromere protein O" Q9BU64 2 24793136-24822376 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 28.7;testis: 28.9" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 9.5;Spermatocytes: 12.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046189 Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA046189: AB_2679579" "unprognostic (1.67e-2)" "unprognostic (2.42e-1)" "unprognostic (1.98e-2)" "prognostic unfavorable (3.54e-4)" "unprognostic (1.79e-1)" "unprognostic (7.48e-3)" "prognostic unfavorable (1.73e-6)" "unprognostic (5.56e-2)" "unprognostic (4.02e-1)" "unprognostic (4.81e-2)" "unprognostic (5.93e-2)" "unprognostic (1.63e-2)" "prognostic unfavorable (5.71e-13)" "unprognostic (4.23e-2)" "unprognostic (2.28e-1)" "unprognostic (1.06e-1)" "unprognostic (1.96e-1)" 6.9 6.0 6.6 7.6 7.8 15.4 6.3 6.2 11.9 4.4 6.6 8.3 2.6 6.5 4.6 3.9 6.3 3.6 3.4 3.3 8.4 6.4 5.3 3.5 4.9 9.2 6.2 6.5 6.6 4.9 4.2 5.2 6.7 7.9 4.4 7.9 3.6 4.1 2.8 5.6 7.9 6.0 4.6 6.3 6.6 4.8 28.9 5.7 28.7 5.0 6.5 11.4 4.7 4.9 1.6 4.1 0.3 1.2 2.1 3.5 1.3 13.9 16.6 19.3 10.2 2.3 3.6 10.7 16.9 10.1 24.1 18.5 21.1 7.1 9.7 2.0 10.5 14.1 7.5 18.9 6.5 16.2 12.6 9.9 15.3 10.5 14.0 1.1 12.7 11.6 1.7 1.1 24.0 5.3 4.4 11.1 11.7 17.8 11.1 14.8 9.8 17.4 9.3 13.8 9.5 10.5 14.1 25.0 5.2 6.1 8.6 12.7 13.9 10.0 7.9 3.7 9.1 7.6 5.4 7.1 22.3 20.4 7.4 18.8 6.8 9.0 19.7 6.9 12.5 17.0 0.0 1.2 0.0 3.5 0.9 1.5 1.6 1.6 2.0 1.9 1.3 1.2 2.7 0.3 2.1 1.1 4.1 2.7 1.3 6.6 7.8 6.2 11.9 8.4 6.4 6.2 6.5 7.9 5.7 3.0 2.1 1.4 0.6 1.0 1.0 4.5 0.0 0.0 1.2 3.5 0.0 1.9 1.7 1.4 3.2 0.9 1.8 0.0 1.2 9.5 2.0 0.5 1.1 0.8 4.1 1.6 0.0 2.5 1.8 7.0 0.3 1.0 1.7 1.0 1.6 1.5 1.0 0.0 1.1 1.4 0.3 0.0 1.4 12.0 7.5 1.3 2.4 0.8 1.3 0.7 CENPP "CENP-P, RP11-19J3.3" ENSG00000188312 "Centromere protein P" Q6IPU0 9 92325484-92620533 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 30.0" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 56.2;Suprabasal keratinocytes: 88.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021787, HPA058945" Uncertain Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA021787: AB_1846524, HPA058945: AB_2683860" "unprognostic (5.48e-2)" "prognostic favorable (3.91e-4)" "unprognostic (1.20e-1)" "unprognostic (2.43e-3)" "unprognostic (2.64e-2)" "prognostic favorable (3.65e-4)" "unprognostic (4.88e-5)" "unprognostic (8.06e-2)" "unprognostic (3.51e-3)" "unprognostic (1.49e-1)" "unprognostic (1.32e-1)" "unprognostic (6.68e-3)" "unprognostic (9.20e-8)" "unprognostic (1.27e-2)" "unprognostic (5.12e-2)" "unprognostic (1.11e-1)" "unprognostic (2.04e-1)" 5.0 5.1 6.8 8.9 8.8 15.5 4.9 14.9 7.4 6.0 3.8 3.5 1.4 4.5 6.4 4.1 8.4 3.6 4.6 4.3 5.4 4.6 3.5 3.2 3.5 7.8 6.1 4.5 4.6 7.5 7.8 9.4 5.3 6.8 4.8 4.5 5.5 5.0 2.8 11.8 30.0 3.2 4.8 4.4 5.4 3.0 8.7 6.5 14.8 3.0 7.4 9.1 4.4 8.0 6.7 4.8 4.1 10.3 5.1 8.2 4.0 7.9 5.0 7.1 5.1 2.9 3.2 6.7 8.4 4.7 10.5 8.4 2.3 4.6 10.1 3.9 2.7 9.7 9.6 6.8 4.6 9.8 14.4 8.0 10.3 4.5 3.3 1.5 21.1 10.0 3.4 2.6 10.2 6.6 1.4 5.3 10.0 11.1 14.7 8.0 5.0 29.6 6.4 5.7 15.0 9.5 10.0 11.6 11.3 1.6 8.0 15.8 5.5 9.5 6.1 3.0 5.3 3.2 6.5 2.5 10.3 5.1 15.5 12.0 9.8 11.4 13.3 11.5 10.5 9.3 3.0 3.2 4.1 4.9 10.3 8.2 6.7 5.3 4.1 3.6 5.7 5.0 4.8 0.8 5.1 5.1 4.8 5.7 4.0 6.8 8.8 14.9 7.4 5.4 4.6 6.1 4.5 6.8 6.5 0.0 0.3 1.5 3.6 56.2 6.4 2.0 2.5 0.0 1.2 0.0 7.9 2.7 1.7 0.9 15.3 3.1 0.7 0.0 2.0 8.2 5.6 2.1 0.0 0.8 13.9 1.6 1.2 1.3 1.3 3.6 4.0 3.0 13.5 0.0 0.6 2.5 1.2 0.0 4.6 1.1 7.5 6.5 6.7 11.1 5.7 88.2 3.2 4.3 1.7 2.4 CENPQ "C6orf139, CENP-Q, FLJ10545" ENSG00000031691 "Centromere protein Q" Q7L2Z9 6 49463378-49493107 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029043, HPA046634, HPA054965" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA029043: AB_2672881, HPA046634: AB_2679728, HPA054965: AB_2682653" "unprognostic (7.39e-2)" "unprognostic (7.33e-2)" "unprognostic (1.37e-2)" "prognostic unfavorable (4.64e-4)" "unprognostic (2.49e-2)" "unprognostic (1.40e-1)" "prognostic unfavorable (2.21e-5)" "unprognostic (1.36e-1)" "unprognostic (1.76e-2)" "prognostic favorable (6.26e-4)" "unprognostic (2.89e-1)" "unprognostic (8.19e-2)" "unprognostic (1.48e-3)" "unprognostic (8.93e-2)" "unprognostic (7.47e-2)" "unprognostic (2.74e-3)" "unprognostic (2.56e-1)" 7.2 7.6 10.4 11.2 15.4 6.4 8.7 10.9 11.4 6.6 5.8 6.4 5.8 4.2 7.5 7.1 12.1 6.4 5.4 10.0 11.5 9.3 7.6 6.8 5.8 10.0 19.8 7.7 10.4 4.8 4.6 8.9 9.1 15.3 7.4 7.5 2.7 5.5 5.4 6.9 6.1 5.1 7.0 18.7 8.8 5.6 8.8 18.3 15.1 6.0 9.1 12.7 9.5 6.4 7.8 5.0 7.2 3.1 4.4 5.6 2.3 16.4 4.6 14.7 9.1 4.0 6.3 13.0 21.4 12.3 20.6 29.0 5.6 6.7 11.2 10.7 6.0 16.1 6.0 7.6 7.7 30.5 12.1 10.7 8.2 7.4 9.0 1.7 17.4 10.4 2.8 4.3 25.2 8.8 5.3 7.5 9.8 12.6 11.2 15.2 4.7 12.2 8.2 9.1 14.4 4.2 8.8 17.4 12.1 6.0 6.8 7.9 7.9 10.0 6.0 11.2 15.2 7.7 16.0 4.4 16.0 12.4 12.5 19.0 5.1 13.2 10.0 10.8 13.1 15.4 4.1 2.2 7.2 4.0 2.7 4.2 7.6 4.3 4.6 2.5 7.8 4.7 4.5 1.6 4.4 3.1 5.0 5.6 2.3 10.4 15.4 10.9 11.4 11.5 9.3 19.8 7.7 15.3 18.3 0.0 2.4 6.7 8.9 7.7 5.4 5.1 7.6 10.7 3.4 7.0 2.0 12.0 6.6 7.0 1.0 6.3 1.6 0.0 6.9 23.5 8.4 4.8 4.6 2.8 8.8 6.4 2.4 13.5 10.8 1.9 8.1 5.5 3.3 7.2 2.7 12.4 6.0 3.6 10.3 3.1 5.0 6.5 5.1 16.8 28.6 6.0 10.4 6.4 4.5 5.4 CENPU "CENP-50, CENP-U, KLIP1, MLF1IP, PBIP1" ENSG00000151725 "Centromere protein U" Q71F23 4 184694618-184734133 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 30.7;lymphoid tissue: 30.0;testis: 50.2" "Cell type enhanced" "Detected in many" 18 "Early spermatids: 353.4;Late spermatids: 668.4;Spermatocytes: 448.9;Spermatogonia: 166.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 14.1;eosinophil: 14.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 14.3" "Cell line enhanced" "Detected in many" "Karpas-707: 58.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA022048 Supported "Nucleoplasm,Centriolar satellite" NA NA "Nucleoplasm, Centriolar satellite" "HPA022048: AB_1853985" "unprognostic (1.47e-1)" "unprognostic (9.88e-2)" "unprognostic (5.02e-2)" "unprognostic (2.37e-1)" "unprognostic (9.45e-2)" "unprognostic (4.97e-2)" "unprognostic (4.39e-3)" "prognostic unfavorable (7.51e-4)" "unprognostic (1.67e-3)" "unprognostic (3.34e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (7.27e-2)" "prognostic unfavorable (1.11e-9)" "unprognostic (2.19e-2)" "unprognostic (7.40e-3)" "unprognostic (4.46e-2)" "unprognostic (2.74e-1)" 2.7 1.7 1.4 7.8 1.0 30.7 3.1 1.2 1.3 2.8 4.4 1.2 2.9 2.8 1.4 3.2 11.2 0.9 1.7 1.0 1.2 0.6 1.4 2.3 2.0 9.5 1.3 0.2 1.1 1.3 0.7 0.6 7.0 1.0 2.0 5.1 0.9 3.5 0.5 1.2 7.1 5.2 1.5 1.0 5.8 2.3 50.2 0.6 30.0 0.9 7.3 9.1 1.6 4.5 0.8 1.7 14.3 2.8 3.0 2.5 0.7 23.3 6.6 28.4 14.3 1.5 2.5 15.1 14.1 6.3 11.6 8.0 7.9 13.5 19.5 1.3 6.6 8.9 9.4 23.4 14.4 11.8 9.4 9.3 16.8 6.0 4.0 0.2 29.6 11.7 1.2 0.7 14.2 2.7 3.9 12.0 20.2 18.4 58.6 21.6 15.5 38.0 18.9 15.0 5.6 8.9 30.1 9.2 5.7 6.4 9.0 20.1 21.4 10.2 13.1 10.7 12.1 18.0 16.2 7.2 10.4 13.5 10.6 16.2 8.7 8.7 16.0 14.5 23.0 33.9 14.1 0.7 14.3 0.6 1.9 0.4 0.8 1.0 1.0 0.5 0.8 0.6 0.8 0.1 3.0 2.8 1.7 2.5 0.7 1.4 1.0 1.2 1.3 1.2 0.6 1.3 0.2 1.0 0.6 8.9 2.7 6.0 3.6 12.4 0.9 2.4 2.5 6.7 10.3 1.8 0.0 13.0 3.3 4.4 353.4 0.7 1.1 23.3 2.2 45.0 5.2 2.9 9.2 0.8 18.2 0.0 0.0 1.3 5.4 668.4 8.3 9.9 0.0 7.2 5.6 0.3 2.7 0.0 6.3 0.6 1.3 19.4 1.0 448.9 166.7 18.7 6.3 4.4 8.5 5.4 CENPV "CENP-V, p30, PRR6" ENSG00000166582 "Centromere protein V" Q7Z7K6 17 16342534-16353656 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Paneth cells: 96.8;Spermatogonia: 116.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 3.6;memory B-cell: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 33.0;HEK 293: 27.0;JURKAT: 32.1;NTERA-2: 32.4" "Low region specificity" "Detected in all" "HPA042529, HPA042616" Enhanced Approved Nucleoplasm,Midbody,Cytosol Yes No Nucleoplasm "Midbody, Cytosol" "HPA042529: AB_10793882, HPA042616: AB_10794050" "unprognostic (7.64e-2)" "unprognostic (4.41e-2)" "unprognostic (5.92e-2)" "unprognostic (9.66e-3)" "unprognostic (1.16e-1)" "unprognostic (1.32e-1)" "unprognostic (2.24e-1)" "unprognostic (6.47e-2)" "unprognostic (1.21e-1)" "unprognostic (4.00e-2)" "unprognostic (7.73e-3)" "unprognostic (7.93e-2)" "unprognostic (4.09e-3)" "unprognostic (2.58e-1)" "unprognostic (1.89e-2)" "unprognostic (2.54e-2)" "unprognostic (3.60e-3)" 4.6 5.6 13.7 4.0 14.7 6.2 6.6 12.0 17.3 4.2 19.5 6.7 2.8 13.6 8.0 5.5 1.3 9.1 3.5 5.7 10.2 10.1 5.2 14.6 2.5 2.3 7.8 11.8 9.1 5.9 3.7 7.3 2.2 5.8 4.6 11.5 2.4 1.6 6.4 25.4 0.9 29.1 6.1 7.3 1.5 18.0 10.6 6.1 22.5 4.0 2.9 2.1 3.2 2.3 3.3 1.0 3.6 0.0 0.0 1.0 0.3 3.1 6.2 33.0 16.6 0.9 0.8 5.7 2.6 2.6 8.3 6.4 6.2 1.4 12.6 5.3 1.9 1.5 0.9 21.3 0.2 5.2 0.0 27.0 2.9 1.6 12.2 9.3 3.0 0.0 2.4 0.8 10.0 5.8 0.9 4.6 32.1 5.1 0.0 2.4 0.5 23.6 10.0 32.4 20.5 0.0 17.0 1.2 1.4 1.9 4.7 17.7 13.5 6.6 0.1 1.5 15.9 0.1 7.4 0.3 0.0 2.7 0.3 0.0 0.0 0.0 7.3 0.0 4.1 0.2 0.0 0.0 3.6 0.3 0.0 0.1 3.3 0.1 0.1 0.7 0.3 1.0 0.9 0.0 0.0 0.0 1.0 0.2 0.3 13.7 14.7 12.0 17.3 10.2 10.1 7.8 11.8 5.8 6.1 0.0 2.4 6.0 17.3 0.9 40.2 3.7 28.1 4.0 6.8 1.8 3.9 11.5 26.6 7.1 12.4 3.6 48.0 0.0 20.1 10.7 2.9 19.6 5.7 43.9 5.4 11.1 37.8 1.3 2.2 6.1 8.1 2.7 8.5 1.0 52.7 28.8 13.5 96.8 11.0 31.1 13.8 25.8 15.6 48.8 116.2 2.3 5.4 4.3 71.8 42.2 CENPW "C6orf173, CUG2" ENSG00000203760 "Centromere protein W" Q5EE01 6 126340174-126348875 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 43.2" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 184.2;Extravillous trophoblasts: 133.8;Spermatocytes: 97.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA067285 Supported Nucleoplasm NA NA Nucleoplasm "HPA067285: AB_2685818" "unprognostic (3.51e-3)" "unprognostic (2.35e-1)" "unprognostic (3.26e-3)" "unprognostic (9.61e-3)" "unprognostic (3.78e-1)" "unprognostic (9.80e-3)" "prognostic unfavorable (1.21e-5)" "unprognostic (1.11e-2)" "unprognostic (2.82e-2)" "unprognostic (9.07e-2)" "unprognostic (5.86e-3)" "unprognostic (1.08e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.07e-1)" "unprognostic (1.85e-1)" "unprognostic (2.30e-1)" "unprognostic (1.22e-1)" 5.5 3.3 3.3 14.8 2.6 27.1 5.2 1.4 4.9 9.9 9.6 1.3 7.7 5.3 17.4 12.4 16.8 5.9 3.5 2.2 5.3 1.5 2.9 2.7 4.0 9.1 1.3 4.5 4.8 1.7 0.0 2.0 4.8 1.6 4.7 11.7 1.8 6.5 2.9 2.1 5.8 7.0 10.5 1.8 5.5 5.0 43.2 0.8 28.6 2.0 21.4 17.0 4.6 7.9 5.2 14.6 2.6 15.2 5.6 8.9 5.0 20.6 14.1 26.6 23.6 3.0 3.2 23.2 16.5 11.9 23.1 28.1 42.5 13.9 24.5 15.0 10.4 36.6 25.5 21.8 26.3 32.2 28.1 40.4 23.7 36.3 44.7 0.9 34.2 17.5 1.8 3.0 19.1 14.2 6.5 24.4 33.3 39.2 15.6 19.0 33.5 27.9 56.4 16.3 17.8 21.4 29.7 18.2 17.0 10.2 9.2 28.8 12.9 14.0 12.6 18.7 22.5 12.5 33.4 13.6 21.2 23.3 29.5 45.3 11.0 21.0 43.6 12.7 43.7 25.2 2.6 13.2 1.8 1.7 15.2 0.6 5.2 3.7 3.4 12.3 2.3 2.9 2.4 2.5 5.6 10.1 14.6 8.9 5.0 3.3 2.6 1.4 4.9 5.3 1.5 1.3 4.5 1.6 0.8 0.0 1.6 16.4 7.3 33.8 1.4 0.3 10.2 0.0 4.5 1.8 2.0 26.4 5.0 14.3 184.2 5.6 11.8 70.0 15.8 133.8 19.2 8.6 13.8 5.7 55.0 3.2 7.5 11.6 18.0 15.9 17.8 25.1 8.5 12.6 13.0 2.2 12.7 11.5 8.5 0.9 1.1 0.0 9.2 97.1 73.0 25.3 17.7 4.5 21.3 31.8 CEP112 "CCDC46, MGC33887" ENSG00000154240 "Centrosomal protein 112" Q8N8E3 17 65635538-66192084 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 39.5" "Group enriched" "Detected in many" 7 "Early spermatids: 912.3;Late spermatids: 1163.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "LHCN-M2: 17.0;RH-30: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024481 Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA024481: AB_1846153" "unprognostic (9.35e-2)" "unprognostic (3.08e-2)" "unprognostic (2.93e-1)" "unprognostic (6.21e-2)" "unprognostic (1.06e-2)" "unprognostic (4.11e-3)" "unprognostic (1.43e-2)" "unprognostic (7.99e-2)" "unprognostic (4.48e-3)" "unprognostic (3.37e-2)" "unprognostic (1.39e-3)" "unprognostic (3.50e-2)" "unprognostic (4.46e-3)" "unprognostic (1.02e-2)" "unprognostic (1.26e-1)" "unprognostic (3.52e-2)" "unprognostic (2.71e-1)" 10.0 3.8 6.0 9.0 8.3 1.7 9.6 2.9 6.5 11.5 6.7 1.9 14.9 1.9 8.8 10.2 4.3 6.9 6.6 7.4 5.9 4.3 5.2 2.9 6.9 2.2 4.3 3.4 7.7 4.3 8.4 28.3 6.6 6.8 8.6 3.2 7.2 2.9 13.9 9.5 3.1 2.9 9.8 7.4 7.9 4.5 39.5 4.3 4.2 6.8 6.9 1.8 6.6 13.6 3.0 4.1 4.3 1.3 2.9 2.7 0.5 2.5 5.3 7.0 2.0 3.8 7.8 0.2 2.3 4.1 2.9 2.7 0.7 1.1 0.9 2.3 5.1 8.3 0.3 1.5 1.5 4.2 1.4 2.4 0.1 2.3 0.9 1.7 0.3 0.1 4.6 2.6 2.7 0.8 5.9 8.9 1.4 0.1 2.7 17.0 0.3 2.6 0.2 0.7 0.5 2.2 0.7 40.1 0.2 3.2 0.1 1.9 3.9 2.5 0.2 1.8 6.4 2.0 0.2 3.9 7.8 4.4 2.0 3.5 1.2 1.0 0.1 2.4 0.1 2.8 2.9 1.3 1.1 1.1 0.6 1.9 1.0 2.7 1.2 0.7 3.0 1.7 1.4 4.3 2.9 0.8 4.1 1.7 0.5 6.0 8.3 2.9 6.5 5.9 4.3 4.3 3.4 6.8 4.3 8.9 27.3 0.8 2.4 2.3 21.5 23.0 2.5 37.5 26.1 1.8 19.6 0.6 1.7 5.2 912.3 18.7 0.0 0.0 4.1 1.2 8.5 1.8 2.3 0.2 1.4 1.6 1.7 8.6 0.6 1163.2 23.0 4.4 13.5 0.0 0.0 14.1 4.6 0.0 18.7 2.8 150.6 12.9 7.2 22.8 13.1 1.4 0.1 0.9 1.5 1.4 CEP126 KIAA1377 ENSG00000110318 "Centrosomal protein 126" Q9P2H0 11 101915015-102001058 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 47.3" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 254.3;Horizontal cells: 96.9;Spermatocytes: 115.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 10.0;EFO-21: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038381, HPA038399" Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA038381: AB_10669780, HPA038399: AB_10670157" "unprognostic (7.61e-2)" "unprognostic (6.75e-2)" "unprognostic (9.07e-2)" "unprognostic (1.02e-2)" "unprognostic (9.31e-2)" "unprognostic (8.87e-2)" "unprognostic (1.55e-4)" "unprognostic (1.52e-2)" "unprognostic (5.77e-2)" "unprognostic (9.55e-2)" "unprognostic (7.72e-3)" "unprognostic (8.87e-2)" "prognostic unfavorable (5.00e-4)" "unprognostic (1.30e-2)" "unprognostic (3.41e-1)" "unprognostic (9.61e-2)" "unprognostic (6.99e-3)" 7.6 11.1 9.0 2.4 20.2 2.4 8.3 16.8 14.8 7.9 4.2 5.0 4.2 2.0 9.1 6.7 5.3 17.5 4.9 4.5 9.6 8.3 3.8 1.4 6.1 3.3 7.5 10.2 11.4 5.0 6.4 47.3 2.6 12.4 6.6 4.8 3.2 3.2 7.6 2.3 8.5 2.7 7.3 9.2 3.1 4.0 19.2 8.9 0.5 7.4 1.5 2.5 3.9 9.7 2.5 4.8 1.4 0.5 3.3 2.0 0.5 0.9 2.2 1.1 1.3 10.0 5.5 0.5 2.1 1.8 1.0 0.9 0.6 3.0 1.3 9.5 1.9 4.4 0.9 1.3 2.4 0.9 3.1 1.5 0.3 3.7 1.2 1.1 0.2 0.3 1.9 4.7 1.3 2.8 5.1 3.0 1.3 0.3 0.4 2.5 1.1 1.1 0.3 0.8 1.1 1.7 0.2 1.1 0.2 2.0 1.2 2.7 4.2 1.3 1.9 0.3 2.0 3.7 0.4 1.7 3.3 1.9 1.0 2.2 2.2 1.2 0.2 3.2 0.3 1.3 0.7 0.5 1.0 2.0 0.1 0.9 1.8 1.2 1.6 0.4 2.5 1.7 1.7 1.4 3.3 0.2 4.8 0.3 0.5 9.0 20.2 16.8 14.8 9.6 8.3 7.5 10.2 12.4 8.9 8.9 7.0 0.5 4.6 0.0 17.6 7.5 5.1 254.3 43.3 17.4 43.2 1.2 3.3 2.0 13.5 3.0 0.0 0.0 0.3 0.7 3.5 2.8 0.0 0.0 0.3 96.9 64.4 3.1 0.0 6.9 49.8 1.4 0.0 0.0 10.3 26.8 1.0 0.0 48.1 4.4 47.8 6.5 1.6 115.1 25.4 0.0 0.1 7.0 1.3 2.0 CEP162 "C6orf84, KIAA1009, QN1" ENSG00000135315 "Centrosomal protein 162" Q5TB80 6 84124241-84227635 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 72.3;Early spermatids: 103.7;Spermatocytes: 62.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030170, HPA030171, HPA030172, HPA030173" Supported Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA030170: AB_10611113, HPA030171: AB_10601567, HPA030172: AB_10602414, HPA030173: AB_10602206" "unprognostic (1.75e-1)" "unprognostic (1.46e-2)" "unprognostic (1.64e-1)" "unprognostic (1.26e-2)" "unprognostic (1.06e-1)" "unprognostic (1.63e-3)" "unprognostic (2.95e-4)" "unprognostic (1.03e-1)" "unprognostic (6.73e-2)" "unprognostic (1.21e-3)" "unprognostic (1.57e-3)" "unprognostic (3.98e-2)" "unprognostic (2.87e-3)" "unprognostic (3.27e-2)" "unprognostic (6.32e-2)" "unprognostic (3.58e-1)" "unprognostic (1.44e-3)" 5.9 4.3 4.2 5.3 6.0 3.8 5.4 9.4 7.8 6.4 6.3 4.8 6.6 2.1 9.1 4.4 4.1 7.2 5.2 4.0 4.5 2.6 7.7 2.6 5.3 4.6 4.8 3.2 7.9 4.1 9.6 19.1 4.5 5.8 4.7 4.9 2.7 5.5 4.6 4.1 4.1 4.2 6.4 7.6 5.8 4.9 14.4 6.4 11.6 7.7 2.1 4.2 7.3 5.4 2.5 1.8 2.2 1.3 0.1 2.6 0.8 2.9 1.3 8.8 9.5 5.2 7.8 5.5 3.3 3.2 4.7 5.8 3.8 4.0 3.2 3.2 2.6 8.4 4.6 5.1 3.1 7.5 8.1 3.6 5.8 5.9 2.8 2.9 6.3 5.6 3.6 2.3 4.8 1.8 6.3 5.2 4.8 11.8 3.7 3.4 1.5 1.6 4.1 5.8 2.1 2.1 9.0 11.3 1.7 3.5 2.7 6.0 7.5 2.4 1.4 2.5 6.6 3.1 4.6 4.2 4.7 4.2 4.1 3.7 2.9 3.9 1.9 2.9 3.5 5.8 0.0 1.3 1.5 1.9 1.2 2.6 2.5 1.5 1.7 0.7 1.6 1.2 2.0 2.2 0.1 1.0 1.8 0.3 0.8 4.2 6.0 9.4 7.8 4.5 2.6 4.8 3.2 5.8 6.4 29.8 14.5 5.0 6.4 0.0 5.2 7.6 0.0 72.3 12.5 8.7 11.8 5.8 5.0 10.5 103.7 6.3 5.1 23.3 6.2 4.6 5.0 3.5 17.4 2.6 4.7 27.0 10.9 8.6 5.6 39.3 10.9 6.1 0.0 1.8 4.5 11.2 5.3 14.0 11.3 5.0 13.8 12.9 3.6 62.7 22.4 0.0 3.2 7.5 5.2 3.3 CEP164 "KIAA1052, NPHP15" ENSG00000110274 "Centrosomal protein 164" Q9UPV0 11 117314557-117413268 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation, DNA damage, DNA repair, Mitosis" "Ciliopathy, Disease mutation, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 428.0;Early spermatids: 226.1;Late spermatids: 212.9;Rod photoreceptor cells: 288.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037605, HPA037606" Uncertain Supported Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA037605: AB_10672908, HPA037606: AB_10672498" "unprognostic (1.92e-1)" "unprognostic (8.99e-2)" "unprognostic (7.98e-2)" "unprognostic (1.14e-1)" "unprognostic (1.47e-1)" "unprognostic (1.00e-1)" "prognostic unfavorable (2.40e-5)" "unprognostic (1.82e-1)" "unprognostic (3.14e-2)" "unprognostic (1.90e-1)" "prognostic favorable (5.93e-4)" "unprognostic (6.54e-2)" "prognostic unfavorable (2.89e-5)" "unprognostic (1.30e-1)" "unprognostic (1.51e-1)" "unprognostic (2.13e-1)" "unprognostic (7.93e-2)" 7.1 6.8 7.8 11.2 10.4 7.0 7.2 17.4 7.8 10.5 6.8 9.1 11.2 4.7 17.4 9.4 9.7 12.9 12.1 4.6 6.9 6.8 7.1 7.2 7.3 7.7 7.4 8.3 13.9 28.1 10.8 19.1 5.1 8.2 7.4 5.8 16.4 6.9 7.6 3.1 8.3 6.2 11.5 10.4 9.7 6.3 29.7 8.3 10.8 9.6 5.0 14.4 8.0 8.0 18.0 21.1 36.5 16.6 11.8 21.4 4.3 9.0 12.6 9.3 18.4 9.4 16.0 3.0 17.9 10.1 12.9 12.7 15.5 14.7 17.9 13.0 11.0 12.7 12.0 10.3 10.5 11.1 17.7 8.5 5.4 12.4 4.9 13.8 7.7 12.1 11.1 9.0 19.5 19.1 11.6 16.7 8.9 14.6 11.7 10.1 7.8 7.1 7.0 6.6 5.9 13.7 9.6 11.1 7.0 5.7 7.8 10.8 15.7 14.3 8.7 10.3 10.9 12.0 9.1 18.0 15.4 9.6 14.8 16.4 4.2 5.0 10.6 7.5 8.8 10.2 30.7 15.7 9.4 15.9 12.9 10.1 15.2 20.0 17.9 5.8 18.0 18.9 15.1 36.5 11.8 16.6 21.1 21.4 4.3 7.8 10.4 17.4 7.8 6.9 6.8 7.4 8.3 8.2 8.3 6.0 16.2 12.3 9.5 6.8 78.2 4.2 7.6 37.5 11.4 10.4 428.0 3.8 1.7 9.8 226.1 15.7 5.1 0.0 12.7 5.7 11.2 7.3 18.5 8.1 11.2 69.9 14.9 8.6 6.9 212.9 22.2 10.3 5.0 18.0 8.8 21.5 9.9 5.8 15.9 4.5 288.7 0.0 13.7 36.7 17.4 7.0 1.8 15.9 9.3 4.7 CEP63 FLJ13386 ENSG00000182923 "Centrosomal protein 63" Q96MT8 3 134485743-134575017 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, Mitosis" "Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 54.1" "Lineage enriched" "Detected in all" 7 "granulocytes: 54.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058154, HPA058313" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA058154: AB_2683624, HPA058313: " "unprognostic (1.80e-1)" "unprognostic (1.03e-2)" "unprognostic (2.13e-1)" "unprognostic (1.38e-2)" "unprognostic (1.12e-1)" "unprognostic (2.08e-1)" "unprognostic (1.60e-2)" "unprognostic (2.23e-2)" "unprognostic (2.71e-2)" "unprognostic (1.32e-1)" "unprognostic (1.71e-1)" "unprognostic (3.08e-2)" "unprognostic (5.24e-2)" "unprognostic (5.75e-2)" "unprognostic (1.05e-1)" "unprognostic (1.66e-1)" "unprognostic (1.33e-1)" 21.6 15.4 17.7 17.1 18.1 25.3 16.5 19.7 22.6 13.8 15.4 14.5 18.8 9.1 13.7 17.6 15.1 12.2 12.3 25.6 17.2 15.0 15.2 20.5 12.4 15.7 20.4 15.7 16.7 17.8 21.8 23.1 13.5 20.0 16.7 14.5 11.1 15.5 17.4 38.1 15.0 11.3 20.2 20.2 15.3 13.9 37.2 21.5 21.7 18.3 14.9 16.3 17.3 19.9 6.1 7.2 54.1 8.2 5.9 5.6 3.5 17.2 7.7 14.6 9.5 21.3 18.1 13.7 18.7 15.4 15.0 12.7 6.1 7.4 19.6 12.0 13.5 14.5 10.3 7.5 10.4 18.2 21.9 4.0 25.3 8.3 8.6 14.7 16.0 11.8 15.7 13.8 8.0 26.7 16.9 14.8 27.4 7.5 17.1 17.6 11.6 19.1 19.1 10.4 11.1 9.1 12.4 21.6 28.0 12.8 10.8 8.6 8.2 16.8 6.6 25.2 18.3 13.5 21.8 16.8 17.0 10.1 16.1 13.8 15.8 10.9 25.2 18.2 17.1 21.5 18.1 6.0 9.9 4.0 6.2 5.4 4.8 3.9 5.1 7.2 6.1 5.6 4.2 54.1 5.9 8.2 4.8 4.8 3.5 17.7 18.1 19.7 22.6 17.2 15.0 20.4 15.7 20.0 21.5 17.9 25.9 21.5 13.0 9.5 30.0 76.9 20.4 45.5 27.3 7.0 19.6 22.1 26.6 22.3 64.2 20.4 10.5 0.0 17.7 22.5 17.3 16.0 50.8 13.9 24.8 30.2 12.6 15.4 22.3 37.5 22.2 24.5 16.9 20.8 15.3 24.6 18.7 17.5 24.4 22.3 42.3 19.4 18.4 95.2 46.4 8.5 14.5 12.7 15.0 12.3 CEP68 KIAA0582 ENSG00000011523 "Centrosomal protein 68" Q76N32 2 65056366-65087004 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040493, HPA040620" Enhanced Supported "Nucleoplasm,Centriolar satellite" NA NA "Nucleoplasm, Centriolar satellite" "HPA040493: AB_10673411, HPA040620: AB_10794144" "unprognostic (7.99e-2)" "unprognostic (6.15e-2)" "unprognostic (5.09e-2)" "unprognostic (4.90e-3)" "unprognostic (1.31e-2)" "unprognostic (1.75e-2)" "unprognostic (4.84e-3)" "unprognostic (8.25e-3)" "unprognostic (9.94e-2)" "unprognostic (5.09e-2)" "unprognostic (9.22e-2)" "unprognostic (1.77e-1)" "prognostic favorable (3.93e-4)" "unprognostic (2.25e-1)" "unprognostic (2.50e-1)" "unprognostic (8.45e-2)" "unprognostic (1.71e-1)" 18.4 7.3 12.7 9.2 17.0 5.0 16.2 24.8 22.2 19.2 13.2 11.9 8.5 6.6 20.0 10.4 11.7 16.9 12.7 15.7 12.5 11.9 8.4 3.3 9.2 10.6 11.3 17.6 26.4 10.6 13.2 7.5 11.8 15.0 14.2 8.6 11.6 12.0 15.4 28.2 13.6 8.7 17.3 10.3 10.2 9.7 7.6 7.8 10.3 11.6 12.9 9.9 13.4 13.0 5.1 8.7 1.5 5.5 5.2 11.1 3.0 2.8 5.1 9.9 7.2 8.9 10.1 18.2 2.7 4.8 4.2 3.7 3.9 2.5 4.8 3.4 4.9 4.3 3.9 6.5 4.1 4.5 5.8 5.5 6.5 1.8 4.7 2.5 3.7 4.7 9.5 5.9 3.8 5.4 7.5 12.0 10.1 6.0 15.5 5.3 3.3 6.1 6.7 10.0 5.2 4.1 6.5 12.0 5.6 3.7 3.8 17.5 11.9 5.4 4.0 5.7 6.4 2.3 2.4 4.7 4.0 5.5 6.2 2.7 17.0 4.7 11.3 2.1 2.9 4.8 1.0 1.7 0.4 3.0 3.1 3.4 3.4 7.0 5.6 4.3 5.1 11.1 6.6 1.5 5.2 5.5 8.7 5.1 3.0 12.7 17.0 24.8 22.2 12.5 11.9 11.3 17.6 15.0 7.8 26.8 10.4 11.5 13.0 6.4 22.8 13.2 5.1 21.4 20.5 8.7 23.6 13.1 8.3 8.8 2.8 39.8 2.7 0.0 18.9 6.3 11.3 5.9 5.8 5.4 8.4 22.3 12.6 17.2 7.9 4.1 35.1 14.4 6.8 26.2 5.7 14.7 10.1 3.5 25.5 7.5 21.7 32.3 11.4 10.7 23.0 5.1 28.5 12.8 10.6 6.3 CEP70 "BITE, FLJ13036" ENSG00000114107 "Centrosomal protein 70" Q8NHQ1 3 138494344-138594538 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 163.4;Late spermatids: 214.6;Spermatocytes: 140.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "gdT-cell: 4.2;MAIT T-cell: 5.0;memory B-cell: 2.9;memory CD4 T-cell: 3.4;memory CD8 T-cell: 3.7;naive B-cell: 2.0;naive CD4 T-cell: 5.9;naive CD8 T-cell: 6.4;NK-cell: 3.6;T-reg: 2.0" "Group enriched" "Detected in many" 8 "B-cells: 2.9;NK-cells: 3.6;T-cells: 6.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036941, HPA036942" Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA036941: AB_10670567, HPA036942: AB_10670957" "unprognostic (1.61e-1)" "prognostic favorable (2.93e-4)" "unprognostic (2.27e-2)" "unprognostic (3.59e-2)" "unprognostic (3.31e-2)" "unprognostic (3.44e-2)" "unprognostic (1.95e-2)" "unprognostic (9.92e-3)" "unprognostic (9.04e-2)" "unprognostic (4.25e-2)" "unprognostic (5.01e-3)" "prognostic unfavorable (9.60e-5)" "unprognostic (8.90e-3)" "unprognostic (8.07e-3)" "unprognostic (1.46e-1)" "unprognostic (8.71e-3)" "unprognostic (6.43e-2)" 5.5 8.3 11.0 5.7 15.8 3.5 9.0 14.7 15.6 20.8 12.2 7.1 22.8 35.7 14.0 14.8 10.2 20.3 8.9 11.3 10.9 15.9 17.0 18.8 11.5 4.2 12.6 10.2 14.4 17.4 16.6 27.8 2.7 14.4 14.3 12.1 12.6 6.1 28.7 10.6 4.6 11.5 14.0 19.1 3.9 8.6 41.5 15.3 24.2 26.2 6.7 4.5 13.3 9.1 2.9 0.2 0.5 0.1 3.6 6.4 2.0 21.6 4.5 10.7 13.0 6.7 7.5 10.0 4.3 8.1 6.0 8.9 6.3 11.8 5.1 10.3 8.0 22.8 9.6 9.7 8.6 13.5 9.0 6.4 14.6 10.5 8.2 10.5 0.7 5.4 40.3 5.0 4.5 11.2 16.0 8.6 16.8 10.6 17.1 9.8 8.2 15.3 0.8 6.3 5.7 10.2 16.9 13.9 13.1 11.4 9.7 13.0 8.5 22.5 5.4 25.5 12.8 27.1 7.1 5.0 4.4 8.4 9.0 5.2 15.9 8.7 17.4 9.8 1.4 15.0 0.4 0.1 0.2 4.2 0.1 5.0 2.9 3.4 3.7 0.1 2.0 5.9 6.4 0.5 3.6 0.0 0.2 2.0 2.0 11.0 15.8 14.7 15.6 10.9 15.9 12.6 10.2 14.4 15.3 29.8 54.7 0.8 31.2 8.7 15.6 23.2 17.8 48.2 38.7 19.2 33.4 5.9 61.3 18.3 163.4 7.1 4.6 0.0 15.5 3.6 6.2 27.5 19.7 12.4 2.2 20.6 15.0 4.9 0.8 214.6 9.2 3.3 10.1 1.0 9.5 19.7 13.7 7.0 12.0 17.0 29.1 6.5 11.8 140.5 9.1 7.0 8.0 4.9 22.3 24.8 CEP83 "CCDC41, NPHP18, NY-REN-58" ENSG00000173588 "Centrosomal protein 83" 12 94306449-94459988 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 88.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038161 Approved Uncertain "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA038161: AB_10674547" "unprognostic (4.98e-2)" "unprognostic (1.64e-2)" "unprognostic (7.22e-2)" "unprognostic (1.75e-2)" "unprognostic (4.76e-3)" "unprognostic (3.59e-2)" "unprognostic (5.44e-3)" "unprognostic (1.70e-1)" "unprognostic (2.24e-2)" "unprognostic (1.92e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (4.98e-4)" "prognostic unfavorable (5.00e-10)" "unprognostic (1.29e-2)" "unprognostic (7.83e-2)" "unprognostic (1.12e-2)" "unprognostic (1.95e-2)" 6.8 9.8 10.1 11.3 10.5 8.4 9.7 11.8 10.1 8.7 7.4 7.6 7.0 5.5 12.3 12.7 6.7 16.2 6.1 19.0 9.0 6.6 8.2 6.3 7.1 7.7 6.2 7.7 11.0 12.2 9.3 12.1 6.3 8.9 6.8 10.3 7.8 10.0 8.5 7.3 6.3 5.4 11.0 6.3 6.9 6.3 22.3 7.3 10.6 9.7 9.4 8.0 6.7 9.2 7.6 8.5 1.9 3.5 5.7 6.6 2.0 5.7 6.4 10.9 10.3 4.8 6.5 9.4 10.1 3.3 7.3 7.6 7.9 4.8 15.0 2.2 3.0 4.7 8.1 13.1 7.7 11.4 8.6 9.5 8.8 6.7 8.0 4.8 14.4 6.1 4.2 6.5 6.1 18.8 4.4 6.9 12.2 11.3 6.1 7.6 5.7 9.8 24.0 12.5 9.8 11.9 13.5 10.3 15.0 6.7 7.2 11.4 4.7 8.5 10.1 6.9 10.2 6.8 9.1 4.0 8.7 5.4 4.3 7.9 8.1 9.0 13.6 3.6 15.3 8.2 0.6 3.5 1.9 5.8 3.5 5.2 6.6 5.8 4.4 7.7 7.6 6.1 5.4 1.4 5.7 1.5 8.5 6.6 2.0 10.1 10.5 11.8 10.1 9.0 6.6 6.2 7.7 8.9 7.3 14.9 12.5 10.7 13.1 0.0 11.9 22.3 0.0 88.3 21.6 3.5 13.7 5.5 1.7 4.2 27.1 6.5 3.8 0.0 2.9 8.9 4.9 7.3 25.5 4.9 5.0 4.8 14.3 1.8 4.0 10.1 10.0 5.1 0.0 19.8 8.2 4.3 2.8 3.5 6.0 3.7 10.0 0.0 6.4 39.4 22.0 0.0 2.7 5.1 10.3 10.2 CEP95 "CCDC45, DKFZp667E1824" ENSG00000258890 "Centrosomal protein 95" Q96GE4 17 64506588-64542461 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 86.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023654, HPA052426, HPA052428, HPA061371" Approved Approved "Nucleoplasm,Vesicles,Mitotic spindle,Centrosome" Yes No Nucleoplasm "Vesicles, Mitotic spindle, Centrosome" "HPA023654: AB_2072077, HPA052426: AB_2681827, HPA052428: AB_2681829, HPA061371: AB_2684495" "unprognostic (1.28e-2)" "unprognostic (9.12e-2)" "unprognostic (3.66e-3)" "unprognostic (4.09e-2)" "unprognostic (3.30e-2)" "prognostic favorable (5.78e-4)" "prognostic unfavorable (2.52e-5)" "unprognostic (6.57e-3)" "unprognostic (7.88e-3)" "unprognostic (1.54e-1)" "unprognostic (1.64e-2)" "unprognostic (3.57e-3)" "prognostic unfavorable (5.76e-5)" "unprognostic (3.48e-1)" "unprognostic (1.84e-2)" "unprognostic (1.34e-1)" "unprognostic (1.79e-3)" 13.0 8.6 10.9 17.1 13.1 37.9 15.5 27.9 15.6 16.7 14.2 16.2 11.6 11.9 26.5 16.6 10.7 17.1 12.3 10.6 11.5 7.8 14.1 11.7 13.0 20.7 13.6 7.9 27.3 15.5 11.8 20.4 8.5 13.0 15.2 13.5 15.6 13.8 19.8 14.6 21.7 14.2 15.0 17.4 13.2 13.3 16.9 13.9 26.4 21.0 8.6 14.7 14.3 14.0 5.9 3.7 2.2 3.6 2.1 10.8 2.4 9.9 6.3 12.9 11.1 3.4 8.9 13.0 5.1 5.2 6.3 9.6 7.6 5.7 15.9 3.3 7.1 6.3 12.6 11.1 9.7 13.1 4.2 8.5 14.1 12.2 14.6 11.5 15.3 7.6 10.1 10.2 7.0 15.7 8.4 5.3 16.6 16.2 11.6 6.9 11.6 19.4 9.8 8.0 10.2 7.9 14.0 23.5 11.8 7.4 15.9 8.2 14.8 6.9 10.2 13.1 20.2 11.2 10.3 7.9 14.5 11.3 6.6 6.9 11.9 9.5 16.9 6.2 11.8 8.8 2.2 3.6 2.2 4.5 2.9 10.8 4.5 5.2 4.5 3.4 5.9 8.0 5.4 1.4 2.1 3.4 3.7 4.2 2.4 10.9 13.1 27.9 15.6 11.5 7.8 13.6 7.9 13.0 13.9 38.7 22.9 11.5 23.2 14.3 26.0 16.7 12.7 65.6 39.8 3.5 43.2 7.8 6.6 16.8 45.2 9.8 15.1 0.0 10.2 9.0 11.5 13.9 27.8 6.6 7.4 17.5 7.5 12.3 9.5 14.2 19.2 10.4 11.8 15.4 12.4 22.7 11.6 11.5 20.1 5.0 86.8 12.9 15.0 30.7 28.8 17.8 5.5 19.7 17.0 19.0 CERCAM "CEECAM1, CerCAM, GLT25D3" ENSG00000167123 "Cerebral endothelial cell adhesion molecule" Q5T4B2 9 128411751-128437351 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.1" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 48.9;Fibroblasts: 70.1;Melanocytes: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 5.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 55.6;ASC TERT1: 59.3;fHDF/TERT166: 50.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021657, HPA051595" Uncertain Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Intracellular and membrane" NA NA "Nucleoplasm, Nucleoli" "Cell Junctions" "HPA021657: AB_1846507, HPA051595: AB_2681545" "unprognostic (2.87e-2)" "unprognostic (1.37e-3)" "unprognostic (1.89e-3)" "unprognostic (2.19e-1)" "unprognostic (4.68e-3)" "unprognostic (7.79e-3)" "unprognostic (3.29e-3)" "unprognostic (5.68e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (5.22e-4)" "unprognostic (1.59e-1)" "unprognostic (5.93e-2)" "prognostic unfavorable (3.33e-16)" "unprognostic (1.34e-2)" "unprognostic (1.04e-1)" "unprognostic (6.05e-3)" "prognostic unfavorable (3.30e-5)" 12.7 5.1 40.0 7.2 65.5 1.6 9.0 10.0 62.1 19.1 6.9 61.2 5.0 4.8 11.4 10.9 8.2 6.0 17.3 8.8 72.8 34.7 4.9 1.8 5.3 2.3 59.5 28.1 14.1 18.8 15.8 21.6 27.4 31.4 11.1 5.2 3.5 13.2 13.6 4.3 8.9 6.0 27.7 78.1 3.3 5.4 5.2 62.1 0.0 6.7 2.4 2.7 15.1 6.6 0.3 2.0 0.3 1.6 1.1 5.3 2.2 9.5 6.1 6.9 7.3 55.6 59.3 5.9 30.9 29.2 8.1 6.1 2.2 0.4 0.0 12.7 50.4 6.9 6.5 3.0 4.1 3.1 2.4 4.9 0.5 5.6 3.3 17.0 1.1 17.3 32.8 2.2 8.8 2.1 33.5 9.1 0.6 2.8 7.6 10.5 18.1 0.4 11.7 0.4 0.4 4.7 0.9 4.8 1.3 3.8 3.6 1.0 1.9 6.9 8.4 3.5 2.3 6.8 2.3 10.1 21.6 5.9 29.6 4.7 8.9 6.9 0.1 20.4 3.4 4.2 0.3 1.1 0.1 3.8 1.6 0.3 0.3 0.3 4.7 1.5 0.1 0.1 5.3 0.3 1.1 0.1 2.0 0.0 2.2 40.0 65.5 10.0 24.5 72.8 34.7 59.5 28.1 31.4 62.1 6.0 13.0 0.0 6.2 7.9 1.1 3.2 0.0 6.7 21.6 10.4 0.0 14.3 0.0 10.7 2.0 7.1 0.0 0.0 2.9 48.9 70.1 3.9 8.1 0.0 5.9 6.4 0.0 18.4 0.6 1.5 22.5 4.7 38.8 1.0 0.0 0.1 6.9 0.0 24.8 0.5 0.7 6.5 15.6 1.0 19.0 3.6 16.4 2.5 0.0 2.0 CERKL RP26 ENSG00000188452 "Ceramide kinase like" Q49MI3 2 181536676-181680665 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.5" "Cell type enhanced" "Detected in some" 21 "Ciliated cells: 52.2;Cone photoreceptor cells: 17.7;Rod photoreceptor cells: 20.6" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 11 "cerebellum: 49.5;pons and medulla: 13.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 26.5;HL-60: 14.7;JURKAT: 17.0;MOLT-4: 35.5;NB-4: 31.3;SCLC-21H: 23.9;THP-1: 14.8" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 31.8" "HPA035443, HPA035444, HPA043203" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA035443: AB_2674625, HPA035444: AB_10672093, HPA043203: " "unprognostic (7.52e-3)" "unprognostic (6.13e-3)" "unprognostic (2.09e-1)" "unprognostic (3.92e-3)" "unprognostic (4.46e-1)" "unprognostic (2.71e-3)" "unprognostic (2.59e-1)" "unprognostic (1.39e-2)" "unprognostic (2.76e-1)" "unprognostic (2.27e-1)" "prognostic favorable (5.25e-4)" "unprognostic (4.54e-2)" "prognostic unfavorable (2.10e-4)" "unprognostic (1.37e-1)" "unprognostic (3.65e-2)" "unprognostic (3.07e-2)" "unprognostic (8.45e-2)" 1.2 0.6 1.2 9.2 2.0 14.4 1.1 49.5 2.5 3.7 1.7 4.2 0.4 3.1 1.0 5.3 0.6 5.8 4.1 0.5 2.9 1.3 8.1 1.3 5.0 13.8 0.6 1.4 2.9 0.8 0.1 2.1 2.0 13.7 1.0 0.0 6.8 1.0 0.4 0.5 0.5 6.4 0.4 1.0 17.9 2.8 1.1 1.1 0.4 0.9 0.4 1.1 4.3 1.3 4.0 5.2 12.6 12.7 4.7 6.9 4.2 0.0 0.5 0.6 0.0 0.0 0.1 0.0 4.2 0.1 0.1 0.1 0.0 0.1 4.4 0.0 0.1 2.6 2.6 0.1 0.1 0.1 0.0 0.4 26.5 0.3 0.0 0.1 14.7 0.7 0.2 0.3 0.1 0.2 4.0 0.0 17.0 0.0 4.7 0.0 0.0 35.5 31.3 0.6 0.0 0.2 7.6 2.2 0.6 0.3 0.0 23.9 0.7 0.0 0.0 0.1 0.2 0.0 14.8 2.4 1.2 0.6 0.1 1.0 11.4 6.4 2.0 0.9 9.9 10.8 2.0 4.7 12.6 4.5 12.7 3.7 4.0 6.4 6.9 5.2 3.4 3.5 4.5 0.7 4.7 10.9 2.9 1.4 4.2 1.2 2.0 49.5 2.5 2.9 1.3 0.6 1.4 13.7 1.1 3.0 0.3 0.0 0.1 0.0 0.4 0.7 0.0 52.2 7.9 0.0 17.7 0.0 8.3 0.0 4.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 7.8 20.6 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 CERS3 "LASS3, MGC27091" ENSG00000154227 "Ceramide synthase 3" Q8IU89 15 100400395-100544995 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase Ichthyosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 25.6;skin 1: 29.0;testis: 37.9" "Cell type enhanced" "Detected in some" 16 "Basal keratinocytes: 16.8;Early spermatids: 19.4;Late spermatids: 12.5;Spermatocytes: 33.6;Suprabasal keratinocytes: 43.8" "Cancer enhanced" "Detected in some" "head and neck cancer: 14.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.3" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "hTCEpi: 38.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA006092, HPA024356" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA006092: AB_1079236, HPA024356: AB_1852721" "unprognostic (5.01e-3)" "unprognostic (3.43e-2)" "unprognostic (6.47e-4)" "unprognostic (2.35e-2)" "unprognostic (5.58e-2)" "unprognostic (1.68e-1)" "unprognostic (6.84e-3)" "unprognostic (3.23e-1)" "unprognostic (1.43e-1)" "unprognostic (2.09e-1)" "unprognostic (1.31e-5)" "unprognostic (2.65e-1)" "unprognostic (4.74e-4)" "unprognostic (1.83e-1)" "unprognostic (4.33e-2)" "unprognostic (1.78e-1)" "unprognostic (4.05e-3)" 0.4 0.0 0.4 0.4 0.4 0.0 1.9 0.4 0.4 6.0 0.4 0.4 0.4 0.0 0.4 0.4 25.6 0.3 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.0 0.4 3.6 0.4 0.4 29.0 0.4 0.4 0.4 0.4 0.0 37.9 0.4 0.4 0.4 0.4 8.5 0.4 11.2 0.0 0.0 1.5 0.6 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.1 0.2 0.2 0.0 0.7 0.3 0.0 0.0 3.3 0.1 0.0 0.0 0.6 0.0 0.0 0.2 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.0 0.0 0.0 3.6 16.8 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.5 0.6 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 33.6 0.4 43.8 0.0 0.0 0.0 7.4 CERS4 "FLJ12089, LASS4, Trh1" ENSG00000090661 "Ceramide synthase 4" Q9HA82 19 8206736-8262421 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 63.6;Muller glia cells: 146.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 21.6;NB-4: 39.0;U-937: 24.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033734, HPA054729" Uncertain Supported Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB033734: AB_2132977, HPA054729: " "unprognostic (5.96e-2)" "prognostic favorable (2.71e-4)" "unprognostic (2.46e-2)" "unprognostic (2.82e-2)" "unprognostic (1.30e-1)" "prognostic favorable (7.83e-4)" "unprognostic (1.74e-1)" "prognostic favorable (3.45e-5)" "unprognostic (1.48e-2)" "unprognostic (3.32e-1)" "prognostic favorable (8.05e-4)" "unprognostic (1.77e-1)" "prognostic favorable (9.63e-5)" "unprognostic (6.08e-3)" "unprognostic (2.69e-2)" "unprognostic (2.91e-2)" "unprognostic (8.08e-3)" 6.2 6.7 17.5 10.5 22.9 2.5 21.6 14.5 19.3 13.2 6.8 24.3 7.8 4.6 9.9 41.8 26.4 11.9 7.7 9.7 16.1 10.8 16.5 32.4 12.9 12.2 26.9 13.3 13.8 56.7 11.6 10.1 2.2 16.8 22.4 3.2 26.2 34.8 12.8 2.1 20.9 6.1 8.5 20.3 8.6 9.9 8.4 29.0 6.4 38.1 9.5 15.9 9.3 13.2 13.3 2.7 16.9 4.4 13.5 5.2 3.5 0.1 0.9 0.9 10.2 0.3 0.0 0.7 1.3 3.4 1.5 0.7 7.6 0.8 15.9 11.3 0.0 4.0 5.5 6.6 0.1 0.7 14.0 5.2 3.1 0.1 21.6 13.2 0.0 8.7 5.1 8.5 3.6 7.8 4.3 0.1 7.3 2.2 0.5 0.0 0.3 1.2 39.0 10.4 0.0 3.8 19.2 0.2 1.2 2.5 0.0 3.9 5.2 1.7 0.3 5.5 7.2 7.5 3.6 0.0 1.2 3.3 7.6 0.0 10.0 8.0 12.2 0.0 24.4 1.1 5.9 4.4 16.9 5.2 2.3 3.9 13.3 3.0 3.1 2.7 12.1 2.8 2.6 14.0 13.5 1.5 2.6 3.5 3.5 17.5 22.9 14.5 19.3 16.1 10.8 26.9 13.3 16.8 29.0 6.0 12.5 16.4 11.3 16.0 23.7 3.0 12.7 16.0 15.9 1.8 17.7 2.2 6.6 15.6 1.1 6.0 0.0 0.0 26.2 0.4 11.8 36.8 12.7 63.6 12.8 11.1 23.0 6.7 9.8 4.6 13.3 5.6 25.3 29.7 0.2 146.0 15.3 0.0 15.2 35.3 25.4 6.5 10.3 0.7 1.7 22.6 2.4 17.5 0.6 9.8 CERS5 "FLJ25304, LASS5, MGC45411, Trh4" ENSG00000139624 "Ceramide synthase 5" Q8N5B7 12 50129306-50167533 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026589 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA026589: AB_1852727" "unprognostic (1.59e-2)" "unprognostic (9.83e-2)" "unprognostic (5.17e-2)" "unprognostic (3.64e-2)" "unprognostic (3.02e-1)" "unprognostic (2.49e-3)" "prognostic unfavorable (4.63e-5)" "unprognostic (5.56e-2)" "unprognostic (1.65e-2)" "unprognostic (9.26e-2)" "unprognostic (1.88e-3)" "unprognostic (5.67e-2)" "prognostic unfavorable (9.33e-11)" "unprognostic (8.37e-2)" "unprognostic (1.03e-1)" "prognostic favorable (5.76e-5)" "unprognostic (3.26e-1)" 18.0 13.2 18.3 13.3 21.6 10.9 18.0 38.3 19.6 21.1 15.0 17.5 8.9 6.3 22.6 20.9 14.1 17.7 14.9 9.9 16.7 11.6 16.0 7.8 14.7 15.1 13.9 19.1 22.5 13.8 23.9 22.4 19.7 14.3 15.6 11.5 14.9 14.6 16.2 5.0 21.5 12.2 21.8 10.3 15.7 13.3 11.6 14.4 12.7 15.5 7.0 14.9 18.4 18.3 21.0 26.1 33.5 35.1 29.0 26.3 22.3 9.2 10.4 23.0 6.5 12.8 10.8 19.5 20.5 17.7 19.7 18.7 24.5 14.7 14.0 17.2 29.0 10.3 8.7 10.0 7.9 19.6 22.1 10.2 11.7 8.8 14.8 25.6 11.9 16.0 18.5 12.0 16.2 15.1 25.9 17.9 12.3 8.8 13.0 24.7 16.2 10.3 32.4 14.7 5.2 10.1 13.5 15.0 10.0 25.6 12.0 7.0 11.4 17.4 8.2 27.5 15.8 11.2 13.7 17.1 17.0 11.4 12.7 8.9 12.7 12.1 11.3 13.4 8.3 7.8 24.8 19.0 28.1 26.0 25.5 22.9 17.9 22.9 22.4 18.2 21.0 17.9 24.3 33.5 29.0 35.1 26.1 26.3 22.3 18.3 21.6 38.3 19.6 16.7 11.6 13.9 19.1 14.3 14.4 17.9 17.3 12.1 17.3 15.3 41.7 5.6 15.3 9.4 14.8 14.0 19.6 27.6 6.6 19.6 0.6 14.9 9.1 0.0 12.2 48.5 20.0 10.2 15.0 3.8 17.4 30.2 15.0 15.4 17.0 1.1 15.5 16.5 11.8 30.7 7.0 21.7 14.2 7.0 16.3 6.8 36.1 32.3 17.6 8.1 7.5 12.5 28.1 20.0 6.0 11.3 CERS6 LASS6 ENSG00000172292 "Ceramide synthase 6" Q6ZMG9 2 168455862-168775137 "Predicted membrane proteins" "Inflammatory response, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 9.0" "Lineage enriched" "Detected in many" 5 "dendritic cells: 9.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044683, HPA063527" Approved Uncertain Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA044683: AB_10965059, HPA063527: AB_2685030" "unprognostic (2.17e-2)" "unprognostic (1.87e-1)" "unprognostic (3.92e-3)" "prognostic unfavorable (7.31e-4)" "unprognostic (3.24e-1)" "unprognostic (2.61e-1)" "prognostic unfavorable (1.10e-4)" "unprognostic (1.28e-1)" "unprognostic (1.11e-2)" "unprognostic (9.80e-2)" "unprognostic (1.64e-2)" "unprognostic (2.93e-2)" "unprognostic (2.38e-1)" "unprognostic (1.14e-1)" "unprognostic (3.06e-2)" "unprognostic (2.41e-1)" "unprognostic (4.80e-2)" 12.3 13.5 17.7 12.2 17.5 9.6 14.2 28.0 23.2 12.3 24.4 6.5 19.8 22.4 17.4 17.0 12.7 9.8 9.7 26.9 14.5 15.9 12.1 11.7 9.4 12.5 11.0 15.9 15.6 7.3 15.8 14.6 8.3 9.2 12.2 27.1 13.4 6.9 17.1 9.4 20.0 28.3 11.0 8.5 6.9 21.0 11.0 8.1 25.1 24.1 7.4 7.5 11.8 30.5 0.8 9.0 0.7 1.7 1.1 1.7 0.5 5.9 5.3 9.5 10.9 23.6 17.6 0.0 6.0 6.1 6.4 8.7 8.4 13.2 0.0 8.7 5.4 9.1 11.3 12.2 13.9 10.8 0.0 8.4 10.9 5.7 6.0 20.7 22.9 5.3 19.5 40.1 13.5 10.6 6.4 3.2 16.3 5.8 0.0 13.3 6.5 20.1 6.4 8.8 12.8 7.8 15.6 18.0 10.3 6.1 17.9 13.2 15.9 5.8 15.0 3.1 8.2 13.3 13.1 1.8 16.5 6.9 4.5 10.3 0.1 0.0 0.0 10.8 12.2 11.0 0.7 1.7 0.0 0.3 1.2 0.6 0.2 0.6 0.3 1.3 0.8 1.7 1.3 0.2 1.1 1.0 9.0 0.0 0.5 17.7 17.5 28.0 23.2 14.5 15.9 11.0 15.9 9.2 8.1 6.0 10.1 10.9 40.4 96.7 20.6 40.6 30.6 25.4 18.2 10.4 0.0 0.5 0.0 12.6 4.2 12.7 42.8 0.0 20.1 0.8 10.8 29.9 10.3 41.4 21.3 35.0 99.7 14.7 43.8 2.7 18.4 31.6 10.1 96.4 94.8 31.2 14.0 35.1 37.4 8.4 2.3 64.7 18.6 3.9 3.0 81.1 0.5 8.6 107.7 39.9 CFAP20 "C16orf80, fSAP23, GTL3" ENSG00000070761 "Cilia and flagella associated protein 20" Q9Y6A4 16 58113588-58129450 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 311.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018195 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA018195: AB_1850408" "unprognostic (9.96e-2)" "unprognostic (5.44e-2)" "unprognostic (3.80e-1)" "unprognostic (7.45e-2)" "unprognostic (2.27e-1)" "unprognostic (7.14e-3)" "unprognostic (9.55e-2)" "unprognostic (2.20e-1)" "unprognostic (7.12e-2)" "unprognostic (3.87e-1)" "unprognostic (2.86e-2)" "unprognostic (1.42e-1)" "unprognostic (1.15e-2)" "unprognostic (9.72e-2)" "unprognostic (9.71e-2)" "unprognostic (7.58e-3)" "unprognostic (1.47e-1)" 13.5 18.4 20.7 10.8 37.3 15.8 16.1 19.4 30.2 16.8 12.5 26.0 12.1 12.8 15.4 18.2 14.6 28.0 13.4 31.4 22.7 27.2 15.5 25.0 15.1 17.0 21.6 18.1 24.9 13.2 22.1 24.4 22.8 20.2 14.5 12.3 16.8 12.8 14.4 8.1 14.9 12.0 13.3 21.7 13.3 11.9 21.6 19.8 30.6 20.2 9.7 15.6 12.5 13.4 23.0 24.6 28.1 13.5 26.9 39.8 21.8 18.0 15.0 24.5 13.1 9.2 7.3 19.2 17.1 12.0 27.2 17.7 23.3 19.6 18.7 24.8 11.5 12.3 18.7 22.6 17.0 27.0 10.7 24.4 10.5 8.8 30.2 10.7 15.9 21.1 8.3 11.8 17.2 15.8 10.4 16.5 29.6 17.5 8.9 21.3 14.0 45.1 32.1 22.5 12.5 30.4 43.8 30.6 17.8 15.0 11.3 22.4 19.8 30.6 12.0 16.7 17.7 10.3 20.0 11.4 16.8 22.0 18.2 19.4 11.0 10.4 36.1 11.0 16.7 22.7 28.1 13.5 22.9 21.9 12.9 21.0 23.0 22.9 23.3 15.0 21.2 31.0 26.2 11.3 26.9 12.7 24.6 39.8 21.8 20.7 37.3 19.4 30.2 22.7 27.2 21.6 18.1 20.2 19.8 11.9 16.9 11.1 38.7 0.0 26.1 47.4 28.1 61.6 29.6 19.2 31.4 88.8 48.0 31.1 311.7 45.8 12.3 0.0 14.6 63.4 35.6 17.8 11.6 30.5 30.2 17.5 23.4 25.2 10.0 99.3 31.4 12.1 0.0 21.6 26.1 29.4 18.1 16.1 29.4 24.8 28.5 19.4 21.5 67.4 31.1 0.0 55.2 14.9 21.3 12.8 CFAP206 "C6orf165, dJ382I10.1, FLJ25974" ENSG00000272514 "Cilia and flagella associated protein 206" Q8IYR0 6 87407983-87464465 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "fallopian tube: 17.7;testis: 60.5" "Cell type enhanced" "Detected in some" 29 "Ciliated cells: 80.3;Early spermatids: 214.5;Spermatocytes: 42.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.2" "Lineage enhanced" "Detected in single" "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "MCF7: 4.5;RPTEC TERT1: 5.4;T-47d: 9.1" "HPA044891, HPA072261" Approved Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA044891: AB_10960832, HPA072261: AB_2686501" "unprognostic (4.31e-1)" "unprognostic (8.75e-3)" "unprognostic (2.40e-1)" "unprognostic (2.31e-1)" "unprognostic (5.51e-2)" "unprognostic (1.68e-1)" "unprognostic (1.17e-1)" "unprognostic (4.68e-3)" "unprognostic (3.13e-2)" "unprognostic (3.99e-3)" "unprognostic (9.08e-3)" "unprognostic (4.22e-2)" "unprognostic (1.46e-1)" "unprognostic (8.54e-2)" "unprognostic (2.26e-2)" 0.2 0.5 1.3 0.3 3.0 0.2 0.5 0.3 2.2 0.9 0.3 3.0 0.2 0.3 0.7 3.4 0.2 17.7 0.4 0.3 2.1 2.0 1.5 0.3 2.4 0.2 0.7 1.4 2.7 0.3 0.8 2.6 0.4 8.1 0.5 0.2 0.3 0.3 0.5 0.2 0.3 0.2 0.3 0.5 0.2 0.2 60.5 0.6 0.0 1.4 0.0 0.2 0.4 0.1 0.0 0.0 1.2 0.0 0.0 0.6 0.0 0.0 1.0 0.5 2.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.2 1.0 0.0 0.0 0.0 2.1 1.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.9 0.0 0.0 0.2 0.0 0.0 0.1 0.9 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.4 1.2 1.1 0.6 0.4 0.5 0.3 0.1 9.1 0.2 0.0 0.5 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.3 3.0 0.3 2.2 2.1 2.0 0.7 1.4 8.1 0.6 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 80.3 13.6 0.0 0.0 0.1 1.7 0.1 214.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.5 2.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 1.1 0.7 0.4 0.0 0.0 42.3 2.0 0.0 0.0 0.0 0.0 0.0 CFAP36 "BARTL1, CCDC104, MGC15407" ENSG00000163001 "Cilia and flagella associated protein 36" Q96G28 2 55519604-55545879 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 1061.9;Spermatocytes: 279.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008994, HPA017061" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA008994: AB_2275429, HPA017061: AB_1846129" "unprognostic (8.11e-2)" "unprognostic (3.21e-3)" "unprognostic (1.24e-1)" "unprognostic (3.36e-2)" "unprognostic (7.98e-2)" "unprognostic (3.68e-1)" "unprognostic (4.65e-3)" "unprognostic (7.79e-2)" "unprognostic (1.51e-2)" "unprognostic (1.58e-2)" "unprognostic (3.66e-3)" "unprognostic (7.63e-2)" "unprognostic (8.57e-3)" "unprognostic (4.94e-2)" "unprognostic (3.35e-2)" "unprognostic (1.56e-3)" "unprognostic (2.96e-1)" 13.0 22.7 34.6 9.9 46.6 7.3 25.3 16.7 39.4 23.3 16.7 10.2 18.1 7.8 24.4 39.1 12.3 32.7 21.1 15.4 28.6 34.9 32.4 9.1 15.1 11.0 27.7 29.5 29.3 15.8 32.8 47.1 10.6 36.7 22.1 12.1 13.5 10.6 24.6 6.5 8.1 8.4 19.7 19.3 8.8 16.6 66.4 14.4 8.9 39.9 7.7 9.8 21.7 13.3 8.0 6.2 6.3 2.9 5.5 25.2 8.3 18.1 14.3 15.6 20.3 20.6 39.8 9.4 11.4 23.4 17.6 14.7 10.8 6.7 6.5 26.7 14.9 26.4 12.0 12.0 15.9 22.7 15.7 23.8 9.5 14.1 11.2 22.6 17.6 11.9 19.6 25.9 23.8 28.2 46.6 19.5 13.6 12.0 5.4 22.2 13.5 10.6 19.6 7.9 11.8 14.4 8.3 18.5 6.8 35.8 10.2 23.4 11.8 15.5 8.0 21.0 8.4 13.0 6.1 10.0 18.0 11.0 18.6 15.4 9.6 4.4 2.2 30.4 8.0 8.2 6.3 2.1 6.2 9.1 2.3 17.5 8.0 25.2 14.5 2.7 5.2 21.0 12.8 2.4 5.5 2.9 6.2 13.7 8.3 34.6 46.6 16.7 39.4 28.6 34.9 27.7 29.5 36.7 14.4 44.7 27.1 4.3 48.0 0.0 37.3 31.9 35.7 182.0 50.0 33.2 7.9 12.5 77.9 54.5 1061.9 38.3 4.5 0.0 53.7 20.8 26.9 36.9 36.0 7.2 22.4 22.3 16.4 30.1 6.5 151.0 69.6 14.2 0.0 22.6 15.7 95.2 35.5 14.0 63.6 119.5 74.3 58.2 36.3 279.8 29.1 0.0 6.5 20.3 10.7 27.7 CFAP45 "CCDC19, NESG1" ENSG00000213085 "Cilia and flagella associated protein 45" Q9UL16 1 159872364-159900163 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 35.5;testis: 29.7" "Group enriched" "Detected in many" 5 "Ciliated cells: 306.5;Early spermatids: 187.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 10.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "eosinophil: 6.0;neutrophil: 4.9" "Lineage enriched" "Detected in single" 8 "granulocytes: 6.0" "Cell line enhanced" "Detected in many" "BEWO: 11.2;HEL: 14.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042204, HPA043618" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA042204: AB_10966555, HPA043618: AB_10959305" "unprognostic (1.88e-1)" "unprognostic (4.15e-2)" "unprognostic (3.95e-1)" "unprognostic (5.18e-3)" "unprognostic (4.78e-3)" "unprognostic (1.49e-1)" "unprognostic (8.80e-4)" "unprognostic (2.57e-1)" "unprognostic (1.76e-1)" "unprognostic (5.21e-2)" "unprognostic (1.43e-1)" "unprognostic (1.92e-1)" "unprognostic (1.08e-12)" "unprognostic (2.95e-1)" "unprognostic (1.87e-1)" "unprognostic (3.83e-3)" "unprognostic (1.65e-1)" 0.3 0.3 2.0 0.4 7.5 0.6 0.5 0.0 0.2 2.5 0.2 11.9 0.0 0.4 1.3 10.5 0.4 35.5 0.2 0.5 3.1 2.8 0.3 0.2 6.1 0.3 0.1 0.1 7.3 0.1 0.1 0.2 3.3 12.5 0.2 0.2 0.0 0.2 0.5 0.2 0.3 0.2 0.4 0.5 0.5 0.6 29.7 3.4 0.0 0.7 0.0 0.3 0.4 0.1 0.7 0.3 6.0 0.3 0.2 0.5 0.2 2.5 0.6 0.0 0.0 0.1 0.3 11.2 1.3 1.6 2.4 1.0 1.9 3.3 1.1 0.5 0.6 1.3 1.6 0.3 0.3 1.4 0.6 0.3 14.5 0.6 0.1 0.7 1.2 0.5 1.0 0.8 2.6 0.9 3.4 1.7 0.4 1.5 0.5 0.4 3.5 0.2 1.1 0.6 2.1 1.2 0.0 1.2 0.5 0.4 0.6 1.0 0.2 1.3 3.9 0.4 3.4 3.8 0.2 2.2 1.0 3.0 2.0 2.4 1.2 0.0 0.4 5.4 0.5 0.8 0.0 0.3 6.0 0.0 0.3 0.0 0.5 0.3 0.5 0.3 0.7 0.0 0.5 4.9 0.2 0.0 0.3 0.0 0.2 2.0 7.5 0.0 0.1 3.1 2.8 0.1 0.1 12.5 3.4 0.0 3.7 0.0 0.7 0.0 0.0 0.8 0.0 306.5 54.6 5.2 0.0 1.5 0.0 1.4 187.0 2.3 0.0 0.0 2.0 6.4 0.4 0.9 3.5 0.0 0.4 0.0 0.0 1.3 1.6 33.1 2.0 0.0 0.0 0.0 0.0 0.5 1.0 0.0 1.4 0.4 0.0 0.0 0.4 19.0 2.3 0.0 0.7 0.0 0.0 1.1 CFAP52 "FLJ37528, WDR16, WDRPUH" ENSG00000166596 "Cilia and flagella associated protein 52" Q8N1V2 17 9576627-9643459 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 29.5;fallopian tube: 46.9;testis: 26.8" "Cell type enriched" "Detected in some" 6 "Ciliated cells: 149.9" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "pons and medulla: 29.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.9;MCF7: 4.8;OE19: 6.2;REH: 3.3;T-47d: 2.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023247, HPA030635" Enhanced Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA023247: AB_1858797, HPA030635: " "unprognostic (1.76e-2)" "unprognostic (2.31e-1)" "unprognostic (1.38e-1)" "unprognostic (1.68e-2)" "unprognostic (2.09e-1)" "unprognostic (2.04e-1)" "unprognostic (3.99e-1)" "unprognostic (3.16e-2)" "unprognostic (2.11e-1)" "unprognostic (3.66e-1)" "unprognostic (2.22e-2)" "unprognostic (2.66e-1)" "unprognostic (7.85e-2)" "unprognostic (1.85e-1)" "unprognostic (9.23e-2)" "unprognostic (4.50e-2)" "unprognostic (7.09e-2)" 0.4 0.6 3.7 0.4 8.4 0.4 0.4 0.3 2.5 2.6 0.4 8.5 0.1 0.9 1.3 6.4 0.4 46.9 0.5 0.4 5.9 6.0 0.5 0.4 3.9 0.3 0.5 0.5 4.8 0.3 0.7 5.4 0.5 29.5 0.5 0.3 0.7 1.3 0.5 0.3 0.5 0.9 0.3 1.1 0.4 0.4 26.8 3.5 0.0 0.8 0.0 0.3 0.5 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 1.6 1.9 0.0 0.7 1.3 0.9 0.9 0.0 0.1 0.0 0.0 0.1 3.9 0.0 0.4 0.0 1.4 2.2 0.0 0.0 0.0 0.5 0.0 0.0 2.6 0.4 0.1 0.1 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.2 4.8 0.0 0.7 0.3 6.2 0.2 3.3 0.0 0.1 0.4 0.9 0.8 0.0 0.7 1.3 0.0 0.9 2.9 0.2 0.0 0.1 0.5 0.0 0.0 0.1 0.3 0.0 0.2 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 3.7 8.4 0.3 2.5 5.9 6.0 0.5 0.5 29.5 3.5 0.0 2.9 0.0 0.2 0.0 0.4 0.3 0.0 149.9 18.2 0.0 5.9 0.5 1.7 0.0 21.1 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 1.7 0.0 0.0 0.0 0.0 0.5 0.1 0.0 1.8 0.2 2.0 0.0 0.0 25.2 0.3 0.0 0.8 0.0 0.0 0.1 CFAP73 "CCDC42B, MIA2" ENSG00000186710 "Cilia and flagella associated protein 73" A6NFT4 12 113149858-113159276 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.2;epididymis: 17.8;fallopian tube: 35.5" "Group enriched" "Detected in some" 8 "Ciliated cells: 42.8;Club cells: 11.4" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.7" "Region enhanced" "Detected in many" "pons and medulla: 27.2" "Cell type enhanced" "Detected in some" "naive B-cell: 1.0;naive CD4 T-cell: 1.3" "Group enriched" "Detected in many" 9 "B-cells: 1.0;T-cells: 1.3" "Cell line enhanced" "Detected in some" "Daudi: 6.4;REH: 3.3;T-47d: 3.9;U-698: 13.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA048539 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Vesicles" "HPA048539: AB_2680434" "unprognostic (2.42e-2)" "prognostic favorable (1.29e-4)" "unprognostic (1.90e-3)" "prognostic favorable (5.52e-4)" "unprognostic (2.32e-2)" "unprognostic (1.18e-3)" "unprognostic (6.49e-2)" "unprognostic (2.94e-1)" "unprognostic (1.33e-1)" "unprognostic (3.14e-1)" "unprognostic (5.68e-2)" "unprognostic (3.43e-2)" "unprognostic (1.62e-4)" "unprognostic (2.03e-4)" "unprognostic (1.60e-1)" "unprognostic (4.03e-2)" "unprognostic (1.55e-2)" 0.2 0.3 4.3 0.5 16.9 2.0 0.3 0.5 0.9 3.1 0.3 15.3 1.0 0.5 1.0 17.8 0.6 35.5 0.4 0.2 5.8 6.1 0.6 0.2 5.7 0.9 0.2 0.9 6.8 0.3 0.7 0.9 0.2 27.2 0.3 0.3 0.0 2.2 0.9 0.5 4.5 0.6 0.2 1.1 0.5 3.9 1.5 4.7 0.0 0.5 0.5 1.3 0.4 0.0 1.0 0.1 0.0 0.0 0.0 1.3 0.2 0.3 0.1 0.4 0.4 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.5 3.1 6.4 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.5 0.3 2.2 0.2 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.4 0.0 0.0 1.1 0.3 1.1 0.4 1.2 0.2 3.3 0.0 0.5 0.9 0.7 0.6 0.1 0.0 0.9 0.0 0.3 3.9 0.0 0.2 0.1 1.1 0.3 0.2 0.6 0.2 13.0 0.9 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 4.3 16.9 0.5 0.9 5.8 6.1 0.2 0.9 27.2 4.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 42.8 11.4 3.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CFDP1 "BCNT, CENP-29, CP27, p97, SWC5, Yeti" ENSG00000153774 "Craniofacial development protein 1" Q9UEE9 16 75293698-75433485 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Enterocytes: 441.3;Paneth cells: 557.6;Proximal tubular cells: 451.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041316, HPA048242" Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA041316: AB_10794371, HPA048242: AB_2680327" "unprognostic (1.45e-1)" "unprognostic (8.64e-2)" "unprognostic (1.13e-1)" "unprognostic (4.88e-1)" "unprognostic (3.97e-2)" "prognostic unfavorable (9.63e-5)" "unprognostic (5.81e-3)" "unprognostic (2.17e-1)" "unprognostic (1.26e-2)" "unprognostic (2.61e-2)" "unprognostic (1.42e-1)" "unprognostic (7.37e-2)" "unprognostic (2.85e-2)" "unprognostic (6.54e-2)" "unprognostic (1.36e-1)" "unprognostic (4.92e-3)" "unprognostic (1.25e-1)" 21.3 33.0 38.3 23.3 32.9 18.7 28.5 31.8 35.4 35.6 24.3 19.5 24.6 18.9 37.4 40.9 21.3 36.1 18.8 19.2 33.7 40.5 40.2 26.6 20.6 16.9 33.6 28.4 54.5 26.9 20.9 53.0 38.5 32.7 28.4 25.8 21.1 23.8 25.6 25.9 20.8 22.2 33.8 38.6 18.0 19.1 38.5 29.7 27.2 28.7 12.6 21.4 26.0 41.1 20.1 28.2 33.7 27.6 15.1 37.8 15.0 16.5 12.3 42.1 15.5 38.3 42.8 12.6 16.6 19.4 22.0 32.0 21.1 22.7 15.9 24.7 20.4 24.7 18.6 32.2 26.4 44.3 6.9 15.3 16.6 11.9 45.1 26.4 17.4 14.5 26.6 22.7 26.6 32.5 38.6 23.9 29.7 23.1 7.4 24.6 37.7 25.6 38.6 20.5 28.1 6.5 46.4 17.3 27.5 24.5 9.1 25.2 21.3 27.8 5.8 22.8 37.9 24.1 31.0 14.2 15.8 17.1 16.6 10.5 14.5 22.6 59.8 15.9 23.2 13.9 28.7 27.3 33.7 19.4 27.6 27.3 19.8 26.7 21.3 28.2 20.1 24.5 23.1 22.4 15.1 25.0 28.1 37.8 15.0 38.3 32.9 31.8 35.4 33.7 40.5 33.6 28.4 32.7 29.7 35.7 47.3 55.9 92.1 51.4 87.2 29.5 86.6 139.2 73.9 109.9 110.0 100.8 167.5 63.8 109.9 72.1 441.3 70.0 82.6 93.0 53.5 100.2 27.7 133.3 67.3 58.8 79.0 55.9 48.2 54.7 115.9 50.3 32.1 44.1 151.7 51.5 79.7 557.6 105.7 451.1 103.9 97.0 53.6 273.8 142.2 57.3 129.5 38.3 90.4 107.8 CFL2 NEM7 ENSG00000165410 "Cofilin 2" Q9Y281 14 34706769-34714823 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease mutation, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 88.5;skeletal muscle: 185.9" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 498.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037078, HPA045599" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 90000000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB037078: AB_259128, HPA045599: AB_2679383" "unprognostic (1.05e-1)" "unprognostic (1.28e-1)" "unprognostic (1.29e-2)" "unprognostic (1.59e-1)" "unprognostic (3.02e-2)" "unprognostic (2.80e-3)" "unprognostic (3.82e-1)" "unprognostic (2.02e-1)" "unprognostic (3.02e-1)" "unprognostic (2.92e-2)" "unprognostic (2.48e-2)" "unprognostic (1.27e-1)" "unprognostic (1.65e-2)" "unprognostic (3.13e-3)" "unprognostic (9.59e-2)" "unprognostic (1.89e-2)" "prognostic unfavorable (2.16e-5)" 14.0 16.5 15.9 8.8 17.7 5.0 6.7 13.6 16.6 13.7 23.2 25.8 9.2 4.7 21.3 10.2 20.7 11.2 7.2 88.5 19.0 14.5 8.7 33.0 7.8 3.7 22.7 10.6 12.9 3.0 9.3 4.5 10.3 28.9 22.4 8.6 7.8 5.4 31.8 185.9 2.6 6.7 38.1 24.6 4.2 11.9 6.9 20.1 0.5 9.0 30.8 3.4 34.7 9.3 8.5 2.9 3.6 1.8 3.2 5.8 1.6 17.8 16.1 10.4 6.7 10.6 39.5 5.8 31.2 36.0 29.9 31.9 12.1 7.7 6.4 12.8 49.7 22.4 3.5 22.1 6.6 52.7 0.9 9.2 1.3 19.1 28.6 17.3 1.6 1.0 29.9 2.3 25.5 14.1 21.0 29.6 0.9 2.0 5.1 36.7 5.0 1.3 0.9 3.4 3.1 24.8 1.1 32.9 1.0 10.8 3.7 2.1 8.9 20.3 4.4 10.5 8.0 9.7 1.6 26.0 29.8 19.8 14.0 14.9 7.1 4.6 2.4 10.9 2.4 7.0 3.6 1.8 2.1 3.7 1.8 5.8 8.5 4.3 4.0 2.9 5.0 3.4 3.5 0.7 3.2 0.8 2.8 3.6 1.6 15.9 17.7 13.6 16.6 19.0 14.5 22.7 10.6 28.9 20.1 98.3 34.5 15.9 86.3 17.7 51.4 498.3 15.3 6.7 14.8 21.0 19.6 25.2 51.4 41.2 2.2 46.0 0.9 0.0 34.0 52.6 52.9 52.5 5.7 99.2 13.2 73.1 9.1 43.6 14.0 6.5 52.9 10.4 28.7 7.2 3.4 80.2 30.0 4.2 92.6 79.1 57.2 32.3 125.1 51.4 51.5 16.9 17.8 14.9 3.7 53.3 CFLAR "c-FLIP, CASH, CASP8AP1, Casper, CLARP, FLAME, FLIP, I-FLICE, MRIT" ENSG00000003402 "CASP8 and FADD like apoptosis regulator" O15519 2 201116104-201176687 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Apoptosis, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Urothelial cells: 475.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 79.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 79.2" "Cell line enhanced" "Detected in all" "U-266/70: 55.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019044, CAB022157, CAB025216" Uncertain Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA Yes "Nucleoplasm, Plasma membrane, Cytosol" "Nuclear bodies" "CAB022157: , CAB025216: , HPA019044: AB_10696204" "unprognostic (4.61e-2)" "unprognostic (5.32e-2)" "unprognostic (2.49e-1)" "unprognostic (1.44e-1)" "unprognostic (2.95e-2)" "prognostic favorable (2.79e-4)" "unprognostic (7.46e-2)" "unprognostic (9.01e-2)" "unprognostic (1.76e-1)" "unprognostic (6.12e-2)" "unprognostic (3.08e-2)" "unprognostic (4.91e-2)" "unprognostic (2.90e-2)" "unprognostic (7.83e-2)" "unprognostic (9.13e-2)" "unprognostic (6.84e-2)" "unprognostic (2.24e-2)" 35.4 17.6 13.7 29.8 17.4 66.8 31.6 26.9 12.6 20.5 25.7 13.5 31.3 17.5 24.7 27.6 21.0 19.2 22.1 58.1 14.7 7.7 24.9 18.9 58.5 34.3 16.8 8.9 14.6 14.3 9.1 18.7 28.3 12.6 23.2 17.7 20.9 21.8 27.4 113.7 16.7 26.8 30.5 13.8 35.7 19.4 10.9 14.8 17.2 31.2 26.2 31.4 24.1 33.7 5.3 6.6 79.2 12.6 8.7 11.8 7.8 5.2 10.7 7.7 4.5 24.0 18.4 9.5 13.3 23.3 8.8 10.8 12.4 19.7 1.4 12.7 15.5 10.7 3.9 2.4 10.1 14.1 39.4 7.5 7.9 9.2 20.1 16.7 5.9 26.3 20.0 10.0 14.9 13.1 10.8 44.7 1.8 26.7 33.2 16.0 4.4 2.7 23.5 2.6 4.2 8.2 2.8 1.9 11.3 11.0 10.8 1.7 3.1 9.0 7.9 10.5 5.4 5.6 11.0 48.4 18.5 7.7 6.8 6.5 55.3 18.2 8.9 13.1 4.8 9.1 16.3 12.1 13.5 11.7 12.3 10.3 5.3 10.1 11.0 6.6 4.0 6.4 8.3 79.2 8.7 12.6 4.6 11.8 7.8 13.7 17.4 26.9 12.6 14.7 7.7 16.8 8.9 12.6 14.8 419.9 201.2 84.2 185.4 48.7 8.5 172.6 96.8 283.7 216.1 66.3 29.5 63.9 63.0 138.6 55.5 265.4 108.1 23.3 63.2 34.2 70.8 195.5 77.6 86.3 61.3 12.7 91.3 184.1 115.5 33.0 48.1 149.2 92.8 261.5 56.6 31.3 121.1 80.7 46.7 84.8 29.0 38.8 55.6 14.4 10.1 75.3 58.6 209.9 41.3 475.0 CGGBP1 "CGGBP, p20-CGGBP" ENSG00000163320 "CGG triplet repeat binding protein 1" Q9UFW8 3 88051944-88149885 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 111.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035568, HPA037017" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035568: AB_10670022, HPA037017: AB_2675433" "unprognostic (2.87e-1)" "unprognostic (2.86e-1)" "unprognostic (2.43e-2)" "unprognostic (4.89e-2)" "unprognostic (1.30e-2)" "unprognostic (2.96e-2)" "unprognostic (6.76e-2)" "unprognostic (2.95e-2)" "unprognostic (8.30e-2)" "unprognostic (3.63e-1)" "unprognostic (1.65e-1)" "unprognostic (5.27e-2)" "unprognostic (1.57e-2)" "unprognostic (1.37e-1)" "unprognostic (3.35e-2)" "unprognostic (3.00e-1)" "prognostic favorable (7.79e-4)" 29.6 23.9 26.1 27.5 28.6 38.5 80.0 33.3 36.9 28.7 28.3 19.4 23.7 23.1 30.7 23.6 23.5 24.2 23.6 33.8 23.1 21.6 28.4 30.8 29.1 39.4 24.4 26.4 37.1 25.9 40.6 33.2 26.4 21.2 27.3 26.0 23.7 25.2 24.9 30.8 19.2 30.0 29.7 28.9 33.9 25.1 22.4 22.0 76.0 32.7 16.7 37.4 27.7 30.9 24.8 19.9 41.6 23.0 20.8 25.1 19.8 8.0 13.8 23.0 16.4 20.3 18.1 7.4 16.1 14.6 17.0 20.2 10.1 11.9 17.6 10.9 14.4 13.3 6.4 18.1 12.2 21.0 26.6 10.0 26.9 12.1 9.0 18.1 17.8 19.2 16.3 12.7 18.7 24.2 21.0 17.3 20.1 12.7 18.4 19.2 12.8 26.7 12.7 12.6 13.5 11.6 17.3 21.6 12.6 12.7 12.3 4.5 15.1 13.6 7.8 38.0 16.9 11.8 21.6 16.7 20.6 15.2 111.3 16.8 13.5 16.3 19.3 15.7 17.4 17.6 41.6 21.2 39.4 23.3 21.7 22.7 22.5 20.7 23.9 19.9 24.8 25.1 20.5 39.8 20.8 23.0 17.9 23.0 19.8 26.1 28.6 33.3 36.9 23.1 21.6 24.4 26.4 21.2 22.0 47.6 40.0 45.5 57.2 47.3 33.0 39.5 35.7 16.0 46.6 38.4 15.7 48.1 56.3 34.4 15.7 65.2 42.3 23.3 36.4 51.7 55.0 57.7 45.1 49.4 36.3 63.5 40.2 61.4 45.7 28.6 64.5 53.4 38.8 34.3 30.1 61.7 41.1 34.9 47.0 52.9 30.4 64.7 68.9 82.4 49.4 43.7 70.1 69.0 31.8 57.8 CGRRF1 "CGR19, RNF197" ENSG00000100532 "Cell growth regulator with ring finger domain 1" Q99675 14 54509812-54539309 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 105.4;Spermatocytes: 79.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002930 Uncertain Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA002930: AB_1078507" "unprognostic (1.81e-1)" "unprognostic (3.76e-1)" "unprognostic (5.61e-2)" "unprognostic (4.38e-1)" "unprognostic (1.01e-1)" "unprognostic (3.21e-1)" "prognostic unfavorable (6.84e-4)" "unprognostic (2.25e-1)" "unprognostic (5.58e-2)" "unprognostic (2.63e-1)" "unprognostic (7.29e-2)" "unprognostic (2.64e-3)" "prognostic favorable (2.57e-8)" "unprognostic (2.94e-1)" "unprognostic (1.61e-1)" "unprognostic (1.48e-1)" "unprognostic (1.74e-1)" 13.3 12.8 18.3 5.7 19.2 10.2 17.3 21.9 18.9 12.7 11.4 16.2 12.7 8.0 14.3 20.1 8.4 12.6 8.3 12.7 15.2 15.4 20.8 10.3 9.9 10.9 16.6 14.6 11.4 19.5 11.2 16.5 10.0 20.1 14.7 9.9 9.8 9.7 16.3 20.7 5.0 9.6 12.4 18.2 8.8 10.2 24.9 16.7 3.0 18.0 6.3 7.2 12.6 9.2 11.9 6.4 31.3 10.7 12.4 13.7 11.7 8.5 7.6 8.0 7.2 13.8 8.6 6.0 8.3 7.5 12.1 11.9 7.0 9.5 4.6 10.5 6.8 13.3 7.5 8.5 7.0 14.3 9.7 7.2 6.5 1.9 8.8 17.2 3.8 3.8 8.5 13.6 9.0 14.8 7.6 8.4 7.8 2.6 5.8 10.9 15.0 3.8 5.8 5.3 7.7 12.0 8.6 9.7 2.8 9.3 11.1 5.7 4.8 6.6 3.5 12.5 7.4 9.4 3.3 7.2 14.9 12.7 6.3 6.9 4.3 5.0 6.7 9.2 4.6 9.9 31.3 7.9 13.4 12.3 9.0 12.3 11.1 13.4 13.5 6.4 11.9 13.7 12.6 8.0 12.4 10.7 5.6 13.5 11.7 18.3 19.2 21.9 18.9 15.2 15.4 16.6 14.6 20.1 16.7 8.9 7.8 12.4 17.2 6.8 17.8 18.5 5.1 18.7 10.3 15.7 9.8 12.5 19.9 19.5 105.4 17.7 12.0 0.0 14.8 9.3 18.6 18.7 28.8 8.6 15.2 11.1 10.3 20.3 11.0 31.0 15.5 13.6 15.1 12.6 8.7 22.4 14.4 12.7 21.2 21.9 12.0 19.4 26.2 79.4 35.5 3.0 10.1 19.2 11.3 11.8 CHAF1A "CAF-1, CAF1, CAF1B, CAF1P150, MGC71229, P150" ENSG00000167670 "Chromatin assembly factor 1 subunit A" Q13111 19 4402662-4445018 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, DNA replication" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Erythroid cells: 46.7;Spermatocytes: 48.8;Spermatogonia: 120.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 15.2" "Group enriched" "Detected in many" 4 "dendritic cells: 15.2;granulocytes: 4.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB015186 Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB015186: AB_628065" "unprognostic (1.91e-1)" "prognostic favorable (8.22e-5)" "unprognostic (2.49e-1)" "unprognostic (4.71e-2)" "unprognostic (2.06e-1)" "unprognostic (1.89e-3)" "unprognostic (5.30e-3)" "unprognostic (8.78e-2)" "unprognostic (2.06e-2)" "unprognostic (2.12e-2)" "unprognostic (2.46e-2)" "unprognostic (1.16e-1)" "unprognostic (8.54e-2)" "prognostic favorable (4.15e-6)" "unprognostic (1.71e-1)" "unprognostic (2.11e-3)" "unprognostic (4.03e-2)" 5.3 5.3 6.3 14.6 7.3 28.2 5.3 12.6 8.8 4.7 7.2 4.9 8.6 6.9 4.7 5.1 11.5 4.7 5.2 4.0 6.1 3.9 3.0 4.5 4.6 13.3 5.5 5.6 4.6 4.4 3.3 4.3 7.5 5.4 6.5 7.2 4.1 7.8 8.1 12.2 11.3 7.0 6.8 4.8 8.2 5.6 20.4 4.9 27.8 3.3 9.8 11.5 6.7 5.9 1.7 15.2 4.3 2.4 1.0 0.8 0.9 21.4 14.7 24.5 15.4 2.4 3.0 12.6 20.4 8.4 17.3 19.6 17.8 7.7 33.1 8.5 6.5 9.8 16.9 20.9 13.9 20.5 19.0 22.9 20.6 21.9 14.0 1.2 23.8 16.8 1.7 2.9 14.2 6.1 3.2 8.1 18.5 24.8 30.0 10.6 12.4 38.4 13.3 27.3 11.0 12.2 28.6 19.4 18.9 4.5 25.6 17.4 13.5 14.0 9.9 8.1 16.1 8.7 17.8 5.8 14.3 12.5 24.2 24.7 15.1 22.3 31.8 12.0 30.7 16.8 2.9 2.3 4.3 0.5 2.4 0.4 1.7 0.6 0.1 2.0 0.8 0.6 0.4 1.2 1.0 0.4 15.2 0.8 0.9 6.3 7.3 12.6 8.8 6.1 3.9 5.5 5.6 5.4 4.9 0.0 4.6 11.2 5.5 8.7 12.5 5.0 2.5 5.3 2.3 5.2 2.0 15.4 1.7 5.7 5.6 3.3 3.8 46.7 5.9 33.8 3.7 3.9 2.3 3.9 10.3 1.6 1.7 2.5 2.8 5.3 2.8 8.7 1.7 12.6 6.2 5.0 5.1 0.0 3.5 2.1 8.4 32.3 3.4 48.8 120.2 13.0 12.2 5.7 10.0 4.1 CHAF1B "CAF-1, CAF1, CAF1A, CAF1P60, MPHOSPH7, MPP7" ENSG00000159259 "Chromatin assembly factor 1 subunit B" Q13112 21 36385378-36419015 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, DNA replication, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 20.7" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 13.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA021679, CAB033604" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB033604: AB_2229411, HPA021679: AB_1846621" "unprognostic (2.28e-2)" "prognostic favorable (5.44e-5)" "prognostic favorable (7.92e-4)" "unprognostic (1.43e-1)" "unprognostic (3.28e-3)" "unprognostic (1.12e-2)" "prognostic unfavorable (6.14e-6)" "unprognostic (2.14e-2)" "unprognostic (1.89e-2)" "unprognostic (1.13e-2)" "unprognostic (2.84e-2)" "unprognostic (6.27e-2)" "unprognostic (7.66e-6)" "unprognostic (5.89e-2)" "unprognostic (5.00e-3)" "unprognostic (9.12e-2)" "unprognostic (1.36e-1)" 2.4 1.4 2.8 3.7 5.9 9.3 4.1 7.2 9.4 2.4 3.0 2.0 1.2 2.8 3.9 2.8 4.4 2.3 1.6 2.9 2.0 2.7 1.7 1.4 2.1 4.5 1.8 4.1 2.7 6.9 3.1 2.1 2.1 3.8 2.9 3.6 4.6 5.2 1.6 20.7 4.4 3.1 2.4 1.5 2.5 2.1 6.2 0.2 12.3 1.7 3.6 7.3 1.8 2.6 2.8 1.3 3.7 0.8 4.4 5.1 1.7 14.8 9.0 15.4 8.7 1.2 3.1 8.4 10.5 6.1 13.0 13.7 10.1 7.9 11.6 4.7 5.4 13.3 5.0 15.8 7.0 10.6 11.7 12.3 18.0 9.7 7.1 0.8 11.5 8.8 1.9 1.7 12.2 5.3 2.6 6.1 14.4 15.7 10.9 6.6 10.3 17.8 6.7 10.7 13.5 6.6 26.2 8.3 6.7 4.5 7.4 9.3 7.7 16.1 12.3 5.8 6.5 9.6 7.8 3.7 10.7 5.3 9.4 12.2 8.0 14.8 13.6 6.8 12.7 13.4 3.1 0.8 1.0 3.7 0.4 3.3 2.6 2.9 2.8 0.7 2.8 1.9 3.0 3.7 4.4 0.7 1.3 5.1 1.7 2.8 5.9 7.2 9.4 2.0 2.7 1.8 4.1 3.8 0.2 0.0 2.4 2.2 5.1 2.5 1.3 0.9 0.0 2.7 3.4 3.5 0.0 4.4 0.0 6.5 7.1 2.1 0.5 0.0 1.9 7.5 1.7 3.3 2.3 0.4 3.7 1.6 0.0 1.3 1.9 5.9 0.6 1.1 5.0 1.8 2.1 2.0 1.8 0.0 0.0 0.2 2.2 6.5 0.5 8.9 13.2 2.0 2.1 1.7 3.7 2.1 CHAMP1 "C13orf8, CAMP, CHAMP, ZNF828" ENSG00000198824 "Chromosome alignment maintaining phosphoprotein 1" Q96JM3 13 114314335-114337626 "Disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006623, HPA008900" Enhanced Enhanced "Nucleoplasm,Nuclear bodies,Midbody ring" Yes No Nucleoplasm "Nuclear bodies, Midbody ring" "HPA006623: AB_1845548, HPA008900: AB_1845547" "unprognostic (6.60e-2)" "unprognostic (1.12e-1)" "unprognostic (1.99e-2)" "unprognostic (1.76e-1)" "unprognostic (4.55e-2)" "unprognostic (1.67e-1)" "unprognostic (3.89e-3)" "unprognostic (2.07e-1)" "unprognostic (9.43e-2)" "unprognostic (1.13e-1)" "unprognostic (4.38e-2)" "unprognostic (1.13e-2)" "unprognostic (4.40e-2)" "unprognostic (3.50e-2)" "unprognostic (3.67e-1)" "unprognostic (4.62e-2)" "unprognostic (2.40e-1)" 13.7 16.8 11.8 12.7 18.5 16.5 13.3 25.2 19.8 12.4 13.3 15.9 10.9 13.7 16.7 11.7 12.6 16.7 10.7 10.3 11.6 12.2 12.7 20.6 12.3 19.9 12.5 12.4 17.8 20.8 12.8 9.5 13.5 16.6 14.5 14.3 12.4 13.2 14.7 16.1 12.6 16.4 14.2 11.4 16.8 16.3 11.6 11.9 35.0 15.2 9.8 23.1 14.3 11.2 7.9 14.5 7.0 6.8 3.7 5.7 2.5 15.4 6.7 24.9 10.5 8.9 13.9 10.7 16.4 13.8 15.6 17.5 9.9 9.4 31.9 6.7 12.8 9.8 9.9 18.1 13.1 23.3 12.3 22.3 20.9 9.7 8.7 10.1 30.4 12.5 13.6 8.2 12.3 12.1 5.5 7.5 11.1 13.2 8.8 19.9 6.1 20.2 8.9 18.7 19.0 8.8 20.3 11.7 11.0 11.8 9.6 12.1 14.4 9.4 21.4 15.5 18.1 12.3 25.7 8.2 8.6 13.8 9.1 10.0 11.3 11.5 34.7 17.1 18.0 16.4 7.0 4.0 5.2 4.7 4.6 5.7 6.8 4.3 4.5 4.5 7.9 3.5 3.9 1.0 3.7 6.8 14.5 2.8 2.5 11.8 18.5 25.2 19.8 11.6 12.2 12.5 12.4 16.6 11.9 8.9 8.1 18.2 6.1 3.0 10.9 5.3 15.3 9.4 1.2 12.2 3.9 11.4 11.6 10.4 0.8 8.6 9.6 0.0 9.9 14.5 8.3 14.3 9.3 18.8 18.9 14.3 10.4 10.4 17.7 1.0 10.9 12.0 11.8 14.4 12.5 8.1 10.8 8.0 10.6 14.0 9.6 6.5 6.2 8.8 20.5 3.3 6.6 8.2 10.4 3.0 CHCHD1 "C10orf34, FLJ25854" ENSG00000172586 "Coiled-coil-helix-coiled-coil-helix domain containing 1" Q96BP2 10 73782047-73783652 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 114.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039046 Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" NA NA "Nucleoplasm, Mitochondria" "Nucleoli fibrillar center" "HPA039046: AB_10673234" "unprognostic (4.97e-2)" "unprognostic (1.90e-3)" "unprognostic (2.96e-1)" "unprognostic (1.31e-3)" "unprognostic (1.80e-1)" "unprognostic (9.85e-2)" "unprognostic (1.75e-2)" "unprognostic (3.33e-1)" "unprognostic (1.35e-1)" "unprognostic (2.24e-2)" "unprognostic (4.53e-1)" "unprognostic (1.91e-2)" "unprognostic (1.52e-1)" "unprognostic (1.25e-1)" "unprognostic (1.54e-1)" "unprognostic (5.58e-2)" "prognostic favorable (5.42e-4)" 16.4 33.6 22.6 21.7 21.5 16.5 32.0 21.3 29.4 16.4 24.7 9.2 25.9 28.0 16.8 38.6 29.5 17.8 25.3 36.1 19.3 18.4 32.9 37.8 28.9 23.8 19.4 20.9 15.6 47.2 16.3 19.7 25.3 21.2 21.5 20.8 12.7 31.9 28.7 45.1 16.6 24.3 22.0 15.3 24.8 23.4 24.8 15.6 21.0 29.5 31.6 20.6 17.0 18.1 30.7 38.2 22.2 27.3 17.9 32.1 18.2 22.5 17.2 14.5 20.5 12.0 11.7 14.6 11.8 13.8 11.9 16.1 15.4 20.6 11.2 13.1 10.4 12.2 16.0 14.1 15.3 9.9 17.1 26.9 8.6 14.4 23.7 14.1 13.1 13.8 10.9 19.1 10.1 6.9 18.1 16.5 15.6 13.0 12.8 15.7 22.8 16.1 29.0 13.8 21.5 114.1 15.4 11.2 14.6 19.4 12.7 7.2 14.1 7.3 51.5 24.1 12.4 28.8 18.3 9.7 7.6 16.6 12.5 20.2 12.8 13.3 17.7 17.7 26.6 5.9 22.2 27.0 15.9 19.7 27.3 23.7 30.7 24.2 23.5 26.6 26.1 20.3 20.5 11.1 17.9 21.5 38.2 32.1 18.2 22.6 21.5 21.3 29.4 19.3 18.4 19.4 20.9 21.2 15.6 38.7 36.6 58.1 32.1 31.1 26.0 66.9 33.1 77.6 54.6 57.6 21.6 127.4 169.1 72.5 37.4 31.2 94.4 46.7 76.3 142.6 26.2 45.5 28.9 109.7 118.2 19.1 59.4 50.3 55.3 7.6 52.3 50.1 38.8 82.0 88.4 53.2 83.5 89.6 51.9 145.7 27.7 51.8 26.8 44.5 49.1 38.0 107.1 39.9 89.5 42.2 CHD1 ENSG00000153922 "Chromodomain helicase DNA binding protein 1" O14646 5 98853985-98928957 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 70.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022236 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA022236: AB_2670915" "unprognostic (2.63e-1)" "unprognostic (2.31e-1)" "unprognostic (1.09e-2)" "unprognostic (4.11e-2)" "unprognostic (7.79e-2)" "unprognostic (7.15e-2)" "unprognostic (6.50e-2)" "unprognostic (1.00e-2)" "unprognostic (1.79e-1)" "unprognostic (2.88e-1)" "unprognostic (4.94e-2)" "unprognostic (3.15e-1)" "prognostic unfavorable (7.25e-6)" "unprognostic (2.69e-1)" "unprognostic (3.33e-1)" "unprognostic (1.52e-1)" "unprognostic (1.17e-1)" 13.0 7.4 5.5 15.8 7.5 41.7 10.2 14.9 5.5 9.4 9.3 4.7 7.9 6.6 11.3 7.5 7.6 10.8 10.6 6.8 4.9 3.1 7.3 10.1 12.1 8.8 8.8 3.2 18.1 8.3 9.3 12.0 11.1 6.4 7.7 7.4 5.6 8.1 11.5 13.2 8.2 12.3 8.3 7.2 17.2 8.6 12.0 7.4 70.1 8.1 5.5 9.3 10.4 11.3 10.1 7.1 16.7 8.2 8.1 8.4 2.2 11.0 10.2 23.9 16.2 8.1 8.4 20.9 11.5 7.5 9.3 12.2 12.6 8.6 9.4 11.2 6.6 15.2 9.2 18.7 12.6 19.5 14.7 14.1 16.6 12.1 9.6 8.9 15.9 12.9 7.2 5.2 16.2 16.4 6.3 11.2 30.8 20.0 14.5 9.3 8.9 31.6 6.9 16.0 3.5 12.4 26.9 16.7 14.0 8.2 10.6 11.2 9.6 14.7 7.7 18.6 13.0 7.5 11.0 12.7 20.1 10.8 12.5 20.2 10.1 10.6 19.9 11.0 16.0 12.0 11.4 8.2 10.7 6.5 7.5 8.2 10.1 6.1 6.1 7.1 9.4 8.4 6.6 16.7 8.1 7.1 5.2 6.3 2.2 5.5 7.5 14.9 5.5 4.9 3.1 8.8 3.2 6.4 7.4 44.7 61.6 41.0 98.1 138.2 37.4 25.7 20.4 61.6 79.6 34.9 41.2 44.3 6.6 31.7 85.6 50.1 37.2 0.0 27.6 32.9 75.7 63.5 85.6 26.0 30.8 31.8 30.5 36.2 71.6 14.8 30.0 68.0 64.1 52.3 28.7 17.0 29.9 35.1 18.0 11.0 50.1 45.3 96.8 51.7 52.7 164.7 75.5 54.3 26.9 58.2 CHD1L ALC1 ENSG00000131778 "Chromodomain helicase DNA binding protein 1 like" Q86WJ1 1 147242641-147295766 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027789, HPA028670" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA027789: AB_10601099, HPA028670: AB_10601257" "unprognostic (1.07e-1)" "unprognostic (3.93e-2)" "unprognostic (1.97e-1)" "unprognostic (3.49e-1)" "unprognostic (1.78e-1)" "unprognostic (2.58e-2)" "prognostic unfavorable (3.07e-4)" "unprognostic (1.86e-2)" "unprognostic (7.83e-2)" "unprognostic (1.39e-2)" "unprognostic (4.97e-2)" "unprognostic (8.21e-2)" "prognostic unfavorable (1.31e-9)" "unprognostic (5.51e-2)" "unprognostic (3.52e-1)" "unprognostic (2.74e-2)" "unprognostic (1.16e-1)" 11.2 12.2 16.1 14.1 16.5 26.9 18.2 23.0 20.0 9.8 16.1 29.5 6.4 18.4 16.0 12.2 10.4 13.4 12.5 9.2 17.3 13.6 11.8 26.1 13.7 16.1 27.3 12.6 9.5 18.5 12.6 17.9 11.8 18.2 13.2 20.0 11.6 9.5 11.9 12.0 15.9 20.9 18.4 24.7 21.3 12.9 27.8 22.2 18.5 8.9 9.4 16.9 8.5 11.9 15.3 19.0 7.6 8.3 8.2 9.1 9.0 19.0 16.5 18.9 12.0 13.3 13.0 15.7 17.1 14.5 16.0 15.1 15.9 13.3 24.8 8.0 17.1 9.8 18.1 16.0 18.6 14.2 24.6 22.4 23.8 13.2 40.5 14.1 30.6 15.3 12.1 9.2 15.8 18.2 13.8 17.5 26.2 27.1 11.6 19.4 21.1 23.2 16.5 24.9 33.1 21.8 26.0 17.5 19.5 15.1 13.6 11.4 19.3 15.4 19.4 14.9 26.1 10.6 44.6 15.9 10.8 16.5 9.7 26.6 10.0 13.8 20.5 22.0 13.5 16.3 7.6 8.1 3.7 9.0 6.8 9.1 12.5 7.9 7.8 19.0 15.3 8.0 8.9 0.8 8.2 8.3 15.8 5.5 9.0 16.1 16.5 23.0 20.0 17.3 13.6 27.3 12.6 18.2 22.2 11.9 17.0 17.4 7.7 10.2 6.5 5.9 15.3 14.7 19.4 5.2 5.9 18.4 18.3 9.2 15.1 12.7 11.7 23.3 7.1 15.4 11.0 9.8 20.8 27.6 18.8 1.6 8.6 3.7 19.8 18.3 6.6 19.1 15.1 13.6 14.8 13.5 9.0 14.0 10.6 11.2 8.8 6.5 10.2 31.2 27.2 9.2 9.8 10.7 18.0 5.8 CHD2 "DKFZp547I1315, DKFZp686E01200, DKFZp781D1727, FLJ38614" ENSG00000173575 "Chromodomain helicase DNA binding protein 2" O14647 15 92900189-93028005 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Myogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060744, HPA060960" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA060744: AB_2684353, HPA060960: AB_2684398" "unprognostic (1.65e-2)" "unprognostic (2.43e-1)" "unprognostic (2.14e-2)" "unprognostic (5.98e-2)" "unprognostic (2.12e-2)" "unprognostic (3.10e-2)" "unprognostic (2.67e-2)" "unprognostic (7.85e-2)" "unprognostic (7.51e-3)" "unprognostic (1.14e-1)" "unprognostic (2.84e-1)" "unprognostic (1.79e-2)" "unprognostic (4.64e-2)" "unprognostic (1.16e-1)" "unprognostic (1.58e-1)" "unprognostic (3.15e-1)" "unprognostic (1.70e-2)" 23.7 16.6 18.7 23.6 21.1 66.7 21.8 35.1 22.8 24.1 19.9 19.7 17.6 15.7 26.1 31.9 20.3 18.4 16.8 15.3 18.5 15.7 17.7 17.6 30.4 25.2 22.1 13.9 26.3 20.9 27.5 41.9 33.1 19.1 22.4 16.1 22.1 21.2 19.9 24.3 25.2 24.3 20.3 30.8 26.9 20.8 20.4 22.4 39.5 28.8 11.3 37.4 34.7 19.0 25.5 17.2 34.5 6.3 8.0 17.5 4.6 10.7 5.9 16.0 7.0 10.0 24.6 12.3 10.1 10.4 6.8 8.5 7.5 14.2 2.6 8.5 8.8 11.7 16.1 9.3 10.0 9.6 0.0 5.5 12.8 11.8 6.4 13.4 13.5 10.1 15.5 12.3 8.1 16.6 14.2 11.6 19.1 13.3 30.4 10.3 6.6 7.0 7.0 10.1 5.3 6.6 10.1 14.6 14.5 7.1 14.5 8.9 9.5 17.6 6.5 13.2 16.8 7.3 11.4 18.4 5.6 7.4 4.8 6.4 29.0 11.6 11.1 8.6 8.1 4.9 14.9 6.3 15.0 12.9 3.3 11.8 25.5 12.6 10.1 3.3 23.4 17.5 12.5 34.5 8.0 5.8 17.2 12.3 4.6 18.7 21.1 35.1 22.8 18.5 15.7 22.1 13.9 19.1 22.4 65.5 165.7 52.5 97.7 146.0 66.2 34.7 25.5 105.7 153.6 43.6 86.4 24.4 3.3 30.1 45.6 46.5 39.7 23.3 32.9 20.4 79.4 107.2 94.9 29.8 22.2 54.0 56.9 23.4 43.8 28.3 32.2 70.9 91.1 47.7 34.3 34.1 46.6 37.7 35.3 8.7 80.7 32.3 55.9 14.4 10.0 158.0 50.6 94.7 35.1 111.1 CHD3 "Mi-2a, Mi2-ALPHA, ZFH" ENSG00000170004 "Chromodomain helicase DNA binding protein 3" Q12873 17 7884806-7912760 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043368, HPA076524" Supported Approved "Nucleoplasm,Nucleoli,Centriolar satellite" No No "Nucleoplasm, Nucleoli, Centriolar satellite" "HPA043368: AB_2678448, HPA076524: AB_2686804" "unprognostic (1.77e-2)" "unprognostic (8.01e-2)" "prognostic unfavorable (2.43e-4)" "prognostic favorable (7.68e-5)" "unprognostic (1.53e-1)" "unprognostic (8.11e-3)" "unprognostic (2.54e-1)" "unprognostic (1.11e-1)" "unprognostic (2.83e-2)" "unprognostic (5.25e-3)" "prognostic favorable (8.36e-4)" "unprognostic (9.11e-2)" "unprognostic (8.31e-2)" "unprognostic (3.98e-2)" "unprognostic (1.50e-1)" "unprognostic (8.90e-3)" "unprognostic (2.20e-3)" 10.4 12.9 31.7 24.3 26.0 18.7 12.5 12.1 28.3 41.1 21.1 4.1 22.5 8.2 46.3 16.1 15.1 25.0 20.0 8.7 30.4 14.2 15.2 2.3 13.1 19.0 8.4 28.4 27.3 15.1 28.5 21.0 8.0 10.7 32.9 11.1 20.7 19.4 23.0 3.3 16.2 14.0 23.3 6.9 14.6 15.8 11.3 5.1 40.6 19.7 7.5 17.7 20.6 28.9 1.6 4.0 4.1 3.5 2.7 7.8 3.6 12.2 30.5 17.9 23.7 21.8 18.3 9.6 14.3 19.2 12.1 13.0 5.9 10.3 34.5 10.9 21.0 9.8 16.6 33.6 15.1 15.3 17.5 19.6 16.7 39.6 0.7 11.7 4.8 32.9 24.1 8.1 16.3 10.9 32.3 22.5 15.8 11.1 0.6 11.3 12.1 13.1 5.5 2.8 12.9 11.3 38.6 21.8 5.2 12.1 29.8 12.2 16.5 35.5 13.8 6.9 5.1 15.9 7.8 28.1 26.3 20.7 6.4 20.5 2.6 0.4 19.5 13.4 13.5 22.4 0.6 2.7 4.1 7.0 1.7 5.5 1.5 6.7 6.6 2.1 1.6 7.8 5.1 2.1 2.7 3.5 4.0 3.6 3.6 31.7 26.0 12.1 28.3 30.4 14.2 8.4 28.4 10.7 5.1 29.8 57.4 11.5 44.3 32.4 61.2 9.7 17.8 24.1 37.5 76.8 7.9 15.1 14.9 21.3 8.9 17.5 12.0 0.0 20.6 16.7 30.0 67.6 38.2 2.1 8.4 42.9 54.5 18.4 21.1 13.0 41.1 14.7 8.5 54.1 12.6 11.3 23.7 7.0 53.7 7.5 15.6 25.8 27.2 12.9 50.5 17.9 13.7 34.6 25.9 53.1 CHD4 "Mi-2b, Mi2-BETA" ENSG00000111642 "Chromodomain helicase DNA binding protein 4" Q14839 12 6570082-6614524 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012008 Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA012008: AB_1846633" "unprognostic (6.11e-2)" "unprognostic (2.26e-2)" "unprognostic (1.71e-2)" "unprognostic (6.40e-3)" "unprognostic (8.99e-2)" "unprognostic (3.36e-3)" "prognostic unfavorable (6.03e-6)" "unprognostic (2.66e-2)" "unprognostic (1.05e-1)" "unprognostic (6.85e-2)" "unprognostic (3.15e-1)" "unprognostic (3.94e-1)" "unprognostic (2.06e-1)" "unprognostic (3.33e-1)" "unprognostic (1.82e-1)" "unprognostic (9.84e-2)" "unprognostic (1.66e-1)" 23.5 34.9 21.9 50.0 33.5 27.2 25.9 29.4 25.1 28.1 29.5 29.3 38.5 18.6 37.2 35.4 29.1 28.0 40.3 52.8 23.5 19.2 29.5 25.0 25.5 30.9 33.6 19.4 34.6 27.4 58.4 25.3 29.5 27.2 21.5 26.0 26.5 24.8 46.2 33.7 31.1 24.4 36.6 30.3 29.4 27.2 29.7 28.9 75.7 38.4 33.7 38.4 34.7 24.3 12.6 16.8 12.8 9.1 13.5 16.7 5.8 20.4 18.7 46.4 17.4 19.0 21.4 27.3 22.7 22.2 25.1 23.2 31.2 15.9 44.1 9.0 25.7 16.4 18.3 43.5 25.0 33.9 33.0 22.4 61.6 29.1 19.4 16.5 48.3 29.6 20.7 12.4 24.3 17.0 31.7 29.3 24.7 48.4 22.0 23.8 25.6 45.8 15.8 44.4 19.0 17.7 39.3 28.5 24.1 15.9 24.2 22.0 28.3 29.2 32.6 22.6 53.2 14.9 27.5 27.2 25.7 54.7 18.8 26.5 35.7 21.2 56.3 17.0 29.5 18.7 9.0 7.7 9.2 12.2 9.1 12.0 10.5 10.3 11.1 7.9 12.6 13.0 12.3 12.8 13.5 8.1 16.8 16.7 5.8 21.9 33.5 29.4 25.1 23.5 19.2 33.6 19.4 27.2 28.9 56.6 102.0 59.1 45.6 60.9 103.2 110.8 66.2 96.4 79.6 83.7 66.8 38.6 11.6 71.4 71.8 70.5 43.4 23.3 62.1 41.7 66.9 40.2 81.1 60.6 61.2 131.9 93.2 49.7 44.2 45.3 60.9 57.6 45.5 56.9 59.2 71.6 76.6 24.6 70.0 30.3 60.2 51.8 73.5 97.0 107.1 59.1 56.9 61.8 61.8 37.3 CHD5 ENSG00000116254 "Chromodomain helicase DNA binding protein 5" Q8TDI0 1 6101793-6180123 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.4;pituitary gland: 22.3;testis: 16.4" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 60.3;Early spermatids: 202.3;Horizontal cells: 212.9;Late spermatids: 67.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "SCLC-21H: 17.0;U-2 OS: 7.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA015809 Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "HPA015809: " "unprognostic (5.03e-4)" "unprognostic (1.89e-1)" "unprognostic (2.47e-3)" "unprognostic (9.40e-6)" "unprognostic (1.91e-2)" "unprognostic (2.98e-2)" "unprognostic (1.06e-1)" "unprognostic (1.09e-1)" "unprognostic (2.97e-2)" "unprognostic (1.95e-2)" "unprognostic (6.64e-4)" "unprognostic (1.34e-1)" "unprognostic (1.34e-4)" "unprognostic (1.16e-1)" "unprognostic (1.63e-1)" "unprognostic (1.96e-1)" "unprognostic (1.98e-1)" 1.1 7.9 19.8 1.3 17.1 1.0 1.0 12.1 41.4 1.2 1.4 0.7 0.0 1.3 1.2 1.2 1.5 1.2 1.2 1.6 15.3 10.1 1.3 1.0 1.2 1.0 4.3 19.1 1.1 1.4 1.3 22.3 1.0 8.0 1.9 1.3 2.3 1.2 4.8 1.2 1.0 1.4 1.2 1.6 1.1 1.2 16.4 0.8 0.0 1.0 0.0 1.0 1.1 0.4 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.8 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.2 2.5 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.3 1.5 0.0 0.1 0.3 1.3 0.0 0.0 0.0 0.0 17.0 0.2 0.2 0.0 0.0 0.0 2.9 0.1 0.0 0.1 7.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 19.8 17.1 12.1 34.2 15.3 10.1 4.3 19.1 8.0 0.8 0.0 0.0 0.0 0.0 0.1 60.3 1.7 0.0 0.0 0.0 3.5 11.8 0.0 0.0 0.0 202.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 212.9 0.0 0.0 0.0 67.4 0.9 0.0 0.0 0.0 0.0 2.0 0.4 0.0 0.4 0.0 48.3 0.0 0.9 3.4 17.0 0.4 0.0 0.0 0.0 0.0 CHD6 "CHD5, dJ620E11.1, FLJ22369, KIAA1335, RIGB" ENSG00000124177 "Chromodomain helicase DNA binding protein 6" Q8TD26 20 41402101-41618494 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 143.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015543 Approved Nucleoplasm NA NA Nucleoplasm "HPA015543: " "unprognostic (5.13e-3)" "unprognostic (1.85e-1)" "unprognostic (1.17e-1)" "unprognostic (1.27e-1)" "unprognostic (6.66e-2)" "unprognostic (1.36e-1)" "unprognostic (4.72e-3)" "prognostic favorable (3.42e-4)" "unprognostic (1.17e-1)" "unprognostic (3.17e-1)" "unprognostic (4.75e-2)" "unprognostic (1.14e-1)" "unprognostic (2.12e-3)" "unprognostic (6.66e-2)" "unprognostic (3.41e-1)" "unprognostic (1.00e-1)" "unprognostic (1.14e-2)" 12.1 12.6 16.5 12.7 16.2 18.1 19.4 34.1 24.9 17.4 11.3 16.6 15.4 6.5 20.4 19.9 11.0 16.3 11.7 12.1 15.8 13.9 11.8 10.7 11.7 12.1 14.7 16.8 26.1 12.5 31.4 30.3 12.9 24.3 19.7 10.0 14.2 14.5 17.0 9.4 14.4 10.5 14.4 17.3 12.0 12.3 11.1 18.2 21.4 21.4 6.7 15.3 16.9 15.0 12.0 11.5 15.1 9.3 10.4 10.4 2.3 6.4 7.6 16.5 7.2 9.4 9.7 11.0 5.7 11.7 10.1 12.4 10.5 5.3 7.7 10.3 9.6 11.4 9.6 10.3 9.7 11.6 2.4 5.0 10.6 7.0 10.1 5.3 8.2 5.3 9.7 9.1 7.3 8.2 10.8 8.7 10.9 8.3 8.8 7.8 17.7 13.0 9.0 5.4 4.0 12.9 10.1 19.6 5.5 6.3 15.0 14.9 10.3 17.2 4.6 11.5 12.6 7.9 6.2 9.9 16.0 7.9 8.5 4.9 8.0 6.4 10.0 7.1 4.0 5.0 15.1 6.5 7.1 8.9 6.2 8.9 8.8 7.7 7.3 5.1 12.0 10.4 8.7 0.9 10.4 9.3 11.5 5.9 2.3 16.5 16.2 34.1 24.9 15.8 13.9 14.7 16.8 24.3 18.2 44.7 25.0 32.1 38.2 16.1 123.2 51.6 22.9 45.5 34.2 21.0 88.4 26.6 18.3 19.0 12.5 32.3 4.8 0.0 13.7 22.1 28.6 28.3 20.8 18.7 14.3 143.0 58.3 23.9 21.3 14.0 46.1 23.5 16.9 32.5 27.7 76.4 14.4 14.0 42.8 10.6 137.4 19.4 29.7 22.1 59.7 15.1 27.3 31.9 20.9 22.3 CHD7 "CRG, FLJ20357, FLJ20361, KIAA1416" ENSG00000171316 "Chromodomain helicase DNA binding protein 7" Q9P2D1 8 60678778-60868028 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "rRNA processing, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 47.1" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 227.8;Muller glia cells: 155.9;Rod photoreceptor cells: 196.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 15 "B-cells: 12.2;granulocytes: 12.6;T-cells: 5.5" "Cell line enhanced" "Detected in many" "AF22: 26.3;SCLC-21H: 24.0" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 110.3" HPA053075 Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA053075: AB_2682035" "unprognostic (3.77e-2)" "unprognostic (3.28e-3)" "unprognostic (3.17e-2)" "prognostic unfavorable (5.34e-5)" "unprognostic (9.59e-2)" "unprognostic (1.14e-1)" "unprognostic (1.86e-3)" "unprognostic (3.41e-2)" "unprognostic (3.06e-1)" "unprognostic (2.73e-1)" "unprognostic (2.46e-1)" "unprognostic (1.33e-1)" "unprognostic (9.09e-2)" "unprognostic (9.21e-2)" "unprognostic (1.75e-1)" "unprognostic (8.20e-2)" "unprognostic (2.17e-1)" 3.9 2.2 7.0 7.9 11.2 25.1 4.1 47.1 9.0 2.3 5.7 13.4 3.1 5.9 2.6 3.2 5.1 3.2 3.1 4.1 8.1 4.3 3.6 3.6 4.7 7.0 8.1 3.3 1.4 6.4 12.4 9.9 5.6 9.9 2.9 5.5 6.4 5.7 2.8 10.3 5.7 6.6 2.4 7.5 6.1 4.5 4.3 12.2 1.6 5.4 2.2 7.3 2.9 5.9 12.2 0.6 12.6 0.6 0.0 5.5 0.4 3.9 2.0 26.3 4.6 0.1 0.0 8.3 0.2 0.0 0.9 0.8 4.9 3.7 7.6 0.5 0.0 1.2 2.4 13.5 3.9 0.8 2.9 7.2 17.9 3.3 6.4 1.1 5.4 3.3 0.5 3.0 0.0 4.4 1.6 3.9 6.2 1.3 6.8 0.6 4.0 8.4 6.2 18.0 3.9 0.9 17.6 6.2 2.4 2.0 4.5 24.0 11.9 0.7 3.0 7.3 9.7 5.3 5.1 4.5 0.3 4.3 0.3 2.1 7.3 4.2 11.9 1.5 0.6 6.7 10.4 0.3 12.6 2.6 0.1 3.3 8.0 2.9 0.9 0.1 12.2 5.5 2.0 7.1 0.0 0.6 0.6 0.2 0.4 7.0 11.2 47.1 6.5 8.1 4.3 8.1 3.3 9.9 12.2 29.8 17.4 46.9 22.3 27.0 32.3 30.7 30.6 20.1 23.9 15.7 227.8 7.1 1.7 15.6 11.9 29.6 17.6 0.0 9.7 5.5 7.1 31.3 38.3 9.5 11.9 66.7 83.8 27.0 12.9 7.6 0.9 10.3 20.3 19.8 30.6 155.9 13.9 22.6 0.4 4.2 196.3 0.0 4.4 4.9 3.4 28.2 5.1 13.8 21.7 25.1 CHD8 "DUPLIN, HELSNF1, KIAA1564" ENSG00000100888 "Chromodomain helicase DNA binding protein 8" Q9HCK8 14 21385194-21456126 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Repressor" "Autism, Autism spectrum disorder, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052186, HPA076133" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA052186: AB_2681754, HPA076133: " "unprognostic (3.45e-1)" "unprognostic (9.71e-2)" "unprognostic (3.31e-1)" "unprognostic (2.67e-1)" "unprognostic (1.14e-1)" "unprognostic (3.43e-1)" "prognostic unfavorable (4.94e-4)" "unprognostic (7.31e-2)" "unprognostic (9.22e-2)" "prognostic favorable (8.35e-4)" "unprognostic (1.64e-1)" "unprognostic (2.63e-2)" "unprognostic (2.54e-3)" "unprognostic (2.88e-1)" "unprognostic (9.24e-2)" "unprognostic (2.51e-1)" "unprognostic (8.07e-3)" 13.9 14.5 13.0 14.8 21.5 34.8 17.0 28.9 25.7 15.8 14.4 26.6 14.1 11.1 18.3 13.4 17.4 15.9 11.7 12.3 13.5 13.3 14.0 11.2 15.5 18.5 15.4 15.2 20.7 19.0 34.7 25.3 15.2 20.3 16.3 14.6 19.3 15.7 14.9 16.9 24.5 16.4 17.2 13.1 19.2 16.1 15.2 18.1 29.9 17.4 10.4 24.8 16.6 14.5 12.3 7.8 12.8 7.4 8.7 8.6 3.0 16.5 21.7 24.1 11.2 15.4 13.3 13.6 13.2 15.2 20.1 20.1 18.8 14.4 27.4 8.3 17.6 15.9 20.3 29.4 18.5 25.4 20.9 13.4 24.0 14.5 22.8 14.3 33.2 22.9 17.9 15.1 22.5 16.2 15.6 17.8 21.7 16.7 14.7 15.1 17.8 23.8 13.6 18.4 16.1 18.4 22.4 18.2 9.2 14.9 30.6 17.6 16.9 20.6 16.1 11.4 22.7 11.3 16.1 20.9 16.7 12.8 9.8 15.6 16.7 19.9 27.4 6.7 12.3 16.6 12.8 4.8 12.1 7.7 5.0 8.6 5.8 6.8 7.5 3.3 12.3 7.4 6.4 11.0 8.7 7.4 7.8 5.7 3.0 13.0 21.5 28.9 25.7 13.5 13.3 15.4 15.2 20.3 18.1 35.7 52.5 15.1 10.4 11.2 32.4 18.1 20.4 36.1 43.3 31.4 25.5 12.2 1.7 19.0 1.6 18.0 11.3 23.3 20.2 10.1 9.9 12.1 26.7 12.4 15.0 22.3 26.0 14.1 20.9 2.5 15.0 13.0 10.1 19.8 16.3 19.2 21.3 14.0 16.6 6.3 22.9 0.0 13.3 26.2 22.4 14.4 10.3 22.3 14.7 11.1 CHD9 "BC022889, FLJ12178, KIAA0308" ENSG00000177200 "Chromodomain helicase DNA binding protein 9" Q3L8U1 16 53055033-53329150 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Cone photoreceptor cells: 473.2;Rod photoreceptor cells: 752.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 42.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042053, HPA049420, HPA066155" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042053: AB_2677823, HPA049420: AB_2680758, HPA066155: " "unprognostic (3.57e-2)" "unprognostic (3.73e-2)" "unprognostic (3.44e-3)" "unprognostic (2.42e-1)" "unprognostic (4.34e-2)" "unprognostic (4.35e-2)" "unprognostic (1.24e-1)" "unprognostic (1.68e-1)" "unprognostic (7.75e-3)" "unprognostic (2.87e-2)" "unprognostic (3.39e-1)" "unprognostic (2.35e-2)" "prognostic favorable (1.84e-4)" "unprognostic (4.96e-2)" "unprognostic (1.74e-1)" "unprognostic (5.09e-2)" "unprognostic (2.87e-1)" 18.0 12.6 14.5 12.5 17.3 30.3 15.7 49.3 19.6 18.5 13.8 6.6 17.4 8.0 14.2 15.0 14.4 13.5 11.6 12.2 15.9 8.2 16.8 12.3 12.3 9.2 16.0 12.3 18.8 12.9 28.1 39.9 12.3 15.1 13.7 11.5 8.9 17.8 15.3 17.1 14.4 11.1 11.6 20.1 11.6 13.4 7.0 18.7 15.6 17.7 11.2 9.4 13.9 15.1 16.4 42.9 23.7 12.7 12.1 8.8 1.7 5.8 6.8 15.2 12.3 11.3 16.6 2.6 10.7 7.9 5.7 2.5 3.7 5.2 7.8 7.0 8.8 3.9 7.1 7.9 5.6 8.0 2.7 5.9 11.0 6.5 2.4 7.9 15.2 9.2 11.5 5.6 8.3 10.5 7.6 8.4 4.4 12.9 2.6 7.1 2.3 7.6 3.5 5.5 1.7 5.2 26.8 18.2 3.3 3.4 5.5 6.4 7.2 9.5 3.1 7.9 5.7 3.4 7.0 16.2 10.7 5.4 3.9 7.1 8.1 5.6 13.6 7.6 6.6 10.5 23.7 9.2 8.9 5.7 7.6 8.8 12.5 3.9 6.2 5.4 16.4 3.1 4.4 3.0 12.1 12.7 42.9 1.9 1.7 14.5 17.3 49.3 19.6 15.9 8.2 16.0 12.3 15.1 18.7 65.5 56.6 64.3 103.8 50.8 251.0 33.9 43.3 68.3 67.1 85.5 473.2 14.5 39.7 49.7 11.6 77.2 66.9 46.7 32.4 24.2 77.4 86.0 91.5 61.4 61.8 208.2 84.2 88.4 58.8 14.5 100.4 67.6 64.1 74.9 67.1 159.3 29.5 60.4 116.0 47.5 752.2 58.2 73.1 79.9 36.0 65.6 20.8 48.9 69.8 73.2 CHEK1 CHK1 ENSG00000149554 "Checkpoint kinase 1" O14757 11 125625136-125676255 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 80.0;seminal vesicle: 66.8" "Cell type enhanced" "Detected in many" 9 "Cholangiocytes: 33.1;Extravillous trophoblasts: 31.3;Spermatogonia: 60.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 11.7" "Lineage enriched" "Detected in many" 6 "T-cells: 11.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" HPA044364 Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA044364: AB_2678913" "unprognostic (6.74e-2)" "unprognostic (3.63e-1)" "prognostic favorable (3.62e-4)" "unprognostic (5.54e-2)" "unprognostic (2.17e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (3.70e-6)" "unprognostic (3.95e-3)" "unprognostic (1.26e-3)" "unprognostic (2.54e-2)" "prognostic unfavorable (3.10e-6)" "unprognostic (1.75e-1)" "prognostic unfavorable (1.04e-8)" "unprognostic (2.89e-2)" "unprognostic (2.64e-1)" "unprognostic (8.16e-2)" "unprognostic (1.33e-1)" 3.0 2.5 2.5 9.0 2.8 14.9 2.1 1.1 2.2 2.5 5.2 1.3 80.0 5.0 1.9 10.2 6.5 1.7 3.6 1.5 2.4 2.4 3.7 2.0 1.8 9.6 3.0 1.2 3.8 4.0 25.5 3.5 3.8 1.5 2.9 6.3 1.6 2.6 66.8 1.2 2.9 5.2 2.3 3.0 3.6 2.8 7.2 1.5 22.4 1.8 4.5 8.8 3.8 3.3 1.9 1.8 1.9 0.7 1.2 11.7 1.0 13.0 10.6 23.9 14.5 4.9 10.5 10.4 18.3 8.8 11.7 12.6 25.9 28.8 34.0 18.8 7.2 15.6 15.7 14.6 9.6 14.5 21.3 6.7 63.1 8.9 13.2 1.5 32.2 12.0 5.4 2.0 14.8 10.5 7.0 13.9 23.2 32.0 30.0 15.4 6.7 47.8 15.8 24.2 21.3 9.6 29.1 22.3 17.9 10.8 17.4 15.1 16.0 15.0 10.4 4.4 16.9 28.0 10.5 9.3 16.9 14.4 8.1 16.8 6.7 12.0 48.5 6.2 24.3 19.8 1.9 0.5 0.3 1.3 0.7 1.2 1.9 3.5 1.6 1.1 1.5 3.3 2.0 0.4 1.2 0.4 1.8 11.7 1.0 2.5 2.8 1.1 2.2 2.4 2.4 3.0 1.2 1.5 1.5 3.0 0.3 6.0 4.4 5.6 1.4 3.7 33.1 2.7 5.7 7.0 0.0 9.6 3.3 3.7 3.3 1.9 3.3 23.3 1.0 31.3 5.6 2.0 0.0 0.8 9.4 0.0 1.7 4.9 0.0 2.2 1.4 2.4 0.0 4.6 5.6 2.7 2.4 3.7 1.1 6.8 1.5 0.0 4.1 23.3 60.3 4.3 6.5 4.4 12.0 1.4 CHEK2 "bA444G7, CDS1, CHK2, HuCds1, PP1425, RAD53" ENSG00000183765 "Checkpoint kinase 2" O96017 22 28687743-28742422 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 23.3;Spermatogonia: 20.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001878, CAB002030" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "CAB002030: AB_563660, HPA001878: AB_1078514" "unprognostic (1.54e-1)" "unprognostic (2.20e-1)" "unprognostic (5.83e-2)" "unprognostic (2.93e-2)" "unprognostic (2.42e-1)" "unprognostic (3.83e-2)" "unprognostic (1.49e-3)" "unprognostic (5.08e-3)" "unprognostic (3.33e-3)" "unprognostic (9.62e-3)" "unprognostic (1.28e-2)" "unprognostic (3.13e-1)" "prognostic unfavorable (7.80e-9)" "unprognostic (2.38e-2)" "unprognostic (1.78e-1)" "unprognostic (7.27e-2)" "unprognostic (6.79e-3)" 5.6 8.3 2.5 13.0 7.0 13.7 5.6 0.7 5.6 6.6 9.8 2.5 4.8 6.8 4.8 10.9 10.0 4.3 6.0 6.0 4.1 2.3 5.3 6.5 7.9 10.1 6.7 1.6 12.9 6.7 1.2 4.2 10.1 5.1 8.3 10.6 8.7 7.0 5.8 2.2 6.3 8.5 5.4 5.0 9.8 5.8 9.7 3.6 13.1 7.5 4.8 13.7 6.2 6.7 11.8 8.7 6.5 8.4 2.9 4.4 3.7 14.9 4.8 13.7 17.0 3.9 19.5 8.8 7.4 8.7 9.8 14.4 12.1 10.2 17.7 6.3 5.2 10.6 14.4 20.8 13.6 11.5 12.6 16.0 23.3 9.2 20.2 3.8 14.7 17.1 8.2 6.3 12.6 11.2 6.0 10.8 14.2 14.0 15.5 9.2 21.0 11.8 23.7 19.3 18.5 12.2 25.6 9.4 20.6 6.1 6.2 8.1 4.6 8.3 14.7 8.2 10.6 10.1 13.6 3.7 7.9 9.5 6.9 3.9 9.4 16.5 34.6 7.5 15.5 10.0 6.5 3.7 1.2 1.1 8.4 2.3 11.8 2.2 2.1 8.7 8.4 4.4 2.8 0.3 2.9 4.1 7.0 2.8 3.7 2.5 7.0 0.7 5.6 4.1 2.3 6.7 1.6 5.1 3.6 8.9 4.5 7.5 4.5 5.7 1.0 1.0 0.0 2.7 4.5 1.8 0.0 10.5 0.0 1.7 4.7 2.2 2.0 23.3 1.2 11.7 8.9 2.3 3.5 0.9 8.4 0.0 1.2 3.1 2.1 0.5 5.8 6.6 1.7 2.8 4.7 0.6 1.3 3.5 4.2 3.2 1.2 0.0 2.8 2.5 20.2 1.9 2.9 4.3 7.9 3.4 CHID1 "FLJ42707, MGC3234" ENSG00000177830 "Chitinase domain containing 1" Q9BWS9 11 867860-915058 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 289.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039374 Uncertain Uncertain "Nucleoplasm,Intermediate filaments" "Intracellular and membrane" No No 1700000 "Nucleoplasm, Intermediate filaments" "HPA039374: AB_10673609" "unprognostic (1.85e-1)" "unprognostic (2.19e-1)" "unprognostic (8.96e-2)" "prognostic favorable (6.76e-4)" "unprognostic (4.82e-2)" "unprognostic (3.22e-1)" "unprognostic (1.97e-2)" "unprognostic (3.62e-2)" "unprognostic (7.88e-2)" "unprognostic (2.29e-1)" "unprognostic (1.12e-2)" "unprognostic (5.21e-2)" "unprognostic (1.74e-3)" "unprognostic (1.15e-1)" "unprognostic (7.53e-2)" "unprognostic (3.29e-2)" "unprognostic (2.89e-2)" 18.2 26.6 19.3 17.8 22.2 16.5 19.7 13.4 25.2 20.4 18.3 14.1 23.3 12.9 18.1 40.1 18.5 27.8 25.9 22.0 16.0 19.3 21.0 47.5 14.2 19.6 17.1 17.8 26.1 63.0 20.1 26.8 27.8 13.7 19.5 12.8 21.0 36.8 23.0 14.5 12.8 14.3 22.4 16.5 29.7 16.8 36.4 12.9 10.9 20.3 21.9 13.8 15.6 15.7 20.5 33.6 8.3 23.1 18.4 17.9 18.8 19.5 19.1 14.6 35.5 56.3 30.0 24.6 21.9 26.1 21.6 21.1 20.9 57.8 16.1 20.6 32.1 21.5 38.8 14.4 25.6 15.9 14.0 35.6 11.5 7.1 19.1 26.0 26.6 10.3 29.0 16.3 14.6 21.3 35.8 18.1 20.5 20.9 41.3 14.9 13.8 14.9 35.0 12.9 37.1 29.1 12.9 14.0 29.0 15.8 5.7 27.9 23.0 23.9 33.7 20.4 15.2 13.6 41.0 17.6 24.7 10.8 6.9 17.7 24.4 20.5 9.7 27.6 23.4 19.2 7.6 23.1 8.3 16.9 20.4 17.9 20.5 16.4 17.6 33.6 15.1 17.4 17.4 3.0 18.4 19.2 31.4 14.1 18.8 19.3 22.2 13.4 25.2 16.0 19.3 17.1 17.8 13.7 12.9 38.7 36.7 23.1 47.9 20.3 39.9 20.1 48.4 30.8 23.9 50.6 17.7 97.8 61.3 53.7 96.5 24.8 30.3 23.3 50.7 67.4 51.5 73.1 28.8 71.4 70.9 28.6 51.2 53.4 51.8 289.6 58.1 27.5 52.3 34.3 40.4 59.1 39.0 45.6 54.8 66.6 40.6 51.8 30.3 108.0 122.6 20.5 76.5 17.5 64.8 43.7 CHM "DXS540, REP-1, TCD" ENSG00000188419 "CHM, Rab escort protein 1" P24386 X 85861180-86047562 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "GTPase activation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003231, CAB016171" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB016171: AB_2229397, HPA003231: AB_1078518" "unprognostic (6.50e-3)" "unprognostic (1.80e-1)" "unprognostic (1.67e-1)" "unprognostic (1.74e-2)" "unprognostic (2.82e-1)" "unprognostic (4.40e-1)" "unprognostic (6.20e-3)" "unprognostic (1.38e-1)" "unprognostic (1.18e-1)" "unprognostic (3.03e-1)" "unprognostic (2.20e-1)" "unprognostic (1.49e-1)" "unprognostic (1.97e-3)" "unprognostic (4.18e-2)" "unprognostic (6.15e-2)" "unprognostic (2.44e-1)" "unprognostic (7.60e-3)" 12.6 18.8 13.9 9.7 23.2 3.2 11.2 17.8 22.9 14.3 9.3 9.0 8.3 6.6 14.5 7.1 9.7 15.9 10.4 9.9 12.6 11.0 17.7 10.9 9.9 9.2 9.3 12.1 11.8 8.3 20.2 31.9 13.2 17.9 11.3 9.3 7.5 10.4 10.8 16.3 8.1 8.0 12.5 12.1 10.8 10.2 6.6 11.9 14.6 15.6 8.4 8.7 12.1 10.4 7.4 4.6 6.2 7.1 4.9 6.0 3.9 9.0 6.0 6.1 4.1 10.1 10.7 3.9 10.7 9.0 7.5 8.3 4.8 8.4 3.1 13.9 7.7 26.3 5.2 13.3 6.0 12.9 6.2 6.4 1.8 8.7 4.9 8.0 7.6 13.6 8.1 5.7 12.1 15.4 8.3 12.8 5.2 6.4 10.7 11.6 2.6 4.7 2.8 9.2 6.3 9.8 5.0 11.0 4.7 7.0 5.3 5.5 8.4 12.9 4.5 10.1 8.9 3.3 3.7 9.1 9.6 6.8 33.3 5.3 4.0 14.7 4.4 10.3 6.5 8.3 6.2 5.8 4.0 5.5 7.1 5.0 6.6 4.4 5.6 4.6 7.4 5.8 6.0 3.2 4.9 5.6 4.6 5.5 3.9 13.9 23.2 17.8 22.9 12.6 11.0 9.3 12.1 17.9 11.9 3.0 8.3 7.5 14.7 6.2 34.6 10.2 17.8 20.1 12.5 15.7 7.9 8.1 16.6 13.3 0.6 14.3 7.3 0.0 10.7 8.0 11.8 18.5 16.1 11.3 13.6 22.3 18.0 14.7 19.4 0.9 14.4 13.8 5.0 11.8 10.6 28.5 13.0 8.6 11.7 27.6 21.2 45.3 13.7 2.9 10.7 6.5 15.3 13.6 8.8 12.6 CHML REP-2 ENSG00000203668 "CHM like, Rab escort protein 2" P26374 1 241628853-241640254 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 44.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029627, HPA029628, HPA062967" Supported Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA029627: AB_2756314, HPA029628: AB_10603784, HPA062967: AB_2797269" "unprognostic (1.63e-1)" "unprognostic (6.84e-2)" "unprognostic (3.57e-1)" "unprognostic (8.00e-2)" "unprognostic (2.46e-1)" "unprognostic (5.66e-2)" "prognostic unfavorable (9.23e-5)" "unprognostic (1.90e-2)" "unprognostic (3.37e-2)" "unprognostic (8.01e-3)" "unprognostic (3.02e-3)" "unprognostic (3.68e-2)" "unprognostic (2.22e-2)" "unprognostic (3.60e-1)" "unprognostic (1.14e-1)" "unprognostic (2.03e-3)" "unprognostic (1.09e-1)" 6.5 3.8 6.0 5.7 10.5 10.8 7.7 3.6 18.0 6.0 6.4 3.1 1.4 3.8 7.6 5.0 6.1 7.2 5.6 5.1 5.3 5.1 6.5 21.1 12.5 10.0 4.9 13.1 13.3 5.6 8.5 8.2 30.7 4.2 3.7 6.1 2.0 5.8 3.0 7.1 6.5 6.5 5.6 3.7 9.3 5.6 9.9 2.2 14.8 11.0 2.2 5.1 5.2 6.6 1.6 2.9 3.0 1.3 0.5 1.4 0.2 17.6 5.5 8.6 6.8 2.6 7.8 16.8 7.0 3.5 6.1 4.2 10.0 3.3 4.8 10.7 4.6 5.0 3.6 12.0 7.6 11.4 9.3 11.0 6.4 22.4 7.0 5.2 15.2 8.3 6.5 3.4 8.1 8.4 4.3 4.7 13.2 17.2 6.0 7.2 6.9 10.0 10.2 11.4 6.7 17.8 15.3 10.6 16.3 6.1 11.0 11.0 18.2 8.8 6.8 7.6 8.8 7.9 9.9 9.6 12.5 24.3 6.3 13.2 7.0 17.2 5.2 12.2 9.2 19.3 3.0 0.9 0.6 0.5 1.3 0.8 1.3 0.3 0.4 0.8 1.6 1.4 1.1 0.1 0.5 0.8 2.9 0.1 0.2 6.0 10.5 3.6 18.0 5.3 5.1 4.9 13.1 4.2 2.2 44.7 6.5 11.1 3.4 7.6 2.6 16.1 2.5 1.4 9.1 0.0 0.0 19.5 5.0 11.7 10.8 6.8 4.2 0.0 17.8 19.9 5.1 3.9 3.5 1.9 6.4 4.8 6.4 3.1 10.7 16.3 9.8 20.4 16.9 13.6 4.0 2.9 18.3 2.8 17.0 2.1 4.3 12.9 10.3 5.9 12.3 6.4 16.8 4.4 4.3 4.2 CHMP1B "C18orf2, CHMP1.5, Vps46B" ENSG00000255112 "Charged multivesicular body protein 1B" Q7LBR1 18 11851396-11854449 "Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "skeletal muscle: 250.9" "Cell type enhanced" "Detected in many" 5 "Suprabasal keratinocytes: 450.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061997, HPA062896" Supported Supported Nucleoplasm,Midbody Yes No "Nucleoplasm, Midbody" "HPA061997: AB_2684653, HPA062896: AB_2684898" "unprognostic (6.73e-2)" "unprognostic (5.35e-2)" "unprognostic (1.09e-2)" "unprognostic (6.74e-3)" "unprognostic (1.80e-1)" "unprognostic (1.35e-3)" "unprognostic (1.44e-1)" "unprognostic (8.44e-3)" "unprognostic (1.90e-1)" "unprognostic (9.44e-3)" "unprognostic (2.37e-3)" "unprognostic (9.20e-2)" "prognostic favorable (7.37e-8)" "unprognostic (1.88e-2)" "unprognostic (1.59e-1)" "unprognostic (2.53e-2)" "unprognostic (1.92e-1)" 16.0 13.6 14.9 12.5 11.6 19.5 13.3 8.8 16.0 10.1 14.1 10.0 13.8 14.0 10.4 14.7 14.5 9.1 14.6 17.0 11.2 12.3 12.2 11.2 11.3 14.0 11.6 11.9 11.3 11.2 9.7 12.4 11.8 12.1 10.3 14.1 9.4 12.6 29.5 250.9 15.2 20.4 11.6 13.8 11.3 12.8 6.8 10.0 14.2 19.9 19.4 9.9 14.3 10.1 6.7 13.1 34.4 16.5 7.4 9.1 10.6 12.3 12.1 15.7 13.3 20.6 14.5 22.8 13.2 22.4 9.0 12.1 15.6 12.4 7.7 19.9 14.3 15.1 10.6 7.1 18.4 8.1 7.1 8.8 5.5 18.5 12.8 15.3 21.2 9.6 21.0 39.9 10.1 23.5 20.3 13.0 17.6 9.4 10.0 14.2 15.3 14.6 16.3 6.6 39.4 6.1 7.5 8.1 13.1 24.1 17.0 15.3 15.3 22.5 10.6 20.2 15.3 8.6 19.6 19.0 20.3 10.7 16.0 14.1 12.0 13.7 9.8 18.8 9.9 9.6 10.9 16.5 27.7 7.2 15.3 6.6 6.5 6.7 8.5 13.1 6.7 8.4 7.7 34.4 7.4 15.0 11.7 9.1 10.6 14.9 11.6 8.8 16.0 11.2 12.3 11.6 11.9 12.1 10.0 62.5 46.0 82.1 114.0 372.7 31.1 17.9 56.0 44.2 44.3 125.6 7.9 122.5 51.4 101.8 65.5 63.6 178.4 0.0 71.3 124.5 68.5 78.7 149.7 34.7 112.4 27.0 137.9 43.0 124.4 36.5 35.1 124.4 150.1 100.0 90.8 29.6 115.6 199.9 35.0 109.2 14.1 77.6 64.8 16.4 20.6 450.0 211.8 80.6 63.8 219.0 CHMP2A "BC-2, CHMP2, VPS2, VPS2A" ENSG00000130724 "Charged multivesicular body protein 2A" O43633 19 58551566-58555124 "Predicted intracellular proteins" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041153, HPA042031" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 49000 Cytosol "Nucleoplasm, Plasma membrane" "HPA041153: AB_10964358, HPA042031: AB_10961727" "unprognostic (1.80e-1)" "unprognostic (4.70e-2)" "unprognostic (7.29e-2)" "unprognostic (1.44e-3)" "unprognostic (6.60e-2)" "unprognostic (2.54e-1)" "unprognostic (3.86e-2)" "unprognostic (2.60e-1)" "unprognostic (1.01e-1)" "unprognostic (1.45e-2)" "unprognostic (2.69e-1)" "unprognostic (1.45e-1)" "unprognostic (2.98e-1)" "unprognostic (2.21e-1)" "unprognostic (3.09e-2)" "unprognostic (4.23e-2)" "unprognostic (2.71e-2)" 40.7 59.6 52.5 37.3 56.7 55.1 41.2 36.3 44.8 39.0 53.2 37.8 50.4 43.5 36.9 61.7 57.4 41.9 60.4 80.6 45.0 40.1 64.8 66.5 36.4 55.8 48.2 38.7 36.9 59.8 46.9 39.1 79.2 38.5 35.2 49.2 33.0 62.4 64.8 75.7 54.9 72.0 42.4 48.5 43.4 45.2 29.4 35.1 34.0 49.8 53.9 44.4 42.5 34.0 17.5 30.5 117.2 34.7 17.0 29.4 24.9 18.0 48.6 15.7 14.4 24.3 30.5 19.4 16.7 34.7 8.9 9.7 14.3 26.9 4.8 24.7 27.9 25.8 14.7 12.9 31.9 7.6 16.1 106.0 11.8 35.6 21.9 47.1 19.5 18.5 35.3 45.3 13.9 44.7 30.4 25.8 22.8 14.0 23.1 26.9 30.5 24.7 18.1 6.5 50.0 37.3 10.7 13.5 36.2 38.8 41.0 18.5 31.4 27.2 36.4 20.0 10.3 27.9 20.0 29.0 45.6 6.6 13.2 19.3 58.9 64.4 15.7 32.1 23.2 29.9 33.5 34.7 46.6 20.2 31.7 17.0 17.5 22.3 22.7 30.5 15.8 15.7 17.7 117.2 17.0 31.6 27.8 29.4 24.9 52.5 56.7 36.3 44.8 45.0 40.1 48.2 38.7 38.5 35.1 92.3 99.1 97.2 231.9 147.1 67.2 100.3 152.8 155.2 81.9 157.1 15.7 253.5 374.7 261.4 89.0 137.1 466.3 70.0 457.0 242.2 112.6 224.1 116.8 190.9 235.9 49.3 149.1 122.8 143.9 66.0 134.3 151.3 204.1 239.9 215.7 135.6 375.5 326.1 125.2 436.3 71.4 84.1 139.8 101.7 97.9 173.4 384.7 105.5 183.9 310.0 CHMP7 MGC29816 ENSG00000147457 "Charged multivesicular body protein 7" Q8WUX9 8 23243637-23262000 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 76.1" "Cell type enhanced" "Detected in many" 4 "B-cells: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 31.7" "Group enriched" "Detected in all" 12 "B-cells: 15.2;T-cells: 31.7" "Cell line enhanced" "Detected in all" "Daudi: 24.9;U-698: 29.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036119 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036119: AB_10673000" "unprognostic (2.94e-3)" "unprognostic (1.64e-1)" "unprognostic (7.59e-3)" "unprognostic (4.51e-2)" "unprognostic (2.47e-1)" "unprognostic (2.83e-3)" "unprognostic (9.00e-2)" "unprognostic (1.84e-1)" "unprognostic (6.44e-2)" "unprognostic (2.74e-1)" "unprognostic (1.39e-1)" "unprognostic (8.98e-3)" "unprognostic (1.88e-2)" "unprognostic (6.80e-3)" "unprognostic (2.06e-1)" "unprognostic (7.54e-2)" "unprognostic (2.30e-1)" 6.4 12.7 7.3 29.2 7.4 15.4 11.0 10.5 9.2 7.5 9.2 5.6 6.4 8.1 10.0 4.5 7.5 7.3 7.6 9.8 6.3 8.0 6.9 7.4 7.2 48.8 7.8 5.8 8.1 12.4 4.4 7.0 5.3 7.3 7.4 7.3 4.1 12.5 7.9 13.8 7.5 13.7 9.8 6.5 26.2 10.5 7.0 6.8 76.1 7.7 5.9 43.3 9.3 13.7 15.2 1.3 1.8 1.9 1.8 31.7 11.8 3.9 5.3 2.9 4.9 2.7 2.7 3.3 3.3 2.3 4.7 4.0 6.1 3.0 24.9 3.9 2.3 4.5 3.7 2.7 3.9 1.8 6.7 5.0 5.2 6.9 3.2 2.4 1.3 7.5 2.3 2.7 4.6 1.3 2.6 3.8 10.8 5.8 3.4 2.7 3.9 4.4 5.8 4.7 3.8 4.1 1.8 2.4 3.4 2.4 5.1 3.7 3.6 2.5 3.7 1.4 1.6 4.0 2.8 4.3 5.8 3.8 4.1 2.5 9.9 5.2 29.8 4.5 4.2 4.3 0.4 1.9 1.8 2.5 1.7 5.2 14.6 16.6 7.7 1.3 15.2 31.7 17.9 1.7 1.8 1.2 1.1 17.3 11.8 7.3 7.4 10.5 9.2 6.3 8.0 7.8 5.8 7.3 6.8 6.0 6.4 49.8 13.7 12.0 9.2 11.6 7.6 5.3 4.5 14.0 3.9 13.5 16.6 17.9 32.6 9.8 13.9 0.0 13.8 15.6 10.2 11.9 11.5 6.4 13.8 12.7 13.2 6.2 6.3 8.9 9.2 9.2 15.1 12.6 11.8 18.4 16.4 10.8 9.9 16.1 10.1 6.5 13.4 14.2 15.2 9.4 17.3 8.7 9.9 17.6 CHN2 "ARHGAP3, RhoGAP3" ENSG00000106069 "Chimerin 2" P52757 7 29146569-29514328 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 89.2;intestine: 44.3" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 299.6;Early spermatids: 94.3;Hepatocytes: 85.0;Late spermatids: 83.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 18.6;HMC-1: 36.3" "HPA018989, HPA019026" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA018989: AB_1846681, HPA019026: " "unprognostic (3.88e-2)" "unprognostic (2.36e-1)" "unprognostic (6.87e-2)" "unprognostic (2.56e-1)" "unprognostic (1.52e-1)" "unprognostic (8.12e-2)" "unprognostic (6.87e-2)" "unprognostic (1.19e-1)" "unprognostic (6.64e-2)" "unprognostic (4.71e-2)" "unprognostic (7.54e-2)" "unprognostic (7.85e-2)" "unprognostic (1.61e-2)" "unprognostic (1.68e-1)" "unprognostic (1.18e-1)" "unprognostic (1.15e-2)" "unprognostic (1.58e-3)" 2.7 4.4 7.9 3.3 21.8 1.4 2.1 89.2 14.7 6.6 14.1 19.2 0.3 44.3 2.7 2.1 1.9 5.0 4.8 6.9 10.5 7.0 8.2 22.0 3.7 2.0 34.7 6.9 13.4 13.9 0.5 1.9 6.4 16.5 5.3 5.9 4.6 1.6 2.9 2.7 1.5 36.3 3.0 16.5 5.1 4.2 2.3 29.2 0.8 4.7 0.0 1.7 3.5 4.0 0.3 8.5 3.9 11.2 9.3 2.5 2.6 0.1 0.4 1.6 0.0 0.0 0.0 9.7 0.0 0.0 0.4 0.0 5.1 1.5 0.5 3.1 0.1 0.6 2.7 5.1 0.0 0.0 9.1 1.7 18.6 0.8 9.9 0.1 0.0 36.3 0.0 3.4 0.0 0.7 0.0 1.9 3.0 0.7 0.2 0.1 0.2 5.0 0.2 0.6 3.4 1.8 0.4 0.0 1.0 9.4 6.3 9.7 0.7 2.2 3.3 5.9 5.5 0.3 1.0 0.2 0.5 0.1 0.0 0.2 1.8 7.1 0.0 0.1 1.1 0.7 3.9 10.5 0.1 2.5 11.2 1.8 0.3 0.4 2.2 8.5 0.2 0.5 1.0 0.6 9.3 6.4 1.0 0.0 2.6 7.9 21.8 89.2 14.7 10.5 7.0 34.7 6.9 16.5 29.2 6.0 5.1 1.4 0.6 2.4 299.6 10.6 2.5 10.7 3.4 3.5 41.2 22.2 0.0 0.2 94.3 5.5 13.6 0.0 1.8 28.5 3.4 1.2 23.1 85.0 15.9 6.4 37.7 1.8 19.1 83.5 4.6 19.6 16.9 0.0 18.9 8.5 0.3 12.9 4.6 1.6 15.0 0.0 1.1 2.3 5.9 0.5 13.7 15.2 8.6 0.6 CHPF2 "ChSy-3, CSGlcA-T, KIAA1402" ENSG00000033100 "Chondroitin polymerizing factor 2" Q9P2E5 7 151232489-151238827 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020992 Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Nucleoplasm, Cytosol" "HPA020992: AB_1847267" "unprognostic (8.31e-2)" "unprognostic (2.14e-3)" "unprognostic (1.02e-3)" "unprognostic (1.14e-1)" "unprognostic (4.79e-3)" "unprognostic (5.25e-2)" "prognostic unfavorable (9.47e-4)" "unprognostic (4.07e-1)" "unprognostic (1.71e-1)" "unprognostic (4.54e-2)" "prognostic favorable (2.51e-4)" "unprognostic (1.04e-1)" "unprognostic (2.68e-3)" "unprognostic (2.24e-1)" "unprognostic (1.49e-1)" "unprognostic (3.22e-2)" "unprognostic (8.59e-3)" 13.5 29.3 13.4 19.0 12.9 22.6 19.1 13.1 20.2 15.3 14.4 11.4 20.7 14.9 19.5 16.9 13.3 14.9 17.6 18.8 13.7 12.5 14.9 20.7 17.4 23.4 11.4 17.4 14.4 23.7 16.7 41.5 18.6 11.8 18.5 10.8 12.2 25.4 19.8 7.9 14.2 17.1 17.3 9.4 28.1 20.1 12.9 11.1 16.2 17.5 7.4 13.7 18.9 12.8 2.7 9.5 9.9 5.6 2.6 5.7 3.7 9.0 7.4 5.0 14.5 17.4 17.3 7.5 19.1 29.8 10.4 12.7 4.9 15.4 2.7 33.8 30.3 14.2 11.4 2.2 13.6 4.5 10.4 6.8 2.9 8.1 6.8 16.3 5.8 24.2 26.4 7.7 9.8 3.5 21.6 16.3 4.6 2.7 8.0 16.5 14.9 5.4 22.9 6.6 3.8 8.6 5.1 2.9 9.1 10.1 7.2 5.4 9.6 10.2 10.1 4.8 3.9 3.9 9.6 22.2 11.6 1.9 15.3 16.1 14.8 2.1 4.0 42.1 7.8 15.6 1.2 5.6 7.9 5.7 5.1 5.4 2.7 3.1 5.1 6.3 2.7 2.2 2.3 9.9 2.6 5.0 9.5 3.4 3.7 13.4 12.9 13.1 20.2 13.7 12.5 11.4 17.4 11.8 11.1 8.9 10.2 11.5 4.8 4.0 9.5 1.6 12.7 4.0 4.5 10.4 3.9 9.1 1.7 10.3 0.5 4.7 10.2 23.3 14.5 12.1 9.7 9.5 5.8 8.3 11.2 23.8 8.1 13.5 11.6 0.7 15.8 8.5 6.8 7.2 10.1 4.3 14.8 15.9 14.2 3.3 6.9 19.4 6.2 3.4 1.7 3.9 8.6 12.1 8.1 8.9 CHRAC1 "CHRAC15, YCL1" ENSG00000104472 "Chromatin accessibility complex 1" Q9NRG0 8 140511298-140517137 "Predicted intracellular proteins" "DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059008 Approved Nucleoplasm NA NA Nucleoplasm "HPA059008: AB_2683878" "unprognostic (6.34e-2)" "unprognostic (7.32e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (2.28e-4)" "unprognostic (1.29e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (4.88e-5)" "unprognostic (8.79e-3)" "unprognostic (1.86e-1)" "prognostic favorable (9.72e-4)" "prognostic unfavorable (5.43e-4)" "unprognostic (4.19e-1)" "unprognostic (6.22e-3)" "unprognostic (7.61e-2)" "unprognostic (1.01e-1)" "unprognostic (6.92e-2)" "unprognostic (1.49e-1)" 24.3 14.7 12.1 15.9 16.0 23.3 18.0 10.1 14.2 17.3 20.9 23.8 11.9 15.5 20.4 12.7 24.1 16.1 19.8 18.7 13.7 10.4 21.4 24.3 16.5 21.6 19.2 7.7 18.2 17.7 15.5 13.1 21.0 13.6 17.8 16.2 17.2 17.6 20.1 28.4 19.1 24.3 21.2 20.8 22.2 18.2 26.1 21.6 36.4 27.5 19.3 24.9 19.3 15.8 19.6 19.5 21.4 23.5 16.1 16.0 12.5 22.4 10.9 10.3 9.7 10.3 17.5 7.8 9.6 14.1 14.1 17.2 14.0 16.3 23.3 14.4 11.8 11.2 14.1 12.2 9.9 19.6 17.8 12.8 33.0 15.2 15.7 9.7 10.9 17.5 8.7 14.5 10.4 20.3 7.6 13.5 14.4 24.3 22.3 12.5 26.4 38.2 11.8 7.5 19.8 18.4 23.1 10.8 18.5 14.1 9.4 14.1 11.7 13.5 9.2 17.0 5.8 17.8 12.6 12.7 16.8 29.3 20.6 20.3 10.7 13.9 28.3 20.2 26.1 13.0 8.7 17.0 20.3 16.0 22.4 15.7 17.3 14.4 15.8 18.7 19.6 15.2 12.6 21.4 16.1 23.5 19.5 12.7 12.5 12.1 16.0 10.1 14.2 13.7 10.4 19.2 7.7 13.6 21.6 14.9 25.1 31.5 36.8 34.1 6.9 11.6 20.4 16.0 29.6 14.0 2.0 19.7 36.5 19.4 15.6 29.5 21.9 0.0 31.3 42.0 24.9 26.9 32.3 18.4 21.6 6.4 20.7 30.1 29.5 26.2 27.0 33.4 18.6 31.5 20.5 25.3 27.4 18.6 23.7 24.5 10.7 71.1 38.1 72.7 63.0 42.4 20.1 29.9 19.3 30.6 CHRM1 ENSG00000168539 "Cholinergic receptor muscarinic 1" P11229 11 62908679-62921807 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 34.7;prostate: 28.2;salivary gland: 25.3" "Group enriched" "Detected in some" 6 "Glandular cells: 2.0;Melanocytes: 3.3;Mucus-secreting cells: 2.1" "Cancer enriched" "Detected in some" 16 "prostate cancer: 27.9" "Group enriched" "Detected in many" 10 "amygdala: 13.2;basal ganglia: 22.0;cerebral cortex: 34.7;hippocampal formation: 14.2;olfactory region: 14.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "MCF7: 4.9;OE19: 15.2" "Group enriched" "Detected in many" 9 "amygdala: 74.1;basal ganglia: 65.6;cerebral cortex: 83.5;hippocampal formation: 100.4;olfactory region: 36.8" "HPA014101, CAB022366" Enhanced Supported Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB022366: , HPA014101: AB_1854210" "unprognostic (3.19e-2)" "unprognostic (2.14e-1)" "unprognostic (2.25e-1)" "unprognostic (1.31e-2)" "unprognostic (7.94e-2)" "unprognostic (2.29e-1)" "unprognostic (1.16e-2)" "unprognostic (2.89e-2)" "unprognostic (1.91e-1)" "unprognostic (2.76e-1)" "unprognostic (2.08e-1)" "unprognostic (8.57e-4)" "unprognostic (4.88e-1)" "unprognostic (6.43e-2)" "unprognostic (1.75e-1)" 0.5 3.7 13.2 0.8 22.0 0.5 3.2 0.2 34.7 0.6 1.3 0.5 0.0 1.0 0.7 0.6 0.8 0.8 0.7 0.6 14.2 1.7 0.7 0.6 2.9 0.6 1.4 14.0 0.5 1.2 1.0 0.1 0.8 0.1 28.2 1.3 1.3 25.3 0.6 0.6 2.6 1.3 0.6 0.3 0.6 1.9 0.6 1.8 0.0 0.8 0.0 0.7 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.1 0.1 15.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.4 0.1 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 22.0 0.2 34.7 14.2 1.7 1.4 14.0 0.1 1.8 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 CHRM4 ENSG00000180720 "Cholinergic receptor muscarinic 4" P08173 11 46385098-46386608 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.7;intestine: 8.0;lymphoid tissue: 17.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 5.0;SCLC-21H: 14.5;U-2 OS: 4.2" "Group enriched" "Detected in many" 6 "amygdala: 26.8;basal ganglia: 65.9;cerebral cortex: 30.5;hippocampal formation: 26.4;olfactory region: 36.4" "Group enriched" "Detected in many" 7 "amygdala: 5.5;basal ganglia: 15.3;cerebral cortex: 8.6;hippocampal formation: 7.6;olfactory region: 20.1" "CAB022444, HPA072083" Enhanced Uncertain "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "CAB022444: , HPA072083: " "unprognostic (7.11e-2)" "unprognostic (3.79e-1)" "unprognostic (5.31e-2)" "unprognostic (7.38e-2)" "unprognostic (8.63e-3)" "unprognostic (1.38e-1)" "unprognostic (6.02e-2)" "unprognostic (1.03e-1)" "unprognostic (1.48e-1)" "unprognostic (2.96e-3)" "unprognostic (4.08e-3)" "unprognostic (5.02e-2)" "unprognostic (3.83e-2)" "unprognostic (3.64e-1)" "unprognostic (1.71e-1)" "unprognostic (3.56e-1)" "unprognostic (5.08e-2)" 0.0 0.5 1.1 0.2 11.7 1.6 0.0 0.0 6.0 0.0 0.6 3.7 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 1.2 8.0 0.1 0.0 17.2 0.8 4.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.7 0.3 0.1 0.2 0.0 3.0 0.0 0.1 0.2 0.1 1.5 0.2 0.3 0.3 0.0 2.6 0.1 1.8 0.1 0.0 2.2 0.3 0.5 0.2 0.0 0.2 0.5 0.6 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.6 0.2 0.0 1.1 0.2 0.2 0.6 0.1 0.2 0.0 5.0 0.0 0.0 0.1 14.5 0.4 0.4 0.1 0.1 0.3 0.1 2.4 0.0 0.4 4.2 0.0 0.1 0.8 0.6 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHRND ACHRD ENSG00000135902 "Cholinergic receptor nicotinic delta subunit" Q07001 2 232525993-232536667 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skeletal muscle: 49.1" "Cell type enriched" "Detected in single" 11 "Muller glia cells: 4.3" "Cancer enriched" "Detected in single" 7 "head and neck cancer: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 72 "RH-30: 43.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "olfactory region: 1.4" "HPA056404, HPA065404" Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA056404: AB_2732603, HPA065404: AB_2732734" "unprognostic (1.69e-2)" "unprognostic (7.93e-2)" "unprognostic (3.28e-3)" "unprognostic (7.75e-3)" "unprognostic (6.04e-2)" "unprognostic (1.10e-1)" "unprognostic (7.25e-2)" "unprognostic (1.90e-1)" "unprognostic (4.97e-8)" "unprognostic (7.52e-2)" "unprognostic (2.86e-1)" "unprognostic (2.46e-1)" 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 49.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 43.8 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHST2 C6ST ENSG00000175040 "Carbohydrate sulfotransferase 2" Q9Y4C5 3 143119331-143124014 "Predicted membrane proteins" "Carbohydrate metabolism, Inflammatory response" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.9" "Group enriched" "Detected in many" 4 "Muller glia cells: 106.5;Sertoli cells: 90.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 11.4" "Group enriched" "Detected in many" 4 "monocytes: 11.4;NK-cells: 4.8" "Cell line enhanced" "Detected in many" "ASC diff: 20.5;ASC TERT1: 21.0;HEL: 16.2;HHSteC: 42.2;HMC-1: 19.4;HSkMC: 22.1;U-266/70: 18.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013620 Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA013620: AB_2668861" "unprognostic (1.55e-2)" "unprognostic (2.20e-1)" "unprognostic (7.64e-3)" "unprognostic (2.75e-1)" "unprognostic (8.97e-3)" "unprognostic (2.83e-1)" "unprognostic (2.70e-2)" "unprognostic (2.06e-1)" "unprognostic (2.76e-1)" "unprognostic (4.11e-2)" "unprognostic (8.96e-3)" "unprognostic (9.15e-2)" "unprognostic (1.31e-2)" "unprognostic (7.57e-2)" "unprognostic (1.67e-1)" "unprognostic (2.58e-3)" "unprognostic (1.34e-1)" 6.5 2.6 8.2 11.6 16.6 20.0 4.1 9.8 15.1 4.6 3.1 6.5 2.6 3.6 6.4 2.7 2.0 1.6 3.1 2.6 7.3 10.4 4.8 1.6 5.1 10.2 10.6 5.8 3.6 2.0 1.5 5.5 15.3 14.0 7.6 2.3 5.9 4.0 15.9 2.7 3.0 4.9 6.0 32.9 17.0 5.4 2.3 4.8 24.7 5.4 0.1 8.1 7.4 5.4 1.4 1.8 0.8 11.4 4.8 0.8 0.9 0.0 0.1 1.0 0.9 20.5 21.0 0.0 1.1 3.2 0.8 0.7 0.0 0.0 0.2 0.7 0.7 1.1 0.0 0.7 2.7 0.4 0.2 0.5 16.2 0.0 0.0 42.2 0.4 19.4 22.1 3.4 1.0 3.5 1.2 1.2 2.5 1.8 1.0 5.3 0.0 3.0 4.1 5.8 0.0 2.7 0.1 0.3 0.0 0.6 0.7 1.3 0.0 0.2 0.0 1.8 1.0 0.0 0.6 4.2 2.5 1.4 3.3 4.7 18.6 0.2 1.1 4.8 3.1 12.8 0.7 0.6 0.8 0.4 4.5 0.0 1.4 0.1 0.2 1.8 1.0 0.8 0.6 0.3 4.8 11.4 0.1 0.5 0.9 8.2 16.6 9.8 15.1 7.3 10.4 10.6 5.8 14.0 4.8 0.0 0.0 14.2 7.0 2.2 20.1 1.2 0.0 0.0 2.3 3.5 2.0 0.4 0.0 0.3 0.1 6.4 0.0 23.3 0.2 0.3 7.1 9.4 11.5 0.0 2.8 1.6 0.0 4.3 6.4 0.4 11.8 13.0 16.9 9.0 0.0 106.5 3.5 0.0 2.1 0.0 19.2 90.5 5.5 0.0 1.9 0.5 0.8 8.7 0.0 15.6 CHST7 "C6ST-2, C6ST2" ENSG00000147119 "Carbohydrate sulfotransferase 7" Q9NS84 X 46573784-46598408 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "monocytes: 91.0;Peritubular cells: 56.6;Sertoli cells: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 15.4" "Group enriched" "Detected in many" 10 "granulocytes: 9.4;monocytes: 8.0;T-cells: 15.4" "Cell line enhanced" "Detected in many" "EFO-21: 18.0;HHSteC: 13.4;NTERA-2: 16.1;PC-3: 13.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA003919, HPA030503" Approved Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Nucleoplasm, Vesicles" "HPA003919: AB_10601258, HPA030503: " "unprognostic (3.16e-1)" "prognostic favorable (7.20e-4)" "unprognostic (1.11e-1)" "unprognostic (2.66e-1)" "unprognostic (1.82e-2)" "unprognostic (7.85e-2)" "unprognostic (9.82e-3)" "unprognostic (3.52e-2)" "unprognostic (2.61e-1)" "unprognostic (2.81e-1)" "unprognostic (2.39e-3)" "unprognostic (6.71e-2)" "unprognostic (1.19e-1)" "unprognostic (8.85e-3)" "unprognostic (8.28e-2)" "unprognostic (1.50e-1)" "unprognostic (4.39e-2)" 13.1 7.5 4.9 3.8 6.6 4.7 12.1 4.7 10.3 10.5 4.4 3.6 2.5 2.2 5.0 4.1 4.2 3.2 10.7 25.6 4.1 4.0 3.6 11.0 5.4 3.7 4.5 4.7 27.0 3.4 2.4 3.4 5.9 3.6 3.9 2.2 1.4 2.7 3.7 4.3 5.4 3.3 3.5 1.9 17.1 3.4 3.6 1.8 2.4 4.2 1.4 2.0 4.1 8.7 1.0 1.0 9.4 8.0 0.4 15.4 1.6 4.1 3.5 3.0 2.7 8.6 6.0 0.1 5.8 4.2 1.5 2.1 0.9 1.6 0.0 18.0 2.4 1.0 3.1 2.9 1.0 1.3 2.4 6.3 0.8 0.3 3.1 13.4 1.4 0.1 2.1 0.9 2.9 2.4 2.7 4.8 1.9 0.0 3.7 1.1 1.9 0.5 1.8 16.1 0.3 13.4 2.7 2.5 7.5 4.2 0.1 6.9 2.7 0.8 0.2 0.7 7.9 1.0 0.3 1.1 4.9 0.5 2.6 2.7 8.7 1.8 1.3 5.4 0.0 0.3 1.2 1.9 0.6 1.4 5.9 1.3 1.0 5.3 2.5 1.0 0.6 1.1 1.0 9.4 0.4 8.0 0.6 15.4 1.6 4.9 6.6 4.7 10.3 4.1 4.0 4.5 4.7 3.6 1.8 0.0 1.9 3.7 1.7 11.0 0.8 5.5 5.1 1.4 1.2 1.8 0.0 3.4 1.7 2.2 0.0 9.8 1.0 0.0 2.2 3.5 12.2 3.3 0.0 2.9 10.3 3.2 0.0 17.2 8.6 0.0 17.5 7.9 13.5 91.0 2.3 3.8 1.9 1.1 56.6 1.1 0.7 51.8 10.3 0.5 1.2 11.5 1.1 7.5 0.7 1.4 CHTF18 "C16orf41, C321D2.4, CHL12, Ctf18" ENSG00000127586 "Chromosome transmission fidelity factor 18" Q8WVB6 16 788046-800737 "Predicted intracellular proteins" "Cell cycle, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 20.9;Extravillous trophoblasts: 16.6;Spermatogonia: 23.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 28.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040976, HPA056209" Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040976: AB_2677232, HPA056209: AB_2683066" "unprognostic (3.83e-2)" "unprognostic (4.97e-2)" "unprognostic (4.25e-2)" "unprognostic (9.35e-2)" "unprognostic (4.59e-2)" "unprognostic (3.02e-3)" "unprognostic (1.80e-3)" "unprognostic (3.02e-2)" "unprognostic (2.61e-1)" "unprognostic (1.19e-1)" "unprognostic (4.00e-2)" "unprognostic (1.44e-2)" "prognostic unfavorable (1.43e-8)" "unprognostic (2.07e-2)" "unprognostic (1.55e-1)" "unprognostic (9.89e-2)" "prognostic favorable (2.78e-4)" 2.4 3.1 8.3 6.7 5.6 16.8 3.1 11.1 4.7 5.0 5.3 4.1 4.1 6.1 4.1 2.8 5.1 3.2 2.4 1.7 2.7 2.3 2.6 2.0 2.9 4.4 4.4 4.6 5.2 3.1 0.7 2.4 4.1 3.5 3.2 1.7 4.0 4.0 2.6 2.4 8.3 7.2 1.8 2.3 5.9 6.7 11.3 4.3 15.5 3.1 3.8 7.3 2.9 3.6 1.0 1.4 4.6 3.0 2.1 2.4 0.7 8.0 3.9 3.2 2.6 0.3 0.2 28.4 5.1 1.4 2.6 1.8 7.0 6.2 9.1 5.3 0.8 1.3 9.0 0.7 3.9 0.0 5.1 11.6 4.0 4.6 3.6 0.0 2.5 7.9 0.1 0.5 2.5 1.3 0.3 2.2 9.5 6.0 3.0 0.6 15.5 9.7 9.3 4.2 1.8 4.8 17.5 8.2 11.8 0.8 2.3 4.2 5.4 3.7 8.2 2.7 0.4 6.0 6.0 1.4 3.8 14.0 6.9 6.8 7.2 2.4 5.1 1.2 3.6 6.6 4.6 0.6 0.0 2.4 3.0 1.5 0.4 1.1 1.9 1.4 1.0 1.3 0.3 0.3 2.1 1.6 0.8 1.4 0.7 8.3 5.6 11.1 4.7 2.7 2.3 4.4 4.6 3.5 4.3 3.0 3.4 3.7 3.2 4.7 20.9 3.6 0.0 2.7 3.4 1.8 2.0 10.9 1.7 2.4 1.0 1.8 0.9 0.0 3.3 16.6 3.3 1.0 4.6 1.8 5.4 6.4 6.3 2.5 2.1 1.1 1.7 2.9 0.0 0.0 3.3 2.8 1.6 0.0 1.4 0.7 6.7 0.0 3.3 13.3 23.5 1.8 7.2 2.5 3.3 1.4 CHTF8 "CTF8, DERPC, FLJ20400" ENSG00000168802 "Chromosome transmission fidelity factor 8" "P0CG12, P0CG13" 16 69118010-69132584 "Predicted intracellular proteins" "Cell cycle, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051872, HPA065522" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA051872: AB_2681647, HPA065522: AB_2685503" "unprognostic (7.86e-3)" "unprognostic (1.99e-2)" "unprognostic (2.59e-2)" "unprognostic (2.46e-2)" "unprognostic (6.44e-2)" "unprognostic (1.75e-2)" "unprognostic (1.73e-2)" "unprognostic (9.86e-3)" "unprognostic (9.88e-2)" "unprognostic (7.45e-2)" "unprognostic (2.96e-1)" "unprognostic (1.02e-1)" "prognostic favorable (3.59e-9)" "unprognostic (3.74e-2)" "unprognostic (1.85e-1)" "unprognostic (3.75e-2)" "unprognostic (1.45e-1)" 27.8 29.9 20.5 25.1 26.8 12.7 34.3 18.5 24.4 29.3 27.8 18.8 36.3 18.4 33.5 40.5 33.1 38.5 26.0 25.7 18.5 15.5 42.0 46.8 27.2 32.2 24.8 23.0 30.9 60.8 37.0 27.6 38.0 17.6 31.4 26.7 31.4 38.7 30.2 22.9 30.4 30.3 30.0 18.7 37.9 30.9 32.1 20.6 51.5 56.9 23.2 37.1 27.8 32.4 35.7 32.5 46.9 35.7 26.3 32.9 32.2 34.2 31.7 42.7 27.3 35.0 34.0 33.4 30.7 29.5 49.2 41.0 34.9 48.9 35.7 40.0 28.3 27.9 41.7 45.4 52.7 41.6 24.4 24.3 36.6 23.2 20.4 29.3 36.0 37.4 29.5 36.2 38.6 28.2 34.9 50.0 28.3 40.3 15.0 41.3 30.0 41.4 35.4 41.1 45.5 24.8 59.1 22.6 46.9 40.1 26.5 36.3 29.4 43.9 19.4 35.9 37.6 34.6 45.1 31.6 30.5 28.8 17.9 27.4 29.2 37.9 53.6 27.6 25.2 34.1 46.9 32.5 28.6 27.1 35.7 30.8 30.5 27.8 31.5 32.5 35.7 28.6 27.2 18.1 26.3 34.9 29.3 32.9 32.2 20.5 26.8 18.5 24.4 18.5 15.5 24.8 23.0 17.6 20.6 14.9 13.9 29.5 17.9 12.8 11.5 12.2 25.5 13.4 7.9 22.7 3.9 56.7 51.4 34.5 5.0 19.0 27.1 0.0 41.8 56.3 18.4 24.1 6.9 34.5 37.5 6.4 27.1 29.4 28.0 14.3 19.8 22.2 11.8 45.9 27.7 18.0 36.9 23.0 25.5 53.5 7.9 6.5 14.7 22.1 41.9 15.1 55.7 20.1 28.1 16.0 CHUK "IkBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16" ENSG00000213341 "Conserved helix-loop-helix ubiquitous kinase" O15111 10 100188298-100229619 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001402, CAB004240, CAB018564" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004240: AB_627784, CAB018564: AB_649197, HPA001402: AB_1079125" "unprognostic (8.61e-3)" "unprognostic (1.70e-1)" "unprognostic (3.74e-2)" "unprognostic (3.01e-1)" "unprognostic (3.02e-2)" "unprognostic (5.93e-2)" "unprognostic (4.02e-2)" "unprognostic (2.09e-1)" "unprognostic (8.58e-2)" "unprognostic (8.39e-2)" "unprognostic (6.73e-2)" "unprognostic (1.49e-1)" "prognostic favorable (1.27e-4)" "unprognostic (2.48e-2)" "unprognostic (1.95e-1)" "unprognostic (1.88e-3)" "unprognostic (2.22e-1)" 16.6 16.6 14.0 14.3 18.9 21.3 14.2 16.0 15.8 11.8 15.0 13.0 13.9 16.1 14.7 12.4 13.5 12.0 11.7 14.5 13.3 17.6 27.2 35.8 14.0 20.8 17.9 6.9 11.4 14.5 19.6 18.2 14.2 16.4 12.9 17.6 9.5 13.9 12.5 23.6 11.0 20.6 16.1 18.6 18.7 15.1 12.5 15.6 22.5 14.5 11.7 15.5 13.8 13.6 3.7 3.4 7.2 4.8 4.0 4.3 1.4 15.8 13.5 13.8 20.6 13.3 12.0 10.6 20.3 20.0 19.0 23.2 15.1 9.4 21.6 12.0 13.8 13.2 15.8 23.0 10.7 21.3 22.9 19.9 14.3 10.7 16.6 11.4 26.4 21.1 9.6 11.5 21.8 21.4 13.2 13.5 17.9 16.2 17.9 20.6 9.6 20.9 16.3 9.0 12.7 9.9 13.7 15.4 9.8 12.0 10.3 8.3 12.3 11.0 8.5 17.6 11.4 17.0 16.2 14.1 11.9 13.4 12.9 23.0 21.1 19.0 21.0 13.0 21.5 9.4 2.6 3.0 5.1 2.4 4.8 4.0 3.7 3.0 4.3 3.4 2.1 3.3 4.2 7.2 4.0 3.2 2.1 2.8 1.4 14.0 18.9 16.0 15.8 13.3 17.6 17.9 6.9 16.4 15.6 11.9 7.8 9.0 4.9 17.5 5.0 6.9 5.1 4.0 4.5 5.2 2.0 5.5 10.0 6.6 6.7 8.3 8.3 0.0 10.3 6.5 5.6 8.2 8.1 13.0 9.4 12.7 5.8 6.2 17.2 6.1 5.8 10.7 6.8 11.8 6.3 4.8 7.9 6.6 5.6 15.3 4.8 19.4 8.1 8.0 13.6 16.7 11.6 7.5 6.0 10.9 CIAO1 "CIA1, WDR39" ENSG00000144021 "Cytosolic iron-sulfur assembly component 1" O76071 2 96266132-96273349 "Predicted intracellular proteins" "Chromosome partition" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017882 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA017882: AB_1846738" "unprognostic (2.34e-1)" "unprognostic (4.68e-2)" "unprognostic (5.32e-2)" "prognostic unfavorable (4.13e-5)" "unprognostic (1.55e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (1.14e-4)" "unprognostic (9.86e-2)" "unprognostic (5.16e-2)" "unprognostic (1.32e-1)" "unprognostic (1.60e-1)" "unprognostic (1.83e-2)" "unprognostic (5.23e-3)" "unprognostic (8.72e-2)" "unprognostic (2.33e-1)" "unprognostic (5.26e-2)" "unprognostic (2.15e-2)" 19.8 39.7 23.6 22.2 27.6 11.1 21.4 17.9 31.9 22.1 18.4 19.9 22.3 20.4 19.4 16.5 24.0 22.3 18.3 26.1 18.3 18.2 25.4 32.5 17.7 17.7 19.2 22.7 20.4 22.2 30.6 17.8 22.2 24.5 16.4 21.1 19.2 22.0 23.5 26.1 16.3 18.5 21.5 19.7 21.8 19.3 19.1 19.0 21.6 19.4 12.2 26.0 19.9 16.9 29.6 39.8 33.1 39.7 25.9 35.2 38.5 20.8 21.0 16.0 14.8 20.6 16.7 26.1 16.1 17.1 26.0 25.7 35.7 15.5 22.1 34.2 19.9 27.8 16.0 24.6 23.8 18.8 11.7 40.6 17.0 15.6 38.6 13.3 19.7 15.5 16.7 19.1 21.6 27.1 15.8 29.0 18.5 21.7 15.1 17.6 33.1 19.6 18.5 22.4 20.7 42.6 19.8 14.1 25.6 17.1 19.6 17.2 19.7 10.0 27.4 19.2 20.8 13.7 14.5 14.9 16.3 23.2 19.3 21.3 20.7 21.8 19.6 21.1 19.2 15.9 30.6 35.3 33.1 32.7 29.3 35.2 25.3 28.7 34.9 39.8 29.6 28.5 34.2 32.4 25.9 39.7 24.0 27.6 38.5 23.6 27.6 17.9 31.9 18.3 18.2 19.2 22.7 24.5 19.0 26.8 26.1 20.5 22.6 25.8 22.9 22.2 15.3 44.2 28.4 14.0 13.7 47.9 33.2 34.2 15.1 24.5 20.7 0.0 29.2 49.0 27.1 21.4 34.8 26.0 40.8 25.4 15.1 16.0 26.9 18.2 18.7 27.5 18.6 45.1 16.9 17.9 30.2 11.5 15.6 66.2 22.6 32.3 23.1 34.8 37.9 30.2 41.6 30.4 20.6 36.3 CIART "BC017397, C1orf51" ENSG00000159208 "Circadian associated repressor of transcription" Q8N365 1 150282543-150287093 "Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 19 "Bipolar cells: 40.0;Cone photoreceptor cells: 96.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "MAIT T-cell: 3.4;memory CD4 T-cell: 3.8;naive CD4 T-cell: 2.4;naive CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 38 "T-cells: 3.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 16.2;Karpas-707: 23.6;U-266/84: 16.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027515, HPA054349" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA027515: AB_10600757, HPA054349: AB_2682457" "unprognostic (1.77e-1)" "unprognostic (5.63e-2)" "unprognostic (4.15e-2)" "unprognostic (4.58e-1)" "unprognostic (4.76e-2)" "unprognostic (4.42e-1)" "unprognostic (5.99e-3)" "unprognostic (2.29e-2)" "unprognostic (1.47e-1)" "unprognostic (1.31e-1)" "unprognostic (1.89e-1)" "unprognostic (4.54e-2)" "unprognostic (1.01e-2)" "unprognostic (1.16e-1)" "unprognostic (1.45e-1)" "unprognostic (1.64e-1)" "unprognostic (2.34e-2)" 4.8 10.0 6.9 2.9 18.4 0.6 6.7 14.2 26.5 9.1 11.8 6.3 11.1 3.0 7.4 8.2 7.3 6.2 4.0 23.5 5.4 7.1 8.3 11.5 3.0 2.1 4.9 5.8 11.5 4.4 7.5 10.6 2.6 8.4 7.2 2.8 20.5 14.2 21.1 40.2 19.7 4.9 12.9 3.1 2.4 7.3 6.3 4.2 0.8 16.1 19.6 6.5 10.3 5.2 0.0 0.0 0.0 0.0 0.0 3.8 0.3 0.1 0.6 4.8 2.2 1.8 0.8 4.1 2.9 7.1 3.8 5.0 1.1 16.2 0.0 5.0 6.2 8.6 2.8 0.1 2.8 5.7 0.0 0.4 0.1 0.2 0.0 6.5 0.9 2.4 2.5 4.3 9.6 2.0 8.9 0.6 0.1 0.1 23.6 2.1 12.5 0.0 0.5 5.3 2.8 11.9 0.6 0.0 0.1 3.8 0.6 2.5 0.9 4.8 0.4 8.6 1.2 4.1 0.4 1.2 10.8 0.1 0.4 6.3 5.0 16.8 0.1 9.7 0.0 6.4 0.0 0.0 0.0 0.5 0.0 3.4 0.0 3.8 0.0 0.0 0.0 2.4 1.2 0.0 0.0 0.0 0.0 0.3 0.3 6.9 18.4 14.2 26.5 5.4 7.1 4.9 5.8 8.4 4.2 0.0 1.0 0.0 5.3 0.0 40.0 5.6 5.1 1.4 2.3 0.0 96.2 0.2 8.3 2.5 0.2 1.1 1.3 0.0 1.3 0.1 0.0 3.5 0.0 3.0 1.0 6.4 2.4 0.6 0.0 1.1 4.9 0.3 0.0 1.8 0.3 18.4 3.1 0.3 8.9 2.6 18.0 0.0 2.9 4.3 7.9 0.0 0.0 0.0 0.6 1.0 CIB1 "CIB, KIP, SIP2-28" ENSG00000185043 "Calcium and integrin binding 1" Q99828 15 90229975-90234047 "Predicted intracellular proteins" "Angiogenesis, Apoptosis, Cell adhesion, Cell cycle, Cell division, Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 1100.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012991, HPA042413, HPA048825" Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "CAB012991: AB_2533205, HPA042413: AB_2732498, HPA048825: AB_2680533" "unprognostic (1.20e-1)" "unprognostic (1.59e-1)" "unprognostic (1.73e-2)" "prognostic favorable (2.26e-5)" "unprognostic (7.56e-2)" "unprognostic (5.51e-2)" "unprognostic (1.21e-2)" "unprognostic (8.29e-3)" "unprognostic (1.77e-1)" "unprognostic (4.09e-2)" "unprognostic (5.25e-3)" "unprognostic (2.44e-1)" "unprognostic (1.29e-3)" "unprognostic (1.85e-1)" "unprognostic (6.31e-2)" "unprognostic (1.39e-1)" "unprognostic (2.68e-2)" 16.5 40.1 15.0 31.1 14.7 42.5 21.8 4.1 13.8 24.1 51.6 15.4 31.0 31.6 12.2 37.2 39.9 37.2 43.3 47.7 14.8 14.0 49.8 74.5 27.9 27.6 17.5 13.8 17.8 67.8 20.2 24.0 20.6 18.3 30.3 34.0 16.7 40.4 44.5 21.2 10.0 67.5 13.9 13.6 29.3 23.8 25.7 11.0 21.5 37.8 27.8 44.3 38.0 16.3 87.9 43.0 49.4 45.4 35.9 55.2 64.9 24.5 55.6 4.9 17.8 21.8 22.9 8.2 26.1 22.8 21.6 19.3 21.8 43.9 7.1 28.2 30.6 27.9 25.6 10.5 30.1 11.7 16.9 23.9 15.9 38.3 36.1 21.5 31.9 15.6 16.2 18.1 20.1 13.9 24.3 27.5 17.8 21.4 11.3 16.4 48.2 24.0 37.2 7.9 47.2 28.6 13.7 13.5 28.9 55.0 42.0 4.1 4.9 35.6 28.9 27.8 9.3 22.5 19.3 17.3 23.9 17.0 28.8 31.9 15.4 24.1 8.3 38.5 36.5 10.2 25.3 39.3 49.4 46.0 45.4 37.7 87.9 55.2 50.2 43.0 70.7 46.0 45.5 22.8 35.9 41.0 28.5 44.3 64.9 15.0 14.7 4.1 13.8 14.8 14.0 17.5 13.8 18.3 11.0 83.4 104.1 147.3 209.7 76.1 10.0 74.5 152.8 653.1 152.4 174.5 9.8 90.9 384.7 302.9 295.2 73.0 544.4 0.0 585.6 97.5 113.1 427.5 136.2 209.7 199.6 3.2 93.2 65.1 107.8 1100.8 97.5 194.3 121.4 222.8 293.7 96.5 506.2 613.7 87.0 538.0 22.1 38.8 86.5 141.6 49.6 58.8 55.3 173.0 242.6 478.0 CIC KIAA0306 ENSG00000079432 "Capicua transcriptional repressor" Q96RK0 19 42268537-42295797 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026388, HPA044341, HPA064725" Approved Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB026388: , HPA044341: AB_2678901, HPA064725: AB_2685335" "unprognostic (2.02e-2)" "unprognostic (4.08e-1)" "unprognostic (1.41e-2)" "unprognostic (3.54e-3)" "unprognostic (3.67e-1)" "unprognostic (4.17e-3)" "unprognostic (1.49e-1)" "unprognostic (2.06e-1)" "unprognostic (4.87e-1)" "unprognostic (1.85e-2)" "unprognostic (1.72e-3)" "unprognostic (3.10e-1)" "unprognostic (4.23e-2)" "unprognostic (1.00e-1)" "unprognostic (2.38e-1)" "unprognostic (1.88e-2)" "unprognostic (1.56e-1)" 18.6 15.7 30.5 22.8 29.9 28.1 20.3 46.8 31.6 17.5 14.7 24.7 13.0 16.5 28.6 12.3 12.3 22.1 17.4 12.1 25.5 15.2 14.9 15.1 15.8 21.5 25.2 20.1 31.5 22.6 16.6 22.6 13.2 20.4 14.4 6.2 19.0 23.8 20.8 21.0 34.1 16.1 16.3 16.5 24.7 14.5 31.5 25.6 13.6 16.8 10.6 13.4 13.6 17.4 2.3 2.0 5.0 2.6 0.6 2.5 1.6 17.7 32.1 12.4 17.0 8.0 15.2 6.1 13.6 11.3 11.5 10.6 9.1 11.0 12.3 12.9 10.7 9.5 8.7 6.9 20.5 3.7 29.9 9.3 10.4 20.3 10.8 10.1 5.8 29.5 18.0 12.1 13.0 7.6 12.1 10.5 7.8 10.1 26.0 6.4 16.9 11.5 11.2 7.7 5.7 18.3 9.9 10.5 7.4 9.6 16.7 16.0 13.1 12.8 8.1 10.1 4.1 9.5 12.5 20.0 27.5 22.3 9.4 16.5 21.6 14.8 8.4 21.3 9.2 16.2 3.4 1.8 1.0 2.5 2.6 1.9 1.7 1.3 1.6 1.7 2.3 0.9 1.5 5.0 0.6 1.9 2.0 0.5 1.6 30.5 29.9 46.8 31.6 25.5 15.2 25.2 20.1 20.4 25.6 0.0 4.0 8.0 14.4 23.0 32.4 5.6 22.9 2.7 1.2 8.7 19.6 5.9 3.3 11.2 3.5 17.5 10.7 0.0 13.1 4.3 11.3 8.6 11.5 17.4 10.3 39.7 14.3 12.3 18.4 2.5 20.1 10.7 23.6 10.8 9.4 17.4 13.4 10.5 17.0 5.0 18.3 25.8 13.7 10.2 22.9 16.9 10.9 11.7 8.4 9.8 CIITA "C2TA, MHC2TA, NLRA" ENSG00000179583 "Class II major histocompatibility complex transactivator" P33076 16 10866222-10943021 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Acyltransferase, Kinase, Transferase" "Cancer-related genes, Disease mutation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 67.2" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 2: 17.9;Macrophages: 36.9;monocytes: 58.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 23.3;REH: 40.9;U-266/70: 8.6;U-698: 12.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB016084, HPA054757" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB016084: AB_627261, HPA054757: " "unprognostic (1.45e-3)" "unprognostic (1.38e-2)" "unprognostic (8.22e-3)" "unprognostic (1.12e-2)" "unprognostic (5.66e-2)" "unprognostic (2.88e-3)" "unprognostic (2.92e-2)" "unprognostic (1.55e-2)" "unprognostic (1.15e-2)" "unprognostic (1.85e-1)" "unprognostic (1.23e-1)" "unprognostic (3.72e-1)" "unprognostic (1.64e-2)" "unprognostic (2.72e-2)" "unprognostic (6.33e-3)" "unprognostic (2.74e-1)" "unprognostic (1.05e-2)" 8.0 5.9 4.6 47.7 7.1 4.3 6.8 1.5 5.5 6.3 3.7 10.6 4.2 10.4 8.1 10.4 4.8 5.2 8.1 4.9 4.7 3.5 8.8 2.9 15.0 27.0 9.4 1.1 2.5 3.5 1.9 4.0 1.2 6.6 5.5 4.3 5.5 13.3 4.3 2.9 4.4 17.4 3.7 15.6 25.9 6.2 1.5 7.4 12.6 6.1 5.2 67.2 6.3 6.8 27.3 19.0 6.5 11.9 0.7 0.5 1.7 0.1 0.2 0.3 0.3 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.3 5.6 5.1 0.8 0.0 0.9 0.9 0.0 0.0 0.1 23.3 0.3 2.9 1.1 0.6 0.0 0.5 0.4 1.0 0.0 0.1 0.0 0.9 0.0 0.3 0.3 2.0 0.1 0.3 0.2 0.4 0.1 0.2 0.1 40.9 0.3 3.6 0.0 1.7 0.9 0.1 0.9 0.3 0.9 0.3 0.5 1.7 0.3 2.1 0.3 0.6 0.2 8.6 0.6 12.1 7.7 0.5 6.9 0.2 11.9 6.5 0.3 9.5 0.1 17.9 0.1 0.5 17.7 27.3 0.1 0.2 2.8 0.7 10.0 19.0 0.4 1.7 4.6 7.1 1.5 5.5 4.7 3.5 9.4 1.1 6.6 7.4 6.0 17.9 12.3 0.3 2.1 0.6 2.8 2.5 2.7 1.2 3.5 0.0 0.1 0.0 2.5 0.6 4.2 3.4 0.0 1.7 0.2 1.0 0.3 10.4 1.0 9.1 0.0 2.4 2.5 15.6 0.0 0.6 36.9 6.8 58.7 0.7 0.4 1.7 0.0 0.0 3.3 0.9 0.0 0.9 0.0 0.0 2.5 0.1 1.0 0.4 0.3 CIPC KIAA1737 ENSG00000198894 "CLOCK interacting pacemaker" Q9C0C6 14 77098097-77117287 "Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 77.7" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA000644 Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA000644: AB_1079206" "unprognostic (3.93e-2)" "unprognostic (6.71e-2)" "unprognostic (2.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.55e-1)" "unprognostic (1.85e-1)" "unprognostic (2.41e-1)" "unprognostic (6.67e-3)" "unprognostic (3.73e-2)" "unprognostic (1.74e-1)" "unprognostic (2.31e-2)" "unprognostic (3.20e-1)" "prognostic favorable (1.77e-10)" "unprognostic (2.28e-1)" "unprognostic (2.32e-1)" "unprognostic (1.13e-1)" "unprognostic (1.21e-1)" 8.9 7.3 20.8 5.9 20.7 3.1 11.4 29.0 24.2 12.8 14.1 27.9 9.9 7.5 10.7 10.0 15.5 21.2 6.7 26.1 21.6 17.5 10.4 10.9 7.9 5.8 22.2 14.9 7.1 7.1 15.8 9.4 6.6 20.5 18.3 14.1 10.6 13.3 18.2 77.7 8.6 7.9 11.8 21.6 6.3 7.1 8.0 23.4 3.4 14.4 13.1 7.1 11.4 8.8 11.4 7.2 7.7 6.7 7.6 5.8 4.2 6.2 8.3 17.6 11.8 7.2 5.7 10.9 4.2 6.5 7.4 6.8 6.6 13.4 15.3 4.0 6.6 6.9 9.5 16.4 6.3 10.2 7.9 4.4 10.2 6.3 6.1 6.8 5.6 7.5 6.6 12.6 7.3 4.6 10.0 8.6 12.4 8.8 6.2 5.6 13.5 13.2 6.8 7.4 14.3 7.2 13.3 7.7 9.2 7.6 10.5 25.1 9.3 7.4 12.1 9.7 7.8 18.9 5.7 10.3 4.9 10.5 6.9 5.0 5.5 3.8 7.4 9.3 4.8 10.3 5.8 5.8 2.1 3.7 6.7 5.8 11.4 5.2 3.9 7.2 9.4 5.6 3.9 7.7 7.6 4.8 2.7 5.3 4.2 20.8 20.7 29.0 22.4 21.6 17.5 22.2 14.9 20.5 23.4 14.9 13.6 0.8 7.0 8.0 24.6 44.8 7.6 14.7 14.8 10.4 55.0 5.6 8.3 4.2 8.7 5.8 18.6 0.0 4.7 3.7 6.0 7.5 1.1 23.6 12.8 11.1 16.7 6.7 14.3 9.9 3.7 5.8 8.5 3.6 15.6 18.9 3.9 10.5 13.4 4.9 36.3 12.9 9.5 14.9 6.1 8.5 11.3 3.9 9.5 5.8 CIRBP CIRP ENSG00000099622 "Cold inducible RNA binding protein" Q14011 19 1259384-1274880 "Plasma proteins, Predicted intracellular proteins" "Stress response" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060537 Supported Nucleoplasm NA NA 33000 Nucleoplasm "HPA060537: AB_2684314" "unprognostic (2.77e-3)" "prognostic favorable (3.63e-4)" "unprognostic (9.80e-2)" "prognostic favorable (1.36e-4)" "unprognostic (3.95e-2)" "unprognostic (2.94e-2)" "unprognostic (3.38e-3)" "prognostic favorable (2.50e-4)" "unprognostic (6.43e-2)" "unprognostic (2.29e-2)" "prognostic favorable (2.69e-4)" "unprognostic (1.82e-1)" "prognostic favorable (3.65e-7)" "unprognostic (1.04e-1)" "unprognostic (5.76e-1)" "unprognostic (2.23e-2)" "unprognostic (1.49e-2)" 57.0 64.6 54.3 54.4 63.7 55.9 72.7 92.0 88.7 78.6 55.7 98.9 75.2 33.2 82.9 86.4 38.5 89.5 75.1 62.4 47.8 57.1 51.7 34.7 51.4 66.6 45.3 95.9 154.5 115.1 101.0 92.2 48.9 61.6 67.8 40.1 115.4 91.5 100.1 119.1 68.5 48.9 93.0 50.0 56.7 60.7 67.4 37.5 33.7 73.7 65.1 63.7 58.5 49.1 70.6 67.4 48.3 54.6 52.3 58.6 40.5 37.4 8.0 59.0 29.9 26.4 29.7 15.4 41.2 58.2 32.4 29.1 14.7 14.5 75.4 22.3 42.6 3.8 17.8 24.7 37.3 25.2 33.7 7.1 44.8 8.5 19.0 96.5 69.3 32.7 72.8 33.6 20.9 91.7 44.7 29.1 38.2 29.4 60.9 33.5 26.5 35.6 18.8 23.3 21.5 13.7 44.4 47.6 37.0 36.6 31.5 28.0 51.0 43.5 19.9 32.7 20.3 41.4 19.6 35.3 23.8 14.6 56.7 35.9 80.8 87.2 63.2 20.5 28.8 31.1 43.5 21.4 48.3 56.1 36.7 57.3 62.5 50.2 50.3 23.9 70.6 57.6 54.1 36.8 52.3 54.6 67.4 58.6 40.5 54.3 63.7 92.0 88.7 47.8 57.1 45.3 95.9 61.6 37.5 190.6 388.3 412.5 566.2 521.1 731.5 217.9 331.2 267.7 194.5 282.6 310.2 478.8 824.0 309.0 59.1 377.8 185.6 93.5 422.6 250.6 423.2 404.8 393.8 127.7 276.6 646.7 416.8 304.5 333.2 163.7 601.8 335.9 696.8 569.9 235.7 848.5 279.0 222.0 469.5 414.6 606.0 368.7 588.0 224.4 542.1 486.7 616.7 487.7 250.2 270.4 CITED1 MSG1 ENSG00000125931 "Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1" Q99966 X 72301638-72307187 "Predicted intracellular proteins" "Apoptosis, Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "epididymis: 247.1;pituitary gland: 62.8;testis: 89.9" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 13.8;Late spermatids: 28.3;Sertoli cells: 12.9" "Cancer enriched" "Detected in many" 6 "thyroid cancer: 134.9" "Region enriched" "Detected in many" 5 "hypothalamus: 18.9" "Cell type enhanced" "Detected in some" "eosinophil: 2.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "AN3-CA: 17.9;SK-MEL-30: 71.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049051 Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA049051: AB_2680612" "unprognostic (7.04e-2)" "unprognostic (3.39e-2)" "unprognostic (1.34e-1)" "unprognostic (1.79e-3)" "unprognostic (8.81e-2)" "unprognostic (5.67e-4)" "unprognostic (3.40e-1)" "unprognostic (9.55e-2)" "unprognostic (4.60e-3)" "unprognostic (4.38e-2)" "unprognostic (6.33e-3)" "unprognostic (1.18e-1)" "unprognostic (1.38e-1)" "unprognostic (2.62e-1)" "prognostic favorable (6.10e-4)" "prognostic favorable (3.95e-4)" "unprognostic (2.99e-2)" 0.5 0.6 3.5 0.5 2.2 0.4 6.0 0.9 2.8 1.3 0.5 0.3 5.3 0.5 1.0 247.1 0.4 0.5 0.4 0.4 2.4 18.9 0.6 0.4 0.5 0.4 1.1 0.9 0.5 0.6 0.4 62.8 0.4 2.7 2.1 0.4 27.8 0.4 1.2 0.4 0.4 0.5 1.7 0.5 0.4 0.4 89.9 0.0 0.0 1.7 0.0 0.4 0.4 0.0 0.0 0.8 2.2 0.5 0.0 1.1 1.1 0.1 0.1 0.7 17.9 0.8 0.0 0.6 0.0 0.2 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.0 6.4 0.4 0.0 1.8 2.5 0.3 0.2 0.0 0.0 0.1 3.5 0.3 0.2 0.2 0.3 0.0 0.0 0.1 0.7 0.1 0.1 0.2 0.0 1.4 1.0 0.1 1.2 0.0 1.2 0.9 0.0 0.2 8.1 4.2 0.1 1.6 71.3 0.1 0.5 0.4 0.0 0.1 0.7 0.1 0.3 0.1 0.1 0.1 0.1 0.2 1.7 0.0 0.5 2.2 0.4 0.0 1.1 0.0 0.2 0.6 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 3.5 2.2 0.9 2.8 2.4 18.9 1.1 0.9 2.7 0.0 0.0 0.0 0.0 1.0 0.1 3.2 0.3 2.5 0.0 0.0 3.5 5.9 0.1 0.0 0.0 13.8 0.2 0.1 0.0 0.7 0.0 0.2 8.6 0.0 0.0 0.1 0.0 1.2 0.0 0.0 28.3 6.9 0.0 3.3 0.0 0.1 0.8 0.4 7.2 2.8 0.3 3.5 12.9 0.3 6.8 3.7 0.0 0.0 0.0 0.1 0.9 CITED2 MRG1 ENSG00000164442 "Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2" Q99967 6 139371807-139374620 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Stress response, Transcription, Transcription regulation" "Activator, Developmental protein, Repressor" "Atrial septal defect, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Extravillous trophoblasts: 592.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 20.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 78.3;fHDF/TERT166: 136.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016157, CAB069879" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB016157: AB_668099, CAB069879: AB_10003446" "unprognostic (7.42e-2)" "unprognostic (2.06e-2)" "unprognostic (1.56e-2)" "unprognostic (8.34e-2)" "unprognostic (4.03e-2)" "unprognostic (1.11e-1)" "unprognostic (2.87e-2)" "unprognostic (1.13e-1)" "unprognostic (4.05e-2)" "unprognostic (1.11e-2)" "unprognostic (3.61e-3)" "unprognostic (1.00e-2)" "prognostic favorable (3.40e-4)" "prognostic unfavorable (3.33e-4)" "unprognostic (1.08e-1)" "unprognostic (1.65e-1)" "unprognostic (2.03e-1)" 42.8 34.5 6.8 27.1 11.2 71.7 35.4 24.2 27.9 22.2 23.6 6.0 19.0 9.3 53.3 26.5 24.1 58.1 27.0 37.7 4.7 6.6 24.9 55.2 40.6 14.3 3.7 7.2 84.0 35.3 58.5 6.0 75.7 17.4 23.3 11.4 26.1 31.4 44.6 44.5 34.8 19.6 23.3 3.7 40.6 21.4 17.7 3.0 11.2 99.7 18.7 16.6 17.6 24.4 1.9 2.9 20.0 6.6 2.3 4.7 2.2 2.9 1.7 6.0 17.7 25.7 27.5 22.7 78.3 58.3 35.8 33.7 15.5 4.4 2.1 11.5 136.2 7.6 3.5 1.8 1.8 25.5 57.8 5.8 42.9 9.8 1.2 21.0 12.6 4.7 21.9 8.4 15.6 12.1 23.4 6.5 1.2 16.0 10.3 46.4 6.4 2.1 15.8 5.6 1.8 2.7 3.0 4.4 18.6 17.2 6.6 6.7 0.1 5.6 21.5 2.5 14.6 9.2 43.6 35.7 28.7 9.1 8.5 4.3 3.0 2.7 3.2 8.8 10.9 2.0 2.1 6.6 20.0 3.0 3.7 4.3 1.0 4.7 4.3 2.9 1.9 4.1 2.1 3.3 2.3 4.9 1.3 2.7 2.2 6.8 11.2 24.2 27.9 4.7 6.6 3.7 7.2 17.4 3.0 107.2 265.7 40.2 132.0 31.8 30.0 100.1 86.6 24.1 53.4 97.7 11.8 110.8 157.5 15.3 1.5 29.2 85.3 163.5 12.7 592.3 59.2 48.6 45.1 58.7 304.1 28.6 95.8 63.8 84.7 5.3 92.0 87.1 79.2 2.8 110.2 49.6 21.5 84.2 57.3 82.4 35.3 97.0 57.9 0.9 1.3 29.5 225.2 123.7 94.5 29.9 CIZ1 "LSFR1, ZNF356" ENSG00000148337 "CDKN1A interacting zinc finger protein 1" Q9ULV3 9 128166064-128204383 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020380, HPA020387" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA020380: , HPA020387: AB_2670425" "unprognostic (1.28e-1)" "unprognostic (5.77e-2)" "unprognostic (2.81e-2)" "unprognostic (3.33e-1)" "unprognostic (1.69e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (1.43e-4)" "unprognostic (6.14e-2)" "unprognostic (1.63e-1)" "unprognostic (7.49e-3)" "unprognostic (3.13e-3)" "unprognostic (8.05e-3)" "unprognostic (2.30e-2)" "unprognostic (1.54e-1)" "unprognostic (2.11e-1)" "unprognostic (3.24e-1)" "unprognostic (8.47e-3)" 31.9 24.3 33.6 23.8 36.0 36.7 36.7 39.4 40.4 31.5 35.7 28.0 21.3 26.8 33.6 20.9 30.3 33.5 26.7 25.5 30.5 19.9 19.7 12.1 22.2 24.8 29.4 27.5 56.3 41.7 23.1 21.1 21.9 23.4 30.1 21.8 23.3 31.3 28.8 51.4 49.6 26.1 40.0 27.3 22.5 28.9 35.4 37.0 30.3 22.8 24.2 27.0 35.2 39.3 6.7 4.6 4.9 5.8 8.1 8.3 3.2 23.0 27.9 23.9 22.5 24.7 29.9 23.4 18.2 27.4 33.5 19.0 25.5 20.3 27.1 15.5 30.7 27.9 33.6 18.4 19.6 18.3 24.6 21.0 25.9 35.0 16.4 28.5 24.0 30.9 28.9 35.1 36.7 31.3 24.4 22.6 17.4 62.6 23.5 20.1 53.9 31.4 24.4 20.7 31.2 28.7 26.7 25.2 27.9 15.1 15.9 29.8 23.1 40.5 28.7 24.0 11.1 29.9 31.3 23.9 35.8 25.5 40.6 34.1 27.3 30.8 26.2 25.3 16.1 38.3 4.6 4.3 4.9 5.0 5.8 4.5 5.7 6.1 6.4 4.6 6.7 6.1 5.5 0.7 8.1 4.3 4.6 8.3 3.2 33.6 36.0 39.4 40.4 30.5 19.9 29.4 27.5 23.4 37.0 3.0 11.7 14.1 19.6 20.6 21.1 8.7 12.7 5.3 9.1 17.4 27.5 19.0 11.6 22.6 63.0 13.4 23.6 0.0 38.7 23.5 21.6 14.9 9.2 4.7 19.4 15.9 21.9 14.7 16.7 60.3 32.2 14.9 18.6 20.8 17.7 17.7 26.4 14.0 29.4 14.6 23.8 12.9 20.8 24.4 24.7 21.8 17.4 17.9 25.5 13.3 CKS1B "CKS1, ckshs1" ENSG00000173207 "CDC28 protein kinase regulatory subunit 1B" P61024 1 154974653-154979249 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 303.7;Extravillous trophoblasts: 535.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA003424, HPA030762" Approved Approved Nucleoplasm,Vesicles,Mitochondria,Cytosol NA Yes "Mitochondria, Cytosol" "Nucleoplasm, Vesicles" "HPA003424: AB_2666948, HPA030762: AB_10670044" "unprognostic (1.06e-2)" "unprognostic (1.62e-1)" "unprognostic (2.84e-1)" "prognostic unfavorable (7.89e-4)" "unprognostic (1.34e-1)" "unprognostic (2.59e-2)" "prognostic unfavorable (2.94e-5)" "unprognostic (2.01e-3)" "prognostic unfavorable (3.12e-5)" "unprognostic (3.63e-2)" "prognostic unfavorable (6.13e-4)" "unprognostic (3.19e-1)" "prognostic unfavorable (6.03e-7)" "unprognostic (3.12e-2)" "unprognostic (1.44e-1)" "prognostic favorable (4.87e-4)" "unprognostic (1.37e-1)" 25.3 14.5 13.5 13.4 19.0 36.4 24.8 4.2 14.6 15.6 17.4 12.4 19.8 14.7 14.7 13.8 28.2 15.2 14.1 16.5 15.3 8.0 16.6 29.5 12.9 23.8 29.5 8.8 14.2 12.8 8.3 9.4 35.6 15.9 11.7 18.8 7.5 12.8 13.1 5.9 22.6 22.9 12.5 19.8 18.0 14.7 22.8 21.5 30.2 15.5 19.3 25.5 11.1 23.3 23.9 30.4 2.2 32.8 9.0 12.2 8.7 59.7 82.4 61.8 33.5 8.9 9.2 49.4 27.8 21.6 60.4 48.4 79.6 88.4 56.9 47.6 18.4 33.9 55.5 61.2 39.9 56.8 51.1 39.7 38.5 36.7 55.9 2.7 46.3 35.4 5.3 17.3 51.6 71.6 12.4 30.3 39.5 62.5 77.4 45.4 59.4 43.4 35.8 78.4 57.4 74.4 43.7 50.9 72.9 21.5 21.9 25.2 63.7 42.0 39.9 46.0 74.9 53.4 64.8 16.8 39.2 40.6 32.4 66.2 47.8 92.7 80.3 24.9 39.5 54.1 0.7 4.4 2.2 7.0 26.0 8.4 23.9 9.9 9.5 7.2 22.6 12.2 11.5 0.6 9.0 32.8 30.4 10.6 8.7 13.5 19.0 4.2 14.6 15.3 8.0 29.5 8.8 15.9 21.5 11.9 26.6 58.1 85.2 193.2 2.1 8.9 68.8 40.2 40.9 27.9 0.0 103.2 68.0 71.4 12.5 39.5 35.7 303.7 98.8 535.3 106.1 48.1 20.7 75.7 110.7 1.6 19.7 30.1 33.8 18.8 70.5 54.9 108.0 55.9 35.3 15.6 87.5 41.8 43.2 64.8 2.4 19.4 106.1 117.9 120.7 178.0 110.3 47.9 49.4 87.8 CKS2 ENSG00000123975 "CDC28 protein kinase regulatory subunit 2" P33552 9 89311198-89316703 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 54.6;testis: 103.2" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 581.2;Spermatogonia: 464.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 54.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003424, HPA030762" Approved Approved Nucleoplasm,Vesicles,Mitochondria,Cytosol NA Yes "Mitochondria, Cytosol" "Nucleoplasm, Vesicles" "HPA003424: AB_2666948, HPA030762: AB_10670044" "unprognostic (8.30e-2)" "unprognostic (3.00e-1)" "unprognostic (1.50e-2)" "unprognostic (2.80e-2)" "unprognostic (2.96e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (2.51e-6)" "unprognostic (3.57e-3)" "unprognostic (7.04e-2)" "unprognostic (1.34e-2)" "prognostic unfavorable (6.85e-4)" "unprognostic (1.24e-2)" "prognostic unfavorable (1.78e-5)" "unprognostic (2.13e-3)" "unprognostic (1.44e-1)" "unprognostic (2.84e-1)" "unprognostic (1.84e-1)" 4.8 22.4 4.2 22.7 6.1 38.1 10.7 4.0 7.5 3.6 10.8 3.0 16.7 10.8 4.6 4.4 20.4 2.8 4.7 3.3 6.1 3.2 11.0 10.2 9.5 24.6 5.2 4.3 3.9 2.6 7.0 2.2 12.4 5.0 4.8 10.7 3.2 4.4 7.6 3.6 6.1 9.3 4.1 5.4 12.6 6.8 103.2 3.6 41.6 4.6 13.5 20.8 8.1 16.7 18.3 54.6 12.4 7.5 11.6 17.9 6.5 84.0 72.1 44.1 29.5 13.0 11.9 32.2 50.1 27.0 55.5 44.5 29.6 41.8 63.0 29.7 18.7 98.8 59.2 52.9 38.6 63.9 49.1 42.8 31.9 52.8 78.5 5.6 65.0 36.4 4.3 8.9 39.7 35.1 21.2 51.3 51.9 38.0 55.2 71.1 63.1 51.0 114.6 64.4 99.0 66.6 44.2 48.5 37.6 43.5 19.3 37.4 22.3 41.6 40.4 40.4 43.2 48.6 37.8 29.1 24.0 45.6 58.0 72.8 44.8 90.7 50.8 35.4 37.7 34.1 10.5 5.9 12.4 7.0 7.5 7.9 18.3 9.6 6.7 6.5 13.5 5.2 6.8 4.2 11.6 4.1 54.6 17.9 6.5 4.2 6.1 4.0 7.5 6.1 3.2 5.2 4.3 5.0 3.6 35.7 93.0 97.3 70.9 248.9 4.2 55.0 5.1 12.0 17.0 14.0 0.0 149.0 19.9 15.2 25.4 26.7 39.1 350.4 9.7 329.6 72.5 59.4 147.1 19.5 152.7 0.0 117.0 28.3 40.0 59.4 23.9 84.8 133.3 33.3 56.8 24.6 23.3 46.9 15.6 148.6 6.0 45.3 99.9 581.2 464.7 261.3 166.8 40.1 104.9 59.3 CLASRP "CLASP, SFRS16, SWAP2" ENSG00000104859 "CLK4 associating serine/arginine rich protein" Q8N2M8 19 45039040-45070956 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA060469, HPA062455" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA060469: AB_2684289, HPA062455: AB_2684770" "unprognostic (2.99e-2)" "unprognostic (2.68e-1)" "prognostic unfavorable (9.77e-4)" "unprognostic (9.03e-2)" "unprognostic (1.37e-1)" "unprognostic (2.76e-3)" "unprognostic (1.58e-2)" "unprognostic (2.62e-1)" "unprognostic (8.52e-2)" "unprognostic (4.01e-2)" "unprognostic (1.76e-3)" "unprognostic (3.48e-2)" "prognostic unfavorable (1.69e-8)" "unprognostic (2.19e-1)" "unprognostic (1.74e-2)" "unprognostic (3.36e-1)" "prognostic favorable (1.02e-5)" 14.5 12.2 14.1 16.5 24.6 40.4 13.6 19.0 25.7 12.0 14.5 27.4 13.0 17.6 14.4 14.5 14.7 13.8 13.4 9.6 16.2 12.2 11.6 11.6 13.9 17.7 26.8 16.2 18.3 28.6 13.7 19.8 12.0 18.4 14.7 9.4 10.7 16.8 17.2 21.5 17.0 20.6 14.6 22.1 18.5 18.3 14.3 22.4 7.8 14.7 9.9 14.1 11.7 15.3 7.1 5.1 9.2 3.6 2.7 4.1 2.0 11.0 15.9 6.5 4.8 2.1 3.4 14.5 9.6 3.6 7.4 7.4 7.3 10.6 17.4 7.3 3.8 2.9 12.2 9.9 7.3 3.3 8.6 14.7 10.3 8.5 9.2 4.9 6.9 14.2 4.2 4.0 5.0 8.9 3.5 5.0 11.8 16.3 9.9 2.5 11.1 18.4 23.0 9.0 7.3 9.3 14.7 7.3 13.2 4.9 11.1 7.5 11.7 7.7 7.4 7.0 3.7 9.5 15.1 7.5 7.3 9.1 6.1 14.5 14.4 11.6 15.6 5.1 11.2 5.9 0.7 3.6 5.5 3.8 2.6 3.5 7.1 2.3 4.1 3.2 6.4 3.3 2.9 9.2 2.7 3.0 5.1 1.9 2.0 14.1 24.6 19.0 25.7 16.2 12.2 26.8 16.2 18.4 22.4 3.0 2.7 25.1 23.5 20.7 25.6 3.6 20.4 2.7 3.4 15.7 15.7 20.7 5.0 9.7 15.9 13.5 27.2 0.0 13.0 24.6 15.0 15.3 12.7 13.9 15.2 19.1 9.2 14.7 17.4 4.6 20.1 18.1 3.3 19.8 22.5 22.0 12.7 21.0 16.6 6.5 28.8 32.3 16.5 61.4 27.7 18.9 30.3 20.0 17.9 18.2 CLBA1 C14orf79 ENSG00000140104 "Clathrin binding box of aftiphilin containing 1" Q96F83 14 104985775-105010482 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 1: 14.9;Ciliated cells: 34.8;Collecting duct cells: 15.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042052, HPA061117" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA042052: AB_2677822, HPA061117: AB_2684434" "unprognostic (1.49e-2)" "unprognostic (4.04e-2)" "unprognostic (4.84e-2)" "unprognostic (2.88e-2)" "unprognostic (5.51e-2)" "unprognostic (1.49e-1)" "unprognostic (5.77e-2)" "unprognostic (9.43e-3)" "unprognostic (1.78e-1)" "unprognostic (8.21e-2)" "unprognostic (3.50e-2)" "unprognostic (2.30e-1)" "unprognostic (4.39e-3)" "unprognostic (3.12e-2)" "unprognostic (1.11e-2)" "unprognostic (9.30e-2)" "unprognostic (2.95e-1)" 2.1 5.3 5.4 2.6 12.5 2.0 6.6 3.5 13.5 7.6 3.4 5.2 11.8 2.3 6.8 15.1 5.1 18.9 6.5 2.4 6.2 6.5 8.9 6.1 7.4 1.8 3.3 5.9 6.8 11.3 13.2 15.3 2.4 5.3 7.6 3.5 7.6 6.3 8.3 1.3 9.2 2.2 4.4 2.1 2.4 5.9 23.9 1.8 1.8 17.6 1.0 2.3 4.2 3.3 1.8 2.3 2.4 1.1 1.0 1.4 0.5 4.0 7.3 2.2 6.9 2.2 3.3 3.4 3.3 3.1 4.0 1.8 0.7 7.2 0.4 7.0 3.3 2.1 8.8 0.8 4.9 2.5 3.3 2.6 0.3 6.3 0.3 7.9 1.7 1.8 2.1 11.4 4.3 8.5 6.8 2.3 3.5 2.4 1.1 2.3 13.8 0.7 5.2 2.9 4.0 7.0 2.6 1.2 2.3 8.6 2.4 14.4 7.5 4.7 2.1 3.8 1.5 15.0 2.5 2.4 5.0 2.3 10.1 2.5 1.4 0.9 0.3 6.4 0.5 3.5 1.8 1.1 0.4 1.4 1.1 0.3 1.2 1.4 0.3 0.5 1.8 0.6 1.3 2.4 1.0 1.0 2.3 0.6 0.5 5.4 12.5 3.5 13.5 6.2 6.5 3.3 5.9 5.3 1.8 14.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 34.8 4.5 15.7 0.0 1.2 3.3 6.2 0.0 0.0 0.0 0.0 1.1 0.7 0.0 0.0 2.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 4.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 CLCA2 CLCRG2 ENSG00000137975 "Chloride channel accessory 2" Q9UQC9 1 86424086-86456558 "Predicted membrane proteins" "Cell adhesion, Ion transport, Transport" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 105.2;lymphoid tissue: 33.9;skin 1: 36.4;tongue: 42.1" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 42.1;Club cells: 22.7;Early spermatids: 20.6;Suprabasal keratinocytes: 47.9;Urothelial cells: 35.8" "Group enriched" "Detected in many" 6 "cervical cancer: 68.3;head and neck cancer: 146.1;lung cancer: 35.2;urothelial cancer: 31.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "hTCEpi: 68.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA047192 Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions" "Intracellular and membrane" NA NA 66000 "Plasma membrane, Cell Junctions" Nucleoplasm "HPA047192: AB_2679977" "unprognostic (1.04e-2)" "unprognostic (1.58e-1)" "unprognostic (3.96e-3)" "unprognostic (6.99e-2)" "unprognostic (6.33e-2)" "unprognostic (1.40e-1)" "unprognostic (6.15e-2)" "unprognostic (1.09e-1)" "unprognostic (1.26e-1)" "unprognostic (2.73e-1)" "unprognostic (9.99e-3)" "unprognostic (1.97e-8)" "unprognostic (3.88e-1)" "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "unprognostic (2.72e-1)" 0.4 0.0 0.1 0.1 0.1 0.0 2.0 0.1 0.1 27.7 0.2 0.1 0.4 0.1 1.1 0.7 105.2 0.1 0.2 0.1 0.1 0.0 0.1 0.1 1.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.2 0.1 1.4 0.3 0.1 5.1 0.1 0.1 36.4 0.3 0.1 0.2 0.1 0.0 0.2 0.1 0.7 0.1 42.1 33.9 6.1 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 12.6 0.5 0.8 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 10.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 68.6 0.3 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 6.0 42.1 0.0 0.3 0.0 10.7 22.7 0.0 0.0 0.2 0.0 0.0 20.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 47.9 0.1 0.0 0.0 35.8 CLCA4 CaCC2 ENSG00000016602 "Chloride channel accessory 4" Q14CN2 1 86547078-86580754 "Predicted membrane proteins" Transport "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 182.1;intestine: 64.2" "Cell type enriched" "Detected in some" 4 "Urothelial cells: 115.2" "Cancer enhanced" "Detected in many" "cervical cancer: 21.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 988 "RT4: 98.7" "HPA017045, HPA064770" Uncertain Approved "Nucleoplasm,Plasma membrane,Aggresome" "Intracellular and membrane" NA NA 210000 "Plasma membrane" "Nucleoplasm, Aggresome" "HPA017045: AB_2291679, HPA064770: " "unprognostic (1.38e-4)" "unprognostic (1.52e-1)" "prognostic favorable (7.47e-4)" "unprognostic (2.73e-2)" "unprognostic (7.03e-2)" "prognostic favorable (8.63e-4)" "unprognostic (7.59e-2)" "unprognostic (3.35e-1)" "unprognostic (1.26e-1)" "unprognostic (6.01e-2)" "unprognostic (1.20e-1)" "unprognostic (2.57e-2)" "unprognostic (2.29e-1)" "unprognostic (5.69e-2)" "unprognostic (3.43e-2)" 0.2 0.1 2.2 8.8 3.0 0.1 0.6 0.0 2.0 12.3 64.2 2.0 0.0 0.1 0.3 0.1 182.1 0.1 0.1 0.1 2.2 0.6 0.1 0.1 0.1 0.1 3.2 1.6 0.1 0.0 0.1 0.0 0.1 3.0 1.8 38.4 0.0 5.9 0.1 0.1 4.5 6.1 0.8 2.4 0.1 0.1 0.1 5.0 0.0 0.1 8.6 21.5 9.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 98.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.0 0.0 2.0 2.2 0.6 3.2 1.6 3.0 5.0 0.0 0.0 0.0 13.3 3.0 0.0 0.2 0.0 2.7 5.7 1.8 0.0 0.0 0.0 0.0 0.3 0.0 18.6 0.0 0.0 0.0 0.0 3.9 9.2 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.5 0.0 0.0 4.1 115.2 CLCN7 "CLC-7, CLC7, OPTA2, PPP1R63" ENSG00000103249 "Chloride voltage-gated channel 7" P51798 16 1444934-1475580 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Transport" "Disease mutation, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 69.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043019, HPA043586" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA043019: AB_10964727, HPA043586: AB_10965322" "unprognostic (2.69e-1)" "unprognostic (3.51e-2)" "unprognostic (1.22e-1)" "unprognostic (5.61e-2)" "unprognostic (1.90e-2)" "prognostic favorable (5.23e-4)" "unprognostic (1.59e-2)" "unprognostic (1.29e-2)" "unprognostic (1.17e-1)" "unprognostic (4.65e-2)" "unprognostic (1.41e-2)" "unprognostic (3.98e-1)" "unprognostic (3.49e-3)" "unprognostic (5.81e-2)" "prognostic unfavorable (3.21e-4)" "unprognostic (2.80e-1)" "unprognostic (2.54e-1)" 19.5 34.7 23.2 18.7 23.0 35.0 19.4 22.9 26.8 16.7 15.5 29.3 15.4 18.3 18.8 16.8 12.5 15.8 17.0 15.0 21.9 17.5 19.5 22.7 17.7 19.6 30.3 18.5 14.2 24.1 30.9 19.5 15.5 22.2 14.6 9.4 34.4 17.5 17.5 22.5 21.7 18.9 17.3 18.0 24.8 18.1 17.6 29.5 16.4 21.8 10.9 14.9 17.2 10.2 2.5 2.3 2.0 6.4 0.5 1.6 1.5 5.0 14.1 8.0 12.6 18.2 9.3 12.6 6.9 15.9 15.1 18.8 11.0 18.9 5.8 14.2 9.3 29.2 10.7 7.2 8.9 4.6 9.2 11.3 4.1 13.2 10.9 31.7 10.6 17.0 18.3 12.3 13.6 11.7 9.3 9.6 14.1 16.7 11.3 7.6 10.1 7.4 18.2 8.0 3.4 8.1 34.8 5.4 16.1 7.5 7.3 9.0 9.2 11.1 14.0 44.3 4.7 12.3 28.4 9.5 13.3 6.1 14.6 6.5 17.2 11.2 6.0 11.1 20.2 8.3 0.0 3.0 2.0 1.6 5.4 0.7 2.2 0.9 0.7 2.3 2.5 0.4 0.6 0.6 0.5 6.4 2.3 0.3 1.5 23.2 23.0 22.9 26.8 21.9 17.5 30.3 18.5 22.2 29.5 0.0 6.9 7.8 4.9 6.5 40.9 2.8 5.1 2.7 5.7 19.2 33.4 8.6 1.7 14.1 8.1 5.7 15.8 0.0 15.2 7.9 8.7 7.7 5.8 13.9 31.5 69.9 11.5 20.3 25.7 7.2 10.6 15.2 37.1 15.4 11.7 24.7 17.3 8.0 7.8 12.3 25.3 0.0 6.9 10.2 9.8 5.9 12.9 9.5 10.0 4.3 CLDN2 ENSG00000165376 "Claudin 2" P57739 X 106900164-106930861 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 31.7;gallbladder: 28.4;kidney: 46.1;liver: 25.2;seminal vesicle: 27.7" "Cell type enhanced" "Detected in some" 21 "Ductal cells: 67.3;Exocrine glandular cells: 42.5;Pancreatic endocrine cells: 28.7;Proximal tubular cells: 138.0" "Group enriched" "Detected in many" 5 "colorectal cancer: 53.3;liver cancer: 24.6;pancreatic cancer: 48.5;renal cancer: 87.2;stomach cancer: 30.5" "Region enriched" "Detected in some" 6 "pons and medulla: 31.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "OE19: 81.0" "Group enriched" "Detected in many" 5 "basal ganglia: 4.6;hippocampal formation: 10.6;pons and medulla: 10.8;thalamus: 9.5" "Not detected" "Not detected" "CAB002609, HPA051548" Enhanced Supported "Nucleoplasm,Cell Junctions" NA NA "Nucleoplasm, Cell Junctions" "CAB002609: , HPA051548: AB_2681530" "unprognostic (2.31e-1)" "unprognostic (2.62e-1)" "unprognostic (3.99e-1)" "unprognostic (1.73e-1)" "unprognostic (1.30e-2)" "unprognostic (1.42e-2)" "unprognostic (6.07e-2)" "unprognostic (7.47e-3)" "unprognostic (2.24e-1)" "unprognostic (8.67e-2)" "unprognostic (8.83e-2)" "unprognostic (8.15e-2)" "unprognostic (1.43e-1)" "unprognostic (1.76e-1)" "unprognostic (2.12e-1)" "prognostic favorable (1.70e-4)" "unprognostic (9.76e-2)" 0.4 1.2 0.4 0.4 0.6 0.0 0.4 0.4 3.4 0.4 0.4 19.4 0.4 5.3 0.4 9.6 0.4 0.1 28.4 0.4 5.0 0.1 46.1 25.2 0.4 0.4 0.4 0.4 0.4 7.8 0.0 0.4 0.4 31.7 0.6 1.0 11.0 0.4 27.7 0.4 0.2 11.3 0.4 0.4 0.4 2.1 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.6 0.4 3.4 5.0 0.1 0.4 0.4 31.7 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.2 15.3 0.0 0.0 1.8 0.0 0.0 13.3 67.3 0.0 0.0 1.0 0.0 42.5 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.0 0.0 2.8 0.1 0.9 28.7 2.9 0.0 138.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 CLDN23 CLDNL ENSG00000253958 "Claudin 23" Q96B33 8 8701938-8704106 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Enterocytes: 128.5;Paneth cells: 76.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "myeloid DC: 3.4;plasmacytoid DC: 3.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 9.8;Daudi: 7.8;RT4: 8.3;SK-BR-3: 8.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA070578 Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA070578: " "unprognostic (1.86e-1)" "unprognostic (1.53e-1)" "prognostic favorable (3.46e-4)" "unprognostic (2.97e-1)" "unprognostic (8.32e-2)" "unprognostic (3.04e-1)" "unprognostic (3.44e-1)" "unprognostic (2.05e-2)" "unprognostic (2.14e-1)" "unprognostic (1.14e-1)" "unprognostic (1.97e-2)" "unprognostic (8.25e-3)" "prognostic favorable (9.65e-8)" "unprognostic (7.76e-2)" "unprognostic (3.17e-2)" "unprognostic (9.59e-2)" "unprognostic (1.33e-3)" 9.1 1.0 0.3 7.1 1.4 0.3 6.1 0.4 0.6 2.6 14.8 0.5 3.8 5.5 1.0 6.3 2.8 1.4 10.6 1.4 0.9 0.2 6.5 13.3 8.7 3.1 1.1 0.3 2.6 3.2 1.5 0.7 15.7 1.7 3.3 8.8 2.8 6.0 2.5 0.9 10.0 20.0 0.5 0.3 2.4 18.0 1.5 0.5 0.4 8.8 4.3 3.0 6.0 5.3 0.5 3.9 0.8 2.4 0.0 0.0 0.6 0.2 3.2 0.0 0.2 1.0 0.1 9.8 2.4 1.9 2.6 4.0 1.9 5.2 7.8 0.0 0.1 1.0 3.1 0.0 0.1 0.2 1.5 0.0 0.0 1.0 0.1 4.6 0.0 0.1 1.3 1.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.3 4.0 0.1 0.2 2.5 0.4 1.6 0.0 0.0 0.0 1.2 8.3 0.4 1.2 3.2 8.5 0.1 1.0 1.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.8 0.0 2.4 0.0 0.5 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 3.9 0.0 0.6 0.3 1.4 0.4 0.6 0.9 0.2 1.1 0.3 1.7 0.5 8.9 1.9 1.3 6.7 0.1 0.0 0.5 20.4 6.7 1.2 1.8 0.0 15.9 6.6 19.6 0.0 1.0 128.5 0.0 9.5 15.2 3.5 2.8 4.6 6.8 15.3 0.0 7.5 8.0 1.9 0.0 0.3 2.9 3.3 1.0 23.5 0.2 20.1 76.4 0.4 3.8 1.1 6.5 2.1 0.0 0.0 0.5 7.9 0.0 18.9 10.5 CLDND1 "C3orf4, Z38" ENSG00000080822 "Claudin domain containing 1" Q9NY35 3 98497912-98523066 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 75.9;brain: 227.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029841 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA029841: AB_10600658" "unprognostic (1.64e-1)" "unprognostic (3.63e-1)" "unprognostic (3.13e-2)" "unprognostic (8.50e-2)" "unprognostic (9.15e-2)" "unprognostic (7.30e-2)" "unprognostic (2.43e-3)" "unprognostic (4.08e-2)" "unprognostic (3.65e-2)" "unprognostic (8.30e-3)" "unprognostic (1.21e-1)" "unprognostic (3.14e-1)" "prognostic unfavorable (5.84e-6)" "unprognostic (5.73e-3)" "unprognostic (6.54e-2)" "unprognostic (3.05e-1)" "unprognostic (1.51e-1)" 14.7 12.4 61.6 10.7 76.1 11.7 14.1 11.9 77.1 14.1 10.4 100.5 3.3 10.0 16.9 12.6 22.6 10.9 14.3 15.9 85.4 52.3 11.0 14.0 12.2 13.6 133.4 28.9 19.1 5.8 7.0 6.7 20.5 72.7 14.6 13.6 4.9 6.8 15.7 9.7 17.6 9.4 18.5 227.4 11.5 7.5 28.5 95.4 4.3 11.5 4.7 14.8 14.7 11.1 19.9 19.7 28.1 18.6 49.5 75.9 28.6 17.9 7.3 22.9 14.0 27.7 21.6 12.5 14.2 19.6 20.0 27.7 14.8 18.3 9.0 19.2 13.6 38.0 24.3 17.6 10.8 35.1 21.2 7.5 18.7 5.2 13.2 22.2 16.8 18.7 25.2 58.3 15.6 16.8 21.5 21.7 17.9 9.3 27.7 28.1 9.4 12.3 11.1 19.9 7.8 15.6 8.3 30.8 11.4 18.7 8.1 8.3 22.8 19.6 6.6 28.1 32.1 6.6 14.3 20.1 26.1 24.1 17.7 18.4 36.7 15.7 14.5 43.6 16.2 33.3 28.1 18.6 19.8 21.7 10.7 40.8 19.9 40.9 39.8 19.7 16.4 16.6 16.9 13.8 49.5 10.5 12.7 75.9 28.6 61.6 76.1 11.9 38.8 85.4 52.3 133.4 28.9 72.7 95.4 32.8 39.6 30.5 103.2 128.0 19.7 48.0 12.7 16.0 23.9 26.2 23.6 44.0 24.9 18.4 58.8 63.1 19.7 46.7 14.2 132.7 70.7 85.5 35.8 18.7 31.6 14.3 27.5 54.0 25.9 62.2 47.8 38.0 108.0 43.3 18.8 28.6 24.0 11.5 43.9 18.2 31.4 51.8 126.4 168.0 50.6 171.8 80.1 103.6 17.1 110.7 CLDND2 MGC33839 ENSG00000160318 "Claudin domain containing 2" Q8NHS1 19 51367098-51369003 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "testis: 31.4" "Cell type enriched" "Detected in many" 15 "Early spermatids: 230.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 11.7" HPA056971 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA056971: AB_2683294" "unprognostic (2.86e-1)" "unprognostic (4.29e-5)" "unprognostic (2.29e-2)" "unprognostic (3.40e-2)" "unprognostic (1.19e-1)" "unprognostic (9.42e-2)" "unprognostic (5.74e-3)" "unprognostic (1.79e-1)" "unprognostic (2.67e-1)" "unprognostic (1.09e-1)" "unprognostic (1.25e-3)" "unprognostic (1.13e-2)" "unprognostic (1.94e-9)" "unprognostic (4.00e-2)" "unprognostic (3.95e-1)" "unprognostic (1.85e-1)" "unprognostic (8.70e-2)" 7.7 7.8 6.8 3.2 11.1 13.3 3.3 10.9 16.5 2.6 3.6 1.4 8.4 7.7 3.0 2.5 2.9 2.8 4.5 2.5 9.9 4.7 2.8 3.5 4.0 3.2 19.6 5.2 6.7 9.1 1.5 2.9 1.8 7.4 3.8 2.4 1.7 7.5 6.0 11.9 1.5 7.1 3.8 10.2 7.3 3.3 31.4 10.6 0.0 2.9 2.2 1.2 3.2 3.0 1.7 3.0 5.8 2.0 5.3 4.5 0.7 2.1 6.0 2.2 3.0 3.3 2.9 1.2 1.0 0.5 1.0 1.3 0.7 7.1 5.6 1.2 0.6 0.7 2.7 0.7 0.3 0.2 3.9 9.7 4.9 9.4 11.7 1.3 1.4 1.4 2.2 1.0 0.2 0.6 1.5 0.7 2.8 3.1 4.1 0.9 1.3 1.2 8.1 0.9 6.1 7.6 1.1 5.1 2.2 1.6 1.6 1.3 1.5 2.6 0.5 2.1 1.1 1.5 0.4 1.4 2.2 4.4 2.3 0.9 3.8 4.0 2.0 5.4 5.6 1.3 5.8 0.9 4.1 3.5 2.0 2.0 1.7 0.8 4.5 1.4 1.1 0.6 1.5 0.5 5.3 0.7 3.0 1.2 0.7 6.8 11.1 10.9 16.5 9.9 4.7 19.6 5.2 7.4 10.6 0.0 5.9 7.8 5.0 1.4 5.5 3.6 12.7 9.4 1.2 15.7 0.0 1.9 3.3 0.7 230.3 1.7 6.6 0.0 0.6 1.1 2.3 4.4 15.1 13.4 2.3 3.2 9.9 7.4 2.4 9.1 5.8 4.6 1.7 1.8 14.5 2.3 0.8 5.8 6.0 3.0 1.9 0.0 2.7 2.3 1.3 2.4 0.7 4.5 10.5 4.6 CLEC16A "Gop-1, KIAA0350" ENSG00000038532 "C-type lectin domain containing 16A" Q2KHT3 16 10944488-11182189 "Disease related genes, Predicted intracellular proteins" Autophagy "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 97.8;Late spermatids: 56.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 51.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035814, HPA035815, HPA061385" Enhanced Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA035814: AB_10600801, HPA035815: AB_10671937, HPA061385: AB_2684498" "unprognostic (3.41e-1)" "unprognostic (4.58e-2)" "unprognostic (7.36e-2)" "unprognostic (1.56e-2)" "unprognostic (3.44e-1)" "unprognostic (1.33e-2)" "unprognostic (3.44e-1)" "unprognostic (2.22e-3)" "unprognostic (4.54e-2)" "unprognostic (7.78e-3)" "unprognostic (2.08e-1)" "unprognostic (3.49e-1)" "prognostic favorable (2.92e-6)" "unprognostic (2.69e-1)" "unprognostic (1.79e-1)" "unprognostic (8.22e-2)" "unprognostic (3.03e-1)" 9.2 9.7 11.1 12.7 13.7 15.8 8.3 17.2 19.5 8.7 9.4 14.2 9.5 11.0 9.4 10.8 11.5 9.7 6.9 10.7 11.0 10.7 11.2 12.9 12.0 11.4 12.4 10.1 7.7 7.3 22.5 21.8 9.6 13.6 8.6 8.6 12.2 9.4 9.2 14.0 15.9 10.8 9.7 14.4 9.5 8.5 43.1 11.6 15.4 11.5 5.2 12.9 8.3 8.7 7.7 5.0 6.6 6.7 4.0 5.6 2.4 5.3 5.7 4.4 5.7 7.4 5.3 3.9 5.5 5.5 4.7 6.2 6.3 10.1 10.6 13.0 6.8 5.1 4.8 5.6 10.4 6.1 51.8 5.9 4.8 7.8 6.7 5.2 5.2 10.6 6.1 5.1 7.7 6.7 4.3 6.4 5.9 8.0 6.7 5.6 8.8 8.3 4.2 3.5 4.7 4.5 11.4 3.7 6.2 9.9 4.0 5.6 7.5 8.0 8.3 4.3 5.4 5.8 8.4 6.8 6.1 8.0 8.9 4.9 4.7 4.1 8.9 7.7 7.7 6.2 5.5 4.5 3.2 5.5 3.7 3.4 4.4 4.7 3.7 3.6 7.7 5.6 4.8 6.6 4.0 6.7 5.0 3.3 2.4 11.1 13.7 17.2 19.5 11.0 10.7 12.4 10.1 13.6 11.6 14.9 7.7 8.2 3.4 6.4 10.8 4.9 12.7 6.7 10.3 3.5 35.3 2.8 0.0 5.2 97.8 3.6 10.5 0.0 5.5 2.1 4.1 3.2 8.1 11.5 4.2 11.1 7.5 9.8 3.8 56.1 5.2 4.4 3.3 10.0 7.0 5.4 5.8 4.9 8.1 2.6 19.1 0.0 3.1 14.4 5.6 7.2 3.2 5.4 6.0 4.1 CLIC2 XAP121 ENSG00000155962 "Chloride intracellular channel 2" O15247 X 155276211-155334657 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 62.3;vagina: 66.1" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 83.4;Alveolar cells type 2: 48.6;Endothelial cells: 49.6;Kupffer cells: 47.8;monocytes: 118.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "intermediate monocyte: 9.5;myeloid DC: 24.5;non-classical monocyte: 6.5" "Group enriched" "Detected in many" 14 "dendritic cells: 24.5;monocytes: 9.5" "Group enriched" "Detected in some" 5 "HDLM-2: 37.3;K-562: 20.2;Karpas-707: 18.6;RPMI-8226: 31.8" "Low region specificity" "Detected in all" "HPA047381, HPA060101" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 290000 "Plasma membrane, Cytosol" Nucleoplasm "HPA047381: AB_2680022, HPA060101: AB_2684204" "unprognostic (3.27e-2)" "unprognostic (5.21e-3)" "unprognostic (9.70e-2)" "unprognostic (7.25e-2)" "unprognostic (9.71e-2)" "unprognostic (3.78e-2)" "unprognostic (1.46e-1)" "unprognostic (4.07e-2)" "unprognostic (2.95e-1)" "unprognostic (1.74e-1)" "unprognostic (1.97e-1)" "unprognostic (3.31e-1)" "prognostic unfavorable (1.74e-5)" "unprognostic (1.97e-2)" "unprognostic (2.97e-2)" "unprognostic (6.63e-2)" "unprognostic (1.54e-1)" 26.5 3.7 3.8 7.5 6.1 3.4 24.1 2.6 4.8 15.5 6.8 0.6 3.3 4.0 11.3 10.5 10.4 6.5 9.8 9.4 3.7 3.4 5.4 6.3 31.0 15.6 7.5 1.4 12.5 2.6 2.0 7.8 4.5 6.8 9.1 6.9 3.0 5.4 3.2 10.3 5.2 7.3 10.2 5.2 32.1 4.7 5.6 4.3 6.9 62.3 8.7 12.4 14.0 66.1 0.0 24.5 0.6 9.5 1.1 0.1 1.0 0.2 0.0 0.4 0.3 0.3 2.1 0.0 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 37.3 0.2 5.2 0.1 0.0 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.2 0.0 0.2 20.2 18.6 0.1 0.1 0.0 0.3 0.1 0.0 0.1 0.1 0.0 31.8 0.1 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.0 0.4 0.0 1.7 0.6 0.7 0.3 1.2 1.6 0.0 0.9 1.1 0.6 0.0 1.8 0.1 0.0 9.5 0.1 0.0 0.0 0.1 24.5 0.0 0.0 0.0 0.6 1.1 6.5 2.5 0.0 1.0 3.8 6.1 2.6 4.8 3.7 3.4 7.5 1.4 6.8 4.3 83.4 48.6 0.8 0.7 11.7 1.1 2.8 0.0 2.7 10.3 0.0 0.0 0.0 0.0 0.0 0.1 49.6 0.0 23.3 0.2 0.1 22.3 0.4 3.5 1.0 4.8 0.0 1.2 19.0 47.8 0.4 12.7 29.8 16.9 118.2 0.0 0.0 0.1 0.0 8.9 0.2 0.3 6.5 4.8 0.0 0.0 12.0 0.0 2.2 0.0 1.4 CLINT1 "CLINT, ENTH, EPNR, KIAA0171" ENSG00000113282 "Clathrin interactor 1" Q14677 5 157785743-157859175 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Urothelial cells: 260.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 95.0;eosinophil: 27.6" "Lineage enriched" "Detected in all" 7 "granulocytes: 95.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043280, HPA056947" Supported Supported Nucleoplasm,Vesicles NA NA 340000 Vesicles Nucleoplasm "HPA043280: AB_10793944, HPA056947: AB_2683283" "unprognostic (1.92e-2)" "unprognostic (6.93e-2)" "prognostic favorable (2.95e-4)" "unprognostic (7.23e-2)" "unprognostic (1.55e-1)" "unprognostic (2.79e-1)" "unprognostic (2.53e-1)" "unprognostic (8.13e-2)" "unprognostic (1.05e-1)" "unprognostic (3.19e-2)" "unprognostic (4.89e-3)" "unprognostic (1.04e-1)" "prognostic favorable (8.88e-5)" "unprognostic (1.91e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (6.77e-4)" "unprognostic (3.56e-1)" 22.0 23.3 12.6 27.1 18.8 38.1 18.8 13.6 14.7 22.0 27.9 10.0 43.8 28.8 19.1 30.3 56.4 17.1 40.3 23.4 14.0 12.7 40.8 48.6 22.3 19.2 11.7 11.7 20.1 25.3 47.9 25.9 30.1 14.3 21.5 23.7 11.3 39.9 47.1 38.7 26.0 34.6 30.9 13.0 19.0 29.4 12.1 13.0 23.6 30.3 23.3 32.8 37.1 33.8 7.8 9.9 95.0 7.8 8.8 12.7 7.5 22.7 33.0 23.5 21.8 32.8 27.7 33.8 32.2 33.4 31.9 45.0 46.0 36.1 43.0 36.9 30.6 41.3 34.5 31.9 37.2 45.5 20.3 25.7 28.6 29.7 22.9 33.5 39.1 38.9 20.5 28.0 35.7 40.3 19.9 29.7 25.3 24.5 24.0 25.5 20.1 30.7 21.8 24.6 22.4 34.2 27.6 35.3 36.3 31.9 41.1 20.7 22.6 23.2 40.3 31.7 31.1 27.7 27.7 29.9 27.9 20.7 25.3 31.5 28.0 26.6 55.2 22.5 44.8 24.4 95.0 7.4 27.6 7.4 7.8 12.7 7.8 7.1 7.3 9.9 7.0 6.2 6.6 2.8 8.8 7.8 7.8 10.1 7.5 12.6 18.8 13.6 14.7 14.0 12.7 11.7 11.7 14.3 13.0 56.6 99.2 47.4 59.4 50.7 20.8 83.7 107.0 167.3 144.5 64.6 7.9 38.0 81.2 70.0 3.2 43.5 56.7 46.7 56.4 59.6 50.0 79.2 80.0 72.7 26.7 11.1 52.4 21.5 38.0 2.9 43.7 46.0 33.7 103.6 70.8 23.6 54.4 66.6 26.9 71.1 17.5 38.8 32.4 38.1 40.0 68.4 57.1 39.6 82.7 260.7 CLK1 ENSG00000013441 "CDC like kinase 1" P49759 2 200853009-200864744 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033141, HPA062405" Approved Supported "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "CAB033141: AB_1121713, HPA062405: AB_2684753" "unprognostic (9.79e-2)" "unprognostic (2.05e-1)" "unprognostic (2.15e-2)" "unprognostic (1.63e-1)" "unprognostic (9.19e-2)" "unprognostic (4.50e-3)" "unprognostic (1.52e-1)" "unprognostic (2.77e-3)" "unprognostic (1.78e-2)" "unprognostic (2.09e-2)" "unprognostic (1.09e-2)" "unprognostic (5.63e-3)" "unprognostic (2.03e-3)" "unprognostic (9.66e-2)" "unprognostic (2.30e-1)" "unprognostic (1.18e-1)" "prognostic favorable (2.28e-4)" 26.3 55.1 27.8 30.5 43.4 97.6 40.2 40.1 40.7 42.2 23.0 19.9 39.1 12.9 29.1 34.5 26.3 19.1 35.8 26.7 31.0 21.9 21.8 35.3 28.2 30.1 56.0 23.1 48.1 20.9 36.6 41.5 40.0 34.4 34.3 16.5 13.7 25.6 37.1 27.3 32.1 14.9 36.8 55.2 32.4 15.1 12.4 52.6 25.0 30.4 20.2 25.6 51.2 71.8 13.2 9.8 26.2 6.2 6.5 14.4 7.4 8.2 6.2 10.4 3.2 11.9 13.1 8.2 9.0 12.8 9.1 12.2 11.6 5.4 2.8 6.1 5.6 5.3 8.9 13.1 4.1 18.7 12.5 11.6 8.5 15.7 14.3 7.1 8.8 14.4 6.0 18.9 11.4 20.2 10.9 5.3 4.5 10.2 37.3 12.9 5.6 10.4 26.8 6.6 5.2 14.2 10.6 12.4 14.8 6.3 5.4 10.5 8.3 7.8 2.9 13.0 6.5 2.4 6.1 8.1 10.2 7.0 9.8 9.8 22.0 9.1 6.5 6.5 7.2 6.9 26.2 6.2 13.3 13.6 4.4 13.1 13.2 12.8 12.1 4.1 10.1 14.4 11.4 12.7 6.5 4.2 9.8 13.0 7.4 27.8 43.4 40.1 40.7 31.0 21.9 56.0 23.1 34.4 52.6 41.7 97.6 120.6 205.3 149.9 55.8 85.6 28.1 76.3 79.6 26.2 94.2 37.9 16.6 25.9 1.9 110.1 100.8 23.3 23.3 39.1 151.1 171.5 133.9 37.6 51.4 49.3 128.8 78.0 91.9 5.1 86.0 167.5 146.8 47.7 56.3 46.1 27.4 66.6 71.1 11.1 91.9 109.9 142.2 31.2 22.0 132.6 75.5 146.6 44.8 153.2 CLK2 clk2 ENSG00000176444 "CDC like kinase 2" P49760 1 155262868-155278491 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055366, HPA059507" Approved Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA055366: AB_2682795, HPA059507: AB_2684044" "unprognostic (2.00e-2)" "unprognostic (1.35e-2)" "prognostic unfavorable (3.77e-4)" "unprognostic (2.84e-2)" "unprognostic (3.16e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (2.82e-4)" "unprognostic (2.38e-1)" "unprognostic (2.36e-1)" "unprognostic (1.36e-2)" "unprognostic (7.66e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (2.95e-9)" "unprognostic (1.70e-1)" "unprognostic (1.40e-1)" "unprognostic (1.11e-1)" "prognostic favorable (5.43e-4)" 15.3 16.6 14.6 15.0 19.0 12.9 17.1 33.1 20.2 22.3 18.0 18.7 18.1 14.5 22.6 19.9 15.5 18.2 13.9 11.8 17.1 7.3 17.3 18.2 14.7 22.2 16.9 16.9 24.7 15.9 29.2 21.6 19.2 13.5 22.1 13.5 16.1 16.4 18.2 10.4 21.4 15.6 17.0 13.5 27.0 13.7 13.7 20.3 18.1 22.9 8.0 22.2 16.7 20.1 2.8 1.9 4.8 1.7 0.7 4.1 1.1 5.9 5.1 18.7 5.7 9.4 5.1 16.0 5.3 6.5 4.1 4.2 5.4 4.3 13.0 7.4 3.6 2.2 8.6 9.3 6.9 3.9 9.4 7.3 10.3 5.4 6.9 8.1 12.8 10.4 4.1 6.4 6.0 12.2 11.9 7.2 11.1 14.5 9.0 6.2 10.3 8.7 7.6 12.2 15.0 7.3 9.7 11.3 13.9 10.5 13.4 8.9 12.7 2.0 6.4 4.9 14.7 9.8 15.7 4.7 2.5 6.8 4.6 4.4 17.2 14.7 11.8 5.1 9.2 2.9 4.8 1.7 3.4 2.0 0.8 2.9 2.8 3.4 1.8 1.8 2.4 3.4 4.1 2.1 0.7 0.8 1.9 1.7 1.1 14.6 19.0 33.1 20.2 17.1 7.3 16.9 16.9 13.5 20.3 14.9 22.4 4.8 4.8 4.0 5.8 13.3 12.7 4.0 18.2 7.0 3.9 6.8 0.0 5.2 6.3 8.3 4.3 0.0 3.8 7.3 7.2 3.9 9.3 5.8 6.0 4.8 6.4 8.0 10.5 5.4 7.2 5.8 3.3 7.2 7.9 5.4 4.4 3.5 2.8 2.8 5.7 6.5 3.3 8.3 3.8 4.0 10.4 4.4 6.3 4.3 CLK3 clk3 ENSG00000179335 "CDC like kinase 3" P49761 15 74598500-74645414 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046817 Approved Supported "Nucleoplasm,Intermediate filaments" NA NA Nucleoplasm "Intermediate filaments" "HPA046817: AB_10964124" "unprognostic (4.10e-2)" "unprognostic (8.43e-2)" "prognostic unfavorable (2.05e-6)" "unprognostic (1.91e-3)" "unprognostic (7.91e-2)" "unprognostic (5.76e-2)" "unprognostic (1.46e-1)" "unprognostic (1.30e-2)" "unprognostic (1.95e-1)" "unprognostic (2.54e-1)" "unprognostic (8.14e-3)" "prognostic unfavorable (5.92e-4)" "unprognostic (1.35e-2)" "unprognostic (2.24e-1)" "unprognostic (9.73e-2)" "unprognostic (2.48e-1)" "unprognostic (2.25e-2)" 20.9 17.2 15.7 24.7 22.5 62.7 31.1 23.4 18.8 24.9 24.6 23.1 16.4 18.6 24.1 17.7 25.3 17.3 21.2 16.4 17.8 13.5 17.2 16.0 19.6 21.9 29.3 14.5 23.7 21.8 19.0 19.9 27.9 16.7 20.6 14.4 19.9 24.8 20.9 28.4 24.1 20.7 19.8 19.2 23.8 19.6 31.5 23.3 28.8 21.0 12.0 23.7 23.2 19.8 38.9 36.0 60.7 46.0 43.6 43.4 39.7 22.3 14.2 18.8 10.5 24.2 18.6 14.9 15.3 24.2 21.9 26.9 19.3 14.8 20.4 11.4 13.6 30.6 15.8 35.0 14.7 14.3 29.0 19.2 25.0 21.1 13.3 38.5 6.7 19.4 23.2 29.4 28.8 24.0 26.8 24.0 20.8 12.2 14.9 12.7 15.8 19.9 22.7 12.0 22.2 10.1 16.1 9.0 13.4 17.1 16.3 10.6 12.5 12.2 13.6 13.5 15.1 12.9 13.5 11.0 13.0 10.0 8.1 20.0 24.5 19.6 16.8 11.4 33.1 16.4 32.9 34.4 45.0 38.5 37.4 37.4 37.7 41.1 39.7 31.9 38.9 42.1 40.1 60.7 43.6 46.0 36.0 43.4 39.7 15.7 22.5 23.4 18.8 17.8 13.5 29.3 14.5 16.7 23.3 6.0 35.5 20.9 38.8 40.0 34.9 14.9 20.4 17.4 18.2 12.2 53.0 22.9 26.6 29.6 59.6 28.3 37.1 23.3 21.0 31.4 22.7 32.5 20.8 10.9 24.3 27.0 28.2 17.2 24.0 14.8 25.6 28.5 27.0 32.5 24.6 17.7 28.8 28.1 19.1 14.2 42.2 12.9 24.4 37.1 17.5 36.6 49.0 39.2 22.6 53.1 CLNS1A "CLCI, ICln" ENSG00000074201 "Chloride nucleotide-sensitive channel 1A" P54105 11 77514936-77637805 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017840, HPA031707, HPA031708, HPA032045" Approved Supported Nucleoplasm,Microtubules,Cytosol No No Cytosol "Nucleoplasm, Microtubules" "CAB017840: , HPA031707: AB_2674002, HPA031708: AB_2674003, HPA032045: AB_2674123" "unprognostic (1.30e-1)" "unprognostic (3.26e-1)" "unprognostic (5.16e-2)" "unprognostic (1.30e-2)" "unprognostic (5.12e-3)" "unprognostic (5.09e-2)" "unprognostic (9.63e-2)" "unprognostic (5.56e-2)" "unprognostic (2.06e-3)" "unprognostic (5.56e-2)" "unprognostic (1.33e-3)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.07e-4)" "unprognostic (2.05e-1)" "unprognostic (9.19e-2)" "unprognostic (5.99e-3)" "unprognostic (1.17e-1)" 22.6 44.7 43.0 31.3 37.3 27.8 36.4 24.5 45.6 30.0 31.9 41.8 26.2 22.1 29.3 47.4 41.5 34.5 29.9 33.2 37.2 39.5 26.8 90.9 20.8 41.2 45.3 31.2 49.2 44.9 26.5 28.9 29.0 38.5 28.7 35.7 29.6 28.2 27.4 43.1 24.4 26.3 26.1 48.5 32.5 28.5 21.7 31.7 47.0 40.5 36.8 45.1 31.9 28.8 33.4 45.9 12.8 34.1 31.8 32.7 30.6 24.2 23.8 39.8 29.6 29.8 42.9 16.1 21.4 33.0 34.9 31.5 58.2 34.7 54.7 35.6 25.9 27.4 29.5 48.1 44.4 42.8 30.6 29.3 53.6 30.0 33.5 25.1 79.3 24.9 34.4 51.9 30.7 58.4 34.6 39.6 33.7 70.3 16.9 34.2 36.0 52.0 64.7 37.6 81.2 44.8 28.1 77.5 58.6 25.2 34.0 40.6 46.2 28.8 32.7 19.8 30.1 44.4 34.7 25.9 26.1 31.9 50.8 20.6 34.0 47.3 58.6 10.3 29.8 20.9 12.8 33.1 12.2 21.0 34.1 24.0 32.1 26.8 23.1 45.9 33.4 32.7 27.5 2.3 31.8 28.7 28.2 23.0 30.6 43.0 37.3 24.5 45.6 37.2 39.5 45.3 31.2 38.5 31.7 14.9 16.9 79.3 88.6 73.5 68.6 66.7 50.9 33.5 48.9 55.8 47.1 114.2 71.3 64.7 13.3 56.2 37.1 0.0 75.8 112.7 69.2 58.1 76.2 62.5 82.7 55.6 30.5 48.5 94.8 10.9 81.1 78.8 72.6 146.9 56.2 179.4 61.9 45.6 64.3 70.3 55.1 51.8 46.4 90.1 100.9 75.3 67.4 77.1 110.2 89.9 CLOCK "bHLHe8, KAT13D, KIAA0334" ENSG00000134852 "Clock circadian regulator" O15516 4 55427903-55547138 "Enzymes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, DNA damage, Transcription, Transcription regulation" "Activator, Acyltransferase, DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001867, HPA027565" Supported Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA001867: AB_1078537, HPA027565: AB_1846975" "unprognostic (1.30e-2)" "unprognostic (9.02e-2)" "unprognostic (4.25e-3)" "unprognostic (2.48e-1)" "unprognostic (3.94e-2)" "unprognostic (2.00e-2)" "unprognostic (1.17e-1)" "unprognostic (1.30e-1)" "unprognostic (4.52e-2)" "unprognostic (4.32e-2)" "unprognostic (3.01e-2)" "unprognostic (5.96e-2)" "unprognostic (4.07e-2)" "unprognostic (8.31e-2)" "unprognostic (1.69e-1)" "unprognostic (5.18e-2)" "unprognostic (7.16e-2)" 9.3 9.2 7.8 5.8 11.7 1.7 8.4 16.2 14.3 12.5 9.5 5.2 9.2 7.1 10.5 8.4 13.9 8.1 6.7 10.5 7.9 7.9 12.4 9.1 8.2 9.4 7.0 9.8 11.7 8.6 18.7 21.9 8.5 8.4 9.7 8.4 5.6 8.2 9.2 16.1 9.4 12.6 13.8 8.3 9.1 9.6 18.5 5.0 4.0 14.7 5.9 5.2 8.4 17.1 2.5 3.6 0.6 3.0 2.9 4.7 1.4 13.6 5.9 5.4 8.4 8.1 8.2 2.7 14.1 11.6 9.9 9.1 3.7 10.9 3.7 7.3 16.4 7.4 11.4 6.9 10.9 16.7 4.5 2.5 2.9 6.3 4.6 7.2 4.7 3.4 4.8 10.9 13.6 13.4 7.4 9.2 3.1 6.7 7.5 14.8 7.5 2.6 2.7 3.9 11.2 6.9 1.7 6.2 2.4 7.6 7.4 5.3 4.7 10.2 12.6 6.4 4.7 4.2 2.6 12.7 13.4 14.4 4.4 18.9 6.8 4.9 2.3 11.9 4.2 10.6 0.0 3.0 0.6 2.8 3.0 4.7 1.4 3.2 2.5 3.6 2.5 1.9 2.4 0.6 2.9 2.7 2.1 3.1 1.4 7.8 11.7 16.2 14.3 7.9 7.9 7.0 9.8 8.4 5.0 38.7 23.0 9.8 18.1 27.6 61.3 50.4 12.7 12.0 13.6 14.0 41.2 9.5 1.7 11.5 25.0 28.9 20.3 0.0 14.4 5.7 30.8 25.1 3.5 25.9 10.1 31.8 38.2 28.8 12.7 12.1 22.2 14.3 10.1 8.2 19.3 29.6 19.8 15.3 33.9 17.0 39.4 12.9 30.8 56.9 73.3 32.9 4.3 10.2 14.9 46.9 CLP1 "hClp1, HEAB" ENSG00000172409 "Cleavage and polyadenylation factor I subunit 1" Q92989 11 57648992-57661868 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, tRNA processing" "Kinase, Transferase" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057770 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA057770: AB_2683523" "unprognostic (1.33e-1)" "unprognostic (7.90e-2)" "unprognostic (1.11e-3)" "unprognostic (2.13e-2)" "unprognostic (4.90e-2)" "unprognostic (3.58e-1)" "unprognostic (1.93e-3)" "unprognostic (1.16e-1)" "unprognostic (3.01e-1)" "unprognostic (1.66e-2)" "unprognostic (8.82e-2)" "unprognostic (7.58e-2)" "unprognostic (8.31e-3)" "unprognostic (3.71e-2)" "unprognostic (1.75e-1)" "unprognostic (8.78e-2)" "unprognostic (3.07e-1)" 10.8 11.7 7.0 11.2 8.8 23.5 9.6 7.2 10.9 8.5 9.3 5.6 7.6 9.0 12.0 10.0 13.6 10.1 6.2 8.1 6.0 4.5 9.9 12.8 8.7 9.9 6.5 5.1 7.3 11.8 7.2 6.8 17.3 6.1 10.5 9.2 5.6 10.3 8.1 16.7 11.8 11.7 11.2 5.0 15.4 11.5 11.3 6.5 15.4 11.8 10.8 13.2 8.8 6.9 16.2 19.0 23.7 19.1 12.8 20.9 11.6 14.2 14.2 14.3 15.1 15.8 10.5 13.6 14.0 15.5 21.1 17.8 13.1 12.9 23.5 17.1 11.6 16.2 17.5 19.7 22.6 23.6 15.9 11.5 12.8 10.2 14.9 12.0 19.5 15.5 11.7 16.1 17.9 12.8 8.6 19.1 11.6 20.6 8.2 17.0 10.1 14.1 22.2 21.9 15.5 15.0 15.1 23.0 25.0 11.3 10.1 7.8 15.2 11.9 12.3 19.1 15.7 22.7 15.0 13.3 11.4 15.4 19.4 11.2 13.2 16.7 25.7 12.4 10.5 12.1 23.7 19.1 19.9 17.6 16.0 20.9 16.2 15.8 17.8 19.0 14.1 18.2 16.6 22.3 12.8 15.7 11.0 16.0 11.6 7.0 8.8 7.2 10.9 6.0 4.5 6.5 5.1 6.1 6.5 8.9 6.1 4.7 9.0 17.2 2.9 2.2 5.1 5.3 9.1 0.0 5.9 13.9 8.3 10.4 21.7 6.7 4.5 0.0 10.2 12.3 8.0 3.5 8.1 4.0 9.5 4.8 2.4 4.9 4.1 1.7 5.2 6.1 8.5 17.2 3.2 3.6 8.3 5.9 8.1 9.0 3.0 6.5 11.3 6.7 13.4 12.7 11.3 7.5 4.7 8.2 CLPX ENSG00000166855 "Caseinolytic mitochondrial matrix peptidase chaperone subunit" O76031 15 65148219-65185342 "Predicted intracellular proteins" Chaperone "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 50.9" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 189.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040262, HPA048199" Approved Supported Nucleoplasm,Mitochondria,Cytosol "Intracellular and membrane" NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA040262: AB_10793961, HPA048199: AB_2680312" "unprognostic (2.78e-1)" "unprognostic (6.58e-2)" "unprognostic (1.21e-1)" "unprognostic (2.69e-2)" "unprognostic (2.00e-2)" "unprognostic (3.06e-1)" "unprognostic (1.18e-3)" "unprognostic (2.64e-1)" "unprognostic (3.99e-2)" "unprognostic (1.29e-1)" "unprognostic (2.53e-2)" "unprognostic (6.99e-2)" "prognostic favorable (1.93e-9)" "unprognostic (1.76e-1)" "unprognostic (2.64e-1)" "unprognostic (5.95e-2)" "unprognostic (3.50e-2)" 10.4 12.8 11.3 8.9 12.7 7.7 10.2 10.9 10.7 11.7 13.4 11.2 4.7 9.3 9.8 10.3 15.5 8.9 9.6 15.9 10.7 9.2 16.8 50.9 9.4 8.8 12.8 8.1 10.8 10.6 11.0 6.3 10.6 9.8 9.7 8.9 7.4 8.9 7.1 25.8 15.6 12.6 10.8 9.7 9.7 9.9 9.3 12.6 17.8 12.9 14.7 10.2 12.5 9.5 7.7 9.8 11.4 7.1 8.2 9.2 4.4 5.3 9.1 8.0 10.1 8.5 11.0 8.6 6.1 6.9 6.8 7.1 9.1 7.5 16.6 5.2 8.2 5.0 11.5 29.3 8.1 7.3 6.5 5.3 12.5 8.9 11.5 12.2 15.9 7.3 13.1 11.2 6.2 11.9 7.8 8.6 9.0 11.4 5.9 7.9 6.8 7.5 14.1 9.0 10.6 4.1 14.8 9.5 17.1 12.7 12.4 7.0 5.7 8.3 13.3 9.0 11.0 6.1 13.5 7.5 6.9 6.0 5.5 5.7 6.3 9.6 8.7 6.7 20.2 5.3 3.5 7.1 10.3 7.6 5.7 7.0 7.7 6.7 5.6 6.4 7.2 9.2 7.3 11.4 8.2 5.1 9.8 5.7 4.4 11.3 12.7 10.9 10.7 10.7 9.2 12.8 8.1 9.8 12.6 32.8 28.6 14.9 17.9 17.1 27.3 62.7 28.1 33.5 33.0 31.4 13.7 35.1 18.3 32.5 87.1 17.9 15.6 0.0 27.4 27.2 19.7 20.0 15.1 79.9 19.8 30.2 9.9 22.1 23.9 189.0 26.7 16.0 16.9 26.2 22.4 24.3 27.3 17.5 28.0 28.4 24.1 25.8 16.0 33.9 29.6 26.3 74.6 19.1 23.3 18.4 CLSPN ENSG00000092853 Claspin Q9HAW4 1 35720218-35769967 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 12.6;lymphoid tissue: 30.4;testis: 10.0" "Group enriched" "Detected in many" 5 "Extravillous trophoblasts: 33.9;Rod photoreceptor cells: 96.1;Spermatocytes: 71.5;Spermatogonia: 133.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Region enriched" "Detected in single" 12 "basal ganglia: 7.0" "Low region specificity" "Detected in all" "HPA026305, HPA026312" Enhanced "Nucleoplasm,Golgi apparatus" Yes Yes "Nucleoplasm, Golgi apparatus" "HPA026305: AB_2671833, HPA026312: AB_2671837" "unprognostic (4.75e-2)" "unprognostic (1.01e-1)" "unprognostic (9.64e-3)" "unprognostic (3.54e-2)" "unprognostic (6.82e-2)" "unprognostic (1.62e-2)" "unprognostic (1.18e-6)" "unprognostic (3.99e-3)" "unprognostic (2.08e-3)" "unprognostic (1.63e-2)" "unprognostic (8.71e-6)" "unprognostic (3.23e-2)" "unprognostic (7.61e-6)" "prognostic favorable (4.92e-4)" "unprognostic (5.12e-1)" "unprognostic (1.73e-1)" "unprognostic (1.29e-1)" 1.5 0.8 0.9 11.5 1.0 12.6 1.7 0.3 3.6 0.9 2.1 0.1 0.0 1.0 0.5 0.9 2.9 0.5 2.8 0.6 1.1 0.6 1.0 0.7 1.9 6.0 0.6 0.1 0.5 0.5 0.3 0.4 4.3 0.7 0.5 2.7 1.9 1.0 0.0 0.4 1.2 3.4 1.0 0.8 4.4 1.1 10.0 0.5 30.4 0.5 4.2 6.6 0.9 1.2 0.9 0.9 3.4 1.1 1.3 1.6 1.1 8.7 7.3 15.9 8.4 1.1 2.1 5.9 18.0 5.0 13.2 17.7 11.5 8.2 18.7 5.8 4.8 9.6 8.8 15.5 6.2 20.7 12.8 7.0 26.3 15.9 5.1 0.0 21.5 15.5 0.4 0.2 22.7 1.6 1.5 7.1 11.2 17.7 13.0 12.6 5.7 22.6 4.9 15.0 6.0 5.2 14.4 24.1 5.6 2.7 14.5 5.9 6.9 15.6 4.8 3.1 11.2 4.1 8.5 5.1 19.0 14.4 11.6 20.0 4.7 11.4 19.7 6.0 15.4 15.3 1.6 1.1 1.1 1.6 0.5 0.5 0.4 1.0 0.8 0.9 0.9 0.4 0.8 3.4 1.3 0.7 0.8 1.3 1.1 0.9 1.0 0.3 3.6 1.1 0.6 0.6 0.1 0.7 0.5 0.0 0.3 1.5 4.6 4.9 7.9 1.1 2.5 0.0 3.4 0.0 11.8 5.5 0.0 1.3 6.2 1.9 0.4 0.0 0.6 33.9 3.9 1.4 1.1 0.0 14.0 1.6 1.2 3.7 3.2 4.9 2.3 6.5 3.3 15.4 1.6 6.6 0.9 1.9 0.4 0.0 96.1 6.5 2.5 71.5 133.3 1.8 8.7 5.1 4.1 2.6 CLUAP1 "CFAP22, FAP22, FLJ13297, IFT38, KIAA0643" ENSG00000103351 "Clusterin associated protein 1" Q96AJ1 16 3500924-3539048 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 215.5;Early spermatids: 173.4;Rod photoreceptor cells: 118.6;Spermatocytes: 118.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036976, HPA044191" Uncertain Supported Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA036976: AB_10602209, HPA044191: AB_2678852" "unprognostic (1.78e-1)" "unprognostic (9.28e-3)" "unprognostic (1.21e-1)" "prognostic favorable (3.01e-4)" "unprognostic (1.57e-1)" "unprognostic (3.67e-1)" "unprognostic (4.53e-2)" "unprognostic (3.63e-2)" "unprognostic (2.04e-1)" "unprognostic (8.44e-2)" "unprognostic (3.13e-1)" "unprognostic (6.94e-3)" "unprognostic (5.11e-3)" "unprognostic (8.43e-2)" "unprognostic (2.07e-1)" "unprognostic (8.94e-3)" "unprognostic (1.12e-2)" 8.3 10.4 12.3 6.8 22.3 3.3 12.7 13.6 18.8 19.2 11.7 12.1 15.7 4.0 23.0 14.7 10.2 27.6 9.5 9.4 11.4 12.5 16.5 6.8 10.5 6.7 11.9 17.8 22.7 10.7 30.5 22.1 9.3 15.8 15.4 8.9 12.0 10.0 18.3 8.8 6.0 6.0 17.6 11.7 5.7 8.8 34.6 10.3 8.2 19.5 6.2 5.2 12.7 9.1 4.7 4.5 2.7 2.7 5.5 19.8 4.1 8.3 10.0 11.6 15.5 17.6 18.4 6.0 10.5 14.2 17.2 12.9 2.8 17.0 4.0 9.3 17.1 10.4 8.7 7.6 12.4 14.8 3.3 7.2 3.7 5.8 5.5 20.6 6.6 4.1 11.8 13.8 16.1 16.1 18.3 9.3 9.0 10.9 0.6 12.7 9.9 6.2 7.3 12.0 3.5 5.9 13.8 8.1 8.2 25.9 2.5 12.9 11.1 6.3 4.9 7.6 9.4 10.3 15.4 6.1 11.8 7.9 9.0 8.1 7.0 5.6 1.1 4.5 3.9 8.1 2.7 2.5 0.7 4.5 2.7 8.5 4.7 13.0 7.7 4.5 4.0 19.8 13.4 1.0 5.5 1.6 4.5 6.7 4.1 12.3 22.3 13.6 18.8 11.4 12.5 11.9 17.8 15.8 10.3 20.8 15.6 4.2 12.2 4.9 38.6 10.9 7.6 215.5 35.2 14.0 102.1 17.4 36.5 18.2 173.4 8.4 4.0 0.0 7.0 6.6 15.6 7.9 4.7 8.9 9.0 36.5 16.8 17.2 3.8 47.7 29.1 4.8 3.3 26.2 7.7 41.5 8.7 3.5 31.1 27.8 118.6 6.5 14.4 118.6 62.8 3.6 7.8 10.2 9.2 4.2 CMIP ENSG00000153815 "C-Maf inducing protein" Q8IY22 16 81445170-81711762 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 5.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HMC-1: 53.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054424, HPA066710" Approved Supported Nucleoplasm,Cytosol NA NA 360000 "Nucleoplasm, Cytosol" "HPA054424: AB_2682484, HPA066710: AB_2685708" "unprognostic (6.84e-2)" "unprognostic (1.99e-1)" "unprognostic (2.89e-2)" "unprognostic (3.76e-1)" "unprognostic (3.02e-2)" "unprognostic (9.83e-3)" "unprognostic (2.28e-2)" "prognostic unfavorable (9.47e-7)" "unprognostic (1.60e-1)" "unprognostic (1.64e-1)" "unprognostic (3.10e-2)" "unprognostic (6.04e-2)" "unprognostic (4.12e-2)" "unprognostic (3.42e-2)" "unprognostic (9.08e-2)" "prognostic unfavorable (1.05e-4)" "unprognostic (1.59e-1)" 19.1 19.7 34.3 25.6 27.9 19.6 15.4 13.1 46.5 28.5 26.5 13.0 7.1 33.5 15.5 14.1 26.5 20.3 27.8 9.3 28.1 35.7 15.8 11.4 18.8 17.2 19.4 30.6 17.7 16.5 8.9 26.4 23.8 19.4 13.4 20.0 7.8 15.5 14.0 6.3 24.5 40.5 19.1 15.7 18.0 28.2 11.0 13.2 20.8 11.3 10.2 16.1 22.2 37.2 0.8 0.5 5.7 1.7 0.5 1.0 0.9 11.5 38.6 7.6 3.9 4.0 3.2 15.7 8.4 5.7 5.3 2.3 13.0 23.8 5.2 7.2 6.9 7.1 11.8 4.9 27.9 5.1 3.3 3.6 24.9 7.3 22.7 4.0 7.6 53.9 3.2 11.9 9.8 12.7 8.1 14.6 9.3 21.6 4.5 3.2 11.6 13.3 9.6 6.0 11.3 8.2 24.1 2.5 5.0 6.6 11.4 40.2 8.0 19.6 7.3 2.4 8.0 5.6 10.2 10.0 8.5 9.1 8.2 7.6 5.7 4.4 22.5 10.1 9.0 3.4 4.8 1.7 2.1 1.0 1.2 0.5 0.1 0.2 0.3 0.5 0.8 0.1 0.5 5.7 0.5 0.3 0.5 0.2 0.9 34.3 27.9 13.1 33.7 28.1 35.7 19.4 30.6 19.4 13.2 11.9 17.6 24.6 49.5 95.4 16.2 6.5 63.7 42.8 20.5 14.0 0.0 39.9 6.6 19.3 59.6 46.7 44.3 0.0 21.1 99.7 24.7 54.5 44.9 29.6 29.0 23.8 69.3 63.8 68.0 71.8 44.0 48.6 11.8 32.5 109.8 7.8 43.7 25.9 134.7 36.3 3.2 12.9 17.6 5.6 13.4 125.5 74.1 20.3 36.4 103.9 CMPK1 "CMPK, UMP-CMPK" ENSG00000162368 "Cytidine/uridine monophosphate kinase 1" P30085 1 47333797-47378839 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Pyrimidine biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053730, HPA058604" Approved Supported Nucleoplasm "Intracellular and membrane" NA NA 2100000 Nucleoplasm "HPA053730: AB_2682244, HPA058604: AB_2683773" "unprognostic (2.16e-2)" "unprognostic (1.16e-1)" "unprognostic (9.39e-3)" "unprognostic (1.18e-1)" "unprognostic (1.09e-3)" "unprognostic (1.50e-2)" "unprognostic (1.59e-2)" "unprognostic (9.88e-2)" "unprognostic (5.80e-2)" "unprognostic (2.90e-2)" "unprognostic (1.71e-2)" "unprognostic (2.61e-1)" "unprognostic (1.28e-2)" "unprognostic (2.58e-2)" "unprognostic (1.06e-1)" "unprognostic (1.02e-3)" "unprognostic (7.36e-2)" 35.0 17.0 28.5 30.4 24.4 14.8 72.2 18.0 35.8 26.8 44.8 17.8 20.9 53.7 16.5 19.3 42.2 13.5 39.2 28.6 28.0 31.4 26.2 88.2 36.8 46.2 35.1 16.8 16.2 42.3 19.3 16.6 16.0 25.4 32.8 48.1 16.2 50.8 18.3 30.4 22.2 64.9 46.9 33.1 21.6 35.9 8.6 18.2 25.6 31.7 26.7 28.0 34.0 39.0 11.2 10.6 23.1 12.4 15.0 17.5 12.1 30.8 17.3 22.4 20.0 40.9 47.9 31.7 54.9 33.1 33.4 34.0 15.4 21.4 45.7 28.3 37.2 31.4 21.0 16.5 28.4 45.8 69.1 13.5 35.5 23.9 26.5 26.7 50.6 26.0 26.8 34.4 27.8 31.3 31.6 34.5 17.1 33.5 36.9 43.5 11.3 41.0 23.9 14.2 40.6 24.0 25.6 38.8 34.3 32.5 34.0 20.3 10.7 39.3 45.7 31.5 30.9 11.3 30.2 32.3 41.8 24.2 39.9 45.1 26.9 37.2 31.2 33.0 31.3 28.5 23.1 10.2 18.2 13.6 10.7 17.5 11.2 15.5 16.7 10.6 10.2 14.7 14.0 4.2 15.0 12.4 8.9 16.0 12.1 28.5 24.4 18.0 35.8 28.0 31.4 35.1 16.8 25.4 18.2 65.5 42.5 120.7 103.0 155.9 32.3 44.9 101.9 57.6 33.0 71.5 15.7 70.1 147.6 156.9 1.2 74.2 219.2 46.7 158.3 115.0 53.6 209.9 94.4 215.9 69.9 41.3 112.9 68.2 97.0 4.1 55.0 98.6 241.3 77.5 273.0 40.6 127.4 150.8 65.7 149.9 26.0 84.1 148.0 8.2 27.2 170.5 99.0 139.5 184.6 187.9 CMPK2 "NDK, TYKi, UMP-CMPK2" ENSG00000134326 "Cytidine/uridine monophosphate kinase 2" Q5EBM0 2 6840570-6866635 "Enzymes, Predicted intracellular proteins" "Pyrimidine biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Erythroid cells: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 14.2;BJ hTERT+ SV40 Large T+ RasG12V: 12.9;HEL: 20.1;MOLT-4: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041430 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA041430: AB_10796674" "unprognostic (2.37e-1)" "unprognostic (6.07e-2)" "unprognostic (5.71e-2)" "prognostic unfavorable (4.71e-4)" "unprognostic (1.82e-1)" "unprognostic (5.08e-2)" "unprognostic (3.80e-2)" "unprognostic (8.93e-2)" "unprognostic (6.63e-2)" "unprognostic (4.54e-3)" "unprognostic (7.39e-3)" "unprognostic (1.43e-1)" "unprognostic (1.09e-3)" "unprognostic (1.28e-1)" "unprognostic (1.77e-2)" "unprognostic (7.69e-2)" "unprognostic (4.32e-2)" 8.8 3.8 3.0 6.8 8.1 14.5 4.2 0.9 5.0 2.7 4.2 4.0 1.3 5.0 2.5 6.4 1.8 2.3 3.4 3.7 3.3 3.9 4.0 3.1 17.9 13.4 3.2 5.7 1.3 3.7 2.9 3.0 4.7 3.6 2.1 2.2 4.7 20.8 4.3 3.0 1.2 6.1 3.1 3.8 7.9 7.4 9.2 0.4 8.8 3.1 1.6 2.6 2.7 1.6 1.4 1.9 7.8 6.4 0.9 0.7 1.2 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.2 14.2 12.9 0.0 1.4 3.1 0.8 0.0 3.7 0.2 0.0 0.0 0.0 0.3 0.2 20.1 0.0 0.0 0.0 0.7 1.4 0.0 0.0 0.1 0.0 0.0 0.0 2.0 4.9 0.1 0.0 0.1 11.0 3.7 0.3 0.0 1.1 3.5 0.0 0.0 0.0 0.4 0.3 0.5 0.2 0.0 1.7 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.0 3.3 0.4 0.0 0.0 3.7 0.9 5.5 2.8 7.8 0.7 6.4 0.4 1.4 0.5 0.4 1.9 0.2 0.5 0.5 1.8 0.9 3.2 0.1 0.6 1.2 3.0 8.1 0.9 5.0 3.3 3.9 3.2 5.7 3.6 0.4 3.0 6.9 2.7 0.8 0.3 1.6 1.4 0.0 4.0 0.0 1.8 0.0 2.0 1.7 2.4 2.5 4.7 5.3 70.0 5.8 2.4 1.9 0.7 2.3 1.3 15.9 0.0 6.9 7.4 6.7 1.1 1.4 5.1 0.0 5.4 1.7 4.6 4.1 1.9 5.3 0.6 0.2 0.0 2.0 0.1 4.1 0.4 0.7 4.3 0.9 1.6 CMSS1 "C3orf26, MGC4308" ENSG00000184220 "Cms1 ribosomal small subunit homolog (yeast)" Q9BQ75 3 99817834-100181732 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042820 Uncertain Approved "Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria" NA NA Nucleoli "Nucleoplasm, Nuclear membrane, Mitochondria" "HPA042820: AB_10795763" "unprognostic (1.50e-1)" "unprognostic (8.28e-2)" "unprognostic (4.61e-2)" "prognostic unfavorable (3.15e-6)" "unprognostic (2.13e-2)" "unprognostic (2.39e-3)" "prognostic unfavorable (5.92e-10)" "unprognostic (1.50e-1)" "unprognostic (5.92e-2)" "unprognostic (5.83e-2)" "unprognostic (6.71e-2)" "prognostic unfavorable (3.10e-4)" "unprognostic (2.18e-3)" "unprognostic (1.56e-1)" "unprognostic (2.26e-1)" "unprognostic (3.25e-1)" "unprognostic (4.04e-2)" 21.4 34.1 23.7 15.1 24.5 17.7 20.6 24.1 27.4 13.4 12.9 9.4 8.2 8.3 19.6 10.7 12.0 13.3 10.5 16.6 24.0 22.2 17.1 17.5 10.8 15.8 15.3 22.3 21.1 26.4 20.7 25.9 11.7 19.2 15.1 12.4 9.3 12.4 14.5 58.2 11.5 9.3 13.8 15.7 12.9 11.0 28.1 13.5 13.6 14.9 14.4 14.7 18.8 15.7 23.5 26.1 1.6 10.9 11.2 19.0 7.9 28.9 13.1 13.0 18.7 9.2 10.9 13.4 13.5 7.3 24.3 20.3 16.3 9.7 31.4 23.7 7.2 21.5 17.5 18.0 15.3 32.2 16.2 17.2 24.7 9.3 13.2 16.6 33.8 13.6 7.4 14.9 18.1 30.3 7.7 16.8 25.4 15.2 20.4 17.6 20.0 27.0 31.5 19.0 27.6 32.9 12.2 21.0 33.6 15.0 7.1 36.7 15.4 13.5 11.0 30.7 13.0 13.3 21.2 4.8 19.3 54.8 11.2 27.4 14.6 29.0 61.0 12.5 37.4 32.2 0.3 4.7 0.8 10.0 10.9 14.2 23.2 14.8 13.5 9.9 23.5 18.7 19.0 1.6 11.2 9.7 26.1 13.7 7.9 23.7 24.5 24.1 27.4 24.0 22.2 15.3 22.3 19.2 13.5 6.0 14.2 29.8 33.2 55.3 30.0 40.3 43.3 29.4 23.9 59.3 17.7 34.3 82.9 17.0 137.8 37.9 1.1 0.0 40.8 46.0 41.2 21.8 61.1 44.9 24.7 120.8 14.5 19.0 5.8 151.1 46.9 25.2 35.4 14.4 13.3 17.6 29.9 0.0 55.2 66.2 21.4 25.8 64.6 105.9 127.7 57.7 18.3 28.7 20.7 22.0 CMTM1 "CKLFH, CKLFH1a, CKLFSF1" ENSG00000089505 "CKLF like MARVEL transmembrane domain containing 1" Q8IZ96 16 66566393-66579137 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 80.7" "Group enriched" "Detected in some" 13 "Early spermatids: 60.6;Late spermatids: 113.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in many" 4 "granulocytes: 8.7" "Cell line enhanced" "Detected in many" "REH: 16.8" "HPA013801, HPA017136" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA013801: AB_1846990, HPA017136: AB_1846992" "unprognostic (2.37e-2)" "unprognostic (7.48e-2)" "unprognostic (3.10e-1)" "unprognostic (2.30e-1)" "unprognostic (3.81e-1)" "unprognostic (5.32e-2)" "unprognostic (2.97e-3)" "unprognostic (5.12e-3)" "unprognostic (1.25e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (5.68e-5)" "unprognostic (2.47e-2)" "unprognostic (1.56e-4)" "unprognostic (1.06e-1)" "unprognostic (1.22e-1)" "unprognostic (3.41e-1)" "unprognostic (3.49e-1)" 0.9 0.8 0.8 1.9 1.2 0.0 0.5 2.2 1.3 0.7 0.9 0.5 0.5 1.7 1.3 1.1 0.6 0.8 1.5 0.7 0.8 1.1 0.8 0.5 0.9 1.2 0.8 0.6 1.7 0.5 0.3 1.1 0.9 0.7 0.7 0.2 0.5 0.6 0.5 0.6 0.6 1.2 0.5 0.9 2.8 0.9 80.7 0.7 0.8 0.7 0.5 0.6 0.9 0.6 0.3 1.9 8.7 2.1 1.3 1.9 1.1 4.2 6.7 1.2 5.6 2.4 2.3 1.2 5.6 2.7 4.5 4.7 1.4 2.9 2.0 3.0 1.6 1.4 3.4 1.9 0.3 2.4 7.4 1.3 0.7 3.0 1.4 1.1 3.9 4.9 1.9 0.5 4.0 0.5 6.9 2.3 4.0 3.5 2.8 1.9 1.6 7.4 3.8 1.0 0.6 2.5 16.8 14.4 4.6 4.0 2.0 3.2 4.3 7.8 0.6 2.0 0.2 2.0 2.8 5.7 8.0 12.7 4.8 2.4 2.8 6.7 7.3 3.8 5.3 9.3 8.7 2.1 7.1 1.9 0.6 1.6 0.2 0.6 0.9 1.9 0.3 0.5 0.6 8.4 1.3 1.2 0.5 0.6 1.1 0.8 1.2 2.2 1.0 0.8 1.1 0.8 0.6 0.7 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 113.2 0.6 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 6.5 0.0 4.8 0.4 0.3 0.1 0.0 0.0 0.0 CMTM3 "BNAS2, CKLFSF3, FLJ31762" ENSG00000140931 "CKLF like MARVEL transmembrane domain containing 3" Q96MX0 16 66603874-66613892 "Predicted intracellular proteins, Predicted membrane proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 178.7;granulocytes: 90.0;Hofbauer cells: 108.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013870, HPA072695" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA013870: AB_1847003, HPA072695: AB_2732210" "unprognostic (1.59e-1)" "unprognostic (2.83e-2)" "unprognostic (7.63e-2)" "unprognostic (1.49e-1)" "unprognostic (4.21e-2)" "unprognostic (1.64e-1)" "unprognostic (1.80e-3)" "unprognostic (6.65e-3)" "unprognostic (7.75e-2)" "unprognostic (1.60e-2)" "unprognostic (1.22e-2)" "unprognostic (7.38e-2)" "prognostic unfavorable (4.42e-6)" "prognostic unfavorable (1.85e-4)" "unprognostic (7.56e-2)" "unprognostic (1.93e-2)" "unprognostic (2.81e-2)" 24.3 8.5 5.4 11.5 6.1 8.0 29.5 1.2 4.6 19.1 7.8 10.0 7.7 3.2 18.0 19.1 10.0 12.2 16.3 15.9 5.9 4.9 8.9 6.1 21.7 34.1 6.7 2.6 25.4 6.5 22.9 5.6 30.8 8.4 16.4 6.0 15.5 9.3 8.7 7.9 11.5 9.1 14.0 8.4 19.0 6.2 61.7 6.9 35.6 8.6 10.4 14.6 13.6 21.1 1.4 19.9 7.0 11.3 6.5 12.0 4.4 1.8 9.6 27.3 19.0 20.4 12.9 16.8 4.9 22.7 10.0 10.0 5.3 6.0 0.0 13.7 13.9 17.5 2.1 18.3 16.4 8.1 9.4 6.5 6.0 1.3 14.9 27.6 17.9 22.2 25.5 1.3 10.6 2.2 41.7 22.8 17.0 9.2 0.2 12.4 2.3 14.5 30.0 13.0 0.1 9.1 45.3 19.1 0.9 4.8 0.2 2.8 9.7 2.4 0.1 15.9 18.5 0.2 16.6 15.1 14.4 17.2 3.4 5.9 1.2 0.1 6.0 9.0 13.9 15.3 6.1 11.3 7.0 7.8 10.9 10.9 1.4 8.8 8.9 9.7 0.8 6.8 8.2 6.6 6.5 6.5 19.9 12.0 4.4 5.4 6.1 1.2 4.6 5.9 4.9 6.7 2.6 8.4 6.9 0.0 10.3 18.2 25.6 13.1 0.6 1.6 5.1 2.7 7.9 5.2 0.0 7.2 0.0 20.2 1.8 33.7 0.0 0.0 5.8 178.7 48.2 33.2 90.0 0.8 108.7 0.0 12.0 41.1 71.2 6.3 36.5 64.5 27.0 11.8 0.5 10.0 25.7 0.0 23.0 2.2 0.6 6.5 19.7 3.9 9.7 7.5 7.9 69.9 0.0 19.4 CMTM8 CKLFSF8 ENSG00000170293 "CKLF like MARVEL transmembrane domain containing 8" Q8IZV2 3 32238679-32370325 "Predicted membrane proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 79.8" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 81.9;Syncytiotrophoblasts: 97.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 4.2;memory CD4 T-cell: 2.8" "Group enriched" "Detected in many" 7 "granulocytes: 4.2;T-cells: 2.8" "Group enriched" "Detected in many" 4 "BEWO: 68.3;SK-BR-3: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA055077, HPA073258" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA055077: AB_2682691, HPA073258: AB_2686591" "unprognostic (9.88e-3)" "unprognostic (1.83e-1)" "unprognostic (1.32e-1)" "unprognostic (3.83e-1)" "unprognostic (1.14e-1)" "unprognostic (3.33e-2)" "unprognostic (9.46e-2)" "unprognostic (5.67e-2)" "unprognostic (8.85e-2)" "unprognostic (1.29e-1)" "unprognostic (7.59e-2)" "unprognostic (2.56e-1)" "prognostic favorable (2.80e-4)" "unprognostic (1.78e-2)" "unprognostic (2.14e-1)" "unprognostic (1.11e-1)" "unprognostic (4.55e-2)" 9.7 9.9 4.3 4.1 3.5 0.9 27.0 1.5 3.4 4.7 6.8 1.3 10.8 5.2 3.4 13.4 4.2 6.3 5.7 8.2 3.6 3.2 8.8 40.0 19.9 12.6 3.9 3.3 2.1 79.8 2.8 3.1 12.4 2.5 8.8 5.5 4.4 13.5 19.2 4.3 6.2 8.1 2.0 3.1 1.5 10.0 1.1 1.6 5.5 20.7 6.0 11.2 4.7 5.6 0.1 0.0 4.2 0.1 0.4 2.8 0.3 3.3 3.5 0.6 4.3 3.1 4.9 68.3 0.0 0.1 0.3 0.4 4.7 4.8 0.0 7.1 0.0 0.0 1.8 5.5 1.1 0.3 0.0 10.1 2.1 0.7 7.9 0.2 0.8 1.7 9.6 3.5 0.4 3.4 1.7 2.7 3.6 0.0 0.0 3.4 2.4 2.7 0.3 1.4 5.1 3.2 3.9 0.8 0.6 4.2 3.8 1.2 1.0 0.5 19.3 1.7 0.8 5.5 0.4 2.4 0.0 5.2 0.0 1.0 0.1 0.1 0.0 0.0 1.5 1.1 0.0 0.1 4.2 0.3 0.0 0.4 0.0 2.8 0.8 0.0 0.1 1.8 0.3 0.0 0.4 0.0 0.0 0.0 0.3 4.3 3.5 1.5 3.4 3.6 3.2 3.9 3.3 2.5 1.6 35.7 27.6 0.8 29.9 10.3 0.0 1.7 12.7 6.7 19.4 0.0 0.0 81.9 10.0 16.6 7.5 35.8 13.1 23.3 32.2 59.6 6.9 51.8 0.0 67.6 8.5 0.0 21.4 46.1 6.0 1.8 2.3 4.1 5.0 1.0 41.2 30.7 28.4 10.5 1.1 21.6 1.7 0.0 4.7 3.4 2.1 5.6 97.1 15.0 21.1 38.8 CMTR1 "FTSJD2, ISG95, KIAA0082, MTr1" ENSG00000137200 "Cap methyltransferase 1" Q8N1G2 6 37433219-37482827 "Enzymes, Predicted intracellular proteins" "mRNA capping, mRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 77.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029954, HPA029979, HPA029980" Enhanced Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA029954: AB_10670558, HPA029979: AB_10671363, HPA029980: AB_10671094" "unprognostic (1.33e-1)" "unprognostic (2.12e-2)" "unprognostic (6.43e-2)" "prognostic unfavorable (1.73e-5)" "unprognostic (1.00e-1)" "unprognostic (3.72e-1)" "unprognostic (1.68e-2)" "unprognostic (6.43e-3)" "unprognostic (2.95e-2)" "unprognostic (9.17e-2)" "unprognostic (5.24e-3)" "unprognostic (1.50e-3)" "unprognostic (3.00e-3)" "unprognostic (3.27e-2)" "unprognostic (9.72e-2)" "unprognostic (2.54e-1)" "unprognostic (1.14e-2)" 14.4 17.4 23.1 17.3 17.7 22.4 14.6 25.0 25.0 14.5 18.0 15.5 21.3 15.0 19.5 19.4 12.6 16.9 15.0 18.8 17.6 16.1 13.9 16.6 15.2 19.2 16.0 22.7 22.6 18.4 24.4 20.2 20.6 16.9 16.3 13.1 17.1 17.6 17.9 28.9 16.6 16.5 17.6 12.5 21.7 15.9 63.9 17.8 18.4 15.7 14.1 20.7 16.2 14.8 11.1 9.8 8.1 13.2 9.7 11.5 7.8 7.0 6.7 9.7 15.8 11.0 10.1 11.8 8.4 11.7 21.5 24.1 10.1 4.7 14.7 9.6 12.4 20.2 7.9 12.3 8.7 16.5 10.1 10.9 8.1 7.8 11.2 8.5 11.6 5.5 8.7 6.5 11.8 8.5 11.3 10.0 13.7 17.9 10.8 11.2 11.5 14.7 10.4 4.8 4.7 6.4 11.7 11.5 8.4 6.9 8.6 10.7 8.1 9.5 7.3 12.1 7.3 12.4 9.0 9.2 12.9 9.7 5.1 9.4 12.4 6.4 77.6 5.1 12.2 14.1 8.1 10.2 6.4 10.1 13.2 8.5 11.1 8.9 10.7 9.8 8.1 9.9 8.0 6.6 9.7 9.9 8.2 11.5 7.8 23.1 17.7 25.0 25.0 17.6 16.1 16.0 22.7 16.9 17.8 8.9 8.6 7.3 3.4 3.2 13.3 7.9 7.6 13.4 15.9 7.0 31.4 14.0 0.0 4.0 20.1 9.0 4.2 23.3 7.4 6.2 6.4 3.4 3.5 7.4 6.6 11.1 8.1 9.2 5.9 8.3 7.2 7.5 3.3 13.6 7.5 10.1 6.4 3.5 6.3 3.5 10.9 6.5 4.9 14.4 9.9 4.1 17.4 8.7 5.4 2.8 CNBP "CNBP1, DM2, RNF163, ZCCHC22, ZNF9" ENSG00000169714 "CCHC-type zinc finger nucleic acid binding protein" P62633 3 129169484-129183922 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063097 Approved Nucleoplasm,Cytosol NA NA 43000 Nucleoplasm Cytosol "HPA063097: AB_2684939" "unprognostic (1.74e-1)" "unprognostic (3.11e-2)" "unprognostic (4.84e-1)" "unprognostic (3.35e-2)" "unprognostic (6.28e-2)" "unprognostic (7.38e-2)" "unprognostic (7.02e-3)" "unprognostic (1.23e-1)" "unprognostic (1.06e-3)" "unprognostic (6.39e-2)" "prognostic unfavorable (3.51e-4)" "unprognostic (4.72e-3)" "unprognostic (4.62e-3)" "unprognostic (1.89e-1)" "unprognostic (2.03e-1)" "unprognostic (2.51e-1)" "unprognostic (1.58e-1)" 54.2 52.8 36.4 33.6 33.7 35.9 46.6 43.5 35.6 58.1 47.1 34.5 40.5 32.4 54.5 49.4 55.6 40.9 48.5 78.2 33.0 32.0 38.0 71.6 47.5 40.6 39.7 30.3 67.4 65.4 39.3 33.5 41.5 33.3 62.3 37.1 41.3 48.9 50.9 182.1 46.7 40.6 71.9 38.0 43.2 43.1 32.1 33.1 39.0 67.3 81.1 41.2 76.1 63.5 74.3 60.3 120.1 84.1 61.7 83.4 172.9 61.7 36.6 53.4 42.3 53.4 45.8 42.2 48.6 77.1 53.0 60.9 53.6 43.5 82.2 41.7 45.2 38.9 46.5 69.8 56.3 71.9 55.1 50.8 79.4 37.8 57.7 53.2 85.1 45.7 44.3 66.2 37.1 134.1 36.1 46.7 46.4 59.4 56.6 55.5 73.9 78.8 62.6 65.1 55.1 61.9 69.3 49.6 97.9 54.9 59.5 72.8 58.3 38.3 37.9 103.0 32.6 43.6 58.6 49.2 39.3 38.7 53.9 49.1 53.2 48.4 129.3 40.5 58.4 51.8 93.4 84.1 96.8 64.1 63.8 80.6 74.3 77.4 68.9 60.3 62.7 83.4 72.0 120.1 61.7 48.9 35.1 73.9 172.9 36.4 33.7 43.5 35.6 33.0 32.0 39.7 30.3 33.3 33.1 241.2 236.8 168.8 346.4 466.2 151.2 559.4 112.1 211.5 257.0 75.0 31.4 228.5 316.7 172.7 25.7 265.4 148.7 46.7 254.5 331.1 308.6 248.1 302.0 134.8 219.0 87.4 164.4 125.8 185.1 30.7 292.6 305.9 301.9 415.6 158.2 306.6 196.4 147.3 300.5 191.8 122.5 258.7 447.2 255.1 271.9 512.9 243.9 251.4 182.3 305.2 CNDP2 "CN2, CPGL, FLJ10830, HsT2298, PEPA" ENSG00000133313 "Carnosine dipeptidase 2" Q96KP4 18 74495816-74523454 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Proximal tubular cells: 371.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 76.6;RPMI-8226: 98.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026196, HPA036898, HPA036899" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 2400000 "Nucleoplasm, Cytosol" "CAB026196: , HPA036898: AB_2675370, HPA036899: AB_2675371" "unprognostic (2.81e-2)" "unprognostic (9.96e-2)" "unprognostic (3.28e-1)" "unprognostic (1.19e-3)" "unprognostic (2.57e-2)" "unprognostic (5.06e-2)" "unprognostic (2.84e-2)" "unprognostic (5.35e-2)" "unprognostic (1.49e-1)" "unprognostic (9.31e-2)" "unprognostic (1.56e-3)" "unprognostic (1.15e-1)" "prognostic favorable (3.50e-6)" "unprognostic (2.37e-3)" "unprognostic (4.65e-3)" "unprognostic (1.51e-1)" "unprognostic (1.34e-1)" 19.0 11.5 31.0 19.1 36.0 6.1 16.9 10.4 33.0 39.4 37.6 45.2 27.0 51.3 12.5 35.3 20.4 38.9 25.9 11.6 31.1 26.4 89.0 66.4 22.1 23.0 36.1 24.1 11.4 27.6 15.7 13.7 28.8 27.2 34.7 22.2 14.1 16.9 32.7 7.5 11.8 71.1 10.4 39.4 39.2 27.2 6.5 32.5 10.9 43.9 11.6 21.4 28.4 12.0 29.6 49.0 12.5 44.4 31.4 23.9 30.3 10.2 13.9 10.1 9.5 12.3 7.3 42.4 10.8 10.2 14.8 14.8 8.0 11.1 13.0 13.7 11.7 11.6 15.6 15.3 20.5 10.6 19.4 6.0 12.9 7.0 12.8 18.0 25.2 20.1 11.0 15.8 12.8 23.1 8.4 12.9 15.6 13.6 76.6 9.8 11.5 13.4 12.1 15.2 6.8 8.3 14.6 11.6 98.6 58.2 43.1 11.0 5.8 8.4 60.2 14.4 25.2 25.2 10.4 13.5 15.9 13.5 3.5 7.2 14.3 58.7 17.3 10.8 18.4 13.2 7.8 30.0 12.5 21.8 44.4 23.8 28.9 17.6 20.3 49.0 29.6 19.1 20.7 4.4 31.4 43.1 43.0 23.9 30.3 31.0 36.0 10.4 33.0 31.1 26.4 36.1 24.1 27.2 32.5 68.5 54.2 53.8 35.3 8.1 33.7 22.9 91.7 60.2 38.7 113.4 15.7 128.9 159.2 142.6 2.2 45.9 105.2 0.0 136.1 106.3 20.6 56.1 11.5 102.8 184.6 41.3 62.7 36.8 86.2 3.2 17.3 82.3 16.9 112.8 71.7 80.3 99.7 74.1 15.6 371.2 24.6 12.9 15.9 4.8 7.3 8.4 91.2 36.3 82.5 47.4 CNGA1 "CNCG, CNCG1, CNG1, RCNC1, RCNCa, RP49" ENSG00000198515 "Cyclic nucleotide gated channel alpha 1" P29973 4 47935977-48016672 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 23.7" "Cell type enriched" "Detected in many" 9 "Rod photoreceptor cells: 880.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.4;RT4: 10.7;U-2 OS: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA076168 Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA076168: AB_2686781" "unprognostic (2.68e-2)" "unprognostic (4.90e-2)" "unprognostic (1.33e-1)" "unprognostic (8.59e-2)" "unprognostic (2.07e-1)" "unprognostic (1.11e-2)" "unprognostic (1.76e-2)" "unprognostic (3.85e-2)" "unprognostic (1.12e-1)" "unprognostic (1.98e-2)" "unprognostic (3.18e-1)" "unprognostic (2.91e-1)" "unprognostic (5.48e-6)" "unprognostic (1.86e-1)" "unprognostic (1.04e-1)" "unprognostic (4.66e-2)" "unprognostic (8.23e-2)" 4.9 1.1 0.6 2.7 1.0 0.1 2.9 0.3 0.5 5.7 6.1 0.2 1.6 2.1 0.6 12.1 13.7 3.9 1.5 1.0 0.6 0.6 4.9 23.7 0.5 0.0 1.3 0.0 1.6 2.1 5.2 4.2 21.3 0.4 6.2 2.3 14.7 4.9 1.7 4.2 5.3 12.7 0.5 0.9 8.2 2.5 1.4 0.2 0.1 2.2 3.6 2.7 8.2 8.8 0.7 2.7 1.2 0.4 1.9 1.6 0.1 3.2 1.2 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.2 2.9 13.4 0.1 0.7 0.0 3.6 2.1 0.3 0.4 0.1 0.0 0.9 0.0 0.3 1.0 0.0 0.1 0.3 0.1 0.6 0.0 0.1 1.6 0.0 1.1 0.9 0.7 0.2 1.3 0.1 0.2 0.6 2.0 3.1 0.1 0.0 0.1 0.6 10.7 0.3 0.1 0.2 0.6 0.2 0.3 1.2 0.0 0.6 0.3 4.2 0.1 0.1 0.9 1.0 0.1 0.1 0.1 2.4 0.2 0.4 0.0 0.5 0.4 0.1 0.3 0.2 1.6 0.3 0.7 0.3 0.6 1.2 1.9 0.2 2.7 0.1 0.1 0.6 1.0 0.3 0.5 0.6 0.6 1.3 0.0 0.4 0.2 0.0 0.0 0.0 1.4 0.1 78.5 0.4 2.5 0.0 0.0 59.3 86.4 0.0 0.0 7.8 0.4 0.1 8.4 0.0 5.9 0.0 0.2 4.0 0.0 30.0 1.3 42.9 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.0 3.2 100.9 1.6 10.5 0.0 0.3 880.8 0.0 3.1 0.3 1.3 2.4 0.2 0.0 2.9 15.6 CNN2 ENSG00000064666 "Calponin 2" Q99439 19 1026581-1039068 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 231.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA049095 Approved Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA 39000000 Cytosol "Nucleoplasm, Actin filaments" "HPA049095: AB_2680627" "unprognostic (2.52e-2)" "unprognostic (2.69e-1)" "unprognostic (1.74e-1)" "unprognostic (4.49e-2)" "unprognostic (3.89e-1)" "unprognostic (5.31e-2)" "unprognostic (1.33e-1)" "unprognostic (2.56e-1)" "unprognostic (4.58e-2)" "unprognostic (6.56e-2)" "unprognostic (3.60e-2)" "unprognostic (3.33e-2)" "prognostic unfavorable (4.70e-7)" "unprognostic (1.28e-2)" "unprognostic (1.87e-1)" "unprognostic (2.50e-1)" "unprognostic (1.54e-1)" 36.6 6.5 1.3 46.2 2.5 44.2 29.2 2.0 3.0 38.2 16.9 5.4 22.2 5.5 35.5 24.5 39.4 25.0 40.1 18.7 1.5 1.5 24.6 15.8 54.7 61.5 3.5 1.5 81.1 26.8 1.9 6.9 21.5 4.8 35.6 7.8 26.3 40.9 34.4 6.1 21.3 17.7 28.2 2.9 59.4 21.1 15.9 2.1 37.0 68.1 27.3 78.6 37.9 51.2 33.6 29.3 115.7 26.3 27.1 57.0 43.1 36.9 12.5 34.9 43.4 18.0 34.3 27.1 33.5 37.1 42.3 32.9 43.0 32.0 24.4 34.4 60.5 9.9 36.5 20.7 53.5 28.2 16.9 1.7 16.9 20.1 33.6 72.2 15.8 39.0 58.3 25.5 26.8 20.2 69.2 23.8 18.4 10.1 38.0 34.4 7.0 1.4 14.5 43.1 30.0 5.5 8.3 12.3 27.5 41.6 44.5 0.0 2.4 42.4 5.8 4.8 26.6 42.1 26.6 58.3 23.2 24.0 35.4 34.1 17.7 13.5 48.5 13.6 19.0 37.0 61.3 18.6 81.0 34.8 24.2 57.0 33.6 43.7 46.4 29.3 30.8 37.3 36.3 115.7 27.1 26.3 13.0 45.6 43.1 1.3 2.5 2.0 3.0 1.5 1.5 3.5 1.5 4.8 2.1 56.6 58.7 76.0 231.3 86.7 0.2 4.8 15.3 20.1 38.7 34.9 9.8 9.0 53.0 56.6 0.4 15.5 36.0 0.0 120.7 81.2 48.8 45.2 57.8 28.4 49.6 0.0 14.8 38.1 67.6 0.6 7.5 75.9 13.5 120.8 32.3 0.8 137.6 21.2 72.2 4.0 6.6 32.3 72.9 1.7 3.1 76.8 9.5 91.5 26.0 151.9 CNOT10 "FLJ12890, FLJ13165" ENSG00000182973 "CCR4-NOT transcription complex subunit 10" Q9H9A5 3 32685145-32773875 "Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 66.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035614, HPA041450" Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Centrosome" Cytosol "HPA035614: AB_10669975, HPA041450: AB_2677487" "unprognostic (3.75e-1)" "unprognostic (4.57e-2)" "unprognostic (4.45e-3)" "unprognostic (6.01e-2)" "unprognostic (9.88e-2)" "unprognostic (4.60e-2)" "prognostic unfavorable (1.03e-6)" "unprognostic (1.88e-1)" "unprognostic (1.50e-1)" "unprognostic (5.09e-3)" "unprognostic (1.80e-1)" "unprognostic (1.81e-2)" "unprognostic (1.65e-2)" "unprognostic (5.44e-2)" "unprognostic (1.84e-2)" "unprognostic (8.75e-3)" "unprognostic (3.43e-1)" 12.3 12.6 11.3 15.2 12.4 16.6 14.0 14.2 13.4 13.4 14.0 12.5 12.8 10.8 19.8 13.5 14.8 16.1 9.8 13.0 10.5 9.4 13.1 13.5 11.4 14.7 9.7 11.9 14.7 14.0 16.0 23.0 11.3 13.3 13.1 15.7 12.2 12.0 10.9 13.5 14.9 14.7 12.8 10.5 15.1 12.2 40.5 10.9 30.2 13.8 11.9 17.4 13.0 12.6 15.0 14.1 16.0 21.0 9.0 18.5 11.2 8.4 9.5 9.9 9.3 4.8 5.5 66.1 7.1 7.2 10.2 11.5 7.2 7.3 13.9 4.8 5.1 6.6 7.4 11.7 9.4 10.2 12.0 12.0 17.8 8.6 6.9 14.0 14.6 6.9 4.0 8.5 11.2 14.9 6.8 8.3 13.0 18.5 10.8 5.9 6.9 13.0 7.1 14.9 9.8 9.1 13.2 6.7 13.8 6.5 9.9 5.6 10.9 10.5 14.8 8.6 7.3 14.4 16.6 5.1 6.3 9.0 8.3 11.8 11.2 22.9 13.9 6.5 11.1 7.6 12.8 11.2 16.0 11.4 15.7 12.3 14.8 18.5 13.6 14.1 15.0 18.5 16.2 8.8 9.0 21.0 7.8 14.4 11.2 11.3 12.4 14.2 13.4 10.5 9.4 9.7 11.9 13.3 10.9 14.9 21.4 14.3 5.8 9.3 15.9 10.8 7.6 32.1 15.9 14.0 31.4 11.6 5.0 11.2 42.3 11.4 11.8 0.0 11.7 14.6 9.8 6.0 10.4 8.5 10.3 14.3 15.0 11.1 14.8 29.1 8.9 12.9 11.8 47.7 8.3 8.0 9.9 14.4 9.9 5.6 18.7 6.5 10.6 35.7 32.4 12.7 6.9 18.3 13.6 6.7 CNOT11 "C2orf29, C40" ENSG00000158435 "CCR4-NOT transcription complex subunit 11" Q9UKZ1 2 101252802-101270316 "Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069823, HPA074943" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA069823: AB_2686209, HPA074943: " "unprognostic (1.72e-1)" "unprognostic (2.51e-1)" "unprognostic (5.43e-2)" "unprognostic (2.77e-2)" "unprognostic (2.02e-2)" "unprognostic (1.13e-3)" "prognostic unfavorable (1.05e-4)" "unprognostic (3.71e-2)" "unprognostic (1.09e-1)" "unprognostic (1.78e-2)" "unprognostic (1.53e-1)" "unprognostic (1.23e-1)" "prognostic unfavorable (8.33e-6)" "unprognostic (4.19e-2)" "unprognostic (2.35e-1)" "unprognostic (3.62e-3)" "unprognostic (2.72e-3)" 13.2 19.0 13.9 19.7 15.1 20.9 14.4 13.3 18.6 17.0 21.5 15.0 19.7 23.0 19.2 18.2 31.9 17.7 23.7 25.6 12.5 12.5 23.9 28.9 14.9 24.1 15.0 13.8 14.3 27.9 16.8 17.6 36.7 16.9 20.6 26.0 16.9 22.5 15.8 27.3 17.5 25.5 15.3 11.1 27.2 25.0 32.5 13.2 39.8 19.4 23.6 30.7 20.7 17.0 4.0 3.6 11.1 3.9 1.6 5.9 1.7 16.2 11.2 18.5 25.6 15.5 18.8 54.9 16.9 21.3 20.9 22.2 24.7 18.8 28.7 20.0 15.0 26.6 19.8 21.9 20.1 25.4 19.5 18.9 24.0 12.2 36.8 17.2 28.7 23.8 14.8 18.5 15.0 16.0 17.3 23.4 16.4 26.7 17.5 18.8 16.8 28.0 31.2 23.0 25.7 16.0 18.0 20.1 22.0 28.6 30.9 27.9 17.7 10.2 30.4 27.1 22.0 19.2 26.6 15.6 16.5 19.0 14.1 14.0 25.2 23.5 22.6 18.1 32.5 19.0 9.1 2.8 4.9 4.5 3.9 3.1 2.9 4.7 5.5 2.2 4.0 4.4 5.9 11.1 1.6 3.6 3.6 5.7 1.7 13.9 15.1 13.3 18.6 12.5 12.5 15.0 13.8 16.9 13.2 6.0 11.2 15.3 19.2 10.4 10.7 25.0 28.1 14.7 6.8 38.4 13.7 55.7 26.6 46.1 5.4 14.6 20.0 0.0 36.3 43.7 10.7 24.8 5.8 25.4 20.2 6.4 10.4 17.2 17.1 6.3 8.9 12.6 5.0 32.5 25.1 16.9 36.3 14.4 11.3 29.3 10.7 38.8 14.7 35.6 15.1 11.2 48.2 20.8 21.3 37.9 CNOT2 "CDC36, NOT2, NOT2H" ENSG00000111596 "CCR4-NOT transcription complex subunit 2" Q9NZN8 12 70242994-70354993 "Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Developmental protein, Repressor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067711 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA067711: AB_2685893" "unprognostic (5.00e-2)" "unprognostic (2.12e-1)" "unprognostic (6.95e-2)" "unprognostic (3.60e-2)" "unprognostic (3.48e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.21e-4)" "unprognostic (7.36e-2)" "prognostic unfavorable (6.86e-4)" "unprognostic (1.32e-1)" "unprognostic (9.70e-2)" "unprognostic (2.99e-2)" "prognostic unfavorable (8.63e-5)" "unprognostic (1.28e-1)" "unprognostic (5.58e-2)" "unprognostic (5.97e-2)" "unprognostic (6.23e-2)" 27.8 19.9 18.9 24.6 23.8 44.5 24.9 53.3 24.7 24.0 21.7 21.9 21.6 20.1 37.5 25.8 22.5 20.6 18.8 20.1 18.7 16.2 21.8 24.1 25.9 24.8 23.8 21.2 26.8 20.5 25.0 41.2 30.1 19.8 24.3 24.9 20.5 21.6 21.9 27.6 36.7 24.4 25.5 23.4 26.8 18.8 16.3 24.8 46.1 22.7 20.9 28.8 24.8 24.5 28.8 33.1 37.1 36.5 32.2 41.3 27.2 19.8 18.9 32.1 20.2 17.7 20.0 26.7 22.0 26.6 24.5 21.0 24.2 19.3 42.6 20.3 25.1 15.7 19.6 22.3 21.6 27.5 20.4 20.2 28.0 17.4 22.7 18.9 36.1 25.0 21.8 24.3 23.0 28.0 36.8 25.9 26.4 25.5 24.7 21.3 21.4 41.2 25.8 27.3 20.3 20.2 32.0 26.5 25.8 22.7 40.0 21.4 25.3 25.9 21.0 18.5 28.7 26.8 30.0 18.9 22.9 15.7 20.9 17.7 22.6 25.8 33.7 23.4 17.7 17.9 37.1 26.0 28.3 29.4 36.5 32.8 28.8 31.9 32.9 33.1 27.6 38.0 41.3 15.1 32.2 29.3 23.0 29.7 27.2 18.9 23.8 53.3 24.7 18.7 16.2 23.8 21.2 19.8 24.8 38.7 39.2 30.3 33.3 45.3 61.2 26.6 50.9 44.2 40.9 34.9 53.0 39.0 28.2 41.8 19.7 42.9 38.2 23.3 38.7 40.0 42.0 37.1 73.0 29.8 35.6 49.3 55.7 44.8 51.1 6.5 42.3 42.3 30.4 26.2 38.5 47.8 37.7 41.8 43.9 21.7 50.2 38.8 47.0 33.9 39.8 56.0 29.6 65.4 35.5 38.9 CNTD1 "CNTD, FLJ40137" ENSG00000176563 "Cyclin N-terminal domain containing 1" Q8N815 17 42798792-42811587 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 31.0" "Group enriched" "Detected in many" 12 "Ciliated cells: 80.3;Early spermatids: 53.3;Late spermatids: 75.8;Spermatocytes: 135.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 2.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 6.3;ASC diff: 4.3;SiHa: 3.3;T-47d: 2.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA023324 Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA Nucleoplasm "Plasma membrane, Focal adhesion sites" "HPA023324: AB_1848931" "unprognostic (5.92e-2)" "unprognostic (1.99e-3)" "unprognostic (3.66e-2)" "unprognostic (2.13e-2)" "unprognostic (1.25e-1)" "unprognostic (6.29e-3)" "unprognostic (6.61e-2)" "unprognostic (1.09e-2)" "unprognostic (7.82e-2)" "unprognostic (6.18e-2)" "unprognostic (1.36e-2)" "unprognostic (2.07e-1)" "unprognostic (5.89e-7)" "unprognostic (1.52e-1)" "unprognostic (1.90e-1)" "unprognostic (2.35e-1)" "unprognostic (1.81e-4)" 0.2 0.1 0.7 0.0 1.4 0.0 1.6 0.2 1.7 0.2 0.6 0.4 0.0 0.0 0.1 0.9 0.1 0.5 0.0 0.1 1.5 0.3 1.2 0.1 0.3 0.0 0.5 0.8 0.3 0.8 0.0 0.1 0.0 0.9 1.1 1.5 0.1 0.5 0.0 0.2 0.1 0.2 0.7 0.8 0.1 2.3 31.0 1.6 0.0 0.1 0.0 0.0 0.2 0.1 0.9 0.1 2.7 0.3 0.1 0.3 0.3 6.3 0.7 0.5 1.3 4.3 1.5 0.0 0.0 0.3 0.4 1.4 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.6 0.0 0.0 1.1 0.2 0.0 0.4 0.6 1.3 0.0 0.0 0.2 0.6 0.0 0.2 0.0 0.2 0.0 0.4 0.7 0.0 0.0 0.0 3.3 0.3 0.8 0.1 2.4 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.3 0.1 0.1 0.5 0.4 0.0 0.3 0.0 0.3 0.2 0.3 0.4 0.1 0.0 0.1 0.9 0.0 0.0 2.7 0.1 0.1 0.0 0.0 0.3 0.7 1.4 0.2 1.7 1.5 0.3 0.5 0.8 0.9 1.6 3.0 2.9 0.0 0.4 0.3 1.6 0.8 0.0 80.3 3.4 0.0 0.0 0.2 5.0 0.2 53.3 0.3 0.5 0.0 0.3 0.3 0.6 7.4 5.8 0.9 0.3 6.4 0.0 0.0 1.0 75.8 2.3 0.7 0.0 0.0 4.6 1.2 0.3 0.0 1.1 0.3 0.4 6.5 0.9 135.1 2.7 0.5 0.2 0.5 2.1 0.9 CNTLN "bA340N12.1, C9orf101, C9orf39, FLJ20276" ENSG00000044459 Centlein Q9NXG0 9 17134982-17503923 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 58.9;Spermatogonia: 51.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 6.9" "Lineage enriched" "Detected in many" 4 "monocytes: 6.9" "Cell line enhanced" "Detected in many" "HEL: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007201, HPA036728, HPA036729" Uncertain Approved Nucleoplasm,Centrosome,Cytosol NA NA Centrosome "Nucleoplasm, Cytosol" "HPA007201: AB_2667775, HPA036728: AB_10670847, HPA036729: AB_10670240" "unprognostic (1.97e-2)" "unprognostic (2.81e-3)" "unprognostic (1.81e-1)" "unprognostic (2.48e-1)" "unprognostic (1.55e-1)" "unprognostic (1.60e-1)" "unprognostic (7.71e-2)" "unprognostic (1.68e-1)" "unprognostic (7.71e-3)" "unprognostic (5.07e-3)" "unprognostic (1.06e-1)" "unprognostic (6.65e-2)" "unprognostic (2.47e-1)" "unprognostic (5.38e-2)" "unprognostic (3.35e-2)" "unprognostic (1.37e-1)" "unprognostic (5.80e-2)" 13.2 5.6 4.3 5.2 5.1 12.5 7.4 15.5 4.5 16.6 8.6 4.2 6.7 2.2 22.6 6.0 6.0 8.0 7.4 4.9 4.2 3.8 5.0 20.0 5.4 4.8 4.9 2.6 15.2 3.6 10.0 13.2 6.1 6.3 9.8 4.0 7.0 3.8 6.3 5.9 3.5 4.4 11.9 8.1 8.6 4.4 8.2 6.8 4.4 5.5 5.8 2.8 11.7 13.5 0.3 1.5 0.8 6.9 1.2 0.2 0.5 5.9 4.1 9.0 5.1 4.5 10.5 0.3 7.0 4.7 5.2 7.2 0.3 2.0 4.3 1.1 4.8 5.7 0.3 10.4 2.9 8.2 0.2 3.7 25.5 8.7 1.5 4.9 3.5 5.6 6.6 1.5 4.4 4.3 4.9 7.4 1.6 0.9 1.0 8.3 0.5 2.8 5.6 7.0 1.0 7.7 4.2 8.3 2.1 3.0 1.5 5.7 5.9 8.5 0.2 2.2 3.7 1.7 8.9 5.4 7.2 2.8 7.8 6.0 3.6 4.3 0.1 3.4 4.4 3.2 0.6 2.7 0.1 0.1 3.3 0.0 0.3 0.2 0.1 1.5 0.3 0.1 0.1 0.8 1.2 6.9 1.5 0.2 0.5 4.3 5.1 15.5 4.5 4.2 3.8 4.9 2.6 6.3 6.8 6.0 14.5 0.8 12.1 7.8 9.1 10.6 5.1 2.7 2.3 8.7 0.0 1.5 5.0 7.5 13.2 20.3 1.3 23.3 10.4 4.0 13.6 3.2 7.0 35.9 15.7 19.1 2.4 19.6 34.5 6.5 42.3 18.3 8.5 26.2 2.6 25.0 4.2 0.0 29.0 6.3 8.4 12.9 15.0 58.9 51.1 4.8 0.8 3.2 3.0 3.5 CNTNAP1 "Caspr, CNTNAP, NRXN4, p190" ENSG00000108797 "Contactin associated protein 1" P78357 17 42682613-42699814 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.7;smooth muscle: 26.7" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 12.8;Sertoli cells: 6.5;Smooth muscle cells: 4.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "TIME: 30.0;U-138 MG: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011772 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA011772: AB_1079541" "unprognostic (4.04e-2)" "unprognostic (3.69e-1)" "unprognostic (2.37e-3)" "unprognostic (1.89e-1)" "unprognostic (5.02e-3)" "unprognostic (1.13e-1)" "unprognostic (3.19e-3)" "unprognostic (1.19e-1)" "unprognostic (2.59e-1)" "unprognostic (9.76e-3)" "unprognostic (1.99e-2)" "unprognostic (1.67e-1)" "prognostic unfavorable (4.16e-14)" "unprognostic (9.52e-3)" "unprognostic (2.27e-2)" "unprognostic (3.11e-2)" "unprognostic (7.37e-3)" 6.1 2.5 35.5 5.9 18.8 1.1 1.7 31.7 48.7 4.7 8.5 2.9 1.4 2.3 12.1 7.1 2.9 7.0 7.1 4.0 29.2 14.8 1.7 0.9 3.9 2.8 10.5 23.9 8.7 6.5 1.7 7.2 5.0 18.4 4.2 4.7 2.1 2.0 7.6 3.5 2.5 2.7 26.7 11.5 3.2 3.9 2.3 13.3 0.0 1.7 0.2 2.9 5.8 3.3 0.0 0.7 0.1 0.0 0.1 1.4 0.0 1.8 2.6 5.8 1.9 9.0 18.4 0.4 10.9 19.1 8.1 7.3 0.3 0.4 0.0 0.6 11.9 8.1 2.1 2.8 0.9 6.3 4.2 0.9 0.0 10.8 2.7 4.4 0.0 0.1 17.9 0.0 7.7 1.5 12.9 10.1 0.1 0.5 3.3 3.1 0.3 0.0 1.6 2.0 0.1 2.6 0.3 0.7 1.0 2.1 0.0 1.1 3.4 3.2 0.0 2.1 5.5 2.1 0.9 30.0 34.8 5.9 8.0 3.0 4.0 2.4 0.1 9.6 0.7 4.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.7 1.4 0.0 35.5 18.8 31.7 48.7 29.2 14.8 10.5 23.9 18.4 13.3 0.0 2.6 0.0 0.1 0.5 12.8 1.1 0.0 1.4 1.2 0.0 3.9 0.0 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.0 2.5 0.4 0.0 0.0 0.1 1.6 0.0 2.5 0.0 0.0 1.4 0.0 0.0 1.0 0.0 0.8 0.1 0.0 0.7 0.0 2.8 6.5 4.4 0.2 0.2 0.3 0.2 0.0 0.0 0.1 CNTNAP5 "caspr5, FLJ31966" ENSG00000155052 "Contactin associated protein like 5" Q8WYK1 2 124025287-124915287 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 22.4" "Cell type enhanced" "Detected in some" 24 "Bipolar cells: 5.6;Cardiomyocytes: 1.4;Distal tubular cells: 1.7;Horizontal cells: 1.6" "Cancer enhanced" "Detected in single" "renal cancer: 0.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.3;HMC-1: 2.1;NTERA-2: 1.7;SCLC-21H: 1.3;SH-SY5Y: 7.4" "Low region specificity" "Detected in all" "HPA069095, HPA069356" Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Vesicles" "HPA069095: AB_2686083, HPA069356: AB_2686127" "unprognostic (6.32e-3)" "unprognostic (6.38e-2)" "unprognostic (1.23e-1)" "unprognostic (2.25e-1)" "unprognostic (1.68e-1)" "unprognostic (7.53e-2)" "unprognostic (6.20e-2)" "unprognostic (3.11e-2)" "unprognostic (2.62e-6)" "unprognostic (3.65e-3)" "unprognostic (5.32e-2)" "unprognostic (9.58e-2)" 0.7 2.8 12.9 0.7 7.9 1.0 0.7 3.3 22.4 0.6 0.8 1.5 0.0 1.0 0.7 0.7 0.7 0.6 4.2 0.7 14.0 4.0 1.2 0.7 0.7 0.7 2.2 8.4 0.6 1.1 0.7 0.8 0.7 15.2 0.8 0.8 0.4 0.6 1.0 0.7 0.8 0.9 0.8 1.9 0.7 0.7 0.9 2.8 0.0 0.7 0.0 0.6 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.3 7.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.9 7.9 3.3 22.4 14.0 4.0 2.2 8.4 15.2 2.8 0.0 0.0 0.0 0.0 0.0 5.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 COA4 "CHCHD8, CMC3, E2IG2" ENSG00000181924 "Cytochrome c oxidase assembly factor 4 homolog" Q9NYJ1 11 73872667-73876988 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040126 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" NA NA "Nucleoplasm, Nucleoli fibrillar center" Mitochondria "HPA040126: AB_10795415" "unprognostic (7.30e-2)" "unprognostic (8.69e-2)" "unprognostic (2.09e-1)" "unprognostic (2.60e-2)" "unprognostic (1.87e-1)" "unprognostic (1.40e-2)" "unprognostic (3.64e-3)" "unprognostic (1.49e-1)" "unprognostic (2.22e-2)" "prognostic favorable (3.87e-4)" "unprognostic (1.31e-2)" "unprognostic (3.97e-2)" "prognostic unfavorable (2.14e-4)" "unprognostic (2.51e-1)" "unprognostic (1.89e-1)" "unprognostic (1.25e-1)" "unprognostic (8.17e-2)" 19.0 46.2 18.9 17.0 17.3 10.8 18.1 12.2 20.2 17.5 23.9 25.7 27.0 24.7 18.0 22.4 24.9 20.1 31.5 35.3 17.7 17.0 33.2 74.7 14.7 20.2 20.5 16.3 23.2 37.1 17.6 17.2 18.3 19.4 21.5 21.1 17.6 21.2 28.0 33.2 14.4 31.2 16.2 21.5 20.1 19.2 13.5 19.4 16.3 38.7 27.6 18.2 21.5 18.9 23.4 32.3 5.3 20.6 16.7 21.2 15.0 20.9 39.1 16.1 23.5 14.3 17.8 16.3 21.4 14.9 25.4 21.5 28.5 26.1 17.8 43.4 17.6 20.5 21.1 24.6 28.6 19.8 23.3 22.4 29.9 24.3 26.7 27.2 20.3 23.5 22.6 27.4 42.4 27.7 14.5 23.3 17.7 25.7 17.6 22.7 39.9 16.0 31.8 21.2 82.8 40.5 18.7 34.7 47.1 26.9 19.4 14.6 24.5 19.8 22.7 57.5 16.5 31.8 20.6 15.9 21.0 18.7 42.2 27.9 21.8 23.6 60.5 11.5 25.4 23.7 5.3 20.5 4.7 15.9 20.6 20.2 23.4 18.7 16.5 24.6 20.4 20.1 21.2 1.4 16.7 19.1 32.3 19.0 15.0 18.9 17.3 12.2 20.2 17.7 17.0 20.5 16.3 19.4 19.4 32.8 29.0 44.7 53.9 47.6 19.8 62.1 89.2 49.5 36.4 52.4 21.6 140.3 109.5 72.0 22.0 43.6 113.7 46.7 82.4 84.7 46.3 77.6 61.1 154.9 85.2 17.5 69.7 28.8 37.8 8.2 50.9 50.0 27.0 51.3 90.6 41.3 87.3 73.7 36.0 190.6 16.4 6.5 34.3 51.0 36.1 44.8 102.3 34.8 108.4 86.3 COA6 C1orf31 ENSG00000168275 "Cytochrome c oxidase assembly factor 6" Q5JTJ3 1 234373456-234384049 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA028588 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA028588: AB_10601123" "unprognostic (6.26e-2)" "unprognostic (1.92e-1)" "unprognostic (3.05e-1)" "unprognostic (1.01e-1)" "unprognostic (7.87e-2)" "unprognostic (1.20e-3)" "unprognostic (4.04e-3)" "unprognostic (4.89e-2)" "unprognostic (2.79e-2)" "unprognostic (6.25e-3)" "unprognostic (9.24e-2)" "unprognostic (2.36e-1)" "prognostic unfavorable (1.12e-5)" "unprognostic (2.38e-1)" "unprognostic (5.24e-2)" "unprognostic (2.19e-1)" "prognostic favorable (7.12e-4)" 11.0 17.8 26.4 14.4 33.9 9.4 16.6 14.3 27.5 9.7 17.7 5.7 12.9 26.4 8.4 20.3 15.5 9.4 14.2 19.1 19.3 15.7 21.4 21.4 13.6 16.2 16.3 16.1 9.1 16.7 7.6 9.5 8.7 13.4 13.3 15.6 6.0 13.6 11.6 52.7 8.7 19.7 10.6 11.4 12.5 14.4 5.8 13.3 13.1 13.6 20.2 12.0 11.6 14.6 27.5 33.3 19.7 31.3 18.3 36.6 20.2 17.8 22.9 8.3 9.4 8.7 17.3 26.4 13.1 8.0 13.8 13.0 17.6 23.9 17.8 24.4 7.5 25.9 22.8 12.9 16.2 11.0 22.1 55.1 8.0 26.0 46.6 33.6 19.6 15.6 11.4 21.8 18.1 14.0 12.1 17.0 19.8 38.8 16.1 14.9 9.5 18.6 38.1 20.4 40.3 10.9 11.1 10.0 35.0 17.2 16.9 14.8 10.8 12.7 22.6 40.4 5.5 20.0 33.9 12.8 16.4 13.6 21.9 39.2 19.2 37.2 21.8 12.5 31.2 29.2 19.7 31.3 9.7 18.5 28.5 18.2 27.5 29.9 23.0 33.3 18.0 31.3 23.1 8.1 18.3 23.8 22.5 36.6 20.2 26.4 33.9 14.3 27.5 19.3 15.7 16.3 16.1 13.4 13.3 8.9 20.0 38.5 39.3 50.8 13.8 71.2 22.9 53.5 26.1 45.4 3.9 44.1 87.9 47.5 2.9 23.3 63.5 23.3 59.9 71.2 34.2 56.7 21.9 46.9 75.0 11.1 21.4 22.1 35.3 3.4 24.2 49.2 28.7 43.3 52.3 20.6 56.3 40.3 26.5 86.4 13.3 19.4 24.5 17.2 25.3 51.3 36.5 30.0 65.5 64.8 COA7 "C1orf163, FLJ12439, RESA1, SELRC1" ENSG00000162377 "Cytochrome c oxidase assembly factor 7 (putative)" Q96BR5 1 52684451-52698366 "Predicted intracellular proteins" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028154, HPA029926" Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA028154: AB_10600656, HPA029926: AB_10602173" "unprognostic (1.88e-1)" "unprognostic (1.02e-1)" "unprognostic (1.29e-2)" "prognostic unfavorable (8.55e-4)" "unprognostic (2.30e-2)" "unprognostic (5.12e-2)" "prognostic unfavorable (7.01e-5)" "unprognostic (1.14e-1)" "unprognostic (2.27e-2)" "unprognostic (1.24e-1)" "unprognostic (4.07e-2)" "unprognostic (7.42e-2)" "unprognostic (2.49e-1)" "prognostic favorable (4.35e-4)" "unprognostic (1.18e-1)" "unprognostic (1.96e-1)" "unprognostic (1.52e-1)" 8.8 8.5 9.0 6.9 10.6 4.6 9.7 7.9 16.6 6.6 10.1 7.0 4.1 10.1 8.5 6.0 9.5 6.6 5.2 8.6 7.6 9.2 12.8 15.7 5.5 4.9 8.4 12.4 6.7 19.1 7.2 7.7 7.4 10.0 4.9 10.3 4.2 6.7 5.2 26.3 8.6 7.2 8.0 7.6 6.1 7.0 4.3 7.8 2.3 9.6 9.9 5.8 6.9 7.9 3.7 5.9 3.3 8.4 2.3 3.4 2.7 12.3 7.1 6.5 10.7 10.6 9.2 14.3 9.4 7.8 11.7 9.9 8.7 4.4 28.5 6.4 5.5 14.8 9.6 15.7 13.2 15.3 8.8 15.8 24.0 11.2 10.1 13.0 23.5 8.2 10.1 11.7 13.3 16.7 5.2 8.0 8.2 21.8 5.1 8.8 8.2 7.9 12.1 28.7 13.3 20.2 15.7 22.3 20.7 10.3 12.6 14.6 7.7 13.6 17.5 17.3 9.6 10.2 16.1 8.8 9.3 12.2 12.7 12.9 10.6 26.6 13.3 4.3 17.1 7.5 3.1 5.9 1.8 2.5 8.4 3.4 3.7 2.6 2.5 5.9 1.8 2.4 2.6 3.3 2.3 4.0 2.8 1.5 2.7 9.0 10.6 7.9 16.6 7.6 9.2 8.4 12.4 10.0 7.8 6.0 11.3 4.5 15.2 10.2 7.3 12.6 5.1 2.7 7.9 3.5 3.9 14.1 23.2 9.6 0.1 8.2 8.5 0.0 11.5 12.9 7.2 10.1 0.0 11.5 12.1 15.9 2.4 4.9 4.9 0.4 6.9 8.2 1.7 9.0 5.5 7.0 9.0 5.8 7.1 14.4 9.6 6.5 7.6 3.7 12.5 11.3 13.8 4.5 9.6 10.7 COG3 SEC34 ENSG00000136152 "Component of oligomeric golgi complex 3" Q96JB2 13 45464898-45536630 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Hepatocytes: 73.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040353, HPA054470" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus, Plasma membrane" "Nucleoplasm, Cytosol" "HPA040353: AB_10794027, HPA054470: AB_2732585" "unprognostic (1.75e-1)" "unprognostic (3.03e-3)" "unprognostic (1.75e-1)" "unprognostic (4.04e-3)" "unprognostic (9.69e-2)" "unprognostic (2.86e-2)" "unprognostic (2.18e-2)" "unprognostic (4.46e-2)" "unprognostic (2.51e-2)" "prognostic unfavorable (9.53e-4)" "unprognostic (5.82e-2)" "unprognostic (1.21e-2)" "unprognostic (4.49e-2)" "unprognostic (7.06e-3)" "unprognostic (1.13e-1)" "unprognostic (8.25e-2)" "unprognostic (1.71e-1)" 12.5 17.4 8.7 17.1 14.0 10.9 17.0 19.7 14.5 16.9 17.1 13.0 22.4 13.2 16.9 20.6 14.4 14.0 12.8 12.5 8.9 9.4 16.5 46.2 12.1 11.7 9.3 10.0 17.9 29.4 10.9 22.6 32.9 11.5 20.9 20.7 12.9 28.3 25.2 12.5 14.7 18.8 13.3 10.1 14.8 15.6 9.9 11.2 17.4 18.5 8.7 18.5 14.8 14.8 5.1 7.2 7.4 4.6 4.9 8.0 3.8 5.4 4.9 9.5 8.6 12.6 14.5 9.1 9.1 13.0 10.6 8.9 7.2 10.1 7.5 4.1 10.8 7.9 12.0 7.8 9.2 16.2 5.8 6.4 8.4 6.0 12.6 15.6 12.3 8.1 10.8 13.9 7.0 25.1 12.9 10.3 7.4 5.4 4.6 12.7 8.4 6.8 11.6 7.8 27.4 6.0 8.0 5.6 7.0 9.9 8.9 4.7 8.6 5.9 11.6 12.1 9.4 7.9 12.8 9.6 5.1 4.0 9.5 5.8 6.5 3.5 7.8 9.8 6.2 9.1 7.4 4.1 7.3 7.5 4.6 8.0 5.1 5.8 6.4 3.1 4.9 6.6 6.1 3.7 4.9 2.9 7.2 6.2 3.8 8.7 14.0 19.7 14.5 8.9 9.4 9.3 10.0 11.5 11.2 8.9 31.8 15.2 12.2 14.1 9.4 16.9 20.4 9.4 23.9 12.2 13.7 12.4 13.3 9.4 12.9 12.1 27.1 23.3 32.9 15.5 10.8 25.6 16.2 73.3 9.8 9.5 21.4 20.3 20.8 7.4 13.0 14.6 10.1 6.4 43.3 5.2 18.0 34.5 12.7 11.9 10.4 6.5 9.9 11.5 6.6 14.1 27.5 17.5 21.4 19.0 COG5 "GOLTC1, GTC90" ENSG00000164597 "Component of oligomeric golgi complex 5" Q9UP83 7 107201555-107564514 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020300, HPA041583" Uncertain Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA020300: AB_2081406, HPA041583: AB_2677564" "unprognostic (3.10e-1)" "unprognostic (1.95e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (9.72e-4)" "unprognostic (2.41e-1)" "unprognostic (3.11e-1)" "prognostic unfavorable (3.77e-4)" "unprognostic (2.40e-2)" "unprognostic (1.84e-1)" "unprognostic (3.40e-3)" "unprognostic (1.94e-1)" "unprognostic (2.06e-1)" "unprognostic (3.91e-3)" "unprognostic (8.73e-2)" "unprognostic (3.90e-2)" "prognostic unfavorable (1.48e-4)" "unprognostic (1.15e-1)" 17.2 15.8 15.2 13.7 14.9 16.5 13.9 16.1 17.7 24.8 12.1 15.0 18.3 8.8 28.4 14.0 16.4 10.9 20.3 25.7 13.3 10.3 12.7 8.9 12.9 9.5 14.7 12.5 16.7 18.9 40.3 28.4 14.4 13.4 25.6 14.1 10.5 34.0 20.6 16.5 15.8 12.5 23.8 17.5 10.8 13.1 12.6 15.3 14.0 26.3 11.5 17.3 13.9 21.4 9.8 8.6 10.1 12.9 7.0 12.3 8.9 16.2 7.5 6.8 2.6 2.0 1.8 6.7 12.0 14.3 6.4 10.2 4.8 7.5 2.3 4.6 11.8 14.7 8.4 2.8 2.1 9.3 11.3 2.1 1.8 3.1 8.0 1.5 4.6 10.7 6.1 1.1 12.5 14.0 12.2 18.4 4.6 5.2 8.9 12.3 8.0 4.8 0.0 0.9 16.0 8.1 2.1 3.0 4.2 5.5 7.8 1.5 10.1 4.1 12.4 13.1 8.5 1.2 3.0 20.9 3.9 6.6 19.9 7.0 2.9 6.7 5.0 10.5 6.4 19.0 9.9 10.8 10.1 9.6 12.5 12.3 9.8 12.0 10.3 8.6 8.2 10.2 10.1 5.1 7.0 12.9 5.5 9.5 8.9 15.2 14.9 16.1 17.7 13.3 10.3 14.7 12.5 13.4 15.3 3.0 13.3 7.0 10.2 10.9 20.8 22.6 5.1 12.0 12.5 14.0 31.4 8.8 1.7 9.2 12.8 11.7 13.0 0.0 9.5 6.7 12.2 18.0 3.5 4.9 10.2 11.1 9.9 7.4 11.0 17.5 10.9 12.3 11.8 10.8 14.9 7.8 8.4 10.5 11.7 5.4 17.5 25.8 6.2 14.0 13.2 11.7 8.8 13.8 12.5 12.3 COIL "CLN80, p80-coilin" ENSG00000121058 Coilin P38432 17 56938187-56961054 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 58.8" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 199.1;Late spermatids: 405.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017524, HPA027885, HPA057480, CAB069400" Enhanced Supported "Nucleoplasm,Nucleoli,Nucleoli fibrillar center,Nuclear bodies" NA NA "Nuclear bodies" "Nucleoplasm, Nucleoli, Nucleoli fibrillar center" "CAB017524: AB_1121780, CAB069400: , HPA027885: AB_2672421, HPA057480: " "unprognostic (1.01e-2)" "unprognostic (3.05e-1)" "prognostic favorable (1.77e-4)" "unprognostic (1.90e-2)" "unprognostic (3.19e-2)" "unprognostic (4.13e-3)" "prognostic unfavorable (1.28e-4)" "unprognostic (1.64e-1)" "unprognostic (4.07e-3)" "unprognostic (3.00e-3)" "unprognostic (2.50e-2)" "unprognostic (2.25e-2)" "unprognostic (1.28e-3)" "unprognostic (2.50e-1)" "unprognostic (2.92e-1)" "unprognostic (3.36e-2)" "unprognostic (7.71e-2)" 8.7 5.6 7.3 5.5 8.1 10.9 8.2 12.6 8.9 8.9 6.4 7.6 4.9 6.7 8.1 8.1 8.5 6.8 4.9 5.3 5.8 5.7 7.0 8.5 5.3 7.7 7.1 6.5 8.6 9.1 8.5 9.7 9.5 8.2 7.8 7.3 5.8 7.5 9.1 7.9 7.8 7.0 5.9 7.2 8.1 6.4 58.8 6.0 12.3 8.7 5.3 8.5 7.7 7.3 22.5 13.7 14.0 13.4 12.7 17.8 8.6 13.2 10.1 20.8 8.0 7.1 8.6 14.4 9.5 9.0 14.6 15.6 13.8 11.5 16.0 19.4 7.6 10.9 7.8 14.1 11.0 20.9 19.2 17.8 26.1 9.7 15.6 7.7 21.9 16.0 7.9 13.8 11.0 11.9 8.7 12.4 9.5 22.5 13.4 13.7 16.8 17.2 14.0 12.2 14.7 10.2 8.2 25.6 12.8 10.0 13.4 17.7 17.5 6.4 6.4 16.0 12.5 23.1 21.5 8.7 17.0 12.9 8.2 12.3 19.9 24.8 18.8 8.9 12.2 10.3 14.0 11.5 13.9 13.9 10.4 15.6 22.5 15.4 14.6 11.3 21.6 17.8 17.2 6.8 12.7 13.4 13.7 15.2 8.6 7.3 8.1 12.6 8.9 5.8 5.7 7.1 6.5 8.2 6.0 11.9 15.2 21.2 34.1 16.7 35.0 13.4 17.8 20.1 25.0 14.0 35.3 36.2 11.6 24.9 199.1 26.3 12.6 0.0 24.1 27.5 24.2 25.8 21.9 21.5 19.3 23.8 23.0 21.5 14.0 405.7 39.1 13.9 3.3 14.4 16.2 26.1 21.4 17.5 28.7 18.7 47.6 12.9 18.4 95.4 43.3 19.8 24.4 22.3 20.7 27.1 COL28A1 ENSG00000215018 "Collagen type XXVIII alpha 1 chain" Q2UY09 7 7356203-7535853 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 12 "Ciliated cells: 16.0;Cone photoreceptor cells: 17.7" "Cancer enhanced" "Detected in many" "glioma: 4.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 3.3;U-266/70: 14.2;U-266/84: 3.8;WM-115: 6.9" "Region enriched" "Detected in single" 8 "olfactory region: 4.5" "Not detected" "Not detected" "HPA043844, HPA060468" Uncertain Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" NA NA "Nucleoplasm, Cytosol" "HPA043844: AB_2732508, HPA060468: AB_2684288" "unprognostic (6.28e-2)" "unprognostic (2.90e-2)" "unprognostic (1.28e-1)" "unprognostic (8.71e-3)" "unprognostic (1.89e-2)" "unprognostic (5.63e-3)" "unprognostic (2.61e-2)" "unprognostic (7.58e-2)" "unprognostic (2.72e-2)" "unprognostic (7.69e-2)" "unprognostic (3.90e-3)" "unprognostic (2.33e-2)" "unprognostic (3.45e-2)" "unprognostic (6.13e-2)" "unprognostic (1.05e-1)" "unprognostic (2.48e-3)" "unprognostic (3.09e-2)" 2.7 3.7 1.0 7.0 1.1 0.3 3.1 2.4 1.6 10.2 11.8 0.6 11.5 1.3 2.9 16.2 14.7 5.5 5.7 7.0 1.3 2.2 2.8 1.9 1.3 1.0 9.8 0.2 2.9 5.8 0.1 12.2 0.5 6.1 5.8 4.7 12.8 19.3 6.2 5.6 2.1 6.6 16.0 7.9 0.3 5.7 3.2 0.2 0.2 1.4 10.2 0.9 8.4 14.2 0.6 0.3 1.6 0.2 2.1 1.0 0.0 2.0 0.0 0.0 0.0 0.2 1.1 0.3 0.1 0.6 0.0 0.0 1.6 0.6 0.3 0.1 0.1 1.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.6 0.0 0.0 0.4 0.3 0.1 0.2 0.0 0.3 2.0 0.2 0.3 0.0 0.9 1.2 0.5 0.0 0.1 0.0 3.3 0.1 0.2 0.0 0.1 1.0 0.0 0.5 0.1 0.9 1.0 0.0 0.7 1.8 0.0 14.2 3.8 0.0 0.2 0.8 6.9 0.5 0.1 0.3 0.1 0.2 0.2 0.1 0.1 0.2 0.0 0.6 0.4 1.0 1.6 2.1 0.1 0.3 0.0 0.0 1.0 1.1 2.4 1.3 1.3 2.2 9.8 0.2 6.1 0.2 0.0 2.6 0.0 0.1 0.2 4.6 0.8 0.0 16.0 5.7 3.5 17.7 0.3 0.0 0.1 0.8 0.0 0.0 0.0 0.2 0.0 0.5 0.1 1.1 0.0 0.1 4.8 0.0 3.1 0.0 0.8 0.9 0.0 0.0 0.0 0.3 2.4 0.5 2.8 0.7 0.3 4.5 0.0 0.0 0.7 0.0 0.1 0.2 0.0 0.3 0.1 COL2A1 "AOM, SEDC, STL1" ENSG00000139219 "Collagen type II alpha 1 chain" P02458 12 47972965-48004554 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Cancer-related genes, Cataract, Deafness, Disease mutation, Dwarfism, Stickler syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "epididymis: 22.7;pituitary gland: 11.0;retina: 8.1;stomach 1: 11.3" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 12.7;Intestinal endocrine cells: 42.2;Muller glia cells: 19.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 55.2;HAP1: 34.6;HEK 293: 12.8" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002214, HPA055753" Approved Approved Nucleoplasm "Secreted to extracellular matrix" No NA Nucleoplasm "CAB002214: AB_563666, HPA055753: AB_2682908" "unprognostic (7.25e-2)" "unprognostic (1.20e-1)" "unprognostic (2.58e-1)" "unprognostic (3.44e-1)" "unprognostic (2.88e-2)" "unprognostic (3.08e-2)" "unprognostic (8.63e-2)" "unprognostic (2.77e-1)" "unprognostic (1.22e-1)" "unprognostic (3.12e-2)" "unprognostic (1.31e-4)" "unprognostic (2.64e-1)" "unprognostic (3.44e-3)" "unprognostic (1.89e-1)" "unprognostic (2.93e-1)" "unprognostic (2.07e-1)" "unprognostic (1.02e-1)" 0.0 0.0 0.1 2.2 0.3 0.0 0.7 0.9 0.9 0.0 0.2 0.3 0.0 0.0 0.3 22.7 0.0 0.0 0.0 0.0 0.5 1.3 0.0 0.0 1.4 0.0 0.0 0.7 1.3 0.0 0.0 11.0 0.4 1.9 2.6 0.4 8.1 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 11.3 2.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 34.6 0.0 0.0 0.0 12.8 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.9 0.9 0.5 1.3 0.0 0.7 1.9 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.8 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.2 0.0 42.2 0.0 0.0 7.1 0.9 0.0 0.0 0.0 0.3 19.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.5 0.7 0.0 0.7 0.0 0.9 0.1 COL4A3BP "CERT, GPBP, STARD11" ENSG00000113163 "Collagen type IV alpha 3 binding protein" Q9Y5P4 5 75356345-75512138 "Disease related genes, Predicted intracellular proteins" "Lipid transport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 52.0;WM-115: 45.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035645, HPA042608" Uncertain Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA035645: AB_10600700, HPA042608: AB_2678075" "unprognostic (2.45e-1)" "unprognostic (7.16e-2)" "unprognostic (6.56e-3)" "unprognostic (1.53e-2)" "unprognostic (2.44e-1)" "unprognostic (9.29e-2)" "unprognostic (4.06e-2)" "unprognostic (3.22e-1)" "unprognostic (2.51e-1)" "unprognostic (1.24e-1)" "unprognostic (1.46e-1)" "unprognostic (4.29e-2)" "prognostic favorable (1.24e-5)" "unprognostic (9.12e-2)" "unprognostic (2.29e-1)" "unprognostic (2.83e-1)" "unprognostic (2.91e-1)" 30.0 25.5 16.5 17.1 21.9 17.9 21.4 34.4 21.2 26.9 19.9 14.9 21.5 13.5 20.5 11.6 21.9 17.1 17.4 14.9 15.2 16.3 21.1 22.7 19.6 13.4 22.5 12.4 17.9 12.4 24.6 25.9 17.8 18.2 19.0 14.6 14.8 17.5 16.1 33.4 14.2 19.3 18.9 16.6 17.2 17.0 21.3 20.7 17.8 37.4 14.3 15.9 21.8 19.1 6.4 9.8 20.9 16.6 5.1 8.8 5.7 16.6 8.6 8.3 7.2 52.0 14.5 11.1 9.4 11.6 7.2 9.6 12.9 9.6 8.1 20.3 9.9 10.0 10.1 12.6 12.9 11.1 9.9 5.8 6.7 9.5 6.8 13.2 6.6 7.8 10.9 9.2 8.5 9.7 11.8 8.3 10.7 12.1 12.2 9.5 8.8 7.9 5.0 10.7 3.8 6.4 6.7 11.0 7.4 11.8 20.2 6.4 6.4 11.8 8.3 11.6 18.3 8.1 11.4 11.3 4.9 5.9 8.8 7.7 11.3 14.9 9.4 8.5 11.4 45.0 5.0 13.9 10.6 6.0 15.6 5.6 6.0 6.2 5.6 9.8 6.4 5.9 5.8 20.9 5.1 16.6 5.7 8.8 5.7 16.5 21.9 34.4 21.2 15.2 16.3 22.5 12.4 18.2 20.7 56.6 58.5 6.4 28.0 16.7 30.7 32.7 22.9 71.0 75.1 17.4 21.6 13.6 18.3 19.6 83.3 28.1 19.2 0.0 19.2 13.9 20.9 36.3 47.5 17.9 31.6 41.3 26.4 55.9 33.0 73.0 32.2 37.4 49.0 19.8 15.6 31.1 21.5 13.1 39.3 22.3 33.1 19.4 19.6 41.5 31.5 23.3 23.2 21.3 14.3 38.3 COL9A2 "EDM2, MED" ENSG00000049089 "Collagen type IX alpha 2 chain" Q14055 1 40300487-40317813 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Deafness, Disease mutation, Dwarfism, Stickler syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.3;pituitary gland: 32.1;retina: 40.8" "Cell type enriched" "Detected in many" 9 "Muller glia cells: 280.3" "Cancer enhanced" "Detected in all" "prostate cancer: 68.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 6.4;myeloid DC: 2.7" "Group enriched" "Detected in many" 6 "dendritic cells: 2.7;granulocytes: 6.4" "Cell line enhanced" "Detected in some" "HDLM-2: 35.4;HMC-1: 34.1;THP-1: 38.3" "Low region specificity" "Detected in all" "HPA056316, HPA075286" Supported Approved Nucleoplasm,Vesicles "Secreted to extracellular matrix" NA NA Vesicles Nucleoplasm "HPA056316: AB_2683099, HPA075286: AB_2732288" "unprognostic (1.42e-2)" "unprognostic (3.54e-2)" "unprognostic (8.94e-2)" "prognostic unfavorable (5.13e-4)" "unprognostic (4.46e-2)" "unprognostic (1.83e-3)" "unprognostic (2.06e-2)" "unprognostic (9.00e-3)" "unprognostic (1.73e-1)" "unprognostic (1.26e-1)" "unprognostic (1.56e-3)" "unprognostic (2.26e-1)" "unprognostic (1.16e-3)" "unprognostic (4.28e-2)" "unprognostic (2.56e-1)" "unprognostic (5.89e-2)" "unprognostic (1.71e-2)" 0.7 2.3 17.2 2.6 19.5 7.6 3.1 2.3 12.1 10.0 3.6 32.0 17.4 4.6 3.9 1.5 0.7 3.7 6.5 1.0 20.8 14.5 4.3 0.6 2.8 4.2 29.8 10.5 0.6 1.7 28.3 32.1 0.9 16.3 8.8 2.6 40.8 13.7 21.3 0.3 2.0 3.3 1.3 35.3 3.2 12.8 0.8 19.7 0.2 4.3 0.9 2.5 4.0 0.5 0.7 2.7 6.4 0.7 0.4 0.3 0.1 4.3 0.1 0.7 0.3 1.0 0.5 2.9 0.0 0.0 0.2 0.5 0.1 2.5 1.2 3.8 0.1 0.0 0.7 0.0 0.0 0.1 35.4 0.5 0.7 0.3 9.9 0.6 0.3 34.1 1.8 0.0 0.0 0.0 0.2 0.0 0.5 0.0 7.4 0.0 0.9 0.4 0.7 0.8 0.0 0.4 0.8 0.0 2.4 0.0 5.2 0.5 0.8 0.0 4.4 0.4 2.6 5.6 38.3 0.0 0.0 4.5 0.0 0.1 0.5 0.0 1.2 0.3 4.5 0.2 0.0 0.2 6.4 0.0 0.5 0.0 0.5 0.2 0.0 2.7 0.7 0.1 0.0 1.1 0.4 0.7 0.3 0.3 0.1 17.2 19.5 2.3 10.8 20.8 14.5 29.8 10.5 16.3 19.7 0.0 3.5 4.5 2.6 0.9 1.8 0.8 7.6 1.4 3.4 24.4 0.0 2.3 0.0 6.3 0.0 0.0 3.3 0.0 0.7 0.4 1.4 7.8 26.4 0.0 3.3 0.0 12.2 1.3 0.3 0.8 2.0 6.5 1.7 30.7 5.5 280.3 3.6 7.0 0.0 0.1 7.8 0.0 0.9 2.6 2.6 0.5 1.1 2.2 12.2 11.1 COL9A3 "DJ885L7.4.1, EDM3, FLJ90759, IDD, MED" ENSG00000092758 "Collagen type IX alpha 3 chain" Q14050 20 62816244-62841159 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 26.4;retina: 37.2;salivary gland: 38.9;thyroid gland: 18.1" "Group enriched" "Detected in many" 5 "Early spermatids: 120.8;Late spermatids: 311.3;Muller glia cells: 91.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "BEWO: 53.7;Hep G2: 21.2;SK-MEL-30: 17.6;WM-115: 21.3" "Low region specificity" "Detected in all" "HPA040125, HPA058323" Supported Approved "Nucleoplasm,Intermediate filaments" "Secreted to extracellular matrix" NA NA Nucleoplasm "Intermediate filaments" "HPA040125: AB_10805604, HPA058323: AB_2683679" "unprognostic (1.14e-3)" "unprognostic (2.14e-2)" "unprognostic (3.93e-1)" "unprognostic (1.21e-3)" "unprognostic (4.25e-2)" "unprognostic (2.39e-2)" "unprognostic (2.33e-1)" "unprognostic (1.24e-2)" "unprognostic (1.27e-1)" "unprognostic (1.25e-1)" "unprognostic (2.39e-1)" "unprognostic (2.13e-1)" "unprognostic (1.64e-2)" "unprognostic (2.94e-1)" "unprognostic (1.51e-1)" "unprognostic (4.79e-2)" "unprognostic (2.67e-1)" 2.2 2.0 11.2 2.3 16.3 1.2 1.5 1.5 8.9 1.7 3.4 26.4 1.6 2.3 1.8 1.5 1.6 1.2 1.4 2.1 14.9 9.8 1.4 1.3 1.3 1.4 18.4 8.1 1.6 5.4 1.1 5.3 1.9 12.4 1.7 1.3 37.2 38.9 3.4 1.5 1.8 2.5 1.4 25.0 1.2 1.8 6.4 15.2 0.0 18.1 1.4 1.2 1.3 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.3 53.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 4.9 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.0 2.5 21.2 0.1 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.2 2.4 2.9 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 17.6 1.8 0.1 1.9 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 21.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 16.3 1.5 8.0 14.9 9.8 18.4 8.1 12.4 15.2 3.0 0.0 13.7 1.7 2.9 1.0 1.2 0.0 0.0 0.0 5.2 9.8 4.0 1.7 1.3 120.8 3.1 0.9 0.0 0.0 35.4 10.4 0.9 0.0 2.4 2.1 0.0 4.1 3.1 2.7 311.3 3.7 1.3 3.3 0.0 2.6 91.3 0.1 6.2 1.4 9.5 2.5 0.0 1.1 2.5 4.1 6.0 3.3 0.0 1.5 0.8 COLGALT2 "C1orf17, GLT25D2, KIAA0584" ENSG00000198756 "Collagen beta(1-O)galactosyltransferase 2" Q8IYK4 1 183929854-184037729 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.0" "Cell type enhanced" "Detected in some" 20 "Early spermatids: 38.2;Late spermatids: 52.3;Sertoli cells: 12.9" "Cancer enhanced" "Detected in many" "glioma: 11.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "basophil: 8.1" "Lineage enriched" "Detected in single" 11 "granulocytes: 8.1" "Cell line enhanced" "Detected in many" "Hep G2: 12.7;OE19: 10.2;SK-MEL-30: 13.7;U-251 MG: 13.1;WM-115: 16.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031749, HPA031750" Approved Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA Nucleoplasm Vesicles "HPA031749: AB_10599298, HPA031750: AB_10611252" "unprognostic (5.44e-3)" "unprognostic (3.08e-1)" "unprognostic (6.29e-5)" "unprognostic (2.08e-1)" "unprognostic (4.41e-2)" "unprognostic (1.54e-1)" "unprognostic (1.16e-1)" "unprognostic (1.09e-2)" "unprognostic (2.52e-1)" "unprognostic (2.00e-1)" "unprognostic (2.25e-1)" "unprognostic (1.19e-1)" "unprognostic (5.13e-9)" "unprognostic (1.53e-2)" "unprognostic (1.92e-1)" "unprognostic (3.21e-2)" "unprognostic (3.80e-2)" 2.1 9.4 10.8 1.7 16.6 1.9 2.8 10.6 39.0 2.0 3.0 31.3 0.0 1.4 3.0 5.2 1.7 3.5 3.7 11.7 15.3 7.9 1.8 1.0 4.5 1.1 20.2 12.9 2.3 3.5 1.0 1.9 0.8 17.4 8.1 2.0 3.5 4.4 3.7 11.0 1.1 1.4 3.0 21.8 1.3 3.4 5.0 22.5 0.0 5.1 1.8 1.5 2.4 1.4 0.0 0.0 8.1 0.0 0.7 0.6 0.1 0.1 0.0 4.4 0.2 2.3 3.4 0.1 1.2 0.5 0.6 0.7 2.1 0.2 0.0 0.3 3.3 0.8 0.0 4.2 0.0 1.1 4.6 2.3 0.3 0.0 12.7 0.1 4.1 0.0 2.0 0.0 0.6 0.1 6.4 0.0 0.1 4.1 5.4 4.6 0.1 0.2 0.2 3.0 10.2 0.0 0.4 0.0 0.0 0.0 0.9 1.7 2.7 0.2 0.0 13.7 2.9 0.0 0.2 0.0 0.5 0.4 0.0 13.1 8.0 0.0 0.0 0.4 2.0 16.9 8.1 0.0 0.1 0.6 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.1 10.8 16.6 10.6 17.2 15.3 7.9 20.2 12.9 17.4 22.5 0.0 0.0 0.0 0.4 0.3 0.8 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 38.2 0.9 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.3 52.3 2.0 1.5 1.7 0.0 0.0 4.8 1.0 0.0 3.9 0.2 0.2 12.9 0.5 0.3 0.4 0.4 0.0 3.5 0.0 0.3 COMMD1 "C2orf5, MGC27155, MURR1" ENSG00000173163 "Copper metabolism domain containing 1" Q8N668 2 61888724-62147247 "Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Transport, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034633, HPA049223" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034633: AB_10601800, HPA049223: AB_2680680" "unprognostic (6.08e-2)" "unprognostic (2.34e-2)" "unprognostic (2.83e-1)" "unprognostic (1.43e-2)" "unprognostic (2.30e-1)" "unprognostic (1.22e-2)" "unprognostic (5.58e-2)" "unprognostic (1.07e-1)" "unprognostic (4.93e-1)" "unprognostic (3.41e-2)" "unprognostic (2.26e-1)" "unprognostic (2.07e-1)" "unprognostic (2.32e-1)" "unprognostic (6.71e-2)" "unprognostic (1.27e-1)" "unprognostic (5.51e-2)" "unprognostic (2.77e-1)" 19.6 26.2 18.6 23.2 22.3 14.2 22.8 26.7 21.4 20.1 16.6 16.7 21.2 18.2 21.0 26.2 25.3 18.0 16.8 41.7 16.1 15.2 25.4 28.8 15.6 17.3 17.8 22.4 19.9 32.8 15.0 30.0 21.2 16.8 19.0 19.0 17.9 26.6 24.3 32.1 21.0 14.4 24.7 19.9 16.1 19.5 26.8 19.0 16.3 23.6 20.3 19.7 17.6 19.5 33.0 42.7 17.1 36.5 31.2 31.8 35.7 10.1 13.1 15.1 11.6 19.4 22.6 12.9 12.2 20.8 24.9 18.2 22.4 9.3 18.0 10.5 22.8 20.9 7.9 8.2 15.0 26.9 19.4 10.0 14.0 7.7 24.7 16.7 21.7 11.0 16.4 17.4 12.1 14.4 18.2 25.0 10.5 8.5 29.5 26.3 19.1 16.7 38.6 12.8 8.4 18.0 12.0 19.6 20.6 22.6 11.2 9.0 10.2 13.8 23.4 12.4 15.4 14.8 9.5 11.7 22.4 19.3 13.9 18.7 12.9 10.1 22.4 13.2 19.3 19.5 16.5 36.5 17.1 25.1 30.8 24.6 33.0 28.4 27.7 42.7 30.7 27.2 29.0 3.0 31.2 26.2 39.6 31.8 35.7 18.6 22.3 26.7 21.4 16.1 15.2 17.8 22.4 16.8 19.0 32.8 32.7 37.2 66.2 48.3 32.5 159.4 33.1 25.4 28.4 33.2 9.8 110.1 109.5 64.2 152.9 54.2 32.7 46.7 56.9 62.1 58.0 45.1 56.6 57.1 88.4 27.0 20.7 56.4 36.8 131.8 38.3 63.2 79.2 174.1 26.2 26.9 53.3 36.5 46.7 157.5 28.9 32.3 61.3 74.2 54.8 54.0 123.1 40.5 29.2 54.2 COMMD10 PTD002 ENSG00000145781 "COMM domain containing 10" Q9Y6G5 5 116084991-116412762 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045441, HPA054156" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA045441: AB_10961905, HPA054156: " "unprognostic (1.14e-1)" "unprognostic (2.15e-2)" "unprognostic (5.38e-2)" "unprognostic (5.72e-2)" "unprognostic (1.79e-1)" "unprognostic (5.72e-3)" "unprognostic (2.12e-2)" "unprognostic (1.51e-1)" "unprognostic (3.02e-2)" "unprognostic (2.64e-1)" "unprognostic (2.07e-1)" "unprognostic (3.14e-1)" "unprognostic (1.84e-3)" "prognostic unfavorable (2.99e-4)" "unprognostic (9.47e-2)" "prognostic unfavorable (6.93e-4)" "unprognostic (1.59e-1)" 20.5 26.6 18.6 22.8 20.3 13.3 21.9 17.9 20.5 20.0 16.9 15.7 26.7 12.7 18.6 31.5 18.6 13.4 16.6 28.4 16.3 16.8 33.2 22.4 15.4 19.0 23.4 15.0 18.2 23.0 15.2 29.1 22.3 18.9 20.6 19.6 15.1 27.2 24.1 15.1 11.5 20.4 18.7 19.1 25.1 19.3 12.9 17.9 19.1 27.0 14.3 20.6 18.2 17.3 12.0 23.6 12.7 21.4 15.9 10.8 13.5 16.1 16.6 17.9 9.5 12.9 18.3 19.9 12.7 13.8 17.7 14.8 13.3 20.3 8.2 15.1 17.4 36.9 9.3 10.0 19.7 26.5 23.8 7.4 9.8 5.6 10.3 14.7 7.7 18.7 11.5 13.2 11.3 13.9 14.5 17.6 11.7 6.3 5.6 23.0 10.7 14.4 18.4 15.4 12.3 7.6 14.6 18.9 23.9 24.8 10.3 9.5 12.7 15.3 13.9 17.7 13.7 17.0 29.3 10.5 15.5 19.0 7.1 21.7 6.1 8.1 21.1 15.0 29.3 17.8 7.6 18.2 12.7 7.8 21.4 10.6 12.0 10.1 9.7 23.6 8.3 9.9 10.1 3.3 15.9 19.6 17.4 10.8 13.5 18.6 20.3 17.9 20.5 16.3 16.8 23.4 15.0 18.9 17.9 8.9 18.3 20.4 27.7 19.7 15.5 37.5 12.7 4.0 11.4 22.7 5.9 38.4 77.9 24.7 1.5 21.0 12.9 0.0 13.3 43.4 28.0 28.2 46.1 11.6 42.0 15.9 10.3 20.9 26.5 2.5 19.5 32.4 30.4 16.2 22.3 29.0 16.3 14.4 19.1 83.0 19.4 0.0 27.8 8.1 16.6 22.0 41.4 22.4 21.0 24.7 COMMD2 HSPC042 ENSG00000114744 "COMM domain containing 2" Q86X83 3 149738470-149752499 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cone photoreceptor cells: 176.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044190 Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA044190: AB_10966289" "unprognostic (2.17e-1)" "unprognostic (8.34e-3)" "unprognostic (6.28e-2)" "unprognostic (1.55e-3)" "unprognostic (1.53e-3)" "unprognostic (1.26e-1)" "prognostic unfavorable (2.78e-4)" "unprognostic (1.45e-1)" "unprognostic (1.02e-2)" "unprognostic (4.93e-2)" "prognostic unfavorable (3.69e-6)" "unprognostic (1.31e-1)" "unprognostic (4.03e-3)" "unprognostic (1.76e-1)" "unprognostic (1.89e-1)" "unprognostic (6.25e-2)" "unprognostic (4.86e-2)" 14.1 11.2 13.3 9.6 16.1 10.3 20.9 22.0 18.3 17.2 10.9 21.1 4.8 10.6 18.8 10.5 14.6 13.2 10.6 11.2 13.4 12.3 21.9 17.2 17.0 13.2 16.0 12.5 18.1 11.3 14.4 14.2 22.3 18.7 14.0 11.7 14.1 14.6 12.2 9.4 13.3 15.8 17.0 19.6 15.2 10.4 9.6 14.4 20.5 19.3 9.6 14.6 12.4 12.8 8.7 10.0 16.4 14.2 11.7 11.4 9.4 17.0 5.0 16.3 9.4 14.3 16.5 10.8 10.7 11.2 16.6 16.8 8.7 10.6 13.7 12.3 10.4 10.5 10.9 15.5 13.0 19.4 10.1 14.8 12.3 6.9 5.8 15.3 17.6 5.6 12.4 14.4 8.2 14.7 11.2 11.6 8.7 6.0 7.8 11.8 5.3 12.2 8.7 18.0 10.4 6.7 11.3 16.5 18.3 15.7 4.5 7.5 11.5 12.4 10.1 22.9 13.5 18.6 11.7 10.1 9.8 3.9 9.7 12.6 14.1 5.5 22.6 9.5 15.9 4.0 16.4 8.2 13.9 8.0 12.0 11.4 8.7 9.8 9.5 10.0 8.0 10.4 10.9 6.4 11.7 14.2 6.2 7.8 9.4 13.3 16.1 22.0 18.3 13.4 12.3 16.0 12.5 18.7 14.4 59.6 21.7 26.8 30.7 18.5 54.4 14.9 30.6 28.1 51.2 21.0 176.7 44.6 36.5 47.3 2.3 33.1 18.8 23.3 34.6 49.7 36.6 22.9 45.1 14.4 39.4 27.0 23.6 31.9 20.9 3.2 33.6 37.2 32.1 121.8 16.3 33.3 44.0 20.1 33.9 23.3 98.2 51.8 29.9 48.9 49.0 18.9 26.7 32.4 20.0 20.5 COMMD3-BMI1 ENSG00000269897 "COMMD3-BMI1 readthrough" 10 22316388-22329542 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 20.9" "HPA030471, HPA030472, HPA036584" Uncertain Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Nucleoli, Cytosol" "HPA030471: AB_2673491, HPA030472: AB_10601090, HPA036584: AB_10670803" "unprognostic (8.63e-2)" "unprognostic (2.36e-2)" "unprognostic (1.83e-2)" 8.5 12.4 4.5 6.6 9.1 2.8 6.9 5.1 8.5 9.7 11.9 4.7 8.3 4.9 4.0 5.9 9.4 8.3 4.3 14.3 4.7 4.1 5.5 6.9 8.0 5.0 6.6 4.7 4.3 11.4 5.7 8.7 4.7 5.7 5.0 2.8 4.2 8.3 14.6 22.8 4.8 7.6 7.0 7.3 7.3 7.6 23.4 6.6 12.3 3.7 7.6 6.4 12.0 5.4 25.0 30.3 25.7 25.8 18.8 21.6 26.6 3.6 13.1 4.6 0.5 5.3 3.6 0.7 3.7 4.1 2.0 5.2 7.2 1.4 1.8 5.5 12.4 9.8 1.7 4.9 8.0 0.6 14.5 1.6 5.0 2.7 3.2 16.3 0.4 2.3 6.4 4.5 7.2 3.8 8.0 5.1 20.9 1.0 5.1 0.6 3.5 14.9 0.5 0.5 8.6 4.1 4.2 5.1 4.0 2.0 4.5 0.4 1.6 7.1 1.7 1.5 1.4 3.2 3.6 6.7 1.6 5.1 0.3 1.0 11.1 13.4 5.9 2.5 11.1 1.6 25.7 25.8 17.2 15.1 23.5 16.6 25.0 16.1 14.7 30.3 21.9 11.0 12.2 3.8 18.8 17.8 29.2 21.6 26.6 4.5 9.1 5.1 8.5 4.7 4.1 6.6 4.7 5.7 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 COMMD5 "FLJ13008, HCaRG, HT002" ENSG00000170619 "COMM domain containing 5" Q9GZQ3 8 144841042-144853736 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046905 Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA046905: AB_2732535" "unprognostic (2.95e-2)" "unprognostic (7.62e-2)" "unprognostic (2.63e-1)" "unprognostic (1.16e-1)" "unprognostic (1.36e-1)" "unprognostic (9.13e-2)" "unprognostic (5.05e-3)" "unprognostic (6.82e-2)" "unprognostic (3.24e-1)" "unprognostic (9.35e-2)" "unprognostic (2.25e-1)" "unprognostic (7.97e-3)" "unprognostic (1.25e-2)" "unprognostic (8.58e-2)" "unprognostic (3.43e-1)" "unprognostic (2.02e-1)" "unprognostic (7.73e-3)" 24.7 22.3 18.2 16.7 18.1 27.6 14.6 26.0 22.9 15.2 19.1 18.1 17.7 17.8 16.6 15.3 18.9 15.9 17.0 20.9 18.4 17.1 18.0 21.8 20.0 21.0 23.8 12.2 13.4 20.3 11.0 18.3 16.3 15.9 15.8 10.5 16.4 22.4 17.4 16.0 17.5 15.5 17.9 18.5 22.2 16.9 11.7 16.8 17.7 23.6 14.3 19.0 20.2 15.1 29.3 36.6 36.3 42.6 32.0 33.8 31.8 15.8 18.6 9.1 12.1 11.2 9.0 8.1 9.2 9.9 15.8 12.5 11.4 12.5 11.0 20.6 11.1 9.1 10.8 11.3 15.2 6.8 14.3 15.9 23.0 17.9 18.9 15.1 7.8 20.0 11.9 13.9 10.7 8.1 7.6 12.1 4.0 16.4 20.3 12.7 28.9 7.0 8.1 13.8 22.2 37.9 9.1 10.5 16.8 15.2 14.2 21.4 18.6 15.4 9.4 13.2 6.3 18.2 14.6 11.1 12.0 23.5 16.7 18.0 8.5 9.0 10.1 16.5 14.5 15.3 28.5 42.6 36.3 29.3 34.6 26.1 29.3 22.8 28.7 36.6 26.1 22.8 25.3 25.7 32.0 21.8 13.4 33.8 31.8 18.2 18.1 26.0 22.9 18.4 17.1 23.8 12.2 15.9 16.8 11.9 16.7 22.5 17.6 24.6 12.1 9.5 15.3 26.8 7.9 15.7 11.8 30.3 33.2 41.3 2.8 30.6 23.3 0.0 35.0 21.2 23.7 27.3 25.3 16.8 60.7 11.1 19.1 24.5 32.2 1.2 17.3 27.5 25.3 40.5 13.4 18.4 39.9 17.3 21.9 30.5 13.8 12.9 15.1 10.9 13.2 26.2 27.7 26.3 16.7 24.3 COMMD8 FLJ20502 ENSG00000169019 "COMM domain containing 8" Q9NX08 4 47450796-47463719 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Proximal tubular cells: 147.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035887 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA035887: AB_10600702" "unprognostic (9.04e-2)" "unprognostic (1.40e-1)" "unprognostic (8.55e-3)" "unprognostic (5.13e-2)" "unprognostic (2.51e-1)" "unprognostic (1.74e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.07e-2)" "unprognostic (4.24e-2)" "unprognostic (3.47e-2)" "unprognostic (1.78e-1)" "unprognostic (3.78e-2)" "prognostic favorable (2.71e-5)" "unprognostic (1.06e-1)" "unprognostic (2.10e-1)" "unprognostic (7.76e-2)" "unprognostic (7.13e-2)" 11.4 14.0 14.7 13.9 21.3 13.1 10.9 9.5 18.8 9.7 12.5 5.7 7.7 13.1 9.7 17.3 21.1 8.3 10.0 19.1 14.1 14.0 32.5 16.1 15.1 21.4 13.9 15.0 8.4 10.4 15.5 20.5 20.0 11.3 9.2 13.4 6.5 9.8 9.2 7.7 12.5 17.1 12.8 11.6 14.5 10.0 16.9 10.9 15.2 15.7 19.7 17.5 15.5 12.7 21.1 32.7 39.8 36.4 23.9 22.9 27.9 12.5 6.9 6.1 3.1 13.0 18.6 8.5 18.9 12.6 12.4 16.9 11.6 14.8 20.1 15.9 17.8 28.1 6.7 19.6 15.4 22.5 11.8 8.8 11.5 7.8 9.0 17.8 28.1 14.9 16.0 20.8 11.8 13.2 11.6 15.7 13.3 8.5 8.2 30.2 7.0 16.7 22.9 4.2 8.5 9.1 8.4 14.0 4.3 35.6 10.3 12.1 6.1 7.8 6.4 15.0 11.2 11.8 18.7 12.9 17.8 17.1 15.8 22.5 8.7 10.4 16.1 19.3 37.0 12.8 39.8 26.2 29.5 21.3 34.9 22.9 21.1 19.6 21.1 32.7 18.8 18.5 21.0 12.9 23.9 36.4 15.3 22.0 27.9 14.7 21.3 9.5 18.8 14.1 14.0 13.9 15.0 11.3 10.9 20.8 13.9 28.1 10.6 20.0 18.5 38.3 10.2 52.2 19.4 27.9 3.9 74.5 91.2 38.2 28.4 22.9 18.0 0.0 40.4 94.8 31.8 6.4 32.3 10.2 81.6 6.4 20.2 20.9 60.2 8.5 50.3 51.3 11.8 59.5 20.0 25.7 23.9 21.5 38.2 147.8 18.8 19.4 34.0 66.9 52.6 26.2 88.4 57.3 24.6 7.3 COMMD9 "FLJ31106, HSPC166" ENSG00000110442 "COMM domain containing 9" Q9P000 11 36269284-36289449 "Predicted intracellular proteins" "Ion transport, Sodium transport, Transcription, Transcription regulation, Transport, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009142 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA009142: AB_1847105" "unprognostic (1.56e-2)" "unprognostic (4.75e-3)" "unprognostic (7.57e-2)" "unprognostic (4.40e-3)" "unprognostic (1.91e-1)" "unprognostic (2.12e-1)" "unprognostic (1.16e-3)" "unprognostic (2.62e-1)" "unprognostic (6.15e-2)" "prognostic favorable (8.54e-4)" "unprognostic (4.94e-2)" "unprognostic (2.40e-1)" "unprognostic (6.08e-3)" "unprognostic (7.24e-2)" "unprognostic (1.71e-1)" "unprognostic (7.31e-3)" "unprognostic (1.88e-1)" 26.9 25.4 28.0 15.8 25.4 32.6 18.5 18.1 36.9 14.3 15.0 26.5 9.5 16.2 12.4 20.4 18.4 16.2 15.8 23.1 25.4 25.7 34.5 28.0 20.4 24.8 27.7 23.8 15.8 23.3 19.4 18.9 18.9 22.8 12.6 19.1 16.0 16.7 11.1 43.6 19.6 16.4 17.0 28.4 26.0 14.8 14.6 17.2 24.7 19.8 21.1 23.6 16.6 12.2 22.5 66.3 28.8 66.2 14.8 18.9 46.4 10.8 13.0 14.3 15.0 22.1 15.5 7.9 13.0 16.9 29.7 28.0 10.5 9.3 12.6 13.0 25.9 23.0 16.1 25.1 17.5 28.1 15.1 29.5 6.9 24.3 18.3 20.8 26.9 20.8 19.5 19.7 16.2 10.0 15.4 24.3 17.0 17.0 13.6 23.3 14.0 17.9 18.7 15.2 21.4 27.6 19.8 32.4 14.9 30.9 10.2 17.5 19.6 18.6 18.5 16.6 12.2 40.4 10.3 16.2 18.0 13.8 42.7 19.0 9.6 19.5 14.2 20.7 25.4 17.2 12.2 66.2 28.8 16.8 59.6 15.7 21.8 16.2 16.1 66.3 22.5 18.7 15.7 7.4 14.8 47.5 25.0 18.9 46.4 28.0 25.4 18.1 36.9 25.4 25.7 27.7 23.8 22.8 17.2 20.8 21.9 17.1 14.2 13.6 18.7 25.5 10.2 6.7 7.9 17.4 9.8 36.2 66.3 59.6 7.5 21.8 19.7 0.0 40.5 47.0 19.1 4.8 18.5 15.5 95.4 4.8 24.6 15.4 46.2 23.1 16.4 57.6 23.6 52.3 18.1 27.7 40.4 17.5 11.0 51.2 20.1 12.9 11.8 28.8 29.3 18.9 20.8 27.7 23.0 8.8 COPA HEP-COP ENSG00000122218 "Coatomer protein complex subunit alpha" P53621 1 160289273-160343400 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "ER-Golgi transport, Protein transport, Transport" Hormone "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028024 Supported Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Secreted to blood" NA NA 260000 "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA028024: AB_10603787" "unprognostic (1.59e-2)" "prognostic unfavorable (6.54e-4)" "unprognostic (2.77e-2)" "unprognostic (2.34e-2)" "unprognostic (3.54e-2)" "unprognostic (5.41e-3)" "prognostic unfavorable (1.08e-4)" "unprognostic (8.42e-2)" "unprognostic (3.14e-1)" "unprognostic (2.21e-1)" "unprognostic (5.03e-2)" "unprognostic (3.10e-1)" "unprognostic (2.05e-2)" "unprognostic (8.70e-2)" "unprognostic (2.03e-1)" "unprognostic (4.94e-2)" "unprognostic (1.39e-1)" 38.3 32.7 29.2 28.9 41.0 22.9 32.4 43.1 48.4 46.3 34.3 53.2 24.5 38.4 37.0 33.1 28.4 31.5 28.6 38.4 33.3 35.2 36.3 64.3 33.8 26.6 42.7 29.3 36.8 47.8 49.1 57.4 45.1 56.2 35.3 39.9 28.8 42.1 33.9 40.5 28.7 50.3 40.4 42.8 36.6 32.8 21.2 35.8 36.0 42.8 21.0 34.1 30.3 27.5 15.4 31.4 25.1 29.1 18.1 21.2 25.3 28.2 22.2 23.6 22.9 60.8 50.1 27.7 38.9 46.3 33.2 39.2 28.9 19.3 20.8 25.3 59.1 19.1 28.5 27.2 28.0 38.3 23.6 18.4 23.9 30.6 30.4 45.7 29.1 25.1 46.8 17.1 44.3 41.3 41.1 38.9 19.9 22.1 23.3 39.6 20.7 18.7 12.6 25.8 37.2 26.0 16.8 27.1 32.0 27.2 26.8 19.6 24.8 44.0 38.7 41.1 41.4 43.1 39.3 45.8 25.0 19.5 33.5 25.5 38.4 26.6 32.1 32.6 15.2 37.2 25.1 29.1 20.1 17.1 27.3 21.2 15.4 14.3 18.3 31.4 12.1 13.2 15.2 10.8 18.1 27.9 13.3 17.5 25.3 29.2 41.0 43.1 48.4 33.3 35.2 42.7 29.3 56.2 35.8 71.5 41.2 52.3 29.9 25.0 49.9 41.1 48.4 53.5 42.1 38.4 76.6 33.9 11.6 44.6 11.0 42.1 70.4 0.0 43.3 55.4 50.4 56.4 43.9 64.8 46.0 42.9 53.2 53.4 85.0 4.5 65.9 62.1 25.3 31.5 79.0 38.2 46.4 45.6 53.4 38.5 48.0 38.8 52.3 37.9 23.8 27.9 57.9 41.5 60.4 44.0 COPG1 COPG ENSG00000181789 "Coatomer protein complex subunit gamma 1" Q9Y678 3 129249606-129277773 "Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037866, HPA037867, HPA045712" Supported Supported "Nucleoplasm,Golgi apparatus,Cytosol" No No 110000 "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA037866: AB_2675710, HPA037867: AB_10697085, HPA045712: AB_2679428" "unprognostic (8.86e-2)" "unprognostic (2.22e-2)" "unprognostic (4.22e-3)" "unprognostic (1.15e-1)" "unprognostic (1.81e-1)" "unprognostic (9.17e-2)" "prognostic unfavorable (1.22e-6)" "unprognostic (6.66e-3)" "unprognostic (1.05e-1)" "unprognostic (5.64e-2)" "unprognostic (8.90e-3)" "unprognostic (3.29e-1)" "unprognostic (1.23e-3)" "unprognostic (2.10e-1)" "unprognostic (3.20e-1)" "unprognostic (2.99e-1)" "unprognostic (1.60e-1)" 25.2 39.4 21.1 22.2 28.0 20.1 37.3 23.6 50.3 43.3 42.1 24.3 50.6 34.2 27.6 66.5 29.5 24.4 34.5 33.4 24.2 26.7 32.4 72.1 36.5 39.4 23.0 21.6 28.6 75.6 47.6 49.7 49.3 34.9 45.1 45.1 22.4 59.9 45.5 24.1 24.3 32.4 29.1 20.7 29.0 36.3 23.6 16.2 26.9 33.0 22.0 27.7 19.9 24.1 15.7 31.9 34.9 33.0 31.1 31.8 26.0 32.7 16.7 24.4 21.1 57.2 46.4 26.0 53.5 51.1 36.9 46.7 30.6 20.4 18.0 31.2 75.9 30.0 19.8 20.1 31.5 40.2 21.9 8.3 29.9 22.1 49.4 52.1 22.6 32.2 48.4 27.8 29.5 48.7 40.6 33.2 13.9 10.4 43.6 44.4 49.8 13.2 23.1 14.5 48.1 20.5 14.4 22.9 34.8 46.0 27.3 15.2 17.8 41.1 30.7 49.0 28.0 34.0 33.1 44.8 20.1 19.1 42.4 20.6 34.1 16.2 31.6 49.1 17.3 38.5 34.9 26.8 20.2 26.2 33.0 31.8 15.0 23.7 25.7 31.9 15.7 18.5 21.6 21.3 31.1 29.7 29.4 23.6 26.0 21.1 28.0 23.6 50.3 24.2 26.7 23.0 21.6 34.9 16.2 14.9 29.8 27.4 13.9 7.8 8.7 19.3 17.8 16.0 18.2 26.2 3.9 52.4 36.5 39.6 7.8 19.4 69.2 46.7 40.7 53.3 25.8 24.8 14.0 53.3 34.3 4.8 37.1 35.6 31.0 3.1 38.0 19.0 21.9 44.1 67.9 14.2 35.7 37.4 29.4 28.8 7.5 19.4 17.3 21.1 16.4 8.9 60.4 20.1 38.2 17.5 COPRS "C17orf79, COPR5, HSA272196, TTP1" ENSG00000172301 "Coordinator of PRMT5 and differentiation stimulator" Q9NQ92 17 31851864-31859337 "Predicted intracellular proteins" "Myogenesis, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 410.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA052552 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA052552: AB_2681868" "unprognostic (1.65e-2)" "unprognostic (4.88e-2)" "unprognostic (2.46e-1)" "unprognostic (4.01e-3)" "unprognostic (3.12e-2)" "unprognostic (1.12e-2)" "prognostic unfavorable (3.69e-4)" "unprognostic (6.88e-2)" "unprognostic (3.10e-1)" "unprognostic (4.44e-2)" "unprognostic (5.28e-3)" "unprognostic (1.01e-2)" "unprognostic (1.19e-3)" "unprognostic (1.02e-1)" "unprognostic (1.35e-1)" "unprognostic (1.48e-1)" "unprognostic (3.11e-2)" 20.9 19.0 32.6 9.7 31.0 6.3 30.3 23.0 37.6 15.3 24.2 11.8 15.6 8.0 15.2 57.3 10.5 24.9 14.9 24.7 28.2 35.5 22.7 31.0 12.3 9.2 29.7 31.3 24.3 20.7 12.2 18.9 9.4 23.9 27.5 13.6 16.0 14.6 23.5 19.9 7.8 7.9 21.2 16.0 8.1 14.1 75.0 14.4 2.6 28.1 11.2 12.7 16.1 18.5 5.8 4.5 3.5 3.5 0.0 3.0 0.4 21.0 27.8 14.0 14.3 22.9 22.1 9.8 23.7 29.8 27.2 27.8 17.4 5.7 12.0 13.3 28.3 53.7 12.7 24.6 14.2 30.9 4.1 36.9 3.3 16.0 20.4 23.4 11.2 9.6 14.1 18.7 36.6 20.1 29.7 14.5 16.1 16.3 10.0 29.6 18.3 16.6 35.6 10.6 13.7 14.0 13.3 26.0 21.7 15.9 13.1 12.6 9.8 14.0 6.8 21.6 12.7 22.3 12.0 8.1 71.6 19.4 25.5 32.8 17.1 15.9 12.1 37.4 10.4 9.6 3.5 3.5 0.0 1.1 3.3 3.0 3.8 1.1 0.2 4.5 5.8 0.6 0.7 1.2 0.0 1.6 1.8 1.5 0.4 32.6 31.0 23.0 37.6 28.2 35.5 29.7 31.3 23.9 14.4 20.8 8.8 21.9 52.7 30.6 43.8 64.8 45.9 28.1 9.1 82.0 9.8 25.3 190.6 93.7 161.6 50.8 5.1 0.0 70.1 45.2 52.1 108.4 3.5 85.5 75.8 25.4 18.9 44.2 26.0 212.9 57.8 35.0 55.6 70.3 14.8 79.2 64.6 3.5 61.2 173.3 30.2 19.4 62.1 410.0 65.8 27.7 22.9 10.1 19.7 32.5 COPS3 "CSN3, SGN3" ENSG00000141030 "COP9 signalosome subunit 3" Q9UNS2 17 17246820-17281293 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Spermatocytes: 228.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021997, HPA050557" Approved Supported Nucleoplasm,Cytosol NA NA 29000 Nucleoplasm Cytosol "HPA021997: AB_1847152, HPA050557: AB_2681176" "unprognostic (3.35e-2)" "unprognostic (3.98e-3)" "unprognostic (1.84e-2)" "unprognostic (6.29e-2)" "unprognostic (6.39e-2)" "unprognostic (1.33e-1)" "unprognostic (2.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.91e-3)" "unprognostic (2.11e-2)" "unprognostic (6.37e-3)" "prognostic unfavorable (1.56e-4)" "prognostic unfavorable (8.65e-5)" "unprognostic (2.04e-1)" "unprognostic (2.48e-1)" "unprognostic (2.40e-1)" "unprognostic (3.03e-3)" 15.2 15.2 16.3 15.7 21.9 51.9 16.3 20.8 24.7 15.4 15.4 15.7 14.9 13.9 14.3 14.1 21.0 12.1 10.0 22.7 17.5 18.8 16.1 21.0 11.7 18.7 17.4 15.2 16.0 26.2 17.6 21.8 21.7 26.7 16.5 17.1 11.9 17.1 15.7 69.4 15.7 13.3 16.9 15.9 14.3 15.8 39.5 11.8 31.4 15.2 24.4 21.9 16.1 14.0 28.1 45.2 37.7 35.8 32.3 33.0 38.2 35.5 33.4 26.2 22.7 12.6 17.2 16.0 27.7 17.0 40.1 32.3 54.7 13.3 49.2 22.5 22.0 18.0 26.0 35.5 27.5 45.6 19.6 50.5 34.3 25.9 23.5 21.5 29.4 39.1 15.5 20.9 27.8 27.9 12.0 23.2 28.7 27.9 18.3 25.3 35.7 54.1 37.3 23.4 39.7 21.5 40.8 46.8 25.6 16.1 15.6 20.5 17.9 24.3 11.3 22.0 78.7 17.0 19.8 16.6 24.4 27.4 44.1 47.3 14.7 19.0 26.3 21.2 29.3 24.6 20.8 30.5 29.4 27.6 35.8 31.9 27.2 32.2 31.6 45.2 28.1 32.2 30.5 37.7 32.3 34.6 21.8 33.0 38.2 16.3 21.9 20.8 24.7 17.5 18.8 17.4 15.2 26.7 11.8 29.8 15.5 44.7 36.9 48.1 21.8 44.5 22.9 17.4 23.9 14.0 13.7 80.5 28.2 39.9 106.3 32.3 14.2 46.7 44.5 69.1 35.2 30.0 39.3 20.8 57.9 23.8 36.0 25.8 31.1 49.2 36.8 45.3 33.7 49.5 34.2 38.1 31.1 11.5 35.7 27.3 28.6 19.4 42.4 228.3 92.9 41.7 87.3 52.2 37.2 29.3 COPS5 "CSN5, JAB1, MOV-34, SGN5" ENSG00000121022 "COP9 signalosome subunit 5" Q92905 8 67043079-67083783 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 275.9;Late spermatids: 320.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004242, HPA004845, HPA051531" Supported Enhanced Nucleoplasm NA NA 27000 Nucleoplasm "CAB004242: AB_627835, HPA004845: AB_1078557, HPA051531: AB_2681522" "unprognostic (1.90e-3)" "unprognostic (1.35e-1)" "unprognostic (1.61e-1)" "unprognostic (2.85e-3)" "unprognostic (2.53e-1)" "unprognostic (4.16e-2)" "unprognostic (2.04e-3)" "unprognostic (1.39e-1)" "unprognostic (2.15e-2)" "unprognostic (4.48e-2)" "unprognostic (4.74e-3)" "unprognostic (1.96e-2)" "unprognostic (1.90e-3)" "unprognostic (2.88e-2)" "unprognostic (1.76e-1)" "unprognostic (2.58e-1)" "unprognostic (1.18e-2)" 20.2 26.3 29.4 19.6 28.6 16.2 28.1 28.5 40.3 18.0 21.7 15.6 20.2 22.0 17.6 21.7 24.0 17.7 15.5 46.8 27.6 27.5 27.4 33.7 16.8 17.5 31.8 29.9 17.0 20.7 23.3 21.7 24.3 33.7 18.3 25.5 9.9 19.6 18.9 64.0 16.8 22.5 23.3 39.2 16.1 20.7 27.4 31.3 19.6 18.5 29.2 22.4 18.3 16.5 20.7 35.1 33.7 30.0 26.5 28.1 22.3 28.8 27.4 23.3 21.3 24.5 26.2 18.5 25.4 20.9 35.3 31.9 17.7 35.6 26.8 11.7 26.2 25.5 24.2 31.2 28.0 39.0 25.7 26.9 38.1 27.5 23.8 23.8 24.0 23.1 23.8 36.0 28.8 37.2 27.3 34.4 28.3 45.0 18.6 31.6 26.8 42.3 42.2 30.9 60.8 31.5 27.2 16.6 21.1 37.4 25.7 14.1 19.5 14.6 28.3 24.6 21.5 46.6 24.8 25.4 18.0 22.2 21.7 19.9 23.4 29.8 35.7 26.2 27.4 24.5 26.0 28.6 33.7 20.8 30.0 21.7 20.7 20.1 23.1 35.1 17.5 21.6 19.1 21.2 26.5 28.3 18.4 28.1 22.3 29.4 28.6 28.5 40.3 27.6 27.5 31.8 29.9 33.7 31.3 20.8 21.3 38.7 36.8 43.8 32.5 99.1 43.3 26.8 29.6 29.6 31.4 115.4 74.6 65.8 275.9 33.7 37.6 0.0 52.3 84.4 39.7 44.8 34.7 33.9 69.9 23.8 32.8 31.9 28.8 320.8 40.0 37.7 27.0 55.9 34.2 45.4 48.3 45.6 48.1 56.1 44.9 32.3 31.6 126.7 59.2 41.5 106.9 39.5 48.7 48.1 COPS6 "CSN6, MOV34-34KD" ENSG00000168090 "COP9 signalosome subunit 6" Q7L5N1 7 100088954-100092200 "Enzymes, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044315 Approved Supported Nucleoplasm "Intracellular and membrane" NA NA 58000 Nucleoplasm "HPA044315: AB_10959750" "unprognostic (1.48e-2)" "unprognostic (2.43e-2)" "unprognostic (6.56e-3)" "unprognostic (1.38e-1)" "unprognostic (5.84e-2)" "unprognostic (2.09e-2)" "unprognostic (3.62e-3)" "unprognostic (2.93e-2)" "unprognostic (2.00e-1)" "unprognostic (2.45e-2)" "unprognostic (4.96e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (6.72e-4)" "unprognostic (1.20e-1)" "unprognostic (3.58e-2)" "unprognostic (8.57e-2)" "unprognostic (8.77e-2)" 25.4 30.0 37.7 20.2 50.6 19.7 25.6 31.5 43.3 32.5 30.4 26.5 15.1 19.3 31.0 39.8 33.4 33.7 32.4 47.2 31.5 32.1 31.7 41.2 20.1 30.4 33.3 32.6 30.8 42.8 38.1 28.2 29.1 34.1 27.4 26.6 25.0 28.3 35.7 53.1 23.4 19.2 45.2 30.1 22.7 26.9 25.5 30.8 29.4 27.6 21.6 25.8 26.7 24.8 53.4 67.6 58.9 64.0 48.2 69.4 45.3 32.3 46.2 27.7 32.9 24.4 29.2 17.6 29.4 45.3 49.3 36.3 37.7 30.7 22.4 38.1 48.2 55.1 24.8 31.3 49.8 50.0 22.3 49.1 19.1 45.8 29.0 51.1 21.6 19.9 28.8 33.1 53.1 56.8 33.0 67.4 34.8 27.4 32.4 58.0 80.6 47.8 32.2 25.0 47.7 55.5 22.9 46.1 53.4 39.2 30.5 43.5 32.3 30.4 60.2 22.3 38.0 24.8 21.4 35.3 47.6 43.4 56.9 51.7 24.0 26.6 45.9 36.0 29.5 70.2 58.9 61.9 51.7 61.1 64.0 61.2 53.4 61.3 57.8 67.6 49.8 48.3 53.9 24.1 48.2 57.4 50.2 69.4 45.3 37.7 50.6 31.5 43.3 31.5 32.1 33.3 32.6 34.1 30.8 47.6 36.9 81.5 102.7 98.2 102.2 140.2 79.0 83.0 60.3 82.0 49.1 166.8 179.1 109.3 59.3 92.0 58.6 46.7 99.3 110.5 106.3 89.3 89.9 52.9 111.6 90.6 72.3 79.8 61.4 119.0 118.2 67.5 148.5 112.8 58.6 129.0 94.7 59.6 117.8 164.9 114.4 97.0 134.0 70.6 115.8 87.7 115.3 82.8 79.4 85.2 COPS7A CSN7A ENSG00000111652 "COP9 signalosome subunit 7A" Q9UBW8 12 6723741-6731875 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026915 Supported Supported Nucleoplasm,Cytosol NA NA 66000 Nucleoplasm Cytosol "HPA026915: AB_1847156" "unprognostic (3.50e-1)" "unprognostic (1.33e-2)" "unprognostic (3.95e-3)" "unprognostic (3.26e-1)" "unprognostic (2.85e-2)" "unprognostic (1.96e-3)" "unprognostic (3.91e-2)" "unprognostic (4.26e-2)" "unprognostic (1.76e-1)" "unprognostic (8.24e-3)" "unprognostic (1.46e-1)" "unprognostic (1.34e-2)" "unprognostic (3.61e-3)" "unprognostic (1.95e-1)" "unprognostic (1.81e-1)" "unprognostic (1.26e-1)" "unprognostic (2.27e-1)" 24.1 26.0 31.6 16.6 38.1 8.8 20.5 29.6 59.5 18.2 18.5 25.0 14.1 15.8 20.1 27.9 29.1 25.8 20.1 42.2 29.6 27.9 26.2 29.6 18.8 14.6 31.6 36.9 20.1 23.1 33.9 24.3 25.4 45.3 24.7 17.5 23.8 22.1 24.5 44.6 20.9 14.1 24.2 22.5 16.2 18.1 14.9 13.9 9.2 26.1 29.6 17.6 22.7 17.6 13.7 27.1 35.9 28.4 11.5 16.5 17.8 19.0 20.2 9.7 9.5 28.9 34.6 23.7 23.6 30.8 23.8 24.2 14.1 26.7 13.3 10.2 31.4 13.9 15.4 13.2 24.0 22.9 18.1 14.6 12.4 13.9 17.8 25.0 12.9 7.6 32.1 23.3 28.1 56.0 29.2 18.5 8.1 8.8 5.4 33.4 15.4 7.5 8.1 26.2 26.1 18.6 5.1 19.9 13.1 20.2 19.2 5.5 13.1 15.5 19.7 25.9 24.8 8.4 18.8 19.0 25.4 13.3 22.4 22.7 6.1 6.6 10.7 43.3 16.7 27.8 29.4 23.1 35.9 15.9 28.4 16.5 11.3 13.7 14.2 27.1 13.7 14.2 14.0 18.7 11.5 22.5 16.8 12.1 17.8 31.6 38.1 29.6 59.5 29.6 27.9 31.6 36.9 45.3 13.9 14.9 13.7 11.2 25.7 12.4 36.3 32.7 15.3 20.1 13.6 22.7 5.9 63.6 56.3 39.4 3.2 19.1 15.8 0.0 43.6 48.1 31.9 27.1 16.1 22.1 54.8 28.6 12.1 22.1 21.6 5.1 21.3 20.6 11.8 61.3 17.1 41.3 38.6 17.5 24.1 38.4 19.6 38.8 24.7 18.1 34.3 12.2 49.4 13.8 17.8 22.0 COPS7B CSN7B ENSG00000144524 "COP9 signalosome subunit 7B" Q9H9Q2 2 231781671-231809254 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 59.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034675, HPA034676" Uncertain Supported Nucleoplasm NA NA 33000 Nucleoplasm "HPA034675: AB_10696360, HPA034676: AB_2674274" "unprognostic (3.21e-1)" "unprognostic (1.59e-1)" "unprognostic (6.25e-3)" "unprognostic (3.59e-3)" "unprognostic (3.50e-1)" "unprognostic (4.77e-2)" "prognostic unfavorable (8.37e-6)" "unprognostic (1.19e-1)" "unprognostic (4.81e-2)" "unprognostic (1.89e-1)" "unprognostic (5.77e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (1.50e-6)" "unprognostic (2.37e-2)" "unprognostic (1.39e-1)" "unprognostic (6.64e-2)" "unprognostic (1.55e-3)" 11.9 19.4 17.4 13.0 25.2 12.4 14.3 20.8 35.0 16.7 17.0 31.0 19.6 8.7 18.4 13.9 15.9 19.6 11.1 13.2 17.3 14.2 14.6 16.9 14.4 20.1 29.7 18.2 18.0 14.1 29.3 40.9 18.5 23.4 18.3 19.3 17.5 17.7 19.9 15.3 20.8 15.8 21.2 21.7 21.8 18.5 24.5 24.5 19.0 17.8 11.8 26.3 15.9 16.9 13.8 12.5 10.3 12.3 15.4 14.2 10.8 11.9 10.6 15.4 17.2 11.7 14.7 17.4 10.0 9.3 16.3 19.5 17.9 13.6 11.6 10.9 12.1 18.8 9.5 23.1 18.0 24.4 19.6 21.6 22.1 9.5 24.9 12.5 23.7 12.9 10.1 18.5 18.2 13.3 14.6 18.5 28.7 24.4 9.6 14.8 15.6 22.4 19.5 24.6 11.7 11.2 26.3 19.1 12.6 12.3 10.6 16.9 14.7 9.5 7.9 17.5 24.2 10.2 19.5 11.9 11.8 11.4 13.0 13.3 15.5 12.6 32.4 11.4 17.0 11.9 10.3 8.2 4.4 13.1 9.4 12.7 13.8 10.3 11.9 12.5 13.0 14.2 10.0 2.0 15.4 12.3 9.7 10.0 10.8 17.4 25.2 20.8 35.0 17.3 14.2 29.7 18.2 23.4 24.5 14.9 9.9 9.7 11.2 11.0 13.1 6.4 5.1 1.4 10.3 15.7 9.8 19.8 11.6 12.0 38.1 8.4 8.6 0.0 8.2 16.7 10.3 10.5 5.7 6.0 13.1 12.7 22.3 16.0 12.1 10.8 16.7 8.9 11.8 13.6 13.8 8.5 10.3 7.0 19.1 7.9 16.3 12.9 10.3 36.2 59.4 7.0 14.9 16.6 12.9 10.5 COPS8 "COP9, CSN8, MGC1297, SGN8" ENSG00000198612 "COP9 signalosome subunit 8" Q99627 2 237085312-237100466 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 79.4;U-138 MG: 94.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036485 Uncertain Supported Nucleoplasm,Cytosol NA NA 110000 Nucleoplasm Cytosol "HPA036485: AB_10670720" "unprognostic (8.61e-2)" "unprognostic (1.20e-1)" "unprognostic (8.74e-2)" "unprognostic (1.07e-3)" "unprognostic (1.20e-1)" "unprognostic (3.54e-3)" "prognostic unfavorable (4.70e-5)" "unprognostic (1.34e-2)" "unprognostic (8.03e-2)" "unprognostic (2.04e-1)" "unprognostic (6.85e-2)" "unprognostic (2.70e-1)" "unprognostic (2.41e-2)" "unprognostic (7.36e-3)" "unprognostic (2.30e-1)" "unprognostic (1.40e-1)" "unprognostic (8.82e-2)" 20.1 23.1 25.2 15.6 37.0 15.7 17.9 15.2 33.8 20.6 14.0 16.7 8.6 7.7 20.9 18.3 12.5 18.0 19.9 37.8 31.7 27.9 24.2 15.6 12.3 13.5 23.6 25.8 23.7 10.8 18.2 15.0 19.8 28.1 16.6 11.7 18.6 12.7 18.1 64.5 12.3 9.7 25.4 21.3 10.4 13.5 20.8 15.4 14.8 17.5 20.3 14.5 18.0 13.2 32.4 26.9 26.1 25.9 32.2 36.2 31.7 9.6 8.2 17.9 8.9 51.6 40.8 11.9 17.0 17.0 17.5 19.5 5.4 9.8 6.7 6.5 18.5 27.7 7.3 17.6 23.2 24.6 15.6 11.3 9.7 10.5 18.9 35.6 12.5 5.8 67.3 26.8 17.6 79.4 21.8 20.5 14.4 13.4 6.4 55.4 9.2 15.4 12.9 15.9 10.5 12.0 11.8 21.4 13.3 21.6 7.8 8.8 15.2 10.2 8.8 25.4 15.0 10.2 10.3 21.5 94.0 15.8 18.4 18.4 12.4 10.3 21.3 29.4 7.7 23.7 21.9 22.8 26.1 29.7 25.0 36.2 32.4 31.7 33.8 26.9 26.9 30.8 32.1 7.0 32.2 25.9 19.4 33.1 31.7 25.2 37.0 15.2 32.3 31.7 27.9 23.6 25.8 28.1 15.4 29.8 19.5 35.0 43.5 67.0 53.6 97.2 33.1 32.1 15.9 31.4 25.5 54.6 121.0 57.0 21.2 51.6 12.7 0.0 35.9 64.8 116.7 38.2 42.6 21.7 53.3 33.4 20.2 38.1 30.8 17.3 67.3 28.8 119.8 55.1 14.7 79.9 40.5 17.5 71.1 72.0 46.0 58.2 89.6 85.8 92.6 56.3 37.2 45.7 18.5 34.8 COPS9 "CSNAP, MYEOV2" ENSG00000172428 "COP9 signalosome subunit 9" Q8WXC6 2 240126563-240136807 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 422.7;Exocrine glandular cells: 329.4;Hofbauer cells: 279.6;Pancreatic endocrine cells: 292.2;Proximal tubular cells: 474.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA044845 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA044845: AB_10962975" "unprognostic (6.05e-3)" "unprognostic (1.44e-1)" "unprognostic (7.22e-2)" "unprognostic (1.04e-1)" "unprognostic (1.04e-1)" "unprognostic (3.72e-2)" "unprognostic (1.72e-3)" "unprognostic (5.64e-2)" "unprognostic (1.79e-2)" "unprognostic (1.26e-1)" "unprognostic (1.25e-3)" "unprognostic (9.02e-2)" "unprognostic (3.02e-1)" "unprognostic (3.71e-1)" "unprognostic (2.26e-2)" "unprognostic (3.03e-1)" "unprognostic (4.37e-2)" 31.9 29.1 81.6 20.6 73.2 24.0 40.9 22.6 61.6 29.1 27.6 22.7 20.5 25.6 17.2 53.2 34.5 23.5 25.4 62.3 75.8 44.7 30.5 23.5 17.8 26.7 64.3 24.3 23.2 64.3 8.9 27.6 17.6 32.9 25.9 18.9 19.0 43.3 26.5 86.9 20.6 24.5 21.1 52.6 22.6 25.8 18.8 25.9 26.5 34.7 41.6 19.8 23.5 20.9 68.2 79.9 90.7 67.7 52.4 82.0 79.9 27.2 36.9 29.1 30.4 40.3 33.0 26.8 39.4 27.6 25.9 33.2 26.7 24.5 7.5 11.9 35.9 41.3 21.9 25.7 36.5 17.9 31.9 94.9 22.6 38.0 82.7 32.1 22.6 21.3 38.7 30.2 19.3 24.1 24.0 37.9 38.6 26.0 16.4 37.6 58.8 36.2 70.6 44.3 34.3 80.7 28.6 39.1 23.5 32.0 47.0 33.8 33.9 20.7 28.2 42.1 23.5 26.0 44.2 30.6 34.3 38.3 43.6 37.4 33.6 28.5 38.0 42.7 26.9 33.7 90.7 67.2 87.6 68.6 66.6 68.0 68.2 71.2 70.1 62.6 52.8 62.6 70.5 24.1 52.4 67.7 79.9 82.0 79.9 81.6 73.2 22.6 61.6 75.8 44.7 64.3 24.3 32.9 25.9 119.1 114.6 0.0 0.0 0.0 0.0 0.0 0.0 123.1 102.4 261.7 0.0 149.7 422.7 189.2 0.0 0.0 0.0 0.0 329.4 162.4 0.0 0.0 57.0 0.0 279.6 0.0 0.0 0.0 0.0 0.0 0.0 87.4 0.0 253.3 0.0 0.0 292.2 0.0 0.0 474.2 0.0 0.0 0.0 0.0 0.0 0.0 110.6 0.0 0.0 0.0 COQ3 bA9819.1 ENSG00000132423 "Coenzyme Q3, methyltransferase" Q9NZJ6 6 99369400-99394204 "Enzymes, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 37.1;Distal tubular cells: 28.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031273, HPA031274" Enhanced Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA031273: AB_10611107, HPA031274: AB_10602176" "unprognostic (1.81e-2)" "unprognostic (2.69e-2)" "unprognostic (1.45e-2)" "unprognostic (4.62e-2)" "unprognostic (2.41e-2)" "unprognostic (2.16e-2)" "unprognostic (1.48e-3)" "unprognostic (1.76e-1)" "unprognostic (3.40e-1)" "unprognostic (8.77e-2)" "unprognostic (9.78e-2)" "unprognostic (1.09e-1)" "prognostic favorable (6.86e-5)" "unprognostic (4.61e-2)" "unprognostic (1.81e-1)" "unprognostic (5.45e-2)" "unprognostic (1.08e-1)" 5.2 7.8 8.6 4.2 10.8 3.2 7.5 13.6 16.3 4.5 8.9 4.5 4.3 6.9 4.3 6.8 8.2 4.5 3.0 21.7 8.2 7.5 10.2 12.4 2.9 7.1 6.9 12.0 6.0 5.7 11.6 7.4 2.5 9.8 6.8 11.0 7.3 11.7 7.6 28.0 5.8 6.3 6.6 4.6 4.8 5.2 2.3 6.0 4.1 4.3 16.8 7.0 7.5 4.6 6.6 8.0 9.4 7.4 9.7 12.5 5.3 12.0 6.9 8.4 11.9 5.5 6.2 11.6 10.4 6.5 15.8 18.3 9.6 5.2 11.8 7.0 7.8 10.2 11.2 14.0 16.3 19.3 12.5 17.9 14.4 9.5 10.3 7.2 20.8 5.7 3.9 10.0 9.3 9.4 3.5 9.6 14.6 21.9 9.0 8.4 11.9 9.1 17.4 10.2 11.9 13.4 4.5 8.6 15.7 12.4 10.5 13.2 7.0 7.2 11.2 13.6 5.9 13.7 13.7 3.4 6.9 10.1 10.6 15.8 3.2 5.9 18.6 8.8 20.2 10.1 9.4 3.3 2.4 6.0 7.4 6.8 6.6 7.6 9.5 8.0 3.1 12.5 9.5 0.5 9.7 6.3 5.2 5.5 5.3 8.6 10.8 13.6 16.3 8.2 7.5 6.9 12.0 9.8 6.0 3.0 3.0 6.1 8.0 3.9 7.1 37.1 7.6 0.0 5.7 3.5 0.0 13.0 28.2 10.0 0.4 4.5 3.2 0.0 9.3 11.0 4.1 2.0 1.1 7.8 5.7 6.4 0.0 3.7 0.6 0.0 7.5 3.3 5.0 1.8 6.5 10.4 7.0 6.0 5.6 8.8 7.8 6.5 8.2 3.4 12.4 3.8 5.3 4.4 9.0 3.1 COQ7 "CAT5, CLK-1" ENSG00000167186 "Coenzyme Q7, hydroxylase" Q99807 16 19067599-19080095 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ubiquinone biosynthesis" "Monooxygenase, Oxidoreductase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "neutrophil: 45.2" "Lineage enriched" "Detected in all" 8 "granulocytes: 45.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067252, HPA071922" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA067252: AB_2685813, HPA071922: AB_2686473" "unprognostic (1.37e-1)" "unprognostic (6.89e-3)" "unprognostic (1.59e-2)" "unprognostic (6.08e-2)" "unprognostic (2.44e-2)" "unprognostic (9.03e-2)" "unprognostic (1.31e-1)" "unprognostic (4.42e-2)" "unprognostic (1.15e-1)" "unprognostic (7.27e-3)" "unprognostic (2.15e-1)" "unprognostic (8.32e-2)" "prognostic favorable (8.23e-12)" "unprognostic (2.19e-1)" "unprognostic (2.76e-1)" "unprognostic (3.14e-2)" "unprognostic (5.27e-2)" 9.1 14.2 13.5 7.8 12.9 4.0 12.6 11.3 18.5 11.2 12.8 12.8 15.2 11.4 14.7 17.4 11.9 15.0 13.9 21.1 12.1 13.0 13.5 11.4 14.6 11.1 12.2 12.0 19.4 12.2 23.7 15.1 9.4 12.9 17.1 12.5 16.5 11.3 14.7 37.3 7.5 12.1 11.1 12.4 8.7 11.8 34.7 10.7 9.4 15.3 24.7 7.6 12.1 10.0 5.1 5.3 45.2 4.0 4.1 4.4 1.8 12.6 13.6 11.8 6.9 6.7 7.1 9.9 7.4 6.1 10.2 10.5 8.6 10.6 9.6 36.1 5.7 11.0 13.4 16.4 9.3 7.4 8.2 16.6 5.1 12.5 26.4 8.3 12.2 11.3 5.9 8.2 9.4 6.9 8.4 8.2 11.6 14.0 9.0 7.1 22.7 12.7 9.9 9.0 4.9 7.3 15.6 13.1 12.3 8.8 8.5 17.2 9.8 6.9 15.3 8.6 6.0 14.1 16.6 8.9 10.8 6.3 7.9 10.6 8.4 13.6 10.5 11.6 7.1 6.9 10.8 4.0 5.8 3.5 3.5 3.3 5.1 3.2 3.1 4.3 5.0 4.4 3.9 45.2 4.1 3.9 5.3 2.0 1.8 13.5 12.9 11.3 18.5 12.1 13.0 12.2 12.0 12.9 10.7 14.9 9.3 38.9 25.6 9.7 30.8 19.0 22.9 21.4 9.1 15.7 37.3 18.0 38.1 20.5 10.9 11.3 47.3 0.0 15.9 14.6 13.0 14.3 25.3 8.9 20.1 19.1 23.1 13.5 18.7 6.2 17.3 15.3 10.1 9.0 30.7 39.8 11.7 24.3 13.1 19.5 53.8 19.4 15.1 77.6 54.5 10.8 26.9 33.1 29.9 22.2 CORO7-PAM16 ENSG00000103426 "CORO7-PAM16 readthrough" 16 4340251-4420494 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Ciliated cells: 1.4;Club cells: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 1.7;HDLM-2: 2.4;THP-1: 1.9;TIME: 1.5" "HPA041657, HPA053586, HPA062721" Uncertain Approved Nucleoplasm,Microtubules,Mitochondria NA NA "Nucleoplasm, Mitochondria" Microtubules "HPA041657: AB_10796351, HPA053586: AB_2682201, HPA062721: AB_2684849" "unprognostic (2.95e-2)" "unprognostic (2.46e-1)" "unprognostic (1.44e-1)" "unprognostic (2.46e-1)" "unprognostic (2.11e-1)" "unprognostic (1.24e-2)" "unprognostic (2.11e-4)" "unprognostic (4.39e-2)" "unprognostic (9.83e-3)" "unprognostic (1.20e-1)" "unprognostic (8.75e-3)" "unprognostic (1.05e-1)" "unprognostic (1.38e-1)" "unprognostic (1.79e-2)" "unprognostic (2.59e-2)" "unprognostic (2.19e-1)" "unprognostic (3.85e-1)" 2.4 3.4 5.4 5.2 7.4 6.7 2.0 3.0 6.0 2.0 2.5 10.0 0.6 3.2 2.2 2.4 2.2 2.9 3.1 2.2 4.8 4.1 2.0 2.9 3.4 11.2 10.9 3.2 2.0 2.0 2.0 1.7 2.4 4.1 2.2 2.0 1.1 2.0 3.0 2.4 3.1 2.5 2.2 10.1 4.5 2.5 4.3 9.9 4.7 2.0 1.2 4.1 2.8 1.8 0.4 0.6 2.7 1.3 0.5 0.8 1.3 0.0 0.0 0.0 0.4 0.0 0.3 0.8 0.2 0.4 0.0 0.0 1.7 0.3 0.0 0.2 0.0 0.3 0.9 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.3 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.7 0.0 0.0 0.7 0.0 0.5 0.0 0.2 1.4 0.2 0.7 0.7 0.0 0.2 0.2 0.6 0.0 0.0 0.0 0.2 0.0 1.9 1.5 0.0 0.0 0.6 0.1 0.6 1.2 0.1 0.0 0.1 0.0 0.0 1.3 0.9 0.8 0.7 0.7 0.3 0.4 0.3 0.6 0.4 0.3 0.3 2.7 0.5 0.4 0.3 0.3 1.3 5.4 7.4 3.0 6.0 4.8 4.1 10.9 3.2 4.1 9.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 COX6B2 "COXVIB2, CT59, FLJ32865" ENSG00000160471 "Cytochrome c oxidase subunit 6B2" Q6YFQ2 19 55349306-55354814 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 66.5" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 23.6;Late spermatids: 19.1;Spermatocytes: 77.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 5.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "CAPAN-2: 22.6;SCLC-21H: 9.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA035014 Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA035014: AB_10601261" "unprognostic (7.43e-3)" "unprognostic (8.72e-2)" "unprognostic (1.42e-1)" "unprognostic (5.75e-2)" "unprognostic (2.59e-2)" "unprognostic (9.23e-3)" "unprognostic (1.88e-2)" "unprognostic (6.45e-3)" "unprognostic (1.02e-1)" "unprognostic (6.82e-2)" "prognostic unfavorable (9.70e-5)" "unprognostic (8.11e-2)" "unprognostic (1.81e-6)" "unprognostic (9.91e-2)" "unprognostic (1.47e-1)" "unprognostic (1.02e-2)" "unprognostic (2.02e-1)" 0.3 0.0 0.4 0.6 0.6 0.7 0.5 0.3 0.6 0.2 3.3 0.2 0.2 0.0 0.2 0.8 0.5 0.4 0.2 0.2 0.2 0.5 0.5 0.2 0.2 0.6 0.4 0.2 0.4 0.2 0.0 0.4 0.2 0.6 0.2 3.5 0.7 0.6 0.2 0.2 1.8 0.2 0.2 0.7 0.2 0.0 66.5 0.3 0.2 0.2 0.2 1.2 0.2 0.4 1.3 1.4 5.7 1.0 1.6 0.9 0.8 2.7 0.4 0.1 0.1 0.0 0.0 0.2 0.4 0.1 0.3 0.5 0.1 22.6 0.1 0.2 0.2 0.3 1.8 0.7 0.2 0.2 0.8 0.7 0.0 1.7 0.1 0.3 0.2 1.8 0.2 2.5 0.4 0.5 1.7 0.0 0.1 0.4 0.2 0.0 0.5 0.1 0.2 0.6 2.3 0.5 0.1 0.0 0.2 0.0 0.4 9.7 0.3 0.3 0.1 0.0 0.6 0.4 0.0 0.4 0.3 0.5 0.1 0.2 1.5 1.2 0.1 0.1 0.3 0.2 1.9 1.0 1.0 0.8 0.5 0.5 0.7 0.7 0.6 0.3 1.3 0.7 0.9 5.7 1.6 0.7 1.4 0.6 0.8 0.4 0.6 0.3 0.6 0.2 0.5 0.4 0.2 0.6 0.3 0.0 0.3 0.0 0.6 0.5 2.1 0.4 0.0 0.0 0.0 0.0 3.9 0.5 0.0 0.6 23.6 0.0 3.2 0.0 0.6 0.2 0.4 0.2 0.0 0.0 0.1 3.2 1.2 0.0 0.0 19.1 0.6 0.0 0.0 0.0 1.3 0.9 5.6 3.5 0.0 0.0 4.1 0.0 0.0 77.8 1.3 0.4 0.3 0.0 4.4 2.5 CPA3 ENSG00000163751 "Carboxypeptidase A3" P15088 3 148865256-148897196 "Enzymes, Plasma proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 111.7" "Cell type enriched" "Detected in some" 15 "granulocytes: 4120.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 1118 "basophil: 111.7" "Lineage enriched" "Detected in single" 1118 "granulocytes: 111.7" "Cell line enriched" "Detected in some" 43 "HEL: 81.5" "Low region specificity" "Detected in single" "HPA006479, HPA008689, CAB020712" Enhanced Approved "Nucleoplasm,Golgi apparatus" "Secreted to blood" NA NA "Golgi apparatus" Nucleoplasm "CAB020712: , HPA006479: AB_1078396, HPA008689: AB_1846009" "unprognostic (1.07e-1)" "unprognostic (3.03e-2)" "unprognostic (2.66e-3)" "unprognostic (9.13e-3)" "unprognostic (3.50e-1)" "unprognostic (1.18e-3)" "unprognostic (2.47e-1)" "unprognostic (1.57e-2)" "unprognostic (2.14e-1)" "unprognostic (9.51e-2)" "unprognostic (1.89e-1)" "unprognostic (5.30e-3)" "unprognostic (3.50e-3)" "unprognostic (5.18e-3)" "unprognostic (3.24e-2)" "unprognostic (1.74e-1)" "unprognostic (1.69e-3)" 12.4 0.6 0.4 12.0 0.4 5.6 6.2 0.4 0.5 25.4 14.1 0.8 4.4 7.1 14.1 21.2 16.5 3.7 50.9 4.5 0.4 0.2 5.8 2.8 37.3 15.2 0.4 0.4 2.0 7.2 0.7 0.8 1.3 0.5 37.3 16.4 8.5 8.8 5.8 1.4 12.7 20.2 24.3 0.4 1.0 13.7 7.1 0.4 3.6 1.4 9.9 7.1 14.0 8.9 0.0 0.0 111.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 81.5 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.1 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 111.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.4 0.4 0.5 0.4 0.2 0.4 0.4 0.5 0.4 29.8 269.3 0.0 0.2 1.4 0.0 0.2 0.0 16.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.6 0.1 4120.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.1 0.0 0.0 0.0 0.3 CPA4 CPA3 ENSG00000128510 "Carboxypeptidase A4" Q9UI42 7 130293134-130324180 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 18.0;skin 1: 41.0" "Cell type enhanced" "Detected in some" 18 "Basal keratinocytes: 15.8;Exocrine glandular cells: 45.1;Pancreatic endocrine cells: 12.8;Suprabasal keratinocytes: 27.0" "Cancer enhanced" "Detected in many" "cervical cancer: 10.0;head and neck cancer: 9.8" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 29.6;hTERT-RPE1: 55.9;LHCN-M2: 60.1;U-2 OS: 32.8;U-87 MG: 59.0" "Low region specificity" "Detected in single" HPA021030 Approved Nucleoplasm,Centrosome,Cytosol "Secreted in other tissues" NA Yes 480000 Nucleoplasm "Centrosome, Cytosol" "HPA021030: AB_1846010" "unprognostic (7.60e-3)" "unprognostic (4.00e-2)" "unprognostic (1.59e-3)" "unprognostic (3.63e-3)" "unprognostic (2.24e-2)" "unprognostic (2.91e-2)" "unprognostic (2.78e-2)" "unprognostic (4.36e-3)" "unprognostic (3.23e-1)" "unprognostic (5.79e-2)" "unprognostic (2.37e-3)" "unprognostic (6.49e-2)" "unprognostic (6.21e-10)" "unprognostic (2.39e-1)" "unprognostic (1.67e-1)" "unprognostic (7.56e-2)" "prognostic unfavorable (1.31e-4)" 2.7 2.3 0.1 0.4 0.4 0.2 2.8 0.1 0.4 8.1 1.1 0.3 0.1 0.1 1.1 1.2 18.0 0.2 0.2 4.4 0.1 1.2 1.2 0.2 0.8 0.3 0.1 0.1 1.8 6.9 0.1 1.1 8.8 0.9 0.3 0.1 0.6 4.4 0.1 0.3 41.0 0.5 0.7 0.7 1.7 0.2 2.2 0.1 0.8 0.1 12.3 2.3 1.7 6.7 0.4 0.4 1.6 0.4 1.5 0.4 0.1 19.4 1.0 0.0 0.0 0.1 0.3 0.0 15.6 29.6 15.9 3.9 0.1 1.7 0.0 3.0 6.6 16.1 1.1 0.0 8.6 16.5 0.0 0.0 0.0 6.3 0.4 0.4 0.0 0.0 0.2 13.9 1.4 2.0 55.9 0.0 0.0 0.0 0.0 60.1 0.0 0.0 0.0 0.1 0.1 2.3 0.0 16.1 0.0 7.5 0.8 0.0 0.0 10.3 4.9 0.1 6.3 0.1 0.0 11.9 3.9 32.8 1.3 1.5 0.0 0.0 0.0 59.0 0.0 0.1 1.0 0.4 0.4 0.4 0.1 0.2 0.3 0.2 0.3 0.0 0.4 0.3 0.3 1.6 1.5 0.2 0.4 0.3 0.1 0.1 0.4 0.1 0.3 0.1 1.2 0.1 0.1 0.9 0.1 3.0 0.3 0.0 0.5 15.8 0.0 0.3 0.0 2.7 2.3 0.0 0.0 3.7 0.0 0.5 0.3 0.1 0.0 0.0 45.1 1.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 1.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 27.0 7.9 0.0 0.0 0.9 CPA5 ENSG00000158525 "Carboxypeptidase A5" Q8WXQ8 7 130344816-130368730 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "blood: 25.2;testis: 30.4" "Group enriched" "Detected in some" 20 "Early spermatids: 46.3;Late spermatids: 106.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory CD4 T-cell: 8.0;naive CD8 T-cell: 20.3;T-reg: 25.2" "Lineage enriched" "Detected in single" 114 "T-cells: 25.2" "Cell line enhanced" "Detected in some" "RH-30: 11.2;RT4: 5.1;U-266/84: 8.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA020322 Approved Nucleoplasm "Secreted in male reproductive system" NA NA Nucleoplasm "HPA020322: AB_10960562" "unprognostic (2.44e-1)" "unprognostic (3.76e-1)" "unprognostic (1.50e-1)" "unprognostic (5.94e-2)" "unprognostic (4.96e-2)" "unprognostic (7.10e-3)" "unprognostic (1.64e-2)" "unprognostic (1.41e-2)" "unprognostic (3.26e-1)" "unprognostic (5.02e-2)" "unprognostic (5.83e-4)" "unprognostic (1.43e-1)" "unprognostic (8.88e-13)" "unprognostic (5.16e-2)" "unprognostic (1.32e-1)" "unprognostic (8.81e-2)" "unprognostic (3.08e-2)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.1 1.6 0.1 0.1 0.1 0.4 0.0 1.0 0.5 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.8 0.4 0.1 0.1 1.6 0.0 30.4 0.1 0.1 0.1 0.1 0.7 0.8 0.1 0.0 0.0 0.2 0.0 0.0 25.2 3.1 0.8 0.0 0.1 0.6 0.0 0.0 0.0 0.4 3.3 0.2 0.4 2.4 0.0 0.0 0.0 0.0 1.1 0.1 0.4 0.7 0.0 0.0 1.9 0.7 0.7 1.2 0.5 0.0 0.0 0.0 1.1 0.0 1.2 1.4 0.0 0.9 0.0 1.6 0.1 0.0 0.4 0.0 0.8 0.0 0.0 0.0 11.2 0.4 1.5 5.1 1.4 0.2 0.0 3.2 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 8.4 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 8.0 4.1 0.0 0.0 2.1 20.3 0.0 0.0 0.0 0.0 25.2 3.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 2.8 0.0 0.0 46.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 106.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.6 1.9 0.0 3.9 0.0 0.0 0.0 CPD GP180 ENSG00000108582 "Carboxypeptidase D" O75976 17 30378905-30469989 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 178.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 19.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052796, HPA055465" Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear speckles" NA NA 930000 "Nucleoplasm, Nuclear speckles" "Nuclear membrane" "HPA052796: AB_2681953, HPA055465: AB_2682823" "unprognostic (1.05e-1)" "unprognostic (1.31e-1)" "unprognostic (3.05e-2)" "unprognostic (3.62e-2)" "unprognostic (6.13e-2)" "unprognostic (1.65e-1)" "unprognostic (7.97e-3)" "unprognostic (4.45e-2)" "unprognostic (2.07e-2)" "unprognostic (2.96e-1)" "unprognostic (1.62e-1)" "unprognostic (3.16e-1)" "unprognostic (1.58e-1)" "unprognostic (3.74e-2)" "unprognostic (7.25e-2)" "unprognostic (3.36e-1)" "unprognostic (1.08e-1)" 16.4 8.0 9.8 12.3 12.4 18.1 17.9 9.1 13.3 28.6 16.2 18.5 10.1 12.9 12.6 10.1 10.0 15.2 33.6 10.5 12.8 10.4 13.4 26.8 20.0 14.2 22.1 11.4 7.8 14.7 21.2 14.9 22.3 13.9 11.4 13.3 7.5 59.7 7.9 10.0 7.8 22.0 15.1 25.9 7.9 24.6 25.0 13.5 5.8 37.2 7.7 10.0 11.5 11.6 0.4 3.4 19.3 5.5 2.1 3.8 2.5 12.2 18.7 16.2 16.7 16.9 32.2 5.8 16.9 24.8 11.7 14.5 21.9 7.9 1.5 21.6 19.4 14.9 8.8 10.5 21.4 19.9 5.8 15.0 3.5 11.5 13.5 20.6 22.7 9.2 57.4 9.6 15.0 14.6 19.6 23.8 5.3 6.7 18.1 9.4 2.4 7.3 6.2 4.5 28.2 4.3 7.0 18.8 4.7 22.0 14.0 4.1 10.3 20.2 17.5 8.8 19.8 16.5 15.8 28.3 11.7 7.7 18.2 16.1 7.3 15.2 5.2 15.0 14.9 9.9 2.8 5.5 6.4 3.4 2.8 3.8 0.2 1.7 2.8 3.4 0.4 1.4 1.7 19.3 2.1 2.3 0.4 1.1 2.5 9.8 12.4 9.1 13.3 12.8 10.4 22.1 11.4 13.9 13.5 29.8 19.2 7.5 28.1 19.6 23.1 10.4 178.3 18.7 27.3 27.9 43.2 20.5 1.7 21.2 75.9 48.4 31.6 0.0 21.4 9.1 26.2 58.6 24.2 67.2 14.9 44.5 31.0 51.0 34.9 41.5 15.5 20.5 28.7 10.0 69.1 11.1 30.2 20.1 15.2 17.7 35.0 0.0 22.6 15.6 24.2 16.3 20.1 20.8 31.5 38.6 CPE ENSG00000109472 "Carboxypeptidase E" P16870 4 165361194-165498320 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 203.7" "Group enriched" "Detected in many" 4 "Bipolar cells: 533.2;Cone photoreceptor cells: 585.1;Glandular cells: 402.2;Intestinal endocrine cells: 564.2;Leydig cells: 463.7;Muller glia cells: 511.1;Peritubular cells: 583.8;Rod photoreceptor cells: 443.0;Sertoli cells: 840.8;Smooth muscle cells: 614.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.5" "Lineage enriched" "Detected in single" 16 "T-cells: 1.5" "Cell line enhanced" "Detected in many" "Hep G2: 49.0;SCLC-21H: 69.0;SiHa: 101.3;SuSa: 59.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003819, CAB024907" Supported Approved Nucleoplasm,Vesicles,Centrosome "Intracellular and membrane" NA NA 470000 Centrosome "Nucleoplasm, Vesicles" "CAB024907: , HPA003819: AB_2667054" "unprognostic (1.84e-1)" "unprognostic (5.64e-3)" "unprognostic (1.61e-1)" "unprognostic (1.70e-2)" "unprognostic (2.51e-1)" "unprognostic (1.44e-2)" "unprognostic (1.65e-1)" "unprognostic (9.52e-2)" "unprognostic (2.91e-3)" "unprognostic (9.01e-2)" "unprognostic (4.84e-3)" "unprognostic (5.56e-3)" "prognostic unfavorable (2.60e-4)" "unprognostic (4.35e-3)" "unprognostic (1.46e-1)" "unprognostic (2.26e-1)" "prognostic unfavorable (2.12e-4)" 27.7 33.8 123.1 4.4 135.5 0.9 21.5 82.9 203.7 10.7 9.6 31.6 5.3 5.0 13.3 94.3 16.4 15.7 14.0 19.6 116.9 56.3 12.0 6.3 11.0 7.6 56.9 70.7 23.4 35.5 33.9 40.0 2.2 53.0 66.5 8.8 13.2 12.0 20.1 11.0 5.5 6.2 18.5 40.5 2.8 19.2 30.4 53.3 0.9 40.7 4.3 7.7 6.3 9.4 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.3 8.9 1.7 7.1 0.7 0.4 0.0 3.6 1.3 2.9 0.0 0.0 0.0 2.6 0.0 0.3 0.2 3.4 0.7 0.7 0.0 13.0 0.0 3.6 49.0 0.5 0.0 0.0 17.3 3.6 0.0 0.0 17.2 0.0 0.0 0.0 0.3 1.8 2.4 0.0 0.4 5.6 0.0 2.0 0.0 0.0 0.1 0.1 0.5 69.0 22.8 101.3 12.7 0.0 59.1 7.6 0.3 0.0 2.7 7.0 0.2 0.2 3.9 0.0 0.3 2.6 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 123.1 135.5 82.9 82.2 116.9 56.3 56.9 70.7 53.0 53.3 0.0 9.3 0.0 67.8 23.2 533.2 32.3 40.8 0.0 3.4 21.0 585.1 0.4 0.0 15.1 5.5 57.1 1.6 0.0 1.5 0.1 129.4 402.2 0.0 7.9 0.8 66.7 564.2 115.4 9.2 11.5 463.7 12.5 82.7 1.8 12.7 511.1 19.3 2.9 583.8 9.6 443.0 840.8 614.9 17.7 9.6 18.2 0.7 1.9 3.7 11.3 CPEB1 "CPEB, FLJ13203" ENSG00000214575 "Cytoplasmic polyadenylation element binding protein 1" Q9BZB8 15 82543201-82648861 "Predicted intracellular proteins" "mRNA processing, Translation regulation" "Activator, Repressor, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 32.0" "Cell type enhanced" "Detected in many" 15 "Late spermatids: 16.0;Spermatocytes: 18.2;Spermatogonia: 47.3" "Cancer enriched" "Detected in some" 6 "testis cancer: 14.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 3.5" "Group enriched" "Detected in many" 27 "B-cells: 1.8;T-cells: 3.5" "Cell line enhanced" "Detected in many" "SK-MEL-30: 16.1;U-2197: 46.5;U-87 MG: 17.0" HPA040396 Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA040396: AB_2676960" "unprognostic (3.97e-2)" "unprognostic (1.01e-1)" "unprognostic (1.44e-2)" "unprognostic (1.77e-3)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.98e-1)" "unprognostic (7.74e-2)" "unprognostic (3.90e-2)" "unprognostic (2.07e-2)" "unprognostic (1.35e-2)" "unprognostic (7.51e-3)" "unprognostic (1.97e-3)" "unprognostic (9.50e-3)" "unprognostic (8.17e-2)" "unprognostic (2.05e-2)" "unprognostic (5.37e-4)" 2.1 5.6 7.5 1.6 10.8 0.5 2.1 11.9 15.7 5.2 5.3 9.4 0.2 1.6 4.2 8.7 4.0 9.2 4.3 2.9 6.2 6.2 1.6 0.8 1.9 0.8 12.4 9.0 15.4 1.6 1.4 8.3 0.6 13.0 2.7 2.9 3.9 1.4 4.4 2.2 1.5 2.2 3.9 7.7 0.9 2.6 32.0 8.1 0.0 2.7 0.0 0.8 5.5 3.8 1.8 0.0 0.0 0.0 0.0 3.5 0.6 0.0 1.5 0.1 0.1 1.1 0.1 0.0 1.2 0.1 0.8 0.6 0.0 0.0 0.0 2.8 0.4 8.7 0.0 2.2 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.8 0.0 1.0 0.6 0.0 1.5 0.0 0.1 0.0 3.3 3.7 0.0 0.5 0.0 0.2 0.0 3.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.6 1.0 4.0 0.2 16.1 5.2 0.0 0.5 0.0 8.4 3.4 46.5 2.5 2.3 5.9 0.6 17.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.7 1.8 0.3 1.8 0.0 0.5 1.2 3.5 0.0 0.0 0.0 0.0 0.0 0.6 7.5 10.8 11.9 15.7 6.2 6.2 12.4 9.0 13.0 8.1 0.0 0.0 0.0 0.3 0.7 10.3 1.2 0.0 4.0 0.0 0.0 9.8 0.0 0.0 0.1 10.9 0.0 0.0 0.0 0.0 0.0 2.1 0.1 1.1 0.0 0.2 11.1 0.0 0.0 0.0 16.0 3.7 0.2 5.0 0.0 0.0 4.5 0.2 0.0 2.1 0.3 3.5 6.5 2.3 18.2 47.3 0.5 0.1 0.0 0.0 0.1 CPEB3 KIAA0940 ENSG00000107864 "Cytoplasmic polyadenylation element binding protein 3" Q8NE35 10 92046692-92291087 "Predicted intracellular proteins" "Translation regulation" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.4;liver: 39.5" "Group enriched" "Detected in many" 4 "Early spermatids: 216.8;Late spermatids: 321.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 6.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 16.1;U-266/70: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070942 Approved "Nucleoplasm,Plasma membrane,Midbody,Cytosol" NA No Cytosol "Nucleoplasm, Plasma membrane, Midbody" "HPA070942: " "unprognostic (4.90e-2)" "unprognostic (2.12e-2)" "unprognostic (3.00e-1)" "unprognostic (5.66e-2)" "unprognostic (1.92e-1)" "unprognostic (2.95e-5)" "prognostic favorable (5.06e-5)" "unprognostic (4.09e-4)" "unprognostic (2.73e-1)" "unprognostic (2.40e-1)" "unprognostic (1.47e-2)" "unprognostic (2.42e-2)" "prognostic favorable (3.84e-9)" "unprognostic (3.33e-2)" "unprognostic (7.42e-2)" "unprognostic (1.36e-2)" "unprognostic (1.40e-1)" 3.1 6.1 11.9 3.0 10.9 2.9 5.0 33.4 24.6 4.0 3.8 4.4 5.5 4.8 3.3 6.8 6.0 3.3 3.4 7.0 10.7 11.5 7.0 39.5 3.6 3.0 10.3 15.1 5.8 5.4 6.6 8.6 2.8 16.4 6.5 4.2 3.0 10.2 8.0 23.4 5.3 4.6 3.4 4.6 4.1 4.5 20.5 7.0 0.3 9.3 5.4 3.4 3.3 4.5 1.8 0.9 6.5 1.5 0.5 0.7 0.5 1.2 0.3 0.4 2.7 0.7 0.7 1.1 1.2 0.9 1.7 1.4 0.9 2.7 1.4 1.3 0.5 0.8 3.4 1.1 0.9 0.9 1.6 1.4 1.9 1.8 1.0 2.0 0.9 2.0 0.7 2.1 1.0 3.1 1.5 1.5 1.9 1.3 16.1 0.7 0.9 1.2 1.1 0.2 1.8 1.3 1.6 2.3 2.8 1.6 0.5 2.0 0.7 1.1 3.1 2.0 1.4 3.9 2.0 1.2 0.8 0.9 0.6 1.0 9.0 2.4 1.5 0.4 3.0 0.2 6.5 1.1 2.2 0.7 1.4 0.5 1.8 0.4 0.7 0.9 0.5 0.4 0.4 1.3 0.5 1.5 0.6 0.3 0.5 11.9 10.9 33.4 24.6 10.7 11.5 10.3 15.1 16.4 7.0 6.0 6.5 0.8 3.2 7.8 25.2 21.8 5.1 2.7 3.4 12.2 47.1 1.8 5.0 2.1 216.8 6.0 7.5 0.0 2.3 1.3 3.9 15.1 3.5 66.1 4.2 28.6 19.0 11.6 22.6 321.1 5.5 7.7 5.0 6.4 9.1 2.5 3.1 3.5 7.4 2.5 21.8 0.0 3.1 11.2 6.8 12.2 1.0 2.5 5.2 5.3 CPEB4 KIAA1673 ENSG00000113742 "Cytoplasmic polyadenylation element binding protein 4" Q17RY0 5 173888280-173961976 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 106.1" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 303.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 9.6" "Lineage enriched" "Detected in many" 4 "granulocytes: 9.6" "Cell line enhanced" "Detected in many" "U-266/70: 39.1;U-266/84: 56.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038394 Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus" Vesicles "HPA038394: AB_10671226" "unprognostic (2.12e-1)" "unprognostic (3.05e-1)" "unprognostic (1.12e-1)" "unprognostic (3.99e-1)" "unprognostic (8.80e-2)" "unprognostic (2.91e-1)" "unprognostic (4.58e-1)" "unprognostic (8.75e-2)" "unprognostic (2.54e-1)" "unprognostic (9.37e-3)" "unprognostic (1.44e-1)" "unprognostic (7.84e-2)" "prognostic favorable (4.99e-8)" "unprognostic (2.66e-1)" "unprognostic (4.73e-2)" "unprognostic (1.42e-2)" "unprognostic (3.83e-2)" 11.9 42.2 25.9 10.3 21.0 39.7 11.5 29.7 30.9 11.3 7.5 10.5 9.8 8.1 8.6 6.0 18.6 6.4 12.1 26.4 22.3 14.7 30.3 44.6 12.5 6.9 15.1 20.7 6.6 21.1 45.7 20.5 17.8 33.3 7.7 8.0 14.4 17.3 13.5 106.1 10.8 8.8 12.5 38.4 9.7 11.3 8.4 18.9 1.5 20.0 16.9 9.3 11.6 15.8 1.6 0.8 9.6 2.3 0.8 1.3 0.6 4.0 5.5 2.7 1.5 5.0 2.9 5.5 7.2 6.7 2.5 3.0 5.2 2.7 5.0 5.2 4.0 8.0 0.3 2.4 3.8 4.1 10.0 2.8 3.3 13.3 3.0 10.7 1.1 6.6 4.5 8.7 6.5 10.0 11.3 2.4 1.8 10.9 12.3 5.7 2.9 0.9 1.0 1.5 1.7 5.5 0.9 2.2 16.6 3.6 7.3 3.1 3.5 0.8 10.1 13.0 4.9 7.0 2.3 7.1 4.1 2.0 2.0 4.6 39.1 56.1 2.6 10.1 2.3 5.2 0.5 1.8 2.0 1.0 1.7 1.0 1.6 1.1 0.8 0.6 1.2 1.3 0.7 9.6 0.8 2.3 0.8 1.0 0.6 25.9 21.0 29.7 30.9 22.3 14.7 15.1 20.7 33.3 18.9 71.5 29.3 27.4 12.7 37.7 148.4 204.8 101.9 49.5 43.3 50.6 127.6 9.5 19.9 29.9 46.6 42.1 41.8 303.7 22.7 4.8 24.4 44.9 87.8 135.7 55.5 138.2 60.1 69.3 106.0 36.0 8.1 47.3 70.9 28.9 21.7 91.5 33.7 35.1 20.1 36.6 121.5 0.0 63.5 43.8 7.5 44.8 51.8 22.9 14.9 35.9 CPED1 "C7orf58, FLJ21986" ENSG00000106034 "Cadherin like and PC-esterase domain containing 1" A4D0V7 7 120988677-121297444 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Fibroblasts: 35.2;Ito cells: 30.7;Peritubular cells: 76.7;Smooth muscle cells: 39.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 7.6;intermediate monocyte: 7.8;myeloid DC: 17.2;non-classical monocyte: 4.8;plasmacytoid DC: 10.3" "Group enriched" "Detected in many" 9 "dendritic cells: 17.2;monocytes: 7.8" "Cell line enhanced" "Detected in many" "BJ hTERT+: 28.7;Hep G2: 16.5;K-562: 55.7;LHCN-M2: 19.7;U-138 MG: 16.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA012058 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA012058: AB_1845761" "unprognostic (7.94e-2)" "unprognostic (1.43e-2)" "unprognostic (1.04e-1)" "unprognostic (4.48e-4)" "unprognostic (1.39e-1)" "unprognostic (1.93e-1)" "unprognostic (5.52e-3)" "prognostic favorable (3.00e-4)" "unprognostic (1.09e-1)" "unprognostic (1.42e-1)" "unprognostic (1.48e-1)" "unprognostic (8.69e-2)" "prognostic unfavorable (4.87e-4)" "unprognostic (6.28e-3)" "unprognostic (5.05e-2)" "unprognostic (3.78e-1)" "unprognostic (6.54e-4)" 21.6 8.3 3.2 8.0 3.7 0.1 7.8 1.1 2.7 19.4 16.3 4.1 15.0 3.7 21.8 15.7 10.5 12.2 14.4 10.3 2.9 1.7 3.9 19.4 9.0 1.5 5.1 1.9 36.8 2.0 0.4 4.5 10.6 3.1 20.7 6.7 18.5 2.8 17.1 24.4 2.9 10.6 48.9 8.7 9.9 8.6 7.1 3.8 0.2 4.9 15.9 1.4 34.3 14.6 1.0 17.2 1.4 7.8 0.0 0.1 2.1 1.9 0.0 0.1 0.0 4.7 13.8 0.1 8.1 28.7 2.8 7.7 0.2 0.1 0.3 0.1 4.3 3.2 0.1 0.1 0.0 7.4 0.1 0.3 2.2 0.1 16.5 8.2 0.0 0.0 5.6 0.0 6.6 0.1 2.2 1.4 0.0 55.7 4.2 19.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 11.3 5.5 0.0 0.2 0.0 0.7 0.0 0.0 0.2 0.1 0.0 0.2 0.8 16.8 0.4 14.0 7.7 1.8 0.0 0.2 1.9 0.0 0.8 1.4 7.6 0.0 0.0 7.8 0.1 1.0 0.0 0.0 17.2 0.3 0.0 0.0 0.3 0.0 4.8 10.3 0.0 2.1 3.2 3.7 1.1 2.7 2.9 1.7 5.1 1.9 3.1 3.8 17.9 0.3 1.3 0.5 2.7 0.0 17.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 3.6 0.0 0.0 0.0 1.5 35.2 0.8 0.0 20.2 3.9 3.2 0.0 30.7 11.5 0.0 19.5 25.2 3.3 1.0 0.0 21.5 0.0 0.0 76.7 0.0 0.2 0.0 39.2 0.3 0.4 1.8 0.3 0.0 0.0 1.3 CPNE1 CPN1 ENSG00000214078 "Copine 1" Q99829 20 35626031-35664956 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047259, HPA072634" Approved Supported "Nucleoplasm,Nuclear membrane" NA NA 160000 "Nucleoplasm, Nuclear membrane" "HPA047259: AB_2680004, HPA072634: AB_2686541" "unprognostic (5.94e-2)" "unprognostic (9.43e-2)" "unprognostic (1.13e-1)" "unprognostic (1.99e-3)" "unprognostic (7.49e-2)" "unprognostic (1.05e-2)" "unprognostic (1.58e-3)" "unprognostic (1.20e-1)" "unprognostic (1.44e-1)" "unprognostic (1.67e-1)" "unprognostic (2.47e-1)" "unprognostic (6.06e-2)" "prognostic unfavorable (2.74e-10)" "unprognostic (3.10e-1)" "unprognostic (8.85e-2)" "unprognostic (1.43e-1)" "unprognostic (1.35e-1)" 32.0 25.3 23.1 32.9 25.6 36.5 31.8 34.0 24.7 35.5 31.5 23.9 26.3 18.4 38.8 35.1 30.8 34.3 27.8 22.1 22.1 16.0 25.4 23.2 33.3 28.7 22.0 24.8 41.6 27.5 21.5 33.3 39.3 19.4 30.0 27.6 27.4 27.9 25.9 23.9 32.9 31.9 40.5 19.2 42.4 26.3 25.6 23.1 64.8 36.3 27.1 44.4 34.9 33.7 39.4 43.9 52.1 31.0 60.1 53.8 44.7 41.5 32.9 18.7 7.8 2.4 3.2 14.2 20.1 36.0 49.0 32.4 98.9 18.3 29.3 19.4 29.9 42.5 16.1 14.4 38.1 30.4 5.4 11.0 73.8 25.9 71.5 22.6 23.9 10.3 20.9 39.2 19.7 23.5 29.8 30.9 30.0 9.6 15.0 23.7 22.9 35.4 32.1 4.6 42.3 31.8 25.3 56.0 19.9 19.9 30.0 13.2 14.7 45.5 21.7 30.8 5.3 22.5 23.9 20.1 52.0 9.5 16.9 21.2 10.1 10.3 20.2 37.4 13.2 11.5 13.6 31.0 52.1 39.6 30.4 53.8 39.4 38.0 36.6 43.9 37.0 37.7 37.4 42.9 60.1 28.9 24.0 46.0 44.7 23.1 25.6 34.0 24.7 22.1 16.0 22.0 24.8 19.4 23.1 17.9 34.1 35.8 60.3 48.9 31.5 13.2 28.1 29.4 40.9 24.4 19.6 114.0 21.6 56.4 30.6 49.6 28.4 0.0 33.1 69.7 50.3 49.5 47.3 20.2 56.7 20.6 32.2 27.6 34.4 9.4 50.6 44.1 45.5 117.2 29.0 24.1 43.3 37.0 58.0 24.9 17.1 45.3 60.4 11.7 24.0 42.9 88.9 76.2 38.1 60.3 CPNE2 CPN2 ENSG00000140848 "Copine 2" Q96FN4 16 57092537-57148367 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.6" "Cell type enhanced" "Detected in many" 8 "Ito cells: 72.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041132 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA041132: AB_2677316" "unprognostic (1.73e-2)" "unprognostic (3.18e-1)" "unprognostic (1.36e-1)" "unprognostic (4.93e-3)" "unprognostic (1.42e-2)" "unprognostic (1.91e-1)" "unprognostic (2.10e-2)" "unprognostic (9.14e-2)" "unprognostic (2.10e-3)" "unprognostic (8.78e-3)" "unprognostic (2.18e-2)" "unprognostic (1.88e-1)" "unprognostic (3.53e-3)" "unprognostic (8.29e-2)" "unprognostic (1.24e-1)" "unprognostic (7.44e-3)" "unprognostic (1.33e-1)" 14.1 3.9 8.4 4.6 15.1 22.8 11.4 7.9 15.4 16.4 12.0 40.6 1.1 2.0 8.8 3.1 6.4 12.0 5.6 5.9 10.6 11.6 4.8 4.3 15.5 8.2 20.8 9.8 5.1 3.3 3.7 4.9 11.5 12.9 5.1 11.9 4.6 3.7 7.4 4.9 4.0 6.6 10.5 13.5 6.0 3.7 15.3 20.1 0.2 5.8 2.2 3.2 6.4 8.3 0.0 2.1 4.0 4.2 0.5 1.2 0.9 8.4 16.3 25.2 13.9 4.5 4.4 4.2 9.2 14.6 21.1 14.8 4.5 9.8 5.0 8.5 13.9 11.7 13.3 9.9 5.5 11.5 6.2 5.8 2.1 6.5 3.8 8.2 1.7 0.2 4.2 6.2 8.2 4.0 15.8 31.0 2.8 5.6 0.1 5.3 3.9 2.5 24.7 5.7 4.1 3.5 31.5 7.9 4.2 14.0 3.2 0.5 10.2 11.7 2.5 7.0 11.9 2.7 33.7 21.8 19.3 10.5 4.8 11.9 1.2 1.0 11.3 12.5 7.4 13.5 0.0 4.2 1.9 0.7 1.2 0.7 0.0 0.4 1.2 2.1 0.0 0.3 0.6 4.0 0.5 0.4 0.1 0.5 0.9 8.4 15.1 7.9 15.4 10.6 11.6 20.8 9.8 12.9 20.1 17.9 6.1 2.9 13.5 2.1 0.0 2.2 2.5 1.4 2.3 5.2 0.0 0.6 5.0 3.9 14.0 20.4 28.0 0.0 3.4 2.1 10.4 9.0 0.0 1.6 20.0 0.0 3.5 72.4 21.2 4.7 6.4 6.9 6.8 3.6 15.7 3.3 5.9 21.0 7.1 1.6 0.0 32.3 14.4 0.5 1.7 3.8 0.7 4.4 15.9 9.9 CPNE3 ENSG00000085719 "Copine 3" O75131 8 86514427-86561498 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 66.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029552 Uncertain Supported Nucleoplasm,Nucleoli,Mitochondria,Cytosol NA NA 52000 "Nucleoplasm, Cytosol" "Nucleoli, Mitochondria" "HPA029552: AB_10600703" "unprognostic (5.63e-3)" "unprognostic (1.47e-1)" "unprognostic (2.95e-2)" "unprognostic (4.22e-3)" "unprognostic (9.92e-2)" "unprognostic (6.58e-2)" "unprognostic (8.40e-2)" "unprognostic (4.76e-2)" "unprognostic (3.50e-1)" "unprognostic (1.19e-1)" "unprognostic (8.64e-3)" "unprognostic (2.77e-1)" "prognostic favorable (5.07e-4)" "unprognostic (1.15e-1)" "unprognostic (4.33e-1)" "unprognostic (1.65e-3)" "unprognostic (1.13e-2)" 26.5 16.6 21.3 9.8 18.0 35.1 20.6 18.8 13.5 26.0 16.4 20.9 13.2 15.1 28.6 12.6 40.5 15.9 14.6 24.4 17.6 19.7 29.8 25.5 16.9 22.6 19.7 10.5 26.7 24.1 25.4 28.9 16.1 17.0 22.4 16.5 21.0 20.6 15.3 10.4 18.7 19.5 20.9 18.7 18.3 16.9 9.7 14.1 30.5 33.6 21.8 29.7 25.4 20.0 14.6 31.4 28.2 24.3 15.0 18.3 14.4 34.6 12.3 8.5 11.0 32.7 25.5 6.9 16.7 24.9 14.0 15.8 7.9 11.9 9.5 11.1 20.3 8.5 26.8 18.2 17.7 25.2 10.1 14.3 1.5 9.0 9.4 11.3 0.8 0.8 17.3 19.2 15.5 20.6 22.6 17.1 4.9 8.5 18.3 17.2 13.4 16.6 0.5 3.2 28.7 17.8 7.9 7.7 44.4 18.1 24.9 18.0 14.1 14.6 66.7 10.5 10.2 25.4 2.6 18.2 12.5 12.2 16.6 12.9 13.2 15.8 2.6 18.0 3.6 11.5 10.8 16.7 26.4 18.3 19.1 14.2 14.6 14.8 12.8 30.8 14.1 13.3 14.3 28.2 15.0 24.3 31.4 10.5 14.4 21.3 18.0 18.8 13.5 17.6 19.7 19.7 10.5 17.0 14.1 128.1 76.8 40.4 87.4 72.7 16.8 108.0 79.0 77.6 69.4 66.3 13.7 59.5 84.6 63.4 1.1 55.4 37.1 23.3 72.9 45.8 62.4 110.2 8.1 86.6 42.9 42.9 48.1 57.7 74.2 2.2 79.4 49.0 50.6 32.5 53.7 70.1 62.4 52.6 82.4 99.4 16.5 58.2 55.6 3.0 10.0 79.5 65.2 47.5 69.8 73.5 CPNE4 "COPN4, CPN4" ENSG00000196353 "Copine 4" Q96A23 3 131533555-132285410 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.2;prostate: 35.7" "Cell type enhanced" "Detected in some" 16 "Cardiomyocytes: 17.1;Glandular cells: 18.5;Intestinal endocrine cells: 4.7" "Cancer enriched" "Detected in some" 6 "prostate cancer: 22.4" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 3.2" "Lineage enriched" "Detected in single" 33 "granulocytes: 3.2" "Cell line enhanced" "Detected in some" "A549: 9.9;AF22: 9.3;Karpas-707: 2.8;RT4: 3.1" "Low region specificity" "Detected in many" "HPA032036, HPA078300" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA032036: AB_10600898, HPA078300: AB_2732377" "unprognostic (7.38e-2)" "unprognostic (2.12e-2)" "unprognostic (1.56e-1)" "unprognostic (1.22e-4)" "unprognostic (2.53e-2)" "unprognostic (1.41e-2)" "unprognostic (8.81e-3)" "unprognostic (3.40e-1)" "unprognostic (2.69e-2)" "unprognostic (1.57e-2)" "unprognostic (2.27e-2)" "unprognostic (1.29e-2)" "unprognostic (9.10e-3)" "unprognostic (1.18e-2)" "unprognostic (1.76e-2)" "unprognostic (1.35e-1)" "unprognostic (2.51e-1)" 1.4 1.4 7.0 0.8 11.6 0.8 0.7 0.4 27.2 1.0 1.1 2.5 0.7 1.6 0.9 1.6 1.1 1.2 0.7 1.9 17.5 5.3 2.1 0.8 1.2 0.7 1.3 11.8 0.7 0.8 3.8 9.5 0.7 3.1 35.7 1.0 0.1 1.1 6.0 0.6 1.0 1.4 1.2 4.6 1.8 1.4 2.3 3.6 0.0 1.1 0.0 0.7 0.7 1.1 0.0 0.0 3.2 0.0 0.0 0.0 0.3 0.0 9.9 9.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.0 2.8 1.3 0.6 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.6 3.1 1.4 0.6 0.0 1.3 0.0 0.2 0.0 0.0 0.0 1.2 2.3 0.3 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.3 7.0 11.6 0.4 27.2 17.5 5.3 1.3 11.8 3.1 3.6 0.0 0.0 0.0 0.4 0.2 0.8 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.5 18.5 0.0 0.0 0.1 1.6 4.7 0.0 0.0 3.6 0.3 0.0 0.0 1.0 0.0 0.2 0.1 0.0 0.0 1.2 0.5 0.0 0.8 1.2 1.1 0.1 0.0 0.0 0.0 0.8 CPSF1 CPSF160 ENSG00000071894 "Cleavage and polyadenylation specific factor 1" Q10570 8 144393229-144409349 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065167, HPA068906" Enhanced Nucleoplasm No No Nucleoplasm "HPA065167: AB_2685426, HPA068906: AB_2686055" "unprognostic (6.37e-2)" "unprognostic (7.72e-2)" "unprognostic (2.41e-2)" "unprognostic (1.21e-1)" "unprognostic (2.93e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (8.64e-4)" "unprognostic (1.05e-1)" "unprognostic (2.00e-3)" "unprognostic (6.45e-2)" "unprognostic (7.54e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (6.54e-5)" "unprognostic (2.40e-1)" "unprognostic (1.91e-1)" "unprognostic (7.90e-2)" "unprognostic (9.66e-3)" 11.9 13.5 13.4 18.6 17.2 27.0 14.3 28.5 18.0 11.7 15.1 16.3 14.9 40.7 17.8 8.9 13.0 16.2 14.3 10.3 13.0 8.2 13.0 15.0 13.7 17.4 16.6 11.5 19.8 22.4 7.3 21.6 11.1 15.4 18.4 7.6 14.9 26.9 13.8 14.7 25.2 29.8 11.7 11.0 21.2 16.3 27.9 16.1 27.1 17.7 10.6 16.0 13.1 13.4 7.5 8.8 4.9 9.3 5.7 10.0 5.8 9.4 13.3 12.1 12.6 6.5 5.2 11.9 8.9 5.6 7.3 7.6 13.4 12.2 10.9 8.7 6.6 4.9 8.6 6.8 7.5 2.0 9.8 19.7 21.4 14.9 21.4 5.5 8.1 13.3 5.7 3.2 6.7 3.9 4.4 9.7 18.2 17.9 9.3 3.6 40.3 21.2 17.1 7.3 7.9 18.8 15.3 4.9 8.7 7.7 14.0 9.9 9.8 11.5 7.2 6.5 3.6 12.7 9.1 8.3 5.0 19.4 11.0 9.8 5.6 4.4 10.3 6.8 13.8 5.9 4.9 7.8 4.9 8.0 9.3 8.4 6.9 8.5 8.4 8.8 7.5 7.5 7.1 1.5 5.7 8.6 4.1 10.0 5.8 13.4 17.2 28.5 18.0 13.0 8.2 16.6 11.5 15.4 16.1 14.9 22.7 3.0 3.6 9.0 10.3 8.3 15.3 8.1 11.4 8.7 11.8 8.9 1.7 7.8 15.6 11.1 19.5 0.0 9.9 9.4 9.3 3.4 13.9 7.2 13.0 7.9 12.6 9.2 8.3 30.3 13.0 13.0 13.5 8.2 23.9 4.3 9.8 11.5 15.2 4.6 13.8 6.5 8.0 24.2 22.0 10.8 6.1 10.4 24.2 3.3 CPSF2 "CPSF100, KIAA1367" ENSG00000165934 "Cleavage and polyadenylation specific factor 2" Q9P2I0 14 92121937-92172145 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024238 Supported Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA024238: AB_1847200" "unprognostic (2.31e-1)" "unprognostic (9.80e-2)" "unprognostic (3.73e-2)" "unprognostic (1.77e-2)" "unprognostic (4.95e-2)" "unprognostic (2.14e-2)" "prognostic unfavorable (4.35e-7)" "unprognostic (1.34e-1)" "unprognostic (2.94e-1)" "unprognostic (1.78e-2)" "unprognostic (2.33e-2)" "unprognostic (6.68e-2)" "unprognostic (8.78e-3)" "unprognostic (2.44e-1)" "unprognostic (2.91e-1)" "unprognostic (8.75e-2)" "unprognostic (4.90e-2)" 20.5 24.0 14.6 24.1 16.3 10.6 16.7 14.5 16.5 18.3 16.4 19.3 21.5 15.1 19.3 16.5 25.7 15.4 15.9 16.3 14.9 13.6 16.8 22.2 17.3 20.1 20.8 11.8 21.5 16.5 24.9 28.9 19.6 16.0 17.1 18.1 14.7 18.5 25.3 36.6 14.9 19.0 18.8 19.7 23.8 17.8 25.7 18.1 44.0 22.6 19.4 25.0 19.7 17.7 9.3 13.0 15.0 14.4 12.8 13.4 9.7 18.5 18.6 19.0 19.6 9.9 8.8 28.3 24.1 23.7 22.5 22.3 16.1 25.9 20.0 15.9 25.7 15.2 27.6 26.1 21.9 32.5 32.3 9.0 29.2 19.2 15.4 29.3 29.4 24.8 14.4 18.8 21.3 38.5 14.9 20.9 21.8 26.3 25.4 24.9 27.2 33.8 10.4 21.5 30.1 17.0 33.4 29.5 17.9 15.3 26.5 21.0 14.2 28.4 16.1 20.5 17.9 33.4 18.5 22.3 18.0 11.4 13.5 20.5 15.3 24.9 40.8 21.8 23.2 27.9 15.0 14.4 10.4 9.6 13.6 12.9 9.3 8.6 10.2 13.0 5.3 7.8 10.5 5.2 12.8 10.7 8.4 13.4 9.7 14.6 16.3 14.5 16.5 14.9 13.6 20.8 11.8 16.0 18.1 26.8 25.6 13.7 10.9 9.2 12.2 21.8 15.3 41.5 31.8 7.0 27.5 21.2 11.6 16.5 18.7 17.9 10.7 0.0 20.6 19.5 15.2 23.6 29.0 24.5 21.6 11.1 13.3 22.1 36.9 8.4 17.5 27.0 3.3 28.9 17.0 14.1 18.7 15.2 21.5 14.4 22.2 32.3 18.6 50.6 43.6 11.2 21.2 16.6 14.4 19.7 CPSF4 "CPSF30, NAR" ENSG00000160917 "Cleavage and polyadenylation specific factor 4" O95639 7 99438922-99457371 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049094, HPA066470" Uncertain Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA049094: AB_2680626, HPA066470: AB_2685672" "unprognostic (4.03e-3)" "unprognostic (1.36e-1)" "unprognostic (1.86e-1)" "unprognostic (1.90e-2)" "unprognostic (2.54e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (5.87e-4)" "unprognostic (5.84e-2)" "unprognostic (2.28e-2)" "unprognostic (3.15e-1)" "unprognostic (3.73e-3)" "unprognostic (3.36e-2)" "prognostic unfavorable (1.68e-4)" "unprognostic (2.47e-2)" "unprognostic (1.30e-1)" "unprognostic (1.37e-1)" "unprognostic (4.23e-2)" 15.2 11.6 19.3 11.8 19.0 15.7 11.8 20.9 25.6 9.3 9.8 19.8 13.1 12.4 11.1 11.4 13.6 11.2 10.3 10.0 21.5 16.0 10.0 11.7 9.3 20.3 16.8 17.4 13.4 25.4 7.3 12.7 15.1 21.9 11.6 10.2 9.9 17.3 12.2 21.2 18.4 9.6 10.5 20.3 13.9 11.5 38.4 14.6 8.7 11.0 10.7 17.8 10.5 10.4 10.2 6.4 3.1 4.1 5.0 9.7 3.9 14.8 13.1 22.3 17.7 9.1 10.5 26.4 9.8 12.4 15.4 20.3 21.4 20.1 21.5 13.4 9.7 19.5 13.0 15.4 15.5 14.8 15.6 16.4 10.2 15.0 20.7 47.9 18.4 13.1 19.0 13.4 16.2 24.8 11.6 14.1 15.7 26.4 25.5 14.5 36.8 37.8 33.8 20.3 20.2 18.5 15.3 15.0 25.4 9.6 14.1 17.7 20.5 11.4 23.7 23.3 24.8 9.9 19.7 7.7 14.5 20.1 24.8 18.8 23.8 25.1 31.2 11.1 18.3 17.1 1.4 4.1 3.1 4.4 3.3 5.8 10.2 6.7 7.9 5.2 8.5 8.5 7.6 1.6 5.0 2.6 6.4 9.7 3.9 19.3 19.0 20.9 25.6 21.5 16.0 16.8 17.4 21.9 14.6 6.0 9.9 6.7 14.2 7.8 3.8 8.6 7.6 1.4 6.8 1.8 9.8 47.0 13.3 12.3 2.7 9.2 7.0 0.0 14.8 28.0 9.5 12.1 12.7 7.6 18.7 6.4 7.5 4.9 8.1 4.2 25.3 10.5 8.5 21.6 10.0 6.9 12.9 3.5 16.3 14.0 6.0 19.4 19.5 14.7 22.0 8.2 38.0 10.1 11.9 12.7 CPSF6 "CFIM, CFIM68, CFIM72, HPBRII-4, HPBRII-7" ENSG00000111605 "Cleavage and polyadenylation specific factor 6" Q16630 12 69239537-69274358 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039973 Supported Enhanced "Nucleoplasm,Nuclear speckles" No No 500000 "Nucleoplasm, Nuclear speckles" "HPA039973: AB_10795242" "unprognostic (1.50e-1)" "unprognostic (3.33e-2)" "unprognostic (4.37e-3)" "unprognostic (5.47e-2)" "unprognostic (4.24e-2)" "unprognostic (7.74e-2)" "prognostic unfavorable (1.91e-6)" "unprognostic (6.82e-2)" "unprognostic (2.91e-3)" "unprognostic (8.57e-2)" "unprognostic (1.52e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (2.11e-4)" "unprognostic (2.20e-1)" "unprognostic (7.63e-2)" "unprognostic (2.05e-1)" "unprognostic (7.41e-2)" 22.3 26.4 29.4 28.1 32.6 52.0 23.1 49.1 32.2 24.8 20.7 24.3 21.3 21.8 27.4 34.5 27.1 23.2 17.0 21.8 24.3 16.4 20.0 19.7 21.6 36.1 23.6 26.8 42.2 23.5 28.6 36.4 21.0 24.9 21.5 21.5 22.2 25.6 21.4 25.4 23.3 23.1 22.3 20.7 24.7 21.9 22.1 25.8 42.8 25.5 10.5 32.9 21.3 24.2 22.0 25.5 21.0 21.5 19.3 30.2 12.4 28.7 24.2 35.8 25.1 13.9 15.9 27.0 19.0 22.7 27.1 25.7 25.2 19.8 45.9 19.6 19.2 15.1 27.2 35.1 22.4 29.0 29.9 23.9 37.0 25.0 28.8 20.8 49.9 27.1 19.0 17.8 21.8 9.0 18.2 20.8 27.7 38.0 49.3 22.4 33.5 46.7 32.7 34.6 24.0 20.7 47.5 28.4 32.1 21.3 34.3 30.2 26.6 25.5 23.9 25.9 22.4 28.7 35.4 23.9 20.5 25.1 19.3 31.0 31.7 25.6 57.4 16.6 29.3 26.3 21.0 17.1 18.7 19.7 21.5 20.9 22.0 22.0 20.2 25.5 19.0 17.0 20.1 5.2 19.3 17.8 18.3 30.2 12.4 29.4 32.6 49.1 32.2 24.3 16.4 23.6 26.8 24.9 25.8 11.9 19.8 32.8 39.9 67.5 52.9 29.0 22.9 21.4 25.0 17.4 35.3 55.0 31.5 46.3 14.2 31.0 20.8 0.0 49.2 71.9 38.1 25.5 34.6 18.7 34.7 84.2 50.4 17.2 27.8 13.5 52.6 28.0 23.6 55.9 26.2 35.0 48.6 21.0 49.8 20.2 42.9 38.8 30.4 71.1 72.7 51.7 42.8 35.2 31.1 46.0 CPSF7 "CFIM59, FLJ12529" ENSG00000149532 "Cleavage and polyadenylation specific factor 7" Q8N684 11 61402641-61430031 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041094 Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041094: AB_10794187" "unprognostic (6.87e-3)" "unprognostic (8.31e-2)" "unprognostic (1.94e-1)" "unprognostic (4.79e-3)" "unprognostic (1.07e-1)" "unprognostic (9.41e-3)" "prognostic unfavorable (9.83e-4)" "unprognostic (5.35e-2)" "unprognostic (2.07e-3)" "unprognostic (7.95e-2)" "unprognostic (2.59e-1)" "unprognostic (3.74e-2)" "unprognostic (3.90e-2)" "unprognostic (2.16e-1)" "unprognostic (1.71e-1)" "unprognostic (2.38e-1)" "unprognostic (6.18e-2)" 23.3 25.6 23.2 24.3 39.0 34.5 25.6 31.6 49.5 26.9 25.4 35.4 34.9 22.6 41.6 33.5 27.0 31.6 19.9 20.9 25.0 19.9 25.2 33.6 24.0 28.5 24.3 24.9 40.5 29.0 36.1 47.8 26.9 29.2 27.6 25.5 33.2 28.4 28.4 36.7 33.9 27.6 32.5 27.2 33.9 26.9 31.3 28.5 45.6 36.0 19.8 32.3 27.1 26.3 10.4 10.5 14.2 8.3 8.5 12.9 7.4 26.5 26.7 37.4 29.6 20.3 18.0 26.3 22.1 21.2 29.4 22.6 31.1 22.9 39.9 23.8 23.6 25.0 32.9 35.8 25.3 36.0 26.4 18.3 33.6 34.4 24.9 20.5 40.6 29.9 19.0 20.7 31.2 45.7 17.9 19.8 26.0 40.3 25.6 21.2 32.2 40.2 33.1 36.7 18.5 21.1 37.9 29.5 32.9 22.0 33.0 25.5 26.0 29.4 26.0 27.2 23.9 36.0 17.5 20.0 32.6 27.9 30.5 22.8 35.5 41.7 46.0 19.0 19.6 23.9 14.2 7.4 9.2 12.2 8.3 12.9 10.4 9.7 12.3 10.5 10.0 10.7 10.8 14.0 8.5 6.1 8.9 6.6 7.4 23.2 39.0 31.6 49.5 25.0 19.9 24.3 24.9 29.2 28.5 32.8 20.5 21.7 16.3 20.6 18.3 9.8 15.3 13.4 11.4 15.7 37.3 22.8 14.9 14.1 22.1 17.5 17.6 0.0 12.1 14.6 16.6 19.0 23.1 26.1 17.2 30.2 21.4 21.5 32.9 20.3 25.3 18.3 3.3 32.5 20.4 26.4 16.1 8.6 23.7 13.4 21.7 38.8 24.7 32.5 26.8 23.1 23.0 19.1 24.2 20.1 CPT2 "CPT1, CPTASE" ENSG00000157184 "Carnitine palmitoyltransferase 2" P23786 1 53196429-53214197 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.0" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 64.6;Hepatocytes: 80.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028201, HPA028202, HPA028214" Enhanced Approved Nucleoplasm,Nucleoli,Mitochondria Yes No "Nucleoplasm, Mitochondria" Nucleoli "HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958" "unprognostic (2.43e-1)" "unprognostic (2.27e-1)" "prognostic favorable (5.27e-4)" "unprognostic (6.48e-2)" "unprognostic (1.88e-1)" "unprognostic (9.34e-2)" "unprognostic (6.48e-2)" "unprognostic (1.75e-2)" "unprognostic (2.86e-1)" "unprognostic (1.67e-1)" "unprognostic (3.00e-2)" "unprognostic (8.97e-2)" "prognostic favorable (1.46e-12)" "unprognostic (4.00e-2)" "unprognostic (2.06e-1)" "unprognostic (1.79e-2)" "unprognostic (2.95e-2)" 7.5 15.5 5.3 6.8 6.1 2.3 6.5 4.0 7.2 5.1 15.4 9.4 10.7 16.6 5.1 7.6 10.5 5.4 11.3 21.4 4.3 4.5 19.8 69.0 6.9 8.3 5.7 3.7 5.3 15.9 10.7 11.5 18.1 6.4 6.0 15.6 13.8 11.8 12.2 13.6 6.0 18.9 5.5 5.2 10.3 10.1 11.2 4.7 9.7 8.3 7.2 10.3 8.0 4.9 5.9 12.4 10.0 13.1 4.8 8.0 6.5 7.7 3.2 7.5 7.3 6.5 3.8 8.5 4.8 4.9 6.9 6.4 1.6 6.5 13.2 7.3 2.2 7.8 7.7 14.0 11.0 5.9 7.3 8.2 7.5 4.3 1.3 9.5 7.1 7.3 8.2 9.4 5.0 4.2 7.7 4.7 11.7 9.6 4.7 4.2 4.5 5.5 5.8 14.0 14.4 8.6 6.4 7.2 13.9 8.6 7.2 11.2 7.6 9.6 12.2 18.1 18.1 14.2 15.2 4.5 3.9 3.1 6.8 3.9 14.5 8.9 8.1 5.0 8.2 5.7 4.1 8.4 10.0 5.1 12.6 6.2 4.5 4.9 5.9 12.4 5.9 8.0 5.5 5.1 4.8 13.1 6.4 7.0 6.5 5.3 6.1 4.0 7.2 4.3 4.5 5.7 3.7 6.4 4.7 11.9 20.8 8.9 5.1 1.5 3.1 12.4 15.3 4.0 3.4 10.4 13.7 64.6 21.6 10.7 1.1 3.6 39.8 0.0 9.3 16.0 2.8 4.8 2.3 80.0 23.6 14.3 13.9 6.7 13.5 2.1 6.4 8.2 6.8 26.2 26.9 10.5 9.8 21.0 4.9 28.3 9.9 6.5 3.2 29.8 16.3 2.3 45.7 7.1 25.3 4.6 CRABP2 CRABP-II ENSG00000143320 "Cellular retinoic acid binding protein 2" P29373 1 156699606-156705816 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 154.2;tongue: 80.5" "Cell type enhanced" "Detected in many" 14 "Fibroblasts: 286.6;Glandular cells: 140.0;Suprabasal keratinocytes: 166.6;Urothelial cells: 412.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.2;naive CD4 T-cell: 1.3;naive CD8 T-cell: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.3" "Cell line enhanced" "Detected in many" "BJ hTERT+: 163.8;MCF7: 62.5;T-47d: 126.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA004135 Supported Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA004135: AB_1846516" "unprognostic (1.17e-2)" "unprognostic (9.30e-2)" "unprognostic (3.07e-2)" "prognostic unfavorable (2.11e-5)" "unprognostic (1.75e-2)" "unprognostic (1.08e-1)" "unprognostic (9.96e-2)" "unprognostic (1.88e-1)" "unprognostic (6.45e-2)" "unprognostic (7.79e-2)" "unprognostic (7.23e-3)" "unprognostic (7.16e-2)" "prognostic unfavorable (3.19e-13)" "unprognostic (3.05e-3)" "unprognostic (1.34e-1)" "unprognostic (3.86e-2)" "unprognostic (2.25e-2)" 4.9 1.1 1.0 1.7 3.2 0.7 16.8 1.3 2.1 66.8 1.3 1.2 38.5 0.0 13.9 2.8 154.2 13.1 2.8 1.2 0.9 2.1 1.4 0.2 0.7 0.4 0.8 2.9 5.9 0.8 2.7 5.0 7.0 3.7 6.7 0.7 7.9 10.6 28.0 0.5 25.7 0.9 8.8 1.1 0.8 0.5 1.1 0.9 2.1 2.2 80.5 33.5 10.0 66.6 0.1 0.0 0.4 0.0 0.0 1.3 0.5 10.4 0.5 12.0 0.1 15.6 23.4 0.0 22.2 163.8 1.8 2.2 18.6 38.6 0.1 11.0 23.6 0.2 13.6 2.9 0.0 0.5 0.2 0.8 0.0 1.4 0.1 3.1 0.0 0.2 7.4 1.1 2.6 0.0 1.4 0.0 0.2 0.1 0.2 0.2 62.5 0.1 0.1 14.4 1.2 5.9 0.1 0.0 0.3 0.2 0.4 29.8 2.1 0.3 38.7 0.1 23.5 126.9 0.0 0.0 0.4 6.8 3.7 1.3 1.0 2.2 0.1 3.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.2 0.0 0.1 1.3 1.2 0.4 0.0 0.0 0.0 0.0 0.5 1.0 3.2 1.3 2.1 0.9 2.1 0.8 2.9 3.7 0.9 0.0 1.6 0.0 100.3 57.8 1.7 0.6 0.0 4.0 10.3 15.7 2.0 42.7 0.0 12.0 2.0 4.3 0.4 0.0 4.5 5.4 286.6 140.0 0.0 0.0 8.9 0.0 0.0 10.4 0.0 0.7 18.4 1.0 59.1 0.0 0.5 0.8 11.9 0.0 35.3 0.0 0.5 0.0 22.7 1.4 6.6 166.6 15.1 2.9 0.6 412.9 CRADD RAIDD ENSG00000169372 "CASP2 and RIPK1 domain containing adaptor with death domain" P78560 12 93677375-93894840 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Apoptosis "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Early spermatids: 112.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005337 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB005337: AB_2085481" "unprognostic (1.07e-2)" "prognostic favorable (9.06e-5)" "unprognostic (9.65e-3)" "unprognostic (5.51e-2)" "unprognostic (2.88e-1)" "unprognostic (3.10e-1)" "unprognostic (3.79e-2)" "unprognostic (8.99e-2)" "unprognostic (1.54e-1)" "unprognostic (7.89e-2)" "unprognostic (6.06e-2)" "unprognostic (3.18e-2)" "prognostic favorable (4.04e-9)" "unprognostic (2.57e-2)" "unprognostic (6.86e-2)" "unprognostic (2.08e-1)" "unprognostic (3.02e-2)" 7.8 15.9 11.0 4.4 14.2 7.1 10.4 12.5 10.4 8.8 9.3 11.5 16.7 14.8 10.6 11.9 9.9 8.3 9.6 35.7 12.3 8.9 14.8 31.4 7.5 7.1 9.8 9.7 8.5 9.7 18.7 21.2 6.5 13.3 9.4 7.5 11.3 10.3 8.8 22.1 8.0 15.4 12.2 11.5 8.3 9.5 15.0 13.2 9.7 8.6 15.5 5.5 10.2 8.4 8.6 7.6 25.3 12.2 10.8 15.0 6.8 6.1 14.0 6.9 7.9 10.1 18.3 8.8 7.1 8.8 6.3 7.4 13.1 2.5 11.1 4.4 8.2 4.8 6.4 7.5 9.4 8.1 11.6 10.1 5.8 6.0 9.6 10.4 5.3 5.7 16.6 14.3 10.1 7.9 6.6 7.5 12.4 16.6 5.3 7.4 9.9 7.8 9.6 8.9 7.0 10.8 13.2 3.6 15.3 6.1 4.6 10.8 10.3 9.6 9.5 17.0 7.0 16.8 10.5 8.0 14.6 7.2 6.9 7.1 12.4 6.7 10.2 6.8 7.9 6.9 24.9 6.9 25.3 14.7 8.3 13.0 8.6 10.3 15.0 5.6 7.2 11.1 8.2 19.4 10.8 12.2 7.6 11.5 6.8 11.0 14.2 12.5 10.4 12.3 8.9 9.8 9.7 13.3 13.2 8.9 4.6 9.0 8.0 6.5 5.7 37.0 5.1 13.4 9.1 7.0 7.9 12.5 19.9 14.5 112.7 14.5 24.0 23.3 19.6 10.0 9.7 13.0 4.6 34.4 9.8 22.3 7.5 9.8 10.0 23.6 16.4 8.8 3.3 9.0 11.8 14.3 16.5 17.6 22.3 46.2 14.1 6.5 17.8 29.5 10.6 7.0 9.0 12.5 12.9 7.4 CRAMP1 "CRAMP1L, KIAA1426" ENSG00000007545 "Cramped chromatin regulator homolog 1" Q96RY5 16 1612325-1677908 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041752 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "HPA041752: AB_10796459" "unprognostic (3.67e-1)" "unprognostic (9.97e-2)" "unprognostic (2.72e-1)" "unprognostic (2.23e-1)" "unprognostic (3.41e-2)" "unprognostic (2.25e-3)" "unprognostic (5.78e-4)" "unprognostic (4.17e-2)" "unprognostic (8.53e-3)" "unprognostic (6.01e-2)" "unprognostic (1.55e-2)" "unprognostic (9.93e-2)" "unprognostic (3.86e-3)" "prognostic favorable (4.93e-4)" "unprognostic (8.57e-2)" "unprognostic (2.29e-1)" "unprognostic (1.33e-2)" 8.5 6.4 9.2 10.5 9.3 13.9 11.6 24.2 11.0 8.4 8.8 11.1 5.1 7.2 11.4 8.3 8.6 9.9 6.5 7.2 8.6 5.4 6.5 4.7 9.2 8.0 9.7 10.5 12.3 9.2 10.2 10.9 8.4 9.4 9.8 7.1 9.8 8.4 9.5 8.9 13.7 8.4 8.8 7.9 9.4 8.5 21.9 9.8 18.1 11.8 4.4 7.5 10.6 11.7 0.8 2.1 0.5 0.6 2.5 1.9 0.5 5.3 8.7 11.0 10.4 7.4 7.4 12.8 6.2 5.5 8.5 6.1 8.0 9.1 5.3 6.0 7.1 5.1 9.0 13.2 6.4 7.8 6.4 13.7 8.4 10.0 4.9 5.4 11.8 13.6 6.4 8.7 10.1 8.2 8.1 8.4 12.0 11.2 4.2 4.6 8.8 7.8 7.3 8.8 3.5 5.4 30.3 5.2 9.3 5.6 5.4 11.5 8.2 9.3 7.7 4.9 8.2 6.2 16.4 9.5 8.1 7.9 6.9 7.9 7.1 10.2 13.6 2.8 7.9 7.2 0.4 0.6 0.0 1.9 0.6 0.9 0.8 0.6 0.6 0.3 0.8 0.9 0.9 0.5 2.5 0.2 2.1 0.3 0.5 9.2 9.3 24.2 11.0 8.6 5.4 9.7 10.5 9.4 9.8 14.9 13.4 0.0 4.3 0.0 7.3 0.0 7.6 5.3 15.9 8.7 17.7 3.5 1.7 4.1 21.2 4.3 3.9 0.0 1.6 2.5 3.3 6.1 4.7 3.4 4.4 3.2 2.4 8.6 6.5 7.6 4.0 2.8 0.0 1.8 8.7 4.5 5.3 3.5 6.3 1.4 17.5 6.5 0.0 13.5 19.0 0.0 4.5 6.4 6.4 4.2 CRAT CAT1 ENSG00000095321 "Carnitine O-acetyltransferase" P43155 9 129094810-129111189 "Enzymes, Predicted intracellular proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 98.6;testis: 71.7" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 149.6;Late spermatids: 410.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019230, HPA020260, HPA022815" Enhanced Approved "Nucleoplasm,Nuclear membrane" NA NA 13000 "Nucleoplasm, Nuclear membrane" "HPA019230: AB_1847212, HPA020260: AB_1847210, HPA022815: AB_2732427" "unprognostic (5.13e-2)" "unprognostic (9.79e-3)" "unprognostic (1.99e-2)" "prognostic favorable (2.36e-4)" "unprognostic (2.19e-1)" "unprognostic (1.14e-1)" "unprognostic (1.15e-2)" "unprognostic (2.18e-1)" "unprognostic (5.11e-2)" "unprognostic (3.24e-2)" "unprognostic (3.13e-3)" "unprognostic (2.03e-1)" "prognostic favorable (0.00e+0)" "unprognostic (1.38e-1)" "unprognostic (9.27e-2)" "unprognostic (1.26e-2)" "unprognostic (7.65e-2)" 11.6 13.4 8.4 4.6 9.2 5.9 10.7 7.5 15.9 8.3 15.4 8.6 6.2 24.3 6.5 9.5 9.4 5.4 10.0 17.3 7.7 7.9 12.9 50.0 4.2 3.1 8.3 9.1 7.3 33.1 16.8 3.2 7.9 9.3 10.5 4.4 8.1 14.7 7.9 98.6 7.0 22.8 8.3 5.2 4.6 8.1 71.7 4.4 2.4 8.0 20.2 4.4 9.3 6.8 2.6 11.3 6.0 11.3 6.0 10.0 8.1 0.1 18.3 6.4 13.1 12.0 16.1 9.3 7.8 8.7 9.5 6.0 3.8 7.4 0.7 4.7 13.1 12.7 3.3 1.7 2.8 3.4 11.8 0.4 3.6 9.2 14.7 17.1 0.1 14.0 14.7 0.0 8.0 0.2 12.1 12.4 3.5 1.6 3.8 9.7 3.6 0.3 8.1 1.5 19.8 8.2 9.1 12.3 6.0 9.2 0.3 2.1 6.6 0.0 4.1 2.7 2.1 26.6 4.0 11.1 14.3 1.0 17.9 7.7 13.0 11.0 0.0 16.9 2.2 9.1 2.5 11.3 6.0 5.0 7.4 10.0 2.4 6.9 6.6 11.3 2.6 4.3 4.7 2.9 6.0 7.3 5.3 6.4 8.1 8.4 9.2 7.5 15.9 7.7 7.9 8.3 9.1 9.3 4.4 6.0 3.0 5.4 4.5 2.9 1.4 52.0 20.4 1.4 3.4 3.5 2.0 38.4 14.9 16.6 149.6 12.6 94.4 0.0 19.6 46.4 21.8 14.9 6.9 58.6 18.0 1.6 14.9 14.1 8.1 410.0 20.4 8.8 5.0 9.0 16.9 13.4 12.1 38.6 23.0 41.0 1.4 6.5 14.6 94.3 6.9 4.0 42.1 10.7 22.1 9.9 CREB1 ENSG00000118260 "CAMP responsive element binding protein 1" P16220 2 207529737-207603431 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Differentiation, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "Early spermatids: 355.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003803, HPA019150" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB003803: AB_562092, HPA019150: AB_1847220" "unprognostic (1.20e-1)" "unprognostic (3.15e-1)" "unprognostic (3.30e-2)" "unprognostic (2.69e-2)" "unprognostic (3.16e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (2.77e-5)" "unprognostic (8.41e-2)" "unprognostic (1.04e-2)" "unprognostic (2.53e-1)" "unprognostic (9.58e-2)" "unprognostic (1.74e-2)" "unprognostic (4.82e-3)" "unprognostic (5.53e-3)" "unprognostic (1.06e-1)" "unprognostic (1.77e-1)" "unprognostic (8.45e-2)" 21.2 12.9 19.4 24.8 17.0 22.9 16.7 25.5 18.7 17.6 15.7 14.3 14.7 12.6 19.3 14.9 17.9 15.4 15.5 14.4 15.4 14.5 14.6 13.1 17.7 21.7 15.8 17.7 20.5 12.9 19.8 20.0 19.8 16.1 16.3 16.2 11.2 16.2 14.9 11.6 14.3 15.2 19.5 19.8 19.0 13.3 39.2 18.5 38.4 19.7 13.3 27.7 16.1 23.6 22.1 20.7 34.8 19.1 28.4 22.5 14.5 15.3 13.8 25.5 9.8 15.0 15.4 14.6 9.9 14.8 17.2 18.1 13.9 15.6 10.0 13.3 14.5 20.2 13.4 23.1 13.5 25.3 15.9 8.3 18.3 12.3 14.2 12.6 17.3 13.5 11.1 10.0 14.2 21.1 17.2 24.1 18.7 12.8 14.6 21.2 10.6 26.2 10.2 18.2 15.4 8.4 20.5 13.9 13.1 15.4 15.9 17.6 15.3 13.7 10.1 11.9 25.5 11.3 18.9 11.5 14.1 15.1 14.7 12.6 13.2 16.7 23.0 17.3 15.9 14.7 16.9 17.0 16.8 17.3 18.0 15.4 22.1 16.6 16.7 20.7 20.2 19.9 13.5 34.8 28.4 19.1 11.3 22.5 14.5 19.4 17.0 25.5 18.7 15.4 14.5 15.8 17.7 16.1 18.5 17.9 12.8 45.4 39.6 63.0 36.1 22.1 12.7 9.4 25.0 12.2 31.4 24.5 19.9 20.2 355.9 44.6 20.0 0.0 17.9 21.7 32.3 41.9 42.7 14.3 25.7 38.1 31.2 31.3 43.4 27.4 24.2 38.0 42.2 36.9 24.2 40.0 21.9 23.5 27.6 15.6 36.9 38.8 34.1 24.7 27.5 50.6 15.6 31.9 23.0 54.8 CREB3L2 "BBF2H7, TCAG_1951439" ENSG00000182158 "CAMP responsive element binding protein 3 like 2" Q70SY1 7 137874979-138002067 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 81.6" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 120.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015068, HPA015534" Enhanced Supported "Nucleoplasm,Endoplasmic reticulum" NA NA "Nucleoplasm, Endoplasmic reticulum" "HPA015068: AB_1847224, HPA015534: AB_2669210" "unprognostic (8.50e-2)" "unprognostic (3.70e-2)" "unprognostic (2.77e-1)" "unprognostic (1.50e-3)" "unprognostic (9.88e-2)" "unprognostic (9.09e-2)" "unprognostic (5.17e-2)" "unprognostic (4.50e-1)" "unprognostic (4.77e-1)" "unprognostic (8.93e-2)" "unprognostic (9.48e-2)" "unprognostic (9.65e-2)" "unprognostic (2.42e-1)" "unprognostic (3.08e-3)" "unprognostic (7.65e-2)" "unprognostic (2.59e-2)" "unprognostic (1.32e-2)" 14.9 19.8 4.7 17.1 9.8 10.8 15.7 1.9 6.0 25.4 16.7 11.4 18.7 11.6 28.2 25.5 12.8 16.2 16.2 20.4 5.6 4.3 17.0 11.7 14.6 15.2 11.8 3.7 25.9 16.0 38.4 28.8 81.6 9.8 15.9 9.5 24.9 26.5 23.3 5.0 6.9 17.5 17.7 6.2 12.1 14.1 9.8 9.1 7.0 35.8 10.9 18.1 21.3 15.7 4.6 12.4 7.4 5.6 6.5 11.8 3.2 4.0 6.3 12.0 0.2 20.5 20.4 9.0 20.4 33.0 14.3 14.5 8.6 3.7 0.8 5.5 22.1 7.8 2.2 7.0 14.9 28.0 5.9 3.5 25.7 8.6 20.5 13.6 7.7 36.9 8.4 9.5 18.0 21.1 14.7 18.8 2.1 13.2 12.0 16.7 7.3 2.4 9.5 4.3 5.6 4.5 5.4 6.5 6.8 11.2 4.2 3.1 7.2 6.6 17.1 9.1 7.3 2.5 5.8 20.0 19.2 2.9 23.1 7.4 14.2 4.9 5.3 23.0 21.8 42.5 7.4 5.6 5.9 8.2 2.9 10.6 4.0 6.0 8.6 5.8 4.6 2.2 3.8 2.1 6.5 1.5 12.4 11.8 3.2 4.7 9.8 1.9 6.0 5.6 4.3 11.8 3.7 9.8 9.1 6.0 20.4 20.6 8.1 10.9 7.2 14.1 20.4 10.7 18.2 22.7 9.8 50.6 11.6 9.3 48.0 20.2 32.0 0.0 15.3 76.5 40.4 27.0 48.5 24.5 49.4 14.3 15.1 30.1 33.2 14.1 57.2 25.1 25.3 10.0 17.0 6.7 15.1 17.3 96.9 9.1 12.4 38.8 42.4 1.1 4.3 6.1 120.8 27.3 14.9 17.2 CREB3L4 "AIbZIP, ATCE1, CREB3, CREB4, hJAL" ENSG00000143578 "CAMP responsive element binding protein 3 like 4" Q8TEY5 1 153967534-153974363 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 49.9" "Cell type enhanced" "Detected in many" 7 "Glandular cells: 54.0;Mucus-secreting cells: 48.0" "Group enriched" "Detected in all" 5 "breast cancer: 47.8;endometrial cancer: 28.7;prostate cancer: 109.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 24.9;OE19: 25.3;SK-BR-3: 55.0;T-47d: 44.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038122 Enhanced Approved "Nucleoplasm,Nuclear membrane,Mitochondria" No No "Nucleoplasm, Nuclear membrane" Mitochondria "HPA038122: AB_10669516" "unprognostic (1.35e-1)" "unprognostic (4.71e-2)" "unprognostic (8.13e-3)" "prognostic favorable (7.21e-4)" "unprognostic (2.04e-1)" "unprognostic (1.40e-2)" "unprognostic (5.51e-3)" "unprognostic (5.02e-2)" "unprognostic (1.01e-1)" "unprognostic (4.40e-2)" "unprognostic (1.62e-1)" "unprognostic (1.70e-1)" "unprognostic (7.12e-3)" "unprognostic (2.13e-1)" "unprognostic (1.06e-1)" "unprognostic (8.83e-2)" "unprognostic (9.34e-3)" 4.3 5.0 3.2 5.4 4.0 2.9 22.6 5.7 3.5 14.6 5.1 4.3 18.3 5.0 8.5 12.1 5.1 8.8 7.9 3.2 2.5 1.4 4.5 8.4 4.7 5.5 3.2 3.0 9.3 7.9 3.7 3.4 6.6 4.0 49.9 6.9 4.7 24.7 11.4 6.1 5.9 5.3 3.4 3.3 4.5 13.2 4.3 3.0 12.9 12.5 6.6 8.3 4.5 15.1 6.6 7.3 2.6 3.5 10.9 6.0 3.1 2.3 3.3 3.1 3.4 2.2 3.3 7.8 1.9 2.2 2.6 2.3 1.5 9.7 4.2 10.1 0.8 2.0 3.7 4.6 3.0 1.4 3.4 1.8 3.1 3.6 2.7 1.8 1.4 2.7 3.5 2.9 2.5 5.7 2.4 2.3 5.1 2.4 5.3 1.2 24.9 2.7 1.1 2.1 25.3 4.0 6.2 3.2 7.8 2.8 1.6 5.9 6.3 2.0 55.0 5.2 4.2 44.1 4.5 1.4 0.8 2.4 1.6 1.5 10.0 5.1 3.1 1.7 2.6 2.5 2.2 3.5 2.6 4.5 1.5 6.0 6.3 2.6 3.3 6.4 6.6 2.5 4.8 0.1 10.9 2.1 7.3 2.1 3.1 3.2 4.0 5.7 3.5 2.5 1.4 3.2 3.0 4.0 3.0 6.0 12.5 2.0 15.5 2.6 4.7 1.7 10.2 18.7 12.5 1.8 2.0 11.1 8.3 11.1 0.0 4.9 3.2 0.0 11.8 13.3 3.3 54.0 5.7 12.3 4.8 0.0 8.6 3.1 7.9 0.0 6.6 2.2 5.0 1.8 48.0 6.0 7.4 3.5 2.1 3.6 7.5 19.4 3.3 3.6 8.7 2.6 3.5 4.4 11.8 3.5 CREB5 "CRE-BPA, H_GS165L15.1" ENSG00000146592 "CAMP responsive element binding protein 5" Q02930 7 28299321-28825894 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 53.3;brain: 38.0" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 116.6;Macrophages: 74.2;monocytes: 74.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "neutrophil: 53.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 53.3" "Cell line enhanced" "Detected in many" "HL-60: 32.2;Karpas-707: 13.5;U-2 OS: 14.2;U-2197: 15.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA050020, HPA061622" Approved "Nucleoplasm,Vesicles,Plasma membrane" NA Yes Nucleoplasm "Vesicles, Plasma membrane" "HPA050020: AB_2680993, HPA061622: AB_2684569" "unprognostic (3.59e-2)" "unprognostic (3.80e-1)" "unprognostic (1.06e-1)" "unprognostic (6.46e-2)" "unprognostic (1.01e-1)" "unprognostic (4.90e-3)" "unprognostic (2.01e-3)" "unprognostic (2.87e-1)" "unprognostic (3.31e-1)" "unprognostic (1.04e-1)" "unprognostic (3.49e-1)" "unprognostic (2.67e-1)" "unprognostic (4.91e-3)" "unprognostic (6.61e-2)" "unprognostic (3.95e-1)" "unprognostic (1.60e-1)" "unprognostic (1.52e-3)" 20.0 3.6 12.1 15.4 19.5 11.5 9.0 10.4 17.8 4.6 5.6 38.0 0.9 2.8 16.3 6.9 7.7 4.7 23.1 10.4 16.7 8.7 6.6 4.6 9.5 6.1 17.9 12.1 2.4 7.0 1.5 2.8 19.5 18.3 3.1 4.3 1.1 6.5 3.0 6.2 5.5 4.2 9.8 14.6 12.6 3.2 2.3 22.7 0.0 3.8 7.0 2.5 5.5 5.0 0.3 4.8 53.3 7.8 0.0 0.0 1.5 0.0 0.3 3.9 0.2 0.2 5.7 0.1 0.3 0.8 2.4 3.6 2.2 1.4 9.9 0.7 0.9 2.4 0.4 0.1 3.4 7.6 0.0 2.7 10.7 2.1 0.2 0.2 32.2 0.4 0.7 0.7 10.2 11.0 0.5 1.6 0.0 1.2 13.5 0.8 0.0 0.0 0.0 4.9 0.0 3.9 0.2 3.7 0.2 4.9 1.0 0.4 2.8 0.1 0.2 1.1 5.7 0.1 0.7 0.4 4.7 14.2 15.5 4.5 0.8 2.2 0.1 5.2 0.2 8.0 0.0 7.8 0.0 0.0 2.7 0.0 0.3 0.0 0.0 4.8 0.0 0.0 0.0 53.3 0.0 0.8 0.0 0.0 1.5 12.1 19.5 10.4 15.6 16.7 8.7 17.9 12.1 18.3 22.7 6.0 11.1 4.5 116.6 19.5 0.0 14.1 22.9 5.3 6.8 12.2 0.0 2.5 1.7 61.9 0.4 14.9 0.0 0.0 23.7 9.2 31.3 32.4 13.9 0.5 8.1 4.8 0.0 7.4 46.4 1.1 5.5 74.2 28.7 74.9 0.0 16.6 30.3 0.0 0.4 18.3 0.6 19.4 10.7 12.5 3.3 11.5 20.7 1.3 0.0 28.7 CREBBP "CBP, KAT3A, RSTS, RTS" ENSG00000005339 "CREB binding protein" Q92793 16 3725054-3880726 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Transcription, Transcription regulation" "Activator, Acyltransferase, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004212, HPA055861" Supported Enhanced "Nucleoplasm,Nuclear bodies" No No Nucleoplasm "Nuclear bodies" "CAB004212: AB_626817, HPA055861: AB_2682948" "unprognostic (1.17e-1)" "unprognostic (8.51e-2)" "unprognostic (1.60e-1)" "unprognostic (1.63e-1)" "unprognostic (1.49e-1)" "unprognostic (5.09e-2)" "unprognostic (9.59e-3)" "unprognostic (6.98e-2)" "unprognostic (8.96e-2)" "unprognostic (1.08e-1)" "unprognostic (1.76e-1)" "unprognostic (2.84e-1)" "prognostic favorable (6.24e-5)" "unprognostic (1.47e-1)" "unprognostic (1.74e-1)" "unprognostic (3.97e-2)" "unprognostic (8.23e-2)" 18.5 10.9 17.2 22.8 17.5 37.0 17.4 42.6 18.8 20.1 17.2 16.8 17.1 9.9 25.1 15.2 14.1 18.9 21.3 14.5 17.1 8.7 11.1 12.3 16.9 14.4 20.5 12.0 31.6 23.4 24.3 13.0 13.3 15.8 18.4 11.6 14.6 14.9 16.7 28.2 20.4 16.4 17.0 13.6 17.4 14.7 29.1 20.2 29.6 19.5 13.8 16.1 19.0 29.9 4.7 2.3 10.6 3.8 2.0 2.7 1.1 5.6 14.5 18.8 8.3 11.5 11.4 9.8 8.1 13.7 14.0 13.7 13.1 10.6 15.6 9.7 15.5 9.0 10.9 21.6 6.7 16.0 26.3 8.7 12.2 13.4 8.3 12.8 12.2 17.6 10.1 6.8 15.6 18.9 8.7 10.5 8.0 13.9 21.4 7.6 19.3 8.1 5.9 15.4 5.4 6.0 38.3 14.9 11.9 5.4 7.6 15.7 10.3 13.9 13.7 8.2 12.7 12.2 12.0 16.3 17.2 17.2 8.8 7.4 10.0 10.8 30.3 3.5 7.3 12.1 2.9 1.7 1.3 2.7 2.2 1.4 4.7 1.3 2.0 1.0 3.3 1.4 1.7 10.6 2.0 3.8 2.3 1.3 1.1 17.2 17.5 42.6 18.8 17.1 8.7 20.5 12.0 15.8 20.2 41.7 45.9 13.8 25.5 49.9 31.9 37.0 43.3 32.1 33.0 10.4 23.6 14.6 5.0 17.4 38.0 35.3 24.0 0.0 17.7 9.4 24.3 32.2 30.0 25.1 17.8 27.0 14.5 32.5 38.7 57.1 52.3 33.5 16.9 27.9 22.4 31.4 22.7 17.3 48.1 10.7 15.8 45.3 36.0 33.1 46.0 51.4 25.7 35.9 23.8 31.6 CREBL2 ENSG00000111269 "CAMP responsive element binding protein like 2" O60519 12 12611827-12645108 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 77.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043738 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA043738: AB_10795041" "unprognostic (2.87e-2)" "unprognostic (1.15e-1)" "unprognostic (2.32e-1)" "unprognostic (7.51e-2)" "unprognostic (7.38e-2)" "unprognostic (4.51e-1)" "unprognostic (1.44e-1)" "unprognostic (5.92e-2)" "unprognostic (1.10e-1)" "unprognostic (4.12e-2)" "unprognostic (5.82e-3)" "unprognostic (6.73e-2)" "prognostic favorable (2.26e-5)" "unprognostic (6.31e-2)" "unprognostic (1.57e-1)" "unprognostic (3.59e-1)" "unprognostic (1.53e-1)" 21.9 77.6 24.3 16.5 31.9 3.0 18.9 21.4 24.6 16.4 13.4 14.6 13.5 13.2 11.4 17.5 10.4 14.9 16.4 14.3 19.8 23.0 28.7 28.2 18.5 18.8 20.2 19.8 22.6 14.2 31.7 31.5 13.8 19.7 17.1 14.2 20.5 15.4 14.4 6.6 14.1 13.3 12.0 20.0 20.2 14.1 17.1 18.3 8.6 25.9 6.7 16.6 17.7 14.0 2.0 4.2 3.6 8.7 1.6 8.1 2.2 5.5 7.2 6.3 7.1 22.3 22.6 12.2 10.9 18.4 8.0 11.1 5.2 8.1 4.8 4.2 13.2 12.2 4.7 9.5 8.3 13.7 26.8 5.7 3.8 7.2 6.3 14.6 5.3 7.1 14.6 15.0 9.4 15.5 27.5 11.7 3.8 3.8 7.6 13.5 8.9 2.8 4.4 18.9 5.3 6.6 3.8 10.9 3.0 15.4 16.1 7.4 8.5 11.0 5.4 19.0 28.5 3.0 6.1 9.4 11.1 7.1 10.9 10.7 6.4 8.5 1.2 13.2 4.6 11.4 1.7 3.8 3.6 2.8 8.7 5.0 1.5 5.5 4.4 4.2 2.0 5.5 4.5 0.7 1.6 3.6 2.1 8.1 2.2 24.3 31.9 21.4 24.6 19.8 23.0 20.2 19.8 19.7 18.3 23.8 21.6 14.3 16.0 19.7 16.9 12.3 22.9 16.0 12.5 31.4 2.0 14.7 34.9 16.6 23.6 20.4 18.6 0.0 19.2 14.9 18.4 35.5 10.3 38.9 36.4 35.0 28.8 22.7 83.1 5.0 33.4 54.7 32.1 45.9 18.1 28.7 18.7 10.5 33.2 48.0 11.0 38.8 9.1 30.0 17.4 25.5 23.0 15.3 15.1 19.2 CREBRF "C5orf41, LRF" ENSG00000164463 "CREB3 regulatory factor" Q8IUR6 5 173056352-173139284 "Predicted intracellular proteins" "Stress response, Transcription, Transcription regulation, Transport, Unfolded protein response" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 19.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015329 Supported Nucleoplasm NA NA Nucleoplasm "HPA015329: AB_2669192" "unprognostic (8.00e-2)" "unprognostic (2.47e-2)" "unprognostic (1.30e-1)" "unprognostic (3.14e-2)" "unprognostic (5.41e-2)" "unprognostic (1.85e-3)" "unprognostic (1.35e-1)" "unprognostic (6.03e-3)" "unprognostic (1.78e-1)" "unprognostic (1.38e-1)" "unprognostic (2.17e-2)" "unprognostic (4.69e-2)" "prognostic favorable (3.20e-7)" "unprognostic (1.40e-2)" "unprognostic (1.81e-1)" "unprognostic (2.52e-1)" "prognostic favorable (9.30e-4)" 18.0 10.6 15.9 9.2 17.3 53.5 16.5 29.7 23.1 13.8 12.4 5.6 11.7 7.9 15.2 11.2 8.5 10.9 9.4 10.0 16.6 6.7 13.9 10.7 16.3 16.0 19.0 11.0 18.4 9.3 16.6 18.0 13.0 14.9 11.8 8.4 6.7 13.2 13.0 12.2 15.6 12.9 16.1 15.1 14.7 10.3 12.0 18.4 9.2 21.7 3.8 9.6 15.3 19.1 4.9 2.6 19.0 2.6 1.3 4.1 1.4 1.0 2.2 2.2 3.4 10.2 13.6 5.2 3.1 15.2 2.9 5.6 3.1 5.2 1.8 7.5 3.1 5.4 1.3 1.0 2.4 4.1 6.8 2.1 1.4 1.5 1.0 7.9 1.1 8.5 8.2 6.2 3.1 7.9 7.2 3.5 2.4 1.3 9.9 3.4 1.9 1.8 1.6 0.7 1.5 1.1 1.7 1.5 2.9 4.1 2.0 1.7 2.6 3.1 1.3 11.5 4.9 1.4 2.1 5.7 4.4 1.4 3.0 0.8 11.1 9.2 3.3 3.3 2.0 1.5 3.5 2.4 4.9 3.3 2.1 3.0 2.6 3.3 2.7 1.2 4.9 4.1 3.2 19.0 1.3 2.6 2.6 2.9 1.4 15.9 17.3 29.7 23.1 16.6 6.7 19.0 11.0 14.9 18.4 47.6 36.6 34.0 20.7 70.3 49.1 53.7 33.1 36.1 27.3 36.6 64.8 8.0 13.3 12.1 4.3 64.3 34.2 93.5 13.6 9.5 43.2 42.5 46.2 31.1 18.6 106.5 73.4 38.1 67.4 5.3 48.1 51.3 62.4 45.1 27.3 35.7 15.8 24.6 51.6 18.2 63.6 58.2 59.3 63.7 44.6 81.2 31.2 53.2 18.8 18.5 CREBZF ZF ENSG00000137504 "CREB/ATF bZIP transcription factor" Q9NS37 11 85659708-85682908 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Rod photoreceptor cells: 112.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021526, HPA063652" Uncertain Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA021526: AB_2670738, HPA063652: AB_2685075" "unprognostic (1.17e-1)" "unprognostic (1.70e-1)" "unprognostic (1.39e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (6.46e-2)" "unprognostic (2.23e-3)" "unprognostic (2.21e-1)" "unprognostic (1.17e-2)" "unprognostic (1.19e-2)" "unprognostic (4.51e-2)" "unprognostic (1.04e-3)" "unprognostic (2.23e-3)" "unprognostic (1.73e-2)" "unprognostic (7.68e-2)" "unprognostic (4.34e-2)" "unprognostic (2.38e-3)" 15.4 18.7 16.6 19.5 23.3 13.2 19.8 31.4 21.7 23.1 18.1 23.7 18.5 22.0 29.0 19.9 15.0 22.3 18.2 13.3 16.9 10.5 14.9 16.2 17.5 25.0 34.0 18.7 31.5 27.2 30.0 23.8 18.3 20.2 21.2 20.6 20.0 19.3 17.0 13.1 18.2 24.4 20.0 21.3 26.1 20.2 12.7 24.8 21.6 27.1 11.7 21.3 19.1 21.3 3.1 2.4 2.3 2.8 1.9 3.8 0.8 3.6 11.1 9.3 3.1 3.9 4.3 11.4 5.8 3.4 5.0 6.6 11.1 17.8 9.3 5.9 3.2 20.7 13.4 7.5 3.9 7.5 7.5 9.3 9.6 32.1 3.4 3.1 9.6 5.6 4.5 9.3 5.5 8.2 4.7 2.8 6.8 8.3 15.8 4.5 5.9 8.6 13.8 3.7 11.0 5.8 17.5 10.7 6.7 4.4 7.0 9.8 9.3 9.2 13.1 2.3 4.9 15.6 15.7 4.3 10.7 8.7 17.2 8.0 5.9 5.2 12.9 2.9 6.9 8.6 1.9 1.6 1.4 2.3 1.4 3.8 3.1 1.5 1.9 2.0 2.9 2.5 2.3 2.3 1.9 2.8 2.4 1.1 0.8 16.6 23.3 31.4 21.7 16.9 10.5 34.0 18.7 20.2 24.8 17.9 19.2 20.4 20.2 36.7 100.5 11.3 12.7 14.7 14.8 21.0 86.4 13.0 8.3 10.5 19.0 26.4 25.1 23.3 7.4 12.3 29.2 26.1 21.9 26.0 8.7 85.8 37.8 22.1 18.6 13.7 28.4 14.6 32.1 9.0 23.6 57.0 8.3 20.9 31.5 5.3 112.5 12.9 28.9 20.0 5.9 36.1 12.0 25.8 19.9 21.0 CREM hCREM-2 ENSG00000095794 "CAMP responsive element modulator" Q03060 10 35126791-35212958 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 74.9" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 1553.0;Late spermatids: 579.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001818, CAB018352" Enhanced Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB018352: AB_673599, HPA001818: AB_1078566" "unprognostic (1.78e-1)" "unprognostic (6.26e-3)" "unprognostic (7.09e-2)" "unprognostic (2.51e-2)" "unprognostic (6.22e-3)" "unprognostic (9.27e-3)" "unprognostic (1.16e-1)" "unprognostic (2.41e-2)" "unprognostic (1.32e-1)" "unprognostic (7.66e-3)" "unprognostic (8.98e-2)" "unprognostic (3.42e-1)" "prognostic unfavorable (1.23e-5)" "unprognostic (4.44e-2)" "unprognostic (4.19e-1)" "unprognostic (1.66e-2)" "unprognostic (1.52e-1)" 21.9 61.4 14.3 21.3 15.1 8.1 15.4 6.2 13.8 10.6 8.0 8.4 10.2 4.1 13.3 10.8 8.2 9.9 19.7 19.5 14.5 15.2 15.4 26.1 19.6 7.1 12.7 8.3 21.4 8.2 8.3 24.2 42.0 20.1 12.2 6.4 9.6 5.7 19.2 10.0 3.2 7.0 11.0 15.5 21.8 7.5 74.9 7.7 8.1 10.8 6.8 7.3 18.1 11.7 6.4 11.2 10.1 4.9 8.6 14.6 8.2 9.1 14.8 12.5 12.8 8.8 9.2 12.5 12.1 9.5 7.6 10.6 1.7 3.9 15.7 11.8 7.0 8.3 2.1 10.7 7.9 11.2 38.5 7.9 5.6 10.2 6.9 10.5 1.3 5.9 8.1 10.0 14.9 4.6 6.7 21.2 11.9 16.2 6.5 11.7 7.4 9.5 4.0 3.7 3.4 34.1 5.9 6.5 2.9 13.4 3.6 2.9 8.0 5.7 5.0 32.0 14.9 2.8 4.1 28.1 5.8 7.5 16.0 7.9 2.9 3.9 5.4 13.9 12.4 5.0 4.7 3.3 10.1 11.5 4.9 14.2 6.4 12.7 10.1 3.8 5.5 9.0 10.4 9.0 8.6 3.6 11.2 14.6 8.2 14.3 15.1 6.2 13.8 14.5 15.2 12.7 8.3 20.1 7.7 17.9 64.8 33.0 45.1 127.4 16.5 58.9 20.4 53.5 31.8 157.1 5.9 87.7 82.9 30.2 1553.0 61.6 13.0 0.0 38.6 102.1 73.7 43.8 344.6 37.7 100.7 9.5 66.1 14.1 50.2 579.8 24.2 113.1 234.5 315.6 10.3 26.0 26.6 17.5 30.8 49.4 18.2 45.3 183.3 211.4 136.9 94.7 192.3 100.1 11.0 45.0 CRIP2 "CRP2, ESP1" ENSG00000182809 "Cysteine rich protein 2" P52943 14 105472962-105480170 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "heart muscle: 180.3" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 702.6;Endothelial cells: 478.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 24.0;T-reg: 29.2" "Group enriched" "Detected in many" 19 "B-cells: 17.9;T-cells: 29.2" "Cell line enhanced" "Detected in many" "A549: 38.5;EFO-21: 39.4;HUVEC TERT2: 36.8;MCF7: 56.5;SK-BR-3: 44.3;T-47d: 37.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042664 Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA 490000 Nucleoli "Nucleoplasm, Plasma membrane" "HPA042664: AB_10797017" "unprognostic (2.68e-1)" "unprognostic (6.53e-3)" "unprognostic (2.11e-3)" "unprognostic (2.19e-1)" "unprognostic (2.39e-1)" "unprognostic (2.14e-1)" "unprognostic (1.63e-2)" "unprognostic (2.56e-1)" "unprognostic (3.20e-3)" "unprognostic (9.68e-2)" "unprognostic (6.96e-2)" "unprognostic (1.14e-1)" "unprognostic (2.04e-2)" "unprognostic (6.25e-2)" "unprognostic (2.35e-2)" "unprognostic (2.39e-2)" "unprognostic (8.26e-3)" 22.8 11.5 27.5 9.1 24.6 1.6 16.9 3.6 30.3 20.2 10.1 9.4 33.7 7.9 15.3 30.6 25.6 29.5 24.5 180.3 22.6 18.7 20.0 6.9 28.5 9.3 13.5 16.9 12.5 12.6 4.3 20.4 29.1 10.4 14.6 3.8 8.8 18.4 28.0 10.7 28.4 9.1 24.9 10.3 13.0 11.3 10.9 7.8 1.0 17.8 23.8 13.3 23.8 17.5 17.9 0.9 0.2 0.5 1.2 29.2 3.4 0.4 38.5 5.6 15.3 0.9 4.0 1.6 1.7 0.4 0.5 0.1 1.2 7.1 0.0 39.4 12.6 0.8 22.0 0.7 9.3 0.0 0.2 0.2 0.0 24.2 14.6 4.1 0.0 3.3 1.9 0.8 0.9 5.3 7.2 36.8 0.0 0.0 0.3 5.5 56.5 0.1 0.1 1.5 7.8 23.1 0.0 0.7 1.6 25.9 0.1 8.5 21.4 2.5 44.3 0.3 0.9 37.9 0.0 14.3 12.8 6.0 0.3 7.1 0.1 0.1 0.1 3.7 0.0 25.7 0.0 0.5 0.0 2.4 0.2 2.3 14.4 24.0 5.3 0.9 17.9 5.9 1.6 0.2 1.2 0.1 0.1 29.2 3.4 27.5 24.6 3.6 30.3 22.6 18.7 13.5 16.9 10.4 7.8 145.9 41.3 6.5 66.0 136.0 2.2 702.6 96.8 105.7 131.9 179.7 3.9 0.9 131.0 90.2 30.6 478.7 0.0 0.0 80.2 15.4 145.8 41.0 7.0 27.0 2.6 89.0 24.2 229.6 13.7 62.0 25.9 11.3 148.5 2.8 0.0 55.2 33.3 0.0 13.8 9.8 3.7 271.7 208.1 5.9 44.5 172.0 26.8 6.4 0.0 77.0 CRIPT HSPC139 ENSG00000119878 "CXXC repeat containing interactor of PDZ3 domain" Q9P021 2 46616416-46625742 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046080, HPA056765" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA046080: AB_2679529, HPA056765: AB_2683230" "unprognostic (3.38e-2)" "unprognostic (4.08e-1)" "unprognostic (1.67e-1)" "unprognostic (7.51e-3)" "unprognostic (1.91e-2)" "unprognostic (1.74e-2)" "prognostic unfavorable (1.19e-4)" "unprognostic (1.10e-1)" "unprognostic (6.07e-2)" "unprognostic (1.54e-2)" "unprognostic (3.38e-1)" "unprognostic (1.44e-1)" "prognostic unfavorable (5.54e-4)" "unprognostic (4.18e-2)" "unprognostic (1.43e-1)" "unprognostic (1.12e-2)" "unprognostic (4.42e-2)" 13.8 17.1 29.3 9.4 26.2 10.0 18.9 24.3 23.9 12.2 11.4 28.7 10.8 15.5 18.2 17.5 12.6 14.6 10.5 22.1 26.5 23.1 19.8 18.8 9.3 11.9 27.6 18.1 17.5 9.8 12.7 21.9 14.3 23.2 14.9 13.4 13.6 16.8 12.5 18.4 13.6 14.2 12.1 36.6 10.1 11.3 12.3 26.2 13.4 14.0 8.8 13.2 14.4 10.8 13.3 14.0 20.9 9.4 11.5 15.5 9.0 15.7 9.3 9.9 8.6 12.2 13.1 12.6 11.0 8.3 9.6 10.0 12.0 12.0 8.5 30.1 12.3 14.0 8.4 10.0 10.7 14.8 18.3 11.8 9.0 11.8 15.4 14.0 8.7 8.6 10.1 14.2 12.3 8.8 20.0 14.3 7.5 13.0 12.8 11.2 8.4 9.0 17.4 10.2 18.6 12.9 8.2 19.0 16.5 13.4 10.2 14.2 20.6 11.5 9.6 15.8 11.2 7.2 8.1 9.9 13.7 11.9 11.1 14.6 9.9 10.6 10.9 17.9 10.3 12.3 20.9 9.4 17.8 8.8 8.4 8.6 13.3 9.8 8.5 9.9 11.2 9.9 9.0 19.1 11.5 6.8 14.0 15.5 9.0 29.3 26.2 24.3 23.3 26.5 23.1 27.6 18.1 23.2 26.2 17.9 10.7 43.3 56.4 38.2 28.4 54.3 40.8 29.4 30.7 29.6 23.6 49.5 58.0 55.6 24.5 30.2 49.6 46.7 34.7 69.1 37.1 49.4 27.7 49.7 42.7 15.9 62.5 25.8 42.4 10.5 33.6 28.6 28.7 45.1 34.8 31.4 60.2 59.6 24.1 73.3 48.6 19.4 42.0 55.7 45.0 46.3 80.0 35.5 29.3 51.5 CRISPLD2 "DKFZP434B044, LCRISP2, LGL1" ENSG00000103196 "Cysteine rich secretory protein LCCL domain containing 2" Q9H0B8 16 84819984-84920768 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 19 "Leydig cells: 251.5;Peritubular cells: 250.0;Smooth muscle cells: 678.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 36.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 36.0" "Cell line enhanced" "Detected in many" "ASC diff: 15.3;BEWO: 23.8;HHSteC: 56.8;HSkMC: 23.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA030054, HPA030055" Approved Approved Nucleoplasm,Nucleoli "Secreted to blood" No No 219000000000 "Nucleoplasm, Nucleoli" "HPA030054: AB_2732452, HPA030055: AB_10611821" "unprognostic (8.91e-3)" "unprognostic (3.05e-1)" "unprognostic (2.63e-2)" "unprognostic (2.02e-2)" "unprognostic (7.12e-2)" "unprognostic (2.30e-1)" "unprognostic (2.11e-2)" "unprognostic (5.58e-3)" "unprognostic (1.48e-1)" "unprognostic (5.50e-2)" "unprognostic (2.67e-1)" "unprognostic (2.87e-2)" "prognostic unfavorable (1.97e-6)" "unprognostic (7.35e-3)" "unprognostic (3.38e-2)" "unprognostic (2.99e-3)" "unprognostic (5.15e-3)" 29.2 11.6 2.2 41.1 5.0 3.0 57.2 2.1 3.6 44.1 26.0 2.5 10.6 4.2 38.5 58.7 21.1 43.6 107.4 19.1 2.1 2.0 10.1 6.7 31.0 21.4 5.5 1.6 37.1 9.1 1.0 6.4 50.2 7.1 31.6 7.3 21.9 6.8 23.6 15.9 12.0 17.5 48.0 8.6 10.0 22.5 16.8 3.1 0.4 15.9 11.4 3.3 40.3 32.7 0.0 0.5 36.0 7.9 0.0 0.1 1.3 0.3 0.7 0.2 2.0 15.3 5.7 23.8 11.6 10.3 9.3 6.6 1.5 0.9 0.0 1.0 10.1 2.7 0.3 0.0 0.0 9.4 0.0 0.0 0.1 0.2 0.0 56.8 0.0 0.1 23.8 0.0 2.7 0.0 3.1 0.0 0.0 0.1 0.1 1.0 0.4 0.1 0.5 0.6 1.5 0.6 0.0 0.1 0.1 0.1 1.8 2.3 0.1 2.7 1.2 0.2 3.4 4.7 0.3 1.3 0.1 0.6 9.7 0.3 0.1 0.0 1.9 0.0 0.2 1.4 4.4 7.9 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 36.0 0.0 0.0 0.0 0.0 1.3 2.2 5.0 2.1 3.6 2.1 2.0 5.5 1.6 7.1 3.1 3.0 2.9 0.8 7.9 41.0 0.6 7.6 0.0 1.4 2.3 0.0 0.0 6.0 0.0 1.1 10.8 12.0 0.4 0.0 0.4 24.6 126.1 19.2 6.9 0.0 4.4 1.6 2.9 60.2 40.4 10.7 251.5 12.2 45.5 0.0 4.2 5.0 0.8 0.0 250.0 0.0 0.5 90.5 678.7 0.9 0.9 37.4 7.6 4.8 1.3 5.2 CRKL ENSG00000099942 "CRK like proto-oncogene, adaptor protein" P46109 22 20917426-20953749 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 89.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000532, HPA001100" Uncertain Enhanced Nucleoplasm,Cytosol NA NA 1500000 Nucleoplasm Cytosol "HPA000532: AB_2666019, HPA001100: AB_1078569" "unprognostic (5.54e-2)" "unprognostic (2.66e-1)" "unprognostic (5.87e-2)" "unprognostic (2.40e-2)" "unprognostic (3.06e-2)" "unprognostic (1.59e-1)" "unprognostic (1.92e-2)" "unprognostic (6.51e-2)" "unprognostic (2.35e-2)" "unprognostic (4.60e-1)" "unprognostic (2.71e-1)" "unprognostic (5.99e-2)" "prognostic unfavorable (8.82e-6)" "unprognostic (8.40e-2)" "unprognostic (1.43e-1)" "unprognostic (9.52e-2)" "unprognostic (1.61e-2)" 16.4 15.2 25.0 18.1 24.1 41.9 18.4 34.0 31.7 17.8 19.9 26.4 12.3 20.2 18.9 12.8 25.2 19.9 13.6 22.6 22.6 23.8 16.4 24.9 19.0 21.3 24.6 26.1 26.9 21.7 22.2 17.9 25.1 20.7 18.8 18.7 16.7 14.5 19.1 48.1 22.7 19.1 18.6 23.6 19.6 14.3 12.6 19.8 35.7 16.6 17.8 24.7 17.7 24.6 11.7 14.8 19.2 21.5 11.0 19.7 16.8 11.5 6.9 15.6 12.2 10.5 6.8 16.8 7.8 9.6 12.1 13.7 11.4 5.2 14.8 6.3 8.2 8.3 14.8 18.2 12.5 14.4 12.5 17.8 20.5 7.5 12.5 10.5 21.8 10.5 6.8 16.6 10.5 18.0 9.9 10.6 12.0 89.5 12.2 9.7 10.8 12.7 10.2 12.2 12.0 7.5 16.5 24.7 3.5 8.0 10.1 10.1 12.9 13.1 11.6 9.5 19.5 9.9 12.2 8.5 19.2 21.9 7.2 9.8 11.8 11.3 17.3 14.2 9.3 11.7 13.4 13.0 19.2 17.5 12.5 18.9 11.6 15.8 17.5 14.8 11.7 19.7 18.4 14.1 11.0 21.5 7.4 12.8 16.8 25.0 24.1 34.0 31.7 22.6 23.8 24.6 26.1 20.7 19.8 8.9 16.2 15.6 11.6 48.1 16.8 20.3 10.2 10.7 10.3 5.2 13.7 17.3 1.7 6.8 20.7 14.3 12.4 23.3 7.3 32.0 16.2 13.4 1.1 21.2 15.0 17.5 19.5 18.4 13.7 43.2 14.1 11.1 23.6 10.8 21.5 16.0 9.1 8.6 14.5 8.4 12.7 12.9 11.1 11.6 11.3 52.8 22.8 10.0 14.5 17.4 CRP PTX1 ENSG00000132693 "C-reactive protein" P02741 1 159712289-159714589 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 66 "liver: 1139.7" "Cell type enriched" "Detected in some" 14 "Hepatocytes: 2991.5" "Cancer enriched" "Detected in some" 13 "liver cancer: 1010.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 8.2;HDLM-2: 7.8;SiHa: 2.7;U-2 OS: 5.5;U-266/84: 13.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB005036, HPA027367, HPA027396" Supported Approved "Nucleoplasm,Vesicles,Intermediate filaments" "Secreted to blood" NA NA 2920000000 5400000000 "Nucleoplasm, Vesicles" "Intermediate filaments" "CAB005036: AB_562362, HPA027367: AB_1847216, HPA027396: AB_1847217" "unprognostic (3.74e-1)" "unprognostic (5.31e-2)" "unprognostic (2.97e-2)" "unprognostic (1.27e-1)" "unprognostic (3.57e-2)" "unprognostic (1.33e-2)" "unprognostic (3.13e-1)" "prognostic unfavorable (4.17e-10)" "unprognostic (3.39e-2)" "unprognostic (3.48e-1)" "unprognostic (5.60e-2)" "unprognostic (6.61e-2)" 0.4 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.0 17.2 0.1 0.1 0.0 0.1 1139.7 0.1 0.1 0.1 0.1 0.1 7.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.3 0.0 0.0 0.0 7.8 0.0 0.3 0.0 0.0 0.0 0.3 0.1 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.5 0.1 0.9 0.0 13.1 2.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 55.9 0.0 0.0 0.0 0.0 109.5 0.0 0.0 0.0 0.0 0.0 0.0 220.4 1.2 0.0 0.0 23.3 52.3 0.0 0.0 0.0 0.0 2991.5 0.1 0.0 0.0 82.9 72.1 0.0 0.0 0.0 0.0 17.2 0.0 0.0 97.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRTC1 "FLJ14027, KIAA0616, MECT1, TORC1" ENSG00000105662 "CREB regulated transcription coactivator 1" Q6UUV9 19 18683677-18782333 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.7" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 41.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022035, HPA063619" Enhanced Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" "Plasma membrane, Cytosol" "HPA022035: AB_1847255, HPA063619: " "unprognostic (5.95e-3)" "unprognostic (2.57e-1)" "unprognostic (9.94e-2)" "unprognostic (8.62e-3)" "unprognostic (9.07e-2)" "unprognostic (1.57e-2)" "unprognostic (1.04e-1)" "unprognostic (5.57e-2)" "unprognostic (2.27e-1)" "unprognostic (6.68e-2)" "prognostic favorable (1.80e-5)" "unprognostic (3.37e-2)" "prognostic favorable (3.83e-5)" "unprognostic (6.83e-3)" "unprognostic (1.02e-1)" "unprognostic (2.51e-2)" "unprognostic (2.03e-2)" 8.6 7.7 26.0 7.4 38.8 3.2 3.8 40.7 30.1 5.0 4.4 6.5 4.3 6.5 6.8 5.6 3.1 10.5 5.5 5.6 17.7 7.8 6.6 4.5 5.7 6.3 6.4 18.1 6.7 10.0 8.4 11.3 6.4 6.0 7.0 2.6 5.1 8.8 9.4 12.4 5.5 6.2 4.3 4.8 8.1 8.0 7.5 10.2 1.9 7.4 1.1 3.7 4.6 3.5 4.1 3.8 1.8 3.4 1.1 3.0 1.3 4.4 8.1 5.9 9.4 5.5 4.6 16.7 4.9 3.3 4.7 4.5 5.4 5.8 6.2 10.4 4.6 3.3 4.8 1.8 3.0 1.1 2.7 14.1 5.2 7.2 8.9 5.3 7.1 14.6 7.5 2.9 4.0 1.2 6.2 2.6 6.4 4.1 5.7 2.6 16.1 4.6 8.1 7.6 2.3 11.9 7.3 2.6 6.8 2.9 7.9 10.8 9.7 5.5 5.2 5.8 2.0 5.8 4.3 4.7 5.3 8.2 9.7 5.6 3.8 3.0 4.1 6.2 7.7 4.0 1.5 3.4 1.8 1.7 1.3 1.8 2.3 2.7 3.0 3.0 4.1 2.3 1.8 1.7 1.1 1.9 3.8 1.8 1.3 26.0 38.8 40.7 30.1 17.7 7.8 6.4 18.1 6.0 10.2 0.0 4.0 4.2 9.5 2.4 24.9 14.0 5.1 2.7 2.3 17.4 25.5 8.5 10.0 3.6 0.7 4.5 5.1 0.0 5.3 2.1 5.4 3.0 2.3 3.4 7.8 41.3 18.4 1.3 5.4 1.7 8.6 3.7 3.3 1.8 6.9 8.9 2.6 8.6 4.6 4.3 14.1 0.0 8.2 2.9 7.2 1.8 8.7 5.1 4.8 2.5 CRTC2 TORC2 ENSG00000160741 "CREB regulated transcription coactivator 2" Q53ET0 1 153947669-153958625 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028454, HPA028465" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA028454: AB_10599617, HPA028465: AB_10601991" "unprognostic (4.91e-3)" "unprognostic (1.47e-1)" "prognostic unfavorable (5.75e-4)" "unprognostic (4.32e-3)" "unprognostic (2.86e-1)" "unprognostic (4.63e-3)" "unprognostic (1.54e-3)" "unprognostic (1.20e-2)" "unprognostic (1.07e-1)" "unprognostic (2.24e-2)" "unprognostic (2.17e-1)" "unprognostic (2.51e-1)" "prognostic unfavorable (1.35e-7)" "unprognostic (7.90e-2)" "unprognostic (2.59e-1)" "unprognostic (3.35e-1)" "prognostic favorable (6.12e-5)" 22.4 19.7 21.0 23.1 26.6 28.7 21.1 31.8 22.8 21.5 18.9 29.5 15.6 13.3 24.3 20.2 17.7 22.7 18.4 17.4 20.4 11.3 21.4 22.9 26.0 31.1 25.7 16.3 32.3 20.6 22.7 19.7 24.2 18.6 20.1 15.9 21.9 20.1 22.1 24.6 24.0 23.5 21.5 19.2 39.4 18.9 18.1 28.1 22.1 23.6 10.9 29.7 23.4 21.0 6.1 4.6 10.1 5.9 4.6 5.0 1.8 14.8 11.2 10.9 12.3 18.0 13.1 16.7 8.4 17.4 16.1 13.3 11.5 15.0 14.3 13.4 14.5 10.9 17.0 13.0 16.9 9.0 18.7 17.0 7.3 11.4 8.8 18.2 11.8 12.2 17.2 16.5 17.7 14.5 12.8 14.9 8.2 11.7 17.3 11.5 23.6 12.8 19.8 8.5 16.2 13.9 9.5 7.5 12.0 17.0 12.1 9.2 15.1 13.5 27.6 20.9 11.2 13.3 23.2 11.0 13.0 11.8 13.9 14.2 28.3 18.3 9.8 12.0 10.1 9.6 5.2 3.9 8.4 4.6 5.9 3.8 4.5 4.7 5.0 3.4 6.1 3.2 3.8 10.1 4.6 4.7 4.6 3.1 1.8 21.0 26.6 31.8 22.8 20.4 11.3 25.7 16.3 18.6 28.1 6.0 10.6 4.8 7.1 21.9 5.2 5.6 10.2 2.7 4.5 12.2 3.9 8.3 1.7 8.1 1.1 11.7 10.9 0.0 8.9 8.2 11.2 9.1 8.1 10.6 9.5 1.6 15.4 10.4 10.5 1.1 11.2 12.0 3.3 11.8 12.1 4.5 11.7 2.9 14.2 2.8 6.9 6.5 11.7 11.5 11.5 19.7 10.2 12.9 7.6 9.6 CRTC3 FLJ21868 ENSG00000140577 "CREB regulated transcription coactivator 3" Q6UUV7 15 90529925-90645345 "Cancer-related genes, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 16.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 40.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043735, HPA063691" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043735: AB_10794286, HPA063691: AB_2685092" "unprognostic (7.60e-2)" "unprognostic (6.13e-2)" "unprognostic (1.35e-1)" "unprognostic (2.31e-2)" "unprognostic (5.12e-2)" "unprognostic (3.51e-1)" "unprognostic (1.75e-2)" "unprognostic (1.69e-1)" "unprognostic (6.48e-2)" "unprognostic (3.60e-1)" "unprognostic (1.47e-1)" "unprognostic (2.23e-1)" "unprognostic (5.22e-3)" "unprognostic (4.67e-2)" "unprognostic (9.32e-2)" "unprognostic (9.51e-2)" "unprognostic (2.30e-1)" 22.3 14.0 13.7 17.0 20.9 11.4 26.6 15.0 16.2 21.2 22.2 27.5 15.3 8.9 23.9 14.5 15.1 19.4 21.5 17.2 14.0 9.7 10.7 11.7 19.2 21.7 24.1 10.9 45.9 13.9 17.1 9.6 20.2 15.7 18.2 11.7 17.4 19.9 22.0 16.1 15.8 13.7 31.8 20.3 13.1 14.2 15.3 23.6 12.8 22.7 9.2 18.1 24.0 29.6 5.3 2.1 16.0 2.5 3.3 6.6 3.0 4.8 8.0 5.5 8.9 11.9 8.8 25.1 6.2 9.0 9.8 9.3 6.6 4.9 0.1 4.5 12.8 8.1 8.2 8.8 5.4 7.7 8.4 10.2 12.3 40.0 3.0 13.5 3.2 21.1 9.9 8.7 8.1 10.9 7.2 7.0 5.5 6.5 2.8 7.2 5.6 1.3 4.6 2.0 1.4 3.7 4.2 8.8 0.2 3.5 10.3 10.1 8.9 18.1 6.0 10.1 6.0 6.0 6.0 8.6 10.9 8.0 10.0 7.1 3.8 5.1 3.7 4.5 6.4 5.2 16.0 2.5 1.4 3.7 0.8 4.2 3.1 4.5 4.0 1.6 5.3 6.6 4.1 0.5 3.3 0.3 2.1 4.2 3.0 13.7 20.9 15.0 16.2 14.0 9.7 24.1 10.9 15.7 23.6 6.0 8.6 37.4 23.2 20.9 21.6 13.4 17.8 0.0 4.5 12.2 25.5 12.1 1.7 12.0 22.9 18.0 6.4 0.0 9.4 36.5 23.1 23.5 23.1 13.5 13.5 54.0 15.0 20.9 19.7 14.7 24.7 21.3 16.9 8.2 10.0 20.4 9.0 10.5 41.1 8.4 55.7 45.3 38.4 7.7 16.5 21.0 14.9 30.5 11.3 31.1 CRY1 PHLL1 ENSG00000008405 "Cryptochrome circadian regulator 1" Q16526 12 106991364-107093829 "Disease related genes, Predicted intracellular proteins" "Biological rhythms, Sensory transduction, Transcription, Transcription regulation" "Photoreceptor protein, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 107.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018762 Approved Supported "Nucleoplasm,Nuclear membrane,Microtubules" NA NA "Nucleoplasm, Nuclear membrane, Microtubules" "CAB018762: AB_2083970" "unprognostic (1.21e-3)" "unprognostic (4.74e-2)" "unprognostic (6.50e-2)" "unprognostic (9.03e-2)" "unprognostic (1.79e-1)" "unprognostic (2.84e-1)" "unprognostic (3.48e-2)" "unprognostic (3.61e-1)" "unprognostic (4.29e-3)" "unprognostic (1.34e-2)" "unprognostic (6.85e-3)" "unprognostic (2.06e-1)" "unprognostic (1.20e-1)" "unprognostic (1.82e-2)" "unprognostic (5.08e-1)" "unprognostic (1.85e-1)" "unprognostic (2.25e-1)" 12.2 12.2 8.7 8.5 12.6 9.5 18.3 29.2 10.3 12.4 14.3 12.4 5.0 10.7 14.3 12.9 10.7 15.8 16.3 12.2 10.5 8.7 16.0 13.7 18.0 5.0 17.4 7.3 10.7 12.9 8.6 10.0 13.4 13.1 11.2 8.3 8.7 9.4 11.8 10.8 8.7 17.6 15.9 15.4 10.1 14.6 37.6 15.1 26.5 20.1 6.2 7.5 9.5 18.4 1.7 3.5 6.8 6.4 4.7 13.9 4.7 8.6 8.9 10.9 12.0 7.8 4.9 19.5 9.3 9.9 19.1 12.9 10.1 5.3 0.0 5.9 8.6 12.2 6.0 14.0 4.7 20.9 8.7 8.7 8.5 7.9 7.1 10.1 8.7 7.5 4.6 5.0 14.0 13.3 9.5 15.8 16.3 9.6 7.7 11.7 6.1 19.5 9.9 13.3 8.4 13.0 17.5 27.6 3.1 13.3 10.2 19.8 10.2 17.6 11.5 5.5 11.2 8.1 4.9 7.0 11.2 12.0 7.6 8.3 14.2 13.2 4.0 5.4 8.3 9.1 6.8 2.5 4.4 11.2 3.8 13.9 1.6 8.5 7.0 3.5 1.7 8.0 7.8 1.1 4.7 6.4 2.3 11.0 4.7 8.7 12.6 29.2 10.3 10.5 8.7 17.4 7.3 13.1 15.1 14.9 14.4 5.1 37.9 61.5 15.5 9.3 10.2 17.4 5.7 10.4 19.6 7.7 14.9 9.5 8.6 13.1 8.8 0.0 14.4 10.4 26.7 29.3 4.7 18.5 5.5 25.4 18.8 12.3 5.4 2.7 10.6 7.7 15.1 21.6 6.8 21.9 15.1 3.6 16.3 13.9 11.9 6.5 11.3 107.6 21.1 51.9 12.6 12.9 5.2 23.3 CRYAA "CRYA1, HSPB4" ENSG00000160202 "Crystallin alpha A" P02489 21 43169008-43172805 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Sensory transduction, Vision" "Chaperone, Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "kidney: 45.5" "Cell type enhanced" "Detected in single" 35 "Muller glia cells: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 140 "Hep G2: 28.9" "HPA037737, HPA038430" Supported Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA037737: AB_2675639, HPA038430: AB_2732478" "unprognostic (3.68e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.5 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 28.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRYAA2 ENSG00000276076 "Crystallin alpha A2" 21 6560714-6564489 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "kidney: 34.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 200 "Hep G2: 28.9" "HPA037737, HPA038430" Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA037737: AB_2675639, HPA038430: AB_2732478" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.4 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 28.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRYBB2 "CCA2, CRYB2, CRYB2A" ENSG00000244752 "Crystallin beta B2" P43320 22 25219522-25231869 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Eye lens protein" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "retina: 26.9" "Cell type enhanced" "Detected in some" 15 "Distal tubular cells: 23.2;Melanocytes: 11.8;Peritubular cells: 7.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 5.2;THP-1: 1.7;U-138 MG: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA043749 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA043749: AB_2678652" "unprognostic (1.28e-1)" "unprognostic (2.71e-2)" "unprognostic (4.09e-2)" "unprognostic (1.95e-1)" "unprognostic (5.06e-2)" "unprognostic (7.04e-2)" "unprognostic (8.57e-3)" "unprognostic (9.51e-3)" "unprognostic (8.55e-2)" "unprognostic (2.46e-2)" "unprognostic (4.13e-2)" "unprognostic (2.01e-1)" "unprognostic (1.73e-5)" "unprognostic (1.44e-2)" "unprognostic (1.60e-1)" "unprognostic (3.28e-1)" "unprognostic (9.89e-3)" 0.8 0.7 2.0 0.5 3.7 0.1 1.7 0.5 1.8 1.0 1.3 0.5 0.5 0.8 0.5 1.8 1.1 0.4 0.5 0.6 2.9 1.5 0.5 0.5 1.4 0.5 0.8 0.5 0.5 0.5 0.0 2.6 0.5 0.9 0.9 1.5 26.9 1.2 0.5 0.6 0.4 1.0 1.0 0.5 0.5 0.2 4.0 0.5 0.5 1.7 0.5 0.5 0.5 0.5 1.4 1.3 0.5 1.1 1.7 1.4 0.7 0.2 0.5 0.1 0.7 0.0 0.4 0.0 0.0 0.2 0.0 0.4 0.0 0.5 0.0 0.6 0.0 1.2 0.8 0.0 0.0 0.2 0.0 1.1 0.6 5.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.3 1.2 0.3 0.6 0.0 0.2 0.1 0.6 0.0 0.2 0.0 0.0 0.9 1.7 0.0 3.0 0.7 0.4 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.5 0.8 0.4 1.4 0.6 0.6 1.4 1.2 0.7 1.1 1.0 1.1 1.2 0.1 1.7 1.1 1.3 0.4 0.7 2.0 3.7 0.5 1.8 2.9 1.5 0.8 0.5 0.9 0.5 0.0 0.0 0.0 0.4 4.7 0.1 0.8 0.0 0.0 0.0 1.8 0.0 0.1 23.2 0.0 2.5 2.4 0.0 0.0 0.2 0.1 0.3 0.3 0.0 0.4 0.2 0.0 0.0 0.6 0.3 4.0 2.3 0.7 11.8 0.0 0.1 0.7 0.4 0.0 7.8 0.7 0.0 0.0 4.2 2.1 2.6 3.3 0.1 0.0 0.0 0.6 CRYBG1 "AIM1, ST4" ENSG00000112297 "Crystallin beta-gamma domain containing 1" Q9Y4K1 6 106360808-106571978 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 61.7;placenta: 96.6" "Group enriched" "Detected in many" 11 "Cytotrophoblasts: 184.0;Syncytiotrophoblasts: 501.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in some" 9 "pons and medulla: 10.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 32.1;HBEC3-KT: 40.2;hTERT-HME1: 31.1" "Region enriched" "Detected in single" 5 "olfactory region: 5.1" "Low region specificity" "Detected in single" "CAB026378, HPA030948, HPA030949" Approved Approved Nucleoplasm,Microtubules,Cytosol NA NA "Nucleoplasm, Microtubules, Cytosol" "CAB026378: , HPA030948: AB_2673670, HPA030949: AB_2673671" "unprognostic (1.66e-1)" "unprognostic (3.44e-2)" "unprognostic (9.02e-3)" "unprognostic (1.13e-1)" "unprognostic (3.80e-1)" "unprognostic (1.52e-1)" "unprognostic (1.40e-1)" "unprognostic (2.27e-2)" "unprognostic (1.08e-1)" "unprognostic (1.23e-1)" "unprognostic (3.69e-3)" "unprognostic (5.61e-2)" "unprognostic (8.97e-2)" "unprognostic (3.53e-2)" "unprognostic (8.89e-2)" "unprognostic (8.60e-2)" "unprognostic (3.25e-2)" 4.6 0.8 0.6 6.8 0.7 6.5 11.3 0.6 0.9 7.4 7.4 1.6 2.5 7.6 1.5 10.8 61.7 2.0 2.0 0.9 1.1 0.6 9.8 3.6 4.0 5.6 0.7 0.7 2.0 5.5 5.0 0.9 96.6 10.3 12.6 5.9 16.0 10.2 4.3 0.8 16.6 7.6 4.4 0.8 6.5 2.5 1.8 0.5 2.3 1.8 24.6 35.8 11.5 13.1 6.8 8.7 3.1 4.4 5.7 10.9 3.9 10.6 0.0 0.0 0.0 9.0 32.1 3.3 1.5 11.8 3.4 3.2 0.7 3.8 16.7 0.7 7.3 4.8 17.2 0.1 40.2 1.7 22.7 0.7 0.0 0.5 5.2 4.2 10.1 0.0 16.0 23.5 6.5 31.1 0.0 14.7 13.2 0.5 2.4 9.2 1.2 2.9 4.0 0.1 0.0 7.1 5.0 0.1 0.1 5.4 25.3 0.7 0.0 6.5 11.1 0.1 1.0 5.5 7.7 4.2 3.9 0.5 0.0 10.6 1.8 1.4 18.2 18.4 12.8 8.3 0.3 3.8 0.4 8.1 4.4 10.9 6.8 10.5 8.9 8.7 3.8 6.7 6.3 3.1 5.7 4.4 1.0 9.9 3.9 0.6 0.7 0.6 0.9 1.1 0.6 0.7 0.7 10.3 0.5 11.9 11.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 23.9 31.4 0.0 184.0 3.3 8.8 0.0 0.0 0.0 0.0 10.8 7.2 0.0 0.0 1.1 0.0 31.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 16.4 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 501.8 0.0 0.0 0.0 CRYBG2 "AIM1L, FLJ38020" ENSG00000176092 "Crystallin beta-gamma domain containing 2" Q8N1P7 1 26321698-26360080 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 43.9;placenta: 55.0" "Cell type enriched" "Detected in some" 5 "Syncytiotrophoblasts: 40.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 7.1;BEWO: 15.5;CACO-2: 25.1;CAPAN-2: 16.9;HaCaT: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA029629 Approved Nucleoplasm NA NA Nucleoplasm "HPA029629: AB_10601331" "unprognostic (2.20e-1)" "unprognostic (2.07e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (5.11e-6)" "unprognostic (1.45e-1)" "unprognostic (1.02e-1)" "unprognostic (6.39e-4)" "unprognostic (1.88e-3)" "unprognostic (1.83e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (3.53e-4)" "unprognostic (2.94e-2)" "unprognostic (4.83e-9)" "unprognostic (9.12e-3)" "unprognostic (3.40e-1)" "unprognostic (6.44e-2)" "unprognostic (1.63e-2)" 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 8.0 4.4 0.0 0.0 4.9 0.9 0.6 43.9 0.2 2.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 55.0 0.0 0.8 1.4 0.1 5.1 0.0 0.0 13.8 10.4 0.0 0.0 0.0 0.9 1.2 0.0 0.1 0.0 22.0 19.8 4.9 16.1 0.7 0.0 2.4 0.1 0.2 1.7 0.3 7.1 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 0.0 0.1 25.1 16.9 0.1 5.1 0.0 0.1 6.3 0.0 4.5 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 1.2 4.0 0.0 0.0 0.0 0.1 0.3 1.6 0.3 0.0 0.0 3.0 0.0 1.2 4.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.5 1.0 0.1 0.5 0.7 1.7 0.7 0.0 0.6 0.5 0.5 2.4 0.2 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 4.9 1.7 1.8 0.0 0.0 0.0 0.0 1.2 4.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 40.6 0.0 0.0 0.0 CRYL1 "GDH, lambda-CRY, MGC149525, MGC149526" ENSG00000165475 "Crystallin lambda 1" Q9Y2S2 13 20403666-20525873 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 104.0;liver: 80.8" "Cell type enhanced" "Detected in many" 15 "Distal tubular cells: 411.1;Hepatocytes: 272.9;Proximal tubular cells: 848.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040403 Enhanced Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane" NA NA 210000 "Nucleoplasm, Nucleoli" "Golgi apparatus, Plasma membrane" "HPA040403: AB_10795632" "unprognostic (1.84e-1)" "unprognostic (1.25e-1)" "unprognostic (3.25e-2)" "prognostic favorable (1.76e-5)" "unprognostic (3.10e-1)" "unprognostic (1.03e-1)" "unprognostic (1.09e-3)" "unprognostic (4.75e-3)" "unprognostic (1.19e-1)" "unprognostic (4.09e-2)" "unprognostic (2.12e-2)" "unprognostic (8.80e-2)" "prognostic favorable (2.30e-9)" "unprognostic (9.00e-2)" "unprognostic (1.30e-1)" "unprognostic (2.39e-2)" "unprognostic (3.11e-1)" 9.8 8.9 21.5 8.8 22.9 3.5 7.0 10.4 17.4 11.8 35.1 26.7 18.9 61.0 9.2 18.0 7.4 9.3 16.1 9.3 18.8 19.8 104.0 80.8 6.8 5.9 24.5 12.3 7.3 15.4 5.3 10.4 5.6 16.8 11.2 16.5 17.2 13.1 20.1 5.4 4.1 45.7 8.0 32.0 6.5 12.0 2.7 16.4 3.2 11.9 5.6 5.5 8.6 5.9 9.3 25.7 1.8 24.3 6.0 15.6 17.5 3.3 2.9 2.5 18.4 14.1 16.3 2.5 4.7 8.5 2.1 1.7 1.1 3.1 0.0 9.1 6.5 4.8 0.8 2.5 4.2 2.1 8.1 2.0 5.9 0.3 23.0 8.1 1.9 5.4 9.6 2.7 1.5 9.7 7.6 22.3 8.7 0.4 2.3 5.5 12.1 5.1 3.0 0.1 28.9 4.5 2.6 1.6 0.4 17.8 7.1 1.8 2.2 2.8 1.3 21.2 1.3 9.1 7.6 21.3 2.6 1.2 6.3 2.9 3.3 0.6 0.0 4.9 3.3 10.5 1.8 21.8 1.4 10.5 24.3 8.5 9.3 14.0 10.0 25.7 9.1 11.0 10.2 0.7 6.0 20.1 2.8 15.6 17.5 21.5 22.9 10.4 17.4 18.8 19.8 24.5 12.3 16.8 16.4 6.0 6.4 19.9 13.2 9.2 5.0 9.8 48.4 10.7 6.8 73.3 11.8 18.1 411.1 21.5 2.6 23.7 181.3 0.0 27.8 9.4 16.4 23.5 24.3 272.9 59.4 1.6 8.7 49.1 76.7 2.9 24.2 36.1 35.4 11.8 69.9 93.7 32.1 152.6 22.6 848.9 10.8 19.4 12.3 0.9 0.2 8.2 17.4 15.3 78.8 12.2 CRYZL1 "4P11, QOH-1" ENSG00000205758 "Crystallin zeta like 1" O95825 21 33589341-33643926 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019120, HPA029399, CAB034129" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB034129: AB_2084755, HPA019120: AB_1847264, HPA029399: AB_10600865" "unprognostic (1.54e-1)" "unprognostic (4.69e-2)" "unprognostic (1.53e-1)" "unprognostic (3.18e-2)" "unprognostic (2.55e-1)" "unprognostic (9.19e-2)" "unprognostic (2.73e-1)" "unprognostic (2.57e-3)" "unprognostic (2.90e-2)" "unprognostic (1.08e-1)" "unprognostic (1.76e-1)" "unprognostic (5.86e-2)" "unprognostic (1.59e-2)" "unprognostic (3.59e-2)" "unprognostic (8.16e-3)" "unprognostic (1.59e-1)" "unprognostic (1.28e-3)" 18.9 17.6 32.6 14.1 27.6 18.4 19.4 36.6 32.4 20.5 21.5 24.8 13.2 13.4 26.9 18.0 17.6 17.2 15.1 17.9 26.4 23.0 21.6 16.0 14.5 14.7 30.8 19.4 20.4 13.6 18.5 27.7 19.3 25.2 17.3 18.8 17.2 15.2 21.7 15.5 20.9 13.3 19.8 29.9 13.2 15.6 28.9 27.0 18.2 22.6 9.7 13.4 20.8 15.6 27.5 30.7 24.8 26.1 31.5 33.8 18.2 20.9 9.3 26.6 19.6 14.4 20.9 13.5 15.0 21.6 19.2 17.3 13.6 16.7 14.8 13.6 18.3 14.9 11.7 14.0 15.4 17.6 13.7 14.7 27.2 19.9 12.3 22.7 17.1 17.4 19.6 13.6 20.3 15.9 25.4 24.1 24.4 20.1 15.4 17.9 10.7 16.5 17.7 18.6 21.7 12.6 15.9 21.3 20.4 27.1 18.9 11.6 18.3 19.7 9.9 21.4 23.3 19.7 12.7 25.4 15.6 14.9 12.8 11.6 25.3 34.8 16.1 20.3 12.8 17.3 21.7 25.2 24.8 24.2 26.1 25.9 26.5 25.9 22.5 30.7 27.5 33.8 27.4 14.4 31.5 23.7 24.2 20.3 18.2 32.6 27.6 36.6 32.4 26.4 23.0 30.8 19.4 25.2 27.0 29.8 15.9 13.6 40.2 20.9 45.3 22.7 35.7 21.4 19.4 29.6 29.5 59.3 41.4 31.7 56.7 31.7 21.2 0.0 25.5 34.3 29.6 18.4 62.5 10.9 28.8 44.5 20.2 20.3 22.2 20.6 40.9 28.3 35.4 34.3 18.6 41.5 22.8 28.1 38.5 36.3 49.0 19.4 44.3 79.9 15.5 18.7 37.3 25.5 29.9 33.3 CSDC2 PIPPin ENSG00000172346 "Cold shock domain containing C2" Q9Y534 22 41560763-41577741 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 84.8;ovary: 48.5" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 64.6;Muller glia cells: 39.5;Proximal tubular cells: 29.3;Sertoli cells: 71.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "HeLa: 8.1;U-2 OS: 29.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003073, HPA076549" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003073: AB_1078578, HPA076549: AB_2686807" "unprognostic (9.42e-2)" "unprognostic (5.52e-2)" "unprognostic (3.66e-3)" "unprognostic (1.36e-1)" "unprognostic (2.06e-1)" "unprognostic (3.52e-1)" "unprognostic (3.93e-2)" "unprognostic (1.60e-1)" "unprognostic (2.70e-3)" "unprognostic (2.35e-2)" "unprognostic (1.93e-1)" "unprognostic (3.72e-1)" "prognostic favorable (6.42e-4)" "unprognostic (8.86e-3)" "unprognostic (6.08e-2)" "unprognostic (1.02e-1)" "unprognostic (9.09e-3)" 2.5 39.0 4.7 2.1 9.6 1.1 1.2 30.5 15.3 16.8 2.6 2.7 5.5 1.6 18.4 2.0 2.2 4.1 2.6 84.8 6.0 8.5 9.9 1.2 2.8 1.1 9.0 6.0 48.5 25.5 1.1 4.1 1.3 17.7 5.3 1.4 5.6 1.4 11.7 1.5 1.1 1.5 9.1 10.5 1.2 1.6 11.1 3.4 0.0 1.1 0.3 1.0 5.8 6.2 1.0 1.0 1.7 1.1 0.4 1.6 0.7 0.0 0.1 1.0 0.1 0.0 0.0 0.1 2.3 0.1 0.0 0.0 0.6 0.0 0.0 0.3 3.1 0.3 0.1 0.0 0.0 0.0 0.0 2.1 0.0 8.1 0.9 2.4 0.0 0.0 1.3 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.7 0.1 0.0 0.0 0.1 0.7 0.0 0.1 0.0 3.3 0.0 0.0 0.0 0.1 29.6 0.2 0.0 0.2 0.1 0.0 0.5 0.0 0.0 1.0 1.0 1.7 1.3 1.1 0.5 1.0 0.8 0.7 1.0 1.0 1.5 0.7 1.0 0.4 0.9 0.2 1.6 0.7 4.7 9.6 30.5 14.7 6.0 8.5 9.0 6.0 17.7 3.4 0.0 0.0 0.0 0.2 0.2 8.1 64.6 0.0 1.4 0.0 7.0 2.0 0.1 16.6 0.3 1.1 0.1 0.0 0.0 9.2 0.1 1.9 0.1 0.0 0.0 0.2 6.4 0.0 0.6 0.0 3.6 4.9 0.0 1.7 0.0 0.0 39.5 2.3 0.0 2.5 29.3 3.1 71.1 22.6 0.2 0.2 0.1 0.2 0.0 0.0 0.0 CSE1L "CAS, CSE1, XPO2" ENSG00000124207 "Chromosome segregation 1 like" P55060 20 49046246-49096960 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 153.6;Spermatogonia: 127.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002140, HPA038059, HPA038060" Enhanced Enhanced Nucleoplasm,Cytosol No No 64000 Nucleoplasm Cytosol "CAB002140: AB_563461, HPA038059: AB_2675811, HPA038060: AB_2675812" "unprognostic (4.01e-2)" "unprognostic (3.15e-2)" "unprognostic (5.63e-2)" "prognostic unfavorable (2.91e-5)" "unprognostic (4.86e-1)" "unprognostic (4.91e-2)" "prognostic unfavorable (2.42e-8)" "unprognostic (3.44e-2)" "unprognostic (1.45e-2)" "unprognostic (2.63e-2)" "unprognostic (2.72e-3)" "unprognostic (2.54e-2)" "prognostic unfavorable (1.89e-4)" "unprognostic (2.59e-1)" "unprognostic (4.84e-1)" "unprognostic (5.71e-1)" "prognostic unfavorable (6.91e-4)" 15.7 18.9 19.5 18.7 23.7 13.7 21.2 24.9 31.3 17.5 14.2 13.4 14.0 12.0 19.5 15.5 25.5 17.3 11.8 17.8 20.0 17.7 18.8 18.7 12.8 24.0 27.3 19.4 18.7 17.3 23.2 16.8 23.1 24.2 16.7 18.4 8.4 15.5 17.0 34.3 20.9 12.4 21.7 31.3 12.6 17.1 50.9 21.0 27.0 14.7 28.1 25.3 18.3 17.5 12.8 14.8 9.4 15.9 16.8 18.0 12.8 36.2 25.2 30.9 23.7 12.0 15.5 33.4 28.6 15.2 90.0 38.2 82.4 29.3 37.1 38.4 18.1 36.5 42.0 45.3 53.7 86.0 6.0 22.0 25.7 29.7 39.9 7.3 28.3 14.2 8.6 20.2 44.0 25.5 12.4 29.7 20.7 36.3 14.7 33.7 12.4 34.1 14.6 25.9 30.3 37.6 21.7 50.8 28.9 19.8 25.3 27.2 15.8 45.7 49.5 16.2 24.5 41.3 18.5 19.1 48.0 40.3 28.2 40.5 8.6 20.8 34.8 28.6 22.9 25.5 9.4 11.8 2.7 11.0 15.2 16.5 12.8 16.8 13.4 14.8 10.4 18.0 15.3 3.3 16.8 15.9 6.6 14.4 12.8 19.5 23.7 24.9 31.3 20.0 17.7 27.3 19.4 24.2 21.0 6.0 23.2 18.2 20.7 26.9 14.3 23.5 35.7 21.4 18.2 26.2 9.8 56.3 11.6 28.2 61.2 21.5 7.8 0.0 23.0 50.5 21.6 15.7 4.6 23.2 26.0 14.3 5.2 20.9 15.1 39.7 23.6 19.3 25.3 29.7 9.1 21.8 23.6 10.5 29.7 17.0 11.9 38.8 19.1 153.6 127.3 30.2 60.8 16.6 18.2 20.0 CSNK1D "CKID, CKIdelta, HCKID" ENSG00000141551 "Casein kinase 1 delta" P48730 17 82239023-82273731 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 287.2;Late spermatids: 600.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB015410 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "CAB015410: AB_831049" "unprognostic (1.07e-2)" "unprognostic (1.27e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (7.04e-4)" "unprognostic (2.38e-2)" "unprognostic (3.43e-2)" "prognostic unfavorable (2.38e-6)" "unprognostic (8.05e-2)" "unprognostic (1.09e-1)" "unprognostic (5.00e-2)" "prognostic favorable (9.62e-5)" "unprognostic (2.23e-3)" "prognostic unfavorable (8.34e-4)" "unprognostic (3.54e-1)" "unprognostic (2.52e-1)" "unprognostic (5.52e-3)" "unprognostic (4.74e-2)" 30.1 36.3 30.8 25.9 30.8 21.0 26.3 36.3 42.8 30.9 33.0 27.7 32.9 32.6 37.9 29.8 31.3 38.0 34.9 28.5 26.2 26.9 32.0 33.5 30.1 25.8 27.2 27.8 31.4 42.8 34.2 35.9 32.8 30.3 35.3 19.3 28.4 38.0 37.7 52.3 26.7 42.3 34.1 21.4 36.4 32.5 48.3 24.6 29.2 33.0 31.8 33.7 31.4 26.1 6.4 11.4 29.6 12.1 8.7 7.6 7.1 21.6 25.8 14.7 20.3 19.4 20.8 29.6 31.9 20.1 22.9 21.5 21.2 18.7 19.8 25.3 22.7 24.3 21.0 13.8 32.3 18.5 16.8 33.4 24.6 20.5 22.6 56.4 20.2 18.9 31.4 23.0 15.5 23.2 28.6 33.3 14.7 27.7 10.5 21.6 25.3 26.0 21.2 15.8 25.7 40.7 22.4 18.2 17.6 24.1 34.0 18.2 32.9 38.1 31.8 35.7 21.4 22.8 26.6 35.1 32.9 29.6 28.6 24.2 23.1 11.1 21.2 26.4 17.3 23.8 4.7 11.0 14.6 7.6 12.1 7.4 6.4 5.9 7.3 11.4 5.6 5.0 5.3 29.6 8.7 11.1 5.5 5.2 7.1 30.8 30.8 36.3 42.8 26.2 26.9 27.2 27.8 30.3 24.6 44.7 51.2 45.8 92.5 50.4 45.6 14.1 25.5 64.3 62.6 40.1 25.5 56.2 28.2 62.7 287.2 39.4 93.0 0.0 60.1 78.4 37.7 85.7 57.8 25.6 57.5 90.6 44.4 40.5 51.6 600.1 27.9 56.2 27.0 73.1 56.1 34.9 72.9 48.0 37.8 40.4 47.4 38.8 58.6 35.2 26.6 42.2 105.8 64.7 38.3 96.3 CSNK1E "CKIE, CKIepsilon, HCKIE" ENSG00000213923 "Casein kinase 1 epsilon" P49674 22 38290691-38318084 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Biological rhythms" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Urothelial cells: 208.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 15.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB009626, HPA026288" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB009626: AB_2084517, HPA026288: AB_1847276" "unprognostic (2.32e-1)" "unprognostic (8.41e-2)" "unprognostic (5.14e-2)" "unprognostic (5.01e-3)" "unprognostic (1.95e-2)" "unprognostic (4.50e-3)" "prognostic unfavorable (8.20e-5)" "unprognostic (2.08e-3)" "unprognostic (3.69e-1)" "unprognostic (1.22e-1)" "unprognostic (9.63e-2)" "unprognostic (4.16e-3)" "prognostic unfavorable (4.67e-6)" "unprognostic (1.91e-1)" "unprognostic (1.66e-1)" "unprognostic (2.58e-1)" "unprognostic (3.25e-3)" 28.5 22.9 30.7 18.3 32.5 21.4 28.6 40.1 42.6 26.4 21.5 32.3 15.7 19.0 37.3 27.3 23.4 28.0 22.1 28.8 31.7 22.3 17.3 11.8 28.4 17.3 28.6 30.1 38.1 25.4 56.2 29.2 33.1 28.7 26.2 17.4 30.5 23.9 23.1 26.3 35.3 17.1 24.0 23.2 20.9 21.8 13.0 33.9 13.3 21.4 14.2 17.4 25.5 28.8 3.7 15.7 4.8 1.8 5.9 4.0 1.2 23.6 11.5 31.3 30.0 15.7 24.1 23.6 30.9 39.5 28.1 27.3 14.8 18.5 17.8 13.5 29.1 18.9 20.2 23.7 42.7 20.4 28.4 51.7 5.7 38.1 11.3 32.3 12.4 15.2 23.0 36.2 42.8 58.0 36.9 29.8 15.6 12.6 36.8 27.1 15.8 17.3 15.3 22.9 17.2 16.7 32.4 22.4 27.9 25.8 19.9 46.4 18.2 26.3 27.3 30.8 19.4 13.9 18.1 33.9 25.5 27.8 14.7 24.6 16.5 23.6 25.1 37.8 14.0 42.6 3.8 1.8 3.4 3.4 0.8 4.0 2.5 3.8 3.4 1.8 3.7 2.1 3.1 4.8 5.9 0.6 15.7 1.7 1.2 30.7 32.5 40.1 38.8 31.7 22.3 28.6 30.1 28.7 33.9 35.7 17.1 22.2 117.4 69.8 122.3 44.0 38.2 16.0 23.9 22.7 56.9 29.6 6.6 26.6 42.8 62.1 10.7 0.0 35.7 33.5 53.2 138.6 3.5 18.6 19.2 68.3 60.3 44.8 14.9 42.7 79.1 18.5 57.3 11.8 40.8 105.4 42.3 29.6 62.2 4.1 58.4 71.1 106.1 6.0 9.6 91.6 104.9 13.4 31.9 208.0 CSNK2A1 "Cka1, Cka2" ENSG00000101266 "Casein kinase 2 alpha 1" P68400 20 472498-543835 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Biological rhythms, Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB020680, HPA059206, HPA061698, CAB069395" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB020680: , CAB069395: AB_1611912, HPA059206: AB_2683948, HPA061698: AB_2732667" "unprognostic (1.19e-1)" "unprognostic (1.44e-1)" "unprognostic (5.44e-2)" "unprognostic (8.28e-3)" "unprognostic (3.62e-2)" "unprognostic (2.04e-2)" "prognostic unfavorable (4.11e-6)" "unprognostic (4.08e-2)" "unprognostic (3.89e-1)" "unprognostic (6.88e-2)" "unprognostic (1.94e-2)" "unprognostic (1.16e-1)" "unprognostic (8.58e-2)" "unprognostic (1.50e-1)" "unprognostic (4.47e-1)" "unprognostic (9.53e-2)" "unprognostic (7.37e-2)" 21.5 26.7 23.2 20.6 31.3 16.7 24.1 26.3 32.8 22.2 26.1 28.2 19.5 21.9 24.3 15.7 31.9 23.3 17.7 29.2 21.8 21.9 24.5 23.1 18.6 21.9 21.3 22.6 24.9 27.5 27.7 24.6 23.1 29.4 20.7 24.2 19.6 23.8 22.4 58.8 27.0 22.5 23.3 21.3 21.8 26.5 51.6 23.2 30.3 22.4 22.4 25.7 26.2 22.8 19.8 25.4 23.3 27.3 18.7 19.4 15.7 44.4 39.7 36.7 22.6 14.0 24.5 23.8 26.1 26.4 30.3 33.8 40.0 29.2 39.7 16.8 21.5 42.6 34.5 40.3 39.1 43.2 13.9 14.6 53.8 10.6 38.7 24.1 46.7 11.9 22.4 41.4 27.9 77.7 29.7 32.7 34.5 52.8 26.2 27.7 14.7 56.1 16.6 52.5 39.9 27.4 33.4 32.1 32.4 26.1 28.2 38.4 30.6 22.3 43.0 39.7 29.7 28.7 18.3 30.7 32.2 27.6 20.8 38.6 27.2 64.0 39.2 16.1 28.1 32.5 23.3 19.7 22.2 16.1 27.3 19.4 19.8 15.7 15.5 25.4 18.9 16.0 15.0 12.1 18.7 25.2 21.1 16.4 15.7 23.2 31.3 26.3 32.8 21.8 21.9 21.3 22.6 29.4 23.2 59.6 72.9 45.0 31.0 36.5 45.7 53.7 33.1 80.3 85.3 41.8 29.5 35.3 34.9 61.1 104.2 34.8 33.8 0.0 43.6 47.2 34.8 36.9 60.3 26.4 28.9 57.2 33.8 22.1 30.2 104.8 38.0 35.3 13.5 67.7 41.3 34.4 54.4 24.6 34.6 56.2 26.8 51.8 32.5 61.3 54.1 43.8 51.4 32.4 39.1 45.0 CSNK2A3 CSNK2A1P ENSG00000254598 "Casein kinase 2 alpha 3" Q8NEV1 11 11351942-11353357 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 12 "Cardiomyocytes: 11.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 5.6" "HPA059206, HPA061698" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA059206: AB_2683948, HPA061698: AB_2732667" "unprognostic (3.10e-2)" "unprognostic (3.39e-1)" "unprognostic (4.65e-2)" "unprognostic (1.55e-3)" "unprognostic (1.82e-2)" "unprognostic (1.60e-1)" "unprognostic (6.25e-4)" "unprognostic (4.36e-2)" "unprognostic (5.42e-2)" "unprognostic (1.88e-1)" "unprognostic (5.46e-3)" "unprognostic (1.07e-1)" "unprognostic (1.50e-1)" "unprognostic (1.31e-1)" "unprognostic (1.32e-1)" "unprognostic (1.42e-1)" "unprognostic (3.38e-2)" 4.6 1.6 1.3 2.8 1.3 0.6 1.9 1.6 5.5 2.8 3.8 0.5 2.1 3.4 1.8 3.8 3.4 1.1 1.6 2.3 1.5 1.2 5.4 3.0 3.7 1.0 1.1 0.7 2.0 1.4 0.6 1.7 2.9 2.0 2.2 0.7 2.1 1.7 3.6 5.3 1.9 2.9 2.9 1.2 0.9 1.3 3.5 0.3 3.6 1.6 1.8 2.7 1.8 1.3 0.7 0.9 1.1 0.6 0.8 1.0 1.2 5.6 1.2 0.2 2.1 0.0 0.0 0.7 0.5 0.3 0.3 0.3 0.0 0.3 0.0 0.4 0.0 1.6 1.9 1.0 0.8 0.0 0.2 0.3 0.0 0.2 0.5 0.0 0.2 0.4 0.6 0.4 0.0 0.6 0.1 0.0 0.8 0.4 0.8 0.7 0.6 1.3 0.7 1.7 0.4 3.0 0.9 0.2 1.0 0.6 1.0 0.5 1.2 1.6 3.2 0.6 0.2 1.2 0.4 0.7 0.9 1.2 0.4 0.6 0.5 0.9 0.8 2.6 0.2 2.6 0.7 0.5 1.1 0.6 0.6 0.9 0.7 0.4 0.7 0.9 0.7 1.0 0.3 0.1 0.8 0.6 0.7 0.7 1.2 1.3 1.3 1.6 5.5 1.5 1.2 1.1 0.7 2.0 0.3 3.0 0.3 0.0 0.8 1.5 1.0 11.1 0.0 1.4 1.2 3.5 0.0 0.6 0.0 0.7 1.7 1.6 0.4 0.0 0.7 0.4 0.5 1.0 1.1 0.0 0.2 3.2 1.2 0.6 1.0 1.4 0.6 0.0 0.0 0.0 0.0 0.8 0.4 0.3 0.0 0.6 0.5 0.0 0.7 0.6 0.9 0.9 0.8 0.8 0.4 0.5 CSPG4 "HMW-MAA, MCSP, MCSPG, MEL-CSPG, MSK16, NG2" ENSG00000173546 "Chondroitin sulfate proteoglycan 4" Q6UVK1 15 75674322-75712848 "Predicted membrane proteins" "Angiogenesis, Differentiation, Tissue remodeling" "Developmental protein, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Sertoli cells: 116.4;Smooth muscle cells: 29.5" "Cancer enhanced" "Detected in all" "melanoma: 74.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "NK-cell: 1.9" "Lineage enriched" "Detected in single" 11 "NK-cells: 1.9" "Cell line enhanced" "Detected in many" "BJ: 20.1;SK-MEL-30: 45.8;U-138 MG: 29.6;WM-115: 43.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001933, HPA002951, CAB016189, HPA042785, HPA050008" Approved Enhanced "Nucleoplasm,Plasma membrane" NA NA 28000000 "Plasma membrane" Nucleoplasm "CAB016189: AB_784821, HPA001933: , HPA002951: AB_1854449, HPA042785: AB_10964270, HPA050008: AB_2680991" "unprognostic (5.21e-2)" "unprognostic (2.17e-3)" "unprognostic (3.55e-2)" "unprognostic (1.01e-2)" "unprognostic (3.56e-2)" "unprognostic (3.58e-1)" "unprognostic (1.09e-2)" "unprognostic (2.11e-2)" "unprognostic (1.07e-1)" "unprognostic (5.00e-2)" "unprognostic (1.63e-1)" "unprognostic (3.14e-1)" "prognostic unfavorable (7.60e-6)" "unprognostic (1.23e-2)" "unprognostic (2.04e-2)" "unprognostic (3.21e-2)" "prognostic unfavorable (4.93e-5)" 36.1 3.1 8.3 10.0 7.9 1.0 19.5 1.6 7.8 15.3 29.2 7.2 6.9 4.6 21.3 14.9 19.9 9.4 18.2 9.2 6.5 5.2 3.5 1.5 10.9 1.4 6.6 5.2 7.0 3.8 3.0 1.6 20.9 6.6 11.4 3.9 10.0 3.4 16.7 25.7 8.0 9.1 37.9 5.4 3.8 14.0 2.5 6.3 0.0 4.7 6.0 1.3 30.3 10.9 0.0 0.1 0.0 0.0 1.9 0.0 0.0 3.6 0.0 0.3 2.2 0.5 3.2 0.0 20.1 9.0 14.1 9.2 0.0 14.0 0.0 0.5 14.0 1.9 0.2 0.0 0.1 4.3 0.1 0.0 0.0 5.9 0.0 3.2 0.0 0.0 1.5 0.0 4.2 0.5 5.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 45.8 0.4 0.3 0.3 0.0 29.6 5.8 1.1 0.2 0.0 0.0 0.0 6.5 0.1 43.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 8.3 7.9 1.6 5.9 6.5 5.2 6.6 5.2 6.6 6.3 0.0 0.0 0.0 0.6 2.5 0.0 9.8 0.0 1.4 1.2 1.8 0.0 0.1 0.0 0.0 0.6 2.8 0.0 0.0 0.0 0.2 6.5 0.6 0.0 0.0 1.1 0.0 0.0 1.3 0.0 0.0 0.3 0.8 11.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 116.4 29.5 0.0 1.3 1.6 0.2 0.0 0.0 0.3 CSPG5 NGC ENSG00000114646 "Chondroitin sulfate proteoglycan 5" O95196 3 47562239-47580792 "Predicted membrane proteins" "Differentiation, Growth regulation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 81.1" "Cell type enhanced" "Detected in some" 25 "Bipolar cells: 28.1;Muller glia cells: 86.9;Rod photoreceptor cells: 19.5;Spermatocytes: 17.2" "Cancer enriched" "Detected in many" 19 "glioma: 48.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 26.8;HEK 293: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049529, HPA067818, HPA071779" Enhanced Approved Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA049529: AB_2680805, HPA067818: AB_2685905, HPA071779: AB_2686446" "unprognostic (2.68e-1)" "unprognostic (2.11e-1)" "unprognostic (8.87e-2)" "unprognostic (3.12e-2)" "unprognostic (2.88e-1)" "unprognostic (7.66e-2)" "unprognostic (5.05e-4)" "unprognostic (1.40e-1)" "unprognostic (3.82e-1)" "prognostic favorable (2.14e-4)" "unprognostic (1.17e-1)" "unprognostic (1.13e-1)" "unprognostic (3.41e-4)" "unprognostic (8.08e-2)" "unprognostic (1.01e-1)" "unprognostic (1.43e-1)" "unprognostic (2.10e-1)" 1.8 1.8 30.6 1.3 25.8 1.1 1.6 7.2 81.1 1.3 1.4 6.7 0.0 1.1 1.3 1.2 1.3 1.4 1.2 1.3 20.2 17.1 1.2 1.2 1.7 1.3 12.9 12.6 1.1 1.4 1.1 0.2 1.8 5.6 1.5 1.3 8.0 1.1 1.1 1.5 1.6 1.3 1.4 6.2 1.1 1.2 2.2 4.1 0.0 1.3 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 26.8 4.7 0.5 0.0 0.7 0.5 0.1 1.0 0.3 0.2 1.6 0.1 2.1 0.0 2.0 0.4 2.2 0.2 0.2 0.0 7.4 0.4 1.1 0.0 0.0 0.3 1.2 0.0 0.9 0.1 0.0 0.7 0.0 0.9 5.2 0.2 0.1 1.2 0.2 0.3 2.6 1.9 2.7 0.4 0.2 0.6 1.1 0.9 2.8 1.3 1.7 3.4 0.1 0.7 1.3 2.4 0.2 0.0 5.6 0.1 1.5 0.6 0.6 0.0 0.4 0.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 25.8 7.2 22.4 20.2 17.1 12.9 12.6 5.6 4.1 3.0 1.3 0.0 0.1 0.7 28.1 1.2 0.0 0.0 0.0 0.0 5.9 0.1 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.2 0.6 0.1 0.0 0.5 0.2 6.4 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 86.9 0.2 0.0 0.0 0.0 19.5 0.0 0.2 17.2 1.0 0.5 0.1 0.0 0.2 0.1 CSRNP1 "AXUD1, DKFZp566F164, FAM130B, TAIP-3, URAX1" ENSG00000144655 "Cysteine and serine rich nuclear protein 1" Q96S65 3 39141855-39154562 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Smooth muscle cells: 150.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 15.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 36.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045207, HPA058463" Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA045207: AB_10967202, HPA058463: AB_2683726" "unprognostic (2.90e-2)" "unprognostic (6.89e-2)" "unprognostic (3.00e-1)" "unprognostic (1.15e-1)" "unprognostic (2.57e-1)" "unprognostic (1.46e-1)" "unprognostic (3.78e-2)" "unprognostic (1.90e-2)" "unprognostic (1.81e-2)" "unprognostic (1.34e-1)" "unprognostic (3.46e-1)" "unprognostic (1.39e-1)" "prognostic favorable (1.07e-4)" "prognostic unfavorable (6.47e-4)" "unprognostic (2.42e-2)" "unprognostic (1.98e-1)" "unprognostic (1.51e-1)" 33.5 24.9 5.9 16.4 11.5 70.1 20.4 4.9 8.6 16.2 14.4 11.4 13.9 5.1 12.9 9.6 25.9 35.8 28.7 19.7 5.4 5.3 9.6 33.3 35.7 7.9 8.8 3.3 24.9 16.3 11.7 17.6 30.9 15.3 15.8 6.8 9.7 10.9 50.1 22.4 19.9 21.0 26.9 11.9 9.2 20.3 11.4 7.5 8.9 14.5 14.6 7.8 21.4 16.9 3.6 3.9 15.9 9.2 2.2 2.5 1.9 2.3 5.3 1.4 2.7 2.7 2.8 4.4 8.7 12.3 7.3 6.0 7.5 2.2 7.8 1.9 6.6 5.3 2.7 1.6 11.6 3.6 11.6 2.2 8.9 4.3 5.6 3.3 2.2 8.9 1.3 6.3 11.5 1.8 6.6 9.9 2.1 6.7 13.9 6.0 7.5 0.4 3.6 6.4 4.0 4.5 3.6 5.8 12.7 5.8 8.7 3.9 0.6 4.8 36.2 2.9 8.6 4.0 4.1 4.9 3.7 16.0 3.1 6.4 3.6 3.0 3.6 8.2 2.8 4.6 0.1 2.7 3.2 1.7 5.6 2.1 3.6 1.6 1.9 3.0 3.6 2.0 1.3 15.9 2.2 9.2 3.9 2.5 1.9 5.9 11.5 4.9 8.6 5.4 5.3 8.8 3.3 15.3 7.5 44.7 66.0 21.2 65.0 91.8 1.4 12.9 17.8 9.4 17.0 10.4 0.0 13.0 8.3 30.2 47.7 63.8 51.3 23.3 34.0 40.3 70.9 58.0 96.7 34.8 35.2 0.0 56.9 49.7 35.1 34.1 1.4 49.4 65.8 20.8 34.8 4.3 37.1 28.1 3.9 4.8 1.6 12.9 150.2 0.2 3.2 69.5 75.9 27.7 25.5 32.3 CSRNP3 "FAM130A2, FLJ32093, PPP1R73, TAIP-2" ENSG00000178662 "Cysteine and serine rich nuclear protein 3" Q8WYN3 2 165469647-165689407 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 31.7;pituitary gland: 21.1" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 49.8;Cone photoreceptor cells: 66.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.9;PC-3: 3.1;SCLC-21H: 9.5;SH-SY5Y: 7.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017905 Approved Uncertain "Nucleoplasm,Nucleoli rim" NA NA "Nucleoli rim" Nucleoplasm "HPA017905: AB_1857757" "unprognostic (2.85e-1)" "unprognostic (1.65e-2)" "unprognostic (1.39e-2)" "unprognostic (1.11e-1)" "unprognostic (1.27e-1)" "unprognostic (3.61e-1)" "unprognostic (8.87e-2)" "unprognostic (1.02e-2)" "unprognostic (2.18e-2)" "unprognostic (2.19e-1)" "unprognostic (4.87e-2)" "unprognostic (1.01e-1)" "unprognostic (1.82e-3)" "unprognostic (7.41e-2)" "unprognostic (5.36e-2)" "unprognostic (3.17e-1)" "unprognostic (1.08e-2)" 2.1 5.5 9.3 1.4 24.9 0.7 6.7 8.8 31.7 5.7 2.0 3.2 0.4 2.1 6.3 2.3 2.0 2.5 2.5 3.4 9.3 10.2 3.7 1.8 1.4 1.1 5.3 13.2 7.8 8.0 6.0 21.1 1.1 7.8 3.9 2.5 4.0 4.9 5.1 0.9 2.1 1.7 5.7 2.9 2.1 2.0 1.9 4.8 0.0 5.3 0.0 1.0 1.9 2.5 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.2 0.6 0.2 0.6 0.0 0.4 0.2 0.6 0.0 0.3 0.0 0.9 0.6 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.4 1.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 3.1 0.0 0.1 0.8 0.7 0.0 9.5 7.7 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.8 0.3 0.0 0.3 0.6 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.3 24.9 8.8 31.7 9.3 10.2 5.3 13.2 7.8 4.8 3.0 3.2 0.0 2.6 4.6 49.8 6.7 10.2 0.0 1.2 10.4 66.8 0.3 3.3 1.8 2.5 2.9 0.5 0.0 2.1 0.1 4.7 0.3 0.0 2.9 2.0 11.1 7.5 1.3 0.3 1.3 6.9 0.0 6.8 0.0 2.6 18.3 1.0 1.9 7.8 5.0 17.9 6.5 14.6 0.7 0.7 4.0 0.2 0.0 2.9 1.4 CSTA "STF1, STFA" ENSG00000121552 "Cystatin A" P01040 3 122325244-122341972 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 312.4;tongue: 421.9" "Cell type enhanced" "Detected in many" 16 "Kupffer cells: 712.6;monocytes: 1063.2;Syncytiotrophoblasts: 279.5" "Cancer enhanced" "Detected in all" "head and neck cancer: 405.0" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 20 "classical monocyte: 74.6;intermediate monocyte: 37.5;myeloid DC: 54.6;neutrophil: 36.0;non-classical monocyte: 21.6" "Group enriched" "Detected in many" 193 "dendritic cells: 54.6;granulocytes: 36.0;monocytes: 74.6" "Cell line enhanced" "Detected in some" "HBEC3-KT: 33.8;hTCEpi: 149.9;THP-1: 93.6;U-698: 59.6;U-937: 29.8" "CAB000469, HPA001031, CAB047315" Enhanced Approved Nucleoplasm,Cytosol No No 39000000 "Nucleoplasm, Cytosol" "CAB000469: , CAB047315: , HPA001031: AB_1078610" "unprognostic (5.22e-3)" "unprognostic (6.10e-2)" "unprognostic (2.64e-1)" "unprognostic (6.07e-2)" "unprognostic (7.79e-3)" "prognostic favorable (5.86e-4)" "unprognostic (4.46e-1)" "unprognostic (1.63e-1)" "unprognostic (1.78e-1)" "unprognostic (7.99e-2)" "unprognostic (2.56e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (2.60e-6)" "unprognostic (8.89e-2)" "unprognostic (3.43e-2)" "unprognostic (9.24e-3)" "unprognostic (1.99e-1)" 2.0 0.2 0.3 4.4 0.8 19.8 4.5 0.2 0.5 55.4 0.4 0.2 1.1 0.0 4.7 1.7 312.4 0.2 0.7 1.0 0.3 0.0 0.4 3.4 6.8 4.8 1.1 0.2 1.8 0.2 0.0 0.3 1.3 0.5 1.3 0.1 0.3 57.4 0.7 0.7 28.2 0.3 0.4 0.7 2.0 2.2 0.3 0.6 2.2 0.3 421.9 99.0 1.5 93.5 0.1 54.6 36.0 74.6 0.2 0.2 32.0 1.7 0.1 0.0 0.4 3.9 7.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.7 0.0 10.5 0.0 33.8 0.0 0.0 0.0 0.0 0.0 0.8 0.8 13.6 0.2 3.8 149.9 0.3 14.7 0.0 0.0 0.1 0.1 3.6 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 16.8 0.0 0.0 1.6 0.9 1.2 0.0 0.1 93.6 0.0 0.2 2.4 0.0 0.1 0.0 0.2 59.6 3.2 29.8 0.0 0.7 74.6 2.2 0.0 37.5 0.2 0.1 0.1 0.1 54.6 0.0 0.0 0.1 36.0 0.2 21.6 1.0 0.1 32.0 0.3 0.8 0.2 0.5 0.3 0.0 1.1 0.2 0.5 0.6 6.0 27.0 9.0 93.6 74.1 0.0 0.0 2.5 30.8 34.2 0.0 0.0 203.1 0.0 2.0 0.2 3.5 1.3 0.0 19.8 10.9 5.6 14.2 12.8 90.0 136.3 0.0 0.0 8.0 712.6 0.6 9.5 248.7 8.5 1063.2 0.5 0.0 27.6 1.1 3.5 0.5 0.0 32.3 4.2 0.1 0.1 179.2 279.5 4.3 0.8 83.6 CSTF1 ENSG00000101138 "Cleavage stimulation factor subunit 1" Q05048 20 56392371-56406369 "Predicted intracellular proteins" "mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019270, HPA047275, HPA065000" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB019270: , HPA047275: AB_2680008, HPA065000: AB_2685400" "unprognostic (2.51e-1)" "unprognostic (1.74e-1)" "unprognostic (1.54e-3)" "unprognostic (1.13e-3)" "unprognostic (1.02e-1)" "unprognostic (1.50e-1)" "unprognostic (8.57e-3)" "unprognostic (3.08e-2)" "unprognostic (2.23e-1)" "unprognostic (2.62e-1)" "unprognostic (1.03e-1)" "unprognostic (4.05e-2)" "unprognostic (3.91e-2)" "unprognostic (2.87e-1)" "unprognostic (2.67e-1)" "unprognostic (1.29e-1)" "unprognostic (3.60e-1)" 14.3 16.6 9.7 15.0 15.9 6.8 17.1 14.8 14.9 13.2 11.9 14.5 9.1 8.1 17.5 12.6 16.4 15.2 12.0 11.9 10.2 9.6 18.1 27.5 12.8 17.2 12.9 9.4 20.1 18.4 20.1 19.0 14.1 12.2 14.1 12.7 14.6 22.8 11.7 18.7 16.9 13.6 13.6 10.5 17.1 14.1 28.2 11.4 32.5 15.8 15.8 21.9 14.9 12.1 15.1 15.7 9.4 11.6 21.0 22.6 12.9 8.6 8.2 10.4 7.2 10.8 9.8 11.4 11.8 13.1 23.6 17.7 17.8 12.6 17.8 12.8 8.6 15.1 14.6 16.7 20.1 27.8 5.6 5.9 17.4 14.7 10.7 6.5 14.5 11.3 9.4 11.7 13.2 11.4 9.0 14.1 11.3 14.7 8.7 14.2 20.2 16.1 7.5 9.6 17.0 10.8 12.0 22.4 15.7 11.4 8.9 11.6 8.0 15.9 43.8 11.7 12.6 17.5 10.1 7.7 19.2 12.3 7.9 11.3 6.1 9.5 19.4 15.1 9.6 9.1 7.5 11.6 9.0 14.9 10.1 19.0 14.8 19.1 16.8 14.9 15.1 21.1 18.4 9.4 21.0 8.2 15.7 22.6 12.9 9.7 15.9 14.8 14.9 10.2 9.6 12.9 9.4 12.2 11.4 8.9 13.3 9.3 10.1 8.1 8.5 8.1 15.3 12.0 7.9 17.4 13.7 26.5 16.6 14.9 11.5 10.5 6.9 0.0 12.9 17.1 7.4 9.9 17.3 19.1 13.4 4.8 4.7 13.5 20.3 4.2 12.7 6.6 5.0 17.2 9.3 12.0 10.7 12.7 12.0 15.9 11.1 19.4 6.2 17.7 36.6 7.8 17.6 15.4 10.7 8.0 CSTF2 CstF-64 ENSG00000101811 "Cleavage stimulation factor subunit 2" P33240 X 100820359-100840932 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 23.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000427, CAB004680" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "CAB004680: AB_425385, HPA000427: AB_1078580" "unprognostic (2.02e-2)" "unprognostic (8.70e-3)" "unprognostic (3.50e-1)" "unprognostic (3.43e-1)" "unprognostic (7.00e-2)" "unprognostic (1.09e-2)" "prognostic unfavorable (8.23e-6)" "unprognostic (2.02e-1)" "unprognostic (4.82e-2)" "unprognostic (2.08e-3)" "unprognostic (5.98e-3)" "unprognostic (2.75e-1)" "prognostic favorable (1.12e-4)" "unprognostic (1.75e-2)" "unprognostic (2.90e-2)" "unprognostic (8.75e-2)" "unprognostic (2.89e-1)" 8.6 11.1 10.1 14.1 14.6 12.2 10.5 18.8 14.5 10.0 14.9 9.1 15.8 11.4 11.9 11.8 30.1 11.3 8.8 7.8 12.7 10.5 10.3 7.9 9.1 14.7 11.2 11.6 9.8 8.1 11.9 12.7 9.5 10.8 10.3 16.5 9.7 13.0 16.8 7.2 11.8 12.7 10.7 12.5 11.8 9.1 18.9 11.2 20.6 9.0 9.4 24.2 11.3 12.8 15.8 19.6 14.6 20.9 19.1 21.2 12.7 16.8 19.9 12.6 12.4 7.3 6.2 18.5 13.5 12.0 22.4 33.7 21.8 15.0 16.6 16.6 8.7 30.7 17.4 31.1 17.0 25.5 15.5 20.0 15.0 18.8 14.9 10.3 19.8 16.9 5.9 8.4 24.2 15.2 6.3 13.5 15.2 24.0 16.6 13.2 20.4 16.5 15.2 36.6 26.3 19.6 17.3 21.9 19.8 8.8 15.5 11.5 14.7 21.5 10.0 9.4 12.8 10.1 11.1 11.1 13.3 21.6 17.1 17.3 10.7 21.9 20.4 11.4 24.0 16.0 14.6 14.6 10.1 21.2 16.5 16.6 15.8 18.7 20.0 19.6 13.4 16.4 16.2 2.4 19.1 20.9 13.5 20.3 12.7 10.1 14.6 18.8 14.5 12.7 10.5 11.2 11.6 10.8 11.2 3.0 0.6 6.0 3.4 3.8 2.0 3.2 0.0 4.0 2.3 0.0 2.0 15.4 5.0 10.9 5.8 3.6 5.1 0.0 7.4 15.4 3.3 1.8 3.5 1.5 9.2 3.2 4.1 2.5 2.1 1.9 4.4 3.2 1.7 7.2 3.5 3.7 10.4 5.7 3.9 3.1 2.4 6.5 3.1 7.6 23.4 3.6 6.4 5.3 6.0 4.8 CSTF2T "CstF-64T, DKFZp434C1013, KIAA0689, tauCstF-64" ENSG00000177613 "Cleavage stimulation factor subunit 2 tau variant" Q9H0L4 10 51695487-51699591 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039216, HPA062021" Approved Enhanced Nucleoplasm,Vesicles No No Nucleoplasm Vesicles "HPA039216: AB_10795462, HPA062021: AB_2684662" "unprognostic (2.60e-2)" "unprognostic (3.75e-2)" "unprognostic (2.93e-2)" "unprognostic (2.17e-1)" "unprognostic (8.59e-2)" "unprognostic (1.06e-1)" "unprognostic (4.06e-3)" "unprognostic (9.13e-2)" "unprognostic (1.19e-1)" "unprognostic (3.42e-1)" "unprognostic (5.92e-2)" "unprognostic (5.36e-2)" "unprognostic (7.63e-2)" "unprognostic (5.19e-2)" "unprognostic (2.22e-1)" "unprognostic (3.31e-1)" "unprognostic (1.96e-1)" 20.2 23.5 16.5 20.0 21.6 14.0 15.2 16.2 24.0 14.8 13.5 29.6 9.9 14.3 16.8 13.4 13.1 19.0 12.7 17.4 18.4 16.6 15.5 15.4 11.9 21.7 21.3 16.5 23.3 16.3 30.2 14.1 14.6 23.5 15.8 13.5 12.6 13.4 12.5 25.0 13.3 16.8 16.8 28.0 24.6 17.7 11.6 20.1 31.9 17.0 12.6 22.9 17.0 13.2 4.6 5.5 5.5 5.1 13.9 6.8 3.2 8.5 10.1 15.3 16.0 21.7 14.9 1.0 12.1 11.3 14.0 13.7 13.5 12.5 24.6 7.0 10.5 8.5 13.4 11.5 12.7 12.8 14.2 13.0 14.2 10.8 2.5 10.5 5.4 13.0 21.4 9.9 12.3 14.4 8.9 10.5 14.5 15.2 14.0 12.1 7.3 22.2 8.8 5.6 10.4 21.9 17.7 30.9 5.2 10.7 7.1 12.9 16.6 10.1 10.6 10.8 16.7 19.7 10.1 11.1 9.0 12.3 8.3 15.0 17.9 6.6 17.7 18.7 12.8 7.7 3.7 5.0 5.5 4.9 5.1 6.8 2.3 3.6 3.8 5.5 4.6 6.2 5.3 1.5 13.9 3.4 3.5 5.7 3.2 16.5 21.6 16.2 24.0 18.4 16.6 21.3 16.5 23.5 20.1 8.9 6.9 15.9 6.1 8.0 14.6 11.4 10.2 17.4 6.8 8.7 7.9 20.3 19.9 13.7 0.7 16.5 6.4 0.0 13.3 13.9 9.3 3.3 19.7 13.7 13.1 19.1 5.8 17.2 15.6 2.1 22.2 12.0 0.0 22.6 6.6 11.8 11.2 6.5 18.7 10.7 12.8 6.5 11.4 36.7 13.8 5.6 5.1 21.5 10.0 4.8 CSTF3 CstF-77 ENSG00000176102 "Cleavage stimulation factor subunit 3" Q12996 11 33077188-33162371 "Predicted intracellular proteins" "mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039743, HPA040168" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA039743: AB_10795682, HPA040168: AB_10794025" "unprognostic (2.38e-1)" "unprognostic (1.46e-1)" "prognostic favorable (1.63e-4)" "unprognostic (3.77e-1)" "unprognostic (4.04e-2)" "unprognostic (4.35e-2)" "prognostic unfavorable (8.20e-6)" "unprognostic (1.47e-1)" "unprognostic (1.67e-2)" "unprognostic (6.42e-3)" "unprognostic (9.73e-2)" "unprognostic (2.41e-1)" "prognostic unfavorable (1.61e-5)" "unprognostic (4.64e-2)" "unprognostic (1.86e-2)" "unprognostic (1.15e-2)" "unprognostic (1.01e-3)" 9.6 16.0 27.4 16.4 38.2 11.2 16.0 30.7 35.5 12.1 13.2 11.2 14.4 16.0 16.2 50.9 16.2 13.0 13.2 11.9 24.9 23.4 15.0 19.5 12.7 20.0 17.7 22.2 17.0 12.8 21.3 45.2 15.6 17.4 18.7 16.9 12.7 13.5 13.3 12.3 21.7 14.6 12.8 20.4 15.9 15.7 21.8 19.1 20.9 19.4 15.1 16.8 13.3 15.2 9.2 11.3 9.4 11.8 9.3 13.3 5.3 18.3 18.3 34.0 22.6 8.9 15.8 25.5 18.7 11.6 20.2 27.2 14.0 15.0 19.9 12.8 11.3 13.6 24.0 29.8 17.1 32.1 20.3 50.5 20.5 39.7 22.9 10.4 26.6 12.7 11.8 12.2 15.2 15.2 16.4 25.9 15.8 27.0 14.6 26.4 13.9 25.0 13.9 16.6 13.4 22.4 20.3 33.7 15.3 21.6 26.1 26.0 14.9 21.2 12.4 14.2 22.5 22.2 17.1 16.0 16.5 21.1 27.4 23.9 13.6 19.1 17.4 20.5 26.4 16.1 5.4 7.9 9.4 9.6 9.9 11.0 9.2 11.4 9.2 11.3 8.3 12.3 12.2 4.3 9.3 11.8 8.6 13.3 5.3 27.4 38.2 30.7 35.5 24.9 23.4 17.7 22.2 17.4 19.1 17.9 16.0 27.9 37.5 16.8 33.5 18.5 25.5 72.3 43.3 55.8 5.9 56.0 53.0 20.9 31.0 22.9 14.4 23.3 14.5 25.8 32.3 29.2 13.9 51.6 24.7 12.7 30.6 12.3 21.3 9.8 27.6 20.7 27.0 28.9 26.0 29.9 17.7 14.4 28.0 36.5 25.0 25.8 21.7 72.7 51.5 16.9 28.3 20.8 31.1 52.5 CT45A1 "CT45-1, CT45.1" ENSG00000268940 "Cancer/testis antigen family 45 member A1" Q5HYN5 X 135713453-135723539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 17 "testis: 12.5" "Cell type enriched" "Detected in some" 5 "Spermatogonia: 5.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HMC-1: 70.1;Karpas-707: 32.4" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" "unprognostic (6.58e-3)" "unprognostic (2.14e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 32.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 6.6 0.0 0.0 0.5 6.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 5.5 0.0 0.0 0.0 0.0 0.0 CT45A10 ENSG00000269586 "Cancer/testis antigen family 45 member A10" P0DMU9 X 135881063-135889086 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 14.1" "Cell type enriched" "Detected in some" 16 "Spermatogonia: 57.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 33.3;K-562: 9.9;Karpas-707: 36.9;U-266/84: 31.0" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" "unprognostic (3.55e-1)" "unprognostic (7.08e-3)" "unprognostic (2.08e-1)" 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 33.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 36.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 7.3 31.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 57.9 0.0 0.0 0.0 0.0 0.0 CT45A2 "CT45-2, CT45.2" ENSG00000271449 "Cancer/testis antigen family 45 member A2" Q5DJT8 X 135811668-135820012 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 42 "testis: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HMC-1: 32.7" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A3 "CT45-3, CT45-4, CT45.3, CT45.4, CT45A4" ENSG00000269096 "Cancer/testis antigen family 45 member A3" Q8NHU0 X 135759846-135768191 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 15.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 29.9;T-47d: 17.5;U-266/84: 90.4" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.1 0.0 0.0 0.6 0.0 0.0 0.1 90.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 CT45A5 "CT45-5, CT45.5" ENSG00000228836 "Cancer/testis antigen family 45 member A5" P0DMU8 X 135777130-135785298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "testis: 10.5" "Group enriched" "Detected in some" 18 "Alveolar cells type 2: 2.2;Spermatogonia: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 18.3;Karpas-707: 12.8;RPMI-8226: 6.8;U-266/84: 66.2" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 2.5 0.0 0.0 0.9 66.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 CT45A6 "CT45-6, CT45.6" ENSG00000278289 "Cancer/testis antigen family 45 member A6" P0DMU7 X 135794706-135802656 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "U-266/84: 47.3" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A7 ENSG00000273696 "Cancer/testis antigen family 45 member A7" P0DMV0 X 135829247-135837268 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 5 "testis: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 4.1;Karpas-707: 3.4;PC-3: 1.0;THP-1: 1.6" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.4 0.0 0.0 0.9 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.7 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A8 ENSG00000278085 "Cancer/testis antigen family 45 member A8" P0DMV1 X 135846499-135854538 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 16 "testis: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AN3-CA: 14.2;HMC-1: 30.1" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A9 ENSG00000270946 "Cancer/testis antigen family 45 member A9" P0DMV2 X 135863776-135871812 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 17 "testis: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "HMC-1: 55.7" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTAG2 "CAMEL, CT6.2a, CT6.2b, ESO2, LAGE-1, LAGE-1a, LAGE-1b, LAGE1, MGC138724, MGC3803" ENSG00000126890 "Cancer/testis antigen 2" O75638 X 154651972-154653579 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 8.5;skeletal muscle: 5.7;testis: 11.9" "Cell type enriched" "Detected in some" 4 "Spermatogonia: 72.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 22.0;K-562: 27.8;OE19: 41.0;RPMI-8226: 61.9;SK-BR-3: 40.5;U-266/84: 70.1" "HPA071467, HPA076586" Enhanced Enhanced "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Nucleoplasm, Vesicles" "Nuclear bodies" "HPA071467: AB_2686402, HPA076586: " "prognostic unfavorable (2.35e-4)" "unprognostic (3.87e-1)" "unprognostic (1.00e-1)" "unprognostic (1.25e-2)" 0.2 1.0 0.4 0.0 0.0 0.2 0.1 0.2 0.5 0.0 0.2 0.0 0.0 0.0 1.0 2.9 0.0 8.5 0.0 0.0 0.1 0.8 0.2 0.0 0.2 0.8 3.6 0.0 0.4 4.4 0.2 0.0 0.1 0.0 5.7 0.2 0.0 0.0 0.0 0.3 0.6 11.9 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.8 0.6 0.0 0.0 0.0 0.0 0.0 41.0 0.0 0.0 0.0 61.9 0.0 0.0 0.0 0.0 0.0 40.5 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.1 0.0 0.5 70.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 3.3 0.0 0.1 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 16.8 72.0 0.0 0.9 0.0 0.0 0.0 CTBP1 BARS ENSG00000159692 "C-terminal binding protein 1" Q13363 4 1211448-1249953 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Host-virus interaction, Transcription, Transcription regulation" "Oxidoreductase, Repressor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004217, HPA018987, HPA044971" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004217: AB_627312, HPA018987: AB_1847307, HPA044971: AB_2679161" "unprognostic (6.19e-2)" "unprognostic (4.78e-2)" "unprognostic (9.14e-2)" "prognostic favorable (4.03e-4)" "unprognostic (3.81e-2)" "unprognostic (6.80e-3)" "unprognostic (2.52e-2)" "unprognostic (1.04e-2)" "unprognostic (9.65e-2)" "unprognostic (2.24e-2)" "unprognostic (6.35e-3)" "unprognostic (3.58e-2)" "unprognostic (3.36e-1)" "unprognostic (2.46e-2)" "unprognostic (3.00e-1)" "unprognostic (3.22e-2)" "prognostic favorable (8.94e-4)" 32.3 35.8 42.4 39.8 44.4 31.3 54.6 70.7 56.1 27.6 29.4 29.2 29.0 44.9 35.8 30.8 31.9 38.2 37.6 41.2 41.5 45.7 29.3 36.0 28.5 48.4 38.0 41.2 35.4 62.2 28.4 48.1 27.2 30.2 32.6 21.6 28.2 44.9 27.9 74.2 33.9 43.6 29.7 29.3 47.0 33.5 16.7 27.2 44.9 29.4 30.5 30.2 32.2 38.6 15.6 25.0 11.6 16.2 16.1 24.5 10.3 22.8 33.9 26.2 32.1 18.4 13.3 22.5 18.1 16.9 22.5 23.0 29.0 55.6 28.1 21.0 21.0 34.9 18.4 15.8 23.8 6.8 21.3 19.1 25.4 38.3 37.0 30.7 22.8 36.3 22.9 18.3 19.1 11.1 21.9 16.8 32.1 28.8 48.3 12.4 37.8 73.3 71.9 31.0 18.7 32.8 51.9 15.8 36.6 14.4 29.2 49.3 30.9 17.3 18.7 23.9 16.5 40.9 35.2 21.4 37.7 21.3 21.6 38.7 35.2 33.5 32.5 29.8 35.6 29.5 8.6 11.9 11.6 24.5 16.2 18.4 15.3 17.2 20.8 14.7 15.6 13.5 19.5 9.3 16.1 15.8 25.0 14.6 10.3 42.4 44.4 70.7 56.1 41.5 45.7 38.0 41.2 30.2 27.2 38.7 35.8 50.6 18.9 30.3 28.2 46.2 45.9 24.1 19.4 34.9 3.9 21.5 10.0 27.3 2.7 34.3 46.6 46.7 35.0 26.5 27.8 33.2 23.1 79.0 37.1 38.1 44.3 48.5 64.1 3.6 41.7 35.1 43.9 24.4 42.4 41.9 38.2 31.6 33.6 29.3 15.7 6.5 27.0 6.0 15.1 33.1 16.6 39.6 51.0 23.8 CTC1 "AAF132, C17orf68, FLJ22170" ENSG00000178971 "CST telomere replication complex component 1" Q2NKJ3 17 8224821-8248095 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052436 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA052436: " "unprognostic (6.47e-2)" "unprognostic (1.06e-2)" "unprognostic (6.16e-3)" "unprognostic (2.81e-3)" "unprognostic (1.33e-1)" "unprognostic (2.20e-3)" "unprognostic (3.96e-1)" "unprognostic (2.07e-2)" "unprognostic (3.00e-1)" "unprognostic (5.66e-2)" "prognostic favorable (6.49e-5)" "unprognostic (2.89e-3)" "unprognostic (3.24e-1)" "unprognostic (5.76e-2)" "unprognostic (1.47e-1)" "unprognostic (1.77e-2)" "unprognostic (1.66e-2)" 9.9 10.0 9.9 15.2 12.2 18.0 12.2 28.5 15.3 10.3 11.3 12.4 8.7 8.9 15.6 12.7 8.2 10.5 10.7 7.0 6.8 7.5 11.8 14.4 13.8 24.1 9.7 7.4 14.5 14.5 12.2 18.5 7.9 9.2 11.2 12.2 11.5 11.0 12.2 5.0 15.5 15.7 13.4 7.4 25.0 9.9 8.8 10.6 32.9 12.5 4.0 23.0 9.1 10.6 6.1 4.6 5.1 2.4 2.7 6.3 2.0 2.5 5.6 5.2 4.9 16.4 3.9 6.5 3.0 3.2 4.3 2.9 4.3 7.6 9.2 3.0 5.1 3.1 8.6 6.1 4.4 2.7 6.7 5.9 4.5 5.4 5.5 2.8 1.4 14.2 3.9 4.9 5.6 7.7 8.5 7.6 13.4 4.3 3.1 3.0 3.3 15.6 6.2 4.3 8.3 1.4 7.4 2.0 5.9 10.9 5.9 4.6 5.3 5.8 7.6 5.0 10.2 4.6 4.3 10.0 1.4 3.2 3.2 3.4 6.5 3.8 6.1 2.6 5.5 3.9 3.6 1.6 2.4 4.7 1.9 4.4 5.0 4.5 4.1 1.5 6.1 6.3 5.8 5.1 2.7 2.4 4.6 3.5 2.0 9.9 12.2 28.5 15.3 6.8 7.5 9.7 7.4 9.2 10.6 0.0 12.0 11.5 2.6 1.6 5.9 3.9 5.1 2.7 3.4 5.2 35.3 5.2 1.7 3.0 2.7 3.1 3.3 0.0 3.3 3.5 2.5 3.2 5.8 8.1 3.3 1.6 6.4 3.7 9.7 4.3 4.0 3.2 0.0 6.4 5.5 2.3 4.5 5.3 2.1 1.5 17.7 0.0 2.8 4.3 4.4 1.8 9.3 7.0 3.2 3.3 CTCF ENSG00000102974 "CCCTC-binding factor" P49711 16 67562407-67639185 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Chromosome partition, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004122, CAB062550, CAB068181, CAB068182" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB062550: AB_2665624, CAB068181: AB_2665625, CAB068182: AB_2665626, HPA004122: AB_2667139" "unprognostic (2.70e-1)" "unprognostic (4.21e-2)" "unprognostic (3.41e-2)" "unprognostic (4.70e-2)" "unprognostic (4.41e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (4.21e-4)" "unprognostic (1.71e-2)" "unprognostic (1.29e-1)" "unprognostic (1.14e-1)" "unprognostic (1.36e-2)" "unprognostic (1.99e-2)" "prognostic favorable (4.06e-4)" "unprognostic (3.47e-1)" "unprognostic (5.99e-2)" "unprognostic (4.58e-2)" "unprognostic (1.11e-2)" 19.1 17.5 22.3 35.0 24.3 32.2 20.2 31.6 26.6 23.0 19.4 20.5 21.0 16.5 24.2 15.4 23.1 21.7 20.3 17.6 21.8 16.7 19.5 19.5 17.2 27.9 22.3 21.0 24.6 21.2 42.4 21.8 23.5 17.9 19.4 23.2 14.3 19.9 24.9 29.4 25.2 21.4 22.0 20.2 26.1 18.5 14.8 22.9 68.8 20.7 16.2 35.5 22.6 26.7 10.1 7.9 9.6 6.2 4.9 7.2 1.9 11.0 17.1 22.8 9.0 10.4 8.9 18.5 10.6 11.3 15.7 15.0 14.0 11.5 34.7 8.6 9.2 8.9 14.4 21.9 11.9 17.7 12.3 14.4 21.1 9.7 16.0 7.1 23.8 20.2 7.2 14.5 11.7 13.1 9.4 11.9 27.9 18.4 14.5 13.0 21.7 50.0 9.1 19.8 12.7 11.5 36.6 18.7 19.1 9.6 16.1 19.5 13.5 19.2 11.2 9.3 12.5 13.8 14.8 11.3 13.6 14.1 10.3 11.6 12.7 15.9 50.6 7.8 14.3 14.5 9.4 3.4 4.9 6.7 3.4 6.3 7.9 7.2 5.4 3.1 10.1 5.9 6.7 9.6 4.9 6.2 7.9 5.4 1.9 22.3 24.3 31.6 26.6 21.8 16.7 22.3 21.0 17.9 22.9 20.8 28.0 26.8 21.6 19.8 33.6 32.3 38.2 17.4 38.7 22.7 7.9 20.9 16.6 25.5 0.9 30.1 18.7 46.7 29.1 27.5 18.8 26.1 18.5 21.3 20.8 42.9 30.0 20.3 23.2 2.0 23.0 23.7 11.8 24.4 25.6 30.4 26.6 14.0 26.9 19.5 27.1 19.4 21.7 15.8 25.6 21.7 24.7 32.3 21.2 29.4 CTCFL "BORIS, CT27, dJ579F20.2" ENSG00000124092 "CCCTC-binding factor like" Q8NI51 20 57495966-57525652 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 35.4" "Cell type enriched" "Detected in some" 6 "Spermatogonia: 114.6" "Cancer enhanced" "Detected in some" "ovarian cancer: 4.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 33 "HMC-1: 33.3;K-562: 45.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA001472 Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA001472: AB_1078583" "unprognostic (2.50e-1)" "unprognostic (4.01e-2)" "unprognostic (7.70e-2)" "unprognostic (1.85e-5)" "unprognostic (9.58e-2)" "unprognostic (2.89e-1)" "unprognostic (6.44e-2)" "unprognostic (5.26e-3)" "unprognostic (3.60e-1)" "unprognostic (2.20e-1)" "unprognostic (9.00e-2)" "unprognostic (4.16e-2)" "unprognostic (4.75e-4)" "unprognostic (2.03e-1)" "unprognostic (2.20e-1)" "unprognostic (4.84e-2)" 0.2 0.1 0.1 0.1 0.4 1.3 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.4 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.4 0.1 0.3 0.1 0.1 0.1 0.4 0.0 0.5 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.2 0.1 0.1 0.3 0.1 35.4 0.1 0.1 0.4 0.1 0.1 0.1 0.1 2.1 1.0 4.3 0.8 0.8 0.8 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.1 33.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.5 0.3 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.0 1.2 0.1 0.1 0.2 1.8 0.7 1.2 0.6 0.7 0.5 1.3 0.4 0.5 0.3 2.1 0.7 0.8 4.3 0.8 0.8 1.0 0.5 0.2 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 6.5 0.4 18.5 114.6 0.0 0.0 0.0 0.0 0.1 CTDP1 FCP1 ENSG00000060069 "CTD phosphatase subunit 1" Q9Y5B0 18 79679801-79756623 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Protein phosphatase" "Cataract, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 89.2;Late spermatids: 97.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 6.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032641, HPA040394, HPA070389" Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB032641: AB_2261235, HPA040394: AB_10794029, HPA070389: AB_2732155" "unprognostic (1.71e-1)" "unprognostic (1.75e-1)" "unprognostic (1.37e-1)" "prognostic favorable (6.43e-4)" "unprognostic (2.64e-2)" "unprognostic (7.99e-2)" "unprognostic (3.47e-3)" "unprognostic (1.83e-1)" "unprognostic (2.54e-1)" "unprognostic (1.15e-1)" "unprognostic (5.21e-3)" "unprognostic (1.99e-2)" "prognostic favorable (5.51e-5)" "unprognostic (5.16e-2)" "unprognostic (8.58e-2)" "unprognostic (2.85e-2)" "unprognostic (4.74e-2)" 10.6 8.2 6.2 12.8 9.5 21.8 9.5 7.5 12.2 7.9 12.0 14.4 5.3 13.4 11.9 9.3 11.4 9.8 10.0 6.6 6.8 5.7 8.9 13.4 10.2 14.4 12.3 5.1 7.7 13.4 4.6 7.9 10.6 9.1 9.1 6.2 8.4 10.6 8.3 12.1 20.9 13.8 8.2 6.8 15.3 12.2 27.2 10.6 26.2 9.4 8.8 14.8 11.4 8.9 0.7 1.5 6.4 1.0 2.4 2.0 0.5 8.1 9.1 5.1 7.2 4.1 3.4 16.9 5.5 4.0 5.0 5.0 6.0 5.2 10.4 2.6 3.6 6.1 10.0 4.3 5.7 2.1 9.6 7.8 5.4 4.5 8.1 5.9 23.7 13.3 5.7 5.5 5.4 2.5 3.1 6.0 7.9 6.5 5.3 1.9 7.3 15.8 18.7 7.9 2.7 12.2 12.3 6.7 12.5 3.7 8.5 7.9 8.1 6.5 6.5 8.7 4.0 5.2 13.9 8.2 8.7 12.6 3.4 5.9 4.5 16.6 10.3 7.4 12.0 6.1 0.0 1.0 6.4 1.3 0.9 1.1 0.7 1.0 2.0 1.5 0.4 1.3 0.7 2.7 2.4 0.9 0.2 0.3 0.5 6.2 9.5 7.5 12.2 6.8 5.7 12.3 5.1 9.1 10.6 0.0 2.6 3.7 4.2 7.6 9.8 3.1 5.1 6.7 3.4 3.5 13.7 7.8 1.7 4.4 89.2 5.2 11.7 23.3 6.2 6.5 4.2 8.1 6.9 5.5 7.7 22.3 5.8 7.4 7.3 97.9 7.2 9.5 6.8 0.0 15.1 7.8 8.0 14.4 9.9 5.7 14.3 0.0 5.1 5.9 6.8 8.8 15.9 13.3 10.6 11.5 CTDSP1 "NLIIF, SCP1" ENSG00000144579 "CTD small phosphatase 1" Q9GZU7 2 218398256-218405941 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062654 Supported Nucleoplasm NA NA Nucleoplasm "HPA062654: AB_2684819" "unprognostic (1.97e-2)" "unprognostic (4.02e-2)" "unprognostic (1.67e-3)" "unprognostic (2.62e-2)" "unprognostic (1.49e-1)" "unprognostic (1.82e-2)" "unprognostic (3.90e-2)" "unprognostic (8.69e-2)" "unprognostic (2.98e-1)" "unprognostic (6.38e-2)" "unprognostic (3.70e-1)" "unprognostic (1.79e-1)" "unprognostic (2.58e-1)" "unprognostic (6.67e-2)" "unprognostic (2.62e-1)" "unprognostic (7.01e-2)" "unprognostic (1.57e-1)" 32.9 22.5 15.9 21.9 13.9 19.9 41.1 12.2 16.4 34.8 30.7 27.6 31.8 24.2 34.5 30.7 31.3 30.9 43.4 25.9 15.5 8.6 34.1 47.5 30.2 33.2 15.0 13.1 44.9 50.8 28.8 12.6 71.3 15.9 41.5 19.8 35.4 34.3 31.5 23.2 30.5 41.3 33.7 12.4 39.1 34.2 15.1 16.1 33.2 41.0 27.2 29.9 32.5 28.4 3.4 6.6 29.3 12.4 6.7 11.0 7.5 10.3 13.3 7.8 25.8 21.4 20.0 29.6 13.9 20.0 13.4 11.7 17.3 25.8 6.2 12.1 24.5 9.2 21.1 11.6 16.7 6.9 22.2 9.1 23.8 16.3 23.1 25.7 14.6 33.4 22.7 20.4 10.2 11.5 21.3 19.7 9.8 19.3 22.4 14.2 28.9 12.8 42.7 5.5 16.5 13.7 17.7 11.1 13.5 17.1 12.7 5.2 13.1 12.1 26.4 13.1 10.4 14.5 35.2 17.2 21.4 13.1 16.3 6.0 14.4 9.3 14.7 19.1 13.9 11.8 20.3 12.4 29.3 11.0 10.2 7.1 3.4 6.7 7.0 6.6 3.2 4.3 5.7 24.5 6.7 10.4 2.3 5.6 7.5 15.9 13.9 12.2 16.4 15.5 8.6 15.0 13.1 15.9 16.1 41.7 40.2 27.7 26.3 24.3 14.0 27.9 45.9 9.4 20.5 29.6 2.0 35.7 28.2 31.7 1.5 43.6 72.4 46.7 37.2 35.9 36.1 31.8 17.4 49.9 35.0 6.4 20.8 58.3 79.9 2.0 55.0 36.2 32.1 26.2 44.5 46.7 32.1 35.1 41.4 42.5 24.7 25.8 34.0 1.6 4.7 17.8 45.4 46.7 37.6 26.7 CTDSP2 "OS4, PSR2, SCP2" ENSG00000175215 "CTD small phosphatase 2" O14595 12 57819927-57846739 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "RH-30: 169.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052607 Uncertain Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA052607: AB_2681883" "unprognostic (7.09e-2)" "unprognostic (2.45e-1)" "unprognostic (1.84e-2)" "unprognostic (3.07e-2)" "unprognostic (4.39e-1)" "unprognostic (5.57e-2)" "unprognostic (1.05e-3)" "unprognostic (2.45e-2)" "unprognostic (1.04e-1)" "unprognostic (1.06e-2)" "unprognostic (1.12e-1)" "unprognostic (4.15e-1)" "unprognostic (7.38e-3)" "unprognostic (5.50e-2)" "unprognostic (6.50e-2)" "unprognostic (2.18e-1)" "unprognostic (3.11e-1)" 44.5 43.6 28.2 31.6 34.8 17.6 39.6 57.1 33.4 49.0 48.4 36.7 47.7 24.4 50.4 32.9 38.0 41.9 37.7 34.6 31.2 16.5 32.8 32.6 51.3 31.3 37.1 19.9 52.5 53.9 33.7 25.4 42.9 31.0 40.5 38.6 29.3 45.8 60.9 48.8 39.9 36.1 44.1 25.7 38.1 43.1 21.0 40.9 62.9 40.1 32.8 33.9 46.1 63.0 7.3 9.3 18.7 9.7 8.2 11.5 7.1 11.0 4.8 23.1 14.7 20.8 35.9 7.7 12.0 22.8 11.9 10.7 6.1 18.1 13.6 13.8 25.5 4.6 8.9 9.6 11.7 12.5 4.5 4.1 18.8 7.4 4.9 19.4 8.5 11.0 34.3 12.4 10.8 9.2 25.6 18.6 8.3 9.8 24.1 5.9 5.1 9.1 5.1 11.7 7.0 6.1 12.2 169.3 17.8 9.3 16.1 4.3 9.6 16.7 9.6 14.4 14.7 17.4 14.9 14.9 10.6 11.6 11.9 4.2 7.2 7.7 16.4 11.9 7.9 8.2 11.5 9.7 14.7 6.9 9.0 8.2 7.3 9.9 8.0 9.3 6.5 11.5 8.7 18.7 8.2 7.7 7.7 6.4 7.1 28.2 34.8 57.1 33.4 31.2 16.5 37.1 19.9 31.0 40.9 68.5 36.0 33.5 41.6 60.0 18.7 31.1 79.0 13.4 23.9 45.4 15.7 36.7 13.3 64.0 44.2 58.1 55.7 0.0 117.0 34.7 57.1 49.1 24.3 49.7 36.0 19.1 46.8 80.4 63.9 111.0 48.1 36.8 40.5 66.7 42.3 41.1 88.4 51.8 45.6 23.9 10.8 71.1 55.2 5.8 25.8 66.6 47.0 40.6 35.4 58.0 CTDSPL "C3orf8, HYA22, PSR1, RBSP3, SCP3" ENSG00000144677 "CTD small phosphatase like" O15194 3 37861960-37984469 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Peritubular cells: 92.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTCEpi: 50.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048325 Approved Approved Nucleoplasm,Vesicles NA NA 10000 Vesicles Nucleoplasm "HPA048325: AB_2680359" "unprognostic (7.35e-2)" "unprognostic (1.36e-1)" "unprognostic (1.21e-1)" "unprognostic (6.48e-3)" "unprognostic (1.73e-1)" "unprognostic (3.35e-2)" "unprognostic (1.66e-3)" "unprognostic (4.30e-2)" "unprognostic (1.96e-1)" "unprognostic (2.55e-1)" "unprognostic (2.98e-3)" "unprognostic (1.20e-1)" "prognostic favorable (6.22e-14)" "unprognostic (3.48e-2)" "unprognostic (6.84e-2)" "unprognostic (1.94e-1)" "unprognostic (2.67e-2)" 12.8 6.3 11.1 7.8 12.4 5.6 22.0 30.2 14.1 15.5 19.9 8.0 25.7 9.3 14.5 18.3 16.8 12.2 37.2 18.9 13.1 5.9 26.7 13.3 19.0 4.9 7.8 9.9 13.7 10.2 8.3 9.4 20.6 6.9 17.5 20.3 15.6 45.5 22.4 12.5 34.8 11.2 21.3 8.1 11.3 19.7 8.1 8.3 2.9 10.0 13.9 6.9 19.6 21.7 0.0 0.2 1.1 0.5 0.0 0.5 5.6 15.8 6.9 2.9 9.0 11.3 16.2 21.4 10.9 13.8 7.6 8.9 10.0 13.0 0.0 6.7 13.5 3.1 13.3 7.0 20.7 6.1 0.0 5.5 9.7 7.4 22.6 10.3 0.0 2.4 8.3 50.9 8.0 9.6 8.6 10.6 4.4 3.1 0.0 12.5 5.0 3.9 0.0 11.8 6.5 1.0 4.4 5.5 0.1 24.3 10.6 2.4 7.5 6.0 10.8 12.2 12.1 10.4 2.6 8.4 5.5 7.7 10.2 6.8 0.2 0.0 0.0 6.1 5.4 10.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.5 0.1 1.1 0.0 0.0 0.0 0.0 5.6 11.1 12.4 30.2 14.1 13.1 5.9 7.8 9.9 6.9 8.3 62.5 19.3 0.0 13.3 26.8 9.6 33.8 71.4 14.7 31.8 22.7 0.0 27.6 19.9 10.8 21.9 17.5 10.3 0.0 4.2 7.7 21.7 12.0 1.1 13.9 6.3 9.5 43.5 19.0 9.5 32.3 66.4 5.5 8.5 0.0 17.7 7.1 10.0 5.8 92.3 14.9 1.6 25.8 22.7 2.8 15.8 25.1 7.9 2.2 29.9 14.2 CTDSPL2 "FLJ10523, HSPC129" ENSG00000137770 "CTD small phosphatase like 2" Q05D32 15 44427234-44529038 "Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 155.1;Late spermatids: 125.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040763, HPA062198" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA040763: AB_10960989, HPA062198: AB_2684708" "unprognostic (6.64e-2)" "unprognostic (4.30e-2)" "unprognostic (1.43e-1)" "unprognostic (2.06e-1)" "unprognostic (7.39e-3)" "unprognostic (5.20e-2)" "unprognostic (7.40e-2)" "unprognostic (1.23e-1)" "unprognostic (5.37e-2)" "unprognostic (2.54e-2)" "unprognostic (3.68e-3)" "unprognostic (5.35e-2)" "unprognostic (8.36e-3)" "unprognostic (7.49e-2)" "unprognostic (1.37e-1)" "unprognostic (1.53e-1)" "unprognostic (1.16e-1)" 17.4 11.1 13.0 15.9 16.3 19.8 17.0 33.2 18.4 17.7 14.2 11.6 15.7 11.2 21.3 13.3 14.6 15.4 13.3 11.8 11.5 9.3 12.8 11.5 14.3 20.1 13.4 10.7 22.7 13.0 13.4 21.1 17.6 11.6 14.7 12.8 12.2 15.6 12.7 17.9 16.0 14.9 16.0 11.6 16.5 11.8 21.7 13.8 35.5 17.4 9.7 20.9 18.4 15.8 12.3 16.0 10.3 13.1 17.0 16.5 11.2 11.0 5.5 23.3 11.7 3.6 8.3 12.9 11.4 9.9 14.9 19.0 11.2 10.4 11.7 11.0 8.1 8.4 15.7 13.4 7.8 17.6 11.6 6.3 14.6 14.5 6.9 5.2 25.1 13.0 6.6 5.9 10.4 13.8 6.5 11.5 15.2 16.9 13.2 10.8 4.7 29.8 8.7 12.3 11.9 7.9 33.4 32.1 10.8 7.9 14.8 10.6 15.7 14.1 11.6 6.5 9.0 15.6 22.8 9.8 18.5 20.1 17.7 19.3 7.8 29.5 36.0 8.7 19.9 14.2 6.0 12.8 10.3 12.7 13.1 11.9 12.3 12.4 11.5 16.0 12.1 13.4 15.0 9.0 17.0 9.9 10.2 16.5 11.2 13.0 16.3 33.2 18.4 11.5 9.3 13.4 10.7 11.6 13.8 17.9 29.4 18.2 12.4 21.9 22.2 21.8 12.7 22.7 43.3 12.2 9.8 15.1 14.9 10.2 155.1 21.2 12.0 0.0 12.6 16.2 20.7 15.1 33.7 11.5 11.8 28.6 8.6 17.8 21.6 125.2 18.7 17.5 15.1 18.0 12.7 18.4 13.2 8.6 12.4 9.8 28.3 25.8 14.1 18.1 34.2 19.2 12.2 22.4 13.8 12.9 CTHRC1 ENSG00000164932 "Collagen triple helix repeat containing 1" Q96CG8 8 103371515-103382997 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 19 "Endothelial cells: 36.6;Fibroblasts: 168.4;Melanocytes: 47.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 2.3;NK-cell: 5.2" "Group enriched" "Detected in many" 5 "granulocytes: 2.3;NK-cells: 5.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 56.2;fHDF/TERT166: 24.7;HHSteC: 37.4;HSkMC: 77.1;WM-115: 70.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059806, HPA061896" Approved Approved Nucleoplasm "Secreted in other tissues" NA NA 320000 Nucleoplasm "HPA059806: AB_2684130, HPA061896: AB_2684633" "unprognostic (2.04e-2)" "unprognostic (4.58e-1)" "unprognostic (2.76e-2)" "unprognostic (1.88e-2)" "unprognostic (1.20e-1)" "unprognostic (1.33e-2)" "prognostic unfavorable (1.67e-4)" "unprognostic (4.17e-2)" "unprognostic (3.64e-2)" "unprognostic (8.63e-2)" "unprognostic (1.12e-2)" "unprognostic (3.73e-2)" "prognostic unfavorable (1.22e-14)" "unprognostic (2.33e-3)" "unprognostic (3.21e-2)" "unprognostic (7.96e-3)" "unprognostic (2.37e-3)" 35.1 1.4 1.1 5.2 1.1 0.0 32.3 0.8 2.3 5.3 3.8 0.5 3.0 2.0 6.9 11.2 3.5 3.0 33.0 4.2 1.1 1.6 2.0 0.7 4.5 7.6 1.6 1.3 3.7 2.1 0.3 2.1 32.2 1.9 4.0 2.1 2.6 23.0 4.2 9.2 17.4 2.1 8.4 2.6 1.4 1.8 8.4 0.8 2.2 4.8 3.7 5.4 31.3 3.6 0.2 0.7 2.3 0.0 5.2 0.4 0.3 2.1 0.1 0.6 0.1 16.9 56.2 0.0 6.3 1.7 0.6 0.9 0.2 1.5 0.2 6.7 24.7 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.1 3.4 37.4 0.1 0.1 77.1 0.1 5.7 0.0 0.2 11.0 0.4 0.0 17.0 3.4 0.3 3.0 7.3 2.0 0.0 10.6 6.4 5.7 0.2 0.5 0.0 1.0 0.8 0.0 0.0 18.9 2.4 0.0 0.0 8.9 0.8 0.3 0.9 0.0 0.5 0.1 0.1 0.4 0.0 70.8 0.0 0.0 2.3 0.1 0.0 0.4 0.2 0.1 0.0 0.0 0.1 0.2 0.3 0.1 5.2 0.0 0.7 0.0 0.3 1.1 1.1 0.8 2.3 1.1 1.6 1.6 1.3 1.9 0.8 3.0 2.9 0.0 0.1 28.4 0.3 0.6 2.5 0.0 0.0 3.5 0.0 5.6 0.0 4.4 0.3 36.6 0.0 0.0 0.6 8.9 168.4 0.6 0.0 0.0 7.0 0.0 1.2 26.4 0.3 0.2 11.5 1.7 47.2 1.0 0.0 5.5 2.4 0.0 0.4 0.3 1.0 0.0 24.7 1.6 15.6 23.8 13.8 0.0 0.0 0.4 CTNNBL1 "C20orf33, FLJ21108, NAP, NYD-SP19, P14, P14L" ENSG00000132792 "Catenin beta like 1" Q8WYA6 20 37693955-37872129 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 296.8;granulocytes: 250.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 76.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004742, HPA027906, HPA027907" Approved Enhanced Nucleoplasm,Centrosome,Cytosol No No Nucleoplasm "Centrosome, Cytosol" "HPA004742: AB_1847323, HPA027906: , HPA027907: AB_10601362" "unprognostic (2.81e-1)" "unprognostic (3.42e-1)" "unprognostic (8.80e-2)" "unprognostic (1.88e-3)" "unprognostic (1.93e-1)" "unprognostic (2.55e-2)" "unprognostic (1.44e-1)" "unprognostic (5.11e-2)" "unprognostic (1.02e-1)" "unprognostic (3.79e-2)" "unprognostic (2.56e-1)" "unprognostic (1.43e-1)" "unprognostic (2.06e-3)" "unprognostic (1.62e-1)" "unprognostic (1.67e-1)" "unprognostic (2.81e-1)" "unprognostic (5.31e-2)" 21.0 14.7 19.6 25.8 21.4 27.3 18.9 20.9 21.3 20.3 23.5 18.4 31.7 16.1 25.4 25.2 18.9 21.0 17.7 25.6 17.5 15.8 19.3 35.3 19.3 26.9 17.9 14.7 21.7 14.6 14.5 22.6 22.4 17.5 19.4 18.1 16.1 15.5 34.3 27.3 20.1 19.7 23.8 16.6 49.5 25.9 35.5 20.6 31.0 15.9 15.5 29.7 22.2 29.3 24.9 31.4 60.3 29.1 21.7 18.2 18.4 15.6 14.4 13.8 10.8 10.0 8.3 21.9 10.0 10.5 24.1 21.3 53.9 12.7 17.4 14.7 10.1 23.3 16.8 18.6 23.7 26.0 8.4 9.2 57.1 7.9 26.3 10.4 18.0 76.0 8.7 14.1 13.6 13.6 8.4 14.3 25.0 15.4 7.2 12.8 12.9 29.2 24.0 12.5 17.6 21.0 20.6 26.8 13.1 10.5 13.1 11.1 13.3 17.4 24.9 17.6 13.4 12.3 14.5 10.6 24.1 14.4 15.8 16.2 8.4 10.6 20.3 17.0 11.3 12.7 60.3 22.3 27.9 15.8 29.1 15.0 24.9 15.4 16.2 31.4 23.4 15.5 16.6 4.9 21.7 28.7 24.7 18.2 18.4 19.6 21.4 20.9 21.3 17.5 15.8 17.9 14.7 17.5 20.6 26.8 26.6 37.0 27.7 20.3 25.3 35.5 20.4 21.4 31.8 17.4 17.7 122.6 31.5 25.9 296.8 26.1 24.4 0.0 30.3 56.0 26.8 18.9 250.2 39.2 44.0 17.5 20.1 31.3 29.7 86.0 31.7 43.3 25.3 129.0 23.0 28.3 25.6 19.8 31.5 32.3 21.0 19.4 40.1 76.5 43.0 19.6 44.3 32.4 19.5 18.6 CTNND2 "GT24, NPRAP" ENSG00000169862 "Catenin delta 2" Q9UQB3 5 10971840-11904043 "Disease related genes, Predicted intracellular proteins" "Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway" "Developmental protein" "Autism, Autism spectrum disorder, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 74.3" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 18.0;Cholangiocytes: 38.2;Early spermatids: 21.0;Late spermatids: 23.3;Muller glia cells: 39.5" "Cancer enriched" "Detected in many" 16 "glioma: 44.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 18.1;MCF7: 8.2;SK-BR-3: 5.4;U-266/84: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015077, CAB037339, HPA071124" Enhanced Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cell Junctions" Cytosol "CAB037339: , HPA015077: AB_2669150, HPA071124: " "unprognostic (7.32e-2)" "unprognostic (1.51e-3)" "unprognostic (2.23e-1)" "unprognostic (5.16e-2)" "unprognostic (5.66e-2)" "unprognostic (2.06e-2)" "unprognostic (1.81e-1)" "unprognostic (2.74e-2)" "unprognostic (9.13e-2)" "unprognostic (9.86e-2)" "unprognostic (8.95e-3)" "unprognostic (2.66e-1)" "unprognostic (9.55e-4)" "unprognostic (5.87e-2)" "unprognostic (1.05e-2)" "unprognostic (1.33e-1)" "unprognostic (4.76e-2)" 1.7 2.4 30.9 1.8 26.3 1.4 2.8 21.6 74.3 1.7 1.8 16.6 0.0 1.7 1.6 1.9 1.6 1.7 4.8 6.0 26.0 17.7 1.5 1.7 2.4 1.6 22.8 20.2 2.1 12.5 1.5 5.7 1.9 11.0 2.6 1.9 2.6 1.7 1.7 1.6 1.5 2.0 1.6 13.3 5.7 1.9 4.2 14.7 0.0 1.7 0.0 1.5 1.6 0.1 0.0 0.0 0.8 0.4 0.0 0.3 0.6 0.0 0.1 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 8.2 0.0 0.0 2.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 5.4 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 3.3 0.0 15.4 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.6 30.9 26.3 21.6 29.1 26.0 17.7 22.8 20.2 11.0 14.7 0.0 0.0 0.0 0.0 0.0 18.0 8.4 38.2 0.0 0.0 1.8 0.0 0.0 3.3 5.4 21.0 0.3 0.0 0.0 5.4 0.0 0.0 3.6 0.0 0.0 0.1 7.9 4.7 0.0 0.0 23.3 1.4 0.0 0.0 0.0 0.0 39.5 3.5 0.0 0.0 0.3 2.6 0.0 0.0 1.4 3.1 0.0 0.0 0.0 0.0 0.1 CTR9 "KIAA0155, p150TSP, SH2BP1, TSBP" ENSG00000198730 "CTR9 homolog, Paf1/RNA polymerase II complex component" Q6PD62 11 10750987-10801625 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 60.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061027, HPA068122" Supported Enhanced Nucleoplasm No No Nucleoplasm "HPA061027: AB_2684418, HPA068122: AB_2685959" "unprognostic (1.92e-1)" "unprognostic (1.82e-1)" "unprognostic (2.89e-1)" "unprognostic (1.16e-1)" "unprognostic (1.18e-2)" "unprognostic (1.58e-1)" "unprognostic (6.27e-2)" "unprognostic (2.42e-1)" "unprognostic (5.26e-2)" "unprognostic (2.80e-1)" "unprognostic (2.63e-1)" "unprognostic (7.27e-2)" "prognostic favorable (3.65e-6)" "unprognostic (6.88e-2)" "unprognostic (1.52e-1)" "unprognostic (1.12e-2)" "unprognostic (1.40e-1)" 16.7 26.7 15.9 19.9 17.4 18.4 26.1 17.5 17.1 21.5 15.8 13.0 20.3 14.2 21.4 44.1 23.7 17.7 13.7 24.2 18.8 14.8 20.5 35.0 15.6 23.8 14.3 14.0 25.4 18.8 36.5 31.4 26.7 16.0 17.5 16.4 14.0 19.1 20.2 24.0 18.3 19.2 16.6 15.7 26.6 17.6 24.4 15.8 39.1 20.9 13.1 21.9 19.6 21.1 11.9 11.9 27.2 12.1 17.5 18.5 9.5 13.0 10.2 14.7 13.9 32.2 12.9 7.2 14.6 9.7 11.8 12.5 16.8 28.1 11.9 8.0 12.0 14.4 13.6 18.0 11.9 19.3 18.3 21.6 60.8 10.8 9.5 10.3 23.8 33.8 11.9 9.8 7.5 10.3 10.9 13.5 11.6 24.5 14.6 14.2 5.9 15.2 9.3 12.2 15.8 12.8 14.1 17.9 8.2 10.2 18.0 6.7 16.1 13.2 13.1 10.2 14.7 11.6 10.5 13.2 10.0 10.3 17.5 7.8 8.0 18.8 13.1 10.7 16.1 10.2 27.2 10.0 19.8 14.1 12.1 18.5 11.6 14.9 13.6 11.9 11.9 14.7 13.8 7.5 17.5 11.2 6.0 12.4 9.5 15.9 17.4 17.5 17.1 18.8 14.8 14.3 14.0 16.0 15.8 53.6 45.6 25.3 36.7 77.4 33.6 39.1 22.9 36.1 45.5 24.4 53.0 31.1 16.6 23.4 13.7 23.9 23.8 0.0 21.3 20.2 22.3 24.0 80.1 34.2 25.0 60.4 25.8 26.4 28.9 6.8 31.1 22.9 11.8 22.6 34.5 29.0 21.5 20.3 29.4 15.6 45.5 25.8 23.6 72.8 63.9 70.9 38.2 33.1 21.5 27.6 CTSV "CTSL2, CTSU" ENSG00000136943 "Cathepsin V" O60911 9 97029679-97039643 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 154.7" "Cell type enhanced" "Detected in many" 12 "Cytotrophoblasts: 114.1;Extravillous trophoblasts: 136.0;Syncytiotrophoblasts: 56.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "NK-cell: 4.2;plasmacytoid DC: 15.7" "Group enriched" "Detected in many" 42 "dendritic cells: 15.7;NK-cells: 4.2" "Group enriched" "Detected in many" 9 "BEWO: 92.0;SuSa: 118.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB017112 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 260000 "Nucleoli fibrillar center, Cytosol" "Nucleoplasm, Plasma membrane" "CAB017112: " "unprognostic (2.40e-1)" "unprognostic (2.74e-2)" "unprognostic (1.50e-1)" "prognostic favorable (8.41e-4)" "unprognostic (7.29e-2)" "unprognostic (5.59e-2)" "prognostic unfavorable (2.83e-5)" "unprognostic (7.04e-3)" "unprognostic (6.06e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (2.87e-4)" "unprognostic (1.86e-2)" "unprognostic (1.78e-1)" "unprognostic (2.41e-2)" "unprognostic (1.33e-1)" "unprognostic (3.04e-3)" "prognostic unfavorable (2.39e-4)" 0.7 0.0 0.4 0.6 0.7 0.0 3.5 0.4 1.0 23.0 1.4 2.0 0.4 0.5 1.5 1.5 9.8 0.6 0.5 0.2 0.8 0.6 9.7 0.4 0.6 0.2 1.5 0.7 0.4 1.1 1.1 0.9 8.7 1.6 0.5 1.6 4.3 5.0 0.6 0.5 25.0 0.6 0.2 3.0 0.2 1.1 32.4 1.0 154.7 0.7 6.3 2.7 0.2 9.9 0.2 15.7 0.2 0.0 4.2 0.0 0.1 5.9 1.8 2.0 5.3 0.1 0.0 92.0 0.0 0.0 1.3 1.0 12.1 5.9 0.0 0.5 0.0 8.8 11.4 9.8 7.2 1.9 0.0 1.3 0.2 0.6 1.8 0.0 0.0 0.8 0.0 2.4 0.3 0.3 0.1 0.4 1.7 0.2 0.0 2.3 2.2 0.1 0.0 12.2 12.0 1.7 0.0 4.4 0.1 1.8 0.7 0.5 0.9 6.0 2.1 2.1 118.9 3.8 0.7 0.0 0.3 6.0 0.0 0.6 1.2 3.2 0.1 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.2 4.2 0.0 15.7 0.0 0.1 0.4 0.7 0.4 1.0 0.8 0.6 1.5 0.7 1.6 1.0 0.0 0.6 1.5 13.2 27.0 4.4 0.8 0.0 0.0 3.4 1.8 9.8 114.1 1.7 1.2 1.5 1.5 1.2 0.0 0.7 136.0 2.6 7.1 0.0 0.0 11.8 0.0 1.7 0.6 0.0 9.6 3.7 1.6 0.0 0.0 0.9 4.5 0.6 1.7 1.1 11.1 26.0 6.5 0.8 34.6 32.6 10.5 56.3 0.0 3.7 6.4 CTXN1 FLJ25968 ENSG00000178531 "Cortexin 1" P60606 19 7924485-7926166 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "brain: 91.1" "Cell type enhanced" "Detected in many" 7 "Glandular cells: 14.7;Late spermatids: 13.4;Spermatogonia: 10.4" "Cancer enhanced" "Detected in all" "ovarian cancer: 138.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 33.9;HEK 293: 23.6;NTERA-2: 25.7;REH: 19.5;SCLC-21H: 20.0;SH-SY5Y: 33.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016669 Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA Nucleoplasm "Plasma membrane, Cell Junctions" "HPA016669: AB_1847330" "unprognostic (1.49e-2)" "unprognostic (3.52e-2)" "unprognostic (1.79e-2)" "unprognostic (2.47e-1)" "unprognostic (1.22e-1)" "unprognostic (1.82e-2)" "unprognostic (5.42e-2)" "unprognostic (2.17e-1)" "unprognostic (2.58e-1)" "unprognostic (2.28e-2)" "unprognostic (1.69e-3)" "unprognostic (3.31e-2)" "unprognostic (1.56e-3)" "unprognostic (4.84e-2)" "unprognostic (3.09e-2)" "unprognostic (3.76e-2)" "unprognostic (9.41e-2)" 2.1 4.8 47.7 2.5 91.1 1.6 2.1 0.0 74.2 5.2 6.1 5.0 3.6 2.6 17.5 5.1 2.4 16.4 1.8 1.6 49.4 16.8 3.1 1.5 3.0 1.6 15.7 20.1 2.7 2.1 2.3 6.5 2.0 4.0 5.5 2.1 0.0 2.1 16.5 1.6 2.8 2.1 7.1 1.5 2.0 2.2 6.1 8.3 0.0 1.8 0.0 1.6 2.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 2.8 7.3 33.9 0.0 0.1 1.7 2.9 0.8 1.4 0.8 0.8 1.7 0.0 5.8 0.7 0.8 12.3 1.6 0.3 0.0 1.0 23.6 0.2 1.9 0.5 0.3 0.6 0.6 0.0 0.9 0.5 0.3 3.5 1.9 3.2 7.1 0.1 0.1 13.7 6.2 4.6 25.7 0.8 11.9 19.5 0.0 2.2 5.2 0.5 20.0 33.6 1.8 0.9 3.1 0.6 7.4 0.2 2.8 0.7 11.9 1.3 1.6 0.2 0.3 1.6 2.8 1.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.7 91.1 0.0 63.8 49.4 16.8 15.7 20.1 4.0 8.3 0.0 0.0 0.0 3.6 1.0 0.2 0.2 0.0 0.0 0.0 8.7 3.9 0.1 3.3 5.0 7.3 0.5 0.0 0.0 0.3 0.4 0.9 14.7 0.0 0.0 0.2 0.0 8.7 0.6 0.0 13.4 1.1 0.1 1.7 0.0 0.0 0.1 2.0 0.2 1.8 7.2 0.4 0.0 4.2 3.6 10.4 1.8 0.2 0.0 0.0 5.9 CUEDC2 "C10orf66, MGC2491" ENSG00000107874 "CUE domain containing 2" Q9H467 10 102423245-102432661 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036544, HPA041829" Uncertain Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA036544: AB_10670111, HPA041829: AB_2677694" "unprognostic (2.10e-1)" "unprognostic (2.80e-2)" "unprognostic (7.31e-2)" "unprognostic (4.24e-2)" "unprognostic (9.78e-2)" "unprognostic (3.09e-1)" "prognostic unfavorable (2.75e-4)" "unprognostic (1.06e-1)" "unprognostic (4.98e-2)" "unprognostic (1.88e-1)" "unprognostic (2.24e-2)" "unprognostic (1.32e-1)" "unprognostic (3.48e-3)" "unprognostic (4.34e-1)" "unprognostic (1.67e-1)" "unprognostic (8.38e-2)" "unprognostic (1.58e-2)" 18.8 26.2 29.9 14.9 28.5 13.0 16.2 22.0 49.7 19.8 20.3 19.0 18.5 10.8 19.6 20.8 17.1 25.1 22.7 38.7 25.5 22.3 20.1 18.2 14.9 15.3 27.5 29.5 27.9 23.3 24.4 16.7 14.6 25.4 20.7 12.6 17.5 21.5 22.4 61.6 13.2 11.2 23.6 23.6 15.1 16.3 13.5 18.2 16.5 20.0 25.5 15.8 17.1 14.9 37.4 50.1 35.5 50.5 38.2 36.1 36.0 15.1 17.4 27.2 32.0 22.7 29.2 10.2 12.8 41.3 27.5 21.1 5.4 15.3 25.3 27.3 21.4 12.5 15.0 17.6 27.7 13.6 22.5 17.9 15.6 14.8 5.4 38.4 11.9 10.6 34.4 25.8 26.8 26.7 53.0 28.3 31.6 12.1 25.3 30.8 16.3 27.8 26.6 9.3 11.7 10.9 32.3 33.3 13.0 27.9 7.0 13.5 32.3 8.6 8.5 26.1 11.7 25.9 19.0 16.2 13.7 13.0 17.4 17.1 31.3 25.3 16.8 24.8 41.7 10.9 34.1 50.5 35.5 32.3 39.7 36.1 34.8 32.1 33.7 50.1 37.4 32.0 30.7 19.2 38.2 24.6 43.3 35.7 36.0 29.9 28.5 22.0 49.7 25.5 22.3 27.5 29.5 25.4 18.2 29.8 21.6 30.6 36.9 28.2 50.1 49.7 40.8 20.1 20.5 43.6 23.6 56.6 68.0 58.9 15.1 40.5 20.8 23.3 40.9 25.8 56.9 34.1 50.7 37.6 66.4 63.5 53.5 53.4 50.0 29.8 52.9 44.6 49.0 116.4 32.4 74.4 42.9 31.6 56.6 125.1 35.9 38.8 58.4 59.4 29.7 29.5 38.1 34.6 33.3 28.6 CUL1 ENSG00000055130 "Cullin 1" Q13616 7 148697914-148801036 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 6 "Early spermatids: 377.8;Late spermatids: 391.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002676, HPA064584" Supported Supported Nucleoplasm,Nucleoli NA NA 190000 Nucleoplasm Nucleoli "CAB002676: , HPA064584: AB_2685294" "unprognostic (3.59e-2)" "unprognostic (1.23e-1)" "unprognostic (5.23e-1)" "unprognostic (1.19e-1)" "unprognostic (5.06e-3)" "unprognostic (9.45e-2)" "unprognostic (1.41e-2)" "unprognostic (8.23e-2)" "unprognostic (2.40e-2)" "unprognostic (3.65e-2)" "unprognostic (3.40e-2)" "unprognostic (2.84e-2)" "unprognostic (2.18e-2)" "unprognostic (3.88e-2)" "unprognostic (1.48e-1)" "unprognostic (2.40e-1)" "unprognostic (7.24e-3)" 26.0 20.9 21.2 20.4 22.4 22.3 27.5 27.5 26.2 23.9 25.8 19.5 22.5 16.7 30.2 23.7 22.7 21.2 18.7 25.7 21.1 21.8 16.9 35.2 20.5 26.5 21.7 16.7 25.0 17.9 24.9 30.7 32.0 21.0 23.9 18.8 22.7 19.6 25.0 58.9 20.5 21.2 37.7 26.3 21.9 22.4 65.6 23.7 16.9 24.5 24.6 24.5 26.1 28.8 16.8 24.1 13.4 17.1 22.1 20.8 16.1 30.8 24.0 23.6 36.5 18.6 20.9 30.0 25.5 30.2 25.8 24.7 25.5 21.6 42.4 20.5 25.2 41.8 20.9 33.7 23.8 30.5 27.7 28.6 25.0 17.0 24.8 21.8 28.4 23.8 17.1 23.4 18.9 19.2 23.4 28.1 21.4 38.6 32.7 28.1 29.5 24.6 32.5 44.2 26.3 23.0 29.9 20.8 40.8 21.2 22.6 34.0 24.9 29.8 35.5 20.1 29.0 11.6 22.6 21.6 18.5 6.4 37.4 29.3 30.7 21.3 42.0 37.6 31.7 27.2 13.4 15.2 12.0 16.1 17.1 18.6 16.8 16.7 18.6 24.1 14.4 20.8 16.7 2.1 22.1 14.5 5.5 15.9 16.1 21.2 22.4 27.5 26.2 21.1 21.8 21.7 16.7 21.0 23.7 32.8 29.7 24.2 26.3 24.7 29.4 23.2 10.2 42.8 42.1 8.7 27.5 57.0 14.9 24.9 377.8 21.8 9.5 23.3 22.9 69.2 23.6 16.6 22.0 37.5 26.1 20.6 15.0 19.0 15.2 391.5 20.1 22.4 27.0 64.1 19.5 32.1 23.7 14.4 28.7 9.3 42.8 32.3 27.8 53.2 33.0 22.2 61.2 20.8 16.5 17.9 CUL2 ENSG00000108094 "Cullin 2" Q13617 10 35008551-35090642 "Cancer-related genes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 245.9;Late spermatids: 133.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002677, HPA024578" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB002677: , HPA024578: AB_1847338" "unprognostic (8.11e-3)" "unprognostic (1.12e-1)" "unprognostic (9.77e-2)" "unprognostic (1.17e-2)" "unprognostic (1.53e-2)" "unprognostic (1.59e-2)" "prognostic unfavorable (8.24e-6)" "unprognostic (2.18e-1)" "unprognostic (1.34e-1)" "unprognostic (1.20e-1)" "unprognostic (4.70e-2)" "unprognostic (6.94e-2)" "prognostic unfavorable (9.32e-5)" "unprognostic (2.26e-2)" "unprognostic (2.31e-1)" "unprognostic (3.70e-1)" "unprognostic (2.29e-1)" 16.2 14.9 17.2 12.6 22.6 14.3 13.6 16.8 20.9 11.6 14.3 9.0 18.1 11.9 13.6 9.5 14.3 12.1 10.1 15.7 15.4 15.1 12.2 17.2 11.9 15.4 14.3 20.8 12.9 17.7 21.4 19.3 21.9 17.3 13.3 13.0 7.0 12.8 14.1 33.7 14.2 12.4 16.1 14.0 15.1 14.5 27.9 15.4 20.3 13.7 14.4 16.6 15.6 12.3 11.4 11.9 10.0 13.7 11.3 17.4 7.7 20.0 11.9 15.7 13.5 18.0 19.9 16.7 23.8 13.3 23.6 23.8 15.9 19.3 16.0 13.2 25.1 17.3 18.6 22.8 21.9 27.1 18.8 14.9 20.9 12.9 14.0 19.8 11.3 13.8 19.1 18.3 25.8 9.0 18.2 26.2 17.1 23.9 14.6 25.7 13.7 18.8 6.3 5.7 13.9 48.8 15.9 25.5 10.0 21.6 15.8 7.7 10.3 13.3 16.8 18.7 18.3 12.7 13.0 24.0 14.6 16.3 24.9 15.5 6.1 8.3 19.3 28.1 25.7 10.2 9.6 9.3 10.0 12.3 13.7 17.4 10.8 14.0 14.7 11.9 11.4 16.7 15.5 4.4 11.3 13.3 5.4 16.6 7.7 17.2 22.6 16.8 20.9 15.4 15.1 14.3 20.8 17.3 15.4 20.8 9.3 10.7 8.3 10.6 12.2 23.2 7.6 22.7 22.7 8.7 9.8 21.0 13.3 16.2 245.9 19.5 10.6 0.0 15.5 16.7 11.8 7.8 19.7 17.9 17.5 22.3 10.3 12.9 19.7 133.1 13.0 19.8 10.1 24.4 9.5 15.3 15.9 7.0 11.0 11.5 13.0 0.0 14.1 33.9 31.3 11.4 31.0 18.1 11.5 8.1 CUL4A ENSG00000139842 "Cullin 4A" Q13619 13 113208193-113267108 "Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058979 Approved Nucleoplasm NA NA Nucleoplasm "HPA058979: AB_2683868" "unprognostic (3.01e-1)" "unprognostic (5.93e-3)" "unprognostic (6.19e-2)" "unprognostic (7.51e-2)" "unprognostic (3.19e-1)" "unprognostic (2.53e-2)" "unprognostic (6.41e-3)" "unprognostic (6.77e-2)" "unprognostic (1.45e-1)" "unprognostic (9.66e-2)" "unprognostic (3.52e-2)" "unprognostic (5.16e-3)" "unprognostic (3.57e-3)" "prognostic favorable (2.84e-4)" "unprognostic (2.95e-1)" "unprognostic (3.91e-2)" "unprognostic (3.48e-1)" 14.6 13.5 9.7 13.9 12.0 20.7 16.5 13.2 10.0 12.0 13.6 12.6 16.1 10.5 13.5 14.4 14.7 11.9 15.0 36.8 8.6 8.4 14.1 23.6 13.3 15.8 10.1 7.0 12.6 23.8 11.2 13.4 13.3 10.6 13.7 11.8 11.2 15.8 15.6 70.5 16.8 12.8 21.7 10.7 13.8 14.0 18.0 9.7 12.8 13.3 25.7 17.4 14.3 15.7 11.7 11.9 11.8 19.3 10.8 22.8 15.4 35.1 18.1 16.7 14.9 20.3 22.8 22.4 36.1 26.0 30.2 23.2 31.2 28.8 42.9 15.7 30.1 29.6 22.5 25.5 19.1 27.4 19.1 25.7 29.0 37.9 23.7 24.3 44.2 19.6 16.4 23.1 17.7 27.3 19.8 19.8 15.8 28.6 8.4 29.2 16.3 22.7 38.7 15.9 47.5 18.2 23.5 18.0 19.9 20.2 16.0 25.5 14.9 18.3 39.1 17.0 15.0 28.7 45.8 28.3 14.9 31.3 16.4 19.8 22.4 16.8 37.8 32.8 35.9 23.1 8.4 13.2 11.8 20.1 19.1 18.6 11.7 20.3 22.8 11.9 10.6 17.1 20.4 4.8 10.8 19.3 9.1 13.2 15.4 9.7 12.0 13.2 10.0 8.6 8.4 10.1 7.0 10.6 9.7 26.8 35.5 13.4 24.4 41.2 13.9 122.7 30.6 18.7 15.9 33.2 9.8 28.7 21.6 25.7 51.2 27.4 20.6 0.0 32.1 30.6 27.2 43.5 10.5 51.3 26.9 27.0 23.0 20.9 47.0 92.3 33.1 25.6 37.1 20.8 33.3 12.5 32.0 17.5 29.7 22.8 17.7 32.3 31.5 57.1 24.5 52.4 33.2 20.6 29.3 36.0 CUL4B ENSG00000158290 "Cullin 4B" Q13620 X 120524609-120575794 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, Ubl conjugation pathway" "Cancer-related genes, Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 78.2;Late spermatids: 113.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "fHDF/TERT166: 61.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003046, HPA011880, CAB017786, HPA058979" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB017786: , HPA003046: , HPA011880: AB_1847340, HPA058979: AB_2683868" "unprognostic (2.34e-2)" "unprognostic (2.74e-2)" "unprognostic (2.69e-2)" "unprognostic (7.73e-3)" "unprognostic (9.66e-2)" "unprognostic (3.91e-1)" "unprognostic (3.88e-3)" "unprognostic (8.99e-2)" "unprognostic (8.12e-3)" "unprognostic (3.20e-2)" "unprognostic (1.07e-1)" "unprognostic (1.90e-1)" "unprognostic (2.87e-3)" "unprognostic (3.83e-2)" "unprognostic (1.35e-1)" "unprognostic (6.82e-2)" "unprognostic (2.84e-1)" 20.9 24.0 19.0 19.2 28.1 12.2 25.3 28.9 25.7 32.6 20.5 12.1 25.7 14.0 24.2 47.2 29.3 19.6 18.5 19.4 18.5 20.2 19.1 20.4 23.8 23.5 17.3 20.4 30.1 18.8 34.4 48.3 17.0 18.4 30.8 17.2 15.7 17.3 27.3 10.8 17.7 16.3 36.0 20.5 19.9 17.0 34.0 17.3 29.8 18.8 13.9 24.1 40.4 22.5 7.6 12.5 15.4 4.3 5.5 8.3 4.9 11.8 10.0 8.4 8.9 36.9 18.8 6.7 26.9 32.3 22.3 23.3 9.0 33.7 11.9 9.2 61.9 39.5 8.8 17.1 7.9 25.4 6.9 8.9 5.8 14.6 6.4 16.0 6.2 8.3 20.9 6.0 12.8 11.1 40.3 39.8 6.4 8.9 9.3 21.5 6.3 8.1 6.5 12.7 13.4 10.2 6.9 8.3 12.1 7.4 5.9 9.5 8.0 19.9 9.8 9.8 10.9 8.3 5.7 52.4 16.0 8.9 21.4 24.1 5.9 10.3 14.8 17.4 8.5 14.4 5.8 4.3 9.0 7.2 3.8 7.7 7.6 7.0 6.6 5.1 5.7 7.9 8.3 15.4 5.5 2.7 12.5 8.2 4.9 19.0 28.1 28.9 25.7 18.5 20.2 17.3 20.4 18.4 17.3 20.8 11.8 6.0 8.4 13.5 15.6 14.3 7.6 17.4 9.1 14.0 13.7 8.8 11.6 8.5 78.2 15.7 9.9 0.0 7.7 19.0 13.1 10.1 13.9 13.5 14.7 23.8 23.6 43.0 28.3 113.1 19.8 13.7 11.8 8.2 16.6 13.0 13.8 3.5 20.1 9.8 12.9 12.9 13.4 11.3 12.1 12.0 8.4 12.9 13.0 8.3 CUTC CGI-32 ENSG00000119929 "CutC copper transporter" Q9NTM9 10 99702558-99756134 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 122.1" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 105.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038619, HPA058231" Enhanced Enhanced Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Cytosol" Nucleoli "HPA038619: AB_10672649, HPA058231: " "unprognostic (1.25e-2)" "unprognostic (5.92e-2)" "unprognostic (2.70e-1)" "unprognostic (8.66e-2)" "unprognostic (7.39e-2)" "unprognostic (1.39e-1)" "unprognostic (3.55e-3)" "unprognostic (8.67e-2)" "unprognostic (5.36e-2)" "unprognostic (1.81e-1)" "unprognostic (5.87e-2)" "unprognostic (2.06e-1)" "prognostic unfavorable (3.81e-7)" "unprognostic (1.00e-1)" "unprognostic (3.42e-2)" "unprognostic (2.41e-1)" "unprognostic (3.97e-1)" 11.6 4.9 5.7 9.8 8.7 7.9 9.8 3.5 6.5 5.3 5.9 7.2 3.5 4.4 4.9 8.0 6.2 5.1 5.8 13.2 5.9 4.7 5.3 11.0 5.1 7.9 8.6 6.6 4.6 4.5 3.5 3.6 4.5 5.5 6.0 6.4 6.9 5.7 5.4 122.1 5.8 6.2 11.6 7.4 9.2 6.0 14.1 8.3 9.2 4.3 25.1 7.3 13.5 11.4 32.8 24.2 47.1 19.4 25.5 36.3 19.3 9.5 20.5 7.2 21.9 26.8 12.3 3.9 7.8 10.1 7.9 8.9 9.4 7.3 34.7 7.0 13.3 3.9 8.2 14.7 13.0 8.8 10.2 14.0 11.5 9.2 14.8 12.4 21.3 5.6 12.7 8.1 12.6 26.2 9.8 13.5 20.2 10.1 7.7 5.9 6.6 19.1 22.0 7.2 9.7 7.7 13.0 8.5 13.3 8.3 3.9 2.4 5.4 3.6 5.7 9.8 10.4 9.1 12.2 7.5 3.3 4.4 3.6 10.3 12.7 16.5 24.3 10.8 45.8 2.9 26.5 19.4 47.1 27.2 15.2 28.3 32.8 25.9 25.9 21.0 29.0 36.3 27.8 30.8 25.5 18.5 24.2 24.7 19.3 5.7 8.7 3.5 6.5 5.9 4.7 8.6 6.6 5.5 8.3 8.9 12.2 21.9 13.0 10.8 16.5 35.8 10.2 20.1 10.3 5.2 7.9 15.9 18.3 14.6 8.1 21.5 4.9 0.0 15.0 10.7 15.3 11.4 30.0 20.2 18.3 11.1 11.6 22.7 17.8 6.8 12.0 15.9 28.7 27.9 7.8 17.8 10.1 10.1 15.2 24.5 27.1 19.4 15.6 105.8 35.1 9.5 11.3 20.1 9.7 10.7 CUX1 "CASP, CDP, CDP/Cut, CDP/Cux, CDP1, Clox, CUT, CUTL1, CUX, Cux/CDP, GOLIM6" ENSG00000257923 "Cut like homeobox 1" "P39880, Q13948" 7 101815904-102283958 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Transport" "Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "non-classical monocyte: 21.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003277, HPA003317" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA003277: AB_10601804, HPA003317: AB_2666891" "unprognostic (5.86e-2)" "unprognostic (5.39e-3)" "unprognostic (9.62e-3)" "unprognostic (1.73e-1)" "prognostic unfavorable (7.51e-4)" "unprognostic (5.85e-2)" "unprognostic (1.54e-1)" "unprognostic (1.04e-1)" "unprognostic (1.50e-1)" "unprognostic (2.89e-3)" "unprognostic (2.20e-1)" "unprognostic (2.50e-1)" "prognostic favorable (5.72e-7)" "unprognostic (1.12e-1)" "unprognostic (8.85e-2)" "unprognostic (1.97e-2)" "unprognostic (2.97e-1)" 19.3 12.7 22.9 19.2 24.4 19.5 12.3 48.6 29.9 31.6 26.4 23.1 17.3 22.2 52.1 17.4 23.9 24.5 23.2 53.8 18.8 18.3 27.4 16.0 22.0 11.8 20.4 11.7 33.0 41.4 34.4 30.2 24.4 16.9 22.8 17.2 26.8 26.3 16.9 31.0 15.9 25.3 27.5 31.6 15.0 23.4 8.3 17.1 44.0 33.5 23.2 24.1 31.8 21.9 2.0 12.1 4.7 21.0 3.0 2.2 4.5 14.5 15.6 11.0 13.7 9.0 18.6 6.9 14.7 15.6 6.2 4.1 9.3 9.4 18.9 23.6 14.5 11.5 12.0 7.0 11.8 3.7 9.0 7.8 6.6 11.6 7.7 23.9 8.5 3.6 12.9 24.1 4.8 10.9 17.9 8.0 12.2 15.3 16.0 5.8 30.0 27.8 10.5 4.5 22.5 16.4 18.4 9.2 22.3 10.2 16.7 10.2 30.3 12.8 32.2 12.5 9.6 6.3 10.3 11.9 26.3 17.8 19.8 8.3 10.5 4.9 40.8 24.3 7.9 18.3 2.1 8.6 1.5 2.1 8.8 2.2 2.0 1.6 2.2 7.0 1.7 1.6 2.2 4.7 3.0 21.0 12.1 1.5 4.5 22.9 24.4 48.6 29.9 18.8 18.3 20.4 11.7 16.9 17.1 92.3 45.5 28.3 27.6 23.4 53.5 101.2 28.1 46.8 45.5 38.4 64.8 44.1 8.3 29.7 7.2 31.1 49.5 0.0 20.8 48.4 40.9 44.0 11.5 30.9 29.9 50.9 40.8 32.5 70.3 7.4 38.3 36.4 16.9 25.2 44.2 49.6 28.5 54.3 57.3 53.1 57.1 25.8 24.5 12.0 13.8 37.9 73.6 20.8 37.2 42.8 CWC27 "NY-CO-10, SDCCAG-10, SDCCAG10" ENSG00000153015 "CWC27 spliceosome associated protein homolog" Q6UX04 5 64768930-65018763 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Disease mutation, Dwarfism, Mental retardation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Early spermatids: 197.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020344, HPA024149, HPA065809" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA020344: AB_1856644, HPA024149: AB_1856645, HPA065809: AB_2685561" "unprognostic (1.71e-1)" "unprognostic (6.47e-3)" "unprognostic (2.79e-2)" "unprognostic (1.80e-1)" "unprognostic (8.91e-2)" "unprognostic (4.00e-3)" "prognostic unfavorable (5.27e-6)" "unprognostic (1.58e-2)" "unprognostic (3.43e-2)" "unprognostic (1.21e-1)" "unprognostic (1.48e-2)" "unprognostic (2.04e-1)" "unprognostic (2.07e-1)" "unprognostic (2.46e-1)" "unprognostic (2.05e-1)" "unprognostic (2.74e-1)" "unprognostic (7.45e-3)" 15.6 16.4 22.0 14.9 30.4 21.7 16.4 30.1 25.6 16.5 17.5 13.8 14.0 11.8 19.4 15.7 17.3 14.9 13.8 22.1 20.6 19.9 17.5 12.1 12.8 17.0 22.3 20.7 23.3 10.9 21.4 28.8 17.5 26.2 18.6 18.7 11.4 13.3 16.0 24.0 13.8 15.9 24.7 23.3 15.0 13.9 19.6 23.6 22.5 17.2 18.2 18.6 18.6 20.0 15.1 14.6 8.6 11.5 17.0 15.9 9.0 15.2 10.2 18.4 34.0 15.8 19.3 20.5 16.1 13.4 18.0 19.0 17.0 19.4 22.7 28.2 16.7 20.3 9.7 19.2 29.1 32.9 18.9 15.7 17.0 17.2 14.1 24.2 17.8 11.6 12.8 22.4 22.7 28.9 16.0 19.0 26.0 16.5 15.0 17.8 15.2 24.7 16.1 14.9 8.0 12.4 23.0 24.7 23.6 17.1 13.3 21.9 9.7 19.6 8.0 18.1 18.3 17.4 26.2 15.8 10.6 18.7 16.9 25.6 11.7 15.2 22.3 19.9 31.3 18.8 8.6 11.5 7.9 12.8 11.3 15.5 15.1 14.2 15.9 14.6 11.9 15.4 15.9 2.5 17.0 8.5 12.0 15.1 9.0 22.0 30.4 30.1 25.6 20.6 19.9 22.3 20.7 26.2 23.6 8.9 25.8 20.1 22.0 14.5 30.0 55.8 20.4 33.5 14.8 14.0 13.7 36.6 18.3 35.9 197.3 26.9 10.5 23.3 28.8 45.9 24.6 20.8 18.5 10.5 28.6 19.1 28.7 14.1 17.2 37.1 35.6 23.8 13.5 29.7 16.0 31.3 33.5 10.5 33.9 21.9 53.9 32.3 28.4 43.0 28.9 17.6 25.7 23.6 26.6 17.4 CWF19L1 "FLJ10998, hDrn1" ENSG00000095485 "CWF19 like 1, cell cycle control (S. pombe)" Q69YN2 10 100232298-100267680 "Disease related genes, Predicted intracellular proteins" Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036889, HPA036890" Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA036889: AB_10670928, HPA036890: AB_10696789" "unprognostic (2.76e-2)" "unprognostic (1.10e-2)" "unprognostic (1.16e-1)" "unprognostic (1.39e-1)" "unprognostic (3.66e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (6.90e-4)" "unprognostic (3.04e-1)" "unprognostic (9.17e-3)" "unprognostic (3.61e-1)" "unprognostic (2.70e-2)" "unprognostic (6.50e-3)" "unprognostic (5.61e-3)" "unprognostic (6.16e-2)" "unprognostic (2.60e-2)" "unprognostic (1.18e-1)" "unprognostic (1.10e-1)" 13.8 9.8 8.6 13.6 12.5 20.5 15.8 18.3 18.6 11.8 9.9 15.4 6.1 7.9 13.8 9.0 11.0 12.9 8.7 10.6 9.0 10.3 11.2 14.8 11.6 19.1 11.5 8.6 14.3 14.1 12.4 12.4 12.2 12.4 10.5 11.5 12.3 11.0 10.6 14.1 14.7 11.8 14.4 11.2 19.1 10.1 19.7 10.8 22.3 13.8 11.2 22.6 12.5 10.1 12.2 12.2 18.6 13.9 13.9 15.4 11.1 14.4 10.9 9.8 14.2 4.8 6.5 10.2 9.5 14.2 22.4 19.2 10.8 11.2 16.7 9.9 8.5 8.3 13.4 22.8 13.0 23.9 11.6 9.2 9.5 9.7 8.8 8.1 23.5 9.1 8.1 5.4 16.3 15.3 7.0 14.8 14.7 11.0 13.9 11.9 8.5 18.3 7.8 7.0 6.7 9.7 6.2 18.6 9.8 6.9 7.9 4.5 8.5 12.4 4.8 12.3 7.1 19.4 6.5 11.8 7.9 10.4 8.8 15.7 11.4 15.2 10.1 10.4 18.5 5.1 9.8 13.9 18.6 12.1 13.2 15.4 12.2 12.7 13.0 12.2 12.0 14.1 13.8 7.2 13.9 11.7 4.8 15.2 11.1 8.6 12.5 18.3 18.6 9.0 10.3 11.5 8.6 12.4 10.8 17.9 9.6 6.6 6.0 3.9 8.4 7.0 5.1 14.7 13.6 5.2 3.9 8.8 6.6 4.5 13.3 7.1 3.6 0.0 6.6 8.9 6.1 4.6 17.3 5.8 8.2 9.5 4.1 3.7 17.3 4.5 6.4 6.0 8.5 13.6 3.4 5.1 5.9 4.8 3.9 5.4 11.9 0.0 7.1 11.4 11.3 6.8 9.2 10.9 4.3 3.8 CXCR2 "CD182, CMKAR2, IL8RB" ENSG00000180871 "C-X-C motif chemokine receptor 2" P25025 2 218125289-218137253 "Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "blood: 216.1" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 2: 17.5;Club cells: 3.4;granulocytes: 5.8;Kupffer cells: 5.0;Macrophages: 4.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 59 "neutrophil: 216.1" "Lineage enriched" "Detected in many" 109 "granulocytes: 216.1" "Group enriched" "Detected in some" 11 "BEWO: 12.4;HL-60: 6.9;HMC-1: 14.4;THP-1: 13.1;U-937: 12.9" "Low region specificity" "Detected in single" "CAB016268, HPA031999, HPA032017" Enhanced Supported "Nucleoplasm,Plasma membrane,Microtubules,Mitotic spindle" NA NA "Plasma membrane" "Nucleoplasm, Microtubules, Mitotic spindle" "CAB016268: AB_626893, HPA031999: AB_2674105, HPA032017: AB_2674112" "unprognostic (4.89e-2)" "unprognostic (2.01e-1)" "unprognostic (5.63e-2)" "unprognostic (1.10e-2)" "unprognostic (1.58e-1)" "unprognostic (3.13e-1)" "unprognostic (1.33e-1)" "unprognostic (2.13e-1)" "unprognostic (5.96e-2)" "unprognostic (1.22e-2)" "unprognostic (5.67e-2)" "unprognostic (1.41e-1)" "unprognostic (7.54e-2)" "unprognostic (1.04e-1)" "unprognostic (7.23e-2)" "unprognostic (8.18e-2)" "unprognostic (5.48e-2)" 9.3 0.9 1.3 25.6 1.5 4.0 0.6 1.2 1.3 5.2 0.6 0.5 2.5 0.0 0.8 1.1 18.1 3.3 5.2 4.3 1.5 0.6 0.7 4.6 16.7 40.5 6.6 0.0 1.2 1.7 0.0 0.7 4.5 1.7 1.9 0.3 1.8 3.3 2.6 0.6 3.0 0.7 1.4 4.1 30.6 1.0 1.1 0.7 0.6 0.6 4.8 10.1 5.4 6.4 0.0 1.6 216.1 1.9 0.4 1.9 1.0 0.0 0.0 0.1 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.9 14.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 1.1 0.2 0.0 0.0 0.3 0.0 1.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.5 0.0 13.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 12.9 0.0 3.6 1.9 3.2 1.9 0.5 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.7 216.1 0.4 0.2 1.6 0.0 1.0 1.3 1.5 1.2 1.3 1.5 0.6 6.6 0.0 1.7 0.7 0.0 17.5 0.0 0.9 0.0 0.0 0.2 0.0 0.0 3.4 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.2 0.2 5.8 0.0 1.6 0.0 0.0 0.0 5.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.0 0.0 1.8 CXorf21 FLJ11577 ENSG00000120280 "Chromosome X open reading frame 21" Q9HAI6 X 30558824-30577844 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.9;bone marrow: 16.0;lymphoid tissue: 16.7" "Cell type enhanced" "Detected in some" 13 "B-cells: 25.2;granulocytes: 15.0;Hofbauer cells: 20.5;Kupffer cells: 21.1;Macrophages: 39.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 7 "THP-1: 59.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA001185 Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA001185: AB_1078591" "unprognostic (1.37e-1)" "unprognostic (2.52e-2)" "unprognostic (4.37e-2)" "unprognostic (2.27e-2)" "unprognostic (3.47e-2)" "unprognostic (5.25e-3)" "unprognostic (9.07e-3)" "unprognostic (5.94e-3)" "unprognostic (1.15e-1)" "unprognostic (1.40e-1)" "unprognostic (3.43e-1)" "unprognostic (3.60e-1)" "unprognostic (1.66e-3)" "unprognostic (8.99e-2)" "unprognostic (1.98e-2)" "unprognostic (3.45e-2)" "unprognostic (3.23e-2)" 6.5 2.1 4.6 9.8 4.0 16.0 2.0 0.8 4.4 1.4 3.0 2.3 0.2 4.3 1.2 2.4 1.4 1.5 3.6 1.5 5.0 2.1 1.9 2.8 6.1 12.9 6.3 0.0 1.0 2.0 0.7 1.5 2.7 5.1 1.5 3.1 1.1 3.3 0.5 0.8 1.1 5.3 1.8 9.9 16.7 3.1 0.8 5.2 9.1 1.4 1.2 9.3 4.8 1.4 11.1 21.9 14.9 18.9 3.2 1.6 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 4.8 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 7.6 0.0 0.0 0.0 7.2 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.1 0.0 0.0 0.0 0.0 0.0 5.6 0.5 2.7 0.0 8.5 0.0 3.4 10.3 11.4 0.8 9.6 0.1 11.1 1.0 0.5 12.0 10.8 1.0 0.7 14.9 3.2 18.9 21.9 1.6 3.5 4.6 4.0 0.8 4.4 5.0 2.1 6.3 0.0 5.1 5.2 0.0 2.2 25.2 0.2 0.5 0.0 0.2 0.0 2.7 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 15.0 0.0 20.5 0.0 0.0 0.6 21.1 0.0 0.0 39.3 8.5 5.4 0.0 2.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.4 0.2 1.3 0.0 0.1 CXorf56 FLJ22965 ENSG00000018610 "Chromosome X open reading frame 56" Q9H5V9 X 119538149-119565408 "Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038245, HPA038617, HPA064831" Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA038245: AB_10672407, HPA038617: AB_10674691, HPA064831: AB_2685364" "prognostic unfavorable (3.45e-4)" "unprognostic (3.88e-3)" "unprognostic (7.82e-2)" "unprognostic (1.03e-3)" "unprognostic (8.92e-2)" "unprognostic (7.74e-3)" "unprognostic (6.38e-3)" "unprognostic (3.89e-2)" "unprognostic (4.11e-1)" "unprognostic (1.51e-2)" "unprognostic (9.63e-3)" "unprognostic (1.68e-3)" "unprognostic (9.26e-3)" "unprognostic (4.68e-3)" "unprognostic (1.45e-2)" "unprognostic (5.51e-2)" "unprognostic (1.90e-1)" 15.9 14.5 18.7 12.7 29.1 19.1 21.1 21.0 24.2 15.0 15.6 18.3 15.1 12.3 17.6 14.5 13.6 17.6 12.4 16.3 16.0 20.5 18.2 14.3 14.6 15.7 18.0 21.3 24.0 16.3 20.5 12.6 29.0 20.2 15.3 15.0 18.6 14.6 16.1 16.4 17.4 12.5 16.2 17.8 15.0 13.0 12.7 17.6 12.8 20.2 13.2 19.0 14.4 13.1 19.4 12.0 16.8 15.4 7.7 12.9 10.9 16.5 19.4 11.7 13.3 13.4 9.8 15.0 11.4 11.8 17.9 16.2 16.8 16.8 26.1 28.7 13.3 37.4 11.0 29.5 15.1 25.2 15.7 22.3 9.3 17.7 11.2 10.7 25.8 15.0 10.8 13.1 21.9 18.8 10.4 12.5 16.5 20.9 16.7 8.7 29.0 16.2 13.6 17.5 21.9 20.1 15.8 12.1 19.7 10.7 13.0 8.1 14.1 22.1 12.3 15.3 13.4 10.2 11.3 12.0 10.8 7.5 20.0 24.1 14.5 25.6 26.6 9.8 25.3 13.8 5.7 12.8 16.8 12.4 15.4 11.4 13.5 10.8 12.9 12.0 19.4 11.1 10.5 6.5 7.7 14.1 11.3 12.4 10.9 18.7 29.1 21.0 24.2 16.0 20.5 18.0 21.3 20.2 17.6 3.0 11.5 11.1 7.2 5.6 15.6 10.6 5.1 8.1 4.5 3.5 5.9 16.9 18.3 7.7 1.2 6.8 8.1 0.0 5.8 16.9 6.7 4.9 17.3 3.9 8.9 7.9 8.2 4.9 10.5 1.0 8.9 7.4 11.8 19.8 5.6 17.0 5.8 8.5 10.6 10.5 10.2 12.9 9.1 3.4 7.8 5.1 29.7 5.7 8.4 7.3 CXorf58 FLJ25444 ENSG00000165182 "Chromosome X open reading frame 58" Q96LI9 X 23907801-23939507 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 8.4" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 18.3;Spermatocytes: 20.0;Spermatogonia: 5.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "monocytes: 1.0;T-cells: 1.8" "Cell line enhanced" "Detected in some" "GAMG: 4.4;PC-3: 2.0;U-266/70: 1.9" "HPA031542, HPA031543, HPA031544" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA031542: AB_2673927, HPA031543: AB_10603789, HPA031544: AB_2673929" "unprognostic (9.74e-2)" "unprognostic (9.17e-3)" "unprognostic (2.52e-1)" "unprognostic (3.64e-2)" "unprognostic (1.90e-2)" "unprognostic (1.24e-1)" "unprognostic (4.16e-2)" "unprognostic (1.73e-1)" "unprognostic (1.68e-2)" "unprognostic (1.43e-1)" "unprognostic (4.14e-3)" "unprognostic (8.19e-2)" "unprognostic (3.82e-2)" "unprognostic (1.10e-1)" "unprognostic (3.21e-2)" "unprognostic (7.39e-2)" "unprognostic (5.06e-3)" 0.1 0.4 0.2 0.1 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.9 0.0 0.2 0.2 0.3 0.6 0.2 0.1 0.0 0.2 0.0 0.4 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.1 0.0 0.3 0.0 0.0 8.4 0.6 0.0 0.2 0.0 0.1 0.2 0.1 1.0 0.0 1.8 0.1 0.7 0.2 0.0 0.0 0.2 0.0 0.3 0.1 0.3 0.1 0.1 0.0 0.8 1.0 0.2 0.0 4.4 0.5 0.1 0.7 0.0 0.4 0.5 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.7 0.6 0.5 0.0 0.0 1.6 0.3 0.2 0.1 0.1 0.1 0.8 0.0 0.1 2.0 0.4 0.0 0.1 1.0 0.0 0.9 0.1 0.5 0.1 0.4 0.1 1.1 0.1 0.4 0.0 0.0 0.2 0.3 1.9 0.9 0.2 0.2 0.1 0.3 0.0 0.0 0.1 0.3 1.0 1.4 0.1 1.3 1.0 0.0 0.1 1.0 0.7 0.0 0.0 0.2 0.2 1.8 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 4.0 0.0 0.0 0.0 0.1 1.7 0.0 18.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 1.0 0.0 0.5 0.1 0.0 0.0 0.0 2.3 0.0 0.0 20.0 5.2 0.0 0.1 0.0 0.0 0.0 CXorf67 ENSG00000187690 "Chromosome X open reading frame 67" Q86X51 X 51406915-51408843 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "placenta: 14.3;testis: 21.4" "Group enriched" "Detected in some" 5 "Sertoli cells: 6.5;Spermatocytes: 4.9;Spermatogonia: 15.6" "Cancer enriched" "Detected in some" 6 "testis cancer: 11.4" "Region enriched" "Detected in single" 5 "cerebellum: 2.8" "Cell type enhanced" "Detected in some" "memory B-cell: 1.1;naive CD4 T-cell: 1.2" "Group enriched" "Detected in many" 11 "B-cells: 1.1;T-cells: 1.2" "Cell line enriched" "Detected in single" 46 "U-2 OS: 27.7" "HPA004003, HPA006128" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA004003: AB_2667113, HPA006128: AB_2667517" "unprognostic (4.21e-2)" "unprognostic (6.36e-2)" "unprognostic (3.37e-2)" "unprognostic (8.58e-3)" "unprognostic (3.57e-4)" "unprognostic (1.47e-6)" "unprognostic (4.55e-2)" "unprognostic (3.06e-2)" "unprognostic (4.26e-1)" 0.1 0.2 0.3 0.2 0.6 0.1 0.1 2.8 0.4 0.1 0.1 0.1 0.1 0.0 0.3 0.4 0.1 0.1 0.1 0.1 0.3 0.5 0.1 0.1 0.2 0.2 0.2 0.1 0.7 0.1 0.0 1.5 14.3 0.1 0.4 0.1 0.1 0.9 0.2 0.1 0.2 0.2 0.1 0.4 0.7 0.1 21.4 0.1 0.1 0.2 0.1 0.1 0.1 0.1 1.1 0.0 0.1 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.7 1.2 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.6 2.8 0.4 0.3 0.5 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 6.5 0.0 4.9 15.6 0.0 1.6 0.0 0.0 0.0 CXXC1 "CFP1, CGBP, hCGBP, HsT2645, PCCX1, PHF18, SPP1, ZCGPC1" ENSG00000154832 "CXXC finger protein 1" Q9P0U4 18 50282343-50288304 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044511 Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA044511: AB_10963081" "unprognostic (4.47e-2)" "unprognostic (1.83e-2)" "unprognostic (1.69e-2)" "unprognostic (1.36e-2)" "unprognostic (1.99e-1)" "unprognostic (1.49e-2)" "prognostic unfavorable (4.18e-6)" "unprognostic (3.82e-1)" "unprognostic (3.24e-1)" "unprognostic (5.08e-2)" "prognostic favorable (2.60e-4)" "unprognostic (1.10e-2)" "unprognostic (1.00e-1)" "unprognostic (3.83e-2)" "unprognostic (2.07e-1)" "unprognostic (2.12e-1)" "unprognostic (2.41e-2)" 12.1 16.9 17.5 20.0 20.3 40.3 12.4 42.4 23.1 15.7 15.2 15.7 18.7 18.3 16.8 10.2 15.5 19.8 17.5 13.6 18.2 12.2 16.5 14.9 13.9 23.6 22.6 13.1 23.6 32.8 13.7 14.3 22.4 18.7 15.6 9.1 14.1 24.7 19.4 12.1 17.2 15.1 17.7 11.7 19.3 17.3 15.5 20.3 25.8 15.5 14.0 18.6 17.5 20.1 22.0 16.6 24.5 16.9 16.0 21.1 15.0 8.3 11.3 8.6 16.2 7.0 4.9 17.8 11.0 7.6 11.0 9.7 8.3 6.3 23.7 5.7 5.0 6.5 13.7 14.3 10.4 3.1 19.4 12.7 19.1 12.4 13.1 5.0 44.7 20.8 4.8 8.1 12.0 6.2 4.0 7.4 18.7 11.8 20.3 5.5 11.8 26.5 22.0 18.9 4.2 7.6 26.7 8.9 19.1 5.9 5.0 18.1 17.4 8.6 5.6 6.9 5.1 7.1 18.9 11.2 15.4 9.8 6.8 9.3 35.0 24.6 19.5 9.7 16.6 13.1 17.7 14.1 24.5 19.2 16.9 21.1 22.0 17.7 19.3 16.6 21.7 19.6 16.2 6.2 16.0 13.1 12.1 19.6 15.0 17.5 20.3 42.4 23.1 18.2 12.2 22.6 13.1 18.7 20.3 17.9 27.2 14.9 11.2 23.8 13.6 6.3 12.7 13.4 20.5 17.4 13.7 32.2 11.6 16.2 12.1 17.9 26.6 0.0 19.0 32.2 14.6 10.7 8.1 12.8 19.3 7.9 33.9 16.0 17.5 7.0 18.4 21.2 8.5 16.2 22.0 17.1 18.2 22.4 18.4 10.6 11.7 6.5 16.4 48.7 18.1 26.3 31.0 27.4 23.1 9.4 CXXC4 IDAX ENSG00000168772 "CXXC finger protein 4" 4 104468312-104494901 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 19.4;pituitary gland: 17.2" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 41.0;Cone photoreceptor cells: 29.5;Horizontal cells: 42.9;Intestinal endocrine cells: 98.1;Rod photoreceptor cells: 25.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.9;memory CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 20 "T-cells: 1.9" "Cell line enhanced" "Detected in some" "AF22: 7.2;AN3-CA: 10.0;Karpas-707: 9.3;RPMI-8226: 5.4;SCLC-21H: 12.5;U-266/70: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036600, HPA036925" Uncertain Uncertain "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA036600: AB_10673659, HPA036925: " "unprognostic (1.37e-2)" "unprognostic (1.12e-1)" "unprognostic (5.75e-2)" "unprognostic (5.86e-2)" "unprognostic (9.07e-3)" "unprognostic (1.14e-1)" "unprognostic (1.75e-2)" "unprognostic (9.69e-3)" "unprognostic (2.75e-1)" "unprognostic (2.45e-1)" "prognostic favorable (2.19e-4)" "unprognostic (1.82e-1)" "unprognostic (4.52e-3)" "unprognostic (5.69e-2)" "unprognostic (1.37e-1)" "unprognostic (2.38e-1)" "unprognostic (4.42e-3)" 2.2 4.3 10.3 0.9 12.0 0.6 4.3 17.5 19.4 2.4 2.5 7.4 0.8 5.4 1.9 5.3 1.0 6.7 1.5 5.3 9.9 14.4 1.7 2.7 2.3 0.7 7.9 9.9 5.6 5.8 3.2 17.2 1.4 10.2 2.1 2.9 7.9 7.5 2.1 1.3 0.8 5.5 1.8 5.3 1.4 4.3 4.9 13.3 0.0 7.1 0.1 0.7 1.6 1.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 7.2 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.6 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 9.3 0.0 0.0 2.7 0.0 2.6 0.1 0.1 0.0 0.0 5.4 0.0 0.1 12.5 2.3 0.0 0.6 0.0 3.1 0.3 0.0 0.0 0.0 1.7 0.0 0.1 10.2 2.5 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.9 0.0 0.8 0.0 0.1 1.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 10.3 12.0 17.5 19.4 9.9 14.4 7.9 9.9 10.2 13.3 0.0 5.4 0.0 0.8 0.2 41.0 12.8 0.0 14.7 2.3 0.0 29.5 0.1 0.0 0.1 0.2 1.6 0.9 0.0 2.9 0.0 0.4 0.5 0.0 2.4 0.1 42.9 98.1 1.3 0.3 0.4 0.3 0.0 1.7 0.0 4.3 13.3 2.1 0.0 10.3 0.7 25.3 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.8 0.4 CXXC5 "HSPC195, RINF, WID" ENSG00000171604 "CXXC finger protein 5" Q7LFL8 5 139647299-139683882 "Predicted intracellular proteins" Transcription "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 68.2" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 594.9;Horizontal cells: 511.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "MAIT T-cell: 10.2;memory B-cell: 27.7;naive B-cell: 29.3;NK-cell: 21.8;plasmacytoid DC: 19.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 57.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036508, HPA058148" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036508: AB_10673620, HPA058148: AB_2683621" "unprognostic (3.08e-2)" "unprognostic (9.03e-2)" "prognostic favorable (2.40e-4)" "prognostic unfavorable (4.10e-7)" "unprognostic (2.91e-1)" "unprognostic (2.05e-1)" "unprognostic (1.11e-3)" "unprognostic (2.28e-2)" "unprognostic (2.12e-1)" "unprognostic (2.72e-1)" "unprognostic (2.26e-1)" "unprognostic (2.79e-2)" "unprognostic (2.63e-2)" "unprognostic (8.02e-2)" "unprognostic (1.44e-1)" "unprognostic (7.26e-2)" "unprognostic (1.57e-1)" 12.3 9.5 22.4 9.3 19.9 22.2 9.2 68.2 38.8 17.5 10.2 39.3 5.1 6.0 9.9 18.0 10.1 18.1 11.4 15.8 23.9 16.7 25.6 33.8 9.0 15.5 30.9 21.7 5.4 24.9 18.2 18.6 10.4 25.4 8.1 7.9 14.2 30.0 11.7 39.7 9.8 9.1 8.4 36.7 18.1 11.4 19.0 27.5 20.5 12.5 7.7 13.5 9.6 9.9 29.3 19.1 0.7 2.1 21.8 10.2 3.4 9.4 8.0 8.8 3.3 12.4 17.0 3.4 6.2 9.5 2.7 5.4 17.6 9.6 12.5 27.6 16.5 16.3 10.9 1.8 4.8 1.3 1.3 3.1 18.6 7.1 12.3 5.3 4.1 0.6 6.1 1.1 4.5 1.3 26.2 0.7 0.4 17.4 2.0 19.5 24.7 4.4 13.2 10.7 10.3 2.2 8.0 18.1 19.1 20.3 6.9 28.2 29.1 2.2 57.1 4.6 20.4 31.2 19.5 3.9 22.2 4.4 10.5 5.5 7.5 15.6 23.6 33.4 1.4 12.2 0.3 2.1 0.1 3.2 0.4 10.2 27.7 0.3 2.3 1.8 29.3 0.2 0.9 0.7 21.8 0.1 19.1 0.4 3.4 22.4 19.9 68.2 38.8 23.9 16.7 30.9 21.7 25.4 27.5 44.7 16.8 79.0 14.3 23.4 189.2 39.2 91.7 25.4 18.2 139.6 23.6 2.7 268.5 104.4 594.9 41.3 10.1 23.3 127.1 18.5 63.9 34.4 20.8 98.7 39.4 511.7 17.9 26.4 25.4 156.4 36.2 34.8 57.3 50.5 49.6 220.2 83.9 5.8 28.7 146.6 42.7 12.9 77.3 5.4 7.8 18.2 31.5 24.5 24.3 15.8 CYB5R2 ENSG00000166394 "Cytochrome b5 reductase 2" Q6BCY4 11 7665100-7677222 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 58.8" "Group enriched" "Detected in many" 5 "Early spermatids: 205.4;Late spermatids: 439.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 5.9;memory B-cell: 12.2" "Group enriched" "Detected in many" 9 "B-cells: 12.2;granulocytes: 5.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 42.5;BJ hTERT+ SV40 Large T+: 22.7;BJ hTERT+ SV40 Large T+ RasG12V: 20.7;HBF TERT88: 18.2;NTERA-2: 23.9;WM-115: 32.7" "Low region specificity" "Detected in many" "HPA038962, HPA061707" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA038962: AB_10675954, HPA061707: AB_2732668" "unprognostic (1.47e-1)" "unprognostic (2.56e-2)" "unprognostic (8.90e-3)" "unprognostic (4.41e-2)" "unprognostic (4.13e-3)" "unprognostic (1.60e-2)" "unprognostic (4.02e-2)" "unprognostic (2.48e-1)" "unprognostic (3.41e-2)" "unprognostic (1.30e-2)" "unprognostic (2.64e-3)" "unprognostic (1.10e-1)" "unprognostic (4.78e-2)" "unprognostic (1.40e-1)" "unprognostic (8.16e-2)" "unprognostic (1.70e-1)" "unprognostic (7.01e-2)" 3.3 1.9 9.3 2.8 12.1 1.9 7.7 3.1 12.3 6.6 2.3 26.1 4.2 1.3 10.0 13.1 8.0 5.2 3.4 2.0 11.2 5.3 2.4 2.5 4.6 3.8 22.3 7.3 14.9 2.2 23.1 0.6 6.7 11.6 7.8 2.7 12.2 12.8 11.6 0.8 23.4 1.7 6.8 12.4 2.0 2.2 58.8 14.5 0.2 2.6 6.7 4.9 5.9 7.1 12.2 0.0 5.9 1.0 0.0 0.2 0.7 2.3 1.2 0.5 0.0 0.1 0.6 7.9 14.8 42.5 22.7 20.7 0.2 3.2 0.0 3.5 7.6 7.0 0.2 0.0 0.1 18.2 0.0 0.0 0.0 1.3 0.3 12.3 0.1 2.3 6.2 0.5 0.1 1.2 0.0 1.9 0.0 2.2 0.0 0.1 0.0 0.0 0.0 23.9 2.4 1.1 11.2 0.0 0.0 0.0 1.5 0.0 0.2 0.1 9.5 0.6 4.0 1.6 3.1 0.0 2.1 0.0 0.1 1.1 0.0 0.0 3.5 0.1 0.0 32.7 0.0 1.0 5.9 0.0 0.5 0.0 12.2 0.2 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.7 9.3 12.1 3.1 12.3 11.2 5.3 22.3 7.3 11.6 14.5 20.8 3.2 0.0 7.4 6.3 0.8 1.9 0.0 8.1 2.3 3.5 19.6 4.6 0.0 1.4 205.4 1.0 0.0 0.0 4.2 16.5 7.1 4.8 2.3 1.1 2.3 0.0 0.0 0.0 0.0 439.8 4.4 1.4 5.0 0.0 1.4 0.8 4.6 0.9 5.6 0.0 37.7 12.9 12.6 63.0 5.9 8.8 3.8 0.0 1.4 10.5 CYB5RL LOC606495 ENSG00000215883 "Cytochrome b5 reductase like" Q6IPT4 1 54169651-54200036 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 9.4" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042671, HPA060463" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA042671: AB_2678107, HPA060463: AB_2684286" "unprognostic (2.03e-1)" "unprognostic (1.36e-1)" "unprognostic (1.72e-2)" "unprognostic (1.84e-2)" "unprognostic (2.15e-1)" "unprognostic (1.13e-3)" "unprognostic (1.90e-4)" "unprognostic (6.45e-3)" "unprognostic (9.75e-2)" "unprognostic (2.04e-1)" "unprognostic (5.93e-2)" "unprognostic (2.58e-1)" "unprognostic (2.35e-1)" "unprognostic (1.80e-2)" "unprognostic (5.08e-2)" "unprognostic (5.74e-2)" "unprognostic (2.86e-1)" 1.7 4.9 1.9 0.8 1.9 1.6 2.4 1.3 1.7 2.5 2.2 2.6 2.5 2.3 2.1 2.9 2.0 3.5 2.1 1.7 2.7 2.6 1.5 2.1 2.3 5.0 4.1 1.8 4.2 1.1 2.1 2.7 3.2 1.4 3.7 3.9 1.5 2.4 1.8 2.5 2.8 1.2 3.1 2.2 2.8 1.8 1.4 1.8 2.6 3.5 3.1 1.5 1.2 3.9 5.3 7.3 7.5 5.9 5.7 2.5 3.1 4.5 6.1 6.6 4.9 4.3 6.6 3.7 2.1 13.9 3.6 11.3 3.3 6.9 7.4 4.6 7.5 8.5 5.0 4.4 6.3 3.8 3.0 4.4 7.2 3.3 4.3 5.3 6.0 8.0 3.1 4.4 4.8 6.3 3.5 7.2 4.5 4.2 10.2 8.9 6.0 2.7 4.5 10.7 5.3 2.1 7.2 6.3 6.1 5.0 4.9 2.4 4.7 3.8 6.9 5.5 4.7 7.5 9.7 5.2 13.6 7.1 2.2 1.8 1.6 1.0 3.5 0.8 1.1 1.5 0.6 1.6 1.4 1.2 1.2 2.6 3.1 0.8 1.8 0.5 1.2 0.0 7.4 0.9 1.0 0.1 3.7 4.2 0.0 9.4 4.5 3.5 3.9 1.5 6.6 2.4 0.0 3.6 0.9 0.0 3.6 1.7 1.5 1.1 2.3 2.1 4.6 0.0 2.4 3.1 1.0 0.6 1.4 1.4 0.0 1.0 0.7 2.0 1.3 0.0 1.8 2.2 3.1 0.0 1.4 0.9 5.3 0.6 0.2 0.5 2.4 0.8 CYC1 UQCR4 ENSG00000179091 "Cytochrome c1" P08574 8 144095027-144097525 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 145.2" "Cell type enhanced" "Detected in all" 4 "Distal tubular cells: 693.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 151.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001247 Supported Approved "Nucleoplasm,Nuclear bodies,Mitochondria,Cytosol" NA NA 110000 Mitochondria "Nucleoplasm, Nuclear bodies, Cytosol" "HPA001247: AB_1078602" "unprognostic (3.07e-2)" "unprognostic (1.79e-1)" "unprognostic (1.65e-1)" "unprognostic (3.66e-2)" "unprognostic (1.25e-1)" "unprognostic (6.52e-2)" "unprognostic (1.39e-1)" "unprognostic (3.92e-3)" "unprognostic (6.23e-2)" "unprognostic (1.98e-1)" "unprognostic (2.26e-1)" "unprognostic (2.15e-1)" "prognostic favorable (5.89e-6)" "unprognostic (6.03e-2)" "unprognostic (1.83e-1)" "unprognostic (2.13e-1)" "unprognostic (3.13e-2)" 16.0 31.3 16.2 13.2 20.1 19.5 12.1 19.1 32.1 13.0 33.3 13.4 14.4 38.1 13.9 10.1 36.2 15.5 13.1 92.1 16.6 14.1 44.8 55.9 11.2 16.5 18.0 18.6 15.0 21.4 17.9 10.6 16.0 17.7 16.5 25.3 13.3 23.3 17.2 145.2 17.7 42.6 16.3 11.8 18.3 22.4 13.9 11.5 21.5 21.7 43.8 18.5 19.9 14.4 34.9 76.7 22.1 60.0 30.2 26.1 58.5 22.2 50.5 13.4 28.0 11.1 12.4 25.9 12.8 15.7 32.7 21.5 35.3 27.9 31.6 29.0 17.1 15.9 33.0 29.3 25.4 12.3 19.3 38.8 33.9 42.7 32.3 20.0 20.0 22.1 18.0 31.9 20.8 41.4 11.0 19.0 21.9 30.8 28.2 17.1 80.0 37.4 18.5 15.6 62.7 151.5 33.0 18.0 55.3 26.9 35.9 36.1 15.9 35.8 49.5 26.3 7.7 40.7 30.7 14.4 20.9 44.6 23.0 39.0 31.4 22.8 23.4 26.6 34.1 26.6 22.1 59.7 15.9 24.1 60.0 25.4 34.9 20.1 25.8 76.7 29.4 19.7 25.4 5.8 30.2 44.8 42.9 26.1 58.5 16.2 20.1 19.1 32.1 16.6 14.1 18.0 18.6 17.7 11.5 17.9 24.8 104.2 137.8 138.6 109.2 340.1 175.8 33.5 25.0 75.0 76.6 235.5 693.0 191.2 55.0 98.8 477.2 70.0 250.0 197.5 112.8 124.7 59.9 203.6 217.6 82.6 140.6 55.3 91.9 71.2 82.3 127.4 170.4 267.9 288.6 98.9 227.1 319.6 85.2 391.4 75.4 71.1 158.3 73.6 93.6 143.2 198.1 79.6 481.1 207.2 CYHR1 "CHRP, KIAA0496, MGC13010" ENSG00000187954 "Cysteine and histidine rich 1" Q6ZMK1 8 144449582-144465677 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053653, HPA059543" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA053653: AB_2682219, HPA059543: AB_2684056" "unprognostic (1.04e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (1.05e-4)" "unprognostic (1.58e-2)" "unprognostic (8.28e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (3.90e-4)" "unprognostic (4.02e-2)" "unprognostic (2.63e-1)" "unprognostic (2.13e-1)" "unprognostic (7.08e-3)" "unprognostic (1.46e-1)" "unprognostic (5.33e-2)" "unprognostic (1.07e-1)" "unprognostic (1.43e-1)" "unprognostic (2.38e-1)" "unprognostic (1.54e-2)" 18.7 26.9 30.3 10.9 30.2 10.3 15.8 49.5 29.5 19.4 16.6 21.4 40.6 14.7 17.1 25.3 15.3 24.3 17.2 33.4 26.4 20.3 16.4 17.2 14.1 13.9 22.0 21.5 19.3 40.2 29.1 28.2 11.2 22.3 28.3 9.5 16.9 40.4 41.6 35.3 22.9 14.5 17.2 16.1 14.7 16.3 26.9 25.6 10.1 19.5 13.8 11.7 19.6 15.8 10.1 19.1 4.8 8.7 3.3 17.4 7.0 11.4 14.8 9.5 12.1 17.0 11.9 12.3 8.4 8.5 7.9 10.6 6.5 16.3 5.3 17.1 12.5 10.3 17.6 7.8 12.7 3.2 12.7 13.1 11.8 17.3 11.3 24.7 3.1 6.5 20.9 16.3 10.2 12.7 17.2 9.3 14.8 17.9 14.6 7.8 27.4 14.9 8.6 6.4 17.9 30.2 14.4 4.0 13.9 12.1 10.6 14.3 8.6 17.8 14.2 18.7 7.8 19.5 12.8 10.8 10.4 11.4 11.3 8.5 7.4 4.9 4.2 14.8 10.8 7.8 2.1 8.7 4.8 7.2 5.6 11.6 9.7 8.9 5.9 9.0 10.1 17.4 9.6 4.4 3.3 6.2 19.1 3.5 7.0 30.3 30.2 49.5 29.5 26.4 20.3 22.0 21.5 22.3 25.6 32.8 21.6 16.6 38.3 27.1 79.2 16.5 38.2 34.8 27.3 55.8 23.6 26.6 36.5 23.2 7.8 28.7 37.7 0.0 24.8 16.3 32.4 46.0 4.7 42.0 22.3 85.8 32.4 36.8 20.6 29.7 46.9 19.0 25.3 32.5 43.9 110.9 24.4 42.1 37.4 30.5 50.8 38.8 24.7 39.5 25.6 33.9 14.0 19.5 43.5 27.8 CYLD "CYLD1, KIAA0849, USPL2" ENSG00000083799 "CYLD lysine 63 deubiquitinase" Q9NQC7 16 50742050-50801935 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway" "Hydrolase, Protease, Thiol protease" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 47.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011713, HPA050095" Approved Supported "Nucleoplasm,Centriolar satellite" Yes No "Centriolar satellite" Nucleoplasm "CAB011713: AB_731794, HPA050095: AB_2681013" "unprognostic (9.83e-2)" "unprognostic (1.17e-2)" "unprognostic (5.01e-2)" "unprognostic (2.83e-2)" "unprognostic (3.84e-1)" "unprognostic (5.06e-2)" "unprognostic (3.87e-2)" "unprognostic (3.24e-2)" "unprognostic (9.46e-2)" "unprognostic (1.11e-1)" "unprognostic (1.18e-2)" "unprognostic (2.32e-1)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (3.43e-2)" "unprognostic (6.83e-2)" "unprognostic (8.42e-2)" 9.3 16.2 13.9 22.9 26.4 51.1 9.1 14.2 20.9 9.2 10.3 18.8 12.8 10.2 16.1 8.1 15.3 8.5 13.3 12.7 15.7 17.0 9.4 13.2 15.6 30.7 16.3 14.3 11.5 12.2 20.3 27.8 9.8 20.0 11.0 12.7 13.3 12.6 10.9 31.7 12.4 14.2 12.5 16.3 23.4 12.4 22.6 13.7 16.9 16.2 8.0 29.3 14.1 12.6 9.2 10.2 31.4 9.8 13.6 19.1 10.2 9.3 2.9 3.4 3.8 5.4 7.8 3.1 13.8 20.2 14.4 8.5 2.4 4.4 10.7 5.0 13.5 15.7 3.6 4.0 8.4 21.5 47.2 6.1 5.3 5.2 2.0 10.7 5.3 25.3 8.5 6.8 17.4 18.2 13.7 5.8 7.6 2.2 9.4 20.1 1.4 5.2 7.7 3.6 2.9 4.9 4.7 6.9 10.3 4.7 3.2 4.4 3.3 11.7 4.0 3.4 5.4 4.0 6.7 6.5 24.7 5.6 8.6 5.6 24.8 23.5 12.0 18.1 6.0 5.2 31.4 8.6 20.8 10.7 9.8 12.9 9.2 15.8 14.4 10.2 6.2 14.7 11.4 19.4 13.6 9.5 6.2 19.1 10.2 13.9 26.4 14.2 20.9 15.7 17.0 16.3 14.3 20.0 13.7 41.7 25.6 39.6 48.8 106.7 75.4 32.7 25.5 12.0 19.4 17.4 88.4 5.4 5.0 18.3 32.8 37.9 13.4 46.7 16.5 3.8 37.2 52.3 78.5 22.1 19.0 63.5 29.9 21.5 32.3 24.7 23.6 47.1 70.9 34.3 10.3 22.6 15.2 18.7 19.8 10.3 49.3 6.5 34.4 52.6 13.8 135.9 3.4 73.4 12.0 56.3 CYP20A1 CYP-M ENSG00000119004 "Cytochrome P450 family 20 subfamily A member 1" Q6UW02 2 203238940-203305611 "Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055872, HPA058461" Uncertain Uncertain "Nucleoplasm,Plasma membrane,Cell Junctions,Actin filaments" No No "Plasma membrane, Cell Junctions, Actin filaments" Nucleoplasm "HPA055872: AB_2682951, HPA058461: AB_2683725" "unprognostic (4.72e-2)" "unprognostic (2.06e-2)" "unprognostic (1.20e-2)" "unprognostic (2.14e-2)" "unprognostic (1.42e-1)" "unprognostic (3.06e-2)" "unprognostic (5.21e-2)" "unprognostic (2.58e-2)" "unprognostic (4.21e-2)" "unprognostic (2.62e-2)" "unprognostic (4.53e-2)" "unprognostic (4.42e-2)" "unprognostic (7.64e-3)" "unprognostic (9.39e-2)" "unprognostic (2.18e-1)" "unprognostic (1.23e-2)" "unprognostic (1.95e-3)" 11.1 14.9 5.0 9.1 6.4 2.8 7.6 6.8 6.1 9.3 8.6 8.6 9.2 6.0 10.8 7.1 8.0 8.0 9.1 7.0 4.5 4.8 13.5 12.5 8.4 7.8 8.1 2.1 13.4 17.3 9.1 13.6 9.4 6.5 9.0 7.8 10.9 9.8 8.8 5.3 6.3 10.5 9.0 6.5 10.1 8.8 10.8 8.1 13.8 16.9 4.3 9.1 7.7 9.7 13.0 13.6 6.8 11.3 8.8 15.5 9.1 5.2 4.9 2.5 4.9 14.6 3.1 5.2 8.9 4.5 3.8 3.9 14.1 7.6 3.8 7.3 5.6 6.4 5.8 3.2 4.0 5.3 5.1 3.8 8.2 3.1 6.4 11.3 9.0 5.2 6.9 3.1 6.1 6.4 2.8 7.5 7.0 12.7 13.1 6.9 7.1 7.5 4.7 9.7 3.8 10.9 5.1 5.7 7.4 4.5 10.4 3.7 5.1 0.3 4.6 7.3 4.6 2.8 4.9 8.5 12.3 4.8 6.1 5.6 8.9 9.7 4.6 7.6 3.6 5.7 5.2 10.4 6.8 14.4 11.3 15.5 11.1 14.9 12.7 7.8 13.0 12.5 9.2 2.2 8.8 10.5 13.6 13.4 9.1 5.0 6.4 6.8 6.1 4.5 4.8 8.1 2.1 6.5 8.1 14.9 28.6 32.8 34.8 11.0 38.9 22.7 35.7 28.1 43.3 15.7 55.0 28.0 10.0 15.4 79.1 37.9 32.7 23.3 17.9 19.0 33.8 32.0 27.8 42.9 33.5 47.7 43.6 74.3 32.1 14.0 113.9 25.8 6.8 21.6 29.9 37.0 13.8 28.1 78.8 22.1 69.0 64.7 26.8 43.2 28.1 11.7 34.1 33.1 28.6 27.5 CYP24A1 "CP24, CYP24, P450-CC24" ENSG00000019186 "Cytochrome P450 family 24 subfamily A member 1" Q07973 20 54153449-54173973 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 38.8;lymphoid tissue: 25.8;urinary bladder: 31.2" "Cell type enhanced" "Detected in some" 11 "Basal glandular cells: 21.1;Basal keratinocytes: 20.3;Club cells: 29.6;Proximal tubular cells: 33.5;Suprabasal keratinocytes: 17.1;Urothelial cells: 39.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.1;memory CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 20 "T-cells: 2.0" "Group enriched" "Detected in some" 16 "A549: 95.1;Hep G2: 27.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA022261, HPA063771" Enhanced Supported "Nucleoplasm,Plasma membrane,Mitochondria" NA Yes "Nucleoplasm, Mitochondria" "Plasma membrane" "HPA022261: AB_1847427, HPA063771: AB_2685120" "unprognostic (1.19e-7)" "unprognostic (1.73e-1)" "unprognostic (2.24e-2)" "unprognostic (7.69e-3)" "unprognostic (3.30e-1)" "unprognostic (2.30e-2)" "unprognostic (1.11e-2)" "unprognostic (2.12e-1)" "unprognostic (2.09e-2)" "unprognostic (5.37e-3)" "unprognostic (1.23e-1)" "unprognostic (6.05e-2)" "unprognostic (5.98e-2)" "unprognostic (1.36e-1)" "unprognostic (4.38e-2)" "unprognostic (2.12e-1)" 0.1 0.1 0.4 0.2 0.7 0.0 2.5 0.1 0.4 2.5 0.1 0.0 0.3 0.0 11.2 0.4 4.4 0.3 0.0 0.1 0.4 0.8 38.8 0.3 1.6 0.1 0.2 0.0 0.1 0.1 0.0 0.7 7.0 0.3 7.0 0.0 0.1 0.3 1.5 0.1 1.0 0.1 0.6 0.2 0.1 0.1 0.3 0.0 0.4 1.4 5.9 25.8 31.2 14.4 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.1 95.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.9 0.0 0.7 0.0 0.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 1.6 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.7 0.1 0.4 0.4 0.8 0.2 0.0 0.3 0.0 0.0 0.0 1.5 21.1 20.3 0.0 0.3 0.0 8.1 29.6 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 6.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 33.5 0.0 0.0 0.0 0.0 0.0 17.1 0.1 0.0 0.0 39.9 CYP2B6 "CPB6, CYP2B, CYPIIB6" ENSG00000197408 "Cytochrome P450 family 2 subfamily B member 6" P20813 19 40991250-41018398 "Plasma proteins, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 44 "liver: 137.3" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 326.3" "Cancer enhanced" "Detected in many" "liver cancer: 28.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 7.0;OE19: 4.9" "Not detected" "Not detected" "CAB033866, HPA048124, HPA062973" Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Intracellular and membrane" NA NA "Nuclear membrane" "Nucleoplasm, Cytosol" "CAB033866: AB_2292644, HPA048124: AB_2680274, HPA062973: AB_2684914" "unprognostic (1.86e-1)" "unprognostic (1.23e-2)" "unprognostic (1.13e-2)" "unprognostic (6.13e-2)" "unprognostic (4.59e-2)" "unprognostic (4.63e-2)" "unprognostic (4.41e-2)" "unprognostic (1.73e-1)" "unprognostic (5.78e-2)" "unprognostic (1.04e-3)" "unprognostic (2.19e-1)" "unprognostic (9.43e-2)" "unprognostic (5.44e-1)" 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.9 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.0 3.0 137.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 1.6 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.9 1.8 3.1 0.8 0.7 0.9 0.1 0.4 0.4 0.5 0.4 0.1 0.0 0.4 0.2 0.3 0.0 0.1 1.5 0.0 0.3 0.3 0.2 0.1 7.0 0.4 0.1 0.1 0.3 0.6 0.4 0.7 0.4 0.4 0.4 0.4 0.0 0.4 0.3 0.1 0.3 0.5 0.7 0.4 0.1 0.2 0.1 0.8 1.8 0.6 4.9 0.4 0.2 0.5 0.4 1.7 0.1 0.9 0.2 0.3 0.1 0.5 0.3 0.7 1.1 0.8 0.6 0.3 0.7 0.5 0.3 0.7 0.9 0.2 1.1 0.3 3.1 0.8 0.4 0.4 0.5 0.4 0.6 0.6 0.4 0.1 1.9 0.5 0.8 2.7 0.7 0.3 1.8 0.9 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.6 0.0 0.3 0.0 0.0 0.2 2.5 1.4 1.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 9.9 46.7 0.2 0.0 0.0 0.1 0.0 326.3 0.0 0.0 0.0 10.4 11.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 7.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 3.2 0.6 CYP2U1 SPG49 ENSG00000155016 "Cytochrome P450 family 2 subfamily U member 1" Q7Z449 4 107931369-107953457 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "lymphoid tissue: 122.7" "Cell type enhanced" "Detected in many" 4 "Melanocytes: 18.6;Peritubular cells: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041622, HPA046754, HPA064827" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA041622: AB_2677583, HPA046754: AB_2679787, HPA064827: AB_2685362" "unprognostic (3.54e-1)" "unprognostic (2.45e-1)" "unprognostic (3.08e-1)" "unprognostic (2.84e-1)" "unprognostic (5.16e-2)" "unprognostic (1.08e-1)" "unprognostic (1.36e-2)" "unprognostic (1.20e-3)" "unprognostic (3.19e-1)" "unprognostic (8.97e-3)" "unprognostic (5.41e-3)" "unprognostic (3.02e-1)" "prognostic favorable (2.75e-5)" "prognostic unfavorable (6.97e-4)" "unprognostic (1.19e-1)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" 8.6 7.9 7.7 4.4 9.1 0.4 7.3 11.3 9.2 7.8 7.3 7.0 4.1 4.0 9.5 4.6 6.3 9.8 6.6 8.8 7.1 7.9 6.4 6.8 6.6 6.7 8.3 5.2 12.0 2.6 10.3 8.1 2.7 7.8 12.4 4.7 8.6 4.5 11.0 4.3 3.1 6.0 12.3 7.0 8.5 4.6 3.9 7.4 122.7 4.7 3.5 5.4 7.3 5.3 2.6 2.7 0.7 5.9 1.6 1.7 0.4 2.5 1.2 3.4 6.3 18.8 9.0 0.5 10.8 16.3 6.6 10.5 0.0 1.7 6.9 0.8 6.4 5.2 0.1 5.3 4.0 10.4 1.9 1.6 1.4 2.4 0.3 7.5 2.0 0.0 10.1 3.4 3.1 2.1 13.5 2.5 7.8 0.1 3.3 5.5 1.8 7.4 0.0 3.5 0.2 3.0 4.2 4.1 0.0 2.1 4.3 6.7 5.0 2.7 4.7 11.5 3.0 2.3 1.0 6.8 4.3 0.5 6.1 4.3 14.0 13.2 2.2 3.5 0.0 4.8 0.0 0.3 0.7 1.2 1.1 0.9 2.0 0.9 1.0 2.2 2.6 1.7 1.3 0.0 1.6 5.9 2.7 0.0 0.4 7.7 9.1 11.3 6.9 7.1 7.9 8.3 5.2 7.8 7.4 3.0 3.8 3.2 3.2 1.0 4.3 3.4 2.5 13.4 3.4 8.7 3.9 0.4 0.0 0.9 9.6 5.8 2.6 0.0 1.7 0.3 5.1 1.7 4.6 6.8 1.9 1.6 2.9 6.7 6.1 6.1 16.4 4.6 18.6 3.6 1.1 9.9 0.4 0.0 16.6 2.4 3.3 0.0 5.2 0.9 4.3 1.3 0.2 1.3 1.6 0.7 CYTH1 "B2-1, cytohesin-1, D17S811E, PSCD1" ENSG00000108669 "Cytohesin 1" Q15438 17 78674048-78782297 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "monocytes: 139.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 36.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047498 Uncertain Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA047498: " "unprognostic (3.82e-3)" "unprognostic (5.49e-2)" "unprognostic (1.34e-2)" "unprognostic (8.17e-2)" "unprognostic (1.63e-1)" "prognostic favorable (6.48e-4)" "unprognostic (6.60e-2)" "unprognostic (3.47e-2)" "unprognostic (3.26e-1)" "unprognostic (9.69e-2)" "unprognostic (4.94e-2)" "unprognostic (1.56e-2)" "unprognostic (1.22e-1)" "unprognostic (2.21e-2)" "unprognostic (4.14e-2)" "unprognostic (1.27e-1)" "unprognostic (1.10e-1)" 17.4 12.4 20.7 28.5 36.0 34.4 12.0 17.7 27.5 10.1 17.4 64.1 5.0 13.2 7.7 6.5 25.9 10.2 15.5 10.3 21.5 16.0 11.5 16.0 25.7 42.3 44.4 27.4 5.9 16.0 7.5 8.4 15.8 32.1 15.2 19.9 10.1 17.3 5.3 17.5 15.9 21.4 10.0 31.2 31.8 24.8 7.9 45.2 19.3 15.2 9.2 50.1 14.4 12.1 24.7 19.1 45.9 20.0 21.8 39.4 31.3 9.1 6.4 6.4 5.5 4.4 5.7 6.2 4.3 3.8 5.3 6.3 4.0 10.3 6.8 4.4 5.7 9.1 8.1 3.1 11.3 4.3 14.3 8.7 2.7 8.1 7.4 3.2 5.6 27.6 2.7 9.3 6.0 6.3 3.6 17.1 23.0 4.5 26.4 6.3 4.7 36.3 5.0 1.6 14.9 5.7 9.6 7.1 23.9 5.8 6.4 3.7 13.6 7.6 14.8 6.0 6.8 7.2 6.7 8.1 4.2 6.2 6.7 4.4 30.7 14.1 25.0 3.1 5.7 4.4 45.9 16.2 31.4 39.4 20.0 28.6 24.7 32.8 31.8 13.7 23.0 36.5 30.7 33.8 21.8 17.6 19.1 24.5 31.3 20.7 36.0 17.7 27.5 21.5 16.0 44.4 27.4 32.1 45.2 56.6 46.2 41.5 26.5 36.6 62.3 16.6 17.8 33.5 31.8 5.2 104.1 2.4 6.6 10.4 23.5 51.6 24.0 0.0 16.1 7.5 15.4 34.8 33.7 24.6 41.7 41.3 26.6 30.7 66.6 33.2 4.0 73.5 35.4 139.7 45.7 16.5 31.3 24.9 4.9 5.8 74.3 6.5 11.7 14.1 15.3 30.1 6.1 71.7 15.2 45.7 CYTH3 "ARNO3, cytohesin-3, GRP1, PSCD3" ENSG00000008256 "Cytohesin 3" O43739 7 6161776-6272644 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 66.6" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 38.8" "Cancer enhanced" "Detected in all" "melanoma: 47.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 5.9" "Group enriched" "Detected in many" 5 "dendritic cells: 1.8;NK-cells: 3.3;T-cells: 5.9" "Cell line enhanced" "Detected in many" "WM-115: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013979 Uncertain Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA013979: AB_1855799" "unprognostic (6.58e-2)" "unprognostic (1.37e-2)" "unprognostic (1.65e-2)" "unprognostic (5.75e-3)" "unprognostic (1.27e-3)" "unprognostic (1.27e-2)" "unprognostic (2.32e-2)" "unprognostic (2.63e-1)" "unprognostic (8.94e-2)" "unprognostic (1.81e-2)" "unprognostic (1.32e-1)" "unprognostic (1.12e-1)" "unprognostic (2.54e-2)" "unprognostic (1.73e-2)" "unprognostic (2.20e-1)" "unprognostic (4.41e-2)" "prognostic unfavorable (2.63e-5)" 24.0 9.1 10.9 6.6 14.4 6.1 22.0 14.2 17.6 10.4 16.4 7.0 5.7 15.1 13.0 8.1 13.4 12.6 13.9 21.1 11.4 7.2 8.8 3.0 14.0 5.4 9.4 10.7 11.0 6.6 9.4 7.1 66.6 9.4 6.8 6.7 17.8 8.6 8.7 12.3 15.6 18.5 15.2 8.5 7.5 9.2 26.0 6.5 2.9 20.4 10.8 5.0 7.7 16.5 0.6 1.8 0.7 0.4 3.3 5.9 0.4 21.6 5.5 5.2 3.6 24.5 29.0 7.4 12.8 11.2 12.7 12.1 8.4 10.8 2.9 7.8 25.8 16.4 20.4 3.6 9.3 8.5 0.2 5.1 0.8 6.5 1.0 11.6 0.9 1.4 20.5 4.2 6.7 9.8 5.7 2.2 4.3 3.4 0.4 9.2 3.5 0.7 3.8 3.6 2.9 7.4 3.8 14.0 1.6 9.8 2.6 3.4 6.5 7.9 27.8 22.5 4.7 1.7 6.1 8.0 8.7 23.2 9.4 7.8 1.0 0.3 3.0 2.8 2.3 35.5 0.7 0.4 0.0 2.2 0.2 5.9 0.3 1.0 2.4 0.4 0.6 0.1 1.5 0.3 3.3 0.4 1.8 0.8 0.4 10.9 14.4 14.2 17.6 11.4 7.2 9.4 10.7 9.4 6.5 14.9 8.0 2.4 1.7 13.5 4.8 16.5 2.5 2.7 3.4 3.5 7.9 12.6 5.0 3.3 9.9 14.7 7.5 0.0 2.4 7.4 14.4 3.0 12.7 1.5 9.9 14.3 2.9 16.0 2.7 12.1 15.3 4.6 30.4 1.0 5.8 8.8 6.4 5.3 12.4 1.0 1.8 38.8 24.0 19.5 10.5 9.9 12.7 5.0 6.9 1.6 CYTIP "B3-1, CASP, CYBR, CYTHIP, HE, PSCDBP" ENSG00000115165 "Cytohesin 1 interacting protein" O60759 2 157414619-157488961 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 53.4;lymphoid tissue: 92.9" "Cell type enriched" "Detected in many" 4 "monocytes: 788.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 14.6;HDLM-2: 11.7;Karpas-707: 39.9;RPMI-8226: 12.2;U-266/70: 68.0;U-266/84: 25.5" "Region enhanced" "Detected in single" "basal ganglia: 0.4" "Not detected" "Not detected" HPA007191 Approved Approved Nucleoplasm,Cytosol No NA Cytosol Nucleoplasm "HPA007191: AB_1855801" "unprognostic (3.61e-3)" "unprognostic (7.96e-3)" "unprognostic (2.00e-2)" "prognostic favorable (9.12e-4)" "unprognostic (5.71e-2)" "unprognostic (1.36e-3)" "unprognostic (9.13e-2)" "unprognostic (1.19e-1)" "unprognostic (6.12e-2)" "unprognostic (7.41e-2)" "unprognostic (1.87e-2)" "unprognostic (1.53e-1)" "unprognostic (1.41e-1)" "unprognostic (1.84e-1)" "unprognostic (5.49e-2)" "unprognostic (5.43e-2)" "unprognostic (3.78e-2)" 9.4 1.4 1.4 33.3 1.6 32.3 3.9 0.8 1.0 4.4 9.7 1.6 0.8 9.3 3.1 4.2 6.6 2.8 5.8 3.8 1.5 1.5 4.1 3.9 26.8 92.9 3.1 0.6 2.9 3.1 0.0 1.5 1.3 2.0 2.4 5.0 3.1 11.5 3.1 1.4 2.1 17.4 2.1 4.3 48.3 14.4 3.3 1.3 40.5 3.2 3.8 61.8 24.1 3.2 21.9 13.0 48.5 53.3 19.9 53.4 31.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 2.0 1.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 39.9 0.2 0.0 0.0 1.6 0.1 0.2 0.0 0.0 0.0 12.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 68.0 25.5 6.6 0.6 1.8 0.0 48.5 8.4 24.5 30.6 27.8 30.9 21.9 32.4 28.9 13.0 21.1 53.4 40.7 48.2 19.9 53.3 6.7 31.3 31.6 1.4 1.6 0.8 1.0 1.5 1.5 3.1 0.6 2.0 1.3 3.0 16.4 102.3 1.0 18.5 0.0 2.0 5.1 0.0 2.3 1.8 0.0 0.5 13.3 0.2 1.2 1.2 0.5 23.3 1.7 9.8 8.5 0.5 6.9 1.0 24.4 0.0 1.7 4.9 80.4 1.7 0.0 153.9 79.2 788.1 1.9 0.0 0.2 0.0 0.0 0.8 0.0 0.0 3.2 0.0 0.2 15.6 2.5 190.7 1.5 0.1 CYYR1 C21orf95 ENSG00000166265 "Cysteine and tyrosine rich 1" Q96J86 21 26466209-26573284 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "breast: 59.8" "Group enriched" "Detected in many" 6 "Endothelial cells: 113.7;Ito cells: 60.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 38 "plasmacytoid DC: 21.1" "Lineage enriched" "Detected in single" 73 "dendritic cells: 21.1" "Cell line enhanced" "Detected in some" "AF22: 9.0;NTERA-2: 25.2;PC-3: 6.9;RH-30: 10.7;SCLC-21H: 21.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034921, HPA067685" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB034921: AB_2089315, HPA067685: AB_2685887" "unprognostic (5.64e-2)" "unprognostic (2.59e-2)" "unprognostic (1.37e-1)" "unprognostic (1.88e-1)" "unprognostic (7.00e-2)" "unprognostic (2.63e-2)" "unprognostic (2.88e-3)" "unprognostic (4.04e-1)" "unprognostic (1.11e-2)" "unprognostic (1.12e-1)" "unprognostic (3.77e-2)" "unprognostic (1.46e-1)" "unprognostic (2.44e-3)" "unprognostic (9.29e-3)" "unprognostic (2.26e-1)" "unprognostic (1.88e-1)" "unprognostic (1.49e-2)" 30.9 28.9 3.8 7.7 4.4 4.0 59.8 2.1 4.3 19.0 8.4 2.7 13.4 3.5 15.1 14.7 13.1 8.6 10.8 29.1 4.7 3.9 10.6 7.1 23.8 13.4 5.6 2.5 9.8 4.5 5.1 3.5 21.7 3.9 11.7 4.0 11.6 5.4 10.5 14.5 4.8 6.8 14.6 5.0 34.1 5.9 9.2 2.5 3.6 11.2 9.1 2.7 11.2 23.9 0.0 21.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.5 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.2 0.0 0.2 0.0 3.5 0.0 0.0 0.0 1.6 0.0 0.0 0.0 25.2 0.0 6.9 0.0 10.7 0.0 1.0 0.0 21.8 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 2.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 21.1 0.0 0.0 3.8 4.4 2.1 4.3 4.7 3.9 5.6 2.5 3.9 2.5 0.0 1.1 0.9 1.1 10.4 0.0 5.6 0.0 1.4 2.3 14.0 0.0 0.1 3.3 0.0 0.6 113.7 0.0 0.0 0.0 0.2 6.1 0.4 0.0 0.0 0.3 0.0 0.0 60.8 2.7 0.9 2.0 1.2 6.8 1.0 0.0 0.5 0.1 0.0 0.0 2.6 0.0 0.0 3.3 0.2 1.1 4.6 0.2 0.0 0.0 0.7 DAAM2 KIAA0381 ENSG00000146122 "Dishevelled associated activator of morphogenesis 2" Q86T65 6 39792298-39904877 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 83.3" "Cell type enriched" "Detected in many" 5 "Sertoli cells: 148.8" "Cancer enhanced" "Detected in all" "melanoma: 21.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 29 "neutrophil: 2.8" "Lineage enriched" "Detected in single" 29 "granulocytes: 2.8" "Cell line enhanced" "Detected in some" "HSkMC: 25.8;JURKAT: 13.8;LHCN-M2: 25.3;SK-MEL-30: 31.3;WM-115: 12.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051300, HPA054630" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA051300: AB_2681430, HPA054630: AB_2682549" "unprognostic (7.53e-2)" "unprognostic (6.02e-3)" "unprognostic (4.49e-2)" "unprognostic (7.93e-2)" "unprognostic (8.24e-2)" "unprognostic (4.28e-2)" "unprognostic (2.43e-2)" "unprognostic (1.05e-3)" "unprognostic (1.33e-1)" "unprognostic (5.89e-2)" "unprognostic (2.17e-1)" "unprognostic (5.24e-2)" "prognostic unfavorable (2.79e-4)" "unprognostic (2.67e-2)" "unprognostic (8.54e-2)" "unprognostic (7.94e-2)" "unprognostic (8.54e-4)" 21.5 17.8 34.8 6.7 43.0 1.7 7.8 4.4 52.2 9.3 6.4 83.3 8.0 7.6 7.5 8.5 28.3 8.9 5.9 6.1 40.4 25.2 5.9 4.0 8.4 2.8 42.8 24.8 7.3 5.2 3.5 2.1 9.4 41.3 8.7 7.1 5.1 4.3 17.6 23.8 4.4 8.9 13.7 48.8 15.5 7.0 8.7 51.9 0.0 5.0 2.1 2.2 4.6 4.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 5.7 0.1 0.1 4.4 5.9 1.0 0.5 0.4 0.0 0.0 0.2 6.6 2.1 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 4.1 0.0 0.0 25.8 0.0 0.1 0.0 7.2 0.0 13.8 0.0 0.0 25.3 0.0 0.6 0.0 0.7 1.3 0.0 0.0 4.6 3.5 0.0 0.0 0.9 1.0 0.0 0.3 31.3 5.6 0.0 0.0 0.2 9.6 2.8 0.1 0.1 0.0 0.0 0.0 0.1 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 34.8 43.0 4.4 28.9 40.4 25.2 42.8 24.8 41.3 51.9 8.9 9.8 0.0 0.8 1.5 1.7 2.1 0.0 2.7 6.8 0.0 0.0 0.4 0.0 0.4 3.6 2.0 0.0 0.0 3.0 0.4 11.3 0.8 0.0 1.0 0.2 0.0 0.0 3.1 15.2 4.2 21.9 3.1 8.5 0.0 0.0 8.2 0.4 0.0 20.8 0.0 1.5 148.8 28.3 0.7 1.1 1.0 0.2 0.0 0.0 1.0 DACH1 DACH ENSG00000276644 "Dachshund family transcription factor 1" Q9UI36 13 71437966-71867192 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 70.5;Horizontal cells: 82.6;Late spermatids: 80.3;Muller glia cells: 155.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 15 "basophil: 4.7;eosinophil: 9.2;NK-cell: 4.9;plasmacytoid DC: 7.5" "Group enriched" "Detected in many" 30 "dendritic cells: 7.5;granulocytes: 9.2;NK-cells: 4.9" "Cell line enhanced" "Detected in some" "AF22: 8.2;HAP1: 12.8;HEK 293: 9.6;HL-60: 20.7;NB-4: 9.2;SCLC-21H: 21.3;SH-SY5Y: 17.1;THP-1: 15.0" "Region enriched" "Detected in many" 5 "basal ganglia: 34.7" "Region enriched" "Detected in all" 5 "basal ganglia: 34.0" "HPA012672, HPA012938" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA012672: AB_1847466, HPA012938: " "unprognostic (3.16e-1)" "unprognostic (5.26e-2)" "unprognostic (1.41e-2)" "unprognostic (2.36e-1)" "unprognostic (4.21e-2)" "unprognostic (5.63e-2)" "unprognostic (2.22e-2)" "unprognostic (8.08e-3)" "unprognostic (2.12e-2)" "unprognostic (2.50e-1)" "unprognostic (3.04e-3)" "unprognostic (4.37e-1)" "unprognostic (2.18e-2)" "unprognostic (1.06e-1)" "unprognostic (2.19e-1)" "unprognostic (1.24e-1)" "unprognostic (5.17e-2)" 4.9 12.2 0.6 3.8 15.5 5.7 9.2 1.8 2.9 11.4 5.4 0.0 3.5 5.4 6.3 4.1 0.9 2.9 15.8 3.0 0.2 10.2 1.9 10.2 0.3 0.0 1.5 0.9 1.8 7.3 24.4 7.3 4.9 7.9 3.5 19.6 1.9 6.9 3.6 0.6 9.6 2.1 2.9 7.8 1.8 6.1 6.6 6.1 0.0 1.2 0.2 2.1 10.2 0.0 7.5 9.2 0.2 4.9 0.0 0.1 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 12.8 0.0 0.0 0.0 9.6 0.1 0.0 0.0 0.2 20.7 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.5 9.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 21.3 17.1 0.0 0.0 0.0 0.0 0.5 15.0 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.1 4.7 0.2 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 4.9 0.0 7.5 0.0 0.1 0.0 1.1 0.0 2.9 1.4 10.4 1.6 0.0 1.4 0.0 7.0 3.9 0.0 5.0 0.5 70.5 17.3 1.1 0.0 0.0 0.0 0.8 9.2 4.7 0.0 0.2 82.6 32.7 1.8 1.6 80.3 3.1 1.1 0.0 0.0 13.3 155.3 0.5 0.0 1.8 3.5 4.8 12.9 1.4 21.1 7.0 1.1 0.0 0.0 3.7 1.8 DACH2 ENSG00000126733 "Dachshund family transcription factor 2" Q96NX9 X 86148458-86832604 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 29.5;epididymis: 9.3;fallopian tube: 8.0" "Group enriched" "Detected in some" 5 "Bipolar cells: 1.3;Horizontal cells: 3.2;Muller glia cells: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HAP1: 11.5" "Low region specificity" "Detected in some" "HPA000258, HPA001367" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA000258: AB_1078618, HPA001367: " "unprognostic (5.73e-3)" "unprognostic (3.22e-1)" "unprognostic (1.54e-6)" "unprognostic (3.66e-1)" "unprognostic (1.98e-1)" "unprognostic (3.34e-1)" "unprognostic (7.71e-2)" "unprognostic (6.48e-1)" "unprognostic (3.17e-2)" "unprognostic (4.10e-2)" "unprognostic (1.06e-1)" "unprognostic (1.91e-2)" "unprognostic (1.28e-1)" "unprognostic (5.74e-3)" "unprognostic (5.01e-3)" "unprognostic (2.63e-2)" 0.9 0.9 7.9 0.6 29.5 0.6 0.6 0.2 17.8 1.0 0.8 0.3 0.0 1.2 1.2 9.3 0.7 8.0 0.6 0.6 13.5 10.8 2.4 0.6 0.9 0.6 3.4 10.4 1.4 1.1 0.7 1.3 0.6 11.8 1.5 0.7 1.6 0.7 0.8 0.6 0.7 1.3 0.8 0.7 0.6 1.4 0.7 1.7 0.0 0.7 0.0 0.6 1.4 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.5 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 29.5 0.2 16.8 13.5 10.8 3.4 10.4 11.8 1.7 0.0 0.0 0.0 0.0 0.3 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 DACT1 "DAPPER, DAPPER1, FRODO, HDPR1, THYEX3" ENSG00000165617 "Dishevelled binding antagonist of beta catenin 1" Q9NYF0 14 58633967-58648321 "Disease related genes, Predicted intracellular proteins" "Neurogenesis, Wnt signaling pathway" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 36.0;Peritubular cells: 26.2;Smooth muscle cells: 15.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "naive CD4 T-cell: 1.9;plasmacytoid DC: 1.6" "Group enriched" "Detected in many" 4 "dendritic cells: 1.6;T-cells: 1.9" "Cell line enhanced" "Detected in many" "SK-MEL-30: 9.5;SuSa: 13.4;U-138 MG: 23.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003016, HPA074619" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA003016: AB_1078623, HPA074619: " "unprognostic (2.47e-2)" "unprognostic (2.72e-2)" "unprognostic (1.79e-2)" "unprognostic (1.22e-1)" "unprognostic (1.03e-2)" "unprognostic (3.55e-2)" "unprognostic (1.37e-1)" "unprognostic (1.17e-2)" "unprognostic (4.79e-2)" "unprognostic (1.93e-1)" "unprognostic (5.42e-2)" "unprognostic (6.54e-2)" "unprognostic (4.16e-2)" "unprognostic (1.64e-2)" "unprognostic (2.54e-1)" "unprognostic (1.37e-3)" "unprognostic (1.89e-3)" 7.1 7.0 5.0 3.2 4.5 1.0 8.7 24.5 6.5 8.2 5.0 2.6 7.0 4.8 7.5 5.1 2.5 4.7 21.4 7.2 3.2 3.0 4.8 3.1 7.4 2.9 4.0 4.6 21.8 2.2 3.5 3.6 9.9 7.8 10.6 5.8 11.5 2.9 11.8 3.5 2.4 4.3 10.0 7.5 5.6 5.7 8.0 3.5 1.6 14.7 1.7 1.8 9.5 12.8 0.4 1.6 0.0 0.0 0.0 1.9 0.1 0.0 0.0 3.0 0.1 3.4 3.8 0.0 1.7 2.1 1.7 1.5 0.2 0.1 0.0 0.1 5.0 3.0 2.5 8.3 0.0 1.0 1.9 1.7 0.0 0.1 0.0 6.2 0.0 1.0 4.4 0.2 6.6 0.0 6.7 0.1 0.5 0.0 0.0 1.2 0.0 0.6 0.0 2.8 0.1 0.7 3.5 4.2 0.0 0.0 0.0 0.0 0.0 4.7 0.0 9.5 13.4 0.0 0.3 0.0 23.8 8.3 0.3 6.0 3.2 1.2 0.0 2.5 1.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 1.9 0.0 0.0 0.0 0.0 1.6 0.0 0.1 5.0 4.5 24.5 6.5 3.2 3.0 4.0 4.6 7.8 3.5 0.0 0.0 0.0 1.2 0.7 0.2 3.0 5.1 0.0 0.0 1.8 0.0 0.1 0.0 2.3 36.0 0.7 0.0 0.0 2.1 0.5 5.2 0.5 0.0 0.0 1.0 0.0 0.0 4.9 2.2 10.6 11.2 0.4 1.7 0.0 0.9 3.8 2.4 0.0 26.2 0.7 0.3 0.0 15.3 6.1 2.8 1.1 0.1 0.0 0.0 0.3 DACT3 "DAPPER3, MGC15476, RRR1" ENSG00000197380 "Dishevelled binding antagonist of beta catenin 3" Q96B18 19 46647612-46661138 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 15.7;Early spermatids: 18.3;Smooth muscle cells: 27.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 5.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 9.4;SH-SY5Y: 23.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043053 Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA043053: AB_10794769" "unprognostic (2.35e-1)" "unprognostic (3.08e-1)" "unprognostic (5.30e-3)" "unprognostic (5.08e-2)" "unprognostic (2.02e-1)" "unprognostic (1.09e-1)" "unprognostic (2.66e-1)" "unprognostic (2.03e-2)" "unprognostic (3.27e-2)" "unprognostic (2.03e-4)" "unprognostic (1.70e-1)" "unprognostic (2.67e-1)" "prognostic unfavorable (7.97e-8)" "unprognostic (1.59e-2)" "unprognostic (4.03e-2)" "unprognostic (3.54e-3)" "prognostic unfavorable (6.66e-4)" 5.2 3.8 21.0 5.8 15.9 1.7 1.6 3.7 32.3 10.7 17.3 24.6 3.5 4.2 21.6 14.8 7.8 10.9 7.4 10.5 21.7 13.9 3.9 2.2 5.6 1.5 17.4 13.6 8.8 1.5 1.4 1.2 2.1 14.1 11.7 7.2 13.7 1.7 25.1 1.7 2.8 4.7 30.3 17.0 4.8 7.4 5.7 9.4 0.0 1.6 1.5 1.3 13.2 6.0 1.6 1.2 5.9 0.9 2.0 0.7 0.3 0.2 0.3 5.2 4.9 1.8 1.4 0.5 2.9 4.7 0.9 1.4 0.3 0.3 0.4 1.9 9.4 1.0 0.3 3.2 0.1 1.0 0.4 1.7 1.3 0.7 0.2 2.6 0.2 2.2 4.7 0.1 1.2 0.0 0.6 0.4 0.8 1.6 1.7 0.8 0.4 0.2 1.2 2.0 0.2 0.7 4.2 1.4 0.3 0.3 0.4 2.0 23.0 0.5 0.2 0.4 5.6 0.4 0.4 0.5 2.4 3.0 2.5 0.5 1.5 0.5 0.7 0.6 0.8 1.8 5.9 0.9 1.0 0.7 0.5 0.5 0.7 0.7 0.5 0.2 1.6 0.7 0.7 4.6 2.0 0.7 1.2 0.5 0.3 21.0 15.9 3.7 32.3 21.7 13.9 17.4 13.6 14.1 9.4 6.0 8.5 0.0 1.1 2.1 13.7 15.7 0.0 0.0 1.2 0.0 2.0 4.3 0.0 0.0 18.3 2.2 0.0 0.0 0.0 2.5 7.3 0.8 5.8 0.0 0.9 1.6 1.7 2.5 1.5 6.1 7.2 1.9 3.3 1.0 0.0 5.8 0.1 0.0 13.8 0.3 4.9 6.5 27.6 2.1 1.7 2.9 8.2 0.0 0.2 0.9 DAG1 "156DAG, A3a, AGRNR, DAG" ENSG00000173402 "Dystroglycan 1" Q14118 3 49468703-49535618 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 62.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001960, CAB016353, HPA070563" Enhanced Supported "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 70000000 "Vesicles, Plasma membrane" Nucleoplasm "CAB001960: , CAB016353: AB_627292, HPA070563: " "unprognostic (1.58e-1)" "unprognostic (5.14e-1)" "unprognostic (6.71e-3)" "unprognostic (3.32e-1)" "unprognostic (7.39e-2)" "unprognostic (9.91e-2)" "unprognostic (1.67e-1)" "unprognostic (3.27e-2)" "unprognostic (8.18e-2)" "unprognostic (3.91e-2)" "unprognostic (5.70e-3)" "unprognostic (1.10e-1)" "prognostic favorable (2.59e-4)" "unprognostic (9.22e-2)" "unprognostic (1.99e-2)" "unprognostic (7.43e-2)" "unprognostic (1.57e-2)" 19.2 17.4 16.5 10.1 21.1 2.8 16.2 17.3 27.1 17.3 23.9 24.1 13.1 14.1 23.4 14.3 19.1 19.6 19.7 40.9 19.9 10.3 22.7 31.7 18.9 6.3 16.7 15.7 22.6 35.0 32.7 15.8 45.6 18.1 18.6 18.9 22.2 19.9 24.3 57.3 18.7 17.5 27.9 14.0 7.3 22.2 29.4 16.3 6.0 15.3 24.0 14.3 20.4 15.0 3.2 3.6 1.8 6.1 1.9 3.7 3.3 19.5 19.5 13.6 33.6 18.2 8.9 62.0 13.8 20.5 23.7 15.3 16.0 20.8 2.7 14.1 22.5 20.1 36.7 11.8 17.9 14.7 2.6 3.9 1.8 19.6 18.2 8.1 2.4 3.9 7.8 16.2 22.5 7.5 21.7 21.2 3.3 2.8 2.1 6.4 15.7 2.0 1.6 14.6 24.1 6.5 1.2 13.2 4.6 18.6 27.5 4.8 9.9 16.6 45.8 22.4 41.3 38.6 4.8 11.1 9.0 14.3 16.7 19.7 2.4 4.9 1.7 10.9 2.6 54.3 1.8 2.8 1.1 3.3 3.5 3.7 3.2 2.8 2.5 1.8 2.6 3.0 2.4 0.6 1.9 6.1 3.6 1.9 3.3 16.5 21.1 17.3 27.1 19.9 10.3 16.7 15.7 18.1 16.3 50.6 13.6 9.0 8.0 12.7 7.8 50.0 30.6 10.7 11.4 33.2 3.9 95.1 1.7 26.2 25.8 16.8 20.6 0.0 69.3 96.3 24.2 13.2 6.9 48.8 18.3 3.2 31.7 17.8 7.2 13.6 19.8 4.0 32.1 5.4 27.5 30.3 50.2 25.1 34.6 6.8 8.7 45.3 23.7 7.0 18.6 14.9 80.2 5.0 26.4 9.0 DAGLB "DAGLBETA, KCCR13L" ENSG00000164535 "Diacylglycerol lipase beta" Q8NCG7 7 6409126-6484190 "Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069377 Supported "Nucleoplasm,Plasma membrane" No No "Plasma membrane" Nucleoplasm "HPA069377: AB_2686132" "unprognostic (2.39e-1)" "unprognostic (4.61e-2)" "unprognostic (2.13e-3)" "unprognostic (1.42e-1)" "unprognostic (9.04e-3)" "unprognostic (3.68e-2)" "unprognostic (1.78e-3)" "unprognostic (2.36e-1)" "unprognostic (2.22e-1)" "prognostic unfavorable (7.18e-5)" "unprognostic (1.25e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.54e-4)" "unprognostic (2.18e-1)" "unprognostic (1.14e-1)" "unprognostic (1.93e-1)" "unprognostic (1.81e-2)" 20.1 28.2 12.6 12.7 20.3 25.8 29.8 18.4 26.1 19.1 18.0 11.4 19.4 15.1 14.3 17.5 16.2 12.5 26.6 18.9 12.4 13.8 24.0 88.0 18.4 25.2 11.6 5.8 22.5 47.0 14.2 19.0 45.7 7.5 14.6 10.6 14.6 34.1 22.3 22.0 22.1 31.3 16.0 13.2 15.1 14.0 27.1 7.9 7.2 23.1 15.1 16.8 15.6 20.8 5.6 18.9 13.6 14.7 2.4 8.4 7.5 10.9 12.5 5.4 7.0 8.2 6.4 4.3 15.4 10.5 13.3 14.4 6.6 12.0 5.9 6.7 7.4 32.5 16.2 8.8 8.1 7.6 2.7 6.1 3.1 14.3 4.5 8.8 8.9 5.0 5.7 13.5 8.9 8.8 5.3 5.7 7.6 8.9 2.9 7.8 7.7 3.1 12.6 19.7 5.4 9.5 27.4 6.2 12.7 8.4 4.0 7.0 4.2 8.7 13.4 2.5 9.0 9.3 16.7 7.0 11.5 21.9 14.4 7.1 3.1 5.6 5.0 5.7 14.0 13.9 6.2 14.7 13.6 4.4 13.9 3.9 5.6 3.5 2.9 18.9 3.6 8.4 4.8 7.3 2.4 12.2 3.2 2.9 7.5 12.6 20.3 18.4 23.4 12.4 13.8 11.6 5.8 7.5 7.9 8.9 13.0 3.9 2.8 14.9 4.2 2.4 2.5 2.7 3.4 5.2 2.0 4.4 0.0 6.2 0.4 6.7 10.9 0.0 5.3 7.7 4.6 4.6 3.5 6.2 14.7 0.0 2.4 8.0 15.4 0.9 5.8 15.3 5.0 11.8 4.7 0.9 9.2 5.8 2.1 1.8 4.5 0.0 5.7 7.2 6.8 11.7 10.4 5.3 6.3 3.2 DALRD3 FLJ10496 ENSG00000178149 "DALR anticodon binding domain containing 3" Q5D0E6 3 49015488-49022293 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 129.7;Late spermatids: 227.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036862 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA036862: AB_10673507" "unprognostic (2.76e-2)" "unprognostic (8.44e-3)" "unprognostic (3.56e-1)" "prognostic favorable (9.03e-4)" "unprognostic (3.77e-1)" "unprognostic (1.52e-1)" "unprognostic (3.33e-3)" "unprognostic (1.19e-2)" "unprognostic (5.33e-2)" "unprognostic (9.52e-2)" "unprognostic (8.07e-2)" "unprognostic (1.11e-1)" "prognostic favorable (2.79e-5)" "unprognostic (1.18e-1)" "unprognostic (1.75e-1)" "unprognostic (1.15e-2)" "unprognostic (2.18e-1)" 9.4 14.1 9.3 13.9 9.0 4.4 21.6 10.2 11.9 11.3 9.5 7.7 14.9 7.2 7.7 14.7 13.1 34.3 14.2 8.6 8.6 7.3 16.0 9.3 10.8 9.1 7.2 9.4 13.5 29.3 12.6 11.1 8.7 6.3 8.4 7.5 8.4 13.2 18.5 7.5 13.0 10.2 6.5 5.1 8.5 9.9 32.0 6.8 21.1 21.1 13.5 12.7 9.5 14.1 17.7 8.2 7.3 9.3 14.5 19.2 9.3 6.2 8.5 5.3 10.5 15.4 20.5 6.6 5.3 14.3 8.8 8.4 6.0 7.8 2.5 7.5 14.0 7.6 4.1 7.0 13.5 6.1 3.8 4.7 2.7 7.9 11.2 10.0 7.5 5.4 13.8 14.0 11.0 24.6 22.3 13.5 5.8 2.1 6.2 8.5 10.6 3.4 5.1 8.9 12.9 8.1 1.7 0.7 17.9 23.3 9.8 3.4 11.4 5.7 15.8 11.9 9.3 11.2 8.3 8.4 3.4 5.4 12.1 4.7 19.9 10.9 1.3 13.0 3.5 6.7 7.1 7.7 3.7 10.2 9.3 18.8 17.7 17.0 12.7 8.2 15.5 14.4 9.3 7.3 14.5 8.6 5.6 19.2 9.3 9.3 9.0 10.2 11.9 8.6 7.3 7.2 9.4 6.3 6.8 14.9 9.8 15.9 21.0 22.8 29.2 1.2 15.3 65.6 19.4 26.2 17.7 23.7 31.5 33.6 129.7 14.3 30.3 0.0 34.6 30.0 20.5 9.2 24.3 5.8 17.2 38.1 18.3 15.4 10.8 227.2 22.5 15.9 20.3 29.7 19.2 23.2 22.0 17.5 17.3 36.2 53.2 45.3 15.5 91.9 33.3 29.7 15.3 17.5 25.0 13.2 DAP ENSG00000112977 "Death associated protein" P51397 5 10679230-10761272 "Predicted intracellular proteins" "Apoptosis, Autophagy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 178.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA029456 Uncertain Approved Nucleoplasm,Vesicles,Mitochondria NA NA "Vesicles, Mitochondria" Nucleoplasm "HPA029456: AB_10601262" "unprognostic (2.70e-2)" "unprognostic (3.48e-1)" "unprognostic (2.25e-1)" "unprognostic (1.88e-2)" "unprognostic (1.95e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (2.15e-5)" "unprognostic (4.05e-2)" "unprognostic (1.19e-1)" "unprognostic (1.52e-3)" "unprognostic (3.50e-1)" "unprognostic (1.91e-2)" "unprognostic (3.03e-3)" "unprognostic (2.11e-1)" "unprognostic (2.39e-1)" "unprognostic (8.58e-3)" "unprognostic (2.04e-2)" 17.4 36.6 13.7 17.9 12.7 10.6 23.1 3.9 11.6 23.5 25.4 11.4 63.4 26.5 21.1 34.7 14.3 18.6 44.0 22.9 13.4 9.1 40.1 78.2 21.6 22.6 10.2 10.1 26.1 178.8 30.0 28.4 26.4 21.8 24.8 20.2 22.7 71.1 76.0 5.9 15.2 42.6 18.3 10.8 23.8 31.6 23.2 9.8 15.5 31.2 12.8 18.6 25.9 16.9 18.1 32.8 27.3 33.2 13.1 17.6 22.5 19.2 14.1 17.5 16.1 32.8 39.7 19.4 47.4 73.7 35.9 41.7 10.0 16.5 8.4 31.2 58.5 22.7 3.8 10.8 28.1 40.0 44.3 7.9 11.3 27.3 24.6 31.0 21.1 8.4 20.4 9.8 23.5 42.7 20.8 66.9 9.5 13.1 28.6 35.1 15.3 11.3 13.5 6.3 26.2 32.3 15.5 7.7 13.9 47.3 35.9 11.9 16.0 48.3 19.7 12.6 14.0 15.6 31.0 32.7 22.3 24.2 14.7 25.1 16.1 20.8 12.4 22.0 41.2 33.4 14.9 33.2 18.6 14.8 29.4 17.6 18.1 15.3 13.0 32.8 12.0 11.3 11.2 27.3 13.1 28.5 26.9 16.1 22.5 13.7 12.7 3.9 11.6 13.4 9.1 10.2 10.1 21.8 9.8 14.9 40.1 32.0 53.6 17.1 8.1 11.0 56.0 12.0 30.7 50.6 5.9 59.1 112.7 83.0 10.9 31.6 98.3 0.0 168.9 84.1 36.6 77.8 35.6 106.2 46.0 4.8 42.5 36.2 35.6 22.8 27.6 32.0 27.0 38.7 87.4 19.0 105.6 63.3 32.2 50.2 7.2 0.0 21.7 33.1 6.1 15.8 84.4 24.1 65.2 69.2 DAP3 "bMRP-10, DAP-3, DKFZp686G12159, MGC126058, MGC126059, MRP-S29, MRPS29" ENSG00000132676 "Death associated protein 3" P51398 1 155687960-155739010 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" Apoptosis "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023687 Approved Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA023687: AB_1847472" "unprognostic (2.60e-1)" "unprognostic (2.13e-2)" "unprognostic (2.35e-1)" "unprognostic (2.37e-1)" "unprognostic (1.90e-1)" "unprognostic (1.20e-3)" "prognostic unfavorable (1.20e-4)" "unprognostic (1.80e-1)" "unprognostic (5.63e-2)" "unprognostic (2.33e-1)" "unprognostic (2.87e-2)" "unprognostic (3.16e-1)" "prognostic unfavorable (4.14e-6)" "unprognostic (1.56e-1)" "unprognostic (1.85e-1)" "unprognostic (2.48e-1)" "unprognostic (1.00e-1)" 27.8 36.5 22.9 26.3 25.9 28.9 34.2 19.5 23.6 23.5 33.4 19.5 22.8 29.4 28.7 28.1 31.3 21.8 23.2 56.3 27.0 26.4 32.8 52.2 23.9 49.0 24.9 23.0 23.3 38.5 20.7 27.1 20.5 23.0 27.9 32.1 24.5 28.0 27.1 64.0 30.9 26.5 36.0 23.2 30.8 30.3 31.6 21.1 44.4 27.6 28.4 38.0 38.0 24.1 39.0 41.1 15.9 35.2 34.0 56.5 39.6 32.4 21.1 17.2 27.3 25.5 32.3 42.5 27.4 29.0 28.2 24.7 38.9 40.0 46.3 55.9 22.3 18.1 33.2 25.6 23.9 30.8 29.0 18.7 28.2 18.8 35.2 34.9 38.6 25.2 27.0 34.3 35.9 47.6 22.1 27.7 43.0 60.9 33.0 29.3 43.2 33.9 45.2 30.5 51.1 34.5 28.0 21.6 49.2 33.5 31.2 20.1 35.6 26.3 77.6 47.2 33.4 48.2 63.5 23.6 24.0 25.3 29.6 45.9 36.1 53.9 53.4 23.9 34.6 30.8 13.9 30.1 15.9 31.3 35.2 51.4 39.0 45.1 38.0 41.1 32.2 56.5 48.4 13.0 34.0 31.9 26.8 45.0 39.6 22.9 25.9 19.5 23.6 27.0 26.4 24.9 23.0 23.0 21.1 41.7 35.8 49.1 58.4 48.8 26.0 99.7 45.9 68.3 58.0 15.7 19.6 67.1 56.3 62.2 13.1 35.0 35.4 93.5 68.2 87.5 44.8 51.6 61.1 48.1 67.9 12.7 24.6 34.4 47.0 10.6 30.0 61.0 33.7 88.4 35.3 13.3 67.0 31.6 23.7 57.4 46.0 12.9 47.2 38.7 26.6 55.2 118.4 64.7 54.9 62.6 DAPK3 "ZIP, ZIPK" ENSG00000167657 "Death associated protein kinase 3" O43293 19 3958453-3971123 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Transcription, Transcription regulation, Translation regulation" "Activator, Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028569, HPA064809" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA028569: AB_10794319, HPA064809: AB_2685357" "unprognostic (5.72e-2)" "unprognostic (3.28e-2)" "unprognostic (3.34e-3)" "prognostic favorable (2.01e-5)" "unprognostic (1.83e-1)" "unprognostic (2.37e-1)" "unprognostic (7.72e-3)" "unprognostic (2.16e-1)" "unprognostic (2.46e-2)" "unprognostic (4.95e-2)" "unprognostic (1.84e-3)" "unprognostic (7.64e-2)" "prognostic unfavorable (6.49e-4)" "unprognostic (9.92e-2)" "unprognostic (1.41e-1)" "unprognostic (5.48e-2)" "unprognostic (2.14e-1)" 18.8 10.2 12.6 16.6 16.4 10.0 17.2 14.5 29.5 22.5 30.1 13.6 11.5 18.5 33.1 11.5 20.2 18.5 21.9 49.2 12.4 11.0 10.9 11.0 24.5 11.6 11.9 16.8 18.8 21.7 11.1 14.6 26.0 19.7 21.3 6.9 18.2 15.3 25.8 45.2 17.8 17.0 38.8 10.6 14.7 23.3 15.7 12.7 11.8 11.4 11.6 12.9 26.7 17.8 15.0 14.7 23.9 15.6 17.3 19.5 11.0 25.7 20.5 12.8 16.1 9.6 10.9 19.8 35.6 28.7 29.1 19.2 37.7 7.8 14.3 17.5 31.2 20.5 20.6 12.5 20.2 10.6 20.9 20.8 5.7 25.1 21.6 30.6 13.8 21.7 24.7 25.3 26.4 15.2 17.5 24.1 9.8 18.1 24.9 17.7 16.8 13.7 10.4 19.9 10.5 16.5 17.2 18.9 13.3 17.5 20.3 20.3 14.1 24.0 28.9 20.4 15.7 20.8 10.9 45.1 37.5 17.0 33.5 44.4 27.8 22.8 16.5 29.8 14.5 19.9 22.1 14.2 23.9 19.5 15.6 14.0 13.5 14.8 17.9 12.6 15.0 11.3 10.8 23.9 17.3 10.6 14.7 17.6 11.0 12.6 16.4 14.5 29.5 12.4 11.0 11.9 16.8 19.7 12.7 23.8 10.9 16.6 82.6 89.4 12.3 27.3 17.8 5.3 7.9 10.4 2.0 40.8 14.9 91.0 24.5 19.4 61.2 0.0 75.9 65.4 32.8 38.1 20.7 6.0 20.1 11.1 26.2 20.3 16.7 17.7 21.0 12.0 35.4 33.3 33.0 11.1 89.1 42.1 21.2 11.5 10.2 32.3 50.1 15.2 15.6 62.7 77.9 17.5 20.3 41.6 DAPL1 ENSG00000163331 "Death associated protein like 1" A0PJW8 2 158795317-158862781 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 53.5;esophagus: 75.6;retina: 63.9;skin 1: 61.3" "Cell type enriched" "Detected in many" 5 "Muller glia cells: 522.1" "Group enriched" "Detected in all" 7 "cervical cancer: 16.2;head and neck cancer: 14.5;lung cancer: 19.7;ovarian cancer: 62.5;thyroid cancer: 30.1" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HaCaT: 3.7;hTCEpi: 22.1;SCLC-21H: 5.7;U-87 MG: 8.1" "Not detected" "Not detected" "HPA046937, HPA058635" Enhanced Approved "Nucleoplasm,Nuclear bodies,Microtubules" NA NA "Nucleoplasm, Nuclear bodies, Microtubules" "HPA046937: AB_2679870, HPA058635: AB_2732625" "unprognostic (3.95e-5)" "prognostic favorable (8.43e-4)" "unprognostic (2.05e-1)" "unprognostic (1.55e-1)" "unprognostic (2.98e-1)" "unprognostic (4.63e-2)" "unprognostic (8.59e-2)" "unprognostic (5.24e-2)" "unprognostic (4.59e-2)" "unprognostic (2.44e-1)" "unprognostic (1.41e-1)" "unprognostic (2.44e-3)" "unprognostic (4.09e-2)" "unprognostic (6.68e-2)" "unprognostic (3.00e-2)" "unprognostic (2.30e-3)" 0.3 14.7 1.4 0.4 1.3 0.0 7.4 0.4 1.0 11.7 1.0 0.8 1.6 0.0 2.1 53.5 75.6 21.1 0.6 0.2 1.5 3.6 1.3 0.2 0.8 0.4 2.8 0.3 3.8 5.7 0.0 5.6 0.2 1.5 2.3 0.0 63.9 6.8 0.4 0.2 61.3 0.5 1.1 0.4 0.2 0.2 2.1 0.8 0.8 21.5 37.3 16.9 2.0 21.1 1.4 4.0 2.9 2.6 2.8 1.3 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.0 0.1 2.3 0.0 0.0 0.0 0.0 0.2 22.1 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.3 5.7 0.0 0.0 0.0 0.6 0.0 0.6 1.1 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 8.1 0.0 0.0 2.9 2.6 1.6 0.5 1.9 1.0 1.2 0.8 0.4 1.0 1.4 0.4 0.5 2.2 2.8 0.6 4.0 1.3 0.5 1.4 1.3 0.4 1.0 1.5 3.6 2.8 0.3 1.5 0.8 0.0 0.0 14.6 31.4 94.9 6.8 0.0 5.1 1.4 17.0 8.7 5.9 5.5 3.3 8.0 10.6 0.5 2.5 0.0 5.1 10.7 4.1 10.8 4.6 12.1 12.9 3.2 2.9 0.6 7.9 43.8 3.7 5.5 11.8 2.8 1.6 522.1 5.7 3.5 2.1 5.8 16.3 0.0 5.1 9.8 4.1 110.7 3.8 1.9 2.5 25.5 DARS2 FLJ10514 ENSG00000117593 "Aspartyl-tRNA synthetase 2, mitochondrial" Q6PI48 1 173824503-173858546 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026506, HPA026528" Enhanced Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA026506: AB_1847482, HPA026528: AB_1847483" "unprognostic (3.14e-2)" "unprognostic (1.52e-1)" "unprognostic (1.06e-1)" "unprognostic (8.85e-3)" "unprognostic (1.33e-1)" "unprognostic (1.14e-2)" "unprognostic (1.05e-3)" "unprognostic (4.10e-3)" "unprognostic (2.20e-1)" "unprognostic (1.42e-1)" "unprognostic (6.17e-2)" "unprognostic (1.15e-1)" "prognostic favorable (1.74e-4)" "unprognostic (3.30e-1)" "unprognostic (1.90e-1)" "unprognostic (1.13e-1)" "unprognostic (4.73e-3)" 17.0 22.2 6.3 10.1 8.1 5.4 9.0 7.5 8.6 7.8 15.1 6.7 8.3 11.7 10.4 6.1 13.4 6.4 5.9 11.2 5.5 6.0 21.9 14.8 8.2 11.0 6.4 4.2 9.5 14.9 18.1 15.3 10.9 10.0 8.5 16.6 10.2 10.2 6.2 10.6 6.0 16.1 6.2 9.0 11.4 11.3 8.4 6.9 26.1 12.2 6.3 12.5 9.7 8.1 9.3 9.0 4.8 10.7 5.0 9.3 5.2 29.0 19.4 12.1 7.5 9.2 13.1 15.5 12.8 10.6 18.5 14.2 18.2 26.1 15.7 17.5 10.2 12.2 29.8 33.4 21.6 25.3 17.9 16.4 13.6 9.7 12.6 9.0 11.5 12.4 9.5 9.9 18.7 19.1 5.9 18.4 11.9 27.5 12.4 15.4 8.0 14.6 6.5 23.4 32.5 17.4 17.2 15.4 28.9 16.8 9.7 15.9 14.5 14.0 31.3 20.2 19.0 32.8 15.2 8.1 9.5 15.0 13.1 20.4 9.7 24.5 18.2 5.5 12.7 20.5 4.4 7.0 4.8 6.6 10.7 9.3 9.3 7.2 5.8 9.0 7.3 7.7 4.8 0.7 5.0 7.4 3.7 5.1 5.2 6.3 8.1 7.5 8.6 5.5 6.0 6.4 4.2 10.0 6.9 3.0 1.9 4.3 3.6 1.5 2.2 10.5 7.6 1.4 3.4 5.2 0.0 7.3 6.6 3.9 1.9 3.2 4.5 23.3 2.3 13.0 3.4 2.3 5.7 4.3 8.9 3.2 4.1 1.3 3.5 1.0 2.8 5.0 1.7 6.4 5.0 2.4 3.6 0.0 1.4 6.4 2.7 0.0 2.3 5.7 6.4 1.4 3.5 2.9 6.0 2.5 DAW1 "FLJ25955, ODA16, WDR69" ENSG00000123977 "Dynein assembly factor with WD repeats 1" Q8N136 2 227871054-227924344 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 14.9;fallopian tube: 24.4;testis: 49.9" "Group enriched" "Detected in some" 12 "Ciliated cells: 69.6;Early spermatids: 83.7;Late spermatids: 157.9;Spermatocytes: 115.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "GAMG: 6.2;HUVEC TERT2: 15.2;U-2197: 28.5" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 25.4" HPA046118 Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA Nucleoplasm "Nuclear bodies, Plasma membrane" "HPA046118: AB_10961428" "unprognostic (1.23e-1)" "unprognostic (1.42e-1)" "unprognostic (1.95e-1)" "unprognostic (1.66e-1)" "unprognostic (4.37e-1)" "unprognostic (1.23e-1)" "unprognostic (5.63e-3)" "unprognostic (2.90e-2)" "unprognostic (9.92e-3)" "unprognostic (1.54e-5)" "unprognostic (1.52e-1)" "unprognostic (6.83e-3)" "unprognostic (1.70e-1)" "unprognostic (3.08e-1)" 0.4 0.1 2.5 0.3 14.9 0.4 0.5 0.0 1.8 0.7 0.3 3.1 0.0 0.1 0.3 3.1 0.6 24.4 0.4 0.4 3.9 3.0 0.3 0.5 2.4 0.3 0.3 2.7 1.3 0.1 0.7 0.2 0.8 14.3 0.2 0.2 0.0 0.3 0.2 2.6 0.3 0.2 0.2 0.3 0.3 0.2 49.9 1.1 0.0 0.2 0.0 0.3 0.3 0.0 0.5 0.5 1.2 0.5 0.2 0.8 0.0 0.6 0.0 0.1 0.0 0.2 0.9 0.4 0.6 0.3 0.6 0.4 3.7 0.3 0.2 0.0 0.1 6.2 0.1 0.0 0.1 1.8 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.1 1.3 0.0 0.7 0.5 4.1 15.2 0.0 0.1 0.2 0.2 0.0 0.0 0.4 0.3 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.2 0.1 0.5 0.0 0.0 0.2 0.1 0.3 1.5 0.1 1.4 28.5 0.0 0.0 0.1 0.2 2.7 0.0 0.2 1.2 0.0 0.2 0.2 0.5 0.8 0.3 0.4 0.4 0.0 0.5 0.6 0.3 0.0 0.2 0.5 0.5 0.6 0.0 2.5 14.9 0.0 1.8 3.9 3.0 0.3 2.7 14.3 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 69.6 9.1 0.0 3.9 0.0 0.0 0.0 83.7 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 157.9 3.1 0.0 0.0 0.0 0.0 0.2 1.7 0.0 2.5 0.0 0.2 0.0 0.0 115.4 1.4 0.1 0.2 0.0 0.0 0.0 DAXX DAP6 ENSG00000204209 "Death domain associated protein" Q9UER7 6 33318558-33323016 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Transcription, Transcription regulation" "Chaperone, Chromatin regulator, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002224, HPA008736, HPA008797, CAB025546, HPA065779" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB002224: AB_563688, CAB025546: , HPA008736: AB_1078625, HPA008797: AB_2797218, HPA065779: AB_2685558" "prognostic favorable (6.05e-4)" "unprognostic (2.90e-1)" "unprognostic (9.66e-2)" "unprognostic (4.04e-2)" "unprognostic (8.55e-2)" "unprognostic (1.36e-1)" "unprognostic (1.46e-3)" "unprognostic (3.48e-1)" "unprognostic (1.92e-1)" "unprognostic (8.58e-3)" "unprognostic (1.34e-1)" "unprognostic (2.01e-2)" "prognostic unfavorable (6.32e-7)" "unprognostic (2.43e-1)" "unprognostic (5.37e-1)" "unprognostic (1.26e-1)" "unprognostic (1.04e-1)" 10.4 14.3 10.7 13.5 11.9 8.8 10.8 11.3 14.8 11.8 12.2 9.4 7.3 11.2 13.2 43.7 13.5 12.6 12.1 9.1 9.7 7.3 9.2 12.0 10.3 18.3 10.2 8.5 13.8 18.6 24.4 10.4 11.6 11.6 13.0 14.1 7.3 10.7 15.2 14.8 11.6 12.7 15.5 8.1 20.4 10.5 20.2 11.5 25.0 16.1 6.8 30.9 11.5 10.9 17.0 5.9 12.6 11.2 15.3 18.2 21.8 2.1 0.0 7.1 2.8 1.2 2.3 4.7 7.0 22.9 17.9 13.2 0.8 2.4 6.9 2.5 5.4 20.5 1.3 0.1 5.7 16.6 8.2 15.6 9.0 12.4 11.1 3.9 9.6 2.6 6.0 8.5 2.0 5.3 5.3 0.5 4.5 5.0 4.5 5.5 5.2 3.8 21.3 0.4 0.1 3.3 5.9 0.1 7.7 1.4 0.7 8.5 2.2 0.0 0.4 3.7 3.5 2.2 0.2 5.9 4.4 5.6 0.2 0.1 7.8 16.2 14.9 3.3 4.4 4.7 7.8 7.5 12.6 16.3 8.0 18.2 16.6 15.4 15.8 5.9 17.0 13.9 14.1 7.4 15.3 11.2 5.9 17.1 21.8 10.7 11.9 11.3 14.8 9.7 7.3 10.2 8.5 11.6 11.5 6.0 21.4 27.0 17.6 52.0 17.3 7.5 15.3 14.7 25.0 12.2 17.7 21.7 19.9 29.4 9.8 20.6 18.0 0.0 33.3 29.5 26.3 21.9 35.9 13.5 21.9 14.3 20.2 11.6 13.7 4.7 16.4 20.8 23.6 60.5 19.5 17.7 46.9 21.0 21.9 11.9 73.3 12.9 23.7 48.8 34.9 53.2 20.7 51.7 20.9 30.2 DAZAP1 MGC19907 ENSG00000071626 "DAZ associated protein 1" Q96EP5 19 1407569-1435687 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004201, HPA004631" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 1700000 Nucleoplasm Cytosol "HPA004201: AB_1078627, HPA004631: AB_1078626" "unprognostic (1.50e-1)" "unprognostic (3.19e-2)" "unprognostic (7.69e-2)" "unprognostic (2.29e-1)" "unprognostic (7.31e-3)" "unprognostic (2.04e-1)" "prognostic unfavorable (5.86e-4)" "unprognostic (1.83e-1)" "unprognostic (2.30e-1)" "unprognostic (6.13e-2)" "unprognostic (1.09e-1)" "unprognostic (8.11e-3)" "unprognostic (2.72e-3)" "unprognostic (2.40e-3)" "unprognostic (8.30e-2)" "unprognostic (1.65e-1)" "unprognostic (2.21e-3)" 22.1 15.0 11.4 33.1 14.2 37.1 32.9 16.1 19.4 15.2 21.4 22.2 17.2 28.3 17.8 11.0 30.9 16.0 13.5 26.7 11.5 9.2 17.1 38.1 18.7 29.2 16.8 12.4 20.7 28.3 11.9 11.4 22.2 13.3 15.9 15.6 16.8 17.0 12.0 31.4 20.2 28.7 17.7 10.9 28.5 22.0 46.8 15.0 43.8 15.9 22.6 21.0 21.4 27.7 7.1 6.1 4.3 7.5 6.5 7.1 3.1 53.2 19.4 13.0 23.7 5.8 7.1 37.4 24.0 12.0 19.7 16.2 19.3 26.4 62.8 14.8 11.7 9.6 30.1 17.2 22.9 16.7 43.9 27.2 32.3 18.6 19.6 13.5 39.1 27.8 7.0 15.1 13.4 24.6 8.4 17.2 26.7 48.1 33.2 12.3 21.8 68.5 34.8 40.2 19.6 19.6 49.4 20.8 38.7 14.8 18.1 25.9 23.3 15.9 25.0 28.9 17.7 22.7 52.2 18.6 16.2 22.0 28.3 52.5 39.3 40.3 49.8 19.6 38.1 24.8 3.2 5.5 4.3 6.5 7.5 7.1 7.1 6.0 6.9 4.9 5.5 6.0 6.4 2.4 6.5 5.2 6.1 6.1 3.1 11.4 14.2 16.1 19.4 11.5 9.2 16.8 12.4 13.3 15.0 8.9 25.1 51.6 76.4 61.6 49.4 34.3 33.1 10.7 18.2 24.4 33.4 33.1 19.9 45.8 41.0 31.5 47.0 23.3 47.1 91.4 34.5 63.8 26.5 38.1 42.1 25.4 31.8 30.7 39.5 45.6 25.9 40.6 38.8 24.4 62.3 27.0 52.0 42.1 22.3 37.7 38.4 25.8 48.4 128.2 37.5 65.5 57.7 39.8 68.9 92.5 DBF4 "ASK, chif, DBF4A, ZDBF1" ENSG00000006634 "DBF4 zinc finger" Q9UBU7 7 87876216-87909541 "Predicted intracellular proteins" "Cell cycle, DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lymphoid tissue: 11.8;testis: 34.2" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 250.0;Spermatocytes: 291.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA042923 Supported "Nucleoplasm,Nuclear bodies" Yes Yes "Nucleoplasm, Nuclear bodies" "HPA042923: AB_2678222" "unprognostic (2.48e-1)" "unprognostic (8.32e-2)" "unprognostic (1.15e-2)" "unprognostic (4.86e-3)" "unprognostic (2.81e-2)" "unprognostic (3.63e-1)" "prognostic unfavorable (4.45e-6)" "unprognostic (1.05e-1)" "prognostic unfavorable (6.86e-4)" "unprognostic (1.46e-3)" "unprognostic (1.05e-3)" "unprognostic (2.78e-3)" "prognostic unfavorable (6.42e-7)" "unprognostic (1.98e-2)" "unprognostic (2.40e-1)" "unprognostic (1.47e-1)" "unprognostic (1.30e-1)" 1.1 1.2 1.4 5.9 2.0 1.8 3.0 1.9 1.9 1.4 2.1 0.0 0.6 1.2 1.2 1.4 1.7 1.1 1.5 1.0 1.5 1.4 1.2 1.1 2.4 5.0 1.3 1.0 3.4 1.3 1.2 1.8 1.4 0.8 1.2 1.2 0.0 1.2 1.1 1.9 1.3 1.5 0.9 1.2 4.6 1.1 34.2 0.7 11.8 1.4 1.9 2.7 1.6 1.1 1.3 0.9 4.0 0.4 0.9 1.6 0.5 1.3 1.4 3.0 3.8 0.7 0.6 0.9 1.4 0.3 1.5 3.0 2.3 0.9 3.1 1.1 0.9 2.6 1.3 3.1 0.8 1.6 2.3 2.1 2.0 1.7 0.5 0.2 2.4 1.6 0.7 0.8 1.7 1.6 0.5 1.3 2.9 1.7 6.5 2.0 2.4 4.2 3.0 3.0 3.1 2.9 1.1 4.7 3.7 1.2 0.2 4.4 2.8 1.9 3.3 1.5 2.5 1.4 2.5 0.6 1.8 2.2 4.7 3.0 3.7 7.7 3.1 1.3 4.4 3.9 4.0 0.4 0.4 1.2 0.3 0.3 0.8 1.1 0.6 0.2 1.3 1.1 1.3 1.1 0.9 0.4 0.9 1.6 0.5 1.4 2.0 1.9 1.9 1.5 1.4 1.3 1.0 0.8 0.7 3.0 13.0 34.9 16.3 13.9 5.8 3.6 0.0 14.7 5.7 8.7 11.8 12.2 3.3 5.4 250.0 8.5 4.5 46.7 12.9 31.0 7.6 10.6 30.1 5.4 13.9 3.2 14.3 7.4 8.8 57.4 14.4 14.2 11.8 9.0 18.6 1.9 10.7 7.0 8.9 4.4 15.5 12.9 8.2 291.4 77.1 11.0 8.0 21.5 15.8 11.4 DBF4B "ASKL1, chifb, DRF1, FLJ13087, ZDBF1B" ENSG00000161692 "DBF4 zinc finger B" Q8NFT6 17 44708608-44752264 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 27.8;Horizontal cells: 28.6;Spermatocytes: 36.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA048465 Uncertain Supported Nucleoplasm,Vesicles NA Yes Nucleoplasm Vesicles "HPA048465: AB_2680405" "unprognostic (2.44e-1)" "unprognostic (1.26e-1)" "unprognostic (6.37e-2)" "unprognostic (2.15e-3)" "unprognostic (1.62e-1)" "unprognostic (6.13e-2)" "unprognostic (1.53e-4)" "unprognostic (7.61e-2)" "unprognostic (1.54e-2)" "unprognostic (4.08e-2)" "unprognostic (8.43e-3)" "unprognostic (1.83e-1)" "unprognostic (4.23e-6)" "unprognostic (1.50e-1)" "unprognostic (3.36e-1)" "unprognostic (2.57e-1)" "unprognostic (1.39e-1)" 2.6 2.0 8.0 5.8 6.1 5.6 3.4 7.1 9.4 3.6 4.1 5.3 3.3 2.4 6.4 11.4 3.5 5.9 4.3 2.0 6.7 3.7 3.1 1.6 3.0 4.7 6.7 4.7 5.9 2.3 2.6 4.5 3.3 6.2 5.4 4.1 6.4 3.3 4.8 5.4 6.5 3.7 5.3 4.7 4.4 3.2 10.9 6.4 6.9 6.8 2.5 5.2 4.2 3.2 1.5 0.9 1.8 1.6 0.0 2.2 0.5 3.9 8.3 6.2 4.5 0.6 1.2 5.4 4.2 1.8 8.9 8.8 3.5 3.4 5.8 2.3 1.5 8.0 3.8 5.4 1.7 10.3 9.6 8.6 7.4 6.3 4.6 0.3 4.9 6.4 0.5 0.6 4.9 1.6 2.0 4.4 9.9 9.3 6.1 4.8 4.1 7.3 3.0 2.7 8.2 4.4 6.5 7.2 2.5 2.1 2.4 3.5 3.7 4.0 1.3 3.3 7.0 4.2 3.3 1.9 3.1 5.9 3.9 7.6 2.8 3.6 7.6 2.3 4.4 4.8 0.0 0.9 1.8 0.3 1.6 0.2 1.5 0.2 0.3 0.9 0.4 0.0 2.2 0.0 0.0 1.3 0.7 0.6 0.5 8.0 6.1 7.1 9.4 6.7 3.7 6.7 4.7 6.2 6.4 0.0 1.4 7.5 2.4 0.6 27.8 1.0 0.0 2.7 3.4 5.2 11.8 3.2 0.0 0.2 8.1 2.2 0.0 0.0 0.7 1.1 1.3 2.2 3.5 0.2 1.2 28.6 4.1 1.3 1.6 5.5 1.1 2.2 5.0 1.0 0.5 11.7 0.3 0.0 2.8 0.3 16.1 0.0 0.9 36.9 11.3 0.1 1.1 1.0 0.6 2.0 DBNDD2 "C20orf35, HSMNP1" ENSG00000244274 "Dysbindin domain containing 2" Q9BQY9 20 45406057-45410610 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 160.5;skeletal muscle: 84.2" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 3.0;Ciliated cells: 9.4;Club cells: 4.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 16 "dendritic cells: 15.0;monocytes: 9.3;T-cells: 7.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043991 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043991: AB_10966212" "unprognostic (6.33e-2)" "unprognostic (1.68e-2)" "unprognostic (1.05e-1)" "unprognostic (2.79e-3)" "unprognostic (2.45e-1)" "unprognostic (1.62e-1)" "unprognostic (1.31e-3)" "unprognostic (8.24e-2)" "unprognostic (5.44e-2)" "unprognostic (3.06e-1)" "unprognostic (3.71e-2)" "unprognostic (2.47e-1)" "unprognostic (1.41e-3)" "unprognostic (2.52e-1)" "unprognostic (1.21e-1)" "unprognostic (2.52e-2)" "unprognostic (3.48e-1)" 12.2 7.8 56.5 9.9 64.9 2.1 15.3 21.3 88.8 11.0 26.4 132.3 5.0 16.6 14.9 13.6 18.3 17.7 10.2 68.4 85.1 47.3 5.9 2.5 13.9 5.8 98.2 31.5 6.5 6.7 18.4 5.0 13.2 51.8 14.2 28.4 3.1 9.0 29.1 84.2 10.4 19.4 31.0 160.5 5.0 13.3 3.0 70.7 2.7 4.8 10.5 8.2 16.8 8.2 0.3 15.0 0.3 9.3 0.6 7.9 3.5 21.7 3.9 3.1 22.0 2.0 0.9 4.4 12.8 13.9 10.7 7.3 10.5 29.8 0.3 2.2 12.6 4.0 32.2 21.5 1.1 6.6 0.1 12.6 18.1 16.8 9.5 12.9 0.9 27.6 0.3 3.7 4.0 3.8 18.7 7.3 18.6 1.3 0.4 0.8 27.6 1.5 1.3 4.1 14.3 23.2 0.0 0.3 0.2 30.6 0.4 7.2 3.7 4.4 2.4 27.5 2.3 30.1 5.6 11.7 0.4 21.3 14.2 13.9 0.3 0.4 0.1 1.5 0.1 3.1 0.0 8.4 0.0 7.9 9.3 2.9 0.1 6.9 5.8 6.0 0.3 6.4 6.0 0.3 0.6 5.0 15.0 5.8 3.5 56.5 64.9 21.3 62.5 85.1 47.3 98.2 31.5 51.8 70.7 3.0 0.3 0.0 0.1 0.0 0.0 1.0 0.0 9.4 4.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.0 0.2 1.1 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.5 0.0 0.0 0.2 0.1 DBNL "ABP1, HIP-55, SH3P7" ENSG00000136279 "Drebrin like" Q9UJU6 7 44044640-44069456 "Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Endocytosis, Immunity, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 9 "monocytes: 471.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020265, HPA027735" Enhanced Supported Nucleoplasm,Cytosol NA NA 15000000 Cytosol Nucleoplasm "HPA020265: AB_1850723, HPA027735: AB_10603790" "unprognostic (9.57e-2)" "unprognostic (1.11e-1)" "unprognostic (1.04e-2)" "unprognostic (5.63e-2)" "prognostic unfavorable (2.12e-5)" "unprognostic (2.25e-1)" "unprognostic (6.18e-3)" "unprognostic (1.83e-1)" "unprognostic (5.88e-2)" "unprognostic (8.92e-2)" "unprognostic (5.76e-3)" "unprognostic (5.92e-2)" "unprognostic (2.11e-1)" "unprognostic (1.79e-1)" "unprognostic (2.10e-1)" "unprognostic (1.46e-1)" "unprognostic (9.51e-2)" 23.9 19.6 21.2 45.4 17.4 34.1 20.5 11.4 24.0 23.9 21.0 19.6 23.5 17.9 22.0 21.8 65.6 19.1 32.7 18.0 18.3 18.8 18.9 18.4 23.6 49.8 19.1 23.8 15.2 19.2 16.7 18.5 25.8 16.1 21.0 15.2 17.2 23.4 22.3 15.9 26.2 23.2 25.2 19.8 46.8 24.7 13.0 15.8 31.0 18.2 32.0 52.3 23.6 31.6 46.7 66.0 64.1 73.7 31.6 35.4 80.5 19.6 28.6 17.9 19.4 22.3 14.4 16.6 32.3 27.0 32.2 27.1 28.7 27.4 44.0 23.5 35.2 40.3 34.9 10.4 37.8 12.1 23.5 12.1 14.9 21.4 16.3 22.7 22.3 27.8 13.6 15.1 30.6 10.7 21.0 22.1 27.5 18.7 15.3 30.5 28.5 39.9 25.1 14.6 20.2 24.2 22.2 14.6 21.8 20.8 27.4 21.8 28.9 22.0 43.3 6.9 13.4 31.9 31.1 35.3 26.5 24.0 15.3 37.4 35.9 15.4 24.6 24.9 25.3 62.6 39.2 66.3 50.2 35.4 73.7 28.0 46.7 26.7 28.8 63.9 45.8 27.0 28.2 64.1 31.6 71.0 66.0 31.3 80.5 21.2 17.4 11.4 24.0 18.3 18.8 19.1 23.8 16.1 15.8 41.7 39.3 122.1 30.1 15.7 32.3 28.5 25.5 16.0 19.4 29.6 33.4 67.1 38.1 80.6 8.5 35.4 50.3 46.7 64.8 122.0 37.7 30.1 63.6 19.2 155.2 38.1 36.4 29.4 130.7 6.2 34.2 90.1 52.3 471.5 44.3 39.0 78.0 73.7 31.8 24.0 36.5 6.5 39.1 19.9 13.0 23.3 73.0 66.0 34.9 51.4 DBR1 ENSG00000138231 "Debranching RNA lariats 1" Q9UK59 3 138161012-138174949 "Predicted intracellular proteins" "mRNA processing" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035365 Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035365: AB_10611956" "unprognostic (1.20e-1)" "unprognostic (3.72e-2)" "unprognostic (8.48e-3)" "unprognostic (2.04e-2)" "unprognostic (2.83e-1)" "unprognostic (9.40e-2)" "prognostic unfavorable (1.36e-4)" "unprognostic (2.33e-1)" "unprognostic (5.24e-2)" "unprognostic (9.99e-2)" "unprognostic (2.60e-1)" "unprognostic (3.33e-2)" "prognostic favorable (1.36e-4)" "unprognostic (5.37e-2)" "unprognostic (1.71e-1)" "unprognostic (5.35e-2)" "unprognostic (4.79e-2)" 11.8 13.5 9.3 10.0 10.5 20.7 12.2 12.5 10.5 13.3 10.1 14.4 12.8 8.3 15.8 13.6 12.3 11.8 12.4 9.3 9.3 8.9 13.4 12.2 15.3 12.6 11.0 10.5 13.7 15.5 13.1 16.1 9.1 10.0 12.3 10.1 12.7 12.8 10.7 10.8 11.9 12.4 11.6 10.9 17.0 18.3 5.8 12.0 22.3 13.2 7.7 13.6 11.0 12.7 8.3 9.8 14.3 11.2 9.2 13.3 7.0 14.9 6.2 11.3 12.5 6.3 5.9 11.7 8.9 6.5 9.6 11.8 10.4 6.7 13.7 17.0 8.0 14.6 11.1 13.0 4.4 12.7 11.7 10.7 14.8 8.1 8.6 7.7 19.1 13.1 8.1 7.4 8.9 8.4 5.7 7.9 12.0 9.6 3.0 9.7 11.5 18.7 11.3 13.0 11.6 7.3 11.8 12.8 12.5 8.3 14.6 10.9 14.1 23.7 8.3 12.7 9.6 15.6 15.7 7.4 8.2 5.7 15.0 10.2 4.5 6.2 28.7 5.3 13.8 10.5 4.8 8.1 14.3 10.4 11.2 13.3 8.3 11.8 9.9 9.8 8.0 12.1 13.1 3.5 9.2 9.0 6.0 9.5 7.0 9.3 10.5 12.5 10.5 9.3 8.9 11.0 10.5 10.0 12.0 6.0 11.7 7.5 3.0 4.6 5.4 4.3 10.2 5.3 5.7 8.7 0.0 9.2 8.3 9.5 0.0 5.3 3.8 0.0 7.7 8.3 6.9 3.6 5.7 6.4 9.2 6.4 5.8 6.7 16.1 0.0 8.1 5.6 3.3 8.2 5.6 8.9 6.1 5.5 7.8 5.1 4.8 0.0 4.2 4.4 2.1 3.6 3.8 10.1 6.6 2.6 DCAF1 "KIAA0800, MGC102804, VPRBP" ENSG00000145041 "DDB1 and CUL4 associated factor 1" Q9Y4B6 3 51395867-51500002 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 8.8;Ciliated cells: 9.4;Club cells: 12.5;Syncytiotrophoblasts: 8.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036142, HPA052445, HPA053203" Approved Supported "Nucleoplasm,Nucleoli fibrillar center" No No Nucleoplasm "Nucleoli fibrillar center" "HPA036142: AB_10669666, HPA052445: AB_2681835, HPA053203: AB_2682080" "unprognostic (7.51e-2)" "unprognostic (3.19e-1)" "unprognostic (3.71e-3)" "unprognostic (1.26e-1)" "unprognostic (5.15e-2)" "unprognostic (9.75e-2)" "unprognostic (2.58e-2)" "unprognostic (1.24e-1)" "unprognostic (8.75e-2)" "unprognostic (2.15e-1)" "unprognostic (2.89e-2)" "unprognostic (2.21e-2)" "prognostic favorable (7.45e-5)" "unprognostic (5.49e-2)" "unprognostic (5.00e-1)" "unprognostic (6.81e-2)" "unprognostic (1.64e-1)" 13.3 12.5 11.5 16.3 12.3 12.9 12.2 17.9 12.5 9.6 10.3 11.0 12.5 7.6 13.1 10.1 11.3 9.2 8.4 8.8 9.6 6.8 11.0 11.1 10.9 13.0 11.1 9.1 11.9 11.1 24.8 12.9 15.4 10.3 10.1 10.9 8.6 12.5 11.8 28.1 14.1 11.8 10.4 9.1 11.9 10.7 50.7 10.9 18.5 14.2 7.6 16.7 12.5 16.5 7.3 6.4 3.3 6.0 7.3 10.7 6.2 10.8 13.4 13.0 11.8 11.8 9.4 12.4 12.2 9.2 13.2 13.0 14.6 10.6 26.5 6.8 9.6 20.3 9.6 24.5 10.9 17.2 18.4 12.1 22.7 18.3 12.5 8.6 29.5 16.5 6.2 12.7 17.1 12.5 8.7 10.2 14.7 13.2 17.3 10.3 11.1 22.5 12.0 13.7 13.0 14.7 9.6 14.0 17.5 10.3 17.0 6.8 12.1 13.5 12.5 7.4 10.0 8.5 12.6 12.8 10.9 14.6 17.9 18.7 11.8 15.9 27.3 12.7 20.3 8.9 3.2 4.0 3.3 9.4 4.5 10.7 7.1 8.1 8.0 6.4 7.3 8.9 7.3 1.0 7.3 6.0 5.2 8.7 6.2 11.5 12.3 17.9 12.5 9.6 6.8 11.1 9.1 10.3 10.9 3.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 9.4 12.5 3.5 0.0 6.6 1.7 5.9 0.0 0.0 0.0 0.0 5.8 4.8 0.0 0.0 5.8 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 4.6 0.0 0.0 6.5 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 DCAF11 "GL014, PRO2389, WDR23" ENSG00000100897 "DDB1 and CUL4 associated factor 11" Q8TEB1 14 24114195-24125242 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA003583, HPA031157" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA003583: AB_2667001, HPA031157: AB_10603002" "unprognostic (1.50e-1)" "unprognostic (4.72e-2)" "unprognostic (3.22e-1)" "unprognostic (8.45e-2)" "unprognostic (1.01e-1)" "unprognostic (9.58e-2)" "unprognostic (1.91e-3)" "unprognostic (1.48e-3)" "unprognostic (3.23e-2)" "unprognostic (4.08e-1)" "unprognostic (1.19e-1)" "unprognostic (2.01e-1)" "prognostic favorable (3.50e-13)" "unprognostic (2.58e-1)" "unprognostic (3.48e-1)" "unprognostic (6.80e-2)" "unprognostic (1.68e-1)" 7.6 20.8 14.4 12.1 15.4 21.7 10.3 14.2 23.0 8.1 14.0 11.5 18.7 23.7 8.8 14.1 13.5 10.5 13.6 13.9 14.1 10.9 15.3 56.2 9.8 13.1 12.3 15.5 11.8 42.5 21.1 12.6 8.6 10.4 11.6 11.3 12.3 18.3 19.4 26.8 8.9 25.2 9.5 9.7 14.2 14.4 13.4 9.4 13.1 17.1 13.2 10.5 10.6 7.3 12.8 18.0 20.9 16.5 23.9 17.2 14.8 6.2 10.5 5.1 4.8 5.9 4.7 9.3 5.1 7.8 9.5 8.9 6.6 10.5 11.0 4.9 6.6 6.3 9.1 8.7 7.4 6.4 11.2 5.2 10.5 11.2 33.5 8.0 13.0 14.6 5.2 8.6 4.9 9.6 6.3 6.9 14.5 6.9 11.2 5.5 19.7 12.9 11.3 3.1 17.1 9.5 12.1 9.5 13.0 6.9 16.0 10.9 7.3 4.4 15.2 7.7 5.8 8.9 11.1 3.9 7.1 5.9 5.7 6.1 17.2 16.2 13.4 5.4 10.5 7.9 15.1 15.3 20.9 15.8 16.5 13.7 12.8 14.2 14.4 18.0 12.5 14.7 13.7 13.2 23.9 13.1 9.3 17.2 14.8 14.4 15.4 14.2 23.0 14.1 10.9 12.3 15.5 10.4 9.4 26.8 50.8 26.1 16.7 7.8 34.9 33.5 33.1 20.1 22.7 36.6 45.2 27.4 39.7 34.6 15.9 12.7 79.6 93.5 40.4 26.6 14.9 21.0 11.6 112.5 32.6 15.9 27.7 18.4 19.3 20.4 8.3 16.1 16.9 40.5 34.2 28.5 29.3 33.2 13.8 39.6 26.0 25.8 13.3 12.6 10.2 9.9 42.2 37.0 39.4 17.0 DCAF13 "DKFZP564O0463, Gm83, HSPC064, Sof1, WDSOF1" ENSG00000164934 "DDB1 and CUL4 associated factor 13" Q9NV06 8 103414714-103443453 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Ubl conjugation pathway" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044504 Uncertain Supported "Nucleoplasm,Nucleoli,Cell Junctions,Centrosome,Cytosol" NA NA "Nucleoplasm, Nucleoli" "Cell Junctions, Centrosome, Cytosol" "HPA044504: AB_2678963" "prognostic unfavorable (4.06e-4)" "unprognostic (4.39e-2)" "unprognostic (1.70e-1)" "unprognostic (4.46e-3)" "unprognostic (3.57e-2)" "unprognostic (7.86e-3)" "prognostic unfavorable (8.05e-6)" "unprognostic (5.92e-3)" "unprognostic (1.97e-1)" "unprognostic (1.27e-2)" "unprognostic (5.54e-3)" "unprognostic (2.31e-2)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.53e-1)" "unprognostic (1.55e-1)" "unprognostic (6.42e-2)" "unprognostic (8.63e-2)" 18.4 20.5 13.8 18.1 15.7 10.6 20.2 11.3 14.3 16.0 16.7 13.0 12.9 13.1 18.1 16.7 24.0 15.3 10.7 15.9 12.4 11.8 35.2 26.5 12.4 18.4 16.5 12.1 20.9 28.9 15.7 34.6 21.2 16.2 16.4 18.5 7.4 15.9 11.3 21.1 13.7 16.8 15.3 13.9 20.4 14.7 25.3 15.0 26.4 17.1 22.6 24.3 16.9 15.5 28.6 26.4 10.3 22.1 24.0 27.2 20.2 25.3 22.8 21.3 21.7 15.5 18.0 16.0 18.9 14.5 18.0 18.5 22.4 24.8 35.3 32.4 19.8 17.8 19.1 28.8 24.2 34.9 33.6 20.5 48.7 13.7 25.4 17.7 19.9 21.0 14.6 16.7 26.5 44.1 11.3 24.9 24.3 32.7 15.5 27.3 20.6 37.8 21.0 32.6 71.8 35.6 24.6 25.9 36.3 26.2 21.2 27.2 25.8 11.8 18.5 21.4 19.6 28.6 13.7 16.4 18.3 29.5 23.6 25.3 17.1 29.8 49.9 24.7 43.6 23.4 8.6 18.6 10.3 18.4 22.1 25.2 28.6 19.8 19.7 26.4 22.1 19.8 20.2 2.0 24.0 16.0 13.7 27.2 20.2 13.8 15.7 11.3 14.3 12.4 11.8 16.5 12.1 16.2 15.0 14.9 14.2 31.8 57.7 70.6 19.2 17.3 7.6 14.7 31.8 31.4 23.6 50.1 33.2 41.0 33.6 28.9 16.1 0.0 42.0 61.5 36.1 25.3 40.3 14.7 39.5 15.9 13.9 17.2 15.4 10.8 22.5 25.0 25.3 30.7 16.0 25.8 34.4 10.5 16.6 66.3 19.8 12.9 36.3 85.0 87.9 67.2 28.4 26.3 25.4 52.2 DCAF17 "C2orf37, FLJ13096" ENSG00000115827 "DDB1 and CUL4 associated factor 17" Q5H9S7 2 171434217-171485052 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Deafness, Diabetes mellitus, Hypotrichosis, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053339, HPA055040" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA053339: AB_2682119, HPA055040: AB_2682680" "unprognostic (1.60e-2)" "unprognostic (1.21e-1)" "unprognostic (4.05e-1)" "unprognostic (1.03e-2)" "unprognostic (1.60e-1)" "unprognostic (5.98e-2)" "unprognostic (5.60e-2)" "unprognostic (2.67e-2)" "unprognostic (2.30e-3)" "unprognostic (2.08e-2)" "unprognostic (1.45e-1)" "unprognostic (1.69e-1)" "unprognostic (1.12e-2)" "unprognostic (1.41e-1)" "unprognostic (4.27e-1)" "prognostic unfavorable (7.10e-4)" "unprognostic (2.79e-2)" 7.9 9.8 12.3 9.7 19.0 5.7 12.2 14.5 12.1 11.2 10.4 14.5 8.7 8.4 16.2 12.5 9.2 9.2 9.0 7.1 13.6 9.4 11.2 8.3 7.3 12.6 19.2 8.0 14.1 13.1 13.8 10.9 10.0 10.9 10.2 9.2 9.4 9.0 10.2 7.4 13.5 9.5 14.6 17.2 11.5 8.1 10.5 17.3 15.4 19.6 5.0 11.0 10.7 11.1 3.9 2.0 2.3 2.9 2.0 7.1 3.0 6.8 5.7 7.4 8.8 9.5 10.2 11.5 6.1 6.2 6.1 5.8 6.7 4.5 19.9 4.5 7.4 4.7 6.8 7.5 7.4 8.5 9.1 5.0 9.1 4.6 12.1 9.6 12.9 6.6 7.9 9.8 7.8 17.4 7.3 6.6 6.3 14.2 6.9 8.4 4.2 14.1 12.0 11.1 5.0 3.6 10.8 9.8 10.8 5.2 6.2 6.6 9.6 5.6 4.9 6.0 7.3 3.8 6.8 7.9 7.1 6.4 4.0 5.2 10.5 14.2 16.8 7.5 6.7 7.3 2.3 2.6 1.0 5.0 2.9 7.1 2.8 4.0 3.5 2.0 3.9 4.4 5.4 0.1 2.0 2.5 1.5 3.5 3.0 12.3 19.0 14.5 12.1 13.6 9.4 19.2 8.0 10.9 17.3 0.0 9.8 4.7 4.5 4.1 9.8 4.0 10.2 5.3 1.2 7.0 11.8 5.6 8.3 4.3 1.7 3.9 4.0 0.0 3.3 4.9 3.8 5.3 3.5 6.0 4.9 7.9 9.8 1.3 8.5 2.7 5.8 4.9 3.3 0.0 4.9 9.1 5.2 2.5 5.6 5.5 14.0 0.0 3.6 15.1 14.7 4.4 4.7 6.5 3.8 4.1 DCAF4 "DKFZp434K114, WDR21, WDR21A" ENSG00000119599 "DDB1 and CUL4 associated factor 4" Q8WV16 14 72926332-72959703 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA047276 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA047276: AB_10959615" "unprognostic (6.01e-2)" "unprognostic (1.96e-1)" "unprognostic (9.31e-2)" "unprognostic (1.78e-2)" "unprognostic (1.78e-2)" "unprognostic (2.36e-1)" "prognostic unfavorable (6.77e-4)" "unprognostic (3.93e-2)" "unprognostic (2.11e-1)" "unprognostic (1.38e-2)" "unprognostic (2.86e-1)" "unprognostic (7.56e-2)" "prognostic favorable (4.90e-4)" "unprognostic (6.80e-2)" "unprognostic (1.87e-1)" "unprognostic (9.96e-3)" "unprognostic (2.11e-2)" 9.0 10.4 6.7 10.2 11.4 7.3 10.8 6.1 19.2 8.4 10.5 12.0 7.5 6.7 14.5 9.8 10.0 8.9 9.9 6.6 7.4 9.2 12.3 9.6 6.3 9.4 9.4 10.9 15.0 17.9 9.4 6.5 14.5 15.4 9.3 10.6 9.0 13.4 8.6 18.2 18.5 8.8 9.6 6.6 9.2 10.7 14.5 6.6 7.9 17.7 7.5 12.1 9.9 9.6 12.0 3.5 1.0 4.5 9.0 7.1 3.1 12.6 6.1 1.5 6.6 6.5 8.6 12.1 7.3 7.4 9.5 11.0 6.8 5.6 16.3 5.5 13.8 8.8 9.6 10.5 11.2 16.8 8.1 5.8 6.8 2.7 8.9 9.4 4.6 11.1 15.2 11.4 10.2 19.2 6.4 3.3 16.0 9.8 10.6 7.6 20.9 7.9 11.6 3.8 12.9 12.7 5.6 8.0 9.3 14.2 7.5 7.8 3.1 4.4 23.1 9.1 6.9 7.8 6.2 5.0 5.1 12.2 14.1 3.6 14.8 14.1 10.9 7.3 3.9 3.2 0.3 1.7 0.3 4.5 2.7 6.7 12.0 5.5 5.1 3.5 10.3 6.4 6.7 1.0 9.0 4.5 2.7 7.1 3.1 6.7 11.4 6.1 19.2 7.4 9.2 9.4 10.9 15.4 6.6 6.0 4.0 9.0 6.0 5.5 2.7 3.6 2.5 2.7 11.4 3.5 3.9 16.9 3.3 5.6 2.9 4.0 1.7 0.0 4.9 16.1 6.1 2.7 0.0 4.0 5.2 0.0 4.1 0.0 2.2 1.9 3.4 1.9 1.7 3.6 3.3 1.6 4.5 6.2 5.3 5.0 3.4 0.0 5.4 6.7 19.4 5.8 4.7 3.2 6.3 3.1 DCAF6 "IQWD1, PC326" ENSG00000143164 "DDB1 and CUL4 associated factor 6" Q58WW2 1 167935783-168075843 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 155.9" "Group enriched" "Detected in all" 4 "Cardiomyocytes: 200.2;Early spermatids: 375.8;Late spermatids: 573.8;monocytes: 176.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054305 Supported "Nucleoplasm,Focal adhesion sites" NA NA "Nucleoplasm, Focal adhesion sites" "HPA054305: AB_2682444" "unprognostic (1.54e-1)" "unprognostic (2.11e-1)" "unprognostic (1.42e-1)" "unprognostic (2.31e-1)" "unprognostic (2.20e-1)" "unprognostic (1.19e-1)" "unprognostic (5.42e-2)" "unprognostic (1.81e-1)" "unprognostic (1.51e-1)" "unprognostic (2.12e-1)" "unprognostic (1.74e-1)" "unprognostic (3.20e-2)" "unprognostic (9.21e-2)" "unprognostic (7.06e-2)" "unprognostic (6.00e-2)" "unprognostic (1.04e-1)" "unprognostic (1.49e-1)" 10.6 17.0 10.9 7.8 12.2 6.2 8.8 10.5 17.8 10.2 11.5 3.9 8.4 6.2 9.5 11.4 9.3 7.7 8.2 43.8 7.6 5.5 9.5 26.2 7.3 4.8 5.2 11.5 8.3 6.1 10.8 11.3 7.8 6.5 10.5 8.7 5.7 10.3 11.9 155.9 6.4 7.8 10.2 4.8 5.9 9.8 21.5 4.8 7.8 8.2 27.3 7.3 9.1 7.3 6.2 7.7 12.5 13.9 4.4 7.2 5.0 23.0 11.0 6.1 9.9 20.3 28.9 21.6 23.6 35.4 16.8 25.1 18.3 19.5 19.1 13.8 30.5 8.0 17.4 9.6 17.7 23.8 10.8 10.2 20.3 16.8 13.1 16.4 9.1 9.7 20.5 17.9 15.9 13.3 25.6 18.3 6.1 22.9 15.8 24.7 5.3 10.1 8.3 3.9 12.9 12.3 7.8 12.7 14.8 41.9 11.3 9.0 7.2 18.9 17.4 12.9 13.4 29.7 11.2 25.8 16.8 10.5 16.2 9.7 17.0 13.8 14.9 22.4 7.8 6.8 6.0 7.0 12.5 6.7 9.6 7.2 6.2 5.4 5.8 7.7 4.5 5.0 6.4 7.2 4.4 13.9 4.6 6.1 5.0 10.9 12.2 10.5 17.8 7.6 5.5 5.2 11.5 6.5 4.8 53.6 33.4 19.8 24.8 51.4 13.4 200.2 45.9 60.2 53.4 24.4 21.6 61.0 14.9 25.7 375.8 29.8 24.8 46.7 16.9 26.6 39.2 32.0 18.5 81.0 17.8 4.8 20.3 25.8 28.6 573.8 53.2 22.6 35.4 176.7 27.3 14.6 18.0 28.1 45.6 26.9 16.7 32.3 37.1 78.4 58.9 34.8 68.0 20.8 28.8 23.7 DCAF7 "HAN11, SWAN-1, WDR68" ENSG00000136485 "DDB1 and CUL4 associated factor 7" P61962 17 63550461-63594266 "Predicted intracellular proteins" "Ubl conjugation pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022948, HPA022962" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA022948: AB_1858820, HPA022962: AB_1858821" "unprognostic (7.75e-2)" "unprognostic (3.31e-1)" "unprognostic (1.37e-3)" "unprognostic (3.78e-2)" "unprognostic (1.03e-1)" "unprognostic (7.24e-2)" "prognostic unfavorable (2.42e-4)" "unprognostic (1.86e-1)" "unprognostic (2.28e-2)" "unprognostic (3.06e-2)" "unprognostic (9.79e-2)" "unprognostic (3.38e-2)" "prognostic favorable (3.49e-4)" "unprognostic (2.40e-2)" "unprognostic (1.97e-1)" "unprognostic (9.95e-2)" "unprognostic (4.18e-2)" 17.0 18.4 27.6 25.8 24.8 7.9 15.6 20.8 27.3 21.1 22.9 27.1 22.5 24.9 19.4 19.4 20.5 19.6 20.1 17.1 24.9 22.3 26.7 20.9 23.5 25.5 22.2 16.5 17.1 20.0 39.2 19.0 25.7 19.4 22.4 25.7 21.1 18.0 24.5 11.5 15.8 26.7 18.8 24.4 28.8 19.8 32.5 22.2 47.1 21.9 13.0 30.3 20.7 16.2 10.2 12.1 13.6 17.3 10.0 13.6 8.4 11.3 16.1 28.4 18.1 9.8 8.1 7.5 11.4 10.1 12.6 10.7 11.8 12.4 21.0 9.2 11.3 13.2 12.2 23.6 16.0 16.3 8.0 15.1 27.4 10.4 13.8 10.2 30.4 15.9 6.8 10.6 7.3 16.9 15.3 19.7 17.9 28.8 9.8 16.0 13.9 32.8 14.7 9.2 19.8 21.9 26.3 33.8 11.9 18.5 17.3 27.4 50.6 10.3 20.0 13.4 26.3 14.7 24.8 20.7 20.9 9.6 10.5 18.7 10.3 13.2 11.3 11.9 19.8 12.4 11.5 12.6 13.6 13.6 15.0 11.0 9.4 9.5 10.5 12.1 10.2 8.7 9.2 5.5 10.0 17.3 9.0 6.6 8.4 27.6 24.8 20.8 27.3 24.9 22.3 22.2 16.5 19.4 22.2 41.7 48.2 37.3 25.6 27.8 52.6 21.4 45.9 42.8 25.0 64.6 72.6 40.4 19.9 43.3 50.6 38.7 48.4 23.3 39.3 40.6 25.0 38.1 58.9 33.4 49.0 62.0 69.2 51.5 52.9 14.3 32.5 48.5 25.3 52.3 48.0 47.3 45.5 31.6 35.7 39.4 51.4 58.2 30.0 54.4 26.8 30.5 18.1 51.0 51.9 37.2 DCAF8 "FLJ35857, H326, WDR42A" ENSG00000132716 "DDB1 and CUL4 associated factor 8" Q5TAQ9 1 160215715-160262531 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA027218, HPA027381" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA027218: AB_10602586, HPA027381: AB_1858808" "unprognostic (3.47e-1)" "unprognostic (1.86e-1)" "unprognostic (4.39e-3)" "unprognostic (1.02e-2)" "unprognostic (2.25e-1)" "unprognostic (1.87e-2)" "unprognostic (3.29e-1)" "unprognostic (1.87e-2)" "unprognostic (3.13e-2)" "unprognostic (9.34e-3)" "prognostic favorable (4.71e-4)" "unprognostic (5.42e-2)" "prognostic unfavorable (3.74e-5)" "unprognostic (3.30e-1)" "unprognostic (7.42e-2)" "unprognostic (3.98e-1)" "unprognostic (1.56e-3)" 26.6 28.7 26.3 21.6 29.5 21.2 26.4 37.6 38.3 22.2 28.0 39.6 31.6 25.0 28.7 38.2 24.6 27.6 29.0 35.8 25.9 20.0 25.6 42.2 23.0 25.5 30.1 29.2 29.8 34.6 45.3 33.1 21.5 31.7 23.8 19.0 29.3 29.0 44.9 86.4 28.8 26.1 26.8 23.8 28.6 28.6 20.8 32.5 25.7 36.9 27.2 22.7 28.0 21.6 26.6 17.8 22.4 21.6 24.9 26.6 14.4 17.1 21.5 24.4 22.0 30.7 23.3 21.3 20.4 28.9 17.1 15.3 22.6 29.8 19.0 38.3 23.1 12.6 21.3 11.8 19.2 10.8 43.5 23.2 21.1 30.1 17.7 25.0 17.6 27.0 27.6 20.3 15.2 22.1 19.0 26.4 24.6 19.0 35.0 15.8 16.3 22.7 17.6 17.5 22.6 21.4 22.3 14.4 37.1 19.6 30.6 16.6 16.0 34.2 38.3 22.9 24.7 35.9 26.7 31.7 21.1 10.9 12.9 18.8 57.5 39.2 30.9 23.5 16.6 17.2 22.4 17.5 18.1 26.6 16.9 26.1 23.7 23.6 25.0 14.8 26.6 26.2 23.8 19.9 24.9 21.6 17.8 24.3 14.4 26.3 29.5 37.6 38.3 25.9 20.0 30.1 29.2 31.7 32.5 53.6 45.7 13.9 17.0 16.4 43.6 50.1 22.9 48.2 38.7 24.4 60.9 25.4 53.0 18.8 1.7 23.6 23.7 0.0 18.8 17.5 22.0 14.7 31.4 60.2 20.7 38.1 24.1 17.2 29.6 1.9 25.9 19.5 13.5 30.7 19.1 36.1 17.3 10.5 30.8 27.6 56.3 12.9 25.5 27.5 17.9 21.1 37.1 28.0 19.0 8.2 DCAKD FLJ22955 ENSG00000172992 "Dephospho-CoA kinase domain containing" Q8WVC6 17 45023340-45061109 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060997 Approved Nucleoplasm NA NA Nucleoplasm "HPA060997: AB_2797262" "unprognostic (1.32e-2)" "unprognostic (4.79e-3)" "unprognostic (9.71e-2)" "prognostic favorable (7.16e-6)" "unprognostic (1.13e-1)" "unprognostic (8.24e-3)" "unprognostic (7.57e-2)" "unprognostic (6.05e-3)" "unprognostic (4.10e-2)" "unprognostic (1.12e-1)" "unprognostic (2.97e-3)" "unprognostic (4.00e-2)" "unprognostic (6.55e-2)" "unprognostic (5.10e-2)" "unprognostic (1.91e-1)" "unprognostic (1.04e-1)" "unprognostic (1.82e-2)" 14.6 26.9 25.1 10.3 28.1 6.5 14.9 20.3 32.6 18.8 11.8 31.2 17.8 10.0 18.7 23.7 19.6 28.2 13.6 29.0 28.0 30.0 13.6 15.9 9.9 11.3 28.7 22.9 26.5 16.5 21.1 25.0 11.8 28.6 21.3 10.5 23.7 38.1 22.5 12.7 21.5 10.2 15.6 24.6 11.2 9.8 11.6 23.6 21.8 27.0 8.7 14.8 17.9 15.6 5.7 13.2 2.2 6.5 4.7 9.4 3.9 7.7 14.8 14.3 21.8 12.3 13.0 7.9 6.9 4.7 8.8 8.9 3.5 8.3 13.9 15.0 6.7 7.7 9.9 9.9 6.7 7.6 43.6 19.0 14.3 7.1 17.5 14.9 6.0 8.3 16.1 15.7 9.8 2.9 8.2 7.5 21.4 13.3 9.7 10.3 17.3 18.7 6.7 7.6 14.0 12.7 11.3 11.7 11.4 7.9 10.2 17.8 22.7 4.7 3.7 8.2 12.9 11.1 8.8 11.3 11.5 7.8 16.4 7.2 12.2 5.8 6.3 20.1 6.2 13.4 1.0 4.5 2.2 7.5 6.5 9.4 5.7 7.6 6.6 7.0 5.1 7.0 7.3 0.8 4.7 4.6 13.2 6.9 3.9 25.1 28.1 20.3 28.1 28.0 30.0 28.7 22.9 28.6 23.6 6.0 8.6 5.4 11.2 6.8 11.1 14.5 10.2 6.7 4.5 19.2 3.9 15.9 19.9 4.0 1.6 4.5 3.4 0.0 4.2 9.1 9.1 8.4 0.0 9.5 6.5 15.9 11.6 6.7 4.6 2.7 8.6 4.6 15.1 25.2 9.2 20.7 3.3 9.0 10.3 12.1 10.5 12.9 7.2 4.6 4.3 6.9 9.4 5.7 12.9 7.9 DCANP1 "C5orf20, DCNP1" ENSG00000251380 "Dendritic cell associated nuclear protein" Q8TF63 5 135444214-135447348 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 1.9;intestine: 2.0;lymphoid tissue: 3.0;skin 1: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.9;plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "THP-1: 6.7" HPA048308 Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA048308: AB_2680349" 0.2 0.0 0.1 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.1 0.0 0.2 0.2 0.5 3.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.4 0.2 0.1 0.1 2.2 2.0 0.0 0.2 2.7 0.1 0.0 0.2 1.6 0.1 0.2 0.0 1.0 0.1 1.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DCK ENSG00000156136 "Deoxycytidine kinase" P27707 4 70992538-71030914 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 80.9" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 186.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 60.9;U-698: 49.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059609, HPA062773" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA059609: AB_2684082, HPA062773: AB_2684865" "unprognostic (9.16e-2)" "unprognostic (2.44e-1)" "unprognostic (5.24e-3)" "unprognostic (4.77e-2)" "unprognostic (3.95e-1)" "unprognostic (6.45e-2)" "prognostic unfavorable (6.90e-7)" "unprognostic (3.04e-2)" "unprognostic (7.19e-2)" "unprognostic (8.28e-2)" "unprognostic (4.51e-1)" "unprognostic (1.33e-1)" "unprognostic (3.37e-2)" "unprognostic (4.47e-2)" "unprognostic (6.82e-2)" "unprognostic (1.33e-1)" "unprognostic (2.27e-2)" 8.0 8.3 11.9 30.9 16.8 17.2 6.9 11.4 14.8 5.6 8.6 10.4 2.6 7.6 7.5 4.4 8.8 5.5 6.1 5.5 12.3 13.1 5.8 4.8 9.7 42.8 11.7 10.3 6.0 5.0 3.6 4.2 7.9 11.1 5.9 10.4 6.4 6.3 4.0 6.8 7.9 12.4 7.5 17.6 17.5 8.2 5.6 8.6 80.9 8.3 3.8 39.9 9.5 6.5 27.9 34.2 17.5 12.7 18.5 24.9 25.1 6.7 4.5 9.9 5.9 3.1 5.5 5.7 17.5 6.5 13.9 11.6 2.9 14.8 60.9 7.6 7.2 8.1 3.9 8.8 5.5 18.8 12.9 5.4 12.6 5.2 4.6 3.2 25.1 16.3 2.7 6.7 8.4 5.1 6.8 7.9 17.3 5.0 23.2 15.8 3.9 31.0 9.9 4.7 11.5 5.5 26.4 20.1 4.8 6.9 4.7 8.8 9.4 6.6 12.9 7.7 4.7 5.8 13.2 6.3 15.7 11.8 13.1 9.4 8.8 5.8 49.4 10.9 15.7 11.6 13.1 10.7 17.5 16.2 12.7 20.3 27.9 21.8 20.0 14.3 26.4 23.4 23.5 5.4 18.5 12.1 34.2 24.9 25.1 11.9 16.8 11.4 14.8 12.3 13.1 11.7 10.3 11.1 8.6 0.0 11.3 75.5 8.0 38.1 13.6 4.6 7.6 1.4 3.4 12.2 5.9 9.8 24.9 17.7 0.4 14.3 9.0 186.9 5.6 16.0 12.9 9.5 23.0 5.3 33.7 17.5 20.2 21.5 48.3 1.1 7.8 41.6 43.9 68.5 17.2 14.3 8.9 7.0 9.6 6.1 8.2 6.5 20.6 34.4 28.8 37.9 3.8 61.7 14.3 6.2 DCLK1 "DCAMKL1, DCDC3A, DCLK, KIAA0369" ENSG00000133083 "Doublecortin like kinase 1" O15075 13 35768652-36131306 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 76.5" "Cell type enriched" "Detected in many" 4 "Muller glia cells: 84.2" "Cancer enhanced" "Detected in many" "glioma: 12.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 16.7;ASC TERT1: 15.8;fHDF/TERT166: 12.9;GAMG: 19.8;HAP1: 10.0;HSkMC: 14.6;NTERA-2: 20.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012405, HPA015040, HPA015655" Enhanced Approved Nucleoplasm,Cytosol NA NA 11000 Nucleoplasm Cytosol "CAB012405: , HPA015040: AB_2669141, HPA015655: AB_2669265" "unprognostic (2.29e-1)" "unprognostic (2.56e-1)" "unprognostic (7.45e-2)" "unprognostic (1.30e-2)" "unprognostic (1.99e-1)" "unprognostic (2.35e-2)" "unprognostic (1.48e-1)" "unprognostic (3.30e-2)" "unprognostic (1.66e-1)" "unprognostic (1.74e-1)" "unprognostic (7.72e-2)" "unprognostic (2.85e-1)" "prognostic unfavorable (4.42e-4)" "unprognostic (1.93e-3)" "unprognostic (1.29e-1)" "unprognostic (1.34e-1)" "unprognostic (1.14e-4)" 13.9 3.3 14.3 4.2 25.0 1.1 8.6 8.6 76.5 12.2 3.5 8.6 0.5 2.0 6.4 5.8 5.8 3.3 7.1 5.8 21.9 21.9 1.9 1.2 3.0 4.3 11.9 22.5 6.4 2.1 1.5 7.4 1.1 13.9 4.7 4.4 0.5 2.5 4.7 1.9 4.7 2.7 17.0 10.4 4.6 2.5 2.2 8.5 0.0 2.1 1.4 2.9 5.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.8 0.0 16.7 15.8 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 12.9 19.8 0.0 10.0 0.2 0.0 0.0 0.6 0.0 0.4 0.0 0.6 0.0 0.0 14.6 7.3 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 20.7 0.0 0.2 0.0 1.1 0.0 0.5 0.0 4.1 2.5 0.0 0.0 1.2 6.1 0.0 0.0 0.0 0.0 3.4 4.3 0.7 0.1 0.0 0.0 1.4 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 25.0 8.6 45.8 21.9 21.9 11.9 22.5 13.9 8.5 8.9 1.1 0.0 1.0 13.5 2.2 5.1 0.0 4.0 4.5 3.5 3.9 0.0 0.0 0.0 1.3 2.9 0.0 0.0 0.0 0.0 9.3 0.5 0.0 0.0 0.1 9.5 0.0 0.6 0.3 0.9 19.2 0.0 13.5 0.0 0.0 84.2 0.3 0.0 3.9 0.2 2.1 6.5 16.8 1.6 0.7 8.4 0.0 0.0 0.0 1.3 DCLRE1A "hSNM1, KIAA0086, PSO2, SNM1" ENSG00000198924 "DNA cross-link repair 1A" Q6PJP8 10 113834725-113854383 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036907 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA036907: AB_10673626" "unprognostic (1.22e-1)" "unprognostic (7.55e-2)" "unprognostic (4.84e-2)" "unprognostic (3.82e-2)" "unprognostic (1.09e-2)" "unprognostic (1.30e-2)" "prognostic unfavorable (5.74e-5)" "unprognostic (1.04e-1)" "unprognostic (1.15e-1)" "unprognostic (2.01e-2)" "unprognostic (2.12e-1)" "unprognostic (1.12e-1)" "unprognostic (3.40e-2)" "unprognostic (4.05e-2)" "unprognostic (2.85e-1)" "unprognostic (3.07e-1)" "unprognostic (6.34e-2)" 3.4 7.1 7.0 4.1 8.1 4.5 6.1 10.2 9.9 5.0 5.3 3.7 4.5 4.7 5.9 6.9 6.5 5.0 4.0 4.8 6.0 6.4 7.3 15.6 7.0 7.5 6.0 2.6 6.5 9.4 10.7 16.9 4.8 8.4 7.4 6.3 5.6 5.4 5.0 6.8 4.2 5.2 4.8 5.5 6.8 5.9 5.2 5.2 8.2 6.1 2.8 6.0 5.1 3.4 1.4 2.1 1.8 0.8 1.9 6.0 2.5 10.8 9.0 13.9 14.0 1.8 3.1 7.9 6.6 6.7 9.0 10.4 7.1 14.9 8.4 7.5 3.3 7.0 9.1 13.2 5.8 11.7 16.5 11.3 14.2 6.0 9.0 6.1 14.9 13.5 2.0 7.0 7.5 13.4 6.0 5.4 11.5 16.3 9.2 5.0 6.4 7.1 6.0 6.7 8.6 4.9 4.2 16.5 5.5 5.9 5.1 6.1 10.0 3.8 6.6 9.7 9.9 7.8 7.3 4.7 5.2 10.3 7.0 10.8 10.7 12.2 13.0 7.8 21.9 7.4 1.8 0.6 1.4 5.8 0.4 3.8 1.4 2.6 3.9 2.1 0.7 1.9 3.2 0.3 1.9 0.8 0.9 6.0 2.5 7.0 8.1 10.2 9.9 6.0 6.4 6.0 2.6 8.4 5.2 6.0 2.6 0.0 0.7 0.6 5.0 6.2 7.6 6.7 3.4 1.8 0.0 2.6 6.6 1.6 0.4 1.4 1.4 0.0 1.0 1.5 1.1 0.9 1.1 6.0 2.6 6.4 3.4 1.8 4.9 0.4 1.4 1.1 0.0 4.6 2.5 3.4 1.3 2.9 1.4 3.1 3.3 0.0 0.7 3.4 4.5 0.5 0.6 2.2 2.5 0.5 DCLRE1B "FLJ12810, FLJ13998, SNM1B" ENSG00000118655 "DNA cross-link repair 1B" Q9H816 1 113905141-113914086 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "monocytes: 15.4;Sertoli cells: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 34.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064934 Supported "Nucleoplasm,Nuclear bodies" NA Yes "Nucleoplasm, Nuclear bodies" "HPA064934: AB_2685387" "unprognostic (1.21e-1)" "unprognostic (3.38e-2)" "unprognostic (4.47e-3)" "unprognostic (4.92e-3)" "unprognostic (1.89e-1)" "unprognostic (1.02e-2)" "prognostic unfavorable (4.50e-5)" "unprognostic (1.31e-2)" "unprognostic (9.67e-3)" "unprognostic (2.73e-2)" "prognostic unfavorable (6.70e-4)" "unprognostic (1.15e-1)" "prognostic unfavorable (5.03e-7)" "unprognostic (1.24e-2)" "unprognostic (2.13e-1)" "unprognostic (1.25e-1)" "unprognostic (5.08e-2)" 8.7 4.9 6.7 8.3 6.8 13.1 7.3 15.4 7.8 6.7 6.8 8.3 0.4 4.3 6.9 4.3 8.4 7.0 5.8 5.4 7.0 5.6 5.3 4.2 8.0 15.1 6.7 4.5 7.7 3.8 3.4 3.1 8.7 6.5 4.4 7.8 6.1 4.6 5.0 3.4 7.0 5.5 8.7 8.5 12.8 4.7 7.2 6.4 20.9 5.1 8.2 9.6 5.9 5.9 2.3 4.2 2.4 7.0 8.7 4.4 3.5 8.3 3.1 5.9 6.6 4.4 3.1 3.7 6.6 4.8 9.1 10.0 3.7 2.7 7.9 4.5 5.1 4.7 4.3 8.1 7.2 11.9 6.8 5.7 6.5 4.9 3.2 1.1 7.4 6.6 3.9 2.5 13.1 7.2 2.5 4.8 9.9 9.8 6.7 9.8 34.0 11.4 5.6 4.6 4.2 7.3 9.2 17.8 3.8 3.1 3.0 5.2 4.6 6.4 5.4 4.3 5.3 3.5 7.5 2.8 11.1 11.8 18.0 9.3 3.2 3.3 8.9 9.3 7.7 18.3 2.4 7.0 1.9 3.4 6.4 4.3 1.4 4.4 3.1 4.2 2.3 2.6 3.6 0.3 8.7 3.7 1.5 2.4 3.5 6.7 6.8 15.4 7.8 7.0 5.6 6.7 4.5 6.5 6.4 3.0 1.3 2.7 1.0 3.2 2.8 0.8 2.5 4.0 0.0 0.0 2.0 3.5 1.7 4.0 0.8 2.3 0.2 0.0 2.4 8.0 1.5 1.2 1.1 1.0 8.9 1.6 2.9 3.1 5.9 0.0 1.7 11.7 0.0 15.4 1.8 0.8 2.7 0.0 2.1 1.4 1.3 25.8 3.8 3.4 12.0 2.4 1.1 2.9 3.4 1.1 DCLRE1C "A-SCID, ARTEMIS, FLJ11360, SCIDA, SNM1C" ENSG00000152457 "DNA cross-link repair 1C" Q96SD1 10 14897359-14954432 "Disease related genes, Predicted intracellular proteins" "Adaptive immunity, DNA damage, DNA recombination, DNA repair, Immunity" "Endonuclease, Exonuclease, Hydrolase, Nuclease" "Disease mutation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069295 Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA069295: AB_2686112" "unprognostic (8.42e-2)" "unprognostic (1.69e-2)" "unprognostic (2.66e-2)" "unprognostic (2.40e-2)" "unprognostic (1.36e-2)" "prognostic favorable (1.30e-4)" "unprognostic (8.02e-4)" "unprognostic (1.23e-1)" "unprognostic (1.24e-1)" "prognostic favorable (7.98e-4)" "unprognostic (1.91e-1)" "unprognostic (4.20e-2)" "prognostic unfavorable (9.03e-8)" "unprognostic (2.43e-2)" "unprognostic (2.32e-1)" "unprognostic (2.51e-1)" "unprognostic (5.45e-3)" 7.0 5.1 4.8 13.8 9.9 15.2 6.9 6.8 5.9 6.2 6.0 6.0 6.2 6.0 5.7 4.8 9.5 5.8 4.6 4.8 5.4 3.5 5.9 3.3 5.9 14.8 6.9 3.4 6.1 4.4 5.3 7.2 5.0 6.3 7.0 6.2 5.0 6.8 9.2 3.7 7.8 7.8 8.2 8.2 13.3 6.9 2.8 8.3 23.3 7.1 5.6 16.5 9.7 8.0 23.5 17.2 19.3 14.5 8.0 12.2 6.7 12.0 5.9 4.9 10.6 5.1 6.6 5.2 7.5 4.0 10.3 10.4 6.5 10.1 16.2 3.0 5.8 7.2 10.1 5.6 3.9 8.5 9.5 5.9 12.1 5.3 4.3 4.0 7.5 14.2 5.3 3.7 9.9 4.1 6.3 5.6 10.6 7.8 13.7 6.2 5.5 11.0 7.3 3.5 10.6 2.7 12.5 6.9 9.1 5.3 4.7 2.7 5.2 8.0 8.4 20.9 4.4 9.8 13.8 4.7 6.3 9.3 13.0 7.9 7.8 13.7 16.6 6.4 8.0 8.8 19.3 11.1 14.9 10.1 14.5 12.1 19.3 11.7 12.2 16.2 23.5 10.2 11.3 10.7 8.0 12.7 17.2 9.0 6.7 4.8 9.9 6.8 5.9 5.4 3.5 6.9 3.4 6.3 8.3 3.0 5.8 22.9 17.0 15.3 24.2 4.1 12.7 8.1 6.8 14.0 58.9 12.5 3.3 7.6 20.7 9.5 9.5 0.0 9.7 17.7 11.3 16.9 5.8 1.0 9.0 30.2 6.4 6.7 17.4 1.5 11.5 16.7 18.6 11.8 5.4 7.2 10.6 11.8 10.6 2.2 42.0 19.4 13.9 10.0 18.4 18.4 4.2 20.2 5.6 35.5 DCP2 NUDT20 ENSG00000172795 "Decapping mRNA 2" Q8IU60 5 112976702-113020970 "Enzymes, Predicted intracellular proteins" "Nonsense-mediated mRNA decay" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 52.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011677, HPA057676" Approved Approved "Nucleoplasm,Cell Junctions,Cytoplasmic bodies" NA NA "Nucleoplasm, Cytoplasmic bodies" "Cell Junctions" "CAB011677: AB_731858, HPA057676: AB_2683500" "unprognostic (2.76e-1)" "unprognostic (3.27e-1)" "unprognostic (2.79e-1)" "unprognostic (3.09e-1)" "unprognostic (1.28e-1)" "unprognostic (3.86e-3)" "prognostic unfavorable (4.84e-4)" "unprognostic (1.87e-1)" "unprognostic (3.64e-2)" "unprognostic (6.26e-2)" "unprognostic (1.15e-1)" "unprognostic (9.30e-2)" "prognostic unfavorable (2.66e-5)" "unprognostic (8.39e-2)" "unprognostic (2.84e-1)" "unprognostic (3.25e-2)" "unprognostic (5.75e-2)" 8.0 7.5 8.1 16.3 9.5 22.9 15.0 16.8 10.9 9.1 6.6 6.4 6.6 6.3 10.5 6.8 7.4 8.0 6.5 6.1 8.1 8.9 8.1 8.1 13.2 19.8 6.9 6.1 12.8 6.2 7.0 12.2 40.2 8.3 8.1 7.3 6.5 9.6 8.6 8.3 9.8 8.7 7.3 7.4 19.9 6.7 6.8 6.5 52.9 7.0 4.1 20.0 8.7 9.1 5.1 6.5 16.3 8.3 3.9 5.9 3.2 3.6 3.1 14.1 11.3 2.8 3.1 22.8 3.3 2.7 4.2 6.1 14.6 7.8 19.1 5.3 1.9 3.4 4.5 16.2 4.5 5.1 5.1 7.0 17.9 2.7 5.8 3.2 10.9 9.3 2.9 3.1 5.1 5.1 4.0 7.1 14.7 13.2 7.5 3.8 4.6 16.0 11.6 12.2 2.2 1.9 15.7 13.4 7.1 6.5 9.3 3.3 7.0 4.6 5.2 6.7 15.3 15.4 14.6 4.6 4.7 8.4 2.4 5.0 5.1 11.2 14.6 2.7 15.3 3.6 12.2 7.2 5.5 4.0 7.1 5.5 5.1 4.9 4.2 6.5 3.6 4.6 4.7 16.3 3.9 8.3 3.5 5.9 3.2 8.1 9.5 16.8 10.9 8.1 8.9 6.9 6.1 8.3 6.5 17.9 15.6 38.9 16.7 24.6 21.6 11.4 5.1 18.7 22.7 19.2 74.6 53.4 16.6 8.9 23.5 21.8 10.0 0.0 10.3 41.1 27.2 25.6 18.5 5.9 27.7 27.0 15.5 27.6 71.2 42.2 17.5 46.5 25.3 36.9 9.1 34.4 12.8 10.5 10.3 11.2 35.2 6.5 17.9 29.3 19.0 23.2 53.9 38.8 11.3 37.6 DCPS "HINT-5, HSL1, HSPC015" ENSG00000110063 "Decapping enzyme, scavenger" Q96C86 11 126303752-126345749 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, mRNA splicing" Hydrolase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 51.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039632, HPA058597" Supported Supported Nucleoplasm,Cytosol NA NA 1400000 Nucleoplasm Cytosol "HPA039632: AB_10794200, HPA058597: AB_2683770" "unprognostic (1.45e-1)" "unprognostic (5.48e-3)" "unprognostic (1.76e-1)" "unprognostic (3.55e-2)" "unprognostic (5.22e-2)" "unprognostic (1.26e-1)" "unprognostic (1.96e-1)" "unprognostic (2.90e-1)" "unprognostic (5.57e-2)" "unprognostic (1.91e-2)" "unprognostic (4.83e-2)" "unprognostic (5.00e-2)" "unprognostic (5.25e-2)" "unprognostic (2.24e-2)" "unprognostic (8.04e-2)" "unprognostic (7.67e-2)" "unprognostic (3.40e-2)" 11.1 13.1 6.8 14.4 8.2 13.5 9.2 8.5 14.5 12.1 10.6 6.8 8.0 7.8 12.4 9.6 14.4 9.9 13.9 10.9 5.5 6.1 13.3 39.6 9.9 18.5 6.3 5.8 11.8 17.2 7.0 9.5 14.1 6.8 12.7 11.7 13.3 17.4 9.4 21.8 11.3 9.7 11.3 7.1 21.9 9.6 13.4 6.5 22.0 12.7 18.5 22.1 15.1 9.8 13.2 39.5 3.2 14.3 7.8 14.6 7.1 9.5 6.0 7.5 12.4 5.8 7.8 6.3 5.1 7.5 7.8 7.9 11.3 19.7 13.0 19.2 8.1 5.1 11.2 10.6 16.0 5.2 24.7 5.7 19.1 6.8 9.8 12.6 20.5 17.3 7.9 10.1 9.9 13.5 3.9 10.4 10.9 7.7 22.4 8.5 13.8 13.0 23.5 5.2 51.3 20.6 9.1 11.0 24.8 7.5 10.7 9.7 7.4 15.4 12.6 9.3 4.7 21.4 12.8 6.6 12.2 5.7 5.8 9.5 9.0 8.3 13.5 3.5 35.5 30.7 1.7 9.2 3.2 8.8 14.3 8.2 13.2 8.5 9.0 15.4 9.0 6.0 6.8 0.5 7.8 12.6 39.5 14.6 7.1 6.8 8.2 8.5 14.5 5.5 6.1 6.3 5.8 6.8 6.5 11.9 12.8 34.4 16.6 6.2 6.5 4.5 53.5 16.0 5.7 40.1 0.0 37.0 48.0 17.0 5.4 8.7 5.2 0.0 25.4 38.8 12.7 9.2 16.2 22.8 26.1 3.2 7.0 7.4 13.7 1.7 15.8 10.4 16.9 14.4 9.7 7.8 16.6 14.0 17.3 10.8 7.1 19.4 11.3 11.2 28.0 7.9 22.7 27.7 13.4 19.7 DCTD ENSG00000129187 "DCMP deaminase" P32321 4 182890060-182917936 "Enzymes, Predicted intracellular proteins" "Nucleotide biosynthesis" "Allosteric enzyme, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035894 Approved Approved Nucleoplasm,Cytosol NA NA 13000 "Nucleoplasm, Cytosol" "HPA035894: AB_10673488" "unprognostic (1.26e-1)" "unprognostic (9.80e-3)" "unprognostic (3.15e-2)" "unprognostic (3.78e-3)" "unprognostic (3.13e-3)" "unprognostic (2.20e-2)" "unprognostic (2.01e-2)" "unprognostic (4.59e-3)" "unprognostic (2.62e-2)" "unprognostic (1.80e-1)" "unprognostic (1.40e-2)" "unprognostic (1.20e-1)" "prognostic favorable (1.81e-4)" "unprognostic (1.35e-1)" "unprognostic (1.59e-1)" "unprognostic (3.89e-2)" "unprognostic (1.12e-1)" 24.8 46.2 24.7 19.9 23.8 12.9 27.3 11.6 28.3 27.1 20.4 17.3 22.6 16.4 26.0 20.1 30.9 25.9 40.9 25.8 22.5 22.2 25.7 47.6 25.8 29.4 21.1 20.3 35.9 51.7 28.3 25.3 18.9 21.3 23.7 21.5 30.0 26.4 22.8 24.8 19.4 19.1 27.4 25.6 24.9 27.2 11.8 16.7 15.0 52.9 21.3 26.0 24.5 25.1 31.9 24.8 23.7 25.7 30.8 36.8 22.7 22.7 21.0 21.4 19.8 32.4 44.3 28.1 43.9 39.2 31.5 19.5 21.3 44.2 7.9 10.9 42.7 21.5 11.3 15.6 27.4 29.0 38.3 11.8 36.5 12.2 25.3 34.8 35.5 22.9 36.8 29.2 27.6 28.8 31.9 26.9 17.5 36.2 79.2 41.8 16.6 23.0 21.7 17.0 9.2 18.3 25.1 15.3 15.3 25.4 27.3 21.2 13.1 20.7 17.9 20.5 20.8 13.7 18.6 31.3 26.2 20.2 12.6 33.4 30.4 16.4 10.1 28.9 23.3 30.8 23.7 22.0 19.7 29.2 25.7 36.8 31.9 25.6 29.7 24.8 21.7 25.5 26.7 1.6 30.8 24.9 19.1 21.9 22.7 24.7 23.8 11.6 28.3 22.5 22.2 21.1 20.3 21.3 16.7 11.9 15.0 31.7 28.8 22.6 4.3 20.6 38.2 18.7 11.4 31.4 3.9 16.6 31.5 61.9 6.3 32.1 15.5 23.3 47.4 19.9 41.7 29.4 22.0 38.0 48.4 3.2 13.9 25.2 29.6 13.2 40.9 29.6 25.3 38.7 28.6 31.5 60.2 10.5 33.2 34.1 6.3 32.3 28.2 9.3 15.4 20.1 6.1 27.4 29.9 34.5 DCTN4 ENSG00000132912 "Dynactin subunit 4" Q9UJW0 5 150708440-150759109 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017532, HPA038026" Uncertain Approved Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "CAB017532: AB_1122152, HPA038026: AB_2675792" "unprognostic (1.38e-1)" "unprognostic (1.66e-1)" "unprognostic (1.69e-3)" "unprognostic (4.06e-1)" "unprognostic (2.53e-1)" "unprognostic (7.87e-3)" "unprognostic (7.82e-3)" "unprognostic (1.37e-2)" "unprognostic (2.08e-1)" "unprognostic (8.41e-2)" "unprognostic (1.38e-1)" "unprognostic (5.86e-2)" "unprognostic (9.68e-3)" "unprognostic (1.29e-1)" "unprognostic (2.18e-1)" "unprognostic (3.00e-3)" "unprognostic (1.83e-1)" 26.1 27.9 27.9 13.3 27.3 41.0 25.7 30.3 36.5 19.8 15.9 32.4 17.7 15.9 20.6 27.6 20.0 18.4 16.5 20.6 27.3 29.0 20.0 22.0 17.8 13.3 30.8 24.0 26.3 32.5 23.9 27.7 25.9 33.2 24.1 18.6 21.3 15.7 22.4 42.0 19.0 15.4 21.3 34.7 13.9 18.0 22.9 25.4 18.8 24.8 15.3 14.5 23.3 16.2 5.0 10.9 16.4 10.7 3.0 6.9 5.2 9.5 11.5 20.9 34.8 25.5 24.7 17.1 17.0 17.1 20.5 20.8 21.5 12.1 9.4 23.8 20.1 18.0 11.7 25.6 19.9 25.2 18.8 20.1 12.1 13.3 13.4 23.3 14.6 17.3 24.9 17.8 18.3 32.3 21.0 14.5 11.7 18.4 12.1 26.6 10.0 8.9 7.8 10.5 11.3 18.1 7.9 12.6 10.4 15.2 16.5 47.4 19.9 18.0 24.6 25.2 15.1 23.8 19.5 16.1 23.0 12.9 15.0 17.9 10.7 13.8 5.6 26.4 19.6 18.7 3.2 10.7 10.5 5.5 7.8 5.6 5.0 6.2 5.4 10.9 4.4 5.9 6.9 16.4 3.0 6.4 5.1 4.3 5.2 27.9 27.3 30.3 33.3 27.3 29.0 30.8 24.0 33.2 25.4 44.7 29.8 14.5 12.5 15.8 19.1 31.7 33.1 13.4 11.4 15.7 19.6 18.8 10.0 10.6 1.9 15.7 15.7 0.0 14.1 14.7 17.4 17.4 11.6 33.6 26.2 28.6 36.1 22.1 41.2 3.3 20.4 19.3 11.8 10.0 26.4 26.6 16.5 17.3 18.0 17.3 31.0 12.9 14.3 18.6 16.7 17.9 24.8 12.9 16.2 14.4 DCTN5 "MGC3248, p25" ENSG00000166847 "Dynactin subunit 5" Q9BTE1 16 23641392-23677455 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042003, HPA063710" Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA042003: AB_10796468, HPA063710: AB_2685101" "unprognostic (5.90e-3)" "unprognostic (3.38e-1)" "unprognostic (1.77e-1)" "unprognostic (2.61e-2)" "unprognostic (3.22e-2)" "unprognostic (1.28e-2)" "prognostic unfavorable (4.02e-4)" "unprognostic (1.18e-1)" "unprognostic (1.25e-1)" "unprognostic (6.36e-2)" "unprognostic (6.78e-2)" "unprognostic (9.28e-2)" "prognostic favorable (4.48e-4)" "unprognostic (1.17e-1)" "unprognostic (1.61e-1)" "unprognostic (1.59e-2)" "unprognostic (9.55e-2)" 16.9 16.4 26.6 17.5 38.8 36.9 15.9 19.0 47.1 15.3 19.3 26.9 13.3 20.9 19.2 13.1 30.4 14.6 14.7 17.3 19.4 17.2 22.0 15.4 17.4 20.7 19.1 23.8 14.7 18.6 23.2 17.6 21.1 29.0 18.4 26.1 17.4 19.7 15.5 21.0 23.8 22.2 22.3 19.7 21.5 19.4 20.1 19.9 16.2 19.6 10.5 31.6 20.9 18.7 14.5 17.0 19.0 19.3 20.2 17.9 16.0 12.0 24.0 23.5 19.5 16.8 12.5 16.5 21.4 13.3 13.8 16.7 26.8 16.7 16.9 17.4 22.3 14.5 12.6 38.7 20.6 17.2 19.3 15.3 20.9 28.8 37.8 11.4 25.4 16.2 10.4 14.9 17.0 18.2 15.4 21.8 21.3 39.8 13.1 22.1 33.3 19.5 7.3 27.7 17.5 10.6 23.9 20.3 18.4 11.2 25.5 19.7 20.5 18.7 15.3 12.7 21.6 21.3 21.6 29.4 18.7 8.5 14.6 14.9 17.9 26.8 27.2 17.8 12.7 20.2 11.2 16.1 19.0 16.2 13.5 17.9 14.5 15.0 17.5 17.0 11.2 12.8 15.1 7.0 20.2 19.3 11.8 17.3 16.0 26.6 38.8 19.0 47.1 19.4 17.2 19.1 23.8 29.0 19.9 14.9 25.8 16.2 11.1 13.1 49.6 23.4 15.3 13.4 15.9 19.2 86.4 26.9 10.0 21.9 17.5 19.4 27.4 23.3 22.1 30.2 15.6 13.0 26.6 12.1 24.5 49.3 21.2 18.4 18.6 20.3 12.0 15.7 6.8 34.3 20.1 24.4 33.6 14.0 17.0 18.9 42.0 12.9 10.5 64.6 15.5 12.4 40.3 18.1 20.8 15.3 DCTPP1 "CDA03, MGC5627, RS21C6, XTP3TPA" ENSG00000179958 "DCTP pyrophosphatase 1" Q9H773 16 30423619-30430075 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002832 Uncertain Approved Nucleoplasm,Cytosol NA Yes 270000 "Nucleoplasm, Cytosol" "HPA002832: AB_1080615" "prognostic unfavorable (1.64e-5)" "unprognostic (1.61e-1)" "unprognostic (1.99e-3)" "unprognostic (1.17e-2)" "unprognostic (1.36e-1)" "unprognostic (4.09e-2)" "prognostic unfavorable (6.28e-4)" "unprognostic (2.23e-1)" "unprognostic (1.07e-1)" "unprognostic (4.35e-2)" "unprognostic (2.43e-2)" "unprognostic (3.65e-2)" "prognostic favorable (9.71e-9)" "unprognostic (1.10e-3)" "unprognostic (8.78e-3)" "unprognostic (1.10e-2)" "unprognostic (2.53e-1)" 15.3 15.8 14.8 25.0 13.2 12.5 20.7 15.5 19.2 12.1 37.4 10.3 11.3 20.7 14.1 14.4 19.7 18.9 28.1 23.3 12.1 12.6 27.0 25.3 11.2 27.6 13.3 16.6 16.6 25.2 16.4 7.7 16.3 11.4 15.4 40.3 10.6 20.5 21.1 28.3 16.1 22.9 13.9 11.3 22.5 16.4 9.9 7.8 21.3 22.6 26.0 25.0 13.2 13.0 47.3 30.9 19.0 24.5 23.1 26.2 25.3 26.6 32.7 14.9 19.2 4.2 5.7 13.8 12.8 7.7 19.4 19.8 24.6 22.8 36.1 27.0 8.0 12.4 21.0 30.9 25.1 24.3 19.0 48.8 21.0 15.0 32.0 5.5 37.5 32.8 6.6 14.3 21.6 12.5 5.9 19.9 19.4 26.4 12.7 13.7 46.5 44.5 42.1 19.7 27.0 26.4 63.2 16.6 47.0 22.4 17.3 31.8 18.0 8.5 30.5 12.0 10.2 26.3 16.1 10.0 15.0 13.4 19.3 23.0 8.4 25.0 46.0 9.9 31.2 17.5 19.0 12.4 11.7 18.8 22.1 26.2 47.3 24.2 21.3 28.7 40.2 21.8 21.0 1.5 23.1 24.5 30.9 24.1 25.3 14.8 13.2 15.5 19.2 12.1 12.6 13.3 16.6 11.4 7.8 17.9 14.6 32.0 37.1 80.1 23.9 33.1 61.1 20.1 19.4 41.8 7.9 81.7 107.8 107.5 10.2 47.2 79.9 0.0 108.6 68.9 31.5 41.3 31.1 18.1 68.6 14.3 37.0 25.2 16.6 36.0 18.1 35.6 45.5 108.2 103.3 19.7 78.9 105.2 18.7 54.0 16.3 19.4 35.0 2.8 33.6 70.1 23.2 25.9 124.8 43.2 DCUN1D1 "DCUN1L1, RP42, SCCRO, SCRO, Tes3" ENSG00000043093 "Defective in cullin neddylation 1 domain containing 1" Q96GG9 3 182938074-182985953 "Predicted intracellular proteins" "Ubl conjugation pathway" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 95.0" "Cell type enriched" "Detected in all" 4 "Late spermatids: 9862.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035911 Uncertain Approved Nucleoplasm,Cytosol NA NA 70000 Nucleoplasm Cytosol "HPA035911: AB_10673489" "unprognostic (2.13e-1)" "unprognostic (2.36e-1)" "unprognostic (4.83e-3)" "unprognostic (1.94e-3)" "unprognostic (1.44e-3)" "unprognostic (6.06e-2)" "unprognostic (5.93e-2)" "unprognostic (1.72e-2)" "unprognostic (9.34e-2)" "unprognostic (9.25e-3)" "unprognostic (4.98e-3)" "unprognostic (7.26e-2)" "unprognostic (1.01e-3)" "unprognostic (1.52e-1)" "unprognostic (2.12e-1)" "unprognostic (5.01e-2)" "unprognostic (3.52e-1)" 5.0 5.2 7.9 5.0 7.1 6.9 4.8 9.3 8.3 4.5 4.9 4.1 2.7 4.9 5.4 4.9 6.7 4.3 4.6 5.5 7.4 5.0 7.2 11.2 4.3 5.0 9.3 6.8 4.7 3.6 4.6 14.6 4.5 8.0 6.1 4.8 2.8 4.9 5.4 14.7 5.2 6.5 8.1 9.2 5.2 4.2 95.0 7.6 7.2 6.7 5.2 6.0 8.4 4.9 7.4 10.7 17.3 9.8 11.2 8.0 5.7 23.3 10.4 13.9 6.0 14.7 14.5 11.8 15.0 16.9 16.9 16.6 15.3 17.4 27.4 33.0 14.0 25.5 13.1 11.6 12.0 22.5 22.4 6.3 26.4 8.1 6.4 9.3 15.5 19.9 10.3 14.7 9.4 8.9 12.5 11.6 16.8 8.8 14.4 12.3 12.5 15.2 8.3 11.3 17.6 9.5 12.0 14.7 18.1 12.2 16.5 10.1 10.1 26.3 18.9 14.1 15.3 38.7 12.6 11.2 10.5 10.1 14.3 17.6 11.9 22.0 27.8 13.2 14.7 15.1 9.4 9.1 17.3 7.8 9.8 7.5 7.4 6.4 7.7 10.7 4.7 7.5 7.9 15.0 11.2 6.3 8.2 8.0 5.7 7.9 7.1 9.3 8.3 7.4 5.0 9.3 6.8 8.0 7.6 20.8 25.6 17.1 21.7 38.5 14.2 28.2 17.8 20.1 27.3 45.4 9.8 16.2 31.5 26.1 2225.5 18.8 26.6 46.7 26.5 15.7 27.7 32.3 28.9 42.3 24.9 17.5 25.8 17.8 32.1 9862.3 80.3 36.4 11.8 45.1 19.9 16.6 27.2 23.4 60.5 33.6 20.5 77.6 25.5 86.4 52.0 37.1 16.7 25.3 19.6 34.8 DCUN1D3 "DKFZp686O0290, FLJ41725, MGC48972, SCCRO3" ENSG00000188215 "Defective in cullin neddylation 1 domain containing 3" Q8IWE4 16 20854925-20900384 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 38.4" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 50.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 30.6;ASC TERT1: 23.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041983, HPA043511" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041983: , HPA043511: AB_2678521" "unprognostic (9.34e-2)" "unprognostic (4.56e-2)" "unprognostic (3.47e-2)" "unprognostic (1.33e-2)" "unprognostic (4.24e-2)" "unprognostic (8.71e-2)" "unprognostic (5.90e-2)" "unprognostic (1.73e-1)" "unprognostic (1.81e-1)" "unprognostic (7.57e-2)" "unprognostic (1.67e-1)" "unprognostic (2.31e-2)" "prognostic unfavorable (5.41e-6)" "unprognostic (1.48e-1)" "unprognostic (1.17e-1)" "unprognostic (5.31e-2)" "unprognostic (2.42e-1)" 19.2 9.9 4.3 6.0 4.6 2.7 17.2 7.9 5.6 7.5 6.0 5.5 3.2 3.4 7.7 5.9 8.5 6.6 9.6 8.9 2.5 2.8 10.0 17.4 9.7 3.1 5.2 3.0 5.3 6.6 6.4 9.5 9.4 6.7 6.6 4.1 6.3 3.9 4.5 38.4 7.1 4.9 11.9 3.9 4.5 6.4 7.9 3.8 1.5 4.8 11.5 4.5 6.7 15.8 1.4 1.6 4.8 2.5 2.6 2.7 1.0 2.7 4.8 2.4 5.2 30.6 23.1 3.3 9.1 7.9 4.6 6.3 6.0 5.2 1.7 7.4 8.9 2.8 3.7 2.8 3.8 6.2 2.3 1.9 1.4 3.8 8.7 8.0 2.2 13.9 15.2 5.2 8.7 4.9 4.9 12.6 1.7 1.6 4.7 9.3 3.7 2.0 3.2 5.7 2.3 1.6 3.4 2.7 1.7 4.0 2.8 2.2 3.0 3.5 3.9 2.1 3.0 2.6 1.0 6.2 9.8 3.4 4.1 2.4 4.0 2.3 1.2 10.4 2.3 5.0 4.8 1.4 1.2 1.7 2.5 1.7 1.0 1.2 2.7 1.6 1.4 1.5 2.7 1.9 2.6 2.2 1.2 1.0 1.0 4.3 4.6 7.9 5.6 2.5 2.8 5.2 3.0 6.7 3.8 11.9 17.1 0.0 12.6 27.8 12.1 4.0 5.1 0.0 6.8 8.7 33.4 3.0 0.0 3.5 50.8 14.3 4.3 0.0 4.4 1.7 12.7 8.1 0.0 12.9 2.1 12.7 19.4 10.4 7.1 34.5 10.0 8.0 11.8 0.0 4.7 5.2 3.9 0.0 9.2 4.0 23.2 6.5 12.2 4.6 3.5 19.7 4.2 4.3 3.8 16.9 DCUN1D4 KIAA0276 ENSG00000109184 "Defective in cullin neddylation 1 domain containing 4" Q92564 4 51843000-51916837 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 89.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036483, HPA036484" Uncertain Supported Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA036483: AB_10670719, HPA036484: AB_10671843" "unprognostic (3.16e-2)" "unprognostic (2.65e-1)" "unprognostic (2.77e-3)" "unprognostic (1.41e-1)" "unprognostic (5.61e-2)" "unprognostic (1.61e-1)" "unprognostic (2.80e-2)" "unprognostic (1.37e-1)" "unprognostic (8.47e-3)" "unprognostic (1.61e-3)" "unprognostic (3.88e-3)" "unprognostic (1.83e-2)" "unprognostic (2.93e-3)" "unprognostic (2.14e-1)" "unprognostic (5.25e-2)" "unprognostic (1.10e-3)" "unprognostic (1.40e-1)" 16.9 22.9 15.9 9.9 26.1 3.5 13.5 15.4 24.8 15.9 14.3 12.8 15.5 7.6 17.8 17.3 13.4 13.6 14.2 14.9 29.8 22.3 19.4 36.5 10.4 10.7 17.7 22.0 20.8 9.8 9.9 19.8 9.3 24.6 16.6 12.0 9.4 15.9 22.9 14.3 10.2 9.8 31.4 24.0 11.4 14.6 20.4 13.4 3.9 16.8 8.6 8.2 20.3 13.7 4.6 2.9 10.2 4.2 4.4 10.7 5.3 5.7 10.3 13.9 20.1 14.3 14.3 5.3 17.9 13.3 10.2 9.2 6.6 6.2 4.3 11.6 20.1 13.5 5.8 17.7 11.2 14.1 2.7 5.2 7.6 8.0 15.9 30.2 10.5 10.3 14.8 13.2 11.7 10.2 13.6 10.2 4.1 8.4 3.2 17.6 8.4 12.9 7.4 8.2 11.6 8.5 6.2 7.2 2.4 13.3 6.8 8.2 8.9 7.7 9.6 14.8 8.2 9.8 6.7 16.6 13.6 11.1 10.9 14.2 5.8 8.3 4.0 9.5 10.1 7.7 5.5 4.2 10.2 7.2 3.7 10.7 4.6 8.1 8.0 2.9 3.3 7.8 8.5 1.7 4.4 2.6 1.9 3.7 5.3 15.9 26.1 15.4 24.8 29.8 22.3 17.7 22.0 24.6 13.4 6.0 13.1 10.4 16.2 33.1 22.1 33.1 20.4 16.0 12.5 15.7 15.7 4.6 11.6 9.4 58.2 21.5 8.7 0.0 10.5 7.4 21.0 13.4 12.7 32.7 7.2 28.6 6.4 18.4 6.3 89.6 13.8 10.8 30.4 3.6 6.9 14.1 10.8 10.5 24.4 19.5 15.9 0.0 18.6 22.8 27.9 29.1 2.9 10.1 8.1 13.7 DCUN1D5 "FLJ32431, MGC2714" ENSG00000137692 "Defective in cullin neddylation 1 domain containing 5" Q9BTE7 11 103062076-103092215 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050863 Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA050863: AB_2681259" "unprognostic (4.47e-2)" "unprognostic (1.96e-1)" "unprognostic (1.29e-1)" "unprognostic (1.47e-2)" "unprognostic (2.99e-1)" "prognostic unfavorable (4.62e-4)" "prognostic unfavorable (2.01e-7)" "unprognostic (1.92e-3)" "unprognostic (1.21e-2)" "prognostic favorable (9.52e-5)" "unprognostic (2.08e-2)" "prognostic unfavorable (4.12e-4)" "unprognostic (2.64e-3)" "unprognostic (1.40e-1)" "unprognostic (1.92e-1)" "unprognostic (6.05e-2)" "unprognostic (1.43e-3)" 20.9 18.3 18.9 17.2 24.5 13.4 19.1 22.5 28.8 12.9 13.5 15.9 11.5 11.4 15.9 13.7 26.5 12.9 10.6 24.2 20.3 16.6 14.4 19.0 13.9 21.5 15.6 21.0 12.2 17.7 14.5 17.0 17.3 23.6 15.4 13.9 9.9 15.6 13.5 38.7 14.0 11.3 18.4 17.5 15.7 16.0 24.0 21.0 19.4 13.2 24.2 21.3 14.4 14.7 14.4 17.3 11.8 13.1 20.5 17.0 13.4 22.3 12.4 13.7 21.0 11.2 14.2 15.2 22.2 12.1 18.3 18.9 47.5 26.2 10.8 39.3 15.8 19.0 21.3 28.8 28.1 18.9 19.0 19.4 28.9 10.7 18.4 19.0 41.4 15.0 12.4 25.0 24.5 25.4 9.6 22.7 26.4 47.2 0.0 17.3 20.2 27.3 32.4 26.7 19.5 31.7 11.6 21.9 27.4 13.9 23.0 18.6 19.7 20.7 21.2 18.4 14.7 24.8 17.4 18.4 14.9 18.1 26.4 19.8 9.1 14.4 36.0 10.6 40.7 15.4 11.8 11.1 10.2 13.8 13.1 16.3 14.4 16.3 14.2 13.7 14.1 14.0 16.3 4.0 20.5 10.0 17.3 17.0 13.4 18.9 24.5 22.5 28.8 20.3 16.6 15.6 21.0 23.6 21.0 14.9 8.3 25.2 44.6 70.6 11.0 26.6 15.3 14.7 14.8 8.7 7.9 51.2 41.4 60.4 3.0 19.7 6.9 23.3 48.3 76.2 37.5 35.6 15.1 21.3 40.1 6.4 13.8 20.9 29.7 5.9 13.3 22.6 28.7 25.2 16.1 14.8 51.7 14.0 18.4 31.1 12.3 25.8 31.1 118.2 114.7 73.1 36.6 24.5 23.4 57.0 DDA1 "C19orf58, MGC2594, PCIA1" ENSG00000130311 "DET1 and DDB1 associated 1" Q9BW61 19 17309518-17323301 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 364.2;Syncytiotrophoblasts: 212.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042134, HPA055272" Approved Approved Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA042134: AB_10794169, HPA055272: AB_2682767" "unprognostic (1.30e-1)" "unprognostic (6.35e-3)" "unprognostic (3.13e-2)" "unprognostic (1.49e-3)" "unprognostic (5.38e-2)" "unprognostic (1.26e-2)" "unprognostic (3.41e-2)" "unprognostic (4.28e-2)" "unprognostic (1.92e-1)" "unprognostic (2.55e-2)" "unprognostic (1.47e-1)" "unprognostic (8.55e-2)" "unprognostic (1.48e-1)" "unprognostic (4.38e-2)" "unprognostic (6.33e-2)" "unprognostic (1.45e-1)" "unprognostic (3.15e-3)" 11.6 15.5 24.5 12.7 26.6 16.1 9.9 14.6 36.2 10.8 14.6 13.5 9.6 15.4 11.6 9.9 13.4 13.5 11.8 16.4 18.9 19.8 12.9 17.9 14.6 14.7 19.0 24.4 12.9 13.4 10.9 10.9 26.4 23.0 12.9 13.1 10.8 13.6 15.9 17.8 20.8 16.9 11.5 13.2 13.4 17.4 29.6 12.0 15.9 10.5 10.9 13.7 12.4 9.9 7.1 12.7 11.5 8.0 6.5 8.8 5.7 12.5 11.2 8.5 6.7 8.9 6.4 13.2 8.5 10.9 13.1 12.1 9.9 11.1 5.0 11.9 8.7 6.3 10.7 6.2 12.4 6.4 8.2 16.5 6.1 8.8 9.3 10.8 6.8 11.9 9.7 14.3 7.8 7.3 8.0 7.6 11.6 7.2 8.7 6.8 6.3 13.7 10.2 9.7 12.6 19.2 8.7 6.7 8.3 10.3 9.4 8.7 13.0 6.2 14.4 7.4 5.3 7.3 9.1 11.4 8.8 7.4 22.6 11.8 10.7 14.5 6.9 19.3 11.8 8.6 5.0 7.3 11.5 8.6 8.0 7.4 7.1 7.2 8.5 5.9 6.6 8.3 8.0 8.2 6.5 6.9 12.7 8.8 5.7 24.5 26.6 14.6 36.2 18.9 19.8 19.0 24.4 23.0 12.0 26.8 13.1 28.4 28.3 48.4 17.7 14.5 2.5 16.0 18.2 26.2 11.8 121.6 33.2 69.0 364.2 20.2 49.3 0.0 40.5 112.0 27.8 33.7 38.1 21.7 56.2 12.7 19.4 14.7 21.1 84.5 20.8 27.9 28.7 77.5 38.9 25.1 96.6 38.6 25.5 44.5 14.3 19.4 29.8 67.3 35.1 54.1 212.0 34.6 23.5 76.5 DDB1 ENSG00000167986 "Damage specific DNA binding protein 1" Q16531 11 61299451-61342596 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 331.8;Rod photoreceptor cells: 442.7;Syncytiotrophoblasts: 325.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032821, HPA045174, HPA068456" Approved Enhanced Nucleoplasm NA NA 170000 Nucleoplasm "CAB032821: AB_639050, HPA045174: AB_2679242, HPA068456: AB_2685992" "unprognostic (3.45e-1)" "unprognostic (8.38e-2)" "prognostic favorable (7.09e-4)" "unprognostic (1.21e-1)" "unprognostic (6.56e-2)" "unprognostic (1.19e-2)" "unprognostic (1.11e-2)" "unprognostic (9.33e-2)" "unprognostic (9.74e-3)" "unprognostic (1.09e-1)" "unprognostic (7.42e-3)" "unprognostic (3.11e-1)" "prognostic favorable (1.51e-8)" "unprognostic (3.44e-1)" "unprognostic (1.58e-1)" "unprognostic (7.30e-2)" "unprognostic (1.25e-3)" 19.3 83.3 19.9 14.1 24.9 16.1 19.7 22.9 33.8 21.3 16.2 24.9 33.3 18.4 23.9 30.6 19.8 26.2 17.4 21.1 18.1 20.8 21.7 26.8 16.0 21.7 18.3 23.4 31.1 23.5 107.3 22.0 80.3 27.3 19.4 17.8 33.0 23.9 27.2 57.1 24.1 19.7 20.7 16.7 17.5 19.7 36.1 14.4 33.3 22.1 20.4 21.0 22.6 17.9 19.6 30.5 17.8 23.5 22.0 32.5 23.8 39.3 42.5 41.2 36.1 39.3 37.1 62.0 37.0 47.9 45.0 34.1 45.9 33.3 59.6 33.0 50.6 26.9 36.8 60.5 44.1 48.6 30.1 32.8 34.2 40.7 47.4 27.6 48.8 29.7 43.7 30.3 44.4 38.4 31.4 48.3 25.5 68.7 32.6 39.5 47.8 60.2 23.0 54.7 24.8 36.7 49.7 52.3 62.3 31.4 43.7 36.8 37.5 40.0 46.8 36.8 38.4 58.0 20.7 39.8 32.0 30.2 36.5 26.2 37.6 39.7 52.9 35.3 26.1 30.9 17.8 20.9 17.7 24.8 23.5 32.5 19.6 22.4 24.8 30.5 17.9 20.7 23.1 2.5 22.0 21.0 16.8 24.4 23.8 19.9 24.9 22.9 33.8 18.1 20.8 18.3 23.4 27.3 14.4 26.8 65.3 45.5 43.2 46.8 67.6 79.5 38.2 42.8 48.9 50.6 331.8 218.9 14.9 38.9 12.5 47.4 47.5 0.0 36.5 109.7 39.2 49.2 29.0 61.1 65.3 82.6 71.2 47.3 39.9 13.6 78.9 30.6 40.5 42.3 50.3 62.6 44.2 28.1 58.4 41.7 442.7 32.3 39.2 87.4 115.3 52.2 325.6 38.3 51.6 46.7 DDB2 "DDBB, FLJ34321, UV-DDB2, XPE" ENSG00000134574 "Damage specific DNA binding protein 2" Q92466 11 47214465-47239240 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" DNA-binding "Cancer-related genes, Disease mutation, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "monocytes: 221.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025912, HPA058406" Enhanced Supported "Nucleoplasm,Cell Junctions" NA NA "Nucleoplasm, Cell Junctions" "CAB025912: , HPA058406: AB_2683708" "prognostic favorable (7.29e-4)" "prognostic favorable (1.58e-4)" "unprognostic (1.49e-1)" "prognostic favorable (1.20e-4)" "unprognostic (4.29e-2)" "unprognostic (2.04e-2)" "unprognostic (2.96e-2)" "unprognostic (6.18e-2)" "unprognostic (2.25e-1)" "unprognostic (3.58e-3)" "unprognostic (3.53e-1)" "unprognostic (1.94e-1)" "unprognostic (4.57e-3)" "unprognostic (1.21e-2)" "unprognostic (4.25e-2)" "unprognostic (9.82e-3)" "unprognostic (1.07e-1)" 12.2 22.2 5.3 13.3 8.6 8.1 11.3 11.0 8.2 16.8 13.5 7.3 13.4 6.0 18.2 14.1 25.4 14.3 13.0 6.1 4.7 2.9 6.6 20.8 11.3 16.1 15.0 5.0 9.8 15.6 6.1 8.6 5.5 6.3 20.9 12.3 8.1 17.6 14.8 6.3 36.9 11.0 19.0 17.6 15.1 9.1 7.6 7.6 23.3 6.6 16.7 26.0 17.3 15.2 11.4 6.1 11.5 11.0 7.4 27.0 9.0 8.4 22.7 9.5 7.1 6.1 12.4 11.2 9.2 21.7 11.9 14.0 3.7 4.9 20.3 1.9 8.4 8.9 14.8 5.4 18.8 5.9 5.0 10.2 4.7 21.7 16.8 6.0 5.5 12.7 16.6 21.4 5.9 13.2 3.8 34.6 5.3 1.2 9.9 19.4 15.9 21.1 2.6 3.0 11.1 8.2 10.6 2.4 10.9 5.0 8.3 5.0 6.2 11.3 3.3 3.0 11.9 20.8 1.8 14.9 36.4 16.6 7.9 4.3 10.4 7.9 4.5 13.7 7.0 13.0 5.9 8.1 11.5 12.1 11.0 11.7 11.4 12.7 11.7 6.1 7.4 9.4 10.1 2.2 7.4 9.2 0.1 27.0 9.0 5.3 8.6 11.0 8.2 4.7 2.9 15.0 5.0 6.3 7.6 14.9 20.3 19.2 35.4 34.6 4.6 7.2 12.7 10.7 13.6 5.2 9.8 2.1 8.3 9.6 1.1 17.8 7.9 0.0 12.0 7.7 14.1 9.5 22.0 12.4 15.9 1.6 7.5 14.1 16.5 1.6 17.5 16.5 18.6 221.8 13.6 14.2 15.3 7.0 9.9 6.2 11.6 0.0 15.5 0.7 9.9 26.5 1.3 38.8 14.0 21.3 DDI2 MGC14844 ENSG00000197312 "DNA damage inducible 1 homolog 2" Q5TDH0 1 15617500-15669044 "Plasma proteins, Predicted intracellular proteins" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 54.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA043119, HPA043225" Approved Enhanced Nucleoplasm,Cytosol NA NA 170000 "Nucleoplasm, Cytosol" "HPA043119: AB_2678326, HPA043225: AB_2678369" "unprognostic (1.93e-1)" "unprognostic (8.03e-2)" "unprognostic (1.26e-1)" "unprognostic (3.38e-2)" "unprognostic (1.02e-1)" "unprognostic (1.35e-3)" "unprognostic (3.04e-2)" "unprognostic (1.63e-2)" "unprognostic (3.31e-3)" "unprognostic (8.31e-3)" "unprognostic (1.02e-3)" "unprognostic (2.24e-1)" "unprognostic (1.51e-3)" "unprognostic (7.56e-2)" "unprognostic (1.84e-1)" "unprognostic (7.63e-2)" "unprognostic (3.77e-2)" 14.8 8.1 5.1 10.5 7.1 10.5 15.0 8.7 8.4 8.7 10.8 8.2 9.8 9.0 12.3 9.6 19.4 7.7 8.3 12.5 5.8 4.7 10.4 24.9 10.2 9.1 6.7 5.2 8.3 9.4 14.8 8.0 11.5 7.5 12.1 7.9 11.5 13.5 13.8 54.8 13.3 9.2 8.0 6.5 9.9 6.9 4.3 6.0 11.1 7.6 11.7 16.4 12.1 12.3 3.8 5.4 0.8 2.3 2.0 3.5 1.4 7.5 4.4 8.0 8.3 11.0 8.7 7.8 4.7 3.6 4.2 3.6 10.7 6.9 19.0 5.6 5.2 3.1 8.0 17.4 7.6 7.1 8.7 11.6 14.8 7.4 10.5 4.7 19.6 7.5 8.6 9.1 7.8 8.4 5.2 8.5 12.4 23.8 7.0 5.1 5.1 11.3 6.5 7.6 11.2 3.6 10.7 11.3 11.2 5.9 6.3 9.8 5.4 8.8 14.4 13.1 9.4 7.5 5.1 7.4 6.0 5.2 6.8 5.8 6.6 8.0 15.4 4.7 14.3 4.7 0.7 2.3 0.4 3.3 2.1 2.9 2.6 2.5 2.6 2.3 3.8 2.8 3.5 0.8 2.0 1.6 5.4 2.3 1.4 5.1 7.1 8.7 8.4 5.8 4.7 6.7 5.2 7.5 6.0 8.9 15.2 11.9 12.2 13.6 23.7 23.0 12.7 29.4 22.7 3.5 13.7 17.5 1.7 6.8 1.5 12.1 15.1 46.7 6.6 16.1 13.9 22.6 1.1 54.8 13.2 33.4 14.5 16.0 21.2 0.4 11.8 12.5 15.1 6.4 22.4 8.0 12.5 3.5 6.3 16.5 36.7 6.5 12.3 10.0 7.8 17.7 33.6 12.7 20.1 12.7 DDIT3 "CHOP, CHOP10, GADD153" ENSG00000175197 "DNA damage inducible transcript 3" P35638 12 57516588-57521737 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Growth arrest, Stress response, Transcription, Transcription regulation, Unfolded protein response, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 50.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 125.3;hTERT-HME1: 63.0;SK-MEL-30: 58.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058416, HPA068416" Uncertain Supported Nucleoplasm No No Nucleoplasm "HPA058416: AB_2683712, HPA068416: AB_2685985" "unprognostic (1.12e-1)" "unprognostic (5.33e-2)" "unprognostic (2.20e-3)" "unprognostic (4.92e-2)" "unprognostic (7.86e-3)" "unprognostic (2.28e-1)" "prognostic unfavorable (6.55e-4)" "unprognostic (8.55e-2)" "unprognostic (1.26e-3)" "unprognostic (9.40e-3)" "unprognostic (4.92e-2)" "unprognostic (4.16e-2)" "unprognostic (3.52e-2)" "unprognostic (3.70e-1)" "unprognostic (1.62e-1)" "unprognostic (2.56e-1)" "unprognostic (6.76e-2)" 19.1 25.5 15.9 8.3 29.9 82.2 21.4 16.7 25.2 14.8 13.5 20.1 15.7 10.6 19.5 55.8 13.0 13.1 16.0 25.8 18.6 19.8 28.8 26.1 17.1 8.8 34.4 15.5 27.3 13.0 13.5 26.8 18.0 32.1 22.8 13.9 27.3 20.7 13.9 18.0 16.3 10.9 15.4 21.8 11.2 14.7 14.3 35.3 2.9 88.9 12.6 9.4 30.2 17.0 13.8 4.6 50.8 5.4 9.2 10.9 5.1 2.6 2.4 1.5 5.3 14.4 9.8 8.4 7.3 16.3 10.9 10.3 8.6 7.0 3.8 7.4 2.1 29.4 3.2 5.9 1.1 11.3 3.1 2.4 2.9 2.7 6.2 125.3 4.6 4.6 27.9 23.7 18.4 63.0 12.8 2.6 4.0 12.6 14.5 4.8 1.6 3.1 6.1 3.0 5.6 5.8 1.7 34.4 3.2 3.8 3.4 3.2 2.4 2.1 2.5 58.5 6.1 5.3 12.5 1.5 7.5 3.2 7.0 6.3 25.7 8.6 4.0 9.0 4.4 13.1 27.5 5.4 13.5 8.0 4.6 7.0 13.8 5.7 7.3 3.7 13.1 10.9 9.9 50.8 9.2 5.1 4.6 6.5 5.1 15.9 29.9 16.7 25.2 18.6 19.8 34.4 15.5 32.1 35.3 17.9 66.4 36.9 73.0 50.0 111.0 146.3 38.2 24.1 25.0 21.0 86.4 37.7 97.8 32.3 4.8 25.9 67.5 0.0 13.8 18.0 63.8 157.0 198.7 17.9 39.8 52.4 221.2 23.4 24.7 5.5 25.9 50.7 84.4 8.2 36.5 118.8 35.9 70.2 35.7 34.7 135.4 12.9 94.3 83.5 13.4 40.0 90.2 46.8 32.1 42.1 DDIT4L "REDD2, Rtp801L" ENSG00000145358 "DNA damage inducible transcript 4 like" Q96D03 4 100185870-100190782 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 106.4" "Cell type enhanced" "Detected in many" 8 "Collecting duct cells: 21.0;Distal tubular cells: 18.3;Extravillous trophoblasts: 14.7;Sertoli cells: 19.4;Smooth muscle cells: 16.0" "Cancer enhanced" "Detected in many" "testis cancer: 19.3" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 7 "T-cells: 2.0" "Cell line enhanced" "Detected in some" "ASC TERT1: 12.9;BJ: 18.8;fHDF/TERT166: 10.2;HSkMC: 9.8;hTERT-RPE1: 21.5;RPTEC TERT1: 13.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA050903 Uncertain "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Plasma membrane" "Nucleoplasm, Actin filaments" "HPA050903: " "unprognostic (2.21e-1)" "unprognostic (1.92e-1)" "unprognostic (1.34e-1)" "prognostic favorable (5.77e-4)" "unprognostic (1.66e-3)" "unprognostic (5.92e-2)" "unprognostic (2.72e-2)" "unprognostic (3.12e-1)" "unprognostic (3.21e-1)" "unprognostic (7.18e-2)" "unprognostic (2.59e-1)" "unprognostic (1.41e-1)" "unprognostic (4.47e-2)" "unprognostic (4.82e-3)" "unprognostic (2.09e-2)" "unprognostic (7.53e-5)" "unprognostic (4.99e-3)" 1.4 0.5 1.5 0.3 6.3 0.3 0.6 2.0 1.6 7.9 0.6 1.7 0.0 0.2 0.9 3.0 2.6 0.9 0.3 3.5 2.1 0.7 6.2 0.2 0.4 0.3 1.5 1.6 2.8 0.2 0.3 1.2 1.3 2.7 3.8 0.5 5.2 6.3 2.6 106.4 0.4 0.3 0.8 2.4 0.5 0.2 1.1 1.7 0.0 0.6 18.6 1.2 0.5 0.9 0.2 0.0 0.0 0.2 0.0 2.0 0.2 0.0 1.4 5.5 0.0 2.5 12.9 0.8 18.8 1.6 0.3 0.1 0.1 0.5 0.0 0.4 10.2 0.4 0.0 3.9 0.3 0.3 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 9.8 0.1 0.2 1.0 21.5 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 6.2 0.0 0.0 0.3 0.0 0.0 13.4 0.0 0.0 0.0 0.3 0.7 2.5 1.4 0.0 0.0 0.1 0.0 0.0 0.0 1.4 2.5 0.0 0.0 4.8 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.2 0.1 2.0 0.0 0.0 0.7 1.4 0.0 0.0 0.0 0.0 1.0 0.2 1.5 6.3 2.0 1.6 2.1 0.7 1.5 1.6 2.7 1.7 0.0 0.0 0.0 0.1 2.4 0.0 4.7 0.0 0.0 0.0 21.0 0.0 1.7 18.3 0.1 0.6 1.5 0.0 0.0 0.0 14.7 5.0 0.8 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 6.8 0.0 0.0 8.3 0.5 0.0 2.1 1.3 0.0 19.4 16.0 0.7 0.1 1.3 3.3 0.0 0.0 0.1 DDN KIAA0749 ENSG00000181418 Dendrin O94850 12 48995149-48999309 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "brain: 40.8;skeletal muscle: 73.8" "Group enriched" "Detected in some" 4 "Collecting duct cells: 3.5;Ito cells: 1.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 10.6;RPMI-8226: 20.1;SCLC-21H: 10.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 33 "amygdala: 228.1;basal ganglia: 257.7;cerebral cortex: 232.0;hippocampal formation: 236.4;olfactory region: 128.1" HPA060952 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA060952: AB_2684396" "unprognostic (2.80e-2)" "unprognostic (3.19e-3)" "unprognostic (4.56e-2)" "unprognostic (8.10e-3)" "unprognostic (1.63e-1)" "unprognostic (1.79e-3)" "unprognostic (6.20e-5)" "unprognostic (8.61e-4)" "unprognostic (2.12e-1)" "unprognostic (1.36e-1)" "unprognostic (1.48e-1)" "unprognostic (5.08e-2)" "unprognostic (1.37e-6)" "unprognostic (1.72e-2)" "unprognostic (5.49e-2)" "unprognostic (1.61e-2)" "unprognostic (1.53e-2)" 0.7 0.7 40.5 0.8 40.8 1.3 0.7 0.0 38.5 0.7 0.7 0.2 0.0 0.7 0.7 3.8 1.0 0.7 0.7 0.9 30.5 2.0 4.8 0.7 0.7 0.9 2.9 9.3 0.7 0.8 0.8 0.0 0.7 0.0 1.6 0.7 0.0 0.7 0.7 73.8 0.8 0.8 0.7 0.0 0.8 0.8 0.8 1.2 0.0 0.7 0.0 0.8 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.3 0.3 0.2 0.6 0.0 0.0 0.1 0.1 0.1 0.1 0.2 4.5 0.4 0.0 0.2 0.0 0.0 1.6 10.6 0.0 0.1 0.5 4.8 2.3 0.5 1.0 0.0 5.5 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.3 0.0 3.5 0.2 0.1 5.3 6.0 0.1 0.8 1.4 4.9 0.3 20.1 0.0 0.1 10.6 1.0 0.2 0.5 0.2 0.1 0.3 0.7 0.1 0.2 0.5 0.2 0.0 1.2 2.3 4.7 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.1 40.5 40.8 0.0 31.9 30.5 2.0 2.9 9.3 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 DDR1 "CAK, CD167, EDDR1, NEP, NTRK4, PTK3A, RTK6" ENSG00000204580 "Discoidin domain receptor tyrosine kinase 1" Q08345 6 30876421-30900156 "CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lactation, Pregnancy" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 145.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 31.8;HBEC3-KT: 24.5;RT4: 32.5;T-47d: 36.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010162, CAB025656, HPA057194" Approved Approved "Nucleoplasm,Cell Junctions" "Intracellular and membrane" NA NA 2100000 "Nucleoplasm, Cell Junctions" "CAB010162: AB_2092090, CAB025656: , HPA057194: " "unprognostic (2.11e-2)" "unprognostic (9.31e-2)" "unprognostic (1.01e-1)" "unprognostic (1.09e-1)" "unprognostic (2.07e-1)" "unprognostic (7.75e-3)" "unprognostic (6.43e-2)" "unprognostic (1.92e-1)" "unprognostic (1.73e-1)" "unprognostic (1.42e-1)" "unprognostic (1.50e-1)" "unprognostic (4.41e-2)" "prognostic favorable (3.31e-10)" "unprognostic (1.42e-1)" "unprognostic (2.53e-1)" "unprognostic (5.49e-3)" "unprognostic (4.09e-2)" 6.7 11.3 23.5 7.9 36.2 2.2 12.5 6.8 42.2 9.7 25.2 57.4 17.6 16.8 7.7 10.5 30.5 31.7 18.9 8.7 27.8 20.8 19.8 3.5 13.2 3.1 55.7 19.8 11.3 20.9 28.2 14.6 13.3 34.7 17.7 14.9 4.0 28.3 20.5 9.1 41.3 32.1 3.1 43.2 5.1 52.2 5.1 37.0 8.7 20.9 10.5 7.6 16.3 16.6 1.8 0.4 0.0 0.2 0.0 1.8 0.9 19.7 6.5 9.2 1.9 0.6 0.9 5.7 0.5 0.1 0.3 0.0 8.7 10.5 0.1 11.0 1.7 9.6 31.8 2.0 24.5 0.1 10.9 3.5 0.0 6.0 2.3 1.8 0.0 0.4 1.2 12.7 0.1 0.2 5.8 0.7 0.5 5.7 0.2 1.4 12.5 0.7 0.0 1.6 10.9 1.3 1.3 6.9 0.7 4.7 32.5 1.6 0.9 1.8 14.7 7.1 3.2 36.5 0.2 1.5 4.6 4.3 0.4 4.6 0.2 0.0 0.8 3.0 0.0 4.0 0.0 0.2 0.0 1.1 0.0 0.8 0.4 0.2 0.7 0.4 1.8 1.2 1.8 0.0 0.0 0.0 0.4 0.0 0.9 23.5 36.2 6.8 25.0 27.8 20.8 55.7 19.8 34.7 37.0 32.8 24.0 2.2 62.3 47.2 5.2 19.9 38.2 33.5 31.8 85.5 0.0 53.4 5.0 115.9 10.8 4.9 88.3 23.3 66.9 19.7 6.5 54.7 1.1 0.4 5.4 6.4 44.4 1.8 0.8 16.6 7.8 2.2 15.1 22.6 55.1 145.4 62.4 74.8 4.9 5.6 7.4 6.5 8.9 0.7 4.5 45.4 38.9 0.0 54.4 76.8 DDX1 DBP-RB ENSG00000079785 "DEAD-box helicase 1" Q92499 2 15591178-15631111 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, mRNA processing, Transcription, Transcription regulation, tRNA processing" "Activator, DNA-binding, Exonuclease, Helicase, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cardiomyocytes: 352.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012280, HPA034502, HPA034503" Enhanced Supported Nucleoplasm,Cytosol NA NA 46000 Nucleoplasm Cytosol "CAB012280: , HPA034502: AB_10794321, HPA034503: AB_10795025" "unprognostic (9.94e-2)" "unprognostic (2.95e-2)" "unprognostic (3.07e-2)" "unprognostic (8.36e-3)" "unprognostic (9.28e-3)" "unprognostic (1.56e-2)" "prognostic unfavorable (9.09e-9)" "unprognostic (2.55e-1)" "unprognostic (2.05e-1)" "unprognostic (4.81e-3)" "unprognostic (3.89e-2)" "unprognostic (2.03e-1)" "prognostic favorable (9.69e-4)" "unprognostic (3.80e-1)" "unprognostic (1.34e-1)" "unprognostic (4.94e-2)" "unprognostic (1.20e-3)" 23.8 28.2 29.3 17.6 35.0 17.1 30.1 35.3 37.2 25.1 24.5 15.0 20.5 21.0 24.3 25.6 27.7 21.0 15.8 47.6 34.7 25.3 35.8 35.2 17.8 16.0 24.5 36.9 23.6 27.6 42.1 41.2 28.1 35.1 22.2 28.1 14.8 23.9 24.5 67.5 24.5 25.9 31.0 21.0 17.1 24.1 19.2 23.0 23.0 29.6 24.8 21.5 26.1 19.8 18.7 22.8 19.2 25.1 23.0 26.6 19.9 19.3 29.7 42.2 31.5 36.7 32.2 48.7 40.7 34.2 40.1 33.8 47.4 20.0 50.3 19.8 46.9 29.6 29.5 57.7 39.1 42.5 21.4 37.5 55.1 39.7 59.7 27.6 45.0 25.9 25.0 26.9 33.4 32.1 25.4 36.1 23.8 56.0 16.6 39.5 27.1 24.6 34.0 54.3 48.9 25.1 29.7 63.9 36.4 45.9 39.0 34.1 42.6 27.8 29.4 37.0 31.6 20.4 19.1 29.1 33.7 34.8 21.1 45.9 21.7 37.7 67.9 30.3 36.1 31.3 19.2 20.0 11.5 20.2 25.1 21.3 18.7 23.4 23.4 22.8 18.0 26.6 23.6 3.1 23.0 23.2 19.5 21.6 19.9 29.3 35.0 35.3 37.2 34.7 25.3 24.5 36.9 35.1 23.0 74.5 45.2 27.6 50.5 35.7 56.6 352.9 63.7 95.0 68.2 85.5 49.1 96.2 121.0 87.1 11.9 56.2 48.4 23.3 104.7 96.0 66.4 31.2 54.4 106.7 46.5 42.9 50.1 40.5 25.3 12.7 67.3 39.1 47.2 31.5 56.7 55.3 88.0 59.6 73.6 95.2 67.2 58.2 49.9 167.4 57.2 36.9 67.1 26.6 62.9 32.7 DDX11 "CHL1, CHLR1, KRG2, WABS" ENSG00000013573 "DEAD/H-box helicase 11" Q96FC9 12 31073845-31104791 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA065197 Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Centrosome" No Yes Nucleoplasm "Nucleoli fibrillar center, Centrosome" "HPA065197: AB_2685430" "unprognostic (6.10e-2)" "unprognostic (1.48e-2)" "unprognostic (1.02e-1)" "unprognostic (5.09e-2)" "unprognostic (1.45e-1)" "unprognostic (2.79e-3)" "prognostic unfavorable (2.40e-4)" "unprognostic (4.87e-2)" "unprognostic (3.89e-3)" "unprognostic (3.53e-1)" "unprognostic (5.66e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (5.23e-8)" "unprognostic (1.89e-2)" "unprognostic (3.64e-2)" "unprognostic (1.02e-1)" "unprognostic (8.03e-3)" 6.3 5.3 6.4 8.0 8.7 21.0 5.9 18.1 10.5 7.6 6.1 6.0 8.8 7.1 11.0 3.7 7.6 7.5 5.1 4.0 7.0 2.7 6.5 7.0 4.9 14.9 8.4 4.6 9.6 19.0 7.7 9.3 5.6 7.1 8.0 8.6 5.0 11.3 7.1 8.8 14.2 12.1 8.0 6.7 10.9 8.0 8.2 9.4 33.2 7.2 6.4 11.1 5.8 7.8 5.8 4.9 1.3 7.3 4.3 5.5 1.9 12.5 12.2 14.2 12.7 2.2 4.8 20.9 7.8 3.9 9.1 9.8 14.5 21.4 16.4 10.9 4.1 8.5 12.4 11.2 10.7 7.3 15.0 23.0 19.5 20.3 8.9 0.8 13.7 12.7 4.5 4.8 11.6 9.1 5.9 4.4 19.7 9.5 36.8 6.5 10.4 23.5 20.5 29.9 15.3 6.6 18.9 22.2 22.8 4.8 14.3 10.2 7.5 8.0 12.3 3.9 24.8 10.4 8.7 3.6 8.0 15.7 15.4 14.1 14.9 11.5 39.2 9.4 11.0 7.2 0.0 2.3 1.3 4.2 2.5 3.3 5.2 4.0 3.1 3.1 5.8 4.1 5.5 1.1 4.3 7.3 4.9 3.4 1.9 6.4 8.7 18.1 10.5 7.0 2.7 8.4 4.6 7.1 9.4 3.0 7.4 12.7 4.5 5.4 7.7 2.2 5.1 6.7 5.7 0.0 13.7 5.2 0.0 2.2 1.3 3.0 4.0 0.0 2.9 5.8 4.3 5.0 5.7 6.6 4.3 7.9 0.0 6.2 4.6 0.9 6.6 4.6 6.8 5.4 5.0 2.3 2.5 2.9 4.2 1.1 25.5 0.0 3.5 3.2 17.6 5.6 2.2 6.9 7.4 4.1 DDX19A "DDX19L, FLJ11126" ENSG00000168872 "DEAD-box helicase 19A" Q9NUU7 16 70346829-70373383 "Enzymes, Predicted intracellular proteins, Transporters" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045252, HPA066668" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045252: AB_10961128, HPA066668: " "unprognostic (3.11e-2)" "unprognostic (1.93e-1)" "unprognostic (9.07e-2)" "unprognostic (3.95e-2)" "unprognostic (2.18e-2)" "prognostic unfavorable (2.38e-4)" "prognostic unfavorable (8.05e-5)" "unprognostic (1.45e-1)" "unprognostic (1.59e-1)" "unprognostic (1.67e-1)" "unprognostic (1.30e-1)" "unprognostic (5.87e-2)" "unprognostic (1.24e-1)" "unprognostic (2.01e-2)" "unprognostic (1.49e-1)" "unprognostic (3.01e-2)" "unprognostic (6.68e-3)" 18.4 20.6 14.5 15.5 19.7 9.8 18.1 16.6 19.6 16.9 19.2 19.2 17.8 9.3 22.0 14.2 19.2 17.1 16.1 22.1 18.6 13.5 16.6 24.8 14.4 18.0 17.1 15.5 21.6 22.5 31.7 17.4 21.8 15.1 15.4 14.4 14.2 14.4 21.1 51.5 15.8 13.5 25.9 15.4 14.1 17.2 9.7 13.7 17.1 19.7 14.4 18.4 19.5 15.5 8.1 14.2 7.9 11.4 8.2 10.3 8.8 13.2 15.0 15.8 16.0 23.8 16.2 15.1 16.9 17.4 26.8 20.9 22.5 9.9 22.2 16.1 17.8 12.7 15.2 28.3 16.8 22.2 7.4 15.4 11.6 12.3 27.6 21.5 20.2 9.7 19.9 12.1 24.4 19.2 13.2 17.0 16.2 27.9 5.8 16.0 19.0 22.4 16.8 25.5 15.8 9.2 27.8 10.6 30.4 16.2 8.2 13.0 17.5 43.3 9.5 12.7 17.1 17.4 12.9 11.5 18.7 14.8 11.8 16.0 16.4 24.6 48.9 12.6 18.5 18.3 7.9 11.4 5.8 10.2 10.7 9.4 7.7 8.9 10.0 14.2 8.1 9.9 10.3 0.7 8.2 9.6 7.3 7.5 8.8 14.5 19.7 16.6 19.6 18.6 13.5 17.1 15.5 15.1 13.7 14.9 20.2 21.7 15.7 8.9 31.9 16.2 28.1 13.4 22.7 10.4 31.4 18.9 8.3 11.1 1.4 13.8 6.6 23.3 12.1 13.1 12.8 16.7 17.3 15.3 12.3 22.3 13.8 14.7 14.5 1.3 24.2 11.8 10.1 17.2 8.8 18.0 11.6 8.6 11.7 10.6 31.0 25.8 15.5 12.2 16.4 8.9 14.4 12.9 11.3 15.9 DDX19B "DBP5, DDX19" ENSG00000157349 "DEAD-box helicase 19B" Q9UMR2 16 70289663-70335283 "Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 170.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037229, CAB037284, HPA046380, HPA066668" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "CAB037229: AB_1840791, CAB037284: AB_1840792, HPA046380: AB_2679645, HPA066668: " "unprognostic (2.91e-2)" "unprognostic (5.37e-2)" "unprognostic (6.48e-2)" "unprognostic (3.55e-2)" "unprognostic (3.98e-2)" "unprognostic (4.05e-2)" "unprognostic (2.93e-2)" "unprognostic (1.98e-2)" "unprognostic (1.40e-1)" "unprognostic (1.05e-1)" "unprognostic (6.33e-2)" "unprognostic (4.07e-1)" "unprognostic (7.95e-2)" "unprognostic (2.19e-1)" "unprognostic (3.50e-1)" "unprognostic (1.04e-1)" "unprognostic (6.32e-2)" 22.2 18.6 8.8 16.6 12.7 19.4 20.1 30.4 16.3 13.1 16.7 14.6 13.8 14.4 15.0 13.9 16.0 13.2 15.2 15.0 8.3 8.3 15.9 33.9 16.6 15.3 10.5 10.7 14.6 21.6 20.3 17.9 12.0 13.2 13.8 18.2 19.3 16.8 15.2 24.8 26.9 16.6 15.7 10.1 17.8 18.5 64.3 12.3 17.4 18.0 16.9 20.8 16.2 13.9 21.1 21.1 27.0 28.6 22.1 35.4 22.5 2.0 12.4 17.7 16.0 9.8 13.1 15.3 10.0 14.2 22.0 23.0 26.4 15.3 16.2 9.5 12.6 8.9 12.2 0.1 5.7 22.8 6.7 11.3 9.6 8.1 21.6 21.1 20.5 9.3 16.1 11.3 16.7 12.7 9.1 16.8 5.0 9.7 7.0 13.4 14.2 0.0 29.7 11.1 7.7 5.2 28.4 9.6 23.4 13.1 11.5 11.6 15.3 23.6 5.4 12.7 8.1 12.1 18.2 10.2 10.4 9.3 8.6 9.2 15.1 7.8 37.7 3.4 16.8 13.4 27.0 22.1 19.0 23.2 28.6 22.3 21.1 20.9 25.3 21.1 19.0 19.0 18.0 4.1 22.1 17.7 6.5 35.4 22.5 8.8 12.7 30.4 16.3 8.3 8.3 10.5 10.7 13.2 12.3 11.9 17.9 27.3 15.3 8.4 17.8 6.6 12.7 29.4 20.5 10.4 11.8 16.5 26.6 35.6 170.5 17.5 27.5 0.0 57.8 18.6 16.1 14.9 10.5 12.4 25.9 9.5 21.1 11.6 14.6 32.4 19.2 19.7 3.3 43.3 14.6 16.0 37.9 34.5 14.9 17.4 15.7 12.9 12.3 78.8 7.4 9.2 26.4 25.5 20.3 15.7 DDX20 "DP103, GEMIN3" ENSG00000064703 "DEAD-box helicase 20" Q9UHI6 1 111755245-111768016 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "testis: 81.7" "Group enriched" "Detected in many" 13 "Early spermatids: 570.4;Late spermatids: 538.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005516, CAB015427" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" "Intracellular and membrane" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "CAB015427: AB_629518, HPA005516: AB_1849612" "unprognostic (3.71e-2)" "unprognostic (5.25e-2)" "prognostic favorable (9.85e-5)" "unprognostic (8.73e-2)" "unprognostic (2.51e-2)" "unprognostic (7.09e-2)" "prognostic unfavorable (6.35e-6)" "unprognostic (1.17e-1)" "unprognostic (5.87e-2)" "unprognostic (7.46e-3)" "unprognostic (4.21e-1)" "unprognostic (5.22e-2)" "unprognostic (1.05e-3)" "unprognostic (2.60e-2)" "unprognostic (2.01e-1)" "unprognostic (4.23e-1)" "unprognostic (1.30e-2)" 3.1 2.8 2.9 2.7 4.3 5.9 9.8 5.8 5.1 2.7 2.6 1.8 2.6 2.0 4.0 2.9 2.6 3.7 1.7 2.0 4.3 1.6 2.7 2.4 4.1 3.8 2.4 1.9 3.9 2.9 4.0 3.9 2.7 3.4 2.9 2.6 1.2 2.6 2.7 5.1 2.5 3.5 2.9 5.6 4.5 2.8 81.7 3.3 5.1 3.2 1.7 4.1 2.9 5.0 11.9 7.4 12.7 7.4 10.5 14.1 7.8 11.4 4.7 12.2 11.0 8.8 7.0 11.4 11.2 8.7 16.1 15.7 7.0 4.0 26.8 8.8 7.6 5.7 9.2 14.4 11.3 18.0 12.2 13.0 13.0 9.2 7.2 8.8 12.8 9.6 7.0 9.9 13.7 13.9 4.5 11.1 10.5 12.4 9.8 12.2 10.8 15.7 13.0 15.3 6.9 9.6 15.4 20.1 6.7 10.5 9.0 12.7 11.5 10.8 13.5 18.0 10.6 8.4 13.6 9.8 9.8 14.5 17.5 13.0 4.9 6.9 20.5 10.2 13.2 22.1 12.7 7.0 6.9 10.0 7.3 13.3 11.9 11.7 11.8 7.4 10.1 14.1 12.3 5.0 10.5 7.4 5.2 11.7 7.8 2.9 4.3 5.8 5.1 4.3 1.6 2.4 1.9 3.4 3.3 11.9 6.5 3.7 7.8 9.6 12.2 5.9 2.5 13.4 12.5 5.2 2.0 8.6 3.3 8.9 570.4 7.1 2.4 0.0 6.0 6.8 4.8 3.0 7.0 4.9 8.0 6.4 4.1 3.7 9.1 538.8 15.3 8.7 1.7 3.6 5.7 6.3 6.3 2.9 12.4 6.9 8.9 6.5 10.3 41.2 25.6 6.4 4.2 7.0 5.8 5.5 DDX21 "GURDB, RH-II/GU" ENSG00000165732 "DExD-box helicase 21" Q9NR30 10 68956128-68985073 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, rRNA processing, Transcription" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Suprabasal keratinocytes: 515.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036592, HPA036593" Enhanced Enhanced "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes No 14000 "Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA036592: AB_10673625, HPA036593: AB_2675208" "unprognostic (3.04e-1)" "unprognostic (6.81e-3)" "unprognostic (1.13e-2)" "unprognostic (1.21e-2)" "unprognostic (1.75e-2)" "unprognostic (6.71e-3)" "unprognostic (1.34e-2)" "unprognostic (1.99e-2)" "unprognostic (1.29e-1)" "unprognostic (1.92e-1)" "prognostic unfavorable (3.12e-4)" "unprognostic (1.64e-1)" "unprognostic (1.39e-2)" "unprognostic (9.33e-2)" "unprognostic (5.41e-2)" "unprognostic (1.24e-2)" "unprognostic (5.74e-3)" 37.5 16.0 10.0 26.6 13.3 46.8 24.4 8.0 11.8 18.5 20.1 7.2 16.2 13.3 18.7 13.7 28.3 20.1 17.6 19.1 11.4 8.0 25.1 48.0 25.9 24.4 14.9 7.2 30.2 27.9 15.6 20.7 22.8 18.3 14.0 17.6 5.9 18.0 17.8 61.2 22.5 18.5 19.0 20.4 43.5 19.0 12.9 13.3 27.1 18.1 24.1 25.8 33.2 22.4 12.6 11.5 17.1 17.3 7.7 15.0 6.2 33.1 19.7 11.5 35.6 10.4 13.8 24.4 22.8 18.4 29.5 25.1 63.7 22.8 50.0 14.1 18.9 13.9 29.6 44.3 28.4 39.6 15.5 31.2 35.0 14.0 26.4 22.3 83.2 33.3 14.1 37.0 35.2 59.0 13.7 21.4 18.8 66.6 25.0 20.7 15.1 32.6 18.1 31.5 15.8 42.1 29.2 18.9 24.6 19.6 17.9 23.9 25.6 20.5 45.5 26.6 14.5 25.8 17.5 22.0 17.3 24.6 23.2 40.0 28.9 38.2 73.9 14.4 63.2 11.7 5.0 9.7 17.1 8.4 15.0 15.0 12.6 10.9 11.0 11.5 10.4 10.3 11.3 4.5 7.7 17.3 10.8 7.9 6.2 10.0 13.3 8.0 11.8 11.4 8.0 14.9 7.2 18.3 13.3 95.3 139.8 208.1 223.1 488.7 27.0 59.4 112.1 83.0 195.7 68.0 39.3 72.5 61.3 111.8 41.5 139.6 52.0 23.3 160.6 118.9 142.8 222.8 164.0 182.5 102.7 23.8 83.2 113.5 149.3 13.6 82.8 170.5 118.1 66.7 97.0 22.8 171.9 92.1 72.5 73.0 27.4 25.8 155.6 101.9 142.2 515.4 115.0 93.8 113.1 301.9 DDX23 "prp28, PRPF28, SNRNP100, U5-100K" ENSG00000174243 "DEAD-box helicase 23" Q9BUQ8 12 48829764-48852842 "Enzymes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038680, HPA039037" Approved Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA038680: AB_10795401, HPA039037: AB_2676317" "unprognostic (1.32e-3)" "unprognostic (8.90e-2)" "unprognostic (8.92e-2)" "unprognostic (7.12e-2)" "unprognostic (5.34e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (3.03e-5)" "unprognostic (3.54e-2)" "unprognostic (5.68e-2)" "unprognostic (2.19e-2)" "unprognostic (1.69e-1)" "unprognostic (8.34e-2)" "unprognostic (5.94e-2)" "unprognostic (9.78e-2)" "unprognostic (6.88e-2)" "unprognostic (2.59e-2)" "unprognostic (1.44e-1)" 26.1 26.5 29.5 35.6 34.2 19.4 27.2 32.8 35.6 26.7 32.8 23.3 27.5 27.9 31.0 22.3 31.0 31.1 25.2 25.1 29.8 20.3 25.2 37.7 27.7 35.2 26.5 25.3 36.2 30.4 32.2 28.1 34.4 25.0 29.9 32.6 24.7 31.1 27.0 44.4 30.6 32.3 29.4 24.1 40.0 30.6 24.9 32.0 46.8 28.2 29.8 38.9 28.9 47.9 12.0 11.5 19.6 13.3 11.2 19.8 10.6 22.0 50.5 24.0 25.4 24.0 16.6 25.5 27.4 21.1 31.1 19.8 49.1 29.5 27.9 30.1 22.7 29.4 20.0 52.0 24.9 26.7 43.7 27.6 37.0 43.0 22.1 12.9 37.3 33.7 16.0 22.4 33.0 19.8 21.4 25.5 24.8 48.9 25.0 22.6 30.7 35.3 35.4 35.7 31.4 24.0 37.8 28.4 22.2 18.4 31.1 29.6 17.3 27.4 31.5 11.4 25.7 30.8 34.3 22.8 23.6 17.3 11.6 21.7 18.9 26.3 33.7 20.0 26.3 12.9 17.1 11.1 19.6 19.5 13.3 19.8 12.0 14.5 17.6 10.8 11.4 14.0 16.9 11.9 11.2 8.9 11.5 13.1 10.6 29.5 34.2 32.8 35.6 29.8 20.3 26.5 25.3 25.0 32.0 23.8 25.5 22.4 12.7 11.4 16.9 17.1 22.9 44.2 31.8 12.2 23.6 22.5 13.3 22.3 6.9 21.0 23.3 23.3 33.5 24.6 16.2 21.2 17.4 16.3 16.7 14.3 13.4 17.8 9.9 4.1 22.7 15.0 13.5 24.4 22.7 24.3 28.9 31.6 20.8 10.2 24.0 19.4 18.4 33.8 36.1 13.2 22.2 24.2 23.9 17.1 DDX25 GRTH ENSG00000109832 "DEAD-box helicase 25" Q9UHL0 11 125903348-125943702 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Differentiation, mRNA transport, Spermatogenesis, Translation regulation, Transport" "Developmental protein, Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 17.3;testis: 64.2" "Group enriched" "Detected in some" 5 "Early spermatids: 250.3;Spermatocytes: 190.6" "Cancer enhanced" "Detected in some" "glioma: 1.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "JURKAT: 16.8;NTERA-2: 11.4;SCLC-21H: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020137 Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA020137: AB_1847552" "unprognostic (5.78e-3)" "unprognostic (9.75e-3)" "unprognostic (7.93e-2)" "unprognostic (5.09e-3)" "unprognostic (1.11e-2)" "unprognostic (1.78e-2)" "unprognostic (1.54e-1)" "unprognostic (2.91e-3)" "unprognostic (6.24e-5)" "unprognostic (2.57e-1)" "unprognostic (2.44e-3)" "unprognostic (3.89e-1)" "unprognostic (3.44e-3)" "unprognostic (1.44e-1)" "unprognostic (1.76e-1)" "unprognostic (9.72e-2)" "unprognostic (1.69e-1)" 0.7 2.8 8.7 0.8 13.2 0.9 0.8 7.9 17.3 0.8 0.8 2.0 0.0 1.0 0.9 0.9 0.8 0.9 0.8 0.7 8.4 7.1 2.7 0.8 0.8 0.8 4.8 8.9 1.2 1.8 2.6 7.1 0.9 5.9 0.9 0.8 2.3 0.8 1.0 0.8 1.6 0.8 0.7 3.4 0.9 1.0 64.2 3.0 0.0 4.3 0.0 0.8 0.7 0.2 0.6 0.5 3.3 0.3 1.3 0.5 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.2 0.2 1.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 16.8 0.0 0.3 0.0 0.5 1.6 0.0 11.4 0.5 0.0 0.4 0.0 0.0 0.0 0.1 9.2 2.1 0.1 0.0 1.6 1.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 2.1 0.3 0.6 0.3 0.2 0.2 0.4 0.5 0.2 0.1 0.6 0.4 0.3 3.3 1.3 0.2 0.5 0.1 0.1 8.7 13.2 7.9 12.5 8.4 7.1 4.8 8.9 5.9 3.0 0.0 0.3 0.0 0.7 0.1 18.2 0.8 0.0 0.0 0.0 0.0 15.7 0.0 3.3 0.1 250.3 0.9 0.0 0.0 0.2 0.1 0.3 0.5 0.0 0.5 0.1 15.9 0.0 0.6 0.0 41.7 3.4 0.1 0.0 0.0 0.0 16.0 0.1 0.0 4.6 1.8 16.0 0.0 0.1 190.6 24.5 0.0 0.0 0.0 0.0 0.1 DDX3X "DBX, DDX14, DDX3, HLP2" ENSG00000215301 "DEAD-box helicase 3, X-linked" O00571 X 41333284-41364472 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Chromosome partition, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation, Translation regulation" "DNA-binding, Helicase, Hydrolase, RNA-binding" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 631.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001648, HPA005631, HPA059585" Supported Supported Approved Nucleoplasm,Cytosol NA NA 110000 Cytosol Nucleoplasm "HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059585: AB_2684073" "unprognostic (2.42e-2)" "unprognostic (1.11e-1)" "unprognostic (8.01e-3)" "unprognostic (1.66e-1)" "unprognostic (8.12e-2)" "unprognostic (6.43e-2)" "unprognostic (1.17e-3)" "unprognostic (1.88e-1)" "unprognostic (9.80e-2)" "unprognostic (1.40e-1)" "unprognostic (3.25e-2)" "unprognostic (2.05e-1)" "unprognostic (1.51e-1)" "unprognostic (2.95e-1)" "unprognostic (4.77e-1)" "unprognostic (9.44e-2)" "unprognostic (2.93e-2)" 80.9 49.3 26.1 40.0 34.5 49.3 46.5 31.1 36.2 52.4 43.3 35.1 21.3 29.5 56.4 25.9 53.5 56.3 42.6 47.6 30.8 24.5 55.6 77.9 45.3 40.4 41.4 29.0 60.1 30.9 68.7 60.2 79.9 37.9 30.0 29.2 30.8 37.4 26.5 63.4 42.2 54.0 57.2 53.9 46.1 43.0 27.0 39.0 49.2 45.6 44.0 42.6 55.8 50.2 13.1 20.5 32.0 21.6 17.3 21.5 17.9 45.8 51.1 47.7 26.2 56.2 47.7 29.1 33.5 47.1 34.4 27.6 52.5 30.9 0.5 23.9 37.4 41.4 31.0 58.3 47.1 57.3 27.2 45.4 29.2 50.8 31.5 29.2 54.7 52.5 34.5 33.4 57.9 56.0 38.5 53.9 25.7 53.6 28.9 31.9 34.7 34.4 17.1 45.9 24.4 20.6 40.4 50.8 37.4 32.4 61.9 32.6 49.4 75.8 38.9 40.1 50.2 35.0 37.2 48.6 35.5 37.9 37.9 39.7 33.7 40.0 45.3 35.7 33.2 33.6 22.5 20.2 17.5 14.8 21.1 21.5 13.1 14.5 16.3 20.5 9.0 16.3 15.1 32.0 17.3 21.6 6.9 14.3 17.9 26.1 34.5 31.1 36.2 30.8 24.5 41.4 29.0 37.9 39.0 80.4 161.8 98.4 138.2 234.8 74.1 130.3 81.5 65.6 85.3 55.8 123.7 79.4 36.5 59.8 317.8 170.8 178.1 116.8 73.8 80.3 155.2 122.4 162.7 142.1 107.7 57.2 176.3 120.3 200.6 631.6 61.5 160.4 121.4 72.1 136.1 88.8 86.2 143.8 59.1 71.7 117.4 71.1 155.5 15.7 55.7 291.5 144.6 132.3 100.9 182.7 DDX3Y DBY ENSG00000067048 "DEAD-box helicase 3, Y-linked" O15523 Y 12904108-12920478 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA-binding, Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 237.5;Late spermatids: 436.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 41.3;HEL: 42.1;U-266/84: 34.9;U-698: 30.7" "Low region specificity" "Detected in all" "HPA001648, HPA005631, HPA059583" Enhanced Supported Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059583: " "unprognostic (3.89e-2)" "unprognostic (1.70e-1)" "prognostic favorable (4.70e-5)" "unprognostic (6.50e-2)" "unprognostic (4.74e-2)" "unprognostic (2.22e-2)" "unprognostic (4.17e-2)" "unprognostic (3.37e-2)" "unprognostic (9.61e-2)" "unprognostic (2.58e-3)" "unprognostic (1.74e-1)" "unprognostic (2.66e-2)" "unprognostic (7.87e-2)" 12.0 10.5 4.9 29.5 14.1 46.1 8.7 17.0 16.3 0.4 24.4 12.6 31.5 7.6 0.4 29.7 12.2 0.4 14.2 10.8 5.6 7.1 8.9 26.5 20.0 17.7 5.7 0.0 0.4 14.5 0.4 12.2 14.0 20.2 26.7 15.8 15.1 20.4 32.6 17.7 8.4 16.0 40.7 6.2 34.3 8.9 41.9 0.0 26.9 10.8 21.4 19.3 14.4 0.0 6.1 8.8 6.5 7.1 6.5 8.4 3.8 0.1 7.7 0.0 0.0 0.0 0.0 5.6 18.9 13.5 10.0 12.3 0.0 0.0 41.3 0.0 18.6 0.0 0.0 0.0 0.0 17.6 10.3 0.0 42.1 0.0 12.4 9.9 0.0 0.0 10.5 11.8 0.0 0.0 0.0 0.0 4.2 0.0 0.0 11.8 0.0 16.3 0.0 7.5 0.0 0.0 0.0 5.0 7.6 10.6 11.4 12.4 0.0 0.0 0.0 13.8 12.7 0.0 9.8 13.5 15.5 0.0 0.0 12.4 22.3 34.9 30.7 1.9 0.0 0.0 1.6 6.2 5.7 8.4 7.1 7.7 6.1 6.4 7.1 8.8 5.9 7.8 6.5 6.5 6.5 4.6 2.5 5.7 3.8 4.9 14.1 17.0 16.3 5.6 7.1 5.7 0.0 20.2 0.0 44.7 70.4 32.3 85.6 83.6 48.4 24.1 12.7 117.8 50.0 8.7 39.3 34.0 5.0 8.7 237.5 56.2 0.0 0.0 0.2 11.4 45.1 53.9 88.1 0.6 15.6 39.7 15.3 28.3 37.0 436.7 35.9 93.0 25.3 15.4 3.7 57.0 8.2 0.0 37.1 14.7 46.4 19.4 59.7 36.2 65.8 70.3 31.6 51.1 0.0 62.4 DDX41 "ABS, MGC8828" ENSG00000183258 "DEAD-box helicase 41" Q9UJV9 5 177511577-177517469 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017911, HPA048803" Supported Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA017911: AB_1847558, HPA048803: AB_2680527" "unprognostic (2.52e-1)" "unprognostic (1.51e-1)" "unprognostic (7.57e-2)" "unprognostic (1.02e-1)" "unprognostic (2.34e-1)" "unprognostic (2.61e-2)" "unprognostic (4.21e-3)" "unprognostic (2.60e-2)" "unprognostic (1.92e-1)" "unprognostic (1.25e-1)" "unprognostic (2.89e-2)" "unprognostic (4.47e-2)" "prognostic unfavorable (2.21e-6)" "unprognostic (1.41e-1)" "unprognostic (1.22e-1)" "unprognostic (2.23e-1)" "unprognostic (1.75e-1)" 17.9 22.7 27.0 25.1 30.7 17.2 16.5 22.8 39.2 19.1 21.2 16.9 18.5 25.5 19.5 16.5 23.0 22.1 17.1 15.3 29.3 20.1 23.7 29.3 16.8 19.9 22.1 24.8 21.2 18.0 22.2 15.1 22.1 27.4 16.3 15.4 19.0 19.0 17.5 36.6 21.7 26.8 16.7 14.8 21.9 19.7 16.8 15.4 24.9 22.9 18.2 23.5 19.6 18.4 15.9 22.5 16.4 22.8 18.6 20.6 18.0 21.2 24.3 13.3 15.7 13.7 16.3 44.9 19.1 11.6 14.1 10.4 39.6 19.8 23.9 29.1 18.0 24.7 17.4 17.4 43.7 9.6 57.0 21.8 30.3 24.7 23.5 18.2 31.3 32.2 15.9 15.4 13.3 17.9 12.0 17.9 23.9 26.2 17.0 16.5 45.8 26.1 15.4 23.5 19.9 19.7 28.4 16.2 28.1 15.7 24.8 15.8 17.3 20.3 27.0 22.8 8.1 18.9 45.8 19.1 25.7 15.2 16.4 29.7 20.5 24.0 40.7 28.2 34.6 16.9 10.6 22.8 16.4 16.1 21.5 20.6 15.9 16.0 15.3 22.5 14.1 14.8 15.5 7.7 18.6 21.4 10.2 15.6 18.0 27.0 30.7 22.8 39.2 29.3 20.1 22.1 24.8 27.4 15.4 23.8 19.1 26.4 18.3 18.7 17.4 7.1 25.5 14.7 15.9 8.7 2.0 40.7 34.9 39.1 8.4 20.3 22.6 23.3 34.4 49.6 19.5 16.0 28.9 16.3 43.7 7.9 10.9 12.3 22.2 16.2 13.8 21.8 11.8 41.5 23.7 15.8 29.9 20.1 19.8 28.9 9.4 12.9 20.6 24.2 23.2 17.8 31.4 22.3 26.3 16.3 DDX5 "G17P1, HLR1, p68" ENSG00000108654 "DEAD-box helicase 5" P17844 17 64499616-64508199 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Helicase, Hydrolase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005868, HPA020043, HPA071154" Supported Supported Nucleoplasm,Nucleoli No No 150000 "Nucleoplasm, Nucleoli" "CAB005868: AB_446484, HPA020043: AB_1847572, HPA071154: " "unprognostic (6.64e-2)" "unprognostic (6.98e-2)" "prognostic favorable (2.12e-4)" "unprognostic (8.94e-2)" "unprognostic (5.08e-2)" "unprognostic (9.85e-2)" "unprognostic (5.80e-2)" "unprognostic (1.61e-2)" "unprognostic (3.17e-2)" "unprognostic (4.71e-2)" "unprognostic (3.03e-3)" "unprognostic (1.44e-1)" "unprognostic (4.00e-1)" "unprognostic (2.08e-1)" "unprognostic (2.37e-1)" "unprognostic (2.17e-1)" "unprognostic (9.28e-3)" 91.6 61.4 46.9 80.0 68.0 108.3 94.7 61.6 58.9 81.6 81.1 53.3 104.2 27.4 106.7 94.5 64.5 96.9 101.4 53.9 48.5 30.6 53.1 68.0 84.8 70.9 62.8 44.1 74.0 49.3 88.9 110.5 56.6 73.1 59.5 55.4 50.9 62.2 103.6 77.6 59.7 54.7 113.1 71.0 67.6 69.0 39.7 57.8 82.1 81.1 77.7 69.3 91.0 63.9 46.9 59.6 66.4 66.2 40.3 60.8 109.8 55.1 20.8 63.0 39.9 58.4 55.0 40.1 54.7 70.6 67.1 67.2 22.5 33.8 80.9 31.4 71.8 47.8 32.9 67.8 62.9 75.9 28.7 48.7 52.6 15.9 17.2 42.8 66.9 56.1 61.9 54.3 61.3 47.8 37.4 71.6 69.9 41.7 69.1 51.7 32.8 139.9 19.5 36.7 50.9 64.3 87.6 66.6 56.9 41.1 26.5 44.3 74.3 53.1 51.5 66.6 56.7 48.2 37.7 50.3 40.8 45.6 43.9 56.6 38.6 76.1 142.8 43.2 32.9 48.1 66.4 62.5 66.4 53.7 56.9 60.8 46.9 42.9 51.7 59.6 46.8 44.5 43.1 37.8 40.3 66.2 37.0 50.2 109.8 46.9 68.0 61.6 58.9 48.5 30.6 62.8 44.1 73.1 57.8 497.3 661.1 481.3 1231.3 781.2 369.6 221.7 262.4 725.4 624.4 350.7 316.1 372.7 283.5 416.6 432.3 643.3 503.6 116.8 366.6 307.8 528.8 417.0 836.7 222.3 399.0 397.3 638.0 483.1 539.2 80.3 384.6 631.0 410.0 779.1 366.4 576.1 376.0 445.4 411.5 208.8 514.0 485.0 599.5 374.0 341.8 652.0 741.9 719.3 310.9 1106.4 DDX51 ENSG00000185163 "DEAD-box helicase 51" Q8N8A6 12 132136594-132144335 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039503 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA039503: AB_10796328" "unprognostic (2.84e-3)" "unprognostic (1.69e-2)" "unprognostic (1.43e-1)" "unprognostic (2.84e-1)" "unprognostic (8.66e-2)" "unprognostic (4.00e-2)" "prognostic unfavorable (4.73e-4)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "unprognostic (4.88e-1)" "unprognostic (3.05e-3)" "unprognostic (5.31e-2)" "unprognostic (3.97e-2)" "unprognostic (2.48e-1)" "unprognostic (4.69e-2)" "unprognostic (3.28e-1)" "unprognostic (1.65e-3)" 10.5 8.5 12.7 12.7 17.1 17.2 10.3 23.5 18.9 8.8 8.4 11.8 10.6 7.8 11.5 12.2 8.5 12.4 10.0 8.1 11.6 9.9 9.5 7.2 8.9 11.1 10.5 16.9 19.6 14.8 10.1 9.8 7.2 11.8 9.3 7.3 8.9 10.7 12.4 13.8 18.0 8.2 10.4 10.5 10.6 9.3 6.7 12.0 9.5 9.9 7.1 10.4 9.3 8.6 2.5 2.3 2.6 2.1 1.6 2.0 1.0 6.2 10.1 4.2 5.3 4.0 3.9 8.0 4.8 2.9 7.2 3.0 6.2 3.1 10.9 4.2 2.9 1.7 6.6 10.5 7.7 3.5 2.6 10.1 12.9 5.4 2.0 4.9 9.0 7.5 3.4 5.7 4.0 3.6 8.1 3.8 12.2 9.5 3.6 2.1 6.2 11.0 18.5 7.4 5.3 17.4 13.1 5.8 12.1 4.9 5.0 10.3 5.4 5.3 7.5 5.3 3.7 6.6 8.3 6.7 2.7 8.3 6.6 11.1 10.2 5.9 12.8 5.6 6.9 6.3 1.1 2.1 1.2 2.0 1.0 0.7 1.5 1.3 0.9 0.6 2.5 1.2 1.6 2.6 1.6 1.0 2.3 0.6 1.0 12.7 17.1 23.5 18.9 11.6 9.9 10.5 16.9 11.8 12.0 3.0 15.9 3.0 6.8 11.1 27.9 4.0 10.2 4.0 13.6 3.5 23.6 6.0 1.7 4.0 0.9 7.7 3.5 0.0 4.5 4.9 6.5 7.3 5.8 6.4 4.9 31.8 8.1 7.4 6.2 0.7 7.8 5.7 10.1 3.6 8.3 11.1 5.4 7.0 7.8 2.9 27.4 0.0 6.4 5.7 9.4 12.3 3.4 6.9 12.1 5.8 DDX52 ROK1 ENSG00000278053 "DExD-box helicase 52" Q9Y2R4 17 37609739-37643464 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 210.7" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056173 Uncertain Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA056173: AB_2683056" "unprognostic (1.05e-2)" "unprognostic (1.85e-1)" "prognostic favorable (9.41e-4)" "unprognostic (4.26e-2)" "unprognostic (9.96e-3)" "unprognostic (6.77e-2)" "prognostic unfavorable (2.44e-6)" "unprognostic (5.10e-2)" "unprognostic (2.94e-2)" "unprognostic (2.79e-1)" "unprognostic (7.50e-2)" "unprognostic (2.43e-1)" "unprognostic (2.36e-1)" "unprognostic (6.95e-2)" "unprognostic (5.58e-1)" "unprognostic (1.26e-2)" "unprognostic (1.28e-1)" 6.4 4.5 4.3 5.3 5.5 9.1 4.6 8.1 6.5 6.9 6.1 4.8 5.0 5.9 7.8 10.7 6.7 3.5 5.0 3.0 4.5 9.4 7.1 4.2 5.1 5.4 3.1 6.3 4.4 6.2 8.8 5.8 6.5 6.1 6.0 4.0 4.1 4.8 6.7 6.0 10.6 4.8 6.2 5.7 4.8 4.8 4.9 8.7 5.7 5.8 6.1 6.0 6.9 4.0 5.7 3.5 4.2 3.5 4.7 1.5 4.8 9.9 1.0 9.8 5.5 4.9 4.2 6.5 5.8 8.6 8.3 5.0 1.8 2.7 4.5 4.3 1.8 4.4 10.9 7.1 11.5 6.5 12.3 6.1 6.2 4.0 5.4 7.8 3.2 5.1 7.3 5.6 6.9 4.1 9.8 2.7 0.8 1.9 5.0 1.5 11.7 4.0 5.6 2.7 0.4 7.6 8.6 5.0 9.7 5.4 7.2 5.8 7.8 1.8 4.8 5.7 3.4 6.0 6.6 7.0 4.4 3.6 7.4 2.4 3.9 5.5 5.7 4.9 5.5 3.4 3.2 3.5 4.2 4.2 3.3 3.6 4.0 3.5 2.3 4.0 3.4 4.7 2.8 3.5 2.4 5.7 3.1 1.5 38.7 19.5 26.1 27.2 30.7 28.6 28.7 28.1 28.1 38.7 26.2 31.4 30.7 29.9 64.6 210.7 26.3 24.7 0.0 45.3 25.7 21.9 24.4 26.5 32.8 22.8 44.5 25.2 29.4 23.8 70.2 22.7 23.7 16.9 47.7 26.7 23.2 47.9 21.0 22.6 32.3 32.6 25.8 12.6 28.9 57.6 29.1 20.9 34.4 36.5 43.1 DDX53 "CAGE, CT26" ENSG00000184735 "DEAD-box helicase 53" Q86TM3 X 22999961-23003589 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 11.5" "Cell type enriched" "Detected in some" 5 "Early spermatids: 47.4" "Cancer enhanced" "Detected in single" "testis cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 4.6;K-562: 6.3;RPMI-8226: 3.3;U-2197: 2.1;U-266/84: 14.1" "Low region specificity" "Detected in many" HPA003186 Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA003186: AB_1078637" "unprognostic (5.76e-1)" "unprognostic (1.12e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.1 0.0 0.4 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 10.0 8.8 0.0 0.0 0.0 0.0 0.0 DDX54 "APR-5, DP97, MGC2835" ENSG00000123064 "DEAD-box helicase 54" Q8TDD1 12 113157174-113185479 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028244, HPA070786" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Nucleoplasm, Nucleoli, Golgi apparatus" "HPA028244: AB_10603885, HPA070786: AB_2686311" "unprognostic (1.61e-2)" "unprognostic (1.14e-1)" "unprognostic (1.23e-1)" "unprognostic (8.54e-2)" "unprognostic (8.57e-2)" "unprognostic (6.39e-2)" "prognostic unfavorable (1.39e-4)" "unprognostic (2.23e-2)" "unprognostic (1.03e-1)" "unprognostic (1.08e-1)" "unprognostic (1.01e-1)" "unprognostic (4.83e-2)" "unprognostic (1.15e-1)" "unprognostic (2.29e-2)" "unprognostic (2.01e-1)" "unprognostic (2.22e-1)" "unprognostic (1.24e-1)" 17.2 17.6 9.2 20.7 12.8 25.4 17.2 9.9 13.6 17.9 16.4 12.4 18.1 20.3 18.0 19.4 19.5 17.2 17.9 20.1 8.8 7.9 22.3 28.6 14.0 19.9 8.1 9.4 22.4 27.0 18.3 7.4 22.6 10.0 16.6 9.0 13.4 17.4 13.9 45.4 18.7 19.4 14.8 8.1 22.2 16.1 11.4 8.6 26.6 23.1 21.6 22.2 16.7 17.5 12.1 13.3 8.0 15.2 11.9 13.0 10.0 26.8 28.1 10.5 19.3 7.0 8.5 27.1 14.6 13.6 20.0 11.0 28.9 13.1 34.9 17.2 12.2 14.9 20.0 18.6 19.0 7.6 20.0 22.8 20.9 15.1 19.7 12.4 34.9 24.8 13.9 15.1 19.3 11.9 16.4 16.3 21.2 30.3 12.5 10.2 24.8 30.0 49.8 24.5 18.9 20.0 22.3 15.5 35.6 10.9 28.1 13.6 12.4 20.7 31.8 13.2 9.0 27.3 27.3 12.1 17.0 19.0 20.1 30.4 18.3 20.8 39.2 15.0 19.5 17.8 8.0 10.0 2.3 12.4 15.2 13.0 11.6 11.4 12.2 13.3 12.1 11.8 12.5 0.6 11.9 9.8 10.0 9.4 10.0 9.2 12.8 9.9 13.6 8.8 7.9 8.1 9.4 10.0 8.6 29.8 28.0 32.1 27.0 15.3 20.2 12.4 20.4 10.7 21.6 12.2 2.0 51.4 21.6 35.0 0.9 19.7 30.2 23.3 43.1 46.0 18.7 23.5 24.3 35.5 34.5 25.4 27.1 15.4 31.7 2.1 27.3 23.0 11.8 23.4 28.6 23.8 38.0 38.2 22.6 34.9 18.1 6.5 18.9 15.4 18.9 17.1 60.5 37.3 38.2 32.3 DDX55 KIAA1595 ENSG00000111364 "DEAD-box helicase 55" Q8NHQ9 12 123602077-123620941 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039962, HPA044101" Approved Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA039962: AB_2676774, HPA044101: AB_2678810" "unprognostic (1.14e-1)" "unprognostic (2.30e-2)" "unprognostic (2.29e-1)" "unprognostic (3.71e-3)" "unprognostic (1.92e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (2.11e-9)" "unprognostic (1.60e-1)" "unprognostic (4.49e-2)" "unprognostic (7.39e-2)" "unprognostic (1.23e-1)" "unprognostic (1.67e-3)" "prognostic unfavorable (8.97e-12)" "unprognostic (9.15e-3)" "unprognostic (2.94e-1)" "unprognostic (3.47e-2)" "unprognostic (1.23e-3)" 15.0 13.5 12.3 16.4 14.0 27.7 16.3 21.4 13.9 13.0 13.2 15.7 16.2 12.0 14.7 13.2 14.2 15.0 11.8 8.8 11.4 10.9 10.2 17.8 11.2 19.9 15.6 10.3 17.5 25.9 13.8 20.3 12.3 14.4 14.4 14.5 11.9 15.2 12.6 12.6 21.4 12.9 11.9 10.5 18.8 11.6 11.2 14.8 16.9 12.2 12.5 16.5 11.9 23.1 13.4 12.8 7.3 10.0 12.2 15.7 8.5 10.1 14.5 11.1 11.2 9.6 7.6 16.8 12.6 4.6 11.3 7.8 16.4 7.5 15.1 10.1 5.5 10.2 12.6 16.9 9.4 13.2 11.3 15.3 20.4 16.0 12.1 7.3 25.0 16.1 6.4 10.0 13.4 15.5 8.8 8.1 12.3 20.8 8.0 7.9 10.5 24.5 34.1 17.2 11.8 14.4 18.5 11.9 9.8 7.9 17.7 13.2 11.0 10.3 13.4 17.2 9.7 23.8 16.2 8.3 9.8 12.9 15.9 15.6 14.8 18.3 27.4 9.3 18.0 16.6 2.8 9.2 7.3 12.0 10.0 12.7 13.4 11.6 12.5 7.5 11.3 15.7 14.7 5.6 12.2 5.9 12.8 9.1 8.5 12.3 14.0 21.4 13.9 11.4 10.9 15.6 10.3 14.4 14.8 20.8 11.5 9.0 8.3 9.7 18.5 2.2 7.6 13.4 10.3 7.0 21.6 11.2 6.6 9.6 42.5 10.5 5.1 46.7 10.4 13.9 10.1 8.4 24.3 8.5 12.6 14.3 6.9 6.2 6.6 50.7 15.8 7.9 6.8 4.6 10.5 15.6 11.6 7.0 13.8 5.4 25.4 6.5 8.5 17.9 19.6 14.8 6.4 10.2 8.3 7.8 DDX59 "DKFZP564B1023, ZNHIT5" ENSG00000118197 "DEAD-box helicase 59" Q5T1V6 1 200623896-200669969 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047166 Approved Approved "Nucleoplasm,Actin filaments" NA NA "Nucleoplasm, Actin filaments" "HPA047166: AB_2679966" "unprognostic (1.99e-1)" "unprognostic (1.60e-1)" "unprognostic (3.44e-2)" "unprognostic (4.87e-2)" "unprognostic (1.18e-2)" "unprognostic (1.13e-1)" "unprognostic (3.05e-2)" "unprognostic (4.83e-2)" "unprognostic (3.40e-3)" "unprognostic (2.43e-3)" "unprognostic (4.16e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (9.02e-4)" "unprognostic (1.62e-1)" "unprognostic (1.65e-1)" "unprognostic (6.66e-2)" "unprognostic (5.98e-2)" 14.0 14.4 12.1 16.4 14.8 23.7 22.7 16.7 11.2 14.5 11.6 10.8 12.6 8.1 15.8 17.6 12.0 13.8 11.4 18.0 12.0 9.9 13.6 15.1 11.8 15.1 15.1 6.7 17.1 21.6 13.9 10.7 46.5 12.8 14.1 12.5 15.0 19.4 12.9 28.6 21.5 12.4 14.0 17.2 20.9 10.4 9.9 14.5 18.5 15.1 10.1 13.2 12.8 12.7 12.2 9.5 23.1 16.2 12.4 15.6 7.9 9.4 10.9 12.7 10.6 5.7 10.0 28.3 10.6 9.5 11.4 9.3 3.4 11.1 9.6 5.4 8.4 9.3 9.0 7.1 10.8 8.1 30.3 7.3 7.3 14.0 10.1 11.5 10.5 13.6 10.7 16.4 8.6 23.5 9.5 8.7 13.8 9.2 14.3 11.0 10.9 6.3 15.8 13.4 5.7 8.9 5.3 8.8 18.5 12.2 11.0 7.7 20.0 16.8 17.5 18.6 17.2 15.1 14.8 7.8 9.6 5.4 9.5 10.9 10.9 14.2 12.7 9.2 6.6 16.4 23.1 10.3 19.0 13.0 8.9 10.6 12.2 10.9 11.7 8.5 11.5 11.3 10.3 18.2 12.4 16.2 9.5 15.6 7.9 12.1 14.8 16.7 11.2 12.0 9.9 15.1 6.7 12.8 14.5 17.9 19.0 14.5 11.1 14.3 3.3 15.9 5.1 10.7 7.9 7.0 2.0 18.5 13.3 7.5 2.0 15.9 7.4 0.0 7.3 22.7 10.8 10.1 19.7 6.4 11.5 6.4 1.2 10.4 8.6 0.2 7.5 11.7 5.0 17.2 10.7 8.5 7.9 8.0 12.7 8.4 6.0 0.0 12.3 12.1 19.0 13.7 36.6 13.1 8.8 8.6 DEAF1 "NUDR, SPN, ZMYND5" ENSG00000177030 "DEAF1, transcription factor" O75398 11 644233-706715 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 36.1" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 57.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 42.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030302 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" "Intracellular and membrane" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA030302: AB_2673421" "unprognostic (1.32e-2)" "unprognostic (3.32e-2)" "unprognostic (3.58e-3)" "unprognostic (5.90e-2)" "prognostic unfavorable (9.70e-4)" "unprognostic (1.54e-2)" "prognostic unfavorable (1.75e-4)" "unprognostic (2.42e-2)" "unprognostic (2.65e-1)" "unprognostic (2.48e-1)" "unprognostic (2.61e-3)" "unprognostic (2.43e-1)" "unprognostic (2.39e-2)" "unprognostic (2.79e-1)" "unprognostic (3.03e-1)" "unprognostic (1.20e-1)" "unprognostic (5.15e-2)" 4.8 5.9 36.1 6.5 19.9 4.5 16.9 19.4 26.2 5.4 4.3 5.3 5.2 4.8 7.5 6.3 6.8 9.8 6.0 8.3 30.2 15.7 4.5 2.8 5.3 4.4 18.3 3.4 6.0 13.2 5.9 14.5 5.2 9.7 6.7 2.2 3.6 11.8 4.7 7.8 6.6 4.0 7.2 8.1 4.0 7.2 5.7 9.8 15.2 12.0 2.7 5.3 7.0 20.3 1.2 4.4 3.3 3.0 3.5 5.9 1.6 7.5 4.6 7.4 3.9 7.3 9.5 5.8 5.6 7.2 11.9 8.7 4.9 6.5 2.1 6.1 5.5 3.2 5.0 7.1 5.1 1.7 9.1 42.1 5.0 2.6 3.7 13.2 11.0 8.2 8.0 7.0 2.1 6.0 7.6 9.4 5.8 11.1 8.8 4.4 3.8 4.1 10.1 17.4 7.8 9.7 10.1 2.6 8.2 8.4 0.9 10.6 11.1 4.0 6.0 4.0 1.9 3.7 3.2 10.8 3.9 2.2 1.6 4.8 9.8 3.6 3.9 4.4 7.3 7.7 0.0 3.0 3.3 2.4 1.7 2.6 1.2 4.7 2.7 4.4 0.8 5.9 3.2 1.8 3.5 1.9 0.5 1.7 1.6 36.1 19.9 19.4 26.2 30.2 15.7 18.3 3.4 9.7 9.8 0.0 3.8 9.0 22.8 11.7 18.3 6.1 10.2 5.3 4.5 33.2 9.8 11.6 44.7 17.9 3.0 13.5 11.1 0.0 9.7 5.1 14.9 30.4 0.0 10.4 8.8 57.2 10.5 4.9 7.0 5.1 18.4 9.0 16.9 12.6 8.6 20.4 12.8 10.7 28.3 22.3 17.1 12.9 15.5 6.7 11.7 13.6 12.9 8.7 8.9 26.8 DEDD "CASP8IP1, DEDD1, DEFT, FLDED1, KE05" ENSG00000158796 "Death effector domain containing" O75618 1 161120974-161132688 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030681, HPA073628" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA030681: AB_2797220, HPA073628: AB_2732230" "unprognostic (2.24e-1)" "unprognostic (2.38e-1)" "unprognostic (4.81e-2)" "unprognostic (5.09e-2)" "unprognostic (4.20e-3)" "unprognostic (5.94e-2)" "prognostic unfavorable (8.48e-4)" "unprognostic (2.52e-1)" "unprognostic (8.70e-2)" "unprognostic (7.66e-3)" "unprognostic (2.33e-2)" "unprognostic (1.47e-2)" "prognostic unfavorable (4.98e-7)" "unprognostic (1.53e-1)" "unprognostic (1.34e-1)" "unprognostic (4.06e-2)" "unprognostic (1.43e-2)" 24.4 15.7 15.8 17.3 16.4 24.2 20.8 19.3 24.0 16.6 20.4 19.3 16.4 19.4 19.6 14.8 24.0 18.4 20.1 18.5 14.3 12.8 16.5 26.3 20.3 17.8 12.9 11.8 22.1 18.7 14.5 14.0 36.7 18.2 17.2 13.1 17.5 18.1 16.0 39.0 21.5 17.9 20.0 13.8 21.2 16.6 35.8 14.7 19.2 18.7 24.2 19.5 20.1 18.5 16.3 21.3 33.6 23.8 16.5 24.0 18.7 13.2 13.1 15.6 13.5 12.0 12.2 10.7 11.4 16.3 13.3 14.8 9.1 23.0 14.2 11.5 17.1 9.8 12.1 11.8 17.8 8.6 14.1 12.8 13.2 15.7 12.2 21.3 9.2 20.1 15.3 19.1 14.2 22.7 17.7 21.3 19.7 11.2 21.3 15.4 20.8 22.3 10.1 25.9 26.6 13.6 18.4 10.7 18.9 13.2 16.2 16.5 25.0 11.6 30.8 19.8 17.8 18.4 18.9 14.9 14.5 15.5 16.8 16.5 29.5 18.6 25.1 17.3 10.0 10.3 33.6 23.8 32.1 19.0 21.9 16.2 16.3 19.0 18.9 21.3 15.4 21.5 17.5 26.6 16.5 22.5 18.8 24.0 18.7 15.8 16.4 19.3 24.0 14.3 12.8 12.9 11.8 18.2 14.7 23.8 9.4 6.8 11.7 22.3 6.0 8.7 12.7 5.3 7.9 8.7 5.9 16.8 19.9 11.5 30.8 18.0 10.6 0.0 16.8 16.5 15.0 8.8 16.1 9.2 13.3 12.7 10.9 14.1 18.6 37.1 10.9 15.9 13.5 17.2 8.7 5.0 11.9 11.5 9.2 11.3 9.2 6.5 18.6 15.7 14.7 21.8 22.5 8.3 9.9 13.7 DEDD2 FLAME-3 ENSG00000160570 "Death effector domain containing 2" Q8WXF8 19 42198598-42220140 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 58.6" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 135.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 22.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043419 Approved Nucleoplasm NA NA Nucleoplasm "HPA043419: AB_10960747" "unprognostic (1.59e-1)" "unprognostic (5.90e-2)" "unprognostic (3.54e-2)" "unprognostic (5.87e-2)" "unprognostic (5.57e-2)" "unprognostic (6.48e-2)" "unprognostic (1.03e-1)" "unprognostic (7.55e-3)" "unprognostic (1.27e-1)" "unprognostic (6.55e-2)" "unprognostic (6.39e-2)" "unprognostic (2.46e-1)" "unprognostic (3.59e-2)" "unprognostic (1.24e-1)" "unprognostic (5.80e-2)" "unprognostic (3.70e-2)" "prognostic favorable (3.26e-6)" 8.7 12.5 9.9 13.5 13.1 22.2 12.3 17.6 14.9 7.8 13.8 6.0 11.5 14.5 7.2 7.9 11.6 9.6 6.4 6.3 9.4 15.4 11.5 11.1 12.9 12.7 14.5 5.7 9.7 11.6 7.1 17.0 10.5 10.4 13.8 5.7 6.3 11.6 8.2 13.6 11.4 13.2 5.8 8.2 17.8 19.7 9.6 10.5 17.2 24.1 6.3 13.2 10.4 58.6 16.9 19.0 49.2 29.1 14.3 21.9 24.2 10.1 22.9 1.5 1.8 3.5 0.8 6.8 4.1 3.6 3.3 2.3 6.4 6.6 6.6 8.0 1.2 3.6 4.0 6.9 1.5 1.5 5.5 18.3 3.2 5.4 9.8 4.3 3.7 6.8 0.5 3.8 2.5 3.5 6.0 1.9 2.8 15.9 7.4 0.9 4.4 3.9 11.8 3.6 9.4 13.8 4.6 2.9 5.7 2.6 3.7 11.8 4.6 3.7 10.9 2.1 2.2 2.0 4.3 3.3 2.5 7.9 1.0 7.4 13.9 6.3 2.1 3.8 5.8 2.6 27.5 21.5 34.5 20.1 27.0 21.9 16.9 18.6 19.2 13.5 16.4 16.8 17.3 49.2 14.3 29.1 19.0 17.4 24.2 9.9 13.1 17.6 14.9 9.4 15.4 14.5 5.7 10.4 10.5 6.0 6.9 42.9 43.3 41.2 27.1 5.5 5.1 21.4 3.4 14.0 11.8 24.7 10.0 21.5 27.8 12.7 56.1 0.0 21.3 35.2 14.6 62.6 72.3 7.4 33.6 14.3 88.4 6.2 27.4 2.8 12.4 48.4 37.1 35.1 33.2 17.2 32.9 38.6 12.0 13.6 18.4 6.5 24.7 15.9 12.6 46.9 135.5 55.4 23.8 77.9 DEF6 "IBP, SLAT, SWAP70L" ENSG00000023892 "DEF6, guanine nucleotide exchange factor" Q9H4E7 6 35297852-35321771 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 43.5;lymphoid tissue: 51.7" "Cell type enhanced" "Detected in many" 10 "Hofbauer cells: 76.8;Late spermatids: 127.4;T-cells: 75.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 27.3;MOLT-4: 23.7;NB-4: 31.6;REH: 21.9;THP-1: 25.3;U-937: 37.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038975, HPA038976" Enhanced Enhanced Nucleoplasm Yes NA Nucleoplasm "HPA038975: AB_10697544, HPA038976: AB_10673409" "prognostic favorable (3.02e-6)" "prognostic favorable (1.08e-4)" "prognostic unfavorable (1.71e-4)" "prognostic favorable (2.37e-4)" "unprognostic (1.93e-1)" "unprognostic (3.63e-3)" "unprognostic (2.24e-1)" "unprognostic (1.53e-2)" "unprognostic (1.64e-1)" "unprognostic (2.12e-1)" "unprognostic (2.14e-1)" "unprognostic (6.21e-3)" "prognostic unfavorable (1.02e-8)" "unprognostic (1.78e-1)" "unprognostic (2.91e-2)" "unprognostic (1.38e-1)" "unprognostic (1.45e-3)" 2.9 2.0 4.5 34.8 4.6 30.3 3.4 0.9 3.1 4.3 4.7 6.9 4.7 5.3 3.1 11.1 15.3 2.7 6.8 2.6 3.8 2.7 3.1 2.5 7.5 42.7 5.3 1.0 2.0 16.5 0.7 5.1 4.2 4.8 10.6 4.0 2.9 14.1 6.7 0.9 14.4 15.2 2.4 7.1 32.6 8.3 6.7 5.0 42.6 4.7 9.3 51.7 6.7 8.6 13.9 21.0 43.5 13.8 25.9 31.5 20.7 7.5 0.0 0.2 0.2 0.0 0.1 9.6 0.8 1.2 0.2 0.2 0.4 3.2 9.0 2.7 0.4 0.0 5.0 0.0 6.4 0.1 0.3 0.3 10.1 0.1 4.0 0.2 18.2 13.3 1.5 8.2 0.1 7.4 0.0 0.0 27.3 4.5 21.7 0.0 3.9 23.7 31.6 0.4 0.9 0.9 21.9 0.2 12.1 0.8 5.7 0.1 0.0 0.6 1.9 1.7 0.4 5.2 25.3 1.2 0.1 0.2 0.0 0.1 12.4 11.4 7.5 0.0 37.9 0.0 16.3 13.8 43.5 31.5 11.0 25.8 13.9 25.7 31.0 21.0 12.5 27.1 26.1 26.7 25.9 9.9 13.9 26.9 20.7 4.5 4.6 0.9 3.1 3.8 2.7 5.3 1.0 4.8 5.0 6.0 10.1 30.6 16.6 10.5 2.3 0.5 5.1 2.7 6.8 5.2 0.0 20.5 0.0 0.7 44.9 1.7 2.9 0.0 8.6 14.6 1.5 5.8 17.3 0.5 76.8 3.2 4.1 3.7 28.3 127.4 2.6 28.4 6.8 7.2 8.5 0.8 5.8 10.5 1.8 0.2 1.6 0.0 1.2 4.2 0.7 10.3 10.5 75.9 7.2 12.7 DEF8 FLJ20186 ENSG00000140995 "Differentially expressed in FDCP 8 homolog" Q6ZN54 16 89947925-89968060 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041745, HPA049434" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041745: AB_2677650, HPA049434: " "unprognostic (4.99e-2)" "unprognostic (1.01e-1)" "unprognostic (9.41e-3)" "unprognostic (1.24e-1)" "unprognostic (1.08e-1)" "unprognostic (8.24e-2)" "unprognostic (1.91e-3)" "unprognostic (9.96e-2)" "unprognostic (2.74e-1)" "unprognostic (1.39e-2)" "prognostic favorable (1.35e-7)" "unprognostic (1.39e-2)" "prognostic favorable (1.95e-8)" "unprognostic (9.05e-2)" "unprognostic (1.40e-1)" "unprognostic (2.32e-2)" "unprognostic (2.09e-1)" 18.0 15.9 25.4 22.4 23.0 25.3 15.6 42.4 30.6 12.6 16.4 15.4 19.4 12.0 17.1 14.1 22.5 14.3 16.3 23.7 23.7 24.8 14.9 12.2 15.4 42.8 28.0 29.0 18.2 22.5 19.0 18.0 11.5 20.5 14.5 9.2 13.9 21.4 18.9 19.5 27.4 13.6 17.6 23.6 16.6 15.2 8.8 15.0 4.8 14.5 13.6 32.4 15.5 23.8 23.0 27.4 32.0 16.7 5.3 11.5 11.1 15.2 31.2 14.2 19.2 14.6 15.5 16.2 23.7 20.2 35.1 16.4 33.0 18.5 18.5 17.9 16.1 14.3 10.1 16.7 28.1 15.6 4.5 47.6 8.3 16.6 47.2 15.8 6.0 13.2 17.4 23.3 25.1 14.8 15.5 26.2 17.1 27.2 6.3 20.8 55.7 11.7 18.2 17.9 7.1 31.9 24.4 10.4 15.8 18.8 14.7 21.0 21.6 38.2 14.3 13.3 7.8 13.3 19.5 26.2 20.3 22.2 10.8 25.1 12.3 8.7 23.2 21.7 15.5 23.7 2.3 16.7 32.0 11.5 13.4 10.5 19.6 9.6 8.4 10.7 23.0 6.6 6.4 22.5 5.3 7.6 27.4 11.4 11.1 25.4 23.0 42.4 30.6 23.7 24.8 28.0 29.0 20.5 15.0 0.0 11.3 33.5 18.0 39.8 22.8 26.6 25.5 8.1 10.3 14.0 25.5 26.2 24.9 43.1 5.6 26.4 18.2 0.0 79.2 44.9 34.3 30.7 9.3 20.2 55.6 28.6 20.7 25.8 24.7 16.0 19.5 29.4 43.9 64.1 14.3 13.8 83.0 14.4 31.5 36.3 23.3 19.4 41.1 5.6 9.0 47.8 27.1 16.2 13.2 19.7 DEGS2 "C14orf66, DES2, FADS8" ENSG00000168350 "Delta 4-desaturase, sphingolipid 2" Q6QHC5 14 100143957-100160163 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 44.5;skin 1: 30.6" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 77.6;Collecting duct cells: 78.5;Intestinal endocrine cells: 53.2;Undifferentiated cells: 46.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 22.9" "Cell type enhanced" "Detected in many" "memory B-cell: 11.9" "Group enriched" "Detected in many" 5 "B-cells: 11.9;granulocytes: 6.4" "Group enriched" "Detected in some" 16 "OE19: 29.1;T-47d: 45.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA046644 Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA046644: AB_2797231" "unprognostic (8.18e-2)" "unprognostic (3.83e-3)" "unprognostic (2.33e-1)" "unprognostic (1.32e-2)" "unprognostic (3.55e-1)" "unprognostic (4.91e-2)" "unprognostic (1.53e-1)" "unprognostic (1.13e-2)" "unprognostic (2.43e-1)" "unprognostic (1.20e-1)" "unprognostic (1.64e-1)" "unprognostic (1.38e-1)" "prognostic favorable (7.94e-7)" "unprognostic (1.03e-3)" "unprognostic (1.26e-1)" "unprognostic (1.14e-1)" "prognostic favorable (1.66e-4)" 0.4 0.3 2.0 2.3 4.6 0.5 5.8 22.9 6.4 5.3 20.2 1.8 0.6 20.8 3.4 4.6 20.9 1.9 13.3 0.3 2.0 1.5 8.7 17.2 2.6 0.8 2.4 1.4 0.8 13.0 0.3 1.6 0.6 2.7 2.5 4.2 0.8 4.5 2.3 0.5 30.6 44.5 0.7 1.9 0.5 17.9 0.7 0.7 0.0 2.4 7.3 11.1 7.1 5.2 11.9 0.7 6.4 0.5 0.2 1.8 0.8 0.0 0.1 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 1.7 0.1 0.1 0.0 29.1 0.0 0.1 0.0 1.5 0.0 0.7 2.2 0.0 0.0 1.3 0.0 0.0 45.3 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.7 0.5 6.4 1.8 0.0 0.0 11.9 0.1 0.8 0.7 5.9 0.0 1.2 0.2 0.2 0.0 0.1 0.0 0.8 2.0 4.6 22.9 6.4 2.0 1.5 2.4 1.4 2.7 0.7 3.0 5.3 0.0 2.8 1.5 4.4 0.4 38.2 77.6 11.4 78.5 0.0 5.9 1.7 13.4 1.0 0.9 31.3 0.0 1.3 1.5 0.3 1.1 9.2 0.2 1.6 0.0 53.2 0.6 1.9 1.5 0.3 1.0 0.0 0.0 43.3 1.2 2.8 43.8 0.0 0.1 24.4 0.0 0.2 0.9 1.9 13.4 31.2 1.3 46.7 17.4 DEK D6S231E ENSG00000124795 "DEK proto-oncogene" P35659 6 18223868-18264823 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Chromatin regulator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB015226, HPA054505, HPA057799" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB015226: , HPA054505: AB_2682508, HPA057799: AB_2683530" "unprognostic (6.35e-2)" "unprognostic (6.11e-2)" "unprognostic (5.04e-3)" "unprognostic (1.40e-2)" "unprognostic (3.66e-1)" "unprognostic (5.02e-3)" "prognostic unfavorable (9.65e-4)" "unprognostic (1.76e-1)" "unprognostic (1.48e-2)" "unprognostic (1.61e-3)" "unprognostic (6.49e-3)" "unprognostic (1.12e-2)" "prognostic unfavorable (3.45e-4)" "unprognostic (1.59e-1)" "unprognostic (1.68e-1)" "unprognostic (2.31e-1)" "unprognostic (3.78e-1)" 30.9 20.0 22.9 41.8 29.5 50.8 28.9 41.5 30.2 31.0 35.8 11.4 24.0 28.2 32.9 19.7 31.0 23.8 19.2 33.5 26.8 14.1 19.3 23.8 29.2 42.7 30.7 17.6 28.3 19.3 20.5 27.8 24.3 27.7 33.9 29.9 11.0 26.8 21.4 40.2 23.2 35.9 51.3 28.1 29.8 24.2 12.6 32.9 58.8 44.9 33.9 38.4 45.1 43.3 40.0 40.2 57.7 49.3 34.0 46.3 35.0 60.9 18.0 47.6 39.7 9.6 16.7 27.7 56.2 31.0 50.7 68.8 29.4 22.9 69.4 59.6 25.3 40.8 36.6 35.2 27.9 85.4 46.7 33.6 42.9 32.3 34.2 9.3 65.3 34.9 8.2 13.9 35.0 27.7 24.0 24.2 25.6 52.1 0.0 32.3 21.9 47.1 29.3 29.2 24.3 20.1 62.8 63.2 40.7 24.4 35.3 29.2 26.8 50.7 44.1 30.6 32.6 39.6 26.9 24.6 59.5 33.0 33.1 69.9 4.2 10.2 73.2 14.2 33.3 55.1 51.1 49.3 21.9 41.4 39.3 46.3 40.0 42.1 42.5 40.2 33.2 33.5 32.0 57.7 34.0 43.9 31.0 40.6 35.0 22.9 29.5 41.5 30.2 26.8 14.1 30.7 17.6 27.7 32.9 113.2 133.1 112.0 157.1 241.0 64.8 174.2 152.8 109.7 146.7 75.0 76.6 208.5 69.6 136.5 15.9 140.0 115.1 443.9 150.2 201.0 139.1 206.8 105.4 107.1 166.8 25.4 84.9 75.5 163.3 15.6 175.4 212.2 96.2 259.7 117.1 119.5 110.8 110.4 180.0 82.7 127.2 207.0 187.2 63.1 177.2 204.1 90.8 150.3 203.5 166.1 DENND1A "FAM31A, FLJ21129, KIAA1608" ENSG00000119522 "DENN domain containing 1A" Q8TEH3 9 123379654-123930152 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 67.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 8.4;granulocytes: 11.2;monocytes: 15.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020481 Supported Nucleoplasm,Vesicles,Cytosol NA NA "Vesicles, Cytosol" Nucleoplasm "HPA020481: AB_2092106" "unprognostic (1.35e-1)" "unprognostic (3.96e-2)" "unprognostic (2.00e-1)" "unprognostic (4.25e-2)" "unprognostic (1.62e-2)" "unprognostic (1.47e-1)" "unprognostic (1.34e-1)" "unprognostic (3.19e-3)" "unprognostic (2.14e-2)" "unprognostic (2.14e-2)" "unprognostic (2.48e-3)" "unprognostic (5.63e-2)" "prognostic favorable (4.11e-5)" "unprognostic (1.25e-1)" "unprognostic (1.51e-1)" "unprognostic (9.66e-2)" "unprognostic (4.31e-2)" 11.4 12.2 17.4 13.9 19.8 32.5 10.0 18.6 21.2 10.9 14.8 12.8 10.3 15.8 13.3 9.0 11.3 13.0 10.5 10.3 15.9 12.8 16.4 14.5 9.4 11.6 11.8 14.9 12.0 8.9 20.1 19.0 23.9 13.9 11.0 14.1 14.5 8.5 11.8 11.0 9.3 17.2 14.4 10.1 20.2 9.9 12.1 13.2 10.6 15.5 5.6 9.5 10.6 17.4 1.5 8.4 11.2 15.2 0.5 1.3 3.2 14.8 8.8 7.9 14.9 5.4 8.5 36.8 14.4 21.8 12.3 10.7 12.0 6.6 11.9 3.0 11.6 16.3 8.4 6.7 10.5 12.0 5.0 5.1 5.6 21.3 8.8 7.2 6.7 3.8 7.8 9.5 10.2 17.5 4.3 10.9 11.6 15.4 9.2 9.9 8.5 8.0 9.7 15.7 17.2 13.4 12.5 7.7 10.1 6.1 5.3 16.8 13.7 11.6 7.7 9.0 5.4 10.5 17.0 5.1 13.3 5.1 15.5 7.5 14.0 10.9 8.2 11.2 13.4 8.8 11.2 15.2 2.8 1.3 10.1 0.7 1.1 0.9 0.6 8.4 1.5 0.6 0.7 9.3 0.5 8.2 1.3 0.4 3.2 17.4 19.8 18.6 21.2 15.9 12.8 11.8 14.9 13.9 13.2 0.0 1.0 7.3 2.3 4.5 15.9 7.7 7.6 1.4 1.2 15.7 15.7 8.6 5.0 4.0 28.4 10.1 17.6 0.0 4.4 27.4 5.2 4.7 4.6 12.1 14.5 30.2 11.5 7.4 15.9 67.9 13.6 10.8 3.3 2.8 6.6 13.5 5.2 10.7 10.6 11.5 12.3 0.0 5.2 3.4 1.1 2.5 7.3 3.8 6.7 3.1 DENND1C "FAM31C, FLJ22757" ENSG00000205744 "DENN domain containing 1C" Q8IV53 19 6467207-6482557 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 26.7;lymphoid tissue: 32.9" "Cell type enhanced" "Detected in many" 10 "B-cells: 28.3;Erythroid cells: 23.3;granulocytes: 16.1;T-cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 13.2;HEL: 8.8;HMC-1: 27.4;MOLT-4: 8.4;THP-1: 8.1;U-937: 18.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA042758, HPA042839" Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA Cytosol "Nucleoplasm, Centrosome" "HPA042758: AB_10962357, HPA042839: AB_10959898" "unprognostic (5.94e-2)" "unprognostic (1.41e-3)" "unprognostic (4.26e-2)" "unprognostic (1.93e-3)" "unprognostic (1.21e-1)" "unprognostic (1.72e-3)" "unprognostic (3.91e-2)" "prognostic favorable (1.23e-4)" "unprognostic (7.76e-3)" "unprognostic (4.45e-2)" "unprognostic (1.89e-2)" "prognostic unfavorable (8.95e-4)" "prognostic favorable (7.51e-14)" "unprognostic (1.37e-3)" "unprognostic (1.27e-1)" "unprognostic (4.53e-2)" "prognostic favorable (5.62e-4)" 2.1 1.3 1.5 22.0 2.5 14.1 2.0 0.5 1.6 1.0 2.8 2.5 0.0 3.4 1.0 1.5 1.7 1.7 3.4 1.0 1.3 1.3 2.2 2.0 5.2 30.1 3.1 0.6 0.8 1.0 0.0 1.1 1.3 2.2 1.7 0.8 1.4 5.4 0.8 0.6 1.0 12.1 0.8 2.7 31.3 3.5 0.5 2.7 32.9 1.8 1.2 25.2 3.0 1.5 16.3 12.2 19.0 20.6 14.1 26.7 20.2 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 13.2 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 8.8 0.0 0.9 0.0 4.3 27.4 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.1 5.7 0.1 0.0 8.4 6.7 0.0 0.3 0.0 1.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.2 1.1 6.1 0.0 18.3 0.0 10.4 11.6 19.0 26.7 20.6 23.4 16.3 19.1 22.9 12.2 13.7 24.8 21.6 17.6 14.1 20.0 7.1 21.9 20.2 1.5 2.5 0.5 1.6 1.3 1.3 3.1 0.6 2.2 2.7 3.0 4.8 28.3 0.0 0.3 0.0 0.9 2.5 2.7 0.0 1.8 0.0 0.1 1.7 0.4 0.6 0.0 1.1 23.3 0.0 0.2 0.2 0.0 16.1 0.0 12.9 0.0 0.0 1.8 9.9 0.4 0.0 9.2 3.3 3.6 0.6 0.0 0.4 0.0 0.0 3.4 0.0 0.0 0.3 0.2 0.7 0.1 0.2 32.3 0.8 0.1 DENND2C "dJ1156J9.1, DKFZp686G0351, DKFZp779P1149, FLJ37099, RP5-1156J9.1" ENSG00000175984 "DENN domain containing 2C" Q68D51 1 114582848-114670422 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 28.7;skeletal muscle: 31.1" "Cell type enhanced" "Detected in many" 14 "Basal glandular cells: 99.0;Basal keratinocytes: 97.0;Suprabasal keratinocytes: 150.2;Urothelial cells: 270.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "basophil: 6.1;eosinophil: 2.1" "Lineage enriched" "Detected in single" 9 "granulocytes: 6.1" "Cell line enhanced" "Detected in many" "U-2197: 10.3;U-266/70: 22.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA029935, HPA054955" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA029935: AB_10601208, HPA054955: AB_2682648" "unprognostic (2.25e-1)" "unprognostic (1.08e-1)" "unprognostic (9.97e-2)" "unprognostic (4.89e-4)" "unprognostic (1.52e-1)" "unprognostic (2.46e-1)" "unprognostic (2.53e-1)" "unprognostic (3.18e-1)" "unprognostic (1.26e-1)" "unprognostic (6.61e-2)" "unprognostic (2.20e-2)" "unprognostic (7.43e-2)" "unprognostic (2.77e-2)" "unprognostic (2.24e-2)" "unprognostic (6.11e-2)" "unprognostic (3.64e-2)" "unprognostic (1.57e-2)" 1.9 0.7 1.5 0.7 1.5 0.8 1.7 1.4 1.1 8.6 1.1 0.5 0.8 0.6 4.2 1.7 28.7 1.0 1.1 1.5 1.3 0.5 0.8 2.1 1.7 1.7 0.6 0.3 1.1 4.0 2.4 3.6 0.3 1.9 2.5 0.6 1.6 3.0 1.4 31.1 10.6 0.6 2.4 0.6 0.5 0.8 4.5 0.2 0.0 1.3 16.0 10.4 6.2 6.6 0.6 0.1 6.1 0.2 0.3 0.5 0.3 1.7 0.0 0.1 1.2 1.5 1.7 0.3 0.5 0.9 0.6 0.9 0.2 0.0 0.0 0.8 3.5 1.2 6.5 1.2 4.0 0.6 0.0 1.6 1.0 0.4 0.1 0.5 0.0 1.6 1.7 3.9 2.4 2.0 0.1 0.2 0.4 0.1 0.3 2.1 5.1 0.2 0.1 0.8 0.0 0.9 0.0 5.5 0.1 0.1 4.9 0.0 0.0 3.9 0.1 0.4 1.1 0.8 0.3 0.2 0.9 1.3 10.3 0.1 22.5 4.0 0.0 0.9 0.0 0.7 6.1 0.2 2.1 0.5 0.0 0.5 0.6 0.1 0.4 0.0 0.4 0.3 0.2 0.5 0.3 0.1 0.1 0.2 0.3 1.5 1.5 1.4 1.1 1.3 0.5 0.6 0.3 1.9 0.2 26.8 2.1 0.0 99.0 97.0 21.6 6.9 12.7 20.1 4.5 7.0 19.6 0.1 0.0 5.6 23.7 8.7 0.0 0.0 6.4 0.0 5.3 46.7 2.3 11.0 0.2 0.0 0.0 13.5 3.4 9.1 4.6 1.6 6.8 1.0 0.8 2.0 20.3 0.0 2.1 0.6 8.7 0.0 8.5 23.4 49.0 150.2 0.0 0.7 0.5 270.3 DENND2D "FLJ22457, RP5-1180E21.2" ENSG00000162777 "DENN domain containing 2D" Q9H6A0 1 111187174-111204535 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 51.0;lymphoid tissue: 67.6" "Cell type enhanced" "Detected in many" 8 "T-cells: 105.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "gdT-cell: 44.8;MAIT T-cell: 38.2;memory CD4 T-cell: 32.5;memory CD8 T-cell: 45.6;naive CD4 T-cell: 51.0;naive CD8 T-cell: 48.4;NK-cell: 45.1;T-reg: 13.7" "Group enriched" "Detected in all" 6 "NK-cells: 45.1;T-cells: 51.0" "Cell line enhanced" "Detected in many" "HDLM-2: 21.0;MOLT-4: 52.9;SK-BR-3: 34.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA043630, HPA048642" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043630: AB_2678589, HPA048642: AB_2680474" "unprognostic (1.72e-3)" "prognostic favorable (1.67e-4)" "unprognostic (2.60e-2)" "unprognostic (7.01e-2)" "unprognostic (1.91e-2)" "prognostic favorable (2.70e-4)" "unprognostic (5.09e-2)" "unprognostic (8.10e-2)" "unprognostic (1.35e-1)" "unprognostic (4.66e-3)" "unprognostic (3.09e-2)" "unprognostic (1.02e-1)" "unprognostic (9.61e-2)" "unprognostic (3.80e-3)" "unprognostic (5.45e-2)" "unprognostic (2.75e-2)" "prognostic favorable (8.66e-5)" 8.9 11.1 0.9 42.9 2.6 3.5 6.5 0.8 1.6 4.9 10.4 1.4 4.9 6.4 2.4 5.9 19.5 6.4 9.9 2.5 1.0 1.0 11.4 9.3 11.5 42.0 2.6 0.8 3.0 7.5 8.8 8.0 20.2 1.9 9.2 6.9 3.7 21.1 4.7 1.3 7.9 13.8 1.3 3.2 33.8 9.0 5.1 1.8 39.2 8.0 7.0 67.6 15.7 8.2 8.2 3.2 3.5 3.5 45.1 51.0 29.6 10.4 0.4 0.0 0.0 2.6 1.0 0.1 0.6 0.0 1.1 0.2 3.1 5.1 11.1 3.7 1.6 0.0 3.3 0.0 0.5 1.1 21.0 0.0 3.3 0.7 0.0 3.9 0.0 3.4 3.1 2.3 0.3 0.0 3.5 0.1 4.2 0.0 3.5 0.3 8.9 52.9 0.3 0.0 13.2 1.4 1.3 0.0 16.1 3.7 11.3 3.7 0.0 3.7 34.3 1.2 0.0 10.1 10.5 0.0 0.0 0.0 0.0 0.0 3.2 1.3 8.3 0.0 9.3 0.0 0.8 3.5 2.3 44.8 2.5 38.2 7.2 32.5 45.6 3.2 8.2 51.0 48.4 3.5 45.1 1.8 2.4 13.7 29.6 0.9 2.6 0.8 1.6 1.0 1.0 2.6 0.8 1.9 1.8 6.0 15.6 29.2 15.0 4.4 0.0 0.9 7.6 18.7 18.2 19.2 0.0 1.2 16.6 23.6 26.8 2.9 16.1 0.0 14.1 2.1 4.1 21.1 17.3 4.9 46.9 0.0 5.8 9.2 28.5 38.6 1.1 9.9 6.8 1.0 23.6 0.0 13.8 14.0 0.4 21.0 0.5 0.0 0.7 13.0 0.7 3.4 9.6 105.1 20.4 26.5 DENND4A "IRLB, MYCPBP" ENSG00000174485 "DENN domain containing 4A" Q7Z401 15 65658046-65792293 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 93.5;Horizontal cells: 104.9;Rod photoreceptor cells: 124.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065343 Uncertain Approved "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA065343: AB_2685476" "unprognostic (1.10e-1)" "unprognostic (8.43e-2)" "unprognostic (4.96e-2)" "unprognostic (1.60e-1)" "unprognostic (1.31e-1)" "unprognostic (3.29e-1)" "unprognostic (8.02e-2)" "unprognostic (2.30e-2)" "unprognostic (8.88e-2)" "unprognostic (2.28e-1)" "unprognostic (1.82e-1)" "unprognostic (1.38e-1)" "unprognostic (1.66e-1)" "unprognostic (7.83e-2)" "unprognostic (3.45e-1)" "unprognostic (2.24e-1)" "unprognostic (3.48e-1)" 13.7 15.7 9.5 13.9 11.3 32.9 9.5 26.7 12.6 10.0 9.6 12.2 6.8 6.9 11.5 6.6 8.0 9.3 13.2 8.2 10.7 8.5 9.8 19.1 12.8 20.8 12.1 9.7 16.3 19.9 17.9 21.2 9.9 11.6 8.1 8.2 14.6 9.5 7.2 15.3 7.6 10.2 12.5 16.6 13.6 10.2 9.0 11.9 16.9 12.7 5.6 20.1 13.4 10.1 9.3 3.1 6.8 3.6 4.4 8.0 1.9 4.8 4.6 2.4 2.5 7.3 8.1 3.0 5.1 6.8 3.4 5.0 2.6 3.9 25.2 3.5 7.4 4.2 9.2 4.7 4.5 6.0 27.9 5.5 23.9 6.0 5.0 4.2 8.1 8.5 5.4 5.1 4.7 10.0 6.0 9.1 5.7 7.2 15.6 3.9 2.6 3.7 4.3 0.7 14.6 3.5 1.8 8.6 21.7 4.0 9.4 3.9 3.7 4.9 3.4 4.4 3.0 3.3 20.7 9.8 4.7 5.3 8.5 7.0 8.5 9.5 9.5 6.7 17.7 3.8 3.1 3.6 6.8 5.3 1.5 8.0 7.8 4.6 6.7 3.1 9.3 4.9 4.7 1.9 4.4 1.2 1.2 4.2 1.9 9.5 11.3 26.7 12.6 10.7 8.5 12.1 9.7 11.6 11.9 14.9 23.9 21.9 25.1 24.7 75.6 10.9 15.3 21.4 21.6 8.7 56.9 4.2 0.0 7.8 1.5 23.3 5.1 93.5 11.3 5.7 14.1 17.9 47.4 23.2 16.5 104.9 16.7 17.8 20.8 2.9 12.0 24.7 23.6 7.2 10.1 24.1 12.2 10.4 11.7 8.7 124.0 6.5 16.4 10.7 9.6 14.9 10.5 29.9 8.9 14.1 DENND4B KIAA0476 ENSG00000198837 "DENN domain containing 4B" O75064 1 153929501-153946696 "Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040188, HPA071133" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA040188: AB_10671168, HPA071133: AB_2732173" "unprognostic (1.75e-1)" "unprognostic (4.75e-2)" "unprognostic (1.59e-2)" "unprognostic (9.42e-2)" "unprognostic (1.12e-1)" "unprognostic (1.45e-3)" "prognostic unfavorable (4.14e-4)" "unprognostic (1.58e-1)" "unprognostic (1.73e-1)" "unprognostic (6.03e-2)" "prognostic favorable (3.18e-5)" "unprognostic (2.21e-1)" "prognostic unfavorable (9.27e-9)" "unprognostic (4.24e-2)" "unprognostic (1.36e-1)" "unprognostic (1.48e-2)" "unprognostic (1.56e-3)" 14.5 9.6 14.4 21.5 13.6 30.7 9.9 23.5 19.7 8.6 8.3 11.9 3.1 9.2 10.3 7.9 7.7 8.8 9.9 12.4 10.5 9.8 8.6 7.9 14.2 25.8 12.5 8.5 12.4 11.0 8.5 8.3 10.1 12.6 7.9 6.3 8.0 10.2 7.6 40.6 8.6 12.7 8.8 9.3 25.9 9.2 5.5 12.9 15.7 9.4 5.9 21.1 10.7 7.7 3.0 4.8 3.9 6.2 2.0 3.9 3.0 5.9 11.5 8.9 8.9 5.3 5.2 9.3 5.8 6.4 9.3 8.8 6.9 6.9 15.0 10.0 3.9 7.1 10.6 8.0 5.4 4.2 13.7 7.2 13.2 12.0 6.6 7.4 13.8 26.9 4.7 9.5 8.7 9.4 7.8 6.6 16.5 14.0 8.5 5.3 12.3 16.7 12.8 12.3 7.1 11.2 18.0 6.0 8.5 4.5 8.9 10.6 13.0 6.2 14.7 8.3 9.3 10.6 34.2 6.8 10.1 9.8 8.3 9.3 25.7 18.0 19.8 6.9 10.9 12.0 2.5 3.8 1.1 3.3 6.2 3.9 2.9 2.6 1.9 3.7 3.0 1.3 2.8 3.9 2.0 4.9 4.8 1.7 3.0 14.4 13.6 23.5 19.7 10.5 9.8 12.5 8.5 12.6 12.9 8.9 13.0 8.3 3.2 4.1 20.5 18.1 12.7 4.0 5.7 7.0 5.9 3.8 5.0 4.4 1.2 10.9 4.3 23.3 5.5 4.0 4.9 4.5 17.3 8.3 15.5 33.4 4.7 11.1 26.6 0.4 6.9 22.4 5.0 6.4 4.8 6.1 5.6 3.5 7.4 2.3 16.9 6.5 5.0 5.4 8.9 3.0 2.9 14.9 6.3 4.3 DEPDC1 "DEP.8, DEPDC1A, FLJ20354, SDP35" ENSG00000024526 "DEP domain containing 1" Q5TB30 1 68474152-68497221 "Predicted intracellular proteins" "Transcription, Transcription regulation" "GTPase activation, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 28.6;testis: 19.5" "Group enriched" "Detected in many" 7 "Early spermatids: 29.0;Erythroid cells: 70.0;Extravillous trophoblasts: 29.4;Late spermatids: 57.0;Spermatocytes: 71.4;Spermatogonia: 20.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "T-reg: 2.6" "Lineage enhanced" "Detected in single" "T-cells: 2.6" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" CAB017845 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA Yes Nucleoplasm "Nucleoli fibrillar center" "CAB017845: " "unprognostic (2.73e-1)" "unprognostic (7.40e-2)" "prognostic favorable (8.70e-5)" "unprognostic (1.23e-3)" "unprognostic (3.06e-1)" "unprognostic (7.73e-3)" "unprognostic (4.37e-6)" "unprognostic (3.39e-3)" "unprognostic (1.57e-3)" "unprognostic (8.59e-2)" "unprognostic (9.04e-6)" "unprognostic (2.18e-1)" "unprognostic (0.00e+0)" "unprognostic (2.39e-2)" "unprognostic (2.27e-1)" "unprognostic (2.83e-2)" "unprognostic (1.11e-1)" 1.3 0.8 0.7 12.1 0.5 5.1 1.9 0.3 0.7 1.2 3.3 0.1 0.5 2.9 0.5 0.7 6.5 0.6 0.3 1.3 2.1 0.6 0.7 0.8 2.0 5.5 0.5 0.2 0.6 0.5 0.3 0.4 7.4 0.3 2.5 4.3 0.5 1.3 0.0 0.4 1.7 3.7 1.5 0.4 3.1 1.4 19.5 0.0 28.6 0.5 5.4 5.7 1.5 2.0 0.3 0.0 0.0 0.0 0.8 2.6 0.3 15.5 7.2 13.8 6.3 0.9 2.0 10.8 20.0 9.2 17.1 14.8 6.0 6.5 0.0 14.9 8.2 27.4 10.5 20.0 10.4 29.0 13.6 13.1 12.7 12.8 3.4 0.2 10.9 0.0 0.7 0.5 19.5 10.9 3.5 12.3 5.6 8.7 12.4 30.3 3.5 0.0 4.1 11.9 6.5 9.9 0.0 41.2 5.1 6.9 4.2 15.5 7.2 20.0 8.5 10.4 9.3 7.7 5.5 7.2 11.0 12.6 19.4 23.1 7.8 16.7 0.1 10.4 3.8 22.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 2.6 0.3 0.7 0.5 0.3 0.7 2.1 0.6 0.5 0.2 0.3 0.0 0.0 0.0 0.0 0.2 3.0 0.4 0.5 0.0 0.0 0.0 1.8 0.0 3.1 0.0 0.1 29.0 0.0 0.7 70.0 0.0 29.4 1.9 1.8 0.0 0.0 6.9 0.0 0.0 0.6 1.9 57.0 0.3 1.3 0.0 0.0 1.9 0.0 0.1 0.0 0.4 0.0 0.2 0.0 1.0 71.4 20.2 1.1 2.4 1.3 2.5 1.4 DEPDC1B "BRCC3, XTP1" ENSG00000035499 "DEP domain containing 1B" Q8WUY9 5 60596912-60700190 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.6;placenta: 71.5" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 17.8;Extravillous trophoblasts: 18.7;Spermatocytes: 32.0;Syncytiotrophoblasts: 39.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 6.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA038255, HPA072558" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA Yes "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA038255: AB_10669521, HPA072558: AB_2686534" "unprognostic (1.38e-1)" "unprognostic (1.99e-2)" "prognostic favorable (2.42e-4)" "prognostic unfavorable (8.55e-4)" "unprognostic (2.23e-1)" "unprognostic (7.93e-2)" "prognostic unfavorable (3.08e-4)" "prognostic unfavorable (6.93e-5)" "unprognostic (2.13e-2)" "unprognostic (8.14e-2)" "unprognostic (1.47e-3)" "unprognostic (2.44e-2)" "unprognostic (1.11e-16)" "unprognostic (1.00e-1)" "unprognostic (1.40e-1)" "unprognostic (1.53e-1)" "unprognostic (8.62e-2)" 0.6 0.6 0.6 3.7 1.5 7.9 0.6 0.8 1.4 1.2 3.3 0.6 0.1 4.8 0.9 0.5 5.2 0.4 19.0 0.4 0.8 0.8 3.3 0.9 1.0 6.9 2.3 0.7 0.6 0.5 0.0 0.3 71.5 1.4 0.5 4.6 0.4 1.3 0.1 0.2 2.1 5.1 0.5 3.2 3.3 2.0 17.0 1.2 21.6 1.5 2.3 7.6 0.9 2.2 1.0 0.6 3.3 0.3 1.4 6.4 0.9 24.0 8.2 25.0 15.2 0.5 0.8 27.4 6.5 4.4 11.5 15.0 13.6 15.3 13.7 16.1 2.0 14.9 8.0 20.0 14.6 15.5 19.5 14.5 17.1 9.4 16.9 0.4 14.4 16.7 0.5 1.5 3.7 5.4 2.2 10.6 14.7 12.2 18.8 10.1 15.1 23.2 12.6 18.4 5.2 13.3 25.8 20.3 11.7 9.3 12.0 13.9 6.4 15.3 5.5 7.2 11.7 10.2 11.5 4.9 4.9 14.4 3.9 16.5 9.5 16.6 27.1 6.1 21.2 13.6 3.3 0.3 1.7 0.5 0.0 0.4 1.0 2.2 1.5 0.6 0.1 0.3 0.3 0.0 1.4 0.0 0.1 6.4 0.9 0.6 1.5 0.8 1.4 0.8 0.8 2.3 0.7 1.4 1.2 0.0 2.6 0.8 0.8 4.1 0.0 0.0 17.8 0.0 0.0 0.0 0.0 1.9 0.0 0.3 1.4 0.1 1.7 0.0 0.2 18.7 0.4 0.5 3.5 0.0 5.2 0.0 0.0 0.0 1.2 1.8 0.3 2.2 0.0 0.0 1.0 0.2 0.7 2.0 0.0 0.5 0.0 6.5 0.4 32.0 8.7 1.8 39.2 0.0 6.3 0.3 DEPDC7 ENSG00000121690 "DEP domain containing 7" Q96QD5 11 33015864-33033582 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 51.8;liver: 42.2" "Cell type enhanced" "Detected in many" 17 "Basal keratinocytes: 30.9;Early spermatids: 98.0;Extravillous trophoblasts: 40.1;Spermatocytes: 27.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 9.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 27.2;RH-30: 20.6;SiHa: 18.8;U-2197: 17.5" "Low region specificity" "Detected in many" HPA015800 Approved Nucleoplasm,Nucleoli,Cytosol Yes No Nucleoli "Nucleoplasm, Cytosol" "HPA015800: AB_1847610" "unprognostic (2.34e-1)" "unprognostic (5.57e-2)" "unprognostic (1.27e-1)" "unprognostic (2.27e-1)" "unprognostic (2.66e-2)" "unprognostic (7.26e-2)" "prognostic favorable (7.26e-4)" "unprognostic (1.80e-1)" "unprognostic (1.22e-1)" "unprognostic (2.92e-1)" "unprognostic (1.17e-3)" "unprognostic (8.99e-2)" "unprognostic (1.89e-2)" "unprognostic (9.30e-2)" "unprognostic (8.09e-3)" "unprognostic (2.64e-1)" "unprognostic (2.94e-2)" 0.6 0.5 2.0 1.4 4.1 0.9 2.0 0.5 2.6 1.7 15.3 4.3 1.2 14.1 1.2 1.4 3.1 0.8 3.1 0.9 2.6 1.4 10.9 42.2 0.7 0.4 4.0 1.5 1.3 2.7 3.5 0.8 1.2 2.8 1.4 3.1 1.2 1.7 1.0 3.3 3.4 51.8 1.0 3.2 0.5 2.2 15.6 3.3 1.8 0.6 2.0 0.9 0.9 2.4 0.0 4.4 9.0 0.7 3.0 3.1 0.6 4.5 2.5 3.7 1.6 2.0 1.9 2.5 8.2 2.7 5.0 6.8 6.7 0.4 0.0 1.9 8.1 2.3 4.7 5.4 1.9 6.0 0.0 7.5 1.3 7.9 9.4 1.6 4.4 5.6 2.4 2.9 2.9 2.1 2.7 0.0 0.0 3.0 0.0 27.2 0.5 0.0 7.1 2.4 3.8 0.0 0.0 20.6 0.0 1.6 0.6 0.8 2.1 18.8 3.3 16.3 2.7 0.8 2.3 0.0 3.2 5.4 17.5 5.2 0.0 0.0 0.0 1.2 0.0 15.9 4.0 0.7 9.0 0.3 0.2 0.0 0.0 0.6 0.3 4.4 0.0 2.9 3.1 0.0 3.0 0.0 1.8 0.0 0.6 2.0 4.1 0.5 2.6 2.6 1.4 4.0 1.5 2.8 3.3 0.0 0.0 0.0 8.3 30.9 0.0 0.0 0.0 1.4 1.2 0.0 0.0 0.3 3.3 0.4 98.0 0.1 8.6 0.0 0.5 40.1 1.6 0.8 2.3 19.4 2.7 0.0 3.4 2.5 0.3 6.3 1.4 2.4 1.7 1.8 1.0 0.0 1.0 0.0 1.1 11.2 0.0 0.0 1.4 27.7 7.6 6.5 1.3 0.0 2.1 0.7 DEPTOR "DEP.6, DEPDC6, FLJ12428" ENSG00000155792 "DEP domain containing MTOR interacting protein" Q8TB45 8 119873717-120050913 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 67.6;skeletal muscle: 65.0" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 72.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 11 "myeloid DC: 17.1" "Lineage enriched" "Detected in many" 11 "dendritic cells: 17.1" "Cell line enhanced" "Detected in many" "Daudi: 30.3;RPMI-8226: 54.0;RPTEC TERT1: 44.7;U-698: 15.9" "Low region specificity" "Detected in all" "CAB020841, HPA023938, HPA023945, HPA024011" Enhanced Supported Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "CAB020841: , HPA023938: AB_1847606, HPA023945: AB_1847607, HPA024011: AB_1847608" "unprognostic (3.41e-1)" "unprognostic (1.95e-1)" "unprognostic (1.53e-2)" "unprognostic (1.15e-2)" "unprognostic (3.19e-1)" "unprognostic (2.57e-1)" "unprognostic (1.08e-1)" "unprognostic (4.13e-3)" "unprognostic (2.43e-1)" "unprognostic (2.49e-2)" "unprognostic (3.24e-2)" "unprognostic (6.02e-2)" "unprognostic (7.29e-2)" "unprognostic (5.66e-2)" "unprognostic (1.02e-1)" "unprognostic (4.16e-2)" "unprognostic (2.84e-2)" 8.1 30.2 6.4 5.2 11.0 1.1 9.7 5.1 9.2 18.9 12.7 17.8 5.7 7.8 16.0 5.7 7.2 12.7 6.1 4.3 7.3 6.3 22.7 7.5 2.7 8.5 9.5 6.1 12.5 5.6 13.3 13.6 4.4 7.5 6.4 4.8 0.7 67.6 7.9 65.0 4.3 7.4 7.7 8.2 5.3 20.0 2.1 11.5 0.7 45.0 20.7 2.7 4.8 5.7 0.1 17.1 0.3 1.5 0.3 0.8 0.8 0.0 1.0 0.1 0.3 6.4 1.9 0.1 0.0 0.1 0.1 0.1 0.7 0.1 30.3 0.7 0.3 0.0 0.1 1.6 0.0 0.1 0.6 0.8 4.1 0.2 0.1 3.9 0.8 7.1 1.7 2.9 0.2 0.1 0.0 0.0 0.5 0.0 5.0 0.1 2.0 0.0 0.7 0.4 13.2 1.0 0.1 1.4 54.0 44.7 1.2 0.9 0.2 0.5 3.3 0.9 0.9 2.9 0.1 0.0 0.1 0.2 6.4 0.1 13.4 3.1 15.9 1.9 1.1 0.2 0.0 0.8 0.0 0.2 1.5 0.7 0.1 0.3 0.6 17.1 0.1 0.8 0.5 0.3 0.3 0.1 0.8 0.3 0.8 6.4 11.0 5.1 9.2 7.3 6.3 9.5 6.1 7.5 11.5 6.0 9.4 4.5 12.1 4.6 2.2 2.2 15.3 0.0 5.7 24.4 0.0 0.5 72.9 3.3 1.3 3.6 3.9 0.0 10.6 1.5 8.2 11.1 11.5 10.5 2.8 0.0 16.0 4.3 11.8 1.1 10.9 7.6 13.5 1.8 2.9 0.9 1.3 20.9 3.2 24.6 0.4 0.0 1.7 3.2 3.2 4.8 0.3 0.0 14.7 16.9 DERA "CGI-26, DEOC" ENSG00000023697 "Deoxyribose-phosphate aldolase" Q9Y315 12 15911172-16037282 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055897 Supported Nucleoplasm NA NA 180000 Nucleoplasm "HPA055897: AB_2682963" "unprognostic (3.05e-1)" "unprognostic (1.26e-1)" "unprognostic (1.06e-2)" "unprognostic (7.26e-2)" "unprognostic (8.12e-2)" "unprognostic (7.74e-2)" "unprognostic (1.36e-1)" "unprognostic (1.47e-2)" "unprognostic (2.76e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (1.32e-4)" "unprognostic (2.13e-1)" "unprognostic (1.09e-1)" "unprognostic (8.74e-2)" "unprognostic (2.17e-2)" "prognostic favorable (3.64e-5)" "unprognostic (3.66e-2)" 20.3 12.0 10.5 10.8 10.8 7.5 11.5 5.2 7.7 11.3 30.3 11.4 12.7 20.2 21.5 14.7 20.0 8.2 11.1 11.7 10.1 9.1 40.9 51.5 13.6 14.1 12.5 6.5 5.8 16.9 6.6 27.5 12.3 11.3 9.2 21.2 11.0 11.4 11.3 15.3 12.4 46.7 10.4 14.6 14.6 10.5 5.5 11.0 13.8 26.6 16.7 14.3 10.1 13.1 12.4 30.2 14.1 28.2 17.1 14.9 15.7 19.0 15.8 12.4 10.9 8.4 19.2 25.4 11.1 10.5 15.2 19.5 19.0 35.4 13.0 9.9 14.2 13.7 13.5 13.4 14.3 27.0 21.7 7.8 11.5 7.9 17.9 12.1 12.1 7.8 12.8 16.6 12.4 25.5 12.9 21.9 11.1 1.6 4.0 27.6 7.0 9.0 10.1 27.0 10.7 7.8 13.8 27.2 8.1 38.1 6.9 9.0 15.3 21.0 7.0 21.9 51.1 37.9 15.2 21.6 16.2 10.7 7.4 11.9 4.3 6.3 22.4 20.8 12.2 11.9 5.4 24.4 14.1 7.2 27.1 7.9 12.4 7.8 7.7 30.2 11.4 8.6 6.9 6.5 17.1 28.2 16.5 14.9 15.7 10.5 10.8 5.2 7.7 10.1 9.1 12.5 6.5 11.3 11.0 41.7 25.0 18.6 24.3 26.1 5.0 11.4 22.9 21.4 22.7 12.2 13.7 54.5 92.9 55.2 33.8 25.2 49.7 0.0 52.2 57.8 21.3 17.5 8.1 44.5 53.2 3.2 25.4 30.7 32.6 3.0 22.7 32.0 69.2 55.9 43.0 20.9 60.6 45.0 28.7 104.3 25.2 6.5 18.6 5.0 14.7 22.6 59.6 10.0 39.9 24.7 DET1 FLJ10103 ENSG00000140543 "DET1, COP1 ubiquitin ligase partner" Q7L5Y6 15 88494440-88546675 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048873 Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Yes No "Nucleoplasm, Microtubules" "Cytokinetic bridge, Cytosol" "HPA048873: AB_2680541" "unprognostic (9.21e-2)" "unprognostic (1.83e-1)" "unprognostic (2.34e-1)" "unprognostic (1.26e-1)" "unprognostic (3.17e-1)" "unprognostic (1.86e-1)" "unprognostic (1.20e-2)" "unprognostic (6.64e-2)" "unprognostic (1.84e-1)" "unprognostic (4.01e-2)" "unprognostic (1.52e-1)" "unprognostic (4.00e-2)" "unprognostic (2.82e-3)" "unprognostic (2.62e-2)" "unprognostic (1.20e-1)" "unprognostic (8.69e-2)" "unprognostic (4.67e-2)" 6.0 9.3 5.5 4.3 7.0 1.9 6.4 5.5 6.8 9.5 6.3 8.2 7.0 5.5 15.9 9.1 3.8 9.6 7.8 8.8 4.3 4.2 5.4 4.5 4.3 4.2 5.0 6.1 17.9 10.1 7.1 6.4 5.6 5.9 8.5 5.6 12.6 6.7 7.4 13.8 4.4 5.9 11.4 5.1 4.4 5.5 3.6 4.6 10.7 6.8 4.1 6.4 7.7 6.0 5.3 7.6 2.9 7.4 3.4 6.6 3.8 2.0 6.8 9.7 7.1 4.8 7.3 1.9 6.6 7.1 5.8 6.1 1.4 6.5 4.0 5.1 8.4 5.7 3.2 11.0 2.0 5.0 0.3 7.0 7.6 3.8 2.4 7.6 2.9 1.6 6.2 7.3 2.7 7.9 4.9 4.5 4.1 9.5 4.8 7.3 3.2 4.1 3.2 4.4 3.2 2.1 4.8 8.0 4.9 3.0 6.0 3.7 5.9 7.4 2.6 16.6 7.1 3.7 6.0 3.6 5.9 4.6 6.0 6.1 2.8 2.0 2.6 6.6 4.9 5.2 0.0 4.8 2.9 5.3 7.4 3.9 4.8 4.6 4.7 7.6 5.3 6.6 5.4 0.7 3.4 4.6 4.1 5.1 3.8 5.5 7.0 5.5 6.8 4.3 4.2 5.0 6.1 5.9 4.6 3.0 2.4 1.7 2.1 0.6 11.9 1.6 0.0 4.0 1.2 3.5 9.8 5.5 1.7 2.6 0.4 2.1 2.6 0.0 3.3 5.7 3.9 1.2 0.0 2.8 3.7 6.4 2.9 1.3 1.2 0.4 4.0 2.3 3.3 4.6 2.5 6.5 2.5 0.0 3.5 1.9 7.2 0.0 3.1 4.8 8.5 1.1 3.4 0.5 2.9 1.3 DFFB "CAD, CPAN, DFF-40, DFF40" ENSG00000169598 "DNA fragmentation factor subunit beta" O76075 1 3857267-3885429 "Predicted intracellular proteins" Apoptosis "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 43.2;Extravillous trophoblasts: 23.7;Horizontal cells: 14.3;Rod photoreceptor cells: 19.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004328, HPA052904" Approved Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "CAB004328: AB_626776, HPA052904: AB_2681985" "unprognostic (2.98e-1)" "unprognostic (5.09e-2)" "unprognostic (4.37e-2)" "unprognostic (1.52e-3)" "unprognostic (6.12e-2)" "unprognostic (1.83e-2)" "unprognostic (1.38e-2)" "unprognostic (1.28e-3)" "unprognostic (2.66e-2)" "unprognostic (1.79e-1)" "unprognostic (7.82e-3)" "unprognostic (4.07e-1)" "unprognostic (1.90e-2)" "unprognostic (9.86e-3)" "unprognostic (3.39e-1)" "unprognostic (2.27e-1)" "prognostic favorable (6.29e-5)" 4.7 4.1 6.0 5.0 7.8 3.8 4.0 13.2 7.8 3.8 4.3 4.2 2.0 12.5 5.9 1.5 3.1 4.9 4.2 4.1 4.1 1.8 2.9 2.0 3.5 2.9 5.4 4.1 6.7 9.3 1.3 8.7 4.8 2.9 3.0 1.6 4.3 3.3 3.3 1.9 2.3 5.6 2.6 3.0 5.6 4.1 1.7 6.3 2.8 3.2 1.0 5.6 4.7 3.4 3.1 6.3 6.9 8.2 2.7 6.4 3.7 3.1 2.9 1.4 4.0 0.9 1.0 0.9 2.7 0.9 3.0 2.9 1.7 1.3 1.2 1.8 0.6 0.3 0.9 0.4 1.7 0.2 7.3 7.5 11.0 1.2 1.6 2.6 6.0 8.6 0.5 0.3 2.7 0.1 0.8 3.3 4.9 6.1 1.3 0.7 0.9 6.6 3.6 2.2 1.1 6.3 5.5 2.3 2.4 0.6 0.4 2.9 5.0 2.0 3.0 8.3 0.0 0.7 3.6 5.0 1.2 1.0 5.8 2.4 2.4 3.6 3.4 1.4 9.4 1.7 5.3 5.5 6.9 4.7 5.1 2.9 3.1 3.0 3.8 6.3 1.2 2.8 4.5 1.7 2.7 8.2 0.1 6.4 3.7 6.0 7.8 13.2 7.8 4.1 1.8 5.4 4.1 2.9 6.3 3.0 5.8 0.0 1.0 0.6 4.4 0.8 2.5 1.4 2.3 1.8 43.2 3.0 1.7 1.9 0.8 2.1 2.0 0.0 1.4 23.7 2.1 0.7 0.0 1.6 2.5 14.3 2.4 3.1 5.3 1.1 1.1 1.9 0.0 0.0 4.1 3.5 1.6 0.0 4.6 2.2 19.3 0.0 0.5 1.8 3.2 0.3 1.1 3.2 3.7 0.7 DGCR8 "C22orf12, DGCRK6, Gy1, pasha" ENSG00000128191 "DGCR8, microprocessor complex subunit" Q8WYQ5 22 20080232-20111877 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 46.8;Rod photoreceptor cells: 59.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 41.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA076916, HPA079351" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA076916: , HPA079351: " "unprognostic (2.57e-1)" "unprognostic (1.12e-1)" "unprognostic (1.97e-1)" "unprognostic (1.81e-1)" "unprognostic (8.34e-2)" "unprognostic (2.75e-3)" "prognostic unfavorable (1.08e-4)" "unprognostic (2.34e-1)" "unprognostic (5.72e-3)" "unprognostic (2.83e-1)" "unprognostic (1.09e-3)" "unprognostic (2.62e-2)" "prognostic unfavorable (5.67e-4)" "unprognostic (1.02e-2)" "unprognostic (4.20e-1)" "unprognostic (4.68e-2)" "unprognostic (2.26e-2)" 7.9 7.8 9.9 10.3 10.1 10.1 9.4 29.8 14.1 9.7 10.3 11.8 13.4 7.6 14.5 8.1 11.7 11.5 10.5 7.8 10.0 6.9 7.9 7.9 8.1 8.9 10.6 9.7 13.9 15.2 11.6 16.8 17.9 10.4 9.5 7.9 11.3 10.5 10.3 19.9 11.3 10.1 12.6 7.4 10.3 10.0 22.4 10.9 11.1 9.8 11.9 9.0 11.5 12.6 1.7 3.3 1.2 6.8 3.2 4.6 2.7 12.1 8.6 11.2 6.6 4.4 7.2 14.3 11.7 7.0 7.9 5.6 9.2 6.2 10.8 6.5 10.9 5.3 11.7 10.2 9.7 6.9 10.6 15.1 11.8 9.1 7.5 11.7 21.7 9.8 5.7 12.2 8.3 6.1 7.3 6.9 6.6 41.6 7.9 9.2 7.8 13.0 6.4 10.9 8.8 6.5 15.6 11.9 3.7 4.8 11.4 12.5 8.0 10.7 6.3 6.8 7.0 6.0 9.3 10.3 11.6 9.7 7.2 11.8 4.4 6.0 10.9 8.6 9.9 11.2 0.0 2.1 1.2 4.5 1.9 3.5 1.7 2.2 4.6 2.9 1.5 2.3 2.6 0.4 3.2 6.8 3.3 2.7 2.7 9.9 10.1 29.8 14.1 10.0 6.9 10.6 9.7 10.4 10.9 6.0 9.3 8.0 4.5 8.5 34.3 2.5 5.1 6.7 6.8 5.2 37.3 11.0 0.0 5.6 46.8 6.7 6.3 0.0 8.7 9.5 5.6 7.7 3.5 11.3 4.6 41.3 7.0 8.6 7.0 31.3 17.0 3.8 5.0 6.4 9.2 15.8 8.6 6.0 9.9 2.8 59.4 6.5 4.7 16.9 13.0 8.2 11.3 6.9 8.2 4.7 DGKA "DAGK, DAGK1, DGK-alpha" ENSG00000065357 "Diacylglycerol kinase alpha" P23743 12 55927319-55954027 "Enzymes, Predicted intracellular proteins" "Lipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 117.1" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 38.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 42.2;hTERT-HME1: 44.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041645, HPA045462" Approved Approved Nucleoplasm,Vesicles,Mitochondria NA NA Vesicles "Nucleoplasm, Mitochondria" "HPA041645: AB_2677595, HPA045462: AB_2679335" "unprognostic (1.12e-3)" "unprognostic (1.43e-2)" "unprognostic (1.62e-2)" "unprognostic (2.63e-2)" "unprognostic (5.23e-2)" "unprognostic (2.04e-1)" "unprognostic (3.62e-1)" "unprognostic (3.31e-2)" "unprognostic (5.28e-2)" "unprognostic (1.94e-1)" "unprognostic (1.82e-2)" "unprognostic (2.46e-1)" "prognostic unfavorable (1.66e-5)" "unprognostic (4.06e-1)" "unprognostic (1.00e-1)" "unprognostic (1.47e-1)" "unprognostic (7.02e-2)" 4.9 4.7 7.1 31.8 8.2 9.7 4.8 6.0 10.8 8.4 13.4 3.6 3.1 20.5 6.9 4.1 42.0 4.9 7.9 3.8 4.6 2.4 3.9 1.5 7.6 28.6 2.1 4.1 4.9 6.4 6.2 3.1 10.2 3.3 10.6 11.0 4.1 16.2 5.3 1.0 33.0 27.2 5.7 3.7 23.1 4.8 4.4 2.6 117.1 4.5 9.6 57.0 13.0 15.1 7.6 4.0 5.4 2.8 5.2 30.2 10.9 6.7 4.3 3.0 4.0 7.5 9.8 0.9 15.2 15.6 6.0 4.4 2.0 11.5 3.8 3.6 10.1 2.0 12.4 3.2 42.2 7.2 3.2 0.7 6.1 9.1 1.1 6.5 1.9 6.0 8.4 22.8 8.3 44.8 20.0 12.2 22.7 0.7 5.9 16.1 0.7 12.5 2.4 0.6 5.6 5.1 5.8 1.0 0.6 14.2 19.5 0.5 1.7 5.0 0.2 0.5 8.2 2.7 2.0 10.9 3.9 2.8 0.8 0.5 0.7 0.3 9.2 4.7 5.2 1.1 5.2 2.8 5.4 6.5 2.0 11.7 7.6 24.3 11.7 4.0 6.4 30.2 18.1 5.2 5.2 1.2 4.0 26.7 10.9 7.1 8.2 6.0 10.8 4.6 2.4 2.1 4.1 3.3 2.6 3.0 6.2 15.6 8.5 13.4 0.8 2.0 0.0 0.0 11.4 5.2 0.0 13.4 0.0 4.1 6.5 3.3 38.4 0.0 8.4 4.0 3.8 8.2 6.9 0.0 3.7 0.0 2.4 4.9 4.1 4.7 3.4 10.2 0.0 16.2 7.5 4.9 15.8 6.2 2.8 0.1 0.4 6.5 3.1 3.8 2.7 12.2 22.1 20.6 5.2 18.0 DGKE "DAGK6, DGK" ENSG00000153933 "Diacylglycerol kinase epsilon" P52429 17 56834099-56869567 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Transferase" "Disease mutation, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Bipolar cells: 167.4;Cone photoreceptor cells: 178.7;Rod photoreceptor cells: 165.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 43.5;MOLT-4: 14.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017167 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA017167: AB_1847638" "unprognostic (1.19e-2)" "unprognostic (2.11e-2)" "unprognostic (2.69e-1)" "prognostic favorable (3.92e-5)" "unprognostic (4.20e-2)" "unprognostic (4.87e-2)" "unprognostic (3.37e-1)" "unprognostic (4.27e-2)" "unprognostic (1.19e-3)" "unprognostic (4.75e-2)" "unprognostic (6.07e-3)" "unprognostic (2.68e-1)" "unprognostic (2.55e-2)" "unprognostic (1.99e-1)" "unprognostic (2.17e-1)" "unprognostic (1.26e-1)" "unprognostic (3.69e-3)" 7.8 4.9 7.8 8.3 17.7 5.5 5.2 21.3 18.6 9.5 7.4 4.4 5.6 5.4 13.3 8.9 5.0 8.2 9.4 4.9 7.4 9.2 4.2 4.9 8.1 9.3 5.6 10.0 7.3 6.5 9.5 14.5 5.5 9.9 8.9 7.0 17.4 4.3 7.3 2.4 3.4 7.1 9.3 6.8 12.7 6.4 12.5 5.4 14.5 8.3 2.5 8.6 6.5 15.3 2.4 2.4 1.2 0.8 1.9 4.5 0.8 1.7 1.6 1.5 0.1 0.3 0.5 0.7 2.9 2.3 2.0 2.3 3.8 2.1 2.5 3.6 1.5 1.0 2.1 3.6 1.6 4.1 8.0 4.7 3.2 4.0 2.5 1.7 6.2 4.5 0.9 2.0 2.1 4.2 1.8 2.7 7.4 2.6 43.5 2.4 2.5 14.5 3.5 1.1 2.2 4.9 4.5 6.3 5.9 2.0 3.8 2.4 1.6 2.3 1.2 0.1 1.0 2.7 3.0 2.4 0.5 2.7 0.8 0.4 5.7 11.7 1.7 1.7 3.6 0.1 0.3 0.5 0.0 2.7 0.4 2.0 2.4 1.9 2.3 0.6 0.9 1.9 2.5 1.2 1.9 0.8 2.4 4.5 0.8 7.8 17.7 21.3 18.6 7.4 9.2 5.6 10.0 9.9 5.4 3.0 5.9 2.2 10.2 7.9 167.4 5.5 15.3 1.4 4.5 15.7 178.7 3.2 0.0 6.5 13.1 23.3 3.4 0.0 4.0 2.2 4.3 13.9 0.0 3.8 1.9 7.9 10.9 32.5 5.6 7.4 4.0 4.1 3.3 2.8 7.1 13.8 4.9 5.5 4.9 0.0 165.4 6.5 10.3 25.4 18.5 5.8 2.9 13.8 4.6 8.8 DHDH HUM2DD ENSG00000104808 "Dihydrodiol dehydrogenase" Q9UQ10 19 48933682-48944969 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 32.4;kidney: 18.0" "Cell type enriched" "Detected in many" 5 "Proximal tubular cells: 56.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 5.8;naive CD4 T-cell: 4.8" "Group enriched" "Detected in many" 31 "granulocytes: 5.8;T-cells: 4.8" "Cell line enhanced" "Detected in many" "JURKAT: 6.3;U-266/70: 6.4;U-266/84: 5.0" "Low region specificity" "Detected in all" HPA044131 Approved Approved "Nucleoplasm,Actin filaments" NA NA "Nucleoplasm, Actin filaments" "HPA044131: AB_10966968" "unprognostic (1.54e-1)" "unprognostic (2.72e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (9.91e-4)" "unprognostic (3.33e-3)" "unprognostic (1.45e-1)" "unprognostic (5.81e-6)" "unprognostic (1.56e-2)" "unprognostic (5.88e-2)" "unprognostic (4.96e-2)" "unprognostic (3.30e-2)" "unprognostic (5.08e-2)" "prognostic favorable (3.15e-4)" "unprognostic (2.93e-2)" "unprognostic (1.23e-1)" "unprognostic (1.67e-1)" "unprognostic (1.54e-1)" 0.3 0.5 1.5 0.1 2.1 0.1 0.2 1.8 1.5 0.1 8.2 0.2 0.1 10.6 0.2 0.4 0.8 0.3 0.8 0.1 2.7 2.0 18.0 0.7 1.9 0.2 0.4 0.4 0.5 0.4 0.2 2.1 1.3 0.6 3.5 0.1 1.2 0.8 0.2 0.3 0.2 32.4 0.1 0.9 1.8 0.7 2.8 0.1 0.4 0.1 0.5 0.7 1.1 0.3 0.1 0.0 5.8 0.0 0.0 4.8 0.5 2.8 0.0 0.2 1.4 0.8 0.6 1.1 0.0 0.4 0.5 1.4 2.7 2.2 0.0 0.5 0.0 1.8 0.8 0.9 2.0 0.9 1.0 2.2 3.9 0.9 1.0 0.0 0.0 0.9 0.5 0.2 1.1 0.0 0.7 0.0 6.3 1.2 0.4 0.0 0.6 0.0 0.2 0.6 4.0 1.8 1.4 0.2 1.9 0.3 0.9 4.2 2.3 0.5 0.3 0.9 0.3 1.9 0.1 0.0 0.0 1.7 0.6 0.1 6.4 5.0 1.6 1.3 0.0 0.4 5.8 0.0 0.9 1.6 0.0 0.8 0.0 1.6 0.7 0.0 0.1 4.8 3.1 0.1 0.0 0.0 0.0 1.2 0.5 1.5 2.1 1.8 1.5 2.7 2.0 0.4 0.4 0.6 0.1 3.0 5.4 0.0 2.6 0.7 1.3 0.4 0.0 0.0 4.5 3.5 0.0 0.1 8.3 1.3 0.5 0.6 1.7 0.0 0.3 0.1 0.5 5.2 1.1 0.0 10.9 0.0 0.0 0.0 0.8 1.4 0.0 0.0 0.0 0.0 0.7 1.5 1.2 2.9 0.0 56.2 4.3 0.0 0.1 0.0 0.6 0.1 0.1 0.0 0.6 2.6 DHODH ENSG00000102967 "Dihydroorotate dehydrogenase (quinone)" Q02127 16 72008588-72027664 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Pyrimidine biosynthesis" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 72.4" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010123, HPA011942" Approved Enhanced Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA010123: AB_1847648, HPA011942: AB_1847649" "unprognostic (4.88e-2)" "unprognostic (1.10e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-2)" "unprognostic (1.41e-3)" "unprognostic (2.10e-1)" "unprognostic (4.27e-2)" "unprognostic (1.31e-2)" "unprognostic (1.26e-1)" "unprognostic (2.68e-1)" "unprognostic (2.14e-1)" "unprognostic (6.40e-2)" "unprognostic (9.26e-3)" "unprognostic (1.98e-1)" "unprognostic (1.97e-1)" "unprognostic (1.14e-1)" "unprognostic (1.81e-1)" 5.9 4.2 4.7 8.8 5.1 2.9 5.0 2.7 5.0 5.9 4.4 6.1 1.4 3.4 6.6 2.3 5.1 5.2 2.3 11.5 4.3 3.0 6.6 72.4 3.4 5.5 4.8 2.7 6.2 9.9 7.1 4.0 2.6 5.2 3.9 4.8 5.9 6.0 4.4 11.7 4.0 3.0 7.5 4.0 3.5 3.4 4.3 5.4 4.0 3.6 7.1 5.1 3.5 3.3 11.2 13.4 3.9 8.1 9.3 12.9 6.8 7.4 15.5 4.5 7.5 2.4 3.2 8.6 6.4 2.6 9.7 7.5 12.2 6.8 16.8 8.7 3.5 5.4 7.9 8.9 6.9 11.5 3.8 8.4 9.2 7.5 12.0 6.8 12.7 6.8 3.1 7.1 11.7 12.3 3.1 7.0 11.4 14.0 3.1 5.9 19.8 12.0 12.2 10.2 12.7 6.1 15.2 5.9 17.7 5.8 4.9 5.4 6.3 8.6 9.2 4.2 5.8 8.2 6.4 3.0 8.9 5.5 8.4 9.3 5.9 10.9 28.4 4.6 14.0 8.1 3.9 8.1 0.9 9.3 7.7 12.7 11.2 8.9 9.0 13.3 10.6 12.4 12.9 2.1 9.3 5.6 13.4 7.1 6.8 4.7 5.1 2.7 5.0 4.3 3.0 4.8 2.7 5.2 5.4 3.0 9.6 9.5 6.4 4.9 5.7 12.1 7.6 9.4 1.2 7.0 3.9 12.0 5.0 6.6 2.1 6.7 0.7 0.0 4.4 9.6 6.0 5.0 8.1 106.1 6.9 3.2 1.2 2.5 5.3 2.3 2.6 3.4 11.8 3.6 4.4 4.8 5.2 2.9 2.1 20.1 4.2 0.0 9.9 7.9 8.0 3.3 2.4 5.0 6.2 4.1 DHPS MIG13 ENSG00000095059 "Deoxyhypusine synthase" P49366 19 12675717-12681902 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hypusine biosynthesis" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014461, HPA029413" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA014461: AB_1847651, HPA029413: AB_10602217" "unprognostic (4.17e-2)" "unprognostic (2.55e-2)" "unprognostic (2.05e-2)" "unprognostic (2.61e-1)" "unprognostic (3.10e-1)" "unprognostic (1.01e-2)" "unprognostic (3.06e-1)" "unprognostic (2.42e-1)" "unprognostic (1.85e-1)" "unprognostic (3.59e-2)" "unprognostic (1.20e-2)" "unprognostic (4.85e-2)" "unprognostic (3.05e-2)" "unprognostic (2.46e-3)" "unprognostic (1.32e-1)" "unprognostic (1.56e-1)" "unprognostic (8.83e-2)" 16.4 30.3 26.9 18.6 31.2 17.0 24.8 43.3 38.8 20.7 25.7 27.5 25.3 23.1 20.9 16.9 21.3 32.3 18.2 26.0 26.3 28.0 23.4 30.3 18.9 24.2 27.5 28.0 34.8 32.0 28.8 32.6 23.2 22.4 24.1 24.5 20.2 24.8 24.6 65.1 25.6 21.5 24.5 29.1 19.5 24.2 13.3 26.3 31.9 24.9 22.9 26.9 23.5 19.2 39.6 29.5 35.8 30.5 27.8 38.1 29.7 20.6 15.3 24.8 13.1 11.1 18.5 5.8 13.3 19.5 25.4 25.6 10.9 10.1 21.4 15.1 14.5 23.4 12.6 17.0 18.8 17.6 18.8 12.0 14.3 16.7 14.2 13.7 17.1 22.9 14.8 23.2 15.3 26.5 25.8 17.8 42.8 13.0 15.3 18.5 41.1 30.4 24.8 19.4 27.0 26.0 20.2 9.3 30.9 19.5 11.1 32.4 43.9 13.4 19.5 22.6 15.7 18.0 28.6 8.9 29.9 12.1 29.2 20.2 48.8 52.5 14.5 18.4 21.0 28.2 14.5 27.0 35.8 24.7 24.2 25.9 39.6 28.9 25.6 29.0 36.9 38.1 28.1 9.7 27.8 30.5 29.5 34.3 29.7 26.9 31.2 43.3 38.8 26.3 28.0 27.5 28.0 22.4 26.3 38.7 21.2 44.9 67.5 49.3 77.6 7.7 22.9 34.8 9.1 31.4 43.2 43.4 72.9 48.6 15.6 35.9 36.2 0.0 32.3 43.6 36.5 53.0 23.1 29.4 38.0 39.7 39.6 18.4 36.3 21.8 41.7 38.3 47.2 71.3 54.9 114.9 45.5 63.3 32.5 75.5 92.9 45.3 55.6 29.6 70.0 44.5 60.1 50.3 52.4 59.7 DHRS1 "FLJ25430, MGC20204, SDR19C1" ENSG00000157379 "Dehydrogenase/reductase 1" Q96LJ7 14 24290598-24299833 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 47.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000599, HPA076886" Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA000599: AB_1078655, HPA076886: " "unprognostic (2.08e-3)" "unprognostic (1.37e-1)" "unprognostic (2.26e-2)" "unprognostic (2.75e-1)" "unprognostic (3.57e-1)" "unprognostic (6.57e-2)" "prognostic favorable (1.18e-5)" "prognostic favorable (6.83e-4)" "unprognostic (3.66e-1)" "unprognostic (1.20e-1)" "unprognostic (2.21e-3)" "unprognostic (9.88e-2)" "unprognostic (2.25e-3)" "unprognostic (1.32e-2)" "unprognostic (1.58e-1)" "unprognostic (2.04e-1)" "unprognostic (2.08e-1)" 6.5 8.9 3.0 6.1 5.0 3.3 7.4 6.3 6.0 8.6 12.0 9.8 8.4 16.1 6.7 8.9 35.7 5.4 10.2 3.7 2.7 3.1 8.5 47.1 6.7 4.8 3.6 5.3 4.2 10.7 11.5 5.2 4.1 6.0 5.5 5.4 7.1 14.0 15.6 1.8 20.8 25.7 4.8 4.4 6.3 6.1 2.8 3.7 5.6 6.6 25.6 16.5 6.0 13.0 10.4 10.7 17.3 9.5 4.2 11.7 4.7 11.1 2.7 2.9 1.1 6.8 7.2 0.7 4.0 8.8 9.5 10.3 1.0 10.9 5.2 1.7 6.2 1.5 9.1 2.2 18.5 4.6 3.5 2.3 1.6 6.5 17.6 3.2 3.1 1.2 6.5 10.9 2.3 1.7 7.7 7.1 4.3 3.2 5.0 7.7 4.5 1.2 1.1 0.5 8.9 4.0 4.0 2.0 7.2 7.3 4.2 2.5 1.9 5.7 7.7 1.9 2.1 3.9 0.9 2.7 0.7 1.8 1.1 1.3 2.8 2.2 2.5 3.4 2.7 0.9 10.0 8.7 17.3 6.9 9.5 7.5 10.4 7.5 6.3 10.7 7.0 7.6 4.2 5.7 4.2 5.9 6.4 11.7 4.7 3.0 5.0 6.3 6.0 2.7 3.1 3.6 5.3 6.0 3.7 20.8 17.9 18.2 23.9 29.2 10.8 13.9 45.9 16.0 18.2 33.2 17.7 40.2 33.2 24.7 15.1 15.7 74.2 0.0 26.8 7.7 17.9 21.4 5.8 70.1 24.0 14.3 18.5 14.1 11.6 27.0 18.7 16.2 43.9 11.8 37.9 14.1 42.2 46.0 19.4 44.2 44.1 25.8 21.7 26.2 9.3 40.0 21.9 26.1 38.6 36.3 DHRS12 "FLJ13639, SDR40C1" ENSG00000102796 "Dehydrogenase/reductase 12" A0PJE2 13 51767993-51804157 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 36.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 15.6" "Low region specificity" "Detected in all" "CAB034238, HPA057028, HPA058315" Uncertain Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "CAB034238: AB_2091845, HPA057028: AB_2683314, HPA058315: AB_2683678" "prognostic favorable (1.41e-4)" "unprognostic (1.98e-2)" "unprognostic (2.98e-1)" "unprognostic (7.57e-2)" "unprognostic (2.98e-1)" "unprognostic (1.42e-1)" "unprognostic (8.47e-3)" "unprognostic (1.70e-1)" "unprognostic (3.51e-1)" "unprognostic (3.99e-2)" "unprognostic (1.21e-2)" "unprognostic (3.98e-1)" "prognostic favorable (2.22e-16)" "unprognostic (2.85e-3)" "unprognostic (1.01e-1)" "unprognostic (2.03e-2)" "unprognostic (3.44e-1)" 15.6 6.4 6.9 4.1 7.1 3.9 11.1 5.2 10.9 9.5 7.6 13.8 7.1 5.5 8.4 16.0 7.7 7.5 7.4 8.3 6.0 6.0 14.2 15.8 8.7 4.8 5.8 6.2 10.4 37.6 11.1 10.0 7.3 8.0 7.7 4.7 14.0 11.5 13.0 10.4 10.1 12.2 8.3 7.2 8.3 7.3 3.9 6.5 4.4 10.2 6.9 9.2 6.4 5.7 6.0 4.5 36.3 7.3 1.6 11.6 5.7 0.9 3.1 5.6 7.6 2.5 5.4 5.2 1.7 3.9 2.2 1.2 3.5 15.6 3.9 1.2 3.2 3.5 1.9 0.1 0.8 0.3 3.6 2.7 1.2 1.0 3.2 6.7 0.7 1.1 3.4 6.0 0.7 3.2 7.1 5.2 3.6 1.6 4.4 2.5 4.5 1.5 3.2 6.7 7.0 0.5 0.5 0.7 6.4 8.8 2.6 3.4 7.1 2.6 5.7 6.8 8.3 5.9 3.9 9.1 1.3 1.9 0.3 1.8 2.1 1.5 1.9 4.0 2.1 4.9 2.9 7.3 0.2 6.4 6.2 11.6 6.0 9.9 8.0 4.0 5.6 8.8 6.2 36.3 1.6 7.0 4.5 8.6 5.7 6.9 7.1 5.2 10.9 6.0 6.0 5.8 6.2 8.0 6.5 11.9 15.0 11.1 11.1 10.1 10.7 13.2 17.8 16.0 7.9 15.7 7.9 20.5 44.7 8.8 21.4 11.2 6.8 0.0 14.6 15.3 9.1 9.3 11.5 27.6 14.7 3.2 9.9 8.6 10.7 43.5 10.3 9.4 13.5 9.0 12.3 24.0 14.0 13.1 9.2 51.9 18.3 0.0 12.3 1.6 6.3 13.0 19.9 13.3 11.5 9.2 DHRS2 "HEP27, SDR25C1" ENSG00000100867 "Dehydrogenase/reductase 2" Q13268 14 23630115-23645639 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 79.9;prostate: 40.2;urinary bladder: 120.7;vagina: 47.1" "Cell type enhanced" "Detected in some" 11 "Extravillous trophoblasts: 10.3;Spermatogonia: 8.5;Syncytiotrophoblasts: 20.7;Urothelial cells: 11.9" "Cancer enriched" "Detected in many" 6 "urothelial cancer: 141.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 49.9;RT4: 59.8;SK-BR-3: 292.6;U-2 OS: 95.8" "Region enriched" "Detected in single" 4 "cerebellum: 2.7" "HPA053915, HPA069551" Enhanced Supported Nucleoplasm,Mitochondria No NA Mitochondria Nucleoplasm "HPA053915: AB_2682307, HPA069551: AB_2686150" "unprognostic (3.07e-1)" "unprognostic (4.91e-2)" "unprognostic (3.44e-2)" "prognostic unfavorable (3.23e-4)" "unprognostic (9.97e-2)" "unprognostic (5.03e-3)" "unprognostic (5.62e-2)" "unprognostic (1.86e-1)" "unprognostic (4.08e-1)" "unprognostic (6.91e-2)" "unprognostic (6.66e-2)" "unprognostic (4.59e-2)" "prognostic unfavorable (3.75e-5)" "unprognostic (1.83e-1)" "unprognostic (1.46e-1)" "unprognostic (1.76e-1)" "prognostic favorable (6.45e-4)" 0.1 0.3 0.3 0.0 0.2 0.0 79.9 0.1 0.2 0.5 0.1 0.1 0.3 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.3 0.8 1.8 5.0 0.2 0.0 0.2 0.0 9.0 5.9 0.3 0.5 5.0 0.1 40.2 0.0 0.1 20.1 0.6 0.1 0.7 0.1 23.1 0.3 3.7 0.8 0.9 0.0 0.0 0.1 0.0 0.0 120.7 47.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.4 0.0 0.0 0.2 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.0 0.1 20.1 1.5 0.1 0.0 49.9 0.0 0.2 1.8 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.0 0.4 2.2 0.1 0.4 0.1 0.0 59.8 0.2 0.3 0.4 292.6 0.3 0.0 0.2 0.0 0.0 0.1 95.8 0.5 0.3 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.2 0.3 0.8 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 5.9 6.6 0.0 3.4 0.0 0.0 0.0 0.2 10.3 0.3 0.2 0.0 0.8 1.6 0.0 3.4 0.0 0.8 3.0 0.0 0.0 0.0 1.0 0.0 0.0 6.7 0.0 1.1 0.1 1.0 6.5 0.0 0.0 8.5 0.1 20.7 0.0 0.5 11.9 DHRS7 "retDSR4, SDR34C1" ENSG00000100612 "Dehydrogenase/reductase 7" Q9Y394 14 60144120-60169856 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 123.5" "Low cell type specificity" "Detected in many" "Cancer enriched" "Detected in all" 5 "prostate cancer: 199.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031121, HPA078401" Enhanced Approved Nucleoplasm,Mitochondria No No 63000 "Nucleoplasm, Mitochondria" "HPA031121: AB_10600803, HPA078401: " "prognostic favorable (6.42e-4)" "unprognostic (5.20e-2)" "unprognostic (6.70e-3)" "unprognostic (1.67e-1)" "unprognostic (2.69e-1)" "prognostic unfavorable (2.51e-4)" "unprognostic (4.65e-2)" "unprognostic (4.31e-2)" "unprognostic (2.62e-1)" "prognostic unfavorable (7.99e-4)" "unprognostic (1.73e-1)" "unprognostic (1.59e-1)" "prognostic favorable (1.92e-10)" "unprognostic (8.35e-3)" "unprognostic (1.48e-1)" "unprognostic (1.07e-1)" "unprognostic (3.61e-1)" 15.0 24.6 12.3 10.1 10.9 10.5 17.9 10.6 12.4 11.1 30.6 10.7 57.3 20.7 11.7 19.4 12.3 9.9 15.3 17.4 11.0 11.4 22.6 27.9 13.1 13.9 14.1 8.8 13.4 17.2 40.2 17.2 6.1 17.8 83.4 13.4 9.1 113.7 93.0 123.5 9.8 48.7 9.6 15.5 11.1 32.6 4.9 11.0 6.4 24.8 16.7 10.1 12.4 15.6 26.0 56.6 121.4 32.2 37.3 50.8 54.0 52.6 15.9 9.2 20.2 47.7 18.7 11.7 17.0 43.8 6.2 13.8 8.8 35.7 5.5 10.2 15.9 15.8 22.7 12.0 23.9 9.1 38.3 11.2 13.6 7.8 14.4 25.1 16.1 0.4 13.9 28.8 9.8 33.3 11.1 11.9 14.0 4.1 11.9 15.5 15.9 9.3 15.3 4.3 31.1 16.1 9.7 12.4 6.4 27.7 18.0 19.8 24.8 17.2 26.1 37.7 11.8 18.3 7.1 8.3 30.9 10.5 8.4 9.7 4.2 1.9 9.8 16.8 15.6 21.2 80.1 32.2 71.6 50.8 22.6 49.9 26.0 36.0 43.9 27.1 21.8 20.2 38.9 121.4 37.3 29.0 56.6 29.0 54.0 12.3 10.9 10.6 12.4 11.0 11.4 14.1 8.8 17.8 11.0 50.6 96.5 40.4 57.0 30.2 23.6 16.5 147.7 46.8 59.1 82.0 78.5 22.0 16.6 184.7 1.5 65.9 155.6 0.0 145.2 76.8 60.2 242.6 172.3 147.5 88.2 39.7 44.6 30.1 58.9 2.0 76.2 101.1 102.9 178.5 77.9 88.0 174.5 89.2 79.2 41.6 54.4 84.1 70.6 1.1 3.1 22.2 17.4 135.7 66.0 41.6 DHX16 "DBP2, DDX16, Prp2, PRPF2" ENSG00000204560 "DEAH-box helicase 16" O60231 6 30653119-30673037 "Enzymes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051455 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA051455: AB_2681491" "unprognostic (7.04e-2)" "unprognostic (1.37e-1)" "unprognostic (7.29e-2)" "unprognostic (7.46e-2)" "unprognostic (1.48e-1)" "unprognostic (1.94e-1)" "unprognostic (4.36e-3)" "unprognostic (1.13e-1)" "unprognostic (2.66e-2)" "unprognostic (3.11e-1)" "unprognostic (8.58e-2)" "unprognostic (1.24e-2)" "unprognostic (9.77e-3)" "unprognostic (4.42e-2)" "unprognostic (1.51e-1)" "unprognostic (2.64e-1)" "unprognostic (8.73e-3)" 12.8 15.8 12.7 16.8 14.0 12.1 14.4 16.8 14.9 13.3 16.2 12.3 15.8 19.3 16.3 13.3 14.9 14.4 14.6 12.4 11.4 7.1 18.0 19.2 13.9 18.2 13.6 8.6 15.6 19.1 24.3 16.6 11.3 13.5 16.4 13.6 14.4 18.0 18.2 23.2 18.4 19.8 16.4 11.0 22.6 14.9 36.8 14.9 18.8 21.6 12.1 16.5 13.2 15.3 4.5 5.9 8.7 7.6 7.1 5.8 4.4 9.7 4.1 6.0 9.3 6.8 4.7 7.1 8.1 6.5 11.7 9.1 9.2 4.0 7.4 7.6 7.2 8.8 9.4 9.8 7.3 9.4 10.4 8.1 7.3 7.4 5.1 6.0 18.4 9.8 4.2 7.1 9.5 8.2 4.7 3.6 9.4 12.1 7.3 5.8 8.1 5.2 9.3 5.7 5.2 5.7 8.8 6.4 7.9 6.2 7.7 7.1 5.8 9.0 9.5 6.6 5.6 7.2 5.6 3.9 7.5 5.2 7.3 11.8 8.7 13.4 7.2 3.6 10.1 9.6 6.0 6.0 8.7 5.8 7.5 5.3 4.4 5.3 4.8 5.9 4.5 4.4 5.0 5.8 7.1 7.6 4.8 5.1 4.4 12.7 14.0 16.8 14.9 11.4 7.1 13.6 8.6 13.5 14.9 20.8 18.1 15.7 10.1 9.6 11.0 13.3 7.6 41.5 26.1 5.2 37.3 16.9 8.3 15.7 71.1 9.2 13.9 23.3 16.1 16.8 9.6 8.3 39.5 7.5 12.3 4.8 5.8 9.8 10.5 36.4 13.3 13.6 5.0 22.6 11.7 9.8 18.4 24.6 11.7 7.8 49.9 19.4 12.2 73.1 30.6 9.4 16.0 16.6 10.1 9.1 DHX34 "DDX34, KIAA0134" ENSG00000134815 "DExH-box helicase 34" Q14147 19 47349281-47382704 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Late spermatids: 48.6;Spermatocytes: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 13.5" "Lineage enriched" "Detected in many" 6 "granulocytes: 13.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042159, HPA043558" Uncertain Uncertain "Nucleoplasm,Intermediate filaments" NA NA "Nucleoplasm, Intermediate filaments" "HPA042159: AB_10963066, HPA043558: AB_10961262" "unprognostic (1.26e-1)" "unprognostic (5.17e-2)" "unprognostic (1.05e-1)" "unprognostic (1.64e-1)" "unprognostic (1.08e-1)" "unprognostic (3.06e-3)" "prognostic unfavorable (8.63e-6)" "unprognostic (9.14e-2)" "unprognostic (4.74e-2)" "unprognostic (5.11e-2)" "unprognostic (4.76e-3)" "unprognostic (2.02e-2)" "prognostic unfavorable (3.16e-6)" "unprognostic (7.38e-2)" "unprognostic (1.59e-1)" "unprognostic (2.72e-1)" "unprognostic (7.21e-3)" 6.8 6.9 12.6 11.0 11.5 20.3 6.6 18.7 13.3 8.2 5.9 9.1 8.9 7.7 10.4 5.3 8.3 9.0 5.7 6.0 11.2 6.4 7.2 10.9 8.9 7.9 12.3 8.4 13.3 12.9 7.8 14.2 7.8 11.4 8.9 4.6 8.5 9.9 8.3 7.8 11.8 7.0 6.6 10.5 13.5 6.7 21.8 12.5 5.6 9.6 4.6 9.6 7.3 11.2 1.5 1.9 13.5 2.2 0.8 1.8 1.1 7.2 19.1 4.7 9.2 4.1 2.8 9.0 5.8 1.9 6.0 5.4 12.2 7.2 11.2 5.9 3.2 6.5 10.7 6.5 7.6 3.1 9.3 17.7 11.7 10.4 9.2 4.6 9.0 5.0 3.6 6.2 10.1 5.7 3.9 4.0 5.1 19.4 4.9 4.0 8.6 8.9 22.6 9.8 9.5 11.5 9.9 3.7 6.7 3.2 9.8 8.4 5.2 7.1 7.1 4.7 5.6 6.4 5.8 4.5 7.0 9.1 4.4 10.2 7.4 10.2 10.4 5.6 6.6 8.2 1.0 2.0 0.8 1.3 2.2 1.2 1.2 1.0 1.8 1.9 1.5 1.6 0.7 13.5 0.8 1.7 1.5 0.6 1.1 12.6 11.5 18.7 13.3 11.2 6.4 12.3 8.4 11.4 12.5 6.0 7.2 2.2 5.1 6.6 7.7 2.8 0.0 6.7 3.4 7.0 2.0 4.2 0.0 4.3 20.8 3.1 3.4 0.0 2.8 4.7 3.0 5.1 3.5 4.4 6.7 0.0 3.5 3.1 5.9 48.6 4.9 10.4 1.7 3.6 3.9 1.5 3.1 2.9 4.6 1.4 5.1 6.5 3.6 24.5 11.7 6.4 4.2 3.2 4.3 5.2 DHX35 "C20orf15, DDX35, FLJ22759, KAIA0875" ENSG00000101452 "DEAH-box helicase 35" Q9H5Z1 20 38962299-39039723 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054451, HPA062700" Uncertain Approved "Nucleoplasm,Nuclear bodies,Centrosome" No No "Nuclear bodies" "Nucleoplasm, Centrosome" "HPA054451: AB_2682491, HPA062700: AB_2684838" "unprognostic (8.31e-2)" "unprognostic (2.34e-2)" "unprognostic (5.51e-2)" "prognostic unfavorable (4.25e-5)" "unprognostic (1.29e-2)" "unprognostic (8.38e-2)" "prognostic unfavorable (5.63e-6)" "unprognostic (9.83e-2)" "unprognostic (2.21e-1)" "unprognostic (6.22e-2)" "unprognostic (4.47e-2)" "unprognostic (5.67e-2)" "unprognostic (8.57e-2)" "unprognostic (1.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.11e-1)" "unprognostic (3.31e-1)" 10.4 7.3 9.7 6.9 14.6 13.9 9.8 9.7 14.3 12.2 23.2 14.8 10.7 9.9 19.7 13.9 13.9 12.5 9.2 16.9 9.0 5.8 10.4 7.5 8.7 12.6 8.2 6.7 13.9 6.5 12.1 13.5 8.4 10.9 13.3 14.3 12.4 10.4 12.6 12.5 11.1 12.4 14.7 9.9 8.4 13.4 12.5 9.4 12.1 8.5 7.6 11.2 15.9 11.8 4.6 6.7 2.0 4.9 5.8 8.2 4.4 7.3 4.5 12.0 4.9 4.6 6.0 8.5 4.4 7.9 10.2 7.8 21.2 7.2 8.5 7.9 8.4 7.9 11.7 8.3 13.0 10.1 2.1 4.1 11.3 10.1 12.0 5.5 13.1 5.9 7.0 8.4 9.0 8.4 6.3 4.5 14.5 11.4 4.9 5.4 6.0 21.4 10.1 6.9 13.4 9.9 10.5 17.5 6.8 3.7 8.5 10.6 8.3 12.1 7.3 11.2 7.8 10.0 10.8 4.4 14.7 8.1 5.8 9.2 4.9 6.4 8.8 8.6 6.0 7.6 0.0 4.9 2.0 5.3 4.5 5.2 4.6 4.5 5.6 6.7 4.3 8.2 4.3 1.0 5.8 3.8 2.4 2.8 4.4 9.7 14.6 9.7 14.3 9.0 5.8 8.2 6.7 10.9 9.4 0.0 3.0 0.8 1.2 0.5 5.8 4.8 5.1 4.0 4.5 1.8 3.9 3.1 1.7 2.5 2.9 2.4 3.3 0.0 1.0 2.0 2.4 2.1 8.1 5.5 4.3 4.8 5.2 5.5 3.7 0.4 5.8 3.1 3.3 2.8 6.2 2.6 1.7 2.9 6.0 1.7 4.6 0.0 2.3 1.7 10.0 1.8 2.5 1.7 4.4 1.0 DHX36 "DDX36, KIAA1488, MLEL1" ENSG00000174953 "DEAH-box helicase 36" Q9H2U1 3 154272546-154324497 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Antiviral defense, Differentiation, Immunity, Innate immunity, Transcription, Transcription regulation, Translation regulation, Transport" "Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 381.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035399 Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA035399: AB_10670115" "unprognostic (8.04e-2)" "unprognostic (1.46e-1)" "unprognostic (1.86e-1)" "unprognostic (3.50e-3)" "unprognostic (2.67e-2)" "unprognostic (3.22e-1)" "unprognostic (8.80e-3)" "unprognostic (1.03e-1)" "unprognostic (7.51e-2)" "unprognostic (1.26e-1)" "unprognostic (3.94e-2)" "unprognostic (3.90e-2)" "unprognostic (2.72e-1)" "unprognostic (5.09e-2)" "unprognostic (5.27e-1)" "unprognostic (4.96e-2)" "unprognostic (1.37e-1)" 16.3 14.0 11.5 14.1 27.5 12.6 15.7 19.0 21.3 17.9 14.7 10.3 12.4 10.7 20.4 10.6 14.5 14.3 13.7 23.9 13.4 12.7 16.7 17.1 14.6 17.0 12.2 15.0 20.0 13.7 34.0 36.2 16.4 20.1 15.7 12.2 9.3 15.5 20.5 53.4 14.7 14.3 15.1 13.7 18.9 13.4 28.3 11.3 24.3 20.4 13.4 17.1 20.7 15.6 6.3 5.9 3.1 5.7 4.8 6.9 1.1 27.0 18.5 25.1 14.4 11.9 16.7 12.5 17.7 17.8 20.2 24.1 18.8 21.8 26.2 28.7 15.5 18.6 17.5 23.6 15.0 31.8 25.1 15.6 19.0 15.9 10.7 20.2 26.4 16.7 18.8 12.7 21.6 26.6 11.0 17.3 16.3 17.8 15.1 18.6 13.2 21.8 5.8 33.4 14.4 17.8 22.7 21.2 37.8 14.5 19.2 23.6 25.1 18.4 19.6 25.7 17.9 20.1 13.5 19.5 21.2 13.4 19.8 35.3 28.4 18.3 37.9 17.1 13.9 22.4 1.9 2.7 3.1 6.9 2.8 4.4 4.7 6.1 4.7 2.3 6.3 5.8 6.0 1.1 4.8 5.7 5.9 5.4 1.1 11.5 27.5 19.0 21.3 13.4 12.7 12.2 15.0 20.1 11.3 53.6 78.8 70.6 103.5 82.5 148.4 52.9 61.1 50.9 96.7 57.6 121.7 106.5 33.2 60.5 381.7 74.4 34.4 23.3 54.3 56.1 68.1 82.0 99.5 71.8 54.2 146.2 88.2 62.6 59.6 255.9 102.4 80.8 50.6 65.9 47.0 93.9 58.1 42.4 114.2 44.2 123.0 77.6 80.4 174.2 142.0 72.6 309.5 99.1 47.7 105.0 DHX38 "DDX38, hPrp16, KIAA0224, PRP16, PRPF16" ENSG00000140829 "DEAH-box helicase 38" Q92620 16 72093562-72112912 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041347, HPA041604" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA041347: AB_10796571, HPA041604: AB_2677577" "unprognostic (2.38e-1)" "unprognostic (1.89e-1)" "unprognostic (1.24e-2)" "unprognostic (3.25e-2)" "unprognostic (1.07e-1)" "unprognostic (1.01e-1)" "unprognostic (6.32e-3)" "unprognostic (8.50e-3)" "unprognostic (6.97e-2)" "unprognostic (1.45e-1)" "unprognostic (7.92e-2)" "unprognostic (1.28e-3)" "unprognostic (4.20e-3)" "unprognostic (2.68e-1)" "unprognostic (9.46e-2)" "unprognostic (2.40e-1)" "unprognostic (2.40e-2)" 21.8 16.5 21.1 22.2 25.0 35.1 20.5 36.0 29.4 18.6 19.5 23.5 19.4 20.1 24.1 13.5 21.1 19.9 18.1 19.2 24.1 13.7 17.3 20.8 20.6 26.1 24.1 20.7 29.0 17.3 36.6 18.7 19.3 20.9 18.3 17.2 17.9 20.4 16.4 33.0 27.2 23.0 23.5 22.5 27.3 19.4 17.5 27.8 24.6 20.8 23.2 23.1 20.5 21.4 10.4 8.1 8.3 10.6 11.8 14.9 6.3 14.5 21.7 15.7 8.8 13.7 10.6 20.7 13.2 12.9 19.7 15.2 26.2 14.6 19.4 11.8 19.8 11.0 19.2 18.2 18.1 15.3 9.7 19.6 14.9 18.4 35.7 12.8 17.5 27.0 14.7 16.7 26.5 19.2 10.5 17.0 14.1 22.0 9.2 12.1 44.8 16.7 19.9 19.8 9.3 12.5 21.6 10.9 19.2 9.5 13.9 14.2 15.6 16.9 8.1 9.3 9.5 14.7 14.6 19.2 19.0 16.9 13.8 14.3 22.8 18.0 37.3 17.9 12.2 14.8 7.4 7.9 8.3 14.9 10.6 13.7 10.4 9.3 10.7 8.1 8.2 10.4 10.8 8.2 11.8 6.6 7.4 10.9 6.3 21.1 25.0 36.0 29.4 24.1 13.7 24.1 20.7 20.9 27.8 23.8 30.1 24.7 9.7 10.9 28.0 7.5 15.3 21.4 30.7 14.0 15.7 11.7 0.0 11.7 6.6 18.0 21.3 0.0 17.7 11.6 13.5 9.4 40.6 11.6 12.9 28.6 29.3 14.1 13.9 9.1 26.7 18.7 8.5 14.4 20.2 18.0 18.2 15.8 23.7 6.5 35.4 19.4 13.3 22.7 15.8 11.2 17.0 23.5 17.1 9.9 DHX40 "ARG147, DDX40, FLJ22060, PAD" ENSG00000108406 "DEAH-box helicase 40" Q8IX18 17 59565525-59608345 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044350 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA044350: AB_10960560" "unprognostic (1.58e-2)" "unprognostic (3.10e-1)" "prognostic favorable (4.05e-5)" "unprognostic (4.09e-2)" "unprognostic (5.23e-2)" "unprognostic (2.84e-1)" "unprognostic (4.57e-3)" "unprognostic (7.53e-3)" "unprognostic (2.86e-2)" "unprognostic (1.80e-1)" "unprognostic (7.23e-2)" "unprognostic (3.08e-1)" "unprognostic (9.48e-3)" "unprognostic (2.22e-1)" "unprognostic (1.25e-2)" "unprognostic (1.11e-1)" "unprognostic (3.10e-1)" 22.4 24.2 16.2 14.0 18.1 19.5 24.8 21.7 18.4 21.4 16.5 17.5 23.7 12.8 27.0 25.0 19.3 24.8 16.5 19.8 17.1 19.5 29.5 13.1 16.7 16.8 17.9 14.7 29.7 21.0 51.3 45.8 21.9 19.0 21.6 15.4 13.7 19.3 27.8 20.4 21.3 12.3 18.9 19.9 15.6 17.2 28.4 16.8 26.1 28.2 16.0 15.5 26.0 19.7 5.4 6.9 18.8 6.6 4.2 10.6 6.1 11.7 21.6 27.5 17.8 16.8 17.4 15.2 10.6 20.4 16.3 18.5 8.4 11.7 15.4 30.0 15.3 17.3 8.7 19.6 15.0 25.3 12.2 28.6 14.1 16.2 9.4 13.1 16.9 6.6 13.3 13.8 13.7 13.4 26.8 17.3 15.2 11.8 14.3 11.0 21.3 20.8 10.5 10.4 14.5 15.8 20.0 19.3 16.8 16.4 9.5 19.5 48.2 19.2 7.6 19.5 14.0 24.7 10.0 14.1 19.7 24.5 7.0 10.4 17.7 19.4 9.9 23.1 11.8 13.4 8.5 6.6 10.5 8.1 6.5 10.6 5.1 5.9 5.8 6.9 5.4 5.9 6.9 18.8 4.2 4.4 3.5 6.0 6.1 16.2 18.1 21.7 18.4 17.1 19.5 17.9 14.7 19.0 16.8 8.9 18.1 9.6 9.0 17.2 11.9 20.3 22.9 61.6 30.7 45.4 17.7 6.9 10.0 15.3 32.5 20.4 12.2 0.0 14.6 7.3 13.9 12.6 3.5 23.8 7.9 47.7 17.7 24.5 16.1 12.2 23.3 12.4 18.6 2.8 17.7 18.8 12.6 11.5 25.1 25.0 13.4 32.3 13.2 56.5 50.9 19.3 10.5 16.6 15.8 9.2 DHX58 "D11LGP2, LGP2" ENSG00000108771 "DExH-box helicase 58" Q96C10 17 42101404-42112733 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "monocytes: 65.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 24.6;BJ hTERT+ SV40 Large T+ RasG12V: 28.8;SK-MEL-30: 14.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA018670, HPA019570" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" Nucleoplasm "HPA018670: AB_1847665, HPA019570: AB_1847666" "prognostic favorable (3.45e-4)" "unprognostic (1.03e-2)" "unprognostic (3.56e-3)" "unprognostic (1.54e-2)" "unprognostic (2.45e-2)" "unprognostic (4.82e-2)" "unprognostic (2.05e-3)" "unprognostic (5.45e-2)" "unprognostic (1.18e-1)" "unprognostic (1.15e-1)" "unprognostic (6.02e-2)" "unprognostic (3.72e-1)" "unprognostic (1.27e-2)" "unprognostic (8.65e-2)" "unprognostic (8.01e-2)" "unprognostic (2.31e-1)" "unprognostic (4.31e-3)" 12.7 16.3 6.7 15.3 7.8 11.1 9.8 2.8 8.4 7.9 9.8 9.6 15.0 8.2 9.6 16.2 8.7 12.0 12.6 5.3 6.5 5.3 11.0 20.9 21.7 14.4 5.9 9.0 12.9 7.4 4.3 9.6 7.0 8.2 10.6 5.0 13.4 18.0 17.1 6.9 7.8 10.5 9.2 7.9 17.1 9.1 10.7 5.1 17.2 7.5 5.6 12.9 10.9 7.6 6.4 7.6 8.6 12.0 7.6 7.1 5.9 1.2 0.0 0.0 0.7 6.2 5.4 0.2 1.7 11.9 24.6 28.8 0.1 7.7 0.1 1.8 2.8 5.6 1.0 0.1 1.9 0.9 4.8 0.1 2.0 1.1 0.4 7.0 1.8 4.6 8.7 3.2 2.1 2.1 4.3 2.9 12.5 0.0 6.8 1.3 0.0 11.0 2.3 0.2 0.3 0.0 4.0 0.0 0.5 2.7 4.5 0.2 0.0 0.8 3.1 14.0 0.0 4.2 1.9 1.2 1.2 0.0 0.4 0.6 2.3 1.9 0.1 2.5 1.7 1.3 3.1 9.9 8.6 4.5 12.0 6.5 6.4 6.4 4.0 7.6 4.9 7.1 5.3 4.0 7.6 10.5 2.5 5.5 5.9 6.7 7.8 2.8 8.4 6.5 5.3 5.9 9.0 8.2 5.1 8.9 4.3 2.7 4.8 1.3 0.6 0.8 5.1 8.1 6.8 7.0 0.0 2.8 1.7 4.9 5.4 4.5 2.4 0.0 6.0 2.8 2.8 5.0 1.1 10.5 8.8 0.0 0.0 5.5 6.0 8.3 8.1 5.0 3.3 65.9 2.8 2.0 5.1 4.9 8.5 3.8 0.6 0.0 2.3 9.6 0.7 1.4 0.7 7.7 1.6 1.8 DHX8 "DDX8, Dhr2, HRH1, PRP22, PRPF22" ENSG00000067596 "DEAH-box helicase 8" Q14562 17 43483865-43544463 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049285 Approved Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" NA NA Nucleoplasm "Nuclear bodies" "HPA049285: AB_2680698" "unprognostic (2.99e-1)" "unprognostic (4.42e-2)" "unprognostic (5.64e-2)" "unprognostic (9.02e-2)" "unprognostic (1.25e-1)" "unprognostic (3.09e-1)" "unprognostic (1.28e-3)" "unprognostic (9.43e-2)" "unprognostic (2.58e-1)" "unprognostic (3.40e-2)" "unprognostic (2.26e-2)" "unprognostic (2.47e-1)" "unprognostic (1.50e-1)" "unprognostic (4.04e-1)" "unprognostic (5.08e-3)" "unprognostic (2.60e-1)" "unprognostic (6.28e-2)" 21.9 18.6 17.5 17.0 22.9 47.8 22.3 21.6 29.8 20.3 21.0 25.3 17.2 17.1 26.1 28.4 26.6 17.9 16.7 18.5 18.1 18.7 18.5 20.1 19.8 21.0 20.8 19.7 19.5 17.4 35.4 23.0 21.7 22.7 22.1 24.6 20.1 21.7 21.7 25.2 32.9 22.0 24.6 19.2 27.3 19.5 34.6 20.6 40.8 20.5 17.8 28.9 19.4 22.6 11.5 16.3 23.3 20.4 9.5 14.9 9.8 12.5 35.7 19.4 24.1 19.4 19.8 10.7 13.2 27.9 29.2 28.1 16.2 12.8 17.4 12.3 25.9 21.0 17.0 29.1 23.2 34.3 18.2 23.0 14.7 27.2 25.1 16.6 25.5 22.4 9.9 19.7 24.0 26.4 14.1 25.9 22.9 16.3 17.2 22.6 13.7 32.3 22.7 15.8 15.3 13.7 19.7 37.0 17.9 19.8 26.4 16.8 25.3 14.8 8.5 11.8 24.4 19.8 25.2 17.6 22.8 12.4 16.4 19.7 12.9 15.3 19.7 18.9 15.9 18.2 23.3 15.2 17.2 13.7 20.4 13.6 11.5 11.4 14.9 16.3 10.6 11.2 10.9 19.2 9.5 19.6 8.4 11.7 9.8 17.5 22.9 21.6 29.8 18.1 18.7 20.8 19.7 22.7 20.6 6.0 12.9 15.2 5.8 10.5 15.7 11.9 12.7 12.0 22.7 21.0 17.7 7.9 11.6 14.1 16.1 13.5 8.9 0.0 15.3 7.0 11.1 7.5 13.9 13.1 9.6 6.4 25.6 12.9 13.3 8.1 11.5 12.0 16.9 17.2 13.1 10.1 15.6 11.5 10.3 10.1 18.6 19.4 11.1 24.9 14.5 11.7 17.7 16.0 10.2 14.4 DHX9 "DDX9, LKP, RHA" ENSG00000135829 "DExH-box helicase 9" Q08211 1 182839369-182887751 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, DNA replication, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, mRNA processing, mRNA splicing, mRNA transport, RNA-mediated gene silencing, Transcription, Transcription regulation, Transcription termination, Translation regulation, Transport" "Activator, DNA-binding, Helicase, Hydrolase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011819, HPA028050, HPA055684" Supported Supported Nucleoplasm,Nucleoli NA NA 97000 Nucleoplasm Nucleoli "CAB011819: AB_777725, HPA028050: AB_10603564, HPA055684: AB_2682885" "unprognostic (8.14e-2)" "unprognostic (9.32e-2)" "unprognostic (1.84e-2)" "unprognostic (4.80e-2)" "unprognostic (1.58e-1)" "unprognostic (7.40e-2)" "prognostic unfavorable (3.17e-4)" "unprognostic (9.98e-2)" "prognostic unfavorable (6.04e-4)" "unprognostic (2.76e-1)" "unprognostic (2.88e-2)" "unprognostic (5.53e-2)" "unprognostic (7.51e-2)" "unprognostic (1.43e-1)" "unprognostic (1.70e-1)" "unprognostic (3.17e-1)" "unprognostic (1.99e-1)" 30.2 25.9 25.7 28.5 28.6 68.9 32.9 42.5 33.1 31.9 24.5 23.3 25.2 19.8 38.2 24.2 27.7 30.6 19.7 22.9 24.4 22.6 36.2 31.4 27.8 32.0 34.2 23.1 37.5 24.9 51.8 35.8 28.5 28.0 25.7 30.1 21.1 28.2 29.4 27.6 26.6 27.0 31.6 25.3 32.8 26.5 29.4 37.4 68.3 30.1 31.6 41.2 32.4 31.9 16.8 22.9 12.0 17.4 14.7 21.9 15.0 35.7 35.0 50.3 27.6 26.3 20.4 49.7 31.7 29.1 46.1 31.3 39.1 27.6 57.4 31.0 28.4 27.6 31.0 76.3 34.3 51.7 23.3 37.9 38.2 28.7 26.4 14.8 55.3 26.2 18.1 17.3 45.2 12.3 20.9 36.0 29.5 60.0 20.6 36.9 31.4 55.9 13.6 63.7 38.5 21.6 51.0 46.9 32.8 29.8 41.6 36.3 41.6 44.9 28.4 18.5 44.2 33.3 31.3 28.1 28.6 32.0 29.0 42.9 21.7 35.4 68.1 18.0 30.4 38.8 5.6 16.0 12.0 19.2 17.4 21.9 16.8 16.8 17.6 22.9 14.6 18.4 19.9 6.5 14.7 14.3 11.1 15.4 15.0 25.7 28.6 42.5 33.1 24.4 22.6 34.2 23.1 28.0 37.4 38.7 64.9 41.5 53.0 47.7 55.9 37.2 35.7 72.3 69.4 48.8 49.1 40.4 16.6 39.6 17.1 44.9 31.7 0.0 43.7 37.7 35.9 40.6 42.8 24.3 35.2 27.0 51.6 38.1 37.7 32.0 55.8 34.4 28.7 27.1 33.8 42.7 42.4 25.9 44.2 33.5 72.8 38.8 45.7 63.0 65.2 41.3 41.4 32.4 45.7 48.7 DIDO1 "BYE1, C20orf158, DATF1, DIO-1, DIO1, dJ885L7.8, FLJ11265, KIAA0333" ENSG00000101191 "Death inducer-obliterator 1" Q9BTC0 20 62877738-62937952 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004374, HPA049904" Supported Approved Nucleoplasm,Vesicles,Cytosol No No Nucleoplasm "Vesicles, Cytosol" "CAB004374: AB_2093108, HPA049904: AB_2680944" "unprognostic (9.56e-3)" "unprognostic (2.62e-1)" "unprognostic (1.80e-1)" "unprognostic (7.47e-2)" "unprognostic (2.68e-1)" "prognostic favorable (5.13e-4)" "unprognostic (9.92e-3)" "unprognostic (4.57e-3)" "unprognostic (2.54e-2)" "unprognostic (2.06e-1)" "prognostic favorable (3.88e-4)" "unprognostic (2.20e-2)" "unprognostic (1.50e-3)" "unprognostic (1.06e-1)" "unprognostic (5.64e-2)" "unprognostic (8.90e-2)" "unprognostic (9.82e-2)" 25.1 15.9 19.7 21.5 21.3 22.8 26.9 38.1 23.2 29.7 24.0 27.0 26.7 18.4 33.2 26.9 20.7 29.2 27.0 23.2 17.9 14.7 18.2 18.3 22.9 27.5 22.9 18.8 37.4 21.4 28.0 25.1 30.6 17.6 24.3 19.2 27.0 26.3 25.5 27.6 34.0 25.2 27.5 17.5 25.8 21.2 24.1 23.1 35.1 25.1 20.5 29.6 26.1 35.6 9.7 8.6 20.9 7.6 10.1 15.3 7.1 11.7 9.1 15.3 8.7 7.9 9.7 8.2 8.9 7.6 33.3 9.7 39.0 12.3 11.7 12.4 10.9 19.3 18.5 13.9 17.3 21.6 6.4 9.4 16.8 15.0 27.8 10.0 15.0 17.4 10.0 23.8 11.5 6.5 7.6 9.1 22.5 16.4 10.7 8.4 11.4 30.3 13.2 12.2 14.4 13.3 21.5 19.6 7.4 5.5 10.5 18.9 11.2 17.9 17.4 11.7 9.6 17.3 17.2 11.3 27.2 19.0 9.0 12.6 7.1 4.6 15.6 12.4 7.6 9.8 20.9 5.6 15.1 12.9 7.6 13.3 9.7 11.3 12.3 4.1 8.2 15.3 14.1 8.6 10.1 5.8 8.6 9.0 7.1 19.7 21.3 38.1 23.2 17.9 14.7 22.9 18.8 17.6 23.1 23.8 26.7 14.9 30.5 21.5 23.5 22.9 17.8 49.5 23.9 24.4 31.4 23.6 19.9 15.5 30.5 21.1 20.9 0.0 12.0 13.2 18.7 23.2 22.0 17.4 12.1 36.5 18.5 19.6 13.2 7.9 32.5 16.3 20.3 17.2 22.7 15.8 17.0 21.0 31.8 9.2 22.1 6.5 17.6 18.9 31.8 22.3 16.5 26.1 20.8 28.8 DIMT1 "DIMT1L, HSA9761" ENSG00000086189 "DIM1 dimethyladenosine transferase 1 homolog" Q9UNQ2 5 62387254-62403939 "Enzymes, Predicted intracellular proteins" "rRNA processing" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042944 Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Cytosol" "HPA042944: AB_2678234" "unprognostic (1.58e-1)" "unprognostic (2.27e-1)" "unprognostic (6.02e-3)" "unprognostic (7.16e-2)" "unprognostic (8.95e-3)" "unprognostic (1.73e-2)" "prognostic unfavorable (6.93e-4)" "unprognostic (8.88e-2)" "unprognostic (1.18e-2)" "unprognostic (1.62e-1)" "unprognostic (5.31e-2)" "unprognostic (3.70e-1)" "prognostic unfavorable (8.90e-12)" "unprognostic (8.89e-2)" "unprognostic (2.89e-1)" "unprognostic (1.49e-1)" "unprognostic (5.15e-2)" 16.7 14.0 18.9 16.7 17.0 10.6 18.9 11.5 23.5 18.6 11.8 12.4 11.8 11.0 16.2 11.9 20.1 14.2 15.3 19.7 19.1 17.0 11.9 16.3 11.7 22.5 18.8 8.5 17.8 28.4 8.9 13.4 16.7 12.3 18.8 9.5 10.0 16.1 18.3 17.9 12.2 11.9 24.6 20.2 22.1 10.2 10.7 9.8 16.3 19.0 19.0 19.2 21.7 13.2 7.9 7.7 5.0 5.6 7.0 13.2 6.1 14.6 8.8 16.1 21.0 11.9 15.8 16.0 18.7 7.1 14.5 15.4 14.2 15.6 30.1 17.2 13.9 15.7 11.4 10.8 11.1 18.4 21.3 18.9 20.6 11.5 11.8 14.3 16.9 15.9 13.7 9.0 14.1 13.8 14.4 12.6 19.8 20.9 13.9 14.8 14.7 24.9 26.1 15.5 6.5 18.5 16.1 16.2 41.5 13.1 13.5 18.0 15.8 16.0 15.0 16.0 12.0 12.1 15.9 13.9 10.0 10.4 14.2 25.6 18.4 19.1 27.1 15.2 30.5 14.8 5.0 3.1 2.3 7.7 5.6 11.7 7.9 10.4 9.3 5.0 6.6 13.2 11.0 0.8 7.0 4.3 7.7 9.3 6.1 18.9 17.0 11.5 14.7 19.1 17.0 18.8 8.5 12.3 9.8 3.0 7.4 18.2 65.3 45.2 5.5 27.9 22.9 13.4 21.6 14.0 9.8 38.5 18.3 24.9 5.1 26.8 3.6 0.0 19.6 38.1 27.3 43.1 12.7 10.9 28.5 0.0 4.6 16.5 16.1 3.6 26.7 17.5 27.0 21.6 11.7 6.0 17.2 2.9 19.1 22.7 4.1 6.5 49.9 12.6 21.1 33.1 29.9 25.4 15.7 57.8 DIO2 "SelY, TXDI2" ENSG00000211448 "Iodothyronine deiodinase 2" Q92813 14 80197527-80387757 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Thyroid hormones biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 67.7;thyroid gland: 128.7" "Group enriched" "Detected in many" 14 "Extravillous trophoblasts: 495.6;Muller glia cells: 220.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 34.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 26.7;fHDF/TERT166: 14.7;HeLa: 30.6;HHSteC: 15.2;SiHa: 55.9;SK-BR-3: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048002 Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Nucleoplasm, Vesicles" "Plasma membrane" "HPA048002: AB_2680230" "unprognostic (1.22e-1)" "unprognostic (1.69e-1)" "prognostic favorable (1.67e-4)" "prognostic favorable (4.62e-6)" "unprognostic (2.76e-1)" "unprognostic (1.22e-1)" "unprognostic (2.22e-1)" "unprognostic (2.17e-1)" "unprognostic (2.07e-1)" "unprognostic (8.78e-2)" "unprognostic (3.68e-2)" "unprognostic (2.48e-1)" "unprognostic (1.00e-3)" "unprognostic (5.08e-2)" "unprognostic (3.43e-1)" "unprognostic (8.40e-2)" "unprognostic (7.15e-2)" 1.3 1.8 13.0 0.9 12.3 0.7 6.1 1.0 19.7 67.7 1.2 1.6 1.9 1.2 15.6 1.1 36.1 0.9 2.5 4.7 14.2 2.7 2.4 0.7 1.2 1.0 4.1 7.6 0.7 1.3 0.9 35.9 5.9 13.2 5.0 1.3 13.1 17.7 12.4 3.0 3.3 1.2 2.4 1.2 0.9 2.5 2.5 1.4 0.0 128.7 15.8 12.0 2.6 13.7 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.4 0.0 26.7 5.7 2.4 0.3 0.0 0.1 0.0 0.1 14.7 0.1 0.5 0.9 0.0 1.9 0.0 0.0 0.0 30.6 0.0 15.2 0.0 0.0 1.7 0.0 0.5 0.0 1.3 0.5 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.5 0.0 0.1 0.2 1.2 0.0 0.0 0.2 0.0 0.0 55.9 11.7 0.1 2.5 0.0 0.0 0.3 0.1 2.4 5.6 6.7 0.9 0.0 0.0 2.5 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 13.0 12.3 1.0 19.7 14.2 2.7 4.1 7.6 13.2 1.4 0.0 0.3 0.0 0.1 2.6 2.9 1.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 18.5 1.4 0.0 0.0 0.0 495.6 26.0 0.2 0.0 0.0 8.2 1.6 0.0 0.6 1.0 9.6 3.1 0.3 5.0 0.0 0.0 220.7 0.6 0.0 3.9 0.0 6.2 0.0 8.2 3.3 0.6 2.6 23.6 0.0 0.0 0.0 DIP2A "C21orf106, Dip2, KIAA0184" ENSG00000160305 "Disco interacting protein 2 homolog A" Q14689 21 46458899-46569852 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 110.0;Rod photoreceptor cells: 214.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052516 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA052516: AB_2681859" "unprognostic (1.05e-1)" "unprognostic (1.94e-1)" "unprognostic (6.52e-2)" "unprognostic (3.88e-2)" "unprognostic (7.30e-2)" "prognostic favorable (9.35e-5)" "unprognostic (1.37e-1)" "unprognostic (1.34e-1)" "unprognostic (1.24e-1)" "unprognostic (1.09e-1)" "unprognostic (3.86e-2)" "unprognostic (1.70e-2)" "unprognostic (6.05e-3)" "unprognostic (1.05e-1)" "unprognostic (8.08e-2)" "unprognostic (2.46e-1)" "unprognostic (1.78e-3)" 10.8 12.6 9.8 18.1 15.0 16.7 13.1 17.1 14.6 10.5 10.3 20.6 8.6 12.5 11.8 7.6 14.3 11.7 9.0 15.4 11.0 7.5 7.5 5.9 10.5 12.5 14.1 10.7 12.1 13.0 10.8 12.6 10.9 14.7 13.7 7.8 15.1 14.1 9.1 18.3 12.9 13.6 9.5 11.4 15.8 13.8 16.9 13.3 16.0 10.2 7.4 11.3 14.9 11.4 4.0 10.4 11.5 6.5 9.3 15.7 4.0 12.5 8.2 16.0 7.5 7.6 7.0 9.9 8.7 6.9 8.7 7.2 14.4 9.7 5.3 8.3 9.1 8.8 6.6 7.0 11.7 5.1 20.5 10.1 18.0 13.4 8.8 5.0 6.5 9.4 6.2 8.0 9.1 9.8 6.6 12.6 10.3 11.6 12.2 7.2 11.3 10.0 9.9 8.7 11.0 8.7 10.2 6.6 10.6 5.3 11.4 8.6 5.5 13.4 8.8 7.7 4.4 9.4 6.4 17.1 7.1 5.1 10.1 6.5 12.6 6.3 5.0 7.7 11.0 11.9 8.1 5.4 11.5 15.7 6.3 9.9 3.2 6.9 10.4 2.9 4.0 5.0 9.7 10.4 9.3 6.5 10.4 5.6 4.0 9.8 15.0 17.1 14.6 11.0 7.5 14.1 10.7 14.7 13.3 38.7 19.2 13.7 8.6 13.1 54.6 23.8 12.7 6.7 20.5 14.0 110.0 8.3 8.3 9.1 14.6 29.2 18.8 0.0 9.4 6.6 14.1 16.4 12.7 9.5 15.0 17.5 23.1 31.9 37.8 18.2 22.2 16.5 6.8 11.8 21.1 15.4 14.7 14.4 20.8 6.8 214.6 25.8 9.0 36.4 28.8 15.4 9.4 23.6 20.0 12.9 DIP2C KIAA0934 ENSG00000151240 "Disco interacting protein 2 homolog C" Q9Y2E4 10 274190-689668 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 3.8" "Group enriched" "Detected in many" 5 "B-cells: 3.8;T-cells: 1.3" "Cell line enhanced" "Detected in many" "U-2197: 21.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030264, HPA059325" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA030264: AB_10600903, HPA059325: AB_2683979" "unprognostic (1.72e-2)" "unprognostic (3.39e-2)" "unprognostic (3.00e-2)" "prognostic unfavorable (8.92e-4)" "unprognostic (8.32e-2)" "unprognostic (1.50e-1)" "unprognostic (2.16e-2)" "unprognostic (1.58e-1)" "unprognostic (2.00e-1)" "unprognostic (6.28e-3)" "unprognostic (5.94e-2)" "unprognostic (3.65e-2)" "prognostic favorable (2.46e-6)" "unprognostic (8.52e-2)" "unprognostic (1.22e-1)" "unprognostic (1.09e-3)" "unprognostic (9.10e-3)" 15.4 8.1 19.9 5.0 25.0 0.9 9.9 23.0 24.7 12.6 20.8 21.2 6.4 6.2 14.1 7.8 12.2 9.1 11.3 17.3 16.3 10.1 19.2 11.5 6.7 3.4 21.7 14.4 18.1 10.4 10.4 7.4 6.3 16.5 11.5 6.3 13.0 5.6 12.7 38.2 5.5 7.3 16.1 14.9 4.5 8.3 9.4 23.1 0.0 7.3 2.9 2.5 11.6 13.0 3.8 0.5 0.1 0.3 0.3 1.3 0.4 0.4 4.0 7.5 4.0 12.7 13.9 6.2 8.9 5.6 6.8 5.6 1.1 1.2 0.3 2.4 14.3 1.8 0.1 4.6 0.7 4.2 0.2 4.1 0.1 2.7 1.2 6.2 0.0 5.6 11.3 3.6 4.3 0.0 10.8 1.5 0.1 0.0 0.8 5.1 10.9 0.4 0.0 1.9 3.4 1.6 6.2 3.1 1.2 4.9 4.6 3.8 5.4 1.5 3.2 12.8 4.1 4.3 0.0 0.1 7.3 1.9 21.7 2.9 0.5 8.6 4.6 9.2 0.2 4.1 0.0 0.3 0.0 0.4 0.0 0.4 2.6 0.8 1.0 0.0 3.8 1.2 1.3 0.1 0.3 0.0 0.5 0.5 0.4 19.9 25.0 23.0 24.7 16.3 10.1 21.7 14.4 16.5 23.1 8.9 4.3 3.7 4.5 7.0 18.1 25.0 22.9 8.1 6.8 3.5 21.6 4.4 0.0 6.9 11.0 6.0 2.8 0.0 3.5 3.4 12.1 4.9 19.7 21.7 4.7 1.6 10.4 8.0 3.5 3.8 10.6 2.0 21.9 1.0 4.1 20.4 6.5 0.0 18.4 14.7 18.0 6.5 17.8 21.3 16.5 3.3 3.2 1.0 6.1 8.1 DIRC1 ENSG00000174325 "Disrupted in renal carcinoma 1" Q969H9 2 188734155-188790104 "Disease related genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 5.9;gallbladder: 2.1" "Group enriched" "Detected in some" 7 "Early spermatids: 1.8;Late spermatids: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "ASC TERT1: 24.7;HSkMC: 9.0" HPA068508 Approved Nucleoplasm NA NA Nucleoplasm "HPA068508: AB_2732783" "unprognostic (3.11e-2)" "unprognostic (1.69e-1)" "unprognostic (3.80e-2)" "unprognostic (2.77e-1)" "unprognostic (2.28e-1)" "unprognostic (4.13e-2)" "unprognostic (2.07e-1)" "unprognostic (1.00e-1)" "unprognostic (7.39e-4)" "unprognostic (6.95e-2)" 1.4 0.0 0.0 0.4 0.0 0.0 5.9 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.7 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 24.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 DIS3 "dis3p, EXOSC11, KIAA1008, RRP44" ENSG00000083520 "DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease" Q9Y2L1 13 72752169-72782096 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "rRNA processing" "Endonuclease, Exonuclease, Hydrolase, Nuclease, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 123.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039281, HPA058762" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039281: AB_10795583, HPA058762: AB_2683810" "unprognostic (1.61e-1)" "unprognostic (1.52e-1)" "unprognostic (1.18e-1)" "unprognostic (8.97e-2)" "unprognostic (8.14e-2)" "unprognostic (1.51e-2)" "unprognostic (1.49e-1)" "unprognostic (2.84e-1)" "unprognostic (6.38e-2)" "unprognostic (8.68e-2)" "unprognostic (1.32e-3)" "unprognostic (3.35e-3)" "unprognostic (1.02e-1)" "unprognostic (2.37e-2)" "unprognostic (3.69e-2)" "unprognostic (7.88e-2)" "unprognostic (1.03e-1)" 25.5 14.7 11.7 17.6 24.8 23.8 22.4 23.4 19.4 20.3 18.8 11.6 17.0 11.8 18.0 19.3 23.1 17.8 16.0 21.6 12.4 13.6 20.2 25.6 19.3 22.2 13.9 17.0 23.4 15.3 15.8 22.8 26.3 18.7 18.0 15.6 9.8 17.4 19.3 19.9 17.3 17.9 17.5 12.9 22.8 16.2 27.7 14.6 23.7 21.3 19.1 23.0 26.7 19.3 6.9 6.8 11.1 9.7 10.3 10.0 5.0 15.7 7.4 14.5 12.2 15.5 18.5 9.6 14.1 17.2 14.4 17.7 11.2 13.2 19.2 12.3 14.4 9.1 13.1 19.8 16.2 23.4 15.7 14.6 22.5 15.8 10.1 19.3 38.0 13.1 19.3 11.4 16.3 21.6 14.4 15.4 14.7 15.0 8.1 17.5 5.5 16.1 18.7 13.6 24.1 8.7 13.0 11.1 8.7 14.4 12.7 13.1 17.3 11.5 9.7 13.6 15.8 9.3 17.4 14.3 8.7 7.1 9.8 14.8 15.6 17.5 15.4 24.4 18.1 12.6 11.1 5.5 7.8 6.5 9.7 9.4 6.9 8.5 7.3 6.8 6.0 8.1 7.6 3.4 10.3 7.6 4.3 10.0 5.0 11.7 24.8 23.4 19.4 12.4 13.6 13.9 17.0 18.7 14.6 32.8 30.4 16.8 29.7 22.7 38.6 24.2 25.5 37.5 45.5 8.7 27.5 20.7 19.9 16.8 123.4 38.3 15.1 0.0 17.3 19.4 13.5 23.6 32.4 21.2 12.8 30.2 29.2 25.2 16.2 100.0 26.7 13.6 11.8 31.5 15.2 20.6 18.9 2.9 26.5 13.6 39.7 6.5 19.6 23.7 35.3 27.4 18.9 21.0 18.6 45.4 DISP2 "C15orf36, DISPB, HsT16908, KIAA1742, LINC00594" ENSG00000140323 "Dispatched RND transporter family member 2" A7MBM2 15 40358235-40378639 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 37.2" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 15.6;Enterocytes: 12.9;Horizontal cells: 17.5;Mucus-secreting cells: 14.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 5.2;HaCaT: 8.1;SCLC-21H: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059903 Uncertain Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA059903: AB_2684156" "unprognostic (3.43e-4)" "unprognostic (7.65e-3)" "unprognostic (4.14e-2)" "unprognostic (2.30e-3)" "unprognostic (1.90e-1)" "unprognostic (1.25e-1)" "unprognostic (4.02e-2)" "unprognostic (3.08e-2)" "unprognostic (1.98e-1)" "unprognostic (2.13e-2)" "unprognostic (1.45e-1)" "unprognostic (6.75e-2)" "unprognostic (4.47e-8)" "unprognostic (1.96e-1)" "unprognostic (3.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.71e-1)" 0.8 2.5 9.0 1.5 7.6 1.3 0.6 37.2 14.5 0.7 4.0 1.0 0.0 3.4 0.9 0.9 0.7 1.1 1.1 0.8 9.0 7.0 0.5 0.7 0.9 1.5 2.9 14.0 1.3 1.4 0.6 2.8 1.0 11.4 0.8 3.9 0.3 1.2 1.8 0.8 1.3 3.0 1.4 2.0 1.1 3.9 2.4 1.8 0.0 3.4 0.0 0.6 1.2 0.4 0.9 1.1 2.9 0.4 1.1 0.6 0.2 1.5 0.6 0.4 2.5 0.1 0.1 0.9 0.2 0.1 1.0 1.5 2.3 0.7 0.2 1.7 0.9 5.2 8.1 0.3 1.3 0.6 0.2 0.5 0.4 0.5 0.1 0.0 0.5 1.5 1.8 0.0 0.3 0.2 0.3 0.5 0.9 0.6 1.0 1.3 0.3 0.2 0.4 0.4 2.0 1.1 0.2 0.4 0.5 0.3 2.1 16.7 2.4 0.3 0.2 0.2 0.5 0.4 0.2 0.5 1.2 0.9 0.2 0.2 0.3 0.2 0.3 0.4 0.7 2.3 2.1 0.4 0.5 0.6 0.3 0.4 0.5 0.4 0.4 0.2 0.9 0.5 0.6 2.9 1.1 0.4 1.1 0.4 0.2 9.0 7.6 37.2 14.5 9.0 7.0 2.9 14.0 11.4 1.8 3.0 5.1 0.0 2.0 0.0 15.6 1.4 2.5 4.0 7.9 3.5 9.8 0.2 0.0 0.3 0.9 1.0 12.9 0.0 0.3 0.2 0.8 1.1 8.1 0.0 0.8 17.5 9.2 0.6 0.0 1.5 1.1 0.9 0.0 0.0 14.1 1.7 0.2 2.9 0.0 0.0 7.2 0.0 0.4 4.2 6.6 0.0 0.2 0.0 4.8 1.0 DISP3 "KIAA1337, PTCHD2" ENSG00000204624 "Dispatched RND transporter family member 3" Q9P2K9 1 11479166-11537584 "Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol metabolism, Differentiation, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.4;testis: 7.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "glioma: 2.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.9;NTERA-2: 3.4;SCLC-21H: 3.2;SH-SY5Y: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054579 Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA054579: AB_2682529" "unprognostic (4.93e-2)" "unprognostic (2.23e-2)" "unprognostic (1.61e-1)" "unprognostic (9.55e-3)" "unprognostic (1.80e-1)" "unprognostic (2.73e-1)" "unprognostic (6.12e-2)" "unprognostic (7.75e-2)" "unprognostic (3.62e-1)" "unprognostic (1.08e-1)" "unprognostic (4.34e-3)" "unprognostic (4.86e-2)" "unprognostic (3.80e-2)" "unprognostic (3.88e-1)" "unprognostic (7.06e-2)" "unprognostic (1.79e-4)" "unprognostic (1.34e-1)" 0.9 1.9 7.3 1.1 10.0 0.9 0.9 4.1 17.4 0.9 1.0 9.0 0.0 1.3 1.1 0.9 0.8 1.0 0.8 0.8 7.3 5.7 0.9 0.8 0.9 1.2 4.0 6.5 0.9 1.6 0.8 4.2 0.8 5.1 1.6 0.9 5.4 0.9 0.8 0.8 0.8 1.3 1.0 2.1 1.1 1.2 7.5 6.8 0.0 0.9 0.0 1.0 0.9 0.1 0.6 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 7.9 0.6 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 3.4 0.0 0.0 0.8 0.0 2.0 0.0 0.2 3.2 11.0 2.4 0.0 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.3 10.0 4.1 12.9 7.3 5.7 4.0 6.5 5.1 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DKC1 "Cbf5, DKC, dyskerin, NAP57, NOLA4, XAP101" ENSG00000130826 "Dyskerin pseudouridine synthase 1" O60832 X 154762742-154777689 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Isomerase, Ribonucleoprotein, RNA-binding" "Disease mutation, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 114.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000166, HPA000447, HPA001022, CAB033086" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA 40000 "Nucleoli fibrillar center" Nucleoplasm "CAB033086: AB_2091314, HPA000166: AB_1078669, HPA000447: AB_1078667, HPA001022: AB_2666175" "unprognostic (9.87e-3)" "unprognostic (1.14e-1)" "unprognostic (1.49e-1)" "prognostic unfavorable (2.66e-5)" "unprognostic (2.86e-1)" "prognostic unfavorable (2.94e-4)" "prognostic unfavorable (1.39e-5)" "unprognostic (7.02e-2)" "prognostic unfavorable (9.13e-4)" "unprognostic (2.53e-2)" "unprognostic (2.35e-2)" "unprognostic (2.63e-2)" "prognostic unfavorable (1.46e-9)" "unprognostic (5.28e-2)" "unprognostic (1.47e-1)" "unprognostic (4.04e-1)" "unprognostic (2.55e-1)" 17.6 18.1 17.2 22.5 17.3 42.3 25.8 19.6 20.7 16.6 20.3 14.8 20.7 17.4 19.7 17.1 33.6 18.5 15.9 16.9 15.4 16.3 15.2 22.5 15.2 26.8 15.6 16.6 23.9 38.7 22.6 24.6 19.1 17.0 17.1 26.2 13.7 20.8 18.7 40.8 25.5 18.5 18.3 20.9 25.8 17.6 33.1 16.7 31.3 26.6 28.7 33.2 16.4 20.8 23.5 18.5 16.7 15.5 20.8 26.8 14.8 36.7 20.5 12.7 18.0 7.9 8.2 18.8 14.0 9.9 21.0 19.9 25.8 18.4 70.3 37.0 11.8 19.6 19.8 38.6 23.1 31.6 16.9 21.5 35.9 21.5 22.4 11.2 47.1 21.6 7.8 22.2 23.2 52.9 7.7 14.5 23.5 32.3 17.7 14.2 21.4 31.7 36.3 21.1 36.8 25.7 27.7 28.5 36.4 13.2 20.9 27.9 13.8 12.4 21.7 19.1 12.9 11.0 19.0 11.6 15.1 22.7 19.4 46.3 32.7 45.2 114.9 10.3 49.9 16.4 4.8 13.1 16.7 21.4 15.5 26.8 23.5 17.6 22.7 18.5 17.1 23.3 22.2 4.0 20.8 14.9 13.4 13.4 14.8 17.2 17.3 19.6 20.7 15.4 16.3 15.6 16.6 17.0 16.7 23.8 28.8 32.8 45.8 88.6 31.1 28.6 17.8 37.5 38.7 24.4 13.7 49.0 34.9 41.0 1.9 32.1 7.5 23.3 39.2 59.7 35.2 32.7 53.4 20.8 39.9 22.3 32.7 14.7 19.2 6.2 23.9 30.6 47.2 38.7 31.9 25.7 36.3 8.6 26.9 18.8 27.3 12.9 41.0 35.3 81.7 85.9 28.6 30.5 47.6 46.7 DLC1 "ARHGAP7, DLC-1, HP, p122-RhoGAP, STARD12" ENSG00000164741 "DLC1 Rho GTPase activating protein" Q96QB1 8 13083361-13604610 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 232.3;Alveolar cells type 2: 178.8;Ito cells: 219.1;Sertoli cells: 219.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 6.5" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.5" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 19.1;hTERT-HME1: 14.0;HUVEC TERT2: 19.2;U-138 MG: 13.7;U-2197: 18.9;WM-115: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017753 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus, Vesicles" "HPA017753: AB_10600805" "unprognostic (1.83e-1)" "unprognostic (1.67e-1)" "unprognostic (1.29e-1)" "prognostic favorable (1.11e-4)" "unprognostic (7.47e-2)" "unprognostic (1.39e-1)" "unprognostic (3.11e-2)" "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (1.12e-1)" "unprognostic (8.46e-3)" "unprognostic (6.49e-2)" "unprognostic (2.02e-2)" "unprognostic (3.56e-3)" "unprognostic (2.79e-2)" "unprognostic (7.33e-2)" "unprognostic (1.67e-1)" 33.9 8.0 8.5 8.8 15.4 4.9 31.9 3.1 11.4 13.6 13.1 16.0 2.0 6.1 12.4 7.4 8.6 10.4 13.1 15.1 10.0 7.3 9.2 24.1 32.4 5.6 18.0 6.8 8.0 6.3 6.3 4.4 22.3 16.2 5.7 4.5 13.6 4.9 4.1 7.6 5.4 8.5 18.7 15.0 16.6 11.1 5.5 16.5 0.0 12.0 6.1 2.9 17.1 17.2 0.0 0.2 6.5 1.3 0.0 0.1 0.0 0.0 0.1 1.7 0.0 12.5 7.1 6.0 0.6 0.1 0.3 0.6 3.9 2.4 0.0 0.2 11.9 5.5 2.0 1.0 1.7 1.1 0.0 0.9 0.3 0.0 4.2 6.5 0.0 3.6 5.5 0.1 19.1 14.0 0.5 19.2 0.0 1.0 0.0 5.7 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 6.0 0.0 0.8 0.0 0.2 6.3 6.5 0.0 0.0 1.9 13.7 7.5 18.9 4.5 0.0 0.0 0.0 10.6 0.0 13.9 6.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 8.5 15.4 3.1 11.0 10.0 7.3 18.0 6.8 16.2 16.5 232.3 178.8 4.3 2.6 13.2 0.5 31.1 22.9 5.3 35.2 3.5 0.0 6.3 1.7 3.0 6.6 118.2 1.0 0.0 3.9 1.5 53.2 1.2 63.8 21.3 3.0 12.7 1.2 219.1 20.0 2.5 67.0 4.3 23.6 0.0 0.1 1.0 3.9 0.2 33.9 1.3 1.6 219.9 63.1 4.9 11.7 8.2 2.3 0.7 0.4 1.8 DLD "DLDH, GCSL, LAD" ENSG00000091140 "Dihydrolipoamide dehydrogenase" P09622 7 107890970-107931730 "Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 284.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044849 Supported Approved Nucleoplasm,Mitochondria NA NA 16000000 Mitochondria Nucleoplasm "HPA044849: AB_2679111" "unprognostic (2.01e-3)" "unprognostic (2.26e-1)" "unprognostic (1.27e-2)" "unprognostic (9.27e-2)" "unprognostic (5.01e-3)" "unprognostic (9.27e-2)" "unprognostic (2.48e-1)" "unprognostic (2.83e-2)" "unprognostic (1.19e-1)" "unprognostic (3.95e-2)" "unprognostic (9.43e-2)" "unprognostic (7.35e-2)" "prognostic favorable (7.58e-9)" "unprognostic (4.08e-2)" "unprognostic (1.88e-1)" "unprognostic (4.45e-3)" "unprognostic (1.18e-1)" 25.7 37.9 14.5 12.7 25.4 12.0 15.2 16.6 27.2 13.2 28.0 10.6 12.2 20.9 13.6 9.6 25.6 11.6 12.7 69.1 16.4 14.4 40.7 37.9 11.0 13.0 16.7 20.1 15.1 14.8 24.6 22.4 15.4 29.3 14.7 26.8 12.8 19.4 14.4 71.5 13.8 29.5 23.7 10.6 17.4 23.0 10.6 10.7 18.7 17.0 31.8 16.9 20.1 11.7 13.5 30.4 45.8 37.8 22.9 19.4 20.2 40.1 32.6 18.1 31.1 26.0 23.0 20.5 23.1 19.5 26.9 20.9 38.0 22.6 39.3 39.9 24.5 44.0 26.7 36.3 32.6 40.7 26.2 21.6 27.6 43.2 27.1 20.0 45.4 28.5 26.2 23.7 28.6 15.6 17.1 32.3 33.0 68.9 29.3 29.2 45.1 37.1 32.9 21.5 48.5 23.7 26.8 29.0 53.3 36.8 60.0 22.5 23.8 37.8 64.0 34.0 37.6 24.4 38.9 20.4 29.8 24.4 57.9 35.1 22.2 42.3 26.4 28.0 48.5 30.7 36.5 22.3 45.8 17.5 28.2 18.5 13.5 17.7 17.3 30.4 12.3 18.7 19.4 14.0 22.9 37.8 10.5 16.8 20.2 14.5 25.4 16.6 27.2 16.4 14.4 16.7 20.1 29.3 10.7 26.8 16.5 23.1 30.6 27.8 45.9 284.8 61.1 37.5 18.2 75.0 21.6 94.8 192.3 59.5 3.8 30.0 47.9 46.7 49.3 49.9 26.3 23.6 26.5 77.8 61.0 20.6 29.4 27.6 36.8 5.6 21.6 34.1 35.4 65.9 39.3 31.3 37.7 56.1 39.6 134.4 33.4 25.8 43.4 41.2 52.4 28.2 90.6 27.7 64.6 28.5 DLG3 "KIAA1232, MRX90, NE-Dlg, NEDLG, PPP1R82, SAP-102, SAP102" ENSG00000082458 "Discs large MAGUK scaffold protein 3" Q92796 X 70444861-70505490 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 2.1;MAIT T-cell: 1.8;memory CD4 T-cell: 1.7;memory CD8 T-cell: 2.4;naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.8;NK-cell: 1.7;T-reg: 2.4" "Group enriched" "Detected in many" 5 "NK-cells: 1.7;T-cells: 2.4" "Cell line enhanced" "Detected in many" "OE19: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001733, HPA078130" Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA001733: AB_1078675, HPA078130: AB_2686879" "prognostic unfavorable (1.69e-4)" "unprognostic (1.87e-3)" "unprognostic (1.37e-1)" "unprognostic (2.77e-1)" "unprognostic (4.65e-2)" "unprognostic (3.44e-2)" "unprognostic (3.64e-1)" "unprognostic (1.20e-2)" "unprognostic (7.79e-2)" "unprognostic (7.92e-2)" "unprognostic (1.26e-1)" "unprognostic (5.98e-2)" "prognostic favorable (1.72e-10)" "unprognostic (3.36e-2)" "unprognostic (5.45e-2)" "unprognostic (1.51e-2)" "unprognostic (1.97e-3)" 2.7 3.3 12.5 6.5 17.6 0.7 10.8 16.4 25.2 9.2 16.0 4.3 14.7 11.7 7.6 23.7 14.5 17.4 16.3 6.0 15.2 10.0 10.8 1.4 7.8 3.1 6.5 10.2 11.2 27.1 21.2 8.9 5.5 8.0 9.6 17.1 10.2 21.0 10.4 1.1 8.4 20.8 11.3 3.4 14.6 13.8 1.9 3.5 3.2 13.8 2.6 8.0 11.2 9.9 0.4 0.0 0.0 0.0 1.7 2.4 0.3 3.4 1.6 9.9 4.2 2.6 3.1 6.9 2.0 2.3 1.1 1.1 9.8 8.1 0.0 4.8 2.0 0.8 7.5 19.2 4.5 0.7 4.0 5.8 0.0 8.8 5.3 5.0 0.1 1.3 3.2 3.0 1.4 3.2 10.2 0.4 6.6 1.8 13.8 1.1 12.1 7.8 0.0 16.7 28.0 11.6 7.3 4.9 1.4 6.7 10.6 4.7 0.3 1.6 19.2 3.7 8.6 10.1 0.0 0.7 1.3 1.3 1.2 1.5 9.1 6.8 4.3 1.9 0.0 1.9 0.0 0.0 0.0 2.1 0.0 1.8 0.4 1.7 2.4 0.0 0.0 1.1 1.8 0.0 1.7 0.0 0.0 2.4 0.3 12.5 17.6 16.4 25.2 15.2 10.0 6.5 10.2 8.0 3.5 17.9 16.1 3.2 4.8 0.7 15.6 16.7 25.5 32.1 12.5 8.7 0.0 5.5 10.0 11.9 0.0 0.3 27.4 0.0 21.3 2.0 5.0 15.9 1.1 0.0 0.6 4.8 24.6 1.8 0.3 0.0 1.4 1.3 1.7 2.8 22.3 10.3 21.5 17.3 6.0 3.7 5.8 6.5 5.1 0.4 1.7 1.8 1.4 3.8 17.2 9.0 DLGAP4 "DAP4, KIAA0964, SAPAP4" ENSG00000080845 "DLG associated protein 4" Q9Y2H0 20 36306336-36528637 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-138 MG: 64.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054105, HPA056378" Approved Approved "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA "Nucleoplasm, Cytosol" "Focal adhesion sites" "HPA054105: AB_2682381, HPA056378: " "unprognostic (1.11e-1)" "unprognostic (1.42e-1)" "unprognostic (9.00e-2)" "prognostic unfavorable (2.24e-5)" "unprognostic (1.35e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (3.73e-6)" "unprognostic (1.23e-1)" "prognostic favorable (9.88e-5)" "unprognostic (1.28e-1)" "unprognostic (2.18e-2)" "unprognostic (8.45e-2)" "prognostic unfavorable (2.48e-4)" "unprognostic (1.07e-1)" "unprognostic (1.13e-1)" "unprognostic (1.37e-1)" "unprognostic (1.53e-1)" 18.8 16.6 25.7 14.3 32.9 4.5 18.0 16.2 31.9 19.0 20.1 9.0 14.9 13.5 23.1 13.1 16.8 18.5 17.0 25.9 23.7 12.7 10.2 11.0 21.6 9.8 9.5 20.7 18.9 30.2 7.7 10.2 16.9 8.8 15.7 10.1 15.4 19.3 21.2 58.0 27.1 13.6 27.2 6.8 14.5 12.2 12.6 10.9 8.3 13.8 16.8 10.8 29.0 15.0 16.1 13.5 19.5 13.1 6.9 12.5 9.1 14.1 12.9 15.8 13.0 15.0 24.6 15.9 21.4 19.6 21.0 14.6 19.4 9.1 4.0 11.6 30.0 18.6 13.7 4.2 21.9 15.7 6.4 1.5 9.1 6.6 13.1 21.7 3.6 7.9 16.2 17.0 24.8 17.4 16.3 20.6 5.7 6.3 11.0 15.8 10.6 7.4 13.9 6.8 10.4 27.6 7.4 4.2 5.5 9.8 7.0 10.4 14.3 14.0 28.5 17.6 16.8 16.3 6.4 20.7 64.1 19.5 27.5 11.7 3.8 2.7 4.3 25.6 4.6 25.1 2.1 12.8 19.5 12.5 13.1 9.8 16.1 11.3 8.7 11.3 14.9 8.8 7.0 18.5 6.9 12.6 13.5 8.7 9.1 25.7 32.9 16.2 31.9 23.7 12.7 9.5 20.7 8.8 10.9 14.9 18.6 15.9 41.2 59.0 31.9 25.0 25.5 17.4 13.6 12.2 7.9 19.6 6.6 45.3 63.3 34.3 19.2 0.0 47.9 41.6 32.7 58.9 11.6 16.3 24.9 69.9 60.7 24.5 18.1 119.1 27.6 21.1 10.1 63.1 29.8 36.4 66.0 24.6 24.8 16.3 27.9 71.1 41.0 13.6 16.2 62.7 46.1 15.0 16.9 46.3 DLK2 "EGFL9, MGC2487" ENSG00000171462 "Delta like non-canonical Notch ligand 2" Q6UY11 6 43450352-43456632 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 19.3" "Cell type enriched" "Detected in some" 7 "Basal glandular cells: 79.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 16.5;HBEC3-KT: 9.0;hTCEpi: 27.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA061223, HPA068672, HPA070955" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles No No Nucleoplasm "Nucleoli, Vesicles" "HPA061223: AB_2684454, HPA068672: AB_2686017, HPA070955: " "unprognostic (4.65e-5)" "unprognostic (1.27e-1)" "unprognostic (1.69e-1)" "unprognostic (9.68e-4)" "unprognostic (2.87e-1)" "unprognostic (3.80e-1)" "unprognostic (4.19e-3)" "unprognostic (1.65e-1)" "unprognostic (2.65e-3)" "unprognostic (4.04e-1)" "unprognostic (1.88e-2)" "unprognostic (1.88e-1)" "unprognostic (9.27e-12)" "unprognostic (7.71e-4)" "unprognostic (8.92e-2)" "unprognostic (1.55e-1)" "unprognostic (6.43e-2)" 1.0 1.1 4.5 1.4 7.9 1.7 4.3 12.2 8.2 2.2 0.7 0.9 6.4 1.1 1.4 3.8 10.5 1.1 0.9 1.8 4.1 4.6 0.7 0.7 1.1 1.7 1.5 4.8 1.7 1.5 0.4 0.5 1.3 0.9 10.4 0.5 0.3 12.4 13.0 0.7 19.3 1.0 0.6 1.5 1.5 1.1 1.1 1.2 1.3 0.8 4.7 3.9 2.2 5.3 0.8 1.8 1.0 0.5 2.5 3.2 0.3 5.2 1.9 0.5 7.9 0.0 0.4 1.8 1.9 2.1 2.2 1.0 1.8 0.2 1.0 1.2 0.4 2.7 16.5 5.6 9.0 0.5 1.0 2.1 0.4 0.9 2.8 0.6 0.3 1.1 0.9 27.2 0.6 5.1 0.7 0.0 3.1 0.4 0.8 0.8 2.0 0.4 0.4 0.7 2.0 2.0 1.1 1.0 0.5 0.3 1.8 5.9 0.6 0.6 0.2 0.3 0.4 0.5 1.6 0.5 0.8 2.5 0.6 3.8 1.2 0.3 1.7 0.1 0.7 0.5 0.9 0.4 0.4 0.7 0.3 3.2 0.6 2.2 2.2 0.1 0.8 0.9 0.4 1.0 2.5 0.5 1.8 0.3 0.3 4.5 7.9 12.2 8.2 4.1 4.6 1.5 4.8 0.9 1.2 0.0 0.3 0.0 79.5 9.0 0.6 0.5 0.0 0.0 7.9 0.0 0.0 0.8 0.0 0.1 0.2 0.3 0.0 0.0 0.0 2.1 0.2 4.3 0.0 0.0 0.1 11.1 1.2 0.0 0.0 0.2 0.3 0.0 1.7 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.9 0.0 0.3 1.2 5.5 2.3 0.2 0.0 0.0 3.9 DLL1 ENSG00000198719 "Delta like canonical Notch ligand 1" O00548 6 170282206-170306565 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway" "Developmental protein" "Autism spectrum disorder, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 36.9" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 59.4;Intestinal endocrine cells: 49.7;Mucus-secreting cells: 76.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "NK-cell: 7.3" "Lineage enriched" "Detected in single" 8 "NK-cells: 7.3" "Cell line enhanced" "Detected in some" "HaCaT: 7.0;HBEC3-KT: 10.8;NB-4: 17.8;THP-1: 14.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA078298 Uncertain Nucleoplasm NA NA 210000 Nucleoplasm "HPA078298: " "unprognostic (1.03e-1)" "unprognostic (9.22e-2)" "unprognostic (2.17e-3)" "unprognostic (1.95e-1)" "unprognostic (2.89e-2)" "unprognostic (6.35e-2)" "unprognostic (1.63e-2)" "unprognostic (1.89e-1)" "unprognostic (9.22e-2)" "unprognostic (1.14e-2)" "unprognostic (1.39e-2)" "unprognostic (2.64e-2)" "unprognostic (5.23e-3)" "unprognostic (3.50e-1)" "unprognostic (1.83e-1)" "unprognostic (4.33e-2)" "unprognostic (1.66e-1)" 8.9 5.7 4.1 5.5 9.0 3.2 8.6 2.5 13.8 7.4 10.3 18.5 2.6 8.1 6.0 3.0 11.1 5.7 11.4 7.2 5.2 4.0 5.8 13.5 6.8 5.6 5.5 5.2 2.5 13.8 2.2 3.1 5.0 10.0 14.5 5.2 14.3 8.9 7.1 3.8 14.3 13.1 3.9 4.6 36.9 5.9 1.6 7.3 0.9 6.1 5.3 6.3 4.5 11.0 0.0 0.0 0.1 0.9 7.3 0.5 0.2 0.9 0.1 4.3 2.7 0.3 0.2 2.3 0.2 0.6 0.3 0.5 1.1 0.1 0.0 0.2 0.1 0.7 7.0 2.7 10.8 0.0 0.2 0.9 0.0 0.0 0.0 0.3 0.0 3.1 0.1 2.0 0.0 1.1 0.2 1.1 0.1 0.0 0.0 0.4 3.0 0.0 17.8 0.6 0.4 0.0 0.8 4.3 0.1 0.0 1.3 1.9 0.1 0.3 0.0 0.0 1.6 0.7 14.7 0.5 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.8 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.5 0.3 0.1 7.3 0.9 0.0 0.0 0.2 4.1 9.0 2.5 11.2 5.2 4.0 5.5 5.2 10.0 7.3 0.0 0.3 0.0 15.5 59.4 0.7 4.6 0.0 10.7 10.3 1.8 21.6 2.4 0.0 0.3 0.3 18.9 1.6 0.0 1.5 5.2 8.9 3.8 5.7 0.0 1.0 0.0 49.7 20.9 3.9 1.2 0.3 2.5 6.8 0.0 76.5 1.0 0.9 2.9 1.1 0.0 0.6 12.9 9.0 0.5 1.9 11.2 3.1 0.0 2.6 0.9 DLL3 SCDO1 ENSG00000090932 "Delta like canonical Notch ligand 3" Q9NYJ7 19 39498895-39508481 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway" "Developmental protein" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 38.5" "Cell type enriched" "Detected in some" 6 "Spermatogonia: 37.2" "Group enriched" "Detected in many" 11 "glioma: 29.2;melanoma: 15.5;testis cancer: 8.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 5.4;naive CD8 T-cell: 3.3" "Group enriched" "Detected in many" 13 "B-cells: 5.4;T-cells: 3.3" "Cell line enriched" "Detected in some" 5 "SK-MEL-30: 42.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA056533 Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA056533: " "unprognostic (2.52e-1)" "unprognostic (3.81e-1)" "unprognostic (3.13e-2)" "prognostic unfavorable (2.94e-4)" "unprognostic (9.85e-2)" "unprognostic (1.41e-2)" "unprognostic (1.65e-3)" "unprognostic (1.85e-1)" "unprognostic (4.82e-2)" "unprognostic (6.58e-2)" "unprognostic (1.06e-2)" "unprognostic (4.20e-2)" "unprognostic (3.82e-4)" "unprognostic (4.94e-2)" "unprognostic (5.13e-2)" "unprognostic (4.15e-2)" "unprognostic (2.97e-1)" 0.6 0.6 8.9 0.7 10.1 0.6 0.6 1.4 38.5 0.5 0.6 10.3 0.0 0.5 0.6 0.5 0.5 0.5 0.5 0.6 6.5 6.8 0.5 0.6 0.6 0.7 4.5 1.9 0.6 0.5 0.6 3.2 0.5 4.3 0.6 0.5 0.0 0.6 0.5 0.5 0.6 0.6 0.5 3.6 0.6 0.6 1.2 2.3 0.0 0.7 0.0 0.6 0.6 0.0 5.4 0.3 0.0 0.0 0.0 3.3 0.4 0.0 2.0 0.4 1.0 0.0 0.0 0.3 0.5 0.0 0.3 0.1 0.3 0.4 0.0 2.0 0.0 0.8 0.0 1.2 0.5 0.1 0.6 3.1 0.1 0.0 0.2 0.1 0.5 2.4 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.5 0.0 0.2 0.0 0.1 0.0 0.4 0.0 3.2 0.3 0.1 0.1 0.1 0.1 7.4 7.6 1.5 0.0 42.1 0.1 0.0 0.1 0.0 0.0 1.4 0.1 0.5 0.7 0.0 0.4 0.0 0.2 1.2 0.0 0.0 0.0 0.9 0.0 0.4 5.4 0.2 1.3 0.3 1.2 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.4 8.9 10.1 1.4 4.8 6.5 6.8 4.5 1.9 4.3 2.3 0.0 0.0 0.0 0.2 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.5 0.0 0.0 0.0 0.5 0.4 0.0 0.2 0.0 0.0 0.2 0.0 2.9 0.0 0.0 1.6 1.1 0.0 1.7 0.0 0.0 0.5 0.2 0.0 1.4 0.0 0.6 6.5 0.0 5.4 37.2 0.1 0.2 0.0 0.0 0.0 DLST DLTS ENSG00000119689 "Dihydrolipoamide S-succinyltransferase" P36957 14 74881891-74903745 "Citric acid cycle related proteins, Enzymes, Predicted intracellular proteins" "Tricarboxylic acid cycle" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003010 Supported Approved Nucleoplasm,Mitochondria NA NA 800000 "Nucleoplasm, Mitochondria" "HPA003010: AB_1078679" "unprognostic (1.62e-1)" "unprognostic (3.01e-1)" "unprognostic (2.45e-3)" "unprognostic (6.36e-2)" "unprognostic (1.29e-1)" "unprognostic (1.21e-2)" "unprognostic (1.16e-1)" "unprognostic (5.83e-2)" "unprognostic (3.03e-1)" "unprognostic (1.37e-1)" "unprognostic (2.12e-2)" "unprognostic (1.18e-1)" "prognostic favorable (1.13e-12)" "unprognostic (3.29e-2)" "unprognostic (1.08e-1)" "unprognostic (1.66e-1)" "unprognostic (4.55e-3)" 32.2 38.6 12.0 22.7 19.9 28.5 31.3 19.1 25.6 31.2 36.0 18.5 15.9 24.7 26.3 28.3 31.4 19.2 29.7 47.6 10.8 11.8 43.7 45.1 20.8 26.7 13.5 13.7 21.5 27.1 25.8 16.2 25.2 19.7 20.9 26.8 19.2 22.3 20.1 59.2 26.9 43.2 32.9 11.4 20.8 24.3 21.0 10.4 23.5 27.2 49.8 28.4 26.9 21.1 3.8 6.3 8.4 4.3 7.7 5.3 3.2 25.8 27.0 20.7 14.6 32.5 36.9 31.7 33.8 34.4 34.6 32.4 26.5 28.1 26.3 14.4 38.8 15.6 29.2 34.8 33.4 36.6 19.0 14.6 21.5 22.6 23.2 33.6 15.2 14.8 37.7 29.3 33.5 41.4 31.2 35.6 11.9 16.4 17.9 37.5 34.7 18.0 21.6 17.7 45.7 25.4 23.1 30.4 14.5 42.9 31.8 24.6 20.9 31.9 42.6 22.0 19.3 39.0 22.0 31.5 21.1 27.6 25.7 23.1 12.7 13.2 23.1 30.8 15.8 22.0 8.4 3.0 5.0 5.0 4.3 4.5 3.8 4.5 3.9 4.7 2.7 4.0 5.3 3.0 7.7 3.9 6.3 4.4 3.2 12.0 19.9 19.1 25.6 10.8 11.8 13.5 13.7 19.7 10.4 6.0 4.5 20.7 19.3 23.5 17.5 23.4 20.4 2.7 3.4 19.2 29.5 33.7 48.0 32.5 6.2 14.6 39.3 0.0 22.3 30.6 23.8 21.8 20.7 37.3 28.4 12.7 14.3 24.5 16.2 3.4 16.7 16.5 21.9 36.1 28.3 8.5 35.0 25.9 19.4 51.5 20.0 25.8 17.9 9.3 11.7 24.8 66.5 20.3 36.1 20.8 DLX4 "BP1, DLX7, DLX8, DLX9" ENSG00000108813 "Distal-less homeobox 4" Q92988 17 49968970-49974959 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 14.7;skin 1: 6.0" "Cell type enriched" "Detected in some" 5 "Extravillous trophoblasts: 67.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 18.6;CACO-2: 13.1;GAMG: 12.4;HAP1: 9.0;K-562: 10.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA059933 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA059933: AB_2684169" "unprognostic (8.12e-2)" "unprognostic (2.48e-1)" "unprognostic (1.26e-2)" "unprognostic (2.29e-3)" "unprognostic (7.49e-2)" "unprognostic (2.71e-1)" "unprognostic (9.35e-3)" "unprognostic (2.85e-2)" "unprognostic (8.73e-2)" "unprognostic (5.93e-2)" "unprognostic (1.29e-2)" "unprognostic (4.34e-2)" "unprognostic (2.88e-13)" "unprognostic (8.79e-3)" "unprognostic (2.77e-1)" "unprognostic (5.00e-2)" "unprognostic (6.86e-2)" 0.4 0.3 0.2 1.2 0.7 0.4 0.7 0.3 0.8 0.8 0.6 0.8 0.2 0.2 0.2 0.6 1.5 0.5 0.2 0.2 0.2 0.2 0.2 0.2 1.3 0.5 0.2 0.2 0.2 0.7 0.1 0.2 14.7 1.4 0.5 0.3 0.5 2.7 0.6 0.2 6.0 1.5 0.2 0.2 0.8 0.3 0.5 0.2 0.2 0.6 3.8 1.2 0.4 0.8 0.1 0.9 0.0 1.3 1.0 0.8 0.3 0.4 1.1 0.0 0.1 0.1 0.0 18.6 0.1 0.1 0.0 0.3 13.1 0.8 0.5 2.7 0.2 12.4 1.8 9.0 0.3 0.0 3.5 4.7 0.3 4.5 1.3 0.0 0.7 3.1 0.0 2.3 0.1 0.0 0.1 0.0 2.7 10.3 0.0 0.0 2.2 0.3 4.7 0.2 2.4 0.0 0.0 4.2 0.4 0.1 0.6 1.5 0.0 0.3 1.6 0.8 2.9 3.3 3.1 0.0 0.0 0.9 0.2 0.0 0.7 0.1 0.0 0.3 2.4 0.0 0.0 0.3 0.0 0.8 1.3 0.0 0.0 0.0 0.4 0.7 0.1 0.2 0.0 0.0 1.0 1.3 0.9 0.0 0.3 0.2 0.7 0.3 0.8 0.2 0.2 0.2 0.2 1.4 0.2 6.0 0.0 0.0 0.3 2.3 0.0 2.0 0.0 2.7 0.0 0.0 0.0 10.5 0.0 0.1 0.0 0.0 0.0 0.0 0.2 67.1 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.5 14.1 0.0 0.0 0.3 DLX5 ENSG00000105880 "Distal-less homeobox 5" P56178 7 97020392-97024950 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Osteogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 17.7;placenta: 44.5;skin 1: 20.6" "Cell type enhanced" "Detected in some" 19 "Cytotrophoblasts: 128.5;Extravillous trophoblasts: 203.8;Sertoli cells: 58.2;Syncytiotrophoblasts: 263.3" "Cancer enriched" "Detected in many" 11 "endometrial cancer: 81.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 32.9;HAP1: 16.5;SuSa: 8.6" "Group enriched" "Detected in many" 4 "basal ganglia: 13.5;olfactory region: 36.5" "Region enhanced" "Detected in many" "olfactory region: 24.3" HPA005670 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA005670: AB_1078681" "unprognostic (3.99e-1)" "unprognostic (1.05e-1)" "unprognostic (2.96e-2)" "unprognostic (1.31e-3)" "unprognostic (1.76e-1)" "unprognostic (2.86e-2)" "unprognostic (6.14e-2)" "unprognostic (2.46e-2)" "unprognostic (5.89e-2)" "unprognostic (6.20e-2)" "unprognostic (1.52e-1)" "unprognostic (1.01e-2)" "unprognostic (7.43e-8)" "unprognostic (1.39e-2)" "unprognostic (3.73e-1)" "unprognostic (1.16e-1)" "unprognostic (2.55e-1)" 1.5 0.6 2.7 0.5 11.5 0.3 1.5 0.1 3.9 10.0 0.6 0.3 1.4 0.7 17.7 1.7 5.8 2.0 0.8 1.2 2.2 4.5 0.4 0.2 0.4 1.9 0.5 2.5 2.1 0.2 0.4 1.9 44.5 0.0 1.8 0.3 0.1 3.6 3.9 0.6 20.6 0.3 1.4 0.2 0.3 0.3 1.2 3.1 2.5 1.6 6.5 2.7 1.5 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 32.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 3.7 16.5 0.0 0.0 0.0 2.8 0.0 0.3 0.2 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 2.1 0.9 1.3 0.1 0.0 0.0 8.6 0.0 0.0 0.0 1.0 0.2 0.2 0.0 0.0 0.0 0.0 2.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 11.5 0.1 3.9 2.2 4.5 0.5 2.5 0.0 3.1 0.0 0.0 0.0 0.7 8.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 128.5 0.0 0.0 0.1 0.5 0.0 0.0 0.0 203.8 2.2 1.1 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 58.2 7.1 1.8 6.0 18.1 263.3 0.0 0.0 1.4 DMAP1 "DNMAP1, DNMTAP1, EAF2, FLJ11543, KIAA1425, MEAF2, SWC4" ENSG00000178028 "DNA methyltransferase 1 associated protein 1" Q9NPF5 1 44213455-44220681 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Growth regulation, Transcription, Transcription regulation" "Activator, Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028419, CAB033018" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB033018: AB_2230431, HPA028419: AB_2672597" "unprognostic (1.91e-3)" "unprognostic (2.79e-3)" "unprognostic (4.90e-2)" "unprognostic (6.52e-2)" "unprognostic (4.80e-2)" "unprognostic (1.43e-3)" "prognostic unfavorable (1.44e-4)" "unprognostic (1.72e-2)" "unprognostic (7.32e-2)" "unprognostic (3.01e-1)" "unprognostic (1.82e-3)" "unprognostic (1.86e-2)" "unprognostic (2.29e-3)" "unprognostic (1.53e-1)" "unprognostic (1.33e-1)" "unprognostic (3.09e-1)" "unprognostic (2.04e-2)" 12.7 31.7 21.5 17.6 22.4 12.5 12.6 21.3 31.5 12.8 13.8 20.4 15.6 13.5 14.0 14.9 12.9 19.8 11.7 20.3 20.7 18.3 14.9 16.1 12.9 17.2 18.0 19.4 23.3 19.9 25.3 15.7 14.3 17.9 13.9 11.9 19.2 21.1 15.2 30.5 18.0 12.7 17.0 15.8 16.7 13.8 13.8 17.0 15.2 18.1 14.3 13.6 12.7 11.4 18.6 15.4 23.2 14.8 26.5 23.1 15.0 12.4 13.2 18.7 9.8 9.7 9.2 21.6 11.0 14.8 26.7 23.1 21.6 15.6 18.7 15.0 17.7 10.5 10.2 16.6 14.2 14.2 14.9 26.9 17.1 23.6 21.3 17.6 16.8 13.1 14.4 15.8 22.0 12.7 17.2 17.2 17.9 11.9 17.2 15.5 14.4 23.4 21.1 26.6 6.4 16.9 23.8 18.9 20.3 14.0 15.8 17.4 14.4 20.7 14.9 21.0 18.9 12.3 19.4 16.5 7.6 22.9 17.4 22.2 20.9 12.5 14.9 14.3 16.7 12.4 23.2 14.8 14.1 21.2 13.1 21.6 18.6 21.4 21.8 15.4 18.6 19.6 19.3 6.4 26.5 10.5 12.4 23.1 15.0 21.5 22.4 21.3 31.5 20.7 18.3 18.0 19.4 17.9 17.0 29.8 27.9 19.5 20.8 17.1 38.2 20.9 20.4 26.8 14.8 10.4 23.6 62.4 24.9 28.1 32.9 20.7 35.1 46.7 36.4 27.8 20.5 10.0 26.5 17.4 28.6 22.3 52.2 18.4 21.5 52.0 16.7 14.0 16.9 27.1 25.6 36.1 20.7 25.9 16.6 28.1 52.1 6.5 19.6 25.4 33.4 15.6 43.8 20.0 24.0 11.9 DMC1 LIM15 ENSG00000100206 "DNA meiotic recombinase 1" Q14565 22 38518949-38570286 "Predicted intracellular proteins" "Cell cycle, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.1" "Cell type enhanced" "Detected in many" 21 "Erythroid cells: 23.3;Sertoli cells: 12.9;Spermatocytes: 61.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 17.7;hTEC/SVTERT24-B: 12.6;U-266/84: 14.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA001232, CAB015397" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "CAB015397: AB_629406, HPA001232: AB_1078683" "unprognostic (1.29e-2)" "unprognostic (3.11e-3)" "unprognostic (4.48e-3)" "unprognostic (5.71e-2)" "unprognostic (6.43e-2)" "unprognostic (2.22e-1)" "unprognostic (8.22e-2)" "unprognostic (2.61e-2)" "unprognostic (4.23e-2)" "unprognostic (3.99e-3)" "unprognostic (7.40e-3)" "unprognostic (1.00e-2)" "unprognostic (2.16e-4)" "unprognostic (3.94e-1)" "unprognostic (2.79e-1)" "unprognostic (7.27e-2)" "unprognostic (2.99e-1)" 1.7 0.6 1.6 4.7 2.0 3.1 4.4 2.2 2.0 2.5 1.3 0.7 1.2 0.4 3.7 2.6 1.5 1.6 1.8 3.3 2.5 1.1 1.0 0.5 1.1 3.9 2.8 1.5 1.8 0.8 0.8 1.1 1.0 3.2 2.9 1.6 2.7 1.0 1.3 1.8 2.5 1.1 3.4 4.4 0.9 1.0 24.1 2.3 8.2 0.8 3.2 4.5 2.0 3.8 1.2 0.8 3.3 1.0 2.5 1.5 0.4 4.9 1.9 3.7 0.1 0.3 1.5 0.2 5.3 0.7 8.5 5.9 0.2 0.6 2.5 0.2 1.4 0.0 0.9 1.4 0.2 9.7 17.7 0.3 9.5 1.4 0.1 0.1 0.8 2.1 0.4 0.0 12.6 0.0 0.0 0.7 8.0 7.1 2.6 3.0 2.8 1.9 7.2 6.5 2.4 0.1 4.2 0.0 3.6 1.1 0.7 7.2 0.4 8.9 0.8 0.1 0.9 1.6 2.1 0.2 0.1 0.5 0.1 0.1 7.1 14.7 4.5 1.5 2.0 0.7 2.2 1.0 0.5 1.5 0.3 0.3 0.5 1.3 0.6 0.8 1.2 1.2 0.5 3.3 2.5 0.6 0.7 0.7 0.4 1.6 2.0 2.2 2.0 2.5 1.1 2.8 1.5 3.2 2.3 0.0 2.9 0.0 0.7 2.1 0.6 2.0 0.0 1.4 4.5 3.5 0.0 0.8 1.7 0.2 1.9 0.6 0.0 23.3 0.0 1.3 1.2 0.2 1.1 0.0 0.8 0.0 0.0 0.6 0.0 1.6 1.4 0.8 0.0 0.0 0.8 2.3 0.1 0.0 1.4 0.0 0.3 12.9 0.8 61.6 8.3 0.5 0.7 1.0 2.1 0.0 DMKN ZD52F10 ENSG00000161249 Dermokine Q6E0U4 19 35497220-35513658 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skin 1: 365.3" "Cell type enriched" "Detected in many" 5 "Suprabasal keratinocytes: 7442.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 9.5" "Cell type enhanced" "Detected in many" "NK-cell: 11.1" "Group enriched" "Detected in many" 5 "NK-cells: 11.1;T-cells: 7.0" "Cell line enhanced" "Detected in many" "A-431: 32.0;CACO-2: 39.6;CAPAN-2: 34.0;HBEC3-KT: 51.9;RPTEC TERT1: 51.3" HPA029406 Enhanced Approved Nucleoplasm,Cytosol "Secreted in other tissues" NA NA 29000000 "Nucleoplasm, Cytosol" "HPA029406: AB_10603661" "unprognostic (5.70e-2)" "unprognostic (2.36e-2)" "unprognostic (3.64e-2)" "unprognostic (1.03e-1)" "unprognostic (1.28e-2)" "unprognostic (2.48e-2)" "unprognostic (3.82e-2)" "unprognostic (3.23e-1)" "unprognostic (1.03e-1)" "unprognostic (8.82e-2)" "unprognostic (2.54e-1)" "unprognostic (9.93e-2)" "prognostic favorable (5.37e-6)" "unprognostic (3.50e-1)" "unprognostic (1.58e-1)" "unprognostic (1.29e-1)" "unprognostic (2.08e-1)" 1.4 1.1 0.6 0.5 4.7 0.6 23.9 0.7 2.0 54.8 1.2 1.1 2.5 1.0 5.6 9.2 25.3 8.7 0.6 1.4 0.7 1.1 11.3 0.8 8.8 0.5 0.9 0.6 11.7 29.5 4.7 13.3 1.7 9.5 5.0 1.0 9.5 8.2 9.1 2.4 365.3 1.2 0.9 0.9 0.6 1.8 0.8 2.3 3.1 25.9 62.9 16.9 3.5 27.5 1.7 0.2 0.0 0.0 11.1 7.0 1.2 32.0 5.2 0.0 0.0 1.3 2.0 9.0 0.1 4.3 0.2 0.3 39.6 34.0 0.0 13.0 0.3 1.6 18.0 9.8 51.9 0.4 0.1 9.5 0.0 0.0 8.8 1.5 0.0 0.1 17.8 14.0 0.9 30.2 3.0 0.0 0.0 0.1 0.0 0.1 28.0 0.0 0.0 28.8 23.3 2.1 0.0 0.0 1.3 51.3 21.2 0.1 0.0 7.8 0.0 3.1 8.6 13.0 0.0 0.0 5.0 15.2 0.1 0.1 0.2 0.0 0.2 4.2 0.0 0.3 0.0 0.0 0.0 7.0 0.0 6.1 1.7 0.6 3.4 0.0 0.2 0.1 2.4 0.0 11.1 0.0 0.2 0.0 1.2 0.6 4.7 0.7 2.0 0.7 1.1 0.9 0.6 9.5 2.3 98.3 94.2 3.7 121.7 1442.2 1.4 15.2 94.3 261.0 92.1 193.7 0.0 0.7 195.6 125.9 15.0 6.0 1.3 0.0 120.1 1.1 57.3 55.5 7.0 2.0 1.0 0.0 47.4 5.5 0.8 67.8 12.0 5.1 290.1 4.6 4.2 9.3 137.6 5.8 14.9 4.4 0.7 0.0 14.2 7.1 16.4 7442.2 1.9 5.3 11.0 72.7 DMRTA2 ENSG00000142700 "DMRT like family A2" Q96SC8 1 50417550-50423500 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 8.5;esophagus: 3.8;pituitary gland: 5.4;testis: 4.0" "Cell type enhanced" "Detected in some" 28 "Early spermatids: 3.7;Intestinal endocrine cells: 1.2" "Cancer enhanced" "Detected in many" "glioma: 5.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.2;HBEC3-KT: 4.3;RH-30: 15.6;SH-SY5Y: 3.3;SiHa: 3.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA043098, HPA062958" Uncertain Approved Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA Mitochondria Nucleoplasm "HPA043098: AB_10796684, HPA062958: AB_2684911" "unprognostic (1.60e-1)" "unprognostic (4.56e-3)" "unprognostic (2.62e-1)" "unprognostic (3.07e-1)" "unprognostic (3.03e-2)" "unprognostic (2.75e-2)" "unprognostic (1.15e-2)" "unprognostic (3.29e-1)" "unprognostic (6.89e-2)" "unprognostic (4.79e-1)" "unprognostic (7.47e-2)" "unprognostic (1.21e-3)" "unprognostic (7.08e-3)" "unprognostic (4.16e-2)" "unprognostic (7.85e-2)" "unprognostic (2.68e-3)" 0.2 0.1 0.4 0.1 1.5 0.2 0.2 0.4 2.1 0.3 0.3 8.5 0.0 0.4 0.2 0.1 3.8 0.2 0.1 0.1 1.2 0.7 0.2 0.2 0.2 0.2 1.2 0.0 0.2 0.1 0.4 5.4 0.2 2.1 0.2 0.3 0.0 0.5 0.2 0.3 0.1 0.2 0.1 2.0 0.3 0.2 4.0 3.7 0.3 0.2 0.5 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 1.9 0.0 1.3 4.3 0.0 0.0 0.1 1.1 0.1 0.0 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 3.3 3.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.4 1.8 1.2 0.7 1.2 0.0 2.1 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 DMRTC1 ENSG00000269502 "DMRT like family C1" Q5HYR2 X 72872025-72943814 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 2.2" "Group enriched" "Detected in many" 17 "B-cells: 2.2;T-cells: 1.2" "Cell line enhanced" "Detected in some" "AN3-CA: 1.6;Daudi: 3.6;JURKAT: 2.6;NTERA-2: 1.2;U-266/70: 1.2;U-266/84: 1.4;U-698: 2.0" "HPA046874, HPA046992" Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA Nucleoplasm "Intermediate filaments" "HPA046874: AB_2679850, HPA046992: AB_2679894" "unprognostic (1.83e-1)" 0.0 1.3 0.0 0.0 0.0 4.0 0.6 0.1 0.0 1.1 0.0 0.1 2.1 0.2 0.0 0.0 0.0 0.0 0.6 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.6 0.7 0.0 1.1 2.0 0.8 0.0 2.2 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 1.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.5 0.0 2.2 0.7 1.2 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DMRTC1B ENSG00000184911 "DMRT like family C1B" Q5HYR2 X 72777009-72848802 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 15.1;ovary: 12.1;pituitary gland: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 2.8" "Group enriched" "Detected in many" 12 "B-cells: 2.1;T-cells: 2.8" "Cell line enhanced" "Detected in some" "HaCaT: 1.0;SK-BR-3: 1.0;SuSa: 2.2;U-266/70: 1.5" "HPA046874, HPA046992" Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA Nucleoplasm "Intermediate filaments" "HPA046874: AB_2679850, HPA046992: AB_2679894" "unprognostic (2.00e-1)" "unprognostic (1.91e-2)" "unprognostic (1.54e-1)" "unprognostic (6.52e-2)" 0.3 4.6 11.0 1.7 15.1 0.1 0.7 4.5 14.3 1.7 0.6 2.2 1.4 0.5 2.2 9.6 0.3 3.3 0.6 0.2 8.6 14.2 1.6 0.2 1.1 1.4 4.9 9.1 12.1 5.2 1.5 12.1 0.2 2.2 3.8 0.8 2.4 1.0 1.9 0.2 0.5 0.5 0.6 2.2 1.3 1.2 7.1 2.9 0.7 3.9 0.2 2.1 0.3 0.2 2.1 0.0 0.0 0.0 0.2 2.8 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.9 0.8 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 2.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.5 0.4 0.0 2.1 2.1 2.8 0.0 0.2 0.0 0.0 0.0 0.2 11.0 15.1 4.5 11.4 8.6 14.2 4.9 9.1 2.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DMTF1 "DMP1, DMTF, hDMP1, MRUL" ENSG00000135164 "Cyclin D binding myb like transcription factor 1" Q9Y222 7 87152361-87196337 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023846 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA023846: AB_1847779" "unprognostic (3.86e-2)" "unprognostic (1.88e-1)" "unprognostic (9.82e-2)" "unprognostic (8.54e-2)" "unprognostic (3.13e-1)" "unprognostic (2.26e-3)" "unprognostic (9.77e-3)" "unprognostic (2.53e-3)" "unprognostic (6.89e-2)" "unprognostic (2.56e-3)" "unprognostic (1.15e-2)" "unprognostic (1.36e-2)" "prognostic unfavorable (4.39e-5)" "unprognostic (6.39e-2)" "unprognostic (1.87e-1)" "unprognostic (1.15e-1)" "unprognostic (1.09e-3)" 16.8 14.2 22.5 17.8 27.2 24.3 19.1 35.2 24.2 19.2 17.8 19.2 22.3 15.0 23.7 35.0 12.3 19.6 14.0 14.1 23.0 15.1 14.5 10.6 18.4 17.2 28.9 20.0 27.1 14.8 24.9 41.6 16.4 23.1 17.0 18.3 14.3 13.4 16.9 10.0 17.9 17.7 19.9 23.6 17.5 13.5 42.0 32.4 29.4 25.0 7.0 16.6 18.2 17.0 10.3 5.9 13.6 5.1 6.6 10.0 3.5 12.2 6.3 27.6 22.8 7.9 13.7 11.5 15.3 6.0 9.1 14.6 5.5 11.4 15.4 11.1 9.7 10.7 6.9 19.5 10.7 17.7 8.1 9.9 11.2 17.2 8.3 7.8 10.4 12.2 12.8 8.5 17.8 17.5 14.9 11.6 16.9 19.2 18.0 14.6 11.4 18.5 12.9 21.6 8.0 11.4 16.1 14.9 10.0 8.2 10.8 18.9 23.5 19.7 7.5 12.0 35.9 11.2 6.5 14.8 16.8 8.3 21.4 13.7 14.2 19.9 28.2 9.4 8.3 14.6 13.6 4.4 8.8 10.0 4.8 9.2 10.3 7.7 7.0 3.6 9.3 9.2 8.2 6.8 6.6 5.1 5.9 9.1 3.5 22.5 27.2 35.2 24.2 23.0 15.1 28.9 20.0 23.1 32.4 20.8 24.8 18.9 14.2 11.6 25.0 9.4 12.7 25.4 20.5 3.5 35.3 12.2 3.3 8.7 19.4 19.5 16.6 0.0 7.0 7.4 11.3 19.7 34.8 8.6 9.4 17.5 18.9 20.9 19.6 9.9 21.6 16.0 0.0 10.8 12.8 11.9 8.1 17.5 21.2 3.0 25.8 32.3 12.0 53.4 18.6 11.0 6.4 27.7 10.3 18.4 DNAAF5 "CILD18, FLJ20397, FLJ25564, FLJ31671, FLJ39381, HEATR2" ENSG00000164818 "Dynein axonemal assembly factor 5" Q86Y56 7 726701-786475 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020243 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA020243: AB_1848750" "unprognostic (9.77e-2)" "unprognostic (9.53e-3)" "unprognostic (2.55e-1)" "unprognostic (2.57e-1)" "unprognostic (8.22e-3)" "prognostic unfavorable (8.42e-4)" "prognostic unfavorable (3.83e-4)" "unprognostic (8.07e-3)" "unprognostic (2.02e-1)" "unprognostic (7.59e-2)" "unprognostic (8.26e-2)" "unprognostic (1.93e-1)" "unprognostic (1.47e-3)" "unprognostic (6.01e-2)" "unprognostic (1.15e-1)" "unprognostic (1.07e-1)" "unprognostic (8.70e-3)" 11.5 13.0 9.3 13.5 11.4 10.7 12.3 17.4 14.2 15.5 16.3 14.7 10.3 12.0 18.4 13.9 16.7 23.4 15.4 18.8 11.6 8.6 15.0 18.2 9.9 11.8 9.5 7.6 20.6 22.5 14.4 21.1 12.1 10.4 16.1 9.9 14.0 17.6 14.3 33.9 12.0 13.6 13.9 9.2 12.5 13.0 14.8 9.4 20.7 15.9 11.2 14.2 15.6 12.4 3.3 4.6 1.4 2.8 3.0 4.7 1.9 30.7 24.4 7.3 16.9 4.8 5.3 18.4 6.4 6.2 8.0 7.6 24.3 16.4 18.9 9.3 6.7 19.1 18.7 13.4 16.1 6.2 3.2 22.8 4.6 14.5 17.5 6.6 14.0 8.4 6.4 6.9 10.0 7.4 5.3 10.8 9.6 29.3 3.9 5.8 30.3 8.3 12.6 26.8 10.2 19.4 15.4 2.3 13.0 9.3 13.0 15.3 25.4 10.5 25.9 7.4 8.7 22.8 11.8 9.0 4.5 16.0 15.3 14.3 7.7 9.2 10.9 9.8 14.8 23.3 0.0 1.9 1.4 2.2 2.8 3.3 1.6 3.5 4.7 2.7 3.3 3.3 2.5 0.0 3.0 2.0 4.6 0.8 1.9 9.3 11.4 17.4 14.2 11.6 8.6 9.5 7.6 10.4 9.4 17.9 7.8 0.0 5.2 0.0 5.8 12.5 5.1 14.7 7.9 8.7 25.5 6.8 13.3 6.0 0.5 5.6 3.8 0.0 3.6 11.2 5.1 3.9 0.0 8.2 5.0 9.5 3.5 5.5 8.2 1.3 6.6 2.7 0.0 0.0 10.5 9.1 8.6 0.0 8.1 8.6 16.1 0.0 3.9 6.7 20.0 0.0 3.8 2.2 11.2 3.5 DNAH17 "DNAHL1, DNEL2, FLJ40457" ENSG00000187775 "Dynein axonemal heavy chain 17" Q9UFH2 17 78423697-78577394 "Predicted intracellular proteins" "Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 45 "testis: 39.4" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 44.2;Cone photoreceptor cells: 82.5;Early spermatids: 36.7;Late spermatids: 24.9" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HeLa: 10.0;MOLT-4: 4.8" "Not detected" "Not detected" "HPA024354, HPA076261" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "HPA024354: AB_1847911, HPA076261: AB_2732305" "unprognostic (4.98e-4)" "unprognostic (2.26e-1)" "unprognostic (2.30e-3)" "unprognostic (8.70e-3)" "unprognostic (6.66e-2)" "unprognostic (9.23e-2)" "unprognostic (3.72e-3)" "unprognostic (8.41e-2)" "unprognostic (2.66e-1)" "unprognostic (1.11e-1)" "unprognostic (1.20e-3)" "unprognostic (8.35e-3)" "unprognostic (1.58e-10)" "unprognostic (5.25e-2)" "unprognostic (1.54e-1)" "unprognostic (5.12e-1)" "unprognostic (6.04e-3)" 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.8 0.1 0.0 39.4 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 1.0 0.0 10.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.1 4.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 6.0 0.3 0.5 0.2 0.6 44.2 2.0 0.0 0.0 0.0 0.0 82.5 0.0 0.0 0.0 36.7 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.2 24.9 0.6 1.3 0.0 0.0 0.0 0.8 0.1 0.0 0.4 0.0 7.2 0.0 0.2 16.2 0.5 0.1 0.0 0.0 0.0 0.1 DNAJB1 "Hsp40, HSPF1, RSPH16B, Sis1" ENSG00000132002 "DnaJ heat shock protein family (Hsp40) member B1" P25685 19 14514770-14529770 "Cancer-related genes, Predicted intracellular proteins" "Stress response" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 291.1" "Cell type enhanced" "Detected in many" 4 "Smooth muscle cells: 802.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 110.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017450, HPA063247" Enhanced Supported Nucleoplasm NA Yes 9600 Nucleoplasm "CAB017450: AB_10631418, HPA063247: AB_2684971" "unprognostic (3.75e-2)" "unprognostic (2.23e-1)" "unprognostic (1.46e-1)" "unprognostic (2.12e-1)" "unprognostic (1.60e-1)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" "unprognostic (1.74e-2)" "unprognostic (3.83e-1)" "unprognostic (1.85e-1)" "unprognostic (7.91e-3)" "unprognostic (2.17e-1)" "prognostic favorable (5.96e-4)" "unprognostic (2.20e-2)" "unprognostic (4.44e-2)" "unprognostic (2.00e-2)" "unprognostic (6.77e-2)" 29.2 76.9 28.5 13.2 30.0 36.2 67.0 41.4 29.4 19.3 15.5 21.5 14.5 10.5 20.4 11.8 72.3 21.7 56.4 23.5 28.2 31.6 23.4 37.7 35.7 10.7 53.4 12.0 32.3 22.6 18.3 25.0 33.5 45.8 29.6 13.1 12.2 18.4 40.8 16.1 25.3 9.5 24.0 40.2 9.4 19.1 37.5 37.9 15.0 28.9 18.0 31.1 19.2 291.1 19.7 15.2 28.2 31.6 23.0 61.6 56.7 36.9 39.3 14.2 15.1 26.2 21.1 8.9 24.6 18.3 39.0 29.5 23.2 20.9 10.2 28.2 20.9 25.5 28.1 29.1 17.7 27.7 10.7 14.4 16.3 26.0 48.6 17.9 11.5 15.5 11.7 42.4 15.1 13.2 20.4 12.8 6.9 24.1 110.7 21.4 23.4 18.5 10.7 15.1 48.9 42.4 14.2 20.0 23.0 17.7 12.7 13.1 9.7 22.3 44.2 24.2 16.6 12.1 11.2 13.3 31.7 19.1 36.5 51.6 49.3 30.2 13.4 22.6 19.9 28.2 11.5 18.9 22.3 36.6 31.1 38.9 19.4 52.5 45.4 15.2 19.7 61.6 47.6 28.2 23.0 31.6 9.1 51.8 56.7 28.5 30.0 41.4 29.4 28.2 31.6 53.4 12.0 45.8 37.9 145.9 105.3 114.6 695.7 378.2 47.1 335.7 48.4 87.0 71.7 22.7 111.9 123.3 34.9 105.0 377.6 275.7 133.0 0.0 143.2 142.5 617.3 678.1 342.8 50.4 134.5 49.3 390.0 73.1 71.9 368.9 58.7 232.5 477.5 35.1 126.4 109.5 97.8 108.7 34.6 43.9 149.2 25.8 802.9 139.1 31.8 418.7 229.9 251.4 123.6 238.8 DNAJB4 HLJ1 ENSG00000162616 "DnaJ heat shock protein family (Hsp40) member B4" Q9UDY4 1 77979175-78017964 "Plasma proteins, Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 89.8" "Cell type enhanced" "Detected in all" 4 "Syncytiotrophoblasts: 151.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 28.6;HUVEC TERT2: 43.5;LHCN-M2: 73.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004995, HPA028383, HPA028385" Approved Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "CAB004995: AB_425882, HPA028383: AB_10599601, HPA028385: AB_10599944" "unprognostic (1.21e-1)" "unprognostic (4.36e-2)" "unprognostic (2.19e-1)" "unprognostic (5.50e-3)" "unprognostic (3.40e-2)" "unprognostic (4.76e-3)" "unprognostic (4.32e-3)" "unprognostic (3.93e-3)" "unprognostic (1.53e-1)" "unprognostic (2.16e-1)" "unprognostic (2.00e-1)" "unprognostic (3.22e-1)" "prognostic unfavorable (2.28e-4)" "unprognostic (1.60e-2)" "unprognostic (1.51e-1)" "unprognostic (7.12e-3)" "unprognostic (1.01e-2)" 23.3 39.0 19.2 8.4 20.7 4.9 16.6 22.7 24.1 21.3 12.7 7.2 9.3 5.4 20.8 10.1 25.0 11.7 25.2 42.0 18.0 16.8 16.0 15.5 21.7 7.0 25.7 9.1 15.3 18.5 16.4 19.1 19.5 23.8 19.4 9.4 5.1 7.0 12.2 33.3 7.6 8.8 23.0 29.5 30.3 11.9 7.8 22.5 2.8 35.1 29.4 5.1 22.1 89.8 3.6 5.0 4.5 1.9 3.1 7.2 2.6 1.4 2.8 3.5 2.1 15.3 28.6 1.6 27.8 7.1 12.4 14.0 0.9 1.8 2.1 4.7 13.2 5.1 2.1 4.5 2.4 21.2 2.3 1.2 1.0 8.3 6.7 20.8 0.5 0.5 11.8 6.7 16.0 4.6 6.9 43.5 0.7 4.5 1.5 73.8 0.1 0.6 1.5 2.2 0.4 1.3 1.1 6.2 1.3 2.9 0.7 2.5 0.8 3.2 2.3 2.6 3.8 0.9 0.9 20.7 17.5 4.3 12.4 3.6 1.3 0.4 1.8 2.3 1.2 3.0 4.5 1.7 2.7 2.6 1.7 4.4 3.6 3.2 3.1 1.7 3.0 7.2 5.1 0.4 3.1 1.9 5.0 4.2 2.6 19.2 20.7 22.7 24.1 18.0 16.8 25.7 9.1 23.8 22.5 56.6 4.6 13.3 77.1 37.1 28.0 82.6 10.2 30.8 20.5 17.4 64.8 46.9 31.5 10.5 126.4 66.1 19.8 23.3 12.8 18.9 83.6 23.4 57.5 18.1 15.9 28.6 20.5 33.2 21.3 48.4 22.7 19.0 62.4 6.4 4.0 35.7 14.8 17.5 32.9 22.8 56.8 25.8 119.1 21.1 13.2 34.4 151.4 15.2 6.5 27.1 DNAJB5 Hsc40 ENSG00000137094 "DnaJ heat shock protein family (Hsp40) member B5" O75953 9 34989641-34998900 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 99.4" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 37.5;Smooth muscle cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "myeloid DC: 7.7;neutrophil: 7.6" "Group enriched" "Detected in many" 5 "dendritic cells: 7.7;granulocytes: 7.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023818, HPA050794" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA023818: AB_1847793, HPA050794: AB_2681241" "unprognostic (1.41e-2)" "unprognostic (3.87e-1)" "unprognostic (2.53e-3)" "unprognostic (5.21e-2)" "unprognostic (1.86e-1)" "unprognostic (3.54e-2)" "unprognostic (7.31e-2)" "unprognostic (2.79e-1)" "unprognostic (2.57e-1)" "unprognostic (1.00e-2)" "unprognostic (1.31e-2)" "unprognostic (1.89e-1)" "unprognostic (1.17e-1)" "unprognostic (4.34e-3)" "unprognostic (2.44e-1)" "unprognostic (1.44e-1)" "unprognostic (1.00e-3)" 7.2 6.3 5.9 5.1 7.2 0.9 2.6 8.6 13.0 6.5 19.1 6.2 9.2 3.8 18.5 9.7 15.7 9.6 8.7 29.3 6.6 6.3 3.7 2.0 3.7 2.2 4.7 3.4 6.5 3.1 2.2 8.6 1.4 6.0 13.8 6.2 5.7 3.7 26.2 99.4 1.5 6.1 29.9 4.5 5.6 11.3 8.1 3.5 1.6 4.4 38.0 2.9 23.0 3.6 0.7 7.7 7.6 1.5 0.5 1.3 0.7 2.5 2.1 13.4 7.1 7.9 6.1 1.5 11.2 8.2 17.3 15.4 1.5 0.6 2.4 2.8 12.3 18.2 0.3 5.1 8.8 14.7 3.5 1.6 0.9 3.1 0.7 9.1 0.3 8.1 8.9 0.6 10.2 5.1 7.7 11.0 4.6 0.2 5.2 13.9 1.8 4.2 3.6 6.3 1.1 4.5 3.2 13.9 1.3 2.4 0.2 5.7 9.3 6.0 0.3 1.3 12.1 2.2 0.8 4.9 8.3 18.2 4.3 3.4 1.9 1.3 1.7 9.5 1.0 8.9 0.1 1.5 0.0 0.4 0.4 1.3 0.7 0.3 0.1 7.7 0.3 0.5 1.1 7.6 0.5 0.1 0.2 1.3 0.7 5.9 7.2 8.6 8.5 6.6 6.3 4.7 3.4 6.0 3.5 6.0 1.0 0.9 1.9 1.8 4.1 37.5 2.5 1.4 1.2 0.0 5.9 0.1 0.0 2.1 5.3 5.2 0.7 0.0 3.0 0.5 3.1 1.5 0.0 1.1 4.7 1.6 0.0 2.5 1.5 5.1 1.4 2.8 5.0 1.0 0.0 12.0 4.2 0.0 7.4 3.7 2.5 6.5 19.4 8.0 0.9 2.6 0.7 0.8 0.0 0.6 DNAJB6 "LGMD1D, MRJ" ENSG00000105993 "DnaJ heat shock protein family (Hsp40) member B6" O75190 7 157335381-157417439 "Disease related genes, Predicted intracellular proteins" Chaperone "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Suprabasal keratinocytes: 839.6;Urothelial cells: 816.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB004670, HPA024258, HPA058593" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004670: AB_425825, HPA024258: AB_1847795, HPA058593: AB_2683767" "unprognostic (4.37e-1)" "unprognostic (1.62e-2)" "unprognostic (3.22e-2)" "unprognostic (9.26e-3)" "unprognostic (6.66e-3)" "unprognostic (4.68e-2)" "prognostic unfavorable (1.12e-5)" "unprognostic (5.71e-2)" "unprognostic (2.62e-2)" "unprognostic (1.01e-2)" "unprognostic (8.41e-2)" "unprognostic (3.19e-1)" "unprognostic (6.33e-2)" "unprognostic (2.24e-1)" "unprognostic (1.54e-1)" "unprognostic (6.45e-2)" "unprognostic (1.52e-1)" 24.0 23.1 38.0 17.9 35.0 51.3 40.5 42.2 41.3 17.1 25.5 21.7 19.1 14.5 23.3 38.8 33.2 20.9 17.3 37.0 31.7 32.2 24.5 16.7 19.4 16.4 37.6 32.2 22.8 18.8 17.2 20.2 24.4 37.7 19.5 17.2 15.3 20.1 25.6 96.9 34.2 15.6 31.7 33.9 17.2 16.8 38.3 35.2 12.2 17.9 23.5 21.9 23.4 51.9 32.7 30.4 74.3 48.1 35.5 42.1 55.0 37.8 23.0 28.0 28.3 28.4 25.8 25.9 42.6 34.9 39.7 43.6 31.3 38.3 14.6 80.3 31.5 36.1 24.3 19.0 29.8 61.6 29.2 26.0 26.1 13.9 22.1 26.2 19.3 22.0 22.6 28.9 30.0 14.3 39.9 29.5 15.7 42.3 14.6 50.8 25.7 48.2 38.1 56.0 26.8 30.7 26.0 20.2 20.3 32.7 23.2 16.9 44.7 33.3 26.1 31.1 60.4 19.0 27.4 36.7 25.1 19.1 59.7 36.6 28.0 39.9 17.1 35.7 44.5 31.7 70.6 41.5 48.8 36.2 41.6 36.1 32.7 33.2 37.2 30.4 28.1 42.1 39.3 74.3 35.5 48.1 27.6 38.9 55.0 38.0 35.0 42.2 41.3 31.7 32.2 37.6 32.2 37.7 35.2 44.7 57.9 61.6 535.0 672.2 87.1 103.2 40.8 135.1 83.0 92.5 76.6 239.3 164.2 120.8 82.9 125.4 92.1 46.7 61.0 198.1 160.4 315.0 212.0 42.7 149.9 89.0 185.4 94.5 124.0 94.1 139.8 162.9 268.2 444.6 63.2 102.0 105.0 73.7 190.2 165.4 87.6 97.0 208.1 297.0 373.7 839.6 425.0 152.3 79.1 816.5 DNAJC17 FLJ10634 ENSG00000104129 "DnaJ heat shock protein family (Hsp40) member C17" Q9NVM6 15 40765155-40807478 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chaperone, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040914, HPA041187" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA040914: AB_10794072, HPA041187: AB_10794192" "unprognostic (9.79e-2)" "unprognostic (9.63e-2)" "prognostic unfavorable (5.89e-4)" "unprognostic (1.66e-3)" "unprognostic (1.46e-1)" "unprognostic (1.32e-2)" "unprognostic (1.51e-1)" "unprognostic (1.40e-1)" "unprognostic (3.65e-1)" "unprognostic (2.84e-1)" "unprognostic (1.94e-1)" "unprognostic (5.98e-2)" "unprognostic (5.37e-2)" "unprognostic (2.72e-1)" "unprognostic (4.78e-1)" "unprognostic (2.64e-2)" "unprognostic (6.58e-2)" 17.0 15.7 19.5 13.0 18.5 7.5 19.8 38.0 22.1 18.3 17.8 20.5 12.7 11.0 20.1 15.4 19.7 19.7 15.2 12.6 14.0 10.3 16.7 23.6 14.7 16.6 16.0 17.3 23.7 16.2 19.4 12.6 18.4 17.2 15.9 15.6 16.2 19.1 16.0 13.6 18.2 15.1 17.2 13.9 19.1 14.1 7.7 19.0 12.1 17.3 11.8 21.2 13.7 17.9 14.8 17.1 19.5 20.0 8.5 26.1 9.2 5.9 5.5 13.9 13.4 6.3 15.8 5.9 11.4 11.3 19.2 15.8 4.4 8.7 9.4 12.6 13.6 8.8 12.7 14.1 18.6 17.0 17.2 8.8 15.8 11.1 4.2 17.8 8.1 14.1 15.6 12.0 15.1 27.3 10.7 17.6 16.1 11.0 5.0 14.6 7.7 11.9 11.0 5.0 14.2 8.1 8.8 11.5 4.8 19.3 11.1 8.8 5.6 8.3 7.7 6.0 10.3 9.8 16.5 17.2 10.9 9.4 12.3 9.6 5.6 16.5 20.5 7.0 21.2 9.2 17.6 15.8 19.5 18.6 20.0 13.1 14.0 15.9 17.3 17.1 14.8 17.3 16.5 5.7 8.5 11.3 13.9 26.1 9.2 19.5 18.5 38.0 22.1 14.0 10.3 16.0 17.3 17.2 19.0 11.9 16.0 10.0 17.1 4.9 14.0 4.7 15.3 18.7 23.9 24.4 11.8 20.3 16.6 15.7 2.0 10.5 21.4 0.0 15.5 13.7 11.3 11.6 20.9 12.5 20.2 12.7 7.5 20.9 9.5 1.4 14.1 15.4 6.8 13.6 12.5 6.6 14.8 20.7 15.2 17.7 9.8 0.0 10.3 4.7 3.9 4.5 14.4 17.8 15.1 19.5 DNAJC25 bA16L21.2.1 ENSG00000059769 "DnaJ heat shock protein family (Hsp40) member C25" Q9H1X3 9 111631352-111654351 "Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 41.9" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 75.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019122 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA019122: AB_1853155" "unprognostic (3.07e-1)" "unprognostic (7.42e-2)" "unprognostic (8.94e-3)" "prognostic favorable (3.73e-4)" "unprognostic (2.08e-2)" "unprognostic (5.66e-2)" "unprognostic (1.60e-2)" "unprognostic (1.04e-1)" "unprognostic (7.81e-2)" "unprognostic (9.65e-2)" "unprognostic (9.04e-2)" "unprognostic (5.09e-2)" "unprognostic (2.52e-3)" "unprognostic (9.44e-2)" "unprognostic (1.37e-1)" "unprognostic (8.30e-2)" "unprognostic (5.19e-2)" 5.1 10.2 3.3 3.9 4.6 1.9 5.8 4.5 4.2 3.4 5.1 2.5 5.7 4.6 4.1 7.7 3.4 3.8 3.6 6.7 4.3 3.8 7.8 41.9 3.5 4.1 2.7 2.3 5.7 7.0 7.4 9.0 4.4 3.3 5.9 3.0 3.6 9.7 4.0 3.6 2.4 6.9 5.0 2.9 2.9 3.7 4.2 1.9 1.4 4.3 2.4 2.2 6.4 4.5 0.6 1.1 1.2 1.9 0.4 0.8 0.3 2.6 2.0 1.4 2.4 14.7 6.6 5.4 10.2 4.9 4.0 4.0 3.9 1.7 2.3 4.0 7.0 6.3 8.6 1.5 2.9 3.9 1.9 2.0 2.3 0.0 7.9 4.8 4.3 3.4 5.7 8.3 3.1 5.9 3.2 3.3 1.3 4.6 2.0 5.1 2.9 1.3 0.2 2.5 5.1 4.8 2.2 7.5 2.1 8.4 2.9 2.4 1.3 5.7 8.0 3.6 2.6 4.2 1.1 6.4 4.9 2.2 13.1 5.8 3.7 5.6 1.3 8.4 2.1 4.3 0.0 0.1 1.2 0.6 1.9 0.2 0.3 0.5 0.0 0.5 0.6 0.5 0.2 0.8 0.4 1.0 1.1 0.8 0.3 3.3 4.6 4.5 4.2 4.3 3.8 2.7 2.3 3.3 1.9 6.0 11.0 14.5 13.2 9.4 7.7 9.0 7.6 13.4 12.5 10.4 19.6 11.8 11.6 13.6 7.8 4.9 17.6 0.0 14.1 18.7 13.1 26.6 1.1 75.4 10.9 12.7 16.6 6.7 5.0 1.4 9.5 7.9 11.8 4.6 14.9 3.9 11.0 7.4 9.6 10.7 20.2 12.9 11.3 29.8 11.9 8.2 11.6 7.9 10.9 17.1 DNAJC6 "KIAA0473, PARK19" ENSG00000116675 "DnaJ heat shock protein family (Hsp40) member C6" O75061 1 65248219-65415869 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Chaperone, Hydrolase, Protein phosphatase" "Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 91.4" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 29.6;Cardiomyocytes: 26.1;Erythroid cells: 23.3;Horizontal cells: 49.3;Rod photoreceptor cells: 21.6" "Cancer enhanced" "Detected in many" "glioma: 5.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HDLM-2: 21.2;HEL: 56.7;K-562: 22.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031182, HPA054917" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA031182: AB_10611957, HPA054917: AB_2682641" "unprognostic (6.99e-2)" "unprognostic (2.00e-3)" "unprognostic (3.19e-1)" "unprognostic (7.94e-7)" "unprognostic (1.59e-1)" "unprognostic (7.61e-3)" "unprognostic (1.87e-4)" "unprognostic (2.98e-1)" "unprognostic (1.89e-1)" "unprognostic (4.14e-1)" "unprognostic (4.22e-3)" "unprognostic (1.53e-1)" "prognostic favorable (2.81e-4)" "unprognostic (1.43e-2)" "unprognostic (1.12e-1)" "unprognostic (1.36e-1)" "unprognostic (8.67e-3)" 2.1 12.1 18.6 2.2 28.5 5.0 2.0 24.2 91.4 2.2 2.8 26.9 0.0 2.3 1.9 1.8 1.7 2.4 2.3 9.0 25.0 26.7 8.5 1.6 2.7 1.6 28.8 23.8 1.9 3.4 2.1 7.5 8.0 40.5 2.5 3.0 2.2 1.7 2.1 1.6 2.1 2.3 2.2 28.7 3.2 2.9 3.2 21.1 0.0 3.0 0.0 1.7 1.8 0.6 0.5 0.5 0.0 0.0 0.6 1.5 0.3 3.5 1.0 0.0 1.6 0.8 0.2 8.4 7.1 11.6 11.7 11.5 0.9 0.1 3.4 0.6 2.9 2.9 0.9 5.1 1.1 9.2 21.2 2.4 56.7 1.9 0.2 0.0 1.9 1.4 1.0 0.8 1.1 5.0 2.2 0.2 2.8 22.0 0.4 2.4 0.6 0.7 0.0 2.3 0.0 0.8 0.0 1.7 0.1 8.9 0.0 14.2 9.7 4.1 5.6 1.9 14.1 2.7 0.1 2.2 1.7 1.2 0.2 2.0 2.1 1.4 1.0 4.8 1.4 2.9 0.0 0.0 0.0 1.5 0.0 0.1 0.5 0.5 0.9 0.0 0.0 0.4 0.6 0.0 0.6 0.0 0.5 0.0 0.3 18.6 28.5 24.2 37.4 25.0 26.7 28.8 23.8 40.5 21.1 0.0 0.3 0.0 0.2 1.1 29.6 26.1 0.0 0.0 0.0 0.0 13.7 4.8 1.7 0.8 1.8 0.7 0.0 23.3 0.6 1.9 1.7 1.3 0.0 0.0 1.1 49.3 6.9 0.0 0.0 1.4 0.0 0.8 6.8 1.8 1.3 3.1 0.4 0.0 0.0 5.9 21.6 0.0 2.3 1.0 2.3 0.3 6.2 0.0 0.5 0.1 DNAJC7 "TPR2, TTC2" ENSG00000168259 "DnaJ heat shock protein family (Hsp40) member C7" Q99615 17 41976433-42021376 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023015, HPA052395" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA023015: AB_1847804, HPA052395: AB_2681811" "unprognostic (3.21e-2)" "unprognostic (2.00e-2)" "unprognostic (2.47e-3)" "unprognostic (8.40e-2)" "unprognostic (1.16e-1)" "unprognostic (5.31e-3)" "prognostic unfavorable (3.35e-4)" "unprognostic (7.71e-2)" "unprognostic (2.58e-2)" "unprognostic (1.90e-2)" "unprognostic (2.48e-2)" "unprognostic (8.37e-2)" "unprognostic (3.37e-2)" "unprognostic (1.06e-1)" "unprognostic (2.42e-2)" "unprognostic (2.32e-2)" "unprognostic (8.93e-3)" 22.9 24.2 42.0 27.6 49.3 24.7 28.3 36.6 44.1 22.2 30.5 25.0 21.0 21.5 18.6 32.3 31.4 19.3 19.9 30.6 36.5 38.6 36.9 30.8 21.8 30.1 38.1 30.5 26.4 29.0 37.7 38.2 24.4 48.2 20.4 29.0 21.0 21.0 22.1 44.3 28.0 22.4 18.9 28.9 23.7 22.0 25.2 32.9 31.8 26.5 29.0 40.9 24.3 33.5 15.8 48.1 14.0 21.2 17.8 16.2 13.2 19.7 33.8 31.8 23.7 19.5 32.8 27.1 20.4 29.0 38.7 31.0 39.0 20.1 30.6 24.3 29.5 28.2 29.8 49.9 36.6 46.2 27.3 70.0 24.6 28.9 54.2 27.9 35.7 22.4 27.2 21.6 35.5 33.4 26.1 30.4 32.1 37.7 21.7 32.7 16.5 38.5 29.6 31.0 19.7 24.7 27.0 36.3 27.0 29.0 25.9 30.9 24.3 17.1 50.8 24.9 36.8 28.5 29.8 23.9 21.2 20.1 22.2 33.8 15.8 35.8 28.3 23.0 26.1 22.5 14.0 20.6 13.6 13.2 21.2 14.6 15.8 14.6 15.1 21.6 15.0 14.4 13.8 8.9 17.8 20.4 48.1 16.2 13.2 42.0 49.3 36.6 44.1 36.5 38.6 38.1 30.5 48.2 32.9 32.8 34.7 92.6 81.7 58.2 80.9 58.1 45.9 41.5 25.0 62.8 127.6 95.7 97.8 80.1 64.8 73.4 61.4 23.3 115.2 83.9 52.6 65.4 55.4 49.4 90.4 60.4 106.9 57.1 81.0 35.7 62.5 108.0 45.5 127.2 54.6 91.4 101.3 56.8 57.7 112.8 125.2 45.3 55.4 75.7 114.1 60.1 106.1 79.9 63.5 83.9 DNAJC8 SPF31 ENSG00000126698 "DnaJ heat shock protein family (Hsp40) member C8" O75937 1 28199456-28233025 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026275, HPA026283" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA026275: AB_2671823, HPA026283: AB_10600907" "unprognostic (1.42e-1)" "unprognostic (2.44e-2)" "unprognostic (5.71e-2)" "prognostic favorable (6.95e-5)" "unprognostic (1.17e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (4.71e-4)" "unprognostic (2.54e-1)" "unprognostic (3.07e-3)" "unprognostic (9.57e-2)" "unprognostic (3.93e-1)" "unprognostic (1.65e-1)" "unprognostic (1.23e-1)" "unprognostic (1.72e-1)" "unprognostic (5.50e-2)" "prognostic favorable (2.39e-4)" "unprognostic (4.84e-2)" 27.3 26.9 35.9 27.8 40.1 27.5 27.7 33.6 40.7 26.3 27.2 33.6 15.8 22.6 33.1 25.9 24.5 23.6 22.5 30.5 31.2 31.7 29.0 29.1 23.4 38.5 34.2 32.5 32.0 15.0 20.0 23.8 32.4 38.2 30.0 25.4 21.4 20.7 26.1 26.4 21.8 21.8 36.0 33.0 30.3 22.3 15.7 36.0 30.8 35.1 19.9 42.8 29.6 27.7 31.9 34.8 29.6 30.8 29.6 37.0 44.0 24.9 12.9 20.4 23.4 24.7 20.3 18.2 20.8 26.0 42.0 38.6 13.5 20.4 28.7 21.6 23.1 20.8 15.5 29.9 20.4 44.6 22.5 22.2 36.8 19.8 23.9 22.3 36.2 30.4 15.5 18.3 26.5 14.0 19.8 27.8 23.9 34.3 20.2 30.6 14.5 27.5 25.4 36.9 15.6 15.0 31.3 30.2 27.5 26.7 20.6 7.4 19.1 27.3 11.7 24.6 15.8 16.8 29.6 21.3 18.8 20.4 41.9 30.9 19.2 25.1 45.1 25.2 44.3 25.4 29.6 30.5 27.8 37.0 29.3 37.0 31.9 33.5 36.1 33.1 30.7 33.6 34.1 16.2 29.6 30.8 34.8 35.1 44.0 35.9 40.1 33.6 40.7 31.2 31.7 34.2 32.5 38.2 36.0 71.5 77.9 119.9 114.0 115.2 95.1 130.7 76.5 89.7 100.1 101.2 23.6 164.5 228.8 122.3 29.6 126.6 51.6 70.0 85.7 129.7 132.6 93.6 134.3 64.5 156.1 65.2 44.2 86.5 68.5 31.5 111.7 136.1 97.8 171.3 45.8 156.0 94.7 57.5 135.4 133.6 90.4 84.1 106.1 126.5 83.5 96.4 187.4 117.7 62.3 94.7 DNAJC9 "JDD1, SB73" ENSG00000213551 "DnaJ heat shock protein family (Hsp40) member C9" Q8WXX5 10 73183362-73248862 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 24.2" "Cell type enhanced" "Detected in all" 5 "Erythroid cells: 140.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035215, HPA035216" Supported Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA035215: AB_10603663, HPA035216: AB_2674522" "unprognostic (4.18e-2)" "unprognostic (1.61e-2)" "unprognostic (7.63e-2)" "unprognostic (2.67e-3)" "unprognostic (3.45e-1)" "unprognostic (6.83e-3)" "unprognostic (2.43e-3)" "prognostic unfavorable (3.26e-4)" "unprognostic (6.20e-2)" "unprognostic (1.66e-1)" "unprognostic (3.91e-1)" "prognostic unfavorable (7.07e-5)" "unprognostic (5.61e-2)" "unprognostic (3.08e-3)" "unprognostic (6.49e-2)" "unprognostic (3.38e-1)" "unprognostic (1.56e-1)" 3.1 4.0 4.0 5.0 4.3 24.2 4.6 12.9 5.8 3.0 4.6 4.2 4.0 3.9 6.8 2.9 1.7 2.7 4.2 5.2 2.8 3.5 2.9 7.7 3.5 5.2 2.6 3.6 4.3 5.4 3.6 5.8 3.6 3.9 3.4 5.3 4.1 3.8 3.1 5.9 3.4 4.3 2.9 9.9 3.1 4.4 15.6 9.4 13.2 4.9 10.6 16.5 8.8 26.5 16.4 21.3 17.6 5.1 5.0 9.4 21.6 12.8 21.7 22.7 28.1 18.7 18.4 7.1 9.5 9.3 18.1 21.3 14.3 24.6 21.3 14.7 39.1 16.8 18.6 3.5 34.3 15.8 4.0 7.9 22.8 20.0 10.6 14.3 23.4 34.9 21.4 17.1 24.6 33.2 26.0 7.8 12.6 46.0 24.7 18.6 10.1 10.8 12.9 10.2 17.2 15.8 26.0 11.3 10.2 13.6 16.1 10.4 14.5 25.7 15.5 32.9 10.0 15.1 29.6 14.6 34.2 9.3 7.3 1.8 13.2 13.0 4.9 14.4 15.6 15.9 14.1 3.0 12.7 15.6 13.8 2.1 10.6 4.7 9.4 16.5 8.8 8.9 10.5 40.2 29.5 42.4 24.8 2.4 25.5 29.4 27.3 8.7 7.9 69.3 18.3 29.2 74.3 18.0 13.1 140.2 27.2 89.2 17.4 20.5 39.5 8.2 51.9 14.3 11.5 9.8 11.3 30.7 13.0 16.8 30.4 31.5 17.2 26.4 30.7 17.3 19.1 11.3 38.3 25.8 22.7 21.1 59.5 38.0 48.5 45.3 32.2 33.3 DNAL1 "1700010H15RiK, C14orf168, CILD16, MGC12435" ENSG00000119661 "Dynein axonemal light chain 1" Q4LDG9 14 73644875-73703732 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 42.4" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 129.8;Early spermatids: 234.2;Spermatocytes: 109.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053129, HPA060974" Approved Approved "Nucleoplasm,Centriolar satellite" NA NA "Nucleoplasm, Centriolar satellite" "HPA053129: AB_2682051, HPA060974: " "unprognostic (1.11e-1)" "unprognostic (1.13e-2)" "unprognostic (2.27e-2)" "unprognostic (4.31e-2)" "unprognostic (1.66e-1)" "unprognostic (4.34e-1)" "unprognostic (4.25e-3)" "unprognostic (2.80e-1)" "unprognostic (2.91e-1)" "unprognostic (2.36e-2)" "unprognostic (3.16e-2)" "unprognostic (1.06e-1)" "prognostic favorable (5.17e-8)" "unprognostic (9.18e-2)" "unprognostic (1.25e-1)" "unprognostic (1.86e-2)" "unprognostic (3.26e-1)" 6.2 6.3 9.9 5.2 15.0 5.2 4.7 9.2 15.6 5.6 4.7 10.6 7.2 2.4 9.8 11.2 4.1 20.2 8.6 7.6 16.0 9.6 9.9 3.9 6.7 4.3 7.3 14.2 7.1 5.7 11.8 15.0 4.2 18.8 5.5 5.0 7.6 5.5 7.7 4.4 2.9 3.1 8.2 8.5 4.1 5.0 42.4 7.6 3.5 14.2 2.9 3.9 4.8 4.4 6.8 10.9 6.3 4.7 3.8 7.5 2.4 9.2 6.8 8.4 7.6 6.0 7.6 6.9 9.3 7.2 12.3 12.7 7.1 14.7 3.7 7.0 9.8 11.6 5.6 7.9 7.2 17.7 5.5 3.3 3.0 10.1 2.5 6.2 3.5 3.8 5.7 5.8 13.3 9.6 9.3 7.8 5.9 3.4 8.5 14.7 15.1 9.0 4.3 3.9 7.7 6.8 6.5 12.7 1.5 10.1 9.8 13.1 6.1 15.5 3.0 7.2 6.9 16.6 2.4 7.4 15.3 27.6 11.4 8.6 5.0 10.4 7.9 12.5 1.8 10.6 6.3 4.3 4.5 5.2 4.7 7.5 4.9 5.1 5.3 3.9 6.8 4.8 5.2 4.1 3.8 3.7 10.9 4.3 2.4 9.9 15.0 9.2 15.6 16.0 9.6 7.3 14.2 18.8 7.6 17.9 12.2 5.6 6.2 2.9 13.9 11.5 20.4 129.8 26.1 17.4 56.9 4.4 8.3 13.8 234.2 10.5 2.6 0.0 12.4 7.6 10.5 6.3 9.3 5.5 7.5 14.3 9.8 8.0 7.5 33.5 16.1 6.3 11.8 8.2 6.0 18.8 9.5 5.1 15.6 18.2 38.1 12.9 8.2 109.4 22.6 1.8 2.1 5.7 5.4 4.1 DNAL4 "dJ327J16, PIG27" ENSG00000100246 "Dynein axonemal light chain 4" O96015 22 38778508-38794198 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 73.8;Late spermatids: 143.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 33.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003647 Approved Approved Nucleoplasm,Nucleoli,Centrosome,Cytosol NA NA Centrosome "Nucleoplasm, Nucleoli, Cytosol" "HPA003647: AB_1078712" "unprognostic (8.45e-2)" "unprognostic (8.15e-3)" "unprognostic (2.35e-1)" "unprognostic (3.14e-3)" "unprognostic (3.74e-1)" "unprognostic (1.52e-1)" "unprognostic (6.46e-3)" "unprognostic (2.81e-1)" "unprognostic (3.32e-1)" "unprognostic (1.81e-1)" "unprognostic (2.06e-1)" "unprognostic (2.07e-1)" "prognostic favorable (1.20e-6)" "unprognostic (1.60e-1)" "unprognostic (1.10e-1)" "unprognostic (8.00e-2)" "unprognostic (4.83e-2)" 8.2 11.4 24.1 9.6 21.9 3.9 13.7 8.6 19.8 17.8 10.1 8.5 19.7 7.3 9.8 15.0 12.3 33.5 12.7 9.9 17.7 15.2 16.0 7.1 12.8 7.5 9.5 15.7 15.8 14.9 19.2 19.3 11.9 7.9 13.2 9.2 13.1 16.4 16.3 4.4 11.4 8.0 7.7 6.4 7.5 11.1 36.5 9.7 13.2 26.1 6.6 8.6 8.4 9.1 12.6 14.8 17.5 11.2 15.7 16.6 8.1 8.9 4.5 9.1 8.2 11.7 11.8 0.0 3.8 7.4 5.9 6.5 2.8 10.5 2.2 8.3 5.5 6.8 4.3 5.7 10.1 4.2 5.5 7.5 1.3 1.3 3.1 18.6 7.1 1.9 9.5 33.2 7.8 14.2 15.5 8.4 10.9 2.6 4.5 7.3 11.1 6.6 7.1 3.6 13.3 3.7 6.5 3.9 2.9 12.4 5.3 12.9 6.9 7.9 6.1 15.4 6.9 11.0 6.9 5.1 5.4 5.5 8.1 3.8 2.8 0.8 1.0 16.1 2.4 5.2 15.6 9.6 12.8 13.5 9.5 16.6 8.7 11.2 12.1 9.8 12.6 13.3 11.0 17.5 15.7 11.2 14.8 10.2 8.1 24.1 21.9 8.6 19.8 17.7 15.2 9.5 15.7 7.9 9.7 6.0 8.0 3.7 11.7 4.9 13.6 3.6 15.3 28.1 12.5 3.5 2.0 23.5 26.6 24.0 73.8 4.5 8.0 0.0 13.8 16.6 7.6 8.9 15.0 2.9 12.2 11.1 12.1 9.8 3.8 143.7 10.9 4.9 8.5 6.4 13.8 10.1 16.3 8.6 7.1 15.7 13.1 6.5 4.4 52.4 14.3 9.3 16.6 6.5 13.4 10.8 DND1 "MGC34750, RBMS4" ENSG00000256453 "DND microRNA-mediated repression inhibitor 1" Q8IYX4 5 140670794-140673586 "Predicted intracellular proteins" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 3.2;testis: 12.0" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 44.0;Horizontal cells: 19.1;Spermatogonia: 26.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.1" "Lineage enriched" "Detected in single" 6 "T-cells: 1.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059723 Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA059723: " 0.5 0.2 1.7 0.4 0.8 0.4 0.7 3.2 0.4 0.6 0.6 0.4 0.4 0.3 0.4 0.5 0.4 0.7 0.4 0.4 0.4 0.4 0.4 0.8 0.5 0.4 0.4 0.4 0.4 0.4 1.0 1.1 0.4 0.4 0.6 0.9 0.4 0.4 0.6 0.4 0.3 0.4 0.5 0.5 0.7 0.4 12.0 0.4 0.4 0.4 0.4 1.4 0.4 0.4 0.2 0.0 0.1 0.0 0.0 1.1 0.0 0.5 0.5 0.8 0.6 0.9 0.4 2.1 0.2 0.9 3.5 3.2 1.0 0.7 0.8 0.3 0.6 0.4 0.8 2.2 1.1 1.4 0.7 2.0 0.3 1.4 0.3 1.4 0.5 1.0 0.7 3.4 2.9 1.8 0.4 1.2 1.1 0.7 0.1 1.2 0.2 0.2 2.6 0.6 0.0 2.2 2.1 0.5 0.4 1.8 0.4 1.4 1.2 0.2 0.1 0.8 0.7 0.3 0.5 0.0 0.8 1.6 0.6 0.1 4.0 1.1 0.4 0.0 0.5 0.8 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.5 0.0 1.7 0.8 3.2 0.4 0.4 0.4 0.4 0.4 0.4 0.4 3.0 1.4 1.3 0.8 0.5 10.3 0.0 0.0 0.0 1.2 3.5 3.9 0.2 0.0 0.2 44.0 0.7 0.4 0.0 0.3 0.3 0.7 1.6 0.0 0.9 0.5 19.1 1.2 0.0 1.0 5.6 0.6 1.1 0.0 0.0 0.1 3.9 0.2 0.0 0.4 0.0 3.8 0.0 0.3 6.9 26.2 0.9 0.2 3.2 0.6 1.2 DNHD1 "C11orf47, CCDC35, DHCD1, DKFZp686J0796, DNHD1L, FLJ32752, FLJ35709, FLJ46184" ENSG00000179532 "Dynein heavy chain domain 1" Q96M86 11 6497260-6593758 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 58.7" "Cell type enhanced" "Detected in many" 13 "Erythroid cells: 46.7;Spermatocytes: 17.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039698, HPA040267, HPA057639" Uncertain Approved "Nucleoplasm,Cytokinetic bridge" Yes No "Nucleoplasm, Cytokinetic bridge" "HPA039698: AB_10795111, HPA040267: AB_2676913, HPA057639: AB_2683486" "unprognostic (1.01e-2)" "unprognostic (2.31e-1)" "unprognostic (5.87e-2)" "unprognostic (2.18e-2)" "unprognostic (9.96e-2)" "unprognostic (2.00e-3)" "unprognostic (1.43e-1)" "unprognostic (3.11e-1)" "unprognostic (5.38e-2)" "unprognostic (1.38e-1)" "unprognostic (1.96e-2)" "unprognostic (9.25e-3)" "unprognostic (5.45e-9)" "unprognostic (2.33e-1)" "unprognostic (2.50e-1)" "unprognostic (4.56e-4)" "unprognostic (8.15e-2)" 1.9 2.1 3.6 1.9 5.9 6.8 2.1 6.8 3.4 2.6 2.9 1.6 2.2 2.2 2.8 3.5 1.3 2.0 3.1 1.8 2.3 1.9 1.5 3.1 3.1 3.4 1.5 1.6 3.3 1.6 1.3 2.0 1.3 2.0 2.3 2.0 2.0 2.3 3.2 1.9 3.4 3.6 6.4 2.2 3.5 1.8 58.7 1.3 1.3 2.5 1.3 2.8 2.2 11.0 1.8 1.5 3.0 0.4 0.1 2.2 0.5 4.3 4.6 4.3 4.0 3.5 5.1 4.3 2.0 2.0 2.3 1.5 3.5 3.9 3.7 0.9 1.6 3.2 7.4 2.1 1.7 2.7 2.3 3.9 3.1 6.0 2.7 2.2 4.3 1.9 3.5 2.9 4.2 6.2 2.2 1.0 5.2 3.7 4.4 1.6 0.9 1.4 4.8 4.3 1.2 3.4 2.2 1.8 2.8 2.4 2.5 2.3 4.4 1.3 4.2 3.1 3.4 2.2 4.6 1.9 2.3 2.5 5.1 2.9 10.7 8.4 5.7 2.2 4.8 2.7 0.0 0.4 3.0 1.3 0.0 1.4 0.3 1.3 0.5 0.6 1.8 1.9 2.2 1.3 0.1 0.3 1.5 1.3 0.5 3.6 5.9 6.8 3.4 2.3 1.9 1.5 1.6 2.0 1.3 0.0 4.3 3.0 1.1 0.8 9.3 3.6 0.0 4.0 5.7 0.0 3.9 0.3 0.0 0.2 8.7 2.2 2.0 46.7 0.3 0.2 1.1 1.8 1.1 4.9 0.7 9.5 0.0 3.1 1.5 9.6 0.9 1.2 0.0 1.0 1.7 5.6 0.3 1.5 1.1 0.3 9.1 0.0 1.2 17.5 1.7 3.3 0.6 0.5 1.7 1.6 DNLZ "bA413M3.2, C9orf151, HEP, RP11-413M3.2, TIMM15, ZIM17" ENSG00000213221 "DNL-type zinc finger" Q5SXM8 9 136359480-136363789 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 7.4;Collecting duct cells: 5.2;Spermatogonia: 4.8;Suprabasal keratinocytes: 8.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 40.2;MCF7: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062738 Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA062738: AB_2684857" "unprognostic (2.81e-1)" "unprognostic (2.93e-1)" "unprognostic (8.73e-3)" "unprognostic (2.05e-2)" "unprognostic (1.30e-1)" "unprognostic (9.31e-2)" "unprognostic (1.93e-2)" "unprognostic (1.61e-2)" "unprognostic (7.61e-2)" "unprognostic (2.30e-1)" "unprognostic (9.51e-3)" "unprognostic (4.50e-2)" "unprognostic (2.56e-2)" "unprognostic (9.07e-2)" "unprognostic (1.17e-1)" "unprognostic (1.50e-1)" "unprognostic (4.90e-2)" 12.6 11.3 13.8 13.0 11.9 13.4 10.4 8.1 13.9 9.7 8.9 9.2 4.0 12.8 10.0 6.2 13.4 7.4 7.1 29.9 11.2 9.1 13.7 14.0 8.0 14.9 11.4 3.5 13.6 25.3 5.0 6.5 7.1 8.5 11.2 2.8 6.2 9.2 7.0 29.6 7.0 7.2 9.9 8.0 13.7 8.3 6.3 6.8 11.6 11.2 7.4 8.9 8.0 9.2 8.6 4.2 8.0 3.1 0.9 6.9 1.2 4.1 7.6 2.6 7.7 1.3 2.8 6.8 6.9 3.8 5.6 2.5 9.1 4.5 9.9 25.3 5.0 4.1 9.2 1.6 4.0 0.6 40.2 10.0 3.5 3.8 3.8 5.2 8.0 6.7 3.5 4.1 4.1 2.5 1.4 2.9 4.3 5.7 7.1 3.6 31.6 9.4 13.1 11.5 6.1 20.1 28.7 3.8 11.4 6.8 4.4 11.7 16.9 7.0 6.5 6.2 1.1 8.1 7.3 6.4 9.4 8.5 6.5 10.5 6.2 8.9 8.7 6.9 3.9 8.6 8.0 1.8 0.3 3.8 3.1 4.8 8.6 5.3 5.6 2.4 5.7 5.4 4.5 1.4 0.9 1.7 4.2 6.9 1.2 13.8 11.9 8.1 11.7 11.2 9.1 11.4 3.5 8.5 6.8 0.0 0.0 1.7 0.9 7.4 0.4 0.8 0.0 0.0 1.2 5.2 0.0 0.8 1.7 0.4 0.1 0.5 0.8 0.0 1.0 0.8 1.0 0.5 0.0 0.9 0.9 0.0 0.0 0.6 0.3 0.0 1.1 1.0 1.7 0.0 1.1 0.5 0.5 0.0 1.1 2.4 0.4 0.0 3.3 0.9 4.8 8.0 0.9 0.0 1.1 1.0 DNM1 DNM ENSG00000106976 "Dynamin 1" Q05193 9 128191655-128255248 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Endocytosis "Hydrolase, Motor protein" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 133.5" "Group enriched" "Detected in many" 10 "Bipolar cells: 113.1;Cone photoreceptor cells: 84.4;Horizontal cells: 47.7;Rod photoreceptor cells: 70.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 49.8;U-87 MG: 19.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005920, HPA049910, HPA061801" Enhanced Supported Nucleoplasm NA NA 440000 Nucleoplasm "CAB005920: , HPA049910: AB_2680948, HPA061801: AB_2797266" "unprognostic (3.25e-2)" "unprognostic (5.49e-2)" "unprognostic (1.34e-3)" "unprognostic (3.95e-2)" "unprognostic (4.57e-2)" "unprognostic (1.16e-1)" "unprognostic (3.60e-3)" "unprognostic (1.20e-1)" "unprognostic (5.53e-2)" "unprognostic (6.53e-2)" "unprognostic (6.62e-3)" "unprognostic (6.30e-1)" "unprognostic (9.58e-2)" "unprognostic (1.10e-1)" "unprognostic (2.02e-1)" "unprognostic (3.07e-3)" "unprognostic (1.10e-3)" 5.9 6.1 31.5 3.3 36.9 2.3 4.6 57.7 133.5 11.7 3.0 2.5 0.0 2.4 4.6 2.7 3.3 6.3 9.0 2.7 33.4 24.0 2.9 1.8 2.5 2.5 18.3 33.0 1.6 4.7 3.2 5.5 2.7 33.0 2.9 2.9 4.3 2.6 3.1 2.3 4.6 3.3 4.4 5.1 1.6 2.6 4.0 1.8 0.0 1.9 0.4 2.3 3.6 3.7 0.3 0.4 0.5 0.3 0.0 0.3 0.7 3.3 49.8 4.5 1.1 1.4 15.2 0.2 3.1 7.5 6.3 2.6 0.6 1.0 0.0 4.3 6.5 0.2 6.0 0.7 0.3 3.5 0.0 4.8 3.1 7.1 0.2 1.0 0.4 2.2 4.0 0.1 4.9 0.0 6.1 0.0 2.9 1.1 0.2 0.0 1.4 0.2 1.0 4.8 0.8 9.1 5.9 0.1 1.5 0.9 0.0 6.5 10.9 10.6 0.3 0.4 0.6 0.1 4.3 0.2 0.2 14.4 14.5 6.3 0.4 0.1 0.3 19.0 0.1 1.0 0.0 0.3 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.4 0.2 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.7 31.5 36.9 57.7 71.8 33.4 24.0 18.3 33.0 33.0 1.8 0.0 0.0 0.0 1.6 7.0 113.1 2.0 7.6 1.4 1.2 0.0 84.4 0.2 1.7 0.7 0.5 1.5 0.6 0.0 0.7 0.2 3.9 0.7 1.1 0.5 8.0 47.7 0.0 0.0 0.8 0.4 2.6 1.9 3.3 1.0 0.1 8.1 1.0 2.9 1.4 3.4 70.6 0.0 4.1 0.3 1.3 6.6 0.7 0.7 0.6 0.5 DNMT1 "CXXC9, DNMT, MCMT" ENSG00000130816 "DNA methyltransferase 1" P26358 19 10133345-10231286 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase" "Deafness, Disease mutation, FDA approved drug targets, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Cytotrophoblasts: 329.4;Spermatocytes: 249.6;Syncytiotrophoblasts: 270.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002694, CAB005876" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "CAB005876: AB_731983, HPA002694: AB_1847810" "unprognostic (3.51e-1)" "unprognostic (1.20e-2)" "unprognostic (1.26e-2)" "unprognostic (1.40e-1)" "unprognostic (3.62e-1)" "unprognostic (7.59e-3)" "prognostic unfavorable (1.46e-4)" "unprognostic (2.90e-1)" "unprognostic (4.23e-3)" "unprognostic (1.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.11e-2)" "unprognostic (1.28e-3)" "unprognostic (7.81e-3)" "unprognostic (1.73e-1)" "unprognostic (8.11e-2)" "unprognostic (1.46e-1)" 12.1 7.6 9.8 20.2 10.8 31.9 11.5 27.1 14.4 12.0 8.6 10.0 4.3 8.1 12.1 8.0 12.0 11.5 7.8 8.0 9.3 8.1 6.9 9.2 11.8 29.7 12.5 7.9 11.1 6.2 10.2 8.8 32.5 8.7 8.3 10.7 7.8 9.3 6.5 6.8 10.8 11.3 11.2 9.1 11.0 9.0 19.9 12.6 31.4 9.5 8.8 28.8 11.4 9.7 12.6 19.0 10.2 13.4 25.0 18.2 6.8 24.3 15.4 19.7 16.7 7.3 7.5 42.3 16.5 13.1 23.8 23.9 14.9 13.3 40.8 10.4 10.1 12.0 16.1 21.7 12.9 24.4 16.0 32.3 59.1 13.8 7.7 3.2 24.0 24.0 5.0 2.5 20.8 8.2 7.2 12.9 12.6 23.4 25.2 17.7 16.2 35.1 32.8 25.9 11.0 22.5 35.6 20.7 22.4 7.5 15.4 21.0 16.3 20.0 9.0 6.4 12.6 9.4 12.2 9.7 40.0 13.7 24.2 24.4 20.6 21.5 48.3 11.6 22.4 31.0 10.2 13.4 3.3 18.2 13.2 15.9 7.9 14.6 12.5 11.3 12.6 16.6 12.3 3.1 25.0 7.9 19.0 12.9 6.8 9.8 10.8 27.1 14.4 9.3 8.1 12.5 7.9 8.7 12.6 6.0 24.5 38.8 19.1 26.3 66.8 11.9 7.6 48.2 29.6 21.0 53.0 329.4 11.6 20.3 42.9 33.0 4.7 93.5 12.4 56.3 25.7 12.5 34.8 12.1 68.9 62.0 15.1 24.5 28.2 38.6 25.9 51.5 13.5 45.1 16.3 39.9 15.7 11.5 26.9 7.6 50.4 12.9 22.0 249.6 179.2 19.6 270.7 54.2 37.6 14.1 DNMT3A ENSG00000119772 "DNA methyltransferase 3 alpha" Q9Y6K1 2 25227855-25342590 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase" "Cancer-related genes, Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 119.8;Horizontal cells: 90.6;Rod photoreceptor cells: 144.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 25.7;REH: 25.4;SH-SY5Y: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009469, HPA026588" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB009469: AB_2093990, HPA026588: AB_1847812" "unprognostic (2.38e-1)" "unprognostic (2.94e-1)" "unprognostic (5.65e-2)" "prognostic unfavorable (1.55e-4)" "unprognostic (8.38e-2)" "unprognostic (7.27e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (2.24e-1)" "unprognostic (7.25e-2)" "unprognostic (2.72e-1)" "prognostic favorable (1.18e-4)" "unprognostic (2.35e-2)" "prognostic unfavorable (2.49e-4)" "unprognostic (1.43e-1)" "unprognostic (1.87e-1)" "unprognostic (1.14e-1)" "unprognostic (2.70e-2)" 7.8 12.4 13.7 12.7 15.5 10.8 8.6 21.6 20.1 9.0 12.7 14.5 7.6 9.1 13.0 12.2 8.0 9.6 8.9 8.2 12.3 6.7 9.4 6.9 9.5 13.6 15.3 10.1 18.3 12.1 6.3 12.6 20.8 10.7 9.3 9.2 12.0 8.5 9.2 29.1 6.6 11.4 11.3 7.9 17.5 11.6 6.6 15.2 20.8 9.1 10.5 11.8 9.8 8.4 3.0 4.1 4.9 4.1 8.7 8.3 2.3 1.1 3.5 14.9 3.6 1.6 1.2 19.5 1.0 0.9 2.0 1.6 8.8 5.7 0.0 2.2 1.9 1.6 1.0 1.6 2.2 1.2 3.7 2.6 6.4 5.3 10.5 3.9 1.3 4.1 3.6 1.1 2.6 0.9 3.9 8.3 14.5 7.3 1.4 1.5 8.5 13.9 15.1 25.7 5.9 1.9 25.4 16.4 2.1 1.2 1.5 8.8 31.3 1.2 8.4 2.6 13.4 1.0 6.7 2.8 2.5 3.3 0.6 1.3 3.2 2.2 8.6 0.9 3.8 2.6 4.7 1.8 3.1 5.2 3.0 7.0 2.3 3.4 4.9 2.0 3.0 8.3 6.6 4.9 8.7 4.1 4.1 2.8 2.3 13.7 15.5 21.6 20.1 12.3 6.7 15.3 10.1 10.7 15.2 6.0 13.3 10.0 8.3 4.6 74.9 13.7 5.1 9.4 12.5 19.2 119.8 30.2 5.0 13.8 1.5 14.6 5.3 0.0 8.5 9.4 14.7 11.7 36.9 5.5 19.8 90.6 12.6 6.2 10.5 1.1 17.8 11.9 6.8 4.6 11.5 22.7 9.2 10.5 14.5 5.6 144.9 19.4 8.2 2.3 13.4 2.3 26.9 18.7 11.0 6.7 DNMT3B ENSG00000088305 "DNA methyltransferase 3 beta" Q9UBC3 20 32762385-32809356 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Activator, DNA-binding, Methyltransferase, Repressor, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.7;testis: 23.3" "Cell type enhanced" "Detected in some" 7 "Cytotrophoblasts: 3.7;Extravillous trophoblasts: 3.8;Horizontal cells: 4.8;Sertoli cells: 6.5;Syncytiotrophoblasts: 4.0" "Cancer enriched" "Detected in all" 25 "testis cancer: 111.7" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 55.3;CACO-2: 20.8;HEL: 21.7;K-562: 20.8;NTERA-2: 74.7;SuSa: 41.2" "Low region specificity" "Detected in some" "HPA001595, HPA001803, CAB069896" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "CAB069896: AB_2094115, HPA001595: AB_1847814, HPA001803: " "unprognostic (7.65e-3)" "unprognostic (3.52e-3)" "unprognostic (1.17e-1)" "prognostic unfavorable (5.04e-4)" "unprognostic (3.42e-1)" "unprognostic (7.27e-2)" "unprognostic (4.39e-4)" "unprognostic (4.18e-3)" "unprognostic (8.60e-3)" "unprognostic (8.48e-2)" "unprognostic (6.79e-2)" "unprognostic (4.65e-2)" "prognostic unfavorable (1.87e-7)" "unprognostic (6.62e-2)" "unprognostic (1.00e-1)" "unprognostic (1.50e-1)" "unprognostic (6.55e-2)" 1.1 0.8 0.9 2.5 0.9 4.7 2.4 4.5 1.4 1.6 2.1 0.7 0.5 0.9 1.3 4.7 1.6 1.1 1.6 1.8 0.8 0.7 2.7 1.2 1.2 1.9 0.9 0.5 1.2 7.5 2.5 1.1 2.8 0.8 1.1 0.8 1.2 3.5 1.6 0.5 5.5 0.8 1.0 0.5 1.3 1.1 23.3 0.8 17.7 2.6 1.7 2.5 2.7 2.2 0.7 1.0 0.0 0.2 0.9 1.3 0.1 0.8 1.1 6.0 1.4 0.1 0.5 55.3 0.7 0.5 0.8 0.8 20.8 0.9 2.1 2.2 0.3 0.9 0.5 3.9 0.3 0.6 0.2 3.1 21.7 0.7 3.9 0.2 0.9 2.2 0.5 0.4 1.2 0.2 0.4 1.4 1.3 20.8 0.6 0.3 3.3 3.3 18.4 74.7 1.9 0.7 3.3 1.0 0.5 2.0 0.9 1.9 1.2 1.3 1.9 0.5 41.2 1.2 1.1 0.3 1.2 2.8 0.6 0.5 1.3 0.6 0.8 0.5 5.9 0.5 0.0 0.2 0.0 0.1 0.1 0.1 0.7 0.2 0.0 1.0 0.0 1.3 0.0 0.0 0.9 0.1 0.9 0.0 0.1 0.9 0.9 4.5 1.4 0.8 0.7 0.9 0.5 0.8 0.8 0.0 1.0 0.0 0.1 0.8 1.4 1.1 0.0 0.0 1.2 0.0 2.0 3.7 0.0 0.9 0.0 0.4 0.0 0.0 0.5 3.8 0.9 0.6 0.0 0.0 0.6 4.8 0.0 0.6 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.8 1.1 0.0 0.4 0.6 2.1 6.5 0.4 0.0 2.5 1.1 4.0 0.0 0.8 0.0 DNPH1 "C6orf108, dJ330M21.3, rcl" ENSG00000112667 "2'-deoxynucleoside 5'-phosphate N-hydrolase 1" O43598 6 43225629-43229484 "Predicted intracellular proteins" "Nucleotide metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 381.3;Proximal tubular cells: 791.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 93.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029675, HPA029676" Enhanced Approved Nucleoplasm,Cytosol No No 370000 Nucleoplasm Cytosol "HPA029675: AB_10599998, HPA029676: AB_10599424" "unprognostic (1.12e-2)" "unprognostic (1.38e-1)" "unprognostic (4.03e-3)" "unprognostic (8.24e-3)" "unprognostic (1.69e-1)" "unprognostic (3.53e-2)" "unprognostic (2.61e-1)" "unprognostic (7.72e-2)" "unprognostic (2.43e-1)" "unprognostic (2.33e-3)" "unprognostic (2.25e-2)" "unprognostic (1.49e-1)" "unprognostic (1.74e-1)" "unprognostic (5.52e-2)" "unprognostic (1.36e-1)" "unprognostic (2.77e-2)" "unprognostic (5.10e-2)" 17.4 25.5 24.1 16.2 27.5 10.1 8.4 7.0 18.7 11.9 39.3 15.0 10.2 53.1 12.3 13.2 19.3 19.5 18.5 12.0 17.3 16.7 48.7 34.7 10.0 14.8 17.2 14.0 13.7 38.8 17.2 9.3 7.3 13.4 13.1 9.7 16.9 22.4 11.8 40.8 10.7 51.0 10.4 10.4 18.8 22.2 5.4 10.8 14.6 14.2 19.2 19.3 12.2 8.9 44.1 36.2 0.9 46.7 7.5 52.6 19.5 32.0 23.5 3.6 15.2 2.6 8.1 11.4 7.8 2.8 5.3 7.0 9.6 11.7 23.1 12.4 2.6 0.2 16.4 2.8 6.2 1.5 12.3 55.9 10.8 21.5 27.2 6.2 9.1 7.1 5.1 7.9 1.6 4.8 2.1 6.9 16.9 24.6 41.0 4.2 53.1 8.7 22.9 7.3 93.7 14.3 14.8 4.9 58.5 9.1 11.0 14.2 17.1 7.2 19.1 15.7 1.2 26.3 30.5 8.6 4.0 7.0 9.1 15.3 28.7 13.1 18.0 2.5 12.3 6.3 0.1 23.3 0.9 9.2 46.7 16.7 44.1 30.4 16.2 36.2 38.2 27.2 18.3 0.8 7.5 33.2 27.4 52.6 19.5 24.1 27.5 7.0 18.7 17.3 16.7 17.2 14.0 13.4 10.8 26.8 33.9 82.4 72.2 54.5 10.6 78.7 186.0 178.0 37.5 109.9 2.0 50.2 381.3 174.9 0.5 25.1 264.9 0.0 92.9 48.7 52.6 77.9 34.5 174.5 265.7 6.4 62.2 33.2 57.1 2.2 62.2 60.3 104.6 40.5 164.0 37.3 143.5 157.8 56.3 791.8 15.3 0.0 47.4 5.4 42.8 64.4 27.0 27.7 262.6 70.6 DNTT TDT ENSG00000107447 "DNA nucleotidylexotransferase" P04053 10 96304396-96338564 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Terminal addition" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 171.0" "Group enriched" "Detected in some" 4 "Early spermatids: 10.3;Late spermatids: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "naive B-cell: 1.2;naive CD4 T-cell: 4.5" "Group enriched" "Detected in many" 15 "B-cells: 1.2;T-cells: 4.5" "Group enriched" "Detected in some" 5 "MOLT-4: 49.7;REH: 172.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036532, HPA044194" Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036532: , HPA044194: AB_10960525" "unprognostic (4.24e-1)" "unprognostic (1.00e-1)" "unprognostic (2.60e-2)" "unprognostic (1.86e-2)" 0.0 0.0 0.1 0.1 0.3 24.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 2.7 0.0 171.0 0.6 0.0 2.1 0.0 0.0 1.2 0.1 0.0 0.0 0.0 4.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.0 0.0 0.0 49.7 0.0 0.0 0.0 0.0 172.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 4.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.3 0.0 0.1 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 4.5 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 DNTTIP1 "C20orf167, dJ447F3.4, Tdif1" ENSG00000101457 "Deoxynucleotidyltransferase terminal interacting protein 1" Q9H147 20 45791937-45811427 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 41.0" "Group enriched" "Detected in all" 7 "dendritic cells: 14.2;granulocytes: 41.0;monocytes: 16.6" "Cell line enhanced" "Detected in all" "PC-3: 74.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045496 Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA045496: " "unprognostic (7.77e-2)" "unprognostic (2.19e-1)" "unprognostic (2.07e-1)" "unprognostic (4.52e-2)" "unprognostic (2.50e-1)" "unprognostic (3.05e-2)" "prognostic unfavorable (1.79e-5)" "unprognostic (6.29e-2)" "unprognostic (7.16e-2)" "unprognostic (1.85e-1)" "unprognostic (5.81e-3)" "unprognostic (5.63e-2)" "prognostic unfavorable (1.90e-6)" "unprognostic (3.18e-1)" "unprognostic (1.54e-1)" "unprognostic (1.19e-1)" "unprognostic (1.30e-1)" 15.2 16.3 15.8 19.0 18.0 31.6 16.0 15.5 19.9 16.4 24.2 15.4 20.5 14.0 23.3 21.3 18.8 20.6 18.6 20.6 14.6 15.3 15.6 18.7 18.2 17.7 14.5 17.6 20.1 24.1 18.2 17.8 18.3 15.1 23.5 32.0 16.1 21.0 21.6 45.0 21.8 19.6 32.6 13.8 21.2 20.7 36.9 11.8 25.2 21.1 19.4 21.7 30.1 16.1 3.2 14.2 41.0 16.6 1.0 3.4 4.5 20.4 10.9 11.3 10.7 8.7 9.4 11.8 7.7 12.5 25.0 22.7 34.5 33.6 8.5 25.3 11.2 39.9 15.5 9.9 16.5 16.6 4.6 12.4 9.2 11.5 22.0 17.7 18.0 15.4 9.4 15.6 16.3 15.8 11.5 14.6 12.4 8.5 8.7 14.8 27.2 14.7 27.9 7.6 11.6 74.6 11.9 14.0 8.8 12.5 9.8 10.6 9.6 15.7 12.8 16.1 9.2 12.7 28.9 8.5 15.0 11.2 14.5 18.4 9.5 6.1 10.5 32.8 11.6 12.8 4.8 16.6 21.6 1.4 6.9 1.4 3.2 1.9 2.4 14.2 2.7 3.4 1.6 41.0 1.0 4.2 5.5 2.7 4.5 15.8 18.0 15.5 19.9 14.6 15.3 14.5 17.6 15.1 11.8 14.9 18.5 22.9 37.2 22.7 18.5 17.9 12.7 24.1 21.6 24.4 3.9 56.0 43.1 57.6 31.1 21.1 32.8 0.0 66.5 35.6 23.6 31.5 5.8 16.8 62.7 19.1 21.4 22.7 26.5 10.6 26.2 33.7 15.1 86.6 70.1 42.1 70.4 51.8 25.5 33.4 24.1 0.0 24.5 77.5 33.7 24.1 48.3 18.1 31.6 54.5 DOC2A ENSG00000149927 "Double C2 domain alpha" Q14183 16 30005509-30023270 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 49.0;testis: 12.6" "Group enriched" "Detected in many" 6 "Ciliated cells: 72.3;Early spermatids: 196.5;Late spermatids: 146.0" "Cancer enhanced" "Detected in many" "renal cancer: 5.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 9.8;SCLC-21H: 26.6;U-937: 12.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 4 "amygdala: 13.5;cerebral cortex: 30.8;hippocampal formation: 24.4" HPA065676 Uncertain "Nucleoplasm,Nucleoli,Cell Junctions" NA NA "Cell Junctions" "Nucleoplasm, Nucleoli" "HPA065676: AB_2685528" "unprognostic (1.46e-3)" "unprognostic (3.39e-1)" "unprognostic (2.30e-2)" "unprognostic (1.31e-1)" "unprognostic (4.26e-2)" "unprognostic (1.40e-1)" "unprognostic (3.66e-2)" "unprognostic (9.14e-2)" "unprognostic (3.90e-2)" "unprognostic (2.89e-2)" "unprognostic (1.28e-3)" "unprognostic (5.13e-2)" "unprognostic (8.29e-3)" "unprognostic (1.71e-1)" "unprognostic (2.74e-1)" "unprognostic (2.68e-1)" "unprognostic (2.61e-1)" 1.2 2.7 18.5 1.0 17.5 3.9 2.3 24.0 49.0 1.3 3.1 0.9 0.3 1.7 1.6 2.4 1.1 3.3 1.8 1.0 15.3 8.3 1.6 1.4 3.5 1.4 2.8 27.4 5.7 1.0 1.3 3.2 1.2 13.1 2.5 2.4 0.0 1.6 1.4 1.1 2.0 2.3 1.8 4.2 3.1 1.7 12.6 1.8 0.0 1.6 0.0 1.2 1.4 0.6 0.6 1.1 1.0 0.4 0.2 0.5 0.3 0.7 1.5 1.1 0.8 0.3 0.0 9.8 0.4 0.7 0.5 0.3 4.0 2.7 0.0 0.9 0.4 1.4 0.2 5.0 2.0 0.2 0.1 0.5 0.8 0.5 0.3 0.7 0.9 2.9 1.2 0.8 0.1 1.1 5.0 0.0 3.3 0.3 0.0 0.0 7.8 2.1 3.6 1.5 3.1 4.2 8.0 0.1 0.4 0.5 0.8 26.6 2.1 0.6 2.8 0.2 2.4 2.7 1.7 0.8 0.3 1.5 0.3 0.3 0.5 0.1 0.1 0.3 12.8 0.3 0.8 0.4 0.0 0.0 0.3 0.1 0.5 0.1 0.3 1.1 0.6 0.5 0.5 1.0 0.2 0.0 0.0 0.1 0.3 18.5 17.5 24.0 36.2 15.3 8.3 2.8 27.4 13.1 1.8 0.0 5.8 0.5 3.1 0.6 1.2 0.6 2.5 72.3 12.5 1.8 21.6 0.3 1.7 0.0 196.5 0.7 0.9 0.0 0.0 0.9 0.7 1.8 0.0 0.0 0.4 0.0 1.2 1.8 1.3 146.0 0.6 1.3 1.7 0.0 2.2 3.1 0.0 0.0 1.8 0.0 1.8 0.0 0.3 1.7 4.1 0.6 0.1 0.0 4.1 0.7 DOCK1 "ced5, DOCK180" ENSG00000150760 "Dedicator of cytokinesis 1" Q14185 10 126905409-127452517 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Phagocytosis" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 1.5;plasmacytoid DC: 2.3" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004378, HPA048692, HPA053277" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004378: AB_2094604, HPA048692: AB_2680495, HPA053277: AB_2682097" "unprognostic (4.27e-2)" "unprognostic (4.22e-3)" "unprognostic (1.49e-3)" "unprognostic (8.98e-3)" "unprognostic (2.57e-2)" "unprognostic (3.31e-1)" "unprognostic (4.12e-1)" "unprognostic (4.80e-2)" "unprognostic (6.85e-2)" "unprognostic (1.55e-1)" "unprognostic (2.75e-2)" "unprognostic (2.42e-1)" "unprognostic (2.61e-3)" "unprognostic (1.87e-1)" "unprognostic (3.85e-2)" "unprognostic (1.18e-1)" "unprognostic (4.83e-2)" 17.1 7.7 27.4 8.1 36.8 1.0 17.4 6.9 25.4 23.5 12.5 27.4 14.3 12.2 18.3 18.0 13.8 17.6 16.2 12.9 24.4 17.8 18.9 9.0 12.8 8.0 34.5 11.4 24.2 12.1 38.6 5.3 17.9 25.0 16.1 13.0 9.4 15.4 18.3 9.7 30.0 13.6 21.2 25.4 8.7 11.0 6.6 32.3 2.2 25.1 9.1 5.5 14.5 18.5 0.0 2.3 0.0 0.7 0.8 0.0 0.0 6.4 12.3 24.0 17.0 12.3 16.6 5.3 12.9 27.3 9.2 9.8 7.6 7.4 0.0 4.3 19.0 8.4 7.3 7.6 9.6 10.8 0.1 7.3 4.0 8.1 8.9 12.1 0.0 6.0 13.4 2.9 9.5 20.7 22.0 21.1 0.0 0.0 0.0 13.8 6.4 0.0 0.0 5.9 4.9 5.5 0.0 15.7 0.1 9.1 7.1 1.4 10.2 13.5 7.6 12.0 17.7 1.9 0.0 22.0 16.6 6.6 4.2 12.3 0.0 0.0 0.0 13.3 0.0 10.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.8 0.0 2.3 0.0 0.0 27.4 36.8 6.9 25.4 24.4 17.8 34.5 11.4 25.0 32.3 29.8 16.9 0.0 12.4 15.2 0.0 10.1 7.6 25.4 23.9 21.0 0.0 12.0 0.0 11.0 9.3 21.5 15.7 0.0 6.2 10.1 12.7 11.5 0.0 7.3 4.9 0.0 5.2 27.0 4.5 18.9 30.2 4.9 6.8 3.6 14.8 7.1 11.6 7.0 34.3 7.8 1.3 12.9 13.4 1.8 7.9 14.2 10.5 0.5 11.7 8.8 DOCK10 "KIAA0694, ZIZ3" ENSG00000135905 "Dedicator of cytokinesis 10" Q96BY6 2 224765090-225042445 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.7;lymphoid tissue: 27.6" "Cell type enhanced" "Detected in many" 11 "granulocytes: 34.8;Horizontal cells: 92.2;Kupffer cells: 46.3;Macrophages: 38.8;monocytes: 40.5;T-cells: 37.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 31.6;HDLM-2: 21.5;TIME: 20.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058106 Enhanced Supported Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA058106: AB_2683606" "unprognostic (6.95e-2)" "unprognostic (1.41e-2)" "unprognostic (1.05e-2)" "unprognostic (2.03e-2)" "unprognostic (1.14e-1)" "unprognostic (1.55e-3)" "unprognostic (1.19e-1)" "unprognostic (6.92e-2)" "unprognostic (3.44e-2)" "unprognostic (3.80e-1)" "unprognostic (3.22e-3)" "unprognostic (3.39e-1)" "unprognostic (1.24e-2)" "unprognostic (1.01e-1)" "unprognostic (2.99e-2)" "unprognostic (2.54e-1)" "unprognostic (7.72e-2)" 4.2 7.6 17.1 16.7 28.8 8.8 4.0 3.0 18.4 9.5 5.9 27.6 0.0 4.1 3.4 1.4 3.4 2.5 6.4 1.8 24.3 14.7 2.9 5.4 7.3 23.9 33.3 9.6 15.9 1.8 1.9 1.4 2.5 23.2 2.0 6.7 1.1 4.1 2.0 1.3 5.0 8.5 4.4 37.7 26.5 6.1 2.3 35.5 27.6 2.7 1.3 18.4 6.6 3.7 6.8 6.2 2.6 9.6 12.8 10.5 4.0 0.0 8.9 2.8 0.0 3.7 7.9 0.0 19.0 15.5 9.1 6.8 0.0 0.0 0.2 0.0 12.0 31.6 0.2 0.0 0.0 7.3 21.5 0.0 0.2 1.9 0.0 0.1 1.8 0.9 1.8 0.2 13.2 5.2 3.6 9.0 2.9 0.0 17.9 15.3 0.8 3.2 2.5 1.1 0.0 2.1 4.3 4.1 2.6 0.4 0.0 0.1 2.3 0.0 0.0 1.9 0.5 0.6 8.2 20.1 9.9 2.4 4.7 6.4 0.0 0.0 0.0 14.0 12.2 4.2 2.6 2.8 0.2 6.2 8.2 6.4 6.8 10.5 8.8 6.2 3.8 10.4 9.0 0.1 12.8 9.6 2.6 7.5 4.0 17.1 28.8 3.0 18.4 24.3 14.7 33.3 9.6 23.2 35.5 3.0 10.8 18.5 0.5 4.1 5.6 0.8 0.0 4.0 4.5 5.2 0.0 0.2 1.7 0.1 1.7 2.2 0.0 0.0 0.0 0.1 2.3 0.5 34.8 0.9 29.1 92.2 2.4 2.5 46.3 2.2 0.6 38.8 8.5 40.5 2.7 1.3 0.3 0.0 0.0 0.2 2.0 12.9 8.6 0.1 0.2 3.6 0.7 37.4 3.3 0.6 DOCK8 "FLJ00026, FLJ00152, FLJ00346, ZIR8" ENSG00000107099 "Dedicator of cytokinesis 8" Q8NF50 9 214854-465259 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 40.5;lymphoid tissue: 61.0" "Cell type enhanced" "Detected in many" 6 "B-cells: 83.1;Cone photoreceptor cells: 72.6;Kupffer cells: 113.9;Macrophages: 79.1;monocytes: 79.4;T-cells: 76.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 17.3;HL-60: 17.2;MOLT-4: 16.1;NB-4: 27.2;REH: 20.2;RT4: 17.9;THP-1: 51.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003218, HPA073349" Enhanced Approved Nucleoplasm,Centrosome,Mitochondria,Cytosol NA NA Centrosome "Nucleoplasm, Mitochondria, Cytosol" "HPA003218: AB_1078695, HPA073349: " "unprognostic (1.56e-1)" "unprognostic (5.90e-2)" "unprognostic (7.75e-2)" "unprognostic (7.55e-3)" "unprognostic (3.31e-1)" "unprognostic (6.28e-3)" "unprognostic (1.79e-1)" "unprognostic (8.12e-2)" "unprognostic (2.72e-2)" "unprognostic (6.72e-2)" "unprognostic (1.90e-1)" "unprognostic (3.89e-2)" "prognostic favorable (9.21e-6)" "unprognostic (2.91e-1)" "unprognostic (3.91e-2)" "unprognostic (3.91e-1)" "prognostic favorable (6.89e-6)" 6.7 12.9 5.6 27.4 8.4 20.8 6.1 1.2 4.1 3.1 3.9 9.2 0.9 3.9 3.0 4.3 6.0 4.1 8.2 2.9 6.3 3.3 7.5 3.9 16.8 35.3 10.2 2.3 2.5 6.4 7.6 3.5 10.4 8.1 4.9 4.1 4.4 10.5 2.4 1.7 3.3 15.0 3.4 13.6 43.5 4.9 7.2 8.9 61.0 5.1 3.0 27.1 10.5 4.0 7.3 15.4 40.5 21.5 6.6 5.5 6.4 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.5 0.4 17.3 1.2 0.0 0.0 0.7 0.2 0.1 0.0 5.9 0.6 0.0 0.0 0.0 0.0 17.2 2.3 0.1 3.2 0.0 0.0 0.0 0.0 0.0 3.7 8.7 0.0 1.0 16.1 27.2 0.1 0.0 0.2 20.2 0.0 6.7 0.0 17.9 0.0 0.0 0.0 0.2 1.2 0.3 0.4 51.7 3.4 0.0 0.1 0.2 0.0 3.5 0.0 0.0 0.0 10.9 0.3 14.2 14.7 16.7 4.6 15.1 3.8 7.3 5.5 4.8 15.4 6.8 4.4 4.2 40.5 6.6 21.5 4.4 5.3 6.4 5.6 8.4 1.2 4.1 6.3 3.3 10.2 2.3 8.1 8.9 8.9 31.0 83.1 1.5 5.7 0.2 2.0 22.9 1.4 3.4 7.0 72.6 44.4 1.7 0.8 24.2 4.8 0.5 0.0 5.9 3.1 2.9 1.1 23.2 2.5 50.8 0.0 8.1 3.1 113.9 11.5 2.8 79.1 8.5 79.4 8.9 1.0 1.4 17.5 0.4 8.7 3.8 12.9 14.4 15.4 4.1 3.3 35.7 76.2 1.0 3.0 DOHH "HLRC1, MGC4293" ENSG00000129932 "Deoxyhypusine hydroxylase" Q9BU89 19 3490822-3500940 "Enzymes, Predicted intracellular proteins" "Hypusine biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041953, HPA076271" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA041953: AB_10795386, HPA076271: " "unprognostic (1.28e-1)" "unprognostic (1.18e-1)" "unprognostic (8.63e-2)" "prognostic favorable (2.24e-4)" "unprognostic (3.66e-1)" "unprognostic (2.01e-2)" "unprognostic (9.45e-2)" "unprognostic (7.26e-2)" "unprognostic (4.65e-2)" "unprognostic (1.13e-1)" "prognostic favorable (3.58e-4)" "unprognostic (9.87e-3)" "unprognostic (1.14e-3)" "unprognostic (4.35e-2)" "unprognostic (1.46e-1)" "unprognostic (1.66e-1)" "unprognostic (3.76e-3)" 8.1 6.5 10.5 6.6 13.0 9.3 3.4 5.5 13.0 3.9 5.5 6.9 2.6 18.9 3.7 4.1 4.1 3.1 4.9 5.1 14.9 9.1 6.0 6.4 4.0 4.5 18.2 6.2 3.8 7.6 3.8 3.9 3.8 8.4 5.1 2.0 3.2 6.0 4.0 23.1 7.0 12.3 2.4 25.5 5.9 7.3 4.2 6.1 4.7 2.9 7.8 4.5 3.1 4.7 11.6 11.0 1.8 6.6 6.9 12.3 4.4 9.2 11.0 1.7 3.6 0.9 1.1 7.4 8.8 1.8 4.3 3.4 15.3 3.8 7.2 6.9 1.3 3.9 9.6 2.7 3.0 0.9 10.6 12.4 7.5 6.2 18.2 3.5 10.0 10.5 1.2 3.0 4.2 1.8 1.5 2.2 8.0 16.3 8.5 1.7 10.5 10.8 11.4 9.8 3.7 14.9 12.3 4.0 10.4 2.6 5.2 10.5 7.7 6.2 5.5 8.8 0.8 7.5 5.5 5.0 5.4 7.4 14.3 16.1 11.3 8.2 9.6 6.4 22.8 6.4 1.1 5.3 1.8 6.2 6.2 8.1 8.1 8.5 12.3 8.7 11.6 12.3 10.4 0.3 6.9 6.6 11.0 9.6 4.4 10.5 13.0 5.5 13.0 14.9 9.1 18.2 6.2 8.4 6.1 6.0 2.1 18.5 14.9 20.9 17.4 7.1 10.2 1.4 2.3 5.2 9.8 25.8 18.3 21.7 7.1 12.1 9.7 0.0 18.5 26.0 13.9 16.8 13.8 8.2 19.0 23.8 12.6 11.1 7.2 17.2 13.0 8.6 18.6 24.4 11.0 13.1 19.1 14.4 14.2 23.9 11.8 0.0 13.7 11.1 12.3 24.1 29.1 12.8 16.1 15.3 DOK2 "Dok-2, p56dok-2" ENSG00000147443 "Docking protein 2" O60496 8 21908873-21913860 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "blood: 138.5" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 113.3;Kupffer cells: 141.8;Macrophages: 166.3;T-cells: 159.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "eosinophil: 138.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 10.1;HEL: 21.6;HMC-1: 46.4;JURKAT: 8.4;THP-1: 16.7;U-937: 16.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB004379, HPA005507, HPA066571" Enhanced Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol" NA NA 1200000 Cytosol "Nucleoplasm, Nuclear bodies, Golgi apparatus" "CAB004379: AB_627449, HPA005507: , HPA066571: AB_2732749" "unprognostic (5.39e-2)" "unprognostic (8.84e-3)" "unprognostic (8.72e-3)" "unprognostic (1.74e-3)" "unprognostic (2.14e-2)" "unprognostic (2.30e-3)" "unprognostic (1.34e-1)" "unprognostic (7.22e-2)" "prognostic favorable (4.31e-4)" "unprognostic (2.22e-1)" "unprognostic (4.19e-2)" "unprognostic (1.90e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (1.88e-1)" "unprognostic (1.24e-2)" "unprognostic (3.19e-1)" "unprognostic (2.80e-1)" 13.6 3.3 0.6 14.2 0.6 8.4 3.5 0.5 0.6 2.4 4.4 0.4 2.1 3.5 2.0 5.9 3.8 2.8 4.8 3.8 0.6 0.7 2.7 4.6 14.0 12.3 1.5 0.2 2.4 2.3 0.0 1.5 5.3 1.4 3.9 1.6 2.6 2.9 0.6 1.4 1.8 5.9 3.4 2.2 28.6 3.2 1.9 0.7 17.9 1.8 2.7 13.5 4.4 9.8 1.4 38.9 138.5 55.9 27.1 52.8 60.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 21.6 0.0 0.0 0.0 0.1 46.4 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.3 1.9 0.0 0.0 0.3 3.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.5 16.2 0.0 44.9 45.1 138.5 39.0 55.9 18.0 1.4 27.4 29.5 38.9 0.6 15.4 19.1 3.4 27.1 49.3 0.7 52.8 60.8 0.6 0.6 0.5 0.6 0.6 0.7 1.5 0.2 1.4 0.7 3.0 27.3 13.0 0.5 10.2 0.0 1.7 0.0 2.7 2.3 3.5 0.0 0.6 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.9 5.1 0.2 36.8 0.9 113.3 0.0 0.0 4.3 141.8 0.0 0.3 166.3 18.6 8.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 3.1 0.3 1.7 7.4 0.8 159.2 0.0 0.9 DOK3 FLJ22570 ENSG00000146094 "Docking protein 3" Q7L591 5 177501907-177511274 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 47.5;bone marrow: 51.8;lymphoid tissue: 50.0" "Cell type enhanced" "Detected in some" 14 "granulocytes: 17.4;Hofbauer cells: 49.3;Kupffer cells: 45.9;Macrophages: 19.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 47.5" "Group enriched" "Detected in many" 6 "B-cells: 12.7;granulocytes: 47.5;monocytes: 23.2" "Cell line enhanced" "Detected in many" "Daudi: 41.4;HMC-1: 33.7;REH: 51.0;U-698: 40.9;U-937: 29.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA077312 Enhanced Supported "Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol" NA NA 750000 "Plasma membrane" "Nucleoplasm, Cytokinetic bridge, Cytosol" "HPA077312: AB_2732339" "unprognostic (2.21e-2)" "unprognostic (1.14e-2)" "unprognostic (2.05e-2)" "unprognostic (5.74e-3)" "unprognostic (2.32e-2)" "unprognostic (1.34e-3)" "unprognostic (4.17e-2)" "unprognostic (2.20e-1)" "unprognostic (8.00e-2)" "unprognostic (1.32e-1)" "unprognostic (1.21e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (3.82e-11)" "unprognostic (1.34e-1)" "unprognostic (7.25e-2)" "unprognostic (1.55e-1)" "unprognostic (3.78e-2)" 6.9 2.4 2.7 22.6 7.1 51.8 4.7 2.7 3.3 1.4 2.4 1.5 0.4 3.6 1.4 2.5 2.4 3.3 2.4 2.2 3.6 2.2 2.3 4.0 10.9 26.3 6.1 0.7 2.0 1.8 0.4 1.4 4.0 4.1 2.1 1.8 2.3 4.1 1.0 1.3 1.0 10.8 2.4 7.6 50.0 2.9 3.1 2.9 1.9 1.7 0.6 21.7 4.8 1.5 12.7 4.8 47.5 23.2 0.1 0.1 7.8 1.4 2.2 1.5 1.8 0.9 0.1 4.0 1.2 0.2 4.0 3.7 3.3 0.6 41.4 0.9 1.0 2.0 2.5 3.4 2.1 1.9 7.5 4.5 6.7 5.2 0.6 0.3 15.6 33.7 0.5 1.3 4.5 0.4 0.4 0.7 3.3 4.6 18.2 1.4 3.8 0.7 19.7 3.8 0.4 3.9 51.0 3.1 0.3 1.2 1.5 2.2 1.4 0.5 0.6 1.8 1.4 3.5 22.1 0.9 3.8 3.6 1.9 1.4 3.7 4.0 40.9 0.8 29.5 0.7 4.7 20.6 19.9 0.1 20.4 0.1 12.7 0.0 0.1 4.8 6.7 0.0 0.0 47.5 0.1 23.2 0.3 0.0 7.8 2.7 7.1 2.7 3.3 3.6 2.2 6.1 0.7 4.1 2.9 0.0 9.3 13.0 0.1 0.2 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.4 0.0 0.0 0.2 0.5 0.4 0.1 17.4 0.0 49.3 0.0 0.0 8.0 45.9 0.0 0.6 19.8 1.7 1.0 0.1 0.5 0.0 0.0 1.1 0.0 0.6 0.0 0.4 3.0 1.9 0.3 0.8 0.0 0.6 0.1 DOK7 "C4orf25, Dok-7, FLJ33718, FLJ39137" ENSG00000175920 "Docking protein 7" Q18PE1 4 3463311-3501473 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 19.1;skeletal muscle: 17.0" "Cell type enhanced" "Detected in some" 11 "Cardiomyocytes: 11.9;Collecting duct cells: 5.2;Early spermatids: 5.5;Intestinal endocrine cells: 5.8;Late spermatids: 4.8" "Cancer enhanced" "Detected in many" "ovarian cancer: 11.0" "Group enriched" "Detected in some" 8 "cerebellum: 8.7;pons and medulla: 2.5" "Group enriched" "Detected in some" 14 "memory B-cell: 6.3;naive B-cell: 3.8;NK-cell: 3.2" "Group enriched" "Detected in many" 15 "B-cells: 6.3;NK-cells: 3.2" "Cell line enriched" "Detected in some" 4 "MCF7: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059449, HPA062780" Approved Enhanced Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA059449: AB_2684023, HPA062780: AB_2732688" "prognostic favorable (8.45e-5)" "unprognostic (2.34e-1)" "unprognostic (2.08e-2)" "prognostic favorable (2.19e-4)" "unprognostic (5.96e-2)" "unprognostic (6.80e-3)" "unprognostic (1.05e-2)" "unprognostic (9.54e-2)" "unprognostic (1.12e-2)" "unprognostic (5.75e-2)" "unprognostic (2.54e-1)" "unprognostic (8.70e-2)" "unprognostic (1.24e-4)" "unprognostic (4.61e-3)" "unprognostic (5.09e-1)" "unprognostic (3.16e-2)" "prognostic favorable (1.28e-4)" 1.2 0.5 0.1 0.2 0.2 0.2 0.5 8.7 0.7 1.5 0.3 1.4 0.1 0.1 1.3 4.7 1.1 5.0 3.7 19.1 0.4 0.6 1.4 0.4 1.7 0.7 0.1 0.1 1.3 4.3 0.0 9.7 0.1 2.5 0.7 0.1 2.4 2.0 6.4 17.0 0.3 0.1 0.7 0.1 0.6 2.2 5.3 0.4 0.1 0.6 1.8 0.6 0.6 0.1 6.3 0.0 0.0 0.0 3.2 0.3 0.2 2.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 2.0 0.0 0.9 0.0 0.1 1.0 0.0 3.5 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 27.8 0.0 1.1 0.2 1.2 0.1 0.0 5.4 0.2 1.8 2.4 0.5 0.1 2.3 0.0 0.0 0.0 6.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.3 0.0 3.8 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.2 0.1 0.2 8.7 0.7 0.4 0.6 0.1 0.1 2.5 0.4 0.0 1.0 0.0 3.2 0.0 0.2 11.9 0.0 1.4 4.5 5.2 0.0 0.0 0.0 1.9 5.5 0.0 0.0 0.0 3.8 0.0 0.3 1.8 0.0 0.0 0.1 0.0 5.8 0.0 0.0 4.8 0.9 0.0 0.0 0.0 2.1 0.0 1.3 0.0 0.0 0.4 0.5 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.7 DOLK "DK1, KIAA1094, TMEM15" ENSG00000175283 "Dolichol kinase" Q9UPQ8 9 128945530-128947619 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Kinase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066767, HPA068706" Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA066767: AB_2732751, HPA068706: AB_2732118" "unprognostic (6.35e-2)" "unprognostic (2.69e-1)" "unprognostic (2.63e-1)" "unprognostic (1.30e-3)" "unprognostic (3.55e-1)" "unprognostic (2.81e-3)" "unprognostic (8.90e-3)" "unprognostic (3.26e-1)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (8.83e-3)" "unprognostic (1.83e-2)" "prognostic favorable (5.53e-4)" "unprognostic (3.20e-2)" "unprognostic (1.06e-1)" "prognostic favorable (6.88e-5)" "unprognostic (6.13e-3)" 11.0 20.2 7.9 7.8 13.8 1.4 9.5 7.0 18.6 9.8 8.6 14.9 7.1 8.8 12.4 16.8 10.9 10.8 10.8 12.0 7.6 9.9 17.5 22.0 10.6 10.6 8.1 6.7 13.2 16.9 19.2 8.0 19.5 16.3 12.3 8.0 14.2 15.5 12.8 7.9 11.4 10.9 11.1 5.9 11.6 12.4 22.4 6.0 12.5 11.0 11.9 12.1 10.4 7.3 9.4 14.2 5.6 16.4 9.8 13.7 9.0 5.1 19.3 6.8 10.1 20.2 10.7 9.3 10.8 17.5 13.3 9.9 15.1 8.2 2.8 5.7 15.6 18.8 36.7 9.3 13.5 6.9 4.7 8.1 3.5 13.3 10.9 20.5 3.8 6.3 14.8 12.5 14.3 7.9 7.8 12.9 4.1 8.6 4.6 14.3 25.4 3.1 3.2 8.8 14.8 12.0 3.2 9.0 11.2 11.9 7.8 6.3 7.0 14.3 11.8 6.3 6.7 20.6 5.1 10.7 12.0 4.3 15.1 8.8 4.4 10.8 2.9 11.3 3.5 9.1 2.3 13.5 5.6 10.2 13.3 9.1 9.4 9.2 11.2 14.2 9.2 12.1 12.3 2.1 9.8 16.4 8.1 13.7 9.0 7.9 13.8 7.0 18.6 7.6 9.9 8.1 6.7 16.3 6.0 6.0 2.6 1.5 3.2 1.5 9.0 3.0 7.6 6.7 3.4 7.0 7.9 21.7 0.0 14.1 10.7 8.3 6.2 0.0 12.3 14.0 5.6 3.1 1.1 8.3 11.4 4.8 1.2 17.2 6.9 2.8 11.2 2.7 3.3 1.8 3.8 11.2 10.4 5.8 5.6 7.2 6.5 0.0 4.1 24.0 14.9 1.1 15.2 1.9 5.5 1.7 DONSON "B17, C21orf60, C2TA, DKFZP434M035" ENSG00000159147 "Downstream neighbor of SON" Q9NYP3 21 33559542-33588708 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 44.4;Spermatocytes: 53.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039558, HPA049033" Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cell Junctions" Cytosol "HPA039558: AB_2676570, HPA049033: AB_2680608" "unprognostic (9.90e-3)" "unprognostic (1.01e-3)" "unprognostic (6.58e-2)" "unprognostic (1.66e-1)" "unprognostic (3.13e-1)" "unprognostic (1.93e-2)" "prognostic unfavorable (8.22e-4)" "unprognostic (4.00e-2)" "unprognostic (5.93e-3)" "prognostic favorable (2.17e-4)" "unprognostic (1.25e-1)" "unprognostic (4.10e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.77e-2)" "unprognostic (1.66e-1)" "unprognostic (2.07e-1)" "unprognostic (8.83e-2)" 6.4 3.5 4.1 9.2 8.0 9.4 10.2 7.8 5.6 6.8 7.1 3.3 3.5 6.1 6.7 5.8 8.3 6.3 5.9 7.5 5.5 4.4 5.6 16.2 5.2 11.1 4.7 4.0 13.5 5.7 11.7 6.9 12.2 8.1 5.7 7.4 4.4 4.8 4.3 5.9 9.1 9.3 5.4 5.2 8.2 5.8 24.0 3.0 26.4 5.0 8.1 10.7 4.5 9.7 0.7 0.5 0.1 0.9 0.4 1.4 0.3 27.4 6.4 13.5 11.8 4.2 7.8 10.5 21.9 9.5 16.8 19.1 18.0 7.5 14.9 5.7 10.9 12.7 8.2 18.2 7.8 18.5 14.9 15.7 27.9 14.1 16.3 3.1 14.8 6.8 5.5 2.5 19.0 4.6 5.0 10.7 7.8 26.6 26.0 14.4 5.6 13.5 5.3 14.0 13.1 7.9 12.1 27.9 15.9 7.5 7.4 14.7 6.1 32.9 10.5 9.6 7.0 13.8 7.5 6.2 16.0 11.2 11.7 15.4 23.6 23.2 24.5 8.9 19.8 18.0 0.0 0.3 0.1 1.4 0.9 0.7 0.2 1.4 0.6 0.2 0.7 0.8 0.1 0.0 0.4 0.0 0.5 0.6 0.3 4.1 8.0 7.8 5.6 5.5 4.4 4.7 4.0 8.1 3.0 3.0 3.4 0.8 7.7 7.2 3.5 3.4 7.6 0.0 1.2 3.5 9.8 8.0 1.7 3.0 44.4 4.5 2.7 0.0 4.0 22.1 6.4 4.6 8.1 5.5 7.6 6.4 1.2 8.6 2.7 16.6 9.5 5.1 6.8 3.6 3.8 2.4 3.7 2.9 13.1 4.2 2.7 0.0 8.1 53.1 21.1 8.5 13.8 5.7 5.1 8.1 DOPEY1 "dJ202D23.2, KIAA1117" ENSG00000083097 "Dopey family member 1" Q5JWR5 6 83067666-83171350 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 37.3;Rod photoreceptor cells: 42.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027902, HPA027904" Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA027902: AB_10600003, HPA027904: AB_10600877" "unprognostic (7.18e-2)" "unprognostic (3.91e-1)" "unprognostic (6.11e-2)" "unprognostic (6.05e-3)" "unprognostic (8.21e-3)" "unprognostic (1.36e-2)" "unprognostic (3.32e-1)" "unprognostic (1.02e-2)" "unprognostic (2.84e-1)" "unprognostic (2.47e-1)" "prognostic favorable (7.36e-4)" "unprognostic (2.13e-1)" "unprognostic (1.20e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-1)" "unprognostic (1.32e-1)" "unprognostic (1.17e-1)" 9.7 8.7 15.7 11.3 19.5 5.5 13.3 25.2 21.2 11.9 9.5 10.1 10.1 9.5 13.9 9.5 9.5 12.0 8.9 10.6 15.2 7.0 8.9 7.5 9.1 8.3 10.9 12.9 17.7 12.1 20.3 21.7 7.3 17.3 12.4 11.0 9.0 13.8 14.9 12.7 16.6 11.7 9.5 13.1 9.5 9.5 14.9 12.8 10.7 16.9 8.5 8.9 12.2 10.7 2.3 2.8 1.4 1.4 1.2 4.1 1.3 3.7 2.7 9.1 8.2 8.2 8.7 4.3 6.4 5.3 4.4 6.4 5.8 0.9 7.3 4.6 6.9 5.5 5.0 9.1 6.9 5.5 6.3 10.3 6.1 3.7 2.1 4.5 8.9 6.4 6.9 9.7 6.1 15.9 5.8 6.4 11.4 12.6 5.4 4.7 3.5 2.6 4.0 1.9 2.7 5.5 7.3 6.9 2.6 5.8 10.5 16.4 3.0 4.8 3.0 1.2 6.8 4.8 5.1 10.7 5.5 2.0 5.6 4.9 6.8 4.8 4.2 3.0 4.1 4.3 0.1 1.3 1.4 1.9 1.4 1.6 2.3 1.6 4.1 2.8 1.9 3.0 1.4 0.2 1.2 1.2 1.2 1.5 1.3 15.7 19.5 25.2 21.2 15.2 7.0 10.9 12.9 17.3 12.8 17.9 7.8 3.2 6.1 10.2 24.8 8.1 2.5 14.7 15.9 3.5 37.3 3.7 1.7 5.4 4.0 6.2 10.2 0.0 7.6 0.9 3.7 2.9 15.1 4.3 3.5 11.1 9.8 8.6 6.9 2.7 9.8 6.4 1.7 1.0 8.3 6.3 4.5 11.8 8.9 4.1 42.6 6.5 4.2 23.8 16.0 8.5 2.9 6.9 8.1 5.9 DOPEY2 "C21orf5, KIAA0933" ENSG00000142197 "Dopey family member 2" Q9Y3R5 21 36156782-36294274 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 43.1" "Cell type enhanced" "Detected in many" 7 "Mucus-secreting cells: 56.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072065 Enhanced Approved Nucleoplasm,Mitochondria Yes No Nucleoplasm Mitochondria "HPA072065: AB_2686486" "prognostic unfavorable (7.08e-4)" "unprognostic (7.68e-2)" "unprognostic (2.50e-2)" "unprognostic (1.99e-1)" "unprognostic (1.84e-1)" "unprognostic (1.66e-2)" "unprognostic (1.04e-2)" "unprognostic (1.01e-1)" "unprognostic (2.38e-1)" "unprognostic (1.36e-1)" "unprognostic (3.13e-2)" "unprognostic (4.35e-2)" "unprognostic (3.01e-2)" "unprognostic (2.59e-2)" "unprognostic (1.39e-1)" "unprognostic (1.06e-1)" "unprognostic (2.85e-1)" 4.6 2.3 5.5 7.5 9.5 17.1 4.9 28.7 11.6 5.1 11.8 3.8 6.8 9.7 2.8 3.3 13.5 3.6 6.5 4.3 4.6 4.0 3.5 7.2 7.2 5.8 3.1 5.8 2.3 3.8 43.1 3.1 4.7 9.5 9.8 12.0 2.8 15.2 9.1 11.1 7.4 13.9 3.8 3.7 5.2 15.8 3.3 3.3 9.3 3.6 7.5 10.6 5.4 6.5 12.0 6.4 6.3 3.2 1.1 3.1 1.3 14.9 3.2 2.4 4.0 2.7 5.2 23.2 7.1 8.5 10.1 6.3 2.2 1.2 2.8 1.1 5.3 7.7 3.1 4.6 1.6 8.2 5.1 4.2 6.4 0.7 0.8 2.4 6.2 3.3 1.8 3.3 6.6 1.7 6.1 4.2 6.7 2.0 4.6 2.9 16.8 4.9 6.4 2.0 17.7 3.3 8.9 1.4 13.6 5.4 6.0 6.5 3.7 4.7 21.5 6.1 3.4 7.8 7.7 7.2 3.9 1.1 5.1 5.7 3.4 8.4 1.3 5.6 13.5 2.2 1.0 3.2 6.3 3.1 3.1 1.7 8.6 2.0 1.8 2.1 12.0 1.3 1.1 5.5 1.1 2.6 6.4 1.5 1.3 5.5 9.5 28.7 11.6 4.6 4.0 3.1 5.8 9.5 3.3 0.0 5.8 31.4 6.9 2.7 5.3 4.0 10.2 6.7 3.4 8.7 3.9 1.5 3.3 8.1 0.7 3.3 17.3 0.0 2.8 9.8 2.8 21.2 8.1 8.5 15.7 0.0 28.2 6.2 15.4 0.0 2.3 12.0 5.0 7.2 56.5 1.5 7.5 24.6 2.8 1.3 3.0 0.0 2.5 4.4 13.0 4.5 6.8 7.5 19.5 10.1 DOT1L "DOT1, KIAA1814, KMT4" ENSG00000104885 "DOT1 like histone lysine methyltransferase" Q8TEK3 19 2164149-2232578 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 64.7" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 62.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011875, HPA071217, HPA074977" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA011875: AB_2668552, HPA071217: AB_2686364, HPA074977: " "unprognostic (1.41e-2)" "unprognostic (1.44e-1)" "unprognostic (2.26e-1)" "prognostic favorable (1.69e-4)" "unprognostic (1.08e-1)" "prognostic favorable (6.00e-4)" "unprognostic (2.53e-3)" "unprognostic (2.21e-1)" "unprognostic (1.57e-2)" "unprognostic (1.67e-2)" "unprognostic (5.25e-3)" "unprognostic (8.18e-3)" "unprognostic (2.56e-1)" "unprognostic (1.73e-3)" "unprognostic (1.43e-1)" "unprognostic (1.12e-1)" "unprognostic (1.67e-1)" 7.3 8.8 7.0 10.7 11.7 20.1 5.1 20.6 11.7 4.5 7.9 9.8 6.0 13.5 6.4 4.9 8.3 5.4 6.9 5.7 7.0 3.6 9.5 8.5 10.0 8.4 11.9 5.3 6.5 10.8 3.6 8.3 11.6 7.1 5.7 4.9 9.5 6.1 7.4 9.8 9.9 13.0 4.2 6.7 10.4 13.3 64.7 9.7 10.5 9.2 7.0 9.1 4.8 5.3 0.7 1.0 3.0 0.9 2.8 1.4 0.6 12.2 6.6 22.4 12.2 1.7 2.5 29.5 7.0 1.5 3.8 3.1 8.4 4.6 14.4 3.4 4.5 3.3 11.0 7.4 3.9 1.8 7.3 9.3 13.2 10.8 8.2 2.7 18.9 24.4 2.4 2.9 7.4 3.8 3.1 3.1 8.2 16.0 15.1 3.0 7.0 15.1 20.9 17.3 7.8 11.8 15.6 6.3 9.9 2.1 5.8 15.0 11.6 4.9 14.6 9.2 6.2 6.7 14.5 4.4 10.7 9.8 15.8 13.4 14.0 18.3 10.0 10.6 13.1 6.2 0.5 0.7 3.0 0.9 0.3 1.4 0.7 0.8 0.2 0.9 0.7 0.5 0.3 0.3 2.8 0.9 1.0 0.1 0.6 7.0 11.7 20.6 11.7 7.0 3.6 11.9 5.3 7.1 9.7 29.8 18.9 9.9 9.3 15.8 25.0 5.2 20.4 6.7 6.8 8.7 62.8 5.3 3.3 10.1 25.8 7.1 25.4 0.0 10.4 11.3 11.0 12.4 5.8 13.1 9.3 12.7 20.0 6.7 11.9 11.9 2.8 14.6 11.8 5.4 10.8 7.3 14.1 14.0 3.2 2.2 26.6 0.0 8.1 28.3 23.5 17.3 13.6 4.9 11.7 14.2 DPEP1 ENSG00000015413 "Dipeptidase 1" P16444 16 89613308-89638456 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Lipid metabolism" "Dipeptidase, Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "intestine: 161.7;kidney: 52.2;pancreas: 100.5" "Cell type enhanced" "Detected in many" 26 "Leydig cells: 268.4;Peritubular cells: 1144.5;Proximal tubular cells: 391.6" "Cancer enriched" "Detected in many" 8 "colorectal cancer: 107.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 5.2;Hep G2: 20.3;HHSteC: 9.2;U-937: 28.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA009426, HPA012783" Enhanced Approved "Nucleoplasm,Cell Junctions" "Intracellular and membrane" NA NA 270000 "Nucleoplasm, Cell Junctions" "HPA009426: AB_1847842, HPA012783: AB_1847843" "unprognostic (3.31e-2)" "unprognostic (3.86e-1)" "unprognostic (1.37e-1)" "unprognostic (1.95e-2)" "unprognostic (1.91e-2)" "unprognostic (4.93e-2)" "unprognostic (1.04e-1)" "unprognostic (1.89e-1)" "unprognostic (3.45e-2)" "unprognostic (5.18e-1)" "unprognostic (8.68e-2)" "unprognostic (1.27e-1)" "prognostic favorable (6.84e-4)" "unprognostic (6.12e-3)" "unprognostic (1.92e-1)" "unprognostic (5.23e-2)" "unprognostic (3.93e-2)" 0.1 0.4 0.1 0.9 0.1 0.0 0.1 0.1 0.1 1.5 53.6 0.1 0.4 16.1 0.2 3.4 0.3 0.1 0.9 0.1 0.1 0.1 52.2 0.1 0.3 0.9 0.1 0.1 0.2 100.5 0.0 0.2 0.1 0.2 0.1 0.0 0.2 0.3 0.4 0.1 0.4 161.7 0.1 0.1 0.9 0.2 9.8 0.1 0.2 0.1 0.1 0.5 0.6 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.1 0.0 1.1 0.1 2.8 0.0 0.0 0.0 0.0 5.2 0.1 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.4 0.0 0.0 20.3 9.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.6 0.7 2.1 0.0 0.0 0.0 1.8 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.1 0.0 28.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 3.0 2.6 14.9 0.0 0.5 3.3 0.3 0.0 0.0 1.2 22.7 0.0 0.1 48.0 0.3 10.3 0.1 4.2 0.0 171.7 0.3 4.5 0.0 1.1 0.0 0.5 0.0 8.5 1.8 0.0 29.1 268.4 1.7 5.0 1.8 1.9 0.0 43.8 11.5 1144.5 391.6 0.1 6.5 0.3 15.6 2.9 0.3 0.3 0.5 1.2 0.0 DPF1 "BAF45b, NEUD4, neuro-d4" ENSG00000011332 "Double PHD fingers 1" Q92782 19 38211006-38229714 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 31.6" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 18.4;Early spermatids: 23.8;Horizontal cells: 42.9;Late spermatids: 17.6" "Cancer enhanced" "Detected in some" "glioma: 5.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 15.7;SCLC-21H: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049148 Enhanced Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "HPA049148: AB_2680653" "unprognostic (7.72e-2)" "unprognostic (2.33e-1)" "unprognostic (5.38e-2)" "unprognostic (4.11e-3)" "unprognostic (8.16e-2)" "unprognostic (2.21e-1)" "unprognostic (1.29e-4)" "unprognostic (1.40e-2)" "unprognostic (2.72e-1)" "unprognostic (5.49e-2)" "unprognostic (4.30e-3)" "unprognostic (2.87e-2)" "unprognostic (1.11e-16)" "unprognostic (2.56e-1)" "unprognostic (3.75e-1)" "unprognostic (6.96e-2)" "unprognostic (8.20e-4)" 1.1 1.5 11.8 1.5 15.7 1.0 0.9 6.4 31.6 0.8 1.0 0.9 0.0 0.9 1.0 0.8 0.8 1.0 1.0 1.0 12.4 7.7 0.8 0.8 1.0 1.1 4.5 11.3 0.9 0.9 0.9 1.3 1.1 2.0 0.9 0.9 0.0 1.2 0.8 1.1 1.2 1.0 1.3 2.1 1.1 0.8 2.5 1.2 0.0 0.8 0.0 1.1 0.9 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 3.5 3.0 12.8 9.3 0.9 0.6 1.3 3.8 2.2 6.5 5.5 2.1 0.3 5.8 2.6 2.9 2.6 2.3 15.7 2.1 2.9 5.5 3.0 1.9 1.4 0.8 0.3 1.4 1.6 0.7 0.0 3.8 1.2 0.8 1.2 4.4 4.3 0.3 6.1 4.9 3.1 0.3 2.3 1.0 3.5 5.8 6.5 1.2 0.6 1.1 18.5 6.4 4.2 0.4 0.8 1.6 1.9 0.3 1.4 9.4 3.0 2.2 3.4 2.3 7.7 7.7 4.9 2.0 3.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 11.8 15.7 6.4 19.6 12.4 7.7 4.5 11.3 2.0 1.2 0.0 0.0 0.0 0.0 2.1 18.4 1.1 0.0 1.4 0.0 0.0 7.9 0.1 0.0 0.0 23.8 0.3 0.0 0.0 0.0 1.7 0.4 0.1 0.0 0.0 0.2 42.9 0.0 0.0 0.0 17.6 0.6 0.0 0.0 0.0 0.0 2.6 0.1 0.0 2.5 0.0 2.9 0.0 1.3 4.9 6.8 1.0 0.1 0.0 0.0 0.0 DPF2 "BAF45d, REQ, ubi-d4" ENSG00000133884 "Double PHD fingers 2" Q92785 11 65333754-65353249 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Chromatin regulator" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020880, HPA056786" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA020880: AB_1847845, HPA056786: AB_2683235" "unprognostic (2.06e-1)" "unprognostic (2.13e-1)" "unprognostic (3.45e-2)" "unprognostic (2.90e-3)" "unprognostic (1.40e-2)" "unprognostic (9.66e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (2.04e-1)" "unprognostic (3.29e-2)" "unprognostic (3.07e-1)" "unprognostic (2.43e-1)" "unprognostic (1.33e-1)" "unprognostic (6.93e-2)" "unprognostic (3.04e-2)" "unprognostic (3.24e-1)" "unprognostic (1.26e-2)" "unprognostic (1.34e-1)" 18.5 16.3 22.5 14.3 26.4 23.0 17.0 29.4 28.6 26.3 24.8 41.7 16.9 14.1 31.5 25.5 19.5 34.9 20.8 27.1 21.4 20.4 14.7 12.2 17.3 21.4 30.4 18.6 46.3 18.1 21.9 17.7 19.8 23.2 22.9 15.9 21.7 19.7 30.5 27.6 14.2 17.9 31.2 27.3 23.3 18.9 27.0 30.3 40.6 26.1 10.8 25.8 25.2 21.3 36.9 26.4 56.1 26.5 41.8 35.2 33.7 13.6 17.3 21.9 19.1 19.7 20.0 12.3 11.8 16.8 26.2 19.0 17.0 16.5 18.6 19.6 16.1 22.5 14.5 25.1 15.2 18.8 21.9 11.0 23.5 12.3 17.2 30.6 21.4 17.4 17.6 14.8 23.3 42.8 19.4 20.9 22.2 22.2 24.3 17.1 22.0 27.0 22.0 24.3 14.7 17.7 29.5 14.3 21.5 16.2 11.4 14.3 13.0 15.3 21.6 20.6 15.0 28.1 11.8 12.2 17.0 15.1 18.5 11.9 29.9 35.1 23.7 10.4 14.1 18.9 53.0 26.5 46.9 29.4 23.9 31.7 36.7 28.6 28.5 26.4 36.9 30.0 27.1 56.1 41.8 26.1 24.2 35.2 33.7 22.5 26.4 29.4 28.6 21.4 20.4 30.4 18.6 23.2 30.3 6.0 8.5 27.4 19.8 20.1 38.5 12.4 43.3 6.7 11.4 31.4 45.2 23.2 16.6 18.4 4.1 25.2 13.2 0.0 15.1 19.3 25.3 18.7 16.1 10.5 16.8 28.6 16.7 19.6 19.3 9.5 54.4 16.4 18.6 24.4 18.2 23.6 16.0 7.0 50.2 15.9 47.0 32.3 28.1 50.6 56.1 20.3 22.2 33.3 15.8 14.8 DPF3 "BAF45c, cer-d4, Cerd4, FLJ14079" ENSG00000205683 "Double PHD fingers 3" Q92784 14 72619296-72894116 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.3;skeletal muscle: 28.4" "Cell type enhanced" "Detected in many" 14 "Cardiomyocytes: 33.3;Cone photoreceptor cells: 102.1;Early spermatids: 36.1;Rod photoreceptor cells: 86.0" "Cancer enhanced" "Detected in some" "glioma: 3.2" "Region enriched" "Detected in all" 5 "cerebellum: 56.3" "Cell type enhanced" "Detected in some" "memory B-cell: 1.1;naive B-cell: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 13.7;BJ hTERT+ SV40 Large T+: 9.4;HEL: 23.3;Karpas-707: 9.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA066790, HPA070601" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA066790: AB_2685724, HPA070601: AB_2686284" "unprognostic (2.38e-2)" "unprognostic (2.96e-1)" "unprognostic (3.25e-1)" "unprognostic (1.56e-2)" "unprognostic (1.55e-1)" "unprognostic (9.98e-2)" "unprognostic (4.80e-2)" "unprognostic (1.19e-2)" "unprognostic (1.33e-1)" "unprognostic (3.54e-2)" "unprognostic (9.71e-3)" "unprognostic (1.02e-1)" "unprognostic (2.02e-1)" "unprognostic (3.85e-3)" "unprognostic (4.08e-2)" "unprognostic (4.80e-2)" "unprognostic (1.96e-1)" 0.7 2.2 6.2 1.1 10.3 3.2 0.8 56.3 7.6 0.9 2.7 8.4 0.0 0.8 0.8 0.5 1.2 0.7 1.0 16.8 6.4 2.5 2.2 4.3 0.8 1.5 8.9 4.5 17.8 0.7 8.4 0.9 0.9 10.4 0.7 2.4 3.4 0.8 0.7 28.4 1.1 1.7 1.2 10.1 1.4 1.1 6.6 10.7 0.0 0.8 6.3 1.8 0.8 0.7 1.9 0.0 0.0 0.3 0.4 0.8 0.2 1.5 0.0 1.2 0.1 0.2 2.3 13.7 4.1 3.9 9.4 3.6 0.0 0.1 0.2 0.2 1.2 0.2 0.1 1.3 0.6 5.8 0.2 0.5 23.3 0.1 0.0 0.3 0.1 0.4 0.6 0.2 2.2 1.6 1.6 3.0 2.5 2.0 9.5 3.0 0.1 1.9 0.2 0.0 0.0 1.3 5.1 0.6 0.3 1.6 0.0 0.9 0.5 0.0 0.1 0.0 0.4 0.0 0.0 6.5 4.6 0.0 1.7 0.5 3.4 0.9 0.3 0.4 0.9 0.1 0.0 0.0 0.0 0.8 0.0 0.0 1.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.2 6.2 10.3 56.3 7.6 6.4 2.5 8.9 4.5 10.4 10.7 0.0 0.0 0.9 0.0 0.6 4.7 33.3 0.0 0.0 0.0 0.0 102.1 2.2 1.7 0.0 36.1 1.8 3.9 23.3 0.3 1.2 0.8 0.1 4.6 4.2 0.4 6.4 0.0 0.6 1.5 22.2 0.3 0.9 0.0 0.0 3.3 8.1 0.5 4.0 4.6 9.9 86.0 0.0 0.8 1.7 0.7 0.3 0.1 2.5 6.3 0.0 DPH1 "DPH2L, DPH2L1, OVCA1" ENSG00000108963 "Diphthamide biosynthesis 1" Q9BZG8 17 2030110-2043430 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation, Dwarfism, Ectodermal dysplasia, Hypotrichosis, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 2: 8.6;Club cells: 4.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069750, HPA073864" Approved Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA069750: AB_2686188, HPA073864: " "unprognostic (5.54e-2)" "unprognostic (1.99e-1)" "unprognostic (1.62e-1)" "unprognostic (1.86e-2)" "unprognostic (1.50e-2)" "unprognostic (1.46e-1)" "unprognostic (2.21e-1)" "unprognostic (1.10e-1)" "unprognostic (3.93e-2)" "unprognostic (2.30e-1)" "prognostic favorable (1.78e-5)" "unprognostic (2.74e-3)" "unprognostic (2.10e-2)" "unprognostic (1.03e-1)" "unprognostic (3.40e-1)" "unprognostic (7.30e-2)" "unprognostic (1.41e-1)" 16.6 22.9 17.6 19.0 22.7 10.3 17.0 38.6 26.5 17.8 17.1 17.2 21.1 17.0 22.2 17.0 17.9 29.0 22.6 20.2 14.1 13.1 21.4 32.7 15.7 22.7 17.0 21.6 25.2 29.4 28.4 42.9 17.3 15.4 26.1 13.3 21.3 25.7 23.9 33.3 29.0 17.3 18.9 11.4 17.8 18.4 19.5 19.9 17.5 21.0 25.8 19.0 17.2 16.0 11.3 9.3 0.7 6.8 5.6 12.0 5.5 9.1 16.1 4.4 10.7 13.8 10.1 12.2 12.1 18.2 20.6 13.4 15.4 7.5 17.9 15.7 35.8 7.9 7.3 14.8 13.6 11.2 4.6 33.9 4.1 7.6 9.2 13.1 5.2 6.8 15.1 13.9 16.5 13.4 14.7 9.3 10.4 14.0 7.4 8.1 12.1 9.1 3.4 4.1 11.2 16.5 10.6 3.1 13.9 9.2 5.7 8.3 9.7 10.9 12.5 12.1 4.3 18.1 4.3 6.4 14.4 6.6 17.7 10.9 7.3 5.0 4.4 14.2 7.1 5.0 0.0 4.6 0.7 9.5 6.8 10.4 11.3 7.8 8.6 9.3 9.5 12.0 8.7 0.3 5.6 4.6 6.7 10.4 5.5 17.6 22.7 38.6 26.5 14.1 13.1 17.0 21.6 15.4 19.9 3.0 8.6 0.0 0.8 0.3 1.9 1.3 0.0 2.7 4.5 0.0 2.0 1.2 0.0 0.4 0.9 0.6 0.4 0.0 0.5 0.7 1.3 0.5 2.3 0.0 0.5 1.6 0.0 0.6 0.0 1.0 0.6 1.0 0.0 0.0 0.3 1.0 0.0 0.0 0.4 0.4 3.0 0.0 1.2 0.7 0.3 0.3 1.1 0.7 0.4 0.6 DPH2 DPH2L2 ENSG00000132768 "DPH2 homolog" Q9BQC3 1 43970000-43973369 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045796 Uncertain Approved Nucleoplasm Yes No Nucleoplasm "HPA045796: AB_2679456" "unprognostic (2.41e-1)" "unprognostic (1.15e-1)" "unprognostic (4.20e-3)" "unprognostic (9.13e-3)" "unprognostic (3.83e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (1.17e-8)" "unprognostic (1.38e-1)" "unprognostic (1.81e-1)" "unprognostic (3.72e-1)" "unprognostic (2.49e-1)" "unprognostic (3.42e-3)" "unprognostic (2.60e-1)" "prognostic favorable (1.37e-4)" "unprognostic (1.38e-1)" "unprognostic (2.41e-2)" "unprognostic (6.37e-2)" 9.6 12.7 13.5 12.4 14.1 7.5 9.8 7.9 18.8 8.3 12.0 12.4 5.9 8.9 9.4 7.5 15.2 10.8 11.5 11.6 11.6 6.3 11.5 21.7 8.5 14.1 13.6 9.3 9.1 21.1 10.4 10.6 8.3 9.7 9.8 11.9 5.8 11.6 9.2 33.4 13.1 9.9 11.2 7.6 13.7 10.6 14.7 12.3 10.8 8.9 14.6 13.5 10.3 7.8 9.0 10.2 0.5 9.2 9.8 10.1 5.8 9.9 11.5 5.2 11.0 3.9 4.1 17.5 5.3 5.8 13.9 11.4 14.6 9.8 16.8 9.1 5.5 7.2 11.5 17.4 15.1 7.5 11.5 15.2 17.3 14.4 15.1 10.3 19.9 9.8 6.3 16.9 16.4 9.1 4.2 9.6 13.4 21.8 9.5 6.9 11.6 17.6 11.0 35.9 16.7 13.2 15.2 11.9 27.2 8.7 8.0 17.9 20.7 7.0 17.8 12.9 7.3 7.5 13.8 6.2 6.7 15.4 11.8 21.1 23.3 38.5 17.2 6.0 22.2 9.8 0.0 6.6 0.3 6.7 9.2 9.9 9.0 6.8 6.9 10.2 8.8 7.0 10.1 0.5 9.8 4.7 8.5 6.6 5.8 13.5 14.1 7.9 18.8 11.6 6.3 13.6 9.3 9.7 12.3 0.0 3.7 17.1 9.7 20.4 6.3 8.5 10.2 6.7 3.4 1.8 9.8 12.3 5.0 14.8 0.3 6.0 2.5 0.0 16.3 12.3 7.0 9.4 4.6 4.2 7.7 3.2 11.5 3.1 1.8 0.9 7.8 5.0 5.0 10.8 6.5 4.5 11.7 0.0 3.5 7.3 5.5 0.0 11.2 8.6 27.1 23.7 7.2 6.9 11.8 8.0 DPH3 "DELGIP, DELGIP1, DESR1, DPH3A, KTI11, MGC20197, ZCSL2" ENSG00000154813 "Diphthamide biosynthesis 3" Q96FX2 3 16257978-16264972 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035287 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA035287: AB_10604113" "unprognostic (2.49e-2)" "unprognostic (8.80e-2)" "unprognostic (2.84e-2)" "unprognostic (3.30e-2)" "unprognostic (1.52e-1)" "unprognostic (1.59e-1)" "prognostic unfavorable (2.24e-4)" "unprognostic (1.22e-1)" "unprognostic (2.83e-1)" "unprognostic (5.06e-2)" "unprognostic (5.83e-2)" "unprognostic (4.13e-1)" "unprognostic (5.90e-3)" "unprognostic (1.82e-2)" "unprognostic (1.55e-1)" "unprognostic (1.19e-2)" "unprognostic (6.44e-2)" 17.6 13.9 15.7 10.6 14.8 8.0 21.3 10.7 15.0 12.6 15.3 8.9 8.2 12.4 13.2 13.0 12.6 11.5 12.1 15.4 14.2 17.3 17.9 27.4 12.5 10.0 19.3 6.9 15.8 9.1 7.6 19.3 17.3 18.6 11.0 10.4 5.6 7.2 13.6 33.2 5.4 32.8 17.3 17.4 15.3 12.0 13.2 12.6 12.8 14.4 10.1 9.0 15.3 12.8 7.3 11.3 25.6 15.6 7.2 10.6 8.7 5.3 7.9 16.9 10.4 31.3 22.9 13.5 15.6 12.5 14.7 17.2 9.7 3.3 5.1 5.2 19.1 12.8 3.3 15.5 9.9 17.7 25.7 10.6 8.5 6.3 10.8 19.7 12.6 8.5 15.8 13.2 20.0 8.7 9.4 13.4 9.3 14.6 8.8 20.8 7.0 9.4 8.2 13.6 8.4 8.2 6.7 11.1 7.9 13.1 4.3 3.7 10.8 7.2 3.6 17.7 14.6 6.9 12.4 15.6 12.7 7.9 22.3 12.9 6.9 22.8 6.8 18.2 14.2 10.9 15.3 12.0 17.8 8.6 15.6 10.6 7.3 9.2 10.4 11.3 6.6 7.8 9.1 25.6 7.2 14.4 4.5 8.1 8.7 15.7 14.8 10.7 15.0 14.2 17.3 19.3 6.9 18.6 12.6 17.9 19.0 32.8 34.6 45.8 11.4 33.0 25.5 25.4 27.3 15.7 11.8 40.7 34.9 45.9 86.0 30.1 55.8 23.3 49.9 63.0 35.9 36.4 50.8 35.8 86.6 6.4 17.1 26.4 41.7 53.8 19.0 47.4 27.0 82.0 20.7 14.9 53.2 34.5 14.9 37.6 13.9 12.9 28.0 54.9 41.1 45.8 67.6 32.4 15.6 45.1 DPH6 "ATPBD4, MGC14798" ENSG00000134146 "Diphthamine biosynthesis 6" Q7L8W6 15 35217345-35546193 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042976, HPA055496" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA042976: AB_10964890, HPA055496: AB_2682835" "unprognostic (9.78e-2)" "unprognostic (1.45e-1)" "unprognostic (1.92e-1)" "unprognostic (1.14e-1)" "unprognostic (1.82e-1)" "unprognostic (1.45e-2)" "unprognostic (1.60e-1)" "unprognostic (9.94e-2)" "unprognostic (1.76e-1)" "unprognostic (1.49e-3)" "unprognostic (7.92e-3)" "unprognostic (1.13e-1)" "unprognostic (4.65e-6)" "unprognostic (9.70e-2)" "unprognostic (5.61e-2)" "unprognostic (2.18e-2)" "unprognostic (7.44e-2)" 13.3 12.7 8.0 6.8 16.1 6.4 15.3 11.6 15.8 14.7 9.2 15.5 10.8 8.5 23.9 17.1 14.7 11.5 10.5 14.4 7.8 7.2 14.7 11.2 8.7 9.3 9.7 12.0 16.7 19.5 15.8 31.7 11.1 13.4 8.5 10.2 14.6 11.5 14.7 24.9 15.2 8.7 16.8 11.1 8.3 9.6 11.3 10.6 7.1 15.3 16.5 10.0 11.0 11.3 8.4 6.3 0.3 6.5 13.2 10.8 4.4 10.5 5.7 9.6 8.1 1.7 7.9 9.4 4.0 7.0 9.7 5.1 7.6 9.9 3.3 9.8 3.7 11.8 12.2 11.1 11.5 11.6 2.6 7.0 12.3 6.5 12.0 10.3 6.5 8.0 6.6 14.6 3.9 18.9 6.0 9.3 7.1 13.5 13.4 8.9 4.1 8.0 6.1 8.5 16.1 5.3 10.0 9.0 4.5 8.4 13.5 7.0 6.9 7.5 8.4 6.4 5.9 29.0 9.1 2.8 9.5 9.2 9.4 6.3 12.0 19.0 8.3 8.2 11.3 9.0 0.0 6.5 0.3 6.2 6.0 7.7 8.4 8.3 8.6 6.3 6.5 10.8 9.5 0.3 13.2 5.6 5.4 5.4 4.4 8.0 16.1 11.6 15.8 7.8 7.2 9.7 12.0 13.4 10.6 14.9 6.9 12.6 16.6 27.5 31.5 11.0 17.8 5.3 17.0 8.7 37.3 22.9 11.6 12.0 2.1 9.5 10.1 23.3 21.1 18.8 11.6 7.6 3.5 7.3 15.0 17.5 5.2 6.7 10.0 1.6 13.0 10.9 15.1 15.4 6.0 16.6 15.1 7.0 6.3 16.4 22.2 0.0 11.3 8.3 15.1 20.3 18.9 5.0 9.2 11.1 DPPA2 "CT100, PESCRG1" ENSG00000163530 "Developmental pluripotency associated 2" Q7Z7J5 3 109293788-109316517 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "placenta: 4.9;testis: 9.0" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 2.7;Extravillous trophoblasts: 9.2" "Cancer enriched" "Detected in some" 41 "testis cancer: 35.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.2" "Group enriched" "Detected in some" 5 "BEWO: 7.6;EFO-21: 14.5;SuSa: 8.7" HPA036134 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA036134: AB_10601547" "unprognostic (2.23e-1)" "unprognostic (2.79e-1)" "unprognostic (1.81e-2)" "unprognostic (3.50e-2)" 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.1 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 14.5 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 8.7 0.5 0.1 0.1 0.1 2.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.4 0.0 0.0 0.0 DPPA4 FLJ10713 ENSG00000121570 "Developmental pluripotency associated 4" Q7L190 3 109326141-109337572 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 10.3;lymphoid tissue: 35.8" "Group enriched" "Detected in some" 6 "Cytotrophoblasts: 18.3;Extravillous trophoblasts: 16.9;Syncytiotrophoblasts: 5.1" "Cancer enriched" "Detected in single" 218 "testis cancer: 59.0" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 11 "plasmacytoid DC: 10.3" "Lineage enriched" "Detected in single" 11 "dendritic cells: 10.3" "Group enriched" "Detected in some" 4 "HAP1: 22.5;NTERA-2: 83.0;SuSa: 32.3" "CAB020678, HPA035249, HPA035250" Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome,Cytosol" Yes NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Mitotic chromosome, Cytosol" "CAB020678: , HPA035249: AB_2674535, HPA035250: AB_2674536" "unprognostic (2.07e-2)" "unprognostic (2.53e-2)" "unprognostic (3.80e-1)" "unprognostic (2.53e-1)" "unprognostic (8.57e-2)" "unprognostic (1.80e-2)" "unprognostic (1.67e-1)" "unprognostic (1.52e-1)" "unprognostic (9.83e-2)" "unprognostic (2.02e-2)" "unprognostic (6.60e-2)" "unprognostic (2.48e-2)" "unprognostic (3.03e-8)" "unprognostic (5.28e-2)" "unprognostic (5.04e-2)" "unprognostic (5.56e-2)" "unprognostic (3.85e-2)" 0.1 0.1 0.2 0.3 1.0 8.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.2 0.6 0.1 0.2 1.3 0.6 0.8 0.3 0.0 0.0 0.0 0.0 2.2 4.2 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.7 0.0 8.1 0.0 35.8 0.1 0.0 1.0 0.4 0.1 0.9 10.3 0.0 0.0 0.7 0.2 0.1 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.2 0.2 0.0 0.7 0.0 10.3 0.0 0.1 0.2 1.0 0.1 0.3 0.6 0.1 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 1.4 1.2 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.3 0.2 1.1 1.0 1.4 0.0 0.0 0.6 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 2.1 0.0 5.1 0.7 0.0 0.3 DPY19L2 "FLJ32949, SPATA34" ENSG00000177990 "Dpy-19 like 2" Q6NUT2 12 63558913-63668939 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 44.0" "Group enriched" "Detected in many" 6 "Early spermatids: 300.2;Late spermatids: 304.6;Spermatocytes: 171.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.4;naive CD8 T-cell: 2.7" "Lineage enriched" "Detected in single" 19 "T-cells: 3.4" "Cell line enhanced" "Detected in many" "U-266/84: 10.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA071264, HPA078305" Enhanced Approved Nucleoplasm,Mitochondria Yes No Mitochondria Nucleoplasm "HPA071264: AB_2686375, HPA078305: " "unprognostic (1.97e-1)" "unprognostic (4.08e-1)" "unprognostic (4.46e-3)" "unprognostic (2.50e-2)" "unprognostic (1.64e-1)" "unprognostic (1.17e-4)" "unprognostic (2.28e-2)" "unprognostic (2.14e-3)" "unprognostic (1.53e-1)" "unprognostic (3.64e-1)" "unprognostic (3.99e-3)" "unprognostic (1.97e-1)" "unprognostic (6.31e-3)" "unprognostic (4.22e-3)" "unprognostic (5.88e-2)" "unprognostic (8.90e-3)" "unprognostic (1.79e-1)" 5.7 4.3 2.6 1.6 5.2 2.1 2.4 5.2 4.5 5.6 2.6 1.4 3.1 0.7 7.8 3.4 1.3 3.7 2.4 12.9 1.8 2.4 6.0 0.3 1.1 0.8 1.7 3.1 7.3 2.3 7.4 10.9 1.2 3.0 5.7 1.2 5.1 2.3 6.3 0.5 1.4 0.9 4.3 0.7 1.1 1.5 44.0 0.9 0.5 8.4 1.4 0.7 2.7 3.1 0.1 0.0 0.1 0.0 0.1 3.4 0.4 1.2 3.1 2.8 6.6 0.7 0.0 0.3 2.1 2.2 2.9 3.8 0.4 1.0 3.4 2.2 0.9 3.6 0.5 3.3 0.3 4.4 1.7 2.0 5.4 1.4 2.0 0.6 3.9 1.7 1.5 0.1 1.4 0.0 7.4 0.8 2.6 2.2 3.4 4.7 2.1 0.2 1.6 2.5 0.5 2.5 0.1 2.3 0.0 5.6 0.5 8.5 0.9 0.8 0.3 1.2 1.2 2.4 1.1 0.6 4.0 5.2 0.6 5.4 9.1 10.4 0.0 4.3 1.9 3.6 0.1 0.0 0.0 0.6 0.0 3.4 0.0 0.1 0.6 0.0 0.1 1.0 2.7 0.0 0.1 0.0 0.0 0.0 0.4 2.6 5.2 5.2 4.5 1.8 2.4 1.7 3.1 3.0 0.9 3.0 0.0 0.0 2.9 0.5 41.9 24.2 2.5 16.0 6.8 12.2 13.7 1.1 5.0 0.4 300.2 2.3 0.0 0.0 0.0 1.1 1.0 3.0 2.3 0.0 0.3 3.2 0.0 0.0 0.0 304.6 6.6 0.0 6.8 0.0 0.0 11.1 0.2 0.0 8.1 5.6 6.2 25.8 15.6 171.9 4.1 0.4 1.1 0.0 0.0 0.9 DPY30 "Cps25, HDPY-30, Saf19" ENSG00000162961 "Dpy-30, histone methyltransferase complex regulatory subunit" Q9C005 2 31867809-32039812 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043761 Supported Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA043761: AB_10960501" "unprognostic (2.76e-2)" "unprognostic (1.48e-1)" "unprognostic (2.52e-2)" "unprognostic (1.07e-2)" "unprognostic (1.64e-1)" "unprognostic (4.57e-3)" "unprognostic (4.14e-3)" "unprognostic (1.91e-1)" "unprognostic (7.87e-2)" "unprognostic (1.01e-3)" "unprognostic (1.45e-2)" "unprognostic (5.75e-2)" "prognostic unfavorable (4.26e-4)" "unprognostic (2.70e-1)" "unprognostic (6.77e-2)" "unprognostic (2.79e-2)" "unprognostic (1.49e-1)" 20.3 41.8 38.2 22.6 34.8 14.6 34.2 30.1 36.0 30.5 25.8 19.4 28.9 23.1 25.6 44.3 31.8 49.7 23.8 23.9 35.4 44.2 42.1 44.7 23.6 24.6 40.4 33.1 24.5 25.8 21.4 39.4 23.4 38.6 32.0 25.6 17.6 34.7 35.1 24.5 26.2 24.6 26.8 41.4 19.8 24.2 13.4 31.0 22.1 49.1 26.9 25.3 26.4 25.4 57.8 35.2 50.6 37.2 34.4 67.7 43.5 52.4 36.3 27.5 21.1 24.1 36.1 36.8 27.3 24.4 22.2 21.9 52.1 42.6 32.4 28.0 24.0 40.8 21.4 25.0 31.6 24.2 37.9 40.2 29.1 26.5 58.4 21.3 29.5 18.2 24.3 36.9 23.8 21.1 30.0 34.9 14.7 34.0 23.1 33.7 57.0 33.1 59.7 37.9 48.6 37.9 27.1 32.4 40.7 38.6 36.2 44.4 31.8 27.1 38.2 36.5 33.9 26.6 21.7 26.8 20.3 32.9 18.8 32.9 27.3 40.3 42.5 21.4 32.2 24.7 46.0 37.2 50.6 36.3 34.0 43.8 57.8 51.0 44.4 35.2 46.1 45.8 43.0 41.4 34.4 37.0 32.1 67.7 43.5 38.2 34.8 30.1 36.0 35.4 44.2 40.4 33.1 38.6 31.0 47.6 52.8 71.9 90.2 87.0 17.3 55.3 81.5 258.3 58.0 97.7 0.0 169.8 240.4 92.4 31.9 66.8 75.0 46.7 102.0 216.8 70.6 105.2 46.1 76.7 107.9 20.6 88.4 52.8 65.3 11.4 67.0 75.2 62.4 109.2 92.2 30.6 113.3 105.2 82.7 223.0 23.2 84.1 62.8 57.6 58.2 107.1 116.0 69.0 110.7 99.5 DPYSL5 "CRAM, CRMP-5, CRMP5, Ulip6" ENSG00000157851 "Dihydropyrimidinase like 5" Q9BPU6 2 26847747-26950351 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 47.1" "Group enriched" "Detected in some" 4 "Cone photoreceptor cells: 80.5;Early spermatids: 30.8;Late spermatids: 97.8" "Group enriched" "Detected in some" 15 "glioma: 17.7;testis cancer: 8.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 41.9;HAP1: 34.9;SCLC-21H: 50.0;SH-SY5Y: 29.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034544, HPA072387" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034544: AB_10671228, HPA072387: AB_2686516" "unprognostic (1.07e-4)" "unprognostic (1.10e-1)" "unprognostic (1.08e-1)" "unprognostic (3.64e-6)" "unprognostic (3.94e-1)" "unprognostic (6.21e-2)" "unprognostic (6.12e-2)" "unprognostic (2.66e-1)" "unprognostic (1.54e-1)" "unprognostic (3.54e-2)" "unprognostic (1.35e-1)" "unprognostic (1.77e-2)" "unprognostic (5.67e-3)" "unprognostic (3.62e-2)" "unprognostic (1.08e-1)" "unprognostic (2.43e-1)" 1.2 4.7 6.1 1.6 18.4 1.1 1.1 7.8 36.6 1.4 1.6 43.5 0.0 1.7 1.2 1.1 1.3 1.2 1.1 1.1 10.3 11.3 1.2 1.1 1.1 1.1 24.3 8.8 1.1 1.1 1.1 2.8 1.2 21.9 1.3 1.5 1.6 1.1 1.1 1.2 1.2 1.7 1.6 47.1 1.1 1.1 10.3 19.7 0.0 1.1 0.0 1.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 41.9 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.3 0.0 1.1 0.0 34.9 0.0 0.0 0.0 7.6 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.0 29.6 1.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.2 0.0 1.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 18.4 7.8 11.8 10.3 11.3 24.3 8.8 21.9 19.7 0.0 0.0 0.0 0.3 0.0 9.2 5.3 0.0 0.0 0.0 0.0 80.5 0.0 0.0 0.0 30.8 0.0 0.0 0.0 0.0 0.0 0.2 0.1 2.3 0.0 0.1 7.9 0.0 0.0 0.0 97.8 1.4 0.2 1.7 0.0 0.0 15.6 0.0 0.0 1.1 0.0 12.4 0.0 0.0 3.2 2.3 0.3 0.0 0.0 0.0 0.1 DR1 "NC2-BETA, NC2B, NCB2" ENSG00000117505 "Down-regulator of transcription 1" Q01658 1 93345888-93369498 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050785, HPA055308" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA050785: AB_2681237, HPA055308: AB_2682779" "unprognostic (1.46e-1)" "unprognostic (9.62e-2)" "prognostic favorable (4.79e-4)" "unprognostic (1.03e-2)" "unprognostic (2.08e-2)" "unprognostic (1.59e-1)" "prognostic unfavorable (9.95e-7)" "unprognostic (8.70e-2)" "unprognostic (6.71e-2)" "unprognostic (1.44e-2)" "prognostic unfavorable (9.11e-4)" "unprognostic (4.30e-2)" "prognostic unfavorable (7.23e-4)" "unprognostic (2.07e-1)" "unprognostic (2.29e-1)" "unprognostic (4.97e-1)" "unprognostic (1.60e-1)" 18.5 15.2 14.6 19.4 17.9 37.2 16.9 20.1 18.7 19.2 19.0 17.5 12.6 19.4 20.7 9.7 26.7 13.6 17.0 19.0 14.5 13.9 17.0 17.8 19.0 28.2 15.0 10.1 17.1 14.3 14.4 17.6 25.9 14.2 17.6 12.2 16.7 18.2 10.9 32.2 27.0 21.4 15.4 15.9 21.8 21.8 44.4 14.9 63.4 17.8 17.8 25.4 20.5 22.1 19.0 28.0 39.8 26.0 16.5 27.9 18.7 33.0 10.4 16.7 21.5 15.5 17.7 20.6 26.8 16.5 18.3 19.6 12.0 12.0 35.1 31.1 19.7 24.9 17.6 20.0 18.5 27.0 29.5 18.8 29.5 21.9 13.1 24.7 34.6 21.8 12.3 22.4 25.4 37.0 19.1 16.2 21.1 30.3 34.0 21.6 10.2 32.8 10.9 27.8 11.5 25.5 28.6 36.9 35.8 12.9 20.2 16.2 20.7 22.8 21.2 28.1 15.8 15.0 27.4 25.1 33.1 26.4 32.3 40.0 19.7 21.8 36.3 9.5 27.7 13.4 36.8 22.8 39.8 19.0 26.0 21.1 19.0 21.0 21.6 28.0 16.1 21.2 20.6 31.9 16.5 22.1 22.9 27.9 18.7 14.6 17.9 20.1 18.7 14.5 13.9 15.0 10.1 14.2 14.9 26.8 23.2 41.0 28.2 152.1 30.2 28.2 22.9 12.0 25.0 34.9 23.6 62.2 38.1 30.0 119.9 35.9 27.5 46.7 24.1 58.0 36.2 39.6 48.4 24.3 46.8 47.7 20.0 32.5 46.7 83.6 26.2 41.6 42.2 63.1 37.3 14.2 36.5 23.0 24.8 31.0 24.1 32.3 43.2 95.6 40.9 140.4 91.9 44.7 23.4 63.0 DRG2 ENSG00000108591 "Developmentally regulated GTP binding protein 2" P55039 17 18087886-18107971 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007716 Approved Supported Nucleoplasm,Vesicles,Cytosol No No "Vesicles, Cytosol" Nucleoplasm "HPA007716: AB_1078705" "unprognostic (7.47e-2)" "unprognostic (1.29e-1)" "unprognostic (4.78e-2)" "prognostic favorable (1.56e-4)" "unprognostic (1.26e-3)" "unprognostic (7.86e-2)" "unprognostic (8.85e-2)" "unprognostic (5.72e-2)" "unprognostic (8.49e-2)" "unprognostic (1.25e-1)" "unprognostic (2.88e-3)" "prognostic unfavorable (7.34e-4)" "unprognostic (3.10e-1)" "unprognostic (2.18e-1)" "unprognostic (1.49e-1)" "unprognostic (5.64e-2)" "unprognostic (1.10e-1)" 19.9 19.9 16.1 17.5 21.8 17.4 19.3 14.7 30.8 19.3 19.3 22.9 16.6 19.2 23.5 22.8 21.6 25.2 18.2 22.4 15.7 17.0 19.1 31.9 15.7 21.2 17.6 16.1 27.6 23.9 20.6 18.8 22.4 17.9 21.1 13.4 18.4 21.7 21.7 33.3 19.4 17.9 18.3 17.1 20.7 17.6 14.6 17.2 21.6 23.6 21.2 25.6 20.5 18.0 12.6 18.4 17.0 20.9 20.0 19.8 14.0 14.9 21.4 7.3 7.2 13.6 14.5 13.9 10.6 10.5 17.2 16.0 22.7 9.0 14.5 13.8 12.2 9.2 15.9 12.0 14.6 11.6 12.8 32.9 6.3 11.4 12.6 14.8 5.8 10.1 16.1 13.0 17.2 14.5 10.0 16.3 19.5 11.1 5.7 10.0 16.9 15.4 9.7 5.4 21.2 15.8 16.6 17.7 26.9 10.2 8.8 4.1 11.8 10.5 6.2 12.9 45.9 12.4 8.8 12.2 8.3 7.9 9.7 17.4 6.5 7.9 8.1 12.0 10.6 15.2 11.6 15.9 17.0 19.8 17.2 16.4 12.2 14.7 15.8 18.4 12.6 14.0 15.3 2.1 20.0 20.9 10.3 18.3 14.0 16.1 21.8 14.7 30.8 15.7 17.0 17.6 16.1 17.9 17.2 0.0 7.7 15.6 18.9 14.8 10.8 3.2 15.3 4.0 6.8 7.0 2.0 32.2 24.9 23.5 5.9 15.7 22.3 0.0 23.6 33.6 16.4 17.5 11.5 14.5 28.1 6.4 20.7 15.4 16.4 10.0 19.8 15.6 11.8 24.4 16.3 18.8 21.1 14.0 23.0 22.6 13.8 6.5 19.6 11.2 10.4 10.2 32.8 24.2 20.9 12.6 DRGX "DRG11, PRRXL1" ENSG00000165606 "Dorsal root ganglia homeobox" A6NNA5 10 49364181-49396016 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 8 "adrenal gland: 13.9;brain: 8.0" "Cell type enriched" "Detected in single" 4 "Melanocytes: 1.7" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in some" 5 "cerebral cortex: 3.3;midbrain: 2.0;pons and medulla: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 8.2;SH-SY5Y: 37.4;U-2197: 13.5" "Region enriched" "Detected in single" 6 "pons and medulla: 4.1" "Low region specificity" "Detected in all" HPA043978 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA043978: AB_10961154" "unprognostic (1.42e-2)" "unprognostic (5.68e-2)" "unprognostic (3.92e-2)" "unprognostic (1.23e-2)" "unprognostic (1.74e-3)" "unprognostic (1.58e-1)" "unprognostic (4.54e-2)" "unprognostic (3.74e-2)" "unprognostic (8.91e-2)" "unprognostic (1.60e-1)" "unprognostic (4.09e-2)" 0.2 13.9 0.0 0.4 0.2 0.3 0.1 0.4 3.3 0.0 0.4 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.5 0.1 2.0 0.6 0.0 0.0 0.0 0.9 0.0 4.8 0.0 0.9 0.0 0.0 0.0 0.0 1.3 0.3 0.0 8.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 37.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 13.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 3.3 0.2 0.3 2.0 0.6 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DRICH1 C22orf43 ENSG00000189269 "Aspartate rich 1" Q6PGQ1 22 23608452-23632321 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 68.5" "Group enriched" "Detected in some" 100 "Early spermatids: 369.6;Late spermatids: 442.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "gdT-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in many" 5 "CACO-2: 15.6" HPA020446 Approved Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA020446: AB_1853151" "unprognostic (7.48e-3)" "unprognostic (3.91e-2)" "unprognostic (2.02e-2)" "unprognostic (6.22e-4)" "unprognostic (6.46e-2)" "unprognostic (8.35e-4)" "unprognostic (2.74e-1)" "unprognostic (2.24e-1)" "unprognostic (1.06e-2)" "unprognostic (2.65e-2)" "unprognostic (5.73e-4)" "unprognostic (3.05e-1)" "unprognostic (1.92e-1)" "unprognostic (8.65e-2)" "unprognostic (8.68e-3)" "unprognostic (7.70e-4)" "unprognostic (1.08e-3)" 0.5 0.5 0.5 0.5 0.5 1.3 0.8 1.0 0.5 0.5 0.5 0.5 0.5 0.1 1.3 9.7 0.5 0.6 0.5 0.5 0.5 0.3 1.2 0.5 0.5 0.7 0.5 0.5 1.3 0.9 8.3 0.8 0.5 0.5 0.7 0.2 0.5 0.5 0.6 0.5 1.3 0.6 0.5 0.5 0.8 0.4 68.5 0.5 0.5 1.0 0.5 0.5 0.5 0.5 0.0 0.0 0.4 0.6 0.0 1.0 0.0 0.7 0.9 2.2 0.6 2.7 0.6 2.0 0.0 0.0 0.1 0.1 15.6 0.6 1.0 0.1 0.6 0.5 1.5 3.0 0.1 0.4 0.2 1.5 0.5 1.2 0.7 1.0 0.4 2.4 1.2 1.3 0.5 0.0 0.9 0.4 0.4 1.2 0.3 0.2 0.8 0.3 0.7 0.2 0.7 0.8 1.6 0.1 0.0 0.4 1.7 1.0 0.7 0.0 1.3 1.1 0.5 0.3 0.1 0.4 0.0 2.8 2.5 0.2 1.0 1.4 0.1 2.6 0.6 0.2 0.0 0.3 0.0 1.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.3 0.0 0.0 0.0 0.5 0.5 1.0 0.5 0.5 0.3 0.5 0.5 0.5 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 369.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 442.6 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.4 0.3 0.0 0.0 0.0 4.1 1.5 0.0 0.1 0.0 0.0 0.0 DROSHA "Etohi2, HSA242976, RN3, RNASE3L, RNASEN" ENSG00000113360 "Drosha ribonuclease III" Q9NRR4 5 31400497-31532196 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ribosome biogenesis, RNA-mediated gene silencing" "Endonuclease, Hydrolase, Nuclease, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031150 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA031150: AB_2673761" "unprognostic (8.37e-3)" "unprognostic (1.81e-1)" "unprognostic (9.56e-2)" "prognostic unfavorable (6.79e-4)" "unprognostic (5.40e-2)" "unprognostic (6.03e-2)" "prognostic unfavorable (1.39e-4)" "unprognostic (3.11e-1)" "unprognostic (4.08e-2)" "unprognostic (9.08e-2)" "unprognostic (1.86e-1)" "unprognostic (5.43e-2)" "unprognostic (1.12e-1)" "unprognostic (1.74e-1)" "unprognostic (2.39e-1)" "unprognostic (6.94e-2)" "unprognostic (2.32e-2)" 15.7 16.8 18.4 17.7 32.1 12.2 16.1 33.7 33.7 17.4 16.3 19.1 12.2 15.9 22.3 25.8 16.0 18.2 14.1 15.2 16.6 15.1 15.3 11.7 13.9 17.8 13.6 16.4 26.7 17.8 23.9 38.9 17.0 18.9 17.2 19.2 23.7 17.5 19.2 23.6 16.0 17.5 16.9 19.4 16.8 16.0 12.8 16.4 25.6 21.9 13.4 19.8 18.2 16.2 4.7 6.4 3.3 4.8 4.8 6.4 3.1 12.4 15.7 17.4 23.6 9.3 11.4 25.1 16.5 8.1 15.4 11.5 16.5 16.2 14.0 19.0 12.1 17.9 10.9 21.4 12.5 17.2 13.1 15.1 17.2 51.6 11.9 8.4 19.2 51.4 8.9 8.8 17.2 8.3 11.8 13.1 15.0 21.8 6.6 13.4 12.4 18.5 14.4 16.4 10.1 12.6 16.8 33.3 10.1 8.7 14.2 9.1 12.0 41.9 17.2 10.1 16.2 15.8 11.1 11.4 14.9 17.3 13.3 15.6 12.1 19.8 15.4 10.3 21.7 14.2 1.8 2.4 3.3 5.2 2.6 5.5 4.2 5.4 6.0 5.2 4.7 6.4 4.4 0.8 4.8 4.8 6.4 5.1 3.1 18.4 32.1 33.7 33.7 16.6 15.1 13.6 16.4 18.9 16.4 11.9 14.7 3.0 4.6 3.2 18.2 21.0 7.6 20.1 15.9 5.2 0.0 6.6 3.3 7.2 2.5 6.2 7.3 0.0 7.0 6.4 7.4 5.0 9.2 5.1 6.7 6.4 10.9 9.2 7.8 4.3 10.0 3.2 1.7 9.0 10.1 10.5 7.8 8.6 12.4 4.2 16.8 6.5 4.7 5.8 8.4 3.0 4.1 5.7 10.0 5.1 DSCC1 "DCC1, hDCC1, MGC5528" ENSG00000136982 "DNA replication and sister chromatid cohesion 1" Q9BVC3 8 119833976-119856010 "Predicted intracellular proteins" "Cell cycle, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 34.2" "Cell type enhanced" "Detected in many" 12 "Extravillous trophoblasts: 15.8;Spermatogonia: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA023780, HPA024401" Uncertain Approved Nucleoplasm NA Yes Nucleoplasm "HPA023780: AB_2671311, HPA024401: AB_2671557" "unprognostic (7.36e-3)" "unprognostic (8.24e-2)" "unprognostic (1.56e-1)" "unprognostic (4.71e-3)" "unprognostic (9.91e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (3.92e-6)" "prognostic unfavorable (3.93e-4)" "prognostic unfavorable (5.73e-4)" "unprognostic (3.24e-3)" "unprognostic (8.12e-3)" "unprognostic (2.72e-2)" "unprognostic (2.32e-9)" "unprognostic (2.75e-2)" "unprognostic (5.01e-1)" "unprognostic (4.40e-2)" "unprognostic (8.18e-2)" 4.3 4.7 3.6 8.5 3.9 9.2 5.4 9.4 5.0 5.1 4.6 3.3 3.5 4.1 6.2 2.4 5.8 3.0 4.7 3.4 3.9 2.6 2.1 2.5 3.3 11.5 4.0 2.0 4.1 7.0 1.3 1.6 4.0 5.3 4.1 6.4 2.1 11.4 4.3 3.9 4.5 4.0 4.9 4.2 4.1 4.0 4.8 5.1 34.2 2.4 5.7 9.5 3.4 5.1 1.4 0.8 0.2 0.2 2.4 3.3 0.9 11.9 5.9 11.7 10.6 1.7 3.1 5.0 8.2 1.7 5.9 6.2 5.3 7.3 21.6 7.2 2.4 3.7 8.8 13.2 5.1 6.4 14.6 11.9 27.5 6.0 6.2 0.5 10.7 9.7 1.4 0.8 7.3 3.5 1.4 1.7 14.5 9.3 9.7 7.1 11.7 28.2 6.7 17.1 31.7 14.6 10.1 11.1 10.3 4.6 7.5 10.5 6.4 4.4 35.1 5.5 9.5 6.5 5.9 1.1 6.5 17.7 6.2 11.9 13.3 19.8 22.9 3.3 17.3 9.4 0.0 0.2 0.2 3.3 0.0 2.5 1.4 0.7 1.6 0.2 0.6 0.4 1.4 0.0 2.4 0.0 0.8 1.1 0.9 3.6 3.9 9.4 5.0 3.9 2.6 4.0 2.0 5.3 5.1 0.0 0.3 0.0 1.9 3.1 0.4 0.7 0.0 2.7 0.0 0.0 0.0 1.8 0.0 1.6 0.1 2.4 0.1 0.0 2.1 15.8 3.5 1.4 4.6 0.0 4.1 0.0 0.0 6.2 1.3 0.0 1.1 0.0 3.3 0.0 0.4 1.3 0.5 0.0 2.5 1.1 0.2 0.0 2.8 1.1 22.6 2.9 1.1 1.3 1.5 0.9 DSE "DS-Epi1, DSEPI, SART2" ENSG00000111817 "Dermatan sulfate epimerase" Q9UL01 6 116254173-116444860 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Isomerase "Disease mutation, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 85.3;Macrophages: 81.1;monocytes: 97.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 8.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA014764, HPA052151" Uncertain Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA014764: AB_1856587, HPA052151: AB_2681746" "unprognostic (1.28e-1)" "prognostic unfavorable (3.36e-4)" "unprognostic (1.38e-1)" "unprognostic (3.23e-3)" "unprognostic (1.21e-1)" "unprognostic (1.48e-2)" "unprognostic (6.76e-2)" "unprognostic (1.02e-2)" "unprognostic (7.81e-2)" "prognostic unfavorable (6.34e-4)" "unprognostic (5.11e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (1.50e-4)" "unprognostic (6.19e-3)" "unprognostic (2.54e-2)" "unprognostic (2.06e-1)" "unprognostic (1.10e-2)" 32.3 10.6 7.4 22.3 10.7 13.1 34.8 5.4 7.7 16.0 12.8 4.9 9.9 5.3 11.7 18.5 13.5 15.3 12.9 16.1 8.1 4.3 11.2 10.4 17.7 13.1 9.8 4.5 21.0 4.0 15.4 20.9 21.7 13.1 13.0 7.1 14.3 9.3 9.4 8.5 16.9 10.7 12.8 16.1 24.9 7.6 10.9 9.0 8.3 8.7 10.9 8.3 14.6 29.4 3.6 8.9 2.5 3.9 0.2 1.1 1.2 10.5 2.3 7.9 7.4 21.5 14.2 9.0 12.5 29.4 15.7 23.1 0.0 3.0 0.3 1.1 21.8 15.8 20.3 1.1 29.4 20.6 10.9 4.8 0.7 3.4 0.1 24.0 0.5 0.5 30.1 12.7 17.4 17.1 8.2 9.2 2.7 0.2 4.8 7.5 0.3 1.4 0.6 4.2 0.0 0.6 1.8 7.3 5.0 10.4 0.7 2.6 2.0 12.1 0.0 0.3 5.7 0.1 1.2 3.4 15.9 4.6 3.9 10.0 1.0 0.3 0.5 8.4 1.3 1.8 0.7 3.1 0.1 1.0 3.9 0.6 3.2 0.9 0.4 8.9 3.6 1.1 0.4 2.5 0.2 2.2 4.2 0.2 1.2 7.4 10.7 5.4 7.7 8.1 4.3 9.8 4.5 13.1 9.0 14.9 2.6 18.6 20.6 46.1 4.1 7.0 5.1 18.7 18.2 3.5 0.0 2.0 6.6 4.0 39.9 11.9 0.0 0.0 7.5 3.7 35.5 14.2 22.0 3.8 39.5 1.6 1.2 57.7 85.3 19.2 50.9 81.1 10.1 97.4 0.7 3.9 9.5 0.0 28.3 6.1 3.0 32.3 29.2 2.6 5.1 34.9 4.1 6.5 1.0 42.4 DSEL "C18orf4, DE-epi2, FLJ11477, NCAG1" ENSG00000171451 "Dermatan sulfate epimerase-like" Q8IZU8 18 67506582-67516980 "Predicted membrane proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 43.3;Extravillous trophoblasts: 69.4;Fibroblasts: 40.8" "Cancer enhanced" "Detected in many" "glioma: 6.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 3.2" "Lineage enriched" "Detected in single" 5 "T-cells: 3.2" "Cell line enhanced" "Detected in many" "BJ: 19.9;BJ hTERT+: 11.5;LHCN-M2: 24.9;U-138 MG: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060942 Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA060942: AB_2684392" "unprognostic (2.49e-1)" "unprognostic (5.00e-1)" "unprognostic (1.67e-1)" "unprognostic (1.19e-5)" "unprognostic (1.56e-1)" "unprognostic (2.71e-1)" "unprognostic (2.40e-3)" "unprognostic (7.11e-2)" "unprognostic (4.91e-1)" "unprognostic (2.83e-1)" "unprognostic (2.19e-2)" "unprognostic (2.47e-1)" "unprognostic (7.95e-3)" "unprognostic (3.25e-2)" "unprognostic (1.24e-1)" "unprognostic (9.70e-3)" "unprognostic (1.16e-4)" 10.2 3.4 8.8 3.2 15.5 1.6 9.4 7.9 12.8 10.9 4.5 15.7 2.5 2.2 5.7 4.0 3.1 7.1 8.3 5.1 8.6 8.4 9.0 7.1 6.0 1.9 13.2 4.5 7.6 3.6 3.6 1.3 11.5 9.7 4.8 3.5 2.4 2.3 4.9 1.9 3.2 2.7 7.4 11.1 4.5 3.1 3.4 10.9 0.0 2.8 1.1 1.6 3.6 8.4 0.2 0.1 0.6 0.1 0.3 3.2 0.3 0.0 0.0 2.4 0.0 4.7 7.0 0.3 19.9 11.5 5.1 2.2 0.0 0.0 0.0 0.0 10.1 1.3 0.1 0.4 0.9 4.9 0.0 0.0 0.0 2.2 0.0 4.0 0.0 0.0 7.0 1.3 3.1 7.4 1.9 1.0 0.0 0.0 0.2 24.9 0.0 0.0 0.0 0.3 0.0 2.1 0.2 5.3 0.0 2.3 0.0 0.9 1.1 1.8 0.0 0.0 1.1 0.0 0.0 1.7 25.9 0.8 1.8 2.2 0.1 0.0 0.0 5.4 0.0 2.2 0.6 0.1 0.2 0.2 0.0 1.7 0.1 0.8 1.2 0.0 0.2 0.5 3.2 0.5 0.3 0.1 0.1 0.2 0.3 8.8 15.5 7.9 9.9 8.6 8.4 13.2 4.5 9.7 10.9 6.0 14.4 2.0 8.0 10.3 9.4 14.3 43.3 0.0 2.3 10.4 3.9 2.4 0.0 7.9 1.1 11.3 0.5 0.0 2.0 69.4 40.8 6.6 4.6 12.9 2.2 3.2 6.3 16.0 2.1 1.4 22.7 2.9 6.8 0.0 0.1 14.3 5.4 0.0 34.6 18.8 4.2 12.9 12.3 13.1 11.7 11.5 7.4 2.5 0.6 5.4 DSN1 "C20orf172, dJ469A13.2, hKNL-3, KNL3, MIS13" ENSG00000149636 "DSN1 homolog, MIS12 kinetochore complex component" Q9H410 20 36751791-36773818 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 90.5;Spermatogonia: 91.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002813, HPA030627" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Kinetochore,Cytosol" Yes Yes Nucleoplasm "Nucleoli fibrillar center, Nuclear bodies, Kinetochore, Cytosol" "HPA002813: AB_1078343, HPA030627: AB_2732460" "unprognostic (3.60e-2)" "prognostic favorable (4.49e-4)" "unprognostic (5.22e-3)" "unprognostic (1.13e-3)" "unprognostic (2.00e-1)" "unprognostic (4.64e-2)" "prognostic unfavorable (4.16e-5)" "unprognostic (3.93e-1)" "unprognostic (9.35e-2)" "unprognostic (5.51e-2)" "unprognostic (2.98e-2)" "unprognostic (7.66e-2)" "prognostic unfavorable (1.54e-5)" "unprognostic (6.92e-2)" "unprognostic (2.53e-1)" "unprognostic (2.58e-2)" "unprognostic (2.84e-1)" 6.7 10.4 5.6 15.6 7.4 11.6 8.2 5.4 7.2 5.1 8.6 4.1 9.5 6.3 9.5 12.0 9.1 5.0 8.1 6.2 5.1 4.7 5.8 8.6 6.1 11.0 4.8 3.9 5.3 5.4 3.6 7.6 12.9 5.1 6.5 10.3 10.1 9.7 8.1 4.6 7.3 8.8 5.9 4.1 11.6 7.0 27.2 4.1 21.2 6.3 11.4 13.8 5.8 5.5 10.9 25.4 21.7 5.9 5.6 6.5 3.7 13.0 11.8 13.9 11.1 5.5 7.2 9.2 16.0 13.6 24.6 27.7 20.5 17.0 15.1 10.7 8.7 27.2 17.2 13.0 12.6 23.5 6.6 8.3 29.4 11.3 13.7 1.2 16.8 13.0 2.7 3.6 17.0 5.4 4.0 12.0 16.4 11.4 12.5 16.1 9.3 21.5 13.0 6.5 23.6 20.9 16.9 42.4 10.0 6.2 7.8 14.3 6.5 19.9 20.5 9.7 10.8 20.9 11.3 6.2 22.5 13.7 22.0 17.2 10.5 14.1 17.1 18.9 15.2 16.0 21.7 3.6 7.5 4.4 5.9 4.9 8.8 4.8 5.8 3.9 10.9 5.9 5.5 6.5 5.6 5.0 25.4 6.5 3.7 5.6 7.4 5.4 7.2 5.1 4.7 4.8 3.9 5.1 4.1 6.0 4.1 9.3 10.2 4.4 8.0 4.1 2.5 10.7 10.3 5.2 27.5 42.7 6.6 5.2 6.3 5.8 6.4 0.0 5.6 29.3 7.5 7.5 3.5 4.5 12.6 6.4 2.4 9.8 3.7 5.8 8.1 6.1 1.7 8.2 9.0 4.8 4.7 5.7 7.1 2.9 15.8 0.0 7.2 90.5 91.3 6.4 39.7 6.4 10.5 10.8 DST "BP240, BPA, BPAG1, CATX-15, FLJ13425, FLJ21489, FLJ30627, FLJ32235, KIAA0728, MACF2" ENSG00000151914 Dystonin Q03001 6 56457987-56954628 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Actin-binding, Muscle protein" "Cancer-related genes, Epidermolysis bullosa, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 10 "Basal glandular cells: 1024.4;Basal keratinocytes: 2104.0;Cone photoreceptor cells: 1319.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 5.3" "Group enriched" "Detected in many" 5 "dendritic cells: 5.3;monocytes: 1.7;NK-cells: 2.1" "Cell line enhanced" "Detected in many" "hTCEpi: 94.5;hTERT-HME1: 70.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030200 Uncertain Approved Nucleoplasm,Microtubules,Cytosol NA NA "Nucleoplasm, Microtubules" Cytosol "HPA030200: AB_10601901" "unprognostic (4.87e-3)" "unprognostic (1.29e-1)" "unprognostic (3.40e-1)" "unprognostic (1.54e-1)" "unprognostic (1.25e-2)" "unprognostic (3.60e-2)" "unprognostic (5.78e-2)" "unprognostic (2.35e-2)" "unprognostic (1.09e-1)" "unprognostic (2.75e-2)" "unprognostic (1.13e-1)" "unprognostic (3.69e-1)" "unprognostic (4.39e-2)" "unprognostic (5.13e-3)" "unprognostic (1.46e-1)" "unprognostic (2.66e-1)" "unprognostic (7.62e-2)" 26.5 29.2 43.4 11.7 57.1 2.5 59.2 43.6 52.4 53.8 31.5 32.1 11.5 15.1 53.6 21.7 37.1 19.4 16.8 28.1 41.2 36.2 18.0 26.6 29.4 5.4 56.5 28.9 30.3 14.0 32.1 28.2 15.1 53.9 22.6 17.4 8.4 23.6 25.3 57.5 81.8 16.9 53.6 54.9 12.8 14.8 11.7 66.5 6.1 7.6 33.6 7.7 19.7 23.7 0.6 5.3 0.3 1.7 2.1 0.4 0.3 12.2 5.9 7.9 4.4 13.1 20.7 4.5 16.5 15.8 6.8 7.6 3.4 3.2 1.9 6.8 37.2 6.8 8.6 6.7 29.0 13.5 11.6 9.9 3.4 10.6 6.2 11.8 3.3 0.0 9.1 94.5 16.6 70.1 11.9 12.9 1.9 2.8 8.1 17.7 3.4 1.0 1.3 6.0 6.8 4.3 0.0 6.1 2.8 20.6 15.8 10.5 7.9 7.0 2.4 11.2 14.1 3.7 5.3 34.5 15.1 12.7 7.2 13.6 9.1 6.4 1.0 10.7 1.8 7.2 0.3 1.7 0.0 0.3 1.3 0.1 0.2 0.4 0.0 3.2 0.6 0.1 0.2 0.1 2.1 1.0 5.3 0.0 0.3 43.4 57.1 43.6 52.4 41.2 36.2 56.5 28.9 53.9 66.5 312.7 10.2 2.2 1024.4 2104.0 540.0 729.3 79.0 49.5 257.0 52.4 1319.4 36.7 6.6 171.1 26.9 93.9 163.1 23.3 56.2 11.1 132.5 139.6 16.2 67.6 21.5 290.8 43.1 50.3 48.7 7.9 123.4 67.7 204.1 62.3 71.1 216.1 150.7 84.2 143.2 6.7 103.8 64.7 142.4 7.1 9.1 749.3 22.2 6.1 19.2 121.2 DTL "CDT2, DCAF2, L2DTL, RAMP" ENSG00000143476 "Denticleless E3 ubiquitin protein ligase homolog" Q9NZJ0 1 212035553-212107400 "Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA replication, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 10.8;lymphoid tissue: 41.2;testis: 37.2" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 17.8;Erythroid cells: 23.3;Extravillous trophoblasts: 13.2;Spermatocytes: 35.9;Spermatogonia: 19.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory CD8 T-cell: 1.5;T-reg: 5.2" "Lineage enriched" "Detected in single" 7 "T-cells: 5.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA028016, HPA032023, HPA032031" Uncertain Supported Nucleoplasm,Nucleoli,Cytosol Yes Yes Nucleoplasm "Nucleoli, Cytosol" "HPA028016: AB_10611958, HPA032023: AB_2674114, HPA032031: AB_2674119" "unprognostic (7.61e-2)" "unprognostic (1.01e-3)" "unprognostic (2.14e-2)" "unprognostic (3.05e-2)" "unprognostic (2.19e-1)" "unprognostic (5.31e-2)" "prognostic unfavorable (4.41e-5)" "unprognostic (8.96e-3)" "unprognostic (2.45e-3)" "unprognostic (8.83e-3)" "unprognostic (2.52e-3)" "unprognostic (2.83e-2)" "prognostic unfavorable (1.71e-9)" "unprognostic (5.93e-2)" "unprognostic (2.01e-1)" "unprognostic (1.96e-2)" "unprognostic (2.82e-1)" 1.3 0.7 0.4 5.4 0.6 10.8 1.3 0.4 0.5 1.2 2.8 0.3 0.1 1.7 1.0 0.6 4.0 0.4 1.5 0.6 0.4 0.4 0.8 1.0 1.6 4.4 0.4 0.1 0.6 0.5 0.6 0.7 5.4 0.2 0.6 4.2 0.2 1.1 0.1 0.4 1.6 3.3 1.4 0.4 4.6 1.1 37.2 0.1 41.2 0.9 5.7 7.5 0.9 1.6 0.7 0.3 0.0 0.4 0.6 5.2 0.7 12.6 10.8 18.5 9.2 1.1 2.3 9.1 15.9 9.9 15.1 22.5 6.7 11.2 9.6 6.0 6.1 9.7 9.9 24.4 13.4 21.8 11.6 11.7 15.3 14.3 8.1 0.0 20.1 9.6 1.0 0.4 24.4 13.0 2.7 6.9 17.0 18.2 19.6 17.4 5.1 26.8 9.2 21.4 9.6 12.5 21.3 32.7 18.5 4.3 8.8 11.6 18.2 15.1 14.5 6.5 19.7 12.4 9.2 3.7 15.1 11.3 15.6 17.9 7.2 11.2 22.2 7.6 13.3 14.6 0.0 0.0 0.0 0.6 0.4 0.0 0.7 0.8 1.5 0.3 0.1 0.0 0.3 0.0 0.6 0.0 0.0 5.2 0.7 0.4 0.6 0.4 0.5 0.4 0.4 0.4 0.1 0.2 0.1 0.0 0.0 7.8 0.4 2.1 0.0 6.1 2.5 0.0 1.2 0.0 0.0 7.5 0.0 0.2 17.8 1.8 0.5 23.3 0.0 13.2 1.2 0.2 0.0 0.0 3.9 0.0 0.0 1.3 0.3 7.9 1.1 1.0 0.0 0.0 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 35.9 19.1 1.5 1.3 1.9 2.9 0.0 DTNA "D18S892E, DRP3, DTN, DTN-1, DTN-2, DTN-3" ENSG00000134769 "Dystrobrevin alpha" Q9Y4J8 18 34493290-34891844 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 106.3;heart muscle: 82.8;skeletal muscle: 90.2" "Cell type enhanced" "Detected in many" 18 "Cardiomyocytes: 121.0;Muller glia cells: 42.7" "Cancer enriched" "Detected in many" 9 "glioma: 28.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 7.0;T-cells: 6.7" "Cell line enhanced" "Detected in many" "MCF7: 17.7;NTERA-2: 19.8;SCLC-21H: 27.8;U-87 MG: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015196, HPA071177" Enhanced Approved "Nucleoplasm,Cell Junctions,Intermediate filaments" NA NA "Cell Junctions, Intermediate filaments" Nucleoplasm "CAB015196: AB_2261797, HPA071177: " "unprognostic (1.57e-1)" "unprognostic (4.57e-2)" "unprognostic (3.13e-3)" "unprognostic (7.82e-6)" "unprognostic (5.03e-1)" "unprognostic (2.43e-3)" "unprognostic (2.73e-1)" "unprognostic (7.42e-2)" "unprognostic (1.23e-1)" "unprognostic (6.27e-2)" "unprognostic (1.35e-4)" "unprognostic (6.89e-2)" "prognostic favorable (2.64e-7)" "unprognostic (6.08e-3)" "unprognostic (3.93e-2)" "unprognostic (1.12e-1)" "unprognostic (7.27e-5)" 9.3 5.3 51.5 4.0 47.6 1.6 7.3 37.7 69.1 4.5 5.4 38.7 0.9 3.4 4.3 13.9 13.9 7.6 7.1 82.8 42.3 46.5 2.7 2.5 4.8 2.3 44.7 21.0 5.4 12.3 1.4 6.1 3.6 51.0 14.6 5.6 3.4 5.7 15.9 90.2 1.8 3.9 15.2 106.3 3.9 3.6 4.7 39.5 0.0 9.3 6.5 2.4 12.8 1.7 1.4 7.0 0.4 1.3 1.0 6.7 1.7 0.3 0.1 7.6 0.0 4.9 13.6 1.2 2.0 7.4 0.3 0.9 1.7 0.0 0.0 4.5 0.8 7.0 0.6 0.9 3.9 0.7 0.0 5.3 0.0 0.4 3.5 3.9 0.1 0.1 10.3 0.8 6.4 2.2 7.3 3.3 0.0 1.1 1.0 2.1 17.7 0.1 0.0 19.8 0.3 4.0 0.0 3.7 12.1 0.3 0.1 27.8 3.2 0.0 0.7 2.0 12.5 10.9 2.6 0.1 8.8 4.8 0.1 2.7 0.6 0.9 0.4 28.4 0.0 3.8 0.4 1.3 0.0 1.4 0.0 1.9 1.4 2.7 1.9 7.0 1.1 2.8 2.0 0.1 1.0 0.0 0.2 6.7 1.7 51.5 47.6 37.7 35.7 42.3 46.5 44.7 21.0 51.0 39.5 0.0 1.4 0.0 0.0 1.3 10.2 121.0 22.9 4.0 1.2 0.0 5.9 0.0 5.0 9.9 3.1 0.7 0.0 0.0 21.8 0.1 2.8 0.9 0.0 0.0 7.1 1.6 0.0 0.0 4.1 1.9 5.5 8.8 5.0 0.0 0.0 42.7 12.5 0.0 0.4 1.5 4.2 12.9 22.8 0.5 1.5 0.9 0.0 0.0 0.0 0.1 DTWD1 "MDS009, MGC111207" ENSG00000104047 "DTW domain containing 1" Q8N5C7 15 49620980-49656232 "Predicted intracellular proteins" "tRNA processing" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042214 Uncertain Approved "Nucleoplasm,Nucleoli rim,Mitotic chromosome,Vesicles" Yes No "Nucleoli rim" "Nucleoplasm, Mitotic chromosome, Vesicles" "HPA042214: AB_2677903" "unprognostic (2.60e-2)" "unprognostic (1.73e-1)" "unprognostic (3.00e-1)" "unprognostic (3.70e-4)" "unprognostic (8.12e-2)" "unprognostic (2.37e-1)" "unprognostic (1.82e-1)" "unprognostic (9.87e-2)" "unprognostic (4.44e-3)" "unprognostic (4.25e-2)" "unprognostic (5.42e-2)" "unprognostic (1.48e-1)" "unprognostic (2.32e-3)" "unprognostic (1.02e-1)" "unprognostic (7.85e-2)" "unprognostic (2.80e-2)" "unprognostic (2.35e-1)" 19.1 12.6 15.7 11.3 27.5 4.2 17.5 16.7 16.0 24.5 20.1 10.9 9.4 6.9 25.2 15.8 11.7 17.0 19.9 12.0 11.5 9.3 10.3 9.9 11.6 10.4 12.9 12.2 21.6 28.5 8.7 22.1 11.2 11.9 19.2 11.2 11.6 18.0 14.2 10.7 10.8 8.9 22.4 11.7 9.4 15.6 8.2 13.1 12.1 15.5 11.8 8.7 21.5 17.2 8.6 21.6 5.4 11.9 11.1 11.5 5.2 4.5 5.3 9.8 5.2 19.6 38.2 7.8 13.1 13.2 17.6 13.0 1.7 3.7 7.2 9.9 16.4 8.1 8.2 6.9 6.9 17.1 4.8 4.9 6.2 10.8 6.4 13.1 8.1 5.4 18.4 9.3 10.9 13.4 15.6 7.2 8.9 11.5 7.7 18.4 9.1 5.4 6.6 6.1 10.1 7.2 7.8 20.2 28.2 5.7 3.2 8.8 6.6 16.0 5.5 12.3 10.6 5.4 11.8 4.7 20.8 8.3 11.7 14.7 6.1 9.3 4.3 18.3 23.2 12.9 5.4 8.6 4.2 6.5 9.8 8.9 8.6 9.6 10.4 10.8 8.6 11.5 10.6 2.1 11.1 11.9 21.6 7.5 5.2 15.7 27.5 16.7 16.0 11.5 9.3 12.9 12.2 11.9 13.1 17.9 12.9 19.8 15.0 17.1 43.1 13.9 17.8 45.5 19.4 33.2 29.5 19.7 26.6 17.7 7.3 16.6 5.6 0.0 18.1 23.0 40.2 17.4 6.9 13.2 17.8 17.5 14.9 23.9 19.3 10.4 35.1 18.5 15.1 4.6 15.4 18.8 20.0 10.5 26.5 15.4 41.6 6.5 46.7 42.3 43.9 16.7 8.1 15.2 18.7 11.1 DTX1 "hDx-1, RNF140" ENSG00000135144 "Deltex E3 ubiquitin ligase 1" Q86Y01 12 113056709-113098028 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 9.7;lymphoid tissue: 13.3" "Cell type enriched" "Detected in many" 15 "Horizontal cells: 162.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 2.3" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 12 "Daudi: 40.9;REH: 16.8;U-698: 41.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051249, HPA055275" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA051249: , HPA055275: AB_2682769" "unprognostic (2.13e-3)" "unprognostic (3.20e-3)" "unprognostic (4.24e-4)" "unprognostic (2.01e-1)" "unprognostic (7.48e-3)" "unprognostic (1.59e-3)" "unprognostic (2.49e-3)" "unprognostic (1.81e-1)" "unprognostic (9.55e-2)" "unprognostic (6.87e-2)" "unprognostic (2.19e-1)" "unprognostic (1.58e-1)" "prognostic unfavorable (3.02e-5)" "unprognostic (2.41e-2)" "unprognostic (4.70e-1)" "unprognostic (1.63e-1)" "unprognostic (4.78e-3)" 9.7 2.3 6.1 8.9 7.0 3.2 3.9 7.3 8.3 0.8 0.7 1.1 0.5 1.6 2.0 0.5 1.2 1.7 1.0 2.7 5.4 5.9 1.7 6.4 0.5 13.3 3.7 4.2 0.5 2.0 0.0 2.2 0.9 4.6 0.8 0.2 1.4 3.2 0.5 0.5 0.5 2.2 0.5 1.1 9.8 1.0 4.9 0.5 0.5 1.3 0.5 8.1 0.5 0.5 2.3 0.0 0.0 0.0 1.0 0.6 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.1 1.7 0.0 0.8 0.0 0.0 16.8 0.0 1.0 0.0 0.0 1.0 2.7 0.1 0.1 1.0 0.0 0.0 0.1 0.4 0.0 1.6 0.0 0.0 0.2 0.0 41.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.5 0.0 0.0 2.3 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.2 6.1 7.0 7.3 7.1 5.4 5.9 3.7 4.2 4.6 0.5 0.0 0.0 2.9 0.0 0.9 1.5 0.7 0.0 0.0 0.0 1.8 7.9 0.0 6.6 1.6 0.6 0.7 0.0 0.0 0.0 0.0 0.8 0.1 6.9 10.5 0.6 162.1 0.0 0.0 0.0 1.1 7.2 0.0 3.3 0.0 0.0 10.3 0.2 0.0 7.1 0.0 2.1 0.0 0.9 0.7 1.2 0.4 0.0 0.0 0.0 0.0 DTX2 "KIAA1528, RNF58" ENSG00000091073 "Deltex E3 ubiquitin ligase 2" Q86UW9 7 76461676-76505995 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 19.1;esophagus: 19.2" "Cell type enhanced" "Detected in many" 4 "Urothelial cells: 51.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 28.3;CAPAN-2: 46.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042931 Approved Supported "Nucleoplasm,Nuclear membrane" NA Yes "Nucleoplasm, Nuclear membrane" "HPA042931: AB_2678227" "unprognostic (1.72e-1)" "unprognostic (1.73e-1)" "unprognostic (1.62e-2)" "unprognostic (1.58e-2)" "prognostic unfavorable (8.47e-4)" "unprognostic (2.85e-2)" "unprognostic (1.28e-3)" "unprognostic (7.54e-2)" "unprognostic (4.76e-2)" "unprognostic (2.28e-2)" "unprognostic (2.10e-2)" "unprognostic (6.56e-2)" "prognostic unfavorable (1.13e-8)" "unprognostic (2.87e-2)" "unprognostic (1.53e-1)" "unprognostic (1.50e-1)" "unprognostic (1.19e-2)" 2.9 1.3 0.4 4.8 0.5 1.5 3.2 0.4 0.2 4.8 5.7 4.1 3.0 0.0 19.2 3.2 3.8 1.8 0.5 0.5 1.6 2.8 3.2 3.9 0.7 2.7 4.3 3.8 2.1 1.8 4.6 3.2 10.5 1.3 2.8 11.6 5.5 1.3 1.1 4.9 6.1 8.3 2.7 4.0 4.6 8.8 7.0 14.7 19.1 14.1 3.3 9.0 6.4 12.9 28.3 4.2 6.2 2.4 2.3 9.1 2.8 2.4 3.1 4.3 7.9 46.8 4.0 2.0 2.8 16.4 9.7 2.2 13.4 1.9 9.0 4.8 2.3 5.8 6.9 3.2 3.3 5.8 4.2 8.2 8.0 4.3 2.4 2.3 7.2 7.0 6.1 3.7 6.3 5.1 11.6 6.1 9.8 4.3 5.6 3.9 7.2 1.4 10.1 1.7 3.5 4.5 7.8 3.8 3.9 7.8 8.9 2.4 17.5 8.4 5.9 11.2 4.6 5.4 4.6 3.8 3.6 9.0 12.4 9.2 13.3 7.6 10.9 5.5 6.0 6.4 7.5 8.4 7.0 6.6 6.9 19.1 3.3 14.1 14.7 9.0 6.4 6.0 5.3 7.3 17.3 30.1 2.6 1.7 5.1 29.4 18.2 7.0 7.9 16.0 3.3 16.6 13.7 4.7 27.5 0.0 9.5 11.1 6.0 16.5 3.5 3.2 18.8 3.2 8.7 9.2 11.1 6.7 5.2 11.6 6.8 9.0 26.8 5.0 19.5 35.3 4.6 2.9 8.7 6.5 4.1 9.2 10.1 30.9 31.5 8.3 21.7 51.5 DTX3 "FLJ34766, RNF154" ENSG00000178498 "Deltex E3 ubiquitin ligase 3" Q8N9I9 12 57604622-57609804 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 66.7" "Cancer enhanced" "Detected in all" "glioma: 54.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "NK-cells: 2.0;T-cells: 5.5" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 31.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059654 Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" No No "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA059654: AB_2684097" "unprognostic (2.31e-2)" "unprognostic (8.80e-2)" "unprognostic (2.06e-2)" "unprognostic (3.68e-1)" "unprognostic (3.35e-1)" "unprognostic (2.58e-2)" "unprognostic (6.91e-2)" "prognostic favorable (9.87e-4)" "unprognostic (1.84e-1)" "unprognostic (4.26e-2)" "prognostic favorable (1.44e-4)" "unprognostic (8.62e-2)" "unprognostic (5.44e-3)" "unprognostic (7.99e-2)" "unprognostic (8.81e-2)" "unprognostic (9.51e-2)" "unprognostic (3.48e-2)" 7.2 18.8 22.7 9.0 35.2 3.5 9.4 47.8 53.6 17.6 22.8 23.7 11.0 6.7 29.7 30.6 9.7 31.8 14.1 20.5 23.8 19.8 11.4 2.4 12.2 11.0 18.3 28.4 36.3 12.0 23.9 32.7 16.0 22.5 21.1 10.1 20.4 13.2 29.5 10.9 7.9 9.4 28.7 16.9 11.2 11.2 7.8 21.6 6.8 16.8 5.1 8.8 11.8 13.5 0.3 0.6 0.0 0.0 2.0 5.5 1.8 3.1 8.2 24.4 0.0 0.0 0.0 0.1 5.0 12.9 11.0 11.2 4.2 13.2 4.4 7.6 10.8 0.1 5.1 0.0 0.6 7.8 11.0 1.5 2.5 12.6 4.4 18.8 0.0 0.0 9.3 6.1 8.4 0.1 31.5 12.3 0.0 0.0 15.0 8.4 6.8 13.4 0.1 19.2 2.5 0.7 0.0 20.3 0.2 1.0 8.2 17.7 28.1 3.9 1.1 2.4 6.1 14.1 6.7 0.0 14.4 5.8 6.6 7.1 24.6 18.4 0.0 9.2 0.0 7.5 0.0 0.0 0.0 5.5 0.0 1.3 0.3 2.1 2.5 0.2 0.3 1.9 3.5 0.0 2.0 0.0 0.6 4.2 1.8 22.7 35.2 47.8 53.6 23.8 19.8 18.3 28.4 22.5 21.6 14.9 14.1 2.2 9.6 5.6 45.2 9.4 5.1 32.1 15.9 12.2 47.1 0.3 11.6 7.6 1.0 4.5 0.0 0.0 1.7 0.2 9.3 8.6 5.7 0.8 0.6 66.7 15.0 14.1 1.6 1.6 31.7 0.5 3.3 1.0 1.1 25.9 3.3 0.0 29.7 2.9 41.2 45.3 29.3 3.5 4.1 2.5 1.0 10.1 0.3 2.5 DTX3L "BBAP, RNF143" ENSG00000163840 "Deltex E3 ubiquitin ligase 3L" Q8TDB6 3 122564238-122575203 "Enzymes, Predicted intracellular proteins" "Antiviral defense, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Protein transport, Transport, Ubl conjugation pathway" "Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 34.2;BJ hTERT+ SV40 Large T+ RasG12V: 42.4;GAMG: 32.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010570 Uncertain Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA010570: AB_1847877" "unprognostic (8.15e-2)" "unprognostic (7.36e-3)" "unprognostic (5.04e-2)" "unprognostic (3.74e-3)" "unprognostic (9.51e-2)" "unprognostic (9.22e-2)" "unprognostic (1.82e-1)" "unprognostic (1.11e-2)" "unprognostic (9.23e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (8.99e-4)" "unprognostic (2.76e-2)" "unprognostic (2.33e-2)" "unprognostic (7.77e-2)" "unprognostic (9.28e-2)" "unprognostic (3.33e-2)" "unprognostic (2.61e-2)" 32.3 13.0 5.9 22.7 8.4 8.1 11.2 2.0 6.8 14.2 18.5 5.9 6.0 14.8 14.0 12.8 17.9 12.0 15.1 21.5 5.0 5.1 17.3 39.2 21.3 18.3 6.4 3.3 21.7 18.5 10.3 13.9 22.2 6.5 20.9 12.1 7.6 13.9 9.8 14.6 6.2 31.8 10.8 9.7 35.2 12.4 4.9 6.9 24.8 23.9 8.0 18.3 17.0 22.1 6.4 6.5 21.9 13.6 7.8 10.2 6.7 11.1 3.4 1.0 2.9 4.6 10.6 3.8 2.9 10.7 34.2 42.4 3.3 11.4 1.2 5.7 4.7 32.9 11.2 3.4 4.6 7.5 9.4 1.3 9.7 2.6 3.5 9.0 4.9 7.6 9.1 5.5 5.1 2.9 6.5 6.4 6.2 1.2 6.9 2.5 3.4 12.0 3.5 0.6 3.4 6.3 13.4 7.8 2.1 8.7 7.2 1.4 1.5 6.0 2.7 21.6 0.7 3.1 6.3 7.9 3.9 5.5 0.3 3.7 2.5 1.4 5.9 6.8 6.5 4.0 12.5 8.5 8.7 9.3 13.6 10.2 5.9 7.8 10.0 6.5 6.4 7.1 7.6 21.9 7.8 13.5 0.7 7.4 6.7 5.9 8.4 2.0 6.8 5.0 5.1 6.4 3.3 6.5 6.9 29.8 25.5 10.7 7.5 7.9 0.2 4.4 20.4 16.0 15.9 7.0 0.0 3.1 0.0 21.6 1.5 16.6 25.5 0.0 27.9 13.8 9.6 16.0 15.1 50.5 24.2 0.0 17.7 24.5 34.9 0.6 7.8 19.5 5.0 20.8 21.5 5.0 28.4 11.5 8.5 11.1 0.2 32.3 6.6 0.9 0.7 5.3 1.5 13.4 16.9 18.6 DUS3L "DUS3, FLJ13896" ENSG00000141994 "Dihydrouridine synthase 3 like" Q96G46 19 5784832-5791238 "Predicted intracellular proteins" "tRNA processing" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA041854, HPA041944, HPA062846" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041854: AB_10794493, HPA041944: AB_10794163, HPA062846: AB_2684879" "unprognostic (1.25e-2)" "unprognostic (7.27e-2)" "unprognostic (1.75e-1)" "unprognostic (9.64e-3)" "unprognostic (6.08e-2)" "unprognostic (6.98e-3)" "unprognostic (1.25e-1)" "unprognostic (1.87e-1)" "unprognostic (4.19e-1)" "unprognostic (3.55e-2)" "unprognostic (7.35e-3)" "unprognostic (4.25e-3)" "unprognostic (7.73e-3)" "unprognostic (1.09e-1)" "unprognostic (1.10e-1)" "unprognostic (1.17e-1)" "unprognostic (2.89e-2)" 9.1 9.4 7.4 11.4 9.4 25.4 9.5 7.1 13.2 8.9 12.4 13.7 8.7 16.6 13.1 7.7 12.3 11.1 11.1 7.8 6.0 5.0 9.9 17.5 7.9 12.6 8.3 6.7 11.8 17.6 4.7 8.6 11.1 7.8 11.8 4.6 12.4 12.4 10.1 14.3 17.5 14.4 7.6 7.5 12.5 12.3 42.5 8.1 15.6 11.7 10.3 11.1 8.8 9.7 13.5 19.2 4.3 18.6 15.8 16.6 9.9 11.0 10.9 3.2 11.0 0.9 1.4 10.3 3.7 2.1 3.9 2.9 16.9 5.1 11.2 14.0 1.5 4.4 7.1 2.6 3.6 0.6 8.2 24.9 7.3 5.6 6.3 5.5 16.4 21.6 3.4 3.8 4.3 3.1 0.5 2.6 7.4 19.6 0.0 2.0 14.3 13.7 16.7 11.2 4.0 29.5 7.1 6.5 13.7 1.6 7.9 10.9 11.0 3.8 6.4 7.2 0.7 4.5 13.4 3.4 5.5 9.7 16.3 15.7 32.2 23.7 10.7 5.3 17.0 6.2 4.3 13.2 3.4 14.8 18.6 16.6 10.2 11.0 13.5 18.7 13.5 15.1 14.4 1.5 15.8 14.4 19.2 12.5 9.9 7.4 9.4 7.1 13.2 6.0 5.0 8.3 6.7 7.8 8.1 8.9 10.6 15.2 16.4 13.1 6.5 2.6 5.1 5.3 6.8 1.8 11.8 16.8 6.6 8.9 27.8 8.0 10.1 0.0 19.1 14.3 10.1 6.1 35.7 6.8 13.3 11.1 7.5 3.7 5.6 6.6 11.8 9.4 5.0 3.6 9.4 4.5 10.0 6.6 6.0 5.6 10.1 19.4 10.8 36.1 10.8 11.2 18.2 10.0 13.6 13.2 DUSP10 "MKP-5, MKP5" ENSG00000143507 "Dual specificity phosphatase 10" Q9Y6W6 1 221701424-221742176 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 35.4" "Cell type enhanced" "Detected in many" 9 "granulocytes: 135.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 15.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 19.2;HaCaT: 42.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016758 Approved Supported "Nucleoplasm,Golgi apparatus,Cytosol" No No Nucleoplasm "Golgi apparatus, Cytosol" "HPA016758: AB_1847880" "unprognostic (1.55e-1)" "unprognostic (2.73e-1)" "unprognostic (1.44e-1)" "unprognostic (6.65e-2)" "unprognostic (3.83e-2)" "unprognostic (2.85e-3)" "prognostic favorable (5.42e-4)" "unprognostic (2.89e-1)" "unprognostic (3.89e-2)" "unprognostic (9.68e-2)" "unprognostic (2.38e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (3.69e-4)" "unprognostic (4.18e-2)" "unprognostic (2.57e-1)" "unprognostic (8.88e-3)" "unprognostic (1.97e-2)" 7.4 4.7 6.0 7.1 11.2 23.2 8.2 5.9 11.1 5.7 10.8 21.1 0.3 2.1 4.9 2.7 7.0 8.5 7.6 3.8 7.2 4.0 2.8 35.4 8.0 9.0 14.0 5.6 2.8 18.3 1.8 2.5 4.5 8.4 3.6 4.9 8.5 9.5 1.7 21.0 8.0 6.2 9.7 10.1 6.4 4.5 3.9 14.1 5.6 5.3 10.6 8.6 8.5 4.1 0.8 5.4 4.6 4.2 15.1 12.7 1.6 6.1 2.6 0.2 0.2 19.2 9.9 0.2 4.1 10.8 6.9 5.3 0.1 1.7 4.8 1.4 10.7 5.0 42.3 0.9 4.0 6.0 12.3 0.5 8.2 1.2 0.7 4.5 3.6 5.6 13.8 2.9 7.4 7.5 3.2 0.2 1.2 0.8 1.7 6.5 0.1 0.7 2.8 0.6 1.3 0.3 0.4 11.7 0.3 2.3 3.7 15.8 1.2 0.5 0.5 17.5 2.5 0.9 2.1 1.5 3.5 0.9 5.3 5.1 2.9 2.0 2.6 5.4 1.6 3.6 4.6 4.2 0.2 3.6 3.7 3.3 0.7 2.5 2.5 5.4 0.8 0.8 1.5 0.3 15.1 1.4 0.2 12.7 1.6 6.0 11.2 5.9 11.1 7.2 4.0 14.0 5.6 8.4 14.1 0.0 1.7 1.9 12.6 45.2 4.5 3.3 10.2 8.1 6.8 3.5 19.6 2.2 0.0 27.3 29.1 6.3 1.0 0.0 7.8 2.7 8.3 10.9 135.7 50.4 22.0 1.6 42.1 1.8 11.0 2.7 23.0 23.9 21.9 13.6 9.9 13.5 21.9 0.0 12.0 0.7 32.3 0.0 5.1 3.8 2.0 36.1 2.9 29.9 2.2 14.4 DUSP11 PIR1 ENSG00000144048 "Dual specificity phosphatase 11" O75319 2 73762184-73780157 "Predicted intracellular proteins" "Hydrolase, Protein phosphatase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021052 Supported "Nucleoplasm,Nucleoli fibrillar center,Cytokinetic bridge" Yes Yes "Nucleoplasm, Nucleoli fibrillar center" "Cytokinetic bridge" "HPA021052: AB_2670577" "unprognostic (2.45e-3)" "unprognostic (1.06e-1)" "unprognostic (2.19e-2)" "unprognostic (7.87e-3)" "unprognostic (9.14e-2)" "unprognostic (5.28e-3)" "prognostic unfavorable (2.10e-7)" "unprognostic (7.20e-2)" "unprognostic (5.43e-2)" "unprognostic (5.85e-2)" "unprognostic (8.67e-3)" "unprognostic (3.84e-2)" "unprognostic (7.56e-3)" "unprognostic (1.41e-1)" "unprognostic (1.47e-1)" "unprognostic (1.47e-3)" "unprognostic (1.46e-1)" 19.6 16.1 15.1 15.1 17.9 29.5 21.4 31.8 21.5 23.1 16.8 16.4 16.2 16.3 29.9 19.8 38.7 37.4 15.2 15.2 17.2 13.9 19.3 16.5 17.2 21.5 12.7 15.8 26.4 14.9 11.6 28.2 19.1 14.0 18.2 16.8 16.5 22.3 20.3 16.2 27.9 19.7 18.9 13.4 21.5 15.4 19.7 13.8 28.7 16.8 16.2 29.3 20.4 27.3 29.9 20.9 42.6 19.1 28.0 37.6 29.2 19.4 8.4 9.1 9.6 16.5 20.7 16.3 14.3 18.7 18.6 19.1 12.1 14.8 25.3 9.2 15.4 16.7 13.6 11.2 28.8 18.0 17.4 11.7 15.5 6.4 18.5 17.3 17.4 14.6 16.7 35.0 16.6 23.1 16.2 20.6 12.4 16.4 14.9 20.6 10.8 16.7 18.6 14.6 18.3 11.7 6.7 24.5 22.7 15.0 16.2 13.5 7.3 13.2 15.8 16.8 11.4 8.4 9.3 11.7 13.3 16.4 15.2 16.8 15.9 12.6 33.4 12.3 17.7 12.9 24.7 19.1 42.6 26.8 16.9 34.6 29.9 31.7 31.6 20.9 28.1 33.9 31.8 29.1 28.0 16.9 15.9 37.6 29.2 15.1 17.9 31.8 21.5 17.2 13.9 12.7 15.8 14.0 13.8 8.9 11.8 34.3 47.9 73.8 9.4 6.9 33.1 26.8 22.7 12.2 3.9 27.8 43.1 24.2 5.9 29.2 13.5 23.3 24.2 35.1 26.6 23.0 41.4 12.9 27.5 4.8 11.5 29.4 22.3 5.6 26.7 20.5 21.9 42.3 19.0 9.3 22.5 17.8 24.1 38.5 13.9 6.5 22.8 23.6 31.8 72.5 32.3 32.4 17.2 54.2 DUSP12 "DUSP1, YVH1" ENSG00000081721 "Dual specificity phosphatase 12" Q9UNI6 1 161749758-161757238 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008840 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA008840: AB_1847884" "unprognostic (3.51e-2)" "unprognostic (2.62e-1)" "unprognostic (1.05e-1)" "unprognostic (2.01e-2)" "unprognostic (2.11e-1)" "unprognostic (4.04e-2)" "prognostic unfavorable (1.99e-5)" "unprognostic (1.86e-1)" "unprognostic (1.06e-2)" "unprognostic (2.25e-3)" "unprognostic (9.52e-2)" "unprognostic (2.42e-3)" "prognostic unfavorable (1.55e-7)" "unprognostic (1.17e-1)" "unprognostic (1.84e-1)" "unprognostic (3.25e-2)" "unprognostic (2.42e-1)" 15.6 12.1 15.0 16.0 17.2 37.8 21.2 27.2 20.3 14.0 14.2 13.9 16.6 11.7 19.5 14.0 12.7 15.6 12.1 11.9 12.6 12.7 14.0 11.4 14.1 18.5 18.6 13.1 18.4 16.7 10.7 18.7 16.4 14.7 13.6 16.0 15.2 13.8 15.1 8.6 12.6 14.4 16.5 12.0 17.4 13.8 8.2 19.4 11.1 15.9 9.4 18.4 14.4 14.1 16.0 17.8 18.7 15.4 23.1 19.4 10.6 18.2 17.3 18.9 12.7 10.1 11.0 17.9 14.6 19.1 22.6 17.5 24.5 16.1 11.1 15.3 17.7 14.2 13.2 14.7 17.9 22.0 14.5 13.0 9.9 15.7 15.9 21.4 21.1 9.9 14.8 19.7 19.6 35.3 12.8 15.7 15.6 17.6 12.2 16.2 17.0 12.3 24.0 30.2 19.4 25.1 18.1 18.5 18.2 12.7 22.5 12.1 25.7 12.4 20.8 24.2 21.7 18.1 24.4 10.9 19.5 18.2 15.2 31.1 20.6 17.0 26.5 12.1 21.4 19.2 18.7 13.9 10.2 16.1 15.4 19.4 15.5 18.1 15.3 17.8 16.0 17.5 19.1 5.5 23.1 9.2 8.2 15.3 10.6 15.0 17.2 27.2 20.3 12.6 12.7 18.6 13.1 14.7 19.4 17.9 10.9 26.6 12.4 12.0 14.1 4.4 7.6 4.0 12.5 7.0 7.9 18.4 18.3 17.8 3.2 19.6 5.3 0.0 21.0 18.7 16.5 15.2 17.4 6.6 17.6 9.5 10.9 16.5 25.1 0.5 8.1 14.3 10.1 19.0 9.7 11.1 16.9 5.8 16.6 14.6 15.6 0.0 20.0 10.6 12.0 11.4 14.8 20.1 11.8 10.7 DUSP14 "MKP-L, MKP6" ENSG00000276023 "Dual specificity phosphatase 14" O95147 17 37489831-37513501 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 152.9;Basal keratinocytes: 159.6;Cytotrophoblasts: 141.3" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 3.2" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.2" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 10.9;BJ hTERT+ SV40 Large T+ RasG12V: 12.7;HBF TERT88: 18.3;U-138 MG: 8.7;WM-115: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019911 Approved Approved Nucleoplasm,Cytosol NA NA 44000 "Nucleoplasm, Cytosol" "HPA019911: AB_1847888" "unprognostic (1.32e-1)" "unprognostic (3.06e-1)" "unprognostic (2.19e-2)" "unprognostic (1.57e-1)" "unprognostic (4.60e-1)" "unprognostic (3.22e-2)" "unprognostic (3.43e-3)" "unprognostic (2.02e-3)" "unprognostic (2.18e-1)" "unprognostic (2.59e-1)" "unprognostic (7.02e-3)" "unprognostic (3.81e-1)" "prognostic unfavorable (6.97e-9)" "unprognostic (7.93e-2)" "unprognostic (1.97e-1)" "unprognostic (1.73e-1)" "unprognostic (1.41e-3)" 4.7 3.7 3.3 2.1 6.6 1.1 3.9 1.8 8.0 3.3 1.0 1.5 0.1 0.7 2.7 1.2 7.2 11.7 5.1 2.6 2.3 2.1 6.5 2.4 1.0 1.9 2.5 3.0 2.9 1.7 3.3 11.6 2.6 1.4 1.4 1.6 2.8 1.1 1.7 8.4 0.9 3.5 2.7 1.7 1.0 3.5 0.8 2.3 8.3 6.1 4.3 1.9 1.0 0.5 0.0 3.2 0.0 0.4 0.4 0.5 1.7 0.1 0.4 0.8 0.0 0.5 1.5 8.2 6.2 10.9 12.7 0.9 1.9 0.1 0.7 5.9 0.1 1.4 0.1 4.8 18.3 0.1 0.6 0.0 1.1 2.0 0.8 0.4 1.3 4.8 2.9 3.8 2.0 0.6 0.2 0.2 0.4 0.0 8.0 0.3 0.8 0.2 0.2 0.0 0.0 0.7 0.5 0.2 2.7 0.7 1.3 0.1 0.4 0.7 1.2 3.2 0.6 1.0 0.8 8.7 2.0 0.1 4.1 0.0 0.2 0.1 0.0 0.0 10.5 0.0 0.0 0.9 0.4 0.0 0.2 0.5 0.1 0.0 0.0 0.2 0.3 0.2 3.2 0.4 0.0 0.0 0.0 0.5 6.0 4.8 5.9 152.9 159.6 6.2 14.2 5.1 52.2 26.1 7.0 7.9 141.3 24.9 33.6 35.0 22.7 0.0 0.0 13.2 71.8 47.7 52.8 87.4 10.2 17.0 14.3 2.4 14.7 2.8 40.7 12.7 10.4 59.1 43.3 1.0 9.0 46.1 1.1 5.6 11.8 18.7 0.0 52.6 28.9 29.2 80.9 56.8 6.4 0.8 72.6 DUSP16 "KIAA1700, MKP-7, MKP7" ENSG00000111266 "Dual specificity phosphatase 16" Q9BY84 12 12474210-12562383 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 56.3;Intestinal endocrine cells: 47.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 6.9" "Lineage enriched" "Detected in many" 5 "T-cells: 6.9" "Cell line enhanced" "Detected in many" "NTERA-2: 23.7;RT4: 21.6;SuSa: 19.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020326 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA020326: AB_1847890" "unprognostic (8.05e-2)" "unprognostic (9.47e-2)" "unprognostic (1.49e-3)" "unprognostic (4.14e-2)" "unprognostic (9.86e-2)" "prognostic favorable (1.01e-4)" "unprognostic (1.75e-2)" "unprognostic (3.52e-2)" "unprognostic (1.13e-2)" "unprognostic (2.11e-1)" "unprognostic (1.78e-1)" "unprognostic (2.82e-1)" "unprognostic (2.34e-3)" "unprognostic (6.35e-3)" "unprognostic (2.42e-1)" "unprognostic (1.46e-1)" "unprognostic (5.76e-2)" 6.4 32.8 6.3 14.8 7.5 3.4 12.5 16.4 7.1 8.8 13.1 6.7 9.5 13.6 11.0 9.1 9.5 6.8 12.3 5.8 6.7 5.4 6.6 34.2 17.0 13.2 8.0 3.6 8.5 13.9 11.6 31.4 21.3 7.7 13.9 11.7 9.2 17.4 9.5 8.3 7.9 20.1 5.7 9.1 12.2 9.9 8.6 9.2 40.7 10.8 6.8 16.7 10.9 13.4 0.1 0.2 1.4 0.1 0.1 6.9 0.5 2.7 4.0 5.1 2.7 1.8 2.3 8.5 1.6 3.7 4.1 5.9 11.9 5.2 0.2 0.9 1.8 7.2 1.8 9.0 1.5 5.8 8.7 4.5 0.4 4.3 13.3 3.8 0.8 1.8 1.8 4.5 3.3 10.7 4.6 3.1 4.6 2.3 7.3 0.3 5.9 1.0 0.6 23.7 7.1 1.3 1.2 1.7 4.9 2.5 21.6 7.8 7.4 6.5 8.7 4.3 19.7 3.3 1.5 2.8 1.8 5.4 1.1 1.9 5.2 6.0 0.9 2.5 1.8 2.5 0.0 0.0 0.0 1.1 0.1 4.6 0.1 3.2 1.5 0.2 0.1 1.1 0.7 1.4 0.1 0.0 0.0 6.9 0.5 6.3 7.5 16.4 7.1 6.7 5.4 8.0 3.6 7.7 9.2 26.8 56.3 2.9 13.7 2.5 4.2 11.2 17.8 16.0 14.8 3.5 2.0 8.1 0.0 11.0 1.1 6.3 28.9 0.0 21.0 2.7 4.1 30.4 23.1 28.4 4.4 6.4 47.6 6.7 8.3 2.0 5.5 2.6 5.0 4.6 7.1 37.1 19.9 17.6 6.3 4.1 4.8 0.0 3.1 1.6 5.8 1.6 25.2 13.4 16.1 12.8 DUSP18 DUSP20 ENSG00000167065 "Dual specificity phosphatase 18" Q8NEJ0 22 30652051-30667890 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 103.5;Late spermatids: 252.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034070, HPA051349" Uncertain Supported Nucleoplasm Yes No Nucleoplasm "CAB034070: AB_2094867, HPA051349: AB_2681450" "unprognostic (1.11e-1)" "unprognostic (2.34e-2)" "unprognostic (3.49e-3)" "unprognostic (4.88e-3)" "unprognostic (1.88e-1)" "unprognostic (9.12e-2)" "unprognostic (3.77e-4)" "unprognostic (1.83e-1)" "unprognostic (1.61e-1)" "unprognostic (3.53e-2)" "unprognostic (9.62e-2)" "unprognostic (4.87e-2)" "unprognostic (1.23e-3)" "unprognostic (6.55e-2)" "unprognostic (1.97e-1)" "unprognostic (4.56e-2)" "unprognostic (1.02e-1)" 5.2 3.9 10.1 7.1 9.7 4.9 5.3 4.1 8.3 5.6 10.1 11.4 4.6 7.8 6.1 8.4 7.5 18.5 8.0 3.8 8.7 7.8 5.5 2.3 9.9 7.2 8.4 3.9 4.4 6.6 5.2 19.5 3.6 9.5 4.6 11.5 4.7 6.1 4.3 2.0 7.9 11.0 6.4 9.0 6.9 8.3 30.8 10.2 8.0 5.8 3.4 7.6 6.0 6.1 6.4 11.2 21.7 13.9 4.3 8.1 4.7 5.3 5.8 2.6 6.5 6.6 13.1 2.5 5.1 5.9 5.2 5.6 3.1 5.7 3.5 3.6 6.4 6.6 4.0 1.6 4.1 5.8 10.0 6.4 1.8 2.0 2.0 2.8 7.5 5.9 3.7 5.8 8.6 3.1 5.8 15.9 4.3 1.8 3.2 5.6 4.6 4.1 1.8 1.0 6.6 3.5 3.0 1.7 1.3 6.3 3.7 6.7 3.8 5.3 2.1 3.7 3.6 4.7 2.1 11.4 10.7 5.8 2.7 2.9 2.3 2.7 1.8 12.1 1.3 5.4 18.3 10.4 19.4 5.9 12.5 4.6 6.4 6.8 5.4 11.2 6.2 4.6 5.5 21.7 4.3 13.9 6.4 8.1 4.7 10.1 9.7 4.1 8.3 8.7 7.8 8.4 3.9 9.5 10.2 17.9 4.8 6.0 10.2 19.1 2.6 1.9 7.6 64.3 11.4 5.2 43.2 1.0 3.3 7.4 103.5 9.0 14.8 0.0 8.2 3.0 9.3 7.5 6.9 0.9 7.3 1.6 34.1 9.8 12.7 252.1 7.8 16.2 8.5 6.4 18.0 9.2 7.0 14.0 6.3 3.0 16.3 6.5 7.2 68.7 18.8 18.6 0.8 8.6 18.5 6.4 DUSP19 "DUSP17, SKRP1" ENSG00000162999 "Dual specificity phosphatase 19" Q8WTR2 2 183078559-183100005 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 20.1;Early spermatids: 10.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021501 Approved Approved Nucleoplasm Yes No Nucleoplasm "HPA021501: AB_1847892" "unprognostic (1.24e-1)" "unprognostic (2.13e-2)" "unprognostic (1.21e-1)" "unprognostic (1.64e-1)" "unprognostic (5.18e-2)" "unprognostic (2.44e-1)" "unprognostic (1.21e-1)" "unprognostic (1.88e-1)" "unprognostic (8.30e-2)" "unprognostic (1.49e-2)" "unprognostic (3.33e-2)" "unprognostic (6.53e-2)" "unprognostic (5.80e-3)" "unprognostic (6.97e-2)" "unprognostic (2.91e-2)" "unprognostic (2.16e-2)" "unprognostic (2.75e-2)" 2.8 4.6 9.2 2.0 16.3 1.0 3.0 2.9 9.6 3.4 4.7 2.2 3.8 3.5 6.8 9.2 4.2 8.4 3.5 7.4 17.4 3.4 4.7 3.0 3.4 2.3 3.3 6.8 4.4 4.3 7.7 10.6 2.7 3.7 4.2 3.0 3.0 2.8 5.4 3.8 3.4 3.0 8.6 2.9 4.0 9.1 10.4 4.7 6.2 4.6 1.1 1.9 4.0 2.7 4.1 1.5 2.0 0.8 2.2 3.2 1.3 0.1 2.4 2.9 1.4 3.9 2.2 0.0 1.1 1.8 4.6 1.6 2.3 3.0 1.0 6.0 1.2 3.3 0.3 5.7 0.8 3.5 5.8 3.2 10.6 1.8 1.6 1.7 2.6 6.5 1.7 0.5 2.3 1.1 2.9 2.6 0.0 3.1 1.6 2.7 1.0 5.0 2.5 2.4 1.0 2.0 4.9 4.5 0.3 1.0 1.1 3.6 1.5 4.0 1.7 2.9 0.2 0.8 1.0 2.0 2.5 2.1 1.7 0.9 2.0 2.4 0.1 3.1 0.4 3.7 2.0 0.5 1.9 2.3 0.8 2.3 4.1 2.1 3.1 0.6 2.2 2.7 2.7 1.3 2.2 0.4 1.5 3.2 1.3 9.2 16.3 2.9 9.6 17.4 3.4 3.3 6.8 3.7 4.7 0.0 2.7 1.7 1.2 0.9 1.7 6.5 2.5 20.1 2.3 1.8 2.0 2.0 5.0 0.6 10.4 1.0 1.6 0.0 0.6 1.2 1.3 0.9 1.1 1.0 0.6 1.6 2.4 1.8 0.6 4.6 1.7 0.1 0.0 1.8 2.0 4.5 0.5 2.5 2.5 2.3 1.0 0.0 1.4 4.7 3.1 1.4 0.6 0.0 2.1 1.3 DUSP2 PAC-1 ENSG00000158050 "Dual specificity phosphatase 2" Q05923 2 96143166-96145440 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 151.1" "Cell type enhanced" "Detected in many" 12 "Melanocytes: 136.7;T-cells: 346.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "gdT-cell: 46.1" "Group enriched" "Detected in all" 10 "NK-cells: 29.6;T-cells: 46.1" "Cell line enhanced" "Detected in many" "Daudi: 15.3;HeLa: 13.9;JURKAT: 14.2;Karpas-707: 17.5;NB-4: 14.5;RT4: 17.4;SCLC-21H: 15.5;U-698: 21.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA071920 Supported "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "HPA071920: AB_2686472" "unprognostic (2.69e-3)" "unprognostic (6.70e-3)" "unprognostic (1.15e-1)" "unprognostic (5.46e-3)" "unprognostic (3.32e-2)" "unprognostic (8.54e-2)" "unprognostic (1.36e-1)" "unprognostic (1.15e-1)" "unprognostic (2.86e-1)" "unprognostic (3.66e-2)" "unprognostic (3.10e-1)" "unprognostic (6.30e-2)" "prognostic unfavorable (4.97e-5)" "unprognostic (1.82e-1)" "unprognostic (2.41e-1)" "unprognostic (3.94e-2)" "unprognostic (1.31e-3)" 6.4 3.1 2.0 13.1 4.3 51.3 2.9 1.3 4.3 4.8 3.9 1.9 7.9 0.8 4.3 18.3 4.1 3.0 8.8 7.4 3.0 1.4 5.5 3.4 15.9 19.0 1.8 0.8 3.0 1.7 0.4 14.6 0.6 2.0 10.7 1.1 2.8 2.0 151.1 1.8 9.8 4.7 3.7 1.6 16.4 2.1 3.3 0.7 43.4 2.4 2.6 12.2 24.6 14.1 3.9 2.3 1.4 2.2 29.6 46.1 7.5 1.5 0.0 0.1 0.1 0.2 0.3 2.3 1.9 0.0 2.8 2.7 4.4 0.3 15.3 5.6 2.1 0.0 1.1 3.8 0.0 0.5 0.2 0.0 0.3 13.9 0.0 1.0 6.3 1.3 0.5 1.0 0.4 0.0 0.0 0.0 14.2 0.0 17.5 0.1 2.6 12.5 14.5 3.4 0.4 5.4 0.0 0.2 12.1 0.1 17.4 15.5 0.8 0.7 0.2 2.8 0.0 1.0 7.2 0.0 0.0 4.1 0.0 0.9 1.2 1.8 21.0 0.0 6.9 0.1 0.5 0.9 0.2 46.1 2.2 22.6 3.9 11.4 41.4 2.3 2.6 7.8 23.9 1.4 29.6 1.8 0.6 3.4 7.5 2.0 4.3 1.3 4.3 3.0 1.4 1.8 0.8 2.0 0.7 0.0 10.6 47.7 90.1 86.0 22.1 33.5 2.5 0.0 1.2 8.7 21.6 0.8 1.7 0.9 0.7 8.2 3.3 0.0 1.2 1.1 24.2 63.5 105.8 2.8 75.6 0.0 84.2 8.6 27.5 0.7 1.7 90.7 136.7 0.0 12.3 1.3 0.9 2.9 1.8 1.0 2.5 0.0 35.3 0.5 4.3 95.9 1.4 346.4 21.8 28.5 DUSP22 "JKAP, JSP1, MKPX, VHX" ENSG00000112679 "Dual specificity phosphatase 22" Q9NRW4 6 291630-351355 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 71.9;U-266/70: 36.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031394 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA031394: AB_10604114" "unprognostic (7.34e-3)" "unprognostic (7.94e-3)" "unprognostic (1.37e-2)" "unprognostic (1.14e-1)" "unprognostic (3.46e-1)" "unprognostic (1.70e-2)" "unprognostic (9.08e-3)" "unprognostic (2.48e-1)" "unprognostic (9.06e-2)" "unprognostic (5.56e-3)" "unprognostic (3.10e-2)" "unprognostic (3.04e-1)" "unprognostic (1.77e-1)" "unprognostic (3.97e-2)" "unprognostic (3.07e-1)" "unprognostic (2.35e-1)" "unprognostic (1.09e-1)" 24.8 13.1 22.0 24.6 31.3 19.4 28.7 12.1 27.5 18.1 29.0 29.8 18.8 21.2 20.6 25.2 29.8 15.0 20.4 31.0 22.6 17.4 16.0 20.3 24.6 27.4 33.5 16.1 13.9 27.9 10.8 14.8 25.9 25.5 16.1 15.9 16.9 20.9 15.5 32.0 30.6 21.8 23.4 29.2 30.0 21.4 41.3 30.0 9.2 19.9 19.0 27.9 22.8 27.4 21.6 18.0 16.3 17.5 2.9 8.2 9.8 3.6 2.2 4.8 7.2 5.6 6.2 6.4 2.7 2.2 2.4 2.9 2.4 4.1 7.7 6.6 2.8 5.1 2.5 6.0 5.0 1.7 18.4 6.9 5.2 1.8 6.6 2.8 1.8 6.8 4.6 15.2 1.7 3.2 4.0 6.8 6.6 4.8 25.7 2.0 2.1 2.7 6.7 2.9 2.7 5.2 5.4 3.3 71.9 4.5 1.6 8.3 3.2 2.3 0.9 7.9 11.0 4.9 2.4 9.3 2.2 2.9 2.2 1.6 36.6 25.8 10.7 0.8 5.1 4.9 16.3 17.5 6.9 5.0 14.0 3.5 21.6 3.9 5.1 18.0 17.5 3.6 5.1 12.0 2.9 12.6 15.4 8.2 9.8 22.0 31.3 12.1 27.5 22.6 17.4 33.5 16.1 25.5 30.0 14.9 17.6 38.7 19.8 23.6 5.2 35.3 10.2 26.8 25.0 5.2 0.0 9.1 18.3 21.3 11.0 33.7 13.8 0.0 45.0 6.9 17.8 14.6 32.3 22.1 25.5 0.0 9.1 22.7 40.0 14.8 14.4 35.8 43.9 83.8 13.0 9.8 28.3 14.0 8.9 14.6 2.6 25.8 27.2 30.7 73.7 32.4 5.5 15.0 14.5 23.5 DUSP23 "DUSP25, FLJ20442" ENSG00000158716 "Dual specificity phosphatase 23" Q9BVJ7 1 159780932-159782543 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 88.0" "Cell type enhanced" "Detected in many" 8 "Exocrine glandular cells: 394.0;Proximal tubular cells: 620.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 46.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028211, HPA045792" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA028211: AB_2672522, HPA045792: AB_10961133" "unprognostic (1.52e-1)" "unprognostic (4.12e-1)" "unprognostic (1.40e-3)" "unprognostic (3.33e-2)" "unprognostic (4.36e-2)" "unprognostic (3.22e-1)" "prognostic unfavorable (3.06e-4)" "unprognostic (3.16e-1)" "unprognostic (4.62e-1)" "unprognostic (3.33e-3)" "unprognostic (4.72e-2)" "unprognostic (3.75e-2)" "prognostic unfavorable (2.59e-5)" "unprognostic (8.58e-2)" "unprognostic (2.84e-2)" "unprognostic (7.47e-2)" "unprognostic (1.39e-1)" 25.0 28.0 7.6 9.3 10.5 11.2 27.3 4.4 9.0 15.5 15.9 5.9 6.6 17.2 12.2 15.0 21.2 10.9 12.6 14.9 7.8 5.2 88.0 80.8 12.1 15.4 8.5 4.6 12.3 21.5 12.5 4.3 7.4 9.6 18.0 9.1 9.5 37.8 10.9 32.8 15.8 16.1 7.7 9.6 8.7 11.0 9.7 7.3 5.7 27.0 17.4 11.4 10.5 19.1 13.6 59.7 49.9 43.2 21.3 24.0 24.0 12.2 13.2 0.1 0.0 12.9 11.1 0.1 5.0 4.1 5.9 4.6 5.4 14.1 0.0 30.0 5.5 1.3 0.5 3.4 4.5 3.2 3.0 1.5 16.9 4.8 0.0 19.3 10.2 13.0 46.8 12.3 3.8 13.9 4.3 22.6 0.0 7.7 6.2 8.3 22.2 1.0 0.4 22.9 22.1 18.9 0.0 0.0 5.8 7.2 2.1 5.8 12.8 9.1 20.0 23.4 2.4 12.9 16.0 16.5 4.9 0.2 0.6 0.0 4.4 10.3 0.1 8.3 8.2 3.7 20.0 43.2 49.9 24.0 33.4 13.3 13.6 18.1 22.5 59.7 9.8 11.0 16.4 43.2 21.3 22.1 13.6 15.7 24.0 7.6 10.5 4.4 9.0 7.8 5.2 8.5 4.6 9.6 7.3 38.7 65.7 25.0 97.5 66.2 8.4 26.4 94.3 38.8 83.0 48.8 5.9 13.5 222.2 148.8 39.6 154.1 106.2 0.0 394.0 20.1 31.9 94.9 53.1 219.9 155.2 1.6 34.0 66.3 86.6 5.5 24.5 94.8 40.5 32.5 101.6 59.7 258.6 101.7 14.9 620.9 7.1 12.9 32.0 3.2 13.0 65.1 4.8 43.7 91.6 102.1 DUSP26 "DUSP24, MGC1136" ENSG00000133878 "Dual specificity phosphatase 26" Q9BV47 8 33591332-33600106 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 147.1" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 76.1;Cardiomyocytes: 54.3;Cone photoreceptor cells: 39.3;Rod photoreceptor cells: 58.5" "Cancer enhanced" "Detected in some" "glioma: 6.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.5" "Lineage enriched" "Detected in single" 16 "B-cells: 1.5" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018221 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA018221: AB_2669813" "unprognostic (2.77e-4)" "unprognostic (2.70e-2)" "unprognostic (2.70e-3)" "unprognostic (5.47e-3)" "unprognostic (2.01e-1)" "unprognostic (1.24e-1)" "unprognostic (1.62e-1)" "unprognostic (2.53e-2)" "unprognostic (2.81e-1)" "unprognostic (1.39e-1)" "unprognostic (4.10e-3)" "unprognostic (1.78e-2)" "unprognostic (2.28e-1)" "unprognostic (1.52e-2)" "unprognostic (1.14e-1)" "unprognostic (8.15e-2)" "unprognostic (5.80e-2)" 1.3 9.3 11.5 1.4 13.1 1.1 1.2 18.2 14.8 1.1 1.7 4.2 0.0 2.4 1.5 3.4 3.0 2.3 1.5 20.1 9.1 15.9 1.6 1.0 1.7 1.1 10.6 8.8 15.1 2.2 1.0 14.0 1.0 7.6 2.6 1.5 4.4 1.5 1.3 147.1 1.0 1.9 2.0 10.0 1.2 2.6 1.6 3.8 0.0 1.1 27.0 1.3 1.4 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 46.2 11.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 13.1 18.2 14.8 9.1 15.9 10.6 8.8 7.6 3.8 0.0 0.0 0.0 0.2 0.0 76.1 54.3 0.0 0.0 0.0 0.0 39.3 0.0 18.3 0.3 2.8 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 23.8 24.6 0.0 0.0 4.4 0.0 0.0 1.7 0.0 0.0 13.3 1.6 0.0 5.6 0.8 58.5 0.0 0.9 0.3 0.1 0.0 0.0 0.0 0.0 0.0 DUSP27 ENSG00000198842 "Dual specificity phosphatase 27, atypical" Q5VZP5 1 167094045-167129165 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 20 "heart muscle: 46.8;skeletal muscle: 64.8;tongue: 18.2" "Cell type enriched" "Detected in some" 10 "Cardiomyocytes: 131.1" "Group enriched" "Detected in many" 6 "colorectal cancer: 12.8;stomach cancer: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "RH-30: 18.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA012912 Approved Nucleoplasm NA NA Nucleoplasm "HPA012912: AB_2668767" "unprognostic (1.26e-2)" "unprognostic (1.74e-1)" "unprognostic (1.44e-3)" "unprognostic (1.22e-1)" "unprognostic (2.10e-3)" "unprognostic (4.65e-2)" "unprognostic (1.53e-1)" "unprognostic (8.19e-2)" "unprognostic (1.07e-2)" "unprognostic (1.48e-1)" "unprognostic (2.44e-2)" "unprognostic (1.15e-1)" "unprognostic (2.72e-1)" "unprognostic (7.65e-2)" "unprognostic (8.23e-2)" "unprognostic (3.39e-1)" 2.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.1 0.0 0.1 46.8 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.8 0.0 0.0 0.9 0.0 64.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.5 18.2 0.8 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 131.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 DUSP3 VHR ENSG00000108861 "Dual specificity phosphatase 3" P51452 17 43766121-43778988 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 106.9" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 242.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 8 "dendritic cells: 19.5;granulocytes: 5.2;monocytes: 17.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063616 Supported Nucleoplasm,Cytosol NA NA 1300000 Nucleoplasm Cytosol "HPA063616: AB_2685061" "unprognostic (1.52e-1)" "unprognostic (3.18e-2)" "unprognostic (1.10e-1)" "unprognostic (8.54e-2)" "unprognostic (1.04e-3)" "prognostic unfavorable (3.00e-4)" "unprognostic (4.83e-2)" "unprognostic (8.98e-2)" "unprognostic (5.13e-1)" "unprognostic (6.01e-2)" "unprognostic (1.78e-1)" "unprognostic (8.40e-3)" "prognostic favorable (5.49e-5)" "unprognostic (2.67e-3)" "unprognostic (5.45e-2)" "unprognostic (1.94e-1)" "unprognostic (1.37e-2)" 17.1 17.8 23.1 10.2 20.8 4.6 22.0 14.3 28.6 12.8 28.4 11.1 16.7 13.4 17.5 18.7 23.6 10.6 19.3 64.0 21.5 18.1 27.1 39.9 17.2 9.0 17.6 19.1 9.1 19.2 27.5 11.4 15.0 17.1 22.6 13.1 14.3 11.1 36.6 106.9 8.9 15.2 31.1 12.7 14.5 19.6 8.0 10.8 1.2 13.9 22.8 6.5 20.7 24.1 1.7 19.5 5.2 17.0 0.9 1.7 5.8 10.5 19.2 7.4 7.9 21.6 11.6 6.3 8.0 19.2 18.8 22.8 18.4 7.1 1.6 12.7 15.0 39.0 9.2 11.4 9.8 19.9 3.6 8.7 5.3 8.8 15.0 26.4 0.6 5.6 10.7 17.8 14.5 12.6 20.6 13.1 5.4 4.8 1.8 21.9 7.6 2.7 2.7 3.4 15.1 14.0 3.4 22.3 4.0 26.1 11.2 4.1 7.5 9.4 6.3 23.6 21.3 28.1 14.9 13.6 21.3 14.5 30.2 13.2 9.8 13.0 0.4 25.3 7.5 7.1 5.2 17.0 3.5 1.0 8.9 1.7 1.7 1.5 1.2 19.5 1.6 1.2 1.1 4.1 0.9 10.8 8.2 0.9 5.8 23.1 20.8 14.3 28.6 21.5 18.1 17.6 19.1 17.1 10.8 23.8 16.8 7.2 42.9 19.9 16.3 242.3 48.4 14.7 9.1 40.1 23.6 14.4 34.9 42.9 73.8 32.1 42.0 0.0 50.5 17.5 18.4 41.2 38.1 99.4 73.0 19.1 34.9 27.6 34.5 128.1 13.6 40.3 10.1 32.5 17.6 14.8 50.2 28.1 24.8 69.4 16.6 32.3 35.5 2.4 2.9 25.2 37.6 6.4 14.6 32.8 DUSP4 "HVH2, MKP-2, TYP" ENSG00000120875 "Dual specificity phosphatase 4" Q13115 8 29333064-29350668 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 46.7;pancreas: 78.6;seminal vesicle: 63.5" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 94.6;monocytes: 131.7;Pancreatic endocrine cells: 166.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "T-reg: 9.6" "Lineage enriched" "Detected in single" 18 "T-cells: 9.6" "Cell line enhanced" "Detected in many" "A549: 29.9;OE19: 27.1;SK-MEL-30: 46.1;WM-115: 37.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061967 Supported Nucleoplasm NA NA Nucleoplasm "HPA061967: AB_2684648" "unprognostic (1.92e-1)" "unprognostic (5.97e-3)" "unprognostic (3.24e-1)" "unprognostic (6.54e-2)" "unprognostic (2.18e-2)" "unprognostic (7.66e-3)" "unprognostic (7.30e-2)" "unprognostic (7.08e-2)" "unprognostic (1.83e-2)" "unprognostic (9.73e-3)" "unprognostic (9.60e-3)" "unprognostic (3.15e-2)" "prognostic unfavorable (4.19e-4)" "unprognostic (6.88e-2)" "unprognostic (1.62e-1)" "unprognostic (1.08e-2)" "unprognostic (6.07e-2)" 10.9 3.4 1.2 3.6 1.1 3.4 17.1 4.8 2.7 4.6 1.7 1.0 46.7 0.8 3.2 0.7 1.6 1.3 13.1 1.5 4.6 0.8 0.7 0.4 3.7 1.8 0.8 0.8 1.2 78.6 0.1 3.7 17.7 0.7 4.3 0.9 17.1 8.9 63.5 2.7 3.5 1.3 1.5 1.1 0.6 20.6 1.7 0.2 3.9 1.2 2.0 4.7 7.4 3.0 0.0 0.5 0.0 0.0 0.2 9.6 0.1 11.1 29.9 17.8 0.8 2.2 0.0 1.5 2.3 12.7 7.0 3.1 0.3 5.7 0.0 6.3 1.0 4.9 3.6 0.2 7.7 4.2 0.3 0.6 0.0 1.0 0.2 0.0 0.1 14.6 1.4 5.1 2.1 13.1 15.4 5.7 0.1 0.1 1.3 14.0 12.6 0.0 2.0 3.1 27.1 18.4 0.3 0.5 2.3 16.1 5.9 0.1 9.8 3.2 15.2 46.1 0.3 3.2 0.3 16.0 5.1 0.0 0.0 1.6 3.5 0.4 0.0 15.6 2.6 37.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 9.6 0.1 1.2 1.1 4.8 2.7 4.6 0.8 0.8 0.8 0.7 0.2 0.0 3.2 1.4 94.6 10.8 34.2 1.9 28.1 29.4 15.9 0.0 11.8 2.7 0.0 64.0 3.5 10.8 0.4 0.0 66.9 37.5 8.4 20.9 5.8 0.0 19.5 41.3 93.8 19.6 5.0 19.7 0.3 25.0 62.4 131.7 7.6 0.9 166.3 0.0 0.0 0.0 2.8 12.9 12.2 0.6 0.4 10.5 14.9 8.5 2.2 92.0 DUSP6 "MKP-3, PYST1" ENSG00000139318 "Dual specificity phosphatase 6" Q16828 12 89347232-89353271 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 125.0" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 270.1;granulocytes: 438.5;Kupffer cells: 216.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 125.0" "Group enriched" "Detected in many" 11 "granulocytes: 125.0;monocytes: 79.7" "Cell line enhanced" "Detected in many" "AN3-CA: 82.0;NB-4: 58.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017566, HPA053188, HPA064692" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB017566: AB_647991, HPA053188: , HPA064692: " "unprognostic (7.35e-2)" "unprognostic (1.50e-2)" "unprognostic (5.77e-2)" "prognostic favorable (7.21e-4)" "unprognostic (2.35e-3)" "unprognostic (2.10e-3)" "unprognostic (3.76e-2)" "unprognostic (1.42e-1)" "unprognostic (8.63e-2)" "unprognostic (1.67e-2)" "unprognostic (3.15e-3)" "unprognostic (2.09e-1)" "unprognostic (5.91e-3)" "unprognostic (1.28e-2)" "unprognostic (3.95e-2)" "unprognostic (1.86e-2)" "unprognostic (2.84e-1)" 37.7 7.5 7.2 15.9 11.7 41.3 24.1 3.4 14.7 11.6 12.4 6.2 5.8 6.1 9.8 8.7 12.0 15.4 25.1 16.2 10.5 6.5 17.1 38.4 28.2 13.3 6.9 7.4 7.5 12.2 15.0 13.7 19.7 7.9 17.4 15.3 44.4 64.3 6.3 12.0 8.5 14.6 11.3 7.1 28.4 10.3 4.8 6.4 6.1 21.0 13.3 17.8 15.2 6.9 1.2 9.2 125.0 79.7 1.2 0.9 32.4 1.1 1.1 24.4 82.0 21.1 18.0 0.0 8.8 11.2 1.8 1.3 7.2 1.3 0.0 2.1 3.7 3.4 9.4 0.1 22.0 2.5 0.1 0.1 3.6 0.2 11.4 15.0 15.7 40.2 3.5 7.7 15.5 14.5 18.4 40.7 0.4 0.0 3.8 5.6 0.5 0.5 58.8 14.8 28.0 20.0 40.0 3.0 1.5 25.2 23.7 0.4 17.4 0.2 0.1 46.7 8.7 1.2 8.8 10.9 6.0 0.1 1.1 4.2 0.6 3.2 0.1 24.9 11.1 38.0 125.0 49.5 22.4 0.9 79.7 0.4 0.2 0.2 0.3 9.2 1.2 0.1 0.3 22.5 1.2 74.4 1.2 0.6 32.4 7.2 11.7 3.4 14.7 10.5 6.5 6.9 7.4 7.9 6.4 95.3 270.1 20.5 66.1 80.7 1.2 8.1 53.5 22.7 111.5 171.0 31.4 63.9 14.9 10.9 1.1 97.2 31.9 0.0 11.9 2.9 29.6 20.6 438.5 128.2 43.3 1.6 18.4 173.1 216.2 1.4 1.4 140.4 11.8 1.8 11.0 9.0 12.3 7.4 3.2 23.5 2.0 25.8 8.5 1.2 1.1 21.7 41.2 18.5 12.8 23.4 DUT dUTPase ENSG00000128951 "Deoxyuridine triphosphatase" P33316 15 48331011-48343373 "Enzymes, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054422, HPA060360" Enhanced Supported Nucleoplasm No Yes Nucleoplasm "HPA054422: AB_2682483, HPA060360: AB_2684262" "unprognostic (1.82e-1)" "unprognostic (3.49e-2)" "unprognostic (7.89e-2)" "unprognostic (5.27e-2)" "unprognostic (2.20e-1)" "unprognostic (7.17e-2)" "unprognostic (1.65e-1)" "unprognostic (1.16e-2)" "unprognostic (4.42e-3)" "unprognostic (1.87e-2)" "unprognostic (4.25e-1)" "unprognostic (3.54e-2)" "unprognostic (3.68e-2)" "unprognostic (4.23e-2)" "unprognostic (1.47e-1)" "unprognostic (2.09e-2)" "unprognostic (1.71e-2)" 26.9 32.9 23.2 51.1 31.8 69.0 31.9 31.7 27.6 26.8 26.3 24.4 27.2 14.5 29.8 31.8 33.7 26.9 28.2 35.5 23.2 26.5 25.4 19.8 25.7 44.7 25.3 23.6 33.4 22.2 23.7 30.7 26.0 22.5 30.3 24.3 28.1 27.5 26.1 25.6 27.3 22.6 25.6 23.9 30.1 25.8 31.9 20.7 120.3 40.5 37.7 43.2 23.5 28.4 34.5 32.3 17.0 24.5 22.2 40.2 24.3 26.1 8.2 20.1 19.0 14.1 15.0 12.0 27.8 17.7 25.7 31.9 9.5 18.1 73.0 15.0 15.2 21.0 36.0 21.1 19.0 25.2 51.4 21.8 59.6 21.7 12.9 7.8 62.4 28.4 9.2 12.9 17.4 9.2 16.7 17.0 43.7 32.2 41.5 18.9 10.6 55.8 73.5 12.7 26.7 15.9 45.5 44.0 76.7 16.9 17.8 29.2 29.7 20.6 16.7 23.8 21.4 23.6 49.8 14.1 26.9 26.0 32.0 36.4 33.5 69.7 71.9 20.3 107.2 29.5 11.3 19.5 17.0 21.7 19.3 28.1 34.5 38.9 34.2 28.2 31.6 40.2 26.5 11.1 22.2 24.5 32.3 34.4 24.3 23.2 31.8 31.7 27.6 23.2 26.5 25.3 23.6 22.5 20.7 50.6 29.3 108.7 177.4 159.5 41.9 99.9 84.1 24.1 61.4 99.5 13.7 138.0 172.5 82.7 26.1 112.3 21.0 140.2 40.7 245.0 140.4 116.4 84.1 71.8 150.1 77.9 92.4 100.1 85.2 25.7 171.2 102.9 146.8 57.7 93.4 81.1 44.6 42.1 166.9 204.1 36.1 155.2 162.6 380.2 218.4 147.3 81.2 113.3 168.7 147.0 DUX4 ENSG00000260596 "Double homeobox 4" Q9UBX2 4 190173774-190185942 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 3.4" "Group enriched" "Detected in some" 21 "Early spermatids: 4.1;Late spermatids: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.5;U-2 OS: 3.7;U-266/70: 8.0;U-266/84: 10.4;U-698: 2.4" HPA058451 Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Nucleoli" "Golgi apparatus, Cytosol" "HPA058451: AB_2683722" 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.5 0.3 0.0 1.1 0.0 0.5 0.1 0.0 0.3 0.0 0.0 0.0 0.3 3.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 2.5 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.6 0.0 0.0 0.0 3.7 0.7 0.0 8.0 10.4 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DVL2 ENSG00000004975 "Dishevelled segment polarity protein 2" O14641 17 7225341-7234545 "Predicted intracellular proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009312, HPA021611, HPA022914, HPA064732" Approved Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "CAB009312: AB_639776, HPA021611: AB_2670776, HPA022914: AB_1847683, HPA064732: AB_2685338" "unprognostic (7.63e-3)" "unprognostic (6.84e-2)" "unprognostic (1.20e-1)" "unprognostic (1.60e-1)" "unprognostic (1.44e-1)" "unprognostic (2.39e-1)" "prognostic unfavorable (4.34e-6)" "unprognostic (5.66e-2)" "unprognostic (8.01e-2)" "unprognostic (8.97e-2)" "prognostic favorable (3.85e-4)" "unprognostic (8.90e-2)" "unprognostic (1.28e-1)" "unprognostic (3.23e-1)" "unprognostic (2.30e-1)" "unprognostic (2.80e-1)" "unprognostic (5.45e-2)" 14.6 16.7 16.9 11.0 24.6 12.5 14.2 22.3 16.2 20.2 15.7 20.0 12.3 12.6 24.3 12.3 22.6 18.0 15.3 12.8 14.5 8.2 13.2 7.8 12.2 14.8 16.7 12.3 30.6 12.7 15.7 26.3 14.9 12.5 18.9 8.6 18.9 14.4 19.3 11.9 21.2 12.9 18.2 10.9 12.7 11.4 14.5 17.0 24.6 16.1 9.5 16.3 16.7 19.7 11.7 7.8 11.6 5.4 7.2 12.1 6.9 13.1 19.2 23.1 23.0 17.7 16.0 10.0 9.2 16.8 22.3 28.6 16.3 11.2 18.8 14.0 10.2 17.4 19.0 19.1 12.4 8.5 18.5 22.0 12.2 20.4 17.1 31.1 6.8 10.6 24.0 21.4 21.1 11.5 15.6 9.2 22.0 10.3 8.9 13.3 12.3 25.9 6.8 7.9 8.8 7.4 38.2 15.0 11.4 12.2 11.7 10.2 20.8 16.7 8.4 20.1 11.0 12.1 9.5 7.6 12.6 11.4 23.5 17.0 13.9 11.6 8.6 14.7 10.3 19.5 11.6 4.7 10.7 12.1 5.4 10.1 10.4 8.3 10.7 5.6 11.7 9.9 10.1 2.1 7.2 5.1 7.8 5.0 6.9 16.9 24.6 22.3 16.2 14.5 8.2 16.7 12.3 12.5 17.0 8.9 8.9 5.7 20.2 15.5 14.9 5.6 7.6 5.3 9.1 17.4 23.6 17.9 5.0 9.3 0.7 9.0 9.3 0.0 9.0 13.9 17.8 13.7 14.9 4.3 12.2 9.5 12.7 7.4 8.2 1.5 24.2 7.4 10.1 12.6 13.0 12.8 6.9 10.5 20.8 4.2 30.2 12.9 11.3 18.9 30.6 16.8 30.6 10.0 20.8 12.0 DXO DOM3Z ENSG00000204348 "Decapping exoribonuclease" O77932 6 31969810-31972292 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 32.8" "Group enriched" "Detected in many" 5 "Early spermatids: 374.6;Late spermatids: 209.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046708 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA046708: AB_2679764" "unprognostic (4.56e-2)" "unprognostic (2.21e-1)" "unprognostic (1.80e-1)" "unprognostic (4.07e-3)" "unprognostic (1.93e-1)" "unprognostic (2.00e-3)" "unprognostic (3.43e-3)" "unprognostic (4.18e-3)" "unprognostic (3.10e-2)" "unprognostic (2.64e-3)" "prognostic favorable (5.87e-4)" "unprognostic (4.29e-2)" "prognostic unfavorable (4.77e-6)" "unprognostic (9.17e-2)" "unprognostic (7.24e-2)" "unprognostic (2.01e-1)" "unprognostic (2.23e-3)" 4.3 18.4 8.3 8.0 11.0 4.2 7.0 15.5 12.4 7.1 5.0 6.5 8.6 7.8 6.4 6.4 4.0 7.9 6.0 8.4 7.7 6.5 8.5 8.7 5.1 4.3 9.0 6.5 10.5 12.3 9.4 12.4 4.7 7.4 7.6 4.2 5.8 5.5 6.8 5.6 3.4 4.1 6.3 4.9 7.2 7.6 32.8 7.3 3.4 8.8 4.7 4.3 6.4 5.5 2.2 3.2 1.5 1.9 3.0 3.3 1.5 3.0 1.3 0.5 14.3 1.7 1.0 1.5 1.7 2.7 4.5 3.7 2.2 2.9 1.0 3.2 5.8 0.8 4.1 1.5 3.2 1.6 1.9 4.4 2.0 2.9 2.9 3.9 0.0 2.7 2.2 2.9 1.8 3.0 2.2 6.6 1.1 2.5 3.2 1.8 4.4 0.1 2.4 0.7 1.9 0.1 0.1 2.0 1.8 5.3 0.8 7.4 5.6 3.3 1.4 3.7 0.5 0.0 4.5 0.9 0.8 4.9 2.8 3.7 1.9 3.4 2.4 2.6 4.6 2.2 0.0 1.0 1.5 1.1 1.9 3.3 1.4 1.4 1.8 3.2 2.2 1.3 1.6 0.6 3.0 1.2 1.2 0.6 1.5 8.3 11.0 15.5 9.4 7.7 6.5 9.0 6.5 7.4 7.3 6.0 11.1 11.2 13.5 7.6 12.9 6.5 7.6 8.1 6.8 3.5 15.7 12.3 16.6 7.5 374.6 6.3 6.1 0.0 10.8 7.9 10.8 9.4 5.8 9.7 5.9 4.8 15.5 6.7 4.9 209.7 16.4 6.7 11.8 4.6 7.0 16.2 6.4 8.6 11.7 11.7 14.7 12.9 10.8 58.1 11.8 4.8 16.8 13.1 6.8 7.3 DYNC2H1 "DHC1b, DHC2, DNCH2, DYH1B, hdhc11" ENSG00000187240 "Dynein cytoplasmic 2 heavy chain 1" Q8NCM8 11 103109431-103479863 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein, Motor protein" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 35.7" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 167.3;Cone photoreceptor cells: 106.0;Rod photoreceptor cells: 86.1;Spermatocytes: 64.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.9" "Group enriched" "Detected in many" 5 "NK-cells: 2.9;T-cells: 2.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 18.0" "Low region specificity" "Detected in all" "HPA039015, HPA039016" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA039015: AB_2676309, HPA039016: AB_10673410" "unprognostic (3.11e-1)" "unprognostic (2.60e-1)" "unprognostic (1.28e-2)" "unprognostic (1.54e-1)" "unprognostic (7.11e-2)" "unprognostic (2.08e-1)" "unprognostic (4.14e-3)" "unprognostic (2.07e-2)" "unprognostic (2.05e-1)" "unprognostic (4.10e-2)" "unprognostic (2.87e-2)" "unprognostic (7.13e-2)" "prognostic favorable (8.49e-5)" "unprognostic (3.75e-3)" "unprognostic (1.62e-1)" "unprognostic (3.88e-2)" "unprognostic (4.11e-3)" 7.3 5.7 6.3 3.8 8.9 1.4 8.4 13.2 9.3 11.5 4.8 5.5 11.0 4.1 11.3 9.6 3.9 14.6 7.8 3.7 7.1 7.1 8.5 2.6 10.2 2.6 4.8 7.9 11.4 5.1 24.2 35.7 3.9 11.2 7.6 2.6 6.2 4.5 10.7 1.6 5.7 3.4 7.8 5.1 4.8 4.2 14.3 5.2 1.1 10.7 3.0 2.4 6.1 6.6 0.5 0.4 0.4 0.2 2.9 2.2 0.0 1.0 2.2 5.7 2.8 8.0 18.0 0.3 3.2 5.2 5.4 5.8 1.2 1.1 0.0 4.5 6.2 2.5 4.3 4.4 6.0 4.3 0.0 4.1 0.8 3.7 0.1 7.7 1.7 1.0 11.2 2.3 12.1 13.9 8.4 2.1 1.1 0.1 0.0 6.9 4.1 0.5 0.4 1.5 0.0 6.1 0.0 4.7 0.1 5.8 0.7 4.1 2.9 5.1 1.4 2.4 1.4 5.3 1.1 5.1 6.5 2.6 6.1 2.1 0.0 0.0 0.0 1.9 5.2 1.9 0.4 0.2 0.0 0.9 0.1 2.2 0.5 0.7 1.1 0.4 0.3 0.8 1.1 0.0 2.9 0.1 0.2 0.0 0.0 6.3 8.9 13.2 9.3 7.1 7.1 4.8 7.9 11.2 5.2 0.0 12.5 0.0 11.5 6.0 22.2 9.4 2.5 167.3 23.9 26.2 106.0 0.3 1.7 5.6 13.4 9.0 0.0 0.0 3.1 0.4 14.8 5.9 3.5 0.8 2.0 30.2 16.6 6.7 1.5 6.5 19.2 3.8 8.5 0.0 0.8 17.7 6.8 1.1 17.3 14.8 86.1 19.4 11.3 64.2 10.4 4.8 0.5 2.5 0.9 5.7 DYNLL1 "DLC1, DLC8, DNCL1, hdlc1, LC8, PIN" ENSG00000088986 "Dynein light chain LC8-type 1" P63167 12 120469850-120498493 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Transcription, Transcription regulation, Transport" "Activator, Motor protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 2849.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039954 Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA Yes 650000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA039954: AB_2676771" "unprognostic (1.94e-1)" "unprognostic (1.08e-1)" "unprognostic (3.43e-2)" "unprognostic (2.88e-2)" "unprognostic (5.63e-2)" "unprognostic (7.09e-2)" "prognostic unfavorable (7.33e-5)" "unprognostic (4.41e-3)" "unprognostic (4.64e-2)" "unprognostic (6.17e-3)" "unprognostic (1.61e-2)" "unprognostic (9.10e-2)" "prognostic unfavorable (7.97e-7)" "unprognostic (4.91e-2)" "unprognostic (2.80e-2)" "unprognostic (7.91e-2)" "unprognostic (1.62e-1)" 45.5 48.5 128.5 34.4 97.8 21.9 54.3 48.4 120.5 50.6 61.8 61.9 31.1 31.6 47.2 64.9 113.7 107.1 46.7 44.2 124.1 105.2 49.7 40.7 40.3 41.2 92.9 90.7 49.0 45.7 30.4 46.4 49.8 67.4 39.9 64.5 24.8 34.0 54.9 15.0 117.3 38.9 75.2 93.6 30.4 45.1 59.4 56.8 35.4 37.1 84.3 65.6 59.0 63.0 55.0 80.6 73.6 55.0 46.7 63.4 50.8 78.6 89.9 89.2 68.4 78.4 83.2 28.7 108.9 50.3 88.9 53.4 84.7 53.1 44.1 58.8 104.0 87.0 71.0 106.0 91.0 88.9 58.4 69.4 43.1 64.5 114.6 79.2 45.0 71.7 50.5 97.5 66.6 54.7 98.8 92.3 47.8 54.0 50.9 117.3 104.1 58.6 97.8 73.2 101.0 104.9 59.9 46.2 54.7 127.0 72.9 61.3 45.3 88.7 77.1 98.8 97.4 76.4 65.8 71.0 68.5 58.5 60.4 93.7 30.6 58.8 43.8 75.9 70.3 87.6 73.6 49.5 63.6 37.7 51.4 28.7 55.0 39.0 39.0 49.1 36.5 25.2 31.5 9.1 46.7 55.0 80.6 63.4 50.8 128.5 97.8 48.4 120.5 124.1 105.2 92.9 90.7 67.4 56.8 181.7 88.8 250.9 293.4 819.1 137.3 144.1 321.0 1203.2 211.5 378.6 78.5 490.2 943.3 628.7 1147.1 421.8 466.9 116.8 472.1 694.2 640.5 264.0 307.3 460.6 658.6 81.0 461.6 421.7 304.4 2849.5 478.4 414.2 565.2 861.2 700.1 95.2 648.6 662.9 659.7 842.5 153.7 362.2 584.0 638.3 583.5 1407.5 841.8 195.6 373.7 348.8 DYNLL2 "Dlc2, DNCL1B, MGC17810, RSPH22" ENSG00000264364 "Dynein light chain LC8-type 2" Q96FJ2 17 58083415-58095536 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 12 "Early spermatids: 366.0;Late spermatids: 723.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039954 Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA039954: AB_2676771" "unprognostic (7.22e-2)" "unprognostic (7.76e-2)" "unprognostic (3.52e-3)" "unprognostic (3.50e-1)" "unprognostic (1.93e-1)" "unprognostic (3.72e-2)" "unprognostic (6.78e-2)" "unprognostic (2.91e-2)" "unprognostic (1.68e-1)" "unprognostic (1.10e-2)" "prognostic favorable (5.26e-4)" "unprognostic (1.24e-1)" "prognostic favorable (1.12e-12)" "unprognostic (2.87e-2)" "unprognostic (1.28e-1)" "unprognostic (1.31e-1)" "unprognostic (7.02e-2)" 15.4 28.3 38.6 11.1 55.2 9.9 11.6 41.1 41.1 12.9 14.5 22.6 16.3 16.2 12.0 15.6 11.9 13.5 13.3 43.8 32.2 40.2 28.1 23.1 11.8 9.4 48.3 28.7 14.4 11.8 36.2 15.0 19.7 40.6 20.6 13.7 15.5 19.2 18.8 64.8 12.6 15.6 14.3 32.5 11.2 12.7 19.0 27.2 7.6 22.0 15.1 11.8 9.9 16.4 1.5 0.8 3.5 3.0 1.5 3.1 0.8 20.7 14.1 29.1 13.2 18.1 10.0 46.3 21.0 8.4 10.2 8.0 31.3 10.1 18.6 23.9 13.0 12.2 11.2 13.4 16.6 17.6 18.3 9.7 20.1 8.3 18.3 14.4 21.5 12.5 10.0 11.4 11.8 9.4 10.7 6.7 15.8 20.0 11.3 9.8 31.4 24.3 8.9 20.0 13.7 14.5 22.5 17.1 7.7 8.8 22.7 19.9 15.9 18.8 7.6 16.0 15.7 22.5 10.1 12.2 20.1 25.3 13.3 15.4 21.2 25.7 22.7 10.3 17.3 14.0 3.5 1.1 2.0 2.6 0.6 2.9 1.3 2.1 2.3 0.5 1.5 2.2 3.1 1.7 1.5 3.0 0.8 1.4 0.8 38.6 55.2 41.1 41.1 32.2 40.2 48.3 28.7 40.6 27.2 11.9 49.9 27.4 30.9 43.6 58.8 158.5 38.2 14.7 29.6 57.6 37.3 88.3 26.6 31.4 366.0 29.3 47.1 23.3 27.0 62.0 29.2 30.1 22.0 85.9 36.0 66.7 64.5 22.1 21.7 723.4 27.3 23.1 62.4 27.1 52.5 69.7 32.5 40.3 25.1 66.7 36.2 25.8 38.5 40.0 41.2 40.3 50.2 19.2 44.1 28.3 DYNLT1 TCTEL1 ENSG00000146425 "Dynein light chain Tctex-type 1" P63172 6 158636474-158644739 "Predicted intracellular proteins" "Cell cycle, Cell division, Cytoplasmic inwards viral transport, Host-virus interaction, Microtubular inwards viral transport, Mitosis, Neurogenesis, Transport, Virus entry into host cell" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046559 Approved Nucleoplasm NA Yes Nucleoplasm "HPA046559: AB_2679698" "unprognostic (1.80e-3)" "unprognostic (3.09e-1)" "unprognostic (3.69e-2)" "unprognostic (2.22e-3)" "unprognostic (5.31e-2)" "unprognostic (7.45e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (5.62e-2)" "unprognostic (1.83e-1)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" "unprognostic (9.58e-2)" "unprognostic (2.72e-3)" "unprognostic (2.61e-1)" "unprognostic (1.74e-1)" "unprognostic (4.73e-2)" "unprognostic (2.92e-2)" 20.2 34.2 20.2 16.6 23.6 8.2 29.6 16.0 22.0 29.3 33.5 17.4 31.1 27.0 30.8 38.5 44.2 42.7 28.7 36.0 18.4 15.1 45.6 25.5 32.3 23.9 26.5 16.9 24.7 19.5 14.2 27.6 25.6 32.5 28.8 33.6 16.0 37.8 31.0 44.9 14.1 55.5 42.4 29.3 27.2 26.7 52.5 22.8 15.7 32.8 30.8 28.9 32.1 27.7 10.8 27.7 99.5 56.5 12.0 20.3 30.9 31.9 22.8 37.7 36.8 39.1 39.9 15.6 33.3 26.9 41.2 48.8 27.0 29.0 7.7 13.9 69.1 31.0 29.5 23.6 35.9 50.1 11.0 32.9 12.2 22.3 31.0 41.3 5.6 8.6 34.3 38.9 33.9 34.1 35.8 52.0 10.9 23.3 9.3 60.4 28.5 2.5 14.7 20.6 57.8 18.7 5.0 20.3 7.0 57.3 22.0 75.6 37.8 46.9 38.4 13.5 33.5 26.1 12.7 45.1 20.5 25.8 21.9 29.8 5.6 7.0 12.9 29.1 23.6 22.1 17.9 56.5 5.4 16.4 52.5 18.1 10.8 17.6 18.5 27.7 6.6 14.6 15.2 99.5 12.0 38.9 13.6 20.3 30.9 20.2 23.6 16.0 22.0 18.4 15.1 26.5 16.9 32.5 22.8 89.3 87.3 54.4 206.4 48.0 16.8 146.9 173.3 546.0 134.2 200.7 11.8 189.7 353.1 366.9 70.1 71.6 286.6 0.0 241.4 159.7 112.4 234.5 58.9 73.1 140.1 22.3 165.8 125.2 101.8 42.1 99.8 99.9 108.0 154.1 199.8 78.6 342.5 284.0 120.2 447.2 40.3 135.8 134.9 320.2 181.7 53.3 179.9 79.1 152.2 375.2 DYRK1B MIRK ENSG00000105204 "Dual specificity tyrosine phosphorylation regulated kinase 1B" Q9Y463 19 39825350-39834201 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Diabetes mellitus, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 89.1" "Group enriched" "Detected in many" 14 "Early spermatids: 145.5;Late spermatids: 469.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SH-SY5Y: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028522, HPA028786" Uncertain Supported "Nucleoplasm,Mitotic chromosome" Yes No Nucleoplasm "Mitotic chromosome" "HPA028522: AB_2672656, HPA028786: AB_10670831" "unprognostic (2.22e-2)" "unprognostic (9.86e-2)" "unprognostic (4.55e-2)" "unprognostic (3.45e-3)" "unprognostic (1.96e-1)" "unprognostic (1.13e-2)" "unprognostic (2.25e-1)" "unprognostic (2.39e-1)" "unprognostic (6.02e-2)" "unprognostic (3.67e-2)" "unprognostic (8.93e-2)" "unprognostic (4.22e-2)" "prognostic favorable (8.83e-4)" "unprognostic (9.73e-2)" "unprognostic (1.12e-1)" "unprognostic (2.53e-2)" "unprognostic (3.88e-2)" 4.8 7.9 7.4 3.7 10.2 5.0 4.0 10.1 13.1 4.5 4.2 7.4 6.1 6.2 6.4 12.3 6.7 8.0 4.6 9.0 6.6 6.1 6.1 3.2 5.4 5.1 4.4 6.7 6.1 5.2 7.1 12.3 3.8 6.4 5.5 3.4 6.7 5.5 5.8 89.1 6.3 5.1 3.9 3.4 5.9 5.2 28.8 4.6 11.2 6.4 25.3 5.3 5.6 4.1 4.7 8.3 4.8 3.2 6.2 7.0 2.6 0.4 8.6 8.4 5.9 4.8 4.5 0.7 2.7 1.7 2.5 2.3 0.8 3.3 1.3 10.6 3.2 0.1 2.9 1.2 1.9 2.2 4.9 7.3 0.6 5.4 0.8 4.0 0.3 1.8 6.1 1.2 0.8 2.8 8.2 0.6 3.3 1.4 1.9 0.4 4.3 1.9 0.8 2.0 2.5 2.0 0.9 0.1 0.6 5.4 2.1 12.2 13.8 4.2 4.2 0.2 4.7 4.1 0.5 4.2 1.1 1.9 0.9 0.8 3.1 1.0 0.9 7.1 0.8 0.4 1.2 3.1 3.2 5.9 3.2 7.0 4.7 4.0 5.9 3.5 3.5 2.2 3.5 4.8 6.2 2.9 8.3 4.2 2.6 7.4 10.2 10.1 13.1 6.6 6.1 4.4 6.7 6.4 4.6 0.0 1.1 13.7 3.6 3.1 14.9 5.3 5.1 1.4 0.0 15.7 19.6 1.8 8.3 11.7 145.5 5.7 9.1 0.0 3.7 1.5 4.0 5.4 1.1 3.0 4.9 9.5 19.5 6.2 9.2 469.8 6.6 2.7 5.0 3.6 9.4 8.1 8.6 8.6 4.9 11.2 13.0 0.0 2.3 22.4 14.0 2.5 1.1 6.9 8.5 3.2 DYRK2 ENSG00000127334 "Dual specificity tyrosine phosphorylation regulated kinase 2" Q92630 12 67648338-67665406 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 72.1;Horizontal cells: 76.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027230, HPA056902" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA027230: AB_1847925, HPA056902: AB_2683271" "unprognostic (5.86e-3)" "unprognostic (4.18e-1)" "unprognostic (4.08e-3)" "unprognostic (2.56e-3)" "unprognostic (1.18e-2)" "unprognostic (1.69e-1)" "unprognostic (3.37e-3)" "unprognostic (7.83e-2)" "unprognostic (2.83e-2)" "unprognostic (1.22e-1)" "unprognostic (1.04e-1)" "unprognostic (3.47e-1)" "unprognostic (2.12e-2)" "unprognostic (2.03e-2)" "unprognostic (1.38e-1)" "unprognostic (1.57e-1)" "unprognostic (1.35e-1)" 12.2 5.3 4.5 20.1 4.8 8.6 8.1 4.4 6.6 10.1 21.3 4.1 8.3 13.7 14.6 9.6 9.6 9.1 16.9 26.1 4.7 3.2 6.3 4.6 10.1 17.9 4.0 3.3 7.6 8.5 3.6 4.4 13.0 5.0 7.1 15.3 6.6 7.2 6.6 23.7 9.4 26.0 11.2 5.3 10.3 14.0 4.4 3.9 34.3 7.6 12.5 17.2 11.1 12.2 2.7 1.9 5.9 1.3 6.9 6.8 1.6 13.8 7.8 11.7 8.4 5.9 8.1 9.4 14.1 9.2 6.9 3.9 10.3 7.7 25.8 17.4 20.3 4.2 16.1 9.3 5.5 7.4 11.1 12.2 4.1 5.2 3.9 2.3 9.4 9.1 6.6 7.9 18.6 14.9 11.7 3.8 11.0 5.1 13.5 8.8 7.9 8.0 4.6 10.1 9.0 12.6 21.5 11.6 11.4 8.0 17.4 15.5 18.3 5.9 7.9 8.1 8.3 5.4 7.9 5.7 11.0 10.4 7.5 11.1 6.5 1.0 14.3 10.5 6.4 11.3 3.2 0.5 5.9 5.2 1.3 4.0 2.7 3.9 6.8 1.9 2.7 3.3 6.1 0.7 6.9 1.3 0.8 3.1 1.6 4.5 4.8 4.4 6.6 4.7 3.2 4.0 3.3 5.0 3.9 8.9 12.2 6.4 9.1 10.1 17.2 33.5 22.9 12.0 10.3 1.8 21.6 2.7 0.0 17.2 0.4 10.5 72.1 0.0 15.8 6.4 18.2 11.3 5.7 4.7 14.1 76.3 23.6 6.2 11.6 1.6 10.6 9.8 8.5 6.4 50.5 15.3 15.6 48.2 12.4 7.5 21.9 12.9 21.1 2.5 8.7 14.2 3.8 21.0 26.7 28.1 DYRK3 "hYAK3-2, RED, REDK" ENSG00000143479 "Dual specificity tyrosine phosphorylation regulated kinase 3" O43781 1 206635536-206684419 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 38.2" "Cell type enriched" "Detected in many" 6 "Early spermatids: 160.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 15 "plasmacytoid DC: 6.1" "Lineage enriched" "Detected in single" 15 "dendritic cells: 6.1" "Cell line enhanced" "Detected in many" "hTERT-HME1: 35.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA075041 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA075041: AB_2686730" "unprognostic (6.51e-2)" "unprognostic (1.24e-2)" "unprognostic (3.36e-2)" "unprognostic (2.03e-1)" "unprognostic (2.81e-2)" "unprognostic (1.23e-1)" "unprognostic (1.20e-4)" "unprognostic (2.69e-1)" "unprognostic (3.91e-1)" "unprognostic (2.71e-1)" "unprognostic (2.79e-3)" "unprognostic (2.52e-1)" "prognostic unfavorable (9.41e-7)" "unprognostic (2.38e-1)" "unprognostic (2.04e-1)" "unprognostic (1.99e-2)" "unprognostic (7.62e-3)" 7.1 2.7 4.2 4.2 3.5 6.2 7.7 1.3 2.7 5.6 2.7 2.6 3.7 1.2 7.6 5.1 2.7 6.2 12.8 16.3 6.0 3.4 3.4 7.4 5.0 1.6 2.6 2.0 7.6 5.2 2.8 11.2 1.2 4.6 4.5 1.5 4.1 5.5 3.0 2.1 2.0 2.1 7.5 2.7 1.8 3.7 38.2 3.1 5.1 11.9 3.0 1.7 5.4 7.6 0.0 6.1 0.0 0.1 0.0 0.3 0.0 2.5 3.5 0.8 4.9 8.7 7.8 0.1 8.2 18.1 7.5 9.7 0.2 1.3 3.7 1.2 9.6 13.2 0.7 4.2 6.6 8.0 0.0 2.8 5.4 4.4 0.8 13.8 3.7 3.5 5.5 4.3 12.9 35.7 7.7 5.8 5.7 10.4 0.7 11.5 0.9 8.2 2.1 6.9 0.2 6.5 20.4 2.6 0.0 2.4 0.1 5.0 3.7 7.3 0.3 10.0 1.0 0.9 0.9 4.3 15.7 5.9 7.6 6.8 2.9 1.1 4.4 9.3 4.1 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 4.2 3.5 1.3 2.7 6.0 3.4 2.6 2.0 4.6 3.1 3.0 5.1 0.5 10.3 5.8 0.1 10.3 2.5 13.4 5.7 1.8 9.8 0.0 0.0 3.0 160.9 4.2 0.0 0.0 1.9 0.1 7.3 3.2 0.0 1.1 0.9 0.0 2.4 2.5 1.5 27.7 3.7 1.9 8.5 1.8 0.3 3.0 1.4 0.0 1.8 1.0 7.4 6.5 10.3 17.6 3.4 3.1 0.3 0.0 0.2 3.5 DZIP1 "DZIP, KIAA0996" ENSG00000134874 "DAZ interacting zinc finger protein 1" Q86YF9 13 95578202-95644703 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 9 "Early spermatids: 313.9;Late spermatids: 570.8;Spermatocytes: 228.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054891, HPA057272, HPA070194" Uncertain Supported "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Nucleoplasm, Cytosol" "Centriolar satellite" "HPA054891: AB_2682631, HPA057272: AB_2683390, HPA070194: AB_2686233" "unprognostic (6.74e-3)" "unprognostic (7.65e-2)" "unprognostic (1.94e-1)" "unprognostic (4.64e-3)" "unprognostic (4.82e-2)" "unprognostic (5.52e-3)" "unprognostic (6.34e-2)" "unprognostic (2.49e-1)" "unprognostic (3.34e-2)" "unprognostic (8.63e-2)" "unprognostic (1.17e-2)" "unprognostic (1.67e-1)" "unprognostic (1.36e-2)" "unprognostic (2.41e-3)" "unprognostic (1.48e-1)" "unprognostic (3.64e-2)" "unprognostic (3.89e-3)" 5.0 6.3 17.2 4.4 17.4 0.4 3.7 13.9 16.1 11.5 6.7 4.1 3.8 2.2 16.2 10.7 6.2 10.7 8.5 3.8 13.1 18.1 16.2 1.7 4.0 3.6 8.7 13.5 24.2 9.6 0.9 8.9 4.6 8.8 7.7 3.7 5.8 3.2 13.3 1.7 1.1 2.6 12.3 5.6 2.8 3.6 27.3 4.5 0.6 1.7 1.8 3.5 5.0 5.2 0.4 0.2 1.2 0.2 0.3 0.3 0.0 1.3 5.0 16.9 17.2 13.1 16.3 3.4 12.2 14.2 13.7 16.5 0.1 0.0 0.0 2.8 9.7 6.2 0.0 11.2 4.5 15.5 0.9 10.0 15.6 3.8 10.6 9.1 0.0 0.1 11.5 0.3 4.2 5.6 22.2 9.2 1.1 0.0 0.0 10.0 0.0 0.0 0.0 7.7 0.0 0.4 0.0 11.6 0.0 13.1 1.8 4.2 11.0 9.3 0.0 0.5 20.8 0.0 5.8 0.7 13.6 6.6 1.8 10.0 0.0 0.0 0.0 3.5 0.0 2.4 1.2 0.2 0.2 0.3 0.1 0.2 0.2 0.1 0.2 0.0 0.4 0.1 0.3 1.1 0.3 0.1 0.2 0.1 0.0 17.2 17.4 13.9 16.1 13.1 18.1 8.7 13.5 8.8 4.5 0.0 0.0 0.0 1.1 0.6 17.7 2.9 0.0 17.4 5.7 1.8 3.9 3.9 6.6 13.1 313.9 2.7 0.0 0.0 0.2 1.8 10.6 0.5 0.0 0.0 0.5 6.4 0.0 3.1 0.0 570.8 35.9 1.2 3.3 3.6 0.0 6.2 0.8 0.0 41.1 19.5 1.2 19.4 13.2 228.9 7.0 0.9 1.5 0.0 0.0 0.3 DZIP1L "DZIP2, FLJ32844" ENSG00000158163 "DAZ interacting zinc finger protein 1 like" Q8IYY4 3 138061990-138115818 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Ciliated cells: 93.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "classical monocyte: 1.8;eosinophil: 1.7;intermediate monocyte: 1.3;myeloid DC: 1.5" "Group enriched" "Detected in many" 17 "dendritic cells: 1.5;granulocytes: 1.7;monocytes: 1.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030404 Approved Supported "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes No Microtubules "Nucleoplasm, Cytokinetic bridge" "HPA030404: AB_10601548" "unprognostic (3.65e-2)" "unprognostic (8.37e-2)" "unprognostic (2.87e-2)" "unprognostic (3.71e-2)" "unprognostic (8.22e-2)" "unprognostic (6.50e-2)" "unprognostic (6.47e-4)" "unprognostic (1.54e-1)" "unprognostic (3.21e-2)" "unprognostic (3.13e-1)" "unprognostic (3.26e-1)" "unprognostic (1.69e-1)" "unprognostic (1.51e-2)" "unprognostic (2.35e-3)" "unprognostic (2.72e-1)" "unprognostic (9.98e-2)" "unprognostic (2.77e-2)" 5.3 2.0 2.2 6.1 2.5 10.9 5.5 12.1 3.3 17.4 5.1 5.3 3.1 2.9 14.8 6.5 4.3 15.2 7.9 3.8 2.4 2.1 5.1 1.2 6.4 2.0 2.6 1.6 12.4 8.3 6.2 5.6 2.7 6.1 9.3 2.1 10.9 2.5 5.0 1.7 10.4 2.3 11.3 3.4 3.1 10.0 4.2 3.4 0.1 4.2 4.2 2.5 8.0 17.8 0.0 1.5 1.7 1.8 0.0 0.0 0.4 5.2 3.1 6.2 5.2 4.0 5.3 1.4 8.6 5.2 5.1 6.5 2.1 0.4 0.0 4.4 7.9 7.1 1.7 4.5 2.0 2.5 1.1 4.4 2.3 6.4 0.3 3.2 1.7 4.0 5.6 2.1 5.6 2.7 5.2 2.8 1.4 1.7 0.0 6.9 0.3 0.0 0.7 7.5 0.0 1.1 0.0 7.2 0.0 2.3 8.4 2.2 4.9 8.8 0.0 4.4 3.6 2.3 3.6 2.1 12.7 5.8 6.1 4.4 0.0 0.0 0.1 5.0 2.5 4.9 0.0 1.8 1.7 0.0 1.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 2.2 2.5 12.1 3.3 2.4 2.1 2.6 1.6 6.1 3.4 3.0 1.3 0.0 0.6 3.2 6.5 2.7 2.5 93.7 11.4 1.8 7.9 0.0 5.0 3.1 15.6 1.8 0.0 0.0 1.1 0.1 3.5 0.5 0.0 0.0 1.4 3.2 0.0 0.0 1.0 1.0 5.8 2.7 0.0 1.0 0.0 2.3 3.7 0.0 3.9 0.5 17.8 0.0 4.7 0.4 1.5 3.8 0.0 0.0 0.0 0.1 E2F1 "RBBP3, RBP3" ENSG00000101412 "E2F transcription factor 1" Q01094 20 33675683-33686404 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.5;lymphoid tissue: 21.9" "Cell type enriched" "Detected in many" 5 "Spermatogonia: 37.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 3.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB000329, HPA008003, CAB019308, HPA029735" Enhanced Supported Nucleoplasm,Centrosome NA Yes "Nucleoplasm, Centrosome" "CAB000329: AB_627476, CAB019308: , HPA008003: AB_1847936, HPA029735: AB_2673176" "unprognostic (7.46e-2)" "prognostic favorable (9.22e-6)" "unprognostic (2.11e-2)" "prognostic unfavorable (4.33e-5)" "unprognostic (1.51e-1)" "unprognostic (1.21e-2)" "prognostic unfavorable (3.83e-5)" "unprognostic (1.25e-2)" "unprognostic (8.23e-2)" "unprognostic (9.66e-2)" "prognostic unfavorable (4.18e-4)" "unprognostic (3.15e-2)" "prognostic unfavorable (8.99e-5)" "unprognostic (1.05e-2)" "unprognostic (7.50e-2)" "prognostic favorable (1.62e-4)" "unprognostic (1.91e-1)" 2.4 5.3 6.8 12.7 9.7 32.5 2.1 1.1 6.4 1.2 4.4 5.1 0.7 3.9 1.4 0.8 5.1 1.5 4.1 2.0 7.1 3.6 0.9 1.7 8.1 9.3 6.2 2.9 3.4 1.2 2.3 0.3 3.3 5.9 1.7 4.8 0.3 1.6 1.4 1.4 5.4 4.9 3.3 6.2 4.8 3.4 12.1 6.0 21.9 1.0 4.9 7.7 1.9 3.1 2.2 0.6 0.7 3.7 1.4 1.2 0.6 16.0 15.6 18.1 14.1 1.8 1.3 13.8 15.4 7.5 19.7 16.6 27.6 16.6 29.6 15.6 6.9 23.9 12.1 8.8 8.2 8.8 8.9 12.6 24.2 23.2 16.0 0.1 11.3 15.3 1.0 0.5 10.8 1.9 2.0 5.0 18.6 6.4 20.9 12.1 14.2 24.0 24.0 5.4 16.2 22.5 23.9 49.4 12.2 3.3 9.8 27.1 19.1 18.8 13.1 7.6 5.4 16.4 14.3 2.7 23.0 13.5 15.9 21.8 20.5 13.8 24.4 19.2 6.7 13.6 0.0 0.0 0.7 0.1 0.9 0.0 2.2 0.6 0.4 0.2 0.2 0.2 1.2 0.3 1.4 3.7 0.6 0.8 0.6 6.8 9.7 1.1 6.4 7.1 3.6 6.2 2.9 5.9 6.0 0.0 0.6 2.9 0.7 2.6 2.2 0.4 0.0 0.0 2.3 0.0 0.0 2.6 0.0 0.9 0.7 0.1 0.5 0.0 0.2 7.9 1.1 0.6 0.0 0.8 3.8 0.0 0.0 0.6 0.0 2.3 2.0 0.9 1.7 0.0 2.9 1.2 0.5 0.0 1.1 0.0 2.0 0.0 0.9 3.8 37.5 1.5 1.5 0.7 4.6 0.9 E2F3 ENSG00000112242 "E2F transcription factor 3" O00716 6 20401906-20493715 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 49.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029779, HPA065012" Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "HPA029779: AB_2732448, HPA065012: AB_2685403" "unprognostic (4.10e-2)" "unprognostic (1.15e-1)" "unprognostic (1.06e-1)" "unprognostic (1.80e-3)" "unprognostic (2.96e-1)" "unprognostic (9.14e-2)" "unprognostic (8.99e-3)" "unprognostic (9.13e-2)" "unprognostic (1.10e-1)" "prognostic favorable (1.69e-4)" "unprognostic (1.14e-2)" "unprognostic (5.64e-2)" "prognostic unfavorable (1.63e-8)" "unprognostic (1.23e-1)" "unprognostic (2.16e-1)" "unprognostic (3.50e-1)" "unprognostic (5.99e-3)" 9.5 8.4 7.6 12.2 13.4 22.1 10.8 1.7 10.1 4.8 7.1 2.9 3.2 6.8 6.3 6.9 8.0 4.9 9.9 11.1 8.3 6.8 14.6 6.1 7.8 19.7 5.8 7.3 4.0 3.6 2.9 3.2 7.4 7.9 5.0 8.6 5.1 4.7 4.5 15.1 4.3 8.0 7.9 5.0 16.9 5.0 8.9 3.1 17.7 11.4 10.2 12.0 9.2 4.8 0.7 3.7 10.3 3.1 4.8 3.6 1.5 6.8 5.6 16.1 17.3 5.4 6.0 11.2 9.3 8.1 8.9 9.9 6.9 4.3 15.4 18.0 8.6 8.3 7.2 18.4 8.3 15.0 6.0 13.0 27.9 9.3 7.7 5.8 18.3 16.8 4.8 6.2 8.7 10.7 9.2 6.1 14.7 30.9 9.5 10.1 7.1 20.7 20.5 12.1 5.3 5.8 22.6 14.2 17.7 10.6 11.9 11.6 21.3 8.6 11.9 12.2 10.3 6.1 11.1 8.2 14.4 9.0 7.1 14.7 6.0 19.0 19.3 3.5 11.3 20.4 6.9 3.1 1.4 2.3 2.3 3.1 0.7 1.5 3.6 3.7 0.7 1.3 2.8 10.3 4.8 1.5 1.6 2.2 1.5 7.6 13.4 1.7 10.1 8.3 6.8 5.8 7.3 7.9 3.1 0.0 1.6 8.2 10.8 8.1 35.1 8.9 7.6 0.0 12.5 7.0 21.6 6.3 8.3 7.0 10.2 5.2 7.9 0.0 5.9 11.3 10.4 18.4 19.7 5.0 14.5 30.2 11.5 19.0 49.7 5.0 2.6 18.9 5.0 8.2 11.3 2.1 11.2 11.6 2.8 20.5 9.2 0.0 8.2 2.7 3.2 7.9 2.6 9.6 12.7 14.2 E2F4 E2F-4 ENSG00000205250 "E2F transcription factor 4" Q16254 16 67192169-67198918 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Cilium biogenesis/degradation, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054128 Supported Nucleoplasm NA NA Nucleoplasm "HPA054128: AB_2682392" "unprognostic (1.74e-1)" "unprognostic (1.81e-1)" "unprognostic (4.73e-2)" "unprognostic (1.01e-1)" "unprognostic (2.76e-1)" "unprognostic (4.39e-3)" "unprognostic (1.05e-3)" "unprognostic (7.50e-3)" "unprognostic (1.37e-1)" "unprognostic (3.55e-2)" "unprognostic (1.06e-1)" "unprognostic (4.21e-2)" "unprognostic (3.60e-2)" "unprognostic (3.04e-2)" "unprognostic (8.44e-2)" "unprognostic (5.50e-2)" "unprognostic (1.17e-1)" 19.9 20.4 19.0 23.1 22.5 51.1 24.9 15.9 22.0 17.0 21.7 15.5 17.2 19.8 23.4 14.6 24.8 20.5 16.8 18.7 14.6 10.9 18.4 16.7 20.8 29.1 20.9 13.4 21.6 26.4 21.5 22.3 27.2 17.6 20.3 20.3 18.6 16.6 18.6 25.2 17.5 22.8 20.8 11.5 31.1 21.4 19.5 20.3 21.1 18.7 15.4 26.0 19.9 17.8 6.9 15.5 10.6 12.5 8.5 11.0 7.5 19.2 15.6 13.3 16.2 19.5 17.0 47.9 14.5 21.6 26.7 25.8 27.6 21.2 24.0 17.6 15.3 18.4 28.3 20.6 20.4 17.5 10.1 21.8 16.2 8.9 28.0 23.7 31.7 34.2 20.0 16.2 21.2 23.7 10.1 23.1 18.6 30.4 8.0 14.0 33.2 36.2 26.2 32.7 20.8 14.1 44.0 28.0 31.8 12.5 14.9 16.2 19.4 39.6 14.9 16.6 11.1 15.1 31.9 16.5 19.0 18.0 13.8 22.6 19.9 17.1 61.5 22.3 21.9 18.0 1.2 12.5 10.6 9.6 11.1 8.1 6.9 8.8 11.0 15.5 6.8 7.2 6.5 8.0 8.5 8.2 6.9 4.2 7.5 19.0 22.5 15.9 22.0 14.6 10.9 20.9 13.4 17.6 20.3 11.9 16.8 20.8 26.3 37.0 21.6 14.4 17.8 8.1 10.3 12.2 3.9 94.8 16.6 22.1 41.8 27.0 20.0 70.0 32.7 70.6 24.4 26.4 26.5 8.5 39.2 20.6 21.9 26.4 17.7 61.9 25.0 26.4 13.5 45.1 22.7 12.4 28.2 14.4 22.3 9.9 17.5 45.3 27.6 29.4 38.5 40.1 66.7 34.9 27.5 33.6 E2F5 ENSG00000133740 "E2F transcription factor 5" Q15329 8 85177225-85217158 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cilium biogenesis/degradation, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "B-cells: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory B-cell: 13.3;naive B-cell: 7.6" "Lineage enriched" "Detected in many" 9 "B-cells: 13.3" "Cell line enhanced" "Detected in many" "AF22: 27.5;Daudi: 54.2;U-698: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055723, HPA065441" Supported Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA055723: AB_2682897, HPA065441: " "unprognostic (8.73e-2)" "unprognostic (3.45e-1)" "unprognostic (3.15e-2)" "unprognostic (1.02e-3)" "unprognostic (6.73e-3)" "unprognostic (1.62e-1)" "unprognostic (3.36e-5)" "unprognostic (1.23e-1)" "unprognostic (9.53e-2)" "unprognostic (1.28e-1)" "unprognostic (3.18e-1)" "unprognostic (3.87e-2)" "prognostic unfavorable (1.89e-6)" "unprognostic (2.88e-2)" "unprognostic (3.25e-2)" "unprognostic (3.64e-1)" "unprognostic (2.95e-3)" 3.0 9.0 6.4 22.2 8.1 1.5 5.9 2.6 5.3 5.0 5.9 4.0 3.4 4.6 5.4 7.4 4.7 7.2 6.6 3.2 5.6 5.6 9.0 4.5 5.1 22.4 4.6 2.7 8.3 14.6 12.7 10.6 4.3 3.8 5.1 7.2 3.4 5.7 5.9 1.1 1.7 7.3 3.8 4.5 9.9 5.1 10.5 3.2 13.6 10.2 3.0 26.0 6.0 7.6 13.3 1.4 0.0 0.0 1.1 0.6 0.6 4.9 5.3 27.5 10.2 0.5 0.7 8.8 1.0 2.2 0.8 2.4 3.2 5.8 54.2 3.8 1.1 9.9 1.0 16.0 1.3 1.0 5.6 7.3 5.5 3.0 7.4 4.4 1.6 0.0 1.0 2.2 1.1 3.9 5.4 0.8 5.7 11.5 0.4 1.5 3.2 5.5 3.6 8.8 9.2 4.7 4.4 1.1 5.8 8.9 3.5 3.4 10.6 0.6 1.9 8.1 11.5 11.6 1.7 0.0 1.3 1.0 1.6 3.6 10.2 6.8 25.9 1.5 1.4 2.7 0.0 0.0 0.0 0.1 0.0 0.0 13.3 0.0 0.0 0.1 7.6 0.2 0.4 0.0 1.1 0.0 1.4 0.6 0.6 6.4 8.1 2.6 4.5 5.6 5.6 4.6 2.7 3.8 3.2 0.0 6.2 16.3 2.8 2.1 0.4 1.0 2.5 9.4 3.4 5.2 9.8 2.7 0.0 2.9 5.2 1.5 1.3 0.0 2.1 0.6 3.0 2.7 1.1 2.4 0.4 0.0 7.5 0.6 1.0 2.9 1.4 0.4 3.3 0.0 3.4 4.3 2.8 0.0 1.8 4.9 1.1 0.0 1.7 11.1 3.4 2.5 0.9 1.9 3.7 1.6 E2F6 E2F-6 ENSG00000169016 "E2F transcription factor 6" O75461 2 11444375-11466177 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 45.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "basophil: 8.3" "Lineage enriched" "Detected in single" 9 "granulocytes: 8.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075185 Supported Nucleoplasm NA NA Nucleoplasm "HPA075185: AB_2732282" "unprognostic (7.13e-2)" "unprognostic (2.44e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (7.13e-4)" "unprognostic (4.18e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (1.20e-5)" "unprognostic (1.90e-1)" "unprognostic (3.05e-3)" "unprognostic (7.58e-2)" "unprognostic (3.17e-3)" "unprognostic (3.64e-3)" "unprognostic (2.08e-3)" "unprognostic (2.72e-2)" "unprognostic (1.02e-1)" "unprognostic (9.01e-2)" "unprognostic (2.13e-1)" 8.4 6.6 4.4 5.0 5.9 5.0 6.2 7.8 8.0 4.1 4.9 7.4 4.7 4.2 8.4 6.6 3.6 7.4 5.0 8.9 4.3 4.9 4.0 6.2 4.5 3.3 5.6 3.8 6.7 5.3 3.9 12.4 5.4 5.0 5.3 3.5 4.7 4.7 6.5 17.7 3.9 4.8 10.6 9.0 5.0 5.7 4.2 7.3 2.9 6.7 4.4 3.7 6.3 4.9 0.0 0.3 8.3 0.3 0.0 0.8 0.2 3.1 4.0 8.5 4.7 3.8 3.1 6.4 3.1 5.5 3.6 3.3 7.8 4.6 7.1 3.6 3.5 7.4 2.3 5.9 4.6 3.8 7.9 8.6 11.3 3.0 9.8 7.6 11.5 11.6 5.3 4.3 3.9 4.7 3.1 3.3 5.5 8.4 11.9 2.9 7.6 6.6 12.7 12.0 3.9 5.3 11.8 9.5 6.3 3.9 2.9 7.2 15.3 3.5 5.2 13.8 3.8 4.8 5.8 2.8 5.3 6.7 3.3 6.9 17.3 12.8 15.4 5.8 11.0 8.0 8.3 0.3 0.1 0.2 0.0 0.8 0.0 0.1 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 4.4 5.9 7.8 8.0 4.3 4.9 5.6 3.8 5.0 7.3 6.0 3.7 5.1 18.6 21.6 12.6 8.0 7.6 4.0 6.8 3.5 15.7 15.4 6.6 10.1 1.0 8.9 3.9 0.0 9.6 11.6 14.7 14.9 0.0 7.3 10.7 12.7 6.4 9.2 3.3 1.5 8.1 8.1 16.9 4.6 4.6 9.1 7.3 3.5 10.6 7.6 11.5 0.0 15.1 14.1 45.7 19.2 18.5 5.7 5.2 12.9 E2F8 FLJ23311 ENSG00000129173 "E2F transcription factor 8" A0AVK6 11 19224063-19241620 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 30.3" "Group enriched" "Detected in some" 5 "Ciliated cells: 8.1;Erythroid cells: 23.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "T-reg: 2.9" "Lineage enriched" "Detected in single" 24 "T-cells: 2.9" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA064882, HPA076614" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol No No Nucleoli "Nucleoplasm, Cytosol" "HPA064882: AB_2685381, HPA076614: " "unprognostic (5.62e-2)" "unprognostic (5.24e-2)" "unprognostic (3.17e-2)" "unprognostic (6.99e-3)" "unprognostic (2.86e-2)" "unprognostic (1.66e-2)" "unprognostic (1.29e-5)" "unprognostic (1.94e-2)" "unprognostic (3.90e-3)" "unprognostic (2.41e-1)" "unprognostic (7.29e-4)" "unprognostic (1.16e-2)" "unprognostic (9.13e-8)" "unprognostic (1.02e-3)" "unprognostic (1.37e-1)" "unprognostic (3.81e-1)" "unprognostic (4.28e-3)" 1.0 0.4 0.4 7.2 0.2 11.5 0.3 0.2 0.4 1.6 3.6 0.2 0.2 3.3 1.2 1.4 8.2 0.9 2.0 3.4 0.2 0.2 0.4 0.5 0.8 6.1 0.2 0.2 0.7 0.3 0.0 0.2 4.0 0.2 0.6 4.8 1.2 1.8 0.9 11.5 2.6 4.6 0.7 0.2 2.4 5.1 4.7 0.2 30.3 0.3 8.0 12.5 3.4 2.1 0.0 0.1 0.0 0.0 0.0 2.9 0.4 14.2 4.2 4.4 6.1 0.2 0.6 18.9 7.9 2.2 9.3 10.1 14.7 4.7 14.1 3.3 2.5 5.5 12.6 10.7 1.0 8.4 9.5 8.7 4.9 2.4 4.0 0.0 7.4 11.8 0.2 0.0 1.9 0.6 0.5 13.0 10.1 10.3 13.7 3.7 6.9 14.6 9.3 4.0 16.1 6.0 15.9 8.2 9.5 4.0 9.6 3.8 4.3 3.5 7.0 0.8 2.4 4.8 8.0 2.5 4.5 5.6 11.0 7.1 4.7 9.5 17.9 5.7 14.7 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.4 0.4 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 1.5 0.0 1.0 0.0 2.0 0.0 8.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.4 23.3 0.0 1.4 0.6 0.0 0.0 0.0 2.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 3.1 0.3 0.2 0.0 2.6 0.6 E4F1 E4F ENSG00000167967 "E4F transcription factor 1" Q66K89 16 2223566-2235742 "Enzymes, Predicted intracellular proteins, Transcription factors" "Cell cycle, Cell division, Growth regulation, Host-virus interaction, Mitosis, Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052042, HPA069007, HPA071325, HPA072309" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA052042: AB_2681705, HPA069007: , HPA071325: AB_2686390, HPA072309: " "unprognostic (3.05e-1)" "prognostic favorable (9.13e-4)" "unprognostic (7.31e-2)" "unprognostic (4.57e-3)" "unprognostic (2.89e-1)" "prognostic favorable (1.10e-4)" "unprognostic (9.16e-2)" "unprognostic (4.23e-2)" "unprognostic (3.08e-1)" "unprognostic (1.87e-1)" "unprognostic (1.29e-2)" "unprognostic (8.49e-3)" "prognostic unfavorable (5.50e-4)" "unprognostic (1.85e-1)" "unprognostic (1.03e-1)" "unprognostic (5.12e-1)" "unprognostic (8.93e-3)" 12.4 12.8 18.1 13.8 15.4 21.0 21.0 26.1 18.9 10.8 10.7 11.9 9.3 13.4 14.8 10.4 11.4 10.9 13.5 9.8 14.3 10.7 11.7 12.9 10.0 13.4 16.7 16.4 13.8 17.0 11.6 14.8 12.0 12.8 15.5 5.0 8.7 20.7 13.7 26.7 23.2 14.7 10.3 9.8 18.8 15.9 14.6 17.2 13.3 17.3 9.3 10.6 10.5 13.4 11.5 11.6 15.2 14.2 8.5 14.7 9.3 6.1 11.8 5.0 9.7 2.9 2.7 11.9 8.6 4.0 6.0 4.0 18.9 9.5 9.0 9.3 3.3 3.3 8.4 4.1 4.4 1.1 9.7 14.6 6.4 19.0 10.2 5.7 8.1 11.3 4.0 5.1 5.4 2.5 3.4 4.0 7.9 14.9 6.3 2.2 17.1 10.6 17.3 11.1 3.8 11.0 19.7 5.4 15.5 3.7 4.4 12.6 9.2 10.5 13.1 6.0 1.9 11.4 11.6 7.1 7.1 9.4 7.1 7.2 12.3 5.9 18.2 3.0 5.8 7.2 7.5 10.7 14.6 14.7 13.1 12.5 11.5 12.0 13.6 11.6 11.5 13.2 11.9 15.2 8.5 14.2 7.0 14.1 9.3 18.1 15.4 26.1 18.9 14.3 10.7 16.7 16.4 12.8 17.2 14.9 8.0 14.5 6.7 6.4 13.9 3.5 5.1 4.0 12.5 10.4 35.3 16.5 10.0 9.5 11.4 7.8 14.4 0.0 9.1 14.7 8.0 8.1 2.3 8.9 11.0 28.6 24.8 6.7 6.1 3.3 10.6 7.6 6.8 9.0 15.3 9.1 9.7 10.5 15.2 6.8 14.0 12.9 9.2 14.8 15.2 7.9 11.2 8.7 11.8 6.0 EAF1 ENSG00000144597 "ELL associated factor 1" Q96JC9 3 15427355-15450635 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 55.7" "Group enriched" "Detected in many" 6 "Early spermatids: 229.6;Late spermatids: 321.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 56.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059516, HPA060569, HPA069538" Supported Enhanced "Nucleoplasm,Nuclear bodies,Vesicles" Yes No "Nucleoplasm, Nuclear bodies" Vesicles "HPA059516: AB_2684048, HPA060569: AB_2684322, HPA069538: AB_2686147" "unprognostic (1.26e-1)" "unprognostic (1.61e-2)" "unprognostic (6.37e-2)" "unprognostic (1.13e-1)" "unprognostic (2.68e-1)" "unprognostic (5.47e-2)" "unprognostic (3.14e-3)" "prognostic unfavorable (6.87e-4)" "unprognostic (3.22e-1)" "unprognostic (3.16e-2)" "unprognostic (3.22e-1)" "unprognostic (8.45e-2)" "unprognostic (2.06e-2)" "unprognostic (5.17e-2)" "unprognostic (1.09e-1)" "unprognostic (1.46e-2)" "unprognostic (1.64e-1)" 15.6 11.5 13.9 12.2 20.0 55.7 11.4 18.1 19.1 9.8 11.7 13.3 11.5 12.7 10.1 9.9 13.1 9.4 12.9 7.6 14.3 18.1 13.7 22.2 12.0 12.4 14.7 13.0 8.0 11.8 13.0 17.6 18.9 18.6 12.7 12.4 9.6 9.5 15.4 8.6 15.9 12.5 10.4 13.7 15.1 13.7 9.7 10.1 14.0 13.0 9.1 12.9 11.9 9.0 5.1 9.9 7.1 7.4 8.1 15.4 4.3 4.0 6.6 7.0 7.1 4.1 3.5 56.2 5.9 4.2 6.8 6.7 9.0 4.5 11.3 3.8 4.3 4.5 3.4 9.0 5.2 7.9 9.2 6.5 9.7 6.0 8.1 9.2 9.1 7.9 4.6 9.3 9.9 6.7 5.2 6.8 9.3 10.3 8.3 5.6 8.3 9.0 5.1 12.4 7.6 6.8 8.3 5.8 6.2 5.9 7.1 7.2 12.6 7.2 6.8 6.9 9.4 10.1 7.3 6.6 7.2 5.3 6.3 8.5 11.0 22.1 11.9 7.0 10.9 8.5 7.1 7.4 4.5 12.0 5.4 15.4 5.1 10.1 9.3 4.3 3.8 6.0 9.8 6.7 8.1 6.5 9.9 10.5 4.3 13.9 20.0 18.1 19.1 14.3 18.1 14.7 13.0 18.6 10.1 8.9 12.9 2.9 7.7 41.7 6.8 4.5 7.6 6.7 10.3 12.2 5.9 7.2 8.3 7.8 229.6 11.7 13.6 0.0 7.0 11.7 16.0 15.1 10.3 27.0 14.1 20.6 33.0 11.6 21.8 321.2 10.6 14.6 21.9 5.4 11.2 4.8 11.8 10.5 11.3 18.9 6.0 25.8 11.3 18.6 11.5 47.4 30.0 20.4 10.9 14.5 EAPP "BM036, C14orf11, FLJ20578" ENSG00000129518 "E2F associated phosphoprotein" Q56P03 14 34515929-34539711 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002916 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA002916: AB_1078715" "unprognostic (8.76e-3)" "unprognostic (1.27e-3)" "unprognostic (2.08e-3)" "unprognostic (1.94e-1)" "unprognostic (4.59e-2)" "unprognostic (1.64e-1)" "unprognostic (2.80e-1)" "prognostic favorable (9.34e-4)" "unprognostic (1.81e-1)" "unprognostic (6.38e-2)" "unprognostic (2.05e-1)" "unprognostic (7.80e-2)" "prognostic favorable (2.23e-6)" "unprognostic (2.64e-1)" "unprognostic (2.68e-1)" "prognostic favorable (2.96e-4)" "unprognostic (3.24e-2)" 30.1 32.8 24.4 23.1 23.5 53.4 36.5 32.4 30.1 30.0 35.0 20.6 25.3 24.7 27.9 33.0 26.3 28.5 19.9 19.9 22.8 26.4 30.1 34.4 20.5 23.2 21.8 25.3 37.3 22.5 31.1 28.1 33.8 27.8 29.4 36.8 21.6 27.3 27.8 41.3 39.1 43.2 23.8 20.9 26.5 23.5 21.6 24.2 34.8 34.1 22.6 24.8 27.7 31.2 36.8 19.3 50.2 26.2 33.6 42.3 24.8 15.1 18.6 17.4 10.2 20.7 21.2 27.1 14.0 21.5 17.5 18.4 8.8 20.2 15.9 19.9 17.0 10.5 14.3 12.8 18.6 20.7 19.8 11.3 11.6 14.6 37.1 28.2 20.6 12.9 24.3 24.0 10.0 26.0 23.2 17.4 22.5 11.5 17.7 16.3 35.5 28.5 16.7 10.2 28.3 20.9 18.1 20.9 15.9 21.1 20.7 14.0 15.5 19.8 19.2 29.8 17.5 33.4 13.2 18.8 9.2 7.8 11.8 9.0 22.4 25.0 16.9 8.6 11.4 11.5 40.7 22.0 45.2 24.8 20.1 29.7 36.8 31.1 28.0 19.3 33.7 31.8 28.8 50.2 33.6 26.2 16.9 42.3 24.8 24.4 23.5 32.4 30.1 22.8 26.4 21.8 25.3 27.8 24.2 20.8 44.0 56.1 67.2 41.2 75.1 29.7 53.5 104.4 45.5 78.5 29.5 102.7 147.6 71.8 11.9 52.6 81.1 23.3 74.0 64.7 52.1 52.3 71.6 87.3 51.6 23.8 63.4 45.4 51.6 7.4 82.8 55.7 86.0 63.1 99.8 110.6 51.5 112.6 88.8 94.6 66.9 71.1 50.1 103.2 38.4 58.2 158.4 91.3 92.5 44.8 EARS2 "KIAA1970, MSE1" ENSG00000103356 "Glutamyl-tRNA synthetase 2, mitochondrial" Q5JPH6 16 23522014-23557731 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, RNA-binding" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043289, HPA043633" Approved Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA043289: AB_10963932, HPA043633: AB_10959901" "unprognostic (3.10e-2)" "unprognostic (1.60e-1)" "unprognostic (3.65e-3)" "unprognostic (4.20e-1)" "unprognostic (3.57e-1)" "unprognostic (4.64e-2)" "unprognostic (2.73e-1)" "unprognostic (2.91e-2)" "unprognostic (1.16e-1)" "unprognostic (2.99e-2)" "prognostic unfavorable (7.20e-4)" "unprognostic (8.09e-2)" "prognostic favorable (3.16e-6)" "unprognostic (2.48e-1)" "unprognostic (1.80e-1)" "unprognostic (1.19e-1)" "unprognostic (4.29e-2)" 8.4 19.0 11.0 8.5 19.0 2.7 13.6 13.4 16.8 11.1 10.0 10.8 12.7 6.4 11.4 10.2 10.5 13.1 7.8 14.9 10.9 11.9 14.5 18.3 7.3 8.1 9.9 14.0 12.0 18.9 32.7 10.9 12.4 10.3 11.3 11.0 8.8 16.4 11.7 17.3 11.1 6.9 8.3 9.3 7.6 9.2 12.6 10.4 6.3 14.5 9.0 11.0 8.6 16.9 3.0 6.2 0.5 5.5 10.6 7.9 3.3 8.2 16.8 7.9 12.7 5.5 7.9 9.6 9.2 7.0 11.4 9.5 12.2 8.4 11.5 9.5 8.5 7.1 9.3 29.7 16.9 10.9 4.6 14.4 6.7 10.3 20.6 8.9 7.4 8.4 8.5 10.1 10.2 14.4 8.6 5.1 11.6 20.7 6.1 8.1 17.5 7.3 5.3 20.8 11.8 5.9 13.2 9.1 22.1 14.4 7.2 14.1 10.4 7.2 13.6 7.3 13.3 18.4 8.3 4.0 9.0 8.0 9.9 11.6 11.2 10.6 9.3 9.1 10.3 13.3 0.0 2.8 0.3 4.2 3.6 7.9 3.0 4.7 4.3 6.2 3.0 4.6 4.5 0.5 10.6 5.5 4.5 3.4 3.3 11.0 19.0 13.4 16.8 10.9 11.9 9.9 14.0 10.3 10.4 8.9 5.1 3.0 3.5 1.9 3.8 9.8 2.5 6.7 2.3 3.5 2.0 12.9 5.0 6.5 2.1 3.5 1.3 23.3 3.1 9.9 3.3 3.5 5.7 10.5 6.3 7.9 5.2 4.3 1.8 1.9 2.3 3.1 5.0 6.4 5.5 2.8 4.1 0.0 1.8 6.8 3.7 0.0 1.9 4.3 10.4 2.6 9.5 2.5 5.5 2.7 EBF1 "EBF, OLF1" ENSG00000164330 "Early B cell factor 1" Q9UH73 5 158695916-159099761 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 16 "Leydig cells: 264.3;Peritubular cells: 114.2;Sertoli cells: 97.0;Smooth muscle cells: 110.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 23.6" "Group enriched" "Detected in some" 62 "memory B-cell: 11.8;naive B-cell: 10.4" "Lineage enriched" "Detected in single" 66 "B-cells: 11.8" "Cell line enhanced" "Detected in some" "ASC diff: 19.4;HSkMC: 15.1;REH: 40.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA061169 Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA061169: AB_2684441" "unprognostic (7.86e-2)" "unprognostic (3.08e-2)" "unprognostic (7.29e-2)" "unprognostic (4.70e-2)" "unprognostic (2.63e-1)" "unprognostic (1.39e-2)" "unprognostic (1.78e-1)" "unprognostic (1.60e-1)" "unprognostic (5.75e-2)" "unprognostic (1.60e-1)" "unprognostic (4.58e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (9.62e-7)" "prognostic unfavorable (7.80e-4)" "unprognostic (5.75e-2)" "unprognostic (5.81e-2)" "unprognostic (4.37e-3)" 33.7 3.3 1.9 9.7 2.5 3.1 25.0 23.6 2.0 15.9 5.8 1.1 9.0 1.2 19.7 13.0 5.0 8.5 9.4 15.5 2.0 2.4 3.3 0.9 5.2 12.7 3.2 1.2 7.4 3.7 1.8 2.6 10.7 4.7 8.5 3.4 10.4 4.7 10.8 15.5 4.8 4.5 25.7 6.6 5.4 3.4 8.4 1.0 0.1 6.8 13.2 9.1 11.7 12.5 11.8 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 6.2 0.0 19.4 8.4 0.0 0.0 0.0 0.2 0.6 0.0 0.0 5.6 0.0 2.3 1.2 0.0 0.2 0.0 0.1 1.3 0.0 0.0 1.6 0.0 0.3 0.0 0.0 15.1 0.0 6.0 0.2 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 40.6 0.2 0.0 0.0 0.0 3.3 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.8 8.5 0.1 0.0 0.0 5.6 4.9 0.4 6.7 0.1 0.0 0.1 0.0 0.0 0.0 11.8 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.9 2.5 23.6 1.6 2.0 2.4 3.2 1.2 4.7 1.0 0.0 0.3 44.7 0.4 10.9 4.1 4.3 0.0 1.4 1.2 1.8 0.0 0.1 0.0 2.4 15.8 55.5 0.0 0.0 0.0 0.3 40.4 0.6 0.0 1.0 0.7 0.0 0.0 2.5 0.8 15.5 264.3 1.0 13.5 16.2 0.0 1.7 0.2 0.0 114.2 0.0 2.0 97.0 110.4 2.2 0.4 6.0 0.3 1.3 0.0 0.5 EBF2 "COE2, FLJ11500" ENSG00000221818 "Early B cell factor 2" Q9HAK2 8 25841730-26045397 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 25.8" "Cell type enriched" "Detected in some" 4 "Sertoli cells: 38.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "pons and medulla: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 12.5;ASC TERT1: 25.5;HSkMC: 25.9;hTEC/SVTERT24-B: 14.4;U-138 MG: 9.3;U-2197: 12.2;U-87 MG: 10.4" "Group enriched" "Detected in many" 4 "basal ganglia: 5.9;cerebellum: 3.4;hypothalamus: 2.4;midbrain: 5.3;pons and medulla: 2.9" "Low region specificity" "Detected in some" "HPA003954, HPA055101" Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA003954: , HPA055101: " "unprognostic (3.70e-1)" "unprognostic (3.88e-3)" "unprognostic (2.69e-2)" "unprognostic (2.47e-3)" "unprognostic (1.03e-1)" "unprognostic (6.10e-2)" "unprognostic (5.92e-2)" "unprognostic (6.75e-2)" "unprognostic (1.11e-2)" "unprognostic (6.13e-3)" "unprognostic (1.58e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.51e-6)" "unprognostic (7.41e-4)" "unprognostic (2.28e-1)" "unprognostic (3.80e-2)" "unprognostic (1.82e-2)" 25.8 1.1 0.2 3.2 0.9 0.1 14.5 0.2 0.2 3.0 4.2 0.0 2.9 0.2 3.0 14.1 5.2 5.1 3.8 16.4 0.2 0.5 0.9 0.2 1.3 4.4 0.9 0.0 3.9 4.0 3.1 0.6 0.8 2.8 3.7 0.7 0.1 1.7 0.8 11.1 1.8 1.0 5.4 10.1 0.2 1.2 4.2 0.0 0.4 7.4 11.6 0.5 6.2 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 12.5 25.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 25.9 0.0 14.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.3 0.1 12.2 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.2 0.2 0.2 0.5 0.9 0.0 2.8 0.0 0.0 0.3 0.0 0.1 0.1 0.0 4.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 5.2 1.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 5.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.3 38.8 9.5 0.2 0.2 0.3 0.0 0.0 0.0 0.0 EBF3 "COE3, DKFZp667B0210" ENSG00000108001 "Early B cell factor 3" Q9H4W6 10 129835283-129963841 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 25.8;lymphoid tissue: 29.9" "Cell type enhanced" "Detected in some" 24 "Cardiomyocytes: 2.4;Endothelial cells: 3.5;Smooth muscle cells: 11.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 6 "hypothalamus: 2.5;midbrain: 5.0;pons and medulla: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 10.1;HAP1: 11.8;LHCN-M2: 18.9;NB-4: 23.8;RH-30: 10.3;SCLC-21H: 24.4;THP-1: 10.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA061169 Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA061169: AB_2684441" "unprognostic (2.96e-1)" "unprognostic (3.78e-2)" "unprognostic (8.63e-3)" "unprognostic (2.60e-2)" "unprognostic (7.68e-2)" "unprognostic (4.50e-3)" "unprognostic (8.53e-6)" "unprognostic (2.93e-2)" "unprognostic (3.99e-2)" "unprognostic (1.04e-1)" "unprognostic (6.12e-2)" "unprognostic (2.63e-1)" "unprognostic (4.16e-3)" "unprognostic (1.37e-3)" "unprognostic (1.66e-1)" "unprognostic (9.49e-2)" "unprognostic (4.58e-2)" 20.0 0.9 0.3 3.4 0.4 0.1 25.8 0.7 0.5 7.3 3.6 0.2 2.5 0.2 5.4 4.9 4.3 3.8 4.3 10.5 0.3 2.5 0.6 0.4 1.0 29.9 5.0 0.3 1.0 1.2 3.6 0.9 3.8 4.8 4.6 0.8 2.0 3.6 2.2 10.9 2.8 1.0 6.3 9.3 0.2 1.6 4.6 0.1 0.5 6.7 6.3 2.4 4.7 16.9 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.1 10.1 7.8 0.1 0.7 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.3 0.0 0.0 11.8 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 2.3 0.0 0.0 0.0 0.7 0.0 0.0 18.9 0.1 0.0 23.8 0.1 0.0 0.0 0.3 10.3 0.0 0.0 0.1 24.4 0.3 0.0 0.0 0.0 0.2 0.0 10.0 0.0 0.0 1.2 6.4 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.7 0.5 0.3 2.5 5.0 0.3 4.8 0.1 0.0 0.0 0.0 0.0 1.6 0.6 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.6 0.0 11.8 0.0 0.9 0.6 0.0 0.0 0.0 0.0 EBLN2 ENSG00000255423 "Endogenous Bornavirus like nucleoprotein 2" Q6P2I7 3 73061659-73063337 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 15.3" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA062510, HPA068795" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA062510: AB_2684787, HPA068795: AB_2686038" "unprognostic (1.23e-2)" "unprognostic (3.34e-2)" "unprognostic (1.43e-1)" "unprognostic (1.35e-1)" "unprognostic (1.41e-1)" "unprognostic (1.29e-3)" "unprognostic (7.44e-2)" "unprognostic (3.94e-2)" "unprognostic (1.81e-2)" "unprognostic (5.24e-3)" "unprognostic (2.89e-1)" "unprognostic (8.19e-3)" "unprognostic (8.38e-6)" "unprognostic (1.54e-1)" "unprognostic (1.47e-1)" "unprognostic (6.06e-2)" "unprognostic (1.12e-1)" 2.2 1.2 0.0 2.1 0.0 15.3 2.6 0.5 0.3 2.4 1.5 1.0 2.6 2.5 1.8 3.1 1.1 2.1 0.1 0.0 0.8 1.8 3.1 1.7 0.1 5.1 2.6 1.2 1.2 1.9 1.6 2.4 3.1 0.5 1.3 2.2 2.1 1.4 1.0 2.1 1.8 0.9 2.4 1.5 2.4 2.9 2.6 2.2 6.3 1.5 1.1 3.8 0.2 1.3 0.9 5.3 4.7 1.4 3.0 4.0 2.1 0.4 1.3 1.0 2.6 4.3 3.3 0.8 2.8 1.3 1.8 2.0 2.2 2.7 1.3 1.2 2.2 5.0 2.3 0.8 4.2 4.9 2.9 1.6 2.7 2.6 2.6 1.8 2.9 1.6 5.1 1.5 2.8 2.0 5.9 3.3 1.1 1.4 5.3 1.3 2.0 1.4 5.5 1.2 2.6 1.3 2.3 0.7 3.9 3.5 1.6 3.4 1.5 2.9 4.0 3.2 5.1 2.4 2.6 1.5 4.6 2.6 0.3 1.5 6.3 3.6 0.5 3.0 1.5 3.2 3.1 0.5 2.6 2.7 3.8 3.3 1.1 0.6 2.2 3.7 0.2 0.0 2.1 5.0 11.6 5.0 4.7 0.8 15.3 2.7 2.3 3.5 7.9 7.1 0.0 3.1 1.5 4.5 4.5 23.3 1.4 5.4 6.2 7.7 1.1 4.4 2.5 3.2 4.1 7.4 3.3 0.2 7.8 3.9 1.7 1.8 3.3 2.8 3.5 3.5 3.5 0.1 5.0 6.5 3.1 3.7 4.8 5.5 12.2 7.5 3.3 11.2 ECD "GCR2, hSGT1" ENSG00000122882 "Ecdysoneless cell cycle regulator" O95905 10 73130155-73169055 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006465 Approved Supported Nucleoplasm,Cytosol Yes No "Nucleoplasm, Cytosol" "HPA006465: AB_2667595" "unprognostic (2.70e-1)" "unprognostic (1.94e-1)" "unprognostic (6.46e-2)" "unprognostic (2.19e-1)" "unprognostic (2.75e-2)" "unprognostic (4.71e-3)" "prognostic unfavorable (6.87e-4)" "unprognostic (1.22e-1)" "unprognostic (3.55e-2)" "unprognostic (6.61e-2)" "unprognostic (3.07e-2)" "unprognostic (1.06e-1)" "unprognostic (2.54e-2)" "unprognostic (1.05e-1)" "unprognostic (6.77e-2)" "unprognostic (7.05e-2)" "unprognostic (3.84e-2)" 23.2 22.3 22.2 22.4 23.8 34.8 23.2 34.7 27.0 20.4 18.6 21.8 20.0 15.6 23.7 20.9 21.2 17.0 20.6 18.8 17.9 16.9 22.4 23.6 17.7 21.4 23.4 16.7 24.1 21.1 32.5 32.1 23.4 25.5 21.8 18.1 16.7 21.4 21.3 19.9 23.3 16.8 19.9 19.4 20.5 18.5 25.4 23.1 32.7 24.2 18.7 22.4 22.1 20.7 20.4 16.8 23.3 26.3 25.4 27.2 15.7 18.9 13.7 15.6 23.6 14.3 14.2 12.8 14.8 23.3 24.2 28.4 24.8 20.0 14.9 14.6 14.5 18.1 15.9 16.6 17.6 24.9 12.1 16.2 18.8 11.2 17.7 21.7 22.4 12.6 15.9 14.7 20.3 25.6 18.7 25.8 13.6 19.4 10.5 22.8 16.0 20.1 12.4 15.9 17.7 39.7 14.9 17.3 8.1 19.4 14.1 6.9 12.9 13.4 30.5 19.0 16.8 17.5 10.8 15.8 10.6 21.4 11.3 17.0 12.2 8.2 25.4 19.7 18.8 9.0 15.0 19.3 20.9 21.8 20.5 23.2 20.4 20.6 21.4 16.8 18.6 27.2 19.4 23.3 25.4 26.3 11.5 19.7 15.7 22.2 23.8 34.7 27.0 17.9 16.9 23.4 16.7 25.5 23.1 26.8 8.9 6.1 23.3 9.7 13.9 10.5 10.2 6.7 23.9 7.0 23.6 20.2 6.6 13.1 32.2 15.5 8.9 23.3 10.7 12.7 11.4 10.9 18.5 8.1 14.5 19.1 10.4 18.4 16.5 7.8 14.7 9.4 13.5 8.2 9.7 9.9 12.3 3.5 12.4 10.3 12.4 6.5 12.7 27.0 12.6 9.5 27.8 13.1 7.3 23.3 ECEL1 "DINE, XCE" ENSG00000171551 "Endothelin converting enzyme like 1" O95672 2 232479827-232487828 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6;ovary: 57.1" "Group enriched" "Detected in some" 19 "Muller glia cells: 76.3;Peritubular cells: 19.8" "Cancer enhanced" "Detected in many" "endometrial cancer: 12.9" "Region enriched" "Detected in many" 5 "hypothalamus: 28.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AN3-CA: 30.1;HeLa: 15.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA067560, HPA069756, HPA077424" Approved Supported Approved "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA Nucleoplasm "Nuclear membrane, Nucleoli" "HPA067560: , HPA069756: , HPA077424: " "unprognostic (1.21e-2)" "unprognostic (1.06e-2)" "unprognostic (4.39e-1)" "unprognostic (4.62e-3)" "unprognostic (2.80e-1)" "unprognostic (9.96e-4)" "unprognostic (7.56e-3)" "unprognostic (1.22e-1)" "unprognostic (9.89e-3)" "unprognostic (8.49e-2)" "unprognostic (1.54e-1)" "unprognostic (2.89e-1)" "unprognostic (1.24e-5)" "unprognostic (3.09e-2)" "unprognostic (3.68e-1)" "unprognostic (7.84e-2)" "unprognostic (5.45e-2)" 0.9 2.6 0.5 0.9 4.0 0.2 0.4 0.7 1.2 0.3 0.4 0.5 0.1 0.3 0.6 4.9 0.3 1.7 1.0 1.1 0.1 28.6 1.0 0.7 0.2 1.2 0.3 0.1 57.1 0.6 0.3 8.9 0.4 5.5 0.3 0.2 11.5 0.3 1.2 1.8 0.3 0.3 1.1 4.5 2.0 0.3 0.8 1.6 0.1 0.5 0.3 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.3 0.0 0.1 0.0 0.4 0.0 0.0 0.0 2.7 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.0 0.7 1.2 0.1 28.6 0.3 0.1 5.5 1.6 0.0 0.0 0.0 0.0 0.0 2.6 1.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.4 0.0 0.0 0.0 0.0 76.3 0.2 0.0 19.8 0.0 1.7 0.0 2.1 0.2 1.7 0.0 0.0 0.0 0.0 0.0 ECM1 ENSG00000143369 "Extracellular matrix protein 1" Q16610 1 150508062-150513789 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Angiogenesis, Biomineralization, Mineral balance, Osteogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 133.2;esophagus: 257.1;lymphoid tissue: 107.2" "Cell type enhanced" "Detected in many" 9 "Fibroblasts: 80.6;Ito cells: 56.4;Melanocytes: 70.9;Pancreatic endocrine cells: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 1.2;myeloid DC: 1.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 77.4;BJ hTERT+: 53.9;fHDF/TERT166: 50.8;hTEC/SVTERT24-B: 36.5;LHCN-M2: 39.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA027241, HPA076029" Enhanced Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" NA NA 12000000000 Cytosol Nucleoplasm "HPA027241: AB_1847976, HPA076029: " "unprognostic (2.89e-2)" "unprognostic (1.17e-1)" "unprognostic (2.11e-1)" "unprognostic (1.13e-2)" "unprognostic (1.09e-1)" "unprognostic (6.79e-3)" "unprognostic (8.42e-2)" "unprognostic (2.15e-2)" "unprognostic (4.90e-2)" "unprognostic (7.50e-2)" "prognostic unfavorable (3.55e-4)" "unprognostic (5.33e-2)" "prognostic unfavorable (1.51e-9)" "unprognostic (1.23e-2)" "unprognostic (1.92e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (1.20e-5)" 16.1 2.5 0.9 1.8 1.3 0.1 11.0 0.9 4.2 37.9 2.8 0.1 7.4 1.5 10.5 133.2 257.1 3.3 30.7 11.6 0.9 1.0 2.5 16.7 3.8 0.2 1.0 1.7 3.0 0.8 0.3 2.0 20.2 4.2 2.6 3.1 1.6 28.7 2.9 3.5 11.5 2.0 5.3 0.8 3.6 2.1 5.9 0.0 0.0 1.8 45.5 107.2 6.0 46.6 0.0 1.8 0.0 1.2 0.0 0.4 1.3 6.2 0.6 2.3 0.0 14.0 77.4 2.1 22.7 53.9 14.2 18.6 0.3 3.5 0.1 0.2 50.8 1.6 13.1 0.0 2.7 14.9 0.1 0.1 0.9 0.8 0.1 3.9 0.0 23.5 6.8 0.1 36.5 1.3 20.9 3.9 0.1 4.8 0.1 39.5 0.0 0.0 0.7 0.2 26.5 0.7 0.3 17.0 0.1 0.5 0.0 0.1 0.0 5.2 0.1 19.4 1.1 0.0 6.0 1.0 30.1 4.5 3.4 4.9 0.1 0.2 0.2 15.8 2.1 4.0 0.0 1.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.9 1.3 0.9 4.2 0.9 1.0 1.0 1.7 4.2 0.0 0.0 0.6 1.4 1.8 13.1 0.7 1.1 12.7 0.0 2.3 3.5 0.0 1.3 0.0 4.8 0.2 4.4 0.2 0.0 3.7 26.0 80.6 1.0 10.3 0.6 16.0 1.6 0.0 56.4 2.1 0.0 9.2 4.8 70.9 0.0 0.3 0.8 42.0 0.0 20.8 0.0 1.1 12.9 16.1 0.5 0.4 16.7 9.2 0.0 0.2 5.8 ECPAS "ECM29, FLJ22036, KIAA0368" ENSG00000136813 "Ecm29 proteasome adaptor and scaffold" Q5VYK3 9 111360692-111484745 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 92.6" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 53.6;Alveolar cells type 2: 52.8;Ciliated cells: 44.2;Club cells: 60.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021646, HPA059795" Uncertain Approved Nucleoplasm Yes No Nucleoplasm "HPA021646: AB_2670788, HPA059795: AB_2684127" "unprognostic (1.64e-1)" "unprognostic (1.57e-1)" "unprognostic (7.42e-2)" "unprognostic (5.72e-2)" "unprognostic (3.81e-1)" "unprognostic (1.79e-1)" "unprognostic (1.80e-2)" "unprognostic (5.12e-2)" "unprognostic (2.02e-1)" "unprognostic (2.17e-1)" "unprognostic (9.99e-2)" "unprognostic (1.67e-1)" "unprognostic (3.72e-3)" "unprognostic (2.67e-1)" "unprognostic (1.34e-1)" "unprognostic (2.09e-1)" "unprognostic (1.05e-1)" 21.0 17.2 16.4 12.9 29.0 13.2 19.4 18.4 18.1 16.6 16.6 14.1 20.8 17.1 18.9 17.2 13.6 14.3 13.2 19.9 27.4 13.7 16.0 16.6 12.7 13.8 15.1 12.8 17.9 19.2 28.5 20.8 12.8 15.7 19.2 16.4 13.7 14.9 23.3 92.6 15.3 17.8 19.5 11.5 13.9 15.7 18.3 11.5 8.7 17.7 23.7 14.5 17.8 18.5 5.6 11.6 4.0 8.6 6.6 8.2 3.6 20.7 19.2 12.9 13.8 30.8 30.9 21.2 25.6 22.0 21.1 14.6 17.8 12.9 21.0 12.1 22.4 17.3 30.3 16.4 17.1 19.7 23.1 10.3 12.9 23.2 25.5 22.9 24.1 14.2 28.0 18.0 21.1 31.5 24.0 21.4 5.3 29.7 29.8 17.2 17.6 0.1 14.1 25.2 26.6 16.1 11.8 39.6 12.6 17.9 18.7 24.7 11.8 21.9 23.6 16.0 14.6 18.5 12.9 23.3 14.2 16.3 21.2 23.4 26.4 49.2 25.8 20.8 10.0 13.1 4.0 8.2 2.7 6.9 8.6 8.2 5.6 7.4 8.0 11.6 5.3 4.5 7.6 2.6 6.6 6.2 5.3 5.8 3.6 16.4 29.0 18.4 18.1 27.4 13.7 15.1 12.8 15.7 11.5 53.6 52.8 0.0 0.0 0.0 0.0 0.0 0.0 44.2 60.3 12.2 0.0 13.8 8.3 18.8 0.0 0.0 0.0 0.0 18.6 9.6 0.0 0.0 22.1 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 19.0 0.0 0.0 20.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 ECSCR "ARIA, ECSM2" ENSG00000249751 "Endothelial cell surface expressed chemotaxis and apoptosis regulator" Q19T08 5 139448556-139462743 "Predicted membrane proteins" "Angiogenesis, Apoptosis, Chemotaxis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 20 "Endothelial cells: 271.3" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.7" "Lineage enhanced" "Detected in single" "T-cells: 2.7" "Group enriched" "Detected in some" 121 "EFO-21: 49.7;HUVEC TERT2: 125.6;TIME: 92.7" HPA063337 Supported "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA063337: AB_2732701" "unprognostic (5.91e-2)" "unprognostic (2.37e-2)" "unprognostic (1.95e-2)" "unprognostic (2.83e-2)" "unprognostic (3.69e-2)" "unprognostic (2.15e-3)" "unprognostic (3.95e-2)" "unprognostic (1.12e-1)" "unprognostic (2.29e-2)" "unprognostic (1.78e-1)" "unprognostic (2.78e-2)" "unprognostic (1.91e-1)" "unprognostic (1.83e-3)" "unprognostic (2.41e-3)" "unprognostic (1.36e-1)" "unprognostic (9.90e-2)" "unprognostic (2.91e-1)" 14.8 1.9 0.8 5.7 1.6 0.0 17.5 0.4 0.7 13.7 6.1 1.0 5.1 1.9 14.3 14.4 11.0 7.9 8.6 26.9 0.8 5.6 4.3 23.4 26.9 1.4 0.7 7.9 1.0 1.3 0.4 19.6 2.9 9.3 4.3 6.8 3.6 5.5 13.4 2.9 3.4 14.3 4.3 12.1 1.1 6.8 1.1 0.1 11.5 14.5 4.6 13.2 13.1 0.6 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 49.7 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 125.6 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 92.7 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.6 1.1 1.0 0.0 0.0 0.1 0.9 0.0 0.1 0.0 0.0 0.6 0.0 0.0 4.6 0.0 0.2 13.3 0.0 0.0 0.0 1.4 1.2 0.0 0.0 0.1 0.0 0.5 0.0 271.3 0.0 0.0 1.0 0.1 2.6 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 5.8 10.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 12.2 0.2 0.0 0.0 0.7 ECSIT SITPEC ENSG00000130159 "ECSIT signalling integrator" Q9BQ95 19 11505916-11529174 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042979 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042979: AB_10964063" "unprognostic (9.88e-2)" "unprognostic (3.57e-3)" "unprognostic (2.93e-1)" "unprognostic (3.55e-3)" "unprognostic (2.27e-2)" "unprognostic (3.35e-2)" "unprognostic (2.18e-1)" "unprognostic (1.24e-1)" "unprognostic (2.92e-1)" "unprognostic (2.18e-1)" "unprognostic (1.01e-2)" "unprognostic (4.08e-2)" "prognostic favorable (1.48e-9)" "unprognostic (2.30e-3)" "unprognostic (1.68e-1)" "unprognostic (2.06e-1)" "unprognostic (5.95e-2)" 15.3 16.8 13.8 10.7 15.5 12.9 12.8 20.0 24.5 13.5 21.0 9.5 11.1 24.2 13.1 6.8 19.7 16.2 13.8 49.5 12.9 11.6 15.6 27.7 8.4 9.9 13.5 10.8 27.2 28.5 14.7 10.5 6.4 12.5 16.3 12.0 13.2 26.8 11.0 64.2 11.8 17.9 12.9 9.1 10.1 18.4 8.2 11.9 13.8 21.4 29.5 12.7 14.1 14.2 21.4 22.3 6.2 20.9 13.1 18.6 15.2 15.0 13.6 8.2 12.1 12.8 14.6 9.2 8.0 11.0 17.5 14.3 20.3 10.5 22.5 17.3 10.5 14.9 20.4 20.9 17.1 6.2 12.9 17.1 21.0 8.8 18.4 12.5 12.0 17.6 15.3 18.8 14.3 16.0 9.1 12.9 21.1 22.7 23.5 6.5 20.8 20.9 17.9 22.4 19.7 36.6 20.9 8.8 30.0 9.5 9.7 31.7 20.0 9.6 16.2 16.2 3.9 18.4 18.2 6.6 18.4 12.8 26.0 15.0 21.0 40.5 11.2 15.3 18.0 13.1 2.1 17.2 6.2 15.2 20.9 17.3 21.4 16.5 14.1 22.3 20.3 18.6 16.9 3.5 13.1 18.6 12.6 18.1 15.2 13.8 15.5 20.0 24.5 12.9 11.6 13.5 10.8 12.5 11.9 8.9 14.9 23.9 52.4 39.5 21.3 69.0 38.2 17.4 17.0 19.2 11.8 33.5 69.6 33.6 15.8 25.3 48.3 0.0 67.2 36.4 26.8 37.2 23.0 46.1 27.4 17.5 35.8 20.9 28.3 43.1 31.9 21.0 27.0 10.0 44.9 20.5 38.7 23.0 30.1 82.0 26.1 32.3 45.3 14.1 40.7 36.6 21.1 21.3 78.1 50.6 ECT2 ARHGEF31 ENSG00000114346 "Epithelial cell transforming 2" Q9H8V3 3 172750682-172821474 "Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Neurogenesis, Protein transport, Transport" "Guanine-nucleotide releasing factor" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 50.8" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 60.9;Erythroid cells: 70.0;Spermatogonia: 37.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA036363, HPA053261" Enhanced Nucleoplasm,Cytosol No Yes Nucleoplasm Cytosol "HPA036363: AB_2732472, HPA053261: AB_2682094" "unprognostic (3.83e-2)" "unprognostic (4.34e-1)" "unprognostic (1.27e-2)" "unprognostic (4.22e-3)" "unprognostic (4.49e-2)" "unprognostic (5.02e-3)" "prognostic unfavorable (6.82e-6)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.82e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.24e-5)" "unprognostic (2.44e-2)" "prognostic unfavorable (1.19e-5)" "unprognostic (1.08e-2)" "unprognostic (1.46e-1)" "unprognostic (1.29e-1)" "unprognostic (1.33e-1)" 6.4 6.0 5.4 9.9 7.2 16.3 7.4 11.1 7.6 9.0 11.0 2.6 2.1 9.1 4.6 2.8 14.9 3.2 6.6 4.2 5.4 5.0 10.1 4.3 8.9 9.6 6.7 5.8 3.2 4.1 4.0 6.1 11.1 10.2 4.1 16.1 2.4 9.0 2.7 2.9 7.0 7.6 7.2 8.4 8.7 9.2 14.7 6.8 50.8 5.7 9.3 10.8 8.0 6.5 2.8 2.6 10.4 3.2 1.3 3.6 1.0 46.2 33.0 26.1 13.5 2.7 5.6 13.0 20.5 16.8 30.8 30.0 18.3 49.1 11.5 31.2 12.0 29.5 20.4 21.0 13.1 42.1 16.4 11.6 7.2 18.1 9.3 1.2 11.1 8.3 1.8 2.2 18.3 18.7 8.7 13.2 17.1 7.4 16.9 24.3 16.3 11.3 8.3 21.2 38.3 18.0 8.1 25.6 14.8 23.4 10.8 17.4 11.2 25.9 29.5 10.4 13.7 49.1 8.3 11.4 15.0 14.4 20.1 42.6 8.3 11.1 21.7 13.2 9.7 19.5 6.8 3.2 1.3 1.8 2.8 1.9 2.2 2.4 1.6 2.4 2.8 1.2 1.8 10.4 1.3 1.2 2.6 3.6 1.0 5.4 7.2 11.1 7.6 5.4 5.0 6.7 5.8 10.2 6.8 6.0 2.7 9.0 4.3 17.3 3.4 3.1 7.6 10.7 4.5 3.5 60.9 4.9 0.0 9.0 2.7 6.4 3.2 70.0 7.9 13.0 7.0 8.8 0.0 1.5 6.1 0.0 4.6 5.5 3.1 2.3 0.9 5.1 6.8 1.8 10.8 2.9 14.3 3.5 1.4 1.9 13.4 0.0 3.3 33.1 37.4 11.2 3.2 1.5 6.2 7.8 EDARADD ENSG00000186197 "EDAR associated death domain" Q8WWZ3 1 236348257-236502915 "Disease related genes, Predicted intracellular proteins" Differentiation "Developmental protein" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 24.6" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 22.7;granulocytes: 20.9;Syncytiotrophoblasts: 18.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 6 "basophil: 24.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 24.6" "Group enriched" "Detected in some" 4 "HMC-1: 37.6;RT4: 30.4" "Group enriched" "Detected in some" 5 "olfactory region: 0.7;thalamus: 0.8" "Low region specificity" "Detected in many" HPA018836 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA018836: AB_1847984" "unprognostic (3.74e-1)" "unprognostic (3.10e-2)" "unprognostic (2.92e-1)" "unprognostic (2.12e-2)" "unprognostic (2.06e-3)" "unprognostic (3.12e-3)" "unprognostic (9.94e-2)" "unprognostic (2.96e-2)" "unprognostic (2.62e-1)" "unprognostic (1.03e-2)" "unprognostic (1.71e-2)" "unprognostic (2.57e-2)" "unprognostic (5.72e-2)" "unprognostic (3.00e-1)" "unprognostic (2.47e-1)" "unprognostic (1.90e-2)" "unprognostic (9.62e-3)" 0.9 0.4 0.5 2.4 0.5 0.2 5.8 0.3 0.4 1.1 1.1 0.1 13.7 0.2 0.9 13.0 7.2 1.0 1.3 2.2 0.4 0.4 2.5 0.6 1.7 1.2 0.5 0.0 0.7 5.5 0.0 0.4 6.4 0.1 11.3 0.2 1.7 3.6 16.6 0.3 5.7 0.7 3.6 0.4 2.9 6.4 4.0 0.2 4.5 6.4 5.3 6.8 15.6 9.9 0.1 0.3 24.6 0.2 2.9 4.0 1.1 0.0 1.8 0.1 0.0 0.0 0.0 7.7 0.0 0.0 0.7 0.4 0.4 0.0 0.0 0.0 0.1 2.0 4.2 3.0 4.5 0.7 6.0 3.6 0.0 0.0 0.6 0.0 0.1 37.6 0.0 1.3 0.5 0.4 0.0 0.0 0.9 0.2 0.0 0.0 0.3 0.1 0.0 1.8 0.0 0.0 1.6 0.0 0.0 0.0 30.4 0.2 0.1 0.0 0.6 0.1 0.2 7.3 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 24.6 0.2 0.0 2.1 0.2 2.7 0.1 3.2 4.0 0.3 0.1 0.3 2.1 0.2 2.9 0.1 0.0 2.9 1.1 0.5 0.5 0.3 0.4 0.4 0.4 0.5 0.0 0.1 0.2 0.0 2.2 0.8 6.8 6.2 0.0 2.8 5.1 1.4 6.8 0.0 0.0 22.7 3.3 1.2 4.8 1.8 0.0 0.0 0.8 12.0 2.0 3.1 20.9 0.0 3.1 0.0 0.0 4.3 2.7 5.8 0.3 0.7 11.8 6.4 0.0 0.4 1.0 0.0 0.4 0.2 0.0 0.0 1.7 3.1 3.4 4.5 18.9 5.0 0.0 5.8 EDC4 "Ge-1, HEDLS, RCD-8" ENSG00000038358 "Enhancer of mRNA decapping 4" Q6P2E9 16 67873023-67884503 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 28.5;Ciliated cells: 8.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041164, HPA043038" Supported Enhanced "Nucleoplasm,Cytoplasmic bodies" NA NA "Cytoplasmic bodies" Nucleoplasm "HPA041164: AB_2677339, HPA043038: AB_2678281" "unprognostic (1.97e-1)" "unprognostic (1.48e-1)" "unprognostic (8.53e-2)" "unprognostic (1.01e-1)" "unprognostic (1.63e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (7.61e-4)" "unprognostic (1.47e-2)" "unprognostic (2.87e-1)" "unprognostic (7.93e-2)" "unprognostic (3.75e-3)" "unprognostic (1.10e-2)" "unprognostic (2.44e-2)" "unprognostic (1.48e-1)" "unprognostic (3.13e-2)" "unprognostic (7.69e-3)" "unprognostic (1.17e-1)" 11.3 12.6 14.4 13.2 20.2 25.2 12.1 33.3 27.0 11.9 18.5 17.5 11.2 16.5 15.5 13.0 14.3 15.4 15.2 11.9 12.8 11.9 12.8 10.8 12.9 18.0 14.4 15.2 19.7 18.6 23.6 18.4 13.1 15.6 13.2 14.3 15.0 13.4 13.4 22.0 19.1 15.0 13.5 10.7 15.4 15.8 18.1 15.1 25.6 12.9 6.8 19.2 15.9 11.4 6.2 6.6 4.4 11.0 9.1 12.2 6.4 9.5 13.4 9.2 8.3 8.7 6.4 18.3 8.8 7.3 17.8 14.4 21.7 9.0 15.7 9.7 12.0 7.6 13.3 18.3 6.9 9.4 6.0 23.2 11.2 8.4 11.5 10.3 13.3 12.5 8.7 9.6 18.0 8.6 10.7 13.5 11.6 19.4 2.8 10.6 14.4 17.4 34.5 9.1 6.4 7.7 26.6 11.2 16.8 7.0 7.0 16.0 8.6 23.3 6.5 6.4 7.9 12.0 18.4 8.9 7.3 10.5 6.8 11.7 15.0 8.7 38.3 5.6 16.3 6.7 0.7 5.9 4.4 10.2 7.0 9.5 6.2 9.0 9.8 6.6 5.4 9.0 6.4 2.9 9.1 11.0 4.8 12.2 6.4 14.4 20.2 33.3 27.0 12.8 11.9 14.4 15.2 15.6 15.1 20.8 28.5 0.0 0.1 0.0 1.3 1.6 0.0 8.1 5.7 0.0 3.9 0.1 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.2 0.2 0.1 3.5 0.0 0.3 0.0 1.2 1.8 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.7 0.4 0.2 0.0 0.0 1.2 6.5 0.0 0.2 0.1 0.1 0.0 0.0 0.3 0.1 EDF1 "CFAP280, EDF-1" ENSG00000107223 "Endothelial differentiation related factor 1" O60869 9 136862119-136866286 "Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" "Activator, Calmodulin-binding, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035642 Approved Supported Nucleoplasm,Cytosol NA NA 140000 "Nucleoplasm, Cytosol" "HPA035642: AB_10611959" "unprognostic (2.07e-1)" "unprognostic (1.25e-2)" "unprognostic (3.97e-2)" "unprognostic (3.58e-3)" "unprognostic (4.49e-2)" "unprognostic (2.32e-1)" "unprognostic (9.05e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-2)" "unprognostic (4.03e-2)" "unprognostic (2.65e-2)" "unprognostic (9.76e-2)" "unprognostic (1.83e-1)" "unprognostic (2.08e-2)" "unprognostic (2.31e-1)" "unprognostic (1.52e-1)" "unprognostic (1.15e-1)" 49.5 68.5 77.7 58.3 67.3 55.6 71.0 68.2 75.2 51.6 68.7 35.1 75.3 106.6 55.0 60.9 68.4 57.3 66.7 83.2 66.5 61.8 65.4 107.5 47.2 75.3 64.9 64.2 72.1 273.4 44.5 64.4 47.7 62.3 64.1 46.5 38.2 123.3 96.5 175.4 69.4 102.3 64.3 71.9 48.8 61.9 49.5 44.8 43.6 64.5 75.1 51.5 51.9 57.7 78.2 116.5 58.0 70.5 68.6 83.6 85.4 63.7 85.8 47.8 48.5 47.7 50.3 94.1 73.7 49.9 59.8 46.7 69.4 44.7 56.1 68.7 64.1 53.3 77.2 37.2 56.4 22.0 60.6 45.3 39.0 108.0 94.3 94.9 66.4 53.4 49.7 72.6 46.8 54.6 55.8 57.4 50.9 56.4 72.7 51.1 139.7 59.2 105.8 50.4 99.2 73.6 52.1 69.8 113.2 79.3 68.2 61.3 58.9 76.9 108.4 74.5 33.0 104.7 93.4 69.5 65.4 49.4 70.7 68.5 42.0 70.1 47.2 85.4 40.0 59.8 45.7 70.5 58.0 69.9 59.9 77.2 78.2 74.8 72.1 70.8 71.9 66.9 68.8 28.2 68.6 48.9 116.5 83.6 85.4 77.7 67.3 68.2 75.2 66.5 61.8 64.9 64.2 62.3 44.8 211.4 257.9 360.4 480.4 463.8 134.8 270.5 479.0 235.5 258.2 298.4 37.3 561.0 978.2 614.3 98.1 432.9 1611.3 163.5 1109.8 593.2 450.9 513.8 287.2 695.8 501.5 89.0 425.8 343.1 356.1 224.5 538.4 426.7 499.4 906.3 749.8 223.0 954.5 1406.3 401.0 993.5 116.5 271.7 418.6 236.6 258.3 542.3 942.8 422.7 608.2 611.5 EDN1 ET1 ENSG00000078401 "Endothelin 1" P05305 6 12290363-12297194 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Vasoactive, Vasoconstrictor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Basal glandular cells: 804.7;Ductal cells: 273.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "non-classical monocyte: 7.9" "Lineage enriched" "Detected in many" 6 "monocytes: 7.9" "Cell line enhanced" "Detected in many" "EFO-21: 109.7;HUVEC TERT2: 72.7;T-47d: 22.4;TIME: 53.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031976, CAB032500, CAB037291" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Secreted to blood" NA Yes 9740 "Nucleoli, Golgi apparatus" Nucleoplasm "CAB032500: AB_2096241, CAB037291: AB_259277, HPA031976: AB_10602489" "unprognostic (1.51e-2)" "unprognostic (2.38e-1)" "unprognostic (3.95e-2)" "unprognostic (9.72e-2)" "unprognostic (3.40e-1)" "unprognostic (1.91e-1)" "unprognostic (6.24e-2)" "unprognostic (2.94e-3)" "unprognostic (1.42e-1)" "unprognostic (8.92e-2)" "unprognostic (4.19e-2)" "unprognostic (3.17e-1)" "unprognostic (8.02e-3)" "unprognostic (2.09e-1)" "unprognostic (1.71e-1)" "unprognostic (1.34e-1)" "unprognostic (3.47e-1)" 35.7 1.5 8.4 6.2 30.8 3.6 19.2 3.2 22.0 8.2 9.2 4.2 1.1 9.0 7.2 15.3 10.8 8.6 11.9 5.2 19.0 6.2 5.7 2.8 25.1 6.7 10.9 5.5 4.3 8.2 1.6 1.0 16.0 25.1 5.4 12.9 6.9 9.7 8.5 25.6 8.2 6.7 9.7 13.5 10.2 6.8 4.8 5.6 0.2 2.9 3.8 2.1 5.3 4.1 0.2 0.2 1.2 7.9 0.0 0.2 0.0 1.6 9.2 0.1 0.0 0.0 0.0 0.0 2.9 2.6 2.4 2.0 11.9 1.4 0.0 109.7 1.1 1.5 0.8 0.0 1.7 1.8 0.1 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 1.0 0.4 0.3 0.7 72.7 0.0 0.0 0.0 9.2 0.2 0.0 0.0 0.1 1.6 0.1 0.0 0.8 0.0 5.8 1.5 0.1 0.0 0.3 8.7 0.0 20.3 22.4 0.1 53.8 6.2 4.9 0.1 3.7 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 7.9 0.1 0.0 0.0 8.4 30.8 3.2 22.0 19.0 6.2 10.9 5.5 25.1 5.6 160.8 31.6 0.8 804.7 168.7 0.0 2.0 5.1 0.0 46.6 36.6 0.0 1.4 3.3 273.4 11.4 170.8 145.3 0.0 195.7 0.6 8.2 167.4 1.1 0.8 1.7 1.6 15.0 109.2 6.3 10.0 5.2 3.6 8.5 19.0 12.9 0.2 217.0 147.3 0.4 5.7 0.0 6.5 6.2 1.1 0.4 56.3 0.7 5.7 34.9 116.8 EDRF1 "C10orf137, DKFZp586F1019, FLJ21617" ENSG00000107938 "Erythroid differentiation regulatory factor 1" Q3B7T1 10 125719515-125764143 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 140.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031820 Approved Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA031820: AB_10600753" "unprognostic (2.10e-1)" "unprognostic (2.69e-1)" "unprognostic (1.53e-1)" "unprognostic (3.64e-2)" "unprognostic (5.46e-2)" "unprognostic (1.01e-2)" "unprognostic (8.84e-4)" "unprognostic (4.76e-3)" "unprognostic (8.67e-2)" "unprognostic (3.51e-2)" "unprognostic (1.63e-3)" "unprognostic (4.62e-2)" "prognostic unfavorable (3.16e-5)" "unprognostic (3.44e-3)" "unprognostic (5.51e-2)" "unprognostic (1.38e-1)" "unprognostic (7.68e-3)" 9.2 6.7 6.3 16.6 9.7 27.9 9.0 20.3 10.0 10.5 8.1 7.7 6.8 7.1 12.2 8.3 7.5 9.8 6.4 7.5 7.4 5.4 5.9 5.0 7.2 12.5 8.8 7.3 13.4 14.0 6.3 18.1 8.2 8.0 10.0 7.3 5.2 19.7 12.7 12.7 8.3 9.0 9.5 7.8 9.3 8.4 21.2 9.0 20.2 7.7 4.5 10.7 10.1 8.7 9.6 9.9 9.1 7.0 6.9 9.7 3.5 9.0 8.8 11.1 12.1 5.2 8.6 5.8 11.4 11.1 13.2 15.0 11.2 7.7 12.2 5.7 7.2 7.3 11.5 17.5 2.7 15.0 8.0 13.9 8.5 7.5 6.5 8.8 12.8 8.8 5.3 4.4 12.6 5.7 11.5 6.2 6.2 8.0 9.4 7.4 3.6 12.7 8.8 16.4 5.6 8.0 10.1 10.6 7.9 4.6 4.2 6.0 11.8 8.5 4.3 7.7 10.7 7.8 4.8 3.9 7.0 7.2 9.2 12.9 12.2 8.1 19.2 7.5 6.3 3.9 9.1 7.0 6.5 7.8 5.8 9.7 9.6 6.9 7.1 6.8 8.1 7.3 7.5 8.4 6.9 4.2 9.9 7.4 3.5 6.3 9.7 20.3 10.0 7.4 5.4 8.8 7.3 8.0 9.0 11.9 8.9 5.6 5.1 5.3 21.0 11.4 10.2 6.7 10.3 10.4 31.4 5.9 0.0 3.9 140.9 7.1 4.7 0.0 6.2 4.9 6.6 5.1 19.7 7.4 3.6 19.1 4.1 6.7 5.3 46.0 19.5 5.8 6.8 4.6 5.7 12.8 7.6 6.5 18.7 2.6 23.7 6.5 6.1 26.7 19.4 7.2 3.8 12.5 6.5 4.2 EED "HEED, WAIT-1" ENSG00000074266 "Embryonic ectoderm development" O75530 11 86244544-86278813 "Disease related genes, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012211, HPA060089, HPA061140" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB012211: AB_2262066, HPA060089: AB_2684201, HPA061140: AB_2684437" "unprognostic (7.46e-2)" "unprognostic (4.40e-2)" "unprognostic (1.65e-1)" "unprognostic (1.02e-2)" "unprognostic (1.33e-1)" "unprognostic (3.13e-2)" "prognostic unfavorable (1.80e-5)" "unprognostic (2.90e-1)" "unprognostic (1.32e-2)" "unprognostic (2.39e-1)" "unprognostic (2.31e-1)" "unprognostic (9.19e-3)" "prognostic unfavorable (1.36e-7)" "unprognostic (1.67e-1)" "unprognostic (1.71e-1)" "unprognostic (1.33e-2)" "prognostic favorable (2.27e-5)" 10.9 12.0 20.1 20.6 19.8 9.7 14.0 33.4 26.5 13.4 14.4 10.4 19.2 15.6 20.0 20.1 16.7 13.5 14.5 10.8 17.7 12.7 13.7 15.1 13.0 31.1 18.3 17.7 16.9 14.1 16.2 21.6 17.6 17.7 15.5 15.0 9.8 13.7 13.8 11.8 14.6 14.6 12.5 18.2 19.5 13.7 12.5 20.5 17.0 14.6 11.9 36.2 14.9 22.8 21.5 6.7 11.3 7.6 8.9 27.3 9.2 11.7 13.5 14.2 6.1 7.9 6.6 16.5 17.4 7.3 15.4 15.6 42.4 22.6 26.5 18.4 4.9 15.9 14.7 16.8 9.2 14.7 27.4 8.0 17.8 13.5 12.6 6.9 18.3 11.9 4.3 6.1 16.4 6.9 6.4 7.0 11.9 19.5 5.7 13.1 19.2 17.0 18.5 10.5 37.6 6.6 18.8 17.6 12.9 10.0 19.4 9.9 8.0 22.3 10.5 4.9 11.0 17.6 7.8 6.9 17.0 16.1 25.0 15.1 3.3 10.6 21.5 4.8 16.1 12.7 11.3 4.5 7.1 13.3 7.2 11.6 21.5 17.4 16.6 6.7 18.8 14.0 15.8 1.9 8.9 7.6 4.4 27.3 9.2 20.1 19.8 33.4 26.5 17.7 12.7 18.3 17.7 17.7 20.5 6.0 9.4 18.2 10.8 22.8 23.0 8.1 7.6 10.7 2.3 7.0 17.7 38.3 16.6 13.6 4.9 15.2 11.5 0.0 8.8 28.8 17.9 8.0 16.1 10.9 14.9 30.2 6.9 14.1 13.6 2.3 21.0 11.3 18.6 36.9 11.2 9.9 10.4 11.4 16.3 6.2 17.7 6.5 14.3 12.7 18.8 14.6 20.8 28.4 11.8 18.4 EEF1AKMT2 "C10orf138, Efm4, METTL10" ENSG00000203791 "EEF1A lysine methyltransferase 2" Q5JPI9 10 124748149-124791870 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 24.1;Distal tubular cells: 56.3;Extravillous trophoblasts: 24.1;Proximal tubular cells: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA050138 Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Vesicles, Cytosol" "HPA050138: AB_2681030" "unprognostic (1.64e-3)" "unprognostic (3.42e-2)" "unprognostic (1.34e-1)" "unprognostic (9.75e-2)" "unprognostic (7.19e-2)" "unprognostic (1.17e-1)" "unprognostic (2.33e-2)" "unprognostic (2.29e-3)" "unprognostic (9.04e-3)" "unprognostic (9.76e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (4.82e-4)" "unprognostic (3.90e-2)" "unprognostic (4.44e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (2.53e-4)" "unprognostic (9.09e-2)" 11.5 11.8 17.6 13.2 19.0 13.0 17.3 25.2 18.0 11.1 12.0 12.5 17.3 6.2 11.8 18.3 10.1 11.7 10.7 14.0 13.8 12.6 16.5 17.8 9.0 9.8 12.3 14.2 16.4 11.3 15.7 15.4 10.2 12.1 12.5 13.3 9.6 15.0 12.2 28.4 10.5 11.2 13.0 14.8 9.6 12.5 28.6 13.3 8.3 17.7 12.1 12.0 9.3 12.5 9.8 6.7 6.0 5.2 10.4 10.8 5.7 19.0 5.0 8.0 10.6 5.0 12.3 6.1 8.9 15.3 12.5 11.6 5.6 13.8 11.5 5.1 7.9 6.4 6.4 7.2 5.8 18.3 11.9 3.8 7.5 5.9 5.9 10.6 11.6 5.5 6.8 7.4 6.2 14.5 9.5 8.4 9.7 11.5 14.5 15.0 6.9 7.3 11.6 8.0 6.7 7.9 3.3 7.8 4.4 5.9 3.8 2.1 7.9 4.8 6.2 14.7 5.6 8.1 12.6 8.5 5.2 6.6 5.8 14.2 6.8 6.0 11.9 7.2 5.4 6.4 6.0 5.0 3.5 8.1 5.0 10.5 9.8 8.8 8.5 6.2 6.6 10.8 8.5 1.5 10.4 5.2 6.7 9.9 5.7 17.6 19.0 25.2 18.0 13.8 12.6 12.3 14.2 12.1 13.3 3.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 4.5 10.4 0.0 24.1 56.3 16.7 0.0 0.0 0.0 0.0 17.6 24.1 0.0 0.0 2.3 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 19.8 0.0 0.0 16.1 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 EEF1AKMT3 "DKFZP586D0919, FAM119B, METTL21B" ENSG00000123427 "EEF1A lysine methyltransferase 3" Q96AZ1 12 57771492-57782541 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 39.7" "Cell type enhanced" "Detected in some" 10 "Exocrine glandular cells: 10.8;Hofbauer cells: 6.6;monocytes: 15.4;Proximal tubular cells: 12.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 7 "RH-30: 59.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA043020, HPA045492" Uncertain Approved "Nucleoplasm,Mitotic chromosome,Centrosome" NA NA Centrosome "Nucleoplasm, Mitotic chromosome" "HPA043020: AB_2678274, HPA045492: " "unprognostic (2.00e-1)" "unprognostic (6.52e-2)" "unprognostic (7.96e-2)" "unprognostic (1.60e-1)" "unprognostic (1.53e-1)" "unprognostic (2.01e-1)" "unprognostic (1.55e-3)" "unprognostic (1.06e-1)" "unprognostic (7.34e-3)" "unprognostic (7.52e-3)" "unprognostic (1.66e-1)" "unprognostic (2.32e-1)" "unprognostic (1.54e-3)" "unprognostic (5.77e-2)" "unprognostic (1.33e-1)" "unprognostic (1.34e-2)" "unprognostic (1.23e-1)" 9.3 6.1 3.1 3.8 3.0 1.6 10.1 3.7 3.8 8.9 5.4 2.5 8.7 2.8 10.1 8.1 6.4 7.2 8.3 3.9 2.5 1.6 10.8 6.1 7.2 5.5 2.1 2.7 10.7 34.4 6.0 3.6 4.5 3.5 7.7 3.7 6.1 39.7 14.6 2.8 6.2 3.3 7.0 2.9 3.8 6.0 4.3 1.4 1.5 8.4 5.1 6.2 7.7 6.9 0.7 3.9 1.2 5.4 1.8 10.6 2.6 1.9 3.5 1.8 2.2 5.3 5.0 1.5 2.2 4.4 3.7 3.7 2.1 3.3 1.1 2.5 3.0 2.6 1.9 1.4 1.3 3.7 1.2 2.1 5.6 1.9 3.5 4.7 1.4 2.4 5.3 3.5 3.8 4.0 6.0 3.9 5.2 3.3 8.9 2.2 1.5 1.6 3.9 1.3 1.4 3.2 3.3 59.3 3.8 2.5 2.2 1.7 2.4 3.9 2.8 2.4 1.7 4.7 3.7 3.7 5.5 3.1 2.2 2.3 1.9 0.8 1.5 4.2 6.0 3.7 0.5 3.9 0.1 2.5 1.5 10.6 0.7 4.9 2.9 3.9 0.7 2.5 1.9 1.2 1.8 5.4 2.0 3.0 2.6 3.1 3.0 3.7 3.8 2.5 1.6 2.1 2.7 3.5 1.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.4 1.8 0.0 2.7 5.0 4.7 0.0 0.0 0.0 0.0 10.8 4.0 0.0 0.0 2.3 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 15.4 0.0 0.0 6.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 EEF1AKMT4 ENSG00000284753 "EEF1A lysine methyltransferase 4" O60344 3 184249650-184259585 "Predicted intracellular proteins" "Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 29.5" "Group enriched" "Detected in some" 4 "Club cells: 5.7;Collecting duct cells: 7.0;Distal tubular cells: 13.3;Ductal cells: 14.2;Exocrine glandular cells: 13.1;Pancreatic endocrine cells: 10.0;Proximal tubular cells: 17.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" HPA062215 Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA062215: AB_2684714" 2.1 1.7 0.2 3.3 0.8 1.8 1.9 0.3 0.5 1.3 4.2 0.0 2.5 2.5 0.6 0.5 4.1 0.4 1.4 2.4 0.4 4.2 29.5 2.3 2.5 0.2 0.0 1.7 8.3 1.0 3.1 8.4 0.8 1.6 2.3 0.8 5.7 2.7 5.4 2.4 4.3 1.1 0.1 3.7 1.6 13.0 0.6 4.8 6.9 4.5 3.7 1.3 1.6 4.9 10.1 1.2 12.0 3.4 7.6 5.6 13.1 6.9 1.6 4.4 2.4 1.6 10.1 1.5 2.9 2.3 2.2 12.9 2.0 15.6 10.3 1.7 12.2 4.9 7.4 7.5 1.3 6.1 8.7 4.1 4.4 8.2 2.9 10.8 3.5 2.0 9.1 2.6 4.5 1.0 1.9 5.2 7.4 14.5 1.1 20.6 4.4 13.1 3.3 17.2 13.1 9.2 2.2 12.6 2.7 3.2 8.0 2.7 3.0 23.7 5.8 2.4 19.9 5.0 1.4 2.6 3.5 6.1 7.6 8.7 17.5 15.4 2.1 17.9 2.7 0.0 12.0 1.2 4.3 9.7 4.8 4.9 4.6 4.2 10.1 3.2 3.3 5.2 0.2 3.4 6.2 9.0 7.6 5.6 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 2.7 5.7 7.0 0.0 0.0 13.3 14.2 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.8 0.0 0.0 10.0 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EEF1AKMT4-ECE2 ENSG00000284917 "EEF1AKMT4-ECE2 readthrough" O60344 3 184249695-184293031 "Predicted membrane proteins" "Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 22.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "REH: 5.1" HPA062215 Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA062215: AB_2684714" 1.2 6.6 0.0 2.1 0.1 0.3 0.3 0.0 1.5 0.6 2.9 0.0 1.5 0.9 0.3 0.3 2.8 0.5 0.6 2.1 0.0 2.8 22.6 1.3 1.5 0.0 0.0 0.9 6.0 1.5 2.0 6.1 0.2 1.4 0.6 0.2 4.0 1.6 3.8 0.3 2.9 0.4 0.0 2.4 0.3 9.7 0.0 3.3 4.9 3.1 2.5 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EEF1D "EF-1D, FLJ20897" ENSG00000104529 "Eukaryotic translation elongation factor 1 delta" P29692 8 143579697-143599541 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Transcription, Transcription regulation" "DNA-binding, Elongation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045101, HPA051002" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA 900000 "Nucleoplasm, Nucleoli fibrillar center" "HPA045101: AB_10963077, HPA051002: AB_2681305" "unprognostic (9.34e-2)" "unprognostic (2.37e-2)" "unprognostic (9.92e-2)" "unprognostic (1.63e-3)" "unprognostic (5.25e-2)" "unprognostic (2.06e-1)" "prognostic unfavorable (3.82e-4)" "unprognostic (8.56e-2)" "unprognostic (3.74e-1)" "unprognostic (2.98e-1)" "unprognostic (1.80e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (2.58e-5)" "unprognostic (3.99e-2)" "unprognostic (2.06e-1)" "unprognostic (2.67e-2)" "unprognostic (2.14e-1)" 58.0 47.7 25.2 48.0 23.6 67.6 61.7 20.1 25.9 56.4 54.7 35.0 50.8 33.8 57.2 50.8 63.0 39.5 68.6 58.5 24.5 20.5 43.0 89.4 49.1 123.8 27.3 18.7 95.0 258.8 23.3 27.8 34.6 22.3 70.7 25.3 50.2 98.6 48.3 95.1 56.2 45.4 65.7 31.2 60.1 49.9 33.4 23.3 73.4 76.4 82.3 77.4 57.8 94.6 122.6 75.1 35.9 46.3 69.1 128.4 143.7 47.2 69.1 30.9 26.6 27.9 34.5 34.3 36.8 47.3 58.7 46.7 94.3 45.1 36.3 38.9 41.0 17.6 47.2 31.8 59.3 25.5 28.7 52.5 35.6 121.9 91.8 41.7 22.1 30.3 66.2 86.8 35.4 40.4 34.1 39.2 30.2 33.3 54.0 33.2 152.8 86.2 56.3 32.5 61.0 91.7 38.3 22.2 71.1 50.1 80.4 30.6 33.2 32.0 78.8 76.9 19.9 58.9 56.7 30.3 34.2 100.5 50.8 79.0 36.7 14.1 37.9 38.4 45.3 29.6 19.5 46.3 21.3 80.0 41.6 103.1 114.0 102.4 83.8 53.3 122.6 128.4 103.5 35.9 69.1 36.6 75.1 96.2 143.7 25.2 23.6 20.1 25.9 24.5 20.5 27.3 18.7 22.3 23.3 151.8 402.8 1440.8 1444.3 1639.8 62.4 3.4 624.2 165.9 319.6 324.5 19.6 620.5 724.5 707.0 361.5 548.9 855.0 397.1 1547.6 714.1 839.0 1217.7 435.3 711.1 705.0 74.7 329.6 699.7 1314.5 782.6 825.3 1016.5 1029.1 1074.0 721.8 200.1 963.8 568.1 595.0 1184.5 78.1 472.1 1232.9 20.2 140.9 1441.1 595.9 1397.5 726.5 1215.8 EEF1E1 "AIMP3, P18" ENSG00000124802 "Eukaryotic translation elongation factor 1 epsilon 1" O43324 6 8073360-8102578 "Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 233.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA027901, HPA057866" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA027901: AB_10611960, HPA057866: AB_2683547" "unprognostic (9.39e-3)" "prognostic favorable (3.16e-4)" "unprognostic (2.23e-1)" "unprognostic (2.36e-2)" "unprognostic (1.42e-2)" "unprognostic (8.21e-2)" "prognostic unfavorable (1.55e-7)" "unprognostic (1.79e-1)" "unprognostic (5.67e-2)" "prognostic favorable (3.24e-4)" "unprognostic (1.13e-1)" "unprognostic (1.76e-2)" "unprognostic (1.52e-2)" "unprognostic (1.37e-1)" "unprognostic (2.97e-1)" "unprognostic (1.24e-1)" "unprognostic (1.13e-1)" 10.5 21.8 20.1 14.2 26.9 34.0 18.5 20.0 24.6 10.8 12.2 13.5 12.3 8.2 13.6 19.2 15.9 10.3 9.5 12.5 19.4 27.0 34.9 19.2 9.9 19.7 26.9 16.2 10.8 26.6 19.8 28.6 11.7 41.2 12.5 15.2 9.6 13.5 13.4 14.4 8.4 8.4 13.3 21.3 11.8 14.8 36.3 19.4 9.9 13.9 15.8 20.3 11.6 9.3 20.9 29.6 6.8 15.0 14.0 21.3 13.5 28.1 14.9 24.0 16.5 7.9 13.3 14.6 23.7 15.0 21.4 22.1 24.3 11.8 30.9 52.3 15.4 39.2 11.7 27.1 27.3 36.1 17.3 35.3 24.9 19.7 42.2 14.7 49.3 18.4 11.1 25.8 25.5 26.5 15.0 30.2 25.5 59.5 8.6 20.4 11.8 21.1 40.1 21.6 27.5 24.0 25.9 14.1 48.5 35.0 21.7 35.7 11.1 10.1 22.8 28.2 33.9 18.1 17.0 15.6 17.9 17.7 16.2 34.3 13.5 61.1 43.9 10.0 20.9 28.4 6.2 11.0 6.8 13.5 15.0 19.1 20.9 18.1 17.8 29.6 20.5 20.3 20.6 1.1 14.0 11.2 13.0 21.3 13.5 20.1 26.9 20.0 24.6 19.4 27.0 26.9 16.2 41.2 19.4 14.9 28.8 28.9 35.2 58.5 35.8 20.7 15.3 33.5 37.5 57.6 9.8 71.1 119.3 54.7 233.2 31.6 7.7 23.3 76.4 54.8 31.5 42.5 15.1 26.4 44.1 28.6 38.5 23.4 30.6 155.8 24.5 35.1 40.5 22.6 35.3 32.1 63.6 7.0 22.3 129.8 16.8 12.9 36.0 118.9 83.7 66.6 27.0 27.3 39.8 36.5 EEF2K eEF-2K ENSG00000103319 "Eukaryotic elongation factor 2 kinase" O00418 16 22206282-22288732 "Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 60.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 4.0;HMC-1: 4.8;NB-4: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007818, HPA056061" Approved Approved Nucleoplasm NA NA Nucleoplasm "CAB007818: AB_598150, HPA056061: AB_2683021" "unprognostic (4.79e-2)" "unprognostic (6.10e-1)" "unprognostic (3.89e-2)" "unprognostic (3.49e-1)" "unprognostic (1.94e-2)" "unprognostic (5.09e-3)" "unprognostic (1.40e-1)" "unprognostic (2.24e-2)" "unprognostic (1.74e-1)" "unprognostic (8.50e-2)" "unprognostic (2.01e-2)" "unprognostic (9.07e-3)" "prognostic unfavorable (2.38e-4)" "unprognostic (2.86e-1)" "unprognostic (1.11e-1)" "unprognostic (1.24e-1)" "unprognostic (1.80e-1)" 16.8 5.5 5.3 8.6 3.7 7.6 12.4 17.5 4.8 14.3 10.7 1.3 9.4 5.6 13.2 8.3 6.1 8.2 12.5 9.0 3.2 3.3 3.7 5.5 9.2 6.7 2.4 4.9 6.4 8.1 3.3 3.0 6.4 4.9 12.5 4.6 4.4 12.4 20.5 16.2 37.5 5.1 15.5 1.6 6.1 6.4 4.6 3.1 4.0 4.4 11.5 6.7 13.3 14.2 0.7 2.3 2.2 0.9 1.3 1.6 0.1 0.1 0.0 0.0 0.0 1.1 1.3 1.0 0.0 0.0 0.2 0.0 0.7 0.0 1.0 0.4 0.0 0.0 4.0 0.6 0.0 0.0 0.4 0.0 1.6 0.7 2.7 0.0 3.8 4.8 0.0 1.0 0.3 0.3 0.9 0.2 0.2 0.5 3.4 0.0 0.0 0.2 4.1 0.4 1.1 0.0 1.0 2.6 0.7 1.2 0.0 1.0 1.6 0.0 0.0 0.4 0.3 0.6 1.2 1.3 2.4 0.9 3.7 0.1 0.8 0.4 1.1 2.8 2.8 0.4 1.5 0.8 0.6 0.5 0.9 0.7 0.4 0.3 0.2 0.2 0.7 0.7 0.3 2.2 1.3 0.5 2.3 1.6 0.1 5.3 3.7 17.5 4.8 3.2 3.3 2.4 4.9 4.9 3.1 20.8 14.1 9.5 7.8 11.2 47.9 16.2 15.3 18.7 12.5 8.7 13.7 15.1 0.0 4.0 41.4 9.5 8.5 0.0 11.6 10.1 9.3 6.6 28.8 14.5 16.0 1.6 2.9 16.0 11.5 60.9 13.3 8.1 8.5 7.2 10.9 7.7 9.6 25.9 14.9 3.0 19.6 6.5 10.3 0.9 3.6 20.1 6.5 7.5 6.8 3.9 EEFSEC "eEFSec, EFSEC, SELB" ENSG00000132394 "Eukaryotic elongation factor, selenocysteine-tRNA specific" P57772 3 128153454-128408646 "Predicted intracellular proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 63.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 12.4;GAMG: 10.3;SH-SY5Y: 8.8;SK-BR-3: 14.7;SK-MEL-30: 12.7;T-47d: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035795 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA035795: AB_10696512" "unprognostic (1.01e-1)" "prognostic favorable (2.98e-5)" "unprognostic (2.53e-1)" "unprognostic (1.32e-3)" "unprognostic (1.12e-1)" "unprognostic (3.03e-1)" "unprognostic (4.37e-3)" "unprognostic (6.06e-2)" "unprognostic (6.78e-3)" "unprognostic (2.84e-1)" "unprognostic (1.61e-2)" "unprognostic (3.83e-2)" "unprognostic (1.12e-2)" "unprognostic (4.31e-2)" "unprognostic (1.99e-1)" "unprognostic (1.70e-1)" "unprognostic (4.11e-2)" 8.2 6.8 5.6 7.9 7.9 3.1 7.9 8.4 9.8 11.6 8.6 9.3 7.3 2.5 10.8 5.4 8.0 9.4 7.1 18.7 7.6 6.4 9.4 18.1 7.1 15.5 5.4 4.2 11.5 8.4 23.9 9.2 9.7 6.9 9.0 4.9 7.2 10.7 11.2 20.3 15.9 15.7 10.0 5.0 9.2 6.9 11.5 6.2 17.2 8.4 6.7 10.5 7.7 7.9 7.1 10.9 7.3 7.8 9.7 7.0 3.8 0.4 0.1 3.4 1.4 0.1 0.2 0.4 0.0 0.2 0.2 0.2 0.3 5.7 12.4 0.1 3.1 10.3 0.9 0.3 0.1 0.1 0.3 0.2 0.0 0.1 0.1 4.9 0.2 0.3 0.1 0.1 3.4 0.1 0.1 0.2 0.0 0.0 0.2 2.9 0.1 6.2 0.3 0.4 0.0 0.1 0.2 0.2 0.8 0.0 0.0 0.3 8.8 0.0 14.7 12.7 0.3 7.9 0.5 0.0 0.1 0.0 0.1 0.2 0.4 0.6 0.3 0.1 0.4 0.2 0.5 7.5 7.3 6.7 7.8 5.6 7.1 5.9 5.8 10.9 5.8 5.6 6.5 0.0 9.7 6.2 4.6 7.0 3.8 5.6 7.9 8.4 9.8 7.6 6.4 5.4 4.2 6.9 6.2 0.0 5.9 11.8 7.7 5.7 8.7 9.4 0.0 2.7 1.2 15.7 2.0 19.4 13.3 5.9 21.8 7.1 5.5 0.0 6.2 14.9 10.0 7.4 27.7 11.9 13.0 12.7 10.9 6.2 6.0 63.4 12.0 8.6 11.8 3.6 8.7 8.3 5.4 0.0 8.1 21.4 6.6 25.8 7.5 26.5 16.0 8.7 24.8 10.2 8.7 5.6 EFCAB1 FLJ11767 ENSG00000034239 "EF-hand calcium binding domain 1" Q9HAE3 8 48710789-48735311 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 61.9" "Group enriched" "Detected in many" 21 "Ciliated cells: 342.6;Early spermatids: 456.6;Late spermatids: 332.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.9" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 4.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 9.1;ASC diff: 4.0;ASC TERT1: 9.3;CAPAN-2: 4.5;hTEC/SVTERT24-B: 3.8;SCLC-21H: 7.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023527, HPA069955" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA023527: AB_2231065, HPA069955: AB_2686220" "unprognostic (5.29e-3)" "unprognostic (7.39e-3)" "unprognostic (1.05e-1)" "unprognostic (2.67e-3)" "unprognostic (4.67e-2)" "unprognostic (2.77e-1)" "unprognostic (9.81e-2)" "unprognostic (1.62e-1)" "unprognostic (2.52e-2)" "unprognostic (1.85e-1)" "unprognostic (5.94e-3)" "unprognostic (7.81e-2)" "unprognostic (4.87e-3)" "unprognostic (4.81e-2)" "unprognostic (1.99e-1)" "unprognostic (2.51e-1)" "unprognostic (3.47e-3)" 0.6 1.5 5.4 0.5 9.5 0.9 2.5 0.2 4.1 8.1 0.8 14.0 10.3 0.9 8.6 19.0 0.9 61.9 0.9 0.6 9.1 8.4 0.6 0.9 16.5 0.5 2.7 3.9 13.7 1.8 0.4 2.0 0.8 23.9 4.2 0.7 1.9 1.8 4.6 0.5 3.5 1.1 2.7 1.4 0.6 0.8 19.7 3.0 0.0 0.5 0.3 0.6 1.4 2.1 1.0 0.0 4.1 0.0 1.1 1.1 0.3 9.1 0.0 1.2 0.0 4.0 9.3 0.0 0.1 0.9 0.0 0.3 0.0 4.5 0.0 0.0 0.2 0.0 2.5 0.0 1.1 0.3 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.1 3.3 0.3 3.8 1.6 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.5 0.0 0.3 0.1 0.0 0.0 0.0 2.1 7.2 0.5 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.5 0.0 1.1 1.0 0.7 0.8 0.0 0.8 0.5 0.3 4.1 1.1 0.0 0.0 0.7 0.3 5.4 9.5 0.2 4.1 9.1 8.4 2.7 3.9 23.9 3.0 0.0 5.1 0.0 6.6 6.1 0.0 0.4 0.0 342.6 18.2 0.0 0.0 0.3 0.0 0.1 456.6 0.1 0.0 0.0 1.3 0.1 1.9 2.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 332.2 4.4 1.2 1.7 0.0 0.0 0.0 2.0 0.0 5.3 0.0 0.0 0.0 0.8 5.7 4.4 1.6 0.2 0.0 0.0 1.8 EFCAB12 C3orf25 ENSG00000172771 "EF-hand calcium binding domain 12" Q6NXP0 3 129401321-129428651 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.4;fallopian tube: 29.9;testis: 24.8" "Cell type enhanced" "Detected in some" 22 "Ciliated cells: 58.9;Early spermatids: 23.2;Late spermatids: 14.5" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 4 "basal ganglia: 14.9;pons and medulla: 24.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Hep G2: 4.7;RPTEC TERT1: 3.8;SCLC-21H: 2.9" "Region enhanced" "Detected in many" "midbrain: 14.2" "HPA037694, HPA057532" Uncertain Supported Approved "Nucleoplasm,Nuclear bodies,Midbody ring" NA NA Nucleoplasm "Nuclear bodies, Midbody ring" "HPA037694: AB_10672605, HPA057532: " "unprognostic (2.06e-3)" "unprognostic (1.87e-2)" "unprognostic (2.96e-2)" "unprognostic (4.34e-3)" "unprognostic (1.81e-1)" "unprognostic (7.59e-4)" "unprognostic (2.37e-2)" "unprognostic (2.60e-1)" "unprognostic (1.13e-1)" "unprognostic (1.64e-1)" "unprognostic (1.81e-2)" "unprognostic (3.84e-1)" "unprognostic (1.20e-1)" "unprognostic (5.72e-2)" "unprognostic (2.27e-1)" "unprognostic (1.57e-2)" "unprognostic (4.59e-2)" 0.7 0.6 2.2 0.7 14.9 1.5 0.9 1.7 3.0 2.0 0.6 7.8 0.0 0.5 1.8 10.1 0.6 29.9 1.5 0.7 4.2 4.3 1.2 2.1 3.6 0.8 0.5 3.5 6.1 1.0 3.1 15.2 0.7 24.4 4.1 0.6 1.5 0.6 0.9 0.5 0.5 0.5 0.6 1.0 0.7 1.0 24.8 1.6 0.0 2.4 0.0 0.9 0.5 0.1 1.4 0.0 1.3 0.4 0.3 0.6 0.0 0.4 2.2 0.7 2.2 0.4 0.1 0.4 0.0 0.2 0.3 0.1 0.8 1.2 0.5 0.4 0.0 0.0 0.3 0.0 0.4 0.3 0.6 0.5 0.6 0.6 4.7 0.3 0.3 0.9 0.5 0.0 0.5 0.0 0.4 0.0 1.3 1.4 0.9 0.0 0.3 0.1 1.7 0.3 0.2 0.1 0.8 0.0 0.5 3.8 0.0 2.9 0.1 0.0 0.0 0.1 0.0 0.8 0.3 0.0 0.0 0.5 1.1 0.2 1.4 1.8 2.2 0.5 0.8 0.2 0.0 0.4 0.8 0.1 0.0 0.3 0.3 0.0 0.6 0.0 1.4 0.3 0.2 1.3 0.3 0.0 0.0 0.2 0.0 2.2 14.9 1.7 3.0 4.2 4.3 0.5 3.5 24.4 1.6 3.0 1.7 0.0 0.1 0.5 0.2 1.1 2.5 58.9 2.3 0.0 2.0 0.0 0.0 0.1 23.2 0.3 0.0 0.0 0.2 0.0 0.2 0.8 0.0 0.8 0.1 4.8 0.0 0.0 0.0 14.5 0.3 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.8 5.2 0.0 0.0 8.2 2.5 0.3 0.0 0.0 0.0 0.1 EFCAB13 "C17orf57, FLJ40342" ENSG00000178852 "EF-hand calcium binding domain 13" Q8IY85 17 47323290-47441312 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "vagina: 29.9" "Group enriched" "Detected in many" 4 "Early spermatids: 161.3;Late spermatids: 143.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "CAB002501, HPA021633, HPA023249, HPA026561" Uncertain Enhanced "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear speckles" "CAB002501: AB_564092, HPA021633: AB_1845594, HPA023249: AB_1845595, HPA026561: AB_1845596" "unprognostic (1.66e-1)" "unprognostic (3.48e-1)" "unprognostic (1.24e-2)" "unprognostic (2.40e-2)" "unprognostic (6.71e-2)" "unprognostic (3.04e-2)" "unprognostic (3.04e-1)" "unprognostic (1.40e-1)" "unprognostic (7.43e-2)" "unprognostic (8.79e-3)" "unprognostic (8.75e-2)" "unprognostic (1.75e-2)" "unprognostic (1.46e-5)" "unprognostic (1.68e-1)" "unprognostic (1.61e-1)" "unprognostic (8.10e-2)" "unprognostic (1.90e-3)" 4.1 2.8 2.9 12.2 3.4 3.4 6.5 2.8 3.8 6.5 4.7 2.3 3.5 4.8 8.9 4.4 2.4 4.2 4.1 3.5 2.3 1.5 7.5 4.0 3.1 4.3 3.6 0.4 5.5 2.8 8.4 7.6 5.4 3.2 9.3 3.4 2.6 5.4 2.0 1.3 2.2 6.3 9.9 3.5 4.6 3.5 20.0 2.7 2.4 14.9 0.7 4.3 5.5 29.9 5.6 1.0 5.3 2.1 0.8 2.6 0.8 0.9 4.0 1.7 0.2 2.1 7.3 3.1 2.2 0.5 0.7 1.2 1.7 5.6 0.3 6.6 0.8 0.0 1.1 0.0 0.4 4.0 0.2 0.6 5.2 3.3 0.5 2.1 4.0 0.6 1.3 1.9 2.7 0.0 5.0 4.5 4.1 1.5 9.9 2.4 0.1 1.7 2.3 0.9 2.8 3.2 4.7 1.3 1.8 9.2 3.2 1.2 0.6 1.2 0.1 2.6 1.3 6.6 4.7 1.6 0.3 1.3 0.4 1.1 10.2 7.0 0.9 6.3 7.8 4.3 5.3 2.1 0.6 1.1 1.2 0.9 4.3 0.9 0.6 1.0 5.6 2.6 1.2 0.0 0.8 0.7 0.4 0.1 0.8 2.9 3.4 2.8 3.8 2.3 1.5 3.6 0.4 3.2 2.7 8.9 2.1 2.0 1.7 0.7 2.3 3.8 0.0 5.3 1.2 0.0 0.0 0.2 0.0 0.7 161.3 6.3 0.5 0.0 0.7 0.2 1.3 1.0 5.8 0.8 1.7 3.2 2.9 3.7 2.1 143.2 1.7 1.3 0.0 1.8 0.2 1.1 1.2 0.0 3.5 0.8 2.6 0.0 2.3 34.1 7.9 0.5 0.0 0.0 0.6 1.0 EFCAB6 "dJ185D5.1, DJBP, FLJ23588, HSCBCIP1, KIAA1672" ENSG00000186976 "EF-hand calcium binding domain 6" Q5THR3 22 43528744-43812337 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.2;testis: 32.2" "Group enriched" "Detected in many" 13 "Early spermatids: 263.3;Late spermatids: 334.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 5.6;RPTEC TERT1: 3.8" "Low region specificity" "Detected in some" HPA003098 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA003098: AB_1079087" "unprognostic (1.85e-1)" "unprognostic (8.85e-3)" "unprognostic (4.45e-2)" "unprognostic (1.04e-5)" "unprognostic (1.00e-1)" "unprognostic (4.25e-2)" "unprognostic (4.96e-2)" "unprognostic (8.82e-3)" "unprognostic (2.02e-1)" "unprognostic (1.54e-1)" "unprognostic (1.91e-3)" "unprognostic (3.66e-2)" "unprognostic (1.71e-3)" "unprognostic (4.54e-1)" "unprognostic (1.82e-1)" "unprognostic (1.65e-3)" "unprognostic (1.33e-2)" 1.2 1.8 3.3 0.8 4.8 0.6 2.1 1.2 4.7 2.2 1.3 3.0 8.9 1.0 2.3 9.3 1.2 11.5 2.2 1.3 2.3 2.6 2.7 1.1 2.6 0.8 1.4 2.4 4.0 2.3 5.2 17.2 0.8 5.7 1.9 0.9 5.2 1.7 4.8 1.0 1.2 0.9 1.3 1.3 0.8 1.8 32.2 1.3 0.0 5.0 0.5 0.8 1.3 1.2 0.3 0.0 0.0 1.3 0.0 0.6 0.1 0.3 0.8 1.2 1.7 1.5 5.6 0.0 1.3 1.0 0.3 0.6 0.0 0.3 0.0 0.8 0.6 2.3 1.6 0.0 0.4 1.2 0.0 0.4 0.0 0.0 0.0 3.3 0.1 0.0 1.9 2.0 1.4 0.4 1.3 0.4 0.5 0.1 0.1 0.9 3.5 0.1 0.3 1.5 1.0 0.5 0.1 0.0 0.1 3.8 0.7 2.3 0.9 3.3 0.1 1.8 1.0 0.6 0.0 0.4 1.0 0.3 1.3 0.3 0.2 0.2 0.0 2.3 0.0 0.5 0.0 0.0 0.0 0.0 1.3 0.6 0.0 0.2 0.0 0.0 0.3 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 3.3 4.8 1.2 4.7 2.3 2.6 1.4 2.4 5.7 1.3 3.0 2.6 0.0 0.8 0.2 4.0 1.4 0.0 22.7 3.4 0.0 5.9 0.0 0.0 0.5 263.3 0.0 0.0 0.0 0.6 0.1 0.3 0.5 1.1 0.0 0.2 6.4 0.0 0.6 0.0 334.9 2.8 0.0 0.0 1.0 0.4 2.0 1.1 0.0 1.4 1.0 12.9 6.5 1.0 23.2 4.7 0.1 0.1 0.0 0.2 0.1 EFCAB7 "KIAA1799, RP4-534K7.1" ENSG00000203965 "EF-hand calcium binding domain 7" A8K855 1 63523372-63572693 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 25.4;Sertoli cells: 25.8;Spermatocytes: 58.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029611, HPA029612, HPA029613" Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "Plasma membrane, Cytosol" "HPA029611: AB_10599972, HPA029612: AB_10600533, HPA029613: AB_10601004" "unprognostic (8.81e-2)" "unprognostic (5.24e-2)" "unprognostic (5.13e-2)" "unprognostic (1.64e-1)" "prognostic favorable (3.65e-4)" "unprognostic (1.70e-2)" "unprognostic (6.53e-4)" "unprognostic (2.99e-1)" "unprognostic (5.81e-3)" "unprognostic (1.69e-1)" "unprognostic (6.28e-2)" "unprognostic (1.66e-1)" "unprognostic (3.78e-2)" "unprognostic (2.18e-1)" "unprognostic (6.97e-2)" "unprognostic (9.90e-2)" "unprognostic (2.73e-1)" 4.3 8.4 12.7 3.5 16.7 3.1 9.3 24.5 19.5 9.4 5.1 3.7 6.4 3.2 9.6 9.8 5.7 12.6 7.2 9.7 11.4 11.8 8.8 2.8 6.2 5.2 8.1 10.8 12.8 4.9 16.3 31.6 5.1 13.7 8.7 5.0 3.5 5.3 8.2 10.8 4.9 3.4 7.5 9.4 4.2 5.0 20.0 10.2 11.5 9.1 2.4 5.2 7.3 12.9 3.3 1.7 9.8 3.3 1.8 2.9 1.1 6.0 5.1 6.7 4.3 7.1 10.6 3.4 3.9 4.3 6.8 8.4 1.6 4.8 4.3 9.4 2.2 13.9 5.6 5.7 3.7 8.2 7.9 4.0 3.4 9.5 3.5 4.5 4.7 3.1 5.7 9.2 8.0 5.4 10.8 5.7 7.9 4.3 7.0 4.4 1.3 9.0 3.2 2.9 4.2 5.1 5.8 10.1 4.2 10.4 3.2 14.4 5.5 7.5 4.2 9.6 9.4 4.3 3.4 1.5 3.8 3.4 11.4 3.7 4.7 8.1 4.9 7.0 3.4 5.6 9.8 0.7 0.2 2.1 0.4 2.9 3.3 2.4 2.5 1.3 2.8 2.5 2.4 0.1 1.8 3.3 1.7 2.7 1.1 12.7 16.7 24.5 19.5 11.4 11.8 8.1 10.8 13.7 10.2 11.9 2.6 2.9 5.2 2.7 8.3 6.2 0.0 25.4 4.5 5.2 3.9 2.9 6.6 2.9 17.3 2.1 0.5 0.0 0.6 1.6 3.0 1.5 2.3 0.8 2.1 0.0 1.7 2.5 2.4 3.2 10.0 1.1 1.7 1.8 1.4 5.8 1.1 0.0 12.7 4.6 10.5 25.8 2.3 58.1 17.7 1.9 1.0 1.3 1.7 0.7 EFHC2 "FLJ22843, MRX74" ENSG00000183690 "EF-hand domain containing 2" Q5JST6 X 44147882-44343672 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.6;fallopian tube: 20.8" "Group enriched" "Detected in many" 4 "Ciliated cells: 64.3;Early spermatids: 62.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "pons and medulla: 20.6" "Group enriched" "Detected in some" 5 "basophil: 14.1;NK-cell: 6.6" "Group enriched" "Detected in many" 5 "granulocytes: 14.1;NK-cells: 6.6" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.2;HEL: 5.4;HMC-1: 18.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034492 Approved Supported Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane" NA NA "Nucleoplasm, Nucleoli fibrillar center" "Plasma membrane" "HPA034492: AB_10671227" "unprognostic (1.93e-1)" "unprognostic (7.80e-3)" "unprognostic (7.35e-2)" "unprognostic (2.75e-1)" "unprognostic (6.83e-3)" "unprognostic (5.07e-2)" "unprognostic (4.29e-2)" "unprognostic (1.75e-2)" "unprognostic (3.50e-2)" "unprognostic (2.90e-2)" "unprognostic (3.88e-2)" "unprognostic (1.86e-2)" "unprognostic (7.89e-2)" "unprognostic (1.06e-1)" "unprognostic (6.13e-4)" "unprognostic (1.64e-3)" "unprognostic (4.97e-2)" 0.7 0.6 4.0 0.8 6.2 1.9 1.2 1.6 3.1 4.6 1.6 6.5 3.7 0.6 5.4 12.6 2.9 20.8 3.0 6.0 4.8 3.9 2.0 0.1 4.5 0.5 1.5 2.0 5.2 0.3 0.9 6.9 1.3 20.6 2.9 0.6 0.6 9.6 5.8 0.1 4.7 0.8 2.6 1.4 0.6 1.6 10.1 3.1 0.4 3.7 1.4 0.9 1.7 1.4 0.1 0.4 14.1 0.0 6.6 2.1 1.4 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 5.2 0.0 0.1 0.0 1.7 0.0 0.4 0.0 0.1 0.0 0.1 5.4 0.0 0.0 0.0 0.0 18.0 0.3 0.3 0.3 0.0 0.2 0.0 0.8 1.5 0.0 0.0 0.0 0.0 2.3 0.6 0.0 0.1 0.3 0.0 0.0 1.5 0.0 0.3 0.6 0.0 0.0 0.0 0.1 1.0 0.0 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 14.1 0.0 0.0 2.1 0.0 0.8 0.1 0.8 0.1 0.4 0.1 0.7 1.0 1.9 6.6 0.0 0.0 0.0 1.4 4.0 6.2 1.6 3.1 4.8 3.9 1.5 2.0 20.6 3.1 0.0 4.6 0.0 5.2 2.7 0.1 12.2 5.1 64.3 2.3 0.0 2.0 0.0 1.7 0.5 62.9 0.0 1.3 0.0 5.3 0.0 1.0 0.7 15.1 0.0 0.2 0.0 0.0 0.0 0.0 12.0 6.4 0.2 0.0 0.0 1.3 4.9 0.7 0.0 6.7 0.0 0.0 6.5 2.1 8.6 10.4 2.5 0.2 0.5 3.5 6.5 EFNB2 "EPLG5, Htk-L, HTKL, LERK5, MGC126226, MGC126227, MGC126228" ENSG00000125266 "Ephrin B2" P52799 13 106489731-106535662 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Angiogenesis, Differentiation, Host-virus interaction, Neurogenesis" "Developmental protein, Host cell receptor for virus entry, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Ito cells: 134.4;Muller glia cells: 92.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.5" "Lineage enhanced" "Detected in single" "NK-cells: 1.5" "Cell line enhanced" "Detected in many" "AF22: 48.7;OE19: 27.9;SH-SY5Y: 24.4;U-87 MG: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008999, CAB009368" Supported Supported Nucleoplasm,Cytosol NA NA 760000 Nucleoplasm Cytosol "CAB009368: AB_2095700, HPA008999: AB_1078721" "unprognostic (1.70e-1)" "unprognostic (1.95e-3)" "unprognostic (1.72e-1)" "unprognostic (5.22e-3)" "unprognostic (4.52e-3)" "prognostic unfavorable (3.11e-6)" "unprognostic (2.32e-2)" "prognostic unfavorable (8.43e-4)" "unprognostic (2.09e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (8.70e-5)" "unprognostic (1.60e-1)" "unprognostic (1.09e-2)" "unprognostic (1.30e-1)" "unprognostic (3.07e-1)" "unprognostic (4.62e-2)" "unprognostic (2.27e-3)" 15.7 4.9 11.2 8.2 11.0 0.8 21.8 8.3 14.0 13.2 23.1 5.8 13.1 13.9 10.8 5.2 11.4 13.6 11.2 11.8 10.4 6.5 9.3 11.8 50.1 7.8 6.2 11.5 8.4 3.7 5.7 6.1 27.7 5.2 11.8 18.4 15.2 12.7 20.6 6.6 14.3 20.6 10.5 5.0 9.3 21.3 7.2 5.9 7.3 11.2 8.8 5.9 7.7 12.4 0.2 0.0 0.4 0.0 1.5 0.0 0.0 11.6 1.1 48.7 0.0 0.1 0.3 0.1 5.3 3.3 5.3 3.0 11.8 17.8 0.0 5.1 1.6 0.4 13.9 1.8 6.8 5.7 0.0 10.4 0.0 4.0 0.0 1.0 3.8 0.3 2.2 12.2 0.2 10.4 2.6 6.6 0.1 0.0 0.0 5.7 2.0 0.1 0.0 2.6 27.9 2.3 9.8 1.9 0.0 7.5 1.5 3.4 24.4 2.0 1.0 0.0 14.3 0.6 0.1 5.2 10.4 0.0 0.3 11.9 0.1 0.0 0.0 21.9 0.2 2.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 11.2 11.0 8.3 14.0 10.4 6.5 6.2 11.5 5.2 5.9 6.0 29.4 1.9 48.4 73.8 9.4 7.4 7.6 9.4 12.5 24.4 0.0 1.1 0.0 6.9 0.4 80.4 63.8 0.0 1.2 2.6 17.1 25.9 18.4 0.4 1.0 6.4 48.6 134.4 8.6 0.5 0.3 1.3 30.4 0.0 38.0 92.0 27.1 53.7 0.4 0.0 2.8 0.0 20.3 0.6 3.2 75.2 1.6 3.2 27.5 75.5 EFS "CASS3, EFS1, EFS2, HEFS, SIN" ENSG00000100842 "Embryonal Fyn-associated substrate" O43281 14 23356402-23365752 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Leydig cells: 18.7;Syncytiotrophoblasts: 15.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 28.2;AN3-CA: 15.4;BEWO: 23.7;SH-SY5Y: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA001581, HPA001790" Approved Uncertain Nucleoplasm,Cytosol No NA Nucleoplasm Cytosol "HPA001581: AB_2666367, HPA001790: " "unprognostic (9.58e-3)" "unprognostic (1.10e-2)" "unprognostic (3.68e-2)" "unprognostic (1.78e-1)" "unprognostic (6.05e-2)" "unprognostic (5.76e-2)" "unprognostic (3.00e-1)" "unprognostic (3.85e-2)" "unprognostic (7.36e-2)" "unprognostic (2.15e-1)" "unprognostic (2.75e-1)" "unprognostic (1.00e-2)" "prognostic unfavorable (4.09e-5)" "unprognostic (3.44e-3)" "unprognostic (1.73e-1)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" 12.0 10.2 11.7 4.4 15.7 0.6 13.1 9.4 21.2 17.9 8.5 29.4 8.0 2.8 17.0 9.8 18.3 10.0 6.7 5.5 14.3 8.3 3.2 1.2 5.7 2.8 14.9 8.2 23.7 1.5 25.0 3.2 33.1 15.6 17.9 3.1 8.3 15.6 18.6 3.8 42.3 3.9 13.0 25.7 4.5 4.7 4.4 16.0 0.4 6.8 15.5 10.0 11.8 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 28.2 15.4 7.1 8.2 23.7 2.1 4.3 0.7 0.3 0.0 0.0 0.0 0.0 11.6 0.1 10.8 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 4.6 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 9.0 0.0 0.0 9.0 3.1 27.0 6.0 0.9 0.0 3.6 6.7 0.0 0.0 3.0 0.0 7.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 15.7 9.4 11.8 14.3 8.3 14.9 8.2 15.6 16.0 0.0 4.1 0.0 7.2 10.3 2.7 0.6 0.0 1.4 4.5 0.0 5.9 8.0 1.7 0.0 0.7 1.4 0.0 0.0 0.0 12.8 13.0 6.3 0.0 0.0 1.3 0.0 0.0 3.1 0.0 0.4 18.7 0.0 6.8 0.0 0.0 8.0 0.0 0.0 13.1 0.1 8.1 6.5 5.1 0.5 0.4 11.7 15.1 0.0 0.0 4.7 EFTUD2 "SNRNP116, Snrp116, Snu114, U5-116KD" ENSG00000108883 "Elongation factor Tu GTP binding domain containing 2" Q15029 17 44849943-44899662 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022021 Supported Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA022021: AB_1848032" "unprognostic (4.28e-2)" "unprognostic (4.12e-2)" "unprognostic (1.98e-3)" "unprognostic (1.32e-1)" "unprognostic (1.94e-1)" "unprognostic (4.98e-2)" "prognostic unfavorable (2.71e-6)" "unprognostic (6.94e-2)" "unprognostic (4.52e-1)" "unprognostic (2.37e-1)" "unprognostic (4.11e-3)" "unprognostic (5.19e-2)" "unprognostic (5.48e-3)" "unprognostic (1.62e-2)" "unprognostic (5.30e-2)" "unprognostic (3.60e-1)" "unprognostic (1.53e-2)" 22.5 26.5 16.0 23.1 27.0 25.0 17.7 13.4 34.9 14.8 20.3 22.0 10.4 16.6 22.1 15.4 27.0 20.2 12.7 22.6 16.6 16.7 21.5 27.7 17.3 25.2 15.8 19.8 15.3 20.0 21.2 15.3 27.5 22.6 14.9 23.2 19.1 27.2 15.7 49.6 22.0 20.3 18.5 15.7 25.9 18.5 30.2 13.1 36.9 18.6 17.9 34.9 18.6 16.0 12.8 31.8 31.6 31.5 15.6 16.9 23.3 22.7 45.6 22.3 36.0 17.1 16.9 26.2 18.1 24.3 45.8 39.8 35.1 19.6 39.4 21.4 22.8 35.3 26.1 48.3 31.7 53.6 39.6 40.1 39.1 28.5 37.3 18.9 46.0 29.1 18.3 18.2 42.4 23.1 17.7 39.6 35.7 48.1 15.4 26.1 22.7 46.1 30.4 22.9 53.8 38.2 32.5 45.3 34.2 26.1 25.6 36.7 21.9 17.8 13.2 18.8 34.1 35.0 29.1 24.0 34.5 26.6 20.8 45.6 16.3 20.4 39.6 27.7 25.7 35.1 12.3 31.5 31.6 15.2 31.0 16.9 12.8 13.5 14.6 31.8 12.5 12.0 13.3 5.1 15.6 29.7 13.7 13.2 23.3 16.0 27.0 13.4 34.9 16.6 16.7 15.8 19.8 22.6 13.1 0.0 12.3 16.4 10.8 10.4 13.9 15.9 28.1 14.7 12.5 17.4 31.4 30.5 3.3 25.5 9.7 16.3 14.6 0.0 23.3 26.0 12.2 9.3 19.6 18.4 34.2 25.4 10.4 17.2 31.7 4.9 11.8 22.3 5.0 49.5 12.0 14.3 21.4 10.5 8.5 10.1 16.1 19.4 9.2 24.7 36.5 12.8 22.8 13.1 20.5 10.3 EGLN2 "HIFPH1, PHD1" ENSG00000269858 "Egl-9 family hypoxia inducible factor 2" Q96KS0 19 40798996-40808433 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 208.8;Late spermatids: 575.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056649 Supported Nucleoplasm NA NA Nucleoplasm "HPA056649: AB_2683203" "unprognostic (1.11e-2)" "prognostic favorable (2.88e-4)" "unprognostic (9.40e-3)" "unprognostic (6.01e-2)" "unprognostic (6.03e-2)" "unprognostic (6.47e-3)" "unprognostic (1.51e-2)" "unprognostic (4.74e-2)" "unprognostic (1.67e-1)" "unprognostic (1.95e-1)" "prognostic favorable (4.81e-4)" "unprognostic (7.10e-2)" "unprognostic (7.48e-2)" "unprognostic (1.69e-1)" "unprognostic (1.35e-1)" "unprognostic (9.99e-2)" "unprognostic (1.38e-3)" 27.4 24.3 24.8 24.7 28.5 23.3 33.5 22.6 28.9 22.2 21.2 21.9 26.4 17.8 24.2 17.8 16.7 18.6 23.4 18.6 25.5 18.7 18.4 19.1 31.6 29.0 21.8 25.7 22.8 16.6 10.6 16.9 42.5 16.9 20.9 15.3 16.5 19.4 25.7 15.5 13.4 16.8 28.1 15.0 42.4 18.0 74.1 18.0 14.4 29.7 17.2 22.7 19.6 25.1 25.1 16.3 68.2 21.5 15.1 30.2 26.5 16.6 45.3 21.0 20.4 27.4 20.1 13.7 18.2 15.3 26.1 28.7 37.4 16.9 14.9 15.5 21.8 23.7 10.8 26.5 20.8 14.0 18.6 15.0 19.8 26.4 14.1 29.5 15.2 27.0 24.6 22.2 24.9 14.3 16.5 32.0 16.4 28.0 14.0 27.4 11.9 28.0 25.2 18.2 26.4 15.8 26.2 10.4 10.1 28.1 25.7 19.4 17.7 29.8 23.6 24.1 18.8 31.1 41.5 29.6 32.7 23.7 13.4 21.4 7.0 10.2 26.2 23.9 22.2 24.2 20.9 19.1 46.8 24.1 21.5 25.3 23.2 28.5 24.9 16.3 25.1 30.2 25.2 68.2 15.1 19.9 11.9 25.6 26.5 24.8 28.5 22.6 28.9 25.5 18.7 21.8 25.7 16.9 18.0 20.8 12.6 13.6 49.3 43.4 36.7 18.6 28.1 2.7 14.8 3.5 13.7 50.5 0.0 14.1 208.8 56.4 58.0 23.3 8.8 21.0 50.6 59.3 17.3 25.1 58.5 20.6 43.0 62.6 37.2 575.5 58.4 26.7 38.8 20.8 28.8 16.5 12.3 49.1 49.1 1.1 12.9 38.8 30.7 124.4 56.4 33.5 110.9 40.2 33.0 59.3 EGR1 "AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225" ENSG00000120738 "Early growth response 1" P18146 5 138465490-138469315 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 923.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 3.5;intermediate monocyte: 5.1;neutrophil: 9.9" "Group enriched" "Detected in many" 8 "granulocytes: 9.9;monocytes: 5.1" "Cell line enhanced" "Detected in many" "ASC TERT1: 39.7;hTCEpi: 57.8;U-266/84: 87.2" "Group enriched" "Detected in all" 6 "amygdala: 88.4;basal ganglia: 148.1;cerebral cortex: 237.4;hippocampal formation: 138.8;olfactory region: 126.1" "Low region specificity" "Detected in all" "CAB019427, HPA029937, HPA029938" Supported Enhanced Nucleoplasm No No Nucleoplasm "CAB019427: AB_2097038, HPA029937: AB_2673258, HPA029938: AB_2673259" "unprognostic (5.47e-2)" "unprognostic (4.09e-1)" "unprognostic (1.57e-1)" "unprognostic (7.74e-2)" "unprognostic (6.32e-2)" "unprognostic (2.66e-1)" "unprognostic (1.80e-1)" "unprognostic (2.96e-1)" "unprognostic (7.36e-2)" "unprognostic (2.97e-3)" "unprognostic (1.75e-1)" "unprognostic (2.94e-2)" "unprognostic (3.51e-3)" "unprognostic (3.57e-2)" "unprognostic (1.03e-1)" "unprognostic (1.67e-1)" "unprognostic (1.98e-3)" 78.7 47.9 5.5 114.3 23.3 18.3 28.7 23.7 25.0 61.8 40.5 31.6 8.0 6.8 51.7 15.6 47.2 187.3 158.4 42.9 7.0 8.1 22.0 68.8 39.7 18.6 4.9 7.0 130.9 23.0 15.8 43.3 24.3 17.8 45.2 21.7 56.1 18.7 100.5 19.4 54.2 29.8 60.8 4.4 8.8 46.1 14.7 2.8 19.4 76.6 67.5 26.6 43.2 20.3 0.9 0.9 9.9 5.1 0.1 0.2 0.4 4.1 0.1 9.0 13.4 24.5 39.7 1.0 7.2 4.5 9.7 7.9 5.1 3.7 0.2 1.1 15.6 33.4 1.9 0.5 14.6 4.5 0.2 0.6 0.5 1.7 1.4 3.1 1.5 11.6 3.1 57.8 8.6 1.9 7.6 0.8 10.6 21.2 5.1 2.8 20.8 0.6 6.5 0.8 15.5 0.0 0.1 1.3 0.7 7.4 2.5 11.3 1.3 8.7 24.2 18.7 9.1 0.3 1.2 0.3 3.5 4.6 1.7 2.7 12.1 87.2 1.7 4.1 19.8 1.0 0.0 3.5 0.4 0.2 5.1 0.0 0.9 0.1 0.1 0.9 0.3 0.2 0.2 9.9 0.1 1.4 0.0 0.2 0.4 5.5 23.3 23.7 25.0 7.0 8.1 4.9 7.0 17.8 2.8 256.1 658.4 51.0 240.2 161.5 44.6 590.3 183.4 53.5 87.6 27.9 60.9 127.7 6.6 145.2 1.2 175.3 431.9 0.0 86.9 88.6 317.5 418.7 343.2 161.3 107.4 3.2 923.5 169.4 153.0 1.8 152.5 134.7 101.3 10.0 629.1 114.5 132.3 391.8 49.8 5.0 87.7 219.9 490.3 2.3 1.9 175.0 108.5 55.8 355.8 76.3 EGR2 KROX20 ENSG00000122877 "Early growth response 2" P11161 10 62811996-62919900 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, DNA-binding, Transferase" "Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 57.1" "Cell type enhanced" "Detected in many" 10 "Intestinal endocrine cells: 70.2;Macrophages: 30.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "intermediate monocyte: 5.5;non-classical monocyte: 5.3" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "U-87 MG: 22.9" "Group enriched" "Detected in many" 10 "amygdala: 2.5;basal ganglia: 3.8;cerebral cortex: 4.9;hippocampal formation: 4.1;olfactory region: 3.0" "Group enriched" "Detected in many" 4 "basal ganglia: 3.7;cerebral cortex: 6.6;hippocampal formation: 5.1;midbrain: 3.0;olfactory region: 9.8" HPA031165 Supported Nucleoplasm NA NA Nucleoplasm "HPA031165: AB_2673768" "prognostic favorable (7.30e-5)" "unprognostic (1.86e-3)" "unprognostic (1.45e-2)" "unprognostic (8.72e-2)" "unprognostic (2.92e-2)" "unprognostic (1.29e-1)" "unprognostic (2.70e-1)" "unprognostic (1.75e-1)" "unprognostic (9.79e-2)" "unprognostic (1.15e-1)" "unprognostic (1.18e-1)" "unprognostic (1.27e-1)" "unprognostic (2.47e-3)" "unprognostic (6.54e-2)" "unprognostic (1.74e-2)" "unprognostic (3.46e-1)" "unprognostic (1.11e-3)" 9.4 4.7 1.8 8.3 9.2 2.7 7.8 1.2 9.9 8.5 2.9 18.7 0.5 0.7 5.8 25.5 3.5 6.1 13.1 16.1 3.3 1.6 3.0 5.2 15.7 5.3 6.0 1.2 7.6 2.2 3.9 10.6 4.9 7.5 7.6 1.5 7.8 3.1 1.3 1.2 15.9 3.1 6.7 3.1 3.6 3.0 4.3 0.7 22.7 57.1 5.0 11.5 8.2 2.4 1.2 1.1 1.5 5.5 0.5 0.4 0.6 0.0 0.2 2.5 1.0 1.8 2.5 0.4 0.5 0.2 0.6 0.8 0.0 0.3 0.6 0.0 0.6 0.7 0.3 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.6 3.9 0.3 0.6 1.3 0.2 0.8 0.1 0.3 0.2 0.8 0.1 1.2 0.0 1.7 0.2 0.1 1.3 0.1 0.3 0.4 0.0 0.2 0.1 0.3 0.2 0.8 4.0 0.5 0.0 0.5 0.1 0.6 0.4 0.2 0.3 1.4 0.6 0.3 22.9 0.5 0.4 0.0 1.1 0.4 0.4 5.5 0.0 1.0 0.0 0.2 1.1 1.2 0.0 0.4 1.5 0.5 5.3 0.0 0.0 0.6 1.8 9.2 1.2 9.9 3.3 1.6 6.0 1.2 7.5 0.7 0.0 18.8 0.5 8.5 18.9 0.9 4.8 0.0 4.0 0.0 0.0 0.0 1.3 0.0 0.9 6.3 2.1 6.9 0.0 0.6 1.1 14.4 7.8 19.7 1.5 22.6 0.0 70.2 5.5 12.4 3.1 1.7 30.3 8.5 1.0 16.6 1.7 0.8 5.8 6.7 0.0 0.5 6.5 4.4 0.1 1.1 10.9 0.9 4.4 14.3 0.8 EGR3 PILOT ENSG00000179388 "Early growth response 3" Q06889 8 22687659-22693302 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.0" "Group enriched" "Detected in many" 4 "granulocytes: 102.0;Intestinal endocrine cells: 272.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "amygdala: 11.5;basal ganglia: 33.6;cerebral cortex: 35.0;hippocampal formation: 13.7;olfactory region: 12.8" "Cell type enhanced" "Detected in single" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.6;HMC-1: 7.5;MCF7: 24.5;SK-MEL-30: 16.4" "Group enriched" "Detected in many" 10 "amygdala: 26.1;basal ganglia: 40.1;cerebral cortex: 47.9;hippocampal formation: 32.4;olfactory region: 18.2" "Group enriched" "Detected in many" 9 "amygdala: 29.0;basal ganglia: 68.2;cerebral cortex: 57.2;hippocampal formation: 56.6;olfactory region: 75.0" "HPA006206, CAB009373" Uncertain Uncertain Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB009373: AB_2097202, HPA006206: AB_10602491" "prognostic favorable (1.83e-4)" "unprognostic (1.15e-1)" "unprognostic (2.40e-1)" "unprognostic (1.21e-1)" "unprognostic (2.89e-2)" "unprognostic (4.07e-2)" "unprognostic (1.00e-1)" "unprognostic (6.44e-2)" "prognostic favorable (4.78e-4)" "unprognostic (3.48e-2)" "unprognostic (5.14e-2)" "unprognostic (1.61e-1)" "unprognostic (2.87e-2)" "unprognostic (2.11e-2)" "unprognostic (4.72e-2)" "unprognostic (2.35e-2)" "unprognostic (1.07e-2)" 20.7 17.7 11.5 12.3 33.6 5.6 7.1 0.8 35.0 7.4 3.3 11.1 0.2 0.9 3.8 1.0 4.0 14.6 20.6 8.5 13.7 2.0 3.0 2.0 4.1 7.3 1.9 12.8 10.6 2.9 12.8 5.0 1.2 3.6 10.3 2.2 2.6 2.3 4.0 1.6 28.4 3.6 8.3 1.6 2.8 5.3 4.1 2.1 5.5 5.8 1.3 5.8 12.3 2.5 0.8 0.0 2.1 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.2 1.5 4.6 0.1 0.4 0.5 0.0 0.0 0.1 0.0 0.1 0.0 1.0 0.3 0.3 0.2 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 7.5 0.4 0.2 0.2 0.0 0.6 0.1 0.1 0.2 0.1 0.0 24.5 0.0 0.2 0.1 1.7 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.1 0.4 0.0 16.4 0.2 1.1 0.0 0.0 0.2 0.1 0.2 0.3 0.3 0.0 0.0 0.7 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 11.5 33.6 0.8 35.0 13.7 2.0 1.9 12.8 3.6 2.1 6.0 18.6 7.5 26.7 20.5 1.6 35.5 0.0 2.7 3.4 0.0 0.0 1.2 0.0 2.5 19.0 17.5 0.9 0.0 3.9 1.1 23.9 18.9 102.0 0.4 3.7 0.0 272.8 20.9 12.3 6.2 2.8 11.0 20.3 0.0 12.8 3.0 2.6 2.9 0.4 0.0 1.1 0.0 23.7 0.0 0.2 43.7 8.1 0.0 4.3 3.1 EHF "ESE3, ESEJ" ENSG00000135373 "ETS homologous factor" Q9NZC4 11 34621093-34661057 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 152.4;salivary gland: 118.0;seminal vesicle: 161.8" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 340.0;Ciliated cells: 235.5;Club cells: 254.8;Urothelial cells: 370.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 10 "myeloid DC: 4.9" "Lineage enriched" "Detected in single" 10 "dendritic cells: 4.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 34.8;HaCaT: 23.9;HBEC3-KT: 26.3;OE19: 29.4;RT4: 53.2;T-47d: 53.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA050923, HPA060734" Enhanced Supported "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" No NA Nucleoplasm "Golgi apparatus" "HPA050923: AB_2681275, HPA060734: AB_2684351" "unprognostic (1.06e-2)" "unprognostic (1.06e-1)" "prognostic favorable (5.81e-4)" "unprognostic (2.82e-1)" "unprognostic (5.62e-2)" "unprognostic (1.22e-3)" "unprognostic (2.44e-1)" "unprognostic (2.04e-1)" "unprognostic (1.38e-1)" "unprognostic (6.79e-2)" "prognostic unfavorable (6.94e-4)" "unprognostic (1.29e-1)" "unprognostic (6.26e-2)" "unprognostic (3.47e-3)" "unprognostic (2.24e-1)" "unprognostic (2.89e-1)" "unprognostic (7.08e-2)" 0.8 1.0 0.8 9.3 0.9 0.0 32.1 0.7 0.7 19.3 16.0 0.5 152.4 6.9 4.5 21.4 69.0 23.0 22.1 0.7 0.9 0.9 11.6 1.6 9.9 0.1 1.5 0.3 4.7 10.5 0.2 0.9 0.5 1.4 20.7 22.3 0.2 118.0 161.8 0.7 12.8 10.1 1.7 3.3 0.7 10.1 1.4 0.5 0.4 1.2 50.3 59.7 13.7 30.3 0.0 4.9 0.0 0.4 0.0 0.0 0.2 11.4 6.7 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.1 34.8 0.0 4.4 0.0 0.0 23.9 0.0 26.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 29.4 0.2 0.0 0.0 0.2 4.7 53.2 0.0 0.0 0.1 3.6 0.0 0.0 53.9 0.1 0.0 0.0 0.3 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.9 0.7 0.7 0.9 0.9 1.5 0.3 1.4 0.5 44.7 66.1 0.0 340.0 97.3 0.0 0.4 43.3 235.5 254.8 52.4 0.0 0.0 13.3 55.4 8.4 0.2 36.0 0.0 76.2 0.0 1.9 138.5 1.1 0.6 0.1 0.0 22.3 0.0 0.0 0.0 0.0 5.3 11.8 9.0 45.3 3.9 68.8 28.8 0.0 0.1 0.0 0.0 2.3 0.1 0.0 148.7 1.1 0.0 33.6 370.0 EHMT1 "bA188C12.1, EHMT1-IT1, Eu-HMTase1, FLJ12879, FLJ40292, KIAA1876, KMT1D" ENSG00000181090 "Euchromatic histone lysine methyltransferase 1" Q9H9B1 9 137618963-137870016 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Chromatin regulator, Methyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 119.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060022, HPA074729" Approved Supported "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA060022: AB_2684190, HPA074729: " "unprognostic (1.18e-1)" "unprognostic (1.64e-1)" "unprognostic (1.19e-2)" "prognostic favorable (6.56e-4)" "unprognostic (1.03e-1)" "prognostic favorable (8.91e-4)" "unprognostic (5.87e-2)" "unprognostic (1.74e-2)" "unprognostic (4.18e-3)" "unprognostic (2.34e-1)" "unprognostic (2.26e-2)" "unprognostic (7.55e-3)" "unprognostic (2.01e-2)" "unprognostic (6.58e-3)" "unprognostic (4.24e-1)" "unprognostic (7.12e-3)" "unprognostic (7.75e-2)" 16.6 18.3 16.4 23.2 22.3 24.9 17.1 23.7 20.4 16.3 20.7 21.6 20.4 17.1 22.0 13.0 17.9 18.5 20.0 12.1 12.8 9.6 12.7 14.9 14.9 25.0 27.8 12.1 21.4 13.6 15.1 16.2 17.9 18.6 16.9 12.4 19.1 16.5 18.0 23.1 17.3 17.9 21.5 12.5 22.1 16.4 30.8 21.5 22.3 18.9 11.0 22.2 19.2 15.7 20.0 19.0 25.0 13.7 13.1 15.6 6.9 11.1 22.4 25.1 23.3 10.7 11.1 21.1 14.8 9.4 10.8 8.9 14.6 14.0 34.3 14.4 11.2 13.1 24.1 15.0 16.2 8.6 19.2 10.6 14.5 22.4 9.3 9.3 22.0 17.4 9.9 11.4 13.1 12.8 8.0 17.8 13.0 21.7 11.9 7.7 25.8 25.8 10.9 24.5 17.7 14.9 33.2 21.6 19.8 9.1 20.6 22.3 18.1 28.1 19.8 6.4 18.8 22.2 17.8 16.7 12.8 13.3 19.6 14.0 7.6 21.1 28.3 9.5 11.8 13.8 13.6 13.7 16.3 15.6 11.7 10.0 13.3 13.5 13.3 10.4 20.0 13.3 11.8 25.0 13.1 12.0 19.0 11.1 6.9 16.4 22.3 23.7 20.4 12.8 9.6 27.8 12.1 18.6 21.5 17.9 16.3 36.9 20.3 15.5 38.3 24.3 17.8 21.4 22.7 21.0 49.1 18.6 3.3 20.9 68.8 24.8 19.8 0.0 18.3 18.0 18.4 25.8 17.4 28.8 17.0 47.7 27.0 17.8 23.4 119.3 33.1 16.5 11.8 23.4 20.2 23.1 20.1 25.9 35.3 11.9 48.0 12.9 15.3 58.1 54.9 17.7 22.2 23.3 20.5 22.0 EHMT2 "BAT8, C6orf30, Em:AF134726.3, G9A, KMT1C, NG36/G9a" ENSG00000204371 "Euchromatic histone lysine methyltransferase 2" Q96KQ7 6 31879759-31897687 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Chromatin regulator, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HL-60: 10.3;NTERA-2: 15.8;U-266/84: 12.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050550, HPA060259" Supported Supported "Nucleoplasm,Nuclear speckles" "Intracellular and membrane" NA NA "Nuclear speckles" Nucleoplasm "HPA050550: AB_2681170, HPA060259: AB_2684234" "unprognostic (3.11e-2)" "unprognostic (2.72e-1)" "unprognostic (4.39e-2)" "unprognostic (1.92e-2)" "unprognostic (5.44e-2)" "unprognostic (3.51e-2)" "prognostic unfavorable (1.79e-4)" "unprognostic (3.55e-2)" "unprognostic (7.41e-2)" "unprognostic (1.01e-1)" "unprognostic (5.89e-2)" "unprognostic (1.88e-1)" "unprognostic (9.78e-3)" "unprognostic (8.72e-2)" "unprognostic (1.84e-1)" "unprognostic (2.25e-1)" "unprognostic (9.03e-2)" 9.4 12.2 13.1 9.6 21.4 7.6 6.3 17.1 17.5 8.0 7.7 12.3 8.4 14.6 15.0 11.7 18.0 7.6 8.1 7.6 12.3 12.4 5.3 4.4 8.5 6.9 12.6 10.6 10.6 13.2 2.2 8.1 6.0 10.3 10.4 4.3 7.2 5.6 9.6 5.2 5.5 10.1 9.6 8.4 9.1 9.8 7.6 14.9 14.6 9.5 4.8 7.2 8.7 7.6 0.3 0.6 0.0 0.7 0.1 1.1 1.3 0.0 3.6 6.4 0.0 2.8 1.5 4.1 2.8 2.3 3.2 2.6 0.0 0.0 0.0 6.3 4.5 3.3 0.0 0.0 6.9 1.5 4.2 9.6 0.0 0.0 0.0 0.0 10.3 0.0 3.9 1.1 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 7.3 0.0 15.8 0.0 0.0 6.9 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.8 5.3 2.7 0.0 0.0 3.0 3.4 2.6 5.7 0.0 9.1 12.4 3.0 3.9 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.2 0.1 0.8 0.6 0.3 0.3 1.1 1.1 0.0 0.1 0.7 0.6 0.2 1.3 13.1 21.4 17.1 16.5 12.3 12.4 12.6 10.6 10.3 14.9 14.9 11.8 22.3 5.6 7.4 59.2 4.5 22.9 9.4 19.4 24.4 39.3 19.7 6.6 12.9 33.8 11.9 8.9 0.0 10.6 12.5 13.2 5.8 13.9 6.4 14.1 36.5 21.7 20.3 9.1 44.9 25.3 9.9 18.6 16.2 15.5 28.2 11.0 5.8 21.5 7.8 48.2 25.8 8.5 6.1 30.6 9.7 4.7 14.9 15.0 2.6 EID1 "C15orf3, CRI1, EID-1" ENSG00000255302 "EP300 interacting inhibitor of differentiation 1" Q9Y6B2 15 48877886-48880183 "Predicted intracellular proteins" "Cell cycle, Differentiation, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA051122, HPA051123" Approved Supported Nucleoplasm NA Yes Nucleoplasm "HPA051122: AB_2681350, HPA051123: AB_2681351" "unprognostic (1.38e-1)" "unprognostic (6.69e-2)" "unprognostic (1.64e-1)" "unprognostic (3.18e-2)" "unprognostic (7.81e-2)" "prognostic unfavorable (9.99e-4)" "unprognostic (1.10e-1)" "unprognostic (2.79e-2)" "unprognostic (1.39e-1)" "unprognostic (1.41e-1)" "unprognostic (6.75e-3)" "unprognostic (2.46e-1)" "unprognostic (3.62e-3)" "prognostic unfavorable (2.91e-4)" "unprognostic (2.04e-2)" "unprognostic (2.13e-1)" "unprognostic (2.09e-1)" 42.6 75.4 69.7 33.0 66.6 18.4 38.1 65.0 77.2 56.1 47.9 36.9 33.6 30.4 58.1 46.0 41.2 46.8 52.9 95.4 63.4 73.2 53.0 42.5 35.1 35.1 58.6 63.7 71.7 38.3 42.0 71.7 32.7 67.6 56.2 24.6 44.9 34.4 53.3 92.7 19.9 29.1 55.3 59.8 39.6 33.4 26.9 44.4 32.8 48.3 38.0 26.9 57.1 35.0 36.4 72.7 55.3 62.9 43.9 65.0 73.4 20.8 17.8 40.6 38.1 35.9 47.9 2.7 55.2 45.7 33.7 44.4 15.4 9.5 28.1 51.3 31.4 24.9 18.9 19.5 19.6 36.6 77.3 20.2 48.2 39.5 0.6 28.1 29.0 22.1 41.8 16.8 22.7 13.6 32.8 37.9 24.6 28.6 27.0 37.3 30.1 20.9 24.4 0.0 14.9 15.7 29.5 50.5 45.8 41.7 23.1 38.7 38.8 34.4 13.1 62.5 33.1 23.9 38.3 42.9 53.7 29.9 50.9 48.1 34.9 95.2 20.0 44.4 64.1 37.7 55.3 62.9 53.7 47.8 56.6 45.1 34.0 54.6 49.5 72.7 36.4 39.9 36.6 8.3 43.9 56.0 72.2 65.0 73.4 69.7 66.6 65.0 77.2 63.4 73.2 58.6 63.7 67.6 44.4 360.3 149.9 104.9 122.0 155.9 338.8 422.3 160.5 255.6 306.0 247.7 113.9 301.2 514.0 334.6 14.7 353.4 52.3 116.8 234.2 122.3 472.2 84.6 181.5 144.0 183.1 225.6 224.3 276.2 202.2 21.3 650.4 211.2 462.2 264.3 93.9 629.6 172.4 94.5 612.4 325.8 264.9 316.9 445.7 102.8 59.4 127.2 91.7 198.0 88.5 76.7 EID2 "CRI2, EID-2, MGC20452" ENSG00000176396 "EP300 interacting inhibitor of differentiation 2" Q8N6I1 19 39538705-39540333 "Predicted intracellular proteins" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 40.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045477 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA045477: AB_10959785" "unprognostic (5.91e-2)" "unprognostic (6.37e-3)" "prognostic favorable (9.73e-4)" "unprognostic (5.93e-2)" "unprognostic (6.50e-2)" "unprognostic (1.39e-1)" "unprognostic (2.52e-2)" "unprognostic (6.53e-2)" "unprognostic (6.02e-2)" "unprognostic (3.43e-1)" "unprognostic (6.88e-3)" "prognostic unfavorable (8.74e-4)" "unprognostic (1.21e-1)" "unprognostic (2.79e-2)" "unprognostic (2.25e-2)" "unprognostic (1.55e-1)" "unprognostic (1.51e-1)" 12.1 19.8 18.0 10.1 18.9 6.5 10.6 16.7 24.5 10.1 9.2 9.5 7.7 8.2 10.9 10.3 8.7 8.9 7.9 9.7 17.8 20.8 15.4 12.8 10.1 9.9 16.2 17.9 10.8 9.3 13.6 14.4 20.6 24.0 11.3 8.2 9.2 8.6 10.5 10.3 8.5 9.3 11.8 10.9 10.5 9.1 9.2 9.4 13.1 12.9 6.0 9.7 8.0 8.6 1.9 1.4 1.8 1.5 0.8 4.2 1.1 13.1 17.8 17.1 11.5 13.8 8.6 2.5 15.8 11.9 12.3 12.8 11.2 4.1 13.4 13.0 10.9 8.4 5.7 15.7 11.4 16.0 12.9 19.7 6.0 10.0 13.3 13.8 10.4 8.9 10.0 7.3 10.2 7.9 9.8 14.3 26.5 9.7 9.4 10.7 8.6 15.0 9.1 9.6 15.9 7.5 14.0 16.3 6.2 15.5 12.1 16.0 11.3 17.1 6.9 10.7 12.0 9.3 6.8 10.3 7.9 28.1 10.5 11.7 14.9 17.3 16.8 7.4 9.8 6.4 0.0 1.2 1.8 2.4 1.5 2.5 1.4 3.0 3.1 1.3 1.9 3.1 4.2 0.5 0.8 1.2 1.4 0.6 1.1 18.0 18.9 16.7 24.5 17.8 20.8 16.2 17.9 24.0 9.4 17.9 8.6 5.2 3.4 9.0 20.6 15.5 12.7 6.7 5.7 14.0 9.8 40.9 1.7 4.4 1.9 12.1 4.0 0.0 4.1 2.1 9.4 4.4 1.1 11.9 9.4 25.4 6.9 9.8 8.6 0.4 9.5 5.1 8.5 1.8 6.0 29.2 4.8 7.0 12.4 9.1 17.3 6.5 9.2 9.8 9.1 6.6 16.2 7.5 6.5 2.1 EID3 "FLJ25832, NSE4B, NSMCE4B" ENSG00000255150 "EP300 interacting inhibitor of differentiation 3" Q8N140 12 104303739-104305205 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 69.1" "Cell type enriched" "Detected in many" 6 "Spermatocytes: 291.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.9;NK-cells: 6.6;T-cells: 9.5" "Cell line enhanced" "Detected in many" "A549: 10.2;BJ: 9.5;BJ hTERT+: 7.8;BJ hTERT+ SV40 Large T+ RasG12V: 7.8;HeLa: 8.6" "Low region specificity" "Detected in single" HPA059367 Uncertain Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA059367: AB_2683992" "unprognostic (1.25e-1)" "unprognostic (5.41e-3)" "unprognostic (5.82e-2)" "unprognostic (8.21e-2)" "prognostic unfavorable (1.14e-4)" "unprognostic (8.02e-2)" "unprognostic (5.88e-5)" "unprognostic (1.06e-1)" "unprognostic (1.31e-1)" "unprognostic (1.66e-2)" "unprognostic (5.38e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (5.96e-5)" "unprognostic (8.70e-2)" "unprognostic (3.54e-1)" "unprognostic (2.04e-3)" "unprognostic (2.87e-2)" 1.7 1.7 2.0 2.9 2.7 3.0 1.7 4.0 2.6 1.6 1.8 1.5 0.2 0.6 2.1 1.9 1.3 1.8 1.8 1.2 1.9 1.9 1.2 0.9 1.8 3.7 1.2 2.3 3.4 1.7 0.9 5.3 1.1 2.2 2.7 0.6 1.7 1.3 4.1 1.5 1.6 1.6 1.6 1.2 1.9 1.4 69.1 1.6 2.3 1.0 0.4 2.5 1.5 1.3 2.9 0.5 0.7 1.5 6.6 9.5 2.6 0.3 10.2 0.3 1.0 2.3 2.4 2.0 9.5 7.8 4.6 7.8 0.2 0.5 0.1 0.1 2.1 2.1 0.2 0.3 0.8 6.8 0.6 0.1 1.9 8.6 1.5 3.4 0.2 0.5 3.2 0.0 2.9 0.6 0.4 0.7 0.4 0.1 0.6 2.8 0.1 3.4 1.4 0.5 0.2 2.0 0.3 0.0 0.1 2.5 0.3 0.1 0.0 6.3 0.4 0.2 0.2 0.0 0.0 1.4 0.1 0.3 2.3 0.4 0.5 0.2 0.1 0.2 0.0 1.0 0.0 0.3 0.5 5.2 1.5 5.5 2.7 6.6 6.2 0.3 2.9 9.5 5.7 0.7 6.6 0.9 0.5 7.6 2.6 2.0 2.7 4.0 2.6 1.9 1.9 1.2 2.3 2.2 1.6 0.0 5.9 2.9 50.8 11.8 3.4 1.1 0.0 4.0 1.2 1.8 25.5 2.0 0.0 2.4 44.2 5.2 1.3 0.0 1.2 1.1 8.0 25.2 1.1 1.7 1.7 11.1 0.0 6.2 4.0 12.9 8.1 6.1 1.7 5.4 0.0 7.6 5.0 0.2 4.2 1.0 17.5 6.5 8.2 291.8 33.6 6.8 2.1 10.2 0.7 39.4 EIF1AD "haponin, MGC11102" ENSG00000175376 "Eukaryotic translation initiation factor 1A domain containing" Q8N9N8 11 65996545-66002176 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054991, HPA058735" Uncertain Approved "Nucleoplasm,Vesicles,Intermediate filaments" NA NA "Nucleoplasm, Vesicles" "Intermediate filaments" "HPA054991: AB_2682664, HPA058735: AB_2683802" "unprognostic (1.11e-1)" "unprognostic (8.83e-2)" "unprognostic (3.03e-1)" "prognostic unfavorable (3.59e-5)" "unprognostic (1.30e-2)" "unprognostic (5.69e-2)" "prognostic unfavorable (8.63e-5)" "unprognostic (1.86e-2)" "unprognostic (1.17e-1)" "unprognostic (8.76e-2)" "unprognostic (1.36e-3)" "unprognostic (2.31e-1)" "unprognostic (1.59e-3)" "unprognostic (7.63e-3)" "unprognostic (1.40e-1)" "unprognostic (1.28e-3)" "unprognostic (3.96e-1)" 16.8 18.4 15.5 17.9 18.8 38.7 16.3 21.8 23.7 16.0 15.3 15.4 19.9 15.0 18.3 16.4 22.1 16.0 15.3 15.6 15.1 16.1 15.2 18.5 16.2 21.1 18.8 11.1 21.5 23.7 22.0 24.0 25.5 17.7 15.8 14.8 17.5 17.8 16.2 27.1 23.4 17.6 14.9 18.2 22.2 16.6 22.3 19.9 21.2 16.0 18.1 27.0 15.5 23.8 14.8 16.1 28.2 15.5 11.6 14.7 9.4 22.4 19.7 16.6 16.5 13.3 13.9 15.6 16.5 16.3 21.2 18.0 18.9 21.7 17.1 29.0 18.9 18.1 15.6 19.7 22.0 19.7 15.8 10.2 24.2 22.6 20.4 16.6 22.1 19.0 11.6 19.3 31.7 21.7 14.5 14.1 18.2 36.0 25.0 30.0 30.0 20.4 24.6 12.4 10.4 21.5 22.5 16.8 33.5 11.9 14.1 12.2 15.0 18.6 25.4 19.3 13.7 24.8 13.7 16.8 27.6 18.7 22.5 15.9 30.6 36.0 35.9 20.1 15.5 18.3 28.2 15.5 10.0 14.7 12.7 11.3 14.8 12.6 10.7 16.1 14.5 12.0 11.0 10.6 11.6 15.3 9.7 11.3 9.4 15.5 18.8 21.8 23.7 15.1 16.1 18.8 11.1 17.7 19.9 3.0 4.8 11.2 10.4 33.5 6.9 13.4 12.7 6.7 2.3 5.2 13.7 14.0 13.3 11.8 12.0 12.7 10.2 0.0 11.3 20.1 11.8 10.7 12.7 13.6 22.0 11.1 2.4 14.7 8.2 11.4 11.2 19.8 11.8 15.4 10.7 6.0 20.7 14.4 5.3 12.8 18.0 6.5 18.9 25.6 21.3 42.8 21.2 17.5 8.0 11.2 EIF2AK1 "HRI, KIAA1369" ENSG00000086232 "Eukaryotic translation initiation factor 2 alpha kinase 1" Q9BQI3 7 6022244-6059230 "Enzymes, Predicted intracellular proteins" "Kinase, Protein synthesis inhibitor, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Cytotrophoblasts: 180.9;Syncytiotrophoblasts: 310.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016496, CAB022082, HPA061675" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB022082: , HPA016496: AB_1848057, HPA061675: AB_2684583" "unprognostic (7.15e-3)" "unprognostic (2.00e-2)" "unprognostic (1.45e-1)" "unprognostic (2.91e-1)" "unprognostic (6.70e-2)" "unprognostic (9.69e-3)" "prognostic unfavorable (6.99e-4)" "unprognostic (2.36e-1)" "unprognostic (2.54e-1)" "unprognostic (1.07e-2)" "unprognostic (1.48e-1)" "unprognostic (8.96e-2)" "unprognostic (2.53e-1)" "unprognostic (1.99e-1)" "unprognostic (5.45e-2)" "unprognostic (9.02e-2)" "unprognostic (1.06e-2)" 21.0 38.2 31.7 25.4 32.7 62.8 26.9 23.9 41.1 22.8 34.5 31.0 20.8 26.5 22.6 28.6 28.4 23.4 21.5 40.0 29.9 30.0 32.0 46.3 22.1 23.3 33.3 30.3 23.0 32.4 61.9 25.4 43.9 33.4 26.4 34.9 23.4 46.4 26.3 31.6 28.9 29.9 17.8 35.6 25.4 34.7 16.3 22.6 37.1 29.0 17.4 29.6 22.4 20.1 11.7 7.5 17.4 7.4 10.4 10.6 4.8 41.8 26.4 21.2 32.2 20.3 18.4 27.9 21.6 19.7 19.3 24.5 24.2 28.3 32.8 23.7 23.7 34.7 29.6 27.5 19.7 24.9 20.3 42.2 33.8 28.7 36.4 16.7 28.7 30.9 14.7 24.9 18.2 19.7 20.4 20.5 25.9 54.0 31.7 18.1 41.9 15.7 36.7 26.6 24.4 29.8 34.7 22.3 38.5 24.6 20.5 26.4 47.5 41.5 55.5 18.4 30.9 41.8 35.2 19.6 11.1 41.5 19.5 22.9 32.3 32.2 33.5 22.4 37.9 32.1 10.6 7.4 17.4 9.5 5.9 6.4 11.7 7.4 10.6 7.5 7.7 8.6 7.7 4.1 10.4 6.5 6.6 8.8 4.8 31.7 32.7 23.9 41.1 29.9 30.0 33.3 30.3 33.4 22.6 35.7 43.2 44.9 27.9 21.2 28.0 44.8 43.3 34.8 29.6 41.8 15.7 180.9 56.3 48.3 6.9 22.4 43.3 116.8 39.3 64.2 22.2 37.8 19.7 55.5 47.3 30.2 37.0 20.3 29.0 11.9 31.9 31.4 23.6 59.5 60.3 40.2 46.9 35.1 35.3 51.5 23.0 12.9 17.0 32.5 42.3 19.6 310.3 35.0 47.0 25.5 EIF2B2 "EIF-2Bbeta, EIF2B" ENSG00000119718 "Eukaryotic translation initiation factor 2B subunit beta" P49770 14 75002911-75012366 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 138.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005841, CAB037105, HPA048028" Enhanced Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane, Focal adhesion sites" Nucleoplasm "CAB037105: AB_1840834, HPA005841: AB_1078725, HPA048028: AB_2680235" "unprognostic (1.10e-1)" "unprognostic (4.41e-2)" "unprognostic (5.70e-2)" "unprognostic (6.71e-2)" "unprognostic (7.64e-2)" "unprognostic (3.45e-3)" "prognostic unfavorable (2.26e-6)" "unprognostic (1.48e-1)" "unprognostic (1.23e-1)" "unprognostic (1.65e-2)" "unprognostic (4.95e-2)" "unprognostic (1.01e-1)" "prognostic favorable (2.95e-4)" "unprognostic (4.15e-2)" "unprognostic (2.74e-1)" "unprognostic (1.44e-1)" "unprognostic (3.28e-2)" 11.8 20.1 11.6 9.2 12.3 9.1 11.6 11.0 16.4 13.2 13.9 13.2 9.2 9.8 11.6 15.8 14.3 10.4 12.6 15.0 11.5 12.0 19.6 18.8 10.3 11.6 13.6 11.4 12.3 12.9 32.3 11.9 20.4 15.7 13.6 12.2 11.7 11.1 14.8 29.0 12.5 13.1 11.0 14.8 12.1 10.9 20.1 11.0 17.7 33.4 11.2 12.7 14.9 9.7 4.2 5.1 7.7 3.9 6.5 8.1 4.8 5.1 6.3 5.1 5.8 5.9 4.9 6.8 3.3 5.5 6.5 7.6 7.9 5.3 4.6 2.1 5.2 4.1 3.9 7.9 7.7 9.8 2.8 5.9 4.0 5.5 5.4 7.7 3.0 4.8 4.5 7.4 8.3 8.6 5.6 22.3 4.0 3.6 4.5 13.9 15.2 4.7 3.7 3.6 6.4 9.3 3.0 6.0 3.8 9.2 6.2 5.5 4.4 3.5 5.0 7.4 6.6 8.1 2.8 5.7 5.0 4.9 2.2 4.2 7.7 6.3 5.4 5.5 3.7 3.8 7.7 3.9 2.8 6.7 3.9 5.6 4.2 5.9 5.4 5.1 4.1 4.4 4.6 2.2 6.5 3.7 4.2 8.1 4.8 11.6 12.3 11.0 16.4 11.5 12.0 13.6 11.4 15.7 11.0 17.9 8.6 15.1 16.5 15.8 25.7 16.1 28.1 10.7 14.8 24.4 43.2 42.7 34.9 31.8 7.6 18.8 14.3 0.0 28.8 47.0 15.5 14.3 20.8 10.5 29.7 27.0 15.0 12.9 16.5 7.8 14.7 14.0 13.5 34.3 9.1 24.2 26.4 12.4 15.2 35.2 27.5 25.8 21.2 39.0 22.8 19.2 138.4 13.8 17.8 15.9 EIF3A "EIF3, eIF3-p170, eIF3-theta, eIF3a, EIF3S10, KIAA0139, TIF32" ENSG00000107581 "Eukaryotic translation initiation factor 3 subunit A" Q14152 10 119033670-119080823 "Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038315, HPA038316" Enhanced Supported Nucleoplasm,Cytosol Yes No "Nucleoplasm, Cytosol" "HPA038315: AB_10672588, HPA038316: AB_10673168" "unprognostic (8.15e-2)" "unprognostic (2.09e-2)" "unprognostic (2.65e-1)" "unprognostic (1.22e-1)" "unprognostic (4.53e-3)" "unprognostic (3.19e-1)" "unprognostic (1.47e-1)" "unprognostic (2.16e-1)" "unprognostic (1.84e-1)" "unprognostic (9.38e-2)" "unprognostic (3.84e-3)" "unprognostic (9.07e-2)" "unprognostic (5.48e-3)" "unprognostic (8.07e-2)" "unprognostic (1.20e-1)" "unprognostic (9.07e-2)" "unprognostic (1.89e-2)" 36.7 27.4 19.6 29.4 20.2 41.4 42.4 22.4 22.3 27.8 29.2 21.7 32.3 26.0 33.4 26.0 35.7 22.7 25.0 36.7 19.9 18.6 28.2 41.5 24.6 39.0 24.2 20.1 29.2 61.9 35.8 33.2 33.7 25.5 26.9 26.4 14.4 31.4 31.6 92.3 36.0 29.2 49.3 29.8 29.8 34.1 18.6 22.6 45.8 28.6 33.6 28.7 40.5 38.9 15.0 20.2 21.6 29.7 14.2 27.6 13.9 50.9 38.6 31.8 43.5 34.6 50.2 24.7 46.4 48.3 29.9 30.1 36.3 33.7 59.8 17.3 38.3 23.6 51.3 41.4 35.6 42.7 32.8 34.0 51.4 29.8 40.3 39.6 75.1 38.2 43.4 40.1 44.1 76.0 50.3 33.9 24.4 52.6 39.5 38.6 30.2 31.1 35.5 30.5 19.8 19.7 32.1 68.8 28.5 28.7 43.1 14.9 31.5 36.5 34.4 48.1 28.7 22.0 48.1 49.7 29.1 26.9 30.3 67.1 34.2 37.5 58.9 30.8 74.2 19.9 21.6 21.2 12.6 16.5 23.9 19.1 15.0 19.9 14.9 20.2 13.3 13.9 15.0 5.7 14.2 29.7 11.6 27.6 13.9 19.6 20.2 22.4 22.3 19.9 18.6 24.2 20.1 25.5 22.6 217.4 278.3 92.9 185.7 270.3 56.3 294.1 114.7 196.7 246.9 61.1 58.9 145.7 23.2 129.2 164.6 122.4 96.0 93.5 158.7 131.5 136.7 213.5 137.9 165.4 112.9 41.3 135.5 80.4 187.8 87.8 100.7 140.0 140.0 160.5 137.9 70.1 165.5 84.2 110.7 43.0 50.4 58.2 140.5 137.2 105.1 318.1 211.0 121.1 152.2 227.0 EIF3B "eIF3b, EIF3S9, PRT1" ENSG00000106263 "Eukaryotic translation initiation factor 3 subunit B" P55884 7 2354086-2380745 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017562, HPA048983" Approved Approved Nucleoplasm,Cytosol NA NA 22000 Cytosol Nucleoplasm "CAB017562: AB_2246341, HPA048983: AB_2680588" "unprognostic (1.50e-3)" "unprognostic (2.71e-1)" "unprognostic (2.34e-2)" "unprognostic (3.92e-2)" "unprognostic (9.45e-3)" "prognostic unfavorable (2.20e-4)" "prognostic unfavorable (4.41e-9)" "unprognostic (4.64e-3)" "unprognostic (3.68e-1)" "unprognostic (1.10e-1)" "unprognostic (1.55e-1)" "unprognostic (3.47e-1)" "prognostic unfavorable (9.66e-6)" "unprognostic (2.38e-1)" "unprognostic (7.54e-2)" "unprognostic (9.00e-2)" "unprognostic (6.18e-3)" 27.5 27.3 16.5 28.9 21.8 38.7 28.8 20.0 26.2 23.5 33.3 22.4 25.7 20.3 29.6 24.1 38.8 28.6 26.2 32.1 15.8 16.5 24.3 51.4 21.7 29.6 22.2 19.4 31.2 66.6 24.2 20.3 34.6 21.1 26.0 24.0 18.0 34.1 24.2 72.3 39.8 23.9 33.0 16.5 31.6 29.7 45.2 19.0 44.9 23.1 34.3 35.9 32.9 29.7 6.5 8.0 3.7 7.3 16.5 9.5 4.4 85.9 44.0 18.2 49.4 20.6 18.7 45.1 30.3 22.7 34.5 32.4 57.4 33.7 50.2 25.0 32.1 48.8 46.9 50.1 39.8 38.1 15.0 58.8 38.2 42.7 38.7 29.1 46.5 28.4 23.2 26.3 37.3 39.3 18.2 27.7 23.4 97.1 23.4 31.5 61.0 22.4 52.3 56.8 30.1 39.6 27.7 36.9 51.7 22.1 39.4 41.6 31.1 32.0 71.3 17.3 33.2 47.4 51.6 29.2 26.7 58.9 40.9 54.5 25.9 34.7 50.9 30.3 52.2 65.1 1.8 7.3 3.7 7.6 6.8 9.5 6.3 7.4 8.4 7.8 6.5 8.8 8.9 0.6 16.5 5.8 8.0 8.7 4.4 16.5 21.8 20.0 26.2 15.8 16.5 22.2 19.4 21.1 19.0 23.8 61.0 27.4 38.7 57.1 36.2 30.7 28.1 24.1 48.9 26.2 60.9 54.0 3.3 33.5 9.1 45.4 29.7 0.0 52.8 53.4 38.1 43.4 16.2 53.9 42.2 49.3 45.8 70.6 38.4 13.9 40.6 33.2 15.1 16.2 54.8 41.2 58.1 20.1 35.0 25.4 44.8 25.8 40.6 29.9 34.0 68.4 69.1 28.9 53.9 38.6 EIF3L "EIF3EIP, EIF3S11, EIF3S6IP, HSPC021, HSPC025" ENSG00000100129 "Eukaryotic translation initiation factor 3 subunit L" Q9Y262 22 37848868-37889407 "Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003028 Approved Approved Nucleoplasm,Nucleoli NA NA 22000000 Nucleoli Nucleoplasm "HPA003028: AB_1078726" "unprognostic (2.07e-2)" "unprognostic (3.02e-2)" "unprognostic (5.06e-3)" "unprognostic (3.20e-1)" "unprognostic (3.79e-3)" "unprognostic (9.86e-2)" "unprognostic (1.35e-1)" "unprognostic (9.65e-2)" "unprognostic (2.66e-1)" "unprognostic (5.81e-3)" "unprognostic (2.35e-1)" "unprognostic (9.74e-2)" "prognostic favorable (6.11e-4)" "unprognostic (1.48e-1)" "unprognostic (1.42e-1)" "unprognostic (2.42e-1)" "unprognostic (2.03e-3)" 30.9 18.4 17.4 17.5 19.8 26.4 55.1 34.4 19.3 40.7 29.1 16.1 16.7 20.8 36.1 18.9 33.4 24.2 14.0 15.5 15.0 15.6 23.7 36.1 18.4 31.3 14.0 13.4 63.4 78.8 20.2 26.8 27.9 17.7 38.7 23.8 21.5 39.6 31.0 40.3 30.6 25.2 35.8 15.6 24.7 22.7 19.6 11.4 44.0 54.8 32.3 31.0 38.6 22.0 33.6 58.1 9.8 35.9 25.0 42.5 55.2 16.8 9.6 27.1 19.6 26.3 58.8 19.5 16.2 39.0 26.2 35.8 16.0 12.5 58.2 4.5 18.9 9.1 10.9 29.8 22.4 30.9 7.6 49.8 20.5 14.0 7.5 16.4 54.4 17.7 31.6 25.7 19.3 29.2 45.4 32.5 19.3 17.0 15.9 30.2 6.6 14.5 25.2 15.4 20.6 25.3 16.6 37.2 17.0 19.9 10.2 19.8 30.6 16.0 18.8 21.9 31.8 14.3 22.0 15.7 16.3 19.9 9.9 12.9 9.5 15.5 23.7 15.3 24.1 13.3 9.8 35.9 9.6 20.7 35.4 34.6 33.6 30.0 25.0 58.1 27.5 42.5 31.8 4.8 25.0 29.1 28.4 29.1 55.2 17.4 19.8 34.4 19.3 15.0 15.6 14.0 13.4 17.7 11.4 110.2 191.5 294.7 357.3 352.7 56.1 1.4 165.6 77.6 174.0 62.8 27.5 578.0 353.1 204.0 111.9 215.8 81.1 116.8 400.6 517.3 230.5 236.6 216.1 101.7 227.0 23.8 189.5 125.8 250.1 286.2 206.0 267.8 215.9 373.3 211.0 74.0 242.7 189.4 199.4 249.7 32.9 161.7 287.4 90.7 87.1 375.5 588.1 261.5 327.6 377.5 EIF4A3 "DDX48, EIF4AIII, Fal1, KIAA0111" ENSG00000141543 "Eukaryotic translation initiation factor 4A3" P38919 17 80135214-80147183 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, rRNA processing, Translation regulation, Transport" "Helicase, Hydrolase, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021878 Supported Supported Nucleoplasm NA NA 73000 Nucleoplasm "HPA021878: AB_1848090" "unprognostic (7.24e-2)" "unprognostic (7.33e-3)" "prognostic favorable (3.57e-5)" "unprognostic (1.29e-2)" "unprognostic (2.95e-1)" "unprognostic (2.52e-2)" "prognostic unfavorable (1.68e-5)" "prognostic unfavorable (1.87e-4)" "unprognostic (3.71e-1)" "unprognostic (5.06e-2)" "unprognostic (4.64e-2)" "unprognostic (2.64e-2)" "unprognostic (9.78e-3)" "unprognostic (5.81e-2)" "unprognostic (9.20e-2)" "unprognostic (1.38e-2)" "unprognostic (2.91e-3)" 27.3 37.0 19.6 23.6 21.5 71.7 22.0 20.3 19.8 24.2 23.8 16.9 19.2 16.2 24.9 18.0 41.5 29.4 17.1 24.2 17.8 12.3 24.5 20.3 21.6 25.4 16.8 19.7 37.5 16.8 17.1 21.9 38.3 13.1 24.7 20.9 14.7 22.1 31.2 19.8 31.2 18.6 18.5 13.7 25.5 20.4 35.1 19.3 30.7 26.9 26.4 30.6 28.9 25.8 38.7 80.4 33.1 41.9 30.2 38.9 48.3 48.1 43.2 28.6 21.1 22.0 13.4 25.0 25.6 18.2 36.3 29.2 46.0 22.5 44.1 17.2 22.3 26.0 32.1 39.1 27.3 40.4 16.2 41.0 27.6 34.2 49.6 21.7 49.7 29.0 20.5 14.0 30.4 24.7 14.7 29.6 25.8 36.7 28.6 21.4 36.8 44.8 25.3 30.7 44.4 40.0 37.1 57.9 34.8 17.7 41.2 39.8 21.7 35.2 68.9 29.5 28.1 45.0 33.5 20.3 22.5 28.9 33.1 40.3 25.1 21.6 81.4 18.2 31.4 23.0 25.7 41.1 33.1 26.7 41.9 34.5 38.7 34.5 30.8 50.3 31.6 32.0 30.7 24.4 30.2 32.9 80.4 38.9 48.3 19.6 21.5 20.3 19.8 17.8 12.3 16.8 19.7 13.1 19.3 38.7 49.5 57.4 240.8 251.5 20.3 50.7 30.6 36.1 62.6 27.9 15.7 121.7 54.7 70.9 25.8 58.9 51.0 23.3 101.3 178.8 96.2 78.8 91.1 26.0 94.7 6.4 57.8 30.7 62.3 10.0 62.2 81.9 97.8 83.8 45.6 43.1 73.7 52.7 46.7 47.7 27.1 84.1 170.0 87.7 109.4 261.3 219.0 53.3 56.0 264.3 EIF4E "EIF4E1, EIF4EL1, EIF4F" ENSG00000151247 "Eukaryotic translation initiation factor 4E" P06730 4 98871684-98930637 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis, Translation regulation" "Initiation factor, RNA-binding" "Autism, Autism spectrum disorder, Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 12 "Early spermatids: 945.1;Late spermatids: 1606.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB004077, CAB016316, HPA068358" Supported Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA 580000 "Cytosol, Cytoplasmic bodies" Nucleoplasm "CAB004077: AB_823488, CAB016316: AB_627502, HPA068358: " "unprognostic (3.07e-3)" "unprognostic (1.43e-1)" "unprognostic (6.53e-3)" "unprognostic (7.52e-2)" "unprognostic (1.41e-1)" "unprognostic (2.43e-3)" "unprognostic (2.03e-5)" "unprognostic (6.55e-3)" "unprognostic (1.09e-2)" "unprognostic (1.33e-1)" "unprognostic (1.28e-1)" "unprognostic (1.63e-1)" "unprognostic (1.10e-3)" "unprognostic (5.40e-2)" "unprognostic (1.43e-1)" "unprognostic (2.31e-2)" "unprognostic (1.28e-1)" 22.3 26.8 25.7 20.1 35.3 25.2 23.1 40.8 38.4 21.4 27.2 23.3 19.1 19.8 21.7 21.4 39.6 19.9 18.8 23.0 26.0 29.9 29.3 26.2 18.8 24.4 27.7 28.4 18.8 16.1 24.7 25.6 21.8 35.3 19.9 33.2 15.4 23.2 21.0 29.8 19.1 19.5 24.8 31.0 19.4 20.6 39.1 23.4 22.4 33.4 27.1 34.2 22.1 24.2 31.3 25.4 36.6 32.0 32.6 32.2 30.0 25.8 22.7 38.7 25.7 22.0 23.2 23.2 49.3 30.9 40.8 30.7 30.4 32.7 52.4 15.9 30.3 25.5 13.1 53.2 37.0 49.9 34.5 15.5 35.6 15.8 27.7 19.0 51.2 27.0 16.5 23.7 31.4 24.9 23.4 31.3 26.3 59.2 24.5 36.1 22.2 47.4 19.8 30.4 50.5 21.1 30.0 26.2 23.3 35.9 23.0 32.8 21.6 22.9 48.8 15.9 27.2 23.8 20.2 23.0 29.5 31.7 26.5 39.7 18.3 46.5 47.4 26.4 26.3 33.4 23.3 22.3 36.6 26.3 25.9 30.5 31.3 29.2 27.0 25.4 26.9 32.2 31.9 16.2 32.6 32.0 21.4 28.7 30.0 25.7 35.3 40.8 38.4 26.0 29.9 27.7 28.4 35.3 23.4 29.8 42.3 104.6 137.6 321.7 85.9 22.3 43.3 40.2 38.7 57.6 33.4 94.3 217.2 77.3 945.1 55.4 92.4 93.5 59.1 125.0 82.5 155.3 50.7 67.4 112.0 81.0 62.0 39.3 59.2 1606.7 46.9 94.3 183.9 85.6 57.3 60.6 65.2 66.6 46.3 112.9 57.1 51.8 118.5 94.7 83.0 324.2 99.5 64.2 72.3 177.8 EIF4EBP1 "4E-BP1, PHAS-I" ENSG00000187840 "Eukaryotic translation initiation factor 4E binding protein 1" Q13541 8 38030341-38060365 "Cancer-related genes, Predicted intracellular proteins" "Translation regulation" "Protein synthesis inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 94.7;salivary gland: 109.8" "Cell type enhanced" "Detected in many" 10 "Exocrine glandular cells: 638.8;Pancreatic endocrine cells: 291.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 53.5;eosinophil: 31.3;intermediate monocyte: 41.2;memory B-cell: 16.3;myeloid DC: 41.3;naive B-cell: 13.5;non-classical monocyte: 31.4;plasmacytoid DC: 31.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB005032, CAB005039, HPA023501" Supported Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB005032: AB_562030, CAB005039: AB_562029, HPA023501: AB_1848095" "unprognostic (1.55e-2)" "unprognostic (2.45e-1)" "unprognostic (1.58e-1)" "prognostic unfavorable (8.86e-4)" "unprognostic (6.94e-2)" "unprognostic (2.69e-1)" "unprognostic (1.94e-2)" "unprognostic (3.27e-2)" "unprognostic (1.61e-1)" "unprognostic (1.16e-2)" "unprognostic (3.18e-3)" "unprognostic (7.21e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.98e-2)" "unprognostic (3.01e-1)" "unprognostic (4.57e-2)" "unprognostic (5.72e-3)" 17.7 3.4 2.5 4.9 3.6 9.2 21.7 1.8 3.2 5.5 15.4 2.0 7.7 6.2 5.3 2.1 22.2 5.0 7.0 9.4 2.2 1.8 6.0 39.6 6.9 7.4 4.3 1.4 9.3 94.7 1.7 2.2 8.7 2.8 7.4 4.6 2.8 109.8 8.0 38.4 4.9 9.0 7.1 4.2 9.3 10.6 3.0 2.7 2.7 3.7 12.6 9.2 11.3 11.1 16.3 41.3 31.3 53.5 4.0 7.6 28.0 20.5 10.6 3.1 18.5 4.0 3.5 13.7 22.8 10.7 12.4 19.8 7.0 5.3 8.0 15.9 11.3 7.5 11.0 10.4 18.6 7.4 6.2 33.7 47.1 4.8 9.7 42.0 15.2 7.6 9.8 30.4 13.7 25.7 3.9 19.8 5.5 25.7 21.5 5.2 12.9 13.3 37.0 23.1 10.4 42.9 11.7 13.1 28.4 4.6 2.0 43.4 33.0 4.6 7.5 53.8 2.0 10.1 17.9 18.6 7.4 24.5 22.0 17.3 31.0 16.8 9.2 17.4 27.0 16.1 5.1 53.5 31.3 3.9 41.2 3.5 16.3 4.5 4.0 41.3 13.5 3.6 3.6 4.7 4.0 31.4 31.3 7.6 28.0 2.5 3.6 1.8 3.2 2.2 1.8 4.3 1.4 2.8 2.7 8.9 8.8 22.0 33.9 66.1 3.6 36.7 76.5 18.7 7.9 19.2 2.0 28.3 24.9 210.7 13.0 33.7 22.3 46.7 638.8 158.3 47.3 50.3 18.4 91.8 194.5 0.0 38.6 74.3 87.1 71.0 40.3 79.1 69.2 40.5 88.6 11.9 291.0 56.1 18.0 71.9 1.8 12.9 44.1 1.1 21.0 74.5 32.3 24.2 76.7 54.2 EIF4EBP2 ENSG00000148730 "Eukaryotic translation initiation factor 4E binding protein 2" Q13542 10 70404379-70428618 "Predicted intracellular proteins" "Translation regulation" "Protein synthesis inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019415, HPA037410, HPA061665" Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "CAB019415: AB_10699019, HPA037410: AB_2675461, HPA061665: AB_2684580" "unprognostic (9.57e-2)" "unprognostic (3.22e-2)" "unprognostic (2.27e-1)" "unprognostic (1.45e-2)" "unprognostic (1.05e-1)" "unprognostic (3.51e-1)" "unprognostic (3.84e-1)" "unprognostic (7.24e-2)" "unprognostic (8.24e-2)" "unprognostic (8.19e-2)" "unprognostic (2.87e-1)" "unprognostic (1.46e-1)" "prognostic favorable (6.69e-6)" "unprognostic (1.05e-1)" "unprognostic (1.62e-1)" "unprognostic (1.53e-1)" "unprognostic (4.61e-2)" 57.3 27.2 22.1 28.2 21.8 20.2 77.1 22.7 23.0 28.7 47.9 16.7 25.9 30.8 24.8 18.3 28.3 22.7 37.9 52.4 18.0 15.8 44.4 40.1 31.8 21.6 19.0 14.7 33.4 28.4 23.2 13.3 36.2 18.6 33.2 31.6 34.8 25.5 50.2 54.5 27.6 51.2 32.4 17.8 30.5 28.7 17.9 16.2 34.8 23.5 29.2 22.1 39.8 64.3 7.0 14.0 20.6 17.5 9.3 14.2 14.2 17.1 5.6 30.7 29.9 59.4 22.6 16.6 10.5 13.1 7.9 8.5 24.5 15.4 17.9 6.4 15.5 4.9 11.1 14.9 9.7 8.9 19.0 7.7 12.9 6.8 9.6 13.9 22.9 9.1 25.1 10.1 9.6 8.7 16.0 11.9 14.8 21.0 16.4 12.1 9.8 19.5 23.6 25.8 17.1 10.2 20.1 12.3 11.5 10.0 17.9 16.6 25.1 14.5 33.5 13.9 21.9 15.2 20.5 12.9 5.1 6.4 8.3 9.3 11.0 21.5 21.1 5.9 34.3 5.2 13.8 15.5 20.6 14.2 13.8 11.6 7.0 11.5 11.7 14.0 6.1 9.8 10.1 17.0 9.3 17.5 4.7 12.5 14.2 22.1 21.8 22.7 23.0 18.0 15.8 19.0 14.7 18.6 16.2 23.8 32.8 41.3 43.1 47.1 42.0 128.1 66.2 17.4 25.0 34.9 19.6 37.6 36.5 37.0 19.7 34.3 154.3 23.3 51.0 104.3 50.6 50.3 11.5 142.1 41.5 22.3 25.4 65.7 88.3 40.0 60.9 37.0 20.3 45.9 79.3 63.3 50.7 84.0 57.7 108.0 15.4 77.6 30.7 32.9 41.7 61.2 47.9 42.4 61.8 85.2 EIF4H "KIAA0038, WBSCR1, WSCR1" ENSG00000106682 "Eukaryotic translation initiation factor 4H" Q15056 7 74174245-74197101 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Initiation factor, RNA-binding" "Cancer-related genes, Williams-Beuren syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 1039.9;Late spermatids: 2062.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030542 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 520000 "Nucleoplasm, Nuclear bodies, Cytosol" "HPA030542: AB_10601368" "unprognostic (2.83e-1)" "unprognostic (9.50e-2)" "unprognostic (2.36e-1)" "unprognostic (1.50e-2)" "prognostic unfavorable (3.89e-4)" "prognostic unfavorable (2.15e-4)" "unprognostic (1.61e-2)" "unprognostic (2.72e-3)" "unprognostic (1.79e-1)" "unprognostic (2.99e-2)" "unprognostic (1.72e-2)" "unprognostic (2.52e-1)" "unprognostic (1.07e-2)" "unprognostic (3.04e-1)" "unprognostic (2.23e-1)" "unprognostic (5.68e-2)" "unprognostic (1.27e-2)" 46.8 42.7 47.6 37.6 52.8 82.3 42.8 56.0 89.5 39.8 44.5 46.6 36.2 43.1 48.1 37.9 58.6 44.4 40.7 47.4 45.6 41.4 34.5 50.7 37.4 42.8 45.4 54.6 54.2 74.3 54.3 30.1 72.2 47.6 44.8 35.1 35.6 60.3 45.4 89.6 53.0 41.5 43.4 59.9 34.6 45.4 52.5 32.1 46.8 43.5 57.9 44.2 43.4 41.4 38.4 57.6 60.2 64.2 46.7 52.0 80.6 87.4 58.3 44.5 53.9 39.7 42.3 50.6 62.6 47.6 51.9 51.1 71.4 67.5 75.2 17.1 57.8 75.1 46.5 49.0 83.2 49.1 50.5 57.4 41.9 54.8 57.3 45.5 70.6 42.3 49.5 52.9 57.6 82.0 61.0 56.8 45.0 73.6 32.7 53.1 74.7 55.7 83.8 59.4 72.7 57.8 65.4 59.7 67.9 43.1 56.0 45.3 57.2 58.4 73.8 49.6 61.4 83.4 45.8 59.0 74.4 50.6 62.2 78.7 38.9 46.4 128.4 58.1 74.2 76.3 45.7 58.4 60.2 43.5 64.2 44.9 38.4 44.7 43.0 57.6 35.3 52.0 42.4 39.0 46.7 63.6 24.4 47.6 80.6 47.6 52.8 56.0 89.5 45.6 41.4 45.4 54.6 47.6 32.1 77.4 68.6 90.9 132.2 105.9 91.7 38.9 66.2 53.5 59.1 41.8 23.6 170.5 91.2 122.8 1039.9 93.3 74.9 46.7 138.2 310.9 112.7 87.9 121.1 74.9 110.6 92.2 86.8 73.6 90.7 2062.3 96.1 91.0 69.2 181.3 80.6 92.2 119.2 69.1 104.0 54.1 63.7 84.1 131.0 55.4 62.9 101.5 330.6 89.7 87.9 119.5 EIF5A "EIF-5A, EIF5A1, MGC104255, MGC99547" ENSG00000132507 "Eukaryotic translation initiation factor 5A" P63241 17 7306999-7312463 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport" "Elongation factor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005042, HPA061298" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB005042: AB_562281, HPA061298: AB_2684472" "unprognostic (3.72e-1)" "unprognostic (1.67e-1)" "unprognostic (8.10e-2)" "unprognostic (2.80e-1)" "unprognostic (6.95e-2)" "unprognostic (1.39e-2)" "unprognostic (1.06e-2)" "prognostic unfavorable (9.04e-4)" "unprognostic (4.10e-1)" "unprognostic (4.11e-2)" "unprognostic (1.64e-2)" "unprognostic (8.25e-2)" "prognostic unfavorable (1.63e-5)" "unprognostic (3.53e-1)" "unprognostic (2.79e-1)" "unprognostic (6.01e-2)" "unprognostic (7.65e-2)" 69.0 55.6 37.9 57.0 40.4 83.1 44.5 35.0 59.8 44.6 54.8 37.5 39.8 47.4 47.2 45.5 107.0 38.1 52.9 55.8 35.6 33.6 58.5 192.9 46.6 67.2 34.3 35.9 50.3 126.0 26.0 34.1 73.9 34.0 38.0 57.2 40.7 87.7 40.7 100.6 71.1 49.0 45.4 29.5 65.5 42.9 56.8 24.2 77.9 57.9 105.4 79.0 48.6 50.7 64.7 87.7 44.4 75.7 75.2 79.3 64.3 132.8 165.9 51.2 102.4 39.5 51.0 71.9 100.3 66.2 135.7 94.9 99.2 56.8 128.8 65.0 77.1 55.6 90.9 111.1 129.3 123.5 71.6 161.3 77.5 137.4 127.0 70.1 58.8 80.2 54.0 67.9 100.2 136.1 45.9 87.1 38.7 106.5 36.0 91.8 82.4 69.1 85.1 97.1 77.7 81.9 68.4 62.2 118.7 81.9 73.9 59.5 77.4 64.3 78.4 62.1 40.8 62.0 45.4 81.5 95.7 68.9 63.5 158.5 30.3 41.4 83.3 90.4 88.6 108.9 44.4 56.0 38.9 65.1 75.7 79.3 64.7 67.1 57.7 85.8 62.6 62.3 62.6 25.1 75.2 68.6 87.7 58.9 64.3 37.9 40.4 35.0 59.8 35.6 33.6 34.3 35.9 34.0 24.2 50.6 35.2 135.1 56.5 310.0 85.2 62.9 114.7 41.5 36.4 59.3 13.7 296.4 63.0 289.3 125.7 155.1 221.7 163.5 206.2 541.5 192.2 120.0 138.2 197.7 267.8 47.7 144.4 98.8 106.6 60.7 93.2 101.1 249.7 306.6 167.0 82.0 274.1 169.5 76.4 70.8 45.7 90.5 172.0 216.9 81.3 274.3 358.2 71.9 197.1 61.2 EIF6 "b(2)gcn, EIF3A, ITGB4BP, p27BBP" ENSG00000242372 "Eukaryotic translation initiation factor 6" P56537 20 35278911-35284985 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Ribosome biogenesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA040873 Enhanced Supported Nucleoplasm NA NA 150000 Nucleoplasm "HPA040873: AB_2677182" "unprognostic (9.00e-2)" "unprognostic (2.65e-1)" "unprognostic (2.06e-1)" "unprognostic (1.38e-1)" "unprognostic (1.75e-1)" "unprognostic (2.24e-1)" "prognostic unfavorable (7.25e-5)" "unprognostic (9.94e-3)" "unprognostic (4.97e-2)" "unprognostic (1.14e-1)" "unprognostic (4.55e-3)" "unprognostic (2.63e-1)" "unprognostic (3.51e-2)" "unprognostic (1.53e-1)" "unprognostic (2.17e-1)" "unprognostic (9.18e-2)" "unprognostic (8.15e-2)" 21.5 24.9 13.7 21.7 13.1 14.3 21.4 12.4 20.3 26.9 29.5 13.4 15.7 33.7 22.5 19.4 59.9 25.2 29.7 14.4 13.1 14.3 39.9 63.7 18.3 27.9 13.1 15.8 22.1 35.6 17.7 15.6 30.8 13.7 21.2 29.0 14.7 27.0 22.7 14.9 40.6 43.2 22.8 11.1 21.4 20.6 24.1 10.9 31.0 30.7 49.7 43.8 24.1 29.8 51.3 64.0 70.4 60.4 47.4 39.3 60.5 37.3 54.7 13.7 15.6 17.1 20.5 17.6 24.9 29.9 52.6 40.0 101.5 35.1 26.8 29.3 30.6 37.4 29.5 28.2 79.4 33.3 6.4 18.8 43.5 21.6 73.0 32.4 22.9 21.2 20.7 51.4 41.0 80.5 22.3 36.0 15.5 28.2 13.3 55.3 36.6 13.3 30.4 16.4 40.3 46.0 18.6 22.6 23.4 68.0 26.5 23.0 19.5 19.1 75.8 27.1 10.5 36.8 17.9 28.3 57.3 24.4 29.1 33.2 14.5 15.5 22.2 28.3 24.6 31.7 70.4 55.8 46.1 36.7 55.8 39.2 51.3 35.6 39.3 64.0 49.7 29.1 34.2 18.8 47.4 60.4 59.6 38.1 60.5 13.7 13.1 12.4 20.3 13.1 14.3 13.1 15.8 13.7 10.9 59.6 54.1 84.3 174.7 249.8 33.4 22.5 127.4 52.2 64.8 157.1 9.8 204.4 167.5 366.1 53.7 83.1 285.9 0.0 331.2 176.5 88.5 134.5 98.0 185.9 157.7 23.8 101.4 49.1 74.5 76.7 75.6 97.4 101.3 301.2 121.5 59.3 490.4 210.5 62.9 381.3 23.8 64.7 103.2 80.7 67.6 302.9 214.1 74.6 166.1 311.8 EIPR1 "EIPR-1, TSSC1" ENSG00000032389 "EARP complex and GARP complex interacting protein 1" Q53HC9 2 3188925-3377882 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 43.9;Distal tubular cells: 43.1;Extravillous trophoblasts: 29.7;Hofbauer cells: 29.7;monocytes: 28.9;Proximal tubular cells: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031231, HPA031232, HPA031233, HPA031234" Approved Supported "Nucleoplasm,Nucleoli,Intermediate filaments" NA NA "Nucleoplasm, Nucleoli" "Intermediate filaments" "HPA031231: AB_10669881, HPA031232: AB_10603222, HPA031233: AB_10670026, HPA031234: AB_2673803" "unprognostic (2.16e-1)" "unprognostic (2.22e-1)" "unprognostic (2.71e-1)" "unprognostic (1.66e-1)" "unprognostic (4.27e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (3.67e-7)" "unprognostic (1.94e-1)" "unprognostic (1.57e-1)" "unprognostic (7.83e-2)" "unprognostic (2.10e-1)" "unprognostic (2.50e-1)" "unprognostic (1.78e-1)" "unprognostic (1.02e-2)" "unprognostic (3.43e-1)" "unprognostic (2.24e-2)" "unprognostic (3.83e-2)" 7.3 12.3 20.1 17.3 24.4 14.2 9.0 26.0 22.9 8.3 11.9 12.1 10.0 10.7 7.7 18.4 14.5 12.0 7.9 10.3 17.7 19.3 12.4 11.4 7.9 15.2 15.1 14.5 5.8 11.6 14.2 20.8 8.0 13.6 7.7 10.9 10.5 9.9 7.4 10.9 9.2 9.3 9.4 12.4 12.0 9.3 9.9 11.5 14.5 20.4 15.5 15.3 11.1 7.7 15.7 23.4 13.9 13.3 16.3 16.9 14.0 10.6 20.1 10.7 12.1 6.8 9.2 24.3 11.2 11.7 13.5 10.3 13.4 13.5 18.7 19.9 11.4 12.8 11.0 8.4 16.2 7.5 14.5 15.9 16.5 12.5 30.9 13.0 16.1 20.6 8.4 14.7 13.7 17.8 7.5 17.1 33.4 18.4 13.0 12.4 19.9 14.9 23.5 12.4 25.2 16.1 17.5 11.4 25.1 16.8 14.8 23.4 27.2 7.9 13.3 12.2 6.0 12.3 15.1 12.0 10.9 5.6 8.9 15.0 14.9 36.0 15.5 12.9 16.8 10.0 13.9 11.8 9.4 16.1 13.3 16.3 13.9 13.4 16.8 21.3 15.7 14.7 15.8 5.0 16.3 11.9 23.4 16.9 14.0 20.1 24.4 26.0 22.9 17.7 19.3 15.1 14.5 13.6 11.5 3.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 8.1 11.4 19.2 0.0 43.9 43.1 25.6 0.0 0.0 0.0 0.0 13.9 29.7 0.0 0.0 3.5 0.0 29.7 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 28.9 0.0 0.0 17.8 0.0 0.0 31.4 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 ELAC1 D29 ENSG00000141642 "ElaC ribonuclease Z 1" Q9H777 18 50967991-50988121 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040867, HPA066483" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040867: AB_10697716, HPA066483: AB_2685675" "unprognostic (1.05e-2)" "unprognostic (1.65e-1)" "unprognostic (6.95e-3)" "unprognostic (1.75e-2)" "unprognostic (8.61e-2)" "unprognostic (5.96e-2)" "unprognostic (3.25e-1)" "unprognostic (3.03e-3)" "unprognostic (5.87e-2)" "unprognostic (2.82e-3)" "unprognostic (3.67e-3)" "unprognostic (6.36e-2)" "prognostic favorable (8.43e-8)" "unprognostic (3.54e-2)" "unprognostic (1.12e-1)" "unprognostic (2.59e-2)" "unprognostic (3.87e-2)" 8.7 15.0 7.7 7.7 9.7 3.3 9.4 7.1 11.9 8.0 9.1 12.8 12.1 7.6 11.3 20.1 7.5 10.0 9.6 7.2 7.3 8.3 12.4 15.2 7.6 11.2 7.6 7.2 8.8 19.5 17.1 15.7 12.3 8.7 9.9 10.8 13.7 20.1 12.2 6.8 7.7 11.7 8.3 7.1 10.8 10.1 16.7 3.9 10.1 15.6 7.0 9.9 8.7 6.6 14.2 12.4 7.8 9.1 16.1 15.7 8.1 7.0 4.9 13.0 11.0 14.6 6.2 5.5 7.8 10.3 7.3 5.2 1.8 6.7 5.5 5.4 7.2 5.8 7.2 4.0 8.2 5.0 12.0 1.1 6.8 1.8 1.3 8.6 17.0 4.9 7.8 6.6 3.9 9.1 5.8 7.6 8.0 6.9 13.8 12.9 3.2 5.9 5.1 6.5 6.0 2.2 6.7 4.6 10.2 8.5 3.0 7.7 8.8 6.4 1.1 12.4 5.7 6.0 13.1 6.7 9.6 5.0 2.8 5.2 12.9 10.8 7.3 8.9 5.7 12.0 4.1 7.8 7.8 13.2 9.1 14.6 14.2 12.7 12.9 12.4 13.6 12.4 15.7 0.9 16.1 8.7 10.4 10.0 8.1 7.7 9.7 7.1 11.9 7.3 8.3 7.6 7.2 8.7 3.9 6.0 6.2 8.5 4.6 2.2 7.1 5.6 5.1 10.7 3.4 3.5 2.0 20.4 16.6 12.5 16.4 5.8 8.8 0.0 12.0 13.8 5.4 6.3 8.1 13.9 13.7 4.8 9.9 8.0 6.6 12.8 4.6 5.2 5.0 10.8 8.3 10.8 10.1 7.0 6.7 17.7 7.4 0.0 5.9 27.3 9.4 3.0 15.8 5.0 9.5 3.4 ELAC2 "FLJ10530, HPC2" ENSG00000006744 "ElaC ribonuclease Z 2" Q9BQ52 17 12992391-13018187 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Endonuclease, Hydrolase, Nuclease" "Disease mutation, Primary mitochondrial disease, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SuSa: 96.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019535 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA019535: AB_1848106" "unprognostic (4.24e-3)" "unprognostic (2.26e-1)" "unprognostic (1.11e-1)" "prognostic favorable (3.24e-6)" "unprognostic (8.64e-2)" "unprognostic (1.53e-1)" "unprognostic (1.65e-1)" "unprognostic (2.47e-1)" "unprognostic (2.22e-1)" "unprognostic (3.98e-1)" "unprognostic (5.31e-3)" "unprognostic (3.09e-1)" "unprognostic (5.31e-3)" "unprognostic (2.21e-1)" "unprognostic (1.15e-1)" "unprognostic (8.09e-2)" "unprognostic (3.70e-2)" 20.3 35.9 15.2 17.2 23.5 13.8 18.6 16.9 30.0 17.5 21.2 24.6 17.9 15.8 22.1 13.1 25.9 19.5 19.6 28.1 14.2 14.3 23.5 34.8 14.2 19.4 18.2 19.5 20.3 24.5 27.5 14.0 21.2 20.5 20.7 25.1 19.4 19.1 26.2 49.2 20.7 18.7 26.6 15.6 25.5 22.8 29.5 17.1 28.1 20.7 20.1 25.9 23.0 16.3 19.9 23.5 9.4 20.4 24.0 25.1 20.9 14.7 23.6 16.3 18.2 13.1 12.8 9.9 16.2 13.0 26.5 17.9 18.9 7.9 26.8 17.7 15.4 10.0 20.0 29.6 18.8 26.6 13.9 29.9 15.7 18.4 12.4 9.7 13.4 21.7 11.4 16.0 20.6 19.2 11.9 18.5 15.9 21.4 8.2 20.1 13.1 23.6 13.4 13.5 28.3 15.8 16.6 28.0 16.8 15.0 13.3 8.4 12.3 20.6 13.4 8.3 96.8 13.3 5.8 18.0 32.8 10.9 13.0 23.8 5.1 9.5 10.8 13.0 14.3 11.9 9.4 14.7 9.3 21.4 20.1 23.0 19.9 20.7 21.3 23.5 17.4 21.5 19.2 2.2 24.0 20.4 13.3 25.1 20.9 15.2 23.5 16.9 30.0 14.2 14.3 18.2 19.5 20.5 17.1 6.0 13.3 13.7 8.6 9.2 10.1 22.9 15.3 10.7 5.7 15.7 2.0 52.4 16.6 22.1 5.2 12.0 10.9 0.0 22.4 24.6 15.4 8.8 9.2 21.8 24.4 11.1 8.1 12.3 14.6 4.2 9.8 10.2 13.5 18.0 10.0 13.8 23.0 16.1 20.1 15.6 10.9 51.8 13.3 25.0 27.4 12.7 28.0 13.8 16.6 7.1 ELAVL1 "Hua, HuR, MelG" ENSG00000066044 "ELAV like RNA binding protein 1" Q15717 19 7958579-8005659 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005256, HPA046298" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA 210000 Nucleoplasm "Nucleoli, Cytosol" "CAB005256: AB_2096342, HPA046298: AB_2679618" "unprognostic (1.19e-1)" "unprognostic (9.66e-3)" "unprognostic (2.46e-2)" "unprognostic (3.98e-1)" "unprognostic (1.04e-1)" "unprognostic (6.37e-3)" "unprognostic (1.81e-2)" "unprognostic (8.44e-2)" "unprognostic (3.75e-2)" "prognostic favorable (4.93e-4)" "unprognostic (2.09e-1)" "unprognostic (1.59e-2)" "unprognostic (7.23e-2)" "unprognostic (6.14e-2)" "unprognostic (1.50e-1)" "unprognostic (1.18e-2)" "unprognostic (1.65e-2)" 19.7 23.8 28.0 22.4 34.1 17.2 22.4 35.4 28.0 23.1 21.4 21.2 19.6 17.9 27.5 19.7 24.4 25.7 16.9 25.2 23.6 17.6 20.8 21.4 19.4 26.5 27.5 22.2 25.7 20.4 29.4 25.4 23.3 26.5 20.4 20.2 19.7 21.2 23.0 27.6 19.2 18.4 30.4 17.7 21.9 19.7 46.7 26.5 40.4 20.6 18.7 30.7 23.4 32.2 17.1 17.6 24.3 14.7 23.2 19.6 9.4 36.1 24.0 40.3 30.3 15.8 15.9 22.7 27.0 22.7 40.2 31.5 34.7 21.1 43.6 38.0 29.6 22.6 25.3 44.9 30.9 34.1 38.9 41.7 38.2 17.7 32.3 23.2 36.2 30.6 19.7 18.6 28.0 17.1 19.1 30.7 33.3 39.2 32.7 27.7 26.8 60.5 29.2 35.9 27.2 30.6 68.1 26.3 28.7 25.5 26.7 29.0 21.2 25.6 25.9 20.4 25.4 29.5 28.6 23.0 37.7 26.4 34.9 46.4 33.4 32.3 45.8 21.1 43.6 32.5 16.4 13.0 24.3 12.2 11.7 12.9 14.0 17.8 19.6 17.6 17.1 16.1 12.4 3.8 23.2 14.7 8.8 13.5 9.4 28.0 34.1 35.4 28.0 23.6 17.6 27.5 22.2 26.5 26.5 23.8 23.9 31.2 59.2 64.3 42.6 27.2 30.6 14.7 13.6 45.4 53.0 76.4 56.3 31.1 188.6 49.4 29.5 0.0 29.2 87.0 49.8 55.0 20.7 78.0 55.5 57.2 40.4 43.0 50.2 108.9 46.6 53.3 49.0 30.7 47.6 43.8 29.8 48.6 53.4 49.4 54.8 51.8 58.0 132.2 59.8 62.0 62.6 49.8 53.0 69.3 ELAVL2 "HEL-N1, HuB" ENSG00000107105 "ELAV like RNA binding protein 2" Q12926 9 23690104-23826337 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 30.7;testis: 45.3" "Cell type enriched" "Detected in some" 4 "Spermatogonia: 154.0" "Cancer enhanced" "Detected in many" "testis cancer: 7.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 10.1;AF22: 15.6;SCLC-21H: 52.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022222, HPA063001" Enhanced Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB022222: , HPA063001: AB_2684918" "unprognostic (3.51e-1)" "unprognostic (4.18e-2)" "unprognostic (2.05e-1)" "unprognostic (1.47e-1)" "unprognostic (6.67e-2)" "unprognostic (1.79e-1)" "unprognostic (4.26e-2)" "unprognostic (8.94e-2)" "unprognostic (3.23e-1)" "unprognostic (1.01e-1)" "unprognostic (9.74e-4)" "unprognostic (3.98e-1)" "unprognostic (9.08e-4)" "unprognostic (8.30e-2)" "unprognostic (1.91e-2)" "unprognostic (2.12e-1)" "unprognostic (2.65e-1)" 1.0 2.4 8.7 1.0 13.4 1.4 1.1 18.3 27.5 1.0 1.3 0.7 0.0 1.0 1.5 1.4 1.1 1.0 1.1 1.0 8.1 19.2 1.4 0.8 1.1 1.0 16.3 18.9 2.1 0.8 1.2 2.5 0.9 30.7 1.2 1.5 0.5 1.0 1.0 1.0 1.5 1.1 1.1 5.0 1.0 1.0 45.3 1.1 0.0 1.2 0.0 1.0 1.6 0.3 1.8 1.1 5.1 0.9 1.4 1.3 0.1 10.1 0.1 15.6 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 4.2 6.5 0.1 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.3 0.3 4.0 0.0 4.7 0.0 0.1 0.0 0.3 0.5 2.2 0.0 0.0 0.0 4.1 0.0 4.9 0.0 5.6 0.1 0.0 0.0 52.1 4.9 0.1 0.1 0.1 4.2 0.2 0.7 0.0 0.1 3.4 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.6 2.7 0.9 1.6 0.5 0.6 0.6 1.0 0.5 0.4 0.4 1.8 1.1 1.3 5.1 1.4 0.5 1.1 0.6 0.1 8.7 13.4 18.3 27.5 8.1 19.2 16.3 18.9 30.7 1.1 0.0 0.0 0.0 0.3 0.9 3.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 34.9 1.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 15.9 4.1 0.0 0.0 30.7 2.8 0.0 0.0 0.0 0.7 2.7 0.0 0.0 1.4 0.0 9.6 0.0 0.3 12.2 154.0 0.6 0.0 0.0 0.8 0.8 ELAVL4 "HUD, PNEM" ENSG00000162374 "ELAV like RNA binding protein 4" P26378 1 50048014-50203786 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.1" "Group enriched" "Detected in some" 11 "Early spermatids: 111.8;Intestinal endocrine cells: 31.6;Late spermatids: 117.9" "Group enriched" "Detected in some" 10 "glioma: 2.6;pancreatic cancer: 0.6;testis cancer: 0.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.4;non-classical monocyte: 3.1" "Lineage enriched" "Detected in single" 5 "monocytes: 3.1" "Cell line enriched" "Detected in some" 19 "SH-SY5Y: 53.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004442, HPA043047" Enhanced Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB004442: AB_627765, HPA043047: AB_2732502" "unprognostic (1.25e-1)" "unprognostic (6.63e-3)" "unprognostic (4.43e-2)" "unprognostic (1.13e-1)" "unprognostic (1.95e-1)" "unprognostic (3.28e-2)" "unprognostic (3.83e-4)" "unprognostic (4.52e-2)" "unprognostic (2.63e-1)" "unprognostic (2.75e-1)" "unprognostic (3.75e-3)" "unprognostic (7.91e-2)" "unprognostic (2.39e-3)" "unprognostic (7.83e-2)" "unprognostic (2.81e-2)" "unprognostic (4.13e-2)" "unprognostic (7.43e-2)" 0.9 11.4 11.5 3.3 12.8 0.8 1.0 11.6 43.1 0.9 3.0 0.9 0.0 2.3 0.9 0.8 1.1 0.9 1.0 1.0 12.3 16.5 0.9 1.0 1.0 0.9 10.6 30.7 0.8 2.8 0.8 7.1 0.9 37.0 1.0 3.8 0.0 0.9 0.9 0.8 1.2 3.1 2.0 8.5 1.0 1.9 7.8 1.4 0.1 0.8 0.0 1.0 0.9 0.5 0.0 0.6 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 53.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.1 0.6 0.0 0.0 11.5 12.8 11.6 40.4 12.3 16.5 10.6 30.7 37.0 1.4 0.0 0.0 0.0 0.0 0.7 0.8 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 111.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 31.6 0.0 4.5 117.9 1.4 2.3 1.7 0.0 0.0 1.0 0.5 0.0 0.4 0.0 3.0 0.0 0.0 7.5 7.9 0.6 0.1 0.0 0.0 0.0 ELF1 ENSG00000120690 "E74 like ETS transcription factor 1" P32519 13 40932028-41061440 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 129.5" "Cell type enhanced" "Detected in all" 5 "granulocytes: 307.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 65.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001755, CAB005172" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB005172: AB_631428, HPA001755: AB_1078732" "unprognostic (1.21e-1)" "unprognostic (8.73e-3)" "unprognostic (4.20e-2)" "unprognostic (8.45e-2)" "unprognostic (2.01e-1)" "unprognostic (1.65e-1)" "unprognostic (1.02e-1)" "unprognostic (3.28e-1)" "unprognostic (2.11e-2)" "unprognostic (5.78e-2)" "unprognostic (3.38e-2)" "unprognostic (2.17e-1)" "unprognostic (6.02e-3)" "unprognostic (2.96e-1)" "unprognostic (4.11e-2)" "unprognostic (8.98e-2)" "unprognostic (3.72e-2)" 27.7 11.5 6.0 37.9 12.5 51.4 22.6 3.4 7.7 19.9 23.4 9.0 12.0 14.5 20.9 15.6 25.1 17.0 19.3 15.8 7.0 4.5 16.6 13.8 28.0 34.8 14.9 3.4 16.7 20.0 12.7 13.9 15.9 11.1 17.4 14.0 10.9 22.0 16.8 13.0 23.8 34.6 14.8 15.1 44.8 15.2 8.5 11.1 129.5 19.4 18.6 44.4 26.7 23.4 20.1 17.1 64.6 26.3 20.7 27.2 20.6 8.0 4.7 3.7 3.6 16.8 17.8 13.7 8.3 20.3 11.6 13.5 12.0 21.4 46.5 5.3 14.0 8.7 18.5 0.7 10.6 7.4 10.2 5.6 41.6 3.9 8.1 12.6 23.6 65.4 18.4 18.6 7.9 15.2 7.7 16.4 22.2 10.1 12.3 7.7 7.3 30.7 13.7 2.8 27.2 3.7 41.3 6.0 13.2 12.1 12.7 1.4 5.0 7.2 7.2 14.7 5.3 5.1 30.6 14.6 5.0 3.0 4.1 2.9 5.7 3.2 30.6 7.0 15.1 10.7 64.6 17.7 38.1 21.9 19.5 23.1 19.1 25.1 24.2 17.1 20.1 27.2 24.0 28.8 20.7 26.3 11.3 24.7 20.6 6.0 12.5 3.4 7.7 7.0 4.5 14.9 3.4 11.1 11.1 71.5 71.4 100.3 182.5 96.7 2.4 28.3 40.8 78.9 75.1 54.1 9.8 29.1 16.6 56.5 37.6 98.4 56.1 46.7 60.7 47.9 62.5 133.5 307.0 22.1 83.5 3.2 55.8 63.3 93.8 11.4 39.7 135.9 114.7 64.1 49.8 7.5 56.2 45.6 40.7 23.7 3.6 38.8 56.7 7.6 8.5 100.4 44.7 171.1 49.4 185.4 ELF2 "EU32, NERF, NERF-1A, NERF-1B, NERF-2" ENSG00000109381 "E74 like ETS transcription factor 2" Q15723 4 139028112-139177218 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006057, HPA071166" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA006057: AB_1078733, HPA071166: AB_2686351" "unprognostic (7.21e-2)" "unprognostic (3.84e-2)" "unprognostic (7.41e-2)" "unprognostic (3.72e-2)" "unprognostic (2.29e-1)" "unprognostic (2.80e-2)" "unprognostic (1.49e-1)" "unprognostic (2.43e-2)" "unprognostic (7.05e-3)" "unprognostic (1.67e-1)" "unprognostic (5.73e-2)" "unprognostic (2.21e-2)" "unprognostic (2.48e-2)" "unprognostic (3.65e-1)" "unprognostic (3.47e-1)" "unprognostic (1.31e-1)" "unprognostic (4.97e-3)" 35.3 12.6 13.2 17.4 24.9 34.3 24.2 29.7 21.6 23.4 22.4 15.2 25.7 12.7 22.9 17.5 18.8 19.0 15.7 20.3 16.1 11.6 15.6 17.4 18.6 19.8 29.3 10.2 25.5 19.5 19.5 23.6 22.8 17.7 23.4 16.9 14.2 21.0 22.4 27.6 19.1 17.9 30.0 23.4 22.8 16.2 30.1 25.1 31.1 21.6 22.4 17.6 25.2 35.0 19.3 19.1 12.5 8.0 10.6 14.8 4.8 9.1 6.8 17.0 12.3 17.2 20.8 16.1 11.1 19.2 11.9 13.7 12.7 18.2 18.6 11.2 14.8 6.3 9.5 25.3 14.8 12.5 11.6 10.9 16.9 15.7 10.9 13.2 18.6 13.4 18.4 15.1 11.3 13.9 16.4 17.7 11.1 27.1 10.7 10.0 15.4 20.8 15.6 10.6 21.6 7.5 20.5 22.1 16.9 14.4 16.1 17.2 19.2 13.5 16.7 9.9 20.0 11.4 21.3 14.8 11.0 9.6 10.0 7.1 24.2 27.0 16.4 8.2 19.0 9.9 8.6 8.0 12.5 12.4 6.4 12.9 15.3 11.8 10.5 8.8 19.3 14.8 13.4 8.0 10.6 6.4 19.1 9.3 4.8 13.2 24.9 29.7 21.6 16.1 11.6 29.3 10.2 17.7 25.1 44.7 22.7 30.8 38.3 47.3 40.0 35.1 38.2 49.5 42.1 38.4 70.7 26.9 36.5 22.2 16.6 56.3 26.2 0.0 21.2 26.4 42.7 41.9 33.5 40.9 19.4 63.5 45.4 47.9 43.9 18.1 48.6 35.4 28.7 25.2 31.6 41.7 20.8 29.6 35.7 13.2 51.7 38.8 55.6 47.2 42.1 41.7 19.8 42.8 26.7 32.4 ELF3 "EPR-1, ERT, ESE-1, ESX" ENSG00000163435 "E74 like ETS transcription factor 3" P78545 1 202007945-202017188 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Inflammatory response, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 100.8" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 1511.9;Glandular cells: 1015.6;Paneth cells: 1043.9;Urothelial cells: 1629.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 40.5;CAPAN-2: 57.8;OE19: 37.3;RT4: 41.5;SK-BR-3: 80.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA003316, HPA003479" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA003316: AB_1078757, HPA003479: AB_1078756" "unprognostic (9.90e-3)" "unprognostic (1.72e-1)" "unprognostic (7.50e-2)" "unprognostic (1.12e-1)" "unprognostic (2.96e-3)" "unprognostic (3.88e-2)" "unprognostic (1.38e-2)" "unprognostic (1.83e-1)" "unprognostic (1.69e-1)" "unprognostic (5.05e-3)" "unprognostic (7.67e-3)" "unprognostic (7.07e-2)" "unprognostic (9.92e-3)" "unprognostic (4.03e-2)" "unprognostic (1.30e-1)" "unprognostic (1.85e-1)" "unprognostic (3.37e-3)" 0.3 0.1 0.1 16.0 0.2 0.0 34.0 0.2 0.2 13.2 80.7 0.2 12.5 34.4 3.8 8.9 59.3 8.6 67.7 1.1 0.1 0.1 38.1 33.3 24.6 0.1 0.1 0.1 5.8 38.4 1.1 1.7 16.7 0.3 39.9 31.3 0.7 37.9 11.3 0.7 3.5 100.8 9.5 0.3 0.2 29.9 1.9 0.1 0.6 5.7 25.5 43.5 44.7 22.7 0.3 0.8 2.0 0.3 0.2 0.3 0.0 10.6 40.5 0.0 0.0 0.0 0.0 12.6 0.0 1.5 0.0 0.0 9.0 57.8 0.0 4.8 0.0 0.3 10.5 0.0 0.0 0.0 1.2 0.0 0.0 7.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.1 0.6 37.3 3.4 0.0 0.0 0.5 15.4 41.5 0.0 0.0 0.4 80.2 0.0 1.9 5.6 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.8 0.3 0.2 0.2 0.1 0.3 0.1 0.1 0.1 0.8 0.3 0.2 0.1 2.0 0.2 0.3 0.2 0.0 0.0 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.3 0.1 273.9 377.1 5.4 575.3 4.5 1.7 1.2 448.4 586.2 343.5 312.3 17.7 60.7 34.9 553.5 0.0 1.1 1511.9 0.0 565.5 107.5 4.2 1015.6 40.3 30.4 7.8 0.0 434.4 0.6 1.3 0.0 0.0 12.0 8.5 25.2 963.0 2.0 453.3 1043.9 0.0 114.1 63.9 0.0 0.4 0.0 0.2 7.3 215.1 2.2 773.6 1629.9 ELF4 "ELFR, MEF" ENSG00000102034 "E74 like ETS transcription factor 4" Q99607 X 130064874-130110716 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 31.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA058595, HPA060277" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA058595: AB_2683768, HPA060277: AB_2684239" "unprognostic (1.33e-1)" "unprognostic (8.51e-2)" "unprognostic (3.83e-1)" "unprognostic (2.13e-2)" "unprognostic (1.14e-1)" "unprognostic (1.80e-1)" "unprognostic (4.43e-3)" "unprognostic (7.86e-3)" "unprognostic (3.50e-2)" "unprognostic (1.80e-1)" "unprognostic (1.29e-2)" "unprognostic (3.95e-1)" "prognostic unfavorable (6.49e-6)" "unprognostic (1.43e-1)" "unprognostic (5.46e-2)" "unprognostic (2.51e-1)" "prognostic favorable (1.42e-4)" 16.9 3.6 2.0 18.1 2.5 27.6 16.9 0.5 3.0 7.7 10.8 3.1 7.0 8.4 10.5 8.1 10.5 9.5 11.0 7.3 3.1 1.2 5.9 2.5 21.9 33.3 3.8 0.9 12.7 4.5 3.8 4.2 23.5 3.0 6.6 10.9 3.6 5.4 7.9 5.7 9.1 16.3 6.4 4.2 18.9 12.3 3.5 2.9 18.1 3.9 7.4 11.5 11.7 14.4 3.9 6.1 9.4 10.3 8.4 10.3 5.1 22.8 8.5 1.5 0.1 3.9 8.5 22.3 10.7 13.6 13.0 14.4 11.8 16.3 11.7 21.4 14.4 18.0 14.9 8.5 12.5 12.7 12.5 7.0 23.0 11.4 5.4 8.8 20.0 29.5 8.8 14.1 20.8 20.6 8.1 12.5 2.6 8.8 3.2 7.0 13.2 3.2 11.4 1.0 11.6 8.4 7.1 2.7 5.0 7.9 26.4 5.9 2.5 9.5 9.3 2.9 8.4 4.6 19.3 11.6 9.1 7.2 16.9 19.6 1.8 0.7 9.4 10.7 18.5 2.1 1.6 5.4 7.8 10.3 10.3 8.3 3.9 6.2 8.8 6.1 3.5 6.2 7.2 9.4 8.4 7.0 3.7 6.3 5.1 2.0 2.5 0.5 3.0 3.1 1.2 3.8 0.9 3.0 2.9 8.9 4.1 0.5 8.0 12.0 0.0 0.6 0.0 6.7 5.7 0.0 0.0 9.1 0.0 2.2 0.1 4.5 15.6 0.0 3.6 31.1 5.6 5.4 1.1 0.4 8.7 0.0 8.6 6.7 10.2 0.4 1.7 8.9 3.3 7.2 6.6 0.0 5.7 14.0 1.1 0.3 0.0 6.5 3.8 0.0 3.8 9.2 9.4 5.3 5.9 15.5 ELF5 ENSG00000135374 "E74 like ETS transcription factor 5" Q9UKW6 11 34478793-34513805 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "breast: 48.8;ductus deferens: 72.2;salivary gland: 85.1;seminal vesicle: 86.9" "Cell type enhanced" "Detected in some" 24 "Alveolar cells type 2: 29.3;Collecting duct cells: 96.0;Cytotrophoblasts: 17.5;Melanocytes: 16.9" "Cancer enhanced" "Detected in many" "breast cancer: 8.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 8 "RT4: 17.8;T-47d: 34.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA062706 Approved Nucleoplasm NA NA Nucleoplasm "HPA062706: AB_2684841" "unprognostic (1.13e-1)" "unprognostic (1.48e-1)" "unprognostic (7.55e-2)" "unprognostic (3.31e-2)" "unprognostic (2.41e-4)" "unprognostic (6.90e-2)" "unprognostic (3.93e-1)" "prognostic favorable (3.64e-4)" "unprognostic (1.12e-1)" "unprognostic (3.40e-2)" "unprognostic (8.15e-2)" "unprognostic (3.15e-2)" "unprognostic (1.78e-3)" "unprognostic (3.09e-1)" "unprognostic (1.98e-1)" "unprognostic (1.05e-1)" "unprognostic (2.86e-1)" 0.1 0.0 0.0 0.0 0.1 0.0 48.8 0.0 0.0 0.5 0.0 0.0 72.2 0.6 0.0 0.1 0.6 0.0 1.1 0.0 0.0 0.0 6.5 0.0 2.4 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.8 0.0 1.4 0.0 0.0 85.1 86.9 0.0 3.5 0.0 1.0 0.0 0.3 0.1 0.1 0.0 0.2 0.0 3.5 1.0 5.8 1.2 0.5 0.5 2.0 1.8 0.7 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.3 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 17.8 0.0 0.0 0.0 3.1 0.0 0.1 34.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 2.0 0.3 0.2 0.5 1.8 0.3 0.2 0.3 0.4 0.3 0.5 0.4 0.4 0.9 0.7 1.8 0.5 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 29.3 0.0 2.5 0.2 0.0 0.3 0.0 5.3 9.1 96.0 0.0 17.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.3 1.9 0.0 0.0 1.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 9.6 0.0 0.0 5.8 ELFN1 PPP1R28 ENSG00000225968 "Extracellular leucine rich repeat and fibronectin type III domain containing 1" P0C7U0 7 1688119-1747954 "Predicted membrane proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 13.3" "Cell type enhanced" "Detected in some" 10 "Cone photoreceptor cells: 5.9;Hepatocytes: 7.8;Ito cells: 9.8;Rod photoreceptor cells: 6.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 19.5;U-138 MG: 12.3;U-2 OS: 18.0;U-2197: 20.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA066382 Approved "Nucleoplasm,Cell Junctions" NA NA 11000 "Nucleoplasm, Cell Junctions" "HPA066382: AB_2732744" "unprognostic (8.45e-2)" "unprognostic (3.39e-3)" "unprognostic (6.54e-4)" "unprognostic (1.64e-1)" "unprognostic (1.30e-1)" "unprognostic (1.44e-1)" "prognostic favorable (9.68e-4)" "unprognostic (4.60e-3)" "unprognostic (1.63e-3)" "unprognostic (6.60e-2)" "unprognostic (4.14e-3)" "unprognostic (1.11e-2)" "unprognostic (2.31e-2)" "unprognostic (7.47e-3)" "unprognostic (8.63e-2)" "unprognostic (2.78e-1)" "unprognostic (4.07e-1)" 1.8 0.8 2.2 0.6 1.4 0.0 0.6 0.0 4.2 3.2 0.3 0.2 2.2 0.3 0.3 0.8 0.8 3.3 1.8 2.2 2.8 13.3 0.3 0.1 2.7 0.0 0.2 0.2 0.2 0.7 0.6 0.0 0.5 0.2 1.2 0.6 0.3 0.5 1.7 1.7 0.2 0.7 0.2 0.0 0.5 0.9 0.5 0.0 0.7 0.0 0.0 0.2 0.0 0.1 0.0 3.0 6.3 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.1 0.3 0.0 3.0 1.3 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 3.5 0.0 2.9 1.2 0.0 0.7 19.5 0.0 1.9 0.0 0.0 2.8 1.3 0.1 0.1 0.0 0.3 0.0 0.2 0.0 12.3 18.0 20.9 0.0 0.0 0.2 5.3 0.0 0.0 1.5 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.5 0.1 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.4 0.1 1.0 1.6 0.0 0.0 0.0 0.0 5.9 0.0 3.3 0.0 0.0 3.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 7.8 0.1 0.0 0.0 9.8 0.6 0.0 0.9 0.0 1.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 6.7 0.0 0.9 0.0 2.7 0.0 0.0 0.0 0.0 0.0 ELFN2 "dJ63G5.3, KIAA1904, LRRC62, PPP1R29" ENSG00000166897 "Extracellular leucine rich repeat and fibronectin type III domain containing 2" Q5R3F8 22 37367960-37427470 "Predicted membrane proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 30.0" "Cell type enriched" "Detected in some" 11 "Bipolar cells: 43.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 8.7;CAPAN-2: 8.4;GAMG: 9.4;RPMI-8226: 8.4;RPTEC TERT1: 16.4;U-2 OS: 18.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000781 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA000781: AB_1079280" "unprognostic (2.74e-1)" "unprognostic (6.81e-2)" "unprognostic (2.80e-2)" "unprognostic (1.31e-5)" "unprognostic (3.28e-1)" "unprognostic (2.51e-2)" "unprognostic (7.76e-2)" "unprognostic (4.25e-2)" "unprognostic (6.05e-2)" "unprognostic (2.80e-2)" "unprognostic (2.02e-1)" "unprognostic (4.51e-1)" "prognostic unfavorable (7.21e-4)" "unprognostic (1.29e-1)" "unprognostic (1.95e-1)" "unprognostic (1.77e-1)" "unprognostic (1.95e-1)" 1.0 2.1 26.8 0.9 10.9 0.9 0.9 0.7 30.0 0.9 0.9 1.9 0.0 0.9 0.9 0.9 0.9 1.0 1.9 0.8 16.2 8.7 1.2 0.8 2.0 1.0 6.7 15.0 0.8 1.1 0.8 0.1 0.8 5.8 2.2 0.9 0.9 0.9 0.9 0.9 1.5 0.9 0.8 3.8 0.9 1.1 4.2 3.9 0.1 0.8 0.0 0.9 0.9 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 8.7 3.7 0.0 0.0 0.0 0.7 0.0 4.0 2.1 0.9 0.0 1.4 8.4 0.2 5.2 2.8 9.4 6.1 0.4 0.8 0.1 0.2 0.0 0.0 3.9 0.0 0.2 0.0 0.1 0.7 0.1 0.3 1.2 3.5 0.3 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.2 5.2 8.0 0.1 0.0 8.4 16.4 0.0 0.7 0.0 3.6 4.6 0.0 0.0 0.0 0.1 0.4 0.0 18.7 0.1 2.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 10.9 0.7 16.8 16.2 8.7 6.7 15.0 5.8 3.9 0.0 3.2 0.0 0.0 0.1 43.2 0.0 2.5 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.3 1.6 0.0 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.0 ELK1 ENSG00000126767 "ELK1, ETS transcription factor" P19419 X 47635521-47650604 "Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003808, HPA036084, HPA064381" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB003808: AB_562282, HPA036084: AB_2674931, HPA064381: AB_2685250" "unprognostic (2.25e-1)" "unprognostic (1.83e-2)" "unprognostic (4.77e-2)" "unprognostic (1.40e-2)" "unprognostic (2.31e-1)" "unprognostic (2.73e-1)" "unprognostic (1.16e-2)" "unprognostic (1.69e-1)" "unprognostic (1.47e-1)" "unprognostic (2.59e-3)" "unprognostic (1.17e-1)" "unprognostic (8.39e-2)" "prognostic unfavorable (3.25e-5)" "unprognostic (1.02e-1)" "unprognostic (2.03e-1)" "unprognostic (1.79e-2)" "unprognostic (1.67e-2)" 12.1 20.9 37.2 10.8 52.2 11.5 8.2 32.6 32.9 11.1 9.4 4.9 14.6 8.1 11.4 17.5 8.5 13.1 9.9 12.4 23.3 11.6 7.7 19.0 8.9 10.4 5.7 22.7 37.7 9.8 12.0 7.5 13.7 6.7 9.3 9.8 7.4 9.8 11.3 17.9 8.6 8.5 10.8 4.4 14.3 7.5 19.1 11.2 8.7 6.9 8.3 11.5 8.9 6.7 7.4 11.7 3.9 9.5 4.2 12.7 6.3 17.2 13.6 7.0 19.4 12.1 14.7 9.7 14.5 17.3 17.8 18.5 9.5 13.1 13.6 8.0 15.7 28.8 10.5 18.4 15.5 16.9 15.1 17.5 11.3 12.5 8.5 26.9 12.3 19.9 14.1 14.1 28.5 19.2 14.9 10.2 19.4 23.4 16.1 14.5 22.8 13.0 14.1 16.2 8.5 28.8 14.2 17.6 21.3 9.5 7.5 15.1 12.6 24.4 8.7 20.5 16.6 22.1 7.9 8.1 20.4 21.2 26.5 13.5 26.7 36.7 14.2 22.6 22.4 12.7 2.0 8.1 3.4 7.4 9.5 8.6 7.4 9.5 8.6 11.7 6.7 8.4 6.8 3.9 4.2 7.8 8.2 12.7 6.3 37.2 52.2 32.6 32.9 23.3 11.6 5.7 22.7 6.7 11.2 0.0 7.0 7.4 10.8 14.9 13.3 7.5 5.1 1.4 4.5 7.0 3.9 6.8 5.0 6.9 2.9 8.0 4.5 0.0 6.4 8.2 8.2 10.6 8.1 11.9 9.0 4.8 9.8 18.4 6.5 0.9 13.0 9.0 6.8 20.8 7.7 8.2 6.0 3.5 28.0 4.4 6.8 6.5 11.3 1.9 7.8 13.9 7.4 7.2 10.5 9.5 ELK3 "ERP, NET, SAP2" ENSG00000111145 "ELK3, ETS transcription factor" P41970 12 96194382-96269835 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 91.0;Endothelial cells: 133.8;Ito cells: 151.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001600 Approved Supported Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA001600: AB_1078752" "unprognostic (3.11e-1)" "unprognostic (8.81e-3)" "unprognostic (6.38e-2)" "unprognostic (5.77e-2)" "unprognostic (7.18e-3)" "unprognostic (1.12e-1)" "unprognostic (1.15e-1)" "unprognostic (5.10e-3)" "unprognostic (7.39e-2)" "prognostic unfavorable (4.93e-4)" "unprognostic (2.29e-2)" "unprognostic (1.13e-1)" "unprognostic (1.20e-3)" "unprognostic (2.90e-3)" "unprognostic (1.61e-1)" "unprognostic (1.70e-1)" "unprognostic (2.05e-2)" 36.9 9.3 5.0 20.9 6.7 8.3 23.5 12.9 4.5 29.2 12.6 7.3 12.0 4.6 45.2 15.6 25.7 15.0 16.3 15.5 4.8 5.1 13.3 8.2 17.1 20.6 6.1 2.8 13.3 5.8 6.6 6.0 15.9 8.9 18.1 7.5 15.7 14.1 8.6 10.5 8.7 11.1 20.8 13.1 32.7 9.1 8.6 6.3 17.4 19.7 25.1 32.1 15.9 20.9 11.3 9.4 4.1 12.8 10.5 24.1 6.3 12.9 7.8 8.0 4.2 20.4 38.4 2.0 16.5 31.7 13.2 10.2 0.4 9.7 2.1 5.7 18.5 9.9 4.6 0.9 26.5 23.3 5.6 3.0 0.6 3.3 2.9 6.2 6.3 1.5 22.5 5.0 27.2 20.6 26.9 31.5 1.6 1.5 8.7 44.5 2.0 1.2 4.2 9.8 1.8 10.4 10.3 13.5 2.3 11.3 3.4 0.4 8.5 5.4 2.4 8.2 12.7 1.3 3.4 19.3 36.3 14.2 22.3 14.3 16.7 13.9 0.5 12.8 7.4 25.1 3.3 12.8 0.3 6.2 6.9 24.1 11.3 14.7 8.4 9.4 9.9 8.9 6.5 4.1 10.5 5.9 3.8 23.4 6.3 5.0 6.7 12.9 4.5 4.8 5.1 6.1 2.8 8.9 6.3 6.0 30.6 17.6 31.5 29.0 0.5 4.8 5.1 91.0 54.6 5.2 3.9 0.9 5.0 18.1 0.6 133.8 0.7 0.0 13.5 3.1 34.2 29.1 16.2 3.6 20.8 0.0 1.2 151.0 36.0 1.3 10.6 22.2 11.8 3.6 3.0 4.7 36.9 2.9 9.9 0.0 0.4 12.9 24.3 0.0 14.7 23.6 0.9 15.9 2.9 67.8 ELK4 SAP1 ENSG00000158711 "ELK4, ETS transcription factor" P28324 1 205597556-205631962 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 95.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028863 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA028863: AB_10602492" "unprognostic (2.08e-1)" "unprognostic (2.71e-2)" "unprognostic (1.98e-1)" "unprognostic (1.59e-1)" "unprognostic (2.15e-1)" "prognostic favorable (4.65e-4)" "unprognostic (2.97e-1)" "unprognostic (1.48e-1)" "unprognostic (1.19e-1)" "unprognostic (3.53e-1)" "unprognostic (1.27e-2)" "unprognostic (2.64e-1)" "prognostic unfavorable (2.94e-6)" "unprognostic (2.21e-2)" "unprognostic (1.26e-1)" "unprognostic (1.08e-1)" "unprognostic (5.58e-3)" 14.1 7.1 10.0 14.7 12.7 12.0 13.8 16.2 10.4 10.1 8.9 10.4 8.6 7.3 11.3 9.2 11.7 9.5 11.4 10.8 10.6 5.0 15.2 15.6 13.8 19.1 10.0 6.9 13.1 12.4 13.6 16.8 9.5 9.5 32.6 8.7 12.2 12.4 8.2 14.7 17.6 13.5 10.5 8.2 18.3 9.4 8.4 11.0 24.4 10.8 8.3 19.6 15.1 13.2 2.2 1.5 8.7 1.1 1.2 3.1 0.6 8.2 7.5 2.9 7.7 7.1 9.1 7.5 5.6 5.8 4.4 5.2 3.2 8.4 17.6 5.3 6.9 3.3 10.4 6.2 6.8 7.7 20.0 4.4 7.6 12.2 6.8 9.7 14.2 30.3 8.0 8.5 7.0 14.4 8.6 18.6 8.4 6.9 14.8 6.2 11.2 11.7 5.3 4.9 1.9 4.5 8.7 18.3 14.3 5.9 18.2 3.5 4.1 14.4 7.9 9.5 5.4 7.3 4.8 13.4 9.0 10.6 8.0 10.5 11.1 10.1 11.9 7.8 5.8 10.5 8.7 0.8 1.2 1.6 1.1 2.1 1.4 1.8 2.1 1.1 2.2 2.2 3.1 0.4 1.2 0.6 1.5 1.8 0.6 10.0 12.7 16.2 10.4 10.6 5.0 10.0 6.9 9.5 11.0 8.9 11.5 21.4 29.2 34.9 95.4 18.7 28.1 17.4 15.9 29.6 11.8 11.3 3.3 12.9 11.6 35.7 9.8 0.0 15.6 5.2 25.6 62.3 27.7 28.9 8.9 23.8 12.6 25.8 20.0 14.0 23.6 18.5 28.7 5.4 15.8 10.6 12.9 3.5 14.5 13.9 26.7 25.8 23.4 20.0 9.8 42.4 15.3 37.4 17.3 61.0 ELL "C19orf17, ELL1, Men, PPP1R68" ENSG00000105656 "Elongation factor for RNA polymerase II" P55199 19 18442663-18522127 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 301.9;Late spermatids: 183.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004202, HPA046076" Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA004202: , HPA046076: AB_2679526" "unprognostic (9.49e-2)" "unprognostic (1.38e-1)" "unprognostic (3.26e-3)" "unprognostic (2.07e-1)" "unprognostic (1.64e-1)" "unprognostic (2.10e-1)" "unprognostic (8.26e-2)" "unprognostic (2.71e-1)" "unprognostic (2.34e-1)" "unprognostic (3.00e-2)" "unprognostic (6.28e-3)" "unprognostic (2.38e-2)" "unprognostic (1.57e-1)" "unprognostic (2.07e-1)" "unprognostic (5.12e-1)" "unprognostic (2.46e-1)" "unprognostic (1.06e-1)" 19.9 7.7 5.1 13.4 9.9 38.4 10.8 17.0 9.7 11.9 13.5 7.7 8.6 10.4 12.6 9.5 9.3 9.1 10.9 9.5 5.8 4.4 9.8 11.6 14.2 10.7 6.2 3.5 12.7 14.6 6.2 10.5 27.0 6.3 10.4 4.4 9.1 10.6 9.0 20.3 13.3 10.9 10.0 5.1 15.9 9.3 31.7 7.7 11.0 7.8 7.2 13.6 18.5 13.2 3.1 8.6 17.2 5.6 2.1 7.9 3.3 8.9 4.4 2.3 4.9 2.5 3.2 17.0 7.1 6.3 5.4 5.2 5.0 7.1 11.3 8.8 4.7 3.7 6.3 3.4 7.8 2.7 9.2 8.0 6.8 4.4 4.3 3.8 7.4 8.7 6.5 6.7 7.0 5.5 4.2 3.8 6.2 9.4 15.6 2.8 7.6 8.7 8.1 7.7 5.4 12.6 7.5 3.7 11.9 3.8 6.3 4.2 4.6 5.2 9.0 7.7 3.1 4.5 9.3 6.3 6.3 4.9 8.6 6.6 25.5 16.0 8.4 8.3 12.6 8.9 0.3 5.6 3.8 4.7 4.1 7.9 3.1 2.9 4.2 4.7 2.3 1.9 2.9 17.2 2.1 2.1 8.6 3.0 3.3 5.1 9.9 17.0 9.7 5.8 4.4 6.2 3.5 6.3 7.7 6.0 6.7 6.0 22.3 24.8 4.1 4.0 10.2 6.7 3.4 3.5 3.9 37.4 10.0 7.0 301.9 11.7 10.5 0.0 7.0 14.6 16.0 13.8 10.5 13.4 16.6 1.6 18.9 8.6 11.5 183.8 6.1 13.8 6.8 11.8 9.0 4.2 8.8 2.9 2.8 5.7 3.5 19.4 28.8 19.0 21.8 26.6 57.4 11.4 6.4 18.6 ELL2 MRCCAT1 ENSG00000118985 "Elongation factor for RNA polymerase II 2" O00472 5 95885098-95962071 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "granulocytes: 168.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 65.4;HDLM-2: 57.6;U-266/84: 41.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013569 Supported Nucleoplasm No No Nucleoplasm "HPA013569: AB_2668853" "unprognostic (1.18e-2)" "unprognostic (1.88e-2)" "unprognostic (3.41e-2)" "unprognostic (2.94e-2)" "unprognostic (1.93e-1)" "unprognostic (5.82e-2)" "unprognostic (9.14e-2)" "unprognostic (3.21e-2)" "unprognostic (1.29e-1)" "unprognostic (8.05e-2)" "unprognostic (9.16e-2)" "unprognostic (1.70e-1)" "prognostic unfavorable (1.31e-4)" "prognostic unfavorable (1.61e-4)" "unprognostic (6.27e-2)" "unprognostic (1.37e-2)" "unprognostic (1.74e-2)" 24.4 9.1 7.1 12.2 13.5 18.1 16.4 5.2 19.3 9.8 7.5 11.5 26.0 6.3 4.2 3.7 27.5 6.4 16.3 17.2 10.5 8.1 7.5 37.1 14.3 10.0 11.4 8.3 11.8 41.3 9.4 14.3 12.5 15.8 18.2 6.0 2.8 43.9 55.7 14.0 25.9 6.8 9.1 13.3 14.9 18.3 6.5 11.9 1.4 7.7 15.4 9.3 12.3 14.8 5.3 0.6 8.7 1.6 2.2 1.5 0.9 6.2 2.4 0.8 0.1 9.5 11.9 0.9 65.4 11.2 21.8 18.6 4.7 1.4 0.2 1.4 34.7 5.1 8.1 2.0 20.8 26.8 57.6 1.5 4.0 10.7 10.3 6.0 0.9 6.9 11.5 14.4 13.2 40.0 13.1 3.4 0.7 2.2 24.8 20.3 0.6 0.0 1.1 1.0 0.9 3.4 0.6 3.9 4.9 4.1 6.0 1.3 0.4 24.0 1.2 1.4 3.2 0.7 0.7 7.1 28.8 5.8 6.6 11.8 17.5 41.5 0.3 14.9 0.4 1.9 8.7 1.1 7.6 0.9 1.6 1.5 5.3 1.3 1.3 0.6 2.6 0.9 0.7 2.5 2.2 1.1 0.4 1.4 0.9 7.1 13.5 5.2 19.3 10.5 8.1 11.4 8.3 15.8 11.9 26.8 88.8 34.3 115.9 162.7 0.3 27.0 5.1 29.4 69.4 17.4 0.0 1.7 5.0 25.9 1.8 31.6 13.4 46.7 78.5 13.7 30.4 143.0 168.5 135.2 36.5 0.0 103.5 21.5 54.4 2.5 7.2 36.9 43.9 38.7 15.1 1.2 61.0 14.4 6.7 13.4 0.1 12.9 55.1 12.8 7.7 149.8 21.6 32.4 12.1 81.4 ELL3 FLJ22637 ENSG00000128886 "Elongation factor for RNA polymerase II 3" Q9HB65 15 43772600-43777543 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 13.3;lymphoid tissue: 24.2" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 5.3;Early spermatids: 1.5;Enterocytes: 1.7;Late spermatids: 1.8;Mucus-secreting cells: 2.0;Undifferentiated cells: 2.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "memory B-cell: 5.3;naive B-cell: 8.5" "Lineage enriched" "Detected in many" 7 "B-cells: 8.5" "Cell line enhanced" "Detected in some" "Daudi: 7.9;U-698: 19.2" "Region enriched" "Detected in single" 11 "olfactory region: 2.4" "Not detected" "Not detected" "HPA028938, HPA073494" Approved Supported "Nucleoplasm,Nucleoli,Mitotic chromosome" NA NA "Nucleoplasm, Nucleoli" "Mitotic chromosome" "HPA028938: AB_10795352, HPA073494: " "unprognostic (2.59e-2)" "unprognostic (4.41e-1)" "unprognostic (1.76e-1)" "unprognostic (1.28e-1)" "unprognostic (3.59e-1)" "unprognostic (2.30e-2)" "unprognostic (1.17e-1)" "unprognostic (2.42e-3)" "unprognostic (1.52e-2)" "unprognostic (3.89e-1)" "unprognostic (2.19e-1)" "unprognostic (3.53e-1)" "unprognostic (1.87e-1)" "unprognostic (3.67e-2)" "unprognostic (8.95e-2)" "unprognostic (1.08e-1)" "unprognostic (1.24e-2)" 0.7 1.1 1.0 24.2 0.6 0.4 2.5 4.7 0.6 2.3 10.6 0.5 1.6 4.8 1.0 1.0 5.5 1.3 0.9 0.6 1.0 0.6 1.8 0.5 0.9 7.5 1.3 0.0 1.3 0.7 0.6 1.2 0.8 2.6 2.1 1.8 0.8 2.0 0.7 1.0 7.0 13.3 0.9 0.6 1.5 1.1 12.3 0.5 0.8 1.1 2.8 16.7 1.3 1.7 8.5 1.0 0.1 0.1 0.1 1.2 0.6 0.6 0.1 0.6 0.2 1.6 0.1 0.1 0.2 0.5 0.8 1.3 0.1 0.5 7.9 0.1 0.7 0.1 2.9 0.3 0.0 0.5 0.7 3.4 0.3 2.6 0.8 0.5 0.0 0.0 0.0 0.5 0.2 0.1 0.1 0.3 0.2 0.3 0.0 0.1 1.2 0.3 0.9 0.0 1.1 0.8 0.8 0.1 0.1 0.2 0.0 3.6 0.2 0.3 1.5 0.3 0.1 3.6 0.2 0.1 0.2 0.0 0.3 0.2 0.0 0.0 19.2 0.2 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.2 5.3 0.5 0.2 0.0 8.5 1.2 0.3 0.1 0.1 0.0 1.0 0.3 0.6 1.0 0.6 4.7 0.6 1.0 0.6 1.3 0.0 2.6 0.5 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 1.7 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.2 0.0 2.0 0.1 ELMOD1 DKFZp547C176 ENSG00000110675 "ELMO domain containing 1" Q8N336 11 107591091-107666779 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 51.1;pituitary gland: 20.8;skin 1: 34.7" "Cell type enhanced" "Detected in some" 11 "Bipolar cells: 30.4;Cone photoreceptor cells: 15.7;Horizontal cells: 35.0;Late spermatids: 14.0;Rod photoreceptor cells: 17.8" "Cancer enriched" "Detected in single" 15 "glioma: 4.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 11.9;RH-30: 27.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038435, HPA066479" Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038435: AB_10795575, HPA066479: " "unprognostic (2.74e-1)" "unprognostic (1.72e-4)" "unprognostic (2.58e-2)" "unprognostic (9.13e-2)" "unprognostic (3.93e-2)" "unprognostic (2.12e-2)" "unprognostic (1.34e-1)" "unprognostic (6.59e-3)" "unprognostic (1.93e-1)" "unprognostic (1.36e-1)" "unprognostic (6.29e-2)" "unprognostic (9.44e-2)" "unprognostic (1.34e-4)" "unprognostic (1.91e-2)" "unprognostic (3.15e-1)" "unprognostic (4.21e-2)" "unprognostic (1.39e-1)" 1.5 4.2 10.7 1.5 41.1 1.3 4.1 12.8 51.1 1.5 1.4 1.7 0.0 1.4 1.6 1.3 1.2 3.6 1.2 4.8 13.8 14.3 4.7 1.3 1.6 1.3 8.7 15.2 1.2 1.2 1.2 20.8 1.2 14.8 2.1 1.3 1.4 1.3 1.2 2.8 34.7 1.3 1.4 6.6 1.2 1.2 2.9 3.9 0.0 1.3 0.0 1.2 1.1 0.1 0.9 0.7 2.4 0.9 1.8 0.5 0.2 0.0 0.0 4.5 0.1 0.0 0.0 0.1 0.2 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.2 3.5 0.4 2.2 0.3 0.4 0.0 1.8 0.1 0.0 0.1 1.2 0.1 0.0 0.4 0.1 0.0 0.0 0.1 11.9 1.5 0.0 0.1 0.8 0.1 0.0 0.1 0.5 0.0 1.8 0.0 27.1 0.0 0.0 0.0 0.2 1.3 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.3 1.3 0.0 0.7 0.1 0.0 0.0 3.6 0.0 2.1 1.6 0.9 0.6 0.4 0.6 0.4 0.5 0.5 0.2 0.2 0.9 0.4 0.5 2.4 1.8 0.6 0.7 0.4 0.2 10.7 41.1 12.8 26.9 13.8 14.3 8.7 15.2 14.8 3.9 0.0 3.8 0.0 0.4 0.0 30.4 3.6 0.0 8.1 2.3 0.0 15.7 0.1 0.0 0.0 8.5 0.7 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.8 0.1 35.0 0.0 0.6 0.3 14.0 0.3 1.4 0.0 0.0 0.0 6.5 0.0 0.0 0.4 3.6 17.8 0.0 0.5 0.9 0.4 2.8 0.0 0.0 0.0 0.3 ELMOD2 MGC10084 ENSG00000179387 "ELMO domain containing 2" Q8IZ81 4 140524158-140553770 "Predicted intracellular proteins" "Antiviral defense" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047600 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" Nucleoplasm "HPA047600: AB_2680098" "unprognostic (1.39e-1)" "unprognostic (1.91e-1)" "unprognostic (6.70e-3)" "unprognostic (2.10e-3)" "unprognostic (4.91e-2)" "unprognostic (3.93e-1)" "unprognostic (1.66e-2)" "unprognostic (1.26e-1)" "unprognostic (1.76e-1)" "unprognostic (7.93e-2)" "unprognostic (1.05e-2)" "unprognostic (3.65e-1)" "prognostic favorable (1.17e-8)" "unprognostic (3.17e-1)" "unprognostic (4.03e-1)" "prognostic unfavorable (6.35e-4)" "unprognostic (1.82e-2)" 11.6 20.8 9.2 11.9 14.0 8.5 16.7 14.0 10.6 13.8 17.9 10.4 24.7 14.4 15.4 15.8 13.9 13.9 10.9 18.0 10.4 11.2 20.6 19.3 14.5 13.9 13.6 9.2 13.0 17.2 20.2 24.1 17.3 13.6 15.5 15.2 12.1 13.5 21.2 8.4 10.5 31.0 12.4 14.4 11.6 12.1 9.1 12.3 18.2 19.6 10.5 11.2 12.1 11.6 6.0 10.6 17.0 7.8 7.8 8.6 4.8 6.6 7.4 15.2 11.6 15.9 18.4 9.8 15.8 15.0 8.8 10.6 7.3 14.2 10.9 7.0 9.8 10.7 6.1 14.4 10.0 10.9 10.5 8.5 8.9 5.8 9.4 14.5 13.6 8.0 12.6 16.7 7.4 7.7 13.9 9.6 13.3 11.4 18.0 15.0 4.8 14.8 4.7 8.0 9.7 6.1 17.4 11.7 7.0 12.7 10.6 7.2 26.8 10.3 10.6 11.3 17.8 10.4 5.7 9.6 20.3 7.3 9.4 16.2 18.9 26.8 13.8 14.8 10.8 15.2 2.6 7.2 8.7 7.5 7.8 8.6 3.8 6.9 8.3 6.1 6.0 7.1 7.0 17.0 7.8 5.9 10.6 8.0 4.8 9.2 14.0 14.0 10.6 10.4 11.2 13.6 9.2 13.6 12.3 26.8 15.3 5.2 9.6 8.1 19.0 12.3 5.1 25.4 5.7 17.4 17.7 19.0 1.7 20.2 2.0 11.7 15.3 0.0 22.7 7.3 13.3 8.8 19.6 24.6 17.2 14.3 8.7 11.1 17.4 1.0 12.0 13.4 16.9 11.8 12.5 18.5 21.7 12.2 10.3 15.1 22.8 6.5 6.1 25.6 19.4 10.2 16.8 10.7 10.8 4.8 ELMOD3 "DFNB88, FLJ21977, RBED1, RBM29" ENSG00000115459 "ELMO domain containing 3" Q96FG2 2 85354394-85391752 "Disease related genes, Predicted intracellular proteins" "GTPase activation" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012126 Approved Uncertain Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA012126: AB_1848130" "unprognostic (1.90e-1)" "unprognostic (9.80e-3)" "unprognostic (1.42e-3)" "unprognostic (1.76e-1)" "unprognostic (3.24e-1)" "unprognostic (1.60e-2)" "unprognostic (1.35e-2)" "unprognostic (1.52e-2)" "unprognostic (4.62e-2)" "unprognostic (5.63e-2)" "prognostic favorable (6.16e-6)" "unprognostic (1.34e-1)" "prognostic unfavorable (1.09e-6)" "unprognostic (5.71e-2)" "unprognostic (1.53e-1)" "unprognostic (9.51e-2)" "prognostic favorable (2.85e-5)" 18.5 14.5 11.0 10.5 17.4 4.9 15.0 15.4 14.7 13.4 12.0 18.4 18.6 9.5 12.7 11.6 8.7 13.8 11.5 9.2 13.2 8.6 10.7 14.4 8.4 9.0 20.2 8.8 12.0 11.4 14.4 15.6 11.7 14.2 13.7 9.7 13.0 11.6 14.5 18.8 9.7 10.6 13.4 11.1 11.1 12.1 12.3 17.4 7.6 13.0 6.8 10.2 11.9 10.7 4.5 4.5 10.8 6.6 6.1 7.6 3.9 4.0 5.2 6.0 8.8 18.7 8.4 3.5 7.5 5.8 11.2 10.3 4.3 2.1 3.1 5.8 6.0 13.7 4.3 8.3 10.3 10.2 11.0 5.8 5.4 2.9 3.0 9.8 4.1 7.2 8.6 9.1 10.6 12.2 9.4 7.9 6.4 5.5 3.7 10.3 3.1 6.0 2.4 2.8 8.4 5.5 4.3 12.2 2.9 5.1 2.5 5.6 2.9 4.6 6.4 6.9 7.1 3.5 3.1 4.4 8.0 4.3 6.9 6.8 4.6 8.2 4.2 8.0 4.8 8.1 9.1 3.9 10.8 7.6 2.6 4.0 4.5 4.9 3.0 4.5 4.1 4.2 7.3 3.5 6.1 6.6 1.2 7.3 3.9 11.0 17.4 15.4 14.7 13.2 8.6 20.2 8.8 14.2 17.4 6.0 5.9 13.7 8.8 4.1 26.2 4.8 12.7 6.7 13.6 10.4 27.5 11.6 6.6 7.1 3.8 7.2 17.8 0.0 7.9 4.9 8.7 10.2 9.2 7.3 7.6 28.6 8.1 9.2 9.2 3.6 17.8 11.0 16.9 12.6 8.9 19.7 7.8 14.0 22.3 4.8 29.2 19.4 6.6 13.0 10.1 5.6 10.4 13.8 11.9 7.1 ELMSAN1 "C14orf117, C14orf43, LSR68" ENSG00000156030 "ELM2 and Myb/SANT domain containing 1" Q6PJG2 14 73715122-73790285 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 34.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003111 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA003111: AB_1078329" "unprognostic (1.54e-3)" "unprognostic (2.69e-1)" "unprognostic (2.83e-1)" "unprognostic (9.69e-3)" "unprognostic (4.04e-1)" "unprognostic (1.88e-2)" "unprognostic (1.03e-2)" "unprognostic (1.12e-1)" "unprognostic (8.55e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (2.02e-1)" "unprognostic (2.89e-1)" "unprognostic (3.36e-3)" "unprognostic (7.35e-2)" "unprognostic (2.44e-1)" "unprognostic (1.11e-1)" "unprognostic (1.96e-1)" 17.8 8.1 11.2 18.7 10.1 18.8 17.4 17.8 9.9 17.3 13.7 14.5 9.7 11.2 16.8 11.1 14.0 12.7 15.8 11.2 8.3 6.3 7.7 7.8 13.9 12.9 7.6 8.2 18.6 8.7 21.4 7.6 12.8 9.4 14.2 6.0 16.8 13.1 13.1 13.4 26.1 14.1 13.9 7.6 18.8 12.6 8.2 11.8 8.8 11.0 9.5 20.0 16.1 15.0 2.9 4.4 3.1 1.9 2.1 1.8 1.3 6.8 7.7 2.8 5.2 2.6 4.5 5.4 2.8 4.8 3.9 3.5 6.7 8.2 10.0 3.2 3.8 4.1 10.6 4.6 7.9 1.6 13.2 2.8 16.0 6.6 2.4 4.3 2.7 34.9 5.9 4.9 3.4 4.3 3.4 6.2 3.5 8.2 9.3 1.9 16.0 6.3 4.4 0.9 3.4 6.4 7.4 15.2 2.6 5.9 7.4 3.6 3.0 10.6 14.7 5.9 1.6 11.3 5.9 12.3 8.1 9.4 6.0 3.0 7.3 3.4 11.1 6.6 3.4 9.4 2.1 1.9 0.7 1.2 0.9 1.8 1.8 0.6 1.3 2.1 2.9 0.7 0.8 3.1 2.1 1.1 4.4 1.4 1.3 11.2 10.1 17.8 9.9 8.3 6.3 7.6 8.2 9.4 11.8 23.8 22.4 64.8 25.5 78.6 20.9 18.6 20.4 13.4 10.3 17.4 49.1 32.2 13.3 17.8 1.6 26.4 41.7 0.0 14.9 23.4 29.6 22.2 22.0 17.1 23.3 11.1 39.2 43.6 34.2 2.2 25.0 22.4 69.2 28.9 30.4 17.8 17.2 28.8 29.4 12.9 33.8 32.3 25.0 1.1 18.8 54.5 24.6 26.7 20.2 5.8 ELOA2 "HsT832, TCEB3B, TCEB3L" ENSG00000206181 "Elongin A2" Q8IYF1 18 47032572-47035621 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 30 "testis: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-2 OS: 1.8;WM-115: 1.2" "HPA041009, HPA043501, HPA048971, HPA049178, HPA050086, HPA053158" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA041009: AB_10959881, HPA043501: AB_10960403, HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: " "unprognostic (2.38e-1)" "unprognostic (4.47e-1)" "unprognostic (2.54e-4)" "unprognostic (2.39e-1)" "unprognostic (8.75e-2)" "unprognostic (5.34e-2)" "unprognostic (3.64e-1)" "unprognostic (5.25e-2)" "unprognostic (1.81e-1)" "unprognostic (1.38e-2)" "unprognostic (3.97e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.6 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.3 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ELOA3 "ELOA3A, HsT829, TCEB3C, TCEB3L2" ENSG00000183791 "Elongin A3" Q8NG57 18 47028202-47030078 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.7" "HPA048971, HPA049178, HPA050086, HPA053158" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: " 0.1 0.1 0.3 0.1 0.8 0.1 0.1 0.6 0.3 0.4 0.1 0.1 0.6 0.1 0.1 0.6 0.1 0.1 0.5 0.4 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.2 0.1 0.6 0.9 0.6 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ELOA3B "HsT828, TCEB3CL" ENSG00000278674 "Elongin A3 family member B" Q3SY89 18 47022287-47023927 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEK 293: 1.0" "HPA048971, HPA049178, HPA050086, HPA053158" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: " 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ELOA3C ENSG00000275553 "Elongin A3 family member C" 18 46968695-46969912 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "epididymis: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049178, HPA050086, HPA053158" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: " 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ELOA3D TCEB3CL2 ENSG00000274744 "Elongin A3 family member D" A6NLF2 18 46962768-46964408 "Predicted intracellular proteins" "Transcription, Transcription regulation" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.0;U-2 OS: 1.6" "HPA048971, HPA049178, HPA050086, HPA053158" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ELP1 "DYS, IKAP, IKBKAP, IKI3, TOT1" ENSG00000070061 "Elongator complex protein 1" O95163 9 108867517-108934116 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, tRNA processing" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 8 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 19.7;Ciliated cells: 12.0;Collecting duct cells: 14.0;Exocrine glandular cells: 18.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 26.9" "Lineage enriched" "Detected in all" 6 "granulocytes: 26.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021340, HPA049677, HPA050686" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB021340: , HPA049677: AB_2680847, HPA050686: AB_2681216" "prognostic unfavorable (1.57e-4)" "unprognostic (8.71e-2)" "unprognostic (5.13e-2)" "unprognostic (4.21e-2)" "unprognostic (6.44e-2)" "unprognostic (4.49e-2)" "unprognostic (2.76e-2)" "unprognostic (1.55e-1)" "unprognostic (1.67e-1)" "unprognostic (4.02e-2)" "unprognostic (1.10e-2)" "unprognostic (2.80e-2)" "unprognostic (1.77e-3)" "unprognostic (1.69e-1)" "unprognostic (1.57e-1)" "unprognostic (2.27e-2)" "unprognostic (4.98e-2)" 10.4 33.0 18.7 10.6 22.9 10.8 13.1 37.6 19.9 13.0 11.5 17.2 11.4 8.2 15.7 17.3 9.8 15.1 10.3 15.3 14.8 15.2 13.0 14.7 11.2 12.8 20.9 17.3 26.4 12.9 41.3 42.3 11.2 20.5 13.1 12.6 15.0 12.0 12.8 11.6 15.7 11.2 14.4 16.7 13.3 11.3 11.7 19.3 12.1 15.4 8.3 13.2 10.4 13.4 2.1 2.7 26.9 2.6 4.0 4.2 1.9 9.2 17.9 15.4 10.0 17.0 16.3 12.6 15.2 10.5 15.5 12.3 16.8 6.8 17.0 6.9 13.6 17.9 23.9 23.6 19.0 17.1 16.0 14.8 9.9 27.8 45.5 12.6 19.3 8.9 12.4 13.3 21.6 20.4 15.7 13.3 21.4 23.4 12.0 14.2 15.8 16.5 12.0 19.6 23.7 17.9 14.4 20.7 10.6 11.7 12.0 18.7 15.0 16.7 16.7 10.3 17.4 21.7 8.7 12.7 8.9 10.3 19.8 15.1 11.4 25.5 8.6 14.9 12.8 12.0 26.9 1.7 2.5 3.1 2.0 4.2 2.1 3.0 4.0 2.7 1.4 2.9 3.6 0.3 4.0 2.6 1.3 2.4 1.9 18.7 22.9 37.6 19.9 14.8 15.2 20.9 17.3 20.5 19.3 11.9 19.7 0.0 0.0 0.0 0.0 0.0 0.0 12.0 5.7 14.0 0.0 5.6 0.0 5.7 0.0 0.0 0.0 0.0 18.1 5.2 0.0 0.0 2.3 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 8.8 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 ELP2 "FLJ10879, STATIP1, StIP" ENSG00000134759 "Elongator acetyltransferase complex subunit 2" Q6IA86 18 36129444-36180556 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation, tRNA processing" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002996, CAB020835" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB020835: , HPA002996: AB_1857552" "unprognostic (5.51e-2)" "unprognostic (1.29e-1)" "prognostic favorable (5.41e-4)" "unprognostic (6.66e-3)" "unprognostic (4.33e-2)" "unprognostic (4.54e-1)" "unprognostic (2.23e-1)" "unprognostic (5.89e-2)" "unprognostic (1.92e-1)" "unprognostic (6.74e-3)" "unprognostic (7.31e-3)" "unprognostic (7.07e-2)" "unprognostic (8.04e-2)" "unprognostic (1.91e-1)" "unprognostic (3.05e-2)" "unprognostic (1.14e-1)" "unprognostic (8.97e-2)" 21.3 19.8 16.5 21.0 22.4 10.5 32.9 23.2 23.6 23.2 19.8 21.6 29.6 14.0 32.3 29.7 15.0 27.2 18.7 21.0 15.8 16.2 17.8 41.0 16.1 17.1 18.6 18.0 46.3 26.7 22.0 43.6 18.7 21.3 28.0 15.4 22.5 19.7 27.4 34.7 23.7 15.6 22.5 18.0 18.1 18.3 19.4 21.7 23.5 20.2 14.1 20.5 25.2 19.5 17.1 14.2 13.4 18.2 17.3 18.8 11.1 10.2 7.4 13.8 12.4 19.6 29.7 15.3 21.2 30.8 17.8 23.9 7.7 9.5 21.5 14.8 17.7 12.0 14.6 17.6 15.7 25.4 9.7 9.5 8.3 12.8 13.3 21.5 26.9 8.9 24.1 18.1 17.7 28.9 27.0 19.9 14.9 13.9 11.4 18.9 12.3 12.9 11.6 16.4 7.9 5.6 21.1 16.6 15.0 16.2 23.9 11.0 21.0 19.9 7.8 31.0 20.8 10.0 13.6 11.7 16.2 9.4 5.9 10.8 13.7 10.8 19.9 13.6 14.5 13.9 13.4 9.7 7.7 10.9 14.3 15.3 17.1 14.7 12.8 14.1 14.3 18.8 16.4 1.6 17.3 18.2 14.2 14.4 11.1 16.5 22.4 23.2 23.6 15.8 16.2 18.6 18.0 21.3 21.7 44.7 27.4 28.6 43.3 29.2 46.3 43.6 7.6 32.1 17.0 33.2 41.2 30.6 24.9 22.1 41.1 26.0 16.0 0.0 19.2 32.9 31.9 48.4 34.8 60.6 20.2 31.8 23.7 20.9 21.8 50.5 40.3 23.1 21.9 40.5 17.8 30.7 16.3 7.0 34.3 14.6 46.5 6.5 29.7 35.8 30.7 32.0 33.3 27.7 22.4 34.1 ELP4 "C11orf19, PAXNEB" ENSG00000109911 "Elongator acetyltransferase complex subunit 4" Q96EB1 11 31509700-31790328 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation, tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038572, HPA038573" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA038572: AB_2676090, HPA038573: AB_2676091" "unprognostic (7.25e-2)" "unprognostic (5.40e-2)" "unprognostic (7.81e-2)" "unprognostic (1.61e-2)" "unprognostic (1.73e-1)" "unprognostic (3.10e-3)" "unprognostic (1.67e-2)" "unprognostic (1.87e-1)" "unprognostic (6.73e-2)" "unprognostic (8.13e-2)" "unprognostic (1.01e-1)" "unprognostic (5.33e-2)" "unprognostic (1.09e-2)" "unprognostic (2.15e-1)" "unprognostic (1.48e-1)" "unprognostic (8.38e-2)" "unprognostic (3.63e-2)" 14.7 14.6 19.8 12.0 19.6 12.9 12.2 55.1 17.6 13.9 15.3 15.2 8.5 8.1 13.9 15.3 15.7 12.5 12.8 17.0 18.5 13.2 18.6 16.0 12.5 15.1 15.7 13.2 13.6 17.5 16.5 19.0 13.3 16.2 12.1 13.8 15.2 11.6 13.6 13.9 16.7 11.1 13.2 17.8 14.6 11.5 14.5 19.1 28.0 11.8 12.3 13.8 13.1 12.2 12.6 12.8 10.2 12.3 9.5 13.6 8.7 8.6 7.6 8.4 10.1 7.8 10.7 2.9 7.8 8.5 11.7 12.9 7.0 7.9 11.9 6.7 7.0 14.2 15.9 10.8 9.8 12.9 9.8 12.5 4.0 9.7 10.4 8.0 8.3 7.9 10.6 6.1 5.0 13.8 9.0 14.0 15.7 17.8 10.8 7.4 13.9 14.1 9.9 4.8 25.5 9.4 8.6 18.0 8.1 17.5 8.8 9.7 4.6 14.3 9.4 6.4 8.5 17.7 12.2 5.7 10.8 9.4 17.5 10.1 4.3 8.1 14.5 7.6 11.8 9.2 7.7 11.1 10.2 9.5 12.3 12.1 12.6 11.2 11.4 12.8 9.0 12.5 11.1 3.3 9.5 12.0 11.2 13.6 8.7 19.8 19.6 55.1 17.6 18.5 13.2 15.7 13.2 16.2 19.1 11.9 8.0 6.3 10.0 7.3 4.3 6.7 2.5 8.1 12.5 7.0 3.9 16.6 24.9 7.1 5.2 4.8 3.4 0.0 9.8 13.2 6.4 3.2 10.4 4.9 10.3 14.3 6.4 3.7 4.7 1.8 4.6 5.6 3.3 8.2 5.2 14.1 5.3 3.5 6.0 22.3 5.9 6.5 7.2 12.1 10.0 7.2 15.8 8.5 7.0 5.0 ELP5 "C17orf81, DERP6" ENSG00000170291 "Elongator acetyltransferase complex subunit 5" Q8TE02 17 7251416-7259940 "Predicted intracellular proteins" "Transcription, Transcription regulation, tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 103.3" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 320.1;Late spermatids: 402.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023279, HPA052411" Uncertain Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA023279: AB_1847613, HPA052411: " "unprognostic (3.73e-2)" "unprognostic (9.21e-3)" "unprognostic (1.24e-1)" "unprognostic (2.39e-3)" "unprognostic (7.72e-2)" "unprognostic (1.22e-1)" "unprognostic (7.70e-2)" "unprognostic (1.53e-1)" "unprognostic (7.83e-3)" "unprognostic (1.60e-2)" "prognostic favorable (2.62e-4)" "unprognostic (1.36e-1)" "unprognostic (1.83e-1)" "unprognostic (8.07e-2)" "unprognostic (2.71e-1)" "unprognostic (1.62e-1)" "unprognostic (2.30e-2)" 12.4 18.2 14.0 13.6 14.0 11.8 10.4 14.1 17.8 11.1 15.5 12.2 13.3 11.4 13.1 13.5 10.9 12.6 11.9 23.0 13.2 12.0 16.5 21.3 9.1 15.0 13.6 12.8 15.2 10.6 9.6 15.9 12.6 12.5 14.0 11.0 16.4 20.9 12.7 28.3 7.8 14.6 18.0 11.2 14.1 10.7 103.3 12.4 23.6 15.7 17.2 16.1 11.6 11.0 31.1 36.7 16.3 29.3 27.6 34.7 21.5 12.4 35.3 15.9 14.4 28.0 22.2 6.9 11.2 13.3 18.0 16.7 35.2 8.2 24.8 12.4 17.8 31.6 9.4 40.2 26.4 13.0 15.3 56.6 22.8 11.9 32.0 13.9 16.2 9.0 15.6 19.9 12.2 24.3 11.4 15.3 31.6 15.7 6.7 27.9 21.1 41.0 31.0 13.1 13.1 24.5 35.3 17.9 13.4 20.0 11.8 7.8 15.5 21.8 6.6 17.2 16.6 9.4 11.8 17.3 10.4 12.2 19.9 17.8 7.8 10.4 28.8 18.9 15.8 13.4 16.3 25.3 12.4 27.9 29.3 34.7 31.1 24.9 25.5 30.0 31.0 26.4 31.2 4.4 27.6 19.3 36.7 33.8 21.5 14.0 14.0 14.1 17.8 13.2 12.0 13.6 12.8 12.5 12.4 8.9 9.4 30.5 41.1 19.6 21.3 59.0 10.2 6.7 18.2 43.6 19.6 35.0 82.9 28.6 320.1 27.1 27.3 0.0 11.8 67.2 24.2 62.2 6.9 20.8 36.0 27.0 40.0 14.1 10.8 402.6 31.7 24.4 20.3 27.1 33.9 22.3 22.6 35.1 31.1 76.9 29.6 38.8 32.4 100.6 36.9 19.1 48.4 32.0 48.2 43.2 ELP6 "C3orf75, FLJ20211, TMEM103" ENSG00000163832 "Elongator acetyltransferase complex subunit 6" Q0PNE2 3 47495640-47513761 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation, tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046358, HPA064545" Uncertain Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA046358: AB_10961011, HPA064545: AB_2685282" "unprognostic (2.00e-3)" "unprognostic (2.27e-1)" "unprognostic (7.41e-3)" "unprognostic (2.41e-2)" "unprognostic (2.67e-1)" "unprognostic (8.62e-2)" "unprognostic (4.24e-3)" "unprognostic (1.66e-1)" "unprognostic (2.11e-2)" "unprognostic (1.24e-2)" "unprognostic (2.07e-2)" "unprognostic (5.38e-2)" "prognostic favorable (3.42e-6)" "unprognostic (1.54e-1)" "unprognostic (9.05e-2)" "unprognostic (2.30e-1)" "unprognostic (6.29e-2)" 10.8 25.9 15.6 16.3 18.5 8.8 15.3 23.2 24.6 12.8 13.3 22.7 19.0 13.3 17.5 22.1 14.2 16.0 13.3 17.0 16.3 15.7 16.4 18.7 11.6 17.5 16.7 21.8 20.8 18.8 16.6 18.8 12.9 19.9 18.1 13.0 18.5 14.8 17.5 23.6 14.7 11.7 16.4 18.6 14.9 13.9 24.9 13.6 23.7 17.8 13.7 17.8 15.5 11.9 20.4 19.5 10.4 12.0 18.4 21.3 14.2 16.9 16.0 21.5 21.7 17.3 16.0 12.2 20.5 14.2 26.2 23.8 15.6 18.0 32.0 12.8 17.7 24.8 10.5 20.8 29.9 16.1 17.8 16.1 28.9 24.8 17.4 19.0 21.8 18.0 17.2 16.2 29.9 19.1 15.3 22.6 27.6 30.2 10.0 26.1 18.7 26.0 24.8 25.7 16.4 27.5 13.1 10.4 19.5 18.4 15.0 19.2 18.7 17.5 14.1 10.6 18.2 19.2 17.6 14.7 26.9 19.2 13.9 25.6 21.1 27.7 29.3 13.9 26.7 27.4 10.4 12.0 8.4 19.5 11.0 15.1 18.7 18.3 19.5 15.0 20.4 17.3 17.4 1.7 18.4 7.6 19.5 21.3 14.2 15.6 18.5 23.2 24.6 16.3 15.7 16.7 21.8 19.9 13.6 6.0 10.5 27.4 16.0 7.4 23.6 21.6 25.5 14.7 13.6 31.4 13.7 38.8 51.4 24.8 6.1 18.9 16.3 0.0 20.7 32.8 14.8 8.1 21.9 25.2 24.9 36.5 16.7 25.8 14.9 10.7 21.3 12.1 15.1 23.4 12.0 39.0 16.7 14.7 28.7 36.1 25.6 6.5 19.3 55.3 23.8 7.3 22.4 26.2 20.4 7.3 EMC6 "MGC2963, TMEM93" ENSG00000127774 "ER membrane protein complex subunit 6" Q9BV81 17 3668815-3669668 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 100.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062681 Uncertain Approved Nucleoplasm,Centrosome NA NA Centrosome Nucleoplasm "HPA062681: AB_2684831" "unprognostic (2.21e-1)" "prognostic unfavorable (7.73e-4)" "unprognostic (2.21e-2)" "unprognostic (1.62e-1)" "unprognostic (1.63e-1)" "unprognostic (6.20e-3)" "unprognostic (4.03e-2)" "prognostic unfavorable (9.39e-5)" "unprognostic (1.86e-1)" "unprognostic (1.08e-1)" "unprognostic (1.30e-2)" "unprognostic (7.58e-3)" "unprognostic (4.17e-2)" "unprognostic (1.94e-1)" "unprognostic (6.37e-2)" "unprognostic (3.27e-1)" "unprognostic (6.32e-2)" 14.6 18.5 15.5 12.2 15.5 21.4 12.5 9.9 21.2 8.9 15.9 14.9 10.0 16.9 9.8 10.8 15.6 9.5 12.1 26.2 14.5 12.3 19.8 42.1 10.2 10.7 14.2 11.0 8.7 24.5 7.6 9.3 16.6 12.2 12.9 9.7 14.6 17.8 10.5 100.1 10.6 16.8 10.1 13.6 12.5 18.8 27.4 11.1 14.3 14.9 31.5 14.3 9.7 9.1 34.5 56.1 40.7 42.0 25.2 43.4 38.5 31.2 30.8 13.5 14.1 9.7 7.8 26.0 22.5 11.0 18.5 17.1 18.6 11.8 19.7 32.8 10.5 16.3 30.2 15.6 15.8 13.4 19.0 58.3 14.3 21.6 25.8 14.1 9.9 14.7 9.8 18.0 17.0 11.9 14.6 14.0 23.7 17.9 14.3 13.5 19.0 20.2 29.2 19.4 19.1 34.8 18.9 12.6 18.6 25.9 8.9 11.1 20.2 18.4 14.5 23.9 14.1 16.9 10.7 15.3 15.5 19.2 23.3 32.8 14.0 15.4 12.9 24.3 13.0 18.6 34.5 42.0 40.7 34.9 39.7 32.0 34.5 39.0 38.3 35.8 32.3 40.6 36.7 31.6 25.2 27.9 56.1 43.4 38.5 15.5 15.5 9.9 21.2 14.5 12.3 14.2 11.0 12.2 11.1 14.9 23.4 62.6 99.3 79.0 40.5 0.3 94.3 53.5 23.9 55.8 33.4 102.2 140.9 117.4 202.1 52.2 55.0 23.3 123.7 126.4 43.1 113.2 54.3 108.8 90.3 31.8 49.3 39.3 53.3 121.5 35.6 54.6 64.1 101.0 61.0 85.4 129.4 63.1 32.2 149.9 38.8 38.8 51.5 146.4 87.0 89.1 107.9 52.2 68.0 156.9 EMC7 "C11orf3, C15orf24" ENSG00000134153 "ER membrane protein complex subunit 7" Q9NPA0 15 34084017-34101948 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010029, HPA047572" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA010029: AB_1078335, HPA047572: AB_2680090" "unprognostic (2.16e-1)" "unprognostic (8.16e-3)" "unprognostic (5.28e-2)" "prognostic favorable (4.68e-5)" "unprognostic (7.75e-2)" "prognostic unfavorable (9.25e-5)" "unprognostic (1.35e-1)" "unprognostic (3.68e-2)" "unprognostic (1.18e-1)" "unprognostic (5.65e-3)" "unprognostic (4.67e-2)" "unprognostic (3.17e-1)" "unprognostic (1.36e-1)" "unprognostic (3.31e-1)" "unprognostic (2.58e-1)" "unprognostic (2.49e-2)" "unprognostic (2.47e-3)" 31.2 45.1 36.8 22.4 41.6 31.8 29.7 22.5 36.8 25.1 30.1 30.9 38.2 25.1 27.1 53.1 25.0 23.0 24.5 36.5 34.0 45.3 52.5 62.3 26.5 24.4 44.0 38.7 24.1 46.7 35.5 33.5 57.6 35.2 31.8 32.3 29.8 29.6 46.0 44.8 28.2 28.1 29.0 42.2 28.5 28.5 39.3 30.8 18.8 35.3 26.7 21.8 26.3 26.2 37.8 68.8 66.6 54.7 32.6 53.7 49.1 14.3 39.6 14.4 18.3 56.4 32.3 15.1 41.2 43.0 38.6 40.1 36.0 17.3 8.5 42.8 40.2 40.1 28.0 20.9 20.7 28.9 20.9 20.7 21.1 59.2 30.7 51.6 21.1 30.1 35.7 39.5 27.6 40.1 26.3 24.2 16.4 20.5 57.0 37.2 16.6 11.7 24.1 12.8 33.8 26.3 14.8 16.7 29.4 40.6 25.5 23.6 17.5 24.5 33.2 20.4 17.9 24.0 34.2 20.3 41.4 16.0 27.3 30.7 38.6 46.6 19.0 41.8 32.4 33.5 66.6 47.3 49.0 42.7 51.0 41.6 37.8 42.9 43.4 43.1 28.9 31.6 39.0 41.3 32.6 54.7 68.8 53.7 49.1 36.8 41.6 22.5 36.8 34.0 45.3 44.0 38.7 35.2 30.8 26.8 26.0 38.7 50.2 77.2 49.7 83.2 45.9 48.2 40.9 97.7 43.2 105.5 33.2 106.2 83.3 62.5 52.0 0.0 149.7 127.4 78.3 46.4 44.9 78.4 102.1 28.6 43.8 56.4 57.1 65.1 83.4 60.8 97.8 64.1 51.6 111.7 112.9 52.6 97.9 61.9 46.3 116.4 76.2 178.6 21.7 75.5 133.9 64.0 55.9 50.3 EMG1 ENSG00000126749 "EMG1, N1-specific pseudouridine methyltransferase" Q92979 12 6970893-6979941 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Methyltransferase, RNA-binding, rRNA-binding, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA039304, HPA039666" Supported Supported "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "HPA039304: AB_2676432, HPA039666: AB_10672891" "unprognostic (1.23e-1)" "unprognostic (1.17e-1)" "unprognostic (6.77e-2)" "unprognostic (1.35e-2)" "unprognostic (2.11e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (3.69e-4)" "unprognostic (2.70e-1)" "unprognostic (1.03e-1)" "unprognostic (2.12e-1)" "unprognostic (9.03e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (2.83e-6)" "unprognostic (2.13e-1)" "unprognostic (2.34e-1)" "unprognostic (6.75e-2)" "unprognostic (1.62e-1)" 8.1 10.1 4.9 12.4 6.6 7.3 8.8 3.6 6.3 5.8 7.5 4.8 11.5 7.5 6.9 9.9 8.1 5.8 7.4 11.6 5.0 7.2 8.3 6.4 8.8 6.4 4.2 8.9 9.4 2.7 5.6 12.6 6.2 7.2 6.8 5.1 8.6 11.4 14.9 5.6 6.7 6.3 5.5 7.7 6.0 4.8 6.1 9.0 8.7 9.5 10.8 7.5 8.7 33.3 20.5 7.7 29.6 20.8 30.1 28.5 17.1 17.1 6.6 8.1 5.2 3.8 27.5 12.8 5.7 10.2 7.0 33.6 18.4 17.3 4.8 7.9 18.6 12.6 6.0 14.6 11.5 12.5 9.8 24.0 16.9 30.9 6.7 24.3 15.6 6.1 8.8 14.8 16.9 5.3 4.4 12.3 11.8 3.9 9.5 20.3 12.6 15.0 54.8 14.2 9.0 17.5 13.4 13.8 6.4 21.8 3.9 11.6 13.5 14.2 12.3 19.7 3.9 18.1 9.2 10.6 13.9 8.7 29.0 4.7 5.3 30.1 11.4 10.6 16.9 4.4 16.6 7.7 24.0 23.8 24.8 30.7 25.5 26.3 18.8 33.3 30.1 27.7 2.3 20.8 29.6 20.5 24.1 28.5 14.9 42.4 35.6 63.8 32.4 13.1 0.0 20.4 42.8 40.9 40.1 7.9 97.4 41.4 64.5 5.3 31.5 18.7 23.3 58.0 98.9 31.9 43.5 60.0 31.0 57.4 15.9 9.2 21.5 24.6 11.1 35.1 40.5 27.0 54.1 22.4 15.6 60.5 17.5 24.4 66.2 13.8 38.8 20.2 28.2 53.8 34.9 62.1 32.8 31.6 55.2 EMP1 "CL-20, TMP" ENSG00000134531 "Epithelial membrane protein 1" P54849 12 13196716-13219939 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 240.9;lymphoid tissue: 129.3" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 616.6;Fibroblasts: 489.5;Melanocytes: 448.7;Suprabasal keratinocytes: 601.1;Urothelial cells: 926.6" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "pons and medulla: 28.6" "Cell type enriched" "Detected in some" 7 "myeloid DC: 7.0" "Lineage enriched" "Detected in single" 14 "dendritic cells: 7.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 132.0;fHDF/TERT166: 91.8;HaCaT: 82.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA051931, HPA056250" Approved Nucleoplasm NA NA Nucleoplasm "HPA051931: , HPA056250: " "unprognostic (1.40e-2)" "unprognostic (7.30e-2)" "unprognostic (8.01e-2)" "unprognostic (1.07e-2)" "unprognostic (1.69e-1)" "unprognostic (1.39e-1)" "unprognostic (8.41e-3)" "unprognostic (1.94e-1)" "unprognostic (2.67e-2)" "prognostic unfavorable (2.26e-8)" "prognostic unfavorable (7.46e-4)" "unprognostic (2.98e-1)" "unprognostic (4.84e-2)" "unprognostic (3.05e-2)" "unprognostic (3.45e-2)" "unprognostic (3.25e-1)" "prognostic unfavorable (9.69e-8)" 63.3 5.0 2.7 8.0 10.4 2.1 20.8 0.8 3.9 51.3 11.6 5.5 4.0 4.6 14.0 10.4 240.9 9.9 25.2 16.1 7.3 2.8 8.9 4.4 18.1 5.9 5.3 0.9 5.7 10.2 2.9 2.8 10.6 28.6 6.3 6.9 17.8 45.4 2.8 12.0 16.8 10.7 17.6 9.7 8.5 6.0 5.2 3.0 0.6 22.5 99.1 129.3 14.1 80.6 0.0 7.0 0.0 0.5 0.1 0.1 0.0 38.9 2.0 1.0 0.2 63.1 132.0 0.1 28.8 52.9 14.9 19.0 0.2 66.0 0.2 20.6 91.8 6.5 82.1 1.1 3.8 20.2 0.7 0.0 0.1 6.9 0.0 15.2 0.2 0.2 41.4 5.6 47.3 13.9 11.8 34.0 0.0 0.2 0.6 35.0 0.1 0.0 0.8 0.7 7.3 6.7 0.1 4.0 0.3 43.5 0.4 0.0 0.0 12.9 1.9 21.5 7.7 0.3 0.2 37.2 33.5 11.8 31.4 15.5 0.1 0.4 0.2 48.8 0.2 39.3 0.0 0.5 0.0 0.1 0.2 0.0 0.0 0.1 0.0 7.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 2.7 10.4 0.8 3.9 7.3 2.8 5.3 0.9 28.6 3.0 190.6 90.0 2.7 198.6 616.6 0.0 9.5 2.5 87.0 247.9 17.4 0.0 0.8 13.3 17.9 0.7 293.7 59.6 0.0 3.9 1.5 489.5 352.1 46.5 2.0 41.5 0.0 45.6 127.7 32.1 0.5 64.5 93.9 448.7 7.2 4.0 2.5 37.6 27.1 102.9 0.2 0.0 6.5 173.1 0.7 0.5 601.1 0.9 5.1 5.6 926.6 EMP2 XMP ENSG00000213853 "Epithelial membrane protein 2" P54851 16 10528422-10580698 "Disease related genes, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 118.7" "Group enriched" "Detected in many" 7 "Alveolar cells type 1: 3868.0;Suprabasal keratinocytes: 1026.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 59.5;RT4: 40.9;SK-BR-3: 58.8;T-47d: 35.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014711, HPA070816" Approved Approved Nucleoplasm,Cytosol No Yes Nucleoplasm Cytosol "HPA014711: AB_1848147, HPA070816: " "unprognostic (1.75e-1)" "unprognostic (4.05e-2)" "unprognostic (3.45e-3)" "unprognostic (4.82e-1)" "prognostic unfavorable (2.23e-4)" "unprognostic (9.27e-2)" "unprognostic (8.90e-2)" "unprognostic (2.41e-2)" "unprognostic (4.40e-1)" "unprognostic (1.86e-1)" "unprognostic (6.24e-2)" "unprognostic (3.19e-1)" "prognostic unfavorable (2.85e-8)" "unprognostic (9.54e-2)" "unprognostic (2.73e-1)" "unprognostic (2.54e-2)" "unprognostic (9.52e-2)" 16.5 2.0 5.0 7.9 5.1 0.0 26.2 3.4 4.7 14.8 10.4 3.4 6.1 4.2 7.3 13.8 35.7 7.4 7.3 14.0 5.5 3.0 3.1 47.5 118.7 5.7 5.4 2.5 14.0 3.2 19.9 3.2 23.5 5.3 11.1 10.0 10.8 9.9 5.8 7.7 40.2 6.6 12.8 3.4 5.3 9.3 5.6 4.1 2.2 7.5 26.4 18.4 10.6 16.3 1.3 1.1 4.1 1.1 1.4 1.0 0.4 6.3 8.8 3.6 4.3 8.2 7.1 7.2 9.1 8.4 5.5 8.3 28.8 22.3 0.0 2.9 10.9 4.0 28.3 9.3 11.2 7.3 0.0 5.9 0.0 18.5 15.7 1.4 0.0 0.1 4.3 3.0 7.3 0.7 1.2 2.3 0.0 2.1 0.6 15.2 59.5 0.1 0.1 4.2 10.3 2.1 1.6 4.2 13.8 1.2 40.9 5.1 5.8 11.2 58.8 3.3 11.0 35.9 1.4 1.2 17.6 7.6 5.9 5.0 0.1 0.2 0.0 7.7 0.1 17.2 3.4 1.0 1.0 0.8 0.8 1.0 1.0 0.8 0.7 0.5 1.3 0.9 0.9 4.1 1.4 1.1 1.1 0.8 0.4 5.0 5.1 3.4 4.7 5.5 3.0 5.4 2.5 5.3 4.1 3868.0 343.3 4.5 123.1 317.0 1.8 48.0 109.5 153.9 326.4 40.1 0.0 59.0 0.0 2.5 4.2 191.2 51.9 0.0 60.2 16.3 121.0 91.1 34.8 181.1 8.8 0.0 100.6 112.3 14.0 5.0 176.6 42.0 82.7 58.7 141.3 5.2 27.3 172.1 259.6 0.0 1.1 51.8 141.5 2.3 13.2 1026.6 40.2 4.3 139.9 220.6 EMSY C11orf30 ENSG00000158636 "EMSY, BRCA2 interacting transcriptional repressor" Q7Z589 11 76444923-76553025 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012234, HPA050777" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB012234: AB_449325, HPA050777: AB_2681232" "unprognostic (1.69e-2)" "unprognostic (8.15e-2)" "unprognostic (1.51e-3)" "unprognostic (3.66e-2)" "unprognostic (2.60e-2)" "unprognostic (1.54e-2)" "unprognostic (3.32e-2)" "unprognostic (3.87e-2)" "unprognostic (2.01e-2)" "unprognostic (7.70e-2)" "unprognostic (8.47e-2)" "unprognostic (5.37e-2)" "unprognostic (2.99e-2)" "unprognostic (1.79e-1)" "unprognostic (1.99e-1)" "unprognostic (6.64e-2)" "unprognostic (8.74e-2)" 14.5 12.1 13.7 12.8 22.7 19.7 15.6 39.4 22.2 17.7 14.3 17.2 12.6 9.0 21.7 14.0 11.5 15.8 11.4 17.2 13.6 10.6 13.1 10.7 17.8 14.3 23.8 10.8 20.9 15.3 23.2 23.1 25.8 16.2 14.6 15.7 14.7 14.0 14.4 18.3 11.6 13.5 18.0 24.8 14.7 13.9 14.4 26.7 22.6 15.1 8.5 14.3 14.2 17.1 7.0 6.2 11.8 5.1 5.0 8.4 4.4 4.9 7.0 16.2 9.9 6.1 6.1 7.1 8.0 8.0 10.5 11.6 11.9 6.9 6.8 7.8 8.7 8.7 10.0 13.1 7.7 16.3 10.8 4.9 10.6 10.3 5.1 3.9 11.5 9.6 5.5 5.2 12.0 10.0 6.7 9.4 11.7 7.3 12.0 8.4 13.3 15.4 6.9 7.0 15.7 9.4 9.9 29.8 9.6 7.2 5.9 10.2 4.4 11.2 7.7 2.4 10.5 15.5 7.1 7.0 9.9 13.5 25.4 5.6 6.7 7.3 19.6 3.3 7.1 7.2 11.8 5.1 10.3 7.2 4.8 6.7 6.4 6.7 8.4 3.8 7.0 6.3 5.8 10.8 5.0 3.8 6.2 6.5 4.4 13.7 22.7 39.4 22.2 13.6 10.6 23.8 10.8 16.2 26.7 14.9 5.6 2.2 6.3 0.0 18.9 0.0 5.1 12.0 11.4 12.2 33.4 13.7 11.6 5.0 0.9 7.1 4.2 0.0 3.7 6.9 8.2 11.7 2.3 5.9 7.4 14.3 7.0 8.0 6.0 1.5 10.6 6.9 0.0 1.0 15.1 10.8 5.6 0.0 11.7 7.7 22.3 12.9 0.0 25.6 7.0 0.0 17.6 8.7 10.4 7.4 EMX2 ENSG00000170370 "Empty spiracles homeobox 2" Q04743 10 117542444-117549546 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 46.8;epididymis: 53.9;seminal vesicle: 76.3" "Cell type enhanced" "Detected in many" 17 "Collecting duct cells: 226.8;Distal tubular cells: 76.3;Leydig cells: 55.8;Proximal tubular cells: 156.2" "Group enriched" "Detected in many" 13 "endometrial cancer: 40.8;ovarian cancer: 52.8;renal cancer: 18.6" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 17.2;fHDF/TERT166: 19.0;RPTEC TERT1: 19.2;RT4: 6.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA003497, HPA065294" Enhanced Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA003497: , HPA065294: AB_2685455" "unprognostic (1.53e-1)" "prognostic favorable (2.80e-4)" "unprognostic (7.21e-3)" "unprognostic (5.41e-3)" "unprognostic (1.69e-1)" "unprognostic (3.53e-2)" "unprognostic (1.34e-1)" "unprognostic (2.41e-1)" "unprognostic (7.33e-2)" "unprognostic (1.76e-1)" "unprognostic (2.77e-1)" "prognostic favorable (2.28e-13)" "unprognostic (3.65e-2)" "unprognostic (1.05e-1)" "unprognostic (4.17e-2)" "unprognostic (1.88e-2)" 4.6 0.5 11.5 0.6 10.3 0.5 1.4 0.5 12.5 23.5 0.7 7.3 46.8 0.5 40.5 53.9 0.7 25.4 1.2 0.6 14.7 2.1 25.5 0.5 0.5 0.7 1.8 10.4 5.7 0.5 0.6 1.1 0.6 2.5 1.9 0.5 3.4 1.3 76.3 5.1 4.7 0.5 22.6 0.6 0.5 0.5 3.6 6.2 0.0 0.5 1.2 0.7 4.2 2.4 0.7 0.5 2.4 0.9 1.0 0.7 0.1 0.0 0.0 0.0 1.9 0.0 0.2 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 17.2 19.0 0.0 0.1 0.4 0.0 0.0 0.0 1.8 0.5 0.1 0.1 0.0 0.1 0.1 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.0 0.1 19.2 6.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.5 0.6 0.5 0.6 0.7 0.4 0.4 0.4 0.4 0.7 0.6 0.5 1.1 1.0 0.9 0.5 0.6 0.1 11.5 10.3 0.5 12.5 14.7 2.1 1.8 10.4 2.5 6.2 0.0 0.0 0.0 1.9 9.5 0.0 1.1 0.0 0.0 0.0 226.8 0.0 0.0 76.3 0.0 1.2 0.8 0.0 0.0 0.0 0.3 13.4 2.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.1 55.8 1.8 20.3 0.0 0.0 0.0 0.0 0.0 38.5 156.2 0.0 51.8 12.2 0.1 0.2 6.6 0.1 0.0 0.0 1.1 EN1 ENSG00000163064 "Engrailed homeobox 1" Q05925 2 118842171-118847678 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adipose tissue: 5.6;brain: 11.4;skeletal muscle: 20.1;skin 1: 10.0" "Cell type enriched" "Detected in some" 5 "Melanocytes: 11.8" "Cancer enhanced" "Detected in many" "breast cancer: 5.6" "Group enriched" "Detected in some" 10 "midbrain: 11.4;pons and medulla: 8.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 14.4;ASC TERT1: 6.5;fHDF/TERT166: 11.3;HSkMC: 12.1;PC-3: 6.8;U-138 MG: 8.8;U-2197: 9.8" "Region enriched" "Detected in single" 5 "midbrain: 5.9" "Region enriched" "Detected in some" 5 "midbrain: 23.9" "CAB014884, HPA073141" Enhanced Approved "Nucleoplasm,Nucleoli rim" NA NA "Nucleoli rim" Nucleoplasm "CAB014884: , HPA073141: AB_2686573" "unprognostic (5.20e-2)" "unprognostic (1.61e-1)" "unprognostic (5.78e-2)" "unprognostic (4.84e-7)" "unprognostic (1.87e-3)" "unprognostic (1.90e-1)" "unprognostic (1.95e-3)" "unprognostic (1.16e-1)" "unprognostic (2.06e-2)" "unprognostic (1.19e-2)" "unprognostic (4.46e-1)" "unprognostic (3.38e-9)" "unprognostic (2.15e-2)" "unprognostic (1.88e-1)" "unprognostic (1.70e-1)" "unprognostic (9.30e-3)" 5.6 0.1 0.0 0.1 0.4 0.0 2.7 0.9 0.4 0.0 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 2.4 11.4 0.0 0.1 0.0 0.1 0.0 0.0 8.8 0.1 0.1 0.2 0.7 0.1 20.1 10.0 0.1 0.1 2.7 0.1 0.1 0.4 0.1 0.2 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.2 0.5 0.2 14.4 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 4.2 0.4 0.5 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.1 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 2.1 0.0 0.0 0.0 8.8 0.9 9.8 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.4 0.2 0.1 11.4 0.0 8.8 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 2.3 0.0 0.0 0.0 0.0 EN2 ENSG00000164778 "Engrailed homeobox 2" P19622 7 155458129-155464831 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 26.5" "Cell type enhanced" "Detected in single" 16 "Spermatocytes: 1.2" "Cancer enhanced" "Detected in many" "melanoma: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 27.5;AN3-CA: 10.1;HAP1: 5.9;HEK 293: 16.7;SK-MEL-30: 8.1" "Region enriched" "Detected in some" 8 "cerebellum: 31.1" "Region enriched" "Detected in some" 6 "cerebellum: 71.6" "HPA045646, HPA069809" Supported "Nucleoplasm,Nucleoli fibrillar center" No No Nucleoplasm "Nucleoli fibrillar center" "HPA045646: AB_2679404, HPA069809: AB_2686205" "unprognostic (2.44e-3)" "unprognostic (1.71e-2)" "unprognostic (4.89e-2)" "unprognostic (7.99e-3)" "prognostic unfavorable (1.74e-6)" "unprognostic (2.54e-1)" "unprognostic (8.02e-2)" "unprognostic (7.00e-2)" "unprognostic (1.15e-1)" "unprognostic (9.87e-3)" "unprognostic (1.07e-1)" "unprognostic (1.94e-1)" "unprognostic (1.03e-13)" "unprognostic (4.91e-3)" "unprognostic (2.72e-1)" "unprognostic (2.24e-1)" "unprognostic (5.64e-3)" 0.3 0.2 0.1 0.0 0.1 0.0 0.1 26.5 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.3 1.3 1.2 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.4 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.5 27.5 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.1 0.0 0.9 0.0 5.9 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.2 3.5 0.0 0.0 0.0 0.0 1.3 0.0 2.1 0.0 0.1 0.2 0.0 0.0 2.0 0.0 8.1 0.0 0.0 1.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.5 0.1 0.0 0.0 0.0 0.0 ENO4 "AC023283.3, C10orf134" ENSG00000188316 "Enolase family member 4" A6NNW6 10 116849512-116911788 "Enzymes, Predicted intracellular proteins" Glycolysis Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.1;epididymis: 12.6;fallopian tube: 13.6" "Cell type enhanced" "Detected in some" 16 "Ciliated cells: 36.1;Cone photoreceptor cells: 21.6;Early spermatids: 11.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 1.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 2.7;MCF7: 8.3;T-47d: 5.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037937, HPA037938" Enhanced Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA037937: AB_10697089, HPA037938: AB_2675746" "unprognostic (2.92e-3)" "unprognostic (1.39e-1)" "unprognostic (1.07e-1)" "unprognostic (6.55e-4)" "unprognostic (8.38e-5)" "unprognostic (1.88e-1)" "unprognostic (2.21e-1)" "unprognostic (5.18e-2)" "unprognostic (1.22e-1)" "unprognostic (2.23e-2)" "unprognostic (3.74e-3)" "unprognostic (2.06e-1)" "unprognostic (2.20e-3)" "unprognostic (1.18e-1)" "unprognostic (9.77e-3)" "unprognostic (9.87e-5)" "unprognostic (1.08e-2)" 0.7 2.1 4.3 0.6 4.3 0.2 2.2 2.6 3.6 1.7 1.0 8.0 0.9 0.3 4.3 12.6 1.4 13.6 1.3 0.5 6.4 4.7 2.3 2.7 3.9 1.2 4.1 4.8 4.2 3.2 3.7 3.4 0.5 12.1 2.1 0.8 3.0 1.6 1.2 0.2 1.1 0.5 0.9 4.4 0.5 0.8 8.8 1.9 0.2 4.2 0.0 0.6 1.8 0.5 1.8 1.0 0.0 0.6 0.0 1.2 0.1 1.5 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.3 1.1 0.0 0.9 2.1 0.2 2.7 0.0 0.7 0.8 0.0 1.5 0.0 1.0 0.3 0.0 0.0 0.0 0.1 0.6 0.6 0.0 0.9 0.1 1.1 0.1 0.0 0.7 8.3 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 1.2 0.6 0.9 0.0 2.2 0.1 0.0 1.8 5.2 0.0 0.5 0.0 0.8 0.4 1.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.4 0.0 1.6 0.2 0.0 0.3 1.8 0.2 0.0 0.0 0.0 0.2 1.0 1.2 0.1 4.3 4.3 2.6 3.6 6.4 4.7 4.1 4.8 12.1 1.9 0.0 0.0 0.0 0.2 0.1 4.4 0.2 0.0 36.1 0.0 0.0 21.6 0.2 0.0 0.3 11.9 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.0 4.8 1.7 0.0 0.0 8.8 1.1 0.1 0.0 1.0 0.0 1.3 0.2 0.0 0.7 0.6 9.0 0.0 0.2 7.6 2.7 0.0 0.1 0.0 0.1 0.0 ENOPH1 "E1, MASA, mtnC" ENSG00000145293 "Enolase-phosphatase 1" Q9UHY7 4 82430562-82461091 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004985, HPA044607" Enhanced Approved "Nucleoplasm,Nuclear bodies" NA NA 140000 Nucleoplasm "Nuclear bodies" "CAB004985: AB_426046, HPA044607: AB_2679019" "unprognostic (6.64e-3)" "unprognostic (3.05e-1)" "unprognostic (6.77e-3)" "unprognostic (1.05e-3)" "unprognostic (1.46e-1)" "unprognostic (1.68e-3)" "prognostic unfavorable (1.74e-5)" "unprognostic (9.99e-3)" "unprognostic (1.18e-1)" "unprognostic (2.17e-1)" "unprognostic (1.59e-1)" "unprognostic (2.05e-1)" "unprognostic (9.30e-3)" "unprognostic (3.68e-2)" "unprognostic (2.22e-1)" "unprognostic (6.52e-3)" "unprognostic (3.52e-2)" 10.2 15.4 43.4 12.1 37.1 14.3 16.3 22.9 38.8 13.8 12.7 34.7 5.1 12.2 10.5 23.3 13.5 10.4 9.0 11.1 44.2 34.9 20.8 13.3 11.1 16.0 47.5 26.4 12.9 14.6 17.8 11.7 17.7 31.0 17.2 15.3 8.9 11.4 11.9 9.8 13.1 11.0 11.1 66.2 12.8 13.2 6.1 29.4 14.2 18.0 8.2 18.6 10.7 9.5 13.0 14.1 4.3 10.4 14.4 20.2 12.2 18.5 12.3 22.1 13.7 13.5 13.3 24.2 21.6 14.5 19.8 17.7 22.4 20.8 37.0 22.7 16.4 21.7 10.0 29.2 27.4 35.9 22.2 13.6 22.4 12.0 29.8 21.9 37.0 19.4 12.8 29.1 20.7 24.6 14.3 20.0 23.5 28.9 20.4 25.8 23.9 40.8 22.0 20.3 47.0 10.0 29.1 33.9 20.1 32.3 18.4 31.3 19.1 12.3 37.3 27.5 20.7 16.8 17.9 14.7 24.6 18.3 24.3 28.5 23.5 20.1 46.1 15.9 23.1 33.0 3.4 8.7 4.3 14.4 10.4 18.0 13.0 17.3 16.5 12.7 11.0 20.2 16.2 0.7 14.4 8.8 14.1 18.4 12.2 43.4 37.1 22.9 38.4 44.2 34.9 47.5 26.4 31.0 29.4 14.9 8.0 28.1 32.4 60.9 36.5 11.3 12.7 12.0 15.9 12.2 15.7 71.0 74.6 41.8 4.1 24.5 12.6 0.0 22.6 47.0 29.3 32.2 38.0 10.2 49.6 27.0 28.2 13.5 22.1 4.1 24.5 27.7 37.1 45.1 21.1 46.8 34.7 8.6 22.6 42.5 27.7 12.9 30.9 6.8 22.6 56.0 39.0 34.8 25.8 31.0 ENPP2 "ATX, PD-IALPHA, PDNP2" ENSG00000136960 "Ectonucleotide pyrophosphatase/phosphodiesterase 2" Q13822 8 119557086-119673453 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Lipid degradation, Lipid metabolism" Hydrolase "Cancer-related genes, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 103.7;placenta: 79.0" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 38.2;Fibroblasts: 51.0;Hofbauer cells: 50.0;Intestinal endocrine cells: 51.9;Melanocytes: 43.9;Proximal tubular cells: 45.6" "Cancer enhanced" "Detected in all" "renal cancer: 46.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 26.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 26.8" "Cell line enhanced" "Detected in some" "AF22: 25.2;ASC diff: 34.5;ASC TERT1: 73.7;BJ hTERT+: 42.4;fHDF/TERT166: 27.3;HSkMC: 33.8;U-2197: 24.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023700, HPA053652" Approved Approved "Nucleoplasm,Golgi apparatus,Actin filaments" "Intracellular and membrane" NA NA 1100000000 "Nucleoplasm, Golgi apparatus" "Actin filaments" "HPA023700: AB_1848170, HPA053652: AB_2682218" "unprognostic (1.17e-2)" "unprognostic (6.29e-2)" "unprognostic (3.63e-2)" "unprognostic (3.93e-2)" "unprognostic (1.23e-1)" "unprognostic (1.37e-1)" "unprognostic (9.70e-3)" "unprognostic (7.14e-2)" "unprognostic (1.29e-1)" "unprognostic (1.26e-1)" "prognostic favorable (2.07e-5)" "unprognostic (5.54e-2)" "unprognostic (3.14e-1)" "unprognostic (2.37e-1)" "unprognostic (5.18e-2)" "unprognostic (2.37e-2)" "unprognostic (1.50e-1)" 29.9 15.4 24.0 18.2 42.0 0.7 26.2 4.4 33.3 19.6 8.1 103.7 1.7 20.8 44.8 6.4 2.9 18.7 12.7 3.6 39.8 21.5 24.9 8.9 13.5 31.0 71.5 20.9 5.3 5.2 0.9 4.1 79.0 59.7 8.5 10.6 67.6 3.4 9.2 3.0 5.4 12.1 28.9 102.4 17.3 8.3 9.7 63.9 3.6 3.7 0.8 26.1 13.4 5.7 0.2 3.8 26.8 0.1 0.2 1.8 0.3 0.0 0.0 25.2 0.0 34.5 73.7 0.0 23.2 42.4 10.0 9.6 0.0 0.0 0.0 0.3 27.3 0.0 0.0 0.5 0.0 7.1 1.8 0.7 0.0 0.0 0.6 15.4 0.0 0.1 33.8 0.2 20.4 1.0 0.1 0.1 0.0 0.0 4.1 0.5 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 20.3 0.4 24.4 0.1 0.2 0.0 0.0 17.1 0.1 0.5 26.8 0.1 5.2 0.0 0.0 0.0 0.2 0.2 0.0 0.5 0.0 1.8 0.6 0.3 0.2 0.0 3.8 0.0 0.3 24.0 42.0 4.4 33.3 39.8 21.5 71.5 20.9 59.7 63.9 11.9 5.1 3.2 0.5 9.4 1.1 1.2 38.2 6.7 1.2 1.8 0.0 3.4 1.7 0.0 34.3 16.3 0.9 0.0 0.0 1.5 51.0 0.1 5.8 0.4 50.0 0.0 51.9 19.0 12.5 3.6 2.8 8.9 43.9 0.0 0.6 3.3 1.2 0.3 3.2 45.6 1.2 0.0 5.1 1.1 0.4 4.5 5.4 0.5 0.6 0.9 ENPP5 ENSG00000112796 "Ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative)" Q9UJA9 6 46159187-46170971 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "epididymis: 116.5" "Cell type enhanced" "Detected in many" 13 "Ciliated cells: 68.3;Muller glia cells: 94.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 13.4" "Lineage enriched" "Detected in many" 6 "T-cells: 13.4" "Cell line enhanced" "Detected in some" "CAPAN-2: 11.7;HSkMC: 7.8;SuSa: 6.9;T-47d: 9.2;U-266/84: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016902 Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 300000 Cytosol Nucleoplasm "HPA016902: AB_1848172" "unprognostic (1.12e-1)" "unprognostic (5.19e-2)" "unprognostic (1.98e-1)" "unprognostic (1.32e-1)" "unprognostic (7.61e-2)" "unprognostic (1.63e-1)" "unprognostic (5.01e-2)" "prognostic favorable (4.57e-4)" "unprognostic (1.96e-1)" "unprognostic (9.89e-2)" "prognostic favorable (4.04e-4)" "unprognostic (7.00e-2)" "prognostic favorable (4.44e-13)" "unprognostic (4.40e-2)" "unprognostic (2.78e-2)" "unprognostic (1.61e-1)" "unprognostic (1.60e-1)" 1.5 4.8 6.5 1.3 10.3 0.8 7.1 9.2 16.1 6.9 2.0 3.3 28.7 1.5 1.6 116.5 1.6 7.9 3.9 3.9 6.6 9.4 12.1 1.0 4.7 1.2 14.2 10.5 5.4 6.2 21.8 23.3 1.5 14.4 14.6 2.3 11.8 6.9 27.5 6.9 1.3 1.6 5.1 5.5 3.2 3.5 16.2 3.5 1.0 24.3 0.9 1.4 5.7 1.7 0.4 0.0 1.0 0.1 2.2 13.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.6 0.1 0.3 11.7 1.9 3.9 0.2 4.0 0.0 0.6 1.6 0.1 0.0 2.6 0.8 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.4 1.9 0.0 0.5 2.5 5.5 0.0 0.0 0.3 0.2 4.9 0.6 5.1 0.2 0.0 4.9 0.0 6.9 9.2 0.0 0.0 0.0 1.3 0.0 0.1 5.8 7.9 0.0 3.1 0.0 0.1 0.0 0.0 0.0 13.4 0.1 7.2 0.4 2.7 8.6 0.0 0.4 0.8 8.2 1.0 2.2 0.0 0.0 0.0 2.6 6.5 10.3 9.2 16.1 6.6 9.4 14.2 10.5 14.4 3.5 11.9 9.8 0.0 4.7 0.8 11.0 8.1 7.6 68.3 9.1 22.7 3.9 4.2 1.7 6.9 0.8 0.1 1.4 0.0 6.5 2.4 3.3 16.0 4.6 0.0 0.3 9.5 7.9 0.6 0.0 1.5 2.6 0.7 0.0 1.0 3.4 94.1 2.7 2.9 11.3 16.2 2.9 6.5 0.7 0.2 2.3 0.5 0.2 3.8 2.5 2.6 ENSA "ARPP-19e, MGC4319, MGC78563, MGC8394" ENSG00000143420 "Endosulfine alpha" O43768 1 150600851-150629612 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "monocytes: 625.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 13 "U-698: 429.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051294 Uncertain Approved Nucleoplasm,Nucleoli,Microtubules,Cytosol NA NA 22000 "Nucleoplasm, Nucleoli" "Microtubules, Cytosol" "HPA051294: AB_2681425" "unprognostic (6.27e-2)" "prognostic favorable (8.24e-4)" "unprognostic (1.06e-1)" "unprognostic (2.21e-2)" "unprognostic (2.58e-1)" "unprognostic (8.24e-2)" "unprognostic (1.94e-3)" "unprognostic (1.82e-1)" "unprognostic (2.02e-1)" "unprognostic (1.44e-3)" "unprognostic (1.21e-1)" "unprognostic (5.40e-2)" "unprognostic (2.21e-3)" "unprognostic (1.26e-1)" "unprognostic (2.75e-1)" "unprognostic (7.64e-2)" "unprognostic (8.07e-3)" 30.3 26.4 48.9 26.9 48.9 46.8 33.0 33.8 69.3 31.7 31.8 28.0 26.8 34.4 29.7 45.4 66.3 26.3 28.5 30.0 42.4 37.9 31.7 32.3 28.6 30.0 42.0 39.0 27.7 30.5 33.0 25.2 37.5 34.6 23.9 30.4 28.5 29.4 22.8 67.7 49.8 34.0 27.3 38.3 23.8 28.7 12.8 27.3 25.8 35.2 42.9 35.5 31.7 36.3 34.4 39.5 49.5 33.6 33.0 33.2 38.4 14.7 7.7 10.8 10.4 6.9 5.7 11.7 6.6 6.7 9.9 8.4 8.7 11.1 13.2 11.0 5.3 6.2 11.9 8.7 14.7 7.3 22.8 12.1 18.9 10.9 6.6 4.6 15.2 24.4 4.5 9.1 10.3 13.2 5.5 9.3 10.5 14.4 27.8 6.6 31.8 15.0 12.4 21.6 17.4 9.6 14.6 9.0 16.4 13.0 13.0 16.2 10.2 9.4 19.8 10.3 9.5 27.1 22.4 9.8 7.4 13.7 8.8 17.1 15.6 22.7 429.6 10.2 17.7 9.7 28.7 30.7 49.5 32.2 33.6 28.9 34.4 27.0 33.2 39.5 31.8 22.3 32.9 29.0 33.0 31.9 30.2 29.8 38.4 48.9 48.9 33.8 69.3 42.4 37.9 42.0 39.0 34.6 27.3 38.7 144.0 138.7 185.4 169.1 60.1 89.1 79.0 109.7 114.9 78.5 43.2 247.9 215.5 139.6 6.0 100.3 151.4 46.7 132.7 150.0 85.0 114.8 218.3 71.0 175.6 63.5 125.5 52.8 77.7 11.1 79.7 128.3 97.8 625.8 119.8 57.9 90.7 136.8 97.9 148.1 46.3 71.1 92.7 22.2 27.4 250.8 320.0 133.9 128.5 226.6 ENTPD7 "FLJ30978, LALP1" ENSG00000198018 "Ectonucleoside triphosphate diphosphohydrolase 7" Q9NQZ7 10 99659506-99706240 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 46.1" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 14.1;Urothelial cells: 22.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014351 Uncertain Approved Nucleoplasm NA NA 24000 Nucleoplasm "HPA014351: AB_1848183" "unprognostic (1.82e-1)" "unprognostic (7.26e-2)" "unprognostic (1.11e-2)" "unprognostic (6.01e-3)" "unprognostic (6.22e-2)" "unprognostic (3.32e-3)" "unprognostic (9.35e-2)" "unprognostic (3.77e-3)" "unprognostic (3.83e-2)" "unprognostic (1.74e-1)" "unprognostic (1.66e-2)" "unprognostic (1.39e-1)" "unprognostic (5.59e-2)" "unprognostic (2.98e-1)" "unprognostic (1.22e-1)" "unprognostic (2.99e-2)" "unprognostic (3.39e-1)" 3.1 5.6 2.2 5.1 2.1 6.4 2.7 2.4 3.3 4.4 15.7 1.3 11.3 18.6 3.9 5.7 9.1 3.1 9.1 3.2 2.0 1.7 6.0 14.5 4.2 7.1 1.4 1.9 3.2 23.9 3.6 8.6 8.5 1.5 5.6 4.9 3.4 9.0 13.2 1.6 4.4 46.1 5.6 1.4 5.4 5.1 3.5 0.5 2.5 3.5 6.0 6.3 11.4 5.0 0.9 7.7 3.7 2.2 2.7 2.2 1.3 5.2 6.0 8.0 14.8 4.0 4.0 9.7 9.9 20.6 12.9 10.8 11.0 5.9 4.5 5.8 13.3 3.9 13.9 6.7 4.0 10.6 1.9 5.3 3.4 4.7 10.1 6.0 12.0 7.8 3.7 6.9 16.2 15.4 15.0 13.0 4.8 6.4 4.4 5.1 4.7 2.4 2.5 4.7 6.5 2.6 0.0 6.2 2.4 14.1 17.0 3.3 6.4 6.9 2.6 8.6 5.7 7.2 6.1 8.2 11.2 7.2 7.2 8.3 4.5 7.5 4.1 10.9 3.7 3.0 0.3 2.2 3.7 2.2 2.2 2.0 0.9 0.8 1.8 5.0 0.3 1.4 0.9 2.0 2.7 1.2 7.7 0.6 1.3 2.2 2.1 2.4 3.3 2.0 1.7 1.4 1.9 1.5 0.5 0.0 0.0 0.0 14.1 7.2 0.4 0.6 0.0 4.0 2.3 5.2 2.0 4.5 0.0 1.9 1.4 1.0 6.5 0.0 4.3 4.4 1.5 1.8 0.0 3.4 1.7 0.0 5.2 0.6 1.2 2.2 0.9 1.3 0.0 6.4 2.7 0.7 3.4 2.9 0.7 1.3 1.8 0.0 1.4 1.4 0.7 6.5 4.2 0.0 1.4 22.1 ENTPD8 "NTPDase-8, UNQ2492" ENSG00000188833 "Ectonucleoside triphosphate diphosphohydrolase 8" Q5MY95 9 137434364-137441816 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 48.1" "Group enriched" "Detected in some" 6 "Enterocytes: 107.0;Mucus-secreting cells: 160.6;Paneth cells: 49.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.1;OE19: 3.0;RPMI-8226: 8.8;T-47d: 4.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA021509 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA021509: AB_1848185" "unprognostic (3.85e-2)" "unprognostic (8.33e-2)" "unprognostic (2.11e-1)" "unprognostic (1.82e-1)" "unprognostic (1.30e-1)" "unprognostic (1.40e-1)" "unprognostic (6.46e-3)" "unprognostic (8.70e-2)" "unprognostic (3.87e-2)" "unprognostic (8.48e-2)" "unprognostic (1.69e-1)" "unprognostic (2.34e-2)" "unprognostic (1.08e-5)" "prognostic favorable (7.17e-4)" "unprognostic (2.17e-1)" "unprognostic (1.15e-1)" "unprognostic (1.78e-1)" 0.4 0.0 0.4 2.6 0.4 0.0 0.4 0.4 0.4 0.4 19.2 0.4 0.4 18.5 0.4 0.4 0.4 0.3 2.2 0.4 0.5 0.0 2.1 9.8 0.8 0.4 0.4 0.4 0.4 1.8 0.0 4.2 0.5 0.4 0.4 7.5 0.8 4.1 0.4 0.4 0.0 48.1 0.4 0.4 0.4 6.1 0.4 0.4 0.6 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.2 2.0 9.1 0.0 0.6 0.0 0.7 0.1 0.0 0.0 0.0 1.5 0.2 0.0 0.6 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.1 0.0 1.6 0.0 0.2 0.1 3.0 0.4 0.0 0.0 8.8 1.4 0.0 0.3 0.9 0.2 0.0 0.1 0.7 4.8 0.2 0.1 0.0 2.4 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.5 0.0 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.3 12.7 0.0 0.0 19.2 0.0 0.0 0.0 0.8 0.0 0.0 107.0 0.0 6.8 0.1 0.0 1.0 0.0 8.2 0.1 0.0 3.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 160.6 0.0 0.5 49.1 0.0 4.4 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 12.7 0.6 ENY2 "DC6, FLJ20480, Sus1" ENSG00000120533 "ENY2, transcription and export complex 2 subunit" Q9NPA8 8 109334324-109345953 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Transcription, Transcription regulation, Translocation, Transport" "Activator, Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024648 Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA024648: AB_2100208" "unprognostic (2.10e-3)" "unprognostic (1.96e-1)" "unprognostic (2.18e-1)" "unprognostic (7.85e-2)" "unprognostic (7.70e-2)" "unprognostic (7.45e-3)" "unprognostic (1.48e-2)" "unprognostic (6.65e-2)" "unprognostic (2.54e-1)" "unprognostic (1.21e-2)" "unprognostic (1.47e-1)" "unprognostic (8.86e-3)" "prognostic unfavorable (7.17e-6)" "unprognostic (1.74e-1)" "unprognostic (1.51e-1)" "unprognostic (8.84e-2)" "unprognostic (2.66e-1)" 31.9 35.0 28.7 28.1 34.3 44.4 34.8 20.6 31.4 28.2 34.5 18.7 28.3 31.8 24.6 33.8 30.1 22.9 19.1 34.0 31.8 26.2 44.1 58.8 24.7 26.6 27.6 28.3 19.6 27.8 16.5 35.8 30.6 29.1 24.0 33.7 19.9 27.2 25.9 66.7 20.3 31.6 28.4 31.9 30.6 29.0 21.3 24.3 26.1 24.3 29.5 30.3 29.6 23.3 14.0 32.1 30.3 38.9 13.0 14.6 22.6 42.3 35.5 52.8 23.7 20.1 25.8 15.2 33.9 21.9 34.8 44.0 26.2 26.4 27.6 31.9 26.3 15.8 21.7 23.6 24.0 42.5 43.7 27.9 53.0 26.7 53.9 21.5 18.2 33.0 19.5 16.4 22.9 21.7 25.5 52.3 27.3 50.4 15.6 39.5 69.1 55.0 41.4 38.3 49.6 34.6 35.1 23.0 34.2 47.0 32.6 31.9 34.4 21.2 26.7 28.9 30.4 33.9 31.6 35.5 23.4 39.5 24.2 34.3 26.7 28.5 52.2 23.6 30.8 27.2 16.3 35.6 30.3 10.7 37.1 13.2 14.0 14.6 13.0 32.1 9.6 12.1 13.3 19.4 13.0 38.9 26.5 14.2 22.6 28.7 34.3 20.6 31.4 31.8 26.2 27.6 28.3 29.1 24.3 65.5 81.6 148.3 163.4 164.9 66.1 154.2 137.6 89.7 112.6 137.9 115.8 224.8 323.3 190.8 103.7 229.2 183.6 46.7 173.6 235.2 173.8 163.6 89.0 317.8 241.4 42.9 147.9 137.5 200.9 78.7 137.2 217.4 150.1 225.4 166.7 92.6 220.3 192.9 105.7 416.4 119.0 77.6 185.8 187.5 108.4 152.6 139.9 126.9 175.3 175.2 EOGT "AER61, C3orf64, FLJ33770" ENSG00000163378 "EGF domain specific O-linked N-acetylglucosamine transferase" Q5NDL2 3 68975214-69013961 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Peritubular cells: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 39.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019460 Approved Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Intracellular and membrane" NA NA "Nucleoplasm, Nuclear membrane" Cytosol "HPA019460: AB_1844628" "unprognostic (2.62e-1)" "unprognostic (3.72e-1)" "unprognostic (1.07e-1)" "unprognostic (1.95e-2)" "unprognostic (8.96e-2)" "unprognostic (6.30e-2)" "unprognostic (2.18e-3)" "unprognostic (6.66e-2)" "unprognostic (1.13e-2)" "unprognostic (2.57e-1)" "unprognostic (1.68e-1)" "unprognostic (3.57e-1)" "prognostic unfavorable (8.97e-5)" "unprognostic (7.41e-2)" "unprognostic (4.67e-1)" "unprognostic (3.44e-2)" "unprognostic (2.04e-1)" 14.9 5.8 3.4 10.1 4.4 3.0 11.9 2.5 4.8 16.8 12.1 4.4 10.2 4.8 23.3 10.4 15.1 11.4 18.1 18.2 3.9 3.6 6.6 5.5 15.8 9.6 4.2 5.0 12.7 7.8 3.9 5.5 15.2 5.1 18.9 5.8 8.7 14.0 24.0 28.0 6.1 7.7 29.4 4.9 10.2 10.1 7.4 2.4 8.3 5.4 14.2 7.3 27.0 9.8 1.7 3.4 5.5 2.2 3.3 9.2 1.8 8.2 2.8 5.4 6.6 7.7 15.2 4.0 11.2 13.7 7.1 9.4 3.7 4.7 0.4 1.7 12.1 6.1 2.7 3.7 14.6 9.0 26.7 2.6 8.6 6.3 5.3 8.6 4.8 3.6 12.6 12.4 9.2 11.7 8.7 39.1 0.3 2.3 5.1 23.8 2.1 0.7 1.5 6.3 2.7 1.3 0.3 5.7 3.5 6.1 19.0 0.5 3.0 12.9 1.0 10.1 6.0 2.8 6.6 20.7 20.1 6.1 2.3 10.8 2.6 8.4 4.0 8.0 7.5 11.2 5.5 2.2 0.0 3.0 1.9 3.5 1.7 4.8 6.4 3.4 1.2 4.1 4.1 0.3 3.3 0.7 0.6 9.2 1.8 3.4 4.4 2.5 4.8 3.9 3.6 4.2 5.0 5.1 2.4 11.9 10.1 1.5 10.1 6.4 2.2 13.7 7.6 8.1 14.8 1.8 15.7 0.8 0.0 4.0 13.9 15.0 2.5 0.0 7.0 3.8 7.5 7.5 0.0 3.8 5.9 0.0 5.8 21.5 5.1 12.0 2.8 7.7 8.5 9.0 3.4 1.3 9.0 2.9 38.2 1.5 4.8 0.0 23.8 1.1 2.4 4.0 0.7 4.4 2.5 5.8 EOMES TBR2 ENSG00000163508 Eomesodermin O95936 3 27715949-27722711 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Adaptive immunity, Differentiation, Gastrulation, Immunity, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.9;brain: 22.6;lymphoid tissue: 21.4" "Group enriched" "Detected in some" 8 "Erythroid cells: 23.3;T-cells: 32.6" "Cancer enhanced" "Detected in many" "testis cancer: 5.8" "Region enriched" "Detected in some" 20 "cerebellum: 22.6" "Group enriched" "Detected in many" 7 "gdT-cell: 10.0;MAIT T-cell: 16.5;memory CD8 T-cell: 12.0;naive CD8 T-cell: 7.5;NK-cell: 17.9" "Group enriched" "Detected in many" 102 "NK-cells: 17.9;T-cells: 16.5" "Cell line enhanced" "Detected in some" "HDLM-2: 10.2;JURKAT: 12.3;SCLC-21H: 5.7" "Region enriched" "Detected in some" 8 "olfactory region: 95.2" "Group enriched" "Detected in many" 13 "cerebellum: 44.2;olfactory region: 21.9" HPA028896 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA028896: AB_10601370" "unprognostic (1.53e-4)" "unprognostic (5.95e-3)" "unprognostic (3.01e-2)" "unprognostic (1.60e-4)" "unprognostic (4.13e-2)" "unprognostic (9.63e-4)" "unprognostic (4.29e-4)" "unprognostic (3.14e-3)" "unprognostic (1.24e-1)" "unprognostic (2.82e-2)" "unprognostic (9.96e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (9.45e-6)" "unprognostic (1.61e-1)" "unprognostic (5.09e-1)" "unprognostic (6.32e-3)" "unprognostic (1.49e-2)" 1.4 0.7 0.5 6.8 0.4 1.6 1.6 22.6 0.4 1.8 0.8 0.0 0.0 0.3 3.2 0.9 1.4 0.6 5.0 0.7 0.4 0.7 1.0 4.9 10.1 15.6 0.5 0.3 1.3 0.9 0.0 0.6 1.6 1.1 2.1 0.9 3.3 2.2 0.1 0.4 0.4 1.8 0.7 0.9 21.4 1.4 0.5 0.0 1.8 1.1 0.9 11.2 3.3 0.8 0.0 0.0 0.1 0.0 17.9 16.5 1.4 0.0 1.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 2.6 2.0 0.0 10.2 1.5 0.0 0.1 0.8 0.0 1.2 0.0 0.1 1.2 0.0 1.4 0.5 0.0 12.3 0.3 0.0 0.0 3.0 2.7 0.0 0.3 0.2 1.2 1.9 0.0 0.0 1.0 0.0 5.7 0.0 0.0 0.0 1.2 0.5 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 10.0 0.0 16.5 0.0 1.9 12.0 0.0 0.0 0.1 7.5 0.1 17.9 0.0 0.0 0.0 1.4 0.5 0.4 22.6 0.4 0.4 0.7 0.5 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 3.7 3.0 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 1.6 0.1 0.0 32.6 0.0 0.0 EP300 "KAT3B, p300" ENSG00000100393 "E1A binding protein p300" Q09472 22 41091786-41180079 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Acyltransferase, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000146, HPA003128, HPA004112" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB000146: AB_2533138, HPA003128: AB_1078745, HPA004112: AB_1078746" "unprognostic (7.67e-2)" "unprognostic (5.56e-2)" "unprognostic (2.29e-1)" "unprognostic (2.52e-1)" "unprognostic (6.10e-3)" "unprognostic (1.66e-1)" "unprognostic (2.21e-2)" "unprognostic (2.13e-1)" "unprognostic (1.54e-1)" "unprognostic (8.97e-2)" "unprognostic (1.74e-2)" "unprognostic (8.54e-2)" "prognostic favorable (7.45e-5)" "unprognostic (7.97e-2)" "unprognostic (1.41e-1)" "unprognostic (1.01e-1)" "unprognostic (8.66e-2)" 16.8 14.8 19.1 13.9 15.5 45.3 14.5 33.0 20.6 14.8 16.8 15.6 18.9 11.1 18.1 11.6 16.8 15.7 16.5 10.7 16.6 8.3 11.5 12.2 14.1 12.9 16.9 12.7 20.2 15.7 26.4 14.5 27.7 13.8 13.2 12.2 12.3 15.3 17.9 19.5 18.2 17.4 13.8 12.7 15.9 14.7 20.6 18.6 29.3 16.9 10.9 14.1 18.7 22.5 4.3 4.4 9.8 3.9 5.7 3.9 2.3 15.7 11.3 19.2 11.9 12.2 13.2 17.2 7.6 11.0 11.4 11.0 14.4 5.8 16.4 6.7 15.0 10.5 12.7 27.7 10.4 12.7 15.9 18.4 12.3 13.0 11.2 13.9 29.2 13.9 12.9 10.9 16.5 13.8 10.0 12.6 9.5 13.0 22.6 9.0 5.8 8.4 9.1 13.8 19.8 7.9 17.3 9.0 10.2 10.8 20.9 6.1 6.5 26.9 13.7 13.1 16.7 9.7 17.0 16.3 11.4 13.8 8.1 10.8 15.5 7.3 25.6 8.4 9.0 10.8 5.0 3.2 3.0 3.7 3.9 3.2 4.3 3.6 3.9 4.4 2.9 3.1 2.6 9.8 5.7 2.1 3.0 2.6 2.3 19.1 15.5 33.0 20.6 16.6 8.3 16.9 12.7 13.8 18.6 62.5 45.1 44.7 19.0 21.9 43.6 25.4 53.5 29.4 18.2 24.4 33.4 15.3 3.3 13.2 12.6 27.2 22.2 46.7 16.0 15.4 23.4 24.1 24.3 24.1 15.9 23.8 23.7 34.4 59.8 3.4 26.7 31.6 8.5 20.8 23.1 31.8 20.2 26.6 28.7 9.2 31.1 25.8 15.6 20.6 29.9 22.6 25.3 26.6 20.3 30.6 EP400 "CAGH32, DKFZP434I225, KIAA1498, KIAA1818, P400, TNRC12" ENSG00000183495 "E1A binding protein p400" Q96L91 12 131949920-132081102 "Plasma proteins, Predicted intracellular proteins" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 6.7;dendritic cells: 7.3;T-cells: 2.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016704, HPA049013" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA016704: AB_1854888, HPA049013: AB_2680598" "unprognostic (2.28e-1)" "unprognostic (4.04e-1)" "unprognostic (4.33e-1)" "unprognostic (8.03e-2)" "unprognostic (1.37e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (3.10e-1)" "unprognostic (1.37e-2)" "unprognostic (4.90e-2)" "unprognostic (2.05e-2)" "unprognostic (2.35e-1)" "unprognostic (1.13e-2)" "unprognostic (2.33e-1)" "unprognostic (4.36e-1)" "unprognostic (2.46e-2)" "unprognostic (2.24e-1)" 14.1 15.5 19.3 23.9 21.9 20.0 16.5 27.4 24.0 17.3 15.6 17.6 13.4 11.4 19.2 25.8 14.0 17.1 18.0 11.1 16.6 12.6 12.3 11.9 13.9 18.9 15.6 17.6 24.6 14.0 24.6 17.9 13.3 13.7 15.6 13.2 14.4 16.1 22.6 19.2 27.9 14.7 16.3 12.0 19.4 13.4 27.0 16.8 22.5 18.0 11.8 16.9 16.0 20.9 6.7 7.3 1.0 1.2 0.8 2.8 0.9 14.7 19.6 18.6 9.2 11.1 11.1 14.6 8.3 6.4 6.4 5.6 11.6 4.6 12.6 7.8 10.3 7.3 11.3 8.9 8.4 8.7 5.2 13.3 18.0 6.6 13.1 9.2 19.3 14.1 9.4 8.0 11.9 10.8 11.1 10.9 8.2 17.4 3.6 9.2 18.6 14.5 26.4 14.8 8.1 17.0 15.4 12.4 5.0 8.6 18.1 15.0 12.6 9.7 6.8 9.4 14.0 11.3 15.2 16.2 10.4 16.1 11.5 12.0 9.2 7.1 12.9 10.8 10.8 10.4 1.0 1.2 0.9 1.9 0.9 2.0 6.7 1.7 1.5 0.9 6.4 2.0 2.8 1.0 0.8 0.8 7.3 1.1 0.9 19.3 21.9 27.4 24.0 16.6 12.6 15.6 17.6 13.7 16.8 3.0 13.2 27.5 9.4 8.9 32.0 12.5 2.5 32.1 13.6 15.7 37.3 10.3 1.7 8.7 9.0 15.0 8.0 0.0 9.0 9.5 10.2 8.9 5.8 9.7 13.2 23.8 13.8 13.5 10.7 6.5 15.3 9.1 6.8 14.4 10.2 14.3 11.8 12.2 15.9 2.9 40.1 19.4 10.3 37.1 33.4 11.4 14.9 14.9 12.1 10.7 EPAS1 "bHLHe73, HIF2A, HLF, MOP2, PASD2" ENSG00000116016 "Endothelial PAS domain protein 1" Q99814 2 46293667-46386703 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Angiogenesis, Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Congenital erythrocytosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 200.8" "Cell type enhanced" "Detected in many" 6 "Endothelial cells: 341.0;Ito cells: 438.9;Smooth muscle cells: 281.4;Syncytiotrophoblasts: 292.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 16 "basophil: 14.9;eosinophil: 7.1" "Lineage enriched" "Detected in single" 21 "granulocytes: 14.9" "Cell line enhanced" "Detected in many" "BEWO: 46.9;BJ hTERT+: 46.2;HHSteC: 58.7;RT4: 58.1;TIME: 58.0;U-138 MG: 50.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031200, HPA069697" Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA031200: AB_2673785, HPA069697: AB_2732139" "unprognostic (1.74e-1)" "unprognostic (9.47e-2)" "unprognostic (1.29e-2)" "unprognostic (2.74e-1)" "unprognostic (5.25e-2)" "unprognostic (1.75e-1)" "unprognostic (2.22e-2)" "unprognostic (8.67e-2)" "unprognostic (6.00e-2)" "unprognostic (9.72e-2)" "unprognostic (1.55e-2)" "unprognostic (9.29e-2)" "prognostic favorable (2.63e-4)" "unprognostic (6.66e-3)" "unprognostic (7.75e-2)" "unprognostic (7.56e-2)" "unprognostic (1.36e-1)" 71.2 14.2 12.5 17.1 15.7 0.8 101.7 5.3 13.9 24.9 20.9 8.9 11.3 12.0 28.8 13.0 21.6 24.8 35.2 40.0 12.8 11.0 35.2 31.2 200.8 27.2 14.3 11.1 20.2 15.5 18.1 9.4 119.6 18.4 20.7 11.5 41.2 13.3 18.7 25.2 13.0 15.6 19.2 12.5 20.5 12.8 13.8 8.0 1.1 43.8 15.2 10.3 32.2 39.3 0.0 0.0 14.9 0.1 0.7 0.1 0.1 5.3 5.7 0.3 0.4 27.6 17.8 46.9 16.9 46.2 9.7 10.6 1.0 0.9 0.0 4.2 32.2 9.7 2.6 0.1 13.5 7.3 0.1 0.2 0.0 1.8 12.0 58.7 0.0 3.4 26.0 18.7 19.0 13.4 7.2 33.4 0.1 0.5 0.0 5.9 4.6 0.1 0.1 0.2 3.7 3.2 0.1 0.6 1.7 6.0 58.1 0.2 12.0 13.3 30.6 3.6 12.5 2.0 2.3 58.0 50.4 1.4 6.7 1.4 0.0 0.0 0.0 36.7 0.9 1.2 14.9 0.1 7.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.1 0.1 12.5 15.7 5.3 12.6 12.8 11.0 14.3 11.1 18.4 8.0 71.5 137.9 8.1 61.5 42.7 3.5 58.5 50.9 30.8 96.7 3.5 9.8 93.6 1.7 15.5 12.6 341.0 66.4 0.0 45.9 256.0 104.5 46.7 40.4 77.4 47.9 0.0 4.1 438.9 58.4 41.8 11.5 23.9 27.0 0.0 13.6 89.1 25.9 40.4 6.0 24.0 57.7 278.1 281.4 1.2 1.7 29.1 292.5 9.6 11.6 58.0 EPB41L2 4.1-G ENSG00000079819 "Erythrocyte membrane protein band 4.1 like 2" O43491 6 130839347-131063322 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 18 "Muller glia cells: 499.6;Rod photoreceptor cells: 1331.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005730, HPA006642" Supported Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA 170000 "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA005730: AB_1848195, HPA006642: AB_1848194" "unprognostic (3.18e-2)" "unprognostic (1.04e-1)" "unprognostic (8.34e-3)" "unprognostic (3.40e-3)" "unprognostic (1.41e-1)" "unprognostic (5.17e-2)" "prognostic unfavorable (2.41e-5)" "unprognostic (1.25e-1)" "unprognostic (1.23e-1)" "prognostic unfavorable (2.16e-4)" "unprognostic (3.24e-1)" "unprognostic (1.63e-1)" "unprognostic (5.63e-2)" "unprognostic (3.64e-2)" "unprognostic (3.82e-1)" "unprognostic (3.48e-2)" "unprognostic (9.19e-2)" 50.2 16.5 29.6 17.3 42.8 3.9 21.1 6.5 40.1 20.5 23.1 32.3 7.2 12.3 23.0 13.7 13.2 25.6 18.0 22.8 33.4 24.6 11.5 12.1 24.4 15.4 50.5 33.1 44.4 9.1 8.2 8.4 26.2 34.8 11.2 23.2 52.0 10.1 15.8 16.0 7.1 21.4 20.6 59.5 25.3 11.7 32.2 51.9 6.8 15.2 14.6 11.6 15.2 16.6 10.5 8.6 0.5 8.8 1.0 2.5 1.3 8.3 8.8 20.0 27.4 13.9 22.3 6.1 14.2 18.0 14.5 20.3 16.8 11.9 10.2 26.7 19.5 11.8 4.3 7.6 13.1 29.0 43.3 17.7 18.3 10.5 9.6 8.2 0.0 22.3 10.9 0.2 25.6 9.9 23.5 22.3 15.6 49.5 29.3 9.2 2.1 14.3 3.1 18.5 35.8 9.6 22.3 24.0 0.9 24.4 8.0 2.1 0.0 5.9 0.1 11.5 21.4 3.0 19.1 27.0 17.1 32.3 28.9 42.7 24.3 0.4 9.5 11.7 0.1 26.0 0.1 3.1 0.5 1.0 8.8 0.9 2.9 1.0 1.2 8.6 10.5 1.7 0.7 0.0 1.0 3.3 2.3 2.5 1.3 29.6 42.8 6.5 39.6 33.4 24.6 50.5 33.1 34.8 51.9 6.0 11.8 15.4 12.1 13.7 52.8 12.6 22.9 20.1 28.4 1.8 212.1 2.8 0.0 28.2 273.7 47.2 31.6 0.0 14.3 5.1 74.8 3.3 42.8 3.4 29.8 27.0 9.8 39.3 104.6 245.3 67.6 61.1 10.1 17.2 36.8 499.6 37.8 21.0 43.5 9.8 1331.8 116.4 56.7 54.3 79.8 8.9 2.1 5.0 21.6 6.8 EPB41L4A NBL4 ENSG00000129595 "Erythrocyte membrane protein band 4.1 like 4A" Q9HCS5 5 112142441-112419316 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 68.8;Ciliated cells: 42.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 20.0;HeLa: 22.6;RT4: 13.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA036580 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA036580: AB_10669908" "unprognostic (1.40e-1)" "unprognostic (1.90e-1)" "unprognostic (1.92e-3)" "unprognostic (3.64e-2)" "unprognostic (4.73e-2)" "unprognostic (5.59e-3)" "unprognostic (4.40e-2)" "unprognostic (8.38e-2)" "unprognostic (1.90e-1)" "unprognostic (3.97e-2)" "unprognostic (1.22e-1)" "unprognostic (1.23e-3)" "prognostic favorable (3.65e-5)" "unprognostic (1.68e-1)" "unprognostic (3.35e-2)" "unprognostic (2.73e-1)" "unprognostic (1.92e-1)" 21.4 3.7 3.5 5.0 4.0 2.1 19.0 2.1 6.1 7.3 3.0 1.7 22.1 1.9 6.1 11.3 13.6 6.2 11.7 9.3 4.0 3.1 10.0 4.8 21.9 6.9 3.7 2.0 4.9 4.2 14.3 4.3 8.9 3.7 5.3 3.8 10.5 7.7 22.0 6.8 7.2 3.2 5.9 4.3 6.7 4.3 4.8 1.9 2.1 15.7 8.2 6.9 5.5 12.2 3.6 0.5 1.3 1.2 0.4 4.8 0.9 0.5 3.5 9.2 0.9 0.0 0.0 1.9 1.3 0.0 0.0 0.0 1.9 7.8 3.8 20.0 0.0 0.5 4.7 0.6 4.3 0.0 0.6 3.2 6.1 22.6 1.2 0.1 1.6 2.0 0.0 1.9 0.0 0.0 1.0 5.8 1.1 1.2 3.6 0.0 1.1 2.8 2.1 1.7 0.7 0.7 1.4 7.0 0.8 5.4 13.6 7.7 4.0 6.8 3.4 2.7 6.7 10.2 0.8 10.0 0.4 1.6 1.2 2.7 3.6 0.7 2.9 0.9 3.2 0.5 1.3 0.4 0.2 4.8 0.6 2.7 3.6 1.5 1.4 0.5 3.3 2.4 4.7 0.5 0.4 1.2 0.3 1.4 0.9 3.5 4.0 2.1 3.9 4.0 3.1 3.7 2.0 3.7 1.9 26.8 7.7 4.2 14.0 5.4 4.0 7.6 68.8 42.8 27.3 14.0 3.9 6.0 10.0 12.3 16.7 18.0 2.6 0.0 6.8 0.9 6.7 12.1 8.1 1.7 2.1 1.6 1.2 30.1 5.6 14.1 1.7 1.3 3.3 4.6 6.3 7.7 10.4 10.5 1.8 20.3 31.5 0.0 4.7 1.6 6.1 7.0 2.1 1.7 4.5 16.3 EPB42 "MGC116735, MGC116737, PA" ENSG00000166947 "Erythrocyte membrane protein band 4.2" P16452 15 43197227-43221125 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell shape, Erythrocyte maturation" "Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 54.8;placenta: 16.1" "Cell type enriched" "Detected in many" 15 "Erythroid cells: 186.9" "Not detected" "Not detected" "Region enriched" "Detected in some" 4 "cerebellum: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 92 "HEL: 43.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040261 Supported Uncertain Nucleoplasm,Cytosol NA NA 7500000 "Nucleoplasm, Cytosol" "HPA040261: AB_10673441" "unprognostic (8.45e-2)" "unprognostic (4.66e-1)" "unprognostic (4.15e-1)" "unprognostic (1.13e-1)" "unprognostic (2.28e-1)" "unprognostic (1.99e-1)" "unprognostic (1.54e-1)" "unprognostic (1.59e-3)" "unprognostic (2.95e-1)" "unprognostic (6.05e-2)" "unprognostic (5.27e-3)" "unprognostic (1.31e-1)" "unprognostic (1.48e-5)" "unprognostic (1.70e-2)" "unprognostic (1.20e-1)" "unprognostic (5.88e-2)" "unprognostic (3.47e-3)" 7.5 0.4 0.4 0.4 0.9 54.8 1.3 4.3 1.0 0.3 0.4 0.3 0.3 0.3 0.3 0.3 0.4 0.5 0.6 1.9 0.4 0.9 0.5 0.9 5.5 0.3 0.5 0.3 0.8 0.3 0.3 0.3 16.1 0.7 0.5 0.3 0.3 0.3 0.3 1.3 1.1 1.0 0.3 0.3 5.3 0.5 2.4 0.3 0.5 1.2 0.3 0.5 1.6 4.5 0.0 0.3 0.2 0.0 0.0 0.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 4.2 0.4 0.9 4.3 1.0 0.4 0.9 0.5 0.3 0.7 0.3 0.0 0.0 0.5 1.2 1.6 3.7 0.3 2.5 0.0 0.0 0.0 5.9 3.3 0.0 0.0 7.7 0.6 1.1 186.9 0.0 1.9 1.7 1.0 4.6 0.5 1.0 6.4 0.0 1.3 0.3 8.0 2.6 0.8 1.7 0.0 0.8 2.8 0.0 1.7 0.7 0.0 7.8 6.5 1.2 12.1 3.8 2.5 5.6 4.4 0.6 1.6 EPC1 Epl1 ENSG00000120616 "Enhancer of polycomb homolog 1" Q9H2F5 10 32267751-32378798 "Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Activator, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028931 Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA028931: " "unprognostic (6.94e-2)" "unprognostic (3.03e-2)" "unprognostic (9.93e-2)" "unprognostic (9.43e-2)" "unprognostic (5.73e-2)" "prognostic favorable (6.40e-4)" "unprognostic (1.80e-2)" "unprognostic (3.83e-3)" "unprognostic (7.43e-2)" "unprognostic (5.55e-2)" "prognostic favorable (6.02e-4)" "unprognostic (4.40e-2)" "unprognostic (1.59e-3)" "unprognostic (1.03e-1)" "unprognostic (1.29e-1)" "unprognostic (2.08e-1)" "unprognostic (1.18e-3)" 17.3 10.0 13.2 19.9 14.3 35.0 19.4 45.3 16.3 20.1 18.0 15.6 13.6 10.6 21.4 15.1 11.7 17.3 12.4 13.5 13.0 10.5 12.3 13.9 13.7 20.5 14.1 10.1 25.4 19.9 20.4 35.7 12.5 12.6 17.2 16.1 15.8 15.1 14.7 22.0 16.8 15.5 21.5 14.3 18.9 13.2 10.2 17.8 41.2 17.9 14.4 19.9 19.1 17.8 12.7 11.1 16.1 6.1 6.6 9.1 3.1 8.0 8.3 17.1 14.4 8.1 11.6 6.7 9.4 5.7 10.3 10.1 5.7 9.6 14.7 6.3 9.5 5.0 7.7 9.0 7.4 7.6 12.1 8.5 12.7 7.0 7.0 8.9 8.6 14.5 9.7 12.4 6.8 5.0 11.9 9.4 9.9 10.6 18.4 9.8 7.9 15.9 6.2 3.8 8.0 3.2 18.0 13.9 7.0 8.4 7.6 13.1 13.5 8.3 6.2 12.6 9.3 6.0 14.3 9.7 7.4 10.6 5.1 7.6 7.9 6.0 15.5 7.2 13.8 6.8 14.6 6.1 10.9 8.6 4.0 9.1 10.7 8.6 7.8 3.9 12.7 8.9 8.1 16.1 6.6 5.8 11.1 8.7 3.1 13.2 14.3 45.3 16.3 13.0 10.5 14.1 10.1 12.6 17.8 38.7 44.0 77.3 86.8 25.3 99.6 29.1 45.9 42.8 43.3 38.4 64.8 30.6 8.3 43.7 7.1 51.7 46.2 23.3 38.1 32.8 45.2 61.4 82.1 31.6 31.0 108.1 94.6 41.1 43.7 8.9 87.8 51.5 38.8 56.9 46.9 54.5 39.7 45.2 64.0 15.9 84.6 97.0 49.1 82.2 32.8 21.8 38.6 107.8 41.2 54.7 EPGN "ALGV3072, EPG, epigen, PRO9904" ENSG00000182585 "Epithelial mitogen" Q6UW88 4 74308473-74315307 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 14.3;esophagus: 39.6;tongue: 25.7" "Cell type enhanced" "Detected in some" 14 "Basal glandular cells: 3.2;Basal keratinocytes: 5.4;Early spermatids: 1.7;Late spermatids: 2.2;Melanocytes: 1.7;Urothelial cells: 2.2" "Cancer enhanced" "Detected in some" "head and neck cancer: 7.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.9" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "hTCEpi: 62.6;U-2197: 28.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA014420 Approved Nucleoplasm,Vesicles,Cytosol "Secreted in other tissues" NA NA "Nucleoplasm, Cytosol" Vesicles "HPA014420: AB_10601551" "unprognostic (7.51e-2)" "unprognostic (8.08e-3)" "unprognostic (1.09e-1)" "unprognostic (1.07e-1)" "unprognostic (1.77e-1)" "unprognostic (2.38e-4)" "unprognostic (2.20e-1)" "unprognostic (2.01e-1)" "unprognostic (1.23e-2)" "unprognostic (1.27e-1)" "unprognostic (4.06e-4)" "unprognostic (3.84e-1)" "unprognostic (7.89e-2)" "prognostic unfavorable (2.40e-4)" 1.1 0.0 0.0 1.3 0.0 0.1 1.0 0.0 0.0 7.9 0.3 0.0 1.0 0.0 0.0 14.3 39.6 1.2 0.3 0.6 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.5 0.0 1.0 0.0 1.7 0.0 0.3 0.0 0.0 2.5 2.8 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.4 0.0 25.7 5.4 0.6 6.5 0.4 0.1 0.0 0.6 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.6 0.1 1.2 0.0 1.0 0.0 0.0 0.0 0.1 7.4 0.0 0.0 0.0 0.1 0.0 62.6 1.0 4.6 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 1.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 3.3 1.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 28.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.4 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 3.2 5.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 2.2 EPHA3 "ETK, ETK1, HEK, HEK4, TYRO4" ENSG00000044524 "EPH receptor A3" P29320 3 89107524-89482134 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 39.0" "Group enriched" "Detected in some" 5 "Fibroblasts: 12.2;Horizontal cells: 19.1;Peritubular cells: 7.8;Rod photoreceptor cells: 16.9;Sertoli cells: 6.5;Smooth muscle cells: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "AF22: 66.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB010462, HPA069390" Approved Supported "Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments,Cytosol" "Intracellular and membrane" NA NA "Nuclear membrane, Plasma membrane, Cytosol" "Nucleoplasm, Actin filaments" "CAB010462: AB_2099218, HPA069390: " "unprognostic (1.48e-3)" "unprognostic (2.30e-2)" "unprognostic (4.95e-2)" "unprognostic (1.90e-1)" "unprognostic (2.96e-2)" "unprognostic (1.47e-2)" "unprognostic (2.03e-1)" "unprognostic (9.10e-3)" "unprognostic (1.24e-3)" "unprognostic (7.43e-2)" "unprognostic (1.83e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (3.28e-7)" "unprognostic (3.63e-2)" "unprognostic (1.88e-2)" "unprognostic (4.05e-2)" "unprognostic (1.20e-2)" 9.7 1.1 2.3 1.7 4.5 0.2 5.1 1.3 8.7 12.3 5.8 0.6 1.4 2.2 13.9 1.3 6.3 2.6 17.2 10.0 2.2 2.5 1.5 4.4 2.7 3.0 2.5 3.4 4.2 2.8 1.2 3.4 17.5 11.9 39.0 5.9 5.4 3.8 6.8 1.7 1.7 3.5 17.3 2.9 1.2 3.7 1.3 2.0 0.0 16.3 6.0 3.0 11.8 12.2 0.3 0.1 0.5 0.1 0.3 0.2 0.0 0.0 0.0 66.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 3.8 0.0 0.2 0.0 0.8 0.0 0.0 4.1 0.0 0.0 0.6 0.7 0.0 1.3 0.0 0.0 0.2 0.0 0.8 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.8 0.0 0.0 0.0 0.6 0.0 0.5 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.5 0.3 0.1 0.1 0.0 0.0 2.3 4.5 1.3 8.7 2.2 2.5 2.5 3.4 11.9 2.0 0.0 0.0 0.0 0.3 0.5 1.5 2.1 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 1.3 1.1 0.0 0.0 0.0 0.1 12.2 0.1 0.0 0.0 0.1 19.1 0.0 0.6 0.0 1.3 2.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 7.8 0.0 16.9 6.5 20.6 0.0 0.0 0.3 0.5 0.0 0.0 0.0 EPHA6 FLJ35246 ENSG00000080224 "EPH receptor A6" Q9UF33 3 96814581-97752460 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.9;ovary: 13.2;testis: 15.5" "Group enriched" "Detected in some" 67 "Early spermatids: 305.1;Late spermatids: 156.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HEK 293: 8.2;U-266/70: 24.9" "Low region specificity" "Detected in many" "HPA007397, HPA058047" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA007397: AB_2667821, HPA058047: AB_2683588" "unprognostic (9.87e-2)" "unprognostic (1.67e-2)" "unprognostic (3.42e-4)" "unprognostic (7.21e-5)" "unprognostic (8.51e-2)" "unprognostic (1.32e-1)" "unprognostic (1.82e-2)" "unprognostic (3.14e-1)" "unprognostic (1.87e-1)" "unprognostic (1.34e-1)" "unprognostic (2.22e-1)" "unprognostic (1.71e-4)" "unprognostic (1.93e-3)" "unprognostic (1.76e-1)" "unprognostic (1.48e-2)" "unprognostic (7.14e-3)" 0.8 0.5 8.7 0.5 9.8 0.3 0.8 27.9 9.9 2.2 5.8 1.1 0.3 0.6 2.2 1.0 2.1 4.2 2.1 1.1 15.4 1.3 1.3 0.5 0.5 0.4 1.1 6.8 13.2 1.4 0.7 0.6 0.5 5.7 2.5 1.8 0.2 0.6 1.7 0.4 0.5 1.1 3.2 0.8 0.4 1.7 15.5 2.8 0.0 4.3 0.0 0.5 2.1 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 8.2 0.0 2.1 0.0 0.0 2.0 0.0 0.0 0.4 0.0 0.8 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 2.1 0.0 0.8 24.9 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 9.8 27.9 9.9 15.4 1.3 1.1 6.8 5.7 2.8 0.0 0.0 0.0 0.1 0.2 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 305.1 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 156.3 2.8 0.0 0.0 0.0 0.0 0.9 0.1 0.0 1.4 0.6 0.2 0.0 0.1 3.4 2.3 0.0 0.1 0.0 0.0 0.0 EPHB2 "DRT, EPHT3, ERK, Hek5, Tyro5" ENSG00000133216 "EPH receptor B2" P29323 1 22710839-22921500 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 25.0" "Cell type enhanced" "Detected in many" 11 "Ductal cells: 42.3;Intestinal endocrine cells: 46.8;Mucus-secreting cells: 53.6;Pancreatic endocrine cells: 38.4;Undifferentiated cells: 82.9" "Cancer enhanced" "Detected in many" "colorectal cancer: 23.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.5;intermediate monocyte: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "GAMG: 34.4;HUVEC TERT2: 29.7;TIME: 29.4;U-251 MG: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB013647, HPA071200" Approved Supported "Nucleoplasm,Plasma membrane" "Intracellular and membrane" No No 290000 "Plasma membrane" Nucleoplasm "CAB013647: , HPA071200: AB_2686360" "unprognostic (2.47e-2)" "unprognostic (2.43e-2)" "prognostic favorable (4.98e-4)" "prognostic unfavorable (1.05e-5)" "unprognostic (3.99e-2)" "unprognostic (8.91e-3)" "unprognostic (1.23e-1)" "unprognostic (2.33e-3)" "unprognostic (1.56e-1)" "unprognostic (7.73e-2)" "unprognostic (1.23e-2)" "unprognostic (2.15e-2)" "unprognostic (2.16e-4)" "unprognostic (1.45e-1)" "unprognostic (8.07e-2)" "unprognostic (2.58e-1)" "unprognostic (3.46e-2)" 3.7 2.9 3.4 15.4 5.4 0.9 2.5 1.9 8.2 3.8 23.9 16.2 4.6 21.6 2.5 3.2 1.1 5.4 4.4 5.4 5.6 6.5 3.5 1.1 3.0 5.5 12.7 3.8 17.9 5.4 6.1 5.4 12.0 8.2 3.3 25.0 2.2 6.6 4.0 0.7 1.8 22.6 4.0 12.1 3.3 2.3 2.9 9.3 0.1 8.4 1.0 2.1 5.3 3.3 0.1 0.6 0.3 2.5 0.1 0.1 0.4 15.9 6.7 6.5 10.4 0.6 0.6 0.0 3.7 0.2 11.3 2.4 2.3 6.4 0.2 8.0 1.6 34.4 15.1 4.4 21.7 3.0 0.0 1.6 0.0 0.7 0.0 6.8 0.0 1.6 2.2 7.0 20.2 0.1 10.0 29.7 0.9 0.6 0.0 2.2 2.3 0.3 0.1 1.5 17.8 4.4 1.9 6.7 0.3 5.5 1.5 7.1 7.4 6.5 0.2 0.0 0.6 0.4 0.2 29.4 4.5 11.8 11.4 25.5 0.0 0.1 0.0 8.4 0.3 0.1 0.3 2.5 0.1 0.1 2.1 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.4 3.4 5.4 1.9 8.2 5.6 6.5 12.7 3.8 8.2 9.3 3.0 0.0 0.0 1.5 0.7 11.6 1.2 12.7 1.4 3.4 0.0 0.0 0.4 0.0 42.3 2.3 0.5 6.8 0.0 6.8 2.2 1.5 1.4 0.0 0.5 9.1 6.4 46.8 0.6 7.5 0.4 0.9 3.7 0.0 0.0 53.6 20.9 38.4 3.5 0.7 0.0 1.7 0.0 1.7 0.5 2.6 0.4 0.9 0.0 82.9 1.0 EPHX3 "ABHD9, FLJ22408" ENSG00000105131 "Epoxide hydrolase 3" Q9H6B9 19 15226919-15233435 "Enzymes, Predicted intracellular proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 34.8;lymphoid tissue: 29.6;skin 1: 33.1;tongue: 39.6" "Group enriched" "Detected in many" 4 "Suprabasal keratinocytes: 37.9;Urothelial cells: 18.6" "Cancer enhanced" "Detected in many" "cervical cancer: 30.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "intermediate monocyte: 4.2;non-classical monocyte: 4.9" "Group enriched" "Detected in many" 18 "dendritic cells: 2.8;monocytes: 4.9" "Cell line enhanced" "Detected in some" "EFO-21: 4.0;NTERA-2: 3.7;OE19: 12.9;SuSa: 5.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA012842 Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA012842: AB_10601648" "unprognostic (1.39e-1)" "unprognostic (1.16e-2)" "unprognostic (1.54e-2)" "unprognostic (1.74e-1)" "unprognostic (8.24e-2)" "prognostic favorable (2.27e-5)" "unprognostic (8.83e-3)" "unprognostic (1.50e-1)" "unprognostic (3.90e-1)" "unprognostic (4.36e-2)" "unprognostic (4.25e-2)" "unprognostic (1.06e-1)" "unprognostic (3.43e-1)" "unprognostic (3.68e-2)" "unprognostic (1.48e-1)" "unprognostic (1.30e-2)" "unprognostic (6.01e-2)" 0.2 0.1 0.1 0.2 0.3 0.1 1.0 0.1 0.3 12.5 0.2 0.2 0.4 0.1 0.9 0.3 34.8 1.1 1.7 0.1 0.5 0.1 1.6 0.2 1.6 0.0 0.2 0.0 0.6 0.0 2.2 2.4 0.2 0.4 1.5 0.1 0.6 3.4 0.6 0.2 33.1 0.2 0.2 0.2 1.2 0.5 2.7 0.2 2.4 0.2 39.6 29.6 2.8 13.6 0.0 2.8 0.2 4.9 0.0 0.0 0.5 0.1 0.3 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.5 0.3 4.0 0.1 0.2 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.6 0.0 0.5 3.7 12.9 0.5 0.0 0.0 0.0 0.1 0.8 1.6 0.2 0.0 0.1 0.0 5.7 0.0 0.0 0.0 0.2 0.5 0.0 0.2 0.0 0.3 0.5 0.0 0.1 0.1 0.0 1.2 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 4.9 2.8 0.0 0.5 0.1 0.3 0.1 0.3 0.5 0.1 0.2 0.0 0.4 0.2 0.0 0.6 0.0 1.5 6.3 0.2 0.3 2.5 1.4 0.0 5.2 0.0 1.5 1.7 0.5 0.3 0.1 0.0 0.0 0.0 2.5 0.7 2.0 0.0 0.0 0.6 0.0 0.0 1.3 1.3 0.0 0.0 1.4 0.0 1.0 0.0 3.1 0.3 0.0 0.0 0.0 0.0 0.0 1.2 2.1 2.1 37.9 2.2 0.0 0.0 18.6 EPM2A "LD, LDE" ENSG00000112425 "EPM2A, laforin glucan phosphatase" O95278 6 145382535-145736023 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Autophagy, Carbohydrate metabolism, Glycogen metabolism" "Hydrolase, Protein phosphatase" "Disease mutation, Epilepsy, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 60.9" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 23.5;Early spermatids: 28.2;Horizontal cells: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 5.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 20.3" "Low region specificity" "Detected in all" "HPA053643, HPA055468" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA053643: AB_2797247, HPA055468: AB_2797252" "unprognostic (2.37e-2)" "unprognostic (1.03e-1)" "unprognostic (1.99e-1)" "unprognostic (3.34e-3)" "unprognostic (2.92e-3)" "unprognostic (1.22e-1)" "unprognostic (2.15e-2)" "unprognostic (1.63e-1)" "unprognostic (2.37e-2)" "unprognostic (1.50e-1)" "unprognostic (1.52e-4)" "unprognostic (2.28e-1)" "prognostic favorable (4.08e-7)" "unprognostic (4.12e-4)" "unprognostic (2.17e-1)" "unprognostic (2.99e-3)" "unprognostic (1.23e-1)" 5.4 6.0 8.8 1.9 9.0 2.2 3.6 4.0 8.9 3.9 11.1 8.6 2.5 3.4 4.8 4.8 8.9 4.3 3.9 19.4 9.6 8.7 8.0 5.7 3.5 3.4 11.9 5.5 5.9 2.9 5.5 3.3 2.0 9.6 6.2 3.4 5.6 3.1 9.2 60.9 2.4 3.3 13.9 13.6 2.5 4.6 3.3 7.1 3.7 4.2 15.7 2.9 10.4 6.0 1.4 1.0 0.3 1.4 5.4 2.4 1.0 1.1 1.7 3.3 6.3 8.2 2.5 1.4 3.0 3.5 2.8 3.4 1.5 1.7 20.3 2.5 3.5 3.4 1.8 1.2 1.3 2.5 7.9 1.7 3.3 2.4 2.5 5.0 11.3 2.0 2.1 6.8 1.7 0.6 3.7 2.0 4.8 1.4 5.2 3.5 2.6 7.5 2.4 3.4 3.0 1.7 4.3 3.0 5.9 2.5 1.7 6.1 6.1 5.3 3.2 7.0 3.1 1.8 6.5 4.3 2.8 1.4 2.6 2.3 3.8 3.8 8.2 2.4 2.7 4.4 0.0 0.1 0.1 0.4 1.4 1.1 1.3 1.1 0.9 1.0 1.4 1.2 2.4 0.3 5.4 0.3 0.9 0.2 1.0 8.8 9.0 4.0 8.9 9.6 8.7 11.9 5.5 9.6 7.1 6.0 1.0 3.2 0.8 0.8 7.9 23.5 5.1 2.7 3.4 1.8 5.9 0.7 10.0 0.9 28.2 1.5 0.3 0.0 2.0 0.6 1.2 1.3 2.3 5.8 2.0 28.6 1.2 1.3 1.5 14.1 2.8 3.1 6.8 0.0 1.5 7.5 1.1 1.1 2.1 6.3 6.7 0.0 2.0 1.6 1.3 0.4 0.3 0.0 1.0 0.3 EPN1 ENSG00000063245 "Epsin 1" Q9Y6I3 19 55675226-55709858 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 273.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEK 293: 71.6" "Low region specificity" "Detected in all" "CAB009729, HPA061136, HPA071503" Approved Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "Nucleoplasm, Vesicles" "CAB009729: AB_2277865, HPA061136: AB_2684436, HPA071503: " "unprognostic (6.93e-2)" "unprognostic (2.47e-1)" "unprognostic (5.30e-2)" "unprognostic (1.32e-1)" "unprognostic (7.94e-2)" "unprognostic (8.76e-2)" "unprognostic (1.23e-2)" "unprognostic (7.23e-3)" "unprognostic (1.18e-1)" "unprognostic (1.28e-1)" "unprognostic (6.16e-2)" "unprognostic (4.63e-2)" "unprognostic (1.05e-2)" "unprognostic (3.86e-3)" "unprognostic (1.57e-1)" "unprognostic (2.78e-3)" "unprognostic (7.92e-3)" 26.7 23.4 34.2 20.6 31.4 15.7 31.4 26.3 47.1 13.5 32.7 17.2 18.1 67.7 13.7 19.8 21.3 15.4 28.2 56.0 28.0 18.6 23.1 36.0 16.5 25.5 17.5 25.9 23.2 54.5 12.1 14.3 15.0 15.8 19.3 13.8 13.5 24.8 22.7 84.7 22.2 59.7 12.2 14.3 26.9 55.1 20.2 13.1 11.2 15.3 26.3 14.6 13.1 16.2 2.2 3.6 4.6 6.9 0.7 2.0 2.4 25.0 34.6 8.6 17.7 10.0 9.6 17.8 18.7 10.7 13.3 13.4 14.4 15.9 15.4 12.8 14.9 11.8 19.2 7.5 14.3 4.8 5.3 71.6 11.3 18.5 17.1 13.8 7.2 10.8 12.4 12.6 11.5 8.3 9.6 12.7 11.1 16.8 13.1 8.7 14.1 11.5 11.9 19.8 18.9 49.0 7.8 11.8 27.0 10.1 14.8 12.5 30.4 17.3 18.8 12.3 6.3 14.1 25.4 21.1 37.1 17.9 13.3 26.9 14.4 13.1 11.0 27.3 14.6 18.3 2.4 3.5 4.4 1.4 4.5 1.0 2.2 1.4 1.3 2.4 2.0 1.4 1.3 4.6 0.7 6.9 3.6 2.0 2.4 34.2 31.4 26.3 47.1 28.0 18.6 17.5 25.9 15.8 13.1 3.0 27.3 32.6 23.9 27.8 31.1 12.9 50.9 10.7 7.9 41.8 62.8 40.3 101.2 45.0 50.6 29.6 273.7 0.0 77.2 65.9 30.7 31.5 10.4 95.7 53.6 27.0 43.3 78.0 103.2 121.6 44.0 36.6 21.9 23.4 108.9 27.8 78.4 136.8 49.8 53.1 37.3 12.9 21.7 45.0 57.1 24.0 43.7 21.8 112.6 32.8 EPN3 "FLJ20778, MGC129899" ENSG00000049283 "Epsin 3" Q9H201 17 50532543-50543750 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Collecting duct cells: 17.4;Cytotrophoblasts: 52.4;Mucus-secreting cells: 17.7" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "cerebral cortex: 6.8;pons and medulla: 17.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 12.0;HBEC3-KT: 16.6;MCF7: 26.7;OE19: 25.1;RT4: 20.9;SK-BR-3: 10.8;T-47d: 24.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "cerebellum: 4.7;midbrain: 7.9;pons and medulla: 7.5;thalamus: 10.2" "HPA055546, HPA063224" Approved Supported Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA055546: AB_2682844, HPA063224: AB_2684964" "unprognostic (1.91e-2)" "unprognostic (1.99e-2)" "unprognostic (2.41e-1)" "unprognostic (2.91e-2)" "unprognostic (1.25e-3)" "unprognostic (2.06e-1)" "unprognostic (5.70e-3)" "unprognostic (7.62e-2)" "unprognostic (1.43e-1)" "unprognostic (1.20e-1)" "unprognostic (6.66e-3)" "unprognostic (1.00e-2)" "prognostic favorable (1.53e-5)" "unprognostic (1.45e-1)" "unprognostic (1.16e-1)" "unprognostic (4.90e-1)" "unprognostic (3.52e-3)" 0.4 7.7 0.5 1.9 0.7 0.4 1.9 1.1 6.8 5.3 7.8 1.5 24.0 5.1 0.7 3.8 26.2 6.0 12.6 6.6 0.5 0.7 10.9 0.4 0.7 0.0 2.0 1.4 10.3 18.3 9.6 0.9 8.4 17.8 9.3 3.4 0.3 16.7 18.7 0.4 19.7 5.1 0.5 0.6 0.3 23.8 2.2 0.0 3.4 1.2 15.9 21.9 8.2 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.1 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 6.1 5.2 0.0 0.1 0.0 0.0 12.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 9.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 26.7 0.1 0.0 0.0 25.1 0.2 0.0 0.0 0.0 0.1 20.9 0.2 0.0 0.0 10.8 0.0 0.1 24.1 0.1 0.6 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 1.1 6.8 0.5 0.7 2.0 1.4 17.8 0.0 0.0 0.0 0.0 3.4 2.1 0.3 4.8 7.6 0.0 0.0 17.4 0.0 52.4 5.0 5.6 0.4 0.1 9.3 0.0 10.0 5.6 0.3 4.4 0.0 0.0 5.1 0.0 3.5 0.0 0.0 1.8 2.6 0.0 0.0 1.0 17.7 0.5 5.2 10.5 0.0 0.0 0.3 0.0 0.3 0.0 0.4 4.8 8.9 0.0 16.6 5.8 EPOP "C17orf96, LOC100170841, PRR28" ENSG00000273604 "Elongin BC and polycomb repressive complex 2 associated protein" A6NHQ4 17 38671703-38675421 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.5" "Cell type enhanced" "Detected in some" 17 "Ductal cells: 3.3;Exocrine glandular cells: 3.4;monocytes: 4.6;Pancreatic endocrine cells: 3.5;Syncytiotrophoblasts: 11.0" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.0" "Lineage enriched" "Detected in single" 8 "T-cells: 1.0" "Cell line enhanced" "Detected in many" "AN3-CA: 16.1;Hep G2: 18.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA055190, HPA056555" Enhanced Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA Nucleoplasm "Cytosol, Cytoplasmic bodies" "HPA055190: AB_2682731, HPA056555: AB_2683172" "unprognostic (9.08e-2)" "unprognostic (3.71e-1)" "unprognostic (5.79e-2)" "unprognostic (6.75e-3)" "unprognostic (1.83e-1)" "unprognostic (1.84e-2)" "unprognostic (1.33e-1)" "unprognostic (1.17e-1)" "unprognostic (1.70e-1)" "unprognostic (1.11e-1)" "unprognostic (2.17e-2)" "unprognostic (2.63e-2)" "unprognostic (1.78e-10)" "unprognostic (8.97e-2)" "unprognostic (2.51e-1)" "unprognostic (1.12e-1)" "unprognostic (1.01e-2)" 1.2 2.0 2.5 1.5 5.1 0.4 1.1 0.0 13.5 0.3 0.2 0.0 2.5 0.2 0.7 0.7 0.7 0.4 0.8 0.4 1.1 0.3 3.4 0.4 2.4 0.3 3.2 0.1 3.6 3.0 0.0 1.2 0.4 0.7 0.3 0.2 0.5 1.2 0.1 1.0 0.2 0.5 0.8 0.6 0.5 5.8 0.8 1.7 0.1 1.1 3.2 1.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 2.9 3.5 2.3 16.1 0.5 0.1 3.9 0.6 0.2 0.7 1.1 3.5 1.1 5.6 3.9 0.4 2.0 2.4 7.5 1.5 1.2 5.8 5.7 1.2 0.6 18.4 1.0 0.6 3.0 0.3 2.6 0.7 1.5 1.5 0.5 6.3 3.8 8.7 0.4 4.7 5.0 1.6 0.5 1.9 3.2 12.0 1.3 12.2 0.4 0.7 3.5 5.4 1.9 2.6 0.6 3.9 3.8 2.3 0.8 0.6 0.7 0.7 0.6 4.6 5.0 7.1 1.3 8.3 2.3 0.0 0.0 0.0 0.4 0.1 1.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.8 0.0 1.4 0.0 3.3 0.0 0.0 0.0 0.0 3.4 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 3.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 ERAP1 "A-LAP, ARTS-1, ERAAP1, KIAA0525, PILS-AP" ENSG00000164307 "Endoplasmic reticulum aminopeptidase 1" Q9NZ08 5 96760810-96808100 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025095, HPA042317" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" NA NA 27000000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB025095: , HPA042317: AB_2677946" "unprognostic (2.33e-3)" "unprognostic (3.45e-1)" "unprognostic (1.84e-3)" "unprognostic (1.34e-1)" "unprognostic (1.86e-1)" "unprognostic (4.38e-1)" "unprognostic (1.88e-3)" "unprognostic (5.37e-2)" "unprognostic (1.45e-1)" "unprognostic (7.94e-2)" "unprognostic (4.52e-2)" "unprognostic (3.23e-1)" "unprognostic (7.09e-2)" "unprognostic (1.36e-1)" "unprognostic (3.93e-2)" "unprognostic (1.19e-1)" "unprognostic (5.14e-2)" 23.8 13.6 9.3 22.7 11.9 11.6 23.3 14.2 14.6 14.5 23.8 10.1 11.2 30.8 14.7 13.4 12.3 14.3 19.9 16.1 9.7 6.8 13.3 23.7 17.8 16.4 13.5 7.6 15.5 16.5 11.1 39.4 28.2 11.4 13.4 21.9 8.5 13.9 15.2 23.1 17.7 39.7 10.6 17.1 19.5 16.5 5.4 13.8 55.5 13.5 9.8 17.8 15.9 14.1 14.9 15.2 19.8 17.5 19.8 21.8 10.7 7.4 4.7 6.4 6.0 35.4 34.7 18.6 5.5 17.7 13.3 23.3 5.9 27.0 22.3 11.5 10.6 18.7 7.6 5.3 11.2 8.3 40.2 2.2 7.2 3.2 4.0 40.6 3.4 13.4 14.4 4.9 15.2 4.7 19.6 18.2 14.5 3.7 21.6 7.9 3.5 32.0 3.6 3.2 0.9 3.1 23.8 8.7 11.1 9.9 11.5 2.4 1.6 8.7 5.9 8.5 4.6 5.1 16.6 14.5 11.4 3.9 1.9 9.0 8.1 15.1 17.3 12.2 11.8 6.7 19.8 13.2 15.6 21.2 11.4 19.7 13.0 18.5 18.2 9.5 14.9 21.8 17.4 14.4 19.8 17.5 15.2 12.3 10.7 9.3 11.9 14.2 14.6 9.7 6.8 13.5 7.6 11.4 13.8 8.9 12.3 13.7 12.1 22.1 11.6 8.5 10.2 22.7 14.8 8.7 2.0 8.0 0.0 10.8 20.0 11.3 25.8 0.0 13.4 9.1 16.1 9.2 14.0 27.0 16.2 3.2 9.9 18.4 31.2 5.2 9.2 18.5 6.8 21.6 25.9 9.7 11.2 17.5 15.2 5.0 7.2 0.0 9.5 1.2 0.7 9.7 7.7 20.0 19.1 12.2 ERCC1 RAD10 ENSG00000012061 "ERCC excision repair 1, endonuclease non-catalytic subunit" P07992 19 45407333-45478828 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Endonuclease, Hydrolase, Nuclease" "Cancer-related genes, Cataract" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004390, HPA029773, HPA050182, CAB072859, CAB072860" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004390: AB_2278023, CAB072859: AB_2665703, CAB072860: AB_2665704, HPA029773: AB_10602129, HPA050182: AB_2681044" "unprognostic (1.54e-3)" "unprognostic (5.99e-2)" "unprognostic (1.58e-1)" "unprognostic (1.34e-1)" "unprognostic (1.41e-3)" "unprognostic (1.97e-1)" "prognostic unfavorable (9.69e-4)" "unprognostic (2.57e-1)" "unprognostic (5.80e-2)" "unprognostic (7.37e-2)" "unprognostic (1.93e-2)" "unprognostic (2.75e-2)" "prognostic unfavorable (9.00e-5)" "unprognostic (6.19e-2)" "unprognostic (1.96e-1)" "unprognostic (1.60e-1)" "unprognostic (1.43e-1)" 25.0 28.2 25.9 20.2 27.5 20.8 30.6 28.4 34.8 26.4 21.5 35.4 20.6 20.8 27.4 34.6 28.6 30.9 24.0 63.5 24.7 24.4 22.9 24.2 21.3 26.3 28.3 25.0 37.6 42.9 31.6 32.0 20.3 27.4 29.1 17.1 29.1 53.8 24.4 43.3 43.5 20.4 26.1 23.5 24.3 22.4 21.6 26.7 22.6 28.4 25.7 25.1 22.0 26.0 16.6 69.0 5.3 29.7 12.6 14.2 17.9 13.9 24.1 20.5 29.9 14.1 26.8 6.5 21.0 28.1 25.5 34.0 2.6 13.7 8.3 5.9 22.3 13.6 10.8 6.5 66.9 15.8 18.0 6.6 12.3 9.2 8.2 29.4 12.4 23.2 19.9 14.4 26.6 24.1 22.3 27.7 9.6 7.5 16.6 40.0 9.4 11.7 10.0 4.8 12.7 9.6 17.7 9.6 11.1 18.7 8.9 8.8 18.5 13.3 11.4 18.3 7.1 13.8 23.8 15.9 23.0 22.0 14.0 21.1 12.3 9.9 8.9 26.5 10.7 69.4 4.7 29.2 5.3 14.2 29.7 9.6 16.4 8.7 11.0 29.3 16.6 7.0 11.3 4.0 12.6 21.8 69.0 10.2 17.9 25.9 27.5 28.4 34.8 24.7 24.4 28.3 25.0 27.4 26.7 20.8 37.2 34.7 96.6 63.0 0.0 31.4 35.7 49.5 35.2 19.2 0.0 32.3 76.3 41.3 22.9 40.9 32.2 0.0 57.1 27.9 72.1 73.7 48.5 24.1 86.0 0.0 38.1 33.2 64.8 84.9 73.4 73.4 64.1 25.2 36.0 0.0 64.4 35.1 53.7 53.0 0.0 45.3 61.7 21.5 39.8 46.2 29.7 37.4 38.3 82.3 ERCC2 "EM9, MAG, MGC102762, MGC126218, MGC126219, TFIIH, XPD" ENSG00000104884 "ERCC excision repair 2, TFIIH core complex helicase subunit" P18074 19 45349837-45370918 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Chromosome partition, DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Ichthyosis, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 33.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005375, HPA038057, HPA069266" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB005375: AB_2100152, HPA038057: AB_2675810, HPA069266: AB_2686104" "unprognostic (1.10e-1)" "unprognostic (5.48e-1)" "unprognostic (5.08e-2)" "unprognostic (9.92e-3)" "unprognostic (1.35e-1)" "unprognostic (1.23e-2)" "unprognostic (1.67e-3)" "unprognostic (1.46e-1)" "unprognostic (3.41e-1)" "unprognostic (1.06e-1)" "prognostic favorable (3.26e-4)" "unprognostic (3.36e-2)" "unprognostic (2.44e-3)" "unprognostic (1.94e-1)" "unprognostic (5.47e-1)" "unprognostic (8.99e-2)" "unprognostic (3.45e-2)" 7.4 15.6 11.4 10.6 17.7 6.7 7.1 9.5 23.8 9.4 8.1 11.7 7.8 7.9 11.7 6.0 6.7 10.0 10.1 7.9 9.4 9.1 8.7 13.2 6.5 9.9 8.2 10.5 9.5 13.1 12.9 10.9 7.2 14.0 8.2 6.4 12.5 9.5 11.8 15.9 10.7 7.1 11.2 5.3 9.7 8.3 17.2 7.8 10.8 10.2 5.1 8.3 9.3 6.6 7.8 17.2 5.0 13.9 11.3 9.8 8.7 12.6 6.2 12.9 18.1 7.7 9.1 6.8 18.0 12.4 23.3 17.9 14.3 8.7 4.5 10.3 17.5 8.5 6.5 9.0 15.1 8.9 10.9 14.8 7.7 11.7 15.1 16.3 12.2 13.6 10.5 2.4 26.6 15.1 13.0 13.5 13.0 18.6 5.1 16.0 6.1 7.1 8.1 5.9 11.6 10.9 13.8 9.2 3.8 6.7 11.2 7.5 8.2 16.0 11.3 6.4 10.2 10.7 16.2 17.5 22.3 12.2 9.4 40.0 11.9 6.8 6.5 6.6 7.4 9.8 0.0 13.3 5.0 7.7 13.9 9.8 7.8 7.4 7.4 17.2 5.8 7.1 7.4 0.4 11.3 10.9 8.3 7.4 8.7 11.4 17.7 9.5 23.8 9.4 9.1 8.2 10.5 14.0 7.8 6.0 4.3 3.6 3.9 5.6 0.0 6.0 10.2 6.7 5.7 5.2 0.0 9.4 11.6 7.6 4.1 3.8 2.9 0.0 7.0 10.0 6.8 3.5 0.0 11.5 9.8 0.0 6.9 9.2 7.3 2.2 6.1 4.6 3.3 1.8 7.8 0.0 6.2 3.5 7.4 11.3 0.0 0.0 5.2 33.8 11.0 5.0 4.0 2.9 7.7 3.3 ERCC3 "BTF2, GTF2H, RAD25, TFIIH, XPB" ENSG00000163161 "ERCC excision repair 3, TFIIH core complex helicase subunit" P19447 2 127257290-127294176 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Ichthyosis, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037153, HPA046077" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB037153: AB_796181, HPA046077: AB_2679527" "unprognostic (2.31e-1)" "unprognostic (1.15e-1)" "unprognostic (3.03e-2)" "unprognostic (1.07e-3)" "unprognostic (1.05e-1)" "unprognostic (8.85e-2)" "prognostic unfavorable (1.62e-7)" "unprognostic (2.74e-1)" "unprognostic (9.13e-3)" "unprognostic (9.25e-2)" "unprognostic (1.25e-1)" "unprognostic (2.46e-2)" "prognostic unfavorable (4.30e-6)" "unprognostic (3.71e-1)" "unprognostic (8.50e-2)" "unprognostic (5.73e-2)" "unprognostic (3.92e-2)" 17.4 20.0 26.1 23.8 28.9 20.5 21.0 35.9 32.0 22.1 19.4 19.7 17.1 11.5 21.6 15.7 19.1 23.6 20.4 20.4 23.2 18.8 17.5 17.4 19.4 23.1 19.7 25.8 23.3 22.4 32.0 26.4 16.3 21.5 20.1 17.1 18.3 18.0 21.8 30.1 19.7 17.3 26.1 16.0 24.5 17.4 39.5 20.1 24.1 19.3 15.8 25.9 22.4 20.8 11.8 13.9 7.2 9.7 18.8 16.2 11.7 22.2 15.3 19.0 20.1 21.1 14.5 23.5 20.5 26.6 33.2 32.2 23.4 16.3 16.9 17.0 18.7 21.5 20.0 28.9 21.6 28.9 26.4 25.9 21.2 18.7 24.6 15.7 18.4 23.1 15.0 20.3 38.3 16.4 21.2 21.3 22.2 20.6 11.1 20.9 22.0 26.2 19.8 27.6 14.5 23.9 21.6 21.8 14.0 18.5 20.8 23.0 24.8 17.5 26.7 26.8 22.7 14.4 21.1 16.9 20.0 22.9 18.1 24.3 19.9 38.8 26.5 17.7 8.9 21.3 6.6 9.5 7.2 16.0 9.7 16.2 11.5 11.8 13.5 13.9 11.8 15.8 10.9 3.1 18.8 7.9 11.3 16.1 11.7 26.1 28.9 35.9 32.0 23.2 18.8 19.7 25.8 21.5 20.1 20.8 13.4 8.2 8.1 6.8 0.0 10.5 5.1 32.1 22.7 7.0 0.0 15.9 1.7 12.0 3.5 14.3 4.9 0.0 13.1 10.3 12.0 6.2 9.3 7.8 12.5 0.0 5.8 12.3 12.6 3.1 15.3 9.2 8.5 12.6 8.2 0.0 12.9 5.8 12.0 7.0 0.0 12.9 8.5 34.7 27.5 8.3 12.2 13.8 9.9 5.6 ERCC4 "FANCQ, RAD1, XPF" ENSG00000175595 "ERCC excision repair 4, endonuclease catalytic subunit" Q92889 16 13920157-13952345 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Endonuclease, Hydrolase, Nuclease" "Cancer-related genes, Cockayne syndrome, Disease mutation, Dwarfism, Fanconi anemia, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 121.2;Late spermatids: 71.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000156, HPA045828" Approved Supported "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Nucleoplasm, Nuclear bodies" "Plasma membrane" "CAB000156: , HPA045828: AB_2679463" "unprognostic (2.05e-1)" "unprognostic (1.52e-1)" "unprognostic (2.12e-3)" "unprognostic (9.41e-2)" "unprognostic (3.35e-1)" "unprognostic (1.40e-2)" "unprognostic (1.64e-2)" "unprognostic (2.26e-1)" "unprognostic (3.59e-1)" "unprognostic (1.56e-1)" "unprognostic (1.18e-1)" "unprognostic (8.49e-2)" "unprognostic (5.26e-2)" "unprognostic (1.67e-1)" "unprognostic (1.15e-1)" "unprognostic (6.30e-2)" "unprognostic (5.88e-4)" 8.4 12.7 8.6 7.0 11.3 5.3 6.4 8.9 9.7 8.1 6.7 9.9 6.0 4.1 8.5 6.8 6.7 8.5 6.8 7.8 7.2 7.1 6.9 7.2 6.9 6.8 10.5 8.8 9.9 7.6 13.3 13.0 5.9 9.6 8.3 5.4 7.1 6.4 7.0 31.3 6.9 5.7 8.5 10.3 7.7 6.6 14.2 8.9 13.7 9.7 5.6 6.4 9.1 7.8 8.4 7.9 8.3 6.8 8.9 7.4 2.6 5.4 7.0 6.4 9.2 10.7 10.1 5.0 7.2 7.7 6.5 8.3 2.4 5.4 9.1 10.4 6.3 5.7 6.9 9.5 4.9 10.1 12.3 5.6 4.5 7.8 6.0 9.8 6.1 5.1 7.6 6.9 8.6 7.3 6.3 8.6 5.5 7.0 10.7 9.1 4.5 8.0 4.1 4.7 2.8 3.7 9.2 13.0 11.2 4.0 3.7 5.3 6.3 8.8 7.2 6.7 5.4 9.1 4.6 9.7 9.6 7.1 8.6 6.3 9.5 11.2 6.3 9.2 7.3 9.8 8.3 6.2 5.4 6.8 6.8 7.4 6.2 6.4 5.1 5.5 8.4 6.4 6.9 7.2 8.9 5.7 7.9 5.8 2.6 8.6 11.3 8.9 9.7 7.2 7.1 10.5 8.8 9.6 8.9 17.9 15.7 9.7 6.8 4.2 0.0 7.9 12.7 18.7 5.7 5.2 0.0 13.6 8.3 10.4 121.2 9.5 2.8 0.0 7.3 5.9 9.9 7.6 1.1 15.7 10.5 0.0 9.2 16.0 11.3 71.5 13.8 10.6 10.1 11.8 5.3 0.0 8.2 0.0 19.8 9.3 0.0 25.8 5.9 46.6 16.7 4.8 10.3 16.0 6.1 4.0 ERCC5 "ERCM2, XPGC" ENSG00000134899 "ERCC excision repair 5, endonuclease" P28715 13 102807146-102876001 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Endonuclease, Hydrolase, Nuclease" "Cancer-related genes, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 44.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045845, HPA050126, HPA050374" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA045845: AB_2679471, HPA050126: AB_2681027, HPA050374: AB_2681106" "unprognostic (1.28e-3)" "unprognostic (1.32e-3)" "unprognostic (1.86e-2)" "unprognostic (9.28e-3)" "unprognostic (6.19e-2)" "unprognostic (8.73e-2)" "unprognostic (1.23e-1)" "unprognostic (8.72e-2)" "unprognostic (2.52e-1)" "unprognostic (2.55e-1)" "unprognostic (7.77e-3)" "unprognostic (5.76e-3)" "prognostic unfavorable (2.96e-6)" "unprognostic (3.56e-2)" "unprognostic (1.56e-1)" "unprognostic (1.67e-1)" "prognostic favorable (6.82e-4)" 22.3 19.1 15.9 16.1 17.8 23.7 20.1 26.4 20.8 19.7 27.0 17.9 27.0 25.0 22.1 25.7 21.0 15.1 21.1 15.4 14.6 13.1 18.7 28.1 19.9 26.4 17.1 16.2 22.9 22.3 15.7 25.6 17.9 19.0 20.1 23.1 15.9 20.5 24.7 14.6 25.8 31.1 17.0 19.4 30.6 21.9 14.0 17.8 40.8 21.8 16.6 26.0 22.4 19.6 10.1 10.8 23.4 17.4 17.7 17.5 12.0 14.8 5.4 10.8 6.8 21.7 20.4 6.6 15.1 20.0 8.7 11.4 8.3 20.8 9.3 7.6 15.2 6.1 15.5 9.6 13.8 9.1 14.1 5.4 13.9 15.7 7.2 10.6 28.3 18.2 19.4 13.3 10.1 15.7 13.8 15.2 19.7 6.5 8.5 15.3 4.0 15.2 19.6 4.7 17.9 7.6 8.3 8.1 9.4 18.0 8.3 7.3 10.8 7.9 13.3 8.0 8.7 11.9 26.4 15.3 6.8 3.4 5.7 9.4 12.5 3.8 4.7 26.4 11.5 8.4 23.4 9.8 18.3 16.7 12.3 15.5 9.6 15.5 17.5 10.8 10.1 16.6 16.1 7.2 17.7 17.4 7.7 16.6 12.0 15.9 17.8 26.4 20.8 14.6 13.1 17.1 16.2 19.0 17.8 3.0 7.4 14.6 5.7 6.4 0.0 25.5 7.6 6.7 13.6 0.0 0.0 7.7 0.0 1.0 44.4 9.0 18.4 0.0 1.1 6.6 8.2 3.7 18.5 17.1 9.3 0.0 4.7 10.4 14.3 23.3 20.4 9.9 6.8 1.0 19.0 0.0 1.4 16.4 14.9 1.2 0.0 19.4 6.1 10.6 6.4 6.0 4.8 25.4 16.6 4.3 ERCC6 "ARMD5, CKN2, CSB, RAD26" ENSG00000225830 "ERCC excision repair 6, chromatin remodeling factor" "Q03468, P0DP91, Q8N328" 10 49455368-49539538 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Neurogenesis, Transcription, Transcription regulation" "DNA-binding, Helicase, Hydrolase" "Age-related macular degeneration, Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Mental retardation, Premature ovarian failure, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 25.1;hTERT-RPE1: 57.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071297 Approved "Nucleoplasm,Nuclear bodies" Yes No Nucleoplasm "Nuclear bodies" "HPA071297: AB_2732177" "unprognostic (1.92e-2)" "unprognostic (1.85e-1)" "unprognostic (9.79e-3)" "unprognostic (7.26e-2)" "unprognostic (5.45e-2)" "unprognostic (2.95e-2)" "unprognostic (3.03e-2)" "unprognostic (2.99e-2)" "unprognostic (1.71e-2)" "unprognostic (1.13e-1)" "unprognostic (1.80e-1)" "unprognostic (4.57e-2)" "unprognostic (1.04e-1)" "unprognostic (8.61e-2)" "unprognostic (4.75e-2)" "unprognostic (1.73e-1)" "unprognostic (7.05e-2)" 7.9 6.9 11.5 6.0 12.3 13.9 11.1 21.0 13.9 9.8 7.0 8.9 10.6 6.4 9.3 8.6 13.5 8.1 7.7 9.1 12.7 6.5 10.1 10.0 8.0 7.9 9.2 11.4 12.5 13.1 20.3 14.2 9.7 10.1 10.5 8.8 9.2 10.5 13.7 9.6 14.4 9.1 7.9 11.8 9.2 7.6 7.8 12.4 7.8 13.6 8.2 9.6 9.9 11.6 7.9 5.1 10.9 8.1 1.6 5.3 2.1 4.8 2.5 1.9 1.2 3.3 5.5 1.5 8.7 12.1 6.0 4.2 2.6 3.0 2.1 1.6 7.8 2.9 4.6 2.7 6.9 6.1 3.4 1.7 1.6 9.6 1.4 1.9 2.2 1.7 1.9 9.4 5.8 25.1 57.2 8.7 1.5 3.2 0.6 7.7 3.5 1.5 1.3 1.7 1.9 4.5 1.4 2.8 1.2 2.0 3.5 2.5 2.7 6.4 2.3 3.9 4.4 4.2 1.2 16.7 3.3 2.7 4.0 2.2 2.3 2.2 2.0 4.1 2.4 2.4 10.9 4.1 9.7 5.3 3.7 4.2 7.9 3.1 2.9 5.1 6.3 3.8 1.8 9.8 1.6 8.1 2.8 4.0 2.1 11.5 12.3 21.0 13.9 12.7 6.5 9.2 11.4 10.1 12.4 14.9 10.4 2.4 1.3 3.2 0.0 4.9 7.6 13.4 12.5 8.7 0.0 1.9 5.0 4.6 8.2 2.0 3.8 0.0 5.3 1.5 3.5 2.3 7.0 4.0 2.3 0.0 1.2 3.7 3.8 10.6 2.6 3.9 1.7 14.4 4.5 0.0 4.8 3.5 2.1 2.8 0.0 6.5 1.9 5.4 4.2 3.6 1.5 5.0 2.4 1.6 ERCC6L "FLJ20105, PICH, RAD26L" ENSG00000186871 "ERCC excision repair 6 like, spindle assembly checkpoint helicase" Q2NKX8 X 72204657-72239047 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 13.1" "Cell type enhanced" "Detected in some" 11 "Cholangiocytes: 2.5;Extravillous trophoblasts: 1.5;Spermatocytes: 1.7;Spermatogonia: 2.0" "Cancer enhanced" "Detected in many" "testis cancer: 11.0" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "NK-cell: 5.3" "Lineage enriched" "Detected in many" 5 "NK-cells: 5.3" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA050492 Approved Uncertain Nucleoplasm,Centrosome,Cytosol No No Centrosome "Nucleoplasm, Cytosol" "HPA050492: AB_2681145" "prognostic unfavorable (1.80e-4)" "unprognostic (2.93e-1)" "unprognostic (1.95e-2)" "unprognostic (5.76e-3)" "unprognostic (2.43e-1)" "unprognostic (2.36e-1)" "unprognostic (9.23e-6)" "unprognostic (8.63e-3)" "unprognostic (1.57e-2)" "unprognostic (1.99e-2)" "unprognostic (3.68e-5)" "unprognostic (4.61e-2)" "unprognostic (0.00e+0)" "unprognostic (2.97e-3)" "unprognostic (9.56e-2)" "unprognostic (1.17e-1)" "unprognostic (6.41e-2)" 0.4 0.5 0.2 3.1 0.2 6.0 3.0 0.9 0.8 1.5 2.2 0.2 0.2 1.5 0.9 0.8 4.6 0.6 1.0 0.2 0.2 0.3 0.5 0.5 0.8 4.7 0.7 0.2 1.2 0.5 0.0 0.6 0.9 0.9 0.7 2.5 0.2 1.1 0.2 2.6 1.3 2.1 0.5 1.3 4.0 1.5 2.0 0.2 13.1 0.5 2.8 5.6 0.7 1.6 0.5 0.3 0.5 0.2 5.3 1.1 0.4 11.0 9.7 8.9 5.6 0.6 1.1 4.9 11.9 5.5 10.4 11.0 7.9 6.9 17.9 4.5 4.2 14.1 9.2 16.8 8.8 18.6 10.2 12.2 6.2 3.4 4.6 0.0 12.0 8.7 0.1 0.5 14.5 2.7 1.7 5.8 9.1 8.1 4.4 10.6 8.7 11.4 7.0 16.2 10.8 15.0 9.6 16.0 3.2 2.6 6.9 7.4 5.3 8.8 5.9 2.2 7.6 4.5 2.7 3.5 7.1 11.4 13.3 7.7 3.5 5.3 15.5 5.0 8.3 7.0 0.0 0.2 0.5 0.1 0.1 0.6 0.2 0.5 0.1 0.1 0.5 0.4 1.1 0.3 5.3 0.2 0.3 1.1 0.4 0.2 0.2 0.9 0.8 0.2 0.3 0.7 0.2 0.9 0.2 0.0 0.0 0.8 0.2 0.2 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.0 0.1 0.3 0.0 0.1 0.1 ERCC6L2 "C9orf102, FLJ37706, RAD26L" ENSG00000182150 "ERCC excision repair 6 like 2" Q5T890 9 95875701-96014571 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021260, HPA022422" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA021260: AB_1859544, HPA022422: " "unprognostic (6.70e-2)" "unprognostic (2.40e-1)" "unprognostic (2.68e-1)" "unprognostic (1.28e-1)" "unprognostic (8.30e-2)" "unprognostic (3.62e-2)" "unprognostic (4.64e-2)" "unprognostic (3.92e-1)" "unprognostic (9.21e-2)" "unprognostic (3.21e-2)" "unprognostic (5.09e-2)" "unprognostic (1.32e-1)" "prognostic favorable (8.70e-5)" "unprognostic (3.63e-1)" "unprognostic (2.32e-1)" "unprognostic (1.07e-1)" "unprognostic (7.39e-2)" 13.5 13.9 14.6 12.7 17.4 7.6 13.6 21.8 19.3 17.7 12.9 13.2 13.9 10.4 18.7 11.8 11.6 11.4 11.8 13.3 14.0 9.7 12.4 11.7 12.7 15.0 15.3 12.2 21.7 10.6 26.2 22.0 11.7 16.1 15.5 11.5 11.0 11.2 12.7 13.9 10.1 13.5 16.1 12.1 15.8 13.4 12.5 15.4 29.7 20.3 7.1 12.4 17.4 13.8 7.3 12.7 4.3 5.3 5.1 12.9 4.0 11.4 14.6 17.3 12.4 6.8 11.6 8.3 10.2 10.4 10.4 11.9 11.2 5.1 13.0 5.7 14.6 14.9 14.3 16.6 7.1 15.4 9.3 8.0 11.7 11.1 7.2 6.6 14.9 11.6 10.3 7.3 12.8 10.2 9.6 9.7 13.4 15.1 7.3 10.7 9.2 12.4 5.6 12.9 12.3 8.8 11.6 22.5 4.6 8.8 10.5 16.2 12.4 7.2 7.6 7.3 9.4 7.1 7.7 10.2 11.7 14.9 14.4 12.0 4.9 7.4 6.2 11.3 7.1 16.9 3.2 4.4 4.3 8.7 5.3 8.4 5.7 8.3 9.3 4.8 7.3 12.9 9.4 2.7 5.1 4.2 12.7 9.9 4.0 14.6 17.4 21.8 19.3 14.0 9.7 15.3 12.2 16.1 15.4 14.9 15.2 4.7 11.1 4.4 0.0 15.9 7.6 21.4 18.2 0.0 0.0 4.5 0.0 7.6 6.2 7.2 5.9 23.3 7.0 2.8 7.5 8.6 15.0 6.0 5.5 0.0 4.7 8.0 9.1 3.0 24.7 10.6 3.3 8.2 7.1 0.0 6.3 3.5 26.2 2.8 0.0 19.4 10.3 15.2 9.6 3.9 4.0 12.8 5.6 7.5 ERF "PE-2, PE2" ENSG00000105722 "ETS2 repressor factor" P50548 19 42247572-42255157 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 139.4;Suprabasal keratinocytes: 95.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058532, HPA067952" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA058532: AB_2683744, HPA067952: AB_2685932" "prognostic favorable (8.07e-4)" "unprognostic (2.86e-1)" "unprognostic (1.47e-2)" "unprognostic (9.07e-2)" "unprognostic (5.21e-2)" "unprognostic (6.66e-2)" "unprognostic (2.21e-1)" "unprognostic (7.27e-3)" "unprognostic (3.61e-2)" "unprognostic (2.20e-1)" "unprognostic (8.63e-3)" "unprognostic (3.24e-1)" "unprognostic (6.41e-2)" "unprognostic (1.63e-1)" "unprognostic (2.85e-1)" "unprognostic (1.91e-2)" "unprognostic (1.54e-2)" 29.0 18.1 17.8 17.5 22.0 11.2 20.4 8.3 29.6 27.0 23.5 48.3 14.9 28.4 29.8 15.5 18.4 34.6 42.1 21.5 17.6 12.0 20.2 27.2 22.8 15.2 26.7 13.7 41.0 24.1 14.1 25.0 15.5 22.7 21.0 8.8 23.7 15.2 15.7 10.1 23.3 28.1 17.4 17.7 19.0 17.5 20.8 25.2 18.0 22.9 18.4 16.2 25.0 18.1 0.6 1.0 3.1 0.2 0.0 0.5 0.1 18.4 44.9 19.4 21.8 4.3 11.2 5.4 17.5 12.5 18.1 18.4 20.3 21.6 15.3 11.1 16.1 16.2 20.3 14.0 40.9 13.3 7.5 9.6 9.2 25.2 25.8 11.8 10.6 15.3 12.6 13.9 13.9 15.4 23.6 15.0 12.5 19.5 12.8 9.8 37.4 12.0 8.0 16.2 17.6 9.7 15.0 7.0 6.4 11.1 16.0 8.9 18.3 19.6 14.5 20.2 13.8 14.5 19.1 17.8 26.7 38.5 9.2 32.2 14.6 16.3 12.2 26.0 11.4 36.0 0.0 0.2 1.7 0.2 0.1 0.2 0.0 0.1 0.1 1.0 0.6 0.3 0.3 3.1 0.0 0.0 0.1 0.5 0.1 17.8 22.0 8.3 29.6 17.6 12.0 26.7 13.7 22.7 25.2 3.0 1.7 8.3 24.0 139.4 14.4 6.5 25.5 1.4 1.2 8.7 21.6 6.2 6.6 16.4 8.0 29.2 22.0 0.0 13.8 4.2 11.4 20.6 11.5 25.3 10.2 9.5 25.3 41.7 13.2 3.1 10.3 15.5 52.3 2.8 21.1 23.4 12.4 25.8 9.6 19.2 11.9 12.9 30.3 2.6 15.6 95.9 12.4 14.9 19.1 12.2 ERG "erg-3, p55" ENSG00000157554 "ERG, ETS transcription factor" P11308 21 38380027-38661780 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Endothelial cells: 84.3;granulocytes: 22.1;Ito cells: 63.3" "Cancer enhanced" "Detected in all" "prostate cancer: 18.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "myeloid DC: 1.7;NK-cell: 1.0" "Group enriched" "Detected in many" 5 "dendritic cells: 1.7;NK-cells: 1.0" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 43.7;MOLT-4: 14.3;REH: 46.4;TIME: 35.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB018377, HPA046598" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB018377: AB_675518, HPA046598: AB_2679715" "unprognostic (2.14e-1)" "prognostic unfavorable (6.18e-6)" "unprognostic (6.44e-3)" "unprognostic (8.64e-3)" "unprognostic (5.65e-2)" "unprognostic (1.91e-1)" "unprognostic (9.03e-4)" "unprognostic (4.30e-2)" "unprognostic (2.63e-2)" "unprognostic (1.29e-1)" "unprognostic (3.42e-2)" "unprognostic (2.89e-1)" "prognostic unfavorable (3.94e-4)" "unprognostic (4.31e-3)" "unprognostic (3.88e-2)" "unprognostic (2.64e-2)" "unprognostic (5.63e-3)" 39.1 4.2 5.7 6.5 8.5 6.6 20.5 3.6 7.0 17.9 5.2 2.3 5.6 3.3 16.9 9.0 6.2 9.2 11.6 10.1 6.2 3.6 10.8 6.0 19.9 7.4 8.0 1.8 7.7 4.8 2.3 3.9 23.2 8.0 8.1 3.6 7.8 4.2 5.6 13.5 5.3 6.2 11.8 4.7 32.5 5.0 4.8 5.0 2.4 10.8 9.1 3.6 9.6 15.8 0.0 1.7 0.0 0.2 1.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 7.1 0.0 0.0 0.3 0.0 0.0 43.7 0.0 0.0 0.0 0.0 0.3 14.3 0.0 0.1 0.0 0.0 46.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 35.4 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 5.7 8.5 3.6 7.0 6.2 3.6 8.0 1.8 8.0 5.0 0.0 4.6 1.9 1.5 3.1 0.0 2.5 7.6 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.5 84.3 0.0 0.0 0.0 0.0 2.1 0.4 22.1 0.8 0.2 0.0 0.0 63.3 9.8 1.5 0.9 1.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.9 3.0 0.0 0.0 0.0 0.6 ERG28 "C14orf1, NET51" ENSG00000133935 "Ergosterol biosynthesis 28 homolog" Q9UKR5 14 75649791-75661189 "Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 130.3;Ductal cells: 84.3;Exocrine glandular cells: 97.0;Extravillous trophoblasts: 121.7;Syncytiotrophoblasts: 97.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043172, HPA063568" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043172: AB_10793942, HPA063568: AB_2685043" "unprognostic (2.68e-3)" "unprognostic (2.11e-2)" "unprognostic (4.55e-1)" "unprognostic (2.05e-1)" "unprognostic (1.75e-1)" "unprognostic (1.34e-3)" "unprognostic (6.25e-2)" "unprognostic (7.66e-2)" "unprognostic (4.64e-1)" "unprognostic (2.66e-2)" "unprognostic (2.47e-1)" "unprognostic (3.01e-2)" "prognostic favorable (4.30e-5)" "unprognostic (1.28e-1)" "unprognostic (2.77e-1)" "unprognostic (9.58e-3)" "unprognostic (2.20e-1)" 6.4 20.0 14.2 6.3 16.3 8.1 12.6 9.2 25.5 11.8 11.7 16.3 10.5 14.9 11.3 29.6 23.7 12.4 11.8 9.4 13.6 15.5 17.6 48.3 19.3 9.4 11.9 10.4 15.0 12.4 16.5 13.2 15.6 17.9 15.5 11.2 26.2 15.4 10.6 6.6 15.6 16.9 10.5 18.2 7.1 9.5 52.2 9.6 7.5 24.3 21.3 15.6 9.2 13.5 18.1 18.2 11.8 6.0 14.2 22.0 13.9 14.2 8.0 16.3 12.6 11.0 20.6 10.1 5.8 18.0 11.3 19.5 12.3 34.1 6.0 8.5 7.2 22.7 15.8 14.3 24.8 13.0 11.3 9.5 6.5 8.2 17.4 16.1 7.1 9.8 25.7 21.4 16.2 9.1 9.1 13.1 16.7 5.8 14.8 7.8 28.0 10.8 7.9 15.8 22.8 13.0 8.7 11.0 12.0 37.1 18.5 14.0 7.8 14.7 12.6 8.7 15.0 21.0 10.6 9.4 6.2 12.5 5.9 5.8 9.7 11.3 13.1 9.9 10.5 10.4 11.8 6.0 8.9 20.1 5.9 19.8 18.1 22.0 20.9 14.2 15.3 20.2 20.1 3.2 14.2 5.9 18.2 19.4 13.9 14.2 16.3 9.2 25.5 13.6 15.5 11.9 10.4 17.9 9.6 20.8 41.5 0.0 0.0 0.0 0.0 0.0 0.0 33.5 20.5 57.6 0.0 130.3 41.4 84.3 0.0 0.0 0.0 0.0 97.0 121.7 0.0 0.0 4.7 0.0 53.6 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 65.9 0.0 0.0 61.2 0.0 0.0 38.9 0.0 0.0 0.0 0.0 0.0 0.0 97.3 0.0 0.0 0.0 ERGIC1 "ERGIC-32, ERGIC32, KIAA1181, NET24" ENSG00000113719 "Endoplasmic reticulum-golgi intermediate compartment 1" Q969X5 5 172834275-172952685 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 213.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018666, HPA018900" Enhanced Enhanced Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA018666: AB_1848241, HPA018900: AB_1848242" "unprognostic (8.86e-2)" "unprognostic (3.50e-2)" "unprognostic (3.44e-2)" "unprognostic (5.71e-2)" "unprognostic (7.96e-2)" "unprognostic (2.46e-2)" "unprognostic (9.53e-3)" "unprognostic (7.02e-3)" "unprognostic (2.06e-1)" "unprognostic (6.25e-2)" "unprognostic (1.77e-2)" "unprognostic (1.77e-1)" "unprognostic (1.74e-2)" "unprognostic (1.67e-1)" "unprognostic (3.86e-2)" "unprognostic (9.28e-2)" "unprognostic (3.22e-2)" 30.2 56.5 14.2 20.6 13.8 12.0 44.6 25.5 18.1 42.9 30.5 12.3 35.6 24.6 26.4 24.9 22.6 23.7 30.3 20.7 14.2 11.4 36.4 120.8 28.6 29.3 14.5 11.4 22.5 55.5 15.6 18.9 25.5 13.5 48.1 32.9 19.2 51.5 29.3 27.1 16.7 32.6 22.0 10.8 30.8 36.5 15.8 13.2 29.1 41.5 20.9 25.8 21.3 45.8 6.6 4.2 20.8 9.2 8.5 3.8 3.0 20.6 19.8 17.0 37.8 65.2 48.8 9.4 42.2 32.0 19.0 17.8 28.1 21.3 19.9 30.2 71.1 32.8 7.6 12.4 56.0 22.4 15.8 12.3 12.3 29.1 15.0 47.8 5.7 3.9 41.3 23.4 28.0 26.3 31.5 30.5 20.9 7.3 28.0 31.5 25.9 16.3 9.8 10.1 49.3 18.3 56.3 11.3 61.2 44.5 12.0 9.6 17.3 14.7 42.0 21.1 17.2 17.5 6.5 23.2 31.1 12.7 29.8 17.1 44.5 49.7 8.3 43.3 13.7 13.6 2.1 4.9 12.1 2.3 7.1 3.8 6.6 1.2 1.5 4.2 4.9 1.0 1.6 20.8 8.5 9.2 2.1 0.7 3.0 14.2 13.8 25.5 18.1 14.2 11.4 14.5 11.4 13.5 13.2 53.6 29.3 64.1 27.9 20.3 36.1 28.5 68.8 20.1 17.0 47.1 15.7 17.7 18.3 91.9 9.5 25.1 68.5 0.0 52.8 71.8 28.5 108.1 23.1 213.3 39.2 20.6 25.0 42.4 73.2 21.3 60.1 52.3 6.8 111.0 176.8 39.2 69.9 52.6 54.8 35.9 11.1 38.8 23.7 1.4 8.9 23.5 7.6 26.1 58.7 42.7 ERH DROER ENSG00000100632 "ERH, mRNA splicing and mitosis factor" P84090 14 69380123-69398627 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002567 Approved Approved Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA002567: AB_1078749" "unprognostic (2.42e-2)" "unprognostic (1.69e-1)" "unprognostic (3.42e-1)" "unprognostic (4.78e-2)" "unprognostic (9.34e-2)" "unprognostic (8.61e-3)" "prognostic unfavorable (7.89e-5)" "unprognostic (1.93e-1)" "unprognostic (1.06e-1)" "unprognostic (8.83e-3)" "unprognostic (2.31e-1)" "unprognostic (9.24e-2)" "unprognostic (2.49e-1)" "unprognostic (1.12e-1)" "unprognostic (9.32e-2)" "unprognostic (4.31e-2)" "unprognostic (2.39e-1)" 42.6 45.4 54.9 43.9 46.7 47.0 51.3 45.1 48.4 46.6 43.5 31.1 39.4 42.1 53.3 63.3 44.8 46.4 35.9 40.6 47.6 51.1 56.1 62.2 34.5 52.5 43.5 48.5 47.8 38.7 23.9 45.5 55.2 45.4 40.4 50.3 41.3 58.5 40.3 43.3 31.0 47.3 46.9 43.6 55.2 35.6 54.6 28.4 72.2 55.2 37.5 64.4 47.7 36.8 38.7 37.3 24.2 32.4 34.1 35.3 38.8 90.9 59.0 59.1 39.4 29.7 21.9 35.8 47.7 27.5 43.1 40.4 60.1 37.8 86.3 21.0 31.9 32.9 26.7 59.8 39.6 51.3 45.0 36.5 43.3 39.2 67.1 45.8 37.6 31.5 24.9 21.3 38.5 34.6 24.5 35.2 56.0 41.7 29.0 35.2 104.0 56.8 53.6 46.1 48.2 56.0 46.1 58.6 29.5 43.4 62.2 45.5 42.4 45.5 41.7 26.1 35.0 51.3 52.7 37.6 42.2 62.5 28.0 47.4 32.6 30.9 96.5 31.3 40.0 40.7 15.3 32.4 24.2 26.1 30.1 25.7 38.7 32.5 28.6 34.0 30.6 30.7 27.2 15.4 34.1 27.1 37.3 35.3 38.8 54.9 46.7 45.1 48.4 47.6 51.1 43.5 48.5 45.4 28.4 56.6 48.3 181.6 193.1 242.6 132.5 105.5 158.0 116.4 66.0 240.8 35.3 400.5 570.3 308.1 69.0 200.3 146.7 93.5 240.5 449.3 263.5 196.9 126.7 237.4 297.7 69.9 181.0 155.9 148.1 29.8 250.8 172.7 291.8 355.3 176.1 207.1 246.0 166.8 243.6 389.2 92.5 187.5 273.0 273.2 229.3 278.7 234.1 150.3 215.6 194.6 ERI2 "EXOD1, KIAA1504, MGC16943, ZGRF5" ENSG00000196678 "ERI1 exoribonuclease family member 2" A8K979 16 20780193-20900349 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 46.7;Spermatocytes: 36.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "basophil: 11.8" "Lineage enriched" "Detected in many" 4 "granulocytes: 11.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035384, HPA035385" Uncertain Supported "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA035384: AB_10602316, HPA035385: AB_2674600" "unprognostic (1.25e-1)" "unprognostic (1.47e-1)" "unprognostic (2.01e-3)" "unprognostic (4.36e-2)" "unprognostic (8.64e-2)" "unprognostic (2.78e-1)" "unprognostic (1.49e-1)" "unprognostic (1.55e-1)" "unprognostic (5.99e-2)" "unprognostic (3.04e-2)" "unprognostic (2.07e-2)" "unprognostic (1.08e-1)" "unprognostic (2.56e-2)" "unprognostic (1.54e-1)" "unprognostic (2.45e-1)" "unprognostic (1.05e-2)" "unprognostic (9.28e-3)" 18.5 14.3 9.2 7.5 10.4 8.5 15.0 7.8 11.9 8.3 11.2 12.0 9.3 12.2 8.2 12.1 12.4 9.1 8.9 8.4 9.0 7.9 12.7 19.4 8.2 5.3 11.7 7.4 9.9 14.4 19.2 14.9 10.1 11.1 12.0 15.7 8.1 10.3 11.0 7.0 10.7 12.1 11.8 12.2 6.4 12.7 21.3 9.7 10.8 9.7 12.1 6.6 9.6 15.1 0.6 2.4 11.8 2.9 0.7 0.9 0.6 10.8 5.2 14.3 6.2 4.4 5.6 8.6 8.5 5.1 7.8 9.9 6.5 11.3 3.0 9.9 4.7 5.4 8.2 14.2 8.9 14.6 9.6 7.5 7.4 6.1 11.2 4.0 14.1 6.2 5.1 11.1 10.5 8.8 4.2 4.7 0.0 23.3 9.0 13.1 9.6 2.0 12.6 8.8 11.3 2.9 16.2 11.7 6.7 7.2 8.5 7.3 8.9 5.5 10.6 6.5 7.9 22.2 15.7 3.5 8.4 4.7 8.0 11.4 5.5 8.3 1.8 7.9 11.5 11.5 11.8 2.3 2.0 0.6 1.7 0.4 0.6 0.5 0.6 2.4 0.1 0.4 0.3 0.1 0.7 2.9 0.8 0.9 0.6 9.2 10.4 7.8 11.9 9.0 7.9 11.7 7.4 11.1 9.7 14.9 4.1 0.0 5.0 4.4 4.5 6.4 5.1 14.7 9.1 8.7 0.0 6.2 8.3 3.5 14.0 2.9 5.1 46.7 4.5 7.5 3.3 4.6 0.0 9.6 7.2 3.2 0.0 2.5 6.1 11.4 5.8 4.1 1.7 6.4 9.6 4.7 4.5 7.8 4.9 5.7 3.1 0.0 3.3 36.3 22.0 3.1 3.1 2.2 7.6 4.3 ERI3 "FLJ22943, PINT1, PRNPIP" ENSG00000117419 "ERI1 exoribonuclease family member 3" O43414 1 44221070-44355260 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Late spermatids: 823.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027147, HPA029895" Approved Approved Nucleoplasm,Cytosol Yes No "Nucleoplasm, Cytosol" "HPA027147: AB_1855725, HPA029895: AB_2673239" "unprognostic (1.31e-1)" "unprognostic (2.39e-2)" "unprognostic (3.26e-1)" "prognostic unfavorable (1.18e-4)" "unprognostic (5.94e-2)" "unprognostic (6.21e-2)" "prognostic unfavorable (2.04e-6)" "unprognostic (6.48e-2)" "unprognostic (2.67e-1)" "unprognostic (6.70e-3)" "unprognostic (5.30e-2)" "unprognostic (2.49e-1)" "unprognostic (1.49e-2)" "unprognostic (2.07e-1)" "unprognostic (7.47e-2)" "unprognostic (1.08e-1)" "unprognostic (2.07e-3)" 12.6 15.4 30.7 8.3 32.0 12.4 15.2 19.7 43.7 15.1 13.4 23.2 10.8 12.3 14.7 22.2 13.4 23.4 12.7 21.1 28.9 25.1 25.3 15.5 11.7 10.0 23.9 26.8 18.6 15.7 24.0 17.2 13.5 22.9 16.7 14.1 14.8 14.7 16.9 35.7 13.3 8.6 17.7 17.9 9.5 10.6 24.4 21.9 9.7 17.6 11.9 11.0 12.5 12.1 18.8 25.3 9.6 22.2 14.8 18.2 15.2 28.6 22.2 28.2 31.2 18.5 23.3 17.7 18.8 25.0 33.4 31.2 14.3 30.7 20.5 31.8 23.1 17.1 16.6 25.2 32.0 23.6 22.9 48.6 22.9 37.5 20.2 27.1 23.1 13.2 23.7 30.1 25.3 34.8 24.8 22.9 22.9 22.3 16.7 21.9 19.3 25.6 21.6 33.4 25.5 35.2 24.7 25.9 30.0 25.9 15.1 48.1 22.7 20.5 28.1 33.2 23.3 18.4 19.1 13.9 22.1 23.1 24.0 28.4 15.9 18.5 22.0 27.4 20.1 27.8 9.4 16.3 9.6 16.7 22.2 18.2 18.8 14.0 16.2 25.3 18.3 16.7 17.2 1.5 14.8 21.3 18.9 18.1 15.2 30.7 32.0 19.7 43.7 28.9 25.1 23.9 26.8 22.9 21.9 23.8 16.8 23.4 29.6 28.0 20.9 13.7 10.2 10.7 9.1 27.9 2.0 80.0 82.9 48.6 192.5 20.2 20.0 0.0 54.5 67.1 42.9 35.8 15.0 21.3 39.5 23.8 113.7 19.6 24.3 823.2 33.6 22.4 45.5 35.1 48.9 30.3 33.0 25.9 34.3 131.8 13.5 6.5 31.1 46.2 48.7 30.2 51.5 15.4 35.1 23.5 ERICH1 ENSG00000104714 "Glutamate rich 1" Q86X53 8 614746-738106 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA003725 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA003725: AB_1853023" "unprognostic (7.19e-2)" "unprognostic (1.38e-2)" "unprognostic (7.73e-2)" "unprognostic (1.43e-2)" "unprognostic (5.60e-2)" "unprognostic (1.02e-1)" "unprognostic (7.51e-3)" "unprognostic (1.55e-1)" "unprognostic (1.87e-1)" "unprognostic (1.67e-1)" "unprognostic (1.36e-1)" "unprognostic (8.45e-2)" "unprognostic (5.11e-2)" "unprognostic (1.27e-1)" "unprognostic (8.63e-2)" "unprognostic (3.07e-1)" "unprognostic (1.42e-1)" 20.2 11.7 12.3 35.7 16.9 30.5 18.1 9.0 15.6 13.6 16.0 13.9 13.7 13.1 21.7 25.6 15.3 13.7 17.1 14.7 15.1 11.4 17.6 15.3 19.4 29.3 14.5 14.0 16.9 12.2 13.8 16.1 16.9 16.9 15.4 11.7 14.0 13.5 19.4 17.2 17.0 15.8 16.2 17.0 22.2 14.9 11.8 14.0 21.8 18.2 13.3 25.0 17.1 15.3 11.7 10.2 18.5 20.9 7.2 6.2 6.0 9.1 13.3 7.1 8.5 7.7 9.4 14.8 8.8 4.7 8.1 8.9 8.4 5.9 21.0 4.2 7.4 15.4 15.5 13.0 13.6 5.8 9.1 16.9 14.7 8.6 12.0 8.6 8.9 13.8 10.8 8.9 6.1 7.9 8.4 8.8 18.6 15.0 12.2 8.1 7.6 17.2 15.9 11.2 10.3 5.9 15.6 4.6 14.4 8.9 17.0 3.3 9.2 6.4 8.3 11.7 12.2 3.5 10.7 14.0 6.0 2.8 0.3 9.4 7.9 20.7 22.7 12.2 14.4 6.2 11.4 20.9 7.2 5.4 19.0 4.8 9.7 6.2 5.3 10.2 11.7 5.3 4.7 18.5 7.2 16.8 7.8 4.4 6.0 12.3 16.9 9.0 15.6 15.1 11.4 14.5 14.0 16.9 14.0 41.7 35.5 50.9 39.7 32.4 21.9 18.6 22.9 28.1 23.9 31.4 11.8 51.9 92.9 32.4 12.1 68.4 34.3 23.3 31.9 51.8 34.0 36.4 39.4 27.6 37.0 46.1 18.9 63.8 70.8 7.5 55.8 69.4 33.7 101.0 32.1 18.6 42.9 38.6 38.2 35.4 20.8 38.8 32.3 46.1 50.7 35.8 45.2 57.3 28.7 29.2 ERICH4 "C19orf69, LOC100170765" ENSG00000204978 "Glutamate rich 4" A6NGS2 19 41443158-41444765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "intestine: 78.1" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 73.4" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "CACO-2: 4.8;Hep G2: 11.1;THP-1: 3.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA042632, HPA048484" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042632: AB_2678090, HPA048484: AB_2680415" "unprognostic (1.41e-1)" "unprognostic (3.05e-1)" "unprognostic (9.52e-2)" "unprognostic (1.24e-1)" "unprognostic (2.76e-1)" "unprognostic (4.03e-5)" "unprognostic (8.53e-2)" "unprognostic (7.54e-2)" "unprognostic (1.97e-1)" "unprognostic (3.09e-2)" "unprognostic (1.04e-1)" "unprognostic (2.79e-1)" "unprognostic (2.35e-1)" "unprognostic (1.16e-1)" 0.6 0.0 0.2 0.2 0.3 0.0 0.6 0.2 0.3 0.4 21.0 0.2 0.2 27.1 0.4 0.4 0.2 0.4 0.5 1.3 0.2 0.0 10.0 0.2 1.2 0.2 0.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.9 0.0 78.1 0.2 0.3 0.2 0.1 0.8 0.2 0.2 0.3 0.2 0.2 0.3 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.2 0.3 0.2 0.0 0.3 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 11.6 0.0 3.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 73.4 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 ERICH5 "C8orf47, FLJ39553" ENSG00000177459 "Glutamate rich 5" Q6P6B1 8 98064311-98093610 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 27.9;retina: 26.7" "Cell type enhanced" "Detected in many" 14 "Cholangiocytes: 84.1;Ciliated cells: 72.3;Ductal cells: 42.6" "Cancer enhanced" "Detected in many" "liver cancer: 23.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 9 "myeloid DC: 5.3" "Lineage enriched" "Detected in single" 10 "dendritic cells: 5.3" "Cell line enhanced" "Detected in some" "A549: 6.5;HAP1: 6.0;HEK 293: 8.8;JURKAT: 11.6;RPTEC TERT1: 5.8;RT4: 15.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA025070, HPA025293, HPA027233" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA025070: AB_1845778, HPA025293: AB_1845779, HPA027233: AB_1845780" "unprognostic (2.88e-3)" "unprognostic (1.49e-1)" "unprognostic (1.41e-1)" "unprognostic (5.96e-2)" "unprognostic (6.86e-2)" "unprognostic (2.39e-1)" "unprognostic (8.66e-2)" "unprognostic (1.57e-1)" "unprognostic (4.66e-1)" "unprognostic (2.84e-2)" "unprognostic (1.16e-1)" "unprognostic (5.73e-1)" "prognostic favorable (3.76e-4)" "unprognostic (4.36e-2)" "unprognostic (9.22e-2)" "unprognostic (3.17e-2)" "prognostic favorable (9.38e-4)" 0.5 0.2 2.3 0.2 6.7 0.0 0.8 0.4 2.2 2.0 3.3 0.1 3.6 4.3 1.1 0.6 0.7 8.8 13.1 5.4 0.7 2.6 8.7 8.1 1.7 0.7 1.0 2.2 1.6 27.9 0.6 1.7 4.1 1.9 2.2 3.0 26.7 1.3 1.9 0.1 0.6 1.3 0.4 1.0 0.2 9.5 3.4 0.5 0.3 0.6 0.0 0.5 3.1 0.5 0.0 5.3 0.0 0.0 0.0 0.5 0.0 0.0 6.5 0.0 0.0 0.1 0.0 3.8 3.4 1.3 1.8 1.4 0.1 2.0 0.0 5.0 0.9 2.8 0.3 6.0 0.1 2.2 0.0 8.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.0 11.6 0.0 0.0 0.1 0.1 0.0 0.7 1.4 0.1 2.6 0.0 0.0 0.1 5.8 15.3 3.5 0.2 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.3 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.3 6.7 0.4 2.2 0.7 2.6 1.0 2.2 1.9 0.5 3.0 0.0 0.0 1.1 0.0 0.0 5.9 84.1 72.3 5.7 7.0 0.0 0.3 0.0 42.6 0.3 0.0 0.7 0.0 16.3 1.5 0.0 3.1 0.0 3.9 0.1 0.0 17.2 0.0 0.0 0.0 0.3 0.8 0.0 0.0 2.3 5.8 17.1 0.0 0.0 19.3 0.0 0.0 0.3 0.0 0.7 0.0 0.1 0.0 3.3 1.3 ERP29 "C12orf8, ERp28, ERp29, ERp31, PDI-DB, PDIA9" ENSG00000089248 "Endoplasmic reticulum protein 29" P30040 12 112013316-112023451 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039363, HPA039456" Enhanced Uncertain Nucleoplasm,Microtubules "Intracellular and membrane" NA NA 4900000 Microtubules Nucleoplasm "HPA039363: AB_10673422, HPA039456: AB_10672963" "unprognostic (2.70e-2)" "unprognostic (1.16e-1)" "unprognostic (1.96e-1)" "prognostic favorable (7.43e-5)" "unprognostic (1.13e-2)" "unprognostic (3.88e-1)" "prognostic unfavorable (2.02e-4)" "unprognostic (1.04e-2)" "unprognostic (2.00e-1)" "unprognostic (1.21e-1)" "unprognostic (5.10e-3)" "unprognostic (2.58e-1)" "unprognostic (3.21e-1)" "unprognostic (2.74e-3)" "unprognostic (3.34e-1)" "unprognostic (1.76e-1)" "unprognostic (6.26e-2)" 19.1 37.1 20.2 32.4 19.8 55.1 39.7 29.5 30.8 23.3 45.8 16.8 66.5 32.0 23.1 38.3 30.6 24.6 39.0 24.2 18.6 24.9 34.9 67.5 33.8 61.2 22.5 19.7 28.5 111.2 33.3 35.9 46.1 23.4 30.9 29.6 23.2 61.5 58.8 13.0 37.0 35.6 27.2 21.4 41.6 39.5 31.7 16.3 35.8 53.8 28.3 37.6 24.4 30.9 49.2 83.9 60.6 43.3 14.8 37.7 46.6 20.3 19.9 14.6 28.4 55.4 22.2 31.2 20.0 24.6 16.3 21.0 30.9 23.7 21.8 15.7 34.8 17.3 25.4 27.2 25.9 13.3 18.6 15.2 24.7 22.6 34.7 37.5 60.3 24.2 31.6 34.0 26.3 30.7 43.4 22.6 23.4 28.1 40.7 12.3 23.6 19.7 109.7 23.8 72.3 15.0 16.4 17.8 70.1 33.4 31.4 13.3 17.9 24.9 20.7 60.1 28.9 25.9 83.2 16.8 13.8 21.4 13.1 14.8 45.2 51.8 18.4 23.3 38.1 10.7 14.8 43.3 60.6 25.5 32.0 27.6 47.9 33.8 31.6 41.9 49.2 37.7 30.7 8.7 14.8 29.0 83.9 31.5 46.6 20.2 19.8 29.5 30.8 18.6 24.9 22.5 19.7 23.4 16.3 77.4 153.2 311.9 160.1 125.5 118.0 81.5 201.2 108.4 83.0 176.2 104.1 416.0 79.6 181.9 5.0 100.2 238.7 46.7 186.3 318.9 107.4 199.9 87.6 289.4 332.4 76.3 189.9 117.9 288.1 11.5 119.3 206.5 160.3 143.3 207.8 130.1 146.6 273.5 100.4 213.5 151.3 51.8 107.2 40.1 200.2 140.8 369.3 228.4 248.2 181.2 ERVMER34-1 envMER34 ENSG00000226887 "Endogenous retrovirus group MER34 member 1, envelope" Q9H9K5 4 52722618-52751640 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "parathyroid gland: 32.0;placenta: 26.9" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 66.3;Extravillous trophoblasts: 80.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 28.2;hTCEpi: 20.3;RPTEC TERT1: 15.1" "HPA011423, HPA024053" Approved Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA 5000000 Nucleoplasm Cytosol "HPA011423: AB_2668510, HPA024053: " "unprognostic (5.34e-2)" "unprognostic (1.29e-1)" "unprognostic (1.91e-3)" "unprognostic (5.86e-2)" "unprognostic (4.08e-4)" "prognostic unfavorable (3.55e-4)" "unprognostic (5.88e-4)" "unprognostic (5.28e-2)" "unprognostic (2.99e-2)" "unprognostic (2.39e-3)" "unprognostic (2.62e-3)" "unprognostic (4.23e-2)" "unprognostic (1.03e-2)" "unprognostic (1.32e-2)" "unprognostic (6.35e-2)" "unprognostic (1.62e-2)" "unprognostic (1.82e-1)" 0.3 1.3 1.2 0.4 0.7 0.2 2.8 0.5 3.0 1.3 0.5 0.0 1.4 0.5 0.9 1.3 3.7 0.7 0.4 6.2 0.8 1.0 4.4 0.3 1.8 1.9 0.6 0.2 3.9 1.7 32.0 0.2 26.9 0.8 0.7 0.7 0.8 1.3 3.0 0.2 1.0 0.5 0.4 1.5 1.9 1.1 1.7 0.3 0.0 2.5 3.7 1.2 1.0 1.8 0.6 0.4 1.2 0.1 0.4 0.3 0.0 4.5 0.2 0.9 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 28.2 6.0 0.0 0.6 0.1 0.4 0.3 0.0 2.0 0.0 0.0 0.2 0.0 0.0 0.2 0.4 0.0 0.0 1.3 20.3 0.0 3.0 0.0 0.0 0.0 1.6 0.0 0.1 0.3 0.0 0.0 1.9 1.8 0.8 0.0 0.0 0.0 15.1 0.4 1.2 0.3 1.9 0.8 0.0 3.0 2.5 0.4 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.1 0.5 0.3 0.1 0.2 0.3 0.3 0.2 0.1 0.6 0.3 0.2 1.1 0.4 0.1 0.4 0.2 0.0 1.2 0.7 0.5 3.0 0.8 1.0 0.6 0.2 0.8 0.3 0.0 0.0 0.0 1.1 0.5 0.0 2.4 0.0 0.0 0.0 7.0 0.0 66.3 0.0 2.3 3.2 0.1 0.0 0.0 0.7 80.6 1.3 1.2 0.0 0.0 6.3 0.0 0.0 0.0 0.0 2.5 2.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.4 0.0 0.0 0.3 0.2 0.4 0.1 14.5 0.0 0.4 1.1 ESCO2 "EFO2, RBS" ENSG00000171320 "Establishment of sister chromatid cohesion N-acetyltransferase 2" Q56NI9 8 27771949-27812640 "Disease related genes, Predicted intracellular proteins" "Cell cycle" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 23.2;lymphoid tissue: 39.8;testis: 10.3" "Group enriched" "Detected in many" 9 "Erythroid cells: 70.0;Spermatocytes: 30.1;Spermatogonia: 77.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 4.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027243, HPA053679" Supported "Nucleoplasm,Golgi apparatus,Cell Junctions" Yes Yes "Nucleoplasm, Golgi apparatus" "Cell Junctions" "HPA027243: AB_2672175, HPA053679: AB_2682227" "unprognostic (7.86e-2)" "unprognostic (1.50e-2)" "prognostic favorable (1.04e-4)" "unprognostic (5.13e-3)" "unprognostic (9.50e-2)" "unprognostic (8.67e-3)" "unprognostic (7.30e-4)" "unprognostic (5.24e-3)" "unprognostic (2.24e-2)" "unprognostic (2.54e-2)" "unprognostic (7.51e-4)" "unprognostic (2.23e-1)" "unprognostic (1.65e-14)" "unprognostic (6.65e-3)" "unprognostic (5.32e-1)" "unprognostic (5.85e-2)" "unprognostic (4.06e-1)" 1.0 1.7 0.5 7.1 0.5 5.5 1.0 0.4 0.6 1.2 9.6 0.1 0.5 11.9 0.6 1.0 5.0 0.3 1.8 1.1 0.7 0.5 1.6 1.4 1.1 4.2 0.5 0.6 0.6 1.0 0.3 0.3 1.5 0.5 0.5 4.5 0.1 1.4 1.4 0.4 1.1 23.2 0.4 0.8 4.7 2.4 10.3 0.2 39.8 0.5 5.3 5.7 1.0 1.8 1.3 1.9 0.8 1.5 0.9 4.6 0.8 25.1 19.1 8.6 10.4 1.1 1.8 4.8 15.1 6.4 14.1 16.1 6.7 5.0 9.3 8.0 3.9 11.8 13.9 10.4 4.1 21.4 7.2 4.4 11.0 8.6 7.1 0.1 5.6 10.3 0.3 0.4 8.2 2.1 1.4 5.2 7.2 8.8 14.2 8.1 4.9 22.6 2.5 5.8 13.8 6.4 10.0 25.7 6.8 4.6 15.2 3.7 5.5 7.6 9.2 3.8 3.3 6.3 6.2 2.3 8.7 18.0 17.5 11.8 1.9 5.0 11.5 4.8 9.4 12.0 0.1 0.7 0.4 0.3 1.5 0.1 1.3 0.7 1.0 1.9 0.1 0.5 0.4 0.8 0.9 0.4 0.2 4.6 0.8 0.5 0.5 0.4 0.6 0.7 0.5 0.5 0.6 0.5 0.2 0.0 6.6 2.2 0.7 2.1 1.5 1.1 0.0 2.7 5.7 0.0 3.9 1.0 0.0 0.3 3.9 0.1 5.3 70.0 0.0 5.5 0.9 0.2 1.1 1.1 4.5 0.0 1.2 0.6 4.1 0.4 1.7 3.5 0.0 0.0 2.3 0.0 0.1 0.8 0.0 0.0 1.8 6.5 0.3 30.1 77.3 0.5 0.8 2.9 4.0 0.9 ESD ENSG00000139684 "Esterase D" P10768 13 46771256-46797232 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039700 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 16000000 "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039700: AB_10697553" "unprognostic (3.05e-1)" "prognostic unfavorable (5.01e-4)" "unprognostic (7.66e-2)" "unprognostic (1.75e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (2.16e-4)" "unprognostic (1.73e-2)" "unprognostic (3.31e-1)" "unprognostic (1.01e-1)" "unprognostic (2.12e-2)" "unprognostic (1.49e-2)" "unprognostic (1.08e-1)" "unprognostic (2.91e-2)" "unprognostic (2.71e-2)" "unprognostic (2.18e-1)" "unprognostic (6.44e-2)" "unprognostic (1.37e-3)" 58.5 30.9 32.0 28.6 29.8 24.2 44.5 23.7 32.0 54.4 37.3 29.0 34.2 31.8 53.2 50.4 54.1 40.6 30.3 45.6 30.7 29.3 58.8 82.2 28.2 31.4 31.7 32.1 61.3 24.9 27.5 47.5 26.4 28.6 55.2 41.7 32.5 31.5 45.2 47.4 29.7 38.4 50.8 37.4 31.1 32.1 32.4 26.7 65.5 78.9 50.9 31.7 62.5 36.9 30.1 48.7 15.1 37.1 29.8 35.7 26.4 22.1 12.9 39.1 26.9 45.9 75.9 10.5 31.9 46.3 44.5 34.7 21.8 27.2 25.2 9.6 38.2 33.3 22.7 43.0 37.7 57.0 28.8 44.7 32.6 13.0 33.5 37.6 63.6 14.0 51.8 35.0 28.7 38.7 53.7 41.7 43.5 31.8 6.8 73.6 21.7 56.4 42.3 10.1 28.7 24.5 44.9 23.0 17.0 63.1 9.0 19.4 22.0 14.2 12.1 25.6 28.1 23.2 36.5 27.8 16.4 19.4 31.5 29.4 4.6 9.9 21.8 35.4 36.5 21.9 7.7 37.1 15.1 15.0 31.5 24.6 30.1 30.0 23.0 40.8 25.3 35.7 27.9 4.3 29.8 28.0 48.7 24.9 26.4 32.0 29.8 23.7 32.0 30.7 29.3 31.7 32.1 28.6 26.7 50.6 42.5 68.7 203.4 119.1 47.0 89.2 124.9 77.6 61.4 146.5 39.3 134.7 305.1 153.5 36.2 95.8 72.1 46.7 90.4 115.2 195.1 96.4 94.6 148.9 197.0 20.6 104.5 112.3 138.2 18.5 247.9 128.5 156.9 100.0 108.9 147.8 82.8 115.8 198.7 400.9 62.5 148.8 210.1 67.4 44.1 113.0 62.2 82.2 173.0 130.7 ESF1 "bA526K24.1, C20orf6" ENSG00000089048 "ESF1 nucleolar pre-rRNA processing protein homolog" Q9H501 20 13714322-13784886 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047083, HPA050396" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA047083: AB_2679924, HPA050396: AB_2681111" "unprognostic (2.81e-1)" "unprognostic (1.54e-1)" "unprognostic (1.82e-1)" "unprognostic (1.31e-2)" "unprognostic (4.83e-3)" "unprognostic (1.01e-2)" "prognostic unfavorable (7.81e-9)" "unprognostic (2.52e-2)" "unprognostic (3.17e-2)" "unprognostic (1.78e-1)" "unprognostic (4.17e-3)" "unprognostic (3.91e-2)" "unprognostic (7.34e-2)" "unprognostic (2.16e-2)" "unprognostic (2.02e-1)" "unprognostic (1.60e-2)" "unprognostic (1.57e-1)" 12.4 10.5 13.5 9.7 19.7 7.1 11.9 17.0 17.4 10.8 8.8 6.9 9.2 7.7 11.2 11.5 11.9 9.2 9.1 9.7 17.2 11.6 10.8 14.6 7.0 10.3 16.8 17.5 14.1 8.7 12.9 20.0 11.9 17.2 12.2 10.7 4.2 8.9 8.6 29.9 11.3 7.5 12.9 28.9 10.7 8.1 14.3 17.9 9.2 11.5 12.1 10.1 11.2 9.2 13.8 14.6 2.0 10.6 11.5 12.4 3.7 13.4 12.8 11.9 6.0 9.1 11.0 6.6 14.4 8.8 10.5 9.0 13.6 12.7 17.7 7.3 6.8 19.6 20.7 17.7 14.4 18.7 4.7 8.4 23.3 5.2 31.9 12.7 28.0 6.4 8.8 10.3 17.2 14.0 7.8 7.9 9.2 32.3 8.1 11.9 11.9 21.2 16.8 11.4 12.5 7.7 13.8 29.5 12.9 7.4 11.9 11.7 7.2 11.6 18.3 17.9 11.6 9.2 12.3 10.7 16.2 11.2 11.8 26.6 8.2 19.7 21.7 6.8 12.3 14.7 1.8 6.9 2.0 8.7 8.6 10.0 13.6 10.0 9.3 6.9 13.8 12.4 11.3 0.4 11.5 10.6 14.6 7.5 3.7 13.5 19.7 17.0 17.4 17.2 11.6 16.8 17.5 17.2 17.9 20.8 32.3 50.2 39.5 55.0 83.6 53.4 40.8 40.2 51.2 31.4 43.2 41.7 28.2 45.6 67.2 39.8 42.3 0.0 36.5 34.4 44.1 25.1 25.4 49.7 38.2 90.6 46.6 38.1 29.7 20.6 60.4 41.3 25.3 49.5 47.3 45.9 48.7 42.1 69.3 31.9 67.2 32.3 50.5 168.4 174.8 46.9 34.7 29.9 52.5 31.5 ESPL1 "ESP1, KIAA0165, SEPA" ENSG00000135476 "Extra spindle pole bodies like 1, separase" Q14674 12 53268299-53293643 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Chromosome partition" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 17.9;lymphoid tissue: 30.3" "Cell type enhanced" "Detected in some" 6 "Enterocytes: 4.1;Hepatocytes: 4.9;Proximal tubular cells: 5.6;Spermatocytes: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 5 "T-reg: 1.8" "Lineage enriched" "Detected in single" 5 "T-cells: 1.8" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "CAB012185, HPA073188" Approved Supported Nucleoplasm,Vesicles NA Yes Nucleoplasm Vesicles "CAB012185: AB_304056, HPA073188: " "unprognostic (1.57e-1)" "unprognostic (3.56e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (5.32e-5)" "unprognostic (2.91e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (2.01e-5)" "prognostic unfavorable (7.14e-4)" "unprognostic (1.59e-2)" "unprognostic (2.48e-1)" "unprognostic (4.17e-3)" "unprognostic (1.18e-2)" "unprognostic (7.42e-13)" "prognostic favorable (7.10e-4)" "unprognostic (2.39e-1)" "unprognostic (7.41e-2)" "unprognostic (1.42e-1)" 0.7 0.4 0.2 7.1 0.4 7.2 0.3 0.2 0.5 3.9 2.3 0.4 0.8 4.2 0.6 0.7 17.9 0.2 0.5 1.0 1.1 0.1 1.0 0.9 0.7 4.1 0.2 0.2 0.3 0.2 0.0 0.2 3.0 0.6 0.4 1.5 0.6 2.6 0.2 0.2 2.7 4.4 0.5 0.2 3.0 0.8 10.9 0.3 30.3 0.3 2.5 7.8 0.7 6.2 0.0 0.0 0.4 0.1 0.0 1.8 0.0 12.6 12.9 13.8 11.3 0.3 1.2 8.5 8.3 4.2 14.3 9.1 7.0 11.1 22.8 4.6 3.4 8.4 10.5 16.0 4.9 7.5 7.1 16.2 15.3 11.7 5.3 0.0 9.6 12.7 0.4 0.3 8.3 4.1 1.4 7.3 11.3 20.5 20.6 4.2 13.1 15.0 8.2 11.2 7.5 7.0 14.1 14.8 9.5 2.0 5.3 10.0 7.7 7.0 10.3 5.4 6.8 17.0 6.4 3.3 7.2 14.0 6.0 11.4 15.3 14.2 15.4 4.1 9.1 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 1.8 0.0 0.2 0.4 0.2 0.5 1.1 0.1 0.2 0.2 0.6 0.3 0.0 0.0 0.0 0.1 0.8 0.0 0.8 0.0 0.0 0.0 3.5 0.0 0.7 0.0 0.2 0.6 0.4 4.1 0.0 0.0 1.9 1.0 0.3 0.0 4.9 2.1 0.0 3.4 1.3 0.6 1.1 0.0 1.3 0.0 0.0 1.2 0.0 1.0 0.2 0.4 5.6 0.0 0.0 0.4 6.5 2.7 0.5 0.2 0.0 3.1 0.5 ESR1 "ER-alpha, Era, ESR, NR3A1" ENSG00000091831 "Estrogen receptor 1" P03372 6 151656691-152129619 "Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 64.5;endometrium 1: 68.9" "Group enriched" "Detected in many" 6 "Early spermatids: 36.0;Hepatocytes: 48.4;Horizontal cells: 58.8" "Group enriched" "Detected in many" 9 "breast cancer: 40.2;endometrial cancer: 24.3;ovarian cancer: 8.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.5" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 9 "MCF7: 24.9;T-47d: 32.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "CAB000037, HPA000449, HPA000450, CAB055099, CAB072858" Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "CAB000037: AB_563706, CAB055099: AB_2101946, CAB072858: AB_2665701, HPA000449: AB_1078753, HPA000450: AB_1078754" "unprognostic (8.28e-2)" "unprognostic (3.02e-2)" "unprognostic (1.43e-2)" "prognostic favorable (5.47e-7)" "unprognostic (4.79e-1)" "unprognostic (2.43e-3)" "unprognostic (4.10e-5)" "unprognostic (9.92e-2)" "unprognostic (2.20e-1)" "unprognostic (7.17e-2)" "unprognostic (7.35e-2)" "unprognostic (3.45e-1)" "unprognostic (1.20e-2)" "unprognostic (7.91e-3)" "unprognostic (6.45e-2)" "unprognostic (1.25e-1)" "unprognostic (1.52e-1)" 3.0 0.9 0.5 1.6 0.5 0.2 16.2 0.8 0.4 64.5 1.5 0.2 2.2 0.1 68.9 27.7 1.1 26.7 1.9 1.1 0.5 0.8 1.5 6.6 3.6 1.6 0.4 0.1 14.2 0.4 0.0 9.3 0.9 0.6 3.6 0.1 2.6 1.6 4.1 2.0 0.6 0.5 20.8 0.4 1.6 0.3 1.9 0.4 1.9 1.3 2.2 2.5 3.8 23.7 0.6 1.0 0.0 0.8 0.3 2.5 1.0 0.3 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.4 0.0 0.0 0.0 0.6 0.0 24.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.1 32.2 0.0 0.0 0.1 0.1 0.3 0.0 3.0 0.5 0.0 0.1 0.3 0.0 0.0 0.8 0.0 0.3 0.2 1.0 0.6 1.3 0.4 1.0 0.4 2.5 0.9 0.0 0.3 0.0 0.0 0.3 1.0 0.5 0.5 0.8 0.4 0.5 0.8 0.4 0.1 0.6 0.4 0.0 0.6 0.0 1.4 0.9 3.8 4.5 0.0 1.4 1.2 0.0 7.9 0.1 1.7 0.0 36.0 0.6 0.0 0.0 0.2 0.1 4.7 0.6 2.3 48.4 0.9 58.8 1.7 6.7 4.7 6.9 3.7 2.4 1.7 0.0 0.0 2.7 0.2 0.0 2.1 3.3 4.0 0.0 1.4 1.6 1.2 1.5 0.1 0.0 0.0 8.4 ESRP1 "FLJ20171, RBM35A" ENSG00000104413 "Epithelial splicing regulatory protein 1" Q6NXG1 8 94641074-94707466 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 65.1" "Cell type enhanced" "Detected in many" 6 "Mucus-secreting cells: 101.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "MAIT T-cell: 1.9" "Lineage enriched" "Detected in single" 19 "T-cells: 1.9" "Cell line enhanced" "Detected in some" "A-431: 33.3;BEWO: 25.6;CAPAN-2: 35.1;HaCaT: 20.4;hTCEpi: 57.4;OE19: 34.8;RT4: 24.4;T-47d: 27.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA023719, HPA023720, HPA067104" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" NA NA "Nuclear bodies" Nucleoplasm "HPA023719: AB_1856124, HPA023720: AB_1856125, HPA067104: AB_2685779" "prognostic unfavorable (9.28e-4)" "unprognostic (7.12e-2)" "unprognostic (2.75e-2)" "prognostic unfavorable (3.56e-4)" "unprognostic (4.12e-1)" "unprognostic (6.99e-3)" "unprognostic (2.70e-1)" "unprognostic (2.61e-2)" "unprognostic (5.19e-2)" "unprognostic (5.51e-2)" "prognostic unfavorable (2.05e-4)" "unprognostic (4.48e-2)" "prognostic favorable (1.96e-8)" "unprognostic (1.34e-1)" "unprognostic (2.63e-1)" "unprognostic (4.96e-2)" "unprognostic (1.29e-1)" 0.6 0.5 0.5 15.1 0.5 0.0 7.6 0.5 0.6 9.7 18.1 0.2 18.7 7.7 3.3 21.3 43.1 6.6 14.5 0.6 0.5 0.5 6.4 0.7 15.5 0.8 0.5 0.2 1.8 65.1 11.8 10.1 18.5 0.3 8.9 20.8 0.2 38.2 15.1 0.5 24.8 12.7 1.9 0.5 0.5 12.1 1.0 0.2 1.4 20.2 30.4 28.9 9.0 16.8 0.0 0.0 0.0 0.0 0.0 1.9 0.0 33.3 0.0 0.0 0.0 0.0 0.0 25.6 0.0 0.0 0.0 0.0 10.9 35.1 0.0 0.9 0.0 0.0 20.4 0.9 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.4 0.0 0.3 0.0 0.0 2.6 0.0 0.0 0.0 16.2 0.4 0.1 3.1 34.8 0.8 0.0 0.0 4.4 4.4 24.4 8.9 0.0 0.0 5.2 3.3 5.6 27.1 0.2 0.0 0.0 0.0 0.0 0.0 3.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.5 0.6 0.5 0.5 0.5 0.2 0.3 0.2 35.7 23.4 0.5 19.5 39.6 0.0 0.7 20.4 30.8 22.7 26.2 0.0 45.8 11.6 18.7 5.9 0.0 53.4 0.0 24.0 54.1 2.0 25.5 1.1 0.0 5.1 0.0 31.9 0.0 0.0 6.8 0.0 0.6 23.6 1.0 101.9 0.0 21.5 42.1 0.7 0.3 0.0 0.0 0.9 0.2 0.7 69.3 51.9 0.0 68.9 33.0 ESRP2 "FLJ21918, RBM35B" ENSG00000103067 "Epithelial splicing regulatory protein 2" Q9H6T0 16 68229111-68238102 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 45.2;pancreas: 41.5" "Cell type enhanced" "Detected in many" 8 "Late spermatids: 63.6;Syncytiotrophoblasts: 48.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 18.4;MCF7: 36.1;RT4: 19.4;SK-BR-3: 19.4;T-47d: 29.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA040751, HPA048597, HPA048618" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA040751: AB_2677115, HPA048597: AB_2680458, HPA048618: AB_2680463" "unprognostic (3.55e-2)" "unprognostic (1.18e-1)" "unprognostic (1.19e-1)" "unprognostic (3.29e-1)" "unprognostic (1.67e-1)" "unprognostic (1.62e-2)" "unprognostic (1.54e-1)" "unprognostic (1.33e-1)" "unprognostic (1.50e-1)" "unprognostic (1.02e-1)" "unprognostic (1.30e-2)" "unprognostic (8.80e-2)" "prognostic favorable (1.30e-6)" "unprognostic (1.24e-1)" "unprognostic (3.16e-1)" "unprognostic (9.04e-3)" "unprognostic (8.75e-3)" 0.4 0.2 0.2 7.6 0.5 0.0 3.9 0.6 0.3 4.7 8.0 0.6 4.1 4.6 1.2 10.2 30.1 2.1 12.4 0.6 0.3 0.1 13.4 45.2 15.6 0.2 0.2 0.2 1.3 41.5 7.0 2.5 11.3 0.7 6.6 5.6 0.8 17.3 5.0 0.3 17.6 8.5 0.6 0.2 0.2 12.8 7.0 0.3 3.0 18.4 25.7 17.1 6.4 9.4 0.0 0.0 0.0 0.8 0.0 0.8 0.0 12.4 0.0 0.0 0.0 0.0 0.0 18.4 0.1 0.0 0.0 0.1 11.7 6.2 0.0 0.5 0.0 0.0 12.9 0.0 9.6 0.0 0.0 8.5 0.0 3.5 9.3 0.2 0.0 0.1 0.0 13.6 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 36.1 0.0 0.0 1.3 9.3 4.2 0.0 0.0 0.0 4.8 19.4 1.3 0.0 6.2 19.4 0.0 1.6 29.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.6 0.3 0.3 0.1 0.2 0.2 0.7 0.3 17.9 12.1 0.0 4.0 5.7 0.5 1.0 15.3 2.7 10.3 22.7 0.0 27.4 0.0 10.0 23.1 0.4 10.3 0.0 12.2 3.2 0.8 6.9 0.0 28.2 2.4 0.0 8.1 0.0 1.5 63.6 0.9 0.0 1.7 1.0 23.1 0.2 11.0 7.0 0.0 3.5 0.2 0.0 0.3 5.7 1.5 7.4 48.9 0.0 15.1 7.1 ESRRA "ERR1, ERRa, ERRalpha, ESRL1, NR3B1" ENSG00000173153 "Estrogen related receptor alpha" P11474 11 64305572-64316743 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 78.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053785, HPA077297" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Microtubules,Cytokinetic bridge" Yes No "Nucleoplasm, Nucleoli fibrillar center, Microtubules" "Cytokinetic bridge" "HPA053785: AB_2682260, HPA077297: " "unprognostic (7.63e-2)" "unprognostic (1.51e-1)" "unprognostic (1.04e-1)" "unprognostic (1.28e-2)" "unprognostic (3.08e-1)" "unprognostic (7.24e-2)" "unprognostic (1.07e-1)" "unprognostic (2.97e-1)" "unprognostic (2.98e-1)" "unprognostic (3.52e-2)" "unprognostic (2.50e-2)" "unprognostic (1.03e-1)" "prognostic favorable (1.34e-7)" "unprognostic (3.43e-3)" "unprognostic (3.19e-2)" "unprognostic (2.38e-2)" "unprognostic (7.20e-2)" 8.2 9.6 6.0 8.9 7.7 7.9 17.8 9.8 9.4 4.3 32.4 4.9 18.3 43.1 4.6 6.2 17.1 4.1 15.7 45.2 6.8 5.0 21.4 26.9 8.7 9.2 10.4 5.2 2.5 20.5 10.1 4.6 11.0 8.0 7.5 12.6 6.0 28.7 14.9 78.3 10.5 46.4 7.1 7.4 9.3 14.1 2.2 6.0 6.0 8.2 27.1 10.0 8.5 12.0 4.1 4.2 8.5 8.4 2.6 5.4 2.4 9.8 15.8 3.9 9.5 5.3 5.2 21.5 9.7 4.7 3.6 3.6 14.5 12.0 13.5 18.2 5.1 9.6 25.4 6.6 13.1 1.4 9.1 8.5 8.7 18.7 11.4 7.4 14.8 22.0 7.2 20.0 8.2 10.8 5.1 5.1 7.2 14.7 7.5 6.0 22.2 7.2 21.0 10.9 11.9 30.1 7.7 7.7 30.3 12.1 20.8 8.3 10.2 4.9 33.0 31.2 2.3 10.2 14.7 11.0 6.7 8.0 18.7 9.8 11.6 9.5 8.9 10.9 14.5 5.2 0.3 4.7 7.1 4.4 8.4 4.4 2.9 3.8 3.1 4.2 4.1 4.1 5.4 8.5 2.6 7.5 3.2 5.1 2.4 6.0 7.7 9.8 9.4 6.8 5.0 10.4 5.2 8.0 6.0 8.9 27.2 29.9 28.0 16.6 29.0 7.9 132.5 5.3 12.5 19.2 31.4 79.6 46.4 50.0 2.6 9.0 143.7 46.7 68.6 49.1 11.9 19.0 7.0 154.8 29.6 31.8 36.4 44.2 93.5 0.2 6.1 20.2 16.9 19.8 71.8 17.3 67.0 94.7 11.3 48.1 19.0 12.9 10.3 2.8 8.0 16.2 112.2 15.3 83.1 49.8 ESRRB "DFNB35, ERR2, ERRb, ERRbeta, ESRL2, NR3B2" ENSG00000119715 "Estrogen related receptor beta" O95718 14 76310712-76501837 "Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 14.5;retina: 50.2" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 14.7;Horizontal cells: 52.4;Late spermatids: 27.9;Rod photoreceptor cells: 40.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 2.8;K-562: 9.7;U-266/70: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA074772 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA074772: " "unprognostic (1.12e-1)" "unprognostic (1.34e-2)" "unprognostic (6.28e-2)" "unprognostic (3.92e-5)" "unprognostic (5.18e-2)" "unprognostic (3.15e-2)" "unprognostic (2.14e-1)" "unprognostic (1.48e-1)" "unprognostic (2.28e-2)" "unprognostic (2.24e-2)" "unprognostic (2.16e-2)" "unprognostic (4.11e-2)" "unprognostic (2.68e-1)" "unprognostic (3.46e-1)" "unprognostic (1.89e-1)" "unprognostic (2.12e-4)" "unprognostic (4.40e-2)" 0.2 0.1 0.3 0.0 1.0 0.0 0.6 0.3 0.6 0.1 0.0 0.8 0.3 0.0 0.1 0.4 0.1 0.1 0.0 7.8 0.3 0.4 14.5 0.1 0.1 0.9 0.5 0.4 0.0 0.2 0.0 0.3 0.1 1.3 0.2 0.0 50.2 0.1 0.4 9.5 0.0 0.1 0.0 0.5 1.2 5.1 2.0 0.2 0.0 0.0 1.2 0.1 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 1.5 0.5 0.0 0.1 0.0 0.6 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 9.7 0.4 0.0 1.3 0.0 0.4 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.5 0.4 0.0 0.0 0.0 0.8 0.0 0.0 1.1 0.0 1.0 0.1 0.5 4.9 1.4 0.0 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 1.0 0.3 0.6 0.3 0.4 0.5 0.4 1.3 0.2 0.0 0.0 0.0 0.0 0.0 1.6 5.5 0.0 0.0 0.0 0.0 2.0 0.0 11.6 0.0 14.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 52.4 0.0 0.0 0.0 27.9 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.0 0.0 0.3 40.7 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 ESRRG NR3B3 ENSG00000196482 "Estrogen related receptor gamma" P62508 1 216503246-217137755 "FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.5;parathyroid gland: 37.2;placenta: 40.8" "Cell type enhanced" "Detected in many" 15 "Cone photoreceptor cells: 55.0;Syncytiotrophoblasts: 179.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "pons and medulla: 49.5" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "RPMI-8226: 15.4;SH-SY5Y: 29.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044678 Uncertain Approved Nucleoplasm No NA Nucleoplasm "HPA044678: AB_10963215" "unprognostic (6.48e-2)" "unprognostic (1.11e-1)" "unprognostic (7.06e-2)" "unprognostic (7.32e-2)" "unprognostic (2.34e-1)" "unprognostic (5.48e-2)" "unprognostic (1.66e-1)" "unprognostic (1.13e-1)" "unprognostic (4.55e-2)" "unprognostic (2.88e-1)" "unprognostic (2.35e-1)" "unprognostic (1.79e-2)" "prognostic favorable (1.13e-11)" "unprognostic (3.04e-1)" "unprognostic (2.55e-1)" "unprognostic (3.65e-4)" "unprognostic (2.05e-1)" 0.5 5.1 2.8 0.4 3.3 0.2 2.9 6.9 10.3 1.4 0.7 0.7 2.2 4.0 0.5 1.5 1.4 2.1 0.8 8.3 3.2 2.6 22.0 0.8 0.7 0.4 6.8 1.7 0.8 4.4 37.2 9.9 40.8 49.5 2.6 0.4 10.7 11.0 2.4 6.3 1.5 3.7 0.9 2.6 1.0 22.2 1.0 1.5 0.0 4.6 7.2 0.4 1.0 0.7 0.4 0.2 1.5 0.0 0.2 0.1 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.0 15.4 2.4 1.7 5.5 29.5 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.4 0.1 0.1 1.5 0.2 0.0 0.2 0.0 0.0 2.8 3.3 6.9 10.3 3.2 2.6 6.8 1.7 49.5 1.5 0.0 2.6 0.0 3.3 0.2 26.3 45.0 7.6 18.7 1.2 22.7 55.0 29.1 46.4 3.1 4.5 0.3 0.0 0.0 2.1 3.1 1.5 8.3 0.0 0.8 3.8 46.1 7.9 0.6 0.8 4.6 0.3 0.0 8.5 0.0 0.7 12.3 0.6 0.2 0.7 23.0 34.7 0.0 1.0 1.4 0.1 0.3 179.8 0.0 0.2 1.4 ESS2 "bis1, DGCR13, DGCR14, DGS-H, DGSI, ES2, Es2el, ESS-2" ENSG00000100056 "Ess-2 splicing factor homolog" Q96DF8 22 19130279-19144684 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 13.0;monocytes: 18.0;Pancreatic endocrine cells: 12.5;Syncytiotrophoblasts: 13.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 11.7;RH-30: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001221, HPA001222" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA001221: AB_1078645, HPA001222: AB_1078647" "unprognostic (8.31e-2)" "unprognostic (1.81e-3)" "unprognostic (2.26e-1)" "unprognostic (2.83e-1)" "unprognostic (5.75e-3)" "unprognostic (4.70e-2)" "unprognostic (2.43e-2)" "unprognostic (6.64e-2)" "unprognostic (2.33e-1)" "unprognostic (1.27e-1)" "unprognostic (3.41e-2)" "unprognostic (1.05e-1)" "unprognostic (1.70e-1)" "unprognostic (5.89e-2)" "unprognostic (9.36e-2)" "unprognostic (3.04e-2)" "unprognostic (1.71e-3)" 4.5 4.0 6.3 5.1 7.2 2.5 4.2 18.9 11.8 5.2 7.9 6.3 3.8 3.6 6.8 4.4 6.4 7.3 4.1 5.9 6.0 6.1 3.9 2.9 4.7 4.9 5.7 6.8 9.4 3.7 5.4 5.2 4.9 5.6 6.4 4.2 5.0 4.4 9.6 6.3 9.3 4.1 6.9 5.0 5.6 5.0 7.2 5.8 6.1 5.0 5.5 6.0 7.2 5.5 1.2 1.5 1.7 1.1 1.8 1.4 1.1 2.1 3.9 2.2 2.6 3.6 0.6 1.0 2.0 1.2 3.4 2.8 3.0 0.7 2.7 0.7 0.9 0.8 3.7 6.6 1.1 1.7 4.3 7.5 0.8 3.3 0.5 0.9 3.4 2.6 0.5 3.9 2.4 0.7 0.9 0.6 2.1 11.7 0.3 1.5 2.1 2.1 2.0 1.9 2.3 3.1 3.2 11.0 0.0 0.9 1.6 5.5 1.2 0.9 1.7 2.4 1.5 1.1 1.3 0.5 3.0 4.4 2.9 1.5 1.5 3.2 1.1 1.0 2.1 2.0 0.3 1.1 1.7 0.9 0.4 0.4 0.4 1.2 0.6 0.7 1.2 1.3 1.4 0.9 1.8 0.5 1.5 0.6 1.1 6.3 7.2 18.9 11.8 6.0 6.1 5.7 6.8 5.6 5.8 6.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 8.1 3.4 8.7 0.0 13.0 11.6 11.7 0.0 0.0 0.0 0.0 9.1 10.4 0.0 0.0 4.7 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 18.0 0.0 0.0 12.5 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 ETAA1 ETAA16 ENSG00000143971 "ETAA1, ATR kinase activator" Q9NY74 2 67397319-67412089 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035048, HPA035049" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA035048: AB_10670300, HPA035049: AB_2674430" "unprognostic (1.23e-1)" "unprognostic (2.56e-1)" "unprognostic (5.79e-2)" "unprognostic (2.10e-1)" "unprognostic (1.30e-1)" "unprognostic (3.39e-2)" "unprognostic (6.47e-2)" "unprognostic (5.53e-2)" "unprognostic (1.12e-2)" "unprognostic (8.33e-2)" "unprognostic (9.89e-2)" "unprognostic (1.87e-1)" "unprognostic (8.52e-3)" "unprognostic (9.85e-2)" "unprognostic (7.88e-2)" "unprognostic (5.01e-2)" "unprognostic (1.14e-2)" 9.3 23.4 6.4 11.0 11.3 6.6 14.7 14.0 10.6 15.4 11.7 6.3 9.4 7.2 14.6 13.9 12.0 13.9 15.7 9.4 8.7 5.5 17.5 11.1 11.3 14.8 9.7 10.4 15.6 16.2 14.2 13.9 8.8 10.7 11.6 9.2 6.1 12.4 13.7 11.4 12.4 11.1 10.6 8.5 11.8 10.5 11.3 10.3 19.2 15.9 9.7 9.8 11.6 12.7 7.5 4.4 3.4 5.2 4.2 7.4 3.1 9.1 7.0 12.0 10.8 9.4 13.0 9.8 9.8 13.0 10.4 10.1 5.6 11.1 17.1 5.4 8.0 14.7 11.2 10.1 11.8 15.0 10.0 8.1 9.5 17.0 8.2 8.9 9.4 9.0 10.2 16.9 7.7 12.1 16.6 16.5 14.0 7.7 7.4 14.3 4.1 13.9 10.4 12.2 14.7 7.7 10.1 19.1 7.9 12.7 6.0 10.1 20.1 9.9 9.1 9.3 12.3 7.9 4.6 11.4 14.2 10.9 6.7 11.4 8.3 7.4 13.8 13.2 10.0 10.7 3.4 2.5 2.0 5.5 4.1 6.0 7.5 5.1 3.2 3.1 7.0 7.0 6.2 0.2 4.2 5.2 4.4 7.4 3.1 6.4 11.3 14.0 10.6 8.7 5.5 9.7 10.4 10.7 10.3 20.8 16.0 0.0 6.9 2.2 4.8 8.5 17.8 22.7 10.3 12.2 0.0 5.7 10.0 15.6 0.3 3.1 4.2 0.0 15.9 5.0 7.6 6.2 5.8 8.2 4.1 4.8 10.3 7.4 5.1 1.5 11.2 6.7 1.7 9.0 6.1 5.2 16.4 3.5 12.4 10.0 4.3 0.0 3.1 11.4 7.8 2.3 1.7 5.0 6.0 4.7 ETNK1 "EKI, EKI1" ENSG00000139163 "Ethanolamine kinase 1" Q9HBU6 12 22625075-22690665 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 201.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010712, HPA029407" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA010712: AB_2668349, HPA029407: AB_2673026" "unprognostic (2.06e-1)" "unprognostic (7.48e-2)" "unprognostic (1.23e-3)" "unprognostic (2.19e-1)" "unprognostic (8.79e-3)" "unprognostic (1.31e-2)" "prognostic unfavorable (5.85e-4)" "unprognostic (3.98e-3)" "unprognostic (8.30e-2)" "unprognostic (7.97e-3)" "unprognostic (2.01e-1)" "unprognostic (1.64e-2)" "unprognostic (4.53e-3)" "unprognostic (2.77e-1)" "unprognostic (2.91e-1)" "unprognostic (3.01e-1)" "prognostic favorable (1.75e-4)" 15.7 17.7 15.2 41.1 19.4 13.7 16.9 19.7 22.2 12.9 33.2 16.4 14.6 27.2 16.6 24.1 14.7 13.1 27.3 10.4 15.6 23.9 22.0 30.2 19.6 18.5 17.2 15.8 17.2 14.9 15.8 30.6 13.4 18.9 13.8 19.5 15.9 16.7 14.7 8.2 17.8 24.5 10.0 17.1 18.3 53.7 22.3 17.5 33.4 17.6 8.2 16.5 14.2 18.6 16.2 10.7 28.1 17.6 14.0 15.7 13.4 6.7 14.0 15.6 14.4 11.3 11.4 11.6 8.0 6.0 8.3 8.6 10.8 17.1 20.1 7.2 5.2 8.7 5.1 13.7 3.8 15.0 16.7 11.1 16.6 6.2 9.3 10.8 15.9 15.3 7.4 3.7 11.2 9.5 13.3 10.3 7.9 19.9 8.5 11.0 4.6 17.3 32.4 30.2 8.7 9.2 15.6 13.8 16.1 13.8 9.2 5.0 8.8 8.7 7.6 12.5 22.4 11.8 15.4 8.8 6.6 10.6 8.9 12.0 6.2 7.7 21.6 8.4 10.4 11.0 28.1 11.7 12.1 12.9 17.5 12.7 16.2 14.1 11.9 10.7 13.0 15.7 15.5 11.5 14.0 17.6 9.7 15.3 13.4 15.2 19.4 19.7 22.2 15.6 23.9 17.2 15.8 18.9 17.5 44.7 25.1 40.9 63.3 128.1 40.4 11.0 53.5 72.3 35.2 41.8 47.1 27.9 23.2 26.3 201.9 28.7 55.0 0.0 39.6 20.3 28.6 70.5 33.5 38.4 37.5 25.4 103.9 27.6 78.9 26.1 22.5 44.7 64.1 22.6 52.6 21.4 29.0 46.1 20.1 26.4 35.5 38.8 44.3 47.7 15.1 148.8 63.0 39.2 36.0 60.2 ETNPPL AGXT2L1 ENSG00000164089 "Ethanolamine-phosphate phospho-lyase" Q8TBG4 4 108742040-108763054 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 53.5;liver: 111.0" "Group enriched" "Detected in some" 7 "Cardiomyocytes: 9.4;Hepatocytes: 22.6;Muller glia cells: 6.4" "Group enriched" "Detected in some" 23 "glioma: 7.9;liver cancer: 21.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 11.0;Hep G2: 4.3;NTERA-2: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044546, HPA072938" Approved Approved Nucleoplasm Yes NA Nucleoplasm "HPA044546: AB_10962867, HPA072938: AB_2686560" "unprognostic (5.20e-3)" "unprognostic (1.33e-1)" "unprognostic (3.93e-1)" "prognostic favorable (9.52e-5)" "unprognostic (5.93e-3)" "unprognostic (3.91e-2)" "unprognostic (2.82e-1)" "unprognostic (6.32e-2)" "unprognostic (2.70e-2)" "unprognostic (1.30e-1)" "unprognostic (3.40e-2)" "unprognostic (1.93e-1)" "unprognostic (1.59e-1)" "unprognostic (1.42e-2)" "unprognostic (9.48e-2)" 1.2 1.9 50.8 1.3 51.3 1.2 1.3 7.9 53.5 1.3 1.2 13.4 0.0 1.3 1.4 1.2 1.3 1.2 1.4 3.2 37.5 20.1 6.2 111.0 1.2 1.2 26.0 28.7 1.3 1.2 1.4 0.1 1.2 15.7 1.2 1.2 0.5 19.9 1.3 1.6 1.2 1.2 1.2 7.3 1.6 10.4 1.5 18.7 0.0 1.9 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.0 0.1 11.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 2.2 0.0 0.5 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.9 0.1 0.2 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.8 51.3 7.9 24.9 37.5 20.1 26.0 28.7 15.7 18.7 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.6 1.0 1.3 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 1.9 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 ETS1 "ETS-1, EWSR2, FLJ10768" ENSG00000134954 "ETS proto-oncogene 1, transcription factor" P14921 11 128458761-128587558 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Immunity, Transcription, Transcription regulation" DNA-binding Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 122.5" "Cell type enhanced" "Detected in many" 8 "Endothelial cells: 159.3;Ito cells: 228.3;T-cells: 181.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 59.4;JURKAT: 62.5;U-698: 79.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002575, HPA063230" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB002575: AB_563721, HPA063230: AB_2684965" "unprognostic (1.76e-2)" "unprognostic (2.49e-1)" "unprognostic (3.18e-3)" "unprognostic (6.22e-2)" "unprognostic (3.07e-1)" "unprognostic (2.56e-1)" "unprognostic (1.24e-2)" "unprognostic (1.57e-1)" "unprognostic (1.35e-2)" "unprognostic (7.17e-2)" "unprognostic (2.46e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (1.30e-5)" "unprognostic (2.02e-1)" "unprognostic (3.08e-2)" "unprognostic (1.38e-1)" "unprognostic (5.48e-3)" 33.2 6.3 4.1 45.9 4.7 6.4 24.0 1.6 3.3 13.3 15.0 3.1 4.9 5.3 18.0 9.3 12.6 8.1 13.6 19.1 4.2 3.7 12.4 9.9 36.7 53.9 4.7 2.9 14.1 6.2 6.7 4.1 11.6 4.2 11.7 6.6 12.7 11.7 5.7 12.9 7.5 19.1 7.9 4.3 68.0 8.8 6.0 2.3 122.5 16.7 9.2 51.4 17.5 18.8 6.0 3.0 20.5 0.4 12.5 17.3 4.7 14.5 2.6 12.7 0.0 5.5 8.9 0.0 11.3 24.2 14.2 13.7 0.8 15.8 52.7 11.6 18.6 32.6 5.1 1.2 32.6 30.0 11.1 0.2 59.4 1.1 0.0 14.8 6.1 0.7 17.4 2.6 12.2 44.7 8.1 11.7 62.5 0.1 11.0 17.0 0.0 30.6 4.5 4.7 1.3 9.5 8.4 20.8 4.1 11.2 16.3 0.1 0.8 5.9 0.1 12.5 8.9 0.0 3.0 21.5 32.0 10.0 6.2 18.5 8.2 1.4 79.5 5.7 11.5 28.0 20.5 0.0 3.0 10.4 0.1 14.6 6.0 14.0 12.6 0.1 4.9 17.3 13.5 0.5 12.5 0.4 3.0 15.5 4.7 4.1 4.7 1.6 3.3 4.2 3.7 4.7 2.9 4.2 2.3 23.8 31.1 40.2 29.1 102.1 0.0 6.2 2.5 2.7 35.2 10.4 0.0 0.2 0.0 33.5 2.0 159.3 6.7 0.0 19.5 0.3 45.7 17.2 18.5 3.8 5.6 0.0 14.9 228.3 20.9 0.9 13.0 5.0 65.8 10.0 13.3 0.1 65.1 5.8 14.5 2.9 0.0 103.5 62.6 0.9 1.5 55.3 0.3 181.5 4.0 30.3 ETS2 ENSG00000157557 "ETS proto-oncogene 2, transcription factor" P15036 21 38805307-38824955 "Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 580.2;Suprabasal keratinocytes: 425.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 16.5;granulocytes: 18.5;monocytes: 14.9" "Cell line enhanced" "Detected in many" "HEL: 60.5;hTCEpi: 55.4;hTERT-HME1: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003176 Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA003176: AB_2666824" "unprognostic (2.06e-1)" "unprognostic (5.91e-2)" "unprognostic (9.16e-3)" "unprognostic (5.33e-3)" "unprognostic (1.38e-1)" "unprognostic (1.58e-1)" "unprognostic (1.88e-3)" "unprognostic (7.36e-2)" "unprognostic (8.99e-3)" "unprognostic (3.66e-2)" "unprognostic (1.02e-1)" "unprognostic (1.77e-1)" "unprognostic (1.95e-2)" "unprognostic (2.12e-1)" "unprognostic (1.89e-1)" "unprognostic (8.10e-2)" "unprognostic (7.10e-2)" 33.6 10.4 25.8 29.6 12.8 44.7 28.5 5.5 36.5 28.4 38.1 7.3 13.7 39.7 27.0 20.3 30.1 21.8 42.6 42.9 16.2 10.8 21.2 75.5 58.3 56.9 13.8 18.2 23.6 11.7 20.0 19.7 23.2 14.2 31.4 50.6 12.9 17.6 17.4 64.2 72.4 59.0 43.3 13.6 68.7 25.8 8.3 11.0 7.2 21.5 28.4 13.7 40.8 35.5 0.2 16.5 18.5 14.9 0.1 2.5 3.6 23.4 5.0 3.5 1.1 4.0 13.6 9.4 5.5 32.0 7.3 9.7 4.4 6.7 5.1 2.7 4.9 10.7 7.0 5.9 14.7 14.0 4.7 2.3 60.5 30.4 11.0 41.2 3.7 5.9 8.0 55.4 10.3 45.2 4.7 5.8 3.4 6.2 0.0 3.2 3.4 11.2 4.0 11.3 7.8 3.3 36.8 2.2 4.7 10.3 15.2 2.7 3.6 15.6 6.4 1.2 1.3 0.3 6.9 6.2 17.6 2.5 11.2 12.0 0.1 0.0 5.1 4.2 12.5 14.6 10.1 9.2 3.3 1.7 12.3 2.0 0.2 1.6 2.5 16.5 0.2 1.6 1.6 18.5 0.1 14.9 4.0 0.1 3.6 25.8 12.8 5.5 36.5 16.2 10.8 13.8 18.2 14.2 11.0 47.6 133.7 24.2 580.2 379.6 2.1 25.0 45.9 141.8 183.1 48.8 0.0 42.0 10.0 60.7 3.0 196.3 148.0 23.3 94.2 94.1 55.2 133.5 49.7 211.1 50.3 0.0 88.0 256.6 144.5 1.7 16.7 174.6 64.1 29.7 182.6 1.0 94.1 98.2 23.3 27.9 1.1 51.8 93.5 0.6 2.9 425.2 148.5 18.1 194.6 292.4 ETV1 ER81 ENSG00000006468 "ETS variant 1" P50549 7 13891228-13991425 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 90.0;salivary gland: 45.8" "Cell type enhanced" "Detected in many" 16 "Alveolar cells type 2: 112.4;Cardiomyocytes: 72.8;Intestinal endocrine cells: 190.4" "Cancer enhanced" "Detected in all" "glioma: 22.5" "Region enriched" "Detected in all" 8 "cerebellum: 90.0" "Cell type enriched" "Detected in single" 5 "T-reg: 3.1" "Lineage enriched" "Detected in single" 5 "T-cells: 3.1" "Cell line enhanced" "Detected in many" "AN3-CA: 22.2;hTERT-RPE1: 25.6;SCLC-21H: 26.3;U-87 MG: 51.8;WM-115: 25.6" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 418.9" "HPA068389, HPA077249" Supported Approved Nucleoplasm No No Nucleoplasm "HPA068389: , HPA077249: AB_2686829" "unprognostic (2.45e-1)" "unprognostic (1.01e-1)" "unprognostic (6.98e-2)" "unprognostic (1.04e-1)" "unprognostic (1.49e-2)" "unprognostic (2.13e-2)" "unprognostic (1.64e-7)" "unprognostic (7.08e-3)" "unprognostic (7.21e-2)" "unprognostic (2.36e-1)" "unprognostic (2.01e-1)" "unprognostic (3.02e-1)" "unprognostic (1.51e-3)" "unprognostic (2.21e-2)" "unprognostic (2.05e-1)" "unprognostic (1.05e-1)" "unprognostic (1.20e-2)" 2.5 12.4 8.1 1.1 11.7 0.2 4.4 90.0 35.2 1.4 2.4 3.1 0.1 1.2 2.4 1.3 1.5 1.1 9.2 18.0 7.0 4.5 2.1 2.0 14.9 0.7 4.5 6.9 1.0 1.6 11.4 7.4 1.9 8.3 3.1 2.4 0.9 45.8 7.1 0.9 1.5 1.9 2.0 3.5 4.5 1.7 4.5 2.9 0.3 6.5 0.9 4.7 1.8 1.3 0.0 0.0 0.0 0.6 0.0 3.1 0.2 0.0 1.6 11.6 22.2 4.1 12.2 0.0 1.0 3.9 0.6 2.6 0.0 5.3 0.0 1.2 1.8 3.2 0.1 0.4 1.2 1.4 0.3 0.5 0.6 1.0 0.0 2.4 3.8 1.5 3.6 0.0 7.6 0.6 25.6 5.0 0.3 3.4 0.1 4.7 0.0 0.0 0.0 17.5 0.6 11.8 0.0 7.1 0.9 7.9 0.1 26.3 5.1 0.0 0.4 6.3 4.2 0.4 0.1 2.7 2.3 0.7 4.5 4.3 4.0 1.2 0.0 51.8 0.2 25.6 0.0 0.2 0.0 0.1 0.6 0.3 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.2 8.1 11.7 90.0 10.9 7.0 4.5 4.5 6.9 8.3 2.9 17.9 112.4 0.0 2.5 0.9 4.2 72.8 38.2 1.4 1.2 3.5 0.0 0.4 5.0 2.7 18.7 5.2 0.0 0.0 0.8 0.3 4.2 0.2 2.3 11.0 2.6 4.8 190.4 1.8 6.0 6.6 1.4 0.8 11.8 0.0 0.7 12.2 0.9 0.0 32.5 2.7 0.4 19.4 8.2 0.5 1.0 1.1 0.2 0.7 1.1 0.3 ETV3 PE-1 ENSG00000117036 "ETS variant 3" P41162 1 157121191-157138474 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "monocytes: 155.1;Suprabasal keratinocytes: 68.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004794, HPA073211" Supported Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA004794: AB_1078761, HPA073211: " "unprognostic (1.65e-1)" "unprognostic (2.37e-1)" "unprognostic (3.78e-2)" "unprognostic (4.39e-2)" "unprognostic (7.59e-2)" "unprognostic (5.23e-2)" "unprognostic (1.38e-2)" "unprognostic (3.30e-1)" "unprognostic (2.36e-2)" "unprognostic (5.37e-2)" "unprognostic (1.34e-2)" "unprognostic (8.02e-2)" "unprognostic (7.26e-3)" "unprognostic (1.18e-1)" "unprognostic (1.22e-1)" "unprognostic (8.97e-2)" "unprognostic (6.65e-2)" 15.2 7.0 8.9 9.2 10.1 17.8 10.9 9.0 9.3 14.2 12.7 10.2 13.1 13.0 13.1 10.6 20.8 10.8 11.3 9.4 8.6 7.7 6.4 7.4 13.0 8.1 8.9 5.7 11.8 7.2 25.9 7.5 19.5 9.9 12.7 8.6 9.7 11.0 8.1 9.9 37.2 15.1 13.2 7.1 10.7 10.4 8.9 11.0 14.4 8.4 13.6 17.0 14.0 14.3 4.4 7.4 8.9 8.1 6.6 10.8 3.8 6.9 6.9 7.2 6.1 10.8 7.2 6.1 6.5 6.9 6.6 6.2 7.3 6.9 8.4 8.4 8.0 3.5 10.8 7.9 10.1 8.5 18.3 5.0 7.0 7.1 3.9 6.5 11.0 11.1 8.0 11.9 9.8 8.2 5.2 6.6 5.5 8.1 6.2 7.3 9.2 3.3 6.2 23.4 10.1 5.3 5.1 8.5 9.6 4.9 26.2 6.0 11.7 7.1 17.0 17.3 13.2 8.6 12.2 11.2 8.3 7.4 8.0 8.2 15.2 7.8 10.2 9.6 6.4 27.3 8.3 8.1 5.4 7.9 6.7 10.8 3.8 6.9 7.8 7.4 4.4 7.2 6.3 8.9 6.6 6.2 2.2 5.2 3.8 8.9 10.1 9.0 9.3 8.6 7.7 8.9 5.7 9.9 11.0 32.8 15.2 9.0 15.3 62.5 2.5 7.3 10.2 24.1 20.5 12.2 9.8 6.4 0.0 5.2 7.3 14.6 16.6 0.0 5.5 6.6 20.6 12.8 21.9 6.8 8.3 1.6 10.3 16.5 13.7 4.7 3.7 27.5 15.1 155.1 11.3 3.8 8.0 11.8 4.2 2.2 5.4 12.9 11.2 6.4 9.0 68.8 12.5 22.4 11.3 42.4 ETV5 ERM ENSG00000244405 "ETS variant 5" P41161 3 186046308-186110318 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 55.3" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 62.8;Syncytiotrophoblasts: 74.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-MEL-30: 56.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009590, HPA063065, HPA073889" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB009590: AB_2101008, HPA063065: AB_2684936, HPA073889: " "unprognostic (3.85e-1)" "unprognostic (5.81e-2)" "unprognostic (1.54e-2)" "unprognostic (3.30e-1)" "unprognostic (9.00e-2)" "unprognostic (2.56e-3)" "prognostic unfavorable (7.85e-9)" "unprognostic (3.52e-3)" "unprognostic (2.97e-1)" "unprognostic (1.22e-2)" "unprognostic (4.18e-2)" "unprognostic (1.48e-1)" "unprognostic (1.57e-3)" "unprognostic (6.80e-2)" "unprognostic (1.57e-1)" "unprognostic (3.58e-2)" "unprognostic (3.84e-3)" 5.8 30.3 13.2 5.5 21.7 1.6 11.3 12.1 35.2 4.7 3.0 15.7 1.3 5.1 6.8 6.2 3.8 4.6 4.8 8.8 13.6 9.4 7.1 6.2 21.9 8.9 9.9 11.0 2.5 25.4 55.3 28.1 24.3 11.5 6.3 3.1 7.4 5.5 5.1 9.8 5.3 2.8 6.1 9.6 10.0 11.9 7.2 6.1 2.0 16.6 1.7 3.6 3.6 3.6 0.6 1.8 0.9 3.1 0.1 0.3 0.5 13.0 9.0 11.6 25.3 7.2 7.4 0.8 11.2 12.6 8.9 9.6 9.9 8.0 0.3 15.1 10.8 13.4 2.2 0.2 8.5 13.2 2.8 0.3 3.8 0.3 11.1 11.9 9.5 7.1 6.5 1.4 14.2 17.4 10.6 13.0 1.3 3.5 4.7 15.1 6.0 1.2 14.5 17.3 3.7 10.2 26.7 11.6 8.7 7.3 3.1 0.5 14.9 2.7 0.1 56.7 4.8 0.0 5.3 12.6 4.9 8.0 12.3 21.9 3.6 14.7 0.1 14.9 7.6 29.1 0.0 0.3 0.1 0.3 3.1 0.0 0.6 0.0 0.0 1.8 0.1 0.0 0.0 0.9 0.1 1.5 1.6 0.0 0.5 13.2 21.7 12.1 31.7 13.6 9.4 9.9 11.0 11.5 6.1 3.0 55.6 4.2 10.8 14.0 15.6 4.7 20.4 1.4 2.3 0.0 11.8 53.9 3.3 8.2 19.2 8.3 1.0 0.0 8.0 16.2 11.4 2.6 8.1 8.5 45.7 4.8 10.3 14.7 47.8 37.8 8.3 13.5 15.1 2.8 0.3 62.8 9.4 0.0 14.5 11.8 15.8 0.0 15.7 17.4 9.3 4.5 74.3 0.9 0.4 1.6 ETV7 "TEL-2, TEL2" ENSG00000010030 "ETS variant 7" Q9Y603 6 36354091-36387800 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 22.2" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 17.9;Cytotrophoblasts: 25.0;Exocrine glandular cells: 20.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 15.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 16.1;BJ hTERT+ SV40 Large T+: 8.4;BJ hTERT+ SV40 Large T+ RasG12V: 16.0;HDLM-2: 33.3" "Low region specificity" "Detected in all" HPA029033 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA029033: AB_10601375" "unprognostic (1.67e-2)" "prognostic favorable (5.16e-4)" "unprognostic (9.48e-2)" "unprognostic (1.57e-2)" "unprognostic (1.51e-1)" "unprognostic (2.62e-3)" "unprognostic (9.08e-2)" "unprognostic (4.11e-2)" "unprognostic (2.08e-2)" "prognostic favorable (5.32e-4)" "unprognostic (6.81e-3)" "unprognostic (1.11e-1)" "unprognostic (1.69e-3)" "unprognostic (5.54e-2)" "unprognostic (4.93e-1)" "unprognostic (1.27e-2)" "prognostic favorable (2.95e-6)" 2.3 2.5 1.7 7.9 1.7 0.9 1.8 0.9 1.5 2.3 15.1 0.9 2.1 14.4 2.0 2.1 4.7 1.9 7.5 0.9 0.9 1.0 3.0 3.6 7.5 4.2 1.1 1.7 3.7 2.4 3.1 9.9 7.2 3.0 5.3 2.2 3.0 8.1 1.5 0.8 15.1 22.2 4.5 1.5 3.3 5.5 1.1 1.3 3.7 5.3 5.5 8.0 4.3 9.8 2.8 0.7 15.4 4.4 0.4 12.0 1.8 2.1 0.3 0.5 1.3 0.0 0.1 16.1 0.2 5.3 8.4 16.0 1.1 4.7 0.7 0.8 0.1 1.4 2.7 0.2 0.9 0.4 33.3 0.6 1.1 0.3 1.2 1.1 0.5 0.6 0.7 1.4 0.4 0.1 0.4 0.2 0.4 0.3 1.0 0.2 0.4 0.7 0.6 1.2 0.7 0.1 3.5 0.3 0.3 0.1 1.3 0.8 0.5 0.8 1.8 0.5 0.8 2.9 1.0 0.7 0.8 0.9 0.4 0.5 0.3 0.5 0.7 0.3 1.9 0.9 0.0 2.9 0.2 1.4 4.4 3.3 2.8 4.5 1.8 0.7 1.1 0.9 1.2 15.4 0.4 1.4 0.0 12.0 1.8 1.7 1.7 0.9 1.5 0.9 1.0 1.1 1.7 3.0 1.3 17.9 17.9 0.0 1.9 1.8 0.2 0.3 0.0 1.4 7.9 0.0 0.0 25.0 0.0 12.2 0.4 0.7 9.3 0.0 20.9 4.3 2.4 3.4 2.3 0.2 2.5 0.0 3.5 0.0 0.8 0.0 1.4 0.5 3.3 10.0 4.6 2.2 12.8 5.8 1.1 0.8 0.6 0.0 8.2 0.9 16.6 3.1 7.1 0.0 4.5 4.3 EVC DWF-1 ENSG00000072840 "EvC ciliary complex subunit 1" P57679 4 5711197-5814305 "Disease related genes, Predicted membrane proteins" "Ciliopathy, Disease mutation, Dwarfism, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Fibroblasts: 8.0;Melanocytes: 5.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+: 26.4;hTERT-HME1: 26.4;hTERT-RPE1: 22.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008703, HPA016046" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA008703: AB_1078765, HPA016046: AB_1848299" "unprognostic (1.69e-1)" "unprognostic (5.39e-2)" "unprognostic (1.15e-1)" "unprognostic (6.58e-2)" "unprognostic (6.61e-2)" "unprognostic (9.37e-2)" "unprognostic (5.40e-2)" "unprognostic (1.07e-1)" "unprognostic (2.30e-1)" "unprognostic (2.56e-2)" "unprognostic (9.63e-2)" "unprognostic (2.82e-1)" "prognostic favorable (5.60e-9)" "unprognostic (3.29e-2)" "unprognostic (1.40e-1)" "unprognostic (1.86e-2)" "prognostic unfavorable (9.47e-5)" 5.0 2.9 2.5 4.6 2.7 0.0 4.1 1.9 2.3 13.2 4.3 1.8 8.4 0.6 17.2 10.1 6.0 8.1 16.0 3.8 2.2 2.2 26.5 3.7 6.4 1.0 2.3 1.4 20.2 9.2 14.9 2.3 1.8 2.9 10.2 1.6 12.0 9.1 5.7 2.4 4.2 2.8 15.8 2.4 2.1 3.6 5.3 1.0 1.0 6.9 3.9 3.8 7.5 9.0 0.1 0.3 1.2 0.1 0.1 0.5 0.0 3.0 3.9 2.2 5.7 14.3 20.7 0.8 6.9 26.4 8.0 10.4 0.0 0.0 0.0 2.2 10.9 13.4 3.7 2.3 5.7 6.6 5.1 1.5 0.0 2.2 1.0 10.6 0.0 0.6 10.2 8.4 10.7 26.4 22.9 5.5 0.0 0.0 0.0 18.5 0.0 0.0 0.0 2.4 0.0 3.6 4.7 6.0 0.0 2.8 0.5 1.2 3.7 0.0 0.0 2.8 2.2 1.4 0.2 9.6 6.8 1.3 4.8 6.0 4.2 3.4 0.3 19.6 0.0 6.4 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.7 0.1 0.0 0.3 0.5 0.0 2.5 2.7 1.9 2.3 2.2 2.2 2.3 1.4 2.9 1.0 3.0 2.9 0.0 1.6 3.1 0.0 1.6 2.5 1.4 1.2 3.5 0.0 0.0 1.7 0.4 0.4 0.0 0.0 0.0 0.0 0.0 8.0 0.7 0.0 0.8 0.0 0.0 0.0 1.3 0.0 0.0 0.9 0.0 5.0 0.0 0.0 2.1 0.2 0.0 0.7 1.1 0.0 0.0 1.7 0.0 0.0 2.5 0.1 0.0 0.0 1.1 EVI2A "EVDA, EVI2" ENSG00000126860 "Ecotropic viral integration site 2A" P22794 17 31317560-31321884 "Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.7;brain: 74.0" "Group enriched" "Detected in many" 4 "granulocytes: 75.5;Hofbauer cells: 100.8;Kupffer cells: 231.8;Macrophages: 127.6;T-cells: 130.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 20.2;Karpas-707: 33.4;RPMI-8226: 51.6" "HPA045033, HPA057051" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA045033: AB_2679191, HPA057051: AB_2683321" "unprognostic (7.75e-2)" "unprognostic (1.54e-2)" "unprognostic (3.48e-2)" "unprognostic (1.39e-2)" "unprognostic (8.49e-2)" "unprognostic (4.89e-2)" "unprognostic (1.88e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (7.55e-4)" "unprognostic (1.90e-1)" "unprognostic (3.54e-2)" "unprognostic (3.15e-2)" "prognostic unfavorable (2.63e-6)" "unprognostic (7.64e-2)" "unprognostic (4.95e-2)" "unprognostic (5.87e-2)" "unprognostic (2.90e-2)" 6.4 4.7 26.8 25.8 36.0 15.1 4.7 3.8 30.0 5.2 6.2 16.5 0.0 6.3 2.2 1.6 3.5 2.1 10.6 2.6 42.5 21.8 2.2 5.3 12.5 27.4 64.7 13.9 1.6 1.6 1.0 1.6 11.6 33.7 2.4 8.2 0.0 3.0 2.0 1.2 1.5 6.8 4.1 74.0 20.4 6.9 1.2 59.7 32.1 2.0 0.6 22.6 14.2 2.2 8.6 17.9 51.7 26.5 8.9 19.2 23.9 0.0 0.0 0.0 0.0 1.7 10.6 0.0 1.3 2.2 1.7 6.1 0.0 0.5 9.0 0.0 1.7 9.9 0.0 0.0 0.1 4.9 0.0 0.0 0.0 0.0 0.0 20.2 10.4 11.4 13.1 0.0 2.4 7.0 2.6 0.6 8.3 0.3 33.4 13.2 0.1 7.4 11.4 0.0 0.0 0.0 7.8 1.3 51.6 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 11.4 4.3 7.3 0.2 0.3 4.8 15.0 0.0 10.1 5.9 7.6 6.0 1.3 26.5 1.0 11.3 12.7 13.7 8.6 16.1 13.1 17.9 4.2 19.2 16.8 51.7 8.9 9.6 5.9 17.1 23.9 26.8 36.0 3.8 24.0 42.5 21.8 64.7 13.9 33.7 59.7 0.0 6.4 31.5 0.3 3.5 0.2 0.3 0.0 2.7 2.3 0.0 0.0 0.6 0.0 0.0 2.0 1.3 0.0 0.0 0.0 0.5 2.6 0.2 75.5 0.8 100.8 0.0 0.0 7.4 231.8 0.0 0.3 127.6 13.5 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.7 0.0 1.6 0.1 0.2 2.8 1.1 130.3 0.0 0.3 EVI2B "CD361, D17S376, EVDB" ENSG00000185862 "Ecotropic viral integration site 2B" P34910 17 31303766-31314112 "CD markers, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 133.6;lymphoid tissue: 72.8" "Cell type enhanced" "Detected in many" 16 "B-cells: 217.4;Kupffer cells: 447.5;Macrophages: 274.7;T-cells: 178.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 133.6" "Group enriched" "Detected in all" 4 "granulocytes: 133.6;monocytes: 34.3" "Cell line enhanced" "Detected in many" "Daudi: 24.2;HHSteC: 19.9;HL-60: 27.3;HMC-1: 38.5;Karpas-707: 27.3;NB-4: 21.6;RPMI-8226: 39.9;THP-1: 34.4" "Low region specificity" "Detected in all" HPA007436 Enhanced Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA Nucleoplasm "Plasma membrane, Focal adhesion sites" "HPA007436: AB_1848307" "unprognostic (1.07e-2)" "unprognostic (1.20e-2)" "unprognostic (5.97e-2)" "unprognostic (4.09e-3)" "unprognostic (2.99e-2)" "unprognostic (1.41e-2)" "unprognostic (3.06e-1)" "unprognostic (3.36e-2)" "unprognostic (1.93e-2)" "unprognostic (1.48e-1)" "unprognostic (1.78e-2)" "unprognostic (2.34e-1)" "prognostic unfavorable (2.05e-4)" "unprognostic (1.56e-2)" "unprognostic (3.32e-2)" "unprognostic (8.64e-2)" "unprognostic (2.73e-2)" 15.0 3.6 4.4 37.7 5.8 44.0 4.2 1.7 4.4 3.7 10.7 6.5 0.3 6.0 2.8 4.8 7.1 4.7 8.1 6.7 6.4 4.4 7.8 7.1 38.5 37.5 10.2 2.6 3.8 2.7 0.4 2.1 4.8 7.8 5.3 8.1 2.5 6.6 1.5 2.3 2.4 23.3 4.2 22.0 72.8 8.0 3.7 6.7 26.1 4.0 3.0 43.0 13.0 7.6 18.6 14.6 133.6 34.3 4.1 16.4 19.8 0.1 0.1 0.0 0.0 1.9 2.5 0.0 0.2 1.7 2.0 3.7 0.0 0.9 24.2 0.0 1.5 7.5 0.1 0.0 0.3 2.2 0.0 0.0 0.5 0.0 0.0 19.9 27.3 38.5 4.6 0.0 1.1 1.5 0.6 1.9 2.0 0.3 27.3 5.7 0.0 7.9 21.6 0.0 0.0 0.0 13.9 0.1 39.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 34.4 2.1 0.5 0.0 0.2 1.9 5.3 0.2 5.3 2.5 9.4 0.6 78.9 30.5 74.5 8.2 23.2 7.9 18.6 12.6 10.6 14.6 14.3 9.7 9.1 133.6 4.1 34.3 8.4 16.4 19.8 4.4 5.8 1.7 4.4 6.4 4.4 10.2 2.6 7.8 6.7 0.0 17.9 217.4 0.6 4.7 0.2 0.4 2.5 4.0 11.4 1.8 0.0 0.5 0.0 0.0 5.3 2.7 0.2 0.0 0.0 0.5 2.8 0.3 78.7 1.7 88.8 0.0 0.0 9.8 447.5 4.7 0.0 274.7 35.4 10.8 0.0 0.0 0.7 0.0 0.4 0.7 0.8 19.4 4.1 0.3 0.5 3.1 0.2 178.5 0.0 1.1 EVPLL ENSG00000214860 "Envoplakin like" A8MZ36 17 18377662-18389647 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 22.2;lymphoid tissue: 10.4" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 2: 1.9;Basal glandular cells: 1.7;Club cells: 2.3;Collecting duct cells: 1.8;Spermatogonia: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.9;HaCaT: 1.9;HeLa: 3.3;hTCEpi: 11.5;RT4: 4.0;SiHa: 2.1;T-47d: 3.5" HPA045728 Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA045728: AB_10960394" "unprognostic (1.34e-1)" "unprognostic (4.88e-2)" "unprognostic (2.06e-5)" "unprognostic (1.58e-1)" "unprognostic (2.08e-2)" "unprognostic (1.64e-2)" "unprognostic (3.07e-1)" "unprognostic (3.62e-1)" "unprognostic (4.60e-4)" "unprognostic (5.28e-2)" "unprognostic (2.58e-1)" "unprognostic (1.43e-2)" "unprognostic (5.06e-2)" 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 3.3 0.5 0.0 0.7 0.4 0.8 0.9 22.2 0.4 0.8 0.0 0.0 0.0 0.9 2.0 1.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 1.7 0.2 0.0 2.1 3.1 0.1 7.8 0.4 1.4 0.0 0.1 1.7 2.5 0.0 0.1 2.2 9.5 10.4 3.5 7.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.0 0.5 0.0 2.1 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.7 0.5 0.0 0.0 0.0 0.0 2.3 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 3.4 1.1 0.0 0.0 0.0 1.0 EVX1 ENSG00000106038 "Even-skipped homeobox 1" P49640 7 27242700-27250493 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 6.5;prostate: 6.4;seminal vesicle: 6.7;urinary bladder: 8.9" "Group enriched" "Detected in some" 29 "Early spermatids: 49.8;Late spermatids: 47.8" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 26 "pons and medulla: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "OE19: 21.4;RT4: 13.3" "Group enriched" "Detected in some" 15 "midbrain: 1.0;pons and medulla: 1.0" "Not detected" "Not detected" HPA055132 Approved Nucleoplasm NA NA Nucleoplasm "HPA055132: AB_2682707" "unprognostic (2.73e-2)" "unprognostic (3.59e-1)" "unprognostic (4.31e-1)" "unprognostic (5.16e-2)" "unprognostic (1.76e-3)" "unprognostic (2.08e-2)" "unprognostic (8.48e-3)" "unprognostic (5.94e-2)" "unprognostic (1.26e-8)" "unprognostic (2.94e-1)" "unprognostic (1.39e-1)" "unprognostic (9.12e-2)" "unprognostic (1.83e-2)" 0.1 6.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 4.2 0.6 0.1 0.1 0.0 0.9 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.5 3.0 6.4 0.7 0.1 0.1 6.7 0.1 0.0 0.1 1.9 0.1 0.1 0.0 1.7 0.1 0.1 0.1 0.1 0.1 8.9 5.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 0.2 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 3.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 47.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.7 EWSR1 EWS ENSG00000182944 "EWS RNA binding protein 1" Q01844 22 29268009-29300525 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Calmodulin-binding, Repressor, RNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004230, HPA051771, HPA062953" Enhanced Enhanced "Nucleoplasm,Nucleoli rim" No No Nucleoplasm "Nucleoli rim" "CAB004230: AB_675526, HPA051771: AB_2681602, HPA062953: AB_2684910" "unprognostic (1.96e-1)" "unprognostic (6.39e-3)" "unprognostic (1.32e-1)" "unprognostic (3.93e-2)" "unprognostic (3.59e-1)" "unprognostic (3.15e-2)" "prognostic unfavorable (1.27e-6)" "unprognostic (1.33e-1)" "unprognostic (1.09e-2)" "unprognostic (2.71e-2)" "unprognostic (7.04e-2)" "unprognostic (9.30e-2)" "prognostic unfavorable (1.21e-5)" "unprognostic (7.33e-3)" "unprognostic (1.79e-1)" "unprognostic (3.67e-2)" "unprognostic (1.50e-3)" 35.3 43.2 45.3 41.3 51.3 67.5 32.1 58.2 48.6 32.4 39.8 43.2 31.3 41.0 45.1 38.5 40.8 37.6 25.9 40.7 40.1 32.8 33.0 48.5 33.4 50.5 32.7 49.9 38.4 32.0 47.2 44.3 34.0 41.7 35.0 39.9 41.5 32.3 38.2 52.8 34.8 36.6 40.5 33.8 44.1 34.5 85.6 32.5 39.9 32.5 30.9 55.4 36.4 34.5 52.0 65.8 50.6 81.1 58.4 67.8 76.1 57.2 44.6 61.4 47.7 31.3 26.0 42.2 34.9 55.8 57.9 49.7 50.8 29.8 78.3 22.1 53.5 44.0 45.0 87.4 71.4 59.7 53.3 62.3 59.1 39.5 48.6 46.9 90.9 42.3 39.7 30.1 48.3 78.4 27.8 44.8 37.5 44.2 35.4 42.8 57.5 91.2 34.8 43.1 47.4 34.0 64.1 59.1 47.3 53.2 60.9 50.3 48.1 43.4 50.9 37.6 42.2 32.7 49.5 45.7 35.4 39.3 22.2 50.6 46.0 36.9 72.6 33.7 40.5 43.0 48.4 57.9 50.6 60.2 81.1 60.7 50.4 56.6 59.6 65.8 52.0 55.8 53.6 43.3 58.4 78.6 35.3 67.8 76.1 45.3 51.3 58.2 48.6 40.1 32.8 32.7 49.9 41.7 32.5 95.3 103.6 96.6 120.0 61.7 71.3 60.0 89.2 124.5 102.4 61.1 70.7 120.3 56.3 106.1 87.5 78.6 71.5 70.0 93.8 108.0 78.0 80.7 117.8 64.2 85.5 77.9 77.7 82.3 69.0 21.4 57.0 89.6 77.6 112.8 73.3 66.1 95.4 94.7 58.4 59.1 77.8 51.8 86.8 180.0 109.0 51.2 127.5 88.0 89.6 101.6 EXO1 "HEX1, hExoI" ENSG00000174371 "Exonuclease 1" Q9UQ84 1 241847967-241895148 "Predicted intracellular proteins" "DNA damage, DNA excision, DNA repair, Immunity, Meiosis" "DNA-binding, Endonuclease, Excision nuclease, Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.6;lymphoid tissue: 31.3;testis: 14.8" "Cell type enhanced" "Detected in some" 14 "Early spermatids: 4.7;Extravillous trophoblasts: 14.1;Spermatocytes: 9.8;Spermatogonia: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA053079, HPA069738" Enhanced "Nucleoplasm,Nuclear bodies" NA Yes Nucleoplasm "Nuclear bodies" "HPA053079: AB_2682037, HPA069738: AB_2732140" "unprognostic (6.33e-3)" "unprognostic (8.54e-3)" "unprognostic (9.47e-3)" "prognostic unfavorable (8.21e-4)" "unprognostic (2.43e-1)" "unprognostic (6.34e-2)" "prognostic unfavorable (6.94e-7)" "unprognostic (1.84e-3)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.40e-2)" "unprognostic (4.81e-3)" "unprognostic (9.40e-2)" "unprognostic (0.00e+0)" "unprognostic (6.72e-2)" "unprognostic (2.29e-1)" "unprognostic (1.75e-1)" "unprognostic (3.57e-1)" 2.1 1.0 0.9 10.3 1.0 15.6 1.0 0.3 1.3 1.3 3.1 0.3 0.1 2.9 0.7 0.8 6.2 0.4 1.3 1.5 0.7 0.6 0.9 1.3 1.5 5.6 0.6 0.3 1.3 1.3 1.8 0.4 4.6 0.7 0.7 3.9 0.3 1.4 0.1 1.0 1.7 4.2 1.0 0.6 5.7 1.5 14.8 0.1 31.3 0.6 4.0 8.1 1.6 2.0 1.4 0.6 2.9 0.7 0.9 3.3 1.0 15.1 10.1 16.7 11.0 1.0 2.7 14.1 20.2 6.8 18.1 19.8 12.6 8.6 16.6 9.9 4.7 9.5 15.1 21.1 8.4 21.5 25.6 18.5 15.4 10.8 6.4 0.3 21.9 11.5 0.6 0.4 18.0 4.9 2.2 5.6 16.3 30.8 21.9 14.4 7.0 23.6 12.4 22.8 18.5 10.0 17.1 15.6 17.7 3.7 9.6 18.7 23.7 13.2 10.7 7.1 8.2 9.9 13.6 2.0 17.6 15.5 16.5 27.2 16.1 21.3 26.7 6.1 17.9 20.9 2.9 0.7 0.0 1.1 0.0 0.0 1.4 1.1 1.1 0.6 1.3 0.6 0.2 0.3 0.9 0.0 0.1 3.3 1.0 0.9 1.0 0.3 1.3 0.7 0.6 0.6 0.3 0.7 0.1 0.0 0.0 0.0 0.1 0.7 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 4.7 0.0 0.0 0.0 0.0 14.1 0.3 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 9.8 6.9 0.1 3.3 0.7 0.6 0.1 EXO5 "C1orf176, DEM1, FLJ21144" ENSG00000164002 "Exonuclease 5" Q9H790 1 40508741-40516556 "Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 57.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028429 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA028429: AB_2092105" "unprognostic (9.44e-2)" "unprognostic (7.36e-2)" "unprognostic (3.69e-2)" "unprognostic (6.65e-2)" "unprognostic (1.66e-1)" "unprognostic (3.23e-2)" "prognostic unfavorable (9.16e-6)" "unprognostic (4.65e-2)" "unprognostic (2.24e-3)" "unprognostic (1.91e-3)" "unprognostic (4.78e-2)" "prognostic unfavorable (2.93e-4)" "unprognostic (9.95e-3)" "unprognostic (4.36e-2)" "unprognostic (4.13e-1)" "unprognostic (9.85e-3)" "unprognostic (2.53e-1)" 8.6 9.1 9.9 8.6 12.4 6.5 16.9 13.9 10.4 8.6 8.4 5.5 11.1 6.9 11.7 8.9 8.5 8.4 7.5 10.3 8.5 5.9 9.9 10.7 8.3 12.3 6.4 10.2 7.5 8.1 8.4 6.9 8.1 6.5 8.9 8.4 7.3 9.0 11.8 6.2 8.2 10.0 12.5 6.1 13.8 7.2 10.1 7.5 15.7 7.3 5.8 16.9 8.6 10.8 11.8 7.9 16.4 9.8 8.6 14.9 7.0 5.5 2.0 5.0 8.3 3.3 3.0 3.4 7.5 1.9 6.8 8.2 3.5 6.7 7.5 4.7 4.8 7.7 6.9 4.8 5.0 8.2 2.5 3.1 6.5 9.4 4.9 4.1 0.0 6.5 3.1 3.2 9.4 3.5 2.0 4.3 5.3 7.5 0.0 9.7 2.3 10.2 5.1 7.5 0.9 0.8 7.8 16.9 2.9 3.4 8.6 6.0 5.3 9.7 3.5 6.2 7.9 4.9 57.6 4.7 4.7 14.1 10.5 7.3 2.2 6.9 0.0 0.6 2.0 9.3 7.5 6.6 16.4 14.9 9.8 12.3 11.8 10.4 10.7 7.9 9.8 12.8 12.4 11.3 8.6 7.2 6.4 13.4 7.0 9.9 12.4 13.9 10.4 8.5 5.9 6.4 10.2 6.5 7.5 0.0 1.7 1.4 0.9 0.8 3.0 0.8 2.5 2.7 2.3 7.0 3.9 3.8 0.0 4.1 0.9 2.5 1.7 0.0 2.1 4.4 2.5 0.7 5.7 1.8 4.4 3.2 1.2 1.8 1.5 0.8 3.1 2.1 1.7 5.4 3.0 4.3 2.6 2.0 1.8 2.1 3.2 6.5 2.3 3.9 3.2 0.9 1.6 2.2 3.7 0.3 EXOC3 "SEC6L1, Sec6p" ENSG00000180104 "Exocyst complex component 3" O60645 5 443158-471937 "Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 31.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037880 Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA037880: AB_2675716" "unprognostic (2.94e-1)" "unprognostic (4.74e-3)" "unprognostic (4.82e-3)" "unprognostic (4.10e-1)" "unprognostic (6.18e-2)" "unprognostic (1.10e-2)" "unprognostic (2.91e-3)" "unprognostic (1.91e-1)" "unprognostic (6.62e-2)" "unprognostic (3.26e-1)" "prognostic favorable (1.54e-4)" "unprognostic (6.54e-2)" "unprognostic (2.33e-1)" "unprognostic (5.02e-2)" "unprognostic (2.97e-1)" "unprognostic (1.82e-1)" "unprognostic (1.70e-1)" 18.7 15.6 22.0 20.7 22.4 19.1 16.5 20.1 28.6 18.1 22.4 22.5 22.3 18.3 22.2 14.9 26.3 19.0 20.9 20.8 22.5 17.3 15.9 14.1 15.6 18.8 23.3 29.5 21.6 23.5 20.8 18.0 17.9 22.7 17.6 13.3 14.5 23.9 20.2 47.5 24.9 17.1 26.7 16.2 18.2 20.8 40.7 21.0 13.3 19.8 20.7 17.4 20.8 17.6 3.6 3.5 31.0 6.2 9.8 6.4 4.4 12.7 21.5 7.3 16.2 12.5 10.8 18.1 11.3 11.8 11.5 13.9 10.8 18.9 10.9 17.7 14.2 14.1 14.6 5.8 9.8 8.4 40.0 10.1 11.7 45.1 8.1 11.7 17.5 29.6 11.0 7.3 12.8 11.3 12.1 12.8 7.2 8.9 7.1 8.9 15.1 12.5 20.8 6.0 7.8 12.9 10.3 8.3 13.9 9.7 16.1 7.3 9.3 28.3 16.1 11.0 7.4 21.7 20.2 9.5 11.4 14.1 8.7 9.1 12.1 8.7 7.7 12.0 21.2 10.3 5.4 5.7 31.0 6.4 6.2 5.4 3.3 5.0 5.1 3.5 3.6 6.4 5.9 7.9 9.8 4.4 2.6 6.4 4.4 22.0 22.4 20.1 28.6 22.5 17.3 23.3 29.5 22.7 21.0 20.8 26.1 14.5 14.7 38.0 13.8 26.6 12.7 33.5 20.5 14.0 33.4 20.2 23.2 23.4 22.8 15.3 23.8 0.0 25.9 19.0 15.8 14.7 23.0 15.7 20.9 60.4 5.2 13.5 24.4 44.8 18.7 21.7 25.3 21.6 18.6 16.9 24.4 20.1 15.9 20.3 19.2 19.4 22.3 30.9 16.2 47.0 28.5 19.1 20.7 20.4 EXOC3L2 "FLJ36147, XTP7" ENSG00000283632 "Exocyst complex component 3 like 2" Q2M3D2 19 45212621-45245431 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 10 "Ito cells: 57.1" "Group enriched" "Detected in some" 4 "basophil: 1.6;neutrophil: 2.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.5" "Group enriched" "Detected in some" 7 "HEL: 18.2;K-562: 16.8" "HPA041595, HPA061110" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" NA NA Vesicles "Nucleoplasm, Golgi apparatus, Cytosol" "HPA041595: AB_10794521, HPA061110: AB_2684431" 3.2 4.3 0.0 2.0 0.0 0.9 3.0 0.0 0.3 3.6 2.1 0.1 2.4 2.3 14.5 1.2 2.3 0.6 6.9 1.9 0.0 12.7 9.4 3.4 6.3 0.0 0.0 3.4 2.8 2.4 3.5 0.4 0.0 3.7 0.2 13.7 3.3 3.6 1.0 2.4 3.9 1.6 0.0 12.6 2.4 2.1 0.0 0.0 4.6 1.5 3.2 1.6 3.3 0.5 0.3 2.5 0.4 0.2 0.4 0.2 0.1 0.3 2.3 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.1 2.2 0.0 0.2 1.2 0.0 0.1 0.0 0.1 0.0 18.2 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 16.8 0.3 0.0 0.2 0.0 0.0 0.2 0.1 0.5 1.3 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.1 0.1 0.7 0.1 0.3 0.4 0.8 1.6 0.3 0.1 0.2 0.1 0.0 0.1 0.2 0.1 1.6 0.4 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.3 2.5 0.2 0.3 0.3 0.1 0.2 0.0 2.2 0.0 0.3 0.3 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 57.1 1.5 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.8 0.0 0.1 0.0 0.1 0.2 3.4 0.6 0.0 0.0 0.0 0.1 EXOC4 "KIAA1699, MGC27170, SEC8, SEC8L1, Sec8p" ENSG00000131558 "Exocyst complex component 4" Q96A65 7 133253073-134066589 "Plasma proteins, Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Rod photoreceptor cells: 229.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031443, HPA031444" Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Cytosol" "HPA031443: AB_10602496, HPA031444: AB_2673886" "unprognostic (1.70e-1)" "unprognostic (1.62e-2)" "unprognostic (2.05e-1)" "unprognostic (5.09e-2)" "unprognostic (1.03e-1)" "unprognostic (4.06e-3)" "unprognostic (8.63e-2)" "unprognostic (2.33e-1)" "unprognostic (4.40e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (6.19e-4)" "unprognostic (9.78e-3)" "prognostic favorable (6.85e-5)" "unprognostic (5.91e-2)" "unprognostic (2.18e-1)" "unprognostic (3.37e-1)" "unprognostic (3.35e-2)" 21.2 23.7 18.5 17.7 22.3 10.5 19.4 25.7 24.4 20.8 17.0 19.7 22.2 11.2 25.8 20.6 21.5 24.2 16.8 16.5 14.7 15.4 15.6 15.2 16.5 12.6 14.2 19.3 27.7 26.5 28.5 31.2 16.4 22.0 16.9 18.8 19.3 20.5 18.8 50.7 24.4 13.7 20.8 18.7 17.9 16.3 17.2 17.3 34.7 22.9 18.3 22.1 26.3 20.6 8.3 16.3 8.1 12.7 18.4 12.4 10.4 17.8 14.7 20.4 20.1 23.9 25.0 7.1 13.1 21.9 11.9 15.7 8.5 25.2 13.4 9.5 24.6 17.5 11.4 10.9 17.9 19.8 20.4 13.1 10.8 15.5 8.9 26.3 14.2 11.8 24.3 22.4 17.0 31.5 26.4 20.3 17.8 15.5 13.4 22.1 11.7 25.8 15.7 15.3 21.5 13.8 11.5 18.1 24.1 19.2 16.0 15.9 25.1 19.7 18.2 21.1 24.0 12.0 13.4 22.0 13.3 7.0 14.0 14.3 21.3 13.0 13.0 39.3 16.7 20.2 8.1 12.0 6.9 11.8 12.7 10.5 8.3 12.3 12.4 16.3 8.0 10.1 10.4 4.0 18.4 10.5 7.3 12.4 10.4 18.5 22.3 25.7 24.4 14.7 15.4 14.2 19.3 22.0 17.3 20.8 21.1 11.9 14.2 16.8 35.3 24.9 7.6 18.7 15.9 14.0 88.4 13.6 3.3 12.9 23.1 21.5 15.8 0.0 15.7 13.8 11.9 17.0 8.1 14.4 15.6 47.7 16.7 24.5 30.4 20.6 16.1 18.0 13.5 12.6 21.4 20.6 13.9 17.5 17.7 13.3 229.7 12.9 10.8 18.1 12.6 14.9 9.4 20.8 18.4 16.9 EXOC6 "DKFZp761I2124, EXOC6A, FLJ1125, MGC33397, SEC15L, SEC15L1, Sec15p" ENSG00000138190 "Exocyst complex component 6" Q8TAG9 10 92834713-93059493 "Plasma proteins, Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Rod photoreceptor cells: 133.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 21.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 46.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036285, HPA059111" Approved Supported Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA036285: AB_10673617, HPA059111: AB_2683907" "unprognostic (1.41e-1)" "unprognostic (1.39e-3)" "unprognostic (5.20e-2)" "unprognostic (2.65e-1)" "unprognostic (1.10e-1)" "unprognostic (1.64e-1)" "unprognostic (1.16e-3)" "unprognostic (7.21e-3)" "unprognostic (3.84e-1)" "unprognostic (2.70e-1)" "unprognostic (1.66e-1)" "unprognostic (8.13e-2)" "prognostic favorable (4.66e-4)" "unprognostic (2.12e-2)" "unprognostic (1.00e-1)" "unprognostic (1.42e-1)" "unprognostic (6.41e-2)" 9.7 19.4 15.3 8.5 16.9 11.6 9.4 18.9 16.2 7.4 9.6 4.5 5.1 8.3 7.3 7.5 4.9 6.3 10.3 7.0 15.5 8.6 7.0 10.8 12.0 16.7 6.1 12.8 5.4 12.5 8.2 17.8 34.6 8.1 9.4 10.8 3.5 7.2 5.0 29.3 6.2 9.8 12.8 6.7 12.6 7.6 10.0 8.1 13.5 29.1 10.2 8.2 9.5 8.2 4.9 7.6 21.2 3.4 1.8 2.5 1.7 8.5 10.7 11.4 7.5 0.6 0.7 4.1 3.9 10.9 3.6 4.4 4.0 7.3 9.7 8.3 1.9 2.9 5.4 9.2 2.5 4.6 8.6 9.3 14.1 3.8 5.0 4.4 15.2 12.6 1.0 1.3 3.2 2.2 6.6 46.7 6.4 11.9 6.5 1.7 4.6 6.4 9.9 1.5 17.4 3.1 9.7 4.9 5.0 7.8 5.8 3.8 5.4 4.1 4.1 5.1 3.0 8.1 8.0 9.5 0.2 3.7 3.4 6.4 4.9 5.2 7.9 1.2 17.2 4.0 3.7 3.4 10.1 2.2 2.7 2.2 4.7 2.5 2.1 3.4 4.9 2.1 2.4 21.2 1.8 2.6 7.6 2.3 1.7 15.3 16.9 18.9 16.2 15.5 8.6 6.1 12.8 8.1 8.1 14.9 14.7 15.9 8.5 3.0 36.3 10.8 22.9 12.0 13.6 15.7 37.3 18.0 5.0 22.6 4.1 34.6 10.2 70.0 13.2 6.2 3.6 13.6 10.4 13.4 17.9 22.3 24.5 55.9 20.6 10.9 4.0 14.9 5.0 4.6 14.7 20.2 13.2 8.5 13.8 7.1 133.9 12.9 3.3 15.7 22.4 4.3 17.2 12.8 10.0 15.7 EXOC6B "KIAA0919, SEC15B, SEC15L2" ENSG00000144036 "Exocyst complex component 6B" Q9Y2D4 2 72175984-72826041 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 51.7" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 77.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034546, HPA063991" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA034546: AB_2674218, HPA063991: AB_2685168" "unprognostic (5.29e-2)" "unprognostic (1.40e-1)" "unprognostic (1.92e-1)" "unprognostic (1.18e-3)" "unprognostic (1.81e-1)" "unprognostic (7.56e-2)" "unprognostic (1.06e-2)" "unprognostic (9.34e-2)" "unprognostic (1.32e-1)" "unprognostic (2.16e-3)" "unprognostic (3.38e-2)" "unprognostic (2.61e-1)" "unprognostic (4.35e-3)" "unprognostic (4.38e-3)" "unprognostic (1.55e-1)" "unprognostic (1.18e-1)" "unprognostic (5.29e-2)" 12.1 14.2 17.9 5.7 23.0 1.9 9.5 19.8 23.3 10.2 7.2 18.0 6.0 8.4 11.8 7.5 16.5 8.7 7.8 51.7 18.3 14.4 8.8 4.8 7.9 3.8 18.5 17.0 17.4 6.0 18.6 11.2 34.7 19.8 9.7 7.0 7.3 7.6 10.9 11.2 27.5 10.7 11.6 15.0 6.0 8.0 7.7 20.4 3.1 11.7 7.8 7.3 9.5 12.6 3.0 1.7 3.2 2.0 1.6 3.4 1.2 11.0 8.4 7.8 9.4 22.4 9.3 13.5 8.1 11.5 7.0 4.6 11.4 1.7 2.9 5.1 13.5 10.5 18.5 6.5 13.4 10.2 2.1 5.3 8.5 5.9 6.5 12.1 1.2 2.9 7.9 19.5 7.9 12.4 11.1 11.4 4.5 0.9 0.0 9.2 3.8 3.2 1.5 8.1 7.6 4.7 1.7 14.0 1.1 6.8 26.0 3.9 3.4 13.9 4.3 5.6 9.0 3.0 1.1 12.6 8.2 7.0 6.9 4.9 2.9 2.9 0.0 9.5 0.6 6.5 3.2 1.9 0.2 2.7 1.7 2.1 2.4 2.1 1.7 1.7 3.0 2.4 3.4 0.0 1.6 2.0 0.6 2.6 1.2 17.9 23.0 19.8 22.8 18.3 14.4 18.5 17.0 19.8 20.4 0.0 5.5 0.0 9.0 23.2 16.7 77.2 15.3 8.1 2.3 8.7 23.6 12.0 5.0 7.6 41.6 13.1 12.8 0.0 10.1 10.9 6.2 6.3 8.1 4.9 4.0 15.9 2.9 9.2 9.1 4.0 7.8 4.5 5.0 1.0 4.1 9.1 8.3 8.6 7.1 4.1 9.9 0.0 8.9 8.7 4.8 32.6 20.6 2.5 3.8 7.8 EXOSC1 "CGI-108, CSL4, Csl4p, hCsl4p, p13, SKI4, Ski4p" ENSG00000171311 "Exosome component 1" Q9Y3B2 10 97436142-97446017 "Plasma proteins, Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038370 Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA038370: AB_10672515" "unprognostic (1.77e-2)" "unprognostic (1.08e-2)" "unprognostic (1.32e-2)" "unprognostic (1.28e-2)" "unprognostic (1.00e-1)" "unprognostic (1.10e-2)" "unprognostic (3.27e-3)" "unprognostic (2.33e-2)" "unprognostic (1.62e-2)" "unprognostic (7.44e-2)" "unprognostic (1.90e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (3.88e-9)" "unprognostic (9.40e-2)" "unprognostic (1.07e-1)" "unprognostic (1.28e-2)" "unprognostic (4.41e-2)" 18.2 23.3 22.3 28.8 26.2 24.8 23.4 22.8 26.6 19.9 21.9 21.4 23.4 21.9 22.9 45.6 25.1 20.2 19.2 19.4 21.6 23.2 20.5 24.6 18.3 30.1 24.2 19.8 22.3 35.0 21.0 33.6 22.8 21.8 21.5 26.2 20.6 32.5 27.7 23.6 22.1 20.7 24.2 22.4 27.4 26.2 15.6 20.8 36.6 23.4 21.1 34.1 23.5 19.9 37.3 32.2 30.9 43.0 18.5 47.2 28.4 19.0 19.3 12.3 20.4 17.1 18.3 16.1 17.0 29.4 23.1 26.9 31.1 21.1 21.4 17.0 19.0 16.0 21.4 19.4 22.9 22.6 22.7 24.0 13.2 16.7 23.5 30.0 29.4 14.5 18.9 30.2 26.1 39.7 26.2 26.8 31.8 15.9 35.6 17.9 24.3 27.9 48.8 19.1 24.7 16.7 20.3 14.4 37.0 15.4 11.0 7.0 12.3 12.0 10.1 25.3 17.0 23.7 33.4 13.2 11.5 13.1 17.4 35.5 22.4 27.4 37.3 18.7 37.3 8.7 24.3 31.6 30.9 28.1 43.0 35.3 37.3 35.5 31.9 32.2 29.4 34.2 29.6 13.0 18.5 39.0 28.1 47.2 28.4 22.3 26.2 22.8 26.6 21.6 23.2 24.2 19.8 21.8 20.8 23.8 21.1 55.1 30.1 16.9 30.3 19.1 28.1 30.8 14.8 41.8 25.5 42.5 33.2 32.2 10.1 26.3 18.7 23.3 36.2 48.1 24.7 20.3 24.3 20.4 45.2 28.6 13.7 32.5 31.3 14.7 30.2 29.3 28.7 64.9 24.4 21.5 34.0 17.3 22.6 35.2 46.4 25.8 28.1 26.2 37.3 21.3 34.4 35.9 26.4 31.4 EXOSC10 "p2, p3, p4, PM-Scl, PM/Scl-100, PMSCL2, RRP6, Rrp6p" ENSG00000171824 "Exosome component 10" Q01780 1 11066618-11099881 "Predicted intracellular proteins" "Nonsense-mediated mRNA decay, rRNA processing" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028470, HPA028484, CAB037141" Supported Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" No No "Nucleoli, Nucleoli rim" "Nucleoplasm, Cytosol" "CAB037141: AB_532315, HPA028470: AB_10599180, HPA028484: AB_10611250" "unprognostic (1.23e-2)" "unprognostic (3.46e-2)" "unprognostic (1.85e-2)" "unprognostic (1.62e-1)" "unprognostic (6.88e-2)" "unprognostic (6.37e-2)" "prognostic unfavorable (2.49e-6)" "unprognostic (3.36e-1)" "unprognostic (4.66e-2)" "unprognostic (2.52e-1)" "unprognostic (5.49e-2)" "unprognostic (2.52e-2)" "unprognostic (7.68e-3)" "unprognostic (3.43e-1)" "unprognostic (9.03e-2)" "prognostic favorable (5.27e-4)" "unprognostic (1.33e-1)" 28.2 21.8 30.4 22.1 31.9 30.8 27.9 58.8 34.7 24.8 22.0 31.9 22.4 18.5 27.0 22.9 27.6 22.7 18.3 18.3 27.8 16.2 22.4 18.2 20.8 26.0 31.5 26.3 31.2 24.2 23.1 32.1 23.5 24.3 22.1 25.9 20.4 24.6 20.5 27.3 33.2 22.7 25.6 23.2 26.0 25.2 20.3 32.7 28.2 20.8 12.5 29.9 23.6 24.6 21.0 21.6 24.8 26.4 27.5 25.9 22.3 23.4 15.0 31.5 12.1 16.8 18.6 18.0 23.2 17.1 40.9 37.2 22.1 34.4 23.7 15.1 22.0 18.2 23.4 34.8 25.9 37.6 26.5 34.8 34.4 29.5 22.4 16.5 27.9 27.4 14.6 22.4 40.1 23.7 15.3 25.4 21.2 36.1 21.9 22.5 13.2 27.4 25.8 20.8 18.0 18.0 28.3 26.8 20.7 24.0 12.0 20.3 19.9 25.0 21.7 27.8 23.1 18.9 25.8 23.0 21.9 22.7 19.6 27.1 13.3 20.8 46.9 22.3 41.7 26.2 24.8 18.2 14.6 22.2 23.4 25.9 21.0 23.1 22.1 21.6 19.9 19.8 22.0 3.6 27.5 26.4 11.0 21.8 22.3 30.4 31.9 58.8 34.7 27.8 16.2 31.5 26.3 24.3 32.7 26.8 16.5 14.1 12.2 11.7 15.3 5.6 10.2 32.1 35.2 5.2 45.2 23.7 8.3 21.4 12.5 17.4 11.3 0.0 27.7 27.8 14.3 7.5 18.6 8.1 21.3 20.6 8.6 12.9 13.8 5.4 27.3 19.0 11.8 23.4 14.7 5.6 24.4 11.9 21.5 6.7 34.8 12.9 11.3 20.9 22.8 11.7 19.0 16.2 16.2 8.0 EXOSC2 "hRrp4p, p7, RRP4, Rrp4p" ENSG00000130713 "Exosome component 2" Q13868 9 130693721-130704894 "Plasma proteins, Predicted intracellular proteins" "rRNA processing" RNA-binding "Deafness, Disease mutation, Dwarfism, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021756, HPA021790" Approved Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA021756: AB_2670809, HPA021790: AB_1848320" "unprognostic (8.19e-2)" "unprognostic (1.93e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (4.36e-4)" "unprognostic (1.22e-1)" "unprognostic (1.95e-2)" "prognostic unfavorable (1.39e-5)" "unprognostic (8.33e-3)" "unprognostic (4.82e-2)" "unprognostic (1.48e-1)" "unprognostic (8.55e-2)" "unprognostic (1.20e-3)" "unprognostic (4.73e-2)" "unprognostic (6.57e-2)" "unprognostic (3.01e-1)" "unprognostic (5.05e-2)" "unprognostic (1.41e-1)" 13.0 14.2 14.4 18.6 17.0 12.7 17.9 22.7 18.0 16.1 14.3 15.8 13.6 11.0 18.7 10.1 16.6 19.0 11.7 12.5 15.8 12.5 14.3 18.4 11.1 16.7 18.5 17.3 22.1 25.0 19.6 12.6 13.1 13.9 13.9 17.4 14.6 14.1 13.7 22.3 13.1 11.5 18.7 12.3 14.0 13.4 8.4 17.6 17.3 14.2 15.7 21.3 15.8 13.9 11.0 10.4 5.6 7.9 16.8 11.7 7.7 13.6 27.9 16.7 14.8 6.0 6.8 12.2 20.5 9.9 20.5 15.9 22.5 11.9 27.2 11.2 11.0 22.6 25.0 26.7 20.4 22.8 16.1 13.0 21.7 27.4 15.6 11.4 32.7 14.4 8.7 7.7 28.8 33.7 7.5 14.5 18.3 23.6 11.8 14.2 24.2 23.0 9.1 20.7 37.4 18.1 18.2 30.7 29.6 9.6 12.7 10.3 11.5 23.9 18.3 10.8 12.2 19.0 11.8 8.9 20.3 15.8 18.0 28.9 6.1 23.8 41.2 14.5 19.1 15.8 1.5 7.7 5.6 10.9 7.9 11.2 11.0 11.0 9.2 10.4 10.4 11.7 10.0 2.0 16.8 5.4 6.8 9.9 7.7 14.4 17.0 22.7 18.0 15.8 12.5 18.5 17.3 13.9 17.6 6.0 18.6 18.5 10.3 9.4 12.8 7.4 2.5 9.4 5.7 3.5 5.9 14.1 5.0 10.0 1.0 6.8 3.6 0.0 9.8 17.2 9.3 5.7 12.7 8.6 11.5 4.8 1.2 7.4 3.8 0.2 7.8 8.0 6.8 4.6 6.4 10.4 7.3 0.0 7.4 8.7 12.5 6.5 10.8 4.2 13.5 7.3 7.0 10.2 10.5 7.1 EXOSC3 "CGI-102, hRrp-40, hRrp40p, p10, RRP40, Rrp40p" ENSG00000107371 "Exosome component 3" Q9NQT5 9 37766978-37801437 "Disease related genes, Predicted intracellular proteins" "rRNA processing" RNA-binding "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 99.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020485 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA020485: AB_10960685" "unprognostic (7.07e-2)" "unprognostic (4.51e-2)" "unprognostic (1.74e-1)" "unprognostic (1.13e-1)" "unprognostic (3.69e-1)" "unprognostic (4.95e-2)" "prognostic unfavorable (7.01e-5)" "unprognostic (3.06e-1)" "prognostic unfavorable (7.39e-4)" "unprognostic (1.71e-3)" "unprognostic (5.38e-2)" "unprognostic (1.08e-1)" "unprognostic (1.20e-2)" "unprognostic (9.25e-3)" "unprognostic (2.07e-1)" "unprognostic (1.64e-1)" "unprognostic (1.04e-1)" 14.5 18.2 14.9 18.8 16.3 11.5 16.7 29.2 19.2 14.2 14.0 14.3 12.9 16.1 14.8 13.2 20.6 12.2 8.6 11.5 13.5 13.2 13.2 16.3 10.8 20.6 17.4 8.2 16.0 11.3 13.0 18.1 13.6 14.1 15.9 13.0 13.2 13.5 14.6 14.9 11.9 12.0 17.9 11.7 16.0 15.8 26.9 18.7 23.1 14.6 13.3 22.5 12.9 15.7 34.5 32.6 22.9 33.7 24.4 32.9 33.7 25.9 18.6 10.0 12.8 6.9 5.4 13.3 15.1 5.9 12.6 11.9 24.3 4.4 20.2 11.4 5.6 14.6 10.1 11.1 10.5 14.6 28.2 18.3 16.3 22.6 22.3 7.8 24.8 15.0 3.9 5.5 9.8 6.2 4.1 6.6 14.8 40.3 9.4 9.0 15.8 22.1 19.9 27.1 23.9 20.9 20.1 12.4 10.9 7.1 8.9 14.6 14.7 8.6 7.1 9.5 8.5 9.4 18.2 7.6 10.3 18.7 12.6 23.5 6.6 16.6 26.8 10.2 19.5 11.3 17.8 29.8 22.9 25.0 33.7 31.9 34.5 30.3 32.9 27.7 30.5 30.6 29.5 18.2 24.4 29.8 32.6 32.1 33.7 14.9 16.3 29.2 19.2 13.5 13.2 17.4 8.2 14.1 18.7 20.8 14.5 32.3 25.9 48.1 6.6 6.4 22.9 12.0 10.3 7.0 0.0 51.2 28.2 35.4 50.5 14.0 12.0 0.0 30.2 64.9 23.2 12.7 28.8 10.4 39.7 6.4 10.3 12.9 23.1 7.4 15.5 17.5 18.6 24.4 15.3 8.9 29.5 17.5 12.4 22.3 6.8 25.8 24.7 99.1 59.2 47.3 26.3 20.0 21.5 22.7 EXOSC4 "FLJ20591, hRrp41p, p12A, RRP41, RRP41A, Rrp41p, SKI6, Ski6p" ENSG00000178896 "Exosome component 4" Q9NPD3 8 144078626-144080647 "Plasma proteins, Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 251.1;Late spermatids: 557.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 91.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024792, HPA065103" Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles, Cytosol" "HPA024792: AB_1848325, HPA065103: " "unprognostic (2.32e-1)" "unprognostic (1.55e-2)" "unprognostic (3.06e-1)" "unprognostic (3.53e-2)" "unprognostic (1.33e-1)" "unprognostic (2.29e-2)" "unprognostic (6.58e-3)" "unprognostic (1.26e-1)" "unprognostic (8.36e-2)" "prognostic favorable (2.23e-4)" "unprognostic (4.32e-2)" "unprognostic (1.41e-1)" "unprognostic (2.30e-2)" "unprognostic (5.18e-2)" "unprognostic (1.23e-1)" "unprognostic (2.71e-1)" "unprognostic (5.11e-2)" 12.3 16.7 12.8 11.4 17.6 13.8 8.9 13.9 20.6 8.1 12.0 10.5 13.6 15.8 9.8 10.4 14.5 10.0 9.3 16.5 11.4 11.2 14.9 21.5 8.7 11.4 11.5 13.0 10.3 15.0 8.0 10.2 11.5 12.0 12.1 6.5 11.6 28.0 14.7 12.1 12.7 11.1 6.7 9.3 13.4 13.9 45.0 9.7 14.8 10.8 10.4 11.1 8.7 7.8 24.7 38.2 19.0 31.8 17.1 16.1 18.8 10.3 22.9 4.1 9.8 3.5 2.7 11.2 8.2 3.4 6.4 6.5 16.0 7.3 6.3 12.0 3.4 4.6 8.6 7.5 8.9 1.9 8.3 25.5 9.0 17.1 17.7 5.9 6.7 10.8 3.8 9.2 7.4 5.9 2.5 3.3 6.9 14.1 4.3 5.2 37.9 10.4 13.3 10.6 11.0 91.9 4.6 6.7 16.3 6.1 10.6 12.9 17.0 10.2 13.2 18.8 2.2 15.0 10.2 3.2 6.6 14.5 15.8 13.8 11.4 13.6 7.9 9.5 10.8 10.3 19.0 31.8 12.5 15.9 29.4 16.1 22.0 12.4 15.4 29.8 24.7 15.9 15.4 9.2 17.1 16.1 38.2 13.7 18.8 12.8 17.6 13.9 20.6 11.4 11.2 11.5 13.0 12.0 9.7 8.9 24.2 15.2 27.4 83.9 8.8 18.2 20.4 18.7 12.5 26.2 7.9 39.9 104.5 49.6 251.1 24.8 32.9 0.0 40.1 34.1 31.5 24.7 13.9 52.3 40.4 6.4 24.9 20.9 31.4 557.6 17.3 24.1 33.7 54.1 29.8 14.1 51.1 45.6 19.8 81.3 6.8 12.9 40.6 52.4 33.8 76.9 40.3 13.8 40.1 33.2 EXOSC5 "hRrp46p, MGC12901, p12B, RRP41B, RRP46, Rrp46p" ENSG00000077348 "Exosome component 5" Q9NQT4 19 41386374-41397479 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Extravillous trophoblasts: 115.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053150, HPA055677" Approved Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA053150: AB_2682058, HPA055677: AB_2682882" "unprognostic (1.24e-1)" "unprognostic (5.68e-2)" "unprognostic (2.99e-1)" "unprognostic (2.53e-3)" "unprognostic (7.50e-3)" "unprognostic (5.74e-2)" "unprognostic (3.83e-3)" "unprognostic (9.23e-2)" "unprognostic (2.36e-1)" "unprognostic (1.54e-1)" "unprognostic (9.39e-2)" "unprognostic (2.35e-2)" "prognostic unfavorable (3.45e-7)" "unprognostic (6.84e-2)" "unprognostic (2.27e-1)" "unprognostic (7.79e-2)" "unprognostic (7.82e-2)" 9.1 14.3 12.6 12.3 16.6 13.1 11.1 7.6 21.3 8.8 12.1 10.8 9.0 10.0 8.1 6.0 14.6 13.6 6.4 11.6 12.0 10.3 7.9 25.1 5.7 17.0 13.4 9.9 13.2 46.9 3.2 4.9 6.5 10.3 9.5 6.6 6.3 14.0 8.1 30.9 18.5 9.5 6.6 14.0 12.7 9.8 7.5 11.8 16.8 15.1 15.7 12.2 11.3 8.6 22.9 36.8 3.3 23.7 17.1 21.1 13.5 17.9 33.5 4.7 13.8 3.0 3.8 11.0 7.6 3.6 12.5 10.3 19.5 13.3 28.0 19.8 3.7 6.4 6.8 9.3 8.5 3.9 17.8 32.1 12.5 12.7 14.9 9.6 22.4 12.4 4.7 19.1 10.0 9.6 3.4 5.8 16.0 16.6 20.1 4.1 23.4 19.3 15.8 16.6 25.4 16.6 18.3 12.9 25.2 5.0 12.8 18.2 13.6 11.0 18.3 18.6 3.2 8.5 27.7 4.6 13.1 11.0 8.3 23.3 31.7 40.5 30.4 10.2 32.4 11.1 3.3 21.7 0.6 13.2 23.7 15.8 21.1 14.4 13.3 34.1 22.9 21.1 18.5 1.5 17.1 14.0 36.8 11.1 13.5 12.6 16.6 7.6 21.3 12.0 10.3 13.4 9.9 10.3 11.8 3.0 3.7 19.5 26.4 27.1 5.6 8.1 17.8 18.7 11.4 17.4 3.9 24.0 31.5 14.5 7.3 9.0 5.1 23.3 18.3 115.4 11.0 15.5 4.7 17.9 26.6 6.4 8.2 4.3 13.8 5.6 15.5 19.8 13.5 14.4 16.8 4.8 20.0 5.8 11.7 19.5 2.1 6.5 18.4 11.9 27.2 29.1 17.7 11.7 30.9 22.0 EXOSC9 "p5, p6, PM/Scl-75, PMSCL1, RRP45, Rrp45p" ENSG00000123737 "Exosome component 9" Q06265 4 121801317-121817021 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 108.4;Spermatocytes: 107.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041838, HPA048257, CAB070171" Approved Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "CAB070171: AB_11026964, HPA041838: AB_10794492, HPA048257: AB_2680331" "unprognostic (7.36e-2)" "unprognostic (1.22e-2)" "unprognostic (2.81e-2)" "unprognostic (2.23e-1)" "unprognostic (2.78e-1)" "unprognostic (3.36e-2)" "prognostic unfavorable (1.04e-4)" "unprognostic (7.89e-2)" "unprognostic (3.73e-2)" "unprognostic (1.66e-2)" "unprognostic (9.25e-2)" "unprognostic (9.85e-3)" "prognostic unfavorable (6.49e-4)" "unprognostic (3.28e-2)" "unprognostic (6.66e-2)" "unprognostic (1.68e-1)" "unprognostic (7.21e-2)" 12.5 12.7 10.1 18.9 14.7 29.7 13.9 16.8 18.6 11.2 9.7 8.1 12.5 7.5 12.5 12.4 13.3 11.8 7.8 13.1 13.5 11.3 11.3 14.0 11.9 19.8 11.3 12.2 12.6 10.4 14.2 15.5 12.1 12.9 10.3 12.0 9.6 10.9 8.9 17.6 12.1 10.3 10.6 11.7 14.2 10.4 36.7 10.0 33.7 9.2 15.4 18.9 12.2 10.5 19.9 15.9 20.1 17.7 11.6 23.6 14.0 19.5 9.2 24.9 14.8 3.9 8.0 12.1 25.4 14.7 36.4 28.2 9.9 16.4 34.3 6.3 15.8 11.0 7.0 26.9 11.8 32.5 15.2 12.3 17.2 14.2 12.8 8.2 29.1 16.0 6.0 6.1 25.4 7.3 7.5 17.9 22.1 29.4 13.6 34.0 11.4 44.6 22.5 13.1 7.6 10.8 24.9 41.7 15.4 12.4 6.4 15.9 16.7 9.3 13.9 15.4 13.2 11.8 18.8 10.8 16.3 24.1 13.7 24.4 19.8 15.0 41.2 16.9 20.3 10.7 12.0 13.3 20.1 18.7 17.7 18.4 19.9 20.5 23.6 15.9 19.9 23.3 20.7 3.3 11.6 17.0 15.7 21.6 14.0 10.1 14.7 16.8 18.6 13.5 11.3 11.3 12.2 12.9 10.0 41.7 15.5 16.4 12.6 11.3 10.7 11.1 7.6 18.7 26.1 3.5 9.8 24.1 1.7 17.1 108.4 14.2 4.5 0.0 26.6 25.0 13.6 7.6 30.1 4.9 21.1 15.9 5.8 12.3 10.3 9.2 12.0 18.0 8.5 20.8 7.9 13.8 16.5 8.7 10.3 7.1 16.3 6.5 11.3 107.2 58.5 12.9 9.2 19.2 10.5 12.9 EXTL2 ENSG00000162694 "Exostosin like glycosyltransferase 2" Q9UBQ6 1 100872372-100895998 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cytotrophoblasts: 175.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020716, HPA068921" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 83000000 Nucleoplasm Cytosol "CAB020716: , HPA068921: AB_2686058" "unprognostic (3.14e-1)" "unprognostic (6.34e-2)" "unprognostic (1.50e-2)" "unprognostic (8.20e-2)" "unprognostic (9.07e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.64e-5)" "unprognostic (7.81e-3)" "unprognostic (1.10e-2)" "unprognostic (1.28e-1)" "unprognostic (3.61e-2)" "unprognostic (3.00e-1)" "unprognostic (3.17e-2)" "unprognostic (6.84e-2)" "unprognostic (7.83e-2)" "unprognostic (1.24e-2)" "unprognostic (4.34e-2)" 7.5 23.0 9.8 4.1 19.9 1.7 10.4 14.7 22.8 13.4 8.7 8.1 9.9 4.5 16.7 13.1 6.0 10.1 10.3 8.2 9.5 13.3 11.2 10.0 7.6 3.4 14.0 12.0 18.8 7.7 17.5 18.7 21.8 20.1 12.3 7.1 8.6 6.0 11.4 5.3 5.9 4.6 15.4 11.4 5.4 6.2 9.7 16.3 6.4 9.3 5.0 3.4 9.0 6.2 2.1 7.4 3.3 1.1 5.3 5.6 1.9 5.2 2.7 20.1 21.0 22.3 16.5 12.8 9.0 14.9 7.1 15.9 2.6 4.0 5.8 8.8 8.3 5.6 5.1 7.3 7.7 14.4 11.8 5.1 7.1 9.7 7.2 7.3 11.0 3.8 19.5 2.7 14.2 2.8 15.0 25.9 7.4 8.9 0.7 17.9 2.7 5.8 6.1 25.3 4.7 6.1 4.2 20.7 4.7 7.6 4.0 8.3 23.6 6.9 1.8 16.2 15.3 4.3 5.0 10.8 17.8 10.5 11.4 9.5 6.2 5.5 3.6 28.3 11.4 5.8 3.3 0.8 0.0 5.6 1.1 2.8 1.9 1.9 3.7 2.5 2.1 2.1 4.8 0.2 5.3 0.9 7.4 0.0 1.9 9.8 19.9 14.7 22.8 9.5 13.3 14.0 12.0 20.1 16.3 11.9 5.9 2.2 11.4 7.6 20.3 9.7 10.2 29.4 14.8 14.0 33.4 175.5 10.0 5.2 19.7 10.8 2.0 0.0 1.8 25.1 33.5 5.4 17.3 14.7 21.3 3.2 9.1 15.4 7.0 27.2 23.3 3.6 21.9 10.0 3.9 18.6 2.5 2.9 32.5 10.8 17.8 12.9 16.5 29.8 8.1 7.0 62.1 6.9 6.3 3.0 EYA1 BOR ENSG00000104313 "EYA transcriptional coactivator and phosphatase 1" Q99502 8 71197433-71592025 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase" "Deafness, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 45.5;pituitary gland: 30.8" "Group enriched" "Detected in some" 8 "Cardiomyocytes: 7.5;Ciliated cells: 12.0;Club cells: 9.1;Early spermatids: 3.9;Late spermatids: 4.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "NK-cell: 9.8" "Lineage enriched" "Detected in many" 4 "NK-cells: 9.8" "Cell line enhanced" "Detected in some" "AN3-CA: 16.8;RH-30: 13.0;SH-SY5Y: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028917 Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA028917: AB_2672826" "unprognostic (3.74e-2)" "unprognostic (1.16e-1)" "unprognostic (1.15e-1)" "unprognostic (1.72e-3)" "unprognostic (5.95e-2)" "unprognostic (9.17e-2)" "unprognostic (2.91e-4)" "unprognostic (1.98e-1)" "unprognostic (1.03e-1)" "unprognostic (1.81e-1)" "unprognostic (9.72e-2)" "unprognostic (1.13e-1)" "unprognostic (4.22e-12)" "unprognostic (1.06e-2)" "unprognostic (1.84e-1)" "unprognostic (3.81e-4)" "unprognostic (1.25e-2)" 1.0 1.1 2.8 0.6 16.8 0.5 0.6 0.2 6.8 4.0 0.6 1.9 0.0 0.7 0.6 2.2 1.0 2.5 0.8 4.6 2.8 2.2 0.6 0.5 1.0 0.6 2.9 2.8 0.8 0.6 45.5 30.8 0.6 4.2 12.4 0.7 15.3 1.2 4.6 3.2 0.6 0.7 3.9 0.4 0.7 0.9 1.3 5.1 4.4 0.9 2.9 0.6 3.5 5.7 0.8 1.9 1.8 2.3 9.8 2.3 0.2 0.1 0.0 3.8 16.8 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 1.0 0.0 0.0 2.7 0.0 1.2 0.0 0.0 0.3 0.0 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.6 0.0 0.0 0.0 1.2 0.0 0.9 0.0 13.0 5.5 0.0 0.0 1.3 31.6 0.0 0.0 1.0 3.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 3.8 0.0 1.2 1.8 0.3 0.6 0.9 0.9 1.9 0.8 0.7 1.9 0.7 0.8 1.3 1.4 1.6 9.8 2.3 1.9 2.3 0.2 2.8 16.8 0.2 2.8 2.8 2.2 2.9 2.8 4.2 5.1 0.0 0.0 0.0 0.0 0.1 0.0 7.5 0.0 12.0 9.1 0.0 0.0 0.6 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.7 1.0 0.1 0.5 0.0 0.0 0.0 EYA3 DKFZp686C132 ENSG00000158161 "EYA transcriptional coactivator and phosphatase 3" Q99504 1 27970344-28088696 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 72.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052432, HPA062889" Uncertain Supported Nucleoplasm Yes No Nucleoplasm "HPA052432: AB_2681831, HPA062889: AB_2684895" "unprognostic (3.57e-1)" "unprognostic (2.61e-1)" "unprognostic (2.85e-1)" "unprognostic (8.74e-2)" "unprognostic (1.39e-1)" "prognostic favorable (5.11e-4)" "unprognostic (1.39e-3)" "unprognostic (2.21e-1)" "unprognostic (4.81e-2)" "unprognostic (1.00e-1)" "unprognostic (9.13e-2)" "unprognostic (8.98e-2)" "prognostic favorable (3.15e-6)" "unprognostic (5.17e-2)" "unprognostic (2.79e-1)" "unprognostic (7.60e-2)" "unprognostic (6.11e-2)" 12.8 10.0 14.9 24.0 12.9 8.6 13.3 21.9 13.8 14.7 10.2 14.4 12.8 10.7 14.4 12.4 19.4 11.8 8.1 11.7 10.6 11.8 21.6 11.3 12.5 15.6 11.1 8.8 12.4 12.9 20.9 29.2 13.8 12.9 11.8 11.7 16.4 11.8 13.1 14.5 16.3 12.2 10.5 10.1 14.2 10.0 20.6 13.7 17.4 17.3 12.2 25.0 10.7 13.8 8.6 12.4 10.5 11.2 10.4 12.1 2.6 10.5 4.4 9.0 6.7 10.6 8.2 5.1 7.7 7.4 9.1 9.0 4.3 6.5 16.7 8.6 5.2 3.4 10.4 16.6 6.4 10.8 8.8 9.3 19.0 9.0 7.7 6.3 18.3 17.5 5.0 5.8 10.0 6.8 7.9 11.6 6.2 17.4 6.5 8.1 4.6 11.7 12.3 18.9 8.4 5.9 8.9 16.6 10.6 10.7 5.9 10.4 5.7 8.3 5.2 7.4 7.6 4.3 4.9 11.1 11.0 5.9 10.1 6.3 9.7 9.7 15.5 7.9 17.9 4.8 7.5 11.2 10.5 12.1 10.4 10.8 8.6 9.5 8.7 12.4 7.6 8.3 9.4 9.7 10.4 8.3 7.7 8.2 2.6 14.9 12.9 21.9 13.8 10.6 11.8 11.1 8.8 12.9 13.7 8.9 9.6 18.4 9.6 15.9 17.4 7.5 2.5 1.4 5.7 24.4 15.7 11.8 13.3 9.9 72.6 10.8 8.6 0.0 7.9 11.4 10.4 8.5 11.5 6.8 8.8 17.5 19.7 15.4 12.3 29.7 9.5 14.3 11.8 10.0 9.2 9.1 11.2 10.2 5.6 11.6 18.9 12.9 8.5 40.6 26.0 19.9 9.2 25.4 8.9 9.9 EYA4 "CMD1J, DFNA10" ENSG00000112319 "EYA transcriptional coactivator and phosphatase 4" O95677 6 133240598-133532120 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase" "Cardiomyopathy, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 65.6" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 1: 11.9;Cardiomyocytes: 13.7;Collecting duct cells: 43.6;monocytes: 12.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 12.7;GAMG: 13.2;HeLa: 35.6;RH-30: 12.1;U-87 MG: 12.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA004805, HPA038771, HPA038772" Enhanced Approved Nucleoplasm No NA Nucleoplasm "HPA004805: AB_10669750, HPA038771: AB_10671865, HPA038772: AB_10673119" "unprognostic (1.60e-1)" "unprognostic (3.34e-1)" "unprognostic (1.27e-1)" "unprognostic (2.04e-9)" "unprognostic (1.64e-1)" "unprognostic (3.08e-2)" "unprognostic (3.44e-2)" "unprognostic (7.21e-2)" "unprognostic (9.07e-2)" "unprognostic (2.04e-2)" "unprognostic (2.80e-1)" "unprognostic (2.29e-1)" "unprognostic (8.27e-4)" "unprognostic (1.82e-3)" "unprognostic (6.67e-2)" "unprognostic (9.55e-2)" "unprognostic (2.51e-2)" 1.6 3.0 1.2 0.2 1.3 0.1 2.4 0.4 1.2 9.7 0.6 2.5 11.1 0.4 2.6 1.9 0.7 8.3 0.7 6.2 1.5 1.2 6.1 0.4 2.0 0.2 2.1 0.8 1.6 0.4 0.2 7.2 0.2 3.5 6.6 0.4 2.7 0.8 13.9 65.6 0.4 0.5 1.9 3.5 0.6 0.7 7.4 1.4 1.8 2.5 5.5 0.7 2.6 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 1.2 0.0 0.0 0.0 0.0 0.0 10.2 0.2 1.5 0.0 0.0 0.0 10.0 0.0 13.2 0.0 7.7 3.3 0.0 0.0 10.0 1.3 35.6 0.0 0.3 0.0 3.5 2.6 0.0 7.3 2.3 1.7 0.0 0.0 0.0 5.4 4.1 0.0 0.0 0.0 0.0 0.1 0.7 0.1 12.1 0.0 0.0 1.9 1.9 2.0 0.1 0.0 5.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.1 3.7 1.6 0.0 12.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.4 1.2 1.5 1.2 2.1 0.8 3.5 1.4 11.9 2.6 0.0 0.1 0.1 0.0 13.7 0.0 0.0 3.4 43.6 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.2 0.0 0.7 0.1 0.0 0.0 0.0 0.0 1.7 0.6 1.3 2.0 0.6 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.6 6.6 0.0 0.0 0.0 0.0 0.1 EZH1 "KIAA0388, KMT6B" ENSG00000108799 "Enhancer of zeste 1 polycomb repressive complex 2 subunit" Q92800 17 42700275-42745049 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Rod photoreceptor cells: 268.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 32.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005478, HPA077684" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA005478: AB_1848340, HPA077684: AB_2732356" "unprognostic (1.01e-1)" "unprognostic (6.02e-2)" "unprognostic (2.19e-2)" "unprognostic (8.57e-2)" "unprognostic (1.89e-1)" "unprognostic (1.84e-3)" "unprognostic (1.76e-2)" "unprognostic (1.18e-2)" "unprognostic (1.25e-1)" "unprognostic (1.55e-3)" "unprognostic (5.22e-3)" "unprognostic (4.11e-3)" "unprognostic (1.48e-2)" "unprognostic (4.60e-2)" "unprognostic (3.29e-1)" "unprognostic (5.39e-2)" "unprognostic (4.74e-2)" 21.7 10.4 15.0 10.1 25.0 9.9 18.7 39.6 26.1 18.4 15.1 21.4 10.0 9.7 29.8 21.2 10.6 18.8 9.7 17.2 19.0 11.2 13.6 5.3 12.6 14.0 13.7 22.0 38.2 8.1 20.0 19.1 9.3 25.6 13.1 12.1 21.5 10.7 19.3 25.4 16.0 14.0 16.4 19.9 16.0 10.6 8.6 16.7 11.9 15.0 7.5 14.9 16.0 15.9 6.2 6.0 18.8 5.4 4.8 8.3 2.3 5.5 5.8 8.0 5.5 32.1 19.4 6.8 8.9 8.2 7.4 7.6 2.7 6.9 8.4 5.6 9.4 7.3 12.6 5.2 5.9 10.7 9.3 9.3 2.9 10.8 3.3 11.0 6.2 7.0 11.1 10.8 5.6 13.6 13.0 6.0 8.5 7.6 11.9 6.5 2.3 10.1 8.0 2.2 5.1 3.0 6.6 8.2 8.9 7.7 5.9 5.5 4.4 4.9 2.4 5.9 11.9 8.5 4.0 6.2 8.0 3.3 9.3 5.6 12.5 6.3 5.0 5.7 6.5 4.0 10.2 5.2 6.9 5.9 5.4 8.3 5.7 5.2 6.0 1.9 6.2 7.7 5.7 18.8 4.8 3.3 6.0 5.7 2.3 15.0 25.0 39.6 26.1 19.0 11.2 13.7 22.0 25.6 16.7 8.9 17.3 10.7 12.1 4.6 67.2 34.7 17.8 38.8 17.0 12.2 62.8 6.1 8.3 9.2 0.4 12.2 6.7 46.7 6.4 2.6 7.5 7.2 19.7 6.7 7.7 44.5 12.5 15.4 11.6 1.1 28.7 10.6 1.7 20.8 4.2 32.0 9.4 6.0 32.2 8.1 268.1 51.8 13.3 9.3 8.8 5.4 9.0 15.9 6.8 7.6 EZH2 "ENX-1, EZH1, KMT6, KMT6A" ENSG00000106462 "Enhancer of zeste 2 polycomb repressive complex 2 subunit" Q15910 7 148807383-148884321 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 25.5;lymphoid tissue: 44.1" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 72.2;Spermatocytes: 126.7;Spermatogonia: 62.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009589 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB009589: " "unprognostic (2.42e-1)" "unprognostic (3.95e-3)" "unprognostic (1.57e-1)" "unprognostic (3.30e-3)" "unprognostic (1.33e-1)" "unprognostic (3.85e-3)" "prognostic unfavorable (2.11e-6)" "unprognostic (2.21e-2)" "prognostic unfavorable (1.96e-4)" "unprognostic (2.32e-3)" "unprognostic (1.58e-3)" "unprognostic (1.69e-3)" "prognostic unfavorable (8.18e-12)" "prognostic favorable (6.97e-4)" "unprognostic (1.83e-1)" "unprognostic (2.12e-1)" "unprognostic (6.67e-2)" 2.0 1.7 1.8 10.6 1.6 25.5 1.4 4.9 2.7 2.6 4.8 1.1 0.1 3.8 1.7 2.8 11.0 0.9 3.0 0.9 0.8 0.6 1.7 3.3 2.3 12.6 1.3 0.3 2.2 3.8 0.6 1.7 3.4 1.4 1.4 5.1 1.8 3.2 1.6 3.7 6.4 4.8 1.5 1.2 5.8 2.7 19.6 1.3 44.1 0.9 5.5 12.4 2.6 3.5 1.5 4.7 1.3 3.9 8.5 10.3 1.7 17.0 8.0 27.3 18.2 0.8 1.4 14.9 13.3 5.4 11.0 11.1 12.0 19.7 30.2 6.5 5.0 10.0 10.5 14.0 4.6 14.0 43.2 14.0 12.9 9.9 9.3 2.2 28.6 10.6 1.2 2.6 8.2 4.4 3.3 6.4 29.3 27.3 20.1 9.8 19.3 55.6 23.9 21.7 15.0 10.8 34.4 15.3 18.7 5.1 8.2 26.1 16.6 16.7 12.7 4.4 7.3 9.3 12.3 3.9 11.7 5.4 23.3 23.8 18.0 19.6 30.4 10.7 19.6 22.9 0.5 2.2 1.3 1.7 1.5 1.3 1.5 3.4 2.9 4.7 0.8 1.9 1.2 0.2 8.5 3.9 1.0 10.3 1.7 1.8 1.6 4.9 2.7 0.8 0.6 1.3 0.3 1.4 1.3 0.0 7.9 6.7 5.7 23.6 4.8 6.5 2.5 14.7 7.9 7.0 33.4 13.6 3.3 9.1 72.2 7.1 6.7 23.3 7.4 29.5 10.8 4.4 21.8 1.3 10.4 14.3 8.6 4.3 8.9 19.2 2.8 10.9 13.5 19.0 10.2 2.0 10.1 9.3 0.7 1.0 21.1 6.5 9.9 126.7 62.4 25.3 25.5 18.7 18.6 4.0 FAAP100 "C17orf70, FLJ22175" ENSG00000185504 "Fanconi anemia core complex associated protein 100" Q0VG06 17 81539885-81553961 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023954, HPA024626, HPA026532" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA023954: AB_1845601, HPA024626: AB_1845602, HPA026532: AB_1845603" "unprognostic (5.25e-2)" "unprognostic (5.40e-2)" "unprognostic (1.31e-1)" "unprognostic (2.03e-2)" "unprognostic (2.91e-1)" "unprognostic (1.85e-2)" "unprognostic (4.87e-3)" "unprognostic (1.30e-1)" "unprognostic (1.16e-1)" "unprognostic (3.49e-2)" "unprognostic (1.05e-3)" "unprognostic (6.91e-2)" "prognostic unfavorable (1.00e-7)" "unprognostic (1.14e-1)" "unprognostic (1.45e-1)" "unprognostic (9.85e-2)" "unprognostic (4.24e-1)" 11.4 10.0 7.7 21.1 8.6 9.8 13.4 33.2 10.9 9.0 12.2 13.4 9.6 13.0 11.1 13.6 11.7 11.0 22.6 9.0 6.9 7.1 11.7 19.3 9.6 20.0 8.4 7.6 12.7 20.1 9.7 14.1 9.6 6.9 12.5 5.5 12.8 15.9 11.9 9.4 16.8 14.0 14.0 7.0 23.8 11.1 11.3 5.9 16.7 15.1 14.5 15.5 9.9 9.2 6.1 6.5 2.3 6.1 4.7 5.3 3.6 7.7 14.1 6.4 17.9 7.6 8.0 9.8 7.9 3.7 9.4 5.8 9.1 9.4 13.8 6.4 10.0 9.4 10.0 3.2 9.4 2.2 3.9 10.3 9.4 14.0 12.4 7.9 10.1 11.1 9.6 7.1 6.9 8.0 12.1 17.9 14.4 13.6 11.2 4.7 14.8 15.6 16.4 7.5 8.9 6.1 14.1 6.5 12.4 7.0 13.7 14.0 11.6 5.7 16.3 6.7 6.9 17.7 13.4 15.1 20.6 13.2 5.4 12.7 13.0 1.0 6.5 5.6 6.4 9.5 0.0 6.1 2.3 5.3 5.6 4.1 6.1 3.4 3.6 5.9 4.7 3.2 2.5 0.9 4.7 2.8 6.5 3.6 3.6 7.7 8.6 33.2 10.9 6.9 7.1 8.4 7.6 6.9 5.9 3.0 9.8 8.8 3.2 0.0 9.8 7.1 10.2 2.7 4.5 14.0 3.9 5.1 3.3 7.3 1.5 5.2 6.4 0.0 6.0 3.9 7.2 4.7 0.0 10.0 7.3 6.4 7.0 8.6 16.4 2.2 4.6 4.7 0.0 4.6 9.1 6.0 7.5 3.5 4.9 5.6 4.5 0.0 4.7 7.4 6.7 0.0 2.6 5.0 8.1 3.2 FAAP20 "C1orf86, FLJ31031" ENSG00000162585 "Fanconi anemia core complex associated protein 20" Q6NZ36 1 2184461-2212720 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA038829 Uncertain Supported "Nucleoplasm,Nuclear bodies,Cell Junctions" NA NA Nucleoplasm "Nuclear bodies, Cell Junctions" "HPA038829: AB_10673476" "unprognostic (1.36e-2)" "unprognostic (2.86e-2)" "unprognostic (2.69e-3)" "unprognostic (1.65e-1)" "unprognostic (2.64e-1)" "unprognostic (6.11e-2)" "prognostic unfavorable (4.57e-4)" "unprognostic (2.81e-1)" "unprognostic (1.36e-1)" "unprognostic (1.80e-1)" "prognostic favorable (2.88e-4)" "unprognostic (1.59e-1)" "unprognostic (1.96e-3)" "unprognostic (1.36e-1)" "unprognostic (1.67e-1)" "unprognostic (4.93e-2)" "unprognostic (8.55e-2)" 33.1 18.8 15.4 14.3 12.1 15.2 20.5 15.4 16.4 17.8 19.1 13.8 19.1 14.6 17.8 17.7 20.3 12.6 14.2 17.0 15.4 14.8 27.7 20.9 15.0 22.5 14.9 10.3 16.9 17.2 8.0 26.4 11.7 13.3 21.8 7.3 20.9 21.4 23.9 27.3 28.1 14.9 15.0 14.3 24.4 30.5 20.2 11.5 35.1 30.5 11.4 16.5 17.1 19.3 13.2 22.0 31.0 8.7 5.1 12.6 5.6 10.4 1.6 2.3 2.8 1.4 1.9 13.8 11.8 4.4 3.9 5.1 2.5 6.9 12.2 17.5 1.8 3.5 5.1 1.6 1.7 1.9 26.0 24.0 10.1 2.7 5.3 5.4 7.0 9.8 3.3 3.9 2.3 2.5 2.4 4.7 9.7 13.9 2.9 2.6 4.3 10.2 21.9 8.2 2.0 21.9 13.7 7.2 11.4 1.8 1.6 18.9 25.3 7.7 3.3 20.2 2.2 3.3 2.9 9.9 6.0 14.3 7.4 6.7 27.5 14.6 17.8 11.2 4.4 2.5 3.6 8.7 31.0 10.1 8.1 10.0 13.2 9.2 10.9 8.8 13.1 12.6 10.4 11.2 5.1 7.5 22.0 7.8 5.6 15.4 12.1 15.4 14.1 15.4 14.8 14.9 10.3 13.3 11.5 6.0 11.0 59.7 76.1 0.0 25.1 17.1 50.9 14.7 12.5 92.5 3.9 105.4 144.2 110.3 81.6 33.1 20.8 23.3 96.1 118.9 7.2 104.6 7.0 78.0 115.2 14.3 42.1 73.1 106.0 249.7 79.7 47.3 0.0 185.8 72.9 43.5 131.8 46.3 77.8 221.5 25.4 64.7 14.6 118.4 32.4 0.0 75.1 55.3 55.7 99.4 FAAP24 "C19orf40, FLJ46828, MGC32020" ENSG00000131944 "Fanconi anemia core complex associated protein 24" Q9BTP7 19 32972209-32978222 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 26.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041168 Uncertain Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA041168: AB_10960496" "unprognostic (1.18e-2)" "unprognostic (1.22e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (4.38e-4)" "unprognostic (6.52e-2)" "unprognostic (2.73e-1)" "unprognostic (2.58e-3)" "unprognostic (3.76e-2)" "unprognostic (1.88e-2)" "unprognostic (3.98e-2)" "unprognostic (2.82e-3)" "unprognostic (3.54e-2)" "prognostic unfavorable (4.00e-7)" "unprognostic (4.37e-3)" "unprognostic (5.30e-1)" "unprognostic (2.31e-3)" "unprognostic (2.15e-1)" 3.7 3.5 1.8 4.1 2.1 5.3 3.9 2.3 2.9 3.0 2.9 2.4 3.3 2.8 3.3 4.6 4.8 2.6 6.7 1.9 1.5 1.7 4.3 2.5 2.3 4.6 3.8 0.9 4.2 2.4 0.2 2.0 6.1 3.1 9.6 4.0 3.3 3.2 1.9 1.0 4.6 5.1 2.2 2.6 6.1 2.8 16.9 2.0 8.7 3.0 3.1 8.6 3.6 2.7 7.2 7.7 16.0 8.0 7.7 6.2 3.7 5.1 12.7 5.3 8.2 2.7 5.6 4.3 6.5 6.9 12.6 16.6 8.9 8.4 6.0 9.7 2.7 9.7 3.6 10.0 4.9 10.1 16.2 5.2 13.0 5.8 6.7 1.6 4.5 6.7 3.1 3.1 7.9 4.8 2.2 5.1 9.8 6.8 6.1 9.2 5.8 9.5 6.0 2.4 7.3 5.7 8.6 4.7 3.3 2.5 3.2 5.5 4.3 7.4 8.6 5.3 5.7 5.9 11.4 3.0 12.6 6.1 5.3 6.0 4.9 10.0 8.2 9.0 9.9 8.1 10.8 6.4 8.7 3.9 7.3 4.4 6.6 4.7 5.6 4.0 7.2 4.3 6.2 16.0 7.7 8.0 7.7 6.0 3.7 1.8 2.1 2.3 2.9 1.5 1.7 3.8 0.9 3.1 2.0 3.0 0.6 6.5 3.2 0.0 1.1 0.4 2.5 0.0 2.3 3.5 2.0 8.6 1.7 1.2 5.9 1.2 2.0 0.0 6.8 13.0 2.2 2.7 1.1 0.4 7.1 4.8 1.2 1.8 4.3 8.0 3.1 3.7 0.0 10.0 2.6 0.2 3.2 3.2 3.2 0.7 1.0 0.0 2.2 26.7 8.0 0.0 4.2 4.4 2.1 2.2 FABP1 L-FABP ENSG00000163586 "Fatty acid binding protein 1" P07148 2 88122982-88128116 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 453.2;liver: 370.7" "Group enriched" "Detected in many" 5 "Enterocytes: 8164.5;Hepatocytes: 5503.1;Paneth cells: 3221.0" "Group enriched" "Detected in many" 14 "colorectal cancer: 175.1;liver cancer: 437.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 23 "neutrophil: 2.3" "Lineage enriched" "Detected in single" 23 "granulocytes: 2.3" "Group enriched" "Detected in some" 7 "CACO-2: 26.2;Hep G2: 83.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002305, HPA028275" Enhanced Approved Nucleoplasm,Cytosol NA NA 32000000 "Nucleoplasm, Cytosol" "CAB002305: AB_563728, HPA028275: AB_10600909" "unprognostic (1.91e-1)" "unprognostic (7.91e-3)" "unprognostic (5.47e-2)" "unprognostic (1.96e-1)" "unprognostic (2.03e-2)" "unprognostic (2.35e-1)" "unprognostic (7.99e-2)" "unprognostic (8.92e-2)" "unprognostic (2.29e-1)" 0.4 0.1 0.4 33.9 0.4 0.0 0.4 0.4 0.5 0.4 153.5 0.4 0.4 137.9 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.2 57.6 370.7 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 97.7 0.4 0.5 0.4 0.4 0.1 453.2 6.7 0.4 0.4 0.2 0.5 0.4 0.4 0.5 0.5 0.4 0.4 0.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 26.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 83.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.2 0.1 0.0 0.0 0.0 1.4 7.7 0.0 0.1 0.8 5.7 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.7 0.1 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.5 0.4 0.2 0.4 0.4 0.4 0.4 0.0 0.0 173.3 0.0 0.0 0.0 0.4 119.8 0.0 0.0 57.6 0.0 0.1 132.6 0.0 0.0 0.0 8164.5 140.2 0.0 0.1 0.0 0.3 133.2 5503.1 1.4 0.0 251.5 124.0 159.5 0.0 0.0 0.0 0.0 0.0 830.4 0.0 0.1 3221.0 0.0 668.9 0.0 0.0 0.0 0.0 0.1 0.0 1.1 51.0 1046.9 0.0 FABP7 "B-FABP, BLBP" ENSG00000164434 "Fatty acid binding protein 7" O15540 6 122779475-122784074 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 62.7;breast: 26.8" "Cell type enriched" "Detected in some" 5 "Muller glia cells: 827.1" "Group enriched" "Detected in many" 6 "glioma: 139.3;renal cancer: 51.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.1" "Group enriched" "Detected in many" 5 "granulocytes: 3.1;NK-cells: 1.1" "Group enriched" "Detected in some" 8 "AF22: 38.7;U-251 MG: 10.5;WM-115: 23.3" "Region enriched" "Detected in all" 6 "olfactory region: 1471.1" "Low region specificity" "Detected in all" "CAB025488, HPA028825, CAB058697" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "CAB025488: , CAB058697: AB_2665600, HPA028825: AB_10602130" "prognostic favorable (2.49e-4)" "unprognostic (1.56e-2)" "unprognostic (2.53e-3)" "unprognostic (5.80e-2)" "unprognostic (2.29e-1)" "unprognostic (1.14e-1)" "unprognostic (7.11e-2)" "unprognostic (2.09e-2)" "unprognostic (3.42e-2)" "prognostic unfavorable (1.65e-6)" "unprognostic (9.83e-2)" "unprognostic (1.30e-2)" "unprognostic (2.50e-1)" "unprognostic (8.66e-2)" 2.1 1.3 34.8 1.1 15.5 1.3 26.8 51.6 62.7 1.1 1.5 13.0 0.0 1.2 1.2 1.3 1.6 1.2 1.2 1.2 32.0 16.4 1.6 1.4 1.1 1.1 11.4 30.3 1.1 1.1 1.0 2.1 1.3 11.2 1.3 1.2 5.7 7.0 3.7 6.7 10.5 1.1 1.1 8.1 1.1 1.3 1.2 6.9 0.0 1.1 0.0 1.1 1.4 0.0 0.4 0.2 3.1 0.3 1.1 0.4 0.0 0.0 0.0 38.7 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 10.5 0.0 0.0 0.0 0.4 0.0 23.3 3.1 0.3 0.1 0.3 0.1 0.3 0.2 0.3 0.4 0.1 0.4 0.3 0.3 0.5 1.1 0.2 0.2 0.1 0.0 34.8 15.5 51.6 27.3 32.0 16.4 11.4 30.3 11.2 6.9 0.0 0.0 0.0 0.1 10.9 6.8 0.4 0.0 0.0 0.0 0.0 11.8 4.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 162.7 1.1 0.0 0.0 0.0 2.5 4.8 0.0 0.0 0.0 0.0 0.0 0.0 28.7 0.0 0.0 827.1 0.0 0.0 0.0 0.2 37.4 0.0 0.8 0.0 0.0 16.6 5.9 0.0 0.0 0.0 FADD "GIG3, MORT1" ENSG00000168040 "Fas associated via death domain" Q13158 11 70203163-70207390 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Immunity, Innate immunity" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 60.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 83.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001464, CAB010209" Supported Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB010209: AB_2100622, HPA001464: AB_1848348" "unprognostic (2.08e-1)" "prognostic unfavorable (6.35e-4)" "unprognostic (6.91e-2)" "unprognostic (9.51e-2)" "unprognostic (3.89e-1)" "prognostic unfavorable (8.22e-5)" "unprognostic (7.25e-3)" "prognostic unfavorable (2.21e-5)" "unprognostic (1.16e-1)" "unprognostic (1.06e-1)" "unprognostic (2.45e-3)" "unprognostic (2.78e-3)" "unprognostic (1.29e-1)" "unprognostic (2.04e-2)" "unprognostic (2.07e-1)" "prognostic favorable (3.45e-4)" "unprognostic (7.29e-2)" 16.1 20.2 7.9 13.3 8.9 7.1 13.5 10.9 11.8 13.7 16.2 10.9 20.8 13.5 18.0 18.7 18.8 13.3 19.7 11.4 7.8 8.0 17.9 17.4 11.0 19.2 10.5 6.6 12.9 24.9 9.1 9.3 26.3 7.9 12.5 12.7 10.1 14.4 14.5 10.3 13.7 16.9 10.1 8.3 18.8 14.0 8.7 7.4 33.5 16.9 12.4 19.8 14.6 15.1 18.6 17.6 42.7 19.5 16.6 24.6 16.0 83.5 14.1 7.0 6.4 8.5 6.9 6.3 14.4 11.4 12.6 8.4 12.0 13.6 12.4 13.9 9.5 12.0 12.4 6.8 12.8 9.8 11.5 7.5 5.6 8.1 6.1 7.7 7.0 7.6 6.8 9.1 13.6 17.3 10.1 11.8 6.9 9.2 6.4 11.0 12.3 8.6 12.5 11.1 19.2 23.3 6.7 17.0 11.9 12.3 6.2 6.2 5.9 10.6 10.0 29.5 8.4 10.8 7.8 13.2 9.8 9.5 15.0 13.7 9.0 6.8 7.3 14.2 7.2 13.7 15.0 17.1 12.7 21.0 17.7 24.1 18.6 22.3 24.6 17.6 16.4 23.2 20.9 42.7 16.6 19.5 16.0 20.7 16.0 7.9 8.9 10.9 11.8 7.8 8.0 10.5 6.6 7.9 7.4 0.0 4.0 17.1 11.9 10.5 6.7 0.1 10.2 0.0 1.2 17.4 0.0 60.4 18.3 47.2 0.5 15.7 19.5 0.0 30.3 34.1 9.5 9.2 1.1 8.3 27.5 3.2 2.4 12.9 9.7 1.1 12.4 8.9 30.4 27.9 12.1 8.9 37.0 16.9 15.6 25.9 3.9 0.0 9.0 6.5 16.6 9.3 25.7 12.5 16.1 13.7 FAF1 "CGI-03, hFAF1, HFAF1s, UBXD12, UBXN3A" ENSG00000185104 "Fas associated factor 1" Q9UNN5 1 50437028-50960263 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 92.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018253, CAB072814" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB072814: , HPA018253: AB_1848351" "unprognostic (1.52e-1)" "unprognostic (1.25e-2)" "unprognostic (6.49e-3)" "unprognostic (4.69e-2)" "unprognostic (6.35e-2)" "unprognostic (1.19e-2)" "prognostic unfavorable (1.87e-5)" "unprognostic (2.51e-1)" "unprognostic (1.02e-1)" "unprognostic (1.82e-1)" "unprognostic (9.52e-2)" "unprognostic (1.58e-1)" "unprognostic (1.58e-1)" "unprognostic (1.17e-1)" "unprognostic (9.00e-2)" "unprognostic (2.01e-3)" "unprognostic (6.42e-3)" 16.0 13.6 11.6 18.0 13.4 17.4 16.7 20.0 16.3 14.1 14.6 19.1 14.5 12.2 17.2 12.9 16.9 13.3 12.2 22.3 11.1 10.8 13.2 14.7 13.3 14.9 16.4 13.3 17.0 21.3 22.8 21.5 12.0 13.1 13.9 13.0 12.5 18.0 17.3 58.4 19.0 15.8 17.3 13.1 10.6 14.5 29.7 15.7 29.6 15.6 19.6 17.8 19.4 14.0 5.6 5.4 7.3 5.0 6.1 9.1 2.4 14.5 10.8 9.4 15.9 9.4 8.9 13.9 14.3 12.9 22.2 20.3 12.0 10.5 23.7 10.6 12.1 19.6 10.9 15.1 13.3 19.0 15.7 13.6 19.6 14.3 12.4 15.3 21.1 11.7 8.3 12.0 23.4 28.8 11.5 11.9 18.0 22.8 0.0 11.4 5.8 21.8 16.8 12.5 19.5 7.8 20.4 20.7 0.0 22.4 13.2 0.1 11.7 12.9 26.5 21.7 13.7 8.3 25.3 7.2 12.6 15.4 15.4 0.1 18.5 19.3 27.5 0.0 30.8 14.4 1.4 3.4 7.3 6.6 4.1 8.7 4.0 5.9 6.4 5.4 5.6 7.0 4.7 1.2 6.1 5.0 4.5 9.1 2.4 11.6 13.4 20.0 16.3 11.1 10.8 16.4 13.3 13.1 15.7 6.0 12.8 13.6 31.6 19.1 19.0 40.5 5.1 21.4 29.6 15.7 25.5 12.7 24.9 7.5 59.2 12.6 15.8 23.3 9.8 23.2 11.1 17.4 5.7 15.1 10.0 15.9 10.9 8.0 9.4 92.2 10.3 9.9 15.1 5.4 16.2 18.8 7.4 8.6 10.3 23.7 31.5 6.5 12.9 31.6 13.9 24.6 12.8 19.5 18.0 32.0 FAH ENSG00000103876 "Fumarylacetoacetate hydrolase" P16930 15 80152490-80186946 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Phenylalanine catabolism, Tyrosine catabolism" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 109.4" "Group enriched" "Detected in many" 4 "Hepatocytes: 250.1;Hofbauer cells: 63.7;Proximal tubular cells: 236.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 76.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041370, HPA044093" Enhanced Approved Nucleoplasm,Cytosol NA NA 230000000 Cytosol Nucleoplasm "HPA041370: AB_2677438, HPA044093: AB_2678806" "unprognostic (3.15e-1)" "unprognostic (5.65e-2)" "unprognostic (1.64e-1)" "unprognostic (6.16e-2)" "unprognostic (2.33e-3)" "prognostic unfavorable (8.51e-4)" "unprognostic (1.19e-2)" "unprognostic (5.83e-2)" "unprognostic (2.51e-2)" "unprognostic (5.21e-2)" "unprognostic (1.80e-1)" "unprognostic (1.23e-1)" "unprognostic (2.17e-2)" "unprognostic (4.21e-2)" "unprognostic (2.99e-1)" "unprognostic (2.93e-1)" "unprognostic (8.98e-2)" 32.1 17.8 4.6 6.1 3.6 4.7 22.8 2.3 3.3 4.7 8.6 3.1 8.3 4.1 5.1 14.8 4.4 6.8 7.1 6.8 4.1 2.8 18.9 109.4 7.9 6.2 4.0 2.1 7.2 6.5 4.8 4.4 2.3 3.5 4.9 3.4 2.4 5.3 5.4 7.7 2.4 7.6 4.4 5.9 6.0 3.3 9.7 3.0 2.3 4.2 4.9 3.9 4.1 6.1 0.1 16.0 16.9 11.7 3.6 5.8 6.1 4.5 7.6 3.1 3.9 14.7 15.1 7.8 5.8 13.3 6.2 5.3 4.6 8.4 0.0 9.6 12.2 8.6 6.7 11.2 13.9 6.0 2.9 6.3 38.8 4.5 23.8 76.6 18.3 21.5 26.1 8.6 5.3 9.6 20.3 8.6 8.9 16.2 8.3 11.5 6.9 5.0 9.1 2.2 3.5 8.7 2.8 4.5 29.1 17.8 5.5 0.1 1.9 6.5 18.0 18.2 5.3 13.7 12.5 29.9 11.3 7.1 6.0 9.8 7.6 15.5 3.1 23.5 42.9 6.3 16.9 11.7 1.9 5.8 4.9 1.5 0.1 1.6 3.9 16.0 0.0 2.0 1.8 0.7 3.6 4.8 1.2 1.5 6.1 4.6 3.6 2.3 3.3 4.1 2.8 4.0 2.1 3.5 3.0 3.0 14.4 5.2 13.1 6.1 0.4 12.0 10.2 5.3 4.5 31.4 0.0 32.5 44.7 8.5 6.3 2.5 15.8 23.3 3.1 9.0 17.2 8.6 42.5 250.1 63.7 0.0 4.1 11.1 20.0 10.6 9.2 23.1 18.6 3.6 11.8 3.5 4.6 14.4 7.4 236.8 0.3 0.0 8.1 1.5 2.1 5.0 18.4 8.7 22.4 12.8 FAHD1 "C16orf36, DKFZP566J2046" ENSG00000180185 "Fumarylacetoacetate hydrolase domain containing 1" Q6P587 16 1826941-1840207 "Enzymes, Predicted intracellular proteins" "Hydrolase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Proximal tubular cells: 175.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025530, HPA043226, HPA043534" Enhanced Enhanced Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB025530: , HPA043226: AB_2678370, HPA043534: AB_2678535" "unprognostic (3.71e-1)" "unprognostic (1.25e-2)" "prognostic favorable (8.27e-4)" "unprognostic (1.99e-1)" "unprognostic (6.74e-2)" "unprognostic (1.01e-3)" "unprognostic (2.89e-2)" "unprognostic (4.32e-1)" "unprognostic (1.13e-1)" "unprognostic (5.36e-2)" "unprognostic (1.65e-1)" "unprognostic (1.38e-1)" "prognostic favorable (2.80e-14)" "unprognostic (1.02e-1)" "unprognostic (1.66e-1)" "unprognostic (1.26e-1)" "unprognostic (3.31e-2)" 10.4 17.0 10.4 6.7 9.9 6.5 9.2 8.6 12.7 6.8 21.7 9.3 8.2 26.7 9.8 10.9 14.8 5.8 10.2 15.8 10.9 11.4 46.8 43.6 5.6 5.2 10.1 9.4 7.9 17.4 9.0 11.1 10.4 9.9 8.1 11.1 8.5 9.1 9.8 20.2 12.4 24.8 6.9 8.8 6.3 14.9 6.9 9.5 4.7 12.5 19.0 5.7 9.9 7.9 18.5 23.1 8.6 27.5 19.6 16.0 13.7 8.4 19.1 9.1 16.1 12.1 8.8 5.7 13.9 6.9 9.3 10.2 12.2 8.8 5.4 11.7 8.6 14.4 17.4 7.1 11.2 8.4 8.2 16.9 4.8 16.5 28.1 11.8 8.3 9.4 11.6 14.7 8.5 5.7 7.9 12.1 6.6 5.0 5.7 11.6 38.7 4.5 12.6 5.4 7.8 14.3 10.4 12.4 15.2 33.4 10.6 17.8 14.8 18.2 14.7 21.8 6.4 21.5 5.7 17.6 15.3 10.9 9.0 7.5 8.2 17.2 6.4 9.7 6.1 6.5 6.5 23.5 8.6 14.4 27.5 13.0 18.5 14.5 15.7 23.1 16.9 16.0 14.9 2.0 19.6 19.1 17.9 14.7 13.7 10.4 9.9 8.6 12.7 10.9 11.4 10.1 9.4 9.9 9.5 23.8 16.0 12.3 12.4 12.5 20.0 37.0 22.9 17.4 17.0 40.1 25.5 18.6 43.1 43.5 88.6 14.7 72.1 23.3 34.0 12.3 14.7 9.4 4.7 30.5 26.4 17.5 28.2 8.0 8.1 38.9 13.6 18.2 15.1 23.4 22.1 16.9 34.9 30.9 14.5 175.3 22.4 12.9 14.1 7.0 8.3 21.0 12.8 10.7 41.2 8.1 FAM103A1 "C15orf18, HsT19360, MGC2560, RAM" ENSG00000169612 "Family with sequence similarity 103 member A1" Q9BTL3 15 82986207-82991057 "Predicted intracellular proteins" "mRNA capping, mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041923, HPA041948" Enhanced Supported Nucleoplasm No No Nucleoplasm "HPA041923: AB_10796467, HPA041948: AB_10797270" "unprognostic (1.51e-1)" "unprognostic (1.16e-2)" "unprognostic (5.30e-2)" "unprognostic (1.03e-2)" "unprognostic (2.21e-1)" "unprognostic (1.15e-1)" "unprognostic (1.96e-1)" "unprognostic (2.58e-1)" "unprognostic (2.32e-2)" "unprognostic (3.63e-3)" "unprognostic (2.09e-2)" "unprognostic (4.72e-2)" "unprognostic (7.46e-3)" "unprognostic (9.57e-2)" "unprognostic (2.72e-2)" "unprognostic (9.47e-2)" "unprognostic (2.45e-1)" 16.1 16.2 16.7 12.8 19.5 21.8 23.2 18.9 25.4 16.4 15.4 11.6 18.9 12.0 16.6 27.8 27.5 17.4 13.1 13.3 15.7 17.9 22.1 23.2 10.9 17.5 16.0 14.4 18.9 21.4 12.5 21.7 29.0 22.7 16.3 17.1 16.3 20.9 14.1 27.0 21.8 18.9 14.6 12.4 16.2 17.6 17.0 11.3 25.8 20.8 19.9 23.9 16.7 17.1 24.9 21.7 46.3 23.4 26.4 26.3 22.5 13.5 18.4 18.0 11.4 11.8 8.8 14.1 14.3 14.4 16.5 13.5 20.5 18.2 7.1 19.1 12.0 18.7 15.9 31.7 13.6 18.1 16.9 23.9 22.1 9.8 24.0 15.5 15.1 19.3 15.3 26.9 12.7 16.8 12.1 10.3 11.7 26.3 14.4 17.3 14.7 11.2 20.0 22.1 17.6 9.4 13.5 15.9 11.1 21.0 26.7 18.0 18.4 14.6 15.6 33.8 30.7 25.1 20.2 7.8 12.2 14.6 11.2 19.8 21.5 40.4 16.7 10.8 21.1 14.3 40.4 23.4 36.3 20.1 22.2 21.8 24.9 23.3 22.0 21.7 21.6 23.3 23.2 46.3 26.4 22.2 20.1 26.3 22.5 16.7 19.5 18.9 25.4 15.7 17.9 16.0 14.4 22.7 11.3 6.0 4.8 34.0 39.0 59.2 23.3 0.0 30.6 18.7 10.3 0.0 23.6 92.6 0.0 0.0 21.7 23.0 29.6 46.7 0.0 69.1 37.1 39.6 35.7 45.7 61.4 27.0 21.9 31.9 31.9 12.7 32.5 19.4 40.5 0.0 26.3 26.1 0.0 52.6 31.8 0.0 27.7 32.3 26.9 59.7 58.6 72.4 77.7 47.3 27.1 48.8 FAM104A FLJ14775 ENSG00000133193 "Family with sequence similarity 104 member A" Q969W3 17 73207353-73236753 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 74.8" "Group enriched" "Detected in all" 4 "Early spermatids: 1144.0;Late spermatids: 1283.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021459, HPA079514" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA021459: AB_1848361, HPA079514: " "unprognostic (1.87e-1)" "unprognostic (1.28e-1)" "unprognostic (5.02e-3)" "unprognostic (3.23e-2)" "unprognostic (2.28e-2)" "unprognostic (3.05e-2)" "prognostic unfavorable (2.12e-7)" "unprognostic (5.19e-2)" "unprognostic (2.31e-2)" "unprognostic (4.88e-2)" "unprognostic (4.20e-2)" "unprognostic (1.20e-2)" "prognostic unfavorable (1.26e-10)" "unprognostic (6.70e-2)" "unprognostic (1.81e-1)" "unprognostic (1.03e-1)" "unprognostic (2.30e-1)" 9.3 7.2 8.7 9.1 9.0 23.2 12.4 10.8 7.9 9.9 9.1 6.9 7.4 7.8 8.4 8.4 10.4 6.6 8.5 11.6 8.1 7.0 6.4 10.0 8.2 10.1 6.9 8.3 8.2 11.4 8.4 11.2 14.2 6.4 9.3 8.1 8.4 8.3 8.0 11.9 11.7 10.1 7.3 7.1 11.8 13.3 74.8 6.5 14.6 9.2 7.1 11.2 9.9 11.6 21.3 19.7 34.3 20.3 26.7 49.5 29.9 23.0 19.0 9.5 17.7 14.7 13.8 31.4 18.9 19.9 20.9 21.6 15.9 14.9 13.5 15.6 18.1 20.3 14.7 12.3 13.8 22.7 15.8 16.5 19.6 16.3 24.0 19.5 17.1 33.8 14.6 18.3 18.5 13.6 13.7 24.4 16.4 15.2 22.6 25.0 15.7 30.4 11.8 13.2 17.0 24.3 16.7 26.7 13.0 15.9 19.0 15.8 21.0 11.0 16.1 20.2 18.7 22.6 17.7 16.9 24.7 28.6 16.8 22.0 22.4 22.1 16.4 22.1 18.8 18.2 24.5 20.3 34.3 24.7 17.6 23.7 21.3 30.3 28.1 19.7 20.2 22.2 26.7 33.3 26.7 18.6 12.8 49.5 29.9 8.7 9.0 10.8 7.9 8.1 7.0 6.9 8.3 6.4 6.5 8.9 12.2 25.3 20.2 50.6 15.0 5.0 20.4 16.0 12.5 21.0 5.9 95.7 26.6 29.8 1144.0 18.8 18.8 23.3 22.0 52.3 27.1 25.6 28.8 17.8 31.7 25.4 19.0 11.1 20.2 1283.3 32.5 21.6 23.6 33.3 24.5 18.6 28.1 24.3 22.6 15.4 19.4 6.5 17.5 121.4 59.8 57.5 271.7 30.5 18.4 48.7 FAM107B "C10orf45, FLJ45505, HITS, MGC11034" ENSG00000065809 "Family with sequence similarity 107 member B" Q9H098 10 14518557-14774897 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 272.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 6 "granulocytes: 17.3;NK-cells: 14.5;T-cells: 32.4" "Cell line enhanced" "Detected in many" "Daudi: 65.1;HDLM-2: 77.8;Karpas-707: 55.8;THP-1: 51.6" "HPA039661, HPA058814, HPA073195" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA039661: AB_10794751, HPA058814: AB_2683825, HPA073195: AB_2732221" "unprognostic (1.24e-1)" "unprognostic (1.91e-2)" "unprognostic (1.15e-1)" "unprognostic (1.80e-2)" "unprognostic (8.90e-2)" "unprognostic (1.09e-2)" "unprognostic (1.67e-1)" "unprognostic (1.50e-1)" "unprognostic (2.36e-1)" "unprognostic (6.82e-2)" "unprognostic (5.60e-2)" "unprognostic (4.63e-1)" "unprognostic (1.41e-1)" "unprognostic (1.80e-1)" "unprognostic (6.93e-2)" "unprognostic (7.01e-2)" "unprognostic (3.53e-2)" 15.0 15.2 30.0 27.5 44.7 48.7 19.3 13.1 21.7 15.0 20.2 56.3 85.8 10.4 15.7 7.0 8.3 7.0 21.8 5.9 44.1 23.8 40.1 47.4 20.8 45.7 49.7 14.6 3.5 40.7 16.4 10.7 17.2 38.5 10.0 14.0 3.9 27.7 85.7 2.1 8.4 17.8 10.5 66.3 15.4 37.9 11.6 44.7 7.5 6.2 4.1 41.9 15.5 9.8 3.5 1.4 17.3 3.7 14.5 32.4 19.2 10.5 22.8 9.1 0.6 1.4 0.3 3.8 10.6 15.3 6.5 4.7 14.0 8.9 65.1 9.6 4.8 2.4 3.3 2.8 6.4 11.6 77.8 2.5 1.8 10.3 16.5 4.9 23.4 4.2 0.7 5.0 2.7 1.3 7.7 27.6 12.9 0.1 55.8 5.0 2.7 5.7 6.8 2.2 12.7 5.0 41.7 7.0 23.9 14.9 6.8 3.4 9.7 4.2 2.2 6.9 8.5 8.2 51.6 9.0 6.8 5.7 21.4 3.5 24.7 22.0 42.1 1.2 20.6 1.8 11.5 1.7 17.3 29.8 2.0 29.1 3.5 24.0 25.1 1.4 3.1 32.4 32.0 7.2 14.5 3.7 1.0 21.1 19.2 30.0 44.7 13.1 21.7 44.1 23.8 49.7 14.6 38.5 44.7 98.3 44.3 102.5 106.0 79.7 4.0 3.9 127.4 91.0 58.0 272.2 2.0 13.9 189.0 38.0 23.9 29.6 36.4 0.0 92.2 29.2 52.6 147.0 117.6 155.2 36.2 190.7 13.7 63.3 52.4 41.5 2.3 57.8 49.0 43.3 91.1 13.5 84.5 17.3 4.6 157.5 13.2 0.0 41.2 55.4 35.6 72.0 52.3 117.6 22.4 208.7 FAM110A "bA371L19.3, C20orf55" ENSG00000125898 "Family with sequence similarity 110 member A" Q9BQ89 20 833715-857463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 83.4" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 131.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 83.4;eosinophil: 24.8;intermediate monocyte: 25.1;non-classical monocyte: 37.7" "Group enriched" "Detected in all" 9 "granulocytes: 83.4;monocytes: 37.7" "Cell line enhanced" "Detected in many" "SK-BR-3: 40.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB034110, HPA069240" Uncertain Uncertain Nucleoplasm,Vesicles,Cytosol Yes Yes "Nucleoplasm, Vesicles" Cytosol "CAB034110: AB_1562838, HPA069240: AB_2686103" "unprognostic (6.33e-2)" "unprognostic (2.53e-2)" "unprognostic (1.57e-2)" "unprognostic (3.43e-2)" "unprognostic (1.81e-1)" "unprognostic (3.37e-2)" "unprognostic (4.90e-3)" "unprognostic (5.55e-2)" "unprognostic (6.01e-2)" "unprognostic (4.78e-2)" "unprognostic (2.35e-2)" "unprognostic (2.47e-1)" "prognostic unfavorable (4.42e-4)" "unprognostic (9.64e-3)" "unprognostic (1.17e-2)" "unprognostic (6.42e-3)" "unprognostic (4.21e-3)" 5.2 3.6 1.7 17.7 4.2 7.4 7.7 1.9 3.9 6.5 8.8 2.0 7.7 10.0 4.0 6.1 22.1 1.9 6.9 4.8 1.7 2.5 4.8 3.9 15.2 18.7 2.1 1.9 2.6 3.5 9.3 5.1 11.1 3.6 11.1 3.4 3.1 12.7 10.5 3.7 39.9 9.2 1.3 1.6 15.1 5.5 2.8 1.3 22.9 7.7 8.0 18.9 7.8 9.7 1.9 5.8 83.4 37.7 1.0 6.4 3.2 12.7 3.4 1.9 3.6 2.2 0.9 13.4 4.0 2.2 2.6 2.3 7.5 8.0 4.1 1.8 2.5 3.6 20.7 1.6 10.5 2.1 3.3 1.1 8.6 2.2 1.9 1.0 2.3 3.0 0.6 13.1 3.5 3.5 0.8 1.7 3.8 4.6 10.3 2.3 7.6 6.5 6.4 2.5 8.2 5.9 6.5 3.4 5.4 1.9 9.2 3.7 4.4 3.4 40.4 1.8 0.8 16.7 3.5 2.2 6.1 4.5 5.5 4.4 3.8 3.2 1.7 0.9 6.1 4.4 83.4 4.4 24.8 2.2 25.1 2.0 1.1 4.0 4.6 5.8 1.9 4.9 4.7 2.5 1.0 37.7 0.6 6.4 3.2 1.7 4.2 1.9 3.9 1.7 2.5 2.1 1.9 3.6 1.3 0.0 6.5 19.9 14.7 29.0 0.2 2.4 5.1 4.0 0.0 10.4 0.0 36.4 1.7 8.3 6.0 5.8 6.9 46.7 5.2 131.1 4.7 17.7 52.8 0.8 17.4 4.8 10.4 18.4 36.5 13.5 3.1 27.8 6.8 6.4 7.5 0.2 10.7 8.0 1.8 2.1 2.5 6.5 5.2 1.9 5.3 32.1 26.2 26.2 7.8 20.9 FAM111A "FLJ22794, KIAA1895" ENSG00000166801 "Family with sequence similarity 111 member A" Q96PZ2 11 59142748-59155039 "Disease related genes, Predicted intracellular proteins" "Antiviral defense, DNA replication, Host-virus interaction" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 73.4" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039529, HPA040176" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA Yes "Nucleoplasm, Nucleoli fibrillar center" "HPA039529: AB_10795149, HPA040176: AB_10793958" "unprognostic (4.12e-3)" "unprognostic (8.47e-2)" "unprognostic (7.80e-3)" "unprognostic (1.00e-1)" "unprognostic (1.81e-1)" "unprognostic (2.41e-1)" "unprognostic (5.83e-3)" "unprognostic (1.81e-1)" "unprognostic (9.88e-2)" "unprognostic (5.96e-2)" "unprognostic (2.74e-2)" "unprognostic (3.53e-2)" "prognostic unfavorable (1.15e-5)" "unprognostic (2.66e-2)" "unprognostic (1.79e-1)" "unprognostic (1.76e-2)" "prognostic favorable (4.39e-4)" 16.3 13.7 4.8 28.1 6.7 9.9 14.5 3.3 4.8 14.7 14.2 8.3 13.2 12.8 18.1 16.8 10.2 11.3 15.9 6.7 5.5 3.9 14.5 11.7 17.5 19.6 7.4 3.8 11.2 10.7 17.8 17.4 10.8 8.1 22.5 11.7 13.2 13.4 13.0 5.6 11.0 19.3 14.0 12.3 29.5 12.9 5.9 6.5 73.4 19.5 12.9 21.3 10.9 13.2 4.6 6.5 7.7 6.3 6.9 8.6 2.4 21.2 5.5 2.7 2.6 6.1 7.4 1.8 30.4 16.6 13.1 19.3 8.3 20.0 31.2 12.8 9.8 17.9 7.4 9.0 13.3 16.6 27.7 0.4 11.7 7.0 2.5 6.3 18.6 15.9 5.1 3.4 12.2 3.9 7.6 12.1 19.3 1.4 25.8 14.1 6.0 28.1 12.5 1.2 6.6 6.0 19.4 9.8 7.3 8.8 19.0 0.0 0.7 15.6 13.1 5.9 1.5 26.9 8.4 11.7 21.4 19.3 14.6 14.2 13.2 13.7 5.1 11.7 13.3 25.7 6.2 6.3 6.7 6.6 5.4 8.6 4.2 4.5 4.8 6.5 4.6 4.4 3.7 7.7 6.9 2.6 1.8 4.6 2.4 4.8 6.7 3.3 4.8 5.5 3.9 7.4 3.8 8.1 6.5 59.6 39.5 24.4 9.7 7.6 2.2 3.9 12.7 46.8 26.1 15.7 0.0 8.9 8.3 10.1 0.0 17.5 12.9 0.0 6.6 1.2 14.9 15.7 26.6 7.9 24.4 0.0 5.8 27.6 31.6 1.1 12.0 25.0 6.8 12.6 19.1 29.9 8.0 15.8 6.3 7.6 6.5 0.0 10.7 0.4 1.9 7.8 3.7 21.8 15.3 10.9 FAM111B CANP ENSG00000189057 "Family with sequence similarity 111 member B" Q6SJ93 11 59107185-59127410 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 43.9" "Cell type enhanced" "Detected in some" 9 "B-cells: 4.8;Basal keratinocytes: 3.8;Hofbauer cells: 3.4;Undifferentiated cells: 6.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "memory B-cell: 5.7;naive B-cell: 5.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038637 Uncertain Approved Nucleoplasm,Cytosol No Yes Nucleoplasm Cytosol "HPA038637: AB_10672522" "unprognostic (2.31e-1)" "unprognostic (2.68e-2)" "unprognostic (1.80e-3)" "unprognostic (6.94e-2)" "unprognostic (1.89e-1)" "unprognostic (1.96e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (1.49e-3)" "unprognostic (1.40e-2)" "unprognostic (4.85e-2)" "prognostic unfavorable (1.17e-5)" "unprognostic (1.01e-2)" "unprognostic (1.24e-5)" "unprognostic (2.94e-2)" "unprognostic (1.80e-1)" "unprognostic (1.20e-3)" "unprognostic (1.24e-1)" 1.3 1.3 0.4 8.9 0.8 3.5 1.9 0.3 1.1 1.8 4.7 0.4 0.3 2.5 0.8 2.0 9.3 0.7 1.8 1.0 0.4 0.4 1.8 2.6 2.1 9.9 0.5 0.3 1.0 0.8 1.4 0.9 2.8 0.8 1.2 5.0 0.3 2.6 0.3 0.5 3.5 4.1 1.3 0.6 5.4 2.8 1.0 0.6 43.9 0.7 9.2 11.1 1.5 2.6 5.7 0.3 3.1 0.2 0.1 1.4 0.3 24.4 6.3 9.4 0.1 1.0 1.8 0.1 18.6 9.3 11.1 16.5 13.3 9.7 30.5 12.6 5.4 9.3 19.0 13.7 12.6 19.8 15.8 3.3 3.3 12.0 5.8 0.0 0.1 3.9 0.4 0.4 10.7 0.8 2.1 5.9 8.3 0.9 28.8 13.0 9.2 19.2 0.2 0.1 14.8 7.4 20.3 14.0 11.9 5.9 21.1 1.8 6.0 15.4 17.8 3.0 3.6 19.7 1.7 3.2 8.6 18.8 26.0 16.9 22.2 16.0 0.2 12.5 0.1 12.3 0.5 0.2 0.2 0.3 0.1 0.2 5.7 0.4 0.7 0.3 5.7 0.2 0.2 3.1 0.1 0.2 0.3 1.4 0.3 0.4 0.8 0.3 1.1 0.4 0.4 0.5 0.3 0.8 0.6 0.0 0.0 4.8 2.0 3.8 0.0 0.3 0.0 2.7 1.2 0.0 0.0 0.6 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.3 0.3 0.8 0.0 0.0 3.4 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 2.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.3 2.4 0.1 0.5 6.3 0.9 FAM114A1 Noxp20 ENSG00000197712 "Family with sequence similarity 114 member A1" Q8IWE2 4 38867677-38945739 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Leydig cells: 102.6;Peritubular cells: 109.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 5.1;intermediate monocyte: 6.3;myeloid DC: 4.3;neutrophil: 3.8;non-classical monocyte: 2.2" "Group enriched" "Detected in many" 6 "dendritic cells: 4.3;granulocytes: 3.8;monocytes: 6.3" "Cell line enhanced" "Detected in many" "ASC diff: 42.5;ASC TERT1: 44.4;BJ hTERT+: 50.7;fHDF/TERT166: 56.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA067948, HPA069104, HPA069701" Uncertain Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" No No "Golgi apparatus, Cytosol" Nucleoplasm "HPA067948: AB_2685931, HPA069104: AB_2686087, HPA069701: AB_2686175" "unprognostic (2.13e-3)" "unprognostic (4.68e-2)" "unprognostic (1.94e-1)" "unprognostic (4.66e-2)" "unprognostic (9.40e-3)" "unprognostic (6.77e-2)" "unprognostic (2.54e-1)" "unprognostic (2.31e-2)" "unprognostic (4.88e-2)" "unprognostic (1.55e-1)" "unprognostic (3.06e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (3.63e-6)" "unprognostic (1.31e-1)" "unprognostic (1.34e-1)" "unprognostic (2.39e-2)" "unprognostic (3.44e-3)" 15.8 27.3 4.4 11.8 7.3 0.3 17.9 2.5 5.1 23.3 18.9 8.0 17.1 9.0 34.1 23.5 19.9 11.4 24.1 14.1 7.0 4.2 9.6 31.8 14.5 6.1 5.8 5.0 21.7 33.4 8.8 18.7 19.1 6.5 22.0 14.0 13.0 59.9 12.6 9.3 10.1 15.8 36.7 6.2 6.3 13.9 10.8 5.8 1.5 11.5 16.7 15.1 29.1 17.8 0.7 4.3 3.8 6.3 0.1 0.2 1.3 8.7 6.3 3.8 4.5 42.5 44.4 1.2 34.6 50.7 14.7 22.5 1.6 6.8 0.0 4.8 56.0 25.1 2.4 0.0 11.0 17.0 0.0 0.9 0.6 6.7 8.1 15.2 0.0 1.2 26.2 3.5 21.3 4.9 33.4 21.0 0.0 0.6 0.0 21.4 2.2 0.0 0.4 0.8 3.7 3.2 0.1 19.1 0.6 4.9 1.7 0.1 1.9 6.9 0.1 7.1 9.4 4.3 0.7 32.0 16.0 7.5 20.0 8.0 0.1 0.0 0.0 26.2 0.6 13.0 0.8 5.1 0.1 0.2 6.3 0.1 0.7 0.2 0.1 4.3 0.3 0.2 0.2 3.8 0.1 2.2 0.5 0.1 1.3 4.4 7.3 2.5 5.1 7.0 4.2 5.8 5.0 6.5 5.8 14.9 10.4 0.0 39.8 10.9 0.1 14.4 10.2 40.2 23.9 7.0 0.0 1.5 8.3 41.1 0.9 28.7 35.9 0.0 54.0 35.9 79.4 79.1 1.1 66.9 14.7 0.0 15.1 30.1 6.7 2.2 102.6 9.9 20.3 5.4 70.8 10.6 41.7 35.1 109.3 8.4 1.0 19.4 25.7 0.5 1.1 8.9 2.9 2.5 27.3 53.6 FAM117A ENSG00000121104 "Family with sequence similarity 117 member A" Q9C073 17 49710332-49789180 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Erythroid cells: 93.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 24.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 35.4;U-266/84: 24.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA022531 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA022531: AB_2101087" "prognostic favorable (5.30e-5)" "unprognostic (8.06e-3)" "unprognostic (2.82e-2)" "unprognostic (1.77e-2)" "unprognostic (2.00e-1)" "unprognostic (3.90e-3)" "unprognostic (1.69e-1)" "prognostic favorable (8.25e-7)" "unprognostic (4.05e-1)" "unprognostic (3.58e-1)" "prognostic favorable (1.81e-4)" "unprognostic (1.99e-2)" "unprognostic (3.73e-2)" "unprognostic (9.12e-2)" "unprognostic (1.45e-1)" "unprognostic (4.07e-2)" "unprognostic (4.66e-2)" 9.9 5.7 7.6 15.5 9.4 42.9 9.6 12.4 5.7 17.4 15.8 5.6 12.2 7.2 21.2 9.6 11.3 12.4 13.3 12.5 5.6 3.7 8.3 10.0 9.0 14.2 2.8 5.4 16.0 17.6 8.6 11.9 4.4 10.8 16.4 6.0 24.3 11.9 21.3 4.0 13.6 13.7 20.7 2.1 26.7 10.3 18.4 3.6 30.0 14.2 6.5 24.1 21.8 8.5 13.9 2.1 24.3 0.9 6.7 5.5 1.8 3.0 0.7 4.9 0.0 2.2 0.4 8.8 1.0 1.7 1.8 3.1 21.7 5.0 14.3 5.4 0.6 8.3 1.7 3.8 3.6 1.4 1.0 6.2 15.8 0.0 6.9 2.4 2.4 12.6 2.1 3.0 3.1 1.7 1.9 3.3 12.4 19.2 12.2 1.7 8.1 15.2 12.7 7.3 4.1 2.4 4.8 4.1 7.5 2.8 2.7 4.9 3.2 1.0 0.4 3.5 5.0 7.2 9.1 0.3 1.8 1.5 1.9 0.8 35.4 24.3 9.5 1.6 3.5 1.5 24.3 0.9 4.9 5.0 0.6 5.5 13.9 3.3 4.2 0.7 9.3 2.7 3.7 1.9 6.7 0.1 2.1 3.2 1.8 7.6 9.4 12.4 5.7 5.6 3.7 2.8 5.4 10.8 3.6 6.0 5.7 11.0 1.2 8.0 12.6 16.1 2.5 1.4 5.7 7.0 13.7 0.9 5.0 1.3 2.3 6.5 0.9 93.5 3.1 1.6 6.1 2.6 2.3 5.0 1.1 4.8 10.3 6.7 3.2 4.5 13.3 3.4 6.8 11.8 4.4 3.9 3.2 0.0 14.5 2.8 3.1 0.0 7.2 17.2 12.4 12.3 0.7 13.1 2.6 0.9 FAM117B "ALS2CR13, FLJ38771" ENSG00000138439 "Family with sequence similarity 117 member B" Q6P1L5 2 202635188-202769757 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003229, HPA028746" Uncertain Approved Nucleoplasm,Centrosome Yes No Nucleoplasm Centrosome "HPA003229: AB_2246696, HPA028746: AB_2672760" "unprognostic (1.39e-2)" "unprognostic (1.47e-1)" "unprognostic (1.53e-2)" "unprognostic (4.59e-2)" "unprognostic (1.07e-2)" "unprognostic (4.07e-3)" "unprognostic (1.55e-2)" "unprognostic (4.84e-2)" "unprognostic (6.21e-2)" "unprognostic (2.55e-2)" "unprognostic (8.40e-3)" "unprognostic (5.75e-1)" "unprognostic (6.01e-2)" "unprognostic (8.93e-2)" "unprognostic (3.18e-1)" "unprognostic (8.59e-2)" "unprognostic (1.37e-3)" 5.8 12.5 10.1 11.1 10.3 4.3 10.0 20.8 18.1 5.5 7.9 3.2 7.1 7.0 5.0 7.5 9.6 6.6 6.2 4.3 8.6 10.8 8.3 3.6 6.2 13.0 5.9 9.1 8.8 11.6 24.7 7.5 11.0 4.7 8.6 7.9 3.7 8.6 9.3 5.8 9.0 6.0 7.3 5.7 8.2 6.6 12.6 5.8 22.4 5.5 4.8 11.7 7.2 12.7 9.0 4.8 2.3 8.9 4.5 9.9 3.3 1.6 2.0 8.9 6.1 3.0 1.7 8.6 0.5 0.8 0.5 1.0 2.5 3.5 6.7 5.5 1.0 1.3 1.6 7.5 3.8 1.5 0.1 6.1 5.6 3.8 9.4 2.4 4.7 2.5 2.3 5.3 1.1 1.7 4.0 2.4 8.9 8.0 1.4 0.5 3.2 12.7 9.9 9.0 4.7 3.8 10.1 1.8 7.8 4.7 4.3 15.1 13.1 6.6 4.4 3.2 7.8 1.9 6.6 1.4 1.1 2.1 1.5 0.9 4.9 2.8 8.9 2.0 3.7 1.1 0.3 4.5 1.6 1.6 8.9 4.0 9.0 3.6 3.1 4.8 8.5 9.9 6.8 2.3 4.5 8.8 1.7 1.3 3.3 10.1 10.3 20.8 18.1 8.6 10.8 5.9 9.1 4.7 5.8 3.0 6.9 14.1 1.9 15.2 4.7 3.9 10.2 2.7 2.3 17.4 3.9 6.1 0.0 6.7 1.7 3.3 5.2 0.0 5.5 4.9 8.4 7.0 5.7 1.7 2.5 6.4 24.8 5.5 22.9 0.9 12.0 9.9 3.3 1.0 12.9 1.9 5.7 7.0 22.3 4.9 2.7 6.5 3.1 4.4 16.3 17.3 2.3 6.4 11.9 5.4 FAM120B "CCPG, KIAA1838, PGCC1" ENSG00000112584 "Family with sequence similarity 120B" Q96EK7 6 170290703-170407065 "Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 32 "Early spermatids: 546.2;Late spermatids: 1520.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037518, HPA037519" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA037518: AB_10671626, HPA037519: AB_10696935" "unprognostic (7.99e-3)" "unprognostic (7.81e-2)" "unprognostic (2.01e-2)" "unprognostic (1.55e-1)" "unprognostic (2.23e-2)" "unprognostic (6.02e-2)" "unprognostic (2.76e-2)" "unprognostic (1.88e-1)" "unprognostic (9.87e-2)" "prognostic unfavorable (1.60e-4)" "prognostic favorable (2.70e-4)" "unprognostic (1.41e-1)" "unprognostic (9.27e-2)" "unprognostic (3.15e-2)" "unprognostic (2.50e-1)" "unprognostic (4.98e-2)" "unprognostic (1.36e-1)" 18.4 20.6 18.5 21.1 28.7 10.7 20.5 28.4 27.7 20.5 16.6 28.5 16.3 15.8 28.3 24.1 16.5 26.8 18.1 18.4 18.1 22.8 17.3 15.6 18.3 16.7 20.6 19.5 23.4 17.0 24.7 32.0 19.5 26.1 22.4 18.6 19.1 21.4 21.2 25.7 18.4 16.2 20.1 21.1 16.9 16.9 20.7 20.4 24.7 22.3 15.3 22.0 19.8 16.3 7.4 9.2 14.7 13.6 15.9 10.2 8.5 5.9 6.1 9.3 11.1 13.4 13.0 5.5 10.0 11.7 8.9 8.9 5.4 4.6 8.4 6.0 14.3 10.4 7.1 9.6 11.5 11.7 12.1 5.9 8.9 5.7 7.1 12.0 8.8 7.2 15.7 12.3 8.2 10.9 15.6 13.7 9.4 9.8 6.9 14.9 12.2 6.4 7.9 4.6 12.3 4.2 5.5 8.7 8.7 9.2 5.3 6.6 10.1 8.6 7.7 3.0 12.0 7.6 17.6 11.6 3.8 6.3 10.0 6.9 8.5 7.1 8.9 10.4 7.3 13.9 14.7 8.1 10.0 8.3 9.0 9.5 6.6 7.9 8.9 9.2 7.4 10.2 8.1 13.9 15.9 13.6 5.3 8.4 8.5 18.5 28.7 28.4 27.7 18.1 22.8 20.6 19.5 26.1 20.4 20.8 14.5 2.7 4.7 3.2 15.0 15.7 15.3 14.7 13.6 14.0 31.4 8.9 0.0 8.3 546.2 15.3 8.6 0.0 8.0 6.4 6.5 11.1 9.3 7.6 9.5 6.4 9.2 11.1 8.2 1520.1 17.8 8.7 18.6 1.8 13.9 6.6 7.9 8.5 13.4 4.9 11.5 32.3 5.3 16.1 11.5 5.1 11.2 5.1 7.4 5.5 FAM122A "C9orf42, MGC17347" ENSG00000187866 "Family with sequence similarity 122A" Q96E09 9 68780034-68784608 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056646 Approved Approved "Nucleoplasm,Nuclear bodies" No No "Nuclear bodies" Nucleoplasm "HPA056646: AB_2683202" "unprognostic (1.88e-2)" "unprognostic (7.62e-2)" "unprognostic (9.17e-2)" "unprognostic (1.48e-2)" "unprognostic (2.55e-2)" "unprognostic (1.16e-1)" "unprognostic (9.79e-2)" "unprognostic (1.45e-2)" "unprognostic (4.18e-1)" "unprognostic (8.49e-3)" "unprognostic (1.45e-2)" "unprognostic (4.58e-3)" "prognostic favorable (1.34e-5)" "unprognostic (9.35e-2)" "unprognostic (3.02e-2)" "unprognostic (2.72e-1)" "unprognostic (6.89e-2)" 21.0 21.3 13.9 12.0 20.2 9.8 21.4 22.5 24.6 23.1 15.5 17.0 12.4 10.0 20.3 15.6 17.6 19.7 14.4 24.2 13.8 14.3 21.5 21.2 14.1 14.7 16.8 14.2 24.2 17.9 25.3 20.8 21.8 18.0 20.6 14.9 22.4 17.0 19.8 20.0 15.1 15.0 17.6 13.9 17.7 15.0 16.2 14.6 18.1 19.1 14.8 15.4 15.7 16.5 5.8 6.7 4.3 5.1 4.5 9.8 2.5 5.4 3.7 5.1 4.4 17.6 11.5 7.0 7.7 7.3 6.9 5.5 1.3 2.7 11.4 3.9 8.2 5.0 10.2 5.7 5.2 8.6 12.3 6.0 6.3 6.1 4.5 10.9 11.4 4.5 9.3 12.0 6.3 4.9 7.8 6.8 8.3 6.7 13.0 7.3 2.9 6.3 3.0 6.5 12.9 6.6 7.8 7.1 3.5 6.2 4.5 8.2 3.7 5.7 4.8 3.9 7.5 2.9 5.0 8.4 6.4 4.6 11.9 5.7 15.3 6.2 4.7 6.9 7.3 7.1 4.3 5.1 3.7 4.5 4.9 4.0 3.6 4.5 4.9 5.7 5.8 9.8 5.5 2.9 4.5 4.8 6.7 4.9 2.5 13.9 20.2 22.5 24.6 13.8 14.3 16.8 14.2 18.0 14.6 3.0 6.0 19.1 16.1 20.9 17.5 13.9 7.6 25.4 6.8 5.2 15.7 24.6 56.3 13.9 23.4 14.8 11.2 46.7 11.9 13.7 16.9 11.3 17.3 15.3 19.0 7.9 17.2 13.5 19.4 11.4 14.1 17.4 13.5 8.2 15.4 31.5 13.0 13.3 15.9 20.3 18.4 45.3 45.6 36.3 17.7 20.7 25.6 17.5 12.5 15.3 FAM122B "DKFZp686L20116, RP11-308B5.5" ENSG00000156504 "Family with sequence similarity 122B" Q7Z309 X 134769566-134797232 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000266 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA000266: AB_1078801" "unprognostic (2.10e-3)" "unprognostic (1.55e-2)" "unprognostic (4.53e-3)" "prognostic unfavorable (7.19e-5)" "unprognostic (1.67e-1)" "unprognostic (2.19e-1)" "unprognostic (1.41e-2)" "unprognostic (3.07e-2)" "unprognostic (1.50e-2)" "unprognostic (2.15e-1)" "unprognostic (7.64e-2)" "unprognostic (1.53e-3)" "unprognostic (2.26e-3)" "unprognostic (2.60e-2)" "unprognostic (7.96e-2)" "unprognostic (2.11e-2)" "unprognostic (3.19e-3)" 13.4 18.5 24.5 18.4 41.5 27.1 14.8 20.9 29.6 15.7 15.4 22.3 13.4 15.5 23.0 27.7 16.2 20.3 13.6 13.9 22.5 21.8 15.2 9.8 15.5 27.2 22.9 24.7 29.3 15.9 29.0 27.8 17.4 21.3 17.3 23.6 13.3 18.8 17.4 10.3 19.4 19.5 20.3 21.8 26.1 18.5 34.5 20.5 21.4 20.7 11.1 26.5 16.3 16.3 1.6 3.8 5.9 1.2 2.7 3.3 1.1 17.8 16.5 13.3 9.4 6.8 8.9 9.3 14.2 12.5 16.1 15.3 14.6 16.0 17.5 28.2 10.3 22.6 12.0 19.5 11.7 29.4 21.6 13.5 17.6 33.0 4.7 4.2 32.3 22.5 5.8 11.6 17.7 7.8 10.5 9.3 18.0 11.4 22.6 16.9 24.1 20.0 28.1 7.2 20.6 17.8 20.4 14.4 15.3 9.8 18.6 12.1 8.6 7.6 10.3 5.1 11.9 5.5 16.7 6.6 13.5 8.8 34.1 30.8 12.5 14.4 22.7 14.4 37.6 16.7 0.1 1.2 5.9 2.1 0.5 2.8 1.6 2.0 2.8 1.2 1.5 2.4 3.3 1.3 2.7 1.1 3.8 2.0 1.1 24.5 41.5 20.9 29.6 22.5 21.8 22.9 24.7 21.3 20.5 11.9 7.2 13.9 12.1 11.9 4.2 9.0 5.1 2.7 11.4 15.7 11.8 7.4 14.9 6.3 1.2 11.9 10.4 23.3 11.9 8.9 11.3 12.7 24.1 6.8 12.5 12.7 5.8 8.0 18.8 3.3 9.8 11.4 16.9 8.2 13.7 3.9 9.6 17.5 6.0 5.9 5.4 0.0 8.2 2.3 3.6 9.8 7.3 24.9 13.2 16.3 FAM122C RP3-473B4.1 ENSG00000156500 "Family with sequence similarity 122C" Q6P4D5 X 134796395-134854835 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 41.5;Erythroid cells: 23.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 14.9" HPA059961 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA059961: AB_2684181" "unprognostic (1.32e-2)" "unprognostic (3.50e-2)" "unprognostic (7.63e-2)" "unprognostic (3.38e-3)" "unprognostic (1.08e-1)" "unprognostic (5.25e-2)" "unprognostic (1.85e-1)" "unprognostic (3.76e-3)" "unprognostic (3.50e-2)" "unprognostic (7.20e-3)" "unprognostic (2.28e-1)" "unprognostic (1.03e-2)" "unprognostic (2.41e-2)" "unprognostic (5.93e-2)" "unprognostic (1.38e-1)" "unprognostic (1.19e-1)" "unprognostic (4.16e-3)" 4.2 3.8 4.1 4.7 6.0 8.7 4.1 2.9 5.0 4.6 3.8 7.9 3.8 1.8 11.5 4.2 3.5 4.7 3.4 3.9 4.0 4.2 3.6 3.2 5.6 7.1 6.3 4.6 22.0 2.1 2.9 5.5 2.9 5.3 4.4 3.2 11.5 6.6 3.2 2.9 3.3 4.0 7.9 6.2 6.4 4.7 12.0 5.2 9.1 3.8 2.1 6.5 5.9 3.5 4.8 7.0 7.3 5.8 4.5 3.8 2.1 1.1 1.4 4.4 4.5 1.2 1.7 2.6 3.7 3.3 3.4 4.7 3.2 4.5 1.5 5.7 1.6 7.4 1.7 3.7 1.3 2.5 3.7 1.4 2.6 14.9 1.4 1.3 3.9 2.3 1.8 0.7 3.3 2.1 2.3 2.8 11.6 10.9 8.7 2.4 6.8 4.0 3.2 2.4 1.2 3.3 6.9 3.0 3.2 1.1 1.0 1.8 3.0 2.3 0.7 3.8 3.3 1.1 1.1 0.9 2.0 1.3 3.1 2.4 3.3 2.9 6.5 2.9 4.4 2.2 2.7 2.8 7.3 2.6 3.1 2.7 4.8 3.0 3.8 1.9 4.1 3.7 3.3 5.3 4.5 5.8 7.0 2.7 2.1 4.1 6.0 2.9 5.0 4.0 4.2 6.3 4.6 5.3 5.2 6.0 5.0 0.0 2.1 1.1 4.2 1.9 0.0 13.4 3.4 1.8 13.7 1.3 1.7 1.0 41.5 5.7 2.3 23.3 1.6 2.2 2.0 1.3 12.7 0.5 1.9 3.2 1.2 4.9 1.9 4.5 3.7 2.7 3.3 3.6 1.7 4.6 2.0 1.1 2.1 1.1 13.0 0.0 2.3 10.7 1.9 1.0 1.6 8.7 1.7 2.2 FAM124A FLJ30707 ENSG00000150510 "Family with sequence similarity 124 member A" Q86V42 13 51222334-51284241 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.3" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 47.1;Rod photoreceptor cells: 43.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "HAP1: 13.3;HUVEC TERT2: 7.9;NTERA-2: 26.1;SH-SY5Y: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048182 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA048182: AB_2680301" "unprognostic (3.94e-3)" "unprognostic (8.76e-2)" "unprognostic (8.05e-2)" "unprognostic (1.05e-2)" "unprognostic (3.34e-1)" "unprognostic (8.37e-2)" "unprognostic (2.59e-2)" "unprognostic (2.08e-3)" "unprognostic (1.52e-1)" "unprognostic (1.14e-1)" "unprognostic (2.43e-2)" "unprognostic (2.03e-1)" "unprognostic (1.24e-1)" "unprognostic (7.38e-3)" "unprognostic (4.51e-2)" "unprognostic (4.54e-3)" "unprognostic (1.05e-2)" 5.3 3.5 7.7 4.7 19.6 0.7 2.6 2.6 15.0 3.3 7.2 40.3 0.3 1.4 3.8 8.4 2.4 3.6 4.3 7.1 13.5 7.4 6.7 1.5 3.3 1.5 29.1 7.7 1.3 2.7 1.2 1.5 6.2 18.8 6.5 2.6 3.8 12.4 8.1 1.8 1.9 2.1 8.9 25.3 13.2 4.1 2.3 26.7 0.3 2.8 0.6 1.1 4.1 1.8 0.8 1.0 2.7 0.9 1.2 0.8 0.3 0.0 1.2 0.9 0.8 0.2 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.5 0.4 0.0 0.0 1.6 0.1 13.3 0.1 0.1 0.0 2.0 0.0 0.3 0.0 1.0 0.6 0.8 0.3 0.1 0.4 0.0 0.0 7.9 3.5 0.1 0.0 0.0 0.2 3.2 0.2 26.1 0.2 2.0 0.7 0.0 1.9 0.0 0.1 1.9 10.0 0.4 1.6 1.5 2.0 0.2 0.7 0.1 0.0 0.9 0.7 0.9 0.2 0.0 0.0 1.2 2.3 1.1 2.7 0.8 0.8 0.8 0.6 0.8 0.6 0.5 0.6 0.4 0.8 0.7 0.7 2.4 1.2 0.9 1.0 0.6 0.3 7.7 19.6 2.6 11.8 13.5 7.4 29.1 7.7 18.8 26.7 0.0 0.0 0.0 2.1 0.7 7.7 8.9 0.0 2.7 0.0 1.8 47.1 0.0 3.3 1.9 3.5 6.8 0.0 0.0 0.7 0.0 0.9 1.6 1.1 0.0 0.2 6.4 0.0 6.7 0.3 3.3 0.6 0.5 3.3 0.0 0.0 3.4 0.8 0.0 0.4 8.4 43.8 0.0 2.1 0.0 1.4 0.1 0.0 0.0 0.0 0.4 FAM124B FLJ22746 ENSG00000124019 "Family with sequence similarity 124 member B" Q9H5Z6 2 224378698-224402085 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 28.8;blood: 18.0" "Group enriched" "Detected in some" 4 "Endothelial cells: 4.4;granulocytes: 4.6;Ito cells: 1.3;Kupffer cells: 1.9" "Cancer enriched" "Detected in many" 10 "testis cancer: 7.3" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 18.0;eosinophil: 11.6" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "HUVEC TERT2: 49.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA070240 Approved Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA070240: AB_2686238" "unprognostic (2.01e-1)" "unprognostic (1.83e-1)" "unprognostic (6.87e-3)" "unprognostic (2.49e-1)" "unprognostic (7.10e-2)" "unprognostic (1.72e-2)" "unprognostic (1.28e-2)" "unprognostic (5.78e-2)" "unprognostic (3.19e-1)" "unprognostic (1.85e-1)" "unprognostic (1.57e-1)" "unprognostic (3.36e-1)" "unprognostic (7.61e-3)" "unprognostic (1.36e-2)" "unprognostic (4.30e-1)" "unprognostic (2.25e-1)" "unprognostic (5.80e-3)" 28.8 0.6 1.6 1.4 1.9 5.9 16.0 0.6 1.8 4.2 2.1 1.6 0.7 1.3 2.4 2.5 2.6 1.8 1.7 2.4 2.2 2.2 1.4 2.6 5.8 0.8 2.0 0.6 2.5 0.5 9.4 0.8 12.5 1.8 3.9 1.5 4.0 1.7 0.6 4.3 2.6 1.5 3.5 2.1 0.8 1.2 2.3 0.2 1.0 2.9 0.8 1.0 3.4 2.6 0.0 5.6 18.0 2.1 3.8 1.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 49.2 0.0 2.2 0.1 0.0 0.0 0.0 0.0 2.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 3.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 2.1 11.6 0.1 1.6 0.0 0.0 0.5 0.0 5.6 0.0 0.0 0.0 0.1 3.8 0.5 0.0 1.7 0.7 1.6 1.9 0.6 1.8 2.2 2.2 2.0 0.6 1.8 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 4.4 0.0 0.0 0.0 0.1 0.2 0.0 4.6 0.2 0.4 0.0 0.0 1.3 1.9 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 FAM126B "HYCC2, MGC39518" ENSG00000155744 "Family with sequence similarity 126 member B" Q8IXS8 2 200973718-201071671 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Cone photoreceptor cells: 155.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 20.3" "Lineage enriched" "Detected in all" 6 "granulocytes: 20.3" "Cell line enhanced" "Detected in all" "U-266/84: 35.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036166, HPA036167, HPA067307" Uncertain Supported "Nucleoplasm,Cell Junctions" NA NA "Cell Junctions" Nucleoplasm "HPA036166: AB_10696651, HPA036167: AB_2674982, HPA067307: AB_2685821" "unprognostic (7.47e-3)" "unprognostic (5.54e-2)" "unprognostic (2.52e-1)" "unprognostic (9.08e-2)" "unprognostic (8.96e-2)" "unprognostic (3.01e-3)" "unprognostic (1.11e-2)" "unprognostic (2.61e-3)" "unprognostic (1.34e-1)" "unprognostic (1.48e-2)" "unprognostic (1.79e-2)" "unprognostic (1.90e-2)" "unprognostic (1.06e-1)" "unprognostic (1.19e-1)" "unprognostic (2.44e-1)" "unprognostic (1.34e-1)" "unprognostic (1.10e-2)" 10.5 6.9 9.8 8.7 17.2 22.1 7.3 28.7 21.1 5.9 10.3 6.5 5.9 9.8 6.8 6.3 12.1 5.8 6.4 6.5 9.3 9.2 12.0 10.9 9.4 7.9 7.3 11.6 7.8 7.1 9.8 16.6 7.2 15.1 5.8 9.6 8.8 7.0 4.9 5.6 10.2 9.3 5.8 8.1 10.6 11.0 6.3 6.4 8.3 10.3 2.9 8.7 5.5 8.1 2.1 1.2 20.3 1.9 2.3 3.4 1.5 3.3 1.8 2.5 2.7 2.7 3.6 5.5 3.2 1.9 2.5 2.5 4.5 4.0 3.1 3.1 3.2 2.4 4.1 5.1 2.0 4.0 4.4 3.2 8.9 4.7 4.1 2.2 10.7 7.8 1.5 2.5 3.5 2.1 2.0 2.5 3.3 8.2 11.4 2.6 2.0 6.4 7.1 1.7 2.2 3.0 3.8 3.8 2.7 2.4 3.7 5.0 2.5 3.4 3.9 2.8 3.4 2.7 4.7 4.9 4.8 3.5 2.4 2.9 8.5 35.4 6.6 2.8 4.2 3.3 1.7 1.4 5.1 3.1 1.8 3.4 2.1 2.6 2.4 1.2 2.0 2.6 3.1 20.3 2.3 1.9 0.9 1.7 1.5 9.8 17.2 28.7 21.1 9.3 9.2 7.3 11.6 15.1 6.4 26.8 19.2 18.5 8.9 46.8 48.4 13.4 20.4 14.7 14.8 19.2 155.1 13.2 14.9 8.8 4.8 18.0 46.6 23.3 9.3 7.9 12.8 13.1 24.3 17.7 10.4 25.4 35.6 34.4 29.2 2.5 29.4 26.5 28.7 13.6 19.0 21.4 15.0 26.6 24.1 13.5 38.9 19.4 17.6 30.8 20.3 64.7 14.5 30.5 16.5 16.1 FAM129B "bA356B19.6, C9orf88, DKFZP434H0820, FLJ13518, FLJ22151, FLJ22298, MINERVA" ENSG00000136830 "Family with sequence similarity 129 member B" Q96TA1 9 127505339-127578989 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 95.6;placenta: 103.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 3.7;intermediate monocyte: 1.3;myeloid DC: 2.4" "Group enriched" "Detected in many" 6 "dendritic cells: 2.4;monocytes: 3.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021284, HPA021417, HPA023261, HPA024312" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA 1200000 "Plasma membrane, Cytosol" Nucleoplasm "HPA021284: AB_1848373, HPA021417: AB_1848374, HPA023261: AB_1848375, HPA024312: AB_1848376" "unprognostic (3.05e-3)" "unprognostic (9.47e-2)" "unprognostic (1.14e-3)" "unprognostic (4.07e-2)" "unprognostic (3.80e-3)" "unprognostic (1.09e-1)" "unprognostic (3.14e-2)" "unprognostic (2.57e-3)" "unprognostic (1.40e-1)" "unprognostic (1.68e-2)" "unprognostic (1.17e-3)" "unprognostic (6.45e-2)" "unprognostic (3.75e-2)" "unprognostic (1.24e-2)" "unprognostic (1.31e-1)" "unprognostic (8.40e-2)" "unprognostic (8.20e-3)" 7.8 17.9 4.5 8.4 5.6 5.1 6.7 6.5 4.2 19.1 13.9 4.2 12.3 11.9 9.6 7.3 95.6 8.9 22.9 8.2 4.8 4.1 9.9 5.5 24.0 5.1 6.9 3.1 9.3 24.8 6.8 5.7 103.7 9.1 12.8 7.2 9.4 23.6 11.7 4.1 17.3 17.1 10.5 7.0 6.8 13.8 5.4 4.2 1.3 39.8 44.6 48.8 11.8 28.3 0.0 2.4 0.5 3.7 0.0 0.5 1.7 22.1 25.3 5.1 6.7 15.6 30.4 24.0 44.1 41.0 24.4 15.1 8.0 24.5 0.0 17.5 49.8 30.1 37.0 4.4 32.6 8.1 4.2 4.7 3.8 37.5 8.3 30.8 0.1 10.8 33.2 20.5 40.1 14.1 44.9 36.6 1.4 7.1 0.2 46.1 26.1 0.2 6.2 5.3 38.1 33.3 2.6 17.3 11.6 20.9 17.8 8.2 3.8 36.0 25.7 15.6 7.6 16.9 1.2 47.3 25.1 10.9 31.5 36.4 0.4 0.8 0.0 70.6 3.6 46.3 0.5 3.7 0.0 0.2 1.3 0.0 0.0 0.5 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 1.7 4.5 5.6 6.5 4.2 4.8 4.1 6.9 3.1 9.1 4.2 65.5 43.5 0.0 30.8 28.7 0.4 4.2 38.2 10.7 36.4 36.6 0.0 59.0 3.3 72.5 1.0 28.6 94.2 0.0 92.9 33.5 19.8 56.7 28.9 1.0 21.5 0.0 21.4 28.8 11.8 1.8 29.7 23.3 21.9 2.8 41.6 12.6 107.3 42.4 47.4 1.5 1.5 12.9 32.0 0.3 1.1 32.6 101.1 2.2 37.3 104.7 FAM129C "BCNP1, FLJ39802" ENSG00000167483 "Family with sequence similarity 129 member C" Q86XR2 19 17523301-17553839 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 37.2;bone marrow: 12.1;intestine: 12.3;lymphoid tissue: 37.9;salivary gland: 9.9" "Cell type enriched" "Detected in some" 37 "B-cells: 63.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 226 "memory B-cell: 10.9;naive B-cell: 19.5;plasmacytoid DC: 37.2" "Group enriched" "Detected in many" 284 "B-cells: 19.5;dendritic cells: 37.2" "Group enriched" "Detected in some" 22 "Daudi: 29.8;REH: 15.0;U-698: 18.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA043277 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043277: AB_10794391" "unprognostic (6.55e-5)" "unprognostic (3.03e-7)" "unprognostic (3.40e-1)" "unprognostic (1.62e-1)" "unprognostic (1.34e-1)" "unprognostic (1.69e-4)" "unprognostic (3.79e-3)" "unprognostic (1.69e-3)" "unprognostic (1.90e-1)" "unprognostic (2.20e-1)" "unprognostic (9.47e-4)" "unprognostic (8.42e-2)" "unprognostic (5.51e-5)" "unprognostic (3.39e-1)" "unprognostic (9.03e-3)" "unprognostic (6.08e-2)" "unprognostic (7.56e-3)" 0.5 0.2 0.2 37.9 0.2 12.1 0.2 0.3 0.2 0.2 0.6 0.0 0.0 0.0 0.2 0.0 2.2 0.2 0.5 0.6 0.2 0.2 0.5 0.3 0.9 17.4 0.2 0.0 0.3 0.2 0.0 0.2 0.3 0.0 0.5 0.0 0.4 9.9 0.2 0.1 0.2 12.3 0.0 0.3 28.5 0.4 0.5 0.0 2.5 0.5 0.4 35.4 3.0 0.4 19.5 37.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 37.2 0.0 0.7 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 1.1 63.2 0.7 0.1 0.1 1.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.4 1.1 0.0 0.1 0.0 0.0 1.3 0.3 0.4 0.0 0.4 1.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.9 0.3 0.1 0.0 0.0 0.3 FAM131B KIAA0773 ENSG00000159784 "Family with sequence similarity 131 member B" Q86XD5 7 143353400-143362770 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 47.1" "Cell type enhanced" "Detected in some" 13 "Distal tubular cells: 1.7;Intestinal endocrine cells: 2.4;Late spermatids: 2.9" "Cancer enriched" "Detected in many" 11 "glioma: 14.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 10.3;hTERT-RPE1: 6.5;NTERA-2: 16.8;PC-3: 16.1;SCLC-21H: 16.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021371, HPA029992" Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA021371: AB_1852341, HPA029992: " "unprognostic (1.70e-1)" "unprognostic (7.26e-2)" "unprognostic (1.29e-1)" "unprognostic (5.61e-2)" "unprognostic (5.97e-2)" "unprognostic (2.54e-2)" "unprognostic (9.99e-2)" "unprognostic (1.04e-3)" "unprognostic (2.19e-1)" "unprognostic (1.10e-1)" "unprognostic (1.17e-1)" "unprognostic (1.00e-1)" "unprognostic (7.99e-5)" "unprognostic (1.31e-2)" "unprognostic (1.66e-1)" "unprognostic (1.02e-2)" "unprognostic (3.53e-2)" 1.5 2.1 10.0 2.0 12.4 0.9 1.2 37.2 47.1 2.7 2.0 15.1 0.0 1.7 4.4 1.0 1.7 1.6 1.4 1.1 9.1 6.8 1.1 0.9 1.5 1.3 14.6 12.3 1.0 0.9 6.4 0.4 0.9 13.8 1.0 2.2 0.0 0.9 1.0 7.7 0.8 2.1 5.6 18.6 1.1 1.4 1.2 11.3 0.0 0.9 0.0 1.1 1.2 0.5 0.0 0.2 0.0 0.5 0.1 2.1 0.2 0.0 0.1 5.0 0.0 4.1 5.2 0.0 0.2 1.2 0.8 0.2 10.3 0.0 0.0 0.0 0.3 0.0 0.2 2.0 0.4 0.7 2.5 0.0 0.3 0.0 0.0 0.1 0.0 0.0 5.7 0.0 0.0 0.0 6.5 0.9 0.1 0.0 0.0 0.7 0.0 0.0 0.3 16.8 0.0 16.1 0.0 0.0 0.0 0.0 0.0 16.4 0.5 0.2 1.2 0.0 1.1 0.0 0.0 0.7 0.3 1.6 0.1 0.0 0.0 0.0 0.0 0.1 3.3 0.1 0.0 0.3 0.0 2.1 0.5 0.8 0.0 0.1 0.0 0.2 0.0 0.0 0.8 0.0 0.1 0.2 0.0 0.0 0.2 10.0 12.4 37.2 25.0 9.1 6.8 14.6 12.3 13.8 11.3 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 2.4 0.6 0.3 2.9 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 FAM133A "CT115, FLJ37659, RP1-32F7.2" ENSG00000179083 "Family with sequence similarity 133 member A" Q8N9E0 X 93674013-93712274 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 14.8;pituitary gland: 8.2;testis: 16.1" "Group enriched" "Detected in some" 9 "Bipolar cells: 12.3;Early spermatids: 14.0;Horizontal cells: 19.1;Late spermatids: 18.2;Spermatocytes: 21.3;Spermatogonia: 34.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 7.1;Karpas-707: 22.2;U-2197: 11.6;U-266/70: 17.4;U-266/84: 37.7" "Low region specificity" "Detected in all" "HPA066175, HPA069513" Uncertain Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA066175: AB_2685629, HPA069513: AB_2686143" "unprognostic (1.75e-1)" "unprognostic (1.21e-1)" "unprognostic (1.67e-3)" "unprognostic (4.45e-1)" "unprognostic (4.05e-2)" "unprognostic (3.86e-3)" "unprognostic (4.22e-2)" "unprognostic (8.76e-2)" "unprognostic (1.09e-2)" "unprognostic (7.42e-2)" "unprognostic (1.39e-2)" "unprognostic (7.12e-4)" "unprognostic (1.67e-3)" "unprognostic (2.13e-1)" "unprognostic (1.47e-2)" "unprognostic (2.99e-3)" 0.5 3.0 4.7 0.4 14.8 0.3 0.8 2.3 7.7 1.7 0.5 0.5 0.0 0.4 1.0 0.8 0.4 1.1 0.7 2.2 2.5 4.5 0.4 0.4 0.5 0.4 2.3 4.4 1.4 0.4 0.4 8.2 0.4 3.7 0.4 0.5 0.2 0.4 0.5 0.3 0.6 0.5 0.8 4.5 0.5 0.4 16.1 2.6 0.0 0.9 0.0 0.3 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 22.2 0.0 0.0 0.0 0.0 0.5 0.0 5.5 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.1 0.0 0.0 0.0 0.4 0.5 11.6 0.5 17.4 37.7 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 14.8 2.3 7.3 2.5 4.5 2.3 4.4 3.7 2.6 0.0 0.0 0.0 0.0 0.6 12.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 19.1 0.0 1.3 0.0 18.2 1.1 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.7 0.0 1.1 0.0 0.2 21.3 34.9 0.1 0.0 0.0 0.0 0.0 FAM133B MGC40405 ENSG00000234545 "Family with sequence similarity 133 member B" Q5BKY9 7 92560793-92590394 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066175, HPA069513" Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA066175: AB_2685629, HPA069513: AB_2686143" "unprognostic (5.54e-2)" "unprognostic (4.42e-1)" "unprognostic (1.07e-1)" "unprognostic (1.26e-1)" "unprognostic (1.61e-1)" "unprognostic (6.70e-2)" "unprognostic (2.42e-2)" "unprognostic (1.54e-2)" "unprognostic (2.87e-3)" "unprognostic (8.56e-3)" "unprognostic (1.11e-1)" "unprognostic (8.85e-2)" "unprognostic (2.73e-3)" "unprognostic (9.01e-3)" "unprognostic (3.16e-1)" "unprognostic (1.87e-1)" "unprognostic (2.38e-2)" 10.5 11.7 18.5 11.1 23.6 32.1 15.1 25.7 23.3 13.6 10.4 8.2 12.0 11.9 13.0 22.5 11.4 10.4 9.2 9.2 13.8 9.1 11.2 14.3 11.2 14.1 15.3 13.2 15.1 13.6 13.4 21.3 12.9 18.0 12.0 11.7 7.5 11.4 10.5 17.1 12.8 10.8 15.7 18.5 12.1 10.6 7.3 17.3 15.9 12.5 7.5 12.8 10.6 12.0 22.5 23.2 9.8 11.7 10.7 17.0 5.9 13.1 6.8 19.2 29.4 11.3 12.0 11.5 14.9 16.1 14.6 17.8 10.9 14.6 21.5 14.5 10.1 12.7 10.6 15.1 9.4 22.4 12.1 19.7 17.4 10.0 21.8 11.8 19.1 15.1 8.0 9.9 11.2 14.0 11.5 8.6 16.8 22.9 27.3 15.6 16.0 30.0 29.9 26.2 12.0 8.8 21.8 19.3 17.8 14.5 14.1 18.6 18.0 12.8 16.3 17.3 18.8 15.1 14.1 9.9 16.8 26.7 19.5 16.7 7.1 7.5 38.5 10.1 25.2 21.6 9.5 11.7 9.8 10.7 10.5 13.9 22.5 13.6 13.2 9.6 18.8 17.0 14.4 4.9 10.7 7.8 23.2 14.3 5.9 18.5 23.6 25.7 23.3 13.8 9.1 15.3 13.2 18.0 17.3 53.6 65.5 102.1 185.5 101.5 81.2 25.7 180.9 38.8 62.6 83.7 70.7 55.8 84.6 78.1 31.4 87.5 92.6 163.5 75.9 52.0 92.4 103.6 86.4 97.3 62.9 52.4 131.6 108.1 107.2 13.2 95.0 114.5 72.6 69.5 83.4 83.5 72.6 112.3 83.4 48.4 75.1 51.8 103.0 97.0 117.4 91.7 59.0 97.2 97.8 127.1 FAM135A "FLJ20176, KIAA1411" ENSG00000082269 "Family with sequence similarity 135 member A" Q9P2D6 6 70412941-70561174 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "Horizontal cells: 225.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031743, HPA031744" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA031743: AB_10600767, HPA031744: AB_10601101" "unprognostic (5.79e-2)" "unprognostic (1.64e-1)" "prognostic favorable (8.00e-4)" "unprognostic (1.59e-1)" "unprognostic (1.66e-2)" "unprognostic (1.08e-1)" "unprognostic (6.69e-4)" "unprognostic (4.08e-2)" "unprognostic (3.87e-2)" "unprognostic (1.58e-1)" "unprognostic (1.02e-1)" "unprognostic (1.41e-1)" "prognostic favorable (3.46e-4)" "unprognostic (3.99e-1)" "unprognostic (2.75e-1)" "unprognostic (6.26e-2)" "unprognostic (2.65e-2)" 5.8 4.3 6.4 9.2 6.8 1.7 5.3 14.0 10.7 9.6 13.3 4.0 5.3 14.9 7.7 4.9 33.8 5.4 8.8 5.2 5.4 5.2 9.6 5.5 5.5 4.1 6.1 7.1 8.0 6.9 16.4 13.8 22.7 8.5 18.9 13.0 4.2 10.4 6.7 5.7 14.2 27.9 4.8 8.9 4.5 12.3 11.0 6.0 4.1 4.8 13.1 10.6 7.6 14.4 3.9 6.3 3.3 5.3 5.4 2.2 1.5 5.9 3.4 7.7 4.8 3.6 2.6 6.9 1.9 3.8 2.1 3.5 6.7 4.8 10.6 13.9 1.4 10.1 5.8 7.6 4.8 3.6 5.1 6.3 4.8 3.7 5.9 4.4 8.9 5.0 2.3 11.1 4.0 11.1 2.6 5.5 3.4 7.6 5.5 2.4 0.7 1.6 4.2 5.0 7.1 2.8 5.2 24.2 5.0 7.9 3.2 8.1 2.4 2.3 2.1 2.3 5.1 1.4 4.0 2.7 1.8 4.6 1.7 4.4 6.6 7.5 4.3 1.3 8.1 3.2 3.3 4.3 0.2 1.5 3.5 1.9 3.0 1.4 0.6 6.3 3.9 2.2 1.3 1.2 5.4 5.3 1.0 1.7 1.5 6.4 6.8 14.0 10.7 5.4 5.2 6.1 7.1 8.5 6.0 26.8 12.2 1.4 9.5 14.2 18.2 9.4 15.3 8.1 5.7 19.2 27.5 2.2 5.0 5.8 24.9 10.0 28.4 0.0 10.7 1.2 5.9 32.9 8.1 5.7 5.1 225.6 22.4 9.2 14.2 17.3 14.4 13.1 5.0 9.0 26.1 12.8 13.3 30.0 12.4 6.8 27.5 6.5 6.6 25.1 8.2 29.4 6.9 3.9 19.4 11.2 FAM135B C8ORFK32 ENSG00000147724 "Family with sequence similarity 135 member B" Q49AJ0 8 138130023-138496822 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 8.1;brain: 14.3;testis: 10.3" "Cell type enhanced" "Detected in some" 27 "Bipolar cells: 27.7;Cone photoreceptor cells: 27.5;Early spermatids: 96.5;Late spermatids: 22.0" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "RH-30: 14.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023911, HPA023950, HPA024815" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "HPA023911: AB_1845791, HPA023950: AB_1845792, HPA024815: AB_10601376" "unprognostic (3.78e-1)" "unprognostic (4.80e-1)" "unprognostic (1.71e-2)" "unprognostic (6.64e-2)" "unprognostic (1.03e-1)" "unprognostic (2.32e-1)" "unprognostic (1.42e-1)" "unprognostic (8.26e-2)" "unprognostic (8.36e-3)" "unprognostic (4.54e-2)" "unprognostic (6.85e-4)" "unprognostic (9.92e-3)" "unprognostic (9.82e-3)" "unprognostic (4.47e-1)" "unprognostic (2.70e-2)" "unprognostic (3.51e-2)" "unprognostic (1.30e-1)" 0.6 8.1 12.1 0.9 6.8 0.6 0.7 13.9 14.3 0.7 2.7 1.3 0.0 1.4 0.6 0.9 0.7 0.7 0.7 0.8 9.3 4.5 1.4 0.8 0.7 0.6 4.6 5.6 0.6 1.9 0.6 3.6 0.6 5.2 1.3 2.3 0.7 0.7 1.4 0.6 0.6 1.4 0.8 2.5 0.6 2.5 10.3 3.5 0.0 0.6 0.0 0.6 1.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 14.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 6.8 13.9 12.3 9.3 4.5 4.6 5.6 5.2 3.5 0.0 0.0 0.0 0.0 0.0 27.7 1.1 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.0 96.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.0 22.0 1.4 0.0 0.0 0.0 0.0 3.4 0.0 0.0 1.1 0.0 1.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 FAM13B "ARHGAP49, C5orf5, FAM13B1, KHCHP, N61" ENSG00000031003 "Family with sequence similarity 13 member B" Q9NYF5 5 137937960-138051961 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036525, HPA041819, HPA071936" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA036525: AB_10696655, HPA041819: AB_2677690, HPA071936: AB_2686474" "unprognostic (8.09e-2)" "unprognostic (1.27e-1)" "unprognostic (2.34e-3)" "unprognostic (9.61e-2)" "unprognostic (1.44e-1)" "unprognostic (3.95e-2)" "unprognostic (1.44e-2)" "unprognostic (2.02e-3)" "unprognostic (6.51e-2)" "unprognostic (6.31e-2)" "unprognostic (1.69e-2)" "unprognostic (3.60e-1)" "prognostic favorable (3.55e-5)" "unprognostic (9.56e-2)" "unprognostic (4.46e-1)" "unprognostic (1.98e-1)" "unprognostic (3.06e-2)" 12.8 27.1 19.7 18.3 22.0 19.1 14.6 29.4 22.6 15.2 16.4 15.8 18.4 8.9 21.1 13.7 13.3 14.6 13.8 18.3 17.0 21.9 13.1 7.9 13.5 17.8 18.5 15.5 23.7 9.3 14.9 17.7 14.6 26.3 23.4 11.6 14.2 12.3 34.4 5.8 10.1 13.5 29.6 13.4 15.3 12.4 29.4 21.5 13.5 14.1 5.7 20.5 21.2 15.2 7.9 3.7 11.9 6.6 7.6 6.2 1.8 9.3 4.7 14.2 11.6 19.0 6.0 11.1 20.8 17.0 15.9 18.6 12.6 8.5 21.2 7.0 18.1 20.4 7.3 8.7 6.5 20.9 16.0 9.4 9.5 11.5 3.9 6.4 15.5 13.2 7.6 3.9 12.1 7.1 8.4 5.4 7.8 5.4 10.9 14.6 6.9 15.5 8.6 5.6 7.3 5.7 11.2 14.1 4.2 9.6 16.8 16.1 14.2 16.2 5.0 20.4 21.4 13.6 15.8 7.1 17.1 7.5 12.6 15.6 8.9 21.0 20.3 9.7 12.7 14.6 11.9 2.9 10.5 6.2 3.9 5.2 6.5 4.4 5.4 2.1 7.9 4.6 5.9 9.1 7.6 6.6 3.7 4.1 1.8 19.7 22.0 29.4 22.6 17.0 21.9 18.5 15.5 26.3 21.5 20.8 13.7 26.1 14.6 13.7 20.6 41.1 12.7 12.0 19.4 5.2 19.6 10.0 3.3 5.4 31.0 13.8 6.7 0.0 2.9 3.6 16.9 10.5 29.0 5.0 12.1 11.1 9.9 18.4 22.1 22.6 15.0 22.6 11.8 3.6 9.8 7.8 5.3 5.5 24.1 3.3 16.2 25.8 24.0 31.0 22.2 12.0 4.3 30.0 7.9 10.7 FAM13C FAM13C1 ENSG00000148541 "Family with sequence similarity 13 member C" Q8NE31 10 59246129-59363181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 36.1;Early spermatids: 31.6;Sertoli cells: 38.8" "Cancer enhanced" "Detected in some" "prostate cancer: 3.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 5.3;HSkMC: 6.9;hTERT-RPE1: 4.6;NTERA-2: 5.7;SCLC-21H: 11.4;SH-SY5Y: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037888 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA037888: AB_10962981" "unprognostic (3.68e-1)" "unprognostic (6.10e-2)" "unprognostic (2.46e-1)" "unprognostic (6.69e-5)" "unprognostic (8.54e-2)" "unprognostic (4.56e-2)" "unprognostic (3.30e-2)" "unprognostic (1.06e-2)" "unprognostic (6.77e-2)" "unprognostic (1.32e-1)" "unprognostic (1.00e-3)" "unprognostic (3.27e-1)" "unprognostic (4.51e-6)" "unprognostic (1.02e-2)" "unprognostic (1.42e-1)" "unprognostic (1.94e-3)" "unprognostic (4.66e-3)" 11.8 17.0 16.1 3.8 22.3 0.3 7.7 12.4 24.9 9.4 6.4 36.6 3.2 4.5 9.0 8.7 14.4 15.3 11.6 7.8 18.9 15.9 3.8 2.3 10.0 4.5 23.8 18.8 22.2 2.5 4.0 8.3 2.9 21.2 17.9 6.7 16.5 4.9 8.7 15.3 7.3 5.0 12.5 33.2 5.0 3.9 5.2 28.9 0.0 6.0 7.6 2.5 7.4 7.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 1.7 0.3 0.1 0.0 1.6 0.0 5.3 2.4 0.2 0.0 0.0 6.9 0.8 0.3 0.0 4.6 0.0 0.0 0.0 0.3 2.8 0.0 0.0 0.0 5.7 0.0 0.5 0.0 1.1 0.0 0.0 1.7 11.4 6.7 0.0 0.3 0.0 0.5 1.0 0.0 0.0 3.3 3.1 0.1 2.6 0.0 0.0 0.1 4.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 22.3 12.4 23.4 18.9 15.9 23.8 18.8 21.2 28.9 0.0 0.0 0.0 9.5 4.2 10.0 2.8 0.0 36.1 1.2 0.0 5.9 0.0 6.6 0.0 31.6 12.6 0.0 0.0 0.0 0.0 3.0 4.5 0.0 0.6 0.0 3.2 0.0 2.5 0.0 17.2 21.3 0.5 3.3 0.0 0.0 8.8 0.0 0.0 19.8 0.4 13.1 38.8 18.6 0.9 0.7 5.5 0.0 0.0 0.0 0.5 FAM149B1 KIAA0974 ENSG00000138286 "Family with sequence similarity 149 member B1" Q96BN6 10 73168166-73244504 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039189, HPA039859" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA039189: AB_10805355, HPA039859: AB_2676712" "unprognostic (2.23e-1)" "unprognostic (7.04e-2)" "unprognostic (1.52e-1)" "unprognostic (4.88e-2)" "unprognostic (6.21e-2)" "unprognostic (1.45e-1)" "unprognostic (2.34e-1)" "unprognostic (4.66e-2)" "unprognostic (3.01e-1)" "unprognostic (5.25e-2)" "prognostic unfavorable (7.81e-4)" "unprognostic (5.13e-2)" "unprognostic (1.96e-3)" "unprognostic (1.22e-1)" "unprognostic (9.21e-3)" "unprognostic (2.68e-1)" "unprognostic (5.24e-2)" 9.3 8.9 21.3 7.3 17.0 5.4 10.1 7.7 15.1 12.2 13.4 14.9 10.3 5.4 9.1 10.6 10.5 11.4 12.8 15.7 19.2 14.2 17.5 15.2 7.9 6.3 20.8 9.8 12.6 9.3 12.9 10.8 10.3 13.6 10.5 8.0 8.1 9.0 9.1 9.4 5.8 9.5 9.3 22.8 5.9 7.2 16.6 13.2 6.2 9.8 13.4 7.3 8.3 7.3 2.7 2.7 5.0 1.8 4.6 3.4 1.3 6.9 5.3 11.9 10.9 26.1 16.3 7.7 8.0 15.7 5.4 9.6 3.3 12.2 5.2 3.1 13.9 6.2 6.7 6.9 10.0 6.5 6.3 3.5 6.6 4.1 5.6 13.6 9.1 4.4 13.9 7.4 7.0 27.3 24.0 13.6 8.3 5.9 9.7 9.8 6.3 6.0 8.6 5.1 15.0 13.9 4.0 7.5 5.3 14.6 7.0 2.6 11.3 6.2 16.7 9.6 11.1 9.6 5.8 7.2 5.3 5.4 5.3 10.0 10.7 4.8 4.6 9.1 9.1 4.2 5.0 0.7 2.5 2.2 1.8 2.8 2.7 2.2 2.1 1.5 2.2 3.4 3.1 1.5 4.6 1.0 2.7 2.5 1.3 21.3 17.0 7.7 15.1 19.2 14.2 20.8 9.8 13.6 13.2 3.0 1.9 3.7 3.0 1.8 6.6 10.2 5.1 10.7 5.7 1.8 5.9 5.8 1.7 3.8 17.7 5.8 4.7 0.0 3.1 4.8 4.3 4.0 2.3 3.4 4.8 3.2 7.5 5.5 4.5 19.6 7.8 2.5 1.7 1.8 5.8 4.2 4.0 0.0 4.2 6.8 12.1 12.9 5.2 10.9 3.8 3.1 6.9 2.1 5.2 3.7 FAM155A ENSG00000204442 "Family with sequence similarity 155 member A" B1AL88 13 107163510-107866735 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.0;pituitary gland: 10.3" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 2: 18.2;Bipolar cells: 15.9;Early spermatids: 42.2;Horizontal cells: 35.0;Late spermatids: 14.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 5.4;RPTEC TERT1: 11.7;SCLC-21H: 7.2;SH-SY5Y: 16.3;U-87 MG: 10.4" "Low region specificity" "Detected in all" "HPA039453, HPA058768" Enhanced Approved Nucleoplasm,Vesicles,Centrosome NA NA "Nucleoplasm, Vesicles" Centrosome "HPA039453: AB_10795290, HPA058768: AB_2683813" "unprognostic (8.40e-2)" "unprognostic (9.98e-3)" "unprognostic (1.48e-1)" "unprognostic (3.38e-3)" "unprognostic (2.69e-1)" "unprognostic (5.88e-2)" "unprognostic (1.40e-1)" "unprognostic (5.74e-2)" "unprognostic (2.62e-1)" "unprognostic (2.08e-1)" "unprognostic (4.26e-1)" "unprognostic (9.06e-2)" "unprognostic (1.02e-5)" "unprognostic (5.56e-2)" "unprognostic (2.34e-1)" "unprognostic (3.45e-2)" "unprognostic (3.69e-3)" 0.9 2.7 10.7 0.6 4.3 0.4 0.6 6.9 19.0 1.5 0.7 0.6 0.0 0.5 1.7 4.0 0.7 0.7 1.3 0.7 8.8 10.8 0.7 0.4 1.2 0.5 6.4 4.9 0.7 0.5 0.4 10.3 1.2 2.0 2.7 0.7 0.7 0.3 3.8 0.4 0.5 0.7 1.2 2.7 0.6 0.7 2.3 0.5 0.0 1.3 0.0 0.9 1.4 0.2 0.2 0.0 0.4 0.1 0.8 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.7 0.0 2.5 0.1 5.4 2.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.8 4.4 0.0 0.0 0.2 0.0 11.7 1.9 7.2 16.3 0.0 0.0 0.0 0.2 4.1 0.0 0.2 5.0 2.0 1.7 0.2 0.0 0.0 0.0 10.4 0.0 3.5 0.4 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.4 0.8 0.0 0.0 0.0 0.0 10.7 4.3 6.9 12.3 8.8 10.8 6.4 4.9 2.0 0.5 3.0 18.2 0.0 0.4 0.1 15.9 0.7 0.0 0.0 3.4 3.5 0.0 0.0 0.0 1.4 42.2 2.9 0.0 0.0 0.0 0.1 1.8 0.8 0.0 0.0 0.2 35.0 0.0 1.8 0.0 14.6 1.7 0.0 0.0 0.0 0.0 7.0 0.3 0.0 1.1 0.0 1.5 6.5 0.2 1.1 0.9 0.0 0.0 0.0 0.0 0.1 FAM160B2 "FLJ21801, RAI16" ENSG00000158863 "Family with sequence similarity 160 member B2" Q86V87 8 22089159-22104898 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025040 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA025040: AB_1856049" "unprognostic (3.45e-1)" "unprognostic (2.08e-3)" "unprognostic (1.60e-1)" "unprognostic (8.85e-3)" "unprognostic (2.28e-2)" "prognostic favorable (4.56e-4)" "unprognostic (2.35e-2)" "unprognostic (4.82e-2)" "unprognostic (1.01e-1)" "unprognostic (2.90e-2)" "unprognostic (8.38e-3)" "unprognostic (7.67e-3)" "unprognostic (3.38e-2)" "unprognostic (6.30e-2)" "unprognostic (1.08e-2)" "unprognostic (1.25e-1)" "unprognostic (2.75e-3)" 15.8 11.8 9.6 13.1 10.0 6.6 14.3 14.3 14.8 12.9 13.2 12.9 20.8 12.0 13.2 16.9 13.7 14.1 14.5 26.0 8.5 6.9 12.3 9.8 11.0 11.2 12.5 10.5 11.4 22.1 15.3 14.1 22.4 10.9 14.4 6.0 13.4 18.8 25.1 15.1 24.4 13.4 25.3 10.4 12.3 16.1 6.4 10.3 6.5 16.0 11.6 13.2 19.9 11.2 2.7 0.9 0.5 1.4 1.7 3.2 2.1 3.7 9.3 4.5 6.9 9.1 8.4 6.9 5.8 12.6 8.6 6.0 3.8 4.6 3.9 6.4 18.2 7.8 5.3 3.3 10.4 1.8 3.4 3.5 5.8 2.5 2.6 12.3 1.5 5.3 14.1 7.1 6.3 4.2 8.9 8.8 8.9 3.9 3.3 8.1 7.8 4.2 2.2 1.8 7.9 3.3 4.4 3.3 2.2 7.3 9.2 1.6 4.8 3.5 7.5 4.8 4.7 4.5 3.4 8.4 8.7 6.7 7.8 4.0 2.6 0.8 0.7 9.2 2.8 9.4 0.0 1.2 0.5 3.2 0.7 1.9 2.7 2.1 2.6 0.8 2.3 1.9 2.7 0.3 1.7 1.4 0.9 0.3 2.1 9.6 10.0 14.3 14.8 8.5 6.9 12.5 10.5 10.9 10.3 11.9 15.0 9.0 8.7 5.3 22.4 21.8 20.4 2.7 4.5 12.2 25.5 7.0 0.0 8.0 3.6 12.2 13.8 0.0 12.8 11.4 8.0 10.8 6.9 12.2 6.4 22.3 12.7 17.8 11.8 1.9 10.0 5.4 1.7 4.6 9.7 12.7 13.7 12.5 5.3 3.8 24.2 0.0 7.3 1.7 5.9 6.6 12.5 8.6 8.6 8.1 FAM168A "KIAA0280, TCRP1" ENSG00000054965 "Family with sequence similarity 168 member A" Q92567 11 73400487-73598189 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.7" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 43.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037580 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA037580: AB_10672906" "unprognostic (2.65e-1)" "unprognostic (2.10e-1)" "unprognostic (1.15e-2)" "prognostic unfavorable (5.51e-4)" "unprognostic (4.60e-2)" "unprognostic (3.24e-2)" "unprognostic (3.24e-2)" "unprognostic (1.29e-1)" "unprognostic (2.64e-1)" "unprognostic (2.18e-2)" "unprognostic (3.07e-1)" "unprognostic (1.58e-1)" "prognostic favorable (6.41e-5)" "unprognostic (2.10e-1)" "unprognostic (1.04e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (9.70e-4)" 12.4 10.3 32.0 9.7 28.5 9.9 12.3 29.1 54.7 15.3 10.1 28.2 7.9 7.9 14.6 16.3 9.3 14.0 13.6 11.8 30.3 22.5 11.8 7.9 9.9 7.8 30.1 29.2 16.9 10.3 34.0 9.2 9.5 34.3 12.7 9.4 9.6 11.3 16.2 16.1 8.0 9.8 17.4 35.3 8.5 8.2 6.4 22.4 5.5 14.5 4.3 7.6 9.9 8.5 1.1 2.6 7.5 4.1 0.9 1.5 0.6 8.3 9.3 20.1 11.5 14.3 16.5 3.2 12.0 14.0 14.1 13.3 9.9 10.4 8.9 11.0 22.1 12.6 7.2 12.5 12.5 16.6 7.0 8.4 10.3 9.6 4.9 5.6 5.7 19.4 16.0 7.9 14.7 7.5 17.2 8.5 14.3 2.7 7.0 13.1 11.7 13.4 4.8 7.1 14.9 12.0 18.4 33.5 4.7 7.3 7.2 13.9 20.7 14.2 10.2 21.3 7.4 17.3 6.3 10.9 15.8 13.5 19.7 9.6 15.6 11.0 16.0 7.8 6.6 14.1 7.5 2.7 1.5 1.5 4.1 0.8 1.0 0.8 1.3 2.1 1.1 1.1 1.3 6.3 0.9 2.9 2.6 1.2 0.6 32.0 28.5 29.1 42.4 30.3 22.5 30.1 29.2 34.3 22.4 3.0 10.9 4.5 1.7 3.4 21.0 18.2 20.4 5.3 11.4 7.0 43.2 1.8 0.0 3.1 18.3 6.3 4.9 0.0 2.3 3.2 6.1 2.6 23.0 15.5 8.6 3.2 12.2 9.8 15.1 18.1 6.9 6.9 5.0 2.8 7.8 24.9 3.6 3.5 12.0 3.1 22.1 6.5 13.3 3.7 4.1 3.3 2.3 2.5 6.6 1.4 FAM171A1 "C10orf38, FLJ12884" ENSG00000148468 "Family with sequence similarity 171 member A1" Q5VUB5 10 15211643-15371062 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.9" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 104.4;Ito cells: 41.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "gdT-cell: 2.6;MAIT T-cell: 6.8;memory CD4 T-cell: 3.8;memory CD8 T-cell: 3.3;naive CD4 T-cell: 7.4;naive CD8 T-cell: 3.7" "Lineage enriched" "Detected in single" 23 "T-cells: 7.4" "Cell line enhanced" "Detected in many" "TIME: 42.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051345 Approved Approved "Nucleoplasm,Plasma membrane" NA NA 96000 "Plasma membrane" Nucleoplasm "HPA051345: AB_2681449" "unprognostic (3.60e-2)" "unprognostic (7.15e-2)" "unprognostic (2.21e-1)" "unprognostic (5.28e-2)" "unprognostic (1.57e-1)" "unprognostic (4.11e-2)" "unprognostic (9.84e-2)" "unprognostic (9.19e-2)" "unprognostic (2.28e-1)" "unprognostic (3.97e-2)" "unprognostic (3.09e-2)" "unprognostic (1.87e-1)" "prognostic favorable (2.71e-5)" "unprognostic (3.08e-1)" "unprognostic (1.86e-1)" "prognostic unfavorable (4.90e-6)" "unprognostic (3.28e-2)" 6.9 3.7 22.1 5.5 37.9 0.2 4.6 11.1 31.8 8.8 16.1 25.3 6.5 13.7 9.7 4.8 4.7 11.8 9.3 7.0 24.1 17.5 17.8 6.2 5.3 3.7 25.1 14.3 10.9 13.8 8.9 1.9 2.9 21.5 8.4 12.9 2.5 10.0 9.4 5.1 2.4 8.9 9.0 43.9 8.5 10.3 2.4 21.9 0.6 4.3 1.1 4.6 6.0 6.2 0.0 0.0 0.0 0.0 0.3 7.4 1.3 0.0 6.3 13.0 5.0 5.3 10.1 0.1 7.9 1.5 4.0 3.5 1.1 7.4 0.0 9.6 20.5 9.1 0.6 9.3 0.1 4.5 2.6 14.6 18.4 2.0 18.2 5.8 0.0 14.9 7.9 1.9 10.9 1.6 14.6 20.0 2.7 7.2 0.0 12.7 0.5 3.1 0.0 12.5 3.5 3.5 12.4 6.9 1.9 5.0 0.0 9.0 11.5 4.4 0.1 0.0 14.5 0.0 0.2 42.6 5.5 23.2 19.9 8.3 2.7 0.7 0.0 12.2 0.0 4.2 0.0 0.0 0.0 2.6 0.0 6.8 0.0 3.8 3.3 0.0 0.0 7.4 3.7 0.0 0.3 0.0 0.0 0.7 1.3 22.1 37.9 11.1 23.1 24.1 17.5 25.1 14.3 21.5 21.9 0.0 0.0 0.0 3.3 1.1 3.8 5.1 104.4 2.7 2.3 14.0 0.0 0.1 3.3 17.1 0.6 18.9 12.0 0.0 10.5 0.1 8.9 13.8 1.1 18.3 0.3 6.4 20.2 41.1 4.4 1.0 4.9 0.0 1.7 1.0 25.9 1.5 15.9 8.6 5.3 4.1 1.1 0.0 6.2 2.3 3.5 1.6 0.1 1.3 31.1 2.1 FAM171B "FLJ34104, KIAA1946" ENSG00000144369 "Family with sequence similarity 171 member B" Q6P995 2 186693971-186765965 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 62.0" "Cell type enriched" "Detected in many" 6 "Bipolar cells: 137.0" "Cancer enriched" "Detected in many" 5 "glioma: 15.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 25.4;U-138 MG: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010639, HPA013434" Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA010639: AB_1852447, HPA013434: AB_2262499" "unprognostic (2.52e-1)" "unprognostic (7.75e-3)" "unprognostic (1.27e-1)" "unprognostic (1.04e-2)" "unprognostic (4.03e-2)" "unprognostic (9.43e-2)" "unprognostic (6.78e-3)" "unprognostic (2.68e-1)" "unprognostic (1.88e-2)" "unprognostic (1.52e-1)" "unprognostic (4.24e-3)" "unprognostic (1.47e-1)" "prognostic unfavorable (9.51e-7)" "unprognostic (4.63e-3)" "unprognostic (1.52e-1)" "unprognostic (2.24e-3)" "prognostic unfavorable (5.03e-4)" 3.1 13.1 32.0 2.0 32.6 1.1 3.7 12.7 62.0 6.7 2.1 5.8 0.1 1.6 7.1 2.6 2.4 3.2 4.9 1.9 25.5 13.1 1.8 1.1 2.0 1.6 9.1 23.0 9.7 1.6 11.4 13.4 3.5 9.7 3.2 2.5 1.4 17.8 2.8 1.3 3.8 1.9 4.5 8.4 2.0 2.4 1.6 10.4 0.0 2.7 0.0 1.7 2.9 1.8 0.3 1.3 1.1 1.7 2.4 1.1 0.5 2.3 2.8 4.2 13.1 12.5 9.5 0.1 2.6 4.6 3.2 4.6 7.7 12.6 0.0 0.9 7.3 5.5 0.3 5.7 2.5 4.6 0.0 3.3 2.8 1.3 0.0 1.0 0.8 1.0 12.1 1.0 2.5 2.0 4.2 7.0 2.2 0.0 25.4 6.1 1.6 1.6 0.0 5.6 0.0 2.8 0.0 8.1 0.6 5.0 9.0 13.2 7.2 1.3 0.8 3.5 2.6 1.0 0.6 4.1 17.6 2.3 0.3 1.6 6.8 6.5 0.0 5.4 0.0 2.4 1.1 0.7 0.3 0.8 1.7 0.7 0.3 1.0 0.9 0.6 0.2 0.6 1.1 0.4 2.4 1.6 1.3 0.1 0.5 32.0 32.6 12.7 30.4 25.5 13.1 9.1 23.0 9.7 10.4 0.0 0.0 0.0 2.1 7.9 137.0 0.8 10.2 0.0 2.3 0.0 13.7 7.9 0.0 0.7 1.4 10.5 0.0 0.0 0.3 0.8 6.6 1.2 0.0 0.0 1.7 22.3 4.6 8.0 0.3 2.5 7.2 1.1 3.3 1.0 0.0 16.5 0.5 0.0 13.1 0.1 15.5 0.0 4.1 0.1 1.4 4.5 6.9 0.0 0.0 0.5 FAM172A "C5orf21, DKFZP564D172" ENSG00000113391 "Family with sequence similarity 172 member A" Q8WUF8 5 93618069-94111699 "Predicted intracellular proteins, Predicted secreted proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012299, HPA045505" Approved Supported Nucleoplasm,Cytosol "Secreted - unknown location" NA NA Nucleoplasm Cytosol "HPA012299: AB_1845724, HPA045505: AB_2679354" "unprognostic (1.12e-2)" "unprognostic (2.17e-1)" "unprognostic (3.10e-2)" "unprognostic (7.78e-2)" "unprognostic (2.03e-2)" "unprognostic (1.23e-2)" "unprognostic (1.41e-1)" "unprognostic (1.98e-2)" "unprognostic (1.51e-1)" "unprognostic (1.57e-2)" "unprognostic (2.52e-3)" "unprognostic (1.91e-1)" "prognostic unfavorable (4.43e-4)" "unprognostic (1.38e-1)" "unprognostic (6.56e-2)" "unprognostic (1.72e-2)" "unprognostic (1.03e-2)" 18.4 15.4 24.2 17.8 21.8 9.8 19.3 28.8 20.8 19.9 14.4 15.5 13.9 11.2 19.1 16.1 17.7 18.8 14.3 14.0 21.0 19.9 18.5 8.0 14.9 22.4 18.9 13.0 23.0 18.2 20.7 28.4 15.1 15.6 19.4 12.3 12.6 14.3 22.6 6.2 11.8 12.9 26.2 20.8 13.6 13.7 8.3 16.6 16.1 22.8 9.5 16.1 19.0 15.7 9.8 7.1 13.1 7.3 12.3 11.9 6.4 4.6 5.4 13.3 14.9 16.0 19.4 6.9 9.9 7.7 4.3 4.3 3.7 6.5 6.7 7.5 11.6 7.7 4.1 4.0 14.0 10.1 4.5 4.8 8.9 11.3 2.5 6.8 6.8 10.3 16.9 8.0 3.9 7.6 15.6 9.8 6.3 1.8 2.0 17.7 5.1 5.7 5.2 2.0 8.6 4.4 6.4 14.0 6.3 6.8 9.0 11.9 21.2 8.0 3.4 7.3 8.7 8.2 8.3 9.7 10.3 9.3 6.7 11.7 8.6 12.5 7.6 16.2 7.6 18.8 13.1 5.4 7.0 11.9 7.3 11.9 9.4 8.9 8.7 7.1 9.8 10.1 10.2 13.0 12.3 5.1 6.8 9.2 6.4 24.2 21.8 28.8 20.8 21.0 19.9 18.9 13.0 15.6 16.6 50.6 23.7 24.4 21.0 10.9 48.1 20.2 28.1 62.9 25.0 10.4 29.5 11.1 51.4 16.4 38.4 23.3 15.8 0.0 18.6 10.7 16.0 19.5 24.3 12.4 10.1 39.7 16.3 17.8 18.0 23.9 35.6 17.5 20.3 22.6 11.5 34.6 17.2 13.9 34.3 27.9 51.6 12.9 17.9 19.0 23.5 8.8 9.2 23.5 16.4 20.4 FAM173B JS-2 ENSG00000150756 "Family with sequence similarity 173 member B" Q6P4H8 5 10226330-10249897 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SiHa: 40.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074513 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA074513: AB_2686698" "prognostic unfavorable (1.32e-6)" "unprognostic (8.87e-3)" "unprognostic (1.23e-3)" "unprognostic (1.20e-1)" "unprognostic (9.24e-2)" "unprognostic (1.41e-2)" "unprognostic (2.07e-2)" "unprognostic (1.53e-1)" "unprognostic (2.54e-2)" "unprognostic (6.90e-3)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (1.14e-2)" "unprognostic (1.79e-1)" "unprognostic (9.06e-2)" "unprognostic (5.61e-2)" "unprognostic (1.03e-1)" 10.1 14.6 17.7 10.4 16.2 3.3 9.0 20.1 18.6 7.9 9.7 12.2 8.8 7.7 9.3 12.6 7.9 9.2 9.9 8.8 14.9 18.1 12.1 13.1 7.5 8.9 18.8 9.9 8.6 6.8 19.2 22.8 5.3 18.6 12.2 12.4 10.3 8.8 12.3 7.3 7.4 7.1 10.1 13.2 5.6 7.8 6.5 18.9 8.4 12.7 6.2 8.7 11.6 13.9 5.7 8.9 11.6 9.7 5.1 8.6 4.5 7.3 8.1 8.0 7.6 8.8 6.7 2.8 11.4 5.7 6.1 4.8 8.5 12.2 9.5 20.5 8.1 15.4 5.5 12.2 10.4 9.9 15.8 7.5 7.9 27.6 6.3 5.9 12.2 9.5 6.1 11.6 10.1 3.4 6.9 11.8 9.4 11.0 9.7 17.2 6.9 6.0 10.8 4.9 17.1 9.8 8.3 5.5 8.4 15.6 9.7 6.4 6.4 40.2 14.2 6.4 6.3 14.5 12.7 6.5 13.0 7.7 7.9 8.3 6.6 7.2 10.6 8.2 14.0 5.3 5.0 9.3 11.6 7.0 9.7 8.4 5.7 6.7 8.5 8.9 4.2 6.8 8.6 3.4 5.1 7.7 3.1 7.8 4.5 17.7 16.2 20.1 18.6 14.9 18.1 18.8 9.9 18.6 18.9 3.0 1.4 3.0 5.1 1.3 8.4 5.9 5.1 14.7 3.4 10.4 2.0 5.0 5.0 6.0 4.1 4.9 3.6 0.0 3.7 3.9 6.3 5.8 9.2 7.4 6.9 9.5 2.4 1.8 4.5 2.5 3.4 2.3 3.3 5.4 3.9 7.8 3.4 6.0 6.3 6.3 12.2 6.5 2.5 10.0 15.8 1.6 2.2 5.0 5.3 3.4 FAM177A1 C14orf24 ENSG00000151327 "Family with sequence similarity 177 member A1" Q8N128 14 35044907-35113130 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053222, HPA055440" Uncertain Approved Nucleoplasm,Vesicles "Secreted to blood" NA NA 180000 Vesicles Nucleoplasm "HPA053222: AB_2682083, HPA055440: AB_2682817" "unprognostic (6.86e-2)" "unprognostic (2.03e-1)" "unprognostic (2.12e-1)" "unprognostic (7.01e-2)" "unprognostic (1.91e-2)" "prognostic unfavorable (9.70e-4)" "unprognostic (4.64e-3)" "unprognostic (6.28e-2)" "unprognostic (7.79e-2)" "prognostic favorable (8.51e-5)" "unprognostic (1.12e-2)" "unprognostic (7.22e-3)" "unprognostic (1.04e-1)" "unprognostic (2.56e-1)" "unprognostic (1.69e-1)" "unprognostic (8.28e-2)" "unprognostic (1.91e-1)" 20.8 25.6 29.5 17.5 29.2 24.9 20.6 14.1 25.9 27.2 45.8 29.2 19.6 32.6 16.3 17.9 22.2 12.7 22.0 44.2 31.6 35.3 35.5 49.1 36.0 10.4 41.1 24.2 14.4 21.5 14.2 43.8 17.7 39.6 37.9 41.6 13.6 19.5 22.3 33.8 17.4 34.0 25.5 45.4 15.7 24.1 42.6 22.2 13.3 31.0 19.0 12.8 27.6 18.2 14.1 16.8 56.7 15.1 9.4 18.5 9.7 20.3 16.5 12.6 10.1 21.8 21.9 17.0 33.3 18.1 17.3 19.0 16.8 27.0 8.5 23.8 31.6 23.6 21.4 15.2 18.8 22.2 23.8 11.6 6.5 20.9 56.8 26.9 9.9 15.1 19.6 24.8 20.9 16.5 25.5 19.8 15.4 15.4 26.2 33.3 29.2 12.2 9.2 10.3 32.1 23.5 7.0 17.8 11.8 31.3 22.1 17.6 15.8 39.3 30.9 25.6 26.0 28.6 7.6 23.2 22.7 20.1 25.2 17.0 20.4 24.4 10.0 14.0 6.6 22.1 20.9 15.1 24.9 10.7 11.4 12.6 14.1 14.2 12.2 10.9 11.3 11.3 11.0 56.7 9.4 9.7 16.8 18.5 9.7 29.5 29.2 14.1 25.9 31.6 35.3 41.1 24.2 39.6 22.2 223.4 156.1 82.9 157.1 142.8 34.3 125.5 66.2 148.5 129.7 99.5 25.5 63.2 101.2 106.7 472.3 134.1 241.2 46.7 217.0 95.5 80.8 234.3 79.8 184.5 67.0 22.3 128.5 82.9 53.3 400.3 50.0 70.6 141.7 179.5 172.8 36.1 275.5 227.7 49.8 271.4 43.2 45.3 134.8 116.8 87.3 149.8 103.1 90.6 196.2 201.3 FAM180A "HWKM1940, UNQ1940" ENSG00000189320 "Family with sequence similarity 180 member A" Q6UWF9 7 135728348-135748846 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 23.0" "Group enriched" "Detected in some" 4 "Basal keratinocytes: 6.6;Cardiomyocytes: 5.2;Fibroblasts: 5.8;Ito cells: 8.0;Leydig cells: 2.6;Melanocytes: 6.8;Peritubular cells: 3.9;Smooth muscle cells: 2.8;Suprabasal keratinocytes: 4.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "basophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "U-2197: 74.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA021224 Uncertain Approved Nucleoplasm "Secreted - unknown location" NA NA Nucleoplasm "HPA021224: AB_1851352" "unprognostic (3.85e-2)" "unprognostic (9.13e-2)" "unprognostic (1.42e-1)" "unprognostic (2.57e-1)" "unprognostic (2.54e-1)" "unprognostic (2.33e-2)" "unprognostic (6.85e-2)" "unprognostic (1.27e-1)" "unprognostic (5.05e-2)" "unprognostic (1.97e-3)" "unprognostic (5.62e-2)" "unprognostic (7.55e-2)" "unprognostic (8.88e-4)" "unprognostic (3.14e-3)" "unprognostic (1.82e-1)" "unprognostic (4.35e-4)" "unprognostic (6.62e-4)" 9.3 2.6 0.1 1.7 0.5 0.0 5.6 0.1 1.0 7.8 5.7 0.3 0.5 0.7 9.4 2.0 5.1 3.0 21.2 14.7 0.1 0.1 8.7 23.0 4.6 0.0 0.1 0.0 8.1 1.1 0.0 0.3 1.4 0.5 6.1 1.8 1.9 2.2 0.1 3.5 5.5 3.2 8.1 0.4 0.9 1.6 3.9 0.1 0.0 4.6 4.8 0.9 6.6 8.3 0.6 0.2 2.0 0.3 0.4 0.5 0.1 0.0 0.0 0.0 0.0 8.1 8.4 0.0 4.2 16.1 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 10.3 1.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 16.7 0.0 74.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.0 0.1 0.1 0.3 0.1 0.2 0.2 0.3 0.2 0.0 0.6 0.4 0.5 0.8 0.4 0.3 0.2 0.2 0.1 0.1 0.5 0.1 1.0 0.1 0.1 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 6.6 0.0 5.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 2.6 0.0 6.8 0.0 0.0 0.0 0.1 0.0 3.9 0.0 0.0 0.0 2.8 0.0 0.0 4.3 0.6 0.0 0.0 0.0 FAM182B ENSG00000175170 "Family with sequence similarity 182 member B" Q5T319 20 25763466-25868225 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 7.6;testis: 9.9" "Group enriched" "Detected in some" 37 "Early spermatids: 201.1;Late spermatids: 281.2" "Cancer enhanced" "Detected in some" "glioma: 1.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 4 "SCLC-21H: 17.4" HPA050100 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA050100: AB_2681014" "unprognostic (8.05e-2)" "unprognostic (1.48e-2)" "unprognostic (1.29e-2)" "unprognostic (3.63e-1)" "unprognostic (2.68e-1)" "unprognostic (1.50e-2)" "unprognostic (1.88e-4)" "unprognostic (1.61e-1)" "unprognostic (3.15e-2)" "unprognostic (1.33e-1)" "unprognostic (4.58e-2)" "unprognostic (3.30e-1)" "unprognostic (2.47e-9)" "unprognostic (2.36e-1)" "unprognostic (4.40e-2)" "unprognostic (6.54e-2)" "unprognostic (3.18e-1)" 0.4 0.9 2.9 0.2 3.8 0.0 0.8 7.6 5.9 0.6 0.2 0.1 1.2 0.3 0.6 6.4 0.2 0.3 3.0 3.7 0.4 0.0 1.2 0.2 2.0 1.7 0.8 0.5 2.7 4.4 1.7 0.1 0.8 0.5 1.2 5.2 0.7 0.4 1.2 0.8 0.6 9.9 1.4 0.0 0.0 0.4 0.2 0.2 2.1 0.1 0.7 1.2 0.4 2.2 1.0 1.2 1.2 0.6 0.1 0.5 0.3 0.0 0.1 0.4 0.0 3.0 0.2 1.3 1.5 1.0 4.1 0.0 0.4 0.0 0.0 0.4 0.0 0.7 0.0 0.3 0.2 1.1 0.9 0.1 0.0 1.1 0.0 0.1 1.4 1.0 2.8 0.0 0.1 1.4 0.7 0.1 1.7 1.6 0.1 0.1 0.6 0.4 0.0 17.4 1.1 0.7 0.2 1.2 1.2 0.5 0.6 0.3 0.2 3.7 0.8 0.5 1.8 0.3 0.8 0.2 0.5 1.5 0.0 0.1 1.7 0.6 0.0 0.6 0.1 1.0 0.3 0.2 0.2 0.9 1.2 2.1 0.7 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 3.0 0.6 0.4 0.0 0.0 0.0 1.8 5.9 0.5 1.7 0.0 201.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 6.4 0.0 0.0 0.0 281.2 2.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.5 6.5 1.4 5.1 1.3 2.5 0.0 0.0 0.0 0.0 FAM184A "C6orf60, FLJ13942" ENSG00000111879 "Family with sequence similarity 184 member A" Q8NB25 6 118959763-119149387 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 31.4" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 2: 90.2;Spermatocytes: 64.6;Syncytiotrophoblasts: 222.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 15.9;HEK 293: 9.4;JURKAT: 13.4;K-562: 13.0;SCLC-21H: 10.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034571, HPA034572, HPA041955" Uncertain Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA034571: AB_10602498, HPA034572: AB_2674228, HPA041955: AB_2677768" "unprognostic (1.21e-1)" "unprognostic (4.11e-3)" "unprognostic (6.95e-2)" "unprognostic (3.40e-3)" "unprognostic (6.80e-2)" "unprognostic (1.64e-2)" "unprognostic (1.03e-1)" "unprognostic (1.18e-4)" "unprognostic (2.59e-1)" "unprognostic (3.19e-1)" "unprognostic (5.16e-4)" "unprognostic (8.38e-3)" "unprognostic (4.02e-2)" "unprognostic (9.11e-3)" "unprognostic (8.16e-3)" "unprognostic (5.70e-2)" "unprognostic (2.32e-1)" 4.0 2.8 14.2 3.7 13.7 0.6 6.1 13.9 16.0 2.8 3.0 4.6 0.4 3.8 3.9 3.6 2.6 3.9 2.3 2.4 11.3 10.5 6.7 6.4 15.3 4.9 9.1 10.0 7.1 5.1 14.2 15.4 31.4 11.9 4.0 1.9 2.7 2.9 4.1 1.2 2.3 2.6 3.1 4.6 1.0 1.7 23.2 7.1 0.1 8.5 1.1 5.8 2.1 2.0 0.5 0.0 0.0 0.2 0.3 1.9 0.0 0.1 0.2 15.9 1.6 0.2 0.2 0.0 0.5 0.3 0.5 0.8 2.1 1.2 1.1 0.0 0.2 6.0 0.0 4.9 0.0 0.2 1.2 9.4 0.5 1.4 7.0 0.1 0.0 1.5 0.3 0.2 0.1 0.0 0.3 0.0 13.4 13.0 0.5 0.2 0.3 0.3 0.0 5.3 0.6 1.2 0.0 0.0 0.0 0.1 0.1 10.4 7.7 0.5 0.5 1.5 3.0 2.1 1.8 0.2 0.8 0.4 0.1 4.0 4.0 4.3 0.3 1.2 0.0 2.0 0.0 0.0 0.0 0.2 0.2 0.6 0.5 0.2 0.0 0.0 0.1 1.5 1.2 0.0 0.3 0.0 0.0 1.9 0.0 14.2 13.7 13.9 12.9 11.3 10.5 9.1 10.0 11.9 7.1 44.7 90.2 0.0 6.1 2.2 36.7 3.9 5.1 60.2 31.8 3.5 27.5 45.2 14.9 0.8 12.9 1.9 0.1 0.0 1.0 13.5 5.0 0.9 5.8 3.4 4.9 12.7 5.8 3.1 0.3 5.4 3.4 0.8 0.0 0.0 0.0 12.5 0.5 0.0 6.7 1.3 27.8 6.5 2.3 64.6 15.4 3.0 222.8 4.1 0.4 1.0 FAM189A1 "KIAA0574, TMEM228" ENSG00000104059 "Family with sequence similarity 189 member A1" O60320 15 29120254-29570723 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 15.3;parathyroid gland: 6.5" "Cell type enhanced" "Detected in some" 7 "Cardiomyocytes: 3.1;Ductal cells: 3.7;Enterocytes: 2.3;Intestinal endocrine cells: 2.9;Paneth cells: 3.5;Undifferentiated cells: 2.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 6.4;HDLM-2: 15.6;Karpas-707: 2.0;REH: 3.7" "Low region specificity" "Detected in many" "HPA009410, HPA010637" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA009410: AB_1852332, HPA010637: AB_1852333" "unprognostic (3.18e-1)" "unprognostic (3.52e-2)" "unprognostic (5.81e-2)" "unprognostic (6.52e-2)" "unprognostic (7.05e-2)" "unprognostic (4.71e-2)" "unprognostic (4.85e-3)" "unprognostic (2.21e-1)" "unprognostic (1.27e-1)" "unprognostic (3.39e-1)" "unprognostic (7.97e-2)" "unprognostic (5.00e-1)" "unprognostic (6.70e-3)" "unprognostic (2.39e-2)" "unprognostic (9.03e-2)" "unprognostic (2.50e-2)" "unprognostic (3.12e-1)" 0.8 1.5 12.8 0.6 7.9 0.4 0.6 4.2 9.5 0.4 4.0 1.5 0.0 1.0 1.1 0.8 0.6 1.5 0.5 0.7 15.3 4.7 1.7 0.5 1.5 0.5 3.5 3.4 0.4 3.3 6.5 0.0 0.7 4.0 0.8 3.0 0.0 1.1 0.5 0.4 0.8 3.2 1.0 0.7 1.3 0.6 2.3 0.3 0.0 1.9 0.0 1.2 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.7 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.3 0.0 0.0 0.0 0.2 15.6 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 2.0 0.0 0.5 0.0 0.0 0.5 0.1 0.0 3.7 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 12.8 7.9 4.2 9.5 15.3 4.7 3.5 3.4 4.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.7 0.0 2.3 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.5 0.9 0.0 0.0 0.0 1.7 0.1 0.2 3.5 1.4 0.8 0.3 0.0 0.2 0.5 1.2 0.0 0.0 0.0 2.9 0.5 FAM189B "C1orf2, cote1" ENSG00000160767 "Family with sequence similarity 189 member B" P81408 1 155247205-155255483 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.2" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006659, HPA050674" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA006659: AB_1078339, HPA050674: AB_2681213" "unprognostic (1.56e-2)" "prognostic unfavorable (4.98e-4)" "unprognostic (1.44e-2)" "prognostic unfavorable (9.59e-5)" "unprognostic (1.46e-2)" "unprognostic (4.86e-3)" "prognostic unfavorable (3.43e-4)" "unprognostic (2.70e-2)" "unprognostic (3.49e-2)" "unprognostic (2.73e-1)" "unprognostic (5.15e-2)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.43e-7)" "unprognostic (4.16e-2)" "unprognostic (5.28e-2)" "unprognostic (1.41e-3)" "unprognostic (3.25e-2)" 18.7 13.5 18.8 12.0 17.3 6.4 20.1 18.3 18.4 11.2 16.9 5.6 16.6 14.4 14.8 6.9 14.7 10.9 13.9 10.3 15.2 11.0 11.0 10.1 10.1 7.8 10.1 16.3 11.6 11.8 15.9 13.2 11.0 19.7 12.3 8.1 7.2 13.9 18.7 41.1 12.9 12.5 17.1 13.0 9.7 13.6 10.3 11.2 3.8 8.9 10.8 7.2 18.6 19.3 0.2 0.2 0.1 0.3 1.2 0.8 0.3 12.6 9.5 8.6 16.2 8.2 11.3 2.5 10.8 8.1 8.1 7.0 10.7 6.8 10.9 16.8 8.2 4.7 12.8 10.2 10.3 3.8 15.5 23.0 7.8 8.0 6.2 11.0 2.5 9.1 10.4 6.5 8.2 7.7 9.4 10.7 6.6 6.5 4.6 6.3 6.8 11.2 3.9 10.8 10.6 23.0 11.6 6.4 12.3 5.5 3.4 12.3 16.5 5.0 18.0 12.6 5.5 14.8 9.8 9.1 7.5 10.4 8.6 11.6 9.9 9.8 5.8 9.1 4.6 6.2 0.0 0.3 0.0 0.1 0.3 0.8 0.1 0.4 0.2 0.2 0.2 0.0 0.2 0.1 1.2 0.0 0.2 0.0 0.3 18.8 17.3 18.3 18.4 15.2 11.0 10.1 16.3 19.7 11.2 3.0 2.1 7.5 10.8 5.4 15.2 10.7 5.1 5.3 2.3 12.2 17.7 10.6 1.7 12.3 3.2 12.6 7.1 0.0 9.0 13.3 7.3 10.3 5.7 5.9 6.9 38.1 6.4 14.1 9.7 4.2 8.9 4.0 6.8 4.6 8.6 7.2 9.9 3.5 8.5 4.8 16.5 0.0 9.8 17.7 6.6 7.2 12.0 3.8 9.2 10.4 FAM192A "C16orf94, NIP30" ENSG00000172775 "Family with sequence similarity 192 member A" Q9GZU8 16 57152466-57186116 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 195.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054382, HPA059652" Uncertain Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA054382: AB_2682469, HPA059652: AB_2684095" "unprognostic (1.69e-2)" "unprognostic (5.20e-2)" "unprognostic (1.36e-1)" "unprognostic (9.20e-3)" "unprognostic (4.69e-3)" "unprognostic (2.45e-2)" "unprognostic (1.01e-2)" "unprognostic (2.22e-1)" "unprognostic (6.09e-2)" "unprognostic (1.52e-2)" "unprognostic (1.41e-1)" "unprognostic (4.19e-1)" "unprognostic (3.00e-1)" "unprognostic (3.87e-3)" "unprognostic (4.14e-2)" "unprognostic (1.58e-1)" "unprognostic (2.56e-3)" 21.2 23.1 39.3 31.3 42.5 60.4 31.0 38.0 45.6 22.4 33.4 41.8 19.1 30.3 25.2 31.0 28.0 25.4 21.9 25.8 37.2 36.3 26.9 27.0 25.3 39.6 44.8 32.5 26.1 33.9 52.1 31.1 28.4 36.7 28.1 41.1 24.7 24.8 24.6 31.8 40.7 32.4 25.4 40.8 42.0 27.5 41.4 40.0 47.2 33.2 21.9 42.6 23.1 23.9 26.6 30.4 48.5 38.1 17.9 22.2 20.8 31.4 40.3 45.0 30.2 19.8 24.5 42.4 37.2 27.9 46.1 29.9 38.1 33.4 47.7 41.9 28.4 23.4 42.3 31.2 37.3 46.8 21.2 25.1 33.2 36.1 39.4 28.6 40.6 47.4 24.5 37.3 43.7 35.5 28.3 32.9 36.4 44.4 15.4 30.3 23.4 44.2 37.9 29.0 23.5 30.4 54.4 65.6 46.2 31.1 26.0 32.4 37.2 68.0 29.0 25.0 32.8 24.0 28.2 32.5 34.2 28.7 24.9 27.7 37.0 28.9 61.3 35.0 29.5 32.6 48.5 26.6 40.1 17.3 30.6 16.8 26.6 16.7 16.0 30.4 23.9 17.4 18.0 36.8 17.9 38.1 21.0 22.2 20.8 39.3 42.5 38.0 45.6 37.2 36.3 44.8 32.5 36.7 40.0 50.6 43.5 36.6 26.3 15.5 24.2 69.4 25.5 62.9 44.3 33.2 11.8 50.4 131.0 53.3 180.9 38.6 42.8 0.0 51.0 50.0 31.3 28.4 54.4 28.0 56.7 35.0 27.6 31.9 55.1 195.2 31.4 62.2 40.5 77.5 31.3 41.0 53.0 34.5 23.3 51.5 20.1 38.8 24.7 107.5 36.5 19.2 44.4 26.2 29.8 26.9 FAM193B "FLJ10404, IRIZIO, KIAA1931" ENSG00000146067 "Family with sequence similarity 193 member B" Q96PV7 5 177519788-177554541 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035847, HPA035848" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA035847: , HPA035848: AB_10601320" "unprognostic (6.58e-3)" "unprognostic (1.07e-1)" "unprognostic (8.95e-3)" "unprognostic (2.94e-1)" "unprognostic (1.81e-1)" "unprognostic (1.15e-3)" "unprognostic (4.07e-2)" "unprognostic (1.48e-2)" "unprognostic (1.91e-1)" "unprognostic (2.24e-1)" "unprognostic (1.71e-3)" "unprognostic (2.78e-2)" "prognostic unfavorable (3.71e-8)" "unprognostic (1.08e-1)" "unprognostic (1.35e-1)" "unprognostic (3.15e-1)" "prognostic favorable (1.30e-5)" 13.5 9.5 18.5 16.5 17.2 35.6 15.8 37.9 20.4 18.1 13.5 13.6 17.2 15.4 19.8 11.6 13.8 13.3 12.3 9.1 18.4 8.0 16.3 18.5 17.0 20.5 17.3 18.3 22.1 22.1 10.3 15.2 15.2 17.0 19.0 11.6 17.1 14.3 14.6 11.6 34.9 18.7 12.7 10.9 27.8 14.9 14.0 16.2 11.7 16.9 9.5 15.3 13.7 23.1 1.3 1.6 2.9 1.8 2.0 2.8 0.9 5.3 7.1 15.8 13.8 7.8 7.6 34.3 4.9 5.2 8.1 7.7 19.1 10.4 10.2 7.5 4.7 10.2 9.3 7.2 10.2 6.0 22.4 7.5 7.2 11.2 9.1 4.6 7.0 14.8 7.5 11.4 6.8 7.5 14.5 8.1 16.2 6.9 10.1 5.7 17.9 12.7 20.4 11.0 4.7 5.7 20.8 3.5 8.6 7.7 15.3 14.7 9.4 5.6 16.3 4.8 12.5 15.9 9.7 10.0 9.0 7.4 5.8 5.7 11.1 4.6 8.2 7.2 11.4 7.4 0.0 1.8 0.7 2.8 0.2 1.8 0.7 1.4 2.0 1.1 1.3 0.7 1.0 2.9 2.0 1.1 1.6 0.9 0.9 18.5 17.2 37.9 20.4 18.4 8.0 17.3 18.3 17.0 16.2 17.9 29.0 6.0 5.1 7.7 10.9 6.4 22.9 8.1 13.6 10.4 17.7 4.3 0.0 5.4 5.1 9.2 9.1 0.0 7.6 6.8 7.8 7.9 4.7 10.4 4.2 11.1 8.1 14.1 7.6 7.4 9.2 7.8 8.5 3.6 13.9 9.1 5.5 5.8 4.9 2.2 12.4 6.5 9.9 10.6 12.9 11.3 3.8 7.9 10.3 5.4 FAM198B "C4orf18, DKFZp434L142, ENED, FLJ38155" ENSG00000164125 "Family with sequence similarity 198 member B" Q6UWH4 4 158124474-158173318 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 83.8" "Cell type enhanced" "Detected in many" 13 "Endothelial cells: 51.3;Hofbauer cells: 56.1;Ito cells: 49.7;Kupffer cells: 140.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "classical monocyte: 23.8;intermediate monocyte: 14.8;myeloid DC: 7.6;non-classical monocyte: 6.8" "Group enriched" "Detected in many" 37 "dendritic cells: 7.6;monocytes: 23.8" "Cell line enhanced" "Detected in many" "ASC diff: 21.5;ASC TERT1: 40.6;HSkMC: 46.6;HUVEC TERT2: 52.0;WM-115: 20.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007227 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "Nucleoli fibrillar center" "HPA007227: AB_1847689" "unprognostic (4.87e-2)" "unprognostic (7.79e-2)" "unprognostic (6.60e-3)" "unprognostic (9.42e-3)" "unprognostic (2.37e-2)" "unprognostic (7.47e-2)" "unprognostic (2.13e-2)" "unprognostic (7.49e-2)" "unprognostic (9.20e-3)" "unprognostic (1.71e-1)" "unprognostic (1.60e-1)" "unprognostic (1.89e-1)" "unprognostic (3.25e-3)" "unprognostic (3.74e-3)" "unprognostic (3.85e-2)" "unprognostic (1.14e-2)" "unprognostic (1.89e-2)" 24.1 83.8 13.9 12.9 12.6 0.9 15.9 22.9 16.0 16.7 8.9 12.1 6.2 4.5 27.5 13.2 6.0 10.6 12.6 25.8 24.2 9.0 4.2 2.9 6.9 7.1 18.6 20.2 50.1 4.8 4.4 2.7 9.5 12.4 8.3 8.1 4.2 7.9 10.8 3.8 3.5 6.3 23.9 25.9 15.7 7.5 7.0 17.5 0.0 8.2 3.1 2.3 14.2 7.3 0.0 7.6 0.4 23.8 0.0 0.0 7.3 3.2 2.6 1.6 0.3 21.5 40.6 3.1 0.8 0.6 0.1 1.0 3.5 1.3 0.0 0.1 1.3 1.4 0.0 19.0 5.0 0.5 0.0 0.0 0.2 0.0 9.7 14.4 0.1 0.0 46.6 1.2 6.6 0.7 2.2 52.0 0.0 3.3 0.0 9.6 0.2 0.0 0.0 0.1 11.3 0.0 0.0 0.1 0.0 0.0 7.3 0.1 0.0 0.0 7.5 2.1 9.6 1.4 0.0 2.5 4.4 4.8 2.6 1.6 0.0 0.0 11.8 0.6 0.0 20.0 0.0 23.8 0.0 0.0 14.8 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.4 0.0 6.8 0.3 0.0 7.3 13.9 12.6 22.9 16.0 24.2 9.0 18.6 20.2 12.4 17.5 8.9 3.8 1.7 1.7 8.1 0.0 30.3 0.0 2.7 2.3 3.5 0.0 3.6 0.0 0.5 2.4 51.3 2.6 0.0 5.0 0.9 14.8 2.4 1.1 0.8 56.1 6.4 1.7 49.7 140.4 4.3 32.5 27.2 8.5 0.0 6.5 0.0 3.2 1.9 39.6 0.0 0.0 6.5 10.3 4.4 0.5 6.5 4.9 2.2 2.9 1.0 FAM199X CXorf39 ENSG00000123575 "Family with sequence similarity 199, X-linked" Q6PEV8 X 104166620-104195902 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 59.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003093 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA003093: AB_1078597" "unprognostic (2.03e-3)" "unprognostic (4.39e-2)" "unprognostic (1.32e-1)" "unprognostic (1.55e-2)" "unprognostic (1.47e-1)" "unprognostic (1.18e-2)" "unprognostic (1.89e-2)" "unprognostic (6.49e-2)" "unprognostic (1.34e-1)" "unprognostic (1.03e-1)" "unprognostic (1.18e-1)" "unprognostic (9.13e-2)" "unprognostic (6.07e-3)" "unprognostic (1.08e-2)" "unprognostic (4.73e-2)" "unprognostic (4.00e-2)" "unprognostic (2.39e-2)" 19.5 13.4 19.6 7.5 24.4 13.0 13.1 17.1 25.9 11.1 9.3 14.2 21.0 8.7 13.0 39.2 9.0 10.5 7.8 8.0 17.4 19.2 17.1 8.6 9.0 8.7 19.3 17.9 13.9 13.1 24.9 11.8 9.9 22.6 11.8 9.7 8.7 10.8 16.6 10.7 10.4 8.2 9.9 16.9 9.2 8.9 10.9 12.9 6.5 19.4 5.6 8.5 9.5 12.8 3.8 2.3 2.6 2.0 1.5 3.9 1.3 16.8 10.8 9.8 10.7 7.3 8.8 9.9 9.0 8.5 11.8 11.1 8.3 14.2 9.4 11.2 8.3 9.3 12.9 17.6 13.3 19.4 4.5 9.8 7.4 13.8 9.4 10.4 14.0 10.5 6.8 17.0 11.6 11.7 18.4 11.9 6.1 8.0 21.2 13.0 12.1 7.5 10.0 9.7 15.0 12.6 8.0 6.4 11.7 20.1 11.4 5.3 6.5 21.7 14.6 15.5 10.1 7.3 7.0 14.5 13.2 4.8 10.2 9.6 10.0 8.3 10.5 14.9 15.2 9.6 2.2 2.0 1.1 2.8 1.5 3.2 1.6 2.6 3.4 2.3 3.8 3.9 2.3 2.6 1.5 2.0 1.2 2.9 1.3 19.6 24.4 17.1 23.3 17.4 19.2 19.3 17.9 22.6 12.9 14.9 12.6 15.2 9.5 21.3 22.7 11.8 17.8 6.7 9.1 59.3 13.7 9.6 19.9 10.2 0.5 13.2 14.0 0.0 16.4 9.6 11.0 12.5 9.2 15.7 14.7 31.8 16.1 14.1 16.6 2.7 10.9 14.1 10.1 6.4 20.2 19.1 13.4 15.9 13.8 20.7 14.6 25.8 10.5 2.6 10.9 23.1 12.2 8.5 14.3 12.7 FAM204A "bA319I23.1, C10orf84, FLJ13188" ENSG00000165669 "Family with sequence similarity 204 member A" Q9H8W3 10 118297930-118342328 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038182, HPA062025" Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA038182: AB_10669519, HPA062025: AB_2684663" "unprognostic (1.60e-2)" "unprognostic (1.42e-1)" "unprognostic (1.35e-2)" "unprognostic (8.45e-2)" "unprognostic (8.52e-3)" "unprognostic (4.47e-2)" "unprognostic (2.42e-2)" "unprognostic (2.13e-2)" "unprognostic (9.68e-2)" "unprognostic (1.32e-1)" "unprognostic (3.33e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (8.59e-4)" "unprognostic (5.55e-2)" "unprognostic (8.33e-2)" "unprognostic (1.22e-1)" "unprognostic (6.76e-3)" 31.2 17.5 30.0 18.5 31.6 40.3 28.1 18.9 37.8 24.9 26.8 20.0 19.6 17.9 27.4 29.5 26.1 19.2 19.2 29.5 25.4 21.7 25.0 24.8 21.4 22.4 23.4 25.9 26.2 21.4 19.1 31.3 19.1 30.4 21.1 21.6 19.4 21.9 20.7 36.3 17.1 18.5 34.0 31.2 24.1 20.8 39.9 20.9 19.8 26.0 21.9 23.0 32.8 18.4 27.4 32.4 36.6 35.1 17.5 27.2 28.7 21.6 9.8 16.1 22.4 16.1 17.6 9.2 17.1 32.3 24.9 22.6 11.5 20.3 15.4 10.7 18.4 11.2 18.7 13.4 17.9 22.7 24.1 16.7 12.7 10.0 10.1 24.1 33.1 18.2 12.1 22.0 18.2 38.4 20.9 21.1 19.9 13.3 18.2 20.5 12.0 20.3 30.8 11.4 9.5 8.7 17.4 31.2 11.2 22.5 11.0 10.4 16.4 11.7 11.0 25.2 8.3 17.5 24.0 14.7 13.1 12.2 11.5 26.0 13.1 11.6 22.1 25.5 35.9 13.2 29.8 31.7 36.6 21.7 34.4 22.7 27.4 24.6 19.8 32.4 20.2 21.3 24.7 17.6 17.5 35.1 23.5 27.2 28.7 30.0 31.6 18.9 37.8 25.4 21.7 23.4 25.9 30.4 20.9 56.6 51.4 57.2 54.8 49.3 36.8 71.2 50.9 53.5 47.8 41.8 68.7 32.9 114.4 58.3 206.7 61.6 25.0 46.7 98.7 40.6 62.0 51.0 65.9 40.6 54.1 31.8 40.3 59.5 64.6 82.8 70.8 79.5 57.3 48.7 48.6 54.4 77.4 58.3 65.7 92.5 54.8 25.8 71.2 217.2 170.6 44.3 25.6 57.4 45.3 52.2 FAM206A "C9orf6, CG-8, FLJ20457, Simiate" ENSG00000119328 "Family with sequence similarity 206 member A" Q9NX38 9 108934181-108950744 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 56.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035917, HPA035918" Uncertain Supported "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes No "Nucleoplasm, Cytosol" "Cytokinetic bridge" "HPA035917: AB_2674860, HPA035918: AB_10670593" "unprognostic (4.89e-2)" "unprognostic (2.62e-1)" "unprognostic (1.85e-1)" "unprognostic (4.00e-3)" "unprognostic (1.05e-2)" "unprognostic (4.23e-2)" "unprognostic (1.91e-3)" "unprognostic (1.10e-2)" "unprognostic (1.83e-2)" "unprognostic (1.42e-1)" "unprognostic (1.16e-2)" "unprognostic (3.50e-2)" "unprognostic (1.57e-2)" "unprognostic (3.25e-2)" "unprognostic (2.03e-1)" "unprognostic (2.28e-1)" "unprognostic (1.62e-1)" 12.0 11.4 16.8 9.0 28.8 12.9 17.8 12.3 19.2 11.6 13.3 12.8 10.3 13.8 12.6 22.9 16.0 18.9 9.9 13.3 16.2 16.0 14.1 12.6 12.0 9.9 16.7 20.0 13.7 13.7 23.3 28.5 10.6 16.0 11.9 15.1 7.6 16.9 13.5 12.2 22.9 15.1 14.4 16.6 7.5 13.0 16.7 14.8 8.4 20.9 10.2 10.6 10.5 11.7 10.6 23.6 24.4 20.7 12.4 16.1 11.9 8.7 9.4 10.3 11.3 18.3 25.5 13.8 8.9 9.6 8.3 6.9 13.9 4.8 8.5 4.9 7.9 11.4 21.2 8.2 8.7 8.3 5.2 8.6 5.2 12.8 13.1 15.3 18.6 7.3 13.4 16.4 10.1 23.3 10.7 11.3 12.6 18.2 8.9 9.8 24.5 13.3 7.5 11.6 26.4 13.8 6.6 16.7 8.9 10.8 9.7 13.2 7.2 12.8 11.2 14.0 10.2 15.2 10.1 7.4 4.6 8.5 20.6 10.5 7.2 18.7 6.3 14.9 7.4 6.8 19.9 20.6 19.0 9.9 20.6 15.2 10.6 15.8 13.1 22.6 6.9 16.1 12.1 24.4 12.4 20.7 23.6 13.0 11.9 16.8 28.8 12.3 19.2 16.2 16.0 16.7 20.0 16.0 14.8 3.0 11.8 0.0 6.0 13.5 3.6 17.7 15.3 56.2 18.2 0.0 9.8 4.9 8.3 4.9 5.5 7.1 6.5 0.0 7.9 8.4 9.1 3.9 2.3 2.9 6.9 6.4 4.1 3.7 2.7 5.5 15.8 5.9 10.1 1.8 7.2 6.0 6.4 8.4 17.3 6.5 6.9 19.4 8.5 29.5 8.8 12.2 6.1 2.2 6.3 4.8 FAM208A "C3orf63, KIAA1105, RAP140, se89-1, TASOR" ENSG00000163946 "Family with sequence similarity 208 member A" Q9UK61 3 56620133-56683237 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006735, HPA017142" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006735: AB_1852384, HPA017142: AB_1852382" "unprognostic (1.46e-1)" "unprognostic (7.97e-2)" "unprognostic (1.07e-2)" "unprognostic (1.79e-1)" "unprognostic (1.92e-1)" "unprognostic (2.51e-2)" "unprognostic (2.30e-3)" "unprognostic (9.31e-2)" "unprognostic (3.91e-2)" "unprognostic (5.93e-2)" "unprognostic (1.51e-1)" "unprognostic (8.84e-2)" "unprognostic (1.73e-1)" "unprognostic (1.90e-1)" "unprognostic (2.04e-1)" "unprognostic (1.67e-1)" "unprognostic (2.74e-1)" 10.3 11.6 11.4 10.9 14.7 8.0 9.8 13.8 11.6 9.9 10.1 14.3 10.5 7.3 12.6 5.8 11.2 11.1 9.0 9.9 9.2 5.4 8.1 5.8 8.5 14.6 15.2 7.1 11.9 12.6 22.9 19.2 7.0 10.5 7.6 9.6 8.6 11.4 7.6 7.4 8.2 10.4 16.9 11.6 10.5 10.2 21.1 13.0 13.8 14.6 4.1 14.2 14.3 12.9 4.1 3.3 3.7 2.6 2.9 4.4 2.0 23.1 9.2 14.4 11.3 7.8 13.7 7.2 10.4 10.7 10.0 10.5 7.6 17.4 36.8 3.9 10.4 16.8 9.3 14.3 12.2 14.6 18.1 7.2 14.4 13.5 3.4 5.5 15.1 22.9 6.5 10.3 9.7 17.6 11.8 12.9 14.0 13.9 21.3 12.7 8.1 18.5 3.0 8.0 12.3 14.2 9.9 14.3 12.2 9.6 17.1 9.6 11.9 22.7 9.1 11.4 8.6 15.0 17.5 13.8 13.0 12.0 11.7 15.8 19.4 27.0 18.7 15.0 22.4 17.1 1.8 2.6 3.7 4.3 2.0 2.8 2.8 3.8 4.4 3.3 4.1 4.1 4.2 0.8 2.9 2.3 2.5 3.3 2.0 11.4 14.7 13.8 11.6 9.2 5.4 15.2 7.1 10.5 13.0 14.9 33.1 18.2 14.9 17.5 31.9 22.6 28.1 33.5 21.6 14.0 21.6 11.6 8.3 12.5 13.8 28.2 12.7 23.3 14.7 7.4 19.2 13.4 17.4 13.0 18.1 35.0 17.9 31.3 45.6 6.3 34.5 23.3 13.5 17.2 17.4 26.0 14.8 10.5 21.5 14.1 25.8 45.3 22.9 72.1 46.0 20.3 7.7 26.1 17.2 10.9 FAM208B "bA318E3.2, C10orf18, FLJ20360, KIAA2006" ENSG00000108021 "Family with sequence similarity 208 member B" Q5VWN6 10 5684838-5763740 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038042, HPA038043, HPA061547" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038042: AB_10673038, HPA038043: AB_10672402, HPA061547: AB_2684558" "unprognostic (3.69e-2)" "unprognostic (3.13e-2)" "unprognostic (9.25e-2)" "unprognostic (8.83e-2)" "unprognostic (8.12e-3)" "unprognostic (4.84e-2)" "prognostic unfavorable (2.91e-4)" "unprognostic (2.39e-1)" "unprognostic (9.21e-2)" "unprognostic (8.36e-2)" "unprognostic (8.85e-2)" "unprognostic (4.88e-3)" "unprognostic (2.90e-3)" "unprognostic (2.98e-1)" "unprognostic (3.50e-1)" "unprognostic (7.79e-3)" "unprognostic (5.23e-2)" 15.4 15.5 10.1 22.9 13.6 16.1 16.4 18.9 13.4 18.7 15.0 11.8 13.6 8.6 21.2 20.7 14.6 19.6 13.4 16.9 12.0 9.3 13.6 15.9 15.1 20.5 15.0 10.6 23.8 19.4 26.2 24.3 16.0 12.6 15.9 15.8 12.9 15.6 17.0 26.9 12.7 16.4 17.4 12.8 16.7 15.7 29.7 14.0 19.5 22.6 14.1 21.1 17.4 22.0 4.3 2.2 1.8 2.4 8.6 3.2 0.8 17.5 14.9 9.6 16.3 12.4 14.8 13.5 15.0 9.6 12.9 16.4 15.7 10.4 35.9 9.6 14.7 8.2 13.9 27.4 15.4 21.0 7.0 18.4 16.7 11.6 10.5 12.4 12.3 10.0 11.3 17.3 21.0 17.9 8.7 14.9 14.0 26.9 8.4 14.4 11.8 15.9 4.4 11.7 11.4 9.7 11.9 13.4 12.5 7.8 16.0 11.8 13.3 14.9 13.6 10.7 11.3 17.8 9.7 14.9 16.4 17.7 31.5 20.4 10.3 9.8 32.1 8.1 12.2 8.6 1.4 2.4 0.5 2.4 2.3 2.2 2.1 1.8 2.3 1.4 4.3 1.8 3.2 1.8 8.6 0.9 2.2 2.4 0.8 10.1 13.6 18.9 13.4 12.0 9.3 15.0 10.6 12.6 14.0 23.8 20.2 21.5 15.6 30.7 32.0 24.6 20.4 12.0 38.7 10.4 35.3 9.2 1.7 13.8 20.4 26.3 9.8 0.0 9.8 8.6 27.3 25.1 3.5 14.3 8.9 20.6 13.2 21.5 13.5 6.2 25.0 14.4 20.3 16.2 15.4 14.3 13.9 11.5 26.9 8.1 36.0 25.8 25.9 60.2 44.9 36.6 6.1 20.8 19.4 27.5 FAM20B "GXK1, KIAA0475" ENSG00000116199 "FAM20B, glycosaminoglycan xylosylkinase" O75063 1 179025804-179076562 "Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007409 Approved Supported "Nucleoplasm,Golgi apparatus" NA NA 280000 "Golgi apparatus" Nucleoplasm "HPA007409: AB_10601649" "unprognostic (7.58e-2)" "unprognostic (1.12e-1)" "unprognostic (4.97e-2)" "unprognostic (6.23e-3)" "unprognostic (3.29e-1)" "unprognostic (3.07e-1)" "unprognostic (4.76e-2)" "unprognostic (7.70e-3)" "unprognostic (7.85e-2)" "unprognostic (3.93e-2)" "unprognostic (5.36e-2)" "unprognostic (1.58e-1)" "unprognostic (3.76e-1)" "unprognostic (2.03e-1)" "unprognostic (1.76e-1)" "unprognostic (3.67e-2)" "unprognostic (3.74e-1)" 18.2 21.3 17.7 12.8 20.9 8.8 26.0 16.1 26.4 15.8 20.8 10.8 13.3 8.7 18.5 14.7 17.5 14.7 17.3 32.9 17.1 17.2 16.2 14.8 14.6 9.1 16.1 19.9 19.0 10.1 22.5 16.9 15.2 15.2 15.6 13.4 14.5 9.9 18.8 19.0 11.4 10.6 25.9 13.6 10.5 14.4 6.8 9.4 7.3 16.5 7.7 9.4 17.6 28.7 4.9 3.6 2.3 2.3 4.4 4.1 1.5 17.9 16.5 12.8 13.5 22.9 24.2 14.2 15.0 17.2 10.6 9.5 8.2 18.0 9.3 19.8 26.4 8.7 13.2 13.0 11.0 15.6 11.8 8.8 29.7 15.6 10.4 11.4 19.6 18.8 14.0 12.1 14.4 11.2 16.2 13.0 13.1 33.0 13.7 16.9 10.0 8.5 7.1 16.8 20.3 3.5 10.5 13.5 12.4 8.9 20.4 17.1 42.1 15.8 18.0 15.3 19.0 15.5 14.4 13.7 16.9 14.9 23.2 20.2 11.2 20.4 8.2 16.8 9.6 16.7 2.3 2.0 0.6 3.8 1.7 4.1 4.2 2.4 3.5 2.2 4.9 3.5 3.2 1.9 4.4 2.3 3.6 2.7 1.5 17.7 20.9 16.1 26.4 17.1 17.2 16.1 19.9 15.2 9.4 6.0 10.7 11.2 8.9 13.9 12.3 31.9 17.8 8.1 7.9 17.4 23.6 8.0 3.3 8.2 4.2 11.2 4.1 0.0 11.0 5.7 12.4 14.8 16.2 12.2 6.9 36.5 13.8 10.4 8.9 2.5 16.4 6.9 15.1 10.0 7.6 7.8 11.0 0.0 20.1 5.4 20.2 12.9 20.3 12.9 15.8 11.3 6.3 6.9 6.6 23.8 FAM20C "DKFZp547D065, DMP4, G-CK, IMAGE:4942737" ENSG00000177706 "FAM20C, golgi associated secretory pathway kinase" Q8IXL6 7 192969-260745 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins" Biomineralization "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 80.6" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 52.4;Hepatocytes: 80.0;Hofbauer cells: 49.0;Peritubular cells: 53.0;Proximal tubular cells: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HSkMC: 50.3;hTERT-RPE1: 39.1;U-87 MG: 31.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019823 Approved "Nucleoplasm,Golgi apparatus" "Secreted in other tissues" NA NA 160000000 "Golgi apparatus" Nucleoplasm "HPA019823: AB_1848389" "unprognostic (1.94e-1)" "prognostic unfavorable (8.89e-4)" "unprognostic (3.15e-2)" "unprognostic (1.03e-2)" "unprognostic (3.33e-3)" "unprognostic (2.47e-2)" "unprognostic (7.86e-2)" "unprognostic (2.45e-3)" "unprognostic (3.35e-2)" "prognostic unfavorable (9.40e-6)" "unprognostic (1.97e-3)" "unprognostic (2.49e-1)" "unprognostic (3.08e-3)" "unprognostic (1.94e-2)" "unprognostic (3.92e-2)" "unprognostic (2.16e-2)" "unprognostic (3.83e-3)" 27.5 10.2 10.8 19.3 16.6 3.3 25.6 7.4 14.9 8.3 20.1 13.5 15.1 12.9 9.5 6.9 11.1 9.7 15.0 15.0 8.8 7.2 31.8 31.6 12.7 5.1 16.9 5.6 11.8 14.8 2.6 9.2 7.2 15.8 15.0 4.6 8.8 80.6 11.8 20.4 6.8 16.5 17.0 17.0 6.9 20.0 5.9 14.8 0.4 9.6 8.4 4.4 20.5 17.5 0.0 0.6 0.0 1.6 0.2 0.0 0.0 13.3 6.5 0.2 9.3 11.9 19.7 0.0 11.9 20.2 6.5 5.2 0.7 8.2 0.0 6.6 17.8 8.8 11.6 1.0 0.5 1.6 2.8 0.6 0.0 3.1 3.5 9.0 0.0 0.9 50.3 1.5 0.2 0.7 39.1 4.5 0.0 0.0 0.1 1.7 1.8 0.0 0.7 6.3 0.1 0.4 1.5 0.3 0.0 4.8 0.0 3.1 0.1 12.4 0.0 1.8 1.2 8.8 6.1 12.5 8.1 4.0 6.9 3.6 0.0 0.0 0.0 31.0 0.8 23.1 0.0 1.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.8 16.6 7.4 14.9 8.8 7.2 16.9 5.6 15.8 14.8 6.0 3.2 2.4 1.9 9.0 20.6 8.1 33.1 5.3 0.0 52.4 0.0 0.5 5.0 1.3 0.0 2.4 3.5 0.0 4.1 0.6 13.5 6.8 3.5 80.0 49.0 1.6 11.3 9.8 15.6 1.1 15.0 14.7 1.7 11.8 4.2 16.6 6.5 3.5 53.0 46.8 8.0 12.9 15.3 0.2 0.7 7.0 0.5 0.0 7.3 1.4 FAM210A "C18orf19, HsT2329, MGC24180" ENSG00000177150 "Family with sequence similarity 210 member A" Q96ND0 18 13663347-13726663 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014324, HPA051564" Uncertain Approved "Nucleoplasm,Golgi apparatus,Mitochondria" NA NA "Nucleoplasm, Golgi apparatus, Mitochondria" "HPA014324: AB_2668972, HPA051564: AB_2681536" "unprognostic (1.32e-1)" "unprognostic (6.98e-2)" "unprognostic (5.78e-2)" "unprognostic (9.18e-3)" "unprognostic (4.13e-2)" "prognostic unfavorable (8.14e-4)" "unprognostic (2.23e-3)" "unprognostic (1.11e-2)" "unprognostic (2.26e-1)" "unprognostic (5.53e-3)" "unprognostic (6.79e-3)" "unprognostic (2.98e-2)" "unprognostic (3.27e-3)" "unprognostic (7.67e-2)" "unprognostic (2.86e-1)" "unprognostic (1.78e-1)" "unprognostic (4.82e-2)" 10.5 8.1 7.5 8.9 7.1 4.0 9.4 8.3 8.8 5.8 9.9 7.2 5.8 11.5 6.6 4.4 13.5 5.7 5.4 27.5 6.4 7.8 12.0 17.6 5.6 7.4 7.4 6.4 8.7 5.6 7.8 7.5 9.3 8.2 7.1 8.5 6.5 7.0 7.6 27.9 5.6 10.9 8.2 9.1 6.4 6.1 10.2 7.3 5.9 8.4 16.3 8.9 14.7 7.9 9.2 8.6 4.3 10.7 7.6 9.7 5.0 12.2 7.0 4.9 4.6 5.8 6.1 7.2 8.5 7.9 9.6 11.2 9.4 6.0 12.7 10.7 6.0 17.8 6.0 9.4 10.6 15.7 8.7 4.4 8.9 5.1 6.8 6.9 15.1 8.4 5.2 8.4 9.2 32.6 6.7 6.1 7.7 12.0 7.0 11.1 8.4 9.3 9.8 5.5 24.1 7.0 7.6 11.7 14.7 7.9 7.8 3.2 5.5 7.4 11.0 20.3 7.4 5.8 7.2 6.7 24.7 24.2 15.2 10.4 7.9 9.8 14.7 13.1 7.9 9.8 3.4 7.0 4.3 8.9 10.7 9.7 8.1 7.6 7.7 8.6 9.2 9.6 9.0 1.2 7.6 5.3 5.6 7.2 5.0 7.5 7.1 8.3 8.8 6.4 7.8 7.4 6.4 8.2 7.3 8.9 8.8 20.4 10.4 49.1 53.0 60.1 5.1 1.4 11.4 7.0 19.6 19.1 18.3 16.3 6.1 15.8 11.7 0.0 7.8 31.2 17.4 9.1 6.9 19.0 18.1 28.6 10.9 5.5 8.4 3.1 8.6 16.6 8.5 11.8 8.4 17.4 10.7 0.0 9.6 21.9 29.7 6.5 16.0 27.0 29.8 50.1 21.5 11.4 17.7 10.4 FAM212A "C3orf54, INKA1" ENSG00000185614 "Family with sequence similarity 212 member A" Q96EL1 3 49803254-49805030 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.8;skin 1: 30.0" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 22.2;granulocytes: 19.8;Hofbauer cells: 41.3;Ito cells: 39.3;Suprabasal keratinocytes: 24.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 19.0;memory B-cell: 25.8;naive B-cell: 23.4" "Group enriched" "Detected in many" 6 "B-cells: 25.8;granulocytes: 19.0" "Cell line enhanced" "Detected in many" "HEL: 31.9;HMC-1: 21.9;NB-4: 17.7;THP-1: 19.7;U-937: 16.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041879 Uncertain Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA041879: AB_10797269" "unprognostic (1.36e-1)" "unprognostic (2.99e-2)" "unprognostic (6.97e-2)" "unprognostic (7.95e-2)" "unprognostic (1.34e-1)" "prognostic favorable (1.96e-4)" "unprognostic (2.70e-2)" "unprognostic (4.35e-2)" "unprognostic (7.28e-2)" "unprognostic (2.94e-1)" "unprognostic (3.35e-3)" "unprognostic (4.61e-2)" "unprognostic (1.90e-3)" "unprognostic (4.95e-2)" "unprognostic (3.90e-2)" "unprognostic (1.45e-1)" "unprognostic (1.40e-2)" 6.0 4.1 5.8 3.2 4.7 5.0 3.5 8.0 6.3 6.8 2.6 4.9 1.4 1.7 5.5 2.8 16.3 2.9 4.8 7.6 4.4 4.3 3.4 1.2 7.3 5.9 6.3 4.8 3.6 2.3 0.8 2.0 5.2 5.6 5.4 1.4 3.2 4.5 3.9 15.3 30.0 3.5 5.3 8.3 6.9 2.2 2.4 4.3 1.8 1.9 10.4 8.4 4.8 8.5 25.8 3.6 19.0 2.9 0.0 1.5 2.8 0.6 0.5 0.7 0.5 0.9 2.0 0.0 1.4 0.9 0.7 0.8 0.0 0.0 6.9 0.2 1.0 0.7 4.1 0.2 4.9 0.0 1.2 0.0 31.9 0.3 0.1 1.3 4.8 21.9 2.7 7.0 1.4 1.3 0.4 2.9 0.5 2.1 0.6 0.6 0.3 0.4 17.7 0.5 0.0 2.8 6.5 0.4 1.5 0.0 7.9 0.3 2.5 1.3 0.2 0.7 0.2 0.1 19.7 1.8 3.6 0.4 1.6 0.6 0.8 0.7 0.5 1.5 16.4 0.8 19.0 0.9 4.3 0.6 2.2 0.1 25.8 0.6 0.7 0.2 23.4 0.9 1.5 0.5 0.0 2.9 3.6 0.6 2.8 5.8 4.7 8.0 6.3 4.4 4.3 6.3 4.8 5.6 4.3 3.0 1.1 0.0 11.6 22.2 1.0 0.0 0.0 1.4 1.2 0.0 0.0 0.2 0.0 0.0 1.6 7.5 0.0 0.0 0.0 0.4 7.5 1.1 19.8 0.0 41.3 0.0 0.0 39.3 2.2 7.4 1.7 0.0 11.8 0.0 0.0 0.3 0.0 0.0 2.1 0.0 0.4 12.9 0.5 1.7 3.2 24.1 0.9 0.0 0.0 4.7 FAM212B "C1orf183, FLJ31105, INKA2" ENSG00000197852 "Family with sequence similarity 212 member B" Q9NTI7 1 111680630-111739424 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in single" 10 "Hofbauer cells: 3.6" "Cancer enhanced" "Detected in many" "glioma: 6.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 13 "neutrophil: 19.2" "Lineage enriched" "Detected in many" 13 "granulocytes: 19.2" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 18.2;U-87 MG: 37.5;WM-115: 14.2" "HPA027809, HPA027810, HPA027811" Approved Supported Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA027809: AB_10599616, HPA027810: , HPA027811: AB_10600872" "unprognostic (1.92e-1)" "unprognostic (9.70e-3)" "unprognostic (1.84e-1)" "unprognostic (1.85e-2)" "unprognostic (2.81e-2)" "prognostic favorable (4.51e-5)" "unprognostic (9.96e-4)" "unprognostic (1.15e-1)" "unprognostic (1.36e-2)" "unprognostic (9.50e-3)" "unprognostic (9.92e-5)" "unprognostic (8.66e-2)" "unprognostic (1.31e-3)" "unprognostic (2.84e-1)" "unprognostic (1.42e-1)" "unprognostic (3.03e-3)" "unprognostic (5.07e-2)" 12.1 1.4 14.9 4.6 11.5 4.0 8.6 5.5 22.4 2.6 3.7 2.9 1.5 1.8 4.9 1.8 11.1 7.9 4.7 12.9 13.1 3.5 3.9 1.4 6.9 2.4 4.8 13.4 3.2 1.7 4.5 0.9 9.4 3.9 4.6 3.3 1.8 2.7 6.3 8.3 8.8 2.9 8.1 3.9 6.3 4.9 4.3 3.7 0.5 3.8 3.5 2.9 3.1 3.9 0.4 0.8 19.2 1.4 0.0 0.0 0.4 1.2 1.1 2.1 1.6 10.7 3.8 0.9 0.9 2.0 1.7 4.0 2.1 0.0 0.9 0.4 0.8 0.8 1.1 1.1 2.4 1.5 2.3 1.1 7.4 0.7 1.9 3.6 0.3 1.2 2.6 10.7 18.2 0.8 0.4 4.5 1.1 0.0 1.7 2.0 1.1 0.4 0.3 0.3 0.9 1.0 1.1 9.9 0.3 0.5 1.7 5.6 1.6 0.5 0.0 4.9 2.3 1.4 1.2 1.7 3.8 6.0 2.0 0.7 10.8 1.9 0.9 37.5 1.8 14.2 0.0 1.3 1.0 0.0 1.1 0.0 0.2 0.0 0.0 0.8 0.4 0.0 0.0 19.2 0.0 1.4 0.3 0.0 0.4 14.9 11.5 5.5 22.4 13.1 3.5 4.8 13.4 3.9 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 FAM212B "C1orf183, FLJ31105, INKA2" ENSG00000284755 "Family with sequence similarity 212 member B" 1 111722064-111755824 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.4" "Group enriched" "Detected in many" 5 "Early spermatids: 52.0;Late spermatids: 39.5;Sertoli cells: 32.3" "Cell type enriched" "Detected in single" 5 "NK-cell: 3.4" "Lineage enriched" "Detected in single" 5 "NK-cells: 3.4" "Cell line enhanced" "Detected in some" "AF22: 2.5;HHSteC: 3.7;HSkMC: 2.9;LHCN-M2: 3.5;SuSa: 3.5;THP-1: 2.5;U-87 MG: 2.5" "HPA027810, HPA027811" Uncertain Uncertain Nucleoplasm,Nucleoli,Vesicles NA NA "Nucleoplasm, Vesicles" Nucleoli "HPA027810: , HPA027811: AB_10600872" 0.1 0.3 0.1 0.4 2.8 0.2 0.1 0.1 1.7 0.1 0.2 1.5 0.1 0.3 1.7 2.0 0.1 0.0 0.3 0.4 0.1 0.7 0.1 0.5 0.2 0.1 0.1 0.1 1.0 0.0 0.1 1.0 1.6 0.8 1.3 0.1 0.1 1.2 0.1 0.0 1.0 2.5 2.6 2.2 0.0 0.7 1.2 2.6 0.8 0.1 0.1 1.9 0.1 0.1 0.2 0.7 0.1 3.4 0.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.2 0.0 3.7 1.5 0.0 2.9 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 3.5 1.3 0.5 1.9 1.8 1.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.8 3.5 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 2.5 2.2 0.0 0.7 0.0 0.0 0.2 0.0 0.2 0.1 0.5 0.3 0.0 0.1 0.3 0.3 0.0 3.4 0.1 0.2 0.2 0.0 0.0 0.0 0.5 3.1 6.2 6.2 0.0 0.0 2.7 0.0 0.0 7.9 0.0 0.0 0.0 52.0 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 6.9 1.3 2.8 39.5 2.0 2.0 6.8 0.0 4.6 1.2 0.0 1.1 5.3 0.0 5.9 32.3 6.1 4.2 2.1 3.4 0.0 0.0 0.9 0.6 FAM213B "C1orf93, MGC26818" ENSG00000157870 "Family with sequence similarity 213 member B" Q8TBF2 1 2586491-2591469 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 26.7;U-2197: 22.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006403 Approved Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA006403: AB_1853870" "unprognostic (1.81e-2)" "unprognostic (2.25e-1)" "unprognostic (2.03e-1)" "unprognostic (2.83e-1)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (1.20e-1)" "unprognostic (8.76e-2)" "unprognostic (3.09e-2)" "unprognostic (1.24e-3)" "unprognostic (2.76e-1)" "prognostic favorable (1.28e-4)" "unprognostic (5.22e-3)" "unprognostic (2.03e-1)" "unprognostic (7.91e-3)" "unprognostic (2.20e-2)" 6.0 9.1 14.7 5.7 14.9 3.8 4.6 7.4 20.0 7.9 15.4 6.2 5.2 22.0 4.5 6.7 5.7 10.5 23.7 3.2 15.0 15.5 7.4 3.5 6.0 5.8 11.7 11.0 7.1 4.6 4.4 4.3 8.4 10.7 5.7 7.4 9.0 5.3 7.7 1.8 6.1 20.2 4.8 6.5 7.4 11.7 3.3 4.7 5.4 5.2 0.9 5.2 6.3 3.5 2.1 2.2 1.5 2.3 7.5 6.3 3.2 7.7 4.3 4.4 4.8 2.1 2.4 0.6 7.0 2.9 6.6 2.9 3.1 9.1 2.0 7.1 4.5 2.7 6.5 3.9 4.9 2.2 5.8 2.0 4.8 3.3 4.9 5.1 2.7 1.4 3.5 2.5 4.6 1.7 3.1 9.3 3.6 6.5 3.1 6.6 5.6 6.3 1.2 5.3 9.0 16.6 6.9 6.5 5.1 6.9 3.9 5.9 9.8 6.0 26.7 8.0 1.1 4.6 1.0 13.5 5.8 6.7 22.9 2.6 2.9 4.3 1.4 5.4 9.2 1.1 1.5 2.0 1.1 3.8 2.3 6.3 2.1 4.2 4.1 2.2 1.5 3.5 5.4 1.5 7.5 2.0 1.0 5.6 3.2 14.7 14.9 7.4 20.0 15.0 15.5 11.7 11.0 10.7 4.7 3.0 1.7 3.9 4.5 3.7 11.0 4.5 12.7 10.7 6.8 33.2 0.0 0.4 6.6 24.6 0.6 11.6 37.6 0.0 8.8 0.4 4.0 3.7 0.0 2.6 8.0 22.3 15.1 12.3 4.9 1.1 4.9 7.6 6.8 8.2 25.7 6.0 31.4 38.2 3.9 11.8 5.2 19.4 8.1 0.9 11.1 4.5 0.6 6.9 32.8 7.0 FAM214A "FLJ10980, KIAA1370" ENSG00000047346 "Family with sequence similarity 214 member A" Q32MH5 15 52581317-52709817 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 27.1;U-698: 30.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039369, HPA040180" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA039369: AB_10795250, HPA040180: AB_10794736" "unprognostic (1.75e-1)" "unprognostic (6.40e-2)" "unprognostic (4.54e-1)" "prognostic favorable (7.27e-6)" "unprognostic (1.08e-2)" "unprognostic (5.96e-3)" "unprognostic (1.32e-3)" "prognostic favorable (8.68e-4)" "unprognostic (6.84e-2)" "unprognostic (2.62e-1)" "unprognostic (2.91e-2)" "unprognostic (2.20e-1)" "unprognostic (2.26e-2)" "unprognostic (1.63e-1)" "unprognostic (3.22e-1)" "unprognostic (3.79e-2)" "unprognostic (6.94e-3)" 21.7 17.1 11.6 15.3 16.2 12.1 18.8 41.3 18.5 11.9 12.0 8.7 32.0 8.8 12.7 6.7 21.1 10.9 8.8 10.5 11.6 5.6 7.7 24.5 9.9 14.5 14.0 14.1 10.4 16.8 24.4 26.0 6.5 11.9 10.1 10.9 9.4 17.3 27.9 47.7 11.9 14.2 13.9 7.1 11.9 12.9 14.9 16.1 12.1 16.4 13.4 18.9 16.4 17.7 7.7 10.0 6.1 0.7 5.4 5.3 1.4 2.4 3.2 3.4 5.8 10.4 6.3 3.9 6.0 10.5 3.2 4.2 1.8 2.6 16.6 7.3 5.6 1.5 4.9 2.4 5.5 2.9 13.3 3.4 4.2 7.2 1.5 3.6 2.0 2.2 14.8 8.9 3.2 3.5 6.1 10.6 5.2 2.4 17.6 4.5 9.5 3.1 5.1 0.6 4.1 3.9 7.6 3.5 12.6 5.3 11.3 3.8 6.7 6.0 11.4 4.5 10.8 17.8 4.4 7.8 3.3 1.0 3.6 1.3 27.1 16.2 30.5 5.6 2.7 1.1 0.8 0.7 6.1 4.7 0.2 5.0 7.7 3.4 3.1 0.9 6.9 3.9 3.6 4.5 5.4 0.3 10.0 5.3 1.4 11.6 16.2 41.3 18.5 11.6 5.6 14.0 14.1 11.9 16.1 41.7 21.9 37.7 12.6 14.4 19.7 22.9 28.1 41.5 25.0 3.5 58.9 2.5 3.3 8.4 2.0 16.5 14.4 0.0 12.8 2.2 16.0 25.3 3.5 34.2 6.1 25.4 27.9 26.4 12.6 2.1 26.2 9.4 25.3 2.8 23.5 29.0 13.2 14.1 30.1 5.6 26.4 12.9 14.1 26.0 8.5 12.5 16.9 27.7 11.5 22.8 FAM214B "bA182N22.6, FLJ11560, KIAA1539" ENSG00000005238 "Family with sequence similarity 214 member B" Q7L5A3 9 35104112-35116341 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 49.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 14.6" "Group enriched" "Detected in many" 4 "dendritic cells: 4.4;granulocytes: 14.6;monocytes: 8.5" "Cell line enhanced" "Detected in many" "TIME: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048831, HPA055751" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA048831: AB_2680535, HPA055751: AB_2682906" "unprognostic (2.91e-3)" "unprognostic (1.56e-1)" "unprognostic (2.82e-2)" "unprognostic (1.31e-1)" "unprognostic (1.10e-1)" "unprognostic (2.26e-1)" "unprognostic (7.22e-3)" "unprognostic (1.04e-1)" "unprognostic (1.06e-1)" "unprognostic (7.72e-3)" "unprognostic (2.38e-2)" "unprognostic (1.70e-2)" "unprognostic (1.02e-2)" "unprognostic (2.92e-1)" "unprognostic (1.31e-1)" "unprognostic (1.10e-2)" "unprognostic (8.15e-2)" 13.0 10.3 14.1 12.4 14.9 35.0 6.7 10.4 18.9 7.3 12.0 25.9 10.7 10.9 7.7 7.9 22.4 6.1 12.5 16.5 15.4 14.4 12.5 7.7 13.6 7.4 17.0 11.4 7.5 5.6 10.4 10.9 26.3 20.8 8.6 11.5 9.3 8.6 11.1 8.9 10.9 10.6 11.8 20.5 19.1 10.7 5.8 8.4 3.7 9.1 12.2 12.0 10.4 8.8 0.5 4.4 14.6 8.5 1.7 2.1 2.5 2.9 2.4 6.7 4.8 5.3 8.2 1.4 14.4 13.0 8.0 5.2 1.6 2.0 0.7 4.3 23.2 21.1 1.3 1.1 4.6 5.2 3.7 0.3 3.7 5.2 1.5 5.4 0.9 15.9 5.8 8.3 9.4 6.0 18.7 15.4 3.7 1.9 2.9 16.7 0.8 1.4 4.4 1.2 2.1 3.6 1.6 1.1 0.8 10.5 0.6 0.4 4.4 2.3 1.6 7.7 7.4 2.1 2.4 26.2 11.3 5.5 5.4 5.2 1.9 1.8 0.3 17.8 1.8 12.5 4.7 5.2 4.7 2.1 6.9 0.7 0.5 1.3 1.4 4.4 0.2 0.5 0.9 14.6 1.7 8.5 1.1 0.7 2.5 14.1 14.9 10.4 18.9 15.4 14.4 17.0 11.4 20.8 8.4 0.0 4.6 1.4 4.6 7.4 3.1 6.5 0.0 0.0 3.4 15.7 13.7 2.3 3.3 9.4 9.8 8.6 21.3 0.0 11.1 7.9 7.4 8.1 8.1 5.4 14.1 0.0 5.2 20.3 27.6 49.2 3.1 21.0 15.1 16.2 9.0 8.4 25.8 14.2 7.4 9.0 3.3 6.5 7.2 3.1 5.4 12.7 3.5 4.8 7.6 6.0 FAM217B "C20orf177, dJ551D2.5" ENSG00000196227 "Family with sequence similarity 217 member B" Q9NTX9 20 59933764-59948680 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041021, HPA056698" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA041021: AB_10959734, HPA056698: AB_2683212" "unprognostic (1.78e-1)" "unprognostic (2.92e-2)" "unprognostic (2.88e-2)" "unprognostic (1.32e-2)" "unprognostic (9.43e-2)" "unprognostic (5.05e-2)" "unprognostic (9.04e-8)" "unprognostic (2.78e-3)" "unprognostic (4.51e-2)" "unprognostic (1.56e-1)" "unprognostic (1.17e-1)" "unprognostic (9.89e-2)" "unprognostic (1.13e-2)" "unprognostic (5.51e-2)" "unprognostic (1.55e-1)" "unprognostic (1.76e-1)" "unprognostic (2.63e-2)" 5.5 5.2 17.7 7.2 18.2 14.7 6.2 18.7 29.6 6.4 5.4 10.7 5.0 6.2 8.6 7.3 5.9 7.2 5.1 11.7 15.5 14.3 6.8 2.8 6.5 10.3 14.4 19.1 13.7 4.0 5.9 14.3 7.7 14.1 9.6 4.6 4.7 5.8 11.8 16.5 4.3 7.1 5.8 10.7 7.4 5.6 10.8 11.6 8.5 8.5 4.9 10.4 7.0 6.8 7.2 8.0 13.8 7.0 9.3 13.5 6.9 5.3 3.7 8.6 5.9 4.1 6.2 6.9 7.7 6.6 8.5 6.2 19.1 11.8 11.9 13.0 3.2 6.8 13.3 9.3 6.4 8.4 6.5 5.8 11.1 9.2 10.9 2.7 17.6 15.1 3.6 7.9 6.2 2.0 3.5 2.5 14.4 7.9 5.1 5.5 9.8 30.7 9.7 8.4 5.0 7.6 7.5 8.5 11.6 3.3 8.4 8.8 10.5 10.3 13.4 11.3 8.4 12.9 12.6 3.5 7.1 8.3 7.3 4.0 8.6 14.6 14.1 9.9 11.6 4.6 9.6 7.0 9.5 11.0 4.6 13.5 6.6 10.6 10.0 8.0 7.2 11.0 11.6 13.8 9.3 4.3 6.4 9.1 6.9 17.7 18.2 18.7 29.6 15.5 14.3 14.4 19.1 14.1 11.6 14.9 14.2 20.3 4.0 4.7 30.9 27.4 10.2 16.0 10.3 10.4 21.6 18.9 14.9 4.7 19.0 13.4 14.2 0.0 7.0 8.9 11.7 8.1 27.8 4.9 15.8 57.2 8.1 13.5 31.8 16.0 16.1 16.4 11.8 10.0 6.2 23.6 7.1 5.8 9.6 11.8 29.6 32.3 16.5 51.9 14.7 4.6 5.7 22.4 9.2 4.3 FAM219A "bA573M23.5, C9orf25, FLJ39031" ENSG00000164970 "Family with sequence similarity 219 member A" Q8IW50 9 34398184-34458570 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 56.9" "Cell type enhanced" "Detected in many" 8 "Horizontal cells: 50.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HDLM-2: 43.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019338, HPA052909" Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA019338: AB_1845819, HPA052909: AB_2681986" "unprognostic (9.96e-3)" "unprognostic (2.16e-1)" "unprognostic (1.50e-2)" "unprognostic (1.23e-2)" "unprognostic (6.81e-2)" "unprognostic (4.07e-2)" "prognostic unfavorable (1.98e-5)" "unprognostic (2.71e-2)" "unprognostic (2.50e-1)" "unprognostic (2.95e-1)" "prognostic favorable (2.46e-4)" "unprognostic (3.46e-3)" "prognostic unfavorable (5.54e-5)" "unprognostic (2.04e-2)" "unprognostic (1.78e-1)" "unprognostic (3.34e-1)" "unprognostic (2.76e-1)" 13.6 10.3 27.8 10.9 27.0 4.9 7.1 26.3 56.9 7.5 6.3 23.3 3.7 7.2 13.2 8.6 6.3 6.5 7.6 17.5 25.4 27.6 6.1 5.0 11.0 7.8 30.8 31.0 10.7 8.4 9.4 10.6 16.3 34.0 9.2 6.6 5.4 7.1 9.7 28.6 12.3 6.7 15.0 25.2 9.8 7.2 6.9 25.6 2.9 7.2 4.0 6.6 6.5 6.4 0.5 0.6 3.8 0.7 0.7 1.5 0.3 12.6 4.9 11.6 6.6 10.8 4.1 11.3 7.7 5.8 6.7 8.5 3.4 2.9 2.8 8.0 7.4 13.3 5.3 9.2 4.9 6.7 43.6 5.2 1.1 6.3 3.6 6.1 2.7 6.5 4.3 5.0 10.0 5.6 8.3 11.0 5.0 2.7 14.0 5.2 2.5 4.2 3.8 7.5 1.7 7.3 5.5 1.9 2.4 4.8 2.7 3.7 11.8 6.6 4.8 3.8 11.1 2.4 2.8 13.0 7.4 5.8 15.3 10.6 3.7 5.3 2.4 21.2 6.4 13.0 2.3 0.6 3.8 1.5 0.4 0.8 0.5 0.8 0.4 0.5 0.4 0.6 0.8 2.0 0.7 0.7 0.6 1.4 0.3 27.8 27.0 26.3 40.8 25.4 27.6 30.8 31.0 34.0 25.6 6.0 3.5 2.2 2.9 5.6 18.4 10.5 0.0 1.4 1.2 3.5 3.9 8.2 0.0 5.2 12.0 14.3 0.9 0.0 4.2 12.1 5.6 5.6 2.3 2.4 5.2 50.9 10.4 5.5 4.6 25.8 3.4 2.3 8.5 3.6 1.6 8.5 5.6 1.4 5.3 2.1 10.5 6.5 8.2 10.3 2.4 5.6 17.3 4.4 0.8 2.6 FAM219B "C15orf17, FLJ00005" ENSG00000178761 "Family with sequence similarity 219 member B" Q5XKK7 15 74899987-74907121 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048929, HPA058064" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA048929: AB_2680561, HPA058064: AB_2683592" "unprognostic (1.12e-1)" "unprognostic (6.10e-2)" "prognostic unfavorable (1.75e-4)" "unprognostic (8.08e-2)" "unprognostic (1.05e-2)" "unprognostic (5.65e-2)" "unprognostic (2.41e-2)" "unprognostic (5.66e-3)" "unprognostic (1.32e-1)" "unprognostic (1.92e-1)" "unprognostic (3.17e-2)" "unprognostic (3.11e-2)" "prognostic favorable (1.29e-4)" "unprognostic (1.13e-1)" "unprognostic (1.46e-1)" "unprognostic (1.30e-1)" "unprognostic (4.91e-3)" 16.5 14.4 12.5 10.0 16.5 5.9 28.7 18.5 20.0 11.3 11.6 10.1 10.3 11.2 11.1 22.9 16.6 14.6 12.1 22.7 13.0 13.6 11.7 4.7 13.4 10.6 13.8 12.5 13.0 11.0 22.3 21.5 9.1 15.1 18.6 9.8 13.8 15.9 13.7 12.0 18.1 10.1 12.8 10.2 18.2 11.2 5.2 11.0 4.4 13.7 8.1 11.8 16.8 11.2 3.7 1.4 6.9 1.5 2.1 3.7 1.1 2.5 5.7 11.1 5.4 15.9 9.9 5.8 8.1 4.1 6.8 5.2 2.3 6.4 7.2 5.3 5.2 4.5 9.1 12.1 4.9 3.7 13.8 12.3 2.9 9.8 1.3 5.9 4.2 7.7 5.6 16.6 2.6 6.4 11.6 5.5 5.3 4.4 5.7 6.5 0.6 3.9 5.3 6.5 6.5 10.0 9.5 3.6 4.0 13.0 5.6 9.7 5.1 7.2 6.3 10.9 6.9 10.0 2.8 10.9 4.6 4.1 3.8 6.4 6.6 4.8 3.5 6.9 10.5 5.2 3.8 1.0 6.9 2.2 1.4 3.7 3.7 2.8 0.9 1.4 2.9 2.3 1.8 2.4 2.1 1.5 0.3 0.3 1.1 12.5 16.5 18.5 20.0 13.0 13.6 13.8 12.5 15.1 11.0 17.9 12.7 13.7 18.7 5.7 40.0 4.0 15.3 14.7 13.6 26.2 55.0 13.3 11.6 12.9 0.7 15.5 16.7 0.0 9.1 9.6 14.2 19.3 24.3 4.7 15.0 22.3 20.1 16.0 10.7 3.2 21.6 14.3 13.5 19.8 16.8 24.9 12.7 14.4 26.9 9.8 65.3 25.8 18.1 7.9 18.5 6.8 7.0 16.6 15.2 19.0 FAM222A "C12orf34, FLJ14721" ENSG00000139438 "Family with sequence similarity 222 member A" Q5U5X8 12 109714228-109770507 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.9" "Cell type enhanced" "Detected in many" 13 "Cone photoreceptor cells: 31.4;Early spermatids: 23.4;Horizontal cells: 73.1;Rod photoreceptor cells: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "SH-SY5Y: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040181, HPA058774" Uncertain Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites,Mitochondria" NA NA "Nucleoplasm, Plasma membrane" "Focal adhesion sites, Mitochondria" "HPA040181: AB_10796448, HPA058774: " "unprognostic (8.59e-3)" "prognostic favorable (1.82e-5)" "unprognostic (1.43e-1)" "unprognostic (1.57e-1)" "unprognostic (1.92e-1)" "unprognostic (2.05e-2)" "unprognostic (1.46e-2)" "unprognostic (1.03e-1)" "unprognostic (6.66e-2)" "unprognostic (8.17e-2)" "prognostic favorable (4.81e-4)" "unprognostic (1.15e-1)" "unprognostic (4.16e-2)" "prognostic favorable (8.59e-4)" "unprognostic (3.93e-2)" "unprognostic (2.77e-1)" "unprognostic (1.24e-1)" 1.8 16.0 7.3 2.3 17.4 2.0 3.0 15.1 25.5 1.6 3.3 37.9 0.0 10.0 1.5 2.7 2.1 1.4 2.6 4.4 11.7 9.6 7.7 2.7 1.8 1.7 23.2 7.9 7.8 6.9 1.5 13.1 1.3 15.1 2.3 3.0 10.3 7.3 2.1 2.8 4.7 5.1 1.8 27.8 6.3 8.0 17.4 23.0 0.0 1.4 0.0 2.1 1.4 2.4 0.2 0.6 0.9 0.2 0.0 0.2 0.0 0.9 1.3 0.7 1.6 0.4 0.0 0.5 0.2 0.1 0.7 0.1 12.0 0.2 0.1 1.0 0.3 0.7 0.5 0.8 0.0 0.2 7.7 1.8 1.5 0.4 2.7 0.1 1.1 1.6 0.0 0.0 0.1 0.0 0.2 0.0 0.8 0.5 0.2 0.1 4.8 0.3 1.5 1.3 1.4 2.4 1.0 3.5 0.5 1.5 0.6 8.5 51.4 1.1 1.6 3.4 0.2 1.9 1.3 0.1 0.2 1.4 0.6 1.0 1.3 1.7 1.0 0.1 0.8 1.7 0.0 0.2 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 7.3 17.4 15.1 13.7 11.7 9.6 23.2 7.9 15.1 23.0 0.0 0.0 0.5 0.6 1.9 21.6 6.1 2.5 0.0 0.0 1.8 31.4 0.1 6.6 1.4 23.4 0.8 0.6 0.0 0.7 0.1 1.7 1.4 0.0 1.3 0.3 73.1 7.5 0.0 0.0 11.0 1.1 0.3 6.8 0.0 4.1 10.0 0.8 0.0 0.4 0.6 48.4 0.0 1.4 0.7 2.6 1.6 0.7 0.0 0.8 0.2 FAM222B "C17orf63, FLJ10700" ENSG00000173065 "Family with sequence similarity 222 member B" Q8WU58 17 28755978-28855232 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051840, HPA062239" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA051840: AB_2681633, HPA062239: AB_2684722" "unprognostic (4.11e-2)" "unprognostic (9.72e-2)" "unprognostic (9.12e-2)" "unprognostic (2.40e-3)" "unprognostic (1.57e-1)" "unprognostic (2.12e-2)" "prognostic unfavorable (3.45e-4)" "unprognostic (1.18e-2)" "unprognostic (1.05e-1)" "unprognostic (8.28e-3)" "unprognostic (1.63e-1)" "unprognostic (1.79e-1)" "unprognostic (3.70e-2)" "unprognostic (2.37e-2)" "unprognostic (1.46e-1)" "unprognostic (3.61e-2)" "unprognostic (7.18e-2)" 9.6 7.6 12.0 11.5 13.4 7.9 9.4 25.4 15.3 10.6 14.0 12.3 9.2 15.3 9.7 10.5 13.9 9.4 11.1 10.6 11.6 9.5 11.6 8.7 9.3 7.6 11.5 10.3 11.4 9.2 15.0 15.2 12.4 13.9 10.5 13.0 16.4 16.8 12.2 42.4 8.5 13.4 9.7 9.5 7.8 10.5 39.4 10.9 10.1 11.1 4.4 9.2 13.3 12.5 7.8 5.7 13.6 8.5 4.1 10.2 4.2 7.7 15.4 13.1 15.2 11.4 8.0 14.4 5.6 5.3 7.9 8.0 19.7 7.7 7.9 11.2 6.2 9.8 10.0 11.0 12.6 6.6 11.0 14.5 8.9 7.7 14.9 13.1 5.6 14.5 8.3 12.5 11.2 10.0 7.9 15.6 9.3 16.7 5.7 16.7 9.9 9.9 4.7 15.0 10.4 5.8 4.7 12.5 8.0 14.0 10.0 14.5 10.1 7.7 15.0 19.6 29.0 11.7 5.5 17.4 5.2 10.8 5.7 8.7 11.6 14.1 5.1 7.2 4.0 9.4 13.6 4.2 11.1 8.2 5.9 10.2 7.8 6.8 8.3 5.6 6.4 9.6 7.9 6.1 4.1 8.5 5.7 5.9 4.2 12.0 13.4 25.4 15.3 11.6 9.5 11.5 10.3 13.9 10.9 3.0 8.2 7.3 7.0 8.4 13.6 11.4 25.5 4.0 5.7 7.0 25.5 6.9 3.3 16.7 45.8 13.1 17.3 46.7 11.5 8.3 7.2 11.3 9.3 11.0 7.6 23.8 24.9 32.5 6.9 35.2 11.5 6.6 6.8 8.2 21.2 5.6 17.4 10.5 7.4 7.8 7.2 0.0 5.6 40.0 32.9 5.8 5.0 5.1 18.4 8.7 FAM227A ENSG00000184949 "Family with sequence similarity 227 member A" F5H4B4 22 38578120-38656629 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 26.2;testis: 15.6" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 80.3;Cone photoreceptor cells: 37.3;Early spermatids: 62.3;Late spermatids: 43.0;Rod photoreceptor cells: 33.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HDLM-2: 11.4;Karpas-707: 21.5" HPA003077 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA003077: AB_1079264" "unprognostic (7.52e-2)" "unprognostic (3.06e-2)" "unprognostic (1.63e-1)" "unprognostic (8.14e-2)" "unprognostic (5.85e-2)" "unprognostic (2.91e-3)" "unprognostic (4.79e-5)" "unprognostic (5.91e-2)" "unprognostic (3.04e-2)" "unprognostic (4.04e-2)" "unprognostic (1.85e-2)" "unprognostic (4.62e-2)" "unprognostic (6.46e-6)" "unprognostic (3.74e-1)" "unprognostic (3.47e-2)" "unprognostic (2.65e-3)" "unprognostic (1.35e-2)" 0.5 1.2 4.7 0.9 7.0 1.5 2.8 0.9 3.1 2.6 0.8 5.0 5.5 0.7 2.3 7.8 0.7 9.3 2.2 0.8 4.2 3.4 2.0 0.5 2.4 0.7 1.9 2.5 1.6 1.5 2.3 26.2 0.6 6.7 1.5 1.0 2.7 1.1 1.8 0.5 2.4 0.6 1.5 0.9 0.7 1.3 15.6 3.0 0.8 3.5 0.1 0.6 1.1 0.7 1.4 1.0 2.3 0.7 1.0 1.3 0.3 0.4 1.2 1.8 2.4 0.4 1.2 0.4 0.2 0.2 0.3 0.2 0.0 1.1 0.2 0.5 0.2 0.5 1.1 0.8 0.2 0.4 11.4 1.1 0.1 3.3 0.2 0.2 0.5 0.5 0.6 0.7 1.3 0.4 1.8 0.2 1.6 0.4 21.5 0.1 0.5 0.5 0.5 0.8 0.2 0.7 1.1 0.1 0.6 0.8 0.3 2.3 0.6 1.5 0.1 0.1 0.7 1.4 0.2 0.4 0.6 0.5 0.5 0.1 2.0 1.0 0.1 0.8 0.2 0.3 2.0 0.7 0.7 0.7 0.6 0.5 0.8 0.7 0.6 0.3 1.4 0.9 1.3 2.3 1.0 0.6 1.0 0.7 0.3 4.7 7.0 0.9 3.1 4.2 3.4 1.9 2.5 6.7 3.0 3.0 1.6 0.0 2.3 2.2 5.7 1.6 5.1 80.3 10.3 5.2 37.3 0.2 0.0 2.9 62.3 1.4 0.0 0.0 2.2 0.2 1.9 2.1 0.0 0.0 0.2 4.8 4.6 0.6 0.0 43.0 2.0 1.0 0.0 0.0 0.4 12.4 1.8 0.0 1.1 0.9 33.1 0.0 1.0 15.4 13.8 3.0 0.1 0.0 1.2 1.4 FAM229B "C6orf225, DKFZp586F0922, LOC619208" ENSG00000203778 "Family with sequence similarity 229 member B" Q4G0N7 6 112087599-112102790 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 118.9" "Group enriched" "Detected in many" 10 "Early spermatids: 2880.3;Late spermatids: 5153.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036068 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA Nucleoplasm "Nucleoli, Golgi apparatus" "HPA036068: AB_10673495" "unprognostic (1.65e-1)" "unprognostic (9.41e-2)" "unprognostic (4.29e-2)" "unprognostic (4.67e-3)" "unprognostic (3.17e-2)" "unprognostic (2.00e-2)" "unprognostic (2.71e-2)" "unprognostic (1.76e-2)" "unprognostic (5.08e-2)" "unprognostic (2.52e-1)" "unprognostic (1.07e-3)" "unprognostic (4.74e-2)" "prognostic favorable (8.76e-4)" "unprognostic (3.74e-3)" "unprognostic (1.36e-1)" "unprognostic (1.80e-2)" "unprognostic (2.06e-2)" 4.7 7.4 18.4 2.1 16.8 2.0 7.7 5.8 14.8 8.2 4.2 17.3 4.3 2.2 9.6 17.0 3.8 23.7 8.8 16.8 15.7 16.2 11.6 11.0 5.2 2.0 20.7 11.2 10.7 4.3 10.0 15.4 5.2 15.3 7.3 3.1 8.6 3.9 11.0 5.9 1.9 2.3 8.6 21.7 2.3 4.3 118.9 13.6 1.6 9.7 2.6 2.0 4.6 2.6 4.0 3.4 2.7 0.3 5.4 8.1 2.8 1.6 4.2 17.4 8.5 15.4 15.3 0.8 6.4 24.5 9.2 19.5 0.7 4.1 1.3 19.0 11.8 9.6 1.0 3.6 9.3 14.8 0.4 12.0 1.5 1.9 6.5 9.6 3.3 0.8 9.3 6.3 15.2 2.6 21.5 9.0 15.2 2.0 3.4 11.2 0.4 6.2 5.4 4.5 1.2 10.1 9.7 4.3 1.3 13.5 0.2 16.2 6.8 5.1 0.6 9.9 9.8 8.3 3.1 5.1 7.7 3.3 29.4 8.5 2.5 0.1 11.7 12.3 2.8 10.2 0.1 0.1 2.7 4.2 0.0 5.3 2.5 3.7 3.3 0.5 4.0 8.1 7.2 0.4 5.4 0.3 3.4 0.4 2.8 18.4 16.8 5.8 14.0 15.7 16.2 20.7 11.2 15.3 13.6 3.0 10.7 4.7 14.7 7.4 29.1 81.9 22.9 313.2 31.8 48.8 11.8 1.2 112.7 25.4 2880.3 27.2 0.0 0.0 9.2 4.2 30.9 16.9 1.1 39.9 2.7 15.9 2.9 34.4 1.9 5153.7 67.3 6.2 23.6 2.8 0.3 63.3 6.5 0.0 85.2 62.8 30.9 58.2 24.7 416.7 35.0 7.5 0.5 4.4 0.6 7.9 FAM234A "C16orf9, DKFZP761D0211, FLJ32603, ITFG3" ENSG00000167930 "Family with sequence similarity 234 member A" Q9H0X4 16 234546-268971 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA011651, HPA071871" Uncertain Uncertain Nucleoplasm,Mitochondria NA NA 3700000 Mitochondria Nucleoplasm "HPA011651: , HPA071871: AB_2732188" "unprognostic (1.00e-1)" "unprognostic (1.85e-2)" "unprognostic (3.49e-1)" "unprognostic (4.80e-2)" "unprognostic (5.51e-2)" "unprognostic (2.03e-1)" "unprognostic (1.54e-2)" "unprognostic (2.55e-1)" "unprognostic (1.93e-1)" "unprognostic (2.21e-2)" "unprognostic (7.52e-2)" "unprognostic (1.16e-1)" "unprognostic (3.28e-2)" "unprognostic (2.23e-1)" "unprognostic (2.73e-1)" "unprognostic (1.25e-1)" "unprognostic (3.68e-1)" 20.2 19.1 11.3 11.7 24.3 6.4 16.5 12.2 16.2 11.6 20.3 56.0 13.7 36.3 17.4 12.6 26.4 14.0 16.0 31.1 8.3 7.3 18.3 15.6 11.4 10.5 39.8 9.0 13.4 29.6 24.3 19.2 15.4 37.8 16.8 12.4 15.5 14.1 15.4 51.4 14.9 26.8 29.0 42.0 9.7 18.8 13.0 27.2 7.2 16.6 16.2 6.3 19.0 11.7 10.3 17.8 12.5 17.4 14.2 11.5 12.5 9.0 18.7 23.4 54.2 36.4 21.7 12.3 22.0 27.9 13.4 17.3 18.9 26.1 8.2 35.8 27.7 11.9 18.3 7.4 13.2 11.2 11.3 13.1 11.5 11.7 15.2 22.2 6.1 6.9 22.5 20.5 18.9 15.5 37.1 21.6 10.8 12.7 2.1 14.5 37.2 6.9 6.8 29.5 13.2 9.5 20.9 16.5 40.8 23.1 8.8 29.7 24.0 35.6 20.9 18.6 20.5 26.7 10.6 21.5 28.3 8.3 15.1 6.7 5.0 2.0 10.8 19.9 9.8 38.5 11.3 17.4 12.5 10.8 16.9 5.6 8.0 9.6 10.2 17.8 10.3 11.1 11.5 7.6 14.2 16.5 6.3 9.3 12.5 11.3 24.3 12.2 16.2 8.3 7.3 39.8 9.0 37.8 27.2 8.9 13.0 2.2 9.1 0.0 8.6 0.0 10.2 12.0 9.1 29.6 23.6 49.9 6.6 41.4 21.8 13.9 34.2 0.0 23.0 42.1 9.7 12.0 8.1 19.8 22.9 9.5 33.9 20.9 14.5 52.2 15.5 11.9 0.0 57.7 30.3 9.3 17.1 51.6 20.5 15.1 11.9 19.4 0.0 16.4 28.1 0.0 55.4 6.9 42.9 9.8 FAM241B C10orf35 ENSG00000171224 "Family with sequence similarity 241 member B" Q96D05 10 69630251-69633599 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.5" "Cell type enhanced" "Detected in some" 10 "Collecting duct cells: 15.7;Distal tubular cells: 10.0;Ductal cells: 23.4;Exocrine glandular cells: 15.9;Pancreatic endocrine cells: 15.7;Proximal tubular cells: 10.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 14.2" "Lineage enriched" "Detected in single" 25 "T-cells: 14.2" "Cell line enhanced" "Detected in many" "PC-3: 26.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034591 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Centrosome" Cytosol "HPA034591: AB_10670572" "unprognostic (1.12e-1)" "unprognostic (6.37e-2)" "unprognostic (3.13e-2)" "unprognostic (1.17e-1)" "unprognostic (7.17e-3)" "prognostic unfavorable (8.64e-4)" "prognostic unfavorable (1.03e-4)" "unprognostic (3.56e-2)" "unprognostic (1.73e-1)" "unprognostic (2.12e-1)" "unprognostic (1.99e-2)" "unprognostic (1.63e-1)" "unprognostic (3.37e-2)" "unprognostic (3.12e-2)" "unprognostic (5.23e-2)" "unprognostic (2.52e-1)" "prognostic favorable (9.72e-4)" 1.4 3.3 13.1 2.0 13.5 1.1 5.3 34.5 23.9 1.3 3.0 3.2 0.6 3.0 2.7 13.0 4.0 4.8 2.1 6.9 15.0 17.8 4.7 2.3 4.1 2.7 10.8 14.4 2.0 7.9 5.6 5.3 1.3 8.3 7.8 2.6 5.1 5.6 5.6 1.6 2.4 2.2 4.5 4.6 0.8 4.2 11.4 2.4 0.7 6.0 0.1 2.4 2.6 1.6 0.3 0.0 0.5 0.0 0.2 14.2 2.8 13.3 14.5 1.8 14.9 0.0 0.0 6.5 1.3 0.3 2.4 2.6 10.5 11.0 0.0 20.4 0.3 8.6 5.5 7.8 4.5 3.4 13.2 10.7 0.0 3.2 4.0 3.9 0.0 4.8 0.0 4.4 0.1 2.3 1.8 0.0 20.1 4.9 0.0 0.2 17.9 0.1 0.0 9.0 5.4 26.9 0.0 0.0 0.1 5.1 7.6 7.6 10.4 5.5 14.0 8.5 3.9 9.6 2.3 0.6 0.3 9.3 0.0 3.9 2.4 6.6 0.0 0.2 0.0 0.3 0.0 0.0 0.0 3.4 0.0 8.9 0.1 8.5 5.6 0.0 0.3 14.2 4.9 0.5 0.2 0.0 0.0 5.3 2.8 13.1 13.5 34.5 23.9 15.0 17.8 10.8 14.4 8.3 2.4 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 8.1 5.7 15.7 0.0 5.6 10.0 23.4 0.0 0.0 0.0 0.0 15.9 4.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 15.7 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 FAM32A "DKFZP586O0120, OTAG-12" ENSG00000105058 "Family with sequence similarity 32 member A" Q9Y421 19 16185380-16192046 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051712 Approved Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA051712: AB_2681582" "unprognostic (3.20e-2)" "unprognostic (1.44e-3)" "unprognostic (1.25e-1)" "unprognostic (1.16e-3)" "unprognostic (1.23e-2)" "unprognostic (2.75e-1)" "unprognostic (3.31e-2)" "unprognostic (1.37e-2)" "unprognostic (3.86e-3)" "unprognostic (1.18e-3)" "unprognostic (1.56e-1)" "unprognostic (9.31e-2)" "unprognostic (3.23e-2)" "unprognostic (4.27e-2)" "unprognostic (1.51e-1)" "unprognostic (1.60e-2)" "unprognostic (6.49e-3)" 37.2 42.9 56.2 34.0 37.6 53.1 43.9 33.4 56.2 29.0 39.9 18.7 33.1 50.5 37.2 35.1 41.2 30.9 35.4 32.5 51.6 35.7 39.8 54.9 31.7 35.5 34.9 45.9 30.3 32.5 25.1 24.8 51.1 41.5 30.4 38.8 18.6 34.6 33.4 52.0 42.7 56.7 35.2 45.8 43.2 40.4 24.1 34.3 32.8 33.5 29.8 37.5 40.3 38.9 27.9 41.5 94.9 65.7 27.6 32.2 51.5 29.3 22.6 35.5 22.9 42.0 32.4 33.7 28.6 32.5 35.4 39.0 31.0 35.6 19.5 50.0 36.8 25.5 22.7 36.3 31.2 31.3 25.7 39.9 36.2 20.4 27.4 34.0 45.5 42.6 37.3 32.9 28.3 26.1 31.5 38.1 40.6 28.3 28.9 34.9 39.1 35.1 47.6 51.0 48.9 55.9 37.1 24.6 32.2 38.7 29.5 30.7 46.6 24.1 23.1 30.6 26.7 19.6 52.1 35.3 27.6 16.4 50.3 35.8 34.5 57.0 30.8 40.1 55.5 23.8 41.0 47.8 94.9 24.7 60.1 26.1 27.9 23.7 26.7 41.5 27.8 28.8 31.4 41.0 27.6 65.7 28.5 32.2 51.5 56.2 37.6 33.4 56.2 51.6 35.7 34.9 45.9 41.5 34.3 41.7 44.0 67.1 29.7 41.4 26.9 32.3 50.9 45.5 35.2 34.9 19.6 83.5 77.9 90.3 13.7 55.9 94.4 0.0 90.4 92.4 53.1 40.3 61.2 86.3 76.1 39.7 65.1 40.5 62.3 28.5 35.9 54.8 55.6 104.6 53.1 39.3 101.4 119.3 49.1 57.2 18.8 25.8 42.9 23.5 40.4 46.5 88.4 65.0 48.0 48.7 FAM35A "bA163M19.1, FAM35A1, MGC5560" ENSG00000122376 "Family with sequence similarity 35 member A" Q86V20 10 87094161-87191468 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 58.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036582 Uncertain Approved "Nucleoplasm,Actin filaments" NA NA Nucleoplasm "Actin filaments" "HPA036582: AB_10670233" "unprognostic (1.08e-1)" "unprognostic (2.72e-1)" "prognostic favorable (6.06e-4)" "unprognostic (1.77e-1)" "prognostic favorable (3.09e-4)" "unprognostic (5.34e-2)" "unprognostic (2.68e-1)" "unprognostic (2.19e-1)" "unprognostic (1.13e-1)" "unprognostic (8.20e-2)" "unprognostic (2.53e-1)" "unprognostic (9.18e-2)" "unprognostic (1.29e-3)" "unprognostic (1.12e-1)" "unprognostic (1.20e-1)" "unprognostic (6.44e-3)" "unprognostic (3.61e-2)" 17.3 16.9 5.4 14.4 7.2 5.4 15.4 6.4 4.9 12.6 20.2 4.7 9.1 15.0 10.8 10.6 12.6 9.3 7.4 11.5 6.0 6.1 31.2 35.3 12.5 16.4 9.0 3.5 12.7 10.2 3.6 19.4 7.4 6.8 14.0 11.6 7.4 11.4 14.0 9.3 9.1 33.1 14.8 6.9 15.6 8.7 7.1 7.9 12.0 30.7 12.6 9.4 12.3 13.6 9.0 10.7 4.9 11.1 11.2 13.7 8.5 16.1 13.1 7.5 17.2 8.5 8.2 11.0 10.9 15.4 14.7 16.2 15.0 12.5 11.9 6.1 14.8 8.6 10.8 18.5 8.3 15.2 16.9 12.2 16.4 12.5 14.1 13.1 25.6 14.4 7.5 15.4 13.4 23.2 13.0 9.8 13.0 20.8 21.5 13.6 9.3 20.7 18.3 8.6 11.8 9.2 12.9 14.9 13.1 13.5 13.6 3.7 15.5 8.4 10.0 14.5 7.3 22.0 14.5 9.5 8.4 7.7 12.5 21.7 12.1 26.4 28.8 14.2 32.0 4.5 4.9 7.0 2.3 6.8 11.1 13.7 9.0 10.3 10.0 10.7 7.2 10.5 10.5 0.1 11.2 8.4 3.7 9.7 8.5 5.4 7.2 6.4 4.9 6.0 6.1 9.0 3.5 6.8 7.9 17.9 16.3 7.2 11.3 9.3 7.7 0.0 15.3 14.7 21.6 0.0 13.7 5.6 0.0 0.0 16.8 8.6 14.8 0.0 0.0 13.2 13.9 20.1 9.2 58.0 13.0 6.4 6.9 16.0 18.4 17.8 19.0 20.0 16.9 0.0 16.0 14.3 0.0 12.9 18.7 0.0 21.1 12.9 5.3 15.7 6.8 9.8 1.8 13.1 15.7 14.6 FAM3A "2-19, DXS560S, XAP-7" ENSG00000071889 "Family with sequence similarity 3 member A" P98173 X 154506159-154516242 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 43.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025016, HPA035268, HPA056991" Uncertain Approved "Nucleoplasm,Nucleoli rim,Mitotic chromosome" "Secreted - unknown location" Yes No "Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "CAB025016: , HPA035268: , HPA056991: AB_2683303" "unprognostic (1.60e-1)" "unprognostic (2.72e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (3.19e-2)" "unprognostic (4.73e-2)" "unprognostic (5.19e-2)" "unprognostic (2.54e-2)" "unprognostic (2.57e-2)" "unprognostic (2.53e-1)" "unprognostic (6.27e-2)" "unprognostic (3.42e-2)" "unprognostic (3.48e-2)" "unprognostic (1.31e-2)" "unprognostic (2.74e-1)" "unprognostic (1.41e-1)" "unprognostic (4.04e-1)" "unprognostic (9.71e-2)" 18.9 18.9 18.9 14.7 20.9 13.7 17.3 13.4 25.7 22.3 21.2 31.1 16.3 37.0 18.2 16.2 19.3 19.1 25.3 31.4 21.3 18.7 19.8 28.5 16.1 16.7 23.0 16.4 29.1 35.5 18.2 22.1 21.0 18.5 20.6 9.9 17.3 29.4 34.7 33.4 15.3 33.7 14.4 25.4 18.4 23.6 10.7 16.8 13.5 28.8 16.1 12.2 16.9 16.9 8.0 13.3 21.2 11.5 8.5 13.3 8.9 16.6 16.0 4.0 13.5 12.2 6.2 11.4 8.5 5.9 5.9 7.0 7.3 10.1 10.8 43.4 14.2 11.5 12.1 6.3 7.5 1.4 8.8 8.6 4.2 14.0 5.1 19.1 2.8 6.8 7.7 6.8 12.1 8.5 7.0 4.1 7.0 8.0 8.0 6.7 17.4 5.2 12.3 1.7 18.1 20.1 6.5 4.0 29.7 6.4 6.9 8.0 6.1 3.9 9.5 14.0 3.1 7.2 4.4 4.5 7.9 4.8 21.4 11.5 30.8 16.8 13.2 14.6 7.4 8.1 21.2 9.9 12.5 13.3 11.5 12.9 6.2 8.2 9.3 9.9 8.0 10.2 11.9 5.0 8.5 9.5 13.3 8.5 8.9 18.9 20.9 13.4 25.7 21.3 18.7 23.0 16.4 18.5 16.8 11.9 14.7 8.0 19.3 14.4 23.0 20.5 25.5 8.1 6.8 21.0 13.7 39.7 23.2 22.8 0.6 17.7 66.7 23.3 37.0 40.6 24.2 23.6 5.7 27.2 26.3 20.6 16.8 20.3 14.9 1.6 31.1 13.9 32.1 19.0 45.1 25.5 24.3 49.1 27.6 26.2 15.2 6.5 16.0 3.7 8.6 18.4 59.6 19.3 33.2 20.3 FAM46A "C6orf37, FLJ20037" ENSG00000112773 "Family with sequence similarity 46 member A" Q96IP4 6 81491439-81752774 "Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Disease mutation, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 106.4" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 311.3;Horizontal cells: 276.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 22.1;fHDF/TERT166: 25.4;HeLa: 25.1;HL-60: 28.8;THP-1: 49.6;U-937: 22.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA051067, HPA067140" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051067: , HPA067140: AB_2685788" "unprognostic (2.02e-1)" "unprognostic (3.02e-2)" "unprognostic (5.39e-2)" "unprognostic (1.12e-1)" "unprognostic (2.86e-2)" "unprognostic (2.62e-3)" "unprognostic (5.93e-2)" "unprognostic (2.48e-2)" "unprognostic (2.53e-1)" "unprognostic (1.03e-1)" "unprognostic (1.40e-3)" "unprognostic (1.26e-1)" "prognostic unfavorable (3.07e-5)" "unprognostic (7.18e-2)" "unprognostic (6.38e-2)" "unprognostic (9.25e-2)" "unprognostic (9.66e-2)" 10.0 7.1 1.4 4.9 1.4 64.7 5.6 2.8 0.9 14.4 17.7 1.3 24.2 5.1 12.8 20.0 4.2 8.8 17.1 19.4 1.2 4.4 3.2 11.8 5.8 2.3 1.4 0.9 20.1 3.5 6.5 20.4 106.4 3.5 16.2 5.6 4.9 49.8 45.6 4.5 7.0 32.6 15.3 2.5 5.8 13.2 6.8 1.4 1.2 7.7 6.7 3.7 13.4 31.1 12.0 12.4 22.4 22.2 8.3 6.2 6.1 1.0 1.5 1.0 0.0 22.1 9.8 1.9 8.4 6.0 5.0 7.6 15.7 0.8 0.1 0.3 25.4 3.2 0.9 0.7 1.3 3.7 0.0 1.9 0.0 25.1 2.4 6.9 28.8 2.2 4.3 0.7 3.9 0.7 16.4 0.6 0.2 0.4 0.0 3.3 4.4 0.0 20.4 0.2 8.9 1.2 0.0 9.1 0.0 0.6 1.9 1.0 1.4 3.7 1.6 2.5 3.3 0.3 49.6 1.4 5.7 1.2 2.4 2.3 0.1 0.1 0.1 8.1 22.3 2.4 16.1 14.9 22.4 6.2 15.1 3.7 8.0 2.4 3.0 12.4 12.0 4.7 4.4 7.3 8.3 22.2 4.3 2.7 6.1 1.4 1.4 2.8 0.9 1.2 4.4 1.4 0.9 3.5 1.4 59.6 92.4 0.9 134.5 49.9 25.9 0.0 45.9 21.4 102.4 0.0 70.7 30.7 0.0 0.0 0.4 20.4 311.3 23.3 0.0 89.3 98.1 34.0 210.9 34.5 26.7 276.5 183.7 6.7 35.9 0.5 95.3 46.7 62.4 0.0 64.6 75.7 0.0 105.2 37.1 0.0 45.1 25.8 43.8 0.9 5.4 31.7 135.5 20.3 33.3 105.6 FAM46C FLJ20202 ENSG00000183508 "Family with sequence similarity 46 member C" Q5VWP2 1 117605934-117628372 "Cancer-related genes, Predicted intracellular proteins" "Host-virus interaction" "Nucleotidyltransferase, RNA-binding, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 114.0" "Group enriched" "Detected in many" 9 "Early spermatids: 418.3;Late spermatids: 1175.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 16.3" "Group enriched" "Detected in many" 17 "B-cells: 9.7;granulocytes: 16.3;T-cells: 9.2" "Cell line enhanced" "Detected in some" "Karpas-707: 74.8;RPMI-8226: 44.6;U-266/70: 20.8;U-266/84: 17.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA054049 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA054049: AB_2682356" "unprognostic (3.76e-2)" "unprognostic (3.85e-3)" "unprognostic (3.24e-3)" "prognostic favorable (3.75e-5)" "unprognostic (1.17e-1)" "unprognostic (1.55e-3)" "unprognostic (3.29e-1)" "unprognostic (2.88e-2)" "unprognostic (5.75e-2)" "unprognostic (1.36e-3)" "unprognostic (9.41e-3)" "unprognostic (3.91e-2)" "prognostic favorable (2.77e-5)" "unprognostic (6.26e-2)" "unprognostic (3.16e-2)" "unprognostic (3.08e-2)" "unprognostic (1.10e-2)" 3.2 1.8 1.2 24.5 1.1 28.9 4.4 1.1 1.1 8.1 16.1 1.8 8.4 5.6 4.8 16.6 6.9 3.3 9.7 6.4 1.2 1.1 5.0 5.5 11.2 16.3 1.2 0.1 8.3 114.0 7.2 5.3 10.6 3.9 6.4 9.5 4.4 37.8 11.9 10.0 1.8 10.6 4.7 1.4 19.1 12.2 34.0 0.2 1.5 10.3 10.9 37.0 9.5 8.6 9.7 0.2 16.3 0.0 0.6 9.2 2.1 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.1 6.7 0.1 0.0 0.4 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 4.2 0.4 9.2 0.0 0.0 0.0 5.4 11.9 0.0 0.0 0.1 0.0 0.0 0.0 2.5 1.2 74.8 0.0 0.9 0.0 5.5 0.9 1.1 0.6 0.0 0.0 44.6 0.0 0.9 0.5 0.0 0.4 0.6 0.4 0.1 0.4 0.0 0.1 0.0 0.5 0.0 0.1 20.8 17.2 0.4 0.4 1.9 0.6 16.3 0.0 10.5 2.5 0.0 2.2 9.7 2.5 3.1 0.0 8.0 0.3 1.4 1.1 0.6 0.0 0.2 9.2 2.1 1.2 1.1 1.1 1.1 1.2 1.1 1.2 0.1 3.9 0.2 6.0 42.9 52.6 7.5 7.6 0.0 0.0 5.1 21.4 36.4 0.0 0.0 1.9 0.0 0.0 418.3 2.8 12.0 93.5 0.0 2.0 7.3 6.6 7.0 4.3 1.1 0.0 19.0 0.0 1.5 1175.9 13.3 2.0 45.5 0.0 35.3 1.1 0.0 8.6 8.5 0.0 0.0 6.5 9.2 12.5 8.5 5.6 1.8 32.0 26.4 7.9 FAM49A "DKFZP566A1524, FLJ11080" ENSG00000197872 "Family with sequence similarity 49 member A" Q9H0Q0 2 16549459-16666331 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 45.8;brain: 39.5" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 90.0;Kupffer cells: 96.6;monocytes: 191.2;Syncytiotrophoblasts: 125.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 23.3;HUVEC TERT2: 18.6;RH-30: 41.7;SK-BR-3: 12.2;TIME: 14.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017847, HPA060398" Approved Approved Nucleoplasm NA NA Nucleoplasm "CAB017847: , HPA060398: AB_2684275" "unprognostic (3.45e-1)" "unprognostic (1.83e-2)" "unprognostic (6.50e-2)" "unprognostic (1.94e-3)" "unprognostic (1.88e-1)" "unprognostic (7.78e-2)" "unprognostic (8.61e-2)" "unprognostic (3.83e-2)" "unprognostic (2.61e-1)" "unprognostic (2.00e-2)" "unprognostic (5.74e-2)" "unprognostic (8.38e-2)" "prognostic unfavorable (1.83e-6)" "unprognostic (1.32e-2)" "unprognostic (3.43e-2)" "unprognostic (3.82e-2)" "prognostic unfavorable (4.46e-4)" 10.8 9.1 22.7 15.6 28.0 15.3 7.0 6.6 39.5 13.7 5.3 7.0 1.2 2.9 8.2 2.1 4.3 6.2 8.7 3.3 17.2 14.1 1.9 6.1 9.6 13.4 10.2 25.2 10.0 2.4 1.1 4.8 15.3 9.9 6.9 5.3 2.9 3.2 7.3 6.0 2.9 4.6 8.6 6.0 20.1 3.4 1.8 6.3 1.9 31.8 1.1 13.6 7.7 7.4 8.9 15.5 45.8 34.4 13.4 5.3 8.5 0.2 0.0 2.6 0.1 2.8 0.8 7.9 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.4 0.0 1.8 1.6 0.6 1.0 0.0 2.8 0.1 1.6 0.0 0.0 1.4 0.0 23.3 1.3 1.0 0.2 0.0 2.1 18.6 0.0 0.1 2.0 1.6 0.1 0.0 5.4 1.1 0.1 0.0 0.9 41.7 0.1 2.2 10.3 0.4 1.5 0.0 12.2 0.0 3.4 0.4 0.7 14.5 0.2 2.4 0.0 0.0 1.2 0.0 1.4 6.1 1.2 0.8 0.0 23.6 31.4 5.3 29.8 0.6 8.9 0.2 2.7 15.5 6.1 0.2 2.1 45.8 13.4 34.4 7.7 0.1 8.5 22.7 28.0 6.6 33.3 17.2 14.1 10.2 25.2 9.9 6.3 3.0 17.3 26.5 17.4 10.0 3.2 1.4 0.0 1.4 9.1 0.0 2.0 40.6 0.0 2.9 0.8 6.0 0.0 23.3 0.8 90.0 12.5 8.1 11.5 1.0 31.7 0.0 0.0 29.4 96.6 0.0 2.0 70.2 28.7 191.2 0.0 22.8 0.2 0.0 1.8 0.0 2.4 12.9 14.1 0.0 2.1 7.3 125.4 11.7 0.0 24.3 FAM49B BM-009 ENSG00000153310 "Family with sequence similarity 49 member B" Q9NUQ9 8 129839593-130017129 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 93.5;bone marrow: 80.1" "Cell type enhanced" "Detected in many" 7 "monocytes: 468.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009076 Enhanced Approved Nucleoplasm,Cytosol NA NA 990000 Nucleoplasm Cytosol "HPA009076: AB_1848402" "unprognostic (4.35e-2)" "unprognostic (5.22e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.24e-4)" "unprognostic (2.80e-2)" "unprognostic (9.61e-3)" "prognostic unfavorable (3.02e-6)" "unprognostic (4.75e-2)" "unprognostic (2.44e-1)" "unprognostic (6.53e-2)" "unprognostic (3.25e-2)" "unprognostic (3.62e-1)" "prognostic unfavorable (3.09e-10)" "unprognostic (3.85e-3)" "unprognostic (1.95e-1)" "unprognostic (2.67e-1)" "unprognostic (2.46e-1)" 19.2 14.5 23.2 42.8 33.1 80.1 20.6 28.0 36.9 7.2 14.3 18.2 5.5 14.2 8.0 10.6 17.9 7.9 14.9 9.8 25.5 25.2 11.8 12.3 19.1 49.6 28.5 19.6 6.4 10.0 7.5 16.1 19.4 21.2 7.6 17.4 7.3 12.0 7.9 16.8 9.0 19.3 13.5 38.8 41.3 12.9 13.6 21.2 28.2 13.8 9.7 46.4 20.6 8.4 21.0 47.3 93.5 42.2 30.8 29.3 43.4 32.2 17.3 18.9 10.6 1.7 2.5 25.2 9.8 9.5 13.6 14.6 9.9 22.3 32.3 21.6 6.4 10.8 16.1 15.6 25.9 20.5 67.5 10.9 32.3 9.7 11.2 6.6 20.9 27.9 4.0 12.1 9.2 19.2 11.2 12.0 26.3 23.1 37.5 14.9 14.4 71.0 15.5 16.0 25.4 24.0 31.0 12.8 54.1 27.9 13.3 12.6 16.5 19.6 12.4 29.0 17.9 14.5 27.2 7.4 5.0 32.4 10.6 20.8 12.5 36.7 53.5 7.9 45.6 13.0 45.5 35.3 65.6 29.3 42.2 22.4 21.0 16.7 23.9 47.3 15.1 15.0 24.6 93.5 30.8 36.5 30.4 22.5 43.4 23.2 33.1 28.0 36.9 25.5 25.2 28.5 19.6 21.2 21.2 29.8 31.5 95.1 103.3 116.3 33.0 23.3 35.7 13.4 33.0 73.3 39.3 108.2 44.7 52.9 13.3 30.0 27.9 0.0 43.3 127.2 26.9 56.3 64.6 16.1 225.8 23.8 26.6 22.7 194.9 6.5 5.8 254.2 45.5 468.9 24.3 12.1 64.0 38.6 4.2 23.5 17.1 19.4 15.5 29.9 40.7 72.6 50.6 182.7 28.1 113.6 FAM50A "9F, DXS9928E, HXC-26, XAP5" ENSG00000071859 "Family with sequence similarity 50 member A" Q14320 X 154444126-154450654 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003585 Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA003585: AB_1080603" "unprognostic (1.95e-1)" "prognostic favorable (2.05e-4)" "prognostic unfavorable (9.52e-5)" "unprognostic (5.39e-2)" "unprognostic (4.73e-2)" "unprognostic (3.32e-1)" "prognostic unfavorable (3.15e-5)" "unprognostic (2.56e-1)" "unprognostic (4.62e-2)" "unprognostic (1.40e-1)" "unprognostic (3.64e-3)" "unprognostic (6.35e-2)" "unprognostic (3.28e-2)" "unprognostic (9.78e-2)" "unprognostic (1.18e-1)" "unprognostic (1.97e-2)" "unprognostic (4.14e-1)" 33.0 29.9 31.4 23.3 46.1 21.7 22.6 42.7 45.3 23.0 27.0 25.6 22.2 24.8 22.2 38.1 18.9 16.4 17.4 31.9 32.6 23.5 24.7 23.2 23.1 16.6 43.5 29.5 20.3 25.1 32.1 41.3 30.5 35.6 23.1 20.2 24.3 27.9 26.6 54.7 16.1 22.9 26.5 31.4 24.1 23.1 7.0 42.9 11.7 25.6 12.4 16.9 24.8 39.9 16.5 24.5 19.4 35.1 19.6 30.3 14.6 26.0 32.5 10.8 15.5 40.6 29.3 21.5 33.9 30.8 33.2 50.8 29.6 12.3 1.3 35.3 35.8 48.5 10.3 25.6 23.7 25.8 19.0 16.3 8.3 39.0 18.6 59.4 7.5 24.9 33.5 17.1 51.1 26.3 24.0 27.2 10.0 10.8 21.3 32.2 17.8 8.9 10.0 7.3 23.1 20.4 13.1 27.3 18.8 21.0 26.4 19.6 13.9 12.3 20.0 40.6 19.5 17.4 14.8 33.0 22.9 18.8 37.5 41.5 49.5 28.4 9.3 31.0 26.5 25.5 14.2 26.6 19.4 22.5 33.9 30.3 16.5 23.4 21.5 24.5 14.0 13.2 18.0 14.4 19.6 35.1 18.8 24.9 14.6 31.4 46.1 42.7 45.3 32.6 23.5 43.5 29.5 35.6 42.9 32.8 52.0 32.9 35.3 23.1 61.4 79.5 50.9 10.7 15.9 27.9 25.5 56.8 48.0 42.2 0.8 43.0 99.3 93.5 58.5 92.1 57.0 45.1 47.2 37.6 125.0 44.5 60.7 39.9 53.7 2.6 72.2 73.5 30.4 61.3 64.6 70.3 63.3 77.2 75.0 89.7 62.4 32.3 59.0 7.2 15.7 22.6 101.7 53.3 49.8 41.4 FAM50B "D6S2654E, X5L" ENSG00000145945 "Family with sequence similarity 50 member B" Q9Y247 6 3849386-3851317 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 42.6;MCF7: 13.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA064111, HPA067817" Approved Enhanced "Nucleoplasm,Cytokinetic bridge,Midbody" Yes NA Nucleoplasm "Cytokinetic bridge, Midbody" "HPA064111: AB_2685191, HPA067817: AB_2685904" "unprognostic (1.15e-1)" "unprognostic (7.76e-2)" "unprognostic (4.28e-2)" "unprognostic (4.43e-2)" "unprognostic (2.12e-3)" "unprognostic (2.69e-1)" "unprognostic (2.38e-2)" "unprognostic (7.13e-2)" "unprognostic (1.60e-1)" "unprognostic (1.79e-1)" "unprognostic (2.15e-1)" "unprognostic (2.90e-1)" "prognostic favorable (4.01e-6)" "unprognostic (1.60e-1)" "unprognostic (3.22e-1)" "unprognostic (1.34e-1)" "unprognostic (9.39e-2)" 7.2 9.5 13.4 5.7 20.6 3.1 5.7 18.7 16.7 6.7 6.8 11.0 8.4 10.1 8.3 6.7 5.5 11.2 8.1 16.0 12.8 14.2 12.9 12.0 6.2 7.1 11.4 14.9 14.4 12.7 5.8 7.7 3.4 9.7 8.2 3.0 5.9 15.2 9.8 41.1 7.9 6.9 10.2 10.8 7.7 7.9 10.2 9.9 5.8 11.8 5.7 5.5 7.5 13.3 14.9 10.1 3.4 9.1 19.4 20.5 5.6 3.1 4.3 0.0 0.0 2.6 2.4 0.2 3.8 1.8 2.6 3.3 0.0 5.9 3.4 4.1 2.7 1.0 2.4 0.0 1.5 1.9 42.6 2.3 0.0 10.2 0.0 2.7 0.0 0.0 2.7 3.0 2.0 0.6 0.8 2.6 0.0 0.0 0.0 2.3 13.4 0.0 4.7 0.9 2.0 2.0 0.0 0.0 0.0 1.2 0.0 6.0 5.3 6.2 3.9 0.2 0.0 4.2 3.8 3.5 0.0 0.4 5.1 0.0 0.0 9.2 0.0 1.4 0.3 7.1 3.4 4.7 2.4 7.1 6.1 16.8 14.9 13.6 9.2 6.1 12.9 11.3 7.1 1.9 19.4 9.1 10.1 20.5 5.6 13.4 20.6 18.7 16.7 12.8 14.2 11.4 14.9 9.7 9.9 14.9 6.5 6.5 5.9 5.7 17.4 15.7 5.1 4.0 7.9 12.2 3.9 3.3 28.2 10.7 24.9 4.1 2.2 0.0 9.9 4.8 5.8 2.7 3.5 18.8 8.7 14.3 1.2 8.6 4.1 25.0 7.8 4.0 11.8 10.0 3.3 19.1 7.9 3.6 10.3 32.6 12.6 0.0 7.9 34.4 39.6 5.8 0.8 4.5 3.3 1.6 FAM53A DNTNP ENSG00000174137 "Family with sequence similarity 53 member A" Q6NSI3 4 1617915-1684302 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 12.7" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 3.6;Early spermatids: 11.4;Spermatocytes: 14.4;Spermatogonia: 11.8" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 9.9" "Low region specificity" "Detected in all" "HPA036452, HPA058138" Enhanced Approved "Nucleoplasm,Actin filaments" NA NA Nucleoplasm "Actin filaments" "HPA036452: AB_10671841, HPA058138: AB_2683619" "unprognostic (8.78e-2)" "unprognostic (1.16e-2)" "unprognostic (2.92e-1)" "unprognostic (2.52e-1)" "unprognostic (7.59e-2)" "unprognostic (3.45e-2)" "unprognostic (5.27e-2)" "unprognostic (1.23e-2)" "unprognostic (1.89e-1)" "unprognostic (2.44e-1)" "unprognostic (5.33e-3)" "unprognostic (7.80e-2)" "unprognostic (2.14e-3)" "unprognostic (3.73e-2)" "unprognostic (1.03e-1)" "unprognostic (5.26e-3)" "unprognostic (1.15e-3)" 1.3 0.8 0.8 0.6 0.7 0.9 1.2 1.6 1.1 0.9 1.0 0.0 1.6 6.0 0.8 2.1 1.5 0.5 1.1 0.7 0.7 1.2 0.7 0.9 1.5 1.5 4.0 1.3 6.8 0.1 1.1 0.2 1.7 0.8 1.5 3.3 0.4 1.0 2.7 0.8 0.9 12.7 5.7 0.2 0.9 0.6 2.4 4.9 0.6 3.8 0.9 4.4 1.0 1.2 0.8 2.0 4.0 1.4 3.5 0.8 6.6 3.6 6.4 4.3 1.6 2.9 3.2 3.3 1.8 2.5 0.2 0.0 1.3 1.7 0.8 0.9 0.8 0.3 0.7 5.6 0.0 1.2 2.7 3.8 3.2 6.4 1.3 1.0 6.8 2.4 0.9 2.8 0.8 1.9 2.0 2.5 0.6 9.1 0.9 0.5 0.1 1.7 1.9 9.9 4.2 2.5 0.5 4.7 1.5 3.1 2.1 1.6 0.3 0.4 1.2 0.8 0.4 1.6 0.8 0.1 1.2 7.8 0.0 1.1 0.6 0.5 3.8 1.2 2.4 0.7 0.8 2.5 1.6 4.4 0.2 0.0 0.9 1.5 4.9 1.0 1.0 0.0 0.0 0.0 0.4 1.1 0.8 3.6 2.5 0.0 0.0 1.8 0.0 0.0 1.7 0.3 11.4 0.5 0.0 0.0 0.8 0.0 0.4 0.4 0.0 0.8 0.2 0.0 0.0 1.3 0.0 1.3 0.6 0.3 0.0 1.0 0.0 0.3 0.4 0.0 0.4 0.3 0.4 0.0 0.9 14.4 11.8 0.4 0.0 0.0 0.4 0.1 FAM69A FLJ23493 ENSG00000154511 "Family with sequence similarity 69 member A" Q5T7M9 1 92832737-92961522 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 25.6;Syncytiotrophoblasts: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015718, HPA017281" Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA015718: AB_1848405, HPA017281: AB_1848406" "prognostic favorable (8.96e-4)" "unprognostic (1.00e-1)" "unprognostic (6.17e-2)" "unprognostic (1.50e-3)" "unprognostic (1.43e-1)" "unprognostic (3.77e-3)" "unprognostic (3.63e-3)" "unprognostic (1.08e-1)" "unprognostic (1.04e-1)" "unprognostic (2.10e-1)" "unprognostic (2.19e-1)" "unprognostic (5.04e-2)" "prognostic unfavorable (1.45e-7)" "unprognostic (1.26e-2)" "unprognostic (5.99e-2)" "unprognostic (2.57e-1)" "unprognostic (1.66e-2)" 13.3 3.4 20.7 10.4 22.5 7.0 7.8 19.4 22.2 7.3 13.2 15.9 4.2 8.8 15.7 3.8 9.3 8.3 11.1 5.3 22.6 18.0 6.1 24.7 4.5 10.1 25.0 12.2 6.0 3.5 20.5 4.1 12.8 17.7 9.5 12.4 5.4 5.5 11.3 7.5 5.6 8.2 19.4 24.7 7.6 8.8 6.4 24.4 9.6 6.2 3.6 8.8 12.2 6.0 22.5 7.1 0.2 0.9 11.8 14.2 6.7 4.3 4.8 2.0 4.8 7.5 14.1 2.4 13.6 28.1 7.7 15.7 2.7 0.9 14.8 2.5 25.0 15.4 5.6 0.3 10.2 12.8 5.9 4.8 0.5 3.8 6.9 2.7 1.3 0.9 8.4 8.2 17.0 3.9 13.1 0.1 9.1 5.2 15.7 9.7 1.6 4.9 1.2 3.5 7.3 1.9 4.4 14.5 4.5 1.1 4.5 4.9 3.8 3.8 3.8 5.0 4.6 1.8 0.4 0.5 9.1 7.0 17.7 4.8 23.8 22.7 17.3 4.3 0.9 0.8 0.0 0.9 0.0 10.5 0.4 8.1 22.5 12.1 8.2 4.3 13.6 14.2 12.1 0.2 11.8 0.2 7.1 10.7 6.7 20.7 22.5 19.4 22.0 22.6 18.0 25.0 12.2 17.7 24.4 0.0 2.4 9.3 3.5 10.1 1.3 3.6 7.6 10.7 1.2 5.2 2.0 25.6 3.3 1.6 1.5 3.0 1.3 0.0 2.1 4.9 9.9 3.7 0.0 13.2 3.7 7.9 0.0 4.9 3.7 2.3 0.9 2.2 6.8 16.2 3.2 0.7 2.8 0.0 7.1 4.4 1.3 0.0 9.2 0.7 1.6 8.2 21.2 5.7 2.5 1.8 FAM69B "C9orf136, MGC20262" ENSG00000165716 "Family with sequence similarity 69 member B" Q5VUD6 9 136712570-136724050 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Endothelial cells: 15.8;Horizontal cells: 25.4;Ito cells: 20.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "naive B-cell: 7.3;plasmacytoid DC: 1.9" "Group enriched" "Detected in many" 34 "B-cells: 7.3;dendritic cells: 1.9" "Cell line enhanced" "Detected in many" "EFO-21: 28.7;HEK 293: 25.7;HUVEC TERT2: 31.9;REH: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054443 Approved "Nucleoplasm,Nuclear bodies,Vesicles" No No "Nuclear bodies" "Nucleoplasm, Vesicles" "HPA054443: AB_2682489" "unprognostic (2.78e-2)" "unprognostic (8.07e-2)" "prognostic unfavorable (1.77e-5)" "unprognostic (3.82e-1)" "unprognostic (1.37e-1)" "unprognostic (5.59e-2)" "unprognostic (1.71e-1)" "unprognostic (6.74e-2)" "unprognostic (6.80e-2)" "unprognostic (2.10e-2)" "prognostic favorable (9.48e-5)" "unprognostic (2.77e-1)" "unprognostic (6.67e-3)" "unprognostic (4.14e-2)" "unprognostic (1.21e-2)" "unprognostic (1.84e-1)" "unprognostic (2.78e-1)" 8.0 3.8 12.3 3.6 14.2 8.2 5.6 19.8 21.4 6.1 4.6 4.9 2.3 4.7 9.6 5.0 4.7 11.0 5.9 18.8 12.3 14.6 6.6 5.5 11.0 4.5 12.4 15.9 5.4 11.9 7.9 11.4 24.5 14.2 6.5 1.3 17.5 11.2 4.5 9.9 13.0 4.4 4.1 5.3 7.9 3.5 7.5 3.2 1.6 7.6 4.1 2.1 3.2 3.1 7.3 1.9 0.0 0.1 0.0 0.0 0.7 0.5 3.4 9.6 9.4 0.0 0.0 8.6 0.3 0.0 0.4 0.4 9.7 1.6 0.8 28.7 0.0 3.1 2.9 4.9 0.1 0.0 1.3 25.7 5.4 0.4 0.3 0.1 0.8 2.9 0.1 0.0 0.1 0.0 1.4 31.9 6.9 6.4 0.9 0.0 4.2 3.7 8.6 14.8 2.1 2.1 20.5 0.2 9.6 0.5 1.0 16.4 17.7 0.4 1.9 7.1 3.1 5.3 5.0 16.3 0.8 7.1 1.3 0.6 5.7 0.5 2.5 0.6 0.8 3.6 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.7 12.3 14.2 19.8 21.4 12.3 14.6 12.4 15.9 14.2 3.2 0.0 5.3 1.4 1.3 0.9 10.5 4.4 0.0 0.0 1.2 0.0 9.8 0.5 3.3 0.6 1.2 15.8 0.0 0.0 0.0 5.3 2.1 1.3 1.1 3.9 0.4 25.4 0.0 20.3 0.6 3.7 4.4 0.2 11.8 0.0 0.0 9.7 0.2 0.0 2.5 1.1 8.3 0.0 0.8 1.2 5.5 0.3 0.2 0.0 0.0 0.0 FAM71F2 FAM137B ENSG00000205085 "Family with sequence similarity 71 member F2" Q6NXP2 7 128672288-128687872 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 7 "testis: 28.1" "Group enriched" "Detected in many" 7 "Early spermatids: 138.1;Late spermatids: 512.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA020513, HPA024248" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA020513: AB_1853077, HPA024248: AB_2671497" "unprognostic (1.01e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-1)" "unprognostic (1.06e-1)" "unprognostic (9.83e-2)" "unprognostic (8.29e-3)" "unprognostic (6.22e-2)" "unprognostic (2.67e-2)" "unprognostic (6.13e-2)" "unprognostic (7.60e-2)" "unprognostic (3.65e-4)" "unprognostic (3.17e-2)" "unprognostic (3.85e-4)" "unprognostic (3.00e-2)" "unprognostic (2.79e-2)" "unprognostic (2.40e-4)" "unprognostic (2.47e-2)" 1.4 1.1 0.7 0.7 1.2 1.3 0.7 1.8 1.1 0.7 0.7 0.7 0.7 0.4 0.7 1.6 0.7 0.5 0.8 0.9 0.7 0.7 0.9 0.7 0.7 0.7 0.7 0.7 0.9 0.7 0.2 2.5 0.7 0.7 0.9 0.5 0.7 1.6 0.7 1.6 1.3 0.7 1.0 0.7 1.2 1.0 28.1 0.7 0.7 0.9 0.7 0.7 0.7 0.7 1.4 1.3 4.2 0.8 1.2 0.9 0.2 0.8 1.3 1.5 2.9 2.6 2.0 0.7 1.7 0.4 0.4 1.0 0.3 1.4 0.9 0.8 2.8 1.0 2.0 0.2 0.7 0.7 0.9 1.3 0.5 2.7 0.2 0.7 0.7 1.9 1.7 0.7 3.0 0.5 2.0 0.4 0.9 0.4 1.4 1.2 1.3 0.4 1.4 0.9 0.3 1.9 1.1 0.3 0.4 1.0 3.5 1.2 0.8 0.7 0.8 2.2 1.9 1.1 0.4 4.3 1.9 0.7 3.9 1.6 2.9 2.5 0.9 1.0 1.2 1.3 3.9 0.8 0.6 0.5 0.4 0.5 0.8 0.6 0.5 0.3 1.4 0.6 0.6 4.2 1.2 0.5 1.3 0.9 0.2 0.7 1.2 1.8 1.1 0.7 0.7 0.7 0.7 0.7 0.7 3.0 2.1 0.0 1.4 0.0 12.1 1.1 0.0 0.0 0.0 3.5 49.1 0.4 0.0 1.3 138.1 0.7 0.3 0.0 0.6 0.7 0.8 1.6 2.3 0.6 0.8 0.0 1.2 1.8 2.2 512.3 3.7 0.2 0.0 1.0 1.3 2.9 1.0 1.5 2.8 0.0 17.9 0.0 0.9 10.2 2.7 0.1 2.1 0.0 1.4 0.8 FAM76A MGC34648 ENSG00000009780 "Family with sequence similarity 76 member A" Q8TAV0 1 27725979-27763122 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 122.7;Late spermatids: 84.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044762, HPA077897" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA044762: AB_10795886, HPA077897: AB_2686867" "unprognostic (1.14e-1)" "unprognostic (1.15e-2)" "unprognostic (7.58e-2)" "unprognostic (2.07e-2)" "unprognostic (2.87e-1)" "unprognostic (2.18e-3)" "unprognostic (4.44e-3)" "unprognostic (2.18e-3)" "unprognostic (3.07e-2)" "unprognostic (1.04e-1)" "unprognostic (4.35e-3)" "unprognostic (5.22e-2)" "prognostic favorable (2.26e-4)" "unprognostic (6.32e-2)" "unprognostic (6.33e-3)" "unprognostic (2.30e-1)" "unprognostic (1.07e-2)" 22.1 8.6 10.6 12.2 17.2 14.3 14.1 17.9 18.3 14.7 12.8 17.4 8.4 10.2 15.9 16.6 13.9 13.8 15.3 13.8 11.3 11.4 13.7 13.8 13.1 11.3 9.5 16.1 14.6 14.4 11.7 19.5 12.8 14.3 12.9 16.2 15.7 12.4 16.8 39.7 15.4 12.1 17.8 11.9 12.1 13.8 28.5 10.9 13.6 18.7 17.8 13.8 14.0 14.1 13.6 14.6 13.7 12.2 12.0 16.0 6.4 8.8 7.1 8.1 8.4 10.3 9.0 14.7 8.3 8.7 12.3 12.1 8.1 11.9 16.1 5.4 9.2 11.6 11.7 10.2 9.1 9.6 8.3 7.7 5.0 10.0 9.5 8.3 7.9 7.8 9.1 9.9 13.4 13.6 6.2 6.1 8.7 9.4 15.2 8.8 8.5 18.7 7.3 12.8 8.5 7.1 11.4 9.7 9.1 9.7 12.7 11.8 5.3 9.5 10.3 9.9 10.4 7.4 3.1 6.5 14.6 6.3 16.8 5.7 13.9 15.1 13.2 9.0 10.4 6.2 10.0 12.2 13.7 14.7 12.1 15.6 12.2 15.3 14.0 10.4 13.6 14.5 16.0 8.3 12.0 12.1 14.6 11.3 6.4 10.6 17.2 17.9 18.3 11.3 11.4 9.5 16.1 14.3 10.9 26.8 17.1 25.3 8.5 16.9 27.1 13.2 7.6 26.8 9.1 22.7 25.5 23.1 18.3 9.7 122.7 11.3 8.6 23.3 8.5 9.5 13.4 4.4 10.5 15.3 10.5 27.0 4.1 20.9 15.6 84.8 15.5 14.5 37.1 7.2 9.5 20.5 8.4 8.5 35.0 12.4 35.8 19.4 17.9 20.0 49.8 23.6 38.0 17.8 8.5 3.9 FAM76B MGC33371 ENSG00000077458 "Family with sequence similarity 76 member B" Q5HYJ3 11 95768942-95790409 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 212.1;Late spermatids: 286.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036608 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" No No Nucleoplasm "Nucleoli fibrillar center" "HPA036608: AB_2675215" "unprognostic (8.17e-2)" "unprognostic (2.26e-1)" "unprognostic (8.21e-2)" "unprognostic (2.39e-2)" "unprognostic (3.12e-2)" "unprognostic (1.43e-2)" "unprognostic (2.30e-1)" "unprognostic (2.64e-2)" "unprognostic (1.01e-2)" "unprognostic (1.65e-2)" "unprognostic (1.22e-1)" "unprognostic (3.90e-3)" "prognostic unfavorable (7.17e-5)" "unprognostic (1.27e-1)" "unprognostic (1.45e-1)" "unprognostic (2.43e-1)" "prognostic favorable (2.72e-4)" 10.1 6.2 5.3 12.1 9.3 35.7 9.3 12.3 9.7 8.5 10.8 6.2 6.1 9.5 8.2 7.5 7.8 7.3 10.1 4.9 6.1 4.4 5.2 13.6 8.2 16.8 10.5 5.6 8.3 6.7 6.3 9.5 8.2 7.1 9.0 5.7 6.3 9.1 8.2 5.6 8.7 9.0 9.8 8.9 8.8 6.6 28.2 10.1 12.0 8.4 4.1 17.8 8.6 7.9 3.0 7.3 8.7 3.0 4.5 7.6 2.8 4.4 3.5 13.1 7.1 2.2 2.2 10.9 7.7 3.8 5.7 6.6 13.0 8.9 17.1 9.9 3.8 7.4 8.7 7.6 2.6 6.1 9.1 5.6 20.0 6.3 6.8 5.5 14.0 11.5 2.8 4.4 6.6 5.9 3.8 5.4 10.2 11.8 9.5 3.2 3.3 15.7 16.5 7.3 4.9 3.2 17.1 9.8 10.0 4.3 5.1 5.5 15.8 9.5 5.4 5.8 4.6 7.2 6.1 5.5 8.0 8.6 9.3 7.0 5.2 11.0 26.3 1.9 13.7 11.2 0.1 2.9 5.2 5.4 3.0 4.4 3.0 4.9 5.4 2.0 2.6 4.5 6.7 8.7 4.5 2.8 7.3 7.6 2.8 5.3 9.3 12.3 9.7 6.1 4.4 10.5 5.6 7.1 10.1 6.0 13.9 22.8 11.5 12.2 15.0 6.9 7.6 10.7 18.2 5.2 25.5 7.4 0.0 6.2 212.1 15.5 9.1 46.7 6.5 8.4 10.6 12.1 10.4 14.7 7.2 11.1 19.5 16.5 14.8 286.0 15.8 16.0 15.1 9.0 12.1 15.6 7.1 11.5 14.5 2.1 13.2 25.8 15.5 20.5 19.2 14.1 6.4 19.2 9.9 9.0 FAM78A "C9orf59, FLJ00024" ENSG00000126882 "Family with sequence similarity 78 member A" Q5JUQ0 9 131258076-131276547 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 23.7;skeletal muscle: 32.3" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 57.8;Early spermatids: 73.4;Late spermatids: 101.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 18.5;HEL: 17.4;HL-60: 17.2;NB-4: 27.2;THP-1: 24.3;U-937: 16.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA021472, HPA023914" Uncertain Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Nucleoplasm, Vesicles" "HPA021472: AB_1848411, HPA023914: AB_1848412" "unprognostic (5.16e-2)" "prognostic favorable (3.67e-4)" "unprognostic (3.65e-2)" "unprognostic (2.07e-2)" "unprognostic (2.71e-1)" "prognostic favorable (2.00e-4)" "unprognostic (3.24e-1)" "unprognostic (5.49e-2)" "unprognostic (1.46e-2)" "unprognostic (5.83e-1)" "unprognostic (5.84e-2)" "unprognostic (6.79e-2)" "unprognostic (1.59e-3)" "unprognostic (2.61e-3)" "unprognostic (7.42e-2)" "unprognostic (2.61e-2)" "unprognostic (2.39e-1)" 4.9 1.5 2.9 9.3 4.6 12.4 2.5 1.1 4.3 1.0 1.6 3.4 0.8 1.8 1.2 1.1 1.1 1.1 2.0 19.2 3.8 2.0 2.1 2.5 8.0 18.4 4.3 1.0 1.8 0.8 0.8 1.0 5.8 3.2 1.3 1.1 5.4 2.7 0.7 32.3 0.8 6.1 1.2 3.6 15.9 2.3 20.1 2.4 23.7 1.5 1.8 15.0 3.1 0.8 14.4 5.2 14.5 10.9 2.5 10.5 6.9 0.3 0.1 1.1 2.6 0.8 0.2 18.5 0.2 0.1 0.2 0.1 0.1 0.1 7.7 0.1 0.1 0.3 0.0 7.4 0.1 0.0 1.9 0.6 17.4 0.2 0.1 0.3 17.2 0.8 0.2 0.4 0.0 0.0 0.2 10.3 5.0 6.1 2.2 0.2 2.6 0.7 27.2 1.2 0.1 0.3 1.8 1.1 10.7 0.1 0.0 0.7 0.9 1.0 0.3 1.0 0.4 0.6 24.3 0.3 1.1 1.2 0.6 0.0 1.6 0.8 4.4 0.1 16.3 0.2 0.4 8.6 14.5 8.6 10.9 6.8 12.5 8.3 9.3 5.2 14.4 10.5 8.7 8.8 2.5 8.1 2.4 8.2 6.9 2.9 4.6 1.1 4.3 3.8 2.0 4.3 1.0 3.2 2.4 0.0 1.0 24.3 0.0 0.8 57.8 12.8 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.0 73.4 3.1 0.0 0.0 0.0 28.2 1.3 0.0 1.1 0.0 22.1 0.0 0.0 3.7 14.3 101.2 4.6 10.1 1.7 5.4 0.0 0.8 0.2 0.0 3.2 0.0 1.7 0.0 0.5 1.2 0.4 0.6 1.1 14.4 0.0 0.1 FAM81A MGC26690 ENSG00000157470 "Family with sequence similarity 81 member A" Q8TBF8 15 59372693-59523549 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.2" "Cell type enhanced" "Detected in many" 16 "Collecting duct cells: 29.6;Horizontal cells: 9.5;Melanocytes: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 5.5;plasmacytoid DC: 12.5" "Lineage enriched" "Detected in many" 5 "dendritic cells: 12.5" "Cell line enriched" "Detected in many" 4 "Daudi: 37.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001847, HPA065797" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA001847: AB_2666462, HPA065797: AB_2685560" "unprognostic (3.43e-3)" "unprognostic (4.47e-3)" "unprognostic (1.93e-1)" "unprognostic (1.32e-3)" "unprognostic (2.15e-1)" "unprognostic (1.30e-2)" "unprognostic (1.53e-2)" "unprognostic (1.43e-1)" "unprognostic (2.39e-1)" "unprognostic (8.90e-2)" "unprognostic (4.68e-2)" "unprognostic (2.13e-1)" "unprognostic (9.95e-3)" "unprognostic (1.08e-2)" "unprognostic (6.53e-2)" "unprognostic (3.76e-1)" "unprognostic (7.80e-2)" 1.0 0.8 13.7 3.1 14.0 0.4 1.8 1.2 32.2 8.4 5.2 3.2 0.7 3.0 3.3 5.7 1.0 7.8 2.1 1.9 16.1 8.7 8.7 0.8 1.1 5.7 5.6 17.7 1.1 2.5 0.6 3.3 1.1 3.7 3.1 6.6 1.2 3.3 2.2 0.9 1.5 1.8 1.7 4.3 1.8 3.1 2.2 1.9 0.0 2.7 0.0 6.6 0.9 1.1 2.6 12.5 0.4 0.6 0.1 0.0 0.3 5.8 8.5 0.6 0.1 0.2 0.1 3.5 0.3 0.0 0.6 1.7 1.0 1.0 37.3 0.2 0.1 8.2 4.5 4.8 1.4 1.1 0.4 2.5 0.0 5.7 0.3 0.0 3.1 0.8 0.0 0.9 0.2 0.4 0.4 0.0 1.5 0.1 0.0 0.5 2.0 0.0 0.1 0.5 1.5 3.1 0.8 8.6 0.9 1.9 2.1 1.8 0.5 3.4 0.1 5.5 0.4 1.5 1.9 0.2 1.4 4.4 1.7 6.3 0.0 0.0 0.4 1.4 1.2 3.9 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 5.5 2.6 0.0 0.0 0.4 0.1 0.0 12.5 0.0 0.3 13.7 14.0 1.2 32.2 16.1 8.7 5.6 17.7 3.7 1.9 0.0 2.2 1.9 0.9 0.5 0.0 6.2 0.0 6.7 1.2 29.6 0.0 0.1 5.0 0.4 0.4 0.6 0.7 0.0 0.2 1.1 0.4 2.1 1.1 0.0 1.1 9.5 1.2 0.0 0.3 0.4 0.3 0.7 8.5 0.0 0.9 1.0 0.3 1.9 0.0 0.1 0.1 0.0 0.9 0.1 1.3 0.4 0.0 0.0 3.7 0.9 FAM83A "BJ-TSA-9, MGC14128" ENSG00000147689 "Family with sequence similarity 83 member A" Q86UY5 8 123178960-123210079 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 44.8;lymphoid tissue: 28.6" "Cell type enhanced" "Detected in some" 14 "Pancreatic endocrine cells: 16.6;Suprabasal keratinocytes: 13.2;Urothelial cells: 19.7" "Cancer enhanced" "Detected in many" "head and neck cancer: 52.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "A-431: 24.3;HBEC3-KT: 37.9;hTCEpi: 20.3;K-562: 59.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA052615 Approved Nucleoplasm NA NA Nucleoplasm "HPA052615: AB_2797244" "unprognostic (4.48e-2)" "unprognostic (2.03e-3)" "unprognostic (1.78e-1)" "prognostic unfavorable (3.85e-4)" "unprognostic (2.49e-1)" "unprognostic (2.68e-1)" "unprognostic (8.67e-2)" "prognostic unfavorable (2.98e-9)" "unprognostic (2.62e-1)" "unprognostic (2.81e-1)" "prognostic unfavorable (4.99e-6)" "unprognostic (2.04e-1)" "unprognostic (2.22e-16)" "unprognostic (2.76e-1)" "unprognostic (1.33e-2)" "unprognostic (2.24e-1)" "unprognostic (6.07e-2)" 0.1 0.3 0.0 0.1 0.0 0.1 0.3 0.0 0.1 15.6 0.4 0.0 8.3 0.6 0.8 2.0 44.8 2.8 1.2 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.7 0.1 0.0 0.1 2.7 0.0 1.3 0.0 0.0 3.1 13.6 0.1 4.4 2.5 0.2 0.0 0.1 0.1 0.3 0.0 0.1 0.3 13.4 28.6 3.1 18.4 0.4 0.3 0.7 0.2 0.3 0.4 0.0 24.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 3.2 0.0 0.0 7.8 0.0 37.9 0.0 0.0 0.0 0.2 2.9 0.0 0.0 0.0 0.0 0.0 20.3 0.0 5.2 0.0 0.0 0.0 59.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 4.3 2.9 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.2 0.4 0.1 0.3 0.1 0.2 0.1 0.0 0.4 0.1 0.2 0.7 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 4.4 0.0 0.6 0.0 4.0 4.5 1.8 0.0 0.0 0.0 0.3 0.6 0.0 0.5 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 1.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 13.2 0.0 0.0 0.4 19.7 FAM83F ENSG00000133477 "Family with sequence similarity 83 member F" Q8NEG4 22 39994949-40043529 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 29.4;seminal vesicle: 33.3" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 31.6;Late spermatids: 52.5;Suprabasal keratinocytes: 30.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 7.1;HaCaT: 7.6;HBEC3-KT: 9.2;hTCEpi: 23.0;hTERT-HME1: 7.2;OE19: 10.3;RT4: 11.0;SCLC-21H: 24.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA051207, HPA064657" Enhanced Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA051207: AB_2681388, HPA064657: AB_2685313" "unprognostic (2.78e-2)" "unprognostic (3.91e-2)" "prognostic favorable (1.73e-4)" "unprognostic (5.36e-2)" "unprognostic (1.48e-5)" "unprognostic (1.39e-2)" "unprognostic (1.75e-1)" "unprognostic (4.75e-2)" "unprognostic (4.79e-1)" "unprognostic (2.48e-1)" "prognostic favorable (9.40e-4)" "unprognostic (3.25e-1)" "unprognostic (1.10e-7)" "unprognostic (2.93e-1)" "unprognostic (2.37e-1)" "unprognostic (2.98e-2)" "unprognostic (8.32e-2)" 1.1 0.2 0.1 2.8 0.2 0.8 4.7 0.2 0.3 2.6 6.9 0.1 29.4 3.0 0.2 7.5 15.4 1.1 4.0 1.5 0.2 0.1 4.8 2.1 1.0 0.1 0.2 0.1 0.5 14.4 2.6 2.6 0.5 0.1 6.3 3.1 0.4 7.8 33.3 0.1 13.8 12.5 0.8 0.2 0.1 5.9 24.9 0.1 1.3 12.6 12.8 8.1 3.0 4.1 0.7 0.5 2.7 0.4 0.6 0.3 0.1 4.8 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 7.1 1.4 0.0 0.0 0.0 0.0 7.6 0.0 9.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 23.0 0.0 7.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 10.3 0.0 0.0 0.0 0.0 0.1 11.0 24.3 0.0 0.2 2.0 0.0 0.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.4 0.3 0.3 0.2 0.2 0.4 0.3 0.2 0.1 0.7 0.3 0.3 2.2 0.6 0.3 0.5 0.1 0.1 0.1 0.2 0.2 0.3 0.2 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 11.8 25.4 0.5 5.1 2.5 2.7 1.2 22.7 0.0 0.1 3.3 8.6 20.7 0.8 31.6 0.0 13.2 0.1 1.6 13.1 1.1 1.0 0.2 0.0 12.6 0.0 0.8 52.5 1.7 0.9 1.7 0.0 18.3 1.0 11.4 20.1 2.1 5.0 0.7 0.0 0.8 7.2 2.2 30.2 1.1 0.0 12.7 15.2 FAM84A "FLJ35392, NSE1" ENSG00000162981 "Family with sequence similarity 84 member A" Q96KN4 2 14632686-14650814 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 34.0" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 143.9;Mucus-secreting cells: 133.7;Syncytiotrophoblasts: 173.8;Undifferentiated cells: 210.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 6.1;hTCEpi: 12.0;RT4: 31.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047703 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047703: AB_2680123" "unprognostic (1.05e-2)" "unprognostic (9.22e-2)" "unprognostic (2.24e-3)" "unprognostic (1.13e-1)" "unprognostic (4.28e-2)" "unprognostic (7.38e-2)" "unprognostic (2.62e-2)" "unprognostic (1.23e-1)" "unprognostic (1.48e-1)" "unprognostic (4.44e-2)" "unprognostic (1.20e-1)" "unprognostic (9.27e-2)" "unprognostic (3.52e-2)" "unprognostic (1.13e-1)" "unprognostic (1.58e-1)" "unprognostic (5.57e-3)" "unprognostic (1.36e-1)" 0.9 1.8 22.0 9.1 14.8 0.6 2.7 3.1 31.8 9.9 34.0 1.7 0.9 22.4 3.0 29.0 22.6 2.8 5.6 2.1 7.7 7.7 3.3 1.8 5.6 0.8 3.6 11.2 7.9 3.3 2.0 3.0 5.9 2.4 11.1 31.9 1.6 15.9 2.5 1.3 14.4 21.3 3.0 2.5 0.8 3.0 20.0 3.9 0.6 2.2 10.4 3.8 9.5 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 1.6 0.4 0.3 0.0 0.2 0.0 0.0 0.2 0.0 6.1 0.6 2.7 0.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.4 12.0 0.0 4.0 0.1 0.0 0.0 0.0 0.0 0.8 4.9 0.0 0.1 0.5 0.0 2.6 0.0 0.0 0.1 4.6 31.9 2.8 1.3 0.0 1.2 0.0 0.2 0.0 0.0 1.9 5.5 0.4 0.0 2.0 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 14.8 3.1 31.8 7.7 7.7 3.6 11.2 2.4 3.9 0.0 1.4 2.4 19.6 10.0 1.7 1.5 2.5 8.1 5.7 29.6 0.0 143.9 10.0 2.2 8.0 14.9 93.2 0.0 6.4 16.6 4.4 47.3 10.3 0.9 10.6 0.0 47.6 30.7 3.8 9.6 4.6 1.1 6.8 1.0 133.7 13.7 5.4 57.5 2.8 0.8 1.1 0.0 11.3 0.5 0.9 23.1 173.8 1.7 210.4 69.9 FAM84B "BCMP101, NSE2" ENSG00000168672 "Family with sequence similarity 84 member B" Q96KN1 8 126552442-126558393 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 62.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 21.6;AN3-CA: 31.3;MCF7: 31.6;PC-3: 21.5;SuSa: 50.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA050782, HPA062115" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA050782: AB_2681235, HPA062115: AB_2684686" "unprognostic (2.46e-3)" "unprognostic (6.37e-2)" "unprognostic (7.36e-2)" "prognostic unfavorable (9.71e-4)" "unprognostic (2.75e-3)" "unprognostic (1.54e-1)" "unprognostic (1.79e-1)" "unprognostic (4.52e-2)" "unprognostic (1.32e-1)" "unprognostic (4.49e-2)" "unprognostic (2.42e-3)" "unprognostic (1.07e-2)" "prognostic favorable (1.96e-8)" "unprognostic (2.04e-3)" "unprognostic (1.58e-1)" "unprognostic (1.18e-1)" "prognostic favorable (1.75e-5)" 8.1 3.0 6.0 6.5 8.2 2.2 20.0 8.7 6.8 10.0 8.0 10.8 11.4 10.7 10.5 11.2 20.9 7.2 16.4 4.8 7.7 5.1 23.5 10.2 10.7 4.7 13.9 3.8 3.7 13.8 9.0 5.6 7.8 11.0 7.3 7.0 18.6 33.3 13.2 2.0 7.5 6.3 4.0 6.2 2.8 14.1 2.7 10.3 1.9 8.3 5.4 8.1 6.3 11.2 1.6 0.1 2.7 0.1 1.9 5.3 1.6 21.6 2.8 1.7 31.3 0.0 0.0 2.1 0.3 0.8 0.2 0.3 0.8 13.0 0.0 14.4 0.0 2.4 9.8 0.9 4.2 0.4 0.0 18.7 0.0 0.0 0.1 0.4 0.0 0.4 0.1 6.0 0.0 2.6 5.2 1.8 5.6 0.0 0.0 0.1 31.6 0.7 0.0 1.6 18.4 21.5 0.0 0.7 0.2 12.8 9.4 8.6 0.0 0.7 10.3 9.3 50.8 15.5 0.2 0.0 0.1 2.9 0.0 0.6 0.4 0.0 0.0 0.2 1.4 5.8 2.5 0.1 2.7 2.7 0.0 2.5 0.6 3.6 5.3 0.0 1.6 3.9 4.0 0.3 1.9 0.0 0.1 4.7 1.6 6.0 8.2 8.7 5.3 7.7 5.1 13.9 3.8 11.0 10.3 11.9 29.5 3.2 9.0 14.9 1.9 5.3 15.3 4.0 13.6 40.1 62.8 4.4 6.6 23.9 0.6 22.7 7.9 0.0 11.6 1.6 8.5 16.8 0.0 20.3 1.3 52.4 26.5 22.7 4.1 1.0 0.6 2.9 33.7 0.0 16.0 31.4 26.7 10.5 0.4 32.9 6.5 0.0 3.9 0.7 0.7 15.3 2.4 5.7 17.5 22.1 FAM89A "C1orf153, MGC15887" ENSG00000182118 "Family with sequence similarity 89 member A" Q96GI7 1 231018958-231040246 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 39.6;placenta: 48.3" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 143.5;Extravillous trophoblasts: 248.1;Rod photoreceptor cells: 96.4;Syncytiotrophoblasts: 232.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 4.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 52.2;SK-MEL-30: 27.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA059052, HPA059578" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA059052: AB_2683890, HPA059578: AB_2684070" "unprognostic (7.80e-2)" "unprognostic (1.20e-1)" "unprognostic (3.58e-3)" "unprognostic (1.32e-2)" "unprognostic (2.77e-1)" "unprognostic (1.41e-2)" "unprognostic (1.98e-2)" "unprognostic (1.10e-1)" "unprognostic (8.05e-3)" "unprognostic (4.85e-1)" "unprognostic (1.54e-1)" "unprognostic (6.44e-2)" "prognostic unfavorable (1.75e-5)" "unprognostic (2.87e-2)" "unprognostic (2.03e-1)" "unprognostic (2.01e-1)" "unprognostic (9.26e-2)" 39.6 12.9 8.0 3.7 8.5 3.9 32.8 3.9 5.4 5.1 3.6 4.9 2.0 1.6 5.7 2.1 3.4 2.7 4.6 4.7 7.9 11.2 8.7 5.7 10.5 6.7 14.0 2.3 4.7 15.0 4.0 4.2 48.3 13.1 4.7 2.4 12.0 3.5 3.9 4.2 14.1 1.8 3.5 10.9 9.6 3.1 2.8 8.3 0.8 3.9 5.0 3.6 4.3 9.7 1.2 0.0 4.3 0.7 0.3 3.0 0.8 0.3 4.8 2.2 4.7 5.5 1.1 52.2 2.7 2.0 1.0 1.8 7.3 4.3 0.0 0.6 1.7 6.0 2.9 4.2 0.6 0.8 14.5 10.2 2.3 0.1 0.3 21.2 1.7 12.6 18.4 9.5 0.0 4.8 0.0 2.6 5.3 18.0 3.0 0.9 1.7 1.1 3.0 3.3 4.3 1.5 5.7 7.3 5.5 3.6 5.1 2.0 5.8 0.9 0.4 27.3 5.2 0.2 10.1 0.4 8.2 0.0 0.1 5.0 6.6 7.9 4.0 2.4 3.4 16.1 4.3 0.7 0.0 0.6 0.1 1.1 1.2 0.8 1.5 0.0 0.6 1.3 3.0 0.0 0.3 0.2 0.0 0.0 0.8 8.0 8.5 3.9 5.4 7.9 11.2 14.0 2.3 13.1 8.3 0.0 1.6 2.7 15.8 26.8 32.0 3.0 2.5 0.0 1.2 0.0 72.6 143.5 3.3 2.1 1.1 20.1 0.0 0.0 2.9 248.1 6.4 12.7 4.6 10.6 41.7 7.9 0.0 5.5 13.1 1.8 2.6 3.0 20.3 0.0 0.4 22.8 4.3 0.0 1.4 4.4 96.4 0.0 2.1 3.8 8.9 28.7 232.7 2.2 0.9 13.3 FAM90A1 FLJ10408 ENSG00000171847 "Family with sequence similarity 90 member A1" Q86YD7 12 8221260-8227618 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.8" "Cell type enhanced" "Detected in some" 15 "Cholangiocytes: 2.5;Early spermatids: 1.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 8 "classical monocyte: 1.1;myeloid DC: 2.8;plasmacytoid DC: 2.0" "Group enriched" "Detected in many" 8 "dendritic cells: 2.8;monocytes: 1.1" "Cell line enhanced" "Detected in some" "BEWO: 5.3;HDLM-2: 7.9;NTERA-2: 19.1" HPA060078 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " "unprognostic (2.10e-1)" "unprognostic (1.68e-1)" "unprognostic (5.21e-2)" "prognostic unfavorable (3.92e-4)" "unprognostic (2.69e-3)" "unprognostic (1.94e-4)" "unprognostic (4.37e-3)" "unprognostic (4.43e-2)" "unprognostic (3.93e-2)" "unprognostic (3.97e-2)" "unprognostic (2.36e-1)" "unprognostic (2.95e-1)" "unprognostic (5.30e-5)" "unprognostic (1.50e-1)" "unprognostic (5.15e-2)" "unprognostic (2.04e-1)" "unprognostic (2.06e-2)" 0.2 2.5 2.1 1.2 4.1 0.1 0.3 4.1 9.8 0.3 0.2 0.6 1.9 1.4 1.0 1.6 2.9 2.0 2.3 2.7 0.5 0.0 1.4 0.8 2.2 5.8 2.5 0.0 3.3 0.4 1.7 0.0 2.8 0.6 0.4 2.3 0.3 0.2 1.8 0.7 0.4 2.1 3.1 0.1 0.6 0.5 0.1 2.8 0.0 1.1 0.1 0.2 0.2 0.0 0.0 0.7 1.3 0.2 0.0 5.3 0.4 0.4 0.1 0.0 0.0 2.2 0.3 0.9 0.1 0.3 0.0 3.4 0.0 0.0 7.9 0.4 0.5 0.0 0.1 0.0 0.1 0.0 0.5 1.3 0.3 0.2 2.5 0.2 0.8 2.9 0.4 0.0 1.1 0.1 2.9 19.1 0.0 0.0 0.2 0.1 0.0 1.3 0.4 0.2 0.4 0.0 0.0 0.1 0.3 0.0 0.9 0.0 0.8 0.0 0.2 0.1 0.4 2.9 0.0 2.0 2.5 0.0 0.0 1.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 2.8 0.0 0.2 0.0 0.0 0.1 0.2 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.6 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.3 0.5 0.7 0.0 0.0 0.0 0.3 0.0 0.1 0.5 0.2 0.1 0.0 0.0 0.1 0.0 FAM90A26 FAM90A26P ENSG00000229924 "Family with sequence similarity 90 member A26" 4 9170409-9176730 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "hTERT-RPE1: 1.1" HPA060078 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " "unprognostic (1.80e-2)" "unprognostic (3.76e-1)" "unprognostic (1.56e-1)" "unprognostic (1.37e-2)" "unprognostic (2.32e-3)" "unprognostic (1.08e-1)" "unprognostic (5.86e-2)" "unprognostic (4.41e-1)" 0.0 0.6 0.1 0.0 0.3 0.1 0.1 0.2 1.6 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.4 0.3 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.7 0.3 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM91A1 FLJ23790 ENSG00000176853 "Family with sequence similarity 91 member A1" Q658Y4 8 123768456-123815452 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027978 Approved Approved Nucleoplasm,Microtubules NA NA "Nucleoplasm, Microtubules" "HPA027978: AB_10600004" "unprognostic (2.21e-2)" "unprognostic (6.13e-2)" "unprognostic (2.95e-2)" "unprognostic (4.56e-3)" "unprognostic (2.39e-1)" "unprognostic (3.80e-2)" "unprognostic (4.42e-3)" "unprognostic (2.59e-2)" "unprognostic (2.53e-1)" "unprognostic (8.55e-2)" "unprognostic (2.30e-2)" "unprognostic (1.16e-1)" "unprognostic (1.31e-1)" "unprognostic (1.50e-1)" "unprognostic (2.58e-1)" "unprognostic (5.40e-2)" "unprognostic (6.19e-2)" 21.9 15.3 12.2 16.1 14.3 39.1 17.3 17.2 15.2 17.3 18.7 11.8 26.7 15.3 16.4 15.5 20.0 13.6 17.3 14.6 12.6 14.4 20.0 30.6 18.4 17.9 15.4 11.6 18.8 15.4 25.2 20.3 26.9 15.6 14.0 16.3 16.1 18.0 24.2 9.2 17.1 23.0 12.8 18.4 31.3 14.4 11.9 14.0 24.4 19.8 12.0 20.0 15.3 16.2 5.7 8.9 12.0 10.4 6.6 4.3 4.2 25.6 17.3 5.5 9.4 10.4 11.3 8.7 14.9 16.2 14.2 18.1 8.5 10.6 12.1 16.7 12.2 11.4 12.6 12.7 16.1 25.3 23.0 12.3 19.0 9.1 10.2 16.3 8.7 24.7 10.6 13.0 18.4 23.1 9.7 12.7 7.7 6.7 17.2 12.7 30.2 14.9 5.7 5.3 21.2 15.6 8.1 8.9 8.9 11.9 26.4 6.5 9.1 19.7 42.6 19.8 8.3 13.1 9.2 12.8 13.5 24.4 14.9 21.6 13.5 25.8 11.7 21.2 15.7 16.4 6.9 8.3 12.0 3.8 10.4 3.4 5.7 3.8 3.2 8.9 5.0 3.3 4.3 11.4 6.6 9.1 3.5 3.3 4.2 12.2 14.3 17.2 15.2 12.6 14.4 15.4 11.6 15.6 14.0 23.8 10.4 19.1 15.9 35.1 12.6 5.6 35.7 4.0 14.8 24.4 21.6 9.7 5.0 10.6 18.5 22.5 17.3 23.3 13.5 10.2 17.4 24.8 8.1 50.5 23.8 22.3 26.4 21.5 65.1 17.5 13.0 29.0 20.3 10.0 18.8 17.4 25.8 17.5 13.8 14.7 19.9 12.9 20.8 11.2 10.5 40.8 16.0 17.5 13.3 39.9 FAM96A "CIA2A, FLJ22875" ENSG00000166797 "Family with sequence similarity 96 member A" Q9H5X1 15 64072559-64094018 "Predicted intracellular proteins" "Chromosome partition" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 89.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040459, HPA063729" Approved Enhanced Nucleoplasm,Cytosol "Intracellular and membrane" No No "Nucleoplasm, Cytosol" "HPA040459: AB_10796456, HPA063729: AB_2685105" "unprognostic (1.15e-1)" "unprognostic (8.49e-2)" "unprognostic (6.59e-2)" "unprognostic (3.58e-1)" "unprognostic (1.30e-1)" "unprognostic (8.07e-2)" "unprognostic (4.06e-3)" "unprognostic (5.02e-2)" "unprognostic (7.16e-2)" "unprognostic (5.87e-2)" "unprognostic (1.04e-1)" "unprognostic (6.48e-3)" "unprognostic (8.06e-3)" "unprognostic (1.81e-1)" "unprognostic (2.58e-1)" "unprognostic (2.11e-2)" "unprognostic (1.50e-2)" 13.6 32.3 11.2 19.1 12.8 17.0 13.9 9.0 10.3 8.5 24.3 13.6 17.7 31.3 8.1 14.9 13.6 8.3 14.0 20.6 11.2 10.8 39.4 89.7 18.1 22.7 15.2 8.0 7.8 27.0 10.6 15.4 25.2 11.2 17.2 20.2 10.7 16.5 15.7 28.2 7.6 45.5 6.4 14.9 25.2 17.9 8.9 13.8 20.5 30.1 18.3 19.3 14.6 9.0 51.8 63.7 23.7 48.6 11.8 21.3 38.2 19.9 29.3 17.9 11.2 15.2 18.7 11.8 15.7 17.5 21.0 22.3 28.9 32.3 33.2 27.7 9.9 27.9 22.1 35.0 15.4 17.9 27.1 18.9 27.0 26.5 27.1 12.0 43.7 23.4 14.7 15.5 13.6 12.2 14.3 21.2 18.7 36.9 25.7 14.8 33.8 16.6 37.9 26.0 24.9 15.6 26.8 23.7 73.5 27.1 23.5 19.2 14.5 12.5 28.6 30.4 20.8 21.0 45.8 12.7 16.7 23.7 19.0 33.8 24.9 58.7 29.8 20.2 79.2 15.8 16.2 48.6 16.9 10.1 44.1 12.4 51.8 15.3 13.5 42.6 48.8 12.3 11.6 23.7 11.8 36.7 63.7 21.3 38.2 11.2 12.8 9.0 10.3 11.2 10.8 15.2 8.0 11.2 13.8 35.7 30.8 96.4 18.3 15.9 7.2 70.8 79.0 45.5 40.9 33.2 3.9 101.5 140.9 70.9 2.4 23.8 94.1 0.0 74.8 83.9 35.7 38.2 19.7 217.6 196.6 14.3 55.4 41.1 140.8 3.6 15.3 99.6 40.5 211.0 97.7 14.5 84.6 87.7 7.8 151.8 6.7 12.9 23.7 21.4 49.8 19.2 74.3 58.6 129.3 21.4 FAM96B "CGI-128, CIA2B, MIP18" ENSG00000166595 "Family with sequence similarity 96 member B" Q9Y3D0 16 66932055-66934423 "Predicted intracellular proteins" "Chromosome partition" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041501, HPA041736" Supported Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041501: AB_10795123, HPA041736: AB_10793932" "unprognostic (2.49e-1)" "unprognostic (3.79e-2)" "unprognostic (8.06e-2)" "unprognostic (5.42e-3)" "unprognostic (3.93e-2)" "unprognostic (4.91e-2)" "unprognostic (4.98e-2)" "unprognostic (8.49e-2)" "unprognostic (1.19e-1)" "unprognostic (1.83e-2)" "unprognostic (1.18e-1)" "unprognostic (8.96e-2)" "unprognostic (5.10e-2)" "unprognostic (1.50e-1)" "unprognostic (9.84e-2)" "unprognostic (6.48e-2)" "unprognostic (1.12e-2)" 22.5 34.2 38.7 26.5 38.2 17.7 31.9 26.8 34.5 19.6 28.8 30.3 19.8 26.3 20.4 27.5 43.5 28.6 25.0 58.0 36.7 33.6 41.6 57.8 27.4 30.6 39.4 27.4 29.5 38.3 23.2 30.0 27.3 30.7 22.0 25.6 16.6 21.9 22.2 89.6 14.2 29.4 22.3 41.4 25.3 24.3 32.2 28.5 24.1 41.2 40.8 25.3 25.7 37.0 51.8 92.7 46.3 52.7 40.7 61.2 44.8 25.6 58.3 19.8 24.8 25.0 23.8 24.1 23.5 26.4 36.1 45.4 61.4 29.9 23.3 30.6 27.7 31.2 34.1 28.3 28.4 25.8 28.9 39.9 14.2 17.3 71.6 47.7 21.0 56.7 23.4 27.6 42.6 37.4 27.5 24.4 41.8 23.8 15.6 29.2 49.4 35.6 50.6 26.4 22.1 70.9 30.5 21.2 44.8 53.4 23.2 34.9 39.0 50.5 13.7 35.6 16.0 15.0 35.0 20.6 27.1 32.2 15.2 32.6 34.3 27.4 59.2 48.1 21.8 35.2 41.5 47.0 46.3 43.2 51.2 42.3 51.8 46.3 46.9 51.7 44.4 37.3 41.5 23.0 40.7 52.7 92.7 61.2 44.8 38.7 38.2 26.8 34.5 36.7 33.6 39.4 27.4 30.7 28.5 74.5 131.2 134.8 130.5 127.4 54.2 121.8 109.5 168.6 113.7 165.7 21.6 175.4 261.9 198.2 44.5 121.5 197.1 23.3 125.1 149.7 134.5 169.2 157.1 149.9 179.2 31.8 148.2 106.2 88.6 19.0 101.5 151.1 155.3 184.9 122.5 115.3 214.6 139.8 101.1 426.3 53.3 155.2 140.2 112.5 201.2 146.8 207.9 152.4 157.1 199.3 FAM98B FLJ38426 ENSG00000171262 "Family with sequence similarity 98 member B" Q52LJ0 15 38454127-38487710 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008320, HPA008502" Enhanced Supported Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA008320: AB_1848419, HPA008502: AB_1848420" "unprognostic (1.05e-2)" "unprognostic (3.13e-1)" "unprognostic (1.15e-1)" "unprognostic (1.00e-2)" "unprognostic (1.54e-2)" "unprognostic (3.09e-2)" "unprognostic (9.25e-3)" "unprognostic (1.74e-1)" "unprognostic (4.69e-2)" "unprognostic (2.18e-1)" "unprognostic (3.15e-1)" "unprognostic (3.15e-2)" "unprognostic (1.51e-2)" "unprognostic (2.26e-1)" "unprognostic (4.36e-2)" "unprognostic (1.94e-1)" "unprognostic (1.13e-1)" 15.6 15.6 20.4 16.9 21.0 10.8 17.0 27.3 24.4 13.7 19.3 12.7 8.7 12.5 17.9 12.9 14.9 14.5 11.0 15.8 20.1 19.6 17.7 10.1 10.6 16.3 18.6 20.3 15.6 10.6 27.5 18.3 20.1 17.7 16.5 15.7 9.3 11.2 14.2 16.2 11.5 12.8 17.4 21.0 13.8 12.0 13.0 14.0 27.4 15.7 12.3 16.8 14.8 13.4 3.5 2.5 3.7 1.1 3.8 6.6 0.7 13.8 7.4 36.5 18.6 6.8 12.5 17.8 17.8 13.0 17.6 17.8 16.3 6.7 9.5 19.7 14.7 17.9 14.7 22.0 18.2 24.8 9.8 11.9 28.2 17.0 12.5 9.8 26.7 16.3 11.5 11.4 15.7 18.3 13.0 18.0 21.2 20.2 12.0 16.8 6.2 22.5 14.3 19.6 15.8 10.3 24.0 19.7 8.0 15.2 18.3 22.5 23.1 19.6 12.6 8.5 17.1 15.4 16.5 15.0 20.1 24.5 13.3 19.9 22.5 20.1 34.8 11.0 17.7 20.8 3.7 0.9 2.5 5.3 0.8 4.6 2.8 5.4 4.4 1.1 3.5 6.6 5.1 0.8 3.8 1.1 2.5 3.3 0.7 20.4 21.0 27.3 24.4 20.1 19.6 18.6 20.3 17.7 14.0 14.9 18.4 13.2 9.5 13.1 35.6 45.7 15.3 22.7 21.6 15.7 15.7 27.3 6.6 14.9 2.3 13.7 9.3 0.0 17.1 17.8 11.1 9.8 12.7 9.4 10.9 19.1 12.1 14.7 14.2 1.7 11.5 11.9 5.0 22.6 19.3 14.8 12.6 5.8 15.9 11.3 27.6 6.5 10.0 28.6 14.6 12.9 18.0 14.9 17.3 12.3 FAM98C FLJ44669 ENSG00000130244 "Family with sequence similarity 98 member C" Q17RN3 19 38403135-38409088 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040930, HPA041730" Approved Approved Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "HPA040930: AB_10795484, HPA041730: AB_10804114" "unprognostic (3.01e-2)" "unprognostic (6.44e-3)" "unprognostic (5.15e-2)" "unprognostic (1.94e-1)" "unprognostic (3.18e-1)" "unprognostic (8.10e-3)" "unprognostic (3.06e-1)" "unprognostic (2.15e-2)" "unprognostic (2.95e-1)" "prognostic unfavorable (8.51e-5)" "unprognostic (2.82e-2)" "unprognostic (8.91e-3)" "unprognostic (1.01e-1)" "unprognostic (2.37e-3)" "unprognostic (2.43e-1)" "unprognostic (2.96e-1)" "prognostic favorable (5.53e-4)" 10.8 8.9 18.3 9.3 16.9 11.0 9.8 17.0 19.9 8.7 14.2 12.8 9.0 19.6 9.9 7.2 14.3 13.8 9.1 11.6 16.0 13.1 9.1 13.4 8.7 9.5 12.3 16.9 10.2 22.4 10.6 8.1 7.6 13.0 12.5 7.0 8.2 17.7 9.5 2.5 17.0 22.2 6.8 12.7 10.1 19.2 5.4 9.7 5.3 11.8 7.7 11.2 9.4 9.5 6.0 3.2 12.6 3.4 3.3 5.6 1.6 10.9 11.9 1.4 6.9 1.5 5.2 6.1 6.4 5.4 6.3 6.7 2.0 8.0 10.0 7.2 3.7 2.2 5.3 2.7 4.6 1.0 16.1 5.6 3.2 2.0 4.6 6.8 2.8 6.0 5.0 9.6 3.2 5.8 3.5 3.7 16.4 9.0 11.0 3.7 12.1 4.0 2.1 1.0 18.2 12.8 8.3 2.9 5.9 7.7 5.8 2.4 7.1 6.4 11.4 3.8 0.7 8.6 8.7 4.8 2.8 7.8 8.8 7.6 11.9 6.0 4.2 7.4 6.5 4.5 0.0 2.3 12.6 3.1 3.3 4.2 2.6 5.6 4.6 3.2 6.0 4.3 3.4 2.0 3.3 3.4 1.2 4.4 1.6 18.3 16.9 17.0 19.9 16.0 13.1 12.3 16.9 13.0 9.7 8.9 9.9 17.1 21.7 19.2 13.2 4.3 10.2 6.7 5.7 22.7 11.8 10.3 18.3 17.4 5.0 9.3 43.8 0.0 28.7 9.4 10.0 14.8 15.0 11.9 9.9 11.1 24.6 10.4 10.5 2.1 17.3 14.7 21.9 12.6 32.7 11.1 19.7 34.5 17.3 15.9 11.6 12.9 11.4 27.3 41.1 26.1 5.1 20.3 33.5 22.0 FAM9B TEX39B ENSG00000177138 "Family with sequence similarity 9 member B" Q8IZU0 X 9024232-9164639 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 3.4;liver: 3.7;testis: 11.4" "Group enriched" "Detected in some" 7 "Spermatocytes: 32.2;Spermatogonia: 62.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 3.4" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.4" "Group enriched" "Detected in some" 49 "U-266/70: 21.2;U-266/84: 22.8" HPA035135 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA035135: AB_10669999" "unprognostic (3.95e-1)" "unprognostic (4.49e-1)" "unprognostic (3.76e-2)" "unprognostic (1.28e-1)" "unprognostic (1.48e-1)" "unprognostic (1.40e-2)" "unprognostic (2.62e-1)" "unprognostic (6.08e-10)" "unprognostic (4.08e-1)" "unprognostic (1.21e-1)" "unprognostic (1.54e-2)" 0.1 0.1 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.2 0.1 2.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.1 0.0 0.6 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.2 0.5 0.5 0.1 0.0 1.1 0.2 11.4 0.1 0.0 0.2 0.6 0.8 0.7 3.4 0.7 0.7 0.4 0.4 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 21.2 22.8 0.1 0.0 0.1 0.0 1.0 0.7 0.4 0.3 0.3 0.3 0.5 0.4 0.3 0.2 0.8 0.4 0.4 3.4 0.7 0.4 0.7 0.3 0.4 0.0 0.6 0.0 0.2 0.2 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 3.9 0.2 1.6 0.0 0.6 0.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 6.5 0.3 32.2 62.0 0.3 0.0 0.0 0.0 0.1 FAN1 "KIAA1018, MTMR15" ENSG00000198690 "FANCD2 and FANCI associated nuclease 1" Q9Y2M0 15 30903852-30943108 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Endonuclease, Exonuclease, Hydrolase, Nuclease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048198 Supported "Nucleoplasm,Cytokinetic bridge,Cytosol" NA NA Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA048198: AB_2680311" "unprognostic (7.18e-3)" "unprognostic (5.63e-2)" "unprognostic (1.96e-1)" "unprognostic (3.30e-2)" "unprognostic (6.99e-2)" "unprognostic (2.86e-1)" "unprognostic (1.97e-1)" "unprognostic (1.19e-1)" "unprognostic (5.94e-2)" "unprognostic (3.53e-2)" "unprognostic (3.53e-2)" "unprognostic (9.67e-2)" "prognostic favorable (1.42e-6)" "unprognostic (3.73e-1)" "unprognostic (1.19e-1)" "unprognostic (8.93e-3)" "unprognostic (1.29e-1)" 5.9 8.9 11.6 6.9 17.4 6.3 12.7 19.6 18.4 15.0 11.4 17.7 11.9 4.6 11.6 22.9 6.5 8.5 8.5 13.0 12.6 11.0 14.7 14.4 6.9 5.5 18.5 11.8 12.5 18.2 7.2 17.0 10.6 15.4 16.4 9.7 8.6 17.3 8.3 16.8 9.3 6.7 11.5 13.0 7.3 8.5 9.4 15.0 5.1 14.3 6.3 5.8 9.0 9.1 4.0 3.6 0.6 1.7 4.5 5.4 1.6 6.3 10.9 3.6 2.0 12.9 11.5 2.4 4.5 1.9 4.8 5.0 7.5 3.3 1.4 8.0 4.8 10.0 12.9 6.1 9.4 4.7 5.1 2.9 1.1 11.2 1.3 5.6 0.9 6.1 3.4 7.0 2.9 7.6 10.4 2.3 6.6 5.4 10.0 7.8 1.4 9.9 4.4 2.8 10.2 2.5 8.4 11.8 2.7 7.0 5.0 8.3 5.8 9.9 6.8 3.5 13.6 6.1 7.6 8.2 15.0 3.6 4.1 5.7 13.8 9.6 1.7 6.5 4.8 1.3 0.1 0.8 0.6 3.7 1.3 4.7 2.8 3.5 1.7 2.7 4.0 5.4 2.8 0.3 4.5 1.7 3.6 3.2 1.6 11.6 17.4 19.6 18.4 12.6 11.0 18.5 11.8 15.4 15.0 14.9 9.6 0.8 4.9 3.7 20.0 15.7 0.0 16.0 13.6 8.7 19.6 5.5 8.3 3.3 8.7 6.7 3.8 0.0 2.5 1.8 3.5 4.6 8.1 11.0 3.2 25.4 7.5 8.0 4.1 5.8 9.8 4.1 5.0 2.8 9.7 14.7 3.3 2.9 6.3 5.1 24.3 6.5 4.2 19.5 12.9 2.0 3.4 6.9 8.3 3.1 FANCA "FA-H, FAA, FACA, FAH, FANCH" ENSG00000187741 "Fanconi anemia complementation group A" O15360 16 89737549-89816657 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.6;testis: 28.8" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 23.3;Spermatocytes: 22.3;Spermatogonia: 33.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA063236 Supported Nucleoplasm NA Yes Nucleoplasm "HPA063236: AB_2684966" "unprognostic (5.99e-2)" "unprognostic (5.68e-2)" "unprognostic (2.36e-1)" "unprognostic (5.12e-2)" "unprognostic (1.87e-1)" "unprognostic (7.11e-2)" "unprognostic (1.45e-4)" "unprognostic (9.21e-2)" "unprognostic (1.58e-2)" "unprognostic (2.05e-1)" "unprognostic (4.82e-3)" "unprognostic (8.48e-4)" "unprognostic (7.82e-10)" "unprognostic (3.67e-2)" "unprognostic (2.05e-1)" "unprognostic (2.94e-1)" "unprognostic (1.62e-1)" 2.1 2.0 2.2 16.5 3.7 17.1 1.7 5.7 6.6 1.7 5.1 1.1 0.6 5.0 1.7 3.1 6.6 1.9 1.6 1.7 1.8 1.4 2.1 5.8 3.3 11.1 1.3 2.7 1.6 1.8 2.3 1.9 11.2 2.4 1.7 6.3 1.5 2.2 0.5 0.7 5.0 5.4 2.0 1.6 6.9 3.5 28.8 0.8 20.6 1.7 4.6 17.6 2.9 2.5 7.4 6.5 9.9 9.2 7.5 9.5 4.2 9.3 14.4 17.3 15.1 1.1 2.2 13.2 11.7 6.4 19.8 8.3 12.6 15.6 23.1 5.5 4.0 6.6 14.5 11.6 8.7 20.9 5.4 19.5 6.8 18.5 25.8 0.7 6.9 7.5 0.7 0.9 16.0 5.1 2.8 6.2 11.7 16.3 7.1 10.3 21.7 13.8 30.0 11.2 12.9 9.0 25.2 13.9 4.2 4.9 8.9 15.5 8.4 17.5 5.2 2.2 10.4 9.4 12.5 4.6 15.9 16.8 8.8 12.2 6.4 7.5 22.9 7.5 15.5 15.1 2.6 7.9 9.9 4.7 8.8 3.3 7.4 2.8 4.1 6.5 5.5 0.7 3.0 9.8 7.5 9.2 0.4 9.5 4.2 2.2 3.7 5.7 6.6 1.8 1.4 1.3 2.7 2.4 0.8 0.0 0.6 13.1 1.4 3.1 8.8 1.6 0.0 1.4 3.4 15.7 9.8 10.9 1.7 1.6 5.3 0.8 2.0 23.3 1.4 7.5 1.3 0.5 2.3 4.0 7.7 3.2 1.7 7.4 4.3 3.5 1.4 6.3 0.0 0.0 6.1 1.4 1.5 0.0 0.0 6.8 7.2 0.0 1.0 22.3 33.2 1.6 21.2 3.2 6.3 2.1 FANCC "FA3, FAC, FACC" ENSG00000158169 "Fanconi anemia complementation group C" Q00597 9 95099054-95426796 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 29.7" "Group enriched" "Detected in many" 5 "Early spermatids: 190.4;Late spermatids: 63.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 10.4" "Lineage enriched" "Detected in many" 6 "granulocytes: 10.4" "Cell line enhanced" "Detected in all" "RH-30: 31.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017793, HPA030771" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB017793: , HPA030771: AB_2673604" "unprognostic (1.48e-2)" "unprognostic (4.33e-2)" "unprognostic (1.10e-1)" "unprognostic (2.63e-1)" "unprognostic (2.14e-1)" "unprognostic (1.32e-2)" "unprognostic (3.41e-3)" "unprognostic (1.26e-2)" "unprognostic (7.45e-3)" "unprognostic (1.37e-1)" "unprognostic (8.00e-3)" "unprognostic (3.19e-2)" "prognostic favorable (6.03e-6)" "unprognostic (2.35e-2)" "unprognostic (1.82e-1)" "unprognostic (1.49e-1)" "unprognostic (5.71e-2)" 4.9 2.7 4.3 8.6 7.0 3.6 4.6 29.7 7.7 4.6 6.4 4.9 5.1 7.1 6.3 4.1 4.5 3.6 5.2 3.2 4.0 2.7 10.0 25.7 6.7 3.7 7.3 1.6 3.3 5.4 2.9 12.1 4.3 6.7 4.4 6.1 4.0 4.0 4.2 4.5 7.7 8.1 2.9 6.4 3.4 4.4 19.6 7.3 7.9 4.3 3.2 6.0 3.5 4.0 1.0 1.3 10.4 1.7 0.3 1.5 0.7 13.6 9.2 12.2 10.6 1.2 3.2 7.7 5.9 3.9 9.5 8.8 10.5 5.8 7.8 4.2 4.3 7.3 16.7 12.3 5.2 5.2 7.4 5.8 6.1 10.4 5.4 2.0 6.1 6.8 2.7 2.2 7.6 3.4 2.6 5.2 7.6 9.1 3.4 6.8 9.6 5.7 3.5 5.8 14.5 5.2 12.2 31.5 3.6 3.9 3.5 17.7 9.4 11.3 4.0 3.4 6.4 4.2 5.1 2.5 8.3 12.2 9.1 8.4 3.6 6.6 4.1 4.5 5.6 9.8 10.4 0.4 0.0 1.3 0.8 1.3 1.0 0.7 1.5 0.4 1.0 1.2 1.0 0.1 0.3 1.7 1.3 1.3 0.7 4.3 7.0 29.7 7.7 4.0 2.7 7.3 1.6 6.7 7.3 3.0 2.1 0.0 2.3 2.3 5.4 1.6 5.1 1.4 3.4 0.0 3.9 2.3 1.7 4.1 190.4 4.3 3.3 0.0 3.6 4.0 2.0 2.5 5.7 25.1 1.8 9.5 0.0 4.3 2.7 63.3 6.1 1.3 1.7 3.6 4.5 2.6 3.4 0.0 2.1 7.7 4.2 0.0 1.6 13.0 10.6 2.4 1.9 1.0 3.8 2.5 FANCD2 "FA-D2, FACD, FAD, FANCD" ENSG00000144554 "Fanconi anemia complementation group D2" Q9BXW9 3 10026414-10101930 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 24.4;testis: 23.3" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 46.7;Spermatocytes: 55.1;Spermatogonia: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 46.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB016117, HPA063742" Approved Supported "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" No No Nucleoplasm "Nucleoli, Nuclear bodies, Cytosol" "CAB016117: AB_2278211, HPA063742: AB_2685110" "unprognostic (3.25e-2)" "unprognostic (1.09e-1)" "unprognostic (6.21e-2)" "unprognostic (1.12e-2)" "unprognostic (2.92e-1)" "unprognostic (3.36e-2)" "unprognostic (1.08e-5)" "unprognostic (2.96e-2)" "unprognostic (1.59e-3)" "prognostic unfavorable (5.00e-5)" "unprognostic (1.23e-2)" "unprognostic (9.14e-2)" "unprognostic (4.41e-10)" "unprognostic (9.11e-3)" "unprognostic (3.99e-1)" "unprognostic (7.76e-2)" "unprognostic (2.89e-2)" 2.0 1.3 0.8 10.3 2.6 12.2 2.4 1.6 2.7 1.7 2.9 1.1 1.0 2.2 2.2 1.8 4.7 2.4 2.5 1.1 0.8 0.9 2.3 1.0 2.4 9.5 1.3 1.2 3.5 3.5 0.6 1.1 5.3 1.4 2.2 4.9 1.6 3.3 0.4 3.0 3.3 6.2 1.2 2.0 7.3 2.4 23.3 1.6 24.4 1.6 5.6 14.6 2.2 2.4 6.8 3.7 5.3 2.6 2.1 2.9 1.0 8.7 9.3 17.8 5.0 0.9 1.4 46.0 8.0 3.6 11.5 9.4 6.9 8.7 17.1 3.8 2.6 9.5 7.6 18.3 6.2 11.5 8.1 12.4 23.3 14.3 6.6 0.1 17.3 14.6 0.4 1.0 13.0 7.2 1.6 6.9 14.7 14.2 19.6 8.7 10.0 14.4 6.7 21.4 6.7 6.5 15.8 14.5 12.1 4.0 9.8 4.9 9.8 9.8 7.7 3.1 13.5 11.8 11.0 4.0 9.6 11.0 5.8 11.6 8.3 16.3 28.9 5.5 17.8 16.3 5.3 1.4 3.7 1.5 1.0 1.3 4.9 2.0 1.2 0.9 6.8 2.5 1.9 3.3 2.1 2.6 3.7 2.9 1.0 0.8 2.6 1.6 2.7 0.8 0.9 1.3 1.2 1.4 1.6 0.0 0.3 9.7 2.8 4.0 2.8 1.6 0.0 1.4 1.2 1.8 9.8 6.6 0.0 1.6 4.4 1.5 0.7 46.7 2.9 12.7 1.3 2.2 1.1 1.0 5.0 0.0 1.2 3.7 3.4 5.6 2.0 5.2 3.3 7.2 2.0 0.8 1.4 2.8 1.4 0.5 5.8 19.4 0.8 55.1 32.4 2.4 5.8 3.8 5.0 2.3 FANCE "FACE, FAE" ENSG00000112039 "Fanconi anemia complementation group E" Q9HB96 6 35452361-35467103 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 18 "Extravillous trophoblasts: 82.2;Syncytiotrophoblasts: 39.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" CAB014893 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB014893: " "unprognostic (2.66e-1)" "unprognostic (8.01e-3)" "unprognostic (7.73e-2)" "prognostic unfavorable (6.25e-4)" "unprognostic (1.99e-1)" "unprognostic (2.80e-3)" "prognostic unfavorable (2.08e-9)" "unprognostic (8.90e-2)" "unprognostic (5.70e-3)" "unprognostic (8.41e-2)" "unprognostic (1.52e-1)" "unprognostic (2.91e-2)" "unprognostic (1.28e-1)" "unprognostic (1.70e-1)" "unprognostic (3.05e-1)" "unprognostic (2.44e-2)" "unprognostic (5.14e-2)" 7.2 2.1 2.6 7.0 3.8 7.2 8.5 5.5 3.9 6.7 4.1 4.8 1.5 3.1 6.1 4.7 10.0 4.9 5.4 4.1 2.8 3.2 2.4 1.7 5.5 5.4 2.4 1.8 10.8 6.9 2.7 4.0 21.3 3.9 6.7 4.1 3.7 5.3 4.0 20.8 16.8 4.7 4.1 3.7 4.6 3.8 12.1 3.5 3.0 5.9 10.1 8.5 6.7 15.0 2.4 1.8 1.0 1.0 2.6 3.6 0.9 5.7 2.8 7.9 17.6 5.7 10.2 21.1 6.9 5.9 9.1 7.9 6.7 3.3 19.6 4.6 4.3 6.9 4.3 8.8 5.9 8.8 6.6 7.6 13.7 6.9 4.3 3.1 8.0 5.6 6.4 17.8 11.1 17.1 2.4 5.3 7.6 12.6 7.3 7.6 6.7 3.7 10.0 3.2 6.2 4.5 11.1 7.5 7.4 2.0 6.3 7.8 7.3 4.0 5.6 6.2 7.6 5.5 26.3 3.2 11.0 9.2 7.0 10.8 4.9 16.9 7.1 2.4 14.8 10.3 0.7 1.0 1.0 2.2 0.6 3.0 0.7 2.8 3.6 0.6 2.4 1.9 1.9 0.6 2.6 0.6 1.8 1.7 0.9 2.6 3.8 5.5 3.9 2.8 3.2 2.4 1.8 3.9 3.5 6.0 0.0 0.8 3.9 7.8 0.5 1.7 0.0 0.0 1.2 0.0 0.0 17.8 0.0 1.2 0.2 2.5 0.9 0.0 0.7 82.2 3.8 2.4 0.0 0.0 5.2 0.0 1.2 1.8 1.2 0.0 1.4 1.3 1.7 0.0 2.9 1.5 1.0 0.0 0.7 0.2 1.7 0.0 2.5 6.9 10.4 6.1 39.0 1.0 3.3 2.7 FANCF FAF ENSG00000183161 "Fanconi anemia complementation group F" Q9NPI8 11 22622519-22626787 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Cancer-related genes, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 15.2" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 123.7" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA008899 Supported Nucleoplasm NA NA Nucleoplasm "HPA008899: " "unprognostic (1.16e-2)" "unprognostic (4.10e-2)" "unprognostic (2.33e-2)" "unprognostic (1.37e-2)" "unprognostic (4.55e-2)" "unprognostic (8.84e-2)" "prognostic unfavorable (2.27e-4)" "unprognostic (4.29e-2)" "unprognostic (1.11e-1)" "unprognostic (2.74e-3)" "unprognostic (3.95e-1)" "unprognostic (1.67e-1)" "unprognostic (2.29e-1)" "unprognostic (3.73e-2)" "unprognostic (1.81e-1)" "unprognostic (9.14e-2)" "unprognostic (7.64e-3)" 1.2 4.1 2.9 3.1 2.8 1.1 3.2 1.0 2.7 3.1 3.4 5.3 3.0 6.0 3.0 6.1 1.7 1.9 2.9 3.9 3.2 4.2 1.8 4.9 3.3 4.2 9.0 3.4 4.5 1.5 2.9 3.7 3.8 3.1 0.4 3.1 4.9 1.1 3.5 5.4 4.6 4.3 3.6 4.8 2.6 2.0 15.2 9.7 11.5 5.7 10.0 15.1 7.3 1.4 4.3 5.6 6.1 2.9 3.5 2.3 2.8 3.3 3.2 3.5 2.8 2.2 7.1 0.7 2.8 5.8 6.1 4.5 4.6 1.6 11.6 2.1 2.7 1.7 4.9 3.4 4.9 2.9 3.3 8.9 1.1 4.9 5.5 5.0 10.3 6.8 9.3 2.0 4.5 12.5 4.6 6.4 12.0 5.4 10.8 2.6 8.0 6.0 5.6 20.9 9.8 1.5 4.9 4.8 6.2 9.9 4.5 3.6 3.3 3.5 5.9 3.9 5.4 6.9 2.1 5.4 2.0 7.6 5.7 5.4 11.5 11.5 5.5 13.5 11.8 10.8 10.8 6.4 15.2 15.1 12.4 0.8 10.0 5.7 9.7 7.3 7.3 3.0 2.1 10.5 5.3 3.0 15.7 4.4 10.2 22.7 2.3 3.5 9.8 9.4 38.1 15.4 123.7 4.7 9.6 0.0 16.2 7.1 3.8 3.9 2.3 8.1 6.0 15.9 3.4 1.8 5.9 13.7 8.9 5.3 5.0 9.0 16.2 11.8 10.5 10.5 9.2 15.4 17.2 6.5 3.1 21.0 15.8 1.9 1.9 11.4 15.5 2.3 FANCI "FLJ10719, KIAA1794" ENSG00000140525 "Fanconi anemia complementation group I" Q9NVI1 15 89243949-89317261 "Disease related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" DNA-binding "Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 44.4;testis: 28.3" "Cell type enhanced" "Detected in many" 11 "Erythroid cells: 46.7;Spermatocytes: 45.0;Spermatogonia: 68.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039972, HPA040379" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA039972: AB_10673265, HPA040379: AB_2676951" "unprognostic (6.88e-2)" "unprognostic (1.37e-2)" "unprognostic (1.66e-1)" "unprognostic (2.50e-2)" "unprognostic (2.99e-1)" "unprognostic (2.64e-2)" "prognostic unfavorable (1.11e-4)" "unprognostic (6.82e-3)" "unprognostic (1.15e-2)" "unprognostic (4.59e-3)" "prognostic unfavorable (3.59e-4)" "unprognostic (1.04e-1)" "prognostic unfavorable (2.71e-13)" "unprognostic (2.40e-2)" "unprognostic (2.72e-1)" "unprognostic (1.27e-1)" "unprognostic (2.12e-1)" 3.7 3.2 1.7 11.1 3.3 16.5 3.3 1.8 5.6 3.8 5.9 3.0 2.7 3.3 3.3 3.3 10.7 2.1 1.8 2.8 2.5 1.5 2.4 2.0 3.5 13.4 5.0 2.6 3.1 2.3 1.8 1.5 7.1 2.9 2.8 7.6 2.3 4.0 1.7 1.3 5.4 4.9 3.8 2.8 6.7 4.6 28.3 3.2 44.4 1.7 9.2 15.4 3.9 4.6 3.8 3.9 17.7 3.8 4.6 10.6 3.0 24.5 28.2 30.2 20.3 2.7 3.9 18.7 23.6 13.6 29.6 36.2 22.3 22.4 45.5 12.8 7.8 18.9 33.7 46.1 16.0 27.9 29.0 28.8 45.1 41.5 10.4 0.4 32.5 23.0 2.1 1.6 20.8 10.6 4.3 12.0 28.1 31.1 33.6 19.7 14.0 33.9 11.2 23.7 16.1 10.4 29.5 44.0 19.5 6.8 45.4 22.5 19.3 24.4 17.3 11.0 21.3 19.1 14.8 8.2 24.6 25.1 22.5 35.8 22.3 46.3 35.1 9.2 29.0 24.6 17.7 2.4 2.8 5.2 3.0 2.9 3.5 5.0 6.8 2.1 3.8 4.1 6.0 3.7 4.6 3.8 3.9 10.6 3.0 1.7 3.3 1.8 5.6 2.5 1.5 5.0 2.6 2.9 3.2 3.0 1.0 3.7 1.8 3.8 2.1 2.7 0.0 8.1 4.5 1.8 0.0 8.3 0.0 1.7 5.9 1.6 1.3 46.7 2.5 15.5 2.7 1.4 2.3 0.8 6.8 1.6 1.2 9.2 3.1 5.3 3.1 4.3 1.7 3.6 4.5 9.5 2.2 0.0 1.4 1.0 1.7 6.5 1.9 45.0 68.0 2.0 10.4 5.2 4.4 1.7 FANCM "FAAP250, KIAA1596" ENSG00000187790 "Fanconi anemia complementation group M" Q8IYD8 14 45135940-45200890 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 55.9;Late spermatids: 151.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055144 Supported Nucleoplasm NA NA Nucleoplasm "HPA055144: AB_2682715" "unprognostic (8.40e-2)" "unprognostic (6.70e-2)" "unprognostic (3.99e-2)" "unprognostic (4.32e-2)" "unprognostic (2.15e-1)" "unprognostic (2.31e-3)" "unprognostic (2.66e-2)" "unprognostic (1.18e-1)" "unprognostic (1.57e-2)" "unprognostic (8.52e-2)" "unprognostic (1.14e-1)" "unprognostic (1.23e-2)" "unprognostic (7.55e-2)" "unprognostic (2.90e-1)" "unprognostic (1.71e-1)" "unprognostic (8.94e-2)" "unprognostic (1.13e-2)" 4.7 3.9 3.9 4.4 8.4 9.8 5.7 8.2 7.9 5.7 3.5 4.9 4.9 2.6 6.7 4.8 4.5 4.2 3.7 3.8 3.4 3.3 4.1 3.1 3.3 6.6 3.2 3.6 6.2 3.3 4.5 4.5 4.4 9.3 3.5 3.8 4.8 4.1 4.8 4.2 5.2 3.5 3.8 3.4 8.9 3.2 15.4 4.2 15.2 3.3 2.9 6.4 3.8 4.3 6.7 3.2 7.6 3.6 2.0 4.1 1.1 7.8 6.8 8.1 7.5 6.4 4.0 6.5 10.3 4.0 8.1 10.5 11.0 6.0 10.3 5.9 2.4 4.6 10.6 9.5 4.4 11.1 7.5 5.2 4.7 7.7 6.0 1.2 12.3 6.1 2.3 1.6 8.1 5.1 1.8 6.9 6.7 8.5 9.1 6.7 7.8 9.0 8.8 3.2 6.0 11.5 8.4 12.6 4.7 3.3 5.6 7.4 1.9 9.1 7.5 3.8 5.4 8.0 5.7 5.4 11.8 11.1 10.8 7.7 4.6 8.3 10.3 2.3 7.6 7.0 7.6 1.3 4.6 4.0 3.6 2.2 6.7 2.5 1.5 1.0 4.2 4.1 3.5 2.1 2.0 1.7 3.2 1.7 1.1 3.9 8.4 8.2 7.9 3.4 3.3 3.2 3.6 9.3 4.2 0.0 1.9 1.5 1.2 2.4 5.2 6.7 2.5 0.0 3.4 1.8 2.0 6.7 0.0 1.6 55.9 2.7 1.0 0.0 2.3 2.8 2.3 0.8 1.1 1.7 3.0 3.2 0.0 5.5 3.7 151.5 8.3 2.7 3.3 4.6 1.6 4.4 1.5 0.0 4.9 1.5 6.1 6.5 4.1 23.6 14.4 1.6 1.9 3.3 2.6 0.3 FANK1 ENSG00000203780 "Fibronectin type III and ankyrin repeat domains 1" Q8TC84 10 125896539-126009592 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.3;fallopian tube: 24.7;testis: 44.7" "Group enriched" "Detected in many" 5 "Ciliated cells: 171.3;Early spermatids: 463.3;Late spermatids: 423.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 14 "T-reg: 28.3" "Lineage enriched" "Detected in single" 284 "T-cells: 28.3" "Cell line enhanced" "Detected in many" "CAPAN-2: 16.7;hTCEpi: 8.6;hTERT-RPE1: 11.4;RPTEC TERT1: 11.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038413 Supported Nucleoplasm NA NA Nucleoplasm "HPA038413: AB_10697249" "unprognostic (4.25e-2)" "unprognostic (4.63e-2)" "unprognostic (1.80e-1)" "prognostic favorable (3.83e-4)" "unprognostic (1.17e-3)" "unprognostic (4.02e-2)" "unprognostic (6.29e-2)" "unprognostic (1.44e-1)" "unprognostic (3.12e-3)" "unprognostic (5.72e-2)" "unprognostic (2.09e-1)" "unprognostic (3.42e-2)" "unprognostic (9.53e-3)" "unprognostic (2.84e-2)" "unprognostic (1.17e-2)" "unprognostic (1.10e-2)" "unprognostic (1.44e-1)" 0.5 2.4 4.1 1.3 8.3 0.7 3.4 0.8 1.8 2.5 2.2 4.0 3.8 1.6 2.3 18.5 2.2 24.7 4.9 0.5 4.9 6.4 4.5 0.1 4.0 0.8 2.7 1.3 5.6 3.1 2.3 7.8 2.0 14.1 1.5 3.3 2.0 1.5 2.9 0.2 3.9 1.9 1.3 2.1 0.3 3.5 44.7 2.4 0.4 5.8 1.1 1.7 1.7 1.4 0.0 0.0 0.0 0.0 0.0 28.3 0.1 6.0 2.1 0.5 3.5 2.7 2.7 3.9 2.4 1.7 0.6 0.5 0.1 16.7 0.0 0.4 1.7 0.9 8.1 0.0 2.9 0.5 0.2 0.1 0.0 0.7 0.0 1.0 0.3 0.6 0.8 8.6 2.3 0.8 11.4 0.9 0.0 0.3 0.0 1.0 5.1 0.0 1.2 0.4 5.5 0.2 0.0 0.2 0.5 11.9 1.7 0.4 1.8 1.8 3.9 0.4 6.7 0.6 0.3 0.8 1.2 2.0 1.6 0.1 0.0 0.3 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.3 0.1 4.1 8.3 0.8 1.8 4.9 6.4 2.7 1.3 14.1 2.4 11.9 4.6 0.0 3.4 4.5 1.5 0.4 2.5 171.3 28.4 12.2 31.4 1.9 11.6 9.8 463.3 2.1 2.0 0.0 7.7 4.4 1.3 3.6 3.5 0.0 0.8 3.2 0.0 1.8 0.3 423.7 3.4 2.2 1.7 0.0 13.0 5.8 9.3 6.8 4.2 6.7 9.5 0.0 1.0 66.4 16.4 3.0 4.2 1.3 4.1 3.3 FARSB "FARSLB, FRSB, PheHB" ENSG00000116120 "Phenylalanyl-tRNA synthetase beta subunit" Q9NSD9 2 222570536-222656337 "Enzymes, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036677, HPA036678, HPA061398" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036677: AB_2675242, HPA036678: AB_10673504, HPA061398: AB_2684504" "unprognostic (9.95e-3)" "unprognostic (1.86e-3)" "unprognostic (7.02e-2)" "unprognostic (7.42e-3)" "unprognostic (1.90e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (6.45e-10)" "unprognostic (8.89e-3)" "unprognostic (4.51e-2)" "unprognostic (3.63e-2)" "unprognostic (5.25e-3)" "unprognostic (6.25e-2)" "prognostic unfavorable (3.21e-5)" "unprognostic (1.36e-1)" "unprognostic (4.38e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (1.25e-4)" 15.7 10.8 11.9 12.6 23.5 11.5 16.0 15.1 28.5 11.6 17.3 13.7 5.9 15.9 14.2 11.7 19.1 10.8 7.2 13.4 13.7 15.1 11.7 18.3 9.0 12.0 11.6 18.0 16.7 18.6 15.0 15.7 8.8 29.4 11.2 20.7 9.6 12.3 11.5 33.2 14.1 11.5 14.9 9.7 10.3 13.9 15.6 11.2 15.6 11.9 17.1 14.2 11.8 12.0 16.3 16.0 1.2 11.4 18.5 20.0 14.6 22.2 13.1 15.3 20.0 14.0 20.1 23.6 22.7 14.4 22.5 18.4 33.2 12.3 10.9 17.3 16.6 18.7 18.8 29.4 25.5 33.1 16.3 15.2 25.1 14.8 21.1 21.8 36.5 10.4 13.4 20.0 25.6 39.4 8.0 21.2 19.3 37.7 22.6 27.3 20.8 21.8 20.7 19.5 26.9 16.4 21.5 36.8 35.4 18.4 14.6 24.8 8.1 9.5 16.7 19.6 19.5 15.5 15.4 11.5 19.3 15.9 27.6 27.4 10.8 10.8 39.9 15.0 24.6 20.1 0.2 8.5 1.2 11.4 10.3 16.8 16.3 15.4 14.0 16.0 14.0 20.0 17.2 0.9 18.5 11.4 8.0 13.3 14.6 11.9 23.5 15.1 28.5 13.7 15.1 11.6 18.0 29.4 11.2 6.0 5.4 20.0 16.1 11.0 15.1 26.0 2.5 16.0 10.3 21.0 3.9 30.6 29.9 19.9 43.7 9.9 12.3 0.0 26.1 35.9 12.8 11.4 4.7 16.2 24.6 3.2 20.1 7.4 9.7 57.3 14.1 10.8 6.8 9.0 19.0 9.8 18.6 7.0 18.7 20.7 17.1 6.5 16.5 59.3 37.3 12.4 18.5 13.3 40.3 12.0 FASTKD3 "FLJ23274, MGC5297" ENSG00000124279 "FAST kinase domains 3" Q14CZ7 5 7859159-7869037 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA068525, HPA074462" Approved Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA068525: AB_2685999, HPA074462: AB_2686692" "unprognostic (5.27e-2)" "unprognostic (1.28e-2)" "unprognostic (1.03e-1)" "unprognostic (1.61e-2)" "unprognostic (1.20e-1)" "unprognostic (5.41e-3)" "prognostic unfavorable (1.87e-5)" "unprognostic (6.66e-3)" "unprognostic (4.56e-3)" "unprognostic (3.19e-2)" "unprognostic (1.61e-2)" "unprognostic (5.82e-3)" "unprognostic (5.68e-3)" "unprognostic (1.58e-2)" "unprognostic (1.46e-1)" "unprognostic (1.19e-1)" "prognostic favorable (8.53e-4)" 7.1 15.5 8.6 9.7 13.3 7.6 12.3 9.1 15.0 8.3 10.7 8.6 7.9 10.4 8.8 10.2 8.9 7.5 6.5 7.2 8.7 7.3 17.8 14.5 8.3 10.0 9.2 13.7 9.3 8.4 13.0 10.8 6.4 8.0 8.6 13.5 8.1 11.1 15.8 10.2 9.0 12.1 7.8 8.8 12.0 9.1 6.0 7.4 12.2 8.9 7.4 12.2 9.1 7.0 9.6 6.7 7.4 7.3 4.8 10.3 4.7 7.1 6.3 6.2 8.0 3.9 4.9 12.1 6.0 5.2 9.5 7.3 9.4 7.7 24.9 12.2 6.3 12.1 7.6 15.1 8.4 13.5 6.8 7.8 8.6 20.6 7.4 5.3 14.2 7.2 5.6 3.6 8.8 5.5 4.3 5.2 10.2 11.8 4.4 7.1 5.1 9.5 8.3 5.6 7.5 9.0 11.1 7.6 5.7 7.7 7.7 4.3 4.1 18.1 8.0 8.8 5.8 7.2 6.6 3.5 9.4 9.6 9.7 9.9 5.1 4.8 15.9 6.2 13.2 7.6 3.8 5.4 7.4 6.1 7.3 8.2 9.6 9.4 6.5 6.7 6.8 10.3 9.7 0.2 4.8 5.7 3.8 10.2 4.7 8.6 13.3 9.1 15.0 8.7 7.3 9.2 13.7 8.0 7.4 14.9 5.1 5.2 1.9 2.3 2.9 3.6 7.6 5.3 0.0 0.0 0.0 6.3 5.0 7.2 0.4 4.3 8.0 0.0 10.3 7.0 4.6 2.3 3.5 9.9 7.3 4.8 6.9 4.9 7.0 0.4 4.9 5.8 1.7 14.4 6.2 3.5 9.3 3.5 4.2 14.9 5.1 0.0 5.1 3.4 5.4 4.8 3.5 6.9 6.6 1.6 FAXC "C6orf168, dJ273F20, MGC2817" ENSG00000146267 "Failed axon connections homolog" Q5TGI0 6 99271169-99350062 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 23.8;Alveolar cells type 2: 17.5;Bipolar cells: 12.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 16.2;HAP1: 14.5;SCLC-21H: 21.3;SH-SY5Y: 14.8;SK-MEL-30: 13.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039106 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA039106: AB_10697546" "unprognostic (8.03e-2)" "unprognostic (4.91e-2)" "unprognostic (5.04e-3)" "unprognostic (6.44e-2)" "unprognostic (3.80e-1)" "unprognostic (5.00e-3)" "unprognostic (7.56e-2)" "unprognostic (7.29e-2)" "unprognostic (7.08e-2)" "unprognostic (1.34e-2)" "unprognostic (2.79e-3)" "unprognostic (2.47e-3)" "unprognostic (6.70e-4)" "unprognostic (1.13e-2)" "unprognostic (1.71e-1)" "unprognostic (4.86e-2)" "unprognostic (3.49e-3)" 0.7 3.3 9.4 2.1 12.2 0.4 4.6 11.0 19.7 1.8 13.3 1.8 5.1 2.3 4.5 15.3 8.6 2.4 3.5 1.3 7.7 10.3 2.5 0.3 2.3 0.4 9.1 9.9 3.4 2.2 9.3 10.4 1.4 7.5 10.1 4.3 1.4 5.8 15.1 0.9 0.4 2.1 19.1 4.8 0.8 5.2 2.8 1.6 0.0 2.0 0.2 0.5 13.6 1.7 1.2 0.6 1.4 0.6 0.8 0.4 0.0 2.3 1.9 6.4 8.8 0.0 0.0 2.3 3.0 1.9 5.0 4.4 1.1 0.7 0.0 0.3 0.6 16.2 0.1 14.5 2.8 4.4 0.0 7.2 0.0 1.2 0.4 0.4 0.0 0.0 0.3 4.6 0.1 2.3 3.7 0.0 1.2 0.3 0.0 1.6 4.1 0.0 0.0 7.5 0.0 2.9 0.0 0.6 0.0 2.7 0.1 21.3 14.8 2.7 2.0 13.0 2.7 6.1 0.0 0.6 1.6 2.9 0.0 9.2 0.0 0.0 0.0 0.1 0.0 11.9 0.8 0.6 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.2 1.2 0.3 0.4 1.4 0.8 0.3 0.6 0.2 0.0 9.4 12.2 11.0 17.4 7.7 10.3 9.1 9.9 7.5 1.6 23.8 17.5 0.0 3.4 0.3 12.6 0.8 0.0 2.7 10.3 1.8 9.8 0.8 8.3 1.7 2.1 0.6 0.0 0.0 0.6 0.1 0.4 4.1 3.5 0.0 0.2 3.2 0.0 1.3 0.8 3.6 0.0 0.4 1.7 0.0 0.2 3.1 1.3 0.0 1.8 0.8 11.6 0.0 0.7 0.9 9.0 0.3 0.2 0.0 0.2 1.0 FBLL1 LOC345630 ENSG00000188573 "Fibrillarin like 1" A6NHQ2 5 168529116-168530634 "Predicted intracellular proteins" "rRNA processing" "Methyltransferase, Ribonucleoprotein, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.9" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 8.1;Cone photoreceptor cells: 5.9;Horizontal cells: 6.4;Intestinal endocrine cells: 6.4;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "SCLC-21H: 19.4;SH-SY5Y: 16.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049546, HPA077724" Uncertain Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA049546: AB_2680811, HPA077724: " "unprognostic (2.75e-3)" "unprognostic (2.37e-2)" "unprognostic (1.06e-1)" "unprognostic (1.91e-1)" "unprognostic (1.26e-1)" "unprognostic (1.22e-1)" "unprognostic (1.87e-2)" "unprognostic (1.43e-1)" "unprognostic (4.41e-2)" "unprognostic (2.45e-1)" "unprognostic (3.80e-3)" "unprognostic (9.69e-2)" "unprognostic (6.55e-3)" "unprognostic (3.15e-1)" "unprognostic (6.18e-2)" "unprognostic (8.32e-2)" "unprognostic (1.22e-1)" 0.8 6.2 10.3 0.9 12.1 0.7 1.1 10.6 24.9 1.0 0.9 0.9 0.0 1.4 0.8 0.8 0.8 1.4 1.1 1.3 11.0 18.4 1.1 0.9 0.9 0.7 9.7 8.5 1.2 2.1 1.8 7.4 1.0 7.9 1.4 0.9 0.5 1.4 1.3 0.9 1.5 1.6 1.1 3.0 0.8 1.4 5.1 1.7 0.0 0.8 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 1.4 0.2 0.1 0.0 0.9 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.7 0.0 0.1 0.1 0.4 0.0 1.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 16.1 1.6 0.0 0.9 0.0 0.0 1.2 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 12.1 10.6 16.9 11.0 18.4 9.7 8.5 7.9 1.7 0.0 0.0 0.0 0.0 0.1 8.1 1.2 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.2 0.1 0.4 0.2 0.0 0.0 0.1 6.4 6.4 0.0 0.0 1.6 0.0 0.0 3.3 0.0 0.1 0.5 0.3 0.0 0.0 0.0 2.6 6.5 0.0 2.3 0.2 0.1 0.0 0.0 0.2 0.0 FBN2 "CCA, DA9" ENSG00000138829 "Fibrillin 2" P35556 5 128257909-128659185 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "placenta: 175.9" "Group enriched" "Detected in many" 7 "Cytotrophoblasts: 251.0;Syncytiotrophoblasts: 136.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 2.5;non-classical monocyte: 5.0" "Lineage enriched" "Detected in many" 5 "monocytes: 5.0" "Cell line enhanced" "Detected in many" "HHSteC: 38.0;HSkMC: 27.1;hTERT-HME1: 59.9;HUVEC TERT2: 33.7" "Region enhanced" "Detected in single" "olfactory region: 2.6" "Low region specificity" "Detected in some" "HPA012853, CAB026401" Enhanced Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" NA NA 4600000 Cytosol Nucleoplasm "CAB026401: , HPA012853: AB_1848588" "unprognostic (2.49e-1)" "unprognostic (1.14e-1)" "unprognostic (7.29e-3)" "unprognostic (1.79e-3)" "unprognostic (6.74e-2)" "unprognostic (2.33e-1)" "unprognostic (4.92e-3)" "unprognostic (9.41e-2)" "unprognostic (1.06e-2)" "unprognostic (4.66e-1)" "unprognostic (1.12e-1)" "unprognostic (8.69e-2)" "unprognostic (8.60e-5)" "unprognostic (1.04e-2)" "unprognostic (3.19e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (7.41e-5)" 0.3 7.9 0.3 1.0 0.3 1.6 0.1 0.2 0.3 1.5 0.7 0.4 1.0 0.2 2.9 0.6 1.1 0.6 0.2 6.7 0.2 0.5 0.2 0.2 0.2 1.3 0.2 0.4 0.9 0.1 0.0 1.3 175.9 0.4 1.0 0.8 6.2 0.4 0.9 0.2 0.3 0.5 0.8 0.4 0.6 0.5 4.6 0.2 0.3 0.9 0.4 0.7 0.4 1.2 0.0 1.1 0.6 5.0 0.0 0.0 0.4 0.0 4.5 16.4 0.0 2.7 4.7 3.4 17.9 0.0 15.9 11.9 0.0 0.0 0.0 0.0 23.9 0.0 2.7 10.6 2.7 14.9 0.0 4.2 0.0 7.5 0.0 38.0 2.3 0.0 27.1 1.4 6.7 59.9 5.1 33.7 0.0 0.0 0.0 9.8 0.0 0.0 0.9 7.1 0.0 5.4 5.1 5.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 14.0 0.0 5.0 0.0 6.4 12.2 18.3 0.0 0.0 0.0 0.0 1.9 0.0 6.7 0.0 2.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.6 0.0 5.0 0.0 0.0 0.4 0.3 0.3 0.2 0.3 0.2 0.5 0.2 0.4 0.4 0.2 0.0 0.3 0.0 0.1 0.0 0.0 11.3 0.0 0.0 2.3 0.0 0.0 251.0 0.0 0.0 2.7 0.4 0.0 0.0 0.0 27.7 3.3 1.5 0.0 0.0 29.6 0.0 0.0 0.0 12.9 5.3 1.1 1.8 1.7 0.0 0.0 3.1 0.1 0.0 2.1 0.0 0.0 6.5 0.2 12.7 3.8 0.4 136.7 0.0 0.0 0.1 FBRS "FBS, FBS1, FLJ11618" ENSG00000156860 Fibrosin Q9HAH7 16 30658431-30670814 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 79.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044117 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA044117: AB_10794394" "unprognostic (1.87e-1)" "unprognostic (8.48e-3)" "unprognostic (2.41e-2)" "unprognostic (9.52e-3)" "unprognostic (1.03e-1)" "unprognostic (4.80e-2)" "unprognostic (2.07e-3)" "unprognostic (7.01e-3)" "unprognostic (6.32e-2)" "unprognostic (7.65e-2)" "unprognostic (4.57e-3)" "unprognostic (1.01e-1)" "unprognostic (1.25e-2)" "unprognostic (2.13e-1)" "unprognostic (4.16e-1)" "unprognostic (1.42e-1)" "unprognostic (1.63e-1)" 13.4 13.0 14.2 19.8 15.4 41.0 9.9 22.6 16.4 12.1 13.6 18.5 12.2 18.3 15.5 8.7 21.5 14.7 10.8 9.4 16.7 8.2 13.1 12.9 13.6 17.1 20.0 10.5 14.3 14.6 16.5 23.8 23.6 13.8 14.6 6.0 13.1 17.5 18.5 16.8 21.3 19.0 10.0 13.0 21.7 13.6 52.9 19.3 22.7 14.8 8.1 19.7 13.8 12.3 2.3 2.9 5.6 2.9 1.2 2.8 2.5 12.4 13.3 7.0 5.8 7.1 7.2 17.9 9.3 7.6 8.0 6.0 7.8 11.5 11.7 15.5 7.5 7.2 10.4 7.4 8.8 3.8 31.4 18.6 15.7 12.4 14.2 17.4 11.4 23.8 10.7 12.0 15.5 7.6 9.0 9.8 10.9 13.6 22.6 5.8 25.6 14.4 22.3 2.0 5.6 8.5 21.0 5.3 12.7 8.4 9.3 9.9 11.1 7.3 14.0 9.8 3.2 31.6 15.1 15.2 18.3 11.2 11.3 12.1 26.6 12.8 11.2 17.6 11.2 10.7 0.0 2.9 2.3 2.4 1.2 2.3 1.9 2.0 2.3 1.5 2.3 0.6 2.8 5.6 1.2 1.7 2.9 0.2 2.5 14.2 15.4 22.6 16.4 16.7 8.2 20.0 10.5 13.8 19.3 14.9 27.4 15.9 13.0 16.7 19.3 7.5 10.2 12.0 4.5 7.0 31.4 7.8 5.0 9.2 62.2 11.7 30.0 0.0 12.8 7.8 12.1 15.9 18.5 7.3 12.3 41.3 16.1 22.1 14.8 79.8 15.8 15.8 10.1 18.0 19.3 13.0 15.7 24.5 15.2 7.2 24.1 0.0 10.3 63.0 21.5 21.2 27.6 17.5 15.3 20.7 FBRSL1 KIAA1545 ENSG00000112787 "Fibrosin like 1" Q9HCM7 12 132489551-132585188 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 34.7" "Low region specificity" "Detected in all" HPA049880 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA049880: AB_2680930" "unprognostic (2.02e-1)" "unprognostic (6.67e-2)" "unprognostic (1.88e-2)" "unprognostic (7.75e-2)" "unprognostic (3.21e-1)" "unprognostic (2.59e-2)" "unprognostic (1.29e-1)" "unprognostic (1.83e-1)" "unprognostic (2.25e-1)" "unprognostic (1.57e-1)" "unprognostic (2.77e-3)" "prognostic unfavorable (9.82e-4)" "prognostic favorable (1.17e-4)" "unprognostic (1.13e-1)" "unprognostic (3.39e-1)" "unprognostic (1.09e-2)" "prognostic favorable (7.21e-4)" 7.6 4.7 4.3 4.9 6.6 5.2 3.2 13.0 9.9 3.4 4.9 2.9 2.9 7.0 4.8 4.6 4.5 4.7 9.6 4.4 4.8 3.1 4.3 5.2 4.2 4.5 9.8 5.5 5.1 12.7 3.9 7.9 4.5 4.5 5.4 1.8 5.0 9.7 4.4 17.9 4.7 7.3 2.9 2.9 10.9 6.1 6.1 4.5 8.0 4.0 2.9 8.6 4.5 3.2 2.8 3.6 4.1 2.0 0.7 1.9 0.9 4.6 7.5 3.4 6.0 1.4 1.8 26.1 4.4 1.1 2.8 1.7 13.6 2.7 7.0 7.7 1.3 2.5 8.7 3.6 2.2 0.9 6.1 18.5 9.0 4.3 10.3 3.0 9.4 9.8 1.6 4.2 2.8 1.9 2.5 2.7 6.0 19.5 1.6 1.2 11.9 12.2 34.7 9.4 3.1 13.2 19.3 3.9 4.9 2.3 4.3 13.9 10.7 4.2 6.6 5.3 1.5 7.2 9.7 4.3 3.1 8.0 5.8 5.5 9.5 4.9 4.6 3.5 9.5 3.9 2.3 1.5 4.1 1.2 1.3 1.3 2.8 1.2 1.2 1.2 2.6 1.1 1.6 1.7 0.7 2.0 3.6 1.9 0.9 4.3 6.6 13.0 9.9 4.8 3.1 9.8 5.5 4.5 4.5 3.0 6.9 0.8 5.2 8.1 22.6 11.3 5.1 5.3 3.4 10.4 39.3 5.8 6.6 5.3 1.3 6.2 15.4 23.3 6.5 4.7 5.2 12.1 1.1 16.3 5.8 11.1 29.7 8.6 12.1 0.4 15.0 8.0 5.0 4.6 19.2 8.6 8.3 15.9 14.5 4.9 22.2 6.5 5.1 6.3 6.1 9.2 9.6 5.7 17.7 7.6 FBXL14 "Fbl14, MGC40195" ENSG00000171823 "F-box and leucine rich repeat protein 14" Q8N1E6 12 1565993-1594165 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Early spermatids: 38.0;Late spermatids: 69.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 30.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053889 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA053889: AB_2682293" "unprognostic (8.67e-2)" "unprognostic (2.89e-2)" "unprognostic (2.82e-1)" "unprognostic (4.00e-1)" "unprognostic (2.66e-1)" "unprognostic (1.85e-1)" "unprognostic (1.22e-1)" "unprognostic (3.06e-3)" "unprognostic (3.77e-1)" "unprognostic (1.27e-1)" "unprognostic (5.90e-2)" "unprognostic (8.98e-2)" "prognostic favorable (9.04e-6)" "unprognostic (5.60e-3)" "unprognostic (1.76e-1)" "unprognostic (9.99e-2)" "unprognostic (3.12e-3)" 6.0 6.0 12.5 8.1 13.0 7.4 4.9 10.2 15.8 5.9 11.7 9.3 4.2 7.3 5.1 3.4 7.2 9.2 7.5 5.7 11.4 9.3 5.4 4.8 6.2 10.4 9.7 7.2 6.8 17.4 9.9 11.3 6.2 7.9 5.2 5.3 6.2 8.2 6.8 3.4 3.6 8.0 3.7 10.5 8.9 14.1 20.1 9.9 21.2 9.4 1.8 6.2 6.3 19.4 3.8 0.6 2.2 0.5 2.4 4.6 0.5 7.8 11.5 3.4 6.0 3.0 3.1 10.1 1.8 3.3 1.7 1.9 12.1 10.4 10.8 2.1 2.0 2.9 5.5 2.8 4.2 0.3 17.8 13.1 13.3 3.3 3.8 3.9 10.0 9.8 4.8 2.0 3.2 2.7 3.1 3.0 9.4 5.4 30.9 2.1 8.6 10.0 5.0 14.3 4.5 4.8 8.8 5.5 6.8 2.8 7.3 6.5 6.4 4.3 6.8 6.7 3.7 5.2 8.4 4.2 3.9 11.9 4.8 6.3 3.6 3.9 13.4 8.2 6.0 5.8 2.2 0.5 0.0 0.4 0.4 0.4 0.9 1.4 1.5 0.6 3.8 1.5 0.7 1.1 2.4 0.5 0.6 4.6 0.5 12.5 13.0 10.2 15.8 11.4 9.3 9.7 7.2 7.9 9.9 0.0 0.0 0.0 0.4 0.0 3.9 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 38.0 1.0 0.7 0.0 0.5 0.1 0.3 0.6 0.0 0.9 0.6 9.5 0.0 3.1 0.3 69.2 0.3 0.4 0.0 1.0 0.7 2.7 0.2 0.0 1.4 0.6 2.9 0.0 0.0 1.2 0.2 0.0 0.1 0.0 1.1 0.2 FBXL17 "DKFZP434C1715, Fbl17, Fbx13, FBXO13" ENSG00000145743 "F-box and leucine rich repeat protein 17" Q9UF56 5 107859035-108382098 "Predicted intracellular proteins, Predicted membrane proteins" "Neurogenesis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036410, HPA036411" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA036410: AB_2675109, HPA036411: AB_10669603" "unprognostic (8.15e-2)" "unprognostic (3.77e-2)" "unprognostic (2.18e-2)" "unprognostic (1.21e-1)" "unprognostic (4.58e-2)" "unprognostic (2.72e-2)" "unprognostic (2.08e-2)" "unprognostic (2.65e-1)" "unprognostic (6.67e-2)" "unprognostic (3.08e-2)" "unprognostic (5.98e-2)" "unprognostic (6.30e-2)" "prognostic favorable (4.60e-8)" "unprognostic (1.86e-1)" "unprognostic (3.34e-1)" "prognostic unfavorable (3.27e-4)" "unprognostic (3.35e-2)" 13.7 13.8 22.2 7.8 27.4 5.4 13.3 18.0 27.4 11.5 9.8 7.9 12.0 10.3 10.1 9.3 12.0 9.3 10.4 25.1 18.5 19.0 16.8 13.6 9.8 12.0 16.8 17.1 9.7 9.8 27.5 12.5 6.1 11.7 12.0 10.5 12.4 9.6 14.4 46.1 9.6 10.5 11.6 12.3 10.4 9.6 8.2 8.9 16.8 23.8 9.7 10.0 10.8 9.0 2.0 1.9 3.3 1.3 1.0 2.3 0.5 6.5 6.5 7.5 13.7 12.6 13.3 5.0 8.0 18.1 6.6 9.0 1.3 13.9 7.3 12.7 12.9 10.2 2.9 6.0 9.2 10.3 7.3 5.4 6.9 7.6 3.2 6.6 4.6 8.0 9.5 13.8 6.1 4.5 12.9 7.8 3.0 1.0 9.5 14.4 4.9 4.0 5.9 1.0 5.0 6.1 5.7 10.1 9.4 9.2 9.1 6.5 11.1 10.4 9.3 9.8 5.5 7.3 11.1 8.4 15.0 4.7 4.6 10.3 7.5 10.4 5.5 13.3 7.1 9.7 0.4 0.9 3.3 2.1 1.3 2.2 1.1 1.9 2.3 1.1 2.0 2.0 1.6 1.7 1.0 0.7 1.9 1.3 0.5 22.2 27.4 18.0 27.4 18.5 19.0 16.8 17.1 11.7 8.9 17.9 16.4 11.5 6.7 14.9 34.9 31.5 10.2 2.7 6.8 27.9 53.0 3.9 14.9 5.4 3.7 11.2 14.7 0.0 11.2 5.4 7.7 10.1 16.1 18.4 7.4 28.6 28.7 21.5 18.4 2.9 13.0 9.7 15.1 1.0 24.2 19.3 10.7 17.3 15.6 11.2 49.7 0.0 7.8 8.6 4.3 21.5 3.8 12.1 14.3 7.0 FBXL18 "Fbl18, FLJ11467" ENSG00000155034 "F-box and leucine rich repeat protein 18" Q96ME1 7 5431335-5513798 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036049 Approved Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA036049: AB_2674918" "unprognostic (2.86e-3)" "prognostic unfavorable (7.88e-4)" "unprognostic (1.26e-2)" "unprognostic (8.73e-3)" "unprognostic (1.72e-2)" "unprognostic (3.70e-1)" "unprognostic (3.98e-4)" "unprognostic (1.50e-2)" "unprognostic (2.74e-1)" "unprognostic (1.51e-3)" "unprognostic (1.04e-2)" "unprognostic (3.69e-1)" "unprognostic (8.28e-4)" "unprognostic (1.46e-1)" "unprognostic (1.64e-1)" "unprognostic (7.30e-4)" "unprognostic (1.73e-3)" 6.4 6.2 11.0 7.2 15.0 8.5 3.7 10.8 17.7 3.0 4.6 8.1 4.3 5.6 5.1 3.4 6.1 4.4 3.3 5.0 10.2 8.0 4.3 3.6 4.4 5.7 6.6 12.3 4.3 8.0 6.2 4.8 4.2 7.6 5.0 3.2 5.6 5.3 3.8 10.8 10.2 5.0 4.3 5.4 5.4 4.6 5.7 7.7 4.3 4.8 2.8 5.6 4.8 3.2 3.4 2.5 8.9 4.0 3.9 2.7 1.8 9.3 12.3 3.5 7.5 3.2 3.4 6.1 5.6 2.9 3.5 3.7 9.3 6.0 4.3 6.8 2.7 6.6 14.8 4.1 9.8 2.6 3.3 5.1 2.2 9.3 3.0 2.4 4.8 3.6 2.8 5.3 5.4 2.6 2.6 4.1 2.7 6.8 3.8 2.4 9.8 2.5 3.0 11.3 3.3 10.2 6.3 6.8 2.3 2.2 4.9 7.6 10.6 8.7 14.8 2.9 4.5 14.5 2.9 9.5 11.5 16.5 8.4 8.5 5.1 6.3 3.3 5.9 5.9 13.6 7.9 3.5 1.3 2.7 3.2 2.7 2.1 1.7 2.5 2.5 3.4 1.9 2.4 8.9 3.9 4.0 2.5 2.0 1.8 11.0 15.0 10.8 17.7 10.2 8.0 6.6 12.3 7.6 7.7 6.0 4.5 0.8 1.7 2.3 8.8 3.9 2.5 2.7 7.9 0.0 3.9 3.2 0.0 1.8 1.1 1.6 2.6 0.0 2.1 2.5 2.3 1.3 2.3 1.7 1.3 1.6 4.6 1.8 3.2 0.0 1.4 2.2 0.0 2.8 1.9 4.8 1.7 2.6 0.7 1.0 6.4 0.0 1.4 2.6 5.1 2.9 1.8 2.9 3.8 1.6 FBXL19 "CXXC11, DKFZp434K0410, Fbl19, JHDM1C" ENSG00000099364 "F-box and leucine rich repeat protein 19" Q6PCT2 16 30923055-30948783 "Predicted intracellular proteins" "Ubl conjugation pathway" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074250 Approved Nucleoplasm NA No Nucleoplasm "HPA074250: " "unprognostic (1.37e-1)" "prognostic unfavorable (3.27e-4)" "unprognostic (1.03e-1)" "unprognostic (3.80e-2)" "unprognostic (1.40e-1)" "unprognostic (2.20e-1)" "prognostic unfavorable (3.54e-4)" "unprognostic (3.61e-2)" "unprognostic (2.52e-1)" "unprognostic (2.89e-1)" "unprognostic (1.48e-1)" "unprognostic (6.95e-3)" "unprognostic (1.37e-3)" "unprognostic (6.02e-2)" "unprognostic (1.60e-1)" "unprognostic (2.45e-2)" "unprognostic (2.38e-2)" 5.5 6.7 17.4 9.8 15.3 8.3 3.8 13.2 23.5 6.8 9.6 3.4 9.5 11.2 7.5 4.4 10.5 6.0 9.4 4.9 17.6 10.5 6.1 3.1 5.8 9.8 9.6 11.6 6.9 6.6 11.0 8.3 11.2 9.5 6.9 4.1 5.2 8.4 7.1 4.5 12.7 9.8 6.2 4.8 9.9 9.3 19.6 8.4 7.3 5.8 4.7 6.7 9.7 7.0 2.1 2.8 1.9 1.7 3.6 1.5 0.4 6.3 17.6 16.8 14.1 3.0 3.1 15.4 8.9 4.8 7.2 6.8 9.2 9.6 10.2 10.6 5.2 5.3 9.3 13.4 9.5 5.3 27.6 41.8 10.9 27.5 13.2 3.8 12.0 27.5 3.2 7.6 8.5 6.1 6.0 11.1 14.2 29.4 9.9 3.8 17.2 13.1 16.6 17.3 4.7 5.8 27.4 5.3 10.0 6.6 8.7 11.9 22.3 3.2 20.4 5.0 9.9 12.5 12.8 11.0 8.4 10.3 5.1 6.3 8.8 7.0 6.0 9.8 18.3 11.7 0.0 1.7 1.9 1.5 0.8 1.2 2.1 0.4 0.6 0.9 0.8 0.2 1.2 1.8 3.6 0.2 2.8 0.7 0.4 17.4 15.3 13.2 23.5 17.6 10.5 9.6 11.6 9.5 8.4 0.0 1.4 0.0 2.0 7.3 5.2 1.4 5.1 0.0 2.3 3.5 11.8 4.8 0.0 4.8 3.5 3.8 5.1 0.0 6.1 4.6 3.0 4.7 0.0 2.1 4.4 1.6 2.4 3.1 2.8 4.5 1.4 2.7 0.0 2.8 5.2 2.6 6.4 3.5 2.5 3.4 5.3 6.5 1.9 4.1 2.5 7.9 7.8 0.9 4.7 6.5 FBXL2 "FBL2, FBL3" ENSG00000153558 "F-box and leucine rich repeat protein 2" Q9UKC9 3 33277025-33403662 "Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 23.6;Early spermatids: 41.5;Late spermatids: 37.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 8.9;LHCN-M2: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061783 Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA061783: AB_2684605" "unprognostic (5.73e-2)" "unprognostic (4.47e-2)" "unprognostic (7.92e-2)" "unprognostic (7.21e-2)" "unprognostic (3.68e-1)" "unprognostic (1.59e-1)" "unprognostic (1.10e-2)" "unprognostic (2.09e-1)" "unprognostic (3.16e-1)" "unprognostic (2.00e-1)" "unprognostic (4.31e-2)" "unprognostic (1.06e-1)" "prognostic favorable (3.35e-4)" "unprognostic (3.30e-3)" "unprognostic (9.72e-2)" "unprognostic (4.28e-2)" "unprognostic (5.90e-2)" 3.2 5.2 8.0 2.2 15.0 1.9 4.1 7.2 18.1 3.7 2.9 4.1 1.8 3.2 5.2 8.2 2.3 6.0 3.0 2.7 8.7 11.3 5.5 1.4 4.6 1.8 6.6 13.4 4.5 3.5 7.7 16.1 5.5 13.1 4.3 1.5 6.4 3.1 6.5 1.5 2.9 2.0 3.5 4.5 2.3 2.5 4.3 2.8 0.0 8.6 0.6 1.5 2.6 2.5 1.3 0.9 2.8 1.0 0.9 1.1 0.1 3.9 1.1 1.6 1.8 2.3 3.8 0.6 3.1 2.5 2.8 4.1 0.8 4.7 0.2 0.9 2.0 1.3 1.0 1.4 3.4 1.9 0.4 1.9 0.7 3.2 0.8 2.8 0.3 0.7 1.5 2.5 1.8 1.3 8.9 5.0 2.8 0.9 0.3 9.4 0.4 0.8 0.7 1.2 0.5 0.9 0.1 1.0 0.1 7.1 1.1 2.0 2.0 1.3 0.8 2.3 2.7 2.2 1.2 3.9 1.4 1.3 1.1 1.7 0.4 0.2 0.2 1.3 0.3 0.9 1.5 1.0 0.7 0.9 0.5 0.7 0.5 0.7 0.9 0.3 1.3 1.1 1.1 2.8 0.9 0.7 0.9 0.4 0.1 8.0 15.0 7.2 18.1 8.7 11.3 6.6 13.4 13.1 2.8 3.0 8.2 0.0 5.1 1.0 16.5 2.0 2.5 13.4 4.5 5.2 23.6 0.4 3.3 3.5 41.5 2.2 0.0 0.0 0.3 1.0 3.6 2.9 0.0 0.0 0.4 17.5 0.0 3.1 0.3 37.9 1.4 1.2 1.7 0.0 0.1 6.7 3.4 0.0 3.9 2.1 14.2 6.5 2.9 11.7 7.9 1.0 0.6 1.3 0.0 3.3 FBXL6 FBL6 ENSG00000182325 "F-box and leucine rich repeat protein 6" Q8N531 8 144355431-144359376 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 31.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 4.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA008867 Approved Nucleoplasm,Vesicles Yes No Nucleoplasm Vesicles "HPA008867: AB_2668161" "unprognostic (2.97e-2)" "unprognostic (3.30e-2)" "unprognostic (1.13e-3)" "unprognostic (3.13e-1)" "unprognostic (9.88e-2)" "unprognostic (1.68e-1)" "unprognostic (6.29e-3)" "unprognostic (2.62e-1)" "unprognostic (1.10e-1)" "unprognostic (1.43e-2)" "unprognostic (9.04e-2)" "unprognostic (9.73e-2)" "prognostic unfavorable (4.49e-10)" "unprognostic (3.93e-2)" "unprognostic (1.44e-1)" "unprognostic (3.53e-1)" "unprognostic (2.00e-1)" 6.1 5.8 3.1 7.7 3.6 6.0 8.2 8.1 5.6 6.9 13.4 3.7 9.9 14.3 4.4 7.5 8.3 4.4 12.0 2.7 2.9 3.1 5.7 15.5 11.6 9.9 3.8 2.6 2.7 13.8 5.1 4.6 6.1 3.2 4.9 6.3 3.6 9.6 9.4 4.6 7.5 19.1 3.1 2.9 8.3 6.2 5.6 3.5 6.0 3.9 6.8 6.5 5.1 4.7 0.7 2.4 1.9 4.3 0.8 1.2 0.2 8.1 2.5 1.8 11.9 2.5 0.6 3.7 4.2 4.6 4.1 2.8 2.7 3.5 3.9 5.2 1.9 2.0 5.4 2.2 5.4 0.9 7.1 3.2 7.9 1.5 6.8 3.8 1.9 7.9 1.1 4.9 2.3 6.1 1.0 3.4 6.0 3.7 6.0 1.5 14.1 5.2 1.9 2.6 8.6 8.0 6.3 2.2 12.5 5.3 2.6 3.0 2.9 4.7 7.2 7.0 1.1 11.9 3.3 2.9 2.0 7.8 9.8 4.9 2.4 1.8 2.7 3.1 4.7 2.6 0.0 0.6 1.9 1.2 1.3 1.1 0.7 0.9 0.8 0.5 0.5 0.1 0.4 0.2 0.8 4.3 2.4 0.1 0.2 3.1 3.6 8.1 5.6 2.9 3.1 3.8 2.6 3.2 3.5 6.0 1.3 10.8 5.1 5.0 9.1 1.2 5.1 1.4 5.7 0.0 13.7 7.4 5.0 3.8 1.7 3.8 31.6 0.0 5.3 8.6 4.5 5.9 1.1 5.9 6.2 1.6 2.4 6.7 4.1 1.0 4.9 7.3 5.0 1.0 13.3 7.3 6.4 9.5 1.8 6.3 8.1 0.0 4.2 2.3 8.0 5.8 3.2 5.9 13.5 5.1 FBXO10 FBX10 ENSG00000147912 "F-box protein 10" Q9UK96 9 37510892-37576349 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 30.0;Late spermatids: 29.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 5.9" "Lineage enriched" "Detected in many" 5 "B-cells: 5.9" "Cell line enhanced" "Detected in many" "AF22: 18.0;HHSteC: 25.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002863, HPA072721" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA002863: AB_10965996, HPA072721: " "unprognostic (2.40e-1)" "unprognostic (2.43e-2)" "unprognostic (5.12e-2)" "unprognostic (1.05e-2)" "unprognostic (1.98e-1)" "unprognostic (3.44e-3)" "unprognostic (1.96e-2)" "unprognostic (1.80e-1)" "unprognostic (5.49e-2)" "unprognostic (9.84e-2)" "unprognostic (2.93e-5)" "unprognostic (1.91e-1)" "unprognostic (2.61e-2)" "unprognostic (2.08e-1)" "unprognostic (1.00e-1)" "unprognostic (2.74e-1)" "unprognostic (1.99e-1)" 3.8 7.5 4.8 7.5 8.3 1.2 3.4 4.4 12.1 3.6 6.7 4.9 6.3 2.8 5.0 16.9 4.7 2.8 4.5 4.3 6.3 5.9 3.9 4.0 3.5 7.7 4.0 6.7 3.1 7.4 6.4 20.8 3.1 3.9 4.0 2.9 5.3 15.0 5.2 27.0 2.9 4.8 5.0 3.1 10.1 3.6 12.2 3.3 2.9 11.7 6.0 7.7 4.5 2.9 5.9 0.8 0.0 0.2 0.2 1.1 0.5 1.6 4.1 18.0 4.6 8.4 3.0 1.4 3.2 5.6 3.9 5.9 2.3 1.1 10.5 1.1 3.3 1.6 0.1 6.5 1.5 2.9 5.8 5.2 2.1 3.8 2.0 25.8 5.5 0.7 6.9 1.2 3.5 2.3 2.6 5.5 1.0 7.2 2.9 6.9 1.4 2.1 1.8 8.3 2.4 1.5 4.1 7.9 1.3 2.2 1.1 3.8 9.6 2.0 2.5 2.2 5.5 1.0 5.7 4.3 2.8 4.9 2.5 2.2 3.6 2.8 1.7 2.4 2.2 2.6 0.0 0.1 0.0 0.7 0.2 0.7 5.9 1.1 0.7 0.0 3.2 0.1 0.1 0.0 0.2 0.2 0.8 0.2 0.5 4.8 8.3 4.4 12.1 6.3 5.9 4.0 6.7 3.9 3.3 0.0 0.6 6.1 0.1 0.2 3.3 1.4 0.0 1.4 0.0 1.8 3.9 0.3 0.0 1.2 30.0 0.6 0.0 0.0 1.3 0.7 0.6 0.6 0.0 0.9 3.2 3.2 5.2 6.7 0.3 29.3 0.9 0.0 1.7 1.0 0.5 1.5 1.4 0.0 1.4 1.3 0.9 0.0 0.9 3.1 1.9 0.5 0.2 0.0 0.3 0.3 FBXO11 "FBX11, UBR6" ENSG00000138081 "F-box protein 11" Q86XK2 2 47789316-47905793 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002690 Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA002690: AB_1848448" "unprognostic (1.18e-1)" "unprognostic (8.65e-3)" "unprognostic (3.93e-2)" "unprognostic (2.05e-2)" "unprognostic (7.92e-2)" "unprognostic (1.42e-1)" "unprognostic (3.85e-2)" "unprognostic (1.02e-1)" "unprognostic (2.55e-2)" "unprognostic (9.82e-2)" "unprognostic (5.77e-2)" "unprognostic (2.33e-2)" "unprognostic (3.21e-2)" "unprognostic (1.55e-1)" "unprognostic (3.71e-1)" "unprognostic (2.19e-1)" "unprognostic (3.20e-2)" 18.0 13.8 18.6 15.7 18.8 17.5 26.1 42.2 31.7 21.3 15.3 12.7 15.1 10.4 28.9 16.8 14.5 16.3 15.0 14.1 16.9 13.6 14.3 17.0 22.3 15.0 17.4 21.7 28.9 12.4 25.2 14.4 14.5 19.7 15.3 13.3 12.0 15.6 16.5 22.9 14.5 13.5 19.9 16.4 14.5 13.3 25.1 16.0 14.6 17.3 9.8 17.2 19.3 21.9 4.7 4.3 8.2 2.7 4.8 6.6 2.0 25.5 13.3 31.9 27.2 22.4 21.1 19.0 17.9 24.6 16.7 16.5 11.2 13.0 16.5 23.4 25.1 20.8 12.7 21.8 18.9 24.7 11.0 10.8 15.4 10.9 17.8 21.5 16.0 16.4 20.6 21.3 14.9 25.2 26.6 21.4 8.3 15.0 17.1 20.5 12.3 15.3 15.6 19.4 16.9 13.1 20.0 29.6 12.3 23.9 20.9 22.5 26.6 16.9 15.9 26.1 24.7 7.4 13.7 23.1 20.8 19.2 13.9 19.6 14.8 7.7 30.1 14.1 15.1 21.1 8.2 2.3 4.3 3.8 2.7 3.8 4.7 3.4 4.1 3.1 3.6 6.6 4.1 4.1 4.8 2.4 4.3 3.6 2.0 18.6 18.8 42.2 31.7 16.9 13.6 17.4 21.7 19.7 16.0 14.9 36.6 13.7 38.4 59.5 42.4 7.8 12.7 37.5 23.9 17.4 31.4 16.6 10.0 15.5 22.2 26.9 15.8 0.0 13.2 13.7 43.3 34.1 27.8 17.0 21.7 52.4 23.0 29.4 42.9 29.9 27.9 40.9 33.7 17.2 16.7 30.9 20.6 14.4 37.4 11.3 39.1 19.4 35.3 51.9 40.4 51.6 30.1 26.6 16.9 57.8 FBXO16 FBX16 ENSG00000214050 "F-box protein 16" Q8IX29 8 28348287-28490318 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 22.9;pituitary gland: 42.3" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 26.8;Cone photoreceptor cells: 33.4;Rod photoreceptor cells: 42.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "plasmacytoid DC: 11.5" "Lineage enriched" "Detected in many" 8 "dendritic cells: 11.5" "Cell line enhanced" "Detected in many" "AF22: 15.7;Karpas-707: 18.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058676, HPA076472" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Vesicles, Plasma membrane, Cytosol" "HPA058676: AB_2683795, HPA076472: " "unprognostic (3.44e-1)" "unprognostic (1.44e-1)" "unprognostic (3.37e-3)" "unprognostic (5.56e-3)" "unprognostic (1.87e-1)" "unprognostic (1.40e-2)" "unprognostic (2.55e-3)" "unprognostic (4.95e-3)" "unprognostic (6.49e-2)" "prognostic favorable (6.70e-5)" "unprognostic (3.41e-3)" "unprognostic (4.90e-2)" "unprognostic (7.15e-2)" "unprognostic (1.71e-2)" "unprognostic (4.85e-2)" "unprognostic (2.72e-2)" "unprognostic (2.07e-1)" 0.9 2.3 7.3 1.3 17.6 2.6 3.4 15.8 9.9 5.4 2.0 1.1 7.6 2.6 1.8 22.9 1.1 5.7 2.1 2.0 4.2 6.8 4.0 7.2 1.9 1.5 4.4 7.5 1.2 6.3 7.2 42.3 1.0 6.3 4.3 2.6 4.6 5.9 7.3 1.1 0.8 3.8 1.2 2.1 1.7 2.7 4.8 1.4 0.0 8.7 0.2 3.3 1.9 1.1 0.6 11.5 1.4 0.3 0.1 0.5 0.2 12.3 2.6 15.7 6.1 0.4 0.0 0.4 0.1 0.6 2.4 4.6 2.4 3.6 4.7 5.7 0.1 6.5 4.1 1.7 2.5 2.4 1.9 2.9 2.2 0.2 1.3 0.3 2.7 1.6 0.2 8.4 0.6 2.6 1.1 0.0 4.0 0.8 18.1 1.0 4.1 0.3 3.7 3.4 1.6 3.6 0.1 3.7 7.2 3.3 2.1 10.2 4.3 0.4 2.5 6.8 2.9 10.9 4.6 0.5 1.3 4.8 2.8 2.2 4.0 3.5 3.9 5.3 0.6 2.8 0.5 0.3 0.1 0.2 0.2 0.5 0.4 0.4 0.3 0.9 0.6 0.2 0.3 1.4 0.1 0.2 11.5 0.3 0.2 7.3 17.6 15.8 9.9 4.2 6.8 4.4 7.5 6.3 1.4 3.0 2.6 0.0 2.3 0.1 7.9 2.0 5.1 26.8 6.8 3.5 33.4 0.5 6.6 4.5 8.6 0.0 0.0 0.0 3.9 0.2 0.9 2.7 0.0 2.4 2.0 4.8 9.8 0.6 1.0 8.4 1.1 0.0 0.0 0.0 1.9 7.8 2.9 0.0 0.7 4.0 42.0 0.0 1.2 7.4 3.4 0.0 0.0 0.0 0.8 1.0 FBXO2 "Fbg1, Fbs1, FBX2, Nfb42, OCP1" ENSG00000116661 "F-box protein 2" Q9UK22 1 11637018-11655785 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.7;pancreas: 52.5" "Cell type enriched" "Detected in many" 5 "Exocrine glandular cells: 606.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 15 "B-cells: 1.4;T-cells: 3.1" "Cell line enhanced" "Detected in some" "CACO-2: 21.1;HBEC3-KT: 18.5;Hep G2: 44.2;SiHa: 83.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005472 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA005472: AB_2667332" "unprognostic (2.02e-2)" "unprognostic (1.28e-1)" "unprognostic (2.10e-1)" "unprognostic (8.13e-3)" "unprognostic (1.80e-1)" "unprognostic (2.61e-2)" "unprognostic (4.01e-2)" "unprognostic (1.30e-2)" "unprognostic (1.18e-2)" "unprognostic (1.41e-1)" "unprognostic (5.44e-2)" "unprognostic (1.68e-2)" "prognostic favorable (3.45e-6)" "unprognostic (5.26e-2)" "unprognostic (5.21e-2)" "unprognostic (4.82e-2)" "unprognostic (1.64e-1)" 1.7 21.8 49.7 2.6 39.2 1.2 7.9 21.1 48.3 2.1 1.8 13.2 2.1 13.7 1.5 6.4 3.6 3.6 2.9 2.6 33.1 32.6 6.9 11.0 3.0 2.5 40.0 23.0 2.2 52.5 17.7 20.2 1.3 25.7 5.1 1.3 2.7 21.7 7.6 1.3 6.6 4.9 1.7 31.4 2.2 3.8 4.4 24.3 1.1 3.7 0.0 3.8 2.6 2.9 1.4 0.1 0.0 0.0 0.0 3.1 0.6 6.9 2.1 0.0 6.8 0.1 0.0 1.0 0.3 0.6 0.1 0.0 21.1 2.0 0.0 8.7 0.0 1.8 0.0 0.7 18.5 0.0 0.1 0.2 0.0 0.2 44.2 0.9 0.0 0.0 0.6 3.4 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.8 0.2 0.0 0.0 0.0 1.6 0.5 0.7 0.9 83.5 0.0 0.8 0.7 4.1 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.4 0.3 0.1 0.0 0.2 0.0 0.0 0.0 1.9 0.0 3.1 1.4 1.2 2.9 0.1 1.1 1.8 2.6 0.0 0.0 0.0 0.0 0.8 0.6 49.7 39.2 21.1 30.3 33.1 32.6 40.0 23.0 25.7 24.3 0.0 1.0 6.6 52.3 17.4 10.7 2.4 17.8 5.3 5.7 45.4 2.0 0.6 72.9 20.7 1.7 0.6 0.0 0.0 606.0 3.5 2.4 21.4 4.6 87.3 0.4 27.0 1.2 2.5 1.6 1.8 32.2 1.2 42.2 5.4 0.0 65.1 127.3 0.0 38.2 5.8 10.3 0.0 1.9 11.4 10.4 8.7 0.8 12.9 0.0 22.5 FBXO27 "Fbg5, Fbx27" ENSG00000161243 "F-box protein 27" Q8NI29 19 38990714-39032785 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 19.6;Cytotrophoblasts: 20.2;Syncytiotrophoblasts: 22.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 16.6" "Low region specificity" "Detected in all" "HPA046800, HPA062242" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA046800: AB_2679813, HPA062242: AB_2684723" "prognostic favorable (2.15e-4)" "unprognostic (7.32e-2)" "unprognostic (2.03e-2)" "prognostic unfavorable (3.53e-5)" "unprognostic (1.48e-3)" "unprognostic (4.38e-3)" "unprognostic (1.02e-1)" "unprognostic (8.95e-2)" "unprognostic (1.67e-1)" "unprognostic (7.31e-3)" "unprognostic (6.80e-2)" "unprognostic (9.31e-2)" "unprognostic (2.25e-2)" "unprognostic (8.72e-3)" "unprognostic (6.04e-2)" "unprognostic (7.51e-2)" "unprognostic (3.21e-2)" 8.9 3.1 11.8 2.0 7.9 2.3 21.3 18.5 14.1 4.5 5.2 4.7 5.2 2.0 3.9 2.3 11.6 4.4 4.4 14.1 8.8 8.8 5.1 5.8 3.9 3.5 7.3 10.5 8.1 3.8 1.4 3.3 3.1 6.4 7.2 6.7 5.1 5.5 6.4 1.5 26.7 3.9 5.8 6.7 2.5 2.8 3.6 4.1 2.9 3.7 6.0 5.6 9.3 7.1 1.6 1.1 4.0 0.7 2.7 0.9 0.3 4.2 5.4 0.2 3.5 7.6 0.4 1.6 0.6 3.3 2.6 2.4 1.8 1.6 0.6 8.6 4.8 4.4 7.4 0.3 3.1 1.7 0.4 0.2 0.2 1.4 0.2 1.3 0.4 1.3 2.7 5.0 2.6 0.2 4.1 1.5 0.2 2.4 0.6 3.6 3.8 0.3 0.6 3.9 1.4 9.9 0.1 0.0 0.6 1.6 16.6 0.3 5.3 8.4 1.1 0.0 2.5 4.4 0.8 1.9 0.3 0.2 0.2 0.4 1.7 3.9 0.9 4.4 0.1 0.1 1.8 0.7 0.4 0.8 0.6 0.5 0.8 0.5 0.6 0.5 1.6 0.9 0.7 4.0 2.7 0.4 1.1 0.5 0.3 11.8 7.9 18.5 14.1 8.8 8.8 7.3 10.5 6.4 4.1 3.0 19.6 0.0 4.6 5.3 7.4 8.3 2.5 6.7 10.3 1.8 0.0 20.2 1.7 1.4 2.5 0.7 0.0 0.0 0.7 3.1 2.1 2.6 7.0 2.5 3.9 7.9 0.0 0.6 0.0 1.7 2.6 1.0 0.0 1.8 0.0 4.0 0.5 0.0 3.9 5.3 2.9 0.0 1.4 5.7 1.3 15.6 22.5 1.3 0.1 4.2 FBXO28 "CENP-30, Fbx28, FLJ10766, KIAA0483" ENSG00000143756 "F-box protein 28" Q9NVF7 1 224114087-224162047 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003289 Supported "Nucleoplasm,Focal adhesion sites" NA NA Nucleoplasm "Focal adhesion sites" "HPA003289: AB_2666879" "unprognostic (4.91e-2)" "unprognostic (5.57e-2)" "unprognostic (1.78e-2)" "unprognostic (1.03e-1)" "unprognostic (1.33e-2)" "unprognostic (1.43e-1)" "unprognostic (2.12e-1)" "unprognostic (8.25e-2)" "unprognostic (2.03e-1)" "unprognostic (7.09e-2)" "unprognostic (5.09e-3)" "unprognostic (2.60e-1)" "unprognostic (1.98e-3)" "unprognostic (9.46e-2)" "unprognostic (1.71e-1)" "unprognostic (1.41e-1)" "unprognostic (2.61e-1)" 17.4 13.1 16.4 14.9 19.7 12.1 19.6 22.5 21.6 18.7 15.9 15.0 13.1 13.3 16.2 13.3 22.2 14.1 15.1 15.0 15.3 15.6 21.4 26.6 14.0 14.9 15.9 13.6 18.7 13.4 25.7 16.2 15.8 20.2 16.5 17.1 11.9 16.6 14.9 24.6 32.3 14.4 15.7 15.6 16.1 13.7 11.9 15.5 19.4 15.7 13.1 16.1 17.5 20.0 10.3 10.0 14.7 8.9 10.9 11.0 5.7 14.1 6.3 9.8 10.4 10.3 11.8 16.1 14.3 11.7 9.7 9.3 8.6 11.1 6.8 14.8 13.0 6.2 12.5 14.4 13.9 16.8 9.6 16.1 8.6 7.9 6.2 12.8 16.3 11.4 11.5 16.8 14.0 25.6 11.4 16.1 8.9 14.1 9.8 17.4 4.6 8.4 8.3 23.3 18.8 13.5 9.0 14.0 12.8 18.3 9.4 15.9 17.0 14.9 22.9 15.9 10.7 12.1 16.4 18.4 12.1 9.2 15.1 26.9 10.7 12.6 10.7 15.0 8.0 23.4 8.9 8.7 14.7 7.8 8.1 10.1 10.3 8.2 9.6 10.0 10.2 8.3 9.1 5.3 10.9 8.9 4.7 11.0 5.7 16.4 19.7 22.5 21.6 15.3 15.6 15.9 13.6 20.2 15.5 6.0 8.8 12.3 21.3 30.5 18.7 10.6 7.6 6.7 11.4 10.4 21.6 12.1 8.3 10.9 19.1 14.2 10.6 23.3 9.8 11.5 11.0 18.7 13.9 22.2 12.3 17.5 17.7 9.8 16.3 11.5 12.0 13.9 27.0 10.8 14.0 10.1 13.4 10.5 12.4 17.9 18.4 12.9 11.3 26.0 26.5 34.3 19.2 17.5 11.9 27.2 FBXO3 "FBA, FBX3" ENSG00000110429 "F-box protein 3" Q9UK99 11 33740939-33774543 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002467 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA002467: AB_2666602" "unprognostic (1.87e-1)" "unprognostic (2.81e-1)" "unprognostic (6.07e-2)" "unprognostic (1.25e-1)" "unprognostic (3.71e-1)" "unprognostic (1.34e-1)" "unprognostic (2.61e-1)" "unprognostic (8.53e-2)" "unprognostic (5.21e-2)" "unprognostic (2.42e-1)" "unprognostic (1.47e-1)" "unprognostic (7.36e-2)" "prognostic favorable (2.46e-9)" "unprognostic (6.96e-2)" "unprognostic (1.92e-1)" "unprognostic (1.27e-1)" "unprognostic (3.19e-2)" 18.2 16.0 18.4 8.7 33.9 14.1 17.4 27.7 30.3 16.1 13.3 17.1 11.5 11.2 16.4 15.8 21.1 15.0 13.5 28.1 17.3 19.3 29.3 25.3 12.2 10.3 15.2 15.4 18.8 16.5 35.9 21.8 15.3 27.8 16.6 15.0 16.7 17.0 16.9 67.6 18.4 16.3 19.0 12.4 12.6 14.6 15.1 15.2 18.6 21.6 24.2 16.6 15.9 16.6 11.1 8.4 13.0 9.2 15.7 22.8 10.4 11.5 10.4 14.1 15.0 17.1 13.5 8.5 13.8 13.9 11.3 14.1 11.8 11.7 7.7 9.8 15.0 13.9 20.1 18.8 18.3 18.9 7.7 26.1 3.9 16.3 9.6 10.9 9.1 9.3 13.6 18.6 7.7 12.4 16.5 14.8 5.7 13.4 15.5 12.6 7.8 6.7 5.3 7.1 26.2 16.0 5.2 31.6 10.9 16.3 14.7 20.0 11.0 19.6 13.5 10.1 14.2 19.5 7.0 13.5 14.0 12.3 19.7 11.6 8.7 11.3 13.1 12.5 7.1 13.7 13.0 7.8 11.1 15.1 7.5 16.6 10.9 17.9 17.0 8.4 11.1 22.8 15.9 8.4 15.7 9.2 4.3 21.4 10.4 18.4 33.9 27.7 30.3 17.3 19.3 15.2 15.4 27.8 15.2 32.8 15.0 18.2 54.0 43.4 58.2 36.0 12.7 33.5 18.2 24.4 25.5 19.9 48.0 41.8 83.0 29.3 20.5 0.0 22.0 24.3 25.4 28.3 16.1 34.2 10.5 54.0 23.0 30.1 12.0 42.2 27.6 14.1 27.0 9.0 18.0 50.1 28.5 19.9 25.5 47.3 42.8 58.2 31.1 51.9 29.8 59.0 30.6 33.2 16.2 46.2 FBXO31 "FBX14, Fbx31, FBXO14, MGC15419" ENSG00000103264 "F-box protein 31" Q5XUX0 16 87326987-87392142 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, DNA damage, Ubl conjugation pathway" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA030150 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA030150: AB_10670559" "unprognostic (4.85e-1)" "unprognostic (5.76e-3)" "unprognostic (1.67e-1)" "unprognostic (1.53e-2)" "unprognostic (4.04e-1)" "unprognostic (2.25e-1)" "unprognostic (3.83e-1)" "unprognostic (1.42e-1)" "unprognostic (2.36e-2)" "unprognostic (3.65e-2)" "prognostic favorable (9.16e-5)" "unprognostic (3.00e-2)" "unprognostic (1.47e-3)" "unprognostic (1.20e-1)" "unprognostic (3.95e-1)" "unprognostic (1.57e-3)" "unprognostic (2.26e-3)" 25.7 11.5 10.5 6.1 12.1 5.4 22.3 39.7 18.7 10.4 14.1 5.9 9.3 9.0 13.3 7.4 10.8 11.1 6.7 17.2 8.3 8.2 5.3 11.3 5.6 6.3 6.9 10.4 13.9 13.5 8.8 16.6 5.4 8.5 9.4 6.4 7.9 10.3 12.0 50.4 8.9 11.4 14.8 4.6 5.3 8.3 9.1 5.6 4.5 6.0 7.0 5.4 12.2 22.6 2.4 0.9 1.4 0.7 0.2 3.7 1.4 4.9 9.4 3.1 8.5 16.2 9.8 9.2 8.6 8.6 8.6 4.5 8.5 4.2 11.5 9.5 9.1 4.3 7.6 6.0 7.2 5.8 5.3 11.1 3.9 5.7 23.9 9.1 3.7 3.3 11.6 6.1 11.2 10.6 5.6 5.2 6.0 11.0 4.5 4.5 7.1 8.7 5.0 6.1 5.1 8.4 11.3 3.7 4.9 3.8 3.5 14.6 7.1 19.2 3.9 5.9 2.4 6.1 3.2 7.2 8.3 6.3 7.8 6.7 10.5 8.1 14.3 6.6 6.9 5.1 1.4 0.6 0.2 1.0 0.6 1.8 2.4 1.7 2.4 0.4 1.6 1.8 1.9 0.9 0.2 0.7 0.9 3.7 1.4 10.5 12.1 39.7 18.7 8.3 8.2 6.9 10.4 8.5 5.6 0.0 2.9 3.7 4.3 13.1 12.3 19.4 0.0 4.0 1.2 5.2 31.4 8.8 0.0 3.1 6.9 8.4 17.0 0.0 4.3 2.7 7.1 3.8 0.0 23.7 3.5 0.0 8.6 3.7 5.1 22.2 7.5 1.9 3.3 4.6 10.4 3.9 3.7 11.5 10.6 4.4 11.8 19.4 9.0 13.5 5.1 11.3 6.1 5.0 13.6 3.5 FBXO32 "ATROGIN1, Fbx32, MAFbx" ENSG00000156804 "F-box protein 32" Q969P5 8 123497889-123541206 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 200.5" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 172.4;Cardiomyocytes: 242.3;Glandular cells: 165.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 2.9;gdT-cell: 3.7;MAIT T-cell: 3.6;memory CD4 T-cell: 5.1;memory CD8 T-cell: 5.4;naive CD4 T-cell: 6.0;naive CD8 T-cell: 7.6;NK-cell: 4.4;T-reg: 4.5" "Group enriched" "Detected in many" 7 "granulocytes: 2.9;NK-cells: 4.4;T-cells: 7.6" "Cell line enhanced" "Detected in some" "GAMG: 17.4;HDLM-2: 59.1;hTERT-RPE1: 20.6;U-251 MG: 17.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA058955, HPA065209" Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA058955: , HPA065209: AB_2685433" "unprognostic (2.55e-1)" "unprognostic (3.62e-1)" "unprognostic (1.80e-1)" "unprognostic (1.54e-2)" "unprognostic (1.91e-1)" "unprognostic (1.25e-1)" "unprognostic (3.64e-2)" "unprognostic (2.11e-2)" "unprognostic (1.23e-1)" "unprognostic (1.31e-1)" "unprognostic (1.10e-2)" "unprognostic (1.93e-1)" "prognostic unfavorable (6.73e-4)" "unprognostic (8.58e-3)" "unprognostic (1.40e-1)" "unprognostic (1.09e-1)" "unprognostic (7.97e-3)" 3.5 1.5 2.4 4.9 5.1 0.8 13.2 1.0 3.8 5.6 31.1 8.9 14.4 2.6 25.3 5.8 8.1 15.8 16.6 26.1 2.9 2.1 1.5 1.0 1.7 4.1 10.2 2.5 9.5 2.0 0.9 5.6 4.9 7.3 19.7 8.0 4.2 8.0 23.1 200.5 3.7 6.5 36.9 8.8 1.7 10.8 3.5 7.6 0.2 9.0 15.1 3.1 24.8 16.1 0.6 0.2 2.9 0.3 4.4 7.6 1.4 1.7 0.3 0.0 0.0 3.8 0.9 0.6 0.3 3.9 0.2 0.4 0.0 1.0 0.0 1.1 2.9 17.4 0.1 0.0 0.3 0.3 59.1 1.3 0.0 2.0 0.0 5.2 0.0 0.2 7.6 2.6 0.9 1.1 20.6 0.2 0.8 0.1 0.5 0.2 0.4 0.2 0.0 0.0 0.7 0.3 0.0 0.0 0.3 0.6 0.5 0.1 0.3 0.4 6.7 6.8 0.4 6.6 0.1 0.2 1.1 0.3 0.3 17.7 6.1 0.8 0.1 4.5 0.0 0.8 2.9 0.3 0.0 3.7 0.2 3.6 0.6 5.1 5.4 0.2 0.6 6.0 7.6 0.2 4.4 0.2 0.1 4.5 1.4 2.4 5.1 1.0 3.8 2.9 2.1 10.2 2.5 7.3 7.6 0.0 3.0 0.9 172.4 10.2 7.9 242.3 2.5 2.7 20.5 7.0 33.4 13.8 8.3 11.6 2.6 7.7 43.7 23.3 26.4 10.2 11.3 165.2 0.0 1.5 4.9 20.6 98.1 0.6 3.2 2.7 36.8 2.9 42.2 1.0 40.8 51.7 39.4 23.2 57.7 3.3 92.8 19.4 73.6 5.4 1.3 5.5 91.3 21.0 19.3 65.2 FBXO33 Fbx33 ENSG00000165355 "F-box protein 33" Q7Z6M2 14 39397669-39432500 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 49.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046657 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA046657: AB_10960398" "unprognostic (8.84e-3)" "unprognostic (6.72e-2)" "unprognostic (3.65e-2)" "unprognostic (2.79e-1)" "unprognostic (1.08e-1)" "unprognostic (3.20e-2)" "unprognostic (1.19e-1)" "prognostic favorable (4.94e-4)" "unprognostic (1.24e-1)" "unprognostic (2.70e-2)" "unprognostic (1.17e-1)" "unprognostic (2.40e-1)" "prognostic favorable (4.58e-4)" "unprognostic (9.61e-2)" "unprognostic (4.54e-1)" "unprognostic (4.41e-2)" "unprognostic (8.58e-3)" 8.9 13.3 8.9 8.9 12.1 49.1 8.4 12.3 19.7 10.1 7.0 7.1 10.0 8.2 8.5 12.0 7.5 8.8 8.6 6.1 10.4 11.7 8.5 8.8 9.0 12.8 9.1 11.0 9.4 7.8 18.4 19.0 8.8 9.3 9.1 6.9 9.4 10.8 12.0 4.4 6.7 8.0 7.7 7.2 10.4 8.2 12.8 7.5 16.6 14.9 5.7 10.6 8.6 8.7 2.5 1.6 7.8 2.2 5.5 4.8 1.3 9.7 6.1 5.6 8.6 20.2 9.5 9.3 9.8 13.3 5.5 6.5 3.6 8.7 11.0 12.2 15.3 5.5 5.0 14.4 9.7 10.0 10.5 9.3 4.3 8.9 9.3 5.7 16.4 16.7 8.8 10.5 9.4 3.0 9.6 4.6 11.0 3.8 10.0 10.8 10.4 14.6 10.3 5.7 8.8 9.2 12.7 9.1 9.9 10.5 12.5 9.7 4.4 8.9 9.4 10.7 8.7 6.9 10.6 5.8 9.4 8.4 13.9 7.8 13.6 16.0 17.3 7.2 7.8 6.9 1.6 1.7 3.7 3.4 2.1 3.2 2.5 3.4 3.7 1.6 2.3 4.8 4.5 7.8 5.5 2.2 1.5 3.4 1.3 8.9 12.1 12.3 19.7 10.4 11.7 9.1 11.0 9.3 7.5 8.9 19.0 17.1 12.7 30.7 22.6 5.9 2.5 1.4 5.7 8.7 41.2 7.0 6.6 7.2 32.0 14.3 14.7 0.0 8.2 7.7 16.9 17.3 10.3 9.0 9.3 27.0 23.0 9.8 19.6 8.0 7.8 14.0 18.6 6.4 12.6 12.4 11.0 7.0 4.9 2.7 16.1 0.0 17.9 19.6 10.2 49.3 17.7 17.5 12.4 20.9 FBXO36 "Fbx36, FLJ37592" ENSG00000153832 "F-box protein 36" Q8NEA4 2 229922302-230013109 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 54.9;Cone photoreceptor cells: 33.4;Early spermatids: 33.5;Spermatocytes: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053865 Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA053865: AB_2682282" "unprognostic (4.39e-3)" "unprognostic (6.51e-2)" "unprognostic (2.38e-2)" "prognostic favorable (2.28e-4)" "unprognostic (2.43e-1)" "unprognostic (1.06e-1)" "unprognostic (1.15e-2)" "unprognostic (2.38e-2)" "unprognostic (2.12e-1)" "unprognostic (1.96e-1)" "unprognostic (1.28e-2)" "unprognostic (8.04e-2)" "unprognostic (7.79e-3)" "unprognostic (3.72e-2)" "unprognostic (1.86e-1)" "unprognostic (1.03e-2)" "unprognostic (2.68e-1)" 4.0 7.8 8.9 1.9 12.6 1.9 7.3 4.1 12.2 6.7 2.8 11.9 4.7 3.2 5.4 8.9 3.8 21.7 3.9 2.9 8.3 9.1 10.3 3.7 4.9 2.1 8.1 6.9 6.8 3.7 11.7 11.7 3.6 10.1 6.4 3.0 9.3 5.0 5.8 2.0 6.1 3.2 3.9 8.9 2.1 3.7 14.0 5.2 2.7 14.8 2.8 2.7 2.9 3.3 2.8 3.6 0.8 1.7 2.7 4.5 1.2 1.3 2.6 3.1 1.2 1.5 9.4 6.1 1.6 4.3 2.3 4.0 0.8 4.1 0.1 0.9 2.8 2.8 1.0 1.4 0.8 4.0 0.3 0.9 0.5 0.9 1.6 6.0 1.0 0.4 9.9 7.0 4.4 3.4 3.0 2.4 4.5 1.8 0.8 2.7 5.2 2.2 2.4 8.1 2.8 2.9 2.6 0.9 0.6 4.1 1.0 2.9 3.7 2.6 2.1 1.1 3.6 4.5 1.8 1.8 3.8 1.4 6.1 0.6 2.8 2.3 0.9 4.7 0.5 2.8 0.1 1.7 0.1 2.5 1.3 2.1 2.8 1.9 1.7 3.6 2.0 4.5 2.5 0.8 2.7 0.9 1.7 3.5 1.2 8.9 12.6 4.1 12.2 8.3 9.1 8.1 6.9 10.1 5.2 8.9 1.4 0.0 2.9 3.4 7.0 3.1 0.0 54.9 10.3 10.4 33.4 1.6 13.3 4.9 33.5 2.4 1.8 0.0 5.8 1.5 3.1 2.8 0.0 2.4 0.9 9.5 0.0 1.8 1.0 5.4 3.1 1.2 3.3 4.6 1.4 6.6 4.5 0.0 3.9 7.5 27.5 6.5 2.7 34.9 10.3 4.0 1.8 0.5 1.5 1.1 FBXO38 "Fbx38, FLJ13962, MOKA, SP329" ENSG00000145868 "F-box protein 38" Q6PIJ6 5 148383935-148442836 "Disease related genes, Predicted intracellular proteins" "Adaptive immunity, Immunity, Ubl conjugation pathway" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 2: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034821, HPA041444" Approved Supported "Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol" Yes No "Nucleoplasm, Plasma membrane" "Cytokinetic bridge, Cytosol" "HPA034821: AB_10669897, HPA041444: AB_2677484" "unprognostic (7.72e-2)" "unprognostic (5.75e-3)" "unprognostic (1.95e-2)" "unprognostic (1.67e-1)" "unprognostic (2.21e-1)" "unprognostic (2.70e-2)" "unprognostic (7.06e-2)" "unprognostic (5.43e-3)" "unprognostic (1.45e-1)" "unprognostic (1.12e-1)" "unprognostic (2.03e-1)" "unprognostic (6.29e-2)" "unprognostic (2.21e-3)" "unprognostic (1.31e-3)" "unprognostic (1.83e-1)" "unprognostic (1.64e-1)" "unprognostic (4.70e-3)" 23.2 19.3 13.8 17.7 21.2 12.6 20.6 20.8 21.1 22.3 18.4 20.0 20.4 13.8 25.2 18.2 17.6 16.7 16.9 24.1 18.8 13.8 19.2 25.7 20.7 19.0 16.3 18.8 19.2 16.9 29.2 34.1 19.7 24.6 22.2 19.3 16.4 19.4 18.7 28.5 19.3 18.4 18.2 17.8 24.8 18.8 20.0 18.9 26.9 18.1 17.1 21.7 21.7 18.0 5.5 8.1 13.7 14.8 8.0 7.9 4.9 8.6 9.2 14.3 10.4 16.1 18.2 7.5 11.3 21.6 16.1 22.1 13.5 10.6 12.5 11.1 18.2 17.0 12.1 14.9 14.2 19.4 13.7 9.6 7.4 13.5 9.1 16.1 20.0 12.2 17.5 12.2 15.4 15.2 17.2 21.6 11.7 8.2 13.6 15.7 3.5 12.6 9.5 6.7 9.6 14.0 11.3 20.9 12.5 15.6 10.1 12.8 12.5 15.0 10.1 14.5 12.8 10.6 14.6 14.0 14.7 5.3 7.7 12.5 16.7 16.8 10.7 14.6 11.5 11.1 13.7 6.3 9.0 5.9 8.6 6.3 5.5 5.5 5.7 8.1 4.8 5.7 7.2 12.0 8.0 14.8 3.9 7.9 4.9 13.8 21.2 20.8 21.1 18.8 13.8 16.3 18.8 24.6 18.9 14.9 40.8 7.0 5.2 3.0 9.8 16.2 7.6 16.0 10.3 10.4 9.8 6.2 5.0 7.4 7.9 6.7 8.0 0.0 5.8 5.5 6.0 8.8 15.1 17.3 11.1 12.7 9.2 13.5 25.7 2.1 8.3 15.0 3.3 4.6 9.8 5.6 8.7 8.6 17.3 7.5 9.2 0.0 4.7 22.1 7.5 3.3 10.3 6.9 9.1 7.1 FBXO4 FBX4 ENSG00000151876 "F-box protein 4" Q9UKT5 5 41925254-41941743 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003362 Approved Nucleoplasm NA NA Nucleoplasm "HPA003362: AB_2666918" "unprognostic (1.43e-1)" "unprognostic (2.10e-2)" "unprognostic (9.25e-3)" "unprognostic (2.65e-2)" "unprognostic (2.50e-1)" "unprognostic (7.32e-2)" "unprognostic (6.15e-2)" "unprognostic (1.48e-2)" "unprognostic (1.62e-3)" "unprognostic (5.42e-3)" "unprognostic (1.69e-1)" "unprognostic (5.42e-2)" "prognostic unfavorable (1.28e-4)" "unprognostic (8.57e-2)" "unprognostic (1.51e-1)" "unprognostic (5.39e-2)" "unprognostic (8.27e-2)" 15.5 13.3 6.6 9.4 9.8 8.5 14.9 7.1 10.3 11.1 9.2 7.8 14.4 9.2 10.0 19.6 10.0 10.5 12.3 8.6 6.3 6.5 9.2 19.9 10.2 12.9 8.9 7.3 12.1 19.3 9.7 9.4 8.6 8.7 11.2 9.7 10.8 11.7 11.7 7.6 11.2 9.9 10.6 7.8 14.8 9.2 11.0 8.2 11.1 16.2 9.9 15.1 11.0 8.9 11.5 9.6 2.6 15.9 8.0 9.9 6.7 5.6 4.1 0.7 10.6 5.7 9.4 6.4 4.8 9.0 8.1 11.1 2.0 15.4 14.5 6.5 6.6 1.8 1.4 2.5 1.6 6.8 5.0 1.0 7.6 15.0 5.3 11.1 12.3 4.9 5.6 3.6 4.1 15.5 3.0 6.1 6.6 7.0 4.6 9.3 2.3 7.8 2.5 0.3 8.1 3.6 1.4 1.6 3.7 5.5 5.5 1.7 3.2 19.0 1.4 7.0 0.4 9.5 13.9 4.3 9.1 2.6 6.1 3.8 7.2 6.2 0.9 9.2 13.7 4.7 2.6 5.1 1.1 8.5 7.4 9.9 11.5 9.5 8.9 9.6 11.1 9.7 8.9 0.3 8.0 15.9 8.5 7.4 6.7 6.6 9.8 7.1 10.3 6.3 6.5 8.9 7.3 8.7 8.2 8.9 11.0 9.3 9.0 11.2 5.8 3.0 15.3 13.4 4.5 10.4 0.0 22.5 10.0 11.5 0.6 7.0 3.6 0.0 14.4 23.5 15.5 4.4 4.7 16.4 14.6 3.2 1.7 8.6 4.0 0.9 9.8 11.5 18.6 4.6 8.4 8.3 9.2 7.0 9.9 17.3 7.1 6.5 9.2 21.8 17.9 12.4 10.4 17.0 10.1 5.4 FBXO41 "Fbx41, KIAA1940" ENSG00000163013 "F-box protein 41" Q8TF61 2 73254682-73284431 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.3" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 10.8;Horizontal cells: 6.4;Intestinal endocrine cells: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055246, HPA058386" Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA055246: AB_2682758, HPA058386: AB_2683701" "unprognostic (1.15e-3)" "unprognostic (9.36e-2)" "unprognostic (2.17e-2)" "prognostic unfavorable (5.76e-4)" "unprognostic (1.74e-2)" "unprognostic (5.85e-2)" "unprognostic (1.55e-3)" "unprognostic (1.58e-1)" "unprognostic (7.97e-3)" "unprognostic (7.55e-2)" "unprognostic (9.13e-3)" "unprognostic (4.35e-2)" "prognostic unfavorable (1.08e-5)" "unprognostic (3.08e-2)" "unprognostic (1.24e-1)" "unprognostic (1.97e-1)" "unprognostic (1.11e-2)" 1.5 3.6 21.9 5.9 19.3 4.2 2.1 21.7 33.3 1.2 2.1 1.7 0.9 2.2 1.9 3.6 1.6 2.0 2.7 1.1 18.8 10.6 0.8 1.1 2.2 9.4 5.9 17.8 2.5 4.1 9.8 7.3 1.1 6.8 3.0 2.4 0.8 3.7 3.3 0.6 3.4 2.7 2.1 2.1 7.5 2.5 2.4 3.5 2.1 1.5 0.0 9.0 2.8 0.8 0.5 0.9 0.0 2.6 1.1 0.7 0.4 3.6 1.8 0.6 0.0 0.1 0.1 0.8 0.7 0.6 1.2 1.5 4.1 2.1 27.0 0.1 0.1 2.7 3.0 3.8 2.4 1.2 11.2 0.3 8.2 4.1 1.7 0.9 12.4 6.3 1.5 0.9 0.0 0.9 3.3 0.2 7.4 1.6 4.4 1.2 0.9 4.3 11.6 2.7 1.3 1.6 15.2 7.0 13.1 0.8 1.3 9.4 3.5 4.6 2.0 2.9 0.2 2.6 5.2 0.2 4.2 3.7 3.8 0.7 5.3 2.2 12.8 1.1 13.7 1.7 0.0 0.5 0.0 0.6 2.6 0.7 0.5 0.4 0.0 0.9 0.2 0.4 0.4 0.0 1.1 0.1 0.7 0.2 0.4 21.9 19.3 21.7 33.3 18.8 10.6 5.9 17.8 6.8 3.5 0.0 1.1 1.7 0.3 0.2 10.8 1.7 2.5 1.4 0.0 1.8 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 2.2 0.1 0.6 0.7 2.3 0.0 1.7 6.4 11.5 1.3 2.6 0.9 0.3 0.9 1.7 1.8 0.0 0.6 1.0 0.0 0.7 0.0 2.2 0.0 0.5 0.5 1.7 0.3 0.0 1.3 0.4 0.1 FBXO42 "Fbx42, KIAA1332" ENSG00000037637 "F-box protein 42" Q6P3S6 1 16246839-16352454 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025071 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA025071: AB_1848461" "unprognostic (1.08e-1)" "unprognostic (2.38e-1)" "unprognostic (1.25e-1)" "unprognostic (3.09e-2)" "unprognostic (1.40e-1)" "unprognostic (1.11e-2)" "prognostic unfavorable (3.72e-4)" "unprognostic (3.22e-2)" "unprognostic (4.00e-2)" "unprognostic (4.22e-2)" "unprognostic (3.96e-2)" "unprognostic (4.61e-2)" "unprognostic (1.22e-2)" "unprognostic (1.13e-1)" "unprognostic (2.53e-1)" "unprognostic (5.78e-3)" "unprognostic (3.91e-2)" 18.2 15.0 18.2 13.0 18.7 11.3 16.1 37.3 23.9 19.1 15.8 17.1 16.1 10.4 24.3 18.5 23.0 18.5 16.3 19.7 16.2 15.9 13.4 15.7 15.2 15.3 16.1 13.4 22.2 22.6 21.2 19.6 16.2 19.5 21.6 15.0 19.0 18.2 22.0 24.3 33.6 12.5 24.9 13.1 15.9 14.3 16.5 17.7 20.1 18.2 10.4 18.9 19.9 22.1 12.2 14.4 18.5 16.8 12.4 12.9 7.9 10.6 5.8 14.2 14.3 17.3 11.2 6.2 11.1 16.9 16.1 15.8 5.4 9.9 11.4 10.0 15.4 11.1 9.8 14.3 10.6 13.3 13.1 6.7 10.6 8.8 6.1 20.6 12.5 13.9 12.0 24.4 14.1 20.5 14.7 16.1 14.4 11.3 16.0 11.4 7.3 12.0 11.0 6.1 14.3 6.6 13.7 8.7 10.1 10.6 3.1 13.4 8.8 12.6 10.6 13.1 13.6 8.6 9.9 10.0 8.2 7.2 13.4 8.6 7.9 8.0 11.6 10.8 16.5 11.2 7.1 12.3 18.5 12.9 16.8 9.7 8.2 9.8 8.2 14.4 12.2 11.3 9.6 10.9 12.4 12.5 6.4 12.2 7.9 18.2 18.7 37.3 23.9 16.2 15.9 16.1 13.4 19.5 17.7 11.9 10.2 12.2 5.3 23.0 20.2 17.1 10.2 2.7 4.5 12.2 43.2 9.2 0.0 6.7 7.2 9.2 7.1 0.0 6.6 11.9 12.2 9.8 2.3 8.6 11.8 27.0 10.3 10.4 12.7 7.2 13.8 14.6 1.7 8.2 5.8 12.5 7.7 7.0 10.6 2.8 21.7 12.9 10.5 13.6 8.8 30.4 22.0 14.4 8.2 4.4 FBXO44 "FBG3, FBX30, Fbx44, Fbxo6a, MGC14140" ENSG00000132879 "F-box protein 44" Q9H4M3 1 11654375-11663327 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 61.7" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003363 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA003363: AB_1078831" "unprognostic (1.39e-1)" "unprognostic (1.34e-1)" "unprognostic (9.59e-2)" "unprognostic (5.34e-2)" "unprognostic (2.82e-1)" "unprognostic (2.97e-2)" "unprognostic (2.44e-1)" "unprognostic (1.31e-2)" "unprognostic (3.32e-1)" "unprognostic (1.93e-1)" "prognostic favorable (2.63e-4)" "unprognostic (2.57e-2)" "prognostic favorable (6.29e-5)" "unprognostic (1.34e-2)" "unprognostic (5.45e-1)" "unprognostic (1.77e-1)" "unprognostic (3.02e-3)" 6.6 21.1 26.6 8.3 39.0 5.3 7.0 61.7 45.0 6.5 5.0 12.3 8.9 14.2 8.5 10.3 7.7 12.1 10.5 13.7 28.7 26.4 12.2 7.7 8.1 16.3 20.7 27.4 11.3 17.8 21.7 19.5 2.4 23.1 13.7 3.4 9.9 25.5 15.4 6.4 22.1 7.8 6.2 14.2 13.4 8.1 8.5 15.3 3.2 13.0 3.3 9.9 7.4 7.5 10.9 5.1 1.5 2.5 1.5 11.7 6.1 7.5 12.2 4.5 17.2 6.7 7.0 6.1 6.1 7.4 6.7 5.8 8.9 14.3 0.2 13.6 6.7 11.2 1.9 9.0 20.3 2.8 8.6 11.0 0.2 6.6 14.8 9.3 0.2 1.1 9.0 13.5 6.3 4.8 13.9 5.2 14.1 4.6 1.9 1.7 4.7 12.6 1.4 4.7 6.8 8.7 5.1 0.2 2.5 10.8 2.7 13.7 11.3 16.0 6.2 27.0 5.8 11.1 6.9 6.4 4.9 11.9 6.5 4.8 12.7 7.1 4.6 11.3 3.2 11.6 1.1 2.1 0.6 11.7 2.4 9.0 10.0 8.0 8.9 3.3 10.9 10.9 7.5 1.5 1.5 2.5 5.1 7.1 6.1 26.6 39.0 61.7 45.0 28.7 26.4 20.7 27.4 23.1 15.3 0.0 9.0 9.1 10.8 16.4 20.1 3.6 5.1 2.7 5.7 15.7 13.7 1.3 26.6 8.0 3.6 3.8 0.8 0.0 5.7 2.4 10.1 9.3 3.5 3.9 5.1 38.1 4.1 5.5 6.2 9.9 21.3 5.0 10.1 5.4 2.0 14.8 6.5 1.1 27.3 9.1 6.8 0.0 6.6 11.1 7.2 14.9 0.7 20.0 2.1 4.7 FBXO46 "20D7-FC4, Fbx46, FBXO34L" ENSG00000177051 "F-box protein 46" Q6PJ61 19 45710629-45730904 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Suprabasal keratinocytes: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 37.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049390 Uncertain Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA049390: AB_2680742" "unprognostic (9.02e-3)" "unprognostic (1.01e-2)" "unprognostic (2.82e-2)" "prognostic unfavorable (2.13e-5)" "unprognostic (9.33e-2)" "prognostic favorable (5.44e-4)" "prognostic unfavorable (1.11e-4)" "unprognostic (1.08e-1)" "unprognostic (2.06e-1)" "unprognostic (6.13e-2)" "prognostic favorable (8.11e-4)" "unprognostic (9.77e-2)" "prognostic unfavorable (5.33e-4)" "unprognostic (5.10e-2)" "unprognostic (1.46e-1)" "unprognostic (3.27e-2)" "prognostic favorable (5.09e-6)" 7.4 7.4 13.8 12.9 13.1 10.4 9.8 10.4 15.7 11.2 10.3 8.6 10.6 9.6 15.7 10.0 20.7 10.7 7.3 8.7 13.3 4.8 7.6 10.5 7.7 17.2 13.9 10.1 17.1 12.6 8.4 10.4 12.3 10.2 10.1 9.7 8.6 11.0 9.0 12.8 12.8 11.4 10.9 9.7 15.8 13.3 11.5 13.0 13.6 12.8 9.2 17.1 10.0 12.4 5.9 2.6 7.1 2.3 1.1 3.7 1.2 7.0 11.0 8.5 9.9 2.2 4.0 9.7 3.7 2.1 2.9 3.4 9.1 9.3 12.3 5.0 2.0 4.2 10.3 6.3 4.7 2.2 15.1 13.3 10.0 37.1 4.9 3.3 4.4 12.9 3.3 4.3 5.0 3.1 7.5 4.4 15.3 7.8 15.0 2.4 6.7 10.2 5.1 5.4 6.6 3.8 13.8 4.7 11.4 3.5 8.5 8.5 7.5 5.9 12.5 4.9 8.5 10.6 5.5 4.9 6.3 5.7 3.4 6.0 14.4 19.9 8.2 7.0 6.2 5.1 7.1 2.3 2.3 3.7 1.8 2.5 4.0 2.8 2.5 1.5 5.9 2.6 3.0 6.7 1.1 2.1 2.6 2.6 1.2 13.8 13.1 10.4 15.7 13.3 4.8 13.9 10.1 10.2 13.0 8.9 4.5 6.0 9.3 23.1 2.8 4.5 7.6 5.3 4.5 7.0 2.0 7.1 1.7 5.5 2.3 4.5 10.4 0.0 4.2 13.6 3.8 7.1 3.5 16.3 3.1 11.1 7.0 4.9 4.3 2.2 5.2 3.6 5.0 3.6 11.7 4.0 5.8 11.8 1.8 1.7 2.7 0.0 3.9 6.0 3.8 31.2 10.4 4.8 8.6 9.6 FBXO5 "EMI1, FBX5, Fbxo31" ENSG00000112029 "F-box protein 5" Q9UKT4 6 152970519-152983579 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "bone marrow: 29.3;lymphoid tissue: 69.0" "Cell type enhanced" "Detected in many" 11 "Erythroid cells: 70.0;Spermatogonia: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB008106, HPA029048" Approved Supported Nucleoplasm NA Yes Nucleoplasm "CAB008106: AB_828450, HPA029048: AB_10602132" "unprognostic (1.22e-2)" "unprognostic (7.21e-2)" "unprognostic (4.61e-3)" "unprognostic (1.24e-2)" "unprognostic (5.92e-2)" "unprognostic (2.94e-2)" "unprognostic (2.43e-8)" "unprognostic (2.46e-2)" "unprognostic (1.55e-2)" "unprognostic (7.32e-2)" "unprognostic (2.89e-1)" "unprognostic (5.86e-2)" "unprognostic (1.25e-9)" "prognostic favorable (8.65e-4)" "unprognostic (1.20e-1)" "unprognostic (1.72e-1)" "unprognostic (1.51e-1)" 4.2 2.9 2.7 13.7 3.1 29.3 3.5 6.6 3.3 5.3 6.1 1.8 1.8 3.5 5.8 3.7 6.1 4.4 3.0 2.4 2.8 2.3 3.0 4.1 3.8 10.8 4.4 1.6 5.1 3.1 2.0 3.4 8.2 3.5 3.9 4.1 1.6 6.9 2.4 1.6 3.3 5.0 3.9 2.4 10.6 3.5 4.2 3.9 69.0 5.6 4.8 11.2 3.5 4.5 6.8 5.3 0.0 3.5 8.8 7.9 3.2 11.1 5.8 24.6 16.5 1.9 3.9 7.8 27.2 12.2 20.5 23.1 11.9 6.7 27.4 8.4 7.2 13.8 10.7 19.4 9.1 24.7 14.6 17.3 27.4 8.6 12.9 3.6 24.5 17.0 2.7 1.7 13.8 10.9 5.0 9.3 14.4 28.9 25.8 18.6 8.5 27.9 15.8 14.3 8.6 8.6 23.6 19.7 17.7 7.2 6.1 16.1 16.7 19.3 10.4 5.1 9.0 7.5 23.0 7.0 15.4 20.1 17.7 31.7 8.6 9.5 40.5 11.2 18.2 18.6 0.0 2.4 0.0 3.8 3.0 5.4 6.8 6.3 6.9 4.6 6.0 6.2 6.4 0.0 8.8 3.5 5.3 7.9 3.2 2.7 3.1 6.6 3.3 2.8 2.3 4.4 1.6 3.5 3.9 0.0 0.6 13.7 3.5 8.9 2.8 1.4 2.5 2.7 5.7 1.8 5.9 6.7 3.3 2.7 0.5 4.5 1.0 70.0 1.4 24.6 7.2 2.7 2.3 1.7 6.5 1.6 4.6 6.2 1.0 0.0 4.0 4.8 1.7 2.8 2.7 4.0 1.3 0.0 5.6 2.9 3.0 12.9 6.6 8.8 32.4 4.5 4.9 7.0 4.3 1.7 FBXO7 "Fbx, FBX7, PARK15" ENSG00000100225 "F-box protein 7" Q9Y3I1 22 32474676-32498829 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Erythroid cells: 373.8;Late spermatids: 465.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032113, HPA032114, CAB034296" Uncertain Supported Nucleoplasm,Cytosol NA NA 430000 "Nucleoplasm, Cytosol" "CAB034296: AB_2102563, HPA032113: AB_2674156, HPA032114: AB_10696202" "unprognostic (3.99e-2)" "unprognostic (1.53e-1)" "prognostic favorable (1.08e-5)" "unprognostic (1.36e-1)" "unprognostic (2.82e-1)" "unprognostic (2.11e-2)" "unprognostic (1.79e-1)" "unprognostic (1.29e-1)" "unprognostic (1.03e-1)" "unprognostic (2.45e-2)" "unprognostic (2.28e-1)" "unprognostic (2.53e-1)" "prognostic favorable (2.66e-10)" "unprognostic (3.33e-2)" "unprognostic (1.65e-1)" "unprognostic (7.02e-2)" "unprognostic (1.79e-3)" 22.9 27.8 25.5 16.2 28.6 92.9 27.7 14.5 30.6 23.7 22.5 55.9 17.0 20.1 22.5 29.6 18.5 28.3 18.8 16.3 29.3 26.2 43.3 51.2 24.9 26.0 39.9 18.2 27.7 26.9 27.6 23.2 31.8 33.4 23.0 22.7 35.9 18.6 23.6 12.4 20.7 28.4 24.0 52.7 29.5 20.6 42.1 24.4 33.3 77.6 16.4 24.4 19.7 26.3 22.0 25.4 60.4 21.7 28.6 33.0 24.9 21.7 15.3 20.0 22.5 30.9 29.4 14.5 18.7 33.8 29.6 35.2 15.1 14.8 20.0 15.6 31.9 26.1 14.5 29.0 23.9 30.4 34.3 26.3 27.6 16.7 23.4 37.7 35.9 24.6 24.6 38.7 26.0 20.0 27.2 31.8 16.0 21.9 26.0 32.0 16.0 17.9 22.5 7.8 29.1 11.4 17.6 21.2 24.1 33.9 22.8 29.3 19.2 23.3 18.7 65.9 29.6 10.4 19.0 22.2 15.5 22.1 14.9 14.6 18.4 19.4 19.2 29.1 18.3 61.7 60.4 18.9 39.8 27.6 21.7 33.0 22.0 25.3 27.0 25.4 19.6 22.4 24.3 7.2 28.6 20.7 16.7 30.7 24.9 25.5 28.6 14.5 30.6 29.3 26.2 39.9 18.2 33.4 24.4 38.7 25.9 50.0 58.7 41.1 27.1 13.4 68.8 16.0 21.6 47.1 17.7 76.9 82.9 65.2 233.2 55.5 48.7 373.8 68.0 90.0 53.6 57.0 55.3 76.9 64.6 31.8 64.9 51.5 51.5 465.0 41.7 49.7 113.1 151.5 41.6 38.9 60.2 45.8 46.0 104.8 33.7 45.3 50.5 117.2 135.2 37.9 59.8 62.3 42.8 67.6 FBXO8 "FBS, FBX8" ENSG00000164117 "F-box protein 8" Q9NRD0 4 174236658-174284264 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SH-SY5Y: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002885 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA002885: AB_1078835" "unprognostic (8.17e-2)" "unprognostic (6.59e-2)" "unprognostic (2.46e-1)" "unprognostic (3.18e-1)" "unprognostic (4.69e-2)" "unprognostic (2.04e-2)" "unprognostic (7.11e-2)" "unprognostic (1.53e-1)" "unprognostic (1.84e-2)" "unprognostic (3.72e-1)" "unprognostic (2.11e-2)" "unprognostic (2.25e-1)" "prognostic favorable (1.29e-7)" "unprognostic (1.29e-1)" "unprognostic (1.39e-1)" "unprognostic (1.40e-1)" "unprognostic (1.72e-1)" 16.8 18.5 13.5 9.2 14.1 7.3 16.4 19.4 14.0 15.6 17.3 14.0 10.7 13.4 13.1 19.5 16.4 15.1 13.1 19.1 13.3 12.0 20.2 43.5 11.8 9.5 14.6 10.1 15.7 22.6 16.5 26.9 27.1 14.3 16.8 15.3 14.7 13.3 13.1 7.4 16.0 18.9 18.8 14.7 13.9 14.7 10.0 14.0 18.2 19.9 6.5 12.4 20.6 18.2 12.6 8.6 19.2 8.9 9.8 15.5 7.8 4.8 3.2 6.6 2.2 14.9 16.3 5.2 9.9 9.1 6.6 6.7 2.5 8.6 3.7 9.4 6.4 5.6 3.1 4.4 5.7 7.0 11.1 10.0 3.2 5.5 4.0 11.4 4.4 3.6 9.3 14.2 6.0 8.0 11.8 6.5 4.1 6.8 19.1 8.6 4.8 4.5 4.6 1.8 7.8 3.4 2.7 4.3 5.8 10.2 2.0 6.2 40.1 4.4 7.8 11.0 6.7 4.4 4.8 7.4 3.8 3.7 11.0 5.5 9.9 4.7 3.1 13.0 3.2 5.3 19.2 6.2 12.7 12.3 7.8 15.5 12.6 14.2 12.1 8.5 10.7 13.5 11.8 6.2 9.8 8.9 8.6 15.0 7.8 13.5 14.1 19.4 14.0 13.3 12.0 14.6 10.1 14.3 14.0 3.0 11.4 16.0 15.8 18.3 11.9 9.0 12.7 18.7 13.6 21.0 5.9 29.9 43.1 14.8 14.7 16.8 18.2 23.3 9.7 44.8 19.0 18.2 2.3 50.0 18.5 17.5 11.6 19.0 16.9 4.1 16.1 8.5 10.1 19.8 20.1 20.7 11.1 19.3 24.8 32.6 16.1 12.9 14.7 33.3 17.4 27.5 74.9 17.5 13.4 20.6 FBXW10 "C17orf1, C17orf1A, Fbw10, HREP, SM2SH2" ENSG00000171931 "F-box and WD repeat domain containing 10" Q5XX13 17 18744024-18779349 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 15.9" "Group enriched" "Detected in some" 5 "Ciliated cells: 8.1;Early spermatids: 30.2;Late spermatids: 8.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.8;ASC diff: 2.1;CAPAN-2: 3.1;HaCaT: 4.3;HeLa: 3.4" HPA047457 Approved Nucleoplasm NA NA Nucleoplasm "HPA047457: " "unprognostic (1.24e-1)" "unprognostic (1.46e-1)" "unprognostic (9.59e-2)" "unprognostic (7.47e-2)" "unprognostic (4.54e-1)" "unprognostic (5.08e-2)" "unprognostic (6.67e-2)" "unprognostic (3.89e-1)" "unprognostic (2.30e-1)" "unprognostic (6.30e-2)" "unprognostic (5.65e-2)" "unprognostic (3.49e-2)" "unprognostic (2.20e-7)" "unprognostic (3.16e-1)" "unprognostic (2.32e-1)" "unprognostic (1.30e-2)" "unprognostic (1.05e-1)" 0.1 0.7 0.1 0.1 0.7 0.0 0.1 1.9 0.6 0.6 0.1 0.1 0.1 0.4 0.1 2.1 0.2 0.8 0.4 0.1 0.6 0.3 0.2 1.1 0.3 0.1 0.1 0.8 0.1 0.1 0.1 0.4 0.1 1.6 0.1 0.0 0.4 0.3 0.2 0.8 0.1 0.4 0.1 0.1 0.1 0.3 15.9 0.1 0.1 1.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 5.8 0.0 0.1 2.1 1.3 0.1 0.0 0.2 0.0 0.3 0.1 3.1 0.1 0.1 0.4 0.2 4.3 0.0 0.0 0.2 0.1 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.6 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.4 1.5 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 1.9 0.6 0.6 0.3 0.1 0.8 1.6 0.1 0.0 1.1 0.0 0.1 0.0 0.0 0.6 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 30.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 3.4 0.4 0.1 0.0 0.0 0.0 0.1 FBXW11 "BTRC2, BTRCP2, Fbw11, Fbw1b, FBXW1B, Hos, KIAA0696" ENSG00000072803 "F-box and WD repeat domain containing 11" Q9UKB1 5 171861549-172006873 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072204 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA072204: AB_2686493" "unprognostic (4.04e-3)" "unprognostic (1.27e-1)" "unprognostic (2.69e-2)" "unprognostic (5.79e-2)" "unprognostic (1.39e-1)" "unprognostic (1.06e-1)" "unprognostic (1.90e-2)" "unprognostic (1.63e-1)" "unprognostic (6.87e-2)" "unprognostic (9.43e-2)" "unprognostic (1.53e-1)" "unprognostic (8.14e-3)" "unprognostic (2.38e-3)" "unprognostic (1.57e-1)" "unprognostic (1.54e-1)" "unprognostic (3.76e-3)" "unprognostic (1.76e-1)" 15.0 17.1 28.1 11.5 29.4 7.9 17.2 29.7 34.4 17.5 11.2 24.7 9.4 10.2 19.2 10.7 20.0 22.7 14.5 30.3 28.9 26.3 19.5 16.5 14.0 14.0 28.8 20.1 21.8 24.1 37.8 15.8 11.2 23.3 16.2 13.3 12.4 11.6 18.1 24.5 11.0 10.3 21.6 30.6 13.6 15.8 11.3 21.2 12.0 17.5 7.0 17.0 12.9 16.0 9.0 8.2 19.1 7.0 12.9 6.2 5.5 15.8 16.3 24.3 21.2 19.1 19.5 12.4 17.1 24.6 21.5 26.9 16.7 10.8 14.6 21.1 21.9 34.2 10.5 17.4 25.8 35.8 19.3 17.3 11.8 17.0 12.8 17.4 13.1 16.9 14.0 18.0 17.2 28.3 23.0 17.8 12.8 7.3 14.7 26.0 11.9 9.1 6.9 9.3 9.4 18.2 13.4 20.5 9.9 16.5 13.5 10.2 17.9 15.1 12.8 31.5 19.1 16.0 14.1 15.5 21.3 10.6 12.8 16.8 15.1 17.0 10.2 14.9 12.6 16.1 19.1 7.0 6.5 5.7 4.7 6.2 8.7 4.9 5.7 6.9 9.0 4.7 5.8 6.7 12.9 5.1 8.2 5.3 5.5 28.1 29.4 29.7 29.9 28.9 26.3 28.8 20.1 23.3 21.2 23.8 16.8 19.4 11.2 16.9 36.7 51.5 45.9 10.7 20.5 26.2 7.9 7.3 36.5 28.4 22.6 21.7 20.1 23.3 31.8 6.4 15.5 19.1 19.7 38.4 11.3 33.4 27.6 25.2 23.9 30.0 27.3 14.9 11.8 18.0 18.3 56.5 43.0 15.8 26.9 26.9 29.9 45.3 18.9 29.7 15.2 20.7 10.1 17.1 15.1 32.6 FBXW2 "FBW2, Fwd2, Md6" ENSG00000119402 "F-box and WD repeat domain containing 2" Q9UKT8 9 120751978-120793412 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 127.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067878 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA067878: AB_2685913" "unprognostic (1.08e-1)" "unprognostic (1.45e-1)" "unprognostic (5.06e-2)" "unprognostic (1.29e-1)" "unprognostic (1.25e-1)" "unprognostic (6.27e-2)" "unprognostic (1.15e-1)" "unprognostic (1.57e-1)" "unprognostic (8.06e-3)" "unprognostic (1.40e-1)" "unprognostic (2.95e-1)" "unprognostic (3.88e-3)" "prognostic favorable (1.38e-6)" "unprognostic (1.66e-1)" "unprognostic (2.75e-1)" "unprognostic (2.86e-1)" "unprognostic (3.83e-2)" 26.4 31.7 17.4 22.9 25.8 35.6 29.7 27.0 30.3 26.0 22.6 22.6 17.4 18.1 28.8 25.2 25.5 22.7 24.2 25.3 18.1 16.1 20.4 25.5 27.4 25.0 15.1 19.8 20.9 27.3 30.7 23.4 18.8 18.8 22.8 22.3 23.8 25.6 23.2 20.2 27.2 20.9 29.7 16.8 30.1 24.5 23.0 16.7 32.9 22.8 15.7 26.6 25.2 23.8 10.6 11.7 17.7 13.2 15.4 19.3 9.6 14.1 18.0 13.5 22.8 25.6 21.1 12.5 19.1 21.9 21.1 20.7 14.2 17.2 21.3 10.1 24.8 21.4 31.3 19.4 19.0 26.4 28.5 8.4 13.8 30.4 20.6 14.5 30.7 19.1 15.3 23.8 23.3 25.0 19.9 24.7 22.2 18.3 23.3 18.3 22.7 22.0 9.2 20.1 24.2 17.2 17.0 21.6 21.3 14.6 16.1 10.8 16.4 26.8 19.9 13.8 16.7 32.5 8.9 18.3 18.1 14.5 29.1 23.5 16.9 33.9 18.6 19.2 13.7 18.5 13.3 12.6 17.7 19.3 12.0 14.7 10.6 14.1 18.1 11.7 6.9 11.7 15.8 13.4 15.4 13.2 10.3 13.4 9.6 17.4 25.8 27.0 30.3 18.1 16.1 15.1 19.8 18.8 16.7 23.8 49.9 14.5 22.8 20.1 19.5 19.1 17.8 17.4 29.6 10.4 11.8 15.7 18.3 22.8 36.2 31.5 18.9 0.0 29.7 24.2 25.1 28.8 15.1 28.7 22.4 31.8 26.6 34.4 30.8 127.2 24.5 23.2 45.5 33.3 21.9 14.7 25.6 22.9 33.6 21.1 23.1 6.5 25.0 40.3 58.2 28.0 14.9 30.5 21.3 22.6 FBXW7 "AGO, CDC4, FBW7, FBX30, FBXW6, FLJ11071, SEL-10, SEL10" ENSG00000109670 "F-box and WD repeat domain containing 7" Q969H0 4 152320544-152536063 "Cancer-related genes, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 60.1;skin 1: 45.0" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 179.3;Suprabasal keratinocytes: 152.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 38.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013793, CAB029987" Supported Supported Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB013793: AB_2533451, CAB029987: AB_2246842" "unprognostic (3.32e-1)" "unprognostic (9.02e-2)" "unprognostic (1.84e-2)" "unprognostic (3.08e-2)" "unprognostic (3.87e-1)" "unprognostic (1.36e-3)" "unprognostic (4.37e-1)" "unprognostic (1.94e-1)" "unprognostic (8.28e-2)" "unprognostic (3.29e-1)" "unprognostic (5.32e-3)" "unprognostic (3.19e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (3.38e-2)" "unprognostic (1.41e-1)" "unprognostic (5.49e-3)" "unprognostic (2.17e-3)" 9.2 6.8 27.0 8.9 27.9 11.1 9.8 27.2 60.1 5.5 6.1 3.6 3.8 4.9 6.0 18.3 9.8 10.6 6.3 10.9 21.4 10.1 4.1 7.3 6.9 9.8 9.1 40.5 6.4 8.0 6.4 7.3 6.2 37.2 5.1 6.9 2.8 7.6 5.3 15.8 45.0 6.5 6.1 6.4 10.1 8.0 13.7 5.7 6.5 6.8 10.6 12.3 7.9 6.5 2.9 2.2 16.6 3.4 7.8 5.0 1.3 4.9 4.0 10.3 7.5 7.2 5.2 8.6 7.2 6.6 4.5 4.2 8.0 6.4 12.9 2.0 6.9 3.4 3.0 8.9 16.2 6.3 7.3 4.2 6.0 4.9 5.7 7.3 14.6 5.5 8.2 25.8 7.7 13.1 4.7 7.8 10.5 9.4 13.8 5.6 7.0 16.8 5.8 5.0 4.2 3.2 16.9 4.4 2.5 5.5 8.6 6.6 5.7 4.6 6.3 3.9 12.2 3.4 6.9 8.2 6.1 6.9 3.1 4.0 38.0 21.7 12.6 4.9 4.8 4.3 16.6 3.1 1.7 5.0 3.4 3.3 2.9 3.7 3.2 1.8 2.4 3.9 3.2 5.5 7.8 2.5 2.2 3.3 1.3 27.0 27.9 27.2 60.1 21.4 10.1 9.1 40.5 37.2 5.7 8.9 18.5 27.6 32.1 179.3 67.8 54.1 7.6 8.1 13.6 8.7 29.5 9.7 3.3 11.6 13.1 26.4 13.5 0.0 11.7 33.1 24.6 28.4 15.1 15.6 9.4 11.1 13.9 17.8 16.2 7.4 14.1 20.2 27.0 16.2 11.7 30.1 15.8 15.8 10.6 6.0 40.5 12.9 25.6 57.9 80.3 152.9 26.1 34.6 11.3 48.9 FCF1 "Bka, C14orf111, CGI-35, UTP24" ENSG00000119616 "FCF1, rRNA-processing protein" Q9Y324 14 74713144-74738620 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 87.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046681 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA046681: AB_10960541" "unprognostic (1.39e-2)" "unprognostic (1.54e-1)" "unprognostic (5.74e-2)" "unprognostic (1.01e-2)" "unprognostic (1.18e-1)" "unprognostic (7.94e-3)" "prognostic unfavorable (5.54e-6)" "unprognostic (3.17e-1)" "unprognostic (3.43e-2)" "unprognostic (7.36e-2)" "prognostic unfavorable (3.54e-4)" "unprognostic (7.79e-2)" "prognostic favorable (2.26e-4)" "unprognostic (3.30e-1)" "unprognostic (1.46e-1)" "unprognostic (3.03e-1)" "unprognostic (1.47e-1)" 23.9 26.0 19.5 18.4 23.0 18.3 27.1 15.7 21.6 25.6 21.6 24.6 25.9 14.4 29.5 18.5 30.4 30.6 17.8 21.9 17.7 18.2 24.6 25.1 21.1 24.2 25.2 17.5 32.7 18.3 23.1 34.5 24.4 23.8 22.8 23.2 20.8 22.7 25.4 26.3 20.3 19.3 23.8 34.9 21.4 19.8 19.4 21.6 28.3 37.8 23.3 30.5 26.6 24.0 19.0 25.2 15.8 14.5 12.1 18.1 6.8 36.1 26.7 19.3 21.8 30.8 27.3 25.5 31.8 24.5 31.8 28.5 29.6 29.9 32.4 20.8 27.7 15.4 26.7 32.2 30.0 56.4 30.0 14.0 22.4 16.8 19.3 22.3 27.3 20.7 21.3 26.6 33.7 35.5 25.3 29.6 28.2 26.8 19.6 28.5 25.8 31.7 9.8 25.9 21.1 31.1 24.2 38.0 15.4 16.2 29.7 13.6 19.8 40.8 21.7 18.1 22.4 27.7 19.1 26.9 25.5 27.3 24.0 36.3 17.3 45.3 50.4 24.2 26.1 28.2 10.0 14.5 15.8 16.6 12.3 18.1 19.0 16.0 14.2 11.2 18.7 17.4 17.8 12.1 12.1 14.2 25.2 15.4 6.8 19.5 23.0 15.7 21.6 17.7 18.2 25.2 17.5 23.8 21.6 6.0 19.4 22.2 6.5 2.7 6.9 18.9 43.3 62.9 18.2 12.2 5.9 10.3 13.3 15.2 17.6 13.6 14.2 46.7 16.3 12.5 7.3 6.1 25.4 87.3 11.2 11.1 9.8 34.4 35.1 8.8 14.4 12.0 0.0 8.2 14.0 14.5 15.2 8.6 15.9 10.7 6.3 12.9 5.2 10.6 11.9 4.3 7.3 13.8 14.2 5.5 FCHO1 KIAA0290 ENSG00000130475 "FCH domain only 1" O14526 19 17747718-17788568 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 25.7;bone marrow: 18.9;brain: 30.2;lymphoid tissue: 22.6;skin 1: 13.4" "Cell type enhanced" "Detected in many" 6 "B-cells: 10.4;granulocytes: 9.2;Kupffer cells: 12.6;Macrophages: 11.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 28.2;RPMI-8226: 19.4;U-937: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041653, HPA062981" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041653: AB_10795641, HPA062981: AB_2684915" "unprognostic (3.02e-1)" "unprognostic (9.52e-2)" "unprognostic (1.80e-1)" "unprognostic (4.54e-3)" "unprognostic (3.62e-2)" "unprognostic (5.63e-2)" "unprognostic (3.80e-2)" "unprognostic (1.23e-1)" "unprognostic (1.84e-1)" "unprognostic (2.16e-1)" "unprognostic (6.93e-2)" "unprognostic (5.48e-3)" "unprognostic (1.72e-9)" "unprognostic (3.76e-3)" "unprognostic (1.18e-1)" "unprognostic (2.21e-1)" "unprognostic (9.77e-3)" 2.2 2.3 13.6 13.7 18.9 18.9 1.9 11.4 15.2 1.1 2.7 30.2 0.0 3.7 1.8 1.8 1.5 1.9 4.5 1.1 17.8 11.7 1.0 2.7 3.4 22.6 23.0 10.0 2.2 0.9 0.8 2.6 1.4 10.8 1.4 2.6 0.6 2.7 1.2 0.9 13.4 4.0 2.1 15.9 13.7 3.5 4.3 23.3 16.4 1.2 0.0 17.3 5.1 1.0 9.9 10.4 25.7 9.5 4.1 5.7 4.4 0.4 5.4 3.5 2.5 0.1 0.1 3.5 0.5 0.1 0.1 0.2 0.7 0.6 28.2 8.1 0.2 0.6 1.1 1.7 1.0 0.1 12.4 0.9 2.2 0.7 2.8 0.3 6.9 4.8 0.0 0.1 0.1 0.2 0.2 0.7 14.0 11.0 13.5 0.0 7.8 16.0 12.5 1.7 6.6 13.4 13.6 0.1 19.4 0.1 0.5 0.6 1.3 0.1 2.8 0.4 0.4 2.7 7.0 0.5 0.1 2.0 0.5 0.2 8.6 3.9 15.2 0.4 17.4 0.3 6.9 6.6 6.5 5.2 9.5 4.5 8.8 5.7 4.5 9.7 9.9 5.5 4.4 25.7 4.1 7.2 10.4 5.2 4.4 13.6 18.9 11.4 15.2 17.8 11.7 23.0 10.0 10.8 23.3 0.0 1.0 10.4 0.4 0.0 6.7 0.8 2.5 0.0 0.0 1.8 0.0 2.7 0.0 0.4 1.0 0.8 0.8 0.0 0.0 3.7 0.4 0.2 9.2 0.0 6.5 0.0 1.2 3.7 12.6 0.0 2.3 11.9 1.7 4.6 1.4 0.2 1.4 0.0 8.1 0.0 0.7 0.0 0.4 0.7 1.7 0.5 0.7 5.4 1.0 0.1 FCHSD1 FLJ00007 ENSG00000197948 "FCH and double SH3 domains 1" Q86WN1 5 141639302-141651419 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Horizontal cells: 50.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043795 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043795: AB_10963435" "prognostic favorable (8.62e-4)" "unprognostic (4.08e-2)" "unprognostic (6.17e-2)" "unprognostic (5.28e-2)" "unprognostic (3.50e-3)" "unprognostic (8.56e-3)" "unprognostic (5.34e-2)" "unprognostic (9.61e-3)" "unprognostic (2.17e-2)" "unprognostic (2.66e-2)" "unprognostic (1.88e-3)" "unprognostic (1.50e-2)" "prognostic unfavorable (6.19e-6)" "unprognostic (2.26e-1)" "prognostic unfavorable (4.77e-4)" "unprognostic (4.12e-3)" "prognostic favorable (1.21e-4)" 7.5 6.6 9.2 16.1 14.1 15.2 8.6 3.0 12.5 11.7 9.9 11.1 4.9 9.7 12.5 8.6 8.6 8.5 13.7 5.4 8.8 6.6 6.8 2.9 9.6 18.6 18.8 4.3 17.7 7.5 23.8 12.6 7.9 14.5 10.0 4.8 5.6 10.3 6.1 2.6 18.5 15.3 8.8 14.5 18.4 10.5 7.4 15.4 7.4 10.6 8.8 23.2 12.1 13.8 5.3 1.9 9.8 3.0 2.3 7.2 2.9 7.3 4.6 6.3 13.1 5.3 6.8 11.0 16.0 8.2 14.4 22.7 8.7 15.8 3.1 8.0 12.3 2.3 4.2 2.0 8.8 6.5 13.0 3.4 6.4 6.2 3.1 4.1 2.0 21.9 8.3 7.1 11.3 3.7 12.2 8.2 0.2 4.0 5.8 1.6 6.5 1.6 3.9 1.8 2.6 4.3 0.0 0.0 2.9 4.9 11.0 0.7 7.1 0.3 6.0 9.1 5.0 7.3 6.1 16.6 0.2 4.0 5.8 6.6 7.0 2.3 1.6 12.6 7.3 6.9 6.3 1.7 5.6 7.0 2.0 5.2 5.3 3.8 7.2 1.9 3.0 3.6 4.9 9.8 2.3 3.0 1.7 5.0 2.9 9.2 14.1 3.0 12.5 8.8 6.6 18.8 4.3 14.5 15.4 0.0 2.1 9.0 3.2 2.4 4.3 0.4 5.1 1.4 2.3 3.5 11.8 0.8 0.0 4.0 6.4 2.9 4.1 0.0 5.7 3.8 3.5 3.0 9.2 0.8 4.7 50.9 4.1 2.5 2.2 4.3 3.7 3.3 3.3 1.8 4.4 1.9 5.6 3.4 3.5 0.3 1.1 6.5 3.1 1.8 3.9 2.5 1.1 10.5 2.4 2.0 FCMR "FAIM3, TOSO" ENSG00000162894 "Fc fragment of IgM receptor" O60667 1 206904386-206923247 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 99.6;intestine: 30.1;lymphoid tissue: 84.9" "Group enriched" "Detected in many" 11 "B-cells: 125.3;T-cells: 41.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 99.6;T-cells: 60.0" "Group enriched" "Detected in some" 5 "RPMI-8226: 53.0;U-266/70: 26.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA003910 Approved Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Secreted to blood" NA NA 2400000 "Focal adhesion sites, Cytosol" Nucleoplasm "HPA003910: AB_1078798" "prognostic favorable (4.23e-4)" "unprognostic (1.16e-3)" "unprognostic (7.48e-2)" "unprognostic (3.06e-3)" "unprognostic (2.04e-1)" "unprognostic (2.69e-3)" "unprognostic (1.15e-1)" "unprognostic (4.85e-3)" "unprognostic (1.03e-1)" "unprognostic (3.97e-1)" "unprognostic (3.23e-2)" "unprognostic (2.01e-1)" "unprognostic (8.15e-3)" "unprognostic (8.06e-2)" "unprognostic (2.12e-2)" "unprognostic (3.74e-2)" "unprognostic (5.05e-3)" 15.5 0.6 0.5 42.9 0.5 2.9 1.5 0.4 0.4 0.8 2.5 0.4 0.3 1.2 1.2 0.8 3.4 1.3 2.6 1.0 0.5 0.5 2.4 1.5 3.9 77.2 0.5 0.0 1.3 0.7 0.0 0.9 0.8 0.2 1.4 2.3 1.3 10.1 0.3 1.9 0.6 30.1 0.4 0.6 78.8 2.8 0.5 0.0 51.8 1.8 1.2 84.9 8.5 1.2 99.6 1.4 5.3 0.4 18.4 60.0 28.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.1 0.1 0.0 0.0 3.4 0.0 0.1 0.3 0.1 0.0 0.4 0.2 0.0 0.1 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.3 0.1 0.6 0.0 0.0 2.7 0.0 7.4 0.0 0.1 1.0 0.1 0.0 0.0 0.0 1.7 0.2 53.0 0.0 0.1 0.0 0.0 1.0 0.2 5.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 26.7 1.9 7.4 0.3 0.0 0.2 0.5 0.2 0.2 20.3 0.4 26.4 80.3 28.1 26.2 0.2 99.6 49.5 33.3 5.3 18.4 0.3 1.4 60.0 28.2 0.5 0.5 0.4 0.4 0.5 0.5 0.5 0.0 0.2 0.0 0.0 4.6 125.3 3.9 0.0 0.0 3.0 7.6 1.4 2.3 0.0 0.0 0.0 0.0 1.3 0.1 0.1 0.0 0.0 2.6 0.1 0.6 2.6 0.0 1.1 3.8 0.0 0.0 5.5 5.1 0.0 0.3 1.2 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.3 0.1 1.0 0.0 0.0 41.7 1.2 7.1 FDPS ENSG00000160752 "Farnesyl diphosphate synthase" P14324 1 155308748-155320666 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Host-virus interaction, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Transferase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 149.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028200 Approved Approved Nucleoplasm,Cytosol NA NA 2000000 Cytosol Nucleoplasm "HPA028200: AB_10612109" "unprognostic (1.23e-1)" "unprognostic (8.46e-3)" "unprognostic (2.47e-2)" "unprognostic (6.57e-2)" "unprognostic (4.58e-2)" "unprognostic (2.84e-2)" "prognostic unfavorable (7.35e-4)" "unprognostic (4.21e-2)" "unprognostic (6.78e-3)" "unprognostic (1.64e-3)" "unprognostic (7.19e-2)" "unprognostic (2.25e-2)" "unprognostic (1.11e-2)" "unprognostic (8.25e-2)" "unprognostic (2.07e-1)" "unprognostic (5.65e-2)" "unprognostic (8.44e-2)" 21.0 57.8 19.3 17.6 26.5 16.5 19.8 12.8 32.2 19.0 25.0 22.6 14.5 45.9 18.0 21.7 41.4 16.7 18.8 19.6 18.6 23.4 23.7 100.8 25.7 19.2 19.5 24.3 15.2 27.5 15.6 12.3 20.2 47.3 16.5 29.7 20.5 29.2 12.9 15.7 29.3 32.3 18.9 23.0 17.7 23.4 15.1 16.5 25.1 19.5 41.7 27.3 13.7 20.8 41.1 39.7 49.4 37.1 45.3 45.5 48.3 36.0 19.6 72.1 26.0 16.9 62.0 25.7 17.2 34.1 27.5 44.8 31.7 85.9 27.5 41.9 15.0 65.7 40.3 42.9 149.6 25.8 15.0 30.7 15.9 35.0 38.3 27.8 25.8 18.3 44.1 23.7 43.7 22.0 12.5 47.9 40.8 28.5 74.2 28.6 38.7 33.0 25.1 43.3 26.8 28.7 28.5 31.3 76.3 72.5 24.1 28.1 24.0 17.7 32.3 29.7 42.9 23.3 70.2 34.8 15.4 18.9 9.5 31.4 31.5 24.2 49.1 15.0 27.6 24.2 30.5 36.0 49.4 39.4 37.1 35.0 41.1 34.8 39.8 39.7 34.2 31.5 39.3 16.5 45.3 27.2 31.4 45.5 48.3 19.3 26.5 12.8 32.2 18.6 23.4 19.5 24.3 47.3 16.5 68.5 144.0 64.8 78.5 32.6 65.5 1.4 107.0 85.6 83.0 50.6 58.9 177.4 116.0 154.2 171.3 113.0 197.2 93.5 286.2 162.6 57.3 89.5 62.2 111.9 95.6 52.4 68.5 133.8 57.6 52.3 56.4 56.4 91.1 217.4 74.5 75.0 194.9 143.8 66.1 113.5 78.0 71.1 63.8 41.9 15.5 52.2 120.0 77.8 106.3 110.3 FDXACB1 "hCG_2033039, LOC91893" ENSG00000255561 "Ferredoxin-fold anticodon binding domain containing 1" Q9BRP7 11 111874056-111881243 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 35.1;Late spermatids: 12.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039012, HPA061375" Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA039012: AB_10670916, HPA061375: " "unprognostic (2.91e-2)" "unprognostic (3.32e-3)" "unprognostic (1.32e-2)" "unprognostic (6.81e-7)" "unprognostic (1.32e-1)" "unprognostic (9.64e-2)" "unprognostic (2.05e-1)" "unprognostic (7.11e-3)" "unprognostic (3.95e-2)" "unprognostic (7.42e-2)" "unprognostic (3.67e-1)" "unprognostic (1.04e-1)" "unprognostic (1.09e-2)" "unprognostic (6.57e-2)" "unprognostic (4.42e-1)" "unprognostic (4.61e-2)" "unprognostic (1.79e-2)" 3.7 6.7 4.4 6.2 5.2 4.0 5.8 2.2 6.1 4.4 3.2 4.7 3.1 4.0 3.9 6.0 3.9 3.7 5.0 2.8 6.6 4.7 3.4 4.3 5.2 8.5 3.6 3.4 4.3 5.1 5.3 3.6 3.0 5.2 3.4 4.2 4.1 6.2 2.2 1.6 6.6 4.3 3.0 5.3 7.6 3.2 11.1 4.0 11.2 3.4 2.6 7.9 4.2 2.7 6.5 4.8 1.8 4.6 5.6 10.4 4.5 1.6 2.1 3.0 6.0 2.3 2.0 1.4 1.2 1.3 1.3 1.6 2.6 3.6 5.9 3.3 1.1 2.2 4.8 2.8 2.7 2.9 7.4 1.3 6.7 1.1 2.1 1.3 6.7 6.0 1.7 1.6 1.9 2.4 1.2 2.3 7.5 4.6 7.9 2.5 2.2 6.4 6.5 1.6 6.6 3.1 4.0 1.9 7.2 3.0 2.9 1.4 2.0 1.8 3.6 1.8 1.9 5.1 4.1 1.8 3.2 3.2 3.6 2.9 4.0 5.8 16.0 1.8 9.9 4.2 0.2 3.2 1.8 6.8 4.6 9.0 6.5 6.1 6.2 4.8 5.2 9.4 10.4 0.9 5.6 3.8 4.6 3.2 4.5 4.4 5.2 2.2 6.1 6.6 4.7 3.6 3.4 5.2 4.0 6.0 1.1 5.4 1.1 0.7 3.2 1.2 0.0 1.4 2.3 0.0 0.0 2.7 5.0 1.7 35.1 1.4 0.7 0.0 2.9 1.8 1.4 1.4 1.1 1.3 3.7 1.6 2.4 1.3 1.0 12.1 2.8 2.7 0.0 2.8 1.1 3.2 1.9 0.0 0.4 2.0 2.1 6.5 0.9 6.5 8.6 1.1 1.8 1.9 1.8 0.9 FEM1A ENSG00000141965 "Fem-1 homolog A" Q9BSK4 19 4791681-4801273 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 103.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016565, HPA063622" Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA016565: AB_1848489, HPA063622: AB_2685063" "unprognostic (4.62e-2)" "unprognostic (1.96e-1)" "unprognostic (1.66e-1)" "unprognostic (6.75e-2)" "unprognostic (3.60e-1)" "unprognostic (2.42e-3)" "unprognostic (2.04e-1)" "unprognostic (6.74e-2)" "unprognostic (1.25e-2)" "unprognostic (9.21e-2)" "unprognostic (2.28e-3)" "unprognostic (6.25e-2)" "unprognostic (6.18e-5)" "unprognostic (3.72e-3)" "unprognostic (1.25e-1)" "unprognostic (1.91e-1)" "unprognostic (4.70e-2)" 3.0 2.4 3.3 2.2 4.4 3.3 4.0 4.1 5.0 2.0 2.7 3.0 0.9 2.2 2.7 4.0 4.2 2.1 1.9 8.6 3.3 2.6 2.2 4.4 2.3 3.8 3.2 2.5 2.1 4.2 4.4 2.3 4.5 3.1 2.8 2.0 2.7 3.1 2.1 103.9 6.9 2.3 2.3 2.2 2.7 2.2 2.2 3.2 4.2 2.1 18.6 3.0 2.5 2.3 7.2 6.8 9.1 8.2 6.8 6.9 4.2 7.2 5.0 4.7 10.1 5.2 3.1 6.8 4.3 3.6 7.0 4.9 7.8 3.3 8.2 4.4 5.3 3.8 7.5 8.2 7.2 4.6 9.7 9.4 8.0 4.0 5.8 7.9 13.2 10.3 4.5 11.1 5.4 7.8 3.3 5.0 11.3 11.7 15.8 4.8 7.3 11.0 4.8 14.4 4.5 12.1 10.3 6.1 8.6 6.3 9.3 15.2 10.8 5.7 10.8 8.1 3.8 8.3 11.5 7.0 6.4 4.6 10.0 11.4 18.4 15.2 7.1 6.6 9.5 9.0 9.1 7.3 7.1 6.9 8.2 6.0 5.3 5.5 6.3 6.8 7.2 5.0 5.7 6.6 6.8 7.3 6.6 3.9 4.2 3.3 4.4 4.1 5.0 3.3 2.6 3.2 2.5 3.1 3.2 23.8 42.3 20.9 12.5 17.9 16.3 5.6 7.6 16.0 21.6 1.8 15.7 18.1 11.6 9.6 4.0 8.8 10.0 23.3 10.1 12.1 7.1 11.5 22.0 13.9 11.0 11.1 12.6 14.1 17.0 2.7 8.3 8.1 3.3 15.4 14.8 11.4 9.9 7.0 7.8 7.9 17.0 6.5 10.3 12.1 5.7 25.7 22.7 12.1 11.9 15.0 FEM1B ENSG00000169018 "Fem-1 homolog B" Q9UK73 15 68277803-68295865 "Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 706.2;Late spermatids: 207.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041920, HPA042192" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041920: AB_10796788, HPA042192: AB_10796574" "unprognostic (1.50e-1)" "unprognostic (1.27e-1)" "unprognostic (1.12e-1)" "unprognostic (1.16e-1)" "unprognostic (2.87e-2)" "unprognostic (6.29e-2)" "unprognostic (1.83e-1)" "unprognostic (3.27e-1)" "unprognostic (9.91e-2)" "unprognostic (1.52e-1)" "unprognostic (2.72e-1)" "unprognostic (6.84e-2)" "unprognostic (1.89e-2)" "unprognostic (3.49e-3)" "unprognostic (1.35e-1)" "unprognostic (2.89e-2)" "unprognostic (4.67e-2)" 13.4 10.5 13.1 11.2 17.0 38.1 17.7 23.0 22.9 14.8 14.6 14.1 13.6 11.1 23.2 12.6 18.5 14.1 11.1 16.9 13.7 13.7 10.4 14.6 11.9 14.2 17.8 16.1 17.4 8.5 14.0 12.9 13.7 17.2 15.0 12.4 12.4 12.3 16.6 42.9 18.7 14.2 22.3 14.3 11.9 10.4 55.4 15.4 12.9 12.9 11.4 13.1 18.7 17.8 4.4 4.4 4.0 7.9 6.5 6.9 3.0 7.3 13.5 14.0 13.1 12.7 11.8 9.3 10.5 11.0 10.8 10.0 9.1 9.9 16.9 7.7 14.2 7.8 26.8 29.0 13.3 9.1 8.0 11.5 18.6 16.0 5.7 11.0 15.1 11.6 10.8 29.1 13.1 31.9 15.6 8.5 8.7 15.5 20.8 9.2 8.6 10.8 7.7 14.2 5.9 4.3 15.7 15.8 21.8 6.9 26.7 18.8 11.9 10.8 11.3 29.1 18.5 10.1 14.1 11.0 19.0 16.7 6.5 9.6 13.6 29.2 18.1 10.8 16.5 11.2 0.0 5.1 3.6 5.7 7.9 5.8 3.7 5.7 6.2 4.4 4.4 6.9 5.0 4.0 6.5 6.3 3.2 3.0 3.0 13.1 17.0 23.0 22.9 13.7 13.7 17.8 16.1 17.2 15.4 20.8 27.8 14.9 44.9 87.6 31.7 35.5 22.9 22.7 17.0 17.4 11.8 13.5 0.0 20.6 706.2 21.1 16.7 0.0 10.4 10.3 23.6 28.1 13.9 27.9 26.6 36.5 19.1 17.2 24.2 207.4 22.7 15.0 38.8 8.2 24.3 16.3 15.2 17.5 26.2 10.5 12.7 25.8 30.9 16.5 6.1 97.2 14.1 11.7 17.4 48.2 FEM1C "EUROIMAGE686608, EUROIMAGE783647, FEM1A, KIAA1785" ENSG00000145780 "Fem-1 homolog C" Q96JP0 5 115520908-115544894 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 58.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059919, HPA060977" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059919: AB_2684161, HPA060977: AB_2684402" "unprognostic (1.14e-2)" "unprognostic (3.02e-1)" "prognostic favorable (1.83e-4)" "unprognostic (1.28e-1)" "unprognostic (3.31e-1)" "unprognostic (7.56e-2)" "unprognostic (1.34e-1)" "unprognostic (1.38e-1)" "unprognostic (1.05e-1)" "unprognostic (4.67e-2)" "unprognostic (5.52e-3)" "unprognostic (1.99e-2)" "prognostic unfavorable (1.55e-4)" "unprognostic (1.64e-1)" "unprognostic (3.37e-1)" "unprognostic (1.37e-2)" "unprognostic (1.05e-2)" 18.2 6.8 15.9 8.6 19.4 58.5 14.6 21.1 19.6 15.1 14.2 12.2 10.7 12.1 11.3 7.5 16.4 8.7 13.8 28.6 13.9 8.6 8.7 16.8 15.3 7.3 12.9 17.1 10.7 12.1 6.9 8.2 7.2 14.9 11.5 13.7 6.4 8.5 9.9 24.3 13.1 17.4 12.2 15.3 9.0 14.2 14.1 14.5 4.1 9.5 15.4 7.4 16.5 10.2 3.3 6.1 6.4 10.9 3.0 5.5 3.6 8.3 5.0 7.3 11.3 13.1 18.5 5.9 13.3 10.6 10.0 11.7 5.5 7.5 8.6 9.1 9.7 11.6 6.6 5.8 11.1 14.8 13.2 5.5 4.5 7.2 4.2 8.7 3.0 6.1 12.1 9.4 12.5 11.4 9.4 9.8 7.2 2.8 11.3 15.1 3.6 7.7 5.0 5.1 5.3 6.4 6.6 13.3 9.3 11.2 15.9 6.0 4.8 8.6 6.0 14.3 6.1 7.8 6.0 17.2 17.3 9.0 15.8 11.8 9.0 6.5 6.9 10.1 8.4 6.9 2.5 6.1 6.4 3.8 9.4 5.5 3.3 4.0 2.8 6.1 1.9 4.6 3.7 6.4 3.0 10.9 1.6 4.4 3.6 15.9 19.4 21.1 19.6 13.9 8.6 12.9 17.1 14.9 14.5 20.8 9.9 10.7 13.5 23.6 14.9 28.2 20.4 13.4 11.4 10.4 19.6 3.5 5.0 10.4 38.8 19.0 31.9 46.7 7.2 6.7 26.4 18.1 12.7 36.5 6.8 4.8 16.0 17.2 16.7 59.6 8.1 16.4 28.7 5.4 24.9 18.7 16.0 17.6 6.3 9.1 26.4 0.0 24.7 6.9 6.1 21.7 4.2 6.9 17.8 26.6 FEN1 "FEN-1, MF1, RAD2" ENSG00000168496 "Flap structure-specific endonuclease 1" P39748 11 61792637-61797244 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "Endonuclease, Exonuclease, Hydrolase, Nuclease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 36.3" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 61.7;Spermatogonia: 63.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002262, HPA006748" Enhanced Enhanced Nucleoplasm,Nucleoli NA Yes 38000 Nucleoplasm Nucleoli "CAB002262: AB_563729, HPA006748: AB_1848494" "unprognostic (1.82e-1)" "unprognostic (2.71e-2)" "unprognostic (3.76e-2)" "unprognostic (2.77e-1)" "unprognostic (1.26e-1)" "unprognostic (6.45e-2)" "prognostic unfavorable (3.39e-6)" "unprognostic (1.50e-2)" "unprognostic (9.82e-2)" "prognostic favorable (7.85e-4)" "unprognostic (2.82e-3)" "unprognostic (5.86e-2)" "prognostic unfavorable (5.73e-6)" "prognostic favorable (9.46e-4)" "unprognostic (1.10e-1)" "unprognostic (4.49e-3)" "unprognostic (4.04e-2)" 4.8 9.6 7.9 14.6 8.5 23.9 7.4 16.9 14.9 4.9 11.0 8.5 5.0 8.1 5.0 6.6 13.3 4.2 7.0 4.6 8.6 8.5 4.9 9.3 5.0 22.5 8.3 9.8 3.9 6.3 5.2 7.9 11.2 12.6 4.7 12.0 7.3 9.3 4.6 11.2 6.8 8.2 6.4 7.1 12.3 7.2 16.2 5.9 36.3 3.5 10.6 25.5 6.1 4.2 11.5 18.1 14.5 9.4 13.3 18.0 7.3 31.2 28.8 31.6 17.0 3.1 3.9 20.1 27.7 15.8 33.9 38.6 25.1 23.6 45.1 21.6 11.7 32.0 33.1 44.4 24.2 34.8 23.7 24.5 23.8 39.3 25.6 2.4 37.0 24.7 2.7 3.3 31.3 8.3 5.0 13.2 25.5 36.0 32.7 28.1 39.4 51.6 33.3 34.7 24.6 28.2 35.4 36.6 46.6 13.5 29.6 36.0 29.9 18.5 24.2 15.9 15.5 35.1 26.0 8.8 30.2 38.2 38.4 27.8 25.9 40.2 46.9 21.1 24.8 26.0 14.5 5.0 10.2 12.4 9.4 13.1 11.5 10.0 11.8 5.8 11.5 11.2 11.3 2.1 13.3 8.8 18.1 18.0 7.3 7.9 8.5 16.9 14.9 8.6 8.5 8.3 9.8 12.6 5.9 0.0 2.1 12.6 4.8 9.2 21.1 4.0 5.1 6.7 3.4 0.0 11.8 28.6 6.6 11.6 16.8 2.7 3.1 23.3 10.5 61.7 7.6 4.4 0.0 6.8 21.8 14.3 4.6 1.3 5.1 9.8 5.2 7.1 5.0 19.0 5.3 29.9 9.3 6.0 6.7 4.7 20.5 0.0 4.2 33.0 63.4 5.4 25.9 14.1 13.0 3.7 FERMT2 "KIND2, mig-2, PLEKHC1, UNC112B" ENSG00000073712 "Fermitin family member 2" Q96AC1 14 52857268-52952435 "Predicted intracellular proteins" "Cell adhesion, Cell shape, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "MAIT T-cell: 3.8" "Lineage enriched" "Detected in single" 39 "T-cells: 3.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040505, HPA072965" Uncertain Supported "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA 58000 "Focal adhesion sites" "Nucleoplasm, Cytosol" "HPA040505: AB_10673300, HPA072965: " "unprognostic (4.38e-2)" "unprognostic (4.25e-2)" "unprognostic (8.00e-3)" "unprognostic (2.42e-2)" "unprognostic (2.51e-2)" "unprognostic (4.89e-3)" "unprognostic (2.50e-2)" "unprognostic (1.92e-1)" "unprognostic (4.21e-2)" "unprognostic (1.07e-1)" "unprognostic (3.58e-1)" "unprognostic (1.99e-1)" "unprognostic (3.87e-2)" "unprognostic (3.96e-3)" "unprognostic (7.69e-2)" "unprognostic (3.14e-1)" "unprognostic (1.73e-3)" 45.9 7.2 15.5 12.3 14.3 0.1 24.4 7.9 12.8 24.1 36.6 12.7 16.0 4.2 41.6 14.2 20.6 22.2 22.2 21.8 18.3 7.5 18.4 35.3 18.1 5.4 15.0 9.1 23.3 6.7 5.8 7.2 37.9 10.7 24.1 11.5 11.0 7.1 41.3 14.5 5.0 11.0 56.7 12.9 11.7 21.4 10.2 15.5 0.6 13.3 6.2 2.1 49.5 16.5 0.0 0.0 0.0 0.0 0.0 3.8 0.0 4.8 4.3 22.8 10.4 37.3 30.7 19.0 32.6 21.1 38.8 24.5 7.3 3.9 0.0 11.1 33.3 7.6 2.1 17.7 2.4 29.2 0.0 4.9 6.8 19.5 8.6 47.9 0.1 2.8 29.5 5.2 21.3 28.3 17.7 20.0 3.7 0.1 34.4 29.0 5.9 1.6 0.1 14.4 0.0 11.3 0.8 23.2 0.0 13.6 4.5 1.4 29.3 34.5 7.7 8.0 24.2 6.7 0.2 25.0 30.6 21.0 24.3 12.0 5.1 6.1 0.1 7.0 0.0 7.3 0.0 0.0 0.0 0.1 0.0 3.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 14.3 7.9 12.4 18.3 7.5 15.0 9.1 10.7 15.5 71.5 50.2 0.0 111.7 16.6 32.8 53.2 20.4 14.7 37.5 38.4 35.3 69.7 26.6 48.1 59.4 87.9 0.0 0.0 28.6 138.3 102.2 34.3 56.6 71.6 9.0 14.3 0.0 120.9 9.2 20.6 69.3 6.2 43.9 8.2 0.0 57.0 23.6 0.0 164.4 37.4 57.4 148.8 146.8 3.4 10.0 7.0 85.8 4.3 0.0 35.6 FES FPS ENSG00000182511 "FES proto-oncogene, tyrosine kinase" P07332 15 90883695-90895776 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Proto-oncogene, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 60.8;lymphoid tissue: 49.7" "Cell type enhanced" "Detected in many" 11 "Hofbauer cells: 40.6;Kupffer cells: 93.1;Macrophages: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 60.8" "Group enriched" "Detected in many" 4 "dendritic cells: 32.6;granulocytes: 60.8;monocytes: 30.5" "Cell line enhanced" "Detected in many" "HEL: 21.3;HL-60: 19.0;HMC-1: 40.7;NB-4: 24.9;THP-1: 37.4;U-937: 16.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA001376 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA001376: AB_1078847" "unprognostic (1.07e-2)" "unprognostic (2.54e-2)" "prognostic unfavorable (5.78e-4)" "unprognostic (2.31e-2)" "unprognostic (4.05e-3)" "unprognostic (7.33e-2)" "unprognostic (1.74e-1)" "unprognostic (2.22e-1)" "unprognostic (1.58e-3)" "unprognostic (1.35e-1)" "unprognostic (4.66e-2)" "unprognostic (5.15e-3)" "unprognostic (1.78e-3)" "unprognostic (2.53e-3)" "unprognostic (6.08e-2)" "unprognostic (1.18e-1)" "unprognostic (1.40e-1)" 14.9 3.4 4.8 9.7 4.1 38.3 12.7 2.4 5.7 6.8 5.4 3.2 4.7 3.0 7.4 5.6 4.9 7.6 7.3 7.9 4.2 2.2 5.2 11.8 12.7 23.3 3.7 0.9 6.4 3.7 1.8 2.7 8.1 7.2 7.7 2.4 5.3 33.8 6.3 3.4 3.5 5.2 5.4 6.9 49.7 4.3 3.2 4.7 3.1 7.2 4.1 4.5 7.2 9.4 1.1 32.6 60.8 30.5 9.3 0.1 13.8 0.1 0.2 0.3 3.6 1.0 3.1 6.1 0.9 0.0 1.8 1.0 0.9 0.0 2.3 0.1 2.0 0.0 0.5 0.6 0.1 0.5 1.2 0.3 21.3 0.0 3.8 2.1 19.0 40.7 3.1 0.0 2.6 0.0 0.0 10.8 3.2 0.6 0.0 0.0 6.9 0.6 24.9 1.0 0.8 0.0 2.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.0 0.9 1.1 0.0 37.4 8.4 0.0 3.7 0.1 0.0 0.0 2.7 0.8 0.1 16.1 0.8 10.4 30.5 60.8 0.1 17.6 0.0 1.1 0.0 0.0 32.6 0.9 0.0 0.0 20.0 9.3 7.3 12.9 0.0 13.8 4.8 4.1 2.4 5.7 4.2 2.2 3.7 0.9 7.2 4.7 3.0 8.0 6.4 4.7 3.4 0.0 2.5 5.1 0.0 0.0 1.8 0.0 4.5 3.3 4.8 1.1 24.5 0.4 0.0 3.9 3.8 6.2 4.0 28.8 8.2 40.6 0.0 2.9 22.7 93.1 4.7 8.3 37.3 6.8 27.1 2.1 2.3 2.0 0.0 9.6 1.3 1.9 12.9 7.2 3.5 9.1 2.5 3.8 10.2 2.6 5.2 FEZF1 ZNF312B ENSG00000128610 "FEZ family zinc finger 1" A0PJY2 7 122301394-122310691 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 16.7;testis: 11.0" "Cell type enriched" "Detected in single" 5 "Spermatocytes: 2.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "hypothalamus: 16.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "NTERA-2: 58.8;SCLC-21H: 25.7" "Region enriched" "Detected in single" 11 "hypothalamus: 13.7" "Region enriched" "Detected in some" 9 "hypothalamus: 6.9" "HPA064639, HPA073693" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA064639: AB_2685308, HPA073693: AB_2686626" "unprognostic (8.48e-2)" "unprognostic (3.41e-2)" "unprognostic (3.64e-1)" "unprognostic (3.43e-2)" "unprognostic (4.17e-1)" "unprognostic (4.10e-2)" "unprognostic (2.64e-3)" "unprognostic (2.54e-1)" "unprognostic (1.34e-1)" "unprognostic (2.96e-2)" "unprognostic (2.55e-1)" "unprognostic (1.48e-2)" 0.6 0.2 6.4 0.2 4.9 0.2 0.2 0.0 2.0 0.2 0.2 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.3 1.0 16.7 0.2 0.2 0.2 0.2 2.0 0.0 0.3 0.2 0.2 3.1 0.2 0.0 0.3 0.2 1.4 0.6 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.3 11.0 3.5 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 58.8 1.4 1.0 0.0 0.0 0.0 0.0 0.1 25.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.8 0.1 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 4.9 0.0 2.0 1.0 16.7 2.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.0 FGD3 "FLJ00004, ZFYVE5" ENSG00000127084 "FYVE, RhoGEF and PH domain containing 3" Q5JSP0 9 92947451-93036236 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 49.2;lymphoid tissue: 48.1" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 52.4;Late spermatids: 74.6;T-cells: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 21.0;Karpas-707: 29.2;RT4: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA020963, HPA021018" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA020963: AB_2670542, HPA021018: AB_2670564" "unprognostic (5.66e-3)" "prognostic favorable (5.51e-4)" "unprognostic (5.05e-3)" "unprognostic (1.75e-2)" "unprognostic (1.14e-1)" "prognostic favorable (2.23e-7)" "unprognostic (2.26e-1)" "unprognostic (1.03e-2)" "unprognostic (2.61e-2)" "unprognostic (2.55e-1)" "unprognostic (2.68e-2)" "unprognostic (2.32e-1)" "unprognostic (8.56e-2)" "unprognostic (3.96e-1)" "unprognostic (1.60e-1)" "unprognostic (9.66e-2)" "unprognostic (1.22e-2)" 3.1 1.5 2.3 20.5 2.5 23.4 3.5 0.5 1.6 1.8 3.1 3.1 1.6 1.9 2.8 2.5 2.8 2.5 3.1 1.5 2.2 2.0 4.6 2.1 7.5 30.5 3.3 1.0 1.1 5.7 0.1 1.0 2.6 2.6 3.2 1.4 2.2 6.6 1.0 0.7 3.1 10.1 1.5 6.3 28.1 2.6 3.9 2.5 48.1 3.5 2.1 25.8 7.7 3.2 11.3 10.3 49.2 24.7 10.5 15.7 17.1 6.4 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 8.0 4.4 5.2 0.3 0.0 0.0 4.2 0.3 0.0 0.0 9.0 0.0 8.2 0.0 0.3 0.0 2.2 21.0 0.0 0.1 0.0 0.0 0.0 0.0 8.8 0.3 29.2 0.0 10.7 9.6 9.2 0.2 2.1 0.5 9.5 0.0 7.4 0.0 16.5 0.6 0.2 0.0 7.1 0.2 0.2 2.8 9.7 0.0 0.0 0.3 0.0 0.0 2.9 2.9 2.4 1.5 4.6 0.0 34.0 13.4 36.7 15.1 17.3 15.5 8.5 15.6 14.1 10.3 11.3 15.7 13.3 49.2 10.5 24.7 4.7 13.5 17.1 2.3 2.5 0.5 1.6 2.2 2.0 3.3 1.0 2.6 2.5 20.8 11.6 2.7 0.7 0.7 0.0 2.2 2.5 0.0 3.4 8.7 0.0 2.1 0.0 5.5 52.4 1.4 0.0 0.0 0.2 2.9 0.8 0.0 18.5 0.6 12.6 0.0 1.7 2.5 17.8 74.6 0.3 12.6 1.7 2.8 0.3 0.3 0.4 0.0 0.4 0.6 4.2 0.0 0.9 1.6 1.9 0.9 3.8 38.3 0.1 0.4 FGF1 "AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-alpha, FGFA, GLIO703, HBGF1" ENSG00000113578 "Fibroblast growth factor 1" P05230 5 142592178-142698070 "Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 65.0;heart muscle: 35.5;kidney: 41.5" "Cell type enhanced" "Detected in some" 18 "Cardiomyocytes: 49.6;Collecting duct cells: 19.2;Cone photoreceptor cells: 15.7;Muller glia cells: 68.6" "Cancer enriched" "Detected in many" 12 "glioma: 33.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 19.8;BJ hTERT+: 14.8;BJ hTERT+ SV40 Large T+: 16.3;BJ hTERT+ SV40 Large T+ RasG12V: 20.6;HBF TERT88: 29.5;hTEC/SVTERT24-B: 20.6;LHCN-M2: 13.7;U-2 OS: 14.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003265, CAB017519" Enhanced Supported Nucleoplasm "Secreted in other tissues" NA NA Nucleoplasm "CAB017519: AB_629473, HPA003265: AB_1848522" "unprognostic (1.25e-2)" "unprognostic (2.43e-1)" "unprognostic (1.06e-1)" "unprognostic (3.41e-3)" "unprognostic (2.55e-2)" "unprognostic (3.52e-1)" "unprognostic (2.77e-1)" "unprognostic (2.39e-1)" "unprognostic (3.63e-1)" "unprognostic (1.57e-2)" "unprognostic (1.89e-1)" "unprognostic (1.54e-1)" "prognostic favorable (2.59e-5)" "unprognostic (3.72e-4)" "unprognostic (2.49e-1)" "prognostic favorable (3.45e-5)" "unprognostic (3.01e-4)" 7.3 3.5 44.2 2.0 43.1 1.5 9.7 10.5 59.9 1.8 1.7 65.0 0.0 1.6 3.1 8.7 2.3 2.1 2.7 35.5 47.4 33.0 41.5 2.0 2.9 1.4 62.6 13.8 1.5 1.4 3.4 1.6 2.3 36.3 2.2 1.8 0.8 5.8 2.6 2.3 2.0 1.7 2.6 57.7 5.5 1.1 2.2 48.6 0.0 4.9 0.8 2.2 1.7 0.4 1.2 1.0 1.8 0.6 0.1 2.3 0.2 2.4 0.1 0.1 0.7 0.5 1.5 0.8 19.8 14.8 16.3 20.6 0.1 0.1 0.5 1.4 6.8 0.9 0.3 0.0 1.5 29.5 0.1 0.0 0.0 0.3 0.1 0.3 0.0 0.2 0.7 0.5 20.6 1.2 4.4 0.0 0.1 0.0 0.7 13.7 0.3 0.0 0.4 0.6 0.0 0.6 0.1 0.7 0.2 0.6 0.1 0.5 1.0 0.0 0.4 0.2 3.9 0.0 0.1 0.4 2.6 14.7 0.3 9.3 0.3 0.1 0.1 3.7 0.1 0.7 0.3 0.3 1.8 2.3 0.1 1.8 0.4 0.8 0.9 0.2 1.2 0.9 1.9 1.7 0.1 0.6 1.0 0.5 0.2 44.2 43.1 10.5 22.6 47.4 33.0 62.6 13.8 36.3 48.6 0.0 0.0 0.0 3.4 0.3 1.6 49.6 0.0 0.0 3.4 19.2 15.7 0.5 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.4 1.8 1.4 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.4 0.0 0.0 3.3 0.0 0.0 68.6 0.7 0.0 0.4 0.0 9.6 6.5 4.7 0.0 0.1 0.0 0.7 0.0 0.0 0.3 FGF12 "FGF12B, FHF1" ENSG00000114279 "Fibroblast growth factor 12" P61328 3 192139395-192767764 "Disease related genes, Predicted intracellular proteins" "Growth factor" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 21.5;brain: 31.9;heart muscle: 75.7" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 381.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 11.8;NTERA-2: 8.1;SCLC-21H: 18.9;U-251 MG: 11.3;WM-115: 13.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071557 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA071557: AB_2686417" "unprognostic (1.67e-3)" "unprognostic (1.29e-1)" "unprognostic (2.26e-2)" "unprognostic (2.50e-5)" "unprognostic (1.75e-1)" "unprognostic (5.66e-2)" "unprognostic (1.04e-1)" "unprognostic (1.80e-1)" "unprognostic (8.03e-2)" "unprognostic (2.11e-2)" "unprognostic (4.00e-2)" "unprognostic (9.19e-2)" "unprognostic (1.87e-7)" "unprognostic (2.41e-2)" "unprognostic (5.36e-2)" "unprognostic (5.59e-2)" "unprognostic (5.99e-2)" 1.2 21.5 8.8 0.7 15.8 0.6 1.0 17.7 31.9 0.9 0.9 1.9 0.0 1.0 1.2 0.7 1.5 1.5 0.9 75.7 6.8 4.1 2.0 0.9 1.2 0.7 5.1 15.8 1.1 4.9 0.7 2.9 0.8 22.3 1.3 0.8 1.1 3.6 4.2 1.1 0.7 0.7 1.0 2.7 6.8 0.9 1.7 2.8 0.0 1.4 0.0 0.7 0.8 0.8 1.1 0.3 1.2 0.4 0.5 0.4 0.1 0.0 0.8 11.8 0.0 0.0 0.0 0.1 0.0 0.1 1.1 1.4 0.0 0.1 0.6 5.7 0.2 0.2 0.1 0.0 0.0 1.3 0.1 0.1 2.4 5.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 2.9 0.1 0.0 0.0 0.1 0.0 3.3 0.0 0.0 8.1 5.4 0.2 0.0 0.1 0.0 3.7 1.4 18.9 0.0 0.0 0.4 0.0 1.4 0.9 0.2 0.3 4.9 2.5 0.0 11.3 0.1 1.8 0.0 1.0 0.0 13.7 1.2 0.2 0.5 0.2 0.3 0.4 1.1 0.2 0.2 0.1 0.5 0.4 0.3 0.6 0.5 0.4 0.3 0.3 0.1 8.8 15.8 17.7 31.9 6.8 4.1 5.1 15.8 22.3 2.8 0.0 0.0 0.0 4.3 0.6 77.1 381.1 0.0 1.4 3.4 5.2 3.9 0.1 6.6 0.7 15.9 4.9 0.0 0.0 11.4 0.2 0.8 1.0 0.0 0.0 0.1 31.8 0.0 8.6 0.3 21.4 6.4 0.0 1.7 0.0 0.0 2.9 4.0 0.2 1.1 0.2 13.0 0.0 0.5 2.1 6.1 0.1 0.0 0.0 0.0 1.4 FGF2 FGFB ENSG00000138685 "Fibroblast growth factor 2" P09038 4 122826708-122898236 "Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins, Transporters" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Fibroblasts: 12.4;Smooth muscle cells: 15.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ: 57.4;BJ hTERT+: 33.7;fHDF/TERT166: 62.3;hTERT-HME1: 34.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000125, HPA065502" Enhanced Supported "Nucleoplasm,Nuclear bodies" "Secreted in other tissues" NA NA 92500 "Nucleoplasm, Nuclear bodies" "CAB000125: , HPA065502: " "unprognostic (1.53e-2)" "unprognostic (3.12e-1)" "unprognostic (1.08e-1)" "unprognostic (7.42e-2)" "unprognostic (2.10e-1)" "unprognostic (3.33e-1)" "unprognostic (6.98e-2)" "unprognostic (1.25e-1)" "unprognostic (2.82e-1)" "unprognostic (1.79e-1)" "prognostic unfavorable (9.85e-4)" "unprognostic (3.37e-1)" "unprognostic (4.61e-3)" "unprognostic (2.36e-1)" "unprognostic (1.81e-1)" "unprognostic (4.45e-2)" "unprognostic (3.45e-3)" 28.1 3.8 19.4 6.9 21.3 0.7 12.1 6.5 15.3 10.2 14.2 10.3 1.9 2.6 17.9 6.3 6.4 10.1 9.4 5.6 17.1 11.0 5.5 2.9 8.3 2.5 9.9 10.7 16.8 2.4 10.1 4.0 8.1 18.6 10.3 5.6 7.5 4.6 11.9 2.0 2.3 4.1 16.2 17.3 1.9 7.6 3.0 12.3 0.0 3.1 3.8 2.7 7.5 14.5 0.8 0.8 0.5 0.5 0.3 1.0 0.0 1.2 3.1 1.8 6.9 4.4 7.4 0.0 57.4 33.7 24.1 14.0 0.0 0.1 0.0 6.7 62.3 19.0 0.2 1.8 0.1 24.3 4.5 0.8 0.0 6.5 0.0 13.0 0.3 0.0 3.9 0.4 23.8 34.4 12.1 2.6 0.0 1.7 1.9 6.2 0.0 0.0 0.0 5.2 0.0 1.4 0.0 0.9 0.0 7.6 0.0 1.0 0.9 11.1 0.0 0.4 10.8 0.0 0.1 2.4 20.0 3.9 7.4 4.9 3.4 3.6 0.0 5.7 0.0 2.1 0.5 0.5 0.4 0.3 0.4 0.2 0.4 0.5 0.4 0.2 0.8 0.7 1.0 0.4 0.3 0.4 0.8 0.7 0.0 19.4 21.3 6.5 15.3 17.1 11.0 9.9 10.7 18.6 12.3 6.0 0.0 0.0 1.5 1.4 3.5 3.9 0.0 0.0 2.3 7.0 0.0 1.8 3.3 6.9 8.7 5.8 0.0 0.0 0.8 0.0 12.4 5.2 0.0 0.4 0.4 0.0 1.7 7.4 0.0 2.5 9.2 0.9 5.0 1.0 0.0 8.4 6.7 0.0 7.8 0.4 1.8 0.0 15.5 3.1 0.2 1.1 4.0 0.0 0.0 0.3 FGF5 ENSG00000138675 "Fibroblast growth factor 5" P12034 4 80266599-80336680 "Disease related genes, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Mitogen" "Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 38.2" "Cell type enhanced" "Detected in some" 16 "Club cells: 1.2;Distal tubular cells: 1.7;Proximal tubular cells: 2.6" "Not detected" "Not detected" "Region enriched" "Detected in many" 9 "cerebellum: 38.2" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 20.2;BJ hTERT+: 38.1;fHDF/TERT166: 27.5;HBF TERT88: 28.7;LHCN-M2: 25.7;U-138 MG: 35.6;U-251 MG: 17.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB010313, HPA042442" Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Secreted in brain" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "CAB010313: AB_2102677, HPA042442: AB_2678001" "unprognostic (6.44e-2)" "unprognostic (6.24e-3)" "unprognostic (8.49e-4)" "unprognostic (1.10e-1)" "unprognostic (2.91e-1)" "unprognostic (2.80e-3)" "unprognostic (6.87e-4)" "unprognostic (2.53e-1)" "unprognostic (1.69e-1)" "unprognostic (3.57e-3)" "unprognostic (1.17e-2)" "unprognostic (3.33e-16)" "unprognostic (3.02e-3)" "unprognostic (3.14e-1)" "unprognostic (2.83e-2)" 0.1 0.1 0.1 1.7 0.1 0.5 0.1 38.2 1.3 0.1 3.1 0.0 0.0 0.4 0.4 0.1 1.3 0.1 9.2 0.3 1.6 0.2 2.3 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.0 1.3 0.1 4.1 0.2 0.1 0.0 0.1 0.0 0.5 0.4 2.8 2.4 0.3 0.1 0.8 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.7 0.7 1.7 0.3 0.2 0.5 0.0 0.0 0.0 0.0 0.0 2.0 7.2 0.0 20.2 38.1 5.3 3.9 0.0 0.0 0.0 0.0 27.5 0.4 0.0 0.0 7.0 28.7 0.0 0.3 0.0 0.0 0.0 0.5 0.2 0.0 2.0 0.0 15.6 7.5 9.0 1.8 0.0 0.0 0.1 25.7 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 6.5 35.6 1.4 1.7 17.0 0.0 0.0 0.0 2.0 0.0 0.7 1.7 0.3 0.3 0.4 0.2 0.5 0.2 0.3 0.4 0.2 0.7 0.5 0.5 0.9 0.2 0.2 0.7 0.2 0.0 0.1 0.1 38.2 1.3 1.6 0.2 0.2 0.2 4.1 0.1 0.0 0.6 0.0 0.5 0.0 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 1.7 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FGF7 KGF ENSG00000140285 "Fibroblast growth factor 7" P21781 15 49423096-49488775 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Heparin-binding, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 101.2;Fibroblasts: 91.0;Leydig cells: 77.1;Smooth muscle cells: 82.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "basophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 24.2;ASC TERT1: 22.3;fHDF/TERT166: 10.0;HSkMC: 22.6;RH-30: 18.0;U-138 MG: 12.2" "Region enriched" "Detected in single" 9 "cerebellum: 9.7" HPA043605 Uncertain Approved Nucleoplasm,Nucleoli "Secreted in other tissues" NA NA "Nucleoplasm, Nucleoli" "HPA043605: AB_10960215" "unprognostic (4.65e-1)" "unprognostic (7.62e-2)" "unprognostic (2.50e-1)" "unprognostic (6.98e-2)" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (3.62e-2)" "unprognostic (5.74e-3)" "unprognostic (2.56e-2)" "unprognostic (7.30e-2)" "unprognostic (5.79e-2)" "unprognostic (1.91e-3)" "unprognostic (1.22e-3)" "unprognostic (7.59e-2)" "unprognostic (1.98e-3)" "unprognostic (1.63e-3)" 39.7 2.7 0.6 9.9 0.6 0.0 16.5 0.6 2.4 73.3 22.2 0.0 10.1 1.1 13.1 16.1 25.2 14.1 25.4 19.1 0.6 0.6 5.9 1.2 44.8 5.5 2.1 0.0 43.7 2.5 2.9 2.8 9.1 0.8 42.5 4.5 2.7 6.4 8.1 25.6 3.6 4.2 38.3 1.4 1.0 6.6 12.7 0.0 0.0 23.2 24.7 2.9 72.2 32.4 0.2 0.1 1.6 0.2 0.3 0.5 0.0 0.1 0.0 0.1 0.1 24.2 22.3 0.0 7.3 4.5 0.0 0.0 0.0 0.1 0.0 0.1 10.0 0.2 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 2.1 0.1 0.0 22.6 0.4 1.9 0.0 0.1 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.1 0.1 0.0 0.1 0.0 18.0 0.0 0.0 0.0 0.9 0.3 0.2 0.0 0.0 0.1 0.1 0.1 0.1 12.2 0.2 0.4 0.0 0.2 0.1 0.0 3.3 0.0 0.2 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.3 0.0 0.2 0.5 0.2 0.0 0.3 0.2 0.1 0.4 0.0 0.6 0.6 0.6 0.6 0.6 0.6 2.1 0.0 0.8 0.0 11.9 13.4 0.9 13.5 12.8 7.9 40.0 5.1 0.0 0.0 8.7 2.0 4.7 101.2 1.1 2.8 5.3 0.0 0.0 0.6 3.8 91.0 9.0 1.1 2.5 1.8 3.2 0.0 0.0 1.0 3.1 77.1 3.1 6.8 0.0 0.0 7.3 0.6 0.0 4.6 24.5 6.0 6.5 82.4 0.3 0.1 11.0 2.4 1.0 0.0 7.1 FGFR2 "BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25" ENSG00000066468 "Fibroblast growth factor receptor 2" P21802 10 121478334-121598458 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" Apoptosis "Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Craniosynostosis, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.8" "Cell type enhanced" "Detected in many" 16 "Cholangiocytes: 191.1;Club cells: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 15 "basophil: 10.8;eosinophil: 4.6" "Lineage enriched" "Detected in single" 35 "granulocytes: 10.8" "Cell line enhanced" "Detected in some" "AN3-CA: 58.9;BEWO: 19.8;CACO-2: 15.4;HaCaT: 17.8;HAP1: 19.1;NTERA-2: 18.9;T-47d: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010886, HPA035305" Uncertain Supported "Nucleoplasm,Vesicles,Cell Junctions" "Secreted - unknown location" NA NA 500000 "Cell Junctions" "Nucleoplasm, Vesicles" "CAB010886: AB_259379, HPA035305: AB_10672862" "unprognostic (5.53e-2)" "prognostic favorable (8.79e-4)" "unprognostic (1.08e-1)" "unprognostic (5.23e-2)" "unprognostic (1.73e-1)" "prognostic favorable (9.32e-4)" "unprognostic (1.53e-1)" "unprognostic (4.96e-3)" "unprognostic (1.74e-1)" "unprognostic (1.56e-1)" "unprognostic (1.07e-1)" "unprognostic (3.74e-2)" "unprognostic (1.01e-1)" "unprognostic (6.11e-2)" "unprognostic (2.54e-1)" "unprognostic (6.93e-2)" "unprognostic (2.25e-1)" 2.1 8.8 16.4 3.0 30.3 0.0 9.9 15.8 21.3 6.8 14.1 55.7 5.6 4.2 22.0 6.6 10.2 12.5 12.5 1.4 20.6 11.1 11.4 16.1 13.1 1.0 41.2 13.3 7.4 12.8 25.5 2.5 6.2 30.2 11.7 8.7 16.4 23.8 24.3 0.4 45.4 4.7 18.3 74.8 0.5 9.3 2.9 32.1 0.8 23.4 1.6 3.4 6.9 8.5 0.1 0.1 10.8 0.1 0.1 0.3 0.0 2.2 0.1 9.2 58.9 0.0 0.0 19.8 0.1 0.0 0.0 0.0 15.4 0.3 0.0 4.2 0.9 0.0 17.8 19.1 4.0 0.0 0.0 4.1 0.0 0.0 0.3 0.4 0.0 3.8 0.0 8.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 18.9 2.7 0.0 0.0 0.0 2.3 5.7 5.0 0.1 0.1 0.1 10.8 0.0 11.5 15.8 0.0 0.0 0.1 2.9 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 10.8 0.1 4.6 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.0 16.4 30.3 15.8 21.3 20.6 11.1 41.2 13.3 30.2 32.1 17.9 31.8 0.0 29.5 35.6 0.0 2.7 191.1 18.7 52.4 34.9 0.0 12.6 0.0 4.0 2.9 0.5 2.6 0.0 0.2 2.7 17.5 9.8 0.0 4.3 2.0 0.0 2.4 3.1 0.3 6.5 1.1 1.3 5.0 1.0 32.0 1.6 0.6 1.4 5.6 11.5 0.1 0.0 2.1 0.9 7.7 24.2 3.3 1.5 3.0 27.7 FGGY FLJ10986 ENSG00000172456 "FGGY carbohydrate kinase domain containing" Q96C11 1 59296638-59810647 "Disease related genes, Predicted intracellular proteins" "Kinase, Transferase" "Amyotrophic lateral sclerosis, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 45.4" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 2: 181.0;Cholangiocytes: 349.1;Hepatocytes: 122.9" "Cancer enhanced" "Detected in all" "liver cancer: 13.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 26.8;RH-30: 18.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054971 Approved "Nucleoplasm,Nuclear bodies" NA NA 110000 "Nucleoplasm, Nuclear bodies" "HPA054971: " "unprognostic (4.15e-1)" "unprognostic (1.87e-1)" "unprognostic (2.31e-2)" "unprognostic (2.80e-2)" "unprognostic (2.02e-1)" "unprognostic (2.20e-3)" "unprognostic (1.47e-3)" "unprognostic (1.80e-2)" "unprognostic (4.09e-1)" "unprognostic (2.78e-1)" "unprognostic (2.92e-1)" "unprognostic (1.47e-1)" "unprognostic (4.36e-3)" "unprognostic (7.22e-2)" "unprognostic (1.44e-1)" "unprognostic (2.70e-1)" "unprognostic (1.78e-1)" 4.5 10.3 5.4 6.5 5.7 1.4 4.6 23.2 5.5 4.9 5.1 4.4 10.1 4.9 9.6 26.1 4.5 7.0 8.6 7.6 3.7 5.0 13.0 45.4 7.8 5.2 6.2 3.3 3.8 8.4 9.9 7.4 2.7 4.4 5.7 4.7 6.8 7.6 8.8 26.0 3.7 7.6 6.3 3.0 3.4 3.8 2.9 3.4 4.5 5.4 4.3 6.9 6.2 3.7 8.2 3.6 3.9 4.8 4.7 8.0 3.0 2.8 0.9 6.1 2.5 3.0 10.8 0.5 2.5 4.3 1.5 2.2 0.0 2.2 3.4 8.3 6.8 2.7 1.2 1.0 7.6 3.1 26.8 0.7 2.3 2.0 5.4 8.0 1.3 1.5 15.2 6.4 3.1 5.0 6.4 2.9 3.9 1.6 2.1 9.7 3.3 1.8 2.0 3.8 8.3 3.3 4.0 18.6 1.3 8.1 5.5 4.7 2.0 3.5 2.1 7.3 5.4 1.7 1.4 2.8 2.5 1.9 2.9 1.7 4.9 1.7 2.9 8.3 5.6 2.3 2.6 2.2 2.2 5.4 2.3 5.0 8.2 2.6 6.6 3.6 6.8 4.8 8.0 3.9 4.7 4.8 1.8 4.5 3.0 5.4 5.7 23.2 5.5 3.7 5.0 6.2 3.3 4.4 3.4 50.6 181.0 3.7 19.6 18.5 9.2 20.3 349.1 56.2 27.3 12.2 11.8 7.6 14.9 35.1 12.9 6.3 8.8 0.0 38.7 3.8 4.5 19.5 9.3 122.9 10.8 7.9 2.4 6.7 8.0 8.9 1.7 8.5 33.7 16.2 9.9 11.7 15.0 7.8 2.8 34.0 15.5 0.0 4.4 3.9 7.9 27.6 3.8 2.9 16.3 26.4 FHL3 SLIM2 ENSG00000183386 "Four and a half LIM domains 3" Q13643 1 37996770-38005606 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 9 "blood: 67.9;skeletal muscle: 247.1;tongue: 100.1" "Cell type enhanced" "Detected in many" 7 "granulocytes: 73.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 9 "eosinophil: 67.9" "Lineage enriched" "Detected in many" 12 "granulocytes: 67.9" "Cell line enhanced" "Detected in many" "HEL: 29.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA045723 Approved Nucleoplasm NA NA Nucleoplasm "HPA045723: AB_10966278" "prognostic favorable (5.62e-4)" "unprognostic (1.12e-1)" "unprognostic (3.02e-3)" "unprognostic (6.97e-2)" "unprognostic (2.26e-1)" "unprognostic (1.88e-2)" "prognostic unfavorable (8.59e-5)" "unprognostic (1.02e-3)" "unprognostic (1.80e-1)" "unprognostic (1.36e-1)" "unprognostic (9.05e-2)" "unprognostic (5.05e-2)" "prognostic unfavorable (4.20e-11)" "unprognostic (8.88e-3)" "unprognostic (2.38e-1)" "unprognostic (4.94e-2)" "unprognostic (2.77e-2)" 7.0 2.0 1.2 3.3 2.1 3.9 4.5 0.6 1.4 5.5 6.4 1.3 2.4 1.1 7.5 8.1 6.9 4.4 3.6 2.3 1.6 1.1 1.7 1.3 2.9 5.0 2.4 0.9 7.6 2.0 1.4 1.1 2.1 2.1 4.8 1.6 2.2 5.5 3.6 247.1 2.6 1.9 12.0 2.2 2.5 2.7 1.7 1.0 0.3 1.8 100.1 4.0 15.5 5.7 0.1 3.8 67.9 5.7 3.0 3.4 2.3 6.2 2.3 6.2 6.3 5.8 23.6 3.9 5.0 9.8 9.4 7.0 5.2 5.0 0.0 8.4 11.2 4.5 2.4 4.0 6.0 4.7 2.3 7.2 29.5 5.1 5.9 22.8 2.3 21.7 20.8 6.9 10.8 6.1 20.1 13.2 3.1 24.8 0.1 17.6 3.3 0.8 10.0 8.1 0.4 1.6 4.0 5.2 0.4 6.2 1.1 0.7 3.2 4.5 0.4 7.2 12.1 1.9 2.0 9.3 4.2 9.5 1.1 4.5 1.6 5.7 0.7 1.9 13.8 4.3 1.3 5.7 67.9 3.2 3.7 3.4 0.0 0.7 1.6 3.8 0.1 0.5 0.7 7.4 3.0 2.4 0.1 1.6 2.3 1.2 2.1 0.6 1.3 1.6 1.1 2.4 0.9 2.1 1.0 0.0 4.0 0.5 16.0 18.5 0.3 3.9 5.1 0.0 4.5 7.0 0.0 7.1 1.7 16.8 0.6 9.3 0.0 0.0 24.2 26.2 19.0 5.1 73.7 0.9 25.9 0.0 0.0 15.4 14.3 0.9 20.8 24.2 5.0 8.2 0.0 2.4 24.2 0.0 30.1 2.5 0.3 25.8 30.6 1.1 14.7 14.2 8.1 12.2 0.0 8.4 FICD "HIP13, HYPE" ENSG00000198855 "FIC domain containing" Q9BVA6 12 108515185-108525837 "Enzymes, Predicted intracellular proteins" "Unfolded protein response" "Hydrolase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 65.6;Late spermatids: 37.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021390, HPA071134" Approved Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA021390: AB_1851340, HPA071134: AB_2686347" "unprognostic (1.00e-1)" "unprognostic (8.76e-2)" "unprognostic (1.76e-2)" "prognostic favorable (4.61e-5)" "unprognostic (6.92e-2)" "unprognostic (2.68e-2)" "unprognostic (5.73e-2)" "unprognostic (2.84e-2)" "unprognostic (8.68e-2)" "unprognostic (2.57e-1)" "unprognostic (3.15e-2)" "unprognostic (1.19e-1)" "unprognostic (7.66e-2)" "unprognostic (1.56e-2)" "unprognostic (6.22e-2)" "unprognostic (3.12e-2)" "unprognostic (3.65e-2)" 4.2 9.6 5.6 6.1 8.2 3.0 4.5 4.0 6.7 8.5 3.8 7.3 10.5 3.9 4.6 15.8 2.3 4.1 4.1 3.5 5.4 5.9 5.2 16.4 5.0 4.9 8.9 5.1 4.8 27.9 4.8 15.3 7.9 6.0 6.1 3.6 10.2 19.7 7.9 2.6 3.4 3.3 4.6 7.5 4.8 5.1 8.5 6.6 5.4 13.6 1.0 6.2 4.1 4.5 5.0 15.2 10.9 5.4 3.1 8.0 1.8 1.9 4.8 2.0 3.9 4.7 3.3 5.4 12.7 6.7 6.0 4.2 3.0 1.9 2.7 4.8 6.0 7.1 2.5 2.1 1.4 5.3 4.5 3.1 1.5 3.7 4.2 18.5 2.2 5.7 1.5 3.0 8.4 12.1 7.4 4.3 2.5 1.0 9.1 5.3 4.4 2.9 2.3 2.1 2.0 8.0 1.7 2.6 6.5 2.8 3.8 1.9 1.3 5.7 2.7 6.2 3.0 4.2 2.2 4.8 6.2 2.2 10.8 4.8 18.2 2.9 0.9 8.5 2.0 4.3 10.9 2.8 4.2 6.8 4.8 8.0 5.0 5.0 6.2 2.7 3.3 2.9 5.6 5.5 3.1 5.4 15.2 3.1 1.8 5.6 8.2 4.0 6.7 5.4 5.9 8.9 5.1 6.0 6.6 0.0 3.0 1.5 2.9 0.7 5.2 1.7 5.1 2.7 0.0 7.0 2.0 4.9 5.0 3.7 65.6 3.7 1.6 0.0 8.1 3.9 4.7 7.7 13.8 4.9 5.7 12.7 1.7 4.9 1.8 37.2 3.1 4.7 6.8 3.6 2.5 14.7 7.6 0.8 9.2 1.8 8.3 12.9 2.7 7.2 6.8 2.9 26.0 4.5 1.6 4.2 FIGN ENSG00000182263 "Fidgetin, microtubule severing factor" Q5HY92 2 163593396-163736012 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Leydig cells: 48.1;Peritubular cells: 32.2;Sertoli cells: 71.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 54 "basophil: 5.4" "Lineage enriched" "Detected in single" 54 "granulocytes: 5.4" "Cell line enhanced" "Detected in many" "AF22: 17.2;SuSa: 10.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034987, HPA057919" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "Vesicles, Cell Junctions" "HPA034987: AB_10669681, HPA057919: " "unprognostic (3.93e-2)" "unprognostic (8.30e-3)" "unprognostic (1.48e-1)" "unprognostic (7.68e-5)" "unprognostic (3.45e-2)" "unprognostic (8.98e-4)" "unprognostic (5.23e-3)" "unprognostic (7.65e-3)" "unprognostic (2.33e-1)" "unprognostic (1.64e-1)" "unprognostic (2.07e-2)" "unprognostic (3.24e-2)" "unprognostic (3.85e-3)" "unprognostic (3.22e-2)" "unprognostic (2.69e-1)" "unprognostic (4.10e-2)" "unprognostic (3.78e-2)" 8.5 7.6 9.6 2.9 13.7 2.8 5.2 5.1 11.9 6.8 5.9 5.5 3.7 2.1 3.3 5.0 2.9 4.5 4.4 10.1 8.8 4.3 7.2 7.9 4.3 2.5 8.7 4.7 14.3 7.2 1.8 12.1 4.4 7.7 4.8 3.4 4.3 8.4 9.9 3.6 3.2 3.6 5.6 9.1 8.7 4.5 4.4 10.5 0.0 3.1 3.0 1.6 4.1 6.3 0.0 0.0 5.4 0.0 0.0 0.0 0.0 5.6 2.0 17.2 0.0 0.0 0.0 6.3 2.2 1.5 1.6 3.0 0.0 2.0 0.0 6.2 2.4 3.2 0.8 5.7 2.4 1.3 0.0 4.2 0.0 3.9 4.1 1.4 0.0 0.0 0.8 2.1 3.1 8.4 2.5 3.7 0.0 0.0 0.0 4.7 1.4 0.0 0.0 7.3 0.4 2.7 0.0 5.8 0.0 4.0 1.9 2.7 2.3 0.0 1.6 1.5 10.1 1.8 0.0 0.3 7.1 6.5 0.0 4.6 1.0 0.0 0.0 2.1 0.0 3.9 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 13.7 5.1 11.9 8.8 4.3 8.7 4.7 7.7 10.5 6.0 5.3 1.4 0.1 1.6 15.3 16.8 10.2 6.7 3.4 12.2 0.0 18.1 1.7 2.5 2.7 0.7 0.0 0.0 1.3 5.9 6.3 0.9 0.0 11.3 1.2 6.4 0.0 7.4 0.0 4.2 48.1 0.2 16.9 0.0 0.0 6.5 1.7 0.0 32.2 6.3 1.9 71.1 13.9 0.2 0.6 0.4 14.1 0.0 0.0 0.0 FIP1L1 "DKFZp586K0717, FIP1" ENSG00000145216 "Factor interacting with PAPOLA and CPSF1" Q6UN15 4 53377643-53460861 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "mRNA processing" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037475, HPA058202" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA037475: AB_10696933, HPA058202: AB_2683636" "unprognostic (3.80e-1)" "unprognostic (5.46e-2)" "unprognostic (5.60e-3)" "unprognostic (1.40e-1)" "unprognostic (7.18e-2)" "unprognostic (4.71e-2)" "prognostic unfavorable (1.51e-4)" "unprognostic (1.87e-1)" "unprognostic (9.00e-3)" "unprognostic (1.14e-2)" "unprognostic (5.48e-2)" "unprognostic (1.42e-1)" "unprognostic (4.07e-1)" "unprognostic (1.10e-1)" "unprognostic (8.66e-3)" "unprognostic (3.10e-2)" "unprognostic (1.39e-1)" 25.7 24.4 20.2 27.6 25.8 35.8 24.0 23.0 25.1 24.5 18.0 19.4 16.1 16.0 27.4 17.7 23.4 22.4 16.2 19.7 17.1 16.6 19.7 19.0 20.3 24.5 20.1 26.0 32.2 16.9 26.6 26.6 28.2 20.9 21.7 21.0 16.2 21.5 18.0 33.9 24.5 20.0 23.5 19.4 24.5 20.4 40.2 22.4 42.4 22.7 17.8 29.2 26.6 22.6 26.5 32.7 36.5 24.0 33.7 32.4 21.3 18.3 12.1 22.2 13.3 16.8 17.1 28.4 23.3 29.3 19.0 14.7 17.6 17.1 33.7 18.1 24.8 17.8 11.6 24.1 17.3 24.7 11.7 13.1 26.6 10.0 16.2 26.7 39.5 22.8 19.6 15.8 24.0 24.6 18.4 14.0 20.4 30.6 15.8 14.9 13.5 35.6 18.2 14.6 23.5 11.9 32.0 10.1 14.8 15.4 16.6 17.3 18.7 16.3 18.8 26.7 21.8 10.7 14.7 14.7 19.5 17.0 18.1 27.9 19.8 11.5 42.6 16.9 24.8 34.7 25.8 16.9 36.5 25.7 17.8 29.2 26.5 25.8 25.1 22.6 24.2 28.9 25.4 20.7 33.7 24.0 32.7 32.4 21.3 20.2 25.8 23.0 25.1 17.1 16.6 20.1 26.0 20.9 22.4 23.8 20.1 45.5 37.4 34.5 40.5 13.1 17.8 45.5 27.3 26.2 17.7 52.0 31.5 34.1 7.4 26.3 21.3 0.0 30.6 43.6 38.6 25.4 47.4 18.7 28.6 73.1 35.2 33.2 19.4 8.8 61.9 27.7 30.4 46.9 24.6 45.2 30.3 31.7 50.2 19.6 28.8 38.8 24.7 112.4 78.8 29.7 72.2 41.5 25.5 30.3 FIZ1 "FLJ14768, ZNF798" ENSG00000179943 "FLT3 interacting zinc finger 1" Q96SL8 19 55591371-55601970 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074026 Approved Nucleoplasm NA NA Nucleoplasm "HPA074026: AB_2686653" "unprognostic (1.97e-2)" "unprognostic (6.59e-2)" "unprognostic (2.54e-2)" "unprognostic (1.01e-1)" "unprognostic (6.43e-2)" "unprognostic (8.33e-3)" "unprognostic (4.51e-3)" "unprognostic (8.69e-2)" "unprognostic (1.15e-1)" "unprognostic (1.30e-1)" "prognostic favorable (8.42e-4)" "unprognostic (7.02e-2)" "unprognostic (7.28e-2)" "unprognostic (1.87e-2)" "unprognostic (6.92e-2)" "unprognostic (3.03e-1)" "prognostic favorable (2.02e-4)" 10.9 8.6 13.9 9.3 16.6 5.8 12.4 17.0 17.8 10.2 10.9 13.6 10.4 10.4 14.5 13.0 8.0 10.9 11.1 10.0 13.7 11.2 11.5 8.1 9.7 8.0 14.2 9.1 12.1 15.4 21.1 13.9 8.6 9.2 11.7 8.7 14.7 14.3 15.5 18.2 10.6 10.7 16.0 12.3 10.5 13.7 9.4 10.8 9.5 14.4 8.6 9.4 9.4 17.6 2.5 3.4 1.9 3.0 2.1 2.6 0.9 7.2 15.5 10.7 7.6 6.2 4.3 12.2 6.1 4.2 7.0 5.3 8.6 8.2 12.7 5.7 3.8 3.8 7.3 7.4 7.7 6.9 10.0 19.4 9.8 10.5 7.5 6.3 8.3 9.3 5.0 12.6 6.0 7.2 6.7 3.5 8.0 12.0 5.9 5.1 6.4 14.7 6.2 11.7 8.8 11.1 15.4 10.0 6.9 7.0 13.4 14.3 16.3 9.6 7.0 6.4 6.6 7.2 9.9 5.5 6.6 10.8 2.4 7.4 15.5 22.8 8.3 9.4 7.9 7.2 0.1 1.7 0.2 1.0 3.0 1.0 2.5 2.6 1.5 1.2 1.5 1.3 1.9 1.9 2.1 1.1 3.4 1.0 0.9 13.9 16.6 17.0 17.8 13.7 11.2 14.2 9.1 9.2 10.8 8.9 0.6 1.4 3.0 3.0 13.9 4.8 10.2 8.1 3.4 5.2 3.9 3.4 0.0 3.4 0.5 3.2 4.8 0.0 3.4 3.0 2.8 3.1 0.0 5.1 4.0 12.7 9.7 3.7 3.0 0.6 2.8 3.4 0.0 1.8 4.2 8.8 4.7 3.5 3.2 4.1 13.7 0.0 2.3 2.6 2.2 1.9 2.9 2.2 5.1 2.7 FKBP14 "FKBP22, FLJ20731" ENSG00000106080 "FK506 binding protein 14" Q9NWM8 7 30010587-30026684 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Isomerase, Rotamase" "Deafness, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013329, HPA026829" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA Cytosol "Nucleoplasm, Golgi apparatus" "HPA013329: AB_1848613, HPA026829: AB_10601651" "prognostic unfavorable (1.60e-4)" "unprognostic (1.12e-3)" "unprognostic (6.84e-2)" "unprognostic (1.23e-2)" "unprognostic (2.36e-1)" "unprognostic (1.41e-3)" "prognostic unfavorable (6.87e-4)" "unprognostic (6.06e-2)" "unprognostic (7.00e-2)" "unprognostic (6.99e-2)" "unprognostic (2.05e-2)" "unprognostic (1.16e-1)" "unprognostic (1.93e-3)" "prognostic unfavorable (4.57e-4)" "unprognostic (1.15e-1)" "unprognostic (2.07e-3)" "prognostic unfavorable (4.25e-4)" 8.8 7.4 8.7 9.2 7.3 5.1 8.8 17.6 7.7 14.9 7.8 4.1 6.9 4.2 12.1 14.2 8.0 8.1 8.5 9.8 7.1 5.2 5.4 9.2 7.6 8.1 9.2 5.2 13.0 9.8 8.6 27.8 10.7 7.1 9.8 6.9 8.4 7.6 10.9 3.3 6.4 5.3 18.8 8.1 6.7 7.2 4.2 7.1 2.6 5.6 5.9 7.7 13.4 8.7 1.6 3.3 2.7 1.2 1.0 1.6 0.6 3.4 2.6 7.4 17.2 19.3 24.8 3.4 17.7 16.6 6.2 12.1 2.2 2.2 1.2 8.4 15.5 7.6 7.6 4.1 6.4 12.4 0.6 5.9 2.8 5.0 6.5 9.8 2.0 4.9 15.5 6.7 10.8 12.8 14.6 13.7 1.8 4.5 2.6 11.1 1.4 1.0 2.4 3.9 3.8 4.8 0.0 5.0 4.0 6.1 3.1 1.9 6.5 6.2 14.2 4.3 9.2 3.2 2.6 11.0 6.6 7.7 11.3 7.0 3.9 4.0 2.1 9.4 1.9 20.6 1.9 1.2 1.2 1.3 0.8 1.0 1.1 1.6 1.1 2.2 1.6 1.5 1.3 2.7 1.0 0.5 3.3 1.4 0.6 8.7 7.3 17.6 7.7 7.1 5.2 9.2 5.2 7.1 7.1 17.9 16.5 3.7 19.2 24.4 15.5 13.5 7.6 2.7 10.3 17.4 25.5 9.5 1.7 6.7 0.3 7.4 3.3 0.0 3.2 24.1 26.4 15.0 2.3 6.6 5.3 14.3 1.2 8.6 2.8 0.0 12.0 5.8 10.1 2.8 7.9 31.5 5.3 14.4 19.4 2.9 19.8 6.5 10.5 0.7 3.3 15.9 13.2 4.3 4.8 24.8 FKBP4 "FKBP52, FKBP59" ENSG00000004478 "FK506 binding protein 4" Q02790 12 2794953-2805423 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Chaperone, Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "vagina: 209.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006148, CAB017441, HPA062857" Supported Enhanced Nucleoplasm,Cytosol NA NA 110000 Cytosol Nucleoplasm "CAB017441: AB_10618759, HPA006148: AB_1078875, HPA062857: AB_2684883" "unprognostic (1.46e-2)" "unprognostic (1.73e-2)" "unprognostic (1.31e-2)" "prognostic unfavorable (7.65e-4)" "unprognostic (1.97e-1)" "unprognostic (1.07e-1)" "prognostic unfavorable (6.12e-5)" "prognostic unfavorable (1.44e-4)" "unprognostic (3.43e-1)" "unprognostic (3.25e-2)" "unprognostic (1.72e-1)" "unprognostic (3.14e-1)" "unprognostic (3.89e-2)" "unprognostic (1.59e-2)" "unprognostic (1.76e-1)" "unprognostic (1.59e-1)" "unprognostic (2.22e-1)" 16.2 21.6 26.0 13.7 30.7 13.3 40.7 50.4 31.9 19.9 22.6 22.8 36.2 13.1 20.1 30.7 34.2 25.7 16.4 20.4 25.0 32.5 31.6 31.3 15.8 11.7 44.7 23.4 23.9 30.3 30.1 19.5 32.0 39.4 30.2 25.3 11.5 30.1 31.6 33.5 25.3 16.1 26.4 25.2 11.5 25.3 36.0 42.1 15.6 47.1 16.5 18.5 17.4 209.6 13.8 6.0 10.9 13.7 8.4 14.0 9.9 15.3 34.2 9.9 16.6 12.3 7.3 47.5 15.1 5.4 25.0 16.9 34.0 18.8 20.5 4.3 9.7 17.4 21.1 61.5 20.5 30.1 37.5 39.4 22.6 25.1 12.0 9.5 17.6 6.2 6.6 18.8 29.5 29.6 14.9 14.5 20.8 20.7 29.3 10.0 44.1 30.9 16.0 84.3 45.3 24.7 18.6 17.4 12.3 21.0 19.6 14.3 20.5 17.5 47.8 7.6 64.7 64.4 12.0 7.7 12.3 38.7 13.8 38.0 7.3 11.2 30.3 10.9 26.4 12.5 10.9 10.8 5.9 12.5 9.8 14.0 13.3 11.1 11.8 6.0 13.8 11.8 13.7 1.5 8.4 13.7 5.3 10.1 9.9 26.0 30.7 50.4 31.9 25.0 32.5 44.7 23.4 39.4 42.1 6.0 8.6 47.9 182.5 127.9 60.2 11.7 40.8 16.0 12.5 50.6 70.7 148.6 131.0 77.3 90.2 33.8 86.8 0.0 22.4 85.7 62.6 189.3 39.1 41.9 54.7 92.2 101.7 12.3 15.0 26.1 32.2 42.7 87.7 52.3 61.6 41.8 62.2 84.2 36.4 112.7 51.3 84.1 88.6 179.1 92.0 116.1 186.7 20.2 77.5 121.3 FKBP5 "FKBP51, FKBP54, P54, PPIase, Ptg-10" ENSG00000096060 "FK506 binding protein 5" Q13451 6 35573585-35728583 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Chaperone, Isomerase, Rotamase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 277.2" "Cell type enhanced" "Detected in many" 7 "Kupffer cells: 325.8;Peritubular cells: 205.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 103.4;ASC TERT1: 64.4;HHSteC: 81.0;HSkMC: 97.8;hTCEpi: 49.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009315, HPA031092, HPA031093, HPA031095" Enhanced Enhanced Nucleoplasm No No Nucleoplasm "CAB009315: AB_2278350, HPA031092: AB_10600195, HPA031093: AB_10601748, HPA031095: AB_2673734" "unprognostic (2.09e-3)" "unprognostic (1.70e-1)" "unprognostic (1.44e-2)" "unprognostic (1.17e-2)" "unprognostic (1.02e-1)" "unprognostic (1.93e-1)" "unprognostic (4.72e-1)" "unprognostic (6.30e-3)" "unprognostic (3.70e-3)" "unprognostic (1.47e-1)" "unprognostic (1.69e-1)" "unprognostic (1.73e-1)" "unprognostic (7.48e-3)" "unprognostic (2.18e-3)" "unprognostic (8.31e-2)" "unprognostic (4.22e-2)" "unprognostic (6.90e-3)" 78.8 20.7 9.5 14.2 15.6 4.9 36.7 2.4 10.9 16.5 29.0 5.1 29.8 2.2 18.6 16.9 29.2 19.4 17.9 26.3 10.6 4.2 44.9 30.7 19.7 55.9 15.7 3.6 27.2 43.7 8.6 33.8 6.0 13.1 18.3 8.2 11.8 30.4 25.1 277.2 20.2 36.7 18.6 18.2 32.3 25.0 14.3 12.4 20.1 24.2 9.8 16.8 22.5 18.4 4.0 30.6 24.9 31.2 11.8 42.3 39.9 5.0 2.2 9.7 14.4 103.4 64.4 0.1 2.7 0.1 1.8 4.1 3.8 0.9 25.0 2.6 0.5 1.5 0.0 5.7 12.1 4.3 9.8 5.5 10.7 1.9 5.3 81.0 6.7 1.1 97.8 49.2 3.1 29.7 1.9 10.5 5.0 11.4 10.2 19.0 3.2 27.9 12.6 2.5 1.1 1.6 12.4 2.5 12.2 8.0 3.0 3.7 2.2 2.2 2.6 0.5 2.2 14.3 7.9 23.2 2.6 2.3 0.3 3.8 4.6 5.3 31.7 0.8 13.2 1.0 13.7 31.2 19.4 20.0 27.0 23.8 3.0 28.2 20.8 30.6 4.0 42.3 30.2 24.9 11.8 12.0 9.2 10.3 39.9 9.5 15.6 2.4 10.9 10.6 4.2 15.7 3.6 13.1 12.4 11.9 9.9 41.7 52.1 15.7 1.7 110.1 79.0 21.4 13.6 5.2 0.0 0.6 19.9 0.5 8.8 66.1 19.7 163.5 6.9 0.9 22.2 38.7 36.0 165.7 28.8 0.0 20.1 130.8 325.8 11.8 149.0 56.5 6.8 91.0 17.5 3.7 3.3 9.3 205.4 16.3 18.2 142.3 28.8 11.6 19.2 18.6 0.3 117.1 19.5 19.5 FKBPL "DIR1, NG7, WISp39" ENSG00000204315 "FK506 binding protein like" Q9UIM3 6 32128707-32130291 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043478, HPA060158" Approved Approved "Nucleoplasm,Mitotic spindle" Yes No Nucleoplasm "Mitotic spindle" "HPA043478: AB_2678500, HPA060158: AB_2684213" "unprognostic (1.80e-1)" "unprognostic (6.80e-2)" "unprognostic (1.14e-1)" "unprognostic (1.03e-3)" "unprognostic (1.02e-1)" "unprognostic (7.67e-2)" "unprognostic (8.22e-3)" "unprognostic (2.25e-2)" "unprognostic (1.22e-1)" "prognostic favorable (8.46e-4)" "unprognostic (1.30e-1)" "unprognostic (8.96e-2)" "unprognostic (5.79e-2)" "unprognostic (7.32e-2)" "unprognostic (4.39e-2)" "unprognostic (2.70e-1)" "unprognostic (1.13e-1)" 3.6 5.6 4.1 2.7 4.7 4.6 7.1 12.1 6.2 4.4 4.5 3.9 8.9 6.0 4.1 8.7 12.7 7.0 4.5 6.0 4.1 3.5 5.9 6.7 4.5 7.7 7.1 2.4 7.0 13.2 6.2 5.0 6.9 5.8 3.8 4.9 3.7 8.0 3.6 5.1 11.5 4.4 5.1 3.6 7.8 6.6 7.6 6.8 10.5 11.6 2.8 6.8 4.7 6.3 3.4 3.7 8.3 4.8 3.3 4.6 1.5 0.0 2.0 4.4 11.9 6.6 4.7 3.8 2.9 3.3 5.5 5.3 9.5 4.0 3.3 3.4 5.1 7.4 2.2 6.2 5.7 3.8 5.9 7.6 0.0 6.6 5.3 3.7 0.0 3.6 4.6 5.8 10.7 6.7 4.1 5.8 8.7 11.1 8.3 5.6 3.2 3.6 4.1 3.3 8.6 1.7 3.0 5.8 7.3 5.7 0.7 8.5 2.0 2.9 5.3 6.4 2.3 9.2 6.4 2.5 8.0 6.6 4.1 7.0 4.4 7.7 3.0 3.1 5.4 4.9 4.9 3.4 2.3 4.6 4.8 4.4 2.8 2.6 3.3 3.7 3.4 3.0 2.9 8.3 3.3 2.5 2.9 1.1 1.5 4.1 4.7 12.1 6.2 4.1 3.5 7.1 2.4 5.8 6.8 6.0 5.1 4.7 3.2 10.0 2.9 2.0 5.1 0.0 4.5 1.8 0.0 8.3 5.0 6.7 2.2 4.5 8.1 0.0 5.9 10.6 7.4 3.3 2.3 2.8 4.5 9.5 5.8 3.7 3.2 4.0 2.6 4.4 6.8 4.6 4.9 6.4 5.4 3.7 3.2 7.7 4.0 0.0 6.2 8.9 8.3 8.9 11.8 6.5 5.0 4.1 FKRP "LGMD2I, MDC1C" ENSG00000181027 "Fukutin related protein" Q9H9S5 19 46746046-46776988 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Cardiomyopathy, Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043115, HPA060454" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Nucleoplasm, Golgi apparatus, Cytosol" "HPA043115: AB_2678324, HPA060454: AB_2684281" "unprognostic (4.44e-2)" "unprognostic (5.20e-2)" "unprognostic (2.19e-2)" "unprognostic (8.37e-3)" "unprognostic (1.83e-2)" "unprognostic (2.25e-1)" "unprognostic (1.02e-1)" "unprognostic (3.85e-1)" "unprognostic (2.99e-2)" "unprognostic (4.59e-3)" "prognostic favorable (8.98e-4)" "unprognostic (3.53e-1)" "unprognostic (2.30e-2)" "unprognostic (2.53e-1)" "unprognostic (2.46e-1)" "unprognostic (1.01e-1)" "unprognostic (2.53e-2)" 13.7 10.7 12.4 12.5 17.5 12.6 9.6 7.4 25.2 10.5 11.5 12.8 13.7 7.8 15.7 8.7 8.3 12.7 10.1 13.1 9.8 12.2 10.7 10.8 11.6 11.0 11.5 11.1 13.3 13.2 12.9 16.9 16.5 14.1 13.6 7.3 13.0 17.8 13.2 23.6 9.6 9.7 13.4 9.1 14.7 10.3 13.0 11.1 8.8 13.5 7.8 7.9 12.3 10.2 6.9 5.0 5.4 4.2 5.6 4.5 2.4 8.4 18.1 12.4 8.7 11.0 12.2 11.1 21.6 14.6 8.9 14.0 11.5 14.7 7.6 12.1 12.4 14.7 9.0 4.6 10.1 8.2 14.9 15.4 8.0 8.7 7.2 9.7 6.2 13.8 13.5 8.7 10.9 10.7 10.4 11.6 4.2 8.0 7.7 8.9 3.8 4.5 15.2 12.1 5.3 4.5 12.3 7.7 2.8 5.6 18.1 8.5 16.2 10.8 5.3 7.1 8.6 6.4 4.9 11.9 13.2 14.0 4.8 17.3 8.2 9.8 7.2 10.7 5.0 17.6 3.4 4.2 2.5 4.1 2.5 2.8 4.6 3.0 4.5 2.6 6.9 3.7 4.5 5.4 5.6 2.6 5.0 1.6 2.4 12.4 17.5 7.4 25.2 9.8 12.2 11.5 11.1 14.1 11.1 8.9 6.1 0.8 4.3 0.7 9.7 13.7 7.6 10.7 6.8 5.2 5.9 7.9 5.0 4.3 7.3 3.9 3.5 23.3 2.1 4.7 4.1 3.6 1.1 13.4 6.3 3.2 7.5 9.2 11.4 9.9 5.2 1.8 5.0 4.6 4.6 6.8 4.9 3.1 3.9 5.8 10.7 6.5 4.7 9.1 4.3 1.4 15.7 5.0 3.6 3.4 FLI1 "EWSR2, SIC-1" ENSG00000151702 "Fli-1 proto-oncogene, ETS transcription factor" Q01543 11 128686535-128813267 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 40.2" "Group enriched" "Detected in many" 6 "B-cells: 32.3;Endothelial cells: 76.4;granulocytes: 22.0;Hofbauer cells: 36.1;Ito cells: 49.7;Kupffer cells: 85.1;Macrophages: 24.6;T-cells: 47.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 41.0;HUVEC TERT2: 22.8;REH: 19.2;TIME: 23.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065030, HPA073099" Approved Supported "Nucleoplasm,Nuclear bodies" Yes NA "Nucleoplasm, Nuclear bodies" "HPA065030: , HPA073099: AB_2686572" "unprognostic (1.38e-2)" "unprognostic (7.46e-2)" "unprognostic (6.16e-2)" "unprognostic (3.74e-2)" "unprognostic (6.22e-2)" "unprognostic (4.26e-3)" "unprognostic (1.33e-1)" "unprognostic (8.32e-3)" "unprognostic (2.97e-1)" "unprognostic (9.91e-2)" "unprognostic (1.60e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (4.60e-4)" "unprognostic (4.79e-2)" "unprognostic (2.07e-2)" "unprognostic (2.62e-1)" "unprognostic (4.79e-2)" 14.7 2.5 3.5 15.8 4.4 10.6 9.9 1.4 3.2 6.7 5.1 3.8 2.1 3.3 7.8 6.5 4.8 5.3 6.0 7.5 3.8 3.1 4.2 3.6 17.4 24.4 6.2 1.6 4.0 3.2 2.5 2.0 11.4 3.8 4.3 3.1 4.8 4.2 3.3 5.2 3.2 6.9 5.7 6.6 40.2 4.1 2.7 4.6 26.8 5.7 2.8 17.9 6.2 6.7 4.5 13.1 20.1 12.0 7.8 8.8 11.6 0.0 0.0 2.1 0.0 0.2 0.4 0.0 1.2 3.4 1.4 1.2 0.0 0.0 7.0 12.5 4.1 0.4 0.0 0.3 5.1 1.6 3.2 0.1 41.0 0.2 0.0 2.4 4.9 5.8 0.3 0.4 3.0 6.9 4.3 22.8 9.8 0.0 9.0 0.3 0.0 4.9 2.8 0.6 0.0 1.2 19.2 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 7.9 23.6 0.2 0.0 0.1 1.3 2.9 6.0 6.0 0.0 11.9 1.9 20.1 9.5 16.1 7.2 10.3 8.8 4.5 6.2 5.8 13.1 3.6 2.6 5.6 7.8 7.8 12.0 2.2 7.4 11.6 3.5 4.4 1.4 3.2 3.8 3.1 6.2 1.6 3.8 4.6 6.0 7.7 32.3 0.2 4.5 0.0 5.0 5.1 1.4 0.0 1.8 0.0 0.3 0.0 0.0 0.5 76.4 0.0 0.0 0.0 0.2 5.6 0.3 22.0 1.0 36.1 0.0 0.0 49.7 85.1 0.0 1.7 24.6 6.8 6.4 0.0 0.1 0.0 0.0 0.7 0.3 0.0 6.5 2.8 0.3 0.1 3.6 0.2 47.8 0.0 0.4 FLII "FLI, Fli1, FLIL, MGC39265" ENSG00000177731 "FLII, actin remodeling protein" Q13045 17 18244836-18258916 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Actin-binding, Activator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007084, HPA008903, CAB016132" Approved Enhanced "Nucleoplasm,Centriolar satellite,Cytosol" NA NA 1800000 "Nucleoplasm, Centriolar satellite, Cytosol" "CAB016132: AB_627613, HPA007084: AB_1848638, HPA008903: AB_1848640" "unprognostic (8.09e-2)" "unprognostic (1.09e-2)" "unprognostic (6.89e-2)" "unprognostic (2.53e-2)" "unprognostic (4.22e-2)" "unprognostic (4.78e-2)" "unprognostic (1.88e-2)" "unprognostic (1.23e-2)" "unprognostic (4.91e-2)" "unprognostic (1.36e-2)" "unprognostic (1.28e-1)" "unprognostic (2.47e-3)" "unprognostic (4.03e-2)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (2.06e-1)" "unprognostic (3.39e-2)" 21.2 16.8 8.6 16.9 12.4 16.6 21.7 11.7 11.4 17.5 18.5 12.8 14.3 14.6 17.3 16.3 25.9 13.7 15.6 28.3 9.3 7.4 19.0 18.8 17.3 13.4 15.0 6.1 15.3 20.0 15.4 13.5 15.8 13.6 17.2 10.7 11.0 21.3 17.0 78.4 14.4 18.9 19.1 11.1 20.0 15.4 15.6 11.9 21.2 15.1 25.4 17.5 21.5 16.3 5.3 16.0 12.9 24.9 5.2 7.2 10.3 58.1 21.0 6.0 9.1 13.8 12.5 9.0 16.2 19.6 18.3 11.4 26.8 13.3 11.4 17.0 18.5 10.6 26.0 8.0 26.9 10.7 9.5 12.5 6.2 15.5 10.6 15.6 6.9 13.2 11.3 16.4 14.9 22.5 11.7 17.6 10.6 5.0 4.6 10.7 17.3 10.2 5.8 6.2 25.7 11.0 10.0 26.8 14.1 13.6 16.5 2.1 3.1 18.8 16.1 8.7 39.0 27.4 5.4 21.7 16.3 16.8 31.3 19.0 4.8 3.5 3.4 15.4 6.7 8.8 4.8 13.6 12.9 7.0 21.4 7.2 5.3 5.8 7.2 16.0 3.6 4.3 4.6 12.0 5.2 24.9 4.7 6.6 10.3 8.6 12.4 11.7 11.4 9.3 7.4 15.0 6.1 13.6 11.9 56.6 34.6 18.1 20.3 20.1 16.0 33.1 25.5 45.5 44.3 24.4 17.7 22.0 13.3 53.5 34.8 28.6 52.0 0.0 48.6 24.9 20.8 27.1 45.1 16.9 44.4 25.4 23.0 27.0 42.1 5.3 30.0 48.8 15.1 55.1 23.3 10.6 95.0 43.3 32.9 17.6 11.3 32.3 21.1 39.6 18.8 17.1 21.3 28.0 32.6 31.1 FLYWCH1 DKFZp761A132 ENSG00000059122 "FLYWCH-type zinc finger 1" Q4VC44 16 2911937-2951208 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 41.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040753, HPA041001" Approved Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA040753: AB_10794880, HPA041001: AB_10794259" "unprognostic (2.26e-1)" "unprognostic (1.66e-2)" "unprognostic (2.93e-1)" "unprognostic (2.06e-3)" "unprognostic (1.71e-1)" "unprognostic (2.68e-2)" "unprognostic (3.51e-2)" "unprognostic (1.92e-1)" "unprognostic (7.44e-2)" "unprognostic (1.19e-1)" "unprognostic (1.19e-3)" "unprognostic (6.61e-2)" "unprognostic (1.61e-1)" "unprognostic (3.84e-2)" "unprognostic (7.33e-2)" "unprognostic (2.19e-3)" "unprognostic (7.91e-2)" 15.6 16.6 13.1 12.6 17.2 12.5 10.2 24.4 27.4 13.6 12.2 17.7 9.5 14.7 14.3 13.4 11.8 11.9 15.0 16.7 12.1 15.9 10.1 5.9 10.7 11.6 15.8 18.5 21.4 12.2 22.6 12.2 9.5 18.8 13.9 4.7 25.3 14.4 15.6 28.1 22.8 14.4 14.1 16.2 19.9 11.0 5.1 10.9 8.5 11.5 8.4 10.3 17.1 15.7 4.6 1.6 2.3 1.6 0.9 5.5 2.1 5.1 18.1 4.1 12.3 6.7 6.9 12.6 9.5 7.5 4.8 4.9 3.0 16.7 12.5 25.4 7.2 7.9 10.7 3.4 6.4 1.0 20.8 10.3 4.2 15.2 10.0 15.1 5.5 14.6 6.1 20.2 10.1 7.4 8.9 6.8 8.4 9.3 13.3 3.7 12.2 12.6 6.7 6.7 3.8 12.4 22.2 6.2 22.4 5.6 3.5 8.9 8.3 10.0 10.9 12.7 2.4 8.5 10.1 12.7 8.1 7.4 15.6 6.3 19.7 16.9 11.2 8.8 9.1 9.4 2.3 1.6 0.6 3.0 0.7 4.9 2.0 4.5 5.5 1.6 4.6 3.9 3.4 0.2 0.9 0.8 1.0 2.2 2.1 13.1 17.2 24.4 27.4 12.1 15.9 15.8 18.5 18.8 10.9 0.0 3.4 2.2 9.5 11.0 41.7 10.2 10.2 4.0 2.3 21.0 33.4 15.4 1.7 6.0 0.4 11.3 5.9 0.0 5.7 6.9 10.4 4.2 0.0 5.5 7.4 31.8 2.4 11.1 13.3 0.9 10.3 5.3 8.5 9.0 4.4 16.6 5.4 3.5 13.4 4.8 36.2 0.0 15.1 0.7 3.2 12.2 7.3 7.2 6.2 5.9 FLYWCH2 ENSG00000162076 "FLYWCH family member 2" Q96CP2 16 2883186-2899382 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041354 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA041354: AB_10795007" "unprognostic (3.57e-2)" "prognostic favorable (9.38e-4)" "unprognostic (7.33e-2)" "unprognostic (8.53e-3)" "unprognostic (4.40e-1)" "unprognostic (3.81e-2)" "unprognostic (4.83e-3)" "unprognostic (8.35e-3)" "unprognostic (8.92e-2)" "unprognostic (1.62e-1)" "prognostic favorable (1.87e-5)" "unprognostic (5.50e-2)" "unprognostic (2.54e-2)" "unprognostic (1.06e-1)" "unprognostic (1.11e-1)" "unprognostic (1.16e-1)" "unprognostic (2.65e-1)" 19.7 33.9 20.8 13.0 24.6 9.3 14.9 28.5 29.5 15.7 15.0 14.7 19.4 20.8 16.8 13.7 20.8 18.3 22.0 23.8 19.8 27.1 20.2 8.3 15.7 12.6 22.8 16.4 19.5 13.9 17.6 21.7 10.3 22.9 22.4 7.4 22.9 25.4 19.6 34.6 15.9 14.6 13.2 18.2 31.4 17.6 22.3 10.4 19.8 27.0 18.6 17.0 14.2 12.6 15.3 25.3 10.1 18.4 9.8 19.3 12.7 8.7 17.6 7.4 17.3 7.4 10.5 10.7 6.8 5.2 7.4 5.0 8.0 11.0 8.6 26.2 6.3 7.1 5.6 4.0 9.5 1.3 14.4 11.0 9.0 17.2 6.3 20.8 5.4 9.2 14.6 7.3 5.9 3.0 9.2 5.7 15.5 6.5 9.5 5.1 40.9 13.9 23.7 8.0 8.3 18.1 27.1 7.8 18.6 5.2 2.6 11.4 14.8 19.0 20.6 13.7 2.9 24.4 18.0 7.8 12.7 10.3 19.7 6.9 15.6 13.6 11.8 7.4 8.0 9.2 5.6 13.0 10.1 15.1 18.4 16.5 15.3 17.5 14.5 18.4 14.3 19.3 16.5 5.6 9.8 17.8 25.3 16.3 12.7 20.8 24.6 28.5 29.5 19.8 27.1 22.8 16.4 22.9 10.4 11.9 12.8 16.0 36.2 18.1 19.5 13.3 12.7 13.4 7.9 41.8 7.9 17.9 71.3 38.9 8.4 30.8 27.6 0.0 48.7 37.6 34.7 40.7 13.9 5.5 30.2 14.3 32.3 13.5 6.5 8.7 19.5 22.5 40.5 23.4 36.2 46.1 36.0 31.6 23.7 43.4 14.1 32.3 33.0 47.7 38.1 24.8 10.1 21.7 32.4 26.3 FMN1 "DKFZP686C2281, FLJ45135, FMN, LD, MGC125288, MGC125289" ENSG00000248905 "Formin 1" Q68DA7 15 32765545-33194733 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 21.9" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 121.0;Cone photoreceptor cells: 208.1;Rod photoreceptor cells: 98.9" "Cancer enriched" "Detected in many" 9 "melanoma: 14.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 9.5;RH-30: 12.8;SK-MEL-30: 13.3;T-47d: 11.6;U-138 MG: 7.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA005465, HPA046786" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005465: AB_1859515, HPA046786: AB_10963545" "unprognostic (1.57e-1)" "unprognostic (5.92e-3)" "unprognostic (1.96e-1)" "unprognostic (2.10e-3)" "unprognostic (3.67e-2)" "unprognostic (3.00e-2)" "unprognostic (1.56e-2)" "unprognostic (2.84e-2)" "unprognostic (3.44e-1)" "unprognostic (3.31e-2)" "unprognostic (7.41e-3)" "unprognostic (3.53e-1)" "unprognostic (4.89e-2)" "unprognostic (2.89e-2)" "unprognostic (3.73e-1)" "unprognostic (4.32e-1)" "unprognostic (7.61e-2)" 7.0 2.1 3.7 3.9 5.3 2.2 4.9 0.6 12.1 8.9 8.5 1.8 2.6 2.6 2.2 4.8 3.9 5.1 4.0 2.4 3.3 2.0 4.7 1.4 7.7 3.3 5.9 7.3 1.1 2.5 2.6 8.0 5.1 4.6 3.8 6.9 21.9 6.4 2.5 2.2 9.2 4.3 3.7 6.4 3.0 11.7 12.4 4.6 1.8 4.7 1.5 2.0 2.7 6.8 0.6 1.8 2.8 0.7 0.1 0.7 0.1 1.6 1.8 0.3 0.2 0.0 0.2 2.0 2.3 1.9 0.6 1.7 0.2 2.2 0.2 0.8 2.8 1.6 1.4 0.0 1.5 1.8 0.0 0.1 1.3 0.4 0.1 0.1 0.0 0.1 0.7 0.0 2.8 0.0 1.3 0.0 0.0 0.0 9.5 4.1 1.7 0.0 0.0 0.5 3.2 0.1 0.2 12.8 2.2 0.8 0.6 0.1 0.3 0.0 1.5 13.3 0.4 11.6 0.0 1.6 7.4 1.2 6.8 0.7 0.0 0.0 0.4 3.5 0.0 4.6 2.8 0.7 0.0 0.3 0.0 0.5 0.0 0.7 0.6 1.4 0.6 0.4 0.0 0.1 0.1 0.0 1.8 0.1 0.1 3.7 5.3 0.6 12.1 3.3 2.0 5.9 7.3 4.6 4.6 38.7 42.2 0.5 2.3 3.3 121.0 3.2 12.7 38.8 27.3 0.0 208.1 9.7 10.0 4.9 11.6 0.7 5.9 0.0 1.6 3.5 1.1 6.3 22.1 0.5 9.0 44.5 8.6 0.0 28.5 9.5 0.9 16.2 32.1 5.4 16.7 4.3 7.1 9.3 0.7 1.1 98.9 0.0 0.9 19.5 14.9 3.0 15.3 1.3 7.9 4.0 FN3KRP "FLJ12171, FN3KL" ENSG00000141560 "Fructosamine 3 kinase related protein" Q9HA64 17 82716683-82730328 "Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cytotrophoblasts: 80.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056172, HPA065831" Approved Approved Nucleoplasm NA NA 14000 Nucleoplasm "HPA056172: AB_2683055, HPA065831: AB_2685565" "unprognostic (1.37e-1)" "unprognostic (4.95e-2)" "unprognostic (1.54e-2)" "unprognostic (2.09e-1)" "prognostic unfavorable (3.26e-4)" "unprognostic (2.31e-1)" "unprognostic (1.25e-2)" "unprognostic (8.67e-2)" "unprognostic (1.26e-1)" "unprognostic (1.99e-1)" "unprognostic (8.84e-2)" "unprognostic (4.32e-3)" "unprognostic (1.60e-2)" "unprognostic (1.31e-1)" "unprognostic (2.23e-2)" "unprognostic (3.97e-2)" "unprognostic (3.71e-2)" 17.6 18.3 27.9 10.8 26.3 12.3 15.7 19.5 27.3 15.3 17.4 27.4 10.0 11.8 18.4 16.7 16.4 16.6 13.0 12.7 26.1 20.8 18.8 23.1 12.8 12.9 25.7 23.0 21.9 15.3 10.8 11.4 17.1 22.2 17.1 14.4 13.2 17.2 20.0 7.3 16.1 13.6 20.3 30.7 13.7 12.6 8.8 21.6 8.2 15.1 9.8 17.5 12.1 12.9 16.5 23.2 18.5 15.5 18.5 23.0 17.1 10.9 44.3 12.1 16.0 5.9 11.3 10.0 20.6 11.5 19.9 16.3 23.4 7.7 9.0 13.8 16.6 18.4 12.6 11.0 15.6 18.0 6.0 19.5 15.1 24.8 26.9 10.5 10.5 8.5 10.4 18.5 18.9 10.4 12.2 14.3 12.8 14.5 5.7 25.4 20.8 20.5 15.6 5.5 24.1 19.3 15.4 30.8 14.0 14.1 21.1 10.1 21.5 34.0 15.4 16.6 21.9 25.7 15.3 12.6 38.7 13.3 27.3 30.3 11.7 12.8 22.4 18.0 13.4 17.8 17.0 14.2 18.5 20.4 15.5 20.0 15.7 19.9 19.5 11.7 16.5 23.0 16.7 2.1 18.5 8.4 23.2 18.6 17.1 27.9 26.3 19.5 27.3 26.1 20.8 25.7 23.0 22.2 21.6 11.9 12.0 13.7 25.9 13.4 17.8 5.2 20.4 10.7 12.5 10.4 7.9 80.4 19.9 17.2 1.3 11.7 9.5 23.3 9.9 35.3 15.1 14.6 12.7 9.0 28.7 3.2 7.5 11.6 9.4 2.3 26.2 11.8 21.9 28.9 13.3 29.2 14.9 17.3 29.7 15.8 14.3 12.9 17.6 9.7 22.6 13.4 52.3 14.9 16.9 21.3 FNDC11 "C20orf195, MGC5356" ENSG00000125531 "Fibronectin type III domain containing 11" Q9BVV2 20 63547891-63556708 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 52.5" "Cell type enriched" "Detected in some" 5 "Ciliated cells: 12.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 3.2;naive B-cell: 6.6" "Lineage enriched" "Detected in many" 6 "B-cells: 6.6" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.5;EFO-21: 4.9;HaCaT: 2.7;OE19: 3.2;SH-SY5Y: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA041341 Approved Nucleoplasm,Vesicles,Aggresome NA NA "Nucleoplasm, Vesicles" Aggresome "HPA041341: AB_10794991" "unprognostic (2.01e-1)" "unprognostic (6.63e-2)" "unprognostic (6.06e-2)" "unprognostic (1.26e-1)" "unprognostic (1.51e-2)" "unprognostic (1.15e-1)" "unprognostic (2.36e-1)" "unprognostic (9.99e-3)" "unprognostic (7.94e-2)" "unprognostic (8.30e-4)" "unprognostic (3.68e-1)" "unprognostic (8.33e-2)" "unprognostic (3.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.05e-1)" "unprognostic (3.75e-1)" "unprognostic (6.81e-2)" 0.1 0.0 0.1 0.2 0.1 0.3 0.1 0.1 0.2 0.2 0.1 0.2 0.1 0.0 0.1 2.2 0.2 1.1 0.2 0.1 0.1 0.3 0.2 0.1 0.5 0.4 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.5 0.3 52.5 0.2 0.1 0.1 0.1 0.3 0.2 0.2 6.6 0.0 1.0 0.0 0.0 0.8 0.2 0.3 0.0 1.8 0.0 0.1 0.1 0.0 0.3 0.6 0.0 0.0 0.1 9.5 0.6 4.9 0.1 0.2 2.7 0.2 0.3 0.0 0.0 0.0 0.2 0.6 0.0 0.2 0.0 1.2 0.0 0.2 0.7 0.0 0.0 0.9 0.0 0.7 0.0 0.0 1.0 0.0 0.1 0.2 3.2 0.8 0.0 0.0 0.1 1.7 0.0 0.4 6.0 0.0 0.0 0.3 0.4 0.1 0.0 0.6 0.1 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.6 0.3 0.0 0.0 1.0 0.1 0.0 0.0 3.2 0.2 0.6 0.0 6.6 0.4 0.2 0.0 0.0 0.0 0.0 0.8 0.2 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 2.3 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 FNDC3A "bA203I16.5, FNDC3, KIAA0970" ENSG00000102531 "Fibronectin type III domain containing 3A" Q9Y2H6 13 48975912-49209779 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008927, HPA012555, HPA012825" Approved Approved "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" NA NA "Nucleoplasm, Golgi apparatus, Centrosome" Cytosol "HPA008927: AB_1078899, HPA012555: , HPA012825: AB_1848985" "unprognostic (1.54e-1)" "unprognostic (1.34e-3)" "unprognostic (8.83e-2)" "unprognostic (1.04e-2)" "unprognostic (1.66e-1)" "unprognostic (1.11e-1)" "unprognostic (2.91e-2)" "unprognostic (5.71e-2)" "unprognostic (6.17e-2)" "unprognostic (3.16e-2)" "unprognostic (1.87e-2)" "unprognostic (4.03e-2)" "prognostic favorable (4.25e-4)" "unprognostic (8.93e-3)" "unprognostic (1.03e-1)" "unprognostic (9.60e-2)" "unprognostic (6.14e-2)" 13.9 27.2 16.9 14.8 24.9 10.0 17.4 19.4 15.0 25.3 22.3 14.6 32.0 17.8 22.4 32.2 10.6 18.2 17.9 14.0 15.0 23.1 20.4 43.0 18.1 12.0 14.6 14.8 25.0 37.4 14.1 59.0 79.8 15.7 15.6 16.2 15.1 22.5 31.6 9.1 9.2 24.7 17.5 14.8 16.2 18.5 18.8 16.6 13.2 34.2 11.6 12.7 17.8 15.4 6.6 7.6 8.7 6.9 3.9 7.9 3.2 4.5 5.2 19.2 5.0 24.3 30.8 3.7 21.3 28.5 20.6 15.0 7.1 11.1 3.4 4.0 16.0 8.9 4.9 11.4 7.2 30.0 8.6 8.8 5.6 15.0 13.0 14.8 5.2 0.9 15.7 10.1 18.2 21.2 19.3 21.2 4.8 6.9 8.5 22.3 1.8 5.1 10.4 9.4 9.8 4.4 4.9 7.6 6.3 17.3 8.4 7.3 12.0 8.0 7.2 15.2 12.7 3.8 10.2 16.6 10.7 7.4 9.9 15.0 10.4 5.4 3.2 8.1 6.7 11.0 3.4 5.7 3.6 5.2 4.0 7.5 6.6 6.1 4.4 3.6 4.9 7.9 6.7 8.7 3.9 6.9 7.6 4.7 3.2 16.9 24.9 19.4 14.5 15.0 23.1 14.6 14.8 15.7 16.6 50.6 43.5 17.9 23.8 16.4 46.2 21.6 25.5 32.1 30.7 34.9 35.3 10.1 11.6 24.5 39.5 33.8 23.2 0.0 31.5 29.4 31.7 42.8 30.1 63.7 22.7 33.4 41.8 27.6 26.5 7.9 31.4 34.7 35.4 25.2 35.7 64.1 29.0 25.4 37.1 38.9 46.7 6.5 26.9 73.8 28.1 10.5 27.0 19.3 22.5 24.4 FNDC4 "FLJ22362, FRCP1" ENSG00000115226 "Fibronectin type III domain containing 4" Q9H6D8 2 27491883-27495245 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 45.9;liver: 57.6" "Cell type enhanced" "Detected in many" 20 "Early spermatids: 165.4;Hepatocytes: 113.4;Late spermatids: 388.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 17.0;ASC diff: 17.4;HUVEC TERT2: 20.9;SH-SY5Y: 16.3;TIME: 19.0;U-87 MG: 14.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051804, HPA063581" Uncertain Approved Nucleoplasm,Aggresome,Cytosol "Intracellular and membrane" NA NA Nucleoplasm "Aggresome, Cytosol" "HPA051804: AB_2681617, HPA063581: AB_2685048" "unprognostic (2.57e-1)" "unprognostic (1.19e-3)" "unprognostic (3.87e-2)" "prognostic unfavorable (5.07e-4)" "unprognostic (1.46e-3)" "unprognostic (1.27e-1)" "unprognostic (4.77e-3)" "unprognostic (7.19e-2)" "unprognostic (1.04e-1)" "unprognostic (9.64e-2)" "unprognostic (8.28e-3)" "unprognostic (4.41e-2)" "unprognostic (1.28e-2)" "unprognostic (1.13e-2)" "unprognostic (5.74e-3)" "unprognostic (2.40e-3)" "prognostic unfavorable (6.11e-4)" 18.5 45.9 13.4 2.7 13.7 0.7 9.1 10.8 29.5 3.8 2.0 4.0 0.5 1.5 2.8 2.8 11.8 1.5 10.0 3.1 15.6 8.5 2.3 57.6 2.0 1.4 12.0 8.6 16.5 4.6 18.6 2.8 2.5 22.2 6.3 2.1 1.9 2.1 3.3 1.3 2.4 1.4 4.7 5.4 3.5 3.2 10.2 3.8 0.0 1.8 0.7 2.7 4.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.7 17.0 17.4 10.7 0.1 3.9 7.8 2.8 2.5 0.7 0.2 0.0 0.4 12.3 3.7 0.0 6.5 2.3 2.5 0.0 1.0 0.8 0.0 8.7 6.5 0.0 0.1 9.1 1.1 4.9 1.0 12.9 20.9 0.0 0.9 0.0 10.3 0.0 0.0 0.0 6.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.1 16.3 0.1 0.0 0.1 1.3 0.0 0.0 19.0 2.7 1.2 1.0 3.0 0.0 0.0 0.0 14.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 13.7 10.8 29.5 15.6 8.5 12.0 8.6 22.2 3.8 0.0 0.3 0.0 2.8 3.1 8.2 2.5 10.2 0.0 0.0 0.0 3.9 0.1 3.3 68.5 165.4 5.8 0.0 0.0 41.6 0.1 8.1 14.7 5.7 113.4 0.5 0.0 0.0 6.2 1.3 388.8 14.4 0.6 3.3 1.8 0.0 12.3 60.5 0.0 11.0 0.2 11.8 0.0 11.3 4.9 3.6 2.0 0.0 0.0 0.0 1.0 FNDC7 FLJ35838 ENSG00000143107 "Fibronectin type III domain containing 7" Q5VTL7 1 108712657-108742740 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 3.0;testis: 5.2" "Cell type enhanced" "Detected in some" 24 "Bipolar cells: 1.1;Early spermatids: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 1.1;Karpas-707: 1.2;U-87 MG: 1.8" "Not detected" "Not detected" "HPA028079, HPA054297" Enhanced Approved "Nucleoplasm,Actin filaments" "Secreted in male reproductive system" NA NA "Actin filaments" Nucleoplasm "HPA028079: AB_10602501, HPA054297: AB_2682441" "unprognostic (2.35e-2)" "unprognostic (2.65e-2)" "unprognostic (3.74e-1)" "unprognostic (8.10e-2)" "unprognostic (1.30e-1)" "unprognostic (1.64e-1)" "unprognostic (1.13e-4)" "unprognostic (1.90e-10)" "unprognostic (1.59e-2)" "unprognostic (1.33e-1)" "unprognostic (1.31e-1)" 0.1 0.1 0.6 0.1 0.8 0.6 0.1 0.4 1.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.7 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.0 0.8 0.1 3.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 5.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.1 0.5 0.6 0.0 0.4 0.2 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.3 0.1 0.9 0.5 0.0 0.9 0.0 0.0 0.1 0.2 0.1 0.6 0.2 0.3 0.1 0.0 1.1 0.0 1.2 0.5 0.0 0.1 0.0 0.0 0.1 1.1 0.3 0.0 0.0 0.0 0.2 0.8 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.5 0.3 0.3 0.1 0.4 0.2 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.4 1.1 1.7 0.7 0.1 0.1 3.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 FOS "AP-1, c-fos" ENSG00000170345 "Fos proto-oncogene, AP-1 transcription factor subunit" P01100 14 75278774-75282230 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 84.5" "Lineage enriched" "Detected in many" 7 "granulocytes: 84.5" "Cell line enhanced" "Detected in many" "hTCEpi: 98.8;OE19: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA018531 Approved Supported Nucleoplasm Yes No Nucleoplasm "HPA018531: AB_1846576" "unprognostic (1.18e-2)" "unprognostic (8.70e-2)" "unprognostic (1.61e-1)" "unprognostic (3.80e-1)" "unprognostic (3.08e-2)" "unprognostic (4.82e-2)" "unprognostic (2.09e-1)" "unprognostic (3.30e-1)" "unprognostic (9.55e-3)" "unprognostic (4.20e-3)" "unprognostic (1.04e-1)" "prognostic favorable (7.81e-4)" "unprognostic (3.20e-2)" "unprognostic (1.52e-2)" "unprognostic (3.22e-1)" "unprognostic (1.43e-1)" "unprognostic (2.66e-2)" 104.8 58.4 17.0 143.7 30.0 157.6 40.7 24.0 21.3 132.3 48.7 52.3 22.1 17.4 79.7 50.5 93.6 239.5 271.8 56.8 17.5 21.4 22.7 47.9 70.7 31.0 23.9 10.6 94.5 32.7 40.9 52.9 130.2 44.6 60.6 49.3 64.4 42.8 255.8 37.5 156.2 44.1 98.1 43.7 18.5 60.7 33.2 26.8 10.1 77.5 226.7 28.1 60.8 54.0 0.0 11.6 84.5 12.3 0.7 0.1 3.3 0.4 0.3 1.5 2.2 13.2 4.0 9.1 1.3 0.5 0.9 0.7 0.9 2.6 0.1 0.4 9.2 9.2 0.6 0.7 15.9 0.2 0.2 0.2 0.2 3.8 0.3 6.1 0.5 9.3 9.9 98.8 0.8 6.0 1.3 0.5 1.9 0.4 4.2 0.2 5.4 0.1 2.6 1.6 35.5 0.5 0.4 0.3 4.8 4.1 4.3 11.4 0.7 2.0 18.3 7.8 4.9 0.3 1.9 1.3 0.1 1.2 0.8 0.4 11.4 11.9 2.0 0.6 1.6 1.2 6.0 12.3 14.6 0.0 3.5 0.0 0.0 0.0 0.1 11.6 0.0 0.0 0.0 84.5 0.7 0.4 0.2 0.0 3.3 17.0 30.0 24.0 21.3 17.5 21.4 23.9 10.6 44.6 26.8 1024.3 2295.6 355.2 364.1 763.7 85.4 943.0 545.2 294.5 662.0 181.5 121.7 1104.1 14.9 389.9 11.8 1089.3 1251.6 70.0 471.9 2288.8 1942.6 1138.8 1518.7 136.0 1546.5 33.4 1566.3 439.5 1852.6 21.7 873.9 1719.6 811.4 159.7 1650.2 515.9 381.7 1444.9 167.6 15.8 410.8 1190.0 1600.6 4.1 8.0 954.8 1909.4 705.6 1252.5 275.6 FOSB "AP-1, DKFZp686C0818, G0S3, GOS3, GOSB, MGC42291" ENSG00000125740 "FosB proto-oncogene, AP-1 transcription factor subunit" P53539 19 45467995-45475179 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 9.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 9.0" "Cell line enhanced" "Detected in many" "GAMG: 12.0;HMC-1: 14.0;hTCEpi: 8.7;Karpas-707: 7.2;SK-BR-3: 10.3" "Group enriched" "Detected in many" 4 "amygdala: 4.1;basal ganglia: 4.2;cerebral cortex: 5.3;hippocampal formation: 4.5;olfactory region: 8.8" "Low region specificity" "Detected in many" "CAB010267, HPA054663" Approved Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB010267: AB_640583, HPA054663: AB_2682562" "unprognostic (7.22e-2)" "unprognostic (9.74e-2)" "unprognostic (2.91e-1)" "unprognostic (3.04e-1)" "unprognostic (1.08e-2)" "unprognostic (2.50e-1)" "unprognostic (1.30e-3)" "unprognostic (9.43e-2)" "unprognostic (2.04e-2)" "unprognostic (2.99e-2)" "unprognostic (2.50e-1)" "unprognostic (1.40e-1)" "unprognostic (3.51e-2)" "unprognostic (4.99e-3)" "unprognostic (8.72e-2)" "unprognostic (4.45e-2)" "unprognostic (4.04e-2)" 72.7 13.0 2.3 111.4 7.4 39.2 10.0 5.5 7.7 62.9 9.0 14.9 2.2 1.7 32.1 6.1 18.9 135.1 102.6 14.1 2.5 2.9 3.4 8.6 22.9 6.0 2.0 1.2 29.1 12.2 8.1 8.1 129.0 8.5 12.2 7.9 38.6 8.7 59.1 2.2 59.5 10.8 36.3 2.5 2.6 30.5 21.7 1.3 4.0 33.6 114.5 8.2 16.7 4.4 0.2 1.7 9.0 1.6 0.2 0.7 0.2 0.4 0.7 0.2 0.3 1.3 0.3 2.3 2.4 1.1 0.7 0.7 0.5 1.0 2.0 0.4 1.5 12.0 0.9 0.5 1.6 0.5 0.3 0.7 0.6 0.7 0.4 0.8 1.1 14.0 0.5 8.7 1.8 2.0 0.4 1.0 2.4 0.7 7.2 0.2 0.2 0.2 1.2 0.5 1.0 0.4 0.5 0.1 1.4 0.7 1.3 3.3 0.4 1.5 10.3 1.2 2.1 0.5 0.8 0.1 0.5 0.6 1.2 0.7 5.4 0.7 0.5 1.1 0.8 1.3 1.5 1.6 1.7 0.3 0.2 0.7 0.1 0.4 0.3 1.7 0.2 0.0 0.0 9.0 0.2 0.1 0.1 0.1 0.2 2.3 7.4 5.5 7.7 2.5 2.9 2.0 1.2 8.5 1.3 637.2 863.6 170.2 357.4 337.9 23.2 156.7 221.7 108.4 179.7 10.4 127.6 182.1 1.7 82.5 6.6 228.5 437.9 23.3 65.2 252.3 314.2 253.2 799.2 48.7 184.0 7.9 843.2 193.3 203.0 5.1 222.4 274.6 163.6 26.2 718.0 71.6 106.5 426.1 55.9 1.9 178.0 297.5 219.5 1.1 3.1 333.0 331.9 203.1 555.5 158.8 FOSL1 fra-1 ENSG00000175592 "FOS like 1, AP-1 transcription factor subunit" P15407 11 65892049-65900573 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 35.2;tongue: 46.8" "Group enriched" "Detected in many" 7 "Basal glandular cells: 279.5;Basal keratinocytes: 300.3;Glandular cells: 139.2;Suprabasal keratinocytes: 296.9;Urothelial cells: 386.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "myeloid DC: 6.9" "Lineage enriched" "Detected in many" 4 "dendritic cells: 6.9" "Cell line enhanced" "Detected in many" "PC-3: 94.2;U-2197: 63.2;WM-115: 142.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB004396, HPA030728" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "CAB004396: AB_627632, HPA030728: " "unprognostic (2.88e-2)" "unprognostic (1.56e-1)" "unprognostic (9.46e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.80e-4)" "prognostic unfavorable (2.05e-4)" "unprognostic (2.70e-1)" "prognostic unfavorable (1.95e-4)" "unprognostic (1.12e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (9.26e-5)" "unprognostic (7.85e-2)" "prognostic unfavorable (6.40e-6)" "unprognostic (2.23e-1)" "unprognostic (1.53e-1)" "unprognostic (2.28e-1)" "unprognostic (2.82e-2)" 22.4 3.7 1.5 8.2 3.1 17.9 3.6 1.1 2.8 5.4 2.8 1.5 0.2 0.8 2.1 2.0 35.2 4.4 24.4 5.8 2.3 1.3 2.2 4.4 7.7 1.7 2.6 0.5 2.6 9.9 0.4 2.0 3.2 6.5 3.1 1.7 0.6 5.4 1.0 6.6 9.2 2.0 3.6 3.5 1.6 8.7 1.5 2.3 0.3 2.1 46.8 16.5 16.6 4.6 0.0 6.9 1.0 1.6 0.0 0.6 1.1 36.6 5.4 0.6 2.4 5.5 5.5 5.3 34.3 31.5 29.7 16.7 1.7 30.5 0.0 7.5 23.7 46.9 6.9 2.2 27.6 25.5 1.1 0.0 2.2 0.5 4.0 6.9 1.4 0.8 2.3 2.8 23.3 35.2 14.5 9.5 0.0 5.3 0.2 38.9 1.5 0.0 3.0 2.5 3.1 94.2 0.1 3.0 0.1 13.8 2.4 0.0 0.0 2.0 0.0 25.7 1.6 0.1 1.3 23.7 35.2 7.2 63.2 50.2 0.0 0.1 0.1 49.5 0.6 142.9 0.0 1.6 0.0 0.3 1.1 0.2 0.0 0.6 0.3 6.9 0.0 0.6 0.0 1.0 0.0 0.5 0.8 0.0 1.1 1.5 3.1 1.1 2.7 2.3 1.3 2.6 0.5 6.5 2.3 6.0 4.1 0.0 279.5 300.3 0.0 0.6 0.0 9.4 19.4 0.0 0.0 1.1 0.0 14.2 0.1 11.3 2.8 0.0 3.1 3.8 23.0 139.2 9.2 0.0 1.8 0.0 10.9 8.0 0.6 0.0 0.3 9.0 42.2 1.8 1.2 0.0 23.7 0.2 0.0 0.0 0.0 0.0 40.8 0.2 0.7 296.9 14.8 0.0 0.7 386.7 FOSL2 "FLJ23306, FRA2" ENSG00000075426 "FOS like 2, AP-1 transcription factor subunit" P15408 2 28392448-28417312 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Smooth muscle cells: 255.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 23.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA004817, CAB013460, HPA061417" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB013460: , HPA004817: AB_1849014, HPA061417: AB_2684509" "unprognostic (1.21e-1)" "unprognostic (3.60e-1)" "unprognostic (1.21e-1)" "unprognostic (8.55e-2)" "unprognostic (1.28e-3)" "unprognostic (3.41e-2)" "unprognostic (7.24e-2)" "unprognostic (3.78e-3)" "unprognostic (1.08e-1)" "unprognostic (7.73e-3)" "unprognostic (1.40e-2)" "unprognostic (2.08e-1)" "unprognostic (2.38e-1)" "unprognostic (2.38e-1)" "unprognostic (1.72e-2)" "unprognostic (1.99e-2)" "unprognostic (2.79e-2)" 62.8 66.9 7.3 24.6 11.2 74.5 22.5 5.4 11.9 34.4 35.4 7.0 15.0 11.4 43.8 16.3 49.6 26.6 42.0 30.3 12.0 4.7 17.2 12.6 32.2 4.4 10.2 3.6 62.0 14.1 4.1 14.2 20.8 15.9 36.4 15.9 11.4 16.2 22.1 56.3 31.1 37.2 40.8 20.0 20.4 25.4 13.8 8.0 2.1 13.6 16.2 14.5 47.1 79.7 0.0 2.5 23.0 6.2 2.7 5.1 2.8 12.5 8.6 0.5 6.7 7.1 12.6 18.2 10.8 11.0 17.3 15.1 10.2 10.0 0.0 15.9 13.8 17.6 12.1 0.7 14.2 15.6 2.9 0.9 1.3 16.1 1.7 11.2 2.2 5.5 20.0 36.4 20.2 17.9 14.6 9.0 0.4 0.1 3.6 11.5 2.0 0.2 6.8 1.0 12.8 4.3 0.5 16.8 1.2 27.7 43.6 4.6 0.6 17.5 10.3 3.1 5.2 1.1 10.1 26.9 36.4 24.6 21.1 15.6 5.6 2.0 0.0 24.1 12.3 6.2 8.8 6.2 5.4 5.1 4.7 5.0 0.0 1.1 2.5 2.5 0.0 0.3 1.7 23.0 2.7 3.8 0.8 0.7 2.8 7.3 11.2 5.4 11.9 12.0 4.7 10.2 3.6 15.9 8.0 29.8 69.6 2.4 72.6 127.2 0.5 23.8 50.9 13.4 25.0 158.7 0.0 19.1 16.6 56.4 1.1 60.9 113.3 0.0 51.5 108.4 60.6 59.1 105.2 12.4 34.3 0.0 26.9 49.7 65.1 2.2 20.8 81.0 81.0 38.7 56.3 0.5 55.4 66.6 23.0 25.4 1.0 25.8 255.1 1.7 2.5 131.7 42.0 34.6 44.8 118.3 FOXA1 HNF3A ENSG00000129514 "Forkhead box A1" P55317 14 37589984-37596059 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 47.0;prostate: 44.4" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 103.5;Glandular cells: 100.2;Intestinal endocrine cells: 81.2;Urothelial cells: 133.4" "Cancer enhanced" "Detected in many" "prostate cancer: 127.0" "Region enriched" "Detected in single" 6 "midbrain: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 16.6;MCF7: 36.1;PC-3: 25.2;RT4: 33.8;SK-BR-3: 34.2;T-47d: 48.4" "Group enriched" "Detected in some" 15 "hypothalamus: 1.0;midbrain: 1.3;thalamus: 1.1" "Region enriched" "Detected in single" 6 "midbrain: 6.1" "CAB011595, HPA050505" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "CAB011595: AB_2104842, HPA050505: AB_2681148" "unprognostic (1.61e-1)" "unprognostic (8.80e-2)" "unprognostic (1.12e-1)" "unprognostic (4.65e-1)" "unprognostic (2.58e-1)" "unprognostic (1.51e-1)" "unprognostic (1.74e-1)" "unprognostic (1.78e-1)" "unprognostic (1.71e-1)" "unprognostic (3.01e-1)" "unprognostic (1.54e-2)" "unprognostic (6.30e-2)" "unprognostic (0.00e+0)" "unprognostic (3.67e-1)" "unprognostic (2.58e-1)" "unprognostic (1.69e-2)" "prognostic favorable (1.00e-4)" 0.1 0.0 0.1 6.1 0.1 0.0 23.5 0.1 0.3 1.5 9.4 0.1 0.1 4.6 0.1 0.5 7.2 1.3 6.5 0.1 0.1 0.3 0.4 47.0 13.2 0.1 2.0 0.1 0.6 0.2 0.0 1.1 0.1 0.2 44.4 6.0 0.2 9.4 0.7 0.1 0.7 5.1 2.4 0.1 0.1 13.0 0.6 0.1 0.2 0.1 4.4 9.9 12.5 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.5 0.0 0.9 0.0 0.0 0.2 0.0 0.1 0.0 0.0 7.4 0.9 0.0 0.5 0.0 0.0 8.4 4.7 1.1 0.0 0.0 8.3 0.0 1.4 16.6 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.0 0.1 0.3 0.0 0.0 36.1 0.0 0.1 0.0 11.0 25.2 0.0 0.4 0.1 3.5 33.8 4.3 0.0 1.6 34.2 0.0 0.0 48.4 0.1 0.0 0.3 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.3 2.0 0.1 0.2 0.1 26.8 38.7 0.0 103.5 0.9 0.0 1.1 25.5 52.2 37.5 3.5 0.0 0.0 0.0 1.8 0.3 0.3 14.7 0.0 2.1 0.0 0.0 100.2 2.3 27.6 0.0 0.0 81.2 1.3 1.2 0.5 0.0 0.1 3.3 1.8 34.4 0.0 3.1 21.0 0.0 0.0 0.0 0.0 0.1 0.5 1.3 0.1 0.0 0.0 25.3 133.4 FOXA2 HNF3B ENSG00000125798 "Forkhead box A2" Q9Y261 20 22581005-22585455 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 44.4;pancreas: 47.9;stomach 1: 20.7" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 89.3;Alveolar cells type 2: 60.1;Cholangiocytes: 48.4;Hepatocytes: 51.3;Mucus-secreting cells: 82.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 10.2;HBEC3-KT: 11.7;Hep G2: 16.2;hTERT-HME1: 7.9;OE19: 13.2;PC-3: 15.1;SCLC-21H: 26.2" "Region enhanced" "Detected in single" "midbrain: 1.1" "Region enriched" "Detected in single" 7 "midbrain: 4.9" "CAB001388, HPA066846" Enhanced Supported "Nucleoplasm,Cell Junctions" NA NA "Nucleoplasm, Cell Junctions" "CAB001388: AB_2262810, HPA066846: AB_2685736" "unprognostic (1.19e-1)" "unprognostic (1.99e-1)" "prognostic favorable (7.57e-6)" "unprognostic (6.82e-2)" "unprognostic (1.50e-6)" "unprognostic (1.38e-1)" "unprognostic (8.17e-2)" "prognostic favorable (6.28e-4)" "prognostic favorable (2.34e-4)" "unprognostic (3.18e-1)" "unprognostic (2.55e-15)" "unprognostic (2.50e-2)" "unprognostic (1.68e-1)" "unprognostic (7.12e-2)" "unprognostic (3.93e-3)" 0.2 0.0 0.2 1.3 0.2 0.0 0.2 0.2 0.3 9.7 4.5 0.2 0.2 2.2 1.8 0.2 0.2 3.8 13.1 0.2 0.2 0.1 0.2 44.4 15.9 0.2 1.4 0.2 3.4 47.9 0.0 0.4 0.3 0.4 0.5 6.0 0.2 0.2 0.2 0.2 0.0 1.8 0.2 0.2 0.2 20.7 0.3 0.2 0.2 2.2 0.2 0.9 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.3 0.0 0.1 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.7 0.0 0.0 16.2 0.0 0.0 0.0 0.0 6.3 0.0 7.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 13.2 15.1 0.0 0.0 0.0 0.5 0.0 26.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.2 0.1 1.4 0.2 0.4 0.2 89.3 60.1 0.0 1.0 0.0 0.0 0.3 48.4 17.4 22.7 0.0 0.0 0.0 0.0 21.4 0.0 0.0 4.9 0.0 31.8 0.0 0.0 0.6 4.6 51.3 0.0 0.0 27.0 0.6 0.3 0.0 0.0 0.0 0.0 1.0 82.6 0.0 24.8 2.9 0.0 0.0 0.0 0.0 0.0 3.7 0.1 0.0 0.0 0.0 33.6 0.0 FOXA3 HNF3G ENSG00000170608 "Forkhead box A3" P55318 19 45863989-45873797 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 36.7;pancreas: 63.3" "Cell type enhanced" "Detected in many" 19 "Intestinal endocrine cells: 79.9;Mucus-secreting cells: 184.0;Paneth cells: 49.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 3.2" "Lineage enriched" "Detected in single" 10 "T-cells: 3.2" "Cell line enhanced" "Detected in some" "HDLM-2: 5.5;Hep G2: 12.9;K-562: 10.3;OE19: 45.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB015154, HPA054034" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB015154: AB_647545, HPA054034: AB_2682349" "unprognostic (2.88e-1)" "unprognostic (6.95e-2)" "unprognostic (2.37e-1)" "unprognostic (2.34e-1)" "unprognostic (1.07e-1)" "unprognostic (2.27e-1)" "unprognostic (2.39e-2)" "unprognostic (1.42e-1)" "unprognostic (6.87e-3)" "unprognostic (1.55e-1)" "unprognostic (6.42e-2)" "unprognostic (1.17e-2)" "unprognostic (2.57e-2)" "unprognostic (1.91e-2)" "unprognostic (3.55e-1)" "unprognostic (3.75e-1)" "unprognostic (2.11e-1)" 0.3 0.0 0.2 5.9 0.2 0.0 0.1 0.1 0.3 0.5 9.7 0.3 0.7 4.7 0.2 0.1 0.2 0.1 13.7 0.5 0.1 0.0 0.9 36.7 0.6 0.1 0.1 0.1 0.1 63.3 0.7 0.1 0.1 0.2 0.3 8.0 0.1 1.0 0.8 0.1 0.1 9.0 0.1 0.1 0.1 17.1 0.7 0.3 0.2 0.1 0.5 0.7 0.1 0.1 0.3 0.0 0.0 0.0 0.0 3.2 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.7 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.5 0.5 0.1 0.0 12.9 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.3 10.3 0.0 0.0 0.1 0.0 0.0 5.2 45.3 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.0 0.0 0.7 3.2 0.0 0.3 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.3 0.1 0.0 0.1 0.1 0.2 0.3 0.0 4.5 1.4 0.5 0.2 0.0 0.4 10.2 0.0 0.0 1.8 0.0 0.0 0.0 9.7 0.1 0.6 22.2 0.0 21.3 0.0 0.1 6.3 4.6 31.7 0.0 0.0 79.9 0.6 2.1 0.0 0.0 0.0 1.7 0.0 184.0 0.0 26.3 49.1 0.0 0.2 0.0 0.0 0.5 2.3 6.4 0.3 0.0 0.0 36.6 0.9 FOXB1 "FKH5, HFKH-5" ENSG00000171956 "Forkhead box B1" Q99853 15 60004222-60061730 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 16.7" "Cell type enriched" "Detected in some" 6 "Early spermatids: 18.1" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.2" "Region enhanced" "Detected in many" "pons and medulla: 16.7" "Cell type enriched" "Detected in single" 4 "T-reg: 3.8" "Lineage enriched" "Detected in single" 38 "T-cells: 3.8" "Cell line enhanced" "Detected in some" "AF22: 7.0;HDLM-2: 15.3;HEK 293: 11.7;JURKAT: 6.1" "Region enhanced" "Detected in some" "hypothalamus: 7.7" "Low region specificity" "Detected in many" HPA073369 Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA073369: AB_2686597" "unprognostic (1.69e-1)" "unprognostic (3.33e-2)" "unprognostic (1.14e-1)" "unprognostic (7.40e-3)" "unprognostic (1.33e-3)" "unprognostic (1.17e-2)" "unprognostic (1.47e-2)" "unprognostic (5.32e-4)" "unprognostic (1.06e-1)" "unprognostic (9.21e-2)" "unprognostic (3.21e-1)" "unprognostic (8.12e-9)" "unprognostic (8.74e-2)" "unprognostic (1.74e-1)" "unprognostic (9.38e-2)" 0.0 0.0 0.3 0.5 4.1 0.2 0.2 0.6 0.0 0.1 0.1 0.6 0.0 0.0 0.6 0.0 0.2 0.9 0.1 0.2 0.1 6.2 0.0 0.1 0.1 1.8 6.5 0.0 0.0 0.4 0.0 0.0 1.9 16.7 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.0 8.4 0.1 1.8 2.6 3.7 0.0 0.1 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.1 2.6 0.0 7.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 15.3 11.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 1.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.8 0.1 0.3 4.1 0.6 0.0 0.1 6.2 6.5 0.0 16.7 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 18.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 FOXC1 "ARA, FKHL7, FREAC3, IGDA, IHG1, IRID1" ENSG00000054598 "Forkhead box C1" Q12948 6 1609972-1613897 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Angiogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Deafness, Disease mutation, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "retina: 32.7;salivary gland: 86.6" "Cell type enhanced" "Detected in many" 8 "Endothelial cells: 40.9;Ito cells: 36.2;Urothelial cells: 55.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "NK-cell: 1.4" "Lineage enriched" "Detected in single" 6 "NK-cells: 1.4" "Cell line enhanced" "Detected in many" "AN3-CA: 39.8;HEK 293: 38.8;RPTEC TERT1: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA040670 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040670: AB_10673412" "unprognostic (2.65e-2)" "unprognostic (1.15e-2)" "prognostic unfavorable (3.53e-4)" "unprognostic (3.22e-2)" "unprognostic (3.22e-2)" "unprognostic (1.24e-1)" "unprognostic (3.30e-2)" "unprognostic (1.54e-2)" "unprognostic (4.04e-3)" "unprognostic (1.58e-1)" "unprognostic (2.33e-3)" "unprognostic (9.55e-2)" "unprognostic (1.11e-2)" "unprognostic (6.48e-2)" "unprognostic (2.04e-1)" "unprognostic (3.83e-3)" "unprognostic (3.74e-1)" 7.7 4.4 2.6 1.3 3.4 1.0 9.4 2.3 3.4 6.6 1.4 2.8 3.2 1.2 2.4 3.8 3.8 3.4 9.8 9.5 3.2 2.1 12.9 1.4 3.8 1.6 4.5 2.3 4.8 2.8 2.2 6.5 3.1 6.5 6.0 1.3 32.7 86.6 4.9 3.6 7.1 1.2 2.1 3.9 0.9 1.1 4.6 2.6 2.8 3.7 4.2 2.9 5.7 4.6 0.0 0.0 0.2 0.1 1.4 0.0 0.0 7.3 0.8 0.2 39.8 1.8 2.1 1.2 3.7 4.4 2.3 1.9 2.8 1.5 0.0 4.3 2.2 1.7 8.4 3.8 2.7 1.9 2.3 38.8 1.5 2.2 1.3 1.2 0.5 2.6 7.0 3.8 3.2 3.6 1.2 3.4 0.2 1.0 0.0 1.0 1.6 0.0 0.8 0.1 3.7 3.2 0.0 1.6 0.2 15.6 5.6 1.5 3.4 4.6 0.0 2.6 2.1 1.1 0.6 0.8 5.1 3.1 2.6 3.9 0.1 0.3 0.0 1.4 1.9 4.5 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.1 0.0 0.0 0.0 2.6 3.4 2.3 3.4 3.2 2.1 4.5 2.3 6.5 2.6 0.0 1.1 0.0 25.0 15.8 0.0 5.6 0.0 26.8 14.8 10.4 0.0 4.5 1.7 3.4 0.4 40.9 0.0 0.0 15.0 0.4 3.6 7.7 0.0 0.0 1.1 0.0 0.0 36.2 0.3 0.9 15.0 1.4 1.7 0.0 0.2 0.3 11.8 0.0 26.5 4.6 0.0 0.0 27.0 0.2 1.9 5.6 0.7 0.0 0.3 55.7 FOXC2 "FKHL14, MFH-1" ENSG00000176692 "Forkhead box C2" Q99958 16 86567251-86569728 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 17.6" "Group enriched" "Detected in some" 5 "Peritubular cells: 29.0;Sertoli cells: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 15.9;HUVEC TERT2: 12.2;LHCN-M2: 19.5;TIME: 21.7;U-138 MG: 11.6;U-2197: 19.5;U-87 MG: 15.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA056302 Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA056302: AB_2683093" "unprognostic (3.17e-2)" "unprognostic (1.76e-3)" "unprognostic (4.87e-2)" "unprognostic (4.32e-1)" "unprognostic (1.15e-1)" "unprognostic (1.60e-2)" "unprognostic (4.49e-2)" "unprognostic (1.15e-2)" "unprognostic (4.71e-2)" "unprognostic (8.88e-2)" "unprognostic (1.47e-1)" "unprognostic (1.73e-1)" "prognostic unfavorable (3.57e-7)" "unprognostic (1.12e-2)" "unprognostic (3.47e-2)" "unprognostic (2.43e-1)" "unprognostic (1.84e-4)" 4.8 5.7 1.1 1.6 1.4 0.5 6.4 1.1 3.4 6.2 2.0 2.2 0.1 1.1 1.6 5.3 3.0 3.9 5.6 8.8 1.1 1.1 9.1 0.9 4.9 5.4 4.3 2.6 4.0 1.3 0.6 3.7 0.9 9.9 2.1 1.0 17.6 4.2 2.9 3.2 1.5 0.9 2.1 8.5 0.5 1.1 7.7 0.7 0.0 3.3 1.0 0.9 4.9 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 5.1 0.0 6.5 8.9 5.0 1.0 0.0 0.0 0.0 0.9 0.9 7.0 0.0 0.1 2.0 4.5 0.0 0.4 0.0 4.9 0.0 1.7 0.0 0.0 0.8 2.2 15.9 5.1 9.2 12.2 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 3.9 0.0 0.0 21.7 11.6 0.0 19.5 0.0 0.0 0.0 0.0 15.2 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.4 1.1 3.4 1.1 1.1 4.3 2.6 9.9 0.7 0.0 0.0 0.0 0.6 0.0 0.0 1.7 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 4.5 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.1 1.4 0.0 1.7 0.0 0.0 0.0 0.2 0.0 29.0 0.0 0.0 19.4 4.2 0.2 0.9 0.0 0.0 0.0 0.0 1.0 FOXD4 "FKHL9, FOXD4a, FREAC5" ENSG00000170122 "Forkhead box D4" Q12950 9 116231-118204 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.7;testis: 3.1" "Cell type enriched" "Detected in single" 7 "monocytes: 4.6" "Low cancer specificity" "Detected in single" "Cell type enriched" "Detected in single" 8 "eosinophil: 1.8" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.8" "Cell line enhanced" "Detected in some" "THP-1: 8.9" HPA012836 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA012836: AB_2105429" "unprognostic (8.27e-2)" "unprognostic (1.09e-2)" "unprognostic (2.38e-3)" "unprognostic (4.75e-2)" "unprognostic (1.02e-1)" "unprognostic (3.87e-3)" "unprognostic (1.22e-1)" "unprognostic (4.20e-2)" "unprognostic (9.46e-2)" "unprognostic (2.52e-4)" "unprognostic (3.66e-4)" "unprognostic (7.06e-3)" "unprognostic (1.14e-2)" "unprognostic (1.44e-2)" "unprognostic (2.43e-1)" "unprognostic (6.26e-2)" "unprognostic (1.02e-3)" 0.6 0.6 1.2 0.5 1.4 0.1 0.1 5.7 1.5 0.4 0.2 0.4 0.7 0.1 0.1 0.3 0.1 0.2 1.3 1.5 1.6 0.2 0.6 0.7 0.8 0.3 0.5 0.2 0.7 0.6 0.7 0.3 0.3 0.5 1.4 0.3 0.6 0.4 0.4 1.0 0.6 3.1 0.2 0.2 0.2 0.1 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.6 0.5 0.0 0.4 0.8 0.4 3.7 0.2 0.4 0.0 0.3 1.0 0.2 3.7 0.6 0.0 0.1 0.0 0.9 0.2 0.3 3.6 3.0 0.0 0.5 0.3 0.2 2.6 1.9 0.5 0.0 0.0 0.1 0.6 0.0 0.2 1.2 1.6 0.1 1.4 0.3 2.1 0.1 0.5 1.8 0.3 0.8 0.5 0.9 1.9 1.8 1.4 1.0 0.6 0.0 0.3 0.9 8.9 0.5 1.1 1.1 0.7 1.3 0.1 0.4 0.8 0.8 2.0 1.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.6 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 FOXD4L1 FOXD5 ENSG00000184492 "Forkhead box D4 like 1" Q9NU39 2 113498665-113501155 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 2.2;bone marrow: 3.0;brain: 3.3;lymphoid tissue: 1.2;testis: 3.1" "Cell type enriched" "Detected in single" 134 "monocytes: 54.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 22 "naive B-cell: 2.2" "Lineage enriched" "Detected in single" 22 "B-cells: 2.2" "Cell line enhanced" "Detected in some" "RH-30: 5.3;THP-1: 3.7" HPA012836 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA012836: AB_2105429" "unprognostic (3.48e-1)" "unprognostic (3.66e-2)" "unprognostic (3.02e-2)" "unprognostic (6.61e-2)" "unprognostic (3.22e-1)" "unprognostic (6.41e-4)" "unprognostic (2.54e-1)" "unprognostic (5.77e-3)" "unprognostic (5.93e-2)" "unprognostic (4.21e-2)" "unprognostic (9.54e-4)" "unprognostic (3.98e-2)" "unprognostic (1.18e-8)" "unprognostic (1.57e-2)" "unprognostic (4.14e-2)" "unprognostic (9.57e-2)" "unprognostic (5.91e-4)" 0.2 0.5 0.4 1.2 1.2 3.0 0.1 3.3 0.8 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.0 0.0 0.6 0.6 0.4 0.1 0.4 0.4 0.3 0.0 0.2 0.0 0.4 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.6 0.2 3.1 0.2 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.6 0.7 1.1 0.0 1.5 0.0 0.6 0.0 0.1 0.3 0.0 2.0 0.9 0.1 0.2 0.1 0.6 0.0 0.1 1.9 1.4 0.8 1.0 1.0 0.0 2.1 1.6 0.0 0.7 0.2 0.0 0.8 0.0 0.9 1.2 1.7 0.3 0.1 0.3 0.9 0.0 0.2 0.7 0.6 5.3 0.7 0.1 0.6 0.7 0.4 0.5 0.1 0.3 0.0 0.4 3.7 0.4 1.7 1.5 0.6 1.3 1.4 1.4 0.7 0.3 1.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 FOXD4L3 FOXD6 ENSG00000187559 "Forkhead box D4 like 3" Q6VB84 9 68302867-68304905 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.6;fallopian tube: 2.4;lymphoid tissue: 2.0" "Cell type enriched" "Detected in single" 12 "monocytes: 1.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "memory B-cell: 1.0" "Lineage enriched" "Detected in single" 7 "B-cells: 1.0" "Cell line enhanced" "Detected in some" "HDLM-2: 1.7;NB-4: 1.2;THP-1: 1.9" HPA012836 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA012836: AB_2105429" "unprognostic (7.93e-4)" "unprognostic (8.71e-2)" "unprognostic (7.04e-2)" "unprognostic (4.75e-2)" 0.0 0.1 0.7 1.4 1.3 0.0 0.0 2.1 2.3 0.3 0.1 0.0 0.0 0.0 0.0 2.4 0.4 0.0 2.6 0.7 0.0 0.0 0.0 1.6 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.1 2.0 0.0 0.9 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.5 0.3 0.0 0.7 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.0 0.3 1.7 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.0 1.0 0.0 0.0 0.4 0.0 0.9 0.1 0.1 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.2 0.5 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.6 0.1 0.8 0.5 0.4 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXD4L4 "bA460E7.2, FOXD4L2" ENSG00000184659 "Forkhead box D4 like 4" Q8WXT5 9 65736555-65738784 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.4" HPA012836 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA012836: AB_2105429" "unprognostic (6.92e-2)" "unprognostic (5.48e-2)" "unprognostic (5.19e-2)" "unprognostic (7.78e-2)" "unprognostic (7.93e-3)" "unprognostic (7.14e-2)" 0.4 0.6 0.3 1.0 1.2 0.0 0.2 1.5 1.3 0.7 0.2 0.0 0.2 0.0 0.2 0.2 0.1 0.4 1.0 0.7 0.2 0.1 0.0 0.1 0.6 0.2 0.0 0.0 0.2 0.2 0.2 0.1 0.4 0.1 0.4 0.0 0.4 0.1 0.2 0.5 0.1 0.5 0.0 0.2 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.7 0.5 1.4 0.0 0.2 0.3 0.7 0.0 0.0 0.2 1.0 0.0 0.5 0.2 0.2 0.1 0.0 0.2 0.0 0.0 0.2 1.1 0.2 0.5 0.0 0.2 0.2 0.7 0.3 0.2 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.7 0.0 0.5 0.2 0.7 0.0 0.1 0.3 0.2 0.0 0.0 0.3 0.8 1.0 0.4 0.0 0.1 0.2 0.7 0.0 0.1 0.5 0.0 0.4 1.0 0.5 0.7 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXD4L5 bA15J10.2 ENSG00000204779 "Forkhead box D4 like 5" Q5VV16 9 65282101-65285209 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" HPA012836 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA012836: AB_2105429" "unprognostic (8.26e-2)" "unprognostic (6.95e-3)" "unprognostic (1.58e-1)" "unprognostic (5.76e-2)" "unprognostic (2.57e-1)" 0.7 1.1 0.3 0.1 0.5 0.0 0.7 0.6 2.2 0.3 0.1 0.1 0.1 1.1 0.4 0.7 0.1 0.2 1.0 0.5 0.5 0.2 0.3 0.2 0.3 0.2 0.2 0.0 0.2 0.5 0.3 0.0 1.2 0.1 0.5 2.0 0.3 0.0 0.2 0.2 0.4 1.0 0.8 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.2 1.1 0.7 2.8 0.5 0.3 3.5 0.6 0.2 0.0 0.0 0.7 0.3 2.0 0.4 0.2 0.3 0.0 1.5 0.2 0.2 2.8 1.7 1.8 0.8 0.9 0.0 1.5 2.7 0.2 0.8 0.2 0.6 1.0 0.0 0.2 2.7 1.1 0.3 0.6 0.3 1.0 0.8 0.3 0.9 0.6 2.2 0.7 0.7 1.4 1.4 2.6 0.6 0.3 0.2 1.8 0.9 3.5 0.4 0.4 2.1 1.2 1.1 0.8 1.7 0.5 0.3 1.9 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXD4L6 ENSG00000273514 "Forkhead box D4 like 6" Q3SYB3 9 41126430-41128463 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 1.8;lymphoid tissue: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.8" HPA012836 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA012836: AB_2105429" "unprognostic (2.41e-1)" "unprognostic (3.41e-1)" "unprognostic (3.61e-1)" 0.0 0.0 1.5 0.0 0.0 1.8 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.7 0.2 0.0 0.5 1.0 0.0 0.1 0.1 0.2 0.0 0.0 0.7 0.1 0.0 0.1 0.1 1.0 0.0 0.0 0.6 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.4 0.0 0.0 0.1 0.2 0.1 0.3 0.1 0.0 0.3 0.0 0.0 0.1 0.6 0.4 0.6 0.2 0.6 0.5 0.3 0.3 0.0 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.7 0.3 0.0 0.8 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXF1 "FKHL5, FREAC1" ENSG00000103241 "Forkhead box F1" Q12946 16 86510527-86515418 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 54.7;urinary bladder: 48.5" "Cell type enhanced" "Detected in some" 22 "Endothelial cells: 4.7;Fibroblasts: 7.2;Ito cells: 4.9;Smooth muscle cells: 19.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BJ: 9.4;BJ hTERT+: 20.7;HHSteC: 20.3;U-2197: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA028886 Approved Nucleoplasm NA NA Nucleoplasm "HPA028886: AB_10601652" "unprognostic (7.91e-2)" "unprognostic (3.02e-3)" "unprognostic (1.23e-1)" "unprognostic (4.38e-2)" "unprognostic (1.84e-2)" "unprognostic (2.62e-3)" "unprognostic (2.37e-2)" "unprognostic (1.08e-1)" "unprognostic (8.22e-2)" "unprognostic (6.07e-3)" "unprognostic (1.06e-1)" "unprognostic (1.91e-2)" "unprognostic (1.29e-2)" "unprognostic (4.89e-2)" "unprognostic (4.20e-2)" "unprognostic (7.11e-2)" "unprognostic (2.44e-1)" 2.2 0.3 2.5 15.4 2.9 0.0 0.8 2.3 4.2 7.9 34.6 1.3 1.6 7.2 2.1 0.9 17.9 1.2 39.7 0.6 3.4 1.9 1.2 2.4 33.1 2.4 3.5 1.0 0.6 0.9 1.1 0.4 18.5 3.5 35.7 9.2 0.5 0.9 4.8 0.3 0.4 18.4 54.7 3.0 0.5 18.4 0.6 3.7 0.0 3.6 2.6 3.3 48.5 25.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 20.7 2.9 1.0 0.0 0.1 0.0 0.0 0.8 2.0 0.0 1.6 0.0 2.5 0.0 1.1 0.0 1.5 0.0 20.3 0.0 1.7 2.1 0.0 3.3 0.4 0.3 3.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 3.1 0.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 8.9 0.0 0.0 0.0 0.0 1.9 0.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.5 2.9 2.3 4.2 3.4 1.9 3.5 1.0 3.5 3.7 0.0 1.1 0.0 0.2 0.2 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 4.7 0.0 0.0 0.0 0.3 7.2 0.7 0.0 0.0 0.3 0.0 0.0 4.9 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 19.6 0.0 0.4 0.3 1.0 0.0 0.0 0.2 FOXJ2 FHX ENSG00000065970 "Forkhead box J2" Q9P0K8 12 8032703-8055503 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008723 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA008723: AB_1078903" "unprognostic (1.68e-1)" "unprognostic (2.70e-1)" "unprognostic (1.22e-2)" "unprognostic (1.11e-1)" "unprognostic (1.37e-2)" "unprognostic (1.10e-1)" "unprognostic (1.60e-1)" "unprognostic (9.65e-2)" "unprognostic (3.08e-1)" "unprognostic (2.74e-3)" "unprognostic (3.40e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (4.63e-4)" "unprognostic (9.01e-2)" "unprognostic (2.48e-2)" "unprognostic (2.30e-2)" "unprognostic (2.02e-2)" 19.6 9.7 7.6 9.2 8.6 14.8 14.2 23.7 14.6 20.8 14.7 11.7 17.3 8.1 20.5 11.6 12.3 14.7 13.3 17.3 9.4 5.8 8.5 6.5 12.9 8.4 8.8 8.4 19.9 11.0 21.0 10.2 12.1 7.3 15.4 9.0 11.7 12.4 19.7 25.7 18.1 10.8 17.9 8.4 11.7 12.5 6.7 9.8 13.0 12.0 13.5 13.2 17.0 14.7 4.2 4.5 6.9 3.5 7.3 5.0 2.4 7.4 6.4 7.0 8.7 8.1 9.0 15.4 10.8 11.1 10.6 7.9 9.0 8.3 0.1 2.0 13.0 9.8 8.2 6.2 7.2 11.4 13.0 4.2 9.9 7.3 3.1 10.2 4.4 27.9 7.9 10.9 13.7 20.1 11.1 7.5 8.1 7.2 5.0 8.5 5.8 6.3 4.0 7.9 11.2 4.3 6.8 10.8 3.6 4.4 5.0 2.9 4.0 13.6 9.5 4.8 15.3 2.2 5.4 6.8 13.0 16.0 9.1 6.5 4.1 4.0 5.0 8.4 3.6 7.6 6.3 3.4 5.1 4.0 2.7 5.0 2.3 4.0 4.6 4.3 4.2 4.7 4.1 6.9 7.3 3.5 4.5 3.1 2.4 7.6 8.6 23.7 14.6 9.4 5.8 8.8 8.4 7.3 9.8 14.9 12.5 3.7 3.9 16.8 9.0 18.0 10.2 2.7 1.2 0.0 7.9 4.7 0.0 5.3 0.2 9.4 4.9 0.0 6.4 2.6 9.1 6.9 3.5 8.3 8.7 7.9 4.7 25.2 15.9 0.5 9.8 9.5 6.8 8.2 8.4 5.0 9.2 3.5 15.9 1.8 7.1 19.4 4.7 0.7 5.8 18.7 5.1 5.3 6.0 3.6 FOXJ3 KIAA1041 ENSG00000198815 "Forkhead box J3" Q9UPW0 1 42176539-42335877 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067284 Approved "Nucleoplasm,Nuclear speckles,Vesicles" NA NA "Nucleoplasm, Nuclear speckles" Vesicles "HPA067284: AB_2685817" "unprognostic (5.60e-2)" "unprognostic (2.26e-2)" "unprognostic (4.24e-2)" "unprognostic (5.15e-2)" "unprognostic (3.18e-2)" "unprognostic (1.56e-2)" "prognostic unfavorable (5.17e-6)" "unprognostic (3.65e-3)" "unprognostic (1.17e-1)" "unprognostic (1.30e-1)" "unprognostic (1.72e-1)" "unprognostic (5.14e-2)" "prognostic unfavorable (4.51e-7)" "unprognostic (2.10e-1)" "unprognostic (1.83e-1)" "unprognostic (1.87e-2)" "unprognostic (5.43e-2)" 24.8 15.1 21.2 20.1 31.3 31.6 25.6 38.2 30.9 22.3 18.4 22.9 15.4 18.8 24.9 18.9 17.4 19.8 16.2 23.5 21.5 20.2 16.8 17.6 20.4 19.6 22.9 19.2 29.5 22.6 31.6 28.7 33.5 21.2 21.7 22.5 18.4 19.0 23.7 44.3 24.3 20.0 22.0 20.7 19.6 20.8 19.0 22.6 29.0 23.7 15.2 22.2 22.8 21.4 12.3 9.7 10.9 9.4 11.6 13.1 4.3 13.8 11.7 12.9 13.4 14.0 17.2 18.6 10.5 15.6 14.2 15.9 10.8 16.7 21.3 11.3 14.7 12.2 13.3 18.0 17.3 24.2 16.0 10.1 23.5 14.9 9.1 12.1 21.5 16.2 12.8 17.2 21.2 26.4 15.2 15.4 17.1 14.1 15.5 16.9 7.9 21.7 12.3 20.1 11.1 10.7 20.4 33.9 14.5 12.1 20.2 18.0 16.9 19.0 22.0 19.1 19.3 11.0 32.1 14.3 14.9 20.0 15.0 17.4 15.4 18.9 17.4 13.5 18.0 11.9 6.0 5.7 6.1 9.0 4.8 10.9 8.0 11.0 9.5 4.6 12.3 11.8 13.1 10.9 11.6 9.4 9.7 7.0 4.3 21.2 31.3 38.2 30.9 21.5 20.2 22.9 19.2 21.2 22.6 11.9 17.6 20.1 9.7 31.5 18.4 37.6 7.6 12.0 15.9 15.7 17.7 11.1 14.9 9.7 14.9 23.2 22.8 46.7 12.6 26.0 14.6 16.6 12.7 14.9 10.3 20.6 25.9 14.1 19.0 14.2 20.8 12.7 10.1 6.4 26.0 14.1 13.7 17.3 18.7 11.0 32.9 6.5 12.3 22.8 22.7 29.2 23.3 12.5 17.9 19.2 FOXK1 IMAGE:5164497 ENSG00000164916 "Forkhead box K1" P85037 7 4682309-4771443 "Predicted intracellular proteins, Transcription factors" "Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 86.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017998, HPA018864" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA017998: AB_1849077, HPA018864: AB_1849079" "unprognostic (3.05e-2)" "unprognostic (5.01e-2)" "unprognostic (1.54e-1)" "unprognostic (1.55e-2)" "unprognostic (3.51e-1)" "unprognostic (3.03e-1)" "prognostic unfavorable (2.54e-6)" "unprognostic (2.34e-2)" "unprognostic (2.62e-2)" "unprognostic (1.73e-3)" "unprognostic (2.66e-3)" "unprognostic (4.96e-2)" "unprognostic (3.79e-3)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" "unprognostic (4.34e-2)" "unprognostic (3.72e-1)" 13.0 16.7 15.5 12.7 16.0 24.7 10.3 18.1 23.8 14.1 15.4 18.4 9.5 10.1 16.9 8.3 12.4 14.4 11.7 13.6 14.4 13.7 10.7 8.4 14.3 11.9 19.3 13.9 15.5 17.6 10.6 22.2 9.9 14.2 11.7 9.3 13.8 12.6 14.0 27.4 21.0 11.3 15.5 12.1 15.6 11.9 14.7 19.9 12.5 9.2 9.5 11.0 14.9 19.0 3.2 2.8 1.9 4.0 3.7 6.5 2.9 8.7 11.3 7.3 14.5 7.2 5.5 9.1 4.0 3.6 2.9 3.3 11.2 10.0 15.0 4.8 6.5 9.4 14.5 7.9 9.9 3.0 4.3 4.9 7.0 11.7 6.3 7.1 8.7 8.1 10.4 5.6 7.0 9.7 4.7 5.6 5.8 15.1 3.3 3.5 10.1 3.3 15.6 11.0 3.6 5.7 12.5 7.3 9.5 4.2 13.1 6.6 8.3 6.1 13.4 4.8 6.0 7.4 11.6 17.1 5.1 16.1 7.8 8.6 9.3 7.6 9.9 6.8 10.2 8.0 1.9 2.4 1.0 4.6 4.0 6.5 3.2 4.5 4.3 2.8 3.2 5.1 4.7 1.4 3.7 3.7 2.3 2.2 2.9 15.5 16.0 18.1 21.4 14.4 13.7 19.3 13.9 14.2 19.9 29.8 13.7 14.4 10.4 29.8 16.7 11.1 10.2 10.7 9.1 14.0 21.6 11.0 5.0 8.8 33.5 14.3 7.8 0.0 13.2 3.8 16.7 21.0 7.0 10.6 9.5 22.3 12.6 11.6 19.4 86.3 17.8 8.8 15.1 10.8 9.2 9.8 16.4 8.6 26.9 14.7 14.2 19.4 34.0 14.0 15.7 43.7 3.3 14.4 15.6 18.8 FOXK2 "ILF, ILF1" ENSG00000141568 "Forkhead box K2" Q01167 17 82519713-82644662 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027523, HPA073491" Approved Supported Nucleoplasm,Vesicles,Mitochondria NA NA Nucleoplasm "Vesicles, Mitochondria" "HPA027523: AB_10601013, HPA073491: " "unprognostic (2.39e-1)" "unprognostic (8.28e-2)" "unprognostic (2.05e-1)" "unprognostic (9.52e-2)" "unprognostic (3.11e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.24e-6)" "unprognostic (3.35e-2)" "unprognostic (2.25e-1)" "unprognostic (5.19e-2)" "unprognostic (2.18e-2)" "unprognostic (2.26e-1)" "unprognostic (3.80e-3)" "unprognostic (2.24e-2)" "unprognostic (4.89e-2)" "unprognostic (1.12e-1)" "unprognostic (1.52e-2)" 16.8 21.2 17.5 14.3 19.2 8.7 19.1 21.3 30.5 17.7 17.1 17.1 16.9 11.2 22.2 13.7 24.2 14.6 13.4 17.1 14.9 14.9 13.0 13.6 15.2 13.6 13.7 17.2 17.6 19.2 25.4 19.8 18.6 15.6 14.9 11.7 13.8 17.1 16.3 41.5 21.6 12.6 19.9 10.3 13.2 15.5 32.3 15.8 21.8 18.6 12.4 13.9 16.4 16.4 4.0 5.9 4.1 2.9 4.1 4.4 1.6 21.7 23.3 21.8 23.8 12.6 13.9 14.6 12.8 14.8 22.5 22.9 22.6 14.0 18.6 9.3 15.8 24.8 12.7 23.2 14.8 21.3 12.7 22.2 19.2 15.4 22.2 19.9 21.4 12.9 13.1 27.1 23.7 27.1 14.0 22.7 20.2 25.6 19.1 12.3 13.0 36.3 13.6 12.5 18.0 17.8 23.9 18.6 15.4 10.3 18.4 36.2 26.7 12.7 32.4 30.2 24.3 22.8 24.8 17.7 29.7 20.8 19.9 25.8 22.1 19.5 24.1 16.0 17.9 15.6 4.1 2.9 3.3 4.4 2.2 3.5 4.0 3.3 4.2 3.3 2.8 2.6 2.9 0.5 4.1 2.3 5.9 3.4 1.6 17.5 19.2 21.3 30.5 14.9 14.9 13.7 17.2 15.6 15.8 47.6 21.9 9.3 7.3 33.1 18.1 17.3 5.1 13.4 18.2 14.0 11.8 10.2 3.3 8.5 11.5 12.8 10.5 0.0 9.1 7.5 13.1 10.0 2.3 11.4 16.3 44.5 10.5 12.9 14.6 18.8 8.6 9.2 11.8 9.0 13.5 9.1 10.2 11.5 12.4 5.4 16.1 0.0 19.6 13.2 9.5 37.6 8.1 6.9 12.1 8.9 FOXL2 "BPES, BPES1" ENSG00000183770 "Forkhead box L2" P58012 3 138944224-138947140 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 13.9;ovary: 55.5;parathyroid gland: 15.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 5.6;fHDF/TERT166: 6.5;HEL: 9.2;hTCEpi: 8.5;K-562: 9.4;SiHa: 6.5;THP-1: 6.7" "Not detected" "Not detected" HPA069613 Enhanced Supported "Nucleoplasm,Midbody ring" NA NA Nucleoplasm "Midbody ring" "HPA069613: AB_2686160" "unprognostic (1.46e-1)" "unprognostic (3.28e-2)" "unprognostic (4.76e-3)" "unprognostic (2.05e-1)" "unprognostic (5.16e-4)" "unprognostic (3.55e-2)" "unprognostic (2.35e-3)" "unprognostic (5.08e-2)" "unprognostic (3.79e-2)" "unprognostic (2.19e-1)" "unprognostic (9.63e-8)" "unprognostic (2.16e-2)" "unprognostic (4.65e-1)" "unprognostic (2.90e-2)" "unprognostic (1.61e-2)" 0.0 1.5 0.3 0.0 1.2 0.0 0.0 0.3 1.0 13.9 0.0 0.6 0.0 0.0 10.0 0.4 0.1 6.4 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.3 0.4 55.5 0.6 15.3 13.1 1.4 0.8 0.2 0.0 1.7 0.0 0.4 0.0 0.2 0.0 0.9 0.3 0.0 0.0 0.8 0.2 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 2.2 0.3 4.0 0.1 0.0 1.7 0.2 0.0 0.4 0.1 0.0 0.4 0.0 2.7 6.5 0.2 1.3 0.0 0.0 0.1 0.0 0.0 9.2 1.1 0.0 0.0 0.1 0.0 0.0 8.5 0.0 0.0 1.4 0.0 0.0 9.4 0.0 3.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 1.8 0.0 0.0 6.5 0.0 0.0 0.3 0.0 6.7 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.3 1.0 0.4 0.2 0.3 0.4 0.8 0.2 0.0 0.0 0.0 0.1 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.9 0.0 0.0 0.0 0.0 FOXM1 "FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident" ENSG00000111206 "Forkhead box M1" Q08050 12 2857681-2877155 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 47.5;testis: 40.1" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 16.5;Erythroid cells: 23.3;Extravillous trophoblasts: 15.0;Late spermatids: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" CAB017832 Uncertain Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA Yes "Nucleoplasm, Nucleoli, Nucleoli rim" Cytosol "CAB017832: " "unprognostic (3.18e-2)" "unprognostic (1.69e-1)" "unprognostic (1.22e-2)" "unprognostic (1.09e-2)" "unprognostic (4.30e-2)" "unprognostic (3.75e-2)" "prognostic unfavorable (1.95e-6)" "prognostic unfavorable (2.92e-4)" "unprognostic (1.01e-2)" "unprognostic (3.25e-2)" "prognostic unfavorable (3.03e-5)" "unprognostic (6.09e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.80e-2)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (1.94e-1)" 1.7 1.7 1.0 9.3 0.9 13.8 2.4 0.4 1.2 2.0 6.5 0.4 1.1 6.0 1.2 2.1 13.5 0.4 4.1 1.2 0.8 0.6 1.3 1.6 2.8 6.6 0.8 0.3 0.8 0.6 0.0 0.5 3.9 0.9 0.9 8.2 0.6 2.6 1.1 0.7 3.7 7.1 4.4 1.2 5.0 3.2 40.1 0.4 47.5 0.6 11.4 11.6 2.0 3.7 0.7 0.6 1.0 0.6 0.4 1.9 0.1 28.5 29.0 22.5 20.7 3.4 4.5 28.7 18.7 18.4 37.9 34.4 36.6 25.6 18.5 4.0 26.7 43.1 22.2 33.7 17.1 37.2 34.5 18.0 20.8 27.8 15.6 0.5 16.7 17.1 2.3 1.9 35.2 24.8 9.0 26.7 21.2 11.6 41.5 29.8 26.8 22.7 7.9 49.7 29.7 21.7 16.5 34.2 9.6 8.9 18.3 12.7 20.1 23.9 20.1 10.9 44.4 19.6 18.7 10.7 30.8 46.8 35.9 64.8 5.5 9.1 26.8 14.3 16.1 32.6 0.4 0.6 0.1 0.4 0.2 0.4 0.7 0.5 0.4 0.2 0.7 0.9 0.3 1.0 0.4 0.1 0.6 1.9 0.1 1.0 0.9 0.4 1.2 0.8 0.6 0.8 0.3 0.9 0.4 0.0 2.2 0.8 0.7 2.6 1.6 0.5 2.5 0.0 1.2 1.8 3.9 1.4 1.7 0.2 16.5 0.3 1.7 23.3 0.0 15.0 1.3 0.8 0.0 0.9 7.3 4.8 0.0 3.1 1.9 20.0 0.9 1.7 0.0 1.8 3.7 0.6 0.2 0.0 0.7 0.0 4.4 0.0 0.0 7.6 5.9 1.3 1.6 2.5 3.7 1.3 FOXN2 HTLF ENSG00000170802 "Forkhead box N2" P32314 2 48314637-48379294 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 45.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003485 Supported Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA003485: AB_1078905" "unprognostic (5.38e-2)" "unprognostic (1.48e-1)" "unprognostic (1.86e-2)" "unprognostic (2.65e-3)" "prognostic favorable (3.85e-4)" "unprognostic (4.00e-1)" "unprognostic (2.32e-2)" "unprognostic (1.52e-1)" "unprognostic (8.95e-2)" "unprognostic (2.59e-1)" "unprognostic (5.15e-3)" "unprognostic (4.14e-2)" "prognostic unfavorable (2.81e-5)" "unprognostic (2.24e-2)" "unprognostic (1.55e-1)" "unprognostic (2.34e-2)" "unprognostic (1.12e-2)" 17.7 6.2 12.7 13.9 17.4 45.5 13.6 23.6 13.8 8.1 7.4 25.0 3.2 8.2 8.2 4.6 9.1 6.5 9.8 8.3 16.1 9.5 6.8 18.7 10.6 17.4 23.3 12.8 6.2 8.4 9.8 7.0 12.6 19.0 6.2 8.0 2.9 7.1 4.7 8.0 5.9 10.1 9.5 23.6 17.2 7.4 6.1 26.0 17.8 7.9 6.9 15.7 10.9 8.2 7.6 11.3 42.3 11.3 8.3 9.9 5.6 6.9 10.7 12.3 10.9 9.8 7.2 13.6 7.8 8.6 6.6 7.4 9.4 8.8 15.3 10.5 9.2 8.1 8.9 7.4 8.9 9.7 11.8 6.5 29.8 7.6 9.4 17.1 16.3 23.8 6.5 3.8 7.1 12.5 5.4 7.0 6.4 14.1 18.3 10.7 5.3 18.0 10.8 9.3 5.2 5.6 9.0 25.8 12.5 5.8 8.9 6.9 7.1 3.8 7.2 13.8 4.4 3.2 9.7 8.1 9.1 9.1 8.6 8.2 9.9 7.4 22.1 7.9 15.1 12.2 35.1 11.1 42.3 8.7 8.9 9.9 7.5 8.3 7.9 11.3 7.6 6.4 6.4 14.1 8.3 11.3 7.0 9.5 5.6 12.7 17.4 23.6 13.8 16.1 9.5 23.3 12.8 19.0 26.0 0.0 6.1 9.5 17.5 13.9 6.9 9.0 15.3 1.4 6.8 1.8 0.0 5.6 5.0 5.3 3.3 17.0 7.7 0.0 4.7 28.3 9.9 31.0 22.0 17.0 16.1 12.7 2.4 19.0 31.1 3.3 11.2 31.1 11.8 35.1 8.6 7.1 8.8 7.0 10.6 4.0 3.7 6.5 13.0 11.1 7.5 18.4 13.8 17.3 8.3 34.0 FOXN3 "C14orf116, CHES1" ENSG00000053254 "Forkhead box N3" O00409 14 89124871-89619149 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059209 Approved Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA059209: AB_2683949" "unprognostic (1.69e-1)" "unprognostic (6.13e-3)" "unprognostic (2.08e-1)" "unprognostic (1.84e-1)" "unprognostic (4.09e-2)" "unprognostic (2.03e-1)" "unprognostic (3.03e-1)" "unprognostic (1.34e-2)" "unprognostic (8.75e-2)" "unprognostic (1.09e-1)" "unprognostic (2.64e-1)" "unprognostic (1.19e-1)" "prognostic favorable (9.58e-5)" "unprognostic (2.22e-2)" "unprognostic (1.88e-1)" "unprognostic (5.53e-2)" "unprognostic (2.11e-1)" 26.8 14.5 12.6 23.2 11.3 33.9 35.2 46.9 10.7 17.2 28.4 15.3 12.2 18.2 19.3 11.2 21.0 17.4 11.9 20.2 12.8 7.8 7.5 15.4 14.1 20.1 11.3 7.4 28.8 15.1 35.0 10.1 11.3 13.2 15.7 11.1 17.8 13.4 12.6 44.3 29.5 31.1 25.1 14.0 13.2 15.9 12.6 13.2 34.0 8.8 18.4 19.9 25.7 31.7 9.6 19.3 21.4 14.2 17.3 24.3 15.2 0.1 2.7 7.3 4.3 29.7 9.6 5.0 5.5 5.9 5.1 8.5 2.6 2.1 8.6 2.9 8.8 3.6 1.9 12.5 8.1 7.6 37.2 2.4 2.8 5.4 9.0 9.6 5.6 5.1 22.5 4.7 0.4 3.6 6.3 10.9 12.1 3.3 24.6 8.6 3.3 11.1 5.6 7.6 5.0 4.9 17.5 24.8 8.0 0.6 8.9 3.8 13.0 8.1 8.1 2.3 24.7 4.5 16.2 19.2 8.9 11.9 8.6 8.3 22.0 37.3 15.5 3.0 10.0 5.2 21.4 13.0 18.8 24.3 14.2 19.5 7.8 16.4 20.8 19.3 9.6 21.5 20.5 5.4 17.3 8.7 4.3 19.2 15.2 12.6 11.3 46.9 10.7 12.8 7.8 11.3 7.4 13.2 13.2 29.8 33.4 42.2 20.1 79.3 120.0 94.3 45.9 13.4 46.6 8.7 0.0 28.4 18.3 8.5 51.6 50.4 42.4 23.3 18.2 16.8 35.5 24.5 12.7 73.7 37.8 74.7 57.0 52.2 76.4 26.5 89.2 69.9 30.4 26.2 40.3 32.4 15.4 24.6 80.2 10.5 9.3 38.8 52.6 2.3 10.0 129.0 24.7 76.1 43.5 22.0 FOXN4 ENSG00000139445 "Forkhead box N4" Q96NZ1 12 109277979-109309220 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 13.1" "Cell type enhanced" "Detected in some" 21 "Spermatocytes: 1.8;Spermatogonia: 2.6" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.8" "Region enriched" "Detected in single" 11 "basal ganglia: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 2.4;SCLC-21H: 6.4;SH-SY5Y: 6.6;U-266/70: 9.1" "Not detected" "Not detected" HPA050018 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA050018: AB_2680992" "unprognostic (1.09e-3)" "unprognostic (9.63e-2)" "unprognostic (1.60e-1)" "unprognostic (1.22e-1)" "unprognostic (1.08e-1)" "unprognostic (2.52e-2)" "unprognostic (1.18e-1)" "unprognostic (3.27e-2)" "unprognostic (7.93e-3)" "unprognostic (2.30e-1)" "unprognostic (1.02e-3)" "unprognostic (1.05e-1)" "unprognostic (1.43e-1)" "unprognostic (6.00e-2)" 0.2 0.0 0.1 0.1 2.7 0.0 0.1 0.2 0.1 1.4 0.3 0.1 0.1 0.0 0.6 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.2 0.9 2.3 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.4 0.1 0.4 0.1 0.1 0.0 13.1 0.1 0.1 0.1 0.1 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 2.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 6.6 0.0 0.1 0.0 0.1 0.2 0.5 0.0 0.0 0.1 0.0 0.0 9.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.7 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.6 0.0 0.0 0.0 0.0 0.0 FOXO1 "FKH1, FKHR, FOXO1A" ENSG00000150907 "Forkhead box O1" Q12778 13 40469953-40666597 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Autophagy, Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 85.9" "Cell type enhanced" "Detected in many" 6 "Ito cells: 72.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 19.3;Daudi: 20.4;HSkMC: 25.7;U-698: 26.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001252, CAB022326" Approved Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB022326: , HPA001252: AB_1078906" "unprognostic (4.72e-2)" "unprognostic (1.81e-1)" "unprognostic (8.54e-2)" "unprognostic (4.35e-1)" "unprognostic (2.42e-1)" "unprognostic (2.52e-1)" "prognostic favorable (3.74e-4)" "unprognostic (6.35e-2)" "unprognostic (1.60e-1)" "unprognostic (8.65e-3)" "unprognostic (1.71e-1)" "unprognostic (1.31e-1)" "prognostic favorable (1.33e-5)" "unprognostic (1.93e-1)" "unprognostic (5.44e-1)" "unprognostic (9.09e-2)" "unprognostic (9.63e-2)" 41.6 6.9 7.0 18.4 11.2 8.0 35.5 2.3 5.0 21.4 13.4 8.4 7.7 3.5 27.4 9.8 9.5 17.2 13.3 9.9 7.8 3.9 8.3 25.6 15.3 22.4 8.3 3.9 46.0 12.2 3.8 6.2 9.5 6.5 7.9 6.8 5.7 7.5 9.3 85.9 12.3 7.6 18.6 9.7 10.8 7.4 12.3 9.0 9.4 13.1 9.0 15.6 14.4 16.2 6.1 0.5 2.8 1.6 1.1 7.1 1.0 0.3 0.6 5.7 0.1 19.3 3.8 5.5 0.8 1.1 0.2 0.1 1.5 1.3 20.4 3.8 0.5 0.9 4.9 4.5 2.4 0.3 9.2 4.6 0.0 0.6 4.5 9.2 0.1 0.5 25.7 16.7 0.1 3.2 1.1 14.5 1.5 0.3 6.5 1.4 0.7 0.0 0.2 8.3 2.8 1.4 14.5 6.7 1.6 10.7 2.6 1.2 0.3 0.7 3.9 0.8 6.9 0.6 0.5 8.5 0.1 1.1 0.0 0.5 3.7 1.4 26.4 0.5 0.9 2.6 0.9 0.8 0.5 1.5 1.0 2.3 3.2 3.9 2.2 0.5 6.1 7.1 5.3 2.8 1.1 1.6 0.0 5.5 1.0 7.0 11.2 2.3 5.0 7.8 3.9 8.3 3.9 6.5 9.0 0.0 4.1 9.5 18.7 26.1 3.0 9.8 7.6 9.4 9.1 8.7 11.8 0.2 0.0 9.5 5.5 37.9 19.3 0.0 15.3 1.7 28.8 9.2 1.1 39.4 5.7 4.8 50.2 72.4 15.5 2.0 17.3 11.0 11.8 18.0 18.4 5.0 15.9 13.6 12.4 6.3 8.3 6.5 9.3 4.8 14.9 23.3 0.7 12.9 9.8 9.1 FOXO3 "AF6q21, FKHRL1, FOXO2, FOXO3A" ENSG00000118689 "Forkhead box O3" O43524 6 108559835-108684774 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Erythroid cells: 210.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 15.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004074, HPA063104" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004074: AB_2106672, HPA063104: AB_2684941" "unprognostic (3.42e-2)" "unprognostic (3.76e-2)" "unprognostic (4.28e-2)" "unprognostic (1.96e-2)" "unprognostic (6.68e-2)" "unprognostic (4.63e-2)" "unprognostic (4.08e-3)" "unprognostic (1.73e-1)" "unprognostic (3.81e-2)" "unprognostic (5.18e-2)" "unprognostic (1.98e-2)" "unprognostic (1.75e-1)" "unprognostic (2.54e-2)" "unprognostic (9.09e-2)" "unprognostic (1.13e-1)" "unprognostic (5.81e-2)" "unprognostic (5.68e-2)" 29.6 7.7 11.5 12.2 12.6 36.7 35.4 28.0 18.1 19.9 16.1 12.6 9.8 7.8 17.4 16.1 22.3 16.5 18.0 12.9 9.7 7.7 10.7 14.0 21.1 16.8 12.4 14.0 28.8 52.3 14.3 8.8 13.1 10.3 13.8 11.0 14.3 21.2 10.5 54.7 20.3 11.3 13.9 7.9 14.2 14.8 13.1 13.2 11.6 13.1 12.7 10.2 17.1 20.3 1.8 2.7 15.7 4.6 3.4 4.0 1.0 9.1 3.3 6.0 9.7 18.6 22.3 7.5 7.6 8.0 6.7 9.2 5.9 8.3 5.9 6.5 8.9 9.8 6.7 6.2 9.3 10.0 5.3 9.0 14.7 2.9 4.4 21.7 3.5 10.8 25.4 18.8 13.7 18.8 9.3 5.0 5.4 9.8 40.1 12.1 5.2 4.9 5.4 3.9 4.4 5.0 5.7 17.1 19.7 13.3 7.0 10.6 27.6 6.5 5.3 7.6 11.0 5.8 11.7 8.0 11.4 6.4 7.0 9.8 0.7 6.9 5.6 6.2 7.1 7.8 6.7 2.9 5.7 3.6 1.5 4.0 1.0 1.9 3.0 1.7 1.8 1.7 2.3 15.7 3.4 4.6 2.7 1.8 1.0 11.5 12.6 28.0 18.1 9.7 7.7 12.4 14.0 10.3 13.2 41.7 39.5 22.4 61.6 60.1 55.0 28.2 73.9 44.2 46.6 24.4 66.8 19.2 14.9 43.0 12.5 63.2 36.2 210.2 26.5 31.0 67.9 115.8 15.0 60.6 39.1 49.3 64.2 66.9 66.3 12.1 98.7 35.8 54.0 43.3 49.3 89.6 53.0 33.6 94.4 15.9 67.1 32.3 89.8 7.2 18.1 40.7 34.4 35.5 29.9 108.9 FOXP1 "12CC4, hFKH1B, HSPC215, QRF1" ENSG00000114861 "Forkhead box P1" Q9H334 3 70952817-71583993 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 40.2" "HPA003876, CAB011501" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB011501: AB_732428, HPA003876: AB_1078907" "unprognostic (2.31e-1)" "unprognostic (4.35e-3)" "unprognostic (2.09e-2)" "unprognostic (3.54e-2)" "unprognostic (2.69e-1)" "unprognostic (2.81e-3)" "unprognostic (1.68e-1)" "unprognostic (1.00e-1)" "unprognostic (1.23e-1)" "unprognostic (2.03e-1)" "unprognostic (4.38e-3)" "unprognostic (3.40e-1)" "unprognostic (6.14e-2)" "unprognostic (1.05e-1)" "unprognostic (8.65e-2)" "unprognostic (1.27e-1)" "unprognostic (6.05e-2)" 24.6 5.1 7.0 30.2 19.2 32.7 21.9 7.2 13.1 16.3 29.3 8.7 10.3 10.1 19.8 9.9 19.6 13.1 19.3 15.5 8.4 5.9 7.6 12.9 26.1 34.0 7.6 10.2 30.3 14.7 7.2 25.7 11.4 7.4 21.6 21.6 11.3 24.6 11.2 12.7 12.2 16.7 34.3 7.9 18.6 20.4 11.7 10.1 38.1 19.8 13.1 27.0 28.5 31.8 29.9 8.4 14.4 9.9 9.2 29.6 11.2 3.8 2.9 7.1 4.8 3.3 9.6 3.4 11.4 13.1 10.0 7.3 21.3 4.5 10.3 1.7 5.1 7.2 2.6 13.1 9.8 16.9 3.1 5.4 5.3 7.1 20.0 8.3 9.9 13.1 9.8 4.0 40.2 17.8 7.0 14.9 6.1 5.3 15.1 4.5 16.8 4.9 3.9 8.7 2.7 18.6 14.9 12.3 1.8 8.2 12.1 6.0 10.9 11.9 3.3 0.7 7.1 2.3 7.3 18.8 13.9 6.0 19.3 15.7 3.8 2.8 14.6 8.8 12.7 2.9 14.4 5.7 6.0 8.3 5.7 9.3 25.8 18.3 10.3 5.3 29.9 29.6 18.9 8.3 9.2 9.9 8.4 15.9 11.2 7.0 19.2 7.2 13.1 8.4 5.9 7.6 10.2 7.4 10.1 68.5 106.7 181.2 154.9 162.6 27.9 38.3 114.7 87.0 93.3 31.4 17.7 37.3 26.6 65.8 141.2 159.5 75.9 70.0 81.8 13.6 54.0 219.0 213.7 53.9 43.0 6.4 260.7 120.9 97.8 57.5 38.9 86.3 35.4 111.0 226.3 20.3 98.8 101.7 23.3 15.6 38.0 90.5 74.6 10.8 6.4 88.7 43.8 126.3 146.7 116.8 FOXP2 "CAGH44, SPCH1, TNRC10" ENSG00000128573 "Forkhead box P2" O15409 7 114086327-114693772 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 48.4;urinary bladder: 31.5" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 27.2;Muller glia cells: 42.1;Suprabasal keratinocytes: 22.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 15.0;RH-30: 27.6;THP-1: 8.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000382, HPA000383, HPA001679" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA000382: AB_1078908, HPA000383: AB_1078909, HPA001679: AB_2666415" "unprognostic (1.21e-1)" "unprognostic (7.85e-2)" "unprognostic (4.89e-2)" "unprognostic (8.83e-3)" "unprognostic (4.66e-1)" "unprognostic (3.69e-4)" "unprognostic (2.04e-2)" "unprognostic (6.22e-2)" "unprognostic (2.17e-1)" "unprognostic (6.70e-3)" "unprognostic (1.22e-1)" "unprognostic (1.77e-1)" "unprognostic (8.04e-2)" "unprognostic (4.16e-3)" "unprognostic (2.84e-1)" "unprognostic (9.81e-2)" "unprognostic (4.19e-2)" 1.7 1.5 0.9 9.4 2.9 0.0 2.0 0.6 2.8 9.4 20.4 0.7 3.6 2.7 18.1 2.1 12.4 3.5 7.7 1.2 0.7 2.9 1.5 2.9 1.4 0.6 2.0 1.0 11.1 4.5 0.0 0.9 0.7 1.8 13.3 5.7 1.4 2.8 1.5 4.6 3.3 4.2 48.4 0.9 0.6 4.6 0.9 0.9 0.6 5.3 3.2 1.2 31.5 5.4 9.4 16.5 11.1 7.2 6.3 10.3 16.3 0.2 2.2 15.0 0.0 3.5 4.7 0.9 2.4 2.6 0.5 0.3 1.0 0.2 0.2 0.6 0.8 0.1 0.3 0.6 0.0 0.1 0.1 5.1 5.6 3.4 4.6 0.0 0.3 0.3 1.2 0.6 0.0 0.0 0.9 0.6 0.0 1.2 2.1 0.5 1.1 1.2 0.8 0.8 0.2 0.7 0.4 27.6 5.3 0.3 6.0 3.9 1.6 0.0 0.9 0.7 1.0 0.7 8.2 1.1 1.0 0.4 1.4 0.4 5.4 0.4 0.6 1.1 0.5 0.4 7.5 5.2 11.1 6.2 7.2 6.3 9.4 7.0 6.8 6.8 7.3 7.2 8.1 5.6 6.3 5.9 16.5 10.3 16.3 0.9 2.9 0.6 2.7 0.7 2.9 2.0 1.0 1.8 0.9 0.0 5.1 0.0 1.7 27.2 0.0 1.4 7.6 12.0 7.9 3.5 2.0 0.1 0.0 0.0 8.1 2.2 4.3 0.0 4.8 0.0 7.2 3.1 0.0 10.6 0.2 12.7 4.1 9.8 1.9 4.5 4.9 0.7 3.3 0.0 11.9 42.1 2.0 16.1 0.7 2.2 1.0 0.0 1.0 0.1 0.2 22.3 0.2 0.0 12.1 2.4 FOXP3 "AIID, DIETER, IPEX, JM2, PIDX, SCURFIN, XPID" ENSG00000049768 "Forkhead box P3" Q9BZS1 X 49250436-49264826 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.9;lymphoid tissue: 23.3" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 2: 1.1;granulocytes: 1.1;Horizontal cells: 3.2;Melanocytes: 1.7;T-cells: 2.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 11 "T-reg: 25.9" "Lineage enriched" "Detected in single" 260 "T-cells: 25.9" "Cell line enhanced" "Detected in some" "MCF7: 8.3;SiHa: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026301, HPA045943" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB026301: , HPA045943: AB_2679508" "unprognostic (2.46e-2)" "prognostic favorable (1.91e-4)" "unprognostic (4.95e-3)" "prognostic favorable (7.02e-4)" "unprognostic (2.55e-4)" "prognostic favorable (4.90e-4)" "unprognostic (2.42e-2)" "unprognostic (3.46e-1)" "unprognostic (1.04e-2)" "unprognostic (1.99e-3)" "unprognostic (8.77e-3)" "unprognostic (1.94e-1)" "unprognostic (2.73e-14)" "unprognostic (5.93e-2)" "unprognostic (4.55e-2)" "unprognostic (1.98e-1)" "unprognostic (1.39e-1)" 0.4 0.4 1.4 20.2 1.3 1.4 0.6 2.2 1.2 0.7 0.8 0.5 1.0 0.6 1.1 7.2 2.6 0.3 3.3 0.4 1.3 1.0 1.1 4.7 1.9 23.3 0.9 0.4 0.6 0.4 0.1 1.2 0.4 0.4 0.9 0.6 0.6 4.0 0.6 0.4 2.5 4.0 0.4 0.7 4.7 1.8 2.7 0.4 23.3 0.8 1.8 20.6 4.9 0.6 0.0 0.0 0.0 0.0 0.0 25.9 0.4 0.3 0.5 0.5 1.2 0.3 0.0 1.5 0.4 0.0 0.4 0.1 0.4 0.3 0.9 0.4 0.4 0.6 0.4 1.0 0.0 0.3 3.1 0.5 0.4 0.6 0.1 0.7 0.7 0.9 0.3 0.5 0.7 0.8 0.0 0.0 1.6 1.5 0.9 0.1 8.3 0.3 0.6 1.3 0.3 0.8 0.6 0.3 0.6 0.4 0.5 0.7 0.4 4.9 0.5 3.0 0.7 1.8 0.7 0.1 0.1 1.6 0.8 0.2 0.9 1.6 1.0 0.5 1.2 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 25.9 0.4 1.4 1.3 2.2 1.2 1.3 1.0 0.9 0.4 0.4 0.4 0.0 1.1 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.4 0.0 2.5 0.0 0.0 FOXP4 FLJ40908 ENSG00000137166 "Forkhead box P4" Q8IVH2 6 41546426-41602384 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 38.6;Mucus-secreting cells: 37.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "CACO-2: 39.3;OE19: 48.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007176 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA007176: AB_1078911" "unprognostic (8.28e-2)" "unprognostic (2.90e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (1.17e-6)" "unprognostic (3.20e-2)" "unprognostic (2.96e-3)" "prognostic unfavorable (9.72e-4)" "unprognostic (2.13e-2)" "unprognostic (7.86e-3)" "unprognostic (4.36e-2)" "unprognostic (2.22e-3)" "unprognostic (9.31e-2)" "unprognostic (1.65e-1)" "unprognostic (2.41e-2)" "unprognostic (1.53e-1)" "unprognostic (1.01e-1)" "unprognostic (1.95e-2)" 12.1 7.8 6.3 13.7 12.6 4.4 15.5 12.3 10.0 28.2 15.8 14.0 16.4 18.7 20.7 8.4 10.5 10.1 29.5 12.9 6.6 7.3 16.4 18.9 14.4 9.1 12.9 4.9 17.1 24.8 5.9 12.6 5.5 9.4 21.7 7.2 21.2 30.1 13.0 7.9 7.1 19.3 11.7 7.9 5.8 37.0 15.4 10.9 12.0 23.9 6.3 14.0 11.7 27.6 2.0 1.0 0.3 0.9 0.6 1.5 0.4 9.1 12.6 15.9 17.0 3.0 1.0 16.3 5.0 2.7 4.5 3.1 39.3 2.9 10.6 9.5 3.0 13.5 7.0 4.6 4.8 1.9 8.4 7.3 8.4 7.0 26.3 5.8 5.3 6.9 2.5 5.9 4.0 2.4 6.6 4.4 6.6 10.4 4.3 2.1 24.8 6.2 9.2 4.0 48.5 4.4 6.8 5.1 7.1 3.9 7.6 4.5 6.4 5.4 12.9 9.0 5.1 7.3 13.0 6.1 5.7 14.2 8.9 8.5 3.4 2.1 14.7 4.7 9.0 5.3 0.3 0.7 0.3 0.7 0.9 1.2 1.0 0.6 1.5 0.6 2.0 0.1 0.3 0.3 0.6 0.3 1.0 1.1 0.4 6.3 12.6 12.3 9.2 6.6 7.3 12.9 4.9 9.4 10.9 0.0 9.4 0.5 4.9 8.1 4.7 14.6 10.2 1.4 3.4 5.2 2.0 2.1 0.0 6.9 22.9 2.8 18.6 0.0 14.0 2.7 5.7 13.8 3.5 15.5 3.6 0.0 38.6 7.4 3.2 16.3 3.7 2.6 1.7 7.2 37.4 0.8 16.6 20.1 8.1 6.9 2.6 12.9 8.9 2.1 7.2 6.8 3.7 3.2 15.0 8.4 FOXQ1 HFH1 ENSG00000164379 "Forkhead box Q1" Q9C009 6 1312440-1314748 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 65.5;vagina: 39.9" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 53.7;Collecting duct cells: 38.4;Suprabasal keratinocytes: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 14.0;HaCaT: 16.4;Hep G2: 34.5;OE19: 46.8;RT4: 14.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA059700 Supported Nucleoplasm Yes NA Nucleoplasm "HPA059700: AB_2684107" "unprognostic (2.04e-3)" "unprognostic (3.44e-1)" "unprognostic (1.10e-1)" "unprognostic (7.18e-2)" "unprognostic (1.50e-3)" "unprognostic (2.15e-1)" "unprognostic (3.26e-2)" "unprognostic (1.15e-3)" "unprognostic (1.04e-2)" "unprognostic (1.06e-1)" "unprognostic (7.65e-3)" "prognostic favorable (6.68e-4)" "unprognostic (1.49e-2)" "unprognostic (3.16e-3)" "unprognostic (2.82e-1)" "unprognostic (3.93e-2)" "unprognostic (1.96e-2)" 0.6 0.5 2.3 0.6 4.0 0.5 1.4 1.6 5.9 7.1 1.9 3.2 0.0 6.9 1.1 0.7 7.2 3.2 31.8 0.5 2.2 1.9 7.1 3.6 5.8 0.5 2.7 1.5 0.5 10.1 0.5 1.8 1.2 3.8 18.2 0.8 7.5 35.8 1.3 0.6 16.8 0.8 6.6 1.9 0.5 65.5 0.6 0.8 0.8 3.1 7.8 11.7 26.3 39.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.4 0.0 0.0 0.0 0.0 0.0 0.2 5.6 0.0 0.0 14.0 8.5 0.0 0.2 0.0 0.0 16.4 0.0 0.7 0.0 0.0 0.4 0.0 3.0 34.5 0.0 0.0 0.9 0.0 6.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.8 0.2 0.0 0.0 0.0 0.1 14.5 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 4.0 1.6 5.9 2.2 1.9 2.7 1.5 3.8 0.8 14.9 8.8 0.0 2.1 53.7 0.0 0.8 0.0 2.7 13.6 38.4 0.0 0.0 1.7 2.4 0.0 0.0 0.0 0.0 12.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.7 0.0 0.0 0.0 6.9 0.0 0.0 3.7 0.0 0.0 0.5 0.0 0.0 39.6 0.0 0.0 0.0 3.1 FOXR2 "FOXN6, MGC21658" ENSG00000189299 "Forkhead box R2" Q6PJQ5 X 55623400-55625325 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "testis: 6.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 117 "NTERA-2: 11.7;SH-SY5Y: 10.3;U-266/70: 6.8;U-266/84: 17.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA034487, HPA057358" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA034487: AB_10795354, HPA057358: AB_2683418" "unprognostic (3.81e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 FOXS1 "FKHL18, FREAC10" ENSG00000179772 "Forkhead box S1" O43638 20 31844301-31845619 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 28 "Peritubular cells: 53.4;Sertoli cells: 129.4;Smooth muscle cells: 31.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 3.2;hTERT-RPE1: 13.3;RH-30: 11.1;U-2 OS: 14.8;U-251 MG: 4.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042475 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA042475: AB_10964265" "unprognostic (2.28e-1)" "unprognostic (8.05e-2)" "unprognostic (1.72e-2)" "unprognostic (5.89e-2)" "unprognostic (3.24e-1)" "unprognostic (1.86e-1)" "unprognostic (3.10e-2)" "unprognostic (4.23e-1)" "unprognostic (2.65e-1)" "unprognostic (1.72e-1)" "unprognostic (1.05e-1)" "unprognostic (4.37e-1)" "prognostic unfavorable (1.10e-8)" "unprognostic (1.09e-3)" "unprognostic (2.04e-2)" "unprognostic (5.02e-2)" "unprognostic (9.00e-2)" 5.9 3.1 2.7 3.0 4.7 0.3 11.7 2.7 4.9 9.7 2.6 4.8 1.8 0.9 15.5 6.2 2.8 3.6 11.7 14.0 3.2 2.6 5.5 0.9 6.5 4.6 4.1 4.8 4.0 1.1 0.8 3.2 14.4 5.2 5.0 1.6 7.0 2.0 7.0 4.5 1.8 1.8 3.7 2.6 5.5 1.6 9.7 0.6 3.0 4.9 7.0 3.1 4.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 11.1 0.1 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.2 0.0 0.1 0.1 0.0 14.8 0.0 4.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 4.7 2.7 4.9 3.2 2.6 4.1 4.8 5.2 0.6 0.0 0.0 0.0 0.1 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.0 0.4 0.0 3.4 0.1 0.0 0.0 0.4 0.0 0.0 1.3 0.0 4.0 4.6 0.0 1.7 0.0 0.0 0.0 3.3 0.0 53.4 0.0 0.0 129.4 31.6 0.5 0.5 0.3 0.2 0.0 0.0 0.0 FPR1 "FMLP, FPR" ENSG00000171051 "Formyl peptide receptor 1" P21462 19 51745172-51804110 "G-protein coupled receptors, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 213.3;lymphoid tissue: 64.4" "Cell type enhanced" "Detected in many" 21 "Hofbauer cells: 97.2;Kupffer cells: 262.0;Macrophages: 111.7" "Cancer enhanced" "Detected in all" "glioma: 23.0" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "neutrophil: 213.3" "Lineage enriched" "Detected in many" 6 "granulocytes: 213.3" "Cell line enriched" "Detected in some" 5 "U-87 MG: 35.0" "Not detected" "Not detected" "HPA046550, HPA061744" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA046550: AB_2679694, HPA061744: AB_2684600" "unprognostic (5.54e-2)" "unprognostic (4.16e-2)" "unprognostic (1.88e-1)" "unprognostic (1.22e-1)" "unprognostic (8.50e-2)" "unprognostic (1.38e-1)" "unprognostic (1.96e-1)" "unprognostic (1.14e-1)" "unprognostic (1.15e-1)" "unprognostic (5.48e-3)" "unprognostic (4.59e-2)" "unprognostic (8.34e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (6.03e-2)" "unprognostic (4.52e-3)" "unprognostic (1.54e-2)" "unprognostic (1.70e-3)" 22.6 3.7 5.2 52.2 12.4 54.5 2.9 1.1 6.3 2.6 2.4 5.9 0.0 1.1 2.3 2.3 3.3 8.4 9.6 11.2 15.7 4.3 6.0 7.5 28.8 58.4 15.5 0.8 1.9 3.5 0.8 2.3 13.0 9.7 1.8 1.2 2.4 2.4 0.9 3.2 1.1 2.2 12.8 14.3 64.4 3.2 2.9 10.1 0.9 2.7 0.7 3.2 7.9 4.6 0.0 8.9 213.3 36.3 0.0 0.0 16.9 0.3 0.5 0.2 0.3 0.4 1.1 0.3 0.2 0.0 0.3 1.0 0.2 0.3 0.6 0.3 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.6 2.8 0.2 0.4 2.4 0.1 0.9 0.8 4.2 0.0 0.2 0.1 0.4 7.1 0.5 0.1 0.2 0.2 0.2 0.4 0.2 0.4 0.0 0.6 0.3 0.1 0.2 0.4 0.1 0.3 0.1 0.6 0.6 0.5 1.2 0.3 0.0 1.7 0.1 0.0 0.3 35.0 0.9 0.1 13.0 36.3 10.0 0.0 15.9 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 213.3 0.0 9.5 0.3 0.0 16.9 5.2 12.4 1.1 6.3 15.7 4.3 15.5 0.8 9.7 10.1 14.9 40.8 6.2 0.2 0.6 0.4 0.2 0.0 16.0 28.4 0.0 0.0 0.9 0.0 0.0 1.2 0.4 0.0 0.0 0.0 1.2 0.9 0.2 24.4 1.7 97.2 0.0 0.0 4.3 262.0 1.3 0.3 111.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 6.5 1.0 0.5 0.6 0.0 2.5 0.0 0.0 0.0 FRAT2 ENSG00000181274 "FRAT2, WNT signaling pathway regulator" O75474 10 97332497-97334709 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Suprabasal keratinocytes: 46.0" "Cancer enhanced" "Detected in all" "testis cancer: 70.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 29.3" "Lineage enriched" "Detected in many" 8 "granulocytes: 29.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049763 Uncertain Approved Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA049763: AB_2680868" "unprognostic (4.93e-2)" "unprognostic (1.28e-2)" "unprognostic (2.13e-1)" "unprognostic (1.46e-1)" "unprognostic (4.04e-3)" "unprognostic (1.87e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (3.17e-3)" "unprognostic (2.60e-1)" "unprognostic (8.02e-2)" "unprognostic (4.60e-2)" "unprognostic (3.25e-2)" "prognostic favorable (2.55e-4)" "unprognostic (7.87e-3)" "unprognostic (4.83e-2)" "unprognostic (2.34e-1)" "unprognostic (9.08e-2)" 5.0 3.8 5.7 8.7 7.5 23.8 9.7 8.6 9.4 5.7 18.8 4.8 10.2 21.9 6.0 5.9 13.2 6.4 7.2 7.7 6.1 4.9 5.8 15.6 12.0 22.4 5.6 2.0 3.0 16.5 4.8 3.2 9.6 7.7 8.8 14.0 5.4 22.4 4.9 8.7 17.8 20.3 3.7 5.9 28.0 11.5 14.9 7.3 9.0 8.1 8.3 11.1 7.9 13.2 1.2 1.9 29.3 3.7 0.6 1.1 1.1 5.3 2.1 3.5 15.7 2.5 2.1 13.0 1.2 4.4 1.9 1.9 3.3 6.2 6.5 4.3 1.2 1.1 10.1 9.1 4.7 1.5 9.7 14.0 8.7 4.5 7.2 1.5 13.9 10.5 1.6 10.1 1.8 5.8 4.0 4.6 5.8 7.5 2.1 0.9 8.7 6.0 17.6 21.7 17.7 8.8 6.2 1.4 9.2 4.5 4.8 6.3 5.2 1.5 9.6 6.0 14.9 14.5 22.0 2.1 1.1 1.4 0.8 3.1 5.8 5.9 3.2 1.3 24.1 0.4 3.3 3.7 7.1 0.6 2.3 0.3 0.5 0.7 0.9 1.9 1.2 1.1 0.7 29.3 0.6 3.5 0.4 0.3 1.1 5.7 7.5 8.6 9.4 6.1 4.9 5.6 2.0 7.7 7.3 0.0 4.6 7.7 21.9 28.2 16.8 5.6 7.6 4.0 2.3 14.0 3.9 4.1 10.0 2.1 31.9 4.7 16.0 0.0 4.5 15.6 4.8 26.8 1.1 8.2 7.7 11.1 13.3 3.1 18.0 31.4 2.0 6.4 10.1 1.0 28.5 4.3 4.1 17.3 2.5 2.2 16.9 0.0 7.6 1.2 3.9 46.0 6.5 5.7 27.3 25.6 FRK "GTK, PTK5, RAK" ENSG00000111816 "Fyn related Src family tyrosine kinase" P42685 6 115931149-116060758 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "FDA approved drug targets, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 41.4" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 73.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 19.0;RT4: 8.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "CAB025217, HPA030479, HPA072590" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB025217: , HPA030479: AB_2732457, HPA072590: " "unprognostic (7.70e-3)" "unprognostic (1.99e-2)" "unprognostic (1.11e-1)" "unprognostic (4.68e-3)" "unprognostic (1.96e-1)" "unprognostic (3.49e-2)" "unprognostic (2.09e-1)" "unprognostic (1.58e-1)" "unprognostic (4.23e-2)" "unprognostic (5.82e-3)" "unprognostic (1.45e-1)" "unprognostic (7.54e-2)" "prognostic favorable (9.66e-7)" "unprognostic (1.52e-2)" "unprognostic (1.34e-1)" "unprognostic (2.02e-2)" "unprognostic (1.10e-1)" 1.5 2.2 0.8 3.0 1.3 1.3 2.6 0.5 0.8 6.4 21.4 0.2 10.2 6.8 1.6 9.0 10.5 2.8 7.3 3.3 1.2 0.8 23.7 19.6 5.6 0.6 1.5 0.5 2.4 5.9 0.3 3.8 2.7 0.8 4.1 5.5 0.8 9.2 6.1 2.9 2.0 41.4 2.5 2.4 1.0 5.5 1.8 0.5 1.2 1.0 5.2 7.4 5.0 3.6 2.2 1.2 3.8 1.2 1.4 2.3 0.3 2.5 4.2 0.7 1.0 0.3 0.3 0.8 0.6 0.2 0.0 0.1 3.3 4.1 1.1 3.9 0.6 0.6 6.1 0.3 1.2 0.1 3.5 0.4 1.4 3.6 2.8 0.2 1.0 0.9 0.3 1.7 0.4 0.4 0.5 0.2 0.7 0.7 2.6 1.0 1.4 0.8 0.6 1.1 19.0 0.7 1.2 3.7 1.3 5.2 8.0 0.9 1.0 0.9 5.4 0.5 1.1 1.6 0.8 1.0 1.2 1.2 0.9 0.6 4.0 2.8 1.8 1.2 0.7 0.8 3.2 1.0 1.0 1.9 0.6 2.3 1.1 1.4 1.7 0.4 2.2 1.1 1.4 3.8 1.4 1.2 1.2 1.0 0.3 0.8 1.3 0.5 0.7 1.2 0.8 1.5 0.5 0.8 0.5 0.0 10.1 0.0 15.3 2.4 0.7 8.4 12.7 22.7 15.9 22.7 0.0 4.3 10.0 16.5 73.1 0.3 35.5 0.0 14.3 3.8 3.5 20.3 3.5 19.2 0.8 6.4 19.0 1.8 0.6 17.7 0.6 0.5 0.0 1.8 13.0 0.3 19.1 20.1 1.1 22.5 0.0 12.9 7.5 1.4 0.7 2.8 0.7 0.5 16.1 34.6 FRMD3 "EPB41L4O, MGC20553" ENSG00000172159 "FERM domain containing 3" A2A2Y4 9 83242990-83538546 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 48.5;skeletal muscle: 42.1" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 102.0;Cardiomyocytes: 66.5;Cone photoreceptor cells: 74.6;Early spermatids: 112.3;Horizontal cells: 95.3;Late spermatids: 100.0;Sertoli cells: 71.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 27.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 2.8;intermediate monocyte: 4.7;neutrophil: 3.8;non-classical monocyte: 2.1" "Group enriched" "Detected in many" 6 "granulocytes: 3.8;monocytes: 4.7" "Cell line enhanced" "Detected in some" "HEL: 11.2;OE19: 23.5;RPMI-8226: 37.7;SCLC-21H: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017285 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA017285: AB_2669569" "unprognostic (4.45e-2)" "unprognostic (1.85e-1)" "unprognostic (1.93e-1)" "unprognostic (6.44e-2)" "unprognostic (2.66e-1)" "unprognostic (2.23e-1)" "unprognostic (8.13e-2)" "unprognostic (3.93e-1)" "unprognostic (3.94e-2)" "unprognostic (1.06e-1)" "unprognostic (2.23e-1)" "unprognostic (5.87e-2)" "prognostic favorable (7.24e-4)" "unprognostic (3.12e-1)" "unprognostic (1.88e-1)" "prognostic favorable (1.79e-4)" "unprognostic (1.68e-3)" 12.7 4.6 3.5 2.8 2.3 3.0 16.8 2.0 3.0 4.6 7.1 1.7 14.3 1.9 5.5 9.8 4.1 1.9 2.9 48.5 3.2 4.5 11.7 0.7 2.9 0.9 3.6 1.7 1.4 1.4 8.9 6.1 8.7 2.9 5.1 4.1 5.3 2.1 35.3 42.1 1.6 10.9 3.5 2.8 4.3 2.2 6.1 0.8 0.0 8.8 11.1 0.7 3.8 5.0 0.6 0.6 3.8 4.7 0.4 0.6 9.2 0.0 2.1 1.8 0.1 0.3 0.1 0.1 2.0 0.1 0.0 0.0 0.2 2.5 0.4 2.3 0.9 0.4 0.1 0.1 0.0 0.0 0.1 0.1 11.2 2.4 1.3 0.1 0.0 0.1 0.5 0.0 0.0 0.1 0.1 1.3 0.0 0.0 0.0 2.4 0.3 0.0 0.0 0.2 23.5 3.5 0.0 1.5 37.7 3.1 4.9 13.9 6.7 0.7 0.1 0.4 0.3 0.8 0.4 2.1 0.1 0.3 0.0 1.4 0.2 0.1 0.0 0.5 3.6 1.4 0.0 2.8 0.0 0.4 4.7 0.6 0.5 0.2 0.1 0.4 0.6 0.1 0.0 3.8 0.4 2.1 0.6 0.0 9.2 3.5 2.3 2.0 3.0 3.2 4.5 3.6 1.7 2.9 0.8 20.8 0.6 0.0 1.0 0.9 102.0 66.5 10.2 0.0 2.3 1.8 74.6 0.3 14.9 2.5 112.3 13.1 26.2 0.0 1.7 0.9 2.1 1.0 0.0 0.2 0.8 95.3 1.2 3.1 4.6 100.0 2.0 1.5 0.0 0.0 19.4 2.0 2.0 7.0 4.6 8.7 4.7 71.1 28.9 1.6 1.4 1.1 0.1 0.0 1.6 1.3 FRMD4A "bA295P9.4, FLJ10210, FRMD4, KIAA1294" ENSG00000151474 "FERM domain containing 4A" Q9P2Q2 10 13643706-14462142 "Disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 76.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 28.2;TIME: 34.4;WM-115: 48.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038449 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA038449: AB_10669539" "unprognostic (6.77e-2)" "unprognostic (1.57e-1)" "unprognostic (1.51e-3)" "unprognostic (5.68e-2)" "unprognostic (1.55e-1)" "prognostic favorable (2.63e-5)" "unprognostic (6.21e-3)" "unprognostic (1.22e-1)" "unprognostic (1.69e-1)" "unprognostic (1.74e-2)" "unprognostic (9.20e-2)" "unprognostic (1.14e-1)" "unprognostic (1.19e-2)" "unprognostic (1.67e-1)" "unprognostic (1.25e-1)" "unprognostic (8.16e-2)" "unprognostic (1.84e-1)" 20.5 2.9 8.2 4.6 13.6 2.6 5.6 4.2 22.4 5.3 3.6 2.0 5.9 2.5 4.3 3.4 4.6 4.4 4.9 5.8 10.3 9.5 5.6 6.0 6.1 5.0 7.3 10.3 3.8 8.5 1.1 9.3 12.3 4.3 5.4 2.9 7.8 7.5 9.6 3.8 18.5 3.4 3.3 5.0 17.1 3.3 7.6 1.5 2.6 3.7 2.0 4.5 4.1 3.6 1.9 2.1 2.0 0.9 1.4 2.0 0.2 1.9 1.2 21.3 0.1 1.9 5.4 5.3 5.5 11.4 8.0 13.1 3.7 0.6 0.0 6.3 5.5 6.0 4.1 0.1 1.0 6.9 0.1 3.1 0.4 0.2 0.0 2.6 0.1 0.3 3.7 1.0 28.2 4.0 22.9 22.6 0.9 4.0 0.1 15.7 2.6 1.3 0.2 3.7 0.1 0.8 0.1 4.7 0.0 5.3 1.7 0.7 3.7 0.0 10.3 17.1 3.6 5.8 0.7 34.4 13.0 3.0 8.4 8.1 0.1 0.0 0.0 10.1 0.3 48.8 0.4 0.5 0.5 0.4 0.9 0.7 1.9 1.8 0.6 0.4 0.8 0.8 0.5 2.0 1.4 0.6 2.1 2.0 0.2 8.2 13.6 4.2 22.4 10.3 9.5 7.3 10.3 4.3 1.5 29.8 1.6 0.0 11.4 31.1 60.0 9.7 25.5 4.0 5.7 31.4 17.7 56.1 10.0 10.6 32.6 27.0 0.2 23.3 3.4 30.6 9.3 7.0 15.0 4.7 31.7 76.3 4.6 46.1 57.5 64.5 2.0 21.7 15.1 4.6 2.5 54.5 2.4 0.0 1.8 1.9 9.9 12.9 25.9 1.0 0.7 28.5 24.0 1.5 5.3 3.6 FRMD7 "FLJ43346, NYS, NYS1" ENSG00000165694 "FERM domain containing 7" Q6ZUT3 X 132076993-132128020 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Neurogenesis "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "endometrium 1: 7.4;kidney: 6.6;smooth muscle: 5.5" "Cell type enriched" "Detected in single" 30 "Distal tubular cells: 8.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.1;HSkMC: 1.6;SuSa: 3.6;U-87 MG: 5.5" "Region enriched" "Detected in single" 29 "olfactory region: 80.8" "Region enriched" "Detected in single" 103 "olfactory region: 45.5" HPA000886 Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA000886: AB_1079269" "unprognostic (3.08e-2)" "unprognostic (1.27e-1)" "unprognostic (1.36e-1)" "unprognostic (3.07e-1)" "unprognostic (4.02e-2)" "unprognostic (1.64e-2)" "unprognostic (2.28e-1)" "unprognostic (2.18e-2)" "unprognostic (3.84e-1)" "unprognostic (3.54e-2)" "unprognostic (3.00e-1)" 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 7.4 1.1 0.0 1.1 0.0 0.1 0.0 0.1 6.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.5 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.6 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FRMD8 "FKSG44, FLJ90369" ENSG00000126391 "FERM domain containing 8" Q9BZ67 11 65386599-65413525 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Suprabasal keratinocytes: 73.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 53.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002861 Approved Approved "Nucleoplasm,Plasma membrane,Centriolar satellite,Cytosol" NA NA "Plasma membrane, Centriolar satellite" "Nucleoplasm, Cytosol" "HPA002861: AB_1078878" "unprognostic (1.54e-1)" "unprognostic (4.07e-1)" "unprognostic (6.28e-2)" "unprognostic (1.73e-2)" "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (9.94e-5)" "unprognostic (9.12e-3)" "unprognostic (1.51e-2)" "unprognostic (6.36e-3)" "unprognostic (1.90e-2)" "unprognostic (6.41e-3)" "unprognostic (4.19e-3)" "unprognostic (1.47e-2)" "unprognostic (7.36e-3)" "unprognostic (3.34e-1)" "unprognostic (2.91e-2)" 14.6 11.9 7.8 18.5 12.1 13.1 15.2 8.9 10.3 12.5 15.1 11.4 6.9 13.6 10.5 12.2 23.9 14.6 17.4 10.0 8.0 5.4 10.5 12.0 15.1 17.3 17.0 8.5 8.9 20.9 5.7 8.2 12.2 11.7 10.7 8.2 7.8 18.6 10.9 12.0 24.3 16.5 8.1 8.9 29.0 11.7 11.3 14.6 16.6 12.4 16.6 21.8 11.0 18.1 10.9 11.4 19.7 14.9 6.5 14.3 9.0 6.9 8.9 3.6 8.4 9.8 5.1 6.4 7.9 7.4 6.8 5.3 8.5 11.6 8.6 17.1 11.2 4.8 12.3 4.6 6.9 2.9 14.3 4.2 11.9 8.2 4.6 5.3 6.7 18.6 6.4 5.5 6.5 3.5 3.7 10.9 8.9 9.9 9.7 7.5 9.5 10.0 9.8 4.0 5.2 11.7 13.4 6.7 9.8 5.6 8.8 7.8 5.4 6.0 24.8 18.9 3.4 9.0 5.5 9.5 7.7 8.0 10.4 4.8 16.7 8.5 8.1 6.7 4.2 53.0 0.8 9.7 13.4 11.5 11.0 12.7 10.9 8.4 14.3 9.1 9.2 7.8 8.4 19.7 6.5 14.9 11.4 8.9 9.0 7.8 12.1 8.9 10.3 8.0 5.4 17.0 8.5 11.7 14.6 3.0 7.2 17.5 19.3 48.2 5.9 7.5 20.4 8.1 6.8 12.2 0.0 5.8 6.6 18.7 22.7 21.1 26.9 23.3 24.9 13.0 14.4 20.4 13.9 9.6 13.4 4.8 12.5 45.4 16.7 3.9 5.8 17.4 18.6 19.0 17.0 3.2 25.9 13.1 6.7 4.2 4.6 6.5 16.0 4.1 8.6 73.0 9.5 21.7 11.2 33.0 FRS3 "FRS2B, FRS2beta, SNT-2" ENSG00000137218 "Fibroblast growth factor receptor substrate 3" O43559 6 41770176-41786542 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 12.7;Spermatocytes: 8.6;Spermatogonia: 10.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030162, HPA030174" Enhanced Uncertain Nucleoplasm NA NA Nucleoplasm "HPA030162: AB_10599976, HPA030174: AB_10602093" "unprognostic (2.52e-2)" "unprognostic (1.31e-1)" "unprognostic (4.30e-2)" "unprognostic (8.91e-2)" "unprognostic (8.13e-2)" "unprognostic (1.67e-2)" "unprognostic (3.79e-2)" "unprognostic (8.47e-3)" "unprognostic (2.96e-1)" "unprognostic (1.83e-1)" "prognostic favorable (3.87e-4)" "unprognostic (4.23e-2)" "unprognostic (3.29e-3)" "unprognostic (2.96e-2)" "unprognostic (8.48e-2)" "unprognostic (5.10e-2)" "unprognostic (3.29e-3)" 6.4 7.0 12.1 4.5 13.6 4.2 3.7 20.4 22.2 4.4 5.1 9.1 2.7 5.4 7.1 3.6 5.4 6.9 5.1 8.2 12.3 15.2 4.0 3.1 5.6 6.0 12.2 12.9 7.5 5.9 4.9 4.9 5.2 13.1 5.5 3.4 5.3 8.1 9.3 13.3 2.5 5.3 5.0 8.0 6.4 5.3 18.5 7.0 3.4 7.4 1.7 3.5 4.7 5.0 1.0 1.7 2.3 1.7 1.4 1.4 0.3 3.1 2.7 4.5 6.3 3.7 4.0 9.5 3.4 4.9 4.0 4.1 3.6 1.9 5.4 3.8 2.9 5.3 2.1 2.9 3.6 3.4 5.5 2.8 3.3 5.0 5.7 4.6 2.7 4.9 3.9 4.3 3.9 3.6 5.3 4.2 13.1 3.6 4.5 3.5 5.1 7.9 6.0 2.3 6.9 2.7 7.5 4.1 3.8 3.5 6.0 6.6 9.9 2.4 3.4 6.9 3.5 4.2 5.4 3.6 7.1 7.5 4.6 3.4 8.0 6.5 8.8 1.9 4.6 2.1 0.0 1.7 2.3 0.9 0.5 0.9 0.3 1.4 0.6 1.1 1.0 0.7 0.3 0.3 1.4 0.4 1.7 0.6 0.3 12.1 13.6 20.4 22.2 12.3 15.2 12.2 12.9 13.1 7.0 0.0 3.0 0.9 1.0 0.9 5.8 2.4 12.7 1.4 1.2 0.0 0.0 1.5 0.0 1.5 0.5 2.8 0.4 0.0 1.2 0.8 1.9 0.9 0.0 0.8 1.7 4.8 1.7 1.3 1.3 0.0 2.3 1.3 3.3 0.0 1.6 2.7 1.0 1.5 4.2 0.5 4.0 0.0 1.2 8.6 10.1 0.5 0.5 0.0 1.4 1.3 FSBP ENSG00000265817 "Fibrinogen silencer binding protein" O95073 8 94372170-94436952 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 1: 3.0;Club cells: 1.2;Ito cells: 1.8;Rod photoreceptor cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 5.3;naive CD4 T-cell: 3.7" "Lineage enriched" "Detected in single" 22 "T-cells: 5.3" "Cell line enhanced" "Detected in many" "AF22: 10.5;hTERT-HME1: 11.0;SK-MEL-30: 10.5" "HPA025059, HPA026509" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA025059: AB_2671718, HPA026509: AB_10602307" 2.2 3.7 3.4 1.6 5.6 2.1 4.1 7.1 7.6 6.7 2.0 2.7 11.0 1.5 3.7 9.6 4.3 14.1 3.1 4.6 3.0 2.4 5.1 4.2 2.6 1.8 3.4 3.6 7.7 4.3 3.2 23.7 2.9 6.4 5.3 2.4 16.4 4.7 15.4 4.4 3.7 1.8 5.3 2.9 1.9 4.6 5.6 3.7 2.3 3.2 3.2 2.6 8.7 4.2 0.2 0.0 0.0 0.0 0.1 5.3 0.7 0.0 1.8 10.5 4.5 1.6 2.8 0.0 0.3 2.3 0.2 2.8 2.5 3.4 0.1 9.2 1.0 0.8 1.9 4.6 1.7 0.9 0.0 2.8 1.4 0.8 3.5 4.7 0.0 0.9 2.8 1.9 2.4 11.0 3.7 3.1 1.4 1.7 4.3 2.5 1.9 0.9 0.7 4.9 2.5 2.2 0.4 0.0 2.8 6.1 7.7 0.1 2.1 0.0 0.0 10.5 8.9 2.6 1.7 2.3 1.9 0.1 0.0 0.3 0.0 2.3 0.4 2.1 1.9 4.0 0.0 0.0 0.0 1.0 0.0 5.3 0.2 1.3 0.3 0.0 0.1 3.7 2.8 0.0 0.1 0.0 0.0 0.2 0.7 3.4 5.6 7.1 7.6 3.0 2.4 3.4 3.6 6.4 3.7 3.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FSIP1 FLJ35989 ENSG00000150667 "Fibrous sheath interacting protein 1" Q8NA03 15 39588357-39782830 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 17.8;pituitary gland: 11.8;testis: 13.9" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 17.4;Early spermatids: 47.1;Late spermatids: 39.8;Spermatocytes: 27.4" "Cancer enriched" "Detected in some" 8 "breast cancer: 6.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 7.3" "Low region specificity" "Detected in many" HPA041002 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA041002: AB_10796565" "unprognostic (1.55e-2)" "unprognostic (1.49e-1)" "unprognostic (9.12e-2)" "unprognostic (2.36e-1)" "unprognostic (1.02e-2)" "unprognostic (1.43e-3)" "unprognostic (5.17e-3)" "unprognostic (5.37e-2)" "unprognostic (9.22e-2)" "unprognostic (1.60e-1)" "unprognostic (1.04e-2)" "unprognostic (2.49e-1)" "unprognostic (1.22e-2)" "unprognostic (1.14e-1)" "unprognostic (3.81e-2)" "unprognostic (2.01e-1)" "unprognostic (1.81e-1)" 0.8 0.7 2.9 0.7 9.3 1.1 1.9 1.0 5.7 0.8 11.7 1.5 0.8 0.5 1.4 2.5 0.6 2.3 0.7 0.8 3.1 3.0 1.6 0.7 0.9 0.5 1.2 4.1 0.7 0.6 1.7 11.8 0.8 4.5 0.8 17.8 0.6 0.5 0.7 0.9 1.7 0.6 0.9 1.1 0.6 1.1 13.9 1.4 0.5 1.0 0.0 0.5 1.0 0.9 1.0 1.0 1.8 1.3 1.5 3.4 1.4 0.6 2.3 6.2 0.9 1.1 2.1 0.1 7.3 1.5 1.2 2.2 1.7 0.6 0.5 0.6 2.1 3.1 1.5 1.0 1.2 1.9 2.5 0.6 4.5 1.7 0.1 0.6 0.9 5.0 1.4 5.2 2.8 1.2 1.6 1.3 2.5 0.2 0.6 1.9 0.3 0.6 0.4 0.7 0.3 1.2 0.6 1.2 0.1 2.4 2.7 1.6 4.7 1.5 0.2 0.3 0.5 2.1 0.5 1.0 3.0 1.7 1.6 0.8 1.3 2.7 0.3 6.2 1.7 1.4 1.8 1.3 1.5 3.4 0.8 2.7 0.8 1.8 2.1 1.0 1.0 1.1 0.9 1.1 1.5 1.0 0.0 0.4 1.4 2.9 9.3 1.0 5.7 3.1 3.0 1.2 4.1 4.5 1.4 0.0 0.3 0.5 0.3 0.6 1.0 0.6 2.5 17.4 3.4 1.8 11.8 0.7 1.7 0.6 47.1 0.1 4.9 0.0 0.4 0.1 0.9 0.7 15.1 0.0 0.1 0.0 0.0 0.6 0.0 39.8 1.1 0.1 0.0 0.0 2.2 1.5 0.1 0.0 0.7 2.4 4.9 0.0 0.2 27.4 7.8 0.0 4.7 1.0 1.5 0.3 FSTL3 "FLRG, FSRP" ENSG00000070404 "Follistatin like 3" O95633 19 676365-683399 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Osteogenesis, Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "placenta: 201.0" "Cell type enriched" "Detected in many" 4 "Extravillous trophoblasts: 2939.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 36.2;hTCEpi: 40.0;SiHa: 73.8;U-2197: 38.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB024899, HPA045378" Approved Supported Nucleoplasm "Secreted in other tissues" NA Yes 6800000 Nucleoplasm "CAB024899: , HPA045378: AB_2679300" "unprognostic (9.86e-3)" "unprognostic (1.32e-3)" "prognostic unfavorable (3.01e-4)" "prognostic unfavorable (3.03e-4)" "unprognostic (2.19e-3)" "unprognostic (1.51e-3)" "unprognostic (8.64e-3)" "prognostic unfavorable (4.61e-7)" "unprognostic (9.50e-2)" "prognostic unfavorable (1.65e-4)" "unprognostic (3.50e-2)" "unprognostic (5.91e-2)" "unprognostic (1.03e-3)" "unprognostic (7.22e-3)" "unprognostic (3.07e-1)" "unprognostic (3.75e-1)" "unprognostic (5.89e-3)" 19.9 29.1 4.0 10.7 6.2 5.6 24.7 1.3 4.2 13.1 14.9 3.8 8.1 3.8 12.8 15.6 12.7 14.1 13.1 27.0 5.0 2.0 13.7 5.1 26.9 8.7 7.3 4.5 16.8 11.7 1.4 5.3 201.0 6.0 14.3 3.1 12.0 4.5 11.0 4.1 6.2 6.5 20.6 10.4 3.9 9.1 34.5 4.9 0.7 7.2 5.5 1.4 16.7 18.3 0.9 2.2 0.1 4.4 0.6 2.6 2.0 1.9 15.9 1.1 0.8 5.0 12.8 36.2 27.0 4.0 6.8 2.5 5.8 3.1 0.8 10.9 18.2 3.9 13.9 0.9 23.0 2.2 1.6 1.9 0.7 22.2 4.7 21.6 1.4 2.6 16.0 40.0 7.5 31.3 17.6 1.2 0.8 1.7 1.1 10.2 7.0 0.5 0.8 1.3 13.1 5.5 1.5 0.7 1.8 9.4 0.3 0.7 1.2 73.8 1.5 0.8 1.4 1.3 0.7 16.2 6.8 23.5 38.1 9.9 1.8 0.8 0.4 1.0 4.2 3.1 0.0 4.4 0.0 1.0 4.4 0.2 0.3 1.4 1.1 2.2 0.9 2.6 1.6 0.1 0.6 3.2 0.9 0.2 2.0 4.0 6.2 1.3 4.2 5.0 2.0 7.3 4.5 6.0 4.9 17.9 3.4 2.2 19.6 12.9 1.6 12.8 30.6 2.7 1.2 8.7 0.0 22.7 6.6 69.7 5.6 4.5 0.9 0.0 56.0 2939.6 52.2 21.7 0.0 0.9 68.4 3.2 1.2 22.1 3.8 6.5 56.7 4.0 5.0 11.8 0.9 7.8 198.1 0.0 25.1 5.6 0.5 45.3 32.5 2.3 7.7 6.8 662.4 2.9 1.7 20.7 FUBP1 "FBP, FUBP" ENSG00000162613 "Far upstream element binding protein 1" Q96AE4 1 77944055-77979110 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006149 Supported Enhanced Nucleoplasm NA NA 200000 Nucleoplasm "HPA006149: AB_1849172" "unprognostic (4.17e-2)" "unprognostic (2.83e-2)" "unprognostic (3.35e-3)" "unprognostic (3.89e-2)" "unprognostic (3.77e-1)" "unprognostic (5.65e-2)" "prognostic unfavorable (9.83e-9)" "unprognostic (2.32e-2)" "unprognostic (2.16e-1)" "unprognostic (1.69e-1)" "unprognostic (3.31e-3)" "unprognostic (9.80e-3)" "unprognostic (9.02e-3)" "unprognostic (1.37e-1)" "unprognostic (1.67e-1)" "unprognostic (6.24e-2)" "unprognostic (9.46e-2)" 23.9 35.5 21.8 42.4 26.9 56.8 27.0 34.0 31.8 24.3 19.6 18.1 23.0 21.8 29.4 35.0 23.5 25.2 18.4 27.5 22.0 22.3 26.6 16.3 27.2 37.6 17.5 28.8 44.4 31.6 36.0 41.5 27.3 26.3 22.4 28.3 22.0 28.2 35.6 27.4 21.3 24.0 22.7 31.3 28.6 22.6 17.6 19.9 64.9 35.0 26.2 40.3 24.0 29.1 16.1 11.3 10.8 16.1 23.5 22.2 12.8 22.3 19.7 46.6 18.5 7.2 9.1 38.2 23.1 13.8 22.2 16.2 19.9 25.0 40.0 10.8 17.1 26.3 22.3 31.2 25.4 29.7 44.0 15.9 25.6 32.7 29.2 15.7 43.8 10.8 11.9 21.0 23.7 18.9 18.2 17.7 27.0 29.3 17.8 17.5 22.5 34.7 21.2 36.4 22.0 14.1 42.7 36.9 15.3 23.0 22.0 24.6 23.2 21.5 20.4 18.2 26.0 24.8 15.9 22.7 21.5 31.3 6.1 27.6 17.1 18.4 51.9 9.3 19.3 21.9 3.8 9.6 10.8 18.7 15.7 22.2 16.1 18.3 19.4 8.7 13.1 17.9 20.9 4.0 23.5 16.1 11.3 21.3 12.8 21.8 26.9 34.0 31.8 22.0 22.3 17.5 28.8 26.3 19.9 68.5 47.3 43.1 67.8 75.3 41.1 65.5 30.6 96.4 89.9 31.4 39.3 42.2 36.5 50.0 27.8 42.8 20.6 0.0 62.7 54.9 40.0 39.3 75.2 20.7 29.1 17.5 52.9 33.7 27.2 15.1 44.5 34.8 37.1 55.9 32.7 36.4 54.2 30.6 28.3 19.7 37.0 32.3 42.4 33.8 40.6 55.2 29.9 54.8 35.4 54.0 FUBP3 FBP3 ENSG00000107164 "Far upstream element binding protein 3" Q96I24 9 130578965-130638352 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047658, HPA058392" Uncertain Approved Nucleoplasm,Cytosol NA NA 6200 Nucleoplasm Cytosol "HPA047658: AB_2680114, HPA058392: AB_2683703" "unprognostic (1.23e-2)" "unprognostic (2.00e-2)" "unprognostic (1.91e-1)" "unprognostic (2.51e-1)" "unprognostic (5.67e-3)" "unprognostic (2.12e-2)" "unprognostic (2.29e-2)" "prognostic unfavorable (2.38e-4)" "unprognostic (3.12e-2)" "unprognostic (7.27e-2)" "unprognostic (4.66e-1)" "unprognostic (4.23e-2)" "prognostic favorable (4.39e-5)" "unprognostic (2.15e-2)" "unprognostic (3.24e-1)" "unprognostic (1.59e-1)" "unprognostic (5.23e-2)" 26.6 24.1 24.3 18.5 24.3 10.5 21.8 23.9 30.3 22.8 24.0 37.7 22.9 19.9 32.7 20.7 24.2 22.1 25.4 24.3 24.6 20.0 22.4 37.6 19.9 18.7 27.4 22.8 25.2 27.7 36.6 23.8 33.8 23.9 26.1 20.4 21.9 26.1 25.3 15.2 22.0 20.5 26.9 30.0 20.2 22.0 30.0 27.5 26.4 39.9 18.1 20.1 23.2 22.9 4.5 5.6 2.1 4.5 7.3 6.9 3.0 20.8 19.2 28.1 23.1 20.3 23.1 35.6 29.9 26.8 24.2 18.8 27.7 19.3 20.2 15.8 28.3 21.4 36.4 23.6 25.4 28.8 22.3 20.2 22.4 30.6 20.3 27.8 33.6 25.3 22.3 20.5 25.4 24.0 20.3 19.7 16.9 35.5 12.6 25.0 28.0 25.9 17.1 36.1 32.9 24.6 23.2 35.0 27.1 21.2 22.1 18.7 30.9 31.8 23.6 19.5 22.1 32.4 25.6 25.0 43.9 20.9 29.5 34.6 11.6 19.1 26.3 24.5 14.6 31.2 0.0 3.7 2.1 4.7 4.5 6.9 4.5 5.1 5.6 5.6 3.3 5.9 5.1 1.0 7.3 3.5 4.9 4.0 3.0 24.3 24.3 23.9 23.7 24.6 20.0 27.4 22.8 23.9 27.5 17.9 19.4 18.0 17.5 29.8 22.5 16.5 25.5 21.4 12.5 15.7 13.7 24.3 24.9 18.3 3.2 20.4 13.2 0.0 16.5 25.4 24.2 24.1 7.0 48.6 22.9 30.2 20.8 30.1 22.9 7.2 19.0 17.2 35.4 16.2 18.9 52.7 20.0 17.3 26.2 29.5 27.4 12.9 30.9 14.3 10.4 35.8 38.3 15.4 15.5 22.6 FURIN "FUR, PACE, PCSK3, SPC1" ENSG00000140564 "Furin, paired basic amino acid cleaving enzyme" P09958 15 90868592-90883458 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 9 "liver: 118.4;placenta: 158.9;salivary gland: 337.9" "Cell type enhanced" "Detected in many" 5 "Exocrine glandular cells: 102.2;Hepatocytes: 114.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009499, HPA067869" Enhanced Supported "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA 41000 "Golgi apparatus" Nucleoplasm "CAB009499: AB_2105095, HPA067869: " "unprognostic (2.46e-1)" "unprognostic (2.73e-2)" "unprognostic (7.33e-2)" "unprognostic (2.30e-2)" "unprognostic (4.11e-3)" "unprognostic (4.37e-2)" "unprognostic (8.11e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (2.24e-1)" "unprognostic (9.92e-3)" "unprognostic (1.78e-1)" "unprognostic (1.96e-1)" "unprognostic (4.52e-3)" "unprognostic (4.57e-2)" "unprognostic (4.46e-2)" "unprognostic (4.27e-3)" "unprognostic (8.20e-2)" 8.3 3.3 3.0 7.5 3.6 16.6 5.9 5.0 4.4 4.1 6.6 2.8 3.5 5.7 4.9 10.8 4.7 4.4 3.9 6.9 3.1 1.8 6.4 118.4 9.5 3.1 2.8 2.7 4.2 22.5 3.8 7.2 158.9 3.5 9.3 2.2 3.0 337.9 4.7 8.7 9.0 5.9 3.1 3.0 8.2 6.0 5.3 2.9 4.8 8.9 5.5 4.1 4.4 4.3 1.5 3.3 10.3 3.3 3.1 1.9 2.0 14.4 8.8 2.0 8.9 14.5 9.4 22.7 18.2 13.9 7.5 5.3 12.9 15.8 0.5 46.8 13.2 13.5 26.0 4.0 9.4 1.6 41.6 10.3 25.3 15.8 16.8 7.7 3.5 41.7 10.6 10.6 8.5 3.9 18.3 24.0 4.2 19.3 2.5 5.0 9.9 1.3 11.4 6.3 12.2 2.6 2.2 7.7 3.3 11.7 11.0 4.0 2.7 15.4 8.4 12.8 9.9 3.0 9.2 35.4 8.5 18.2 13.0 26.6 4.5 25.6 1.2 16.2 11.4 17.2 7.5 3.3 10.3 1.9 1.1 1.4 1.5 1.2 1.2 2.1 1.0 0.6 0.8 7.4 3.1 0.7 3.3 0.9 2.0 3.0 3.6 5.0 4.4 3.1 1.8 2.8 2.7 3.5 2.9 3.0 30.9 6.7 7.5 17.2 11.9 15.0 10.2 1.4 5.7 21.0 23.6 16.5 0.0 44.3 0.4 25.5 23.8 23.3 102.2 11.4 12.3 26.5 15.1 114.9 22.3 7.9 36.4 23.4 26.1 0.2 10.3 24.1 15.1 7.2 27.3 11.7 83.4 21.8 10.3 5.6 25.2 25.8 12.5 2.3 3.4 20.1 70.5 11.7 16.1 13.9 FUS "ALS6, FUS1, hnRNP-P2, HNRNPP2, TLS" ENSG00000089280 "FUS RNA binding protein" P35637 16 31180110-31194871 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA-binding, RNA-binding" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008784, CAB033036, CAB058691" Supported Enhanced Nucleoplasm NA NA 190000 Nucleoplasm "CAB033036: AB_2105208, CAB058691: AB_2665583, HPA008784: AB_1849181" "unprognostic (3.06e-2)" "unprognostic (2.53e-1)" "unprognostic (1.86e-2)" "unprognostic (8.68e-2)" "unprognostic (1.44e-1)" "unprognostic (8.03e-2)" "prognostic unfavorable (4.38e-4)" "unprognostic (2.15e-2)" "unprognostic (1.00e-1)" "unprognostic (5.22e-3)" "unprognostic (1.01e-1)" "unprognostic (1.01e-3)" "unprognostic (1.12e-3)" "unprognostic (1.87e-1)" "unprognostic (5.27e-1)" "unprognostic (1.66e-1)" "unprognostic (1.49e-2)" 44.0 24.2 35.0 47.1 43.3 41.7 29.9 64.1 59.0 39.7 32.4 48.6 22.6 28.0 54.5 44.7 29.6 48.6 35.9 32.0 32.7 34.6 30.3 24.4 27.7 51.3 31.1 39.0 66.7 28.8 41.7 24.8 44.1 39.2 29.1 30.2 39.3 27.6 30.5 43.6 24.3 28.7 46.5 33.7 36.2 27.7 40.7 30.7 66.3 29.1 40.1 49.6 30.3 31.4 16.4 22.3 24.2 29.0 14.2 24.8 9.4 48.3 42.0 55.3 35.9 13.6 11.6 58.9 65.2 23.7 29.8 22.8 56.6 32.6 74.6 46.5 32.9 36.9 21.1 55.1 42.2 28.5 44.3 35.8 63.0 31.7 57.0 22.8 67.0 43.4 23.5 11.6 43.0 29.2 14.3 28.4 44.4 66.8 25.4 37.0 59.2 48.6 59.3 84.2 29.4 46.1 79.9 73.7 42.7 33.3 35.5 36.1 64.8 42.8 30.2 32.3 36.7 36.4 74.6 35.2 47.8 48.0 31.5 68.8 23.6 45.2 105.0 26.7 45.6 57.7 5.6 17.5 24.2 24.8 29.0 24.0 12.8 17.4 21.8 19.3 16.4 20.3 21.1 14.9 14.2 25.1 22.3 13.9 9.4 35.0 43.3 64.1 59.0 32.7 34.6 31.1 39.0 39.2 30.7 95.3 108.8 163.2 313.8 128.6 263.0 87.0 94.3 111.1 129.7 99.5 123.7 234.5 58.0 142.1 94.6 197.5 188.3 46.7 133.2 323.0 212.4 178.2 227.1 52.9 180.4 190.7 203.5 174.3 132.4 22.8 284.5 176.9 156.9 172.3 132.7 214.0 132.4 175.4 202.6 57.5 247.1 161.7 222.6 158.2 225.3 134.9 246.8 262.6 169.5 255.7 FUT10 ENSG00000172728 "Fucosyltransferase 10" Q6P4F1 8 33370824-33473422 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 187.5;Late spermatids: 217.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053970, HPA058655" Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Golgi apparatus" "Intracellular and membrane" NA NA "Nucleoplasm, Endoplasmic reticulum, Golgi apparatus" "HPA053970: AB_2682327, HPA058655: AB_2683789" "unprognostic (6.02e-2)" "unprognostic (4.61e-2)" "unprognostic (2.85e-3)" "unprognostic (6.24e-2)" "unprognostic (1.01e-1)" "unprognostic (4.80e-2)" "unprognostic (5.40e-3)" "unprognostic (6.07e-2)" "unprognostic (2.84e-1)" "unprognostic (2.23e-1)" "unprognostic (9.10e-3)" "unprognostic (2.76e-4)" "unprognostic (3.06e-3)" "unprognostic (1.58e-2)" "unprognostic (1.11e-1)" "unprognostic (2.87e-3)" "unprognostic (6.01e-3)" 5.6 7.2 7.9 3.9 10.9 2.0 8.9 18.8 8.6 10.9 6.3 6.9 5.0 6.4 10.5 5.3 5.8 8.4 4.8 5.4 7.4 4.5 8.3 5.2 6.0 4.1 5.8 7.2 13.6 10.9 14.5 11.7 8.2 6.8 6.0 6.9 12.4 6.7 5.9 2.4 9.7 6.1 7.3 5.1 3.8 5.7 4.1 4.6 5.8 6.9 2.2 6.0 6.6 7.2 2.4 3.5 1.9 1.5 3.8 4.1 2.1 2.2 4.4 7.1 8.4 11.1 11.3 3.7 4.5 7.3 4.4 5.9 6.7 3.9 2.5 5.5 5.6 3.7 6.1 10.2 4.1 4.4 5.7 3.9 8.4 3.7 7.3 5.1 1.8 3.0 7.9 7.4 1.1 5.4 9.4 8.7 4.6 7.6 3.4 4.1 1.3 6.5 2.8 10.0 6.3 2.9 4.9 5.5 1.4 6.2 5.5 2.4 2.3 2.5 3.8 4.9 7.8 3.8 1.9 7.1 3.3 1.5 8.5 3.5 1.4 2.2 1.7 2.0 5.4 3.4 1.1 1.5 1.9 3.7 0.7 4.0 2.4 2.2 3.5 3.5 1.0 2.5 2.4 1.1 3.8 0.5 2.0 4.1 2.1 7.9 10.9 18.8 8.6 7.4 4.5 5.8 7.2 6.8 4.6 3.0 1.3 0.0 2.6 2.4 3.1 2.2 5.1 1.4 3.4 3.5 9.8 9.6 1.7 4.1 187.5 3.0 2.6 0.0 3.5 5.8 4.1 1.1 5.7 3.9 3.0 3.2 3.5 4.3 1.8 217.3 6.4 1.9 1.7 2.8 2.9 31.7 3.1 0.0 4.6 2.8 10.8 0.0 2.8 1.6 2.4 1.5 5.0 0.5 2.9 1.3 FUT8 ENSG00000033170 "Fucosyltransferase 8" Q9BYC5 14 65410592-65744121 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 13.5;NK-cells: 12.0;T-cells: 8.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017129, HPA043410" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB017129: , HPA043410: AB_2678467" "unprognostic (1.67e-1)" "unprognostic (1.63e-1)" "unprognostic (3.28e-2)" "unprognostic (1.65e-3)" "unprognostic (2.10e-1)" "unprognostic (5.61e-2)" "unprognostic (1.41e-1)" "unprognostic (8.81e-2)" "unprognostic (2.00e-2)" "unprognostic (1.33e-3)" "unprognostic (8.09e-2)" "unprognostic (1.94e-1)" "unprognostic (1.04e-3)" "unprognostic (1.40e-1)" "unprognostic (2.94e-1)" "unprognostic (1.40e-1)" "unprognostic (8.28e-3)" 7.2 7.6 16.2 12.0 21.1 3.3 9.4 24.1 18.1 6.7 9.8 29.1 16.1 15.4 8.7 5.0 6.5 14.0 10.1 5.2 19.8 12.9 6.2 2.9 7.0 11.2 20.5 11.2 7.2 10.5 6.2 5.2 18.8 17.3 5.4 10.4 7.1 33.7 13.7 3.5 4.9 15.1 9.5 39.8 8.5 27.6 13.1 23.6 8.4 7.5 2.4 15.2 14.4 5.6 13.5 2.2 0.5 1.7 12.0 8.2 2.5 34.4 6.8 3.3 30.3 14.6 11.0 20.5 11.1 17.0 7.7 8.6 5.3 12.7 9.2 9.5 10.9 21.2 2.6 7.8 3.0 11.8 34.0 3.4 9.2 2.5 6.9 7.5 2.0 7.6 27.7 2.0 10.6 5.0 33.8 19.5 4.5 3.4 7.8 5.5 17.7 9.8 5.1 4.4 16.0 23.9 6.7 2.9 5.3 13.8 9.7 7.0 5.3 5.9 2.8 2.4 20.7 2.8 3.3 42.5 10.1 10.9 4.5 8.9 15.7 6.0 21.9 20.5 3.6 3.2 0.5 1.7 0.5 3.5 0.6 3.5 13.5 5.6 5.1 2.2 6.8 6.1 6.0 0.2 12.0 1.1 2.2 8.2 2.5 16.2 21.1 24.1 17.3 19.8 12.9 20.5 11.2 17.3 23.6 11.9 33.3 42.9 6.7 10.8 10.6 5.6 10.2 16.0 22.7 12.2 3.9 38.8 0.0 7.7 28.3 11.3 6.8 0.0 28.1 24.2 15.8 5.7 7.0 3.2 11.0 7.9 5.2 15.4 12.1 10.9 11.8 7.0 1.7 1.8 17.5 35.8 36.1 8.5 12.7 7.8 8.0 0.0 10.3 31.6 26.2 8.5 11.8 13.8 9.4 4.6 FUT9 Fuc-TIX ENSG00000172461 "Fucosyltransferase 9" Q9Y231 6 96015984-96215612 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 37.7;stomach 1: 35.4" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 2.9;Exocrine glandular cells: 1.6" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.5" "Cell line enhanced" "Detected in some" "MCF7: 4.2;OE19: 4.1;RT4: 9.5;SCLC-21H: 9.7;SK-BR-3: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070923 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Yes No Nucleoplasm "Microtubules, Cytokinetic bridge, Cytosol" "HPA070923: AB_2686323" "unprognostic (1.60e-1)" "unprognostic (2.48e-1)" "unprognostic (5.99e-3)" "unprognostic (1.33e-1)" "unprognostic (2.40e-1)" "unprognostic (2.97e-1)" "unprognostic (1.35e-1)" "unprognostic (2.85e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-1)" "unprognostic (6.43e-3)" "unprognostic (5.60e-2)" "unprognostic (1.65e-2)" "unprognostic (3.03e-2)" 1.1 1.7 18.5 1.1 22.5 1.1 1.9 37.7 28.6 1.1 1.1 10.7 0.0 4.1 1.4 1.2 1.1 1.4 1.1 1.1 20.0 6.2 1.2 1.1 1.1 1.1 10.2 24.0 1.1 8.0 1.1 0.9 1.7 13.8 1.5 1.2 0.0 1.1 1.5 1.2 1.1 1.1 1.1 10.2 1.1 35.4 1.1 16.5 0.0 1.2 0.0 1.1 2.2 0.4 0.3 0.2 1.5 0.1 0.2 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 2.1 4.1 0.0 0.0 0.0 0.0 0.0 9.5 9.7 0.2 0.0 5.5 0.0 0.2 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.8 0.2 0.0 0.2 0.0 0.0 18.5 22.5 37.7 28.6 20.0 6.2 10.2 24.0 13.8 16.5 0.0 0.0 0.0 0.6 0.0 2.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.1 FXYD1 PLM ENSG00000266964 "FXYD domain containing ion transport regulator 1" O00168 19 35138808-35143109 "Predicted membrane proteins" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "heart muscle: 134.1;liver: 137.1;skeletal muscle: 299.8" "Group enriched" "Detected in many" 4 "Fibroblasts: 170.5;Hepatocytes: 393.6;Leydig cells: 398.4;Muller glia cells: 148.5;Peritubular cells: 120.6;Sertoli cells: 116.4;Smooth muscle cells: 231.4" "Cancer enhanced" "Detected in many" "liver cancer: 8.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 11.7" "Group enriched" "Detected in many" 5 "B-cells: 11.7;T-cells: 7.1" "Cell line enhanced" "Detected in some" "ASC diff: 31.0;ASC TERT1: 9.0;HSkMC: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026873 Approved Nucleoplasm,Nucleoli,Cytosol No NA "Nucleoplasm, Cytosol" Nucleoli "HPA026873: AB_1855471" "unprognostic (5.58e-3)" "unprognostic (6.60e-2)" "unprognostic (3.37e-2)" "unprognostic (1.31e-2)" "prognostic unfavorable (6.91e-4)" "unprognostic (1.54e-2)" "unprognostic (1.72e-2)" "unprognostic (3.54e-3)" "unprognostic (8.13e-2)" "unprognostic (5.11e-2)" "unprognostic (8.64e-2)" "unprognostic (2.66e-1)" "prognostic unfavorable (7.59e-8)" "unprognostic (9.97e-3)" "unprognostic (2.25e-1)" "unprognostic (1.65e-1)" "unprognostic (1.92e-2)" 28.2 8.1 35.7 5.2 40.7 2.0 21.8 16.8 34.7 46.5 16.9 25.5 7.1 5.0 26.3 17.9 18.8 31.1 14.8 134.1 23.8 19.9 4.5 137.1 14.1 3.0 36.1 23.7 34.0 6.2 2.1 4.3 8.6 21.5 21.6 7.9 14.1 6.4 20.7 299.8 5.8 7.5 27.7 19.0 6.2 8.4 7.5 14.8 0.0 3.9 29.0 3.5 12.7 23.7 11.7 0.7 1.2 0.7 2.0 7.1 0.7 0.7 0.0 0.0 0.1 31.0 9.0 0.8 3.7 0.1 0.0 0.0 0.0 0.2 2.4 1.0 0.0 0.1 0.6 0.7 0.4 0.0 2.2 0.9 0.4 0.0 1.2 3.5 0.2 0.2 12.8 0.0 0.1 0.3 0.3 0.1 0.1 0.6 2.5 0.1 0.0 0.0 0.5 0.1 1.8 0.4 0.0 0.1 0.6 0.0 0.0 0.2 0.1 0.4 0.1 1.0 0.2 0.1 4.0 0.3 0.0 0.4 0.3 0.0 0.0 0.0 0.3 0.6 0.4 5.1 1.2 0.3 0.0 1.4 0.7 0.9 11.7 4.1 1.7 0.3 6.6 0.8 1.0 0.6 2.0 0.7 0.7 7.1 0.7 35.7 40.7 16.8 34.7 23.8 19.9 36.1 23.7 21.5 14.8 0.0 0.0 3.7 5.1 26.2 1.4 0.3 2.5 5.3 0.0 24.4 3.9 1.3 0.0 0.1 1.2 6.0 1.3 0.0 4.2 1.5 170.5 2.1 0.0 393.6 4.2 0.0 0.0 49.1 11.0 5.1 398.4 4.1 50.6 0.0 0.4 148.5 1.6 2.5 120.6 0.0 7.0 116.4 231.4 3.8 11.7 23.8 2.4 4.9 0.6 2.3 FXYD3 "MAT-8, PLML" ENSG00000089356 "FXYD domain containing ion transport regulator 3" Q14802 19 35115879-35124324 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 160.2;salivary gland: 141.7" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 1850.8;Mucus-secreting cells: 1977.6;Paneth cells: 3546.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 3.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 3.2" "Cell line enhanced" "Detected in some" "HaCaT: 70.3;hTCEpi: 128.0;OE19: 239.6;RT4: 66.8;SK-BR-3: 65.8;WM-115: 47.1" HPA010856 Enhanced Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA Nucleoplasm "Plasma membrane" "HPA010856: AB_1078915" "unprognostic (2.18e-3)" "unprognostic (2.78e-2)" "unprognostic (8.37e-3)" "unprognostic (3.31e-3)" "unprognostic (6.38e-2)" "unprognostic (3.02e-1)" "unprognostic (2.64e-3)" "unprognostic (1.60e-1)" "unprognostic (3.59e-1)" "unprognostic (1.03e-1)" "unprognostic (2.32e-2)" "unprognostic (3.88e-1)" "prognostic unfavorable (1.15e-6)" "unprognostic (4.17e-2)" "unprognostic (2.08e-1)" "unprognostic (5.06e-2)" "unprognostic (7.69e-3)" 0.4 0.1 1.6 29.5 2.3 0.0 20.4 1.7 2.1 30.0 133.2 1.1 2.3 8.6 3.9 2.9 82.1 9.0 56.6 0.8 1.4 0.3 2.1 0.5 35.8 0.3 2.1 0.8 1.9 28.9 0.0 3.7 41.9 2.2 58.4 160.2 15.8 141.7 3.5 0.5 64.2 36.4 7.5 1.8 0.4 50.6 0.7 1.0 2.5 0.5 93.2 49.8 48.7 42.5 0.3 3.2 0.6 0.1 0.0 0.2 0.5 12.6 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.4 18.5 0.0 0.0 0.0 0.1 70.3 0.0 26.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 128.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.2 0.0 0.1 0.0 239.6 0.1 0.0 0.0 0.0 0.0 66.8 15.7 0.1 0.0 65.8 4.8 0.1 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.2 0.6 0.0 0.0 3.2 0.0 0.5 1.6 2.3 1.7 2.1 1.4 0.3 2.1 0.8 2.2 1.0 708.7 211.8 0.0 720.0 512.4 2.3 1.3 239.5 860.6 417.5 127.4 0.0 696.6 1.7 18.8 0.1 3.8 1850.8 0.0 640.2 148.4 41.3 1079.2 23.0 0.6 70.8 1.6 937.0 0.0 0.0 0.0 0.0 12.2 391.4 2.8 1977.6 233.2 377.2 3546.9 0.0 0.6 8.5 0.0 25.8 0.2 0.2 756.6 1264.5 0.7 1253.7 1183.0 FXYD6 ENSG00000137726 "FXYD domain containing ion transport regulator 6" Q9H0Q3 11 117836976-117877486 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" Schizophrenia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 142.8" "Group enriched" "Detected in many" 4 "Ito cells: 132.6;Leydig cells: 220.4;Peritubular cells: 341.9;Sertoli cells: 349.3" "Cancer enriched" "Detected in all" 6 "glioma: 71.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "classical monocyte: 21.9" "Lineage enriched" "Detected in many" 6 "monocytes: 21.9" "Cell line enhanced" "Detected in some" "AF22: 37.9;HAP1: 25.0;RH-30: 15.7;SCLC-21H: 57.4;SH-SY5Y: 32.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041334, HPA042284" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041334: AB_10970752, HPA042284: AB_2677931" "unprognostic (2.18e-3)" "unprognostic (2.70e-2)" "unprognostic (1.60e-2)" "prognostic unfavorable (1.05e-5)" "unprognostic (3.31e-2)" "unprognostic (1.15e-1)" "prognostic favorable (5.87e-4)" "unprognostic (4.51e-2)" "unprognostic (3.78e-2)" "unprognostic (1.07e-2)" "prognostic favorable (5.97e-4)" "unprognostic (3.44e-2)" "prognostic favorable (4.38e-5)" "unprognostic (4.64e-2)" "unprognostic (1.47e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.60e-4)" 12.9 38.7 41.2 9.5 46.2 3.1 8.1 49.1 142.8 24.3 52.0 30.2 9.2 7.6 54.8 19.0 9.8 26.7 29.0 25.6 35.4 51.6 12.3 10.4 21.5 8.5 18.4 59.5 82.8 9.5 3.5 28.5 5.6 20.2 35.6 11.7 11.9 9.8 22.9 11.0 3.9 16.3 58.5 12.8 42.8 17.6 23.2 18.5 2.9 15.9 6.4 5.9 38.1 13.9 0.0 3.6 0.5 21.9 0.0 0.3 5.1 0.0 0.2 37.9 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 1.4 0.1 25.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.4 1.6 0.1 7.6 0.0 0.0 0.0 15.7 0.2 0.9 0.0 57.4 32.7 0.0 0.1 1.3 10.9 0.6 0.6 0.0 0.0 9.1 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 21.9 0.0 0.0 5.3 0.3 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 5.1 41.2 46.2 49.1 78.8 35.4 51.6 18.4 59.5 20.2 18.5 6.0 2.1 0.0 2.7 6.0 2.1 4.8 2.5 2.7 1.2 0.0 2.0 0.8 1.7 5.2 2.2 57.8 0.0 0.0 0.3 1.1 30.7 2.3 0.0 0.4 57.8 1.6 12.0 132.6 22.4 8.6 220.4 9.7 15.1 3.6 0.0 51.6 0.6 0.0 341.9 0.0 3.0 349.3 63.8 1.4 3.2 3.3 1.1 0.0 0.0 1.4 FYB1 "ADAP, FYB, FYB-120/130, SLAP-130" ENSG00000082074 "FYN binding protein 1" O15117 5 39105255-39274528 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 153.7;lymphoid tissue: 63.5" "Cell type enhanced" "Detected in some" 17 "Extravillous trophoblasts: 65.7;Hofbauer cells: 145.5;Macrophages: 50.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 153.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HEL: 16.3;JURKAT: 58.0;MOLT-4: 55.5;REH: 16.2;U-937: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025336, HPA026796, HPA067427" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 6600000 "Plasma membrane" Nucleoplasm "CAB025336: , HPA026796: AB_10964126, HPA067427: " "unprognostic (5.65e-2)" "unprognostic (2.92e-2)" "unprognostic (1.56e-2)" "unprognostic (6.26e-2)" "unprognostic (4.08e-1)" "unprognostic (3.29e-2)" "unprognostic (2.60e-1)" "unprognostic (1.97e-1)" "unprognostic (1.24e-1)" "unprognostic (5.63e-2)" "unprognostic (5.35e-2)" "unprognostic (3.21e-1)" "prognostic unfavorable (2.24e-4)" "unprognostic (2.40e-1)" "unprognostic (4.14e-2)" "unprognostic (8.99e-2)" "unprognostic (1.51e-1)" 7.0 3.5 6.3 36.0 18.3 22.1 3.9 1.8 10.1 3.5 4.4 8.3 0.3 4.1 2.7 6.5 4.9 4.2 7.9 3.5 6.8 6.6 5.7 6.2 13.8 35.5 15.5 2.7 2.6 2.5 1.3 3.5 8.7 11.7 3.8 5.3 3.0 5.4 1.5 1.9 2.4 11.7 5.6 29.4 41.5 5.2 3.5 12.2 63.5 4.1 1.8 28.0 10.1 3.6 0.1 11.9 153.7 41.3 8.6 28.7 30.8 0.0 1.1 0.0 0.0 0.1 0.0 6.2 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.2 4.5 0.0 0.1 0.0 0.0 0.0 16.3 0.0 0.0 0.0 6.1 5.2 0.0 0.1 0.0 0.1 0.0 0.0 58.0 0.0 0.0 0.0 0.0 55.5 3.5 0.0 0.0 0.0 16.2 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.1 1.6 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 21.5 0.0 11.9 33.8 32.3 7.9 38.6 5.5 0.1 22.5 13.8 11.9 0.1 28.7 17.3 153.7 8.6 41.3 3.0 21.7 30.8 6.3 18.3 1.8 10.1 6.8 6.6 15.5 2.7 11.7 12.2 14.9 34.3 0.0 0.0 0.0 0.0 0.0 0.0 6.7 10.3 14.0 0.0 25.9 8.3 0.0 0.0 0.0 0.0 0.0 0.0 65.7 0.0 0.0 14.0 0.0 145.5 0.0 0.0 0.0 0.0 0.0 0.0 50.3 0.0 10.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 33.6 0.0 0.0 0.0 FZD10 CD350 ENSG00000111432 "Frizzled class receptor 10" Q9ULW2 12 130162459-130165740 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 26.9;lymphoid tissue: 18.6" "Cell type enhanced" "Detected in some" 17 "Basal glandular cells: 3.9;Basal keratinocytes: 7.4;Smooth muscle cells: 14.4;Suprabasal keratinocytes: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 8.6;BEWO: 9.9;hTCEpi: 5.7;RPTEC TERT1: 3.0;RT4: 4.8" "Region enhanced" "Detected in some" "thalamus: 7.6" "Low region specificity" "Detected in many" "HPA014484, HPA014485" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA014484: AB_1849132, HPA014485: AB_1849134" "unprognostic (2.41e-3)" "unprognostic (3.29e-1)" "unprognostic (4.74e-2)" "prognostic favorable (5.05e-7)" "unprognostic (2.81e-2)" "unprognostic (4.63e-2)" "unprognostic (8.62e-3)" "unprognostic (6.33e-2)" "unprognostic (5.41e-2)" "unprognostic (3.77e-2)" "unprognostic (2.70e-1)" "unprognostic (2.24e-3)" "unprognostic (2.66e-9)" "unprognostic (2.18e-1)" "unprognostic (3.07e-1)" "unprognostic (1.49e-2)" "unprognostic (1.07e-1)" 1.1 0.4 1.0 0.5 1.9 0.2 1.5 5.4 2.1 11.6 0.6 2.1 1.6 0.4 5.1 3.4 26.9 2.2 7.1 0.5 1.0 1.0 0.4 0.2 2.0 0.9 1.6 1.2 3.4 1.1 0.2 1.4 9.2 1.9 3.7 0.6 3.0 5.4 3.1 1.2 10.2 0.7 0.9 1.2 0.3 1.0 0.7 2.0 0.6 1.7 9.0 18.6 5.1 7.2 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 8.6 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 1.5 0.7 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.1 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 3.0 4.8 0.1 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.0 1.9 5.4 2.1 1.0 1.0 1.6 1.2 1.9 2.0 0.0 0.3 0.0 3.9 7.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 1.1 0.0 0.0 0.2 0.3 2.5 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 14.4 0.0 0.4 7.4 0.7 0.0 0.0 1.1 FZD2 ENSG00000180340 "Frizzled class receptor 2" Q14332 17 44557459-44559570 "Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 17.9;Kupffer cells: 11.1;Leydig cells: 21.6;Peritubular cells: 17.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 3.5;myeloid DC: 5.6;plasmacytoid DC: 2.6" "Group enriched" "Detected in many" 6 "dendritic cells: 5.6;monocytes: 3.5" "Cell line enhanced" "Detected in many" "A549: 25.9;BJ hTERT+ SV40 Large T+: 25.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA057667 Uncertain Approved "Nucleoplasm,Nuclear bodies,Cell Junctions" NA NA "Nucleoplasm, Nuclear bodies" "Cell Junctions" "HPA057667: AB_2683497" "unprognostic (6.94e-2)" "unprognostic (1.12e-2)" "unprognostic (3.04e-2)" "unprognostic (8.83e-3)" "unprognostic (2.04e-1)" "unprognostic (5.29e-3)" "unprognostic (1.44e-2)" "unprognostic (2.29e-1)" "unprognostic (9.45e-2)" "unprognostic (5.61e-2)" "unprognostic (1.15e-2)" "unprognostic (1.86e-1)" "unprognostic (5.10e-3)" "unprognostic (1.19e-2)" "unprognostic (6.35e-2)" "unprognostic (1.05e-1)" "unprognostic (4.17e-3)" 2.3 2.8 2.3 3.9 5.8 0.9 3.2 0.7 3.1 16.1 2.9 2.1 3.0 2.9 10.8 7.6 2.4 6.6 7.7 5.8 3.2 1.5 5.0 0.5 6.9 3.1 2.1 2.9 12.1 2.7 1.6 1.9 8.4 4.9 4.2 0.8 14.3 2.9 7.9 1.8 1.1 3.6 3.3 2.0 3.7 2.1 6.5 1.8 1.1 5.3 2.4 3.1 3.8 4.3 0.2 5.6 0.0 3.5 0.0 0.8 0.6 7.6 25.9 14.9 8.5 3.3 2.9 0.3 21.5 13.1 25.8 18.6 20.0 4.4 0.0 6.8 5.3 7.8 3.6 1.7 1.8 6.2 1.9 5.0 0.8 4.2 0.1 4.3 0.1 4.4 5.5 1.4 6.2 4.2 15.2 1.1 2.7 1.6 0.2 6.5 4.0 3.4 2.0 16.3 0.0 4.8 9.9 4.5 1.3 3.3 0.3 1.9 6.4 2.7 0.7 1.6 9.7 8.3 3.6 0.4 13.9 12.4 2.6 12.6 0.6 0.4 1.9 2.6 1.4 6.3 0.0 3.5 0.0 0.1 0.2 0.0 0.0 0.0 0.8 5.6 0.2 0.0 0.2 0.0 0.0 0.2 2.6 0.0 0.6 2.3 5.8 0.7 2.1 3.2 1.5 2.1 2.9 4.9 1.8 17.9 0.0 0.0 0.2 0.6 0.0 1.7 0.0 0.0 0.0 1.8 0.0 1.4 0.0 0.3 0.4 0.6 0.0 0.0 1.6 0.4 5.1 0.1 0.0 0.0 4.5 0.0 1.2 1.3 11.1 0.0 21.6 4.2 0.0 2.8 0.0 6.4 0.5 0.0 17.0 0.1 0.2 0.0 1.0 0.3 0.9 0.4 1.9 0.0 0.0 0.0 FZD3 ENSG00000104290 "Frizzled class receptor 3" Q9NPG1 8 28494205-28574268 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Neurogenesis, Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 92.3;Rod photoreceptor cells: 82.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.8" "Group enriched" "Detected in many" 5 "dendritic cells: 11.8;T-cells: 3.1" "Cell line enhanced" "Detected in many" "AF22: 31.1;Karpas-707: 16.0;SCLC-21H: 22.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB024995, HPA042320" Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "CAB024995: , HPA042320: AB_2677948" "unprognostic (1.21e-1)" "unprognostic (1.73e-1)" "prognostic favorable (1.17e-4)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (2.57e-4)" "unprognostic (1.69e-2)" "unprognostic (4.26e-4)" "unprognostic (2.11e-1)" "prognostic favorable (3.71e-4)" "unprognostic (2.86e-2)" "unprognostic (1.68e-2)" "unprognostic (1.09e-2)" "unprognostic (1.38e-1)" "unprognostic (4.44e-2)" "unprognostic (3.77e-2)" "unprognostic (6.09e-3)" 2.2 6.4 13.3 3.4 21.1 3.2 5.4 14.4 20.9 5.3 4.4 5.2 8.7 3.2 7.5 15.6 4.4 7.8 3.2 3.0 9.1 7.8 5.7 1.9 2.6 4.3 4.4 14.4 15.0 7.1 8.2 12.5 3.1 9.6 9.6 3.1 4.3 7.0 12.4 2.7 3.3 2.5 5.8 5.4 1.8 5.1 9.9 4.3 1.3 7.4 0.3 3.3 5.2 3.7 1.6 11.8 0.9 0.3 1.1 3.1 0.9 8.2 1.7 31.1 5.8 0.0 0.4 4.8 0.3 0.6 1.7 0.8 1.7 1.7 4.1 1.5 0.2 3.8 2.9 4.7 4.9 1.2 5.1 3.6 2.6 0.6 1.1 0.0 1.4 4.6 0.3 2.6 0.1 1.3 0.3 0.3 4.1 1.9 16.0 0.1 2.0 0.1 3.2 7.8 3.5 2.6 1.8 4.6 3.7 2.4 2.4 22.9 6.2 1.6 4.3 4.8 4.2 4.2 2.2 0.0 0.0 8.4 1.1 2.1 2.9 3.3 3.7 2.4 0.0 1.5 0.9 0.3 0.0 2.2 0.2 2.8 1.6 1.6 3.1 1.2 0.9 2.2 2.3 0.2 1.1 0.0 11.8 0.0 0.9 13.3 21.1 14.4 20.9 9.1 7.8 4.4 14.4 9.6 4.3 8.9 8.1 7.8 6.9 6.0 26.0 5.2 2.5 12.0 15.9 8.7 92.3 9.6 1.7 10.9 12.8 3.0 1.0 0.0 12.8 7.4 7.3 12.2 5.7 2.4 3.3 20.6 27.5 11.6 1.8 11.0 44.5 2.9 32.1 0.0 4.2 15.3 14.2 3.5 48.1 10.2 82.4 25.8 13.9 23.2 29.3 4.1 4.0 2.5 5.5 6.4 FZD4 "CD344, EVR1" ENSG00000174804 "Frizzled class receptor 4" Q9ULV1 11 86945679-86955391 "CD markers, Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 75.7" "Cell type enhanced" "Detected in many" 18 "Collecting duct cells: 34.9;Endothelial cells: 26.3;Ito cells: 108.6;Sertoli cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 25.9;Hep G2: 32.6;HSkMC: 18.8;HUVEC TERT2: 36.8;TIME: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA042328, HPA074833" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA042328: AB_10962494, HPA074833: AB_2686716" "unprognostic (6.49e-2)" "unprognostic (1.49e-2)" "unprognostic (1.03e-1)" "unprognostic (1.03e-1)" "unprognostic (5.87e-2)" "unprognostic (5.51e-2)" "unprognostic (1.82e-1)" "unprognostic (6.97e-2)" "unprognostic (3.33e-2)" "unprognostic (3.79e-2)" "unprognostic (1.36e-2)" "unprognostic (2.22e-1)" "prognostic favorable (8.60e-5)" "unprognostic (1.05e-2)" "unprognostic (9.96e-2)" "unprognostic (9.22e-2)" "unprognostic (1.97e-1)" 75.7 5.3 3.4 6.0 4.8 0.5 57.8 1.5 4.3 11.5 9.0 1.4 32.6 2.0 13.1 13.5 6.3 9.6 8.7 12.5 3.1 2.2 17.0 8.9 19.0 4.7 2.9 3.2 12.8 6.0 4.4 10.1 7.3 5.5 9.3 4.3 20.0 7.1 56.0 17.9 3.7 5.4 8.6 2.8 8.6 8.2 5.5 1.6 0.5 11.4 11.1 3.0 8.3 20.7 0.4 0.2 0.8 0.4 1.4 0.3 0.0 0.5 0.4 1.1 2.0 25.9 6.8 1.5 3.2 2.9 1.2 1.3 2.7 0.3 0.0 0.7 1.0 1.7 1.1 1.2 0.5 1.0 0.1 0.8 1.0 0.8 32.6 7.7 0.0 0.0 18.8 0.2 1.1 0.2 3.0 36.8 0.0 1.4 0.1 0.8 0.8 0.0 0.0 1.5 2.8 7.4 0.0 1.9 0.0 3.6 5.3 0.2 0.3 1.3 0.4 0.5 2.3 4.7 0.0 18.0 3.1 2.1 3.6 0.6 0.1 0.5 0.0 0.4 0.0 0.8 0.7 0.3 0.1 0.3 0.2 0.1 0.2 0.3 0.2 0.1 0.4 0.2 0.3 0.8 1.4 0.4 0.2 0.0 0.0 3.4 4.8 1.5 4.3 3.1 2.2 2.9 3.2 5.5 1.6 0.0 2.2 1.9 0.4 1.3 0.7 7.8 7.6 1.4 1.2 34.9 9.8 0.1 3.3 0.6 0.4 26.3 0.8 0.0 1.4 0.1 4.3 0.8 0.0 10.4 0.2 0.0 0.0 108.6 11.2 1.7 8.6 0.9 0.0 0.0 1.1 0.3 1.0 0.0 6.3 6.9 0.1 32.3 5.1 0.2 3.0 0.5 0.2 0.0 0.6 0.1 FZR1 "CDC20C, CDH1, FZR, FZR2, HCDH, HCDH1, KIAA1242" ENSG00000105325 "Fizzy and cell division cycle 20 related 1" Q9UM11 19 3506273-3538330 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 78.7;Late spermatids: 132.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043536 Approved Supported "Nucleoplasm,Nuclear membrane" NA Yes "Nucleoplasm, Nuclear membrane" "HPA043536: AB_10968058" "unprognostic (2.78e-1)" "prognostic favorable (1.75e-4)" "unprognostic (1.15e-1)" "prognostic favorable (2.57e-4)" "unprognostic (1.60e-1)" "unprognostic (1.36e-2)" "unprognostic (9.20e-2)" "unprognostic (1.61e-1)" "unprognostic (9.70e-2)" "unprognostic (1.18e-1)" "unprognostic (4.15e-3)" "unprognostic (1.41e-2)" "unprognostic (3.75e-1)" "unprognostic (5.41e-3)" "unprognostic (1.75e-1)" "unprognostic (9.04e-2)" "unprognostic (1.04e-1)" 10.3 16.9 15.4 12.0 19.9 37.2 10.6 39.1 23.1 13.3 13.8 17.7 11.0 29.0 14.6 10.1 14.6 12.3 14.5 10.3 13.0 16.6 12.0 13.8 10.7 12.6 11.7 14.3 16.4 20.6 13.2 22.5 15.4 16.1 12.3 5.0 14.9 24.6 15.1 18.1 15.7 18.0 12.0 10.7 15.3 16.3 29.7 14.1 18.9 15.6 9.3 15.8 10.6 12.9 3.0 1.7 5.7 2.1 3.3 3.5 1.5 23.2 14.2 12.1 11.8 3.4 5.6 10.5 14.8 7.6 14.3 11.3 14.3 11.5 12.9 7.6 9.5 7.8 13.9 6.7 12.3 2.9 17.6 13.1 6.2 10.0 14.0 7.5 11.1 13.1 5.0 6.5 8.8 5.1 5.4 9.2 12.5 11.1 20.8 7.7 12.2 19.6 7.9 11.3 7.2 11.1 14.6 11.6 12.6 7.3 11.8 11.6 14.0 13.1 9.3 7.2 2.8 9.7 8.8 13.9 9.8 12.2 23.7 25.2 24.1 5.6 9.9 13.4 21.7 11.9 3.5 1.9 5.7 3.5 2.1 2.0 3.0 3.4 2.4 1.7 2.6 1.8 2.7 3.7 3.3 1.5 1.4 2.4 1.5 15.4 19.9 39.1 23.1 13.0 16.6 11.7 14.3 16.1 14.1 0.0 5.3 15.1 31.9 15.9 20.9 2.9 2.5 1.4 3.4 12.2 9.8 18.6 5.0 14.2 78.7 8.5 17.3 46.7 13.0 11.5 11.2 17.6 3.5 14.7 14.4 28.6 20.7 7.4 6.5 132.8 11.8 11.0 11.8 25.2 14.5 8.3 21.4 17.3 8.9 10.8 14.3 6.5 9.9 25.7 16.2 19.7 38.0 9.6 12.2 24.3 GABARAPL2 "ATG8, ATG8C, GATE-16, GATE16, GEF2" ENSG00000034713 "GABA type A receptor associated protein like 2" P60520 16 75566351-75577881 "Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036726 Uncertain Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA036726: AB_10672476" "unprognostic (3.29e-2)" "unprognostic (3.16e-2)" "unprognostic (1.30e-2)" "unprognostic (7.00e-2)" "unprognostic (4.44e-2)" "prognostic unfavorable (7.63e-4)" "unprognostic (2.58e-1)" "unprognostic (6.85e-2)" "unprognostic (2.13e-1)" "unprognostic (4.95e-2)" "unprognostic (9.86e-3)" "unprognostic (1.33e-2)" "prognostic favorable (5.95e-8)" "unprognostic (3.11e-3)" "unprognostic (3.84e-3)" "unprognostic (1.37e-2)" "unprognostic (3.85e-1)" 29.6 47.4 69.0 18.0 70.5 24.7 33.8 52.3 61.4 29.4 23.9 54.2 26.0 18.7 25.7 47.1 21.7 30.9 23.7 76.6 59.6 69.5 42.0 31.4 25.4 23.4 73.4 52.5 28.9 25.8 46.2 33.6 31.8 52.4 33.4 23.6 30.8 27.3 31.0 52.7 24.3 19.4 28.2 72.0 25.7 21.8 20.2 45.4 17.5 35.7 22.4 26.8 22.6 19.3 38.2 47.0 87.8 25.4 18.9 35.1 35.9 23.9 20.4 34.9 16.4 54.2 47.8 17.7 28.2 40.9 38.7 43.6 18.7 31.1 34.6 34.8 32.1 23.4 20.7 25.9 26.4 47.9 14.9 49.4 20.4 18.8 27.7 29.6 19.5 36.9 33.0 37.5 32.5 24.3 35.3 31.4 31.4 29.8 14.2 38.6 33.9 28.8 37.4 20.9 27.0 22.9 32.5 16.8 41.7 40.4 15.7 41.1 43.0 44.1 10.6 40.5 29.1 34.0 30.8 28.6 16.8 25.7 24.4 15.1 40.5 38.3 72.4 40.5 19.0 24.7 47.8 25.3 61.1 23.9 23.4 30.6 38.2 25.6 27.3 30.4 32.1 23.3 21.8 87.8 18.9 25.4 47.0 35.1 35.9 69.0 70.5 52.3 61.4 59.6 69.5 73.4 52.5 52.4 45.4 80.4 128.3 143.1 246.6 244.3 234.3 274.6 119.8 196.7 104.6 165.7 43.2 221.0 581.9 172.6 40.2 247.2 151.5 210.2 153.9 100.3 212.4 297.8 105.3 119.0 199.3 290.8 266.6 200.1 176.9 47.4 225.5 212.5 244.6 505.9 147.5 338.5 185.4 241.8 245.4 443.3 155.9 155.2 146.3 296.3 235.3 239.5 326.2 159.2 111.7 275.4 GABPA "E4TF1-60, E4TF1A, NFT2, NRF2, NRF2A" ENSG00000154727 "GA binding protein transcription factor alpha subunit" Q06546 21 25734570-25772460 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003258, CAB004411, HPA028791" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004411: AB_627648, HPA003258: AB_1078928, HPA028791: AB_10602598" "unprognostic (5.50e-2)" "unprognostic (2.40e-1)" "unprognostic (3.74e-2)" "unprognostic (2.68e-1)" "unprognostic (3.98e-2)" "unprognostic (1.17e-2)" "unprognostic (3.01e-1)" "unprognostic (2.73e-1)" "unprognostic (2.56e-2)" "unprognostic (1.76e-1)" "unprognostic (4.07e-1)" "unprognostic (7.34e-2)" "prognostic unfavorable (3.97e-5)" "unprognostic (1.62e-1)" "unprognostic (1.77e-1)" "unprognostic (5.70e-2)" "unprognostic (2.73e-3)" 25.3 15.2 11.6 17.0 16.9 13.6 18.3 15.9 15.4 17.6 17.1 11.4 18.8 12.7 19.5 15.9 15.1 15.4 13.6 18.6 12.5 9.5 14.6 18.8 13.3 18.8 12.9 9.0 20.4 13.3 19.4 20.3 34.5 12.5 18.0 14.2 10.8 14.2 15.4 18.2 11.5 17.0 15.8 18.4 20.0 12.3 19.5 16.3 37.7 27.3 10.3 19.0 18.4 35.3 8.9 6.6 12.0 8.2 10.8 10.3 6.1 12.8 5.3 15.8 11.2 16.2 22.0 12.2 10.3 11.6 8.6 8.5 6.7 11.0 27.6 8.2 11.9 8.3 5.9 17.5 10.5 14.3 15.6 16.2 19.2 7.2 6.4 11.0 20.4 13.0 16.0 10.3 11.4 10.8 14.1 15.8 15.1 17.5 16.7 14.3 6.4 22.0 8.9 21.8 14.0 7.4 18.4 22.7 16.9 10.0 8.6 9.7 13.1 18.5 11.8 12.6 10.0 10.5 15.8 15.5 10.4 9.6 11.3 8.5 13.4 11.5 24.5 10.8 15.7 12.5 12.0 6.8 11.5 7.4 8.2 9.9 8.9 8.6 8.7 6.6 8.4 10.3 8.7 8.7 10.8 6.0 3.4 8.6 6.1 11.6 16.9 15.9 15.4 12.5 9.5 12.9 9.0 12.5 16.3 8.9 11.8 14.7 10.4 10.3 6.6 6.7 15.3 6.7 13.6 21.0 0.0 14.8 3.3 6.9 5.5 20.4 9.0 0.0 7.0 10.8 11.7 9.2 5.8 17.5 10.8 12.7 8.6 22.7 19.7 2.1 16.4 11.5 6.8 7.2 13.3 20.9 7.5 8.6 20.8 8.5 9.4 19.4 12.0 27.7 17.4 11.0 21.1 13.1 11.2 11.6 GABPB1 "E4TF1-47, GABPB, GABPB2" ENSG00000104064 "GA binding protein transcription factor beta subunit 1" Q06547 15 50275392-50355408 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019653, HPA067444" Supported Supported "Nucleoplasm,Cytoplasmic bodies" NA Yes Nucleoplasm "Cytoplasmic bodies" "HPA019653: AB_1849370, HPA067444: AB_2685842" "unprognostic (7.79e-3)" "unprognostic (2.42e-2)" "unprognostic (3.84e-1)" "unprognostic (1.92e-1)" "unprognostic (9.33e-2)" "unprognostic (3.99e-2)" "unprognostic (3.25e-2)" "unprognostic (5.65e-2)" "unprognostic (1.86e-2)" "unprognostic (8.94e-3)" "unprognostic (1.23e-1)" "unprognostic (4.54e-3)" "prognostic unfavorable (2.53e-4)" "unprognostic (3.18e-2)" "unprognostic (2.37e-1)" "unprognostic (1.13e-1)" "unprognostic (3.93e-3)" 15.4 12.6 8.1 13.8 16.8 31.7 14.3 16.0 14.0 12.7 9.5 8.4 8.6 8.1 14.1 10.8 13.8 12.0 12.6 10.3 8.8 7.2 9.1 16.2 15.2 25.7 9.1 8.7 12.1 10.6 8.7 11.5 15.1 7.3 11.4 11.8 10.7 12.1 8.1 15.2 10.4 12.8 13.9 7.3 17.1 11.2 17.3 9.9 35.7 16.2 12.5 20.8 13.4 11.9 23.1 16.8 26.8 15.0 19.1 21.1 14.3 11.8 13.7 20.1 15.6 5.3 7.5 26.9 15.7 12.4 18.6 16.4 23.3 9.8 15.6 9.6 12.9 14.7 19.7 18.0 13.4 23.7 21.6 10.7 18.5 14.3 15.8 12.8 17.7 14.4 9.9 13.2 17.4 22.7 10.5 32.4 17.2 16.9 19.8 12.3 27.0 26.1 16.0 13.8 13.1 9.3 32.3 14.7 14.9 11.2 15.2 19.0 15.7 13.9 13.2 15.8 20.1 11.5 17.6 15.4 17.0 14.1 29.6 27.9 14.1 19.2 27.5 10.5 16.4 17.0 26.8 12.2 23.6 15.9 15.0 21.1 23.1 15.7 16.9 16.8 21.3 14.6 16.8 12.4 19.1 11.1 13.3 20.4 14.3 8.1 16.8 16.0 14.0 8.8 7.2 9.1 8.7 7.3 9.9 8.9 9.1 53.0 89.7 41.9 40.4 15.3 12.7 8.1 0.0 7.0 33.4 37.1 3.3 11.0 80.1 35.3 15.8 0.0 6.7 41.1 28.6 72.8 47.2 24.6 31.6 35.0 48.5 39.3 56.1 27.9 53.5 11.6 18.6 25.2 23.1 30.3 11.9 21.0 36.0 6.5 40.6 25.8 24.5 27.4 31.1 31.2 46.3 116.7 26.4 90.9 GABPB2 MGC29891 ENSG00000143458 "GA binding protein transcription factor beta subunit 2" Q8TAK5 1 151070578-151125542 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 26.5" "Low region specificity" "Detected in all" "HPA028471, HPA058483" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA028471: AB_10602319, HPA058483: AB_2683730" "unprognostic (1.21e-1)" "unprognostic (7.03e-3)" "unprognostic (2.76e-2)" "unprognostic (9.95e-2)" "unprognostic (5.50e-2)" "unprognostic (1.71e-2)" "unprognostic (2.70e-1)" "unprognostic (2.11e-2)" "unprognostic (4.65e-2)" "unprognostic (7.71e-2)" "unprognostic (1.98e-2)" "unprognostic (8.02e-2)" "unprognostic (1.75e-2)" "unprognostic (1.61e-2)" "unprognostic (2.71e-1)" "unprognostic (2.03e-1)" "unprognostic (1.90e-3)" 9.9 8.3 9.5 9.3 13.3 12.2 10.9 12.3 12.2 10.0 8.5 14.8 10.7 7.0 10.1 8.0 8.7 10.2 10.7 11.0 11.6 5.8 7.9 6.4 7.7 9.9 14.4 9.7 17.6 7.8 15.1 12.8 6.5 11.4 9.4 9.8 11.0 7.6 12.6 10.0 13.9 8.1 12.0 10.2 10.1 9.8 20.2 15.2 15.7 10.0 11.6 9.8 9.9 16.6 4.7 5.0 4.7 5.1 2.6 4.8 2.6 6.9 2.4 1.7 2.1 6.1 9.0 2.2 6.4 4.0 3.7 2.6 0.7 5.2 7.2 2.4 6.1 2.0 6.1 3.7 3.3 5.5 2.7 1.4 2.0 3.8 0.1 4.1 7.8 4.1 4.9 3.8 5.1 7.7 2.9 1.4 7.7 4.8 5.1 4.4 9.8 10.8 1.4 0.8 4.0 2.7 3.2 2.8 3.4 3.1 1.9 3.0 1.2 8.2 2.9 2.4 1.7 7.2 8.6 4.1 1.0 3.2 6.6 5.1 2.8 1.3 26.5 3.0 5.9 4.4 3.6 2.8 1.6 4.4 3.3 2.7 3.1 4.8 3.9 2.5 4.7 4.3 4.7 4.7 2.6 5.1 5.0 1.7 2.6 9.5 13.3 12.3 12.2 11.6 5.8 14.4 9.7 11.4 15.2 8.9 12.6 13.8 9.2 10.2 26.2 21.4 25.5 24.1 18.2 12.2 23.6 4.9 8.3 5.6 28.3 9.0 9.8 0.0 5.1 4.2 10.8 6.2 6.9 5.9 7.3 31.8 9.2 16.0 14.8 13.9 20.8 8.0 8.5 9.0 15.4 15.4 4.6 10.5 20.1 3.3 39.9 6.5 16.0 54.6 51.3 8.8 3.8 14.4 14.9 6.7 GABRA1 EJM5 ENSG00000022355 "Gamma-aminobutyric acid type A receptor alpha1 subunit" P14867 5 161847063-161899981 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "brain: 58.6" "Cell type enriched" "Detected in some" 24 "Bipolar cells: 209.5" "Cancer enriched" "Detected in single" 5 "glioma: 1.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 3.7;SCLC-21H: 1.1;U-2 OS: 1.6;U-87 MG: 2.3;WM-115: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022502, HPA029363, HPA055746" Enhanced Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB022502: , HPA029363: , HPA055746: AB_2682904" "unprognostic (2.58e-2)" "unprognostic (4.78e-3)" "unprognostic (1.84e-1)" "unprognostic (3.31e-1)" "unprognostic (2.43e-1)" 1.0 2.6 8.5 1.0 21.9 1.0 1.0 35.2 58.6 1.0 1.0 1.8 0.0 1.1 1.0 1.0 1.0 1.0 1.0 1.0 10.5 8.8 1.0 1.0 1.0 1.0 6.7 22.0 1.0 1.0 1.0 0.1 1.0 7.4 1.2 1.0 0.2 1.0 1.1 1.0 1.0 1.0 1.0 1.3 1.1 1.5 1.1 0.0 0.0 1.0 0.0 1.3 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.7 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.1 0.0 0.0 2.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 21.9 35.2 49.8 10.5 8.8 6.7 22.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 209.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GABRA2 ENSG00000151834 "Gamma-aminobutyric acid type A receptor alpha2 subunit" P47869 4 46248427-46475230 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 52.6" "Group enriched" "Detected in some" 4 "Collecting duct cells: 38.4;Enterocytes: 16.9;Intestinal endocrine cells: 30.6" "Cancer enhanced" "Detected in some" "glioma: 0.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-2 OS: 9.6;U-87 MG: 4.5;WM-115: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029363, CAB079061" Supported Uncertain "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" Nucleoplasm "CAB079061: , HPA029363: " "unprognostic (2.03e-2)" "unprognostic (2.77e-1)" "unprognostic (2.45e-4)" "unprognostic (6.87e-3)" "unprognostic (2.65e-1)" "unprognostic (2.08e-1)" "unprognostic (1.01e-1)" "unprognostic (4.09e-1)" "unprognostic (6.90e-3)" "unprognostic (8.83e-2)" "unprognostic (2.22e-5)" "unprognostic (1.75e-1)" "unprognostic (1.15e-1)" "unprognostic (2.67e-1)" "unprognostic (3.04e-2)" 2.2 1.3 38.5 1.4 34.4 1.2 1.9 10.4 52.6 1.7 4.5 4.9 0.0 2.0 1.4 11.7 1.7 1.0 1.6 1.0 38.9 7.7 8.8 1.4 1.0 1.4 3.7 31.0 1.9 1.0 0.9 0.6 1.5 10.5 1.0 3.5 0.0 1.2 1.9 1.0 1.3 7.7 1.3 6.9 2.3 1.6 1.5 7.1 0.0 1.1 0.0 1.4 1.2 0.8 0.2 0.3 1.0 0.1 0.1 0.1 0.0 0.5 0.5 0.1 0.6 0.0 0.0 0.5 0.3 0.0 0.0 0.0 2.1 0.6 0.2 0.5 0.0 0.1 0.8 0.0 0.0 0.2 0.5 0.5 0.1 0.7 0.3 0.8 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.8 0.2 0.0 0.4 0.0 0.3 0.9 1.8 0.1 0.0 0.6 0.4 0.1 0.6 0.2 0.0 0.1 0.3 0.0 0.6 0.4 0.4 0.1 0.5 9.6 0.5 0.1 0.8 1.2 0.2 4.5 0.4 5.1 1.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.1 0.1 0.3 0.0 0.0 38.5 34.4 10.4 31.4 38.9 7.7 3.7 31.0 10.5 7.1 0.0 0.0 0.0 0.0 0.1 1.5 0.4 0.0 0.0 0.0 38.4 3.9 0.0 3.3 0.0 6.4 0.2 16.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 30.6 0.0 0.0 6.9 0.6 0.0 1.7 0.0 1.9 0.3 0.0 0.9 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.6 0.0 GABRA3 ENSG00000011677 "Gamma-aminobutyric acid type A receptor alpha3 subunit" P34903 X 152166234-152451358 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 30.1" "Cell type enriched" "Detected in some" 4 "Hofbauer cells: 12.1" "Cancer enriched" "Detected in many" 7 "testis cancer: 16.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "GAMG: 9.1;HMC-1: 7.7;Karpas-707: 13.0;PC-3: 7.6;U-266/70: 7.0;U-266/84: 11.6;U-87 MG: 7.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000839, HPA029363" Approved Supported Uncertain "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA000839: AB_1078929, HPA029363: " "unprognostic (9.63e-3)" "unprognostic (2.04e-1)" "unprognostic (2.02e-1)" "unprognostic (1.18e-2)" "unprognostic (7.07e-2)" "unprognostic (5.42e-2)" "unprognostic (2.34e-6)" "unprognostic (1.24e-1)" "unprognostic (2.70e-1)" "unprognostic (2.39e-2)" "unprognostic (2.63e-2)" "unprognostic (1.73e-1)" "unprognostic (7.29e-6)" "unprognostic (7.42e-3)" "unprognostic (6.20e-2)" "unprognostic (8.13e-2)" 0.7 0.7 7.7 0.6 15.2 0.7 0.7 1.3 30.1 2.2 0.8 3.3 0.0 0.8 1.2 0.8 1.3 0.7 0.7 0.7 10.9 15.9 0.7 0.7 0.7 0.7 4.7 10.5 0.6 0.7 0.6 0.9 5.2 6.2 0.8 0.8 0.4 0.7 1.8 0.8 1.1 0.9 0.8 2.1 0.7 0.7 1.8 1.1 0.0 0.7 0.0 0.9 1.8 0.4 0.0 0.1 1.5 0.3 0.3 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 13.0 0.0 0.0 0.0 0.0 2.4 5.5 7.6 0.0 0.0 0.0 0.0 0.0 0.2 4.7 0.0 4.8 0.4 0.3 0.1 1.2 0.0 4.9 6.5 0.3 1.4 7.0 11.6 0.0 7.7 0.0 4.9 1.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.3 0.1 0.2 0.0 7.7 15.2 1.3 28.4 10.9 15.9 4.7 10.5 6.2 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 3.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 12.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.9 0.0 1.6 0.0 0.0 0.3 GABRA5 ENSG00000186297 "Gamma-aminobutyric acid type A receptor alpha5 subunit" P31644 15 26866363-26949207 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "brain: 52.6" "Cell type enhanced" "Detected in single" 18 "Spermatogonia: 1.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "A549: 26.4;HAP1: 9.1;NTERA-2: 10.9;U-2 OS: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA029363, HPA077031, CAB079022" Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB079022: , HPA029363: , HPA077031: AB_2686825" "unprognostic (6.33e-2)" "unprognostic (8.94e-3)" "unprognostic (1.04e-1)" "unprognostic (2.50e-1)" "unprognostic (1.81e-1)" "unprognostic (3.75e-1)" "unprognostic (9.50e-3)" "unprognostic (2.57e-1)" "unprognostic (7.63e-2)" "unprognostic (8.50e-2)" "unprognostic (1.44e-2)" 0.8 0.8 12.0 0.8 48.2 0.8 0.8 0.1 52.6 0.8 0.8 0.8 0.0 0.8 0.8 0.7 2.5 0.8 1.5 0.9 20.9 6.0 0.9 0.8 0.8 0.8 2.3 15.2 0.7 0.7 0.7 0.1 0.8 1.0 1.0 0.7 0.0 0.7 0.9 0.7 0.8 0.7 1.4 0.3 0.8 1.1 1.4 2.0 1.3 0.9 0.0 1.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.4 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 9.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 48.2 0.1 26.0 20.9 6.0 2.3 15.2 1.0 2.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 GADD45B "DKFZP566B133, GADD45BETA, MYD118" ENSG00000099860 "Growth arrest and DNA damage inducible beta" O75293 19 2476122-2478259 "Predicted intracellular proteins" "Apoptosis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Smooth muscle cells: 2211.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029816 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029816: AB_10601325" "unprognostic (1.32e-1)" "unprognostic (4.51e-2)" "unprognostic (3.94e-3)" "unprognostic (5.06e-2)" "unprognostic (1.53e-2)" "unprognostic (3.09e-2)" "unprognostic (2.46e-3)" "unprognostic (2.02e-3)" "unprognostic (1.07e-1)" "unprognostic (1.07e-2)" "unprognostic (2.95e-1)" "unprognostic (2.79e-1)" "unprognostic (4.37e-2)" "unprognostic (1.09e-3)" "unprognostic (3.90e-2)" "unprognostic (8.27e-3)" "unprognostic (6.00e-2)" 50.5 37.3 10.3 24.6 33.8 142.2 34.2 6.7 26.4 20.0 29.2 17.9 4.1 9.7 14.2 10.7 17.6 34.3 44.6 59.0 22.5 15.6 26.2 143.6 49.8 14.7 17.1 3.9 36.3 45.5 16.7 27.5 22.6 32.4 27.2 6.6 26.6 28.1 36.9 38.4 22.1 12.3 14.5 32.8 14.7 27.1 12.4 13.1 6.7 53.9 29.5 13.7 35.0 15.0 12.2 13.5 45.1 14.9 14.9 22.6 10.1 21.4 4.3 0.5 2.9 16.3 12.6 1.3 21.9 6.4 17.3 8.9 6.0 8.3 10.2 14.9 10.8 6.2 11.9 1.1 7.3 4.2 7.8 3.9 1.1 4.7 2.3 27.7 2.3 7.1 20.4 4.7 5.2 25.8 18.7 6.8 1.1 0.5 27.8 17.8 6.9 2.6 11.4 2.6 2.1 9.2 9.9 7.9 16.0 7.8 3.9 0.2 0.2 24.4 18.3 7.0 10.0 9.7 17.2 27.9 17.3 15.9 12.3 27.3 12.5 9.2 4.2 4.2 6.9 5.6 11.7 11.8 45.1 22.6 14.9 20.4 7.4 15.8 17.3 11.9 12.2 14.1 18.5 34.5 14.9 11.6 13.5 19.1 10.1 10.3 33.8 6.7 26.4 22.5 15.6 17.1 3.9 32.4 13.1 393.1 604.5 105.2 327.2 303.6 9.8 755.2 165.6 246.3 216.1 48.8 5.9 91.9 162.5 250.0 1.5 410.0 221.1 0.0 188.1 49.6 617.1 761.5 748.2 106.8 373.8 12.7 81.8 133.2 143.4 1.7 68.4 643.2 490.9 244.3 77.7 120.7 209.6 203.4 27.6 91.0 27.0 174.6 2211.4 1.6 5.7 269.9 120.6 154.5 59.8 284.3 GADD45GIP1 "CKBBP2, CKbetaBP2, CRIF1, MGC4667, MGC4758, PLINP-1, Plinp1, PRG6" ENSG00000179271 "GADD45G interacting protein 1" Q8TAE8 19 12953119-12957236 "Predicted intracellular proteins, Ribosomal proteins" "Cell cycle, Host-virus interaction" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055205, HPA065048, HPA071910" Supported Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA055205: AB_2682736, HPA065048: AB_2685412, HPA071910: " "unprognostic (5.82e-2)" "unprognostic (2.62e-2)" "unprognostic (4.49e-2)" "unprognostic (2.08e-1)" "unprognostic (8.14e-3)" "unprognostic (2.49e-1)" "unprognostic (1.20e-1)" "unprognostic (1.65e-1)" "unprognostic (9.67e-2)" "unprognostic (7.73e-3)" "unprognostic (1.06e-1)" "unprognostic (7.09e-2)" "unprognostic (1.03e-1)" "unprognostic (1.62e-1)" "unprognostic (1.25e-1)" "unprognostic (1.50e-2)" "unprognostic (1.73e-1)" 23.9 31.8 32.7 22.3 29.1 28.1 19.3 17.2 31.4 16.9 18.9 11.2 17.9 21.1 19.2 20.0 22.3 17.5 25.0 41.9 26.4 27.6 24.3 31.5 15.3 21.0 26.0 23.6 20.7 29.6 10.1 18.5 21.3 17.7 18.7 9.7 13.1 36.2 21.7 85.5 18.4 19.2 19.5 19.3 19.8 20.0 17.2 17.1 14.8 27.0 37.9 14.8 17.5 21.5 34.2 17.7 4.8 14.1 16.1 23.6 10.6 20.1 17.2 7.2 10.1 5.1 6.6 10.1 14.9 7.5 14.9 12.3 23.7 8.2 14.6 24.9 8.9 10.7 14.1 8.8 14.5 3.9 9.5 43.2 10.3 23.2 26.6 12.4 17.1 15.8 7.8 11.8 10.3 8.5 7.9 8.6 14.1 15.6 5.7 9.2 29.6 27.0 36.0 19.9 13.1 54.3 20.1 7.3 23.3 11.4 11.9 22.2 20.3 11.1 15.0 16.8 3.7 11.7 16.2 13.9 28.9 10.1 25.1 27.3 22.7 15.8 15.1 20.1 21.5 16.6 4.1 14.1 4.8 14.4 13.4 14.5 34.2 22.1 22.8 17.7 28.0 23.6 17.4 0.9 16.1 11.3 16.9 17.5 10.6 32.7 29.1 17.2 29.1 26.4 27.6 26.0 23.6 17.7 17.1 38.7 48.8 182.3 139.8 129.1 56.0 138.4 114.7 85.6 58.0 130.9 21.6 278.6 339.8 261.6 30.0 159.5 164.2 116.8 326.4 297.6 155.1 145.6 72.7 225.1 217.4 35.0 133.6 149.8 133.3 39.7 177.2 143.5 170.4 318.4 137.1 65.9 279.8 125.8 160.1 483.6 62.7 187.5 150.4 81.2 152.0 140.6 170.8 107.6 173.2 145.0 GAL3ST1 CST ENSG00000128242 "Galactose-3-O-sulfotransferase 1" Q99999 22 30554635-30574587 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Sphingolipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 28.7;gallbladder: 13.4;intestine: 25.1;kidney: 13.3;stomach 1: 7.2" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 38.2;Enterocytes: 17.4;Muller glia cells: 29.4;Proximal tubular cells: 18.9" "Cancer enriched" "Detected in many" 6 "renal cancer: 38.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 22.7;CACO-2: 6.3;EFO-21: 12.3;K-562: 5.3;OE19: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001220, HPA077138" Approved Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" NA NA Vesicles Nucleoplasm "HPA001220: AB_1078933, HPA077138: " "unprognostic (2.69e-2)" "unprognostic (3.12e-4)" "unprognostic (5.93e-2)" "unprognostic (1.08e-2)" "unprognostic (2.32e-1)" "unprognostic (6.50e-3)" "unprognostic (1.53e-2)" "unprognostic (2.23e-1)" "unprognostic (2.89e-1)" "unprognostic (5.18e-2)" "unprognostic (1.19e-1)" "unprognostic (4.43e-2)" "prognostic unfavorable (1.79e-4)" "unprognostic (2.33e-1)" "unprognostic (4.23e-2)" "unprognostic (1.24e-1)" "unprognostic (3.56e-2)" 0.8 0.6 8.4 0.7 9.6 1.2 0.8 1.4 12.3 1.4 11.3 25.8 0.0 24.2 1.3 2.3 0.8 2.2 13.4 0.5 12.1 8.3 13.3 1.6 1.5 0.9 14.0 2.6 1.2 2.9 0.6 0.5 1.3 12.4 1.2 2.8 0.3 1.0 1.9 1.9 2.1 25.1 0.7 28.7 0.7 7.2 2.5 7.8 0.0 0.6 0.0 0.4 1.0 0.7 2.3 2.8 2.3 0.7 0.3 0.8 0.0 0.1 22.7 0.4 0.2 0.0 0.0 1.7 0.0 0.1 0.0 0.0 6.3 3.1 0.3 12.3 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.8 0.3 0.2 4.1 0.5 0.1 0.3 0.2 0.0 0.1 0.1 0.0 0.0 0.3 5.3 0.6 0.0 0.1 0.3 0.9 3.3 8.5 0.3 0.2 0.1 0.6 0.9 0.1 0.3 1.5 0.0 0.4 0.2 0.6 0.1 0.1 0.6 0.2 0.1 0.2 0.0 2.0 1.2 0.3 0.1 0.1 0.2 0.9 0.7 0.1 0.4 0.5 0.7 1.8 0.7 0.8 0.2 2.3 0.5 0.8 2.3 0.3 0.3 2.8 0.1 0.0 8.4 9.6 1.4 10.3 12.1 8.3 14.0 2.6 12.4 7.8 0.0 0.0 0.0 0.1 0.3 0.7 0.6 38.2 0.0 0.0 3.5 0.0 0.0 13.3 5.6 0.9 0.1 17.4 0.0 9.7 0.0 0.0 0.2 0.0 1.3 0.1 0.0 10.5 0.0 0.8 0.6 1.4 0.0 0.0 0.0 7.4 29.4 4.6 7.0 2.1 18.9 1.1 0.0 0.0 3.1 7.5 0.3 0.2 0.0 8.0 0.0 GAL3ST4 FLJ12116 ENSG00000197093 "Galactose-3-O-sulfotransferase 4" Q96RP7 7 100159244-100168750 "Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 37.8" "Cell type enriched" "Detected in some" 6 "Hofbauer cells: 38.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 4.4;naive CD4 T-cell: 15.0;naive CD8 T-cell: 4.5;plasmacytoid DC: 4.3" "Group enriched" "Detected in many" 26 "dendritic cells: 4.3;T-cells: 15.0" "Cell line enhanced" "Detected in many" "WM-115: 29.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038137, HPA038138" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038137: AB_10697239, HPA038138: AB_2675854" "unprognostic (4.22e-2)" "unprognostic (2.97e-2)" "prognostic unfavorable (5.44e-4)" "unprognostic (8.64e-2)" "unprognostic (3.01e-2)" "unprognostic (1.40e-1)" "unprognostic (3.10e-2)" "unprognostic (1.81e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.57e-4)" "unprognostic (2.80e-1)" "unprognostic (2.25e-1)" "prognostic unfavorable (4.14e-4)" "unprognostic (3.98e-2)" "unprognostic (9.67e-2)" "unprognostic (1.89e-2)" "unprognostic (5.36e-2)" 3.9 5.4 8.4 4.2 9.4 1.0 4.1 1.5 10.9 7.8 6.5 18.6 0.4 4.1 9.0 3.7 8.4 6.3 5.9 4.9 8.0 3.8 1.8 1.0 5.3 2.9 11.9 4.7 7.6 1.5 1.6 4.6 9.8 8.1 6.5 7.0 4.2 24.9 4.3 1.9 27.8 8.9 10.6 14.9 2.7 2.8 4.4 10.2 37.8 2.0 2.4 3.9 7.3 10.6 0.1 4.3 0.3 0.1 0.2 15.0 2.2 0.0 0.6 4.0 1.8 3.6 7.1 7.6 2.2 2.2 1.3 1.8 0.4 0.2 0.7 0.5 7.4 2.3 8.6 0.2 1.3 0.4 0.0 0.4 0.2 0.1 0.2 2.4 0.4 2.4 8.7 3.4 3.9 0.4 2.8 2.5 3.1 1.1 0.1 2.4 0.3 2.7 0.1 1.3 8.2 0.9 2.2 1.8 0.1 0.0 0.3 0.2 1.7 0.6 0.0 4.6 0.7 0.0 0.2 2.2 0.2 1.2 0.3 0.1 0.1 0.1 1.7 1.4 0.4 29.6 0.0 0.1 0.0 0.5 0.0 0.0 0.0 4.4 0.3 0.0 0.1 15.0 4.5 0.3 0.2 0.1 4.3 1.1 2.2 8.4 9.4 1.5 10.9 8.0 3.8 11.9 4.7 8.1 10.2 0.0 0.3 0.0 2.0 3.8 0.0 0.8 2.5 0.0 1.2 0.0 0.0 0.3 0.0 0.5 0.1 0.5 0.0 0.0 0.0 0.2 6.0 0.3 0.0 0.0 38.9 0.0 0.0 1.8 0.3 0.0 4.4 0.7 5.0 1.0 0.6 0.5 0.5 2.9 4.9 0.0 0.0 0.0 2.2 0.4 0.2 7.0 0.7 0.0 6.0 0.9 GALE SDR1E1 ENSG00000117308 UDP-galactose-4-epimerase Q14376 1 23795599-23800804 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Galactose metabolism" Isomerase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Mucus-secreting cells: 119.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007340 Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA007340: AB_1078934" "unprognostic (1.65e-1)" "unprognostic (1.78e-1)" "unprognostic (5.25e-2)" "unprognostic (1.41e-2)" "unprognostic (3.03e-3)" "unprognostic (1.17e-2)" "unprognostic (3.19e-3)" "unprognostic (1.84e-1)" "unprognostic (1.59e-1)" "unprognostic (2.65e-1)" "unprognostic (1.56e-2)" "unprognostic (1.34e-1)" "unprognostic (2.25e-1)" "unprognostic (7.51e-2)" "unprognostic (2.12e-1)" "prognostic favorable (2.68e-4)" "unprognostic (1.41e-2)" 4.4 5.5 4.8 5.6 6.1 1.8 5.0 4.3 8.7 9.1 22.3 3.2 12.4 20.0 3.0 6.0 26.2 6.4 34.7 3.7 4.0 4.1 18.2 26.1 7.7 3.9 3.7 5.2 2.4 15.9 7.7 3.5 29.4 3.5 4.8 23.8 5.5 32.1 6.9 1.7 3.9 30.4 4.1 3.6 8.6 46.7 3.4 2.6 3.7 2.3 9.8 19.6 8.1 8.4 3.1 10.6 2.0 18.6 19.4 5.2 4.7 16.3 19.7 7.9 12.5 2.9 4.2 7.7 11.2 15.2 19.9 14.9 18.0 55.1 3.9 15.8 6.5 26.7 18.2 7.0 28.7 15.1 8.3 4.5 11.0 10.0 19.5 30.1 4.7 3.3 8.9 15.1 18.3 46.0 20.1 17.0 8.5 12.2 1.0 14.1 17.5 7.8 5.1 2.2 23.0 19.2 9.3 7.7 4.9 32.2 11.0 3.1 7.0 20.3 18.4 19.9 9.4 13.5 3.9 9.3 14.5 21.7 14.9 13.7 5.1 12.2 5.1 15.4 20.2 7.8 1.1 7.7 1.7 5.1 15.5 5.2 3.1 3.1 4.1 10.6 1.0 3.6 2.5 2.0 19.4 18.6 3.0 5.1 4.7 4.8 6.1 4.3 8.7 4.0 4.1 3.7 5.2 3.5 2.6 11.9 33.5 8.2 17.9 6.8 14.3 3.1 40.8 12.0 19.4 38.4 15.7 47.8 29.9 42.8 20.5 9.8 92.2 0.0 103.0 85.9 6.3 18.2 10.4 31.8 81.7 7.9 11.6 9.2 3.7 5.1 4.4 12.2 23.6 29.7 119.4 20.6 62.8 84.5 3.2 64.1 13.1 0.0 5.3 14.6 9.7 4.3 80.6 7.5 58.2 38.3 GALK2 GK2 ENSG00000156958 "Galactokinase 2" Q01415 15 49155656-49367869 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043564, HPA048267" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043564: AB_2678557, HPA048267: AB_2680335" "unprognostic (2.27e-2)" "unprognostic (1.45e-1)" "unprognostic (2.38e-1)" "prognostic favorable (7.31e-4)" "unprognostic (3.04e-1)" "unprognostic (9.78e-2)" "unprognostic (2.66e-1)" "unprognostic (1.95e-1)" "unprognostic (2.30e-1)" "unprognostic (8.67e-3)" "unprognostic (2.25e-2)" "unprognostic (2.43e-1)" "prognostic favorable (1.88e-5)" "unprognostic (2.33e-1)" "unprognostic (9.79e-2)" "unprognostic (2.13e-2)" "unprognostic (1.93e-1)" 12.7 24.9 10.2 9.2 15.3 6.5 12.4 15.7 15.3 14.7 16.3 15.3 25.6 21.5 16.0 9.9 11.5 13.5 9.9 14.2 11.3 10.3 32.3 28.4 12.7 8.0 16.2 9.4 11.5 18.5 19.4 34.2 10.8 15.3 11.1 17.9 13.2 12.2 16.3 12.5 11.6 17.9 11.8 13.9 12.8 13.9 9.2 14.8 14.6 16.7 10.9 11.5 10.3 11.6 9.6 10.4 24.2 11.3 12.8 23.1 8.7 6.3 7.4 3.4 4.5 8.8 13.7 10.0 6.6 8.8 6.6 7.8 9.4 6.7 2.0 5.3 6.9 8.2 9.3 13.5 9.4 9.3 11.4 4.0 11.8 7.0 7.9 9.6 8.1 3.7 7.1 17.3 7.0 17.5 7.6 13.3 4.9 11.8 11.5 7.1 6.8 5.9 6.5 1.4 19.3 7.1 7.2 4.2 30.6 12.2 6.0 4.1 2.7 7.3 15.2 12.4 7.1 7.5 7.9 7.2 6.4 4.4 26.3 6.2 9.5 32.7 3.9 10.0 31.1 8.8 24.2 10.6 18.6 12.8 11.3 13.6 9.6 13.1 12.6 10.4 6.7 10.5 10.7 5.4 12.8 10.8 9.2 23.1 8.7 10.2 15.3 15.7 15.3 11.3 10.3 16.2 9.4 15.3 14.8 3.0 9.3 11.5 12.7 4.9 12.6 1.1 30.6 30.8 9.1 5.2 35.3 12.4 24.9 15.8 5.0 7.1 15.5 23.3 11.4 23.6 8.9 10.4 2.3 24.2 17.8 14.3 8.6 22.7 14.6 3.1 10.6 11.0 13.5 13.6 22.6 10.3 11.8 17.0 10.6 37.9 24.8 0.0 7.5 19.1 5.4 5.5 21.5 10.8 15.8 9.5 GALM ENSG00000143891 "Galactose mutarotase" Q96C23 2 38665910-38741237 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 54.2" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 102.0;Proximal tubular cells: 198.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 29.7" "Group enriched" "Detected in all" 5 "granulocytes: 13.2;T-cells: 29.7" "Cell line enhanced" "Detected in many" "Karpas-707: 27.8;U-266/70: 31.3" "Low region specificity" "Detected in all" "HPA035472, HPA035473, HPA064835" Enhanced Approved Nucleoplasm NA NA 570000 Nucleoplasm "HPA035472: AB_10669906, HPA035473: AB_2674642, HPA064835: AB_2732723" "unprognostic (5.02e-2)" "unprognostic (1.10e-1)" "unprognostic (2.67e-1)" "unprognostic (9.20e-2)" "unprognostic (1.88e-2)" "unprognostic (9.99e-3)" "unprognostic (1.63e-2)" "unprognostic (2.80e-3)" "unprognostic (1.87e-1)" "unprognostic (7.17e-2)" "unprognostic (6.65e-2)" "unprognostic (6.45e-2)" "prognostic favorable (9.06e-5)" "unprognostic (1.70e-2)" "unprognostic (1.62e-1)" "unprognostic (4.34e-1)" "prognostic favorable (1.32e-4)" 11.2 54.2 3.1 10.4 2.5 0.7 4.6 1.9 2.7 5.9 28.4 2.5 44.3 22.7 6.8 11.8 3.4 11.6 13.3 7.7 2.5 1.8 39.1 28.8 5.8 6.4 2.4 1.9 6.4 7.9 10.4 2.4 3.1 2.9 8.1 10.7 15.3 7.9 29.1 4.6 2.2 39.8 5.4 3.3 4.1 5.0 4.7 2.1 6.4 7.4 3.3 9.3 6.5 5.2 2.8 4.5 13.2 2.1 2.3 29.7 5.3 0.0 10.6 3.3 0.0 11.1 6.5 5.9 1.3 4.0 3.0 4.9 11.9 5.6 4.1 7.9 5.9 6.0 1.7 4.6 0.3 6.0 18.7 7.7 2.2 2.9 23.7 4.0 0.9 0.1 4.5 0.1 6.8 0.0 4.2 3.4 0.0 6.3 27.8 5.5 0.3 9.1 14.8 5.0 22.6 3.5 5.7 0.2 8.0 3.9 18.4 0.6 4.7 0.0 7.6 5.4 4.4 3.6 2.1 1.3 1.0 0.2 7.3 0.4 31.3 21.1 0.1 6.9 2.6 0.1 13.2 2.1 1.8 10.2 1.5 15.0 2.8 16.0 14.8 4.5 2.5 5.8 5.0 5.1 2.3 0.2 0.4 29.7 5.3 3.1 2.5 1.9 2.7 2.5 1.8 2.4 1.9 2.9 2.1 26.8 11.2 12.5 6.5 6.0 2.9 17.3 22.9 24.1 9.1 66.3 0.0 17.0 21.6 9.1 0.8 9.3 102.0 0.0 13.3 25.1 14.3 6.4 6.9 40.4 91.8 3.2 12.7 6.2 12.3 0.5 18.7 36.1 16.9 12.6 36.5 34.6 10.1 63.0 91.9 198.6 7.1 6.5 9.6 1.0 2.1 5.3 5.3 24.5 72.8 4.7 GALNT10 GalNAc-T10 ENSG00000164574 "Polypeptide N-acetylgalactosaminyltransferase 10" Q86SR1 5 154190730-154420984 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 43.7" "Cell type enhanced" "Detected in many" 4 "Peritubular cells: 47.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 74.0;TIME: 40.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007525 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA 830000 "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA007525: AB_1849443" "unprognostic (6.99e-2)" "unprognostic (4.33e-2)" "unprognostic (9.85e-2)" "prognostic favorable (3.33e-6)" "unprognostic (1.63e-1)" "unprognostic (6.98e-2)" "unprognostic (6.95e-3)" "unprognostic (2.38e-1)" "unprognostic (3.34e-1)" "prognostic unfavorable (5.69e-4)" "unprognostic (2.88e-3)" "unprognostic (2.63e-1)" "unprognostic (1.54e-1)" "unprognostic (7.76e-3)" "unprognostic (1.22e-1)" "unprognostic (1.61e-2)" "unprognostic (3.08e-1)" 9.5 13.5 8.4 15.4 9.1 10.1 8.7 3.2 6.2 15.9 10.6 14.4 1.0 8.8 4.9 11.5 5.9 9.2 17.8 7.7 6.9 7.5 6.8 3.4 10.1 11.5 7.2 5.2 43.7 9.2 14.1 9.7 5.2 10.1 8.3 9.4 31.6 11.6 2.4 5.6 4.0 12.4 14.1 7.7 16.7 13.8 4.3 9.2 5.6 10.6 4.2 9.3 7.5 10.0 4.7 3.1 5.7 3.8 3.9 7.5 2.1 6.2 21.4 5.2 4.5 11.1 9.9 4.0 18.1 10.1 7.2 6.9 3.0 14.4 4.1 12.8 30.4 12.9 1.1 2.4 14.1 6.6 10.6 1.7 11.2 4.1 4.0 8.5 2.4 10.9 12.3 3.3 5.8 8.6 74.0 13.8 3.1 2.5 13.0 12.3 6.5 0.2 1.6 2.0 17.6 4.4 1.2 2.7 4.1 10.0 4.3 0.7 1.7 8.0 30.0 2.3 8.0 11.6 1.8 40.5 17.6 4.2 4.3 19.2 3.7 3.6 2.2 11.5 4.8 5.3 3.4 2.7 5.3 7.5 3.6 6.6 4.5 4.3 4.8 3.1 4.7 1.9 5.3 5.7 3.9 3.8 2.7 3.5 2.1 8.4 9.1 3.2 6.2 6.9 7.5 7.2 5.2 10.1 9.2 8.9 36.1 12.3 3.5 4.2 3.5 4.1 5.1 0.0 12.5 14.0 3.9 0.6 8.3 9.3 10.6 13.4 15.5 23.3 26.2 1.2 9.1 9.9 10.3 4.7 7.2 0.0 2.9 19.0 15.4 16.0 35.4 9.7 0.0 6.4 16.1 20.8 26.5 11.5 47.0 2.9 11.4 6.5 7.3 1.7 3.1 3.1 0.7 13.8 9.3 2.8 GALNT14 "FLJ12691, GalNac-T10, GalNac-T14" ENSG00000158089 "Polypeptide N-acetylgalactosaminyltransferase 14" Q96FL9 2 30910467-31155202 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "kidney: 42.7" "Cell type enhanced" "Detected in some" 18 "Distal tubular cells: 11.6;Ito cells: 11.1;Proximal tubular cells: 39.7" "Cancer enriched" "Detected in many" 7 "renal cancer: 45.9" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "neutrophil: 10.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 10.6" "Cell line enhanced" "Detected in many" "A549: 13.1;RPMI-8226: 15.2;RPTEC TERT1: 22.4;RT4: 16.6;SCLC-21H: 12.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030138 Approved "Nucleoplasm,Golgi apparatus" NA NA 9400 "Golgi apparatus" Nucleoplasm "HPA030138: AB_2673332" "unprognostic (5.69e-2)" "unprognostic (1.35e-1)" "unprognostic (2.05e-2)" "unprognostic (2.82e-3)" "unprognostic (3.85e-2)" "unprognostic (2.10e-2)" "unprognostic (3.32e-1)" "unprognostic (7.58e-2)" "unprognostic (1.96e-1)" "unprognostic (2.80e-1)" "unprognostic (1.22e-3)" "unprognostic (1.12e-1)" "unprognostic (3.18e-3)" "unprognostic (5.18e-3)" "unprognostic (2.67e-2)" "unprognostic (2.56e-1)" "unprognostic (9.51e-3)" 1.2 1.5 1.5 0.9 3.7 4.3 1.1 1.8 9.6 1.4 0.6 1.8 0.3 0.6 0.6 1.0 10.2 1.1 3.7 0.4 1.6 1.5 42.7 1.2 0.6 2.6 1.2 2.3 0.9 2.7 7.6 5.7 0.2 0.9 1.7 0.2 2.1 1.7 0.2 0.4 1.9 3.1 0.7 0.8 1.8 0.6 1.6 0.3 0.1 1.1 1.0 4.2 2.0 1.4 1.4 0.0 10.6 0.0 0.0 0.0 0.1 11.1 13.1 0.0 0.0 0.0 0.0 0.0 3.7 2.0 2.5 0.3 0.0 0.0 10.4 3.8 0.2 0.0 0.0 0.4 0.5 0.4 0.3 1.3 5.8 0.0 0.0 0.0 8.4 0.0 0.1 2.3 0.0 8.6 0.1 0.0 0.3 0.0 9.3 0.0 5.1 0.0 0.0 6.2 0.0 0.0 7.3 0.0 15.2 22.4 16.6 12.3 8.9 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 9.8 0.0 0.2 0.9 2.8 0.0 0.0 5.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.1 1.5 3.7 1.8 9.6 1.6 1.5 1.2 2.3 0.9 0.3 0.0 0.0 0.8 3.8 2.5 0.2 0.4 0.0 0.0 1.2 8.7 0.0 0.0 11.6 2.5 5.3 0.6 0.4 0.0 0.3 0.0 0.2 0.8 0.0 0.0 0.1 0.0 0.0 11.1 0.6 5.8 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.0 39.7 0.3 6.5 0.8 0.4 3.4 0.6 0.0 0.0 0.0 1.0 GALNT17 "GalNAc-T17, GalNAc-T19, GalNAc-T5L, GALNTL3, ppGalNAc-T17, WBSCR17" ENSG00000185274 "Polypeptide N-acetylgalactosaminyltransferase 17" Q6IS24 7 71132169-71713600 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.9" "Cell type enhanced" "Detected in single" 28 "Collecting duct cells: 1.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.6;NTERA-2: 7.2;RPMI-8226: 8.0;SK-BR-3: 30.5;SuSa: 10.0" "Low region specificity" "Detected in all" "HPA013624, HPA047986" Approved Uncertain "Nucleoplasm,Nucleoli,Nuclear bodies,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "Nucleoli, Nuclear bodies" "HPA013624: AB_1858787, HPA047986: " "unprognostic (2.79e-2)" "unprognostic (6.83e-2)" "unprognostic (5.54e-2)" "unprognostic (3.66e-3)" "unprognostic (1.50e-1)" "unprognostic (2.62e-1)" "unprognostic (6.41e-2)" "unprognostic (5.18e-2)" "unprognostic (1.00e-1)" "prognostic favorable (4.60e-4)" "unprognostic (2.00e-1)" "unprognostic (4.73e-1)" "unprognostic (1.96e-2)" "unprognostic (9.63e-3)" "prognostic favorable (3.91e-4)" "unprognostic (1.92e-1)" "unprognostic (7.94e-3)" 1.8 7.8 8.2 2.1 13.9 0.5 1.2 25.7 42.9 2.3 4.9 1.7 1.9 0.8 7.9 4.6 8.9 4.4 2.7 19.4 13.2 4.6 2.3 0.6 3.5 0.5 2.1 12.0 22.3 9.4 0.6 4.1 0.7 4.5 9.1 1.4 1.2 1.7 8.3 1.9 0.8 1.5 12.3 1.2 3.3 1.1 3.8 0.8 0.3 9.4 0.0 1.8 10.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.5 0.0 0.0 30.5 0.0 10.0 0.0 0.0 0.0 0.0 2.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 13.9 25.7 22.5 13.2 4.6 2.1 12.0 4.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GALNT6 GalNAc-T6 ENSG00000139629 "Polypeptide N-acetylgalactosaminyltransferase 6" Q8NCL4 12 51351247-51392867 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 35.4" "Cell type enriched" "Detected in many" 4 "granulocytes: 164.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 23.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 33.6;CACO-2: 33.2;OE19: 28.5;SK-BR-3: 33.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA011762, HPA017086" Enhanced Approved "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA 2900000 "Nucleoplasm, Golgi apparatus" "HPA011762: AB_1849450, HPA017086: AB_1849452" "unprognostic (2.03e-1)" "unprognostic (6.65e-2)" "unprognostic (2.26e-2)" "prognostic favorable (9.85e-4)" "unprognostic (1.35e-2)" "unprognostic (1.18e-1)" "unprognostic (7.15e-3)" "unprognostic (2.05e-1)" "unprognostic (2.27e-2)" "prognostic favorable (5.40e-4)" "unprognostic (1.88e-2)" "unprognostic (5.25e-2)" "unprognostic (7.13e-4)" "unprognostic (5.65e-3)" "unprognostic (3.18e-1)" "unprognostic (2.16e-2)" "unprognostic (1.18e-2)" 3.1 1.8 4.0 4.1 9.5 4.4 10.6 1.0 5.1 19.5 13.4 15.4 0.5 11.8 0.9 14.4 2.8 3.7 6.8 0.8 7.1 3.6 2.5 0.8 4.1 4.0 14.4 3.6 1.4 6.3 0.4 1.6 9.9 5.8 1.3 3.9 0.9 23.8 6.3 0.6 5.5 16.9 0.8 8.3 5.5 35.4 0.8 9.7 6.6 1.8 2.3 6.6 2.2 2.2 2.9 3.7 23.8 6.5 10.8 3.4 2.8 11.5 1.2 0.2 0.0 0.0 0.1 18.5 19.3 33.6 8.3 5.6 33.2 6.1 0.1 1.8 10.9 0.0 11.1 0.6 8.4 5.2 2.6 1.2 7.3 0.2 0.2 0.3 3.9 26.1 0.7 7.8 7.4 7.1 0.0 20.3 4.2 1.6 0.3 0.0 22.6 12.4 2.9 1.6 28.5 20.9 0.0 0.0 3.3 6.5 0.8 0.1 7.4 0.1 33.8 0.0 3.9 18.8 1.7 23.9 0.0 4.2 0.0 0.0 0.6 0.1 1.0 2.3 8.7 0.1 4.5 4.4 23.8 3.4 3.7 1.4 0.8 1.7 2.6 3.7 2.9 2.7 2.3 0.8 10.8 6.5 3.1 1.1 2.8 4.0 9.5 1.0 5.1 7.1 3.6 14.4 3.6 5.8 9.7 3.0 3.7 15.2 2.7 2.6 0.4 0.8 2.5 10.7 14.8 1.8 0.0 11.3 3.3 2.7 1.6 1.4 20.4 0.0 9.8 40.7 1.7 5.0 164.7 0.0 13.2 0.0 0.0 2.5 12.0 1.0 0.0 11.8 1.7 1.0 14.2 0.0 15.6 26.2 0.4 1.8 0.0 0.0 0.9 0.2 1.2 8.2 4.0 8.7 9.2 5.4 GALNT7 GALNAC-T7 ENSG00000109586 "Polypeptide N-acetylgalactosaminyltransferase 7" Q86SF2 4 173168753-173323967 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 67.4" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 70.2;Glandular cells: 85.7;Mucus-secreting cells: 125.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064243, HPA065317" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA 5000000 "Golgi apparatus" Nucleoplasm "HPA064243: AB_2685223, HPA065317: AB_2685465" "unprognostic (1.81e-1)" "unprognostic (2.11e-1)" "prognostic favorable (4.53e-4)" "unprognostic (1.37e-3)" "unprognostic (1.48e-1)" "unprognostic (6.86e-3)" "unprognostic (2.72e-2)" "unprognostic (1.77e-1)" "unprognostic (2.85e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (7.65e-4)" "unprognostic (1.33e-1)" "unprognostic (4.66e-3)" "unprognostic (3.05e-1)" "unprognostic (3.19e-1)" "unprognostic (2.34e-3)" "unprognostic (5.97e-2)" 3.7 4.4 8.4 7.4 8.4 5.0 12.0 27.6 8.0 13.4 23.3 9.4 2.8 14.1 9.3 5.5 12.0 4.9 9.5 3.5 6.5 5.2 4.9 1.2 4.5 5.2 10.8 7.0 7.2 14.9 5.3 5.6 6.3 11.2 20.3 26.7 6.2 20.1 4.2 1.4 3.1 16.2 8.4 16.3 5.7 32.8 6.4 8.8 67.4 6.6 4.4 9.6 9.4 4.8 5.0 9.8 16.8 11.4 5.5 6.8 4.7 20.4 10.7 10.6 3.3 5.7 8.4 15.2 5.4 6.1 5.1 7.0 3.3 32.5 11.4 4.0 4.8 13.7 17.5 4.4 9.5 6.9 44.2 8.7 13.9 22.3 0.1 3.8 20.4 9.9 5.4 8.6 11.3 5.7 19.3 33.5 8.3 9.2 17.8 25.7 6.7 15.0 11.3 10.4 20.4 7.1 15.0 9.8 2.9 37.2 9.6 8.5 6.5 2.5 15.0 7.4 14.4 6.0 6.1 40.0 3.6 16.2 0.1 11.6 5.2 0.0 6.1 14.8 12.3 13.0 9.6 11.4 14.6 4.3 6.0 6.2 5.0 4.9 4.6 9.8 3.1 3.9 3.0 16.8 5.5 6.1 4.1 6.8 4.7 8.4 8.4 27.6 8.0 6.5 5.2 10.8 7.0 11.2 8.8 6.0 29.4 4.7 7.8 1.5 36.4 5.9 12.7 14.7 30.7 19.2 2.0 0.9 0.0 12.2 1.8 6.9 70.2 0.0 43.4 2.9 6.6 85.7 23.1 0.0 9.6 9.5 21.9 8.0 21.3 3.1 8.6 8.8 8.5 8.2 125.7 7.5 33.8 50.7 4.9 8.6 23.6 12.9 6.8 2.3 4.4 1.0 0.7 4.4 37.4 15.7 GALR1 "GALNR, GALNR1" ENSG00000166573 "Galanin receptor 1" P47211 18 77250549-77277896 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 5.3;brain: 3.5;pituitary gland: 4.9" "Group enriched" "Detected in some" 6 "Ciliated cells: 21.4;Early spermatids: 46.5;Intestinal endocrine cells: 16.9" "Cancer enriched" "Detected in single" 6 "glioma: 1.0" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" "Region enhanced" "Detected in some" "hypothalamus: 6.1" "Low region specificity" "Detected in many" HPA074584 Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA074584: " "unprognostic (1.65e-1)" "unprognostic (1.56e-2)" "unprognostic (2.85e-1)" "unprognostic (3.00e-1)" "unprognostic (2.11e-1)" "unprognostic (2.77e-3)" "unprognostic (1.31e-2)" "unprognostic (5.34e-3)" "unprognostic (7.33e-3)" "unprognostic (9.49e-2)" "unprognostic (2.18e-1)" 1.1 5.3 1.2 0.3 0.8 0.7 0.5 0.0 3.5 0.0 0.3 0.4 0.2 0.5 0.0 0.3 0.1 0.1 0.7 2.0 0.1 0.5 0.0 0.1 0.8 0.1 0.5 0.0 4.9 0.0 0.8 0.5 0.5 0.7 0.1 0.4 0.5 0.1 0.9 0.0 0.3 0.4 0.3 0.0 0.0 0.1 0.4 0.4 1.6 0.2 0.5 0.3 0.0 0.3 0.4 0.6 0.8 0.5 1.2 0.6 0.2 0.5 0.1 0.1 0.8 1.1 0.8 0.2 0.4 0.2 0.4 0.4 0.3 0.1 1.1 0.6 1.1 0.8 0.5 0.3 0.5 0.8 0.8 0.4 0.3 0.3 0.5 0.3 0.5 0.4 1.6 0.1 0.9 0.4 0.9 0.6 0.1 0.5 0.5 0.4 0.4 0.2 0.6 1.5 0.5 0.2 0.4 0.4 0.9 0.5 0.4 0.6 0.6 0.7 1.1 0.1 0.6 0.3 0.4 0.8 0.3 0.4 1.0 0.2 0.3 0.3 0.2 0.3 0.3 0.3 0.2 0.1 0.4 0.2 0.2 1.6 0.5 0.2 0.4 0.1 0.0 0.0 5.1 0.0 0.7 0.0 1.8 0.4 0.0 21.4 1.2 1.8 0.0 0.0 0.0 0.0 46.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.0 0.1 0.0 16.9 0.0 0.0 3.6 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.0 GAPDHS "GAPD2, GAPDH-2, GAPDS" ENSG00000105679 "Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic" O14556 19 35533412-35545316 "Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "testis: 154.6" "Cell type enriched" "Detected in some" 4 "Late spermatids: 6946.0" "Cancer enriched" "Detected in single" 97 "melanoma: 13.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 16.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042666 Enhanced Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA042666: AB_2678104" "unprognostic (3.74e-1)" "unprognostic (1.59e-1)" "unprognostic (7.41e-2)" "unprognostic (1.56e-1)" "unprognostic (2.06e-1)" "unprognostic (1.04e-1)" "unprognostic (8.81e-2)" "unprognostic (2.96e-1)" "unprognostic (1.03e-1)" "unprognostic (6.45e-3)" "unprognostic (2.37e-1)" 0.3 0.5 0.3 0.8 0.3 0.2 0.3 0.3 0.4 0.3 0.3 0.3 0.3 0.6 0.5 1.6 0.6 0.2 0.8 0.8 0.3 0.3 0.3 0.3 0.3 1.6 0.3 0.3 0.7 1.3 0.0 0.3 0.3 0.3 0.3 0.0 4.2 1.3 0.3 0.3 4.4 0.6 0.3 0.3 1.2 0.4 154.6 0.3 0.3 3.6 0.3 0.3 0.6 0.3 2.1 1.0 1.2 0.8 1.4 2.0 0.8 4.5 16.5 4.6 6.9 0.0 0.0 3.9 1.3 0.0 0.0 0.0 10.0 7.6 7.5 2.2 0.0 1.9 5.5 0.0 0.0 0.0 7.3 8.0 5.0 10.5 5.1 0.1 4.5 6.0 0.0 0.0 0.0 0.0 2.9 0.0 7.3 12.0 4.4 0.0 14.1 1.7 2.1 6.2 2.9 2.2 5.3 3.2 5.8 0.0 4.5 8.3 3.7 1.7 4.2 4.9 3.3 3.4 1.9 1.5 5.3 6.0 1.3 1.9 12.3 3.3 4.4 2.9 8.1 1.9 0.0 0.8 1.2 1.1 0.6 2.0 1.1 0.4 1.9 1.0 2.1 1.1 1.2 0.0 1.4 0.3 0.8 0.3 0.8 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1712.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 6946.0 23.0 0.0 42.2 0.0 0.0 0.0 0.0 0.0 26.9 0.0 0.0 25.8 0.2 30.4 13.5 0.1 0.0 0.0 0.0 0.0 GAR1 NOLA1 ENSG00000109534 "GAR1 ribonucleoprotein" Q9NY12 4 109815510-109824740 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059098 Supported Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA059098: AB_2683904" "unprognostic (9.72e-2)" "unprognostic (6.94e-2)" "unprognostic (3.04e-2)" "unprognostic (4.47e-2)" "unprognostic (2.40e-1)" "unprognostic (1.24e-2)" "prognostic unfavorable (2.64e-5)" "unprognostic (1.01e-2)" "unprognostic (1.73e-1)" "unprognostic (4.17e-3)" "unprognostic (2.14e-2)" "unprognostic (2.45e-3)" "unprognostic (1.17e-1)" "unprognostic (5.11e-2)" "unprognostic (1.11e-1)" "unprognostic (6.49e-2)" "unprognostic (1.08e-3)" 16.6 18.9 15.2 19.5 19.9 34.7 22.4 11.0 16.5 14.6 20.9 12.4 15.5 17.0 24.3 14.8 26.6 17.2 17.8 11.6 14.2 13.3 15.6 20.0 13.7 17.2 15.5 17.1 20.2 24.1 15.7 19.1 24.8 13.8 17.3 21.0 14.5 23.3 17.5 13.8 25.4 16.3 19.0 18.1 18.8 15.1 27.7 16.3 29.5 17.3 27.6 22.4 15.5 15.5 11.3 9.3 7.4 9.3 9.5 10.7 4.3 15.9 18.5 12.7 17.2 6.8 9.7 11.0 16.6 9.0 13.7 11.1 28.8 20.2 38.8 10.9 12.5 14.6 7.6 23.3 16.5 22.8 11.5 22.9 23.2 16.7 31.5 16.5 49.5 12.2 8.8 17.3 16.9 12.1 9.6 16.6 17.9 55.2 11.9 16.8 34.0 30.6 34.2 20.7 25.2 22.4 20.7 20.8 14.4 18.0 22.4 18.7 19.2 10.4 27.2 14.7 10.1 9.6 14.8 14.4 13.7 19.2 10.1 21.1 15.1 24.5 48.0 9.8 24.3 14.8 7.4 5.9 3.3 9.7 9.3 10.3 11.3 9.2 9.8 9.3 10.0 10.7 9.9 1.0 9.5 8.0 9.2 9.6 4.3 15.2 19.9 11.0 16.5 14.2 13.3 15.5 17.1 13.8 16.3 3.0 13.4 29.0 25.3 51.4 11.1 12.3 15.3 34.8 30.7 15.7 13.7 56.9 21.6 40.4 1.1 23.2 12.3 46.7 46.3 54.6 20.3 18.3 18.5 18.7 31.5 4.8 17.9 17.8 12.3 3.6 20.4 16.5 16.9 10.8 34.7 25.7 41.7 24.6 17.7 33.6 8.6 6.5 18.6 42.1 37.3 52.4 73.5 17.0 40.4 30.3 GAREM1 "C18orf11, FAM59A, FLJ21610, GAREM" ENSG00000141441 "GRB2 associated regulator of MAPK1 subtype 1" Q9H706 18 32124877-32470484 "Predicted intracellular proteins" Mitogen "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 43.5" "Cell type enhanced" "Detected in many" 6 "Glandular cells: 48.3;Urothelial cells: 68.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 5.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 12.2;hTERT-HME1: 21.2;RT4: 18.0;SH-SY5Y: 14.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040709, HPA042046" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA040709: AB_2677090, HPA042046: AB_2677818" "unprognostic (9.52e-2)" "unprognostic (4.13e-3)" "unprognostic (2.67e-2)" "unprognostic (3.32e-3)" "unprognostic (3.62e-1)" "unprognostic (5.53e-3)" "unprognostic (1.87e-2)" "unprognostic (1.93e-1)" "unprognostic (1.66e-1)" "unprognostic (5.59e-2)" "prognostic unfavorable (6.73e-5)" "unprognostic (1.45e-1)" "prognostic favorable (5.49e-6)" "unprognostic (2.36e-1)" "unprognostic (2.56e-3)" "unprognostic (4.99e-2)" "unprognostic (4.65e-2)" 11.1 8.7 9.7 2.9 10.9 8.0 6.0 17.6 11.1 6.0 7.2 19.5 0.3 6.5 4.2 3.4 11.0 4.8 4.9 8.9 11.8 5.8 15.3 12.5 5.2 1.3 16.3 10.1 4.4 43.5 1.9 5.1 4.8 13.2 4.3 6.3 3.0 11.2 5.1 7.7 13.9 7.8 4.6 12.9 3.1 12.7 6.7 16.4 0.0 3.5 3.1 2.9 9.3 9.1 1.9 5.0 2.6 1.0 3.1 1.4 0.0 1.0 1.6 1.7 0.3 4.7 3.3 4.8 0.3 0.0 0.0 0.0 0.3 2.6 3.0 2.5 0.2 2.0 3.4 2.6 5.0 0.0 1.0 1.6 0.0 3.0 1.0 2.4 0.3 0.2 3.9 12.2 0.2 21.2 0.2 0.2 1.8 0.1 0.6 1.8 2.5 0.8 0.1 1.9 7.9 0.9 1.2 6.9 5.3 6.1 18.0 5.7 14.9 3.9 5.1 0.2 2.2 1.0 2.6 0.2 1.2 1.4 0.0 0.5 2.1 0.2 0.7 1.9 0.0 1.4 0.0 1.0 0.2 0.5 0.1 0.2 0.3 0.8 0.5 0.1 1.9 1.0 1.4 2.6 3.1 0.1 5.0 0.1 0.0 9.7 10.9 17.6 11.1 11.8 5.8 16.3 10.1 13.2 16.4 8.9 35.2 0.0 30.5 0.0 31.8 0.0 7.6 8.1 15.9 24.4 3.9 15.6 1.7 9.4 10.1 0.0 6.3 0.0 11.4 2.0 0.3 48.3 3.5 7.7 1.6 39.7 3.5 0.6 3.7 2.5 1.7 0.9 0.0 1.0 10.2 41.9 10.3 7.0 4.9 20.9 7.0 0.0 0.0 1.4 2.5 0.0 28.0 0.0 8.3 68.5 GARNL3 "bA356B19.1, DKFZp761J1523" ENSG00000136895 "GTPase activating Rap/RanGAP domain like 3" Q5VVW2 9 127224265-127393660 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.3" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 11.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.8" "Group enriched" "Detected in many" 4 "dendritic cells: 3.8;T-cells: 1.3" "Cell line enhanced" "Detected in many" "OE19: 7.8;RPMI-8226: 5.6;SH-SY5Y: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028757, HPA074886" Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA028757: AB_2294383, HPA074886: AB_2732270" "unprognostic (3.15e-2)" "unprognostic (7.19e-2)" "unprognostic (2.25e-2)" "unprognostic (3.40e-2)" "unprognostic (3.12e-2)" "unprognostic (1.19e-3)" "unprognostic (5.58e-3)" "unprognostic (3.00e-2)" "unprognostic (1.97e-1)" "unprognostic (4.24e-3)" "unprognostic (6.88e-4)" "unprognostic (2.22e-1)" "unprognostic (3.23e-7)" "unprognostic (6.39e-2)" "unprognostic (6.60e-2)" "unprognostic (7.04e-3)" "unprognostic (1.78e-5)" 4.2 8.4 11.4 2.5 13.5 0.4 6.4 33.3 19.6 9.1 3.6 12.9 3.8 3.0 10.6 6.6 7.0 8.5 5.8 16.3 7.5 9.6 3.4 3.0 3.8 2.0 7.8 10.7 6.6 3.5 15.7 3.1 2.3 12.9 9.0 3.1 4.3 7.0 6.4 2.2 4.3 2.7 10.1 7.2 2.4 2.9 4.0 9.4 0.0 8.6 1.5 2.1 7.9 4.8 0.5 3.8 0.0 0.5 0.0 1.3 0.2 0.8 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.5 0.3 1.7 1.8 0.6 0.0 1.6 0.1 0.6 0.9 3.2 0.0 0.3 0.0 1.3 0.0 2.7 1.8 0.8 0.7 0.3 0.1 2.5 0.0 0.0 2.3 1.2 2.8 1.3 1.0 0.1 0.9 0.0 0.6 0.7 7.8 2.6 0.1 1.9 5.6 3.0 3.9 2.0 6.1 1.3 4.4 0.5 1.0 1.5 0.0 0.0 0.3 1.8 0.0 0.6 3.9 3.7 1.9 0.8 0.9 0.8 0.0 0.5 0.0 1.2 0.1 0.3 0.2 0.1 1.3 0.5 0.5 0.8 0.0 0.0 0.0 0.0 3.8 0.6 0.2 11.4 13.5 33.3 19.6 7.5 9.6 7.8 10.7 12.9 9.4 0.0 0.0 0.0 1.8 2.4 11.8 6.2 5.1 0.0 3.4 3.5 0.0 0.5 1.7 0.3 1.4 1.0 0.5 0.0 0.6 0.1 3.7 3.3 0.0 1.8 0.7 1.6 1.2 1.3 1.8 0.4 6.9 0.6 1.7 0.0 0.9 5.7 0.6 0.9 3.2 1.1 0.9 0.0 1.7 1.4 3.9 1.8 0.2 0.0 0.8 0.8 GAS2 ENSG00000148935 "Growth arrest specific 2" O43903 11 22625642-22813055 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell shape, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 37.2;lymphoid tissue: 19.6;pancreas: 22.7" "Cell type enhanced" "Detected in some" 15 "Cardiomyocytes: 10.9;Cholangiocytes: 10.2;Ciliated cells: 6.7;Hepatocytes: 20.2" "Cancer enhanced" "Detected in many" "liver cancer: 4.0" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 9 "Hep G2: 19.9;JURKAT: 11.3;Karpas-707: 40.7;SCLC-21H: 11.9;U-266/84: 13.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058904 Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" Yes NA "Plasma membrane, Cytosol" "Nucleoplasm, Nucleoli" "HPA058904: AB_2683850" "unprognostic (5.48e-3)" "unprognostic (1.00e-1)" "unprognostic (6.85e-2)" "unprognostic (1.16e-2)" "unprognostic (7.87e-2)" "unprognostic (2.08e-2)" "unprognostic (1.08e-1)" "unprognostic (1.49e-1)" "unprognostic (1.23e-1)" "unprognostic (3.71e-2)" "unprognostic (1.70e-2)" "unprognostic (3.30e-5)" "prognostic favorable (6.13e-4)" "unprognostic (5.85e-2)" "unprognostic (4.22e-2)" "unprognostic (7.94e-2)" "unprognostic (3.58e-2)" 0.7 1.1 2.1 1.1 3.6 0.4 0.9 0.9 2.2 1.2 0.7 1.4 1.2 2.0 1.1 1.3 1.0 1.5 2.7 3.6 2.1 2.5 5.3 37.2 1.3 1.1 4.3 1.2 2.3 22.7 0.5 4.8 0.7 4.5 1.3 0.7 0.5 2.2 0.9 4.8 1.0 1.8 0.6 8.6 1.5 2.6 1.1 3.2 19.6 1.1 3.0 1.0 1.8 0.7 1.0 0.6 0.3 0.0 0.1 1.7 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.2 0.1 0.0 19.9 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 11.3 0.7 40.7 0.0 0.1 0.1 0.0 0.1 1.1 0.0 0.4 0.2 2.0 0.0 0.5 11.9 0.6 0.0 0.0 0.2 0.1 0.0 0.0 0.8 0.0 0.2 0.5 0.0 0.5 13.5 0.0 0.2 0.0 0.2 0.0 0.0 0.3 0.2 0.0 1.7 1.0 0.4 0.0 0.0 0.9 1.6 0.4 0.0 0.1 0.0 0.6 0.3 0.1 2.1 3.6 0.9 2.2 2.1 2.5 4.3 1.2 4.5 3.2 0.0 0.0 0.0 0.2 0.1 2.7 10.9 10.2 6.7 0.0 0.0 0.0 0.0 0.0 0.8 1.7 0.0 0.0 0.0 2.9 0.0 0.3 0.1 0.0 20.2 0.0 0.0 0.0 0.6 0.0 3.7 0.6 0.0 0.0 0.0 0.0 0.3 2.6 0.3 0.0 2.1 0.9 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.9 0.3 GATA1 "ERYF1, GATA-1, GF1, NF-E1, NFE1" ENSG00000102145 "GATA binding protein 1" P15976 X 48786554-48794311 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "blood: 78.3;bone marrow: 37.0" "Group enriched" "Detected in some" 10 "Early spermatids: 11.8;Erythroid cells: 23.3;granulocytes: 35.9;Late spermatids: 20.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 6 "eosinophil: 78.3" "Lineage enriched" "Detected in single" 784 "granulocytes: 78.3" "Group enriched" "Detected in some" 9 "HEL: 50.8;HMC-1: 52.4;K-562: 54.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA000232, HPA000233, CAB009195" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB009195: AB_2232148, HPA000232: AB_1078949, HPA000233: AB_1078951" "unprognostic (1.93e-1)" "unprognostic (7.54e-2)" "unprognostic (8.95e-3)" "unprognostic (3.84e-3)" "unprognostic (2.25e-1)" "unprognostic (3.00e-4)" "unprognostic (4.87e-2)" "unprognostic (3.48e-2)" "unprognostic (4.44e-2)" "unprognostic (1.95e-2)" "unprognostic (6.04e-2)" "unprognostic (7.71e-3)" "unprognostic (4.13e-2)" "unprognostic (2.24e-1)" "unprognostic (2.78e-1)" "unprognostic (9.10e-2)" "unprognostic (2.71e-2)" 0.7 0.2 0.1 2.4 0.7 37.0 0.3 0.0 0.3 0.7 0.3 0.0 0.0 0.6 4.9 2.4 0.4 0.3 0.6 2.3 0.1 0.3 0.4 0.8 5.6 0.2 0.6 0.0 0.1 0.1 0.1 0.5 2.8 0.3 1.4 0.4 1.6 0.3 0.2 0.1 0.6 0.8 2.4 0.3 4.9 0.5 3.1 0.0 1.5 0.6 1.1 0.6 0.9 0.6 0.0 0.0 78.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.8 0.0 0.0 0.0 0.0 52.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.0 0.1 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 78.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.1 0.7 0.0 0.3 0.1 0.3 0.6 0.0 0.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 23.3 0.0 0.7 0.0 0.0 35.9 0.0 0.5 0.0 0.0 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 GATA2 NFE1B ENSG00000179348 "GATA binding protein 2" P23769 3 128479427-128493185 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Phagocytosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 81.2;ductus deferens: 85.8;seminal vesicle: 209.1" "Group enriched" "Detected in many" 5 "Extravillous trophoblasts: 226.1;granulocytes: 616.3;Syncytiotrophoblasts: 268.8" "Cancer enhanced" "Detected in all" "prostate cancer: 36.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 339 "basophil: 81.2" "Lineage enriched" "Detected in single" 813 "granulocytes: 81.2" "Cell line enhanced" "Detected in many" "BEWO: 57.0;HEL: 70.3;HMC-1: 38.1;SH-SY5Y: 66.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA005633, CAB024847" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB024847: , HPA005633: AB_1078954" "unprognostic (1.71e-1)" "unprognostic (8.90e-2)" "unprognostic (1.12e-1)" "unprognostic (8.61e-2)" "unprognostic (8.67e-2)" "unprognostic (4.17e-2)" "unprognostic (5.96e-3)" "unprognostic (7.30e-2)" "unprognostic (3.98e-2)" "unprognostic (4.12e-2)" "unprognostic (3.58e-2)" "unprognostic (3.04e-1)" "prognostic favorable (2.04e-4)" "unprognostic (2.50e-1)" "unprognostic (8.07e-2)" "unprognostic (2.08e-1)" "prognostic favorable (5.22e-5)" 7.0 6.2 2.1 1.5 2.4 2.5 7.9 1.2 1.9 22.4 2.8 1.4 85.8 2.5 20.6 5.4 3.2 23.0 9.7 4.8 1.5 1.0 7.6 0.6 16.1 2.2 1.8 1.1 4.6 5.8 3.4 4.5 51.8 2.4 27.8 1.8 6.1 1.9 209.1 3.5 4.1 3.4 8.4 1.4 5.1 2.9 2.7 1.5 0.4 3.3 2.7 1.5 22.4 12.4 0.0 0.0 81.2 0.0 0.0 0.0 0.4 4.7 1.1 0.2 3.1 0.4 0.1 57.0 10.6 9.1 3.6 1.3 1.9 2.1 0.1 3.0 6.3 0.3 5.0 2.9 0.0 1.5 0.0 1.6 70.3 7.8 3.1 0.8 7.1 38.1 0.0 0.0 0.1 0.0 0.5 5.7 0.0 18.4 0.1 0.0 1.7 0.0 14.4 0.2 0.0 0.3 0.0 1.4 0.0 0.1 4.2 4.4 66.4 2.7 14.1 0.4 3.0 2.7 2.9 10.2 0.2 0.1 2.5 1.4 0.0 0.0 0.0 0.1 0.4 0.7 81.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.1 2.4 1.2 1.9 1.5 1.0 1.8 1.1 2.4 1.5 6.0 48.7 0.5 16.6 4.2 0.2 6.1 0.0 1.4 3.4 71.5 0.0 50.4 1.7 0.3 5.8 56.9 0.0 0.0 12.6 226.1 5.8 36.8 616.3 0.0 9.5 0.0 2.9 34.4 0.8 4.0 0.6 2.9 8.5 0.0 0.0 0.0 1.3 0.0 0.4 0.1 0.2 0.0 7.6 0.5 2.8 2.0 268.8 0.0 0.1 10.0 GATA3 HDR ENSG00000107485 "GATA binding protein 3" P23771 10 8045378-8075203 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 97.8;skin 1: 61.7" "Cell type enhanced" "Detected in many" 19 "Cytotrophoblasts: 243.8;Extravillous trophoblasts: 651.3;Syncytiotrophoblasts: 949.1" "Group enriched" "Detected in many" 24 "breast cancer: 190.0;urothelial cancer: 87.0" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 42 "gdT-cell: 9.7;MAIT T-cell: 13.3;memory CD4 T-cell: 18.2;memory CD8 T-cell: 14.1;naive CD4 T-cell: 10.0;naive CD8 T-cell: 9.0;NK-cell: 16.6;T-reg: 18.9" "Group enriched" "Detected in many" 54 "NK-cells: 16.6;T-cells: 18.9" "Cell line enhanced" "Detected in some" "BEWO: 33.3;MCF7: 79.6;RT4: 32.6;SH-SY5Y: 28.0;T-47d: 103.7" "Region enriched" "Detected in single" 6 "midbrain: 7.3" "Group enriched" "Detected in some" 38 "midbrain: 25.5;pons and medulla: 17.5;thalamus: 20.0" "CAB016217, HPA029730" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB016217: AB_2108591, HPA029730: AB_10601907" "unprognostic (1.70e-1)" "unprognostic (7.23e-2)" "unprognostic (3.58e-2)" "unprognostic (2.00e-1)" "unprognostic (7.03e-3)" "unprognostic (4.68e-3)" "unprognostic (4.23e-2)" "unprognostic (9.65e-2)" "unprognostic (2.06e-1)" "unprognostic (2.55e-1)" "unprognostic (3.83e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.13e-4)" "unprognostic (1.48e-1)" "unprognostic (5.16e-2)" "unprognostic (6.31e-2)" "unprognostic (1.82e-3)" 2.0 2.0 0.3 3.4 0.3 0.9 17.8 0.3 0.3 1.8 0.5 0.1 44.4 0.1 0.4 13.5 0.8 0.4 0.4 0.9 0.3 0.4 12.9 0.7 1.6 2.7 0.8 0.0 0.3 0.4 55.0 3.8 53.4 1.4 8.1 0.0 1.8 8.9 97.8 0.8 61.7 1.2 3.4 0.4 2.7 0.5 0.8 0.1 42.4 3.3 0.6 3.4 26.9 16.4 0.2 0.0 0.3 0.0 16.6 18.9 3.0 5.5 1.3 0.0 0.0 0.0 0.0 33.3 0.1 0.0 0.0 0.0 2.0 5.0 0.0 0.0 0.0 0.0 4.9 0.5 0.1 0.0 16.0 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.3 0.1 2.6 7.8 0.0 0.0 0.0 79.6 8.7 0.0 0.6 1.0 0.7 0.4 0.4 0.1 0.0 32.6 1.6 28.0 0.0 4.5 0.0 6.1 103.7 0.0 0.0 0.4 1.0 0.2 0.7 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 9.7 0.0 13.3 0.2 18.2 14.1 0.0 0.0 10.0 9.0 0.3 16.6 0.0 0.0 18.9 3.0 0.3 0.3 0.3 0.3 0.3 0.4 0.8 0.0 1.4 0.1 0.0 8.9 0.5 60.9 84.1 0.0 1.2 0.0 0.0 1.2 169.3 0.0 243.8 0.0 0.2 0.0 4.9 0.0 0.0 0.3 651.3 6.9 27.0 2.3 0.5 27.7 0.0 0.0 9.8 4.0 0.0 0.0 2.2 8.5 1.0 0.0 0.0 2.6 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.2 173.9 949.1 56.1 0.0 68.0 GATA5 "bB379O24.1, GATAS" ENSG00000130700 "GATA binding protein 5" Q9BWX5 20 62463497-62475970 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 22.1;intestine: 23.6" "Cell type enhanced" "Detected in some" 14 "Cardiomyocytes: 4.1;Fibroblasts: 1.8;Ito cells: 4.3;Late spermatids: 1.5" "Cancer enhanced" "Detected in many" "stomach cancer: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.6;HEL: 5.0;K-562: 7.9;SiHa: 3.5;T-47d: 8.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA067583 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA067583: AB_2685867" "unprognostic (2.21e-1)" "unprognostic (2.28e-1)" "unprognostic (1.79e-1)" "unprognostic (2.10e-2)" "unprognostic (2.66e-1)" "unprognostic (2.39e-1)" "unprognostic (2.62e-1)" "unprognostic (8.34e-2)" "unprognostic (1.69e-2)" "unprognostic (5.70e-2)" "unprognostic (1.27e-2)" "unprognostic (7.96e-3)" "unprognostic (2.00e-2)" "unprognostic (1.04e-1)" "unprognostic (2.36e-2)" "unprognostic (5.39e-3)" 1.9 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 4.4 15.9 0.0 5.2 14.8 3.8 1.7 0.3 9.1 22.1 6.8 0.0 0.0 3.3 0.7 1.6 0.0 0.0 0.0 3.1 0.0 0.3 0.6 0.6 0.0 11.3 0.0 1.0 0.4 0.8 0.1 0.3 23.6 18.3 0.2 0.1 10.3 16.8 0.0 0.0 1.2 0.0 0.0 14.1 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 2.6 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.3 5.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.6 3.5 0.0 0.0 1.6 8.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.2 1.8 0.0 0.0 0.0 0.3 0.0 0.0 4.3 0.0 1.5 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.7 0.1 0.0 0.0 0.0 0.0 GATA6 ENSG00000141448 "GATA binding protein 6" Q92908 18 22169443-22202528 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Atrial septal defect, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 77.2" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 78.9;Mucus-secreting cells: 48.1;Undifferentiated cells: 48.1" "Cancer enhanced" "Detected in many" "stomach cancer: 26.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "basophil: 5.7" "Lineage enriched" "Detected in single" 13 "granulocytes: 5.7" "Cell line enhanced" "Detected in many" "BEWO: 26.8;CACO-2: 32.6;hTERT-RPE1: 12.5;OE19: 17.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB011581, HPA066629" Approved Supported Nucleoplasm Yes No Nucleoplasm "CAB011581: AB_732529, HPA066629: AB_2685695" "unprognostic (1.90e-1)" "unprognostic (1.14e-1)" "unprognostic (1.11e-1)" "unprognostic (4.48e-2)" "unprognostic (1.51e-1)" "unprognostic (1.72e-2)" "unprognostic (2.16e-1)" "unprognostic (9.43e-2)" "unprognostic (4.36e-2)" "unprognostic (3.47e-1)" "unprognostic (2.61e-1)" "unprognostic (8.45e-3)" "prognostic unfavorable (1.92e-9)" "unprognostic (8.75e-3)" "unprognostic (2.07e-1)" "unprognostic (1.91e-1)" "unprognostic (2.12e-2)" 9.7 26.6 0.2 8.4 0.2 0.0 9.4 0.2 0.2 9.8 24.7 0.9 1.5 12.5 19.5 10.3 3.3 15.3 51.3 40.4 0.2 0.2 3.9 15.5 14.9 11.1 0.2 0.1 77.2 52.2 0.1 0.5 5.2 0.7 24.3 6.0 0.4 1.5 1.1 1.5 0.9 43.5 32.2 0.4 18.9 26.9 9.7 0.0 0.1 6.3 0.7 0.6 30.3 16.5 0.0 0.0 5.7 0.0 0.0 0.4 0.0 4.7 0.7 0.0 0.0 1.0 0.5 26.8 0.1 0.1 0.4 0.4 32.6 1.8 0.0 1.6 0.5 1.7 5.2 0.2 2.1 0.7 0.0 6.5 0.0 2.0 2.8 7.1 0.2 0.3 0.2 4.2 5.9 4.4 12.5 4.5 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 17.4 4.6 0.0 0.5 0.1 0.2 1.3 0.4 0.0 5.0 2.9 1.3 1.4 0.8 0.0 0.3 0.7 0.8 5.5 0.8 0.0 0.0 0.0 3.0 0.1 4.7 5.7 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.7 0.0 41.7 27.5 0.0 3.5 0.8 0.0 78.9 25.5 2.7 7.9 0.0 0.0 0.5 0.0 22.6 47.7 6.2 29.3 0.0 16.9 9.5 20.0 2.8 4.7 8.3 1.4 0.0 25.0 17.8 0.3 5.9 3.1 0.8 0.0 0.0 48.1 0.0 30.5 17.5 9.6 0.0 0.0 32.3 5.5 0.9 1.0 0.6 1.6 0.0 48.1 2.1 GATAD1 "FLJ22489, ODAG, RG083M05.2" ENSG00000157259 "GATA zinc finger domain containing 1" Q8WUU5 7 92447448-92459432 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 125.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006105, HPA072785" Enhanced Nucleoplasm Yes No Nucleoplasm "HPA006105: AB_1078956, HPA072785: AB_2686556" "unprognostic (8.37e-2)" "unprognostic (1.01e-1)" "unprognostic (7.31e-3)" "unprognostic (6.24e-2)" "unprognostic (6.03e-2)" "unprognostic (1.36e-1)" "unprognostic (8.65e-3)" "unprognostic (6.43e-2)" "unprognostic (5.16e-2)" "unprognostic (4.30e-2)" "unprognostic (2.18e-1)" "unprognostic (2.16e-1)" "unprognostic (9.91e-2)" "unprognostic (2.93e-1)" "unprognostic (1.36e-1)" "unprognostic (3.44e-2)" "unprognostic (1.98e-3)" 20.1 20.9 14.7 13.7 32.1 8.7 21.1 19.5 23.5 23.1 18.2 32.9 20.8 17.6 23.2 29.8 13.7 21.7 20.0 14.9 18.3 13.4 21.5 17.5 22.5 12.4 37.7 21.4 32.9 27.3 19.7 22.5 19.3 22.1 21.7 18.3 19.5 17.0 21.2 10.4 15.3 16.9 22.2 28.9 18.9 21.1 11.5 31.8 6.5 28.1 8.0 11.3 21.4 18.7 4.5 3.8 7.3 3.8 3.1 3.0 1.1 8.6 5.5 11.3 11.8 14.7 17.0 9.1 8.7 13.0 9.2 12.7 6.0 13.5 6.5 12.1 6.4 21.6 10.4 7.7 5.9 9.8 11.3 8.4 8.3 5.5 8.3 20.5 9.9 22.5 12.8 14.2 7.0 20.6 16.6 10.3 4.8 16.8 14.0 10.0 12.5 3.8 14.1 15.2 14.0 10.6 5.1 13.4 8.5 9.9 9.8 10.1 16.0 11.4 12.1 16.3 14.7 6.8 13.4 9.4 14.8 11.3 22.3 11.1 11.3 3.9 7.2 12.4 6.5 20.2 7.3 3.8 3.4 2.6 2.3 2.5 2.8 2.0 1.6 2.0 4.5 2.1 3.0 3.9 3.1 2.5 3.8 2.0 1.1 14.7 32.1 19.5 23.5 18.3 13.4 37.7 21.4 22.1 31.8 44.7 54.7 23.8 32.5 11.7 77.4 13.2 20.4 45.5 33.0 45.4 66.8 21.8 3.3 18.5 3.3 25.3 24.9 0.0 19.1 19.7 20.3 33.0 50.9 19.5 21.7 58.8 16.1 30.1 26.3 3.4 42.0 29.9 20.3 10.8 35.4 86.9 22.4 33.6 32.9 13.5 125.5 19.4 26.7 10.7 7.0 15.6 17.3 18.5 29.9 26.0 GATAD2A p66alpha ENSG00000167491 "GATA zinc finger domain containing 2A" Q86YP4 19 19385826-19508931 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006759, HPA024373" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006759: AB_1079549, HPA024373: AB_1849522" "unprognostic (1.07e-1)" "unprognostic (2.79e-2)" "unprognostic (1.40e-1)" "unprognostic (5.64e-3)" "unprognostic (3.41e-1)" "unprognostic (1.86e-1)" "unprognostic (9.04e-3)" "unprognostic (9.53e-2)" "unprognostic (2.12e-1)" "unprognostic (2.58e-2)" "unprognostic (6.62e-3)" "unprognostic (4.69e-2)" "unprognostic (3.06e-3)" "unprognostic (4.50e-2)" "unprognostic (2.43e-1)" "unprognostic (3.30e-2)" "unprognostic (9.84e-2)" 19.2 16.1 14.7 24.4 15.3 30.5 25.9 11.1 14.2 12.9 22.2 12.2 20.4 24.8 16.7 16.1 23.3 13.1 17.4 16.3 16.2 11.3 21.2 28.7 22.3 29.9 12.8 10.1 16.0 28.5 13.8 16.2 26.9 15.3 11.7 13.0 18.1 16.7 20.2 17.9 29.9 26.4 13.1 14.8 28.1 19.5 42.0 11.4 34.1 16.1 15.3 24.6 16.3 23.0 3.2 4.9 12.3 4.9 3.7 5.2 2.7 18.7 16.1 15.0 22.2 6.2 6.5 31.6 14.8 10.1 15.5 14.8 29.1 19.9 36.8 22.6 14.8 10.3 15.7 14.0 13.1 9.0 12.5 15.2 27.0 16.1 16.0 15.3 29.9 23.4 10.3 9.7 16.1 13.1 5.1 15.4 21.3 43.0 11.9 8.9 21.2 35.3 11.9 31.6 17.4 14.7 37.7 15.1 17.1 8.0 24.8 28.5 15.9 12.8 15.6 18.7 10.2 14.1 12.6 30.0 29.5 14.2 34.4 27.6 14.9 18.7 39.4 18.4 25.3 17.1 5.6 4.9 4.5 5.2 2.3 3.1 3.1 3.1 4.2 2.1 3.2 2.3 2.6 12.3 3.7 4.5 4.9 2.1 2.7 14.7 15.3 11.1 14.2 16.2 11.3 12.8 10.1 15.3 11.4 11.9 16.3 12.4 16.8 49.5 14.4 10.6 10.2 9.4 12.5 14.0 17.7 20.2 11.6 19.7 14.7 28.5 34.2 0.0 26.2 27.9 19.3 19.6 16.2 25.1 23.4 22.3 15.0 25.2 24.1 13.3 14.4 19.3 30.4 16.2 28.2 17.4 36.9 32.3 13.1 22.5 18.5 19.4 21.7 12.1 33.7 48.6 30.7 35.5 26.9 23.0 GATAD2B P66beta ENSG00000143614 "GATA zinc finger domain containing 2B" Q8WXI9 1 153789030-153923360 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017015 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA017015: AB_1854905" "unprognostic (1.90e-1)" "unprognostic (5.02e-2)" "prognostic unfavorable (1.30e-4)" "unprognostic (4.43e-2)" "unprognostic (2.59e-3)" "unprognostic (1.07e-1)" "unprognostic (3.79e-2)" "unprognostic (4.37e-2)" "unprognostic (2.02e-2)" "unprognostic (3.29e-1)" "unprognostic (1.28e-1)" "unprognostic (6.40e-2)" "prognostic unfavorable (3.08e-4)" "unprognostic (1.53e-1)" "unprognostic (1.92e-1)" "unprognostic (2.51e-1)" "unprognostic (5.17e-2)" 12.9 9.6 16.5 16.2 19.8 22.2 13.6 33.2 24.4 12.0 12.4 22.2 10.5 10.7 15.7 9.0 14.6 13.1 9.6 19.3 16.3 11.0 8.8 10.5 15.9 18.4 15.1 12.3 17.1 16.0 19.4 11.1 14.4 14.7 10.8 9.6 12.3 10.7 14.6 20.2 17.2 11.9 17.6 13.9 14.6 11.6 24.6 17.9 29.5 19.1 7.6 17.7 12.1 14.4 1.3 2.9 6.7 1.1 1.5 1.4 0.7 4.8 9.2 8.2 9.0 1.7 5.4 4.9 3.0 7.3 9.6 11.3 4.4 7.6 9.5 7.2 6.8 5.1 9.8 11.4 5.9 7.9 8.6 7.9 9.3 10.0 1.8 5.6 5.6 13.3 4.2 4.2 10.7 21.3 4.6 9.1 13.4 6.9 13.1 1.9 9.0 20.1 1.5 3.6 3.8 4.5 20.5 4.1 10.4 1.9 6.8 9.5 10.0 11.2 13.8 5.9 6.3 12.7 4.8 8.1 9.4 8.4 5.2 6.4 17.8 12.0 14.6 5.3 3.7 8.1 6.7 1.1 0.9 1.3 0.5 1.3 0.7 0.6 1.4 0.3 1.3 0.5 0.6 6.4 1.5 0.5 2.9 1.1 0.7 16.5 19.8 33.2 24.4 16.3 11.0 15.1 12.3 14.7 17.9 8.9 11.8 11.8 11.6 38.9 43.4 14.5 22.9 12.0 9.1 24.4 37.3 8.2 6.6 10.9 12.5 23.4 7.9 23.3 12.3 5.5 12.9 16.7 24.3 19.5 11.9 33.4 22.8 24.5 27.8 5.2 25.0 17.4 13.5 34.3 19.5 18.6 14.4 20.9 32.9 7.9 35.5 6.5 19.8 25.5 19.8 41.5 8.2 24.5 14.0 16.0 GATD1 "FLJ34283, PDDC1" ENSG00000177225 "Glutamine amidotransferase like class 1 domain containing 1" Q8NB37 11 767220-777488 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 41.7;Alveolar cells type 2: 23.2;Collecting duct cells: 21.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 50.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008812 Uncertain Supported Nucleoplasm "Secreted - unknown location" NA NA Nucleoplasm "HPA008812: AB_10962724" "unprognostic (3.39e-1)" "unprognostic (2.48e-2)" "unprognostic (1.31e-1)" "unprognostic (3.58e-2)" "unprognostic (2.82e-2)" "unprognostic (3.03e-2)" "prognostic unfavorable (3.98e-4)" "unprognostic (3.50e-2)" "unprognostic (2.19e-1)" "unprognostic (5.67e-2)" "unprognostic (5.23e-3)" "unprognostic (4.89e-3)" "prognostic favorable (3.79e-5)" "unprognostic (2.84e-2)" "unprognostic (8.40e-2)" "unprognostic (6.11e-2)" "unprognostic (6.61e-3)" 16.7 36.5 26.6 16.3 24.9 10.6 19.1 30.9 29.8 15.1 15.0 20.7 19.8 23.3 17.7 22.4 16.6 18.8 20.0 16.7 27.0 26.2 19.8 18.6 15.3 15.6 25.8 19.4 21.9 16.6 15.5 22.9 16.4 22.0 18.6 10.5 15.8 20.0 23.8 19.2 27.2 21.5 12.6 21.7 17.2 19.1 17.5 21.5 12.8 17.0 13.0 11.5 11.9 14.3 4.0 9.5 1.3 8.7 1.7 4.7 2.8 16.8 9.8 9.4 10.1 4.4 6.8 9.1 10.0 4.4 9.3 8.3 7.0 26.4 9.2 3.7 6.6 10.1 18.1 7.0 8.9 4.7 11.7 50.6 5.6 14.7 14.8 7.6 10.5 12.0 9.7 9.9 4.0 6.1 8.6 7.1 10.7 13.7 8.4 5.2 4.9 11.8 11.3 9.0 5.5 18.0 13.0 6.4 11.5 8.2 3.8 24.4 9.6 9.7 13.9 6.8 2.6 12.0 6.9 13.0 10.1 7.6 5.4 7.7 10.1 5.1 11.7 15.3 14.0 8.2 1.3 7.0 1.3 4.7 8.7 3.4 4.0 4.5 4.4 9.5 3.5 3.9 2.6 0.7 1.7 3.5 5.5 2.1 2.8 26.6 24.9 30.9 27.7 27.0 26.2 25.8 19.4 22.0 21.5 41.7 23.2 0.0 0.0 0.0 0.0 0.0 0.0 13.4 13.6 21.0 0.0 11.0 5.0 9.7 0.0 0.0 0.0 0.0 6.5 6.9 0.0 0.0 5.8 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 8.2 0.0 0.0 11.7 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 GBA2 "AD035, DKFZp762K054, KIAA1605, SPG46" ENSG00000070610 "Glucosylceramidase beta 2" Q9HCG7 9 35736866-35749228 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism" "Glycosidase, Glycosyltransferase, Hydrolase, Transferase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 108.0;Rod photoreceptor cells: 95.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024026 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA024026: AB_1849530" "unprognostic (3.34e-2)" "unprognostic (2.90e-1)" "unprognostic (2.99e-1)" "unprognostic (1.06e-2)" "unprognostic (1.41e-1)" "unprognostic (5.83e-3)" "unprognostic (2.20e-2)" "unprognostic (2.09e-2)" "unprognostic (3.99e-2)" "unprognostic (8.69e-2)" "prognostic favorable (6.00e-4)" "unprognostic (9.01e-3)" "prognostic favorable (1.24e-11)" "unprognostic (7.62e-3)" "unprognostic (2.94e-1)" "unprognostic (7.69e-2)" "prognostic favorable (6.60e-4)" 15.6 19.3 28.9 17.0 23.3 11.0 24.3 42.3 41.6 14.8 35.1 17.0 28.4 41.5 19.0 22.3 16.6 16.8 21.4 34.6 22.4 21.0 34.8 25.0 20.9 17.3 23.7 19.5 16.4 20.9 27.9 27.1 19.3 36.6 23.9 32.8 28.4 27.7 25.5 46.1 23.5 51.1 23.3 21.0 23.4 26.9 11.6 19.5 10.9 25.4 15.5 16.4 18.2 16.9 5.6 6.8 12.2 6.1 3.1 7.3 3.1 7.9 13.2 18.2 17.6 8.9 5.4 18.5 10.8 8.5 11.0 11.7 14.6 6.4 8.5 7.9 6.6 23.8 8.3 17.4 7.3 5.6 12.1 11.9 9.2 34.4 15.6 9.8 13.6 22.8 9.3 13.7 9.3 9.8 26.9 28.8 8.6 8.9 16.4 10.2 7.9 3.7 14.1 18.8 16.2 20.9 6.8 7.3 7.2 15.3 18.8 14.9 19.9 6.1 15.2 10.7 23.3 10.4 12.4 20.1 12.0 14.5 10.2 13.1 11.2 7.1 7.1 15.0 5.0 9.3 12.2 4.4 2.9 6.0 6.1 4.1 5.0 5.8 7.3 4.2 5.6 3.7 3.2 4.9 3.1 3.7 6.8 4.0 3.1 28.9 23.3 42.3 41.6 22.4 21.0 23.7 19.5 36.6 19.5 11.9 10.1 8.0 16.1 6.5 73.4 10.9 20.4 21.4 14.8 26.2 108.0 8.7 18.3 9.9 12.7 13.7 68.4 0.0 10.4 7.6 7.4 14.9 13.9 16.3 7.9 49.3 34.3 26.4 15.4 17.0 11.5 10.1 11.8 7.2 32.8 15.5 12.6 56.1 9.2 16.5 95.2 12.9 9.9 8.6 4.9 8.7 18.5 12.5 30.3 22.5 GBP2 ENSG00000162645 "Guanylate binding protein 2" P32456 1 89106132-89150456 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 23.9;HDLM-2: 26.3;RT4: 33.0" "HPA042682, CAB045975" Supported Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB045975: AB_10584474, HPA042682: AB_2678113" "prognostic favorable (7.57e-4)" "unprognostic (2.92e-2)" "unprognostic (3.65e-2)" "unprognostic (3.02e-2)" "unprognostic (1.34e-1)" "unprognostic (4.68e-2)" "unprognostic (2.70e-2)" "unprognostic (1.10e-1)" "unprognostic (1.53e-1)" "unprognostic (2.75e-3)" "prognostic unfavorable (5.73e-5)" "unprognostic (1.14e-1)" "prognostic unfavorable (2.14e-10)" "unprognostic (7.75e-2)" "unprognostic (1.65e-1)" "unprognostic (1.29e-2)" "prognostic favorable (1.10e-5)" 40.1 39.4 4.7 24.4 14.3 8.9 31.9 2.3 11.0 38.2 35.7 3.3 9.5 11.0 29.0 20.6 39.0 17.5 18.5 12.6 4.6 4.1 21.6 17.9 42.8 21.3 14.3 2.9 35.5 4.9 39.8 5.9 17.3 12.2 48.7 13.8 12.4 14.2 15.4 20.1 19.5 39.6 48.1 26.7 27.5 20.2 13.0 6.0 7.7 22.0 18.2 15.3 63.1 40.3 3.1 8.5 78.9 44.2 20.1 61.2 22.2 6.1 0.5 0.0 0.0 17.7 15.4 4.6 1.6 15.9 2.6 6.1 0.1 9.7 0.0 23.9 10.6 12.0 1.2 0.0 0.2 1.4 26.3 0.0 0.1 4.5 1.3 4.7 0.7 1.1 16.1 0.1 3.9 0.0 8.9 18.0 0.0 0.3 1.0 7.3 0.0 0.0 5.8 0.0 5.6 0.4 0.1 6.8 0.0 5.0 33.0 0.0 0.2 7.8 2.2 0.2 0.5 0.2 1.0 12.2 2.0 0.4 2.8 1.7 19.1 0.0 0.0 6.1 0.1 0.3 12.2 20.5 6.6 24.6 31.2 32.6 3.1 26.3 27.1 8.5 2.7 18.0 18.9 78.9 20.1 44.2 0.5 61.2 22.2 4.7 14.3 2.3 11.0 4.6 4.1 14.3 2.9 12.2 6.0 23.8 30.1 5.9 100.6 41.3 0.1 2.8 28.1 24.1 17.0 17.4 0.0 26.1 0.0 75.3 22.8 54.8 48.0 23.3 62.4 50.9 30.1 66.0 44.1 22.2 33.3 0.0 9.8 22.1 68.8 22.5 4.4 82.4 8.5 45.9 9.7 0.6 67.5 28.1 8.1 7.7 0.0 19.4 69.6 0.7 2.1 54.1 48.3 77.8 8.6 78.8 GBX2 ENSG00000168505 "Gastrulation brain homeobox 2" P52951 2 236165236-236168369 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 11.9" "Cell type enhanced" "Detected in single" 26 "Early spermatids: 1.8" "Group enriched" "Detected in some" 6 "glioma: 1.7;testis cancer: 6.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 32.5;BEWO: 5.6;PC-3: 9.6;TIME: 5.1" "Group enriched" "Detected in some" 6 "basal ganglia: 0.7;thalamus: 1.4" "Region enhanced" "Detected in many" "thalamus: 6.3" HPA067809 Approved Nucleoplasm Yes NA Nucleoplasm "HPA067809: AB_2685900" "unprognostic (5.30e-2)" "unprognostic (1.15e-1)" "unprognostic (7.09e-2)" "unprognostic (1.59e-1)" "unprognostic (2.91e-2)" "unprognostic (4.49e-2)" "unprognostic (2.14e-2)" "unprognostic (1.72e-2)" "unprognostic (2.91e-1)" "unprognostic (8.13e-2)" "unprognostic (6.99e-2)" "unprognostic (3.55e-4)" "unprognostic (8.69e-7)" "unprognostic (2.08e-1)" "unprognostic (1.01e-2)" "unprognostic (5.47e-2)" "unprognostic (9.39e-4)" 0.1 0.1 0.3 0.4 5.8 0.1 0.1 11.9 3.6 0.1 0.2 4.2 0.0 0.3 0.1 0.1 0.2 0.1 0.1 0.4 0.6 3.8 0.2 0.3 0.1 0.1 1.2 0.3 0.1 0.1 0.1 0.2 1.4 6.3 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.2 0.3 4.6 0.1 0.1 1.3 2.8 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.6 32.5 1.2 0.0 0.0 5.6 0.4 0.0 0.9 0.0 0.7 0.0 0.0 0.6 0.0 1.0 0.0 0.2 0.1 0.2 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.6 0.0 2.1 0.0 0.4 0.8 0.0 0.2 0.8 0.0 9.6 0.0 3.5 0.0 0.3 0.0 0.4 0.2 1.1 0.0 0.3 1.0 0.0 0.0 5.1 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.8 11.9 0.0 0.6 3.8 1.2 0.3 6.3 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 GCAT KBL ENSG00000100116 "Glycine C-acetyltransferase" O75600 22 37807905-37817176 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 81.6" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 68.0;Hepatocytes: 55.7;Proximal tubular cells: 62.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020460, HPA063924" Approved Supported "Nucleoplasm,Nuclear speckles,Mitochondria" Yes No Nucleoplasm "Nuclear speckles, Mitochondria" "HPA020460: AB_1849548, HPA063924: " "unprognostic (1.61e-1)" "unprognostic (1.80e-2)" "unprognostic (8.38e-2)" "unprognostic (1.05e-1)" "unprognostic (1.10e-2)" "unprognostic (4.17e-2)" "unprognostic (2.40e-1)" "unprognostic (1.37e-2)" "unprognostic (3.56e-2)" "unprognostic (2.76e-3)" "unprognostic (1.12e-1)" "unprognostic (2.51e-1)" "unprognostic (1.36e-3)" "unprognostic (8.00e-2)" "unprognostic (1.97e-1)" "unprognostic (4.73e-3)" "unprognostic (3.99e-1)" 2.9 6.0 8.9 2.4 8.8 8.1 4.2 8.3 12.3 4.5 4.7 5.2 8.0 3.5 3.0 4.0 6.3 3.9 6.0 21.5 8.6 8.4 8.1 19.1 2.3 2.1 10.1 7.4 4.0 81.6 3.5 3.7 2.2 7.4 12.2 3.5 4.3 12.0 5.0 10.3 3.2 3.2 3.1 6.3 1.1 4.4 5.9 4.3 2.8 10.7 9.3 4.3 3.3 2.2 0.3 2.5 0.8 1.3 2.3 7.1 2.8 8.8 2.3 5.9 33.9 12.3 10.0 4.2 12.7 13.4 9.7 8.2 5.1 1.0 2.8 6.0 5.7 5.7 5.2 5.9 9.0 2.2 1.2 10.8 6.2 7.4 20.3 20.1 10.9 8.1 11.7 5.5 6.4 14.1 3.1 7.9 11.4 15.7 3.3 4.5 7.8 11.4 20.2 2.5 13.9 9.4 12.0 1.3 16.2 12.2 7.0 12.3 8.4 9.9 16.1 6.8 2.2 12.9 5.3 5.9 9.8 5.3 6.5 4.4 10.8 5.3 5.8 6.7 10.2 10.2 0.2 1.3 0.8 1.5 1.2 0.6 0.3 3.4 1.0 2.4 0.1 7.1 2.9 0.6 2.3 0.8 2.5 3.3 2.8 8.9 8.8 8.3 12.3 8.6 8.4 10.1 7.4 7.4 4.3 6.0 12.5 2.9 15.2 6.9 9.8 43.3 7.6 4.0 6.8 10.4 3.9 12.8 68.0 6.1 3.6 5.6 6.3 0.0 8.8 17.8 7.5 19.5 9.2 55.7 4.0 7.9 2.4 3.1 2.2 4.3 3.4 1.6 20.3 1.8 23.9 17.3 6.8 3.5 9.2 62.4 1.9 6.5 10.8 13.4 27.1 5.3 23.2 4.9 25.5 11.2 GCC2 "GCC185, KIAA0336" ENSG00000135968 "GRIP and coiled-coil domain containing 2" Q8IWJ2 2 108448561-108509415 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035849, HPA035850" Enhanced Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA035849: AB_10671941, HPA035850: AB_2674821" "unprognostic (1.35e-1)" "unprognostic (1.29e-2)" "unprognostic (2.45e-2)" "unprognostic (2.04e-1)" "unprognostic (1.01e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (4.24e-4)" "unprognostic (1.59e-1)" "unprognostic (3.11e-2)" "unprognostic (2.02e-1)" "unprognostic (1.06e-1)" "unprognostic (6.53e-2)" "unprognostic (6.53e-3)" "unprognostic (3.99e-1)" "unprognostic (4.71e-1)" "unprognostic (9.61e-2)" "unprognostic (1.64e-2)" 10.9 10.6 12.0 15.2 21.6 20.5 13.1 5.0 16.8 11.9 13.6 3.9 26.7 13.4 10.9 32.0 9.5 12.4 13.2 8.0 9.3 5.8 12.8 8.3 14.2 13.0 7.8 15.6 17.6 13.1 11.5 24.3 8.6 15.0 14.6 13.6 4.3 14.9 32.3 9.6 9.3 18.1 8.4 11.4 11.7 18.1 15.5 10.5 11.1 13.8 6.1 10.0 16.3 11.3 14.3 17.6 20.3 8.8 7.9 23.0 4.5 7.6 5.8 7.7 2.7 5.7 13.6 13.4 10.6 12.6 4.0 6.7 11.3 9.4 8.9 12.7 7.3 9.0 6.3 4.3 7.5 8.6 10.8 7.5 12.1 9.9 7.5 6.2 15.6 8.9 14.4 7.1 10.6 8.9 7.7 7.0 7.0 15.4 7.3 7.6 4.7 6.5 8.1 12.3 3.7 7.7 6.6 9.0 8.4 4.7 12.7 8.0 9.1 11.9 8.8 9.1 7.4 4.4 5.1 12.0 8.3 12.5 7.9 4.1 9.7 16.9 10.7 9.3 4.0 5.1 20.1 5.2 13.7 15.4 4.6 14.9 14.3 16.9 16.0 4.0 13.6 23.0 19.7 20.3 7.9 8.8 17.6 12.3 4.5 12.0 21.6 5.0 16.8 9.3 5.8 7.8 15.6 15.0 10.5 140.0 86.0 63.4 57.6 21.2 153.9 76.3 66.2 305.1 113.7 99.5 131.6 36.7 43.1 92.4 48.8 52.5 110.3 0.0 71.8 48.3 34.8 87.9 78.7 28.8 32.2 66.7 82.1 52.2 44.7 34.5 66.2 49.5 32.1 88.4 140.1 60.4 93.5 112.2 77.8 56.4 118.6 51.8 39.6 164.6 90.6 15.3 54.3 109.0 68.0 89.7 GCFC2 "C2orf3, DNABF, GCF, TCF9" ENSG00000005436 "GC-rich sequence DNA-binding factor 2" P16383 2 75652000-75710989 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077882 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA077882: AB_2686864" "unprognostic (1.98e-1)" "unprognostic (5.18e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (9.59e-4)" "unprognostic (5.67e-3)" "unprognostic (2.75e-1)" "unprognostic (2.34e-2)" "unprognostic (3.74e-2)" "unprognostic (8.80e-2)" "unprognostic (4.21e-2)" "unprognostic (1.63e-1)" "unprognostic (5.71e-2)" "unprognostic (3.20e-2)" "unprognostic (8.37e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (6.07e-2)" 13.7 10.0 10.3 10.8 11.2 9.7 14.8 12.7 12.2 17.6 9.9 11.2 11.9 5.6 14.7 16.8 14.9 12.9 8.8 15.4 10.7 10.2 15.5 24.3 8.6 11.1 10.2 12.0 16.9 13.8 9.0 14.9 12.2 10.4 13.5 5.9 8.8 11.8 13.7 34.0 22.1 11.9 9.7 10.9 11.8 9.5 10.9 11.4 20.9 15.9 11.7 9.7 13.5 10.6 14.3 11.0 3.0 7.3 3.9 12.7 7.5 8.8 8.9 5.4 6.5 3.1 4.3 8.2 5.8 4.9 6.2 5.9 10.5 6.5 8.7 8.7 4.0 7.4 3.4 7.6 4.1 8.1 12.8 16.2 6.7 8.6 27.7 5.5 11.5 6.5 4.4 5.2 3.0 9.0 6.2 7.5 11.0 10.0 5.0 5.8 7.1 11.9 19.7 9.8 6.2 10.0 14.1 12.9 21.5 10.5 9.5 11.2 14.7 8.0 8.5 10.0 3.9 6.7 5.2 7.2 5.2 7.9 8.4 11.7 6.1 10.3 6.7 5.6 7.0 12.7 0.5 6.7 3.0 9.1 4.3 10.5 14.3 8.8 10.6 7.8 9.9 12.7 11.6 0.4 3.9 7.3 11.0 9.3 7.5 10.3 11.2 12.7 12.2 10.7 10.2 10.2 12.0 10.4 11.4 14.9 9.1 14.6 16.9 24.6 11.5 17.6 10.2 16.0 25.0 12.2 0.0 30.8 18.3 11.2 25.1 14.5 5.2 0.0 16.4 17.8 18.4 14.5 12.8 22.2 11.1 15.9 15.5 16.5 12.4 55.1 15.5 10.3 13.5 4.6 6.8 10.0 11.5 7.0 9.2 13.6 8.7 12.9 17.6 11.4 19.4 21.7 19.8 5.7 9.6 14.4 GCH1 "DYT14, DYT5, DYT5a, GCH, GTPCH1" ENSG00000131979 "GTP cyclohydrolase 1" P30793 14 54842008-54902852 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis" "Allosteric enzyme, Hydrolase" "Disease mutation, Dystonia, Parkinsonism, Phenylketonuria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 26.8;liver: 58.2" "Cell type enhanced" "Detected in many" 12 "Hepatocytes: 82.5;Intestinal endocrine cells: 203.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 11.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 11.8;Daudi: 13.3;SH-SY5Y: 29.7" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 15.7" HPA028612 Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" No No Nucleoplasm "Nuclear membrane, Cytosol" "HPA028612: AB_10602135" "unprognostic (3.77e-2)" "unprognostic (2.67e-3)" "unprognostic (6.73e-2)" "unprognostic (2.39e-1)" "unprognostic (9.26e-2)" "unprognostic (1.27e-1)" "unprognostic (7.26e-2)" "unprognostic (1.75e-1)" "unprognostic (3.97e-1)" "prognostic favorable (8.69e-4)" "prognostic favorable (1.41e-4)" "unprognostic (1.23e-1)" "unprognostic (1.96e-2)" "unprognostic (7.22e-3)" "unprognostic (1.76e-2)" "unprognostic (2.23e-1)" "prognostic favorable (6.67e-4)" 4.8 5.2 1.3 5.7 4.5 26.8 2.1 0.6 1.1 2.2 5.5 1.2 1.5 7.5 1.8 1.9 3.8 1.3 1.6 1.5 1.6 4.3 7.9 58.2 11.6 6.7 2.9 0.7 1.4 3.2 0.3 2.5 2.5 2.8 2.9 4.0 5.2 2.5 4.7 1.4 2.5 9.1 2.0 1.7 10.0 4.2 3.6 1.1 13.0 2.3 2.0 8.5 2.9 2.5 1.6 3.0 0.4 11.5 2.3 3.2 1.3 1.9 0.6 0.7 3.5 0.0 0.0 11.8 0.0 1.2 0.8 2.2 0.9 0.6 13.3 3.3 0.1 1.8 2.0 5.7 0.9 0.0 5.2 5.0 0.3 0.2 1.9 5.7 0.0 1.2 1.4 1.6 1.9 0.0 0.0 0.4 9.1 0.8 0.0 0.0 6.8 7.2 0.2 1.1 2.9 4.5 5.9 1.4 0.0 1.7 2.8 5.9 29.7 2.5 1.5 0.7 0.3 5.7 1.6 0.2 0.1 2.0 3.7 2.3 5.7 4.3 3.2 2.5 4.6 0.0 0.0 3.0 0.2 3.0 6.3 2.5 0.8 1.6 2.1 3.0 1.6 3.2 1.8 0.4 2.3 11.5 0.1 2.3 1.3 1.3 4.5 0.6 1.1 1.6 4.3 2.9 0.7 2.8 1.1 3.0 4.5 8.1 28.1 66.2 0.0 3.3 5.1 2.7 7.9 5.2 2.0 1.8 6.6 8.3 0.4 11.7 16.0 23.3 8.1 40.5 8.2 17.3 0.0 82.5 5.6 0.0 203.8 6.2 24.0 0.6 0.3 13.3 10.1 6.4 15.2 0.3 9.8 14.0 4.6 38.4 0.2 0.0 15.5 1.1 4.7 66.6 3.5 22.3 8.9 32.9 GCHFR "GFRP, HsT16933" ENSG00000137880 "GTP cyclohydrolase I feedback regulator" P30047 15 40764020-40767710 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 73.4" "Group enriched" "Detected in many" 4 "Hepatocytes: 655.3;Hofbauer cells: 541.0;Proximal tubular cells: 464.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 32.6;RPTEC TERT1: 41.8;SCLC-21H: 37.5;SK-BR-3: 26.8" "Group enriched" "Detected in many" 5 "cerebellum: 11.6;midbrain: 14.1;pons and medulla: 9.8" HPA046258 Enhanced Supported Nucleoplasm NA NA 59000 Nucleoplasm "HPA046258: AB_10967205" "unprognostic (2.50e-1)" "unprognostic (1.49e-2)" "unprognostic (1.28e-1)" "unprognostic (1.72e-2)" "unprognostic (9.89e-3)" "unprognostic (3.51e-3)" "unprognostic (1.57e-1)" "prognostic favorable (5.62e-4)" "unprognostic (4.63e-2)" "unprognostic (1.67e-1)" "unprognostic (3.81e-1)" "unprognostic (2.31e-1)" "unprognostic (7.03e-3)" "unprognostic (9.28e-3)" "unprognostic (2.91e-2)" "unprognostic (1.84e-1)" "unprognostic (2.55e-1)" 9.0 4.9 3.8 6.6 6.0 7.9 37.6 9.7 5.0 7.2 16.5 1.5 0.9 18.3 2.0 2.7 13.4 5.1 6.2 8.1 4.6 4.1 16.3 73.4 16.4 10.5 2.8 2.3 7.1 3.9 1.5 5.1 4.7 8.8 5.0 3.4 6.5 6.0 1.7 1.9 7.3 31.7 1.3 3.1 3.5 4.4 3.4 1.3 10.3 5.0 4.0 12.6 4.4 6.1 13.0 25.4 27.1 21.0 33.1 38.6 27.0 0.1 2.2 1.8 9.4 2.7 1.0 4.8 0.6 2.2 1.1 2.1 24.9 14.1 12.7 9.0 0.5 0.7 1.7 4.5 0.8 0.2 9.8 7.7 12.4 18.8 32.6 2.3 8.1 4.3 2.3 1.1 0.5 0.1 0.8 4.1 1.0 6.2 3.9 0.3 4.6 2.2 16.4 4.6 2.3 16.2 17.8 0.1 7.7 41.8 6.6 37.5 0.5 5.6 26.8 2.8 2.4 7.2 8.3 0.0 0.1 0.3 0.6 0.1 0.2 1.6 7.8 1.4 18.0 1.1 4.3 21.0 27.1 22.7 6.4 38.0 13.0 20.1 21.0 13.6 9.6 20.8 13.5 3.3 33.1 5.6 25.4 38.6 27.0 3.8 6.0 9.7 5.0 4.6 4.1 2.8 2.3 8.8 1.3 3.0 49.6 29.9 20.8 12.9 2.5 0.1 86.6 49.5 36.4 61.1 11.8 137.3 64.6 36.4 0.5 12.7 72.2 0.0 28.6 23.2 12.4 34.2 43.8 655.3 541.0 0.0 58.3 19.0 74.4 0.0 16.4 34.2 64.1 7.2 41.6 11.7 22.0 106.6 8.1 464.4 18.1 0.0 4.2 0.4 10.0 13.0 30.6 47.3 99.7 27.8 GCKR ENSG00000084734 "Glucokinase regulator" 2 27496842-27523684 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "liver: 60.9" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 76.9" "Cancer enriched" "Detected in some" 8 "liver cancer: 14.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 12.7;Hep G2: 19.4;HUVEC TERT2: 6.2;TIME: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB034098, HPA052227" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB034098: AB_2247323, HPA052227: " "unprognostic (3.31e-1)" "unprognostic (2.11e-3)" "unprognostic (2.27e-1)" "unprognostic (6.97e-2)" "unprognostic (1.68e-2)" "unprognostic (5.70e-2)" "unprognostic (2.31e-1)" "unprognostic (1.70e-1)" "unprognostic (1.52e-1)" "unprognostic (4.12e-1)" "unprognostic (2.25e-3)" "unprognostic (1.65e-1)" "unprognostic (1.02e-7)" "unprognostic (6.51e-2)" "unprognostic (1.18e-1)" "unprognostic (9.27e-3)" "unprognostic (1.50e-2)" 0.2 2.0 0.1 0.1 0.3 0.2 0.1 0.2 0.2 0.1 0.4 0.1 0.1 0.2 0.1 0.3 0.4 0.0 3.9 0.5 0.1 0.0 0.2 60.9 0.1 0.1 0.1 0.1 2.0 0.9 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.2 1.3 0.1 0.1 0.5 3.1 0.9 0.2 0.1 0.1 0.1 0.2 0.1 0.1 2.4 0.8 2.6 1.2 1.7 0.9 0.7 0.2 0.4 0.4 0.2 0.3 0.2 0.1 0.0 0.1 0.3 0.0 0.4 0.1 0.2 0.5 0.7 0.2 0.2 0.2 0.0 0.0 0.1 0.0 12.7 0.5 19.4 0.8 0.1 0.4 0.3 1.0 0.5 0.1 2.2 6.2 0.0 0.0 0.2 0.2 0.1 0.1 0.7 0.1 0.0 0.0 0.3 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.2 0.1 0.1 0.5 0.1 3.8 0.1 0.3 0.6 0.2 0.4 0.1 0.2 1.2 0.1 0.2 2.6 1.2 0.3 0.6 1.0 0.6 0.8 0.4 0.4 0.1 2.4 0.9 0.8 2.1 1.7 0.3 0.8 0.1 0.7 0.1 0.3 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 5.1 0.0 0.0 0.0 0.0 0.0 0.0 7.6 6.3 0.4 0.0 0.0 9.0 0.0 0.0 0.3 0.0 76.9 0.1 0.0 0.0 1.3 1.9 2.8 0.3 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 GCLC "GCS, GLCL, GLCLC" ENSG00000001084 "Glutamate-cysteine ligase catalytic subunit" P48506 6 53497341-53616970 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glutathione biosynthesis" Ligase "Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.2" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 102.4;Intestinal endocrine cells: 212.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 49.2;Hep G2: 42.0;OE19: 68.1;RT4: 45.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009569, HPA036359, HPA036360" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA 3600000 Nucleoplasm "Nucleoli, Cytosol" "CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789" "unprognostic (8.41e-2)" "unprognostic (1.27e-2)" "unprognostic (5.65e-2)" "unprognostic (2.42e-1)" "unprognostic (1.58e-1)" "unprognostic (2.76e-1)" "unprognostic (2.60e-1)" "unprognostic (7.50e-2)" "unprognostic (9.94e-3)" "unprognostic (4.67e-3)" "unprognostic (1.30e-1)" "unprognostic (5.23e-2)" "prognostic favorable (3.83e-6)" "unprognostic (3.78e-2)" "unprognostic (8.91e-2)" "prognostic unfavorable (8.24e-4)" "unprognostic (2.30e-2)" 15.8 11.1 12.9 9.0 16.0 14.4 13.0 5.4 15.1 6.8 16.2 21.6 8.2 18.9 9.2 5.3 20.0 29.1 14.9 7.4 13.1 10.6 15.4 69.2 12.9 10.1 21.6 12.2 6.2 12.4 6.6 5.4 6.2 13.0 13.0 12.2 5.2 11.2 10.1 7.0 8.6 14.8 11.9 13.6 16.8 14.8 5.2 17.5 3.1 14.1 32.4 10.6 34.4 12.3 1.6 4.2 2.2 1.9 8.0 2.3 0.6 7.3 49.2 4.0 9.5 4.8 2.2 5.4 3.7 6.0 2.8 3.3 7.2 17.1 14.0 7.1 3.3 21.5 10.5 12.3 27.1 3.8 11.0 7.6 9.3 9.5 42.0 5.5 12.3 5.8 3.4 11.5 3.1 14.1 3.7 4.2 12.3 5.1 4.4 1.3 7.7 10.5 4.9 7.5 68.1 4.6 3.5 2.5 12.3 9.1 45.4 11.7 5.7 6.2 10.0 6.5 6.1 6.8 5.8 5.9 2.5 8.8 6.4 5.5 5.9 9.1 8.1 6.3 8.8 4.2 2.2 1.1 0.6 1.2 1.9 0.8 1.6 1.0 2.3 4.2 1.0 0.6 1.3 0.5 8.0 1.8 3.0 1.6 0.6 12.9 16.0 5.4 11.9 13.1 10.6 21.6 12.2 13.0 17.5 0.0 3.7 7.8 42.9 30.9 12.8 17.8 25.5 48.2 47.8 0.0 23.6 5.2 10.0 12.8 1.4 13.5 19.9 46.7 11.0 6.5 8.7 44.8 2.3 102.4 19.8 7.9 212.1 9.2 60.1 1.0 6.1 16.4 8.5 6.4 16.3 13.8 17.1 8.5 8.9 19.8 4.0 12.9 10.3 3.3 8.1 21.8 6.5 10.7 13.8 89.1 GCLM GLCLR ENSG00000023909 "Glutamate-cysteine ligase modifier subunit" P48507 1 93885205-93909456 "Cancer-related genes, Predicted intracellular proteins" "Glutathione biosynthesis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 210.2;Glandular cells: 272.8;Urothelial cells: 201.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009568, HPA023696, CAB040554" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 1000000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB009568: AB_2107835, CAB040554: , HPA023696: AB_1849560" "unprognostic (2.31e-1)" "unprognostic (7.92e-2)" "unprognostic (8.85e-3)" "unprognostic (1.56e-2)" "unprognostic (2.83e-2)" "unprognostic (4.64e-2)" "prognostic unfavorable (9.83e-6)" "unprognostic (2.37e-1)" "unprognostic (1.07e-1)" "unprognostic (3.53e-1)" "unprognostic (3.51e-2)" "unprognostic (3.89e-2)" "unprognostic (2.19e-2)" "unprognostic (1.09e-2)" "unprognostic (1.79e-1)" "unprognostic (2.43e-1)" "unprognostic (2.34e-3)" 10.3 17.5 7.0 6.0 7.7 11.3 23.9 5.7 8.9 4.5 22.8 4.2 11.5 16.6 3.5 6.5 8.8 12.8 12.5 7.7 6.8 8.9 17.8 41.7 8.4 10.4 9.2 5.7 4.6 6.9 6.3 5.1 10.3 8.7 5.3 5.2 6.4 6.7 6.4 19.2 3.4 20.0 3.4 7.7 6.9 6.1 3.2 2.8 5.6 15.0 23.0 8.6 8.9 8.0 3.2 1.9 3.3 0.7 4.6 6.7 1.2 13.1 20.9 2.3 4.5 7.8 4.9 8.9 15.8 9.8 12.0 9.0 3.5 7.8 5.0 31.6 10.2 39.2 13.3 3.4 6.4 9.7 13.5 4.6 34.9 14.2 15.0 14.6 12.8 5.6 6.0 2.4 24.4 3.9 4.8 13.1 5.7 13.8 7.4 8.6 2.5 9.2 3.0 7.9 12.6 10.0 4.3 7.0 7.3 8.5 15.4 5.4 2.2 14.8 11.7 5.5 27.5 2.6 8.0 13.7 12.6 7.4 23.6 23.6 6.7 8.5 5.2 10.4 7.2 4.4 3.3 0.7 1.3 5.3 0.4 3.1 2.6 5.0 6.7 0.6 3.2 3.2 3.2 2.9 4.6 0.5 1.9 1.3 1.2 7.0 7.7 5.7 8.9 6.8 8.9 9.2 5.7 8.7 2.8 38.7 18.4 13.3 119.7 10.2 23.7 13.5 53.5 49.5 19.4 27.9 5.9 60.1 21.6 24.6 3.0 14.5 25.6 210.2 10.7 16.4 25.0 272.8 19.6 71.6 16.8 31.8 50.4 41.7 17.7 1.9 19.8 15.4 8.5 10.8 9.3 19.3 22.5 7.0 11.7 45.8 12.6 0.0 44.3 22.8 40.4 8.2 37.6 34.6 13.2 201.0 GCNA "ACRC, NAAR1" ENSG00000147174 "Germ cell nuclear acidic peptidase" Q96QF7 X 71578411-71613583 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 29.4" "Cell type enhanced" "Detected in some" 20 "Collecting duct cells: 3.5;granulocytes: 2.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA023476, HPA030870" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA023476: AB_1844530, HPA030870: " "unprognostic (6.01e-2)" "unprognostic (2.30e-1)" "unprognostic (1.43e-2)" "unprognostic (4.37e-3)" "unprognostic (1.39e-1)" "unprognostic (2.35e-4)" "unprognostic (5.84e-2)" "unprognostic (1.31e-1)" "unprognostic (3.16e-1)" "unprognostic (1.68e-1)" "unprognostic (1.03e-2)" "unprognostic (2.06e-1)" "unprognostic (5.07e-10)" "unprognostic (2.30e-1)" "unprognostic (5.06e-2)" "unprognostic (4.74e-1)" "unprognostic (1.15e-5)" 1.4 6.9 1.2 1.7 1.7 1.6 1.2 3.7 1.7 1.2 1.2 1.2 1.2 1.0 1.2 1.4 1.2 0.9 1.2 1.2 1.3 2.5 1.2 1.8 1.4 2.6 1.2 1.2 1.5 1.7 0.4 1.2 1.2 1.7 1.2 1.0 1.2 1.2 1.2 3.1 1.7 1.5 1.2 1.2 3.9 0.9 29.4 1.2 1.2 1.6 1.2 1.4 1.2 1.2 1.4 0.6 1.1 0.6 1.4 3.3 0.5 0.6 1.1 2.2 2.0 4.5 4.2 1.3 3.6 1.9 1.2 2.1 2.0 1.3 5.5 2.7 1.9 1.2 2.6 4.3 0.2 1.8 0.9 2.9 1.1 4.9 0.5 1.2 1.0 5.1 1.6 6.9 1.0 1.0 4.6 0.8 4.3 1.5 3.5 2.5 0.7 0.4 3.9 2.2 2.5 2.6 1.0 0.1 4.0 2.8 1.6 1.3 0.2 1.2 0.6 3.0 2.4 0.4 3.5 1.4 1.3 2.6 1.8 1.0 1.0 2.5 2.2 2.5 2.1 2.2 0.6 0.6 0.1 0.7 0.3 1.3 1.4 1.7 3.3 0.3 0.5 1.0 1.1 1.1 1.4 0.1 0.6 3.0 0.5 1.2 1.7 3.7 1.7 1.3 2.5 1.2 1.2 1.7 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 2.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 GCNT4 C2GNT3 ENSG00000176928 "Glucosaminyl (N-acetyl) transferase 4, core 2" Q9P109 5 75025346-75030899 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 13.6;intestine: 13.1;stomach 1: 10.4" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 35.7;Cytotrophoblasts: 27.4;Syncytiotrophoblasts: 20.4" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 13.6" "Group enriched" "Detected in many" 54 "granulocytes: 13.6;T-cells: 11.6" "Cell line enriched" "Detected in some" 5 "RT4: 26.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037431 Approved Supported "Nucleoplasm,Golgi apparatus" No NA "Golgi apparatus" Nucleoplasm "HPA037431: AB_10670382" "unprognostic (1.88e-2)" "unprognostic (5.63e-2)" "unprognostic (6.05e-2)" "unprognostic (1.28e-1)" "unprognostic (1.12e-1)" "unprognostic (4.98e-2)" "unprognostic (4.11e-3)" "unprognostic (1.63e-2)" "unprognostic (3.47e-1)" "unprognostic (2.20e-2)" "unprognostic (4.49e-3)" "unprognostic (6.04e-2)" "prognostic favorable (1.93e-7)" "unprognostic (8.39e-2)" "unprognostic (1.93e-1)" "unprognostic (6.06e-2)" "unprognostic (5.82e-2)" 0.6 0.6 0.3 1.0 0.7 0.0 0.9 0.0 2.3 1.1 1.1 13.1 1.4 0.6 1.3 1.1 2.5 0.3 0.3 0.1 1.8 0.4 1.0 1.7 0.1 0.9 3.0 8.4 0.1 3.0 1.0 0.2 0.5 2.4 1.0 1.5 10.8 0.7 0.0 0.6 10.4 1.0 0.5 1.1 6.4 2.0 0.0 0.0 13.6 0.1 0.2 11.6 1.6 0.2 0.1 1.0 1.6 1.8 0.6 0.1 2.0 5.2 1.0 0.9 2.5 0.1 0.0 0.2 1.5 0.6 0.7 1.0 1.8 0.2 0.0 0.0 0.8 0.2 0.2 0.8 0.0 0.0 0.3 2.9 0.1 0.4 0.0 0.0 1.5 0.0 0.3 0.1 0.0 1.4 0.0 0.4 5.7 0.0 0.0 0.0 2.6 0.2 26.6 0.0 0.0 0.2 0.0 0.0 5.4 0.0 0.0 0.0 0.5 0.1 0.7 0.1 0.0 0.0 0.0 0.3 0.0 0.1 13.6 0.0 0.0 0.9 0.0 3.5 0.0 8.1 2.6 0.0 0.0 8.1 5.9 0.1 0.2 0.1 0.0 11.6 1.6 3.0 5.3 0.0 5.5 0.6 0.0 0.4 35.7 0.0 4.5 12.2 0.0 27.4 8.3 6.1 0.1 1.0 6.7 0.0 3.7 0.7 1.1 1.5 7.0 0.8 2.1 0.0 0.0 4.9 0.8 0.0 3.7 0.0 0.0 1.0 0.5 0.0 4.9 1.7 2.5 0.6 0.0 6.5 0.9 0.0 0.2 0.1 20.4 0.0 0.6 4.1 GCOM1 "FLJ30973, GRINL1A, MYZAP-POLR2M" ENSG00000137878 "GRINL1A complex locus 1" 15 57591908-57714745 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 107.1;smooth muscle: 42.3" "Cell type enhanced" "Detected in some" 8 "Alveolar cells type 1: 3.0;Cardiomyocytes: 2.8;Paneth cells: 3.5" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "cerebellum: 10.4;pons and medulla: 3.9" "Cell type enhanced" "Detected in some" "naive B-cell: 3.6;naive CD4 T-cell: 4.0" "Group enriched" "Detected in many" 5 "B-cells: 3.6;monocytes: 1.5;T-cells: 4.0" "Cell line enhanced" "Detected in some" "HEL: 25.3;RH-30: 7.1;RT4: 8.0;TIME: 10.9" "HPA039827, HPA068141" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA039827: AB_10673364, HPA068141: AB_2685962" "unprognostic (1.10e-1)" "unprognostic (3.62e-4)" "unprognostic (1.10e-1)" "unprognostic (5.43e-3)" "unprognostic (1.31e-3)" "unprognostic (1.55e-1)" "unprognostic (1.29e-1)" "unprognostic (7.69e-4)" "unprognostic (1.22e-1)" "unprognostic (3.22e-3)" "unprognostic (3.13e-2)" "unprognostic (1.27e-1)" "unprognostic (2.61e-1)" "unprognostic (4.03e-2)" "unprognostic (7.44e-2)" "unprognostic (1.67e-1)" "unprognostic (5.78e-2)" 6.7 4.6 1.2 1.9 1.4 2.9 10.3 10.4 1.3 4.1 3.6 0.1 2.3 3.6 5.2 1.2 9.9 1.3 2.3 107.1 1.2 1.6 1.2 0.9 7.6 1.7 1.2 0.0 2.3 5.6 0.4 1.0 9.1 3.9 10.2 1.3 0.0 4.6 2.7 7.3 2.6 5.8 42.3 1.0 2.6 3.3 2.5 0.0 0.0 1.1 5.0 4.8 25.3 9.5 3.6 0.5 0.4 1.5 0.0 4.0 4.5 3.3 0.6 0.0 3.3 0.0 0.0 0.8 0.6 2.3 1.1 1.0 2.4 3.3 0.0 0.5 0.0 2.9 2.1 0.0 2.0 0.9 0.0 0.1 25.3 0.7 0.1 0.0 0.1 0.1 0.1 0.1 0.3 5.0 0.1 1.0 0.1 1.3 0.0 0.2 0.4 0.0 0.0 0.1 4.6 0.1 0.0 7.1 0.0 0.0 8.0 0.0 0.8 0.7 0.7 0.0 0.5 3.2 0.0 10.9 0.3 2.1 0.3 0.2 0.2 0.0 0.0 2.1 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 1.2 0.7 0.0 0.5 3.6 4.0 0.0 0.4 0.0 1.5 0.0 0.3 4.5 1.2 1.4 10.4 1.3 1.2 1.6 1.2 0.0 3.9 0.0 3.0 0.3 0.0 0.2 0.0 0.0 2.8 0.0 1.4 1.2 0.0 0.0 0.1 0.0 1.4 0.0 0.3 1.3 0.0 0.9 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.0 0.0 0.0 1.3 3.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.3 GDA ENSG00000119125 "Guanine deaminase" Q9Y2T3 9 72114595-72257193 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.8;intestine: 54.5;liver: 27.6" "Group enriched" "Detected in many" 7 "Enterocytes: 113.2;Hepatocytes: 49.7;Paneth cells: 91.2;Proximal tubular cells: 84.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 11.1;EFO-21: 44.1;HeLa: 15.4;hTCEpi: 20.6;OE19: 50.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 11 "amygdala: 39.7;basal ganglia: 31.5;cerebral cortex: 63.2;hippocampal formation: 79.5;olfactory region: 28.4" "HPA019352, HPA024099, HPA030387" Enhanced Approved Nucleoplasm No NA 1300000 Nucleoplasm "HPA019352: AB_1855593, HPA024099: AB_1855594, HPA030387: AB_10602351" "unprognostic (2.64e-2)" "unprognostic (7.10e-2)" "unprognostic (2.83e-2)" "unprognostic (2.92e-1)" "unprognostic (4.35e-2)" "unprognostic (8.45e-2)" "unprognostic (2.00e-1)" "unprognostic (5.60e-2)" "unprognostic (3.26e-1)" "unprognostic (1.32e-1)" "unprognostic (1.55e-1)" "unprognostic (5.56e-2)" "prognostic favorable (2.66e-5)" "unprognostic (2.23e-1)" "unprognostic (6.70e-2)" "unprognostic (2.77e-1)" "unprognostic (8.30e-4)" 0.5 1.7 26.7 1.8 27.7 0.5 0.5 0.4 33.8 1.0 20.6 0.9 7.7 47.4 2.4 0.6 0.5 4.7 13.1 0.5 25.7 15.0 21.4 27.6 0.5 0.5 2.9 27.4 0.4 1.7 10.8 1.7 10.3 0.8 0.4 5.5 0.0 0.4 4.1 1.1 1.6 54.5 0.5 0.6 0.5 2.0 1.0 0.2 0.0 0.4 1.0 2.6 3.4 0.5 1.4 0.5 3.0 0.7 1.0 1.0 0.1 11.1 1.4 0.0 0.0 0.0 0.0 0.2 0.0 8.1 0.0 0.0 1.0 6.3 0.0 44.1 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 20.6 0.0 0.2 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 50.0 0.0 0.0 0.0 0.3 0.3 2.5 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 3.0 0.7 0.3 1.0 0.6 0.3 0.6 0.5 0.4 0.3 1.4 0.7 0.7 1.9 1.0 0.4 0.5 0.5 0.1 26.7 27.7 0.4 33.8 25.7 15.0 2.9 27.4 0.8 0.2 0.0 0.3 1.7 0.5 0.0 0.0 0.6 12.7 0.0 0.0 0.0 0.0 0.1 3.3 9.2 1.0 0.0 113.2 0.0 9.7 1.0 0.4 0.6 0.0 49.7 0.2 0.0 4.6 1.3 1.0 0.0 0.3 0.0 0.0 1.0 11.2 0.0 4.4 91.2 0.0 84.2 0.0 0.0 0.3 0.4 4.2 0.1 1.6 0.0 7.8 0.8 GDF6 "BMP13, KFS, KFS1, SGM1" ENSG00000156466 "Growth differentiation factor 6" Q6KF10 8 96142330-96160792 "Disease related genes, Predicted secreted proteins" Apoptosis "Cytokine, Developmental protein, Growth factor" "Disease mutation, Dwarfism, Leber congenital amaurosis, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 11.8;placenta: 16.9" "Cell type enhanced" "Detected in some" 13 "Cardiomyocytes: 2.0;Distal tubular cells: 1.7" "Cancer enhanced" "Detected in some" "renal cancer: 2.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.2" "Group enriched" "Detected in some" 6 "hTERT-RPE1: 15.4;LHCN-M2: 24.5;SuSa: 12.5" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.6" HPA045206 Uncertain Supported "Nucleoplasm,Nuclear membrane,Vesicles" "Secreted to blood" NA NA Vesicles "Nucleoplasm, Nuclear membrane" "HPA045206: AB_10962508" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "unprognostic (1.83e-2)" "unprognostic (9.66e-9)" "unprognostic (6.49e-2)" "unprognostic (1.47e-1)" "unprognostic (1.41e-1)" "unprognostic (3.18e-2)" "unprognostic (3.80e-3)" "unprognostic (1.09e-3)" "unprognostic (5.37e-2)" "unprognostic (8.13e-3)" "prognostic unfavorable (2.17e-4)" "unprognostic (5.88e-4)" "unprognostic (1.88e-2)" "unprognostic (2.68e-2)" "unprognostic (1.71e-1)" 2.5 0.2 1.4 1.5 0.9 0.0 0.8 0.1 1.7 0.3 1.4 0.3 1.5 0.6 3.0 0.7 0.8 1.0 6.6 11.8 0.9 1.0 0.4 0.7 0.4 1.9 0.9 0.1 2.2 1.3 0.1 0.3 16.9 1.1 0.6 0.5 2.9 0.1 2.7 0.8 0.0 1.6 1.8 0.2 0.1 1.4 1.1 1.1 0.1 1.4 0.1 0.1 3.2 2.1 0.1 1.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.8 0.4 2.9 1.9 0.0 1.7 1.5 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 2.4 0.0 0.4 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 2.2 0.0 15.4 0.1 0.0 0.0 0.0 24.5 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.6 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.4 0.9 0.1 1.7 0.9 1.0 0.9 0.1 1.1 1.1 0.0 0.0 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.7 0.1 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.2 0.0 0.0 0.0 GDNF "ATF1, ATF2, HFB1-GDNF" ENSG00000168621 "Glial cell derived neurotrophic factor" P39905 5 37812677-37839686 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes, Disease mutation, Hirschsprung disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.1;skeletal muscle: 12.4" "Cell type enhanced" "Detected in single" 9 "Fibroblasts: 1.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "cerebellum: 14.1" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 25.0;SuSa: 7.8;U-87 MG: 7.6;WM-115: 27.5" "Region enhanced" "Detected in single" "basal ganglia: 2.5" "Low region specificity" "Detected in many" "CAB005210, HPA070283" Supported Approved Nucleoplasm,Vesicles "Secreted in other tissues" NA NA Vesicles Nucleoplasm "CAB005210: AB_2247684, HPA070283: AB_2686246" "unprognostic (1.08e-1)" "unprognostic (6.30e-2)" "unprognostic (3.54e-2)" "unprognostic (8.87e-2)" "unprognostic (1.09e-1)" "unprognostic (1.08e-1)" "unprognostic (5.33e-2)" "unprognostic (1.92e-1)" "unprognostic (3.71e-2)" "unprognostic (2.01e-2)" "unprognostic (2.41e-1)" "unprognostic (2.10e-1)" "unprognostic (1.16e-4)" "unprognostic (2.04e-1)" "unprognostic (8.86e-2)" "unprognostic (1.05e-1)" "unprognostic (4.42e-2)" 1.9 0.3 0.6 1.9 2.3 0.0 0.4 14.1 1.3 0.8 9.4 0.4 0.4 1.6 1.7 3.4 1.0 0.9 0.9 0.9 0.6 0.4 1.0 0.7 0.4 0.4 0.6 1.2 4.5 0.4 0.0 0.4 6.3 1.4 1.6 3.1 1.1 0.4 6.3 12.4 1.4 2.5 2.5 0.5 0.4 1.9 3.9 2.4 0.4 0.4 1.5 0.4 0.6 1.1 0.8 0.4 1.2 0.3 0.9 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 3.4 2.1 0.6 0.9 0.0 0.0 0.0 0.0 4.5 0.0 0.1 0.0 0.0 1.2 0.0 0.1 0.0 0.2 0.3 0.1 0.1 0.0 1.0 0.1 25.0 0.0 0.8 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.1 0.2 0.0 0.0 0.0 5.4 0.0 0.0 0.1 0.2 0.0 0.1 0.1 1.7 7.8 0.0 0.0 0.0 3.4 0.0 0.8 3.9 2.3 0.0 0.0 7.6 0.0 27.5 0.4 0.3 0.2 0.3 0.2 0.3 0.2 0.3 0.3 0.1 0.8 0.2 0.4 1.2 0.9 0.2 0.4 0.1 0.0 0.6 2.3 14.1 1.3 0.6 0.4 0.6 1.2 1.4 2.4 0.0 0.0 0.0 0.0 0.8 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.5 0.0 0.0 0.6 0.0 0.8 0.3 0.1 0.0 0.0 0.5 GDPD3 MGC4171 ENSG00000102886 "Glycerophosphodiester phosphodiesterase domain containing 3" Q7L5L3 16 30104810-30113856 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 30.8;lymphoid tissue: 40.8;tongue: 36.6" "Cell type enhanced" "Detected in many" 18 "Early spermatids: 50.9;Extravillous trophoblasts: 52.5;Late spermatids: 201.8;Proximal tubular cells: 62.4" "Cancer enhanced" "Detected in all" "urothelial cancer: 21.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 12 "eosinophil: 1.6;neutrophil: 5.1" "Lineage enriched" "Detected in single" 19 "granulocytes: 5.1" "Group enriched" "Detected in many" 5 "MCF7: 13.7;OE19: 16.9;SK-BR-3: 48.5" "Region enhanced" "Detected in single" "cerebellum: 0.9" "Low region specificity" "Detected in many" "HPA041148, HPA041470" Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" NA NA Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA041148: AB_10794545, HPA041470: AB_10795121" "unprognostic (4.12e-1)" "unprognostic (2.29e-2)" "unprognostic (2.01e-1)" "unprognostic (9.99e-2)" "unprognostic (2.53e-1)" "unprognostic (4.57e-3)" "unprognostic (1.09e-1)" "unprognostic (1.36e-1)" "unprognostic (4.53e-1)" "unprognostic (8.86e-3)" "unprognostic (6.59e-3)" "unprognostic (1.95e-1)" "prognostic unfavorable (5.89e-9)" "unprognostic (3.11e-1)" "unprognostic (3.13e-1)" "unprognostic (1.12e-1)" "unprognostic (8.79e-3)" 3.0 0.9 1.2 10.5 1.2 0.5 2.5 5.7 1.3 9.4 11.3 1.2 1.2 4.0 2.8 3.4 30.8 2.1 3.6 1.7 1.2 0.7 5.9 1.2 3.7 2.3 1.2 1.2 3.3 1.2 0.4 2.3 12.9 2.5 2.4 7.4 1.2 4.9 1.2 1.3 5.3 8.6 2.4 1.2 4.1 8.3 1.2 1.2 1.9 2.3 36.6 40.8 2.7 9.2 0.1 0.0 5.1 0.2 0.0 0.2 0.0 5.3 0.0 1.9 0.5 0.5 2.8 1.6 0.5 0.4 0.5 0.6 0.6 3.7 0.6 0.7 0.3 0.1 0.5 0.5 0.2 0.5 1.0 1.5 0.1 0.8 2.5 0.5 0.2 0.4 0.1 0.7 1.5 0.1 1.5 2.1 2.0 0.4 0.9 0.7 13.7 0.4 0.9 1.1 16.9 0.2 2.5 0.6 2.9 1.1 2.4 0.5 0.9 0.0 48.5 0.3 0.5 0.9 1.0 1.5 0.5 0.5 1.1 0.5 1.6 0.3 0.6 1.4 0.8 0.3 0.1 0.0 1.6 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 5.1 0.0 0.1 0.0 0.1 0.0 1.2 1.2 5.7 1.3 1.2 0.7 1.2 1.2 2.5 1.2 6.0 0.6 0.0 0.6 1.1 1.1 0.9 0.0 1.4 1.2 5.2 0.0 20.4 5.0 1.0 50.9 4.0 43.6 0.0 1.2 52.5 2.1 1.4 0.0 0.0 2.8 1.6 3.4 3.7 3.0 201.8 3.1 0.7 1.7 1.0 28.5 0.2 11.2 12.9 2.8 62.4 1.7 6.5 1.4 1.2 1.2 1.8 7.8 1.5 4.7 3.9 GEMIN2 SIP1 ENSG00000092208 "Gem nuclear organelle associated protein 2" O14893 14 39114223-39136973 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015426, HPA046570, HPA057114" Enhanced Supported "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" Nucleoli "CAB015426: AB_629517, HPA046570: AB_2679703, HPA057114: AB_2683340" "unprognostic (4.53e-1)" "unprognostic (1.56e-1)" "unprognostic (1.52e-1)" "unprognostic (5.07e-3)" "unprognostic (1.04e-1)" "unprognostic (3.52e-2)" "prognostic unfavorable (3.88e-6)" "unprognostic (8.62e-3)" "unprognostic (3.05e-2)" "unprognostic (1.99e-3)" "unprognostic (3.08e-1)" "unprognostic (3.03e-1)" "unprognostic (4.53e-3)" "unprognostic (1.52e-1)" "unprognostic (1.58e-1)" "unprognostic (3.95e-1)" "unprognostic (6.78e-2)" 10.0 8.2 13.2 8.1 16.9 15.2 13.3 15.7 15.2 10.1 9.5 10.9 5.2 11.4 9.3 12.5 10.2 9.9 7.2 12.4 13.8 10.1 8.2 9.2 9.1 14.1 11.0 13.8 11.3 8.5 4.3 16.1 9.0 13.4 8.4 10.9 8.9 7.7 7.7 18.9 10.4 8.0 12.6 12.4 9.5 8.4 13.2 12.8 11.9 9.8 9.9 13.3 11.3 9.6 17.1 15.8 8.9 12.6 11.6 15.5 8.7 11.6 16.7 16.5 12.0 5.8 6.7 8.5 5.5 4.4 14.9 14.8 14.6 13.7 17.2 11.6 4.7 5.3 8.9 22.1 9.4 15.7 8.8 12.9 10.0 10.2 36.2 11.8 15.2 6.6 3.6 9.0 9.4 13.5 4.4 13.0 15.2 11.9 12.6 8.3 23.1 16.6 14.6 11.5 14.1 18.8 15.5 18.0 10.8 8.3 7.6 16.1 3.2 11.7 9.0 6.0 9.4 20.5 6.7 5.3 6.9 10.2 6.7 9.0 13.2 20.5 25.2 3.3 16.2 9.6 8.1 12.3 8.9 14.3 12.6 10.1 15.4 13.2 14.0 15.6 17.1 14.9 15.5 3.4 11.6 10.4 15.8 11.4 8.7 13.2 16.9 15.7 15.2 13.8 10.1 11.0 13.8 13.4 12.8 6.0 3.0 7.5 7.2 7.6 6.3 5.2 2.5 13.4 6.8 5.2 9.8 12.3 10.0 9.9 33.1 8.0 1.8 0.0 5.6 15.4 11.2 5.3 5.7 5.8 10.0 4.8 3.5 9.8 10.0 32.0 8.3 6.6 6.8 7.2 6.7 7.1 6.1 0.0 9.2 11.5 6.4 6.5 5.2 19.3 14.7 6.9 3.2 10.2 8.8 4.2 GEMIN6 FLJ23459 ENSG00000152147 "Gem nuclear organelle associated protein 6" Q8WXD5 2 38751534-38785000 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 82.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035726, HPA035727" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA035726: AB_10669528, HPA035727: AB_2674753" "unprognostic (1.97e-2)" "unprognostic (3.83e-1)" "unprognostic (2.32e-1)" "unprognostic (1.31e-2)" "unprognostic (1.86e-1)" "unprognostic (2.10e-2)" "unprognostic (3.82e-3)" "unprognostic (3.10e-2)" "unprognostic (8.13e-2)" "unprognostic (3.53e-3)" "unprognostic (2.71e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (2.94e-4)" "unprognostic (2.47e-1)" "unprognostic (2.38e-1)" "unprognostic (1.04e-1)" "unprognostic (1.67e-2)" 9.2 17.0 10.8 12.8 11.7 4.8 12.0 8.2 13.1 9.3 10.2 8.4 8.1 12.7 12.0 15.5 11.8 13.2 8.1 8.1 9.6 10.5 17.7 21.0 8.1 13.9 9.9 11.0 14.8 18.8 9.2 11.7 10.5 9.7 9.2 12.6 8.5 11.0 8.0 15.8 7.7 10.7 12.5 11.9 12.9 11.1 29.2 13.1 12.7 13.5 11.0 16.9 10.6 9.3 20.5 14.8 4.6 17.1 15.0 18.4 12.9 18.3 15.0 10.6 12.3 13.8 12.1 18.1 15.7 7.9 14.0 11.7 15.9 8.8 25.2 18.1 8.1 19.6 8.8 16.3 15.3 20.4 21.6 20.7 16.3 8.9 25.8 9.5 13.6 8.6 8.2 11.3 18.6 9.3 9.6 14.6 6.9 16.7 8.8 13.9 13.0 16.4 17.5 18.1 21.7 18.1 11.4 18.6 13.8 12.5 6.5 13.3 20.9 4.0 15.3 11.8 12.9 7.9 4.7 7.9 13.6 17.3 10.6 23.4 18.2 35.5 24.6 10.9 20.7 13.5 1.6 15.5 4.6 13.0 17.1 14.2 20.5 13.4 13.2 14.8 18.9 16.5 17.0 2.4 15.0 15.2 10.9 18.4 12.9 10.8 11.7 8.2 13.1 9.6 10.5 9.9 11.0 9.7 13.1 11.9 29.5 25.3 9.1 7.3 6.4 7.8 12.7 26.8 19.4 10.4 3.9 26.1 24.9 19.8 82.9 13.0 7.8 0.0 15.5 32.0 12.3 7.4 11.6 27.0 23.8 11.1 1.2 14.1 20.8 15.1 19.0 18.7 10.1 19.8 9.8 8.4 17.6 13.9 10.6 51.5 7.4 19.4 10.3 50.9 17.2 10.0 6.1 10.8 17.0 6.5 GEMIN7 FLJ13956 ENSG00000142252 "Gem nuclear organelle associated protein 7" Q9H840 19 45079195-45091524 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 82.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052075 Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA052075: AB_2681718" "unprognostic (3.32e-1)" "unprognostic (1.48e-2)" "unprognostic (3.84e-1)" "unprognostic (3.17e-2)" "unprognostic (1.60e-1)" "unprognostic (7.00e-2)" "prognostic unfavorable (5.86e-5)" "unprognostic (7.78e-2)" "unprognostic (2.17e-1)" "unprognostic (2.95e-1)" "unprognostic (1.47e-3)" "unprognostic (1.20e-1)" "prognostic unfavorable (9.64e-11)" "unprognostic (7.01e-2)" "unprognostic (4.54e-1)" "unprognostic (1.83e-1)" "prognostic favorable (8.00e-4)" 9.7 10.6 8.9 13.0 12.2 18.3 12.3 22.1 19.0 8.1 13.6 10.0 8.2 18.9 10.0 8.7 18.5 9.0 9.6 13.3 9.8 9.7 12.4 20.2 10.3 21.6 10.0 9.0 8.5 24.1 6.1 20.4 12.9 12.8 11.9 13.2 12.7 16.8 9.5 20.7 14.7 16.5 9.7 6.9 24.3 17.4 5.3 10.5 12.8 12.5 14.7 17.1 13.1 11.7 28.4 22.9 15.2 14.3 29.6 32.0 18.9 20.6 27.5 16.2 19.8 12.4 12.9 12.5 16.0 11.7 24.5 27.3 16.7 13.3 20.8 11.0 13.7 13.6 13.0 23.4 19.0 14.8 16.6 30.4 22.9 12.6 21.7 17.4 18.2 13.7 19.3 15.6 13.6 9.9 12.6 23.8 12.6 23.9 21.8 9.5 30.6 17.4 19.0 15.2 31.8 14.3 21.0 7.5 26.9 18.5 15.3 16.1 11.3 12.5 27.1 14.0 13.7 18.3 19.6 12.8 9.1 17.3 5.9 20.9 22.7 33.4 33.1 14.6 18.5 14.6 10.7 14.3 15.2 32.0 11.5 30.2 28.4 23.6 29.4 20.1 23.7 18.3 23.8 7.9 29.6 8.3 22.9 19.8 18.9 8.9 12.2 22.1 19.0 9.8 9.7 10.0 9.0 12.8 10.5 17.9 8.9 32.5 8.8 16.1 5.3 8.4 15.3 1.4 10.3 3.5 0.0 31.5 18.3 34.5 1.1 9.8 16.8 0.0 29.3 47.6 11.6 8.3 3.5 17.9 30.0 1.6 12.7 15.4 21.9 2.4 13.3 14.3 11.8 82.0 18.3 7.7 35.1 20.3 6.0 21.2 3.2 6.5 7.1 4.3 8.8 20.7 21.6 21.7 24.0 11.1 GEMIN8 "FAM51A1, FLJ20514" ENSG00000046647 "Gem nuclear organelle associated protein 8" Q9NWZ8 X 14008279-14029893 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028613 Uncertain Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA028613: AB_10602905" "unprognostic (7.10e-2)" "unprognostic (1.91e-3)" "unprognostic (1.83e-1)" "unprognostic (1.87e-3)" "unprognostic (2.58e-1)" "unprognostic (5.42e-2)" "prognostic unfavorable (7.78e-5)" "unprognostic (3.87e-3)" "unprognostic (3.29e-1)" "unprognostic (2.40e-2)" "unprognostic (5.52e-2)" "unprognostic (2.40e-1)" "unprognostic (4.74e-2)" "unprognostic (4.23e-2)" "unprognostic (2.07e-2)" "unprognostic (7.75e-2)" "prognostic favorable (7.73e-5)" 13.4 13.5 14.5 12.9 17.0 12.0 19.9 12.3 20.0 16.5 13.9 24.0 27.3 9.0 21.5 16.9 13.2 22.8 16.4 15.5 14.8 14.0 16.7 12.9 14.5 16.0 16.6 14.7 28.9 22.2 18.7 27.4 10.3 21.0 13.1 11.9 16.8 24.7 30.2 7.6 15.7 10.0 17.1 23.3 12.5 13.6 8.2 12.7 14.6 21.3 7.9 13.2 12.7 13.0 11.3 15.4 0.8 6.9 9.9 15.2 7.5 6.3 6.4 7.5 1.8 12.2 18.7 3.7 6.0 6.7 5.2 3.6 3.3 11.0 14.8 14.2 4.9 6.0 8.5 4.6 10.4 5.0 7.9 9.5 3.8 4.7 7.4 7.1 9.0 8.0 15.0 17.2 9.0 15.7 16.0 11.2 11.4 6.6 13.1 7.8 8.5 9.1 14.2 8.1 7.5 3.7 13.9 5.2 26.3 8.7 6.3 7.4 20.5 6.4 11.9 7.0 17.2 16.3 9.0 8.5 3.8 2.2 11.1 2.4 8.9 4.4 9.3 8.8 5.5 2.2 0.6 6.7 0.2 9.4 6.4 11.6 11.3 15.2 8.9 12.2 9.8 13.1 9.8 0.8 9.9 6.9 15.4 8.4 7.5 14.5 17.0 12.3 20.0 14.8 14.0 16.6 14.7 21.0 12.7 6.0 6.2 8.5 10.4 6.8 3.1 5.0 7.6 13.4 13.6 8.7 0.0 12.2 16.6 18.2 14.8 7.7 3.9 0.0 10.4 14.3 8.3 6.0 5.8 5.9 9.6 9.5 3.4 4.3 4.8 0.8 9.5 5.5 1.7 8.2 9.9 6.0 11.9 5.8 8.1 30.7 5.6 0.0 8.0 4.4 5.3 8.3 7.0 6.4 10.3 7.1 GEN1 "FLJ40869, Gen" ENSG00000178295 "GEN1, Holliday junction 5' flap endonuclease" Q17RS7 2 17753858-17788941 "Predicted intracellular proteins" "DNA damage, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 27.5" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA020078, HPA021141" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA020078: AB_2670352, HPA021141: AB_2670599" "unprognostic (2.25e-1)" "unprognostic (2.33e-1)" "unprognostic (1.52e-2)" "prognostic unfavorable (1.68e-4)" "unprognostic (8.64e-2)" "unprognostic (1.67e-3)" "unprognostic (7.90e-4)" "unprognostic (4.53e-2)" "unprognostic (1.70e-3)" "unprognostic (8.60e-3)" "unprognostic (8.04e-2)" "unprognostic (6.99e-2)" "unprognostic (1.89e-12)" "unprognostic (3.97e-3)" "unprognostic (1.61e-1)" "unprognostic (3.56e-1)" "unprognostic (1.49e-3)" 3.0 3.0 2.8 15.6 4.0 14.9 3.9 2.3 5.1 3.2 5.9 3.7 4.3 3.3 2.1 11.1 9.0 2.4 4.7 2.8 2.9 2.5 3.4 11.2 3.3 11.9 2.3 3.2 1.8 3.8 2.6 8.6 4.4 4.8 4.6 7.6 7.3 8.8 3.7 2.7 8.8 6.9 1.6 2.8 8.5 3.4 27.5 2.2 24.3 3.4 11.3 13.7 2.6 5.2 5.1 2.2 1.1 1.4 1.2 2.1 1.0 16.3 8.6 9.6 7.4 2.3 3.3 14.0 11.8 4.4 7.4 8.0 10.4 8.6 19.7 4.6 4.8 6.4 11.5 9.5 8.6 10.8 11.6 6.1 10.6 9.6 5.9 1.6 12.1 10.9 2.2 3.3 9.5 5.8 2.3 4.8 9.1 11.7 13.0 12.1 9.7 9.4 11.3 6.7 6.8 4.3 10.8 22.0 7.2 4.3 10.8 10.4 13.8 5.9 10.3 4.7 7.1 6.7 5.4 5.6 15.5 7.1 8.5 12.5 8.0 14.1 30.0 6.9 12.7 10.0 0.3 1.4 1.1 1.1 1.1 0.9 5.1 1.2 2.1 2.0 2.9 1.3 1.4 0.7 1.2 1.3 2.2 1.7 1.0 2.8 4.0 2.3 5.1 2.9 2.5 2.3 3.2 4.8 2.2 6.0 2.2 6.5 2.3 2.5 5.5 3.9 2.5 6.7 11.4 3.5 11.8 3.1 0.0 1.9 3.9 1.4 6.4 23.3 2.0 3.6 3.9 2.5 1.1 4.2 3.3 3.2 1.7 1.3 3.5 2.7 1.7 2.6 1.7 2.8 4.8 3.8 2.0 3.5 0.7 2.1 3.2 6.5 3.8 12.3 9.0 1.6 2.7 1.0 4.3 2.6 GET4 "C7orf20, CEE, CGI-20, H_NH1244M04.5, TRC35" ENSG00000239857 "Golgi to ER traffic protein 4" Q7L5D6 7 876552-896436 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 8 "Cone photoreceptor cells: 3.9;Horizontal cells: 7.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019765 Uncertain Enhanced "Nucleoplasm,Nucleoli,Mitotic chromosome,Cytosol" Yes No "Nucleoplasm, Cytosol" "Nucleoli, Mitotic chromosome" "HPA019765: AB_1845750" "unprognostic (2.80e-2)" "unprognostic (2.40e-2)" "unprognostic (2.10e-2)" "unprognostic (9.66e-4)" "unprognostic (9.86e-2)" "unprognostic (8.64e-2)" "unprognostic (4.10e-2)" "unprognostic (1.74e-1)" "unprognostic (2.59e-1)" "unprognostic (6.28e-2)" "unprognostic (2.43e-1)" "unprognostic (1.21e-1)" "unprognostic (7.65e-2)" "unprognostic (8.18e-2)" "unprognostic (1.26e-1)" "unprognostic (5.93e-2)" "unprognostic (9.47e-2)" 13.7 39.8 22.4 14.8 21.4 28.5 15.3 22.1 23.5 10.3 15.5 20.9 19.0 21.8 12.3 23.8 18.8 14.6 12.8 18.7 16.4 15.4 27.8 37.5 12.2 15.1 22.9 21.5 16.5 32.6 11.3 32.9 21.7 18.9 16.8 9.9 15.2 25.0 21.9 53.7 29.7 20.9 12.6 18.9 16.9 22.2 32.0 22.7 12.5 16.0 21.8 12.5 14.3 17.3 23.3 31.5 28.9 30.7 24.9 27.3 21.9 26.3 13.0 9.1 13.4 4.7 3.3 28.9 7.3 5.2 9.4 9.4 35.3 33.0 9.7 7.7 4.2 26.2 16.8 10.2 8.0 4.1 3.9 17.5 5.3 10.2 19.9 10.4 9.1 9.9 4.9 9.7 8.2 5.4 7.1 7.4 11.3 34.5 9.0 5.2 20.0 6.9 21.9 32.7 15.6 19.5 14.5 1.6 10.4 8.3 15.6 16.5 17.8 6.7 24.9 10.6 11.6 18.9 16.2 7.4 6.9 15.6 16.0 10.0 13.6 8.5 12.5 7.1 15.7 17.5 16.8 27.4 28.9 24.2 24.7 23.7 23.3 26.5 24.0 27.7 23.2 26.0 27.3 21.1 24.9 30.7 31.5 24.5 21.9 22.4 21.4 22.1 23.5 16.4 15.4 22.9 21.5 18.9 22.7 0.0 1.9 0.0 0.2 0.9 0.8 0.4 0.0 2.7 3.4 0.0 3.9 0.9 0.0 0.6 3.6 0.1 1.6 0.0 0.6 0.6 0.3 0.4 1.1 0.0 0.6 7.9 0.0 0.0 0.3 1.5 0.0 2.5 0.0 0.0 1.9 0.2 0.8 0.0 0.0 0.6 1.1 0.0 0.2 0.5 1.0 0.9 1.4 0.9 1.7 0.8 GFI1B ZNF163B ENSG00000165702 "Growth factor independent 1B transcriptional repressor" Q5VTD9 9 132944000-132991687 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "blood: 71.0;bone marrow: 29.2" "Cell type enriched" "Detected in some" 5 "Erythroid cells: 70.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "basophil: 31.2;eosinophil: 71.0" "Lineage enriched" "Detected in many" 26 "granulocytes: 71.0" "Group enriched" "Detected in some" 5 "HEL: 55.6;HMC-1: 36.0;K-562: 17.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB004420, HPA006291" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "CAB004420: AB_2110132, HPA006291: " "unprognostic (1.79e-2)" "unprognostic (2.90e-4)" "unprognostic (6.54e-2)" "unprognostic (1.76e-1)" "unprognostic (2.33e-1)" "unprognostic (1.54e-2)" "unprognostic (2.53e-3)" "unprognostic (1.05e-1)" "unprognostic (2.47e-1)" "unprognostic (1.54e-1)" "unprognostic (4.61e-2)" "unprognostic (3.71e-2)" "unprognostic (2.17e-1)" "unprognostic (2.53e-1)" "unprognostic (1.53e-2)" "unprognostic (1.41e-1)" 0.2 0.0 0.2 2.2 0.2 29.2 0.1 0.1 0.2 0.9 4.2 0.2 0.0 0.8 0.4 0.7 0.8 0.2 3.5 0.8 0.2 0.1 0.3 0.4 2.5 0.0 0.1 0.0 0.1 0.2 0.0 0.1 1.2 0.0 4.2 0.3 0.2 0.1 0.1 0.3 0.8 6.3 1.0 0.2 3.3 0.3 4.0 0.0 1.0 0.2 0.0 0.5 0.4 0.2 0.0 0.3 71.0 2.7 0.1 0.1 2.4 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.6 0.1 7.8 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 55.6 0.1 0.0 0.0 0.0 36.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 17.1 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 31.2 0.0 71.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.8 0.1 2.7 0.1 0.0 2.4 0.2 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.8 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 70.0 0.0 0.1 0.0 0.5 13.9 0.0 0.1 0.0 1.2 0.0 0.8 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.2 0.0 0.3 0.1 GFM1 "EFGM, EGF1, GFM" ENSG00000168827 "G elongation factor mitochondrial 1" Q96RP9 3 158644278-158692575 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034764, HPA034765, HPA061405" Enhanced Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA034764: AB_2674320, HPA034765: AB_10669849, HPA061405: AB_2684505" "unprognostic (1.26e-1)" "unprognostic (1.61e-1)" "unprognostic (5.48e-3)" "unprognostic (4.48e-3)" "unprognostic (1.84e-1)" "unprognostic (3.40e-1)" "unprognostic (4.75e-2)" "unprognostic (6.05e-2)" "unprognostic (2.48e-1)" "unprognostic (8.36e-2)" "prognostic unfavorable (9.20e-4)" "unprognostic (2.79e-1)" "prognostic favorable (1.16e-7)" "unprognostic (1.62e-1)" "unprognostic (4.78e-1)" "unprognostic (3.32e-2)" "unprognostic (8.78e-2)" 20.1 23.3 17.6 14.1 18.6 14.7 19.8 32.8 23.4 11.4 20.7 17.8 19.1 18.8 15.4 17.9 16.2 14.3 12.6 27.9 18.0 17.9 34.1 42.2 13.5 13.2 18.9 19.5 13.2 17.0 30.9 16.4 17.4 22.6 15.3 23.3 13.8 16.3 15.4 46.5 15.4 16.0 16.0 18.5 14.2 17.1 19.8 17.8 14.5 21.4 17.6 13.6 15.0 13.2 13.2 16.5 10.8 19.8 16.0 21.1 11.5 30.1 17.3 8.4 10.2 13.5 8.8 11.3 15.6 13.6 21.8 17.1 23.1 18.6 25.9 19.8 11.6 10.4 18.4 18.8 14.5 24.4 14.3 12.7 21.5 11.9 12.8 15.4 27.6 11.7 12.2 17.2 14.1 13.1 6.2 14.6 14.4 22.3 15.9 19.8 16.7 16.2 11.0 19.1 32.4 11.7 15.7 10.1 41.7 17.4 12.7 15.3 14.8 24.6 33.4 26.5 7.0 41.1 22.5 10.7 14.6 7.2 22.8 24.6 30.6 19.3 47.1 13.8 23.2 16.3 10.8 13.2 9.1 16.1 19.8 21.1 13.2 15.0 16.9 16.5 11.9 17.6 18.5 1.9 16.0 14.0 8.6 11.9 11.5 17.6 18.6 32.8 23.4 18.0 17.9 18.9 19.5 22.6 17.8 17.9 14.7 27.9 22.5 19.2 53.1 51.8 17.8 28.1 12.5 12.2 29.5 26.9 10.0 16.6 12.5 28.9 18.2 23.3 21.6 15.7 18.2 17.8 18.5 53.5 25.1 14.3 18.6 25.8 22.5 5.7 21.0 23.4 16.9 31.5 21.4 25.3 16.3 5.8 15.9 31.0 49.5 12.9 21.9 25.1 32.1 18.3 25.7 20.0 24.7 18.2 GFM2 "EFG2, FLJ21661" ENSG00000164347 "G elongation factor mitochondrial 2" Q969S9 5 74721204-74767371 "Predicted intracellular proteins" "Protein biosynthesis" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 69.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036863, HPA069871" Uncertain Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA036863: AB_2675354, HPA069871: " "unprognostic (2.58e-3)" "unprognostic (7.04e-2)" "unprognostic (8.54e-3)" "unprognostic (1.98e-1)" "unprognostic (4.49e-2)" "unprognostic (2.05e-2)" "unprognostic (1.73e-1)" "unprognostic (1.64e-1)" "unprognostic (1.40e-1)" "unprognostic (3.80e-2)" "unprognostic (2.10e-2)" "unprognostic (1.29e-1)" "prognostic favorable (1.33e-5)" "unprognostic (9.55e-2)" "unprognostic (4.15e-1)" "unprognostic (8.52e-3)" "unprognostic (9.82e-2)" 9.7 23.8 14.7 8.7 22.4 12.1 13.1 14.2 24.8 10.7 12.8 12.7 17.8 8.3 12.3 16.8 13.0 21.6 8.7 29.5 18.5 15.6 21.9 30.8 9.1 10.3 13.8 18.1 11.6 12.9 19.8 24.9 12.9 20.4 12.5 15.3 11.6 15.7 11.2 26.4 10.5 10.3 10.4 11.7 10.3 16.3 13.7 10.4 18.0 12.3 12.8 14.2 12.3 12.6 8.3 6.1 17.1 9.8 15.6 7.4 4.6 19.4 16.6 14.0 26.6 10.7 14.5 14.3 21.4 13.0 21.9 23.4 18.2 12.7 20.1 22.9 11.3 34.4 16.3 28.2 29.9 28.5 17.7 16.6 11.9 16.8 12.4 13.6 11.6 13.1 16.3 13.4 17.3 20.8 15.6 14.8 19.9 19.9 16.8 24.8 10.9 16.0 7.1 5.8 7.2 15.1 20.1 22.9 22.9 16.0 12.4 23.7 12.8 24.7 19.0 21.1 15.9 16.5 20.2 11.8 8.4 14.4 10.6 13.5 9.8 18.7 20.4 12.8 16.6 12.8 17.1 6.3 8.0 6.6 6.5 6.4 8.3 5.4 7.2 6.1 7.0 7.4 7.2 3.3 15.6 9.8 4.0 6.2 4.6 14.7 22.4 14.2 24.8 18.5 15.6 13.8 18.1 20.4 10.4 11.9 11.7 3.9 6.5 5.4 9.7 10.0 5.1 69.6 6.8 7.0 5.9 15.7 18.3 8.3 5.7 5.8 7.8 23.3 4.6 13.5 5.0 5.3 2.3 19.6 8.4 15.9 5.2 6.7 9.8 1.4 6.6 5.5 8.5 25.2 8.9 12.0 7.6 8.6 7.1 8.4 8.0 0.0 5.2 15.4 9.5 6.0 13.4 4.6 9.0 6.5 GFOD1 "ADG-90, C6orf114, FLJ20330" ENSG00000145990 "Glucose-fructose oxidoreductase domain containing 1" Q9NXC2 6 13357830-13487662 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 87.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 12.8;NK-cell: 11.4" "Group enriched" "Detected in many" 5 "granulocytes: 12.8;NK-cells: 11.4" "Cell line enhanced" "Detected in many" "HEL: 18.8;HMC-1: 29.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029096 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted - unknown location" No No "Nucleoplasm, Cytosol" "Plasma membrane" "HPA029096: AB_10602320" "unprognostic (5.00e-2)" "unprognostic (1.34e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (2.29e-5)" "unprognostic (8.49e-2)" "unprognostic (1.95e-3)" "unprognostic (1.36e-2)" "unprognostic (2.81e-1)" "unprognostic (2.34e-2)" "unprognostic (3.11e-2)" "unprognostic (6.49e-2)" "unprognostic (1.15e-1)" "prognostic unfavorable (6.72e-5)" "unprognostic (9.79e-2)" "unprognostic (1.61e-1)" "unprognostic (3.56e-1)" "unprognostic (4.66e-3)" 15.7 3.8 9.4 4.6 11.5 17.5 8.7 28.5 22.3 5.4 5.0 4.0 0.5 3.5 4.0 2.6 12.1 4.3 11.8 18.5 11.9 7.1 2.1 6.6 8.2 6.6 6.3 14.2 1.7 2.3 3.9 3.3 6.8 6.6 4.4 5.2 1.5 3.4 3.0 15.5 4.7 5.6 8.3 4.2 12.0 8.2 1.5 4.1 1.9 3.9 4.5 6.9 4.7 7.6 2.3 0.2 12.8 0.8 11.4 1.4 0.8 7.4 0.7 0.6 1.3 1.1 1.1 0.8 0.6 0.3 0.4 0.2 0.2 0.5 10.2 10.6 0.7 0.6 6.6 2.0 3.2 0.4 0.7 3.8 18.8 3.9 3.9 1.5 5.4 29.1 0.6 2.5 1.0 2.8 1.6 5.7 2.7 0.6 0.9 0.8 2.4 1.2 3.3 1.0 2.5 2.2 4.1 1.4 5.2 0.3 1.4 3.5 0.6 2.5 0.4 2.4 1.4 0.6 0.5 7.7 0.9 2.0 2.2 3.3 8.5 4.8 12.2 0.8 3.2 0.2 0.1 0.4 12.8 1.4 0.7 0.2 2.3 0.2 0.6 0.2 1.9 0.1 0.5 0.3 11.4 0.8 0.0 0.1 0.8 9.4 11.5 28.5 18.7 11.9 7.1 6.3 14.2 6.6 4.1 0.0 2.6 12.7 4.9 18.0 38.9 87.7 12.7 12.0 0.0 0.0 0.0 0.4 0.0 4.3 0.0 36.2 13.5 46.7 2.7 27.6 5.8 2.3 4.6 16.8 2.4 1.6 8.1 33.2 15.8 0.0 2.3 10.4 11.8 0.0 11.8 2.0 18.1 31.7 1.1 0.5 3.0 12.9 20.8 0.0 1.7 19.6 0.6 34.8 3.3 4.7 GFOD2 "FLJ23802, MGC11335" ENSG00000141098 "Glucose-fructose oxidoreductase domain containing 2" Q3B7J2 16 67674531-67719421 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 77.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040939, HPA041112" Uncertain Supported Nucleoplasm,Cytosol "Secreted - unknown location" NA NA Nucleoplasm Cytosol "HPA040939: AB_10796564, HPA041112: AB_10794541" "unprognostic (9.80e-2)" "unprognostic (2.20e-1)" "unprognostic (2.06e-2)" "unprognostic (3.16e-3)" "unprognostic (4.62e-2)" "unprognostic (1.38e-1)" "unprognostic (2.93e-2)" "unprognostic (5.61e-3)" "unprognostic (1.19e-1)" "unprognostic (2.22e-2)" "prognostic favorable (5.95e-4)" "unprognostic (1.17e-1)" "prognostic favorable (8.66e-4)" "unprognostic (1.90e-1)" "unprognostic (1.76e-1)" "unprognostic (7.87e-2)" "unprognostic (9.64e-2)" 9.0 9.4 9.6 7.7 13.8 13.4 8.6 42.9 18.9 10.7 10.6 5.0 9.4 10.7 8.1 5.9 21.8 12.2 8.4 6.8 10.1 12.4 9.8 24.4 7.9 6.9 8.2 11.1 5.6 9.0 14.1 11.7 19.4 10.8 7.4 8.7 6.4 8.7 7.2 6.5 14.1 8.1 8.6 5.7 12.8 7.5 8.3 5.1 6.1 9.7 13.2 12.8 9.0 16.4 9.1 6.5 10.6 5.5 6.4 10.2 4.1 9.3 15.2 9.3 19.2 9.5 7.1 11.0 7.8 10.1 14.6 15.0 12.9 8.6 15.8 7.3 9.0 7.8 11.8 9.6 9.0 12.4 9.4 11.8 4.0 8.1 18.3 7.2 6.5 7.8 5.9 10.4 19.3 5.8 7.2 21.0 16.2 8.2 3.1 8.1 19.9 10.6 7.8 12.6 5.6 8.3 17.0 5.5 12.2 8.9 13.3 19.1 11.2 19.3 6.5 5.9 5.7 9.9 4.3 16.1 11.4 11.4 10.1 7.7 8.0 11.3 17.2 7.0 9.5 8.1 0.7 5.5 5.7 5.6 3.5 9.0 8.0 9.5 9.6 5.6 9.1 8.4 6.6 10.6 6.4 3.4 6.5 10.2 4.1 9.6 13.8 42.9 18.9 10.1 12.4 8.2 11.1 10.8 5.1 0.0 5.9 5.4 11.8 20.4 12.7 3.7 20.4 20.1 10.3 10.4 13.7 8.1 5.0 17.9 77.4 35.6 18.8 0.0 10.2 17.9 10.3 10.3 4.6 39.5 5.8 20.6 41.5 26.4 6.3 21.4 8.1 4.7 8.5 3.6 15.0 11.3 13.3 18.2 10.6 10.1 9.9 6.5 12.3 14.2 17.9 23.8 18.5 10.2 15.6 15.5 GFPT1 "GFA, GFAT, GFAT1, GFPT" ENSG00000198380 "Glutamine--fructose-6-phosphate transaminase 1" Q06210 2 69319769-69387254 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms" "Aminotransferase, Transferase" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Mucus-secreting cells: 215.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047240 Approved "Nucleoplasm,Nucleoli,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli" "Nucleoli fibrillar center" "HPA047240: " "unprognostic (4.38e-3)" "unprognostic (8.20e-2)" "prognostic favorable (7.13e-5)" "unprognostic (2.97e-1)" "unprognostic (1.32e-1)" "unprognostic (2.40e-2)" "unprognostic (1.08e-2)" "unprognostic (2.11e-1)" "unprognostic (2.99e-1)" "unprognostic (3.14e-1)" "unprognostic (4.84e-2)" "unprognostic (5.00e-2)" "unprognostic (3.83e-2)" "unprognostic (9.49e-2)" "unprognostic (1.78e-1)" "unprognostic (1.63e-1)" "unprognostic (2.58e-1)" 16.7 11.4 6.4 12.7 7.8 5.6 18.3 7.8 10.1 16.8 27.0 6.4 41.2 14.5 10.1 18.7 11.6 9.5 19.4 11.3 6.0 9.8 17.8 49.1 14.1 4.7 6.5 5.7 11.1 34.9 13.9 39.6 36.5 7.0 17.2 27.5 7.7 39.7 34.0 9.2 6.1 28.2 8.7 6.2 8.2 24.6 13.9 4.8 8.5 35.2 7.7 18.1 10.6 16.2 5.6 4.1 5.9 3.4 4.1 6.8 3.0 9.6 6.7 8.7 5.4 24.2 16.7 18.7 18.5 17.2 8.7 11.1 21.4 8.8 8.7 6.7 17.1 10.9 4.7 10.8 5.6 14.4 7.9 4.1 10.1 5.0 22.1 28.7 6.9 4.0 10.5 27.6 16.9 32.4 12.1 8.1 7.5 8.4 14.2 17.0 5.7 7.2 7.2 11.2 19.9 5.6 7.3 18.0 4.4 14.2 7.7 5.3 3.0 6.9 12.8 24.7 18.7 5.1 4.3 12.4 7.8 10.4 13.3 8.8 10.2 6.8 6.6 12.7 4.7 8.9 5.9 2.8 3.4 6.8 3.2 6.5 5.6 6.1 6.6 3.6 3.4 6.1 5.6 1.3 4.1 3.4 4.1 4.3 3.0 6.4 7.8 7.8 10.1 6.0 9.8 6.5 5.7 7.0 4.8 47.6 43.8 21.6 18.1 25.2 14.6 39.1 43.3 62.9 45.5 41.8 11.8 23.5 14.9 29.0 71.7 15.1 126.6 0.0 78.9 58.2 37.0 83.5 24.2 49.7 15.2 6.4 72.2 19.6 8.8 12.1 21.6 14.3 50.6 39.7 215.3 10.9 58.8 74.8 26.5 24.3 13.7 19.4 31.7 89.0 45.3 18.3 28.7 16.6 120.1 30.1 GFRA1 "GDNFR, GDNFRA, GFR-ALPHA-1, RET1L, RETL1, TRNR1" ENSG00000151892 "GDNF family receptor alpha 1" P56159 10 116056925-116273467 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 13 "Exocrine glandular cells: 12.1;Fibroblasts: 17.1;Hepatocytes: 38.6;Muller glia cells: 12.1" "Cancer enriched" "Detected in many" 11 "breast cancer: 40.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 17.1;BJ hTERT+ SV40 Large T+ RasG12V: 29.9;EFO-21: 18.2;fHDF/TERT166: 33.0;HBF TERT88: 25.0;MCF7: 21.8;U-251 MG: 20.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043829 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA 89000 "Golgi apparatus" Nucleoplasm "HPA043829: AB_2678689" "unprognostic (2.07e-2)" "unprognostic (2.46e-1)" "unprognostic (7.60e-2)" "unprognostic (1.06e-3)" "unprognostic (4.10e-2)" "unprognostic (6.95e-3)" "unprognostic (2.35e-3)" "unprognostic (1.48e-3)" "unprognostic (3.16e-1)" "unprognostic (2.06e-3)" "unprognostic (1.31e-2)" "unprognostic (2.46e-2)" "unprognostic (1.94e-1)" "unprognostic (1.20e-3)" "unprognostic (1.69e-1)" "unprognostic (2.27e-2)" "unprognostic (3.64e-2)" 24.0 4.3 6.3 9.5 13.8 0.3 26.8 0.8 8.4 12.5 14.9 1.8 5.9 2.2 6.7 23.4 11.1 12.7 11.5 6.4 4.8 6.7 7.0 21.9 3.2 7.4 9.5 2.7 10.0 7.3 2.2 3.9 0.3 2.9 12.1 4.8 3.4 5.4 6.6 7.5 6.8 7.2 9.8 3.4 5.8 7.8 5.3 1.9 2.6 2.6 10.7 8.1 10.5 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 4.8 0.0 0.0 0.0 0.0 2.9 0.1 17.1 29.9 0.0 0.0 0.0 18.2 33.0 0.0 0.0 0.0 0.0 25.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 4.3 0.0 1.5 0.0 3.6 0.0 0.0 2.2 21.8 2.7 0.0 1.9 0.0 0.0 0.0 0.7 0.0 1.9 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.1 0.0 0.1 0.0 20.3 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 13.8 0.8 4.6 4.8 6.7 9.5 2.7 2.9 1.9 0.0 0.0 0.9 0.0 5.0 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.5 0.0 0.0 0.0 12.1 0.0 17.1 0.1 5.8 38.6 0.0 0.0 5.8 0.0 1.0 8.3 7.5 0.0 5.0 0.0 0.0 12.1 0.2 0.0 0.0 1.1 0.3 0.0 8.6 0.1 0.4 4.0 0.0 0.0 0.0 0.1 GGA1 ENSG00000100083 "Golgi associated, gamma adaptin ear containing, ARF binding protein 1" Q9UJY5 22 37608475-37633564 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 83.8" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 173.5;Spermatocytes: 198.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048280, HPA051016" Supported Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA048280: AB_2680338, HPA051016: AB_2681312" "unprognostic (1.64e-1)" "unprognostic (1.42e-2)" "unprognostic (4.08e-1)" "unprognostic (9.23e-3)" "unprognostic (2.00e-1)" "unprognostic (2.77e-2)" "prognostic unfavorable (6.29e-4)" "unprognostic (2.32e-2)" "unprognostic (2.81e-1)" "unprognostic (1.32e-1)" "prognostic favorable (4.86e-4)" "unprognostic (1.42e-2)" "unprognostic (1.53e-2)" "unprognostic (1.14e-2)" "unprognostic (1.19e-1)" "unprognostic (2.22e-1)" "unprognostic (1.16e-3)" 10.7 15.8 13.5 12.2 14.0 17.3 10.8 21.8 18.4 11.6 10.6 19.3 14.5 13.1 12.9 14.1 13.3 13.8 11.8 10.2 12.5 10.6 12.0 14.1 10.9 14.0 17.7 13.2 18.1 13.9 20.6 19.4 12.5 13.5 12.0 9.6 17.7 16.7 16.7 17.1 17.1 12.0 9.3 14.2 15.8 12.8 83.8 16.6 12.1 15.4 9.9 14.2 10.6 11.0 6.4 5.0 4.9 7.7 7.6 18.0 7.6 18.4 12.9 16.2 15.7 14.2 11.7 17.8 15.2 12.3 13.5 15.0 11.5 10.5 28.3 10.4 10.9 8.3 17.2 14.3 17.0 12.4 24.2 23.8 11.2 23.2 12.3 13.9 27.5 21.9 14.2 15.2 19.1 12.1 22.1 12.6 14.4 22.6 18.4 13.8 17.6 12.2 29.5 12.7 18.6 13.3 13.6 13.0 12.1 13.9 15.0 14.9 26.5 9.7 20.4 23.6 16.1 21.3 20.0 15.1 18.4 18.0 16.5 12.1 39.7 15.9 29.3 20.6 16.7 16.1 4.9 7.7 4.3 14.0 7.6 17.3 6.4 5.6 18.0 5.0 4.1 4.2 13.0 3.3 7.6 5.5 4.3 5.8 7.6 13.5 14.0 21.8 18.4 12.5 10.6 17.7 13.2 13.5 16.6 23.8 36.3 43.5 27.8 21.5 53.9 15.9 15.3 34.8 22.7 41.8 78.5 30.7 5.0 30.2 118.6 26.2 53.9 0.0 17.7 31.6 17.1 20.5 48.5 18.1 69.1 23.8 31.2 32.5 44.8 173.5 24.5 44.5 15.1 46.9 35.7 41.0 27.7 42.1 21.2 10.3 73.2 25.8 21.2 198.9 40.2 25.0 47.5 91.4 34.6 30.1 GGT7 "D20S101, dJ18C9.2, GGTL3, GGTL5" ENSG00000131067 "Gamma-glutamyltransferase 7" Q9UJ14 20 34844720-34872860 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glutathione biosynthesis" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 38.6;Horizontal cells: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013204, HPA013339" Approved Approved Nucleoplasm,Vesicles NA NA 1500000 Vesicles Nucleoplasm "HPA013204: AB_1850347, HPA013339: AB_2668816" "unprognostic (1.32e-3)" "unprognostic (2.33e-1)" "unprognostic (9.31e-2)" "prognostic unfavorable (1.26e-5)" "unprognostic (1.27e-1)" "unprognostic (6.55e-2)" "unprognostic (1.46e-3)" "unprognostic (2.49e-2)" "unprognostic (3.49e-1)" "unprognostic (1.16e-2)" "unprognostic (3.34e-3)" "unprognostic (3.61e-2)" "unprognostic (5.00e-3)" "unprognostic (1.81e-1)" "unprognostic (1.63e-1)" "unprognostic (5.50e-2)" "unprognostic (2.00e-1)" 6.8 6.7 21.6 6.7 23.7 2.9 8.5 42.6 29.1 9.5 11.5 9.7 14.3 9.8 12.3 19.5 6.4 10.5 11.4 13.8 19.7 17.0 9.9 7.2 9.0 10.3 11.2 32.1 13.4 19.5 20.8 18.3 8.5 19.2 11.4 9.6 6.9 18.8 15.3 31.6 11.1 9.0 9.6 11.0 8.3 12.9 5.0 15.6 4.9 16.3 4.3 8.2 9.3 8.5 6.1 2.6 1.5 3.0 3.2 12.8 1.8 2.2 3.3 17.0 17.4 13.4 12.0 15.1 9.4 9.6 7.8 11.6 17.4 11.1 0.0 11.2 7.3 7.9 1.5 7.3 4.1 5.1 0.7 13.1 6.7 5.9 9.1 12.0 0.3 11.1 17.4 4.7 8.7 4.0 23.3 0.6 8.9 5.0 1.2 5.3 3.8 1.7 3.4 3.9 3.8 1.7 0.0 11.6 10.7 11.3 3.3 9.9 11.6 4.8 7.7 12.1 6.7 5.9 6.1 0.2 26.8 10.7 2.5 5.3 13.1 1.7 0.8 31.5 0.6 9.8 1.5 3.0 1.4 7.4 2.0 2.1 5.6 6.3 2.8 2.6 6.1 12.8 8.9 0.3 3.2 0.7 1.4 4.8 1.8 21.6 23.7 42.6 29.1 19.7 17.0 11.2 32.1 19.2 15.6 3.0 2.4 0.9 17.1 6.5 38.6 1.6 22.9 1.4 3.4 17.4 11.8 18.6 0.0 13.9 2.1 2.1 10.5 0.0 4.9 9.8 11.9 9.2 2.3 10.2 4.0 38.1 10.4 0.6 1.9 0.5 11.5 2.4 10.1 3.6 16.0 9.4 6.7 14.0 7.4 5.1 16.9 6.5 8.6 11.1 10.6 3.8 14.1 4.1 17.8 12.0 GID8 "bA305P22.1, C20orf11, FLJ20602, TWA1" ENSG00000101193 "GID complex subunit 8 homolog" Q9NWU2 20 62938119-62948475 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049929, HPA055047" Approved Supported "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA049929: AB_2680957, HPA055047: AB_2682682" "unprognostic (1.35e-1)" "unprognostic (4.06e-2)" "unprognostic (5.90e-2)" "prognostic unfavorable (4.78e-4)" "unprognostic (1.19e-1)" "unprognostic (8.25e-2)" "unprognostic (3.88e-2)" "unprognostic (4.58e-2)" "unprognostic (2.16e-1)" "unprognostic (1.83e-1)" "unprognostic (2.72e-2)" "unprognostic (1.43e-1)" "prognostic favorable (3.22e-4)" "unprognostic (3.97e-1)" "unprognostic (1.43e-1)" "unprognostic (2.01e-1)" "unprognostic (6.87e-2)" 14.0 14.1 23.0 15.4 18.7 35.5 21.5 20.7 23.5 20.8 18.6 14.3 21.0 15.1 18.2 19.5 55.9 23.0 19.0 15.9 17.4 10.9 15.6 29.6 15.2 24.2 15.5 22.9 30.6 30.0 22.2 15.7 15.1 14.7 17.8 16.1 17.7 21.2 17.7 19.7 34.0 17.1 19.8 14.1 19.6 20.1 22.4 17.2 23.6 20.6 26.0 24.6 22.8 28.7 9.3 9.8 16.0 10.4 12.9 15.0 8.3 15.7 10.1 15.1 13.6 12.5 9.8 14.8 8.8 7.4 25.3 11.5 48.5 15.4 19.8 15.2 11.4 10.4 18.3 13.8 18.3 15.4 5.2 6.8 18.4 13.1 23.2 9.8 21.4 15.6 10.8 20.4 10.9 12.7 9.2 12.3 13.2 14.1 8.6 8.7 22.1 25.4 19.1 15.2 26.3 15.1 20.2 28.4 11.8 9.3 22.3 15.7 12.9 20.8 20.5 12.8 11.7 28.5 20.7 12.3 15.2 19.1 11.9 11.9 9.1 10.4 20.6 10.2 10.5 9.6 5.8 10.4 16.0 11.7 8.7 13.7 8.4 12.3 13.0 9.8 9.3 13.6 15.0 15.2 12.9 8.1 7.4 10.6 8.3 23.0 18.7 20.7 23.5 17.4 10.9 15.5 22.9 14.7 17.2 17.9 27.2 31.3 42.8 45.8 21.3 25.4 43.3 17.4 20.5 38.4 5.9 83.9 34.9 39.5 12.5 33.3 40.2 46.7 35.2 85.8 31.3 46.5 26.5 68.6 45.9 15.9 43.3 38.6 41.2 13.8 30.5 33.4 23.6 50.5 43.5 27.0 35.3 31.6 39.6 32.0 15.2 12.9 28.3 38.7 59.5 69.8 131.2 40.8 49.4 46.5 GIN1 "FLJ20125, GIN-1, TGIN1, ZH2C2" ENSG00000145723 "Gypsy retrotransposon integrase 1" Q9NXP7 5 103086000-103120151 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 24.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037402, HPA061362" Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA037402: AB_10672790, HPA061362: AB_2684491" "unprognostic (3.89e-2)" "unprognostic (5.52e-2)" "unprognostic (1.57e-2)" "unprognostic (1.53e-1)" "unprognostic (7.98e-2)" "unprognostic (1.81e-1)" "unprognostic (4.64e-2)" "unprognostic (3.02e-2)" "unprognostic (4.66e-2)" "unprognostic (3.01e-2)" "unprognostic (9.60e-3)" "unprognostic (1.20e-1)" "prognostic favorable (1.63e-4)" "unprognostic (1.89e-1)" "unprognostic (4.39e-1)" "unprognostic (3.14e-2)" "unprognostic (3.08e-2)" 6.0 9.3 5.0 5.7 9.5 1.4 8.0 15.0 9.6 9.0 7.0 6.5 6.1 4.9 7.0 5.6 7.2 6.4 3.7 12.7 5.8 5.1 7.9 8.3 5.6 6.6 14.0 4.2 11.0 6.0 8.4 17.4 5.1 9.4 8.3 6.7 3.6 6.1 7.6 14.6 4.5 5.9 5.8 11.4 6.9 6.3 9.3 10.8 8.6 9.1 6.1 6.7 9.4 9.5 4.6 3.3 4.8 7.1 3.7 8.3 2.8 5.5 6.0 7.6 5.5 3.6 9.3 6.2 7.4 5.1 5.6 5.0 3.6 7.2 3.3 7.0 2.9 4.8 6.6 7.0 10.5 7.6 4.2 5.6 4.8 5.8 4.0 7.5 4.3 3.1 3.6 11.7 5.1 10.5 6.0 4.4 5.5 4.2 4.9 8.8 4.0 5.9 2.8 6.5 4.0 9.4 5.3 8.7 8.6 7.4 4.6 6.2 4.5 4.9 4.1 7.1 5.7 12.0 6.5 3.6 5.7 3.5 6.1 5.6 6.0 4.8 4.8 7.3 6.8 4.6 0.4 2.7 4.8 3.4 3.4 3.9 4.6 4.6 5.0 3.3 3.8 5.6 5.6 3.8 3.7 7.1 3.2 8.3 2.8 5.0 9.5 15.0 9.6 5.8 5.1 14.0 4.2 9.4 10.8 8.9 4.0 1.4 4.8 0.8 9.5 16.5 0.0 8.1 3.4 5.2 0.0 6.6 19.9 6.7 1.0 3.0 3.2 0.0 3.7 4.0 2.4 3.6 16.1 3.9 4.8 0.0 4.1 3.1 3.2 0.2 4.6 5.3 0.0 3.6 3.3 8.5 3.6 3.1 6.3 6.7 12.1 6.5 3.9 24.0 12.8 1.8 6.9 4.3 3.2 3.1 GINS1 "KIAA0186, PSF1" ENSG00000101003 "GINS complex subunit 1" Q14691 20 25407727-25452628 "Predicted intracellular proteins" "DNA replication" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.1;testis: 21.4" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 43.6;Extravillous trophoblasts: 14.7;Late spermatids: 17.2;Spermatogonia: 20.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051185 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA051185: AB_2681378" "unprognostic (6.10e-3)" "unprognostic (2.58e-1)" "unprognostic (5.37e-3)" "unprognostic (1.74e-3)" "unprognostic (2.00e-1)" "unprognostic (3.11e-2)" "prognostic unfavorable (4.61e-7)" "unprognostic (5.86e-3)" "unprognostic (1.42e-2)" "unprognostic (1.32e-2)" "prognostic unfavorable (5.62e-4)" "unprognostic (1.44e-1)" "prognostic unfavorable (5.42e-11)" "unprognostic (5.24e-2)" "unprognostic (1.03e-1)" "unprognostic (4.60e-2)" "unprognostic (2.55e-1)" 1.5 1.9 4.1 11.7 4.2 4.5 2.2 7.4 4.3 2.2 4.5 1.3 0.0 4.3 2.2 1.0 8.5 1.4 2.3 1.0 2.2 2.2 2.2 2.0 1.4 7.2 1.9 2.1 1.7 1.8 1.1 0.8 5.5 2.2 1.4 5.9 1.3 2.1 0.7 0.7 5.3 4.1 2.8 1.8 3.4 2.9 21.4 0.9 20.1 1.0 6.4 10.5 2.6 3.2 2.6 2.3 1.3 1.0 1.9 3.5 0.9 18.0 16.4 20.2 13.1 1.1 1.6 20.4 8.0 3.9 15.5 16.5 14.2 18.1 22.3 9.2 3.3 11.5 21.0 17.6 14.8 18.0 5.9 6.1 15.3 6.0 17.2 0.4 20.0 7.0 0.7 0.8 14.7 3.0 2.1 8.2 12.8 14.7 14.7 9.2 19.5 30.7 15.0 13.7 12.6 8.6 22.0 23.3 15.1 5.9 12.2 8.5 8.9 8.2 19.6 6.9 11.9 18.6 10.1 3.7 12.2 13.2 7.9 14.6 5.9 16.7 17.6 3.2 19.6 13.7 0.8 0.8 0.5 1.5 1.0 0.9 2.6 1.1 0.5 2.1 1.7 0.8 1.4 1.3 1.9 1.0 2.3 3.5 0.9 4.1 4.2 7.4 4.3 2.2 2.2 1.9 2.1 2.2 0.9 0.0 1.1 0.8 0.4 2.9 1.3 0.3 0.0 2.7 2.3 1.8 0.0 5.0 0.0 1.3 43.6 0.1 0.5 0.0 0.6 14.7 1.4 0.4 1.1 0.0 4.8 0.0 1.2 1.3 1.3 17.2 0.6 1.5 0.0 0.0 1.2 1.3 0.4 0.0 1.1 1.8 0.1 0.0 0.9 8.9 20.9 1.3 2.1 0.0 2.8 0.4 GINS2 "Pfs2, PSF2" ENSG00000131153 "GINS complex subunit 2" Q9Y248 16 85676198-85690073 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 25.2;testis: 21.3" "Cell type enhanced" "Detected in many" 11 "Spermatocytes: 65.9;Spermatogonia: 96.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 11.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 72.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA057285 Uncertain Approved Nucleoplasm No Yes Nucleoplasm "HPA057285: AB_2683398" "unprognostic (3.22e-2)" "unprognostic (1.13e-3)" "unprognostic (2.04e-3)" "unprognostic (2.09e-1)" "unprognostic (2.64e-1)" "unprognostic (1.30e-1)" "unprognostic (2.45e-3)" "unprognostic (2.58e-2)" "unprognostic (1.67e-2)" "unprognostic (2.52e-3)" "unprognostic (2.19e-2)" "unprognostic (5.82e-3)" "unprognostic (5.70e-3)" "unprognostic (4.54e-2)" "unprognostic (6.30e-2)" "unprognostic (5.44e-3)" "unprognostic (1.60e-1)" 0.9 1.5 3.5 15.9 3.7 13.2 3.6 3.8 2.1 1.9 6.5 1.9 1.5 4.7 1.8 2.6 7.1 0.9 2.2 1.6 4.8 1.5 1.3 3.3 1.4 8.7 2.2 1.5 1.9 4.4 2.6 1.4 4.6 1.6 2.6 7.4 1.9 2.0 0.7 3.2 3.1 5.9 1.5 2.3 7.6 2.1 21.3 1.8 25.2 1.8 8.0 13.3 1.9 3.0 1.4 1.7 1.5 3.3 4.3 11.1 2.4 13.4 9.7 19.0 7.9 0.5 1.9 5.0 9.3 3.7 13.7 8.5 12.8 9.0 15.9 5.1 3.2 7.2 10.3 20.0 7.6 13.3 5.5 17.3 7.8 7.4 14.4 0.1 5.4 4.3 0.5 0.9 8.2 3.2 1.7 5.8 12.9 21.4 3.8 7.9 28.2 19.1 20.5 10.6 11.9 7.4 26.8 11.5 8.8 4.4 5.6 26.2 8.3 13.4 2.7 2.7 7.9 27.6 7.4 3.5 9.0 12.1 8.4 10.6 7.1 12.5 72.1 5.2 11.5 10.2 0.7 0.3 1.5 1.4 1.3 0.2 1.4 4.7 3.1 1.7 1.0 2.2 1.6 1.2 4.3 3.3 1.0 11.1 2.4 3.5 3.7 3.8 2.1 4.8 1.5 2.2 1.5 1.6 1.8 3.0 0.0 6.7 6.6 8.1 7.1 1.1 0.0 2.7 4.5 3.5 2.0 17.0 3.3 6.0 8.2 0.6 1.6 23.3 1.3 22.7 3.1 2.7 1.1 1.7 19.7 7.9 2.9 0.0 0.6 22.2 1.1 2.8 0.0 1.0 8.2 3.4 1.5 5.8 1.8 0.3 8.0 19.4 3.1 65.9 96.9 3.3 10.6 5.1 29.9 1.6 GINS3 "FLJ13912, PSF3" ENSG00000181938 "GINS complex subunit 3" Q9BRX5 16 58295080-58406144 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 15.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-698: 53.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041216, HPA048209" Uncertain Enhanced Nucleoplasm No No Nucleoplasm "HPA041216: AB_10794989, HPA048209: AB_2680314" "unprognostic (3.12e-1)" "unprognostic (1.10e-1)" "unprognostic (4.04e-3)" "unprognostic (6.34e-2)" "unprognostic (4.70e-2)" "unprognostic (2.82e-1)" "unprognostic (1.75e-4)" "unprognostic (7.76e-2)" "unprognostic (1.76e-3)" "unprognostic (7.19e-2)" "unprognostic (4.50e-2)" "unprognostic (2.67e-3)" "unprognostic (1.14e-7)" "unprognostic (9.76e-3)" "unprognostic (5.34e-2)" "unprognostic (8.23e-2)" "unprognostic (1.07e-2)" 5.5 10.6 3.3 5.6 11.4 9.9 4.4 20.4 4.7 5.9 6.6 3.2 13.2 4.3 5.6 5.5 11.5 3.4 3.3 8.2 3.5 3.6 5.3 4.2 6.1 10.0 5.8 1.5 2.8 2.3 6.0 4.2 6.3 4.5 3.5 6.0 3.3 4.8 10.0 3.9 5.4 5.0 5.1 4.1 11.9 3.4 8.0 4.9 17.5 4.9 14.3 13.1 3.8 7.9 4.7 10.9 0.5 2.4 5.0 4.1 2.1 7.3 8.3 10.0 5.4 1.1 1.4 5.0 8.4 3.7 13.4 10.2 6.1 7.4 12.8 6.7 2.8 10.1 7.0 9.2 7.0 15.2 7.1 11.3 7.5 4.7 7.4 0.6 9.5 12.9 1.6 1.3 6.9 2.4 3.0 9.1 10.7 11.9 5.5 5.6 7.5 17.3 8.7 9.4 6.3 17.1 30.1 11.1 16.3 4.9 4.7 11.6 7.7 13.9 9.2 4.6 4.2 4.8 7.8 3.8 9.1 10.6 5.4 10.4 5.5 7.1 53.9 6.3 9.6 11.0 0.2 2.4 0.2 2.9 2.2 2.1 3.5 2.4 4.1 5.5 4.7 2.3 3.6 0.5 5.0 1.2 10.9 3.2 2.1 3.3 11.4 20.4 4.3 3.5 3.6 5.8 1.5 4.5 4.9 0.0 1.6 5.2 3.9 1.5 1.3 3.0 0.0 1.4 1.2 0.0 2.0 4.9 0.0 3.1 15.8 2.8 0.5 0.0 1.8 6.7 1.0 1.5 1.1 0.8 2.4 4.8 0.0 2.5 2.1 7.1 1.4 1.1 1.7 2.8 0.6 1.5 1.5 0.0 1.1 0.4 1.8 6.5 1.5 4.2 8.1 2.0 2.6 2.5 2.2 5.4 GINS4 "MGC14799, SLD5" ENSG00000147536 "GINS complex subunit 4" Q9BRT9 8 41529206-41545046 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "B-cells: 13.0;monocytes: 15.4;Spermatogonia: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024663, HPA026580" Uncertain Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA024663: AB_1857224, HPA026580: AB_1857225" "unprognostic (7.74e-2)" "unprognostic (3.72e-2)" "unprognostic (2.25e-3)" "prognostic unfavorable (2.30e-5)" "unprognostic (1.70e-1)" "unprognostic (4.01e-2)" "unprognostic (1.71e-3)" "unprognostic (8.01e-3)" "unprognostic (4.03e-3)" "unprognostic (1.50e-2)" "unprognostic (4.34e-4)" "unprognostic (1.79e-1)" "unprognostic (3.67e-5)" "unprognostic (2.40e-3)" "unprognostic (1.39e-1)" "unprognostic (4.11e-1)" "unprognostic (3.22e-1)" 2.0 3.0 2.3 6.2 4.7 9.0 2.7 1.6 3.7 2.7 3.4 6.8 0.0 2.5 2.4 3.0 6.0 1.6 2.4 5.7 3.7 1.8 2.2 2.2 2.5 7.9 5.9 3.3 2.6 1.3 1.6 1.2 4.8 2.8 1.8 5.1 1.9 2.6 0.8 3.7 3.4 3.7 2.4 4.7 5.0 2.1 8.6 5.6 14.0 2.1 5.7 9.6 2.1 3.0 5.8 5.2 3.9 1.4 2.7 6.7 1.7 9.7 14.0 19.8 8.9 1.2 1.6 8.2 13.9 8.4 14.4 17.0 12.9 8.5 13.5 5.7 7.0 11.0 7.4 15.9 11.4 21.3 5.0 8.9 19.6 10.3 8.7 0.3 4.2 10.2 0.8 0.5 23.8 5.3 3.3 7.1 16.4 9.6 4.5 10.1 6.6 17.6 4.8 11.0 10.4 7.7 16.6 18.5 5.7 5.1 9.3 6.1 4.8 9.8 4.4 4.0 10.5 11.3 4.7 4.9 9.8 14.9 18.0 13.9 5.3 7.8 16.1 7.0 10.1 23.7 2.4 1.4 0.5 3.0 1.3 1.7 2.4 4.8 2.0 0.7 5.8 3.1 2.0 3.9 2.7 0.7 5.2 6.7 1.7 2.3 4.7 1.6 3.7 3.7 1.8 5.9 3.3 2.8 5.6 0.0 1.4 13.0 2.6 2.5 5.0 0.8 0.0 0.0 1.2 8.7 2.0 6.2 0.0 1.3 0.5 0.7 0.4 0.0 1.6 10.0 2.6 1.1 1.1 0.5 4.0 0.0 3.4 1.3 1.9 0.0 1.1 4.0 0.0 15.4 2.3 1.9 1.5 0.0 2.1 0.8 1.8 0.0 1.4 7.7 11.5 1.0 4.9 4.9 3.3 0.8 GIPC1 "C19orf3, GIPC, GLUT1CBP, Hs.6454, NIP, RGS19IP1, SEMCAP, SYNECTIN, TIP-2" ENSG00000123159 "GIPC PDZ domain containing family member 1" O14908 19 14477760-14496149 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 262.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043958, HPA061786" Approved Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "HPA043958: AB_10963436, HPA061786: AB_2756319" "unprognostic (2.80e-1)" "unprognostic (1.16e-1)" "unprognostic (8.21e-2)" "unprognostic (1.03e-1)" "unprognostic (2.82e-1)" "unprognostic (1.07e-1)" "unprognostic (1.18e-2)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" "unprognostic (4.82e-2)" "unprognostic (3.53e-2)" "unprognostic (7.72e-2)" "unprognostic (1.04e-2)" "unprognostic (7.17e-3)" "unprognostic (1.70e-1)" "unprognostic (1.16e-1)" "unprognostic (8.82e-2)" 16.4 15.1 17.4 12.0 21.0 2.0 11.2 12.1 28.8 19.4 51.0 29.7 15.3 14.2 11.9 14.9 71.2 14.4 21.2 17.9 16.9 14.8 18.7 16.9 20.5 7.9 18.3 23.0 10.2 15.1 6.5 12.4 24.0 23.0 14.0 23.9 15.2 22.1 19.6 26.8 40.4 13.3 15.8 21.8 10.8 35.7 6.5 16.6 11.1 18.2 26.0 24.7 17.1 26.3 2.0 4.0 2.4 1.2 1.5 12.1 1.9 66.0 30.7 9.4 14.7 8.7 8.8 7.4 24.8 12.6 20.5 18.6 16.4 25.1 0.9 46.8 17.5 13.7 38.0 8.0 20.8 7.0 6.8 14.4 12.9 21.0 16.0 26.8 1.3 16.0 10.1 20.8 12.4 10.9 12.2 13.8 9.8 6.0 11.4 10.4 49.3 4.2 2.6 10.2 37.0 30.8 4.4 7.9 8.8 25.2 57.9 8.8 9.8 13.9 34.3 31.8 5.1 21.5 7.2 23.8 29.0 16.0 40.4 26.5 10.7 13.6 3.3 24.3 10.5 30.4 2.4 0.8 0.1 5.8 1.2 5.4 2.0 5.9 5.9 1.2 1.0 4.9 3.9 0.3 1.5 0.5 4.0 12.1 1.9 17.4 21.0 12.1 28.8 16.9 14.8 18.3 23.0 23.0 16.6 26.8 14.6 11.5 47.9 101.2 65.6 12.9 17.8 4.0 15.9 78.5 33.4 29.4 44.7 162.1 0.8 27.0 262.4 0.0 146.8 55.5 40.6 96.5 10.3 16.4 46.4 71.5 41.3 19.0 9.5 1.9 19.0 13.8 55.6 37.9 62.6 60.8 195.2 130.6 23.7 38.4 38.1 19.4 38.2 7.4 20.6 148.3 21.5 13.8 65.5 154.2 GIPC2 "FLJ20075, SEMCAP-2" ENSG00000137960 "GIPC PDZ domain containing family member 2" Q8TF65 1 77979542-78138449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 64.0" "Cell type enhanced" "Detected in many" 13 "Enterocytes: 48.7;Proximal tubular cells: 149.4;Undifferentiated cells: 50.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.9;naive CD4 T-cell: 1.4" "Lineage enriched" "Detected in single" 17 "T-cells: 1.9" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.2;HaCaT: 4.9;Hep G2: 18.3;HUVEC TERT2: 19.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA051212, HPA062684" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051212: , HPA062684: AB_2684833" "unprognostic (1.72e-2)" "unprognostic (9.37e-2)" "prognostic favorable (5.49e-4)" "unprognostic (1.09e-2)" "unprognostic (1.43e-1)" "unprognostic (2.29e-2)" "unprognostic (2.01e-1)" "unprognostic (2.35e-1)" "unprognostic (7.63e-2)" "unprognostic (2.22e-1)" "unprognostic (5.91e-2)" "unprognostic (1.44e-1)" "prognostic favorable (2.11e-6)" "unprognostic (6.55e-2)" "unprognostic (1.78e-1)" "unprognostic (4.18e-2)" "unprognostic (1.29e-1)" 6.4 17.0 0.8 3.2 0.9 0.0 4.0 0.4 1.0 2.6 27.0 0.3 0.2 19.6 5.4 4.5 5.7 1.4 8.1 3.1 0.5 0.5 21.3 10.4 3.2 2.2 0.5 0.3 3.7 24.7 3.3 2.5 1.6 1.3 2.1 7.8 1.5 6.9 1.0 1.8 2.7 64.0 1.4 0.6 22.7 3.0 2.2 0.4 0.1 1.5 4.9 1.4 2.5 5.1 0.1 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.0 5.2 0.0 0.8 0.0 0.4 0.9 4.1 2.7 1.2 0.0 0.4 0.0 4.9 0.0 0.0 2.7 0.1 0.0 0.6 0.0 18.3 1.0 0.0 0.0 0.8 0.0 2.9 0.1 0.0 19.3 0.0 0.0 0.1 2.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.9 0.0 1.0 0.6 0.0 0.1 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.4 1.0 0.5 0.5 0.5 0.3 1.3 0.4 0.0 2.2 1.3 2.0 11.4 0.4 2.6 25.5 12.0 3.4 8.7 2.0 5.2 28.2 9.6 1.7 13.7 48.7 0.0 29.0 1.9 1.6 0.5 0.0 39.9 10.0 0.0 2.9 11.1 0.6 0.5 1.1 0.2 0.0 1.8 34.6 0.0 18.0 31.7 0.0 149.4 0.5 0.0 1.3 0.5 0.2 19.1 1.4 0.5 50.7 5.6 GIPC3 "C19orf64, DFNB15, DFNB72, DFNB95" ENSG00000179855 "GIPC PDZ domain containing family member 3" Q8TF64 19 3585553-3593541 "Disease related genes, Predicted intracellular proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 6 "Ito cells: 16.0;Rod photoreceptor cells: 20.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.2" "Lineage enriched" "Detected in single" 9 "T-cells: 1.2" "Cell line enhanced" "Detected in some" "HeLa: 12.3;HMC-1: 7.9;THP-1: 14.8;WM-115: 29.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067765 Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA 13000 Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA067765: " "unprognostic (1.77e-1)" "unprognostic (1.73e-1)" "unprognostic (5.13e-2)" "unprognostic (6.99e-2)" "unprognostic (1.22e-1)" "unprognostic (1.76e-2)" "unprognostic (1.41e-1)" "unprognostic (3.67e-3)" "unprognostic (4.76e-2)" "unprognostic (2.97e-1)" "unprognostic (5.06e-3)" "unprognostic (2.26e-2)" "unprognostic (1.51e-3)" "unprognostic (1.96e-2)" "unprognostic (1.67e-1)" "unprognostic (2.75e-1)" "unprognostic (9.06e-2)" 5.5 2.4 1.3 1.3 1.3 0.0 3.0 1.3 1.3 3.4 1.5 1.9 5.0 1.0 4.5 3.2 6.0 2.2 2.1 2.7 1.3 0.6 4.1 1.6 4.5 2.0 1.3 1.3 1.3 1.3 4.6 1.3 1.3 1.3 4.3 1.3 1.9 1.3 5.2 1.3 1.1 5.4 9.3 1.3 4.8 2.0 1.3 2.2 2.0 3.8 1.3 1.4 1.3 13.0 0.1 0.1 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.6 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.9 0.0 1.0 0.0 0.1 4.4 12.3 0.0 0.5 0.0 7.9 0.1 0.0 0.7 0.0 0.0 1.4 0.1 2.0 0.0 0.2 0.0 0.0 0.7 0.5 0.0 0.8 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.3 0.0 3.0 0.8 0.0 14.8 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 29.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.6 0.5 0.0 0.0 0.0 0.1 0.0 0.3 1.3 1.3 1.3 1.3 1.3 0.6 1.3 1.3 1.3 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 16.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 20.5 0.0 1.2 0.0 0.4 0.3 0.1 0.0 0.0 0.0 GJA1 "CX43, GJAL, ODD, ODDD, ODOD, SDTY3" ENSG00000152661 "Gap junction protein alpha 1" P17302 6 121435692-121449727 "Cancer-related genes, Disease related genes, Predicted membrane proteins" "Cancer-related genes, Cataract, Disease mutation, Hypotrichosis, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 232.3;Basal keratinocytes: 208.6;Cardiomyocytes: 174.1;Fibroblasts: 139.5;Suprabasal keratinocytes: 330.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 73.4;HUVEC TERT2: 56.2;NTERA-2: 57.2;SuSa: 74.9;U-87 MG: 55.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010753, HPA035097, HPA047551, HPA069245" Enhanced Supported Supported "Nucleoplasm,Vesicles,Cell Junctions" NA NA "Vesicles, Cell Junctions" Nucleoplasm "CAB010753: AB_476857, HPA035097: AB_2674460, HPA047551: AB_2732540, HPA069245: " "unprognostic (3.37e-2)" "unprognostic (3.41e-3)" "unprognostic (2.95e-1)" "unprognostic (4.18e-2)" "unprognostic (1.48e-2)" "unprognostic (1.67e-2)" "unprognostic (1.27e-1)" "unprognostic (6.78e-2)" "unprognostic (2.89e-2)" "unprognostic (1.56e-1)" "unprognostic (5.47e-2)" "unprognostic (1.00e-1)" "unprognostic (4.88e-2)" "prognostic unfavorable (4.99e-5)" "unprognostic (2.39e-1)" "unprognostic (1.29e-1)" "unprognostic (3.00e-3)" 19.7 65.2 78.6 5.5 69.7 0.4 14.2 32.4 44.4 64.5 4.0 23.8 6.1 4.2 23.5 5.5 17.3 7.8 23.0 36.0 87.3 25.5 3.6 2.5 15.2 4.4 42.9 39.9 10.5 4.5 94.7 5.7 63.8 53.7 20.0 4.8 26.3 7.1 35.7 3.4 86.3 4.4 25.6 38.7 1.1 6.4 8.3 64.3 0.5 38.9 9.9 7.6 14.8 32.2 0.5 0.5 0.4 0.5 0.0 0.4 0.0 0.0 6.6 29.3 0.0 16.0 9.9 0.0 21.9 44.6 7.4 18.1 0.1 0.0 0.0 2.4 8.5 6.3 2.8 0.7 13.4 24.1 0.0 8.0 0.3 2.7 0.0 20.0 0.0 0.0 26.4 14.5 27.1 9.8 73.4 56.2 0.0 0.0 0.6 1.4 1.2 0.0 11.7 57.2 0.0 7.3 0.0 0.0 0.5 29.6 3.2 0.0 0.4 0.0 0.0 0.0 74.9 2.3 0.0 41.3 22.8 6.3 19.2 14.1 0.0 0.0 0.0 55.7 0.0 3.2 0.4 0.5 0.0 0.2 0.0 0.2 0.0 0.3 0.0 0.2 0.5 0.4 0.4 0.0 0.0 0.1 0.5 0.1 0.0 78.6 69.7 32.4 42.8 87.3 25.5 42.9 39.9 53.7 64.3 232.3 73.8 0.0 121.0 208.6 0.2 174.1 0.0 5.3 14.8 1.8 2.0 46.7 0.0 69.9 0.3 111.0 0.0 0.0 3.5 8.1 139.5 19.9 8.1 0.0 7.5 0.0 0.0 22.7 0.3 1.1 2.3 2.8 42.2 1.0 0.0 0.1 17.0 0.0 3.9 0.0 0.2 0.0 27.8 0.3 0.1 330.6 16.7 0.0 0.0 45.0 GK5 MGC40579 ENSG00000175066 "Glycerol kinase 5 (putative)" Q6ZS86 3 142157527-142225607 "Enzymes, Predicted intracellular proteins" "Glycerol metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042606, HPA057998" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA042606: AB_10795509, HPA057998: AB_2683573" "unprognostic (7.79e-2)" "unprognostic (5.15e-2)" "unprognostic (2.02e-2)" "unprognostic (1.33e-1)" "unprognostic (3.07e-2)" "unprognostic (3.60e-2)" "unprognostic (9.89e-3)" "unprognostic (3.13e-1)" "unprognostic (2.77e-2)" "unprognostic (1.76e-2)" "unprognostic (7.76e-2)" "unprognostic (2.03e-1)" "unprognostic (1.12e-2)" "unprognostic (2.10e-3)" "unprognostic (4.49e-2)" "unprognostic (1.32e-1)" "unprognostic (5.59e-3)" 6.1 12.2 5.6 5.7 7.2 10.8 10.9 9.0 9.4 11.5 10.9 8.4 11.5 14.4 10.9 14.8 7.9 7.2 8.3 5.4 5.5 4.1 5.7 3.1 6.2 3.5 9.3 6.0 11.5 4.8 5.4 20.3 3.7 12.6 13.5 11.8 6.7 14.8 14.7 5.0 8.8 14.0 9.4 11.6 3.5 8.1 6.2 5.3 4.6 7.4 4.2 6.1 8.5 6.7 1.3 1.1 3.6 5.3 3.8 3.8 0.5 11.0 2.8 4.0 2.7 8.3 15.9 6.9 3.7 2.6 4.1 2.6 4.2 6.1 8.0 3.3 3.5 4.5 4.7 4.6 3.5 5.4 2.8 4.4 5.2 6.6 3.1 4.5 5.9 6.9 6.5 3.1 2.7 3.6 2.6 2.3 9.2 4.5 4.9 7.3 7.1 5.2 4.9 2.6 7.4 3.2 4.9 4.3 2.9 4.2 6.9 3.9 2.9 10.2 10.8 3.3 2.5 15.0 3.9 2.5 3.2 2.7 7.1 4.0 5.1 4.9 8.1 5.8 3.7 5.4 3.6 1.1 0.7 3.8 0.9 1.9 0.5 1.3 1.4 0.8 1.3 1.0 1.7 3.2 3.8 5.3 1.1 0.6 0.5 5.6 7.2 9.0 9.4 5.5 4.1 9.3 6.0 12.6 5.3 35.7 27.8 0.0 11.1 3.5 30.1 9.3 15.3 21.4 27.3 26.2 27.5 11.1 6.6 12.3 2.0 5.9 31.1 0.0 17.9 6.4 7.8 21.5 8.1 11.1 5.0 14.3 26.9 2.5 10.0 3.6 31.4 8.2 3.3 1.0 51.9 13.2 13.9 39.1 43.9 5.1 35.7 25.8 4.9 4.2 4.7 3.4 5.7 17.5 38.6 11.6 GLB1L2 ENSG00000149328 "Galactosidase beta 1 like 2" Q8IW92 11 134331874-134378341 "Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 36.2" "Cell type enriched" "Detected in many" 4 "Rod photoreceptor cells: 158.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 11.2" "Cell type enhanced" "Detected in many" "gdT-cell: 5.8;NK-cell: 5.8" "Group enriched" "Detected in many" 23 "NK-cells: 5.8;T-cells: 5.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 19.6;HaCaT: 20.7;OE19: 47.6;SCLC-21H: 14.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA054808, HPA059955" Uncertain Approved Nucleoplasm,Vesicles "Secreted - unknown location" NA NA Nucleoplasm Vesicles "HPA054808: AB_2682608, HPA059955: AB_2684178" "unprognostic (2.63e-2)" "unprognostic (9.77e-3)" "unprognostic (2.32e-2)" "unprognostic (2.20e-2)" "unprognostic (8.07e-2)" "unprognostic (1.54e-1)" "unprognostic (5.98e-2)" "unprognostic (2.08e-2)" "unprognostic (1.51e-1)" "unprognostic (8.31e-2)" "unprognostic (1.67e-1)" "unprognostic (1.48e-1)" "unprognostic (4.73e-2)" "unprognostic (1.22e-2)" "unprognostic (2.64e-1)" "unprognostic (3.88e-3)" "unprognostic (1.01e-1)" 0.8 1.2 1.6 4.4 4.2 0.1 4.5 0.3 2.5 6.0 13.5 4.5 8.7 3.6 20.5 6.6 3.0 17.1 15.7 0.8 2.2 2.7 13.8 0.3 4.1 1.3 0.9 1.4 9.5 6.5 22.7 8.6 5.4 11.2 23.5 7.8 36.2 5.2 17.4 0.8 5.9 2.7 5.6 0.7 0.2 5.7 7.0 0.3 1.4 15.0 5.2 2.6 5.1 2.9 0.2 0.0 0.0 0.0 5.8 5.8 0.8 6.0 0.6 3.3 1.8 0.0 0.0 2.2 0.0 0.0 0.0 0.0 5.1 19.6 0.0 6.5 0.0 2.7 20.7 9.9 0.1 0.0 0.0 9.4 0.0 2.6 0.2 0.9 0.0 11.4 0.1 0.3 0.0 0.0 0.0 0.0 3.0 9.9 0.0 0.0 5.8 1.6 1.1 1.8 47.6 7.2 0.0 0.0 0.5 5.6 4.3 14.0 5.2 4.4 5.6 0.0 0.5 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 1.2 0.0 0.0 0.0 5.8 0.0 2.3 0.0 1.3 2.3 0.0 0.2 1.6 2.6 0.0 5.8 0.0 0.0 0.0 0.8 1.6 4.2 0.3 2.5 2.2 2.7 0.9 1.4 11.2 0.3 0.0 2.6 0.0 4.2 1.9 6.1 1.0 2.5 8.1 3.4 0.0 39.3 0.2 0.0 2.0 1.7 0.6 9.7 0.0 2.1 0.9 1.5 7.6 0.0 0.0 0.2 4.8 8.6 0.0 0.0 4.9 1.1 0.0 5.0 0.0 5.8 8.1 1.7 8.2 0.7 8.1 158.9 0.0 1.9 2.3 4.2 0.6 0.1 1.3 10.7 2.6 GLDC "GCSP, NKH" ENSG00000178445 "Glycine decarboxylase" P23378 9 6532464-6645783 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 22.3;liver: 40.3;placenta: 10.6" "Cell type enhanced" "Detected in many" 17 "Cytotrophoblasts: 59.4;Extravillous trophoblasts: 35.6;Hepatocytes: 126.2;Syncytiotrophoblasts: 38.4" "Cancer enhanced" "Detected in many" "testis cancer: 41.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 66.8;CACO-2: 15.9;HMC-1: 14.5;RPTEC TERT1: 27.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002318, HPA052887" Enhanced Supported Nucleoplasm,Mitochondria NA NA 570000 Mitochondria Nucleoplasm "HPA002318: AB_1849700, HPA052887: AB_2681980" "unprognostic (6.73e-2)" "unprognostic (1.19e-1)" "unprognostic (6.50e-2)" "prognostic unfavorable (5.24e-5)" "unprognostic (1.50e-1)" "unprognostic (7.87e-2)" "unprognostic (1.81e-1)" "unprognostic (1.50e-1)" "unprognostic (2.40e-1)" "unprognostic (1.74e-1)" "unprognostic (2.47e-2)" "unprognostic (2.69e-1)" "prognostic favorable (3.50e-4)" "unprognostic (1.65e-2)" "unprognostic (1.27e-1)" "unprognostic (5.62e-3)" "unprognostic (1.17e-2)" 0.2 0.3 3.9 1.0 3.4 0.4 0.4 3.1 5.6 0.3 0.8 1.6 0.0 0.7 0.4 4.2 1.4 0.6 0.6 0.1 2.9 2.2 22.3 40.3 0.8 1.1 1.9 2.9 0.3 0.1 0.0 1.7 10.6 2.1 0.4 0.3 3.2 0.9 0.8 0.9 1.5 0.6 0.1 1.9 0.8 0.8 1.1 1.8 0.0 2.6 0.0 1.9 0.8 0.0 2.9 0.7 2.3 0.5 0.8 0.6 1.1 0.1 1.3 0.6 7.2 0.0 0.1 66.8 0.0 0.0 0.0 0.0 15.9 0.1 0.1 1.6 0.0 0.2 0.1 0.0 0.1 0.0 0.3 3.8 0.0 0.0 10.6 0.0 0.0 14.5 0.0 0.0 0.5 0.0 0.2 2.7 1.2 0.0 0.1 0.3 0.3 0.2 0.0 7.8 1.2 1.2 0.3 0.0 0.1 27.7 0.3 6.4 3.3 0.0 6.2 0.0 4.1 1.4 0.0 0.9 0.1 0.2 0.8 0.3 0.3 9.2 0.0 0.2 0.7 1.5 1.5 0.5 0.5 0.5 0.3 0.5 2.9 0.6 0.4 0.1 0.9 0.4 0.5 2.3 0.8 0.5 0.7 0.2 1.1 3.9 3.4 3.1 5.6 2.9 2.2 1.9 2.9 2.1 1.8 0.0 0.0 4.3 0.0 0.0 0.3 0.6 7.6 0.0 0.0 29.6 0.0 59.4 5.0 0.0 8.8 0.0 0.0 0.0 0.2 35.6 0.0 0.0 0.0 126.2 6.1 0.0 0.0 3.1 2.1 9.0 0.3 0.0 0.0 0.0 0.0 8.6 0.1 0.0 0.0 29.3 0.2 0.0 0.3 4.4 5.0 0.0 38.4 0.5 0.0 0.0 GLI1 GLI ENSG00000111087 "GLI family zinc finger 1" P08151 12 57460135-57472262 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 21 "Leydig cells: 27.3;Peritubular cells: 40.3;Sertoli cells: 12.9" "Cancer enhanced" "Detected in many" "testis cancer: 7.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 5.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 5.2" "Cell line enhanced" "Detected in many" "AN3-CA: 12.2;BJ hTERT+: 7.8;NTERA-2: 7.9;RH-30: 35.9;U-266/70: 10.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB009460, HPA065172, HPA068903" Uncertain Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB009460: AB_2111764, HPA065172: AB_2685427, HPA068903: AB_2732122" "unprognostic (4.97e-4)" "unprognostic (5.53e-2)" "unprognostic (1.26e-1)" "unprognostic (5.58e-3)" "unprognostic (1.11e-1)" "unprognostic (1.49e-1)" "unprognostic (1.80e-2)" "unprognostic (9.00e-2)" "unprognostic (1.88e-1)" "unprognostic (1.43e-1)" "unprognostic (8.52e-2)" "unprognostic (1.02e-1)" "unprognostic (1.53e-8)" "unprognostic (4.59e-3)" "unprognostic (2.98e-2)" "unprognostic (2.78e-2)" "unprognostic (1.04e-2)" 3.2 1.7 4.0 2.1 2.5 0.6 2.1 8.2 4.4 14.4 3.5 0.0 3.0 3.7 12.8 8.3 0.7 4.7 8.3 2.7 2.9 1.9 3.2 1.8 2.0 1.3 1.5 2.0 4.7 1.0 0.1 1.2 0.6 3.3 5.6 4.9 9.6 2.9 4.3 3.1 2.4 3.7 3.8 2.8 1.2 2.4 6.2 2.5 0.6 3.3 3.4 1.4 4.8 4.6 0.9 0.4 5.2 0.2 0.1 0.5 0.1 0.0 5.6 1.7 12.2 0.2 0.0 0.2 0.7 7.8 1.3 1.4 0.2 0.4 1.9 0.0 0.3 1.4 1.0 1.0 0.7 0.2 2.1 0.1 0.0 0.6 0.1 1.3 0.3 0.6 0.5 0.2 1.3 0.4 2.5 0.2 1.2 0.4 4.1 0.6 0.0 0.4 0.2 7.9 0.4 0.5 0.6 35.9 0.8 1.5 0.0 0.0 0.1 0.1 0.0 0.2 1.4 0.0 0.1 0.0 1.4 4.5 0.4 0.2 10.0 0.4 3.2 1.2 0.8 2.2 2.2 0.2 0.9 0.1 0.0 0.0 0.9 0.2 0.0 0.0 0.4 0.4 0.3 5.2 0.1 0.1 0.4 0.5 0.1 4.0 2.5 8.2 4.4 2.9 1.9 1.5 2.0 3.3 2.5 0.0 0.0 0.5 0.3 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 27.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 40.3 1.0 0.0 12.9 0.5 0.3 0.8 0.5 0.1 0.0 0.0 0.1 GLI2 "HPE9, THP1, THP2" ENSG00000074047 "GLI family zinc finger 2" P10070 2 120735623-120992653 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Disease mutation, Holoprosencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 23.3" "Group enriched" "Detected in some" 4 "Leydig cells: 23.3;Peritubular cells: 29.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 19.6;NTERA-2: 11.9;U-2 OS: 20.3;WM-115: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "CAB008558, HPA074275" Approved Supported Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "CAB008558: AB_2111910, HPA074275: AB_2686677" "unprognostic (6.76e-2)" "unprognostic (2.51e-1)" "unprognostic (1.05e-1)" "unprognostic (9.83e-3)" "unprognostic (4.63e-2)" "unprognostic (2.04e-1)" "unprognostic (9.43e-2)" "unprognostic (1.65e-2)" "unprognostic (2.19e-3)" "unprognostic (2.58e-1)" "unprognostic (9.23e-3)" "unprognostic (1.81e-2)" "unprognostic (4.49e-10)" "unprognostic (1.13e-1)" "unprognostic (8.88e-2)" "unprognostic (2.32e-2)" "unprognostic (1.42e-3)" 2.1 1.6 3.6 2.9 5.3 0.2 2.3 3.1 3.4 8.0 4.4 1.9 1.5 0.9 8.6 2.6 3.9 5.8 8.8 3.3 3.7 1.0 1.7 0.8 2.9 0.7 1.3 1.5 23.3 0.8 0.7 2.6 1.7 3.6 6.2 1.4 5.9 1.8 2.4 1.6 3.7 3.2 4.5 1.6 2.0 3.9 5.4 2.1 1.7 1.6 4.7 2.6 4.3 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 19.6 3.9 2.1 4.2 0.0 7.5 1.7 3.3 2.1 0.0 0.6 0.0 0.8 3.7 0.5 0.3 5.5 0.0 1.6 0.0 3.5 0.5 4.8 0.0 4.7 0.0 1.5 2.1 0.0 10.6 0.0 2.2 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 11.9 1.2 6.0 0.0 2.2 1.2 0.0 0.0 0.8 3.4 3.4 0.0 0.5 4.1 0.0 0.2 5.9 0.0 20.3 2.1 0.0 0.0 0.0 0.0 7.4 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 5.3 3.1 3.4 3.7 1.0 1.3 1.5 3.6 2.1 0.0 0.0 0.0 0.0 1.8 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.1 6.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 23.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 29.0 0.0 0.0 0.0 2.3 0.0 3.8 1.5 0.0 0.0 0.0 0.0 GLI3 "ACLS, GCPS, PAP-A, PAPA, PAPA1, PAPB, PHS, PPDIV" ENSG00000106571 "GLI family zinc finger 3" P10071 7 41960950-42237870 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 31.6" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 20.8;Syncytiotrophoblasts: 28.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 26.6;WM-115: 19.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005534 Approved Supported Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA005534: AB_1078973" "unprognostic (2.53e-1)" "unprognostic (2.41e-2)" "unprognostic (7.58e-2)" "unprognostic (8.22e-3)" "unprognostic (1.10e-1)" "unprognostic (1.28e-2)" "unprognostic (1.01e-1)" "unprognostic (5.35e-3)" "unprognostic (2.24e-1)" "unprognostic (7.38e-2)" "unprognostic (4.03e-1)" "unprognostic (3.54e-2)" "unprognostic (1.48e-5)" "unprognostic (9.13e-3)" "unprognostic (5.41e-2)" "unprognostic (3.21e-3)" "unprognostic (7.00e-2)" 7.3 2.6 4.6 6.8 5.4 0.3 9.4 0.8 6.4 21.1 13.1 2.9 10.9 1.4 31.6 10.0 7.3 10.8 7.0 2.0 4.2 1.7 2.3 0.7 5.8 2.4 1.8 2.1 17.6 1.5 0.8 1.9 13.4 1.8 10.6 3.8 5.1 3.7 14.3 2.2 9.7 4.2 13.8 0.9 1.8 3.8 2.3 3.0 1.7 6.1 8.7 4.0 6.4 9.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 26.6 0.2 6.9 12.6 1.7 1.6 5.6 4.8 5.6 0.1 0.0 0.0 1.0 11.1 6.2 5.5 3.6 4.3 4.1 0.0 3.3 0.0 3.3 0.0 4.4 0.0 0.1 10.4 6.3 5.0 4.0 2.8 4.4 2.9 0.0 0.1 2.2 2.4 0.3 0.0 12.0 0.0 10.1 6.3 0.1 0.7 0.0 4.4 0.7 0.0 2.6 3.3 2.0 11.4 4.4 0.0 4.6 5.9 8.5 8.2 2.8 0.0 0.0 0.0 4.4 0.1 19.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.6 5.4 0.8 6.4 4.2 1.7 1.8 2.1 1.8 3.0 0.0 4.8 0.0 6.8 20.8 1.8 1.4 0.0 1.4 1.2 1.8 0.0 17.7 0.0 0.0 11.6 2.8 0.0 0.0 0.0 12.0 18.1 3.2 1.1 0.0 2.8 0.0 0.0 2.5 0.3 4.3 17.8 0.0 8.5 0.0 0.0 11.8 0.1 0.0 3.2 3.4 0.8 12.9 14.6 0.4 0.9 13.6 28.6 0.0 0.0 3.7 GLI4 "HKR4, ZNF928" ENSG00000250571 "GLI family zinc finger 4" P10075 8 143267433-143276931 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023131 Uncertain Approved "Nucleoplasm,Cytokinetic bridge" Yes No "Nucleoplasm, Cytokinetic bridge" "HPA023131: AB_2671080" "unprognostic (4.98e-2)" "unprognostic (2.69e-1)" "unprognostic (5.64e-3)" "unprognostic (1.65e-1)" "unprognostic (9.07e-2)" "unprognostic (2.71e-2)" "unprognostic (1.00e-2)" "unprognostic (4.57e-2)" "unprognostic (2.22e-1)" "unprognostic (2.65e-1)" "unprognostic (7.45e-3)" "unprognostic (5.03e-1)" "unprognostic (6.88e-3)" "unprognostic (4.61e-2)" "unprognostic (1.23e-1)" "unprognostic (3.21e-2)" "unprognostic (3.71e-3)" 13.5 5.7 14.9 15.7 17.6 11.6 10.6 12.8 12.0 10.0 12.0 13.7 13.7 14.2 10.0 6.9 10.7 8.3 8.9 8.5 16.4 12.4 9.6 11.2 9.6 13.9 10.3 11.6 11.0 18.4 8.0 7.4 5.0 8.5 9.7 8.6 13.5 20.0 14.0 10.3 13.8 13.4 11.8 9.7 13.4 11.6 11.6 6.9 12.0 10.6 12.8 17.1 9.0 8.2 1.5 3.5 0.9 1.1 3.4 2.2 0.6 4.9 10.2 4.8 7.5 7.9 3.2 5.3 2.9 1.8 2.2 2.7 2.9 14.5 6.4 5.6 4.8 3.2 6.5 2.6 3.3 1.5 11.3 7.7 9.9 4.7 3.3 5.6 3.0 3.3 10.1 1.7 3.0 6.6 5.2 4.8 10.0 5.2 10.8 6.1 13.4 14.2 2.5 4.4 9.4 14.3 8.7 2.2 6.4 5.3 11.2 4.6 5.4 8.9 3.8 6.0 4.6 16.9 1.4 2.7 3.4 9.4 4.8 3.0 14.4 6.7 5.1 5.5 5.9 5.5 0.0 1.1 0.0 1.4 1.0 2.2 1.5 1.6 0.9 0.6 1.4 2.0 1.0 0.9 3.4 0.0 3.5 2.1 0.6 14.9 17.6 12.8 12.0 16.4 12.4 10.3 11.6 8.5 6.9 0.0 0.0 12.9 14.5 6.5 14.5 1.4 17.8 0.0 0.0 12.2 19.6 4.5 21.6 2.4 5.2 4.0 13.1 0.0 3.4 3.6 7.8 6.9 4.6 8.1 6.0 6.4 11.1 7.4 9.1 3.1 15.0 5.6 8.5 2.8 7.4 11.3 3.5 17.3 15.6 14.0 11.5 6.5 11.3 13.3 13.3 9.4 2.4 13.8 13.0 5.5 GLIS2 NPHP7 ENSG00000126603 "GLIS family zinc finger 2" Q9BZE0 16 4314761-4339597 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Ciliopathy, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Peritubular cells: 31.8;Smooth muscle cells: 30.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-2197: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062755, HPA065406" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA062755: , HPA065406: " "unprognostic (2.86e-1)" "unprognostic (3.27e-2)" "unprognostic (5.96e-2)" "prognostic unfavorable (1.59e-5)" "unprognostic (3.76e-1)" "unprognostic (5.15e-2)" "unprognostic (8.13e-2)" "unprognostic (6.65e-2)" "unprognostic (3.94e-1)" "unprognostic (2.37e-3)" "unprognostic (3.59e-1)" "unprognostic (2.48e-1)" "prognostic favorable (8.06e-6)" "unprognostic (1.59e-3)" "unprognostic (3.18e-2)" "unprognostic (1.24e-2)" "unprognostic (4.40e-3)" 3.6 6.0 1.5 2.3 1.6 0.0 2.4 4.3 2.4 5.0 4.4 1.2 5.8 1.0 1.2 4.3 7.4 8.4 0.9 1.2 11.5 0.3 7.8 1.4 1.4 8.0 3.2 2.2 5.3 5.7 5.6 0.2 3.0 5.8 1.1 1.5 1.2 4.3 0.2 0.8 2.7 1.9 5.3 0.5 5.6 2.7 0.3 0.0 0.2 0.0 0.0 0.1 0.0 4.0 10.6 1.7 3.9 1.4 5.7 3.6 4.5 4.3 1.6 1.2 2.9 3.0 0.0 7.9 4.9 1.9 2.6 1.0 4.5 0.1 4.7 0.0 0.0 8.1 1.5 6.2 0.0 0.8 3.3 1.1 1.5 0.7 2.3 1.5 0.1 0.3 1.8 1.1 2.6 0.1 0.9 3.8 0.6 1.8 6.8 2.3 4.8 0.0 0.1 0.8 3.7 5.2 2.2 1.0 0.6 6.3 0.7 3.4 2.4 3.9 28.0 1.4 0.8 0.5 1.3 0.9 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 14.9 9.8 0.0 6.2 4.9 10.4 4.9 20.4 2.7 4.5 12.2 3.9 0.1 16.6 10.0 0.1 6.0 0.0 0.0 7.4 0.9 20.7 2.6 0.0 0.6 0.3 6.4 0.0 5.5 0.0 0.4 20.4 1.2 3.3 1.8 0.0 9.4 7.6 0.0 31.8 19.5 6.5 0.0 30.9 0.0 3.4 2.5 0.9 0.0 0.0 1.7 GLIS3 "MGC33662, ZNF515" ENSG00000107249 "GLIS family zinc finger 3" Q8NEA6 9 3824127-4348392 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Congenital hypothyroidism, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 57.8" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 45.9;Collecting duct cells: 66.3;Ductal cells: 42.5;Intestinal endocrine cells: 42.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+: 15.4;HSkMC: 23.4;RPTEC TERT1: 14.5;U-251 MG: 12.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA056426 Approved Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA056426: AB_2683128" "unprognostic (6.24e-2)" "unprognostic (2.30e-2)" "unprognostic (1.54e-1)" "unprognostic (3.63e-3)" "unprognostic (4.10e-1)" "unprognostic (1.88e-1)" "unprognostic (1.81e-2)" "unprognostic (7.14e-2)" "unprognostic (4.66e-2)" "unprognostic (1.26e-1)" "unprognostic (1.17e-1)" "unprognostic (2.63e-1)" "unprognostic (1.91e-3)" "unprognostic (6.88e-3)" "unprognostic (8.54e-2)" "unprognostic (1.04e-1)" "unprognostic (6.35e-2)" 5.6 2.8 5.6 4.4 7.4 1.0 2.9 3.5 9.5 13.4 2.9 10.7 33.5 1.6 6.1 6.5 1.5 15.0 14.7 4.7 8.9 4.5 11.4 5.1 5.7 2.6 7.7 3.8 10.4 17.3 6.4 8.8 2.8 16.3 5.3 4.0 4.6 5.2 57.8 2.1 1.4 2.2 5.1 26.7 3.8 3.2 4.6 10.2 0.0 29.3 1.4 1.7 5.6 8.8 0.0 0.0 1.8 0.9 0.3 0.7 0.0 0.6 6.7 2.0 0.0 2.7 7.4 0.2 5.1 15.4 2.3 3.4 1.1 2.4 0.0 4.0 3.7 7.7 0.0 1.3 0.0 4.8 1.5 1.0 0.0 0.3 0.0 8.1 0.7 0.0 23.4 0.0 7.1 0.7 4.2 0.4 0.0 0.0 0.1 1.9 0.2 0.0 0.9 0.1 0.0 0.9 0.0 4.6 0.0 14.5 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 5.1 2.6 0.6 2.7 12.1 0.0 0.0 0.0 7.1 0.0 3.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.7 1.1 0.3 0.9 0.0 0.1 0.0 5.6 7.4 3.5 9.5 8.9 4.5 7.7 3.8 16.3 10.2 8.9 20.0 0.9 6.4 1.6 0.2 1.1 45.9 29.4 30.7 66.3 0.0 2.0 0.0 42.5 3.6 5.8 2.0 0.0 20.0 2.7 6.6 10.3 1.1 6.6 2.1 0.0 42.0 6.2 1.0 1.8 12.7 2.7 3.3 3.6 1.1 22.1 34.5 2.9 10.6 17.0 0.2 0.0 10.3 0.7 4.3 1.1 3.5 1.0 3.5 3.9 GLMN "FAP48, FKBPAP, GLML, GVM, VMGLOM" ENSG00000174842 "Glomulin, FKBP associated protein" Q92990 1 92246402-92298987 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 96.2;Rod photoreceptor cells: 128.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031446, HPA031448" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA031446: AB_2797222, HPA031448: AB_2673888" "unprognostic (4.20e-2)" "unprognostic (3.47e-2)" "prognostic favorable (1.71e-4)" "unprognostic (7.37e-2)" "unprognostic (1.38e-1)" "unprognostic (7.24e-2)" "prognostic unfavorable (2.42e-5)" "unprognostic (7.32e-2)" "unprognostic (2.07e-3)" "unprognostic (4.59e-2)" "unprognostic (9.88e-2)" "unprognostic (1.81e-2)" "prognostic unfavorable (5.89e-8)" "unprognostic (7.33e-2)" "unprognostic (5.21e-2)" "unprognostic (1.89e-1)" "unprognostic (3.58e-1)" 4.9 6.6 12.5 8.1 14.8 9.0 10.3 21.3 19.5 7.4 6.8 6.6 5.1 5.1 11.5 8.6 10.1 6.3 5.7 7.2 9.4 6.9 6.4 5.2 5.3 10.6 6.8 13.2 8.3 4.7 8.5 13.6 7.9 8.6 7.6 7.3 13.9 4.9 6.9 7.5 13.5 6.6 6.9 8.0 7.6 5.8 11.2 5.7 13.3 9.0 4.8 12.1 7.9 6.9 2.5 2.0 1.4 1.4 9.0 5.5 1.9 12.2 4.7 15.8 8.7 5.6 8.9 14.6 8.5 7.1 10.7 9.6 9.7 4.9 12.4 13.8 5.1 15.3 9.3 8.3 7.8 15.5 8.8 11.7 16.6 9.4 9.6 5.6 20.9 8.7 6.9 4.5 12.5 5.7 4.2 11.5 10.8 13.7 7.6 14.0 2.8 12.8 15.9 24.1 5.8 8.6 11.1 21.7 8.6 12.1 11.9 14.6 7.6 14.9 14.1 8.9 9.2 6.7 20.2 7.2 7.8 7.5 13.3 12.8 6.7 9.2 15.7 2.9 21.1 4.5 0.0 0.7 1.4 3.2 1.4 5.5 2.5 3.5 3.9 2.0 1.5 3.1 3.6 0.2 9.0 0.8 1.4 2.7 1.9 12.5 14.8 21.3 19.5 9.4 6.9 6.8 13.2 8.6 5.7 8.9 8.8 10.0 10.8 7.9 25.7 7.5 5.1 1.4 4.5 12.2 96.2 13.1 1.7 5.2 1.5 6.8 2.0 0.0 4.5 9.1 10.4 6.7 8.1 2.0 7.2 25.4 10.3 4.9 2.4 1.0 11.5 5.3 8.5 4.6 4.2 13.3 4.5 2.9 7.4 6.8 128.0 6.5 8.1 13.0 28.1 7.9 13.2 20.1 3.9 6.3 GLO1 GLOD1 ENSG00000124767 "Glyoxalase I" Q04760 6 38675925-38703141 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Lyase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "HMC-1: 249.9" "Low region specificity" "Detected in all" "CAB040541, CAB040542, HPA059791" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" No No 1600000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB040541: , CAB040542: , HPA059791: AB_2684126" "unprognostic (4.33e-2)" "unprognostic (1.09e-1)" "unprognostic (4.37e-2)" "unprognostic (1.08e-2)" "unprognostic (3.96e-3)" "unprognostic (2.51e-1)" "prognostic unfavorable (5.21e-4)" "unprognostic (5.09e-2)" "unprognostic (2.10e-2)" "unprognostic (1.28e-2)" "unprognostic (2.61e-2)" "unprognostic (8.71e-2)" "unprognostic (1.20e-2)" "unprognostic (9.29e-2)" "unprognostic (1.83e-1)" "unprognostic (2.54e-1)" "unprognostic (6.21e-2)" 22.2 30.5 42.1 19.5 42.3 11.4 32.0 25.4 42.3 27.1 42.1 19.7 22.9 48.1 25.3 49.2 28.2 31.5 17.8 39.2 37.8 37.7 37.1 65.3 30.7 31.6 38.9 29.7 37.6 25.9 33.2 12.6 26.7 40.6 74.0 22.7 21.7 21.7 28.2 57.5 31.3 64.3 28.9 37.6 25.6 21.3 12.9 21.4 19.8 32.6 42.5 24.3 28.6 24.7 25.9 28.6 8.5 15.6 10.8 24.4 14.7 18.5 8.6 24.8 24.6 11.8 21.3 21.9 16.2 15.4 22.8 23.8 20.9 7.1 20.7 12.8 12.9 27.2 12.3 21.2 20.9 28.9 18.8 32.7 30.6 11.1 19.5 17.7 11.6 249.9 18.2 12.9 21.6 15.5 14.9 24.6 14.7 24.1 13.8 21.3 15.7 18.1 14.8 17.8 16.6 16.9 15.8 30.0 13.5 20.8 14.1 19.3 19.5 11.4 15.9 30.5 17.8 18.4 58.4 10.1 17.8 16.4 15.4 25.6 10.9 20.5 56.8 6.4 30.1 28.5 8.5 9.8 6.9 18.0 15.6 24.4 24.7 18.1 18.3 18.3 25.9 17.1 17.9 1.2 10.8 12.1 28.6 15.7 14.7 42.1 42.3 25.4 42.3 37.8 37.7 38.9 29.7 40.6 21.4 122.1 136.6 86.9 79.7 57.5 55.3 121.3 48.4 88.3 91.0 85.5 19.6 91.3 210.5 107.2 3.6 70.9 36.2 0.0 64.3 264.4 68.8 192.8 67.2 86.8 68.4 65.2 35.1 200.1 112.1 4.7 77.6 69.2 99.5 129.8 41.3 160.8 66.2 35.7 103.3 107.3 50.7 45.3 65.9 11.9 15.7 77.0 61.2 59.9 55.5 125.1 GLRX2 "bA101E13.1, GRX2" ENSG00000023572 "Glutaredoxin 2" Q9NS18 1 193090866-193106114 "Predicted intracellular proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 19 "Early spermatids: 789.5;Late spermatids: 1440.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 69.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023087, HPA057224" Supported Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA023087: AB_1849778, HPA057224: AB_2683373" "unprognostic (4.80e-2)" "unprognostic (3.77e-2)" "unprognostic (8.04e-2)" "unprognostic (2.33e-1)" "unprognostic (1.13e-1)" "unprognostic (4.99e-2)" "unprognostic (2.40e-3)" "unprognostic (5.11e-2)" "unprognostic (3.21e-2)" "unprognostic (2.38e-2)" "unprognostic (1.10e-2)" "unprognostic (2.38e-1)" "prognostic unfavorable (3.30e-7)" "unprognostic (6.23e-2)" "unprognostic (1.73e-1)" "unprognostic (6.21e-2)" "unprognostic (4.48e-2)" 14.1 17.9 13.8 9.7 12.2 10.7 16.3 7.4 22.0 7.8 14.9 6.6 7.4 14.7 6.7 14.5 13.1 5.1 8.8 23.5 13.0 13.3 14.3 28.2 7.8 6.1 16.5 13.1 5.4 10.4 4.6 9.9 9.5 22.3 21.8 11.7 7.4 8.6 11.6 28.5 8.9 12.7 10.9 12.3 7.6 10.3 27.9 8.7 2.3 7.7 11.6 9.0 9.6 10.2 10.8 17.4 19.6 21.4 11.6 14.1 10.9 13.9 17.2 4.4 9.8 16.3 10.6 7.8 20.5 8.9 17.0 14.1 10.6 13.4 6.2 11.5 8.5 20.7 13.6 5.2 11.7 17.4 13.7 9.7 12.0 11.6 12.3 17.4 9.8 12.1 7.1 10.2 23.3 11.8 6.6 10.7 4.1 17.7 6.6 20.5 19.3 7.8 18.0 5.1 22.3 12.6 7.1 7.1 14.2 16.3 9.2 4.2 3.8 8.3 24.6 69.6 6.8 10.7 11.1 6.5 13.3 3.4 28.9 21.1 13.3 13.7 11.9 12.7 11.3 18.4 7.8 15.2 19.6 10.8 17.9 11.9 10.8 11.3 9.7 17.4 8.2 10.2 11.4 7.6 11.6 21.4 7.3 14.1 10.9 13.8 12.2 7.4 22.0 13.0 13.3 16.5 13.1 22.3 8.7 8.9 8.5 18.7 19.2 16.3 7.1 57.9 15.3 8.1 7.9 15.7 5.9 33.7 24.9 36.1 789.5 17.5 28.0 0.0 35.9 32.5 22.1 28.9 45.1 29.9 40.5 1.6 13.3 10.4 12.1 1440.5 16.1 26.5 25.3 24.4 19.0 6.6 33.9 28.1 17.0 53.0 11.2 6.5 24.5 10.8 26.4 17.3 20.7 13.8 20.9 15.9 GLYR1 "BM045, HIBDL, N-PAC, NP60" ENSG00000140632 "Glyoxylate reductase 1 homolog" Q49A26 16 4803203-4847342 "Predicted intracellular proteins" "DNA-binding, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017022, HPA048226, HPA050136" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB017022: , HPA048226: AB_2680320, HPA050136: AB_2681028" "unprognostic (4.72e-1)" "unprognostic (1.65e-1)" "unprognostic (3.19e-2)" "unprognostic (8.20e-2)" "unprognostic (2.77e-1)" "unprognostic (1.97e-2)" "unprognostic (3.86e-2)" "unprognostic (3.18e-2)" "unprognostic (1.53e-1)" "unprognostic (1.64e-1)" "unprognostic (1.41e-1)" "unprognostic (8.47e-3)" "prognostic favorable (8.74e-7)" "unprognostic (3.34e-1)" "unprognostic (4.38e-2)" "unprognostic (1.77e-1)" "unprognostic (2.86e-1)" 24.1 33.2 39.1 29.4 37.4 27.5 22.5 26.3 44.8 24.8 32.6 31.0 32.8 30.7 30.0 20.6 32.1 33.9 26.1 28.3 29.8 24.8 39.0 30.5 24.5 27.6 27.0 33.1 22.2 27.4 53.4 34.7 24.1 37.1 30.4 32.3 28.5 29.9 29.4 41.6 24.3 29.9 30.1 27.3 30.7 33.9 17.4 26.0 27.6 29.6 17.2 30.0 35.3 22.7 7.6 8.3 22.2 14.5 5.2 7.5 5.5 13.1 14.7 24.3 15.1 21.4 17.2 23.3 24.9 18.6 19.1 16.4 20.7 23.5 21.5 23.8 22.9 15.7 14.6 30.4 20.9 17.3 34.9 18.3 22.1 17.7 14.5 12.1 35.7 41.2 16.3 16.6 18.0 13.3 18.4 24.2 20.3 37.0 18.6 20.7 21.4 29.0 19.8 28.8 19.8 11.1 37.5 19.1 26.4 23.5 19.8 29.7 15.1 27.0 25.3 11.5 27.9 28.4 37.8 26.8 13.1 14.7 59.1 15.5 15.5 21.6 45.0 9.4 17.8 26.8 6.3 10.9 5.7 7.5 9.8 6.5 5.1 4.9 7.1 7.3 7.6 5.2 4.6 22.2 5.2 14.5 8.3 4.9 5.5 39.1 37.4 26.3 44.8 29.8 24.8 27.0 33.1 37.1 26.0 35.7 45.5 25.1 16.3 16.9 31.8 36.2 30.6 93.7 46.6 29.6 27.5 23.2 56.3 20.8 7.9 26.3 37.1 0.0 16.8 26.4 21.1 25.4 30.1 47.3 28.0 42.9 44.5 25.8 38.6 8.0 22.5 29.5 20.3 44.1 38.4 22.8 24.2 37.4 15.2 42.9 40.9 19.4 16.9 20.9 24.5 21.1 29.9 17.5 33.2 17.0 GMEB1 "P96PIF, PIF96" ENSG00000162419 "Glucocorticoid modulatory element binding protein 1" Q9Y692 1 28668732-28719353 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044811, HPA052975" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA044811: AB_10959666, HPA052975: AB_2682003" "unprognostic (1.52e-1)" "unprognostic (3.55e-2)" "unprognostic (2.49e-2)" "prognostic favorable (1.94e-4)" "unprognostic (2.71e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (8.91e-7)" "unprognostic (1.42e-2)" "unprognostic (1.41e-1)" "unprognostic (6.88e-2)" "unprognostic (1.39e-1)" "unprognostic (3.38e-2)" "unprognostic (8.41e-2)" "unprognostic (4.79e-3)" "unprognostic (3.44e-1)" "unprognostic (1.75e-1)" "unprognostic (1.13e-2)" 8.3 6.6 8.0 14.0 6.5 21.1 8.7 13.5 9.0 8.8 8.0 8.4 6.4 5.4 10.9 8.0 10.4 8.5 8.0 6.8 7.8 4.9 6.6 7.3 8.7 11.3 5.8 7.0 12.1 7.5 8.6 8.8 16.4 5.8 7.2 8.4 8.0 7.4 6.8 10.3 9.3 8.6 9.1 6.3 11.5 7.4 11.4 6.4 25.3 7.5 7.0 14.1 7.9 12.4 10.8 9.7 14.4 12.7 10.6 12.8 6.3 9.3 6.8 11.6 10.4 3.8 7.1 8.2 10.0 7.3 6.5 9.7 2.1 7.6 17.3 5.3 9.3 3.9 3.7 10.3 7.8 8.5 19.7 6.3 16.1 7.1 4.1 5.8 13.3 8.3 5.7 5.6 15.7 10.2 5.7 8.9 8.7 9.6 13.9 7.8 8.2 8.3 4.4 15.4 6.3 4.6 5.6 7.9 8.0 4.9 7.7 8.5 7.0 9.5 6.5 6.5 8.1 4.9 6.9 9.0 4.5 10.8 7.6 13.5 6.2 10.5 9.7 5.4 12.5 7.0 10.0 8.2 14.4 11.1 10.2 8.4 6.6 10.6 12.8 9.7 10.8 8.8 9.3 11.8 10.6 12.7 7.2 8.9 6.3 8.0 6.5 13.5 9.0 7.8 4.9 5.8 7.0 5.8 6.4 6.0 24.8 13.5 13.9 15.0 22.8 4.2 5.1 5.3 12.5 14.0 11.8 11.6 5.0 9.2 8.0 10.6 9.6 23.3 9.5 13.6 7.3 9.8 27.7 5.6 9.4 23.8 7.5 17.8 12.9 2.2 8.9 11.7 1.7 8.2 11.1 17.5 9.5 10.4 7.4 4.9 23.9 19.4 7.6 14.4 27.4 14.6 27.0 15.9 9.2 15.6 GMEB2 "KIAA1269, P79PIF, PIF79" ENSG00000101216 "Glucocorticoid modulatory element binding protein 2" Q9UKD1 20 63587602-63627041 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009706, HPA067455" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA009706: AB_1078996, HPA067455: AB_2685845" "unprognostic (4.55e-1)" "unprognostic (5.65e-2)" "unprognostic (3.16e-1)" "unprognostic (1.38e-3)" "unprognostic (1.36e-1)" "unprognostic (4.85e-2)" "unprognostic (2.77e-3)" "unprognostic (2.04e-1)" "unprognostic (5.47e-2)" "unprognostic (5.43e-2)" "unprognostic (2.01e-2)" "unprognostic (2.04e-2)" "unprognostic (6.86e-3)" "unprognostic (2.82e-2)" "unprognostic (3.84e-1)" "unprognostic (3.46e-1)" "unprognostic (2.29e-1)" 9.3 8.2 7.4 9.0 9.8 29.8 8.4 13.5 11.5 8.7 10.5 7.7 6.9 9.6 10.6 6.1 10.0 11.0 9.5 7.4 8.1 6.2 7.7 9.3 8.7 11.5 6.0 6.5 11.5 17.6 9.6 9.5 14.5 7.2 9.9 5.1 9.8 16.0 7.5 10.1 10.0 11.0 10.3 7.1 12.1 8.8 18.8 5.7 24.7 18.0 9.5 10.4 9.2 13.8 3.0 2.6 4.4 5.6 1.9 4.5 2.2 10.8 6.6 8.1 7.0 4.0 3.7 10.8 7.5 4.8 12.1 6.4 20.5 8.1 8.6 7.9 6.5 8.8 15.5 6.3 11.1 5.4 4.6 7.1 6.6 9.7 9.8 5.3 6.3 11.1 5.2 10.6 7.8 9.8 5.1 5.3 11.0 9.8 6.3 4.2 11.6 15.4 13.9 5.8 12.9 10.7 16.8 8.3 7.9 5.0 9.6 12.2 10.0 13.6 12.0 7.8 3.9 14.7 10.4 6.6 13.4 7.3 7.9 8.3 12.0 9.8 13.7 8.0 5.9 8.6 0.0 1.9 3.2 4.5 2.6 4.3 2.1 4.0 3.9 2.1 3.0 4.5 3.9 4.4 1.9 5.6 2.6 2.7 2.2 7.4 9.8 13.5 11.5 8.1 6.2 6.0 6.5 7.2 5.7 3.0 6.4 2.2 10.1 5.4 5.1 2.8 7.6 1.4 4.5 3.5 0.0 3.7 1.7 3.9 18.0 4.7 5.1 0.0 4.6 5.3 3.0 11.1 2.3 5.7 3.8 7.9 9.2 4.3 2.8 5.1 3.7 2.6 1.7 1.0 7.9 1.7 5.0 7.0 5.3 3.0 4.7 6.5 3.7 14.9 9.7 4.6 9.6 4.3 5.3 10.3 GMFB GMF ENSG00000197045 "Glia maturation factor beta" P60983 14 54474484-54489196 "Plasma proteins, Predicted intracellular proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002954 Approved Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 1000000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA002954: AB_1078997" "unprognostic (7.93e-2)" "unprognostic (7.69e-3)" "unprognostic (4.81e-3)" "unprognostic (2.99e-2)" "unprognostic (1.12e-2)" "unprognostic (2.06e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (1.48e-2)" "unprognostic (1.90e-1)" "unprognostic (1.03e-1)" "unprognostic (1.11e-1)" "unprognostic (4.29e-2)" "prognostic favorable (9.48e-5)" "unprognostic (1.80e-1)" "unprognostic (2.82e-1)" "unprognostic (1.23e-1)" "unprognostic (9.09e-2)" 14.2 13.2 37.9 12.9 26.7 14.2 15.3 25.1 41.6 11.8 19.8 23.9 6.1 19.1 11.6 8.5 9.3 8.4 9.7 9.6 36.7 30.1 19.9 14.7 13.8 13.3 36.9 28.3 9.8 7.3 10.1 13.6 17.9 25.6 9.0 20.7 6.6 7.0 8.0 4.1 7.8 17.5 10.5 54.4 10.1 10.7 6.2 21.7 6.4 12.8 6.1 13.5 10.0 7.4 9.1 12.8 16.4 14.5 9.0 8.8 6.8 30.9 12.6 25.1 18.4 27.2 34.0 18.8 31.8 23.4 23.1 28.9 14.4 27.5 28.5 15.0 31.2 13.9 11.5 25.3 22.0 36.6 10.3 8.7 14.3 14.1 13.3 23.2 19.9 12.5 25.7 20.6 20.0 19.8 24.1 20.8 13.2 10.4 10.1 36.5 15.4 12.1 7.7 16.2 17.6 13.4 12.3 29.5 8.2 29.5 29.5 14.9 23.2 22.1 18.9 24.1 21.7 20.8 15.8 16.4 33.6 25.5 17.0 19.7 3.6 6.3 17.8 28.3 12.3 21.2 8.7 11.0 9.2 6.1 13.5 8.5 7.6 7.2 6.0 12.8 9.1 7.8 8.2 16.4 9.0 14.5 5.2 8.8 6.8 37.9 26.7 25.1 33.5 36.7 30.1 36.9 28.3 25.6 21.7 23.8 14.4 20.4 43.8 53.1 17.7 15.0 22.9 8.1 19.4 24.4 3.9 33.3 18.3 34.4 20.5 17.5 29.2 0.0 20.1 73.0 27.8 40.5 21.8 23.6 41.6 20.6 28.7 16.0 30.4 3.9 18.7 44.4 43.9 37.9 30.3 17.7 30.2 31.6 14.9 40.9 14.6 12.9 26.8 12.6 9.8 38.1 48.7 22.4 32.6 39.2 GMFG ENSG00000130755 "Glia maturation factor gamma" O60234 19 39328353-39342372 "Plasma proteins, Predicted intracellular proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 276.5;bone marrow: 80.9;lymphoid tissue: 109.5" "Cell type enhanced" "Detected in many" 8 "B-cells: 303.1;Hofbauer cells: 397.1;Ito cells: 301.4;Kupffer cells: 575.9;Macrophages: 461.8;T-cells: 456.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HMC-1: 77.0;JURKAT: 55.8;Karpas-707: 59.8;NB-4: 43.6;REH: 49.0;THP-1: 76.8;U-937: 52.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002954 Uncertain Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 1500000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA002954: AB_1078997" "unprognostic (1.22e-2)" "prognostic favorable (7.35e-4)" "unprognostic (2.37e-2)" "unprognostic (1.21e-3)" "unprognostic (9.93e-2)" "unprognostic (2.14e-2)" "unprognostic (1.19e-1)" "unprognostic (4.84e-2)" "unprognostic (1.00e-1)" "unprognostic (2.09e-1)" "unprognostic (3.09e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (9.11e-6)" "unprognostic (3.01e-1)" "unprognostic (8.76e-3)" "unprognostic (1.06e-1)" "unprognostic (5.27e-3)" 22.6 6.1 7.3 29.6 7.4 80.9 16.8 2.2 4.8 6.0 8.8 4.0 1.7 5.3 4.4 9.4 6.4 7.3 8.7 7.5 6.0 4.9 9.4 9.7 28.5 42.2 8.6 2.3 4.7 3.6 1.1 3.1 18.0 5.8 6.1 7.9 4.9 8.1 2.3 5.4 4.2 17.8 6.8 8.2 86.0 5.9 2.9 5.6 109.5 9.8 7.0 37.1 11.1 7.5 39.1 57.2 276.5 79.4 41.6 88.0 106.7 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 3.8 33.5 0.3 0.0 0.0 0.2 0.0 0.1 0.1 11.3 0.0 36.4 0.0 0.5 0.6 39.0 77.0 0.1 0.0 0.0 0.1 0.1 2.0 55.8 1.3 59.8 0.3 0.0 35.5 43.6 0.0 0.0 0.0 49.0 0.4 21.9 0.0 5.2 0.1 0.0 0.1 0.2 0.2 0.0 0.1 76.8 20.0 0.0 0.4 0.1 0.1 3.4 11.6 38.3 0.2 52.7 0.3 185.2 79.4 178.1 37.7 72.3 40.0 39.1 56.7 46.6 57.2 35.0 55.9 46.4 276.5 41.6 78.9 22.2 88.0 106.7 7.3 7.4 2.2 4.8 6.0 4.9 8.6 2.3 5.8 5.6 26.8 152.0 303.1 2.8 16.6 0.0 3.1 10.2 16.0 31.8 0.0 0.0 3.0 0.0 0.8 9.5 165.1 0.3 23.3 0.6 3.4 16.0 1.1 229.0 5.5 397.1 0.0 0.0 301.4 575.9 18.8 1.7 461.8 70.9 127.2 0.3 0.3 0.3 0.0 0.4 3.9 0.0 45.3 14.6 8.1 3.0 12.9 4.6 456.6 0.3 1.4 GMIP ARHGAP46 ENSG00000089639 "GEM interacting protein" Q9P107 19 19629476-19643667 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 32.7;bone marrow: 31.0;lymphoid tissue: 40.0" "Cell type enhanced" "Detected in many" 8 "Hofbauer cells: 20.7;Kupffer cells: 34.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042484, HPA045481" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042484: AB_2678018, HPA045481: AB_2679343" "unprognostic (7.54e-2)" "unprognostic (5.35e-3)" "unprognostic (3.10e-3)" "unprognostic (4.54e-3)" "unprognostic (1.44e-1)" "unprognostic (1.24e-3)" "unprognostic (1.23e-2)" "unprognostic (4.29e-2)" "unprognostic (1.12e-1)" "unprognostic (2.30e-1)" "unprognostic (6.85e-2)" "unprognostic (6.75e-3)" "prognostic unfavorable (3.97e-5)" "prognostic favorable (3.03e-4)" "unprognostic (4.92e-2)" "unprognostic (2.54e-1)" "prognostic favorable (5.15e-4)" 6.1 2.8 3.5 20.3 4.9 31.0 4.0 0.9 4.1 2.9 6.9 4.3 2.7 7.0 2.7 3.2 6.2 4.4 7.9 3.3 4.3 3.4 4.2 3.9 11.7 28.0 4.2 2.5 2.4 4.6 10.6 3.0 3.9 3.4 4.1 4.6 2.7 6.0 4.5 1.5 4.9 15.3 2.9 4.9 40.0 11.1 2.2 3.1 26.8 6.2 2.7 23.2 6.1 4.5 6.6 6.7 32.7 13.9 4.2 6.4 4.6 4.4 2.1 2.8 3.0 3.1 1.6 11.2 2.8 2.5 1.7 1.6 1.7 6.1 11.0 5.8 2.0 2.2 5.4 1.8 3.1 1.1 3.8 2.8 3.5 3.3 1.8 0.9 9.8 43.8 2.0 2.1 1.8 1.0 2.0 3.8 9.9 2.3 4.0 1.8 6.6 6.1 16.2 1.6 5.8 3.8 10.6 1.2 6.3 3.2 10.7 2.4 7.2 3.9 4.1 1.6 2.2 3.8 14.1 7.0 3.2 1.8 3.6 2.1 2.0 0.8 9.1 2.0 12.9 2.1 2.9 8.3 21.5 6.4 10.6 5.9 5.9 4.0 5.7 6.7 6.6 4.5 4.6 32.7 4.2 13.9 6.1 4.5 4.6 3.5 4.9 0.9 4.1 4.3 3.4 4.2 2.5 3.4 3.1 0.0 15.1 15.6 1.1 1.0 0.0 0.6 2.5 1.4 2.3 0.0 0.0 0.5 0.0 3.8 0.1 1.4 13.3 0.0 4.2 4.6 0.9 1.6 6.9 0.9 20.7 0.0 0.0 2.5 34.3 0.0 0.6 16.5 1.7 17.2 6.3 0.2 9.4 12.2 0.7 0.6 0.0 0.0 0.9 0.1 1.5 1.0 0.7 15.9 5.8 2.6 GMNN Gem ENSG00000112312 "Geminin, DNA replication inhibitor" O75496 6 24774931-24786099 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle" "DNA replication inhibitor" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 95.0" "Cell type enhanced" "Detected in many" 8 "Paneth cells: 272.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011458, CAB047327, CAB047328, HPA049977, HPA054597" Enhanced Enhanced Nucleoplasm Yes No Nucleoplasm "CAB011458: AB_2110946, CAB047327: , CAB047328: , HPA049977: AB_2680978, HPA054597: AB_2682538" "unprognostic (1.37e-1)" "unprognostic (3.43e-3)" "unprognostic (3.91e-3)" "unprognostic (1.52e-2)" "unprognostic (1.28e-1)" "unprognostic (4.37e-2)" "unprognostic (2.90e-3)" "unprognostic (8.29e-2)" "unprognostic (1.23e-3)" "prognostic favorable (4.13e-4)" "prognostic unfavorable (9.77e-4)" "unprognostic (1.33e-2)" "prognostic unfavorable (7.82e-5)" "unprognostic (2.25e-1)" "unprognostic (7.92e-2)" "unprognostic (3.63e-2)" "unprognostic (5.90e-3)" 4.5 3.9 10.7 11.2 19.0 24.1 10.7 15.6 9.4 4.9 17.1 3.2 9.7 7.6 5.3 6.3 8.0 7.3 4.7 3.7 11.0 10.2 10.8 8.4 4.4 12.0 13.6 9.8 7.2 95.0 2.6 7.5 7.9 10.7 18.4 18.9 3.4 4.2 11.6 3.7 17.3 7.4 5.7 7.9 12.6 9.7 19.6 11.9 26.1 13.2 11.0 9.7 15.2 7.4 8.5 9.2 15.8 6.7 5.3 15.2 5.6 24.9 14.8 37.6 15.5 5.3 5.7 25.1 24.5 13.0 29.5 32.4 28.7 9.0 25.1 31.3 7.9 21.7 14.7 32.5 18.1 31.8 9.3 34.0 34.4 26.4 47.0 5.0 26.7 12.6 4.6 5.9 17.9 7.0 6.1 14.5 19.6 43.2 13.4 20.8 19.5 50.1 28.9 20.5 20.4 11.7 29.2 29.4 32.2 12.4 21.8 30.2 18.6 11.0 18.2 21.6 22.1 19.1 16.4 7.1 18.1 18.3 20.8 41.5 14.9 45.7 47.1 5.5 50.4 25.9 5.3 5.3 15.8 4.6 6.7 5.8 8.5 8.9 7.1 7.4 4.5 6.6 7.3 3.0 5.3 4.7 9.2 15.2 5.6 10.7 19.0 15.6 9.4 11.0 10.2 13.6 9.8 10.7 11.9 6.0 14.1 15.7 25.3 29.3 8.9 9.4 15.3 33.5 52.4 41.8 2.0 52.0 8.3 78.3 58.9 14.3 21.2 0.0 100.1 110.5 15.8 27.7 12.7 15.3 45.0 11.1 24.9 9.8 9.2 17.5 8.9 12.4 21.9 19.8 24.9 29.4 43.9 272.7 10.3 14.6 12.1 19.4 12.3 132.2 59.4 55.6 40.7 17.5 87.0 19.7 GMPPA ENSG00000144591 "GDP-mannose pyrophosphorylase A" Q96IJ6 2 219498867-219506989 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035512, HPA035513" Approved Approved Nucleoplasm NA NA 17000 Nucleoplasm "HPA035512: AB_2674660, HPA035513: AB_10671934" "unprognostic (3.43e-1)" "unprognostic (3.95e-2)" "unprognostic (7.75e-3)" "unprognostic (1.40e-3)" "unprognostic (4.87e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (5.57e-1)" "unprognostic (2.39e-1)" "unprognostic (2.25e-1)" "unprognostic (1.17e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.90e-10)" "prognostic favorable (5.24e-4)" "unprognostic (1.28e-1)" "unprognostic (2.01e-1)" "unprognostic (2.28e-1)" 12.0 15.8 10.3 13.6 14.7 9.9 12.9 10.2 14.6 21.1 17.7 16.5 23.2 17.1 16.7 44.3 14.8 14.6 12.0 16.2 10.4 7.0 22.5 54.1 12.8 11.0 15.8 11.5 12.7 39.8 17.6 28.8 21.4 12.2 21.2 20.0 12.6 37.4 20.3 12.6 10.2 23.6 16.0 13.2 21.1 17.6 9.6 14.3 8.9 24.8 8.1 18.4 13.7 13.5 16.6 21.8 29.2 27.0 17.2 18.4 16.0 14.2 11.7 7.3 12.8 28.1 25.0 19.4 24.9 33.4 29.3 36.5 21.5 13.6 7.7 17.7 35.9 18.9 13.5 13.4 21.5 25.5 15.0 11.6 15.1 12.0 38.1 25.4 7.8 17.8 19.1 17.5 27.5 31.3 15.3 17.9 10.0 26.7 22.6 22.7 17.8 7.7 14.8 7.5 17.5 12.8 6.1 7.8 13.8 16.8 9.7 9.4 8.2 10.4 15.8 17.0 16.0 10.5 12.7 10.3 17.0 11.8 30.6 13.5 15.6 6.2 9.3 34.8 8.8 19.0 29.2 26.5 17.7 15.8 26.7 18.4 16.6 12.6 16.6 21.7 10.4 9.4 8.7 5.9 17.2 27.0 21.8 16.3 16.0 10.3 14.7 10.2 14.6 10.4 7.0 15.8 11.5 12.2 14.3 14.9 15.6 10.0 10.6 4.9 6.1 11.8 10.2 6.7 11.4 15.7 5.9 32.0 29.9 19.9 0.5 6.3 37.6 0.0 26.4 64.3 15.8 14.8 18.5 33.8 30.0 1.6 10.4 13.5 17.8 1.9 17.0 17.9 11.8 13.6 41.5 10.3 19.7 34.5 12.7 28.1 3.5 12.9 7.2 4.6 6.4 7.4 39.5 8.5 23.6 11.6 GMPR2 ENSG00000100938 "Guanosine monophosphate reductase 2" Q9P2T1 14 24232422-24239242 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Purine metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000904, HPA067884, HPA068782" Uncertain Approved Nucleoplasm,Nucleoli No No 160000 Nucleoplasm Nucleoli "HPA000904: AB_1078998, HPA067884: AB_2685916, HPA068782: AB_2686032" "unprognostic (1.95e-2)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (1.03e-1)" "unprognostic (9.86e-2)" "unprognostic (5.98e-2)" "unprognostic (3.24e-1)" "unprognostic (5.21e-3)" "unprognostic (9.24e-2)" "unprognostic (3.08e-1)" "unprognostic (7.88e-2)" "unprognostic (1.16e-1)" "prognostic favorable (2.21e-5)" "unprognostic (2.30e-1)" "unprognostic (1.96e-1)" "unprognostic (2.29e-1)" "unprognostic (1.12e-2)" 18.9 44.2 19.6 14.6 24.2 11.5 26.2 13.6 31.7 22.5 21.1 25.1 20.3 21.3 18.8 26.3 17.8 28.7 23.4 15.0 20.1 21.9 39.1 26.3 19.0 18.1 23.0 21.2 26.1 26.9 49.1 22.4 22.7 26.0 20.3 21.6 21.9 22.6 23.7 16.1 14.4 21.7 18.2 20.3 25.5 21.2 10.6 19.1 21.6 43.0 11.2 21.0 21.8 17.6 7.5 14.4 32.3 14.0 7.6 14.9 11.0 9.2 10.6 14.3 9.3 16.6 23.5 13.1 10.9 19.4 15.3 19.6 12.4 7.3 12.3 9.9 15.9 9.8 12.8 15.8 23.6 21.9 11.6 11.6 9.7 6.6 45.2 15.6 15.8 15.2 22.0 16.9 8.1 16.8 21.4 24.8 17.7 5.6 11.6 15.4 17.2 15.7 14.2 11.1 13.6 13.8 11.9 9.7 10.1 21.1 15.2 10.1 14.4 7.8 17.2 14.6 15.2 14.9 12.7 12.7 7.3 5.8 9.5 7.9 25.9 24.8 8.1 6.0 12.1 7.0 9.0 14.0 7.2 10.1 11.2 10.7 7.5 10.2 11.2 14.4 7.1 9.1 10.2 32.3 7.6 11.3 6.5 14.9 11.0 19.6 24.2 13.6 31.7 20.1 21.9 23.0 21.2 26.0 19.1 23.8 16.0 23.8 32.5 9.7 16.4 10.5 40.8 33.5 25.0 50.6 3.9 53.9 86.2 34.2 9.9 19.0 34.2 0.0 29.0 39.0 17.4 19.6 31.1 22.4 45.3 17.5 9.9 11.6 32.6 7.7 26.7 30.1 20.3 23.4 20.4 34.1 30.5 30.6 23.7 96.9 13.6 25.8 25.8 15.2 9.6 9.4 41.2 23.0 27.6 21.0 GNAI1 ENSG00000127955 "G protein subunit alpha i1" P63096 7 80133955-80219402 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transport" Transducer "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 195.4;Suprabasal keratinocytes: 187.2;Syncytiotrophoblasts: 153.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "NK-cell: 20.0" "Lineage enriched" "Detected in many" 5 "NK-cells: 20.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022449, HPA042141" Approved Supported Nucleoplasm,Nucleoli,Centrosome NA NA 9000000 Centrosome "Nucleoplasm, Nucleoli" "CAB022449: , HPA042141: AB_2677870" "unprognostic (2.29e-1)" "unprognostic (2.83e-2)" "unprognostic (2.64e-2)" "unprognostic (1.54e-1)" "unprognostic (7.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.92e-2)" "unprognostic (2.08e-2)" "prognostic unfavorable (5.09e-4)" "unprognostic (9.78e-2)" "unprognostic (1.26e-1)" "unprognostic (4.48e-1)" "unprognostic (9.41e-3)" "prognostic unfavorable (6.47e-4)" "unprognostic (1.12e-1)" "unprognostic (1.94e-2)" "unprognostic (1.53e-1)" 33.2 23.4 17.2 5.4 26.2 1.5 14.4 14.4 33.7 9.4 10.5 36.9 3.0 6.9 10.0 3.0 16.6 9.0 8.6 5.7 23.8 18.3 25.9 13.1 10.3 3.4 40.3 21.9 14.3 5.4 2.5 7.3 30.4 26.2 10.1 9.0 2.8 4.9 9.5 4.2 32.4 5.3 12.2 49.7 5.7 8.3 11.1 32.0 0.9 11.1 3.2 4.6 15.5 9.0 0.1 3.7 2.1 1.5 20.0 2.3 0.7 2.9 20.8 19.0 0.1 23.7 15.2 8.7 12.6 15.2 11.2 13.9 0.0 3.2 0.1 4.1 13.5 9.6 3.0 10.6 12.9 14.9 0.1 9.7 17.8 18.3 1.3 24.0 2.3 3.8 16.3 32.8 6.0 17.3 9.1 7.5 0.0 1.4 0.0 21.0 0.5 0.1 0.1 5.5 0.1 7.5 8.3 7.3 8.9 33.5 10.0 13.9 9.6 13.5 0.2 10.8 16.3 2.6 0.4 13.3 25.1 17.7 5.8 4.7 0.1 0.0 0.1 6.6 1.3 11.1 2.1 0.7 0.7 0.1 0.7 0.0 0.0 0.3 0.2 3.7 0.1 2.3 0.9 0.3 20.0 1.5 0.3 0.2 0.7 17.2 26.2 14.4 25.5 23.8 18.3 40.3 21.9 26.2 32.0 17.9 14.4 0.8 17.7 195.4 3.7 6.1 15.3 36.1 13.6 27.9 0.0 72.1 74.6 6.5 0.9 24.0 2.9 0.0 3.3 66.5 57.4 6.1 27.9 16.8 8.7 25.4 19.1 18.4 1.0 3.5 31.1 5.8 97.8 4.6 7.3 46.1 6.8 7.0 70.0 9.8 5.0 109.9 38.2 6.2 40.1 187.2 153.4 0.0 8.5 14.5 GNAI2 "GIP, GNAI2B" ENSG00000114353 "G protein subunit alpha i2" P04899 3 50226292-50259355 "Predicted intracellular proteins" "Cell cycle, Cell division" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007704 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 53000000 Cytosol "Nucleoplasm, Plasma membrane" "HPA007704: AB_1849230" "prognostic favorable (1.03e-4)" "unprognostic (3.89e-1)" "unprognostic (3.35e-2)" "unprognostic (8.40e-3)" "unprognostic (2.58e-1)" "unprognostic (2.32e-2)" "unprognostic (2.59e-2)" "unprognostic (3.23e-1)" "unprognostic (1.08e-3)" "unprognostic (6.01e-2)" "unprognostic (7.00e-3)" "unprognostic (1.12e-1)" "unprognostic (6.24e-3)" "unprognostic (1.44e-1)" "unprognostic (4.30e-2)" "unprognostic (4.33e-2)" "unprognostic (1.38e-1)" 81.9 37.8 50.8 69.5 47.2 102.5 53.4 17.7 45.3 56.2 47.9 67.2 34.5 22.6 51.4 41.1 44.4 47.1 55.5 57.0 44.6 48.0 34.1 50.9 72.8 78.7 53.3 34.3 54.0 21.4 24.9 42.1 81.3 46.8 44.3 22.5 38.5 25.8 60.0 29.6 29.0 35.7 53.6 81.8 96.7 30.1 28.5 45.9 70.0 37.7 32.4 55.5 60.7 49.8 5.3 14.2 35.8 19.4 6.1 8.4 5.6 15.3 8.3 25.2 25.2 31.0 38.9 4.5 33.5 54.1 48.4 49.8 9.3 21.7 18.3 14.7 75.6 26.2 12.3 17.9 46.8 31.0 39.1 6.3 46.2 22.6 14.5 30.6 42.2 61.6 37.7 20.9 43.7 17.9 40.0 113.3 15.7 3.0 39.9 48.2 19.9 35.6 45.6 13.5 7.5 32.6 22.4 12.1 26.8 31.1 17.4 6.1 10.6 24.5 7.4 15.4 21.6 11.7 43.8 98.5 41.7 24.5 39.3 33.5 25.2 32.2 16.1 47.0 57.6 49.9 2.6 16.5 23.4 8.4 19.4 4.9 5.0 6.3 7.6 14.2 5.3 5.0 5.7 35.8 6.1 15.0 11.7 6.6 5.6 50.8 47.2 17.7 45.3 44.6 48.0 53.3 34.3 46.8 45.9 38.7 40.4 91.6 50.8 50.5 26.8 19.8 53.5 14.7 25.0 41.8 13.7 65.7 5.0 114.9 164.1 226.6 12.0 23.3 53.2 68.9 80.2 40.6 86.7 69.5 291.0 6.4 88.5 179.9 279.9 235.2 84.0 263.9 79.2 299.4 19.5 264.2 106.8 32.8 89.8 22.6 18.1 51.8 75.6 14.0 24.7 55.0 97.4 119.3 13.3 55.9 GNAI3 87U6 ENSG00000065135 "G protein subunit alpha i3" P08754 1 109548611-109618321 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" Transducer "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cone photoreceptor cells: 329.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022099, HPA042141" Approved Approved Nucleoplasm,Nucleoli,Centrosome NA NA 8400000 Centrosome "Nucleoplasm, Nucleoli" "CAB022099: , HPA042141: AB_2677870" "unprognostic (2.19e-1)" "unprognostic (1.64e-1)" "prognostic favorable (1.62e-4)" "unprognostic (1.44e-2)" "unprognostic (2.59e-1)" "unprognostic (9.45e-3)" "prognostic unfavorable (5.30e-6)" "unprognostic (2.56e-3)" "unprognostic (2.18e-2)" "prognostic favorable (4.59e-4)" "unprognostic (1.83e-3)" "unprognostic (6.91e-2)" "prognostic unfavorable (4.34e-4)" "unprognostic (7.27e-2)" "unprognostic (1.39e-1)" "unprognostic (1.25e-2)" "unprognostic (1.66e-2)" 25.2 13.0 12.3 15.5 11.3 26.4 15.8 12.8 10.7 19.0 14.7 10.3 14.3 12.1 19.7 15.7 34.8 12.5 13.2 9.3 12.3 9.4 18.1 25.8 13.2 23.8 13.1 8.3 18.4 13.7 10.7 11.0 22.4 11.5 17.2 13.8 8.0 16.2 14.4 8.6 27.9 17.0 15.9 12.9 21.6 12.1 14.0 12.0 22.2 12.9 25.2 20.6 20.0 20.4 6.1 9.6 16.8 13.1 5.8 7.2 9.3 14.1 5.0 9.6 5.6 9.2 11.1 7.9 10.7 8.6 10.9 10.9 7.6 4.9 7.6 7.1 11.4 6.7 7.5 9.0 10.9 15.3 8.5 5.5 6.6 8.6 6.5 7.9 10.3 6.1 8.2 9.3 12.6 8.7 7.6 13.1 5.8 8.6 7.5 10.8 9.6 7.9 8.4 9.6 6.8 5.8 5.7 22.6 4.9 12.1 10.8 6.2 10.8 7.5 8.5 11.7 7.8 6.5 9.1 11.8 9.2 12.7 13.8 12.1 8.0 9.0 8.8 15.3 10.2 14.3 8.5 9.1 16.6 6.8 13.1 7.2 6.1 6.7 6.5 9.6 5.0 5.6 6.4 16.8 5.8 12.3 4.3 6.9 9.3 12.3 11.3 12.8 10.7 12.3 9.4 13.1 8.3 11.5 12.0 41.7 29.8 72.9 89.8 134.3 27.1 11.7 28.1 46.8 34.2 55.8 329.9 74.3 54.7 94.8 7.0 65.3 47.7 23.3 88.0 115.2 72.4 62.2 45.1 49.5 96.4 23.8 80.9 47.9 103.4 6.0 45.1 89.9 70.9 77.5 58.1 44.4 82.3 52.6 44.6 40.9 23.4 51.8 82.4 64.2 49.4 164.6 89.4 82.8 47.9 147.8 GNAL ENSG00000141404 "G protein subunit alpha L" P38405 18 11688956-11885685 "Disease related genes, Predicted intracellular proteins" Transducer "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 82.7" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 15.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "basal ganglia: 82.7" "Group enriched" "Detected in some" 4 "basophil: 1.1;gdT-cell: 4.2;memory CD8 T-cell: 2.9;naive CD8 T-cell: 2.2;neutrophil: 1.7" "Group enriched" "Detected in many" 5 "granulocytes: 1.7;T-cells: 4.2" "Cell line enhanced" "Detected in many" "Daudi: 18.4;HeLa: 18.8;U-2 OS: 9.7" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 13 "basal ganglia: 183.9" "CAB015464, HPA051160" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB015464: AB_831819, HPA051160: AB_2732564" "unprognostic (2.29e-3)" "unprognostic (7.43e-2)" "unprognostic (8.14e-3)" "unprognostic (3.41e-5)" "unprognostic (4.71e-2)" "unprognostic (9.58e-3)" "unprognostic (9.93e-3)" "unprognostic (1.87e-1)" "unprognostic (2.36e-1)" "unprognostic (7.17e-2)" "unprognostic (1.82e-3)" "unprognostic (6.05e-2)" "unprognostic (1.23e-3)" "unprognostic (1.09e-1)" "unprognostic (3.85e-2)" "unprognostic (4.26e-2)" "unprognostic (7.03e-2)" 7.2 1.5 17.8 3.0 82.7 0.7 4.2 2.7 18.1 8.0 3.7 3.2 3.3 1.6 6.7 2.4 8.2 4.1 4.6 2.2 7.1 7.6 4.2 1.3 2.5 5.1 6.6 5.3 3.2 1.3 1.0 20.7 2.9 8.8 9.9 3.7 2.1 4.6 18.1 18.3 7.0 2.0 9.9 3.3 1.8 2.1 6.2 11.3 0.9 8.0 1.4 5.7 9.5 7.7 0.4 0.2 1.7 0.2 0.5 4.2 1.4 0.5 6.1 7.4 0.5 0.6 0.1 0.8 0.1 0.2 0.5 0.0 6.5 1.1 18.4 1.2 0.1 4.2 0.3 6.9 5.9 0.0 3.8 6.3 0.1 18.8 3.7 0.0 0.2 0.4 0.9 8.8 0.0 0.1 0.3 0.0 0.2 1.6 0.2 0.2 0.2 0.2 0.5 6.1 5.0 0.1 0.1 1.0 0.2 0.4 0.2 6.9 0.1 8.6 0.4 2.1 1.8 0.2 0.2 1.0 0.7 9.7 0.3 1.8 0.3 0.1 0.1 0.3 0.2 0.2 1.1 0.2 0.4 4.2 0.1 0.1 0.4 0.5 2.9 0.0 0.3 0.2 2.2 1.7 0.5 0.1 0.2 0.1 1.4 17.8 82.7 2.7 12.7 7.1 7.6 6.6 5.3 8.8 11.3 3.0 5.1 0.0 10.1 9.4 6.7 3.4 0.0 13.4 7.9 3.5 15.7 0.4 1.7 0.4 3.6 4.4 1.4 0.0 2.7 2.8 5.6 4.9 5.7 1.3 0.9 3.2 0.0 0.6 0.3 2.2 0.9 1.3 13.5 0.0 0.2 0.9 1.2 2.0 2.8 3.8 3.1 6.5 13.9 1.9 5.3 6.6 0.5 1.3 1.2 12.9 GNAS "GNAS1, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI" ENSG00000087460 "GNAS complex locus" "O95467, P63092, P84996, Q5JWF2" 20 58839718-58911192 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Transducer "Cancer-related genes, Cushing syndrome, Disease mutation, Dwarfism, Obesity, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 303.3;thyroid gland: 304.5" "Cell type enhanced" "Detected in all" 5 "Horizontal cells: 1781.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010337, HPA018122, HPA027478, HPA028386" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA Nucleoplasm "Plasma membrane, Cytosol" "CAB010337: AB_631538, HPA018122: AB_1849236, HPA027478: AB_10599284, HPA028386: AB_10601983" "unprognostic (7.48e-2)" "unprognostic (1.41e-1)" "unprognostic (3.90e-2)" "unprognostic (4.77e-2)" "unprognostic (8.37e-3)" "unprognostic (2.82e-2)" "unprognostic (4.53e-3)" "unprognostic (8.01e-2)" "unprognostic (4.29e-2)" "prognostic favorable (8.76e-4)" "unprognostic (2.07e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (3.49e-4)" "unprognostic (5.24e-3)" "unprognostic (1.61e-1)" "unprognostic (8.25e-2)" "unprognostic (1.36e-1)" 56.2 79.0 84.2 34.4 44.5 42.1 87.4 86.0 107.4 43.2 42.3 25.4 27.0 33.2 37.2 44.7 41.0 43.6 34.4 106.0 71.0 144.0 39.6 35.3 46.6 44.6 75.8 64.7 43.6 118.1 120.9 303.3 49.8 85.6 36.3 31.5 42.7 171.6 31.1 172.9 26.3 34.9 40.5 61.4 36.9 42.4 18.2 27.4 56.0 304.5 80.6 41.0 37.3 44.6 27.3 41.5 29.9 36.2 25.3 24.2 24.6 9.7 32.8 55.4 25.8 94.2 43.0 49.8 56.4 51.6 64.5 46.3 95.8 50.6 32.0 87.9 73.2 46.2 42.3 50.8 75.1 43.7 21.1 30.6 35.6 49.9 62.7 43.5 20.7 22.4 51.3 38.2 31.3 42.2 51.2 48.9 39.5 31.2 43.7 42.5 133.6 105.4 50.6 17.6 6.4 34.7 64.9 48.5 56.5 51.7 38.7 68.7 157.4 78.4 77.9 62.9 50.7 59.5 56.7 53.7 85.7 77.0 30.8 53.1 76.8 49.5 67.6 37.6 10.1 43.7 29.9 24.8 29.5 20.7 35.7 22.1 26.7 22.0 22.2 37.8 27.3 21.3 24.2 29.1 25.3 36.2 41.5 23.3 24.6 84.2 44.5 86.0 107.4 71.0 144.0 75.8 64.7 85.6 27.4 205.4 224.1 189.5 151.9 115.9 363.0 884.0 242.0 250.3 255.9 247.7 53.0 672.6 376.4 220.5 577.5 343.9 323.7 303.7 196.1 292.5 221.9 260.9 133.0 165.2 333.8 1781.3 444.7 335.7 327.9 1338.6 245.7 276.8 210.9 147.9 250.3 861.2 313.5 239.3 185.3 130.9 175.1 207.0 226.4 48.2 25.4 103.0 1013.3 142.4 268.2 212.5 GNL3L "FLJ10613, GNL3B" ENSG00000130119 "G protein nucleolar 3 like" Q9NVN8 X 54530211-54561071 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036314, HPA036315" Supported Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA036314: AB_10669986, HPA036315: AB_2675055" "unprognostic (9.71e-3)" "unprognostic (6.58e-2)" "unprognostic (6.24e-2)" "unprognostic (1.99e-2)" "unprognostic (1.13e-2)" "unprognostic (1.38e-1)" "unprognostic (2.92e-2)" "unprognostic (5.46e-2)" "unprognostic (8.44e-2)" "unprognostic (9.97e-2)" "unprognostic (4.91e-3)" "unprognostic (7.87e-2)" "unprognostic (8.05e-3)" "unprognostic (2.99e-2)" "unprognostic (1.51e-1)" "unprognostic (1.75e-3)" "unprognostic (1.10e-1)" 12.7 12.9 10.3 16.1 12.3 19.2 12.5 8.6 13.1 10.8 10.2 14.8 10.5 8.5 15.2 10.2 16.3 11.0 10.1 15.3 8.1 8.0 12.0 12.5 13.0 15.5 13.0 10.8 13.2 17.5 15.9 16.9 12.0 10.2 10.6 13.3 12.3 13.3 12.4 24.0 13.2 13.5 15.0 11.5 17.6 11.7 5.9 13.9 20.5 18.0 12.0 18.6 13.7 13.1 17.2 11.4 20.2 15.2 21.8 17.7 11.5 11.2 28.0 5.8 11.9 6.0 4.1 10.7 6.7 4.9 7.6 6.0 23.6 9.3 15.8 13.0 9.7 9.9 11.0 19.3 8.4 10.5 10.9 10.0 15.9 22.4 11.1 4.6 24.6 15.7 5.8 4.1 17.7 10.7 3.1 8.1 9.0 10.3 16.0 7.6 21.8 13.9 5.1 16.7 6.7 15.7 15.0 13.2 15.3 5.7 17.8 9.4 5.7 22.0 13.6 6.3 12.2 17.9 6.3 11.6 13.8 13.8 13.3 11.4 12.0 15.3 20.3 7.1 20.4 15.3 18.9 14.2 15.1 17.7 12.6 16.1 15.0 16.2 15.4 11.4 17.2 12.4 13.0 20.2 21.8 15.2 9.6 8.6 11.5 10.3 12.3 8.6 13.1 8.1 8.0 13.0 10.8 10.2 13.9 11.9 21.0 11.9 2.9 1.1 9.4 7.0 5.1 12.0 18.2 3.5 11.8 6.4 3.3 6.0 0.2 6.0 4.6 0.0 7.6 5.4 3.3 2.8 10.4 3.9 4.4 7.9 3.4 7.4 11.9 0.0 5.2 6.1 0.0 6.4 4.3 3.7 7.8 3.5 2.8 3.3 8.0 6.5 4.1 1.2 7.4 1.8 4.6 8.2 3.9 3.1 GOLGA3 "GCP170, golgin-160, MEA-2" ENSG00000090615 "Golgin A3" Q08378 12 132768909-132828858 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Rod photoreceptor cells: 104.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039809, HPA040044" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA039809: AB_10962348, HPA040044: AB_10981600" "unprognostic (1.93e-1)" "unprognostic (7.91e-2)" "unprognostic (6.80e-2)" "unprognostic (1.41e-1)" "unprognostic (2.56e-2)" "unprognostic (4.08e-2)" "prognostic unfavorable (2.73e-4)" "unprognostic (1.10e-1)" "unprognostic (7.69e-2)" "unprognostic (1.55e-2)" "prognostic favorable (3.87e-4)" "unprognostic (2.99e-1)" "prognostic unfavorable (6.47e-5)" "unprognostic (1.40e-2)" "unprognostic (1.45e-1)" "unprognostic (2.01e-2)" "unprognostic (1.20e-1)" 17.5 14.2 14.7 17.6 17.0 13.8 14.5 23.7 21.4 20.1 19.9 17.6 20.6 12.3 18.2 20.0 18.3 14.3 20.7 17.0 14.6 16.7 11.2 18.7 15.5 16.0 15.8 13.2 20.5 39.1 16.1 32.1 18.8 16.2 18.0 16.8 14.3 26.9 19.8 20.5 21.4 15.5 24.6 12.9 18.2 22.2 13.9 14.1 9.8 15.3 15.4 18.2 17.1 16.1 7.3 8.0 5.1 4.6 7.3 7.5 3.5 9.8 20.1 7.2 12.1 25.3 17.1 13.3 16.9 12.8 10.7 9.3 19.0 4.4 13.4 9.1 24.9 9.0 10.3 7.8 10.2 7.3 3.5 9.0 13.5 20.3 12.4 14.7 14.7 19.9 12.9 12.5 14.4 14.5 13.7 10.3 9.3 13.1 5.3 11.1 15.2 12.8 13.7 7.4 7.7 13.6 10.2 8.0 4.8 6.8 23.5 9.1 5.8 14.0 12.5 8.0 8.1 16.3 10.9 21.1 12.6 9.3 14.1 10.8 16.4 13.7 18.2 15.8 8.8 16.0 5.1 4.2 3.6 7.5 4.5 6.6 4.6 5.5 5.9 4.1 7.3 6.3 6.6 3.2 7.3 4.6 8.0 4.5 3.5 14.7 17.0 23.7 21.4 14.6 16.7 15.8 13.2 16.2 14.1 41.7 37.6 16.4 9.3 19.3 25.8 31.4 10.2 16.0 26.1 14.0 94.2 11.6 6.6 14.1 23.9 20.0 46.6 23.3 24.0 20.0 25.5 24.2 11.5 23.7 14.3 17.5 21.4 18.4 8.8 27.7 23.9 11.4 16.9 12.6 43.4 20.3 26.8 27.5 21.2 8.4 104.5 6.5 19.6 19.4 23.9 29.0 19.3 14.1 19.7 22.6 GOLGA4 "GCP2, GOLG, golgin-240, p230" ENSG00000144674 "Golgin A4" Q13439 3 37243177-37366751 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cardiomyocytes: 608.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035102, HPA040675" Supported Supported "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA035102: AB_10601472, HPA040675: " "unprognostic (9.46e-2)" "unprognostic (1.55e-1)" "unprognostic (1.18e-2)" "unprognostic (5.67e-2)" "unprognostic (1.44e-1)" "unprognostic (1.54e-1)" "unprognostic (5.61e-2)" "unprognostic (1.38e-1)" "unprognostic (5.79e-3)" "unprognostic (3.90e-2)" "unprognostic (5.62e-2)" "unprognostic (8.55e-2)" "prognostic favorable (3.62e-6)" "unprognostic (7.16e-2)" "unprognostic (1.04e-1)" "unprognostic (3.92e-2)" "unprognostic (1.33e-1)" 22.3 20.6 16.7 14.0 29.0 11.4 30.6 26.9 27.1 19.1 25.1 14.5 29.1 23.9 12.8 18.4 22.0 11.3 16.7 34.3 18.1 12.3 22.1 32.7 15.2 12.2 30.5 12.8 14.8 27.7 27.1 42.8 34.5 18.9 21.1 18.1 20.2 24.8 24.4 64.6 29.8 29.1 19.0 23.9 14.8 21.2 26.0 24.9 10.3 29.9 22.6 11.8 20.5 24.8 10.0 9.9 19.8 11.0 13.0 14.9 3.2 23.7 16.5 8.5 10.7 22.5 19.4 21.7 30.6 25.7 12.1 14.6 14.1 13.3 8.2 8.0 26.0 13.9 14.0 13.5 21.7 25.2 10.4 9.9 11.1 14.6 22.4 22.6 11.7 8.1 10.4 20.8 19.0 37.2 19.6 17.5 6.2 13.5 12.9 19.4 10.2 8.9 5.1 9.3 12.2 15.7 2.0 25.8 8.6 15.0 25.0 5.5 7.3 18.9 20.5 23.4 17.1 30.2 8.6 21.0 12.4 14.4 23.9 21.8 15.9 11.2 7.2 22.0 10.3 14.5 19.8 5.5 12.0 14.9 6.4 12.5 8.1 9.2 10.3 4.5 10.0 9.6 7.2 7.7 13.0 11.0 9.9 6.0 3.2 16.7 29.0 26.9 27.1 18.1 12.3 30.5 12.8 18.9 24.9 220.3 277.4 69.8 105.1 140.7 166.1 608.0 73.9 104.4 195.7 43.6 337.7 86.2 24.9 103.7 122.0 85.9 153.6 23.3 105.1 100.5 87.0 136.9 59.1 125.8 75.0 178.0 85.9 71.8 62.7 17.5 111.0 62.5 65.8 83.8 108.9 122.0 118.5 95.4 106.8 55.9 360.2 84.1 88.0 351.1 212.3 153.6 208.7 59.7 96.2 157.6 GOLGA6A "GLP, GOLGA6" ENSG00000159289 "Golgin A6 family member A" Q9NYA3 15 74069857-74082550 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Group enriched" "Detected in some" 29 "liver: 6.2;testis: 15.7" "Cell type enriched" "Detected in some" 16 "Early spermatids: 37.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.9;SuSa: 2.3;U-266/70: 5.2" "HPA044978, HPA050087, HPA072134" Supported Approved Nucleoplasm,Vesicles,Centrosome NA NA Vesicles "Nucleoplasm, Centrosome" "HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: " "unprognostic (1.68e-1)" "unprognostic (2.09e-2)" "unprognostic (9.50e-2)" "unprognostic (9.67e-2)" "unprognostic (6.70e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.3 0.1 0.1 0.0 0.0 0.2 0.3 0.0 5.2 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 GOLGA6B ENSG00000215186 "Golgin A6 family member B" A6NDN3 15 72654738-72666394 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 34 "liver: 8.4;testis: 10.5" "Cell type enriched" "Detected in single" 60 "Early spermatids: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.0;SuSa: 1.3;U-266/70: 2.5;U-266/84: 1.1" "HPA044978, HPA050087, HPA072134" Supported Approved Nucleoplasm,Vesicles,Centrosome NA NA Vesicles "Nucleoplasm, Centrosome" "HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: " "unprognostic (5.47e-3)" "unprognostic (1.88e-2)" "unprognostic (2.07e-1)" "unprognostic (2.01e-1)" "unprognostic (2.03e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.1 1.0 0.0 0.6 0.0 0.3 0.8 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.5 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA6C ENSG00000167195 "Golgin A6 family member C" A6NDK9 15 75258599-75270199 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 17 "testis: 12.5" "Cell type enriched" "Detected in single" 72 "Early spermatids: 7.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 1.3;SuSa: 1.6" "HPA044978, HPA050087, HPA072134" Supported Approved Nucleoplasm,Vesicles,Centrosome NA NA Vesicles "Nucleoplasm, Centrosome" "HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: " "unprognostic (6.53e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.2 0.0 0.1 0.0 0.3 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.3 0.0 1.3 0.0 0.1 0.3 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 1.6 0.3 0.0 0.7 0.0 0.1 0.1 0.0 0.8 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA6D ENSG00000140478 "Golgin A6 family member D" P0CG33 15 75282835-75295807 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "testis: 14.2" "Cell type enriched" "Detected in some" 6 "Early spermatids: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 2.6;Karpas-707: 1.1;NTERA-2: 1.5;SuSa: 3.2;U-266/70: 2.9;U-266/84: 1.3" "HPA044978, HPA050087, HPA072134" Supported Approved Nucleoplasm,Vesicles,Centrosome NA NA Vesicles "Nucleoplasm, Centrosome" "HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: " "unprognostic (7.95e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.1 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.1 0.0 0.2 0.3 0.0 0.0 2.9 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 GOLT1B "CGI-141, GOT1, YMR292W" ENSG00000111711 "Golgi transport 1B" Q9Y3E0 12 21501781-21518408 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055909, HPA066383" Approved Supported Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA055909: AB_2682967, HPA066383: AB_2685667" "unprognostic (1.22e-2)" "unprognostic (3.07e-3)" "unprognostic (1.84e-1)" "unprognostic (3.65e-1)" "unprognostic (3.45e-1)" "unprognostic (5.37e-3)" "prognostic unfavorable (1.99e-8)" "unprognostic (2.24e-2)" "unprognostic (1.60e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (2.32e-4)" "unprognostic (1.36e-1)" "prognostic unfavorable (4.83e-10)" "unprognostic (3.13e-1)" "unprognostic (2.14e-1)" "unprognostic (6.78e-2)" "unprognostic (1.04e-1)" 21.1 26.0 18.3 18.2 24.4 23.4 20.4 31.9 30.4 22.3 14.7 18.9 13.8 12.0 16.9 18.9 15.3 14.6 16.4 17.0 19.1 22.4 23.2 40.1 19.9 16.0 20.1 16.2 14.1 30.9 11.3 34.9 31.1 23.8 19.0 16.8 16.1 17.4 15.3 15.9 14.5 13.0 19.6 22.2 17.8 15.3 11.6 17.5 13.5 19.1 11.6 15.6 22.5 14.2 17.7 22.2 26.7 22.9 14.8 21.1 19.4 11.4 12.1 10.0 12.9 20.2 31.5 17.0 45.1 17.2 14.3 23.4 15.8 17.0 6.9 11.6 23.4 26.6 11.1 8.3 9.3 25.1 10.1 7.9 10.1 7.9 11.0 22.5 13.0 13.0 15.9 18.2 17.1 31.5 24.6 12.9 8.6 6.3 7.7 21.9 10.7 5.8 21.6 27.6 9.9 8.7 5.0 24.4 14.5 11.8 7.0 2.7 8.4 18.4 7.2 24.6 33.8 10.0 14.7 14.4 16.9 18.4 20.8 24.5 7.5 16.3 18.3 23.1 12.5 22.7 26.7 20.6 14.8 17.9 22.9 21.1 17.7 21.1 19.5 20.2 16.5 19.3 19.2 5.6 14.8 20.9 22.2 20.4 19.4 18.3 24.4 31.9 30.4 19.1 22.4 20.1 16.2 23.8 17.5 8.9 14.1 38.8 20.4 41.4 28.9 15.5 15.3 8.1 25.0 15.7 9.8 25.0 23.2 28.8 2.7 27.1 10.5 0.0 29.2 54.0 45.6 35.7 20.8 21.7 37.8 17.5 12.6 17.8 21.3 3.6 16.1 35.7 50.6 22.6 22.7 17.8 30.7 14.4 18.7 17.4 6.7 12.9 30.7 22.9 31.0 55.8 53.5 33.1 13.2 20.5 GON4L "FLJ20203, GON-4, GON4, YARP" ENSG00000116580 "Gon-4 like" Q3T8J9 1 155749662-155859400 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 123.7;Rod photoreceptor cells: 164.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA006986, HPA057305, HPA074504" Uncertain Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA006986: AB_1080620, HPA057305: AB_2683408, HPA074504: AB_2686696" "unprognostic (3.16e-2)" "unprognostic (9.26e-3)" "unprognostic (1.68e-1)" "prognostic unfavorable (4.19e-4)" "unprognostic (9.85e-3)" "unprognostic (5.21e-2)" "unprognostic (1.83e-2)" "unprognostic (1.15e-1)" "unprognostic (7.49e-2)" "unprognostic (7.50e-2)" "unprognostic (1.69e-1)" "unprognostic (1.94e-1)" "unprognostic (5.12e-3)" "unprognostic (3.52e-1)" "unprognostic (2.87e-1)" "unprognostic (3.26e-2)" "unprognostic (5.83e-2)" 17.4 12.5 13.5 16.1 18.9 13.6 18.3 30.1 21.6 17.6 15.7 14.4 18.7 11.8 25.8 18.3 13.7 15.9 12.0 14.0 14.8 10.2 14.9 12.7 16.7 18.3 14.8 13.0 17.2 16.3 26.0 22.3 15.9 15.3 16.1 15.4 16.3 15.2 15.8 18.8 17.8 17.5 18.3 16.5 21.1 15.1 14.1 16.0 25.1 18.8 11.4 24.8 16.9 16.0 7.0 5.2 10.2 4.7 8.4 6.6 2.5 11.4 9.5 18.4 11.3 11.6 14.6 11.6 10.4 12.9 13.5 13.2 11.3 10.5 13.2 11.4 13.6 6.8 13.3 13.6 12.1 15.7 12.3 9.6 13.2 11.7 6.3 11.0 15.5 12.3 12.9 10.7 14.9 14.2 13.9 15.9 14.7 16.8 5.1 11.3 11.7 13.4 9.4 20.3 14.4 10.9 12.4 11.7 14.7 9.9 13.8 10.3 17.3 12.7 12.9 10.0 19.4 14.1 18.6 17.8 11.0 9.1 11.2 12.9 20.7 13.8 22.2 9.6 9.3 12.1 5.0 4.7 4.0 6.6 3.7 4.4 3.7 4.3 4.6 4.7 7.0 4.5 4.1 10.2 8.4 3.1 5.2 4.2 2.5 13.5 18.9 30.1 21.6 14.8 10.2 14.8 13.0 15.3 16.0 14.9 32.6 21.4 18.8 10.8 69.8 18.6 15.3 16.0 34.2 19.2 123.7 20.5 8.3 19.9 17.3 35.0 19.8 0.0 15.7 19.3 20.6 22.5 38.0 11.0 17.2 73.1 31.2 23.4 16.3 8.5 32.5 21.6 15.1 34.3 17.7 44.4 18.7 20.1 25.8 10.1 164.4 38.8 17.6 49.5 37.5 15.3 37.6 34.6 19.6 19.5 GON7 C14orf142 ENSG00000170270 "GON7, KEOPS complex subunit" Q9BXV9 14 93202894-93207094 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 19 "Ciliated cells: 174.0;Distal tubular cells: 58.0;Proximal tubular cells: 40.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA051832 Approved Supported "Nucleoplasm,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli rim" "HPA051832: AB_2681628" "unprognostic (2.28e-2)" "unprognostic (1.96e-3)" "unprognostic (2.79e-2)" "unprognostic (1.45e-3)" "unprognostic (3.43e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (1.53e-5)" "unprognostic (3.40e-3)" "unprognostic (8.82e-2)" "unprognostic (1.45e-3)" "unprognostic (2.47e-3)" "unprognostic (7.37e-2)" "prognostic favorable (3.08e-4)" "unprognostic (2.96e-1)" "unprognostic (1.17e-1)" "unprognostic (2.67e-1)" "unprognostic (2.77e-1)" 7.3 15.5 11.4 8.7 13.2 5.4 11.0 11.3 13.4 14.6 14.2 4.9 21.5 12.5 6.8 20.5 7.5 33.8 9.8 18.6 10.9 13.6 21.1 14.7 10.1 13.7 10.4 11.3 7.6 11.5 9.5 14.8 6.1 13.2 8.7 12.9 7.6 9.4 12.1 13.2 5.1 17.4 6.4 8.2 10.3 9.3 8.9 9.5 13.6 14.6 9.5 11.8 8.3 8.8 14.2 14.8 10.7 10.8 10.6 17.6 8.8 4.9 6.7 7.0 7.2 6.2 7.6 5.6 6.3 5.8 9.2 10.5 4.3 7.8 15.5 4.8 4.0 6.8 7.0 7.7 5.5 10.9 9.0 6.0 4.0 9.8 10.3 4.7 15.3 7.7 4.6 5.2 7.0 5.8 2.4 6.8 10.6 9.5 10.4 8.2 16.6 10.3 13.4 4.6 19.5 13.2 14.9 9.0 8.0 9.0 6.4 11.6 7.8 5.7 7.3 10.3 4.2 9.5 10.8 4.5 4.7 5.7 8.3 5.0 11.5 25.6 14.6 9.8 9.4 5.7 10.7 9.7 8.1 9.6 10.8 12.5 14.2 11.0 10.1 12.3 9.8 10.4 11.4 3.5 10.6 9.8 14.8 17.6 8.8 11.4 13.2 11.3 13.4 10.9 13.6 10.4 11.3 13.2 9.5 6.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 174.0 18.2 14.0 0.0 15.3 58.0 24.7 0.0 0.0 0.0 0.0 19.0 15.9 0.0 0.0 9.3 0.0 32.3 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 11.8 0.0 0.0 13.8 0.0 0.0 40.6 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 GORAB "FLJ11752, GO, NTKL-BP1, SCYL1BP1" ENSG00000120370 "Golgin, RAB6 interacting" Q5T7V8 1 170532129-170553446 "Disease related genes, Predicted intracellular proteins" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027208, HPA027250, HPA027746" Approved Enhanced "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus, Cytosol" "Nucleoplasm, Nucleoli" "HPA027208: AB_10599622, HPA027250: AB_10611253, HPA027746: " "unprognostic (1.59e-1)" "unprognostic (1.12e-1)" "unprognostic (1.03e-1)" "unprognostic (1.69e-1)" "unprognostic (4.75e-3)" "prognostic favorable (1.39e-4)" "prognostic unfavorable (5.26e-4)" "unprognostic (8.48e-3)" "unprognostic (2.94e-2)" "unprognostic (2.06e-2)" "unprognostic (1.43e-1)" "unprognostic (3.77e-2)" "prognostic unfavorable (7.83e-12)" "unprognostic (2.52e-2)" "unprognostic (2.83e-1)" "unprognostic (7.71e-2)" "unprognostic (1.70e-1)" 7.7 14.7 8.4 9.4 9.2 0.5 10.6 8.7 9.5 10.7 9.4 4.8 7.0 4.8 8.8 10.5 6.3 6.8 6.7 8.2 7.4 7.8 7.2 11.1 6.8 9.6 6.3 8.1 12.6 9.7 6.5 20.6 9.4 8.7 11.1 10.4 6.3 8.8 13.1 3.3 6.5 7.0 6.4 11.1 10.4 5.6 8.6 7.3 8.7 10.5 4.2 9.7 10.4 10.0 6.2 7.3 1.2 7.4 7.9 9.4 5.5 5.1 5.0 9.6 3.6 12.9 9.6 6.3 7.8 12.1 6.9 7.2 3.2 8.8 7.5 9.0 7.9 4.5 6.5 9.5 4.6 9.2 8.0 2.9 5.0 6.5 4.0 8.7 6.6 5.1 8.3 4.5 7.4 6.9 8.6 5.4 4.3 6.8 3.7 7.3 1.2 9.5 6.0 8.5 11.6 6.3 5.7 6.4 10.0 6.2 3.8 2.5 5.3 6.5 7.9 18.2 6.4 5.0 11.7 6.9 11.0 5.8 4.3 10.8 6.7 7.3 6.6 9.2 6.0 9.8 1.0 7.4 0.0 4.7 7.4 7.4 6.1 8.3 7.2 7.3 6.2 7.3 6.2 1.2 7.9 5.7 4.6 9.4 5.5 8.4 9.2 8.7 9.5 7.4 7.8 6.3 8.1 8.7 7.3 0.0 10.7 6.0 2.9 2.5 3.9 6.7 7.6 1.4 6.8 5.2 2.0 5.2 3.3 9.4 1.6 7.4 5.1 0.0 5.3 5.6 10.4 4.1 12.8 5.8 6.3 4.8 0.0 3.7 6.3 2.6 13.0 3.9 3.3 10.0 6.4 3.4 5.8 7.0 6.0 4.4 7.2 6.5 8.5 13.1 7.7 1.4 4.7 5.7 6.0 2.7 GOSR2 "Bos1, GS27" ENSG00000108433 "Golgi SNAP receptor complex member 2" O14653 17 46923075-46975524 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 10 "Early spermatids: 276.4;Late spermatids: 609.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB017456, HPA048956, HPA054472" Uncertain Supported "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "CAB017456: AB_10532285, HPA048956: AB_2680569, HPA054472: AB_2682499" "unprognostic (3.28e-2)" "unprognostic (1.18e-1)" "unprognostic (1.49e-2)" "unprognostic (3.54e-2)" "unprognostic (1.30e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (3.80e-4)" "unprognostic (7.43e-2)" "unprognostic (2.13e-1)" "unprognostic (2.41e-2)" "unprognostic (7.23e-3)" "unprognostic (2.41e-1)" "unprognostic (2.46e-3)" "unprognostic (4.50e-1)" "unprognostic (3.07e-1)" "unprognostic (2.84e-3)" "unprognostic (4.29e-2)" 22.4 24.6 27.9 18.7 27.8 12.5 22.6 22.2 31.1 24.1 25.3 28.9 38.0 43.9 25.9 30.0 19.7 19.6 21.4 28.7 25.2 26.5 37.4 39.7 21.0 23.8 27.0 22.8 27.5 33.6 26.8 40.6 27.6 23.5 22.0 25.1 25.8 28.4 29.8 34.4 19.2 38.2 27.1 27.8 31.5 20.6 38.8 18.4 23.6 24.9 15.2 30.7 20.9 21.0 16.9 15.5 15.1 37.0 13.9 17.6 15.5 18.3 20.8 14.8 18.0 25.3 18.2 17.2 26.4 26.1 28.8 26.1 26.3 11.5 16.4 15.1 33.3 30.3 13.4 19.2 21.5 35.7 35.0 14.7 24.7 17.1 25.7 28.0 19.2 20.0 19.0 21.1 23.5 33.6 22.2 23.6 19.0 24.1 22.2 20.8 20.3 20.8 10.4 13.7 25.8 29.6 17.9 28.8 19.0 18.2 15.8 13.1 27.6 14.5 8.7 20.4 27.1 24.3 13.4 27.6 27.3 17.6 21.2 25.2 28.9 16.2 25.9 25.8 12.4 29.9 15.1 15.5 13.1 16.8 28.9 15.5 14.8 15.0 13.8 15.5 16.9 14.9 13.0 1.8 13.9 37.0 14.0 17.6 15.5 27.9 27.8 22.2 31.1 25.2 26.5 27.0 22.8 23.5 18.4 23.8 18.9 31.8 12.9 14.7 15.9 13.2 17.8 13.4 9.1 31.4 5.9 25.2 19.9 30.2 276.4 16.2 24.0 23.3 37.2 27.0 16.9 16.6 13.9 19.8 38.2 22.3 6.9 20.9 22.6 609.8 15.5 16.8 10.1 24.4 14.3 15.6 42.8 20.1 13.4 42.5 18.6 0.0 15.6 29.6 24.5 14.8 44.1 16.0 10.2 20.7 GOT1 AST1 ENSG00000120053 "Glutamic-oxaloacetic transaminase 1" P17174 10 99396870-99430624 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Amino-acid biosynthesis" "Aminotransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 116.9;liver: 82.9;skeletal muscle: 102.1" "Cell type enhanced" "Detected in all" 9 "Cardiomyocytes: 398.1;Distal tubular cells: 203.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064532, HPA072629" Enhanced Supported Nucleoplasm,Cytosol NA Yes 130000000 Nucleoplasm Cytosol "HPA064532: AB_2685279, HPA072629: AB_2686540" "unprognostic (6.40e-2)" "prognostic favorable (6.23e-4)" "unprognostic (5.99e-2)" "unprognostic (2.84e-2)" "unprognostic (2.82e-1)" "unprognostic (2.96e-2)" "unprognostic (5.25e-2)" "unprognostic (1.08e-3)" "unprognostic (6.67e-2)" "unprognostic (1.45e-1)" "unprognostic (1.79e-2)" "unprognostic (1.79e-1)" "prognostic favorable (3.72e-13)" "unprognostic (1.93e-2)" "unprognostic (4.23e-1)" "unprognostic (6.85e-2)" "unprognostic (1.00e-1)" 3.3 14.0 15.7 3.6 32.1 2.0 5.9 22.9 56.4 13.5 12.0 9.7 5.9 14.7 3.4 7.0 10.3 4.6 12.2 116.9 19.4 19.0 34.6 82.9 3.5 3.4 17.8 16.4 3.8 8.2 15.9 4.9 3.7 49.9 5.9 14.7 9.0 12.4 7.2 102.1 4.5 12.7 5.4 7.7 3.6 10.1 9.3 4.7 3.3 11.7 31.3 7.1 4.9 4.0 10.6 21.4 3.9 16.8 11.4 15.6 8.8 17.2 9.6 11.3 28.6 8.7 7.5 32.0 14.2 26.1 24.7 27.1 21.7 14.1 16.9 4.9 11.9 21.0 21.7 25.8 18.7 27.4 5.8 11.0 6.4 12.3 28.2 46.5 18.3 11.0 11.9 20.2 21.0 57.1 16.8 12.0 11.2 16.5 26.5 15.8 15.6 9.8 13.8 7.2 27.0 13.4 10.7 10.8 17.6 43.2 9.5 4.9 7.2 10.7 15.2 52.9 17.4 29.0 6.3 5.5 6.3 14.1 6.8 16.2 18.9 22.3 17.3 16.6 9.6 8.4 2.4 5.3 3.9 12.4 14.7 11.4 10.6 13.5 12.9 12.9 10.2 10.2 14.5 0.5 11.4 16.8 21.4 15.6 8.8 15.7 32.1 22.9 56.4 19.4 19.0 17.8 16.4 49.9 4.7 14.9 14.4 29.9 39.5 10.5 86.5 398.1 96.8 26.8 14.8 69.8 58.9 29.8 203.9 43.4 86.1 13.5 75.3 46.7 27.1 14.9 9.9 11.6 32.2 145.9 26.2 71.5 18.9 17.2 11.6 9.5 10.3 9.5 47.2 14.4 30.8 29.4 25.5 30.3 13.4 123.7 55.6 12.9 14.1 28.9 11.5 9.2 46.1 12.1 50.2 36.7 GP6 GPVI ENSG00000088053 "Glycoprotein VI platelet" Q9HCN6 19 55013705-55038264 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Blood coagulation, Hemostasis" Receptor "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 8.9" "Cell type enhanced" "Detected in some" 13 "Cone photoreceptor cells: 5.9;Early spermatids: 10.5;Late spermatids: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 12 "HEL: 13.9;K-562: 5.9;U-2 OS: 4.0" HPA066482 Approved Approved Nucleoplasm "Intracellular and membrane" NA NA 28000000 Nucleoplasm "HPA066482: AB_2685674" "unprognostic (3.06e-3)" "unprognostic (4.58e-2)" "unprognostic (1.74e-5)" "unprognostic (1.94e-1)" "unprognostic (1.20e-1)" "unprognostic (3.52e-2)" "unprognostic (7.50e-4)" "unprognostic (2.81e-1)" "unprognostic (1.00e-1)" "unprognostic (4.18e-2)" "unprognostic (3.04e-1)" "unprognostic (1.12e-1)" "unprognostic (1.53e-1)" "unprognostic (2.62e-1)" "unprognostic (3.32e-2)" "unprognostic (5.44e-3)" "unprognostic (2.70e-2)" 0.3 0.3 0.8 0.4 1.4 4.4 0.9 4.6 1.6 1.3 0.4 0.3 0.3 0.1 1.1 0.3 2.1 0.5 0.5 5.4 0.7 0.9 0.4 1.5 1.4 0.3 0.3 0.3 0.6 0.3 0.6 0.3 2.8 0.3 0.6 0.4 2.0 0.7 3.0 0.3 3.2 0.3 0.3 0.3 8.9 0.1 4.2 1.0 0.3 0.6 0.3 0.3 0.7 1.8 0.0 0.3 1.3 0.2 0.0 0.1 4.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.6 0.2 0.0 0.2 0.2 0.5 13.9 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.3 5.9 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.5 0.1 0.0 0.1 0.2 0.1 0.0 0.4 0.2 0.2 0.1 4.0 0.1 0.0 0.3 0.0 0.4 0.1 0.4 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 4.0 0.8 1.4 4.6 1.6 0.7 0.9 0.3 0.3 0.3 1.0 0.0 0.0 0.0 0.1 0.0 1.5 0.4 0.0 1.4 0.0 0.0 5.9 0.1 0.0 0.0 10.5 0.3 0.3 0.0 0.3 0.2 0.2 0.3 1.1 0.0 0.1 3.2 0.0 2.5 1.2 6.4 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 2.4 0.0 0.0 1.1 0.9 0.1 0.5 0.0 0.0 0.7 GP9 "CD42a, GPIX" ENSG00000169704 "Glycoprotein IX platelet" P14770 3 129060767-129062406 "CD markers, Disease related genes, Predicted membrane proteins" "Blood coagulation, Cell adhesion, Hemostasis" "Bernard Soulier syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 27.1;bone marrow: 10.0;lymphoid tissue: 24.5" "Group enriched" "Detected in some" 11 "Early spermatids: 14.0;Late spermatids: 13.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 8.8;neutrophil: 7.5" "Lineage enriched" "Detected in many" 6 "granulocytes: 8.8" "Cell line enriched" "Detected in some" 14 "HEL: 43.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA063182 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 68000000 "Plasma membrane, Cytosol" Nucleoplasm "HPA063182: AB_2684956" "unprognostic (1.70e-1)" "unprognostic (3.97e-1)" "unprognostic (1.10e-1)" "unprognostic (3.80e-2)" "unprognostic (2.50e-2)" "unprognostic (3.24e-1)" "unprognostic (2.53e-2)" "unprognostic (8.47e-2)" "unprognostic (8.70e-2)" 0.2 0.1 0.1 0.1 0.1 10.0 0.1 0.0 0.6 0.4 0.5 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.1 5.0 0.8 0.1 0.1 0.4 4.8 0.0 0.8 0.2 0.5 0.1 0.0 0.3 1.5 0.4 0.1 0.4 0.2 0.0 0.6 0.2 0.0 0.1 0.0 0.1 24.5 0.3 2.2 0.0 0.0 0.6 0.6 0.0 0.6 3.0 0.1 1.5 8.8 0.6 0.0 0.2 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.6 0.1 0.1 0.3 0.1 0.0 0.0 0.2 0.3 0.1 0.0 0.0 7.5 0.0 0.0 1.5 0.0 27.1 0.1 0.1 0.0 0.6 0.8 0.1 0.8 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 13.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GPALPP1 "AD029, bA245H20.2, KIAA1704, LSR7" ENSG00000133114 "GPALPP motifs containing 1" Q8IXQ4 13 44989529-45037669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038966, HPA058739" Uncertain Approved "Nucleoplasm,Nucleoli rim" NA NA "Nucleoli rim" Nucleoplasm "HPA038966: AB_10672656, HPA058739: AB_2683804" "unprognostic (4.99e-2)" "unprognostic (1.71e-1)" "unprognostic (1.61e-1)" "unprognostic (8.81e-2)" "unprognostic (3.65e-2)" "unprognostic (2.63e-2)" "unprognostic (8.86e-2)" "unprognostic (6.08e-2)" "unprognostic (2.72e-2)" "unprognostic (1.39e-2)" "unprognostic (1.06e-1)" "unprognostic (4.56e-2)" "unprognostic (1.41e-3)" "unprognostic (3.37e-2)" "unprognostic (6.38e-2)" "unprognostic (5.88e-2)" "unprognostic (3.94e-2)" 15.6 17.9 19.8 13.8 28.1 16.4 15.0 27.6 24.9 18.1 15.0 15.0 14.5 13.7 18.3 15.5 14.4 13.8 12.5 14.4 19.4 15.3 13.9 13.7 12.7 19.1 14.2 23.3 20.9 12.2 9.1 17.8 19.7 16.8 14.9 15.0 10.8 12.7 16.0 15.0 10.3 14.4 17.6 14.3 16.1 15.3 13.9 19.9 19.4 19.6 12.6 18.8 15.6 15.8 10.4 13.0 11.1 8.5 10.1 10.6 5.1 8.7 7.6 14.3 8.8 6.8 11.3 10.0 12.6 10.4 14.7 14.1 13.2 16.3 20.1 8.4 10.2 10.1 14.8 14.0 10.2 16.5 17.3 16.5 15.2 9.8 9.3 11.0 21.5 7.5 8.8 7.3 9.6 8.7 8.9 11.7 15.1 13.1 4.4 10.8 9.8 20.4 14.9 9.8 21.4 7.1 20.0 11.8 8.5 8.2 8.8 5.8 10.0 10.7 6.3 8.1 10.4 6.6 17.2 13.4 7.9 5.7 9.3 9.5 6.0 7.4 20.2 8.5 13.3 10.2 2.6 8.5 11.1 9.0 7.1 7.6 8.7 9.5 7.6 10.7 10.4 10.6 9.6 4.0 10.1 6.5 13.0 7.8 5.1 19.8 28.1 27.6 24.9 19.4 15.3 14.2 23.3 16.8 19.9 29.8 22.7 5.7 13.2 6.4 23.5 13.2 15.3 32.1 29.6 22.7 17.7 25.3 19.9 11.4 3.8 17.3 7.4 0.0 11.5 10.3 16.4 9.8 20.8 15.3 13.1 22.3 17.2 14.7 14.8 2.0 24.7 11.7 11.8 4.6 10.7 22.5 10.0 10.5 25.1 16.1 24.3 25.8 13.2 44.4 20.4 8.2 15.2 13.8 12.5 11.6 GPATCH1 "ECGP, FLJ10206, FLJ38686, GPATC1" ENSG00000076650 "G-patch domain containing 1" Q9BRR8 19 33080880-33130542 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043430, HPA043604" Approved Uncertain "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Nucleoplasm, Plasma membrane, Cell Junctions" "HPA043430: AB_10960493, HPA043604: AB_10960499" "unprognostic (2.38e-2)" "unprognostic (1.71e-2)" "unprognostic (9.95e-2)" "prognostic unfavorable (8.20e-4)" "unprognostic (2.41e-1)" "unprognostic (1.28e-2)" "unprognostic (4.60e-3)" "unprognostic (3.54e-2)" "unprognostic (5.17e-2)" "unprognostic (3.56e-2)" "unprognostic (6.53e-2)" "unprognostic (5.37e-3)" "unprognostic (8.10e-2)" "unprognostic (4.57e-2)" "unprognostic (1.25e-1)" "unprognostic (1.45e-2)" "unprognostic (6.88e-3)" 8.8 8.0 11.0 10.0 12.2 6.9 9.8 21.2 15.7 9.7 9.9 13.8 8.3 11.0 13.0 9.6 9.1 8.9 8.2 7.8 11.1 7.9 9.6 7.3 7.1 9.4 10.5 7.1 15.9 8.8 13.5 11.8 12.9 10.3 10.1 9.7 8.6 9.6 10.8 10.3 11.4 10.6 9.7 7.5 9.6 10.2 8.9 11.1 13.6 10.0 5.6 13.1 10.3 11.4 6.5 5.7 17.4 6.4 3.0 9.7 4.4 7.4 15.8 7.5 7.9 5.0 5.7 6.2 6.8 4.8 10.5 8.8 11.2 7.0 10.6 8.8 5.4 4.9 6.6 9.4 5.6 9.1 18.3 5.8 10.0 5.9 8.2 6.5 17.3 6.7 4.9 6.6 7.1 6.5 5.0 5.8 8.4 10.5 6.7 5.1 9.6 9.9 5.7 5.2 9.9 6.7 10.1 9.5 4.7 4.8 4.6 8.3 5.6 10.8 6.8 3.8 6.8 5.6 12.5 6.5 9.1 6.8 5.0 9.7 5.7 9.2 9.2 5.7 8.8 8.3 17.4 6.0 6.5 6.1 6.4 4.2 6.2 5.7 7.6 5.7 6.5 9.7 6.1 4.4 3.0 3.3 5.0 8.4 4.4 11.0 12.2 21.2 15.7 11.1 7.9 10.5 7.1 10.3 11.1 8.9 6.4 5.7 4.7 5.5 9.4 8.5 2.5 5.3 11.4 7.0 13.7 9.0 13.3 6.2 2.0 4.5 8.1 0.0 3.9 4.6 5.2 3.1 16.1 4.5 3.5 3.2 4.1 8.6 8.2 1.5 9.5 4.8 8.5 5.4 6.5 7.4 6.6 5.7 7.8 4.8 11.2 0.0 4.9 14.4 11.6 3.1 4.6 7.4 5.6 2.6 GPATCH11 "CCDC75, CENP-Y, CENPY, FLJ38348" ENSG00000152133 "G-patch domain containing 11" Q8N954 2 37084451-37099244 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Spermatocytes: 69.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038231, HPA038232" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA038231: AB_2675904, HPA038232: AB_10675788" "unprognostic (1.28e-2)" "unprognostic (1.58e-1)" "unprognostic (2.45e-1)" "unprognostic (1.80e-1)" "unprognostic (3.88e-2)" "unprognostic (2.23e-2)" "unprognostic (4.58e-3)" "unprognostic (2.40e-2)" "unprognostic (2.44e-2)" "unprognostic (4.39e-2)" "unprognostic (1.16e-1)" "unprognostic (1.26e-1)" "unprognostic (8.64e-3)" "unprognostic (4.31e-2)" "unprognostic (4.44e-2)" "unprognostic (3.40e-2)" "unprognostic (7.16e-2)" 26.0 8.5 14.4 9.4 15.8 11.0 11.1 16.0 17.5 9.9 6.0 10.7 4.0 6.2 7.3 5.2 6.8 5.1 5.9 6.9 14.3 13.9 7.3 7.3 8.0 14.8 16.1 16.2 8.2 4.4 6.6 11.2 7.3 15.3 5.6 6.6 4.9 5.2 5.8 7.3 7.6 6.4 5.7 22.7 9.7 6.2 14.1 15.5 8.6 8.5 2.8 14.3 8.0 8.2 9.3 12.9 5.9 2.8 7.3 4.9 1.5 6.4 3.9 6.7 5.1 14.3 6.6 7.1 11.7 4.7 7.1 5.8 4.9 2.8 7.5 6.6 4.3 6.1 4.6 7.8 2.8 10.6 12.7 8.6 13.6 5.3 4.9 4.6 16.2 14.9 4.3 5.0 9.7 5.5 4.7 6.2 4.7 12.7 35.5 8.2 3.2 10.4 9.0 2.8 10.7 5.5 8.7 14.2 20.9 3.1 2.8 8.0 7.5 6.1 3.9 5.7 5.6 4.1 7.5 6.8 12.9 7.1 9.3 12.8 13.9 14.3 11.5 9.2 13.7 11.3 5.9 2.8 2.3 4.9 2.0 4.9 9.3 3.7 4.1 3.8 7.8 4.0 4.1 0.9 7.3 0.8 12.9 2.6 1.5 14.4 15.8 16.0 17.5 14.3 13.9 16.1 16.2 15.3 15.5 11.9 7.2 15.2 2.2 3.8 24.7 12.0 10.2 14.7 4.5 10.4 23.6 7.4 10.0 6.9 21.3 12.8 9.6 23.3 12.4 22.3 6.4 1.9 11.5 12.1 11.4 12.7 2.9 17.8 11.9 3.6 15.0 15.8 3.3 9.0 5.2 28.4 10.9 3.6 20.8 7.1 47.4 12.9 5.7 69.5 41.8 4.6 3.2 9.6 5.2 1.8 GPATCH2L "C14orf118, FLJ10033, FLJ20689" ENSG00000089916 "G-patch domain containing 2 like" Q9NWQ4 14 76151916-76254342 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 149.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018856 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA018856: AB_1845553" "unprognostic (5.98e-2)" "unprognostic (1.44e-2)" "unprognostic (7.07e-2)" "unprognostic (1.26e-2)" "unprognostic (1.51e-2)" "unprognostic (5.59e-2)" "unprognostic (6.63e-3)" "unprognostic (1.81e-2)" "unprognostic (2.89e-2)" "unprognostic (2.70e-1)" "unprognostic (2.05e-2)" "unprognostic (5.60e-2)" "unprognostic (5.81e-2)" "unprognostic (7.79e-2)" "unprognostic (2.14e-1)" "unprognostic (8.09e-2)" "unprognostic (1.81e-1)" 15.3 12.4 15.5 14.6 20.6 40.1 14.3 17.9 22.4 12.8 14.1 18.1 9.0 10.5 17.0 12.9 14.8 12.3 16.0 20.6 11.2 9.3 12.2 11.2 16.2 14.5 14.3 12.7 16.2 12.4 14.0 20.2 14.1 16.7 14.4 13.9 17.9 13.4 13.8 18.2 13.9 14.0 19.1 12.2 13.0 12.8 19.7 14.4 18.1 14.4 8.7 16.2 15.5 15.0 8.7 10.6 11.5 10.9 7.6 8.1 5.1 12.3 16.4 12.9 10.6 7.8 13.6 10.9 14.7 10.4 14.6 14.2 10.9 20.9 15.0 8.8 11.2 11.7 14.9 15.8 9.8 25.4 16.6 9.0 13.6 16.5 7.0 10.0 8.9 19.3 12.4 9.3 12.2 15.9 11.1 14.6 12.8 13.6 21.0 12.7 20.5 11.9 11.9 16.6 7.4 11.9 13.5 16.1 7.6 10.1 25.2 10.7 13.8 16.7 14.8 8.4 14.1 17.2 14.3 16.1 18.7 10.9 10.4 11.1 21.0 19.8 19.4 15.0 12.4 19.1 6.9 10.9 11.5 5.7 9.3 4.8 8.7 3.1 8.1 10.6 6.8 6.7 4.8 8.3 7.6 6.7 8.2 6.4 5.1 15.5 20.6 17.9 22.4 11.2 9.3 14.3 12.7 16.7 14.4 14.9 15.6 16.6 30.0 20.7 94.4 44.7 17.8 22.7 23.9 17.4 98.2 13.6 3.3 16.8 141.6 25.3 21.3 0.0 11.4 9.6 27.5 39.6 42.7 11.3 21.8 149.4 45.9 26.4 38.7 102.9 23.0 38.6 21.9 26.2 16.2 55.2 22.1 31.6 35.3 9.2 132.1 25.8 33.0 51.4 25.3 23.8 14.5 30.2 17.9 37.0 GPATCH3 "FLJ12455, GPATC3" ENSG00000198746 "G-patch domain containing 3" Q96I76 1 26890488-26900466 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease mutation, Glaucoma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032078, HPA054973" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA032078: AB_10603671, HPA054973: AB_2682656" "unprognostic (2.93e-2)" "unprognostic (1.33e-2)" "unprognostic (7.34e-2)" "unprognostic (9.63e-2)" "unprognostic (1.42e-1)" "unprognostic (9.44e-2)" "prognostic unfavorable (1.23e-7)" "unprognostic (4.37e-2)" "unprognostic (7.75e-2)" "unprognostic (6.46e-2)" "prognostic favorable (6.42e-4)" "unprognostic (3.77e-1)" "unprognostic (3.22e-3)" "unprognostic (2.31e-2)" "unprognostic (3.81e-2)" "unprognostic (2.59e-1)" "unprognostic (6.82e-2)" 11.7 14.5 13.1 10.2 13.6 31.8 13.0 19.5 20.9 9.4 11.7 15.8 11.8 13.0 11.8 14.5 11.6 10.3 12.0 9.6 11.6 10.9 10.9 14.8 10.5 12.4 12.6 10.8 11.8 11.8 12.0 10.1 13.3 13.6 10.3 10.1 10.1 10.4 10.5 21.5 16.0 11.7 10.4 12.1 15.4 12.0 17.2 16.2 16.9 10.1 10.5 11.7 10.5 12.2 12.4 17.4 22.4 16.8 8.1 16.0 12.8 8.9 7.4 7.0 11.1 6.7 6.5 9.5 7.0 8.0 14.1 12.3 9.8 10.7 8.3 7.8 6.9 7.4 9.4 11.6 12.9 7.4 9.3 17.5 16.0 16.2 20.8 9.5 11.1 11.2 10.0 12.0 14.1 7.5 6.1 9.1 11.3 18.8 11.0 5.8 8.2 9.4 21.6 16.3 10.4 11.2 12.0 9.9 13.2 7.1 4.9 9.2 11.3 13.6 12.0 20.9 7.9 10.6 11.6 9.3 9.1 10.5 12.2 7.9 14.2 19.4 11.0 8.2 16.0 7.9 22.4 16.8 19.7 16.0 13.7 12.9 12.4 13.3 14.0 17.4 12.1 14.0 13.2 7.1 8.1 15.8 13.3 11.4 12.8 13.1 13.6 19.5 20.9 11.6 10.9 12.6 10.8 13.6 16.2 3.0 4.6 13.4 4.8 8.7 5.6 3.1 2.5 2.7 2.3 0.0 11.8 13.7 5.0 9.3 0.6 6.8 9.9 0.0 10.7 8.1 6.2 3.7 5.7 5.1 9.5 4.8 10.9 8.0 7.6 1.0 4.9 7.3 8.5 18.0 4.7 5.6 8.3 7.0 6.7 6.7 4.8 6.5 7.1 8.9 22.9 8.5 25.2 10.2 5.2 4.2 GPATCH4 "DKFZP434F1735, FLJ20249, GPATC4" ENSG00000160818 "G-patch domain containing 4" 1 156594487-156601496 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028323, HPA054319" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA028323: AB_10601017, HPA054319: AB_2682447" "unprognostic (2.80e-2)" "unprognostic (4.61e-2)" "unprognostic (3.45e-1)" "unprognostic (1.28e-1)" "unprognostic (1.48e-1)" "unprognostic (1.89e-2)" "prognostic unfavorable (3.17e-5)" "unprognostic (2.40e-1)" "unprognostic (1.01e-2)" "unprognostic (1.33e-3)" "unprognostic (9.60e-2)" "unprognostic (6.39e-3)" "prognostic unfavorable (3.70e-4)" "unprognostic (1.07e-1)" "unprognostic (1.71e-1)" "unprognostic (6.03e-2)" "unprognostic (6.80e-2)" 18.2 13.3 14.7 16.9 27.7 9.4 15.1 6.9 22.5 10.0 12.1 8.3 3.9 9.7 13.8 10.0 14.0 11.6 7.2 11.9 12.6 12.1 18.0 23.1 10.0 15.7 15.3 12.4 15.3 12.9 19.6 16.2 10.0 24.2 12.6 14.6 5.7 11.5 11.9 47.1 10.9 10.0 15.1 10.2 16.6 12.5 8.8 13.2 8.0 10.3 19.0 19.1 12.5 10.1 16.6 10.1 0.3 11.2 10.7 15.9 7.6 17.1 23.7 10.0 14.4 9.2 7.1 13.0 21.3 8.5 16.7 9.8 24.2 13.0 41.4 17.7 14.9 10.8 12.0 22.7 18.8 18.5 12.3 22.5 24.7 23.2 18.5 8.3 55.1 16.0 8.0 15.9 31.6 28.0 4.7 11.7 13.5 40.4 10.4 13.5 32.0 22.6 13.3 43.8 29.9 25.0 22.6 17.1 28.7 11.5 20.4 15.8 23.8 20.4 44.9 13.1 11.4 14.7 26.8 17.8 15.9 21.7 16.5 38.1 19.1 21.0 53.4 14.4 28.6 24.0 0.0 5.4 0.1 13.3 10.5 13.4 16.6 13.5 14.7 10.1 16.6 15.4 15.9 0.3 10.7 11.2 6.4 8.5 7.6 14.7 27.7 6.9 22.5 12.6 12.1 15.3 12.4 24.2 13.2 29.8 34.7 41.0 38.8 65.5 7.1 24.8 28.1 16.0 40.9 15.7 7.9 31.9 21.6 38.5 7.6 30.2 8.5 23.3 48.9 40.5 22.6 43.6 56.6 37.8 33.7 7.9 35.5 14.7 10.7 7.4 24.7 22.6 21.9 19.8 19.7 4.3 44.1 14.0 25.1 25.9 5.9 32.3 59.0 37.1 39.9 54.7 12.9 29.7 28.3 36.6 GPBP1L1 SP192 ENSG00000159592 "GC-rich promoter binding protein 1 like 1" Q9HC44 1 45627304-45688113 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028593 Approved Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites,Cytosol" NA NA Nucleoplasm "Plasma membrane, Focal adhesion sites, Cytosol" "HPA028593: AB_10602906" "unprognostic (1.39e-1)" "unprognostic (8.41e-2)" "unprognostic (1.44e-3)" "unprognostic (6.60e-2)" "unprognostic (6.35e-2)" "unprognostic (1.97e-3)" "unprognostic (2.42e-3)" "unprognostic (9.79e-2)" "unprognostic (3.91e-2)" "unprognostic (1.94e-3)" "unprognostic (1.12e-2)" "unprognostic (4.11e-1)" "unprognostic (1.25e-2)" "unprognostic (6.63e-2)" "unprognostic (4.51e-1)" "unprognostic (7.56e-3)" "unprognostic (6.13e-2)" 29.9 20.5 16.9 21.2 23.7 24.9 25.2 24.4 18.6 27.4 36.9 33.3 29.7 31.6 26.3 23.8 34.8 22.5 19.7 23.9 17.3 17.0 30.2 38.9 28.3 29.1 33.2 12.4 24.7 46.9 24.4 36.6 25.7 22.1 26.4 37.2 29.8 33.5 35.3 29.6 31.0 58.0 25.7 28.2 30.6 26.2 33.2 27.2 40.5 37.7 30.3 35.4 32.5 27.5 13.5 17.8 29.8 22.1 20.0 20.0 15.4 15.8 9.8 17.1 18.1 20.2 19.7 23.4 12.6 21.0 18.3 23.1 9.8 17.8 22.0 16.5 17.3 19.3 16.6 18.7 19.0 23.3 25.1 13.3 28.5 11.4 15.2 27.8 28.4 26.5 14.3 41.6 14.3 41.0 24.7 23.1 28.3 24.3 19.6 20.8 8.5 25.2 25.6 24.3 21.4 11.2 16.6 22.2 16.1 21.0 15.7 21.1 14.1 20.8 30.8 32.1 34.8 14.0 33.6 19.6 13.2 13.9 14.2 19.1 19.2 17.8 16.2 13.9 23.8 13.8 16.4 16.6 29.8 17.8 21.2 18.9 13.5 17.6 17.4 17.8 11.5 19.4 18.9 17.7 20.0 22.1 10.2 20.0 15.4 16.9 23.7 24.4 18.6 17.3 17.0 33.2 12.4 22.1 27.2 56.6 19.5 31.8 35.2 57.7 23.3 41.7 45.9 16.0 29.6 57.6 33.4 23.0 43.1 29.6 10.8 38.3 66.9 46.7 33.6 29.3 24.3 50.8 58.8 72.6 22.6 35.0 36.8 31.9 45.9 13.4 19.0 33.1 21.9 23.4 66.9 16.0 42.8 46.0 20.1 45.1 32.3 19.4 35.3 70.7 75.4 59.2 38.0 35.1 54.0 53.8 GPC4 K-glypican ENSG00000076716 "Glypican 4" O75487 X 133300103-133415490 "Plasma proteins, Predicted membrane proteins" "Deafness, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 47.6;Extravillous trophoblasts: 33.8;Proximal tubular cells: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 47.7;HAP1: 27.3;NTERA-2: 25.0;RPTEC TERT1: 63.0;SuSa: 57.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA030834, HPA030836" Approved Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA 170000 "Plasma membrane" Nucleoplasm "HPA030834: , HPA030836: AB_10601327" "unprognostic (9.60e-2)" "unprognostic (8.67e-2)" "unprognostic (2.29e-1)" "unprognostic (8.21e-2)" "unprognostic (8.51e-3)" "unprognostic (5.90e-3)" "unprognostic (5.68e-2)" "prognostic favorable (3.51e-4)" "unprognostic (2.54e-2)" "unprognostic (1.26e-1)" "unprognostic (5.87e-3)" "unprognostic (1.30e-1)" "prognostic favorable (1.25e-5)" "unprognostic (1.97e-1)" "unprognostic (2.89e-1)" "unprognostic (2.75e-1)" "unprognostic (2.72e-1)" 39.7 9.9 16.3 10.7 5.3 0.3 6.8 3.7 4.9 14.6 21.6 8.2 3.4 10.0 11.7 16.3 18.6 11.2 23.7 9.6 9.5 5.0 39.6 2.4 25.6 7.1 5.1 6.6 12.4 12.5 9.4 20.4 26.9 9.5 10.3 10.7 9.3 12.2 11.6 20.3 4.3 11.3 16.9 7.9 6.5 19.8 7.2 6.4 5.2 12.4 11.6 2.0 17.1 11.7 0.9 0.6 0.1 0.7 0.0 0.0 0.2 0.0 0.0 47.7 1.8 2.0 0.3 5.9 0.3 0.0 0.0 0.0 0.0 0.1 0.0 16.4 0.2 0.0 0.0 27.3 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 25.0 0.0 0.7 0.1 4.3 0.0 63.0 1.8 0.0 0.3 0.2 0.0 0.0 57.9 0.7 0.7 0.0 4.9 5.8 0.0 3.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 16.3 5.3 3.7 4.9 9.5 5.0 5.1 6.6 9.5 6.4 47.6 20.3 0.0 3.3 1.3 0.0 3.4 5.1 9.4 9.1 22.7 0.0 0.3 3.3 6.4 0.4 0.6 2.9 0.0 10.9 33.8 6.9 1.1 0.0 0.0 2.5 0.0 2.4 0.0 0.8 0.9 2.0 2.4 1.7 1.8 9.3 0.8 12.6 3.5 0.4 34.9 0.0 0.0 14.4 1.2 21.2 0.4 2.6 0.0 10.2 0.6 GPC5 ENSG00000179399 "Glypican 5" P78333 13 91398607-92873682 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.4;kidney: 14.8;testis: 11.3" "Cell type enriched" "Detected in some" 23 "Distal tubular cells: 54.7" "Cancer enhanced" "Detected in some" "glioma: 2.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.0" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 11 "CACO-2: 31.4;HeLa: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040152, HPA044081" Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA040152: AB_2676863, HPA044081: AB_2678801" "unprognostic (4.99e-3)" "unprognostic (2.20e-2)" "unprognostic (1.00e-1)" "unprognostic (9.93e-5)" "prognostic unfavorable (4.37e-4)" "unprognostic (4.46e-1)" "unprognostic (1.93e-1)" "unprognostic (1.80e-2)" "unprognostic (9.49e-3)" "unprognostic (3.52e-2)" "unprognostic (1.21e-5)" "unprognostic (2.19e-2)" "unprognostic (1.82e-6)" "unprognostic (3.03e-2)" "unprognostic (2.43e-1)" "unprognostic (1.11e-1)" "unprognostic (6.69e-3)" 0.8 3.8 11.8 1.1 18.3 0.8 0.7 3.1 18.9 0.6 1.5 2.9 0.1 0.7 0.6 0.9 0.6 0.8 1.6 2.3 11.8 6.0 14.8 2.9 6.5 1.0 7.3 5.6 1.5 0.8 0.6 7.7 1.4 19.4 0.9 1.5 0.0 0.8 1.5 0.6 0.7 0.8 0.8 4.4 0.7 0.9 11.3 6.6 0.0 2.7 0.0 0.7 0.6 0.3 0.5 0.4 0.3 1.8 2.0 1.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 18.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 1.0 0.0 0.5 0.0 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 2.2 0.1 0.3 0.0 0.0 0.0 0.7 0.4 0.0 0.5 0.1 1.2 0.4 0.2 0.0 0.5 0.3 2.0 1.8 0.0 0.0 0.2 11.8 18.3 3.1 8.6 11.8 6.0 7.3 5.6 19.4 6.6 0.0 2.4 0.0 0.1 0.0 0.0 0.4 0.0 0.0 2.3 0.0 0.0 0.1 54.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 GPCPD1 "GDE5, GDPD6, KIAA1434" ENSG00000125772 "Glycerophosphocholine phosphodiesterase 1" Q9NPB8 20 5544404-5611026 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 145.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 26.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042987 Approved Nucleoplasm NA NA Nucleoplasm "HPA042987: AB_2678254" "unprognostic (2.25e-2)" "unprognostic (2.45e-2)" "unprognostic (3.41e-1)" "prognostic favorable (1.30e-4)" "unprognostic (2.93e-2)" "unprognostic (8.10e-2)" "unprognostic (1.63e-1)" "unprognostic (1.39e-2)" "unprognostic (3.76e-2)" "unprognostic (1.67e-1)" "unprognostic (1.46e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (3.73e-4)" "unprognostic (1.56e-1)" "unprognostic (1.22e-1)" "unprognostic (1.51e-1)" "unprognostic (2.30e-2)" 12.9 12.9 10.6 21.8 17.6 56.7 12.7 29.6 28.2 12.2 8.8 9.1 36.7 7.4 12.5 10.5 10.6 12.6 13.2 12.6 12.2 10.1 8.1 8.1 43.6 30.6 13.1 8.9 18.1 8.9 4.5 10.3 13.4 19.4 9.6 10.6 11.0 34.2 31.2 31.8 9.1 15.1 21.5 14.6 24.9 8.8 8.1 4.0 12.1 13.4 17.0 17.5 13.7 9.8 4.2 4.5 16.2 7.1 3.6 4.6 3.4 3.8 7.3 5.0 4.0 3.3 3.9 5.7 6.1 4.9 3.5 2.4 3.8 3.0 8.6 1.1 3.4 3.2 1.3 6.2 12.1 3.4 1.8 2.0 11.8 0.8 4.4 16.0 7.2 5.4 8.3 15.8 2.1 26.1 3.6 3.7 5.4 6.7 4.5 3.2 2.1 6.5 3.9 2.7 6.8 4.2 4.7 6.0 3.1 4.8 3.2 1.9 2.5 2.7 11.9 5.7 5.2 2.8 20.3 4.1 3.0 2.2 8.2 3.9 4.3 7.4 9.2 0.9 8.9 3.3 2.6 7.1 9.0 4.0 5.5 3.1 4.2 3.0 3.3 4.5 3.8 4.6 3.1 16.2 3.6 5.5 2.0 2.4 3.4 10.6 17.6 29.6 28.2 12.2 10.1 13.1 8.9 19.4 4.0 20.8 56.2 34.4 13.7 14.7 16.4 35.1 15.3 13.4 31.8 21.0 5.9 24.1 3.3 10.4 145.3 24.3 12.0 70.0 7.9 13.9 20.4 21.1 42.7 15.3 42.6 11.1 18.9 20.9 80.0 39.0 5.2 52.4 10.1 10.0 20.3 9.1 6.0 8.6 3.2 6.3 19.4 6.5 35.6 39.0 9.5 24.0 40.7 32.0 10.4 44.4 GPER1 "CEPR, CMKRL2, DRY12, FEG-1, GPCR-Br, GPER, GPR30, LERGU, LERGU2, LyGPR" ENSG00000164850 "G protein-coupled estrogen receptor 1" Q99527 7 1082208-1093815 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Cell cycle, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Hepatocytes: 22.2;Kupffer cells: 13.5;Paneth cells: 8.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 4.3;intermediate monocyte: 4.2;myeloid DC: 8.4" "Group enriched" "Detected in many" 18 "dendritic cells: 8.4;monocytes: 4.3" "Cell line enhanced" "Detected in many" "AN3-CA: 10.1;Daudi: 10.6;Hep G2: 19.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA016718, HPA027052" Approved Approved Nucleoplasm,Nucleoli,Vesicles,Cytosol NA NA Nucleoli "Nucleoplasm, Vesicles, Cytosol" "HPA016718: , HPA027052: AB_10612112" "unprognostic (4.74e-2)" "unprognostic (1.32e-1)" "unprognostic (3.09e-2)" "prognostic favorable (1.17e-4)" "unprognostic (2.17e-1)" "unprognostic (6.17e-2)" "unprognostic (3.45e-1)" "unprognostic (6.38e-2)" "unprognostic (2.40e-1)" "unprognostic (1.23e-1)" "unprognostic (1.42e-2)" "unprognostic (2.49e-1)" "unprognostic (2.37e-2)" "unprognostic (1.79e-2)" "unprognostic (1.58e-1)" "unprognostic (7.26e-2)" "unprognostic (7.78e-2)" 14.2 10.9 12.1 3.6 13.2 1.2 11.5 5.1 11.1 6.4 7.1 5.6 3.5 2.0 5.4 1.8 5.5 4.8 3.2 6.0 8.3 6.2 7.4 19.5 25.6 6.4 8.6 8.7 3.3 4.0 1.8 4.7 13.3 6.1 6.8 3.7 5.2 4.2 11.8 8.6 2.8 2.6 5.5 4.1 6.5 23.9 2.2 8.6 1.3 16.5 2.3 2.8 6.4 7.2 0.3 8.4 0.0 4.3 0.0 0.0 1.6 0.9 0.4 0.2 10.1 2.5 2.4 1.0 5.8 3.9 1.8 3.3 0.2 0.2 10.6 1.0 7.3 0.1 0.5 0.1 0.0 0.2 2.2 1.8 0.0 1.3 19.4 0.3 0.1 0.7 1.3 0.0 1.1 0.0 1.4 0.5 0.2 0.1 0.1 0.4 0.7 0.0 0.3 1.9 2.0 6.9 0.9 0.0 0.0 0.2 0.0 0.1 4.0 0.0 0.4 2.1 0.8 0.2 0.1 1.4 0.4 2.6 6.1 1.8 0.0 0.0 3.6 3.4 0.2 0.2 0.0 4.3 0.0 0.0 4.2 0.0 0.3 0.0 0.0 8.4 0.1 0.0 0.0 0.0 0.0 1.1 0.2 0.0 1.6 12.1 13.2 5.1 11.1 8.3 6.2 8.6 8.7 6.1 8.6 0.0 0.0 0.0 0.0 0.5 0.0 2.5 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 2.2 1.3 0.0 2.8 0.5 1.4 0.7 0.0 22.2 0.5 0.0 1.2 0.6 13.5 0.6 2.6 1.7 0.0 0.0 2.5 4.3 0.8 8.2 1.1 3.0 0.4 0.0 4.1 0.3 3.1 0.3 0.0 0.0 1.5 0.0 GPI "AMF, NLK" ENSG00000105220 "Glucose-6-phosphate isomerase" P06744 19 34359480-34402413 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Gluconeogenesis, Glycolysis" "Cytokine, Growth factor, Isomerase" "Cancer-related genes, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 321.8;Late spermatids: 797.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018655, HPA024305, CAB040563, HPA052171" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" No No 140000000 "Plasma membrane, Cytosol" Nucleoplasm "CAB018655: AB_2112653, CAB040563: , HPA024305: AB_1849922, HPA052171: AB_2681748" "unprognostic (1.03e-1)" "unprognostic (8.39e-3)" "unprognostic (2.39e-2)" "unprognostic (1.38e-2)" "unprognostic (4.52e-2)" "unprognostic (6.45e-3)" "unprognostic (1.95e-2)" "unprognostic (8.52e-3)" "unprognostic (3.18e-1)" "unprognostic (1.45e-1)" "unprognostic (4.93e-2)" "unprognostic (2.75e-1)" "unprognostic (3.24e-3)" "unprognostic (2.62e-2)" "unprognostic (2.43e-1)" "unprognostic (2.60e-3)" "unprognostic (2.88e-2)" 62.1 66.6 43.4 27.6 58.2 83.3 34.8 62.6 88.7 20.6 36.6 20.8 23.7 48.2 21.1 20.6 45.3 24.2 33.5 107.2 42.0 45.6 51.3 77.9 19.6 29.6 39.3 64.3 22.5 21.4 66.9 33.7 20.4 50.2 23.7 37.2 36.2 34.6 33.9 144.7 29.4 44.3 34.2 22.8 23.1 26.7 19.7 19.0 23.8 26.1 68.5 32.6 32.5 25.2 16.2 26.3 74.8 40.9 14.5 27.5 24.6 76.8 108.3 9.5 74.2 31.2 23.2 22.7 29.7 23.5 37.5 45.2 61.0 27.3 50.7 44.1 29.0 25.5 53.6 57.3 64.5 42.6 56.3 23.2 65.0 52.2 64.2 20.2 84.2 42.4 31.8 26.7 44.2 23.0 47.4 35.0 34.4 33.1 40.1 26.3 65.2 36.6 29.5 25.7 69.7 38.4 34.3 25.1 95.7 46.9 51.8 51.9 30.2 59.8 105.5 21.6 17.8 23.9 26.9 30.1 14.2 31.2 40.1 45.7 74.2 42.1 46.0 47.2 64.1 28.6 38.5 22.9 74.8 22.5 35.2 27.5 16.2 20.7 25.5 26.3 13.3 17.5 20.7 1.6 14.5 40.9 8.7 21.6 24.6 43.4 58.2 62.6 88.7 42.0 45.6 39.3 64.3 50.2 19.0 26.8 40.2 23.1 22.0 23.0 92.5 198.3 38.2 21.4 25.0 54.1 70.7 38.6 97.8 77.9 321.8 30.6 90.3 0.0 57.9 60.0 36.8 27.8 22.0 68.1 78.6 224.1 61.2 47.9 41.6 797.8 34.2 41.9 33.7 45.9 67.6 28.6 75.7 25.9 28.7 79.1 62.2 19.4 38.7 6.9 7.6 28.7 32.8 47.1 102.1 32.5 GPKOW "GPATC5, GPATCH5, Spp2, T54" ENSG00000068394 "G-patch domain and KOW motifs" Q92917 X 49113389-49123801 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000287, HPA001894" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA000287: AB_1079015, HPA001894: AB_1079014" "unprognostic (3.34e-2)" "unprognostic (9.54e-3)" "unprognostic (8.95e-2)" "unprognostic (2.36e-1)" "unprognostic (1.10e-1)" "unprognostic (1.19e-1)" "unprognostic (2.03e-3)" "unprognostic (1.02e-1)" "unprognostic (9.29e-2)" "unprognostic (7.96e-2)" "unprognostic (4.32e-1)" "unprognostic (7.08e-2)" "unprognostic (1.14e-2)" "unprognostic (3.17e-1)" "unprognostic (2.73e-1)" "unprognostic (1.59e-1)" "unprognostic (1.89e-2)" 14.9 14.6 20.1 11.8 23.1 15.0 13.8 24.3 25.3 14.5 14.8 22.6 11.7 15.3 15.5 13.4 14.7 17.0 11.3 17.0 17.6 20.1 12.3 15.8 12.8 14.1 22.9 28.9 14.3 11.5 22.4 15.8 14.7 20.0 13.8 13.9 12.1 13.4 19.3 31.9 16.9 14.1 15.3 20.3 14.0 13.5 8.0 22.3 15.7 14.2 9.0 14.9 14.8 12.1 21.3 17.0 20.7 24.8 17.8 29.5 14.6 20.5 21.9 14.7 12.3 13.0 11.3 16.0 13.4 15.1 21.3 22.7 15.9 20.7 8.6 10.3 16.4 21.9 14.6 16.2 15.8 14.0 18.1 17.3 9.0 18.4 11.2 15.6 10.6 19.1 12.3 20.2 17.0 17.4 12.6 15.9 17.5 11.0 13.6 13.8 33.5 14.5 17.7 10.4 11.1 17.5 18.2 16.2 23.4 10.9 26.3 12.3 14.3 15.5 14.8 14.3 16.2 28.4 13.9 17.7 12.4 18.8 17.9 12.6 21.0 14.3 11.7 15.9 17.7 19.0 19.3 16.8 20.7 29.5 23.1 24.0 15.4 23.2 22.0 17.0 21.3 19.7 18.5 13.3 17.8 24.8 15.5 22.7 14.6 20.1 23.1 24.3 25.3 17.6 20.1 22.9 28.9 20.0 22.3 17.9 8.3 11.7 11.1 7.1 14.9 10.4 28.1 6.7 17.0 7.0 3.9 23.1 13.3 22.4 0.8 10.8 14.9 23.3 22.2 16.9 13.4 9.1 11.5 13.0 14.5 4.8 7.5 9.8 7.0 1.3 14.4 10.8 5.0 15.4 10.8 15.8 21.4 21.0 14.2 17.0 11.7 38.8 14.4 5.2 17.9 8.7 36.6 14.4 10.7 10.8 GPN1 "ATPBD1A, MBDIN, NTPBP, RPAP4, XAB1" ENSG00000198522 "GPN-loop GTPase 1" Q9HCN4 2 27628247-27651508 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036793, HPA036794, CAB037303" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "CAB037303: AB_477173, HPA036793: AB_2675318, HPA036794: AB_10672230" "unprognostic (9.42e-2)" "unprognostic (1.44e-1)" "unprognostic (5.64e-2)" "prognostic unfavorable (2.88e-5)" "unprognostic (2.57e-1)" "unprognostic (1.63e-3)" "prognostic unfavorable (1.71e-5)" "unprognostic (3.50e-2)" "unprognostic (8.27e-3)" "unprognostic (8.93e-2)" "unprognostic (4.05e-3)" "unprognostic (2.34e-1)" "unprognostic (1.21e-2)" "unprognostic (2.51e-1)" "unprognostic (1.13e-1)" "unprognostic (2.01e-1)" "unprognostic (1.72e-1)" 24.3 24.3 18.8 18.7 23.2 28.1 26.3 22.9 27.2 18.3 21.6 20.7 13.7 19.3 21.3 21.2 26.7 21.0 18.2 21.5 17.2 22.1 29.7 29.2 18.2 29.2 20.0 16.1 24.6 35.4 19.8 18.5 31.1 23.3 18.8 25.6 14.3 23.0 17.6 30.9 25.0 25.3 22.1 16.4 26.6 20.8 30.2 15.9 29.0 26.9 22.5 28.3 21.5 24.3 29.1 35.8 28.5 28.2 39.6 38.6 29.7 32.7 18.6 17.6 12.7 16.6 17.0 17.9 18.3 18.3 26.0 19.3 20.3 17.2 20.5 17.9 20.0 24.1 14.3 24.4 22.8 26.4 19.1 17.0 23.4 15.0 24.7 21.6 34.3 12.3 17.5 20.1 26.7 25.1 18.1 27.1 18.7 29.0 19.3 30.7 19.1 20.7 25.7 30.4 25.0 18.4 20.9 52.1 21.4 21.0 18.9 15.7 24.9 20.1 22.6 20.3 17.1 13.6 19.9 22.0 22.7 33.6 11.2 42.9 22.3 24.0 55.2 32.7 29.8 18.6 28.5 24.7 21.1 33.4 28.2 36.0 29.1 31.1 38.6 35.8 25.2 27.7 34.1 3.7 39.6 26.3 18.5 30.3 29.7 18.8 23.2 22.9 27.2 17.2 22.1 20.0 16.1 23.3 15.9 11.9 7.2 7.2 18.2 19.3 7.9 9.7 17.8 10.7 14.8 14.0 3.9 36.5 19.9 46.3 69.8 14.5 10.8 0.0 31.4 38.5 20.1 18.3 24.3 8.6 29.3 11.1 16.7 15.4 18.9 67.5 13.8 19.3 21.9 33.3 13.3 12.0 35.5 10.5 10.3 15.6 9.1 12.9 20.8 26.2 22.6 16.3 27.7 33.0 19.5 16.6 GPR1 ENSG00000183671 "G protein-coupled receptor 1" P46091 2 206175316-206218047 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 19.1" "Group enriched" "Detected in some" 8 "Extravillous trophoblasts: 10.0;Muller glia cells: 4.9" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 10.7;pons and medulla: 6.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "HHSteC: 53.7;hTCEpi: 24.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010525 Uncertain Supported "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Vesicles" "HPA010525: AB_1078919" "unprognostic (5.32e-2)" "unprognostic (1.20e-1)" "unprognostic (2.82e-1)" "unprognostic (2.25e-2)" "unprognostic (3.27e-5)" "unprognostic (1.36e-1)" "unprognostic (4.00e-3)" "unprognostic (1.49e-2)" "unprognostic (7.89e-2)" "unprognostic (9.94e-2)" "unprognostic (3.42e-3)" "unprognostic (5.65e-2)" "unprognostic (4.29e-4)" "unprognostic (8.48e-4)" "unprognostic (1.21e-1)" "unprognostic (2.68e-2)" "unprognostic (3.06e-3)" 2.3 5.0 0.5 0.6 10.7 0.1 1.7 0.4 1.2 4.1 0.6 4.8 1.6 0.2 1.3 0.7 6.6 1.1 2.7 3.8 1.6 0.5 0.7 0.0 0.5 3.1 0.2 0.3 3.2 0.1 0.0 0.4 19.1 6.6 0.7 0.6 1.1 1.5 0.4 1.5 6.7 0.5 2.3 0.3 0.2 0.2 1.6 1.0 0.0 0.7 2.2 1.2 3.1 7.7 0.5 0.1 1.4 0.2 0.5 0.2 0.6 0.8 0.1 0.7 0.0 0.1 3.0 0.2 5.5 9.5 3.4 2.9 0.0 0.0 0.0 0.3 2.7 0.2 0.1 0.2 0.0 1.1 0.0 0.1 0.0 1.8 0.0 53.7 0.0 0.0 2.2 24.2 4.9 7.9 4.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 2.7 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 2.4 1.1 0.0 0.0 0.6 0.0 0.0 0.1 4.1 1.9 4.8 0.4 0.0 0.0 0.0 1.5 0.0 0.1 1.3 0.2 0.3 0.2 0.0 0.1 0.3 0.2 0.1 0.0 0.5 0.2 0.2 1.4 0.5 0.1 0.1 0.2 0.6 0.5 10.7 0.4 1.2 1.6 0.5 0.2 0.3 6.6 1.0 0.0 0.0 0.0 0.6 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.9 0.6 0.0 0.0 0.3 GPR107 "FLJ20998, KIAA1624, LUSTR1, RP11-88G17" ENSG00000148358 "G protein-coupled receptor 107" Q5VW38 9 130053426-130140169 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031704 Supported Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA031704: AB_10601018" "prognostic unfavorable (3.56e-5)" "unprognostic (7.48e-2)" "unprognostic (6.76e-2)" "unprognostic (1.36e-1)" "unprognostic (2.46e-1)" "unprognostic (8.72e-2)" "unprognostic (1.10e-3)" "unprognostic (1.35e-2)" "unprognostic (2.18e-1)" "unprognostic (3.39e-2)" "unprognostic (2.59e-1)" "unprognostic (1.85e-1)" "prognostic favorable (1.87e-5)" "unprognostic (4.10e-2)" "unprognostic (5.83e-2)" "unprognostic (6.50e-2)" "unprognostic (1.34e-3)" 21.0 21.6 24.2 16.6 26.8 12.5 23.7 28.1 28.0 25.0 24.0 35.9 20.5 13.3 24.0 19.1 22.5 26.2 20.9 20.6 22.3 26.6 24.4 22.9 23.0 17.4 29.5 23.1 21.8 26.6 34.4 21.6 40.7 29.9 28.4 26.3 29.3 23.0 24.4 20.5 25.6 15.4 26.7 28.8 17.2 18.9 23.9 22.9 17.3 40.0 15.4 19.7 19.4 17.3 2.0 3.4 6.3 6.3 1.4 2.4 2.3 12.7 18.7 17.9 14.1 19.2 20.4 17.9 20.4 23.0 17.3 17.3 17.9 17.4 7.1 15.1 22.5 20.3 32.2 13.7 12.6 14.9 11.0 9.2 7.5 23.0 10.2 18.6 15.6 11.0 17.0 19.7 17.2 17.4 19.7 15.9 8.6 10.6 7.1 14.8 15.7 8.3 6.3 12.0 26.0 14.2 7.9 26.3 11.2 14.5 17.8 6.3 13.8 26.7 19.0 14.4 16.3 33.3 8.2 18.7 22.0 11.8 17.9 15.4 4.5 15.0 6.8 19.6 7.5 20.7 2.8 5.7 3.4 1.5 6.1 2.1 1.8 1.6 1.7 3.4 2.0 1.0 2.4 6.3 1.4 6.3 2.1 1.5 2.3 24.2 26.8 28.1 27.6 22.3 26.6 29.5 23.1 29.9 22.9 23.8 17.1 3.9 4.2 5.7 15.8 20.6 25.5 13.4 12.5 15.7 37.3 11.3 0.0 11.0 5.3 9.0 11.9 0.0 15.2 14.5 12.6 12.8 5.8 11.5 13.2 17.5 9.2 24.5 18.1 4.9 17.5 8.3 13.5 13.6 17.2 12.0 17.7 10.5 18.0 6.1 15.2 0.0 8.9 11.7 9.5 9.5 22.3 6.5 13.2 7.3 GPR137 "C11orf4, GPR137A, TM7SF1L1" ENSG00000173264 "G protein-coupled receptor 137" Q96N19 11 64270062-64289500 "Predicted intracellular proteins, Predicted membrane proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 64.8" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 157.3;Late spermatids: 445.6;Spermatocytes: 157.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 15.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062871 Uncertain Approved "Nucleoplasm,Nucleoli,Actin filaments" NA NA "Nucleoplasm, Nucleoli" "Actin filaments" "HPA062871: AB_2684889" "unprognostic (2.25e-1)" "unprognostic (4.21e-2)" "unprognostic (6.81e-2)" "unprognostic (1.06e-1)" "unprognostic (1.29e-3)" "unprognostic (6.37e-2)" "prognostic unfavorable (5.34e-4)" "unprognostic (5.68e-2)" "unprognostic (1.83e-2)" "unprognostic (7.61e-3)" "prognostic favorable (6.18e-4)" "unprognostic (4.95e-2)" "unprognostic (8.66e-3)" "unprognostic (3.67e-3)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (5.41e-1)" 10.3 12.2 18.6 12.8 21.8 10.4 12.0 20.0 23.1 8.9 10.5 13.2 13.8 11.2 9.0 10.4 10.5 13.3 10.3 9.7 18.5 14.3 14.0 14.1 9.3 10.8 15.4 9.1 7.3 9.4 16.4 10.1 28.9 16.5 10.5 5.8 12.4 13.9 12.8 9.9 15.9 11.4 7.1 12.7 11.3 13.6 64.8 14.4 9.9 14.3 5.5 9.3 9.5 16.2 3.9 3.4 15.7 3.0 1.9 3.4 1.4 9.0 20.3 7.0 20.2 13.7 7.3 29.7 10.8 9.1 10.8 7.0 14.9 12.8 9.3 18.8 6.8 19.4 18.2 9.8 6.0 3.1 29.5 12.3 8.9 20.8 9.5 7.8 5.8 17.3 9.1 9.5 9.4 7.2 7.4 5.8 11.2 7.9 22.8 6.4 23.0 6.5 15.8 9.5 7.4 20.2 13.2 7.5 15.1 7.5 12.4 11.2 13.6 13.1 18.0 11.7 7.4 19.7 2.5 9.3 30.0 20.8 22.6 7.8 18.3 33.5 7.8 21.4 5.0 18.2 1.7 3.0 5.3 2.7 2.8 3.4 2.8 2.3 2.0 3.1 3.9 2.6 2.2 15.7 1.9 2.3 3.4 1.6 1.4 18.6 21.8 20.0 23.1 18.5 14.3 15.4 9.1 16.5 14.4 3.0 9.1 11.8 16.0 12.8 13.4 4.4 10.2 9.4 4.5 12.2 11.8 40.6 13.3 33.8 157.3 14.0 21.2 0.0 23.3 58.9 21.7 17.8 2.3 8.9 21.4 19.1 15.5 9.8 9.1 445.6 17.8 11.8 13.5 20.8 13.8 33.6 24.9 14.0 15.2 15.2 6.0 25.8 12.5 157.6 37.2 13.2 100.0 12.8 13.4 18.0 GPR161 RE2 ENSG00000143147 "G protein-coupled receptor 161" Q8N6U8 1 168079543-168137667 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 27.1;smooth muscle: 21.0" "Cell type enriched" "Detected in many" 8 "Horizontal cells: 149.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 24.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015576, HPA072047" Uncertain Approved Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA015576: AB_1849283, HPA072047: AB_2686484" "unprognostic (1.45e-1)" "unprognostic (3.78e-2)" "unprognostic (2.68e-2)" "unprognostic (1.58e-3)" "unprognostic (1.87e-1)" "unprognostic (6.84e-2)" "unprognostic (3.24e-3)" "unprognostic (1.48e-1)" "unprognostic (1.19e-1)" "unprognostic (5.04e-2)" "unprognostic (5.45e-2)" "unprognostic (1.31e-2)" "unprognostic (5.57e-6)" "unprognostic (3.93e-2)" "unprognostic (1.84e-2)" "unprognostic (1.03e-2)" "unprognostic (6.34e-2)" 2.4 0.9 2.1 3.6 1.7 0.0 1.9 1.2 4.0 7.3 4.9 3.1 8.5 0.8 27.1 8.2 7.4 7.7 5.6 2.4 2.8 1.5 1.1 0.4 2.8 0.4 3.0 1.2 7.6 11.0 4.9 1.3 1.3 3.0 8.2 2.3 3.4 2.3 9.4 0.8 1.5 2.1 21.0 3.0 1.2 2.2 3.0 0.8 1.4 1.2 1.7 0.7 2.8 6.8 0.3 1.2 1.5 0.5 0.2 0.3 0.2 6.1 3.8 15.5 9.9 3.7 6.6 0.0 5.9 6.5 5.1 5.4 24.0 1.0 0.0 3.3 8.9 9.6 18.4 3.7 5.8 3.0 2.3 4.8 2.2 3.0 0.1 1.6 0.6 1.5 2.3 3.8 4.4 7.1 11.9 10.2 1.9 2.0 0.1 7.7 0.5 0.7 0.1 6.3 10.3 6.0 1.8 6.7 0.0 2.7 1.7 3.1 13.7 6.5 0.2 17.8 6.1 3.4 0.7 13.7 10.5 5.5 14.1 6.7 0.0 0.0 0.0 2.8 0.0 2.7 1.5 0.3 0.2 0.1 0.3 0.1 0.1 0.1 0.0 1.2 0.3 0.1 0.3 1.3 0.2 0.5 0.3 0.0 0.2 2.1 1.7 1.2 4.0 2.8 1.5 3.0 1.2 3.0 0.8 3.0 0.6 0.0 5.0 1.9 1.7 2.0 0.0 1.4 1.2 0.0 0.0 0.4 0.0 3.6 0.4 6.3 0.0 0.0 7.2 0.2 6.3 4.6 0.0 0.0 0.7 149.4 0.0 4.3 1.8 0.6 6.9 1.3 1.7 1.8 1.7 2.7 2.9 0.0 15.9 0.0 1.5 19.4 12.2 0.0 0.7 1.3 0.3 0.0 2.3 2.3 GPR27 SREB1 ENSG00000170837 "G protein-coupled receptor 27" Q9NS67 3 71754050-71756496 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 23.2;parathyroid gland: 29.6" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 11.0;Collecting duct cells: 12.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "eosinophil: 3.7;neutrophil: 10.5" "Lineage enriched" "Detected in single" 12 "granulocytes: 10.5" "Cell line enhanced" "Detected in some" "EFO-21: 13.0;HL-60: 12.5;MCF7: 10.8;NTERA-2: 21.5;RPTEC TERT1: 10.4;SH-SY5Y: 8.2;T-47d: 7.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029395 Approved Approved "Nucleoplasm,Plasma membrane,Actin filaments,Cytosol" NA NA Nucleoplasm "Plasma membrane, Actin filaments, Cytosol" "HPA029395: AB_10602907" "prognostic favorable (5.63e-4)" "unprognostic (2.99e-1)" "unprognostic (3.23e-2)" "unprognostic (3.22e-1)" "unprognostic (7.14e-3)" "unprognostic (1.50e-2)" "unprognostic (2.17e-2)" "unprognostic (1.18e-2)" "unprognostic (3.22e-1)" "prognostic favorable (1.21e-6)" "unprognostic (2.97e-3)" "unprognostic (4.97e-2)" "unprognostic (1.51e-2)" "unprognostic (1.21e-2)" "unprognostic (2.71e-2)" "unprognostic (1.45e-2)" "unprognostic (6.79e-2)" 1.7 4.5 14.9 1.7 23.2 14.5 4.3 4.4 15.4 3.4 1.0 5.8 1.7 0.6 5.5 3.3 2.7 7.7 1.2 3.5 12.8 12.4 3.2 0.9 2.4 5.5 10.6 8.8 5.0 2.6 29.6 5.1 2.0 5.9 5.7 0.7 3.3 1.7 5.1 1.8 1.9 0.7 3.3 16.8 3.7 2.4 4.2 3.6 0.0 6.8 1.2 0.5 2.1 2.8 0.0 0.2 10.5 0.8 0.0 0.4 0.1 0.0 0.8 1.5 1.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 13.0 0.0 0.6 0.0 3.2 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 12.5 0.7 0.0 2.2 0.0 0.9 0.0 0.0 2.7 0.0 0.0 0.0 10.8 0.9 0.2 21.5 0.0 0.0 0.0 0.0 0.0 10.4 5.8 2.3 8.2 2.8 0.0 0.0 2.9 7.5 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.8 3.7 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.1 10.5 0.0 0.1 0.0 0.0 0.1 14.9 23.2 4.4 9.9 12.8 12.4 10.6 8.8 5.9 3.6 0.0 1.4 0.0 4.0 1.6 11.0 2.8 5.1 2.7 2.3 12.2 3.9 1.1 1.7 0.4 0.1 0.0 0.0 0.0 0.0 1.1 0.9 4.5 0.0 0.0 1.0 0.0 1.2 0.0 5.1 0.0 0.9 0.5 0.0 0.0 0.0 0.5 0.4 0.0 1.1 0.0 0.3 0.0 0.4 0.2 0.9 1.5 0.2 0.0 0.0 1.8 GPR34 ENSG00000171659 "G protein-coupled receptor 34" Q9UPC5 X 41688973-41697277 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 60.8" "Cell type enhanced" "Detected in some" 23 "granulocytes: 35.9;Hofbauer cells: 198.9;Kupffer cells: 113.1;Macrophages: 46.2" "Cancer enhanced" "Detected in all" "glioma: 26.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 14 "basophil: 60.8;eosinophil: 25.3" "Lineage enriched" "Detected in many" 20 "granulocytes: 60.8" "Cell line enhanced" "Detected in some" "HMC-1: 5.0;JURKAT: 2.6;U-937: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010668, CAB025490" Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB025490: , HPA010668: AB_1849294" "unprognostic (1.26e-2)" "unprognostic (1.08e-1)" "unprognostic (1.43e-2)" "unprognostic (1.44e-2)" "unprognostic (1.20e-1)" "unprognostic (3.74e-2)" "unprognostic (5.83e-3)" "unprognostic (5.13e-2)" "unprognostic (1.59e-2)" "unprognostic (9.81e-3)" "unprognostic (7.19e-2)" "unprognostic (1.74e-1)" "unprognostic (3.96e-1)" "unprognostic (2.72e-3)" "unprognostic (1.14e-1)" "unprognostic (1.88e-3)" "unprognostic (3.18e-2)" 25.1 12.4 15.1 9.7 16.6 0.4 15.0 2.1 11.7 10.5 9.1 13.5 1.0 4.4 4.9 6.6 5.8 5.5 12.2 5.9 16.0 9.5 11.7 5.3 11.4 26.8 22.4 7.5 5.4 4.4 2.8 3.3 29.3 15.4 5.7 9.3 4.9 7.1 6.4 2.1 2.4 11.4 11.5 34.0 22.3 5.1 5.0 21.4 1.9 3.4 1.5 11.1 12.5 3.7 0.3 0.4 60.8 2.8 3.0 0.1 0.5 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 1.0 0.4 0.0 0.2 0.0 0.1 5.0 0.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.3 0.0 0.0 0.2 0.7 0.3 0.0 0.4 0.1 1.1 0.0 0.3 0.1 0.3 0.2 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.4 0.1 0.8 0.1 0.0 0.0 0.1 0.6 1.3 0.0 60.8 2.2 25.3 0.0 2.8 0.0 0.3 0.1 0.0 0.4 0.1 0.0 0.0 0.2 3.0 1.5 0.0 0.1 0.5 15.1 16.6 2.1 11.7 16.0 9.5 22.4 7.5 15.4 21.4 0.0 3.2 2.7 0.2 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.3 0.0 0.0 0.0 1.3 1.7 0.1 35.9 0.0 198.9 0.0 1.2 3.1 113.1 0.6 0.9 46.2 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 19.4 0.0 0.0 0.1 0.9 2.1 1.7 0.0 0.0 GPR50 "H9, Mel1c" ENSG00000102195 "G protein-coupled receptor 50" Q13585 X 151176653-151181465 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "pituitary gland: 64.9" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "hypothalamus: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HEK 293: 9.6;SuSa: 8.1" "Region enriched" "Detected in some" 6 "hypothalamus: 16.8" "Region enriched" "Detected in some" 9 "hypothalamus: 6.4" "HPA049862, HPA054678" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA049862: AB_2680920, HPA054678: AB_2682570" "unprognostic (8.84e-3)" "unprognostic (5.59e-2)" "unprognostic (1.15e-1)" 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.3 1.4 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 64.9 3.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR63 "PSP24(beta), PSP24B" ENSG00000112218 "G protein-coupled receptor 63" Q9BZJ6 6 96794126-96837463 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Early spermatids: 21.8;Late spermatids: 26.5;Spermatocytes: 22.8;Spermatogonia: 9.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 7.8;HHSteC: 12.8;Karpas-707: 19.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039103 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA039103: AB_10672841" "unprognostic (8.22e-2)" "unprognostic (2.77e-1)" "unprognostic (1.71e-2)" "unprognostic (1.02e-2)" "unprognostic (1.83e-1)" "unprognostic (1.33e-1)" "unprognostic (2.65e-2)" "unprognostic (1.15e-1)" "unprognostic (3.39e-1)" "unprognostic (2.53e-2)" "unprognostic (7.29e-3)" "unprognostic (3.00e-1)" "unprognostic (2.03e-3)" "unprognostic (1.67e-1)" "unprognostic (1.34e-1)" "unprognostic (2.34e-1)" "unprognostic (2.30e-2)" 1.8 3.4 3.8 3.1 11.0 0.8 1.6 7.5 10.7 3.3 3.9 1.6 1.0 5.1 1.9 1.5 2.0 2.8 2.7 1.9 3.2 2.2 1.4 0.5 1.4 0.9 2.2 6.4 4.0 5.0 3.9 4.3 2.5 10.1 3.3 6.2 2.5 1.7 2.2 1.0 1.7 3.6 3.6 1.4 1.3 4.1 8.0 5.2 2.5 2.3 0.0 0.9 2.2 4.8 0.8 0.9 2.6 0.6 1.4 1.1 0.1 0.0 0.1 1.5 0.3 2.2 0.8 0.4 0.9 0.0 0.0 0.2 0.2 1.1 0.0 0.0 0.1 1.2 1.1 4.9 2.3 0.0 7.8 3.8 4.7 0.4 0.0 12.8 2.9 0.5 2.4 0.4 0.0 3.5 0.3 0.0 7.0 3.4 19.2 0.4 0.4 2.2 0.0 5.0 0.0 0.7 0.0 1.8 3.8 0.3 0.2 2.3 1.4 0.3 3.1 0.5 1.7 1.2 0.6 0.0 1.3 2.0 0.2 1.8 1.5 0.8 0.1 0.8 1.8 1.0 0.8 0.6 0.2 0.6 0.2 0.3 0.7 1.1 0.6 0.1 0.8 1.0 0.9 2.6 1.4 0.2 0.9 0.3 0.1 3.8 11.0 7.5 10.7 3.2 2.2 2.2 6.4 10.1 5.2 0.0 0.0 0.0 0.8 1.6 1.1 0.5 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.4 21.8 0.1 0.0 0.0 0.8 0.6 0.9 1.0 0.0 0.0 0.2 0.0 2.9 1.8 0.0 26.5 3.1 0.0 1.7 0.0 0.4 0.3 0.5 0.0 4.6 0.0 0.2 0.0 1.1 22.8 9.3 0.3 0.1 0.0 0.5 0.3 GPR87 GPR95 ENSG00000138271 "G protein-coupled receptor 87" Q9BY21 3 151294086-151316952 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 24.8;skin 1: 19.7;tongue: 21.9" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 127.1;Suprabasal keratinocytes: 59.6;Syncytiotrophoblasts: 171.4;Urothelial cells: 178.7" "Group enriched" "Detected in many" 6 "cervical cancer: 44.1;head and neck cancer: 40.1;lung cancer: 22.0;urothelial cancer: 23.3" "Region enriched" "Detected in single" 12 "pons and medulla: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 31.5;HaCaT: 25.2;HBEC3-KT: 33.5;hTCEpi: 44.8;hTERT-HME1: 18.8;RT4: 13.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA066313 Approved "Nucleoplasm,Lipid droplets,Mitochondria" No No "Lipid droplets, Mitochondria" Nucleoplasm "HPA066313: AB_2685656" "unprognostic (5.81e-2)" "unprognostic (2.12e-1)" "unprognostic (4.07e-3)" "unprognostic (8.60e-2)" "unprognostic (1.28e-2)" "unprognostic (4.61e-3)" "unprognostic (3.28e-2)" "unprognostic (1.27e-1)" "prognostic unfavorable (4.62e-6)" "unprognostic (8.64e-2)" "unprognostic (1.50e-3)" "unprognostic (3.66e-4)" "unprognostic (8.73e-2)" "unprognostic (3.80e-2)" "unprognostic (2.17e-1)" 0.0 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.4 6.5 0.0 0.0 2.8 0.0 0.4 2.1 24.8 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.6 11.1 5.1 4.5 0.0 0.0 9.5 4.0 0.0 19.7 0.0 0.4 0.0 0.0 0.2 0.7 0.0 2.0 0.0 21.9 13.5 6.2 13.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 31.5 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.2 0.0 0.0 11.5 0.0 0.0 0.0 0.1 25.2 0.0 33.5 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 44.8 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 1.1 13.2 0.0 0.0 5.6 0.1 0.0 0.9 0.1 0.0 0.0 0.0 3.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.6 0.0 127.1 52.7 0.0 0.0 0.0 4.0 20.5 3.5 0.0 46.3 0.0 1.3 0.1 0.2 0.0 0.0 0.6 10.3 2.1 36.4 1.1 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 10.1 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 59.6 171.4 0.0 0.0 178.7 GPRASP2 "FLJ37327, GASP2" ENSG00000158301 "G protein-coupled receptor associated sorting protein 2" Q96D09 X 102712176-102717733 "Predicted intracellular proteins" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.0" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 16.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 4.7" "Group enriched" "Detected in many" 4 "dendritic cells: 1.6;NK-cells: 2.1;T-cells: 4.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017438 Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA017438: AB_1849504" "unprognostic (8.74e-3)" "unprognostic (1.99e-1)" "unprognostic (2.47e-2)" "unprognostic (5.14e-3)" "unprognostic (4.60e-2)" "unprognostic (5.06e-2)" "unprognostic (1.12e-1)" "unprognostic (1.89e-2)" "unprognostic (2.99e-1)" "unprognostic (1.06e-1)" "prognostic favorable (5.71e-4)" "unprognostic (1.42e-1)" "prognostic favorable (4.60e-6)" "unprognostic (1.19e-2)" "unprognostic (9.03e-2)" "unprognostic (8.05e-2)" "prognostic unfavorable (6.63e-5)" 3.7 12.2 13.8 1.5 22.6 0.2 6.1 16.9 30.0 7.7 3.7 3.4 1.7 1.3 13.8 7.4 3.3 8.8 4.0 10.9 15.8 22.3 8.1 5.2 3.9 1.2 8.7 22.5 24.8 7.1 13.3 11.5 2.8 18.7 10.2 2.5 3.6 6.6 9.8 5.2 4.4 1.8 8.3 7.2 3.0 2.2 3.6 4.1 0.8 12.0 1.3 1.3 3.6 3.8 0.4 1.6 0.0 0.6 2.1 4.7 1.2 0.5 5.1 13.7 10.5 4.3 5.2 1.0 7.8 7.0 6.7 13.1 1.7 2.4 0.0 2.7 8.0 3.4 1.8 16.3 4.2 8.5 0.0 6.3 0.7 1.5 0.4 3.1 1.2 1.0 5.4 4.5 7.5 0.3 7.9 4.7 1.3 1.9 0.5 8.1 2.4 3.6 0.5 6.8 1.6 7.1 4.7 2.2 0.0 4.2 1.9 3.0 9.4 7.8 1.6 1.0 4.4 4.4 2.7 4.2 4.8 10.0 9.6 7.4 0.2 0.3 0.0 6.4 0.8 2.6 0.0 0.4 0.0 0.9 0.6 0.8 0.4 1.1 1.3 0.8 0.4 4.7 1.9 0.0 2.1 0.2 1.6 1.6 1.2 13.8 22.6 16.9 30.0 15.8 22.3 8.7 22.5 18.7 4.1 0.0 1.0 0.0 5.3 2.1 16.1 14.9 10.2 0.0 4.5 5.2 2.0 5.0 8.3 1.3 0.4 4.3 0.2 0.0 0.8 0.6 4.9 3.2 0.0 7.3 0.8 15.9 2.9 8.0 1.6 0.8 11.2 0.3 0.0 0.0 1.3 10.0 1.5 1.9 11.7 7.7 6.4 6.5 4.1 4.4 4.3 2.6 1.8 0.0 1.1 0.5 GPRC5B RAIG-2 ENSG00000167191 "G protein-coupled receptor class C group 5 member B" Q9NZH0 16 19856691-19886167 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 108.0" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 172.9;Late spermatids: 145.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "naive CD4 T-cell: 6.5" "Lineage enriched" "Detected in many" 4 "T-cells: 6.5" "Cell line enhanced" "Detected in many" "EFO-21: 39.2;HHSteC: 26.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015247 Enhanced Supported Nucleoplasm,Nucleoli,Vesicles NA NA Vesicles "Nucleoplasm, Nucleoli" "HPA015247: AB_1849323" "unprognostic (1.26e-1)" "unprognostic (1.32e-1)" "prognostic unfavorable (9.27e-5)" "unprognostic (2.60e-3)" "unprognostic (3.28e-1)" "unprognostic (2.46e-1)" "unprognostic (3.97e-2)" "unprognostic (5.70e-2)" "unprognostic (1.42e-1)" "unprognostic (2.26e-2)" "unprognostic (2.76e-2)" "unprognostic (1.27e-1)" "prognostic favorable (6.30e-4)" "unprognostic (4.73e-2)" "unprognostic (1.06e-1)" "unprognostic (4.42e-3)" "unprognostic (6.78e-3)" 12.6 4.4 45.2 3.2 55.9 1.0 7.3 22.8 108.0 5.4 2.9 95.1 4.9 4.0 7.1 9.3 5.5 12.7 9.2 22.3 47.8 28.7 12.1 2.7 3.9 4.6 63.1 34.9 13.7 12.7 9.5 3.8 9.3 38.6 6.3 2.3 3.8 20.8 11.5 35.1 2.5 3.3 5.1 61.6 2.2 22.7 19.6 63.1 0.0 7.2 2.6 2.7 6.2 3.0 0.0 0.0 0.0 1.5 0.0 6.5 1.3 0.4 12.6 12.5 2.2 12.9 0.9 2.3 0.1 3.1 1.2 0.8 11.5 0.4 0.0 39.2 0.4 8.2 0.6 9.2 0.0 0.7 0.0 3.3 0.0 0.0 0.0 26.8 0.0 0.0 1.1 0.0 2.1 0.0 3.3 6.1 0.3 2.6 0.2 2.8 0.6 0.0 0.0 13.7 0.0 6.0 3.6 0.0 0.0 0.4 5.8 9.7 0.8 1.4 0.8 11.3 4.1 0.0 0.2 1.2 0.0 1.5 6.1 0.3 0.1 0.0 0.0 0.6 0.1 0.7 0.0 0.1 0.0 0.0 1.5 0.0 0.0 1.6 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.3 0.0 0.0 1.3 45.2 55.9 22.8 40.5 47.8 28.7 63.1 34.9 38.6 63.1 0.0 4.0 0.9 4.6 1.1 30.1 13.4 35.7 5.3 7.9 29.6 0.0 3.9 1.7 47.7 172.9 30.1 0.0 0.0 56.2 1.2 9.7 4.3 0.0 0.0 3.3 0.0 0.0 6.2 1.0 145.0 22.2 1.1 15.1 1.8 0.0 20.5 53.7 0.0 25.1 0.1 5.7 12.9 9.2 2.8 1.5 1.5 2.1 0.0 0.0 1.7 GPRC5C RAIG-3 ENSG00000170412 "G protein-coupled receptor class C group 5 member C" Q9NQ84 17 74424851-74451653 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 76.2" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 193.6;Hepatocytes: 148.3;Paneth cells: 149.7;Sertoli cells: 142.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 31.1" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 10.2" "Group enriched" "Detected in many" 9 "dendritic cells: 10.2;monocytes: 4.7" "Cell line enhanced" "Detected in many" "Hep G2: 24.0;HMC-1: 42.2;RPTEC TERT1: 56.9;RT4: 26.3;T-47d: 32.0" "Region enriched" "Detected in many" 9 "cerebellum: 47.7" "Low region specificity" "Detected in all" HPA029776 Enhanced Uncertain "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA029776: AB_10602324" "unprognostic (1.48e-1)" "unprognostic (3.35e-1)" "unprognostic (6.01e-2)" "unprognostic (2.37e-3)" "unprognostic (1.80e-2)" "unprognostic (1.09e-2)" "unprognostic (4.40e-2)" "unprognostic (1.57e-1)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" "unprognostic (9.61e-3)" "unprognostic (1.05e-1)" "prognostic favorable (1.58e-5)" "unprognostic (7.58e-2)" "unprognostic (3.70e-2)" "unprognostic (2.75e-2)" "unprognostic (1.54e-3)" 4.3 4.1 5.2 2.2 5.3 0.0 7.7 31.1 5.7 19.7 15.4 4.4 17.0 10.0 5.8 9.9 5.3 12.5 17.6 7.7 5.3 2.6 43.8 46.1 11.5 2.8 4.8 4.9 12.3 76.2 12.0 3.4 4.5 6.1 15.1 6.2 18.0 16.8 11.7 25.4 9.2 15.2 3.9 4.6 5.1 44.7 4.4 4.1 1.9 42.2 10.2 3.5 12.6 8.0 0.7 10.2 0.1 4.7 0.0 0.1 0.3 4.6 16.7 1.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 21.4 0.0 13.3 0.1 5.4 14.7 2.2 0.3 0.0 0.0 2.7 0.0 1.2 24.0 4.9 0.0 42.2 0.4 7.6 0.0 0.0 22.7 0.0 0.0 1.2 0.3 0.0 5.2 0.1 4.5 2.7 23.1 19.4 0.0 0.0 1.1 56.9 26.3 8.1 0.7 0.8 1.8 0.0 10.9 32.0 1.2 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 2.1 0.6 0.1 0.0 1.7 0.1 0.0 3.4 0.0 0.7 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 4.7 10.2 0.0 0.3 5.2 5.3 31.1 5.7 5.3 2.6 4.8 4.9 6.1 4.1 3.0 48.9 1.5 39.6 12.0 0.8 193.6 68.8 22.7 18.2 129.1 0.0 0.7 24.9 53.1 0.1 8.7 61.7 0.0 58.9 7.1 19.9 46.9 10.3 148.3 9.6 4.8 43.7 25.8 8.5 0.5 16.7 4.2 3.3 5.4 47.3 18.8 37.9 149.7 20.8 51.6 0.8 142.3 56.7 0.4 3.0 9.8 21.2 1.5 44.1 40.9 GPRIN3 "FLJ42625, GRIN3" ENSG00000185477 "GPRIN family member 3" Q6ZVF9 4 89236386-89308010 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.0" "Cell type enhanced" "Detected in many" 8 "Intestinal endocrine cells: 75.7;Sertoli cells: 77.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 41.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 47.1;RPMI-8226: 12.1;SCLC-21H: 12.6;U-266/70: 7.3;U-266/84: 5.7" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 4 "basal ganglia: 53.1" "HPA043148, HPA057666, HPA059092" Enhanced Approved Nucleoplasm,Nucleoli No NA Nucleoli Nucleoplasm "HPA043148: AB_2678341, HPA057666: AB_2683496, HPA059092: AB_2683902" "unprognostic (9.05e-2)" "unprognostic (4.92e-2)" "prognostic favorable (7.22e-5)" "unprognostic (2.89e-2)" "unprognostic (1.78e-1)" "unprognostic (1.07e-3)" "unprognostic (3.36e-1)" "unprognostic (1.98e-1)" "unprognostic (1.17e-2)" "unprognostic (2.22e-1)" "unprognostic (1.34e-3)" "unprognostic (3.13e-1)" "prognostic favorable (8.33e-4)" "unprognostic (1.91e-1)" "unprognostic (5.35e-2)" "unprognostic (3.93e-1)" "unprognostic (7.82e-4)" 7.0 1.8 4.0 11.5 9.1 8.9 3.2 41.0 5.0 3.5 7.2 2.8 0.0 8.4 2.3 1.7 1.8 2.1 5.6 5.4 3.6 4.1 5.5 2.8 11.2 12.7 4.1 3.1 4.8 7.0 1.1 12.4 1.4 6.5 2.1 9.8 6.4 2.9 1.0 2.1 1.6 7.0 2.0 6.0 12.9 4.7 1.1 6.2 5.3 2.9 1.4 10.5 4.5 2.4 0.3 1.5 0.1 2.2 2.9 6.6 1.4 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 47.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 12.1 0.1 0.0 12.6 0.2 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.3 5.7 0.0 0.2 0.0 0.0 0.1 0.5 0.0 4.8 1.7 6.6 0.3 4.7 3.7 1.5 0.1 1.9 1.9 0.1 2.9 2.2 0.0 5.3 1.4 4.0 9.1 41.0 5.0 3.6 4.1 4.1 3.1 6.5 6.2 0.0 19.9 3.7 0.7 1.0 9.4 14.6 5.1 1.4 9.1 3.5 0.0 0.1 1.7 1.1 0.1 3.6 9.6 0.0 8.2 0.0 2.3 0.2 7.0 0.0 18.9 25.4 75.7 2.5 26.9 0.0 0.3 31.5 1.7 5.4 25.1 0.8 1.7 5.8 1.1 1.8 10.3 77.6 8.2 0.1 0.1 0.9 0.2 34.6 21.8 0.3 GPS1 "COPS1, CSN1" ENSG00000169727 "G protein pathway suppressor 1" Q13098 17 82050691-82057470 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047448, HPA052848" Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA047448: , HPA052848: " "unprognostic (1.96e-1)" "unprognostic (5.89e-2)" "unprognostic (1.50e-1)" "unprognostic (9.65e-2)" "unprognostic (3.41e-1)" "unprognostic (2.19e-1)" "unprognostic (4.75e-3)" "unprognostic (2.18e-2)" "unprognostic (3.17e-1)" "prognostic favorable (3.06e-4)" "unprognostic (1.18e-3)" "unprognostic (1.92e-1)" "unprognostic (4.96e-3)" "unprognostic (4.07e-1)" "unprognostic (8.90e-2)" "unprognostic (1.45e-1)" "unprognostic (2.15e-1)" 23.5 23.9 27.2 19.3 28.2 23.6 18.8 27.7 47.2 20.5 18.7 33.3 19.8 22.4 21.5 21.1 22.2 24.5 19.2 33.4 28.7 26.7 29.6 39.9 17.2 21.6 28.7 25.9 25.3 34.4 23.2 22.3 20.8 28.0 23.2 12.0 25.1 37.1 28.9 67.1 26.5 19.7 16.8 23.7 20.7 21.9 36.0 18.2 32.3 25.3 29.8 20.6 19.5 17.0 26.1 37.3 25.2 34.5 29.7 44.0 36.0 27.1 50.8 18.9 24.7 13.4 12.9 26.8 18.3 14.7 29.1 24.1 44.4 17.0 13.5 16.5 18.3 21.2 20.7 18.0 23.4 9.9 8.9 64.3 22.8 28.5 49.2 22.3 24.8 22.1 18.5 17.2 25.7 15.4 11.7 30.3 23.4 21.3 15.6 16.1 53.7 42.2 28.2 24.0 26.2 38.0 26.0 26.0 21.9 17.9 28.4 32.5 50.9 18.6 34.5 27.0 15.1 39.1 22.5 17.2 29.1 34.5 22.4 29.3 28.7 12.0 14.2 22.7 16.0 26.1 19.6 34.5 25.2 33.0 31.7 34.5 26.1 34.8 33.0 37.3 24.5 25.0 31.2 5.4 29.7 28.6 25.7 44.0 36.0 27.2 28.2 27.7 47.2 28.7 26.7 28.7 25.9 28.0 18.2 11.9 21.9 21.6 19.7 22.2 28.4 50.0 28.1 32.1 18.2 19.2 23.6 60.9 51.4 48.6 24.6 27.5 66.9 23.3 60.4 58.8 33.4 21.0 24.3 47.8 53.5 46.1 39.6 30.7 32.4 58.5 27.9 36.5 32.1 45.9 33.5 36.5 43.4 45.6 29.7 84.8 24.9 6.5 35.6 48.3 48.5 26.2 45.2 25.8 42.2 17.0 GPS2 ENSG00000132522 "G protein pathway suppressor 2" Q13227 17 7311324-7315564 "Cancer-related genes, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Activator, Repressor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Erythroid cells: 116.8;Late spermatids: 206.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067540 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA067540: AB_2685860" "unprognostic (1.53e-2)" "unprognostic (3.43e-1)" "unprognostic (3.33e-2)" "unprognostic (1.71e-3)" "unprognostic (1.55e-1)" "unprognostic (1.53e-4)" "unprognostic (1.37e-2)" "unprognostic (1.33e-1)" "unprognostic (3.18e-2)" "unprognostic (2.84e-1)" "prognostic favorable (7.50e-5)" "unprognostic (1.37e-2)" "prognostic unfavorable (3.42e-5)" "unprognostic (2.09e-1)" "unprognostic (1.44e-1)" "unprognostic (6.87e-2)" "unprognostic (1.28e-3)" 21.8 22.8 21.1 17.6 20.9 27.8 25.0 18.2 25.4 18.5 23.4 19.1 14.4 14.4 20.0 15.5 24.6 19.9 15.5 35.3 19.9 17.1 28.7 30.1 18.5 15.2 19.5 16.9 20.9 23.0 26.6 21.1 21.9 16.5 17.5 20.2 14.3 19.7 21.5 72.4 23.0 25.7 18.2 21.2 20.6 18.0 45.8 22.1 21.2 22.4 21.0 21.1 19.2 25.0 55.2 48.3 58.1 46.4 28.2 57.0 38.8 19.8 38.5 12.3 16.8 24.6 13.9 14.2 14.4 17.0 29.1 25.1 26.7 10.2 22.4 10.9 19.7 20.8 27.2 15.6 28.0 22.6 27.3 24.5 20.7 36.6 33.0 17.5 12.4 24.2 13.1 19.4 40.1 10.7 13.1 17.0 20.2 12.5 5.3 30.2 16.8 24.1 13.1 16.8 20.9 16.1 18.5 22.8 22.9 21.6 22.4 16.4 27.5 23.4 15.0 19.7 14.4 14.8 12.1 10.2 13.7 14.1 18.9 33.4 17.5 24.8 14.9 20.5 14.6 23.8 44.1 35.3 58.1 40.8 43.0 38.4 55.2 45.5 45.8 29.5 43.3 42.5 38.5 56.4 28.2 46.4 48.3 57.0 38.8 21.1 20.9 18.2 25.4 19.9 17.1 19.5 16.9 16.5 22.1 11.9 9.6 21.7 8.7 14.1 27.6 1.0 15.3 18.7 21.6 19.2 62.8 11.4 21.6 17.7 78.1 12.8 48.4 116.8 23.3 9.1 9.8 7.6 18.5 9.5 8.9 36.5 16.1 9.8 14.9 206.1 19.5 12.6 18.6 19.8 16.9 17.6 18.7 21.0 14.5 19.3 44.7 19.4 13.6 30.3 47.1 14.8 16.4 27.7 17.5 7.3 GPSM1 "AGS3, DKFZP727I051" ENSG00000160360 "G protein signaling modulator 1" Q86YR5 9 136327476-136359605 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 32.2;Cone photoreceptor cells: 21.6;Muller glia cells: 33.2;Rod photoreceptor cells: 40.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 36.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042199, HPA060736" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA042199: AB_10959329, HPA060736: " "unprognostic (1.73e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (6.07e-4)" "unprognostic (4.07e-3)" "unprognostic (3.44e-1)" "unprognostic (1.29e-1)" "unprognostic (1.19e-1)" "unprognostic (1.37e-2)" "unprognostic (2.03e-2)" "unprognostic (1.48e-1)" "unprognostic (5.96e-3)" "unprognostic (3.37e-2)" "prognostic unfavorable (3.30e-4)" "unprognostic (4.66e-2)" "unprognostic (1.84e-1)" "unprognostic (6.42e-2)" "unprognostic (7.48e-2)" 7.8 10.2 15.2 5.6 8.3 5.6 4.2 38.6 23.0 10.5 5.3 12.8 4.8 4.7 13.4 10.1 2.6 7.1 8.3 25.5 8.8 11.6 5.5 1.8 13.8 3.2 8.8 14.2 16.4 28.1 4.4 6.6 8.8 10.5 12.7 2.2 20.4 7.7 8.6 2.8 12.0 4.6 9.0 9.1 8.0 6.1 12.0 9.9 2.8 3.9 3.7 2.0 5.0 8.2 0.4 0.7 0.0 2.0 0.0 2.1 0.3 1.7 2.8 6.7 11.7 3.9 6.7 5.6 19.3 8.1 5.5 3.0 5.6 1.8 0.0 8.2 11.7 4.6 1.3 1.0 4.0 1.2 15.2 11.4 2.2 9.1 1.0 16.5 0.1 2.8 10.9 2.7 5.0 2.9 6.8 5.5 2.7 5.8 0.1 3.6 6.3 1.0 2.1 7.1 0.6 10.2 36.1 12.1 5.6 1.5 1.3 16.4 20.4 3.6 0.4 6.0 2.7 8.1 3.8 8.9 10.2 8.1 11.8 3.9 3.5 0.1 0.0 6.1 0.0 9.6 0.0 0.3 0.0 0.7 2.0 0.8 0.0 1.2 0.1 0.7 0.4 0.5 0.3 0.0 0.0 0.0 0.0 2.1 0.3 15.2 8.3 38.6 18.8 8.8 11.6 8.8 14.2 10.5 9.9 3.0 3.5 0.0 2.1 3.8 32.2 9.7 0.0 0.0 0.0 0.0 21.6 0.4 10.0 2.6 0.5 3.6 0.0 0.0 1.6 0.7 8.4 3.9 5.7 0.0 1.0 9.5 1.7 5.5 0.8 1.1 9.8 1.8 8.5 0.0 0.0 33.2 5.9 0.0 8.9 0.0 40.9 0.0 4.7 0.0 1.7 2.9 0.2 0.0 0.0 2.4 GPX2 GSHPX-GI ENSG00000176153 "Glutathione peroxidase 2" P18283 14 64939152-64942905 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Oxidoreductase, Peroxidase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 126.9;liver: 195.2" "Cell type enhanced" "Detected in many" 9 "Cholangiocytes: 484.1;Hepatocytes: 821.3;Mucus-secreting cells: 410.2;Undifferentiated cells: 621.9;Urothelial cells: 833.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 2.4" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "OE19: 309.4" "Region enhanced" "Detected in single" "pons and medulla: 1.3" "Not detected" "Not detected" HPA003545 Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003545: AB_10962695" "unprognostic (3.54e-1)" "unprognostic (1.08e-2)" "unprognostic (1.51e-1)" "unprognostic (1.90e-3)" "unprognostic (4.75e-3)" "prognostic unfavorable (5.10e-4)" "unprognostic (2.96e-2)" "unprognostic (2.93e-2)" "unprognostic (7.87e-2)" "unprognostic (1.54e-2)" "unprognostic (8.45e-2)" "unprognostic (1.44e-1)" "unprognostic (2.77e-2)" "unprognostic (4.39e-2)" "unprognostic (3.39e-2)" "unprognostic (6.66e-4)" "unprognostic (1.73e-2)" 0.1 0.0 0.1 23.8 0.2 0.0 0.8 0.2 0.1 5.5 50.4 0.5 2.0 14.4 0.3 1.0 53.0 0.6 126.9 0.2 0.1 0.2 29.4 195.2 2.0 0.1 0.1 0.1 0.9 7.0 0.0 0.2 0.1 0.2 16.8 71.6 0.1 59.7 4.1 0.3 3.9 35.4 5.6 0.2 0.1 57.8 0.4 0.1 0.5 0.2 44.0 7.4 56.3 15.0 0.2 0.0 0.5 0.8 2.4 0.1 0.0 0.0 71.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.6 0.0 0.4 0.0 0.1 19.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 66.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 309.4 0.0 0.0 0.0 0.0 0.0 47.5 21.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.5 2.4 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.0 0.0 11.8 173.3 8.9 0.1 0.4 484.1 2.7 2.3 22.7 0.0 0.1 10.0 152.1 13.5 0.5 203.5 0.0 233.6 0.1 0.4 34.2 13.8 821.3 0.0 0.0 110.6 14.1 19.9 38.7 0.9 0.3 0.0 5.4 410.2 0.0 220.5 261.9 0.0 18.9 0.6 0.0 1.0 0.5 0.0 8.4 0.0 6.9 621.9 833.9 GPX4 "MCSP, PHGPx" ENSG00000167468 "Glutathione peroxidase 4" P36969 19 1103926-1106791 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Developmental protein, Oxidoreductase, Peroxidase" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Late spermatids: 13901.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008630, HPA047224, HPA058546" Enhanced Approved Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA 220000 "Nucleoplasm, Mitochondria" "CAB008630: AB_1616685, HPA047224: AB_2679990, HPA058546: AB_2683749" "unprognostic (8.42e-3)" "prognostic favorable (7.18e-4)" "unprognostic (8.14e-3)" "prognostic favorable (1.84e-5)" "unprognostic (1.00e-1)" "unprognostic (8.72e-2)" "unprognostic (2.53e-3)" "unprognostic (8.49e-2)" "unprognostic (2.69e-2)" "unprognostic (1.47e-1)" "prognostic favorable (7.72e-4)" "unprognostic (1.29e-1)" "prognostic favorable (8.61e-4)" "unprognostic (1.61e-2)" "unprognostic (2.20e-1)" "unprognostic (6.67e-3)" "unprognostic (2.96e-2)" 163.0 76.4 63.3 27.1 73.7 33.3 102.3 33.5 83.7 53.3 49.1 42.4 33.8 56.9 27.2 74.7 35.6 38.4 46.9 64.4 54.2 60.2 75.3 119.0 44.7 41.7 74.6 47.3 47.1 35.1 33.1 54.7 46.4 49.3 44.7 25.5 82.3 61.6 46.9 98.2 36.3 58.5 43.6 46.5 32.4 27.7 170.4 36.5 29.9 52.8 49.8 39.2 51.2 47.0 56.7 64.0 85.2 85.2 28.4 58.5 110.5 28.7 32.7 47.3 100.0 143.5 85.1 52.7 22.8 82.3 43.5 44.4 66.7 39.0 10.4 24.9 46.0 36.8 32.4 27.6 33.0 21.3 58.3 49.9 19.6 29.4 94.1 83.5 23.0 31.5 84.4 50.3 22.0 37.1 78.5 60.8 36.5 27.4 26.3 35.9 73.8 38.9 39.5 44.8 64.1 52.8 53.9 6.4 30.1 47.2 71.5 40.8 25.8 44.7 42.4 46.4 30.3 41.4 56.3 51.4 46.3 30.8 79.3 28.5 92.2 62.5 24.3 43.6 46.2 26.5 75.6 85.2 85.2 37.0 62.0 43.0 56.7 54.3 38.6 64.0 47.8 58.5 41.7 42.4 28.4 68.3 44.1 46.8 110.5 63.3 73.7 33.5 83.7 54.2 60.2 74.6 47.3 49.3 36.5 166.7 171.0 287.8 409.7 453.0 334.7 225.6 313.4 467.1 233.2 448.4 92.3 508.2 1349.6 448.1 3338.1 251.8 690.8 163.5 318.5 1086.5 512.4 561.5 339.3 667.2 1047.6 197.0 381.4 302.0 479.7 13901.3 356.4 828.7 642.7 2643.8 270.1 239.3 473.5 361.2 294.2 2040.3 183.4 239.3 381.6 862.4 171.8 408.3 818.0 223.7 258.1 558.8 GRAMD2B "FLJ21313, GRAMD3, NS3TP2" ENSG00000155324 "GRAM domain containing 2B" Q96HH9 5 126360132-126496494 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 89.7;Club cells: 84.2;Collecting duct cells: 38.4;Extravillous trophoblasts: 38.4;Syncytiotrophoblasts: 49.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 4.6;MAIT T-cell: 4.8;memory CD4 T-cell: 2.6;memory CD8 T-cell: 3.9;myeloid DC: 2.5;naive CD4 T-cell: 5.1;naive CD8 T-cell: 3.1;NK-cell: 1.7;plasmacytoid DC: 6.5;T-reg: 3.8" "Group enriched" "Detected in many" 6 "dendritic cells: 6.5;NK-cells: 1.7;T-cells: 5.1" "Cell line enhanced" "Detected in many" "BJ hTERT+: 39.4;CAPAN-2: 26.5;fHDF/TERT166: 25.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009678, HPA010095" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Cytosol "Nucleoplasm, Golgi apparatus" "HPA009678: AB_2112580, HPA010095: AB_1849952" "unprognostic (2.34e-1)" "unprognostic (4.01e-1)" "unprognostic (4.63e-2)" "unprognostic (3.42e-2)" "unprognostic (6.82e-2)" "unprognostic (1.95e-2)" "unprognostic (6.76e-2)" "unprognostic (3.84e-2)" "unprognostic (9.90e-2)" "unprognostic (7.42e-2)" "unprognostic (2.09e-2)" "unprognostic (3.78e-1)" "unprognostic (2.20e-3)" "unprognostic (3.56e-3)" "unprognostic (2.39e-1)" "unprognostic (9.24e-2)" "unprognostic (1.12e-2)" 8.3 12.0 30.8 5.2 31.6 1.3 29.5 10.2 25.3 27.5 21.8 38.7 9.7 22.5 24.0 11.9 7.7 26.8 8.7 9.2 38.8 15.9 25.9 18.0 7.8 5.1 21.8 28.3 21.1 6.8 9.0 7.2 44.3 26.4 14.2 23.4 14.9 15.5 20.9 2.8 17.5 26.1 17.6 29.7 4.3 12.9 3.3 31.8 3.6 35.6 3.7 8.6 11.6 11.1 0.8 6.5 0.5 0.7 1.7 5.1 2.1 21.4 1.2 1.0 4.8 21.7 7.5 6.5 22.5 39.4 10.7 14.6 1.0 26.5 0.0 9.7 25.2 0.2 5.5 0.3 9.1 11.4 1.8 1.6 1.0 2.5 1.3 5.1 0.0 0.7 12.6 4.1 9.8 3.3 13.5 0.0 0.0 0.0 0.0 18.5 2.2 0.0 0.3 1.1 4.9 1.5 0.4 6.4 5.0 14.4 23.8 0.4 0.0 4.1 2.3 7.0 5.1 8.1 1.3 1.9 2.1 0.7 3.9 4.2 1.4 1.1 0.0 0.4 0.0 6.4 0.5 0.5 0.0 4.6 0.7 4.8 0.8 2.6 3.9 2.5 0.4 5.1 3.1 0.5 1.7 0.5 6.5 3.8 2.1 30.8 31.6 10.2 25.3 38.8 15.9 21.8 28.3 26.4 31.8 14.9 17.1 0.0 0.0 0.0 0.0 0.0 0.0 89.7 84.2 38.4 0.0 23.4 19.9 13.1 0.0 0.0 0.0 0.0 7.5 38.4 0.0 0.0 3.5 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.8 0.0 0.0 18.5 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 49.0 0.0 0.0 0.0 GRAP2 "GADS, GRBLG, GrbX, Grf40, Mona" ENSG00000100351 "GRB2-related adaptor protein 2" O75791 22 39901082-39973721 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 138.0" "Group enriched" "Detected in many" 4 "granulocytes: 142.1;T-cells: 44.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "gdT-cell: 19.5;MAIT T-cell: 14.4;memory CD4 T-cell: 14.4;memory CD8 T-cell: 21.1;naive CD4 T-cell: 12.2;naive CD8 T-cell: 22.5;T-reg: 12.0" "Lineage enriched" "Detected in many" 9 "T-cells: 22.5" "Cell line enhanced" "Detected in some" "HEL: 14.4;JURKAT: 57.1;K-562: 13.9;MOLT-4: 38.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA005788, CAB022073" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 260000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB022073: , HPA005788: AB_1079021" "unprognostic (1.96e-4)" "unprognostic (1.82e-4)" "unprognostic (4.19e-2)" "unprognostic (8.91e-4)" "unprognostic (2.92e-2)" "unprognostic (5.56e-5)" "unprognostic (1.27e-2)" "unprognostic (8.41e-3)" "unprognostic (4.69e-2)" "unprognostic (9.29e-2)" "unprognostic (5.17e-3)" "unprognostic (2.83e-2)" "unprognostic (1.75e-3)" "unprognostic (2.10e-1)" "unprognostic (2.20e-2)" "unprognostic (1.34e-1)" "unprognostic (8.06e-2)" 1.6 0.4 0.3 7.7 0.7 7.6 1.5 0.3 0.4 1.1 2.3 0.6 0.4 2.9 2.3 1.6 1.6 1.2 3.5 2.8 0.6 0.4 1.2 1.8 6.4 12.6 0.9 0.4 1.0 0.8 0.0 0.6 1.1 0.6 2.4 1.9 1.2 2.4 1.2 0.5 1.4 6.2 2.0 2.2 13.2 2.9 2.4 0.3 138.0 1.3 1.5 11.3 3.0 1.9 2.1 0.4 2.5 0.2 1.7 22.5 25.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 14.4 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 57.1 13.9 0.0 0.0 0.0 38.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.8 0.2 0.0 19.5 0.1 14.4 1.0 14.4 21.1 0.4 2.1 12.2 22.5 2.5 1.7 0.1 0.3 12.0 25.9 0.3 0.7 0.3 0.4 0.6 0.4 0.9 0.4 0.6 0.3 0.0 10.7 1.3 0.0 1.4 0.7 0.8 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.8 0.1 0.0 23.3 0.2 0.0 1.1 0.6 142.1 1.7 0.2 0.0 1.2 1.8 1.8 2.1 0.3 1.6 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 4.4 1.5 1.0 0.1 44.5 0.0 0.3 GRB14 ENSG00000115290 "Growth factor receptor bound protein 14" Q14449 2 164492812-164621848 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 17.7" "Cell type enhanced" "Detected in many" 15 "Distal tubular cells: 77.9;Hepatocytes: 35.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.7;HUVEC TERT2: 10.8;RPTEC TERT1: 8.9;TIME: 13.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB022294, HPA035052, HPA035053" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB022294: , HPA035052: , HPA035053: AB_2674432" "unprognostic (2.60e-1)" "unprognostic (6.34e-2)" "unprognostic (1.74e-2)" "unprognostic (6.75e-2)" "unprognostic (7.47e-2)" "unprognostic (8.33e-5)" "unprognostic (5.00e-2)" "unprognostic (3.55e-1)" "unprognostic (2.47e-2)" "unprognostic (2.33e-1)" "unprognostic (5.71e-2)" "unprognostic (8.33e-3)" "unprognostic (2.71e-1)" "unprognostic (1.89e-3)" "unprognostic (7.10e-2)" "unprognostic (5.19e-2)" "unprognostic (9.27e-2)" 1.6 2.9 1.0 1.2 1.5 0.0 6.0 0.7 3.6 0.8 1.2 0.0 1.1 1.2 0.6 7.5 1.7 0.5 0.3 10.8 5.7 1.1 8.3 17.7 0.7 0.1 0.9 2.0 2.4 6.0 0.0 1.8 2.2 1.4 0.8 0.4 1.2 1.0 0.5 3.2 0.5 0.8 0.6 0.6 0.6 1.1 3.1 0.4 0.0 5.5 3.0 0.1 0.6 1.1 0.0 0.0 0.4 0.1 0.0 0.0 3.0 0.9 5.7 0.4 0.0 0.7 0.0 0.0 0.5 0.0 0.0 0.0 2.4 0.6 0.0 3.5 0.0 1.0 0.4 0.9 1.6 0.4 0.0 4.9 0.0 0.3 1.4 0.1 0.0 0.0 0.4 1.0 2.1 0.0 1.9 10.8 0.0 0.0 0.1 1.7 2.3 0.0 0.0 2.1 0.2 1.4 0.0 0.0 0.1 8.9 0.4 3.4 0.4 0.0 0.3 0.0 1.1 0.6 0.0 13.5 0.2 1.5 0.0 0.1 0.5 0.1 0.0 3.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.0 1.0 1.5 0.7 3.6 5.7 1.1 0.9 2.0 1.4 0.4 0.0 4.8 0.0 0.3 0.1 0.1 16.1 15.3 0.0 0.0 15.7 0.0 0.1 77.9 7.2 1.3 0.8 0.0 0.0 2.9 0.1 0.2 0.5 0.0 35.1 0.0 0.0 0.0 1.8 0.6 2.1 8.6 0.1 18.6 1.0 2.7 0.1 6.3 0.0 16.3 12.2 0.8 12.9 0.0 0.7 2.1 0.0 0.1 0.0 0.2 0.1 GRB2 NCKAP2 ENSG00000177885 "Growth factor receptor bound protein 2" P62993 17 75318076-75405709 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Extravillous trophoblasts: 288.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002589, HPA030749, HPA030750" Approved Supported Nucleoplasm,Nucleoli NA NA 1900000 Nucleoplasm Nucleoli "CAB002589: AB_10693935, HPA030749: AB_2673590, HPA030750: AB_2673591" "unprognostic (4.83e-3)" "unprognostic (1.85e-1)" "unprognostic (1.14e-1)" "unprognostic (3.42e-3)" "unprognostic (1.70e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (6.04e-7)" "unprognostic (1.01e-2)" "unprognostic (2.73e-1)" "unprognostic (1.80e-2)" "unprognostic (1.06e-2)" "unprognostic (1.89e-2)" "unprognostic (1.08e-2)" "unprognostic (8.13e-2)" "unprognostic (3.40e-2)" "unprognostic (1.56e-1)" "unprognostic (1.58e-1)" 29.0 29.2 36.1 48.2 40.3 56.3 23.6 42.2 41.6 18.5 27.8 28.2 19.1 29.2 28.3 19.4 27.0 22.1 22.5 32.2 34.7 33.9 24.9 32.2 33.7 54.8 30.9 29.2 21.8 16.7 21.8 21.8 33.1 26.9 21.4 27.9 21.8 21.2 25.6 27.8 18.6 30.5 30.6 42.6 56.7 22.8 10.8 27.1 45.8 20.4 15.6 53.1 29.8 19.2 24.7 25.0 64.9 42.8 12.0 13.4 20.7 25.3 22.1 15.2 18.3 16.9 15.8 34.7 26.8 21.8 28.3 27.2 19.0 17.1 33.1 15.9 24.4 23.4 15.2 21.9 19.3 29.3 16.3 20.1 35.5 14.6 27.6 15.2 40.8 69.4 14.6 20.2 29.5 14.7 16.3 33.9 31.9 23.9 23.0 20.5 31.6 47.8 39.5 10.5 24.6 22.6 28.6 32.6 24.0 21.5 18.9 18.4 26.6 22.7 22.1 28.3 28.3 24.4 66.0 21.5 27.1 20.6 21.5 27.3 42.3 32.5 53.3 20.9 32.0 19.4 25.1 32.1 38.5 13.4 38.4 11.7 23.7 12.1 13.2 25.0 24.7 12.7 12.0 64.9 12.0 42.8 16.7 13.2 20.7 36.1 40.3 42.2 41.6 34.7 33.9 30.9 29.2 26.9 27.1 56.6 54.7 133.3 29.5 41.8 36.1 52.5 45.9 71.0 58.0 15.7 29.5 59.8 44.7 59.4 2.0 57.8 58.2 23.3 55.2 288.5 37.3 45.6 117.1 36.3 231.5 33.4 40.2 41.7 166.3 4.0 23.3 221.8 43.9 209.2 41.2 45.1 62.3 69.1 39.3 55.3 47.2 6.5 46.7 17.7 47.0 39.1 72.9 66.3 37.4 100.3 GRHL1 "LBP-32, MGR, TFCP2L2" ENSG00000134317 "Grainyhead like transcription factor 1" Q9NZI5 2 9951693-10002277 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.3;skin 1: 34.4" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 69.0;Suprabasal keratinocytes: 115.9;Syncytiotrophoblasts: 154.4;Urothelial cells: 97.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 4.8;neutrophil: 1.7" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.8" "Group enriched" "Detected in some" 4 "BEWO: 66.4;SK-BR-3: 34.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA005798, HPA006420" Enhanced Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA005798: AB_1079026, HPA006420: AB_1079025" "unprognostic (2.26e-3)" "unprognostic (5.80e-2)" "unprognostic (8.35e-2)" "unprognostic (7.33e-3)" "unprognostic (2.70e-1)" "unprognostic (2.76e-2)" "unprognostic (4.43e-3)" "unprognostic (6.73e-2)" "unprognostic (1.68e-1)" "unprognostic (1.00e-1)" "unprognostic (8.83e-2)" "unprognostic (1.68e-1)" "unprognostic (1.14e-4)" "unprognostic (3.66e-1)" "unprognostic (3.40e-1)" "unprognostic (4.04e-2)" "unprognostic (2.14e-1)" 1.7 0.6 1.5 0.2 2.4 2.8 15.9 2.0 1.6 10.2 0.9 0.2 10.8 0.3 0.9 3.8 40.3 0.7 1.0 1.6 1.9 1.2 2.5 4.9 2.3 0.2 0.7 1.4 0.5 1.5 12.9 2.6 31.0 0.8 6.1 0.2 1.8 17.5 9.7 0.9 34.4 0.7 5.1 0.6 0.6 1.3 1.6 0.4 0.4 2.8 22.3 25.3 6.7 16.9 0.1 0.2 4.8 0.2 0.5 0.6 4.5 3.2 0.0 0.4 0.9 0.1 0.1 66.4 0.3 0.4 0.2 0.3 0.2 2.3 0.4 0.1 0.0 0.4 2.0 4.0 0.4 0.9 0.9 1.8 0.1 0.6 1.2 0.0 0.2 0.3 0.1 1.7 1.9 0.0 0.0 0.3 0.7 0.6 1.2 0.0 4.2 0.6 0.5 0.2 1.0 0.7 0.2 0.3 0.5 0.4 12.6 0.7 0.5 0.6 34.9 0.8 5.7 4.2 0.1 0.3 0.2 0.8 1.0 0.4 0.8 0.5 0.4 0.2 0.5 0.5 0.0 0.2 4.8 0.1 0.1 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.6 4.5 1.5 2.4 2.0 1.6 1.9 1.2 0.7 1.4 0.8 0.4 3.0 7.2 0.0 18.6 35.5 20.9 1.2 0.0 6.7 29.6 19.2 58.9 48.9 0.0 2.8 6.0 3.1 0.5 0.0 8.0 69.0 6.1 30.1 10.3 5.7 6.7 11.1 3.4 3.1 1.3 2.1 0.0 2.7 20.3 1.0 0.6 1.7 4.8 0.0 0.4 1.7 11.8 0.0 6.1 5.1 5.3 115.9 154.4 1.3 0.4 97.4 GRHL2 "BOM, DFNA28, FLJ13782, TFCP2L3" ENSG00000083307 "Grainyhead like transcription factor 2" Q6ISB3 8 101492432-101669726 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Corneal dystrophy, Deafness, Disease mutation, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 47.9;seminal vesicle: 42.4" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 29.8;Ciliated cells: 40.2;Club cells: 27.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "NK-cell: 1.2" "Lineage enriched" "Detected in single" 5 "NK-cells: 1.2" "Cell line enhanced" "Detected in some" "A-431: 15.6;CACO-2: 11.4;HaCaT: 19.1;hTCEpi: 14.9;MCF7: 13.1;OE19: 15.3;RT4: 28.1;T-47d: 33.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004820, HPA062839" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA004820: AB_1857928, HPA062839: AB_2684878" "prognostic unfavorable (6.43e-4)" "unprognostic (2.54e-2)" "unprognostic (4.09e-2)" "unprognostic (2.95e-2)" "unprognostic (2.68e-1)" "unprognostic (4.79e-2)" "unprognostic (1.90e-1)" "unprognostic (2.66e-1)" "unprognostic (1.64e-1)" "unprognostic (8.59e-2)" "prognostic unfavorable (6.27e-4)" "unprognostic (2.61e-2)" "unprognostic (8.29e-4)" "unprognostic (4.54e-3)" "unprognostic (2.64e-1)" "unprognostic (1.08e-1)" "unprognostic (1.03e-2)" 0.4 0.3 0.4 3.3 0.4 0.0 11.3 0.3 0.4 6.0 9.9 0.0 34.7 2.1 1.6 16.4 18.7 5.2 10.3 0.4 0.4 0.4 6.4 0.7 11.3 0.0 0.4 0.0 1.5 22.1 7.1 1.5 47.9 0.1 15.2 5.6 0.1 15.0 42.4 0.4 18.0 8.6 1.6 0.4 0.4 5.9 0.6 0.0 1.7 12.7 14.3 12.2 7.4 8.4 0.0 0.0 0.0 0.0 1.2 0.2 0.0 15.6 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 11.4 7.8 0.0 0.0 0.0 0.0 19.1 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 28.1 0.5 0.0 0.0 6.2 0.0 1.9 33.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.4 0.3 0.4 0.4 0.4 0.4 0.0 0.1 0.0 29.8 8.8 0.0 9.3 21.6 0.0 0.4 10.2 40.2 27.3 10.4 0.0 12.4 5.0 6.5 2.2 0.4 5.9 0.0 4.8 5.9 0.8 10.0 0.0 0.0 1.3 0.0 1.2 0.0 0.0 4.1 0.0 0.0 1.7 1.0 10.0 0.0 7.4 7.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 22.7 16.6 0.0 7.6 5.1 GRHL3 "SOM, TFCP2L4" ENSG00000158055 "Grainyhead like transcription factor 3" Q8TE85 1 24319322-24364482 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 59.0;lymphoid tissue: 60.1;tongue: 51.5" "Group enriched" "Detected in some" 5 "Suprabasal keratinocytes: 86.8;Urothelial cells: 72.5" "Cancer enhanced" "Detected in many" "urothelial cancer: 28.9" "Region enhanced" "Detected in some" "pons and medulla: 3.6" "Group enriched" "Detected in some" 12 "eosinophil: 1.0;neutrophil: 1.4" "Lineage enriched" "Detected in single" 14 "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "BEWO: 21.4;HaCaT: 16.8;MCF7: 25.9;OE19: 9.4;RT4: 29.6;SuSa: 16.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA059960 Enhanced Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA059960: AB_2684180" "unprognostic (8.99e-2)" "unprognostic (1.23e-1)" "unprognostic (3.95e-2)" "unprognostic (7.83e-3)" "unprognostic (7.58e-3)" "unprognostic (6.28e-3)" "unprognostic (1.20e-1)" "unprognostic (6.34e-2)" "unprognostic (9.01e-3)" "unprognostic (4.03e-2)" "unprognostic (1.24e-1)" "unprognostic (7.36e-2)" "unprognostic (8.59e-4)" "unprognostic (9.79e-2)" "unprognostic (1.83e-1)" "unprognostic (6.97e-3)" "unprognostic (7.42e-2)" 0.1 0.1 0.1 0.1 0.9 0.0 1.0 0.2 0.9 9.0 0.1 0.2 0.0 0.2 0.6 0.8 59.0 0.2 0.6 0.1 1.1 0.3 0.6 0.5 0.1 0.0 0.1 0.0 0.1 0.1 0.9 0.1 1.1 3.6 3.6 0.1 0.0 5.9 0.9 0.2 21.7 0.1 0.5 3.0 0.0 0.2 1.1 0.1 0.5 0.1 51.5 60.1 12.3 11.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.5 1.2 0.4 0.0 0.0 0.0 21.4 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 16.8 0.0 1.5 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.6 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 25.9 0.0 0.1 1.1 9.4 0.0 0.0 0.0 0.1 2.1 29.6 0.1 0.0 0.0 2.9 0.0 16.3 1.9 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.1 0.9 0.2 0.1 1.1 0.3 0.1 0.0 3.6 0.1 0.0 1.1 0.0 8.8 12.8 0.0 0.4 0.0 2.7 2.3 1.8 0.0 3.5 0.0 0.2 0.4 0.1 0.0 0.0 0.0 0.1 0.3 9.1 0.0 0.4 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 1.8 0.0 86.8 15.4 0.0 0.0 72.5 GRHPR "GLXR, PH2" ENSG00000137106 "Glyoxylate and hydroxypyruvate reductase" Q9UBQ7 9 37422666-37436990 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 172.0" "Cell type enhanced" "Detected in all" 9 "Hepatocytes: 748.4;Proximal tubular cells: 664.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022971, HPA078575" Enhanced Approved Nucleoplasm,Cytosol NA NA 1400000 Cytosol Nucleoplasm "HPA022971: AB_1849975, HPA078575: " "prognostic favorable (7.00e-5)" "unprognostic (6.84e-2)" "unprognostic (2.62e-1)" "unprognostic (2.64e-3)" "unprognostic (5.78e-3)" "unprognostic (3.04e-1)" "unprognostic (1.02e-3)" "unprognostic (1.22e-1)" "unprognostic (2.24e-1)" "unprognostic (4.49e-2)" "unprognostic (5.88e-2)" "unprognostic (2.36e-1)" "prognostic favorable (5.39e-9)" "unprognostic (1.04e-1)" "unprognostic (2.11e-1)" "unprognostic (1.15e-1)" "unprognostic (1.79e-1)" 12.8 33.7 16.3 13.8 17.4 9.9 12.3 9.5 22.3 12.1 17.6 27.5 11.6 17.2 14.3 18.1 17.6 12.9 18.1 29.2 15.8 14.7 41.9 172.0 9.7 13.8 20.0 16.5 17.0 15.5 9.5 8.8 13.2 15.5 14.2 10.2 13.5 21.6 14.0 40.0 14.8 14.6 14.2 19.4 10.0 13.3 13.0 18.7 9.5 15.1 25.2 13.6 13.4 11.7 30.6 33.2 17.8 30.3 28.9 25.9 22.4 31.9 46.2 26.2 23.9 24.1 26.8 26.5 25.6 34.0 35.0 38.1 17.4 13.9 30.7 15.1 30.0 26.2 14.5 15.0 33.4 20.9 41.0 18.8 18.0 43.0 30.9 38.1 17.1 18.7 31.9 29.4 20.2 26.1 29.6 30.3 21.0 32.9 12.7 30.7 24.5 16.6 17.6 15.9 29.2 20.1 16.4 19.2 17.0 46.6 18.2 10.9 19.6 22.0 42.1 23.9 24.7 23.7 22.1 32.9 19.2 30.9 13.3 22.1 10.1 7.7 20.5 27.3 9.9 28.1 17.8 30.2 15.0 19.4 30.3 16.2 28.6 20.7 22.0 33.2 30.6 20.4 17.3 7.0 28.9 24.7 29.8 25.9 22.4 16.3 17.4 9.5 22.3 15.8 14.7 20.0 16.5 15.5 18.7 53.6 20.9 43.5 39.7 38.5 33.3 86.0 219.1 29.4 26.1 48.8 19.6 128.8 210.5 67.4 10.2 41.4 82.6 46.7 77.8 76.0 63.3 42.0 49.6 748.4 97.6 22.3 59.7 76.1 83.4 10.4 69.0 49.3 75.9 86.6 59.5 85.7 64.8 60.5 92.6 664.7 23.4 77.6 62.6 17.5 16.2 49.2 74.4 37.9 71.9 35.2 GRIK5 "GluK5, GRIK2, KA2" ENSG00000105737 "Glutamate ionotropic receptor kainate type subunit 5" Q16478 19 41998321-42069498 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.9" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 21.4;Horizontal cells: 17.5;Muller glia cells: 8.3;Rod photoreceptor cells: 20.6" "Cancer enhanced" "Detected in many" "glioma: 15.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "eosinophil: 1.0" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.0" "Cell line enhanced" "Detected in some" "HEL: 9.0;hTERT-RPE1: 14.5;NTERA-2: 8.9;REH: 24.4;SCLC-21H: 7.0;SH-SY5Y: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074001 Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA074001: AB_2732248" "unprognostic (4.99e-2)" "unprognostic (3.40e-1)" "unprognostic (1.30e-3)" "unprognostic (6.68e-3)" "unprognostic (4.28e-2)" "unprognostic (3.86e-1)" "unprognostic (5.82e-1)" "unprognostic (2.23e-1)" "unprognostic (3.89e-2)" "unprognostic (1.73e-2)" "prognostic favorable (7.23e-4)" "unprognostic (8.43e-2)" "prognostic unfavorable (9.32e-4)" "unprognostic (6.47e-3)" "unprognostic (5.77e-2)" "unprognostic (4.57e-2)" "unprognostic (6.12e-2)" 1.7 5.4 9.6 2.3 12.2 3.4 2.4 17.2 23.9 2.7 6.9 4.9 1.3 1.2 3.8 2.7 2.4 4.5 2.6 5.6 21.7 8.9 3.8 0.3 0.6 2.6 5.0 5.3 5.3 3.5 17.8 9.1 0.3 5.5 4.5 1.6 5.8 0.7 8.9 1.0 1.1 1.4 6.7 7.6 1.8 2.7 13.6 3.5 1.0 10.3 0.3 1.0 2.2 2.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.2 9.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 14.5 0.0 0.4 0.0 0.4 0.0 0.1 0.1 0.0 8.9 0.1 0.0 24.4 0.0 0.1 4.0 0.0 7.0 15.5 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 1.0 0.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 12.2 17.2 12.7 21.7 8.9 5.0 5.3 5.5 3.5 0.0 0.0 0.0 0.1 0.3 21.4 2.3 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.8 1.4 0.0 0.0 0.0 0.0 0.0 0.4 0.1 4.6 0.0 0.0 17.5 0.0 0.0 0.0 2.2 0.9 0.0 0.0 0.0 0.0 8.3 0.1 0.0 0.4 0.0 20.6 0.0 0.9 3.8 1.5 0.4 0.0 0.0 0.0 0.0 GRK3 "ADRBK2, BARK2" ENSG00000100077 "G protein-coupled receptor kinase 3" P35626 22 25564849-25729294 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 28.0" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 2: 44.1;Club cells: 30.7;Extravillous trophoblasts: 22.7;Hofbauer cells: 25.0;monocytes: 47.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "classical monocyte: 4.8;eosinophil: 5.6;intermediate monocyte: 8.0;memory B-cell: 4.9;myeloid DC: 3.7;naive B-cell: 6.2;non-classical monocyte: 7.4;plasmacytoid DC: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 20.4;JURKAT: 33.6;SH-SY5Y: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000804 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA000804: AB_1078281" "unprognostic (1.02e-1)" "unprognostic (4.38e-2)" "unprognostic (5.68e-3)" "unprognostic (4.33e-2)" "unprognostic (2.09e-1)" "unprognostic (3.67e-2)" "unprognostic (3.29e-1)" "unprognostic (1.78e-2)" "unprognostic (1.97e-1)" "unprognostic (3.54e-1)" "unprognostic (1.95e-3)" "unprognostic (5.79e-2)" "unprognostic (1.01e-3)" "unprognostic (1.74e-1)" "unprognostic (2.87e-3)" "unprognostic (1.89e-2)" "prognostic favorable (1.29e-4)" 28.0 6.0 11.9 12.4 10.8 7.0 11.3 7.9 18.9 4.7 4.0 3.1 0.7 3.0 5.7 3.1 2.7 9.1 5.0 4.6 15.7 8.3 3.0 3.4 9.4 14.1 9.7 9.8 4.1 8.4 4.4 8.2 4.5 9.6 8.2 4.3 4.8 3.7 1.9 1.4 4.1 6.1 6.2 4.9 23.2 4.0 14.8 2.7 11.6 4.5 1.3 15.2 6.7 2.5 6.2 3.7 5.6 8.0 0.0 0.4 1.6 0.0 1.9 5.8 1.9 4.1 0.5 8.5 0.6 1.8 1.8 3.2 3.0 3.3 10.6 0.1 0.1 5.2 0.1 5.8 4.3 5.5 20.4 3.8 4.9 0.6 6.7 0.1 15.8 8.3 1.0 3.0 1.3 2.3 0.3 0.3 33.6 0.5 0.0 2.1 2.6 11.3 1.1 4.1 5.7 0.0 5.1 9.3 1.8 0.0 3.1 13.7 18.5 1.0 0.0 4.4 5.6 1.6 6.3 0.1 0.0 12.0 0.1 2.3 1.2 4.2 8.3 7.8 5.6 1.8 0.6 4.8 5.6 0.0 8.0 0.3 4.9 0.0 0.3 3.7 6.2 0.1 0.2 0.3 0.0 7.4 3.2 0.4 1.6 11.9 10.8 7.9 18.9 15.7 8.3 9.7 9.8 9.6 2.7 14.9 44.1 0.0 0.0 0.0 0.0 0.0 0.0 12.0 30.7 0.0 0.0 1.5 1.7 7.0 0.0 0.0 0.0 0.0 1.6 22.7 0.0 0.0 17.4 0.0 25.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 47.7 0.0 0.0 3.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 GRWD1 "GRWD, RRB1, WDR28" ENSG00000105447 "Glutamate rich WD repeat containing 1" Q9BQ67 19 48445773-48457022 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042643, HPA055680" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoli, Nucleoli rim" Nucleoplasm "HPA042643: AB_10795510, HPA055680: AB_2682884" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (4.99e-2)" "unprognostic (1.00e-1)" "unprognostic (3.46e-1)" "unprognostic (7.77e-2)" "prognostic unfavorable (2.16e-4)" "unprognostic (1.71e-2)" "unprognostic (5.68e-2)" "unprognostic (2.69e-2)" "unprognostic (7.70e-2)" "unprognostic (2.83e-2)" "unprognostic (8.10e-2)" "unprognostic (1.78e-1)" "unprognostic (3.09e-1)" "unprognostic (2.02e-1)" "unprognostic (5.07e-2)" 16.9 15.5 9.2 15.7 11.1 14.8 15.5 12.9 14.1 13.6 14.1 10.4 11.9 15.6 18.7 12.8 20.0 15.0 16.2 16.9 7.8 8.6 13.0 26.3 12.5 17.5 11.0 10.3 19.3 35.5 16.5 10.3 14.7 9.5 13.8 8.0 12.0 18.6 14.4 29.1 18.3 11.5 13.3 8.2 19.4 14.7 13.1 10.9 18.6 17.3 19.0 17.3 14.1 18.0 21.1 18.4 1.4 17.8 17.4 22.6 16.5 17.0 45.1 7.7 14.4 6.3 6.2 6.6 13.3 6.4 19.2 16.1 25.3 12.7 24.4 11.6 8.3 10.8 14.6 19.1 20.6 7.6 18.2 25.8 22.2 15.3 18.0 7.3 20.9 14.3 7.4 11.4 18.1 9.2 4.3 9.5 13.4 31.0 15.4 8.0 17.7 22.0 52.6 20.9 18.2 13.2 27.4 8.6 17.5 8.0 21.1 17.3 9.6 15.0 21.3 6.6 4.8 10.5 10.6 10.1 17.9 15.1 7.8 31.6 15.7 35.9 22.8 6.0 18.9 20.8 0.1 11.0 1.4 19.6 17.8 22.6 21.1 18.1 19.5 18.4 20.4 21.3 19.7 0.8 17.4 13.5 13.6 15.6 16.5 9.2 11.1 12.9 14.1 7.8 8.6 11.0 10.3 9.5 10.9 3.0 17.4 22.9 20.9 41.1 12.6 6.5 15.3 18.7 14.8 12.2 0.0 35.6 19.9 28.0 1.7 18.0 7.3 0.0 15.7 30.6 18.6 13.5 19.6 14.7 21.5 20.6 18.4 11.6 10.7 14.6 15.8 12.4 27.0 35.1 9.0 5.3 18.5 7.0 11.7 15.3 13.0 19.4 20.2 6.1 34.7 35.5 29.3 20.0 13.4 17.6 GSDMA "FLJ39120, GSDM, GSDM1" ENSG00000167914 "Gasdermin A" Q96QA5 17 39953263-39977766 "Predicted intracellular proteins, Transporters" Necrosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 35.7;tongue: 19.4" "Cell type enhanced" "Detected in some" 15 "Collecting duct cells: 3.5;Hofbauer cells: 4.9;Kupffer cells: 6.0;Suprabasal keratinocytes: 2.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 7.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "granulocytes: 1.9;T-cells: 5.6" "Cell line enhanced" "Detected in some" "HBEC3-KT: 7.3;hTCEpi: 5.0;hTERT-HME1: 9.8" "Not detected" "Not detected" "HPA023313, HPA064826" Enhanced Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA 7100 "Plasma membrane, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA023313: AB_1850378, HPA064826: AB_2685361" "unprognostic (1.32e-2)" "unprognostic (2.01e-1)" "unprognostic (2.95e-2)" "unprognostic (1.06e-1)" "unprognostic (3.62e-1)" "unprognostic (1.97e-1)" "unprognostic (7.77e-2)" "unprognostic (1.39e-1)" "unprognostic (3.24e-1)" "unprognostic (3.52e-2)" "unprognostic (2.71e-1)" "unprognostic (2.90e-2)" "unprognostic (1.06e-2)" "unprognostic (9.86e-2)" "unprognostic (7.45e-2)" "unprognostic (3.63e-2)" "unprognostic (3.79e-2)" 2.1 0.4 0.2 0.4 0.1 0.0 2.2 0.1 0.1 1.1 0.6 0.0 0.0 0.1 0.4 8.6 1.9 0.3 0.3 2.0 0.2 0.2 0.4 0.2 0.7 8.5 0.2 0.7 0.2 0.2 1.0 0.9 0.9 0.1 0.2 0.6 0.0 0.6 0.0 0.9 35.7 0.3 0.5 0.2 0.3 0.2 0.9 0.0 0.8 0.2 19.4 7.8 0.8 1.1 0.6 0.5 1.9 0.4 0.6 5.6 1.0 0.4 0.1 0.0 0.3 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.0 0.0 0.1 0.0 7.3 0.0 0.2 0.5 0.9 0.6 0.5 0.0 0.3 1.6 0.0 5.0 0.9 9.8 0.1 0.0 0.1 0.2 2.4 0.0 1.0 0.0 0.2 0.1 0.5 0.1 0.6 0.0 0.9 0.2 0.7 0.0 0.2 0.2 0.3 0.0 0.1 0.6 0.1 0.1 0.3 0.7 0.1 0.1 0.3 0.1 0.6 0.4 0.1 0.0 1.7 0.4 0.4 4.8 0.2 5.6 0.3 3.1 1.8 0.2 0.6 1.6 2.5 1.9 0.6 0.3 0.5 1.1 1.0 0.2 0.1 0.1 0.1 0.2 0.2 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 1.3 6.0 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.4 0.0 0.0 0.0 0.0 GSDMB "GSDML, PRO2521" ENSG00000073605 "Gasdermin B" Q8TAX9 17 39904595-39919854 "Predicted intracellular proteins, Transporters" Necrosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 71.3" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 65.9;Mucus-secreting cells: 26.1;Paneth cells: 57.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.8" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "SK-BR-3: 103.0" "CAB013681, HPA023925, HPA052407" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB013681: , HPA023925: AB_1850383, HPA052407: AB_2681819" "unprognostic (5.78e-2)" "prognostic favorable (3.41e-5)" "unprognostic (1.27e-1)" "unprognostic (5.70e-2)" "unprognostic (6.85e-2)" "unprognostic (2.81e-1)" "unprognostic (1.10e-1)" "unprognostic (6.44e-2)" "unprognostic (3.81e-1)" "unprognostic (8.72e-2)" "unprognostic (2.34e-2)" "unprognostic (1.71e-2)" "prognostic unfavorable (5.13e-11)" "unprognostic (1.88e-1)" "unprognostic (1.99e-1)" "unprognostic (8.91e-2)" "prognostic favorable (5.91e-9)" 4.0 0.0 1.3 13.3 2.0 1.3 2.8 4.8 1.7 2.1 33.1 1.4 2.0 25.2 1.3 1.7 1.3 1.3 14.4 1.3 1.3 0.6 2.2 17.1 2.4 3.5 1.3 1.3 2.0 2.8 0.0 1.3 1.8 1.3 3.5 22.4 1.3 1.3 2.7 1.3 2.8 71.3 3.9 1.3 4.7 18.1 1.4 1.5 1.6 2.9 1.3 2.8 4.1 4.5 0.8 0.0 1.8 0.0 0.1 2.8 0.4 0.4 0.3 0.6 0.1 1.5 1.0 0.6 0.4 0.2 0.1 0.4 0.3 12.2 0.6 0.5 0.3 0.2 1.6 0.3 0.3 0.9 2.5 0.4 0.2 0.1 0.1 0.4 0.0 0.1 0.6 2.0 0.5 0.7 1.0 0.2 2.0 0.2 0.7 0.1 0.1 0.6 1.3 0.1 3.9 0.4 0.6 0.2 0.9 0.0 0.4 0.2 0.3 0.1 103.0 0.3 3.1 0.5 0.4 0.3 0.4 0.7 1.1 0.2 2.2 1.9 0.6 0.1 0.4 0.0 0.0 0.0 1.8 1.1 0.0 0.0 0.8 2.8 1.4 0.0 0.0 2.6 0.6 0.7 0.1 0.0 0.0 0.4 0.4 1.3 2.0 4.8 1.7 1.3 0.6 1.3 1.3 1.3 1.5 3.0 11.8 4.2 1.2 1.6 2.1 2.4 12.7 2.7 4.5 5.2 3.9 1.2 0.0 1.6 4.4 1.4 65.9 0.0 7.0 0.6 1.4 1.5 1.1 8.1 0.3 1.6 5.8 0.0 1.9 3.3 1.1 1.1 3.3 1.8 26.1 2.0 7.3 57.5 1.8 0.0 2.3 0.0 2.1 0.5 1.1 3.0 0.2 2.5 15.0 5.0 GSDMD "DF5L, FLJ12150, GSDMDC1" ENSG00000104518 "Gasdermin D" P57764 8 143553207-143563062 "Predicted intracellular proteins, Transporters" "Immunity, Inflammatory response, Innate immunity, Necrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 225.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004656, HPA044487" Uncertain Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "CAB004656: AB_426076, HPA044487: AB_2678957" "unprognostic (1.11e-2)" "unprognostic (8.44e-2)" "unprognostic (6.72e-2)" "unprognostic (4.00e-2)" "unprognostic (4.38e-2)" "unprognostic (1.10e-1)" "unprognostic (1.66e-1)" "unprognostic (2.65e-1)" "unprognostic (7.20e-2)" "unprognostic (6.36e-2)" "unprognostic (4.66e-2)" "unprognostic (8.90e-2)" "prognostic unfavorable (1.43e-4)" "unprognostic (8.51e-3)" "unprognostic (1.60e-1)" "unprognostic (1.96e-1)" "unprognostic (6.77e-3)" 15.1 13.3 4.8 19.7 5.9 18.6 19.2 2.2 4.6 12.1 25.4 3.9 17.2 23.3 13.9 15.6 14.5 13.7 22.4 11.6 5.1 2.6 21.7 64.6 19.0 28.1 6.8 2.8 14.8 18.3 6.9 6.9 17.0 6.8 13.6 7.2 10.9 17.9 15.0 8.7 5.8 31.7 13.0 5.3 42.9 13.2 4.1 5.0 17.2 20.0 9.8 15.9 11.5 13.1 19.6 22.9 20.8 32.3 19.6 30.4 21.6 11.5 6.7 0.1 0.0 4.2 4.7 8.7 5.4 11.3 14.4 13.8 3.4 15.4 5.3 9.4 5.6 6.5 4.6 0.2 8.8 4.4 15.3 1.0 11.0 2.2 6.5 5.1 3.1 0.5 9.9 0.8 5.2 3.1 5.7 11.6 11.2 0.5 13.8 0.6 0.4 23.5 3.9 0.1 8.2 20.9 10.6 1.3 14.1 6.2 15.1 0.2 0.2 17.3 10.7 11.5 2.6 19.8 7.0 5.4 0.1 17.9 1.2 6.9 4.6 7.0 0.1 8.5 7.1 5.9 20.8 21.9 20.0 26.5 32.3 22.8 19.6 24.5 26.5 22.9 17.2 18.9 20.9 18.9 19.6 26.7 13.2 30.4 21.6 4.8 5.9 2.2 4.6 5.1 2.6 6.8 2.8 6.8 5.0 11.9 26.1 49.1 34.0 9.6 0.2 9.7 45.9 20.1 18.2 29.6 0.0 56.0 51.4 54.3 1.8 43.6 225.0 0.0 80.6 77.0 30.7 33.5 27.6 63.6 55.5 0.0 38.1 73.1 50.7 3.2 21.9 36.3 16.9 82.0 83.9 26.1 56.4 154.3 21.2 93.5 1.1 58.2 23.5 0.9 6.6 7.9 34.9 68.6 85.6 32.7 GSE1 KIAA0182 ENSG00000131149 "Gse1 coiled-coil protein" Q14687 16 85169525-85676204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 81.9" "Cell type enhanced" "Detected in all" 5 "Cone photoreceptor cells: 137.4;Syncytiotrophoblasts: 152.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 43.6;K-562: 48.4;T-47d: 49.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036365, HPA042090" Approved Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA036365: AB_10601762, HPA042090: " "unprognostic (1.12e-2)" "unprognostic (6.29e-2)" "unprognostic (1.12e-1)" "unprognostic (4.57e-2)" "unprognostic (5.31e-2)" "unprognostic (1.63e-1)" "unprognostic (1.76e-1)" "unprognostic (1.77e-1)" "unprognostic (2.60e-1)" "unprognostic (6.41e-2)" "prognostic favorable (5.20e-4)" "unprognostic (2.29e-3)" "unprognostic (1.32e-3)" "unprognostic (8.41e-2)" "unprognostic (8.46e-2)" "unprognostic (3.81e-1)" "unprognostic (1.88e-1)" 15.8 11.1 4.9 18.2 6.6 17.3 21.4 18.0 9.5 13.5 14.9 2.9 14.6 9.7 11.0 11.7 11.6 10.9 16.1 18.7 3.8 5.8 11.1 10.1 23.5 6.5 3.8 5.7 17.8 28.0 34.4 26.9 81.9 3.7 8.7 7.2 18.2 17.7 25.2 22.5 13.3 14.8 8.8 4.2 12.1 13.2 10.4 2.1 59.0 14.9 12.0 17.4 10.2 16.9 3.5 2.5 4.5 6.0 1.9 3.2 1.1 4.5 8.2 5.5 13.8 3.5 3.2 43.6 6.2 4.3 3.5 1.3 7.0 6.3 2.7 7.5 7.0 3.1 4.3 8.7 2.3 1.8 5.0 7.3 19.8 7.7 8.6 4.6 9.1 11.3 6.1 5.7 3.7 1.8 3.6 0.9 16.1 48.4 0.5 1.1 30.7 32.6 8.0 9.6 5.0 2.4 21.5 1.8 6.9 3.2 1.7 35.9 24.9 12.2 22.9 1.1 5.2 49.9 22.8 1.5 7.2 9.0 1.9 1.6 7.5 4.5 15.9 4.1 5.8 6.3 4.0 1.6 4.5 3.2 2.9 3.1 3.5 1.2 2.0 2.5 3.4 0.6 2.4 1.3 1.9 6.0 0.0 0.0 1.1 4.9 6.6 18.0 9.5 3.8 5.8 3.8 5.7 3.7 2.1 62.5 65.7 11.5 7.5 12.5 61.9 31.4 33.1 24.1 29.6 36.6 137.4 45.4 1.7 14.3 3.8 19.0 19.6 46.7 10.5 65.7 18.6 12.3 41.7 26.7 11.0 33.4 57.4 15.4 8.9 4.7 43.7 13.5 10.1 3.6 60.0 5.2 16.5 17.3 57.7 4.4 61.6 6.5 7.1 1.8 17.8 26.2 152.4 17.0 22.4 10.5 GSK3B ENSG00000082701 "Glycogen synthase kinase 3 beta" P49841 3 119821323-120094417 "Enzymes, Predicted intracellular proteins" "Biological rhythms, Carbohydrate metabolism, Differentiation, Glycogen metabolism, Neurogenesis, Wnt signaling pathway" "Developmental protein, Kinase, Serine/threonine-protein kinase, Signal transduction inhibitor, Transferase" "Alzheimer disease, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 135.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016263, HPA028017" Approved Supported Nucleoplasm No No 81000 Nucleoplasm "CAB016263: AB_2279451, HPA028017: AB_10600708" "unprognostic (1.09e-2)" "unprognostic (2.62e-1)" "unprognostic (1.40e-1)" "unprognostic (2.17e-3)" "unprognostic (1.15e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (8.20e-5)" "unprognostic (3.39e-2)" "unprognostic (1.11e-1)" "unprognostic (1.67e-2)" "unprognostic (1.05e-3)" "unprognostic (6.79e-2)" "prognostic favorable (1.52e-4)" "unprognostic (2.39e-1)" "unprognostic (2.58e-1)" "unprognostic (1.28e-2)" "unprognostic (1.16e-1)" 17.6 17.6 17.4 13.8 21.3 25.0 13.7 32.7 28.3 15.8 16.0 15.6 7.1 15.5 14.5 12.6 20.3 12.4 14.4 20.8 17.1 22.4 15.7 21.7 17.1 17.5 17.0 22.6 14.0 14.9 25.0 19.2 24.1 18.1 13.9 17.9 14.9 18.5 11.7 23.9 21.6 18.2 17.1 13.4 26.3 13.3 30.8 14.4 46.5 17.4 8.4 14.1 14.2 15.7 1.7 2.0 10.6 3.1 1.4 3.0 1.0 28.7 13.9 23.3 13.5 15.5 15.8 22.6 16.2 31.2 15.6 14.3 15.0 11.8 11.7 10.0 23.1 18.1 19.7 11.0 31.5 24.3 7.9 3.1 17.0 10.4 11.2 17.7 17.5 22.9 15.9 21.2 16.6 34.0 12.7 17.1 15.5 7.2 22.8 20.4 15.6 18.5 4.9 12.7 11.0 14.4 7.4 19.9 11.2 11.3 20.6 17.6 10.9 19.1 13.9 18.7 23.8 17.2 11.8 21.9 22.4 25.3 7.0 9.6 15.1 13.9 22.6 13.9 11.7 17.8 4.3 2.9 7.5 2.4 2.6 2.1 1.1 2.0 3.0 2.0 1.7 2.0 1.5 10.6 1.4 3.1 1.6 1.3 1.0 17.4 21.3 32.7 28.3 17.1 22.4 17.0 22.6 18.1 14.4 29.8 26.1 16.6 27.4 45.2 58.2 34.8 17.8 13.4 17.0 17.4 56.9 22.4 10.0 21.7 114.4 21.8 32.1 0.0 28.0 43.2 22.6 25.0 17.3 20.3 19.0 135.1 25.8 23.9 27.9 40.1 12.0 22.7 33.7 24.4 23.3 27.6 35.4 22.6 18.7 11.5 40.3 12.9 20.0 34.2 22.5 35.9 35.9 24.1 20.4 35.8 GSS ENSG00000100983 "Glutathione synthetase" P48637 20 34928433-34956027 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Glutathione biosynthesis" Ligase "Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054508, HPA059315" Enhanced Supported Nucleoplasm NA NA 23000000 Nucleoplasm "HPA054508: AB_2682509, HPA059315: AB_2683976" "unprognostic (5.80e-2)" "unprognostic (1.50e-1)" "unprognostic (1.14e-1)" "unprognostic (7.21e-2)" "unprognostic (3.63e-2)" "unprognostic (5.68e-2)" "prognostic unfavorable (7.21e-5)" "unprognostic (2.90e-2)" "unprognostic (8.52e-2)" "unprognostic (3.64e-1)" "unprognostic (6.49e-2)" "unprognostic (1.50e-1)" "prognostic favorable (7.31e-6)" "unprognostic (3.35e-3)" "unprognostic (1.96e-1)" "unprognostic (1.42e-3)" "unprognostic (1.52e-1)" 12.9 29.8 14.7 13.2 21.0 16.0 16.2 9.2 27.6 12.7 26.9 17.2 28.9 20.0 11.5 47.5 25.6 18.5 18.3 14.6 15.0 15.9 30.5 30.9 12.1 11.7 15.1 15.1 11.6 10.3 17.5 15.6 27.2 15.3 18.6 27.6 15.4 19.1 19.4 10.7 19.1 21.4 12.9 13.3 13.3 15.7 16.8 9.2 17.0 18.0 12.0 21.0 14.4 13.9 7.3 24.3 7.9 21.3 15.2 18.3 14.9 18.2 22.2 10.9 15.3 12.7 13.2 15.5 15.6 14.4 24.6 20.4 40.7 22.3 12.9 20.8 16.0 23.8 17.4 15.9 39.7 20.8 6.0 9.0 51.0 14.1 40.4 17.9 12.8 18.0 13.9 42.5 23.1 39.1 11.0 17.4 17.6 24.6 10.6 29.8 20.1 20.4 18.2 6.4 24.1 28.7 18.8 21.9 30.7 35.2 18.7 21.4 12.5 27.5 25.8 20.5 6.2 31.7 11.7 13.7 28.3 16.1 18.6 13.4 10.8 10.0 14.2 24.1 14.1 16.8 7.9 20.3 4.6 18.0 21.3 16.1 7.3 14.5 18.3 24.3 5.2 16.9 14.3 5.3 15.2 19.0 13.5 17.5 14.9 14.7 21.0 9.2 27.6 15.0 15.9 15.1 15.1 15.3 9.2 17.9 8.0 10.4 28.7 23.4 20.6 14.0 30.6 8.1 12.5 24.4 9.8 69.5 21.6 40.0 44.5 14.6 44.5 0.0 41.7 42.0 15.3 18.9 17.3 23.3 52.3 33.4 22.5 5.5 16.2 108.3 9.5 20.4 15.1 40.5 44.4 26.6 32.4 28.8 17.3 95.3 15.4 25.8 12.2 16.4 14.7 21.1 41.0 20.3 70.9 22.9 GSTCD FLJ13273 ENSG00000138780 "Glutathione S-transferase C-terminal domain containing" Q8NEC7 4 105708778-105847728 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 93.7;Late spermatids: 41.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 11.4" "Lineage enriched" "Detected in all" 5 "granulocytes: 11.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046160, HPA061782" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA046160: AB_10961048, HPA061782: AB_2797265" "unprognostic (4.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.06e-3)" "unprognostic (4.44e-3)" "unprognostic (6.44e-2)" "unprognostic (6.43e-2)" "unprognostic (1.84e-3)" "unprognostic (4.30e-2)" "unprognostic (2.43e-1)" "unprognostic (1.53e-1)" "unprognostic (1.38e-2)" "unprognostic (5.46e-2)" "unprognostic (8.67e-2)" "unprognostic (8.59e-2)" "unprognostic (2.68e-1)" "unprognostic (1.32e-2)" "unprognostic (7.02e-2)" 6.5 6.1 7.6 7.2 10.1 9.3 11.2 11.0 9.7 8.2 7.3 8.4 5.7 5.2 9.3 10.0 10.0 8.8 7.7 5.6 7.4 7.8 10.3 5.7 6.3 9.4 7.5 6.5 7.2 6.3 7.6 13.1 7.2 10.0 8.2 8.3 14.4 7.4 7.6 5.6 6.9 5.9 8.4 10.5 6.9 6.6 20.5 6.4 15.1 10.7 5.4 9.8 7.1 7.1 2.0 1.9 11.4 1.9 1.9 2.2 0.9 7.7 7.0 16.1 14.0 4.1 5.5 12.1 10.9 5.6 13.6 12.4 6.5 14.9 9.3 5.7 4.6 7.9 6.4 18.3 11.5 19.2 13.8 5.5 7.8 6.8 8.8 1.9 14.3 5.4 2.9 5.8 12.4 9.6 5.1 8.3 9.5 14.9 8.5 11.4 6.3 14.9 5.3 8.8 11.4 8.9 10.3 9.5 5.3 14.8 5.7 13.1 5.8 8.5 12.1 4.7 14.8 10.9 5.8 6.2 10.1 10.6 6.2 8.5 3.2 6.7 5.2 6.3 7.4 13.8 0.9 1.4 0.6 1.3 1.7 1.5 1.5 1.2 0.4 1.4 2.0 1.4 2.2 11.4 1.9 1.9 1.9 0.2 0.9 7.6 10.1 11.0 9.7 7.4 7.8 7.5 6.5 10.0 6.4 6.0 3.8 1.5 3.4 2.3 19.6 2.2 10.2 1.4 1.2 8.7 25.5 4.9 3.3 4.6 93.7 3.6 2.9 0.0 4.3 6.8 3.5 4.0 2.3 5.3 6.3 20.6 4.1 3.1 4.7 41.2 7.8 3.0 5.0 4.6 3.5 7.2 5.2 0.0 4.2 3.7 22.0 0.0 4.2 7.2 4.7 3.8 2.7 2.5 4.4 1.7 GSTO1 "GSTTLp28, P28" ENSG00000148834 "Glutathione S-transferase omega 1" P78417 10 104235356-104267459 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Oxidoreductase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 137.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 123.8" "Low region specificity" "Detected in all" "HPA037603, HPA037604" Enhanced Approved Nucleoplasm,Cytosol NA NA 200000000 Cytosol Nucleoplasm "HPA037603: AB_2675574, HPA037604: AB_10672283" "prognostic favorable (6.95e-4)" "unprognostic (9.23e-2)" "unprognostic (1.43e-2)" "unprognostic (6.83e-2)" "unprognostic (7.16e-2)" "prognostic unfavorable (8.83e-4)" "unprognostic (1.38e-2)" "unprognostic (1.84e-1)" "unprognostic (9.23e-3)" "unprognostic (4.57e-2)" "unprognostic (7.65e-2)" "unprognostic (2.13e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.86e-2)" "unprognostic (1.29e-1)" "unprognostic (5.51e-3)" "unprognostic (5.82e-2)" 29.6 31.9 19.9 21.8 24.4 35.8 20.0 15.0 24.3 17.8 29.7 16.8 17.8 36.3 16.5 21.4 22.6 15.2 24.7 67.9 19.7 21.5 32.7 137.3 32.0 35.7 23.2 23.1 19.7 21.2 18.6 23.2 26.3 17.0 18.2 20.8 18.0 25.3 21.2 42.7 13.3 41.0 21.4 18.9 26.8 19.8 7.0 14.2 30.8 32.9 24.0 16.8 28.0 18.8 18.7 55.4 85.5 68.3 21.8 25.5 68.0 31.7 21.8 16.9 28.8 23.7 45.3 7.3 41.5 73.7 27.6 30.0 27.3 34.0 28.3 18.0 27.5 35.2 18.3 11.0 36.8 29.1 14.1 26.4 20.9 15.5 59.6 42.5 26.7 35.1 34.3 15.7 40.0 48.3 39.3 52.7 26.5 42.9 17.7 57.7 17.3 20.7 37.6 15.6 34.4 15.2 15.3 11.1 11.9 40.9 20.4 8.4 10.5 13.4 9.6 123.8 29.8 10.5 21.5 48.6 32.7 17.1 50.8 36.9 0.3 0.4 0.2 61.3 46.5 12.9 85.5 68.3 19.2 18.3 57.2 22.0 18.7 22.6 23.4 55.4 15.0 19.7 19.8 19.5 21.8 43.9 25.7 25.5 68.0 19.9 24.4 15.0 24.3 19.7 21.5 23.2 23.1 17.0 14.2 71.5 58.2 98.7 286.1 83.2 26.3 290.4 244.5 58.9 78.5 96.0 19.6 399.2 281.8 289.2 13.5 118.6 130.2 70.0 215.9 135.5 154.5 94.2 142.1 611.8 643.1 22.3 99.4 338.8 323.0 12.0 106.2 397.5 119.8 265.1 129.8 50.2 258.3 117.9 106.1 410.6 24.7 148.8 123.7 5.4 2.6 68.8 92.8 101.2 167.3 176.7 GSTT2B GSTT2P ENSG00000133433 "Glutathione S-transferase theta 2B (gene/pseudogene)" P0CG30 22 23957414-23961186 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "breast: 83.4" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 24.9;Erythroid cells: 23.3;Hepatocytes: 27.7;Muller glia cells: 19.5;Peritubular cells: 26.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 22.6;HHSteC: 33.3;SK-MEL-30: 23.0;T-47d: 25.5" HPA000750 Uncertain Supported Nucleoplasm,Cytosol No No Cytosol Nucleoplasm "HPA000750: AB_1849804" "prognostic favorable (5.06e-4)" "unprognostic (5.14e-2)" "unprognostic (1.90e-1)" "unprognostic (4.51e-2)" "unprognostic (7.13e-2)" "unprognostic (8.41e-3)" "unprognostic (2.58e-1)" "unprognostic (7.99e-2)" "unprognostic (1.15e-1)" "unprognostic (1.92e-1)" "unprognostic (1.76e-2)" "unprognostic (4.11e-1)" "unprognostic (1.18e-2)" "unprognostic (2.04e-1)" "unprognostic (1.07e-1)" "unprognostic (1.48e-2)" "unprognostic (2.19e-3)" 1.6 11.7 2.7 0.7 1.9 0.0 83.4 0.0 4.2 2.6 1.5 0.1 1.7 2.9 2.6 1.4 1.1 2.4 1.7 2.9 1.3 6.1 2.0 0.1 2.5 3.1 3.2 0.9 3.6 0.8 6.1 0.2 1.2 2.5 1.3 11.4 0.7 2.7 1.4 0.9 2.6 0.5 2.5 0.1 0.7 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.3 6.5 0.3 0.0 22.6 0.5 0.6 0.9 3.2 1.8 4.6 4.8 9.7 0.0 0.0 5.1 7.9 12.0 9.5 0.0 10.0 2.1 0.0 0.8 0.3 12.7 1.5 33.3 0.0 3.6 13.7 1.6 13.2 2.7 13.3 3.7 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.1 0.3 4.8 0.0 16.8 0.0 10.2 0.0 0.4 9.5 3.1 0.0 23.0 0.0 25.5 0.3 12.3 3.8 2.6 0.5 2.4 0.0 0.0 0.0 2.4 0.0 9.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.0 2.2 0.0 8.7 0.0 3.5 0.1 2.5 0.0 2.3 0.0 0.0 1.2 24.9 7.2 0.4 1.6 0.0 23.3 7.9 3.6 0.1 7.9 1.1 27.7 8.3 0.0 1.2 15.4 4.0 1.3 9.2 0.2 0.0 5.4 0.4 19.5 4.7 0.0 26.9 3.8 2.6 6.5 0.3 0.5 0.4 0.0 1.5 0.0 0.0 2.3 GSTZ1 "GSTZ1-1, MAAI, MAI" ENSG00000100577 "Glutathione S-transferase zeta 1" O43708 14 77320884-77331597 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Phenylalanine catabolism, Tyrosine catabolism" "Isomerase, Multifunctional enzyme, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 90.4" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 348.1;Late spermatids: 326.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 60.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004701 Approved Approved Nucleoplasm,Cytosol NA NA 62000 Cytosol Nucleoplasm "HPA004701: AB_1078990" "prognostic favorable (4.93e-4)" "unprognostic (1.08e-1)" "unprognostic (2.56e-1)" "unprognostic (2.16e-3)" "unprognostic (4.55e-1)" "unprognostic (3.03e-2)" "unprognostic (8.03e-3)" "unprognostic (1.98e-1)" "unprognostic (2.18e-1)" "prognostic favorable (3.73e-4)" "unprognostic (7.90e-2)" "unprognostic (1.73e-1)" "prognostic favorable (1.12e-7)" "unprognostic (1.00e-1)" "unprognostic (1.11e-1)" "unprognostic (4.12e-1)" "unprognostic (4.92e-2)" 4.6 12.9 5.6 5.9 6.8 2.8 8.5 2.1 9.0 5.0 8.1 10.8 7.5 8.1 4.1 9.5 9.0 5.5 8.0 5.5 5.4 5.0 8.9 90.4 4.4 10.7 6.9 6.9 2.8 7.1 9.3 5.1 11.0 5.8 8.0 8.0 9.5 22.5 4.7 14.8 7.4 7.2 3.8 7.9 5.0 5.9 18.2 5.2 8.6 8.3 14.3 8.9 4.9 4.5 8.2 15.3 7.2 16.0 3.4 5.6 5.0 6.5 12.5 9.9 7.0 6.3 8.7 16.8 4.1 4.2 7.7 10.9 4.2 16.5 14.6 5.9 4.8 4.8 8.4 6.7 7.9 7.4 7.7 6.7 7.1 4.8 8.9 9.9 2.6 5.9 8.1 8.6 4.4 7.5 4.3 6.6 8.7 5.9 13.5 5.1 60.8 4.0 5.5 2.9 22.6 10.0 7.0 10.4 11.3 11.7 8.0 10.9 9.9 9.1 18.2 12.9 5.8 29.7 3.9 4.5 6.0 20.4 6.8 3.0 10.1 10.8 12.8 15.6 4.0 7.5 6.6 11.1 7.2 1.9 16.0 1.9 6.4 3.4 2.8 15.3 8.2 2.9 2.4 1.1 3.4 13.5 10.4 5.6 5.0 5.6 6.8 2.1 9.0 5.4 5.0 6.9 6.9 5.8 5.2 6.0 8.1 12.7 18.0 11.8 6.8 12.0 50.9 10.7 5.7 8.7 3.9 76.5 39.7 34.9 105.1 8.7 47.2 23.3 59.7 57.9 10.6 19.8 3.5 348.1 39.6 15.9 27.6 9.8 28.3 326.5 10.9 14.4 16.9 35.1 36.9 20.9 39.0 38.6 5.6 58.4 11.2 0.0 10.3 33.5 24.7 12.3 63.7 7.7 45.9 17.7 GSX1 "Gsh-1, GSH1" ENSG00000169840 "GS homeobox 1" Q9H4S2 13 27792643-27794768 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "brain: 7.1" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 29 "glioma: 3.9" "Region enhanced" "Detected in many" "hypothalamus: 7.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "JURKAT: 3.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA047096 Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA047096: AB_2679929" "unprognostic (1.62e-1)" 0.1 0.1 1.6 0.1 3.2 0.1 0.1 0.9 4.0 0.1 0.1 2.5 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.7 7.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.9 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 3.2 0.9 1.5 0.7 7.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GTF2A1 TFIIA ENSG00000165417 "General transcription factor IIA subunit 1" P52655 14 81175452-81221377 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000869 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA000869: AB_1080253" "unprognostic (1.93e-1)" "unprognostic (1.31e-1)" "unprognostic (7.98e-3)" "unprognostic (1.40e-1)" "unprognostic (1.50e-2)" "unprognostic (1.20e-1)" "unprognostic (6.04e-3)" "unprognostic (1.65e-1)" "unprognostic (1.14e-1)" "unprognostic (1.85e-1)" "unprognostic (7.49e-2)" "unprognostic (2.76e-1)" "unprognostic (3.87e-2)" "unprognostic (4.04e-2)" "unprognostic (2.44e-1)" "unprognostic (2.11e-1)" "unprognostic (5.88e-2)" 16.9 14.9 18.2 15.7 23.3 8.7 17.1 32.6 23.4 15.7 12.9 17.7 12.7 12.2 16.0 20.1 17.9 12.5 13.1 12.7 17.0 17.8 15.3 18.4 11.6 18.9 16.2 17.0 17.6 14.7 21.0 20.6 24.5 19.9 14.8 14.7 14.0 14.5 13.1 20.3 14.7 12.4 16.2 18.5 17.2 13.4 23.9 16.7 36.3 30.4 11.3 18.5 15.9 15.0 1.3 3.2 9.3 3.9 1.5 2.3 0.8 10.7 10.7 22.6 15.1 12.9 10.9 8.2 12.9 13.4 12.0 10.8 15.9 10.9 17.5 10.6 10.8 8.8 8.1 15.5 9.8 21.3 14.8 4.6 16.0 12.4 9.5 12.7 11.2 16.5 10.0 7.6 16.4 21.5 12.5 12.1 14.4 9.7 24.2 15.3 17.9 28.4 6.6 12.2 8.2 10.4 15.3 19.8 10.8 8.0 22.0 21.4 12.6 30.6 12.5 13.7 11.4 18.7 9.5 15.2 12.2 9.3 16.8 13.5 19.5 20.8 18.2 9.7 13.0 19.2 9.3 1.2 2.1 2.3 0.9 2.0 1.3 2.1 1.3 0.7 1.2 1.9 2.1 2.0 1.5 3.9 3.2 1.1 0.8 18.2 23.3 32.6 23.4 17.0 17.8 16.2 17.0 19.9 16.7 17.9 12.8 11.5 8.0 16.0 22.8 23.4 2.5 6.7 14.8 22.7 33.4 12.6 1.7 9.6 55.2 18.0 15.4 0.0 11.2 10.7 13.2 14.4 30.0 23.7 14.5 38.1 17.9 17.8 25.7 4.9 11.8 19.2 10.1 28.9 16.5 23.4 10.4 14.1 12.7 12.6 15.2 25.8 15.6 25.1 26.2 21.3 21.7 16.0 10.9 8.0 GTF2A2 "HsT18745, TFIIA" ENSG00000140307 "General transcription factor IIA subunit 2" P52657 15 59638062-59657541 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 117.1" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 673.0;Late spermatids: 563.9;Spermatocytes: 832.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056239 Supported Nucleoplasm NA NA Nucleoplasm "HPA056239: AB_2683074" "unprognostic (2.18e-2)" "unprognostic (3.21e-1)" "unprognostic (9.37e-2)" "unprognostic (1.09e-2)" "unprognostic (1.16e-1)" "unprognostic (1.53e-2)" "unprognostic (3.06e-2)" "unprognostic (1.31e-2)" "unprognostic (7.35e-2)" "unprognostic (6.29e-2)" "unprognostic (3.47e-1)" "unprognostic (7.13e-2)" "unprognostic (1.58e-1)" "unprognostic (2.79e-1)" "unprognostic (2.74e-2)" "unprognostic (1.47e-1)" "unprognostic (8.90e-2)" 20.7 25.7 19.3 22.6 27.5 26.3 35.2 19.1 21.8 17.4 26.6 14.3 18.3 17.5 20.6 24.3 27.0 18.3 18.6 38.6 21.0 20.3 22.3 24.2 24.1 28.3 22.5 18.3 21.4 23.8 13.0 26.1 18.6 24.9 18.2 22.6 16.1 26.3 25.3 26.7 14.6 18.2 20.0 28.8 19.4 18.2 117.1 15.9 20.8 21.8 26.3 21.2 18.2 24.7 41.1 65.0 53.2 44.1 36.2 41.8 39.2 31.2 44.5 29.8 28.6 18.2 15.2 34.4 35.3 16.3 28.9 29.2 48.0 12.7 29.0 33.0 22.6 43.5 26.9 30.0 21.2 21.3 50.4 24.6 33.0 34.6 30.2 24.2 35.9 29.7 14.5 20.5 24.4 20.8 21.0 18.9 22.4 47.1 29.7 23.7 21.9 23.3 27.6 40.0 10.5 26.1 22.0 31.5 35.5 28.2 37.0 32.3 34.7 32.8 37.7 32.9 41.8 26.2 38.0 26.0 28.1 49.9 31.3 63.2 29.6 85.8 63.1 32.0 60.5 34.0 45.3 44.0 53.2 31.0 44.1 32.2 41.1 36.3 34.3 56.6 33.0 31.3 34.1 22.9 36.2 40.8 65.0 41.8 39.2 19.3 27.5 19.1 21.8 21.0 20.3 22.5 18.3 24.9 15.9 38.7 50.9 81.9 137.1 87.6 47.3 113.7 63.7 109.7 76.2 61.1 45.2 183.6 179.1 136.5 673.0 78.8 67.4 93.5 130.5 166.8 100.9 133.1 78.7 71.5 131.0 47.7 78.8 68.2 95.2 563.9 116.5 102.0 75.9 159.7 82.6 100.0 143.4 101.9 129.0 103.7 52.7 64.7 97.3 832.7 160.9 93.3 127.0 86.6 107.2 228.6 GTF2B TFIIB ENSG00000137947 "General transcription factor IIB" Q00403 1 88852932-88891944 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Acyltransferase, DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061626 Supported Supported "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA061626: AB_2684570" "prognostic favorable (4.81e-4)" "unprognostic (5.21e-2)" "unprognostic (3.94e-3)" "unprognostic (1.27e-1)" "unprognostic (1.66e-1)" "unprognostic (2.43e-1)" "unprognostic (1.08e-2)" "unprognostic (2.65e-2)" "unprognostic (4.37e-3)" "unprognostic (3.37e-1)" "unprognostic (1.37e-2)" "unprognostic (3.13e-1)" "unprognostic (1.42e-2)" "unprognostic (1.10e-2)" "unprognostic (1.40e-1)" "unprognostic (4.06e-3)" "unprognostic (3.74e-2)" 23.7 27.0 22.2 27.1 29.8 54.9 30.2 25.7 30.0 24.2 21.9 12.5 19.2 18.8 23.4 32.9 26.4 23.0 24.6 16.0 22.0 21.7 23.7 34.8 22.8 30.6 24.3 17.9 28.2 23.8 21.6 25.9 30.2 23.8 19.2 24.7 13.8 24.9 20.8 21.6 26.4 29.3 21.6 20.6 30.0 22.5 15.2 23.5 44.4 27.6 24.0 30.8 22.6 22.7 28.6 31.6 51.1 28.2 25.8 34.4 23.8 19.7 7.4 19.0 9.4 28.9 20.3 23.0 16.7 22.2 25.1 26.8 9.8 13.7 22.9 19.1 15.7 30.0 11.9 20.2 17.9 22.1 22.6 18.9 24.1 12.3 16.4 18.8 27.8 14.8 17.8 18.3 22.0 12.8 18.7 13.2 22.8 21.5 19.8 26.3 7.0 28.3 25.3 14.6 19.1 16.3 18.1 23.4 17.4 26.7 22.1 14.4 12.6 15.9 19.9 29.2 18.2 8.5 27.6 11.7 10.7 13.1 18.6 20.0 19.4 13.4 30.4 7.1 23.6 9.0 37.9 25.5 39.3 25.6 28.2 29.1 28.6 28.5 27.2 31.6 24.2 34.4 29.5 51.1 25.8 28.1 21.3 34.2 23.8 22.2 29.8 25.7 30.0 22.0 21.7 24.3 17.9 23.8 23.5 6.0 30.1 29.7 68.6 41.1 13.1 8.1 12.7 40.2 23.9 10.4 2.0 67.5 33.2 42.9 11.6 26.6 28.2 23.3 34.0 50.4 30.8 22.8 48.4 15.3 36.1 17.5 19.4 13.5 28.9 5.6 33.6 39.2 27.0 35.1 21.2 24.1 41.2 59.6 27.6 32.3 17.3 12.9 41.6 21.4 28.5 43.7 125.5 54.6 17.7 77.4 GTF2E1 "FE, TFIIE-A" ENSG00000153767 "General transcription factor IIE subunit 1" P29083 3 120742637-120783069 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 21.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009884, HPA056359, HPA066881" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB009884: AB_2279381, HPA056359: AB_2683106, HPA066881: AB_2685740" "unprognostic (3.19e-1)" "unprognostic (1.40e-1)" "unprognostic (2.05e-1)" "unprognostic (1.05e-2)" "unprognostic (8.94e-2)" "unprognostic (3.23e-1)" "unprognostic (4.36e-3)" "unprognostic (2.62e-1)" "unprognostic (2.64e-2)" "unprognostic (1.59e-1)" "unprognostic (4.38e-2)" "unprognostic (9.34e-3)" "unprognostic (5.10e-2)" "unprognostic (8.29e-3)" "unprognostic (4.94e-1)" "unprognostic (3.19e-2)" "unprognostic (2.97e-1)" 11.1 18.0 8.6 10.7 9.9 6.6 10.0 9.1 9.9 9.2 8.5 11.6 7.3 7.8 13.3 8.1 9.4 7.6 6.4 8.5 8.8 8.3 12.9 12.7 8.4 14.0 9.3 7.6 10.5 14.5 8.4 12.9 11.9 9.1 8.2 10.4 7.9 18.7 10.2 12.8 7.8 9.8 10.0 11.9 14.0 7.8 16.3 8.9 25.6 9.6 10.0 14.9 9.2 9.5 10.9 10.5 16.8 12.9 11.9 12.0 8.7 9.2 13.0 16.3 9.9 12.3 5.7 14.2 6.2 5.7 9.8 10.6 15.5 6.7 15.2 11.0 4.6 7.6 11.2 15.0 8.2 13.8 10.5 3.5 19.6 9.5 12.9 9.6 17.6 11.9 7.5 8.9 7.3 10.4 6.7 15.0 13.1 13.6 8.0 10.3 10.6 14.5 8.9 15.5 9.0 12.1 12.0 19.2 11.3 9.7 6.0 3.5 10.8 9.4 8.2 8.4 15.4 10.4 13.6 13.1 9.2 10.1 2.9 7.0 7.1 7.7 21.8 9.7 17.9 8.8 16.8 8.5 13.0 8.5 12.9 11.1 10.9 10.1 12.0 10.5 9.1 11.1 10.7 6.2 11.9 11.7 4.9 11.4 8.7 8.6 9.9 9.1 9.9 8.8 8.3 9.3 7.6 9.1 8.9 3.0 4.1 11.0 2.7 1.6 4.5 4.5 10.2 2.7 6.8 7.0 0.0 7.7 5.0 4.5 5.6 3.6 2.6 0.0 3.9 7.0 3.1 2.6 12.7 3.8 8.1 15.9 1.2 6.2 6.5 2.0 2.0 6.3 3.3 12.6 3.2 5.2 4.3 0.0 4.6 4.8 4.1 0.0 1.9 12.6 21.5 2.3 7.3 5.0 3.5 2.8 GTF2E2 "FE, TF2E2, TFIIE-B" ENSG00000197265 "General transcription factor IIE subunit 2" P29084 8 30578318-30658251 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004816, CAB009603, HPA025065" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB009603: AB_2114537, HPA004816: AB_2667252, HPA025065: AB_10601658" "unprognostic (4.84e-2)" "unprognostic (7.38e-3)" "unprognostic (6.20e-3)" "unprognostic (9.09e-2)" "unprognostic (6.30e-2)" "unprognostic (4.38e-1)" "unprognostic (6.05e-3)" "unprognostic (8.69e-2)" "unprognostic (2.29e-1)" "unprognostic (4.72e-2)" "unprognostic (1.57e-2)" "unprognostic (4.09e-2)" "prognostic unfavorable (5.82e-7)" "unprognostic (8.25e-2)" "unprognostic (1.72e-1)" "unprognostic (1.05e-3)" "unprognostic (1.24e-1)" 19.0 21.9 11.4 16.2 17.0 7.5 26.7 21.2 13.1 16.4 19.1 10.7 15.1 16.8 17.7 15.8 20.0 12.3 11.7 12.7 11.1 10.9 14.7 21.1 13.4 20.3 11.6 12.2 24.2 44.6 14.1 22.5 14.5 11.9 14.2 14.4 12.1 12.6 13.8 9.9 14.8 26.2 16.3 11.6 17.2 20.9 31.0 11.7 21.4 17.2 10.6 22.0 16.9 27.5 16.4 8.0 5.6 4.2 8.7 7.9 2.6 21.7 17.6 12.2 12.8 32.9 29.4 9.2 23.6 21.4 19.4 24.8 10.5 15.6 28.1 20.1 21.0 28.1 15.4 20.0 22.0 25.9 12.5 11.8 14.0 12.3 24.9 32.0 6.7 12.4 21.5 29.2 20.8 21.2 19.4 26.7 21.0 26.9 17.3 30.4 14.7 32.8 16.9 13.7 26.3 21.2 17.3 13.2 14.0 21.0 14.9 9.4 12.2 13.1 8.8 18.4 16.8 8.5 8.3 20.3 12.8 13.3 10.8 16.0 17.7 24.0 30.4 20.2 11.6 16.9 3.0 4.2 5.6 3.9 3.3 4.2 16.4 6.0 7.9 7.2 9.3 5.9 5.9 2.2 8.7 3.3 8.0 6.7 2.6 11.4 17.0 21.2 13.1 11.1 10.9 11.6 12.2 11.9 11.7 0.0 9.6 39.5 36.7 42.6 8.9 7.8 17.8 21.4 11.4 14.0 9.8 36.2 16.6 26.8 61.8 21.5 30.5 0.0 29.1 39.9 29.8 60.5 11.5 25.6 31.1 4.8 12.7 27.6 20.2 43.8 36.5 28.3 20.3 76.7 19.8 7.3 37.7 23.2 66.4 35.1 13.8 25.8 30.9 56.0 82.0 40.7 51.9 30.9 21.8 88.4 GTF2F1 "BTF4, RAP74, TF2F1, TFIIF" ENSG00000125651 "General transcription factor IIF subunit 1" P35269 19 6379569-6393981 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 199.3;Late spermatids: 301.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022793, HPA028707, HPA070752" Supported Enhanced "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA022793: AB_1857946, HPA028707: AB_2672745, HPA070752: AB_2732163" "unprognostic (1.30e-2)" "unprognostic (6.05e-3)" "unprognostic (2.00e-1)" "prognostic favorable (8.39e-4)" "unprognostic (3.18e-1)" "unprognostic (8.46e-2)" "unprognostic (1.05e-1)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (5.99e-2)" "unprognostic (6.45e-3)" "unprognostic (6.96e-2)" "prognostic favorable (9.80e-4)" "unprognostic (1.34e-2)" "unprognostic (7.02e-2)" "unprognostic (9.92e-2)" "unprognostic (4.25e-1)" 24.9 26.0 32.5 26.6 33.1 41.1 22.6 60.7 47.3 25.5 24.7 18.8 26.1 35.2 31.7 22.6 30.8 29.9 26.5 22.9 28.9 25.9 24.4 21.7 19.8 34.9 23.9 36.3 59.8 40.7 31.8 33.4 19.9 26.6 24.6 16.3 22.3 33.9 24.4 25.6 21.8 31.9 27.6 26.4 26.7 26.4 39.4 23.1 23.6 36.4 19.7 22.2 26.0 39.8 24.4 21.5 28.4 21.4 19.0 23.8 14.1 38.3 28.3 20.6 32.7 13.9 22.6 16.3 27.0 25.3 33.7 32.2 29.6 15.2 23.4 38.0 17.7 24.2 35.0 19.3 17.1 16.6 35.7 24.6 32.5 21.1 26.3 24.2 37.6 26.4 23.7 22.9 24.0 18.4 28.6 19.8 23.2 39.6 31.8 18.6 26.7 37.3 21.4 37.3 17.8 36.1 34.6 22.8 29.9 18.8 22.0 25.3 34.8 27.9 21.4 29.8 13.0 27.2 30.0 28.0 26.5 22.3 45.7 38.0 56.5 63.4 25.3 33.0 39.5 29.6 7.0 21.4 14.0 20.5 20.6 23.8 24.4 18.4 19.5 16.9 23.3 21.7 18.8 28.4 19.0 19.1 21.5 17.6 14.1 32.5 33.1 60.7 47.3 28.9 25.9 23.9 36.3 26.6 23.1 44.7 44.6 45.7 42.2 21.6 25.9 26.2 20.4 115.1 78.5 24.4 7.9 38.5 18.3 42.3 199.3 33.5 64.5 23.3 44.2 36.6 30.1 27.3 60.3 23.7 51.8 23.8 29.2 52.8 50.9 301.8 41.1 31.9 32.1 62.3 38.4 32.6 42.6 35.9 46.7 29.3 28.8 32.3 43.2 51.5 36.8 18.3 45.2 56.5 40.9 36.7 GTF2F2 "BTF4, RAP30, TFIIF" ENSG00000188342 "General transcription factor IIF subunit 2" P13984 13 45120515-45284909 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006912 Supported Supported Nucleoplasm,Microtubules NA NA Nucleoplasm Microtubules "HPA006912: AB_1080256" "unprognostic (3.39e-1)" "unprognostic (2.65e-2)" "unprognostic (3.27e-1)" "unprognostic (1.29e-1)" "unprognostic (4.51e-2)" "prognostic unfavorable (1.65e-5)" "unprognostic (3.67e-2)" "unprognostic (3.17e-1)" "unprognostic (3.36e-2)" "unprognostic (2.53e-3)" "unprognostic (2.31e-2)" "unprognostic (4.76e-2)" "unprognostic (1.25e-1)" "unprognostic (2.09e-1)" "unprognostic (6.53e-3)" "unprognostic (3.94e-2)" "unprognostic (6.44e-3)" 15.1 24.7 23.5 21.1 23.6 22.5 20.9 12.0 21.0 16.3 21.8 14.8 18.5 14.9 16.8 23.4 21.8 12.0 15.9 27.5 21.4 21.1 18.3 16.0 15.1 17.5 22.9 19.0 17.3 14.6 16.5 27.5 23.9 18.2 16.7 21.2 18.2 20.8 20.2 32.0 31.5 12.9 28.2 19.5 17.8 15.2 22.2 24.2 22.6 19.2 27.7 19.9 20.5 19.0 15.4 16.3 24.9 15.3 16.1 12.9 8.5 15.5 5.8 11.1 8.2 6.8 10.1 9.2 17.2 11.3 17.5 17.2 9.8 24.5 15.7 9.7 12.5 17.1 17.4 16.6 13.8 25.7 11.8 14.4 18.5 7.8 12.8 10.9 20.5 10.6 8.4 21.2 13.1 22.2 19.9 11.2 12.3 13.1 5.9 47.1 8.7 15.0 23.6 13.2 25.1 14.4 14.1 8.4 9.0 38.2 5.5 5.9 9.9 8.7 8.6 14.3 10.9 7.0 16.8 8.8 14.8 12.6 11.7 29.3 3.8 5.2 15.7 17.2 13.2 15.4 12.0 14.2 24.9 9.7 14.1 11.5 15.3 11.3 11.5 16.3 15.4 12.9 12.6 19.8 16.1 15.3 12.7 12.3 8.5 23.5 23.6 12.0 21.0 21.4 21.1 22.9 19.0 18.2 24.2 38.7 28.0 38.3 76.6 66.6 18.2 68.7 10.2 33.5 33.0 10.4 3.9 28.1 41.4 45.9 94.3 28.4 21.3 23.3 28.9 40.9 31.4 27.4 39.2 17.8 42.4 7.9 27.1 12.3 27.1 62.8 22.5 37.1 72.6 31.5 24.5 34.7 38.8 25.9 29.7 30.5 18.5 6.5 27.8 59.2 80.1 63.6 28.3 27.1 37.6 64.0 GTF2H1 "BTF2, P62, TFIIH" ENSG00000110768 "General transcription factor IIH subunit 1" P32780 11 18322295-18367044 "Cancer-related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004637, HPA046660" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004637: AB_425470, HPA046660: AB_2679743" "unprognostic (2.25e-1)" "unprognostic (2.33e-1)" "unprognostic (9.78e-2)" "unprognostic (2.38e-1)" "unprognostic (2.63e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (5.98e-9)" "unprognostic (7.71e-2)" "unprognostic (4.24e-2)" "unprognostic (2.81e-1)" "unprognostic (1.33e-1)" "unprognostic (2.26e-2)" "unprognostic (7.42e-3)" "unprognostic (8.31e-2)" "unprognostic (1.24e-1)" "unprognostic (7.90e-2)" "unprognostic (2.94e-1)" 27.1 26.4 24.1 18.2 28.8 10.5 33.0 32.6 35.7 21.5 21.6 19.3 24.1 18.0 23.5 23.1 26.2 18.6 22.9 21.4 24.1 20.4 25.9 25.0 19.1 23.7 19.6 22.2 27.2 24.3 27.1 32.4 24.3 27.4 22.5 20.9 21.2 25.8 26.0 20.8 32.4 21.7 20.6 21.1 23.4 20.5 38.5 23.3 22.7 29.3 21.7 25.7 22.9 22.2 12.0 11.8 20.3 12.1 15.9 13.9 8.8 12.3 11.4 9.6 13.7 22.1 17.6 12.1 18.5 20.0 16.5 19.0 11.9 4.9 20.7 7.4 19.0 23.8 17.2 15.8 17.0 21.4 9.1 15.6 13.4 11.7 12.0 31.5 25.7 14.6 19.8 20.4 10.2 32.4 13.6 14.5 11.0 20.5 11.0 23.7 11.5 12.9 20.5 8.4 20.8 16.5 13.3 20.5 9.6 13.6 17.0 11.0 11.9 15.3 14.8 22.8 8.7 7.7 15.1 10.7 22.3 10.8 39.8 15.0 5.6 13.3 15.2 19.2 20.2 21.1 20.3 10.9 11.3 9.1 11.0 9.8 11.7 11.5 10.1 11.8 12.0 13.9 11.1 7.9 15.9 12.1 6.5 11.0 8.8 24.1 28.8 32.6 35.7 24.1 20.4 19.6 22.2 27.4 23.3 14.9 12.8 15.4 18.2 42.8 16.7 22.8 22.9 28.1 22.7 10.4 19.6 21.2 6.6 19.7 33.7 20.4 13.9 0.0 26.5 23.5 19.3 19.1 17.4 11.4 21.7 20.6 7.5 21.5 18.0 32.8 15.8 23.4 21.9 24.4 11.2 20.1 23.7 8.6 15.2 18.8 19.3 6.5 26.4 48.3 30.1 45.2 23.6 15.3 15.5 21.4 GTF2H3 "BTF2, P34, TFIIH" ENSG00000111358 "General transcription factor IIH subunit 3" Q13889 12 123633739-123662606 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004844, HPA053562" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA004844: AB_2667265, HPA053562: AB_2682191" "unprognostic (1.07e-1)" "unprognostic (1.36e-1)" "unprognostic (6.02e-2)" "unprognostic (6.13e-3)" "unprognostic (2.29e-1)" "unprognostic (7.34e-2)" "prognostic unfavorable (6.72e-8)" "unprognostic (1.02e-1)" "unprognostic (1.22e-3)" "unprognostic (3.30e-1)" "unprognostic (1.37e-1)" "unprognostic (1.10e-1)" "unprognostic (5.68e-3)" "unprognostic (4.71e-2)" "unprognostic (1.22e-1)" "unprognostic (7.49e-2)" "unprognostic (2.80e-2)" 15.8 15.8 17.4 15.2 22.0 12.2 19.7 23.2 23.8 16.1 17.2 21.4 9.3 13.0 18.4 18.1 22.5 19.4 12.3 13.5 16.9 17.3 15.8 25.3 12.1 18.8 16.7 19.8 16.9 10.8 16.1 24.0 16.1 24.6 17.1 21.1 14.8 15.6 15.4 16.1 16.1 13.7 18.2 17.9 17.3 14.6 17.9 16.1 23.6 17.2 23.1 19.4 15.7 15.2 7.4 8.6 10.5 8.6 12.8 11.7 5.2 18.7 10.0 12.9 16.5 16.0 17.9 18.3 14.3 17.7 22.1 15.0 10.5 9.7 21.9 17.6 19.6 8.9 12.8 21.3 25.9 26.6 18.5 15.0 17.9 9.3 15.1 22.5 36.0 11.9 19.0 19.8 17.9 40.7 16.7 15.8 27.4 26.7 7.3 19.9 12.2 17.9 12.2 16.6 13.3 18.5 18.5 19.7 12.3 11.4 18.3 11.6 10.3 18.9 9.2 14.3 14.8 25.8 21.8 10.4 13.9 10.6 21.5 22.9 13.5 18.3 21.6 16.0 18.4 15.9 10.5 5.6 7.2 9.9 8.6 10.0 7.4 8.1 10.4 8.6 7.3 11.7 10.5 0.8 12.8 7.8 7.3 8.1 5.2 17.4 22.0 23.2 23.8 16.9 17.3 16.7 19.8 24.6 16.1 20.8 22.4 7.5 9.7 10.4 16.0 5.6 12.7 24.1 26.1 12.2 9.8 22.3 3.3 8.5 5.3 7.0 6.5 0.0 9.5 18.5 12.9 9.2 24.2 14.7 16.0 15.9 6.4 9.8 7.9 1.9 10.9 9.5 1.7 16.2 10.5 21.6 8.9 12.4 10.6 12.5 13.5 12.9 7.9 18.7 24.9 11.5 19.8 6.9 15.1 10.0 GTF2I "BAP-135, BTKAP1, DIWS, IB291, SPIN, TFII-I, WBSCR6" ENSG00000263001 "General transcription factor IIi" P78347 7 74657667-74760692 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004595, HPA026638" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004595: AB_628345, HPA026638: AB_1857959" "unprognostic (3.47e-1)" "unprognostic (2.26e-2)" "unprognostic (3.63e-1)" "unprognostic (1.61e-1)" "unprognostic (3.21e-1)" "unprognostic (1.11e-1)" "unprognostic (7.08e-2)" "unprognostic (2.53e-2)" "unprognostic (1.15e-2)" "unprognostic (1.63e-1)" "unprognostic (8.80e-3)" "unprognostic (1.28e-1)" "prognostic favorable (6.35e-6)" "unprognostic (7.70e-2)" "unprognostic (1.60e-1)" "unprognostic (1.19e-1)" "unprognostic (5.88e-2)" 10.2 14.3 12.6 10.2 14.3 4.0 11.5 13.1 15.2 11.3 8.6 15.4 6.0 9.1 10.5 9.6 9.9 12.5 10.8 8.6 12.8 13.5 10.2 10.2 8.8 18.1 9.7 12.1 8.5 29.0 12.4 9.8 12.9 12.1 6.9 12.1 11.7 10.3 13.4 10.9 7.9 11.1 8.8 7.5 12.0 4.3 16.0 21.2 22.3 6.3 11.6 10.3 7.1 16.8 14.8 10.9 6.9 14.2 13.2 5.8 29.6 24.5 50.8 49.8 28.1 25.0 10.6 18.8 17.3 20.8 20.7 17.0 36.2 35.8 7.6 23.0 27.7 26.1 49.7 22.6 26.9 26.9 26.3 18.2 29.1 23.6 16.9 34.5 27.3 23.1 19.5 15.7 16.2 30.5 27.8 12.1 35.5 17.1 25.0 27.6 28.7 30.9 54.4 63.3 15.3 31.6 17.6 29.3 27.3 51.7 42.6 54.4 34.2 51.5 17.2 44.6 26.3 22.9 24.8 28.6 15.4 14.3 23.9 20.2 17.8 56.9 16.3 20.9 28.5 5.1 6.9 10.9 8.3 5.1 13.2 14.6 11.3 12.9 10.5 16.8 13.1 12.9 2.8 14.2 4.2 14.8 5.7 5.8 74.5 52.9 73.0 73.2 53.3 262.6 25.7 193.6 52.2 54.6 113.4 267.0 84.7 48.0 123.3 33.9 79.4 49.7 0.0 72.6 51.4 66.4 111.8 12.7 84.7 68.3 236.8 108.4 117.2 104.4 29.3 141.5 49.6 52.3 67.7 67.6 192.8 108.5 76.4 181.4 83.8 173.7 84.1 49.5 22.3 38.3 80.4 60.4 45.7 63.2 92.7 GTF2IRD1 "BEN, Cream1, GTF3, MusTRD1, RBAP2, WBSCR11, WBSCR12" ENSG00000006704 "GTF2I repeat domain containing 1" Q9UHL9 7 74453790-74602604 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 62.8" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 29.7;Cone photoreceptor cells: 31.4;Rod photoreceptor cells: 38.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044254 Approved Supported Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA044254: AB_10964747" "unprognostic (8.92e-2)" "unprognostic (6.94e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (9.71e-5)" "unprognostic (2.24e-1)" "unprognostic (3.35e-2)" "unprognostic (2.71e-3)" "unprognostic (3.77e-2)" "unprognostic (1.84e-2)" "unprognostic (6.26e-2)" "unprognostic (4.89e-3)" "unprognostic (3.31e-1)" "unprognostic (2.53e-1)" "unprognostic (8.61e-2)" "unprognostic (1.08e-1)" "unprognostic (3.06e-2)" "unprognostic (2.25e-3)" 4.6 7.6 4.3 5.1 6.8 0.6 6.3 4.4 7.8 9.4 8.2 8.2 9.2 7.0 7.4 8.7 16.4 7.0 8.6 7.7 3.9 5.5 9.3 3.6 7.2 2.6 8.5 5.3 8.6 10.0 21.1 25.3 5.3 6.6 8.2 5.5 21.6 11.3 8.3 62.8 15.6 5.2 12.1 5.6 1.6 8.8 4.5 5.7 1.3 16.4 12.9 7.3 10.5 13.2 0.6 1.8 2.7 0.5 0.6 0.7 0.1 9.3 5.9 12.9 14.1 10.4 5.1 0.1 4.0 10.6 7.8 8.2 10.2 13.4 2.4 3.0 8.0 19.2 5.4 10.2 4.7 5.8 0.1 6.1 0.4 19.9 11.4 33.4 0.1 0.3 7.1 19.2 5.4 22.6 18.3 4.0 4.7 6.8 0.0 8.7 11.8 1.2 8.2 10.3 11.3 6.1 12.6 7.5 8.7 14.8 6.5 10.6 14.5 9.8 17.8 8.7 6.8 10.6 9.3 2.2 8.1 8.3 5.2 9.0 0.5 1.4 3.9 3.3 0.1 6.5 1.2 0.5 0.5 0.3 0.2 0.3 0.4 0.7 0.2 1.8 0.6 0.3 0.4 2.7 0.6 0.1 0.6 0.2 0.1 4.3 6.8 4.4 7.8 3.9 5.5 8.5 5.3 6.6 5.7 8.9 8.0 0.0 9.4 7.0 29.7 7.2 7.6 10.7 4.5 8.7 31.4 0.9 10.0 6.4 0.5 2.7 3.3 0.0 8.1 1.4 4.6 16.3 2.3 2.6 2.2 20.6 4.1 1.8 2.4 0.0 3.7 4.0 6.8 1.0 4.0 5.6 8.5 2.9 5.3 12.4 38.9 0.0 4.6 0.0 5.1 5.8 2.4 0.0 6.8 14.2 GTF2IRD2 "FLJ37938, GTF2IRD2A" ENSG00000196275 "GTF2I repeat domain containing 2" Q86UP8 7 74796144-74851551 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 35.0" "HPA056679, HPA056680" Approved Nucleoplasm NA NA Nucleoplasm "HPA056679: AB_2683205, HPA056680: AB_2683206" "unprognostic (7.91e-5)" "unprognostic (3.90e-3)" "unprognostic (1.43e-2)" "unprognostic (5.35e-2)" "unprognostic (2.02e-1)" "unprognostic (1.85e-2)" "unprognostic (5.47e-2)" "unprognostic (6.80e-3)" "unprognostic (1.22e-1)" "unprognostic (6.11e-2)" "unprognostic (4.43e-5)" "unprognostic (3.18e-2)" "unprognostic (8.97e-3)" "unprognostic (2.58e-1)" "unprognostic (6.35e-2)" "unprognostic (1.19e-1)" "unprognostic (1.59e-4)" 3.9 4.3 3.1 2.1 2.0 4.0 5.6 2.1 2.1 6.0 5.6 3.2 5.6 3.1 3.1 6.0 2.5 4.6 2.8 2.7 4.6 6.4 4.3 2.8 2.8 9.3 6.6 4.3 5.6 1.9 6.5 3.8 4.9 4.3 21.6 3.2 3.8 4.5 2.7 3.4 5.3 2.6 6.0 2.9 4.5 4.2 14.9 12.4 10.4 6.8 5.0 9.8 6.6 9.7 3.4 4.4 6.6 6.4 4.2 4.0 3.3 3.4 4.0 4.4 0.7 8.1 2.6 0.9 5.4 6.7 2.0 0.1 2.1 3.3 1.2 0.8 2.5 5.0 4.6 6.0 3.4 0.4 3.9 3.2 1.1 3.1 4.8 3.9 1.9 6.0 5.3 3.6 9.0 1.3 9.7 7.3 10.4 2.3 2.5 1.5 9.1 9.2 8.5 3.3 10.3 13.6 35.0 7.5 3.9 7.4 6.5 3.7 5.9 1.5 1.0 5.3 4.1 1.7 2.6 5.1 2.4 12.6 10.4 6.8 7.2 3.4 3.9 5.0 14.9 7.6 9.8 7.0 10.0 9.2 5.9 1.1 5.0 3.3 12.4 6.5 6.6 17.9 20.6 19.7 9.7 2.9 23.8 10.1 22.9 25.4 21.6 12.2 53.0 5.5 3.3 17.6 17.8 5.8 12.5 0.0 24.7 5.1 9.3 11.3 13.9 8.1 3.9 35.0 25.9 16.5 5.1 3.8 40.6 6.9 10.1 8.2 20.3 16.6 22.6 21.0 24.4 4.2 42.7 12.9 8.6 2.7 2.0 3.8 5.4 12.9 24.0 6.8 GTF2IRD2B ENSG00000174428 "GTF2I repeat domain containing 2B" Q6EKJ0 7 75092573-75149817 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 12.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA056679, HPA056680" Approved Nucleoplasm NA NA Nucleoplasm "HPA056679: AB_2683205, HPA056680: AB_2683206" "prognostic favorable (3.27e-4)" "unprognostic (1.32e-2)" "unprognostic (1.07e-1)" "unprognostic (2.70e-1)" "unprognostic (1.25e-1)" "unprognostic (1.53e-2)" "unprognostic (2.19e-2)" "unprognostic (6.28e-2)" "unprognostic (1.32e-1)" "unprognostic (2.86e-1)" "unprognostic (8.90e-4)" "unprognostic (1.54e-2)" "unprognostic (7.21e-3)" "unprognostic (2.31e-1)" "unprognostic (3.61e-1)" "unprognostic (3.18e-3)" "unprognostic (2.65e-5)" 7.3 6.7 6.3 9.2 13.4 7.5 9.9 5.9 9.4 11.2 11.0 11.4 4.6 2.7 13.4 4.4 5.4 12.7 9.2 12.3 7.9 4.5 8.7 9.5 8.2 7.3 11.0 6.7 21.7 10.4 10.5 7.5 4.2 10.8 12.9 5.7 9.8 7.2 8.4 18.8 4.7 5.6 11.3 5.8 4.4 8.7 3.5 14.1 6.3 7.8 4.0 7.1 13.0 6.7 12.8 1.5 5.1 1.9 1.6 3.3 0.5 12.1 5.6 8.7 9.8 7.0 9.8 6.6 6.7 10.1 3.2 8.2 2.5 9.8 8.1 6.6 6.9 12.3 4.4 4.1 4.3 3.9 9.8 3.8 6.0 7.2 5.1 13.6 8.8 8.6 9.0 9.0 2.6 11.6 11.2 4.6 3.0 7.6 17.1 10.4 8.7 6.2 20.5 8.7 11.1 8.2 12.0 2.8 11.3 9.0 9.3 8.5 14.9 13.4 14.8 14.3 2.5 14.4 8.9 7.2 8.1 5.4 7.6 8.5 6.7 4.0 20.7 4.2 9.0 17.8 0.5 1.3 5.1 1.2 1.9 2.0 12.8 2.1 2.6 1.2 5.7 3.3 1.3 1.7 1.6 1.1 1.5 2.7 0.5 6.3 13.4 5.9 9.4 7.9 4.5 11.0 6.7 10.8 14.1 0.0 9.6 11.3 4.4 3.9 8.5 20.6 12.7 9.4 2.3 7.0 11.8 1.7 0.0 10.5 11.1 6.6 8.1 0.0 11.3 1.6 8.2 4.5 3.5 11.1 2.2 12.7 18.5 8.0 8.9 3.6 25.3 3.5 20.3 4.6 13.8 4.8 12.0 14.0 15.9 2.9 12.7 12.9 10.3 2.3 1.3 3.8 2.5 5.7 13.8 3.4 GTF3A "AP2, TFIIIA" ENSG00000122034 "General transcription factor IIIA" Q92664 13 27424544-27435823 "Predicted intracellular proteins, Transcription factors" "Ribosome biogenesis, Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007990 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA007990: AB_1857960" "unprognostic (9.88e-3)" "unprognostic (3.40e-1)" "unprognostic (2.16e-1)" "unprognostic (1.36e-1)" "unprognostic (2.87e-1)" "unprognostic (1.45e-1)" "unprognostic (1.57e-2)" "unprognostic (8.64e-2)" "unprognostic (7.53e-2)" "unprognostic (1.21e-1)" "unprognostic (1.39e-1)" "unprognostic (3.41e-1)" "prognostic unfavorable (3.43e-6)" "unprognostic (1.98e-1)" "unprognostic (1.33e-1)" "unprognostic (3.26e-1)" "unprognostic (1.41e-1)" 28.1 19.5 33.8 23.4 32.4 36.9 39.1 20.4 29.4 16.7 21.0 13.6 17.5 14.0 14.5 27.1 20.4 16.6 21.5 88.6 30.6 19.3 23.6 59.9 19.2 42.5 26.0 12.6 13.0 53.5 8.3 15.6 13.5 16.2 16.5 20.2 14.6 35.2 19.0 60.2 14.0 17.4 19.1 22.5 36.8 20.9 11.5 18.0 50.6 15.9 39.7 42.1 21.6 16.9 58.8 57.7 29.0 33.7 45.2 72.2 82.3 17.9 14.4 14.3 28.4 20.2 22.6 18.1 19.0 18.6 25.4 16.5 21.0 28.7 52.9 13.3 23.5 15.7 12.6 28.5 27.6 35.7 55.5 16.0 43.9 14.4 23.2 23.3 81.6 30.3 18.0 29.2 23.4 30.8 19.3 22.6 53.8 34.0 19.1 29.4 30.7 64.9 89.2 24.0 61.7 36.8 30.3 33.3 50.1 28.5 7.2 32.2 16.7 13.1 19.9 27.9 18.5 15.1 42.9 12.8 13.2 13.6 9.9 19.8 12.0 21.3 60.8 14.0 52.6 23.9 18.9 33.4 29.0 53.0 33.7 72.2 58.8 54.7 57.5 42.8 48.0 42.4 48.0 7.3 45.2 30.9 57.7 66.5 82.3 33.8 32.4 20.4 29.4 30.6 19.3 26.0 12.6 16.2 18.0 41.7 33.6 153.3 47.9 56.1 40.6 185.2 79.0 29.4 37.5 26.2 27.5 70.6 127.6 132.7 27.3 76.8 14.6 23.3 165.6 158.6 74.3 71.7 74.9 132.8 192.6 33.4 33.5 33.2 126.7 60.5 59.0 122.2 92.8 166.9 56.5 34.4 144.7 24.6 54.8 167.8 27.4 84.1 74.1 27.7 142.9 56.2 35.2 149.5 64.4 57.8 GTF3C1 TFIIIC220 ENSG00000077235 "General transcription factor IIIC subunit 1" Q12789 16 27459555-27549913 "Predicted intracellular proteins, Predicted membrane proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 88.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "gdT-cell: 20.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051617, HPA075900" Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA051617: AB_2681553, HPA075900: " "unprognostic (6.46e-2)" "unprognostic (6.86e-3)" "unprognostic (2.16e-1)" "unprognostic (5.59e-2)" "unprognostic (6.65e-2)" "unprognostic (2.90e-2)" "prognostic unfavorable (8.73e-4)" "unprognostic (8.23e-2)" "unprognostic (9.25e-3)" "unprognostic (5.32e-2)" "prognostic favorable (9.56e-4)" "unprognostic (2.10e-1)" "prognostic favorable (1.25e-4)" "unprognostic (2.06e-1)" "unprognostic (5.67e-2)" "unprognostic (5.56e-3)" "unprognostic (8.23e-3)" 13.6 18.4 19.4 12.1 25.9 17.3 10.6 25.3 31.2 17.3 12.8 21.0 18.8 11.0 19.0 12.0 39.3 19.9 16.5 23.7 15.8 16.2 16.9 13.2 14.1 13.5 14.3 19.1 20.7 24.0 33.8 33.2 13.5 15.8 35.4 12.4 22.3 15.3 16.9 29.5 41.5 11.7 19.3 12.8 14.2 15.7 24.4 17.1 25.2 35.8 18.8 21.0 12.3 20.7 1.9 4.2 2.1 2.1 7.8 20.6 3.6 12.9 28.5 21.0 24.5 18.9 15.3 11.9 14.1 15.9 19.6 16.8 21.3 12.2 14.2 20.8 17.2 15.0 14.5 26.6 17.9 16.2 6.4 25.5 11.8 24.1 30.4 10.6 13.4 15.7 18.7 13.7 24.0 10.7 13.2 19.4 16.5 14.5 11.7 15.4 31.8 14.9 16.2 28.2 7.0 13.6 27.9 26.0 14.6 12.3 13.6 26.6 17.8 14.2 12.1 8.7 17.6 21.7 10.2 20.5 19.8 12.0 12.4 14.4 12.5 11.3 14.5 8.2 15.0 14.5 1.0 2.1 2.1 20.6 1.9 15.2 1.9 2.4 10.3 2.7 1.6 2.5 6.7 1.6 7.8 2.0 4.2 2.5 3.6 19.4 25.9 25.3 31.2 15.8 16.2 14.3 19.1 15.8 17.1 17.9 22.9 5.6 6.3 16.4 42.3 23.4 10.2 25.4 15.9 12.2 88.4 6.4 5.0 10.2 2.0 12.8 10.9 0.0 9.9 3.8 13.3 16.1 18.5 12.5 9.2 25.4 28.8 15.4 12.3 4.0 17.8 6.4 3.3 8.2 15.9 13.3 13.1 8.6 14.9 7.9 30.3 12.9 7.2 19.1 14.9 18.1 3.5 27.7 11.1 6.2 GTF3C2 "KIAA0011, TFIIIC110" ENSG00000115207 "General transcription factor IIIC subunit 2" Q8WUA4 2 27325849-27357034 "Predicted intracellular proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 56.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008274, HPA035836" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA008274: , HPA035836: AB_10601813" "unprognostic (1.76e-1)" "unprognostic (9.64e-2)" "unprognostic (9.89e-2)" "prognostic unfavorable (8.25e-5)" "unprognostic (1.33e-1)" "unprognostic (4.88e-2)" "prognostic unfavorable (1.21e-8)" "unprognostic (1.57e-1)" "unprognostic (1.77e-2)" "unprognostic (1.47e-1)" "unprognostic (2.59e-2)" "unprognostic (7.39e-2)" "unprognostic (1.86e-2)" "unprognostic (1.01e-1)" "unprognostic (1.94e-1)" "unprognostic (7.97e-2)" "unprognostic (3.00e-1)" 16.5 23.7 15.4 21.9 19.8 17.0 18.1 22.5 22.5 19.4 22.1 25.0 25.3 18.7 19.8 25.1 30.6 21.3 21.7 19.0 13.3 11.9 21.7 17.9 20.5 20.5 15.5 12.5 19.5 27.4 30.8 19.0 22.8 19.4 18.6 24.1 26.3 26.5 19.2 28.8 27.9 24.5 20.2 12.4 25.2 20.9 24.8 15.2 28.3 25.3 21.6 30.1 20.0 18.4 12.7 14.9 23.2 17.1 12.0 15.6 17.4 29.7 26.8 22.6 21.7 13.4 13.1 33.1 10.9 14.9 14.4 12.3 19.9 19.1 26.2 19.7 15.1 14.9 18.0 33.2 20.9 13.9 20.6 28.9 22.0 18.1 26.2 12.3 23.9 22.0 16.4 18.9 16.4 21.2 13.8 18.4 17.9 30.6 19.7 13.9 24.5 22.1 17.5 42.5 24.2 17.0 27.4 25.0 29.3 20.4 22.5 21.0 37.1 11.7 28.3 19.9 20.2 15.1 13.7 14.2 17.6 19.3 13.3 20.3 21.9 23.9 58.8 17.6 19.4 19.2 23.2 16.0 13.3 14.4 14.8 15.6 12.7 12.8 15.3 14.9 12.7 13.2 12.4 8.6 12.0 17.1 9.5 8.2 17.4 15.4 19.8 22.5 22.5 13.3 11.9 15.5 12.5 19.4 15.2 17.9 16.6 6.0 8.4 8.8 10.7 9.8 12.7 9.4 13.6 5.2 21.6 16.1 8.3 13.6 56.2 5.8 12.4 23.3 19.6 19.5 8.6 8.8 17.4 9.3 14.2 9.5 3.4 11.1 14.6 49.8 8.6 9.8 5.0 11.8 20.6 8.8 16.8 3.5 7.4 10.2 16.7 6.5 8.2 7.9 18.8 11.0 16.7 10.2 17.1 11.6 GTF3C3 "TFIIIC102, TFiiiC2-102" ENSG00000119041 "General transcription factor IIIC subunit 3" Q9Y5Q9 2 196763032-196799725 "Predicted intracellular proteins, Predicted membrane proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069179 Supported "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA069179: AB_2686099" "unprognostic (1.44e-1)" "unprognostic (2.63e-2)" "unprognostic (1.89e-1)" "unprognostic (4.52e-2)" "unprognostic (5.88e-2)" "unprognostic (3.64e-2)" "prognostic unfavorable (1.26e-6)" "unprognostic (1.92e-1)" "unprognostic (9.28e-2)" "unprognostic (1.39e-1)" "unprognostic (2.09e-1)" "unprognostic (5.62e-2)" "unprognostic (3.36e-2)" "unprognostic (2.79e-1)" "unprognostic (2.72e-1)" "unprognostic (1.70e-1)" "unprognostic (3.08e-2)" 19.3 20.3 14.9 14.3 20.0 34.6 23.4 17.3 21.2 17.3 15.3 16.3 14.1 13.1 19.7 18.7 18.1 17.5 21.5 16.1 12.6 11.7 16.2 16.6 15.1 20.0 20.9 16.4 20.3 23.5 21.5 30.8 20.4 23.4 17.2 18.3 11.8 17.7 15.0 22.6 23.9 20.1 18.3 22.3 19.4 18.0 17.5 20.3 29.8 18.6 19.1 18.7 19.5 25.4 14.3 11.8 16.3 15.0 12.6 14.3 7.4 11.0 11.9 21.4 16.2 10.4 14.3 23.7 18.4 12.4 18.4 17.5 26.1 17.4 22.8 14.4 11.7 22.8 16.1 21.4 17.9 23.7 25.8 20.3 28.7 33.3 23.8 17.9 24.8 21.9 19.9 18.7 15.4 21.0 19.6 17.4 22.8 32.5 33.3 10.0 20.3 24.5 20.3 13.9 13.1 22.0 19.9 17.7 15.6 13.8 26.5 15.8 16.9 14.3 11.8 15.3 33.4 11.1 18.9 15.1 15.8 13.1 12.6 16.4 20.3 24.7 16.8 17.7 18.4 14.5 16.3 11.0 10.8 11.2 10.5 13.4 12.6 11.5 12.2 11.8 14.3 14.3 12.9 7.1 12.6 15.0 10.4 12.4 7.4 14.9 20.0 17.3 21.2 12.6 11.7 20.9 16.4 23.4 20.3 20.8 13.6 6.8 10.9 3.5 18.1 30.2 2.5 41.5 21.6 14.0 17.7 12.7 11.6 11.2 3.0 12.8 8.4 0.0 10.8 10.4 8.9 7.4 13.9 6.8 11.6 0.0 12.0 14.1 10.5 3.8 12.4 10.3 6.8 23.4 9.0 12.6 13.5 7.0 10.3 8.1 14.9 6.5 7.8 43.3 19.0 4.8 13.2 10.2 10.3 6.8 GTF3C4 "KAT12, TFIIIC90" ENSG00000125484 "General transcription factor IIIC subunit 4" Q9UKN8 9 132670035-132694955 "Enzymes, Predicted intracellular proteins" Transcription "Acyltransferase, DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069369 Supported Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA069369: AB_2686130" "unprognostic (7.02e-2)" "unprognostic (9.01e-2)" "unprognostic (1.31e-1)" "unprognostic (4.10e-2)" "unprognostic (8.20e-2)" "unprognostic (2.78e-1)" "unprognostic (3.71e-3)" "unprognostic (1.69e-2)" "unprognostic (1.58e-1)" "unprognostic (1.76e-1)" "unprognostic (4.77e-1)" "unprognostic (1.92e-2)" "prognostic favorable (2.99e-4)" "unprognostic (1.65e-1)" "unprognostic (1.23e-1)" "unprognostic (2.35e-1)" "unprognostic (1.54e-2)" 6.9 8.5 12.3 6.6 11.6 7.8 11.6 23.8 13.9 10.8 8.0 7.0 5.6 5.3 10.2 9.3 11.4 9.5 7.4 7.8 8.7 8.1 8.7 7.4 8.9 10.9 9.4 11.6 15.0 8.4 16.6 10.1 9.7 8.9 8.9 7.7 7.6 11.3 8.4 11.6 14.5 6.6 8.6 5.6 6.3 8.1 16.9 6.4 11.6 13.3 5.3 9.3 8.8 7.9 2.3 2.1 1.5 1.5 2.1 3.1 0.9 8.5 12.2 15.5 13.3 7.7 9.1 11.2 8.2 10.9 11.7 8.6 14.9 6.4 13.3 5.6 10.7 10.9 19.8 23.7 13.5 13.0 8.0 9.8 11.2 17.6 6.3 7.6 16.5 7.1 7.0 10.3 12.0 15.7 7.1 10.0 8.9 18.2 6.8 8.4 14.0 10.1 7.7 19.7 13.0 11.9 10.0 18.9 11.7 8.6 7.2 21.6 14.6 14.8 15.0 9.1 10.1 20.9 6.8 10.4 19.4 10.9 8.8 12.3 2.8 6.4 14.8 8.2 10.4 11.9 0.1 1.5 1.2 2.5 1.3 2.0 2.3 2.2 3.1 1.2 2.2 2.3 2.4 1.5 2.1 1.2 2.1 2.0 0.9 12.3 11.6 23.8 13.9 8.7 8.1 9.4 11.6 8.9 6.4 17.9 8.6 7.8 6.7 27.2 15.0 11.2 2.5 18.7 6.8 3.5 13.7 6.2 6.6 7.2 4.8 9.0 3.5 0.0 5.4 6.0 11.5 9.1 1.1 7.8 5.4 19.1 12.6 7.4 7.3 2.1 17.5 4.6 3.3 2.8 7.4 11.3 5.8 7.0 18.0 5.6 16.9 0.0 7.6 15.1 12.6 35.0 5.4 6.1 8.0 4.6 GTF3C5 "TFiiiC2-63, TFIIIC63, TFIIICepsilon" ENSG00000148308 "General transcription factor IIIC subunit 5" Q9Y5Q8 9 133030675-133058503 "Predicted intracellular proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067063, HPA069805" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA067063: AB_2685773, HPA069805: AB_2686201" "unprognostic (1.07e-2)" "unprognostic (1.78e-3)" "unprognostic (5.58e-2)" "unprognostic (2.35e-1)" "unprognostic (1.62e-1)" "unprognostic (1.27e-1)" "unprognostic (7.97e-3)" "unprognostic (4.01e-2)" "unprognostic (1.54e-1)" "unprognostic (1.22e-1)" "unprognostic (1.10e-2)" "unprognostic (1.58e-2)" "unprognostic (1.45e-3)" "unprognostic (4.55e-3)" "unprognostic (1.13e-2)" "unprognostic (1.33e-1)" "unprognostic (8.73e-2)" 21.2 24.6 20.1 18.2 30.4 33.3 21.8 38.7 30.6 21.9 25.0 39.6 20.6 24.7 23.1 21.9 28.0 25.7 16.2 24.5 20.8 17.3 20.9 25.1 18.8 23.1 31.9 19.9 41.3 24.6 24.4 26.0 24.9 22.7 24.0 18.5 21.3 26.4 20.1 36.7 31.2 23.6 20.6 23.0 23.9 20.4 24.2 30.8 43.5 22.1 29.3 29.2 19.5 22.5 11.2 12.0 28.4 13.2 13.8 17.0 11.5 11.7 22.0 19.2 17.9 10.5 9.1 25.6 11.5 13.0 22.2 15.7 23.1 19.6 19.8 10.9 12.7 17.9 28.8 22.9 20.8 12.6 20.1 19.0 22.6 25.2 21.3 16.1 18.4 48.7 12.8 13.9 23.3 16.2 10.9 19.5 65.7 29.2 19.5 11.5 39.3 29.4 25.6 24.9 27.4 22.1 31.2 19.2 25.0 14.6 13.8 23.0 17.0 19.0 21.1 12.1 12.2 27.0 26.3 11.9 26.7 20.7 16.4 19.0 7.5 15.2 21.5 13.3 13.6 18.0 28.4 11.0 14.9 11.8 13.2 17.0 11.2 12.2 15.3 12.0 10.8 14.0 12.4 6.6 13.8 10.7 11.6 13.4 11.5 20.1 30.4 38.7 30.6 20.8 17.3 31.9 19.9 22.7 30.8 8.9 14.7 20.4 14.8 11.0 14.4 27.1 7.6 10.7 13.6 15.7 7.9 34.8 24.9 20.8 3.0 14.3 26.2 23.3 26.2 32.0 16.6 10.9 16.1 15.3 19.8 14.3 13.8 20.9 15.5 3.6 16.1 10.8 15.1 16.2 14.6 20.6 22.9 23.0 20.1 10.2 17.1 45.3 15.6 17.2 28.4 14.4 34.8 19.1 21.2 15.3 GTF3C6 "bA397G5.3, C6orf51, TFIIIC35" ENSG00000155115 "General transcription factor IIIC subunit 6" Q969F1 6 110958560-110967890 "Predicted intracellular proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 95.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056179, HPA061345" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA056179: AB_2683058, HPA061345: AB_2684485" "unprognostic (6.98e-2)" "unprognostic (1.38e-1)" "unprognostic (2.66e-1)" "unprognostic (3.04e-1)" "unprognostic (6.99e-2)" "unprognostic (2.34e-1)" "prognostic unfavorable (7.27e-6)" "unprognostic (2.08e-2)" "unprognostic (9.79e-3)" "unprognostic (2.89e-1)" "unprognostic (5.42e-2)" "unprognostic (7.75e-2)" "unprognostic (1.42e-3)" "unprognostic (9.31e-2)" "unprognostic (1.69e-1)" "unprognostic (2.39e-2)" "unprognostic (1.14e-2)" 17.0 21.6 26.4 14.3 25.3 12.8 14.6 10.9 17.4 15.8 22.1 14.2 12.7 17.4 12.3 12.9 17.3 16.4 23.0 32.1 21.2 20.1 31.1 23.5 10.9 15.6 24.8 17.8 15.6 14.7 21.6 15.5 11.0 18.1 32.7 18.4 12.1 14.7 16.1 95.8 10.4 17.5 15.7 21.4 19.7 18.1 20.3 20.3 17.9 13.2 30.7 18.7 17.2 13.1 36.2 38.8 19.0 37.6 23.4 63.5 33.3 14.8 27.8 19.6 20.6 9.7 19.2 26.8 25.1 18.3 24.1 19.6 40.2 11.1 21.0 24.0 22.3 4.6 6.3 21.9 21.4 18.1 31.6 36.9 39.5 25.8 51.8 19.6 56.0 32.2 19.3 17.3 18.4 17.6 13.1 26.6 26.6 47.4 11.4 34.9 28.7 27.6 58.1 27.1 14.8 22.4 27.6 15.0 17.6 31.3 32.6 17.4 24.7 18.1 2.4 18.6 13.8 9.1 30.1 28.3 6.0 18.2 44.1 37.9 10.0 20.4 35.9 6.3 33.7 30.0 19.0 26.9 14.9 25.1 37.6 27.9 36.2 31.6 30.9 35.6 26.3 24.8 29.2 4.3 23.4 29.9 38.8 63.5 33.3 26.4 25.3 10.9 17.4 21.2 20.1 24.8 17.8 18.1 20.3 65.5 40.1 59.5 60.5 27.0 36.8 263.0 203.8 61.6 42.1 99.5 15.7 80.1 258.6 151.4 140.9 51.7 98.6 23.3 256.8 207.8 47.9 134.2 52.1 79.5 242.8 25.4 105.5 52.8 67.6 203.2 60.1 78.3 52.3 200.2 92.0 74.5 175.0 112.2 64.3 317.0 26.5 64.7 52.8 104.2 113.1 26.0 75.6 66.1 106.5 98.7 GTPBP6 "FLJ20977, PGPL" ENSG00000178605 "GTP binding protein 6 (putative)" X 304529-318819 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013336, CAB034924, HPA035467, HPA055418" Approved Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB034924: AB_2115410, HPA013336: , HPA035467: AB_10671104, HPA055418: " "unprognostic (5.00e-2)" "unprognostic (5.10e-2)" "unprognostic (1.60e-1)" "unprognostic (1.10e-2)" "unprognostic (4.90e-2)" "unprognostic (2.30e-3)" "prognostic unfavorable (8.87e-4)" "unprognostic (1.17e-1)" "unprognostic (2.95e-1)" "unprognostic (6.10e-2)" "prognostic favorable (1.71e-4)" "unprognostic (3.38e-2)" "unprognostic (4.45e-2)" "unprognostic (4.99e-3)" "unprognostic (2.23e-1)" "unprognostic (2.35e-1)" "unprognostic (5.05e-2)" 6.3 4.9 22.2 5.6 40.5 8.1 33.6 30.5 29.9 18.9 5.2 0.6 0.6 7.0 17.0 0.6 4.7 6.3 3.1 19.7 22.7 5.9 21.1 4.0 4.1 6.0 39.5 15.0 18.2 11.9 2.1 16.6 16.6 26.4 4.1 1.6 0.6 11.2 4.7 22.8 5.7 7.6 1.9 25.5 6.4 7.5 2.4 34.2 0.6 4.1 0.6 1.9 3.7 25.4 7.3 11.1 8.1 6.3 5.3 9.2 3.8 15.2 25.3 5.6 11.7 6.5 7.1 20.9 9.5 7.1 12.1 11.1 38.7 12.8 19.2 13.6 5.3 16.4 9.5 5.9 9.2 2.0 15.9 17.2 15.8 12.4 26.4 17.6 10.6 15.5 8.8 12.3 8.0 5.9 4.5 9.7 12.8 11.6 9.0 4.9 30.2 18.8 14.0 13.7 3.1 18.1 8.4 9.9 30.6 7.0 17.9 15.8 13.5 10.4 11.8 17.5 3.2 10.6 9.3 12.8 17.7 12.3 26.1 14.6 12.3 11.0 29.6 9.2 14.0 8.1 8.1 6.3 6.7 7.8 6.3 7.6 7.3 6.9 8.7 6.1 6.0 8.5 7.7 0.9 5.3 5.8 11.1 9.2 3.8 22.2 40.5 30.5 29.9 22.7 5.9 39.5 15.0 26.4 34.2 17.9 16.3 23.9 39.0 25.0 27.0 16.8 28.1 5.3 10.3 26.2 25.5 20.5 44.7 10.7 0.9 23.7 23.1 0.0 12.8 38.8 22.6 37.4 11.5 32.1 26.3 12.7 17.1 14.1 12.6 1.4 18.1 23.2 25.3 11.8 23.0 15.2 11.3 8.6 17.7 74.7 25.1 6.5 31.3 5.1 12.1 23.2 24.6 27.7 32.2 44.8 GTSF1 "FAM112B, FLJ32942" ENSG00000170627 "Gametocyte specific factor 1" Q8WW33 12 54455950-54473602 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 20.3;testis: 62.3" "Cell type enhanced" "Detected in many" 24 "Early spermatids: 927.5;Late spermatids: 1408.5;Spermatocytes: 345.5" "Cancer enriched" "Detected in many" 5 "testis cancer: 23.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HL-60: 47.4;HMC-1: 35.4;K-562: 46.4;NB-4: 71.8;THP-1: 66.2;U-266/84: 53.1;U-937: 35.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA038876, HPA038877" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA038876: AB_10670911, HPA038877: AB_2676251" "unprognostic (1.17e-1)" "unprognostic (2.15e-2)" "unprognostic (2.12e-2)" "unprognostic (1.59e-1)" "unprognostic (1.11e-2)" "unprognostic (6.74e-3)" "unprognostic (2.56e-2)" "unprognostic (3.94e-2)" "unprognostic (9.93e-2)" "unprognostic (1.16e-1)" "unprognostic (1.45e-1)" "unprognostic (7.59e-2)" "unprognostic (3.97e-5)" "unprognostic (4.16e-3)" "unprognostic (1.92e-1)" "unprognostic (2.77e-1)" "unprognostic (9.18e-2)" 0.3 0.2 0.3 1.5 0.4 1.8 0.5 0.1 0.2 0.1 0.2 0.2 0.0 0.3 0.1 0.5 0.3 0.2 0.3 0.3 0.4 0.2 0.3 0.4 0.7 1.7 0.3 0.0 0.2 0.2 0.0 0.2 9.9 0.2 0.2 0.6 0.1 0.2 0.0 0.4 0.2 0.6 0.0 0.3 3.3 0.2 62.3 0.0 3.0 0.2 0.0 3.5 0.5 0.2 19.7 19.7 13.5 6.1 17.6 20.3 9.7 0.1 0.0 0.0 0.0 0.0 0.0 24.9 0.0 0.0 0.0 0.0 0.0 0.0 18.7 8.9 0.0 0.0 0.0 25.3 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 47.4 35.4 0.0 0.0 0.0 0.0 0.0 0.0 14.2 46.4 19.2 0.0 0.0 0.0 71.8 0.0 0.0 0.0 0.0 0.0 25.9 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.4 0.0 66.2 0.2 0.0 1.7 0.0 0.1 19.3 53.1 0.1 0.0 35.4 0.0 13.5 5.9 10.5 14.4 5.6 17.9 19.7 17.0 20.3 9.7 16.5 15.8 16.6 2.7 17.6 6.1 19.7 17.6 9.7 0.3 0.4 0.1 0.2 0.4 0.2 0.3 0.0 0.2 0.0 0.0 1.1 3.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 46.1 0.0 0.0 927.5 0.0 0.0 0.0 0.0 96.3 0.2 0.0 1.1 0.0 10.8 0.0 0.0 0.0 2.4 1408.5 14.7 3.3 3.3 15.4 0.0 0.0 0.0 0.0 9.6 0.0 0.0 12.9 0.3 345.5 99.5 0.3 22.5 7.5 0.0 0.0 GUCD1 "C22orf13, LLN4, MGC1842" ENSG00000138867 "Guanylyl cyclase domain containing 1" Q96NT3 22 24540423-24555935 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 73.3" "Cell type enhanced" "Detected in all" 4 "Enterocytes: 117.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022786 Approved Nucleoplasm NA NA Nucleoplasm "HPA022786: AB_1845711" "unprognostic (1.58e-1)" "prognostic favorable (6.84e-4)" "unprognostic (2.83e-3)" "unprognostic (1.24e-2)" "unprognostic (1.22e-1)" "unprognostic (6.51e-2)" "unprognostic (1.61e-1)" "unprognostic (3.96e-2)" "unprognostic (1.89e-1)" "prognostic favorable (7.26e-4)" "unprognostic (1.28e-1)" "unprognostic (3.55e-2)" "unprognostic (1.76e-2)" "unprognostic (4.36e-2)" "unprognostic (8.63e-2)" "unprognostic (1.59e-1)" "unprognostic (3.01e-2)" 16.7 12.8 7.6 13.6 7.2 25.8 19.0 5.1 7.5 9.0 37.4 8.7 9.7 23.3 7.8 9.8 14.3 7.4 19.7 35.7 7.0 5.6 29.3 73.3 12.2 11.9 8.0 5.3 10.2 30.0 7.0 6.7 11.3 6.8 11.7 12.8 9.0 8.7 8.7 28.9 8.8 59.9 13.5 8.0 14.9 15.8 9.1 5.7 13.4 10.6 14.5 13.8 14.3 8.0 23.3 6.5 23.7 7.0 3.3 4.4 5.5 13.9 13.1 11.7 14.3 24.6 23.1 9.3 13.9 22.4 24.4 23.9 19.9 10.9 26.5 9.1 18.9 15.1 18.6 13.4 16.2 13.1 25.4 16.2 11.3 13.0 18.1 19.9 29.3 22.4 23.3 13.0 24.3 11.2 15.0 25.7 13.3 11.3 26.6 18.3 16.5 16.9 12.6 11.0 35.2 11.3 19.5 19.0 26.0 19.1 15.5 12.2 12.0 16.7 22.8 11.9 9.5 18.0 20.9 17.1 52.6 21.7 16.3 11.7 25.9 17.7 18.6 21.6 16.5 17.7 7.8 7.0 23.7 3.8 7.0 4.4 18.6 3.6 3.9 6.5 23.3 3.5 3.9 7.4 3.3 6.6 4.7 3.4 5.5 7.6 7.2 5.1 7.5 7.0 5.6 8.0 5.3 6.8 5.7 14.9 23.9 38.4 10.3 11.0 4.9 45.6 94.3 2.7 10.3 5.2 5.9 15.8 44.7 22.0 10.3 15.4 117.4 46.7 56.9 16.4 16.6 31.1 15.0 103.6 23.7 3.2 19.0 20.9 20.4 5.8 17.5 13.3 16.9 33.3 46.5 13.7 39.7 66.2 15.2 65.8 12.4 25.8 17.9 20.5 32.8 9.7 13.6 9.5 37.7 15.7 GUCY1A1 "GC-SA3, GUC1A3, GUCY1A3" ENSG00000164116 "Guanylate cyclase 1 soluble subunit alpha 1" Q02108 4 155666711-155732349 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "cGMP biosynthesis" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 55.2" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 2: 41.4;Club cells: 12.5;Collecting duct cells: 10.4;Distal tubular cells: 16.6;Ductal cells: 15.1;Proximal tubular cells: 10.2" "Cancer enhanced" "Detected in all" "prostate cancer: 24.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 7.6;non-classical monocyte: 9.2;plasmacytoid DC: 11.6" "Group enriched" "Detected in many" 27 "dendritic cells: 11.6;monocytes: 9.2;NK-cells: 7.6" "Cell line enhanced" "Detected in some" "HAP1: 6.1;HEK 293: 5.0;Karpas-707: 8.7;MOLT-4: 15.9;RPTEC TERT1: 10.9;RT4: 12.7;SH-SY5Y: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010887, HPA056004, HPA058617" Uncertain Supported Nucleoplasm NA NA 6100 Nucleoplasm "CAB010887: AB_259901, HPA056004: AB_2683007, HPA058617: AB_2732624" "unprognostic (4.81e-3)" "unprognostic (2.60e-1)" "unprognostic (3.03e-1)" "unprognostic (2.15e-1)" "unprognostic (1.99e-2)" "unprognostic (7.77e-3)" "unprognostic (1.07e-1)" "prognostic favorable (2.38e-4)" "unprognostic (1.85e-3)" "unprognostic (6.46e-2)" "unprognostic (3.42e-2)" "unprognostic (7.16e-2)" "prognostic unfavorable (7.59e-4)" "unprognostic (1.60e-2)" "prognostic unfavorable (3.59e-4)" "unprognostic (2.27e-1)" "unprognostic (6.55e-3)" 10.9 5.3 12.4 10.2 19.9 0.9 11.1 3.4 11.6 13.7 31.2 7.3 2.8 5.6 14.7 6.0 7.0 6.8 8.3 21.0 9.0 7.2 11.6 5.1 13.2 7.3 4.7 12.5 5.4 8.5 55.2 5.8 16.3 6.3 17.2 6.9 39.7 7.0 9.8 4.5 3.6 10.1 18.8 6.6 8.5 12.9 2.1 8.5 4.5 8.1 7.3 5.9 6.4 10.6 0.1 11.6 0.3 9.2 7.6 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 6.1 0.0 0.0 0.0 5.0 1.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.0 3.3 0.0 8.7 0.0 0.0 15.9 0.0 0.0 0.0 0.2 3.5 0.0 2.6 10.9 12.7 2.2 8.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.3 0.0 2.3 0.1 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 7.6 9.2 11.6 0.0 1.0 12.4 19.9 3.4 11.6 9.0 7.2 4.7 12.5 6.3 8.5 8.9 41.4 0.0 0.0 0.0 0.0 0.0 0.0 4.0 12.5 10.4 0.0 0.4 16.6 15.1 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 3.5 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 GUF1 FLJ13220 ENSG00000151806 "GUF1 homolog, GTPase" Q8N442 4 44678427-44700926 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" Hydrolase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003934, HPA024222" Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA003934: AB_1079034, HPA024222: AB_2671488" "unprognostic (1.32e-2)" "unprognostic (1.55e-1)" "unprognostic (1.66e-2)" "unprognostic (3.65e-3)" "unprognostic (7.56e-2)" "unprognostic (1.37e-1)" "unprognostic (5.59e-2)" "unprognostic (2.60e-1)" "unprognostic (1.37e-2)" "unprognostic (3.03e-2)" "unprognostic (1.56e-3)" "unprognostic (7.38e-3)" "prognostic favorable (2.66e-6)" "unprognostic (4.98e-3)" "unprognostic (1.74e-1)" "prognostic unfavorable (1.65e-5)" "unprognostic (5.40e-2)" 10.0 11.3 12.7 7.5 16.6 11.4 10.8 9.7 17.7 7.6 11.5 9.4 8.7 9.4 10.2 9.1 13.2 8.9 7.9 12.3 12.6 9.9 15.1 16.0 6.6 10.8 10.4 11.6 10.6 9.3 11.5 11.3 7.8 13.0 10.6 12.4 7.4 10.4 8.0 31.1 11.5 12.5 7.6 11.8 9.7 15.4 11.7 11.1 13.9 11.2 13.1 9.3 11.7 9.2 4.8 4.7 4.6 6.1 5.2 7.0 3.9 7.7 3.9 7.4 9.4 3.1 6.4 16.3 10.6 5.6 11.1 8.6 7.0 5.6 16.9 8.5 5.2 10.1 6.2 12.7 12.3 12.7 5.7 8.1 20.2 3.4 4.8 10.0 21.9 8.7 6.4 5.6 8.2 7.2 5.2 7.9 10.1 20.3 3.3 8.9 3.8 12.2 4.6 4.8 5.6 9.3 8.8 15.3 7.1 3.3 3.0 10.2 7.6 6.8 2.9 7.5 6.0 4.5 6.4 7.9 7.6 8.8 10.1 12.7 12.2 11.1 12.4 8.3 13.1 6.4 1.1 4.6 4.6 4.7 6.1 6.1 4.8 4.7 4.2 4.3 4.4 4.5 4.6 0.1 5.2 4.0 4.7 7.0 3.9 12.7 16.6 9.7 17.7 12.6 9.9 10.4 11.6 13.0 11.1 6.0 7.4 12.1 7.4 3.5 9.7 19.3 2.5 22.7 10.3 7.0 2.0 11.2 11.6 7.9 1.4 6.8 9.1 23.3 8.8 14.4 7.3 8.4 1.1 13.4 10.4 11.1 10.9 10.4 11.7 1.5 5.2 6.6 6.8 6.4 12.4 8.6 11.9 5.8 6.7 8.4 10.2 0.0 8.2 9.2 9.6 6.1 11.2 8.9 11.9 9.1 GUK1 ENSG00000143774 "Guanylate kinase 1" Q16774 1 228139962-228148984 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028118, HPA048587, HPA068324" Approved Uncertain Nucleoplasm,Cytosol NA NA 240000 Nucleoplasm Cytosol "HPA028118: AB_2756308, HPA048587: AB_2680453, HPA068324: " "unprognostic (9.15e-2)" "unprognostic (2.63e-2)" "unprognostic (3.60e-3)" "unprognostic (7.91e-2)" "unprognostic (8.54e-3)" "unprognostic (1.24e-1)" "unprognostic (3.55e-3)" "unprognostic (2.05e-1)" "unprognostic (3.47e-1)" "unprognostic (7.32e-2)" "unprognostic (3.38e-2)" "unprognostic (5.28e-2)" "prognostic unfavorable (8.85e-5)" "unprognostic (2.91e-1)" "unprognostic (5.41e-1)" "unprognostic (2.39e-2)" "unprognostic (6.12e-2)" 44.6 38.2 106.4 32.5 76.0 76.7 43.0 25.2 74.4 31.5 33.3 30.1 27.3 41.5 26.3 34.1 77.0 28.0 42.5 61.6 93.1 43.9 31.9 43.5 34.6 39.0 60.0 52.9 24.7 62.2 12.8 26.0 29.2 40.1 25.5 12.1 37.4 66.5 29.4 35.8 59.6 42.1 34.8 49.6 36.1 44.3 22.2 34.9 27.5 31.6 29.3 24.1 45.9 44.5 43.9 97.7 110.1 62.9 55.8 83.7 84.5 57.5 20.3 9.0 27.7 27.1 32.6 45.0 38.4 19.7 22.4 17.6 11.6 40.1 21.7 45.6 25.0 18.8 38.3 7.7 42.1 2.4 33.0 59.7 12.9 50.1 25.2 49.3 14.6 22.7 45.2 25.7 15.6 12.6 16.1 30.2 47.0 34.7 34.7 18.3 48.0 65.8 31.5 28.1 28.2 88.0 25.2 16.9 57.6 21.1 27.1 29.6 53.1 24.7 42.4 49.6 2.4 31.3 31.5 52.7 40.9 27.0 59.9 63.1 32.0 34.6 24.0 51.5 23.8 41.2 55.5 57.1 110.1 77.3 59.8 75.2 43.9 64.8 83.7 48.9 36.6 48.7 61.1 74.9 55.8 62.9 97.7 64.6 84.5 106.4 76.0 25.2 74.4 93.1 43.9 60.0 52.9 40.1 34.9 56.6 78.2 181.8 216.6 586.3 182.4 113.0 193.6 93.7 91.0 225.1 675.4 207.7 588.6 495.6 100.8 397.7 599.7 607.3 597.7 329.8 327.6 443.3 180.0 320.2 368.6 103.3 258.9 305.7 236.3 483.4 216.3 309.1 492.6 406.6 288.0 169.2 724.2 491.0 229.1 543.7 445.9 245.8 394.4 82.0 73.0 629.1 219.5 279.1 243.7 436.5 GVQW3 ENSG00000179240 "GVQW motif containing 3" Q3ZCU0 11 76381313-76414619 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 2: 3.8;Ciliated cells: 4.0;Club cells: 4.5;Distal tubular cells: 8.3;granulocytes: 3.5;Proximal tubular cells: 5.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057405 Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Centrosome" NA NA "Nucleoplasm, Centrosome" "Endoplasmic reticulum" "HPA057405: AB_2683429" "unprognostic (8.90e-2)" "unprognostic (1.16e-1)" "unprognostic (8.27e-2)" "unprognostic (1.92e-1)" "unprognostic (9.04e-3)" "unprognostic (8.56e-2)" "unprognostic (8.87e-2)" "unprognostic (2.91e-2)" "unprognostic (7.28e-3)" "unprognostic (2.21e-1)" "unprognostic (1.04e-2)" "unprognostic (1.49e-1)" "unprognostic (4.05e-4)" "unprognostic (7.45e-2)" "unprognostic (1.09e-1)" "unprognostic (9.28e-2)" "unprognostic (2.13e-1)" 3.3 5.8 7.0 4.7 11.8 3.5 5.8 13.9 14.3 5.0 3.2 5.0 2.2 4.5 6.7 4.0 1.8 7.1 2.5 3.2 6.2 5.2 5.1 2.5 2.9 6.0 4.0 7.2 8.4 16.0 3.2 15.9 3.0 8.7 3.5 4.9 7.6 9.1 3.3 2.9 4.5 3.6 3.5 4.2 5.0 4.2 9.6 4.6 5.5 5.5 0.4 5.7 2.8 4.0 3.1 1.7 5.1 1.2 3.8 4.1 1.2 1.7 2.2 9.4 5.0 2.3 4.7 2.5 1.2 1.0 2.2 2.1 6.5 3.9 7.4 3.3 1.2 3.6 5.3 5.1 1.3 3.0 5.1 3.0 3.8 8.4 2.1 1.2 3.4 2.0 1.1 1.5 3.4 1.3 2.1 1.4 9.6 2.4 4.4 0.7 2.1 4.7 5.6 1.5 2.3 3.3 6.9 5.5 4.6 0.7 1.8 12.2 4.3 2.9 1.3 0.8 3.7 3.8 1.0 0.8 3.9 3.8 6.1 1.4 4.8 2.3 6.8 1.2 3.0 2.2 3.5 1.2 1.2 3.7 0.7 2.5 3.1 3.8 1.7 1.7 3.1 4.1 4.1 5.1 3.8 0.8 1.2 3.3 1.2 7.0 11.8 13.9 14.3 6.2 5.2 4.0 7.2 8.7 4.6 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 4.0 4.5 1.8 0.0 0.9 8.3 1.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 3.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.8 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 GXYLT2 GLT8D4 ENSG00000172986 "Glucoside xylosyltransferase 2" A0PJZ3 3 72888073-72998138 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 37.7;Fibroblasts: 14.2;Late spermatids: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 14.6;JURKAT: 14.1;MOLT-4: 22.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA068429 Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Midbody ring" Yes No Nucleoplasm "Cytokinetic bridge, Midbody ring" "HPA068429: AB_2685988" "unprognostic (9.43e-2)" "unprognostic (8.87e-3)" "unprognostic (1.90e-1)" "unprognostic (4.77e-2)" "unprognostic (3.33e-2)" "unprognostic (7.04e-2)" "unprognostic (4.79e-3)" "unprognostic (5.29e-2)" "unprognostic (5.25e-2)" "unprognostic (5.10e-2)" "unprognostic (2.00e-1)" "unprognostic (7.33e-2)" "prognostic unfavorable (1.46e-7)" "unprognostic (3.22e-3)" "unprognostic (4.70e-1)" "unprognostic (2.51e-1)" "prognostic unfavorable (2.42e-5)" 8.7 7.2 3.1 6.2 4.0 2.1 5.2 1.1 4.0 10.2 4.5 8.1 3.4 0.9 8.4 9.3 4.2 6.7 12.4 20.6 3.4 2.4 2.2 1.0 5.2 2.4 5.6 4.7 24.8 11.9 2.8 3.8 4.9 4.2 11.3 2.7 10.7 8.0 5.2 2.2 2.6 2.5 12.0 5.4 1.0 2.6 8.4 4.7 14.9 12.1 3.7 2.3 12.2 6.9 0.4 3.0 1.7 0.1 0.8 1.4 0.1 0.1 1.1 0.0 7.2 6.6 13.0 1.1 1.1 2.7 2.6 6.4 0.3 0.8 0.0 2.0 3.0 14.6 0.1 0.7 1.4 2.5 0.0 0.8 0.0 4.8 7.7 8.4 3.0 0.0 12.5 0.7 6.3 1.0 3.9 0.0 14.1 3.5 0.1 1.5 1.6 22.3 0.1 4.3 0.1 1.4 0.1 6.1 0.0 0.8 1.1 0.7 3.3 6.2 0.3 0.8 1.4 2.4 0.9 0.0 2.8 9.0 8.7 4.1 0.6 0.1 0.1 7.3 1.4 4.9 0.4 0.1 0.2 0.2 0.1 0.2 0.2 0.2 0.1 0.1 0.4 0.2 0.2 1.7 0.8 0.1 3.0 1.4 0.1 3.1 4.0 1.1 4.0 3.4 2.4 5.6 4.7 4.2 4.7 3.0 1.6 0.0 1.5 1.6 0.6 9.8 2.5 1.4 1.2 0.0 0.0 0.1 0.0 0.0 37.7 0.0 0.9 0.0 1.0 0.2 14.2 1.3 0.0 0.0 0.3 0.0 3.4 1.3 0.0 17.8 7.5 0.3 0.0 0.0 2.3 2.5 1.2 0.0 6.7 0.4 0.4 0.0 1.0 2.9 3.2 0.4 0.7 0.0 1.5 0.4 GYG2 GN-2 ENSG00000056998 "Glycogenin 2" O15488 X 2828788-2882820 "Enzymes, Predicted intracellular proteins" "Glycogen biosynthesis" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 76.7;brain: 21.2;breast: 30.4" "Cell type enhanced" "Detected in many" 11 "Hepatocytes: 15.8;Intestinal endocrine cells: 19.5" "Cancer enhanced" "Detected in all" "melanoma: 42.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 17.1;Hep G2: 13.7;NTERA-2: 16.9;SK-MEL-30: 36.5;SuSa: 27.1" "Low region specificity" "Detected in all" "HPA005495, HPA064686" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol No No "Nucleoli, Cytosol" Nucleoplasm "HPA005495: AB_1079035, HPA064686: AB_2685323" "unprognostic (4.45e-2)" "unprognostic (4.21e-2)" "unprognostic (6.41e-3)" "unprognostic (8.50e-2)" "unprognostic (2.07e-3)" "unprognostic (5.16e-1)" "unprognostic (1.74e-2)" "unprognostic (1.18e-1)" "unprognostic (7.43e-3)" "unprognostic (6.74e-2)" "prognostic favorable (3.01e-5)" "unprognostic (9.76e-2)" "unprognostic (6.10e-5)" "unprognostic (1.78e-1)" "unprognostic (5.05e-3)" "unprognostic (5.41e-2)" "unprognostic (6.60e-2)" 76.7 1.4 4.6 1.3 4.6 0.5 30.4 2.1 3.7 2.1 3.5 8.2 0.7 1.2 4.2 0.9 1.0 3.6 1.7 1.7 3.9 2.9 1.4 9.9 0.7 0.7 5.5 2.9 1.9 3.2 0.4 0.5 1.6 12.9 2.7 2.0 4.2 2.8 4.4 0.5 1.2 1.3 2.8 21.2 0.5 2.2 0.8 5.1 0.0 1.3 0.5 0.6 2.9 1.4 1.0 0.6 0.6 0.4 1.2 0.7 0.0 0.0 5.2 17.1 0.0 10.2 0.0 12.4 0.5 3.0 3.0 3.8 12.7 0.3 0.0 1.4 2.1 3.1 0.0 9.6 0.2 2.9 0.1 2.7 0.0 0.2 13.7 3.0 0.0 4.2 3.7 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.8 0.0 0.4 16.9 0.1 0.0 2.8 5.7 0.0 0.0 0.0 0.0 0.3 0.0 0.1 36.5 27.1 1.6 10.4 0.0 0.0 3.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.2 0.7 0.5 0.4 0.3 0.1 1.0 0.3 0.2 0.6 1.2 0.4 0.6 0.4 0.0 4.6 4.6 2.1 3.7 3.9 2.9 5.5 2.9 12.9 5.1 0.0 0.0 0.0 0.9 0.3 0.9 0.6 2.5 0.0 0.0 0.0 3.9 5.3 5.0 0.8 0.3 0.0 0.2 0.0 3.4 7.0 1.9 1.7 0.0 15.8 0.9 0.0 19.5 0.0 1.3 0.0 0.6 0.0 3.3 0.0 1.3 1.8 2.8 0.0 2.8 2.1 0.0 0.0 0.9 0.3 0.4 0.3 1.9 0.0 2.0 0.5 GYPA "CD235a, GPA, MN, MNS" ENSG00000170180 "Glycophorin A (MNS blood group)" P02724 4 144109303-144140786 "Blood group antigen proteins, CD markers, Predicted membrane proteins" "Host-virus interaction" "Blood group antigen, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "bone marrow: 56.9" "Cell type enriched" "Detected in some" 311 "Erythroid cells: 1331.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "HEL: 57.0" "CAB002658, HPA014811" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "CAB002658: , HPA014811: AB_1849827" "unprognostic (1.60e-1)" "unprognostic (2.47e-2)" 0.1 0.0 0.2 0.1 0.4 56.9 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.3 1.7 1.3 3.2 0.1 0.3 0.1 0.1 0.1 0.0 0.3 4.8 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 6.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.5 0.3 0.4 0.2 0.2 0.6 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.2 0.9 0.1 0.2 0.2 1.5 0.2 0.6 0.2 0.2 0.2 0.3 0.0 0.8 0.2 0.4 0.1 0.5 0.2 0.3 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.3 0.0 0.0 1331.6 0.0 1.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 GZF1 "dJ322G13.2, ZBTB23, ZNF336" ENSG00000125812 "GDNF inducible zinc finger protein 1" Q9H116 20 23362182-23373063 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024520 Uncertain Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA024520: AB_10963938" "unprognostic (3.11e-1)" "unprognostic (3.18e-2)" "unprognostic (1.40e-1)" "unprognostic (1.33e-1)" "unprognostic (1.26e-1)" "unprognostic (5.65e-2)" "prognostic unfavorable (9.81e-7)" "unprognostic (8.98e-2)" "unprognostic (2.66e-1)" "unprognostic (8.70e-2)" "unprognostic (3.88e-2)" "unprognostic (1.92e-1)" "unprognostic (3.97e-2)" "unprognostic (1.22e-1)" "unprognostic (2.42e-1)" "unprognostic (1.13e-3)" "unprognostic (1.45e-1)" 7.6 25.8 12.3 7.1 12.5 35.7 6.6 14.1 17.2 8.8 7.1 14.9 8.0 5.4 9.0 7.6 6.1 8.2 7.5 15.6 11.5 10.6 9.2 8.7 7.1 6.5 13.0 10.4 11.4 7.8 12.0 9.8 8.4 12.9 8.3 5.9 7.1 7.7 11.2 10.0 5.8 5.6 10.7 12.4 6.7 6.6 16.5 13.0 7.4 9.6 5.3 6.3 9.3 9.8 3.2 4.4 3.4 4.5 1.3 3.2 2.4 5.6 9.9 6.4 6.4 7.5 7.4 5.1 6.9 6.4 7.1 6.7 7.5 4.5 11.5 6.1 5.9 13.9 10.1 7.3 9.3 8.1 1.9 4.8 10.6 4.0 10.1 9.8 6.3 6.5 7.4 6.9 7.7 11.8 10.0 4.7 8.0 7.2 18.0 10.1 7.4 9.8 7.9 4.7 7.9 13.7 6.5 15.3 7.9 5.3 5.7 9.9 5.7 6.1 11.0 14.4 5.5 7.2 9.2 6.1 11.6 6.7 8.7 7.3 14.7 6.0 10.1 3.4 29.0 6.2 0.0 4.5 2.0 2.0 2.7 1.5 3.2 3.0 3.1 4.4 1.6 3.0 3.2 3.4 1.3 3.2 3.7 0.9 2.4 12.3 12.5 14.1 17.2 11.5 10.6 13.0 10.4 12.9 13.0 6.0 8.1 15.7 2.5 9.6 11.4 16.2 0.0 8.1 4.5 3.5 17.7 4.0 6.6 3.2 14.0 6.7 2.7 0.0 2.9 2.8 5.9 2.4 12.8 4.5 7.4 6.4 5.2 2.5 13.7 21.5 8.6 10.9 1.7 0.0 2.6 10.8 3.5 2.9 7.8 3.8 11.4 0.0 11.2 16.3 8.0 7.3 4.7 2.5 3.3 1.6 H1F0 "H10, H1FV" ENSG00000189060 "H1 histone family member 0" P07305 22 37805093-37807436 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 158.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 85.2;U-2 OS: 110.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000843 Supported Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus,Actin filaments" Yes No "Nucleoplasm, Nuclear bodies" "Golgi apparatus, Actin filaments" "HPA000843: AB_1079062" "unprognostic (1.29e-2)" "unprognostic (1.68e-1)" "unprognostic (1.69e-2)" "unprognostic (1.27e-1)" "unprognostic (3.31e-3)" "unprognostic (1.19e-1)" "unprognostic (2.18e-1)" "unprognostic (3.85e-1)" "unprognostic (7.68e-2)" "unprognostic (1.86e-1)" "unprognostic (5.95e-3)" "unprognostic (4.86e-3)" "prognostic favorable (7.68e-7)" "unprognostic (3.40e-1)" "unprognostic (1.47e-1)" "unprognostic (1.37e-3)" "unprognostic (1.73e-1)" 21.7 13.6 27.5 14.7 24.9 158.1 32.3 35.7 41.7 48.2 37.9 20.4 11.3 35.8 42.7 18.5 66.0 31.7 38.5 30.3 23.5 17.6 33.2 90.6 22.8 15.0 16.0 23.8 48.5 43.5 20.2 25.6 33.6 23.5 43.7 34.0 28.3 43.2 12.4 53.5 53.2 59.2 28.0 18.6 16.3 34.6 15.2 18.8 56.3 36.1 33.4 32.0 24.9 45.2 0.1 6.3 12.5 9.0 0.1 2.4 4.7 20.2 8.8 27.4 12.1 7.2 6.6 38.9 16.5 34.6 48.5 69.2 35.9 32.5 0.0 4.1 13.7 11.3 39.8 0.0 11.4 34.6 0.1 2.0 34.3 3.2 23.8 25.4 0.0 0.1 6.2 20.3 24.3 27.4 0.5 12.8 7.9 0.0 0.0 3.7 33.6 5.7 3.3 10.6 85.2 43.5 9.5 16.3 7.0 7.6 5.5 6.3 35.4 45.7 31.2 60.2 12.8 24.3 21.5 8.5 3.7 110.7 16.3 3.3 0.0 2.3 0.1 4.5 12.4 10.5 12.5 7.6 11.3 0.1 9.0 0.1 0.0 0.8 0.2 6.3 0.1 2.4 0.3 4.2 0.1 7.7 5.7 0.2 4.7 27.5 24.9 35.7 41.7 23.5 17.6 16.0 23.8 23.5 18.8 26.8 114.5 10.0 163.5 62.0 29.8 40.3 107.0 97.7 135.4 97.7 3.9 33.1 106.1 132.1 1.8 71.9 117.5 280.4 159.3 112.5 82.5 175.2 22.0 68.2 59.5 42.9 119.1 63.3 67.8 3.7 85.4 44.3 81.0 92.8 180.5 46.0 119.5 160.1 57.0 42.8 5.6 109.9 96.7 55.8 24.9 78.3 183.8 7.0 103.1 138.2 H1FX "H1X, MGC15959, MGC8350" ENSG00000184897 "H1 histone family member X" Q92522 3 129314771-129316277 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "bone marrow: 381.6;lymphoid tissue: 238.6" "Cell type enhanced" "Detected in all" 6 "Basal glandular cells: 485.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 139.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB012235, HPA040099, HPA068431" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "CAB012235: , HPA040099: AB_2676846, HPA068431: " "unprognostic (1.01e-2)" "unprognostic (1.12e-2)" "unprognostic (4.13e-2)" "unprognostic (8.48e-2)" "unprognostic (6.94e-2)" "unprognostic (2.23e-1)" "unprognostic (4.00e-2)" "unprognostic (1.46e-2)" "unprognostic (1.16e-1)" "unprognostic (5.51e-2)" "unprognostic (5.28e-3)" "unprognostic (1.44e-2)" "unprognostic (2.88e-1)" "unprognostic (1.15e-1)" "unprognostic (2.85e-1)" "unprognostic (3.24e-1)" "unprognostic (2.50e-2)" 23.1 13.1 11.9 19.0 14.5 381.6 33.7 29.0 22.9 30.9 21.0 9.6 13.4 21.1 26.0 19.6 34.5 25.1 24.0 27.5 11.3 11.2 12.9 24.9 30.9 44.2 6.7 16.3 39.0 22.4 18.4 20.5 15.0 6.9 26.2 7.8 18.4 32.3 16.3 30.8 40.5 26.0 19.1 9.6 29.9 29.0 14.2 6.3 238.6 21.9 18.1 20.5 35.6 25.0 5.7 10.8 15.9 5.3 4.8 8.3 2.2 19.9 10.6 20.1 8.7 2.0 2.4 19.1 8.8 6.4 10.5 11.1 6.3 11.0 2.5 9.7 3.1 7.0 20.1 8.4 5.6 1.6 18.3 16.3 7.6 8.2 8.6 8.7 8.8 2.0 4.9 7.7 4.2 9.7 4.7 6.0 35.4 11.7 45.5 1.4 20.9 40.7 17.5 18.8 3.6 12.0 29.4 8.6 23.7 3.2 4.2 32.1 37.2 9.3 4.6 26.6 4.0 18.2 17.8 5.9 8.1 42.6 7.9 7.3 139.5 53.3 21.5 6.6 8.4 8.9 0.4 5.3 15.9 4.3 3.7 4.0 4.4 6.7 5.1 7.4 5.7 8.3 4.3 1.2 4.8 3.3 10.8 5.1 2.2 11.9 14.5 29.0 22.9 11.3 11.2 6.7 16.3 6.9 6.3 14.9 12.8 95.3 485.3 89.5 119.1 25.5 63.7 2.7 3.4 89.0 29.5 60.0 94.5 42.6 7.4 89.9 34.4 70.0 71.0 93.0 97.3 173.5 5.7 38.5 77.7 138.2 153.1 85.3 93.5 8.0 92.0 75.7 118.1 25.2 86.3 209.9 59.2 48.9 48.8 25.1 84.3 122.9 82.1 13.2 36.5 96.0 57.2 72.6 52.5 312.3 H2AFJ "FLJ10903, MGC921" ENSG00000246705 "H2A histone family member J" Q9BTM1 12 14774383-14778002 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 148.5" "Group enriched" "Detected in all" 5 "Early spermatids: 2365.3;Late spermatids: 2711.3" "Cancer enhanced" "Detected in all" "prostate cancer: 151.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 52.0;MCF7: 67.2;RT4: 48.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (9.38e-2)" "unprognostic (8.49e-2)" "unprognostic (9.15e-2)" "unprognostic (7.06e-2)" "unprognostic (2.43e-3)" "unprognostic (4.70e-2)" "unprognostic (3.92e-2)" "unprognostic (7.67e-2)" "unprognostic (1.16e-1)" "unprognostic (1.14e-1)" "unprognostic (5.37e-2)" "unprognostic (4.05e-2)" "unprognostic (3.32e-3)" "unprognostic (3.43e-2)" "unprognostic (8.66e-3)" "unprognostic (5.22e-3)" "unprognostic (3.87e-3)" 37.8 27.6 3.6 15.0 11.6 14.6 36.7 2.2 5.2 19.1 27.3 9.9 21.7 16.0 15.4 26.7 29.9 13.9 34.0 24.8 4.3 3.8 22.2 16.7 22.7 16.9 9.0 5.1 12.7 47.7 4.8 5.0 25.5 6.8 49.2 8.6 18.2 67.6 25.7 20.4 26.8 18.7 18.6 11.8 15.7 17.8 148.5 5.8 14.4 19.3 25.3 17.4 26.5 29.3 7.2 39.1 23.8 44.5 19.8 25.1 24.2 21.2 52.0 2.0 0.0 23.7 15.8 33.9 16.0 8.9 6.5 6.3 10.2 35.1 0.0 10.1 7.7 0.0 20.4 1.2 12.1 1.7 1.1 0.9 0.8 18.4 8.6 34.1 0.0 8.1 20.5 13.3 8.9 8.3 2.6 12.9 0.0 0.0 0.0 3.2 67.2 0.1 5.6 3.3 15.5 11.9 8.4 0.0 4.1 10.3 48.2 0.6 0.2 20.3 25.2 0.0 7.5 38.4 6.5 12.7 0.0 6.2 9.5 3.1 5.2 7.5 0.0 1.8 0.0 5.1 23.8 44.5 9.3 18.0 24.5 16.3 5.8 17.8 13.4 39.1 7.2 12.7 13.7 15.4 19.8 21.4 19.4 25.1 24.2 3.6 11.6 2.2 5.2 4.3 3.8 9.0 5.1 6.8 5.8 41.7 33.7 49.1 304.8 105.8 15.7 27.9 175.8 202.1 68.2 136.1 21.6 108.3 127.6 141.6 2365.3 89.2 383.6 303.7 335.4 99.7 141.6 500.9 63.4 107.1 207.7 11.1 230.0 119.7 205.3 2711.3 162.8 122.0 217.6 210.2 226.5 28.4 179.6 287.5 91.9 223.3 35.9 265.1 186.8 506.4 29.2 123.0 134.1 87.3 219.6 347.8 H2AFX H2AX ENSG00000188486 "H2A histone family member X" P16104 11 119093854-119095467 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "lymphoid tissue: 135.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012264, HPA041189, HPA051647" Supported Supported "Nucleoplasm,Nuclear speckles" Yes No Nucleoplasm "Nuclear speckles" "CAB012264: AB_297215, HPA041189: AB_2677357, HPA051647: AB_2681563" "unprognostic (1.44e-1)" "unprognostic (1.96e-1)" "unprognostic (6.46e-2)" "unprognostic (6.41e-2)" "unprognostic (3.07e-1)" "unprognostic (3.25e-1)" "prognostic unfavorable (1.51e-4)" "unprognostic (2.32e-3)" "unprognostic (1.93e-1)" "unprognostic (3.07e-3)" "unprognostic (6.78e-2)" "unprognostic (9.31e-2)" "prognostic unfavorable (5.47e-9)" "unprognostic (1.21e-3)" "unprognostic (1.20e-1)" "unprognostic (1.20e-1)" "unprognostic (1.99e-2)" 5.9 10.1 10.7 17.9 9.4 24.0 4.2 9.4 13.9 5.0 12.0 15.2 2.5 15.4 5.7 2.8 9.8 5.5 4.0 4.7 10.6 10.1 6.4 5.0 7.1 17.0 13.3 5.3 8.0 9.2 3.8 8.1 12.8 9.3 6.4 5.4 6.3 5.8 6.3 7.2 10.8 13.7 4.2 13.6 11.1 12.6 28.3 9.5 135.1 5.9 11.3 23.2 4.8 6.6 2.0 3.4 7.4 2.4 3.8 3.4 1.8 26.4 16.0 25.3 15.1 2.3 1.7 26.7 30.1 9.2 17.0 15.0 25.3 11.4 18.2 18.2 6.9 12.8 27.5 11.9 8.6 4.6 26.8 33.5 36.9 4.4 26.0 2.4 18.1 23.0 1.4 1.9 7.2 4.4 2.7 8.5 24.0 29.8 30.0 8.1 67.5 41.4 54.2 18.4 12.1 33.9 40.5 29.8 8.5 7.7 11.5 27.0 32.1 23.9 13.9 4.2 4.5 20.8 13.8 10.4 16.5 43.6 13.4 22.3 8.2 8.0 18.4 3.8 29.5 32.1 7.0 2.4 7.4 3.4 1.1 1.8 2.0 3.4 3.4 3.4 1.8 2.3 2.0 1.2 3.8 1.5 1.5 2.8 1.8 10.7 9.4 9.4 13.9 10.6 10.1 13.3 5.3 9.3 9.5 6.0 12.6 41.6 30.9 27.4 17.4 16.3 15.3 2.7 9.1 7.0 19.6 39.1 10.0 14.6 7.0 21.1 36.5 46.7 9.9 93.2 26.6 29.8 32.3 3.6 37.9 9.5 33.3 25.8 20.0 2.5 13.3 24.5 18.6 37.9 33.9 37.9 14.1 24.5 10.3 7.5 43.2 12.9 36.5 72.1 17.9 24.7 53.7 30.5 50.3 20.8 H2AFY macroH2A1.2 ENSG00000113648 "H2A histone family member Y" O75367 5 135333900-135399914 "Plasma proteins, Predicted intracellular proteins" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041189, HPA050962" Supported Supported Nucleoplasm NA NA 4700000 Nucleoplasm "HPA041189: AB_2677357, HPA050962: AB_2681292" "unprognostic (1.05e-1)" "unprognostic (3.63e-2)" "unprognostic (1.60e-3)" "unprognostic (2.78e-2)" "unprognostic (1.27e-1)" "unprognostic (7.88e-2)" "prognostic unfavorable (2.89e-5)" "unprognostic (3.17e-1)" "unprognostic (3.34e-2)" "unprognostic (2.53e-3)" "unprognostic (9.43e-2)" "unprognostic (2.21e-1)" "unprognostic (8.89e-3)" "unprognostic (8.34e-2)" "unprognostic (5.96e-2)" "unprognostic (1.56e-1)" "unprognostic (1.15e-1)" 34.9 26.0 24.8 32.2 27.2 75.1 21.7 37.6 27.6 22.5 40.0 19.7 14.0 40.2 22.0 21.8 60.7 22.4 38.8 41.9 21.4 28.8 23.8 24.1 36.7 39.4 24.1 26.5 21.8 16.6 24.2 25.8 30.0 21.0 20.2 43.2 24.4 28.3 14.0 34.9 33.4 52.0 21.9 21.8 33.8 28.5 21.4 16.9 76.9 22.2 40.7 47.2 28.7 29.6 16.0 51.8 23.8 45.6 21.5 15.9 30.1 45.6 32.2 49.7 34.0 23.3 13.9 44.7 19.2 20.7 34.2 24.2 50.6 45.9 54.2 32.8 15.5 29.0 31.2 37.2 81.4 25.7 29.3 37.1 64.7 38.0 34.0 17.1 30.7 28.5 14.7 22.1 28.5 30.7 21.0 21.9 37.1 22.4 22.3 19.4 39.9 88.2 58.5 19.4 54.7 17.2 79.8 28.3 38.3 42.4 52.2 70.0 44.1 37.4 36.4 30.8 27.2 43.2 85.1 17.6 30.0 25.3 22.0 39.1 10.7 43.5 50.8 25.0 69.3 21.1 4.1 45.6 20.5 10.8 30.1 9.1 11.7 14.0 13.4 51.8 16.0 13.6 11.2 23.8 21.5 19.0 37.3 15.9 30.1 24.8 27.2 37.6 27.6 21.4 28.8 24.1 26.5 21.0 16.9 89.3 73.9 95.3 103.9 115.3 133.0 49.8 99.3 112.4 113.7 75.0 90.3 125.6 61.3 217.9 39.7 83.0 188.9 46.7 110.7 116.9 69.9 135.3 50.8 51.0 384.3 322.6 171.4 63.8 399.4 18.3 56.7 337.9 86.0 166.9 190.1 115.6 179.5 156.5 77.4 76.7 166.8 71.1 91.4 52.4 75.0 139.4 153.4 97.8 202.7 196.4 H2AFY2 macroH2A2 ENSG00000099284 "H2A histone family member Y2" Q9P0M6 10 70052796-70112280 "Predicted intracellular proteins" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ductal cells: 38.2;Intestinal endocrine cells: 62.8;monocytes: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 9 "dendritic cells: 12.6;monocytes: 5.4;T-cells: 6.4" "Cell line enhanced" "Detected in many" "AF22: 49.3;AN3-CA: 28.6;SCLC-21H: 36.5;SH-SY5Y: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035865, HPA041189" Enhanced Supported Nucleoplasm No No Nucleoplasm "HPA035865: AB_10672099, HPA041189: AB_2677357" "unprognostic (1.62e-2)" "unprognostic (9.62e-2)" "unprognostic (1.46e-2)" "unprognostic (1.46e-2)" "unprognostic (7.71e-3)" "unprognostic (1.85e-1)" "unprognostic (3.44e-2)" "unprognostic (5.37e-2)" "unprognostic (1.67e-1)" "unprognostic (9.17e-2)" "unprognostic (7.32e-2)" "unprognostic (1.80e-2)" "unprognostic (1.31e-2)" "unprognostic (3.27e-2)" "unprognostic (4.58e-2)" "unprognostic (8.78e-2)" "unprognostic (4.66e-2)" 4.7 3.7 9.3 9.0 9.8 2.0 11.3 21.8 12.1 16.1 10.9 12.2 26.0 9.8 22.5 14.8 18.7 18.1 17.9 13.9 7.3 9.8 12.6 10.2 6.3 5.9 6.6 9.2 18.3 12.5 14.3 18.8 2.6 6.3 19.7 12.1 10.6 11.7 23.5 15.6 11.4 10.6 16.7 9.3 3.4 9.2 18.9 7.4 6.9 15.3 11.7 9.9 14.1 12.5 0.0 12.6 0.4 5.4 0.9 6.4 3.1 1.3 7.3 49.3 28.6 0.6 1.5 0.0 2.2 0.0 4.3 3.0 0.2 14.7 0.0 6.2 0.8 2.6 7.5 3.7 11.9 1.3 19.2 17.8 0.0 0.0 15.1 3.0 0.5 0.4 1.9 8.7 1.5 2.4 6.6 0.0 2.1 0.0 0.0 4.1 10.2 0.0 0.0 20.4 0.0 12.5 0.0 0.0 0.0 8.8 9.1 36.5 35.5 7.5 0.0 0.1 10.7 11.0 5.6 0.0 0.0 8.6 3.5 1.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.0 3.6 5.4 4.5 0.0 4.8 4.3 12.6 0.0 5.0 6.4 0.4 0.9 3.3 0.1 3.4 3.1 9.3 9.8 21.8 12.1 7.3 9.8 6.6 9.2 6.3 7.4 0.0 2.7 0.0 17.3 7.2 11.3 6.0 7.6 8.1 2.3 14.0 0.0 0.4 21.6 38.2 0.8 2.8 2.6 0.0 7.0 0.3 4.8 11.1 2.3 3.6 4.8 0.0 62.8 3.7 3.2 1.8 3.4 6.3 1.7 46.9 11.0 2.4 11.8 3.5 4.6 5.7 2.6 6.5 0.5 2.3 3.8 9.5 0.8 4.3 19.4 15.3 H2AFZ "H2A.Z, H2AZ" ENSG00000164032 "H2A histone family member Z" P0C0S5 4 99948086-99950388 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Basal keratinocytes: 1666.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022549, HPA057236" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB022549: , HPA057236: AB_2683377" "unprognostic (1.21e-2)" "unprognostic (2.97e-3)" "unprognostic (1.03e-3)" "unprognostic (7.60e-2)" "unprognostic (1.97e-1)" "unprognostic (8.74e-3)" "prognostic unfavorable (1.02e-5)" "unprognostic (2.29e-3)" "unprognostic (1.98e-1)" "unprognostic (4.99e-3)" "unprognostic (9.70e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (2.16e-6)" "unprognostic (3.02e-1)" "unprognostic (1.33e-1)" "unprognostic (6.34e-2)" "unprognostic (1.52e-1)" 23.5 22.5 28.9 40.7 40.4 113.9 31.1 39.5 38.0 26.3 45.0 13.9 26.9 33.2 40.4 23.1 53.5 24.0 27.9 32.1 28.6 28.1 37.1 26.9 32.4 70.6 32.9 26.2 32.6 19.8 14.5 30.3 32.0 26.1 30.2 43.2 29.5 29.4 27.2 28.3 30.1 34.0 46.2 26.7 46.1 37.4 32.2 31.3 139.8 29.7 47.9 81.0 51.6 29.9 46.7 54.1 139.3 87.0 41.3 80.9 120.4 86.8 61.2 127.7 65.7 26.4 22.3 42.0 92.3 66.6 95.4 89.9 62.8 101.6 154.7 33.6 46.9 63.9 31.7 111.5 90.0 103.5 67.9 77.6 79.3 72.4 71.2 15.9 141.2 66.9 17.5 39.4 73.4 41.2 27.5 94.0 94.3 78.0 94.3 108.8 120.7 116.9 117.5 73.7 98.6 58.7 100.9 93.5 64.7 53.0 52.9 83.3 64.3 57.0 108.9 106.4 45.4 55.6 109.4 49.1 61.6 117.5 42.1 117.8 54.5 80.5 184.7 69.0 94.5 96.4 61.8 63.2 120.2 38.1 68.7 42.2 46.7 60.5 49.8 54.1 39.3 56.9 47.2 139.3 41.3 87.0 36.1 80.9 120.4 28.9 40.4 39.5 38.0 28.6 28.1 32.9 26.2 26.1 31.3 59.6 72.1 223.6 636.0 1666.4 166.9 102.6 150.3 116.4 97.8 188.5 51.1 382.0 321.7 310.6 14.8 301.1 184.6 210.2 358.1 1168.3 589.6 472.9 172.9 101.8 614.7 60.4 273.0 216.0 285.6 36.7 187.6 455.0 843.5 1029.8 227.7 128.4 329.3 211.3 212.2 354.3 185.1 187.5 662.3 476.9 167.0 1432.4 337.2 318.1 419.3 624.2 H2BFS ENSG00000234289 "H2B histone family member S" P57053 21 43565189-43565648 "Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 65.0" "Cell type enriched" "Detected in single" 5 "Syncytiotrophoblasts: 3.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 23.7;U-2 OS: 23.4;U-266/84: 23.8" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (1.29e-1)" "unprognostic (4.33e-3)" "unprognostic (2.06e-2)" 1.1 0.9 0.2 7.4 0.3 1.8 2.6 0.3 0.8 1.8 1.7 0.4 1.1 2.3 2.4 4.3 4.9 4.2 4.2 4.9 0.5 0.5 4.0 3.3 12.2 0.1 0.5 2.2 4.2 0.0 0.0 4.5 0.4 5.3 1.8 0.8 3.0 2.1 1.0 0.4 3.0 1.8 0.7 5.7 2.0 7.9 0.0 65.0 2.6 7.1 6.1 2.1 1.3 7.7 6.2 16.0 4.9 1.6 3.6 3.2 2.1 3.3 0.6 0.9 2.2 0.9 2.4 2.6 1.3 3.2 2.0 4.6 1.1 0.6 8.8 0.8 2.5 2.5 0.2 0.7 0.9 2.2 3.6 0.6 5.0 0.2 0.3 0.9 4.5 2.5 0.4 0.6 0.0 1.2 0.3 0.4 23.7 2.8 0.9 6.1 1.0 2.2 0.3 4.1 2.6 0.8 0.5 8.7 0.7 0.7 3.5 2.5 10.5 3.2 2.1 0.5 11.1 1.4 0.9 1.7 23.4 1.1 0.6 7.6 23.8 5.0 1.1 11.8 1.0 10.0 2.1 15.0 1.2 2.2 1.0 5.7 1.2 1.3 2.8 7.7 1.6 1.1 16.0 1.6 4.9 6.2 3.6 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 H2BFS ENSG00000274559 "H2B histone family member S" 21 5972924-5973383 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 16.0" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 2.9;Ciliated cells: 4.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 23.7;U-2 OS: 23.4;U-266/84: 23.8" "HPA042205, HPA043013, HPA048671" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (3.37e-2)" "unprognostic (2.63e-1)" 0.4 0.3 0.5 1.0 0.0 0.0 1.0 0.9 1.4 1.3 2.9 3.3 2.8 2.8 0.0 0.0 2.2 0.3 2.3 0.2 1.2 0.0 0.8 3.7 0.9 1.9 0.0 0.0 0.0 1.8 0.7 0.6 1.1 0.9 1.6 1.0 1.2 7.7 6.2 16.0 4.9 1.6 3.6 3.2 2.1 3.3 0.6 0.9 2.2 0.9 2.4 2.6 1.3 3.2 2.0 4.6 1.1 0.6 8.8 0.8 2.5 2.5 0.2 0.7 0.9 2.2 3.6 0.6 5.0 0.2 0.3 0.9 4.5 2.5 0.4 0.6 0.0 1.2 0.3 0.4 23.7 2.8 0.9 6.1 1.0 2.2 0.3 4.1 2.6 0.8 0.5 8.7 0.7 0.7 3.5 2.5 10.5 3.2 2.1 0.5 11.1 1.4 0.9 1.7 23.4 1.1 0.6 7.6 23.8 5.0 1.1 11.8 1.0 10.0 2.1 15.0 1.2 2.2 1.0 5.7 1.2 1.3 2.8 7.7 1.6 1.1 16.0 1.6 4.9 6.2 3.6 3.2 11.9 2.9 0.9 0.8 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.1 1.0 0.0 0.0 0.0 1.8 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.6 H3F3A "H3.3A, H3F3" ENSG00000163041 "H3 histone family member 3A" P84243 1 226061851-226072001 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 258.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 258.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 258.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011481, CAB037178, HPA042570" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB011481: AB_880446, CAB037178: AB_532248, HPA042570: AB_2678056" "unprognostic (1.82e-1)" "unprognostic (1.95e-2)" "unprognostic (1.00e-1)" "unprognostic (2.19e-3)" "unprognostic (2.83e-2)" "unprognostic (3.74e-1)" "unprognostic (9.83e-3)" "unprognostic (4.71e-2)" "unprognostic (1.77e-3)" "unprognostic (3.69e-2)" "unprognostic (1.29e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.21e-6)" "unprognostic (3.66e-2)" "unprognostic (8.03e-3)" "unprognostic (2.21e-3)" "unprognostic (6.03e-2)" 39.0 43.4 37.2 83.4 33.4 126.8 67.9 45.0 42.8 44.6 54.0 31.6 62.9 47.9 43.4 60.6 66.3 42.4 49.6 59.4 36.1 31.2 45.9 59.2 73.2 217.9 37.8 23.2 44.4 79.7 30.8 34.8 59.1 29.2 38.4 59.4 42.7 49.0 49.7 37.0 47.1 50.0 42.0 48.6 71.9 41.4 87.6 31.7 148.9 38.5 71.0 84.1 43.5 47.6 39.2 44.6 258.7 56.9 23.6 34.9 60.5 53.9 30.8 120.2 67.8 33.4 38.9 90.3 25.6 31.1 41.6 32.9 32.1 90.0 51.9 56.9 31.4 20.7 51.8 59.4 46.6 40.9 32.1 102.6 64.2 45.6 42.9 33.1 65.9 78.0 35.6 54.0 29.1 38.3 56.4 61.5 67.9 90.4 88.9 47.3 31.2 136.8 122.6 163.0 137.1 61.1 92.6 87.8 133.8 86.0 57.7 117.4 174.5 73.0 92.4 63.2 71.8 104.7 154.7 34.6 30.3 42.3 40.9 74.1 39.6 50.7 90.7 28.9 63.0 64.7 40.0 56.9 80.8 23.1 44.9 23.6 39.2 25.0 24.9 44.6 36.0 23.7 25.7 258.7 23.6 50.8 36.6 34.9 60.5 37.2 33.4 45.0 42.8 36.1 31.2 37.8 23.2 29.2 31.7 485.3 628.9 1112.7 1421.3 1190.0 539.7 34.4 1036.9 1187.2 831.4 919.5 155.1 1193.7 1374.4 1195.9 1414.0 1038.4 1355.7 2359.5 1184.4 1689.1 947.0 1270.6 649.3 699.9 1338.0 554.6 1437.2 842.8 2198.6 1327.8 1016.5 1622.8 1010.6 1191.2 1707.9 908.2 1197.9 2104.2 985.0 1310.8 429.3 976.6 889.6 588.0 858.5 1210.5 1352.2 961.6 1983.9 1893.1 H3F3B H3.3B ENSG00000132475 "H3 histone family member 3B" P84243 17 75776434-75785893 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 570.8;bone marrow: 441.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 570.8" "Lineage enriched" "Detected in all" 6 "granulocytes: 570.8" "Low cell line specificity" "Detected in all" "CAB037166, CAB037187, CAB037221, HPA042570" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB037166: AB_2115285, CAB037187: AB_477069, CAB037221: AB_477076, HPA042570: AB_2678056" "unprognostic (1.66e-1)" "unprognostic (8.42e-3)" "unprognostic (3.42e-2)" "unprognostic (1.06e-1)" "unprognostic (1.81e-1)" "unprognostic (1.95e-1)" "unprognostic (2.41e-1)" "unprognostic (2.43e-3)" "unprognostic (3.37e-2)" "unprognostic (1.64e-1)" "unprognostic (5.88e-2)" "unprognostic (1.07e-1)" "unprognostic (1.26e-3)" "unprognostic (9.20e-2)" "unprognostic (4.81e-2)" "unprognostic (2.33e-1)" "unprognostic (1.99e-1)" 57.2 41.2 38.1 58.9 48.6 441.9 71.4 60.2 47.0 86.6 44.6 65.9 42.7 37.9 60.5 77.7 93.2 70.2 75.8 35.1 38.5 33.9 42.8 48.1 64.2 62.3 50.4 41.2 141.0 90.9 33.0 41.5 58.5 42.7 60.5 26.6 65.8 58.4 55.4 71.1 114.0 58.0 63.7 51.8 65.9 45.1 66.9 46.2 78.6 58.9 69.1 55.7 78.5 71.9 78.9 88.1 570.8 98.4 80.0 77.2 203.5 117.9 104.8 43.8 43.2 25.0 39.2 60.6 55.9 49.5 68.7 55.2 112.2 84.0 59.1 53.4 32.5 48.6 46.5 34.6 77.3 39.1 32.2 78.0 52.7 55.9 94.9 56.5 87.5 67.9 42.8 47.9 70.4 90.8 30.6 51.6 38.6 74.6 106.3 35.3 173.6 125.6 73.5 35.1 38.2 117.1 93.6 80.2 64.4 54.2 70.1 88.9 98.7 56.7 83.2 120.0 24.4 65.2 94.6 48.1 123.3 109.1 53.2 148.0 128.6 76.0 71.0 65.2 83.5 67.2 182.8 98.4 259.3 74.4 86.9 70.2 78.9 71.8 70.5 86.7 65.3 77.2 64.5 570.8 80.0 78.9 88.1 76.0 203.5 38.1 48.6 60.2 47.0 38.5 33.9 50.4 41.2 42.7 46.2 851.6 868.5 887.7 3350.2 2457.1 1722.8 361.5 690.4 1184.5 958.9 922.9 382.9 1428.6 1080.9 1926.0 2467.5 1156.8 1059.1 327.1 1563.3 1285.8 1898.2 1719.4 1592.3 352.8 1655.2 575.2 1610.5 672.8 901.1 452.7 934.0 1810.8 1808.5 1233.6 1221.5 2460.8 1745.6 1627.3 545.9 699.9 1161.2 983.1 2751.1 2035.3 943.0 3026.0 2929.8 1269.9 852.2 2611.9 HABP4 "IHABP4, SERBP1L" ENSG00000130956 "Hyaluronan binding protein 4" Q5JVS0 9 96450201-96491336 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 44.8" "Group enriched" "Detected in many" 11 "Early spermatids: 193.7;Late spermatids: 710.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 4.1;T-cells: 4.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055969, HPA062366" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA055969: AB_2682991, HPA062366: " "unprognostic (1.67e-1)" "unprognostic (7.99e-2)" "unprognostic (2.12e-3)" "unprognostic (2.40e-1)" "unprognostic (1.77e-1)" "unprognostic (5.91e-2)" "unprognostic (1.36e-2)" "unprognostic (3.63e-2)" "unprognostic (3.49e-1)" "unprognostic (2.42e-2)" "unprognostic (1.75e-3)" "unprognostic (1.36e-1)" "prognostic favorable (1.10e-7)" "unprognostic (2.25e-1)" "unprognostic (1.40e-1)" "unprognostic (4.93e-2)" "unprognostic (3.62e-2)" 13.2 11.9 31.2 6.1 44.8 1.7 6.5 14.1 40.6 7.9 5.5 12.4 1.5 3.0 8.2 6.8 7.2 5.3 8.1 19.1 26.1 24.9 23.5 5.7 6.1 6.8 27.1 20.5 11.7 4.8 13.8 7.4 3.4 31.6 8.3 4.2 8.4 4.1 10.6 9.4 6.1 3.3 10.6 19.4 5.0 5.0 21.8 13.0 0.4 11.2 2.2 4.9 7.6 6.5 4.1 0.1 0.3 0.8 1.0 4.0 0.7 7.3 8.4 10.7 11.4 23.7 20.3 7.6 10.0 11.2 7.5 8.2 12.5 12.3 3.7 5.0 14.8 24.0 5.4 8.9 1.9 6.1 4.5 5.3 1.4 4.0 20.8 12.1 0.3 1.5 8.2 3.4 8.6 6.8 11.5 5.3 4.3 1.7 11.1 13.5 7.5 0.1 2.3 5.0 10.3 8.2 3.8 9.3 0.1 12.8 3.2 6.8 4.6 5.3 3.2 15.9 8.3 2.3 1.6 9.1 10.4 2.4 19.0 8.4 7.0 6.9 1.6 8.3 2.9 15.3 0.0 0.1 0.0 1.4 0.3 1.4 4.1 4.0 3.2 0.0 1.7 2.8 2.8 0.3 1.0 0.8 0.1 3.0 0.7 31.2 44.8 14.1 33.8 26.1 24.9 27.1 20.5 31.6 13.0 0.0 6.1 3.4 7.8 10.2 22.0 10.6 15.3 1.4 9.1 17.4 0.0 2.2 14.9 3.7 193.7 17.8 0.8 0.0 5.0 6.7 7.8 8.5 1.1 5.0 5.5 22.3 12.6 13.5 1.5 710.5 12.7 4.0 16.9 3.6 0.9 17.1 4.8 0.0 22.3 39.6 11.3 6.5 17.6 18.6 5.9 6.9 1.1 7.5 1.1 5.1 HACL1 "2-HPCL, HPCL, PHYH2" ENSG00000131373 "2-hydroxyacyl-CoA lyase 1" Q9UJ83 3 15560704-15601852 "Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 34.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035496, HPA035497, HPA073760" Approved Supported Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA035496: AB_10601328, HPA035497: AB_2674653, HPA073760: AB_2686633" "unprognostic (6.64e-3)" "unprognostic (2.82e-2)" "unprognostic (2.24e-3)" "unprognostic (3.82e-1)" "unprognostic (4.08e-2)" "unprognostic (1.77e-1)" "unprognostic (2.96e-2)" "unprognostic (6.31e-2)" "unprognostic (8.27e-3)" "unprognostic (5.23e-2)" "unprognostic (3.30e-2)" "unprognostic (1.44e-1)" "prognostic favorable (2.63e-5)" "unprognostic (6.62e-2)" "unprognostic (2.66e-1)" "unprognostic (3.23e-2)" "unprognostic (9.07e-2)" 12.9 12.1 9.1 7.3 12.5 7.6 11.6 20.7 14.1 9.0 22.4 13.5 5.8 39.6 13.1 13.2 6.7 7.9 6.6 7.9 6.7 6.0 18.8 38.1 7.5 9.0 9.1 8.3 7.9 14.3 12.9 16.8 6.4 10.1 8.2 9.0 10.9 8.5 6.9 15.7 9.9 31.6 7.2 8.2 11.0 11.5 18.4 10.3 16.6 15.1 6.1 10.7 8.2 6.5 8.5 6.5 34.1 9.1 9.1 9.3 5.0 6.0 12.5 4.0 13.9 7.0 5.6 39.4 5.9 9.6 12.7 12.5 12.9 6.0 6.2 4.3 8.0 5.0 4.5 9.2 11.4 11.3 5.2 17.5 12.2 9.5 12.5 10.5 13.3 10.7 6.4 8.4 18.0 7.5 3.8 15.9 8.3 10.0 10.4 10.8 13.3 6.4 6.3 9.1 9.6 14.6 6.0 9.8 8.2 13.6 9.5 4.2 5.5 8.8 9.7 11.6 6.6 3.1 12.5 9.7 6.9 6.8 8.5 10.8 12.8 21.6 12.2 12.9 12.1 7.8 34.1 6.5 7.0 6.0 8.2 9.3 6.4 6.5 7.5 6.5 8.5 6.4 7.1 1.4 9.1 9.1 4.0 7.8 5.0 9.1 12.5 20.7 14.1 6.7 6.0 9.1 8.3 10.1 10.3 8.9 15.9 11.9 9.6 9.2 18.3 4.9 12.7 37.5 15.9 10.4 27.5 24.4 11.6 10.9 53.9 11.1 8.8 0.0 22.1 15.1 8.6 8.1 12.7 26.4 11.8 12.7 8.7 8.6 9.1 43.3 21.6 8.7 11.8 24.4 5.8 22.5 12.7 10.5 14.5 27.1 32.9 6.5 9.0 49.7 22.6 6.1 15.8 18.7 8.6 5.8 HAND1 "bHLHa27, eHand, Hxt, Thing1" ENSG00000113196 "Heart and neural crest derivatives expressed 1" O96004 5 154474972-154478264 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 25.9;intestine: 35.1;smooth muscle: 14.2" "Cell type enriched" "Detected in some" 8 "Cardiomyocytes: 13.6" "Group enriched" "Detected in some" 5 "colorectal cancer: 0.6;testis cancer: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "SH-SY5Y: 36.0;SuSa: 67.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA040925 Uncertain Uncertain "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA040925: AB_10796563" "unprognostic (2.37e-2)" "unprognostic (8.29e-2)" "unprognostic (2.46e-3)" "unprognostic (7.23e-2)" "unprognostic (5.21e-2)" "unprognostic (6.38e-3)" 0.2 6.0 0.1 9.7 0.1 0.0 0.1 0.1 0.1 0.1 35.1 0.0 0.0 4.4 0.1 0.0 0.1 0.1 5.3 25.9 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.2 3.6 0.0 5.4 2.6 0.1 0.1 0.0 0.1 0.1 20.8 14.2 0.1 0.1 0.1 0.2 0.0 0.7 0.1 0.0 0.0 9.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 36.0 0.0 0.0 0.0 67.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 HAND2 "bHLHa26, dHand, Hed, Thing2" ENSG00000164107 "Heart and neural crest derivatives expressed 2" P61296 4 173524969-173530229 "Predicted intracellular proteins, Transcription factors" "Angiogenesis, Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 61.4;placenta: 62.9" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 81.1;Leydig cells: 36.5" "Cancer enhanced" "Detected in many" "pancreatic cancer: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "SH-SY5Y: 120.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019591, CAB025576" Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB025576: , HPA019591: AB_2670199" "unprognostic (4.11e-2)" "unprognostic (7.50e-3)" "unprognostic (2.43e-2)" "unprognostic (1.25e-2)" "unprognostic (1.95e-1)" "unprognostic (2.44e-2)" "unprognostic (1.82e-1)" "unprognostic (2.24e-1)" "unprognostic (1.28e-2)" "unprognostic (2.56e-1)" "unprognostic (2.44e-1)" "unprognostic (1.35e-1)" "unprognostic (3.27e-2)" "unprognostic (4.95e-2)" "unprognostic (1.56e-1)" "unprognostic (6.39e-3)" 4.2 24.2 0.2 10.9 0.2 0.0 4.7 0.4 0.2 34.3 42.7 0.2 7.5 1.9 42.7 7.9 16.6 9.7 61.4 54.1 0.2 0.2 0.2 8.2 0.2 0.1 0.2 0.0 13.4 3.8 0.0 0.3 62.9 0.0 13.1 3.6 5.2 1.1 4.2 0.6 1.7 13.5 37.5 0.2 1.8 19.9 5.4 0.0 0.0 1.5 2.7 2.2 25.7 12.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 6.9 3.5 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.5 0.0 0.0 0.7 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 120.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 1.9 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 81.1 2.5 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.1 0.0 0.0 0.0 0.4 1.1 13.7 0.0 0.0 0.0 2.3 0.0 0.0 11.1 0.0 0.8 36.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 2.2 0.1 0.1 0.3 1.9 0.0 0.0 0.0 HAS1 HAS ENSG00000105509 "Hyaluronan synthase 1" Q92839 19 51713112-51723994 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 23.7;lymphoid tissue: 13.7;ovary: 23.6" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 23.7;Fibroblasts: 9.0;Melanocytes: 8.5;Smooth muscle cells: 24.7;Suprabasal keratinocytes: 15.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "eosinophil: 5.9;neutrophil: 1.6" "Lineage enriched" "Detected in single" 15 "granulocytes: 5.9" "Cell line enriched" "Detected in some" 4 "U-87 MG: 51.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067602 Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA067602: AB_2685871" "unprognostic (3.56e-2)" "unprognostic (1.19e-1)" "unprognostic (4.43e-2)" "unprognostic (5.26e-4)" "unprognostic (7.17e-3)" "unprognostic (7.05e-2)" "unprognostic (1.02e-1)" "unprognostic (5.49e-4)" "unprognostic (4.80e-2)" "unprognostic (1.99e-2)" "unprognostic (8.43e-2)" "unprognostic (1.72e-1)" "unprognostic (2.30e-11)" "unprognostic (9.12e-4)" "unprognostic (8.99e-2)" "unprognostic (3.73e-4)" "unprognostic (2.43e-2)" 23.7 0.5 0.6 13.7 1.3 2.8 1.0 1.5 1.9 0.6 1.2 0.4 1.1 0.1 0.8 2.5 1.3 5.8 5.5 5.9 1.4 2.0 0.3 0.6 4.5 0.3 0.6 0.3 23.6 2.2 0.0 0.3 0.3 0.6 0.4 0.5 1.0 0.3 1.2 2.1 2.7 4.0 3.6 0.9 0.7 0.7 0.9 0.3 0.3 0.3 0.8 0.3 1.8 0.3 0.1 0.1 5.9 0.1 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 51.0 0.0 0.1 0.0 0.1 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.6 0.0 0.0 0.1 0.0 0.1 0.6 1.3 1.5 1.7 1.4 2.0 0.6 0.3 0.6 0.3 0.0 2.6 0.0 0.1 23.7 4.2 0.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 9.0 0.1 2.3 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.3 0.3 8.5 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.6 0.0 24.7 0.0 0.1 15.6 0.1 0.0 0.0 0.1 HASPIN GSG2 ENSG00000177602 "Histone H3 associated protein kinase" Q8TF76 17 3723903-3726699 "Enzymes, Predicted intracellular proteins" "Cell cycle" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 7.5;lymphoid tissue: 26.7;testis: 26.7" "Cell type enriched" "Detected in single" 5 "Extravillous trophoblasts: 2.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027422, HPA030698" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA027422: AB_10601812, HPA030698: AB_2673575" "unprognostic (1.15e-2)" "unprognostic (2.78e-2)" "unprognostic (7.06e-2)" "unprognostic (2.14e-2)" "unprognostic (8.05e-2)" "unprognostic (2.81e-1)" "unprognostic (1.01e-4)" "unprognostic (1.57e-2)" "unprognostic (6.60e-2)" "unprognostic (1.77e-1)" "unprognostic (2.75e-3)" "unprognostic (3.82e-3)" "unprognostic (0.00e+0)" "unprognostic (5.65e-3)" "unprognostic (3.09e-2)" "unprognostic (1.31e-1)" "unprognostic (1.73e-1)" 1.2 0.3 0.3 11.8 0.6 7.5 1.8 0.5 0.3 0.5 1.5 0.2 0.0 2.2 0.3 0.4 2.8 0.6 1.3 0.6 0.2 0.2 0.8 0.4 2.6 5.8 0.4 0.0 0.4 0.5 0.0 0.3 1.3 0.2 0.7 1.5 0.2 1.0 0.0 1.2 0.9 3.6 0.4 1.2 4.9 1.7 26.7 0.3 26.7 0.7 1.7 7.3 0.8 1.0 2.8 1.5 2.1 0.6 0.0 1.2 0.4 7.5 8.3 7.7 8.6 0.5 1.0 6.4 7.0 5.3 13.8 13.6 6.5 3.1 18.6 4.0 3.8 5.5 12.3 13.8 6.7 13.2 0.1 11.5 9.2 6.7 3.8 0.3 5.3 9.5 0.6 0.5 10.3 6.4 1.6 6.3 14.8 8.1 16.4 6.9 3.9 10.7 3.1 6.7 5.8 5.7 11.2 9.7 5.0 2.0 5.3 3.1 4.5 6.1 4.2 2.4 7.0 4.2 5.0 3.2 6.1 7.0 6.8 12.1 3.1 3.5 9.0 3.6 7.7 7.3 0.4 0.6 2.1 0.2 0.5 0.2 0.7 0.8 0.0 1.1 2.8 1.2 0.2 0.2 0.0 0.0 1.5 0.1 0.4 0.3 0.6 0.5 0.3 0.2 0.2 0.4 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 HAT1 KAT1 ENSG00000128708 "Histone acetyltransferase 1" O14929 2 171922448-171983682 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036788, CAB037191" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB037191: AB_477070, HPA036788: AB_10672267" "unprognostic (1.76e-1)" "unprognostic (1.01e-2)" "unprognostic (7.39e-3)" "unprognostic (8.24e-3)" "unprognostic (2.76e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (5.72e-5)" "unprognostic (2.71e-2)" "unprognostic (9.08e-3)" "unprognostic (3.69e-2)" "unprognostic (1.56e-2)" "unprognostic (1.24e-1)" "unprognostic (3.23e-2)" "unprognostic (6.89e-2)" "unprognostic (1.80e-1)" "unprognostic (3.97e-2)" "unprognostic (6.69e-2)" 24.3 23.7 14.3 20.8 21.4 30.9 25.7 18.4 16.7 17.6 18.2 14.0 17.7 11.8 20.7 15.6 21.3 17.7 14.8 26.2 16.7 13.0 27.5 22.1 18.8 26.9 21.2 12.9 21.8 23.0 22.3 32.2 21.1 21.4 20.8 19.3 13.1 25.5 15.6 53.9 18.6 15.8 22.9 20.5 22.5 20.2 15.9 21.5 35.4 26.1 31.8 27.8 22.1 16.9 21.0 16.0 29.9 32.1 25.9 28.1 19.2 34.2 16.4 29.0 26.5 15.4 16.0 20.5 35.8 23.9 39.6 41.4 38.0 23.8 38.5 23.2 21.6 33.6 27.3 31.4 29.3 61.2 21.7 31.1 33.9 27.1 34.3 7.5 42.8 21.3 9.5 17.0 52.2 17.5 12.5 24.9 26.9 35.1 25.3 44.9 23.9 33.5 39.2 24.1 41.8 17.2 26.9 36.6 26.1 23.5 34.6 18.6 15.3 30.0 16.8 30.4 23.4 23.4 43.5 12.6 35.6 27.5 29.9 36.0 11.1 25.6 45.3 24.0 30.7 30.8 23.8 21.1 29.9 20.8 24.5 25.8 21.0 22.1 21.3 16.0 18.4 22.2 24.2 24.0 25.9 32.1 8.2 28.1 19.2 14.3 21.4 18.4 16.7 16.7 13.0 21.2 12.9 21.4 21.5 32.8 31.1 44.9 101.4 65.9 23.1 47.4 17.8 45.5 30.7 26.2 31.4 65.0 69.6 36.4 42.5 37.9 16.0 23.3 40.9 71.6 41.6 50.0 40.3 18.4 45.8 27.0 13.7 28.3 32.7 8.9 28.4 37.8 30.4 19.0 18.1 49.8 25.8 18.2 34.6 35.3 35.7 38.8 59.0 45.9 63.7 46.0 48.7 40.6 27.7 61.2 HAUS2 "C15orf25, CEP27, FLJ10460, HsT17025" ENSG00000137814 "HAUS augmin like complex subunit 2" Q9NVX0 15 42548810-42569994 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039965 Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA039965: AB_10673025" "unprognostic (5.17e-2)" "unprognostic (1.59e-1)" "unprognostic (2.36e-1)" "unprognostic (6.69e-2)" "unprognostic (5.57e-2)" "unprognostic (3.55e-3)" "unprognostic (1.47e-3)" "unprognostic (1.62e-2)" "unprognostic (2.24e-1)" "unprognostic (2.17e-1)" "unprognostic (1.17e-3)" "unprognostic (1.33e-1)" "unprognostic (6.81e-3)" "unprognostic (4.54e-2)" "unprognostic (2.58e-1)" "unprognostic (3.22e-1)" "unprognostic (2.62e-3)" 18.7 11.3 13.1 12.1 11.5 49.9 18.6 13.3 15.4 9.9 11.9 11.1 5.6 8.9 14.0 10.4 12.8 9.7 9.3 10.8 14.1 13.6 10.3 11.0 16.8 16.6 14.6 13.9 12.1 12.1 8.4 9.9 11.6 13.1 8.8 10.8 8.5 10.5 8.5 13.5 11.8 9.5 12.3 18.7 11.2 9.7 13.7 11.7 18.4 10.1 11.8 13.0 10.8 14.0 10.3 7.2 7.5 13.5 4.4 8.7 4.3 11.4 6.1 11.2 7.2 5.6 6.4 10.9 11.7 7.0 11.0 9.3 12.4 7.3 7.4 5.7 6.4 10.7 19.3 11.9 7.5 11.1 9.6 6.9 10.1 10.7 9.6 8.1 17.7 9.3 5.5 5.7 8.8 9.1 5.7 11.1 9.9 17.6 9.1 10.7 7.2 13.0 14.3 9.8 16.1 8.0 14.7 13.7 9.6 7.0 8.3 9.1 7.6 11.7 11.3 6.9 8.5 11.3 13.2 8.7 17.0 12.4 26.2 21.7 13.9 39.0 22.2 10.6 19.5 12.9 7.3 7.7 7.5 8.4 9.0 8.3 10.3 8.3 6.0 6.5 8.9 6.1 8.3 3.8 4.4 13.5 7.2 8.7 4.3 13.1 11.5 13.3 15.4 14.1 13.6 14.6 13.9 13.1 11.7 11.9 15.6 14.6 18.4 12.0 7.6 4.0 7.6 21.4 11.4 3.5 15.7 11.4 3.3 13.3 21.6 11.3 6.5 0.0 14.3 22.8 9.4 20.3 23.2 7.3 19.4 15.9 16.6 10.4 15.8 5.3 10.3 19.4 1.7 21.6 9.7 6.1 15.3 8.6 10.6 11.0 15.2 19.4 11.2 23.2 8.5 13.4 11.2 15.3 9.0 16.0 HBZ "HBZ-T1, HBZ1" ENSG00000130656 "Hemoglobin subunit zeta" P02008 16 152687-154503 "Predicted intracellular proteins" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 8.9;placenta: 5.0;testis: 9.9" "Group enriched" "Detected in some" 4 "Hofbauer cells: 144.1;Late spermatids: 212.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 79 "K-562: 227.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA063268, HPA064073, HPA071726" Approved Approved Nucleoplasm,Cytosol NA NA 160000000 Cytosol Nucleoplasm "HPA063268: , HPA064073: , HPA071726: AB_2732184" "unprognostic (3.56e-1)" "unprognostic (1.32e-1)" 0.8 0.0 0.8 0.1 0.5 8.9 0.6 0.6 0.6 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 1.6 3.3 0.7 0.3 0.1 1.1 0.6 0.1 1.1 0.1 0.7 0.1 0.0 0.1 5.0 0.1 1.2 0.0 0.1 0.1 0.1 0.9 0.5 0.1 0.1 0.1 0.8 0.1 9.9 0.1 0.1 0.1 0.1 0.1 0.1 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 227.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.5 0.6 0.6 0.7 0.3 1.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 41.3 0.7 0.0 23.3 0.0 16.4 1.4 0.0 0.0 0.0 144.1 0.0 0.0 0.0 0.0 212.4 0.6 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.4 0.0 0.7 6.5 2.0 1.1 0.9 0.1 8.7 0.0 0.0 0.0 HCFC1 "CFF, HCF-1, HCF1, HFC1, MGC70925, MRX3, PPP1R89, VCAF" ENSG00000172534 "Host cell factor C1" P51610 X 153947553-153971807 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Host-virus interaction" "Chromatin regulator" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018312, HPA078588" Supported Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA018312: AB_1850522, HPA078588: " "unprognostic (2.05e-3)" "unprognostic (2.92e-2)" "unprognostic (1.15e-1)" "unprognostic (1.06e-1)" "unprognostic (2.64e-1)" "unprognostic (5.13e-2)" "prognostic unfavorable (4.31e-6)" "unprognostic (1.35e-2)" "unprognostic (1.60e-1)" "unprognostic (1.74e-1)" "prognostic favorable (9.62e-5)" "unprognostic (1.45e-1)" "unprognostic (1.29e-3)" "unprognostic (1.99e-2)" "unprognostic (2.12e-1)" "unprognostic (1.73e-2)" "unprognostic (2.80e-1)" 16.0 19.2 18.2 23.7 18.5 48.3 14.2 24.4 23.3 13.9 20.0 17.3 14.1 16.8 26.3 13.6 18.2 18.8 20.8 14.7 17.0 12.7 15.6 17.2 19.0 24.9 14.6 16.1 20.4 15.6 21.9 26.4 13.8 15.8 17.7 11.2 13.8 21.5 20.6 27.8 18.2 18.3 19.7 20.0 25.2 18.0 15.3 17.9 52.3 16.4 15.6 17.6 17.4 18.3 4.8 8.0 1.7 5.6 2.8 6.7 3.5 15.4 20.1 13.7 17.3 5.7 4.1 20.1 6.3 4.9 7.5 6.9 21.2 10.4 28.1 16.3 8.2 12.4 12.7 14.7 10.4 3.9 14.8 17.3 16.8 16.0 16.6 3.9 20.6 27.9 6.4 6.8 13.1 5.7 4.5 8.0 20.5 23.3 17.8 5.3 21.6 28.5 26.7 17.7 10.1 12.4 33.3 11.3 16.9 5.7 14.4 15.2 16.5 11.7 12.2 6.5 6.9 11.2 18.6 10.5 14.4 17.8 12.4 20.4 28.3 38.7 35.2 11.7 20.1 13.6 1.7 4.0 1.7 6.0 5.6 4.3 4.8 4.8 4.6 4.5 4.4 4.9 6.7 0.8 2.8 4.0 8.0 3.2 3.5 18.2 18.5 24.4 23.3 17.0 12.7 14.6 16.1 15.8 17.9 17.9 19.1 10.4 11.5 14.7 17.2 34.6 17.8 4.0 9.1 12.2 13.7 13.4 3.3 15.2 0.4 15.8 11.7 0.0 14.1 18.9 12.9 17.4 3.5 23.1 18.5 19.1 18.4 19.0 30.2 1.3 16.1 12.5 5.0 16.2 20.4 15.0 16.1 7.0 20.5 8.6 11.5 6.5 13.7 6.5 25.1 12.2 13.3 17.5 20.9 13.1 HCFC1R1 "FLJ20568, HPIP" ENSG00000103145 "Host cell factor C1 regulator 1" Q9NWW0 16 3022620-3024286 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 204.8" "Cell type enhanced" "Detected in many" 4 "Proximal tubular cells: 247.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 84.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059647 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA059647: AB_2684094" "unprognostic (2.24e-2)" "unprognostic (8.13e-2)" "unprognostic (9.85e-3)" "unprognostic (6.03e-2)" "unprognostic (3.91e-1)" "unprognostic (2.72e-1)" "unprognostic (1.61e-2)" "unprognostic (2.12e-1)" "unprognostic (3.43e-3)" "unprognostic (2.23e-1)" "unprognostic (2.96e-2)" "unprognostic (1.17e-1)" "unprognostic (1.30e-3)" "unprognostic (4.89e-2)" "unprognostic (1.49e-1)" "unprognostic (2.02e-1)" "unprognostic (1.23e-1)" 19.7 28.9 49.3 10.2 61.0 7.8 23.9 25.4 37.5 30.4 17.5 13.5 17.7 14.3 20.5 18.4 20.7 19.4 28.0 27.8 37.2 38.6 24.9 11.1 19.1 10.6 40.9 23.9 24.3 10.4 19.9 19.5 16.5 23.0 22.8 10.0 11.5 15.1 42.4 204.8 25.0 13.9 28.7 23.2 9.1 11.2 11.4 14.7 7.5 13.5 37.0 9.1 24.7 17.2 14.1 26.2 8.4 21.6 13.7 20.2 9.6 12.4 32.9 6.6 8.0 27.1 35.7 6.3 3.9 24.9 12.3 33.8 6.9 15.0 8.7 13.5 23.3 10.7 16.4 6.6 24.2 5.7 11.9 15.6 3.8 26.2 11.5 22.2 6.3 7.5 44.1 15.7 12.8 14.0 84.8 17.1 6.6 5.2 17.4 13.7 11.2 3.8 9.9 14.4 7.2 6.9 13.7 5.9 24.3 43.8 2.5 11.4 9.6 9.6 15.4 15.5 16.8 10.2 5.8 4.9 20.3 56.9 17.2 10.6 10.6 10.3 7.6 8.6 3.9 4.6 2.7 21.6 8.4 12.3 15.5 11.6 14.1 15.9 13.3 26.2 13.5 11.8 14.2 4.5 13.7 13.5 13.0 20.2 9.6 49.3 61.0 25.4 37.5 37.2 38.6 40.9 23.9 23.0 14.7 53.6 12.9 28.9 60.6 75.9 26.6 39.3 50.9 16.0 18.2 188.5 5.9 91.7 203.9 41.6 3.8 35.9 68.0 0.0 23.5 101.8 139.4 33.1 39.3 41.9 104.8 19.1 42.0 61.4 66.0 10.1 89.2 41.2 60.8 50.5 33.1 31.3 26.9 48.9 167.6 247.7 19.7 122.9 137.0 14.0 37.3 57.5 45.1 20.8 42.9 31.5 HCFC2 HCF-2 ENSG00000111727 "Host cell factor C2" Q9Y5Z7 12 104064457-104106524 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 190.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006227 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA006227: AB_1079042" "unprognostic (4.22e-3)" "unprognostic (1.22e-1)" "unprognostic (1.08e-1)" "unprognostic (7.66e-2)" "unprognostic (3.15e-2)" "unprognostic (2.11e-2)" "unprognostic (1.46e-1)" "unprognostic (1.07e-2)" "unprognostic (1.59e-1)" "unprognostic (1.43e-2)" "unprognostic (2.71e-2)" "unprognostic (4.54e-2)" "unprognostic (4.23e-3)" "unprognostic (1.16e-2)" "unprognostic (2.24e-1)" "unprognostic (1.19e-2)" "unprognostic (7.23e-2)" 11.5 10.0 11.9 4.7 13.2 3.2 12.9 3.8 11.1 11.5 14.4 9.1 8.7 7.2 12.6 7.5 9.1 8.5 8.1 7.7 9.3 5.8 8.5 10.2 9.1 5.9 12.5 8.1 11.8 9.1 10.4 14.3 10.6 10.0 10.8 6.3 6.8 8.0 14.6 17.5 7.4 7.5 19.0 10.2 6.8 9.9 19.2 11.0 9.1 10.1 5.1 5.0 12.8 10.3 1.8 2.2 2.8 5.0 2.5 3.2 1.7 1.9 2.1 2.2 1.9 12.4 12.4 1.6 8.5 3.9 6.6 3.8 1.0 0.9 1.9 3.0 6.6 2.4 2.1 2.7 1.5 7.1 3.2 2.6 1.9 2.0 0.9 8.4 1.6 3.1 7.7 4.2 4.1 3.4 9.5 5.0 3.0 2.2 4.1 11.7 1.7 2.8 3.7 0.4 1.2 4.4 2.3 7.3 1.2 2.9 1.3 3.2 2.4 4.2 3.0 3.2 1.6 4.8 1.7 7.5 10.4 1.4 5.3 2.9 5.2 1.5 1.7 4.9 2.1 4.1 1.3 2.0 2.8 2.6 3.7 3.1 1.6 2.5 3.2 2.2 1.8 3.0 3.2 0.5 2.5 5.0 1.2 2.8 1.7 11.9 13.2 3.8 11.1 9.3 5.8 12.5 8.1 10.0 11.0 11.9 16.0 8.4 6.6 7.1 18.4 9.6 0.0 10.7 11.4 5.2 19.6 4.3 8.3 4.8 190.7 11.3 6.9 0.0 2.9 3.5 9.5 3.2 16.2 9.0 6.3 22.3 8.1 15.4 9.4 44.6 20.1 6.9 6.8 4.6 3.3 13.8 2.7 3.2 26.2 7.0 22.6 12.9 10.3 57.9 10.2 6.4 9.0 9.6 3.3 3.1 HDAC1 "GON-10, HD1, RPD3L1" ENSG00000116478 "Histone deacetylase 1" Q13547 1 32292086-32333635 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005017, HPA029693, CAB068191" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB005017: AB_2248344, CAB068191: AB_2665664, HPA029693: AB_10601659" "unprognostic (2.51e-2)" "unprognostic (9.10e-2)" "unprognostic (2.92e-1)" "unprognostic (2.98e-1)" "unprognostic (9.15e-2)" "unprognostic (3.57e-3)" "prognostic unfavorable (5.76e-7)" "unprognostic (9.57e-2)" "unprognostic (5.02e-2)" "unprognostic (3.47e-2)" "unprognostic (7.06e-2)" "unprognostic (4.44e-2)" "prognostic unfavorable (1.04e-5)" "unprognostic (6.86e-2)" "unprognostic (3.78e-1)" "unprognostic (7.16e-2)" "unprognostic (1.72e-1)" 13.8 22.8 12.8 33.5 14.8 15.0 21.1 5.1 13.0 21.9 35.7 16.0 34.8 22.2 24.6 17.5 40.6 21.0 43.8 12.4 12.5 8.5 21.1 21.5 17.2 33.3 14.7 8.6 27.7 20.5 17.2 27.1 24.4 12.2 25.2 33.9 18.0 27.8 31.3 6.6 16.9 32.7 22.1 13.3 32.6 27.8 20.0 16.7 59.4 36.8 21.2 51.1 26.0 25.1 47.7 32.1 59.8 44.6 42.4 49.2 54.7 29.4 18.0 11.6 23.0 6.8 8.1 24.1 20.9 23.4 28.0 25.9 32.9 53.1 45.4 38.8 23.0 28.5 34.4 35.5 28.4 31.1 42.4 35.3 31.3 21.6 25.2 16.0 55.4 45.4 14.6 15.6 21.7 14.4 22.0 21.2 59.5 41.0 18.1 12.3 22.4 63.1 31.2 26.8 35.2 46.1 43.6 27.5 20.2 30.3 42.6 9.1 11.5 34.8 23.5 43.8 47.7 27.7 43.1 24.5 18.7 21.9 5.7 50.8 11.0 23.7 62.3 15.4 46.0 24.2 37.0 27.7 59.8 43.2 35.5 35.4 47.7 42.4 46.1 32.1 44.3 49.2 45.7 19.9 42.4 44.6 20.1 42.5 54.7 12.8 14.8 5.1 13.0 12.5 8.5 14.7 8.6 12.2 16.7 23.8 38.4 50.1 48.1 22.0 15.5 18.2 56.0 80.3 48.9 64.6 15.7 81.3 81.2 57.2 10.0 40.9 97.1 0.0 65.1 93.0 21.5 29.1 29.0 28.2 38.0 11.1 82.9 63.8 40.8 5.9 38.0 31.0 27.0 42.3 101.3 32.1 65.7 108.7 41.8 25.9 13.9 58.2 37.7 45.1 76.2 22.2 78.1 50.7 115.8 49.8 HDAC2 "RPD3, YAF1" ENSG00000196591 "Histone deacetylase 2" Q92769 6 113933028-114011308 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005054, HPA011727" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB005054: AB_562295, HPA011727: AB_1850540" "prognostic unfavorable (7.07e-4)" "unprognostic (1.44e-1)" "unprognostic (2.67e-1)" "unprognostic (2.56e-2)" "unprognostic (2.61e-2)" "unprognostic (1.89e-2)" "prognostic unfavorable (5.39e-10)" "unprognostic (2.03e-1)" "unprognostic (2.63e-2)" "unprognostic (9.00e-2)" "unprognostic (2.01e-1)" "unprognostic (3.92e-1)" "unprognostic (1.84e-2)" "unprognostic (1.96e-1)" "unprognostic (2.42e-1)" "unprognostic (9.80e-2)" "unprognostic (3.51e-1)" 25.8 33.8 25.8 30.1 31.3 34.9 58.7 32.8 36.5 32.1 30.7 25.6 32.2 22.0 38.7 36.7 36.3 32.7 23.3 27.6 26.5 26.9 31.6 22.2 29.9 41.5 29.6 26.5 39.2 31.5 31.7 45.1 38.1 27.9 32.1 36.1 17.5 29.3 39.0 33.9 30.8 26.1 36.1 31.1 30.7 29.9 47.4 27.4 64.0 35.1 31.3 32.5 33.1 47.3 27.0 35.7 28.2 32.6 26.3 32.6 24.3 24.6 17.0 79.6 45.7 20.5 23.5 33.3 29.5 24.1 34.8 41.7 45.1 18.2 20.4 24.6 26.5 35.8 19.4 54.0 29.8 58.7 29.0 37.3 49.1 22.1 26.0 27.4 49.8 22.2 18.9 20.1 37.0 34.8 34.1 40.5 36.1 63.1 20.7 57.6 20.7 44.6 45.1 45.0 26.4 23.5 30.3 39.7 18.7 35.9 29.8 53.3 45.2 23.3 22.0 24.5 50.0 16.0 58.1 32.7 22.2 25.5 23.2 48.8 16.5 21.7 48.8 18.8 48.0 37.6 23.1 27.6 28.2 21.1 26.6 28.1 27.0 25.9 22.7 35.7 22.3 32.6 29.7 16.3 26.3 32.6 30.9 24.5 24.3 25.8 31.3 32.8 36.5 26.5 26.9 29.6 26.5 27.9 27.4 53.6 49.8 31.2 71.8 170.6 26.7 56.1 33.1 81.7 79.6 50.6 3.9 139.9 36.5 140.8 72.3 70.5 33.4 140.2 91.3 114.1 97.6 61.7 53.2 30.8 91.5 14.3 96.4 47.9 63.7 84.2 76.8 67.2 79.2 128.0 68.7 30.1 115.2 49.1 63.3 52.8 23.5 38.8 84.5 123.0 166.8 168.8 173.7 50.7 90.3 79.6 HDAC3 "HD3, RPD3, RPD3-2" ENSG00000171720 "Histone deacetylase 3" O15379 5 141620876-141636870 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005583, HPA052052, CAB072336" Supported Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "CAB005583: AB_562296, CAB072336: , HPA052052: AB_2681708" "unprognostic (6.65e-2)" "unprognostic (1.96e-1)" "prognostic favorable (3.39e-4)" "unprognostic (1.17e-1)" "unprognostic (1.24e-1)" "unprognostic (1.07e-1)" "unprognostic (1.19e-2)" "unprognostic (3.16e-1)" "unprognostic (5.56e-2)" "unprognostic (2.45e-2)" "prognostic favorable (3.95e-4)" "unprognostic (1.12e-1)" "prognostic unfavorable (2.65e-6)" "unprognostic (1.85e-1)" "unprognostic (1.63e-2)" "unprognostic (2.28e-3)" "unprognostic (2.17e-1)" 15.9 28.8 19.6 12.2 17.6 18.1 18.6 22.6 20.8 15.6 14.1 11.2 13.1 10.6 17.3 17.6 22.8 16.3 14.0 16.8 18.0 8.9 14.5 23.3 24.4 36.4 13.4 14.2 17.3 24.7 20.9 17.3 14.3 18.8 13.6 14.4 13.6 17.5 13.7 24.5 26.7 15.2 17.2 10.8 20.1 15.5 11.9 12.6 18.5 14.4 9.6 23.7 17.5 17.0 22.1 46.7 16.4 22.6 14.1 23.1 16.9 21.3 14.5 27.0 40.9 26.1 20.8 17.5 15.6 34.3 35.4 50.8 31.0 18.3 31.1 20.2 20.2 25.2 18.6 27.1 36.5 43.9 26.5 29.1 24.3 13.3 17.6 18.4 29.2 22.3 17.7 23.5 20.5 26.8 18.4 22.8 28.1 23.7 16.6 22.3 20.2 32.4 25.3 23.8 13.3 11.5 23.5 28.2 22.4 18.9 21.5 22.6 18.3 20.6 21.4 25.7 17.9 22.8 18.5 11.5 22.0 13.8 16.8 25.5 13.5 16.6 29.3 18.5 27.8 18.8 13.2 22.4 16.4 15.9 22.6 20.8 22.1 19.8 19.2 46.7 20.1 21.7 18.0 9.5 14.1 19.0 23.9 23.1 16.9 19.6 17.6 22.6 20.8 18.0 8.9 13.4 14.2 18.8 12.6 8.9 10.4 32.3 23.0 39.3 30.6 12.3 15.3 5.3 11.4 12.2 56.9 47.2 18.3 28.5 7.6 20.2 15.4 0.0 31.4 44.3 29.3 18.8 18.4 14.8 34.9 47.7 17.2 20.9 15.4 3.4 20.8 33.0 30.4 66.7 17.7 27.7 27.2 14.0 20.8 15.7 30.4 25.8 24.0 22.3 24.5 44.9 51.1 31.9 22.7 26.5 HDAC4 "BDMR, HA6116, HD4, HDAC-4, HDAC-A, HDACA, KIAA0288" ENSG00000068024 "Histone deacetylase 4" P56524 2 239048168-239401654 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "Autism spectrum disorder, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 54.6" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 73.9;Late spermatids: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 10.5;classical monocyte: 7.4;neutrophil: 28.3" "Group enriched" "Detected in many" 8 "granulocytes: 28.3;monocytes: 7.4" "Cell line enhanced" "Detected in many" "JURKAT: 30.4;MOLT-4: 28.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048723, HPA071448" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nuclear speckles" "Nucleoplasm, Cytosol" "HPA048723: AB_2680501, HPA071448: " "unprognostic (1.54e-1)" "unprognostic (1.76e-2)" "unprognostic (1.33e-1)" "unprognostic (1.18e-3)" "unprognostic (2.43e-2)" "unprognostic (2.39e-3)" "unprognostic (3.06e-4)" "unprognostic (1.00e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (6.33e-4)" "prognostic favorable (1.13e-4)" "unprognostic (1.40e-1)" "unprognostic (4.82e-3)" "unprognostic (2.40e-1)" "unprognostic (3.26e-2)" "unprognostic (1.32e-2)" "unprognostic (6.04e-2)" 7.9 6.8 6.1 6.8 5.2 17.1 4.6 6.4 12.3 11.3 21.4 4.6 4.3 2.5 10.2 6.4 8.8 9.0 24.6 5.2 5.0 6.0 3.2 3.1 4.2 4.3 6.1 5.4 8.5 5.8 4.9 8.3 2.5 5.2 7.5 4.8 8.3 3.7 7.3 54.6 6.9 6.5 15.8 4.2 5.4 7.0 8.1 4.3 6.5 4.8 13.2 5.6 10.2 4.6 0.5 1.7 28.3 7.4 2.1 1.2 0.4 3.8 3.8 4.9 5.9 2.8 4.7 5.8 4.0 2.7 3.2 3.1 1.7 7.0 1.8 1.6 3.4 4.6 3.8 3.4 1.6 1.6 10.6 1.8 2.8 4.7 5.6 3.7 4.3 2.6 3.2 4.1 5.9 4.7 1.6 3.4 30.4 4.0 4.1 1.5 4.7 28.1 5.9 3.8 4.8 2.0 7.3 9.2 2.8 3.7 4.9 3.9 6.9 5.6 2.5 9.8 2.9 1.3 11.9 5.4 3.7 0.3 6.4 5.4 2.9 2.7 3.5 5.4 6.0 7.4 10.5 7.4 1.1 0.9 2.4 1.1 0.5 0.9 0.8 0.8 0.5 0.5 1.0 28.3 2.1 1.0 1.7 1.2 0.4 6.1 5.2 6.4 7.5 5.0 6.0 6.1 5.4 5.2 4.3 3.0 9.0 3.7 2.2 7.0 11.5 10.1 7.6 0.0 3.4 10.4 2.0 1.2 0.0 2.4 73.9 5.8 4.5 0.0 1.8 1.5 8.0 5.0 2.3 5.8 2.9 15.9 5.8 13.5 22.7 47.3 10.9 5.5 5.0 0.0 5.5 10.1 1.7 0.0 11.7 1.2 7.1 0.0 5.6 2.2 2.1 8.4 1.1 8.7 5.7 2.2 HDAC6 "FLJ16239, HD6, JM21, KIAA0901, PPP1R90" ENSG00000094631 "Histone deacetylase 6" Q9UBN7 X 48801377-48824982 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Autophagy, Transcription, Transcription regulation" "Actin-binding, Chromatin regulator, Hydrolase, Repressor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003714, CAB004236, HPA026321" Supported Supported Nucleoplasm NA NA 39000 Nucleoplasm "CAB004236: AB_627708, HPA003714: AB_1850544, HPA026321: AB_1850546" "unprognostic (9.53e-2)" "unprognostic (1.59e-1)" "unprognostic (2.66e-2)" "unprognostic (2.42e-2)" "unprognostic (2.82e-2)" "unprognostic (4.11e-3)" "unprognostic (2.17e-2)" "unprognostic (1.16e-1)" "unprognostic (7.68e-2)" "unprognostic (2.83e-1)" "unprognostic (1.16e-3)" "unprognostic (2.33e-2)" "unprognostic (6.10e-2)" "unprognostic (1.47e-1)" "unprognostic (6.60e-2)" "unprognostic (2.34e-1)" "prognostic favorable (3.34e-4)" 14.6 13.7 23.4 12.8 29.8 19.0 14.4 34.2 30.1 12.7 14.1 24.4 14.9 16.9 16.0 14.7 13.1 15.7 11.7 11.9 21.7 24.8 32.8 43.3 15.1 13.9 27.2 22.4 18.7 15.5 26.7 24.4 15.1 27.0 12.3 15.9 15.1 12.2 15.3 18.2 11.3 16.1 15.0 20.9 15.3 14.2 24.7 22.4 19.0 15.7 9.5 14.0 11.7 12.1 5.7 9.7 6.3 12.4 4.0 5.8 5.0 15.1 12.9 25.3 9.6 10.2 9.3 17.1 7.2 6.2 14.0 13.8 12.4 13.0 14.6 7.0 8.2 17.9 10.8 15.3 7.7 12.1 13.6 9.7 20.0 15.4 12.7 9.6 9.2 31.0 13.5 12.6 10.9 13.2 12.5 11.6 18.5 21.9 16.2 8.8 5.3 13.0 14.4 9.4 6.9 12.3 11.2 27.2 15.0 8.0 6.6 13.0 12.8 14.6 4.4 8.7 34.3 18.3 8.6 9.4 10.9 14.1 14.9 6.9 14.9 14.8 10.6 11.1 11.9 10.8 0.0 5.8 6.3 5.8 9.7 4.1 4.3 4.0 4.2 8.6 5.7 3.9 3.7 2.9 4.0 12.4 9.7 4.4 5.0 23.4 29.8 34.2 30.1 21.7 24.8 27.2 22.4 27.0 22.4 17.9 30.9 11.7 10.4 6.6 37.4 9.5 12.7 9.4 20.5 17.4 47.1 9.6 16.6 6.3 37.4 7.7 17.6 0.0 6.4 10.4 8.4 7.6 5.8 45.7 9.7 38.1 13.8 11.6 10.0 14.2 13.0 9.2 5.0 15.4 11.6 26.8 6.8 11.5 10.6 39.4 33.8 12.9 8.0 31.5 13.0 5.1 8.1 6.7 13.6 6.4 HDAC8 "HDACL1, MRXS6, RPD3, WTS" ENSG00000147099 "Histone deacetylase 8" Q9BY41 X 72329516-72573103 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "Disease mutation, FDA approved drug targets, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048560 Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA048560: AB_2680442" "unprognostic (1.42e-1)" "unprognostic (6.62e-3)" "unprognostic (3.20e-2)" "unprognostic (9.24e-3)" "unprognostic (1.10e-1)" "unprognostic (1.10e-1)" "unprognostic (4.64e-2)" "unprognostic (6.03e-2)" "unprognostic (1.58e-1)" "unprognostic (2.81e-2)" "unprognostic (3.17e-2)" "unprognostic (9.68e-2)" "unprognostic (8.42e-2)" "unprognostic (2.33e-3)" "unprognostic (9.10e-2)" "unprognostic (7.15e-3)" "unprognostic (2.12e-3)" 9.6 22.5 14.7 9.9 16.2 10.2 12.4 31.4 20.6 12.6 10.4 13.9 11.5 8.6 12.3 28.2 11.0 9.4 9.4 12.6 15.0 15.2 16.8 18.6 10.2 9.6 14.9 9.4 12.8 15.9 13.6 22.0 11.2 19.3 13.3 12.8 14.3 12.2 10.3 10.4 9.3 8.4 13.1 12.2 9.5 10.7 3.6 14.0 8.0 15.0 8.2 11.9 10.4 10.1 9.4 12.8 19.7 13.2 7.7 11.4 7.7 12.5 17.1 12.6 17.4 17.3 12.9 8.7 7.3 14.1 11.2 12.7 12.4 12.9 8.7 23.0 10.0 17.5 9.2 23.5 14.2 14.9 14.3 16.7 11.5 22.0 14.4 9.5 19.1 20.4 13.5 10.4 13.7 10.3 15.9 17.2 11.7 12.8 24.4 14.9 15.8 8.9 25.1 17.5 19.3 24.8 12.2 16.2 15.6 19.5 13.2 9.0 19.7 17.1 13.7 17.5 16.4 6.9 16.3 12.9 9.2 13.3 13.2 8.1 9.4 15.0 11.1 12.5 21.1 11.9 7.2 13.2 19.7 8.8 11.8 6.9 9.4 9.5 7.3 12.8 9.1 7.6 7.1 0.7 7.7 10.5 4.8 11.4 7.7 14.7 16.2 31.4 20.6 15.0 15.2 14.9 9.4 19.3 14.0 3.0 18.8 8.1 10.0 5.5 16.0 10.8 12.7 13.4 10.3 7.0 41.2 14.3 8.3 11.9 0.5 10.5 8.1 0.0 10.7 11.6 8.6 13.3 11.5 9.7 13.8 22.3 8.7 11.6 7.8 1.3 10.9 10.6 6.8 6.4 9.1 10.8 10.1 2.9 9.9 17.8 16.8 25.8 9.5 5.1 0.7 5.5 11.3 11.4 9.7 10.9 HDAC9 "HD7, HDAC, HDAC7B, KIAA0744, MITR" ENSG00000048052 "Histone deacetylase 9" Q9UKV0 7 18086949-19002416 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 197.2;Late spermatids: 49.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 29.5" "Group enriched" "Detected in many" 9 "B-cells: 21.8;dendritic cells: 29.5;monocytes: 9.7" "Cell line enhanced" "Detected in many" "HAP1: 55.1;hTERT-HME1: 26.4;SH-SY5Y: 22.0;U-698: 21.8;WM-115: 22.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028926 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA028926: AB_10602327" "unprognostic (2.06e-2)" "unprognostic (2.67e-1)" "unprognostic (2.30e-1)" "unprognostic (1.17e-1)" "unprognostic (2.74e-1)" "unprognostic (5.54e-2)" "unprognostic (2.20e-2)" "unprognostic (2.32e-1)" "unprognostic (2.21e-1)" "unprognostic (2.45e-1)" "unprognostic (5.01e-1)" "unprognostic (7.58e-2)" "unprognostic (1.29e-1)" "unprognostic (3.94e-2)" "unprognostic (1.32e-1)" "unprognostic (1.02e-1)" "unprognostic (6.87e-3)" 10.7 13.5 12.6 10.7 16.2 5.9 8.4 19.1 16.9 11.6 7.4 11.3 7.5 3.8 17.8 6.7 4.7 10.5 7.5 14.9 13.1 12.0 3.9 3.1 5.7 18.9 13.9 14.9 3.0 2.7 3.0 17.7 6.8 11.2 12.5 6.2 9.7 6.9 16.5 15.5 3.8 8.4 14.4 17.6 17.4 9.1 8.7 18.2 2.9 5.5 5.4 19.3 7.1 9.6 21.8 29.5 0.5 9.7 2.0 2.1 4.5 12.5 0.0 2.1 0.0 0.3 2.8 0.0 0.7 7.4 3.1 5.3 0.1 4.1 5.4 13.9 8.3 17.1 1.9 55.1 1.0 8.1 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 1.0 1.0 9.8 26.4 2.7 0.1 0.8 0.0 8.4 4.3 0.0 0.5 1.1 6.7 0.0 1.2 1.5 0.8 3.1 1.7 3.3 3.9 22.0 0.1 0.1 4.0 3.3 0.2 4.9 0.5 11.4 3.6 0.6 7.1 9.7 4.1 21.8 3.0 0.5 22.5 0.1 9.7 0.0 1.7 6.7 1.7 21.8 0.6 0.8 29.5 16.3 0.0 0.9 0.5 2.0 3.8 6.4 2.1 4.5 12.6 16.2 19.1 16.9 13.1 12.0 13.9 14.9 11.2 18.2 6.0 3.2 26.4 0.4 2.2 32.0 12.1 0.0 1.4 4.5 0.0 15.7 0.1 3.3 6.6 197.2 11.1 0.0 0.0 0.6 0.1 5.7 1.4 1.1 0.8 10.5 19.1 6.9 13.5 45.7 49.8 1.4 31.1 15.1 0.0 0.4 5.0 7.0 0.2 0.7 0.0 27.3 6.5 6.9 10.3 8.8 1.8 0.1 8.7 0.0 2.0 HDDC2 "C6orf74, CGI-130, dJ167O5.2" ENSG00000111906 "HD domain containing 2" Q7Z4H3 6 125219962-125302078 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Distal tubular cells: 286.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035677 Approved Approved Nucleoplasm,Nucleoli NA NA 19000 Nucleoli Nucleoplasm "HPA035677: AB_10603768" "unprognostic (8.34e-2)" "unprognostic (5.41e-2)" "unprognostic (6.52e-2)" "unprognostic (6.25e-2)" "unprognostic (2.78e-2)" "unprognostic (6.39e-3)" "unprognostic (1.04e-3)" "unprognostic (1.76e-1)" "unprognostic (2.18e-1)" "unprognostic (2.38e-2)" "unprognostic (8.59e-3)" "unprognostic (5.13e-2)" "unprognostic (4.56e-2)" "unprognostic (2.54e-1)" "unprognostic (3.68e-2)" "unprognostic (1.80e-2)" "unprognostic (9.54e-2)" 17.5 29.8 50.5 12.0 36.1 11.3 21.1 26.4 31.7 14.8 15.2 11.1 31.6 12.4 12.9 25.2 19.6 17.2 12.4 34.7 41.1 37.0 31.3 8.9 13.4 18.8 45.0 18.9 18.3 22.9 16.3 15.6 11.5 23.4 15.7 16.9 19.3 54.8 42.0 42.8 13.5 16.1 19.0 25.8 12.2 14.4 25.7 16.8 12.9 24.3 35.4 18.2 17.7 11.2 27.3 15.4 4.4 14.2 23.6 33.9 17.7 8.6 24.1 15.0 61.5 12.2 16.8 20.9 11.6 17.7 12.6 13.1 37.9 10.4 40.0 25.2 22.1 29.1 8.6 21.0 17.0 16.1 15.7 49.3 18.5 13.4 37.2 27.8 23.9 13.7 23.5 26.2 17.9 41.3 19.8 9.0 22.2 69.9 17.3 27.2 48.0 18.5 25.2 17.6 25.8 19.6 27.9 11.9 8.4 29.4 11.0 29.4 14.3 14.2 27.7 25.4 14.7 16.2 40.6 5.5 12.7 14.0 19.5 23.4 20.6 14.2 33.1 18.3 43.3 25.9 4.4 14.2 2.5 22.9 12.2 18.7 27.3 25.3 31.0 14.7 22.0 31.4 33.9 3.2 23.6 11.1 15.4 21.5 17.7 50.5 36.1 26.4 31.7 41.1 37.0 45.0 18.9 23.4 16.8 23.8 38.7 42.4 51.6 39.6 51.4 109.7 33.1 34.8 30.7 59.3 13.7 75.6 286.8 71.8 43.7 26.4 42.4 23.3 86.1 127.4 62.7 54.8 36.9 18.1 98.5 65.2 61.9 11.6 46.6 33.2 84.3 41.0 75.9 12.6 64.1 45.8 55.3 45.6 107.8 202.1 18.2 38.8 76.2 115.5 66.8 37.6 38.2 62.3 78.2 45.1 HDDC3 MGC45386 ENSG00000184508 "HD domain containing 3" Q8N4P3 15 90929964-90935196 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040895 Approved Approved Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA040895: AB_10795494" "unprognostic (1.03e-1)" "unprognostic (3.78e-2)" "unprognostic (1.32e-1)" "unprognostic (1.29e-2)" "unprognostic (1.10e-1)" "unprognostic (3.75e-2)" "unprognostic (2.53e-1)" "unprognostic (3.57e-1)" "unprognostic (1.28e-1)" "unprognostic (5.93e-3)" "unprognostic (1.08e-1)" "unprognostic (1.91e-2)" "unprognostic (3.43e-2)" "unprognostic (2.26e-1)" "unprognostic (4.86e-2)" "unprognostic (3.15e-1)" "unprognostic (4.65e-1)" 14.3 18.8 16.3 8.9 17.1 10.7 11.3 10.3 17.6 8.2 13.1 9.3 12.6 12.4 5.4 12.8 7.7 12.7 7.1 15.2 12.9 12.3 14.7 18.3 7.8 9.0 14.6 12.5 10.3 30.3 15.1 10.4 10.4 11.0 8.7 11.1 9.7 24.8 14.0 14.2 9.3 17.1 6.1 11.4 13.1 11.2 4.5 8.2 11.8 12.0 10.1 10.7 7.5 7.5 19.9 25.3 5.6 15.6 16.4 21.5 14.3 6.7 8.3 2.9 3.5 6.7 6.8 4.9 4.5 6.2 4.3 6.3 4.1 14.0 12.7 4.8 3.8 3.4 10.5 6.1 10.6 3.6 16.1 12.9 16.0 3.2 9.3 13.7 6.1 7.9 5.9 16.8 7.8 14.0 6.8 9.4 10.6 12.7 11.5 3.8 9.8 8.3 5.3 2.4 25.5 8.5 7.0 1.1 20.3 8.8 7.1 7.4 4.7 3.8 10.7 11.4 6.4 16.2 16.5 5.3 2.7 5.9 4.4 5.8 18.8 21.1 8.8 9.8 12.0 7.9 5.6 11.8 4.7 14.0 15.6 18.4 19.9 18.4 16.2 15.9 17.5 21.5 15.7 2.8 16.4 14.2 25.3 17.4 14.3 16.3 17.1 10.3 17.6 12.9 12.3 14.6 12.5 11.0 8.2 26.8 6.1 27.0 11.4 4.9 12.4 0.8 43.3 20.1 19.4 15.7 3.9 39.0 64.6 34.0 3.9 14.7 23.8 23.3 49.1 27.5 8.7 13.1 6.9 33.8 39.5 14.3 19.1 15.4 12.9 2.4 13.3 18.0 13.5 48.7 31.2 29.5 27.9 30.6 11.0 53.5 35.3 6.5 7.3 16.3 14.0 7.3 20.3 17.5 34.4 10.3 HDGF HMG1L2 ENSG00000143321 "Heparin binding growth factor" P51858 1 156742107-156766925 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Growth factor, Heparin-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026035, HPA048728, HPA053422" Enhanced Enhanced Nucleoplasm NA NA 300000 Nucleoplasm "CAB026035: , HPA048728: AB_2680503, HPA053422: AB_2682146" "unprognostic (2.80e-1)" "unprognostic (9.63e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (6.02e-4)" "unprognostic (9.06e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (2.43e-8)" "unprognostic (9.80e-3)" "unprognostic (2.34e-2)" "prognostic favorable (9.84e-4)" "unprognostic (2.45e-3)" "unprognostic (3.67e-2)" "unprognostic (1.40e-3)" "unprognostic (8.66e-3)" "unprognostic (2.14e-1)" "unprognostic (2.06e-1)" "unprognostic (3.86e-2)" 27.6 24.0 24.4 26.4 24.6 78.7 51.5 26.7 22.1 29.7 57.9 22.4 23.9 40.6 22.1 22.9 53.0 34.9 38.1 41.7 23.5 18.3 64.5 92.6 38.0 32.6 23.7 12.9 29.0 35.3 25.6 19.0 49.1 20.4 21.3 37.5 15.9 26.5 30.6 57.2 39.2 83.1 21.7 25.5 30.0 25.6 11.8 22.4 79.0 38.3 64.8 44.0 30.9 29.6 7.5 14.5 10.4 12.3 6.1 9.7 7.8 72.9 36.2 41.6 19.8 24.1 33.2 46.0 24.2 61.9 56.8 37.2 40.9 78.0 49.4 47.9 48.2 25.3 51.7 61.9 54.4 56.6 40.0 43.9 42.2 52.6 35.7 32.1 61.8 35.7 23.8 52.2 44.4 86.8 45.3 41.8 39.1 55.2 41.4 46.2 53.7 50.9 68.5 73.5 117.0 51.4 57.5 24.9 65.9 62.4 24.7 62.2 67.6 57.8 76.5 29.1 53.8 61.1 96.1 36.9 28.8 44.7 36.4 61.4 55.9 69.4 86.0 38.3 49.2 36.6 6.0 12.3 10.4 8.5 10.4 6.3 6.7 7.3 7.5 14.1 7.5 6.6 6.2 7.1 6.1 11.4 14.5 9.7 7.8 24.4 24.6 26.7 22.1 23.5 18.3 23.7 12.9 20.4 22.4 65.5 86.4 36.5 146.2 130.9 60.7 81.8 79.0 123.1 80.8 68.0 25.5 38.8 68.0 89.5 37.7 46.6 109.5 70.0 112.1 90.8 73.3 173.1 30.0 144.0 46.2 50.9 119.7 27.6 33.2 33.1 37.7 55.8 37.1 37.9 83.0 56.2 134.0 51.8 43.2 94.2 31.4 19.4 48.5 28.7 24.6 139.4 45.9 41.5 82.1 206.9 HDGFL2 "Hdgfrp2, HRP2" ENSG00000167674 "HDGF like 2" Q7Z4V5 19 4472287-4502211 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 49.1" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 31.1;Ductal cells: 22.5;Extravillous trophoblasts: 24.9;Hofbauer cells: 21.7;monocytes: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042559, HPA044208" Enhanced Supported Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA042559: AB_2678049, HPA044208: AB_2678858" "unprognostic (1.33e-1)" "unprognostic (2.38e-2)" "unprognostic (5.47e-3)" "unprognostic (6.57e-3)" "unprognostic (6.80e-2)" "unprognostic (1.96e-2)" "unprognostic (1.52e-2)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" "unprognostic (1.97e-1)" "prognostic favorable (6.57e-4)" "unprognostic (2.12e-2)" "unprognostic (1.36e-1)" "unprognostic (9.73e-3)" "unprognostic (4.75e-1)" "unprognostic (1.58e-1)" "unprognostic (2.05e-1)" 10.3 9.6 15.4 10.0 13.6 8.1 10.3 15.3 21.0 9.7 8.8 9.0 8.0 10.1 12.3 10.4 6.6 10.2 9.9 8.5 16.6 13.5 9.8 9.9 7.3 10.2 11.9 13.2 15.9 10.6 8.3 10.2 9.6 10.5 10.1 5.0 7.8 11.3 16.8 39.4 10.9 9.2 12.0 8.8 10.3 9.2 49.1 9.5 13.6 7.3 6.2 7.4 7.7 9.0 7.0 2.2 3.6 1.8 2.3 2.4 0.8 27.7 16.4 28.5 26.4 12.4 12.7 19.9 22.4 12.1 24.7 22.0 18.7 12.1 24.5 13.1 16.4 13.0 15.9 18.9 20.4 14.5 27.3 30.0 15.0 12.3 24.6 16.1 14.8 21.5 18.1 11.1 16.9 8.3 17.6 22.5 23.2 17.2 30.9 11.9 19.7 33.4 29.7 32.6 11.2 29.5 33.3 23.5 15.7 15.3 14.2 31.5 31.1 21.8 12.5 18.1 16.3 12.3 23.6 29.7 15.6 21.4 29.3 21.1 38.4 20.0 17.2 21.9 23.9 16.4 0.0 1.8 3.6 1.4 1.1 0.4 1.1 1.5 1.1 1.6 7.0 2.4 0.9 0.5 2.3 0.6 2.2 1.8 0.8 15.4 13.6 15.3 21.0 16.6 13.5 11.9 13.2 10.5 9.5 6.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 17.4 9.1 12.2 0.0 31.1 16.6 22.5 0.0 0.0 0.0 0.0 17.5 24.9 0.0 0.0 1.1 0.0 21.7 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 26.2 0.0 0.0 19.1 0.0 0.0 18.1 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 HDGFL3 "Hdgfrp3, HRP-3" ENSG00000166503 "HDGF like 3" Q9Y3E1 15 83112738-83208018 "Predicted intracellular proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 6 "Alveolar cells type 2: 16.2;Ciliated cells: 17.4;Club cells: 19.4;Collecting duct cells: 19.2;Ductal cells: 17.4;Exocrine glandular cells: 20.2;monocytes: 18.0;Pancreatic endocrine cells: 18.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 5.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040719 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA040719: AB_2677097" "unprognostic (1.28e-3)" "unprognostic (1.13e-1)" "unprognostic (3.52e-2)" "unprognostic (3.38e-2)" "unprognostic (1.53e-1)" "unprognostic (2.55e-2)" "unprognostic (1.91e-2)" "unprognostic (2.95e-2)" "unprognostic (2.99e-2)" "unprognostic (4.68e-2)" "unprognostic (1.93e-3)" "unprognostic (3.39e-2)" "unprognostic (1.73e-1)" "unprognostic (1.06e-2)" "unprognostic (3.55e-1)" "unprognostic (1.25e-1)" "unprognostic (1.85e-1)" 9.5 12.9 30.0 6.8 18.8 5.4 9.3 16.0 28.8 11.0 10.6 11.6 4.8 3.7 13.2 17.9 8.5 9.7 9.1 11.8 25.1 24.2 7.9 2.9 8.1 6.3 20.0 19.0 11.3 4.4 42.3 12.9 7.1 13.1 11.2 6.7 7.7 4.3 10.9 5.7 5.0 4.5 11.6 20.2 7.5 5.2 18.5 12.3 5.4 13.9 4.3 5.5 12.3 14.4 0.7 0.7 2.6 0.9 5.1 1.6 0.4 4.5 4.0 11.8 6.1 5.0 6.9 4.0 4.4 7.7 4.6 4.8 0.3 8.6 0.1 5.4 1.1 5.0 1.8 13.0 6.6 6.8 21.5 6.8 7.4 2.1 0.1 7.0 0.2 1.2 4.1 5.6 5.3 9.3 7.2 11.0 8.1 5.6 0.2 8.6 4.7 4.4 0.4 8.8 0.0 2.3 0.1 11.6 0.0 6.9 9.4 15.0 11.4 6.6 1.6 5.6 9.0 1.8 0.8 9.6 9.7 7.3 1.9 13.3 1.4 0.5 5.6 4.5 3.5 6.5 1.6 0.9 2.6 1.6 0.4 0.2 0.3 0.5 0.3 0.5 0.7 0.6 0.7 2.4 5.1 0.3 0.7 0.1 0.4 30.0 18.8 16.0 28.8 25.1 24.2 20.0 19.0 13.1 12.3 11.9 16.2 0.0 0.0 0.0 0.0 0.0 0.0 17.4 19.4 19.2 0.0 0.3 13.3 17.4 0.0 0.0 0.0 0.0 20.2 0.4 0.0 0.0 4.7 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 18.0 0.0 0.0 18.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 HEATR3 FLJ20718 ENSG00000155393 "HEAT repeat containing 3" Q7Z4Q2 16 50065941-50106387 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Kupffer cells: 25.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041990, HPA058579" Uncertain Enhanced Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA041990: AB_10793940, HPA058579: AB_2683762" "unprognostic (7.36e-3)" "unprognostic (2.72e-1)" "unprognostic (2.01e-3)" "unprognostic (1.97e-1)" "unprognostic (1.20e-1)" "unprognostic (4.80e-3)" "prognostic unfavorable (4.11e-5)" "unprognostic (7.68e-2)" "unprognostic (5.11e-2)" "unprognostic (8.79e-2)" "unprognostic (4.96e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (5.16e-6)" "unprognostic (2.26e-1)" "unprognostic (1.76e-1)" "unprognostic (1.86e-1)" "unprognostic (3.17e-2)" 14.7 13.6 8.8 17.8 16.1 10.1 9.3 19.5 14.0 10.2 11.5 12.4 11.1 10.1 9.2 10.3 13.0 8.5 9.4 9.9 9.4 9.6 10.7 20.7 10.5 14.6 10.9 8.1 7.1 19.2 14.8 13.3 12.1 8.7 8.4 13.8 7.8 12.4 7.8 19.6 13.3 10.9 11.3 10.5 21.6 11.4 15.6 11.1 14.5 6.4 10.7 12.9 9.2 8.0 2.4 4.2 2.2 7.0 2.0 2.9 2.2 10.8 11.1 10.3 16.3 6.4 8.6 11.1 13.2 8.8 13.3 5.3 13.6 8.3 20.5 9.6 12.6 5.0 13.0 12.4 9.9 15.5 5.2 13.3 10.1 7.8 17.2 9.2 17.5 20.6 6.7 6.8 9.4 5.7 5.8 10.7 10.9 12.8 3.6 13.0 6.7 13.4 22.0 12.1 13.2 11.6 14.9 14.0 16.6 7.4 8.9 13.4 7.1 12.8 16.6 8.3 8.3 7.5 12.8 13.9 10.7 7.2 8.2 10.1 8.7 6.9 18.4 10.6 17.7 10.5 1.3 6.2 1.4 2.6 7.0 2.8 1.6 1.6 2.9 4.2 2.4 2.3 2.4 2.2 2.0 6.1 3.7 2.6 2.2 8.8 16.1 19.5 14.0 9.4 9.6 10.9 8.1 8.7 11.1 3.0 4.3 2.7 0.7 2.9 7.2 5.2 5.1 2.7 1.2 1.8 15.7 3.0 6.6 2.2 9.3 3.6 3.8 0.0 2.6 2.9 2.6 1.9 1.1 6.7 8.3 1.6 3.4 2.5 25.3 13.3 3.1 7.0 1.7 3.6 3.3 1.9 2.6 2.9 2.1 3.4 7.3 0.0 2.1 4.8 4.5 1.5 0.8 4.4 4.9 1.4 HEBP1 "HBP, HEBP" ENSG00000013583 "Heme binding protein 1" Q9NRV9 12 12974864-13000273 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056417, HPA075277" Approved Approved Nucleoplasm,Vesicles NA NA 130000 Vesicles Nucleoplasm "HPA056417: AB_2683122, HPA075277: AB_2686741" "unprognostic (1.65e-1)" "unprognostic (2.31e-2)" "unprognostic (9.28e-2)" "unprognostic (5.67e-3)" "unprognostic (4.45e-3)" "unprognostic (5.42e-3)" "unprognostic (2.70e-1)" "unprognostic (2.44e-1)" "unprognostic (6.04e-2)" "unprognostic (3.50e-2)" "unprognostic (1.94e-3)" "unprognostic (6.19e-2)" "unprognostic (2.28e-3)" "unprognostic (5.71e-2)" "unprognostic (1.64e-1)" "unprognostic (4.02e-2)" "unprognostic (4.43e-2)" 23.4 36.0 12.3 7.6 21.1 16.0 24.5 7.7 14.0 17.7 46.8 18.0 20.0 79.8 14.2 13.9 13.9 13.6 25.4 18.3 11.8 11.7 20.4 48.5 16.2 11.2 16.7 8.0 27.8 27.6 13.3 9.0 13.9 17.2 17.8 7.6 20.0 18.2 16.4 12.8 19.1 79.1 22.9 22.2 19.3 13.4 11.2 15.1 5.5 52.8 13.9 8.7 18.2 23.9 5.3 21.4 9.0 27.4 7.1 9.4 9.9 17.0 10.3 7.2 12.6 54.4 42.4 4.9 15.5 22.1 14.9 19.9 6.5 6.2 5.0 6.2 30.3 12.7 15.5 8.9 12.3 17.3 0.7 7.3 2.8 12.3 16.5 39.1 4.9 2.7 32.6 11.7 19.7 24.5 46.1 30.4 6.0 3.1 4.3 25.2 10.6 4.0 8.1 10.0 16.6 7.3 9.3 20.5 5.1 12.0 16.4 4.0 3.6 20.6 9.6 19.2 21.8 5.0 7.4 33.2 11.0 13.3 17.3 8.0 4.0 3.2 1.8 17.5 9.0 4.4 4.6 27.4 6.8 4.3 19.8 6.0 4.9 7.3 4.7 21.4 5.3 9.4 5.4 9.0 7.1 26.5 10.7 4.1 9.9 12.3 21.1 7.7 14.0 11.8 11.7 16.7 8.0 17.2 15.1 50.6 17.6 17.9 45.0 33.3 5.0 24.6 79.0 4.0 6.8 54.1 3.9 30.7 84.6 74.8 15.7 52.4 88.1 46.7 88.6 23.2 57.2 40.0 1.1 121.3 73.3 6.4 19.5 141.2 67.3 5.6 82.6 41.0 59.1 62.3 33.8 30.7 71.9 44.1 88.4 72.5 5.8 51.8 41.2 13.8 7.4 31.6 22.0 21.8 48.4 46.5 HECTD1 KIAA1131 ENSG00000092148 "HECT domain E3 ubiquitin protein ligase 1" Q9ULT8 14 31100112-31207804 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Urothelial cells: 267.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002929, HPA054461" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA002929: AB_1850574, HPA054461: AB_2682496" "unprognostic (6.71e-2)" "unprognostic (4.86e-2)" "unprognostic (5.31e-2)" "unprognostic (1.25e-1)" "unprognostic (1.64e-1)" "unprognostic (6.99e-2)" "unprognostic (1.32e-1)" "unprognostic (7.03e-2)" "unprognostic (2.29e-2)" "unprognostic (3.13e-2)" "unprognostic (3.60e-3)" "unprognostic (1.51e-1)" "prognostic favorable (1.20e-6)" "unprognostic (6.53e-2)" "unprognostic (1.22e-1)" "unprognostic (1.07e-1)" "unprognostic (9.91e-3)" 22.0 22.3 14.2 21.0 16.8 22.0 18.5 22.3 18.9 19.4 17.9 15.2 20.2 11.5 17.6 15.7 30.4 16.1 15.2 26.2 13.5 14.3 18.0 35.2 15.0 14.1 14.5 14.5 18.2 15.1 34.8 20.5 27.0 18.8 16.8 15.5 16.8 18.9 16.4 88.5 24.3 16.3 15.6 13.7 16.4 18.8 18.9 14.4 16.7 24.8 23.0 18.6 18.6 22.3 10.6 9.3 12.6 8.6 8.9 8.1 3.3 28.8 18.1 15.9 9.9 50.4 26.4 15.2 17.7 17.9 15.8 13.7 13.5 15.7 22.7 18.8 32.3 11.3 19.6 21.2 16.0 24.1 13.9 8.7 23.2 14.9 54.0 23.5 24.1 17.0 23.2 22.1 17.8 28.0 22.0 29.1 13.5 16.6 10.5 24.6 23.7 9.3 10.3 12.1 25.3 16.5 17.3 18.4 9.9 24.7 30.0 11.8 13.9 25.9 18.0 15.7 20.2 18.9 15.6 29.1 18.4 14.4 13.2 15.0 11.5 16.4 25.6 8.7 12.2 15.5 12.6 8.6 11.3 7.1 7.1 8.1 7.2 8.0 6.3 9.3 10.6 6.7 6.6 4.4 8.9 5.3 7.8 8.0 3.3 14.2 16.8 22.3 18.9 13.5 14.3 14.5 14.5 18.8 14.4 44.7 63.3 37.1 68.0 76.9 78.2 103.0 22.9 155.2 84.2 68.0 92.3 53.4 10.0 37.6 2.9 56.2 38.8 23.3 31.4 36.2 49.1 82.9 31.3 79.7 25.8 62.0 46.8 39.9 39.7 6.7 63.9 34.4 32.1 29.7 30.4 36.8 41.9 28.1 70.0 20.0 175.8 45.3 41.2 53.4 107.2 100.5 117.1 37.4 37.3 267.3 HECTD2 FLJ37306 ENSG00000165338 "HECT domain E3 ubiquitin protein ligase 2" Q5U5R9 10 91409280-91514829 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 25.5;Horizontal cells: 27.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "NK-cell: 6.7" "Lineage enriched" "Detected in many" 7 "NK-cells: 6.7" "Cell line enhanced" "Detected in many" "AF22: 21.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037767 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA037767: AB_10671378" "unprognostic (6.35e-2)" "unprognostic (1.33e-1)" "unprognostic (3.26e-2)" "unprognostic (3.34e-1)" "unprognostic (6.65e-3)" "unprognostic (1.10e-2)" "unprognostic (9.37e-4)" "unprognostic (1.42e-1)" "unprognostic (1.59e-1)" "unprognostic (2.31e-1)" "unprognostic (2.54e-3)" "unprognostic (4.44e-2)" "prognostic unfavorable (1.67e-5)" "unprognostic (6.98e-3)" "unprognostic (1.39e-1)" "unprognostic (1.93e-1)" "unprognostic (5.84e-2)" 8.7 8.8 16.5 6.9 17.9 2.4 10.8 20.3 19.5 14.3 10.1 5.1 9.1 4.6 17.2 16.6 8.3 12.1 11.4 8.1 11.9 8.7 7.3 4.7 8.7 4.7 5.8 11.3 16.8 7.4 14.4 18.6 10.2 6.5 24.8 7.6 7.5 7.7 24.3 7.7 6.8 6.0 18.4 6.8 5.3 7.5 9.7 6.4 2.9 9.8 5.1 3.6 13.7 10.5 0.6 0.4 0.1 0.8 6.7 1.0 0.5 4.1 2.1 21.4 8.8 4.7 5.2 3.8 3.4 4.5 6.9 6.3 0.2 3.9 0.0 2.9 3.4 4.0 0.3 5.8 2.4 8.5 4.4 7.2 2.4 15.0 1.3 2.4 0.4 1.6 5.3 2.2 5.0 4.3 9.7 5.1 5.1 3.1 10.7 10.6 1.9 2.5 1.3 8.9 0.4 2.1 6.4 14.1 2.4 4.8 1.2 5.0 5.4 6.6 1.5 6.7 6.9 9.7 1.4 5.4 6.9 4.8 0.5 6.3 0.7 1.4 5.9 6.1 0.0 4.0 0.0 0.1 0.0 1.0 0.8 0.6 0.2 0.5 0.7 0.4 0.6 0.5 0.6 0.1 6.7 0.2 0.0 0.1 0.5 16.5 17.9 20.3 19.5 11.9 8.7 5.8 11.3 6.5 6.4 0.0 3.2 0.0 7.0 5.5 21.3 6.5 5.1 5.3 5.7 5.2 25.5 0.3 18.3 2.4 1.5 8.3 0.7 0.0 3.0 0.3 11.3 4.2 3.5 0.8 5.3 27.0 8.6 9.2 7.0 1.5 11.2 3.8 6.8 3.6 3.0 12.0 2.5 0.6 13.4 1.3 8.2 12.9 7.6 6.7 8.1 3.9 0.3 1.5 1.3 3.0 HECTD4 "C12orf51, FLJ34154, KIAA0614" ENSG00000173064 "HECT domain E3 ubiquitin protein ligase 4" 12 112160188-112382439 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 43.3" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 133.5;Horizontal cells: 76.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041062, HPA045473" Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA041062: AB_2677281, HPA045473: AB_2679338" "unprognostic (9.27e-2)" "unprognostic (2.35e-1)" "unprognostic (6.50e-2)" "unprognostic (1.33e-1)" "unprognostic (3.38e-1)" "prognostic favorable (2.97e-4)" "unprognostic (3.52e-2)" "unprognostic (2.13e-1)" "unprognostic (2.28e-1)" "unprognostic (1.21e-2)" "unprognostic (4.95e-2)" "unprognostic (1.06e-1)" "unprognostic (2.89e-2)" "unprognostic (2.81e-2)" "unprognostic (1.89e-1)" "unprognostic (1.58e-2)" "unprognostic (4.51e-3)" 6.8 7.1 11.3 6.3 16.3 26.6 7.7 43.3 22.7 8.9 9.0 14.0 10.8 5.4 11.1 10.0 10.0 9.0 6.5 6.6 10.1 10.3 7.4 6.3 7.3 8.1 11.4 13.7 10.9 10.1 13.8 14.0 8.0 17.2 12.3 7.4 9.4 8.7 9.6 12.9 16.6 7.0 8.8 13.0 7.4 8.8 14.6 12.7 8.3 12.8 5.0 7.7 8.3 9.0 2.9 2.4 2.8 1.2 1.0 1.8 0.7 5.6 10.7 8.6 7.6 11.7 7.9 4.9 4.2 4.0 5.4 4.6 10.4 1.9 6.0 3.8 6.8 5.7 5.8 11.2 5.5 4.1 7.7 10.1 8.4 11.3 5.8 4.2 6.0 8.3 6.6 6.7 8.3 5.5 10.1 8.2 11.2 10.5 4.7 5.1 6.3 7.1 12.7 4.1 7.8 8.0 9.6 4.4 3.9 4.3 9.0 14.0 9.6 9.7 9.5 3.7 8.4 7.1 8.5 11.9 6.3 4.6 6.6 5.6 15.9 6.0 6.7 5.1 3.9 4.0 2.8 1.2 0.6 1.8 0.5 1.2 1.1 0.6 0.9 0.8 2.9 1.0 0.9 1.4 1.0 1.1 2.4 0.1 0.7 11.3 16.3 43.3 22.7 10.1 10.3 11.4 13.7 17.2 12.7 17.9 17.3 9.3 7.3 10.2 47.4 18.5 12.7 10.7 5.7 12.2 133.5 8.5 0.0 7.5 5.6 10.9 9.7 0.0 7.5 3.9 9.1 13.7 8.1 13.9 5.7 76.3 26.5 16.0 7.6 4.5 10.6 7.0 6.8 7.2 12.4 17.8 8.4 8.6 14.9 4.4 55.4 0.0 8.3 19.1 8.0 13.0 7.4 7.9 11.9 6.5 HELLS "LSH, Nbla10143, PASG, SMARCA6" ENSG00000119969 "Helicase, lymphoid specific" Q9NRZ9 10 94501434-94613905 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Developmental protein, Helicase, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 46.4" "Cell type enhanced" "Detected in many" 13 "Spermatocytes: 69.2;Spermatogonia: 174.0" "Cancer enhanced" "Detected in all" "testis cancer: 16.1" "Region enhanced" "Detected in many" "cerebellum: 11.9" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 22.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004491, HPA063242" Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" No Yes Nucleoplasm "Golgi apparatus, Vesicles" "CAB004491: AB_627895, HPA063242: AB_2684968" "unprognostic (1.94e-1)" "prognostic favorable (1.36e-4)" "unprognostic (9.85e-2)" "unprognostic (3.38e-2)" "unprognostic (8.65e-2)" "unprognostic (4.85e-3)" "unprognostic (1.76e-5)" "unprognostic (7.59e-3)" "unprognostic (7.03e-3)" "unprognostic (6.49e-2)" "unprognostic (2.05e-2)" "unprognostic (9.45e-5)" "unprognostic (9.93e-13)" "unprognostic (2.25e-2)" "unprognostic (1.72e-1)" "unprognostic (6.24e-2)" "unprognostic (3.03e-2)" 1.4 2.0 1.2 28.8 1.5 14.8 3.0 11.9 3.2 4.2 5.0 0.7 3.3 3.5 5.8 6.0 8.6 2.5 3.6 2.1 1.3 2.0 3.9 2.0 2.5 11.9 1.4 1.7 4.3 1.9 2.7 4.7 9.0 1.3 3.4 5.5 3.3 2.8 2.0 0.6 5.2 5.3 2.1 1.7 8.3 3.6 18.7 0.7 46.4 1.7 8.1 15.1 3.6 4.4 13.6 22.0 0.7 0.8 5.6 10.9 1.5 19.9 19.7 25.5 32.3 1.0 2.4 13.8 15.3 9.9 12.8 20.2 26.0 16.2 24.7 6.1 5.1 10.8 20.2 14.6 12.2 18.3 23.9 16.8 13.1 20.0 20.8 0.6 24.7 11.9 1.3 0.7 15.3 7.3 3.5 8.8 16.7 7.1 15.8 15.1 20.1 26.0 12.3 26.4 14.6 8.8 24.3 22.7 5.7 8.7 25.8 10.2 8.3 18.1 5.2 2.7 22.2 22.1 8.0 6.2 14.0 7.1 12.8 18.3 8.2 15.6 26.4 7.0 15.3 6.4 0.1 0.5 0.0 4.4 0.8 1.5 10.9 7.2 6.2 1.3 13.6 3.5 5.0 0.7 5.6 0.6 22.0 10.9 1.5 1.2 1.5 11.9 3.2 1.3 2.0 1.4 1.7 1.3 0.7 8.9 3.8 23.8 8.2 19.2 13.6 0.8 7.6 8.1 17.0 21.0 0.0 25.8 3.3 5.8 0.8 4.9 2.1 23.3 5.5 31.3 11.0 3.1 5.7 2.6 12.8 6.4 10.4 8.0 1.3 3.6 8.3 6.2 1.7 9.0 6.5 5.0 3.9 0.0 5.3 1.4 9.4 19.4 6.2 69.2 174.0 8.7 9.3 12.5 23.7 4.4 HELQ Hel308 ENSG00000163312 "Helicase, POLQ like" Q8TDG4 4 83407343-83455856 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036852, HPA036853" Approved Approved "Nucleoplasm,Nuclear speckles" NA NA "Nuclear speckles" Nucleoplasm "HPA036852: AB_2675349, HPA036853: AB_10672102" "unprognostic (4.58e-2)" "unprognostic (3.25e-2)" "unprognostic (1.12e-2)" "unprognostic (1.12e-1)" "unprognostic (4.80e-2)" "unprognostic (5.56e-2)" "unprognostic (1.14e-1)" "unprognostic (5.13e-3)" "unprognostic (7.14e-2)" "unprognostic (8.62e-2)" "prognostic favorable (9.07e-4)" "unprognostic (2.03e-1)" "prognostic favorable (2.76e-4)" "unprognostic (3.54e-2)" "unprognostic (1.43e-1)" "unprognostic (1.57e-1)" "unprognostic (1.37e-1)" 10.5 20.8 6.3 12.2 7.8 7.2 10.4 12.6 9.2 10.7 9.8 9.3 8.2 5.6 9.9 8.7 8.2 9.1 9.0 10.5 6.2 5.7 11.9 10.0 8.0 15.3 6.8 5.7 17.4 8.1 13.3 20.7 11.7 9.0 11.4 7.2 11.0 10.0 10.4 14.6 8.7 9.8 8.0 8.4 14.4 8.4 10.7 7.4 18.5 14.3 8.3 13.4 10.2 9.2 10.1 4.6 6.8 4.7 5.5 9.7 2.9 4.3 3.3 7.1 4.6 8.7 9.2 3.7 6.5 9.8 8.5 8.4 3.1 4.5 12.2 5.2 5.6 5.8 4.4 8.6 4.8 8.9 7.0 3.8 7.3 5.4 4.2 5.6 8.8 18.0 7.1 6.5 6.7 7.0 7.5 6.7 8.2 9.6 10.7 8.6 5.1 8.0 6.3 3.6 6.9 2.4 6.2 8.2 4.3 7.0 2.7 5.8 4.8 6.3 6.9 7.1 7.1 4.3 9.5 5.1 6.4 5.6 8.2 5.1 9.9 4.2 10.3 5.4 6.7 7.1 5.4 3.7 6.8 5.7 4.0 5.4 5.8 6.3 6.4 4.6 10.1 9.7 8.7 2.3 5.5 4.7 4.5 7.8 2.9 6.3 7.8 12.6 9.2 6.2 5.7 6.8 5.7 9.0 7.4 3.0 9.4 10.0 8.0 3.8 9.2 9.2 7.6 22.7 7.9 5.2 7.9 9.6 10.0 5.1 20.9 7.1 3.5 0.0 4.8 8.1 6.4 4.9 7.0 4.0 9.1 6.4 0.0 10.4 5.6 5.8 12.0 8.4 6.8 7.2 4.5 9.1 4.7 6.0 7.4 8.8 13.2 0.0 8.2 20.0 12.8 3.3 9.6 13.1 5.2 4.7 HEMGN "CT155, EDAG, NDR" ENSG00000136929 Hemogen Q9BXL5 9 97926791-97944856 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 71.1;placenta: 20.2;testis: 32.5" "Group enriched" "Detected in some" 149 "Early spermatids: 1388.7;Erythroid cells: 724.2;Late spermatids: 1114.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 8.2" "Group enriched" "Detected in many" 27 "granulocytes: 2.1;NK-cells: 2.9;T-cells: 8.2" "Cell line enriched" "Detected in some" 4 "K-562: 77.0" "Region enriched" "Detected in all" 5 "cerebellum: 55.9" "HPA019572, HPA019604, HPA019606" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA019572: AB_1850588, HPA019604: AB_1850590, HPA019606: AB_1850591" "unprognostic (1.94e-1)" "unprognostic (3.15e-3)" "unprognostic (2.50e-2)" "unprognostic (9.00e-3)" "unprognostic (2.12e-3)" "unprognostic (2.48e-1)" "unprognostic (6.45e-4)" "unprognostic (2.77e-1)" "unprognostic (5.74e-2)" "unprognostic (2.25e-1)" 0.3 0.2 0.2 0.4 0.2 71.1 0.2 0.2 0.3 0.2 0.2 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.3 1.0 0.2 0.2 0.3 0.9 5.4 0.5 0.2 0.0 0.6 0.2 0.0 0.3 20.2 1.1 0.2 0.0 0.1 0.2 0.0 0.2 0.2 0.2 0.0 0.3 2.8 0.2 32.5 0.0 17.1 0.3 0.2 0.5 1.4 4.8 0.0 0.1 2.1 0.1 2.9 8.2 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 77.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.4 0.0 0.0 0.0 2.1 0.1 0.0 0.4 0.1 0.8 0.0 2.3 1.1 0.1 0.0 8.2 3.3 1.0 2.9 0.0 0.0 1.2 4.4 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 1388.7 0.0 0.0 724.2 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.3 1114.5 5.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 6.5 0.0 7.2 3.3 0.0 0.5 0.0 0.0 0.0 HEPACAM2 FLJ38683 ENSG00000188175 "HEPACAM family member 2" A8MVW5 7 93188586-93226524 "Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 43.4;kidney: 24.5;pituitary gland: 16.1" "Group enriched" "Detected in some" 23 "Intestinal endocrine cells: 209.3;Mucus-secreting cells: 364.1;Paneth cells: 298.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 37 "SCLC-21H: 63.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA012381 Supported "Nucleoplasm,Vesicles,Mitotic spindle" Yes NA 89000 "Vesicles, Mitotic spindle" Nucleoplasm "HPA012381: AB_1853037" "unprognostic (2.01e-3)" "unprognostic (6.05e-2)" "prognostic favorable (9.73e-5)" "unprognostic (1.33e-2)" "unprognostic (7.27e-2)" "unprognostic (2.24e-2)" "unprognostic (4.48e-2)" "unprognostic (8.40e-3)" "unprognostic (7.61e-2)" "unprognostic (8.68e-2)" "unprognostic (5.37e-3)" "unprognostic (4.93e-2)" "unprognostic (3.64e-3)" "unprognostic (2.06e-1)" "unprognostic (4.73e-2)" "unprognostic (3.82e-1)" "unprognostic (6.34e-2)" 0.1 0.2 0.2 8.5 0.2 0.6 3.4 0.1 0.1 0.1 29.4 0.1 5.3 11.8 0.1 0.4 0.2 0.1 0.8 0.3 0.2 0.2 24.5 0.2 0.4 0.1 0.2 0.1 0.1 5.5 0.0 16.1 0.4 0.2 0.7 38.9 0.1 4.1 1.2 0.1 0.1 43.4 0.4 0.2 0.2 4.0 1.4 0.1 0.3 0.1 0.1 2.1 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.1 0.2 0.1 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 8.3 0.0 2.1 0.0 6.7 0.0 0.0 0.0 0.0 1.2 4.6 0.0 0.0 0.0 209.3 0.0 0.0 1.9 0.0 0.0 6.8 0.0 364.1 0.0 0.0 298.7 0.0 0.0 0.0 0.0 0.0 4.5 0.7 0.1 0.1 0.0 12.4 0.0 HERC6 FLJ20637 ENSG00000138642 "HECT and RLD domain containing E3 ubiquitin protein ligase family member 6" Q8IVU3 4 88378739-88443111 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 5 "BJ hTERT+ SV40 Large T+: 47.0;BJ hTERT+ SV40 Large T+ RasG12V: 35.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035846 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA035846: AB_10673487" "unprognostic (1.95e-2)" "unprognostic (2.71e-1)" "unprognostic (2.23e-2)" "unprognostic (2.67e-2)" "unprognostic (8.61e-2)" "unprognostic (2.98e-2)" "unprognostic (2.78e-2)" "unprognostic (3.27e-1)" "unprognostic (1.49e-1)" "unprognostic (5.95e-2)" "unprognostic (1.52e-2)" "unprognostic (6.22e-2)" "prognostic favorable (7.14e-5)" "unprognostic (1.80e-1)" "unprognostic (2.59e-1)" "unprognostic (8.43e-3)" "unprognostic (3.77e-2)" 8.0 7.5 7.8 7.2 10.2 7.3 6.3 2.1 14.6 13.6 6.3 5.9 3.4 5.4 13.2 9.6 23.9 10.4 11.2 9.8 7.7 8.4 10.4 5.0 8.3 4.6 7.3 15.8 9.8 6.3 5.2 8.4 7.1 8.5 9.1 6.5 7.2 28.4 5.7 2.9 4.3 7.1 8.5 5.6 8.0 7.3 3.9 5.3 9.0 5.9 7.6 7.8 7.2 13.8 3.6 2.7 4.5 6.4 5.6 13.4 4.2 2.6 1.7 0.1 0.3 0.1 1.6 0.5 0.3 8.8 47.0 35.0 0.1 3.3 0.0 0.6 0.8 7.6 1.0 4.3 2.2 3.1 5.3 0.9 2.4 1.5 0.2 1.5 4.3 1.7 2.1 0.5 3.6 0.1 2.8 1.3 2.0 0.0 0.6 1.0 1.5 2.0 1.3 0.6 2.3 0.9 1.3 0.0 0.1 3.2 3.2 0.1 1.1 3.2 1.1 5.2 2.4 1.9 0.8 0.4 0.6 0.9 0.1 0.8 0.1 0.0 0.0 2.1 1.0 2.1 4.4 3.1 4.5 6.7 3.1 13.4 3.6 9.4 6.5 2.7 2.7 7.5 5.1 1.9 5.6 6.4 0.3 11.8 4.2 7.8 10.2 2.1 14.6 7.7 8.4 7.3 15.8 8.5 5.3 11.9 8.8 2.4 4.4 2.5 11.4 10.6 5.1 16.0 10.3 5.2 15.7 4.9 0.0 6.6 0.9 8.4 5.2 0.0 15.0 1.3 3.7 8.2 5.7 2.1 4.3 1.6 1.7 4.3 3.7 1.3 4.0 2.2 5.0 4.6 2.9 4.3 9.1 3.1 5.3 3.6 1.0 6.5 2.0 0.5 1.1 1.0 2.1 7.7 1.7 6.2 HES1 "bHLHb39, FLJ20408, HES-1, Hes1, HRY" ENSG00000114315 "Hes family bHLH transcription factor 1" Q14469 3 194136145-194138732 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 883.9;Paneth cells: 936.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "eosinophil: 19.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 19.5" "Cell line enhanced" "Detected in many" "EFO-21: 26.2;hTCEpi: 32.9;OE19: 32.2;SK-BR-3: 27.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066929 Supported Nucleoplasm NA NA Nucleoplasm "HPA066929: AB_2732753" "unprognostic (1.79e-2)" "unprognostic (2.41e-1)" "unprognostic (1.79e-2)" "unprognostic (4.44e-2)" "unprognostic (1.00e-1)" "unprognostic (1.46e-1)" "unprognostic (3.01e-2)" "unprognostic (1.05e-1)" "unprognostic (4.64e-1)" "unprognostic (2.62e-2)" "unprognostic (2.04e-2)" "unprognostic (1.40e-2)" "unprognostic (1.71e-2)" "unprognostic (1.44e-1)" "unprognostic (1.74e-1)" "unprognostic (1.85e-1)" "prognostic favorable (2.04e-5)" 31.0 10.9 8.4 7.9 9.3 0.6 30.1 5.5 8.1 28.4 18.9 14.1 36.1 17.2 21.2 15.9 47.8 9.9 11.5 21.2 9.5 6.0 22.1 27.4 37.9 3.7 6.3 8.8 15.7 21.2 19.7 15.1 23.5 8.8 35.1 20.5 58.7 31.0 89.6 32.8 56.0 12.6 9.7 8.4 10.7 23.9 11.7 8.0 2.3 36.3 29.7 40.3 26.3 39.8 0.5 0.1 19.5 4.8 0.0 0.0 0.1 3.0 0.9 7.2 9.3 2.2 0.0 1.8 1.4 4.2 0.3 0.1 12.3 8.9 0.4 26.2 0.5 4.4 17.6 1.3 8.3 0.1 2.5 15.1 11.1 1.1 3.1 0.0 0.0 10.5 0.8 32.9 0.2 3.8 5.0 9.9 0.6 5.3 0.4 0.0 14.6 15.6 15.2 6.7 32.2 6.1 0.0 0.5 0.3 9.7 24.2 0.4 0.5 7.1 27.4 12.3 8.6 7.7 0.8 7.6 0.8 7.8 0.1 10.5 0.0 0.0 0.0 0.5 0.0 15.0 0.0 0.1 19.5 0.0 3.1 0.0 0.5 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 4.8 0.0 0.0 0.1 8.4 9.3 5.5 8.1 9.5 6.0 6.3 8.8 8.8 8.0 23.8 99.8 66.4 291.3 109.2 14.2 64.5 387.3 165.9 238.8 186.7 15.7 27.9 160.8 197.9 1.4 288.1 452.8 0.0 176.3 4.8 322.5 246.0 301.9 136.4 23.9 9.5 153.8 713.3 61.6 4.3 54.4 73.1 75.9 37.9 274.4 883.9 162.1 936.3 17.7 69.0 39.9 161.7 297.1 1.1 1.5 259.2 174.9 9.6 593.0 248.6 HES3 bHLHb43 ENSG00000173673 "Hes family bHLH transcription factor 3" Q5TGS1 1 6244192-6245578 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 4 "lymphoid tissue: 6.8" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 28 "testis cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "NTERA-2: 16.1" "Region enriched" "Detected in single" 30 "cerebellum: 39.0" "Low region specificity" "Detected in many" "HPA047927, HPA072697" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047927: AB_2680213, HPA072697: " "unprognostic (7.42e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HES4 bHLHb42 ENSG00000188290 "Hes family bHLH transcription factor 4" Q9HCC6 1 998962-1000172 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 291.1;Glandular cells: 254.1;Paneth cells: 238.4;Smooth muscle cells: 271.9;Urothelial cells: 423.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "eosinophil: 12.4" "Lineage enriched" "Detected in many" 8 "granulocytes: 12.4" "Cell line enriched" "Detected in some" 8 "HEK 293: 66.9" "Low region specificity" "Detected in all" HPA062465 Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA062465: AB_2684771" "unprognostic (6.23e-2)" "unprognostic (3.77e-2)" "unprognostic (7.07e-2)" "prognostic favorable (3.85e-4)" "unprognostic (1.18e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.99e-4)" "unprognostic (6.25e-3)" "unprognostic (2.34e-1)" "unprognostic (1.62e-2)" "unprognostic (3.77e-1)" "unprognostic (7.76e-2)" "prognostic unfavorable (6.27e-4)" "unprognostic (3.97e-1)" "unprognostic (3.87e-2)" "unprognostic (1.86e-1)" "unprognostic (5.08e-3)" 14.8 4.0 8.3 3.9 15.6 2.8 8.7 2.5 16.9 7.6 10.8 2.9 4.8 5.4 7.8 9.0 7.5 6.8 9.6 13.6 5.9 9.4 5.3 3.2 9.1 2.2 7.3 4.0 4.2 14.8 3.1 5.7 6.1 7.2 10.4 2.6 12.8 5.6 9.4 8.0 7.8 4.2 12.1 3.4 8.6 6.1 3.4 3.1 9.0 3.6 8.4 3.3 10.6 5.6 0.0 0.3 12.4 1.4 0.0 0.0 0.0 4.6 0.5 0.5 0.0 0.0 0.0 5.9 2.8 0.3 1.7 1.8 0.7 1.5 0.0 6.7 0.2 0.8 8.2 0.7 0.1 0.0 0.0 66.9 0.0 0.7 0.9 0.6 0.0 0.5 0.0 0.7 0.1 0.1 0.2 0.2 0.8 1.3 0.1 0.0 2.4 3.7 0.2 0.0 1.0 6.5 0.0 0.6 1.4 0.6 0.0 0.4 1.5 1.9 4.7 8.4 0.2 3.5 0.0 0.3 0.5 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 12.4 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 8.3 15.6 2.5 7.0 5.9 9.4 7.3 4.0 7.2 3.1 0.0 0.0 0.0 291.1 46.2 3.5 11.8 22.9 0.0 2.3 55.8 0.0 0.9 26.6 14.8 0.8 15.3 10.3 0.0 2.5 35.2 22.6 254.1 55.1 0.0 4.4 0.0 10.3 16.0 3.5 0.8 6.9 13.3 109.6 1.0 10.5 119.5 9.0 238.4 14.5 0.6 10.7 161.7 271.9 2.3 28.1 72.3 2.9 0.7 11.0 423.0 HES5 bHLHb38 ENSG00000197921 "Hes family bHLH transcription factor 5" Q5TA89 1 2528745-2530245 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.7" "Cell type enriched" "Detected in some" 22 "Muller glia cells: 105.2" "Cancer enhanced" "Detected in some" "glioma: 3.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.7;HaCaT: 5.1;HAP1: 1.1;SCLC-21H: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA065458, HPA076164" Enhanced Approved "Nucleoplasm,Nuclear speckles,Cytosol" No NA Nucleoplasm "Nuclear speckles, Cytosol" "HPA065458: AB_2685492, HPA076164: AB_2732303" "unprognostic (2.04e-3)" "unprognostic (2.83e-2)" "unprognostic (4.26e-2)" "unprognostic (2.75e-3)" "unprognostic (5.26e-3)" "unprognostic (1.60e-4)" "unprognostic (1.76e-4)" "unprognostic (1.60e-1)" "unprognostic (5.30e-2)" "unprognostic (9.51e-2)" "unprognostic (1.16e-1)" "unprognostic (4.67e-1)" "unprognostic (9.95e-4)" "unprognostic (1.14e-3)" "unprognostic (1.45e-1)" "unprognostic (3.89e-2)" "unprognostic (1.72e-1)" 1.1 0.9 11.1 1.1 12.7 1.4 2.8 3.5 16.7 1.0 1.9 1.2 0.4 1.2 1.9 2.7 1.6 1.1 1.2 2.3 9.7 11.2 1.0 1.0 1.4 1.1 4.1 15.8 1.0 0.9 1.0 2.4 2.2 1.6 1.3 1.4 6.3 1.2 1.1 1.6 6.2 1.2 0.9 0.9 1.0 1.2 2.0 1.9 0.0 1.1 1.9 1.4 1.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 5.1 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 12.7 3.5 16.7 9.7 11.2 4.1 15.8 1.6 1.9 0.0 0.0 0.0 0.2 0.1 2.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 105.2 0.0 3.5 0.0 0.0 4.8 0.0 0.7 0.0 0.0 1.3 0.0 0.0 1.1 0.1 HES7 bHLHb37 ENSG00000179111 "Hes family bHLH transcription factor 7" Q9BYE0 17 8120590-8124092 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.3;salivary gland: 10.5" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 2.4;Melanocytes: 3.3;Smooth muscle cells: 4.2" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 6.7;Daudi: 7.2;HAP1: 9.2;HDLM-2: 7.3;HeLa: 13.7" "Low region specificity" "Detected in single" "Region enhanced" "Detected in single" "cerebellum: 0.8" HPA072105 Uncertain Approved Nucleoplasm,Nucleoli No NA Nucleoplasm Nucleoli "HPA072105: AB_2686488" "unprognostic (1.98e-1)" "unprognostic (7.91e-3)" "unprognostic (1.16e-3)" "unprognostic (1.08e-2)" "unprognostic (2.11e-1)" "unprognostic (4.99e-2)" "unprognostic (2.84e-1)" "unprognostic (5.13e-2)" "unprognostic (1.32e-2)" "unprognostic (2.04e-1)" "unprognostic (2.74e-1)" "unprognostic (1.22e-5)" "unprognostic (2.99e-2)" "unprognostic (4.79e-2)" "unprognostic (2.69e-2)" "unprognostic (1.55e-1)" 0.4 0.4 1.0 0.3 1.0 0.2 0.5 9.3 2.4 1.4 0.3 0.6 0.2 0.0 2.0 0.2 0.7 0.6 0.6 1.3 1.5 0.5 1.1 0.2 0.9 0.6 1.0 0.2 1.5 0.5 0.0 0.4 3.6 2.1 0.6 0.2 0.9 10.5 2.5 1.1 0.6 0.3 0.4 1.5 0.3 0.2 2.3 0.2 0.2 0.8 0.2 0.5 1.3 0.9 0.2 0.1 0.0 0.1 0.3 0.2 0.1 6.7 0.5 0.5 2.3 0.2 0.3 0.3 0.4 0.6 0.8 2.4 0.1 0.4 7.2 0.1 0.0 1.1 0.7 9.2 0.6 0.0 7.3 4.4 0.3 13.7 0.1 0.8 0.8 0.9 0.2 1.2 2.0 5.2 1.3 0.1 1.2 0.2 3.2 0.1 0.1 0.1 0.4 0.2 0.5 1.7 0.7 0.4 1.2 0.2 0.0 0.3 3.3 0.4 0.0 0.4 0.1 0.1 0.0 0.7 0.0 1.5 1.6 2.3 4.5 0.9 0.4 0.7 0.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.1 0.0 0.1 1.0 1.0 9.3 2.4 1.5 0.5 1.0 0.2 2.1 0.2 0.0 0.0 0.0 0.9 1.9 2.4 0.9 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 1.2 1.0 0.0 0.0 0.0 0.0 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 3.3 1.0 0.0 0.5 0.0 0.0 0.4 0.0 0.8 0.0 4.2 0.0 0.6 1.4 0.2 0.0 0.0 0.1 HESX1 "ANF, RPX" ENSG00000163666 "HESX homeobox 1" Q9UBX0 3 57197843-57226521 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 14.7;lymphoid tissue: 15.2" "Cell type enhanced" "Detected in some" 11 "Spermatocytes: 10.7;Spermatogonia: 5.8" "Cancer enhanced" "Detected in many" "testis cancer: 6.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 4.0;plasmacytoid DC: 4.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 40.4;U-266/84: 12.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA024187 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA024187: AB_1850620" "unprognostic (6.47e-2)" "unprognostic (1.66e-3)" "unprognostic (5.50e-2)" "unprognostic (1.19e-3)" "unprognostic (5.04e-2)" "unprognostic (2.83e-2)" "unprognostic (3.96e-1)" "unprognostic (3.21e-2)" "unprognostic (1.93e-1)" "unprognostic (3.46e-3)" "unprognostic (9.48e-2)" "unprognostic (2.79e-3)" "unprognostic (1.39e-3)" "unprognostic (4.17e-2)" "unprognostic (3.15e-2)" "unprognostic (4.50e-3)" "unprognostic (1.14e-1)" 1.5 2.6 2.1 1.4 2.0 4.2 3.5 1.4 2.3 1.4 1.4 1.4 14.7 1.0 1.4 5.7 1.4 1.2 2.1 1.4 2.2 2.3 2.7 4.8 1.5 15.2 3.3 2.4 2.1 2.5 3.4 2.6 3.4 1.4 1.9 0.8 2.3 1.5 7.0 1.4 5.7 1.4 1.4 5.1 4.6 2.1 8.7 2.0 3.0 3.3 1.4 1.8 1.4 1.4 1.5 4.6 0.3 4.0 1.1 0.3 0.5 0.7 0.6 1.4 2.7 0.2 1.0 0.4 0.0 0.2 0.4 0.8 0.2 2.4 1.9 0.4 0.0 0.6 0.1 0.7 0.7 0.5 1.1 1.5 2.7 0.7 0.1 1.8 1.0 0.2 2.5 0.7 0.2 1.5 1.3 0.4 4.3 0.4 2.5 0.1 0.1 1.2 5.1 40.4 0.5 0.5 0.4 0.9 1.0 1.9 0.2 0.6 2.0 0.6 0.8 1.5 0.8 0.6 4.1 0.3 1.8 0.7 0.6 0.8 7.4 12.5 6.0 0.7 1.7 1.0 0.0 2.1 0.3 0.3 4.0 0.0 1.5 0.1 0.0 1.1 1.1 0.2 0.0 0.3 1.1 0.3 4.6 0.0 0.5 2.1 2.0 1.4 2.3 2.2 2.3 3.3 2.4 1.4 2.0 0.0 0.3 0.0 0.8 0.3 0.2 0.5 2.5 0.0 0.0 1.8 0.0 1.4 0.0 0.2 0.3 1.6 0.8 0.0 0.2 1.0 0.6 0.7 0.0 0.9 1.7 1.6 0.0 0.6 1.8 0.0 0.9 1.3 0.0 1.0 0.0 2.0 0.6 0.0 0.4 1.0 2.4 0.0 0.3 10.7 5.8 1.0 0.5 0.5 0.4 0.0 HEXIM1 "CLP-1, EDG1, HIS1, MAQ1" ENSG00000186834 "Hexamethylene bisacetamide inducible 1" O94992 17 45148502-45152101 "Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Syncytiotrophoblasts: 390.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008926, CAB011625" Supported Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB011625: AB_2233058, HPA008926: AB_1079048" "unprognostic (2.82e-2)" "unprognostic (1.08e-1)" "unprognostic (1.15e-1)" "unprognostic (2.72e-2)" "unprognostic (2.39e-1)" "unprognostic (2.27e-1)" "unprognostic (1.10e-1)" "unprognostic (1.34e-2)" "unprognostic (4.74e-2)" "unprognostic (1.44e-1)" "unprognostic (2.32e-2)" "unprognostic (1.20e-2)" "unprognostic (1.83e-2)" "unprognostic (2.77e-1)" "unprognostic (1.58e-1)" "unprognostic (2.89e-3)" "unprognostic (1.26e-2)" 14.8 25.3 30.0 12.6 25.3 30.4 13.7 41.4 37.4 16.2 21.0 10.7 18.5 17.8 17.0 17.2 18.6 18.2 18.6 16.0 31.1 15.6 20.9 19.0 15.8 11.8 24.9 19.2 14.8 15.6 12.2 24.4 56.7 27.5 19.9 10.8 12.6 16.4 25.2 29.7 22.6 20.2 19.5 31.4 20.7 17.3 17.1 21.7 8.9 17.2 14.3 12.3 17.8 30.6 3.7 3.4 15.9 6.7 3.8 4.6 2.3 13.0 41.6 8.7 12.5 14.4 7.7 21.3 11.6 10.5 9.6 10.8 19.5 18.6 5.7 35.9 12.2 4.6 10.6 5.2 11.4 7.8 11.8 12.4 17.7 22.9 23.8 12.6 11.0 23.6 9.0 9.8 7.1 3.1 24.2 4.8 10.1 7.8 13.9 7.2 17.5 11.5 12.8 8.0 12.1 12.6 4.8 7.6 7.0 25.3 23.2 4.7 3.5 17.5 19.8 18.7 9.2 20.6 8.7 9.1 9.7 13.5 5.5 21.5 12.7 4.0 3.7 8.9 10.4 11.0 15.9 4.3 6.6 4.5 6.1 2.7 3.3 4.6 4.0 3.3 3.7 4.2 4.4 10.5 3.8 6.7 3.4 3.9 2.3 30.0 25.3 41.4 37.4 31.1 15.6 24.9 19.2 27.5 21.7 68.5 92.7 29.4 49.2 75.1 23.7 46.8 86.6 41.5 59.1 24.4 21.6 110.7 6.6 30.0 2.1 58.5 171.5 23.3 20.3 55.9 57.3 53.6 120.4 33.6 37.7 14.3 50.7 41.1 29.4 2.1 32.5 51.4 50.6 42.3 63.9 24.3 22.5 108.7 41.1 40.3 26.5 25.8 75.9 2.1 6.4 62.5 390.9 55.4 47.5 30.7 HEXIM2 FLJ32384 ENSG00000168517 "Hexamethylene bisacetamide inducible 2" Q96MH2 17 45160700-45170040 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 36.4" "Group enriched" "Detected in many" 6 "Early spermatids: 121.3;Late spermatids: 208.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 30.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023323, HPA028455" Enhanced Supported "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA023323: AB_1850651, HPA028455: AB_10602603" "unprognostic (9.03e-3)" "unprognostic (2.18e-2)" "unprognostic (4.01e-2)" "prognostic favorable (2.53e-4)" "unprognostic (2.36e-1)" "unprognostic (6.35e-3)" "unprognostic (9.70e-2)" "unprognostic (1.34e-2)" "unprognostic (1.03e-1)" "prognostic favorable (9.85e-4)" "unprognostic (2.34e-3)" "unprognostic (1.93e-1)" "unprognostic (1.29e-2)" "unprognostic (2.32e-3)" "unprognostic (6.98e-2)" "unprognostic (2.04e-1)" "unprognostic (1.90e-2)" 4.0 7.7 8.3 4.2 8.0 3.6 3.4 9.0 11.8 4.3 4.8 5.0 6.5 8.8 4.3 5.6 4.2 5.1 7.9 6.3 6.7 6.2 9.3 9.6 4.1 5.6 7.8 6.7 5.7 9.3 7.5 6.1 3.0 6.6 5.1 2.5 6.9 9.9 5.5 36.4 5.6 6.4 4.3 5.4 5.2 6.9 27.7 6.4 6.4 9.1 6.6 3.0 4.7 4.7 9.7 13.2 10.0 12.2 7.3 8.6 13.3 5.0 18.2 4.0 8.9 4.5 7.4 7.7 2.8 3.4 4.6 5.1 6.9 13.5 3.1 14.8 2.0 2.3 8.4 3.9 3.4 1.4 7.2 6.3 2.3 17.0 30.9 3.2 2.0 5.2 6.4 3.3 4.0 1.4 8.9 2.2 6.5 2.5 7.8 2.1 8.7 3.2 4.3 4.4 7.1 8.0 4.3 6.1 9.5 5.8 5.0 4.8 4.2 2.5 5.1 11.7 3.0 13.6 3.4 2.2 8.3 4.4 5.5 6.6 12.2 12.9 2.9 6.5 3.7 6.2 8.4 12.2 10.0 5.4 9.7 8.6 9.7 3.8 6.1 10.3 6.5 3.0 5.3 8.3 7.3 3.0 13.2 4.6 13.3 8.3 8.0 9.0 11.8 6.7 6.2 7.8 6.7 6.6 6.4 0.0 1.0 4.7 3.5 1.8 12.7 0.2 5.1 0.0 1.2 1.8 3.9 10.7 16.6 3.9 121.3 4.0 4.0 0.0 1.4 4.5 3.4 1.8 6.9 6.2 6.3 3.2 4.6 2.5 7.0 208.9 5.5 2.8 3.3 4.6 4.3 8.0 2.1 3.5 6.7 26.1 10.6 0.0 3.4 18.2 12.0 2.6 5.1 1.3 4.1 1.6 HEY1 "bHLHb31, CHF-2, CHF2, HERP2, HESR-1, HESR1, HRT-1" ENSG00000164683 "Hes related family bHLH transcription factor with YRPW motif 1" Q9Y5J3 8 79764010-79767863 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.6" "Cell type enhanced" "Detected in many" 6 "Endothelial cells: 39.4;Extravillous trophoblasts: 39.7;Intestinal endocrine cells: 35.4;Melanocytes: 32.1" "Cancer enhanced" "Detected in all" "glioma: 43.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "neutrophil: 9.9" "Lineage enriched" "Detected in many" 6 "granulocytes: 9.9" "Cell line enhanced" "Detected in many" "HEK 293: 49.4;PC-3: 11.2;SK-MEL-30: 33.8;WM-115: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055599, HPA063472" Enhanced Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Nuclear membrane, Cytosol" "HPA055599: AB_2682858, HPA063472: AB_2685018" "unprognostic (1.15e-1)" "unprognostic (5.06e-2)" "unprognostic (5.13e-3)" "unprognostic (2.12e-1)" "unprognostic (1.86e-3)" "unprognostic (8.47e-2)" "unprognostic (4.21e-3)" "unprognostic (9.56e-2)" "unprognostic (1.72e-1)" "unprognostic (7.22e-2)" "unprognostic (1.25e-2)" "unprognostic (6.71e-3)" "unprognostic (5.92e-3)" "unprognostic (5.77e-2)" "unprognostic (8.53e-2)" "unprognostic (1.74e-2)" "unprognostic (1.00e-1)" 13.3 3.8 13.7 3.6 22.9 1.8 8.8 11.2 60.6 8.9 4.4 10.7 0.0 3.3 3.8 2.4 4.6 3.9 5.7 13.4 11.3 11.6 3.8 2.9 16.4 3.3 11.9 9.3 2.6 4.3 3.0 9.9 20.3 12.5 4.5 3.9 10.3 4.5 3.0 10.3 3.5 3.2 4.4 9.1 2.8 3.6 3.9 10.5 1.3 5.0 3.7 3.7 5.2 2.5 0.0 0.0 9.9 1.7 0.0 0.3 0.1 0.6 0.0 0.4 3.5 0.3 0.3 9.0 0.8 0.8 0.1 0.1 0.1 0.0 1.6 0.9 0.3 0.4 2.2 1.8 0.1 0.2 0.1 49.4 0.0 1.6 0.9 0.5 0.0 0.4 0.5 1.4 0.0 6.2 0.3 1.6 0.0 3.2 1.4 0.5 0.1 0.0 0.2 0.2 0.1 11.2 0.0 1.9 1.4 0.1 1.5 2.0 5.7 0.0 1.0 33.8 8.4 0.0 0.0 1.1 0.2 0.9 0.0 0.6 1.2 0.2 0.0 1.2 0.0 11.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.9 0.0 1.7 0.0 0.0 0.1 13.7 22.9 11.2 12.3 11.3 11.6 11.9 9.3 12.5 10.5 0.0 2.6 0.0 2.2 2.9 5.3 3.2 0.0 8.1 3.4 0.0 0.0 5.4 13.3 2.1 3.3 39.4 0.9 0.0 1.0 39.7 2.7 1.6 10.4 0.5 1.6 20.6 35.4 13.5 0.6 1.6 0.0 2.1 32.1 0.0 1.9 6.0 0.5 5.8 0.4 0.3 11.5 0.0 6.1 0.7 4.1 2.6 19.6 0.0 2.3 1.8 HFE HLA-H ENSG00000010704 Hemochromatosis Q30201 6 26087281-26098343 "Disease related genes, Predicted membrane proteins" "Ion transport, Iron transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Kupffer cells: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 26.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017276, HPA053470" Approved Supported "Nucleoplasm,Plasma membrane" No No "Plasma membrane" Nucleoplasm "HPA017276: AB_1850677, HPA053470: AB_2682163" "unprognostic (6.96e-2)" "unprognostic (7.87e-2)" "unprognostic (1.73e-1)" "unprognostic (1.24e-2)" "unprognostic (6.07e-3)" "unprognostic (7.58e-2)" "unprognostic (4.23e-1)" "unprognostic (1.77e-1)" "unprognostic (8.21e-3)" "unprognostic (1.78e-1)" "unprognostic (3.31e-3)" "unprognostic (1.82e-1)" "unprognostic (1.33e-2)" "unprognostic (2.12e-2)" "unprognostic (1.38e-1)" "unprognostic (1.33e-1)" "unprognostic (3.17e-1)" 7.2 13.7 2.2 4.4 2.7 0.0 6.2 1.2 2.5 6.7 7.1 3.5 10.3 4.2 6.8 13.9 7.6 5.2 13.3 8.9 2.0 1.4 5.4 12.8 9.0 16.1 2.3 2.0 8.1 16.2 14.6 2.2 7.6 4.3 12.6 5.3 13.7 7.0 8.1 3.1 3.2 5.8 10.4 3.2 14.4 6.1 4.9 1.2 2.0 7.7 3.9 5.0 8.6 5.2 3.5 4.6 1.9 10.5 0.2 2.2 3.4 8.2 18.9 0.3 9.2 14.0 10.8 0.0 5.9 14.1 7.6 12.0 1.6 16.8 0.8 16.1 9.7 11.5 5.3 0.0 6.9 9.7 2.1 0.1 0.2 4.5 1.2 2.7 0.0 0.3 11.1 2.0 8.4 0.7 6.7 5.1 0.0 0.3 0.2 6.5 3.4 0.0 0.1 0.4 3.9 0.0 1.1 0.0 0.1 6.3 5.5 0.0 0.0 3.5 0.0 5.1 0.1 26.9 0.9 3.9 5.4 0.5 5.3 5.1 0.1 0.1 0.1 8.0 0.1 11.6 1.2 10.5 0.0 1.7 10.2 1.3 3.5 1.7 2.2 4.6 1.5 0.4 1.2 1.9 0.2 8.2 0.3 0.3 3.4 2.2 2.7 1.2 2.5 2.0 1.4 2.3 2.0 4.3 1.2 3.0 3.2 1.9 2.3 1.4 0.7 2.8 5.1 6.7 7.9 5.2 2.0 1.2 0.0 2.5 0.1 3.0 3.4 0.0 3.0 0.6 3.0 3.8 2.3 8.1 8.8 0.0 1.7 8.6 21.1 0.0 3.4 5.7 0.0 0.0 3.7 3.7 2.5 0.0 5.6 2.2 2.0 0.0 1.4 0.2 1.0 3.0 1.5 0.7 3.7 1.3 HGH1 "Brp16, C8orf30A, C8orf30B, FAM203A, FAM203B, FLJ40907, LOC51236" ENSG00000235173 "HGH1 homolog" Q9BTY7 8 144137769-144140843 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042470 Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" Nucleoplasm "HPA042470: AB_2678013" "unprognostic (2.13e-2)" "prognostic unfavorable (3.12e-4)" "unprognostic (9.72e-2)" "unprognostic (2.63e-1)" "unprognostic (9.82e-2)" "unprognostic (2.17e-1)" "unprognostic (7.89e-3)" "unprognostic (1.16e-1)" "unprognostic (2.42e-1)" "unprognostic (1.30e-2)" "unprognostic (4.39e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (3.72e-5)" "unprognostic (4.62e-3)" "unprognostic (3.10e-1)" "unprognostic (2.27e-1)" "unprognostic (1.48e-1)" 13.4 12.3 6.3 7.7 5.5 4.6 7.6 7.3 8.6 5.5 11.8 5.2 4.9 5.0 6.5 3.8 8.7 5.1 5.5 5.1 5.2 3.6 8.2 15.1 5.1 9.5 5.7 7.3 9.7 12.8 6.8 4.4 3.8 6.1 8.6 4.5 5.9 10.5 6.4 13.2 8.9 5.9 5.8 3.8 8.8 15.7 7.9 4.7 11.3 11.0 4.7 8.6 4.9 7.7 2.1 0.9 0.0 0.9 2.2 2.9 0.6 4.8 1.6 1.2 2.2 1.7 1.1 3.0 8.3 0.7 1.8 1.2 2.1 1.3 14.3 11.5 1.5 0.7 5.1 2.3 1.1 0.5 6.8 8.8 5.4 1.4 1.0 1.6 3.0 3.6 0.7 3.6 2.0 1.2 0.6 0.8 3.0 15.4 0.5 1.1 4.1 10.3 2.8 3.3 1.8 28.4 12.9 1.0 2.1 1.0 1.1 2.5 2.7 3.8 2.1 2.8 0.4 1.8 1.1 2.9 1.0 8.8 3.1 9.9 8.6 5.5 3.5 1.0 5.1 1.7 0.0 0.6 0.0 1.5 0.9 0.9 0.5 1.9 2.9 0.9 2.1 1.8 1.3 0.0 2.2 0.7 0.7 0.6 0.6 6.3 5.5 7.3 8.6 5.2 3.6 5.7 7.3 6.1 4.7 0.0 3.7 7.0 2.2 0.0 4.0 2.0 2.5 2.7 1.2 5.2 0.0 9.8 10.0 2.8 9.3 0.4 2.0 0.0 1.6 10.1 0.9 2.8 0.0 8.3 10.9 6.4 4.7 1.3 1.3 15.4 6.9 2.8 0.0 1.0 5.2 8.6 2.5 4.9 3.2 8.4 3.8 6.5 0.3 6.5 15.2 0.0 2.6 4.3 6.8 1.6 HHEX "HEX, HOX11L-PEN, PRHX" ENSG00000152804 "Hematopoietically expressed homeobox" Q03014 10 92689951-92695646 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation, Wnt signaling pathway" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 71.4" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 94.3;Ductal cells: 86.4;Endothelial cells: 66.2;Hepatocytes: 48.7;Hofbauer cells: 58.0;Ito cells: 65.1;Kupffer cells: 61.3" "Cancer enhanced" "Detected in all" "thyroid cancer: 56.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 46 "basophil: 7.9;classical monocyte: 14.7;eosinophil: 21.4;intermediate monocyte: 16.4;memory B-cell: 21.4;myeloid DC: 11.3;naive B-cell: 25.0;neutrophil: 11.8;non-classical monocyte: 17.8;plasmacytoid DC: 13.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 26.0;HEL: 28.2;HMC-1: 31.3;HUVEC TERT2: 30.9;K-562: 42.9;NB-4: 28.6;U-937: 22.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA051894, HPA055460" Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA051894: AB_2681653, HPA055460: AB_2682820" "prognostic favorable (8.83e-4)" "prognostic favorable (3.91e-5)" "unprognostic (2.98e-2)" "unprognostic (7.92e-2)" "unprognostic (6.46e-2)" "unprognostic (1.57e-2)" "prognostic unfavorable (6.23e-4)" "unprognostic (1.56e-2)" "unprognostic (1.13e-1)" "unprognostic (1.96e-2)" "unprognostic (5.27e-3)" "unprognostic (1.07e-1)" "prognostic unfavorable (3.25e-5)" "unprognostic (8.82e-2)" "unprognostic (2.41e-1)" "unprognostic (4.86e-2)" "unprognostic (8.50e-2)" 6.3 8.2 2.8 12.0 3.6 28.1 13.7 0.9 2.2 4.5 3.2 3.0 1.1 2.3 3.6 3.8 2.9 2.7 18.0 7.3 2.8 2.1 2.8 33.1 15.3 29.7 3.6 0.9 1.9 15.6 0.7 1.5 6.4 2.8 4.3 2.4 2.3 1.9 1.6 2.8 2.2 8.4 9.3 2.9 18.3 2.7 1.9 2.8 1.8 71.4 2.0 11.3 6.5 7.1 25.0 13.5 21.4 17.8 0.3 0.3 4.9 3.1 5.9 3.1 0.0 0.2 0.2 0.0 1.6 13.5 2.2 1.9 1.1 0.7 3.0 26.0 0.2 0.0 0.6 2.7 0.0 2.7 0.0 3.2 28.2 2.4 19.0 6.3 16.4 31.3 0.0 0.0 1.9 0.0 1.1 30.9 0.0 42.9 0.0 0.1 0.9 0.1 28.6 0.0 8.6 3.4 9.6 0.9 0.0 0.2 1.2 1.4 0.3 1.8 0.0 0.0 0.1 0.9 8.7 10.7 0.0 0.1 0.0 0.0 0.7 0.5 6.0 0.0 22.7 14.9 7.9 14.7 21.4 0.3 16.4 0.1 21.4 0.0 0.0 11.3 25.0 0.0 0.0 11.8 0.3 17.8 13.5 0.1 4.9 2.8 3.6 0.9 2.2 2.8 2.1 3.6 0.9 2.8 2.8 0.0 4.8 30.4 1.6 5.7 0.0 2.0 94.3 1.4 2.3 0.0 0.0 0.5 0.0 86.4 0.2 66.2 0.0 0.0 10.0 0.8 2.1 2.9 6.9 48.7 58.0 0.0 5.1 65.1 61.3 0.4 0.3 22.7 6.8 1.8 0.3 0.0 14.5 0.0 1.1 0.0 0.0 0.0 1.9 0.2 1.4 3.1 0.9 5.2 0.2 0.6 HHIP "FLJ20992, HIP" ENSG00000164161 "Hedgehog interacting protein" Q96QV1 4 144646021-144745271 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.5;lung: 29.7" "Cell type enhanced" "Detected in some" 22 "Alveolar cells type 2: 177.0;Leydig cells: 126.0;Peritubular cells: 41.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 2.6" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.6" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 69.8;TIME: 80.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA012616 Uncertain Approved Nucleoplasm "Secreted in other tissues" NA NA Nucleoplasm "HPA012616: AB_1850687" "unprognostic (3.86e-2)" "unprognostic (1.19e-1)" "unprognostic (1.02e-2)" "unprognostic (7.12e-3)" "unprognostic (8.18e-2)" "unprognostic (2.43e-2)" "unprognostic (1.02e-1)" "unprognostic (3.60e-1)" "unprognostic (1.95e-2)" "unprognostic (4.20e-1)" "unprognostic (1.90e-2)" "unprognostic (1.89e-1)" "unprognostic (9.66e-3)" "unprognostic (7.13e-3)" "unprognostic (1.05e-1)" "unprognostic (5.18e-2)" "unprognostic (2.38e-1)" 4.0 5.2 9.9 1.7 22.2 2.3 1.1 2.3 16.0 3.4 6.5 31.5 0.0 5.5 4.1 8.1 1.0 1.2 3.0 1.1 16.0 6.3 2.4 12.7 29.7 1.0 21.6 9.9 2.2 4.8 1.0 1.1 1.0 17.5 9.8 6.8 4.4 1.3 6.2 1.3 1.1 8.2 1.3 12.3 1.0 11.2 3.7 26.5 2.3 1.6 0.0 1.0 7.1 1.0 0.1 2.6 0.5 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.7 3.8 69.8 6.2 0.0 0.0 1.0 0.0 9.8 0.0 0.9 0.0 0.6 0.1 14.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.5 0.0 0.8 0.0 0.5 0.4 0.0 2.1 0.0 0.0 0.4 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 2.6 0.0 0.0 9.9 22.2 2.3 16.0 16.0 6.3 21.6 9.9 17.5 26.5 11.9 177.0 0.0 0.0 0.0 1.4 1.1 0.0 8.1 6.8 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.3 0.0 0.4 0.0 16.1 0.0 0.1 0.0 0.0 16.0 0.0 1.8 126.0 1.0 1.7 0.0 0.0 0.2 0.1 0.0 41.4 0.0 3.5 0.0 0.4 0.2 0.2 0.5 0.0 0.0 0.0 0.0 HHLA3 ENSG00000197568 "HERV-H LTR-associating 3" Q9XRX5 1 70354805-70385339 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 51.4;Proximal tubular cells: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA031323 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA031323: AB_10601477" "unprognostic (2.31e-3)" "unprognostic (8.35e-2)" "unprognostic (3.29e-2)" "unprognostic (6.61e-2)" "unprognostic (2.44e-1)" "unprognostic (1.29e-1)" "unprognostic (8.24e-3)" "unprognostic (9.87e-2)" "unprognostic (2.07e-1)" "unprognostic (3.08e-2)" "unprognostic (3.67e-1)" "unprognostic (1.69e-1)" "prognostic unfavorable (2.03e-4)" "unprognostic (1.75e-1)" "unprognostic (3.92e-2)" "unprognostic (5.16e-1)" "unprognostic (3.60e-2)" 6.9 20.0 18.2 4.1 19.5 7.6 8.5 6.9 19.3 8.9 6.4 20.1 7.2 4.6 8.2 25.7 8.0 15.8 6.8 5.1 15.8 16.5 16.8 17.6 4.6 9.7 17.5 14.6 18.0 15.5 15.8 14.1 6.8 13.4 11.4 6.1 13.1 14.4 8.6 2.8 11.0 4.3 7.9 17.0 7.3 5.2 8.9 15.4 5.8 13.6 3.2 9.0 7.6 13.2 13.4 8.5 4.5 3.0 5.2 11.2 3.9 7.8 3.6 14.0 7.9 12.1 9.9 2.0 2.2 5.1 3.7 4.8 1.2 9.0 7.4 9.7 9.3 16.8 4.9 13.7 6.3 6.6 21.1 7.9 5.0 7.5 3.5 11.8 2.4 4.0 12.8 7.5 7.9 9.3 8.4 1.2 9.9 9.1 21.1 5.4 5.8 4.9 8.5 13.8 5.6 4.8 10.3 1.0 3.6 17.1 1.2 5.1 4.0 16.8 5.3 9.9 17.6 3.1 5.5 3.1 4.0 2.3 8.3 2.7 10.6 8.5 20.2 8.1 7.5 7.7 4.5 2.5 1.4 6.5 3.0 6.5 10.5 6.7 7.0 3.7 13.4 11.2 9.9 0.7 5.2 2.2 8.5 10.8 3.9 18.2 19.5 6.9 19.3 15.8 16.5 17.5 14.6 13.4 15.4 0.0 3.2 6.0 11.4 4.5 2.8 1.2 20.4 8.1 5.7 21.0 0.0 12.7 51.4 5.7 0.6 4.6 2.6 0.0 6.6 11.5 5.4 10.3 6.9 17.4 6.9 6.4 4.1 11.1 8.6 1.0 6.9 2.7 1.7 12.6 3.9 18.6 6.4 5.8 14.2 35.6 2.8 0.0 5.1 3.7 13.4 7.4 13.3 4.9 5.0 8.3 HIC2 "HRG22, KIAA1020, ZBTB30, ZNF907" ENSG00000169635 "HIC ZBTB transcriptional repressor 2" Q96JB3 22 21417404-21451463 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 31.5;Extravillous trophoblasts: 34.4;Syncytiotrophoblasts: 33.1" "Cancer enriched" "Detected in all" 5 "testis cancer: 17.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 28.6;K-562: 49.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031884, HPA059399" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA031884: AB_10602234, HPA059399: AB_2684003" "unprognostic (2.37e-1)" "unprognostic (2.73e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (7.42e-5)" "unprognostic (1.83e-1)" "unprognostic (3.83e-1)" "unprognostic (3.62e-2)" "unprognostic (3.11e-1)" "unprognostic (1.05e-1)" "unprognostic (1.49e-2)" "unprognostic (1.21e-4)" "unprognostic (1.28e-1)" "unprognostic (4.83e-3)" "unprognostic (7.34e-3)" "unprognostic (3.33e-1)" "unprognostic (3.86e-2)" "unprognostic (5.64e-2)" 4.0 2.8 3.7 5.2 9.1 8.1 8.1 4.9 6.3 4.0 4.1 4.3 5.0 3.7 6.5 5.6 4.4 3.7 2.5 3.0 3.5 3.8 2.8 2.9 3.3 3.9 2.7 6.8 6.2 5.9 4.3 5.9 15.1 4.3 2.7 2.6 3.2 6.1 2.3 12.3 2.4 4.3 2.3 4.4 4.6 4.7 11.4 3.1 2.2 4.2 3.0 2.6 2.3 4.9 1.3 2.2 0.7 1.1 0.6 1.5 0.4 0.8 1.0 5.9 1.7 0.5 0.4 28.6 0.5 0.2 0.6 0.5 10.8 0.3 2.0 0.6 0.3 0.4 2.3 4.1 0.3 0.3 1.3 6.1 2.7 1.4 5.9 0.5 2.3 1.2 0.4 0.2 0.8 0.3 0.3 0.4 0.8 49.3 0.8 0.3 0.8 1.0 2.4 6.2 1.9 0.8 2.6 2.6 0.3 0.3 1.4 1.6 2.9 0.7 0.8 1.0 6.4 0.5 3.6 0.8 0.9 2.2 0.8 0.6 1.7 1.3 2.2 0.7 1.0 0.6 0.0 0.8 0.4 0.3 0.5 1.5 1.3 1.3 0.5 0.5 0.5 1.5 0.8 0.7 0.6 1.1 2.2 0.3 0.4 3.7 9.1 4.9 6.3 3.5 3.8 2.7 6.8 4.3 3.1 3.0 0.6 3.2 4.5 4.8 13.2 2.8 7.6 0.0 1.2 1.8 13.7 31.5 0.0 2.1 11.9 4.7 7.7 0.0 2.1 34.4 6.5 5.5 1.1 2.4 8.7 7.9 5.8 2.5 1.8 22.9 5.2 2.8 5.0 1.0 6.1 2.5 2.2 2.9 9.6 1.1 6.5 6.5 3.8 8.6 27.4 4.0 33.1 4.9 8.5 6.0 HIF1A "bHLHe78, HIF-1alpha, HIF1, MOP1, PASD8" ENSG00000100644 "Hypoxia inducible factor 1 alpha subunit" Q16665 14 61695513-61748259 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 47.8" "Lineage enriched" "Detected in all" 6 "granulocytes: 47.8" "Cell line enhanced" "Detected in many" "LHCN-M2: 119.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000907, HPA001275, CAB017442" Approved Enhanced "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Nucleoplasm, Nuclear bodies" "Plasma membrane" "CAB017442: AB_10621732, HPA000907: AB_2666139, HPA001275: AB_1079057" "unprognostic (1.07e-2)" "unprognostic (1.13e-3)" "unprognostic (9.41e-2)" "unprognostic (1.07e-1)" "unprognostic (2.51e-2)" "unprognostic (1.90e-1)" "unprognostic (2.94e-3)" "unprognostic (3.40e-1)" "unprognostic (4.05e-1)" "unprognostic (1.39e-1)" "unprognostic (1.77e-2)" "unprognostic (8.39e-2)" "unprognostic (1.24e-1)" "unprognostic (3.23e-2)" "unprognostic (3.58e-1)" "unprognostic (7.35e-2)" "unprognostic (3.88e-2)" 31.9 62.0 15.6 45.2 17.8 125.2 24.9 22.7 18.5 45.7 15.3 12.3 23.5 10.8 17.7 31.3 31.2 21.7 50.0 19.4 17.5 16.5 76.4 42.7 42.8 27.3 18.3 11.0 34.5 12.7 13.7 26.8 24.2 25.1 17.6 13.9 14.0 24.6 36.2 8.0 17.4 16.9 18.7 27.2 57.3 16.0 21.1 12.4 24.7 26.9 18.4 28.8 37.8 21.5 6.6 6.0 47.8 6.8 6.2 7.9 5.1 38.0 15.2 15.3 43.7 24.3 39.2 20.7 31.7 38.2 39.9 36.0 6.6 12.6 9.3 23.9 39.1 11.4 9.0 9.8 52.0 50.0 4.0 5.1 5.7 14.0 11.4 54.2 2.4 6.2 68.3 16.5 29.3 31.4 53.9 25.1 5.4 3.8 0.0 119.1 7.9 7.4 2.9 13.8 6.0 20.1 0.5 34.3 2.7 51.5 25.3 12.9 14.3 59.4 8.5 20.9 21.8 8.9 4.5 14.9 90.7 20.3 30.0 26.6 5.0 7.2 10.6 47.8 4.7 24.5 11.2 6.8 47.8 3.8 5.5 4.9 6.5 5.0 4.4 6.0 6.6 7.9 5.1 18.2 6.2 5.6 2.9 3.4 5.1 15.6 17.8 22.7 13.2 17.5 16.5 18.3 11.0 25.1 12.4 65.5 115.1 54.6 71.5 94.4 49.4 37.3 86.6 33.5 69.4 247.7 47.1 22.6 87.9 226.7 3.1 113.7 30.7 0.0 216.2 57.6 82.5 54.8 217.2 23.7 123.2 147.8 63.8 177.4 143.9 3.6 22.5 156.8 97.8 76.7 36.5 141.2 213.6 23.0 45.6 116.2 52.0 51.8 129.7 27.4 24.9 76.9 21.3 60.6 34.8 75.6 HIF1AN "DKFZp762F1811, FIH1, FLJ20615, FLJ22027" ENSG00000166135 "Hypoxia inducible factor 1 alpha subunit inhibitor" Q9NWT6 10 100529072-100559998 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048742, HPA065302, CAB069903" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB069903: AB_10000508, HPA048742: AB_2680507, HPA065302: AB_2685458" "unprognostic (4.07e-2)" "unprognostic (7.75e-2)" "unprognostic (2.35e-2)" "unprognostic (3.83e-2)" "unprognostic (1.67e-2)" "unprognostic (1.21e-1)" "unprognostic (8.07e-3)" "unprognostic (8.82e-2)" "unprognostic (2.54e-1)" "unprognostic (1.41e-3)" "unprognostic (1.54e-2)" "unprognostic (3.05e-2)" "unprognostic (3.01e-2)" "unprognostic (3.09e-2)" "unprognostic (9.92e-2)" "unprognostic (1.41e-1)" "unprognostic (3.24e-2)" 8.8 12.7 11.6 11.9 10.8 7.6 12.9 9.5 14.1 9.2 10.7 11.5 8.8 9.7 11.6 10.4 11.1 9.6 12.5 16.0 10.2 9.4 10.3 8.8 9.3 12.3 13.0 9.5 14.5 14.3 17.1 10.6 10.2 10.8 10.7 9.3 9.2 10.6 12.1 46.8 13.3 10.6 14.9 9.7 11.1 10.0 17.9 10.3 13.5 8.1 14.8 12.3 10.8 10.8 9.7 8.5 16.9 14.0 10.1 11.3 9.3 9.1 9.7 13.1 13.2 20.4 8.5 11.4 9.8 23.7 14.6 17.2 15.0 7.9 9.9 8.9 14.6 10.8 10.7 11.5 8.8 15.9 10.9 7.0 9.4 8.6 11.4 10.6 11.3 12.6 8.3 8.9 14.1 15.5 20.6 8.2 13.3 4.1 5.6 16.3 9.6 12.1 7.4 4.3 7.8 4.7 8.8 16.3 4.8 10.1 12.3 5.0 8.3 8.4 5.2 9.2 11.5 17.8 6.1 6.8 7.5 9.7 7.3 9.8 7.6 7.7 7.6 12.4 9.3 5.5 13.1 8.8 16.9 9.8 12.4 9.6 9.7 10.1 9.0 8.5 7.5 9.8 9.9 9.3 10.1 14.0 3.1 11.3 9.3 11.6 10.8 9.5 14.1 10.2 9.4 13.0 9.5 10.8 10.3 0.0 6.2 14.3 9.8 9.7 16.8 34.6 12.7 4.0 5.7 10.4 15.7 23.3 8.3 15.7 15.4 9.0 14.8 0.0 12.1 15.1 7.1 8.2 5.8 8.7 13.0 23.8 12.7 7.4 17.7 39.0 10.3 10.4 3.3 16.2 11.3 14.3 15.3 14.0 11.3 14.7 21.9 6.5 12.2 39.9 22.2 10.2 27.3 11.7 11.4 8.4 HIF3A "bHLHe17, IPAS, MOP7, PASD7" ENSG00000124440 "Hypoxia inducible factor 3 alpha subunit" Q9Y2N7 19 46297046-46343433 "Predicted intracellular proteins, Transcription factors" "Angiogenesis, Apoptosis, Stress response, Transcription, Transcription regulation" "Developmental protein, Repressor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 39.5;Leydig cells: 126.2;Muller glia cells: 84.5;Peritubular cells: 97.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 8.3;HHSteC: 16.9;HSkMC: 14.9;TIME: 13.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041141 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA041141: AB_10803997" "unprognostic (9.20e-2)" "unprognostic (2.99e-1)" "unprognostic (5.48e-2)" "prognostic unfavorable (6.90e-9)" "unprognostic (4.12e-2)" "unprognostic (2.35e-2)" "unprognostic (3.57e-3)" "unprognostic (1.30e-1)" "unprognostic (3.32e-2)" "unprognostic (1.38e-2)" "unprognostic (3.76e-2)" "unprognostic (7.07e-2)" "unprognostic (3.41e-4)" "unprognostic (1.55e-2)" "unprognostic (1.61e-1)" "unprognostic (4.45e-4)" "unprognostic (5.98e-2)" 15.8 7.7 17.9 4.9 9.8 2.5 8.7 10.6 11.1 15.8 16.1 4.7 6.7 3.1 8.1 10.3 11.6 9.8 9.2 31.2 21.4 6.8 4.5 2.1 13.5 5.2 10.8 8.3 17.7 5.1 2.1 12.1 42.4 9.8 9.7 4.5 10.0 4.3 13.1 12.3 3.6 7.0 26.9 11.2 21.7 14.1 3.3 11.4 0.0 3.2 5.6 2.0 18.8 14.6 1.0 1.3 3.3 1.1 0.5 0.7 0.1 0.0 0.0 1.3 0.3 3.8 8.3 0.4 0.0 0.0 0.0 0.0 1.9 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 16.9 0.1 0.6 14.9 0.0 0.0 0.0 0.1 2.9 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.1 0.0 2.1 0.0 0.2 13.6 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.7 0.2 0.1 3.3 0.4 0.8 0.4 0.4 0.4 0.5 0.4 0.4 0.2 1.0 0.6 0.7 3.1 0.5 1.1 1.3 0.2 0.1 17.9 9.8 10.6 11.1 21.4 6.8 10.8 8.3 9.8 11.4 3.0 2.6 0.0 2.1 1.0 1.4 39.5 10.2 0.0 1.2 0.0 0.0 0.2 1.7 0.0 1.4 36.8 0.0 0.0 0.0 0.2 7.5 1.3 0.0 0.5 0.5 0.0 1.2 28.8 1.0 2.6 126.2 0.2 3.3 0.0 1.1 84.5 0.1 1.5 97.2 0.0 2.1 6.5 4.2 1.2 3.1 1.9 0.5 0.0 1.4 0.5 HIGD1A "DKFZP564K247, HIG1, RCF1A" ENSG00000181061 "HIG1 hypoxia inducible domain family member 1A" Q9Y241 3 42784298-42804531 "Predicted membrane proteins" "Electron transport, Respiratory chain, Stress response, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Distal tubular cells: 535.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 89.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA043336 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA043336: AB_10795039" "unprognostic (6.46e-2)" "unprognostic (3.72e-3)" "prognostic favorable (2.12e-4)" "unprognostic (3.65e-2)" "unprognostic (8.87e-2)" "unprognostic (3.53e-1)" "unprognostic (3.70e-1)" "unprognostic (8.45e-2)" "unprognostic (6.14e-2)" "unprognostic (2.94e-1)" "unprognostic (1.24e-1)" "unprognostic (8.94e-2)" "prognostic favorable (3.99e-8)" "unprognostic (7.37e-2)" "unprognostic (3.01e-1)" "unprognostic (1.52e-1)" "unprognostic (3.88e-2)" 27.7 30.4 50.1 15.5 43.4 9.6 20.4 20.3 56.4 18.3 63.8 25.2 10.8 35.2 15.7 24.8 36.7 13.5 18.8 68.6 43.2 43.3 45.9 78.4 15.3 16.0 54.4 35.9 12.8 12.8 14.7 29.2 17.2 50.9 24.4 67.3 21.8 16.6 26.8 34.9 15.0 28.4 22.8 58.8 13.0 31.6 14.7 20.7 8.9 28.1 30.6 16.9 20.1 25.0 11.9 89.9 25.9 26.6 12.3 18.8 30.1 27.4 15.4 34.3 28.1 87.8 52.5 33.4 37.1 30.5 36.4 33.4 27.2 28.0 16.8 22.3 32.4 22.6 16.6 27.5 40.9 45.5 24.1 30.4 51.9 27.7 50.3 40.1 29.8 24.5 54.4 45.0 27.8 38.8 18.1 31.9 25.6 51.2 18.0 50.7 11.2 16.4 10.9 28.8 23.3 37.6 13.4 24.3 11.9 89.7 68.2 14.5 18.9 32.5 24.7 35.0 35.7 24.7 22.5 27.9 21.5 19.5 60.1 38.3 16.8 34.7 34.7 28.3 31.7 16.6 16.9 14.7 25.9 15.4 22.7 13.7 11.9 15.1 15.1 16.3 8.5 12.9 15.3 14.9 12.3 26.6 89.9 18.8 30.1 50.1 43.4 20.3 56.4 43.2 43.3 54.4 35.9 50.9 20.7 50.6 73.8 43.3 134.0 116.5 33.4 319.5 79.0 48.2 60.3 130.9 9.8 99.0 535.5 105.9 6.7 57.3 183.7 93.5 127.6 162.8 82.5 160.2 92.2 169.5 69.4 27.0 78.7 55.3 46.3 9.1 28.4 70.1 167.0 114.6 120.5 121.0 198.7 300.1 49.1 213.1 25.1 77.6 125.8 135.9 72.8 178.8 250.8 45.7 135.9 173.3 HIKESHI "C11orf73, HSPC138, HSPC179, OPI10" ENSG00000149196 "Hikeshi, heat shock protein nuclear import factor" Q53FT3 11 86302211-86345931 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 123.6;Extravillous trophoblasts: 118.1;Hofbauer cells: 82.9;monocytes: 87.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012708, HPA035063, HPA035064" Approved Approved "Nucleoplasm,Nuclear speckles,Nuclear bodies" NA NA "Nuclear speckles" "Nucleoplasm, Nuclear bodies" "HPA012708: , HPA035063: AB_10601143, HPA035064: AB_2674441" "unprognostic (1.10e-3)" "unprognostic (5.09e-2)" "unprognostic (1.92e-1)" "unprognostic (2.40e-2)" "unprognostic (1.50e-1)" "unprognostic (2.18e-1)" "prognostic unfavorable (8.81e-4)" "unprognostic (9.92e-2)" "unprognostic (1.16e-1)" "unprognostic (2.67e-2)" "unprognostic (8.24e-2)" "unprognostic (3.19e-2)" "prognostic unfavorable (4.01e-12)" "unprognostic (1.76e-1)" "unprognostic (2.58e-1)" "unprognostic (1.33e-3)" "unprognostic (1.71e-1)" 23.4 24.1 25.7 16.0 23.3 15.5 31.1 19.1 24.0 21.1 23.5 20.1 14.5 10.2 27.4 24.9 24.6 18.2 15.5 36.1 23.9 23.8 11.7 20.0 16.9 22.0 30.2 18.9 26.2 22.6 18.7 32.0 26.6 25.9 18.1 19.2 15.7 15.4 29.2 46.9 20.2 13.0 30.0 25.1 18.1 15.9 15.3 26.6 23.8 20.8 23.6 28.1 21.6 24.0 30.0 33.3 20.6 26.7 25.9 39.5 20.7 9.0 9.7 23.8 13.1 20.2 25.2 12.6 13.9 16.9 14.6 17.5 29.0 25.2 9.2 32.3 18.4 27.8 19.4 17.6 30.7 15.6 19.6 15.5 14.8 16.1 21.5 27.3 18.1 12.2 17.8 31.2 17.4 20.8 18.9 27.9 17.7 15.8 21.1 29.8 24.6 21.6 43.1 19.5 59.2 6.6 16.7 11.7 20.6 25.0 17.1 14.8 12.8 17.4 13.0 9.4 25.2 20.9 12.2 14.1 17.3 12.2 34.7 10.3 9.1 20.6 17.7 8.8 17.2 17.0 19.6 26.7 20.6 25.2 24.7 27.7 30.0 30.9 27.3 33.3 24.9 27.2 27.6 5.5 25.9 24.3 25.9 39.5 20.7 25.7 23.3 19.1 24.0 23.9 23.8 30.2 18.9 25.9 26.6 35.7 27.2 0.0 0.0 0.0 0.0 0.0 0.0 50.9 27.3 26.2 0.0 123.6 34.9 65.4 0.0 0.0 0.0 0.0 58.0 118.1 0.0 0.0 20.9 0.0 82.9 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 87.4 0.0 0.0 48.4 0.0 0.0 30.7 0.0 0.0 0.0 0.0 0.0 0.0 64.8 0.0 0.0 0.0 HILPDA "C7orf68, FLJ21076, HIG-2, HIG2" ENSG00000135245 "Hypoxia inducible lipid droplet associated" Q9Y5L2 7 128455849-128458418 "Predicted membrane proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.4;esophagus: 71.4" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 142.7;Syncytiotrophoblasts: 201.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 31.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010515 Approved Supported "Nucleoplasm,Lipid droplets" "Intracellular and membrane" NA NA "Lipid droplets" Nucleoplasm "HPA010515: AB_1850710" "unprognostic (1.10e-2)" "unprognostic (1.68e-2)" "unprognostic (1.88e-2)" "unprognostic (2.27e-1)" "unprognostic (2.10e-2)" "unprognostic (2.70e-2)" "prognostic unfavorable (4.30e-11)" "unprognostic (9.20e-3)" "unprognostic (4.07e-3)" "unprognostic (2.49e-1)" "unprognostic (4.06e-3)" "unprognostic (2.15e-2)" "prognostic unfavorable (2.05e-7)" "unprognostic (2.23e-2)" "unprognostic (2.77e-1)" "unprognostic (1.50e-2)" "unprognostic (1.27e-1)" 24.5 5.2 25.3 5.5 34.2 14.1 16.2 8.6 53.9 15.7 14.4 6.4 2.8 4.7 9.1 6.3 71.4 7.9 7.2 16.7 25.1 8.5 10.4 10.3 13.2 4.9 22.4 3.1 22.9 5.0 3.0 4.2 25.7 46.5 7.0 6.2 2.8 7.7 6.1 5.2 14.4 4.4 6.9 66.4 3.0 6.4 10.1 21.1 1.7 5.6 6.9 6.0 60.5 18.6 9.2 5.9 31.7 3.6 6.9 3.3 2.0 11.2 23.8 13.0 14.2 17.8 6.6 24.4 4.1 5.2 8.7 9.7 5.9 10.3 7.7 3.3 6.2 8.9 7.2 7.3 8.8 11.1 4.2 6.7 4.7 5.0 5.3 4.0 7.4 6.5 10.9 7.6 6.8 4.6 8.9 7.1 12.2 6.8 3.2 8.6 13.9 22.2 13.5 16.1 8.3 10.5 16.8 6.1 11.9 4.8 16.8 12.5 11.5 6.4 45.2 8.0 12.2 36.8 7.2 5.2 11.2 5.5 8.4 5.1 3.1 2.3 9.8 21.1 11.5 9.6 9.2 3.5 31.7 2.3 3.6 3.3 7.8 2.9 2.8 3.4 9.2 3.0 2.9 1.4 6.9 2.7 5.9 1.9 2.0 25.3 34.2 8.6 53.9 25.1 8.5 22.4 3.1 46.5 21.1 8.9 5.6 5.8 11.4 57.1 6.2 3.1 5.1 33.5 47.8 1.8 17.7 95.4 0.0 16.4 0.3 26.9 2.9 0.0 7.6 142.7 49.5 20.7 17.4 3.2 23.2 25.4 12.6 7.4 4.3 1.7 28.1 20.8 35.4 20.8 7.7 14.1 55.4 5.5 23.0 8.4 22.5 6.5 49.5 5.9 16.3 45.5 201.6 5.1 15.3 8.0 HINT1 "HINT, PKCI-1, PRKCNH1" ENSG00000169567 "Histidine triad nucleotide binding protein 1" P49773 5 131159027-131171735 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Hydrolase "Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044577 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 3600000 Cytosol "Nucleoplasm, Plasma membrane" "HPA044577: AB_10795618" "unprognostic (2.00e-1)" "unprognostic (9.27e-2)" "unprognostic (2.04e-2)" "unprognostic (1.03e-2)" "unprognostic (1.19e-1)" "unprognostic (1.35e-1)" "unprognostic (8.30e-3)" "unprognostic (2.48e-1)" "unprognostic (1.30e-2)" "unprognostic (6.49e-2)" "unprognostic (6.50e-3)" "unprognostic (4.43e-2)" "unprognostic (4.39e-3)" "unprognostic (2.08e-1)" "unprognostic (1.74e-1)" "unprognostic (1.67e-1)" "unprognostic (3.68e-1)" 28.5 46.5 56.6 46.2 51.6 50.5 64.7 42.9 78.4 29.8 53.3 20.4 49.1 36.5 30.6 43.8 44.3 42.3 36.7 61.4 47.3 43.9 65.4 124.4 38.9 54.7 48.7 50.6 32.2 62.9 43.9 39.6 24.6 40.8 41.3 50.0 22.6 44.4 41.8 84.0 38.3 41.3 37.9 37.5 32.5 32.5 30.5 25.1 29.4 47.5 56.6 39.4 29.1 45.1 26.6 46.5 19.2 25.3 20.9 40.3 52.9 37.7 55.2 43.5 88.9 30.9 33.6 40.1 28.8 26.9 29.1 33.8 53.9 52.9 52.0 57.4 36.8 60.7 23.3 34.6 75.7 26.9 45.4 63.6 20.0 78.3 69.0 64.9 31.2 6.4 44.8 66.9 34.8 58.6 58.2 36.3 80.5 30.4 113.7 37.2 41.6 52.6 78.5 42.1 42.2 44.1 38.1 43.4 94.0 54.6 48.7 53.3 33.4 38.1 26.1 45.4 61.9 31.6 45.6 39.9 38.4 21.8 30.5 58.4 32.7 41.8 45.1 53.8 50.4 35.4 19.2 25.3 9.6 21.7 12.8 29.7 26.6 40.3 28.6 39.2 25.7 32.0 25.3 5.0 20.9 12.9 46.5 27.0 52.9 56.6 51.6 42.9 78.4 47.3 43.9 48.7 50.6 40.8 25.1 262.0 219.1 629.2 1214.3 1155.8 179.6 456.1 1044.6 465.7 406.0 678.7 43.2 639.6 1409.2 899.0 635.9 429.8 1359.9 186.9 676.8 1374.0 368.2 1313.3 104.1 1865.9 757.5 139.8 670.7 421.1 431.2 132.3 363.3 562.9 916.1 1617.7 889.8 207.2 821.7 984.4 393.5 2245.6 149.7 239.3 466.3 357.2 194.1 1001.8 382.0 568.5 1197.2 1396.9 HIPK1 "KIAA0630, MGC26642, MGC33446, MGC33548, Myak, Nbak2" ENSG00000163349 "Homeodomain interacting protein kinase 1" Q86Z02 1 113929192-113977869 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 90.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 62.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016664 Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA016664: AB_1850725" "unprognostic (2.98e-1)" "unprognostic (3.94e-2)" "unprognostic (4.89e-3)" "unprognostic (2.52e-2)" "unprognostic (6.47e-2)" "unprognostic (9.84e-3)" "unprognostic (4.64e-3)" "unprognostic (7.22e-2)" "unprognostic (7.52e-2)" "unprognostic (1.45e-2)" "unprognostic (1.26e-1)" "unprognostic (1.15e-1)" "unprognostic (8.63e-2)" "unprognostic (1.84e-1)" "unprognostic (2.64e-1)" "unprognostic (1.94e-2)" "unprognostic (1.99e-2)" 15.1 16.8 21.2 14.7 23.0 90.1 13.6 38.1 20.4 20.4 14.4 20.7 14.5 10.2 15.5 14.2 18.7 27.3 17.5 27.9 22.9 17.2 14.8 13.8 19.3 14.7 15.0 16.4 18.7 16.8 20.7 23.8 13.8 21.3 14.4 15.2 20.7 13.0 14.9 19.7 18.5 13.4 15.1 18.3 15.9 14.8 33.5 21.3 47.2 23.3 13.1 15.5 17.3 26.7 2.3 6.2 9.8 4.2 4.3 6.0 2.3 8.2 6.7 9.3 7.1 10.9 5.7 6.3 5.7 6.9 8.1 7.8 7.7 3.2 11.1 7.8 9.0 3.0 5.6 12.0 6.6 11.8 8.0 6.0 16.1 8.4 8.1 9.1 12.8 20.0 6.2 9.7 10.4 10.6 7.7 12.0 19.7 11.0 12.0 11.6 62.4 16.8 7.3 9.5 6.2 6.0 10.2 27.3 3.9 7.3 7.1 4.1 5.5 10.4 11.2 7.3 10.8 6.5 18.5 11.6 8.0 10.8 13.0 8.6 7.5 5.8 9.6 9.0 10.4 18.2 3.4 4.2 8.2 5.5 3.7 5.2 1.7 4.9 4.9 3.1 2.3 5.0 6.0 9.8 4.3 2.6 6.2 3.6 2.3 21.2 23.0 38.1 20.4 22.9 17.2 15.0 16.4 21.3 21.3 50.6 37.0 12.9 14.8 54.6 47.6 27.1 22.9 64.3 20.5 26.2 66.8 9.7 5.0 12.5 82.7 29.3 18.8 70.0 18.3 7.9 25.0 26.7 45.1 33.6 19.9 69.9 35.7 23.9 54.6 73.8 20.4 35.5 20.3 15.4 24.2 28.9 17.0 17.3 35.0 13.4 60.3 25.8 37.0 35.4 26.0 70.4 11.9 47.3 22.4 23.0 HIPK2 ENSG00000064393 "Homeodomain interacting protein kinase 2" Q9H2X6 7 139561570-139777778 "Enzymes, Plasma proteins, Predicted membrane proteins" "Apoptosis, DNA damage, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.1" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 209.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 17.8" "Lineage enriched" "Detected in many" 6 "granulocytes: 17.8" "Cell line enhanced" "Detected in many" "HDLM-2: 42.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007611 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA007611: AB_1850730" "unprognostic (1.35e-3)" "unprognostic (1.49e-2)" "unprognostic (1.65e-1)" "unprognostic (7.65e-2)" "unprognostic (5.50e-2)" "unprognostic (9.44e-2)" "unprognostic (2.76e-1)" "unprognostic (4.66e-2)" "unprognostic (1.44e-1)" "unprognostic (2.76e-2)" "unprognostic (3.42e-3)" "unprognostic (4.58e-2)" "prognostic favorable (9.99e-4)" "unprognostic (1.38e-1)" "unprognostic (7.82e-2)" "unprognostic (3.93e-3)" "unprognostic (1.03e-2)" 19.6 9.8 58.8 7.4 53.6 14.4 12.6 8.5 39.8 5.5 7.4 54.5 5.2 8.2 4.7 5.2 10.2 9.9 5.5 30.5 60.0 39.9 28.2 17.5 8.6 5.3 66.1 16.4 6.6 12.3 17.2 7.6 10.8 26.4 10.7 5.8 9.4 11.5 7.1 21.6 3.2 6.2 4.8 56.2 7.3 15.4 2.6 38.6 1.7 10.4 2.8 4.9 6.8 7.4 0.6 0.5 17.8 2.9 0.2 1.4 0.5 4.1 18.5 8.6 5.2 21.0 15.1 1.0 2.3 2.3 2.6 2.7 1.3 2.3 0.0 5.3 4.3 16.0 0.2 3.9 6.0 6.5 42.6 1.6 19.0 3.0 6.5 11.8 5.2 5.2 22.9 3.9 11.8 17.8 6.1 6.4 3.6 11.0 5.2 19.8 3.1 6.5 3.7 2.2 2.3 12.7 7.8 4.7 0.5 11.7 0.7 5.2 4.8 5.2 0.1 2.6 1.6 2.9 2.1 21.5 9.1 4.3 10.5 11.3 25.8 15.3 3.7 18.6 2.8 4.9 17.8 1.1 2.7 0.2 0.9 0.3 0.6 0.5 0.1 0.5 0.3 1.4 0.4 1.5 0.2 2.9 0.2 0.0 0.5 58.8 53.6 8.5 25.2 60.0 39.9 66.1 16.4 26.4 38.6 14.9 31.1 34.2 22.5 8.2 100.5 179.2 58.6 29.4 29.6 61.1 143.3 6.0 29.9 26.8 2.4 43.9 23.1 0.0 58.5 1.5 18.6 91.5 42.8 127.8 14.7 209.7 64.5 159.0 115.1 3.1 12.0 28.9 42.2 32.5 35.2 61.0 53.9 17.5 17.7 62.8 59.6 45.3 63.6 0.9 1.7 8.3 8.0 30.2 23.3 40.0 HIRA "DGCR1, TUP1, TUPLE1" ENSG00000100084 "Histone cell cycle regulator" P54198 22 19330698-19447450 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 50.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 74.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB039243, CAB039244, HPA050714, HPA052902" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB039243: , CAB039244: , HPA050714: AB_2681219, HPA052902: AB_2681984" "unprognostic (1.32e-1)" "unprognostic (1.74e-3)" "unprognostic (2.45e-3)" "unprognostic (1.11e-1)" "unprognostic (4.59e-2)" "unprognostic (2.46e-1)" "unprognostic (2.42e-2)" "unprognostic (2.17e-2)" "unprognostic (2.50e-1)" "prognostic favorable (8.11e-4)" "prognostic favorable (3.97e-4)" "unprognostic (9.05e-2)" "prognostic favorable (5.18e-6)" "unprognostic (4.84e-2)" "unprognostic (8.57e-2)" "unprognostic (6.36e-2)" "unprognostic (1.32e-3)" 9.9 9.8 14.8 10.0 13.6 19.9 7.4 16.7 16.3 8.0 11.7 10.9 9.4 12.4 11.9 8.4 9.7 11.5 10.0 9.2 13.4 11.6 12.8 15.0 9.1 11.4 11.3 10.0 10.8 11.3 25.6 11.4 7.6 9.8 7.6 9.4 8.9 8.6 8.7 15.3 10.8 12.1 10.3 8.3 10.2 10.1 10.5 10.6 20.3 50.0 4.6 10.0 8.9 18.2 8.2 2.9 6.1 1.2 3.6 2.4 1.2 8.1 7.1 10.1 10.4 9.9 6.5 7.1 6.8 7.9 11.3 11.2 16.2 4.7 15.7 3.4 8.8 6.8 9.6 14.3 8.6 7.3 9.8 16.6 14.6 7.7 14.8 10.8 33.7 10.8 7.9 8.4 8.8 8.7 6.1 8.1 15.9 74.9 8.4 6.4 10.0 16.5 12.0 9.2 19.2 7.2 13.2 14.4 4.6 6.5 9.0 14.8 9.9 7.8 7.9 9.4 5.3 5.0 11.8 9.4 7.8 11.6 7.9 8.0 9.0 8.9 16.5 9.0 10.9 6.4 6.1 1.2 5.0 2.3 1.2 2.4 3.7 1.3 2.3 1.5 8.2 0.6 1.7 2.2 3.6 0.6 2.9 0.6 1.2 14.8 13.6 16.7 16.3 13.4 11.6 11.3 10.0 9.8 10.6 6.0 0.3 6.9 1.9 8.1 8.5 2.0 5.1 0.0 0.0 5.2 2.0 3.2 5.0 5.3 5.7 3.6 7.0 0.0 7.7 3.0 4.1 3.8 0.0 18.1 5.6 15.9 2.4 7.4 10.8 1.6 4.6 2.5 10.1 3.6 8.5 4.5 6.6 10.8 6.3 9.3 4.0 6.5 4.2 7.1 7.5 9.3 2.5 3.3 13.3 1.8 HIRIP3 ENSG00000149929 "HIRA interacting protein 3" Q9BW71 16 29992321-29996436 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 94.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051897, HPA063205" Approved Enhanced Nucleoplasm No No Nucleoplasm "HPA051897: AB_2681655, HPA063205: AB_2684963" "unprognostic (6.99e-2)" "prognostic favorable (2.74e-5)" "unprognostic (4.75e-2)" "unprognostic (2.83e-1)" "unprognostic (1.08e-1)" "unprognostic (4.48e-2)" "unprognostic (9.55e-2)" "unprognostic (1.80e-2)" "unprognostic (3.58e-2)" "unprognostic (8.53e-3)" "unprognostic (3.85e-2)" "unprognostic (2.07e-1)" "unprognostic (4.26e-3)" "unprognostic (5.22e-2)" "unprognostic (1.69e-1)" "unprognostic (1.97e-2)" "unprognostic (2.35e-2)" 9.4 11.3 16.8 9.2 26.8 15.0 10.0 23.4 17.9 10.9 11.3 20.7 10.0 9.6 11.3 10.8 9.5 12.5 9.0 17.6 16.4 14.6 10.6 13.6 12.8 12.7 22.9 13.6 18.2 11.4 20.0 14.2 8.4 15.3 10.1 7.5 11.5 12.8 15.5 29.0 13.3 9.2 13.3 20.1 10.8 8.5 34.0 23.9 21.0 11.8 9.0 11.9 10.3 12.4 13.9 14.6 10.8 13.9 9.7 16.6 8.3 11.0 11.8 18.2 12.3 5.8 6.3 6.3 8.8 7.2 9.6 8.1 9.9 12.1 19.6 18.6 5.8 6.5 8.3 11.9 10.8 6.3 19.4 14.3 21.0 15.7 11.1 5.4 18.6 18.5 3.4 8.2 9.1 13.6 5.1 5.5 22.6 10.9 25.0 5.0 8.1 26.9 11.8 6.0 7.2 7.5 29.4 20.3 22.5 6.1 4.8 13.2 15.8 8.4 7.5 6.2 4.6 10.6 13.3 5.4 12.9 9.6 9.0 8.6 17.3 12.1 13.4 11.9 17.5 17.3 3.5 5.9 10.8 13.4 9.2 9.3 13.9 15.3 12.4 4.9 11.7 16.1 14.9 2.7 9.7 13.9 14.6 16.6 8.3 16.8 26.8 23.4 17.9 16.4 14.6 22.9 13.6 15.3 23.9 62.5 22.9 6.7 16.0 11.3 36.1 27.0 10.2 26.8 20.5 8.7 13.7 21.2 24.9 8.4 13.9 14.6 13.6 0.0 10.7 25.6 12.2 5.7 30.1 12.3 16.1 14.3 9.2 8.6 9.9 8.2 19.0 13.5 5.0 10.0 9.1 34.7 6.1 10.5 21.2 15.3 39.9 12.9 19.6 94.0 51.7 9.9 9.6 19.2 13.3 4.2 HIST1H1A "H1.1, H1a, H1F1" ENSG00000124610 "Histone cluster 1 H1 family member a" Q02539 6 26017085-26017732 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 57.2" "Cell type enriched" "Detected in some" 9 "Spermatogonia: 131.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "T-reg: 4.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 2.1;REH: 4.4;RPTEC TERT1: 1.5;U-2 OS: 3.9" "Not detected" "Not detected" "HPA043753, HPA056830" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "HPA043753: AB_2678654, HPA056830: " "unprognostic (3.80e-1)" "unprognostic (1.82e-1)" "unprognostic (1.15e-1)" "unprognostic (1.96e-1)" "unprognostic (1.21e-1)" "unprognostic (3.05e-1)" 0.8 1.4 1.0 3.9 0.9 1.1 0.8 0.9 3.3 3.5 0.8 0.0 0.4 0.7 3.6 3.9 6.2 1.1 3.4 2.8 1.0 0.8 3.7 5.3 0.7 1.3 0.8 0.6 7.9 0.8 0.7 1.0 0.7 0.6 0.9 0.9 0.9 0.7 1.5 0.7 2.0 0.8 0.7 0.7 0.9 0.8 57.2 0.0 15.1 2.7 10.6 12.4 1.2 0.8 1.4 1.2 0.0 0.1 0.0 4.9 0.4 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.7 1.3 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.6 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.8 0.0 0.2 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 4.4 0.0 0.0 1.5 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 3.9 0.5 0.0 0.2 0.5 0.0 0.5 0.0 0.5 0.0 0.0 0.0 1.5 0.1 0.0 1.4 2.8 0.3 0.6 0.0 1.7 0.1 0.0 0.0 0.0 1.2 4.9 0.4 1.0 0.9 0.9 3.3 1.0 0.8 0.8 0.6 0.6 0.0 0.0 0.3 0.0 1.0 0.1 0.0 3.4 0.0 1.4 1.2 0.0 0.0 0.1 14.9 0.0 0.3 0.0 0.0 0.0 0.2 3.6 0.6 0.2 1.1 2.1 1.6 0.0 0.0 4.3 0.3 0.9 0.9 0.2 1.7 0.0 0.0 0.5 0.2 0.0 1.8 0.3 1.0 0.0 0.4 4.9 131.8 0.4 0.3 0.0 0.0 0.3 HIST1H1B "H1.5, H1b, H1F5, H1s-3" ENSG00000184357 "Histone cluster 1 H1 family member b" P16401 6 27866849-27867529 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "lymphoid tissue: 342.6" "Cell type enhanced" "Detected in some" 10 "Extravillous trophoblasts: 3.8;Hofbauer cells: 2.6;Kupffer cells: 2.2;Macrophages: 1.8;T-cells: 1.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 4.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 13.0;dendritic cells: 12.7;T-cells: 3.4" "Cell line enhanced" "Detected in many" "MOLT-4: 14.0;NB-4: 7.7;U-698: 6.0" "CAB012241, HPA055907, HPA060331" Supported Supported Nucleoplasm NA NA 510000 Nucleoplasm "CAB012241: , HPA055907: AB_2682966, HPA060331: " "unprognostic (2.34e-1)" "unprognostic (3.75e-4)" "unprognostic (2.12e-2)" "unprognostic (3.63e-2)" "unprognostic (1.05e-1)" "unprognostic (2.37e-2)" "unprognostic (1.91e-2)" "unprognostic (4.93e-2)" "unprognostic (1.20e-1)" "unprognostic (8.47e-2)" "unprognostic (6.23e-3)" "unprognostic (5.85e-2)" "unprognostic (5.68e-4)" "unprognostic (2.10e-1)" "unprognostic (9.79e-2)" "unprognostic (1.35e-1)" 1.1 0.4 0.4 22.9 0.5 18.2 2.1 0.5 0.4 1.7 7.3 0.0 0.0 0.3 0.5 1.0 10.2 0.3 1.9 0.6 0.5 0.5 0.4 0.6 3.9 10.7 0.5 0.0 0.4 0.4 0.3 0.4 6.4 0.0 0.4 0.5 0.0 0.8 0.3 0.4 1.4 7.0 0.3 1.7 14.4 1.3 1.7 0.0 342.6 0.6 10.5 26.0 2.0 0.7 13.0 12.7 0.7 1.1 1.8 3.4 2.1 2.2 0.0 0.8 0.0 0.0 0.0 1.7 0.7 0.6 1.0 0.6 0.7 1.5 2.7 0.4 0.8 0.7 0.8 0.0 0.0 0.1 0.8 1.0 3.6 0.1 0.0 0.0 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.9 1.9 2.7 1.9 0.1 0.4 14.0 7.7 2.1 2.1 0.0 4.2 0.0 0.0 0.4 0.0 1.9 1.1 2.4 0.3 0.0 0.8 1.0 2.5 0.8 1.4 0.1 1.4 1.1 2.9 0.0 6.0 2.0 0.9 1.3 0.0 0.9 0.0 3.3 0.9 1.7 4.8 3.1 3.4 5.1 13.0 1.7 1.8 0.7 1.8 1.1 12.7 3.4 2.1 0.4 0.5 0.5 0.4 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.3 0.1 0.0 0.0 2.6 0.0 0.0 0.6 2.2 0.0 0.3 1.8 0.0 0.0 0.3 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.6 1.8 0.9 0.1 HIST1H1C "H1.2, H1c, H1F2, H1s-1" ENSG00000187837 "Histone cluster 1 H1 family member c" P16403 6 26055787-26056428 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 353.5" "Cell type enhanced" "Detected in all" 6 "Glandular cells: 442.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 79.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 79.7" "Cell line enhanced" "Detected in many" "K-562: 50.0;SiHa: 47.6;U-2 OS: 93.7;U-266/70: 103.9;U-266/84: 98.7" "Low region specificity" "Detected in all" "CAB011507, HPA055907" Supported Supported "Nucleoplasm,Nucleoli rim" NA NA 1800000 "Nucleoplasm, Nucleoli rim" "CAB011507: AB_2117984, HPA055907: AB_2682966" "unprognostic (4.43e-2)" "unprognostic (1.57e-3)" "unprognostic (1.31e-2)" "unprognostic (2.96e-2)" "unprognostic (5.47e-1)" "unprognostic (1.22e-1)" "unprognostic (1.96e-1)" "unprognostic (1.64e-1)" "unprognostic (1.13e-1)" "unprognostic (1.07e-1)" "prognostic unfavorable (1.12e-4)" "unprognostic (1.45e-1)" "prognostic unfavorable (1.56e-4)" "unprognostic (1.85e-1)" "unprognostic (8.93e-2)" "unprognostic (3.08e-1)" "prognostic favorable (8.06e-5)" 25.1 17.4 10.1 32.1 10.2 94.7 36.0 23.8 12.8 29.8 23.3 8.1 14.3 15.0 24.7 21.0 48.6 16.6 27.4 37.6 9.3 7.3 23.8 43.1 31.4 37.2 8.2 8.7 34.4 46.6 2.3 5.8 29.1 6.9 44.3 21.2 26.5 22.0 9.5 69.1 21.0 21.1 22.9 12.5 28.4 25.6 33.7 5.4 353.5 21.7 28.5 39.7 38.8 28.0 14.9 5.9 79.7 3.2 3.3 8.6 4.2 5.9 4.2 3.1 3.4 8.1 1.6 0.1 2.9 4.9 14.1 15.0 2.3 4.3 0.4 17.2 3.9 5.1 2.6 1.0 2.3 3.9 5.7 3.7 2.4 4.7 2.6 2.4 1.1 5.9 11.5 3.1 1.8 3.1 4.3 2.2 2.7 50.0 37.6 7.0 2.6 3.0 2.6 1.7 14.5 6.5 1.6 1.4 19.1 8.3 4.3 8.2 2.8 47.6 8.2 3.3 3.1 10.1 1.7 1.0 6.4 93.7 1.9 1.3 103.9 98.7 4.5 4.7 38.9 2.2 35.8 2.6 79.7 3.8 2.6 4.8 9.8 6.3 4.1 5.6 14.9 5.8 4.4 43.0 3.3 3.2 5.9 8.6 4.2 10.1 10.2 23.8 12.8 9.3 7.3 8.2 8.7 6.9 5.4 65.5 28.8 111.5 307.6 7.2 72.6 41.5 30.6 100.4 35.2 66.3 47.1 37.6 44.7 79.4 2.2 29.5 161.7 256.9 100.4 59.2 37.4 442.5 18.6 102.4 61.4 49.3 37.3 33.7 27.5 4.2 24.2 37.4 3.3 16.2 65.1 147.0 86.1 92.5 10.3 161.0 135.9 25.8 23.3 14.2 90.3 6.9 249.6 48.4 36.8 295.6 HIST1H2AA "bA317E16.2, H2AFR" ENSG00000164508 "Histone cluster 1 H2A family member a" Q96QV6 6 25726132-25726527 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 518 "testis: 453.1" "Group enriched" "Detected in some" 15 "Spermatocytes: 219.3;Spermatogonia: 217.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 30 "HEK 293: 3.0" "Not detected" "Not detected" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (4.53e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 453.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 219.3 217.6 0.0 0.0 0.0 0.0 0.0 HIST1H2AB "H2A/m, H2AFM" ENSG00000278463 "Histone cluster 1 H2A family member b" P04908 6 26033176-26033568 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "lymphoid tissue: 133.2" "Cell type enhanced" "Detected in some" 9 "B-cells: 2.2;Early spermatids: 2.6;Melanocytes: 1.7" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 9.2" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (9.53e-3)" "unprognostic (3.93e-2)" "unprognostic (5.40e-2)" "unprognostic (5.96e-2)" "unprognostic (1.01e-1)" "unprognostic (1.43e-1)" "unprognostic (7.13e-2)" "unprognostic (2.58e-1)" "unprognostic (2.49e-1)" "unprognostic (1.04e-3)" "unprognostic (3.28e-1)" "unprognostic (7.78e-2)" "unprognostic (1.47e-1)" "unprognostic (1.47e-3)" 0.7 0.3 0.2 7.6 0.0 9.6 2.6 0.2 0.6 0.5 1.7 0.0 0.0 0.3 0.5 0.3 5.0 0.3 0.7 2.6 0.0 0.6 0.3 1.7 5.9 0.0 0.0 0.3 0.3 0.3 0.0 2.6 0.0 0.5 0.3 0.2 0.3 0.3 0.3 0.3 2.2 0.3 0.1 8.2 0.7 8.3 0.0 133.2 0.3 1.5 12.2 0.3 0.0 4.2 1.8 3.4 1.5 1.4 2.4 0.3 0.2 1.0 0.5 3.6 0.0 0.0 0.0 0.0 0.0 0.9 1.8 0.0 0.3 1.8 0.9 0.0 0.1 0.6 0.5 0.0 0.6 0.9 2.2 1.1 0.5 9.2 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.4 1.0 0.0 1.4 2.0 2.0 3.6 0.0 3.5 1.2 0.7 1.5 0.0 3.0 0.4 0.1 2.1 0.0 0.1 0.1 0.6 1.0 0.0 0.3 4.0 0.3 0.2 1.5 2.5 0.1 0.6 3.7 0.3 0.0 0.1 3.4 0.8 1.5 0.0 4.2 1.5 2.4 1.8 3.1 0.6 0.8 0.7 1.4 0.1 0.2 0.6 0.3 0.0 0.0 2.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.9 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.6 0.3 1.0 0.0 0.0 1.7 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 1.1 0.0 0.5 0.0 0.4 0.5 HIST1H2AC H2AFL ENSG00000180573 "Histone cluster 1 H2A family member c" Q93077 6 26124145-26139116 "Cancer-related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 116.1;lymphoid tissue: 202.5" "Cell type enhanced" "Detected in many" 6 "Glandular cells: 177.7;Urothelial cells: 208.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 116.1" "Lineage enriched" "Detected in all" 17 "granulocytes: 116.1" "Cell line enhanced" "Detected in many" "HSkMC: 31.4;OE19: 26.8;SiHa: 26.9;U-2 OS: 27.1;U-266/84: 27.0" "Low region specificity" "Detected in all" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (4.89e-2)" "unprognostic (1.97e-1)" "unprognostic (7.15e-3)" "unprognostic (1.34e-1)" "unprognostic (4.70e-1)" "unprognostic (1.33e-1)" "unprognostic (3.25e-1)" "unprognostic (1.37e-1)" "unprognostic (8.16e-2)" "unprognostic (2.57e-1)" "unprognostic (1.61e-3)" "unprognostic (1.75e-1)" "unprognostic (1.19e-2)" "unprognostic (2.58e-1)" "unprognostic (1.17e-1)" "unprognostic (1.20e-1)" "unprognostic (5.89e-3)" 13.6 14.5 13.6 22.5 16.4 19.0 29.9 7.3 9.8 35.6 21.0 12.2 17.9 18.1 13.2 32.8 27.5 23.6 13.9 12.6 18.5 12.4 21.4 34.1 29.2 28.5 18.6 8.5 23.8 15.7 3.7 13.4 26.2 8.5 37.2 15.0 21.1 10.4 17.0 17.5 15.4 21.6 14.4 27.0 26.4 26.9 16.3 10.4 202.5 24.5 9.2 34.9 29.6 25.8 6.6 4.5 116.1 3.6 1.9 2.1 48.3 5.5 1.6 1.9 0.6 16.1 8.8 0.8 2.8 1.7 8.5 7.3 2.1 1.4 0.2 13.8 5.6 5.7 6.7 1.5 2.9 6.1 5.3 0.9 0.9 0.7 0.3 12.6 0.9 6.4 31.4 5.0 1.8 5.5 10.8 0.5 0.7 13.9 10.2 3.7 4.6 0.9 1.0 2.3 26.8 0.5 0.6 1.0 16.3 8.1 0.6 2.9 1.2 26.9 5.7 8.8 8.2 13.1 1.4 1.8 5.2 27.1 2.3 1.2 13.3 27.0 1.5 1.9 14.0 2.2 36.0 2.0 24.4 1.4 1.5 1.2 3.3 1.5 1.0 1.4 6.6 2.1 1.1 116.1 1.9 3.6 4.5 2.0 48.3 13.6 16.4 7.3 9.8 18.5 12.4 18.6 8.5 8.5 10.4 32.8 12.8 27.7 117.6 2.6 22.0 22.6 15.3 24.1 12.5 68.0 7.9 13.9 23.2 18.9 3.5 18.0 86.9 0.0 11.7 21.5 13.7 177.7 10.4 51.3 13.8 17.5 93.4 16.0 10.5 0.5 13.0 8.0 5.0 12.6 30.9 10.9 33.5 129.8 7.1 77.4 22.6 19.4 16.5 2.4 2.2 7.3 63.5 18.7 26.1 208.4 HIST1H2AD "H2A.3, H2A/g, H2AFG" ENSG00000196866 "Histone cluster 1 H2A family member d" P20671 6 26198851-26199243 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 14 "lymphoid tissue: 225.6" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 16.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "U-266/70: 21.2;U-266/84: 6.9" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (5.03e-2)" "unprognostic (1.11e-2)" "unprognostic (7.27e-2)" "unprognostic (3.56e-1)" "unprognostic (9.17e-2)" "unprognostic (1.45e-1)" "unprognostic (9.09e-3)" "unprognostic (6.72e-2)" "unprognostic (1.92e-1)" "unprognostic (4.34e-1)" "unprognostic (1.81e-1)" "unprognostic (2.88e-2)" "unprognostic (1.10e-9)" "unprognostic (2.00e-1)" "unprognostic (1.34e-1)" "unprognostic (3.27e-1)" "unprognostic (2.14e-2)" 2.6 1.8 0.9 13.8 1.1 14.7 6.3 0.8 1.3 8.0 4.6 0.0 3.2 1.5 2.0 3.1 9.2 1.3 2.8 5.5 1.2 1.3 2.3 3.6 4.8 15.9 1.1 0.5 3.4 1.9 1.1 1.5 4.6 1.0 6.8 2.2 1.5 2.5 4.3 1.2 3.2 4.3 2.3 3.6 10.8 1.8 5.7 0.6 225.6 1.4 5.1 14.3 5.3 8.6 7.0 5.7 16.0 1.8 1.1 3.8 0.8 0.8 0.0 0.3 0.3 0.0 0.0 0.0 0.6 0.3 1.9 0.0 2.4 0.3 0.0 1.7 0.3 0.2 0.4 0.0 0.3 0.2 0.1 1.3 0.2 1.6 0.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.5 3.5 1.7 0.0 0.1 2.9 1.3 1.7 0.0 0.3 1.5 0.5 1.5 0.4 0.1 1.5 0.3 0.7 1.4 0.1 0.0 0.5 0.5 0.0 1.5 4.1 0.0 1.1 21.2 6.9 2.5 0.8 1.8 0.7 2.2 0.2 3.2 1.1 1.8 1.1 2.0 1.5 3.8 1.0 7.0 1.4 1.1 16.0 1.1 1.3 5.7 2.0 0.8 0.9 1.1 0.8 1.3 1.2 1.3 1.1 0.5 1.0 0.6 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 HIST1H2AE "H2A.1, H2A/a, H2AFA" ENSG00000277075 "Histone cluster 1 H2A family member e" P04908 6 26216975-26217483 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 139.6" "Group enriched" "Detected in many" 7 "Basal glandular cells: 99.4;Glandular cells: 104.2;Urothelial cells: 88.8" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 26.7" "CAB012242, HPA041189" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB012242: AB_470265, HPA041189: AB_2677357" "unprognostic (4.26e-2)" "unprognostic (1.55e-2)" "unprognostic (4.66e-2)" "unprognostic (1.53e-1)" "unprognostic (2.45e-1)" "unprognostic (1.50e-1)" "unprognostic (2.48e-2)" "unprognostic (7.22e-2)" "unprognostic (1.24e-2)" "unprognostic (6.99e-2)" "unprognostic (1.21e-3)" "unprognostic (1.30e-2)" "unprognostic (7.64e-2)" "unprognostic (1.15e-1)" "unprognostic (2.41e-1)" "unprognostic (2.20e-1)" "unprognostic (9.36e-2)" 0.3 1.8 0.9 19.1 0.9 13.5 33.8 4.9 6.2 3.7 3.8 0.2 3.2 2.8 2.2 13.6 7.2 3.0 2.4 2.2 0.5 0.8 1.5 1.9 11.4 0.0 3.0 2.0 1.1 0.4 0.0 2.9 0.5 10.6 1.6 1.4 2.7 2.5 0.1 2.4 3.4 2.0 3.5 5.9 2.0 5.1 0.0 139.6 2.0 7.4 11.4 2.3 0.0 6.1 15.4 11.4 2.1 4.0 4.2 10.1 2.8 0.0 2.1 0.0 3.5 0.7 0.5 0.9 1.4 3.1 2.1 1.4 2.3 0.1 7.8 0.3 2.8 2.4 1.0 1.4 1.2 3.1 2.6 1.9 4.2 1.8 0.6 0.2 2.9 6.2 0.7 1.3 0.1 0.9 1.5 0.5 7.7 2.1 0.2 5.2 6.3 5.4 2.5 9.8 2.6 5.0 1.7 9.9 1.3 1.6 8.6 3.6 7.7 2.6 1.7 1.5 10.6 2.8 0.0 0.1 0.6 1.3 1.2 26.7 0.0 0.0 1.1 3.8 1.9 11.4 2.0 6.3 2.7 2.1 3.8 4.3 3.0 4.2 5.0 6.1 1.6 2.1 9.4 4.0 1.2 15.4 3.6 10.1 3.0 13.0 11.1 99.4 1.3 3.3 0.4 0.0 0.0 2.3 1.8 0.0 6.5 1.7 2.8 2.5 0.5 13.7 0.0 0.0 4.1 2.1 104.2 2.3 2.1 14.1 3.2 10.4 1.8 1.5 1.8 0.9 5.7 0.0 2.8 12.1 1.7 0.3 10.8 0.4 4.0 0.1 0.0 0.2 0.7 9.1 1.3 11.6 10.0 8.1 88.8 HIST1H2AG "H2A.1b, H2A/p, H2AFP, pH2A/f" ENSG00000196787 "Histone cluster 1 H2A family member g" P0C0S8 6 27133042-27135291 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "lymphoid tissue: 305.4" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 16.3;Enterocytes: 7.3;Late spermatids: 10.6;Paneth cells: 10.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 9.7" "Group enriched" "Detected in many" 4 "B-cells: 4.4;granulocytes: 9.7;T-cells: 3.8" "Cell line enhanced" "Detected in many" "K-562: 9.9;SiHa: 11.5;U-266/84: 31.2" HPA041189 Supported Approved Nucleoplasm NA Yes Nucleoplasm "HPA041189: AB_2677357" "unprognostic (4.86e-2)" "unprognostic (6.89e-2)" "unprognostic (1.66e-1)" "unprognostic (3.94e-1)" "unprognostic (8.67e-2)" "unprognostic (1.03e-3)" "unprognostic (1.95e-1)" "unprognostic (5.78e-2)" "unprognostic (2.41e-1)" "unprognostic (2.37e-1)" "unprognostic (2.14e-3)" "unprognostic (1.53e-2)" "unprognostic (7.36e-2)" "unprognostic (5.98e-2)" "unprognostic (6.48e-2)" "unprognostic (8.22e-3)" "unprognostic (9.54e-2)" 2.4 1.6 1.1 25.1 1.2 6.3 8.7 0.7 1.0 3.3 9.7 0.0 1.0 3.8 2.0 3.7 15.7 1.0 3.2 2.7 1.3 1.6 1.1 2.6 6.0 13.5 2.3 0.0 1.4 0.9 0.3 1.0 8.7 0.3 2.5 2.3 0.3 2.1 1.5 1.1 1.4 7.1 0.9 2.3 20.2 1.8 16.1 0.0 305.4 1.5 12.3 28.9 2.4 2.0 4.4 1.3 9.7 0.8 1.1 3.8 7.7 1.3 1.8 1.6 1.4 4.9 1.0 1.0 0.5 0.7 1.6 0.2 0.8 1.4 0.4 2.0 0.5 1.5 2.8 1.9 0.8 1.1 2.4 1.1 0.7 3.6 0.0 1.0 0.7 1.5 1.8 0.4 0.5 0.5 0.8 0.5 1.3 9.9 4.7 0.1 1.7 1.8 1.1 0.9 2.0 1.2 1.2 1.5 5.1 0.3 0.3 6.1 1.5 11.5 1.8 0.6 0.7 0.0 0.4 0.6 1.8 4.0 1.4 0.7 8.4 31.2 3.2 0.3 1.1 1.1 9.7 0.4 0.7 0.6 0.3 1.3 3.0 2.3 1.6 0.6 4.4 2.2 1.8 3.5 1.1 0.8 1.3 3.8 7.7 1.1 1.2 0.7 0.9 1.3 1.6 2.3 0.0 0.3 0.0 0.0 1.4 2.2 1.4 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 16.3 0.3 7.3 0.0 0.0 2.9 0.3 1.4 0.0 0.4 2.1 4.8 1.2 0.0 0.6 10.6 0.0 1.0 0.0 1.0 3.1 1.2 0.1 10.5 0.0 0.0 0.0 0.0 0.3 2.2 3.0 0.4 2.5 2.5 2.9 1.0 HIST1H2AH "dJ86C11.1, H2A/S, H2AFALii" ENSG00000274997 "Histone cluster 1 H2A family member h" Q96KK5 6 27147129-27147515 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "lymphoid tissue: 301.1" "Cell type enriched" "Detected in some" 5 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in many" "naive B-cell: 16.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 9.0;MOLT-4: 9.3;NB-4: 10.2" "CAB004030, HPA041189" Supported Approved Nucleoplasm NA Yes Nucleoplasm "CAB004030: AB_2118804, HPA041189: AB_2677357" "unprognostic (4.07e-1)" "unprognostic (2.73e-3)" "unprognostic (4.04e-2)" "unprognostic (4.01e-1)" "unprognostic (2.02e-1)" "unprognostic (5.35e-3)" "unprognostic (3.90e-2)" "unprognostic (3.20e-1)" "unprognostic (2.36e-1)" "unprognostic (2.38e-3)" "unprognostic (2.91e-1)" "unprognostic (2.32e-1)" "unprognostic (9.74e-3)" "unprognostic (1.87e-1)" "unprognostic (1.26e-4)" 0.8 0.7 0.0 26.0 0.0 20.2 1.5 0.0 0.4 3.1 6.6 0.0 0.6 1.0 1.8 2.6 6.4 1.0 2.7 1.3 0.0 0.5 0.4 4.1 5.4 0.0 0.0 2.4 0.5 0.4 0.0 9.0 0.0 0.6 0.9 0.1 1.7 0.6 0.4 0.6 6.5 0.9 0.0 13.9 0.7 23.5 0.0 301.1 0.6 9.0 27.3 1.9 0.0 16.2 2.2 0.0 2.4 5.1 4.7 2.3 2.6 3.5 1.1 4.9 0.0 0.0 0.7 0.3 0.6 0.6 0.0 2.6 1.0 3.8 0.9 0.0 0.6 0.3 1.0 0.0 0.0 2.1 9.0 4.7 3.0 0.0 0.0 3.2 1.8 0.0 0.0 1.2 0.0 0.0 0.9 1.8 4.8 2.4 0.9 0.4 9.3 10.2 3.2 0.9 1.2 3.4 3.1 5.0 0.0 0.3 2.5 0.6 1.4 0.5 0.2 0.1 1.0 1.5 0.0 0.8 2.8 0.2 2.7 2.9 2.9 6.1 1.3 4.6 0.8 0.0 0.9 0.0 2.6 2.4 1.2 3.8 4.7 4.2 2.2 16.2 2.4 1.6 0.0 5.1 1.5 1.5 0.8 2.3 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.7 0.0 0.3 1.7 0.1 1.6 23.3 0.3 1.9 0.3 0.8 1.1 0.0 0.7 0.0 1.7 1.8 1.2 4.3 0.6 0.6 0.0 0.0 0.3 0.2 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.5 0.2 2.5 1.0 0.6 HIST1H2AI "H2A/c, H2AFC" ENSG00000196747 "Histone cluster 1 H2A family member i" P0C0S8 6 27808199-27808701 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 23 "lymphoid tissue: 349.3" "Cell type enhanced" "Detected in single" 10 "T-cells: 1.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 17.7;U-266/84: 48.6" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (1.23e-1)" "unprognostic (6.21e-3)" "unprognostic (6.82e-2)" "unprognostic (5.57e-3)" "unprognostic (1.38e-1)" "unprognostic (4.48e-2)" "unprognostic (9.11e-3)" "unprognostic (1.13e-1)" "unprognostic (1.96e-1)" "unprognostic (1.27e-1)" "unprognostic (9.54e-5)" "unprognostic (5.50e-2)" "unprognostic (1.50e-5)" "unprognostic (1.43e-1)" "unprognostic (1.85e-1)" "unprognostic (1.89e-1)" "unprognostic (6.24e-2)" 1.7 1.2 0.7 36.2 0.9 10.7 2.8 0.6 0.7 1.5 6.3 0.0 0.5 2.3 1.1 1.4 14.2 1.4 2.8 4.8 1.1 1.1 1.0 1.3 3.5 25.8 0.6 0.0 1.2 0.4 1.4 0.6 5.4 0.0 1.3 5.8 0.0 1.3 0.3 0.5 1.1 7.1 0.5 4.3 21.9 2.2 4.3 0.0 349.3 1.0 15.2 26.8 2.3 2.0 3.0 2.6 4.8 0.8 2.5 4.0 2.0 0.9 3.7 0.9 0.6 0.4 0.2 0.3 0.7 0.1 1.2 0.9 1.1 0.6 1.0 2.2 0.3 0.6 0.7 0.0 0.6 0.5 3.6 4.8 1.5 5.9 3.1 0.4 0.4 0.8 1.7 0.2 0.4 0.1 1.0 0.2 1.2 17.7 4.2 0.0 4.6 2.6 2.8 0.9 3.1 1.3 1.3 0.0 6.9 1.4 0.7 5.2 1.0 10.3 1.5 0.3 0.3 6.3 0.4 0.2 0.5 2.0 0.4 0.4 3.9 48.6 2.0 0.4 4.1 0.3 0.0 0.5 3.6 0.9 0.8 0.7 2.1 3.2 0.9 2.3 3.0 0.7 0.4 4.8 2.5 0.8 2.6 4.0 2.0 0.7 0.9 0.6 0.7 1.1 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.2 0.4 HIST1H2AJ "H2A/E, H2AFE" ENSG00000276368 "Histone cluster 1 H2A family member j" Q99878 6 27814354-27814740 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "lymphoid tissue: 357.7" "Cell type enriched" "Detected in some" 29 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 10.0;Karpas-707: 12.1;MCF7: 16.8" "Low region specificity" "Detected in some" HPA041189 Supported Approved Nucleoplasm NA Yes Nucleoplasm "HPA041189: AB_2677357" "unprognostic (8.95e-3)" "unprognostic (4.08e-3)" "unprognostic (3.28e-2)" "unprognostic (5.72e-3)" "unprognostic (2.29e-2)" "unprognostic (2.69e-2)" "unprognostic (6.06e-2)" "unprognostic (1.97e-2)" "unprognostic (1.05e-1)" "unprognostic (2.18e-1)" "unprognostic (9.39e-3)" "unprognostic (3.43e-1)" "unprognostic (9.35e-2)" "unprognostic (1.51e-1)" "unprognostic (1.88e-2)" 0.6 0.1 0.0 7.2 0.0 16.5 0.2 0.0 0.2 1.0 5.2 0.0 0.0 0.3 0.3 0.6 6.6 0.3 0.8 0.2 0.0 0.3 0.4 2.2 3.1 0.0 0.0 0.1 0.1 0.1 0.0 3.6 0.0 0.2 0.4 0.0 0.1 0.1 0.1 0.4 3.9 0.1 0.0 10.5 0.8 5.2 0.0 357.7 0.1 7.9 23.1 1.5 0.0 4.2 2.7 2.5 0.5 0.4 5.9 5.0 4.0 0.0 1.2 0.0 0.0 0.0 1.0 1.2 1.2 1.1 2.6 2.1 0.2 3.9 0.4 0.7 0.1 1.1 0.0 1.1 0.6 1.9 0.6 5.6 0.5 10.0 0.3 0.0 2.1 0.0 0.3 0.5 0.3 0.0 1.5 2.1 0.0 12.1 0.3 16.8 6.7 6.1 2.0 1.7 3.5 6.0 0.0 2.3 0.2 2.4 0.5 0.8 1.1 1.2 0.5 0.3 0.4 4.1 0.0 0.0 2.4 0.4 0.2 6.2 3.9 3.8 1.3 4.5 2.8 0.0 0.1 0.0 0.7 0.5 0.9 0.7 3.4 3.1 2.7 4.2 1.1 0.4 2.5 0.4 0.2 0.3 5.9 5.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 46.7 0.0 1.6 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.6 0.0 0.4 0.3 HIST1H2AK "H2A/d, H2AFD" ENSG00000275221 "Histone cluster 1 H2A family member k" P0C0S8 6 27837947-27838339 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "lymphoid tissue: 115.7" "Cell type enhanced" "Detected in some" 8 "Ciliated cells: 1.4;granulocytes: 1.1;Melanocytes: 1.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 4.3;AN3-CA: 4.9;HeLa: 5.1;SCLC-21H: 4.8;U-266/84: 7.2" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" 1.5 4.1 0.0 11.1 0.5 3.2 3.5 0.9 1.3 2.8 2.3 0.2 0.5 1.0 1.7 1.6 4.4 2.7 4.1 2.5 0.0 0.2 0.4 4.4 8.4 0.8 0.0 3.3 0.0 0.0 0.1 1.7 0.3 2.3 0.4 0.9 1.7 1.1 0.7 0.0 1.5 0.3 1.6 7.0 1.3 3.9 0.5 115.7 1.6 2.8 12.3 2.1 0.0 6.0 1.2 0.0 0.6 1.1 3.8 5.1 0.0 4.3 0.0 4.9 0.0 0.0 0.0 0.7 0.0 0.4 0.0 1.4 0.0 0.2 0.2 0.8 0.5 2.2 1.0 0.0 0.6 1.4 1.2 1.7 5.1 0.6 0.7 0.3 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.6 1.9 0.0 0.0 0.7 1.6 0.0 0.0 0.2 0.0 0.6 0.4 0.0 1.0 0.3 4.8 0.8 0.0 0.0 0.0 0.1 0.5 0.0 0.2 0.5 0.5 0.0 0.3 1.9 7.2 1.0 0.0 0.3 0.5 0.0 0.1 0.0 2.3 0.0 1.8 5.8 2.6 2.4 0.0 6.0 3.8 2.8 0.0 1.1 0.6 1.2 2.7 5.1 0.0 0.3 0.5 0.3 0.1 0.7 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.8 0.1 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.2 0.9 0.0 0.0 HIST1H2AL "dJ193B12.9, H2A/i, H2AFI" ENSG00000276903 "Histone cluster 1 H2A family member l" P0C0S8 6 27865355-27865747 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "lymphoid tissue: 288.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 7.2;MOLT-4: 8.9" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (2.45e-2)" "unprognostic (2.94e-2)" "unprognostic (5.88e-2)" "unprognostic (2.46e-3)" "unprognostic (3.17e-1)" "unprognostic (1.82e-1)" "unprognostic (3.86e-2)" "unprognostic (2.08e-2)" "unprognostic (4.18e-1)" "unprognostic (2.38e-1)" "unprognostic (4.01e-2)" "unprognostic (4.29e-1)" "unprognostic (2.41e-2)" "unprognostic (2.12e-1)" "unprognostic (6.21e-2)" 1.1 0.5 0.0 24.8 0.0 16.4 1.3 0.0 0.5 1.1 4.5 0.0 0.0 1.1 0.8 1.7 7.6 0.3 1.8 1.5 0.0 0.4 0.4 3.4 10.2 0.0 0.0 0.3 0.3 1.5 0.0 5.2 0.0 0.3 0.3 0.0 0.7 0.3 0.3 0.5 4.4 0.3 0.0 12.9 0.7 13.1 0.0 288.3 0.3 9.6 26.4 0.5 0.0 9.6 4.7 8.8 3.6 0.1 2.0 1.1 4.2 1.7 0.9 0.0 0.0 0.0 1.1 1.7 0.7 1.4 1.7 0.0 1.4 3.2 1.2 0.0 1.0 1.2 0.0 0.0 0.4 3.1 7.2 1.2 0.0 1.2 0.0 0.8 1.5 0.0 0.0 0.4 0.0 0.0 0.0 1.7 5.5 3.3 0.5 3.8 8.9 6.4 2.9 1.7 1.3 4.6 0.0 0.5 0.7 2.6 2.1 2.0 1.2 0.0 0.8 0.0 0.4 1.2 0.0 0.2 0.0 1.4 3.0 5.6 0.0 6.5 1.4 4.1 1.3 2.4 2.0 1.3 0.1 1.7 0.0 3.3 1.7 2.0 4.7 9.6 0.7 1.0 8.8 0.1 3.6 3.4 1.7 1.1 0.0 0.0 0.0 0.5 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.9 0.4 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.1 0.1 0.0 0.4 0.5 HIST1H2AM "H2A.1, H2A/n, H2AFN" ENSG00000278677 "Histone cluster 1 H2A family member m" P0C0S8 6 27892757-27893149 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "lymphoid tissue: 315.3" "Cell type enhanced" "Detected in some" 11 "B-cells: 2.2;Ciliated cells: 4.0;granulocytes: 2.3;T-cells: 3.2" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 25.2" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (6.05e-2)" "unprognostic (4.03e-1)" "unprognostic (2.04e-1)" "unprognostic (2.79e-1)" "unprognostic (1.26e-1)" "unprognostic (1.11e-2)" "unprognostic (6.48e-2)" "unprognostic (2.70e-1)" "unprognostic (6.36e-2)" "unprognostic (4.64e-3)" "unprognostic (2.65e-3)" "unprognostic (4.24e-1)" "unprognostic (8.85e-6)" "unprognostic (2.44e-1)" "unprognostic (3.18e-1)" "unprognostic (8.80e-2)" "unprognostic (1.30e-1)" 1.2 1.5 0.0 30.7 0.0 9.3 2.3 0.2 0.2 2.1 6.1 0.1 2.3 1.4 1.3 2.6 10.7 0.3 3.9 2.2 0.0 0.6 1.7 4.7 12.7 0.0 0.0 0.4 1.2 0.0 0.0 10.4 0.3 0.9 1.8 0.0 1.3 2.2 0.7 1.0 6.5 0.0 1.1 15.3 1.7 4.8 0.0 315.3 1.3 11.4 28.9 2.5 0.0 10.3 14.7 28.7 6.2 4.8 8.5 7.0 3.2 2.7 2.1 5.1 0.3 0.3 4.5 0.9 0.7 2.6 3.5 1.0 1.3 5.4 3.7 0.8 2.5 2.2 1.6 1.7 1.7 3.5 1.3 2.7 3.4 3.6 0.0 1.6 2.2 1.3 0.0 1.8 0.0 0.2 2.6 3.9 11.6 7.5 0.4 5.3 11.0 7.8 3.8 2.0 1.3 6.7 3.5 9.6 1.3 0.7 8.1 1.5 5.6 0.6 0.7 1.1 4.9 1.6 0.0 1.1 0.1 1.2 1.7 8.1 25.2 12.6 1.5 9.5 1.0 28.7 3.4 12.5 6.8 3.8 4.1 8.9 5.9 5.7 11.4 10.3 2.5 2.8 11.5 4.8 6.2 14.7 8.5 7.0 0.0 0.0 2.2 0.1 0.5 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.1 2.3 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 3.2 0.4 0.0 HIST1H2BB "H2B/f, H2BFF" ENSG00000276410 "Histone cluster 1 H2B family member b" P33778 6 26043277-26043657 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 104.9" "Cell type enhanced" "Detected in some" 10 "Enterocytes: 1.6;Spermatogonia: 1.5" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 10.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "K-562: 3.7;Karpas-707: 3.6;MOLT-4: 4.5;NB-4: 4.9;THP-1: 5.5;U-266/84: 6.1" "Low region specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (2.92e-2)" "unprognostic (9.15e-2)" "unprognostic (3.29e-1)" "unprognostic (2.18e-1)" "unprognostic (2.36e-1)" "unprognostic (1.26e-1)" "unprognostic (6.10e-2)" "unprognostic (1.03e-1)" "unprognostic (2.66e-1)" "unprognostic (2.58e-1)" 0.4 0.3 1.0 6.4 0.3 6.6 0.6 0.5 1.0 0.5 1.0 0.0 0.0 1.1 0.4 0.5 4.1 0.6 0.3 1.0 0.2 0.8 0.3 1.7 3.0 0.1 0.4 0.3 0.5 0.3 0.0 0.9 1.0 0.3 0.3 0.2 0.3 0.3 1.3 1.0 0.8 0.3 0.8 5.8 0.5 15.8 0.1 104.9 0.3 4.8 7.4 0.3 0.0 2.1 10.5 4.2 1.1 0.2 3.9 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.4 1.1 1.6 0.0 0.0 0.0 1.0 0.0 1.2 0.0 0.0 0.0 0.7 0.3 0.0 1.3 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.6 0.0 0.3 1.4 0.6 3.7 3.6 0.0 0.0 4.5 4.9 2.2 0.7 2.1 2.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.0 0.3 5.5 0.0 0.3 0.3 0.3 0.9 0.8 6.1 0.0 0.7 1.8 1.3 4.2 1.1 0.8 1.5 0.1 3.9 2.1 3.9 1.6 3.3 1.6 2.0 0.8 3.6 0.2 0.4 10.5 2.9 0.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.6 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.4 0.0 0.0 0.6 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.3 1.5 0.3 0.1 0.0 0.3 0.0 HIST1H2BC "H2B.1, H2B/l, H2BFL" ENSG00000180596 "Histone cluster 1 H2B family member c" P62807 6 26114873-26123926 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 115.7;lymphoid tissue: 143.2" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 42.1;Glandular cells: 78.6;Urothelial cells: 103.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 20 "neutrophil: 115.7" "Lineage enriched" "Detected in all" 26 "granulocytes: 115.7" "Cell line enhanced" "Detected in many" "K-562: 17.0;SiHa: 33.6;U-2 OS: 23.5;U-266/70: 19.4;U-266/84: 23.8" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (8.30e-3)" "unprognostic (2.60e-2)" "unprognostic (2.37e-2)" "unprognostic (9.26e-2)" "unprognostic (3.20e-2)" "unprognostic (5.08e-2)" "unprognostic (4.72e-1)" "unprognostic (6.45e-2)" "unprognostic (9.22e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (9.01e-4)" "unprognostic (2.08e-1)" "prognostic unfavorable (1.75e-5)" "unprognostic (5.41e-2)" "unprognostic (7.38e-2)" "unprognostic (2.49e-1)" "unprognostic (6.60e-3)" 7.8 5.8 5.5 21.3 7.1 31.3 10.7 2.1 5.9 12.9 11.5 5.9 12.8 5.2 4.1 13.1 20.9 10.8 8.1 5.8 6.5 4.6 8.4 20.2 15.3 11.4 5.4 4.1 5.6 9.6 1.7 9.9 17.5 3.8 31.7 4.1 5.9 12.4 18.6 20.0 10.0 6.0 4.3 10.4 11.7 10.6 9.4 4.5 143.2 6.4 8.7 23.4 12.9 14.3 4.3 2.8 115.7 1.3 1.2 1.8 2.7 3.0 1.8 0.9 0.9 0.9 0.5 1.1 3.0 1.1 2.0 1.7 2.4 1.8 1.1 5.7 1.0 1.5 2.3 1.2 1.2 1.0 2.7 1.0 0.9 2.7 4.1 1.2 1.4 3.8 12.6 0.7 0.8 0.5 1.0 0.8 0.9 17.0 9.5 3.8 3.4 3.2 3.1 1.0 3.2 5.5 1.4 1.3 7.0 3.5 0.7 4.3 1.4 33.6 2.6 1.2 2.6 14.3 1.3 2.4 2.5 23.5 1.5 1.2 19.4 23.8 5.7 1.1 3.7 1.7 4.5 1.1 5.8 1.2 1.3 1.6 2.3 1.8 1.7 0.8 4.3 1.4 1.0 115.7 1.2 1.2 2.8 1.1 2.7 5.5 7.1 2.1 5.9 6.5 4.6 5.4 4.1 3.8 4.5 6.0 2.7 3.0 40.5 0.8 3.0 1.8 5.1 21.4 7.9 3.5 0.0 3.9 1.7 6.8 42.1 2.9 9.5 0.0 8.0 5.4 4.1 78.6 4.6 13.0 5.8 0.0 1.7 1.8 3.7 4.5 1.4 4.6 0.0 1.8 7.4 2.9 25.5 9.9 1.1 3.5 3.9 0.0 1.8 1.8 3.2 1.0 35.8 10.1 4.9 103.5 HIST1H2BD "H2B/b, H2BFB" ENSG00000158373 "Histone cluster 1 H2B family member d" P58876 6 26158146-26171349 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "lymphoid tissue: 174.9" "Cell type enhanced" "Detected in many" 6 "Glandular cells: 105.0;Proximal tubular cells: 75.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 37.2;U-266/84: 39.2" "Low region specificity" "Detected in some" "HPA042205, HPA043013, HPA048671, CAB062336" Supported Approved Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "CAB062336: AB_10622324, HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (2.39e-2)" "unprognostic (1.58e-2)" "prognostic unfavorable (3.84e-4)" "unprognostic (1.32e-1)" "unprognostic (1.98e-1)" "unprognostic (2.83e-2)" "unprognostic (1.54e-1)" "unprognostic (8.10e-2)" "unprognostic (2.28e-1)" "unprognostic (3.54e-2)" "unprognostic (3.68e-3)" "unprognostic (2.17e-1)" "unprognostic (4.74e-3)" "unprognostic (1.08e-1)" "unprognostic (1.56e-1)" "unprognostic (3.91e-2)" "unprognostic (1.34e-2)" 7.9 6.6 6.0 33.2 9.0 36.4 17.3 14.0 8.9 33.6 17.0 2.9 13.2 8.2 9.5 21.4 18.2 17.4 11.1 17.4 7.5 4.2 19.9 25.3 13.8 32.3 7.7 7.1 33.1 21.7 2.2 11.5 10.1 7.4 43.4 12.9 8.3 13.0 14.7 12.0 14.7 9.5 13.0 18.7 11.0 18.8 7.1 5.6 174.9 9.5 23.9 18.9 13.2 32.7 15.6 12.9 19.3 4.5 6.8 9.6 2.0 5.3 12.2 3.7 2.1 29.3 2.7 1.1 4.7 2.7 6.2 3.9 4.1 4.4 2.4 30.1 5.6 6.9 8.5 2.1 2.0 2.9 11.0 5.2 1.6 9.8 4.3 3.1 2.1 4.6 19.2 3.2 1.7 2.4 2.4 1.5 2.3 16.9 13.5 1.1 19.3 4.8 5.4 3.9 23.1 5.7 1.9 2.4 16.0 5.8 3.9 12.0 5.1 29.9 7.8 4.6 7.6 19.8 0.8 0.9 7.7 20.1 3.1 1.0 37.2 39.2 6.1 1.0 10.0 1.5 19.3 1.5 10.5 5.8 3.4 7.4 8.4 8.9 9.6 3.7 15.6 8.4 5.7 16.6 6.8 4.5 12.9 5.8 2.0 6.0 9.0 14.0 8.9 7.5 4.2 7.7 7.1 7.4 5.6 3.0 5.6 15.9 54.2 1.5 13.9 21.3 12.7 53.5 10.3 21.0 0.0 6.4 19.9 4.3 27.1 2.8 22.0 0.0 3.8 6.2 3.0 105.0 2.3 20.7 3.9 41.3 44.7 1.3 4.0 5.4 6.6 6.9 3.3 3.6 20.2 4.0 12.0 33.1 1.4 75.4 10.4 0.0 1.4 0.9 0.7 2.4 33.0 6.9 14.3 63.6 HIST1H2BE "H2B.h, H2B/h, H2BFH" ENSG00000274290 "Histone cluster 1 H2B family member e" P62807 6 26172059-26184655 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 26 "lymphoid tissue: 165.1" "Cell type enhanced" "Detected in many" 7 "B-cells: 5.6;Glandular cells: 5.8;Horizontal cells: 9.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 8.2;REH: 8.0" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (2.14e-1)" "unprognostic (1.65e-1)" "unprognostic (1.27e-1)" "unprognostic (7.06e-3)" "unprognostic (8.28e-2)" "unprognostic (1.31e-1)" "unprognostic (7.98e-2)" "unprognostic (3.16e-1)" "unprognostic (1.58e-1)" "unprognostic (1.69e-2)" "unprognostic (3.78e-3)" "unprognostic (1.11e-1)" "unprognostic (1.55e-6)" "unprognostic (3.03e-2)" "unprognostic (4.86e-2)" "unprognostic (2.30e-1)" "unprognostic (3.11e-2)" 0.7 1.1 0.4 12.2 0.8 5.9 1.8 0.6 1.7 2.5 2.9 0.1 1.8 1.1 1.5 2.9 5.5 1.6 1.6 1.9 0.5 1.7 0.3 1.5 6.7 0.0 1.2 2.1 1.2 0.7 0.0 2.4 0.2 5.2 1.5 0.7 4.0 2.2 2.1 1.9 2.0 1.8 1.6 4.5 2.5 5.4 0.0 165.1 1.2 6.4 7.1 1.8 0.0 3.6 3.1 5.5 1.7 1.6 2.9 0.8 0.5 3.7 3.0 0.9 3.0 0.4 0.4 3.1 1.0 0.5 0.3 0.8 2.1 0.7 1.4 0.5 1.7 4.3 0.5 1.1 0.6 1.6 1.0 0.5 1.5 0.2 0.2 0.3 2.5 0.6 0.2 0.6 0.3 1.1 0.3 0.9 2.4 1.8 0.1 1.6 4.6 8.2 2.4 1.6 1.0 8.0 0.2 2.6 1.4 1.8 2.7 3.7 4.0 1.5 0.9 1.6 2.8 1.6 0.8 1.5 2.7 1.1 1.9 2.4 4.5 0.6 0.6 1.4 0.5 5.2 1.7 2.4 2.0 1.3 1.6 2.1 2.0 2.5 0.7 3.6 1.8 1.7 5.5 1.6 1.5 3.1 2.9 0.8 0.0 0.0 5.6 4.5 0.0 4.3 0.3 2.5 2.7 0.0 1.8 3.9 0.7 0.0 0.1 0.1 0.1 0.5 0.0 0.0 0.9 0.3 5.8 1.1 1.0 0.8 9.5 1.2 0.6 4.1 0.0 1.4 0.7 0.0 1.0 0.4 1.2 0.2 0.0 0.7 0.4 2.4 0.0 0.0 1.6 0.9 0.0 0.7 0.0 1.6 4.0 HIST1H2BF "H2B/g, H2BFG" ENSG00000277224 "Histone cluster 1 H2B family member f" P62807 6 26199520-26200715 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "lymphoid tissue: 252.2" "Cell type enhanced" "Detected in some" 8 "B-cells: 6.7;Basal glandular cells: 3.6;Bipolar cells: 5.4;Glandular cells: 5.5;Urothelial cells: 5.1" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 6.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "U-266/70: 21.8;U-266/84: 15.3" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (1.15e-2)" "unprognostic (2.17e-1)" "unprognostic (1.12e-1)" "unprognostic (1.38e-2)" "unprognostic (4.58e-2)" "unprognostic (2.86e-1)" "unprognostic (1.47e-1)" "unprognostic (6.80e-3)" "unprognostic (3.15e-1)" "unprognostic (1.89e-1)" "unprognostic (2.95e-1)" "unprognostic (7.27e-3)" "unprognostic (4.29e-11)" "unprognostic (4.88e-3)" "unprognostic (4.45e-1)" "unprognostic (1.15e-2)" "unprognostic (1.30e-1)" 0.4 1.2 0.0 17.3 0.1 3.8 5.7 0.3 0.7 2.7 3.3 0.4 1.0 0.5 1.6 1.3 9.9 1.3 1.2 0.6 0.0 0.5 0.4 2.5 7.0 0.0 0.2 0.8 0.6 0.4 0.0 3.2 0.2 5.4 1.1 0.5 1.4 1.3 0.2 0.4 3.0 0.3 0.9 8.3 1.3 2.2 0.1 252.2 0.4 3.3 14.6 2.4 0.0 3.0 0.7 6.2 0.7 0.4 1.5 1.2 0.4 0.2 0.2 0.4 0.3 0.0 0.2 0.1 0.1 0.6 0.1 0.5 0.0 0.5 0.9 0.0 0.3 0.9 0.4 0.1 0.3 0.7 0.2 0.3 1.4 0.1 0.1 0.1 0.7 0.2 0.0 0.1 0.1 0.0 0.1 0.4 1.7 3.9 0.0 0.1 3.3 1.4 0.5 0.7 0.5 1.2 0.6 2.4 0.1 0.1 2.1 0.3 4.2 0.8 0.0 0.3 3.8 0.2 0.1 0.3 1.9 0.0 0.5 21.8 15.3 1.2 0.1 1.0 0.4 0.0 0.2 1.4 0.7 0.3 1.5 0.7 0.7 0.8 0.4 3.0 0.6 1.2 6.2 0.4 0.7 0.7 0.6 1.2 0.0 0.3 6.7 3.6 0.0 5.4 0.0 2.5 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.4 0.0 5.5 0.0 0.4 1.0 0.0 0.0 1.3 0.8 0.0 0.0 0.8 0.0 0.0 0.4 1.2 0.0 1.4 0.0 0.0 0.2 0.0 0.0 0.2 1.1 0.0 0.5 2.5 1.0 5.1 HIST1H2BG "H2B.1A, H2B/a, H2BFA" ENSG00000273802 "Histone cluster 1 H2B family member g" P62807 6 26215159-26216692 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 75.2" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 58.7;Glandular cells: 91.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SiHa: 8.9;T-47d: 18.1;U-266/70: 16.9" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (1.40e-2)" "unprognostic (1.34e-2)" "unprognostic (4.55e-2)" "unprognostic (1.13e-1)" "unprognostic (1.05e-1)" "unprognostic (4.19e-2)" "unprognostic (1.63e-2)" "unprognostic (8.54e-2)" "unprognostic (6.69e-2)" "unprognostic (1.55e-1)" "unprognostic (2.36e-2)" "unprognostic (2.79e-2)" "prognostic unfavorable (1.70e-8)" "unprognostic (1.15e-1)" "unprognostic (1.24e-1)" "unprognostic (1.71e-1)" "unprognostic (2.97e-2)" 0.4 1.5 0.7 16.5 1.2 8.9 20.2 5.1 3.4 4.3 2.9 0.5 5.1 1.8 2.8 4.0 6.6 2.1 1.8 1.7 0.2 1.2 0.6 2.0 7.2 0.1 2.0 1.3 1.9 0.4 0.5 1.6 0.7 10.3 3.0 1.2 5.0 5.8 0.3 1.6 2.2 2.8 4.7 3.1 2.9 6.7 0.3 75.2 1.0 6.9 8.3 4.3 0.0 5.8 14.6 12.0 1.6 1.3 6.2 2.0 2.5 0.1 1.2 0.0 3.9 0.2 0.3 3.1 0.2 2.0 0.8 0.3 2.2 0.0 3.2 0.3 0.8 2.7 1.1 1.0 1.1 2.2 1.3 0.7 1.2 1.1 0.6 0.3 2.1 1.5 0.5 0.6 0.0 0.1 0.4 0.1 7.8 0.1 0.0 1.8 2.2 1.7 1.2 5.9 1.6 1.5 0.7 4.4 1.2 0.6 7.3 1.1 8.9 3.3 1.0 3.4 18.1 0.8 0.2 0.0 1.0 0.3 0.4 16.9 0.1 0.0 0.3 1.1 0.5 12.0 1.2 2.5 2.0 0.9 6.2 3.7 3.1 3.8 4.4 5.8 1.5 1.3 5.6 1.3 1.6 14.6 2.7 2.0 0.0 12.7 29.3 58.7 0.8 40.1 0.7 5.1 4.0 4.5 5.2 5.9 6.3 0.0 4.8 0.6 0.5 27.1 0.0 0.0 6.6 3.2 91.9 9.3 2.5 17.2 23.8 29.8 2.5 3.5 0.0 2.0 8.0 0.0 1.8 17.9 9.5 1.1 16.4 0.0 1.3 3.0 6.5 0.4 1.4 16.2 0.0 20.1 10.7 14.2 42.2 HIST1H2BH "H2B/j, H2BFJ" ENSG00000275713 "Histone cluster 1 H2B family member h" Q93079 6 26251651-26253710 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 23 "lymphoid tissue: 220.5" "Cell type enhanced" "Detected in some" 13 "B-cells: 6.7;Enterocytes: 8.5;Extravillous trophoblasts: 21.0;Paneth cells: 8.6" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 4.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 4.7" "Cell line enhanced" "Detected in many" "AF22: 7.5;U-266/70: 18.1" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (5.83e-2)" "unprognostic (6.27e-3)" "unprognostic (4.50e-2)" "unprognostic (9.18e-2)" "unprognostic (5.52e-2)" "prognostic unfavorable (7.52e-4)" "unprognostic (5.06e-3)" "unprognostic (3.08e-3)" "unprognostic (1.58e-2)" "unprognostic (2.75e-2)" "unprognostic (1.86e-1)" "unprognostic (3.22e-1)" "unprognostic (2.96e-8)" "unprognostic (1.60e-1)" "unprognostic (1.39e-1)" "unprognostic (2.40e-2)" "unprognostic (1.95e-3)" 0.9 0.6 0.0 25.6 0.0 3.1 2.1 0.0 0.0 0.9 5.5 0.0 0.9 7.8 1.0 2.4 8.4 1.5 4.0 1.8 0.0 0.7 0.0 2.2 11.3 0.0 0.0 0.4 0.1 0.0 0.0 4.9 0.0 1.2 2.2 0.0 1.8 0.1 0.0 0.6 8.1 0.1 0.0 9.6 1.6 3.3 0.0 220.5 0.4 9.5 23.3 1.4 0.0 1.0 0.9 4.7 0.4 1.0 0.7 9.3 1.8 0.1 7.5 0.0 0.0 0.1 1.2 0.9 0.4 1.3 0.6 2.5 1.1 0.0 1.8 0.1 1.9 3.6 0.0 0.6 1.9 0.9 0.1 1.4 5.6 0.4 0.0 0.0 4.3 0.3 0.3 0.5 0.5 0.0 0.3 1.0 2.7 6.6 0.1 2.0 3.8 2.7 1.7 0.0 1.9 4.1 0.0 1.0 0.0 2.8 3.4 3.1 4.4 1.5 0.6 0.3 2.2 3.4 0.0 0.6 0.0 0.8 3.2 18.1 4.5 0.0 0.5 1.5 4.0 3.5 0.4 0.7 0.5 0.0 0.2 1.0 0.3 0.7 0.9 0.6 0.1 0.2 4.7 1.0 0.2 0.4 0.7 9.3 0.0 0.0 6.7 2.8 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 8.5 0.0 0.2 21.0 0.5 1.0 0.0 0.0 6.1 0.0 0.0 0.6 2.2 0.0 0.0 0.5 0.0 0.0 2.7 0.0 0.0 8.6 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.3 3.8 4.9 3.7 3.6 HIST1H2BI "H2B/k, H2BFK" ENSG00000278588 "Histone cluster 1 H2B family member i" P62807 6 26272976-26273356 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "lymphoid tissue: 150.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 5.4;MOLT-4: 15.1;THP-1: 6.3" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (1.59e-1)" "unprognostic (7.10e-2)" "unprognostic (8.53e-2)" "unprognostic (1.52e-1)" "unprognostic (2.80e-1)" "unprognostic (2.03e-2)" "unprognostic (1.02e-1)" "unprognostic (7.22e-3)" "unprognostic (4.82e-2)" "unprognostic (1.05e-1)" "unprognostic (1.10e-1)" "unprognostic (1.01e-2)" 0.5 0.1 0.0 19.0 0.0 8.9 1.2 0.4 0.1 1.3 3.1 0.0 0.5 0.1 0.7 2.1 6.6 0.4 2.0 1.3 0.0 0.3 0.1 2.0 6.3 0.0 0.0 0.7 0.1 0.1 0.0 2.8 0.0 0.1 0.3 0.0 1.3 0.3 0.1 1.2 1.9 0.1 0.1 11.1 0.4 1.9 0.0 150.8 0.4 8.2 14.5 2.2 0.0 4.7 0.7 0.9 1.3 0.4 4.6 0.2 1.9 0.8 1.2 0.0 0.0 0.0 0.2 0.7 0.7 2.0 5.4 0.8 0.0 0.9 0.5 0.5 0.7 0.9 1.8 0.5 0.8 2.7 0.0 0.4 0.8 0.6 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 1.8 2.2 0.0 3.9 0.0 0.8 15.1 2.5 2.9 0.6 0.0 4.1 0.0 5.0 0.0 0.4 0.3 0.9 1.1 1.0 0.0 0.1 0.0 6.3 0.9 0.9 0.0 0.6 3.1 3.2 0.4 0.0 1.1 0.5 2.2 0.2 0.5 0.0 3.4 1.3 2.2 2.2 3.2 4.6 0.7 4.7 1.4 0.8 0.9 0.4 0.1 0.3 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 HIST1H2BJ "H2B/r, H2BFR" ENSG00000124635 "Histone cluster 1 H2B family member j" P06899 6 27125897-27132750 "Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 124.3" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 63.4;Erythroid cells: 23.3;Glandular cells: 25.8;Spermatocytes: 30.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "neutrophil: 13.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 13.6" "Cell line enhanced" "Detected in many" "K-562: 42.1;Karpas-707: 24.8;SiHa: 37.9;U-2 OS: 42.0;U-266/70: 35.8;U-266/84: 44.0" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (4.02e-2)" "prognostic favorable (1.51e-4)" "unprognostic (8.58e-2)" "unprognostic (2.34e-2)" "unprognostic (1.18e-1)" "unprognostic (1.26e-2)" "unprognostic (3.03e-1)" "unprognostic (2.98e-1)" "unprognostic (1.88e-1)" "unprognostic (1.49e-2)" "unprognostic (1.90e-3)" "unprognostic (2.23e-1)" "unprognostic (3.57e-4)" "unprognostic (8.67e-2)" "unprognostic (5.80e-2)" "unprognostic (1.57e-2)" "unprognostic (6.16e-2)" 4.1 2.2 1.5 30.0 2.4 10.7 11.3 0.9 1.9 12.8 6.2 1.6 3.9 2.1 3.1 5.9 12.8 5.1 2.8 6.0 2.5 1.7 1.9 3.9 7.3 12.0 3.2 0.9 1.3 5.1 0.6 1.2 5.1 2.9 8.0 3.0 0.5 4.0 4.8 5.9 2.9 2.8 2.8 5.9 12.0 5.1 30.5 2.2 124.3 2.7 10.1 22.3 5.2 9.4 2.2 1.0 13.6 0.6 0.7 2.4 14.7 3.8 4.8 1.4 1.3 7.2 0.5 1.9 2.1 1.3 8.5 3.6 4.1 2.2 0.6 6.9 2.3 3.9 2.8 2.1 1.9 4.7 4.5 3.6 1.1 5.5 0.2 0.6 0.5 3.0 3.4 0.2 1.8 0.8 1.2 0.5 1.7 42.1 24.8 2.2 2.0 1.7 2.5 1.7 3.9 4.5 0.9 1.2 3.8 1.0 1.4 9.4 1.1 37.9 2.5 1.1 2.1 0.1 1.5 1.1 2.1 42.0 1.6 0.9 35.8 44.0 10.1 0.5 11.8 1.0 1.8 0.6 0.7 0.5 0.5 0.8 1.6 0.7 0.3 0.4 2.2 0.4 0.5 13.6 0.7 0.2 1.0 2.4 14.7 1.5 2.4 0.9 1.9 2.5 1.7 3.2 0.9 2.9 2.2 0.0 0.0 0.0 10.4 5.5 0.0 2.0 0.0 0.0 0.0 1.8 0.0 1.2 0.0 0.4 63.4 0.6 4.0 23.3 0.3 3.2 2.4 25.8 0.0 1.5 3.3 0.0 12.6 4.9 2.6 19.3 1.1 2.4 6.8 4.6 2.6 0.0 2.4 7.0 1.4 0.0 0.0 0.0 3.1 30.9 9.1 4.6 5.1 4.5 2.3 9.5 HIST1H2BK "H2BFAiii, H2BFT" ENSG00000197903 "Histone cluster 1 H2B family member k" O60814 6 27146418-27146798 "Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 243.8" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 23.8;Basal keratinocytes: 28.0;Melanocytes: 38.8;Suprabasal keratinocytes: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 117.4;U-2 OS: 107.1;U-266/84: 140.9" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (1.78e-2)" "unprognostic (4.70e-3)" "unprognostic (9.00e-3)" "unprognostic (1.30e-1)" "unprognostic (3.81e-1)" "unprognostic (4.50e-2)" "unprognostic (6.50e-2)" "unprognostic (4.27e-2)" "unprognostic (2.15e-1)" "unprognostic (1.29e-3)" "unprognostic (3.46e-3)" "unprognostic (9.49e-2)" "prognostic unfavorable (5.77e-5)" "unprognostic (3.93e-2)" "unprognostic (1.49e-1)" "unprognostic (7.59e-2)" "unprognostic (2.37e-2)" 9.4 6.0 3.0 39.8 4.1 7.8 8.6 2.4 3.6 14.9 11.0 2.5 10.5 8.4 8.0 14.6 19.1 13.5 10.5 9.8 4.3 3.7 4.0 19.3 12.7 25.9 3.6 2.3 8.5 17.4 0.6 5.9 18.7 2.0 16.0 5.3 3.5 11.3 10.7 3.7 6.3 10.3 6.9 7.6 28.0 13.7 30.6 1.9 243.8 8.9 32.3 26.4 11.5 16.7 26.5 22.1 60.7 16.2 5.0 11.5 12.5 6.2 16.3 2.6 4.5 11.7 4.4 9.0 10.4 7.5 15.0 9.7 14.7 8.3 2.0 35.1 5.9 10.5 8.2 3.1 3.2 2.2 9.3 15.7 3.5 10.2 0.5 5.1 2.7 21.3 21.0 2.8 2.5 2.8 4.2 3.0 1.3 117.4 23.8 6.7 17.1 5.0 5.0 2.3 22.7 7.0 3.2 1.7 26.5 5.6 2.8 13.2 7.6 61.8 21.2 5.6 2.4 54.8 3.2 3.4 6.7 107.1 6.2 1.8 32.7 140.9 18.6 3.9 28.0 3.8 33.8 9.4 60.7 4.1 8.3 3.9 20.3 4.2 4.1 9.6 26.5 5.0 3.9 60.1 5.0 16.2 22.1 11.5 12.5 3.0 4.1 2.4 3.6 4.3 3.7 3.6 2.3 2.0 1.9 23.8 9.4 4.3 0.6 28.0 0.0 0.4 0.0 13.4 6.8 0.0 0.0 1.2 0.0 1.3 0.1 2.1 2.6 0.0 1.0 2.6 1.9 0.5 4.7 1.7 0.9 0.0 0.0 2.5 2.2 0.0 0.0 4.9 38.8 4.6 1.0 0.0 2.0 1.1 0.0 0.0 0.0 0.0 1.5 0.4 3.0 29.2 3.2 9.6 1.2 0.5 HIST1H2BL "dJ97D16.4, H2B/c, H2BFC" ENSG00000185130 "Histone cluster 1 H2B family member l" Q99880 6 27807444-27807931 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "lymphoid tissue: 217.6" "Cell type enhanced" "Detected in single" 13 "Club cells: 1.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 7.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MOLT-4: 13.2;U-266/84: 13.0" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (2.43e-1)" "unprognostic (2.06e-2)" "unprognostic (5.32e-3)" "unprognostic (2.46e-2)" "unprognostic (2.22e-1)" "unprognostic (1.02e-3)" "unprognostic (2.32e-3)" "unprognostic (2.66e-1)" "unprognostic (9.22e-2)" "unprognostic (1.87e-2)" "unprognostic (1.71e-2)" "unprognostic (1.64e-1)" "unprognostic (8.02e-3)" "unprognostic (3.25e-2)" "unprognostic (1.81e-1)" "unprognostic (1.82e-1)" "unprognostic (2.86e-2)" 1.2 1.0 0.2 13.9 1.0 13.7 1.6 1.4 0.6 1.8 5.1 0.0 0.3 0.6 0.8 0.6 7.4 0.9 0.9 1.3 0.9 0.7 0.3 0.6 1.5 3.5 0.5 0.0 1.3 1.2 1.2 0.2 1.9 0.0 1.2 1.1 0.0 0.7 0.2 0.2 0.9 3.9 0.7 2.8 4.8 0.8 1.5 0.0 217.6 1.2 5.9 15.6 1.1 1.2 1.9 1.2 7.7 0.6 0.4 2.0 0.9 2.4 2.2 0.7 2.3 0.0 0.0 0.1 1.4 0.4 1.3 3.3 1.0 1.7 0.9 0.5 0.3 0.7 1.6 0.0 0.2 0.4 1.1 3.2 1.7 3.1 3.8 0.0 2.8 2.4 1.0 0.0 0.0 0.0 0.2 0.7 2.1 2.2 5.8 0.0 6.1 13.2 4.9 2.2 1.6 3.4 3.1 0.0 1.4 0.0 2.2 3.1 1.1 4.0 1.6 0.2 0.2 1.4 1.0 0.5 0.1 1.7 1.3 1.0 3.3 13.0 4.3 0.4 5.1 0.5 0.6 0.5 4.0 1.1 0.2 1.3 1.9 0.6 1.1 1.2 1.3 0.4 0.6 7.7 0.4 0.6 0.7 2.0 0.9 0.2 1.0 1.4 0.5 0.9 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.2 0.2 HIST1H2BM "dJ160A22.3, H2B/e, H2BFE" ENSG00000273703 "Histone cluster 1 H2B family member m" Q99879 6 27815044-27815424 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "lymphoid tissue: 232.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.6;NK-cells: 1.5;T-cells: 1.7" "Cell line enhanced" "Detected in many" "Karpas-707: 17.7;NB-4: 11.4;REH: 7.3;U-266/70: 13.7;U-698: 7.0" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (3.83e-1)" "unprognostic (8.85e-4)" "unprognostic (3.74e-1)" "unprognostic (2.00e-1)" "unprognostic (3.00e-1)" "unprognostic (1.11e-1)" "unprognostic (1.38e-1)" "unprognostic (3.37e-1)" "unprognostic (9.46e-3)" "unprognostic (3.02e-1)" "unprognostic (1.04e-1)" "unprognostic (5.70e-1)" "unprognostic (2.65e-1)" 0.1 0.1 0.0 19.9 0.0 11.6 0.1 0.0 0.2 1.6 3.4 0.0 0.0 0.1 0.7 0.9 8.4 0.1 1.4 0.3 0.0 0.1 0.3 1.8 7.3 0.0 0.0 0.3 0.1 0.1 0.0 1.5 0.0 0.5 1.1 0.0 0.3 0.1 0.1 0.8 3.8 0.1 0.5 13.9 0.5 3.5 0.0 232.2 0.1 9.4 27.6 0.1 0.0 2.6 0.4 0.3 0.3 1.5 1.7 0.0 1.5 0.0 0.3 0.0 0.0 0.0 1.2 0.4 0.2 0.5 2.1 0.4 0.3 2.3 0.0 0.0 0.5 1.1 0.0 0.0 0.0 1.2 0.0 0.8 0.2 0.8 0.0 0.0 2.0 0.0 0.0 0.8 0.0 0.0 0.0 0.7 0.2 17.7 0.0 0.5 4.6 11.4 3.4 1.1 0.8 7.3 0.0 0.4 0.0 0.0 0.2 2.0 0.8 1.1 0.0 0.1 1.0 3.4 0.0 0.0 2.0 1.2 0.1 13.7 0.5 7.0 1.1 1.3 0.9 0.0 0.1 0.1 1.5 0.3 1.7 1.9 1.7 1.5 0.4 2.6 0.1 1.2 0.3 1.5 0.0 0.2 0.6 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 HIST1H2BN "H2B/d, H2BFD" ENSG00000233822 "Histone cluster 1 H2B family member n" Q99877 6 27837760-27865798 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 13 "lymphoid tissue: 193.3" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 27.8;Rod photoreceptor cells: 26.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 14.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 8.9;SCLC-21H: 9.8;U-266/84: 9.2" "Low region specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (2.29e-1)" "unprognostic (2.82e-2)" "unprognostic (1.33e-1)" "unprognostic (3.25e-2)" "unprognostic (3.22e-2)" "unprognostic (6.66e-2)" "unprognostic (1.87e-1)" "unprognostic (1.67e-1)" "unprognostic (3.04e-1)" "unprognostic (4.41e-2)" "unprognostic (2.95e-3)" "unprognostic (2.05e-3)" "unprognostic (1.14e-4)" "unprognostic (9.62e-2)" "unprognostic (3.91e-1)" "unprognostic (9.62e-2)" "unprognostic (2.22e-2)" 2.4 7.2 2.3 14.0 3.3 9.3 3.1 4.9 6.2 3.4 4.5 1.0 4.4 1.8 3.4 3.7 7.6 3.2 3.7 6.4 3.7 2.4 2.3 5.3 5.4 8.0 4.1 4.2 5.0 8.3 4.2 3.8 4.5 1.4 4.0 2.5 1.7 3.3 4.7 4.6 2.3 4.3 2.5 9.4 7.0 2.4 6.8 0.5 193.3 6.1 6.2 10.9 3.6 2.2 6.0 6.2 14.6 2.6 1.0 2.8 1.4 1.4 0.2 1.5 1.5 1.2 2.0 0.9 0.7 1.1 0.7 0.8 0.5 0.9 0.8 3.0 0.7 0.9 2.1 1.3 0.5 0.3 1.5 4.5 0.7 3.7 1.4 1.4 1.0 3.7 1.3 0.4 0.1 1.3 1.1 0.2 1.4 8.9 7.0 0.8 1.8 2.9 4.5 1.4 1.2 1.0 2.1 1.0 5.3 0.4 0.9 9.8 2.0 3.5 1.3 3.0 1.0 2.5 0.8 1.5 2.2 2.1 1.2 0.7 6.1 9.2 3.6 0.7 1.7 0.7 2.3 2.6 1.7 2.6 2.4 1.8 5.8 2.0 1.9 5.0 6.0 1.3 1.2 14.6 1.0 1.8 6.2 2.8 1.4 2.3 3.3 4.9 6.2 3.7 2.4 4.1 4.2 1.4 0.5 0.0 3.2 20.4 5.8 0.9 7.5 2.3 0.0 5.3 2.3 0.0 2.0 9.8 1.7 0.1 3.8 2.7 27.8 0.0 0.7 3.9 3.3 5.0 3.5 1.7 9.0 6.4 4.1 1.8 4.3 0.9 2.8 4.9 6.8 1.0 10.0 15.8 0.8 7.0 1.8 2.0 26.9 0.0 8.3 0.9 2.1 2.0 4.2 20.0 5.2 1.7 HIST1H2BO "H2B.2, H2B/n, H2BFN" ENSG00000274641 "Histone cluster 1 H2B family member o" P23527 6 27893463-27893843 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "lymphoid tissue: 164.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 29.4" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (7.22e-2)" "unprognostic (1.77e-3)" "unprognostic (9.47e-2)" "unprognostic (4.43e-2)" "unprognostic (6.67e-2)" "unprognostic (7.52e-2)" "unprognostic (2.47e-2)" "unprognostic (3.48e-2)" "unprognostic (1.55e-2)" "unprognostic (7.91e-2)" "unprognostic (7.81e-3)" "unprognostic (2.88e-3)" "unprognostic (4.04e-7)" "unprognostic (4.39e-2)" "unprognostic (3.41e-1)" "unprognostic (4.39e-2)" "prognostic favorable (4.89e-4)" 1.9 0.4 0.0 14.9 0.0 8.1 1.5 0.0 0.0 0.9 3.9 0.0 0.0 0.9 0.6 1.6 9.9 0.0 0.7 1.5 0.0 0.3 0.5 2.6 7.4 0.0 0.0 0.0 0.0 0.7 0.0 4.4 0.1 0.3 1.5 0.0 1.2 0.0 0.3 1.5 2.1 0.1 0.5 8.1 0.7 1.4 0.0 164.5 0.0 7.1 15.4 1.1 0.0 2.6 2.2 6.5 0.8 1.3 1.7 5.5 2.2 2.9 1.5 4.4 0.7 0.0 2.7 0.8 0.1 5.5 5.4 1.1 1.3 2.6 1.9 0.2 1.2 2.3 2.5 0.5 0.7 1.8 1.9 1.7 4.5 1.7 0.0 0.2 1.1 0.3 0.0 0.4 0.5 0.1 1.4 2.1 6.5 7.3 0.2 0.5 11.2 9.4 1.7 1.7 2.2 6.5 1.5 4.9 0.9 0.3 6.3 1.3 4.7 1.2 0.7 0.5 2.0 0.2 0.0 1.5 0.3 1.7 2.0 8.1 29.4 7.5 0.9 9.5 0.7 1.3 0.3 3.8 0.8 0.6 1.1 1.4 0.8 1.7 2.2 2.6 0.5 0.5 6.5 1.3 0.8 1.7 1.4 5.5 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 HIST2H2AA3 "H2A.2, H2A/q, H2AFO, HIST2H2AA" ENSG00000203812 "Histone cluster 2 H2A family member a3" Q6FI13 1 149842188-149842736 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 67.4" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 2: 76.9;Ciliated cells: 64.3;granulocytes: 22.1" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Karpas-707: 19.8;U-266/70: 96.9;U-266/84: 53.8" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (2.41e-2)" "unprognostic (3.79e-1)" "unprognostic (1.53e-1)" "unprognostic (2.89e-1)" "unprognostic (2.20e-1)" 6.1 2.7 3.7 6.8 3.7 67.4 7.8 3.7 5.4 10.1 4.0 3.7 3.7 4.2 3.7 3.7 6.5 5.4 5.0 4.5 3.7 1.6 5.6 9.9 14.6 4.4 3.7 3.7 5.1 3.7 0.4 3.7 8.9 3.7 35.8 1.7 3.7 22.4 3.7 4.5 11.7 3.7 3.7 8.0 12.8 9.6 11.2 3.7 18.9 3.7 3.7 5.4 3.7 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 2.3 0.6 0.0 5.3 2.5 3.6 3.0 0.0 1.0 1.5 3.8 2.3 0.0 0.9 0.3 1.1 0.4 2.5 0.0 0.7 7.0 0.9 2.4 0.0 0.7 11.8 2.0 0.9 1.0 0.0 0.9 0.0 7.8 19.8 1.2 0.0 0.0 5.9 0.0 2.9 4.2 0.8 0.0 7.4 1.4 1.8 0.0 0.0 6.7 0.0 0.2 0.0 5.2 2.0 2.0 0.7 8.9 0.0 0.5 96.9 53.8 2.1 5.6 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 3.7 3.7 5.4 3.7 1.6 3.7 3.7 3.7 3.7 17.9 76.9 0.0 7.4 10.5 0.0 2.8 0.0 64.3 13.6 1.8 0.0 0.2 0.0 0.1 1.4 0.0 0.0 0.0 0.2 0.1 2.8 4.2 22.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 9.3 10.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.2 13.7 1.8 1.9 0.0 4.1 HIST2H2AA4 H2A/r ENSG00000272196 "Histone cluster 2 H2A family member a4" Q6FI13 1 149851061-149851624 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 164.8;lymphoid tissue: 101.1" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 2: 89.0;Ciliated cells: 155.2;Club cells: 42.1;granulocytes: 40.7" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.5" "Cell type enriched" "Detected in all" 5 "neutrophil: 164.8" "Lineage enriched" "Detected in all" 9 "granulocytes: 164.8" "Cell line enhanced" "Detected in many" "SiHa: 27.3;U-266/70: 68.1;U-266/84: 60.4" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (1.63e-1)" "unprognostic (1.77e-1)" "unprognostic (1.76e-1)" "unprognostic (8.47e-2)" 4.5 6.5 0.0 9.8 1.2 9.0 2.5 0.3 2.6 5.2 5.7 1.5 2.5 5.7 5.5 3.4 9.1 2.4 4.2 4.0 0.7 3.0 2.5 8.8 7.1 0.1 0.0 4.3 5.0 0.0 0.5 6.5 1.6 9.5 0.0 2.1 4.2 2.6 3.5 5.8 5.4 0.9 0.8 8.4 4.2 21.6 0.1 101.1 1.9 4.8 11.5 5.8 2.3 9.3 17.2 164.8 17.9 3.5 4.2 18.8 3.8 9.7 1.3 2.2 0.0 1.2 3.1 8.2 0.0 0.0 0.0 6.6 3.9 0.0 9.3 0.0 2.6 5.3 0.0 0.0 0.0 5.3 12.8 1.2 8.0 4.3 0.0 1.2 7.5 0.0 0.0 0.0 0.0 2.3 0.0 4.4 8.3 19.7 0.0 24.7 4.2 1.2 3.7 21.0 10.2 3.7 1.5 6.7 0.0 2.0 9.8 4.1 27.3 7.5 2.1 1.3 13.0 2.7 0.0 2.7 20.9 3.8 1.0 68.1 60.4 4.6 0.0 6.2 3.1 24.2 17.9 32.8 3.2 10.5 3.3 5.9 2.8 3.0 12.0 9.3 2.2 2.0 164.8 3.5 12.4 17.2 4.2 18.8 23.8 89.0 0.0 6.7 0.0 0.0 22.0 0.0 155.2 42.1 3.5 0.0 0.3 0.0 0.6 1.5 0.0 0.0 0.0 0.3 0.2 0.3 5.6 40.7 1.6 0.9 0.0 0.0 0.0 0.6 1.0 0.3 0.7 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.2 0.0 2.2 0.9 0.1 4.8 HIST2H2AB ENSG00000184270 "Histone cluster 2 H2A family member b" Q8IUE6 1 149887524-149887916 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 126.3" "Cell type enhanced" "Detected in some" 11 "Bipolar cells: 2.4;Collecting duct cells: 1.8;Cone photoreceptor cells: 2.0;Horizontal cells: 1.6;Intestinal endocrine cells: 1.7;Muller glia cells: 4.3;Rod photoreceptor cells: 2.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 8.0;U-266/70: 4.9;U-266/84: 5.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB011483, HPA041189" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB011483: AB_732909, HPA041189: AB_2677357" "unprognostic (6.31e-2)" "unprognostic (6.63e-2)" "unprognostic (2.22e-2)" "unprognostic (2.31e-1)" "unprognostic (3.09e-1)" "unprognostic (3.34e-1)" "unprognostic (2.42e-3)" "unprognostic (1.99e-1)" "unprognostic (1.53e-1)" "unprognostic (2.03e-1)" "unprognostic (1.84e-1)" "unprognostic (1.69e-1)" "unprognostic (9.97e-3)" "unprognostic (5.33e-2)" "unprognostic (2.00e-2)" "unprognostic (4.36e-2)" 2.4 1.6 1.2 6.4 1.6 21.1 2.9 2.6 2.4 6.8 2.6 0.6 0.6 1.2 1.9 1.6 5.1 1.5 2.2 1.5 1.4 1.3 1.6 1.8 4.2 3.0 1.2 1.9 7.4 3.0 2.2 1.4 2.3 0.0 4.2 2.0 3.9 1.9 1.9 2.5 4.7 2.9 4.0 2.7 4.8 1.9 2.1 0.1 126.3 1.7 2.1 9.0 7.1 2.4 10.2 4.3 11.6 2.0 4.3 4.5 0.8 1.3 0.0 0.7 0.7 0.0 0.0 1.1 0.9 0.0 0.0 1.4 0.0 1.0 0.8 0.6 0.0 0.0 1.0 1.0 0.0 0.0 0.3 1.5 0.0 0.8 0.7 0.0 0.0 1.5 0.0 0.0 0.6 0.0 0.2 0.0 1.1 1.1 1.1 0.7 0.0 8.0 3.4 0.9 0.8 1.7 1.7 0.5 1.3 0.0 0.5 2.3 1.0 2.3 0.0 0.2 0.2 0.3 3.5 0.0 1.0 3.4 0.0 0.7 4.9 5.3 1.4 2.1 0.3 0.6 1.3 1.6 0.8 2.7 2.0 2.7 3.8 4.5 4.0 2.3 10.2 2.7 2.7 11.6 4.3 1.9 4.3 2.6 0.8 1.2 1.6 2.6 2.4 1.4 1.3 1.2 1.9 0.0 0.1 0.0 0.0 0.0 0.5 0.0 2.4 0.4 0.0 0.0 0.0 1.8 2.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.2 1.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.3 0.0 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 HIST2H2AC "H2A, H2A/q, H2AFQ" ENSG00000184260 "Histone cluster 2 H2A family member c" Q16777 1 149886975-149887364 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 47.7;bone marrow: 86.5;lymphoid tissue: 80.6" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "MCF7: 45.3" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (5.50e-3)" "unprognostic (4.97e-2)" "unprognostic (9.34e-2)" "unprognostic (6.95e-2)" "unprognostic (1.49e-1)" "unprognostic (9.78e-3)" "unprognostic (1.01e-1)" "unprognostic (2.25e-1)" "unprognostic (1.81e-1)" "unprognostic (3.24e-2)" "unprognostic (4.25e-2)" "unprognostic (7.87e-2)" "prognostic unfavorable (1.20e-10)" "unprognostic (1.42e-1)" "unprognostic (1.73e-1)" "unprognostic (4.89e-2)" "prognostic favorable (7.86e-5)" 10.5 8.5 4.2 6.5 4.2 86.5 8.6 3.1 4.1 13.8 7.5 2.8 5.4 4.6 8.1 6.0 10.9 6.4 8.1 13.2 3.9 3.1 8.2 6.1 10.5 12.5 2.9 3.7 15.3 15.8 3.6 7.6 8.4 2.3 10.6 4.3 13.8 6.0 10.1 7.2 10.1 6.4 9.7 7.6 10.7 5.8 4.9 2.4 80.6 6.0 8.1 10.5 16.2 8.9 15.8 11.6 47.7 15.9 7.9 11.0 10.8 2.6 3.2 3.7 11.2 0.0 0.6 5.5 0.7 0.9 1.8 2.7 1.9 0.7 5.5 0.1 0.2 0.3 1.2 0.2 1.2 0.0 0.3 4.4 1.3 0.4 9.4 0.0 3.2 2.9 0.7 0.2 0.1 0.4 0.1 1.3 1.4 1.1 6.7 0.4 45.3 3.8 3.2 4.8 3.1 7.8 1.2 1.5 1.0 0.7 1.9 1.1 5.2 1.5 0.8 2.5 0.3 0.4 3.2 1.1 0.8 7.4 1.4 1.9 3.1 1.9 2.8 2.0 4.4 1.6 17.0 15.9 8.1 11.0 10.6 10.0 6.2 9.7 8.7 8.1 15.8 6.8 6.7 47.7 7.9 10.6 11.6 7.3 10.8 4.2 4.2 3.1 4.1 3.9 3.1 2.9 3.7 2.3 2.4 6.0 6.4 11.2 15.2 3.3 9.8 1.6 7.6 2.7 5.7 1.8 9.8 4.0 8.3 12.0 3.7 6.8 8.0 46.7 11.6 15.4 4.3 7.6 8.1 6.4 8.1 7.9 9.1 6.2 7.6 2.1 7.5 12.4 3.3 19.0 6.1 13.7 11.0 4.3 6.0 3.9 14.1 0.0 6.2 0.4 1.6 5.5 7.3 11.7 6.3 11.2 HIST2H2BE "H2B, H2B.1, H2B/q, H2BFQ" ENSG00000184678 "Histone cluster 2 H2B family member e" Q16778 1 149884459-149886652 "Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 198.1" "Cell type enhanced" "Detected in many" 6 "Glandular cells: 128.7;Syncytiotrophoblasts: 134.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 29.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 29.9" "Cell line enhanced" "Detected in many" "Karpas-707: 24.3;U-266/70: 40.5;U-266/84: 21.7" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (1.49e-1)" "unprognostic (3.10e-2)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.63e-1)" "unprognostic (1.89e-1)" "unprognostic (2.52e-1)" "unprognostic (1.37e-1)" "unprognostic (8.28e-2)" "unprognostic (4.65e-2)" "unprognostic (3.27e-1)" "unprognostic (1.91e-1)" "unprognostic (1.30e-1)" "unprognostic (4.74e-2)" "unprognostic (4.41e-2)" "unprognostic (7.82e-2)" "unprognostic (2.20e-1)" "unprognostic (2.86e-3)" 14.3 16.2 9.8 22.2 10.0 19.4 16.9 17.2 14.0 31.3 9.0 11.2 10.5 6.4 18.5 24.9 25.5 13.3 9.6 51.1 13.1 10.1 12.5 10.2 27.5 24.5 12.4 8.7 28.0 13.4 5.8 15.4 17.2 8.5 72.8 7.6 19.4 24.1 15.3 43.1 33.5 8.6 18.8 18.2 22.0 17.5 9.3 11.6 198.1 12.1 12.4 25.3 27.2 33.8 2.3 4.5 29.9 5.5 0.7 1.2 5.1 1.1 1.1 1.9 0.4 10.3 2.8 0.9 4.1 2.7 1.7 0.5 0.4 1.8 0.2 1.1 3.6 2.4 4.5 1.5 0.7 0.9 1.4 1.2 0.3 4.6 0.8 3.2 0.3 5.4 9.4 3.4 0.7 2.8 2.1 0.5 1.7 4.9 24.3 2.1 6.9 1.2 2.1 1.2 9.4 2.5 1.5 0.7 5.5 1.6 0.9 13.1 2.1 14.1 1.9 1.0 4.8 10.0 0.9 0.7 1.3 14.7 0.9 0.3 40.5 21.7 1.1 1.7 1.5 0.8 8.4 2.1 3.8 0.7 3.2 1.2 0.8 0.9 1.1 1.6 2.3 1.2 1.1 29.9 0.7 5.5 4.5 1.0 5.1 9.8 10.0 17.2 8.5 13.1 10.1 12.4 8.7 8.5 11.6 8.9 11.7 10.4 57.7 5.4 47.2 56.8 2.5 12.0 5.7 34.9 21.6 22.3 23.2 13.5 1.1 4.5 15.3 23.3 5.9 10.4 14.1 128.7 10.5 5.9 22.3 20.6 53.7 8.6 11.0 0.0 4.6 16.7 18.6 4.6 18.8 12.9 8.3 21.0 0.4 8.8 32.5 0.0 9.8 0.5 6.1 11.8 134.0 22.4 9.0 59.1 HIST2H2BF ENSG00000203814 "Histone cluster 2 H2B family member f" Q5QNW6 1 149782689-149812373 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "lymphoid tissue: 117.6" "Cell type enhanced" "Detected in many" 6 "Glandular cells: 16.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 11 "neutrophil: 21.7" "Lineage enriched" "Detected in many" 11 "granulocytes: 21.7" "Cell line enhanced" "Detected in many" "U-266/70: 32.1" "Not detected" "Not detected" "CAB007814, HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB007814: AB_598159, HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (9.02e-3)" "unprognostic (7.78e-2)" "unprognostic (5.30e-4)" "unprognostic (3.00e-1)" "unprognostic (1.21e-1)" "unprognostic (2.17e-1)" "unprognostic (2.08e-2)" "unprognostic (8.33e-2)" "unprognostic (3.46e-2)" "unprognostic (5.36e-2)" "unprognostic (3.87e-5)" "unprognostic (3.72e-2)" "unprognostic (3.54e-7)" "unprognostic (1.84e-1)" "unprognostic (2.59e-2)" "unprognostic (9.42e-3)" "unprognostic (7.62e-2)" 5.6 17.7 3.9 14.9 3.5 3.7 7.1 8.5 5.6 17.4 3.8 3.7 3.2 1.5 5.6 6.2 7.1 7.9 3.6 12.1 3.4 2.4 5.0 4.2 14.6 27.5 3.2 3.8 24.2 6.2 2.6 4.4 5.1 3.2 16.7 2.5 3.5 3.7 5.5 1.2 10.9 3.4 6.0 7.7 12.7 7.9 5.9 3.1 117.6 4.4 6.3 16.7 6.1 21.5 2.0 0.8 21.7 1.1 0.6 0.8 0.2 0.4 0.6 0.6 0.6 4.6 3.1 0.3 7.9 4.1 6.0 5.3 0.3 2.2 0.4 0.6 4.5 5.2 1.3 0.1 0.5 4.7 1.2 0.9 0.4 1.5 0.0 6.7 0.2 1.8 5.5 0.0 7.8 1.9 1.7 3.4 0.3 1.2 2.4 0.8 0.9 3.1 3.8 0.4 4.1 1.0 0.3 1.1 0.7 2.9 0.4 2.7 7.3 4.2 3.5 0.3 0.7 1.3 9.8 1.4 1.5 0.0 11.5 2.0 32.1 1.0 1.3 5.3 0.3 3.4 0.0 1.0 0.2 0.6 0.8 0.7 0.6 0.8 0.3 0.8 2.0 0.4 0.3 21.7 0.6 1.1 0.8 0.2 0.2 3.9 3.5 8.5 5.6 3.4 2.4 3.2 3.8 3.2 3.1 0.0 0.3 2.2 6.9 0.3 6.0 1.7 0.0 4.0 1.2 1.8 2.0 1.5 3.3 1.0 0.9 0.4 5.1 0.0 0.3 1.2 0.9 16.2 0.0 0.6 6.7 4.8 3.4 2.5 4.9 1.4 2.6 2.9 0.0 1.8 2.7 6.6 0.7 2.9 0.0 0.5 0.9 6.5 1.5 0.2 0.4 0.5 4.3 4.9 1.8 5.7 HIST3H2A MGC3165 ENSG00000181218 "Histone cluster 3 H2A" Q7L7L0 1 228456979-228457873 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.8;lymphoid tissue: 62.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 35.8" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 18.7;SCLC-21H: 15.8;U-266/70: 18.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (3.65e-3)" "unprognostic (1.95e-1)" "unprognostic (1.01e-1)" "unprognostic (2.71e-1)" "prognostic favorable (3.73e-4)" "unprognostic (1.84e-3)" "unprognostic (2.49e-2)" "unprognostic (4.51e-2)" "unprognostic (1.18e-2)" "unprognostic (1.06e-2)" "unprognostic (3.20e-2)" "unprognostic (1.96e-1)" "unprognostic (6.67e-3)" "unprognostic (1.24e-1)" "unprognostic (1.39e-1)" "unprognostic (1.02e-1)" "unprognostic (7.76e-2)" 2.5 20.5 4.3 7.0 8.3 11.1 5.8 35.8 8.1 9.9 3.8 2.4 2.0 7.7 5.0 4.4 7.0 4.2 3.8 4.9 5.4 4.6 1.6 1.0 2.5 5.1 5.6 5.3 8.3 4.5 3.5 5.0 3.4 6.5 7.0 2.8 13.9 6.6 3.9 1.0 6.4 4.2 1.5 5.2 6.6 4.7 3.5 4.8 62.3 1.9 5.6 9.3 2.9 9.3 3.4 3.4 5.1 7.1 6.8 11.7 4.3 3.6 1.9 2.6 3.5 2.1 2.2 3.1 1.8 1.7 5.2 3.6 1.9 3.0 1.6 2.2 0.4 0.0 8.9 1.8 0.8 1.2 2.6 18.7 2.6 2.5 0.0 5.0 1.8 5.2 4.8 5.3 1.0 2.2 2.1 2.2 3.4 9.0 0.0 0.0 5.1 2.3 0.0 3.9 2.1 4.8 0.0 0.0 13.6 0.8 2.2 15.8 11.1 6.3 5.6 12.1 0.4 9.9 1.3 0.8 0.0 0.0 7.0 1.6 18.8 13.4 0.0 1.8 1.8 1.3 5.1 1.7 0.0 7.1 3.1 5.1 3.4 6.8 5.3 3.4 2.0 5.3 5.2 0.7 6.8 7.1 0.6 11.7 4.3 4.3 8.3 35.8 5.9 5.4 4.6 5.6 5.3 6.5 4.8 0.0 0.3 7.5 21.8 1.1 18.2 5.5 5.1 18.7 13.6 3.5 45.2 11.8 6.6 3.3 0.6 1.0 6.0 23.3 2.7 9.5 3.1 30.8 13.9 0.0 23.0 39.7 35.1 1.3 8.0 1.1 19.2 14.3 3.3 25.2 26.6 24.1 9.7 17.3 8.1 1.1 6.4 0.0 4.6 0.5 2.7 5.1 45.0 41.5 17.4 32.1 HIST3H2BB ENSG00000196890 "Histone cluster 3 H2B family member b" Q8N257 1 228458107-228460470 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 56.0" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 1: 6.0;Cone photoreceptor cells: 5.9;Erythroid cells: 23.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 12.8" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "U-266/70: 18.5" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (5.53e-3)" "unprognostic (2.41e-1)" "unprognostic (3.39e-3)" "unprognostic (5.25e-2)" "unprognostic (8.20e-3)" "unprognostic (8.78e-3)" "unprognostic (1.74e-2)" "unprognostic (2.41e-2)" "unprognostic (1.62e-1)" "unprognostic (1.21e-1)" "unprognostic (2.96e-2)" "unprognostic (1.05e-1)" "unprognostic (2.34e-2)" "unprognostic (9.74e-2)" "unprognostic (1.05e-1)" "unprognostic (1.15e-1)" "unprognostic (2.59e-1)" 2.0 4.7 1.2 12.1 3.1 2.8 1.3 12.8 3.2 8.9 1.3 1.1 0.6 2.1 1.4 2.0 4.1 6.2 1.7 2.2 1.5 2.2 1.3 0.9 2.1 5.4 1.2 1.5 1.6 1.7 1.7 2.0 1.5 4.1 2.2 1.5 3.4 2.0 2.0 1.8 4.8 1.7 1.2 6.2 4.5 2.4 2.1 0.7 56.0 1.7 5.9 11.8 2.0 7.9 1.5 1.1 3.4 1.5 1.1 0.9 0.5 0.2 0.3 0.3 0.2 0.0 0.0 0.2 0.2 0.0 0.2 0.1 0.5 1.0 0.1 0.1 0.0 0.0 2.6 0.1 0.1 0.1 0.6 0.6 0.0 0.8 0.0 0.1 0.0 0.5 0.0 0.1 0.1 0.2 0.1 0.0 0.4 0.2 0.1 0.0 0.3 0.4 0.1 0.4 0.3 0.2 0.0 0.0 0.8 0.0 0.2 1.5 0.5 1.0 0.4 0.3 0.1 3.7 0.1 0.1 0.0 0.0 0.5 0.1 18.5 4.4 0.0 0.2 0.1 0.1 1.7 1.0 0.5 0.5 0.5 0.7 1.3 0.8 0.9 0.2 1.5 0.9 0.7 3.4 1.1 1.5 1.1 0.7 0.5 1.2 3.1 12.8 3.1 1.5 2.2 1.2 1.5 4.1 0.7 6.0 0.0 0.0 1.2 0.1 3.8 0.8 0.0 4.0 0.0 0.0 5.9 0.2 1.7 0.0 0.0 0.0 0.2 23.3 0.0 0.1 0.0 0.5 0.0 0.0 0.7 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.7 2.9 0.0 0.3 0.0 0.0 0.3 0.0 0.5 0.0 0.1 0.3 0.8 2.5 0.4 0.5 HIST3H3 "H3.4, H3/g, H3FT, H3t" ENSG00000168148 "Histone cluster 3 H3" Q16695 1 228424845-228425325 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 194 "testis: 107.8" "Cell type enhanced" "Detected in some" 29 "Early spermatids: 2.8;Late spermatids: 13.2;Spermatocytes: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.5;MCF7: 1.3;THP-1: 1.8" "CAB001386, CAB003812, HPA042570" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB001386: , CAB003812: AB_365490, HPA042570: AB_2678056" "unprognostic (4.45e-1)" "unprognostic (4.66e-2)" "unprognostic (1.36e-1)" "unprognostic (3.78e-3)" "unprognostic (1.75e-2)" "unprognostic (4.04e-2)" "unprognostic (1.39e-2)" "unprognostic (2.26e-2)" 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.4 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.1 107.8 0.0 0.0 0.2 0.0 0.0 0.4 0.3 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 1.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 1.8 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.2 0.0 0.8 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.4 0.0 0.0 0.0 0.0 0.0 HIST4H4 MGC24116 ENSG00000197837 "Histone cluster 4 H4" P62805 12 14767999-14771131 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 36.7" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 9.8;Enterocytes: 9.5;Rod photoreceptor cells: 18.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 19.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 8.1" "CAB011503, CAB037279, HPA042201" Supported Supported Nucleoplasm NA NA 30000000 Nucleoplasm "CAB011503: AB_873863, CAB037279: AB_1079064, HPA042201: AB_2677898" "unprognostic (1.87e-1)" "unprognostic (6.84e-2)" "unprognostic (1.70e-2)" "unprognostic (6.89e-2)" "unprognostic (2.16e-2)" "unprognostic (4.86e-2)" "unprognostic (3.67e-2)" "unprognostic (9.69e-3)" "unprognostic (4.54e-2)" "unprognostic (3.25e-2)" "unprognostic (5.35e-2)" "unprognostic (6.62e-3)" "unprognostic (4.38e-2)" "unprognostic (1.02e-2)" "unprognostic (1.33e-3)" "unprognostic (2.01e-1)" "unprognostic (1.28e-3)" 7.1 4.6 2.3 7.4 7.6 2.5 4.7 6.7 4.9 6.9 6.2 1.1 3.3 5.0 5.4 7.1 8.9 6.0 5.4 5.9 2.8 2.5 11.0 3.3 6.3 7.2 2.5 2.1 8.3 36.7 2.1 5.1 7.1 2.1 16.0 4.8 6.1 12.7 5.5 2.8 6.4 8.9 3.3 3.1 21.8 10.1 6.6 1.7 16.9 9.9 6.8 18.6 6.6 6.8 5.5 3.6 19.7 2.1 2.1 3.4 1.1 2.1 0.8 0.1 2.6 2.9 0.0 1.5 1.3 0.1 1.1 0.9 1.4 8.1 2.0 0.5 0.7 0.0 1.4 0.0 1.0 0.6 2.5 1.1 0.0 5.2 2.1 0.8 0.5 2.0 2.0 0.6 0.2 1.2 0.0 0.0 0.6 0.0 2.6 0.1 1.1 0.5 0.7 2.8 0.7 0.3 2.2 0.0 3.9 0.0 5.8 1.0 1.4 5.3 1.4 0.3 0.6 1.0 1.0 1.8 0.5 4.2 1.1 1.6 2.8 1.7 5.8 1.9 0.0 1.3 0.0 1.9 0.2 2.0 2.1 3.4 4.1 2.3 2.2 2.1 5.5 2.0 2.2 19.7 2.1 0.7 3.6 3.2 1.1 2.3 7.6 6.7 4.9 2.8 2.5 2.5 2.1 2.1 1.7 0.0 0.0 2.2 1.3 0.5 6.2 2.0 0.0 1.4 1.2 1.8 9.8 0.8 0.0 0.7 0.0 0.6 9.5 0.0 1.0 0.3 0.9 0.6 0.0 0.9 1.4 0.0 1.7 0.6 2.1 0.0 1.1 0.6 0.0 1.8 1.4 2.3 0.8 2.0 0.7 0.8 18.8 0.0 1.3 0.2 0.5 1.0 1.4 4.5 1.4 0.5 HIVEP1 "CIRIP, CRYBP1, MBP-1, PRDII-BF1, Schnurri-1, ZAS1, ZNF40, ZNF40A" ENSG00000095951 "Human immunodeficiency virus type I enhancer binding protein 1" P15822 6 12008762-12164999 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050724, HPA067457" Approved Supported "Nucleoplasm,Nuclear bodies,Mitochondria,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Mitochondria, Cytosol" "HPA050724: AB_2616457, HPA067457: " "unprognostic (2.55e-1)" "unprognostic (5.85e-2)" "unprognostic (1.15e-1)" "unprognostic (6.03e-2)" "unprognostic (1.75e-2)" "unprognostic (5.65e-3)" "unprognostic (4.83e-2)" "unprognostic (1.38e-1)" "unprognostic (2.20e-1)" "unprognostic (1.85e-1)" "unprognostic (5.69e-2)" "unprognostic (1.98e-1)" "unprognostic (4.40e-2)" "unprognostic (3.01e-2)" "unprognostic (2.21e-1)" "unprognostic (4.49e-2)" "unprognostic (2.38e-1)" 22.3 5.5 6.4 20.1 5.6 20.5 13.1 8.0 10.0 11.5 12.6 5.4 13.9 7.0 10.0 10.6 12.9 9.2 10.6 8.8 5.6 7.1 7.3 17.1 13.3 12.4 5.3 6.7 11.6 11.7 23.3 12.2 8.7 7.8 10.5 9.5 7.7 10.9 17.6 8.2 14.1 11.8 12.9 5.9 15.2 7.2 7.3 5.0 23.8 7.7 14.2 16.2 17.3 23.1 5.6 9.6 12.9 4.9 3.6 4.6 0.7 5.2 3.9 5.1 2.8 4.0 5.2 4.9 4.3 3.7 3.6 3.9 2.5 2.8 4.4 9.4 5.2 8.5 5.1 5.0 6.1 4.9 9.5 2.9 2.0 3.7 2.4 3.3 2.3 1.7 3.6 6.2 7.2 11.2 7.5 10.4 3.0 21.1 5.1 7.7 3.9 3.8 2.1 4.3 1.8 2.0 2.1 6.6 6.9 2.1 5.8 4.8 3.5 10.6 8.7 3.0 11.9 5.1 3.1 16.8 9.0 4.0 8.3 4.9 20.5 17.1 7.9 2.7 3.1 3.7 2.4 2.2 2.2 1.4 2.2 1.0 3.4 2.3 0.9 1.3 5.6 4.0 2.3 12.9 3.6 4.9 9.6 4.6 0.7 6.4 5.6 8.0 10.0 5.6 7.1 5.3 6.7 7.8 5.0 26.8 19.2 6.5 21.7 28.6 19.2 7.4 10.2 22.7 26.1 7.0 11.8 2.9 3.3 4.8 2.1 15.5 11.3 0.0 6.3 1.8 12.7 18.9 7.0 11.4 4.9 20.6 10.4 7.4 8.5 1.5 3.4 19.0 18.6 45.9 12.5 13.2 8.5 9.7 4.2 2.7 9.1 0.0 13.4 3.6 3.1 29.2 4.3 7.5 7.1 23.3 HIVEP2 "HIV-EP2, MBP-2, MIBP1, Schnurri-2, ZAS2, ZNF40B" ENSG00000010818 "Human immunodeficiency virus type I enhancer binding protein 2" P31629 6 142751467-142956698 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 83.8;Suprabasal keratinocytes: 82.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 23.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055954 Supported Nucleoplasm NA NA Nucleoplasm "HPA055954: " "unprognostic (1.35e-2)" "unprognostic (1.61e-2)" "unprognostic (8.48e-2)" "unprognostic (2.03e-2)" "unprognostic (2.55e-1)" "unprognostic (1.20e-2)" "unprognostic (7.71e-2)" "unprognostic (8.44e-2)" "unprognostic (1.50e-1)" "unprognostic (1.34e-2)" "unprognostic (1.19e-2)" "unprognostic (1.93e-1)" "unprognostic (8.09e-3)" "unprognostic (1.25e-2)" "unprognostic (5.32e-2)" "unprognostic (1.71e-1)" "unprognostic (1.10e-1)" 11.3 9.7 13.9 13.6 17.4 4.2 9.2 29.8 30.1 6.3 7.2 5.9 3.8 6.1 8.6 7.3 11.7 15.9 13.5 10.5 15.7 10.4 8.5 7.7 10.6 14.9 9.3 12.8 18.5 13.4 19.0 8.7 9.6 12.7 7.3 6.3 7.1 10.9 8.6 24.3 10.6 8.0 10.1 13.5 10.4 6.5 2.7 8.5 18.6 11.2 9.6 15.5 12.5 12.0 2.1 1.1 2.3 0.6 1.7 3.9 1.2 3.7 0.7 0.9 3.3 7.3 8.2 2.6 5.4 13.8 3.4 4.1 0.3 3.1 5.9 3.4 23.7 6.4 2.4 1.5 11.0 8.3 2.2 1.7 1.6 2.4 1.4 5.5 5.1 0.0 7.5 11.0 13.8 15.9 7.8 1.8 4.7 0.1 5.4 5.7 4.2 6.7 2.2 0.8 0.9 5.4 8.9 6.0 0.5 3.1 6.5 9.0 3.8 7.1 5.9 4.0 1.6 1.0 3.0 1.9 11.4 2.8 9.5 4.7 11.3 1.8 12.7 3.2 4.0 5.3 0.0 0.3 0.0 1.6 0.6 3.6 2.1 3.9 3.2 1.1 1.3 3.9 3.0 2.3 1.7 0.5 0.5 2.9 1.2 13.9 17.4 29.8 30.1 15.7 10.4 9.3 12.8 12.7 8.5 20.8 27.5 3.2 41.6 83.8 14.1 18.3 10.2 30.8 39.8 7.0 23.6 1.9 0.0 10.2 1.5 14.3 3.8 0.0 12.9 1.0 34.3 37.8 3.5 4.3 2.3 28.6 3.4 6.7 3.4 0.9 10.9 11.1 23.6 5.4 4.5 2.3 17.1 7.0 14.9 2.3 2.3 0.0 30.9 0.5 0.9 82.7 3.9 12.8 2.9 53.2 HIVEP3 "FLJ16752, KBP-1, KBP1, KIAA1555, KRC, Schnurri-3, SHN3, ZAS3, ZNF40C" ENSG00000127124 "Human immunodeficiency virus type I enhancer binding protein 3" Q5T1R4 1 41506365-42035925 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.3;lymphoid tissue: 16.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 17.9;hTEC/SVTERT24-B: 9.3;Karpas-707: 10.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005728 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA005728: AB_10612117" "unprognostic (2.87e-3)" "unprognostic (2.38e-2)" "unprognostic (4.65e-2)" "unprognostic (2.56e-1)" "unprognostic (1.55e-2)" "unprognostic (6.50e-2)" "unprognostic (2.70e-3)" "unprognostic (3.73e-1)" "unprognostic (1.50e-2)" "unprognostic (1.06e-1)" "unprognostic (1.19e-1)" "unprognostic (2.41e-1)" "unprognostic (2.07e-8)" "unprognostic (1.43e-1)" "unprognostic (1.38e-2)" "unprognostic (1.13e-2)" "unprognostic (3.21e-1)" 4.2 1.5 7.5 5.4 5.7 3.8 3.6 20.3 11.7 1.2 1.4 5.1 0.0 1.2 1.1 1.1 3.2 1.3 2.0 2.1 6.1 3.0 1.4 1.2 4.6 4.1 4.8 4.7 1.6 2.4 2.3 8.3 1.8 6.5 2.2 1.5 0.5 3.7 1.1 1.6 11.7 1.3 2.2 5.0 2.9 1.9 1.4 5.1 16.6 2.9 1.8 5.4 1.9 1.6 1.0 1.5 0.1 3.7 0.2 2.1 1.1 1.8 0.6 0.2 1.7 2.3 1.0 0.0 0.9 0.2 2.3 4.0 0.1 0.3 3.8 0.6 0.9 1.4 2.6 0.4 0.4 3.1 17.9 0.5 0.2 0.8 0.0 0.4 0.3 0.3 5.6 0.4 9.3 1.1 0.6 0.5 1.3 0.0 10.8 1.7 1.1 2.8 0.8 0.6 0.6 2.2 1.9 2.8 2.0 1.5 0.3 2.0 0.6 2.5 0.7 0.5 1.1 0.8 3.2 3.3 2.0 2.2 0.6 4.4 3.2 1.3 2.6 8.1 0.2 7.3 0.1 1.7 0.0 2.1 3.7 0.5 0.6 0.9 1.0 1.5 1.0 0.2 0.8 0.1 0.2 3.1 0.3 0.3 1.1 7.5 5.7 20.3 11.7 6.1 3.0 4.8 4.7 6.5 5.1 6.0 8.0 2.2 24.6 21.1 15.2 5.1 0.0 1.4 12.5 1.8 2.0 0.3 1.7 3.1 7.6 4.3 2.1 23.3 2.4 2.8 11.6 16.0 1.1 2.8 6.1 23.8 3.5 13.5 5.1 18.7 8.1 10.5 5.0 0.0 1.1 15.6 2.3 0.0 3.9 2.2 3.5 6.5 9.0 8.6 8.3 7.5 0.7 17.0 0.8 7.3 HJURP "DKFZp762E1312, FAKTS, hFLEG1, URLC9" ENSG00000123485 "Holliday junction recognition protein" Q8NCD3 2 233833416-233854566 "Predicted intracellular proteins" "Cell cycle" "Chaperone, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 27.4;lymphoid tissue: 51.1;testis: 20.9" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 12.4;Erythroid cells: 46.7;Extravillous trophoblasts: 13.7;Spermatocytes: 18.4;Spermatogonia: 12.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 4.2" "Group enriched" "Detected in many" 4 "granulocytes: 1.2;monocytes: 1.3;T-cells: 4.2" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA008436, HPA027261" Uncertain Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitochondria" Yes Yes "Nucleoplasm, Nucleoli, Nucleoli rim" Mitochondria "HPA008436: AB_1850757, HPA027261: AB_2672184" "unprognostic (5.63e-2)" "unprognostic (9.15e-2)" "unprognostic (1.87e-1)" "unprognostic (1.44e-3)" "unprognostic (3.62e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (3.37e-5)" "prognostic unfavorable (2.46e-4)" "prognostic unfavorable (6.49e-4)" "unprognostic (9.48e-2)" "prognostic unfavorable (7.72e-5)" "unprognostic (7.60e-2)" "unprognostic (0.00e+0)" "unprognostic (7.42e-2)" "unprognostic (5.58e-2)" "unprognostic (1.89e-2)" "unprognostic (5.74e-2)" 1.4 0.9 0.1 12.2 0.4 27.4 2.2 0.1 0.7 1.1 3.7 0.3 0.1 2.6 0.6 1.8 8.0 0.3 0.7 1.1 0.1 0.2 1.0 1.2 2.0 8.1 0.2 0.1 0.6 0.4 0.0 0.2 3.1 0.2 0.7 3.6 0.3 1.5 1.0 0.2 2.6 4.8 1.1 0.4 5.8 2.4 20.9 0.1 51.1 0.4 3.0 11.6 1.0 2.8 0.5 0.3 1.2 1.3 0.5 4.2 1.7 17.0 23.1 22.6 10.6 0.8 1.8 14.1 25.6 12.3 18.3 20.0 16.2 18.7 5.3 2.9 10.1 32.6 20.0 18.0 13.3 24.4 12.5 6.8 20.6 18.6 15.7 0.1 16.9 14.2 0.6 0.5 14.9 10.3 5.2 11.4 16.5 17.4 13.3 33.6 17.2 23.7 18.7 19.3 13.4 16.0 18.4 33.9 9.5 9.4 10.3 13.0 8.1 14.8 11.2 10.5 10.8 8.4 13.1 8.3 19.8 21.6 14.5 27.7 12.7 10.0 21.4 11.9 12.5 49.3 0.6 0.2 0.2 0.3 0.2 0.2 0.4 0.7 0.6 0.3 0.5 0.3 0.5 1.2 0.5 1.3 0.2 4.2 1.7 0.1 0.4 0.1 0.7 0.1 0.2 0.2 0.1 0.2 0.1 0.0 0.3 0.8 0.4 1.1 0.0 0.8 0.0 0.0 3.4 0.0 0.0 1.1 0.0 0.0 12.4 0.1 0.9 46.7 0.0 13.7 0.3 0.4 0.0 0.0 5.7 0.0 0.0 2.5 2.4 7.4 0.6 2.1 0.0 0.0 0.7 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.3 18.4 12.9 0.6 1.3 1.3 1.2 0.6 HKR1 ZNF875 ENSG00000181666 "HKR1, GLI-Kruppel zinc finger family member" P10072 19 37312837-37369365 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 102.1;Rod photoreceptor cells: 129.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA036126, HPA044855" Approved Approved Nucleoplasm,Mitochondria No No "Nucleoplasm, Mitochondria" "HPA036126: AB_10670708, HPA044855: AB_2679113" "unprognostic (1.04e-2)" "unprognostic (9.68e-2)" "unprognostic (1.75e-1)" "unprognostic (3.58e-1)" "unprognostic (2.78e-1)" "unprognostic (4.81e-2)" "unprognostic (2.29e-1)" "unprognostic (1.02e-3)" "unprognostic (4.92e-3)" "unprognostic (9.82e-2)" "prognostic favorable (4.41e-4)" "prognostic unfavorable (5.18e-5)" "unprognostic (1.34e-1)" "unprognostic (5.04e-2)" "unprognostic (2.00e-1)" "unprognostic (2.39e-1)" "unprognostic (1.20e-3)" 13.0 25.8 14.6 13.2 22.4 12.6 24.9 29.8 27.2 20.5 14.5 22.9 21.5 7.7 24.8 24.1 12.4 22.9 17.9 26.9 14.6 15.6 19.3 12.3 12.9 14.3 14.9 17.4 22.6 14.2 31.0 35.5 17.2 21.2 27.5 13.8 49.4 18.7 19.3 18.1 27.1 13.4 17.0 13.3 20.2 14.2 22.6 15.5 16.4 30.9 13.7 20.1 15.0 15.6 12.4 7.9 10.0 5.1 9.9 14.8 5.7 4.1 10.4 13.5 17.9 9.9 8.6 9.4 7.0 10.7 13.1 14.2 5.2 4.9 14.6 17.1 7.4 5.9 3.5 8.8 9.4 13.6 7.6 15.0 5.1 12.6 5.6 13.0 4.7 12.5 12.7 11.6 8.8 19.4 13.4 7.9 10.5 0.9 0.9 9.4 8.4 10.5 9.3 27.1 7.2 6.0 7.1 5.9 5.6 11.4 16.8 16.8 22.8 7.0 9.0 8.8 20.6 12.8 9.0 7.1 10.4 7.5 7.8 10.9 18.8 19.7 15.1 1.1 5.8 11.6 10.0 4.2 6.6 8.0 5.1 14.8 10.7 10.6 11.4 6.3 12.4 14.4 12.0 4.0 9.9 3.6 7.9 12.2 5.7 14.6 22.4 29.8 27.2 14.6 15.6 14.9 17.4 21.2 15.5 6.0 2.9 7.8 6.4 4.6 45.3 16.5 2.5 18.7 11.4 10.4 102.1 9.3 16.6 7.7 9.5 11.1 2.9 0.0 6.8 4.6 6.1 9.7 11.5 5.9 6.1 39.7 9.2 9.2 3.7 5.9 11.2 5.5 8.5 9.0 5.0 22.8 5.1 3.5 12.0 10.9 129.7 6.5 7.6 15.5 16.3 5.4 8.2 8.5 5.4 7.3 HLA-DPB1 HLA-DP1B ENSG00000223865 "Major histocompatibility complex, class II, DP beta 1" P04440 6 33075926-33087201 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 99.4" "Cell type enhanced" "Detected in many" 19 "B-cells: 1312.2;Hofbauer cells: 1159.7;Kupffer cells: 1265.6;Macrophages: 2334.4;monocytes: 5192.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 90.1" "Group enriched" "Detected in all" 8 "B-cells: 57.8;dendritic cells: 90.1;monocytes: 40.6" "Group enriched" "Detected in some" 6 "HDLM-2: 47.2;REH: 22.5" "HPA011078, HPA058509" Enhanced Approved "Nucleoplasm,Cell Junctions" NA NA 730000 "Cell Junctions" Nucleoplasm "HPA011078: AB_1079378, HPA058509: AB_2683737" "unprognostic (5.44e-3)" "unprognostic (7.03e-3)" "unprognostic (9.84e-2)" "prognostic favorable (3.38e-4)" "unprognostic (9.43e-2)" "unprognostic (1.80e-2)" "unprognostic (1.52e-1)" "unprognostic (1.51e-3)" "unprognostic (1.77e-2)" "unprognostic (5.64e-2)" "unprognostic (1.57e-1)" "unprognostic (4.34e-1)" "unprognostic (4.35e-2)" "unprognostic (1.80e-1)" "unprognostic (4.17e-2)" "unprognostic (3.58e-2)" "unprognostic (1.85e-1)" 29.6 31.9 9.8 52.8 15.1 6.9 22.0 6.1 7.7 15.5 11.8 14.9 6.9 14.4 15.3 23.4 9.8 11.0 26.6 29.6 9.7 10.4 25.5 12.4 79.9 99.4 23.5 6.0 10.8 10.5 4.3 11.5 6.2 19.6 19.4 6.6 22.2 25.0 15.4 6.1 14.8 33.7 8.9 35.3 88.8 15.8 4.3 16.2 51.9 14.2 20.7 69.3 35.5 11.9 57.8 90.1 1.1 40.6 2.8 7.6 23.5 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.4 0.2 0.1 0.0 0.0 0.0 0.0 47.2 2.2 1.3 0.0 0.0 0.0 0.0 0.1 1.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.6 0.0 0.0 22.5 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.7 0.0 0.2 0.0 0.0 6.0 0.1 3.9 0.0 0.0 0.0 0.2 18.7 1.1 5.3 40.6 0.7 57.8 1.9 7.6 90.1 56.9 0.7 4.2 0.4 2.8 17.0 25.7 7.2 23.5 9.8 15.1 6.1 7.7 9.7 10.4 23.5 6.0 19.6 16.2 62.5 286.9 1312.2 21.4 267.0 12.2 9.3 73.9 46.8 77.3 27.9 15.7 5.1 3.3 33.6 3.2 238.9 10.6 0.0 13.0 4.7 50.0 41.9 61.1 5.5 1159.7 7.9 9.2 88.4 1265.6 4.0 25.3 2334.4 307.1 5192.2 12.2 24.1 8.0 4.0 19.8 36.3 19.2 45.3 33.2 1.2 5.9 203.9 7.6 173.0 6.5 13.9 HLF MGC33822 ENSG00000108924 "HLF, PAR bZIP transcription factor" Q16534 17 55265012-55325065 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 78.8" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 122.6;Hepatocytes: 152.5;Horizontal cells: 87.4" "Cancer enhanced" "Detected in many" "liver cancer: 13.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory CD4 T-cell: 2.4;T-reg: 2.1" "Lineage enriched" "Detected in single" 25 "T-cells: 2.4" "Cell line enriched" "Detected in some" 6 "Hep G2: 60.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA068156, HPA071210" Enhanced Nucleoplasm Yes NA Nucleoplasm "HPA068156: AB_2685963, HPA071210: AB_2686361" "unprognostic (1.24e-1)" "unprognostic (1.19e-3)" "unprognostic (1.27e-1)" "unprognostic (1.35e-1)" "unprognostic (3.30e-1)" "prognostic favorable (1.88e-4)" "unprognostic (5.30e-3)" "prognostic favorable (2.71e-7)" "unprognostic (1.42e-1)" "unprognostic (3.44e-2)" "unprognostic (1.24e-3)" "unprognostic (2.19e-1)" "prognostic favorable (3.55e-6)" "unprognostic (8.47e-2)" "unprognostic (1.64e-1)" "unprognostic (6.85e-2)" "unprognostic (1.60e-2)" 9.5 15.2 13.3 2.0 26.2 1.0 10.8 15.2 38.0 10.5 10.6 6.4 2.4 1.7 10.3 8.5 18.1 9.3 6.1 15.9 12.6 6.9 9.2 78.8 9.5 2.1 6.6 24.5 34.6 2.7 2.8 8.0 1.5 12.3 9.9 3.1 23.7 15.9 9.5 5.3 11.6 3.0 14.3 5.5 5.7 4.7 3.4 6.3 0.0 23.4 7.1 5.6 9.2 5.2 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 10.0 0.2 0.0 0.0 60.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.0 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.9 0.0 0.1 0.1 5.0 0.0 4.2 0.2 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.1 1.9 1.7 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.1 13.3 26.2 15.2 38.0 12.6 6.9 6.6 24.5 12.3 6.3 3.0 36.8 0.0 4.7 19.8 122.6 31.9 15.3 1.4 11.4 7.0 9.8 0.1 10.0 1.5 0.9 8.6 0.0 0.0 0.8 0.0 6.0 1.2 0.0 152.5 0.1 87.4 2.9 4.9 4.1 2.7 26.2 1.0 10.1 0.0 0.1 54.5 0.3 0.0 36.7 18.9 13.0 12.9 6.2 0.3 2.7 24.1 1.0 2.2 0.0 0.5 HLTF "HIP116A, HLTF1, RNF80, SMARCA3, SNF2L3" ENSG00000071794 "Helicase like transcription factor" Q14527 3 149030127-149086554 "Enzymes, Predicted intracellular proteins" "Transcription, Ubl conjugation pathway" "Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 88.3;Spermatocytes: 110.2;Spermatogonia: 89.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015284, HPA049001" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA015284: AB_1857263, HPA049001: AB_2680594" "unprognostic (3.21e-2)" "unprognostic (3.46e-2)" "unprognostic (6.81e-2)" "unprognostic (1.95e-3)" "unprognostic (4.29e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (7.27e-4)" "unprognostic (3.01e-2)" "unprognostic (2.13e-2)" "unprognostic (2.27e-1)" "unprognostic (4.78e-2)" "unprognostic (9.00e-3)" "unprognostic (1.39e-1)" "unprognostic (2.94e-1)" "unprognostic (3.42e-1)" "unprognostic (2.83e-2)" "unprognostic (1.07e-2)" 10.2 22.1 12.6 8.4 17.6 9.0 12.4 29.3 23.8 11.1 11.0 12.4 6.2 4.8 12.4 9.6 7.1 10.8 8.6 16.5 15.8 16.6 15.6 16.3 7.1 9.8 15.7 19.0 17.6 12.0 16.5 25.1 7.3 29.9 14.7 7.0 11.3 9.3 11.1 9.7 5.1 6.6 12.7 19.0 7.5 8.7 37.7 14.0 17.1 19.0 4.8 9.6 10.0 7.8 8.4 9.2 8.8 2.3 5.4 10.4 3.5 24.6 12.0 17.2 13.4 11.5 14.9 1.7 16.7 10.0 12.4 14.5 9.7 17.2 15.9 20.5 7.7 24.3 0.7 23.0 6.6 20.8 8.8 11.2 38.2 9.4 3.9 7.2 10.0 15.9 9.4 3.6 9.2 5.4 19.0 7.1 26.0 13.3 10.4 16.9 12.4 20.5 15.4 12.9 12.5 15.1 23.8 19.3 2.5 10.2 8.0 17.0 10.0 25.4 11.8 23.0 9.5 35.2 9.8 5.0 14.6 8.8 20.5 18.2 15.4 8.6 20.8 14.3 13.7 5.6 8.8 1.3 4.0 5.6 2.1 10.4 8.4 4.9 7.2 3.9 5.4 7.2 7.4 0.2 5.4 2.3 9.2 4.4 3.5 12.6 17.6 29.3 23.8 15.8 16.6 15.7 19.0 29.9 14.0 23.8 14.8 13.8 7.6 4.9 88.3 34.8 17.8 30.8 21.6 29.6 39.3 6.6 29.9 7.9 9.5 10.8 1.3 0.0 7.3 8.2 10.6 11.9 53.2 14.9 7.6 44.5 4.7 15.4 4.0 5.8 31.4 7.5 5.0 3.6 6.2 35.2 6.8 2.8 30.4 15.6 75.2 12.9 14.1 110.2 89.0 3.8 1.4 13.8 6.6 4.3 HLX "HB24, HLX1" ENSG00000136630 "H2.0 like homeobox" Q14774 1 220879400-220885059 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 54.0" "Cell type enhanced" "Detected in many" 13 "Erythroid cells: 23.3;Hofbauer cells: 27.0;Ito cells: 38.6;monocytes: 67.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 25.8;neutrophil: 28.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 28.5" "Cell line enhanced" "Detected in many" "SK-MEL-30: 13.5;THP-1: 47.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA005968 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA005968: AB_1079066" "unprognostic (6.18e-2)" "unprognostic (1.38e-1)" "unprognostic (1.88e-3)" "unprognostic (2.57e-2)" "unprognostic (9.19e-3)" "unprognostic (1.76e-1)" "unprognostic (1.40e-1)" "unprognostic (5.14e-3)" "unprognostic (1.06e-1)" "unprognostic (9.73e-2)" "unprognostic (3.19e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (7.28e-6)" "unprognostic (8.44e-3)" "unprognostic (3.68e-2)" "unprognostic (1.15e-1)" "unprognostic (1.36e-1)" 27.7 3.0 2.7 8.8 3.0 54.0 18.4 0.9 2.3 5.7 24.3 2.0 3.8 4.5 7.4 3.6 8.7 5.0 7.5 15.2 3.3 0.9 4.0 11.5 14.3 10.5 6.2 0.3 4.9 4.9 1.8 2.0 14.0 2.5 6.9 2.4 4.2 2.3 3.8 10.4 5.7 11.1 4.2 6.4 10.9 3.1 3.9 3.1 1.4 6.3 3.0 3.2 10.4 12.9 2.2 5.5 28.5 6.3 0.2 0.1 1.8 0.0 1.9 0.0 1.4 4.3 6.9 3.6 5.2 8.6 6.0 5.0 0.4 0.1 0.0 0.1 3.2 1.1 0.0 1.1 0.0 2.5 1.3 3.8 0.0 2.2 0.2 7.6 1.7 0.4 8.0 0.2 6.7 0.4 0.5 2.6 0.0 2.2 0.0 0.8 0.0 0.0 6.2 0.2 0.0 3.6 0.1 4.1 0.0 0.6 0.0 0.0 2.0 0.7 0.1 13.5 0.3 0.0 47.4 0.8 4.0 0.0 0.6 4.1 0.0 0.0 0.0 6.5 5.4 1.6 25.8 6.3 10.7 0.0 1.8 0.0 2.2 0.0 0.0 5.5 1.1 0.0 0.0 28.5 0.2 0.3 3.5 0.1 1.8 2.7 3.0 0.9 2.3 3.3 0.9 6.2 0.3 2.5 3.1 8.9 7.7 1.5 0.1 2.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.3 11.7 0.0 23.3 0.3 0.6 4.6 0.1 3.5 6.7 27.0 0.0 0.0 38.6 17.7 0.0 2.3 17.3 0.0 67.7 0.0 0.0 0.2 0.0 1.4 0.0 0.0 6.5 9.5 0.1 1.0 2.8 0.3 0.0 0.0 0.1 HMBOX1 "FLJ21616, HNF1LA, HOT1, PBHNF" ENSG00000147421 "Homeobox containing 1" Q6NT76 8 28890394-29064764 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055855, HPA058586, CAB070418" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" Yes No Nucleoplasm "Nuclear bodies, Cytosol" "CAB070418: AB_11154826, HPA055855: AB_2682945, HPA058586: AB_2683764" "unprognostic (2.68e-3)" "unprognostic (2.30e-3)" "unprognostic (4.52e-2)" "unprognostic (1.41e-1)" "unprognostic (1.85e-1)" "unprognostic (1.03e-3)" "unprognostic (1.20e-1)" "unprognostic (2.75e-3)" "unprognostic (1.49e-1)" "unprognostic (4.25e-2)" "unprognostic (1.89e-2)" "unprognostic (1.65e-1)" "unprognostic (1.51e-1)" "unprognostic (3.84e-2)" "unprognostic (2.81e-1)" "unprognostic (1.02e-1)" "unprognostic (1.47e-1)" 10.8 23.1 16.4 10.5 15.5 21.2 10.4 18.6 15.8 9.2 8.4 13.9 8.5 6.7 14.9 8.6 9.6 8.7 9.4 12.7 14.6 8.2 10.1 10.0 15.9 11.0 16.6 10.1 13.9 10.9 13.5 13.6 14.6 15.9 7.6 8.8 9.9 11.7 12.5 9.7 12.1 10.2 11.6 20.0 11.8 9.3 16.8 18.2 13.0 13.7 5.6 12.6 10.4 14.3 6.6 4.8 5.0 9.0 2.2 5.5 2.6 5.1 5.6 6.2 7.1 5.8 6.1 5.2 2.2 2.9 3.5 4.0 2.5 3.3 12.6 5.5 3.8 5.1 4.4 12.1 4.5 4.9 4.6 2.1 13.1 10.5 3.4 4.6 4.4 8.8 2.9 6.5 4.6 8.7 4.3 7.8 7.6 18.5 12.5 4.9 2.9 8.0 2.2 4.3 5.5 1.4 6.6 6.1 2.9 2.5 9.5 2.7 8.0 4.3 3.3 4.7 5.3 3.3 4.0 11.1 3.2 14.9 3.3 3.1 3.8 3.9 4.9 4.3 5.4 4.6 5.0 4.8 2.0 4.0 4.9 5.5 6.6 3.9 3.5 4.8 5.7 5.0 4.8 2.7 2.2 9.0 3.8 1.7 2.6 16.4 15.5 18.6 15.8 14.6 8.2 16.6 10.1 15.9 18.2 14.9 18.6 25.2 14.5 14.8 25.2 15.7 17.8 10.7 7.9 27.9 37.3 10.8 13.3 6.7 69.0 38.3 15.5 0.0 12.5 9.2 16.2 17.3 16.2 11.9 9.1 28.6 16.7 55.9 16.7 24.1 33.1 25.5 15.1 5.4 12.9 28.7 10.4 14.0 29.7 6.9 30.0 19.4 16.5 36.7 13.2 17.2 16.0 21.8 12.1 16.0 HMCES "C3orf37, DC12, SRAPD1" ENSG00000183624 "5-hydroxymethylcytosine binding, ES cell specific" Q96FZ2 3 129278828-129306186 "Predicted intracellular proteins" "DNA damage" "DNA-binding, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044968 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA044968: AB_2679160" "unprognostic (9.18e-3)" "unprognostic (1.11e-3)" "unprognostic (4.16e-2)" "unprognostic (2.80e-2)" "unprognostic (2.93e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (4.41e-4)" "unprognostic (1.87e-1)" "unprognostic (2.29e-1)" "unprognostic (3.00e-1)" "unprognostic (4.12e-3)" "unprognostic (6.32e-2)" "unprognostic (5.46e-2)" "unprognostic (1.71e-2)" "unprognostic (1.74e-1)" "unprognostic (1.25e-2)" "unprognostic (9.08e-3)" 16.4 10.8 15.9 29.8 23.1 15.1 15.2 19.2 22.8 13.2 16.3 9.3 18.1 13.3 13.4 11.8 19.6 12.8 13.9 27.9 13.6 16.7 13.1 24.6 12.5 42.6 14.9 18.6 14.4 7.3 62.2 11.2 10.5 14.4 12.7 14.8 12.2 13.0 13.0 24.9 16.2 13.2 15.5 10.4 14.4 11.9 17.8 9.7 36.5 14.3 14.3 57.5 12.8 15.1 33.3 14.9 32.9 19.7 13.3 24.4 15.5 33.6 15.2 17.5 20.2 21.8 9.0 15.8 11.9 9.6 17.3 13.5 23.8 15.9 65.4 12.9 10.6 13.5 24.7 22.1 25.5 20.1 13.1 11.8 13.5 12.3 16.9 9.4 11.7 10.0 8.6 13.3 14.4 14.2 8.4 10.4 14.6 13.6 57.8 9.5 44.5 16.7 10.1 11.3 24.6 9.9 15.0 15.0 11.4 18.2 20.2 17.5 10.8 26.5 16.7 16.1 11.3 28.5 11.9 8.4 8.7 15.3 20.7 15.2 32.2 19.0 65.8 10.4 9.5 9.6 14.8 13.8 32.9 17.1 14.2 17.7 19.1 20.9 20.1 13.8 33.3 20.8 22.7 27.7 13.3 19.7 14.9 24.4 15.5 15.9 23.1 19.2 22.8 13.6 16.7 14.9 18.6 14.4 9.7 29.8 24.6 19.3 61.1 51.7 17.8 29.9 35.7 14.7 10.3 21.0 9.8 34.4 31.5 32.8 6.8 25.4 21.3 23.3 41.3 29.6 19.4 28.9 21.9 24.3 17.4 25.4 20.2 17.2 6.9 7.8 22.7 20.3 55.6 19.8 13.3 37.7 25.1 17.5 29.4 15.1 10.3 12.9 33.2 68.2 65.8 38.3 29.3 37.3 28.7 50.3 HMG20A "FLJ10739, HMGX1, HMGXB1" ENSG00000140382 "High mobility group 20A" Q9NP66 15 77420412-77485607 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Late spermatids: 61.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008126 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA008126: AB_1079072" "unprognostic (2.04e-1)" "unprognostic (6.87e-2)" "unprognostic (2.88e-1)" "unprognostic (1.11e-1)" "unprognostic (2.56e-1)" "unprognostic (1.70e-1)" "unprognostic (1.38e-1)" "unprognostic (1.04e-1)" "unprognostic (1.64e-1)" "unprognostic (1.14e-1)" "unprognostic (4.61e-2)" "unprognostic (1.75e-1)" "unprognostic (9.74e-3)" "unprognostic (3.40e-1)" "unprognostic (1.58e-1)" "unprognostic (1.50e-1)" "unprognostic (2.65e-1)" 12.5 17.5 19.7 14.7 27.3 8.6 13.0 24.7 28.8 16.8 14.0 21.0 12.6 11.6 20.7 12.5 12.9 12.8 14.3 22.9 18.5 19.5 13.2 22.3 14.3 21.6 17.3 16.7 21.4 11.8 14.2 21.5 19.8 19.8 11.9 16.0 19.4 12.4 13.5 31.9 12.0 12.4 15.1 17.4 31.2 12.0 18.7 14.7 30.5 15.1 10.3 19.6 16.9 13.7 17.7 16.1 9.4 13.7 27.6 21.2 13.8 7.6 12.5 24.1 16.8 10.1 12.6 9.6 10.2 15.2 12.2 13.4 7.7 11.7 13.0 11.9 11.6 9.3 10.5 33.8 12.9 12.5 11.6 16.5 27.0 11.1 10.1 15.0 19.6 16.2 14.0 9.1 10.6 11.9 15.9 23.9 17.1 20.1 11.0 10.6 5.6 15.6 12.6 17.3 6.7 6.0 20.6 23.3 14.6 13.6 13.4 9.4 20.5 16.4 10.1 30.6 24.1 9.7 20.5 15.0 14.2 12.8 6.7 12.3 15.0 31.9 26.1 11.0 28.1 17.0 4.6 12.4 9.4 18.1 12.1 21.2 17.7 14.2 16.7 16.1 16.0 19.2 17.2 2.2 27.6 13.7 12.2 13.2 13.8 19.7 27.3 24.7 28.8 18.5 19.5 17.3 16.7 19.8 14.7 11.9 7.8 11.5 5.2 7.8 19.1 33.9 20.4 1.4 11.4 10.4 23.6 12.0 5.0 8.8 21.4 15.8 8.5 23.3 7.0 7.7 12.4 4.3 12.7 28.8 14.0 36.5 17.2 25.2 32.4 61.1 11.8 12.6 13.5 19.0 17.1 16.2 8.0 14.0 13.1 7.7 19.4 19.4 7.6 21.3 13.7 6.5 11.6 11.5 11.4 4.7 HMG20B "BRAF25, BRAF35, HMGX2, HMGXB2, SMARCE1r, SOXL" ENSG00000064961 "High mobility group 20B" Q9P0W2 19 3572777-3579088 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 228.6;Melanocytes: 217.6;Syncytiotrophoblasts: 254.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 81.6;WM-115: 84.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050220, HPA053157, HPA069832" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA050220: AB_2681056, HPA053157: AB_2682061, HPA069832: AB_2686210" "unprognostic (2.97e-1)" "unprognostic (1.84e-2)" "unprognostic (2.57e-1)" "prognostic favorable (1.72e-7)" "unprognostic (2.18e-2)" "unprognostic (1.77e-2)" "unprognostic (1.12e-1)" "unprognostic (2.97e-1)" "unprognostic (1.66e-1)" "unprognostic (4.62e-2)" "unprognostic (3.19e-2)" "unprognostic (1.43e-2)" "unprognostic (1.71e-1)" "unprognostic (1.91e-3)" "unprognostic (2.78e-2)" "unprognostic (1.84e-1)" "prognostic favorable (2.89e-5)" 22.2 19.0 14.4 19.2 17.1 18.7 22.8 7.1 15.0 23.7 24.5 18.5 28.3 20.4 27.0 22.6 26.0 20.6 28.9 17.4 16.3 8.2 25.0 23.3 17.4 13.0 20.3 9.9 19.0 21.7 19.3 9.8 35.2 14.8 33.6 12.9 18.8 36.6 23.5 12.5 25.9 24.6 22.6 14.6 18.6 24.2 19.0 16.2 44.8 29.4 14.0 25.0 24.0 24.4 18.6 32.7 31.1 35.2 27.7 22.9 24.8 18.6 8.0 7.2 17.3 9.1 8.2 13.3 12.1 8.8 11.0 8.4 2.9 6.8 10.2 11.4 8.7 10.0 9.1 4.2 8.2 6.6 9.0 9.6 5.0 26.2 7.6 5.8 6.8 24.7 7.0 9.9 6.3 4.2 11.3 11.1 9.2 8.3 17.0 7.2 25.3 12.7 12.3 8.3 16.0 16.2 8.5 12.7 13.9 8.2 12.0 4.5 13.8 16.9 29.4 81.6 7.2 22.2 18.4 15.9 5.9 13.3 20.8 10.2 16.0 8.4 7.1 15.3 17.3 84.1 19.1 34.5 31.1 21.2 33.6 18.9 18.6 18.3 22.9 32.7 15.9 19.7 18.9 19.0 27.7 35.2 29.5 19.9 24.8 14.4 17.1 7.1 15.0 16.3 8.2 20.3 9.9 14.8 16.2 26.8 17.1 34.9 44.6 62.6 3.3 5.9 22.9 17.4 19.4 17.4 9.8 97.1 77.9 53.0 20.8 36.2 53.8 0.0 39.7 228.6 45.8 57.3 38.0 17.4 72.0 7.9 64.1 27.0 24.0 36.4 34.5 48.2 217.6 123.6 117.2 30.7 48.6 54.6 42.1 56.9 17.4 32.3 56.2 38.7 15.6 69.8 254.0 28.8 59.7 56.3 HMGA1 HMGIY ENSG00000137309 "High mobility group AT-hook 1" P17096 6 34236873-34246231 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 107.3" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 784.6;Pancreatic endocrine cells: 1097.2;Urothelial cells: 1250.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB032200, HPA065612, HPA068442" Enhanced Approved Nucleoplasm,Nucleoli NA NA 18000 Nucleoplasm Nucleoli "CAB032200: AB_2117771, HPA065612: , HPA068442: " "unprognostic (1.81e-1)" "unprognostic (1.25e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (7.13e-4)" "unprognostic (1.57e-1)" "unprognostic (1.20e-3)" "prognostic unfavorable (1.29e-6)" "prognostic unfavorable (3.36e-4)" "unprognostic (8.54e-2)" "unprognostic (1.84e-2)" "prognostic unfavorable (8.71e-4)" "unprognostic (1.55e-1)" "unprognostic (8.22e-2)" "unprognostic (4.52e-3)" "unprognostic (1.19e-1)" "unprognostic (4.37e-1)" "unprognostic (2.65e-2)" 15.8 3.5 14.8 35.7 13.5 55.4 13.0 13.8 19.0 26.1 22.0 5.9 7.7 42.3 8.6 7.2 79.4 15.1 17.8 13.0 11.7 12.6 14.6 6.9 16.0 46.1 10.7 8.7 3.9 13.0 4.1 5.1 31.8 12.5 8.7 21.2 9.9 22.0 6.9 33.7 38.3 36.0 3.8 8.4 31.6 24.2 32.6 7.2 107.3 12.5 39.6 72.7 13.0 29.6 26.6 33.4 12.8 10.1 7.3 22.4 11.0 121.6 48.2 24.7 17.2 11.5 85.4 108.0 49.2 56.3 38.2 21.3 31.5 85.4 57.4 24.8 20.1 24.0 26.1 29.1 87.7 30.4 12.5 19.5 17.6 16.2 42.1 24.4 62.8 20.3 36.6 9.8 69.1 36.1 98.7 115.2 32.8 70.8 2.9 53.1 12.3 54.4 77.4 120.4 60.7 81.6 80.9 0.5 63.3 25.8 11.2 43.2 18.3 5.2 25.0 45.4 40.8 10.0 67.4 99.8 19.9 62.8 28.9 46.0 23.6 36.5 74.1 42.1 26.2 99.3 6.2 10.1 12.8 10.2 10.1 13.3 26.6 18.7 16.0 30.7 16.4 22.4 17.7 2.6 7.3 9.4 33.4 21.0 11.0 14.8 13.5 13.8 19.0 11.7 12.6 10.7 8.7 12.5 7.2 26.8 23.7 124.5 686.8 384.1 27.4 24.5 38.2 10.7 36.4 38.4 3.9 784.6 39.7 243.5 6.1 27.0 148.7 46.7 242.2 663.0 71.9 750.7 66.8 10.6 337.7 11.1 112.2 16.0 59.4 17.5 5.2 107.5 86.0 66.7 165.5 27.9 1097.2 162.4 2.5 9.0 27.8 0.0 34.9 38.5 398.0 315.9 688.1 51.7 282.8 1250.0 HMGA2 "BABL, HMGIC, LIPO" ENSG00000149948 "High mobility group AT-hook 2" P52926 12 65824131-65966295 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cell cycle, Cell division, DNA condensation, Growth regulation, Mitosis, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 25.3" "Cell type enhanced" "Detected in some" 10 "Early spermatids: 15.7;Hofbauer cells: 6.8;Late spermatids: 6.8;Pancreatic endocrine cells: 11.8;Undifferentiated cells: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 63.0;hTERT-RPE1: 46.0;SuSa: 44.3" "Not detected" "Not detected" "CAB017809, HPA039076" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "CAB017809: , HPA039076: AB_2676335" "unprognostic (2.39e-1)" "unprognostic (6.00e-2)" "unprognostic (2.08e-1)" "unprognostic (3.68e-3)" "unprognostic (5.21e-3)" "prognostic unfavorable (4.79e-4)" "unprognostic (4.05e-3)" "unprognostic (6.17e-3)" "unprognostic (6.71e-2)" "unprognostic (1.16e-1)" "unprognostic (1.54e-6)" "unprognostic (3.33e-2)" "unprognostic (4.55e-5)" "unprognostic (4.22e-2)" "unprognostic (2.53e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (2.86e-4)" 6.5 0.3 0.5 3.8 0.8 8.1 2.1 0.2 0.6 2.5 7.6 0.4 0.0 2.4 2.7 0.1 1.1 2.4 3.3 0.5 0.3 0.4 1.0 0.4 0.5 0.1 0.3 1.3 2.1 1.7 0.0 1.7 0.3 0.6 0.5 4.6 0.4 0.5 1.8 2.0 0.7 5.1 0.7 1.7 0.8 2.1 25.3 0.0 0.8 1.1 3.0 0.1 0.8 2.8 0.7 0.3 3.8 2.1 1.3 0.7 0.1 9.1 4.0 63.0 9.0 3.0 16.5 0.0 29.1 13.3 5.1 5.1 5.2 3.9 0.0 18.9 1.3 24.0 4.0 10.4 25.1 24.5 0.0 10.9 0.0 0.1 31.5 1.7 0.8 0.1 12.5 1.5 11.0 19.8 46.0 20.1 0.0 0.0 0.1 29.1 0.0 0.0 5.1 36.9 0.8 18.1 2.4 3.1 0.0 13.6 0.0 0.0 0.0 0.0 0.0 16.0 44.3 0.1 0.1 23.5 18.5 5.5 14.1 8.7 0.0 0.0 0.0 22.4 0.0 4.2 3.8 1.0 0.7 0.5 0.6 0.3 0.3 0.4 0.5 0.2 0.7 0.4 0.7 2.5 1.3 2.1 0.3 0.3 0.1 0.5 0.8 0.2 0.6 0.3 0.4 0.3 1.3 0.6 0.0 0.0 1.4 0.0 2.2 0.0 0.0 1.2 0.0 4.0 0.0 0.0 0.0 0.8 0.0 3.0 15.7 0.1 3.3 0.0 0.7 0.3 0.9 0.4 0.0 0.0 6.8 0.0 0.0 0.6 0.0 6.8 0.3 0.0 0.0 0.0 4.7 0.0 11.8 3.5 0.0 0.0 0.0 0.0 0.8 0.5 0.2 0.1 0.7 0.0 8.5 0.9 HMGB1 "DKFZp686A04236, HMG1, HMG3, SBP-1" ENSG00000189403 "High mobility group box 1" P09429 13 30456704-30617597 "Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Autophagy, Chemotaxis, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Inflammatory response, Innate immunity" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003506, CAB005873" Supported Supported Nucleoplasm "Intracellular and membrane" NA NA 2000000 Nucleoplasm "CAB005873: AB_444360, HPA003506: AB_1079070" "unprognostic (9.56e-2)" "unprognostic (1.34e-1)" "unprognostic (1.97e-2)" "unprognostic (1.07e-1)" "unprognostic (4.44e-2)" "unprognostic (4.29e-2)" "unprognostic (3.16e-2)" "unprognostic (4.33e-2)" "unprognostic (5.73e-2)" "unprognostic (1.73e-1)" "unprognostic (2.64e-2)" "unprognostic (2.30e-2)" "unprognostic (4.28e-3)" "unprognostic (5.22e-3)" "unprognostic (4.67e-1)" "unprognostic (9.13e-3)" "unprognostic (1.97e-2)" 52.0 40.0 71.2 57.0 86.8 147.8 57.6 69.6 66.1 56.0 55.0 59.6 45.1 47.6 69.7 48.8 58.5 50.2 39.4 40.3 71.2 58.7 42.4 61.1 43.6 104.8 90.3 57.3 56.1 34.5 28.4 53.3 42.7 70.6 47.5 67.3 40.0 43.0 51.7 62.6 41.2 51.6 70.3 85.8 53.8 44.8 27.1 91.2 68.8 48.9 48.3 120.9 51.0 79.5 90.8 78.1 133.2 74.8 87.6 102.9 132.3 51.7 40.1 93.3 69.6 26.2 26.1 36.7 66.1 36.0 64.0 43.4 63.5 87.2 105.3 34.5 59.8 58.9 58.0 97.5 53.3 110.6 55.3 40.9 110.6 29.2 58.2 14.3 158.7 67.6 17.2 28.4 47.5 44.2 33.4 85.5 88.4 73.3 37.9 56.4 96.1 202.3 170.6 78.5 91.5 45.0 170.5 128.5 61.9 59.9 51.4 84.5 76.4 60.6 45.1 33.7 47.0 44.2 119.3 53.0 42.9 62.2 45.9 76.6 34.3 44.2 225.8 17.6 105.2 90.0 127.3 74.8 133.2 75.5 60.7 84.2 87.9 86.6 84.5 78.1 90.8 78.6 74.9 96.4 87.6 57.4 77.3 102.9 132.3 71.2 86.8 69.6 66.1 71.2 58.7 90.3 57.3 70.6 91.2 425.8 414.0 667.0 861.1 702.7 391.2 150.7 517.2 421.6 417.5 572.3 123.7 686.8 649.9 789.1 90.9 697.7 331.0 1354.9 842.5 1201.1 600.0 601.9 525.2 664.2 641.9 185.9 406.1 530.3 511.2 73.5 666.8 690.7 639.4 489.7 477.4 551.6 916.3 480.9 626.9 664.3 236.9 640.3 823.7 170.6 1295.4 604.9 389.5 703.9 724.3 741.7 HMGB2 HMG2 ENSG00000164104 "High mobility group box 2" P26583 4 173331695-173335125 "Plasma proteins, Predicted intracellular proteins" "Chemotaxis, DNA recombination, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 95.9;bone marrow: 325.8;lymphoid tissue: 187.1" "Cell type enhanced" "Detected in all" 15 "Erythroid cells: 2616.4;Extravillous trophoblasts: 751.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 166.6;MOLT-4: 171.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003506, CAB037206, HPA053314" Enhanced Supported Nucleoplasm,Nucleoli "Intracellular and membrane" NA Yes 380000 Nucleoplasm Nucleoli "CAB037206: AB_1079071, HPA003506: AB_1079070, HPA053314: AB_2682109" "unprognostic (2.82e-1)" "unprognostic (8.52e-3)" "unprognostic (2.56e-1)" "unprognostic (8.37e-2)" "unprognostic (8.05e-2)" "unprognostic (1.21e-2)" "prognostic unfavorable (3.76e-5)" "unprognostic (2.12e-1)" "prognostic unfavorable (3.13e-4)" "unprognostic (4.41e-2)" "prognostic unfavorable (7.04e-4)" "unprognostic (9.65e-2)" "prognostic unfavorable (7.60e-12)" "unprognostic (1.60e-2)" "unprognostic (2.83e-2)" "unprognostic (2.68e-2)" "unprognostic (1.21e-2)" 18.8 5.9 10.3 48.9 13.2 325.8 19.9 6.6 9.5 17.1 24.0 8.6 7.9 15.7 18.6 16.2 28.6 15.4 13.8 23.4 9.5 10.2 13.2 6.9 25.4 59.8 12.5 8.2 29.0 5.8 2.9 8.0 18.5 9.3 19.0 21.2 12.2 13.8 8.6 46.2 15.5 21.5 25.3 13.3 36.7 13.0 26.7 10.6 187.1 18.7 23.0 61.6 27.1 18.5 11.6 16.8 95.9 20.5 11.9 39.9 14.3 34.9 8.4 72.2 32.2 9.0 9.0 27.7 26.1 19.9 28.8 25.8 23.7 48.8 118.3 5.9 14.5 15.4 13.7 47.3 14.2 45.0 72.4 22.1 130.0 21.2 34.7 8.8 115.0 50.2 8.7 4.3 14.4 32.8 15.7 29.5 62.9 49.0 166.6 26.3 29.2 171.4 106.6 26.3 20.9 14.6 86.7 37.1 43.9 16.5 15.0 62.5 56.4 26.3 15.3 11.7 26.4 21.2 83.9 16.9 12.9 38.3 15.9 39.1 53.9 30.1 135.4 11.0 84.1 33.6 95.9 20.5 57.6 15.6 8.5 14.1 11.6 22.7 21.2 16.8 8.8 15.0 14.3 47.8 11.9 6.8 6.8 39.9 14.3 10.3 13.2 6.6 9.5 9.5 10.2 12.5 8.2 9.3 10.6 26.8 58.1 117.6 176.4 141.0 43.0 211.0 35.7 147.2 66.0 52.4 33.4 154.7 121.0 20.6 24.5 124.1 53.3 2616.4 14.4 751.8 109.8 81.7 104.4 22.2 176.6 42.9 71.7 149.1 275.5 29.5 97.5 149.6 64.1 109.2 104.0 79.8 10.0 83.9 54.1 36.3 129.5 77.6 96.6 461.9 435.2 117.1 107.7 264.5 185.0 64.8 HMGB3 "HMG2A, HMG4, MGC90319" ENSG00000029993 "High mobility group box 3" O15347 X 150980509-150990775 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" DNA-binding Microphthalmia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 54.3" "Cell type enhanced" "Detected in many" 15 "Cytotrophoblasts: 337.0;Extravillous trophoblasts: 539.5;Syncytiotrophoblasts: 1171.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HBEC3-KT: 108.8;U-698: 98.0" HPA062583 Enhanced Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA062583: AB_2684800" "unprognostic (2.85e-3)" "unprognostic (2.82e-2)" "unprognostic (2.16e-1)" "unprognostic (1.08e-2)" "unprognostic (1.16e-1)" "unprognostic (4.60e-2)" "unprognostic (2.66e-3)" "unprognostic (4.54e-3)" "unprognostic (2.70e-2)" "prognostic favorable (9.85e-5)" "unprognostic (6.03e-2)" "unprognostic (1.96e-2)" "prognostic favorable (6.15e-4)" "unprognostic (2.58e-2)" "unprognostic (9.29e-2)" "unprognostic (1.41e-1)" "unprognostic (1.11e-1)" 4.4 5.4 7.9 4.8 7.1 20.3 4.1 2.8 10.3 10.8 12.0 4.7 3.9 7.3 6.3 13.4 10.2 4.4 3.2 4.5 9.8 7.6 9.0 41.6 5.9 6.3 6.1 7.3 3.1 7.1 18.7 1.6 54.3 9.7 3.7 9.2 5.3 9.7 4.3 20.5 6.8 7.6 3.6 5.0 8.4 4.0 26.0 3.2 18.2 6.2 5.1 9.5 4.9 3.7 3.1 6.5 11.8 5.3 0.9 6.2 2.3 37.7 16.7 52.8 27.5 2.2 6.6 65.8 16.6 10.9 19.3 10.0 13.2 15.7 26.5 53.5 12.7 10.9 18.2 48.1 108.8 21.8 18.0 14.0 23.0 16.2 20.8 3.3 34.6 11.7 5.2 25.8 7.9 20.0 4.9 24.9 16.3 11.9 15.7 22.9 29.0 38.1 26.6 31.3 24.8 20.5 46.8 43.0 15.0 14.2 18.1 38.1 24.9 24.7 26.6 8.2 31.5 23.5 22.9 18.7 8.0 19.0 25.5 36.5 14.3 17.8 98.0 9.6 17.7 16.3 0.0 4.8 11.8 0.5 3.2 0.1 3.1 2.4 3.3 6.5 0.6 0.0 0.2 0.6 0.9 5.3 3.3 6.2 2.3 7.9 7.1 2.8 10.3 9.8 7.6 6.1 7.3 9.7 3.2 35.7 27.4 16.2 16.0 21.1 0.5 13.2 10.2 145.9 134.2 29.6 2.0 337.0 31.5 72.8 184.3 11.3 24.9 186.9 75.5 539.5 20.8 18.7 8.1 72.9 88.3 0.0 63.0 10.4 18.3 46.6 3.4 26.0 20.3 35.1 29.3 3.1 76.6 25.9 3.2 39.4 1.4 0.0 8.3 19.9 49.6 17.8 1171.0 14.0 52.8 17.0 HMGCS1 HMGCS ENSG00000112972 "3-hydroxy-3-methylglutaryl-CoA synthase 1" Q01581 5 43289395-43313512 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 117.0" "Cell type enhanced" "Detected in many" 5 "Suprabasal keratinocytes: 206.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "AF22: 120.5;GAMG: 80.3;HBEC3-KT: 69.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032907, HPA036913, HPA036914" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" No No 310000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB032907: AB_2118319, HPA036913: AB_2675380, HPA036914: AB_10671751" "unprognostic (1.31e-1)" "unprognostic (5.12e-3)" "unprognostic (6.82e-3)" "unprognostic (4.59e-2)" "unprognostic (8.39e-2)" "unprognostic (2.49e-2)" "unprognostic (1.03e-1)" "unprognostic (3.14e-2)" "unprognostic (1.27e-2)" "unprognostic (3.13e-1)" "unprognostic (6.40e-3)" "unprognostic (9.15e-2)" "prognostic favorable (3.87e-6)" "unprognostic (1.09e-1)" "unprognostic (9.22e-2)" "unprognostic (3.03e-2)" "unprognostic (2.37e-2)" 6.0 16.5 13.3 8.1 24.4 4.3 12.8 8.4 38.2 16.9 15.5 16.9 9.5 27.8 6.8 11.5 53.0 4.1 7.5 5.1 19.4 18.8 10.5 117.0 26.9 6.2 10.4 20.7 15.4 8.4 10.8 5.0 6.9 59.3 12.9 14.2 13.0 18.5 7.7 5.0 25.2 17.1 6.3 25.8 4.4 13.4 9.8 8.1 3.3 7.5 58.1 23.3 6.1 21.4 9.3 7.8 6.9 7.7 6.7 7.9 3.3 14.9 7.2 120.5 13.8 7.0 27.9 8.1 2.4 9.5 3.4 6.9 12.5 21.6 15.9 5.4 3.4 80.3 11.8 30.0 69.5 3.6 3.4 36.0 5.9 6.6 16.9 11.1 12.8 4.2 15.3 8.4 18.1 7.2 2.1 3.5 14.8 10.5 43.5 2.8 6.9 11.5 15.6 21.6 6.0 3.8 8.3 16.9 17.6 53.4 23.2 10.3 5.0 12.3 6.2 3.6 18.2 9.6 17.0 4.2 2.6 13.0 2.7 2.2 5.9 8.9 21.7 2.3 15.4 2.3 5.5 4.0 3.7 5.6 7.4 5.6 9.3 6.2 7.9 7.8 7.5 5.3 7.3 6.9 6.7 7.7 6.5 5.7 3.3 13.3 24.4 8.4 32.1 19.4 18.8 10.4 20.7 59.3 8.1 62.5 124.5 45.6 35.9 96.3 27.9 7.4 56.0 48.2 36.4 45.4 49.1 20.4 11.6 30.6 5.0 19.7 86.8 0.0 52.0 35.5 35.0 65.2 59.8 78.4 20.7 46.1 88.4 23.4 20.8 1.8 11.8 17.2 25.3 78.5 44.0 19.7 36.3 30.9 13.4 17.7 43.3 0.0 24.9 14.1 7.8 206.6 37.2 20.1 31.2 65.0 HMGN1 "FLJ27265, FLJ31471, HMG14, MGC104230, MGC117425" ENSG00000205581 "High mobility group nucleosome binding domain 1" P05114 21 39342315-39349647 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Rod photoreceptor cells: 1229.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012260, HPA048694" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB012260: AB_304786, HPA048694: AB_2680496" "unprognostic (4.49e-2)" "unprognostic (5.52e-2)" "unprognostic (4.85e-2)" "unprognostic (6.28e-2)" "unprognostic (2.20e-1)" "unprognostic (5.21e-3)" "unprognostic (8.50e-3)" "unprognostic (1.32e-1)" "unprognostic (2.46e-3)" "unprognostic (5.68e-2)" "unprognostic (3.02e-2)" "unprognostic (5.24e-2)" "prognostic unfavorable (8.74e-7)" "unprognostic (3.20e-1)" "unprognostic (3.72e-2)" "unprognostic (3.84e-2)" "unprognostic (8.98e-3)" 16.8 24.5 18.1 56.3 18.0 37.4 27.0 11.1 21.3 27.3 28.5 14.4 30.6 26.3 21.4 38.9 46.4 21.3 28.2 25.5 17.0 17.5 33.0 30.4 42.3 76.6 15.8 13.6 28.7 44.1 26.9 29.1 30.9 19.1 27.7 28.9 36.4 37.1 27.1 10.1 25.6 32.0 27.4 23.4 41.7 26.0 42.5 15.9 58.5 31.2 24.4 63.1 23.3 26.7 46.9 60.2 55.0 16.5 33.8 43.9 42.2 52.7 12.4 44.5 29.5 8.1 15.8 31.3 27.9 19.8 27.2 25.1 23.3 42.8 117.2 26.7 25.4 32.7 11.2 32.6 39.2 36.2 48.1 34.7 90.1 18.5 29.9 21.1 79.6 31.3 17.5 37.2 27.2 33.4 22.5 41.8 50.5 70.6 20.2 43.5 64.5 78.6 67.8 83.1 69.7 25.6 85.6 24.3 46.2 45.6 24.6 41.5 36.5 60.9 36.3 31.7 20.4 48.6 79.8 24.8 13.3 13.9 10.4 28.1 24.9 39.6 72.7 18.9 85.8 35.3 14.6 16.5 55.0 30.1 14.0 33.6 46.9 38.6 31.3 45.3 41.6 43.6 38.0 11.0 33.8 12.9 60.2 43.9 42.2 18.1 18.0 11.1 21.3 17.0 17.5 15.8 13.6 19.1 15.9 86.4 145.9 405.1 420.9 247.4 248.1 51.9 242.0 123.1 138.8 270.4 312.2 505.6 625.1 409.9 439.9 204.9 244.5 70.0 307.2 777.0 197.4 519.9 214.8 146.7 471.8 227.2 331.4 117.2 150.3 120.6 162.8 266.2 231.2 589.7 353.2 267.5 330.8 252.6 188.1 435.0 1229.1 32.3 110.2 66.2 129.4 274.3 503.6 343.9 504.7 585.4 HMGN2 HMG17 ENSG00000198830 "High mobility group nucleosomal binding domain 2" P05204 1 26472450-26475972 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB018371, HPA077364" Supported Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "CAB018371: , HPA077364: AB_2686835" "unprognostic (3.10e-2)" "unprognostic (6.88e-2)" "unprognostic (3.10e-3)" "unprognostic (4.13e-2)" "unprognostic (4.06e-1)" "unprognostic (2.27e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (2.36e-1)" "unprognostic (2.44e-3)" "unprognostic (2.86e-2)" "unprognostic (1.05e-3)" "unprognostic (5.23e-3)" "prognostic unfavorable (3.92e-4)" "unprognostic (3.00e-2)" "unprognostic (2.54e-1)" "unprognostic (8.21e-2)" "unprognostic (1.15e-1)" 30.6 34.9 36.0 52.4 32.3 169.1 37.6 30.8 39.1 51.3 43.4 30.3 53.6 30.0 46.1 60.6 44.1 50.1 51.6 37.6 30.5 32.0 35.9 37.1 62.9 100.2 32.7 30.5 64.7 59.4 16.7 52.7 49.6 26.0 48.0 49.9 42.5 58.9 51.9 41.1 33.9 41.3 68.1 40.4 50.0 33.2 29.9 31.1 104.6 48.6 52.5 83.2 43.7 38.7 60.4 81.4 157.4 73.6 38.6 83.4 103.5 83.3 28.9 83.9 35.2 7.8 18.1 32.8 41.3 23.8 80.9 62.5 29.8 78.2 93.9 39.5 33.6 23.6 48.2 105.8 41.0 68.9 57.8 74.9 100.8 34.3 29.1 14.7 213.4 58.9 19.0 21.6 44.2 26.2 16.9 37.6 62.7 79.7 45.1 42.4 61.6 152.1 97.0 70.3 96.0 53.8 105.9 131.8 57.5 25.4 22.9 83.7 51.9 124.1 34.9 45.7 21.8 57.2 101.2 27.9 40.4 75.5 77.3 68.8 55.2 74.8 104.6 25.9 224.6 80.0 30.3 59.9 157.4 34.2 69.0 32.0 60.4 46.8 41.4 60.9 59.1 51.5 41.7 53.1 38.6 73.6 81.4 83.4 103.5 36.0 32.3 30.8 39.1 30.5 32.0 32.7 30.5 26.0 31.1 318.6 348.4 323.5 270.1 256.3 146.9 79.2 191.1 714.7 343.5 247.7 133.5 686.4 315.0 197.4 143.3 140.8 163.3 537.3 235.1 491.1 459.0 285.8 361.7 123.4 660.0 89.0 554.4 172.5 336.2 26.8 172.0 473.8 215.9 762.9 372.7 230.4 94.5 305.1 142.8 214.8 300.1 122.9 297.7 273.8 419.4 186.6 772.2 318.1 517.4 227.4 HMGN3 TRIP7 ENSG00000118418 "High mobility group nucleosomal binding domain 3" Q15651 6 79201245-79234738 "Predicted intracellular proteins" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018370, HPA027971, HPA063572" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB018370: , HPA027971: AB_1850808, HPA063572: AB_2732703" "unprognostic (1.02e-1)" "unprognostic (2.04e-2)" "unprognostic (5.92e-2)" "unprognostic (5.26e-2)" "unprognostic (3.48e-1)" "unprognostic (3.88e-2)" "unprognostic (5.24e-2)" "prognostic favorable (2.76e-4)" "unprognostic (8.78e-2)" "unprognostic (5.31e-3)" "unprognostic (1.47e-3)" "unprognostic (5.81e-2)" "prognostic unfavorable (1.02e-7)" "unprognostic (1.70e-2)" "unprognostic (1.09e-1)" "unprognostic (2.69e-1)" "unprognostic (6.43e-3)" 26.6 57.2 53.6 22.9 52.7 18.8 37.2 73.1 84.6 26.1 28.3 22.6 28.4 27.7 29.9 55.4 29.0 66.8 26.4 68.6 53.3 33.4 52.5 44.6 34.4 35.5 70.8 36.1 34.9 27.8 38.7 66.8 35.4 53.0 27.4 23.5 28.0 47.4 30.6 41.8 24.8 22.3 33.0 53.2 27.7 31.0 24.8 63.5 21.9 36.1 37.9 32.8 26.1 25.6 28.0 52.3 7.7 38.3 32.8 29.4 36.4 14.3 13.1 45.9 19.8 18.5 15.2 10.4 10.0 10.8 11.2 16.5 73.2 12.2 0.1 18.6 8.1 15.0 9.2 29.8 11.3 11.1 42.3 25.0 50.7 41.0 38.1 11.8 41.4 7.7 18.4 12.7 7.4 4.1 10.9 25.0 10.8 29.6 40.6 18.1 13.1 19.0 80.1 33.6 12.5 32.9 32.6 70.1 14.7 77.1 21.0 18.7 25.1 19.1 22.0 14.1 42.2 12.5 70.0 10.9 3.1 13.7 10.8 22.1 35.0 51.6 0.2 1.7 0.1 15.0 7.7 38.3 3.2 29.4 36.2 25.5 28.0 20.6 24.6 44.8 23.2 24.3 29.2 1.8 32.8 33.3 52.3 21.9 36.4 53.6 52.7 73.1 84.6 53.3 33.4 70.8 36.1 53.0 63.5 89.3 143.6 96.0 158.6 151.9 231.2 376.3 186.0 619.7 254.8 230.3 70.7 769.9 510.6 171.3 36.2 149.3 30.7 0.0 172.6 615.0 191.6 116.6 106.3 217.9 268.2 184.3 262.2 186.6 174.4 27.1 173.2 154.2 244.6 542.8 88.7 204.1 113.5 63.1 157.0 607.4 113.5 142.3 169.0 21.1 50.0 131.0 464.4 124.6 105.7 145.7 HMGN4 "HMG17L3, NHC" ENSG00000182952 "High mobility group nucleosomal binding domain 4" O00479 6 26538405-26546254 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077364 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA077364: AB_2686835" "unprognostic (1.91e-1)" "unprognostic (2.48e-2)" "unprognostic (5.88e-2)" "unprognostic (8.81e-2)" "unprognostic (4.10e-2)" "unprognostic (6.02e-2)" "unprognostic (4.00e-3)" "unprognostic (1.96e-1)" "unprognostic (1.78e-1)" "unprognostic (3.22e-1)" "unprognostic (7.81e-3)" "unprognostic (2.09e-1)" "unprognostic (3.06e-2)" "unprognostic (1.64e-1)" "unprognostic (8.02e-3)" "unprognostic (9.01e-2)" "unprognostic (6.07e-3)" 26.3 26.8 16.8 28.9 20.8 16.6 32.0 21.8 26.5 29.0 34.0 16.2 27.5 21.1 42.0 31.7 28.1 32.0 28.6 29.4 14.3 18.2 31.0 10.7 25.5 50.3 15.5 18.3 33.0 24.1 24.4 18.5 23.7 15.9 35.3 31.4 21.1 24.7 36.6 30.8 21.0 32.7 45.3 16.7 33.2 23.1 26.8 15.6 38.2 36.2 24.0 38.1 35.1 34.4 31.8 25.9 57.0 22.1 30.6 39.7 37.7 23.3 9.7 17.2 23.2 23.6 35.9 11.7 20.6 35.1 31.5 42.9 9.2 14.9 28.5 31.4 29.0 29.8 11.1 30.4 25.9 34.6 35.2 28.1 30.0 13.5 16.9 25.9 24.4 30.4 27.0 35.1 24.8 40.7 26.1 29.1 34.8 27.0 46.6 27.9 12.2 40.5 27.7 10.4 18.6 15.9 15.0 20.8 48.6 22.1 16.7 28.9 25.4 17.6 13.4 38.1 21.2 14.7 11.7 22.1 21.4 15.7 19.2 17.5 29.6 79.7 24.5 10.1 56.4 27.3 57.0 19.1 34.9 39.2 18.0 37.5 31.8 39.7 39.6 25.9 27.3 33.6 32.1 28.3 30.6 22.1 20.8 39.4 37.7 16.8 20.8 21.8 26.5 14.3 18.2 15.5 18.3 15.9 15.6 3.0 4.3 10.9 3.3 6.6 0.2 1.2 10.2 1.4 12.5 1.8 0.0 3.0 5.0 1.6 0.3 2.2 2.6 0.0 1.2 8.5 3.7 1.8 8.1 1.0 3.8 0.0 0.0 3.7 3.2 0.0 1.4 9.2 8.5 8.2 1.5 1.9 1.9 1.7 2.5 6.1 0.2 0.0 3.1 0.2 1.1 4.4 6.8 8.5 1.2 1.7 HMGN5 NSBP1 ENSG00000198157 "High mobility group nucleosome binding domain 5" P82970 X 81113701-81201942 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 48.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 45.0;Karpas-707: 66.4" "Low region specificity" "Detected in all" "HPA000511, HPA076238" Approved Supported Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA000511: AB_1079505, HPA076238: " "unprognostic (1.49e-2)" "unprognostic (1.44e-1)" "unprognostic (3.72e-2)" "unprognostic (1.55e-1)" "unprognostic (1.07e-1)" "unprognostic (3.98e-2)" "unprognostic (1.08e-1)" "unprognostic (1.96e-1)" "unprognostic (9.63e-3)" "prognostic favorable (6.60e-4)" "unprognostic (2.78e-3)" "unprognostic (1.16e-1)" "unprognostic (2.32e-3)" "unprognostic (3.06e-2)" "unprognostic (1.07e-1)" "unprognostic (6.53e-2)" "unprognostic (1.08e-1)" 5.2 11.4 14.7 3.1 15.6 12.5 6.5 6.0 12.0 8.6 10.6 5.1 12.3 10.2 7.7 30.9 9.8 7.5 4.8 5.4 16.1 14.3 16.2 9.9 3.9 2.0 13.2 10.1 9.5 5.6 11.9 39.8 2.0 10.4 7.0 7.9 3.5 5.6 9.3 3.6 5.2 10.8 7.3 22.1 8.2 5.9 48.6 19.6 10.9 8.1 8.6 2.7 7.8 6.0 6.5 11.0 2.8 3.1 3.4 10.2 3.4 0.2 2.2 5.9 28.8 5.0 1.6 1.2 1.6 2.5 0.4 0.7 0.7 10.9 45.0 5.1 0.7 0.4 1.9 34.8 4.1 1.1 26.3 13.9 18.8 21.2 0.3 0.5 31.2 18.6 1.3 1.1 1.8 1.7 1.6 2.3 29.0 24.8 66.4 2.9 1.0 28.4 11.1 26.2 6.3 7.6 1.1 24.6 21.2 7.1 0.8 0.2 0.7 0.2 0.6 1.9 5.3 3.6 7.4 2.6 0.9 7.7 4.5 6.1 4.6 1.9 7.2 2.8 12.3 1.6 2.0 3.1 1.4 8.5 1.6 7.7 3.6 5.2 4.6 5.3 6.5 10.2 8.7 2.8 3.4 2.5 11.0 1.7 3.4 14.7 15.6 6.0 12.0 16.1 14.3 13.2 10.1 10.4 19.6 8.9 13.1 10.4 21.3 14.2 2.8 11.3 17.8 72.3 14.8 43.6 0.0 0.5 58.0 9.9 14.1 16.1 17.1 70.0 16.2 0.4 10.2 18.1 12.7 74.1 13.2 1.6 16.7 19.0 13.3 43.8 27.3 13.9 8.5 1.0 22.4 20.4 6.7 17.5 38.5 60.3 1.5 45.3 19.4 7.2 8.4 13.0 0.3 7.5 39.1 17.4 HMGXB4 "HMG2L1, THC211630" ENSG00000100281 "HMG-box containing 4" Q9UGU5 22 35257452-35295807 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Wnt signaling pathway" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000725, HPA076681" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA000725: AB_1079073, HPA076681: " "unprognostic (2.22e-1)" "unprognostic (1.12e-1)" "prognostic favorable (3.24e-5)" "unprognostic (4.81e-2)" "unprognostic (1.93e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (4.79e-4)" "unprognostic (2.85e-2)" "unprognostic (8.25e-3)" "unprognostic (6.67e-3)" "prognostic unfavorable (1.16e-4)" "unprognostic (1.62e-1)" "unprognostic (8.71e-3)" "unprognostic (1.13e-1)" "unprognostic (1.98e-1)" "unprognostic (1.20e-1)" "unprognostic (8.54e-2)" 13.6 11.6 11.4 11.4 17.6 28.6 13.6 17.4 15.1 14.4 10.9 17.2 9.5 10.6 17.4 8.4 14.4 14.5 10.8 9.8 10.0 8.6 8.6 8.0 10.2 10.5 14.4 13.8 21.7 10.9 9.4 7.6 20.2 12.4 12.4 12.2 8.7 11.9 12.7 17.2 14.4 13.1 15.0 12.6 10.0 10.3 12.1 16.9 20.0 10.6 10.2 11.6 14.8 13.5 11.8 9.4 22.6 12.5 7.4 13.1 4.7 13.1 2.9 20.6 10.3 5.0 9.9 5.9 13.7 18.0 13.4 12.5 2.2 4.9 15.8 6.1 13.5 8.5 8.1 8.9 9.6 15.6 13.8 10.0 14.5 3.9 2.9 6.8 30.4 14.8 9.0 8.4 11.2 8.6 8.1 9.2 12.1 11.3 13.1 9.9 6.0 18.3 7.3 9.5 9.1 8.8 14.7 19.4 5.5 7.5 9.7 13.0 12.8 12.2 8.9 9.8 6.8 6.1 9.5 8.5 12.2 27.0 14.1 11.2 14.1 13.7 19.7 10.3 9.3 17.3 22.6 11.1 13.8 12.6 12.5 10.8 8.9 12.1 13.1 8.8 11.8 8.1 9.2 16.8 7.4 11.5 9.4 10.1 4.7 11.4 17.6 17.4 15.1 10.0 8.6 14.4 13.8 12.4 16.9 11.9 14.4 20.9 45.0 18.5 60.2 11.2 38.2 10.7 25.0 26.2 33.4 42.1 24.9 34.2 7.5 26.4 25.5 23.3 25.8 44.6 29.1 49.7 52.9 21.9 26.9 63.5 16.3 35.6 29.7 7.7 49.8 31.0 8.5 24.4 24.8 21.2 29.9 24.5 53.4 18.1 66.1 38.8 27.8 50.4 77.1 19.7 54.1 24.1 26.6 46.9 HMX3 NKX5-1 ENSG00000188620 "H6 family homeobox 3" A6NHT5 10 123135962-123137741 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.8;intestine: 5.7" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in some" 11 "hypothalamus: 6.8;pons and medulla: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 3.5;HEL: 5.6;HeLa: 5.1;K-562: 18.3;NB-4: 6.3;SiHa: 5.1" "Region enhanced" "Detected in single" "hypothalamus: 1.3" "Group enriched" "Detected in many" 5 "basal ganglia: 2.3;hypothalamus: 8.0" HPA069659 Approved "Nucleoplasm,Centriolar satellite" Yes No Nucleoplasm "Centriolar satellite" "HPA069659: AB_2686165" "unprognostic (1.79e-1)" "unprognostic (9.65e-2)" "unprognostic (6.07e-2)" 1.9 0.1 0.0 1.5 0.1 0.0 0.0 0.0 0.4 0.1 3.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.8 0.9 0.0 0.4 0.2 0.0 0.0 0.9 0.7 0.0 1.3 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 2.0 0.0 0.0 0.8 0.7 5.6 5.1 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 18.3 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.1 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 6.8 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HNF1A "HNF1, LFB1, MODY3, TCF1" ENSG00000135100 "HNF1 homeobox A" 12 120978543-121002512 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 24.2;kidney: 17.2;liver: 15.6" "Cell type enhanced" "Detected in some" 8 "Enterocytes: 16.0;Hepatocytes: 13.9;Paneth cells: 14.4;Proximal tubular cells: 13.2;Undifferentiated cells: 8.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "A549: 6.2;CACO-2: 20.5;Hep G2: 22.4;OE19: 10.7" "Not detected" "Not detected" "Not detected" "Not detected" "CAB010430, HPA035231" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB010430: AB_2116746, HPA035231: AB_2674528" "unprognostic (5.92e-3)" "unprognostic (8.47e-2)" "unprognostic (4.12e-3)" "unprognostic (6.18e-3)" "unprognostic (3.72e-1)" "unprognostic (1.27e-2)" "unprognostic (9.18e-2)" "unprognostic (9.18e-2)" "unprognostic (2.99e-1)" "unprognostic (2.01e-1)" "unprognostic (9.77e-3)" "unprognostic (5.21e-2)" "unprognostic (6.25e-3)" "unprognostic (5.55e-2)" "unprognostic (2.48e-1)" "unprognostic (6.93e-3)" 0.1 0.0 0.1 0.8 0.1 0.0 0.1 0.1 0.1 0.1 17.3 0.1 0.1 13.7 0.1 1.5 0.1 0.8 5.1 0.1 0.1 0.0 17.2 15.6 0.1 0.1 0.1 0.1 0.2 6.3 0.0 0.1 0.1 0.1 0.1 2.1 0.1 0.1 0.1 0.1 0.0 24.2 0.5 0.1 0.1 3.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.5 1.8 0.3 0.3 0.4 0.2 0.0 6.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 20.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 0.2 0.2 0.3 0.2 0.3 0.4 0.4 0.1 0.5 0.4 0.4 1.6 0.3 0.3 0.5 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.1 0.6 0.8 2.5 0.0 0.0 1.8 0.0 0.0 0.0 2.3 0.0 0.0 16.0 0.0 4.6 0.1 0.0 0.4 0.0 13.9 0.1 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 6.7 0.5 3.2 14.4 0.0 13.2 0.2 0.0 0.1 0.1 0.0 0.3 0.0 0.0 8.9 0.2 HNF1B "HNF1beta, LFB3, MODY5, TCF2, VHNF1" ENSG00000275410 "HNF1 homeobox B" P35680 17 37686432-37745247 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "gallbladder: 34.7;kidney: 66.2;pancreas: 18.6" "Cell type enhanced" "Detected in many" 9 "Cholangiocytes: 73.9;Collecting duct cells: 54.1;Distal tubular cells: 38.1;Ductal cells: 37.2" "Cancer enhanced" "Detected in many" "renal cancer: 32.5" "Cell type enriched" "Detected in single" 5 "memory B-cell: 1.0" "Lineage enriched" "Detected in single" 5 "B-cells: 1.0" "Cell line enriched" "Detected in some" 5 "RPTEC TERT1: 53.3" "Group enriched" "Detected in some" 5 "basal ganglia: 0.7;hypothalamus: 2.3" "Not detected" "Not detected" "HPA002083, CAB068192" Enhanced Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB068192: AB_2665649, HPA002083: AB_1080232" "unprognostic (2.52e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-2)" "unprognostic (5.29e-3)" "unprognostic (5.29e-2)" "unprognostic (3.00e-2)" "unprognostic (1.58e-2)" "unprognostic (1.31e-1)" "unprognostic (1.29e-1)" "unprognostic (1.51e-1)" "unprognostic (1.71e-2)" "unprognostic (2.33e-1)" "prognostic favorable (6.00e-4)" "unprognostic (7.06e-2)" "unprognostic (2.26e-1)" "unprognostic (7.49e-2)" "prognostic favorable (2.51e-6)" 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 1.1 4.5 0.0 4.8 3.8 0.9 7.8 0.0 2.8 34.7 0.0 0.0 66.2 7.7 3.7 0.0 0.0 0.0 0.8 18.6 1.6 0.0 0.6 0.0 1.6 3.4 0.0 0.0 3.8 0.0 0.0 5.5 0.3 0.0 0.0 3.7 1.0 0.0 0.0 0.0 0.0 0.0 1.0 0.6 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.8 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 53.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.9 10.2 0.0 2.2 0.0 0.0 0.6 73.9 5.3 3.4 54.1 0.0 0.0 38.1 37.2 26.8 0.0 10.9 0.0 22.1 0.0 0.0 1.8 5.7 4.0 0.1 0.0 13.8 0.0 0.3 7.4 0.6 0.0 0.0 1.8 11.4 0.0 25.3 7.0 0.0 31.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 19.4 2.7 HNF4A "HNF4, MODY, MODY1, NR2A1, TCF14" ENSG00000101076 "Hepatocyte nuclear factor 4 alpha" P41235 20 44355700-44434596 "Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 65.5;kidney: 30.5;liver: 57.3" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 146.5;Hepatocytes: 160.5;Paneth cells: 94.8;Proximal tubular cells: 115.9;Undifferentiated cells: 91.6" "Cancer enhanced" "Detected in many" "colorectal cancer: 48.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "CACO-2: 52.3;Hep G2: 38.5;OE19: 14.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004712, CAB019417" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB019417: AB_2295208, HPA004712: AB_1079075" "unprognostic (2.47e-1)" "unprognostic (3.08e-1)" "unprognostic (2.34e-1)" "unprognostic (2.29e-1)" "unprognostic (8.54e-2)" "unprognostic (1.56e-2)" "unprognostic (6.90e-2)" "unprognostic (4.79e-3)" "unprognostic (2.59e-2)" "unprognostic (3.77e-2)" "unprognostic (2.45e-2)" "unprognostic (1.05e-1)" "unprognostic (2.75e-2)" "unprognostic (8.40e-3)" "unprognostic (2.12e-1)" "unprognostic (2.70e-2)" 0.2 0.2 0.2 13.4 0.2 0.0 0.2 0.2 0.3 0.2 54.0 0.2 0.1 33.0 0.2 6.2 0.2 0.4 15.7 0.2 0.2 0.2 30.5 57.3 0.3 0.1 0.2 0.1 0.3 22.7 0.0 0.2 0.1 0.2 0.2 14.4 0.2 0.2 0.1 0.2 0.2 65.5 0.3 0.2 0.2 7.1 0.4 0.1 0.1 0.2 0.1 0.1 0.2 0.4 0.4 0.6 1.2 0.8 0.8 0.4 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 52.3 2.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 38.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 14.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.4 0.4 0.4 0.7 0.8 0.8 0.6 0.3 0.0 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.1 0.2 0.1 0.0 0.0 0.5 0.3 0.0 0.0 1.1 43.3 0.0 0.0 12.2 0.0 0.0 13.3 6.8 3.1 0.0 146.5 0.0 19.4 0.0 0.0 0.3 4.6 160.5 0.0 0.0 34.4 3.7 5.1 16.4 0.3 0.0 0.0 1.8 62.7 0.0 17.5 94.8 0.4 115.9 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 91.6 0.1 HNF4G NR2A2 ENSG00000164749 "Hepatocyte nuclear factor 4 gamma" Q14541 8 75407914-75566843 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 139.6" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 53.6;Mucus-secreting cells: 31.7;Paneth cells: 41.9;Undifferentiated cells: 25.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "gdT-cell: 1.3" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "A549: 4.5;CAPAN-2: 16.8;Karpas-707: 4.7;OE19: 10.3;PC-3: 5.1;THP-1: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA005438, HPA010610" Enhanced Enhanced "Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol" NA NA Nucleoplasm "Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA005438: AB_1850822, HPA010610: AB_2668318" "unprognostic (2.09e-1)" "unprognostic (2.90e-1)" "unprognostic (1.77e-2)" "unprognostic (9.44e-2)" "unprognostic (5.60e-2)" "unprognostic (4.65e-2)" "unprognostic (5.26e-2)" "unprognostic (1.27e-2)" "unprognostic (3.92e-1)" "unprognostic (8.09e-2)" "unprognostic (3.68e-2)" "unprognostic (1.83e-2)" "unprognostic (6.93e-3)" "unprognostic (1.67e-2)" "unprognostic (2.11e-1)" "unprognostic (4.22e-2)" "unprognostic (2.47e-2)" 0.2 0.2 0.5 5.0 0.5 0.0 0.3 0.3 0.3 0.6 56.2 0.1 0.3 35.9 0.4 1.1 0.4 0.3 12.6 0.2 0.3 0.3 6.1 12.1 0.4 0.0 0.4 0.2 0.2 10.9 0.0 0.2 0.0 0.3 0.6 6.9 0.2 0.4 0.6 0.2 0.2 139.6 0.2 0.3 0.2 2.6 0.9 0.1 0.1 0.2 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.1 4.5 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.3 16.8 0.0 2.4 0.0 2.0 0.0 2.1 0.0 0.0 0.0 1.9 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.5 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.3 0.3 10.3 5.1 0.0 0.0 0.3 2.9 0.1 0.3 1.7 0.3 0.1 0.0 0.2 0.3 5.6 0.0 0.3 0.1 0.1 0.0 1.2 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.3 0.3 0.3 0.3 0.4 0.2 0.3 0.1 0.0 0.6 0.5 0.6 0.0 0.0 0.2 17.8 9.4 1.2 3.5 0.0 0.0 5.0 2.2 1.7 0.0 53.6 0.0 3.7 0.0 0.0 1.1 0.0 9.0 0.0 0.0 15.6 0.0 0.0 4.5 0.0 0.0 0.0 0.0 31.7 0.0 5.6 41.9 0.0 13.6 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 25.9 2.8 HNMT ENSG00000150540 "Histamine N-methyltransferase" P50135 2 137964020-138016364 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Methyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hofbauer cells: 259.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 19 "classical monocyte: 34.6;intermediate monocyte: 26.7;myeloid DC: 20.9;non-classical monocyte: 14.6" "Group enriched" "Detected in many" 22 "dendritic cells: 20.9;monocytes: 34.6" "Cell line enhanced" "Detected in many" "Hep G2: 60.9;HSkMC: 24.9;RT4: 31.6;SuSa: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035480, HPA035481, HPA073754" Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA 64000 "Nucleoplasm, Cytosol" Centrosome "HPA035480: AB_2674645, HPA035481: AB_10672094, HPA073754: " "unprognostic (1.32e-1)" "unprognostic (3.53e-1)" "unprognostic (5.44e-2)" "unprognostic (2.09e-2)" "unprognostic (2.81e-1)" "unprognostic (2.33e-1)" "unprognostic (2.29e-2)" "unprognostic (6.02e-2)" "unprognostic (5.69e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (3.41e-4)" "unprognostic (5.24e-2)" "unprognostic (1.34e-2)" "unprognostic (1.76e-2)" "unprognostic (5.34e-2)" "unprognostic (1.21e-1)" "prognostic favorable (4.68e-4)" 41.4 5.8 12.2 12.3 11.1 3.3 28.8 10.7 11.3 27.6 16.3 8.6 13.9 8.7 22.2 21.4 11.6 14.6 21.6 14.7 12.7 7.8 33.4 74.2 21.9 17.0 13.7 9.2 33.1 14.1 24.5 5.5 14.3 11.2 22.3 17.7 8.7 14.1 20.1 4.9 8.1 11.1 13.2 14.8 18.5 11.5 11.7 14.6 1.0 7.3 8.5 6.5 21.3 12.0 0.5 20.9 1.2 34.6 0.1 0.2 9.2 0.2 0.3 1.5 4.1 17.5 18.8 0.1 1.1 1.7 0.1 0.7 7.8 4.4 0.2 13.8 4.5 0.3 0.4 3.2 0.0 0.0 0.2 1.6 0.1 13.0 60.9 7.9 0.0 0.2 24.9 0.0 6.2 0.0 1.4 4.4 0.1 0.2 0.3 13.1 0.9 0.0 0.2 7.8 10.4 1.6 0.1 0.5 0.0 18.8 31.6 0.1 0.4 5.9 7.7 0.0 31.3 0.2 14.3 1.2 1.3 3.4 1.8 4.4 0.1 0.0 0.2 5.9 7.5 0.9 0.8 34.6 0.2 0.2 26.7 0.1 0.5 0.1 0.1 20.9 0.3 0.1 0.2 1.2 0.1 14.6 0.6 0.2 9.2 12.2 11.1 10.7 11.3 12.7 7.8 13.7 9.2 11.2 14.6 26.8 39.0 13.7 77.1 31.6 0.5 1.6 140.1 52.2 86.4 57.6 0.0 45.4 104.5 84.7 1.2 4.9 45.2 0.0 42.0 69.7 45.8 47.7 0.0 146.0 259.0 0.0 15.7 23.4 235.2 1.6 121.7 155.2 54.0 68.5 65.8 22.3 57.9 100.1 99.0 189.5 0.5 77.6 52.5 0.5 0.6 22.6 31.5 5.0 76.2 102.7 HNRNPA0 "hnRNPA0, HNRPA0" ENSG00000177733 "Heterogeneous nuclear ribonucleoprotein A0" Q13151 5 137745651-137754376 "Plasma proteins, Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036569, HPA059404" Enhanced Enhanced Nucleoplasm No No 110000 Nucleoplasm "HPA036569: AB_10670840, HPA059404: AB_2684004" "unprognostic (5.51e-2)" "unprognostic (4.86e-2)" "unprognostic (2.00e-2)" "unprognostic (3.78e-1)" "unprognostic (8.99e-2)" "unprognostic (2.52e-1)" "unprognostic (2.65e-3)" "unprognostic (1.06e-1)" "unprognostic (1.77e-1)" "unprognostic (1.23e-1)" "prognostic favorable (3.74e-4)" "unprognostic (6.86e-2)" "prognostic favorable (1.99e-4)" "unprognostic (2.34e-1)" "unprognostic (4.57e-1)" "unprognostic (2.66e-2)" "unprognostic (7.39e-2)" 25.6 30.9 18.1 31.8 21.4 40.7 62.9 35.2 43.8 27.0 21.2 11.5 17.2 21.0 38.1 26.3 25.7 29.3 29.5 29.1 15.7 18.0 17.4 18.5 40.4 61.2 16.5 22.5 42.7 34.8 15.1 20.4 30.7 16.6 22.1 17.2 20.0 18.6 20.8 38.1 23.2 23.1 33.4 16.8 24.2 24.3 25.7 13.6 50.1 26.2 22.5 21.6 24.8 24.2 5.2 6.1 8.0 4.4 7.8 7.1 1.5 14.4 14.5 28.2 28.4 13.9 8.9 29.0 11.1 9.2 10.0 11.6 27.0 11.4 26.3 16.1 9.5 11.0 13.3 15.2 17.3 12.2 13.2 21.2 17.0 9.3 16.3 12.8 15.5 18.1 14.3 12.2 7.9 9.2 11.0 13.8 23.9 13.8 17.7 10.0 18.8 29.0 20.9 22.0 6.9 10.6 34.9 20.6 13.2 9.8 16.7 35.8 29.1 14.3 10.0 18.8 32.3 12.7 18.0 13.4 16.0 13.7 8.8 21.1 17.9 14.4 18.7 10.4 18.0 15.8 4.2 2.4 8.0 5.9 4.1 7.1 4.2 5.6 5.9 4.2 5.2 6.1 6.0 2.6 7.8 4.4 6.1 3.2 1.5 18.1 21.4 35.2 43.8 15.7 18.0 16.5 22.5 16.6 13.6 80.4 53.0 188.3 346.9 489.4 73.3 31.1 99.3 37.5 62.6 96.0 35.3 296.0 145.9 218.1 24.7 188.8 85.5 70.0 128.8 402.7 254.2 247.7 94.6 65.2 171.4 79.4 226.9 148.0 122.8 31.9 146.2 137.9 266.6 273.3 165.1 127.6 167.3 162.1 141.8 99.3 53.7 84.1 348.8 141.2 79.6 423.3 305.8 240.4 208.3 323.0 HNRNPA1 "ALS20, hnRNP-A1, hnRNPA1, HNRPA1" ENSG00000135486 "Heterogeneous nuclear ribonucleoprotein A1" P09651 12 54280193-54287088 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transport" "Ribonucleoprotein, RNA-binding" "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001609, HPA001666, HPA005812, HPA007185, CAB010894" Supported Enhanced Nucleoplasm NA NA 10000000 Nucleoplasm "CAB010894: AB_261962, HPA001609: AB_2666383, HPA001666: AB_1850836, HPA005812: AB_2667441, HPA007185: AB_2667768" "unprognostic (1.38e-3)" "unprognostic (1.90e-1)" "unprognostic (1.59e-2)" "unprognostic (5.98e-3)" "unprognostic (2.82e-2)" "unprognostic (2.46e-1)" "unprognostic (1.22e-2)" "unprognostic (9.71e-2)" "unprognostic (3.34e-2)" "unprognostic (2.91e-2)" "unprognostic (3.72e-2)" "unprognostic (3.51e-2)" "unprognostic (6.88e-3)" "unprognostic (2.32e-2)" "unprognostic (1.14e-1)" "unprognostic (1.48e-1)" "unprognostic (9.54e-3)" 36.4 33.3 31.7 55.6 37.4 99.5 45.1 48.3 43.0 52.2 38.9 38.4 33.9 35.2 54.1 41.6 41.3 39.5 20.4 31.9 29.7 28.5 40.5 76.2 29.7 51.7 33.1 23.1 123.6 46.1 34.4 36.7 49.9 42.6 35.3 38.7 28.1 33.4 31.5 40.5 37.3 35.6 34.9 40.1 59.5 34.1 69.6 33.3 88.7 42.1 62.0 62.7 37.5 45.8 61.6 72.5 17.9 51.1 86.6 98.1 105.8 84.3 77.7 166.2 131.5 51.4 82.2 90.4 77.8 89.3 86.3 73.2 116.3 93.1 222.9 76.5 53.9 27.9 76.2 111.0 111.6 104.9 87.1 84.5 123.7 111.5 200.3 27.3 175.9 81.5 73.2 43.2 57.0 85.0 82.0 94.4 100.5 136.9 94.0 71.9 109.4 191.5 190.3 175.1 58.7 55.2 186.9 132.7 108.5 93.5 127.5 93.3 128.0 57.7 118.8 86.2 92.3 74.2 110.4 79.7 64.4 86.5 64.9 99.6 84.4 85.3 149.4 42.2 111.0 56.3 12.0 39.5 17.9 61.9 51.1 96.1 61.6 82.7 72.3 72.5 55.2 98.1 89.4 4.2 86.6 41.3 55.9 70.9 105.8 31.7 37.4 48.3 43.0 29.7 28.5 33.1 23.1 42.6 33.3 282.9 416.9 979.2 866.3 1257.9 240.2 144.8 512.1 277.1 532.3 279.2 88.4 1846.9 626.6 1015.4 131.7 691.4 446.7 116.8 1834.6 2353.9 905.7 556.1 513.1 175.1 878.1 103.3 791.7 392.3 666.2 95.5 972.8 726.1 558.5 1333.7 1093.4 203.6 1143.2 522.5 697.3 587.0 150.2 446.3 924.5 196.6 318.3 1103.1 1822.1 976.0 1319.8 750.5 HNRNPA1P48 ENSG00000224578 "Heterogeneous nuclear ribonucleoprotein A1 pseudogene 48" 16 51553436-51647132 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" 9 "Ductal cells: 74.5;Exocrine glandular cells: 119.5;granulocytes: 106.3;Intestinal endocrine cells: 64.6;monocytes: 100.0;Pancreatic endocrine cells: 81.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEK 293: 1.0" "HPA001666, HPA005812" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA001666: AB_1850836, HPA005812: AB_2667441" "unprognostic (2.61e-2)" "unprognostic (2.08e-1)" "unprognostic (3.22e-2)" "unprognostic (2.07e-3)" "unprognostic (7.23e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.11e-4)" "unprognostic (1.48e-1)" "unprognostic (2.86e-1)" "unprognostic (6.09e-2)" "unprognostic (1.55e-3)" "unprognostic (7.66e-2)" "unprognostic (5.84e-2)" "unprognostic (2.17e-2)" "unprognostic (1.17e-1)" "unprognostic (1.95e-3)" "unprognostic (2.11e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 26.2 13.4 0.0 0.0 0.0 8.9 0.0 26.8 40.9 1.8 0.0 0.0 10.0 74.5 0.0 0.0 0.0 0.0 119.5 0.0 0.0 0.0 106.3 0.0 0.0 0.0 64.6 0.0 0.0 0.0 0.0 11.0 0.0 100.0 0.0 0.0 81.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HNRNPA2B1 HNRPA2B1 ENSG00000122566 "Heterogeneous nuclear ribonucleoprotein A2/B1" P22626 7 26189927-26201529 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transport" "Ribonucleoprotein, RNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001666, HPA005812, CAB012403, HPA065537" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA 11000000 Nucleoplasm "CAB012403: , HPA001666: AB_1850836, HPA005812: AB_2667441, HPA065537: AB_2685507" "unprognostic (1.19e-1)" "unprognostic (4.45e-1)" "unprognostic (2.33e-1)" "unprognostic (6.39e-2)" "unprognostic (5.64e-2)" "unprognostic (8.04e-3)" "prognostic unfavorable (1.03e-6)" "unprognostic (1.25e-2)" "unprognostic (9.12e-3)" "unprognostic (4.35e-3)" "unprognostic (1.31e-1)" "prognostic unfavorable (5.12e-4)" "prognostic unfavorable (8.01e-5)" "unprognostic (6.74e-2)" "unprognostic (3.36e-2)" "unprognostic (2.02e-1)" "unprognostic (1.56e-2)" 82.2 97.4 85.1 105.3 106.3 90.9 74.4 123.3 87.4 77.1 85.7 89.4 68.7 87.5 92.6 71.9 90.4 75.1 51.7 87.9 82.4 71.8 113.4 103.7 76.2 127.7 118.6 57.0 121.0 75.7 107.2 121.2 100.7 96.3 75.5 98.6 64.4 71.4 66.5 167.2 58.7 94.8 73.7 139.7 116.5 74.1 73.1 135.4 180.3 81.9 104.4 140.7 74.2 128.8 33.7 46.5 35.1 52.4 32.1 42.5 36.0 124.0 105.9 154.2 115.6 39.7 36.3 71.4 79.6 62.1 88.0 79.7 97.8 90.4 226.9 76.1 73.8 105.0 86.6 164.9 104.0 124.0 70.5 100.5 137.5 127.8 116.9 33.3 148.0 94.2 34.3 54.5 83.7 76.4 46.4 90.8 104.9 161.7 74.2 88.8 100.4 158.3 173.1 136.6 95.1 81.7 147.2 125.3 95.0 101.6 108.6 90.1 110.5 95.7 94.3 58.1 98.3 105.7 128.9 78.4 49.5 102.5 67.0 135.8 98.6 195.4 215.9 63.8 168.7 93.2 17.4 38.7 35.1 42.5 52.4 38.6 33.7 35.5 36.6 46.5 29.2 35.6 35.6 13.0 32.1 48.4 43.6 36.1 36.0 85.1 106.3 123.3 87.4 82.4 71.8 118.6 57.0 96.3 135.4 452.6 512.0 456.4 620.8 656.0 459.5 635.5 267.5 721.4 702.9 326.2 280.8 790.3 391.3 484.7 96.5 561.1 396.4 280.4 392.8 789.3 528.7 417.7 617.9 353.4 530.6 295.6 471.8 332.7 355.7 124.0 380.5 569.8 372.8 501.4 392.2 570.4 369.1 357.7 366.7 366.6 518.1 433.4 564.3 596.8 448.9 524.9 905.5 489.7 465.4 566.2 HNRNPA3 HNRPA3 ENSG00000170144 "Heterogeneous nuclear ribonucleoprotein A3" P51991 2 177212563-177223958 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001666, HPA005812, HPA066381" Supported Enhanced Nucleoplasm NA NA 1500000 Nucleoplasm "HPA001666: AB_1850836, HPA005812: AB_2667441, HPA066381: AB_2685666" "unprognostic (2.85e-2)" "prognostic favorable (4.87e-4)" "unprognostic (2.21e-1)" "unprognostic (1.26e-1)" "unprognostic (2.14e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.95e-5)" "unprognostic (2.46e-1)" "unprognostic (3.15e-3)" "unprognostic (2.80e-3)" "unprognostic (3.65e-2)" "unprognostic (4.56e-2)" "prognostic unfavorable (9.57e-7)" "unprognostic (6.95e-2)" "unprognostic (3.04e-1)" "unprognostic (4.55e-2)" "unprognostic (1.10e-2)" 22.9 17.6 24.7 29.5 28.0 29.8 19.5 22.3 29.3 24.3 24.8 16.1 13.7 18.0 26.5 26.9 33.8 20.8 20.9 16.7 20.8 14.2 23.9 20.3 23.7 29.9 40.4 17.7 35.6 19.3 20.6 20.1 27.0 26.5 19.0 28.7 14.9 20.0 28.4 28.0 23.2 23.5 23.4 35.0 24.8 19.7 22.2 27.3 23.0 30.7 18.4 40.6 20.5 28.2 15.2 26.4 7.4 15.8 15.6 18.7 9.3 63.7 43.0 94.5 48.2 25.0 22.3 72.5 48.9 23.0 38.5 36.7 85.5 33.0 128.6 37.3 37.7 51.6 36.8 93.3 61.1 72.5 59.0 56.9 95.8 65.2 169.2 26.9 102.9 59.7 24.8 27.4 57.3 42.7 21.4 52.5 57.2 68.4 44.3 48.8 85.9 71.7 41.5 51.6 73.5 40.5 91.9 80.2 40.2 53.7 126.1 55.4 49.9 72.7 22.7 29.5 71.3 32.8 64.7 58.1 49.4 55.1 34.3 70.4 40.3 71.5 110.0 29.4 68.4 31.9 4.9 15.3 7.4 18.7 15.8 15.0 13.9 15.0 16.5 16.4 15.2 13.8 13.9 6.6 15.6 14.9 26.4 17.3 9.3 24.7 28.0 22.3 29.3 20.8 14.2 40.4 17.7 26.5 27.3 154.9 215.2 221.2 361.3 312.4 188.7 56.1 86.6 283.7 291.2 151.8 92.3 425.0 102.8 195.6 26.3 270.9 149.7 46.7 236.9 457.8 255.4 219.8 270.4 155.4 295.4 139.8 263.9 182.3 180.4 26.3 189.6 227.7 182.2 276.9 212.7 161.7 237.6 169.9 197.0 126.2 152.7 148.8 302.8 280.0 218.2 288.8 414.8 248.4 249.1 343.8 HNRNPAB "ABBP1, FLJ40338, HNRPAB" ENSG00000197451 "Heterogeneous nuclear ribonucleoprotein A/B" Q99729 5 178204507-178211163 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046688 Approved Enhanced Nucleoplasm NA NA 380000 Nucleoplasm "HPA046688: AB_10964924" "unprognostic (2.23e-1)" "unprognostic (6.21e-2)" "unprognostic (2.61e-2)" "unprognostic (1.96e-2)" "unprognostic (8.69e-2)" "unprognostic (1.17e-1)" "unprognostic (1.22e-3)" "unprognostic (4.09e-2)" "unprognostic (6.17e-3)" "prognostic favorable (9.79e-4)" "unprognostic (9.12e-3)" "unprognostic (4.23e-2)" "prognostic unfavorable (1.35e-7)" "unprognostic (3.47e-2)" "unprognostic (1.82e-1)" "unprognostic (3.53e-1)" "unprognostic (2.08e-1)" 34.9 41.7 16.5 47.8 18.4 44.6 32.5 17.9 19.1 30.0 54.0 20.4 24.9 37.0 33.9 23.0 50.9 27.3 38.6 44.4 15.4 17.8 50.0 72.4 29.8 36.5 20.6 12.4 39.1 39.1 25.5 20.5 36.7 16.8 26.8 47.1 19.4 31.3 26.7 53.3 43.4 55.0 38.7 18.9 53.5 31.9 26.5 15.9 75.6 34.6 46.3 41.3 38.7 36.8 5.9 11.4 15.1 7.2 5.7 6.6 2.2 46.1 38.5 59.4 57.4 22.0 19.4 85.9 52.0 24.1 41.6 44.9 70.9 34.7 74.8 48.0 27.8 50.8 30.6 51.4 70.6 51.7 115.6 60.6 47.0 31.0 43.3 22.0 59.4 40.1 19.1 33.4 37.3 37.6 17.2 37.2 30.0 38.3 34.2 41.7 124.3 71.6 57.4 54.4 47.6 55.5 58.5 35.8 44.3 35.1 49.5 54.7 42.6 40.5 56.6 36.6 38.8 33.9 36.4 33.3 50.9 43.0 35.8 71.0 40.1 46.8 88.0 20.6 65.8 41.2 2.8 4.8 15.1 5.5 7.2 6.2 5.9 4.6 6.6 4.6 5.0 4.5 5.3 0.9 5.7 7.1 11.4 4.8 2.2 16.5 18.4 17.9 19.1 15.4 17.8 20.6 12.4 16.8 15.9 29.8 43.7 80.2 123.5 250.0 24.2 39.9 48.4 25.4 44.3 47.1 17.7 71.8 43.1 103.9 4.5 77.1 177.1 93.5 130.6 169.9 80.3 113.7 44.9 96.2 90.6 15.9 114.3 57.1 60.6 7.9 68.4 88.9 64.1 41.5 155.2 31.3 147.7 149.7 82.7 85.7 26.4 77.6 138.6 57.6 139.0 297.1 95.7 42.1 166.2 201.2 HNRNPC "hnRNPC, HNRPC" ENSG00000092199 "Heterogeneous nuclear ribonucleoprotein C (C1/C2)" P07910 14 21209136-21269494 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005223, HPA051075, CAB075755, CAB075756" Supported Enhanced Nucleoplasm NA NA 1400000 Nucleoplasm "CAB005223: AB_2117508, CAB075755: AB_2665761, CAB075756: AB_2665762, HPA051075: AB_2681335" "unprognostic (1.92e-3)" "unprognostic (1.02e-2)" "unprognostic (1.43e-1)" "unprognostic (2.44e-1)" "unprognostic (1.42e-2)" "unprognostic (5.21e-3)" "prognostic unfavorable (7.72e-5)" "unprognostic (8.66e-3)" "unprognostic (5.96e-3)" "prognostic favorable (1.19e-4)" "unprognostic (3.31e-3)" "unprognostic (5.30e-3)" "prognostic unfavorable (7.29e-5)" "unprognostic (7.36e-2)" "unprognostic (3.73e-3)" "unprognostic (2.28e-3)" "unprognostic (5.42e-2)" 41.1 53.9 51.8 51.1 64.0 71.6 55.1 72.1 65.5 49.6 41.9 45.3 47.3 35.3 51.0 51.1 53.4 54.3 38.0 41.1 47.9 45.1 50.0 51.9 43.0 76.7 54.8 42.1 72.8 57.8 38.3 63.3 54.7 43.7 45.2 47.8 43.9 36.0 44.5 44.5 39.8 39.5 57.6 54.8 55.8 37.4 62.4 52.4 49.3 53.0 37.9 75.6 45.3 45.9 78.3 104.6 119.0 73.3 64.8 89.1 142.9 94.7 79.3 119.5 68.1 79.4 73.5 84.2 60.5 73.6 102.2 87.3 74.7 72.0 168.5 38.5 76.1 66.5 71.7 164.3 102.5 139.5 109.7 87.7 84.5 62.6 111.4 90.3 129.2 70.6 76.1 83.8 75.4 180.2 89.4 107.3 95.6 129.7 72.0 80.8 91.1 154.1 122.9 124.3 95.0 73.9 123.6 95.3 83.0 109.0 86.1 66.3 61.6 73.5 71.0 67.0 110.2 66.7 116.1 69.4 36.8 66.4 43.6 86.9 65.3 97.8 164.4 34.3 105.3 72.0 57.8 73.3 71.2 65.9 63.5 86.1 78.3 78.0 70.2 104.6 68.7 89.1 75.0 119.0 64.8 59.7 67.5 80.3 142.9 51.8 64.0 72.1 65.5 47.9 45.1 54.8 42.1 43.7 52.4 142.9 216.7 293.4 537.0 476.4 166.6 113.3 191.1 426.9 343.5 261.7 186.5 541.0 240.4 270.5 104.5 231.5 115.2 93.5 187.7 622.0 348.5 363.8 401.3 193.0 344.7 109.7 214.8 160.2 259.6 47.1 249.9 333.4 197.4 316.6 194.2 147.6 213.3 119.3 217.1 276.6 280.5 148.8 296.7 355.3 259.1 471.9 731.7 329.0 278.1 447.5 HNRNPD "AUF1, HNRPD" ENSG00000138668 "Heterogeneous nuclear ribonucleoprotein D" Q14103 4 82352498-82374503 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "DNA-binding, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004911 Supported Enhanced Nucleoplasm NA NA 550000 Nucleoplasm "HPA004911: AB_1078250" "unprognostic (9.60e-3)" "unprognostic (1.01e-2)" "unprognostic (9.09e-2)" "unprognostic (2.65e-1)" "unprognostic (1.74e-1)" "unprognostic (1.77e-1)" "unprognostic (1.03e-3)" "unprognostic (1.75e-2)" "unprognostic (6.23e-2)" "unprognostic (2.06e-2)" "unprognostic (1.08e-2)" "unprognostic (1.03e-2)" "unprognostic (1.40e-2)" "unprognostic (5.93e-2)" "unprognostic (1.08e-1)" "unprognostic (2.81e-1)" "unprognostic (1.31e-2)" 45.5 40.0 35.4 58.8 46.1 88.0 49.4 49.1 40.6 55.2 49.8 37.2 40.5 45.1 56.2 39.1 55.5 47.9 48.5 40.8 28.4 27.4 36.4 40.6 43.2 72.2 26.5 37.1 64.5 48.9 51.6 38.7 51.9 32.9 44.9 45.8 41.5 52.9 48.6 51.6 49.5 49.9 53.1 27.9 61.4 46.7 30.4 30.7 136.1 41.5 53.7 80.4 58.2 49.9 17.8 21.8 18.0 11.9 12.4 17.5 5.9 60.1 23.9 103.1 32.7 13.6 17.8 48.7 47.4 36.6 54.7 47.2 42.7 53.5 123.3 34.4 32.1 29.1 29.8 81.9 35.5 86.0 22.9 42.3 88.3 32.9 57.8 27.8 117.0 45.5 21.7 15.9 44.1 44.7 28.1 49.4 60.3 97.1 42.7 46.4 23.2 142.4 81.3 85.7 45.1 22.2 105.5 104.8 51.1 45.6 36.9 52.1 56.2 46.7 40.7 23.6 50.2 30.4 46.7 41.7 42.3 57.7 32.5 60.9 45.3 35.6 143.5 32.5 60.5 48.1 18.0 10.8 10.8 13.2 11.3 14.5 17.8 15.9 16.5 12.3 14.4 17.5 14.5 13.1 12.4 11.9 21.8 17.2 5.9 35.4 46.1 49.1 40.6 28.4 27.4 26.5 37.1 32.9 30.7 95.3 129.9 97.5 173.8 232.1 125.8 176.6 81.5 117.8 162.7 106.4 58.9 238.7 59.7 146.2 21.6 142.9 61.9 93.5 181.6 291.7 117.2 144.5 88.0 106.3 135.9 101.7 140.7 111.1 121.5 16.8 115.6 129.0 86.0 133.5 128.6 156.0 133.5 42.1 96.2 65.2 99.6 109.9 139.4 99.7 128.2 200.9 227.5 109.0 142.2 181.5 HNRNPDL "HNRPDL, JKTBP, laAUF1" ENSG00000152795 "Heterogeneous nuclear ribonucleoprotein D like" O14979 4 82422564-82430408 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, RNA-binding" "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056820, HPA063147" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA056820: AB_2683246, HPA063147: AB_2684950" "unprognostic (1.41e-1)" "unprognostic (1.59e-1)" "unprognostic (1.38e-1)" "unprognostic (3.29e-3)" "unprognostic (1.11e-1)" "unprognostic (3.13e-1)" "unprognostic (6.30e-3)" "unprognostic (7.19e-2)" "unprognostic (4.05e-2)" "unprognostic (3.59e-1)" "unprognostic (3.46e-1)" "unprognostic (5.56e-3)" "unprognostic (4.07e-2)" "unprognostic (1.72e-1)" "unprognostic (2.67e-2)" "unprognostic (5.26e-2)" "unprognostic (1.03e-2)" 60.5 43.9 52.0 58.8 82.9 98.2 58.8 67.6 79.7 50.1 51.9 60.4 42.9 41.8 73.7 57.8 45.3 53.5 42.4 47.7 49.0 44.7 43.0 37.4 52.9 64.4 86.9 74.2 101.7 66.0 43.5 41.0 46.2 79.0 49.8 44.5 31.6 46.4 52.3 89.7 46.0 47.8 60.6 69.4 55.7 51.1 32.8 80.8 48.3 49.0 59.2 51.3 44.9 51.5 27.7 20.3 14.4 31.1 17.6 35.6 19.9 52.6 27.9 104.1 20.6 39.1 21.4 34.2 57.1 62.1 50.9 48.5 38.3 43.7 98.3 36.4 61.8 26.3 41.1 78.4 52.7 59.8 21.6 56.8 56.9 45.2 68.6 18.4 96.7 42.4 37.7 15.3 56.9 51.0 40.3 40.3 62.8 73.7 40.8 49.3 22.0 90.3 67.9 71.4 47.8 33.0 81.1 84.1 44.9 59.3 34.5 44.3 76.6 35.5 45.9 33.5 49.0 48.0 55.0 33.8 51.4 63.5 33.6 68.1 48.0 45.9 108.2 45.0 56.6 43.2 14.4 15.7 13.2 28.5 25.7 23.3 27.7 25.5 26.0 12.6 26.8 35.6 30.6 6.7 17.6 31.1 20.3 19.4 19.9 52.0 82.9 67.6 79.7 49.0 44.7 86.9 74.2 79.0 80.8 253.1 256.3 276.8 560.8 585.3 217.8 173.8 101.9 365.4 381.1 144.8 100.1 445.7 252.0 241.5 42.1 260.0 120.7 23.3 220.9 513.8 334.8 344.9 370.4 124.1 286.8 166.8 226.5 117.9 193.0 32.1 196.8 307.6 295.3 348.1 161.4 241.5 205.1 122.8 190.6 215.4 158.8 161.7 311.0 158.6 399.4 484.4 435.7 307.9 180.7 425.7 HNRNPF HNRPF ENSG00000169813 "Heterogeneous nuclear ribonucleoprotein F" P52597 10 43385617-43409166 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016884, HPA069667" Supported Enhanced Nucleoplasm NA NA 2500000 Nucleoplasm "HPA016884: AB_1856444, HPA069667: AB_2686166" "unprognostic (9.93e-2)" "unprognostic (2.26e-2)" "unprognostic (1.81e-1)" "unprognostic (3.65e-2)" "unprognostic (6.39e-2)" "unprognostic (3.33e-2)" "prognostic unfavorable (5.85e-4)" "unprognostic (1.51e-2)" "unprognostic (6.37e-2)" "unprognostic (6.33e-3)" "unprognostic (4.89e-3)" "unprognostic (1.07e-2)" "unprognostic (1.95e-2)" "unprognostic (3.77e-3)" "unprognostic (3.35e-1)" "unprognostic (3.71e-1)" "unprognostic (2.22e-1)" 48.1 34.0 19.9 41.2 34.9 43.3 56.1 23.2 22.3 31.1 44.5 31.6 26.9 41.1 34.9 32.6 50.4 39.2 35.7 26.2 21.7 18.3 42.3 68.3 40.4 55.9 33.7 13.9 54.2 39.7 22.5 28.1 37.5 32.5 35.4 37.8 26.2 36.9 25.0 40.0 40.6 57.5 41.6 27.5 58.7 39.2 66.4 31.2 77.5 40.6 42.3 56.9 46.2 57.4 58.3 59.7 52.0 62.5 63.2 75.8 89.4 46.3 49.3 30.7 46.4 37.6 41.3 45.0 36.4 61.2 51.2 60.6 46.1 64.9 93.5 23.4 39.3 30.1 65.8 81.9 59.4 42.2 39.1 49.0 59.5 30.7 59.2 46.5 87.2 60.5 50.1 47.2 39.7 73.3 29.8 43.9 46.2 60.1 42.5 38.6 72.4 85.2 47.8 23.1 70.6 41.7 71.7 28.8 44.3 52.3 71.9 37.9 38.1 37.0 68.1 55.1 34.9 75.8 42.7 32.7 23.6 44.9 38.6 57.4 38.3 64.5 56.7 38.3 83.9 23.0 38.5 54.4 52.0 62.3 62.5 75.8 58.3 65.5 68.6 59.7 48.1 55.7 52.5 36.5 63.2 55.5 33.4 72.6 89.4 19.9 34.9 23.2 22.3 21.7 18.3 33.7 13.9 32.5 31.2 125.0 101.0 151.2 286.6 298.4 46.3 53.4 129.9 188.7 104.6 106.4 45.2 238.4 149.2 179.9 260.2 132.4 146.6 93.5 123.9 343.0 154.8 203.1 114.2 201.4 197.1 46.1 121.7 118.4 187.9 81.6 135.2 151.7 94.5 200.2 160.4 105.7 142.1 149.4 110.7 162.5 134.4 97.0 151.4 223.4 171.5 288.8 176.0 209.8 206.2 283.8 HNRNPH1 "hnRNPH, HNRPH1" ENSG00000169045 "Heterogeneous nuclear ribonucleoprotein H1" P31943 5 179614178-179634784 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Basal keratinocytes: 688.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000914, HPA001359, HPA016884, CAB032820" Supported Enhanced Nucleoplasm NA NA 2100000 Nucleoplasm "CAB032820: AB_2248257, HPA000914: AB_2666143, HPA001359: AB_1079076, HPA016884: AB_1856444" "unprognostic (9.01e-2)" "unprognostic (3.83e-1)" "unprognostic (3.45e-3)" "unprognostic (8.82e-2)" "unprognostic (1.01e-1)" "prognostic favorable (7.85e-4)" "prognostic unfavorable (3.29e-7)" "unprognostic (7.99e-2)" "unprognostic (6.22e-3)" "unprognostic (1.56e-1)" "unprognostic (8.65e-3)" "unprognostic (8.64e-3)" "prognostic unfavorable (3.46e-4)" "unprognostic (1.40e-2)" "unprognostic (1.54e-1)" "unprognostic (2.40e-3)" "unprognostic (1.72e-3)" 40.1 36.2 26.8 86.3 31.0 90.5 45.4 73.4 33.2 55.6 38.2 26.6 54.7 30.2 52.4 44.3 41.7 37.7 45.3 30.3 25.6 23.3 36.5 42.3 37.0 59.8 33.0 30.3 60.1 41.3 24.4 46.1 43.6 28.9 40.8 34.7 34.4 53.5 60.3 51.3 44.3 43.0 61.6 31.3 65.2 34.4 42.5 34.3 113.2 47.5 61.5 62.0 57.3 54.4 26.3 34.7 18.4 27.7 24.3 36.8 13.8 51.6 39.4 62.4 40.8 22.4 12.3 50.5 30.8 16.0 40.3 26.6 53.4 34.4 86.0 27.9 22.4 34.2 33.1 58.1 36.3 36.2 72.0 41.7 46.8 65.0 67.0 26.3 61.1 45.1 12.9 26.4 39.3 24.8 25.1 21.9 36.5 58.7 45.5 23.9 35.4 93.0 56.9 72.3 28.9 29.0 82.9 71.0 51.0 20.7 61.6 59.6 50.7 59.8 40.9 53.8 34.7 38.9 79.3 35.9 59.1 42.0 26.9 69.6 37.4 80.9 90.1 32.0 58.5 69.0 18.4 18.0 17.5 26.0 27.7 34.3 26.3 27.8 27.9 26.6 22.7 35.5 36.8 3.5 24.3 20.8 34.7 31.7 13.8 26.8 31.0 73.4 33.2 25.6 23.3 33.0 30.3 28.9 34.3 107.2 244.9 156.8 156.9 688.7 112.1 115.5 160.5 113.8 153.6 148.3 123.7 142.0 66.3 86.3 122.9 189.6 133.1 303.7 106.4 163.6 207.4 153.7 235.1 192.4 96.7 66.7 245.0 179.2 181.7 67.9 103.3 177.8 317.2 101.0 168.3 82.9 89.4 147.3 110.3 55.5 160.3 181.1 190.5 157.9 116.9 627.7 161.0 200.5 170.7 155.5 HNRNPH2 "FTP3, hnRNPH', HNRPH', HNRPH2" ENSG00000126945 "Heterogeneous nuclear ribonucleoprotein H2" P55795 X 101408295-101414133 "Disease related genes, Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Syncytiotrophoblasts: 253.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000914, HPA001359, CAB004436, HPA016884" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004436: AB_627737, HPA000914: AB_2666143, HPA001359: AB_1079076, HPA016884: AB_1856444" "unprognostic (1.00e-1)" "unprognostic (5.57e-2)" "unprognostic (2.10e-1)" "unprognostic (2.70e-1)" "unprognostic (5.48e-2)" "unprognostic (1.71e-2)" "unprognostic (3.83e-2)" "unprognostic (1.47e-2)" "unprognostic (3.88e-1)" "unprognostic (3.04e-1)" "unprognostic (2.22e-1)" "unprognostic (2.99e-1)" "prognostic favorable (7.37e-4)" "unprognostic (8.09e-2)" "unprognostic (1.04e-2)" "unprognostic (3.66e-1)" "unprognostic (6.68e-2)" 49.5 44.2 43.4 34.6 51.9 38.3 42.7 49.1 53.9 37.0 32.2 33.8 33.3 34.1 36.6 39.7 36.7 32.7 28.2 35.9 40.3 42.4 49.8 46.1 34.5 30.1 37.1 46.4 47.8 28.4 77.5 50.0 44.9 48.8 37.9 35.9 25.0 30.4 45.2 54.8 40.0 43.6 39.7 36.7 42.2 30.6 18.9 34.2 44.0 44.1 39.9 39.9 41.7 34.4 16.7 28.8 65.9 32.1 22.1 19.4 22.6 31.1 21.7 42.6 25.5 37.6 32.8 20.4 26.7 37.2 25.2 51.6 18.3 28.0 32.1 27.3 37.3 34.7 28.7 48.5 36.9 34.6 31.2 23.8 23.8 52.7 24.8 32.2 29.5 23.4 33.3 34.0 24.9 24.5 30.5 34.2 17.7 24.1 46.5 38.2 39.9 24.2 26.0 26.8 51.0 21.3 23.2 45.4 31.2 54.3 41.6 19.6 35.8 39.8 19.0 30.1 31.5 24.2 28.2 37.1 14.1 25.9 40.1 10.9 15.7 22.5 22.7 29.0 34.3 17.5 29.3 29.4 43.2 18.1 32.1 19.4 16.7 17.7 18.2 28.8 15.6 18.7 19.2 65.9 22.1 30.4 12.1 16.3 22.6 43.4 51.9 49.1 53.9 40.3 42.4 37.1 46.4 48.8 34.2 26.8 63.6 43.1 84.4 63.0 39.8 45.6 33.1 44.2 47.8 85.5 11.8 120.9 84.6 83.4 2.9 54.0 50.2 23.3 64.4 53.5 57.5 42.3 80.8 70.6 73.2 15.9 58.3 47.3 65.5 4.3 51.2 73.1 65.8 105.6 41.2 38.4 56.0 48.0 55.5 110.9 28.7 77.6 49.5 8.0 21.3 63.0 253.0 48.5 42.5 60.2 HNRNPH3 "2H9, HNRPH3" ENSG00000096746 "Heterogeneous nuclear ribonucleoprotein H3" P31942 10 68331174-68343191 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038264 Supported Nucleoplasm NA NA 560000 Nucleoplasm "HPA038264: AB_10697246" "unprognostic (1.72e-1)" "unprognostic (3.04e-1)" "unprognostic (1.70e-1)" "unprognostic (2.85e-1)" "unprognostic (7.25e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.30e-5)" "unprognostic (6.17e-2)" "unprognostic (8.29e-2)" "unprognostic (1.75e-1)" "unprognostic (2.32e-1)" "unprognostic (9.81e-3)" "unprognostic (2.75e-3)" "unprognostic (7.70e-2)" "unprognostic (3.49e-1)" "unprognostic (1.81e-1)" "unprognostic (1.06e-3)" 44.9 41.8 47.1 37.9 53.2 51.3 42.8 57.3 48.1 45.1 39.2 49.8 33.2 33.4 58.2 29.2 38.2 42.4 27.8 40.3 45.0 42.3 42.7 34.4 34.6 43.7 57.3 42.2 71.4 27.0 41.2 61.5 50.4 45.6 53.1 40.4 30.4 28.1 39.7 50.4 38.5 41.9 61.1 81.9 38.0 33.7 40.5 65.3 48.9 60.5 31.6 45.8 55.4 78.7 13.6 17.4 29.0 19.3 17.5 22.7 10.6 42.4 41.2 66.0 20.5 25.9 16.1 42.6 37.5 19.7 35.2 29.2 70.3 37.6 67.3 20.6 24.7 27.9 28.5 53.0 36.1 54.5 41.3 28.0 52.1 37.2 42.4 22.7 59.5 28.8 10.5 33.1 40.0 71.3 29.2 26.6 36.1 64.4 23.4 38.9 58.8 52.5 64.6 43.8 31.2 49.0 44.0 55.3 21.8 28.2 35.3 29.8 32.5 39.8 27.5 39.1 39.5 29.2 30.4 28.9 32.5 54.8 17.1 50.4 28.4 38.3 68.7 18.2 29.5 25.5 14.7 15.3 29.0 15.0 17.0 15.5 13.2 17.8 17.2 17.4 13.6 22.7 18.6 19.8 17.5 19.3 14.3 15.8 10.6 47.1 53.2 57.3 48.1 45.0 42.3 57.3 42.2 45.6 65.3 95.3 107.8 84.3 251.6 289.4 114.7 95.6 43.3 145.9 130.8 69.8 90.3 123.5 51.4 76.1 15.9 108.9 62.8 23.3 72.3 174.4 129.1 149.0 135.4 36.5 84.8 82.6 103.3 67.5 62.9 15.8 89.2 95.2 123.2 90.2 71.6 97.7 64.9 83.4 113.1 58.5 138.2 129.4 182.3 279.8 178.3 233.2 160.4 86.3 75.4 187.4 HNRNPK "CSBP, HNRPK, TUNP" ENSG00000165119 "Heterogeneous nuclear ribonucleoprotein K" P61978 9 83968083-83980616 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, Ribonucleoprotein, RNA-binding" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004435, HPA007644, CAB016225, HPA044105" Supported Enhanced Nucleoplasm NA NA 5000000 Nucleoplasm "CAB004435: AB_627734, CAB016225: , HPA007644: AB_1079077, HPA044105: AB_2678812" "unprognostic (4.84e-2)" "unprognostic (4.69e-1)" "unprognostic (1.15e-2)" "unprognostic (8.42e-3)" "unprognostic (2.78e-2)" "unprognostic (9.83e-3)" "prognostic unfavorable (6.68e-5)" "unprognostic (3.46e-3)" "unprognostic (8.11e-2)" "unprognostic (1.47e-1)" "unprognostic (8.85e-3)" "unprognostic (2.81e-2)" "unprognostic (2.76e-3)" "unprognostic (2.23e-3)" "unprognostic (6.50e-2)" "unprognostic (4.59e-1)" "unprognostic (2.82e-1)" 79.0 92.0 70.0 80.7 81.7 146.9 97.2 88.0 104.8 77.9 70.0 68.8 80.9 74.5 96.3 69.0 95.8 79.6 67.5 80.4 68.2 71.5 76.0 90.9 77.7 125.0 80.9 72.9 96.5 102.8 91.4 74.5 92.3 67.3 69.4 75.2 58.6 76.5 104.6 101.4 78.7 76.7 100.9 86.3 96.1 72.5 60.3 78.6 162.5 79.9 80.8 106.9 81.0 77.1 59.7 76.1 92.7 71.0 75.6 73.2 136.4 122.3 84.6 145.5 86.1 69.9 77.5 116.9 86.6 107.7 108.5 102.2 70.8 87.7 145.4 59.6 90.6 94.1 94.1 145.4 105.1 132.5 99.9 85.6 102.0 74.2 100.3 92.6 126.4 101.3 78.8 80.4 92.5 123.1 81.8 110.4 82.7 103.7 74.7 106.7 107.3 156.7 86.7 129.2 124.4 82.4 136.9 116.0 96.9 105.1 101.0 94.4 112.1 91.1 97.2 86.3 105.3 96.2 107.5 90.3 75.6 89.1 76.6 112.8 78.7 103.0 105.6 72.2 102.4 106.8 77.4 71.0 90.1 53.9 69.2 67.3 59.7 62.5 61.2 76.1 56.8 65.1 59.3 92.7 75.6 65.8 45.2 73.2 136.4 70.0 81.7 88.0 104.8 68.2 71.5 80.9 72.9 67.3 78.6 190.6 233.2 308.4 456.1 449.4 175.4 171.5 206.4 338.6 282.1 249.5 84.4 518.7 334.9 379.2 22.5 338.4 245.6 163.5 321.8 621.5 373.1 281.2 324.9 300.6 341.5 147.8 371.7 237.6 349.5 31.1 309.8 311.8 310.4 423.8 309.1 344.3 335.2 270.0 301.9 310.5 156.5 271.7 398.2 345.1 248.3 392.2 609.3 308.9 346.3 397.3 HNRNPL HNRPL ENSG00000104824 "Heterogeneous nuclear ribonucleoprotein L" P14866 19 38836388-38852347 "Plasma proteins, Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016326, HPA051748, HPA052661" Supported Enhanced Nucleoplasm NA NA 130000 Nucleoplasm "CAB016326: AB_627736, HPA051748: AB_2681588, HPA052661: AB_2681905" "unprognostic (5.33e-2)" "unprognostic (4.58e-2)" "unprognostic (2.27e-1)" "unprognostic (9.67e-3)" "unprognostic (8.99e-3)" "unprognostic (4.90e-3)" "prognostic unfavorable (3.25e-6)" "unprognostic (1.45e-1)" "unprognostic (8.85e-2)" "unprognostic (2.41e-1)" "prognostic unfavorable (9.69e-4)" "unprognostic (1.57e-2)" "prognostic unfavorable (1.96e-11)" "unprognostic (2.17e-2)" "unprognostic (4.23e-2)" "unprognostic (1.58e-2)" "unprognostic (4.39e-2)" 44.1 43.3 32.8 47.1 37.1 102.7 40.6 48.9 47.6 38.9 46.2 42.5 35.9 43.7 47.8 34.8 50.1 36.2 42.0 39.7 31.8 31.9 39.9 52.9 43.2 48.0 36.2 32.5 41.6 41.6 36.1 28.1 47.9 34.7 34.6 49.1 35.6 37.5 39.8 44.7 50.7 48.1 49.4 34.3 44.8 38.2 34.9 39.4 102.8 53.0 36.8 67.6 37.9 40.5 3.1 6.2 3.5 3.8 2.2 3.6 1.9 46.2 36.6 46.5 29.9 18.5 21.8 43.9 38.5 26.6 35.8 34.1 39.2 35.6 73.5 31.5 24.7 27.2 28.4 57.3 43.2 53.3 56.6 31.1 60.7 23.3 34.9 19.7 56.0 41.1 23.7 20.5 36.1 35.7 20.5 39.5 32.5 58.8 38.1 37.3 36.6 57.9 34.6 54.7 32.5 25.4 75.3 53.2 46.2 40.1 34.8 39.0 36.2 38.7 30.4 15.5 33.8 39.8 31.2 35.3 35.9 40.9 31.5 55.3 36.6 49.1 82.7 23.1 49.6 39.2 1.1 2.6 1.7 3.5 3.8 2.7 2.2 2.5 2.1 3.5 3.1 2.7 2.2 3.5 2.2 2.8 6.2 3.6 1.9 32.8 37.1 48.9 47.6 31.8 31.9 36.2 32.5 34.7 39.4 20.8 57.5 59.4 53.2 31.5 76.3 16.1 20.4 25.4 36.4 21.0 60.9 36.1 6.6 30.0 12.1 37.0 50.9 0.0 38.1 29.7 32.6 50.4 38.1 62.1 23.8 31.8 60.4 42.4 60.8 8.9 26.2 37.5 25.3 31.5 62.4 41.8 34.9 35.1 21.2 17.8 69.2 19.4 36.3 19.1 19.6 41.5 43.7 49.8 62.6 36.9 HNRNPLL HNRPLL ENSG00000143889 "Heterogeneous nuclear ribonucleoprotein L like" Q8WVV9 2 38561978-38603586 "Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 114.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046084 Approved Approved Nucleoplasm,Mitochondria,Cytosol No No Nucleoplasm "Mitochondria, Cytosol" "HPA046084: AB_10960895" "unprognostic (2.27e-2)" "unprognostic (1.75e-1)" "unprognostic (3.63e-2)" "unprognostic (5.18e-1)" "unprognostic (2.10e-3)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.22e-4)" "unprognostic (1.52e-2)" "unprognostic (1.52e-1)" "unprognostic (1.80e-1)" "unprognostic (4.20e-2)" "unprognostic (1.01e-1)" "unprognostic (1.53e-1)" "unprognostic (2.25e-1)" "unprognostic (2.28e-1)" "unprognostic (1.26e-1)" "unprognostic (9.30e-2)" 16.6 19.5 14.9 13.3 16.2 47.3 20.0 22.1 17.5 18.2 16.4 10.8 17.0 16.2 21.9 19.4 14.4 17.6 16.5 14.3 17.8 11.8 12.5 11.6 17.6 12.1 13.2 19.2 19.9 16.8 18.8 16.4 13.8 10.9 16.8 13.0 13.5 14.0 22.8 13.1 12.0 13.6 14.2 12.8 12.0 16.3 24.8 12.4 40.0 19.2 11.5 11.5 20.8 26.4 1.0 6.9 5.3 3.6 3.6 21.7 3.5 16.8 7.9 23.2 13.6 11.3 10.7 14.5 15.9 13.1 14.0 11.7 8.9 9.8 0.2 14.3 14.2 14.9 10.8 14.6 11.9 14.4 25.1 12.7 12.3 14.9 22.5 10.7 22.9 12.7 8.4 9.5 11.5 12.9 13.8 14.5 11.3 20.8 38.2 16.3 7.8 24.9 12.5 23.3 16.3 14.5 4.9 16.3 8.2 11.9 22.2 15.9 17.8 14.0 12.3 11.7 13.5 10.4 9.9 15.0 10.5 15.7 11.4 13.0 20.9 20.9 0.1 9.0 5.7 12.7 5.3 3.6 5.1 6.2 1.8 11.0 0.2 15.1 11.6 6.9 1.0 4.6 2.9 2.5 3.6 0.7 0.1 21.7 3.5 14.9 16.2 22.1 17.5 17.8 11.8 13.2 19.2 10.9 12.4 17.9 18.9 4.2 29.5 25.4 12.6 14.4 2.5 10.7 19.4 26.2 7.9 22.8 16.6 20.6 114.5 19.1 12.9 0.0 21.3 24.7 25.6 21.8 9.2 6.4 22.1 6.4 13.8 19.6 15.4 35.0 25.6 26.7 37.1 31.5 16.9 24.6 17.7 17.5 49.1 16.3 10.4 38.8 23.7 68.1 29.6 18.6 18.5 17.5 18.7 17.6 HNRNPM "CEAR, HNRNPM4, HNRPM, HNRPM4, HTGR1, NAGR1" ENSG00000099783 "Heterogeneous nuclear ribonucleoprotein M" P52272 19 8444767-8489114 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016113, HPA024344" Supported Enhanced Nucleoplasm NA NA 170000 Nucleoplasm "CAB016113: AB_627739, HPA024344: AB_1850879" "unprognostic (2.12e-1)" "unprognostic (8.59e-2)" "unprognostic (2.51e-2)" "unprognostic (2.06e-2)" "unprognostic (1.27e-1)" "unprognostic (1.52e-3)" "prognostic unfavorable (1.80e-6)" "unprognostic (2.44e-1)" "unprognostic (2.59e-2)" "unprognostic (6.91e-3)" "unprognostic (4.70e-3)" "unprognostic (7.34e-2)" "unprognostic (3.62e-2)" "unprognostic (1.22e-3)" "unprognostic (1.02e-1)" "unprognostic (2.17e-1)" "unprognostic (1.73e-1)" 41.1 38.3 43.2 57.1 44.8 83.6 39.3 66.1 56.7 41.0 45.8 32.8 45.7 42.0 51.5 35.5 54.5 40.7 41.2 38.3 40.4 29.0 38.9 53.9 37.9 55.7 36.4 35.5 56.3 36.0 57.6 42.2 44.8 37.5 37.9 41.1 35.7 40.4 52.4 98.8 43.4 40.8 48.7 39.6 50.1 38.3 41.0 45.4 91.7 41.4 40.0 64.7 37.9 64.3 26.0 32.4 16.5 35.0 30.6 36.6 28.2 61.8 42.0 79.8 31.9 18.3 20.4 50.8 37.4 28.1 46.6 35.5 59.8 19.0 91.4 49.9 33.7 33.5 38.2 81.3 46.7 58.7 57.0 67.1 81.1 42.7 57.2 19.0 82.8 43.4 21.0 23.7 39.5 16.5 13.7 41.7 34.4 81.3 26.3 36.9 42.1 79.5 71.8 68.6 34.1 51.2 89.7 69.2 43.2 24.5 60.0 43.9 48.8 62.8 33.9 35.0 39.8 40.3 49.4 48.4 40.7 49.3 42.7 69.7 38.6 71.1 106.1 30.5 67.6 44.2 6.9 28.2 16.5 36.0 35.0 36.6 26.0 31.4 35.9 32.2 24.6 34.0 33.0 7.7 30.6 25.7 32.4 31.6 28.2 43.2 44.8 66.1 56.7 40.4 29.0 36.4 35.5 37.5 45.4 119.1 188.2 159.3 181.9 147.8 207.0 80.6 96.8 250.3 285.5 111.7 66.8 237.5 82.9 166.9 9.2 145.2 70.1 116.8 237.4 247.6 125.5 75.8 253.7 134.1 152.1 130.3 182.7 108.6 128.8 17.2 105.0 125.4 104.6 223.6 109.3 163.0 169.0 103.7 133.7 73.2 167.9 207.0 191.9 152.3 129.3 119.7 219.3 156.9 140.9 130.8 HNRNPR "hnRNP-R, HNRPR" ENSG00000125944 "Heterogeneous nuclear ribonucleoprotein R" O43390 1 23303771-23344336 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011687, HPA026092" Supported Enhanced Nucleoplasm NA NA 50000 Nucleoplasm "CAB011687: AB_2295532, HPA026092: AB_1850885" "unprognostic (1.86e-1)" "unprognostic (2.12e-1)" "unprognostic (1.45e-2)" "unprognostic (1.17e-1)" "unprognostic (1.92e-1)" "unprognostic (5.70e-2)" "prognostic unfavorable (1.32e-5)" "unprognostic (2.29e-2)" "unprognostic (1.67e-2)" "unprognostic (3.01e-1)" "unprognostic (1.15e-3)" "unprognostic (3.28e-2)" "unprognostic (7.65e-2)" "unprognostic (1.37e-1)" "unprognostic (4.95e-2)" "unprognostic (4.14e-2)" "unprognostic (4.12e-1)" 27.1 30.4 31.2 36.1 34.7 33.8 31.2 41.0 32.2 32.4 27.4 34.3 29.5 26.5 42.2 23.7 33.2 32.7 20.3 25.6 29.1 27.9 25.1 25.1 28.1 39.6 35.0 27.9 44.3 32.8 40.5 40.9 40.9 27.5 27.3 31.3 26.5 28.1 27.7 31.1 27.8 26.8 41.0 34.1 28.8 24.9 20.3 40.0 68.3 29.9 29.7 40.9 29.0 29.4 21.9 23.6 20.8 23.2 26.1 28.5 19.8 36.7 22.9 47.0 27.8 16.8 16.8 22.2 25.0 25.5 35.3 25.5 15.7 25.5 45.0 12.3 30.3 21.3 21.2 48.5 32.4 46.3 31.2 32.9 43.0 30.3 28.3 17.0 53.2 29.0 18.7 20.0 33.1 26.8 18.0 26.2 34.8 38.6 31.4 27.1 21.1 60.7 15.5 26.5 25.4 21.1 43.5 45.9 31.7 23.8 18.0 30.0 31.3 32.8 27.8 20.2 27.0 22.3 23.8 26.5 23.7 32.4 29.0 29.6 19.9 29.6 60.7 17.9 45.5 25.8 8.7 18.5 20.8 25.4 22.5 27.7 21.9 24.3 25.2 23.6 20.1 26.3 24.4 6.6 26.1 23.2 13.9 28.5 19.8 31.2 34.7 41.0 32.2 29.1 27.9 35.0 27.9 27.5 40.0 110.2 90.3 90.8 156.4 113.3 122.1 64.1 76.5 147.2 144.5 83.7 41.2 198.0 77.9 84.8 12.3 105.1 51.1 23.3 109.3 227.4 125.2 131.2 163.3 64.4 93.4 119.2 111.7 58.3 74.5 13.1 111.9 91.5 79.2 159.7 84.5 155.0 99.5 59.6 109.6 54.2 110.8 84.1 129.6 143.8 153.0 113.4 172.9 111.0 103.7 158.3 HNRNPU "C1orf199, FLJ30202, FLJ37978, hnRNPU, HNRNPU-AS1, HNRPU, NCRNA00201, SAF-A" ENSG00000153187 "Heterogeneous nuclear ribonucleoprotein U" Q00839 1 244840638-244864560 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Cell division, Differentiation, Host-virus interaction, Mitosis, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor, Ribonucleoprotein, RNA-binding" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011532, HPA041057, HPA058707" Supported Enhanced Nucleoplasm NA NA 840000 Nucleoplasm "CAB011532: AB_732983, HPA041057: AB_2677278, HPA058707: AB_2683796" "unprognostic (1.38e-1)" "unprognostic (1.67e-1)" "unprognostic (1.31e-2)" "unprognostic (1.99e-1)" "unprognostic (3.63e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (8.88e-5)" "unprognostic (2.26e-2)" "unprognostic (4.09e-3)" "unprognostic (1.87e-2)" "unprognostic (6.59e-2)" "unprognostic (1.12e-2)" "unprognostic (7.45e-2)" "unprognostic (1.21e-1)" "unprognostic (3.01e-2)" "unprognostic (2.98e-1)" "unprognostic (4.62e-1)" 55.6 57.5 55.3 55.3 68.1 87.3 60.9 80.2 61.7 53.4 47.9 57.7 49.6 38.9 61.4 74.9 53.3 55.9 48.0 47.4 53.3 51.5 68.5 61.2 45.1 52.2 60.5 51.8 76.0 51.7 85.9 48.6 55.4 47.2 56.5 51.1 43.9 49.0 54.3 69.7 43.9 50.3 58.0 55.4 62.3 49.4 47.8 64.5 121.5 61.7 41.5 64.3 57.5 97.9 17.3 25.1 17.0 11.7 15.1 21.7 7.3 47.9 38.6 51.3 40.2 26.9 23.3 50.4 34.4 22.2 31.6 28.2 36.9 32.0 75.9 32.3 29.0 30.3 37.8 68.6 39.0 50.3 31.9 46.0 65.4 34.2 56.3 28.3 74.8 39.8 26.2 23.6 34.4 36.6 28.4 32.3 47.9 85.1 28.2 42.6 34.3 79.6 77.8 89.0 36.0 35.2 79.9 64.0 41.2 50.9 35.4 42.9 42.3 54.2 35.9 41.6 39.1 49.4 84.4 38.9 31.7 46.7 33.7 60.7 46.6 50.8 74.0 26.0 64.2 45.3 14.1 11.7 15.5 15.3 10.1 16.2 17.3 18.6 18.4 12.4 17.0 21.7 18.3 17.0 15.1 11.0 25.1 15.8 7.3 55.3 68.1 80.2 50.4 53.3 51.5 60.5 51.8 47.2 64.5 303.7 307.6 169.4 272.6 241.0 145.0 162.6 101.9 311.8 396.9 183.2 172.8 181.9 82.9 177.3 334.5 193.4 127.0 0.0 156.7 227.3 175.2 162.2 346.3 111.1 161.8 133.5 190.1 114.8 193.9 392.9 142.4 255.5 116.4 215.6 139.7 150.4 156.6 124.3 134.0 103.9 204.8 142.3 205.0 166.3 161.8 209.2 211.3 200.3 159.5 244.9 HNRNPUL1 "E1B-AP5, E1BAP5, FLJ12944, HNRPUL1" ENSG00000105323 "Heterogeneous nuclear ribonucleoprotein U like 1" Q9BUJ2 19 41262496-41307598 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046290, CAB046477, HPA049475" Enhanced Enhanced Nucleoplasm NA NA 20000 Nucleoplasm "CAB046477: AB_2120664, HPA046290: AB_2679616, HPA049475: AB_2680783" "unprognostic (5.52e-2)" "unprognostic (6.37e-2)" "unprognostic (4.55e-2)" "prognostic unfavorable (1.84e-5)" "unprognostic (1.39e-1)" "unprognostic (4.29e-2)" "unprognostic (3.45e-3)" "unprognostic (1.94e-1)" "unprognostic (6.08e-2)" "unprognostic (2.86e-1)" "unprognostic (1.76e-1)" "unprognostic (3.59e-2)" "unprognostic (5.78e-2)" "unprognostic (2.32e-1)" "unprognostic (1.66e-1)" "unprognostic (8.05e-2)" "unprognostic (2.39e-1)" 44.8 37.1 31.0 40.7 32.2 72.3 40.4 35.9 40.3 48.9 48.0 47.3 38.1 38.6 50.3 33.3 43.6 41.4 43.6 52.9 28.9 24.6 29.1 28.4 39.0 45.5 30.8 26.7 58.8 44.9 34.3 33.7 27.9 28.8 38.3 35.8 40.8 45.4 44.7 50.9 48.4 40.1 55.5 29.7 41.2 39.6 54.3 34.5 85.2 39.6 45.9 50.2 52.7 44.1 9.4 13.0 13.2 6.7 11.5 19.3 4.8 58.1 77.5 46.0 42.4 22.7 27.1 17.6 35.6 40.8 44.3 40.6 45.1 44.8 52.2 24.3 42.5 24.8 19.2 43.4 40.1 50.3 51.0 37.7 57.7 35.8 35.0 26.5 53.8 53.6 29.0 25.3 39.5 36.7 39.8 41.1 39.4 41.1 49.4 39.1 44.4 68.4 31.6 35.1 55.6 28.3 44.7 37.4 29.0 32.4 61.6 36.8 33.6 78.4 45.1 20.2 32.9 34.6 59.9 40.8 49.9 48.6 22.7 65.8 58.2 37.4 49.1 31.6 43.9 65.7 9.0 5.9 9.4 12.3 6.2 19.3 8.6 14.9 12.6 6.7 9.4 10.1 8.0 13.2 11.5 6.7 13.0 9.8 4.8 31.0 32.2 35.9 40.3 28.9 24.6 30.8 26.7 28.8 34.5 74.5 69.5 91.1 39.9 49.9 61.0 56.5 33.1 53.5 34.2 29.6 68.7 44.1 38.1 50.3 36.2 49.6 41.7 93.5 54.0 50.7 57.7 39.1 56.7 37.5 55.7 46.1 73.6 58.9 80.2 56.6 80.0 61.8 33.7 61.3 60.4 65.5 55.5 31.6 67.1 24.6 98.2 77.6 60.1 100.8 116.2 52.7 44.6 105.4 68.9 37.6 HNRNPUL2 "DKFZp762N1910, HNRPUL2" ENSG00000214753 "Heterogeneous nuclear ribonucleoprotein U like 2" Q1KMD3 11 62712630-62727349 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA041632, HPA056696, HPA067699" Supported Enhanced Nucleoplasm NA NA 23000 Nucleoplasm "HPA041632: AB_10960896, HPA056696: AB_2683211, HPA067699: AB_2685891" "unprognostic (3.06e-3)" "unprognostic (2.31e-1)" "unprognostic (7.48e-2)" "unprognostic (9.27e-3)" "unprognostic (4.38e-2)" "unprognostic (1.95e-1)" "unprognostic (1.91e-2)" "unprognostic (2.21e-1)" "unprognostic (2.83e-1)" "unprognostic (4.99e-3)" "unprognostic (2.35e-1)" "unprognostic (6.43e-2)" "unprognostic (2.50e-1)" "unprognostic (3.92e-2)" "unprognostic (2.17e-1)" "unprognostic (2.33e-2)" "unprognostic (6.45e-2)" 26.6 17.3 35.3 24.5 42.1 22.1 25.8 52.1 42.3 28.1 32.2 23.5 22.9 26.8 27.6 37.0 28.5 23.7 27.2 23.7 31.9 29.6 24.2 19.5 24.0 30.1 32.8 35.2 26.3 25.3 33.1 19.5 26.9 27.7 26.3 27.8 21.6 28.0 31.2 38.8 35.1 28.6 34.2 26.7 29.5 24.0 17.1 28.4 36.6 20.8 14.8 34.6 26.6 31.3 4.0 5.0 4.4 3.8 2.6 5.1 1.7 35.9 17.1 28.9 17.3 16.3 20.0 4.8 23.2 14.3 18.6 14.4 11.8 12.6 42.4 11.9 19.8 15.7 20.3 18.0 22.9 25.0 17.9 9.3 39.8 22.2 13.3 14.5 41.6 26.7 15.5 18.1 17.5 21.9 14.4 22.6 11.0 15.0 16.2 21.3 21.6 41.3 37.8 13.6 13.7 13.8 29.1 26.4 20.2 23.2 22.6 17.1 19.1 24.0 20.4 24.4 14.5 14.9 18.1 24.5 21.6 9.5 26.7 24.4 20.3 16.8 42.0 19.4 20.1 19.7 3.2 2.9 4.4 5.1 1.9 3.7 3.4 3.7 4.3 1.7 4.0 2.9 3.6 3.8 2.6 3.8 5.0 3.3 1.7 35.3 42.1 52.1 42.3 31.9 29.6 32.8 35.2 27.7 28.4 26.8 8.9 31.2 12.6 26.2 27.8 37.2 33.1 8.1 13.6 50.6 9.8 21.3 5.0 24.6 5.7 28.7 53.9 0.0 31.1 22.2 25.3 20.4 15.0 34.6 32.7 39.7 36.9 39.3 58.6 5.2 38.9 27.8 13.5 22.6 52.8 16.6 29.1 47.2 43.2 21.9 17.9 32.3 27.8 12.9 20.1 28.1 21.1 24.9 53.4 15.9 HOMEZ KIAA1443 ENSG00000215271 "Homeobox and leucine zipper encoding" Q8IX15 14 23272422-23299447 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Early spermatids: 220.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036316, HPA036317" Approved Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA036316: AB_2675056, HPA036317: AB_10669787" "unprognostic (3.70e-2)" "unprognostic (7.58e-2)" "unprognostic (6.36e-2)" "unprognostic (3.93e-2)" "unprognostic (9.11e-2)" "unprognostic (5.23e-2)" "unprognostic (1.20e-2)" "unprognostic (1.59e-2)" "unprognostic (1.37e-1)" "prognostic favorable (2.41e-5)" "unprognostic (2.23e-1)" "unprognostic (1.77e-1)" "prognostic favorable (1.17e-11)" "unprognostic (2.62e-1)" "unprognostic (2.00e-1)" "prognostic favorable (1.75e-4)" "unprognostic (3.23e-1)" 7.6 8.3 6.6 7.2 6.8 1.7 9.2 4.6 6.6 9.3 8.5 12.1 18.5 8.1 8.4 11.2 14.4 9.1 12.7 8.9 6.4 5.1 11.6 8.8 7.2 6.4 6.5 5.4 12.5 11.0 8.0 7.0 6.6 7.2 11.1 7.6 12.2 13.6 22.0 12.0 9.1 8.4 8.6 7.6 8.1 9.9 39.9 7.4 16.0 14.7 6.3 11.3 12.9 8.3 4.3 7.4 10.8 7.2 3.6 6.3 3.9 4.3 4.4 8.5 8.2 13.4 5.9 9.5 4.8 6.2 4.5 5.6 1.8 9.5 9.5 3.9 4.4 10.7 14.6 11.4 11.6 5.6 5.1 3.9 3.3 3.6 8.8 16.8 4.8 2.8 9.2 11.9 3.4 7.7 10.2 8.6 11.0 9.2 4.0 7.9 9.8 3.7 3.4 3.4 13.8 2.6 5.8 6.4 4.1 8.6 18.3 2.7 3.5 4.5 12.9 5.1 13.9 7.8 5.9 9.1 3.2 1.4 3.9 2.1 16.0 6.8 3.3 1.7 3.5 4.6 4.1 7.2 10.8 5.7 7.1 4.6 4.3 4.9 4.8 7.4 3.9 5.4 6.3 1.4 3.6 4.9 4.7 6.2 3.9 6.6 6.8 4.6 6.6 6.4 5.1 6.5 5.4 7.2 7.4 6.0 6.5 6.9 14.8 2.5 4.7 6.5 10.2 6.7 9.1 22.7 5.9 6.0 11.6 9.6 220.5 3.5 6.3 0.0 9.5 5.4 4.6 9.3 3.5 4.4 7.6 9.5 3.5 5.5 2.9 54.5 6.4 5.5 3.3 20.8 9.8 6.8 8.8 3.5 7.1 15.1 3.4 6.5 3.8 5.7 4.5 4.4 7.8 2.9 9.3 27.4 HORMAD1 "CT46, DKFZP434A1315" ENSG00000143452 "HORMA domain containing 1" Q86X24 1 150698060-150720888 "Predicted intracellular proteins" "Differentiation, Meiosis, Oogenesis, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 78.1" "Cell type enriched" "Detected in some" 6 "Spermatocytes: 709.1" "Cancer enhanced" "Detected in many" "testis cancer: 6.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "classical monocyte: 1.2;neutrophil: 4.4" "Group enriched" "Detected in many" 4 "granulocytes: 4.4;monocytes: 1.2" "Cell line enhanced" "Detected in some" "A549: 5.7;HeLa: 4.5;hTCEpi: 19.4;SiHa: 5.9;SuSa: 6.8;THP-1: 11.2;U-2 OS: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA028346, HPA037850" Enhanced Approved Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA028346: AB_2672564, HPA037850: AB_10696358" "unprognostic (7.21e-2)" "unprognostic (7.88e-2)" "unprognostic (1.05e-1)" "unprognostic (8.15e-2)" "unprognostic (9.06e-2)" "unprognostic (3.91e-3)" "unprognostic (4.08e-2)" "unprognostic (1.76e-1)" "unprognostic (1.50e-1)" "unprognostic (1.72e-1)" "unprognostic (1.56e-2)" "unprognostic (5.17e-3)" "unprognostic (3.79e-9)" "unprognostic (3.32e-2)" "unprognostic (1.18e-1)" "unprognostic (1.27e-1)" "unprognostic (3.49e-2)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 1.8 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 3.2 0.1 0.1 0.1 0.4 0.0 78.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.6 4.4 1.2 0.0 0.2 0.1 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.1 0.0 0.1 4.5 0.0 0.0 0.0 0.1 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.9 0.0 0.1 6.8 0.0 11.2 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 1.2 0.3 0.2 0.4 0.0 0.2 0.1 0.0 0.6 0.1 0.0 0.0 4.4 0.0 0.5 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 54.2 0.1 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.6 22.1 4.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 32.3 0.1 709.1 118.4 8.2 1.8 0.0 0.0 0.0 HORMAD2 "CT46.2, MGC26710" ENSG00000176635 "HORMA domain containing 2" Q8N7B1 22 30080174-30177075 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 21.3" "Cell type enriched" "Detected in some" 4 "Spermatocytes: 115.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "THP-1: 1.2;U-2197: 3.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA003074, HPA043880" Enhanced Supported Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA003074: AB_1850916, HPA043880: " "unprognostic (1.43e-1)" "unprognostic (6.77e-3)" "unprognostic (2.33e-1)" "unprognostic (1.36e-2)" "unprognostic (8.19e-3)" "unprognostic (1.96e-1)" "unprognostic (2.50e-2)" "unprognostic (2.12e-1)" 0.1 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 3.4 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 21.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.3 0.1 0.1 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 1.3 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 115.1 2.7 0.0 0.0 0.0 0.0 0.0 HOXA10 "HOX1, HOX1H" ENSG00000253293 "Homeobox A10" P31260 7 27170591-27180261 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 48.2;endometrium 1: 45.6" "Cell type enhanced" "Detected in many" 11 "Fibroblasts: 28.2;Intestinal endocrine cells: 65.4;Mucus-secreting cells: 25.9;Paneth cells: 38.6;Undifferentiated cells: 27.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basophil: 7.8;NK-cell: 12.7" "Group enriched" "Detected in many" 4 "granulocytes: 7.8;NK-cells: 12.7" "Cell line enhanced" "Detected in many" "HEK 293: 56.0;THP-1: 29.4;U-937: 30.5" "Not detected" "Not detected" "Not detected" "Not detected" "CAB019384, HPA071918" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "CAB019384: , HPA071918: " "unprognostic (4.98e-2)" "unprognostic (5.66e-2)" "unprognostic (1.93e-1)" "unprognostic (1.47e-1)" "unprognostic (3.01e-2)" "unprognostic (2.73e-3)" "unprognostic (2.61e-2)" "unprognostic (1.41e-2)" "unprognostic (8.05e-2)" "unprognostic (2.71e-2)" "unprognostic (3.83e-3)" "unprognostic (1.57e-1)" "unprognostic (7.13e-2)" "unprognostic (8.46e-3)" "unprognostic (1.03e-1)" "unprognostic (1.90e-1)" "unprognostic (1.35e-2)" 5.9 2.7 0.3 4.6 0.4 1.2 2.5 0.3 0.3 48.2 15.9 0.3 4.0 0.0 45.6 5.4 0.3 3.4 0.5 0.3 0.3 0.0 7.9 0.3 0.3 0.5 0.3 0.3 1.3 0.3 0.0 0.3 7.7 0.3 22.2 5.3 0.3 0.6 6.6 28.0 2.4 3.1 19.2 0.4 0.3 0.0 3.4 0.3 2.2 0.3 0.3 0.3 19.0 7.6 0.2 1.2 7.8 0.1 12.7 2.3 0.3 6.2 1.3 0.0 18.7 9.4 9.1 0.0 12.4 8.5 5.7 5.3 1.8 5.5 0.0 3.5 9.7 0.0 7.0 4.8 0.0 4.2 2.8 56.0 6.5 4.8 0.1 0.2 2.8 9.9 5.7 0.3 0.4 0.0 0.0 8.6 1.9 0.2 0.0 4.1 0.0 0.0 19.0 0.0 5.0 5.9 0.6 1.2 0.0 10.9 2.9 14.8 0.0 4.3 0.0 0.0 2.1 0.0 29.4 0.0 0.0 5.2 6.6 0.0 0.1 0.0 0.0 0.0 30.5 0.1 7.8 0.1 0.3 2.3 0.0 0.0 0.1 0.0 0.2 1.2 0.2 0.0 0.0 0.0 12.7 0.0 0.4 0.0 0.3 0.3 0.4 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.0 0.0 5.8 3.3 0.0 1.0 0.0 0.0 0.0 7.0 0.0 0.4 16.6 0.0 0.0 0.2 18.7 0.0 0.0 0.4 28.2 11.3 0.0 0.0 0.7 0.0 65.4 0.0 4.6 0.0 0.0 2.3 5.0 0.0 25.9 0.0 0.0 38.6 0.4 20.7 0.0 0.0 12.7 1.4 2.3 3.6 0.5 4.4 27.1 7.4 HOXA11 "HOX1, HOX1I" ENSG00000005073 "Homeobox A11" P31270 7 27181510-27185223 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 35.7;endometrium 1: 60.9;smooth muscle: 27.3" "Cell type enhanced" "Detected in some" 10 "Distal tubular cells: 5.0;Fibroblasts: 4.3;Intestinal endocrine cells: 5.1;Smooth muscle cells: 2.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 14.7;BJ hTERT+: 17.8;HEK 293: 25.0;THP-1: 17.9;U-937: 23.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA006770, HPA035623" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA006770: AB_2667672, HPA035623: AB_10601576" "unprognostic (5.95e-2)" "unprognostic (9.23e-2)" "unprognostic (3.07e-2)" "unprognostic (2.70e-2)" "unprognostic (6.29e-2)" "unprognostic (9.78e-2)" "unprognostic (2.82e-3)" "unprognostic (4.36e-2)" "unprognostic (1.61e-2)" "unprognostic (3.05e-2)" "unprognostic (2.08e-3)" "unprognostic (1.73e-2)" "prognostic unfavorable (2.57e-5)" "unprognostic (2.17e-2)" "unprognostic (6.90e-2)" "unprognostic (2.03e-2)" "unprognostic (2.56e-1)" 1.5 0.4 0.0 1.7 0.0 0.0 2.0 0.0 0.0 35.7 9.3 0.0 5.7 0.0 60.9 8.8 0.0 0.7 0.0 0.2 0.0 0.0 3.6 0.1 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 9.0 0.0 16.5 2.4 0.0 0.1 6.3 4.9 0.7 0.2 27.3 0.0 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.0 20.1 6.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.3 0.1 0.0 6.8 8.4 5.9 0.0 14.7 17.8 10.5 7.5 0.1 0.8 0.0 3.4 12.5 0.0 1.6 8.7 0.0 7.7 0.8 25.0 3.1 6.1 0.3 0.5 6.2 0.9 3.7 0.3 0.0 0.0 0.0 7.6 0.6 0.2 0.0 1.1 0.1 0.0 4.8 0.0 2.1 7.4 0.4 0.0 0.1 5.0 4.3 3.2 0.0 3.6 0.0 1.0 2.1 0.6 17.9 0.0 0.1 7.2 1.6 0.7 0.0 0.0 0.0 0.1 23.4 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 5.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 4.3 2.0 0.0 0.0 0.3 0.0 5.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.6 0.7 HOXA13 "HOX1, HOX1J" ENSG00000106031 "Homeobox A13" P31271 7 27193503-27200106 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 48.5;prostate: 25.1" "Group enriched" "Detected in some" 15 "Basal glandular cells: 2.9;Enterocytes: 7.7;Fibroblasts: 3.5;Glandular cells: 4.8;Intestinal endocrine cells: 8.1;Mucus-secreting cells: 9.8;Paneth cells: 5.8;Undifferentiated cells: 9.7;Urothelial cells: 2.8" "Cancer enhanced" "Detected in many" "prostate cancer: 10.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 15.5;HEK 293: 21.6;PC-3: 10.7;RT4: 23.9;THP-1: 10.2;U-937: 11.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046098, HPA069061" Supported "Nucleoplasm,Mitotic chromosome,Intermediate filaments" NA NA Nucleoplasm "Mitotic chromosome, Intermediate filaments" "HPA046098: AB_2679536, HPA069061: " "unprognostic (7.20e-2)" "unprognostic (1.89e-1)" "unprognostic (1.02e-1)" "unprognostic (8.04e-4)" "unprognostic (1.06e-3)" "unprognostic (2.24e-2)" "unprognostic (1.79e-1)" "unprognostic (1.40e-2)" "unprognostic (9.22e-3)" "unprognostic (7.30e-3)" "unprognostic (8.39e-3)" "unprognostic (1.54e-1)" "unprognostic (1.42e-11)" "unprognostic (2.58e-3)" "unprognostic (1.38e-1)" "unprognostic (1.72e-1)" "unprognostic (1.36e-2)" 0.6 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.1 48.5 6.9 0.0 7.1 0.0 5.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 16.5 0.0 25.1 8.6 0.0 0.1 17.9 1.2 0.4 0.1 15.7 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 12.1 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.9 0.0 1.4 0.1 0.0 0.0 7.6 8.3 3.0 1.9 1.5 0.1 0.0 0.9 3.5 0.4 0.0 15.5 0.0 2.5 0.0 21.6 1.0 4.1 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 4.9 0.0 6.6 10.7 1.5 0.4 0.0 0.0 23.9 0.4 0.0 1.9 0.0 0.1 1.2 0.0 10.2 0.0 0.3 2.7 0.1 0.1 0.0 0.0 0.0 0.0 11.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 7.7 0.0 0.0 0.1 3.5 4.8 0.0 0.0 0.1 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 9.7 2.8 HOXA2 HOX1K ENSG00000105996 "Homeobox A2" O43364 7 27100354-27102811 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.1" "Cell type enhanced" "Detected in some" 17 "Intestinal endocrine cells: 4.6;Ito cells: 6.2;Melanocytes: 1.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 44 "pons and medulla: 15.7" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.8" "Cell line enhanced" "Detected in some" "AN3-CA: 16.8;HaCaT: 6.9;RPTEC TERT1: 5.5" "Region enriched" "Detected in single" 35 "pons and medulla: 6.1" "Region enriched" "Detected in single" 27 "pons and medulla: 7.7" HPA078220 Approved Nucleoplasm,Vesicles Yes NA "Nucleoplasm, Vesicles" "HPA078220: AB_2686880" "unprognostic (7.30e-2)" "unprognostic (4.90e-4)" "unprognostic (2.81e-1)" "unprognostic (7.43e-4)" "unprognostic (1.44e-1)" "unprognostic (2.01e-2)" "unprognostic (1.17e-1)" "unprognostic (2.96e-1)" "unprognostic (1.85e-3)" "unprognostic (1.48e-2)" "unprognostic (1.84e-1)" "unprognostic (1.58e-2)" "unprognostic (4.98e-9)" "unprognostic (1.34e-1)" "unprognostic (1.33e-1)" "unprognostic (9.36e-2)" "unprognostic (1.28e-2)" 2.7 1.6 0.3 1.9 0.1 0.0 2.6 0.1 0.2 1.4 4.5 0.2 8.7 1.5 3.4 9.7 8.3 6.3 4.9 1.8 0.1 0.0 4.2 0.7 4.7 1.9 0.3 0.1 3.8 0.4 9.6 0.1 0.1 15.7 2.8 3.5 0.1 0.1 4.1 1.2 2.7 4.3 2.4 18.1 2.9 3.7 0.8 0.1 3.8 2.2 2.9 3.3 3.2 3.5 0.0 0.0 1.8 0.3 0.0 0.1 0.0 1.2 0.8 4.2 16.8 0.0 0.0 0.0 0.2 0.1 0.0 0.1 2.2 4.1 0.2 1.9 0.2 2.3 6.9 0.2 0.0 0.0 0.0 2.4 0.0 0.1 0.4 1.9 0.1 0.3 1.0 0.0 3.6 3.4 0.0 2.8 0.4 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.1 1.1 1.0 0.7 0.0 5.5 0.7 1.2 0.0 0.2 0.0 1.1 0.3 0.0 0.0 2.8 0.0 0.2 1.2 0.6 0.0 0.0 0.1 0.1 0.7 3.0 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.1 0.2 0.1 0.0 0.3 0.1 15.7 0.1 0.0 0.0 0.0 0.3 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 4.6 6.2 0.0 0.0 0.0 0.0 1.7 0.0 1.3 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 1.4 0.3 HOXA3 "HOX1, HOX1E" ENSG00000105997 "Homeobox A3" O43365 7 27106184-27152581 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Ito cells: 9.2;Mucus-secreting cells: 14.6;Proximal tubular cells: 11.0;Undifferentiated cells: 13.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 5 "pons and medulla: 6.6" "Cell type enhanced" "Detected in some" "neutrophil: 3.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 19.1;CACO-2: 12.3;CAPAN-2: 32.9;HEK 293: 14.7;WM-115: 17.6" "Region enriched" "Detected in single" 31 "pons and medulla: 2.9" "Region enriched" "Detected in single" 34 "pons and medulla: 5.0" HPA029157 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA029157: AB_10601020" "unprognostic (1.32e-1)" "unprognostic (3.71e-2)" "unprognostic (1.58e-1)" "unprognostic (3.85e-3)" "unprognostic (2.94e-2)" "unprognostic (5.48e-2)" "unprognostic (2.81e-2)" "unprognostic (2.05e-2)" "unprognostic (8.61e-2)" "unprognostic (6.00e-2)" "unprognostic (1.27e-1)" "unprognostic (2.09e-2)" "prognostic unfavorable (2.52e-6)" "unprognostic (1.03e-1)" "unprognostic (1.35e-1)" "unprognostic (3.65e-2)" "unprognostic (5.82e-2)" 5.3 2.6 0.5 11.0 0.5 0.0 8.9 0.5 0.5 3.9 13.7 0.7 9.8 3.9 7.5 7.2 6.9 16.0 4.7 4.7 0.5 0.0 9.9 1.5 5.2 3.5 1.3 0.5 5.5 0.6 5.4 0.5 0.5 6.6 5.6 4.9 0.5 0.5 4.2 7.2 3.8 7.8 3.6 4.7 2.5 6.3 2.7 0.5 6.7 2.5 9.8 2.7 9.4 6.0 0.5 1.3 3.8 1.1 1.3 0.5 0.3 5.7 6.8 0.0 19.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 12.3 32.9 0.9 9.5 0.5 2.6 7.7 0.3 0.8 0.0 0.2 14.7 0.2 0.1 9.9 0.6 0.3 0.3 1.2 0.0 1.5 1.8 0.0 1.8 0.8 0.6 0.1 0.7 0.3 0.0 0.5 0.0 1.6 4.2 6.8 2.2 0.0 5.6 2.6 2.8 0.0 1.0 0.0 2.7 0.3 0.5 0.4 8.1 0.0 1.0 2.0 1.5 0.0 0.0 0.3 0.6 1.2 17.6 1.7 0.2 0.7 0.5 0.2 0.0 0.5 0.3 0.5 1.3 0.1 0.0 0.3 3.8 1.3 1.1 0.1 0.5 0.3 0.5 0.5 0.5 0.5 0.5 0.0 1.3 0.5 6.6 0.5 0.0 0.0 0.0 3.0 1.0 0.0 0.6 0.0 0.0 0.0 3.5 0.0 0.0 5.0 0.0 6.5 1.4 5.0 0.0 0.0 0.0 1.1 2.2 1.1 0.0 0.1 0.0 4.1 9.2 0.3 7.3 0.6 0.0 3.3 0.0 14.6 0.0 0.0 7.0 0.0 11.0 0.0 0.0 4.2 1.2 0.4 1.1 0.0 0.0 13.6 2.6 HOXA6 "HOX1, HOX1B" ENSG00000106006 "Homeobox A6" P31267 7 27145396-27150603 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 10.4" "Cell type enhanced" "Detected in some" 12 "Distal tubular cells: 5.0;Enterocytes: 3.5;Intestinal endocrine cells: 8.6;Paneth cells: 4.8;Undifferentiated cells: 4.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 8 "basophil: 5.9;NK-cell: 2.0" "Group enriched" "Detected in many" 8 "granulocytes: 5.9;NK-cells: 2.0" "Group enriched" "Detected in some" 9 "AN3-CA: 29.3;HEK 293: 39.9" "Region enriched" "Detected in single" 34 "pons and medulla: 3.5" "HPA004203, HPA077900" Approved Supported "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA004203: AB_1079079, HPA077900: " "unprognostic (1.70e-1)" "unprognostic (6.76e-3)" "unprognostic (2.70e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.06e-1)" "unprognostic (6.06e-2)" "unprognostic (9.73e-2)" "unprognostic (6.32e-2)" "unprognostic (2.94e-2)" "unprognostic (7.82e-2)" "unprognostic (2.17e-1)" "prognostic favorable (2.03e-4)" "unprognostic (1.45e-1)" "unprognostic (2.81e-2)" "unprognostic (3.93e-1)" 3.2 2.9 0.0 1.2 0.0 0.0 2.3 0.0 0.0 1.6 5.4 0.0 6.7 4.6 0.1 10.4 0.0 0.0 0.0 0.0 5.9 0.0 2.3 0.8 0.0 0.0 0.0 0.5 0.0 0.0 2.5 1.5 0.0 2.2 1.0 3.2 4.2 1.4 1.0 0.0 1.2 0.0 0.0 0.0 4.3 1.3 0.1 0.5 5.9 0.1 2.0 0.2 0.0 0.5 0.9 0.0 29.3 0.0 0.0 0.1 0.2 0.3 0.2 0.3 0.7 3.4 0.7 1.1 0.2 0.1 1.3 0.7 0.0 0.0 0.8 39.9 0.4 0.5 0.4 0.0 0.6 1.0 2.4 0.0 0.0 0.3 0.0 1.3 0.9 0.2 0.0 0.3 0.3 0.0 0.1 0.0 0.1 1.0 3.8 0.0 0.0 2.8 1.8 3.1 0.0 1.3 0.1 0.6 0.0 0.3 0.3 0.0 0.0 0.4 1.6 1.0 0.0 0.0 0.6 0.0 2.8 2.9 5.9 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 2.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 5.0 0.0 0.0 0.1 3.5 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.1 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 4.8 0.0 1.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 4.4 1.0 HOXA7 "HOX1, HOX1A" ENSG00000122592 "Homeobox A7" P31268 7 27153716-27157936 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 27.8" "Group enriched" "Detected in many" 5 "Distal tubular cells: 111.0;Proximal tubular cells: 39.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 14 "pons and medulla: 9.2" "Cell type enriched" "Detected in some" 5 "NK-cell: 7.7" "Lineage enriched" "Detected in many" 5 "NK-cells: 7.7" "Cell line enhanced" "Detected in many" "HAP1: 19.7;RPTEC TERT1: 24.4;SCLC-21H: 19.7" "Region enriched" "Detected in single" 12 "pons and medulla: 1.4" "Region enriched" "Detected in single" 10 "pons and medulla: 2.9" HPA074048 Supported "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA074048: AB_2686655" "unprognostic (5.40e-2)" "unprognostic (2.34e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (7.87e-5)" "unprognostic (3.30e-1)" "unprognostic (2.53e-1)" "unprognostic (3.02e-1)" "unprognostic (3.24e-2)" "unprognostic (2.14e-1)" "unprognostic (1.83e-1)" "unprognostic (1.04e-2)" "unprognostic (1.14e-1)" "prognostic favorable (1.15e-5)" "unprognostic (9.08e-2)" "unprognostic (8.90e-2)" "unprognostic (2.58e-1)" "unprognostic (1.25e-1)" 6.5 14.5 0.2 4.8 0.2 0.0 11.2 0.3 0.6 7.3 10.0 0.2 7.9 0.0 5.0 15.4 3.0 12.2 0.5 0.2 0.2 0.0 25.4 0.4 2.6 3.5 0.2 0.2 6.2 0.2 0.3 0.2 1.3 9.2 8.2 7.2 0.2 0.2 8.9 27.8 8.2 6.1 8.1 14.3 3.7 3.2 2.7 0.2 1.6 0.9 0.2 1.1 11.4 6.7 0.2 0.9 0.0 0.0 7.7 1.6 0.2 6.9 2.4 0.0 7.5 0.0 0.0 0.4 2.5 4.3 5.2 6.0 3.6 2.7 4.8 7.0 1.9 0.2 4.8 19.7 0.0 3.1 0.0 12.4 0.3 2.8 0.1 0.5 0.4 0.2 4.1 0.2 0.6 7.0 0.0 9.8 8.4 0.0 0.0 1.9 1.2 0.0 1.1 0.3 5.0 0.7 2.5 4.6 0.0 24.4 4.8 19.7 0.0 13.6 0.0 0.0 1.4 0.2 1.9 0.8 0.0 4.7 14.0 2.4 0.0 0.1 0.1 0.0 9.4 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.2 0.9 0.0 0.0 0.1 0.0 7.7 0.0 0.6 0.4 0.2 0.2 0.2 0.3 0.6 0.2 0.0 0.2 0.2 9.2 0.2 0.0 0.0 0.0 7.5 8.0 0.0 0.3 0.0 0.0 0.0 12.2 0.0 0.4 111.0 0.0 15.9 2.2 3.0 0.0 0.0 4.6 2.7 4.0 0.0 0.0 0.2 0.0 15.5 0.0 0.0 2.1 0.6 0.5 3.3 0.0 11.2 0.0 0.1 10.4 0.0 39.0 0.0 0.0 7.3 0.4 0.2 10.8 0.2 0.9 15.7 2.6 HOXA9 "HOX1, HOX1G" ENSG00000078399 "Homeobox A9" P31269 7 27162435-27175180 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 35.1" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 46.4;Intestinal endocrine cells: 37.7;Proximal tubular cells: 60.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basophil: 5.4;myeloid DC: 6.0;NK-cell: 11.7" "Group enriched" "Detected in many" 5 "dendritic cells: 6.0;granulocytes: 5.4;NK-cells: 11.7" "Cell line enhanced" "Detected in some" "HEK 293: 43.6;PC-3: 15.2;RPTEC TERT1: 15.0;SCLC-21H: 40.5;U-937: 14.5" "HPA061982, HPA076200" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA061982: AB_2684651, HPA076200: " "unprognostic (4.72e-1)" "unprognostic (1.23e-2)" "unprognostic (2.86e-1)" "unprognostic (5.24e-3)" "unprognostic (2.36e-1)" "unprognostic (2.02e-1)" "unprognostic (8.35e-2)" "unprognostic (8.44e-3)" "unprognostic (5.50e-2)" "unprognostic (5.71e-2)" "unprognostic (9.87e-3)" "unprognostic (4.42e-2)" "unprognostic (2.80e-3)" "unprognostic (6.45e-2)" "unprognostic (7.58e-2)" "unprognostic (1.92e-2)" "unprognostic (1.35e-1)" 3.2 3.4 0.2 8.8 0.1 2.4 8.7 0.1 0.2 15.5 12.8 0.2 4.1 0.0 10.4 16.8 1.4 12.2 0.3 0.1 0.1 0.0 35.1 0.1 0.8 0.7 0.1 0.1 2.0 0.1 0.0 0.1 1.4 0.4 16.6 4.5 0.2 0.5 5.6 21.0 13.3 8.2 13.1 0.7 1.0 0.0 2.4 0.1 2.6 0.3 0.3 0.3 16.2 11.4 0.5 6.0 5.4 1.0 11.7 1.5 0.5 12.7 0.0 0.0 6.4 2.1 1.6 0.0 5.1 4.1 0.4 0.4 0.8 0.5 0.1 0.5 2.7 0.0 11.9 8.2 0.0 0.4 0.0 43.6 0.1 0.3 0.0 0.2 0.0 0.1 2.2 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 15.2 2.7 0.0 0.0 15.0 0.2 40.5 0.0 5.4 0.0 0.1 0.2 0.0 10.7 0.4 0.0 4.0 4.9 0.0 0.0 0.0 0.0 0.0 14.5 0.0 5.4 1.0 0.0 1.5 0.2 0.2 0.2 0.0 0.1 6.0 0.5 0.3 0.1 0.9 11.7 0.4 1.9 0.2 0.5 0.2 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.8 10.6 22.2 0.0 0.6 0.0 0.0 0.0 17.4 0.0 0.3 46.4 0.0 0.0 0.2 7.9 0.0 0.0 0.3 10.8 14.2 0.0 0.0 0.3 0.0 37.7 0.0 4.8 0.0 0.0 1.6 5.0 0.0 19.1 0.0 0.0 18.4 0.0 60.8 0.0 0.0 3.6 0.0 0.6 24.1 0.2 4.4 19.4 11.5 HOXB13 ENSG00000159184 "Homeobox B13" Q92826 17 48724763-48729178 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "intestine: 18.6;prostate: 38.3" "Cell type enhanced" "Detected in some" 17 "Glandular cells: 62.7;Intestinal endocrine cells: 187.8;Mucus-secreting cells: 92.1;Paneth cells: 66.2;Undifferentiated cells: 64.4" "Cancer enriched" "Detected in many" 17 "prostate cancer: 187.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.3" "Cell line enriched" "Detected in some" 13 "PC-3: 59.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB004438, HPA062852, HPA065019" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004438: AB_627744, HPA062852: AB_2684880, HPA065019: AB_2685406" "unprognostic (4.81e-2)" "unprognostic (2.57e-2)" "unprognostic (4.40e-2)" "unprognostic (1.33e-2)" "unprognostic (5.85e-3)" "unprognostic (1.88e-2)" "unprognostic (1.19e-2)" "unprognostic (3.19e-2)" "unprognostic (1.17e-2)" "unprognostic (6.65e-2)" "unprognostic (1.74e-1)" "unprognostic (4.27e-2)" "unprognostic (4.73e-11)" "unprognostic (1.39e-2)" "unprognostic (4.50e-2)" "unprognostic (1.12e-1)" 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 2.4 10.8 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.4 0.1 38.3 18.6 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 3.6 2.4 0.1 0.2 1.3 0.1 0.1 0.1 0.0 0.6 2.0 0.0 4.6 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.9 1.0 0.0 1.0 0.0 0.5 0.0 3.0 0.0 0.0 0.3 1.4 0.9 0.6 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.1 0.2 0.1 0.0 0.1 0.0 0.7 59.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.9 0.0 1.4 0.2 0.0 0.2 0.0 0.2 1.7 1.7 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 37.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 40.4 0.0 0.0 0.2 0.3 62.7 0.0 0.0 0.1 0.0 187.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 92.1 0.0 0.0 66.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 64.4 6.4 HOXB2 "HOX2, HOX2H" ENSG00000173917 "Homeobox B2" P14652 17 48540894-48544989 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 53.1" "Cell type enhanced" "Detected in many" 13 "Collecting duct cells: 50.6;Distal tubular cells: 132.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in some" 6 "pons and medulla: 12.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 21.0;EFO-21: 20.3;HEK 293: 23.0;HMC-1: 45.9;WM-115: 20.1" "Region enriched" "Detected in single" 34 "pons and medulla: 4.7" "Region enriched" "Detected in single" 29 "pons and medulla: 5.4" HPA047857 Supported Nucleoplasm NA NA Nucleoplasm "HPA047857: AB_2680184" "unprognostic (8.58e-3)" "unprognostic (4.39e-2)" "unprognostic (4.13e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (1.99e-4)" "unprognostic (3.16e-1)" "unprognostic (2.12e-2)" "unprognostic (7.72e-2)" "unprognostic (3.57e-1)" "unprognostic (1.75e-2)" "unprognostic (2.60e-1)" "unprognostic (3.24e-1)" "unprognostic (3.04e-3)" "unprognostic (4.12e-1)" "unprognostic (5.75e-2)" "unprognostic (5.29e-2)" "unprognostic (2.89e-1)" 9.2 11.0 0.2 6.3 0.3 1.9 24.2 0.3 0.2 14.5 15.4 0.4 53.1 2.4 6.9 32.5 19.3 12.2 12.8 4.5 0.5 0.1 25.6 2.8 6.4 4.4 2.0 0.3 6.4 1.6 8.9 0.9 1.7 12.9 8.2 1.7 0.8 0.6 33.2 6.1 3.7 6.4 7.5 19.4 6.8 6.7 2.7 0.2 2.4 3.0 3.9 2.6 7.9 16.3 0.8 6.0 5.0 0.4 2.2 9.5 1.3 0.0 0.7 21.0 0.0 4.8 5.6 0.0 1.9 0.0 0.0 0.0 0.3 0.1 0.0 20.3 5.8 0.0 0.0 3.1 0.0 0.0 0.1 23.0 7.9 0.8 0.0 8.5 0.0 45.9 3.5 0.0 9.1 3.6 0.2 3.3 0.0 15.5 0.0 12.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 10.4 0.0 15.0 1.8 0.0 0.0 1.5 0.0 12.0 1.5 11.0 0.0 0.1 0.0 1.3 0.2 0.0 0.0 0.0 0.0 8.2 0.0 20.1 5.0 0.4 0.0 4.2 0.4 1.3 0.2 6.2 4.7 1.9 0.8 9.5 3.9 0.0 2.2 0.3 6.0 7.3 1.3 0.2 0.3 0.3 0.2 0.5 0.1 2.0 0.3 12.9 0.2 3.0 1.4 5.2 6.2 6.3 0.0 0.8 0.0 1.4 2.3 50.6 0.0 14.4 132.6 0.8 0.6 5.6 0.0 0.0 0.2 23.9 18.1 7.9 20.7 0.0 6.8 0.0 2.4 21.5 12.6 0.9 0.0 11.9 11.8 6.4 1.3 0.0 0.1 1.1 0.0 17.2 0.0 0.0 30.9 1.7 6.8 5.0 20.8 27.4 0.7 21.3 HOXB3 "HOX2, HOX2G" ENSG00000120093 "Homeobox B3" P14651 17 48548870-48604912 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 56.7;epididymis: 44.9;seminal vesicle: 68.4" "Group enriched" "Detected in many" 5 "Collecting duct cells: 94.2;Early spermatids: 27.9;Ito cells: 27.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 20.7;EFO-21: 18.1;HEK 293: 21.9;RPTEC TERT1: 17.0;U-251 MG: 19.5" "Region enriched" "Detected in single" 40 "pons and medulla: 9.3" "Region enriched" "Detected in single" 29 "pons and medulla: 12.9" "CAB009860, HPA064990" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB009860: AB_2119262, HPA064990: AB_2685398" "unprognostic (5.88e-2)" "unprognostic (1.01e-1)" "unprognostic (5.61e-2)" "unprognostic (7.04e-2)" "unprognostic (8.39e-3)" "unprognostic (1.72e-1)" "unprognostic (1.52e-1)" "unprognostic (2.88e-2)" "unprognostic (3.09e-2)" "unprognostic (4.32e-3)" "unprognostic (8.14e-2)" "unprognostic (8.27e-2)" "unprognostic (3.17e-1)" "unprognostic (7.60e-2)" "unprognostic (7.85e-2)" "unprognostic (2.32e-1)" "prognostic favorable (8.45e-6)" 8.3 4.5 1.0 7.3 1.1 0.2 8.0 1.0 1.0 11.3 16.4 1.0 56.7 2.3 10.1 44.9 5.5 17.7 3.6 1.7 1.0 0.0 16.3 1.6 4.8 1.6 1.0 1.0 2.8 1.7 6.7 1.0 3.8 2.6 4.1 4.9 1.0 1.0 68.4 4.0 2.9 11.3 3.5 4.8 6.5 7.8 3.7 1.0 1.0 1.8 1.0 1.1 6.4 5.2 0.1 2.8 1.7 0.9 1.4 1.1 0.4 3.3 7.0 4.7 2.2 3.9 5.5 1.2 0.1 0.0 0.1 0.1 3.2 20.7 1.7 18.1 14.8 2.3 0.1 1.0 0.3 0.0 5.3 21.9 5.1 3.1 0.0 6.4 0.0 13.6 6.4 0.0 6.1 0.4 2.8 6.4 6.7 6.9 0.1 3.8 0.1 0.3 0.1 0.1 6.7 0.7 0.0 3.4 0.7 17.0 3.1 0.0 0.0 0.7 0.0 3.3 3.8 6.6 1.4 7.2 2.2 7.1 1.2 19.5 1.8 2.1 0.1 4.6 0.0 3.8 1.7 0.1 0.0 0.9 0.1 0.4 0.0 0.5 1.1 0.3 0.1 0.8 1.0 0.0 1.4 0.9 2.8 1.1 0.4 1.0 1.1 1.0 1.0 1.0 0.0 1.0 1.0 2.6 1.0 0.0 3.4 0.0 2.3 2.3 0.0 0.8 0.0 0.0 1.2 94.2 0.0 2.5 6.6 0.2 27.9 7.7 7.4 0.0 0.0 0.7 5.1 3.6 8.1 0.2 0.6 0.0 2.4 27.6 2.1 7.9 0.3 1.0 5.0 0.0 6.3 0.0 0.4 3.5 0.4 0.6 0.0 0.0 3.3 4.5 9.2 1.3 0.3 1.3 9.7 4.7 HOXB4 "HOX2, HOX2F" ENSG00000182742 "Homeobox B4" P17483 17 48575513-48580111 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 13.3" "Cell type enhanced" "Detected in many" 15 "Collecting duct cells: 61.1;Cytotrophoblasts: 18.4;Spermatogonia: 21.8" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "EFO-21: 23.4;HEK 293: 11.3;HMC-1: 14.4;K-562: 11.4" "Region enriched" "Detected in single" 36 "pons and medulla: 3.7" "Region enriched" "Detected in single" 23 "pons and medulla: 7.5" HPA057432 Uncertain Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA057432: AB_2683437" "unprognostic (2.71e-2)" "unprognostic (3.87e-2)" "unprognostic (8.97e-3)" "unprognostic (5.39e-3)" "unprognostic (1.14e-2)" "unprognostic (1.66e-1)" "unprognostic (2.65e-2)" "unprognostic (1.59e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (2.23e-4)" "unprognostic (3.22e-2)" "unprognostic (1.14e-1)" "unprognostic (3.41e-1)" "unprognostic (2.10e-1)" "unprognostic (4.85e-2)" "unprognostic (9.25e-3)" "unprognostic (3.41e-3)" 4.4 2.4 0.0 1.5 0.0 0.0 2.9 0.0 0.0 4.2 8.1 1.2 2.3 13.3 2.7 8.5 1.5 0.4 0.0 0.0 5.7 0.7 3.6 0.6 0.0 0.0 0.7 1.8 0.0 1.0 0.6 1.1 0.0 4.8 0.8 0.9 4.3 2.0 2.4 3.0 3.9 0.5 0.6 0.2 1.3 1.7 0.3 2.4 0.0 0.1 0.6 0.7 0.1 0.1 0.3 0.0 0.1 4.9 3.9 1.9 0.0 0.0 0.2 0.1 2.2 2.0 3.1 23.4 1.5 0.4 0.1 4.1 0.0 0.0 8.0 11.3 7.6 0.7 0.0 5.0 0.0 14.4 3.8 0.0 5.7 0.0 0.8 6.6 5.2 11.4 0.2 5.6 0.0 1.8 0.0 0.0 2.1 0.0 0.0 4.4 1.6 4.6 1.9 0.0 0.0 0.6 0.0 2.9 1.6 0.4 1.5 2.5 0.3 0.2 0.8 0.2 1.9 4.0 0.7 1.6 0.0 2.2 0.0 0.1 0.0 0.7 0.0 0.1 0.3 0.2 0.5 0.0 0.1 0.2 0.1 0.0 0.6 0.0 2.4 0.0 0.1 0.0 0.0 1.7 0.9 3.4 0.0 0.8 0.0 1.4 0.0 61.1 0.0 18.4 10.0 0.1 0.0 7.1 0.8 0.0 0.0 11.0 9.7 0.4 3.5 0.0 3.2 0.0 0.0 15.4 1.8 0.0 0.3 1.9 5.0 0.0 2.0 0.0 0.0 1.9 0.0 1.4 0.0 0.0 5.2 0.2 21.8 1.6 5.0 10.5 1.5 2.6 HOXB5 "HOX2, HOX2A" ENSG00000120075 "Homeobox B5" P09067 17 48591257-48593961 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.4;ductus deferens: 25.9;seminal vesicle: 27.6" "Cell type enhanced" "Detected in some" 16 "Collecting duct cells: 50.6;Distal tubular cells: 21.6;Mucus-secreting cells: 13.9" "Cancer enhanced" "Detected in many" "endometrial cancer: 28.1" "Region enriched" "Detected in single" 33 "pons and medulla: 25.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 21.5;RPTEC TERT1: 16.1" "Region enriched" "Detected in single" 90 "pons and medulla: 24.0" "Region enriched" "Detected in single" 128 "pons and medulla: 14.7" "HPA043851, HPA074454" Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA043851: AB_2732509, HPA074454: AB_2686690" "unprognostic (6.50e-2)" "unprognostic (1.63e-1)" "unprognostic (4.22e-2)" "prognostic favorable (6.28e-4)" "unprognostic (6.48e-3)" "unprognostic (7.12e-2)" "unprognostic (8.14e-2)" "prognostic unfavorable (4.61e-4)" "unprognostic (2.47e-1)" "unprognostic (1.47e-3)" "unprognostic (5.10e-2)" "unprognostic (9.64e-2)" "unprognostic (7.61e-3)" "unprognostic (8.08e-3)" "unprognostic (1.35e-1)" "unprognostic (2.86e-2)" "prognostic favorable (8.59e-5)" 3.4 3.1 0.2 2.1 0.2 0.0 5.0 0.2 0.7 5.4 10.5 0.2 25.9 1.5 2.2 18.5 0.6 7.2 0.2 0.7 0.2 0.0 16.0 0.4 5.2 0.8 0.2 0.2 1.9 0.5 0.9 0.2 1.2 25.4 1.3 4.7 0.2 0.6 27.6 0.2 0.5 9.5 1.6 22.5 2.0 4.3 0.7 0.2 0.2 0.7 0.2 0.2 3.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 4.8 0.0 2.5 2.4 2.7 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 5.2 2.7 0.6 0.0 0.2 0.0 0.0 0.0 21.5 0.9 5.6 0.0 4.2 0.0 1.2 1.4 0.0 2.9 0.0 0.8 1.4 0.1 1.6 0.0 3.3 0.0 0.0 0.0 0.0 2.7 1.7 0.0 1.0 0.0 16.1 1.6 0.0 0.0 0.1 0.0 2.3 0.1 0.4 0.0 5.3 0.7 2.1 0.5 0.3 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.7 0.2 0.0 0.2 0.2 25.4 0.2 0.0 0.6 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 50.6 0.0 0.0 21.6 0.0 0.6 2.4 8.9 0.0 0.0 0.0 3.7 0.1 0.0 0.0 0.5 0.0 4.1 9.2 5.0 0.0 0.0 0.0 1.7 0.0 13.9 0.0 0.0 3.5 0.4 0.4 0.0 0.0 1.0 7.2 10.8 0.3 0.0 0.0 11.5 0.0 HOXB6 "HOX2, HOX2B" ENSG00000108511 "Homeobox B6" P17509 17 48595751-48604992 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 73.7;seminal vesicle: 56.7" "Group enriched" "Detected in many" 8 "Collecting duct cells: 129.1;Distal tubular cells: 96.2" "Cancer enhanced" "Detected in many" "endometrial cancer: 32.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 1.5" "Group enriched" "Detected in many" 6 "B-cells: 1.5;T-cells: 1.0" "Cell line enhanced" "Detected in many" "EFO-21: 13.4;HEK 293: 36.8;RPTEC TERT1: 25.0;TIME: 13.9" "Region enriched" "Detected in single" 60 "pons and medulla: 10.6" "Region enriched" "Detected in single" 25 "pons and medulla: 14.6" HPA042063 Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA042063: AB_10796470" "unprognostic (5.01e-2)" "unprognostic (4.48e-2)" "unprognostic (1.99e-1)" "prognostic favorable (2.46e-4)" "unprognostic (1.30e-1)" "unprognostic (8.80e-3)" "unprognostic (5.64e-2)" "unprognostic (2.06e-3)" "unprognostic (3.97e-2)" "unprognostic (1.84e-2)" "unprognostic (6.97e-2)" "unprognostic (6.64e-2)" "unprognostic (2.50e-3)" "unprognostic (2.53e-3)" "unprognostic (5.76e-2)" "unprognostic (7.11e-2)" "unprognostic (4.19e-3)" 5.2 4.3 0.3 18.1 0.3 0.0 3.8 0.3 0.3 12.0 8.5 0.3 73.7 0.5 7.2 30.5 0.4 8.7 0.3 0.3 0.3 0.0 26.6 0.4 3.4 0.3 0.3 0.3 0.6 0.6 1.9 0.3 1.5 0.9 4.3 3.8 0.3 0.3 56.7 1.0 0.6 8.2 1.8 10.0 1.7 5.9 1.8 0.3 0.3 0.3 0.3 0.3 4.2 10.0 1.5 0.2 0.0 0.0 0.0 1.0 0.3 2.3 5.5 0.0 2.9 2.5 2.7 0.0 0.0 0.0 0.0 0.0 2.9 3.6 0.0 13.4 6.5 0.9 0.0 0.6 0.2 0.0 0.1 36.8 3.2 9.1 0.0 3.8 0.2 8.6 3.3 0.1 5.3 0.1 2.0 2.5 0.2 2.1 0.0 7.3 0.1 0.0 0.1 0.0 9.1 2.2 0.0 6.2 0.3 25.0 1.2 0.0 0.0 2.0 0.0 3.6 0.0 0.9 1.2 13.9 0.5 2.9 2.3 10.1 0.0 0.0 0.0 0.4 0.0 4.5 0.0 0.0 0.0 0.7 0.0 0.2 1.4 0.4 1.0 0.2 1.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.9 0.3 0.0 0.0 0.0 0.4 0.7 0.0 0.2 0.0 0.0 0.0 129.1 0.0 0.2 96.2 0.1 0.6 2.2 14.0 0.0 1.6 1.6 2.6 0.3 0.0 0.0 1.4 0.0 7.5 4.9 14.7 0.0 0.9 1.7 0.0 0.0 7.5 0.0 0.9 14.1 0.0 2.1 0.0 0.0 2.1 4.2 6.8 1.0 0.2 1.0 10.3 0.6 HOXB7 "HOX2, HOX2C" ENSG00000260027 "Homeobox B7" P09629 17 48607227-48633572 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 62.3" "Cell type enhanced" "Detected in many" 9 "Collecting duct cells: 82.0;Distal tubular cells: 126.0;Enterocytes: 102.1;Mucus-secreting cells: 73.3;Paneth cells: 56.1;Undifferentiated cells: 65.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 6 "pons and medulla: 4.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 30.4;OE19: 26.5;RPTEC TERT1: 24.2;SK-MEL-30: 28.8" "Region enriched" "Detected in single" 45 "pons and medulla: 6.0" "Region enriched" "Detected in single" 14 "pons and medulla: 1.5" HPA049940 Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA049940: AB_2616461" "unprognostic (6.76e-2)" "unprognostic (6.76e-2)" "unprognostic (1.03e-1)" "unprognostic (1.44e-1)" "unprognostic (1.39e-3)" "unprognostic (1.42e-2)" "unprognostic (1.69e-2)" "unprognostic (8.05e-3)" "unprognostic (9.16e-2)" "unprognostic (9.91e-2)" "unprognostic (7.01e-3)" "unprognostic (7.81e-3)" "unprognostic (1.17e-2)" "unprognostic (1.56e-2)" "unprognostic (1.06e-1)" "unprognostic (2.41e-1)" "prognostic favorable (2.39e-4)" 8.3 8.3 0.0 7.3 0.3 0.1 17.2 0.1 0.6 10.0 8.1 0.1 24.1 0.5 4.1 62.3 0.8 4.2 0.3 1.1 0.0 0.0 23.7 0.8 1.7 2.4 0.1 0.3 2.3 0.6 0.4 0.5 4.1 4.1 5.2 7.0 0.1 0.1 22.1 2.4 2.2 12.4 3.5 20.1 2.2 4.6 3.0 0.2 0.1 0.5 0.1 0.6 5.8 15.1 2.2 1.8 0.0 0.0 2.0 4.7 0.5 16.9 7.4 0.0 0.1 5.3 8.0 0.0 0.0 0.0 0.1 0.3 11.3 0.3 0.3 30.4 7.1 8.8 2.5 0.0 0.0 0.0 7.8 5.5 2.6 5.8 0.0 4.4 0.0 5.5 5.2 2.3 5.2 0.0 1.3 16.0 5.3 2.8 0.1 16.8 4.4 0.3 0.1 0.0 26.5 0.0 0.0 14.4 1.9 24.2 5.7 0.0 0.0 5.7 0.0 28.8 0.4 1.4 1.6 13.7 0.0 9.3 7.5 13.1 0.9 2.2 0.0 0.1 0.0 21.3 0.0 0.0 0.0 3.8 0.0 1.9 1.9 0.7 2.1 0.0 2.2 0.0 1.4 0.0 2.0 0.0 1.8 4.7 0.5 0.0 0.3 0.1 0.6 0.0 0.0 0.1 0.3 4.1 0.2 0.0 0.0 3.7 0.8 4.8 0.0 0.3 0.0 0.0 0.0 82.0 0.0 6.2 126.0 0.0 0.1 2.2 102.1 0.0 1.1 14.9 8.2 0.7 4.7 0.0 8.8 0.0 35.1 1.3 7.8 0.0 0.6 2.8 23.6 2.8 73.3 0.0 0.5 56.1 0.0 27.8 0.0 0.0 8.0 1.4 23.4 1.8 1.5 1.0 65.0 3.1 HOXB8 "HOX2, HOX2D" ENSG00000120068 "Homeobox B8" P17481 17 48611377-48614939 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 49.3;ductus deferens: 45.4;epididymis: 39.2;kidney: 16.1;seminal vesicle: 34.6" "Group enriched" "Detected in some" 7 "Collecting duct cells: 83.7;Distal tubular cells: 61.3;Intestinal endocrine cells: 42.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 33.3" "Region enriched" "Detected in single" 82 "pons and medulla: 8.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 20.9;HDLM-2: 9.4;HEK 293: 21.6;LHCN-M2: 11.0;RPTEC TERT1: 23.0" "Region enriched" "Detected in single" 48 "pons and medulla: 6.8" "Low region specificity" "Detected in many" HPA075905 Supported Nucleoplasm NA NA Nucleoplasm "HPA075905: AB_2686767" "unprognostic (4.44e-1)" "unprognostic (2.60e-1)" "unprognostic (1.01e-1)" "unprognostic (2.13e-1)" "unprognostic (1.94e-2)" "unprognostic (9.07e-5)" "unprognostic (6.63e-3)" "unprognostic (1.40e-3)" "unprognostic (6.00e-2)" "unprognostic (5.66e-3)" "unprognostic (2.93e-2)" "unprognostic (1.14e-2)" "prognostic favorable (1.30e-7)" "unprognostic (1.77e-2)" "unprognostic (6.64e-2)" "unprognostic (4.57e-2)" "unprognostic (2.88e-3)" 3.5 4.3 0.0 1.6 0.0 0.0 2.5 0.0 0.0 7.7 2.1 0.0 45.4 0.0 2.1 39.2 0.0 0.9 0.0 0.0 0.0 0.0 16.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.4 0.2 0.2 8.2 1.9 0.8 0.0 0.1 34.6 0.2 0.4 4.0 1.1 49.3 0.0 4.3 2.8 0.0 0.1 0.1 0.0 0.0 5.0 6.7 0.0 0.0 0.0 0.1 0.0 0.6 0.0 1.1 3.3 0.0 0.4 0.4 0.6 0.4 0.0 0.0 0.0 0.0 0.1 0.4 0.0 20.9 3.3 0.4 0.0 0.0 0.0 0.0 9.4 21.6 0.5 0.0 0.0 0.2 0.0 3.1 0.6 0.0 0.0 0.0 0.4 1.4 0.1 6.2 0.0 11.0 0.0 0.0 0.2 0.0 7.0 0.0 0.0 2.1 0.0 23.0 0.6 0.0 0.0 0.3 0.0 3.1 0.0 0.2 0.0 5.2 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.0 83.7 0.0 0.0 61.3 0.0 0.1 0.5 1.3 0.0 0.0 0.7 0.4 0.2 0.0 0.0 0.2 0.0 42.3 0.0 0.0 0.2 0.3 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.4 4.3 0.0 0.0 0.3 0.5 9.6 0.0 0.0 0.0 4.1 0.0 HOXB9 "HOX2, HOX2E" ENSG00000170689 "Homeobox B9" P17482 17 48621159-48626356 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "ductus deferens: 27.3;epididymis: 42.8;intestine: 16.6;kidney: 15.3;seminal vesicle: 23.5" "Cell type enhanced" "Detected in some" 24 "Collecting duct cells: 55.8;Distal tubular cells: 33.2;Intestinal endocrine cells: 169.5;Mucus-secreting cells: 37.2;Undifferentiated cells: 43.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 56.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 79.2;HEK 293: 30.5;HMC-1: 31.3;K-562: 33.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA004928 Supported Nucleoplasm NA No Nucleoplasm "HPA004928: " "unprognostic (2.16e-2)" "unprognostic (1.46e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (4.47e-4)" "unprognostic (1.38e-4)" "prognostic unfavorable (6.64e-5)" "unprognostic (3.15e-2)" "unprognostic (1.60e-3)" "unprognostic (6.30e-3)" "unprognostic (3.41e-2)" "unprognostic (5.94e-3)" "unprognostic (1.04e-1)" "unprognostic (2.28e-3)" "unprognostic (1.43e-1)" "unprognostic (5.34e-2)" "unprognostic (1.85e-1)" "unprognostic (6.00e-2)" 0.5 0.8 0.1 1.9 0.2 0.0 0.4 0.1 0.3 5.3 16.6 0.1 27.3 0.0 1.4 42.8 0.1 0.4 0.1 0.1 0.1 0.1 15.3 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.4 0.3 0.5 0.2 1.1 10.4 0.1 0.1 23.5 0.2 0.2 11.3 1.0 3.5 0.2 0.2 2.0 0.1 0.1 0.1 0.1 0.1 2.0 2.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 4.1 1.4 0.0 7.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 1.7 0.0 8.5 0.2 0.9 0.0 1.3 0.0 0.0 79.2 30.5 13.8 0.5 0.0 0.5 0.2 31.3 0.0 0.0 0.0 0.8 2.4 0.0 0.6 33.6 0.0 1.3 0.0 0.0 0.1 0.0 1.8 1.3 0.0 5.3 0.4 13.8 0.0 0.0 0.0 1.0 0.0 8.7 0.1 0.1 0.0 0.1 0.0 7.9 0.0 2.4 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 55.8 0.0 0.0 33.2 0.0 0.1 0.2 12.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 169.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 37.2 0.0 0.1 11.5 0.0 0.7 0.0 0.0 0.1 0.5 0.7 0.0 0.0 0.0 43.2 0.1 HOXC10 HOX3I ENSG00000180818 "Homeobox C10" Q9NYD6 12 53985065-53990279 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 16.2;skeletal muscle: 53.2" "Cell type enhanced" "Detected in some" 19 "Basal keratinocytes: 18.8;Distal tubular cells: 53.0;Proximal tubular cells: 81.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 78.1;ASC diff: 23.1;ASC TERT1: 21.3;fHDF/TERT166: 17.9;T-47d: 26.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA053919 Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA053919: AB_2682308" "unprognostic (1.44e-2)" "unprognostic (1.09e-1)" "unprognostic (4.56e-4)" "unprognostic (1.57e-1)" "unprognostic (1.59e-3)" "unprognostic (1.98e-1)" "unprognostic (1.73e-2)" "unprognostic (1.23e-1)" "unprognostic (9.60e-3)" "unprognostic (3.96e-2)" "unprognostic (7.37e-3)" "unprognostic (2.25e-2)" "unprognostic (3.56e-2)" "unprognostic (5.07e-2)" "unprognostic (5.24e-3)" "unprognostic (1.91e-1)" 8.0 0.7 0.0 0.2 0.0 0.0 1.1 0.0 0.1 0.5 0.3 0.0 0.4 0.0 1.6 6.8 0.1 2.5 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.8 0.0 0.0 3.4 0.0 0.1 0.0 0.3 0.0 1.0 0.0 0.0 0.0 1.3 53.2 6.8 0.8 0.5 0.9 0.0 0.0 2.9 0.0 0.2 0.0 0.0 0.0 0.8 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.8 0.0 78.1 23.1 21.3 0.1 2.7 6.5 3.7 3.5 0.1 0.2 0.1 0.7 17.9 0.5 8.4 1.1 0.0 1.8 3.9 1.5 0.7 9.7 0.0 0.1 0.0 1.0 10.0 0.1 0.2 0.0 0.0 0.0 2.2 0.6 0.0 2.5 0.4 0.0 1.9 0.0 9.5 0.3 0.0 0.1 0.0 8.2 0.0 0.0 1.0 1.8 2.7 4.0 0.1 26.6 0.5 0.0 2.2 2.8 0.0 3.4 0.3 0.0 0.0 0.0 0.4 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.3 0.0 0.0 0.0 15.7 0.0 0.0 53.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.7 81.2 0.0 0.0 0.1 3.0 4.5 16.8 0.1 0.0 0.0 0.0 HOXC11 HOX3H ENSG00000123388 "Homeobox C11" O43248 12 53973126-53977643 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 7.0;skin 1: 9.2" "Group enriched" "Detected in some" 5 "Basal keratinocytes: 6.6;Distal tubular cells: 1.7;Fibroblasts: 2.3;Melanocytes: 3.3;Spermatocytes: 3.8;Suprabasal keratinocytes: 3.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 23.3;BJ hTERT+: 11.7;HaCaT: 10.3;T-47d: 18.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA038291 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038291: AB_10674552" "unprognostic (1.50e-3)" "unprognostic (1.93e-2)" "unprognostic (1.14e-2)" "unprognostic (1.51e-1)" "unprognostic (1.93e-3)" "unprognostic (1.17e-2)" "unprognostic (6.90e-3)" "unprognostic (1.32e-2)" "unprognostic (7.41e-3)" "unprognostic (4.46e-3)" "unprognostic (2.25e-1)" "unprognostic (3.26e-3)" "unprognostic (3.99e-2)" "unprognostic (1.06e-1)" "unprognostic (1.82e-1)" 4.8 0.0 0.1 0.1 0.1 0.0 1.2 0.1 0.1 2.5 0.1 0.1 0.1 0.8 2.0 1.0 0.1 0.7 0.1 0.1 0.1 0.0 2.0 0.1 0.1 0.7 0.1 0.1 0.5 0.1 0.0 0.1 0.6 0.3 0.5 0.0 0.1 0.1 2.0 7.0 9.2 2.7 0.4 0.1 0.1 0.0 1.6 0.1 0.5 0.1 0.1 0.1 1.2 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.7 0.0 23.3 2.2 3.4 0.0 3.4 11.7 5.0 3.7 0.2 0.9 0.0 0.2 3.2 0.0 10.3 4.4 0.0 2.3 0.6 0.1 0.1 7.6 0.0 0.0 0.1 0.1 0.6 0.9 0.0 0.3 0.0 0.0 0.2 1.0 0.0 3.2 1.4 0.0 0.0 0.0 6.6 0.0 0.0 0.4 0.0 0.4 0.8 0.0 0.1 2.1 5.3 2.0 0.2 18.4 0.0 0.0 0.0 4.0 0.3 0.2 0.0 0.0 0.0 0.0 0.4 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 6.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 3.8 0.2 3.3 0.0 0.0 0.0 0.0 HOXC4 "HOX3, HOX3E" ENSG00000198353 "Homeobox C4" P09017 12 54016931-54056030 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.7;ovary: 31.6" "Cell type enhanced" "Detected in some" 12 "Early spermatids: 3.5;Leydig cells: 2.8;Proximal tubular cells: 2.4;Sertoli cells: 6.5;Spermatocytes: 2.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 27 "pons and medulla: 29.7" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 14.1;HDLM-2: 18.1;HEK 293: 19.9;SH-SY5Y: 16.9" "Region enriched" "Detected in single" 24 "pons and medulla: 9.9" "Region enriched" "Detected in single" 13 "pons and medulla: 3.7" HPA053910 Supported Nucleoplasm NA NA Nucleoplasm "HPA053910: AB_2682305" "unprognostic (2.78e-2)" "unprognostic (8.51e-2)" "unprognostic (2.96e-6)" "unprognostic (3.30e-2)" "unprognostic (6.27e-2)" "unprognostic (1.81e-2)" "unprognostic (1.24e-1)" "unprognostic (6.63e-3)" "unprognostic (6.42e-2)" "unprognostic (1.42e-1)" "unprognostic (8.83e-3)" "unprognostic (4.37e-2)" "unprognostic (7.81e-2)" "unprognostic (8.43e-2)" "unprognostic (1.50e-1)" "unprognostic (2.11e-4)" "unprognostic (9.82e-2)" 16.2 4.4 0.7 3.2 0.7 0.0 17.9 0.7 0.7 1.3 2.3 0.6 1.4 0.9 11.5 17.8 6.0 20.9 1.0 1.0 0.7 0.7 15.4 0.8 0.9 3.2 1.1 0.0 31.6 0.7 0.0 0.7 5.8 29.7 2.4 0.0 0.3 0.7 1.3 8.1 4.2 9.2 4.4 10.5 1.2 2.6 8.3 0.9 0.0 1.0 0.0 1.8 2.1 3.4 1.1 0.5 0.0 0.0 0.0 1.1 0.0 3.0 3.1 0.0 14.1 5.9 3.0 0.0 1.4 1.5 1.4 1.0 0.1 2.6 12.2 0.1 10.7 0.0 2.7 0.2 0.3 0.9 18.1 19.9 0.1 1.4 0.0 0.7 1.4 0.4 7.8 1.4 8.5 1.4 0.0 0.2 4.0 0.6 0.0 5.4 0.1 1.7 0.3 0.1 0.5 0.0 3.9 4.5 0.0 6.1 0.0 0.0 16.9 2.2 0.7 7.9 0.7 10.6 0.7 0.0 7.4 4.2 0.6 7.5 3.2 3.5 6.3 0.4 1.3 7.7 0.0 0.0 0.0 0.8 0.0 0.8 1.1 0.0 0.8 0.0 0.7 0.0 1.1 0.0 0.0 0.0 0.5 0.6 0.0 0.7 0.7 0.7 0.7 0.7 0.7 1.1 0.0 29.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 3.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 1.8 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 2.4 0.0 6.5 0.0 2.8 0.4 0.0 0.2 0.7 0.0 0.0 HOXC5 "HOX3, HOX3D" ENSG00000172789 "Homeobox C5" Q00444 12 54032853-54035358 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.8;ovary: 13.4" "Cell type enhanced" "Detected in some" 8 "Collecting duct cells: 1.8;Distal tubular cells: 1.7;Fibroblasts: 2.4;Leydig cells: 2.3;Peritubular cells: 2.5;Smooth muscle cells: 2.1;Spermatocytes: 3.2" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.7" "Region enriched" "Detected in single" 14 "pons and medulla: 8.8" "Group enriched" "Detected in some" 5 "gdT-cell: 5.9;naive CD8 T-cell: 1.9" "Lineage enriched" "Detected in single" 59 "T-cells: 5.9" "Cell line enhanced" "Detected in many" "AN3-CA: 8.5;ASC diff: 5.1;ASC TERT1: 6.2;HSkMC: 5.8;SH-SY5Y: 9.3" "Region enriched" "Detected in single" 40 "pons and medulla: 4.8" "Region enriched" "Detected in single" 7 "pons and medulla: 1.0" HPA026794 Uncertain Supported "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA026794: AB_10612118" "unprognostic (1.57e-1)" "unprognostic (7.73e-3)" "unprognostic (1.70e-2)" "unprognostic (2.49e-1)" "unprognostic (1.16e-3)" "unprognostic (2.87e-3)" "unprognostic (6.89e-2)" "unprognostic (9.53e-3)" "unprognostic (1.86e-2)" "unprognostic (2.69e-2)" "unprognostic (2.01e-3)" "unprognostic (1.17e-2)" "unprognostic (7.53e-3)" "unprognostic (2.19e-3)" "unprognostic (1.08e-2)" 1.8 1.6 0.2 1.0 0.2 0.0 1.8 0.2 0.6 0.2 1.6 0.2 0.2 0.3 0.5 5.3 1.7 8.0 1.5 0.2 0.2 0.0 1.5 0.2 0.2 0.3 0.4 0.2 13.4 0.2 0.0 0.2 1.4 8.8 0.2 0.0 0.8 0.2 0.2 4.2 2.1 4.6 2.5 2.6 0.2 3.9 2.4 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 5.9 0.3 0.9 2.2 0.0 8.5 5.1 6.2 0.0 0.5 0.4 1.0 0.7 3.6 0.5 0.0 0.6 2.5 0.0 1.4 0.2 0.0 0.3 2.7 3.0 0.0 1.0 0.1 0.2 0.0 0.1 5.8 0.6 4.1 0.4 0.0 0.0 0.0 0.0 0.0 1.8 1.3 0.0 0.1 0.0 1.5 0.3 0.0 0.0 0.0 1.2 0.0 0.0 9.3 0.6 0.2 4.4 1.2 1.7 0.1 0.0 1.5 0.9 3.2 0.3 0.0 0.0 0.0 0.2 0.2 3.2 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.6 0.2 0.0 0.4 0.2 8.8 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 1.7 0.0 0.2 0.0 0.0 0.0 0.2 0.1 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.9 0.0 0.0 2.1 3.2 0.6 0.6 0.2 0.0 0.0 0.0 HOXC6 "HOX3, HOX3C" ENSG00000197757 "Homeobox C6" P09630 12 53990624-54030823 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 31.2" "Cell type enhanced" "Detected in many" 12 "Distal tubular cells: 14.9;Fibroblasts: 27.4;Leydig cells: 20.8;Peritubular cells: 14.2;Spermatocytes: 39.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 17 "pons and medulla: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 38.1;fHDF/TERT166: 19.0;HDLM-2: 31.8" "Region enriched" "Detected in single" 23 "pons and medulla: 1.5" "Not detected" "Not detected" HPA054981 Supported Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA054981: AB_2682662" "unprognostic (3.54e-2)" "unprognostic (9.20e-2)" "unprognostic (1.68e-6)" "unprognostic (3.92e-2)" "unprognostic (1.10e-3)" "unprognostic (5.01e-4)" "unprognostic (5.52e-3)" "unprognostic (3.32e-3)" "unprognostic (2.81e-1)" "unprognostic (6.26e-2)" "unprognostic (8.82e-2)" "unprognostic (3.70e-3)" "prognostic unfavorable (3.55e-6)" "unprognostic (8.63e-2)" "unprognostic (5.76e-2)" "unprognostic (1.40e-2)" "unprognostic (4.71e-2)" 10.9 11.2 0.4 1.2 0.4 0.0 16.3 0.4 0.4 0.7 1.9 0.6 0.4 0.0 3.9 14.8 3.1 13.5 0.4 2.0 0.4 0.0 11.3 0.4 0.9 3.0 0.4 0.4 31.2 0.4 0.0 0.4 4.0 7.0 0.8 0.0 0.4 0.4 0.4 11.0 7.6 8.8 6.1 8.1 1.0 0.3 3.3 0.4 0.4 0.6 0.8 0.4 0.7 2.5 0.0 0.0 0.1 0.0 0.0 0.5 0.0 2.5 1.8 0.0 38.1 13.9 13.3 0.4 1.9 1.9 3.1 2.9 1.6 2.9 1.1 2.5 19.0 0.9 4.3 1.5 0.2 2.8 31.8 11.0 2.0 4.9 0.0 1.5 0.2 4.8 12.6 2.0 6.2 2.2 0.0 0.1 0.1 1.3 0.0 11.0 0.6 0.0 1.2 0.0 0.3 1.6 0.0 1.4 0.0 9.6 0.1 0.0 4.7 2.9 2.8 7.8 3.4 6.7 0.5 0.0 4.0 8.6 4.3 2.7 0.3 0.3 0.0 1.4 0.3 8.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 7.0 0.4 0.0 0.0 0.0 0.0 5.6 0.0 0.3 0.0 0.0 0.0 3.5 0.0 0.3 14.9 0.0 1.1 0.2 0.0 0.0 0.0 2.5 27.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 20.8 0.4 11.8 0.0 0.0 0.2 0.0 0.0 14.2 7.8 1.9 6.5 5.0 39.3 1.1 3.4 0.2 0.0 0.0 0.0 HOXC8 "HOX3, HOX3A" ENSG00000037965 "Homeobox C8" P31273 12 54009106-54012362 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 16.7;ovary: 25.2;skeletal muscle: 12.8" "Cell type enhanced" "Detected in some" 12 "Fibroblasts: 17.3;Melanocytes: 10.1;Peritubular cells: 7.4;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 24.2;ASC TERT1: 15.8;fHDF/TERT166: 28.1;HSkMC: 19.3;LHCN-M2: 21.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028911, CAB037020" Uncertain Supported Nucleoplasm,Microtubules NA NA Nucleoplasm Microtubules "CAB037020: AB_1840935, HPA028911: AB_10602236" "unprognostic (1.03e-1)" "unprognostic (5.90e-2)" "unprognostic (6.26e-6)" "unprognostic (4.89e-2)" "unprognostic (5.20e-4)" "unprognostic (5.34e-3)" "unprognostic (2.43e-3)" "unprognostic (1.28e-1)" "unprognostic (3.61e-2)" "unprognostic (1.45e-2)" "unprognostic (3.52e-2)" "prognostic unfavorable (1.47e-5)" "unprognostic (2.47e-1)" "unprognostic (1.84e-2)" "unprognostic (4.68e-2)" "unprognostic (1.14e-2)" 5.2 5.4 0.4 0.7 0.2 0.0 7.1 0.2 0.3 0.5 0.5 0.2 0.2 0.0 0.3 16.7 0.4 6.3 0.6 0.6 0.2 0.0 7.0 0.2 0.2 2.2 0.2 0.5 25.2 0.2 0.0 0.2 1.9 0.4 0.3 0.0 0.2 0.2 0.2 12.8 2.6 4.8 7.9 2.5 0.2 0.0 2.6 0.2 0.3 0.7 0.2 0.2 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 8.5 24.2 15.8 0.1 1.6 0.0 2.8 1.8 2.5 1.3 0.0 0.2 28.1 0.4 1.0 2.2 0.7 3.2 2.9 3.0 0.4 1.1 0.0 3.0 0.0 3.3 19.3 2.2 9.0 5.3 0.3 0.2 0.5 0.3 0.0 21.1 0.7 0.0 0.2 0.0 0.1 0.4 0.0 0.0 0.0 3.2 0.0 0.0 1.1 2.9 0.5 7.4 2.1 0.8 0.0 0.0 0.5 4.5 3.9 0.9 0.0 0.0 0.0 0.5 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.3 0.2 0.0 0.2 0.5 0.4 0.2 0.0 0.0 0.0 0.1 4.0 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 17.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.8 0.0 10.1 0.0 0.0 0.0 0.0 0.0 7.4 4.4 0.8 6.5 1.7 5.4 2.7 3.8 0.2 0.0 0.0 0.0 HOXC9 "HOX3, HOX3B" ENSG00000180806 "Homeobox C9" P31274 12 53994895-54003337 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 18.9;skeletal muscle: 28.3" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 34.9;Fibroblasts: 20.8;Melanocytes: 37.1;Proximal tubular cells: 16.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 14.7;HDLM-2: 18.7;HEK 293: 22.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA063965, HPA072160" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063965: AB_2685162, HPA072160: AB_2686491" "unprognostic (2.38e-1)" "unprognostic (1.03e-1)" "unprognostic (3.19e-5)" "unprognostic (1.23e-1)" "unprognostic (4.09e-3)" "unprognostic (7.12e-2)" "unprognostic (6.92e-3)" "unprognostic (1.06e-3)" "unprognostic (4.32e-1)" "unprognostic (1.58e-2)" "unprognostic (7.38e-2)" "unprognostic (4.08e-2)" "unprognostic (9.85e-2)" "unprognostic (8.33e-2)" "unprognostic (2.01e-1)" "unprognostic (2.74e-2)" "unprognostic (1.53e-1)" 18.9 2.5 0.0 1.2 0.0 0.1 12.8 0.0 0.1 0.5 0.2 0.0 0.4 0.1 1.7 7.8 0.3 6.3 0.1 0.1 0.0 0.0 12.2 0.1 0.1 4.3 0.0 0.0 5.6 1.0 0.1 0.0 2.0 0.0 0.9 0.1 0.0 0.5 0.2 28.3 5.7 4.4 1.2 0.5 0.1 0.1 4.3 0.0 0.1 0.2 0.2 0.3 1.3 1.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 2.2 0.0 14.7 5.9 4.9 1.0 1.5 1.4 1.9 1.3 0.6 2.2 0.0 1.1 5.8 0.3 2.6 0.3 1.5 1.7 18.7 22.8 0.4 3.3 0.5 0.6 0.0 3.4 5.5 2.5 2.8 1.3 0.0 1.8 0.1 4.6 0.0 3.9 1.6 0.0 1.3 0.0 1.1 0.2 0.2 2.8 0.0 4.4 1.4 0.0 4.3 5.3 2.8 5.8 0.4 4.4 0.2 0.0 3.5 6.3 1.0 1.8 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.3 34.9 0.0 3.4 0.1 0.0 0.0 0.3 10.4 20.8 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.6 4.4 0.3 37.1 0.0 0.0 0.0 0.3 0.0 7.4 16.7 0.0 6.5 2.5 7.6 8.9 8.3 0.3 0.0 0.0 0.0 HOXD1 "HOX4, HOX4G" ENSG00000128645 "Homeobox D1" Q9GZZ0 2 176188579-176190907 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.9;epididymis: 14.1;seminal vesicle: 20.4" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 21.0;Distal tubular cells: 21.6;Enterocytes: 18.8;Mucus-secreting cells: 16.6;Undifferentiated cells: 20.6" "Cancer enhanced" "Detected in many" "ovarian cancer: 6.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 5.9;Hep G2: 6.0;RPTEC TERT1: 18.8;RT4: 14.4;SCLC-21H: 5.0" "Region enriched" "Detected in single" 5 "pons and medulla: 1.2" "Low region specificity" "Detected in many" "HPA040062, HPA056900" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA040062: AB_2676826, HPA056900: AB_2683270" "unprognostic (8.78e-2)" "unprognostic (9.97e-2)" "unprognostic (7.11e-3)" "unprognostic (1.06e-3)" "unprognostic (2.70e-1)" "unprognostic (3.19e-2)" "unprognostic (7.33e-2)" "unprognostic (4.10e-2)" "unprognostic (2.85e-1)" "unprognostic (2.44e-1)" "unprognostic (9.64e-2)" "unprognostic (4.02e-1)" "unprognostic (1.54e-5)" "unprognostic (4.33e-3)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (1.32e-1)" 2.4 0.6 1.5 1.1 3.5 0.3 2.0 0.6 3.9 0.5 5.2 18.8 11.8 0.7 0.8 14.1 0.9 8.8 1.4 0.3 4.1 2.2 6.8 0.2 5.7 0.9 9.8 1.3 1.2 0.5 0.2 0.2 0.3 15.5 1.7 3.7 0.3 1.0 20.4 0.3 1.2 4.4 0.9 18.9 1.5 0.7 2.2 6.3 0.0 0.4 0.0 0.5 4.6 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 5.9 0.3 0.5 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 6.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 18.8 14.4 5.0 0.9 0.0 0.0 0.9 0.8 0.0 0.0 3.3 0.0 0.2 0.7 0.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 3.5 0.6 3.2 4.1 2.2 9.8 1.3 15.5 6.3 3.0 21.0 0.0 0.2 3.8 0.0 0.0 0.0 0.0 4.5 7.0 0.0 0.0 21.6 0.0 0.0 2.9 18.8 0.0 0.0 0.0 0.1 0.5 2.3 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 3.3 0.0 16.6 0.0 0.1 11.5 0.4 2.9 0.0 0.0 0.1 2.6 6.4 2.3 0.0 0.0 20.6 1.8 HOXD10 "HOX4, HOX4D" ENSG00000128710 "Homeobox D10" P28358 2 176108790-176119942 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 21.7;endometrium 1: 38.2" "Cell type enhanced" "Detected in some" 16 "Collecting duct cells: 14.0;Distal tubular cells: 13.3;Intestinal endocrine cells: 23.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 7.3;HEK 293: 26.0;RPTEC TERT1: 18.7;SCLC-21H: 7.3;SiHa: 10.9;U-251 MG: 8.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA065871 Approved "Nucleoplasm,Cytosol,Cytoplasmic bodies" No NA Nucleoplasm "Cytosol, Cytoplasmic bodies" "HPA065871: AB_2685573" "unprognostic (4.29e-3)" "unprognostic (2.51e-1)" "unprognostic (2.98e-3)" "unprognostic (1.69e-1)" "unprognostic (1.80e-3)" "unprognostic (6.82e-2)" "unprognostic (1.04e-5)" "unprognostic (1.19e-2)" "unprognostic (1.99e-1)" "unprognostic (2.19e-1)" "unprognostic (5.24e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (1.92e-6)" "unprognostic (2.15e-3)" "unprognostic (4.57e-2)" "unprognostic (4.86e-1)" "unprognostic (1.27e-1)" 0.9 0.0 0.1 1.2 0.1 0.0 21.7 0.1 0.1 10.3 9.5 0.1 1.4 0.0 38.2 2.8 1.2 1.6 0.6 0.6 0.1 0.0 16.3 0.1 0.8 0.2 0.1 0.1 2.7 0.1 0.0 0.1 3.0 0.1 9.5 4.3 0.1 0.5 5.1 0.2 1.0 0.1 14.2 0.1 0.1 0.0 3.9 0.1 0.2 0.3 0.4 1.4 2.1 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 7.3 0.0 0.0 0.3 0.0 26.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 18.7 0.0 7.3 1.9 10.9 0.0 0.0 1.4 0.0 0.0 1.6 0.0 1.4 0.6 8.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 4.6 0.8 0.0 0.3 0.0 0.0 0.0 14.0 0.0 0.0 13.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 1.4 0.0 0.0 0.1 0.0 23.2 0.0 0.0 0.0 1.7 0.0 1.7 0.0 3.9 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 5.2 2.0 HOXD11 "HOX4, HOX4F" ENSG00000128713 "Homeobox D11" P31277 2 176104216-176109754 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "endometrium 1: 15.8" "Group enriched" "Detected in some" 4 "Basal glandular cells: 21.0;Collecting duct cells: 21.0;Distal tubular cells: 8.3;Glandular cells: 6.3;Intestinal endocrine cells: 19.9;Mucus-secreting cells: 8.7;Undifferentiated cells: 6.0;Urothelial cells: 11.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 20.8;RPTEC TERT1: 2.6;SCLC-21H: 6.3;SiHa: 2.5;U-251 MG: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA055155 Supported Nucleoplasm NA NA Nucleoplasm "HPA055155: AB_2682719" "unprognostic (1.99e-1)" "unprognostic (1.48e-1)" "unprognostic (2.32e-2)" "unprognostic (9.05e-2)" "unprognostic (1.85e-3)" "unprognostic (2.48e-1)" "unprognostic (1.93e-2)" "unprognostic (2.13e-2)" "unprognostic (6.73e-2)" "unprognostic (5.00e-2)" "unprognostic (2.11e-8)" "unprognostic (2.09e-3)" "unprognostic (2.49e-2)" "unprognostic (2.27e-3)" 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 5.4 4.2 0.0 0.0 0.0 15.8 0.4 0.3 0.1 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.6 0.3 5.7 0.9 0.0 0.0 2.9 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 1.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 1.3 0.0 0.0 0.1 0.0 20.8 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.3 6.3 0.3 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 21.0 0.3 0.0 0.2 0.0 0.0 0.0 21.0 0.0 0.0 8.3 0.0 0.0 0.2 1.0 0.0 0.0 0.1 0.9 6.3 0.0 0.0 0.3 0.0 19.9 0.0 0.0 0.0 0.9 0.0 1.7 0.0 8.7 0.0 0.1 2.9 1.1 0.2 0.0 0.0 0.1 0.0 0.3 0.6 0.0 0.0 6.0 11.2 HOXD13 "HOX4I, SPD" ENSG00000128714 "Homeobox D13" P35453 2 176092891-176095938 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 14.0;intestine: 13.1;prostate: 13.8;seminal vesicle: 19.0;vagina: 15.0" "Cell type enhanced" "Detected in some" 20 "Basal glandular cells: 10.8;Intestinal endocrine cells: 28.0;Mucus-secreting cells: 11.6;Undifferentiated cells: 8.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 9.8;HEK 293: 28.1;HL-60: 31.2;JURKAT: 8.8;NB-4: 18.6;SCLC-21H: 8.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA064064 Approved Nucleoplasm NA NA Nucleoplasm "HPA064064: AB_2685186" "unprognostic (2.04e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (6.95e-5)" "unprognostic (2.52e-3)" "unprognostic (7.25e-2)" "unprognostic (2.08e-2)" "unprognostic (4.62e-2)" "unprognostic (1.77e-1)" "unprognostic (4.66e-1)" "unprognostic (1.01e-2)" "unprognostic (2.82e-4)" "unprognostic (4.95e-2)" "unprognostic (3.70e-2)" "unprognostic (9.98e-3)" 0.4 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 14.0 13.1 0.1 0.1 0.0 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 13.8 8.8 0.1 0.1 19.0 0.6 0.0 0.1 3.7 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 3.8 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 1.2 2.6 0.0 0.0 0.0 0.0 0.0 2.7 0.0 9.8 0.0 1.5 0.0 28.1 4.2 0.0 0.0 0.0 31.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 2.0 0.0 0.0 0.0 0.0 18.6 1.0 0.0 1.5 0.0 0.1 0.0 0.0 0.2 8.2 2.0 1.9 0.0 4.5 0.1 0.0 0.0 0.0 1.0 0.0 0.4 2.6 0.0 0.0 0.0 1.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 10.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 28.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 8.3 5.5 HOXD3 "HOX1D, HOX4, HOX4A" ENSG00000128652 "Homeobox D3" P31249 2 176136612-176173102 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 25.9;epididymis: 36.4;seminal vesicle: 22.6" "Group enriched" "Detected in some" 5 "Collecting duct cells: 8.7;Distal tubular cells: 13.3;Early spermatids: 12.5;Leydig cells: 3.7;Peritubular cells: 4.2" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 8.0;HSkMC: 9.5;RPTEC TERT1: 9.9;SCLC-21H: 14.2;SH-SY5Y: 9.5;SK-MEL-30: 3.9" "Region enriched" "Detected in single" 36 "pons and medulla: 3.8" "Region enriched" "Detected in single" 32 "pons and medulla: 6.7" "HPA051831, HPA063671" Supported "Nucleoplasm,Nuclear bodies" No NA Nucleoplasm "Nuclear bodies" "HPA051831: , HPA063671: AB_2685083" "unprognostic (1.13e-1)" "unprognostic (3.28e-1)" "unprognostic (1.52e-2)" "unprognostic (6.50e-2)" "unprognostic (1.31e-1)" "unprognostic (7.07e-2)" "unprognostic (1.97e-2)" "unprognostic (1.54e-2)" "unprognostic (9.56e-2)" "unprognostic (5.57e-2)" "unprognostic (1.08e-1)" "unprognostic (1.56e-1)" "unprognostic (2.57e-4)" "unprognostic (1.47e-3)" "unprognostic (1.55e-1)" "unprognostic (3.44e-1)" "unprognostic (7.44e-2)" 6.2 1.1 0.4 3.2 0.4 0.2 19.6 0.2 0.2 8.7 3.6 0.0 22.5 0.3 25.9 36.4 1.1 4.8 2.0 0.4 0.8 0.5 8.5 0.2 0.3 0.8 1.5 0.0 7.0 0.3 0.2 0.2 0.2 0.5 2.1 0.4 0.0 0.6 22.6 0.7 0.7 0.4 4.0 7.2 1.9 0.3 3.6 0.0 0.0 0.4 0.2 0.3 1.7 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.9 0.1 0.0 0.1 0.0 0.0 0.1 1.5 0.0 0.0 0.1 0.0 0.0 0.0 9.5 0.8 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 9.9 0.5 14.2 9.5 0.1 0.1 3.9 0.2 0.0 0.0 0.6 0.0 0.2 0.7 0.4 0.0 0.1 0.0 0.3 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.2 0.2 0.8 0.5 1.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 13.3 0.0 12.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.1 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.2 1.6 0.0 0.0 0.3 0.7 0.5 1.1 0.0 0.0 0.5 0.0 HOXD4 "HOX4, HOX4B" ENSG00000170166 "Homeobox D4" P09016 2 176151222-176153226 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 21.0;seminal vesicle: 26.2" "Cell type enhanced" "Detected in some" 17 "Collecting duct cells: 15.7;Leydig cells: 4.4;Proximal tubular cells: 5.3;Sertoli cells: 6.5" "Cancer enhanced" "Detected in many" "ovarian cancer: 5.3" "Region enriched" "Detected in some" 7 "pons and medulla: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 9.3;HEK 293: 22.1;RPTEC TERT1: 16.4;SK-MEL-30: 6.1" "Region enriched" "Detected in single" 28 "pons and medulla: 8.2" "HPA054383, HPA070349" Approved Supported "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA054383: AB_2682470, HPA070349: AB_2686258" "unprognostic (9.37e-2)" "unprognostic (1.54e-1)" "unprognostic (1.03e-3)" "unprognostic (1.10e-3)" "unprognostic (9.21e-2)" "unprognostic (5.17e-3)" "unprognostic (5.19e-2)" "unprognostic (6.69e-3)" "unprognostic (1.66e-1)" "unprognostic (3.47e-1)" "unprognostic (1.49e-1)" "unprognostic (2.50e-1)" "unprognostic (7.78e-2)" "unprognostic (1.12e-2)" "unprognostic (9.93e-2)" "unprognostic (5.81e-2)" "unprognostic (1.61e-1)" 3.4 4.9 0.5 0.5 0.5 0.0 4.0 0.5 0.7 2.8 3.4 0.5 13.8 0.2 15.6 21.0 0.5 7.9 0.5 0.5 0.5 0.0 10.2 0.5 0.5 0.6 1.1 0.5 9.7 0.5 0.0 0.5 0.5 7.6 1.5 0.8 0.5 0.5 26.2 1.3 1.0 3.5 5.3 3.7 4.4 0.4 1.5 0.5 0.5 0.8 0.5 0.5 2.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.1 1.8 0.0 0.1 0.4 0.0 0.6 0.5 0.0 0.0 9.3 1.6 0.4 0.1 1.5 0.0 0.2 0.0 22.1 0.2 0.0 0.0 0.3 0.0 0.0 5.0 1.5 0.0 0.2 0.1 3.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 16.4 2.6 1.3 2.2 0.3 0.0 6.1 0.4 0.0 0.0 2.8 0.2 0.1 1.4 1.2 0.0 0.0 0.0 1.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.5 0.7 0.5 0.0 1.1 0.5 7.6 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 3.7 2.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 4.4 0.0 1.7 0.0 0.6 0.0 0.1 0.0 2.8 5.3 0.0 6.5 0.5 0.2 0.2 0.5 0.0 0.0 1.2 0.0 HOXD9 "HOX4, HOX4C" ENSG00000128709 "Homeobox D9" P28356 2 176122720-176124937 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 26.2" "Cell type enhanced" "Detected in some" 10 "Collecting duct cells: 22.7;Distal tubular cells: 31.5;Leydig cells: 31.7;Peritubular cells: 25.1;Sertoli cells: 38.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 8.7;HEK 293: 12.2;RPTEC TERT1: 14.4;SH-SY5Y: 16.8;SK-MEL-30: 9.2;TIME: 12.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA068683 Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA068683: AB_2686018" "unprognostic (1.89e-1)" "unprognostic (9.41e-2)" "prognostic unfavorable (8.25e-4)" "unprognostic (1.37e-1)" "unprognostic (1.03e-2)" "prognostic favorable (9.58e-4)" "prognostic unfavorable (1.08e-5)" "unprognostic (6.62e-2)" "unprognostic (4.58e-2)" "unprognostic (1.54e-2)" "unprognostic (2.56e-3)" "unprognostic (6.71e-2)" "unprognostic (4.77e-3)" "unprognostic (8.38e-2)" "unprognostic (5.94e-2)" "unprognostic (1.89e-1)" "unprognostic (9.44e-2)" 4.1 2.7 0.2 1.7 0.4 0.0 11.4 0.2 0.2 13.1 10.8 0.2 10.4 0.0 26.2 12.0 1.6 5.1 2.6 0.5 0.2 0.0 19.7 0.2 0.7 2.4 0.2 0.2 8.9 0.2 0.0 0.2 1.6 0.4 13.0 2.2 0.2 0.4 16.0 3.8 3.9 1.1 12.6 0.6 3.7 0.1 9.8 0.2 0.3 2.2 2.2 1.3 2.4 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 1.2 0.8 1.0 0.8 0.0 0.0 0.0 8.7 1.1 0.6 5.7 0.0 0.0 0.7 0.0 12.2 0.0 0.7 0.0 0.1 0.0 0.0 2.8 0.4 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 14.4 5.3 3.3 16.8 4.1 0.0 9.2 0.8 0.0 0.0 12.7 0.0 2.8 4.1 4.4 0.0 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.4 0.2 0.0 0.0 0.0 1.5 2.2 0.0 0.6 0.0 0.0 0.0 22.7 0.0 0.0 31.5 0.0 0.2 11.7 0.0 0.0 0.0 0.2 1.0 0.9 0.0 0.0 0.2 0.0 7.5 0.0 0.0 0.5 31.7 0.0 1.7 0.0 2.1 0.0 0.0 0.0 25.1 2.2 0.0 38.8 0.8 0.7 1.2 1.6 0.0 0.0 4.1 0.5 HPDL "4-HPPD-L, GLOXD1, MGC15668" ENSG00000186603 "4-hydroxyphenylpyruvate dioxygenase like" Q96IR7 1 45326905-45328533 "Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 38.4" "Cell type enhanced" "Detected in some" 21 "Cytotrophoblasts: 24.6;Undifferentiated cells: 6.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 47.2;HL-60: 13.3;NB-4: 16.6;SK-BR-3: 29.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 35 "hippocampal formation: 0.7;hypothalamus: 0.9;midbrain: 2.0;pons and medulla: 0.9;thalamus: 0.8" "HPA031997, HPA057346" Supported Nucleoplasm,Mitochondria No NA Mitochondria Nucleoplasm "HPA031997: AB_10602909, HPA057346: AB_2683415" "prognostic favorable (1.81e-4)" "unprognostic (1.36e-1)" "unprognostic (2.46e-1)" "prognostic unfavorable (1.60e-5)" "unprognostic (1.02e-2)" "unprognostic (6.71e-2)" "unprognostic (3.93e-3)" "unprognostic (1.25e-1)" "unprognostic (1.63e-1)" "prognostic favorable (1.03e-4)" "unprognostic (1.08e-3)" "unprognostic (2.52e-2)" "unprognostic (6.66e-2)" "unprognostic (1.26e-2)" "unprognostic (1.00e-1)" "unprognostic (3.03e-2)" "unprognostic (1.43e-1)" 0.9 0.7 2.7 3.1 4.2 3.6 1.0 7.6 3.4 2.0 8.4 2.4 0.0 5.4 1.0 1.3 3.6 1.0 1.8 3.0 2.7 2.4 0.7 0.2 0.8 2.6 2.5 1.8 1.0 0.3 0.2 0.4 5.1 3.1 1.7 7.1 38.4 1.3 0.6 3.3 1.1 4.7 0.9 2.2 2.8 7.8 1.4 0.6 6.4 1.0 4.2 2.3 0.8 1.6 3.1 0.7 0.0 0.3 2.1 1.5 0.8 0.0 0.4 0.1 0.0 0.0 0.1 47.2 0.6 0.0 0.8 0.2 11.7 3.1 2.4 0.1 0.6 0.0 2.8 0.0 0.1 0.2 0.0 0.1 0.2 5.1 0.0 0.3 13.3 0.3 0.5 0.1 0.5 0.0 0.0 0.9 0.0 0.0 2.2 0.1 5.8 8.6 16.6 0.2 9.1 0.0 2.6 0.0 7.7 0.1 0.1 9.3 0.6 6.0 29.8 4.6 0.6 0.0 2.5 0.4 0.0 0.1 0.4 0.0 0.3 0.1 8.3 0.0 0.0 0.5 0.0 0.3 0.0 0.4 0.1 1.5 3.1 0.7 1.2 0.7 0.3 0.9 0.8 0.0 2.1 0.0 0.0 0.4 0.8 2.7 4.2 7.6 3.4 2.7 2.4 2.5 1.8 3.1 0.6 0.0 0.0 1.9 1.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 24.6 3.3 0.5 0.1 0.3 0.7 0.0 0.0 1.7 0.4 0.9 0.0 0.0 2.1 0.0 1.2 0.6 0.0 0.0 0.3 0.0 0.0 0.0 3.0 0.0 1.1 0.0 0.0 0.3 0.3 0.0 0.4 0.0 2.1 1.0 4.2 0.0 6.6 1.0 HPGD SDR36C1 ENSG00000164120 "15-hydroxyprostaglandin dehydrogenase" P15428 4 174490177-174523154 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism" Oxidoreductase "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 193.3" "Cell type enhanced" "Detected in many" 13 "Enterocytes: 273.6;Extravillous trophoblasts: 488.8;granulocytes: 816.1;Urothelial cells: 266.0" "Cancer enhanced" "Detected in many" "urothelial cancer: 52.4" "Region enriched" "Detected in single" 4 "pons and medulla: 3.8" "Group enriched" "Detected in many" 5 "basophil: 37.7;T-reg: 15.1" "Group enriched" "Detected in many" 71 "granulocytes: 37.7;T-cells: 15.1" "Cell line enhanced" "Detected in some" "A549: 27.7;ASC diff: 17.2;HEL: 60.6;RT4: 94.3;SuSa: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004919, HPA005679" Enhanced Supported Nucleoplasm,Cytosol No NA Cytosol Nucleoplasm "HPA004919: AB_1079081, HPA005679: AB_1079080" "unprognostic (1.23e-3)" "unprognostic (1.61e-1)" "unprognostic (5.96e-2)" "unprognostic (1.25e-1)" "unprognostic (1.09e-2)" "unprognostic (2.53e-2)" "unprognostic (1.27e-1)" "unprognostic (2.23e-1)" "unprognostic (1.08e-1)" "unprognostic (4.28e-2)" "unprognostic (3.54e-3)" "unprognostic (2.34e-2)" "prognostic favorable (3.20e-4)" "unprognostic (2.44e-1)" "unprognostic (2.59e-1)" "unprognostic (1.37e-4)" "unprognostic (2.33e-2)" 5.1 2.6 0.5 7.9 0.6 0.0 24.6 0.4 0.6 23.0 73.3 0.5 2.5 22.9 13.4 7.5 32.0 4.5 10.7 1.2 0.6 0.7 8.5 63.7 22.9 7.9 0.8 0.5 2.3 0.4 0.0 0.9 193.3 3.8 20.1 8.4 4.6 3.0 1.1 1.6 15.3 64.5 9.3 0.5 2.9 36.3 1.9 0.5 5.5 0.4 5.0 7.9 61.2 31.8 0.1 0.2 37.7 0.1 0.3 15.1 1.0 0.0 27.7 0.0 0.0 17.2 1.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 2.5 2.5 0.0 0.0 0.0 0.5 60.6 2.1 0.0 0.0 0.3 0.1 0.9 0.4 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.2 0.0 0.2 15.8 1.4 2.8 0.0 0.2 5.7 94.3 0.1 0.1 0.0 0.2 0.6 20.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 37.7 0.1 5.4 3.7 0.0 5.7 0.1 1.9 1.6 0.2 0.0 0.6 1.5 0.4 0.3 0.0 0.0 15.1 1.0 0.5 0.6 0.4 0.6 0.6 0.7 0.8 0.5 3.8 0.5 14.9 46.1 5.2 57.7 15.3 3.1 0.4 43.3 5.3 20.5 21.0 0.0 25.6 18.3 2.4 1.1 0.5 273.6 0.0 86.5 488.8 12.1 51.1 816.1 165.7 20.7 0.0 8.1 18.4 16.1 0.2 18.4 10.6 72.6 1.0 48.2 0.0 26.0 217.5 0.0 68.8 0.6 0.0 6.6 0.4 0.4 19.6 47.4 50.3 31.0 266.0 HPGDS "GSTS, GSTS1, GSTS1-1, H-PGDS, PGD2, PGDS" ENSG00000163106 "Hematopoietic prostaglandin D synthase" O60760 4 94298535-94342876 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Isomerase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 24.8" "Group enriched" "Detected in many" 10 "granulocytes: 1000.1;Hofbauer cells: 476.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "basophil: 15.8" "Lineage enriched" "Detected in single" 25 "granulocytes: 15.8" "Group enriched" "Detected in some" 8 "HEL: 32.4;HMC-1: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA024035 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA 170000 "Vesicles, Cytosol" Nucleoplasm "HPA024035: AB_1855743" "unprognostic (5.71e-2)" "unprognostic (5.80e-3)" "unprognostic (1.17e-1)" "unprognostic (5.36e-3)" "unprognostic (2.76e-1)" "unprognostic (2.38e-4)" "unprognostic (1.01e-2)" "unprognostic (4.41e-3)" "unprognostic (1.35e-1)" "unprognostic (7.75e-4)" "unprognostic (1.44e-1)" "unprognostic (1.14e-1)" "unprognostic (5.15e-3)" "unprognostic (4.07e-2)" "unprognostic (6.48e-2)" "unprognostic (2.61e-2)" "unprognostic (6.14e-2)" 14.3 2.9 8.0 1.6 12.1 1.6 5.8 2.0 7.7 5.4 6.9 4.4 0.2 7.5 4.7 3.3 4.1 2.5 9.3 3.0 8.4 3.6 2.5 1.3 12.7 0.9 9.6 2.4 1.5 1.8 1.7 1.5 24.8 9.0 6.4 7.5 2.9 3.8 2.2 1.4 5.8 8.6 5.8 14.6 1.4 4.4 1.8 12.1 1.5 1.2 2.8 1.5 4.5 3.5 0.0 0.1 15.8 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.0 2.5 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 8.0 12.1 2.0 7.7 8.4 3.6 9.6 2.4 9.0 12.1 11.9 75.3 0.0 0.8 3.7 0.0 0.0 0.0 2.7 6.8 0.0 0.0 2.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.5 4.1 4.0 1000.1 0.0 476.4 0.0 6.8 0.0 3.9 0.0 0.3 14.5 3.3 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.1 0.0 0.1 4.6 4.6 0.0 0.0 0.1 HPSE "HPA, HPSE1, HSE1" ENSG00000173083 Heparanase Q9Y251 4 83292461-83335153 "Enzymes, Predicted secreted proteins" "Cell adhesion" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Hofbauer cells: 15.9;Kupffer cells: 27.7;Macrophages: 10.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 17.8;neutrophil: 12.8" "Group enriched" "Detected in many" 5 "granulocytes: 12.8;monocytes: 17.8" "Cell line enhanced" "Detected in many" "Karpas-707: 23.3;OE19: 20.5" "Region enhanced" "Detected in some" "olfactory region: 4.5" "Low region specificity" "Detected in all" "CAB009813, HPA055344" Supported Nucleoplasm,Vesicles "Secreted to extracellular matrix" No No 9700000 Nucleoplasm Vesicles "CAB009813: AB_2120854, HPA055344: " "unprognostic (6.57e-2)" "unprognostic (1.22e-2)" "unprognostic (9.13e-2)" "unprognostic (5.92e-3)" "unprognostic (1.12e-1)" "unprognostic (1.25e-1)" "unprognostic (1.24e-2)" "unprognostic (5.65e-2)" "unprognostic (7.06e-2)" "unprognostic (1.90e-1)" "unprognostic (1.50e-1)" "unprognostic (9.62e-3)" "unprognostic (3.27e-1)" "unprognostic (2.78e-1)" "unprognostic (3.04e-3)" "unprognostic (4.15e-2)" "unprognostic (3.70e-3)" 4.9 5.1 3.0 6.8 3.5 2.2 1.2 0.8 2.4 3.6 6.2 7.1 0.0 2.3 2.9 2.8 14.5 5.7 3.0 5.8 3.2 1.5 3.0 5.6 8.2 16.1 7.1 1.4 7.5 1.1 15.5 2.3 11.3 3.4 1.1 7.0 0.7 12.5 2.1 0.7 6.9 3.6 2.1 7.0 19.0 2.4 6.0 2.8 1.6 1.4 16.9 9.7 2.4 4.9 0.3 1.9 12.8 17.8 1.4 3.4 4.8 7.6 0.3 0.0 1.0 1.8 0.5 0.0 0.9 4.2 1.9 8.1 0.2 5.7 0.2 1.4 2.1 13.0 7.4 9.7 1.3 3.4 0.7 0.9 2.0 5.5 0.1 1.0 1.3 4.6 0.8 2.9 1.3 9.2 0.8 10.2 1.3 0.0 23.3 0.8 1.6 0.1 0.1 0.4 20.5 1.4 0.0 0.3 0.3 5.3 0.2 5.5 0.0 10.6 5.9 0.8 1.5 0.8 1.8 11.8 0.8 2.7 0.8 0.9 0.3 3.6 0.1 6.1 6.2 1.4 0.2 17.8 0.0 1.0 6.7 0.7 0.2 1.9 0.7 1.9 0.3 1.4 1.2 12.8 1.4 0.9 0.1 3.4 4.8 3.0 3.5 0.8 2.4 3.2 1.5 7.1 1.4 3.4 2.8 6.0 4.1 0.0 2.6 3.1 0.0 0.4 0.0 2.7 3.4 1.8 0.0 0.5 0.0 1.3 0.6 0.6 5.1 0.0 1.2 2.3 0.6 1.5 0.0 0.2 15.9 0.0 6.3 3.1 27.7 0.0 0.6 10.2 0.0 0.0 2.9 0.0 0.8 8.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 3.1 1.3 3.2 4.6 3.7 HR "ALUNC, AU" ENSG00000168453 "HR, lysine demethylase and nuclear receptor corepressor" O43593 8 22114415-22133384 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Oxidoreductase" "Disease mutation, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 50.5;tongue: 23.8" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 93.6;Cone photoreceptor cells: 31.4;Paneth cells: 28.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 9.9;HaCaT: 38.1;OE19: 18.4;SiHa: 13.2;T-47d: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054888 Supported Nucleoplasm NA NA Nucleoplasm "HPA054888: AB_2682630" "unprognostic (9.11e-2)" "unprognostic (2.12e-2)" "unprognostic (7.32e-2)" "unprognostic (4.68e-3)" "unprognostic (6.49e-2)" "unprognostic (2.80e-1)" "unprognostic (1.53e-2)" "unprognostic (2.45e-1)" "unprognostic (1.23e-1)" "unprognostic (1.21e-1)" "unprognostic (1.90e-1)" "unprognostic (1.75e-1)" "unprognostic (2.27e-2)" "unprognostic (8.00e-3)" "unprognostic (1.81e-1)" "unprognostic (2.32e-1)" "unprognostic (2.28e-2)" 2.6 1.8 3.8 3.2 6.1 0.8 4.7 19.8 17.0 2.1 7.5 9.6 0.1 5.5 1.5 0.9 12.1 1.9 6.7 1.9 5.3 4.0 0.9 0.8 1.2 1.0 6.1 6.8 0.8 1.3 0.7 1.7 0.9 4.9 2.3 4.0 6.7 3.4 5.4 1.1 50.5 5.3 2.3 3.8 1.1 8.4 5.2 6.6 0.0 2.6 23.8 4.4 3.6 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 9.9 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 9.8 0.7 0.5 38.1 0.0 0.9 0.0 0.0 0.0 0.0 8.0 0.0 2.2 0.0 0.0 1.9 6.2 0.0 0.6 0.6 0.0 1.0 0.0 0.1 0.0 5.7 0.6 0.1 0.0 18.4 7.6 0.8 0.0 0.2 0.1 2.6 0.4 2.2 13.2 3.0 3.0 0.1 14.1 0.0 0.0 0.2 8.4 0.0 0.4 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 6.1 19.8 17.0 5.3 4.0 6.1 6.8 4.9 6.6 0.0 0.0 0.0 4.2 10.6 93.6 2.4 0.0 0.0 0.0 1.8 31.4 0.0 0.0 0.1 0.1 0.4 16.7 0.0 0.6 0.1 1.3 2.3 0.0 0.0 0.0 9.5 7.5 0.6 0.0 1.1 3.1 0.0 20.3 0.0 10.4 3.9 0.2 28.1 6.7 0.0 6.6 0.0 5.1 0.0 0.3 15.6 0.7 0.0 12.0 3.9 HRAS HRAS1 ENSG00000174775 "HRas proto-oncogene, GTPase" P01112 11 532242-537287 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002015, HPA049830, HPA070222" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB002015: , HPA049830: AB_2680903, HPA070222: " "unprognostic (3.06e-2)" "unprognostic (2.98e-2)" "unprognostic (7.01e-2)" "unprognostic (3.08e-3)" "unprognostic (3.49e-3)" "unprognostic (3.87e-1)" "prognostic unfavorable (2.32e-4)" "unprognostic (1.07e-1)" "unprognostic (2.25e-1)" "unprognostic (1.50e-1)" "unprognostic (2.88e-3)" "unprognostic (9.85e-2)" "unprognostic (2.81e-1)" "unprognostic (1.85e-1)" "unprognostic (1.80e-1)" "unprognostic (1.58e-2)" "unprognostic (1.38e-1)" 12.3 11.4 25.2 9.1 34.5 5.0 16.2 16.1 25.3 7.9 9.5 8.1 10.8 8.9 6.2 9.2 22.3 8.3 10.9 28.7 22.2 22.4 8.2 6.5 8.9 8.0 23.2 12.9 7.7 9.7 11.7 10.3 10.1 15.0 10.0 6.2 8.2 10.1 12.7 51.8 32.0 8.2 8.4 17.0 6.5 7.2 6.1 11.0 5.9 8.1 24.5 9.3 9.9 19.8 2.1 1.1 0.7 4.6 0.1 2.0 0.3 22.1 19.7 9.4 8.4 5.8 4.1 12.2 11.0 5.9 17.4 14.8 9.9 8.8 8.6 3.4 15.0 12.3 17.6 10.0 26.8 4.9 7.0 22.4 4.4 7.9 8.6 8.9 3.5 3.4 6.3 30.0 9.4 10.2 3.6 8.6 7.2 8.9 12.5 9.7 18.2 12.9 12.2 9.6 7.7 19.5 10.3 11.9 7.6 9.7 5.5 36.7 14.6 10.3 18.3 7.9 5.9 15.0 6.8 13.7 15.5 12.2 5.7 14.2 4.6 6.2 6.5 14.6 6.4 14.5 0.0 0.6 0.7 1.4 1.2 1.6 0.8 1.4 1.3 0.7 2.1 2.0 0.6 0.0 0.1 4.6 1.1 2.0 0.3 25.2 34.5 16.1 21.1 22.2 22.4 23.2 12.9 15.0 11.0 11.9 12.5 12.6 82.5 116.5 44.6 21.9 15.3 17.4 4.5 33.2 17.7 72.6 63.0 32.7 1.1 22.2 44.1 0.0 32.3 45.3 34.0 46.2 2.3 13.4 33.9 46.1 28.2 19.0 7.6 5.2 15.8 17.6 60.8 16.2 22.1 28.3 35.8 21.0 21.5 42.9 29.1 32.3 38.7 4.7 23.4 127.5 65.3 12.2 21.3 96.6 HRCT1 "LGLL338, PRO537, UNQ338" ENSG00000196196 "Histidine rich carboxyl terminus 1" Q6UXD1 9 35906192-35907141 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 25.3" "Cell type enhanced" "Detected in many" 22 "Enterocytes: 63.2;Mucus-secreting cells: 49.5;Paneth cells: 238.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 13.8;HBEC3-KT: 7.6;HeLa: 11.3;Hep G2: 8.5;U-2197: 20.4;U-251 MG: 9.5" "Low region specificity" "Detected in all" HPA067038 Approved Nucleoplasm NA NA Nucleoplasm "HPA067038: AB_2685767" "unprognostic (2.48e-2)" "unprognostic (4.88e-2)" "unprognostic (2.43e-2)" "unprognostic (2.49e-1)" "unprognostic (5.69e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (6.63e-2)" "unprognostic (2.53e-2)" "unprognostic (1.90e-1)" "unprognostic (2.44e-2)" "unprognostic (1.80e-1)" "unprognostic (1.18e-1)" "unprognostic (2.00e-1)" "unprognostic (9.41e-2)" "unprognostic (2.80e-1)" "unprognostic (9.43e-2)" 25.3 1.9 1.9 3.6 2.8 0.4 21.4 0.9 3.4 5.3 16.8 1.8 1.4 11.2 4.2 3.9 6.6 3.5 2.1 7.6 2.6 1.6 17.6 1.8 5.2 5.0 2.4 2.3 2.2 1.6 0.3 0.7 4.7 3.6 3.6 14.8 5.8 4.6 4.0 6.1 4.2 14.3 6.5 1.5 0.8 2.5 5.3 1.4 0.0 3.5 1.2 1.5 4.6 3.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.6 4.6 0.0 0.2 0.4 0.1 0.0 0.1 1.2 0.0 13.8 0.3 2.6 0.0 0.0 7.6 0.0 0.0 0.0 0.0 11.3 8.5 1.8 0.0 0.0 4.5 3.9 1.5 0.9 0.6 4.7 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 3.5 1.8 0.0 0.2 0.0 2.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 3.9 0.2 4.1 20.4 9.5 0.0 0.0 0.0 2.4 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.8 0.9 3.4 2.6 1.6 2.4 2.3 3.6 1.4 6.0 1.0 0.0 0.4 1.9 1.5 0.6 2.5 1.4 3.4 0.0 0.0 20.6 1.7 0.8 0.0 21.2 63.2 0.0 0.2 6.6 4.2 0.6 0.0 0.4 1.6 0.0 1.2 35.0 0.8 0.0 10.0 0.9 1.7 0.0 49.5 7.5 2.7 238.4 8.9 9.3 2.6 12.9 4.6 0.0 0.2 1.6 2.2 0.0 18.6 0.1 HS6ST1 HS6ST ENSG00000136720 "Heparan sulfate 6-O-sulfotransferase 1" O60243 2 128236716-128318577 "Disease related genes, Predicted intracellular proteins" Transferase "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 71.5;granulocytes: 54.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 39.5;HMC-1: 62.8;SCLC-21H: 34.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044586 Approved Nucleoplasm "Intracellular and membrane" NA NA 27000 Nucleoplasm "HPA044586: AB_10963057" "unprognostic (9.94e-2)" "unprognostic (8.93e-3)" "unprognostic (4.94e-3)" "unprognostic (6.69e-3)" "unprognostic (1.99e-2)" "unprognostic (1.31e-1)" "unprognostic (1.39e-2)" "unprognostic (3.21e-2)" "unprognostic (2.87e-1)" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (4.28e-2)" "unprognostic (1.21e-2)" "unprognostic (2.77e-1)" "unprognostic (1.11e-1)" "unprognostic (1.32e-3)" "unprognostic (3.66e-2)" 13.2 32.0 22.4 8.0 16.2 4.1 9.2 17.2 33.2 16.2 9.6 13.5 23.8 8.3 8.8 6.4 19.3 17.1 20.1 8.1 17.3 13.9 22.8 29.5 9.1 7.1 17.8 18.8 16.2 24.2 8.9 7.5 11.5 16.5 13.1 6.9 10.5 12.2 23.9 20.1 14.2 11.3 6.4 14.9 18.2 6.3 14.7 15.6 10.9 7.0 6.7 8.0 19.1 11.1 2.0 5.5 5.8 3.0 0.5 2.6 1.2 3.5 5.2 14.0 8.0 5.4 10.2 7.5 4.4 5.7 4.5 2.5 2.6 2.4 3.5 39.5 5.7 2.1 9.6 5.3 8.7 1.7 5.7 5.4 3.0 1.9 25.6 6.6 5.3 62.8 13.7 10.3 3.6 1.1 1.5 2.4 9.5 1.9 3.6 1.6 7.5 14.1 23.5 16.7 1.4 3.2 4.6 3.8 18.0 4.1 10.8 34.4 8.6 3.6 9.1 2.0 9.8 3.7 2.0 2.8 4.0 8.9 14.8 3.5 2.1 2.1 0.7 2.4 3.8 2.9 5.8 1.6 1.4 2.6 1.0 0.4 1.9 1.0 1.6 1.1 2.0 1.0 1.0 0.5 0.5 3.0 5.5 0.5 1.2 22.4 16.2 17.2 33.2 17.3 13.9 17.8 18.8 16.5 15.6 23.8 12.8 5.2 10.5 14.3 8.1 6.1 7.6 10.7 9.1 71.5 29.5 7.4 5.0 10.2 0.8 7.7 7.1 0.0 5.1 34.4 11.6 6.8 54.4 15.1 8.6 20.6 2.9 30.7 11.7 2.0 10.9 6.2 6.8 6.4 5.2 7.8 7.9 8.2 15.9 2.8 33.7 6.5 5.1 1.1 3.1 14.9 19.5 2.5 4.1 7.8 HS6ST2 ENSG00000171004 "Heparan sulfate 6-O-sulfotransferase 2" Q96MM7 X 132626016-132961395 "Predicted intracellular proteins, Predicted membrane proteins" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.5;kidney: 17.3;ovary: 18.2" "Cell type enhanced" "Detected in some" 16 "Cytotrophoblasts: 31.0;Leydig cells: 58.1;Peritubular cells: 33.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 29.5" "Cell type enhanced" "Detected in single" "NK-cell: 1.8" "Lineage enhanced" "Detected in single" "NK-cells: 1.8" "Cell line enhanced" "Detected in some" "HEK 293: 19.6;HeLa: 13.3;RH-30: 28.4;RT4: 14.1;SH-SY5Y: 35.5" "Low region specificity" "Detected in all" "HPA034625, HPA034626" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA034625: AB_10612119, HPA034626: AB_2674252" "unprognostic (7.62e-3)" "unprognostic (4.89e-2)" "unprognostic (2.89e-1)" "unprognostic (1.41e-1)" "unprognostic (3.24e-1)" "unprognostic (5.54e-2)" "unprognostic (1.44e-1)" "unprognostic (1.71e-2)" "unprognostic (1.14e-2)" "unprognostic (2.13e-1)" "unprognostic (1.06e-1)" "unprognostic (3.57e-1)" "unprognostic (8.39e-5)" "unprognostic (1.36e-3)" "unprognostic (1.44e-1)" "unprognostic (2.54e-1)" "prognostic favorable (6.03e-4)" 0.4 3.2 6.5 0.9 29.5 0.1 2.6 3.0 6.7 1.0 0.8 0.8 0.6 0.3 4.5 3.2 5.0 2.5 0.5 0.4 4.1 9.1 17.3 0.2 1.0 0.3 3.5 0.9 18.2 6.5 0.1 1.3 9.9 3.3 5.4 1.2 0.0 1.1 1.6 6.7 0.3 0.2 2.0 3.3 0.2 1.1 7.9 0.7 0.7 0.6 1.7 2.7 2.3 0.6 0.0 0.0 0.0 0.0 1.8 0.6 0.0 4.3 0.0 6.2 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 7.1 0.0 0.0 6.5 0.0 0.0 0.2 9.2 0.0 0.0 0.0 19.6 0.0 13.3 0.0 0.0 0.0 0.0 0.3 8.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.2 0.1 0.0 5.0 3.0 0.2 0.0 28.4 0.0 5.7 14.1 0.7 35.5 6.2 0.0 0.0 10.7 0.0 0.0 0.0 0.0 1.1 4.1 9.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 6.5 29.5 3.0 5.8 4.1 9.1 3.5 0.9 3.3 0.7 0.0 0.0 0.0 0.1 0.2 0.0 0.7 0.0 13.4 7.9 3.5 0.0 31.0 5.0 0.0 0.4 0.4 0.0 0.0 1.6 1.3 2.2 0.2 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.4 58.1 0.0 0.0 0.0 0.0 5.3 1.2 0.0 33.2 0.0 0.0 0.0 0.3 0.2 1.2 0.3 14.5 0.0 0.0 0.2 HS6ST3 ENSG00000185352 "Heparan sulfate 6-O-sulfotransferase 3" Q8IZP7 13 96090839-96839562 "Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.7" "Cell type enhanced" "Detected in some" 13 "Horizontal cells: 3.2;Pancreatic endocrine cells: 1.0;Rod photoreceptor cells: 1.8;Spermatogonia: 1.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "RT4: 19.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA078257 Approved "Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments" "Intracellular and membrane" NA NA 9800 "Nucleoplasm, Nuclear membrane" "Plasma membrane, Actin filaments" "HPA078257: AB_2732374" "unprognostic (2.34e-2)" "unprognostic (1.90e-2)" "unprognostic (2.82e-2)" "unprognostic (1.72e-2)" "unprognostic (4.88e-2)" "unprognostic (2.78e-2)" "unprognostic (1.55e-1)" "unprognostic (3.67e-3)" "unprognostic (8.11e-3)" "unprognostic (1.19e-1)" "prognostic favorable (6.12e-5)" "unprognostic (1.54e-4)" "unprognostic (2.24e-1)" "unprognostic (1.57e-3)" "unprognostic (9.89e-2)" 0.9 4.5 1.5 0.0 1.9 0.0 0.0 0.4 18.7 1.9 0.0 0.2 2.1 2.2 0.2 0.1 0.0 0.2 3.2 2.7 0.7 0.0 0.0 0.0 0.9 0.0 2.1 0.0 0.7 0.0 0.1 0.0 0.0 0.1 0.6 0.1 0.0 1.6 0.4 0.0 0.7 0.1 2.4 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.0 1.2 0.0 1.3 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 19.6 1.0 0.8 0.1 0.1 0.0 0.3 0.6 0.0 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.5 0.1 0.0 0.4 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 HSBP1L1 "FLJ10967, MGC189743" ENSG00000226742 "Heat shock factor binding protein 1 like 1" C9JCN9 18 79964561-79970822 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 4 "granulocytes: 17.0;T-cells: 17.4" "Cell line enhanced" "Detected in many" "HHSteC: 51.5;SK-MEL-30: 29.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA048273 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA048273: AB_2680337" "unprognostic (2.08e-1)" "unprognostic (2.14e-1)" "unprognostic (1.14e-2)" "unprognostic (5.85e-2)" "unprognostic (2.71e-2)" "unprognostic (3.70e-2)" "unprognostic (8.15e-3)" "unprognostic (8.86e-2)" "unprognostic (1.47e-1)" "unprognostic (1.16e-1)" "unprognostic (2.53e-3)" "unprognostic (7.41e-2)" "unprognostic (4.70e-2)" "unprognostic (1.67e-1)" "unprognostic (2.12e-1)" "unprognostic (8.28e-2)" "unprognostic (1.76e-2)" 7.2 15.4 10.7 4.8 9.9 2.9 18.2 15.2 13.3 10.9 16.3 3.0 14.2 6.9 7.0 11.5 14.4 9.3 8.3 5.8 11.4 7.8 15.2 37.9 11.1 3.8 9.4 5.9 5.7 21.2 8.3 8.2 11.0 15.5 8.9 13.0 8.9 18.5 19.9 12.4 12.1 5.6 6.3 7.1 5.3 10.5 2.1 9.7 0.7 15.2 14.3 6.4 6.6 9.7 1.8 2.0 17.0 4.2 3.1 17.4 3.9 9.1 2.2 0.0 0.1 1.3 4.5 3.9 4.4 9.5 4.4 3.8 4.6 6.0 0.0 1.1 5.3 0.0 5.2 8.0 5.1 1.9 9.3 2.1 0.0 2.3 2.2 51.5 0.0 0.0 5.1 14.4 0.4 3.2 9.2 0.1 1.3 0.0 0.0 0.2 7.4 0.0 0.0 0.0 5.1 9.8 0.1 0.0 0.0 15.6 2.0 0.1 0.4 4.7 5.8 29.1 0.4 3.3 2.0 0.0 0.0 0.0 0.1 0.0 0.0 4.4 0.0 0.0 2.4 0.1 17.0 4.2 5.2 3.8 2.7 4.6 1.5 6.6 4.1 1.7 1.8 17.4 9.3 0.2 3.1 0.9 2.0 2.9 3.9 10.7 9.9 15.2 13.3 11.4 7.8 9.4 5.9 15.5 9.7 50.6 25.1 0.9 60.6 35.3 8.5 11.5 38.2 46.8 43.3 47.1 21.6 106.1 58.0 53.9 0.9 19.8 71.4 23.3 54.4 55.1 20.9 68.1 18.5 107.1 37.6 19.1 11.1 22.7 19.6 0.7 18.4 16.9 37.1 1.0 74.8 21.2 100.9 96.8 23.0 57.9 28.4 0.0 11.6 1.4 0.6 50.6 98.2 12.5 87.5 81.2 HSCB "DNAJC20, HSC20, Jac1" ENSG00000100209 "HscB mitochondrial iron-sulfur cluster cochaperone" Q8IWL3 22 28742031-28757515 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018447, HPA031518" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA018447: AB_1853867, HPA031518: AB_2673919" "unprognostic (8.19e-3)" "unprognostic (6.48e-2)" "unprognostic (9.62e-3)" "prognostic favorable (3.78e-4)" "unprognostic (3.30e-1)" "unprognostic (7.02e-2)" "unprognostic (1.15e-1)" "unprognostic (2.53e-2)" "unprognostic (5.83e-2)" "unprognostic (7.38e-3)" "unprognostic (4.44e-1)" "unprognostic (2.81e-1)" "unprognostic (1.54e-3)" "unprognostic (2.19e-1)" "unprognostic (3.39e-1)" "unprognostic (2.12e-1)" "prognostic favorable (8.38e-4)" 9.6 18.8 13.1 9.2 13.9 4.9 12.4 13.7 12.9 14.1 11.6 9.1 20.3 13.7 11.5 8.8 11.8 10.4 11.4 9.6 12.3 8.3 12.9 29.5 7.3 15.5 15.8 9.0 16.5 15.2 6.2 16.1 8.7 10.6 15.9 7.7 8.2 28.2 17.5 14.6 9.2 10.0 8.9 12.2 10.9 12.8 6.0 13.2 6.9 14.4 8.1 10.3 15.0 10.5 12.9 11.3 7.7 14.4 9.7 8.5 5.8 9.3 6.0 2.5 3.8 4.6 11.8 4.8 6.9 9.7 10.3 6.3 2.6 3.4 10.6 3.3 3.8 2.5 6.6 4.8 4.5 4.9 10.0 19.5 3.6 4.7 7.4 9.8 6.6 5.4 7.9 9.9 5.7 9.0 5.3 7.8 3.2 5.6 9.3 4.1 13.5 3.0 6.1 6.0 10.3 14.8 6.0 7.8 11.9 11.1 2.7 8.5 7.7 3.8 14.6 18.4 2.1 6.0 4.1 4.1 14.1 7.4 13.3 6.2 13.1 10.7 9.1 9.9 4.9 9.3 7.7 7.9 3.6 6.3 14.4 7.6 12.9 6.4 7.4 11.3 9.9 7.0 8.5 0.4 9.7 11.0 5.9 4.8 5.8 13.1 13.9 13.7 12.9 12.3 8.3 15.8 9.0 10.6 13.2 20.8 15.8 20.1 22.7 10.3 4.8 6.0 22.9 32.1 26.1 19.2 5.9 13.2 24.9 21.9 3.3 15.8 10.3 0.0 24.7 12.0 16.6 18.9 22.0 33.0 23.7 4.8 19.0 17.2 14.9 2.6 17.3 18.5 13.5 19.8 13.1 9.7 21.0 7.0 11.0 37.1 8.1 6.5 15.6 12.2 16.1 13.7 11.1 17.8 19.7 12.8 HSD11B2 SDR9C3 ENSG00000176387 "Hydroxysteroid 11-beta dehydrogenase 2" P80365 16 67430652-67437553 "Disease related genes, Predicted membrane proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 62.8;kidney: 119.9;salivary gland: 66.0" "Group enriched" "Detected in many" 5 "Collecting duct cells: 181.5;Enterocytes: 273.5;Mucus-secreting cells: 229.5;Paneth cells: 137.2;Syncytiotrophoblasts: 95.8;Undifferentiated cells: 114.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NTERA-2: 8.7;OE19: 21.3;RPMI-8226: 10.2;RT4: 10.3;SCLC-21H: 11.4;SK-BR-3: 10.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB032443, HPA042186, HPA056385" Enhanced Approved "Nucleoplasm,Lipid droplets" NA NA "Lipid droplets" Nucleoplasm "CAB032443: AB_2233199, HPA042186: AB_2677888, HPA056385: AB_2683110" "unprognostic (2.87e-3)" "unprognostic (5.24e-2)" "unprognostic (7.10e-2)" "unprognostic (6.55e-2)" "unprognostic (9.29e-3)" "unprognostic (3.14e-1)" "unprognostic (2.68e-2)" "unprognostic (2.07e-1)" "unprognostic (2.21e-3)" "unprognostic (2.25e-3)" "unprognostic (3.27e-2)" "unprognostic (2.34e-1)" "prognostic favorable (9.51e-5)" "unprognostic (7.20e-2)" "unprognostic (3.19e-1)" "unprognostic (1.55e-2)" "unprognostic (1.84e-1)" 0.4 1.0 0.6 22.2 2.3 0.0 3.2 2.0 1.7 4.8 42.8 0.3 1.3 9.4 3.8 3.6 2.5 2.4 8.3 0.5 0.5 0.1 119.9 1.2 2.3 0.7 0.3 0.8 4.8 2.1 0.0 0.4 42.3 1.1 3.7 24.5 0.4 66.0 1.4 0.4 13.8 62.8 4.3 0.3 1.5 2.1 1.4 1.3 0.5 3.8 3.3 1.6 1.5 4.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 2.6 0.8 0.3 1.1 0.1 1.3 2.8 0.0 0.0 0.1 0.1 4.5 1.0 0.0 2.1 0.0 0.1 5.8 3.9 0.4 0.0 0.0 1.3 0.0 0.5 4.8 0.4 0.5 0.0 1.3 2.3 0.2 0.0 0.0 0.0 3.5 0.3 0.0 0.0 2.8 0.1 0.1 8.7 21.3 0.7 0.0 0.1 10.2 0.4 10.3 11.4 0.7 0.6 10.2 0.4 1.0 4.9 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 2.3 2.0 1.7 0.5 0.1 0.3 0.8 1.1 1.3 0.0 0.3 0.0 8.0 1.3 0.0 0.5 33.1 0.0 1.2 181.5 0.0 0.8 38.1 1.7 0.1 0.0 273.5 0.0 2.7 0.7 3.1 15.6 9.2 1.3 1.3 0.0 25.8 1.3 0.0 0.0 23.6 0.0 1.7 0.0 229.5 0.0 0.8 137.2 6.3 14.6 0.0 12.9 0.4 0.2 1.0 3.0 95.8 0.0 114.3 5.7 HSD17B6 "HSE, RODH, SDR9C6" ENSG00000025423 "Hydroxysteroid 17-beta dehydrogenase 6" O14756 12 56752161-56787790 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "liver: 241.2" "Cell type enriched" "Detected in many" 10 "Hepatocytes: 1569.2" "Cancer enriched" "Detected in many" 5 "liver cancer: 170.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 11.8;U-266/84: 14.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA059141 Enhanced Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA059141: AB_2683922" "unprognostic (7.70e-2)" "unprognostic (8.76e-2)" "unprognostic (5.08e-2)" "unprognostic (1.92e-2)" "unprognostic (2.01e-1)" "unprognostic (3.79e-2)" "prognostic favorable (6.32e-4)" "unprognostic (1.06e-2)" "unprognostic (3.21e-1)" "unprognostic (1.44e-1)" "unprognostic (1.35e-1)" "unprognostic (6.74e-2)" "unprognostic (2.50e-10)" "unprognostic (1.26e-1)" "unprognostic (1.79e-1)" "unprognostic (1.08e-1)" "unprognostic (1.05e-1)" 1.1 0.5 3.6 1.4 5.2 0.2 0.3 1.2 2.4 9.4 3.3 0.5 2.6 0.6 4.1 0.7 1.6 0.9 2.6 0.4 1.6 1.4 0.5 241.2 8.7 0.3 2.0 2.6 1.1 0.3 0.2 0.0 0.9 0.6 7.9 1.3 1.4 0.2 10.2 0.2 0.2 0.7 11.3 1.0 6.2 0.8 3.2 0.8 0.0 13.3 0.0 0.3 9.9 2.3 2.0 2.0 0.1 1.3 0.1 3.4 0.8 0.3 0.7 1.7 0.3 1.7 1.2 2.0 3.6 3.1 1.7 1.7 0.4 0.4 10.2 1.5 0.4 0.5 0.3 5.3 0.9 1.0 6.5 2.0 3.2 1.0 0.5 1.1 1.6 5.3 0.9 0.3 1.0 0.5 0.5 0.0 9.0 0.9 11.8 0.8 2.1 4.6 1.0 6.6 0.6 0.6 6.3 0.7 2.5 0.2 1.2 9.7 2.0 1.7 3.1 0.8 0.6 0.5 1.3 0.3 0.8 0.8 3.6 0.9 10.3 14.6 6.7 1.2 5.9 0.6 0.0 0.2 0.1 3.0 0.6 3.4 2.0 2.5 2.4 0.6 1.1 3.3 2.2 0.0 0.1 1.3 2.0 2.8 0.8 3.6 5.2 1.2 2.4 1.6 1.4 2.0 2.6 0.6 0.8 160.8 89.7 28.7 2.3 1.1 0.2 0.2 35.7 2.7 17.0 0.0 0.0 1.3 0.0 0.0 2.5 0.4 0.0 23.3 0.0 2.4 4.8 9.9 0.0 1569.2 0.3 0.0 0.0 31.3 41.1 1.5 11.5 0.1 0.0 1.8 0.3 1.0 0.1 0.0 1.4 0.0 0.6 12.9 3.7 13.6 10.6 1.4 0.3 4.4 0.3 0.9 HSF1 HSTF1 ENSG00000185122 "Heat shock transcription factor 1" Q00613 8 144291591-144314722 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "DNA damage, DNA repair, Host-virus interaction, mRNA processing, mRNA transport, Stress response, Transcription, Transcription regulation, Transport" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 199.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004239, HPA008888" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004239: AB_627753, HPA008888: AB_1079088" "unprognostic (7.08e-2)" "unprognostic (1.89e-2)" "unprognostic (6.07e-2)" "prognostic unfavorable (8.93e-4)" "unprognostic (1.55e-1)" "unprognostic (5.63e-2)" "prognostic unfavorable (4.95e-4)" "unprognostic (5.69e-3)" "unprognostic (1.05e-1)" "unprognostic (4.35e-2)" "unprognostic (1.40e-2)" "unprognostic (1.47e-1)" "unprognostic (1.41e-1)" "unprognostic (1.07e-2)" "unprognostic (2.23e-1)" "unprognostic (2.13e-1)" "unprognostic (1.12e-1)" 24.7 22.9 17.4 21.0 20.9 20.8 30.8 24.4 23.6 21.3 26.9 18.3 17.7 18.9 23.3 16.7 25.5 28.5 22.9 42.8 17.0 17.5 21.2 19.5 20.3 23.6 17.4 15.9 32.4 36.8 25.8 21.8 22.8 17.8 26.7 15.2 20.7 26.4 24.6 55.2 20.3 17.8 35.1 14.4 20.3 23.6 42.6 17.8 23.2 29.9 24.2 19.8 30.3 33.9 16.9 20.3 20.3 24.2 12.9 18.4 14.2 14.9 20.3 8.8 7.5 14.8 13.9 14.6 11.2 10.1 11.1 9.7 13.5 13.1 17.2 16.5 15.5 10.9 10.9 13.4 16.1 7.1 10.9 15.4 21.6 20.8 18.4 23.3 6.2 16.7 13.4 15.1 15.6 28.8 11.9 14.9 15.8 14.3 10.3 11.1 30.3 21.0 9.5 11.3 19.5 58.5 13.7 7.6 21.8 7.9 15.2 13.2 10.7 17.1 13.7 19.8 9.6 15.5 12.8 15.1 11.5 25.8 18.0 18.3 7.2 5.5 14.7 16.3 11.7 10.9 10.6 18.9 20.3 14.5 19.9 15.2 16.9 15.7 18.4 20.3 15.5 15.6 13.9 8.1 12.9 24.2 10.3 18.1 14.2 17.4 20.9 24.4 23.6 17.0 17.5 17.4 15.9 17.8 17.8 6.0 9.1 21.9 60.6 45.6 58.9 41.2 17.8 10.7 19.4 27.9 58.9 60.8 127.6 35.7 199.9 36.5 42.1 116.8 35.5 68.5 39.0 54.5 38.0 51.9 43.8 65.2 39.3 33.7 16.6 84.0 34.5 33.3 32.1 83.0 34.7 20.4 41.5 46.0 40.3 29.1 29.9 58.2 52.3 56.5 53.2 39.6 92.8 41.7 42.2 66.0 HSF2 ENSG00000025156 "Heat shock transcription factor 2" Q03933 6 122399546-122433119 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Stress response, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatogonia: 81.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016067, HPA031455" Approved Supported Nucleoplasm No No Nucleoplasm "CAB016067: AB_627754, HPA031455: AB_10670702" "unprognostic (1.62e-2)" "unprognostic (1.23e-1)" "unprognostic (1.55e-1)" "unprognostic (5.42e-2)" "unprognostic (2.27e-3)" "unprognostic (1.45e-1)" "prognostic unfavorable (1.51e-6)" "unprognostic (3.40e-3)" "unprognostic (2.60e-1)" "unprognostic (2.58e-1)" "unprognostic (1.25e-3)" "unprognostic (3.03e-1)" "prognostic unfavorable (7.65e-4)" "unprognostic (9.27e-2)" "unprognostic (5.44e-2)" "unprognostic (1.89e-1)" "unprognostic (2.42e-1)" 9.6 13.7 9.0 6.7 14.7 20.6 11.4 17.8 19.4 12.7 9.3 9.9 9.2 6.3 14.4 9.8 8.7 11.1 6.9 20.3 9.2 11.3 6.4 4.9 7.7 11.5 9.7 15.5 14.3 5.9 13.5 18.5 7.3 18.0 10.4 6.5 9.7 7.7 12.1 37.9 10.2 7.8 12.6 9.2 8.5 8.5 31.7 9.3 14.3 8.3 15.9 10.7 13.1 8.6 6.6 3.8 4.0 4.2 7.0 21.3 7.7 4.3 4.5 23.6 19.2 10.6 8.5 6.6 7.8 18.6 14.3 22.5 6.7 3.7 16.6 6.8 9.7 16.6 5.5 15.7 7.5 20.2 16.7 19.1 16.2 4.4 13.8 10.8 11.9 8.3 10.7 11.5 11.8 13.6 13.4 8.6 15.2 17.3 8.3 13.5 5.8 19.5 15.6 7.2 6.4 6.5 18.1 9.6 5.3 10.8 4.9 25.2 16.9 8.1 6.6 7.5 18.2 5.7 13.1 5.1 7.8 9.0 8.6 11.7 12.1 11.5 21.2 8.4 7.9 10.1 3.4 2.7 4.0 8.5 3.2 9.1 6.6 8.1 7.4 3.8 5.4 21.3 16.0 0.4 7.0 4.2 2.6 8.8 7.7 9.0 14.7 17.8 19.4 9.2 11.3 9.7 15.5 18.0 9.3 17.9 9.3 5.2 10.6 28.2 20.9 21.0 5.1 22.7 12.5 0.0 25.5 13.0 10.0 6.1 46.7 10.5 2.4 0.0 3.7 6.2 14.4 6.6 8.1 4.3 6.7 20.6 6.3 6.2 4.5 14.0 9.5 7.3 18.6 1.8 5.7 13.8 4.2 4.3 9.2 6.1 32.6 25.8 13.7 42.8 81.2 22.5 2.6 11.4 4.6 5.8 HSF2BP ENSG00000160207 "Heat shock transcription factor 2 binding protein" O75031 21 43529192-43659493 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 28.5" "Group enriched" "Detected in many" 6 "Early spermatids: 98.0;Late spermatids: 32.5;Spermatocytes: 127.5;Spermatogonia: 47.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "B-cells: 1.5;NK-cells: 1.5;T-cells: 2.8" "Cell line enhanced" "Detected in many" "HBEC3-KT: 14.6" "Low region specificity" "Detected in some" "HPA031724, HPA075775" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA031724: AB_10601022, HPA075775: " "unprognostic (1.91e-2)" "unprognostic (1.19e-1)" "unprognostic (7.27e-3)" "unprognostic (1.54e-4)" "unprognostic (2.62e-1)" "unprognostic (1.78e-2)" "unprognostic (9.36e-4)" "unprognostic (3.38e-2)" "unprognostic (1.13e-1)" "unprognostic (4.55e-2)" "unprognostic (1.79e-1)" "unprognostic (3.11e-1)" "unprognostic (1.44e-2)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (8.77e-4)" "unprognostic (6.00e-2)" 0.7 0.8 1.3 0.6 3.1 0.5 1.1 1.4 4.1 0.9 0.6 3.5 1.8 0.6 1.1 1.1 0.8 1.2 0.7 0.7 1.3 1.5 0.8 0.6 0.6 0.7 2.3 3.0 1.4 0.6 1.2 2.3 1.6 2.7 0.8 0.6 2.6 1.2 1.4 0.5 0.8 0.7 0.7 2.0 0.5 0.7 28.5 1.6 1.0 1.0 0.0 0.6 0.8 0.8 1.5 0.2 0.0 0.1 1.5 2.8 0.8 5.1 1.1 1.4 0.6 0.2 1.4 1.3 1.8 1.1 1.9 1.6 6.9 5.1 3.9 2.9 1.0 6.6 2.0 0.7 14.6 0.6 1.0 1.3 0.6 2.2 0.4 1.7 1.6 0.4 0.9 9.6 0.8 4.5 8.8 0.5 2.3 1.5 1.2 4.5 0.9 2.2 1.6 4.5 1.2 2.2 3.3 1.4 0.5 2.3 1.0 1.5 1.1 3.8 1.9 2.0 0.6 2.0 1.9 2.9 1.0 3.5 0.2 2.7 1.4 0.9 3.1 1.0 3.4 2.6 0.0 0.1 0.0 0.2 0.0 1.6 1.2 0.5 1.4 0.2 1.5 2.7 2.8 0.0 1.5 0.1 0.2 0.0 0.8 1.3 3.1 1.4 3.6 1.3 1.5 2.3 3.0 2.7 1.6 0.0 0.0 0.0 1.2 0.8 1.0 0.4 0.0 4.0 1.2 0.0 0.0 1.5 0.0 1.0 98.0 0.1 0.0 0.0 0.2 2.3 1.0 0.7 0.0 0.0 0.6 0.0 0.0 0.6 0.0 32.5 1.7 0.3 0.0 0.0 0.0 2.3 1.6 0.0 1.4 0.5 2.5 12.9 1.0 127.5 47.1 0.4 0.7 0.0 0.0 1.0 HSPA12B "C20orf60, dJ1009E24.2" ENSG00000132622 "Heat shock protein family A (Hsp70) member 12B" Q96MM6 20 3732667-3753111 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 17 "Endothelial cells: 38.3;Ito cells: 12.3;Late spermatids: 10.5;Peritubular cells: 14.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "non-classical monocyte: 3.1" "Lineage enriched" "Detected in single" 11 "monocytes: 3.1" "Cell line enhanced" "Detected in some" "CACO-2: 6.4;EFO-21: 6.7;HUVEC TERT2: 12.8;TIME: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013659, HPA015639" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA013659: AB_1234541, HPA015639: AB_1851192" "unprognostic (1.00e-1)" "unprognostic (1.14e-1)" "unprognostic (1.30e-1)" "unprognostic (6.99e-2)" "unprognostic (4.53e-2)" "unprognostic (2.09e-1)" "unprognostic (1.21e-1)" "unprognostic (6.40e-2)" "unprognostic (1.57e-1)" "unprognostic (1.07e-2)" "unprognostic (6.45e-2)" "unprognostic (8.74e-2)" "unprognostic (2.61e-2)" "unprognostic (1.75e-2)" "unprognostic (1.47e-1)" "unprognostic (4.05e-1)" "unprognostic (1.66e-2)" 22.7 3.4 2.6 4.6 4.9 1.8 19.4 1.5 5.5 11.0 4.3 3.9 4.3 2.6 11.7 8.1 6.2 6.2 10.7 14.6 3.1 2.7 5.7 3.0 26.8 2.3 4.1 2.8 6.4 4.8 2.1 1.8 13.9 5.1 5.1 2.0 7.2 5.3 5.4 13.5 4.8 3.6 6.1 2.8 21.2 3.2 5.2 1.8 0.4 6.1 9.6 2.1 4.7 7.5 0.1 0.2 0.0 3.1 0.0 0.2 0.0 0.6 2.3 1.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 6.4 0.2 0.3 6.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.8 0.1 0.0 3.4 0.2 0.1 0.1 0.2 0.0 0.1 0.0 2.0 12.8 0.5 0.4 0.2 0.0 1.4 0.5 1.2 1.4 0.0 1.1 2.3 0.3 0.7 0.0 0.0 1.2 1.0 0.4 0.2 0.1 0.2 0.2 0.7 7.1 0.2 3.0 1.0 0.5 0.5 0.4 0.7 0.2 1.1 0.6 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 3.1 0.0 0.0 0.0 2.6 4.9 1.5 5.5 3.1 2.7 4.1 2.8 5.1 1.8 0.0 0.0 0.0 0.0 1.6 0.4 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.2 38.3 0.0 0.0 0.0 0.1 8.6 0.0 0.0 0.0 0.4 0.0 0.0 12.3 2.7 10.5 6.9 0.0 0.0 0.0 0.0 2.5 0.0 0.0 14.5 0.0 0.6 0.0 0.4 1.4 1.1 1.0 0.3 0.0 0.0 0.1 HSPA1A "HSP70-1, HSPA1" ENSG00000204389 "Heat shock protein family A (Hsp70) member 1A" P0DMV8 6 31815464-31817946 "Predicted intracellular proteins" "Host-virus interaction, Stress response" "Chaperone, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "breast: 216.1;vagina: 741.6" "Cell type enhanced" "Detected in many" 13 "Basal glandular cells: 6419.7;Glandular cells: 2245.3;Urothelial cells: 2114.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 8.8;monocytes: 4.7;T-cells: 4.5" "Cell line enriched" "Detected in some" 10 "HEK 293: 310.1" "CAB017451, CAB032815, HPA052504" Supported Approved Nucleoplasm,Vesicles,Cytosol NA Yes 77000000 "Nucleoplasm, Vesicles" Cytosol "CAB017451: AB_10013742, CAB032815: AB_627759, HPA052504: AB_2681854" "unprognostic (2.44e-1)" "unprognostic (2.27e-1)" "prognostic unfavorable (1.54e-5)" "unprognostic (6.86e-2)" "unprognostic (2.01e-1)" "unprognostic (1.98e-1)" "unprognostic (1.18e-2)" "unprognostic (6.17e-3)" "unprognostic (2.47e-2)" "unprognostic (1.74e-2)" "unprognostic (8.43e-3)" "unprognostic (1.43e-1)" "unprognostic (1.47e-1)" "unprognostic (2.38e-1)" "unprognostic (6.48e-2)" "unprognostic (4.12e-2)" "unprognostic (1.51e-1)" 29.1 74.5 35.3 18.4 48.0 3.5 216.1 40.4 36.0 8.8 22.6 27.4 41.1 3.6 33.1 32.3 36.7 14.5 14.6 40.3 37.5 28.8 35.3 49.5 54.7 14.1 89.2 10.8 15.1 31.2 3.5 23.8 22.1 67.4 47.8 11.4 6.1 28.3 52.7 66.7 57.9 17.3 36.4 47.0 35.6 19.3 10.9 85.9 1.3 26.8 16.3 11.8 41.3 741.6 1.0 0.5 8.8 4.7 1.2 4.5 0.5 0.0 31.3 0.0 0.0 1.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 1.7 0.0 0.0 0.0 2.3 0.0 0.2 310.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 3.4 4.5 1.8 4.7 1.0 1.0 2.5 2.3 0.5 0.4 1.2 1.1 8.8 1.2 2.5 0.5 4.5 0.5 35.3 48.0 40.4 36.0 37.5 28.8 89.2 10.8 67.4 85.9 137.0 84.3 135.2 6419.7 321.9 290.0 857.6 71.4 100.4 76.2 120.4 357.4 38.6 34.9 77.7 73.7 681.4 145.3 0.0 18.8 85.4 940.7 2245.3 456.0 74.4 220.0 193.9 449.0 109.9 284.5 25.8 558.4 1365.8 796.3 117.2 187.3 954.1 43.5 340.1 151.0 60.4 639.2 148.8 1629.0 48.6 175.8 294.0 87.2 208.8 111.9 2114.2 HSPA1B HSP70-2 ENSG00000204388 "Heat shock protein family A (Hsp70) member 1B" P0DMV9 6 31827735-31830255 "Predicted intracellular proteins" "Host-virus interaction, Stress response" "Chaperone, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 508.1" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 2896.7;Glandular cells: 1002.7;Smooth muscle cells: 978.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "A549: 24.5;Karpas-707: 72.8" "CAB008640, HPA052504" Approved Approved Nucleoplasm,Vesicles,Cytosol NA Yes "Vesicles, Cytosol" Nucleoplasm "CAB008640: AB_1617331, HPA052504: AB_2681854" "unprognostic (1.20e-1)" "unprognostic (1.74e-1)" "unprognostic (4.23e-3)" "unprognostic (3.23e-2)" "unprognostic (3.54e-1)" "unprognostic (1.15e-1)" "unprognostic (2.76e-3)" "unprognostic (9.50e-2)" "unprognostic (3.45e-1)" "unprognostic (4.42e-2)" "unprognostic (6.92e-2)" "unprognostic (4.88e-2)" "unprognostic (5.74e-2)" "unprognostic (1.15e-1)" "unprognostic (9.17e-3)" "unprognostic (4.69e-2)" "unprognostic (5.99e-2)" 21.9 89.9 25.0 20.3 31.1 5.7 129.4 30.8 23.6 8.4 14.6 17.0 36.6 6.2 19.9 40.5 24.4 13.2 12.6 29.2 25.5 22.5 18.6 28.7 30.8 6.3 61.9 8.5 29.3 36.7 35.1 21.6 6.4 53.8 31.1 8.4 5.6 39.7 48.5 102.8 11.3 11.0 27.9 33.4 10.0 20.5 11.8 55.1 0.9 32.1 14.3 9.7 43.4 508.1 1.1 0.6 1.4 1.3 0.4 0.4 0.3 0.2 24.5 0.1 0.0 1.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.2 0.2 7.6 1.3 0.0 1.0 0.0 0.0 0.0 0.5 7.6 0.0 0.2 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 72.8 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.1 0.0 0.1 0.0 1.8 0.0 0.4 0.0 0.0 0.1 5.1 0.0 0.1 11.9 0.1 0.1 0.0 0.0 0.0 0.5 1.3 1.4 0.1 0.2 0.1 0.2 0.4 0.0 0.6 1.1 0.0 0.0 0.8 0.4 0.7 0.5 0.3 0.3 25.0 31.1 30.8 23.6 25.5 22.5 61.9 8.5 53.8 55.1 104.2 64.8 61.6 2896.7 212.6 40.4 440.6 20.4 54.9 58.0 66.3 123.7 73.9 16.6 33.6 1.7 185.0 221.9 0.0 13.7 87.7 515.0 1002.7 354.9 16.3 116.6 44.5 304.9 19.6 74.0 3.1 204.3 481.3 609.0 26.2 172.9 237.3 22.8 291.0 51.6 32.9 140.4 103.5 978.7 12.8 50.3 194.0 217.2 75.6 121.8 675.8 HSPA1L "HSP70-HOM, hum70t" ENSG00000204390 "Heat shock protein family A (Hsp70) member 1 like" P34931 6 31809619-31815065 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "testis: 29.1;vagina: 17.0" "Group enriched" "Detected in many" 19 "Early spermatids: 201.6;Late spermatids: 418.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Lineage enriched" "Detected in single" 4 "T-cells: 1.7" "Cell line enhanced" "Detected in some" "ASC diff: 1.9;EFO-21: 2.1;HEK 293: 6.8;U-266/70: 2.8;U-266/84: 2.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA043285, HPA052504" Enhanced Approved Nucleoplasm,Vesicles NA NA 49000000 Vesicles Nucleoplasm "HPA043285: AB_10962482, HPA052504: AB_2681854" "unprognostic (1.80e-1)" "unprognostic (8.70e-2)" "unprognostic (2.52e-3)" "unprognostic (6.97e-4)" "unprognostic (2.69e-2)" "unprognostic (1.17e-2)" "unprognostic (4.24e-2)" "unprognostic (4.33e-2)" "unprognostic (1.71e-1)" "prognostic favorable (1.02e-4)" "unprognostic (5.26e-3)" "unprognostic (9.96e-2)" "prognostic favorable (4.63e-4)" "unprognostic (4.48e-2)" "unprognostic (4.30e-1)" "unprognostic (1.02e-1)" "unprognostic (1.53e-3)" 0.4 0.5 1.8 0.5 2.2 0.5 1.2 1.4 3.1 0.5 0.7 1.5 0.0 0.3 0.8 3.0 0.8 1.5 0.3 0.5 2.0 1.1 0.9 0.7 1.7 0.7 4.5 0.8 1.1 1.5 0.3 0.7 1.0 2.6 1.2 0.6 0.2 0.4 1.5 3.9 0.6 0.8 0.5 4.6 1.1 0.8 29.1 3.2 0.0 2.0 0.0 0.7 0.5 17.0 0.3 0.0 0.4 0.1 0.0 1.7 1.1 0.0 1.7 0.0 0.0 1.9 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.5 0.0 0.0 0.0 1.0 0.0 0.0 6.8 0.0 0.0 0.2 0.2 1.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.0 0.2 0.0 0.0 0.2 0.3 0.0 2.8 2.4 0.0 1.7 0.0 0.0 0.0 0.1 0.4 0.4 0.0 0.0 0.0 1.0 1.3 0.0 0.3 1.5 1.6 0.3 0.0 0.0 0.0 1.7 1.1 1.8 2.2 1.4 3.1 2.0 1.1 4.5 0.8 2.6 3.2 0.0 0.6 0.0 0.6 0.8 2.1 3.6 0.0 1.4 1.2 0.0 7.9 0.4 0.0 0.7 201.6 1.0 0.5 0.0 0.2 0.4 0.5 1.1 0.0 0.9 1.1 3.2 1.7 3.1 2.4 418.3 4.6 1.5 5.0 1.8 0.6 3.3 0.3 0.8 2.1 0.3 2.8 0.0 1.4 16.4 7.7 0.1 0.3 2.5 1.0 0.3 HSPA2 ENSG00000126803 "Heat shock protein family A (Hsp70) member 2" P54652 14 64535905-64546173 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Stress response" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 87.0;skeletal muscle: 90.5" "Group enriched" "Detected in many" 5 "Collecting duct cells: 125.6;Distal tubular cells: 202.2;Extravillous trophoblasts: 456.2;Spermatocytes: 391.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 25.1;BEWO: 39.2;BJ hTERT+: 33.5;CAPAN-2: 17.8;SCLC-21H: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000798, HPA052504" Enhanced Supported Approved Nucleoplasm,Vesicles NA NA 77000000 Vesicles Nucleoplasm "HPA000798: AB_1079090, HPA052504: AB_2681854" "prognostic favorable (1.78e-4)" "unprognostic (1.72e-1)" "unprognostic (2.73e-1)" "unprognostic (1.08e-2)" "unprognostic (3.78e-2)" "unprognostic (2.90e-2)" "unprognostic (7.11e-2)" "prognostic unfavorable (9.11e-4)" "unprognostic (1.31e-1)" "unprognostic (3.14e-2)" "unprognostic (2.09e-1)" "unprognostic (2.60e-1)" "unprognostic (5.31e-2)" "unprognostic (1.14e-1)" "unprognostic (1.90e-1)" "unprognostic (8.36e-2)" "unprognostic (1.25e-1)" 5.2 3.3 21.1 5.2 45.3 1.5 5.2 3.7 37.6 3.3 23.3 87.0 0.1 4.4 13.8 12.8 25.2 7.2 4.2 22.8 33.2 18.7 26.6 2.6 4.5 3.2 71.0 20.6 2.4 3.8 7.5 4.3 37.6 37.7 3.8 6.9 3.5 10.2 4.0 90.5 14.8 7.8 17.9 83.8 8.5 5.7 58.8 65.2 0.0 2.3 8.2 3.9 12.4 4.0 0.7 0.3 2.4 0.6 0.9 3.7 0.5 9.9 25.1 3.9 0.0 2.8 0.2 39.2 14.2 33.5 5.7 9.4 0.9 17.8 2.4 5.7 15.4 1.2 11.2 0.0 0.7 3.5 1.4 1.9 0.0 1.4 0.0 2.8 0.0 3.4 1.3 0.5 0.8 0.0 1.4 0.4 0.1 0.0 2.0 2.8 4.4 0.1 0.1 2.8 3.8 3.0 1.9 0.0 0.0 8.8 1.5 34.8 2.0 0.6 1.2 0.0 1.4 0.9 1.0 0.5 0.1 0.0 1.2 0.0 2.6 0.0 0.0 3.1 0.0 3.8 0.9 0.2 0.1 1.8 0.4 0.1 0.7 1.7 0.8 0.0 0.5 0.6 0.6 2.4 0.9 0.6 0.3 3.7 0.5 21.1 45.3 3.7 28.3 33.2 18.7 71.0 20.6 37.7 65.2 0.0 6.9 3.7 22.1 48.0 0.8 28.8 5.1 0.0 1.2 125.6 0.0 29.0 202.2 6.3 19.7 28.0 12.9 0.0 4.7 456.2 53.6 6.7 12.7 0.8 13.8 0.0 27.0 29.4 4.3 20.1 8.1 5.5 28.7 0.0 33.0 13.8 5.0 6.6 7.1 1.2 2.3 25.8 25.0 391.8 54.3 36.9 63.5 5.3 9.3 12.3 HSPA4 "HS24/P52, HSPH2" ENSG00000170606 "Heat shock protein family A (Hsp70) member 4" P34932 5 133051962-133106449 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Stress response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010023, CAB025529" Uncertain Approved Nucleoplasm,Cytosol NA NA 10000000 "Nucleoplasm, Cytosol" "CAB025529: , HPA010023: AB_1851206" "unprognostic (2.54e-2)" "unprognostic (3.59e-1)" "unprognostic (2.91e-2)" "unprognostic (2.62e-1)" "unprognostic (5.30e-2)" "unprognostic (2.52e-3)" "prognostic unfavorable (4.13e-4)" "unprognostic (2.31e-3)" "unprognostic (2.90e-1)" "unprognostic (2.40e-1)" "unprognostic (1.53e-1)" "unprognostic (2.85e-1)" "unprognostic (4.44e-3)" "unprognostic (2.54e-1)" "unprognostic (1.09e-1)" "unprognostic (4.05e-2)" "unprognostic (1.41e-1)" 20.6 35.0 26.6 25.6 27.6 20.5 39.0 25.9 35.6 19.4 20.5 18.7 19.9 17.4 23.3 20.2 42.0 19.2 18.9 32.9 26.4 31.9 30.3 31.1 17.2 28.9 30.9 24.5 23.2 19.5 37.1 32.8 24.5 34.3 18.9 23.9 16.0 20.3 19.2 48.3 19.6 18.5 23.6 25.9 20.0 20.9 39.8 29.5 27.3 26.8 24.8 38.6 24.5 77.1 27.7 17.9 15.5 23.0 14.1 14.9 11.5 32.4 44.7 31.2 50.9 29.8 25.1 56.8 35.6 26.8 34.6 42.9 83.9 34.1 54.0 37.5 34.2 81.6 29.0 54.2 58.9 50.1 24.9 31.1 39.8 30.0 45.9 23.8 24.7 34.9 24.9 24.9 44.5 29.3 19.8 32.9 26.4 41.6 16.7 37.7 28.6 34.6 18.4 42.8 25.3 20.7 31.8 38.3 28.7 31.2 42.8 24.9 20.5 33.9 17.8 47.3 61.0 26.2 24.2 28.8 31.5 45.3 26.9 42.1 19.3 42.6 41.5 26.9 41.0 31.2 14.8 14.4 15.5 12.6 23.0 14.9 22.6 11.6 13.0 17.9 27.7 12.1 11.2 9.6 14.1 16.4 6.8 11.3 11.5 26.6 27.6 25.9 35.6 26.4 31.9 30.9 24.5 34.3 29.5 59.6 36.4 64.0 74.4 37.2 50.9 98.8 30.6 76.3 54.6 21.0 51.1 57.8 23.2 43.7 30.6 26.4 31.6 23.3 43.2 54.8 30.3 48.9 54.2 27.0 56.2 33.4 45.3 19.0 22.6 20.2 21.6 43.3 28.7 66.7 30.9 56.8 43.7 22.8 24.4 39.4 121.6 25.8 30.7 92.5 94.9 36.5 72.9 27.7 26.5 65.5 HSPA6 HSP70B' ENSG00000173110 "Heat shock protein family A (Hsp70) member 6" P17066 1 161524540-161526910 "Plasma proteins, Predicted intracellular proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 67.6;vagina: 99.8" "Cell type enhanced" "Detected in many" 11 "Basal glandular cells: 208.5;Cone photoreceptor cells: 119.8;Glandular cells: 327.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 67.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 67.6" "Cell line enriched" "Detected in some" 7 "Karpas-707: 34.0" "CAB017452, HPA028549, HPA052504" Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "CAB017452: AB_10618032, HPA028549: AB_10601817, HPA052504: AB_2681854" "unprognostic (3.90e-2)" "unprognostic (2.05e-1)" "unprognostic (5.87e-2)" "unprognostic (2.59e-1)" "unprognostic (2.40e-1)" "unprognostic (6.36e-3)" "prognostic unfavorable (7.26e-4)" "unprognostic (4.61e-2)" "unprognostic (1.29e-1)" "unprognostic (1.93e-1)" "unprognostic (1.68e-1)" "unprognostic (2.25e-1)" "prognostic unfavorable (1.98e-5)" "unprognostic (2.33e-2)" "unprognostic (1.49e-1)" "unprognostic (1.19e-2)" "unprognostic (2.04e-1)" 6.8 11.9 9.4 10.3 12.4 3.5 43.0 3.5 6.0 1.4 1.9 2.2 1.7 1.9 2.2 1.3 3.2 1.1 9.6 4.5 4.5 9.3 3.1 14.6 13.5 2.1 13.7 1.3 9.3 5.4 0.9 5.4 20.8 5.7 3.3 1.9 1.7 2.9 5.8 1.4 4.4 1.7 4.2 13.2 11.2 3.6 1.4 5.0 1.3 5.8 1.8 2.8 3.1 99.8 0.0 2.5 67.6 9.0 1.6 1.4 2.1 0.5 1.0 0.0 0.2 0.0 0.8 0.7 0.4 0.3 0.1 0.3 0.3 0.5 0.1 1.5 0.1 0.5 0.2 0.3 0.2 0.2 0.3 0.0 0.2 0.9 0.0 0.0 0.1 2.2 0.1 0.7 0.3 0.0 0.0 0.0 0.1 0.4 34.0 0.0 0.0 0.1 0.8 0.0 0.2 3.6 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.1 0.6 1.9 0.1 0.3 0.4 0.1 0.1 0.3 0.3 2.3 4.7 0.2 0.0 0.9 0.8 1.5 0.8 7.5 2.7 1.4 9.0 0.2 0.0 0.1 0.7 2.5 0.0 0.0 0.3 67.6 1.6 7.3 0.0 0.0 2.1 9.4 12.4 3.5 6.0 4.5 9.3 13.7 1.3 5.7 5.0 8.9 12.4 14.4 208.5 26.1 28.3 9.9 0.0 2.7 2.3 5.2 119.8 0.9 0.0 0.1 1.3 20.4 0.0 0.0 0.0 6.9 58.3 327.0 2.3 0.0 62.4 9.5 68.0 1.3 51.5 0.4 5.2 96.6 97.8 0.0 0.0 27.5 0.4 0.0 0.0 1.0 32.8 0.0 68.0 1.9 0.2 19.1 15.3 34.5 0.0 46.1 HSPA8 "HSC70, HSC71, HSP73, HSPA10" ENSG00000109971 "Heat shock protein family A (Hsp70) member 8" P11142 11 123057489-123063230 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Stress response, Transcription, Transcription regulation" "Chaperone, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Basal glandular cells: 2008.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002056, HPA052504" Uncertain Approved Nucleoplasm,Vesicles NA Yes 210000000 Nucleoplasm Vesicles "CAB002056: , HPA052504: AB_2681854" "unprognostic (2.28e-3)" "unprognostic (1.19e-3)" "prognostic favorable (6.14e-6)" "unprognostic (1.75e-1)" "unprognostic (1.84e-2)" "unprognostic (5.70e-2)" "prognostic unfavorable (1.93e-4)" "unprognostic (9.65e-3)" "unprognostic (3.82e-1)" "unprognostic (9.64e-2)" "unprognostic (2.93e-1)" "unprognostic (3.22e-1)" "prognostic favorable (3.81e-4)" "unprognostic (2.53e-1)" "unprognostic (1.83e-1)" "unprognostic (2.74e-1)" "unprognostic (7.16e-2)" 70.0 96.8 93.7 78.1 102.8 58.1 73.8 119.5 125.1 52.8 64.1 72.0 77.3 77.7 59.9 98.3 83.4 76.2 76.7 106.4 83.1 102.4 128.6 114.2 68.9 93.3 105.7 72.4 66.7 191.1 97.2 98.3 71.6 169.2 65.3 81.0 53.1 62.4 69.9 224.6 31.2 74.4 75.4 91.8 79.7 92.7 58.3 98.1 92.9 90.9 98.3 124.4 76.1 123.2 77.4 47.5 41.1 84.2 76.1 124.3 200.0 81.9 124.3 82.5 71.3 76.5 82.0 109.4 163.1 90.4 199.5 120.1 186.5 108.0 133.6 103.0 90.7 141.2 111.7 235.9 59.1 199.2 115.5 35.8 144.9 58.5 90.9 20.9 140.8 111.4 43.7 95.7 61.3 19.1 103.7 106.7 18.2 156.8 69.6 159.8 73.0 146.4 104.5 130.6 200.3 110.8 132.1 58.9 75.5 103.3 60.0 84.8 64.2 118.8 129.0 45.0 91.8 112.5 55.1 104.9 100.3 80.5 86.1 144.5 47.0 115.8 114.7 111.7 201.3 120.9 30.3 41.5 41.1 96.5 82.9 115.9 77.4 113.4 105.2 47.5 53.7 109.6 105.1 14.9 76.1 84.2 34.4 124.3 200.0 93.7 102.8 119.5 125.1 83.1 102.4 105.7 72.4 169.2 98.1 178.6 194.1 380.7 2008.3 250.8 192.6 358.3 247.1 397.5 238.8 123.9 119.8 806.4 447.6 560.1 23.5 383.9 634.1 256.9 544.3 848.9 487.1 803.7 432.1 181.5 715.5 171.6 498.1 192.8 238.1 50.8 206.0 453.5 501.0 661.9 246.7 285.3 500.3 403.3 253.8 795.2 189.9 239.3 546.5 180.9 436.7 248.7 1264.6 601.2 394.7 698.3 HSPB11 "C1orf41, HSPCO34, IFT25, PP25" ENSG00000081870 "Heat shock protein family B (small) member 11" Q9Y547 1 53916574-53945929 "Predicted intracellular proteins" "Differentiation, Protein transport, Spermatogenesis, Stress response, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030140 Uncertain Approved Nucleoplasm,Cytosol NA NA 18000 Nucleoplasm Cytosol "HPA030140: AB_10600713" "unprognostic (5.73e-2)" "unprognostic (6.37e-3)" "unprognostic (8.81e-2)" "unprognostic (2.99e-3)" "unprognostic (1.01e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (9.58e-7)" "unprognostic (5.12e-1)" "unprognostic (6.70e-3)" "unprognostic (8.31e-3)" "unprognostic (2.22e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (1.03e-6)" "unprognostic (1.84e-2)" "unprognostic (2.74e-1)" "unprognostic (5.38e-2)" "unprognostic (1.97e-2)" 12.2 19.7 21.5 20.1 19.5 22.6 19.5 13.1 18.6 17.4 15.6 9.5 19.4 11.0 19.1 30.6 19.0 31.9 11.0 12.9 15.4 16.0 16.0 20.0 19.9 24.0 15.0 18.7 20.8 13.4 9.5 31.3 18.2 16.8 15.1 14.6 22.4 13.3 25.1 5.6 16.0 13.1 17.8 17.3 16.0 15.6 19.6 10.0 27.1 40.4 15.0 24.2 23.5 14.3 28.6 35.9 37.5 20.0 31.1 35.0 16.8 20.7 8.9 27.5 6.5 9.5 12.6 11.1 18.6 15.9 25.8 30.5 20.5 11.7 25.1 14.5 12.6 46.9 16.9 11.3 17.7 30.9 20.3 16.3 30.8 19.3 27.5 10.3 15.4 21.6 13.1 13.5 24.4 6.9 17.0 13.5 15.4 18.0 6.0 32.1 4.3 34.3 23.8 11.1 16.4 19.3 23.3 34.9 12.9 20.9 23.1 14.0 11.5 26.3 12.1 16.7 27.5 75.5 22.4 10.0 18.1 22.2 20.2 19.5 10.9 16.2 24.8 28.6 14.5 15.5 35.4 14.8 37.5 28.0 19.0 25.1 28.6 27.8 33.0 16.8 22.9 21.9 28.0 10.3 31.1 20.0 35.9 35.0 16.8 21.5 19.5 13.1 18.6 15.4 16.0 15.0 18.7 16.8 10.0 29.8 26.1 55.8 65.1 94.4 20.9 30.8 43.3 235.5 68.2 48.8 7.9 156.8 99.5 53.0 36.0 40.6 41.8 0.0 57.6 83.4 59.6 60.9 60.0 64.4 99.0 12.7 74.2 30.1 40.7 11.5 57.0 60.6 74.2 95.6 37.1 67.6 70.4 49.1 59.8 97.6 16.4 38.8 75.1 103.5 92.0 72.4 97.7 63.3 38.8 99.6 HSPB7 cvHSP ENSG00000173641 "Heat shock protein family B (small) member 7" Q9UBY9 1 16014028-16019594 "Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "heart muscle: 524.6;skeletal muscle: 551.1" "Cell type enriched" "Detected in many" 48 "Cardiomyocytes: 2261.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "fHDF/TERT166: 83.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA027639 Approved Approved Nucleoplasm NA NA 43000 Nucleoplasm "HPA027639: AB_10601756" "unprognostic (1.11e-1)" "unprognostic (1.05e-1)" "unprognostic (1.28e-3)" "unprognostic (7.44e-3)" "unprognostic (8.35e-2)" "prognostic unfavorable (5.29e-4)" "unprognostic (1.02e-1)" "unprognostic (5.32e-2)" "unprognostic (2.47e-3)" "unprognostic (3.19e-3)" "unprognostic (6.94e-2)" "unprognostic (1.55e-1)" "unprognostic (1.20e-2)" "unprognostic (1.18e-2)" "unprognostic (1.51e-2)" "unprognostic (9.98e-2)" "prognostic unfavorable (1.26e-4)" 32.3 9.6 0.1 3.3 0.1 0.1 9.0 0.9 0.2 7.0 8.4 0.3 1.3 0.7 12.6 8.0 15.7 4.5 8.2 524.6 0.1 0.0 4.1 0.2 1.2 2.7 0.2 0.3 4.8 1.0 1.1 0.2 0.7 0.9 4.7 0.9 1.7 4.4 2.7 551.1 1.0 2.1 20.1 0.4 0.3 6.1 1.3 0.0 0.0 9.6 70.1 7.2 12.0 4.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 19.6 0.8 0.4 4.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 83.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.2 0.0 0.0 0.5 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.8 0.0 0.0 0.0 0.4 0.0 3.0 0.0 0.3 0.0 0.3 0.0 3.9 0.1 0.4 0.0 2.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.2 0.1 0.0 0.2 0.3 0.9 0.0 0.0 0.0 0.0 0.1 2.9 0.2 2261.8 0.0 0.0 0.0 3.5 0.0 2.4 11.6 1.1 29.5 0.7 0.0 0.0 0.2 1.4 11.2 0.3 0.0 0.0 1.4 1.6 0.0 0.0 0.0 47.4 13.3 0.3 0.0 0.0 0.0 3.0 0.0 0.0 6.3 0.0 0.4 0.0 43.4 1.7 1.0 2.3 2.7 0.0 0.0 0.1 HSPB8 "CMT2L, E2IG1, H11, HSP22, HspB8" ENSG00000152137 "Heat shock protein family B (small) member 8" Q9UJY1 12 119178642-119221131 "Disease related genes, Predicted intracellular proteins" "Stress response" Chaperone "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 152.6" "Group enriched" "Detected in many" 7 "Cardiomyocytes: 553.3;Syncytiotrophoblasts: 1120.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 28.7;HeLa: 21.4;MCF7: 37.7;SuSa: 24.7;U-87 MG: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015876 Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Cytosol "Nucleoplasm, Nuclear bodies" "HPA015876: AB_1850458" "unprognostic (1.52e-2)" "unprognostic (6.97e-2)" "unprognostic (1.96e-2)" "unprognostic (1.42e-1)" "unprognostic (1.88e-1)" "unprognostic (1.99e-3)" "prognostic unfavorable (2.98e-4)" "unprognostic (2.47e-1)" "unprognostic (4.03e-2)" "unprognostic (7.91e-2)" "unprognostic (6.48e-3)" "unprognostic (1.11e-1)" "unprognostic (1.30e-1)" "unprognostic (2.05e-3)" "unprognostic (2.05e-1)" "unprognostic (6.36e-2)" "unprognostic (2.17e-2)" 12.2 4.4 19.3 8.2 22.7 0.7 6.8 2.0 18.1 15.3 52.7 34.1 13.1 2.8 18.6 7.2 42.9 9.6 12.0 107.9 17.4 17.6 16.3 1.7 13.4 3.3 27.4 14.7 5.7 7.7 73.3 3.0 64.3 24.5 40.1 11.9 21.7 11.4 79.4 152.6 10.0 7.9 65.5 35.0 13.6 20.6 3.6 19.3 5.4 8.0 42.1 26.7 55.6 18.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.3 4.9 0.2 0.0 5.7 4.5 18.8 10.6 9.4 2.1 0.1 11.8 0.2 0.0 28.7 14.6 16.9 0.7 0.1 0.0 0.3 0.0 0.4 0.0 21.4 1.0 3.9 0.0 0.0 4.9 1.7 7.1 0.6 7.8 4.3 0.0 0.0 0.0 5.2 37.7 0.0 0.1 2.2 0.0 7.0 0.0 7.8 1.0 15.5 2.0 0.1 0.3 4.0 0.5 2.2 24.7 9.7 0.0 6.0 5.2 13.2 6.8 0.5 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 22.7 2.0 16.0 17.4 17.6 27.4 14.7 24.5 19.3 41.7 54.8 0.5 84.4 90.9 0.6 553.3 10.2 4.0 6.8 5.2 7.9 125.9 0.0 51.2 12.3 27.0 0.0 0.0 9.8 10.9 43.0 15.6 1.1 0.0 16.9 1.6 0.0 27.0 1.8 8.5 1.4 3.2 11.8 1.8 0.0 46.4 18.4 0.0 0.4 38.9 2.2 6.5 115.6 0.2 0.0 25.1 1120.5 3.2 0.0 73.8 HSPG2 "perlecan, PRCAN, SJS1" ENSG00000142798 "Heparan sulfate proteoglycan 2" P98160 1 21822245-21937297 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Angiogenesis "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 104.4" "Cell type enriched" "Detected in many" 7 "Ito cells: 621.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 3.0" "Lineage enriched" "Detected in single" 12 "dendritic cells: 3.0" "Cell line enhanced" "Detected in many" "EFO-21: 46.8;HUVEC TERT2: 103.4;TIME: 82.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB009820, HPA018892, CAB020718, HPA072690" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 1700000000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB009820: AB_2119229, CAB020718: , HPA018892: AB_1850597, HPA072690: " "unprognostic (1.61e-1)" "unprognostic (1.57e-2)" "unprognostic (4.93e-2)" "unprognostic (9.60e-2)" "unprognostic (2.38e-2)" "unprognostic (8.56e-2)" "unprognostic (4.55e-1)" "unprognostic (1.90e-2)" "unprognostic (9.35e-2)" "unprognostic (2.19e-3)" "unprognostic (5.82e-2)" "unprognostic (2.83e-1)" "unprognostic (1.21e-3)" "unprognostic (1.17e-2)" "unprognostic (4.86e-2)" "unprognostic (1.46e-2)" "prognostic unfavorable (2.82e-4)" 54.8 12.8 1.1 22.9 1.5 0.2 19.8 0.8 1.5 37.3 32.3 2.4 37.2 6.2 62.8 37.6 32.7 20.6 60.0 30.2 1.2 1.2 15.7 8.9 12.5 7.8 2.5 1.2 19.8 9.4 4.6 3.4 24.6 3.8 32.0 2.5 24.6 15.5 22.3 20.8 12.2 13.7 104.4 1.8 16.4 18.9 11.4 0.7 3.4 16.9 20.1 8.5 66.2 28.2 0.2 3.0 0.0 0.0 0.0 0.2 0.0 7.0 6.5 2.2 7.7 22.6 17.2 8.6 10.7 2.7 3.1 2.8 7.9 14.5 0.5 46.8 16.5 0.1 4.4 0.5 5.2 0.7 0.1 0.7 2.4 7.0 5.7 4.7 0.0 0.6 10.4 1.6 3.2 0.9 4.7 103.4 0.0 3.1 0.9 4.2 1.9 0.0 3.2 1.9 3.2 2.9 1.0 9.2 0.9 6.0 0.9 0.2 0.6 8.1 3.4 4.7 2.0 1.3 1.2 82.5 6.1 8.0 4.7 0.3 0.0 1.0 0.4 1.6 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 3.0 0.0 0.0 1.1 1.5 0.8 1.5 1.2 1.2 2.5 1.2 3.8 0.7 65.5 28.7 5.2 10.9 23.5 0.7 4.5 40.8 1.4 12.5 87.2 0.0 9.4 0.0 63.1 1.0 75.0 34.2 0.0 21.9 85.1 58.4 6.6 22.0 2.8 6.1 3.2 2.4 621.2 31.6 2.2 69.6 3.5 57.3 2.8 12.8 1.4 55.1 20.7 65.0 0.5 0.5 32.3 38.8 0.4 4.1 15.6 7.8 6.4 13.9 8.3 HSPH1 "HSP105A, HSP105B, KIAA0201, NY-CO-25" ENSG00000120694 "Heat shock protein family H (Hsp110) member 1" Q92598 13 31134974-31162388 "Cancer-related genes, Predicted intracellular proteins" "Stress response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "vagina: 286.1" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 738.6;Urothelial cells: 485.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002060, HPA028675, HPA031569" Uncertain Enhanced Nucleoplasm,Cytosol No Yes 820000 Cytosol Nucleoplasm "CAB002060: AB_563775, HPA028675: AB_10601581, HPA031569: AB_2673938" "unprognostic (1.10e-2)" "unprognostic (4.94e-2)" "unprognostic (5.44e-2)" "unprognostic (1.36e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (4.90e-4)" "prognostic unfavorable (1.41e-5)" "unprognostic (5.03e-2)" "unprognostic (1.38e-1)" "unprognostic (1.74e-1)" "unprognostic (1.53e-1)" "unprognostic (3.13e-1)" "unprognostic (7.45e-3)" "unprognostic (9.61e-2)" "unprognostic (2.58e-1)" "unprognostic (2.04e-1)" "unprognostic (7.89e-2)" 13.7 19.8 36.6 12.2 57.1 9.8 33.7 11.7 44.0 14.7 10.6 9.8 13.0 6.1 13.3 21.7 13.9 31.0 18.1 14.2 34.8 40.3 16.6 14.8 15.9 17.4 36.5 16.3 13.4 10.1 15.1 24.1 19.8 32.7 14.5 14.5 3.6 7.0 17.3 10.5 11.0 6.4 15.7 34.8 9.0 12.2 35.0 34.6 12.1 22.5 7.8 23.8 17.0 286.1 9.0 6.8 2.1 14.6 13.7 12.8 5.5 13.7 26.5 21.8 2.1 21.0 11.9 14.5 23.9 21.3 37.2 17.3 31.1 21.5 35.8 15.0 16.6 52.9 26.8 84.1 21.2 48.1 28.0 10.6 31.0 14.6 27.4 6.9 21.5 24.8 7.5 49.2 24.8 14.3 19.5 21.5 12.6 25.9 5.7 26.1 18.8 30.8 24.6 31.0 67.6 19.8 24.3 17.9 11.8 28.1 16.8 22.6 18.8 21.8 21.4 11.0 34.9 7.2 21.0 13.1 12.8 16.3 18.4 26.4 4.5 14.7 30.7 10.7 26.1 21.4 1.0 3.9 2.1 6.6 9.6 8.1 9.0 8.4 10.0 6.8 7.8 12.8 11.9 0.4 13.7 14.6 5.3 5.3 5.5 36.6 57.1 11.7 44.0 34.8 40.3 36.5 16.3 32.7 34.6 122.1 81.5 33.2 738.6 190.6 38.7 130.6 17.8 302.5 185.4 43.6 392.7 17.7 24.9 44.8 71.1 92.6 26.2 0.0 31.1 55.8 207.2 407.7 251.8 21.5 79.0 28.6 217.9 24.5 27.7 22.4 31.4 113.0 155.3 47.7 22.5 16.6 37.1 45.6 36.7 22.8 57.7 38.8 156.8 128.9 138.0 125.3 35.6 28.0 26.7 485.8 HTATSF1 TAT-SF1 ENSG00000102241 "HIV-1 Tat specific factor 1" O43719 X 136497079-136512346 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000504 Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA000504: AB_10752094" "unprognostic (3.56e-2)" "prognostic favorable (3.78e-4)" "unprognostic (1.72e-1)" "unprognostic (2.56e-2)" "unprognostic (6.72e-2)" "unprognostic (3.70e-1)" "unprognostic (3.32e-3)" "unprognostic (3.27e-1)" "unprognostic (2.09e-2)" "unprognostic (1.49e-1)" "unprognostic (1.73e-2)" "unprognostic (3.37e-2)" "prognostic favorable (8.13e-8)" "unprognostic (7.12e-2)" "unprognostic (2.67e-2)" "unprognostic (2.25e-2)" "unprognostic (4.05e-1)" 14.5 40.9 26.2 11.8 24.7 18.3 19.6 29.5 22.2 15.2 13.4 19.4 12.9 9.6 15.9 24.7 12.3 14.5 11.5 25.2 23.8 29.9 17.5 12.7 10.4 12.1 26.9 17.6 25.5 10.9 25.6 71.7 21.2 21.4 15.1 14.2 11.9 10.6 16.6 72.2 13.6 9.8 14.4 28.1 10.2 12.4 15.8 19.0 14.5 19.4 22.6 13.3 12.7 12.9 17.1 14.1 19.2 16.1 23.6 24.9 13.1 42.0 22.5 28.5 20.2 21.3 16.1 25.2 19.5 17.4 16.7 16.3 13.3 18.9 31.6 47.5 18.9 19.4 18.2 34.5 14.6 21.7 24.1 29.3 19.7 28.5 16.3 11.8 37.0 16.0 14.2 19.1 18.3 11.3 11.7 16.9 47.6 18.1 23.4 21.4 31.3 36.8 31.9 16.4 37.9 33.5 29.1 35.5 28.8 17.9 29.8 20.2 31.4 18.5 15.5 15.3 25.2 11.5 26.7 16.3 20.4 15.4 23.1 34.9 13.7 18.8 26.3 13.0 52.9 14.3 19.2 10.1 16.4 21.9 10.5 24.4 17.1 24.1 22.2 14.1 15.9 24.9 22.2 3.4 23.6 16.1 10.3 24.0 13.1 26.2 24.7 29.5 22.2 23.8 29.9 26.9 17.6 21.4 19.0 47.6 40.5 17.9 31.9 26.3 49.7 142.2 15.3 58.9 68.2 47.1 9.8 79.5 41.4 30.5 4.9 27.0 20.7 0.0 29.6 57.8 33.4 28.5 33.5 20.4 33.5 39.7 77.9 10.4 19.3 9.9 41.7 26.7 30.4 26.2 34.6 55.0 26.0 14.0 50.5 24.8 43.9 45.3 33.5 21.8 87.9 23.2 97.7 40.6 29.3 30.6 HTR2B "5-HT(2B), 5-HT2B" ENSG00000135914 "5-hydroxytryptamine receptor 2B" P41595 2 231108230-231125118 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 26.0" "Cell type enhanced" "Detected in some" 14 "Cone photoreceptor cells: 3.9;Ito cells: 5.5;monocytes: 10.8;Peritubular cells: 4.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "basophil: 3.8;T-reg: 2.9" "Group enriched" "Detected in many" 29 "granulocytes: 3.8;T-cells: 2.9" "Group enriched" "Detected in some" 4 "HHSteC: 7.0;HSkMC: 13.3;SK-MEL-30: 24.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA012867, HPA063658" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA012867: AB_1856710, HPA063658: AB_2685079" "unprognostic (1.86e-1)" "unprognostic (3.55e-2)" "unprognostic (1.20e-3)" "unprognostic (1.45e-2)" "unprognostic (1.12e-1)" "unprognostic (1.16e-1)" "unprognostic (1.53e-2)" "unprognostic (1.00e-1)" "unprognostic (1.33e-2)" "unprognostic (1.15e-4)" "unprognostic (3.59e-1)" "unprognostic (2.17e-2)" "unprognostic (1.42e-3)" "unprognostic (7.44e-4)" "unprognostic (1.81e-1)" "unprognostic (1.17e-1)" "unprognostic (1.14e-2)" 2.3 17.9 0.2 5.8 0.3 0.7 4.1 0.3 0.6 17.8 7.3 0.2 1.7 1.0 14.9 9.5 5.7 1.9 0.8 4.6 0.3 0.3 5.6 2.5 1.8 0.5 0.3 0.4 4.3 0.3 0.3 0.4 26.0 0.9 2.6 1.5 1.8 0.5 1.0 0.2 0.2 6.3 12.8 0.3 0.4 5.2 3.3 0.3 2.4 6.8 1.0 0.4 4.9 0.8 0.0 0.1 3.8 0.0 0.0 2.9 0.0 0.1 0.2 0.0 0.1 0.4 3.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.0 0.1 0.3 13.3 0.0 0.0 0.0 0.0 2.5 1.1 0.1 0.0 0.0 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.1 24.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.8 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 2.9 0.0 0.2 0.3 0.3 0.6 0.3 0.3 0.3 0.4 0.9 0.3 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.0 2.7 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.6 0.1 0.3 0.0 0.0 0.9 2.6 1.6 0.0 5.5 1.2 0.0 0.6 0.0 0.0 10.8 0.0 0.0 0.1 0.0 4.9 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 HTT "HD, IT15" ENSG00000197386 Huntingtin P42858 4 3074681-3243960 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Disease mutation, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 170.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002756, HPA026114" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB002756: , HPA026114: AB_1851330" "unprognostic (2.05e-1)" "unprognostic (1.09e-1)" "unprognostic (8.79e-3)" "unprognostic (1.08e-1)" "unprognostic (1.66e-1)" "prognostic favorable (3.26e-4)" "unprognostic (1.52e-2)" "unprognostic (8.33e-2)" "unprognostic (8.06e-2)" "unprognostic (2.15e-1)" "unprognostic (1.87e-2)" "unprognostic (6.04e-2)" "prognostic favorable (2.41e-12)" "unprognostic (9.46e-3)" "unprognostic (1.99e-1)" "unprognostic (6.53e-2)" "unprognostic (3.84e-2)" 12.9 13.8 19.4 16.6 18.3 14.1 12.3 24.7 32.3 10.0 13.6 11.6 11.0 10.5 11.5 15.9 16.3 11.6 9.4 8.9 19.7 12.1 11.3 13.1 21.5 18.1 11.8 19.5 13.0 27.0 29.5 13.0 12.0 12.8 10.5 11.4 13.3 10.2 11.4 19.1 25.4 12.8 12.0 10.4 17.4 12.0 14.9 10.4 17.4 13.3 7.3 15.6 11.7 9.6 2.9 3.5 2.8 4.5 2.9 4.3 1.9 12.4 8.7 12.2 7.2 22.4 12.8 12.4 5.8 7.2 8.8 8.3 11.5 8.1 19.1 6.2 14.0 16.1 7.1 14.4 10.6 8.9 5.0 10.6 18.2 12.4 12.2 5.3 12.2 26.7 8.9 6.5 17.2 8.1 6.0 10.2 8.6 11.9 6.9 7.7 12.0 13.0 11.5 14.9 6.3 14.1 11.7 11.7 3.7 9.4 12.9 13.4 9.5 10.4 3.9 10.2 9.7 10.8 7.6 14.1 12.3 7.7 8.4 13.0 5.3 6.2 15.2 9.2 11.3 8.8 0.0 2.6 2.8 3.5 3.4 2.4 2.9 2.7 4.3 3.5 2.4 2.0 2.4 0.4 2.9 4.5 2.6 3.5 1.9 19.4 18.3 24.7 32.3 19.7 12.1 11.8 19.5 12.8 10.4 23.8 15.0 13.9 7.0 12.2 42.6 10.1 20.4 5.3 13.6 14.0 170.8 10.3 5.0 10.2 9.0 10.8 18.4 0.0 14.9 9.2 10.8 13.1 11.5 13.5 23.3 42.9 17.7 23.9 23.5 7.5 15.0 14.5 8.5 13.6 11.4 19.1 18.0 20.1 11.0 9.8 45.2 12.9 7.1 10.4 19.4 17.6 7.0 10.2 16.2 9.9 HUNK ENSG00000142149 "Hormonally up-regulated Neu-associated kinase" P57058 21 31873315-32044633 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 10.6;BEWO: 13.0;RH-30: 14.4;SCLC-21H: 11.7;SiHa: 10.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027295, HPA027372" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA027295: AB_2672203, HPA027372: AB_2672239" "unprognostic (9.09e-3)" "unprognostic (7.29e-2)" "unprognostic (1.42e-1)" "unprognostic (5.95e-3)" "unprognostic (1.99e-1)" "unprognostic (2.12e-4)" "unprognostic (4.00e-2)" "unprognostic (6.90e-2)" "unprognostic (5.07e-1)" "unprognostic (2.27e-1)" "unprognostic (9.09e-2)" "unprognostic (1.13e-1)" "prognostic favorable (7.48e-5)" "unprognostic (8.84e-2)" "unprognostic (2.22e-1)" "unprognostic (1.39e-1)" "unprognostic (6.69e-2)" 1.7 1.9 2.7 2.9 3.5 0.5 2.1 3.2 6.4 1.1 5.9 0.2 12.6 2.4 9.0 3.4 1.1 3.3 1.0 1.7 3.7 3.2 6.0 1.3 1.7 0.7 1.2 2.1 1.8 15.7 0.2 4.7 7.6 1.4 4.0 6.5 9.1 1.5 11.1 0.6 5.0 4.4 4.1 0.9 0.4 2.1 1.8 0.2 0.4 1.1 2.2 1.0 3.8 7.7 1.0 0.7 1.7 0.5 0.5 0.5 0.1 0.0 3.0 10.6 0.1 0.0 0.0 13.0 1.0 0.0 0.2 0.0 4.2 0.1 0.0 0.4 4.9 0.2 0.1 6.2 0.0 0.0 0.0 3.2 0.0 2.8 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.9 0.2 0.9 8.0 0.0 0.1 0.1 14.4 0.0 1.1 0.0 11.7 7.8 10.3 0.8 0.4 7.7 4.3 1.1 0.0 0.0 7.5 0.0 0.0 0.1 0.0 1.4 0.0 0.0 5.0 0.8 0.5 0.5 0.5 0.3 0.3 0.5 0.5 0.3 0.2 1.0 0.5 0.5 1.7 0.5 0.3 0.7 0.4 0.1 2.7 3.5 3.2 6.4 3.7 3.2 1.2 2.1 1.4 0.2 6.0 7.8 0.0 1.8 4.5 4.3 3.2 17.8 1.4 4.5 7.0 2.0 8.1 0.0 3.8 0.0 0.9 2.7 0.0 2.9 11.6 10.6 1.6 0.0 0.9 2.3 3.2 4.7 0.0 0.0 0.0 0.3 0.0 3.3 0.0 3.9 11.4 2.6 2.9 0.0 1.5 1.2 0.0 1.4 0.9 0.7 5.1 5.1 0.0 9.0 0.8 HUS1B ENSG00000188996 "HUS1 checkpoint clamp component B" Q8NHY5 6 655939-656963 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 4.3" "Cell type enhanced" "Detected in some" 9 "monocytes: 3.6;Sertoli cells: 6.5;Spermatocytes: 7.6;Spermatogonia: 4.7" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEK 293: 4.4;U-266/84: 5.1;WM-115: 5.5" "Not detected" "Not detected" "HPA034511, HPA063449" Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034511: AB_2674203, HPA063449: AB_2685014" "unprognostic (3.56e-4)" "unprognostic (3.68e-2)" "unprognostic (4.81e-2)" "unprognostic (1.95e-1)" "unprognostic (3.45e-2)" "unprognostic (1.36e-1)" "unprognostic (4.95e-2)" "unprognostic (6.53e-2)" "unprognostic (9.44e-2)" "unprognostic (8.46e-2)" "unprognostic (8.76e-3)" "unprognostic (1.43e-1)" "unprognostic (4.13e-10)" "unprognostic (7.99e-2)" "unprognostic (2.02e-1)" "unprognostic (1.09e-1)" "unprognostic (1.30e-1)" 0.5 0.1 0.1 0.5 0.1 3.3 0.6 0.0 0.0 1.4 0.4 1.3 0.9 0.7 0.9 0.2 0.6 0.5 0.2 0.1 0.6 0.8 1.0 0.2 0.3 0.8 0.0 0.0 0.8 1.1 1.4 0.2 0.5 0.1 0.0 0.9 0.3 1.0 0.6 1.0 0.1 4.3 0.7 0.2 0.3 1.2 1.6 1.6 0.0 0.7 0.0 1.9 0.6 0.7 0.0 0.0 1.8 0.0 0.0 1.7 0.2 0.1 0.0 0.1 0.8 0.1 0.3 0.5 0.1 0.4 0.0 0.5 0.0 0.4 1.3 4.4 0.9 0.0 0.0 0.4 0.0 1.5 0.0 0.3 0.4 0.4 0.0 0.1 1.1 1.7 1.0 0.5 0.0 0.5 2.4 2.8 0.0 1.4 0.9 0.8 2.5 0.2 0.6 1.0 0.2 0.3 0.0 0.7 0.5 0.1 0.1 0.4 0.7 0.8 1.5 0.4 2.3 5.1 1.0 0.1 0.6 5.5 0.0 0.7 0.0 0.7 0.3 0.5 1.6 1.1 0.9 0.0 0.8 1.0 1.9 0.0 0.0 0.0 1.6 0.7 0.6 0.0 0.0 0.5 0.6 0.6 0.8 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.1 0.7 0.7 0.0 0.0 0.5 1.0 0.4 0.5 0.0 0.0 0.7 0.0 0.0 2.5 0.0 0.0 0.9 0.0 0.0 3.6 0.0 0.5 0.9 0.0 1.1 0.0 1.7 6.5 0.5 7.6 4.7 1.5 1.3 1.5 0.2 0.3 HUWE1 "Ib772, KIAA0312, UREB1" ENSG00000086758 "HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase" Q7Z6Z7 X 53532096-53686729 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Differentiation, DNA damage, DNA repair, Ubl conjugation pathway" "DNA-binding, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002548, CAB022718" Approved Enhanced Nucleoplasm,Cytosol NA NA 3400 "Nucleoplasm, Cytosol" "CAB022718: , HPA002548: AB_1080489" "unprognostic (4.73e-2)" "unprognostic (9.06e-2)" "unprognostic (1.31e-1)" "unprognostic (1.59e-2)" "unprognostic (6.64e-2)" "unprognostic (3.16e-2)" "unprognostic (1.33e-2)" "unprognostic (2.21e-1)" "unprognostic (3.56e-1)" "unprognostic (5.51e-2)" "unprognostic (1.33e-1)" "unprognostic (8.89e-2)" "unprognostic (8.10e-3)" "unprognostic (2.17e-1)" "unprognostic (1.32e-1)" "unprognostic (3.67e-2)" "unprognostic (2.45e-1)" 24.6 28.2 27.7 23.8 43.3 22.4 28.0 37.0 41.1 31.8 25.9 34.3 26.6 17.1 31.9 52.4 27.4 26.5 23.1 27.1 28.0 31.8 30.3 26.2 20.3 23.1 30.0 30.2 43.3 27.8 59.8 34.2 27.2 34.6 27.3 22.7 25.6 26.4 29.6 59.1 50.1 22.1 33.9 23.9 26.6 25.7 28.4 27.7 32.4 27.6 20.7 28.6 27.0 22.9 5.1 7.2 8.2 7.0 6.9 8.9 3.5 50.2 31.0 20.2 14.2 35.4 21.2 24.9 15.1 19.5 16.0 16.7 23.6 16.2 26.4 10.3 27.5 28.8 24.2 45.6 25.3 21.9 38.0 20.2 21.0 27.8 18.3 32.5 31.4 12.9 20.2 19.0 38.3 44.1 15.8 27.6 20.7 20.9 17.1 20.7 31.0 17.0 17.6 27.6 13.8 22.3 15.7 27.8 16.0 26.5 34.9 16.9 12.2 42.7 19.1 13.6 39.5 27.3 15.3 35.1 14.7 21.1 21.0 19.2 15.0 14.8 23.0 15.7 30.8 21.1 4.0 4.7 8.2 7.2 3.8 8.9 5.1 6.9 7.6 6.7 5.1 4.9 4.9 4.2 6.9 7.0 7.2 5.7 3.5 27.7 43.3 37.0 41.1 28.0 31.8 30.0 30.2 34.6 27.7 47.6 43.2 23.8 25.3 26.8 53.1 98.6 45.9 37.5 36.4 38.4 47.1 26.9 1.7 35.4 22.3 29.2 24.7 0.0 30.4 29.3 24.4 33.4 20.9 43.1 21.9 77.9 45.8 31.3 25.6 21.6 26.2 26.1 25.3 40.5 28.4 20.9 40.0 17.3 36.7 12.2 31.9 12.9 33.0 17.1 43.7 36.4 31.7 37.1 29.2 40.4 HYPK "C15orf63, FLJ20431, HSPC136" ENSG00000242028 "Huntingtin interacting protein K" Q9NX55 15 43796142-43803043 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 51.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055252 Uncertain Supported Nucleoplasm,Microtubules NA NA Nucleoplasm Microtubules "HPA055252: AB_2682759" "unprognostic (2.89e-2)" "unprognostic (5.82e-2)" "unprognostic (2.14e-2)" "unprognostic (7.58e-3)" "unprognostic (1.15e-1)" "unprognostic (1.08e-3)" "unprognostic (3.55e-1)" "unprognostic (1.48e-1)" "unprognostic (4.41e-2)" "unprognostic (1.04e-1)" "unprognostic (5.36e-3)" "unprognostic (2.39e-3)" "unprognostic (6.52e-7)" "unprognostic (2.05e-1)" "unprognostic (8.89e-2)" "unprognostic (2.61e-1)" "unprognostic (2.78e-4)" 7.5 11.3 10.8 10.1 13.7 22.1 7.3 29.4 11.1 7.0 8.3 8.4 7.0 8.4 8.5 8.8 8.2 7.9 7.3 17.3 9.3 6.5 13.2 30.5 13.7 11.3 13.3 9.7 10.4 18.0 6.7 11.9 8.1 14.1 13.3 13.5 5.7 11.0 7.1 36.8 13.4 10.2 7.4 8.6 11.1 14.4 14.0 12.0 6.0 11.1 13.1 11.0 8.3 10.8 7.8 3.9 8.3 8.9 4.4 9.6 1.5 1.5 1.9 5.6 3.4 4.7 5.4 3.5 3.0 1.3 2.2 1.6 4.9 1.8 2.5 1.8 1.5 1.3 5.2 4.7 3.6 2.2 2.5 3.3 3.5 9.0 2.7 2.4 2.0 2.7 4.2 6.7 1.6 3.0 6.2 2.3 5.0 3.9 4.9 2.3 4.2 2.5 5.1 1.8 3.0 4.1 3.2 1.8 2.9 3.7 5.5 3.5 2.5 2.4 5.0 0.7 3.9 5.0 2.4 4.5 6.2 3.6 4.1 2.8 5.8 6.1 5.8 4.8 5.9 2.4 6.2 4.4 4.2 5.4 3.2 8.0 3.2 7.5 6.3 3.0 7.8 9.6 7.8 8.3 4.4 8.9 3.9 5.2 1.5 10.8 13.7 29.4 11.1 9.3 6.5 13.3 9.7 14.1 12.0 6.0 12.6 9.5 13.9 26.7 10.4 0.8 5.1 14.7 15.9 7.0 51.1 5.6 8.3 1.5 2.3 5.8 5.5 0.0 7.2 3.8 9.7 13.6 8.1 5.5 3.4 12.7 10.3 8.6 2.1 0.9 4.6 13.4 21.9 2.8 7.6 4.0 4.7 3.6 2.1 8.6 27.1 0.0 15.0 4.2 3.7 32.6 4.1 8.6 7.1 8.1 IAH1 ENSG00000134330 "Isoamyl acetate hydrolyzing esterase 1 (putative)" Q2TAA2 2 9473658-9496543 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 336.0;Late spermatids: 365.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040523, HPA076040" Approved Approved Nucleoplasm NA NA 160000 Nucleoplasm "HPA040523: AB_2677021, HPA076040: " "unprognostic (1.51e-2)" "unprognostic (1.19e-2)" "unprognostic (1.27e-1)" "unprognostic (9.41e-2)" "unprognostic (9.35e-2)" "unprognostic (2.06e-2)" "unprognostic (5.40e-2)" "unprognostic (2.28e-2)" "unprognostic (2.98e-2)" "unprognostic (5.40e-2)" "unprognostic (7.39e-2)" "unprognostic (2.43e-1)" "prognostic unfavorable (3.64e-4)" "unprognostic (2.26e-1)" "unprognostic (1.44e-1)" "unprognostic (2.42e-2)" "unprognostic (3.91e-2)" 27.3 34.5 27.3 21.0 27.0 19.6 28.7 19.6 35.3 26.7 25.6 21.9 19.9 18.3 22.3 30.5 22.8 24.2 24.2 46.2 24.5 25.1 31.4 40.4 20.9 24.6 23.7 24.6 27.0 24.7 24.1 23.0 21.2 25.5 23.2 27.0 19.7 20.8 28.0 28.7 15.4 25.2 30.3 25.9 18.6 20.7 49.9 17.9 21.2 26.9 23.7 27.6 24.6 20.8 27.2 36.4 20.2 25.5 23.2 30.4 15.8 12.3 12.6 1.3 0.1 23.4 43.9 0.2 11.0 23.6 15.6 14.6 0.1 13.8 6.4 5.2 31.8 10.2 8.4 4.6 9.3 15.0 25.7 12.7 8.2 5.0 7.1 43.9 0.0 6.2 26.2 28.0 11.0 13.1 27.0 14.7 11.1 0.1 4.0 30.6 12.1 30.1 0.9 1.8 14.8 12.2 7.5 0.0 1.9 23.5 6.6 9.0 18.3 8.3 10.9 15.2 0.6 11.8 13.9 12.0 11.9 5.2 5.3 16.3 3.2 0.2 2.2 16.7 5.0 13.1 13.9 25.5 20.2 22.7 23.2 24.0 27.2 25.9 24.9 33.9 22.4 20.8 23.5 13.9 23.2 25.3 36.4 30.4 15.8 27.3 27.0 19.6 35.3 24.5 25.1 23.7 24.6 25.5 17.9 29.8 25.8 55.8 83.9 79.8 31.5 39.7 33.1 32.1 21.6 47.1 11.8 63.9 77.9 59.8 336.0 31.5 41.6 46.7 67.5 89.5 85.0 53.7 35.8 48.9 77.7 39.7 24.6 34.4 61.8 365.3 86.9 75.3 87.7 139.7 25.4 36.5 72.8 31.6 68.6 109.3 51.1 97.0 76.9 214.7 46.8 83.7 37.2 66.0 46.0 86.6 IARS "IARS1, ILRS" ENSG00000196305 "Isoleucyl-tRNA synthetase" P41252 9 92210207-92293756 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029806 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA029806: AB_10601818" "unprognostic (1.32e-3)" "unprognostic (2.94e-2)" "unprognostic (2.27e-2)" "unprognostic (8.23e-2)" "unprognostic (1.33e-1)" "unprognostic (1.26e-2)" "prognostic unfavorable (4.98e-7)" "unprognostic (2.00e-2)" "unprognostic (3.80e-2)" "unprognostic (1.10e-1)" "unprognostic (4.96e-2)" "unprognostic (3.67e-2)" "unprognostic (1.40e-2)" "unprognostic (2.88e-2)" "unprognostic (4.71e-2)" "unprognostic (2.21e-1)" "unprognostic (7.76e-3)" 20.6 31.0 19.1 21.1 28.5 13.8 24.8 24.5 32.1 22.8 23.7 17.5 25.8 13.6 31.9 24.8 29.7 23.8 15.1 26.0 21.4 18.5 24.5 29.9 24.4 24.1 21.6 20.6 28.4 42.8 57.4 29.0 21.1 31.6 23.6 26.7 17.1 25.2 27.7 47.4 25.4 18.8 32.6 20.0 23.1 29.0 18.7 16.9 25.1 52.3 26.7 28.8 22.1 20.5 14.5 15.3 1.9 7.3 18.6 18.6 9.7 35.0 36.3 20.3 32.0 33.5 37.8 32.2 37.2 35.5 29.5 36.1 12.7 22.6 47.6 14.7 57.4 32.5 43.9 62.6 48.4 37.3 29.9 23.3 29.0 31.3 22.6 70.8 39.5 21.5 36.8 54.4 51.4 85.1 19.4 31.0 57.2 51.1 43.3 41.4 25.5 36.5 15.4 32.9 74.5 33.6 25.6 30.9 22.9 24.3 17.6 26.0 21.6 25.2 27.7 35.0 22.9 22.2 24.8 22.8 21.8 27.3 36.0 30.2 31.7 40.5 25.2 51.0 30.5 40.2 1.9 6.7 0.5 14.7 7.3 18.6 14.5 14.5 14.9 15.3 10.7 14.7 15.3 0.8 18.6 6.2 6.2 12.9 9.7 19.1 28.5 24.5 32.1 21.4 18.5 21.6 20.6 31.6 16.9 17.9 25.5 29.7 27.4 60.8 34.2 44.5 40.8 24.1 27.3 17.4 43.2 23.5 13.3 22.2 8.9 20.8 5.4 0.0 25.9 26.2 31.1 25.2 36.9 26.0 15.7 9.5 11.5 16.0 21.6 4.0 26.4 17.7 13.5 11.8 23.8 15.5 26.0 8.6 27.6 29.1 34.6 6.5 32.5 39.2 38.1 59.2 14.5 18.7 26.3 27.4 IBTK "BTBD26, BTKI, DKFZP564B116" ENSG00000005700 "Inhibitor of Bruton tyrosine kinase" Q9P2D0 6 82169983-82247754 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023826, HPA048438" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA023826: AB_1851378, HPA048438: AB_2680392" "unprognostic (3.13e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (2.72e-2)" "unprognostic (1.75e-2)" "unprognostic (2.48e-1)" "unprognostic (2.78e-1)" "unprognostic (5.93e-2)" "unprognostic (1.97e-2)" "unprognostic (6.18e-2)" "unprognostic (1.90e-2)" "unprognostic (8.81e-2)" "unprognostic (3.02e-2)" "unprognostic (1.08e-2)" "unprognostic (7.33e-2)" "unprognostic (1.09e-1)" "unprognostic (7.27e-2)" "unprognostic (9.78e-2)" 12.8 26.4 8.7 11.0 13.3 4.8 13.2 15.9 16.0 13.9 12.0 14.9 16.7 11.7 14.3 10.9 14.7 12.9 8.9 13.9 8.8 8.7 16.3 39.1 12.1 15.5 11.8 7.7 13.9 20.4 19.9 22.2 9.0 14.5 11.5 15.1 11.2 14.6 17.6 30.9 7.2 16.5 15.1 12.9 12.7 15.8 6.2 10.8 13.6 14.9 14.5 10.0 13.5 10.1 3.9 4.3 3.0 4.6 2.2 6.0 1.9 5.6 11.8 8.6 7.2 10.5 14.4 3.8 13.3 14.7 11.1 12.0 6.2 6.7 11.2 8.5 15.7 14.5 6.1 6.9 7.4 13.3 15.0 5.1 12.0 6.3 9.6 14.6 13.8 7.3 12.4 12.5 10.5 26.1 10.2 10.8 7.8 11.0 7.0 11.6 8.7 4.8 4.5 3.8 8.8 6.3 7.0 18.2 4.4 16.7 13.1 5.8 6.4 9.0 11.3 7.0 7.9 10.6 8.5 8.7 6.4 4.8 8.0 10.6 7.3 11.3 5.2 7.1 9.2 8.2 3.0 2.7 2.1 4.4 2.5 6.0 3.9 4.3 3.9 4.3 2.6 4.4 4.0 0.0 2.2 4.6 3.2 5.9 1.9 8.7 13.3 15.9 16.0 8.8 8.7 11.8 7.7 14.5 10.8 38.7 33.8 23.8 28.4 12.0 54.8 60.8 53.5 34.8 47.8 36.6 51.1 20.9 13.3 28.0 2.7 24.4 34.5 46.7 44.8 13.7 23.6 45.7 35.8 65.2 23.9 49.3 37.3 24.5 29.4 1.3 23.9 31.7 21.9 38.7 34.6 33.5 42.5 29.1 19.8 27.2 36.7 25.8 20.6 19.7 24.7 10.2 7.9 21.8 28.8 63.3 ICAM3 "CD50, CDW50, ICAM-R" ENSG00000076662 "Intercellular adhesion molecule 3" P32942 19 10333776-10339823 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Phagocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 172.3;bone marrow: 51.5;lymphoid tissue: 68.5" "Cell type enhanced" "Detected in many" 7 "B-cells: 138.5;Hepatocytes: 150.6;Kupffer cells: 110.3;T-cells: 189.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 172.3" "Lineage enriched" "Detected in all" 4 "granulocytes: 172.3" "Cell line enhanced" "Detected in many" "Karpas-707: 65.6;NB-4: 42.3;RPMI-8226: 49.2;U-266/84: 34.9;U-937: 34.5" "CAB002498, HPA049820" Enhanced Approved "Nucleoplasm,Nuclear membrane,Mitochondria" NA NA 370000000 Mitochondria "Nucleoplasm, Nuclear membrane" "CAB002498: AB_563593, HPA049820: AB_2680897" "unprognostic (6.85e-4)" "unprognostic (5.28e-3)" "unprognostic (3.09e-3)" "unprognostic (1.57e-2)" "unprognostic (5.34e-3)" "unprognostic (5.79e-6)" "unprognostic (5.05e-3)" "unprognostic (3.73e-2)" "unprognostic (1.73e-3)" "unprognostic (7.93e-2)" "unprognostic (3.45e-2)" "unprognostic (2.54e-1)" "unprognostic (5.62e-4)" "unprognostic (1.13e-1)" "unprognostic (1.06e-2)" "unprognostic (3.43e-1)" "unprognostic (1.84e-1)" 6.8 2.8 1.7 23.5 1.9 51.5 5.5 0.6 1.5 3.0 6.8 1.1 1.2 4.3 1.7 3.0 4.0 2.9 7.2 6.4 1.1 0.9 5.1 28.7 13.2 68.5 1.8 1.4 1.7 6.8 0.2 0.4 4.8 1.5 2.8 3.3 2.4 10.3 1.3 5.0 1.6 11.9 1.8 1.0 39.4 5.4 1.4 1.0 47.6 3.0 5.7 38.4 4.5 4.9 25.5 28.4 172.3 33.5 31.0 41.0 43.1 2.7 1.3 1.0 3.0 1.6 1.3 1.7 1.7 1.1 1.4 1.2 1.1 1.8 0.0 5.8 1.5 0.0 1.1 0.0 1.2 0.4 20.3 0.8 5.2 1.2 5.1 0.8 18.7 21.1 1.1 1.0 1.6 0.6 1.5 0.6 10.9 2.8 65.6 1.6 5.5 2.4 42.3 0.7 6.9 9.2 1.5 0.6 49.2 1.4 2.4 0.3 1.3 1.4 4.6 3.7 0.5 4.0 5.3 1.1 6.5 0.5 7.1 1.6 3.2 34.9 7.8 4.6 34.5 5.0 15.3 33.1 72.0 33.8 24.4 41.0 25.5 32.7 31.2 28.4 23.9 29.3 27.4 172.3 31.0 33.5 4.8 36.9 43.1 1.7 1.9 0.6 1.5 1.1 0.9 1.8 1.4 1.5 1.0 3.0 43.3 138.5 7.1 7.2 0.1 0.0 25.5 9.4 4.5 5.2 0.0 10.4 53.0 13.7 4.2 18.0 53.5 0.0 30.7 20.6 13.1 14.3 30.0 150.6 21.1 1.6 5.2 26.4 110.3 7.2 5.8 19.9 52.3 12.6 29.1 1.5 17.7 45.3 3.9 54.2 1.2 0.0 13.3 0.5 0.9 7.3 3.9 189.2 31.2 8.4 ICE1 KIAA0947 ENSG00000164151 "Interactor of little elongation complex ELL subunit 1" Q9Y2F5 5 5420664-5490234 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054452, HPA061934" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA054452: AB_2682492, HPA061934: AB_2684641" "unprognostic (1.45e-2)" "unprognostic (9.73e-2)" "unprognostic (6.92e-2)" "unprognostic (2.39e-3)" "unprognostic (4.42e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (1.66e-4)" "unprognostic (1.16e-1)" "unprognostic (4.29e-1)" "unprognostic (1.78e-1)" "unprognostic (3.51e-1)" "unprognostic (1.27e-1)" "unprognostic (2.25e-2)" "unprognostic (4.59e-2)" "unprognostic (2.72e-1)" "unprognostic (3.02e-2)" "unprognostic (2.33e-1)" 14.3 13.2 16.3 13.2 17.3 17.4 18.1 26.7 20.6 17.7 15.1 10.3 13.4 10.6 18.3 14.2 11.6 15.0 10.8 12.3 14.4 13.3 15.5 11.3 12.0 15.5 15.5 16.8 21.7 14.2 27.3 22.5 18.5 17.1 13.5 12.0 8.8 12.9 14.0 28.2 12.8 13.4 20.0 16.3 14.0 13.6 10.7 14.2 21.6 15.5 13.8 16.2 15.5 17.8 3.4 3.8 3.6 2.3 3.4 3.9 1.2 9.3 11.9 13.6 13.0 13.3 13.1 17.6 8.1 9.7 9.8 10.9 9.1 7.0 12.7 11.4 11.7 19.4 8.9 18.7 9.5 16.6 17.6 9.5 10.3 35.9 6.6 8.1 23.2 8.5 10.4 10.3 11.7 18.3 9.8 12.1 9.7 14.6 10.7 10.2 8.2 16.9 8.3 11.5 6.0 10.1 19.9 12.4 8.6 8.3 10.7 8.9 9.2 28.3 9.3 10.9 13.8 8.0 7.4 13.6 12.8 16.4 16.4 12.7 11.7 13.7 21.6 10.8 17.6 10.8 1.5 1.8 3.6 3.3 2.3 3.9 3.4 3.0 3.1 1.7 3.0 2.7 3.2 0.5 3.4 1.2 3.8 3.5 1.2 16.3 17.3 26.7 20.6 14.4 13.3 15.5 16.8 17.1 14.2 20.8 25.6 14.9 12.0 0.0 37.6 27.4 12.7 12.0 26.1 15.7 29.5 30.4 21.6 19.6 4.4 21.2 9.3 0.0 19.5 19.2 15.8 14.8 10.5 11.3 13.3 42.9 8.6 13.5 16.1 4.5 20.8 13.6 0.0 22.6 10.5 25.0 19.3 5.8 20.8 12.0 34.8 6.5 20.8 30.9 45.8 0.0 9.2 21.3 9.9 15.5 ICE2 "BRCC1, FLJ11896, NARG2" ENSG00000128915 "Interactor of little elongation complex ELL subunit 2" Q659A1 15 60419609-60479160 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040058 Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA040058: AB_10795686" "unprognostic (3.80e-1)" "unprognostic (1.72e-1)" "unprognostic (1.61e-1)" "unprognostic (5.59e-3)" "unprognostic (8.78e-3)" "unprognostic (2.71e-1)" "unprognostic (8.29e-2)" "unprognostic (2.22e-1)" "unprognostic (8.39e-3)" "unprognostic (1.68e-1)" "unprognostic (3.45e-1)" "unprognostic (3.56e-2)" "unprognostic (1.18e-2)" "unprognostic (1.06e-1)" "unprognostic (2.92e-2)" "unprognostic (1.95e-1)" "unprognostic (5.74e-2)" 12.1 11.5 7.7 9.2 11.5 6.7 11.0 9.8 9.2 11.4 9.1 10.2 14.1 6.1 11.9 8.0 9.6 10.3 8.8 8.2 8.2 6.0 10.6 9.2 8.6 10.9 13.3 6.3 15.4 9.1 44.0 25.6 10.2 9.7 11.7 9.6 7.7 9.4 9.9 10.7 9.1 8.6 10.8 10.1 10.0 9.0 8.6 13.4 19.5 14.0 8.1 12.3 10.7 11.3 10.9 6.6 5.9 7.4 4.4 11.7 6.9 8.8 15.7 13.3 12.7 10.1 11.1 6.9 5.2 8.2 8.4 9.2 12.2 6.6 15.5 11.6 5.6 16.0 16.9 17.6 7.0 11.7 18.6 7.9 15.6 11.1 7.1 5.4 17.1 11.1 5.5 8.6 6.9 12.6 11.2 13.8 15.4 23.8 14.6 10.4 3.8 13.6 4.5 16.5 16.3 10.6 16.3 10.5 13.6 6.8 11.0 15.1 14.5 7.4 7.6 9.3 16.4 12.3 8.9 6.5 11.8 10.4 9.9 16.2 6.9 18.5 22.7 7.7 19.8 10.8 4.5 5.1 5.9 7.1 7.4 11.7 9.1 8.7 9.2 6.6 10.9 11.6 11.2 0.8 4.4 6.0 5.6 8.9 6.9 7.7 11.5 9.8 9.2 8.2 6.0 13.3 6.3 9.7 13.4 17.9 15.8 17.6 16.5 0.0 29.6 17.7 20.4 36.1 31.8 19.2 37.3 19.5 18.3 10.4 12.5 20.1 9.3 0.0 8.9 12.2 12.2 19.1 28.9 17.1 11.7 28.6 18.5 30.7 12.4 11.9 23.6 15.1 0.0 16.2 15.0 18.4 12.8 17.0 16.6 15.6 33.3 0.0 8.0 17.7 31.4 0.0 12.2 23.5 18.8 16.8 ID1 "bHLHb24, dJ857M17.1.2" ENSG00000125968 "Inhibitor of DNA binding 1, HLH protein" P41134 20 31605283-31606515 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Developmental protein, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 163.1" "Cell type enhanced" "Detected in many" 8 "Ito cells: 1636.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "neutrophil: 3.9" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.9" "Cell line enhanced" "Detected in many" "EFO-21: 75.9;HaCaT: 72.3;PC-3: 75.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025915, HPA051456, HPA058518" Approved Enhanced Nucleoplasm "Intracellular and membrane" Yes No Nucleoplasm "CAB025915: , HPA051456: AB_2681492, HPA058518: AB_2683740" "unprognostic (3.89e-2)" "unprognostic (3.45e-2)" "unprognostic (2.62e-2)" "unprognostic (3.19e-2)" "unprognostic (1.27e-2)" "unprognostic (1.74e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (4.85e-4)" "unprognostic (2.29e-1)" "unprognostic (1.58e-1)" "unprognostic (2.14e-2)" "unprognostic (7.83e-2)" "unprognostic (1.67e-2)" "unprognostic (1.71e-3)" "unprognostic (2.97e-1)" "unprognostic (6.17e-3)" "unprognostic (3.41e-3)" 28.6 12.3 8.2 15.2 9.1 4.4 33.2 5.6 13.8 36.3 33.3 15.4 38.5 36.4 25.9 11.6 78.0 25.1 19.0 33.5 8.7 8.4 22.3 23.4 57.4 17.9 10.0 7.9 12.3 5.8 4.0 25.7 22.1 14.3 56.4 13.1 34.9 10.5 163.1 23.0 16.5 40.6 16.9 8.1 15.3 48.6 7.8 4.0 2.4 78.8 36.2 21.0 80.0 26.4 0.4 0.7 3.9 0.7 0.3 0.5 0.5 10.7 35.5 0.4 7.2 4.7 2.1 27.7 45.5 1.8 8.4 0.9 18.7 16.2 0.0 75.9 12.1 9.9 72.3 5.9 2.5 1.3 0.8 3.7 5.9 30.8 60.2 6.4 0.1 0.3 8.7 10.4 0.0 0.6 14.0 5.1 4.0 13.0 0.3 16.1 14.0 1.6 0.2 25.5 48.0 75.7 0.1 29.7 0.5 1.6 29.7 13.8 12.9 37.8 13.6 0.3 20.1 8.3 1.0 27.1 22.6 44.0 7.2 30.5 0.8 0.8 0.6 26.3 5.6 3.0 0.0 0.6 0.9 0.1 0.2 0.0 0.1 0.1 0.0 0.7 0.4 0.0 0.5 3.9 0.3 0.7 0.0 0.0 0.5 8.2 9.1 5.6 13.8 8.7 8.4 10.0 7.9 14.3 4.0 220.3 143.7 26.8 631.9 90.9 1.0 20.7 76.5 89.7 271.8 216.3 3.9 104.2 31.5 429.0 5.6 483.5 528.2 0.0 472.2 442.0 137.2 501.4 21.9 90.9 22.4 0.0 550.7 1636.4 76.9 5.9 26.4 25.7 86.0 13.6 450.7 80.6 190.0 770.0 0.4 2.7 4.0 12.9 193.3 1.9 2.2 76.9 74.5 24.9 241.9 477.9 ID2 "bHLHb26, GIG8" ENSG00000115738 "Inhibitor of DNA binding 2" Q02363 2 8678845-8684453 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Developmental protein, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 274.1" "Cell type enhanced" "Detected in all" 12 "monocytes: 3286.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 110.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 108.1;HEK 293: 69.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027612 Approved "Nucleoplasm,Nuclear bodies,Centrosome" NA NA "Nucleoplasm, Nuclear bodies" Centrosome "HPA027612: AB_10599729" "unprognostic (2.53e-1)" "unprognostic (8.16e-3)" "unprognostic (8.51e-2)" "unprognostic (6.66e-2)" "unprognostic (2.24e-1)" "prognostic favorable (9.95e-4)" "unprognostic (4.39e-2)" "unprognostic (6.31e-2)" "unprognostic (1.95e-1)" "unprognostic (2.07e-1)" "unprognostic (1.11e-1)" "unprognostic (2.81e-1)" "unprognostic (5.98e-2)" "unprognostic (2.42e-2)" "unprognostic (1.74e-1)" "unprognostic (1.38e-3)" "unprognostic (1.92e-3)" 34.2 37.4 24.9 19.1 20.6 69.8 31.5 11.3 57.3 21.9 34.0 22.9 13.2 20.7 18.6 11.6 12.1 28.1 33.5 46.1 20.0 14.6 31.2 117.5 25.4 22.4 19.0 35.3 59.7 15.0 274.1 17.2 14.8 20.0 27.2 26.4 13.3 24.5 72.7 8.8 16.6 20.4 19.2 15.8 21.3 16.2 7.1 14.2 19.0 46.8 15.1 10.2 31.8 38.0 0.3 25.0 110.4 26.0 90.9 42.4 18.0 0.2 20.0 8.2 10.1 13.3 2.1 31.5 22.8 2.7 10.2 4.3 40.0 1.0 0.5 27.1 39.0 2.6 17.2 5.3 0.1 3.0 108.1 69.9 14.4 12.3 48.9 3.9 10.7 40.5 3.6 0.4 4.7 0.2 2.8 0.2 1.0 0.8 17.1 15.8 6.7 1.1 1.2 15.0 47.9 15.7 1.4 5.7 10.7 10.2 9.0 15.6 22.1 1.2 17.3 1.7 21.7 2.9 6.4 4.1 12.6 2.2 18.7 1.3 1.3 1.0 12.4 16.0 33.0 6.8 9.0 8.2 110.4 42.4 24.2 25.3 0.3 13.1 29.5 25.0 0.2 16.4 31.4 11.2 90.9 26.0 1.1 1.0 18.0 24.9 20.6 11.3 57.3 20.0 14.6 19.0 35.3 20.0 14.2 131.0 257.3 44.9 93.2 116.7 9.4 147.7 272.6 71.0 147.9 96.0 15.7 219.0 470.9 258.1 11.1 189.7 226.3 46.7 138.3 130.1 269.8 153.6 916.1 393.6 669.0 6.4 409.1 414.4 336.8 15.3 115.1 499.1 268.2 3286.8 521.6 478.8 95.2 300.6 30.8 190.8 24.4 19.4 173.1 1.6 4.7 91.5 557.0 879.8 224.4 39.6 ID3 "bHLHb25, HEIR-1" ENSG00000117318 "Inhibitor of DNA binding 3, HLH protein" Q02535 1 23557918-23559794 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Myogenesis, Transcription, Transcription regulation" Repressor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 117.9" "Cell type enhanced" "Detected in many" 6 "Ito cells: 1041.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 47.4;naive B-cell: 42.9" "Group enriched" "Detected in many" 37 "B-cells: 47.4;T-cells: 24.9" "Cell line enhanced" "Detected in many" "U-698: 84.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021353, HPA024677" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB021353: , HPA024677: AB_2671647" "unprognostic (6.73e-2)" "unprognostic (2.48e-1)" "unprognostic (5.19e-2)" "prognostic favorable (1.27e-5)" "unprognostic (5.58e-3)" "unprognostic (1.46e-1)" "unprognostic (8.98e-2)" "unprognostic (7.76e-2)" "unprognostic (3.89e-2)" "unprognostic (6.47e-3)" "unprognostic (2.42e-1)" "unprognostic (1.50e-1)" "unprognostic (2.52e-2)" "unprognostic (1.36e-1)" "unprognostic (2.01e-1)" "unprognostic (4.37e-3)" "unprognostic (8.36e-2)" 33.5 12.2 13.3 18.9 15.5 6.0 41.6 2.4 14.4 22.0 25.9 16.6 31.4 18.9 21.7 17.8 20.6 33.8 22.9 42.2 21.1 12.4 21.3 11.1 25.8 15.3 16.6 9.1 27.2 10.2 4.2 31.1 31.3 17.7 38.9 13.0 42.6 9.1 117.9 17.0 14.2 17.0 13.3 16.9 12.4 21.6 6.9 20.7 20.5 82.8 19.3 10.7 35.0 72.1 47.4 0.9 0.5 0.2 0.0 24.9 6.1 3.3 20.4 7.0 24.5 3.2 0.4 8.2 24.6 2.1 13.8 1.7 1.2 0.1 21.8 25.4 9.2 2.9 28.2 8.6 3.2 1.4 0.1 9.0 0.3 26.6 11.0 9.9 0.0 0.0 10.3 17.3 0.3 0.2 12.1 12.2 8.7 0.1 0.2 12.5 8.0 2.9 0.0 6.1 16.3 5.1 27.2 13.0 0.7 0.1 7.7 10.3 8.1 23.5 17.4 1.7 5.5 4.5 0.6 25.3 19.6 10.5 9.7 12.8 6.8 6.2 84.2 4.3 0.2 11.4 0.0 0.2 0.0 0.6 0.2 0.2 47.4 10.9 2.1 0.7 42.9 18.2 7.2 0.5 0.0 0.2 0.9 24.9 6.1 13.3 15.5 2.4 14.4 21.1 12.4 16.6 9.1 17.7 20.7 107.2 66.6 152.0 308.3 182.4 2.9 23.8 20.4 28.1 46.6 198.9 9.8 146.2 19.9 195.6 1.1 558.2 223.7 0.0 376.5 627.5 200.0 250.3 15.0 3.4 67.3 4.8 415.6 1041.7 65.7 1.8 38.0 95.2 236.2 34.3 461.1 365.1 130.9 345.5 0.7 5.7 12.4 511.0 604.0 0.5 0.6 165.7 233.5 45.9 226.0 105.9 ID4 bHLHb27 ENSG00000172201 "Inhibitor of DNA binding 4, HLH protein" P47928 6 19837386-19840684 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "thyroid gland: 154.6" "Group enriched" "Detected in many" 4 "Basal glandular cells: 188.3;Muller glia cells: 371.8;Smooth muscle cells: 607.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 17.2;AN3-CA: 22.6;EFO-21: 51.6;HEK 293: 28.9;SCLC-21H: 46.6;SuSa: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075639 Supported Nucleoplasm NA NA Nucleoplasm "HPA075639: " "unprognostic (3.25e-3)" "unprognostic (7.37e-3)" "unprognostic (1.80e-1)" "unprognostic (6.34e-3)" "unprognostic (4.17e-2)" "unprognostic (1.06e-1)" "unprognostic (1.03e-1)" "unprognostic (2.05e-1)" "unprognostic (2.87e-1)" "unprognostic (1.65e-2)" "prognostic favorable (2.49e-4)" "unprognostic (7.26e-2)" "unprognostic (1.66e-3)" "unprognostic (2.41e-2)" "unprognostic (3.13e-2)" "unprognostic (1.03e-3)" "unprognostic (2.57e-3)" 33.1 2.1 29.3 5.3 29.6 1.1 16.9 13.2 31.1 21.1 5.1 29.0 7.2 4.9 22.9 7.0 12.1 34.1 6.8 25.2 32.3 20.6 11.7 2.4 14.6 3.5 14.5 19.0 22.9 11.8 2.0 13.1 13.2 24.9 18.7 4.6 5.7 16.0 26.6 1.8 31.3 4.0 14.2 12.5 11.4 11.9 10.8 20.0 0.0 154.6 4.4 3.5 10.5 11.5 1.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.3 17.2 22.6 0.5 0.0 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.0 51.6 5.8 0.1 8.8 0.0 0.0 0.2 0.0 28.9 0.0 0.0 0.2 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.4 2.4 0.0 0.0 0.0 0.0 3.0 6.1 46.6 0.6 0.0 0.8 3.0 15.0 1.4 0.0 0.0 0.1 2.7 0.0 0.7 0.0 0.0 0.5 0.7 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 29.3 29.6 13.2 19.2 32.3 20.6 14.5 19.0 24.9 20.0 89.3 35.7 0.0 188.3 73.7 10.2 30.8 0.0 10.7 26.1 64.6 2.0 7.6 43.1 14.4 1.3 5.8 7.9 0.0 2.9 6.2 57.9 86.7 0.0 0.0 2.5 3.2 87.7 17.2 0.3 4.4 7.5 4.1 84.4 0.0 4.8 371.8 2.1 31.7 0.0 61.2 12.2 0.0 607.2 0.9 0.6 68.6 4.9 0.0 2.8 35.0 IDO1 "IDO, INDO" ENSG00000131203 "Indoleamine 2,3-dioxygenase 1" P14902 8 39902275-39928444 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Immunity, Tryptophan catabolism" "Dioxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 77.7;placenta: 33.2" "Cell type enriched" "Detected in some" 552 "monocytes: 4555.6" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 17 "eosinophil: 77.7" "Lineage enriched" "Detected in many" 17 "granulocytes: 77.7" "Cell line enriched" "Detected in some" 7 "EFO-21: 36.6" "Region enriched" "Detected in single" 13 "basal ganglia: 30.5" "Low region specificity" "Detected in all" "HPA023072, HPA023149, HPA027772, CAB072820" Enhanced Supported Nucleoplasm,Vesicles,Mitochondria,Cytosol NA NA Cytosol "Nucleoplasm, Vesicles, Mitochondria" "CAB072820: , HPA023072: AB_1846220, HPA023149: AB_1846221, HPA027772: AB_1846222" "unprognostic (1.68e-2)" "unprognostic (1.71e-2)" "unprognostic (4.08e-3)" "unprognostic (7.21e-3)" "unprognostic (1.90e-1)" "unprognostic (1.09e-2)" "unprognostic (1.86e-1)" "unprognostic (3.06e-2)" "prognostic favorable (5.27e-4)" "prognostic favorable (3.32e-4)" "unprognostic (3.59e-2)" "unprognostic (2.74e-1)" "prognostic unfavorable (1.12e-7)" "unprognostic (4.18e-2)" "unprognostic (4.42e-2)" "unprognostic (1.16e-1)" "unprognostic (1.97e-2)" 8.7 0.2 0.9 11.2 0.9 0.0 1.4 0.9 0.9 4.0 1.5 0.9 0.9 2.6 2.6 0.9 1.2 0.6 1.3 1.0 0.9 0.0 0.9 0.9 16.8 14.1 0.9 0.9 0.9 0.9 0.0 0.9 33.2 0.9 1.6 2.1 1.9 0.9 0.9 2.5 0.3 5.9 0.9 2.0 6.2 2.2 0.9 0.9 0.9 7.2 0.9 8.9 2.3 0.9 0.0 4.6 77.7 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.5 2.6 0.1 0.3 0.0 36.6 0.0 1.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.2 0.0 0.1 0.0 0.1 0.0 4.5 0.1 77.7 0.0 0.2 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.9 0.9 0.9 0.9 0.9 0.0 0.9 0.9 0.9 0.9 0.0 0.3 0.0 0.0 0.3 0.0 0.2 0.0 0.0 3.4 0.0 0.0 0.0 0.0 2.5 2.6 0.9 0.0 0.0 6.7 0.0 0.2 0.4 0.0 0.0 0.8 0.0 0.0 0.0 8.2 1.3 0.0 6.0 0.0 4555.6 0.0 3.0 0.6 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.4 IER2 ETR101 ENSG00000160888 "Immediate early response 2" Q9BTL4 19 13150415-13154908 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 120.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 57.5;U-266/84: 73.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055387, HPA060574" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA055387: AB_2682802, HPA060574: AB_2684324" "unprognostic (3.09e-2)" "unprognostic (1.78e-1)" "unprognostic (1.99e-1)" "unprognostic (4.86e-2)" "unprognostic (3.86e-2)" "unprognostic (2.47e-2)" "unprognostic (2.10e-1)" "unprognostic (3.31e-1)" "unprognostic (2.35e-2)" "unprognostic (7.05e-2)" "unprognostic (1.78e-1)" "unprognostic (1.54e-2)" "unprognostic (5.69e-2)" "unprognostic (1.91e-1)" "unprognostic (2.14e-1)" "unprognostic (2.86e-1)" "unprognostic (1.01e-1)" 34.1 24.4 11.5 13.4 16.1 68.2 19.1 13.3 16.8 16.4 20.3 10.1 28.7 12.6 20.3 13.0 22.3 66.8 16.4 16.2 14.1 5.9 16.8 19.9 25.4 14.0 19.2 13.7 33.9 21.6 15.1 17.0 19.9 14.9 26.4 10.0 11.6 34.4 27.1 4.2 45.6 13.7 24.1 15.3 17.1 25.3 7.0 14.2 6.7 29.0 6.7 11.9 18.3 26.4 23.8 14.3 120.1 27.5 28.4 38.4 30.3 14.0 8.4 6.6 10.0 4.4 5.9 14.6 10.9 5.9 7.5 4.4 7.1 8.5 8.3 11.1 7.9 12.7 9.5 3.0 6.3 3.8 4.9 5.7 10.9 14.3 5.9 5.4 13.7 12.2 3.0 15.7 8.1 5.1 9.2 8.8 8.7 27.5 11.2 2.9 23.0 8.2 57.5 12.6 15.2 36.4 16.0 6.7 9.9 6.8 8.3 8.2 11.8 12.2 37.7 24.7 5.4 4.4 8.3 15.8 16.0 10.9 13.2 31.4 33.1 73.6 8.6 8.6 27.4 12.3 40.5 23.4 37.6 38.4 27.5 33.1 21.3 27.0 30.7 14.3 23.8 18.1 22.7 120.1 28.4 24.7 6.5 25.3 30.3 11.5 16.1 13.3 16.8 14.1 5.9 19.2 13.7 14.9 14.2 163.8 583.5 268.0 446.3 283.3 80.9 53.2 336.3 91.0 145.6 90.7 33.4 412.8 44.7 562.1 8.3 433.3 636.2 23.3 334.1 457.3 546.3 696.8 470.7 72.3 507.9 14.3 939.8 260.9 263.5 8.1 127.8 482.9 224.4 162.3 744.6 230.0 421.9 589.0 36.4 32.7 128.3 633.8 468.1 4.5 8.9 386.1 765.7 449.7 550.7 402.2 IER5 ENSG00000162783 "Immediate early response 5" Q5VY09 1 181088712-181092899 "Predicted intracellular proteins" "Stress response, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029894 Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA029894: AB_10601433" "unprognostic (1.18e-1)" "unprognostic (1.31e-1)" "unprognostic (2.55e-1)" "prognostic favorable (2.42e-7)" "unprognostic (1.00e-2)" "unprognostic (1.47e-1)" "unprognostic (2.63e-3)" "prognostic unfavorable (1.18e-4)" "unprognostic (2.81e-3)" "unprognostic (8.37e-2)" "unprognostic (1.46e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (2.36e-4)" "unprognostic (1.26e-2)" "unprognostic (2.54e-1)" "unprognostic (1.11e-1)" "unprognostic (1.09e-1)" 9.4 7.2 4.7 16.2 5.4 45.7 13.8 6.2 12.6 7.8 7.8 5.1 5.9 6.6 12.8 5.3 20.9 14.3 10.3 22.9 6.0 4.9 3.7 6.7 22.6 9.6 10.1 5.7 4.4 4.3 1.8 4.6 34.5 6.9 6.7 6.9 3.7 5.7 4.9 42.3 16.6 10.8 9.6 7.2 27.3 6.8 5.1 5.0 11.2 4.3 22.9 19.8 8.4 16.3 5.4 1.6 5.4 7.8 1.5 2.1 0.9 12.1 10.7 5.9 5.1 8.2 11.4 15.8 21.6 23.0 12.3 10.9 2.9 6.9 4.0 9.6 8.3 8.6 22.5 1.9 14.7 8.0 23.0 9.3 3.6 5.5 2.0 12.9 4.1 11.7 8.1 15.0 14.2 9.5 9.3 8.3 3.4 14.8 18.3 21.6 5.5 4.1 6.6 6.1 4.6 5.4 4.7 10.3 15.1 4.4 6.7 8.6 9.3 10.9 10.7 23.9 7.5 8.5 3.6 12.5 8.8 15.5 10.0 13.0 12.1 4.2 3.1 6.9 4.4 2.4 5.4 2.1 3.8 1.6 7.8 1.9 5.4 1.4 2.1 1.6 3.6 0.3 0.9 1.8 1.5 7.3 0.2 1.8 0.9 4.7 5.4 6.2 12.6 6.0 4.9 10.1 5.7 6.9 5.0 20.8 75.0 63.8 120.3 62.0 22.9 92.8 17.8 14.7 19.4 8.7 35.3 8.9 0.0 9.0 3.6 66.0 73.5 0.0 6.0 36.7 51.2 79.2 34.7 4.9 43.9 7.9 54.2 36.2 111.7 8.2 11.2 133.8 43.9 41.5 70.2 18.9 15.6 54.7 8.9 1.1 19.9 0.0 68.4 3.6 5.0 52.1 28.6 25.4 34.5 130.7 IER5L bA247A12.2 ENSG00000188483 "Immediate early response 5 like" Q5T953 9 129175552-129178262 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Collecting duct cells: 45.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 15.5;SiHa: 21.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA021327 Approved Nucleoplasm NA NA Nucleoplasm "HPA021327: AB_2121674" "unprognostic (2.46e-1)" "unprognostic (3.73e-3)" "unprognostic (3.90e-3)" "unprognostic (8.49e-3)" "unprognostic (1.21e-1)" "unprognostic (5.65e-2)" "unprognostic (3.37e-3)" "prognostic unfavorable (1.48e-6)" "unprognostic (6.91e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-1)" "unprognostic (3.99e-2)" "unprognostic (1.08e-3)" "unprognostic (7.23e-3)" "unprognostic (1.03e-1)" "unprognostic (5.50e-2)" "unprognostic (2.29e-1)" 12.6 11.3 6.0 6.4 9.0 3.3 31.3 2.1 15.3 29.6 8.2 3.5 14.9 5.0 17.4 10.8 13.0 11.0 14.3 14.9 6.4 5.0 14.8 15.0 9.4 8.1 5.5 3.9 35.0 5.4 3.2 8.0 9.8 7.9 15.2 3.7 6.1 8.1 30.1 8.4 8.0 5.3 10.5 11.8 5.7 11.1 6.2 4.1 1.2 9.4 4.9 3.8 20.7 25.5 0.0 0.3 2.1 1.1 0.4 0.8 0.2 5.2 15.5 4.4 8.4 3.3 5.2 13.4 7.9 0.7 1.2 1.2 0.8 8.7 0.1 3.2 1.8 3.6 11.5 0.2 0.9 0.2 0.7 1.1 0.0 3.3 1.4 2.5 0.1 0.1 5.7 1.2 0.9 0.1 7.0 0.5 0.1 0.4 2.8 0.2 13.5 0.1 0.6 0.4 1.3 8.2 0.7 0.3 2.2 4.7 0.7 2.0 2.6 21.8 7.1 8.9 1.9 2.2 1.4 3.2 7.6 4.5 5.1 11.2 1.5 1.0 0.1 9.6 1.5 3.3 0.0 1.1 0.0 0.3 0.6 0.0 0.0 0.1 0.8 0.3 0.0 0.0 0.0 2.1 0.4 0.2 0.1 0.0 0.2 6.0 9.0 2.1 9.0 6.4 5.0 5.5 3.9 7.9 4.1 14.9 1.7 2.9 5.9 6.1 6.0 1.4 20.4 2.7 4.5 45.4 0.0 3.5 8.3 10.6 0.7 11.1 16.9 0.0 22.8 5.4 12.9 12.2 0.0 9.7 25.2 3.2 10.3 29.4 15.4 1.1 10.0 9.2 13.5 3.6 14.6 14.0 18.0 9.3 6.7 14.3 2.7 25.8 20.8 0.0 1.7 4.0 6.8 1.0 8.4 6.7 IFFO2 ENSG00000169991 "Intermediate filament family orphan 2" Q5TF58 1 18904281-18956686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 76.8" "Cell type enhanced" "Detected in many" 10 "Basal glandular cells: 68.5;Basal keratinocytes: 107.4;Suprabasal keratinocytes: 87.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 11 "basophil: 10.6" "Lineage enriched" "Detected in many" 11 "granulocytes: 10.6" "Cell line enhanced" "Detected in many" "HDLM-2: 50.5" "HPA015987, HPA064603" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA015987: AB_2121678, HPA064603: AB_2685296" "unprognostic (1.43e-1)" "unprognostic (1.06e-2)" "unprognostic (2.81e-2)" "unprognostic (1.18e-1)" "unprognostic (1.39e-1)" "unprognostic (2.08e-2)" "unprognostic (2.03e-2)" "unprognostic (1.78e-1)" "unprognostic (4.34e-2)" "unprognostic (2.27e-3)" "unprognostic (3.24e-3)" "unprognostic (7.42e-2)" "unprognostic (3.24e-2)" "unprognostic (5.24e-3)" "unprognostic (2.72e-1)" "unprognostic (4.71e-1)" "unprognostic (1.36e-1)" 3.5 5.1 3.8 5.0 7.8 5.7 8.9 22.3 6.4 6.7 4.6 6.2 4.9 1.4 4.7 2.2 28.7 3.6 4.8 2.7 4.4 4.0 4.9 8.9 5.0 5.3 6.8 3.6 2.4 14.5 13.0 4.0 4.7 9.3 6.6 2.0 3.4 7.9 6.5 4.3 76.8 2.5 13.5 8.9 3.9 2.9 1.4 4.6 3.2 4.3 33.2 11.3 6.3 8.8 0.8 0.6 10.6 0.3 0.3 1.0 0.1 8.4 13.8 3.7 10.3 2.4 1.9 6.0 6.4 4.2 3.5 2.4 18.9 9.9 0.1 8.2 4.8 4.0 21.2 2.8 13.5 2.8 50.5 2.5 0.1 2.6 7.4 1.7 1.4 16.2 1.2 13.8 4.7 6.0 5.8 7.4 0.4 0.6 1.7 2.3 1.7 1.4 1.3 1.6 8.7 3.3 4.7 2.3 3.6 2.0 5.4 11.9 0.6 4.8 6.8 4.7 4.0 1.8 0.7 20.2 4.7 6.6 2.7 18.3 3.6 3.9 0.2 3.2 2.1 5.5 10.6 0.3 0.0 0.6 0.3 0.8 0.8 0.5 0.7 0.1 0.3 0.5 1.0 0.1 0.3 0.0 0.6 0.5 0.1 3.8 7.8 22.3 6.4 4.4 4.0 6.8 3.6 9.3 4.6 3.0 4.8 0.9 68.5 107.4 5.7 5.5 15.3 12.0 4.5 1.8 0.0 4.1 1.7 12.7 1.2 7.1 1.0 0.0 15.2 5.8 3.6 12.6 3.5 3.9 2.0 23.8 2.4 6.2 0.8 2.2 1.1 4.0 13.5 2.8 0.6 5.1 13.4 2.9 2.8 8.1 1.6 0.0 8.5 0.7 0.5 87.7 3.3 2.9 1.0 39.7 IFI16 "IFNGIP1, PYHIN2" ENSG00000163565 "Interferon gamma inducible protein 16" Q16666 1 158999968-159055155 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Autophagy, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA002134, CAB016293" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "CAB016293: AB_627775, HPA002134: AB_1079099" "unprognostic (7.23e-3)" "unprognostic (2.20e-2)" "unprognostic (5.15e-2)" "unprognostic (7.70e-3)" "unprognostic (1.87e-1)" "unprognostic (6.08e-2)" "unprognostic (1.80e-1)" "unprognostic (5.83e-2)" "unprognostic (5.04e-2)" "unprognostic (2.26e-2)" "unprognostic (5.92e-3)" "unprognostic (7.62e-2)" "prognostic unfavorable (1.11e-16)" "unprognostic (5.07e-2)" "unprognostic (4.08e-1)" "unprognostic (7.97e-2)" "unprognostic (1.14e-1)" 64.2 21.0 10.9 42.5 18.0 10.2 34.8 6.7 11.4 28.5 18.6 9.6 7.8 7.5 32.5 21.8 32.8 25.0 33.4 24.8 16.5 7.5 13.3 10.2 32.1 51.0 19.5 6.3 32.6 5.5 3.2 7.0 21.4 18.0 23.0 15.2 10.9 33.6 11.2 14.6 23.7 21.6 29.1 32.2 63.2 11.8 14.2 16.0 81.8 19.1 24.2 41.8 30.9 27.6 28.9 20.8 51.2 21.0 27.9 24.6 16.9 7.0 0.5 2.4 0.1 17.0 56.4 0.0 15.0 40.3 42.3 56.3 0.0 9.1 41.5 12.9 9.2 13.6 20.5 0.3 15.2 16.9 12.8 0.1 10.6 3.1 0.0 31.9 3.6 0.7 53.1 27.3 21.6 30.8 20.3 44.4 36.7 0.2 30.4 23.4 0.0 48.7 3.4 6.5 0.0 5.5 23.0 15.6 47.9 5.9 2.7 1.1 0.0 19.6 0.1 42.6 10.2 0.0 4.3 25.0 10.9 5.1 30.6 6.3 28.4 13.2 39.0 31.3 12.0 26.2 2.5 21.0 0.1 18.9 20.5 16.9 27.6 18.1 19.3 20.8 28.9 11.5 14.6 51.2 27.9 18.5 15.6 24.6 16.9 10.9 18.0 6.7 11.4 16.5 7.5 19.5 6.3 18.0 16.0 35.7 66.1 149.1 95.2 84.3 0.2 6.9 22.9 58.9 119.4 40.1 0.0 3.0 1.7 32.6 4.0 196.0 5.6 0.0 40.2 1.9 91.8 23.0 129.9 2.9 175.9 0.0 11.6 126.4 165.6 4.9 108.7 168.3 79.2 49.5 16.2 31.8 42.0 24.6 49.8 4.4 0.9 84.1 124.0 2.6 1.9 59.6 2.7 201.5 21.7 108.0 IFI35 IFP35 ENSG00000068079 "Interferon induced protein 35" P80217 17 43006725-43014456 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Paneth cells: 132.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 50.9;BJ hTERT+ SV40 Large T+ RasG12V: 75.1;GAMG: 27.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA045946, HPA075580" Approved Supported "Nucleoplasm,Intermediate filaments,Cytosol" NA NA 93000 "Nucleoplasm, Cytosol" "Intermediate filaments" "HPA045946: AB_2679509, HPA075580: " "prognostic favorable (1.41e-4)" "unprognostic (1.14e-2)" "unprognostic (1.82e-1)" "unprognostic (2.16e-1)" "unprognostic (1.32e-1)" "unprognostic (3.26e-1)" "unprognostic (3.90e-3)" "unprognostic (1.14e-1)" "unprognostic (6.92e-2)" "unprognostic (9.78e-3)" "unprognostic (6.51e-3)" "unprognostic (1.22e-1)" "prognostic unfavorable (4.03e-5)" "unprognostic (3.55e-1)" "unprognostic (3.62e-2)" "unprognostic (1.34e-2)" "unprognostic (1.49e-1)" 24.9 27.9 9.3 18.1 12.4 14.6 15.1 5.0 9.3 10.7 20.5 9.4 12.8 15.9 13.6 17.4 11.3 14.0 15.5 13.2 7.7 7.0 21.8 26.2 17.7 20.2 9.4 8.1 19.2 11.0 8.3 10.1 15.8 9.5 24.2 13.6 19.5 18.7 10.8 6.4 7.3 33.6 14.1 9.2 31.5 14.9 5.7 9.7 19.5 30.3 8.3 17.8 13.2 10.1 13.2 23.3 22.2 43.2 18.6 17.6 24.9 2.9 7.0 0.0 0.3 6.1 7.4 1.5 2.0 20.7 50.9 75.1 2.5 11.2 0.9 4.0 5.9 27.0 1.7 0.3 3.1 4.1 7.9 1.4 2.2 2.5 9.3 15.1 2.4 4.8 10.2 1.2 7.1 0.9 4.6 4.6 1.9 1.2 15.0 2.0 2.9 5.1 1.9 0.0 2.7 3.1 4.3 0.0 5.5 6.3 2.6 1.3 0.0 3.9 1.5 20.4 0.1 6.5 4.7 2.2 3.7 0.0 1.1 3.1 13.3 4.9 0.2 6.7 1.9 3.6 19.1 35.9 20.5 16.6 43.2 15.2 12.9 12.9 15.4 21.7 13.2 10.4 12.8 22.2 18.6 39.3 23.3 17.6 24.9 9.3 12.4 5.0 9.3 7.7 7.0 9.4 8.1 9.5 9.7 14.9 8.9 23.1 25.1 9.3 0.8 4.8 10.2 6.7 10.3 17.4 2.0 20.6 34.9 37.8 8.8 26.3 85.0 0.0 56.2 27.8 22.8 23.2 7.0 27.6 74.5 1.6 30.4 32.5 38.4 27.5 26.7 42.9 23.6 77.5 32.6 8.6 36.2 132.5 22.3 67.8 0.8 6.5 13.0 0.3 0.1 8.2 8.7 29.8 22.2 28.2 IFI44 "MTAP44, p44, TLDC5" ENSG00000137965 "Interferon induced protein 44" Q8TCB0 1 78649796-78664078 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Endothelial cells: 36.8;Ito cells: 48.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 46.1;BJ hTERT+ SV40 Large T+ RasG12V: 57.0;GAMG: 46.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA027148, HPA043858" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA027148: AB_1851411, HPA043858: AB_2678702" "unprognostic (1.20e-1)" "unprognostic (6.53e-2)" "unprognostic (5.70e-2)" "unprognostic (4.13e-3)" "unprognostic (1.63e-1)" "unprognostic (8.81e-2)" "unprognostic (5.52e-2)" "unprognostic (8.30e-2)" "unprognostic (1.88e-1)" "unprognostic (1.78e-2)" "unprognostic (2.72e-3)" "unprognostic (1.51e-1)" "prognostic unfavorable (1.37e-8)" "unprognostic (1.71e-1)" "unprognostic (2.07e-3)" "unprognostic (8.89e-2)" "unprognostic (4.90e-2)" 35.2 12.6 10.2 16.2 11.7 47.8 13.0 4.3 8.2 10.0 8.1 6.6 10.5 10.5 13.6 29.9 15.2 8.3 24.9 10.7 10.8 9.8 26.9 11.2 18.6 16.5 11.9 10.5 10.9 5.2 3.0 19.6 11.4 10.5 11.0 5.3 11.3 35.4 13.2 7.5 5.5 8.8 10.2 15.1 32.3 11.2 4.8 11.0 22.3 13.8 11.3 8.1 13.6 8.0 2.2 5.9 3.7 13.0 6.1 12.4 5.5 1.9 0.0 0.3 0.0 1.4 9.6 0.0 1.2 16.8 46.1 57.0 0.0 5.6 2.6 13.1 1.2 46.6 1.0 0.0 0.7 7.5 5.6 0.0 6.7 4.9 0.0 1.9 0.0 0.0 6.0 0.0 19.9 0.2 3.6 8.6 1.7 0.0 9.0 10.9 0.0 5.5 0.4 0.0 0.0 3.7 4.3 13.9 0.3 1.3 1.2 0.1 0.3 0.4 0.1 19.7 0.0 0.0 0.2 10.5 8.5 3.6 0.9 8.4 0.7 0.9 0.0 13.1 7.6 2.3 0.3 13.0 0.1 6.2 12.3 12.4 2.2 9.1 5.9 5.9 1.6 3.9 5.0 3.7 6.1 6.3 1.7 4.3 5.5 10.2 11.7 4.3 8.2 10.8 9.8 11.9 10.5 10.5 11.0 26.8 23.9 0.5 8.9 3.2 0.0 4.5 5.1 21.4 15.9 8.7 0.0 0.2 0.0 9.9 0.4 36.8 0.8 0.0 10.8 0.2 9.8 3.6 17.4 2.4 27.7 0.0 6.4 48.5 34.5 0.5 12.4 26.5 5.0 4.6 1.5 0.8 8.5 0.0 16.3 2.1 0.2 19.4 9.5 0.0 0.4 4.0 0.0 12.5 1.5 11.7 IFI44L "C1orf29, GS3686" ENSG00000137959 "Interferon induced protein 44 like" Q53G44 1 78619922-78646145 "Predicted intracellular proteins" "Antiviral defense" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Endothelial cells: 70.0;Peritubular cells: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 25.6;BJ hTERT+ SV40 Large T+ RasG12V: 27.8;GAMG: 9.2;HSkMC: 14.9;SK-MEL-30: 11.7" "Low region specificity" "Detected in all" "HPA053247, HPA060372" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA053247: AB_2682088, HPA060372: AB_2684267" "unprognostic (2.41e-1)" "unprognostic (1.77e-1)" "unprognostic (9.99e-3)" "prognostic unfavorable (2.95e-4)" "prognostic favorable (3.82e-4)" "unprognostic (1.35e-1)" "unprognostic (4.52e-3)" "unprognostic (1.44e-2)" "unprognostic (2.54e-1)" "unprognostic (3.26e-2)" "unprognostic (3.33e-3)" "unprognostic (1.61e-1)" "prognostic unfavorable (1.06e-4)" "unprognostic (7.58e-2)" "unprognostic (1.10e-3)" "unprognostic (2.24e-1)" "unprognostic (9.03e-2)" 33.6 5.3 9.4 6.2 10.6 36.2 7.6 3.3 10.4 3.8 4.0 12.3 2.7 3.5 10.6 19.7 3.8 4.9 15.0 7.4 9.2 11.0 15.7 4.9 9.5 5.1 10.6 9.4 6.6 2.2 1.9 5.6 8.6 21.6 5.4 3.1 14.4 26.3 5.2 3.5 2.7 3.8 7.0 17.2 23.1 3.7 5.0 12.2 21.6 10.0 4.9 5.2 10.4 3.2 3.6 2.2 2.3 5.6 4.4 2.2 1.5 0.0 0.0 1.0 0.0 0.5 6.9 0.0 0.2 5.3 25.6 27.8 0.0 0.3 5.7 3.1 0.1 9.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.5 0.0 0.6 0.1 0.1 14.9 0.1 1.9 0.3 4.8 0.2 0.0 0.0 0.8 0.5 0.0 0.3 0.1 0.0 0.0 2.6 0.0 0.0 0.0 1.3 0.1 0.0 0.0 6.9 0.0 11.7 0.0 0.0 0.1 0.2 0.2 0.4 0.5 0.7 1.2 0.2 0.0 4.2 0.0 0.0 0.1 5.0 0.3 0.5 5.6 1.6 3.6 2.2 1.7 1.6 1.6 0.8 0.8 2.3 4.4 2.1 2.2 0.5 1.5 9.4 10.6 3.3 10.4 9.2 11.0 10.6 9.4 21.6 12.2 0.0 9.0 7.2 2.5 3.5 0.0 1.7 2.5 17.4 9.1 7.0 0.0 0.1 0.0 4.0 0.6 70.0 0.0 0.0 7.5 0.1 6.1 1.5 2.3 0.0 22.8 0.0 0.0 22.1 13.0 1.8 21.9 14.1 3.3 2.8 0.0 1.2 1.6 0.0 45.3 0.6 0.2 6.5 4.2 0.3 0.0 1.8 0.2 6.2 0.0 3.1 IFNGR2 "AF-1, IFNGT1" ENSG00000159128 "Interferon gamma receptor 2" P38484 21 33402896-33479348 "Disease related genes, FDA approved drug targets, Predicted membrane proteins" Receptor "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Glandular cells: 309.5;Urothelial cells: 502.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 55.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001535 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA001535: AB_1078432" "unprognostic (9.58e-2)" "unprognostic (5.18e-3)" "unprognostic (1.53e-1)" "unprognostic (5.03e-2)" "unprognostic (1.37e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.25e-4)" "unprognostic (3.29e-1)" "unprognostic (1.54e-1)" "unprognostic (3.53e-2)" "unprognostic (3.25e-2)" "unprognostic (9.49e-2)" "prognostic unfavorable (1.13e-10)" "unprognostic (6.74e-3)" "unprognostic (2.49e-1)" "unprognostic (8.02e-2)" "unprognostic (2.15e-3)" 27.2 13.4 11.9 20.8 12.6 45.1 64.4 4.6 18.0 12.5 21.6 5.7 13.0 18.5 10.6 14.1 21.9 11.5 15.2 17.7 11.1 10.1 14.6 20.2 26.3 46.3 8.7 9.4 13.0 21.7 7.1 12.6 20.5 12.2 14.9 11.7 12.1 21.9 11.7 13.1 16.7 20.0 15.3 18.1 27.4 30.3 14.1 7.2 7.9 18.1 19.4 18.9 14.8 26.8 13.2 7.7 55.1 22.8 0.3 3.3 13.8 3.0 2.6 1.3 2.7 3.8 6.5 4.3 8.8 6.4 2.0 3.3 3.1 1.7 5.3 4.9 5.3 5.9 2.3 2.8 6.1 1.1 20.4 17.2 1.5 1.1 2.7 2.6 7.6 4.8 4.9 4.0 3.5 3.5 3.8 5.2 2.6 8.0 2.6 2.8 0.9 1.8 5.2 4.9 3.6 16.7 4.5 4.2 4.4 2.2 4.1 1.9 4.7 4.4 0.5 8.4 0.7 1.6 4.9 8.8 2.5 5.5 2.1 2.1 5.6 7.6 6.8 2.2 6.8 12.0 12.9 22.2 14.8 0.1 22.0 0.1 11.5 1.3 0.1 7.7 13.2 3.3 1.4 55.1 0.3 22.8 2.4 1.4 13.8 11.9 12.6 4.6 18.0 11.1 10.1 8.7 9.4 12.2 7.2 38.7 25.1 76.3 178.2 64.0 8.7 16.6 43.3 13.4 19.4 26.2 7.9 28.1 23.2 100.9 35.4 41.3 130.0 0.0 48.9 66.1 81.2 309.5 59.9 24.9 150.7 14.3 49.5 36.8 129.5 44.6 38.9 162.5 54.0 211.0 45.2 7.8 102.1 105.2 30.8 39.8 7.2 12.9 30.1 3.9 1.7 61.2 14.5 13.8 35.8 502.7 IFRD2 "IFNRP, SKMc15, SM15" ENSG00000214706 "Interferon related developmental regulator 2" Q12894 3 50287732-50292918 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068560 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA068560: AB_2686005" "prognostic favorable (7.22e-4)" "unprognostic (5.19e-2)" "unprognostic (2.08e-2)" "unprognostic (8.61e-3)" "unprognostic (3.88e-1)" "unprognostic (2.30e-2)" "unprognostic (1.19e-2)" "unprognostic (2.24e-1)" "unprognostic (1.62e-1)" "unprognostic (2.01e-1)" "unprognostic (1.91e-2)" "unprognostic (7.78e-3)" "prognostic favorable (2.50e-4)" "unprognostic (3.07e-2)" "unprognostic (1.03e-1)" "unprognostic (1.58e-1)" "unprognostic (1.13e-1)" 11.0 10.0 5.2 10.8 7.7 6.9 15.4 9.0 6.6 7.9 13.7 6.4 21.2 10.7 6.9 7.7 11.8 8.0 17.0 23.9 4.9 4.5 11.1 41.1 8.4 6.5 7.8 3.5 9.8 34.7 10.2 7.6 6.7 7.1 15.6 8.3 8.0 23.7 22.3 39.2 7.8 12.0 8.5 4.9 9.4 18.4 9.9 6.9 7.4 15.8 24.3 8.5 7.8 7.5 17.5 17.8 3.9 16.9 18.5 25.2 15.2 22.8 23.6 6.5 20.5 6.7 7.8 15.1 17.6 9.6 21.7 15.4 19.4 23.5 15.7 13.0 12.1 18.6 13.4 13.6 28.2 11.2 14.9 27.3 22.6 31.2 22.8 13.3 22.9 14.3 7.2 24.3 22.6 28.4 7.2 18.3 14.1 14.3 12.9 12.7 21.5 14.9 26.9 16.4 28.5 46.0 9.8 9.5 35.7 12.9 13.8 11.6 11.2 11.1 30.8 11.1 6.6 14.6 22.0 13.2 18.1 22.8 31.2 35.5 9.1 15.5 13.4 14.4 30.1 26.4 3.9 12.5 1.7 17.9 16.9 25.2 17.5 18.9 17.1 17.8 17.3 20.2 18.3 1.1 18.5 9.3 17.5 14.9 15.2 5.2 7.7 9.0 6.6 4.9 4.5 7.8 3.5 7.1 6.9 17.9 27.7 30.0 43.2 59.8 16.6 1.6 33.1 2.7 15.9 19.2 19.6 29.0 24.9 47.3 66.9 24.8 23.6 0.0 77.7 36.7 26.6 71.8 7.0 44.0 28.7 17.5 15.0 9.8 9.4 95.0 12.7 14.5 33.7 19.0 24.8 13.0 62.8 21.0 13.4 43.7 11.7 0.0 48.6 17.2 16.2 60.0 25.4 20.8 46.4 75.9 IFT27 "BBS19, RABL4, RAYL" ENSG00000100360 "Intraflagellar transport 27" Q9BW83 22 36758202-36776256 "Disease related genes, Predicted intracellular proteins" "Differentiation, Protein transport, Spermatogenesis, Transport" "Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 246.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "U-138 MG: 60.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018418 Uncertain Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA018418: AB_1856029" "unprognostic (3.04e-2)" "unprognostic (7.25e-3)" "unprognostic (7.06e-2)" "prognostic favorable (1.91e-4)" "unprognostic (9.04e-2)" "unprognostic (6.05e-2)" "unprognostic (6.22e-2)" "unprognostic (1.98e-1)" "unprognostic (2.16e-1)" "unprognostic (7.75e-3)" "unprognostic (4.85e-3)" "unprognostic (2.10e-1)" "unprognostic (9.62e-3)" "unprognostic (8.08e-2)" "unprognostic (1.41e-1)" "unprognostic (1.95e-1)" "prognostic favorable (5.55e-4)" 10.9 17.0 21.1 12.7 27.4 8.5 9.2 13.4 20.6 14.9 12.8 15.8 21.9 13.4 12.5 22.1 10.9 40.5 13.0 18.5 19.3 20.6 16.4 17.4 10.2 9.5 19.4 16.4 14.9 17.6 20.9 30.2 8.9 20.0 16.4 11.0 16.1 15.4 19.6 14.7 9.6 12.9 9.9 17.4 9.3 13.7 20.1 14.5 18.6 23.2 6.0 9.8 11.0 11.8 17.7 27.0 23.3 22.6 14.5 19.9 13.9 6.2 7.9 9.3 10.5 7.5 7.2 5.5 5.2 6.6 6.7 6.0 0.3 5.8 6.9 9.0 4.7 9.8 5.8 5.1 5.7 5.2 13.2 13.5 1.8 1.6 0.0 13.8 2.2 8.6 5.8 9.4 7.2 3.3 5.5 7.1 5.7 3.2 5.7 4.5 11.6 2.7 1.9 5.0 12.3 10.3 13.0 0.0 3.8 6.6 4.1 9.0 9.8 5.4 4.2 12.9 8.2 9.4 3.9 4.2 60.8 3.5 7.8 0.9 13.5 8.2 2.4 9.4 5.5 12.8 8.5 22.6 23.3 18.3 16.4 18.2 16.7 15.2 16.8 27.0 17.7 15.1 14.3 8.1 14.5 19.3 20.9 19.9 13.9 21.1 27.4 13.4 20.6 19.3 20.6 19.4 16.4 20.0 14.5 6.0 17.3 15.2 23.2 20.7 32.7 16.8 20.4 246.3 38.7 38.4 27.5 18.3 89.5 24.7 40.8 18.3 24.3 0.0 20.1 14.0 30.5 29.6 33.4 18.6 34.4 28.6 51.2 27.6 14.9 13.6 25.3 19.2 33.7 9.0 39.8 51.0 18.0 14.4 29.7 43.0 34.6 12.9 18.6 105.4 16.8 29.1 14.6 23.5 29.0 23.3 IGDCC3 "HsT18880, PUNC" ENSG00000174498 "Immunoglobulin superfamily DCC subclass member 3" Q8IVU1 15 65327127-65378040 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.8;parathyroid gland: 16.6;placenta: 12.2" "Cell type enhanced" "Detected in some" 18 "Cone photoreceptor cells: 31.4;Cytotrophoblasts: 90.9;Late spermatids: 38.7;Syncytiotrophoblasts: 34.6" "Cancer enhanced" "Detected in many" "testis cancer: 5.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 42.7;CACO-2: 10.7;Hep G2: 33.7;SuSa: 17.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA015713 Uncertain Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA015713: " "unprognostic (7.11e-2)" "unprognostic (1.99e-1)" "unprognostic (4.24e-2)" "unprognostic (7.25e-3)" "unprognostic (6.67e-2)" "unprognostic (7.35e-3)" "unprognostic (3.93e-2)" "unprognostic (1.53e-1)" "unprognostic (1.82e-2)" "unprognostic (4.56e-1)" "unprognostic (1.61e-1)" "unprognostic (1.78e-1)" "unprognostic (5.77e-5)" "unprognostic (4.15e-1)" "unprognostic (1.26e-1)" "unprognostic (1.28e-1)" "unprognostic (1.33e-2)" 0.2 0.6 3.5 0.4 2.1 0.2 1.7 10.8 4.6 1.0 0.5 3.3 0.0 0.3 1.6 0.4 0.2 1.4 0.4 0.4 3.2 2.6 0.6 0.2 0.3 0.2 2.5 1.7 1.7 0.3 16.6 2.9 12.2 2.6 0.5 0.3 0.6 0.2 0.5 0.5 0.4 0.3 0.6 2.2 0.3 0.4 4.7 2.7 3.7 1.7 0.0 0.2 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.7 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 10.7 0.1 0.0 0.1 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.4 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.6 0.0 0.0 0.0 17.7 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 2.1 10.8 4.6 3.2 2.6 2.5 1.7 2.6 2.7 0.0 0.0 0.0 0.2 0.0 4.0 0.5 0.0 0.0 0.0 1.8 31.4 90.9 0.0 0.0 18.8 0.0 0.0 0.0 0.0 1.7 0.4 0.1 0.0 0.0 6.1 0.0 0.0 0.0 0.0 38.7 0.6 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.4 0.0 1.6 0.0 0.0 0.9 12.6 0.0 34.6 0.0 0.0 0.0 IGDCC4 "LOC57722, NOPE" ENSG00000103742 "Immunoglobulin superfamily DCC subclass member 4" Q8TDY8 15 65381464-65423072 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 14.1" "Cell type enhanced" "Detected in some" 13 "Cone photoreceptor cells: 29.5;Fibroblasts: 17.9;Leydig cells: 32.2;Rod photoreceptor cells: 12.0" "Cancer enhanced" "Detected in many" "glioma: 6.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.1;AF22: 10.2;CAPAN-2: 8.9;EFO-21: 5.1;HSkMC: 5.7;NTERA-2: 7.7;SuSa: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008510, HPA008576" Approved Approved Approved Nucleoplasm,Cytosol NA NA 34000000 "Nucleoplasm, Cytosol" "HPA008510: , HPA008576: AB_1079496" "unprognostic (1.16e-1)" "unprognostic (9.38e-2)" "unprognostic (1.92e-2)" "unprognostic (1.20e-2)" "unprognostic (1.58e-1)" "unprognostic (1.77e-2)" "unprognostic (2.75e-3)" "unprognostic (9.94e-2)" "unprognostic (4.18e-2)" "unprognostic (3.65e-2)" "unprognostic (3.29e-2)" "unprognostic (6.36e-2)" "unprognostic (1.83e-8)" "unprognostic (3.30e-2)" "unprognostic (4.54e-2)" "unprognostic (2.33e-1)" "unprognostic (5.32e-3)" 1.7 6.2 8.3 3.7 5.0 0.2 1.3 2.0 4.9 6.1 1.4 8.0 0.0 1.0 2.3 7.2 2.6 2.9 6.7 2.2 6.2 4.1 0.6 0.3 0.7 1.1 5.6 3.1 13.3 0.7 0.2 2.4 8.2 6.1 0.9 1.2 1.6 1.5 1.3 14.1 1.5 1.7 3.1 5.0 0.5 1.9 2.5 6.5 0.0 4.6 4.0 1.5 4.7 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 10.2 0.0 0.0 1.1 0.1 0.4 0.0 0.0 0.4 0.6 8.9 0.0 5.1 0.4 0.0 0.0 2.5 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.4 0.0 0.0 5.7 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 1.8 0.0 0.0 0.8 7.7 0.0 0.0 0.0 2.5 0.0 3.6 0.0 0.0 0.1 0.0 0.0 0.5 6.1 0.0 0.0 0.0 4.1 2.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 5.0 2.0 3.9 6.2 4.1 5.6 3.1 6.1 6.5 0.0 0.0 0.0 0.0 2.1 5.8 2.0 0.0 0.0 0.0 3.5 29.5 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.5 17.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 32.2 0.4 5.0 0.0 0.0 0.5 0.3 0.0 3.9 0.7 12.0 6.5 0.5 0.4 0.9 1.0 0.7 0.0 0.0 0.0 IGF2 "C11orf43, FLJ44734, IGF-II" ENSG00000167244 "Insulin like growth factor 2" P01344 11 2129112-2149603 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Carbohydrate metabolism, Glucose metabolism, Osteogenesis" "Growth factor, Hormone, Mitogen" "Cancer-related genes, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "placenta: 330.5" "Group enriched" "Detected in some" 9 "Cytotrophoblasts: 871.9;Extravillous trophoblasts: 2792.3;Syncytiotrophoblasts: 1348.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 115.4;Hep G2: 79.2;LHCN-M2: 45.5;RH-30: 56.5;SH-SY5Y: 68.8" "Low region specificity" "Detected in all" "HPA007556, HPA007993" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" NA NA 609000000 1700000000 Vesicles "Nucleoplasm, Cytosol" "HPA007556: AB_2667860, HPA007993: AB_1851474" "unprognostic (1.54e-1)" "unprognostic (1.65e-2)" "unprognostic (1.31e-1)" "unprognostic (7.08e-2)" "unprognostic (2.30e-3)" "unprognostic (2.59e-1)" "prognostic favorable (7.12e-4)" "unprognostic (7.92e-2)" "unprognostic (2.59e-2)" "unprognostic (1.68e-2)" "unprognostic (3.69e-2)" "unprognostic (1.85e-1)" "unprognostic (1.79e-3)" "unprognostic (2.00e-2)" "unprognostic (8.98e-2)" "unprognostic (8.93e-3)" "unprognostic (5.78e-2)" 16.6 8.0 1.3 4.5 2.0 0.5 23.3 2.3 1.9 23.4 5.0 3.4 4.7 1.0 9.9 32.0 5.2 17.2 4.5 20.5 1.5 1.6 8.1 39.7 1.9 1.1 3.5 1.6 20.4 5.5 0.7 5.0 330.5 7.6 10.4 1.0 33.2 2.6 6.7 21.9 1.7 2.3 7.5 17.0 2.0 3.2 12.4 0.2 1.8 2.6 14.5 1.8 15.2 14.1 0.0 0.1 0.5 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 15.2 0.1 0.4 0.0 115.4 0.0 0.0 1.1 0.0 0.3 0.0 0.1 0.9 1.1 0.0 0.0 0.0 0.0 79.2 20.3 0.0 0.0 24.7 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 45.5 0.3 0.0 0.1 0.1 0.0 0.2 0.0 56.5 0.1 0.0 0.1 4.5 68.8 0.0 0.0 0.0 12.0 0.5 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.0 1.3 2.0 2.3 1.4 1.5 1.6 3.5 1.6 7.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 871.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2792.3 0.0 0.0 0.0 0.0 192.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1348.9 0.0 0.0 0.0 IGFBP3 "BP-53, IBP3" ENSG00000146674 "Insulin like growth factor binding protein 3" P17936 7 45912245-45921874 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Apoptosis "Growth factor binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 320.7" "Cell type enhanced" "Detected in many" 19 "Basal keratinocytes: 406.6;Extravillous trophoblasts: 1874.7;Urothelial cells: 581.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 28.9" "Lineage enriched" "Detected in many" 5 "dendritic cells: 28.9" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 422.0;U-2197: 175.0;U-87 MG: 90.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB010360 Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" NA NA 3250000000 5600000000 Vesicles "Nucleoplasm, Cytosol" "CAB010360: AB_2233528" "unprognostic (4.46e-3)" "unprognostic (4.84e-2)" "prognostic unfavorable (1.08e-4)" "unprognostic (2.30e-1)" "unprognostic (1.15e-1)" "unprognostic (6.54e-2)" "prognostic unfavorable (1.64e-4)" "unprognostic (8.14e-3)" "unprognostic (3.31e-2)" "unprognostic (2.03e-1)" "unprognostic (9.67e-3)" "unprognostic (2.80e-1)" "prognostic unfavorable (5.07e-7)" "unprognostic (2.36e-2)" "unprognostic (4.14e-2)" "unprognostic (2.37e-3)" "unprognostic (2.63e-1)" 47.4 1.6 4.4 10.6 2.7 0.0 52.1 2.7 4.1 44.3 21.3 1.7 3.2 6.9 58.4 8.1 11.7 14.9 5.4 41.6 4.4 2.6 11.1 80.4 11.7 12.7 3.7 1.9 49.2 2.2 0.6 19.2 320.7 4.1 22.5 6.1 9.1 6.4 9.3 13.9 23.9 10.2 22.9 3.8 18.7 8.3 12.1 3.1 2.2 5.6 8.6 8.3 32.0 26.3 0.0 28.9 0.0 0.0 0.0 6.0 1.7 9.6 2.9 5.7 0.0 4.3 1.8 0.0 42.1 7.6 3.6 1.9 0.0 7.8 0.0 13.4 422.0 1.8 23.2 0.0 0.1 1.5 0.0 0.0 0.0 1.0 0.0 1.1 0.0 0.0 14.8 0.6 0.7 2.7 5.7 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 3.9 2.6 20.8 0.6 1.6 14.6 0.5 0.7 13.3 0.0 0.0 0.0 41.7 0.0 175.0 2.3 0.6 0.0 0.0 90.6 0.0 14.0 0.0 0.0 0.0 5.2 0.0 4.3 0.0 6.0 5.6 0.0 0.0 2.8 4.7 0.0 0.0 0.0 28.9 0.3 1.7 4.4 2.7 2.7 4.1 4.4 2.6 3.7 1.9 4.1 3.1 3.0 4.6 0.0 95.2 406.6 0.6 9.7 7.6 33.5 117.2 216.3 0.0 45.9 10.0 71.8 0.8 62.6 0.4 0.0 1.7 1874.7 137.7 80.4 1.1 1.7 72.5 0.0 263.4 181.7 8.2 1.9 266.9 3.0 15.1 12.6 1.6 0.4 19.7 2.9 6.3 0.7 0.6 0.0 28.8 0.4 0.4 213.8 129.0 8.2 0.6 581.2 IGFBPL1 bA113O24.1 ENSG00000137142 "Insulin like growth factor binding protein like 1" Q8WX77 9 38408994-38424447 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 11.0;pituitary gland: 7.4;thyroid gland: 27.2" "Group enriched" "Detected in some" 6 "Hofbauer cells: 1.4;Intestinal endocrine cells: 1.7;Spermatogonia: 1.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 67.8;NTERA-2: 18.6;RH-30: 19.5;SCLC-21H: 69.8;SH-SY5Y: 67.7;SuSa: 43.0" "Group enriched" "Detected in some" 4 "basal ganglia: 12.5;olfactory region: 16.2" "Low region specificity" "Detected in many" HPA051354 Uncertain Uncertain Nucleoplasm,Vesicles "Secreted to blood" NA NA "Nucleoplasm, Vesicles" "HPA051354: " "unprognostic (5.63e-2)" "unprognostic (3.33e-1)" "unprognostic (5.22e-2)" "unprognostic (2.42e-1)" "unprognostic (2.56e-2)" "unprognostic (1.92e-1)" "unprognostic (1.30e-1)" "unprognostic (5.66e-2)" "unprognostic (2.26e-1)" "unprognostic (3.05e-1)" "unprognostic (2.00e-2)" "unprognostic (2.35e-1)" "unprognostic (2.73e-1)" "unprognostic (3.94e-1)" "unprognostic (3.92e-2)" "unprognostic (1.59e-2)" "unprognostic (6.67e-2)" 1.6 2.6 3.8 1.1 11.0 0.3 0.4 4.7 4.7 0.7 1.0 1.0 0.0 1.9 2.1 0.5 0.7 1.0 1.9 3.7 3.3 2.3 0.7 0.6 1.2 0.4 1.4 1.5 0.5 1.6 0.4 7.4 1.1 1.8 1.6 0.7 0.2 0.5 2.9 0.3 0.3 1.2 2.1 0.6 0.4 2.5 3.3 1.5 2.6 27.2 0.0 0.4 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 67.8 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 8.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 18.6 0.0 0.1 0.0 19.5 0.1 0.0 0.0 69.8 67.7 1.1 0.0 0.0 43.0 0.3 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 11.0 4.7 4.7 3.3 2.3 1.4 1.5 1.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.1 0.0 0.0 0.0 IGFL2 UNQ645 ENSG00000204866 "IGF like family member 2" Q6UWQ7 19 46143106-46161299 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "skin 1: 26.8;tongue: 24.8" "Cell type enhanced" "Detected in some" 8 "Early spermatids: 5.9;Late spermatids: 3.9;Spermatocytes: 8.0;Spermatogonia: 7.0;Suprabasal keratinocytes: 4.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 24 "memory CD4 T-cell: 2.4" "Lineage enriched" "Detected in single" 24 "T-cells: 2.4" "Group enriched" "Detected in some" 64 "CACO-2: 28.9;OE19: 58.1" HPA059137 Uncertain Approved "Nucleoplasm,Plasma membrane" "Secreted in other tissues" NA NA Nucleoplasm "Plasma membrane" "HPA059137: AB_2683920" "unprognostic (1.53e-1)" "unprognostic (7.87e-2)" "unprognostic (1.64e-1)" "unprognostic (1.69e-2)" "unprognostic (7.30e-2)" "unprognostic (9.74e-2)" "unprognostic (1.92e-1)" "unprognostic (1.81e-1)" "unprognostic (1.84e-1)" "unprognostic (1.68e-1)" "unprognostic (4.26e-3)" "unprognostic (9.63e-3)" "unprognostic (4.14e-9)" "unprognostic (1.27e-1)" "unprognostic (2.76e-2)" "unprognostic (8.73e-2)" "unprognostic (9.91e-3)" 1.5 0.0 0.4 0.1 0.1 0.0 1.8 0.1 0.4 0.3 0.3 0.1 0.1 0.0 0.1 0.5 1.0 0.0 0.1 1.1 0.1 0.1 0.1 0.1 0.8 1.2 0.4 0.1 0.1 0.1 3.4 0.1 1.6 0.9 0.1 0.7 0.1 0.5 0.1 0.1 26.8 0.1 0.1 0.3 0.1 0.0 2.4 0.1 0.4 0.1 24.8 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 28.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.4 0.1 0.1 0.4 0.1 0.9 0.1 0.0 0.0 0.0 0.0 1.9 1.9 0.4 0.0 0.0 1.2 0.0 0.0 3.2 0.0 0.0 5.9 0.0 0.5 0.0 0.2 0.1 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.9 0.0 0.0 1.7 0.0 0.2 0.4 0.0 0.0 0.0 0.0 1.9 0.0 0.4 8.0 7.0 4.1 2.2 0.0 1.3 0.0 IGHMBP2 "CATF1, CMT2S, HCSA, HMN6, SMARD1, SMUBP2, ZFAND7" ENSG00000132740 "Immunoglobulin mu binding protein 2" P38935 11 68903842-68940602 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Helicase, Hydrolase, Ribonucleoprotein, RNA-binding, tRNA-binding" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 77.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004092, HPA060994" Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA004092: , HPA060994: AB_2684406" "unprognostic (1.17e-1)" "unprognostic (1.04e-1)" "unprognostic (7.17e-2)" "unprognostic (3.96e-1)" "unprognostic (1.54e-1)" "unprognostic (1.69e-1)" "unprognostic (3.59e-3)" "unprognostic (4.31e-2)" "unprognostic (3.81e-1)" "unprognostic (1.19e-1)" "prognostic favorable (5.89e-4)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.29e-8)" "unprognostic (1.69e-1)" "unprognostic (3.73e-2)" "unprognostic (4.06e-2)" "unprognostic (2.18e-2)" 7.2 6.0 6.9 8.1 11.0 13.8 9.4 17.7 14.9 8.1 14.6 8.3 14.3 9.7 12.0 5.4 8.8 8.5 7.8 7.7 6.6 5.3 6.7 8.7 7.3 7.9 4.6 7.0 9.4 9.6 7.7 6.0 6.5 6.6 9.0 6.1 7.9 12.7 10.0 12.2 11.7 9.4 8.1 4.1 8.9 9.1 36.9 5.7 10.0 7.3 5.9 8.8 8.8 8.3 5.0 3.3 4.7 12.1 2.7 5.1 2.7 8.0 9.3 5.6 8.9 4.5 3.5 8.4 8.1 5.1 10.0 6.6 18.8 8.1 7.0 11.4 4.1 8.1 12.9 9.3 5.1 4.2 8.3 7.8 10.0 10.9 6.1 5.2 7.6 9.5 2.6 6.1 10.6 5.4 5.0 5.1 12.4 11.7 9.0 3.4 6.3 11.9 13.6 4.9 11.0 9.8 10.0 8.4 8.6 4.7 7.3 8.9 6.5 9.6 8.2 19.1 3.8 12.7 5.7 6.9 8.6 7.6 11.5 8.3 10.1 7.7 8.1 6.1 7.4 7.8 0.0 3.9 2.2 5.1 3.3 4.7 5.0 3.4 4.0 3.3 3.3 2.4 3.3 4.7 2.7 12.1 2.5 4.0 2.7 6.9 11.0 17.7 14.9 6.6 5.3 4.6 7.0 6.6 5.7 6.0 10.6 2.9 3.6 5.0 9.1 4.3 5.1 2.7 6.8 1.8 19.6 3.9 1.7 4.8 77.4 5.8 3.5 0.0 4.3 3.8 5.0 6.2 6.9 4.7 5.0 11.1 2.9 2.5 3.2 25.6 7.2 5.2 1.7 8.2 3.4 6.6 4.9 5.8 6.7 2.0 9.6 0.0 6.6 20.9 6.5 5.8 5.6 5.1 4.3 4.8 IGSF11 "BT-IgSF, CT119, Igsf13, MGC35227, VSIG3" ENSG00000144847 "Immunoglobulin superfamily member 11" Q5DX21 3 118900557-119146068 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Growth regulation" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8;ovary: 21.1;testis: 39.9" "Group enriched" "Detected in some" 7 "Cone photoreceptor cells: 70.7;Early spermatids: 226.0;Late spermatids: 237.3" "Group enriched" "Detected in many" 9 "glioma: 9.2;melanoma: 10.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.0;HEL: 4.4;SK-MEL-30: 26.2;U-266/70: 9.1;U-266/84: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046377 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Cell Junctions" "Nucleoplasm, Cytosol" "HPA046377: AB_10966195" "unprognostic (2.05e-1)" "unprognostic (1.29e-1)" "unprognostic (1.62e-1)" "unprognostic (1.88e-1)" "unprognostic (1.17e-2)" "unprognostic (1.89e-3)" "unprognostic (2.51e-2)" "unprognostic (3.56e-2)" "unprognostic (3.91e-1)" "unprognostic (1.44e-1)" "unprognostic (2.20e-1)" "unprognostic (8.70e-2)" "unprognostic (1.08e-1)" "unprognostic (5.03e-4)" "unprognostic (1.39e-1)" "unprognostic (3.42e-2)" "unprognostic (7.57e-2)" 1.1 10.5 12.5 1.4 14.6 0.9 1.2 3.4 23.9 1.3 2.6 27.8 0.0 1.1 1.6 2.3 2.0 1.6 1.9 2.2 12.3 6.0 10.6 0.9 1.0 1.0 25.2 8.9 21.1 5.1 3.8 1.4 1.1 15.3 1.3 1.8 7.0 1.4 2.0 2.9 2.6 1.6 1.5 20.5 1.0 1.4 39.9 20.7 0.0 5.0 0.0 1.1 1.1 0.7 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 6.0 0.2 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.7 2.0 0.0 0.0 0.0 0.1 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.4 0.0 0.0 26.2 1.7 0.5 0.1 0.0 0.0 1.0 0.0 0.0 9.1 10.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 12.5 14.6 3.4 13.6 12.3 6.0 25.2 8.9 15.3 20.7 0.0 0.0 0.0 0.1 0.3 5.1 1.1 0.0 0.0 0.0 0.0 70.7 0.1 0.0 0.3 226.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 237.3 3.4 0.2 3.3 0.0 0.0 24.3 0.2 0.0 1.8 5.1 24.8 0.0 0.0 11.7 5.9 0.0 0.1 0.0 0.0 0.2 IGSF23 ENSG00000216588 "Immunoglobulin superfamily member 23" A1L1A6 19 44613630-44636781 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 6.0;intestine: 19.9;liver: 20.6" "Group enriched" "Detected in some" 8 "Cholangiocytes: 7.6;Early spermatids: 7.7;Hepatocytes: 9.2;Late spermatids: 8.1" "Cancer enriched" "Detected in some" 10 "liver cancer: 12.4" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "neutrophil: 6.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.0" "Cell line enhanced" "Detected in some" "CACO-2: 14.0;Hep G2: 8.3;SiHa: 6.4" "HPA051811, HPA054591" Uncertain Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA051811: AB_2681621, HPA054591: AB_2682535" "unprognostic (1.54e-1)" "unprognostic (1.84e-3)" "unprognostic (5.74e-2)" "unprognostic (1.53e-3)" "unprognostic (4.58e-2)" "unprognostic (1.11e-1)" "prognostic favorable (7.20e-6)" "unprognostic (7.35e-3)" "unprognostic (2.71e-1)" "unprognostic (3.27e-2)" "unprognostic (2.93e-3)" "unprognostic (1.52e-1)" "unprognostic (1.19e-8)" "unprognostic (1.26e-1)" "unprognostic (6.38e-2)" "unprognostic (9.17e-2)" "unprognostic (2.85e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 10.8 0.1 0.1 12.2 0.1 0.5 0.1 0.1 0.1 0.6 0.1 0.1 0.4 20.6 0.1 0.1 0.1 0.1 0.1 3.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.9 0.1 0.1 0.0 19.9 0.1 0.6 0.1 0.0 1.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 6.0 1.2 0.0 0.0 0.2 0.4 0.8 0.0 0.5 0.0 0.0 0.7 0.5 0.7 0.0 0.6 14.0 0.5 0.0 1.0 0.4 0.3 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.3 8.3 0.0 0.0 0.1 0.4 0.0 0.8 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 6.4 2.3 0.0 0.0 0.3 0.0 2.6 0.5 0.5 0.6 0.0 1.2 0.0 0.0 0.1 0.3 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 7.7 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.6 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 IGSF3 "EWI-3, MGC117164, V8" ENSG00000143061 "Immunoglobulin superfamily member 3" O75054 1 116574399-116667755 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 42.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 62.5;WM-115: 60.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036305, HPA036306" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036305: AB_2675050, HPA036306: AB_10671245" "unprognostic (9.87e-2)" "unprognostic (3.64e-1)" "unprognostic (9.51e-2)" "prognostic unfavorable (1.98e-4)" "unprognostic (2.97e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (4.03e-6)" "unprognostic (9.40e-2)" "unprognostic (4.41e-1)" "unprognostic (2.42e-1)" "prognostic unfavorable (2.03e-4)" "unprognostic (4.18e-1)" "prognostic favorable (2.87e-6)" "unprognostic (5.29e-2)" "unprognostic (4.23e-2)" "unprognostic (2.57e-1)" "unprognostic (1.08e-1)" 1.4 1.5 1.9 1.2 5.1 0.1 7.7 2.5 8.3 5.8 5.7 1.5 3.0 6.7 2.5 6.5 22.0 1.7 3.5 7.9 1.8 2.8 10.7 0.8 7.4 0.3 1.8 2.8 0.7 4.5 1.4 2.7 42.9 4.1 5.1 5.1 7.8 9.3 5.5 1.1 16.1 12.9 2.4 1.7 0.5 7.3 3.6 0.9 6.2 8.1 9.0 9.3 8.2 9.8 0.0 0.2 0.3 0.6 0.0 0.7 0.2 5.4 9.3 7.2 1.8 1.6 3.5 19.3 0.0 0.2 0.7 0.2 5.3 3.1 0.0 2.9 0.0 4.0 15.2 3.2 7.5 0.3 62.5 2.3 2.9 3.6 0.1 0.0 0.2 5.7 0.4 5.9 0.0 1.3 1.3 0.0 1.0 0.9 0.0 0.1 19.1 0.2 0.1 4.5 3.3 0.2 2.2 8.8 0.0 5.5 6.8 4.2 12.8 2.2 21.5 13.7 14.4 7.2 0.3 0.0 1.2 4.3 0.0 5.6 0.0 0.3 0.0 0.5 0.1 60.3 0.0 0.6 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.2 1.9 5.1 2.5 8.3 1.8 2.8 1.8 2.8 4.1 0.9 14.9 25.2 0.0 7.0 17.4 1.9 14.4 12.7 8.1 5.7 14.0 0.0 10.1 3.3 13.2 1.8 2.1 14.7 0.0 1.7 24.6 6.6 7.2 1.1 0.0 1.9 6.4 2.9 1.8 1.6 2.1 1.1 0.9 8.5 5.4 5.5 12.8 11.2 8.6 0.0 11.3 0.5 0.0 2.1 0.5 4.3 24.2 11.1 0.0 7.1 9.6 IKZF1 "hIk-1, Hs.54452, IKAROS, LyF-1, PPP1R92, ZNFN1A1" ENSG00000185811 "IKAROS family zinc finger 1" Q13422 7 50304068-50405101 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.7;bone marrow: 55.2;lymphoid tissue: 86.7" "Cell type enhanced" "Detected in many" 11 "B-cells: 46.7;Kupffer cells: 47.2;Macrophages: 43.8;monocytes: 70.3;T-cells: 103.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 26.9;HDLM-2: 45.8;HMC-1: 42.9;JURKAT: 26.3;MOLT-4: 33.5;REH: 36.3;U-698: 68.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB009247, HPA035221, HPA035222" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB009247: AB_2124699, HPA035221: AB_2674524, HPA035222: AB_2674525" "prognostic favorable (4.28e-4)" "prognostic favorable (2.02e-4)" "unprognostic (2.49e-3)" "unprognostic (2.41e-3)" "unprognostic (5.59e-1)" "prognostic favorable (8.63e-4)" "unprognostic (1.45e-2)" "unprognostic (1.37e-2)" "unprognostic (1.15e-2)" "unprognostic (2.43e-1)" "unprognostic (6.63e-2)" "unprognostic (2.95e-1)" "unprognostic (1.69e-3)" "unprognostic (1.71e-1)" "unprognostic (2.84e-2)" "unprognostic (6.77e-2)" "unprognostic (4.67e-2)" 3.5 1.5 2.9 25.5 3.8 55.2 2.3 0.7 1.8 1.6 3.6 2.8 0.8 2.4 1.6 2.1 2.2 2.4 2.9 1.6 3.4 1.8 2.5 2.3 8.3 44.4 5.9 1.1 1.1 1.3 0.2 1.2 1.2 3.4 2.2 2.5 1.5 5.2 0.7 0.9 1.9 14.5 1.4 5.1 31.0 3.7 1.1 4.1 86.7 2.4 1.2 26.3 4.5 2.9 24.0 12.6 12.8 23.6 12.8 28.7 12.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.8 0.0 9.2 0.0 0.0 0.0 16.3 42.9 0.0 0.0 0.0 0.0 0.0 0.0 26.3 11.9 3.2 0.0 0.0 33.5 16.2 0.4 0.0 0.0 36.3 0.0 7.6 0.0 0.0 0.3 0.3 0.1 0.2 0.1 0.0 0.0 22.5 0.0 0.0 0.3 0.0 0.0 14.6 7.5 68.8 0.1 17.7 0.1 10.2 7.7 12.8 20.4 23.6 17.0 24.0 21.2 19.9 8.2 21.3 28.7 20.7 11.2 12.8 22.3 12.6 17.1 12.7 2.9 3.8 0.7 1.8 3.4 1.8 5.9 1.1 3.4 4.1 3.0 16.4 46.7 0.1 2.5 0.0 1.1 5.1 2.7 3.4 1.8 0.0 0.3 0.0 0.1 3.0 2.9 0.0 23.3 0.0 0.2 3.4 0.1 22.0 1.0 27.1 0.0 0.0 4.3 47.2 4.5 0.0 43.8 18.6 70.3 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 2.1 0.0 0.7 2.4 0.6 103.3 0.0 0.1 IKZF2 "Helios, ZNFN1A2" ENSG00000030419 "IKAROS family zinc finger 2" Q9UKS7 2 212999691-213152427 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 55.8" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 21.4;T-cells: 23.3;Urothelial cells: 48.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 5.7;NK-cells: 7.2;T-cells: 7.1" "Cell line enhanced" "Detected in many" "JURKAT: 36.7;MOLT-4: 15.5;RT4: 14.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059142 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA059142: AB_2683923" "unprognostic (2.29e-1)" "unprognostic (1.04e-1)" "unprognostic (7.81e-2)" "unprognostic (1.42e-1)" "unprognostic (2.87e-2)" "unprognostic (2.80e-3)" "unprognostic (2.98e-1)" "unprognostic (3.03e-1)" "unprognostic (5.12e-2)" "unprognostic (1.37e-1)" "unprognostic (1.01e-2)" "unprognostic (1.21e-1)" "unprognostic (3.56e-3)" "unprognostic (4.05e-1)" "unprognostic (2.09e-1)" "unprognostic (5.93e-3)" "unprognostic (7.09e-2)" 3.4 2.4 6.1 4.1 12.4 5.9 4.0 8.0 8.6 4.9 2.6 5.3 7.6 1.0 2.3 3.9 24.8 3.4 3.6 2.8 6.3 2.6 2.1 2.1 3.7 7.4 11.8 3.4 2.5 3.0 9.7 6.9 3.2 8.6 5.4 2.0 2.3 13.5 9.2 4.3 10.4 2.5 1.2 9.1 5.9 5.2 2.8 13.4 55.8 9.2 5.5 7.5 11.9 11.6 1.5 0.7 5.7 0.0 7.2 7.1 0.3 1.4 0.5 2.8 0.1 9.2 9.4 1.7 1.7 2.0 0.4 0.9 0.7 2.4 1.9 2.3 1.0 0.2 3.4 0.0 0.9 1.4 0.0 0.4 1.0 1.8 0.2 0.1 4.5 0.3 9.1 0.8 0.0 0.2 2.3 0.0 36.7 0.5 1.6 0.8 2.6 15.5 4.5 0.5 1.1 0.4 9.2 1.8 0.0 0.8 14.7 0.8 0.5 0.0 1.9 0.0 2.4 2.5 0.4 4.7 2.6 2.0 1.2 0.3 3.1 0.9 10.6 1.3 0.0 0.5 4.1 0.0 5.7 2.5 0.0 6.5 0.2 0.8 1.9 0.0 1.5 0.4 1.9 0.0 7.2 0.0 0.7 7.1 0.3 6.1 12.4 8.0 8.6 6.3 2.6 11.8 3.4 8.6 13.4 8.9 9.3 3.9 11.1 5.3 4.0 6.2 0.0 21.4 15.9 7.0 3.9 3.0 0.0 1.6 1.0 2.2 1.1 0.0 2.6 1.1 1.5 14.9 3.5 1.7 1.6 0.0 2.9 1.3 1.3 0.0 1.7 1.8 1.7 1.0 2.3 2.4 3.4 0.0 2.1 0.9 7.0 0.0 2.7 0.7 0.4 7.5 3.3 23.3 1.0 48.0 IKZF3 "Aiolos, ZNFN1A3" ENSG00000161405 "IKAROS family zinc finger 3" Q9UKT9 17 39757715-39864188 "Predicted intracellular proteins, Transcription factors" "B-cell activation, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.7;lymphoid tissue: 55.1" "Group enriched" "Detected in many" 5 "Alveolar cells type 2: 27.4;B-cells: 90.1;granulocytes: 44.2;T-cells: 76.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 8.3;T-cells: 17.7" "Group enriched" "Detected in some" 4 "Daudi: 27.2;Karpas-707: 14.3;U-266/70: 17.3;U-266/84: 19.2;U-698: 44.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA024377, HPA073266" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA024377: AB_1859477, HPA073266: " "unprognostic (5.43e-3)" "prognostic favorable (6.85e-6)" "unprognostic (6.10e-2)" "unprognostic (1.01e-1)" "unprognostic (2.93e-2)" "prognostic favorable (4.16e-4)" "unprognostic (1.36e-2)" "unprognostic (3.14e-3)" "prognostic favorable (5.42e-4)" "unprognostic (8.03e-3)" "unprognostic (1.65e-1)" "unprognostic (3.19e-1)" "prognostic unfavorable (7.38e-4)" "unprognostic (9.13e-2)" "unprognostic (2.20e-1)" "unprognostic (5.51e-2)" "unprognostic (1.05e-3)" 1.7 0.7 0.5 41.7 0.5 3.1 1.0 0.5 0.5 1.1 4.5 0.0 0.6 1.8 1.2 0.6 3.6 1.2 2.4 0.9 0.6 0.6 1.5 1.4 5.3 30.5 0.6 0.0 0.9 0.9 0.0 0.7 0.4 0.1 1.5 1.7 1.2 5.5 1.3 0.6 0.8 11.3 1.2 0.9 41.0 3.3 2.6 0.1 55.1 1.6 1.8 54.1 4.0 1.3 8.3 0.3 0.7 0.1 2.6 17.7 4.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 27.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.1 0.1 1.6 0.2 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.7 14.3 0.0 0.1 2.4 0.9 0.1 1.5 0.0 0.1 0.1 4.9 0.0 1.6 0.1 0.1 0.5 0.2 0.0 0.0 0.1 0.3 0.1 0.1 0.2 0.1 0.0 17.3 19.2 44.1 0.0 0.1 0.0 0.5 0.1 0.4 16.3 0.1 17.7 8.3 6.7 12.1 0.0 7.7 2.8 7.5 0.7 2.6 0.1 0.3 10.6 4.1 0.5 0.5 0.5 0.5 0.6 0.6 0.6 0.0 0.1 0.1 8.9 27.4 90.1 2.1 0.1 1.4 4.0 0.0 1.4 10.3 1.8 0.0 0.1 0.0 0.1 11.6 1.2 0.0 0.0 0.0 0.3 0.2 1.4 44.2 0.6 0.1 0.0 0.0 5.5 6.5 7.4 0.0 0.7 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.2 1.4 0.0 0.1 4.9 2.0 0.1 0.2 76.1 0.0 1.4 IKZF4 "Eos, ZNFN1A4" ENSG00000123411 "IKAROS family zinc finger 4" Q9H2S9 12 56007659-56038435 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 1.3;T-reg: 5.3" "Lineage enriched" "Detected in single" 13 "T-cells: 5.3" "Cell line enhanced" "Detected in many" "HDLM-2: 28.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046270, HPA049016" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA046270: AB_2679607, HPA049016: AB_2680600" "unprognostic (2.27e-1)" "unprognostic (7.09e-2)" "unprognostic (1.34e-1)" "unprognostic (8.95e-3)" "unprognostic (5.67e-2)" "unprognostic (2.08e-2)" "unprognostic (3.63e-3)" "prognostic favorable (3.46e-4)" "unprognostic (2.42e-1)" "unprognostic (5.43e-2)" "prognostic favorable (4.37e-4)" "unprognostic (6.52e-2)" "unprognostic (7.97e-2)" "unprognostic (3.64e-1)" "unprognostic (1.26e-1)" "unprognostic (9.98e-3)" "unprognostic (7.74e-3)" 5.6 14.5 7.7 7.4 8.5 6.7 8.1 13.9 7.6 7.2 6.9 6.5 7.1 3.4 7.7 8.5 4.1 10.0 5.9 5.6 6.3 6.3 5.6 4.1 7.3 4.2 5.9 9.8 16.2 5.7 20.8 22.1 5.9 9.2 8.1 4.3 9.2 3.7 8.6 16.8 4.1 4.5 10.8 8.4 4.1 5.7 9.1 5.9 5.2 8.8 4.5 4.5 6.4 14.0 0.3 0.3 0.0 0.4 0.1 5.3 0.3 1.3 1.5 9.2 3.1 1.9 2.0 2.1 1.5 2.5 1.7 2.5 4.7 2.0 0.8 1.6 2.3 1.9 0.9 1.1 1.2 3.8 28.2 1.4 5.2 1.5 2.3 2.1 2.4 2.1 3.4 1.7 1.8 1.4 3.2 1.7 0.2 8.1 4.5 2.7 1.5 3.0 1.2 4.0 1.4 1.1 2.6 2.5 1.1 2.5 1.4 3.6 3.0 2.0 0.6 3.3 2.4 2.4 2.6 0.9 1.5 2.6 1.4 1.1 2.7 1.6 1.3 3.0 2.4 1.9 0.0 0.3 0.0 0.3 0.3 0.5 0.3 1.3 0.0 0.2 0.2 0.3 0.4 0.0 0.1 0.4 0.3 5.3 0.3 7.7 8.5 13.9 7.6 6.3 6.3 5.9 9.8 9.2 5.9 3.0 10.3 1.4 1.5 3.2 18.9 5.7 10.2 1.4 4.5 3.5 7.9 2.7 1.7 2.4 8.5 3.4 1.6 0.0 3.8 2.1 5.0 1.9 1.1 5.6 2.4 7.9 5.8 4.9 8.6 1.6 8.1 2.3 5.0 5.4 2.7 16.7 2.9 2.5 10.3 3.3 11.5 0.0 9.2 18.4 4.9 2.9 3.3 2.5 2.2 1.4 IKZF5 "FLJ22973, Pegasus, ZNFN1A5" ENSG00000095574 "IKAROS family zinc finger 5" Q9H5V7 10 122990806-123008817 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015297, HPA051574" Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA015297: AB_1855183, HPA051574: AB_2681538" "unprognostic (2.42e-1)" "unprognostic (1.08e-1)" "unprognostic (4.64e-2)" "unprognostic (2.76e-2)" "unprognostic (1.44e-2)" "unprognostic (1.66e-3)" "unprognostic (2.68e-1)" "unprognostic (9.14e-3)" "unprognostic (5.43e-2)" "unprognostic (2.99e-1)" "unprognostic (6.88e-2)" "unprognostic (1.63e-2)" "unprognostic (3.98e-3)" "unprognostic (4.17e-2)" "unprognostic (6.03e-2)" "unprognostic (6.96e-2)" "unprognostic (3.15e-2)" 11.7 11.7 20.3 9.2 23.5 38.0 16.6 24.9 20.5 12.0 9.2 22.1 7.5 8.8 12.5 13.6 9.4 9.9 8.4 9.4 18.0 14.5 11.8 14.7 10.6 13.4 28.9 13.5 19.3 14.8 14.2 22.9 10.7 21.2 11.6 9.8 11.2 10.6 8.8 12.3 13.7 10.8 9.8 21.8 11.6 9.9 13.4 26.8 14.7 13.6 7.0 12.4 9.4 11.1 7.6 6.7 8.2 8.0 9.7 13.4 6.7 6.0 3.0 6.1 10.3 9.8 9.0 6.7 5.1 10.9 6.8 8.3 4.8 7.1 15.2 3.8 6.2 3.7 8.3 10.7 7.6 10.0 8.4 9.5 9.7 5.0 7.2 6.5 11.7 8.8 7.1 10.5 8.1 17.6 9.4 7.4 10.1 13.3 10.2 7.3 4.4 10.6 12.9 5.6 4.5 4.2 8.7 7.6 8.6 5.6 4.2 6.6 5.9 4.2 5.2 9.8 5.1 4.3 7.5 7.5 4.9 4.1 7.1 8.1 9.5 5.1 14.3 6.3 20.6 2.9 7.5 6.3 8.2 9.4 8.0 10.9 6.2 8.6 9.0 6.7 7.6 11.9 13.4 6.1 9.7 7.7 4.7 10.9 6.7 20.3 23.5 24.9 20.5 18.0 14.5 28.9 13.5 21.2 26.8 11.9 12.5 11.4 9.2 28.6 11.6 12.9 7.6 14.7 14.8 5.2 13.7 5.2 8.3 4.5 3.4 10.1 6.6 0.0 4.5 5.0 9.9 14.8 16.2 13.2 5.6 11.1 17.2 6.7 9.7 2.0 12.4 9.8 15.1 4.6 8.4 7.7 3.6 6.5 9.9 8.9 14.1 12.9 11.3 24.0 22.1 28.2 12.0 15.8 6.0 7.6 IL13RA1 "CD213a1, IL-13Ra, NR4" ENSG00000131724 "Interleukin 13 receptor subunit alpha 1" P78552 X 118727572-118794539 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "monocytes: 235.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 6.9;eosinophil: 7.1;myeloid DC: 10.9;neutrophil: 19.0" "Group enriched" "Detected in many" 6 "dendritic cells: 10.9;granulocytes: 19.0;monocytes: 6.9" "Cell line enhanced" "Detected in many" "HDLM-2: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001587 Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 4500000 Vesicles Nucleoplasm "HPA001587: AB_1079133" "unprognostic (5.14e-3)" "unprognostic (4.72e-2)" "unprognostic (7.12e-2)" "unprognostic (7.75e-2)" "unprognostic (8.81e-3)" "unprognostic (3.82e-2)" "unprognostic (1.11e-1)" "unprognostic (1.89e-1)" "unprognostic (1.51e-1)" "unprognostic (2.44e-1)" "unprognostic (1.90e-1)" "unprognostic (8.21e-2)" "prognostic unfavorable (1.19e-8)" "unprognostic (1.88e-2)" "unprognostic (2.37e-2)" "unprognostic (2.82e-2)" "unprognostic (5.08e-2)" 31.5 17.5 9.3 15.3 13.3 2.1 19.8 3.6 10.2 16.6 23.8 12.6 7.2 18.9 16.6 18.0 33.0 15.4 17.7 17.5 11.4 9.4 22.7 73.3 27.7 33.9 15.2 6.0 25.2 12.9 9.5 16.1 15.2 13.4 15.3 25.2 14.5 21.8 13.0 22.3 10.2 37.7 16.3 24.5 17.4 18.5 9.9 11.9 4.8 24.0 20.1 20.0 16.5 15.4 1.9 10.9 19.0 6.9 0.0 0.1 1.7 8.2 10.3 4.9 13.5 11.2 33.2 8.9 17.4 24.2 8.3 10.8 6.0 15.4 0.0 30.6 23.9 24.1 7.9 5.3 7.4 9.2 45.2 4.1 1.4 9.3 15.1 6.8 0.1 3.6 30.1 6.7 11.3 14.0 25.1 17.3 0.0 4.4 0.9 11.7 12.1 0.0 2.2 4.5 15.8 9.9 0.0 12.1 0.0 12.4 9.1 1.8 1.7 27.3 10.0 6.8 6.7 6.4 7.9 22.0 16.2 7.7 27.3 13.6 0.2 4.1 0.0 35.8 4.3 6.8 0.0 6.9 7.1 0.0 1.7 0.0 1.9 0.0 0.0 10.9 1.8 0.0 0.0 19.0 0.0 0.6 1.9 0.1 1.7 9.3 13.3 3.6 10.2 11.4 9.4 15.2 6.0 13.4 11.9 65.5 43.2 10.0 29.8 15.2 2.0 9.2 53.5 40.2 51.2 27.9 15.7 7.4 8.3 30.4 30.3 46.6 51.4 0.0 85.9 27.9 14.8 39.1 0.0 133.7 39.4 0.0 89.3 79.8 108.2 5.6 22.5 97.3 20.3 235.4 131.1 39.2 63.8 20.1 17.7 20.5 10.7 32.3 30.6 3.6 26.6 10.7 7.9 3.8 25.1 29.4 IL13RA2 "CD213a2, CT19, IL-13R, IL13BP" ENSG00000123496 "Interleukin 13 receptor subunit alpha 2" Q14627 X 115003975-115019977 "Cancer-related genes, CD markers, Predicted membrane proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 16.1;testis: 31.5" "Cell type enhanced" "Detected in some" 28 "Early spermatids: 253.7;Ito cells: 63.3;Late spermatids: 36.6;Spermatocytes: 64.6" "Cancer enhanced" "Detected in many" "glioma: 17.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "PC-3: 27.0;U-2197: 86.8;U-251 MG: 58.3;U-87 MG: 34.6" "Region enhanced" "Detected in some" "olfactory region: 8.7" "Low region specificity" "Detected in many" "HPA045831, HPA067363" Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "Nucleoplasm, Vesicles" "HPA045831: , HPA067363: " "unprognostic (1.97e-1)" "unprognostic (2.83e-1)" "unprognostic (6.62e-4)" "unprognostic (7.39e-2)" "unprognostic (8.45e-2)" "unprognostic (1.80e-1)" "prognostic favorable (3.55e-4)" "unprognostic (3.54e-1)" "unprognostic (2.85e-1)" "unprognostic (1.92e-2)" "unprognostic (2.20e-3)" "unprognostic (2.19e-2)" "unprognostic (1.53e-5)" "unprognostic (1.58e-1)" "unprognostic (1.63e-1)" "unprognostic (9.70e-3)" "unprognostic (1.20e-1)" 0.5 4.8 3.7 3.9 11.3 0.0 0.8 0.3 3.1 1.2 0.4 2.1 5.7 0.3 0.9 4.4 0.5 0.1 0.8 0.6 5.1 11.2 3.5 9.6 1.0 0.1 1.2 2.6 0.1 0.1 0.5 16.1 2.1 3.9 4.3 0.7 1.6 0.8 3.7 0.0 0.1 0.3 0.4 0.6 0.2 0.1 31.5 1.4 0.0 1.3 0.2 0.2 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.7 0.0 5.9 5.7 0.0 0.0 0.0 0.0 0.0 0.1 2.9 9.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.1 0.9 5.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.0 0.5 0.0 0.0 1.4 0.4 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.0 86.8 58.3 0.0 0.0 0.0 34.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 11.3 0.3 3.1 5.1 11.2 1.2 2.6 3.9 1.4 0.0 0.0 0.0 2.6 0.1 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 253.7 1.0 0.0 0.0 0.0 0.0 0.4 2.3 0.0 0.4 0.0 0.0 4.1 63.3 4.8 36.6 2.6 0.0 0.0 1.0 0.0 0.0 5.5 0.0 4.6 0.0 0.0 0.0 0.2 64.6 2.1 0.0 0.0 0.0 0.0 2.5 IL15 "IL-15, MGC9721" ENSG00000164136 "Interleukin 15" P40933 4 141636599-141733987 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 5 "monocytes: 96.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 15.5;Karpas-707: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "CAB004457, HPA037738" Approved Supported "Nucleoplasm,Nuclear speckles" "Secreted to blood" NA NA 182000 "Nucleoplasm, Nuclear speckles" "CAB004457: AB_2124575, HPA037738: AB_2675640" "unprognostic (1.10e-2)" "unprognostic (1.53e-1)" "unprognostic (1.04e-2)" "unprognostic (8.57e-2)" "unprognostic (8.77e-3)" "unprognostic (1.69e-1)" "unprognostic (1.17e-1)" "unprognostic (2.90e-1)" "unprognostic (1.80e-1)" "unprognostic (1.48e-1)" "unprognostic (5.20e-2)" "unprognostic (1.74e-2)" "unprognostic (3.75e-2)" "unprognostic (1.09e-1)" "unprognostic (4.03e-2)" "unprognostic (3.29e-2)" "unprognostic (1.54e-1)" 7.7 3.7 1.1 21.3 1.5 2.9 9.2 1.8 2.2 6.0 8.8 0.8 2.2 6.3 11.3 7.4 5.6 4.6 9.9 9.3 1.1 1.5 6.9 3.7 14.4 18.8 2.3 1.6 3.2 3.1 0.5 4.5 9.9 2.1 7.7 5.7 5.9 6.9 3.6 9.1 3.2 14.2 7.1 2.6 17.0 5.3 2.6 2.0 9.8 18.1 5.9 11.0 9.8 16.9 3.7 4.6 8.1 14.0 2.6 4.5 4.4 2.4 5.2 0.2 0.5 0.8 4.7 1.3 5.6 5.2 5.8 4.7 2.8 6.8 2.3 7.3 4.8 5.0 3.6 0.1 3.0 3.2 15.5 1.4 0.4 13.7 0.4 3.9 1.6 1.1 1.7 1.2 3.8 0.4 11.9 3.7 1.8 3.8 15.2 3.7 0.8 3.4 0.3 2.6 1.8 1.6 0.9 13.4 0.3 7.6 0.6 0.5 1.3 2.4 3.7 2.7 0.6 0.9 0.2 5.5 5.9 3.8 1.7 3.4 10.7 1.3 0.7 6.3 0.6 2.1 8.1 14.0 0.8 2.5 12.4 4.5 3.7 2.9 2.2 4.6 3.4 1.2 1.3 1.0 2.6 12.5 0.1 1.5 4.4 1.1 1.5 1.8 2.2 1.1 1.5 2.3 1.6 2.1 2.0 0.0 3.2 10.4 2.8 5.5 0.3 2.4 0.0 4.0 7.9 5.2 0.0 1.0 0.0 8.1 4.0 11.3 3.9 0.0 12.2 1.8 7.2 4.3 0.0 1.7 4.9 0.0 0.0 11.6 18.3 1.5 2.6 19.3 8.5 96.4 4.7 15.1 14.3 3.5 1.1 8.4 0.5 6.5 3.1 0.5 0.7 3.0 0.2 6.4 2.3 2.1 IL17RA "CD217, CDw217, hIL-17R, IL-17RA, IL17R" ENSG00000177663 "Interleukin 17 receptor A" Q96F46 22 17084954-17115694 "CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 50.0" "Cell type enhanced" "Detected in many" 8 "Kupffer cells: 84.8;Macrophages: 43.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 15.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HL-60: 27.6;NB-4: 24.3;THP-1: 35.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB024996 Enhanced Approved Nucleoplasm,Cytosol "Secreted - unknown location" NA NA 20000 "Nucleoplasm, Cytosol" "CAB024996: " "unprognostic (1.92e-1)" "unprognostic (3.15e-1)" "unprognostic (1.65e-2)" "unprognostic (9.83e-2)" "unprognostic (7.66e-2)" "unprognostic (5.15e-2)" "unprognostic (3.56e-2)" "unprognostic (1.22e-2)" "unprognostic (1.41e-2)" "unprognostic (8.52e-2)" "unprognostic (1.91e-1)" "unprognostic (3.04e-1)" "unprognostic (1.96e-2)" "prognostic favorable (8.35e-4)" "unprognostic (2.16e-2)" "unprognostic (1.27e-1)" "unprognostic (6.51e-3)" 17.7 7.6 6.5 13.6 13.8 40.5 24.7 4.0 6.7 8.6 8.1 7.7 4.6 6.2 7.4 9.4 6.8 7.8 7.4 8.8 6.1 4.9 8.3 11.6 16.8 39.2 10.3 2.0 7.7 7.7 6.9 5.4 6.2 8.3 6.9 5.7 5.3 7.0 5.3 5.3 8.6 9.1 8.3 11.2 23.4 7.3 5.3 9.7 50.0 7.9 3.2 11.0 6.3 12.8 0.5 3.6 15.6 6.9 1.4 2.4 2.0 3.6 2.1 1.9 2.5 3.9 2.3 2.5 5.5 3.6 2.6 3.3 2.0 2.4 3.3 2.3 5.5 3.4 6.0 2.7 2.6 1.8 5.4 3.2 0.0 1.2 1.3 4.5 27.6 8.6 3.4 3.8 2.3 1.8 2.5 2.7 2.7 1.4 3.5 2.6 3.1 3.3 24.3 1.1 4.7 2.1 0.7 0.4 0.6 2.4 2.7 1.3 0.0 3.8 3.3 2.7 2.3 2.5 35.0 7.5 2.0 2.9 3.0 2.0 2.8 1.5 1.6 2.9 13.4 2.1 6.7 6.9 6.1 1.1 3.2 0.9 0.4 1.5 1.1 3.6 0.5 2.4 1.8 15.6 1.4 2.9 1.7 0.9 2.0 6.5 13.8 4.0 6.7 6.1 4.9 10.3 2.0 8.3 9.7 11.9 13.1 6.7 5.5 7.8 2.0 4.5 15.3 5.3 3.4 5.2 7.9 5.4 0.0 8.0 2.5 9.3 15.1 0.0 10.8 10.6 8.2 8.5 7.0 9.6 29.2 3.2 12.7 20.9 84.8 1.4 8.3 43.1 8.5 3.6 13.1 3.8 10.5 11.8 4.2 3.1 3.2 12.9 9.0 1.4 14.7 5.9 5.4 20.0 10.6 9.3 IL17RB "CRL4, EVI27, IL17BR, IL17RH1" ENSG00000056736 "Interleukin 17 receptor B" Q9NRM6 3 53846580-53865800 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 63.0;liver: 26.6" "Group enriched" "Detected in many" 4 "Intestinal endocrine cells: 28.0;Proximal tubular cells: 57.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 11.1;Hep G2: 32.2;OE19: 25.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002837, HPA005482" Enhanced Approved "Nucleoplasm,Plasma membrane,Mitotic spindle,Centriolar satellite" "Intracellular and membrane" NA NA "Nucleoplasm, Plasma membrane" "Mitotic spindle, Centriolar satellite" "HPA002837: , HPA005482: AB_1234567" "unprognostic (1.85e-3)" "unprognostic (4.22e-3)" "unprognostic (1.60e-3)" "unprognostic (2.86e-2)" "unprognostic (1.42e-2)" "unprognostic (6.20e-3)" "unprognostic (1.62e-2)" "unprognostic (6.09e-3)" "unprognostic (1.30e-1)" "unprognostic (5.41e-2)" "unprognostic (4.75e-2)" "unprognostic (4.27e-2)" "prognostic favorable (6.61e-4)" "unprognostic (8.10e-2)" "unprognostic (6.97e-2)" "unprognostic (5.29e-1)" "unprognostic (7.15e-3)" 1.1 2.1 13.4 2.2 12.2 0.9 9.2 15.1 14.7 17.1 5.8 6.8 0.0 5.1 5.0 1.3 1.9 3.2 2.4 2.5 17.1 7.4 63.0 26.6 3.5 2.3 11.9 6.4 1.8 5.3 1.4 3.9 1.2 11.2 2.5 6.1 1.9 4.1 1.0 1.4 2.3 5.1 1.2 11.3 1.4 3.4 2.5 15.2 0.0 2.9 0.0 1.0 1.7 1.0 0.9 1.1 4.1 0.6 0.5 3.1 0.5 0.8 1.7 2.5 1.9 0.0 0.0 4.0 1.7 0.0 0.0 0.0 11.1 0.8 2.5 0.6 0.5 0.9 0.4 6.8 0.0 0.0 0.9 1.9 3.3 3.4 32.2 0.0 3.0 1.8 0.0 0.0 0.0 0.0 2.2 0.0 0.9 2.6 1.2 0.0 2.2 0.5 1.2 6.8 25.2 1.4 0.9 1.0 2.9 0.7 2.9 3.6 2.1 5.6 1.3 1.0 1.9 5.2 1.1 1.3 1.7 1.9 1.5 2.1 2.6 2.9 1.6 1.5 1.8 0.9 4.1 0.6 0.2 1.0 0.6 0.6 0.5 2.1 0.6 0.2 0.9 0.8 0.9 0.3 0.5 0.2 1.1 3.1 0.5 13.4 12.2 15.1 14.7 17.1 7.4 11.9 6.4 11.2 15.2 0.0 2.6 0.0 2.0 0.2 0.0 3.4 10.2 0.0 2.3 0.0 0.0 0.3 8.3 3.7 0.8 0.0 1.3 0.0 1.3 0.9 0.2 6.7 2.3 8.9 0.1 0.0 28.0 0.6 0.0 0.0 1.1 0.8 0.0 0.0 4.3 4.5 2.7 2.0 0.4 57.9 0.0 0.0 0.6 0.4 1.3 0.1 0.3 0.0 6.6 0.5 IL17RD "FLJ35755, IL-17RD, IL17RLM, SEF" ENSG00000144730 "Interleukin 17 receptor D" Q8NFM7 3 57089982-57170306 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 15.4;Late spermatids: 17.2;Leydig cells: 10.6;Peritubular cells: 24.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 10.6;AN3-CA: 28.7;NTERA-2: 16.6;SH-SY5Y: 43.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039577, HPA043550" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA039577: AB_2676580, HPA043550: AB_2678546" "unprognostic (4.67e-2)" "unprognostic (1.52e-1)" "unprognostic (2.31e-1)" "unprognostic (2.72e-2)" "unprognostic (1.33e-2)" "unprognostic (9.62e-2)" "unprognostic (1.17e-2)" "unprognostic (1.60e-1)" "unprognostic (3.72e-1)" "unprognostic (2.11e-3)" "unprognostic (4.79e-2)" "unprognostic (1.25e-1)" "prognostic favorable (2.92e-9)" "unprognostic (2.90e-1)" "unprognostic (2.21e-1)" "unprognostic (2.63e-3)" "unprognostic (9.58e-3)" 2.7 1.3 5.2 1.8 6.5 0.4 8.9 2.8 6.1 14.7 7.7 7.6 7.4 0.9 18.5 13.7 3.4 8.4 6.1 3.0 4.8 3.6 7.1 0.5 1.1 0.7 4.0 2.4 12.6 1.4 20.8 14.0 0.7 5.7 8.1 2.5 10.2 7.2 10.8 1.0 2.6 1.8 14.7 7.2 3.1 2.2 11.2 3.1 0.0 1.0 2.2 1.4 8.9 5.2 0.6 0.6 1.5 0.5 0.6 0.4 0.0 1.6 0.3 10.6 28.7 0.0 0.2 1.7 0.2 0.1 0.1 0.3 0.2 0.7 0.0 0.0 0.6 2.3 0.1 2.0 0.4 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.2 7.1 0.4 0.2 0.0 0.0 0.5 0.2 0.0 0.0 16.6 0.9 0.8 0.0 3.8 0.0 2.2 0.4 0.2 43.7 0.4 0.6 1.2 3.6 0.3 0.0 0.3 0.5 0.7 0.5 1.7 0.0 0.0 0.0 0.3 0.0 0.7 1.4 0.5 0.3 0.3 0.3 0.2 0.4 0.3 0.3 0.1 0.6 0.4 0.4 1.5 0.6 0.3 0.6 0.3 0.0 5.2 6.5 2.8 4.0 4.8 3.6 4.0 2.4 5.7 3.1 0.0 2.9 0.0 1.6 0.8 0.0 1.1 2.5 2.7 2.3 0.0 0.0 0.3 0.0 2.6 15.4 2.2 0.0 0.0 0.2 0.1 3.7 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 17.2 10.6 0.7 0.0 0.0 0.3 0.5 0.6 0.0 24.4 5.1 0.0 0.0 0.4 8.8 7.6 0.6 0.1 0.0 0.0 0.5 IL18 "IGIF, IL-18, IL-1g, IL1F4" ENSG00000150782 "Interleukin 18" Q14116 11 112143251-112164117 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 53.9;skin 1: 57.2" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 160.8;Kupffer cells: 163.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 17.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 26.5;CAPAN-2: 42.1;HaCaT: 38.5;HBEC3-KT: 29.0;hTCEpi: 44.4;PC-3: 25.8;U-2 OS: 50.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA003980, CAB007772" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Secreted to blood" NA Yes 196000 "Nucleoplasm, Golgi apparatus" Cytosol "CAB007772: AB_562304, HPA003980: AB_1851670" "unprognostic (2.31e-3)" "unprognostic (3.25e-1)" "prognostic favorable (2.78e-4)" "unprognostic (3.41e-2)" "unprognostic (1.25e-1)" "unprognostic (1.62e-1)" "unprognostic (1.65e-1)" "unprognostic (8.15e-2)" "unprognostic (3.23e-1)" "unprognostic (2.78e-1)" "unprognostic (1.96e-3)" "unprognostic (4.13e-1)" "unprognostic (3.58e-2)" "unprognostic (1.51e-1)" "unprognostic (3.19e-2)" "unprognostic (3.15e-2)" "unprognostic (9.01e-2)" 9.4 2.6 5.3 12.5 7.9 10.8 5.2 1.3 5.3 18.5 13.1 6.4 2.5 8.6 2.1 3.7 53.9 3.3 11.9 2.1 5.7 3.1 17.5 3.6 15.2 22.6 7.4 1.4 1.4 7.0 0.3 3.3 2.6 8.2 5.5 11.6 2.2 8.3 1.4 3.8 57.2 9.1 4.0 24.7 26.6 5.1 1.7 7.5 3.9 1.8 21.2 26.5 9.1 35.4 0.5 17.1 10.4 6.9 13.8 0.3 1.6 26.5 9.3 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 5.1 42.1 0.0 6.1 0.0 0.7 38.5 0.0 29.0 0.0 0.0 0.2 4.0 9.5 2.1 0.9 2.1 7.7 0.0 44.4 0.0 10.3 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 7.3 25.8 0.0 0.0 0.0 19.0 5.7 0.0 0.0 18.3 12.2 0.1 0.2 7.3 5.8 0.0 0.1 50.0 0.3 8.2 0.1 0.0 0.1 0.0 15.4 0.0 3.5 6.0 10.4 0.1 6.9 0.0 0.4 0.0 0.0 17.1 0.5 0.0 0.3 6.7 13.8 3.7 3.8 0.0 1.6 5.3 7.9 1.3 5.3 5.7 3.1 7.4 1.4 8.2 7.5 160.8 35.5 7.5 33.3 109.2 1.7 0.7 22.9 73.6 43.3 8.7 0.0 2.1 68.0 27.4 1.8 2.4 69.7 0.0 126.1 2.6 5.4 10.6 97.2 2.0 69.6 0.0 13.9 6.2 163.5 0.9 0.0 66.1 3.3 30.7 23.3 1.7 111.9 97.0 4.2 13.2 37.2 6.5 2.2 0.6 0.5 97.2 1.5 27.7 45.4 67.4 IL1R1 "CD121A, D2S1473, IL1R, IL1RA" ENSG00000115594 "Interleukin 1 receptor type 1" P14778 2 102064544-102179874 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Inflammatory response" "Hydrolase, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Club cells: 93.3;Ito cells: 139.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 95.6;ASC TERT1: 42.7;HHSteC: 30.0;HSkMC: 117.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001237, HPA005823, CAB007779, HPA029560" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Secreted to blood" NA NA 1000000 "Nucleoplasm, Vesicles" "Plasma membrane, Cytosol" "CAB007779: AB_562073, HPA001237: , HPA005823: AB_2667445, HPA029560: AB_2673094" "unprognostic (6.16e-3)" "unprognostic (3.55e-2)" "unprognostic (3.33e-1)" "unprognostic (1.22e-1)" "unprognostic (4.26e-2)" "unprognostic (7.10e-2)" "unprognostic (2.01e-1)" "unprognostic (3.36e-2)" "unprognostic (1.44e-1)" "unprognostic (3.16e-1)" "unprognostic (4.26e-2)" "unprognostic (7.77e-2)" "prognostic unfavorable (6.92e-6)" "unprognostic (2.48e-2)" "unprognostic (6.95e-2)" "unprognostic (4.83e-2)" "unprognostic (7.73e-2)" 48.6 25.2 2.6 18.2 5.2 4.0 92.4 2.4 3.9 47.8 21.0 2.5 34.3 5.2 15.2 30.2 18.2 17.1 25.8 27.0 4.2 2.5 23.7 74.8 40.5 28.0 5.6 1.1 25.1 17.1 16.9 7.3 66.2 10.9 26.0 8.4 8.6 12.7 36.4 15.5 13.5 13.0 15.1 10.0 19.2 15.6 13.4 2.8 3.5 33.6 9.0 9.6 32.0 36.4 0.1 0.1 4.0 0.5 0.8 1.8 0.2 0.2 1.8 0.0 1.5 95.6 42.7 0.6 4.0 18.2 2.8 4.3 0.8 0.5 0.0 2.9 8.0 5.0 0.8 0.0 0.3 2.4 7.9 0.0 0.1 0.4 4.4 30.0 0.0 0.0 117.7 0.3 3.2 0.7 1.2 1.2 0.0 0.5 0.1 4.1 0.8 0.0 0.1 0.1 0.8 0.1 0.0 0.3 0.0 2.7 1.9 0.0 0.0 1.8 1.1 0.0 0.5 1.6 0.1 0.0 8.2 0.5 13.7 0.3 0.0 0.0 0.0 3.2 0.0 0.5 0.6 0.5 0.1 0.0 0.0 0.7 0.1 1.1 0.0 0.1 0.1 0.0 0.1 4.0 0.8 0.0 0.1 1.8 0.2 2.6 5.2 2.4 3.9 4.2 2.5 5.6 1.1 10.9 2.8 23.8 55.6 3.7 27.6 27.6 0.0 3.9 28.1 40.2 93.3 5.2 0.0 5.3 3.3 21.6 6.4 58.3 0.0 0.0 18.7 76.6 77.2 84.5 1.1 43.2 5.1 0.0 1.2 139.3 12.4 9.4 25.9 21.6 18.6 9.0 0.7 7.3 15.4 0.0 1.4 6.2 1.0 6.5 23.1 0.7 0.9 33.8 20.0 2.6 0.9 19.6 IL1RN "ICIL-1RA, IL-1RN, IL1F3, IL1RA, IRAP, MGC10430" ENSG00000136689 "Interleukin 1 receptor antagonist" P18510 2 113107214-113134016 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 217.8;lymphoid tissue: 194.7;tongue: 123.7" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 163.8;Hofbauer cells: 319.3;Suprabasal keratinocytes: 294.2;Urothelial cells: 333.6" "Cancer enhanced" "Detected in all" "head and neck cancer: 92.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "classical monocyte: 17.1;myeloid DC: 17.1;neutrophil: 65.2" "Group enriched" "Detected in many" 332 "dendritic cells: 17.1;granulocytes: 65.2;monocytes: 17.1" "Cell line enhanced" "Detected in some" "A-431: 21.1;HaCaT: 41.7;RT4: 40.8;THP-1: 11.8" "Not detected" "Not detected" "HPA001482, CAB009633" Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Secreted to blood" NA NA 291000 Nucleoplasm "Centrosome, Cytosol" "CAB009633: AB_2125576, HPA001482: AB_1078437" "unprognostic (3.85e-3)" "unprognostic (3.96e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (3.00e-4)" "unprognostic (2.21e-1)" "unprognostic (3.63e-2)" "unprognostic (3.15e-2)" "unprognostic (2.55e-1)" "unprognostic (4.46e-2)" "unprognostic (9.54e-2)" "prognostic unfavorable (6.85e-4)" "unprognostic (5.59e-3)" "prognostic unfavorable (2.66e-6)" "unprognostic (2.05e-1)" "prognostic unfavorable (8.23e-4)" "unprognostic (4.25e-2)" "unprognostic (1.03e-1)" 17.3 0.2 0.2 7.2 0.3 32.9 1.1 0.2 0.5 27.2 3.8 0.6 1.4 1.1 1.5 0.7 217.8 0.2 4.1 0.5 0.2 0.0 0.5 23.5 2.9 1.9 0.3 0.2 0.4 0.4 0.1 0.3 3.1 0.6 1.6 0.3 0.4 30.9 1.3 0.5 14.4 3.7 0.7 0.2 3.6 5.7 1.4 0.2 1.0 0.7 123.7 194.7 3.3 42.2 0.0 17.1 65.2 17.1 0.0 0.0 4.9 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.4 41.7 0.0 1.2 0.0 0.0 0.0 0.1 0.0 7.0 0.0 0.1 7.9 0.0 5.4 0.2 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.2 0.0 5.6 0.0 4.7 0.0 0.0 0.0 0.0 0.0 40.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 11.8 0.1 0.5 0.0 0.3 0.0 0.3 0.0 0.1 4.0 4.7 0.1 0.0 17.1 0.3 0.0 7.6 0.0 0.0 0.0 0.0 17.1 0.0 0.0 0.0 65.2 0.0 3.4 0.1 0.0 4.9 0.2 0.3 0.2 0.5 0.2 0.0 0.3 0.2 0.6 0.2 6.0 10.6 0.5 50.9 163.8 0.0 0.3 12.7 18.7 17.0 3.5 0.0 1.3 0.0 17.2 35.3 2.2 6.5 0.0 25.2 2.5 6.6 30.8 9.3 38.4 319.3 0.0 0.0 3.1 35.8 72.7 0.6 100.5 23.6 1.0 0.6 0.0 89.0 0.0 0.4 0.0 0.0 0.0 6.6 0.7 0.1 294.2 3.8 0.9 2.2 333.6 IL31RA "CRL, CRL3, GLM-R, Glmr, IL-31RA" ENSG00000164509 "Interleukin 31 receptor A" Q8NI17 5 55851379-55922853 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Amyloidosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.3;tongue: 6.4" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 1.8;Spermatocytes: 2.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 6 "amygdala: 10.3" "Group enriched" "Detected in some" 5 "classical monocyte: 2.2;myeloid DC: 1.2" "Group enriched" "Detected in many" 8 "dendritic cells: 1.2;monocytes: 2.2" "Cell line enhanced" "Detected in some" "GAMG: 25.6;HBEC3-KT: 7.8;hTERT-HME1: 9.4;U-2 OS: 13.9;U-87 MG: 16.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "cerebral cortex: 1.5;hippocampal formation: 1.1" "HPA051532, HPA068114" Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA051532: , HPA068114: AB_2732779" "unprognostic (1.14e-1)" "unprognostic (5.65e-2)" "unprognostic (1.97e-1)" "unprognostic (5.13e-2)" "unprognostic (2.70e-2)" "unprognostic (2.95e-3)" "unprognostic (7.34e-2)" "unprognostic (3.54e-1)" "unprognostic (5.38e-2)" "unprognostic (2.95e-3)" "unprognostic (7.75e-5)" "unprognostic (5.55e-2)" "unprognostic (2.65e-6)" "unprognostic (7.73e-2)" "unprognostic (7.68e-2)" "unprognostic (4.02e-1)" "unprognostic (1.76e-2)" 0.3 0.1 10.3 1.0 0.1 5.3 0.2 0.1 0.4 0.2 1.5 0.0 0.0 0.4 1.2 1.8 1.7 0.1 0.2 0.4 1.6 0.2 0.3 0.3 0.5 0.1 0.1 0.0 0.5 0.7 0.0 0.7 0.7 0.0 1.0 0.4 0.4 1.3 0.2 2.6 2.5 0.8 1.8 0.1 0.3 0.5 5.9 0.0 1.4 0.5 6.4 0.5 0.5 2.2 0.0 1.2 0.2 2.2 0.0 0.1 0.4 0.0 1.0 0.0 0.0 0.0 0.4 0.4 0.1 0.4 0.2 0.2 0.0 0.1 0.0 0.0 0.2 25.6 0.0 0.0 7.8 1.6 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 5.2 2.6 3.7 9.4 0.4 2.9 0.0 0.0 0.3 1.2 0.0 0.0 1.2 0.0 0.0 5.2 0.0 1.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.5 1.3 0.4 13.9 0.0 0.8 0.0 0.0 0.0 16.1 0.0 2.2 0.1 2.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 10.3 0.1 0.1 0.4 1.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.5 0.1 0.9 0.0 0.0 0.0 IL33 "C9orf26, DKFZp586H0523, DVS27, IL1F11, NF-HEV" ENSG00000137033 "Interleukin 33" O95760 9 6215786-6257983 "Predicted intracellular proteins, Predicted secreted proteins" Transcription Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Ciliated cells: 112.4;Club cells: 135.4;Endothelial cells: 153.6;Ito cells: 400.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "hTERT-RPE1: 19.9;U-2197: 60.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007057, HPA022899, HPA024426" Supported Supported Nucleoplasm,Vesicles "Secreted to blood" NA NA Nucleoplasm Vesicles "CAB007057: , HPA022899: , HPA024426: AB_1845820" "prognostic favorable (4.42e-4)" "unprognostic (8.36e-2)" "unprognostic (5.67e-3)" "unprognostic (7.67e-3)" "unprognostic (4.27e-1)" "unprognostic (1.63e-1)" "unprognostic (2.59e-3)" "unprognostic (2.66e-3)" "unprognostic (3.18e-1)" "unprognostic (2.05e-1)" "unprognostic (1.43e-1)" "unprognostic (8.08e-2)" "unprognostic (1.58e-3)" "unprognostic (4.70e-3)" "unprognostic (4.10e-2)" "unprognostic (2.64e-1)" "unprognostic (6.85e-3)" 19.7 8.6 13.7 17.7 13.2 0.0 14.8 7.4 6.7 33.0 16.7 4.6 9.1 3.4 29.2 14.8 32.3 13.5 13.8 29.6 12.7 5.6 3.9 22.3 22.0 57.7 5.8 7.9 18.6 2.5 1.9 6.0 25.2 5.9 39.8 8.3 16.6 9.5 13.9 6.6 18.1 9.6 42.0 6.3 7.9 21.6 9.2 6.0 1.3 13.9 11.6 17.4 53.2 15.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 6.2 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.2 0.1 0.1 19.9 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 13.2 7.4 6.7 12.7 5.6 5.8 7.9 5.9 6.0 6.0 11.1 0.0 10.2 21.5 0.0 5.6 7.6 112.4 135.4 0.0 0.0 0.0 0.0 2.2 0.6 153.6 0.0 23.3 6.7 0.0 9.7 1.7 1.1 2.6 0.1 0.0 10.3 400.8 26.5 0.7 19.0 1.5 1.7 0.0 0.0 9.6 7.1 0.0 11.7 0.0 0.0 0.0 12.4 0.0 0.4 42.3 0.1 1.5 0.1 1.7 IL37 "FIL1, FIL1(ZETA), FIL1Z, IL-1F7, IL-1H4, IL-1RP1, IL1F7" ENSG00000125571 "Interleukin 37" Q9NZH6 2 112912971-112918882 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skin 1: 55.0" "Cell type enhanced" "Detected in single" 22 "Suprabasal keratinocytes: 2.5" "Cancer enriched" "Detected in some" 6 "lung cancer: 6.5" "Cell type enriched" "Detected in single" 28 "NK-cell: 2.8" "Lineage enriched" "Detected in single" 28 "NK-cells: 2.8" "Cell line enhanced" "Detected in some" "BJ hTERT+: 4.9;PC-3: 10.6;RT4: 5.7" "HPA054371, HPA057950" Uncertain Supported Nucleoplasm,Vesicles "Secreted to blood" NA NA 76700 "Nucleoplasm, Vesicles" "HPA054371: AB_2682465, HPA057950: AB_2683561" "unprognostic (1.79e-1)" "unprognostic (1.29e-1)" "unprognostic (1.64e-1)" "unprognostic (3.71e-5)" "unprognostic (1.11e-1)" "unprognostic (2.58e-2)" "unprognostic (1.09e-2)" "unprognostic (1.28e-2)" "unprognostic (9.54e-2)" "unprognostic (8.26e-3)" "unprognostic (3.95e-2)" "unprognostic (1.66e-1)" "unprognostic (8.92e-2)" "unprognostic (1.35e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 55.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.9 0.0 0.8 0.1 0.0 0.0 0.2 0.4 4.9 0.3 0.5 0.5 0.6 0.0 0.5 0.3 0.5 0.1 0.2 0.8 1.5 0.3 0.0 1.8 0.2 0.8 0.0 0.0 0.3 0.0 0.0 0.5 1.2 0.4 0.0 0.1 0.0 0.1 1.1 0.0 0.0 1.4 0.5 0.4 10.6 0.1 0.0 0.0 0.0 5.7 0.4 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.1 2.5 0.0 0.0 0.0 0.0 IL4I1 FIG1 ENSG00000104951 "Interleukin 4 induced 1" Q96RQ9 19 49889654-49929539 "Enzymes, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 38.6;testis: 48.8" "Cell type enriched" "Detected in many" 12 "monocytes: 1188.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 38.6" "Group enriched" "Detected in many" 6 "monocytes: 13.0;T-cells: 38.6" "Cell line enhanced" "Detected in some" "EFO-21: 18.0;HDLM-2: 31.2;Karpas-707: 25.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA045598 Enhanced Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA "Nucleoplasm, Cytosol" "HPA045598: AB_10969138" "unprognostic (6.23e-2)" "unprognostic (1.32e-2)" "unprognostic (8.39e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (5.61e-2)" "unprognostic (3.74e-3)" "unprognostic (7.03e-2)" "unprognostic (2.52e-2)" "unprognostic (3.84e-3)" "unprognostic (1.49e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.23e-10)" "unprognostic (2.10e-1)" "unprognostic (1.01e-1)" "unprognostic (6.44e-2)" "unprognostic (2.11e-3)" 5.4 3.3 4.0 30.9 4.6 7.1 4.1 5.8 5.6 4.6 4.1 5.5 2.9 8.2 5.9 3.4 4.5 8.2 5.4 4.2 3.9 3.5 11.0 3.5 6.7 15.5 4.0 3.2 6.2 3.7 1.5 5.1 6.8 4.3 5.3 3.8 3.9 4.1 5.0 6.2 3.4 7.4 3.8 7.2 7.6 6.2 48.8 4.4 14.6 4.1 4.4 12.3 6.5 4.9 0.2 4.1 0.1 13.0 0.4 38.6 3.0 0.5 0.6 0.4 0.4 0.0 0.4 0.1 0.3 1.0 0.8 1.1 0.3 1.0 1.8 18.0 0.2 1.5 0.3 0.2 0.0 0.1 31.2 0.1 0.8 0.0 0.2 0.1 0.6 6.4 0.5 0.2 0.3 0.0 0.2 1.4 0.2 0.1 25.3 0.0 0.2 0.4 1.0 0.2 0.4 0.1 0.5 0.5 1.7 1.2 1.6 0.4 0.4 0.2 0.5 0.3 0.1 0.2 1.4 1.5 3.8 0.5 0.0 0.5 2.2 4.7 1.0 0.5 0.2 0.4 0.1 8.0 0.1 2.3 13.0 38.6 0.2 5.0 4.3 4.1 0.1 0.1 0.0 0.1 0.4 1.6 0.4 0.2 3.0 4.0 4.6 5.8 5.6 3.9 3.5 4.0 3.2 4.3 4.4 0.0 0.0 0.0 0.5 8.7 0.0 0.6 0.0 0.0 1.2 3.5 0.0 0.3 0.0 1.9 52.0 3.1 0.0 0.0 3.4 0.6 1.4 1.0 1.1 0.0 102.3 0.0 0.0 1.8 1.8 11.1 0.3 40.3 3.3 1188.5 0.0 0.1 0.5 0.0 0.4 1.6 0.2 0.0 2.1 11.9 2.5 7.2 0.7 5.0 0.1 1.4 IL4R CD124 ENSG00000077238 "Interleukin 4 receptor" P24394 16 27313668-27364778 "Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "granulocytes: 107.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 34.4" "Group enriched" "Detected in all" 6 "B-cells: 34.4;granulocytes: 11.9" "Cell line enhanced" "Detected in many" "Daudi: 36.5;HBEC3-KT: 35.1;U-698: 34.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB004451, HPA050124, HPA070380" Enhanced Approved "Nucleoplasm,Plasma membrane,Centriolar satellite" "Secreted to blood" NA NA 49000 "Nucleoplasm, Plasma membrane" "Centriolar satellite" "CAB004451: AB_626889, HPA050124: AB_2681026, HPA070380: " "unprognostic (6.80e-2)" "unprognostic (6.35e-2)" "unprognostic (2.84e-1)" "prognostic favorable (6.43e-4)" "unprognostic (1.12e-1)" "unprognostic (1.14e-1)" "unprognostic (2.33e-2)" "unprognostic (1.95e-3)" "unprognostic (1.34e-1)" "unprognostic (1.54e-1)" "unprognostic (2.41e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (1.23e-5)" "unprognostic (1.49e-2)" "unprognostic (1.73e-1)" "unprognostic (1.36e-1)" "unprognostic (9.58e-2)" 20.7 14.8 8.7 31.6 10.6 36.9 12.0 4.4 7.7 20.8 30.3 5.9 11.5 10.9 18.0 12.8 24.7 13.6 25.1 12.3 6.7 4.4 13.3 39.1 40.9 44.8 10.8 1.7 14.7 11.3 3.8 5.5 16.1 10.1 18.8 15.1 12.3 7.7 11.5 7.2 9.9 18.6 39.6 13.6 31.8 21.1 10.4 9.8 9.1 8.6 13.7 38.4 31.6 15.4 34.4 1.6 11.9 2.6 3.3 4.0 1.8 11.5 3.0 2.0 3.9 1.0 4.6 4.2 7.3 8.5 2.9 2.4 6.2 32.0 36.5 9.1 11.5 5.7 12.3 2.1 35.1 2.5 31.6 1.0 6.8 1.8 9.5 13.2 1.8 19.4 7.0 14.2 13.5 8.0 15.5 15.7 2.1 2.9 3.1 4.7 5.1 0.1 5.5 2.4 10.4 2.7 0.1 15.2 2.9 13.6 13.2 0.6 0.3 1.0 7.0 1.6 5.3 2.7 7.0 23.5 6.7 3.0 5.9 5.1 1.8 0.5 34.0 0.7 6.1 0.0 0.5 2.6 4.7 1.7 1.1 1.3 7.7 2.6 1.7 1.6 34.4 4.0 1.9 11.9 3.3 0.6 1.6 1.8 1.8 8.7 10.6 4.4 7.7 6.7 4.4 10.8 1.7 10.1 9.8 26.8 51.7 49.6 35.5 11.7 0.0 2.2 20.4 17.4 30.7 1.8 0.0 15.0 0.0 31.7 0.1 31.5 27.6 0.0 28.2 3.5 13.9 27.2 107.5 47.4 22.9 0.0 22.4 54.6 31.1 0.2 0.3 21.3 13.5 40.5 32.8 0.0 35.6 22.1 0.0 1.1 0.0 38.8 27.4 0.5 1.9 13.0 20.8 20.3 15.0 38.2 ILF2 NF45 ENSG00000143621 "Interleukin enhancer binding factor 2" Q12905 1 153661788-153671048 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007484 Supported Supported Nucleoplasm No No 3800000 Nucleoplasm "HPA007484: AB_1079137" "unprognostic (1.97e-3)" "unprognostic (8.68e-2)" "unprognostic (3.44e-2)" "unprognostic (3.15e-2)" "unprognostic (8.75e-3)" "unprognostic (9.70e-2)" "prognostic unfavorable (5.71e-8)" "unprognostic (2.64e-1)" "unprognostic (4.66e-2)" "unprognostic (3.22e-3)" "unprognostic (1.94e-2)" "unprognostic (3.03e-1)" "prognostic unfavorable (5.57e-4)" "unprognostic (2.61e-1)" "unprognostic (4.17e-2)" "unprognostic (2.65e-1)" "unprognostic (2.09e-1)" 35.9 39.2 26.3 32.8 27.1 58.1 43.7 25.6 32.8 34.8 33.8 32.7 23.5 24.2 37.8 39.6 46.0 33.9 27.8 32.0 24.7 28.4 64.1 45.4 35.3 38.1 33.2 29.2 46.5 52.8 38.4 36.8 53.3 30.8 29.9 40.4 25.0 50.4 28.3 49.1 38.5 27.7 34.3 26.7 39.8 33.9 58.0 28.5 117.0 58.5 45.5 54.0 32.1 30.9 49.5 55.4 34.5 39.9 52.4 52.5 76.4 48.8 38.1 67.4 47.3 28.3 26.7 53.9 36.5 41.5 65.9 47.6 56.1 39.9 67.7 56.3 36.3 31.9 37.5 80.2 38.8 63.9 36.7 52.1 50.8 31.1 48.0 26.0 78.6 37.6 24.3 22.3 50.3 54.7 27.7 61.3 40.5 63.6 32.2 54.8 65.1 105.0 35.2 96.2 72.1 58.1 76.5 58.4 63.9 31.6 47.4 60.6 56.3 42.5 53.0 43.1 66.3 57.9 68.1 37.3 34.0 43.6 30.5 60.1 55.9 77.9 136.6 28.5 48.7 51.3 34.5 39.9 28.7 39.8 38.3 50.1 49.5 46.4 42.9 55.4 40.7 52.5 45.6 3.7 52.4 30.3 53.6 51.0 76.4 26.3 27.1 25.6 32.8 24.7 28.4 33.2 29.2 30.8 28.5 53.6 62.2 87.8 197.1 175.8 35.7 58.5 71.4 62.9 69.4 36.6 25.5 182.2 111.0 167.4 37.9 93.1 44.0 0.0 137.2 213.8 109.6 107.7 92.3 28.6 110.7 27.0 102.4 40.5 43.7 25.3 55.5 80.0 106.3 135.3 65.7 79.9 127.2 65.6 61.9 162.5 27.6 64.7 108.0 316.3 160.4 138.9 217.7 99.4 100.9 173.0 ILF3 "DRBP76, MPHOSPH4, MPP4, NF90, NFAR-1" ENSG00000129351 "Interleukin enhancer binding factor 3" Q12906 19 10654261-10692417 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001897 Supported Enhanced Nucleoplasm,Nucleoli,Mitochondria No No 1100000 "Nucleoplasm, Nucleoli, Mitochondria" "HPA001897: AB_1078703" "unprognostic (2.39e-1)" "unprognostic (9.44e-2)" "unprognostic (1.51e-1)" "unprognostic (1.25e-1)" "unprognostic (7.53e-2)" "unprognostic (5.55e-3)" "unprognostic (1.11e-3)" "unprognostic (2.96e-1)" "prognostic unfavorable (1.57e-4)" "unprognostic (3.45e-2)" "unprognostic (1.04e-1)" "unprognostic (4.38e-2)" "prognostic unfavorable (9.65e-4)" "unprognostic (7.57e-3)" "unprognostic (7.61e-2)" "unprognostic (1.03e-1)" "unprognostic (6.20e-2)" 31.0 39.0 29.6 45.5 26.8 88.2 34.5 48.3 35.2 34.2 30.2 30.8 35.2 30.3 45.4 31.7 40.5 41.9 32.5 34.0 25.5 20.0 28.1 25.6 34.1 44.9 24.7 27.8 52.8 36.8 34.9 34.9 31.8 32.3 34.9 27.3 35.5 35.1 46.2 50.1 37.7 37.2 33.2 33.3 44.5 32.6 54.3 28.0 58.6 43.4 32.4 41.1 38.5 32.1 18.7 18.7 11.5 14.3 15.4 19.4 8.0 45.7 37.3 60.4 55.2 13.1 18.0 35.2 29.3 24.9 49.2 38.6 42.7 26.6 57.2 29.1 26.3 30.1 41.0 65.2 39.6 44.4 36.5 58.0 74.2 32.9 39.8 18.8 53.4 37.1 17.0 17.7 39.0 43.8 18.8 42.0 33.4 63.3 45.0 28.6 37.7 88.5 85.8 72.5 24.2 41.0 65.2 57.5 39.5 19.6 48.6 66.7 48.5 37.7 30.0 21.8 28.6 25.4 34.3 33.7 40.4 38.4 41.8 57.7 38.6 52.8 69.4 22.6 57.1 43.5 11.5 13.4 7.1 19.4 10.4 16.1 14.7 15.9 17.3 16.8 18.7 15.7 16.0 2.1 15.4 14.3 18.7 15.0 8.0 29.6 26.8 48.3 35.2 25.5 20.0 24.7 27.8 32.3 28.0 92.3 128.4 63.8 84.3 76.5 92.4 59.0 50.9 96.4 131.9 40.1 80.5 65.6 23.2 66.6 12.8 60.9 40.0 46.7 69.0 90.4 57.8 80.9 92.6 46.1 63.0 89.0 109.3 33.7 53.5 14.4 70.8 66.0 37.1 46.9 68.0 70.5 72.3 56.1 58.7 38.2 92.6 32.3 67.0 108.6 117.8 67.2 59.3 68.2 82.6 87.0 ILK ENSG00000166333 "Integrin linked kinase" Q13418 11 6603708-6610874 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004041, HPA048437" Enhanced Supported "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA 130000000 "Plasma membrane, Focal adhesion sites" Nucleoplasm "CAB004041: AB_2127050, HPA048437: AB_2680391" "unprognostic (1.78e-1)" "unprognostic (2.26e-2)" "unprognostic (5.26e-2)" "unprognostic (2.12e-2)" "unprognostic (7.57e-2)" "unprognostic (1.01e-1)" "unprognostic (6.19e-3)" "unprognostic (5.25e-3)" "unprognostic (1.49e-2)" "unprognostic (9.65e-2)" "unprognostic (2.64e-1)" "unprognostic (8.12e-2)" "prognostic favorable (2.44e-4)" "unprognostic (4.01e-3)" "unprognostic (9.27e-2)" "unprognostic (2.42e-1)" "unprognostic (6.36e-3)" 20.9 17.6 11.0 22.3 11.9 7.5 37.0 9.4 14.6 40.2 75.1 14.7 41.9 13.5 75.4 25.2 35.7 33.2 41.1 35.1 11.1 9.2 21.6 15.1 21.9 18.9 11.5 14.0 24.2 22.3 20.4 10.9 22.2 11.5 39.9 24.6 19.3 19.4 89.9 18.5 12.4 22.2 103.5 10.6 20.2 33.2 14.2 11.0 8.2 17.5 14.1 13.6 60.8 25.9 19.5 45.9 76.5 49.4 45.3 25.8 63.7 23.9 18.5 29.2 10.1 45.2 32.1 13.3 35.3 69.8 41.8 51.0 19.3 28.3 9.0 9.4 57.7 41.0 19.3 16.3 29.9 42.0 15.7 14.8 13.0 17.7 15.0 30.3 10.4 14.9 30.8 14.1 28.2 21.6 42.9 39.8 7.8 11.9 10.7 54.5 18.0 9.2 17.8 18.4 20.4 21.8 9.6 15.3 9.6 30.6 19.2 5.1 11.5 16.7 23.1 19.4 29.8 16.1 11.9 46.0 52.5 23.7 21.7 17.1 7.8 4.8 12.7 38.9 15.7 24.4 48.3 49.4 76.5 25.8 47.9 25.1 19.5 23.3 24.4 45.9 17.1 14.7 18.5 31.7 45.3 44.4 18.5 25.7 63.7 11.0 11.9 9.4 14.6 11.1 9.2 11.5 14.0 11.5 11.0 41.7 17.0 28.3 58.4 44.9 13.9 0.3 66.2 18.7 15.9 54.1 7.9 94.6 49.7 120.2 46.5 56.1 64.4 46.7 108.6 153.9 93.0 39.7 29.0 24.9 111.6 7.9 36.5 84.1 50.9 110.9 66.2 80.3 81.0 196.6 43.0 50.2 101.4 57.5 138.6 74.7 29.6 155.2 137.9 31.1 15.7 37.8 92.0 54.3 41.7 41.9 ILKAP "DKFZP434J2031, FLJ10181, PPM1O" ENSG00000132323 "ILK associated serine/threonine phosphatase" Q9H0C8 2 238170401-238203729 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004752, HPA056099" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA004752: AB_1851753, HPA056099: AB_2797255" "unprognostic (1.50e-1)" "unprognostic (1.62e-1)" "unprognostic (1.23e-1)" "unprognostic (1.03e-1)" "unprognostic (6.78e-2)" "unprognostic (9.75e-2)" "prognostic unfavorable (1.04e-4)" "unprognostic (1.60e-1)" "unprognostic (3.07e-2)" "unprognostic (3.88e-2)" "unprognostic (1.37e-3)" "unprognostic (7.03e-2)" "prognostic unfavorable (9.89e-6)" "unprognostic (6.24e-2)" "unprognostic (6.63e-2)" "unprognostic (2.63e-2)" "unprognostic (1.20e-1)" 17.0 17.1 19.4 31.3 22.2 34.6 24.2 34.1 23.4 18.7 23.4 29.5 22.0 20.5 23.0 22.7 19.4 19.0 21.8 20.9 20.6 19.8 17.8 20.8 27.1 25.7 23.9 21.4 22.1 24.1 17.5 24.7 18.1 22.7 21.5 18.9 20.2 19.0 24.9 32.8 19.4 19.0 26.5 19.8 22.2 18.1 21.2 25.5 23.9 22.6 19.0 24.8 18.1 26.1 18.9 20.7 24.1 18.1 17.4 23.8 16.2 17.9 11.7 17.3 16.9 13.5 9.0 17.7 19.0 12.9 19.3 16.8 10.8 9.6 11.5 4.9 13.7 23.1 15.4 22.3 15.8 19.6 20.5 22.2 29.8 11.6 23.7 20.8 19.0 23.6 9.4 10.9 20.5 20.7 9.5 14.4 15.7 22.9 7.5 16.4 21.6 19.1 25.9 16.1 17.0 11.3 23.4 35.4 10.6 14.2 8.6 25.5 12.6 12.8 13.8 30.4 13.8 10.8 19.8 12.9 18.8 17.2 25.2 20.2 13.4 13.4 20.7 15.4 21.4 15.9 24.1 15.1 19.6 22.5 18.1 20.1 18.9 20.0 21.0 20.7 18.5 23.8 18.6 5.3 17.4 15.1 15.8 22.4 16.2 19.4 22.2 34.1 23.4 20.6 19.8 23.9 21.4 22.7 25.5 11.9 22.4 26.5 25.9 24.0 27.2 20.9 5.1 17.4 13.6 24.4 27.5 31.9 36.5 21.9 7.1 20.3 20.0 23.3 24.8 34.9 21.1 24.0 33.4 14.1 30.1 36.5 18.3 17.2 12.7 9.1 26.2 19.1 28.7 35.1 21.4 23.4 21.2 17.5 27.6 24.2 27.2 32.3 28.0 48.7 60.2 25.1 33.8 27.1 22.5 19.3 IMP3 "BRMS2, C15orf12, FLJ10968, MRPS4" ENSG00000177971 "IMP3, U3 small nucleolar ribonucleoprotein" Q9NV31 15 75639085-75648706 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis, rRNA processing" "Ribonucleoprotein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060955, HPA061177" Enhanced Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA060955: AB_2684397, HPA061177: AB_2684445" "unprognostic (6.01e-2)" "unprognostic (5.40e-3)" "unprognostic (7.04e-2)" "unprognostic (7.64e-3)" "unprognostic (1.61e-1)" "unprognostic (1.22e-1)" "unprognostic (8.44e-2)" "unprognostic (4.51e-2)" "unprognostic (2.69e-3)" "unprognostic (1.18e-1)" "unprognostic (1.59e-1)" "unprognostic (1.14e-1)" "unprognostic (1.25e-1)" "unprognostic (8.26e-2)" "unprognostic (1.19e-1)" "unprognostic (1.23e-1)" "unprognostic (3.22e-2)" 21.2 28.4 21.9 23.0 24.0 18.9 34.3 20.1 28.8 19.4 31.0 15.4 17.5 27.5 14.7 24.5 35.6 20.1 25.2 21.7 21.1 19.7 28.2 49.7 21.1 28.5 17.6 19.6 23.0 29.1 12.6 17.3 16.9 16.7 23.3 19.2 17.5 28.3 25.4 37.6 29.3 31.5 11.0 15.5 28.5 25.9 12.4 13.3 33.7 30.0 37.5 27.9 19.6 21.8 40.7 34.0 23.0 31.1 33.3 47.2 48.1 20.4 23.2 11.3 19.5 20.1 11.5 16.7 17.3 13.8 14.2 16.4 17.8 18.1 24.5 18.9 9.0 15.7 34.0 37.1 28.0 12.6 18.4 44.5 25.7 19.1 30.8 14.8 26.0 17.9 10.5 23.2 11.4 14.1 10.6 9.3 20.1 33.1 20.0 12.8 24.6 20.6 63.7 30.3 20.9 24.5 22.5 13.8 26.9 19.2 27.9 19.3 19.9 14.6 25.6 31.4 17.1 22.3 24.3 10.5 18.5 14.9 13.2 23.3 27.4 50.4 27.5 20.4 42.3 12.1 18.5 31.1 23.0 42.0 23.9 45.1 40.7 40.5 40.4 33.4 38.7 47.2 44.5 4.0 33.3 23.0 34.0 38.7 48.1 21.9 24.0 20.1 28.8 21.1 19.7 17.6 19.6 16.7 13.3 35.7 34.5 89.1 67.5 203.1 22.0 11.4 66.2 52.2 52.4 38.4 13.7 88.6 122.7 81.1 1.3 74.4 52.6 23.3 93.2 83.2 66.4 58.7 46.3 101.8 81.8 20.6 42.2 68.2 45.6 4.1 56.4 60.5 92.8 116.4 61.3 53.7 92.0 59.6 41.4 158.4 20.3 25.8 71.8 14.0 43.8 207.5 45.9 74.0 84.6 70.1 IMPA2 ENSG00000141401 "Inositol monophosphatase 2" O14732 18 11981025-12030883 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 90.1" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 373.0;Extravillous trophoblasts: 196.1;Proximal tubular cells: 383.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 14.4;neutrophil: 18.7" "Group enriched" "Detected in many" 14 "dendritic cells: 5.3;granulocytes: 18.7;monocytes: 6.8" "Cell line enhanced" "Detected in many" "BEWO: 60.5;OE19: 67.8;RPTEC TERT1: 29.2;SiHa: 36.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA029561 Approved Approved Nucleoplasm,Mitochondria Yes No Nucleoplasm Mitochondria "HPA029561: AB_10601932" "unprognostic (1.16e-1)" "unprognostic (1.28e-2)" "unprognostic (4.76e-3)" "unprognostic (2.50e-2)" "unprognostic (4.25e-2)" "unprognostic (3.25e-3)" "unprognostic (4.26e-3)" "unprognostic (4.08e-2)" "unprognostic (1.87e-1)" "unprognostic (1.96e-2)" "unprognostic (4.56e-2)" "unprognostic (4.24e-3)" "prognostic favorable (0.00e+0)" "unprognostic (1.95e-1)" "unprognostic (1.19e-1)" "unprognostic (2.08e-2)" "unprognostic (3.35e-2)" 6.2 2.8 1.5 5.2 1.9 6.9 10.7 0.3 1.5 6.8 12.2 0.7 1.6 5.6 7.3 3.0 40.3 4.1 17.5 20.1 1.4 0.5 41.3 21.0 6.5 4.6 2.2 0.3 3.1 90.1 1.0 5.7 35.6 1.3 17.5 7.8 3.4 9.8 2.5 55.0 30.4 9.2 40.0 1.4 4.8 13.5 1.5 2.0 3.1 8.0 31.4 10.3 22.6 14.7 0.7 5.3 18.7 6.8 0.1 0.6 1.8 6.2 9.7 2.6 4.6 3.4 2.5 60.5 1.6 4.3 0.7 1.0 7.8 5.0 1.3 3.8 2.3 5.7 4.3 3.1 1.6 0.2 7.4 3.8 0.0 12.7 6.7 2.0 10.7 0.5 5.8 8.7 2.3 1.2 2.0 0.9 7.0 1.5 0.0 2.5 6.2 4.3 5.6 9.1 67.8 7.3 7.3 7.3 6.4 29.2 3.5 3.5 0.0 36.5 8.3 3.5 3.4 7.8 13.4 0.0 1.3 2.5 17.9 1.6 5.0 13.3 3.7 5.8 7.2 2.2 3.3 6.8 14.4 0.4 4.9 0.2 0.7 0.4 0.1 5.3 0.2 0.2 0.3 18.7 0.1 3.0 3.7 0.6 1.8 1.5 1.9 0.3 1.5 1.4 0.5 2.2 0.3 1.3 2.0 17.9 25.4 6.9 15.2 93.8 0.2 10.6 45.9 9.4 9.1 21.0 0.0 35.5 373.0 57.8 2.3 5.8 44.1 0.0 96.5 196.1 13.1 33.2 2.3 62.3 36.5 0.0 16.8 8.6 39.4 4.7 4.4 16.7 13.5 4.6 70.8 21.8 73.4 51.8 3.5 383.7 0.9 103.5 9.5 0.4 11.7 123.6 88.9 4.4 78.2 45.7 IMPACT RWDD5 ENSG00000154059 "Impact RWD domain protein" Q9P2X3 18 24426616-24453535 "Predicted intracellular proteins" "Differentiation, Neurogenesis, Stress response, Translation regulation" "Actin-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 84.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 28.4" "Lineage enriched" "Detected in all" 4 "granulocytes: 28.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041045, HPA041968" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA041045: AB_10793866, HPA041968: AB_10795603" "unprognostic (1.13e-1)" "unprognostic (8.59e-2)" "unprognostic (1.15e-2)" "unprognostic (1.62e-1)" "unprognostic (5.12e-2)" "unprognostic (7.94e-2)" "unprognostic (3.29e-2)" "unprognostic (6.14e-2)" "unprognostic (2.94e-2)" "unprognostic (2.15e-1)" "unprognostic (8.20e-2)" "unprognostic (1.22e-1)" "prognostic favorable (7.90e-4)" "unprognostic (5.60e-3)" "unprognostic (9.27e-2)" "unprognostic (1.99e-3)" "unprognostic (5.60e-3)" 16.2 23.9 18.7 12.0 24.4 11.5 21.1 6.1 17.0 14.0 14.5 14.4 16.8 13.3 16.1 23.9 18.7 12.2 14.7 17.7 15.6 28.8 21.0 18.5 12.9 13.5 19.9 12.0 15.9 16.9 22.8 28.5 17.1 22.8 15.6 12.6 13.8 23.6 19.1 15.0 12.2 13.5 20.4 26.9 11.9 13.0 40.3 10.7 10.9 27.7 14.1 11.7 16.3 11.8 3.2 6.7 28.4 6.7 4.9 4.4 3.2 10.3 5.9 10.2 12.7 10.0 15.3 16.8 13.9 16.6 7.8 7.8 2.0 9.1 6.3 14.1 14.7 4.8 12.2 3.4 15.4 11.7 0.0 3.1 9.3 6.3 3.3 15.2 36.7 9.0 13.1 11.8 5.2 32.3 9.5 14.9 0.0 7.8 0.0 12.7 9.6 0.0 6.4 17.0 18.3 6.6 0.0 20.1 3.1 8.5 16.4 8.5 10.6 19.7 8.7 14.2 8.5 12.3 12.4 18.2 31.8 4.2 5.9 5.8 12.1 15.5 0.1 12.8 4.6 13.6 28.4 5.3 9.7 2.5 6.7 3.3 2.2 3.2 2.4 6.7 3.2 3.4 2.9 0.8 4.9 4.7 4.7 4.4 3.2 18.7 24.4 6.1 17.0 15.6 28.8 19.9 12.0 22.8 10.7 17.9 9.3 4.5 10.1 10.1 10.9 23.6 20.4 25.4 20.5 14.0 2.0 25.1 31.5 14.4 11.8 15.3 11.3 0.0 19.5 18.0 20.0 11.5 19.7 29.8 23.9 4.8 15.0 19.6 14.8 14.8 15.0 15.2 18.6 17.2 28.0 35.3 16.5 0.0 25.5 38.3 11.1 12.9 18.5 84.6 69.0 12.7 13.7 10.0 20.0 9.0 IMPAD1 "FLJ20421, gPAPP, IMPA3" ENSG00000104331 "Inositol monophosphatase domain containing 1" Q9NX62 8 56957933-56993844 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009411 Supported Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 560000 "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA009411: AB_1079138" "unprognostic (1.62e-2)" "unprognostic (7.89e-3)" "unprognostic (6.58e-2)" "unprognostic (6.42e-2)" "unprognostic (2.00e-1)" "unprognostic (8.59e-2)" "unprognostic (1.88e-1)" "unprognostic (1.67e-2)" "unprognostic (2.09e-1)" "unprognostic (4.53e-2)" "unprognostic (4.24e-3)" "unprognostic (1.41e-1)" "unprognostic (1.43e-2)" "unprognostic (1.68e-3)" "unprognostic (2.89e-1)" "unprognostic (1.68e-1)" "unprognostic (1.05e-1)" 30.6 33.9 17.8 13.9 23.7 9.6 17.6 23.6 33.1 24.7 17.7 30.9 17.8 11.7 23.2 15.2 17.7 15.6 18.0 25.2 19.9 21.6 21.3 32.6 16.5 10.3 23.6 21.1 16.0 25.2 30.4 20.4 23.3 27.2 28.8 16.2 25.2 28.7 22.5 41.4 13.4 12.3 23.0 21.7 13.0 14.7 19.0 19.5 12.0 24.4 18.1 13.0 17.2 14.9 1.9 2.0 6.1 4.6 6.8 2.4 0.6 17.4 14.5 11.2 11.5 34.5 23.7 15.4 26.6 25.9 19.1 16.7 7.2 12.5 10.9 20.4 28.2 13.6 14.3 13.5 17.9 28.4 15.0 9.7 21.3 10.3 12.9 21.5 13.5 15.2 19.0 18.0 17.1 27.8 17.7 25.3 10.3 9.1 19.9 20.9 9.3 16.4 8.1 8.3 20.0 5.4 11.5 10.1 12.3 19.8 10.4 4.3 12.2 14.9 18.4 15.1 12.3 16.4 9.9 21.1 25.9 14.9 25.5 19.0 20.5 17.1 11.7 35.4 11.3 15.8 2.9 1.9 1.1 2.0 1.2 1.6 1.3 1.3 1.2 1.4 1.9 1.5 2.4 6.1 6.8 4.6 2.0 0.9 0.6 17.8 23.7 23.6 33.1 19.9 21.6 23.6 21.1 27.2 19.5 20.8 18.6 9.0 24.5 48.3 29.9 43.1 25.5 8.1 12.5 45.4 15.7 15.1 5.0 17.1 13.5 27.0 19.0 0.0 23.5 68.2 45.0 43.5 9.2 61.6 24.1 38.1 33.4 38.1 25.6 4.2 23.6 23.8 15.1 5.4 33.4 25.1 24.0 17.5 33.6 16.8 27.4 32.3 38.9 34.6 22.2 52.2 28.3 14.9 16.0 33.9 INCA1 ENSG00000196388 "Inhibitor of CDK, cyclin A1 interacting protein 1" Q0VD86 17 4988130-4997610 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 41.6" "Cell type enhanced" "Detected in many" 22 "Early spermatids: 105.7;Late spermatids: 240.7;Spermatocytes: 81.7;Spermatogonia: 50.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 19.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044359, HPA052401" Uncertain Approved "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA044359: AB_10794289, HPA052401: AB_2681816" "unprognostic (1.78e-2)" "unprognostic (9.38e-2)" "unprognostic (4.08e-2)" "unprognostic (9.81e-2)" "unprognostic (1.22e-2)" "unprognostic (1.02e-2)" "unprognostic (9.54e-3)" "unprognostic (7.88e-2)" "unprognostic (2.68e-1)" "unprognostic (2.66e-2)" "prognostic favorable (3.61e-5)" "unprognostic (3.14e-2)" "unprognostic (1.68e-1)" "unprognostic (9.54e-2)" "unprognostic (2.04e-1)" "unprognostic (1.17e-1)" "unprognostic (1.05e-1)" 1.7 2.2 5.5 3.5 6.3 0.5 2.5 10.1 7.2 2.3 2.2 3.1 1.0 7.0 3.3 1.6 3.1 2.0 4.5 3.9 4.9 2.1 2.3 2.6 2.7 5.0 5.1 3.0 5.5 2.2 0.9 4.4 1.6 5.9 2.7 0.3 1.7 3.6 1.5 6.1 5.0 4.9 1.2 4.1 4.3 3.1 41.6 3.6 0.5 5.2 1.3 0.4 2.8 9.4 1.5 1.3 0.7 4.4 0.3 2.4 0.6 4.0 4.6 3.3 3.0 2.2 0.9 3.9 4.4 0.4 1.2 1.2 3.2 4.8 19.1 2.9 1.2 3.8 11.4 0.5 0.2 0.7 8.0 4.8 4.1 5.5 2.1 1.5 0.6 10.2 1.2 0.0 0.7 0.4 7.1 0.4 6.8 5.1 9.0 0.8 2.1 5.8 1.3 1.4 1.8 1.2 7.1 1.7 1.7 0.8 1.3 9.7 2.9 2.1 2.8 2.6 3.6 5.7 0.9 8.8 4.1 1.6 3.9 3.3 1.5 0.8 0.9 4.0 10.2 2.1 0.5 2.4 0.0 0.8 4.4 2.0 1.5 1.2 1.7 0.9 1.0 2.4 1.9 0.7 0.3 3.4 1.3 0.7 0.6 5.5 6.3 10.1 7.2 4.9 2.1 5.1 3.0 5.9 3.6 0.0 0.6 0.5 1.2 1.0 0.4 0.5 2.5 1.4 1.2 3.5 2.0 0.5 0.0 0.6 105.7 0.6 6.8 0.0 1.4 0.6 1.4 0.5 4.6 1.3 1.2 0.0 0.0 0.6 0.0 240.7 6.6 1.2 1.7 1.0 1.6 4.6 1.1 7.0 1.1 1.7 0.8 6.5 1.2 81.7 50.4 0.6 0.7 0.0 1.8 0.9 INCENP FLJ31633 ENSG00000149503 "Inner centromere protein" Q9NQS7 11 62123973-62153163 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 36.1" "Cell type enhanced" "Detected in many" 4 "monocytes: 8.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 2.9;NK-cell: 4.0" "Group enriched" "Detected in many" 6 "granulocytes: 2.9;NK-cells: 4.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013292, HPA051339, HPA070550" Enhanced Supported "Nucleoplasm,Nuclear bodies,Kinetochore,Midbody" Yes Yes "Nuclear bodies, Kinetochore" "Nucleoplasm, Midbody" "CAB013292: AB_2533405, HPA051339: AB_2732566, HPA070550: AB_2686279" "unprognostic (6.31e-2)" "unprognostic (7.29e-2)" "unprognostic (1.65e-3)" "unprognostic (7.35e-2)" "unprognostic (3.18e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (1.25e-4)" "prognostic unfavorable (8.58e-4)" "unprognostic (1.63e-2)" "unprognostic (4.37e-2)" "prognostic unfavorable (5.76e-5)" "unprognostic (1.74e-2)" "unprognostic (1.08e-3)" "unprognostic (1.17e-3)" "unprognostic (1.22e-1)" "unprognostic (1.36e-1)" "unprognostic (2.78e-3)" 5.1 5.0 6.9 9.2 8.2 23.8 7.7 19.3 13.6 6.9 6.5 5.7 2.8 9.5 5.7 11.7 22.2 5.3 4.7 4.1 5.9 5.0 3.9 3.8 5.0 14.1 6.9 7.9 5.3 5.4 6.0 3.1 5.7 6.9 4.2 5.3 4.9 10.6 4.6 6.7 9.8 7.5 4.9 5.1 7.5 6.4 12.3 6.4 36.1 8.5 8.5 13.2 5.9 8.6 0.2 0.0 2.9 0.3 4.0 0.5 0.0 27.0 25.9 19.7 16.8 2.6 3.2 10.5 17.0 7.4 15.9 10.2 13.6 18.4 25.1 14.1 5.8 17.6 26.6 19.5 10.3 12.5 22.3 13.5 16.4 25.5 11.1 1.0 18.8 23.4 1.6 2.3 15.3 8.9 2.6 9.5 18.3 17.3 21.0 8.7 22.0 30.3 15.4 21.2 10.5 12.7 28.4 24.8 18.9 4.5 13.6 15.0 16.3 17.1 11.1 10.5 8.2 17.4 6.8 10.6 15.7 20.1 22.4 18.1 11.2 17.2 28.2 8.7 12.4 18.8 2.9 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.5 0.2 4.0 0.1 0.0 0.0 0.0 6.9 8.2 19.3 13.6 5.9 5.0 6.9 7.9 6.9 6.4 3.0 2.9 2.2 0.8 4.9 1.9 0.9 0.0 4.0 5.7 0.0 0.0 1.6 0.0 1.7 0.8 0.8 1.3 0.0 2.1 6.0 0.8 1.0 3.5 0.9 3.5 0.0 0.0 0.0 0.8 0.2 2.6 2.5 3.3 8.2 2.0 2.3 1.7 1.5 1.4 0.3 2.2 0.0 0.4 6.9 5.8 2.9 1.8 2.5 1.7 1.0 ING1 "p24ING1c, p33, p33ING1, p33ING1b, p47, p47ING1a" ENSG00000153487 "Inhibitor of growth family member 1" Q9UK53 13 110712736-110723339 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 141.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016136, CAB017773, HPA052591" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB016136: AB_628077, CAB017773: , HPA052591: AB_2681876" "unprognostic (1.14e-2)" "unprognostic (3.25e-2)" "unprognostic (3.51e-2)" "prognostic favorable (5.81e-4)" "unprognostic (4.62e-2)" "unprognostic (3.47e-2)" "unprognostic (3.36e-1)" "unprognostic (1.87e-1)" "unprognostic (9.43e-2)" "unprognostic (2.27e-1)" "unprognostic (1.81e-1)" "unprognostic (1.22e-1)" "unprognostic (1.36e-3)" "unprognostic (1.35e-1)" "unprognostic (7.05e-3)" "unprognostic (6.78e-2)" "unprognostic (2.40e-3)" 11.8 11.1 8.9 11.7 10.2 24.9 19.8 12.8 12.1 15.7 14.9 6.9 9.5 13.9 16.3 8.3 10.7 13.7 20.0 9.5 9.4 9.0 9.3 16.7 14.1 20.5 11.6 8.0 25.8 11.8 3.8 9.5 13.3 11.7 13.3 6.6 9.5 13.6 10.9 12.2 8.5 13.6 11.1 10.2 17.6 10.0 26.0 12.0 22.0 11.5 8.3 10.6 18.3 14.8 15.5 3.0 21.4 3.7 12.3 11.6 6.1 17.6 7.0 12.7 12.1 6.0 4.1 12.7 9.1 7.7 5.9 7.2 13.3 12.6 11.4 14.9 3.6 9.2 11.2 5.1 4.5 5.0 21.3 9.7 10.0 9.7 9.9 3.4 13.2 9.7 3.7 4.7 5.1 3.1 4.7 4.1 12.4 9.3 9.6 3.8 10.1 22.8 15.3 12.4 11.0 5.9 16.6 6.4 6.4 5.1 9.1 12.5 13.5 9.0 18.1 12.5 4.6 6.1 15.7 6.2 7.3 9.0 7.6 10.2 11.6 11.7 14.5 12.2 10.9 11.9 21.4 2.9 11.1 10.8 3.6 11.1 14.8 9.1 9.7 2.8 15.5 9.4 7.8 4.0 12.3 3.7 3.0 11.6 6.1 8.9 10.2 12.8 12.1 9.4 9.0 11.6 8.0 11.7 12.0 8.9 22.6 17.6 10.5 32.3 15.2 21.4 10.2 21.4 6.8 7.0 13.7 11.0 6.6 9.1 141.8 18.0 28.4 0.0 6.0 70.2 33.8 19.5 2.3 22.9 14.7 3.2 12.0 9.8 17.1 32.8 8.6 12.7 16.9 6.4 20.1 14.5 6.8 19.3 13.8 11.1 20.2 12.9 25.0 17.0 16.6 38.1 12.8 13.1 18.4 17.1 ING2 "ING1L, p33ING2" ENSG00000168556 "Inhibitor of growth family member 2" Q9H160 4 183504994-183511096 "Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019486, HPA021517" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA019486: AB_1851780, HPA021517: AB_10601914" "prognostic favorable (5.43e-4)" "unprognostic (1.04e-1)" "unprognostic (2.81e-1)" "unprognostic (3.74e-2)" "unprognostic (3.89e-3)" "unprognostic (4.56e-2)" "prognostic unfavorable (8.87e-4)" "unprognostic (7.47e-3)" "unprognostic (2.27e-1)" "unprognostic (1.09e-3)" "unprognostic (1.65e-2)" "unprognostic (1.97e-1)" "unprognostic (2.30e-3)" "unprognostic (6.19e-2)" "unprognostic (4.43e-1)" "unprognostic (5.52e-2)" "unprognostic (7.82e-2)" 6.1 28.5 7.8 4.4 12.2 20.0 7.6 8.3 10.3 6.2 13.0 6.0 5.9 10.1 4.2 11.6 15.7 8.0 8.1 5.0 8.0 8.9 10.4 9.4 6.1 6.0 9.9 6.0 34.4 17.3 6.3 18.8 11.5 9.5 6.0 6.3 6.5 6.8 6.7 16.2 7.4 23.1 6.8 11.0 7.2 7.5 16.9 7.2 11.5 9.1 10.9 6.8 10.3 9.4 11.4 7.4 21.8 7.9 3.5 10.7 3.9 14.8 7.8 12.8 10.4 20.3 13.3 11.1 16.6 14.1 13.0 11.9 7.6 15.0 11.5 3.7 12.1 9.5 6.3 7.6 14.1 18.7 8.0 6.9 17.0 9.1 9.1 5.9 13.2 19.3 10.1 11.3 13.6 5.3 9.5 6.7 9.6 10.4 40.8 10.4 14.5 18.4 15.8 9.2 4.8 10.5 8.6 6.4 17.8 15.0 7.3 12.1 8.3 9.7 13.6 4.0 8.3 6.4 9.9 4.6 8.7 14.8 6.8 9.6 8.7 5.7 7.2 16.9 12.0 6.1 13.1 6.2 21.8 3.6 6.3 5.5 11.4 7.6 6.5 7.4 8.1 10.7 9.0 7.4 3.5 7.9 7.0 5.6 3.9 7.8 12.2 8.3 10.3 8.0 8.9 9.9 6.0 9.5 7.2 6.0 16.0 25.2 16.6 43.8 23.5 7.6 25.5 54.9 15.9 15.7 11.8 20.8 63.0 17.7 41.4 15.0 33.7 46.7 30.8 78.8 23.6 23.6 39.3 19.2 26.7 23.8 17.9 10.4 16.1 27.5 76.5 29.3 25.3 8.2 19.6 27.5 27.8 28.1 50.5 28.3 21.0 19.4 21.1 80.2 75.2 40.4 17.7 18.3 20.5 27.7 ING3 "Eaf4, FLJ20089, MEAF4, p47ING3" ENSG00000071243 "Inhibitor of growth family member 3" Q9NXR8 7 120950749-120977216 "Disease related genes, Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 57.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004762, HPA067388, HPA067575" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA004762: , HPA067388: AB_2685831, HPA067575: AB_2685863" "unprognostic (1.35e-1)" "unprognostic (6.34e-2)" "unprognostic (1.36e-1)" "unprognostic (1.78e-1)" "unprognostic (3.03e-1)" "unprognostic (1.39e-2)" "unprognostic (4.26e-2)" "unprognostic (7.09e-3)" "unprognostic (4.07e-2)" "unprognostic (5.18e-2)" "unprognostic (8.04e-3)" "unprognostic (2.86e-1)" "unprognostic (6.90e-2)" "unprognostic (3.96e-2)" "unprognostic (1.52e-1)" "unprognostic (1.72e-1)" "unprognostic (5.64e-2)" 9.6 9.1 7.4 8.8 9.9 57.7 9.6 21.5 13.8 9.0 9.6 5.5 11.1 7.3 11.1 9.7 8.0 9.7 7.7 7.6 7.3 7.3 8.8 8.4 12.3 11.9 7.6 12.2 11.9 12.1 7.9 17.7 13.0 11.1 9.5 10.6 6.7 10.0 11.5 7.7 6.1 12.9 11.4 8.8 16.4 10.4 8.6 9.6 19.0 12.6 10.4 11.2 8.3 8.4 15.8 15.0 32.7 19.5 18.5 16.9 9.8 9.3 2.8 12.7 7.1 4.8 3.8 4.3 6.4 5.1 9.3 10.9 3.6 10.9 15.2 2.9 5.6 9.8 4.6 12.2 5.0 10.7 10.6 21.4 11.0 10.6 2.1 6.6 21.2 13.1 2.8 2.6 8.2 5.8 4.5 14.5 9.6 24.6 24.7 8.9 3.2 17.4 12.7 15.3 5.3 5.2 8.6 9.1 12.6 9.4 9.7 11.5 12.5 6.6 13.7 6.9 8.2 3.1 8.3 5.1 9.5 3.5 20.4 11.6 11.3 7.2 22.9 4.8 14.3 7.9 22.3 19.1 16.5 13.9 19.5 13.4 14.4 14.1 12.6 15.0 15.8 14.4 13.1 32.7 18.5 19.1 11.2 16.9 9.8 7.4 9.9 21.5 13.8 7.3 7.3 7.6 12.2 11.1 9.6 17.9 13.6 22.2 20.2 6.8 20.4 12.6 7.6 13.4 7.9 7.0 3.9 33.3 18.3 10.3 4.0 18.5 17.3 23.3 15.7 21.2 19.3 14.2 33.4 11.1 15.3 25.4 11.5 19.6 26.6 3.9 12.7 19.0 15.1 15.4 14.0 17.3 12.9 14.8 9.2 9.7 17.2 19.4 22.6 15.0 13.9 9.8 38.2 21.8 12.4 13.9 ING4 "my036, p29ING4" ENSG00000111653 "Inhibitor of growth family member 4" Q9UNL4 12 6650280-6663148 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Chromatin regulator" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031817, HPA057338" Approved Supported Nucleoplasm Yes No Nucleoplasm "HPA031817: AB_2674056, HPA057338: AB_2683412" "unprognostic (2.95e-1)" "unprognostic (1.92e-2)" "unprognostic (1.40e-1)" "unprognostic (2.71e-3)" "unprognostic (9.44e-2)" "unprognostic (5.76e-3)" "unprognostic (1.65e-2)" "prognostic favorable (5.16e-4)" "unprognostic (3.67e-2)" "unprognostic (1.80e-1)" "unprognostic (7.66e-3)" "unprognostic (1.52e-1)" "unprognostic (4.32e-2)" "unprognostic (1.31e-1)" "unprognostic (9.88e-2)" "unprognostic (2.17e-1)" "unprognostic (1.42e-2)" 15.0 17.7 30.7 13.0 27.6 9.3 25.9 36.7 34.3 20.0 20.2 22.3 18.9 16.2 23.8 29.5 17.1 25.5 16.3 18.9 27.9 21.0 19.0 20.7 16.6 22.2 30.2 24.8 26.7 17.9 21.1 18.7 19.5 29.9 21.1 20.3 15.5 20.2 22.5 15.6 26.2 16.9 21.4 25.0 24.9 17.6 13.3 29.0 29.5 24.2 10.2 21.3 20.0 18.3 29.4 23.9 19.4 33.1 25.1 29.1 25.2 4.3 5.9 17.6 8.3 13.7 13.7 11.3 5.8 9.4 9.7 11.7 2.6 19.9 7.6 3.8 8.1 7.7 6.9 8.6 6.8 10.8 14.6 12.7 10.8 10.8 5.4 8.0 4.2 5.1 13.7 15.8 5.1 6.6 31.5 14.5 14.8 5.0 4.3 9.2 3.1 15.4 6.5 25.9 9.6 5.7 14.6 9.2 7.9 12.0 5.0 7.3 19.0 9.0 3.0 10.7 26.6 4.0 11.8 10.9 4.0 8.1 4.5 3.7 5.3 7.2 10.0 10.7 6.6 4.0 19.4 22.0 17.7 25.0 29.3 22.7 21.9 20.8 21.0 23.9 29.4 29.1 24.8 14.1 25.1 33.1 18.5 20.7 25.2 30.7 27.6 36.7 34.3 27.9 21.0 30.2 24.8 29.9 29.0 20.8 14.7 22.9 10.7 7.2 29.6 9.0 10.2 14.7 18.2 17.4 17.7 33.6 24.9 19.0 1.7 21.5 11.8 0.0 7.1 11.0 15.1 13.3 27.6 6.0 21.9 33.4 24.2 18.4 14.5 4.2 31.9 20.8 10.1 36.1 19.7 32.7 10.9 18.6 35.3 17.9 26.3 32.3 19.8 20.0 16.4 8.8 25.6 32.4 17.1 7.0 INIP "C9orf80, HSPC043, hSSBIP1, MISE, SOSS-C" ENSG00000148153 "INTS3 and NABP interacting protein" Q9NRY2 9 112683926-112718236 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020382 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA020382: AB_1845840" "prognostic unfavorable (7.08e-4)" "unprognostic (1.67e-1)" "unprognostic (9.64e-2)" "unprognostic (2.35e-1)" "unprognostic (8.05e-2)" "unprognostic (8.56e-2)" "unprognostic (1.01e-2)" "unprognostic (6.29e-2)" "unprognostic (1.08e-1)" "unprognostic (1.47e-1)" "unprognostic (1.11e-2)" "unprognostic (4.47e-3)" "prognostic favorable (2.00e-8)" "prognostic favorable (2.53e-4)" "unprognostic (2.28e-1)" "unprognostic (3.50e-2)" "unprognostic (1.26e-1)" 9.0 11.3 16.1 9.8 17.3 11.4 14.7 18.7 22.9 10.9 12.4 21.0 4.4 12.8 9.6 11.2 12.6 10.4 11.0 9.3 16.8 15.6 15.1 13.7 10.5 16.6 18.6 14.4 11.0 8.1 11.1 18.4 7.5 20.6 8.9 14.8 7.8 10.2 8.6 7.6 11.4 13.4 9.7 19.3 12.5 8.7 8.2 18.2 17.3 13.6 6.1 17.1 12.6 9.2 15.0 21.2 25.1 23.0 13.1 19.5 14.8 8.5 8.4 11.6 16.6 10.1 10.8 11.9 12.1 6.7 10.7 10.7 10.0 7.0 23.0 7.6 8.3 7.7 12.2 11.4 5.3 14.3 27.3 6.7 9.5 10.0 9.4 6.5 19.2 7.2 5.3 8.0 11.2 9.2 5.2 9.9 11.7 16.3 15.0 11.6 13.9 17.0 9.9 6.0 15.5 15.6 19.1 24.7 9.9 12.1 11.7 15.2 11.4 15.2 9.8 7.8 8.1 14.6 12.0 8.1 8.6 13.5 16.7 11.6 7.5 31.3 19.4 11.0 11.2 14.4 17.7 19.7 25.1 13.4 23.0 17.5 12.5 17.2 19.5 21.2 15.0 19.0 16.3 16.0 13.1 19.8 7.5 15.8 14.8 16.1 17.3 18.7 22.9 16.8 15.6 18.6 14.4 20.6 18.2 20.8 17.0 13.2 16.0 32.5 16.5 12.9 22.9 8.1 18.2 14.0 15.7 18.3 48.0 20.2 1.5 17.9 14.2 0.0 14.2 26.5 13.3 15.6 25.5 15.3 22.8 41.3 21.5 13.5 17.4 1.5 13.0 29.0 18.6 36.9 17.3 19.3 18.3 8.6 11.3 21.9 15.7 0.0 14.1 12.9 18.3 36.5 12.4 21.8 18.0 24.0 INO80 "hINO80, Ino80, INO80A, INOC1, KIAA1259" ENSG00000128908 "INO80 complex subunit" Q9ULG1 15 40978880-41116354 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis" "Actin-binding, DNA-binding, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041484, HPA048601" Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA041484: AB_2677506, HPA048601: " "unprognostic (5.39e-3)" "unprognostic (2.25e-1)" "unprognostic (2.73e-1)" "unprognostic (1.02e-1)" "unprognostic (1.51e-1)" "unprognostic (3.92e-2)" "unprognostic (4.24e-2)" "unprognostic (1.84e-1)" "unprognostic (1.93e-1)" "unprognostic (6.30e-2)" "unprognostic (1.18e-1)" "unprognostic (6.69e-2)" "prognostic favorable (6.30e-4)" "unprognostic (1.77e-1)" "unprognostic (1.76e-1)" "unprognostic (7.72e-2)" "unprognostic (1.47e-2)" 14.0 10.6 11.8 13.9 13.4 20.7 13.9 29.5 13.0 12.3 13.2 17.4 11.5 11.3 14.9 13.4 15.1 12.6 12.4 10.6 12.8 7.8 12.1 12.9 14.8 13.4 10.2 10.3 15.4 17.8 18.8 13.3 16.4 12.1 12.5 13.9 13.8 11.9 15.7 23.0 16.4 13.2 13.3 9.5 14.5 12.3 13.9 11.6 18.1 13.3 12.6 15.8 13.9 13.3 5.2 2.3 0.9 2.7 5.7 3.4 1.5 9.2 9.2 8.0 7.8 12.6 10.6 9.3 8.6 14.1 13.1 11.4 11.2 7.8 9.9 7.0 13.1 16.3 18.2 14.7 15.0 13.9 11.4 7.5 12.3 12.7 8.4 12.1 12.1 12.1 10.5 13.9 10.5 27.9 8.7 12.5 10.8 13.7 8.5 8.7 7.7 8.8 8.0 8.4 15.8 10.1 13.6 8.5 7.9 9.9 19.4 10.6 7.3 6.3 13.9 5.8 8.3 7.8 14.7 14.3 10.4 9.5 13.2 13.8 9.4 6.4 16.2 12.2 18.0 8.6 0.9 2.7 0.6 2.7 1.7 3.3 3.2 3.4 3.0 2.3 5.2 3.4 3.2 0.9 5.7 1.2 1.8 2.6 1.5 11.8 13.4 29.5 13.0 12.8 7.8 10.2 10.3 12.1 11.6 8.9 25.5 24.6 15.0 7.6 28.4 14.9 12.7 24.1 23.9 15.7 21.6 11.1 6.6 14.7 1.7 13.7 9.7 0.0 11.5 9.4 10.4 13.3 15.1 8.7 8.7 25.4 12.6 11.6 14.9 1.2 13.6 9.5 6.8 18.0 9.2 11.8 12.4 11.0 14.9 9.4 28.8 6.5 11.3 18.4 22.0 11.2 16.0 12.1 11.9 12.8 INO80B "hIes2, HMGA1L4, HMGIYL4, IES2, PAP-1BP, PAPA-1, ZNHIT4" ENSG00000115274 "INO80 complex subunit B" Q9C086 2 74455023-74457960 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Suprabasal keratinocytes: 27.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA070644 Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA070644: AB_2732159" "prognostic favorable (2.89e-4)" "unprognostic (2.24e-2)" "unprognostic (5.62e-2)" "unprognostic (6.59e-3)" "unprognostic (9.45e-2)" "unprognostic (3.82e-2)" "unprognostic (2.20e-3)" "unprognostic (1.21e-2)" "unprognostic (1.16e-1)" "unprognostic (1.54e-2)" "unprognostic (7.52e-3)" "unprognostic (2.18e-1)" "prognostic unfavorable (1.56e-5)" "prognostic favorable (8.44e-4)" "unprognostic (1.51e-1)" "unprognostic (3.21e-1)" "unprognostic (1.18e-3)" 18.7 22.4 31.0 20.5 33.4 21.4 22.6 31.3 48.6 23.3 16.2 15.6 24.8 24.0 28.5 23.4 22.6 26.8 21.5 19.7 39.3 20.0 20.3 22.5 18.7 22.5 19.6 32.6 39.8 31.8 36.6 32.3 14.0 38.2 25.6 16.7 15.5 32.1 37.6 28.1 39.7 18.0 20.0 49.6 19.3 22.1 28.3 25.0 21.3 30.0 15.9 24.7 20.6 23.8 4.9 6.5 6.8 5.4 4.4 3.8 1.3 12.8 14.3 3.9 5.7 8.2 13.3 11.9 12.2 9.8 8.4 7.4 9.2 14.2 22.1 15.0 8.0 8.0 13.6 3.7 8.3 8.0 20.8 14.2 16.6 6.7 8.9 8.4 16.1 7.4 12.0 14.7 12.0 14.7 22.8 10.9 11.5 9.3 7.2 7.2 15.4 18.3 21.3 2.8 8.0 19.7 10.7 15.8 20.1 10.2 9.0 7.3 15.3 6.3 16.2 5.4 5.3 5.4 5.1 9.7 6.9 12.5 14.0 8.7 28.5 22.1 8.0 15.3 9.6 7.0 3.9 5.4 2.0 2.7 3.7 3.2 4.8 2.9 1.5 3.1 4.9 2.7 2.3 6.8 4.4 2.8 6.5 3.8 1.3 31.0 33.4 31.3 48.6 39.3 20.0 19.6 32.6 38.2 25.0 0.0 2.1 4.8 2.3 24.8 13.2 0.8 2.5 9.4 4.5 3.5 11.8 3.7 0.0 13.2 1.7 3.1 6.9 0.0 23.3 3.6 3.3 1.2 5.7 8.9 4.9 12.7 4.6 4.3 7.8 5.1 2.8 5.6 5.0 16.2 7.5 4.9 15.7 3.5 2.8 6.8 15.3 0.0 8.0 4.9 2.3 27.7 4.5 6.4 5.5 1.4 INO80E "CCDC95, FLJ90652" ENSG00000169592 "INO80 complex subunit E" Q8NBZ0 16 29995294-30005793 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043146 Approved Supported "Nucleoplasm,Nucleoli rim" NA NA Nucleoplasm "Nucleoli rim" "HPA043146: AB_10794923" "unprognostic (5.61e-2)" "unprognostic (3.50e-2)" "unprognostic (3.46e-2)" "unprognostic (2.75e-2)" "unprognostic (3.38e-1)" "unprognostic (5.73e-2)" "unprognostic (7.14e-2)" "unprognostic (1.90e-2)" "unprognostic (1.31e-1)" "unprognostic (2.56e-1)" "unprognostic (1.13e-2)" "unprognostic (3.41e-2)" "unprognostic (2.02e-2)" "unprognostic (4.74e-3)" "unprognostic (5.21e-2)" "unprognostic (2.55e-1)" "unprognostic (3.98e-3)" 26.7 30.0 31.2 37.1 31.6 27.5 29.1 28.8 37.9 32.9 35.4 35.1 37.7 18.0 33.8 34.0 31.7 43.8 29.2 25.0 30.1 26.1 30.1 31.0 28.5 30.2 30.7 30.0 39.7 29.2 44.7 29.8 24.8 27.8 32.2 39.5 26.3 33.9 39.3 28.1 28.3 38.9 43.0 33.8 30.6 28.6 28.3 28.0 39.1 35.9 24.6 46.9 34.1 28.3 4.5 4.8 4.2 5.4 2.6 4.8 15.3 23.0 27.6 18.3 27.5 17.3 15.2 17.2 20.7 23.9 31.3 30.6 16.2 26.3 31.2 32.0 23.4 19.5 15.2 23.3 34.9 26.9 32.0 21.7 15.1 17.6 22.3 20.4 20.0 17.3 17.3 29.2 35.5 29.1 18.1 37.6 41.3 19.2 16.5 29.1 33.8 41.9 24.0 37.6 16.2 13.6 55.5 22.5 29.9 22.6 12.0 28.8 35.4 11.3 19.3 25.3 16.7 25.0 16.7 19.9 20.8 15.2 18.6 25.6 15.9 35.3 28.7 23.3 29.0 29.6 0.7 4.7 4.2 3.9 3.2 3.4 4.5 2.9 4.8 4.8 2.9 2.5 3.0 2.7 2.6 5.4 4.0 4.3 15.3 31.2 31.6 28.8 37.9 30.1 26.1 30.7 30.0 27.8 28.0 35.7 18.7 19.5 16.5 13.2 13.7 0.8 17.8 10.7 21.6 19.2 19.6 31.2 28.2 25.8 1.7 21.5 30.4 0.0 34.0 32.5 19.0 13.1 15.1 14.1 24.5 7.9 33.8 18.4 23.1 4.2 24.2 23.2 18.6 23.4 24.9 18.4 29.2 28.1 26.2 22.3 19.3 25.8 24.0 36.7 21.8 15.1 15.1 29.3 29.5 13.7 INPP4A INPP4 ENSG00000040933 "Inositol polyphosphate-4-phosphatase type I A" Q96PE3 2 98444854-98594390 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 46.8;Kupffer cells: 37.8;T-cells: 39.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Karpas-707: 34.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001628 Approved Supported "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA001628: AB_10961254" "unprognostic (3.45e-1)" "unprognostic (2.39e-2)" "unprognostic (1.74e-2)" "prognostic unfavorable (3.70e-6)" "unprognostic (1.58e-1)" "unprognostic (3.10e-2)" "unprognostic (1.15e-3)" "unprognostic (9.44e-2)" "unprognostic (1.37e-2)" "unprognostic (1.23e-1)" "unprognostic (9.65e-2)" "unprognostic (3.70e-2)" "unprognostic (2.90e-2)" "unprognostic (4.89e-2)" "unprognostic (1.20e-1)" "unprognostic (1.08e-2)" "unprognostic (1.97e-2)" 9.0 15.0 11.4 13.5 23.1 12.3 7.0 24.0 28.4 7.5 8.5 8.3 3.8 7.7 8.2 5.7 8.4 6.7 11.0 10.8 12.9 7.8 8.1 7.2 13.5 17.0 6.1 19.8 8.3 8.2 12.7 7.0 8.6 17.9 6.8 8.6 16.1 9.3 7.2 13.6 7.3 12.1 10.5 10.4 24.0 8.4 6.4 6.8 17.6 8.4 2.7 13.4 16.8 6.9 0.8 5.9 3.8 5.1 5.8 6.4 1.8 6.4 5.4 10.0 8.0 5.7 6.5 10.0 5.6 5.0 6.0 6.2 6.9 5.7 4.1 6.4 8.2 7.3 6.0 7.1 5.5 4.9 13.7 6.1 4.8 4.9 3.2 5.1 9.1 17.8 5.8 5.2 5.7 5.1 5.1 8.4 23.3 4.4 34.2 4.4 7.8 13.8 8.1 9.4 3.6 5.3 6.0 7.0 26.7 2.9 19.8 6.6 8.6 6.4 5.2 5.1 10.7 2.4 7.3 7.9 7.0 8.9 5.5 3.8 24.3 14.1 2.8 5.7 8.7 6.0 2.0 1.8 3.8 5.5 3.9 6.4 0.8 3.1 3.7 1.9 0.2 4.3 4.9 2.0 5.8 5.1 5.9 1.6 1.8 11.4 23.1 24.0 28.4 12.9 7.8 6.1 19.8 17.9 6.8 6.0 9.6 10.0 4.7 7.1 46.8 10.5 2.5 0.0 10.3 5.2 7.9 7.2 3.3 3.9 12.8 10.1 1.7 0.0 1.3 6.6 7.2 4.6 0.0 3.2 9.0 31.8 5.2 14.7 37.8 5.4 8.6 17.7 10.1 4.6 5.4 9.2 3.8 3.4 11.3 2.2 13.8 6.5 9.0 9.7 11.2 5.4 7.9 39.8 3.5 5.4 INPP5E "CORS1, JBTS1, pharbin, PPI5PIV" ENSG00000148384 "Inositol polyphosphate-5-phosphatase E" Q9NRR6 9 136428619-136439823 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism" Hydrolase "Ciliopathy, Disease mutation, Joubert syndrome, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065758 Approved Supported "Nucleoplasm,Golgi apparatus,Focal adhesion sites" NA NA "Golgi apparatus, Focal adhesion sites" Nucleoplasm "HPA065758: AB_2685554" "unprognostic (1.99e-1)" "unprognostic (8.68e-2)" "unprognostic (1.87e-2)" "unprognostic (1.23e-2)" "unprognostic (4.00e-1)" "unprognostic (6.92e-2)" "unprognostic (9.60e-3)" "unprognostic (3.21e-1)" "unprognostic (5.81e-2)" "unprognostic (2.65e-2)" "prognostic favorable (1.82e-4)" "unprognostic (2.03e-1)" "unprognostic (3.04e-2)" "unprognostic (3.76e-1)" "unprognostic (5.48e-2)" "unprognostic (4.64e-1)" "unprognostic (2.66e-2)" 14.3 11.2 14.9 15.3 10.4 8.9 19.2 19.9 19.1 10.5 10.7 11.5 11.1 10.3 13.1 10.1 8.4 17.2 9.4 11.9 12.6 12.0 10.2 9.0 10.1 13.5 8.4 12.3 14.7 11.6 11.4 12.3 9.8 13.2 9.9 5.2 11.0 14.4 12.9 11.6 18.2 10.7 10.7 6.6 19.4 8.6 15.2 10.3 8.5 12.5 6.2 10.7 8.8 19.3 2.6 1.0 1.9 0.5 0.0 2.4 0.6 6.2 7.2 8.5 8.4 4.3 5.6 10.5 7.5 4.4 5.8 3.7 7.4 4.4 7.8 7.7 6.3 8.3 17.5 3.7 5.1 2.2 24.3 14.7 5.2 12.4 4.9 7.3 6.1 8.5 6.0 4.8 6.4 5.7 6.9 5.6 10.0 8.8 7.2 4.9 10.3 7.8 13.4 5.5 3.9 12.0 14.3 6.5 5.8 5.2 6.1 8.9 8.0 7.2 6.8 5.2 6.1 10.9 9.1 8.0 17.9 6.7 7.2 13.0 7.8 6.3 3.3 9.2 5.4 6.5 0.0 0.5 1.9 2.0 0.0 1.3 2.6 2.3 1.5 0.5 1.7 0.8 1.6 0.4 0.0 0.3 1.0 2.4 0.6 14.9 10.4 19.9 19.1 12.6 12.0 8.4 12.3 13.2 10.3 3.0 5.8 2.9 1.5 4.8 7.1 4.1 7.6 6.7 3.4 3.5 2.0 2.0 1.7 4.5 0.3 5.8 2.8 0.0 4.8 2.0 3.9 2.0 9.2 3.0 2.6 14.3 5.8 2.5 3.8 0.7 6.9 3.5 5.0 4.6 2.9 8.5 5.3 0.0 5.3 2.2 11.4 0.0 4.8 9.8 7.8 4.3 0.7 4.3 4.3 1.6 INSM2 "IA-6, Mlt1" ENSG00000168348 "INSM transcriptional repressor 2" Q96T92 14 35534042-35537054 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 2.3;brain: 5.2;salivary gland: 1.6;testis: 2.9" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 2.0;Rod photoreceptor cells: 6.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 134 "SH-SY5Y: 50.5" "Region enhanced" "Detected in single" "hypothalamus: 1.3" "Low region specificity" "Detected in some" "HPA044885, HPA051925" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA044885: AB_10794779, HPA051925: AB_2681664" "unprognostic (9.88e-2)" "unprognostic (8.74e-2)" "unprognostic (2.35e-1)" "unprognostic (1.08e-3)" "unprognostic (3.29e-3)" "unprognostic (1.72e-1)" "unprognostic (2.51e-1)" "unprognostic (2.26e-3)" "unprognostic (2.60e-3)" "unprognostic (7.51e-2)" "unprognostic (1.75e-2)" "unprognostic (2.36e-3)" "unprognostic (5.00e-1)" 0.3 2.3 1.0 0.5 2.8 0.2 0.3 0.5 5.2 0.2 0.2 1.0 0.0 0.5 0.2 0.2 0.2 0.2 0.2 0.2 0.8 5.0 0.2 0.2 0.3 0.2 1.9 1.2 0.2 0.2 0.2 0.1 0.2 2.7 0.2 0.2 0.7 1.6 0.2 0.2 0.4 0.2 0.2 0.4 0.2 0.2 2.9 0.2 0.2 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 50.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.8 0.5 4.6 0.8 5.0 1.9 1.2 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.0 INTS1 "DKFZp586J0619, INT1, KIAA1440, NET28" ENSG00000164880 "Integrator complex subunit 1" Q8N201 7 1470277-1504367 "Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021658, HPA053009" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA021658: AB_1852402, HPA053009: AB_2682016" "unprognostic (3.20e-2)" "unprognostic (2.85e-2)" "unprognostic (2.47e-2)" "unprognostic (2.08e-1)" "unprognostic (1.97e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.66e-4)" "unprognostic (7.72e-3)" "unprognostic (3.11e-1)" "unprognostic (1.90e-2)" "prognostic favorable (4.83e-4)" "unprognostic (4.30e-1)" "unprognostic (5.10e-3)" "unprognostic (1.81e-1)" "unprognostic (1.51e-1)" "unprognostic (1.56e-2)" "unprognostic (1.81e-3)" 15.4 14.6 17.8 16.1 17.2 28.5 15.2 26.5 28.1 12.2 14.5 19.2 10.1 19.0 15.0 11.0 15.8 13.3 14.4 13.0 13.5 11.0 13.8 13.8 12.0 18.2 13.5 10.1 18.2 23.0 11.6 15.8 12.6 15.2 14.7 6.0 15.6 25.6 14.5 43.3 20.4 17.6 15.1 10.0 19.3 17.9 27.3 14.0 18.0 15.9 10.8 14.9 13.7 14.8 6.0 3.7 4.4 2.7 3.1 4.8 2.1 20.6 18.0 7.0 18.2 5.2 4.0 24.5 8.8 4.9 6.8 6.0 19.8 16.1 11.1 9.3 6.3 13.7 21.4 3.9 10.4 1.9 5.4 21.7 7.9 25.6 13.0 6.0 13.7 11.9 5.4 4.9 7.0 5.0 4.1 7.4 15.9 22.0 8.9 4.1 25.0 7.7 37.6 38.5 7.6 16.2 19.6 8.0 11.3 3.2 15.7 13.3 32.8 12.6 23.2 8.0 4.2 18.4 13.8 13.6 11.2 32.2 9.3 14.3 18.7 9.8 10.8 12.6 11.9 22.9 4.4 2.7 2.9 4.8 2.1 3.0 2.7 3.5 3.8 3.7 6.0 2.2 2.8 2.2 3.1 1.8 2.1 4.2 2.1 17.8 17.2 26.5 28.1 13.5 11.0 13.5 10.1 15.2 14.0 11.9 29.1 6.0 4.2 5.3 30.1 38.9 20.4 4.0 9.1 10.4 23.6 10.7 0.0 14.5 18.4 11.3 33.3 0.0 19.9 8.3 10.3 8.7 1.1 21.2 12.9 46.1 17.3 16.5 23.4 32.2 12.4 11.6 5.0 8.2 18.2 15.8 17.3 15.6 14.5 12.9 36.0 25.8 8.2 19.4 11.0 6.9 12.7 10.1 20.1 5.4 INTS10 "C8orf35, FLJ10569, INT10" ENSG00000104613 "Integrator complex subunit 10" Q9NVR2 8 19817140-19852083 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039129, HPA050570" Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA039129: AB_10794424, HPA050570: AB_2681180" "unprognostic (9.11e-2)" "unprognostic (8.41e-3)" "prognostic favorable (4.00e-4)" "prognostic favorable (1.22e-4)" "unprognostic (4.54e-2)" "unprognostic (9.79e-3)" "unprognostic (1.15e-1)" "unprognostic (1.14e-3)" "unprognostic (3.41e-1)" "unprognostic (1.38e-1)" "unprognostic (1.67e-2)" "unprognostic (2.62e-1)" "unprognostic (8.58e-3)" "unprognostic (1.34e-3)" "unprognostic (1.08e-1)" "unprognostic (2.34e-2)" "unprognostic (1.33e-1)" 21.9 20.9 31.4 18.9 30.2 22.8 23.5 38.5 28.4 23.7 23.2 23.2 19.9 21.3 18.8 17.4 21.8 31.4 17.0 20.9 31.1 27.1 25.0 42.7 19.2 21.9 28.3 18.4 21.6 39.1 18.1 25.5 18.0 21.2 24.5 22.2 17.3 23.2 26.0 20.7 25.7 19.5 22.0 28.7 21.4 19.4 12.0 24.3 26.9 34.9 21.1 25.0 20.8 23.7 17.8 20.0 8.8 15.0 16.9 21.2 12.6 15.0 22.0 12.1 15.8 18.2 20.4 16.6 11.0 18.7 15.4 14.7 12.2 7.6 42.4 19.4 12.0 16.7 16.2 14.3 14.1 17.3 8.4 16.1 19.6 24.6 23.7 13.5 16.9 13.6 16.2 22.3 11.5 17.9 9.6 14.7 24.5 23.6 34.1 10.4 13.1 30.5 20.2 17.2 33.5 12.0 16.5 14.6 27.5 19.1 23.4 12.4 9.8 15.5 19.4 13.6 11.7 10.1 17.3 12.0 9.8 14.1 23.0 15.3 9.6 12.2 32.1 20.0 23.9 16.1 6.6 15.0 8.8 13.9 13.8 21.2 17.8 17.8 17.5 20.0 15.1 19.9 17.6 5.4 16.9 11.5 17.0 19.9 12.6 31.4 30.2 38.5 28.4 31.1 27.1 28.3 18.4 21.2 24.3 14.9 45.6 29.2 34.7 33.4 56.9 17.3 35.7 92.3 43.3 19.2 49.1 29.7 29.9 37.3 45.1 29.2 27.1 0.0 34.7 39.2 34.7 41.9 34.6 51.9 36.5 66.7 19.5 28.8 32.4 20.0 32.2 27.8 16.9 22.6 31.4 31.4 30.6 24.6 32.9 30.0 84.8 12.9 31.5 8.1 27.2 39.4 18.7 35.8 39.8 27.6 INTS11 "CPSF3L, CPSF73L, FLJ20542, INT11, RC-68" ENSG00000127054 "Integrator complex subunit 11" Q5TA45 1 1311585-1324691 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 66.8;Extravillous trophoblasts: 54.3;monocytes: 63.1;Syncytiotrophoblasts: 64.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028379, HPA029025" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA028379: AB_10599598, HPA029025: AB_10600425" "unprognostic (7.54e-2)" "unprognostic (2.14e-3)" "unprognostic (2.33e-2)" "unprognostic (2.56e-1)" "unprognostic (2.99e-2)" "unprognostic (9.34e-2)" "prognostic unfavorable (7.44e-4)" "unprognostic (3.97e-1)" "unprognostic (1.71e-1)" "unprognostic (2.75e-2)" "unprognostic (1.33e-2)" "unprognostic (3.08e-2)" "unprognostic (1.72e-2)" "unprognostic (1.27e-1)" "unprognostic (2.76e-3)" "unprognostic (5.14e-2)" "unprognostic (5.62e-3)" 21.4 22.5 22.8 25.4 24.9 23.2 26.9 50.8 30.4 26.5 31.2 32.1 24.1 29.1 33.1 39.8 25.3 39.1 24.8 29.8 23.7 19.8 23.5 26.7 19.7 25.7 25.9 25.8 34.1 33.5 24.1 26.9 25.8 21.0 29.5 19.9 20.4 33.8 28.0 52.8 28.6 25.4 34.0 20.0 27.3 27.9 57.8 25.9 28.5 23.3 23.5 22.5 27.5 25.7 24.6 37.7 22.0 42.2 28.4 35.2 32.4 21.3 22.1 12.5 23.9 21.5 17.5 13.5 11.8 19.8 27.4 20.3 19.9 27.1 24.0 17.1 24.0 16.6 15.7 18.5 26.4 12.2 22.4 24.2 18.4 30.1 26.7 33.1 14.5 20.3 29.5 14.4 25.0 37.6 15.7 28.7 23.6 21.8 21.8 13.5 19.3 28.7 19.8 15.2 20.6 23.8 22.6 11.8 34.4 19.2 10.9 17.6 16.3 11.9 32.2 33.5 10.1 17.3 21.3 20.5 17.1 15.5 19.4 15.0 34.2 36.6 31.1 23.9 25.9 8.4 22.0 32.3 20.8 31.7 37.2 33.8 24.6 28.1 29.3 37.7 20.3 26.5 24.9 15.3 28.4 42.2 24.5 35.2 32.4 22.8 24.9 50.8 30.4 23.7 19.8 25.9 25.8 21.0 25.9 35.7 28.9 0.0 0.0 0.0 0.0 0.0 0.0 26.8 23.9 17.4 0.0 66.8 26.6 47.9 0.0 0.0 0.0 0.0 46.7 54.3 0.0 0.0 9.3 0.0 36.8 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 63.1 0.0 0.0 47.3 0.0 0.0 29.5 0.0 0.0 0.0 0.0 0.0 0.0 64.4 0.0 0.0 0.0 INTS12 "INT12, PHF22, SBBI22" ENSG00000138785 "Integrator complex subunit 12" Q96CB8 4 105682627-105895986 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035772, HPA041814" Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies, Plasma membrane" "HPA035772: AB_10671109, HPA041814: AB_2677687" "unprognostic (5.30e-2)" "unprognostic (4.54e-2)" "unprognostic (1.84e-3)" "unprognostic (1.78e-1)" "unprognostic (3.68e-2)" "unprognostic (2.58e-3)" "prognostic unfavorable (2.67e-4)" "unprognostic (3.95e-2)" "unprognostic (1.13e-1)" "unprognostic (1.53e-3)" "unprognostic (3.00e-2)" "unprognostic (3.48e-2)" "unprognostic (5.93e-3)" "unprognostic (3.62e-1)" "unprognostic (1.37e-1)" "unprognostic (2.16e-2)" "unprognostic (2.06e-1)" 16.7 13.5 18.7 12.5 20.7 25.3 20.0 17.3 18.1 14.5 17.0 13.4 11.6 17.0 16.1 17.9 13.6 14.4 12.3 19.3 18.3 15.3 18.2 21.4 15.4 12.1 16.5 11.5 15.0 16.0 17.3 20.7 11.2 17.4 18.1 15.4 10.4 14.8 13.7 28.2 14.1 21.0 16.6 19.3 15.9 14.9 12.6 13.8 22.1 31.1 15.9 15.4 13.8 12.6 20.6 27.6 33.3 17.0 27.1 21.9 14.0 12.7 6.8 15.7 16.2 15.5 18.5 11.4 15.2 15.8 19.2 20.0 9.6 14.6 18.5 8.5 17.1 14.9 7.5 17.2 21.9 23.8 19.3 10.4 13.9 11.1 13.5 25.0 24.4 12.7 17.4 28.5 19.0 28.6 12.5 17.6 15.7 20.6 14.5 20.5 13.5 28.6 15.2 6.8 18.7 10.5 14.7 17.1 14.1 17.8 8.7 17.0 13.6 10.7 17.8 16.7 12.9 14.4 14.4 11.4 12.6 13.0 13.6 16.2 22.5 20.8 27.5 14.0 16.7 24.9 33.3 15.9 24.1 17.9 16.8 20.0 20.6 20.6 20.2 18.0 19.3 21.6 20.2 12.1 27.1 17.0 27.6 21.9 14.0 18.7 20.7 17.3 18.1 18.3 15.3 16.5 11.5 17.4 13.8 11.9 7.3 22.4 10.3 9.7 9.6 17.3 17.8 5.3 5.7 3.5 9.8 14.1 36.5 19.4 33.3 13.5 8.0 0.0 17.7 15.1 9.7 14.5 24.3 8.9 15.5 9.5 5.8 12.9 6.7 20.9 11.2 9.1 6.8 19.0 5.5 11.2 16.6 8.2 7.8 12.9 9.0 0.0 10.3 13.0 12.6 9.2 15.3 10.7 8.3 10.0 INTS13 "ASUN, C12orf11, FLJ10637, Mat89Bb, NET48, SPATA30" ENSG00000064102 "Integrator complex subunit 13" Q9NVM9 12 26905181-26938326 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 20.8;Extravillous trophoblasts: 13.8;Hofbauer cells: 13.1;Pancreatic endocrine cells: 13.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039543, HPA040109, HPA073020" Uncertain Enhanced "Nucleoplasm,Nuclear bodies,Vesicles" NA NA Nucleoplasm "Nuclear bodies, Vesicles" "HPA039543: AB_10795150, HPA040109: , HPA073020: " "unprognostic (2.09e-1)" "unprognostic (8.48e-3)" "unprognostic (2.75e-2)" "unprognostic (1.40e-3)" "unprognostic (3.94e-2)" "unprognostic (3.01e-2)" "prognostic unfavorable (1.17e-10)" "unprognostic (5.22e-3)" "unprognostic (5.28e-2)" "unprognostic (1.67e-2)" "unprognostic (1.78e-3)" "unprognostic (3.75e-3)" "prognostic unfavorable (3.16e-6)" "unprognostic (1.02e-1)" "unprognostic (8.51e-2)" "unprognostic (4.37e-2)" "unprognostic (4.78e-2)" 10.0 20.9 10.5 11.5 14.7 15.3 11.5 11.4 11.4 10.5 10.0 22.3 4.6 9.0 10.6 10.4 14.1 8.1 7.5 10.2 12.3 9.8 12.6 14.3 8.0 14.1 18.8 7.4 9.2 11.9 9.3 17.6 9.2 22.4 10.1 10.4 8.9 9.4 6.6 16.9 11.4 8.5 11.6 30.2 17.9 14.1 10.9 14.1 26.6 10.7 11.6 15.1 16.9 9.6 7.4 6.8 5.1 5.4 16.4 18.7 7.1 9.4 10.5 6.4 13.6 9.2 14.8 9.1 13.2 8.0 12.5 14.2 15.7 12.6 24.0 13.9 7.3 12.4 13.6 15.6 12.4 21.3 11.0 9.6 18.7 13.0 12.9 16.5 31.7 11.6 8.1 9.6 20.4 43.4 16.6 16.2 10.6 19.8 9.5 13.7 10.9 16.6 58.3 27.8 13.0 18.9 11.7 18.7 32.1 10.7 8.7 5.1 4.9 11.6 9.2 13.3 23.2 12.5 6.9 10.6 14.9 11.0 24.9 16.0 4.9 5.6 35.1 9.9 22.0 10.4 4.2 5.4 5.1 10.5 3.7 15.5 6.8 13.1 12.9 6.8 7.4 9.4 11.5 1.8 16.4 3.2 4.6 18.7 7.1 10.5 14.7 11.4 11.4 12.3 9.8 18.8 7.4 22.4 14.1 20.8 8.5 0.0 0.0 0.0 0.0 0.0 0.0 5.3 4.5 5.2 0.0 10.1 3.3 12.3 0.0 0.0 0.0 0.0 10.4 13.8 0.0 0.0 7.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 10.0 0.0 0.0 13.3 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 INTS14 "C15orf44, DKFZP564O1664, VWA9" ENSG00000138614 "Integrator complex subunit 14" Q96SY0 15 65578753-65611289 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 32.4;Extravillous trophoblasts: 24.9;Syncytiotrophoblasts: 41.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040255, HPA040651" Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear bodies,Mitochondria" No No "Nucleoplasm, Nuclear bodies, Mitochondria" "Nuclear membrane" "HPA040255: AB_10805710, HPA040651: AB_10796559" "unprognostic (2.92e-1)" "unprognostic (3.01e-1)" "unprognostic (2.78e-1)" "unprognostic (2.41e-1)" "unprognostic (4.06e-1)" "unprognostic (2.35e-2)" "unprognostic (1.36e-1)" "unprognostic (1.63e-1)" "unprognostic (5.80e-2)" "unprognostic (5.60e-2)" "unprognostic (2.57e-2)" "unprognostic (2.67e-2)" "unprognostic (1.03e-3)" "unprognostic (1.92e-2)" "unprognostic (1.23e-1)" "unprognostic (5.75e-2)" "unprognostic (1.30e-1)" 16.6 20.2 12.1 14.1 14.9 13.1 20.2 12.0 19.1 20.1 20.0 20.8 17.3 12.3 25.5 25.3 19.6 22.3 18.4 12.4 11.3 12.9 22.7 23.2 14.4 17.5 14.1 10.4 20.2 22.0 16.1 23.5 23.5 13.9 18.9 21.6 19.9 27.5 21.7 11.8 17.5 19.9 17.0 11.9 23.5 17.5 19.7 9.9 32.4 26.1 16.1 24.0 17.7 16.2 13.4 13.6 12.9 8.6 14.8 20.3 10.4 12.0 21.9 22.1 17.6 12.3 15.5 14.2 13.3 17.3 22.3 20.6 19.5 28.6 19.8 18.8 16.6 18.5 24.5 47.0 22.4 19.6 17.3 28.5 17.2 16.3 21.1 24.6 17.6 22.2 15.0 22.4 16.9 26.0 16.5 24.1 30.8 23.6 11.6 15.6 19.2 19.9 17.0 16.1 30.6 12.2 17.2 18.6 22.6 17.3 22.6 15.9 12.6 16.1 16.4 22.3 19.7 15.3 20.5 11.8 15.4 16.2 13.7 21.0 11.5 21.3 26.7 15.5 32.2 17.9 12.9 7.5 3.9 14.3 8.6 16.2 13.4 14.8 16.3 13.6 10.5 15.7 14.3 0.8 14.8 6.2 12.0 20.3 10.4 12.1 14.9 12.0 19.1 11.3 12.9 14.1 10.4 13.9 9.9 20.8 7.5 0.0 0.0 0.0 0.0 0.0 0.0 20.1 10.3 12.2 0.0 32.4 18.3 15.6 0.0 0.0 0.0 0.0 13.7 24.9 0.0 0.0 7.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 16.2 0.0 0.0 12.8 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 41.6 0.0 0.0 0.0 INTS3 "C1orf60, FLJ21919, INT3, SOSS-A" ENSG00000143624 "Integrator complex subunit 3" Q68E01 1 153728067-153774808 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074391 Approved Approved Nucleoplasm,Nucleoli "Intracellular and membrane" NA NA Nucleoli Nucleoplasm "HPA074391: AB_2686685" "unprognostic (2.36e-1)" "unprognostic (1.94e-2)" "unprognostic (8.75e-3)" "unprognostic (6.97e-3)" "unprognostic (3.26e-1)" "unprognostic (4.48e-2)" "unprognostic (1.71e-2)" "unprognostic (2.85e-1)" "unprognostic (1.75e-1)" "unprognostic (2.45e-1)" "prognostic favorable (5.42e-4)" "unprognostic (1.79e-1)" "prognostic unfavorable (1.34e-6)" "unprognostic (1.21e-1)" "unprognostic (1.85e-1)" "unprognostic (1.18e-3)" "unprognostic (8.29e-2)" 16.2 21.9 18.8 14.4 20.0 12.0 16.3 20.7 23.1 20.4 19.9 19.5 25.1 10.0 24.4 23.7 14.3 26.7 20.5 15.3 16.0 10.6 17.9 11.1 16.6 12.6 15.9 16.4 30.8 17.5 23.6 23.6 16.5 15.6 15.9 11.4 16.1 14.0 31.0 16.2 16.9 14.7 21.2 13.4 15.4 17.6 16.5 16.0 16.2 18.6 9.2 14.1 19.9 18.8 1.8 3.8 2.7 6.2 2.7 2.5 1.5 13.2 13.9 10.1 14.5 11.5 13.0 10.3 10.1 7.3 12.1 9.8 9.7 12.6 11.5 20.3 13.3 7.2 13.5 19.3 13.0 9.9 12.1 11.3 7.2 21.2 4.6 7.8 10.7 13.0 11.7 6.5 10.4 9.5 11.0 11.6 8.6 10.1 9.4 9.3 10.8 10.0 5.7 12.4 15.3 12.9 13.6 5.7 7.4 6.2 17.4 8.0 11.7 9.6 23.2 6.4 14.7 13.4 14.5 8.5 12.0 5.2 11.8 9.1 8.4 7.7 12.7 13.1 6.6 8.3 1.3 1.8 2.0 2.1 1.4 2.5 1.3 1.3 2.0 3.8 1.8 1.4 1.5 2.7 2.7 6.2 0.8 1.3 1.5 18.8 20.0 20.7 23.1 16.0 10.6 15.9 16.4 15.6 16.0 20.8 21.4 8.8 8.7 9.3 22.5 4.0 10.2 13.4 10.3 29.6 19.6 11.5 0.0 10.1 12.1 12.6 8.1 0.0 7.1 11.7 11.9 9.9 5.7 13.6 10.7 20.6 11.6 27.0 11.8 5.9 8.9 14.3 6.8 13.6 16.1 19.3 9.6 10.8 11.3 12.4 23.9 25.8 9.0 9.3 13.0 8.9 8.6 7.7 12.2 11.2 INTS5 "INT5, KIAA1698" ENSG00000185085 "Integrator complex subunit 5" Q6P9B9 11 62646848-62653302 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046181, HPA056915" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA046181: , HPA056915: AB_2683276" "unprognostic (2.87e-1)" "unprognostic (9.51e-2)" "unprognostic (9.11e-2)" "unprognostic (9.70e-2)" "unprognostic (2.71e-1)" "unprognostic (6.41e-2)" "unprognostic (1.97e-2)" "unprognostic (5.52e-2)" "unprognostic (1.90e-1)" "unprognostic (5.95e-2)" "unprognostic (2.33e-1)" "unprognostic (5.09e-2)" "prognostic favorable (8.44e-5)" "unprognostic (7.08e-3)" "unprognostic (2.97e-2)" "unprognostic (3.36e-1)" "unprognostic (1.35e-2)" 13.8 13.2 9.1 14.0 8.9 6.5 17.2 9.7 16.5 12.8 11.0 7.0 14.3 10.9 16.0 10.6 16.0 19.1 14.0 14.3 7.4 6.7 12.0 19.9 11.6 22.3 7.8 7.6 15.4 21.3 17.4 9.5 12.1 6.9 12.4 8.5 11.0 16.0 17.4 17.3 15.7 11.2 11.9 5.5 14.8 12.4 9.4 6.6 26.0 16.4 10.8 12.8 12.6 15.7 7.6 7.2 5.1 6.2 10.1 14.3 7.0 11.3 14.0 8.3 7.7 16.4 12.0 7.7 9.4 9.7 12.8 9.2 9.9 12.7 21.7 17.1 11.9 10.6 17.8 16.6 21.9 6.2 13.5 11.5 11.2 11.2 6.6 14.8 12.3 10.8 13.8 17.2 13.6 11.7 9.7 12.6 9.7 17.1 12.8 10.9 23.3 14.0 14.4 12.6 13.5 17.8 14.5 11.2 26.0 9.8 7.5 11.2 9.4 10.6 14.9 14.6 6.1 21.1 8.5 10.4 12.2 9.5 18.7 8.4 18.1 13.8 15.6 14.1 9.3 11.5 5.1 6.2 4.8 8.7 4.6 14.3 5.8 8.2 7.7 7.1 7.6 9.6 8.7 2.6 10.1 5.1 7.2 6.1 7.0 9.1 8.9 9.7 16.5 7.4 6.7 7.8 7.6 6.9 6.6 3.0 5.6 8.0 6.1 1.9 7.0 2.2 5.1 8.1 6.8 3.5 0.0 11.4 10.0 10.5 4.9 4.5 4.9 0.0 9.1 9.3 3.8 5.2 9.2 10.4 7.6 9.5 6.4 8.6 5.1 6.0 6.1 3.3 0.0 13.6 7.3 10.3 9.3 0.0 7.4 7.5 3.6 12.9 4.9 5.2 13.4 3.6 16.6 5.7 6.8 4.7 INTS6 "DBI-1, DDX26, DDX26A, DICE1, HDB, INT6, Notchl2" ENSG00000102786 "Integrator complex subunit 6" Q9UL03 13 51354077-51454264 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001552, HPA001846" Supported Supported "Nucleoplasm,Actin filaments" NA NA Nucleoplasm "Actin filaments" "HPA001552: AB_1078659, HPA001846: AB_1847669" "unprognostic (1.99e-1)" "unprognostic (4.81e-2)" "unprognostic (3.58e-2)" "unprognostic (4.94e-2)" "unprognostic (1.08e-1)" "unprognostic (1.18e-1)" "unprognostic (1.79e-1)" "unprognostic (1.14e-1)" "unprognostic (3.19e-2)" "unprognostic (6.70e-2)" "unprognostic (9.16e-2)" "unprognostic (3.32e-2)" "unprognostic (3.18e-2)" "unprognostic (2.80e-1)" "unprognostic (5.83e-2)" "unprognostic (2.36e-1)" "unprognostic (6.26e-2)" 13.3 13.7 12.9 14.4 14.6 11.3 23.9 23.8 15.8 12.5 11.9 10.6 17.4 9.5 12.1 10.9 16.4 10.3 12.3 13.0 14.1 8.9 11.1 24.5 13.6 15.7 16.9 9.1 14.6 44.2 14.4 24.1 11.5 13.2 12.2 9.5 8.5 12.3 19.2 10.6 13.3 13.9 12.2 12.3 11.4 12.9 46.4 17.8 21.7 13.0 9.5 13.4 12.3 15.9 6.1 6.5 7.8 2.8 6.7 9.2 3.2 7.7 6.1 14.9 7.1 8.5 18.4 9.9 15.0 15.0 15.9 11.9 7.9 19.3 9.6 3.4 12.6 9.9 13.9 19.4 9.3 23.6 17.4 5.6 16.6 9.9 9.6 20.8 19.7 16.0 13.5 18.1 16.5 26.2 21.5 14.7 13.5 11.1 14.2 17.3 6.0 13.7 15.0 11.3 22.5 7.5 9.4 10.0 7.5 12.6 5.1 8.9 9.5 15.7 12.3 12.0 12.7 7.1 22.5 10.2 8.6 7.0 10.1 9.8 13.9 8.8 14.8 7.7 11.8 14.6 7.3 2.8 4.2 7.9 1.8 8.9 4.9 5.9 7.1 2.8 6.1 8.4 9.2 7.8 6.7 2.0 6.5 6.3 3.2 12.9 14.6 23.8 15.8 14.1 8.9 16.9 9.1 13.2 17.8 23.8 43.8 51.1 45.0 67.9 60.8 71.8 43.3 12.0 20.5 21.0 111.9 60.8 13.3 19.6 64.4 45.0 74.9 0.0 22.6 39.9 44.2 57.5 48.4 31.6 30.7 42.9 72.9 63.8 51.1 64.5 40.9 38.9 21.9 23.4 75.3 60.6 22.3 52.1 29.7 9.9 77.1 25.8 47.4 97.7 42.2 63.2 61.7 60.9 65.3 59.9 INTS8 "C8orf52, FLJ20530, INT8, MGC131633" ENSG00000164941 "Integrator complex subunit 8" Q75QN2 8 94813311-94881746 "Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 48.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057299 Approved Approved Nucleoplasm Yes No Nucleoplasm "HPA057299: AB_2683403" "unprognostic (1.08e-2)" "unprognostic (3.12e-2)" "unprognostic (1.28e-1)" "unprognostic (5.86e-2)" "unprognostic (1.96e-1)" "unprognostic (4.81e-2)" "prognostic unfavorable (2.54e-6)" "unprognostic (3.07e-2)" "unprognostic (6.87e-2)" "unprognostic (9.77e-3)" "unprognostic (4.84e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.24e-1)" "unprognostic (5.60e-2)" "unprognostic (1.11e-1)" "unprognostic (3.96e-2)" 10.5 10.0 12.7 19.3 16.1 16.6 14.3 17.1 16.0 19.2 15.4 9.1 12.5 9.4 14.4 8.3 15.9 10.6 9.2 15.2 11.6 12.6 10.2 10.8 11.5 19.3 12.4 9.5 15.0 20.1 14.7 22.9 11.4 11.1 14.0 18.2 9.7 12.9 13.7 15.6 12.5 15.1 16.7 12.5 17.0 14.6 35.1 10.7 31.9 13.3 7.6 16.1 17.1 13.2 13.0 9.7 14.4 9.8 10.9 13.0 4.5 22.1 14.1 21.5 18.8 7.8 18.8 11.5 12.4 11.1 15.6 14.5 9.4 16.2 22.4 11.5 8.7 19.5 14.0 26.3 12.4 20.9 25.1 14.0 19.8 8.5 9.2 9.5 10.5 14.6 7.5 5.9 15.0 12.9 17.9 17.1 15.1 18.9 16.9 9.4 14.3 22.4 8.7 12.7 48.5 24.5 18.8 8.7 12.7 13.0 11.4 16.1 8.9 11.7 3.2 10.6 18.4 16.1 13.4 11.9 7.3 8.5 13.6 10.7 10.5 18.1 19.2 9.4 21.1 13.9 2.1 9.8 14.4 5.2 6.8 8.4 13.0 12.2 13.0 9.7 10.4 12.2 7.2 9.9 10.9 6.6 5.7 9.9 4.5 12.7 16.1 17.1 16.0 11.6 12.6 12.4 9.5 11.1 10.7 14.9 7.5 11.3 9.5 5.3 13.4 7.3 5.1 18.7 10.3 7.0 31.4 8.3 3.3 7.1 14.4 9.0 7.4 0.0 11.7 10.7 9.0 7.2 12.7 5.3 8.6 27.0 17.2 9.8 13.5 3.4 15.0 12.4 6.8 16.2 11.4 7.0 10.0 11.5 15.2 3.5 19.6 6.5 8.9 48.8 29.4 6.0 7.1 10.1 9.9 6.7 INTS9 "CPSF2L, FLJ10871, RC-74" ENSG00000104299 "Integrator complex subunit 9" Q9NV88 8 28767661-28890242 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051615, HPA066822" Enhanced Nucleoplasm Yes No Nucleoplasm "HPA051615: AB_2681552, HPA066822: AB_2685729" "unprognostic (2.19e-2)" "unprognostic (1.45e-2)" "unprognostic (1.79e-2)" "prognostic favorable (9.45e-4)" "unprognostic (2.46e-1)" "unprognostic (1.56e-3)" "unprognostic (6.91e-3)" "prognostic favorable (7.71e-4)" "unprognostic (3.64e-2)" "unprognostic (5.01e-2)" "unprognostic (4.72e-2)" "unprognostic (2.48e-3)" "prognostic favorable (1.91e-5)" "unprognostic (2.51e-2)" "unprognostic (2.73e-1)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" 10.8 28.8 10.5 14.1 13.4 8.1 11.0 14.2 16.5 11.3 11.7 15.5 7.7 9.3 16.4 16.1 14.1 13.7 9.1 13.0 9.5 7.6 12.8 9.3 11.4 17.9 15.2 8.1 11.4 12.5 13.4 24.0 11.4 12.1 11.6 12.9 17.9 15.5 10.6 14.1 12.4 11.9 12.8 13.5 20.4 11.7 15.2 13.3 28.4 17.2 8.5 23.1 13.2 11.2 17.6 24.3 15.5 19.3 19.9 17.0 9.3 13.2 9.4 11.3 12.0 14.0 6.6 5.0 6.1 8.4 10.7 11.9 6.5 7.5 13.2 8.6 6.2 9.6 11.1 21.8 12.5 15.0 5.5 8.9 13.2 5.3 11.3 10.2 6.6 10.3 7.5 9.0 12.9 9.3 5.8 13.2 19.1 27.8 7.7 7.1 7.3 30.5 12.0 15.3 15.6 6.1 19.7 13.1 6.9 7.5 9.2 8.2 15.0 6.3 8.3 11.1 9.5 8.0 7.5 7.7 6.2 16.0 10.5 7.7 4.0 2.7 16.4 9.6 11.1 8.8 12.1 17.7 15.5 15.4 19.3 14.3 15.4 13.7 17.0 24.3 17.6 12.5 13.1 7.2 19.9 13.7 12.8 16.3 9.3 10.5 13.4 14.2 16.5 9.5 7.6 15.2 8.1 12.1 13.3 6.0 3.4 4.7 2.4 2.1 2.1 4.6 7.6 1.4 2.3 3.5 5.9 6.7 1.7 3.0 6.1 2.9 2.3 0.0 4.5 3.8 3.8 1.4 0.0 1.6 6.7 1.6 5.8 2.5 4.1 3.3 7.2 2.9 3.3 4.6 4.0 2.0 4.7 0.0 4.2 3.3 5.5 0.0 2.8 3.0 3.3 2.6 4.0 3.2 3.3 1.4 IP6K1 "IHPK1, KIAA0263" ENSG00000176095 "Inositol hexakisphosphate kinase 1" Q92551 3 49724294-49786542 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cone photoreceptor cells: 84.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040825 Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA040825: AB_10960426" "unprognostic (6.18e-2)" "unprognostic (1.33e-1)" "unprognostic (3.58e-2)" "unprognostic (4.71e-2)" "unprognostic (1.99e-1)" "prognostic favorable (2.08e-4)" "unprognostic (9.97e-3)" "unprognostic (8.45e-2)" "unprognostic (1.16e-1)" "unprognostic (2.11e-1)" "prognostic favorable (6.85e-4)" "unprognostic (1.29e-2)" "prognostic favorable (5.77e-5)" "unprognostic (8.75e-2)" "unprognostic (1.67e-1)" "unprognostic (9.24e-2)" "unprognostic (1.64e-2)" 14.2 17.5 23.5 12.9 26.9 12.1 15.8 38.6 40.4 17.7 16.1 20.7 16.1 13.6 21.4 14.5 19.6 20.0 14.7 13.7 23.8 23.5 16.3 15.9 16.9 16.3 17.9 18.3 30.2 21.9 30.3 16.7 18.3 21.2 14.3 13.2 18.6 18.3 21.1 9.0 18.2 12.7 19.5 16.9 16.9 13.7 27.3 14.8 22.3 17.1 8.4 14.4 16.3 15.6 6.8 4.1 24.0 4.8 6.9 9.7 6.0 12.3 15.0 17.6 20.6 18.4 14.2 14.2 16.5 17.4 27.1 23.8 19.5 12.9 10.8 10.7 18.2 18.4 9.2 24.8 14.9 15.4 21.7 19.8 24.4 23.0 13.1 20.4 14.9 17.1 16.5 18.6 29.2 17.7 15.3 22.6 12.6 16.0 12.7 13.3 11.0 18.1 15.6 18.9 9.8 25.0 11.5 12.5 21.6 17.5 18.9 9.5 19.0 21.0 13.7 18.9 10.6 11.0 22.0 20.2 15.2 15.3 20.8 19.1 15.5 20.8 11.5 13.9 17.3 15.5 2.5 4.8 8.2 8.7 3.9 8.8 4.6 8.0 9.6 4.1 6.8 9.7 9.5 24.0 6.9 4.8 2.9 8.2 6.0 23.5 26.9 38.6 40.4 23.8 23.5 17.9 18.3 21.2 14.8 23.8 10.5 11.8 13.7 13.9 37.4 8.9 15.3 17.4 10.3 12.2 84.4 15.7 5.0 12.1 69.3 16.6 12.9 23.3 11.3 13.2 13.6 16.1 19.6 10.6 10.8 28.6 26.5 17.8 11.8 11.8 19.5 10.7 18.6 14.4 12.2 22.0 16.3 8.6 15.6 10.3 70.3 19.4 11.5 17.9 22.6 16.4 23.0 23.5 11.0 13.3 IP6K2 IHPK2 ENSG00000068745 "Inositol hexakisphosphate kinase 2" Q9UHH9 3 48688003-48740353 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Phospholipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007532, HPA070811" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cell Junctions" NA NA "Nucleoplasm, Nucleoli fibrillar center" "Cell Junctions" "HPA007532: AB_1851542, HPA070811: AB_2732165" "prognostic favorable (1.25e-4)" "unprognostic (2.55e-2)" "unprognostic (8.86e-2)" "unprognostic (6.69e-3)" "unprognostic (1.01e-1)" "unprognostic (1.49e-2)" "unprognostic (1.76e-3)" "prognostic favorable (2.95e-4)" "unprognostic (6.57e-3)" "unprognostic (1.56e-1)" "unprognostic (1.92e-3)" "unprognostic (1.99e-2)" "unprognostic (1.24e-1)" "unprognostic (1.35e-1)" "unprognostic (1.64e-1)" "unprognostic (3.50e-2)" "prognostic favorable (1.83e-4)" 18.3 31.1 40.4 20.0 55.9 51.7 28.2 74.1 37.3 29.5 32.5 23.7 34.0 36.9 34.6 56.1 30.0 28.1 24.0 19.0 30.7 19.2 32.4 24.3 18.4 22.5 35.4 27.6 33.9 28.1 23.5 42.3 20.7 29.4 34.9 41.9 22.2 28.3 32.1 19.1 50.0 31.6 21.1 28.3 25.5 27.6 26.0 37.4 31.7 35.7 21.6 19.5 24.1 34.0 27.3 22.8 50.7 25.7 27.9 35.1 19.0 8.5 16.7 34.7 24.4 19.6 24.5 25.1 16.3 18.3 18.7 21.7 13.8 22.9 15.1 13.4 15.2 23.5 22.3 17.3 24.4 17.5 17.8 15.2 17.3 51.7 29.6 15.9 16.4 16.9 23.2 35.6 25.4 21.0 24.9 25.9 49.1 12.9 19.0 21.7 19.0 35.0 22.5 26.6 16.7 31.0 14.7 11.5 16.5 25.4 41.0 21.7 32.8 35.3 24.0 17.3 28.8 23.2 27.7 18.4 20.4 20.3 12.8 16.1 17.6 20.8 21.3 18.5 19.2 17.8 50.7 22.5 38.5 29.7 21.6 26.5 27.3 25.8 27.7 21.7 25.7 24.2 24.9 35.3 27.9 25.7 22.8 35.1 19.0 40.4 55.9 74.1 37.3 30.7 19.2 35.4 27.6 29.4 37.4 65.5 38.7 24.2 78.6 73.7 63.9 10.1 33.1 69.6 69.4 94.2 37.3 101.3 64.6 51.7 30.9 42.0 85.6 0.0 41.6 64.1 64.4 60.2 53.1 20.7 35.7 19.1 105.7 35.0 15.3 14.2 75.1 31.2 25.3 34.3 96.2 28.0 50.1 90.2 64.3 55.6 50.0 51.8 35.7 56.7 54.0 72.5 103.7 47.2 78.7 75.6 IP6K3 "IHPK3, INSP6K3" ENSG00000161896 "Inositol hexakisphosphate kinase 3" Q96PC2 6 33721670-33746905 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 22.5;skeletal muscle: 87.9" "Cell type enhanced" "Detected in some" 12 "Cardiomyocytes: 10.9;Hepatocytes: 5.8;Horizontal cells: 9.5;Proximal tubular cells: 3.6;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 13.0;cerebral cortex: 6.2;midbrain: 22.5;pons and medulla: 7.7;thalamus: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 16.2;HSkMC: 5.8;LHCN-M2: 25.7;RH-30: 11.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA053644, HPA062531" Approved Approved Nucleoplasm,Cytosol Yes NA Nucleoplasm Cytosol "HPA053644: AB_2682214, HPA062531: " "unprognostic (3.23e-2)" "unprognostic (2.87e-1)" "unprognostic (2.07e-5)" "unprognostic (1.07e-3)" "unprognostic (2.20e-1)" "unprognostic (5.10e-3)" "unprognostic (1.38e-1)" "unprognostic (1.75e-1)" "unprognostic (2.45e-1)" "unprognostic (2.47e-2)" "unprognostic (1.24e-2)" "unprognostic (2.94e-3)" "prognostic unfavorable (6.09e-4)" "unprognostic (1.63e-2)" "unprognostic (2.01e-1)" "unprognostic (2.66e-3)" "unprognostic (1.33e-1)" 2.2 1.0 2.1 0.8 13.0 0.5 0.9 0.6 6.2 1.2 2.2 11.8 1.4 0.8 1.6 1.4 5.2 1.3 0.6 10.0 3.2 1.3 4.7 7.7 2.0 0.6 22.5 1.1 0.6 0.7 0.5 0.5 3.8 7.7 2.8 1.0 1.2 1.4 1.8 87.9 0.5 1.1 1.8 9.2 1.4 0.9 0.6 15.2 0.0 9.9 8.1 0.5 1.5 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.6 0.1 0.2 0.2 1.9 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 16.2 0.0 0.0 5.8 0.8 0.1 0.4 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.4 4.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.1 13.0 0.6 6.2 3.2 1.3 22.5 1.1 7.7 15.2 0.0 0.0 0.0 0.0 0.0 2.2 10.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 5.8 0.2 9.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 3.6 0.1 6.5 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.1 IPMK ENSG00000151151 "Inositol polyphosphate multikinase" Q8NFU5 10 58191517-58267934 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Phospholipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 48.0;Suprabasal keratinocytes: 50.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 6.4" "Group enriched" "Detected in many" 4 "granulocytes: 6.4;monocytes: 2.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037837, HPA057542" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA037837: AB_10670166, HPA057542: AB_2683460" "unprognostic (4.52e-2)" "unprognostic (3.29e-2)" "unprognostic (4.22e-3)" "unprognostic (6.85e-2)" "unprognostic (2.41e-2)" "unprognostic (1.99e-1)" "unprognostic (1.39e-3)" "unprognostic (2.10e-1)" "unprognostic (9.39e-2)" "unprognostic (2.23e-1)" "unprognostic (1.55e-1)" "unprognostic (8.56e-2)" "prognostic unfavorable (9.96e-7)" "unprognostic (1.79e-1)" "unprognostic (4.33e-1)" "unprognostic (1.27e-3)" "unprognostic (9.02e-3)" 12.2 4.1 5.4 6.8 5.6 2.8 6.7 8.7 5.6 5.9 19.4 3.5 2.1 9.5 3.2 5.6 10.8 3.8 8.6 7.4 5.2 5.5 5.3 21.3 11.0 13.8 4.9 3.3 4.8 6.0 22.5 6.1 13.8 4.3 4.4 7.5 4.8 6.4 4.4 9.8 9.0 28.1 4.9 6.0 14.1 4.4 2.9 3.8 11.7 5.9 4.9 5.9 10.4 12.3 0.7 1.0 6.4 2.1 0.4 0.9 0.4 14.7 3.8 5.6 5.4 5.5 6.5 4.9 3.9 8.4 3.4 6.8 7.6 9.5 11.8 8.0 4.6 3.2 4.6 4.7 5.2 10.8 5.4 3.6 2.9 3.8 7.2 3.3 4.6 6.7 7.1 4.7 5.7 11.5 3.8 7.2 3.5 1.9 6.1 5.9 3.7 6.2 8.9 3.5 6.0 3.6 0.4 12.1 5.5 6.2 3.8 3.9 6.8 5.1 13.6 3.9 9.6 11.3 5.6 6.2 3.7 7.1 7.7 4.9 13.1 7.7 9.4 6.9 4.9 1.4 2.3 1.5 3.3 0.4 1.6 0.4 0.7 0.4 0.2 1.0 0.4 0.9 0.3 6.4 0.4 2.1 0.4 0.1 0.4 5.4 5.6 8.7 5.6 5.2 5.5 4.9 3.3 4.3 3.8 6.0 3.4 9.7 9.1 48.0 9.1 2.4 5.1 17.4 7.9 1.8 5.9 8.5 3.3 3.2 1.9 3.2 22.2 0.0 4.2 17.8 16.0 7.8 6.9 11.4 9.0 12.7 8.1 8.6 27.1 1.0 2.6 17.3 25.3 1.0 11.7 3.7 6.2 16.4 1.8 7.3 5.4 6.5 12.2 9.8 4.3 50.7 7.9 4.3 9.0 14.3 IPO11 RanBP11 ENSG00000086200 "Importin 11" Q9UI26 5 62403972-62628582 "Plasma proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 35.3;Ito cells: 41.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 51.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065346, HPA067097" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA065346: , HPA067097: AB_2685776" "unprognostic (9.29e-2)" "unprognostic (2.88e-2)" "prognostic favorable (1.70e-4)" "unprognostic (1.01e-1)" "unprognostic (3.35e-2)" "unprognostic (9.21e-2)" "prognostic unfavorable (4.28e-5)" "unprognostic (4.26e-2)" "unprognostic (6.45e-2)" "unprognostic (1.26e-3)" "unprognostic (9.63e-2)" "unprognostic (5.09e-2)" "unprognostic (8.38e-3)" "unprognostic (1.62e-1)" "unprognostic (1.67e-1)" "unprognostic (1.06e-1)" "unprognostic (2.24e-2)" 25.5 15.3 13.6 14.2 17.1 8.8 22.2 18.4 18.3 19.5 13.7 14.2 17.4 10.4 19.9 13.9 18.6 16.1 16.4 20.0 15.2 13.4 18.5 16.9 12.8 14.2 14.9 13.7 18.6 14.4 23.9 20.9 24.4 17.1 15.9 13.7 13.2 14.8 16.6 19.0 14.0 12.3 17.0 14.4 26.3 13.7 30.9 13.3 18.8 21.7 15.7 15.0 19.8 24.4 4.2 3.6 12.2 5.6 18.0 5.3 3.2 11.9 11.3 10.5 16.1 8.5 11.6 14.2 12.9 9.9 13.6 15.2 12.6 9.4 20.5 10.3 13.1 17.0 9.9 21.6 15.0 21.4 7.7 11.4 9.5 11.6 11.3 6.2 10.8 5.5 8.2 8.7 16.2 17.5 6.8 51.2 10.2 17.9 6.7 13.5 11.3 11.4 14.0 13.4 7.0 6.9 13.9 15.5 18.6 8.4 11.8 11.1 6.5 11.3 8.9 9.2 11.0 11.5 7.5 23.0 8.2 9.0 9.0 11.7 5.3 8.6 14.2 10.1 15.1 9.7 12.2 2.1 1.8 3.5 3.4 4.2 3.1 3.7 3.6 3.6 4.2 5.3 3.8 2.1 18.0 5.6 2.3 2.3 3.2 13.6 17.1 18.4 18.3 15.2 13.4 14.9 13.7 17.1 13.3 8.9 3.0 6.0 3.7 7.6 3.6 10.7 0.0 30.8 4.5 7.0 2.0 6.2 3.3 3.3 35.3 30.0 1.7 23.3 4.6 5.4 5.8 4.2 12.7 5.8 4.4 4.8 2.9 41.7 6.5 18.8 5.2 4.5 3.3 1.8 5.5 3.3 2.5 0.0 3.9 3.4 4.8 6.5 6.6 12.9 16.3 7.8 4.2 4.9 4.6 4.0 IPO5 "IMB3, KPNB3, MGC2068, Pse1, RANBP5" ENSG00000065150 "Importin 5" O00410 13 97953658-98024297 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 11 "Early spermatids: 1043.3;Late spermatids: 1438.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009110, HPA040983, HPA056548" Approved Supported Nucleoplasm,Cytosol NA NA 92000 "Nucleoplasm, Cytosol" "CAB009110: AB_2264985, HPA040983: AB_2677236, HPA056548: AB_2683169" "unprognostic (5.20e-2)" "unprognostic (6.94e-2)" "unprognostic (9.47e-2)" "unprognostic (1.31e-1)" "unprognostic (2.96e-3)" "unprognostic (2.16e-3)" "unprognostic (2.19e-2)" "unprognostic (5.27e-3)" "unprognostic (6.19e-2)" "unprognostic (2.51e-1)" "unprognostic (1.45e-1)" "unprognostic (1.06e-1)" "unprognostic (9.64e-2)" "unprognostic (1.82e-1)" "unprognostic (2.40e-1)" "unprognostic (1.66e-1)" "unprognostic (2.73e-1)" 26.3 13.8 16.5 14.5 18.3 13.0 23.5 16.3 20.2 20.2 19.7 15.9 13.5 9.6 21.1 13.4 19.4 18.9 12.4 23.9 15.7 12.7 18.9 23.2 14.1 16.0 20.8 15.9 33.5 60.7 12.5 13.0 14.3 15.3 19.1 16.6 11.0 13.9 20.2 65.0 13.5 11.3 25.5 24.3 14.9 18.9 79.5 19.4 23.3 23.0 24.1 21.1 21.8 23.9 8.0 11.0 1.1 7.3 10.3 12.3 6.1 28.6 19.3 36.3 33.2 24.7 62.9 22.3 42.2 33.3 59.5 42.3 39.6 22.1 82.8 14.8 50.7 13.4 25.0 75.4 28.9 82.3 20.9 23.7 45.1 36.7 31.0 17.7 48.6 16.1 35.3 19.0 48.2 40.6 25.4 33.8 25.6 31.1 11.2 50.7 7.8 36.7 13.2 36.4 43.3 23.2 47.2 41.3 24.5 14.3 18.8 26.9 22.0 21.6 25.3 15.8 46.0 19.2 26.9 23.7 40.2 20.2 20.0 38.3 15.0 18.4 25.8 41.5 30.9 27.5 0.5 4.4 1.1 7.1 7.3 12.3 8.0 8.3 8.8 11.0 7.6 11.6 9.6 0.6 10.3 5.1 5.4 8.5 6.1 16.5 18.3 16.3 20.2 15.7 12.7 20.8 15.9 15.3 19.4 17.9 23.8 15.7 33.9 36.9 31.1 68.2 35.7 18.7 22.7 21.0 5.9 28.6 23.2 26.7 1043.3 35.1 7.8 0.0 36.0 38.4 34.0 35.8 13.9 40.9 21.3 60.4 33.9 28.3 24.1 1438.4 48.9 18.7 25.3 14.4 20.2 40.9 32.7 3.5 41.4 35.7 20.2 25.8 49.1 109.7 53.2 32.2 27.0 19.2 36.5 33.9 IPO7 "Imp7, RANBP7" ENSG00000205339 "Importin 7" O95373 11 9384622-9448126 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019002, HPA056590" Approved Approved Supported Nucleoplasm,Cytosol NA NA 26000 "Nucleoplasm, Cytosol" "HPA019002: AB_1856059, HPA056590: AB_2683180" "unprognostic (1.92e-1)" "prognostic unfavorable (4.98e-4)" "unprognostic (9.50e-2)" "unprognostic (1.27e-1)" "unprognostic (3.68e-1)" "unprognostic (1.60e-2)" "prognostic unfavorable (6.57e-4)" "unprognostic (1.19e-2)" "unprognostic (7.60e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (8.38e-6)" "unprognostic (3.06e-1)" "unprognostic (1.55e-1)" "unprognostic (1.13e-1)" "unprognostic (8.08e-2)" "unprognostic (2.17e-1)" "unprognostic (3.90e-3)" 23.9 20.6 21.8 18.6 24.4 12.3 36.0 24.1 30.6 24.3 27.4 14.4 19.3 17.0 25.7 19.3 29.0 20.3 20.3 37.7 22.8 23.4 26.5 24.7 22.0 23.2 23.3 17.4 23.4 25.9 33.1 19.1 26.5 24.8 24.4 22.1 12.0 21.4 22.4 88.2 17.1 16.1 53.4 25.7 16.6 21.5 9.7 16.8 20.8 34.3 28.5 20.9 43.7 33.9 3.8 5.8 1.3 6.3 6.9 5.4 1.6 37.7 29.5 34.8 27.6 35.3 45.6 27.9 46.0 29.6 34.0 36.8 25.5 34.8 35.4 16.8 35.3 30.9 29.7 49.3 35.7 56.9 16.8 40.7 29.3 33.5 25.6 22.1 44.7 22.3 29.1 38.7 22.4 52.7 34.8 40.1 12.2 43.9 21.3 44.3 15.3 26.9 21.9 34.2 35.0 34.3 28.4 54.8 16.0 28.1 35.7 13.8 27.2 20.5 40.7 33.1 28.9 18.7 22.5 31.5 41.9 28.9 43.1 49.1 6.2 23.6 24.5 27.5 24.2 22.7 0.1 2.5 0.6 2.7 4.8 5.4 3.8 3.1 3.9 5.8 3.1 3.9 3.2 1.3 6.9 6.3 2.7 2.8 1.6 21.8 24.4 24.1 30.6 22.8 23.4 23.3 17.4 24.8 16.8 62.5 53.8 24.3 76.2 128.0 37.1 127.5 30.6 49.5 67.1 33.2 55.0 44.9 28.2 32.5 3.3 40.5 18.6 0.0 35.7 54.7 55.8 105.1 35.9 39.4 31.6 33.4 29.9 25.2 47.7 3.6 25.9 41.8 37.1 26.2 36.8 30.1 37.3 28.8 33.6 35.8 38.8 12.9 55.6 15.4 22.6 129.4 30.7 22.3 45.0 129.0 IPO8 "IMP8, RANBP8" ENSG00000133704 "Importin 8" O15397 12 30628988-30695986 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018439, HPA023765" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA018439: AB_1851771, HPA023765: AB_1851773" "unprognostic (1.63e-2)" "unprognostic (1.40e-1)" "unprognostic (1.73e-1)" "unprognostic (5.14e-2)" "unprognostic (2.15e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (1.35e-4)" "unprognostic (2.66e-2)" "unprognostic (5.42e-2)" "unprognostic (1.20e-1)" "unprognostic (2.97e-1)" "unprognostic (1.38e-1)" "prognostic favorable (8.62e-5)" "unprognostic (9.75e-2)" "unprognostic (2.95e-1)" "unprognostic (3.14e-3)" "unprognostic (2.24e-1)" 15.7 20.9 21.2 17.3 22.5 10.0 15.4 19.8 22.6 17.4 25.2 12.3 15.9 17.9 22.4 16.0 22.9 17.2 18.3 18.9 17.9 14.5 22.5 23.3 15.6 17.5 14.8 20.3 21.1 23.9 54.4 27.8 17.2 19.0 18.4 22.6 11.9 16.7 18.5 19.8 16.6 22.6 21.3 15.9 20.4 17.8 27.5 14.6 24.8 22.1 13.1 18.0 21.6 20.4 8.0 3.6 7.3 6.0 6.0 7.5 2.8 16.9 19.9 19.1 14.0 18.0 20.7 26.8 18.8 18.1 15.0 17.7 13.6 17.7 21.9 16.5 23.0 15.9 11.0 21.1 20.3 21.9 25.5 14.9 17.9 23.9 12.4 11.8 25.9 14.1 16.7 12.8 23.9 20.4 27.1 24.7 15.4 15.9 16.5 21.2 8.6 19.5 16.0 37.2 23.4 7.6 16.0 40.1 17.7 18.9 23.5 11.8 14.5 19.7 14.4 10.4 35.5 23.0 9.4 22.0 14.4 12.7 31.0 16.3 16.3 22.1 33.2 17.6 15.6 24.9 7.2 4.5 5.4 4.8 6.0 7.1 5.6 5.4 5.2 3.3 8.0 5.9 7.5 7.3 6.0 5.5 3.6 6.1 2.8 21.2 22.5 19.8 22.6 17.9 14.5 14.8 20.3 19.0 14.6 8.9 18.9 11.0 5.4 8.5 11.5 16.9 10.2 8.1 21.6 10.4 11.8 9.8 3.3 8.6 29.2 13.9 11.7 23.3 11.9 6.0 9.1 6.7 11.5 22.4 13.9 7.9 6.4 24.5 22.2 6.4 8.1 12.1 8.5 3.6 13.0 12.1 11.0 5.8 12.4 12.9 14.6 12.9 11.2 9.1 3.2 8.2 15.0 7.7 13.0 7.5 IQCA1 "DRC11, FLJ22527, IQCA" ENSG00000132321 "IQ motif containing with AAA domain 1" Q86XH1 2 236324147-236507542 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 27.8;thyroid gland: 30.0" "Cell type enriched" "Detected in many" 5 "Ciliated cells: 163.3" "Cancer enhanced" "Detected in many" "thyroid cancer: 9.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 4.4" "Group enriched" "Detected in many" 4 "NK-cells: 1.2;T-cells: 4.4" "Cell line enhanced" "Detected in some" "EFO-21: 4.0;HBEC3-KT: 3.7;HeLa: 4.4;hTERT-RPE1: 8.7;SuSa: 5.5;U-2 OS: 15.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA057320 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA057320: " "unprognostic (1.73e-2)" "unprognostic (6.38e-2)" "unprognostic (3.75e-3)" "unprognostic (1.62e-2)" "unprognostic (6.27e-3)" "unprognostic (1.73e-2)" "unprognostic (3.23e-5)" "unprognostic (1.55e-1)" "unprognostic (7.23e-3)" "unprognostic (1.39e-1)" "unprognostic (3.03e-2)" "unprognostic (1.62e-1)" "prognostic favorable (2.54e-4)" "unprognostic (1.19e-3)" "unprognostic (1.67e-3)" "unprognostic (1.91e-3)" "unprognostic (5.30e-2)" 1.8 2.7 13.4 1.4 19.2 0.8 3.5 3.8 11.6 2.2 1.0 6.7 0.4 0.9 3.4 9.1 1.6 17.8 3.5 1.1 12.9 10.0 6.6 0.8 5.1 1.3 8.8 9.3 4.7 2.4 0.9 27.8 1.1 13.0 3.1 1.0 2.7 2.6 2.8 0.8 0.9 1.2 1.5 3.2 5.5 1.1 7.4 8.0 1.4 30.0 0.0 1.6 3.0 1.0 0.7 0.0 0.0 0.0 1.2 4.4 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.4 0.2 0.0 0.1 0.3 0.1 0.0 0.0 4.0 0.0 1.1 0.0 0.0 3.7 0.0 0.0 0.1 0.0 4.4 0.0 0.1 0.0 0.0 0.3 2.0 0.0 0.0 8.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 5.5 0.0 0.0 0.1 0.0 15.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.2 0.8 0.0 0.7 1.1 4.4 0.0 1.2 0.0 0.0 0.3 0.1 13.4 19.2 3.8 10.0 12.9 10.0 8.8 9.3 13.0 8.0 14.9 15.9 0.0 6.7 0.5 20.3 0.8 12.7 163.3 30.7 3.5 15.7 0.4 0.0 10.2 19.7 3.8 0.0 0.0 1.4 3.6 0.9 1.1 1.1 0.0 0.3 0.0 0.0 1.3 0.0 11.0 2.0 0.5 0.0 0.0 0.0 0.2 1.7 0.0 5.6 7.9 1.8 0.0 0.3 23.3 27.1 0.3 0.2 0.0 0.0 2.6 IQCD "CFAP84, DRC10" ENSG00000166578 "IQ motif containing D" Q96DY2 12 113195441-113221094 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 22.4;testis: 33.8" "Group enriched" "Detected in many" 7 "Ciliated cells: 124.5;Early spermatids: 118.9;Late spermatids: 69.7;Spermatocytes: 74.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 3.6;classical monocyte: 2.8;myeloid DC: 2.1;plasmacytoid DC: 3.7" "Group enriched" "Detected in many" 5 "dendritic cells: 3.7;granulocytes: 3.6;monocytes: 2.8" "Cell line enhanced" "Detected in many" "BJ hTERT+: 22.4;GAMG: 8.9;RPTEC TERT1: 11.1;U-698: 12.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA046810, HPA048782" Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA046810: AB_2679818, HPA048782: AB_2680519" "unprognostic (3.90e-2)" "unprognostic (4.61e-2)" "unprognostic (4.97e-2)" "unprognostic (4.28e-3)" "unprognostic (1.81e-1)" "unprognostic (7.11e-2)" "unprognostic (2.26e-5)" "unprognostic (2.23e-1)" "unprognostic (3.38e-2)" "unprognostic (3.04e-1)" "prognostic favorable (3.90e-4)" "unprognostic (1.54e-1)" "unprognostic (3.48e-3)" "unprognostic (4.09e-2)" "unprognostic (3.22e-2)" "unprognostic (1.79e-1)" "unprognostic (5.20e-2)" 1.2 1.2 2.8 1.3 6.4 0.6 1.8 2.0 3.8 2.6 1.1 6.8 1.7 0.6 2.3 6.3 1.8 22.4 1.4 1.6 3.8 3.2 3.4 0.6 3.0 1.3 4.8 1.5 2.5 1.4 5.4 8.7 1.2 11.4 1.1 1.2 1.6 1.2 1.7 0.7 0.9 0.7 1.4 2.5 0.6 1.0 33.8 6.4 0.0 4.0 1.1 3.3 1.6 1.0 0.6 3.7 3.6 2.8 0.0 0.1 0.5 2.7 3.2 1.1 0.8 1.2 1.3 0.7 0.4 22.4 1.1 1.5 0.5 8.7 3.0 2.4 0.6 8.9 0.5 0.5 0.9 1.8 0.2 0.9 1.0 1.1 0.5 0.7 0.3 0.7 0.5 0.7 3.5 1.1 6.1 0.7 1.2 0.2 0.2 0.2 3.2 0.2 5.8 0.2 1.4 0.8 0.2 0.5 0.8 11.1 3.4 2.5 1.0 0.7 1.1 3.5 0.9 4.0 1.7 0.3 0.5 1.7 1.1 0.6 0.9 0.7 12.0 1.6 0.1 1.9 3.6 2.8 0.0 0.1 0.2 0.0 0.6 0.0 0.0 2.1 0.2 0.0 0.1 0.1 0.0 0.0 3.7 0.0 0.5 2.8 6.4 2.0 3.8 3.8 3.2 4.8 1.5 11.4 6.4 3.0 1.7 0.0 2.7 2.2 0.4 3.4 5.1 124.5 11.4 5.2 13.7 1.2 11.6 2.3 118.9 0.1 1.3 0.0 0.7 0.2 2.4 1.7 0.0 0.4 1.9 0.0 6.3 1.8 0.0 69.7 2.0 1.3 3.3 2.8 0.6 6.5 0.7 0.3 4.9 11.8 4.8 0.0 1.4 74.6 4.7 1.5 1.6 0.8 0.0 3.5 IQCE KIAA1023 ENSG00000106012 "IQ motif containing E" Q6IPM2 7 2558972-2614734 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 360.6;Late spermatids: 290.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 8.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019515 Approved Approved Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA019515: AB_1851855" "unprognostic (2.29e-1)" "unprognostic (2.54e-1)" "unprognostic (3.78e-2)" "prognostic favorable (5.91e-4)" "unprognostic (7.96e-3)" "unprognostic (3.75e-1)" "unprognostic (2.54e-3)" "unprognostic (1.31e-1)" "unprognostic (4.04e-3)" "unprognostic (1.30e-2)" "unprognostic (1.66e-2)" "unprognostic (2.84e-1)" "unprognostic (2.04e-2)" "unprognostic (2.82e-2)" "unprognostic (6.97e-2)" "unprognostic (7.56e-3)" "unprognostic (3.13e-2)" 5.5 7.6 15.1 6.8 17.0 7.0 7.4 11.1 18.7 6.9 10.2 12.8 6.7 13.1 9.6 12.3 6.6 17.1 11.2 7.1 14.3 15.6 7.1 3.6 9.1 4.7 12.0 12.1 9.7 8.4 12.9 15.4 4.1 11.3 8.1 9.9 7.3 9.8 11.2 4.5 8.1 10.9 7.9 11.1 5.1 10.6 35.3 9.6 2.8 11.9 3.0 3.9 6.0 7.4 0.7 4.3 8.3 2.1 0.3 1.3 0.3 20.0 10.5 4.5 13.8 5.6 8.5 7.8 4.2 7.1 5.6 6.1 5.4 11.6 1.4 4.9 9.8 12.2 10.4 3.1 4.9 5.9 3.5 6.5 2.7 12.7 1.7 4.1 7.2 4.0 3.5 8.1 5.4 5.7 6.5 6.0 5.8 8.6 2.6 7.4 20.4 3.2 5.5 3.9 9.0 7.7 3.1 5.2 5.2 6.0 9.4 9.5 11.2 4.7 20.0 4.4 3.3 24.6 9.8 5.9 4.7 9.5 17.8 7.1 2.9 4.9 0.3 9.2 5.2 13.1 1.1 1.4 3.6 1.3 2.1 0.5 0.5 0.7 0.6 0.6 0.7 0.5 1.1 8.3 0.3 0.7 4.3 0.3 0.3 15.1 17.0 11.1 18.7 14.3 15.6 12.0 12.1 11.3 9.6 11.9 11.0 0.0 5.0 4.8 7.8 7.7 22.9 60.2 14.8 12.2 56.9 3.7 14.9 16.6 360.6 3.6 15.8 0.0 17.4 6.9 6.4 7.3 1.1 2.8 8.7 19.1 8.1 7.4 6.4 290.7 13.0 5.9 0.0 10.8 10.7 14.1 17.5 11.8 14.5 8.1 38.1 19.4 3.6 43.3 53.7 3.8 1.6 4.4 10.0 3.3 IQGAP3 ENSG00000183856 "IQ motif containing GTPase activating protein 3" Q86VI3 1 156525405-156572604 "Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.8;intestine: 13.0" "Cell type enhanced" "Detected in some" 14 "Cholangiocytes: 5.1;Late spermatids: 16.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 2.6" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA030142, HPA030143" Uncertain Approved "Nucleoplasm,Nucleoli rim" Yes Yes "Nucleoli rim" Nucleoplasm "HPA030142: AB_10600108, HPA030143: AB_10601104" "unprognostic (9.99e-3)" "unprognostic (5.24e-2)" "unprognostic (3.26e-1)" "unprognostic (1.55e-3)" "unprognostic (1.52e-1)" "unprognostic (4.69e-3)" "prognostic unfavorable (8.94e-6)" "unprognostic (1.86e-3)" "unprognostic (1.72e-1)" "unprognostic (1.98e-1)" "unprognostic (6.35e-3)" "unprognostic (1.03e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (4.46e-2)" "unprognostic (1.53e-1)" "unprognostic (6.30e-2)" "unprognostic (6.81e-2)" 3.2 1.2 0.3 5.4 0.3 14.8 0.6 0.3 0.8 1.4 10.1 0.4 1.3 7.0 1.1 3.7 9.8 0.3 1.8 1.8 0.4 0.2 1.5 1.1 2.6 1.4 0.3 0.3 0.5 0.4 0.0 0.3 6.5 0.8 0.8 5.5 0.4 1.8 0.3 0.5 3.8 13.0 2.9 1.5 1.5 5.1 6.8 0.3 12.2 0.4 3.1 7.3 0.9 3.1 0.2 0.9 0.5 0.3 0.6 2.6 0.0 23.5 11.4 10.7 7.5 0.6 1.7 5.2 17.5 11.7 17.2 15.5 13.0 21.8 2.1 6.5 10.3 9.1 22.5 7.3 9.0 15.5 0.0 6.5 3.1 22.4 6.4 0.1 3.8 0.0 0.5 1.0 14.4 21.3 4.2 10.0 5.1 6.3 3.4 12.6 12.4 2.2 5.5 7.8 23.3 11.5 7.6 12.0 2.4 4.4 8.1 6.8 10.5 15.9 18.7 6.4 13.1 14.9 10.3 6.5 15.6 18.7 12.7 20.6 1.6 0.8 1.0 5.2 6.1 17.6 0.5 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.1 0.6 0.1 0.1 0.1 0.2 0.6 0.3 0.9 2.6 0.0 0.3 0.3 0.3 0.8 0.4 0.2 0.3 0.3 0.8 0.3 0.0 0.0 0.5 0.0 1.1 0.0 0.8 5.1 0.0 0.0 0.0 0.0 1.2 0.0 0.1 4.7 0.0 1.1 0.0 0.0 3.1 0.5 0.2 0.0 0.0 3.4 0.0 1.2 4.3 0.3 16.8 0.3 2.2 0.0 0.0 2.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 3.8 2.4 0.9 0.7 0.0 2.9 0.4 IQSEC3 "KIAA1110, MGC30156" ENSG00000120645 "IQ motif and Sec7 domain 3" Q9UPP2 12 66765-178460 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.8" "Group enriched" "Detected in some" 4 "Bipolar cells: 32.6;Horizontal cells: 108.1" "Cancer enhanced" "Detected in many" "ovarian cancer: 3.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 1.2;plasmacytoid DC: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 9.7;U-266/70: 13.0;U-266/84: 3.1;U-937: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039025 Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA039025: AB_10672768" "unprognostic (2.73e-2)" "unprognostic (1.56e-2)" "unprognostic (1.26e-2)" "unprognostic (4.24e-3)" "unprognostic (4.32e-2)" "unprognostic (1.28e-1)" "unprognostic (4.44e-2)" "unprognostic (5.14e-2)" "unprognostic (3.91e-1)" "unprognostic (8.82e-3)" "unprognostic (2.83e-3)" "unprognostic (7.16e-2)" "unprognostic (2.28e-2)" "unprognostic (1.01e-2)" "unprognostic (1.18e-1)" "unprognostic (1.48e-2)" "unprognostic (1.36e-2)" 5.6 1.3 5.6 0.7 4.2 0.8 0.4 19.8 15.5 1.6 0.4 0.5 0.0 0.5 2.0 0.5 0.4 5.2 2.2 1.9 6.5 5.1 2.4 0.2 2.9 0.5 3.7 4.7 2.1 1.2 0.0 2.2 1.3 5.0 1.5 0.2 0.4 0.2 4.5 1.3 0.2 0.7 1.9 1.4 0.3 0.6 1.2 0.8 0.0 0.3 0.0 0.2 1.3 0.6 0.0 2.1 0.0 0.0 0.5 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.1 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 13.0 3.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 1.2 0.0 0.5 0.0 2.1 0.0 0.4 5.6 4.2 19.8 12.4 6.5 5.1 3.7 4.7 5.0 0.8 3.0 0.0 0.0 0.0 0.2 32.6 1.2 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 1.1 0.1 2.3 0.0 1.2 108.1 0.0 1.8 1.0 3.3 0.6 0.0 0.0 0.0 0.0 6.1 0.2 0.0 0.0 4.5 15.7 0.0 0.0 2.2 8.8 0.1 0.0 0.5 0.0 0.0 IRAK1 "IRAK, pelle" ENSG00000184216 "Interleukin 1 receptor associated kinase 1" P51617 X 154010500-154019980 "Enzymes, Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Exocrine glandular cells: 97.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004461, HPA054476" Supported Supported Nucleoplasm,Cytosol No No Cytosol Nucleoplasm "CAB004461: AB_2249106, HPA054476: AB_2682501" "unprognostic (4.46e-3)" "unprognostic (9.32e-2)" "unprognostic (1.71e-2)" "unprognostic (5.04e-3)" "unprognostic (7.09e-3)" "unprognostic (4.43e-3)" "prognostic unfavorable (3.03e-4)" "unprognostic (7.89e-3)" "unprognostic (3.36e-2)" "unprognostic (3.69e-2)" "unprognostic (1.95e-1)" "unprognostic (6.64e-2)" "prognostic unfavorable (2.06e-4)" "unprognostic (2.76e-3)" "unprognostic (2.36e-1)" "unprognostic (2.21e-3)" "unprognostic (3.04e-1)" 22.3 23.7 12.1 25.0 11.4 48.3 38.5 7.7 14.8 11.1 24.8 10.8 13.4 29.9 13.2 12.4 25.5 12.2 23.1 14.1 9.9 12.3 23.7 46.9 18.5 37.5 12.6 7.9 15.1 34.6 8.1 15.2 14.3 11.9 18.0 11.0 10.1 31.9 15.9 32.6 15.9 34.6 11.5 12.7 34.0 19.3 14.3 9.8 17.0 12.6 20.4 26.7 17.2 15.3 10.0 13.0 6.7 10.6 6.3 6.7 3.4 77.0 30.0 4.3 34.6 8.5 6.8 18.5 11.5 10.9 17.8 16.5 23.7 34.2 32.9 64.8 12.3 27.3 21.1 9.8 18.8 6.9 25.8 29.3 12.0 27.0 14.1 19.5 28.3 20.6 9.4 16.5 16.9 18.7 9.2 10.6 6.7 21.1 38.1 12.4 28.4 11.6 25.3 10.5 24.6 59.8 30.2 21.5 55.2 11.8 14.6 23.8 17.2 13.7 15.3 22.7 1.7 5.9 30.2 14.5 21.6 34.2 49.3 71.3 48.0 30.6 60.3 31.5 34.1 22.3 1.3 8.7 6.7 6.7 10.6 5.9 7.5 5.3 5.3 5.4 10.0 3.1 6.1 5.9 6.3 8.1 13.0 2.5 3.4 12.1 11.4 7.7 14.8 9.9 12.3 12.6 7.9 11.9 9.8 0.0 14.1 25.2 11.0 11.8 8.1 8.2 20.4 6.7 19.4 10.4 5.9 9.6 6.6 45.8 0.6 13.7 36.0 0.0 97.4 17.8 12.1 24.0 12.7 32.6 52.7 15.9 19.7 10.4 45.4 1.8 16.7 26.5 13.5 11.8 24.2 14.0 61.0 24.6 20.1 13.3 5.0 0.0 14.5 1.7 6.3 11.4 10.3 14.0 28.8 23.4 IRF1 MAR ENSG00000125347 "Interferon regulatory factor 1" P10914 5 132481609-132490798 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 103.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 47.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011662, HPA063131" Supported Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB011662: AB_775784, HPA063131: AB_2684945" "unprognostic (1.30e-3)" "unprognostic (2.00e-2)" "unprognostic (2.47e-3)" "unprognostic (1.21e-1)" "unprognostic (2.27e-1)" "unprognostic (4.48e-2)" "unprognostic (3.67e-1)" "unprognostic (1.64e-1)" "unprognostic (1.52e-2)" "unprognostic (2.24e-2)" "unprognostic (6.93e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (1.09e-7)" "unprognostic (1.93e-2)" "unprognostic (1.50e-1)" "unprognostic (1.21e-1)" "unprognostic (9.53e-3)" 19.7 8.5 4.1 64.2 9.9 43.8 21.0 3.9 4.6 10.6 27.3 4.0 4.4 31.1 11.4 9.9 12.4 11.8 18.1 11.8 4.2 3.5 14.2 20.9 49.3 41.0 6.8 1.4 11.5 14.5 2.8 8.8 24.7 10.3 18.9 13.6 10.3 13.2 10.3 14.0 8.4 52.1 11.3 8.0 51.7 17.5 5.7 4.9 36.6 26.5 14.7 33.0 14.7 26.7 12.1 16.2 103.0 42.1 21.3 28.5 21.3 9.0 7.4 0.6 2.5 7.2 6.2 14.9 4.3 18.5 13.9 17.4 3.8 27.1 9.0 5.9 6.5 20.8 12.7 2.3 10.5 4.7 19.1 2.5 12.1 3.5 2.7 47.5 5.9 10.4 11.8 2.6 10.3 9.8 8.7 6.5 6.0 2.1 34.8 3.8 5.0 32.0 9.9 0.8 2.8 5.2 37.2 7.8 11.0 7.1 10.2 1.4 1.1 4.6 10.4 4.4 3.4 1.7 8.1 4.1 8.0 2.8 4.6 6.4 27.6 6.9 6.4 9.1 9.4 5.7 23.1 26.2 40.2 28.5 40.0 19.4 12.1 18.7 22.9 16.2 11.5 11.5 16.0 103.0 21.3 42.1 8.2 20.2 21.3 4.1 9.9 3.9 4.6 4.2 3.5 6.8 1.4 10.3 4.9 95.3 109.6 113.9 70.4 78.3 13.4 11.8 35.7 113.8 61.4 21.0 31.4 19.3 16.6 94.9 95.1 107.4 136.0 23.3 99.6 32.8 121.3 247.1 102.7 13.6 47.7 1.6 83.5 49.7 57.7 7.8 25.3 107.0 69.2 266.1 57.5 16.3 73.7 119.3 7.4 13.9 36.6 12.9 178.3 1.1 3.6 72.3 9.4 207.0 53.2 80.6 IRF2 ENSG00000168310 "Interferon regulatory factor 2" P14316 4 184387713-184474580 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 173.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 50.9;Karpas-707: 53.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030813, CAB032306, HPA057327" Supported Enhanced "Nucleoplasm,Cell Junctions,Cytosol" NA NA Nucleoplasm "Cell Junctions, Cytosol" "CAB032306: AB_2249157, HPA030813: AB_10600718, HPA057327: AB_2683410" "prognostic favorable (6.95e-5)" "unprognostic (1.69e-3)" "unprognostic (5.43e-2)" "unprognostic (1.59e-3)" "unprognostic (2.70e-2)" "unprognostic (1.46e-1)" "unprognostic (2.48e-2)" "unprognostic (4.05e-2)" "unprognostic (8.37e-3)" "unprognostic (2.90e-2)" "unprognostic (4.00e-2)" "unprognostic (2.35e-1)" "unprognostic (6.87e-3)" "unprognostic (8.55e-3)" "unprognostic (5.25e-2)" "prognostic favorable (8.34e-5)" "unprognostic (1.31e-3)" 27.5 30.6 15.2 31.0 19.3 11.3 21.0 21.5 16.4 21.5 23.7 28.8 16.6 21.2 19.8 16.5 20.5 18.1 17.3 16.1 15.3 12.1 15.3 26.1 24.0 38.7 22.8 9.7 28.0 14.9 12.4 24.5 19.7 17.8 20.5 20.4 16.8 22.1 16.1 21.9 18.1 27.7 21.2 22.4 39.4 21.3 8.4 22.0 36.1 24.0 12.6 34.5 28.8 26.4 22.2 16.2 83.9 27.5 18.1 21.9 17.2 6.1 4.5 5.6 3.7 12.3 12.7 3.3 4.5 14.2 11.1 11.7 1.3 11.9 3.8 2.4 6.7 9.1 5.7 3.8 8.6 7.2 50.9 2.1 10.5 2.5 8.2 12.2 6.4 8.9 13.6 7.9 6.3 16.5 9.6 8.4 4.6 2.0 53.1 4.6 4.3 12.3 7.8 1.2 5.6 3.3 16.2 2.1 16.9 8.5 9.5 2.4 3.7 6.4 5.3 9.3 2.4 4.1 5.8 6.9 3.2 3.5 3.6 3.9 15.2 12.1 3.3 6.7 6.3 5.6 17.7 19.4 34.5 16.4 25.3 16.9 21.2 16.3 17.6 16.2 22.2 17.5 17.3 83.9 18.1 27.5 4.1 21.9 17.2 15.2 19.3 21.5 16.4 15.3 12.1 22.8 9.7 17.8 22.0 35.7 23.2 51.9 43.4 43.6 11.8 19.6 28.1 64.3 26.1 24.4 5.9 27.6 31.5 24.5 0.1 35.9 32.5 23.3 26.4 13.4 30.4 57.1 26.5 32.6 42.8 19.1 29.4 37.4 73.6 1.3 34.5 47.6 18.6 173.1 25.9 25.5 27.3 37.4 49.8 23.7 7.8 38.8 24.7 0.2 1.1 38.9 22.3 58.6 20.9 59.3 IRF2BP1 "DKFZP434M154, IRF-2BP1" ENSG00000170604 "Interferon regulatory factor 2 binding protein 1" Q8IU81 19 45883607-45886170 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 38.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042164, HPA049480" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA042164: AB_2677882, HPA049480: AB_2680785" "unprognostic (5.90e-2)" "unprognostic (1.34e-1)" "unprognostic (8.86e-2)" "unprognostic (9.49e-2)" "unprognostic (1.78e-1)" "unprognostic (2.61e-2)" "unprognostic (1.62e-1)" "unprognostic (1.67e-1)" "unprognostic (3.03e-1)" "unprognostic (1.01e-1)" "prognostic favorable (2.32e-4)" "unprognostic (2.60e-1)" "prognostic favorable (3.85e-5)" "unprognostic (1.33e-2)" "unprognostic (6.99e-2)" "unprognostic (2.66e-1)" "unprognostic (5.07e-3)" 14.2 11.9 12.2 9.0 14.1 6.7 8.7 23.1 26.2 12.7 11.2 12.6 10.6 14.4 15.3 8.1 8.2 12.4 12.6 10.8 11.8 11.7 12.0 14.8 10.0 9.5 13.2 12.8 20.3 18.5 12.4 15.6 8.6 12.5 13.5 4.8 12.6 19.6 15.2 33.4 13.4 12.4 9.3 8.7 15.6 16.4 8.0 12.8 17.4 13.7 8.0 8.6 12.0 8.7 2.7 2.0 1.4 1.7 2.4 3.6 1.6 8.3 12.8 3.2 7.0 2.7 1.7 5.2 6.2 3.6 5.0 4.4 4.8 4.0 6.8 4.7 3.1 2.9 7.9 2.2 2.3 1.4 8.5 22.3 6.8 3.6 6.0 5.5 7.0 6.4 2.4 3.2 2.6 1.9 3.1 3.0 8.5 10.7 5.4 1.9 6.5 14.2 38.4 5.9 3.1 11.4 16.4 3.7 5.8 3.5 4.7 9.5 16.2 6.5 8.6 7.8 1.2 7.1 13.1 4.3 4.3 8.7 3.3 8.7 14.8 16.3 4.0 5.8 6.7 6.2 0.0 1.2 0.4 2.8 1.7 2.8 2.7 2.5 2.3 1.1 2.3 3.6 2.2 1.4 2.4 0.7 2.0 2.3 1.6 12.2 14.1 23.1 26.2 11.8 11.7 13.2 12.8 12.5 12.8 0.0 1.4 10.4 5.2 9.5 13.2 0.9 5.1 1.4 0.0 10.4 0.0 9.7 11.6 6.7 1.3 4.7 7.9 0.0 8.1 6.2 7.3 7.0 0.0 7.6 4.2 9.5 9.2 5.5 2.6 1.0 17.3 3.9 8.5 2.8 9.8 12.0 6.1 10.5 10.3 10.1 6.4 19.4 7.3 3.6 1.9 9.8 7.3 4.8 8.0 2.6 IRF2BP2 IRF-2BP2 ENSG00000168264 "Interferon regulatory factor 2 binding protein 2" Q7Z5L9 1 234604269-234609525 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Urothelial cells: 396.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 75.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027815, HPA062269" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA027815: AB_10609994, HPA062269: AB_2684732" "unprognostic (1.15e-3)" "unprognostic (1.02e-1)" "unprognostic (3.90e-1)" "unprognostic (2.13e-1)" "unprognostic (3.41e-3)" "unprognostic (1.69e-1)" "unprognostic (1.74e-3)" "unprognostic (1.97e-2)" "unprognostic (8.77e-2)" "unprognostic (2.19e-1)" "unprognostic (3.69e-2)" "unprognostic (2.83e-1)" "prognostic unfavorable (6.42e-4)" "unprognostic (1.25e-1)" "unprognostic (2.70e-1)" "unprognostic (3.14e-1)" "unprognostic (3.77e-1)" 17.9 14.5 11.3 21.1 12.9 48.0 29.9 16.5 17.6 19.8 19.3 13.8 10.9 13.9 20.3 13.1 17.3 17.1 31.6 19.6 12.7 11.5 12.3 20.4 35.0 30.3 11.1 10.6 25.3 22.6 15.9 10.8 11.1 13.9 18.5 18.1 16.8 19.6 12.9 18.8 25.2 20.0 11.6 15.0 16.2 17.0 23.9 11.3 28.6 21.1 14.6 19.5 17.4 19.4 4.0 17.4 8.9 4.5 2.8 5.1 2.3 7.5 11.7 8.4 12.9 17.7 14.1 10.1 6.1 5.2 3.7 4.1 6.7 9.4 0.0 14.4 5.8 12.3 10.5 4.5 8.0 5.7 12.4 10.6 7.3 9.2 19.8 14.4 26.9 25.7 16.5 18.6 8.1 15.3 21.0 9.1 6.9 6.3 15.6 9.3 2.2 6.8 28.7 7.6 17.8 4.5 13.4 3.9 17.9 7.0 6.3 16.9 11.9 9.8 13.1 19.1 8.7 12.6 75.3 10.2 13.1 5.5 9.7 11.4 34.7 9.0 2.5 6.5 24.6 17.7 8.9 4.5 7.6 4.1 3.4 4.2 4.0 5.0 4.8 4.5 3.9 5.1 4.3 2.3 2.8 1.8 17.4 3.7 2.3 11.3 12.9 16.5 17.6 12.7 11.5 11.1 10.6 13.9 11.3 125.0 159.6 51.3 373.3 289.5 29.7 48.7 129.9 73.6 138.8 48.8 9.8 34.2 11.6 50.2 20.2 107.9 65.6 70.0 43.0 37.5 72.0 119.8 103.0 148.0 75.7 55.6 139.8 102.5 119.4 18.0 64.5 110.8 104.6 13.6 101.3 95.4 59.9 66.6 76.4 35.8 18.6 77.6 123.6 20.5 17.0 346.3 66.4 45.8 141.3 396.8 IRF2BPL "C14orf4, EAP1, KIAA1865" ENSG00000119669 "Interferon regulatory factor 2 binding protein like" Q9H1B7 14 77024543-77028699 "Plasma proteins, Predicted intracellular proteins" Transferase "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050862, HPA061333" Approved Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA050862: AB_2681258, HPA061333: AB_2684481" "unprognostic (5.58e-2)" "unprognostic (6.48e-2)" "unprognostic (1.99e-3)" "prognostic unfavorable (5.52e-4)" "unprognostic (8.78e-3)" "unprognostic (1.57e-2)" "unprognostic (2.70e-1)" "unprognostic (1.81e-1)" "unprognostic (5.74e-2)" "unprognostic (2.53e-2)" "unprognostic (2.51e-3)" "unprognostic (5.39e-2)" "unprognostic (1.03e-3)" "unprognostic (2.55e-1)" "unprognostic (9.33e-2)" "unprognostic (1.14e-1)" "unprognostic (1.58e-2)" 24.2 21.6 12.7 13.7 13.0 7.9 24.4 20.3 17.9 21.0 21.0 9.8 18.2 11.0 19.3 13.3 16.3 26.3 23.4 21.3 12.9 12.3 19.7 16.3 15.6 12.7 13.8 7.4 36.9 18.2 35.8 17.2 13.7 15.7 20.2 6.0 19.7 26.2 20.2 15.9 17.0 11.1 18.4 13.5 18.4 13.9 15.3 13.4 27.4 27.6 7.1 9.8 21.8 24.6 2.1 12.2 9.9 2.4 6.5 3.4 0.7 6.8 6.0 14.9 16.7 4.5 4.2 21.3 7.2 5.9 2.0 2.7 2.8 11.3 2.4 5.3 6.1 5.8 10.7 2.5 5.3 1.7 11.4 8.8 3.0 5.9 3.8 5.9 0.8 13.8 5.6 4.2 3.6 3.2 16.3 2.7 5.0 4.5 27.4 2.6 18.7 9.2 6.4 6.7 2.9 31.3 1.9 4.2 5.6 7.1 10.1 11.6 16.8 10.2 10.7 17.8 4.2 7.4 1.5 4.7 9.5 9.3 3.1 4.6 10.6 11.3 4.1 14.7 2.1 11.8 1.5 1.6 1.4 3.4 2.2 3.2 1.7 3.0 3.1 1.4 2.1 2.5 2.6 9.9 6.5 2.4 12.2 2.9 0.7 12.7 13.0 20.3 14.1 12.9 12.3 13.8 7.4 15.7 13.4 20.8 14.7 25.3 28.2 65.5 56.8 14.7 38.2 8.1 9.1 61.1 27.5 17.1 31.5 19.5 1.2 24.8 5.6 0.0 16.4 44.6 44.5 25.7 25.5 42.3 28.3 9.5 45.8 48.5 47.9 2.7 27.9 17.0 33.7 0.0 13.5 45.5 16.0 3.5 32.2 19.3 10.0 38.8 33.3 1.7 28.8 44.3 38.4 25.5 11.9 17.6 IRF4 "LSIRF, MUM1" ENSG00000137265 "Interferon regulatory factor 4" Q15306 6 391739-411447 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 48.7" "Group enriched" "Detected in some" 6 "Melanocytes: 42.2;monocytes: 92.8" "Cancer enriched" "Detected in many" 9 "melanoma: 27.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory B-cell: 9.5;myeloid DC: 9.0;naive B-cell: 9.7;plasmacytoid DC: 10.4;T-reg: 4.8" "Group enriched" "Detected in many" 5 "B-cells: 9.7;dendritic cells: 10.4;T-cells: 4.8" "Cell line enhanced" "Detected in some" "HDLM-2: 50.2;Karpas-707: 46.7;RPMI-8226: 45.1;U-266/70: 42.2;U-266/84: 31.4;WM-115: 25.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA002038, HPA002698, CAB013508" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB013508: , HPA002038: AB_1079148, HPA002698: AB_1851893" "prognostic favorable (6.44e-4)" "unprognostic (1.88e-3)" "unprognostic (1.00e-3)" "unprognostic (1.72e-4)" "unprognostic (2.74e-1)" "prognostic favorable (1.64e-6)" "unprognostic (4.72e-2)" "unprognostic (1.05e-1)" "unprognostic (1.89e-2)" "unprognostic (5.74e-4)" "unprognostic (8.51e-2)" "unprognostic (1.12e-1)" "unprognostic (9.18e-7)" "unprognostic (2.38e-1)" "unprognostic (6.24e-2)" "unprognostic (2.90e-1)" "unprognostic (3.65e-2)" 7.1 0.5 0.4 36.6 0.4 18.4 4.0 0.4 0.4 17.4 13.9 0.1 0.4 5.0 2.2 0.7 6.4 1.2 4.1 1.6 0.4 0.5 1.4 5.6 4.2 31.5 0.5 0.0 1.9 0.7 0.0 0.7 0.5 0.1 1.5 4.8 15.8 21.3 1.9 0.7 4.5 11.1 0.3 0.6 33.8 4.6 1.7 0.1 15.2 1.3 2.4 48.7 8.4 4.2 9.7 10.4 0.0 1.6 0.2 4.8 1.3 0.1 0.0 0.0 0.0 5.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.9 0.0 45.1 0.0 0.0 0.1 0.0 0.0 0.0 7.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.2 31.4 13.7 0.0 0.0 25.6 0.0 1.6 0.0 0.6 1.2 0.0 9.5 0.9 0.9 9.0 9.7 1.6 0.7 0.0 0.2 1.2 10.4 4.8 1.3 0.4 0.4 0.4 0.4 0.4 0.5 0.5 0.0 0.1 0.1 0.0 4.0 12.0 0.1 7.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.6 0.0 0.6 0.2 0.0 0.2 0.2 0.0 0.0 1.8 0.0 0.0 3.1 6.9 42.2 92.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.1 3.8 0.1 6.2 0.0 0.0 IRF6 "LPS, OFC6, VWS, VWS1" ENSG00000117595 "Interferon regulatory factor 6" O14896 1 209785623-209806175 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 344.0;Suprabasal keratinocytes: 482.8;Urothelial cells: 297.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "cerebellum: 8.6;pons and medulla: 4.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 16.4;HaCaT: 59.6;HBEC3-KT: 21.8;hTCEpi: 48.0;hTERT-HME1: 24.0;RT4: 21.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA063121, HPA076162" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA063121: AB_2684942, HPA076162: AB_2686780" "unprognostic (2.59e-1)" "unprognostic (1.79e-3)" "unprognostic (1.74e-1)" "unprognostic (7.80e-2)" "unprognostic (1.33e-2)" "unprognostic (4.94e-3)" "unprognostic (1.46e-1)" "unprognostic (1.36e-1)" "unprognostic (7.82e-2)" "unprognostic (1.46e-1)" "unprognostic (1.74e-3)" "unprognostic (2.03e-1)" "prognostic favorable (0.00e+0)" "unprognostic (2.70e-1)" "unprognostic (2.66e-2)" "unprognostic (2.14e-1)" "unprognostic (4.42e-2)" 1.0 6.3 1.1 4.1 1.0 0.3 13.3 8.6 0.9 11.7 12.9 1.0 38.6 9.2 3.9 31.4 63.7 7.6 17.5 10.3 1.1 0.8 12.9 18.4 8.8 0.3 0.9 0.7 3.9 13.9 10.3 6.8 26.7 4.4 21.8 11.3 1.5 24.8 34.6 0.6 45.6 20.3 3.1 1.1 1.2 9.5 4.3 0.3 13.0 22.1 32.3 33.8 15.0 19.1 0.9 0.5 2.0 1.0 0.6 2.8 0.7 16.4 0.0 0.0 0.0 0.1 0.0 6.2 0.0 0.1 0.0 0.0 3.4 5.8 0.0 0.0 0.0 0.0 59.6 0.0 21.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.0 0.0 24.0 0.0 0.9 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.3 4.6 0.0 0.0 0.0 0.0 2.1 21.3 5.3 1.7 0.4 9.5 0.5 1.1 6.8 0.1 0.0 0.0 0.0 0.0 0.0 0.2 4.2 0.0 0.0 0.0 0.0 0.2 0.1 2.0 2.8 1.0 1.9 0.6 0.6 0.9 0.5 0.9 2.1 1.1 0.1 0.6 0.1 0.2 0.0 0.7 1.1 1.0 8.6 0.9 1.1 0.8 0.9 0.7 4.4 0.3 14.9 7.2 0.8 177.1 344.0 0.0 23.2 40.8 46.8 50.0 33.2 0.0 79.7 23.2 31.5 0.9 4.3 54.6 0.0 16.8 20.9 7.3 126.3 2.3 30.2 7.1 0.0 57.5 1.3 1.2 0.0 0.6 2.3 33.7 1.8 54.2 5.2 36.6 51.8 0.0 10.3 0.4 0.0 10.3 9.0 3.6 482.8 135.1 0.0 36.4 297.3 IRF7 ENSG00000185507 "Interferon regulatory factor 7" Q92985 11 612553-615999 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 81.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 12 "plasmacytoid DC: 81.1" "Lineage enriched" "Detected in all" 12 "dendritic cells: 81.1" "Cell line enhanced" "Detected in some" "EFO-21: 6.1;JURKAT: 2.9;Karpas-707: 10.7;SCLC-21H: 5.3;SK-BR-3: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB017694, HPA052757" Approved Supported Nucleoplasm,Cytosol No NA Nucleoplasm Cytosol "CAB017694: AB_2280489, HPA052757: AB_2681937" "unprognostic (1.39e-2)" "unprognostic (3.26e-2)" "unprognostic (1.08e-3)" "unprognostic (2.45e-1)" "unprognostic (4.52e-2)" "unprognostic (2.73e-1)" "unprognostic (1.04e-2)" "unprognostic (2.52e-2)" "unprognostic (1.39e-1)" "unprognostic (1.16e-1)" "unprognostic (7.08e-2)" "unprognostic (8.13e-2)" "prognostic unfavorable (1.71e-10)" "unprognostic (2.50e-1)" "unprognostic (1.07e-1)" "unprognostic (2.58e-1)" "unprognostic (4.71e-2)" 9.6 4.7 4.5 9.9 6.1 17.2 12.1 2.9 4.9 4.8 4.6 2.5 2.2 2.2 4.2 5.1 6.9 4.9 9.0 5.2 3.7 2.0 8.2 23.3 11.6 12.8 4.6 1.4 4.8 3.6 2.2 3.8 4.8 5.5 5.3 2.9 5.2 5.4 7.4 6.1 4.1 8.4 5.7 4.5 19.0 4.5 4.0 5.2 8.5 9.0 2.4 12.8 7.5 3.9 2.5 81.1 3.7 6.6 2.1 1.5 1.8 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.3 0.0 0.0 0.2 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.5 0.2 0.1 2.9 0.0 10.7 0.9 0.0 0.7 0.0 0.0 1.5 0.0 0.0 0.3 0.0 0.0 0.1 5.3 0.0 0.0 3.2 0.0 0.9 0.0 1.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.7 3.7 1.1 6.6 1.1 2.5 1.0 1.2 3.3 2.4 1.1 1.2 1.7 2.1 6.1 81.1 1.5 1.8 4.5 6.1 2.9 4.9 3.7 2.0 4.6 1.4 5.5 5.2 14.9 24.2 54.6 23.1 30.6 0.2 4.4 12.7 16.0 9.1 19.2 0.0 5.2 8.3 25.9 3.8 20.4 38.6 23.3 15.1 33.9 18.3 29.0 31.1 24.9 34.1 0.0 25.2 10.4 19.3 16.9 11.2 41.8 35.4 75.7 24.1 2.9 23.7 31.6 4.6 5.9 4.3 12.9 17.5 0.4 6.1 24.8 20.1 31.9 10.1 30.8 IRF8 "ICSBP, ICSBP1, IRF-8" ENSG00000140968 "Interferon regulatory factor 8" Q02556 16 85898803-85922609 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Autophagy, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 197.4;lymphoid tissue: 64.4" "Cell type enhanced" "Detected in many" 13 "B-cells: 159.1;Hofbauer cells: 61.3;Kupffer cells: 76.1;Macrophages: 82.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "plasmacytoid DC: 197.4" "Lineage enriched" "Detected in many" 6 "dendritic cells: 197.4" "Cell line enhanced" "Detected in some" "Daudi: 35.6;THP-1: 60.1;U-698: 140.9;U-937: 19.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002267, HPA002531, CAB013480" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB013480: AB_2533439, HPA002267: AB_1079143, HPA002531: AB_1851904" "unprognostic (2.09e-3)" "unprognostic (7.51e-2)" "unprognostic (5.16e-2)" "unprognostic (1.19e-1)" "unprognostic (7.54e-2)" "unprognostic (3.46e-3)" "unprognostic (3.19e-2)" "unprognostic (5.31e-3)" "unprognostic (1.23e-1)" "unprognostic (1.20e-1)" "unprognostic (1.66e-1)" "unprognostic (5.31e-2)" "unprognostic (3.14e-3)" "unprognostic (3.97e-2)" "unprognostic (9.66e-3)" "unprognostic (4.04e-1)" "unprognostic (1.10e-2)" 12.4 4.0 6.8 36.1 8.8 19.2 6.7 2.6 5.3 2.3 7.8 8.3 6.8 12.3 2.3 3.0 3.7 2.9 5.6 2.9 5.8 3.3 5.6 9.9 11.7 60.4 9.3 3.1 2.1 3.1 0.2 2.2 2.7 6.7 3.3 10.0 2.2 6.1 8.9 1.5 2.6 36.4 3.6 10.9 64.4 6.5 2.2 8.8 18.4 3.6 2.3 63.3 8.3 2.1 31.8 197.4 0.7 10.8 8.9 0.3 9.8 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 3.8 0.0 35.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.8 0.0 3.2 0.0 1.1 0.1 4.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 60.1 0.0 0.0 1.6 0.0 0.1 0.0 0.0 140.9 0.0 19.9 0.0 0.5 10.7 0.2 0.2 10.8 0.3 29.3 0.1 0.1 23.7 31.8 0.3 0.2 0.7 8.9 7.2 197.4 0.0 9.8 6.8 8.8 2.6 5.3 5.8 3.3 9.3 3.1 6.7 8.8 0.0 6.2 159.1 1.1 9.3 0.0 1.2 2.5 0.0 2.3 0.0 0.0 0.5 1.7 0.4 1.4 3.9 16.1 0.0 1.2 4.7 6.4 0.9 2.3 5.6 61.3 0.0 27.5 3.1 76.1 3.7 0.3 82.3 42.2 7.2 5.8 0.4 0.2 11.9 0.0 2.2 0.0 6.5 4.4 0.5 5.5 8.2 0.9 13.8 19.3 2.5 IRS1 HIRS-1 ENSG00000169047 "Insulin receptor substrate 1" P35568 2 226731317-226799759 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Transducer "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 56.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 1.0;naive B-cell: 1.2" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005261, HPA046433" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB005261: AB_649615, HPA046433: AB_2732524" "unprognostic (2.20e-1)" "unprognostic (1.98e-2)" "unprognostic (2.52e-1)" "unprognostic (1.59e-2)" "unprognostic (3.86e-3)" "unprognostic (1.61e-1)" "unprognostic (1.44e-1)" "unprognostic (1.80e-3)" "unprognostic (5.47e-2)" "unprognostic (2.24e-2)" "unprognostic (5.48e-3)" "unprognostic (1.10e-1)" "unprognostic (1.36e-3)" "unprognostic (1.46e-2)" "unprognostic (6.92e-2)" "unprognostic (3.23e-2)" "unprognostic (7.55e-3)" 7.0 9.9 3.1 5.0 2.7 0.6 11.7 9.6 5.4 13.3 14.2 1.4 3.9 4.0 17.2 5.0 3.8 13.9 11.5 6.3 3.9 2.2 5.2 12.0 5.0 2.5 2.3 2.6 21.9 7.1 3.4 2.5 9.1 4.2 9.8 2.9 5.5 3.3 7.5 23.3 5.1 6.5 11.7 2.6 3.3 5.8 2.4 1.7 17.1 23.4 5.6 2.5 14.6 15.8 1.2 0.4 0.0 0.2 0.0 0.3 0.2 3.2 15.0 10.9 0.4 15.1 9.0 0.0 9.0 7.1 12.0 7.8 8.5 8.3 1.3 1.5 6.1 8.3 5.7 0.7 8.6 6.9 3.3 0.6 0.0 1.0 4.0 7.5 0.3 0.0 12.5 4.8 9.5 8.6 7.3 0.0 1.3 1.6 13.3 8.1 12.8 2.7 3.7 4.4 2.0 8.3 0.6 14.2 0.1 5.5 10.8 1.9 0.3 2.9 2.1 4.8 9.2 8.0 0.1 0.7 16.0 14.6 12.2 8.6 6.2 2.5 2.0 15.8 0.3 4.7 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.1 0.1 0.1 1.2 0.2 0.1 0.0 0.0 0.0 0.4 0.3 0.2 3.1 2.7 9.6 5.4 3.9 2.2 2.3 2.6 4.2 1.7 17.9 5.8 0.5 24.9 31.5 18.2 11.5 12.7 4.0 6.8 0.0 0.0 5.2 14.9 12.8 1.3 2.0 11.1 0.0 9.5 0.7 21.2 13.8 0.0 56.3 1.6 19.1 2.4 3.1 1.0 0.0 21.0 0.6 15.1 0.0 7.5 7.6 8.9 10.4 13.8 2.2 1.9 12.9 14.2 1.1 0.7 20.7 15.3 0.0 5.7 21.8 IRX1 IRX-5 ENSG00000170549 "Iroquois homeobox 1" P78414 5 3596054-3601403 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.1;breast: 36.0;salivary gland: 20.9" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 6.0;Collecting duct cells: 5.2;Distal tubular cells: 13.3;Smooth muscle cells: 4.5" "Group enriched" "Detected in many" 6 "breast cancer: 5.6;glioma: 6.6;testis cancer: 15.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 7.2;REH: 29.0;U-251 MG: 11.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043160 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA043160: AB_10794771" "unprognostic (1.52e-2)" "unprognostic (1.26e-2)" "unprognostic (2.27e-1)" "unprognostic (3.73e-2)" "unprognostic (4.30e-3)" "unprognostic (2.70e-1)" "unprognostic (2.02e-2)" "unprognostic (2.03e-2)" "unprognostic (9.78e-4)" "unprognostic (5.11e-2)" "unprognostic (2.78e-2)" "unprognostic (3.58e-2)" 5.3 0.4 2.6 0.4 2.1 1.4 36.0 6.6 1.5 0.4 0.4 2.0 6.0 0.4 0.4 1.7 0.8 0.4 0.4 1.0 3.1 3.2 13.9 0.4 8.0 0.6 4.2 1.0 0.4 0.7 0.4 0.7 0.4 16.1 0.5 0.4 2.8 20.9 1.5 0.4 6.8 0.4 0.4 5.1 0.4 0.4 0.5 1.6 3.0 0.5 0.5 0.9 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.4 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 1.4 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 29.0 0.0 0.0 2.3 0.0 1.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.1 6.6 0.2 3.1 3.2 4.2 1.0 16.1 1.6 6.0 3.0 0.0 0.0 3.2 0.5 2.0 0.0 2.7 1.2 5.2 0.0 0.2 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.5 0.0 0.2 2.6 0.2 0.0 0.0 0.0 IRX2 ENSG00000170561 "Iroquois homeobox 2" Q9BZI1 5 2745845-2751662 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.9;breast: 27.9;lung: 32.8;salivary gland: 26.6" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 101.3;Alveolar cells type 2: 59.1;Basal keratinocytes: 179.6;Suprabasal keratinocytes: 114.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "pons and medulla: 36.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 40.5;BEWO: 24.3;HaCaT: 13.8;hTCEpi: 26.6;SK-BR-3: 16.3" "Group enriched" "Detected in many" 5 "midbrain: 31.6;pons and medulla: 21.8;thalamus: 12.3" "Low region specificity" "Detected in all" "HPA050895, HPA054669" Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA050895: AB_2616458, HPA054669: AB_2682566" "unprognostic (9.79e-2)" "unprognostic (1.93e-2)" "unprognostic (8.48e-2)" "unprognostic (5.50e-3)" "unprognostic (8.12e-2)" "unprognostic (3.07e-3)" "unprognostic (1.33e-1)" "unprognostic (7.47e-3)" "unprognostic (1.95e-1)" "unprognostic (3.07e-1)" "prognostic favorable (8.84e-4)" "unprognostic (2.62e-2)" "unprognostic (3.98e-7)" "unprognostic (4.40e-2)" "unprognostic (2.49e-1)" "unprognostic (3.67e-2)" "unprognostic (8.97e-2)" 2.4 0.1 0.8 0.1 2.8 0.1 27.9 8.4 1.7 0.4 0.7 0.7 4.4 0.1 0.1 2.5 3.1 0.2 0.1 2.1 1.9 1.7 14.3 0.1 32.8 0.3 3.9 0.2 0.1 1.9 2.7 1.4 9.0 36.9 3.9 0.3 1.8 26.6 1.4 0.3 17.7 0.1 0.1 4.8 0.1 8.7 3.1 2.2 0.0 1.4 3.1 3.2 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 40.5 0.0 2.2 1.6 24.3 2.4 1.3 2.0 1.6 4.8 0.0 0.0 0.0 4.5 0.0 13.8 0.0 9.9 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 26.6 0.9 8.2 0.0 0.0 0.0 0.0 0.0 1.4 7.8 0.0 0.0 4.5 10.5 0.0 0.0 2.5 0.0 9.0 0.0 1.5 0.0 7.9 16.3 0.0 6.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.8 8.4 0.5 1.9 1.7 3.9 0.2 36.9 2.2 101.3 59.1 0.0 14.0 179.6 0.5 2.4 0.0 10.7 30.7 7.0 0.0 23.0 23.2 0.1 3.9 0.5 0.5 0.0 0.0 17.1 12.8 15.9 1.1 0.0 2.8 0.0 0.0 0.0 0.0 8.9 0.0 1.3 18.6 0.0 1.5 0.2 0.5 1.9 0.0 0.5 2.4 0.0 16.9 0.7 3.8 114.7 12.7 0.0 1.9 9.2 IRX4 ENSG00000113430 "Iroquois homeobox 4" P78413 5 1877413-1887236 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 11.2;heart muscle: 11.0;skin 1: 14.2" "Cell type enhanced" "Detected in some" 21 "Basal keratinocytes: 43.0;Glandular cells: 12.7;Suprabasal keratinocytes: 17.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 19 "pons and medulla: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 31.0;HaCaT: 11.5;HBEC3-KT: 6.4;MCF7: 5.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 12 "pons and medulla: 1.9" HPA064094 Uncertain Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA064094: " "unprognostic (1.00e-2)" "unprognostic (1.00e-1)" "unprognostic (1.90e-1)" "unprognostic (3.01e-1)" "unprognostic (1.35e-2)" "unprognostic (2.77e-1)" "unprognostic (1.53e-1)" "unprognostic (1.35e-1)" "unprognostic (7.52e-2)" "unprognostic (7.54e-2)" "unprognostic (4.26e-1)" "unprognostic (1.70e-2)" 0.2 0.2 0.1 0.1 0.1 0.3 5.1 0.1 0.2 2.4 0.1 0.1 0.1 0.1 0.1 0.1 11.2 0.1 0.1 11.0 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.1 2.7 7.8 0.1 0.1 6.7 0.1 1.2 14.2 0.1 1.0 0.1 0.1 0.1 1.7 0.1 0.1 0.1 2.5 2.1 0.1 7.3 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 11.5 0.0 6.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 5.5 0.7 0.0 0.1 3.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 2.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 2.7 0.1 0.0 0.0 0.0 4.2 43.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.2 0.6 12.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.3 17.7 3.1 0.0 0.0 1.3 IRX6 "IRX-3, IRX7" ENSG00000159387 "Iroquois homeobox 6" P78412 16 55323760-55330760 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 11.1;breast: 18.9;heart muscle: 11.1;skin 1: 9.3" "Cell type enhanced" "Detected in some" 11 "Collecting duct cells: 5.2;Hofbauer cells: 3.5;Late spermatids: 3.8;Melanocytes: 3.3" "Cancer enhanced" "Detected in many" "melanoma: 5.9" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Lineage enriched" "Detected in single" 11 "B-cells: 1.1" "Cell line enhanced" "Detected in some" "AF22: 2.4;HEK 293: 2.9;RPTEC TERT1: 10.6;SK-MEL-30: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA018332 Uncertain Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA018332: AB_1851920" "unprognostic (1.22e-1)" "unprognostic (1.02e-1)" "unprognostic (4.93e-4)" "unprognostic (2.48e-2)" "unprognostic (6.50e-2)" "unprognostic (3.46e-1)" "prognostic favorable (3.34e-4)" "unprognostic (3.63e-2)" "unprognostic (4.36e-2)" "unprognostic (2.93e-2)" "unprognostic (1.50e-2)" "unprognostic (2.83e-2)" "unprognostic (9.63e-3)" "unprognostic (7.12e-3)" "unprognostic (5.48e-2)" "unprognostic (5.23e-3)" 11.1 0.0 0.2 0.2 1.4 0.0 18.9 0.2 0.5 3.3 0.2 0.2 0.2 0.0 0.6 0.2 0.5 0.0 0.2 11.1 0.2 0.4 1.5 0.2 2.3 0.2 0.2 0.2 0.5 0.2 0.1 0.2 0.2 0.2 0.2 0.0 2.0 2.5 0.2 2.7 9.3 0.2 0.2 0.2 1.6 0.0 0.6 0.2 3.5 0.7 0.2 2.3 0.2 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.6 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 10.6 0.0 0.2 0.1 0.1 1.8 6.8 0.1 0.6 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.2 0.5 0.2 0.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.7 0.6 1.1 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 3.8 0.0 0.0 3.3 1.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.3 0.9 0.1 0.0 0.0 0.0 ISG20L2 FLJ12671 ENSG00000143319 "Interferon stimulated exonuclease gene 20 like 2" Q9H9L3 1 156721891-156728799 "Predicted intracellular proteins" "Ribosome biogenesis" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 98.1" "Group enriched" "Detected in many" 29 "Early spermatids: 725.4;Late spermatids: 2397.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028005, HPA054285" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA028005: AB_2126319, HPA054285: " "unprognostic (1.67e-2)" "unprognostic (7.87e-2)" "unprognostic (2.80e-1)" "prognostic unfavorable (4.63e-4)" "unprognostic (3.52e-1)" "unprognostic (1.65e-2)" "prognostic unfavorable (6.15e-5)" "unprognostic (1.02e-1)" "unprognostic (9.55e-2)" "unprognostic (6.05e-2)" "unprognostic (2.40e-1)" "unprognostic (8.17e-2)" "prognostic unfavorable (4.80e-5)" "unprognostic (5.11e-2)" "unprognostic (2.68e-1)" "unprognostic (3.82e-3)" "unprognostic (2.32e-1)" 8.0 7.9 8.5 9.5 10.5 12.1 9.7 15.4 11.2 8.6 8.9 10.2 8.9 7.7 10.6 8.5 13.8 9.3 7.9 8.2 7.9 6.1 8.6 10.1 7.9 11.1 8.5 7.6 11.1 9.3 8.4 10.6 10.5 8.3 8.8 11.3 7.5 8.8 9.0 7.2 10.6 10.5 11.6 7.9 10.6 9.2 98.1 9.4 14.1 8.4 7.6 14.3 9.8 9.2 9.5 8.0 20.4 10.6 11.9 9.9 5.5 13.5 10.2 9.5 10.1 9.9 7.7 14.6 9.7 9.2 13.4 9.3 14.0 10.8 25.6 12.3 7.9 6.0 18.8 22.0 16.3 10.3 13.3 13.8 13.8 7.9 7.9 9.8 33.1 15.1 7.7 16.1 12.4 13.6 8.2 12.1 11.8 22.1 12.0 8.6 18.5 15.0 8.6 30.1 29.2 17.6 18.5 10.8 16.9 9.2 10.6 18.6 23.5 11.7 32.0 9.3 14.7 20.6 21.3 7.2 7.6 11.0 8.7 18.8 15.9 24.6 33.3 6.8 16.8 9.8 20.4 8.3 15.5 8.5 10.1 9.9 7.7 7.0 8.7 8.0 9.5 6.8 8.3 16.0 11.9 10.6 5.1 6.2 5.5 8.5 10.5 15.4 11.2 7.9 6.1 8.5 7.6 8.3 9.4 26.8 40.8 21.7 36.3 47.1 22.4 9.3 25.5 21.4 35.2 7.0 23.6 30.5 14.9 20.2 725.4 23.9 29.3 0.0 15.0 33.1 22.9 32.1 26.6 16.8 18.7 22.3 30.6 18.4 19.8 2397.2 27.0 25.7 21.9 10.8 28.3 18.4 18.3 21.0 24.4 10.9 18.9 25.8 24.7 35.8 26.8 53.1 31.4 27.7 23.0 34.6 ISL1 "Isl-1, ISLET1" ENSG00000016082 "ISL LIM homeobox 1" P61371 5 51383391-51394738 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 30.3" "Cell type enhanced" "Detected in many" 17 "Bipolar cells: 118.7;Horizontal cells: 41.3;Intestinal endocrine cells: 87.9;Syncytiotrophoblasts: 28.6" "Cancer enhanced" "Detected in some" "pancreatic cancer: 4.1" "Group enriched" "Detected in some" 5 "basal ganglia: 4.0;hypothalamus: 5.5;pons and medulla: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "SH-SY5Y: 82.3" "Group enriched" "Detected in some" 8 "basal ganglia: 13.8;hypothalamus: 17.5;thalamus: 6.5" "Group enriched" "Detected in some" 11 "basal ganglia: 8.5;hypothalamus: 8.6" "HPA048613, HPA057416" Approved Approved "Nucleoplasm,Nuclear speckles,Mitochondria" NA NA Nucleoplasm "Nuclear speckles, Mitochondria" "HPA048613: , HPA057416: AB_2683431" "unprognostic (4.97e-2)" "unprognostic (2.22e-2)" "unprognostic (1.69e-1)" "unprognostic (2.41e-3)" "unprognostic (5.52e-2)" "unprognostic (6.79e-2)" "unprognostic (9.21e-2)" "unprognostic (9.42e-2)" "unprognostic (5.55e-3)" "unprognostic (1.77e-1)" "unprognostic (1.48e-1)" "unprognostic (2.48e-1)" "unprognostic (9.11e-3)" "unprognostic (4.39e-3)" 2.2 1.5 0.0 0.0 4.0 0.0 0.1 0.0 0.2 14.4 1.6 0.0 4.2 2.3 1.3 0.5 0.2 0.0 0.2 0.0 0.0 5.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.4 0.0 2.8 10.0 2.0 13.2 2.5 6.4 1.0 30.3 0.1 1.1 0.7 0.6 0.1 0.0 10.7 1.6 0.7 3.1 0.3 0.2 0.4 2.4 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.6 1.2 0.9 0.0 0.0 1.9 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.8 0.0 0.8 0.0 0.0 0.0 5.3 82.3 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 4.0 0.0 0.2 0.0 5.5 0.0 0.0 2.0 0.7 0.0 0.0 0.0 3.5 1.3 118.7 0.3 0.0 0.0 0.0 0.0 3.9 20.5 0.0 0.0 13.2 0.1 0.0 0.0 0.0 8.9 0.4 1.2 0.0 0.0 2.3 41.3 87.9 0.0 0.0 2.7 0.3 0.0 0.0 0.0 0.6 3.4 6.8 0.0 0.0 0.0 11.3 0.0 0.1 0.7 0.7 0.9 28.6 0.0 0.0 3.7 ISM2 "FLJ32147, TAIL1, THSD3" ENSG00000100593 "Isthmin 2" Q6H9L7 14 77474394-77498850 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 45 "placenta: 193.8" "Group enriched" "Detected in some" 9 "Cytotrophoblasts: 240.2;Extravillous trophoblasts: 440.1;Syncytiotrophoblasts: 148.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "basal ganglia: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "BEWO: 91.4" "Not detected" "Not detected" "HPA039314, HPA039742" Supported Supported Nucleoplasm "Secreted in female reproductive system" NA NA Nucleoplasm "HPA039314: AB_10673239, HPA039742: AB_10673427" "unprognostic (5.69e-2)" "unprognostic (9.17e-3)" "unprognostic (2.58e-2)" "unprognostic (1.41e-3)" "unprognostic (3.73e-2)" "unprognostic (2.34e-1)" "unprognostic (2.16e-2)" "unprognostic (3.09e-3)" "unprognostic (2.11e-1)" "unprognostic (4.13e-1)" "unprognostic (8.10e-2)" "unprognostic (1.42e-2)" "unprognostic (9.36e-2)" "unprognostic (1.83e-1)" "unprognostic (5.67e-2)" "unprognostic (3.95e-1)" 0.7 0.0 0.2 0.2 4.2 0.0 0.1 0.1 0.3 1.1 0.2 0.1 0.3 0.1 2.7 0.9 0.2 0.5 0.1 0.1 0.1 0.8 0.6 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.1 0.5 193.8 0.2 3.2 0.0 0.2 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.4 0.2 0.1 0.2 0.1 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 91.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.2 0.1 0.3 0.1 0.8 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 240.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 440.1 0.3 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.4 0.0 148.4 0.0 0.0 0.0 ISPD "hCG_1745121, IspD, Nip" ENSG00000214960 "Isoprenoid synthase domain containing" A4D126 7 16087527-16421322 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 17 "basophil: 10.7" "Lineage enriched" "Detected in single" 22 "granulocytes: 10.7" "Cell line enhanced" "Detected in many" "BEWO: 8.5;HEL: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043810, HPA053554" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA043810: AB_10964489, HPA053554: AB_2682185" "unprognostic (4.65e-3)" "unprognostic (5.92e-2)" "unprognostic (2.61e-1)" "unprognostic (9.41e-2)" "unprognostic (1.49e-2)" "unprognostic (1.29e-1)" "unprognostic (1.19e-1)" "unprognostic (7.07e-2)" "unprognostic (3.47e-2)" "unprognostic (3.39e-2)" "unprognostic (6.01e-2)" "unprognostic (2.07e-1)" "prognostic favorable (1.38e-11)" "unprognostic (4.01e-2)" "unprognostic (1.78e-4)" "unprognostic (6.26e-2)" "unprognostic (2.79e-1)" 3.0 3.8 4.2 1.9 4.5 2.6 3.0 7.7 7.7 3.7 2.9 3.9 3.4 1.8 4.7 2.4 2.0 2.8 3.2 7.1 4.4 4.5 7.0 10.0 2.9 1.5 4.7 3.9 2.7 3.9 3.6 5.7 8.0 4.6 3.5 3.0 5.7 5.5 10.1 4.5 2.6 1.8 3.7 4.9 1.4 10.2 3.9 2.4 1.1 2.6 2.4 1.4 3.2 3.7 0.3 0.4 10.7 0.1 0.4 0.3 0.0 0.3 2.4 1.3 1.9 1.1 1.5 8.5 1.9 1.3 1.6 1.4 2.7 2.2 0.0 4.1 2.7 0.8 3.1 1.4 0.0 2.9 1.0 1.5 11.7 1.5 0.6 1.4 0.9 1.5 2.7 1.2 1.3 0.2 0.8 1.2 1.0 2.8 0.3 4.2 0.5 1.1 1.1 2.2 1.0 0.3 0.0 1.9 0.1 2.8 0.8 2.0 1.3 1.4 2.5 2.5 2.7 1.7 2.6 1.3 2.3 2.1 0.3 2.2 0.2 0.0 0.0 1.9 2.7 2.8 10.7 0.1 0.4 0.3 0.0 0.2 0.1 0.2 0.2 0.0 0.3 0.3 0.2 0.6 0.4 0.0 0.4 0.0 0.0 4.2 4.5 7.7 7.7 4.4 4.5 4.7 3.9 4.6 2.4 0.0 2.9 0.0 1.6 0.3 6.0 7.3 0.0 2.7 4.5 3.5 7.9 2.1 1.7 1.0 7.5 2.2 0.4 0.0 0.6 7.9 2.2 2.2 1.1 4.7 0.7 4.8 1.2 4.9 0.3 1.2 1.4 0.0 1.7 0.0 2.0 4.1 2.6 0.0 3.2 5.8 5.8 0.0 0.7 6.6 6.1 0.9 2.4 0.5 1.2 1.7 ISX RAXLX ENSG00000175329 "Intestine specific homeobox" Q2M1V0 22 35066136-35087387 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "intestine: 22.2" "Group enriched" "Detected in some" 49 "Enterocytes: 22.5;Intestinal endocrine cells: 18.7;Mucus-secreting cells: 15.4;Paneth cells: 21.0;Undifferentiated cells: 19.5" "Cancer enhanced" "Detected in some" "colorectal cancer: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "CACO-2: 3.5;Hep G2: 9.8" "Not detected" "Not detected" HPA060328 Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA060328: AB_2684254" "unprognostic (5.02e-2)" "unprognostic (2.68e-1)" "unprognostic (2.23e-1)" "unprognostic (3.33e-1)" "unprognostic (3.86e-1)" "unprognostic (2.55e-1)" 0.1 0.0 0.1 2.0 0.1 0.0 0.1 0.1 0.1 0.1 16.3 0.1 0.1 22.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 15.8 0.1 0.1 0.1 0.1 0.0 19.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 ISYNA1 "Ino1, INOS, IPS" ENSG00000105655 "Inositol-3-phosphate synthase 1" Q9NPH2 19 18434388-18438301 "Enzymes, Predicted intracellular proteins" "Inositol biosynthesis, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 83.6" "Cell type enhanced" "Detected in many" 14 "Cytotrophoblasts: 829.0;Sertoli cells: 310.4;Syncytiotrophoblasts: 865.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 4.0;NK-cells: 11.9;T-cells: 8.5" "Cell line enriched" "Detected in many" 4 "BEWO: 103.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007931, HPA008232, CAB020720" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB020720: , HPA007931: AB_2667940, HPA008232: AB_2668018" "unprognostic (1.87e-2)" "unprognostic (1.86e-1)" "unprognostic (2.98e-2)" "unprognostic (3.16e-2)" "unprognostic (3.88e-1)" "unprognostic (1.81e-2)" "unprognostic (2.49e-1)" "unprognostic (3.12e-1)" "unprognostic (1.74e-1)" "unprognostic (2.28e-2)" "unprognostic (2.73e-2)" "unprognostic (5.08e-2)" "prognostic unfavorable (9.23e-4)" "unprognostic (2.23e-2)" "unprognostic (9.26e-2)" "unprognostic (1.19e-2)" "unprognostic (1.50e-1)" 7.9 8.4 7.1 3.0 5.7 4.5 7.1 2.7 6.7 9.9 3.5 10.0 44.2 3.4 13.9 12.3 4.5 20.0 6.5 8.0 5.7 7.4 12.7 4.1 4.7 3.8 4.1 4.1 31.6 25.5 7.7 12.6 44.2 16.2 9.5 1.3 19.3 8.8 34.4 8.2 3.4 3.9 3.0 2.3 10.5 3.7 83.6 3.5 3.0 5.6 3.8 3.3 5.9 7.8 4.0 1.9 0.9 0.2 11.9 8.5 4.9 2.8 8.6 20.5 6.1 0.1 0.0 103.8 1.3 0.2 0.1 0.0 4.9 5.2 0.0 7.0 0.6 0.0 7.4 0.6 0.0 0.0 7.7 23.6 10.3 0.5 15.9 2.2 0.1 0.2 1.6 0.1 0.6 0.1 0.0 1.3 0.2 21.1 0.4 0.0 16.6 0.7 0.7 10.7 2.6 6.9 14.2 0.0 4.8 1.7 0.0 6.3 15.8 0.3 1.9 10.5 4.4 14.0 1.1 3.9 0.1 0.2 0.1 0.3 3.3 1.4 0.6 0.6 0.4 3.6 0.9 0.1 0.0 7.6 0.2 5.9 4.0 7.4 6.7 0.7 2.3 6.1 8.5 0.8 11.9 0.1 1.9 5.2 4.9 7.1 5.7 2.7 6.7 5.7 7.4 4.1 4.1 16.2 3.5 3.0 0.6 2.2 67.1 10.6 0.0 4.2 7.6 4.0 4.5 45.4 2.0 829.0 44.7 34.8 81.2 19.7 1.3 0.0 7.5 57.3 25.4 8.5 13.9 0.9 73.6 0.0 62.2 19.0 5.3 178.1 34.5 3.7 21.9 7.2 2.6 7.2 4.6 0.0 47.4 4.7 0.5 310.4 167.1 59.2 21.8 5.0 865.2 9.6 4.6 31.8 ITCH AIP4 ENSG00000078747 "Itchy E3 ubiquitin protein ligase" Q96J02 20 34363235-34511393 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 102.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021126, HPA049032, CAB072824, CAB072825" Supported Enhanced Nucleoplasm,Vesicles No No Nucleoplasm Vesicles "CAB072824: , CAB072825: , HPA021126: AB_1851941, HPA049032: AB_2680607" "unprognostic (2.51e-1)" "unprognostic (6.95e-2)" "unprognostic (1.25e-3)" "unprognostic (3.22e-2)" "unprognostic (1.77e-1)" "unprognostic (1.13e-1)" "unprognostic (2.78e-1)" "unprognostic (9.29e-3)" "unprognostic (1.94e-1)" "unprognostic (3.89e-3)" "unprognostic (1.28e-3)" "unprognostic (1.42e-1)" "unprognostic (1.84e-2)" "unprognostic (1.30e-1)" "unprognostic (2.24e-1)" "unprognostic (3.23e-2)" "unprognostic (2.21e-1)" 20.7 16.7 18.9 15.4 26.9 20.5 17.5 19.8 26.7 23.9 18.2 37.9 15.2 16.9 18.4 15.1 35.9 14.5 14.5 17.9 20.4 15.9 21.1 46.5 18.5 16.8 29.2 16.5 19.3 17.1 21.6 26.3 26.9 29.0 17.5 20.4 16.7 20.1 18.4 24.0 19.2 20.3 19.8 30.4 17.3 17.3 34.8 32.3 22.3 22.7 13.0 23.6 19.6 21.0 7.3 11.4 19.6 6.2 6.2 11.4 2.7 20.2 13.4 13.7 9.8 15.1 21.6 16.4 16.5 18.9 20.7 20.2 37.6 31.3 9.9 16.0 21.0 28.2 25.7 20.8 33.3 25.2 7.4 6.7 28.8 11.4 22.5 15.8 11.8 13.0 11.0 17.0 17.4 27.4 18.7 15.5 14.4 16.3 17.2 16.1 10.1 17.2 6.2 6.6 12.5 15.9 14.5 28.9 22.9 12.3 35.3 8.4 6.1 30.8 12.1 18.5 14.1 14.5 10.7 15.0 24.7 14.8 16.1 12.2 13.7 14.3 14.5 15.3 7.6 14.4 3.6 5.8 6.1 10.8 6.2 11.4 7.3 3.8 5.7 4.5 6.9 3.3 4.9 19.6 6.2 3.8 11.4 4.8 2.7 18.9 26.9 19.8 26.7 20.4 15.9 29.2 16.5 29.0 32.3 11.9 17.9 13.3 15.9 13.4 19.6 20.1 7.6 28.1 33.0 29.6 23.6 15.1 5.0 11.7 46.0 17.5 21.6 0.0 14.1 17.6 16.0 23.0 18.5 43.1 14.0 14.3 11.5 16.5 22.8 102.3 20.8 21.2 25.3 23.4 15.8 34.3 16.6 21.0 14.5 18.0 26.8 12.9 17.8 25.7 21.5 14.2 39.2 20.6 9.9 38.9 ITFG2 "FGGAP1, MDS028" ENSG00000111203 "Integrin alpha FG-GAP repeat containing 2" Q969R8 12 2812622-2859791 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 60.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038664, HPA038665" Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Cytokinetic bridge" Yes No "Nucleoplasm, Endoplasmic reticulum" "Cytokinetic bridge" "HPA038664: AB_10672722, HPA038665: AB_2676138" "unprognostic (5.70e-2)" "unprognostic (2.74e-1)" "unprognostic (1.73e-2)" "unprognostic (2.96e-1)" "unprognostic (2.46e-2)" "unprognostic (6.27e-2)" "unprognostic (1.47e-2)" "unprognostic (3.64e-2)" "unprognostic (1.60e-2)" "unprognostic (4.36e-2)" "unprognostic (5.05e-3)" "unprognostic (8.40e-2)" "unprognostic (2.60e-1)" "unprognostic (4.24e-1)" "unprognostic (5.89e-1)" "unprognostic (4.35e-2)" "unprognostic (7.43e-2)" 12.2 16.1 11.1 15.4 14.0 12.0 14.3 17.8 17.2 16.2 13.2 23.2 21.3 11.8 19.6 16.6 13.2 17.2 14.7 12.0 8.7 9.8 15.0 11.4 14.4 14.0 13.3 9.9 29.0 28.4 22.7 23.0 13.8 13.3 13.8 14.7 22.1 23.0 19.5 7.8 10.9 13.9 13.5 10.6 20.3 14.8 10.6 15.2 25.4 26.2 9.3 23.0 14.4 15.3 17.7 12.9 5.4 21.2 13.8 14.4 10.0 4.8 7.1 8.3 6.6 7.2 8.3 7.7 10.8 6.1 13.1 9.7 15.3 12.0 11.1 3.0 10.1 6.6 6.2 12.7 10.7 9.8 9.8 7.6 15.7 8.1 6.1 13.3 14.2 8.5 11.1 12.8 11.9 18.4 10.8 8.9 10.7 8.4 12.1 7.4 14.6 20.5 8.3 16.9 11.0 5.5 10.4 9.2 6.4 7.8 8.2 4.0 12.7 13.4 11.8 4.8 11.7 7.3 6.6 9.1 8.7 5.4 8.3 20.6 1.6 0.9 16.9 5.7 8.3 8.6 2.8 10.9 5.4 13.7 14.3 12.8 17.7 10.5 13.4 12.9 17.1 14.4 13.5 1.3 13.8 21.2 9.8 8.5 10.0 11.1 14.0 17.8 17.2 8.7 9.8 13.3 9.9 13.3 15.2 11.9 19.9 25.1 8.5 3.0 34.9 15.1 15.3 9.4 13.6 12.2 60.9 23.3 10.0 7.9 42.6 6.0 13.5 0.0 6.3 8.5 9.4 7.3 5.8 10.2 11.3 30.2 9.1 13.5 7.2 9.0 15.5 9.8 1.7 9.0 12.6 14.7 6.1 16.1 12.4 4.4 52.4 6.5 8.4 12.6 17.9 3.4 14.5 25.9 16.4 4.6 ITGA2 CD49b ENSG00000164171 "Integrin subunit alpha 2" P17301 5 52989326-53094779 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 300.3;Glandular cells: 266.4;Pancreatic endocrine cells: 350.7;Urothelial cells: 321.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 29.9;HaCaT: 30.2;hTERT-RPE1: 28.1;HUVEC TERT2: 27.8;TIME: 23.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017690, HPA060991, HPA063556" Enhanced Approved Nucleoplasm,Cytosol Yes No 46000000 Nucleoplasm Cytosol "CAB017690: AB_1124939, HPA060991: AB_2684405, HPA063556: AB_2685040" "unprognostic (8.35e-2)" "unprognostic (1.33e-1)" "unprognostic (3.85e-3)" "unprognostic (1.07e-1)" "unprognostic (1.22e-1)" "unprognostic (3.70e-2)" "unprognostic (2.67e-3)" "unprognostic (2.38e-2)" "unprognostic (1.87e-1)" "unprognostic (1.69e-2)" "prognostic unfavorable (1.02e-5)" "unprognostic (4.27e-1)" "unprognostic (3.88e-2)" "unprognostic (2.87e-2)" "unprognostic (1.84e-1)" "unprognostic (1.30e-1)" "unprognostic (1.11e-1)" 1.9 14.0 2.9 4.7 13.4 0.4 7.9 1.8 6.8 7.1 6.5 22.5 12.1 7.6 5.1 10.4 16.7 2.8 9.3 2.5 5.4 3.6 15.1 1.8 17.2 1.4 18.3 4.5 1.8 2.7 16.1 2.5 4.8 10.7 8.5 6.0 0.8 15.8 16.8 1.2 16.9 17.0 2.5 8.4 9.1 7.4 1.3 13.0 1.5 2.5 7.4 10.0 7.5 11.1 0.5 1.5 1.7 0.6 0.2 0.6 0.3 19.4 5.0 0.4 0.2 1.3 2.4 1.5 19.6 29.9 0.7 1.2 9.3 13.7 0.0 3.4 8.3 11.5 30.2 1.6 22.1 2.8 0.0 1.5 1.4 1.2 5.5 4.5 0.2 0.4 0.9 3.8 19.7 3.5 28.1 27.8 1.0 0.0 0.0 0.5 3.6 0.2 0.0 1.2 5.0 10.0 0.0 0.1 0.0 6.3 10.3 0.2 1.1 1.0 1.3 2.0 0.8 3.2 0.0 23.8 3.6 2.1 0.5 3.9 0.0 0.0 0.0 21.6 0.0 15.8 1.7 0.6 0.2 0.6 0.2 0.4 0.4 0.5 0.5 0.1 0.5 0.5 0.6 0.8 0.2 0.1 1.5 0.4 0.3 2.9 13.4 1.8 6.8 5.4 3.6 18.3 4.5 10.7 13.0 53.6 13.6 0.0 300.3 134.2 2.3 1.2 20.4 88.3 161.5 50.6 3.9 0.2 8.3 157.1 0.0 15.8 20.6 0.0 144.3 1.6 1.9 266.4 1.1 0.0 0.3 0.0 13.3 5.5 0.0 0.0 1.1 3.8 11.8 1.8 32.4 18.0 350.7 15.2 0.0 2.9 5.0 0.0 4.2 0.0 0.9 32.5 0.3 1.9 28.1 321.7 ITGA9 "ALPHA-RLC, ITGA4L, RLC" ENSG00000144668 "Integrin subunit alpha 9" Q13797 3 37452115-37823514 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Ito cells: 62.0;Kupffer cells: 24.9;Leydig cells: 38.3;Peritubular cells: 70.4" "Cancer enhanced" "Detected in all" "thyroid cancer: 23.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 2.1" "Lineage enhanced" "Detected in single" "granulocytes: 2.1" "Cell line enhanced" "Detected in some" "CACO-2: 9.4;HEL: 7.5;SH-SY5Y: 11.2;SuSa: 17.0;WM-115: 5.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030609 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions" "Intracellular and membrane" NA NA 250000 Vesicles "Nucleoplasm, Plasma membrane, Cell Junctions" "HPA030609: AB_10600815" "unprognostic (2.35e-2)" "unprognostic (3.36e-2)" "unprognostic (5.58e-2)" "unprognostic (3.94e-2)" "unprognostic (4.48e-2)" "unprognostic (2.85e-2)" "unprognostic (3.10e-1)" "unprognostic (8.87e-3)" "unprognostic (3.23e-1)" "unprognostic (2.31e-1)" "unprognostic (2.04e-1)" "unprognostic (1.51e-1)" "unprognostic (1.78e-2)" "unprognostic (1.50e-2)" "unprognostic (1.07e-1)" "unprognostic (1.72e-2)" "unprognostic (3.16e-2)" 8.5 15.5 3.1 5.3 3.7 5.8 9.6 1.6 5.7 17.9 11.1 2.9 5.8 4.6 17.3 7.5 12.3 6.9 17.8 25.0 4.5 2.0 4.6 13.6 8.3 16.8 3.4 2.7 7.5 2.1 2.4 3.0 7.3 2.6 10.0 5.3 8.4 4.7 8.7 3.7 3.5 8.7 16.2 4.0 30.5 10.9 10.2 2.7 1.0 35.4 7.2 3.6 7.4 8.4 0.0 0.7 2.1 0.2 0.0 0.0 0.4 0.2 0.0 4.1 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.0 9.4 0.0 3.0 1.3 0.0 0.1 0.2 3.6 0.0 0.0 0.0 0.6 7.5 0.1 0.2 0.2 0.0 4.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.4 0.2 0.0 0.2 0.5 11.2 0.1 0.5 0.6 17.0 0.0 2.9 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.2 5.8 2.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 3.1 3.7 1.6 5.7 4.5 2.0 3.4 2.7 2.6 2.7 0.0 14.3 0.0 1.0 2.3 0.8 13.2 2.5 0.0 5.7 1.8 0.0 0.2 0.0 0.1 0.9 18.0 0.0 0.0 0.0 0.2 3.2 0.2 5.8 0.2 2.2 0.0 0.0 62.0 24.9 3.1 38.3 1.3 3.3 0.0 0.0 0.5 0.0 0.0 70.4 0.0 0.0 0.0 3.3 0.5 0.9 1.5 0.2 0.0 0.0 0.3 ITGB1BP1 "ICAP-1A, ICAP-1alpha, ICAP-1B, ICAP1, ICAP1A, ICAP1B" ENSG00000119185 "Integrin subunit beta 1 binding protein 1" O14713 2 9403475-9423547 "Predicted intracellular proteins" "Angiogenesis, Biomineralization, Cell adhesion, Differentiation, Notch signaling pathway, Transcription, Transcription regulation" Mitogen "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Distal tubular cells: 331.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067348, HPA071538" Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA067348: AB_2732765, HPA071538: AB_2686413" "unprognostic (2.21e-1)" "unprognostic (8.31e-2)" "unprognostic (2.09e-1)" "prognostic unfavorable (1.03e-5)" "unprognostic (4.39e-2)" "unprognostic (5.88e-3)" "prognostic unfavorable (4.67e-5)" "unprognostic (3.13e-1)" "unprognostic (1.24e-1)" "unprognostic (2.33e-1)" "unprognostic (6.46e-2)" "unprognostic (4.66e-2)" "prognostic unfavorable (7.10e-5)" "unprognostic (3.75e-2)" "unprognostic (2.01e-1)" "unprognostic (1.14e-3)" "unprognostic (4.08e-3)" 61.1 15.0 19.0 11.6 29.2 16.1 73.0 17.6 24.0 24.5 16.3 9.9 10.2 7.7 18.0 16.6 13.3 15.0 14.4 23.9 17.1 15.6 23.6 7.7 13.4 12.1 19.7 18.7 14.3 7.6 14.8 9.7 14.1 19.4 11.1 14.8 11.4 7.7 15.1 16.0 16.6 8.6 22.1 19.2 8.6 11.2 5.6 17.0 10.2 11.2 12.1 14.8 12.8 33.6 20.7 29.5 35.2 27.3 24.1 31.3 24.9 16.2 11.7 13.8 15.8 49.4 41.9 7.5 29.9 20.5 27.1 21.1 15.5 10.2 18.0 13.5 41.0 17.7 15.4 21.1 19.6 30.0 48.6 10.6 16.4 13.8 19.4 17.2 12.6 17.9 23.6 16.2 24.8 17.7 23.5 23.6 13.8 9.1 14.9 33.5 14.5 22.3 8.2 11.2 27.0 19.7 12.8 19.0 16.7 27.4 13.4 15.0 14.5 16.6 12.9 20.2 13.4 9.4 9.6 15.0 24.3 17.9 32.3 33.2 15.0 32.2 26.3 33.3 17.4 16.8 35.2 23.0 27.9 30.4 27.3 28.9 20.7 26.5 29.4 29.5 17.5 20.6 26.5 5.0 24.1 20.0 26.6 31.3 24.9 19.0 29.2 17.6 24.0 17.1 15.6 19.7 18.7 19.4 17.0 26.8 17.8 55.0 30.0 54.4 22.1 77.9 25.5 26.8 17.0 36.6 2.0 41.1 331.5 76.9 20.7 75.2 19.2 23.3 63.1 65.6 89.2 30.0 39.4 18.4 81.8 33.4 31.9 48.5 32.7 17.0 50.3 60.8 92.8 103.6 36.3 33.6 74.4 28.1 53.7 63.2 23.3 90.5 99.4 10.4 19.0 55.2 26.3 45.7 35.3 48.0 ITGB3 "CD61, GP3A, GPIIIa" ENSG00000259207 "Integrin subunit beta 3" P05106 17 47253846-47311816 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 36.6" "Cell type enhanced" "Detected in some" 10 "Late spermatids: 4.1;Proximal tubular cells: 3.5;Sertoli cells: 6.5" "Group enriched" "Detected in many" 6 "melanoma: 7.5;renal cancer: 3.6;thyroid cancer: 11.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 19 "basophil: 2.8;neutrophil: 2.8" "Lineage enriched" "Detected in single" 19 "granulocytes: 2.8" "Cell line enhanced" "Detected in many" "EFO-21: 46.6;HEL: 41.2;RPTEC TERT1: 26.8;U-87 MG: 21.1;WM-115: 67.2" HPA027852 Approved Supported "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA 710000000 "Plasma membrane" Nucleoplasm "HPA027852: AB_10601760" "unprognostic (1.13e-2)" "unprognostic (1.97e-3)" "unprognostic (2.47e-1)" "unprognostic (3.00e-2)" "unprognostic (1.91e-2)" "unprognostic (6.04e-3)" "unprognostic (3.70e-1)" "unprognostic (3.00e-1)" "unprognostic (1.44e-1)" "unprognostic (3.85e-1)" "unprognostic (6.35e-2)" "unprognostic (7.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.03e-2)" "unprognostic (2.72e-2)" "unprognostic (1.48e-1)" "unprognostic (1.17e-3)" 10.0 0.6 1.0 6.2 2.5 2.7 7.0 0.4 1.6 4.6 13.6 0.9 2.4 2.2 9.7 5.7 6.4 6.4 2.8 8.5 0.7 0.6 16.0 3.7 5.2 1.2 2.3 0.1 4.6 0.6 0.7 1.6 23.5 1.6 6.4 4.8 1.8 2.5 11.5 4.9 2.4 5.0 17.0 1.8 9.5 3.6 2.6 0.6 0.2 36.6 1.9 0.9 11.0 7.8 0.1 0.0 2.8 0.1 0.0 0.0 9.5 0.0 0.4 0.1 0.0 2.4 1.0 0.0 1.2 6.1 2.6 2.4 0.0 0.0 0.1 46.6 0.3 3.6 0.0 0.0 0.0 3.4 0.9 0.0 41.2 0.1 0.0 2.0 0.0 0.0 1.0 0.0 15.6 0.4 1.8 11.6 0.6 0.1 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.1 0.0 26.8 0.0 0.0 0.1 1.5 0.0 8.4 2.4 0.0 0.0 12.6 0.5 0.7 0.3 2.8 0.0 0.0 0.3 21.1 0.0 67.2 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 9.5 1.0 2.5 0.4 1.6 0.7 0.6 2.3 0.1 1.6 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.1 2.7 1.4 0.0 0.0 0.4 0.0 0.8 0.1 0.0 0.8 0.8 0.0 0.0 1.8 0.0 4.1 0.3 0.3 0.0 0.0 0.0 0.0 1.0 0.0 1.1 3.5 0.0 6.5 1.9 0.0 2.3 0.4 1.0 0.0 0.0 0.1 ITGB3BP "CENPR, HSU37139, NRIF3, TAP20" ENSG00000142856 "Integrin subunit beta 3 binding protein" Q13352 1 63440770-63593721 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 117.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" HPA028463 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA028463: AB_10601435" "unprognostic (4.98e-2)" "unprognostic (5.88e-3)" "unprognostic (6.28e-3)" "unprognostic (3.96e-2)" "unprognostic (4.58e-1)" "prognostic favorable (4.32e-4)" "prognostic unfavorable (7.24e-5)" "unprognostic (2.68e-2)" "unprognostic (7.89e-3)" "unprognostic (2.15e-2)" "unprognostic (1.35e-1)" "unprognostic (4.97e-3)" "prognostic unfavorable (8.45e-6)" "unprognostic (1.34e-2)" "unprognostic (5.24e-2)" "unprognostic (7.34e-3)" "unprognostic (6.14e-2)" 8.3 11.3 10.9 11.2 14.2 8.3 12.8 17.6 16.3 11.8 8.6 3.1 4.4 6.5 10.1 13.8 13.6 11.3 9.0 6.5 12.5 3.6 13.2 7.1 8.1 13.8 17.6 3.6 15.5 12.6 15.1 29.4 8.3 13.7 10.7 8.9 4.5 12.5 6.4 6.1 8.6 8.7 9.6 16.5 12.0 9.6 17.1 15.0 17.6 11.6 9.0 13.6 11.0 11.5 13.5 6.8 7.1 3.3 11.6 10.2 5.7 24.2 11.6 13.7 11.3 3.3 10.5 12.8 11.8 7.1 20.6 25.3 6.5 11.2 22.1 9.1 2.9 10.3 17.5 10.9 11.3 25.3 16.4 26.1 16.8 16.4 13.1 3.6 23.0 11.1 2.5 8.9 11.5 9.4 9.6 10.5 12.9 19.4 29.5 2.7 10.1 24.7 21.3 18.0 9.2 13.1 16.1 24.7 32.7 13.5 7.0 18.3 11.0 13.5 7.7 18.7 21.5 7.8 7.7 6.4 7.0 10.4 14.5 17.7 14.9 24.0 20.8 11.5 28.9 10.8 7.1 3.3 0.9 5.8 2.4 9.5 13.5 9.0 8.7 4.0 12.8 10.2 8.7 1.0 11.6 2.9 6.8 9.5 5.7 10.9 14.2 17.6 16.3 12.5 3.6 17.6 3.6 13.7 15.0 8.9 8.6 52.6 43.2 30.1 9.4 9.9 28.1 37.5 35.2 24.4 9.8 31.6 24.9 34.7 65.0 20.2 5.0 70.0 29.7 49.0 20.3 18.0 23.1 7.9 25.3 6.4 16.7 20.3 24.1 95.1 19.8 17.0 20.3 27.1 16.7 21.1 28.9 0.0 24.4 21.0 14.0 32.3 21.7 117.9 61.4 28.5 16.0 26.2 24.8 25.4 ITGB6 ENSG00000115221 "Integrin subunit beta 6" P18564 2 160099666-160200313 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Amelogenesis imperfecta, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 62.1" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 142.9;Alveolar cells type 2: 159.2;Pancreatic endocrine cells: 133.9;Spermatocytes: 219.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 37.5;RPTEC TERT1: 74.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023626, CAB073536" Approved Approved "Nucleoplasm,Cell Junctions,Centrosome" NA NA "Nucleoplasm, Cell Junctions" Centrosome "CAB073536: , HPA023626: AB_2671267" "unprognostic (1.27e-1)" "unprognostic (1.57e-2)" "unprognostic (6.90e-2)" "unprognostic (8.22e-3)" "unprognostic (3.61e-3)" "unprognostic (1.50e-2)" "unprognostic (1.72e-3)" "unprognostic (2.04e-2)" "unprognostic (1.72e-1)" "unprognostic (7.06e-2)" "prognostic unfavorable (5.03e-6)" "unprognostic (1.04e-1)" "unprognostic (2.73e-1)" "unprognostic (4.97e-2)" "unprognostic (1.23e-1)" "unprognostic (2.16e-1)" "unprognostic (1.00e-1)" 0.3 0.3 0.3 3.1 0.3 0.0 8.7 0.3 0.3 4.1 8.3 0.1 4.5 3.5 2.1 2.5 18.7 1.2 12.0 0.7 0.3 0.3 62.1 0.3 28.8 0.1 0.3 0.1 1.5 3.8 7.0 2.2 18.7 0.2 7.5 3.0 0.1 3.8 4.8 31.5 1.9 11.7 2.0 0.3 0.3 7.9 0.6 0.1 0.1 4.9 6.8 5.9 12.8 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 37.5 0.0 0.2 0.0 0.0 7.7 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 8.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 1.1 0.0 0.0 0.0 2.4 0.0 0.0 2.9 0.0 74.9 12.4 0.0 0.0 0.0 11.8 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.2 0.1 142.9 159.2 0.0 106.9 9.3 0.0 37.4 10.2 8.1 77.3 68.0 0.0 6.6 0.0 51.3 71.2 2.2 10.3 0.0 92.6 5.2 3.3 42.3 3.5 0.8 2.0 0.0 0.0 1.8 0.8 24.4 2.6 2.5 1.7 3.6 14.1 0.8 133.9 21.0 1.1 0.2 0.0 0.0 2.7 219.5 2.4 7.4 3.9 0.0 11.2 104.4 ITGB7 ENSG00000139626 "Integrin subunit beta 7" P26010 12 53191318-53207307 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 31.3;lymphoid tissue: 37.6" "Cell type enhanced" "Detected in many" 10 "B-cells: 35.7;granulocytes: 29.9;T-cells: 27.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 99 "Karpas-707: 295.2;RPMI-8226: 230.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA042277 Approved "Nucleoplasm,Nuclear membrane,Vesicles,Plasma membrane,Cytosol" NA NA 42000 "Plasma membrane, Cytosol" "Nucleoplasm, Nuclear membrane, Vesicles" "HPA042277: AB_10793877" "unprognostic (5.34e-2)" "unprognostic (4.47e-2)" "unprognostic (2.80e-3)" "unprognostic (1.40e-2)" "unprognostic (6.57e-4)" "unprognostic (3.51e-5)" "unprognostic (3.11e-3)" "unprognostic (1.37e-2)" "unprognostic (3.58e-1)" "unprognostic (2.18e-1)" "unprognostic (9.63e-3)" "unprognostic (3.36e-1)" "unprognostic (1.02e-2)" "unprognostic (2.16e-1)" "unprognostic (6.95e-2)" "unprognostic (9.34e-2)" "unprognostic (2.47e-4)" 1.8 1.4 1.4 29.1 1.8 7.5 1.5 0.6 1.2 1.8 8.7 2.9 0.8 6.7 2.3 2.8 6.6 2.0 5.6 1.4 1.5 1.0 5.4 5.1 4.9 26.4 1.9 1.0 1.1 1.3 0.7 1.7 1.8 2.4 2.7 5.6 2.1 10.7 2.2 1.0 6.4 15.1 1.5 2.0 26.7 4.3 0.9 2.0 7.8 3.6 4.4 37.6 4.6 3.0 10.1 15.4 31.3 1.9 7.5 23.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 295.2 0.0 0.0 0.0 0.4 0.0 2.4 0.0 0.1 0.0 230.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.2 0.2 0.1 0.1 22.6 1.9 31.3 19.3 0.5 14.3 10.1 19.4 23.0 15.4 8.3 16.3 17.1 0.5 7.5 0.1 4.2 22.7 5.2 1.4 1.8 0.6 1.2 1.5 1.0 1.9 1.0 2.4 2.0 3.0 8.5 35.7 0.3 1.9 0.0 0.4 2.5 0.0 0.0 7.0 3.9 0.1 6.6 0.2 0.0 0.1 0.0 0.0 0.5 0.1 1.0 0.1 29.9 1.6 13.8 0.0 0.0 0.6 3.0 0.0 0.0 7.0 6.8 7.2 0.3 6.6 0.6 0.0 0.0 4.4 0.7 0.0 0.4 0.2 1.1 3.1 0.1 27.7 0.9 1.3 ITPA "C20orf37, dJ794I6.3, HLC14-06-P" ENSG00000125877 "Inosine triphosphatase" Q9BY32 20 3208868-3223870 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022824, HPA073963" Approved Supported Nucleoplasm,Cytosol NA NA 69000 "Nucleoplasm, Cytosol" "HPA022824: AB_1851960, HPA073963: " "unprognostic (1.58e-2)" "unprognostic (1.98e-1)" "unprognostic (1.73e-1)" "unprognostic (3.57e-1)" "unprognostic (4.63e-2)" "unprognostic (1.53e-2)" "prognostic unfavorable (2.54e-5)" "unprognostic (1.11e-2)" "unprognostic (1.68e-1)" "unprognostic (1.76e-1)" "unprognostic (1.83e-1)" "unprognostic (2.28e-1)" "unprognostic (1.94e-2)" "unprognostic (8.34e-2)" "unprognostic (3.63e-1)" "unprognostic (1.24e-1)" "unprognostic (1.84e-1)" 17.7 27.5 18.6 24.7 21.2 20.4 17.7 10.2 22.7 21.3 21.4 18.3 20.6 22.9 18.1 17.3 31.0 26.6 19.6 25.9 18.1 13.5 22.9 20.3 22.7 30.6 20.5 24.1 16.5 43.8 17.6 10.2 17.0 16.2 14.6 16.8 13.2 19.9 21.5 19.5 23.4 19.0 16.3 16.3 20.6 19.3 16.7 19.5 15.2 24.9 29.0 24.1 14.6 17.7 19.3 30.7 11.3 31.0 24.7 24.1 18.2 32.7 25.9 12.8 13.3 8.5 12.6 8.5 14.9 20.7 19.6 17.2 20.7 30.5 14.1 13.6 13.6 19.2 28.5 17.6 22.3 13.7 9.2 26.3 35.3 10.7 31.4 16.1 15.1 12.0 12.0 17.1 18.4 11.5 8.1 14.9 11.4 24.2 9.7 17.5 15.0 17.8 43.9 21.4 37.0 26.2 17.1 17.8 37.0 26.8 10.4 19.4 22.9 11.7 41.1 27.3 5.9 17.1 25.2 10.4 22.0 12.3 14.4 31.4 14.5 18.2 26.7 10.2 28.0 23.9 11.3 25.7 8.8 20.7 31.0 18.0 19.3 18.9 21.8 30.7 17.8 14.2 17.2 1.4 24.7 21.9 28.3 24.1 18.2 18.6 21.2 10.2 22.7 18.1 13.5 20.5 24.1 16.2 19.5 20.8 43.1 32.8 43.8 35.6 18.3 8.0 40.8 26.8 37.5 41.8 13.7 62.7 49.7 88.7 2.3 18.6 41.6 0.0 90.9 108.9 44.0 43.6 41.5 32.1 103.0 4.8 26.4 29.4 43.0 2.3 28.7 50.7 38.8 123.6 48.5 17.1 82.5 52.6 20.8 63.4 20.3 19.4 36.4 14.6 19.4 43.0 47.0 46.3 66.6 52.1 ITPKB "IP3-3KB, IP3KB" ENSG00000143772 "Inositol-trisphosphate 3-kinase B" P27987 1 226631690-226739323 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 63.1" "Cell type enhanced" "Detected in many" 5 "Endothelial cells: 35.8;Ito cells: 27.0;Smooth muscle cells: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-MEL-30: 28.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030273, HPA072923" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA030273: AB_10601127, HPA072923: AB_2686558" "unprognostic (4.54e-2)" "unprognostic (3.85e-2)" "unprognostic (8.41e-3)" "unprognostic (9.37e-3)" "unprognostic (1.53e-1)" "prognostic favorable (1.72e-5)" "unprognostic (1.24e-1)" "prognostic favorable (6.65e-4)" "unprognostic (2.29e-1)" "unprognostic (9.57e-2)" "unprognostic (1.41e-2)" "unprognostic (1.75e-2)" "unprognostic (3.23e-3)" "unprognostic (2.90e-2)" "unprognostic (7.46e-2)" "unprognostic (6.54e-3)" "unprognostic (7.87e-2)" 23.8 4.2 34.7 13.0 35.1 14.8 15.2 11.1 33.6 14.3 19.7 32.4 8.5 6.0 27.1 15.6 12.6 15.3 8.9 7.8 27.9 24.8 9.7 3.2 13.4 22.7 50.4 16.3 8.8 4.8 10.1 4.2 13.5 40.0 13.1 6.3 20.8 24.9 21.3 9.8 10.5 12.5 32.6 63.1 19.0 12.4 3.2 34.0 20.0 5.9 4.3 17.1 19.6 8.5 3.1 0.9 7.7 3.5 3.0 7.9 2.6 2.8 3.0 4.9 5.7 3.9 2.5 1.3 0.8 3.4 1.6 3.7 0.5 3.6 13.1 4.7 0.7 0.3 4.2 6.3 2.5 0.8 1.8 4.3 5.8 3.4 0.0 1.5 5.4 10.3 2.8 3.7 1.7 1.6 4.4 10.7 6.7 0.0 1.8 0.2 2.7 9.9 7.3 10.9 2.1 4.9 3.8 8.9 2.9 11.5 4.6 2.9 3.8 2.3 1.7 28.6 5.1 7.3 6.1 7.4 2.1 1.6 1.8 4.6 0.1 4.6 16.0 0.5 4.9 7.5 1.2 1.4 7.7 4.4 2.1 3.9 1.9 5.3 4.5 0.9 3.1 7.9 5.7 5.4 3.0 3.5 0.8 3.0 2.6 34.7 35.1 11.1 27.9 27.9 24.8 50.4 16.3 40.0 34.0 0.0 6.1 11.1 3.8 10.9 0.3 5.6 0.0 2.7 5.7 7.0 0.0 0.5 3.3 2.0 2.0 35.8 1.3 0.0 2.0 1.1 8.5 6.5 9.3 0.9 16.4 0.0 4.1 27.0 17.7 16.5 6.6 8.6 18.6 2.8 2.6 1.4 2.3 3.2 8.9 0.5 0.0 0.0 32.0 0.9 2.3 8.8 0.3 22.3 2.9 2.1 ITPR2 "CFAP48, IP3R2" ENSG00000123104 "Inositol 1,4,5-trisphosphate receptor type 2" Q14571 12 26336515-26833198 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 47.1" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 137.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 36.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059144, HPA062260" Uncertain Supported "Nucleoplasm,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" Nucleoplasm "HPA059144: AB_2683925, HPA062260: AB_2684728" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (1.22e-1)" "unprognostic (4.53e-1)" "unprognostic (2.25e-1)" "unprognostic (2.37e-2)" "unprognostic (3.59e-3)" "unprognostic (8.70e-2)" "unprognostic (1.66e-1)" "unprognostic (8.61e-2)" "unprognostic (2.06e-2)" "unprognostic (1.63e-1)" "unprognostic (1.54e-2)" "unprognostic (2.82e-1)" "unprognostic (9.13e-2)" "unprognostic (3.99e-2)" "unprognostic (3.76e-1)" 8.8 20.6 12.8 14.5 13.8 6.1 18.5 9.3 15.0 7.9 9.9 7.8 3.7 6.0 7.2 7.8 12.0 7.3 8.0 7.1 14.2 6.0 14.4 47.1 6.5 8.1 12.8 4.6 8.0 9.2 17.4 9.9 11.9 13.0 6.6 7.8 4.8 17.6 3.8 4.7 13.3 8.9 5.4 20.3 12.5 5.9 3.4 15.3 35.3 5.3 6.6 10.7 5.5 8.1 4.3 9.0 17.3 5.2 3.6 3.1 0.7 2.7 1.2 1.6 2.6 5.0 5.1 1.8 2.5 3.5 1.8 1.9 0.1 1.4 9.4 1.6 3.4 1.9 3.0 8.7 5.3 2.4 2.2 2.9 7.5 2.5 15.1 4.6 6.7 3.4 4.8 0.7 3.7 7.0 3.5 16.6 3.7 3.3 3.0 2.2 2.3 4.7 9.0 7.2 2.4 0.9 1.5 3.9 5.9 4.1 4.3 0.5 2.6 11.4 2.1 6.3 7.0 4.3 3.3 36.3 3.6 1.4 3.4 3.2 2.8 2.1 17.6 3.3 3.1 2.3 17.3 5.2 7.1 2.4 2.2 2.0 4.2 2.1 1.9 1.0 4.3 2.5 2.2 13.5 3.6 3.0 9.0 3.1 0.7 12.8 13.8 9.3 15.0 14.2 6.0 12.8 4.6 13.0 15.3 44.7 38.7 25.7 17.2 18.5 3.1 19.1 35.7 8.1 13.6 22.7 137.4 16.2 6.6 19.4 2.6 26.3 10.3 23.3 20.5 7.7 11.6 22.1 43.8 96.9 31.6 0.0 75.3 16.5 35.2 4.7 16.7 48.3 32.1 6.4 36.5 12.6 14.9 35.3 16.6 14.6 67.9 0.0 11.7 2.8 4.9 23.3 23.3 16.0 8.4 14.6 IVD ACAD2 ENSG00000128928 "Isovaleryl-CoA dehydrogenase" P26440 15 40405795-40435947 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 123.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041391, HPA044250" Enhanced Supported Nucleoplasm,Mitochondria NA NA 66000 Mitochondria Nucleoplasm "HPA041391: AB_2677449, HPA044250: AB_2678875" "unprognostic (9.30e-2)" "unprognostic (3.31e-1)" "unprognostic (1.36e-2)" "unprognostic (4.24e-2)" "unprognostic (7.53e-2)" "unprognostic (1.74e-1)" "prognostic favorable (1.95e-5)" "unprognostic (1.50e-2)" "unprognostic (2.53e-1)" "unprognostic (2.84e-2)" "unprognostic (4.08e-2)" "unprognostic (2.31e-1)" "prognostic favorable (2.91e-9)" "unprognostic (1.40e-1)" "unprognostic (3.40e-2)" "unprognostic (1.14e-1)" "unprognostic (5.46e-3)" 12.3 32.0 15.4 13.2 20.6 6.7 24.3 14.4 18.0 12.7 13.7 20.5 23.3 12.3 11.8 16.6 8.9 17.2 22.7 30.4 13.8 16.1 28.9 71.9 14.2 10.4 16.1 15.9 19.4 18.9 19.5 23.9 7.4 16.3 21.0 13.0 14.4 11.8 31.9 30.6 3.5 9.8 13.7 14.7 11.0 14.4 11.2 15.7 8.6 55.7 12.2 9.0 11.2 7.9 11.6 34.1 14.3 29.8 14.7 13.5 8.6 8.7 5.3 9.7 17.4 15.4 13.5 0.4 13.5 13.2 17.3 10.8 19.8 7.6 0.3 25.8 17.0 14.9 10.3 18.4 19.9 10.7 12.6 14.8 22.7 15.4 19.0 27.1 9.2 22.6 20.6 6.9 9.6 20.2 20.0 17.1 24.4 1.0 1.1 15.5 13.8 11.4 14.3 8.2 0.5 16.9 16.7 13.3 10.4 20.5 23.7 16.6 9.2 18.6 40.5 8.2 9.4 34.9 40.7 14.5 14.4 9.4 10.1 10.8 21.8 14.9 0.3 13.5 9.2 14.1 5.8 10.2 14.3 13.5 16.1 12.6 11.6 7.5 11.4 22.3 9.9 8.4 11.7 1.3 14.7 29.8 34.1 9.7 8.6 15.4 20.6 14.4 18.0 13.8 16.1 16.1 15.9 16.3 15.7 26.8 46.2 14.3 16.6 2.1 24.6 72.6 45.9 42.8 40.9 41.8 13.7 16.5 81.2 15.9 4.4 18.0 17.7 23.3 13.0 4.8 15.4 16.0 32.5 123.8 25.1 15.9 18.9 17.2 20.2 4.9 19.0 13.9 5.0 31.5 22.5 25.1 14.1 3.5 23.3 60.9 18.9 19.4 13.9 19.0 4.3 0.5 8.2 12.2 33.1 11.2 IWS1 "DKFZp761G0123, FLJ10006, FLJ14655, FLJ32319" ENSG00000163166 "IWS1, SUPT6H interacting protein" Q96ST2 2 127436207-127526886 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035719, HPA061866" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035719: AB_10669527, HPA061866: AB_2684628" "unprognostic (3.11e-2)" "unprognostic (1.31e-1)" "unprognostic (1.80e-2)" "unprognostic (3.07e-2)" "unprognostic (1.44e-1)" "unprognostic (1.17e-2)" "unprognostic (8.49e-2)" "unprognostic (1.05e-1)" "unprognostic (4.27e-2)" "unprognostic (2.25e-1)" "unprognostic (4.32e-2)" "unprognostic (9.96e-2)" "unprognostic (1.42e-2)" "unprognostic (1.50e-1)" "unprognostic (9.10e-2)" "unprognostic (9.01e-2)" "unprognostic (9.81e-2)" 18.6 16.5 21.7 24.5 30.8 25.4 22.9 32.7 25.3 19.6 18.6 23.6 19.1 21.2 21.7 23.1 19.6 18.3 17.8 30.8 24.3 21.4 18.9 27.0 19.1 24.2 32.4 21.8 16.7 18.8 26.8 30.6 35.6 24.9 21.1 22.6 13.4 19.9 19.1 40.5 17.2 20.1 21.0 27.9 23.4 18.4 20.3 32.3 31.4 18.8 24.8 25.2 19.1 23.0 15.7 13.6 18.3 16.4 15.0 13.2 9.2 21.9 15.0 30.3 19.7 23.3 19.4 31.7 32.1 22.0 29.9 25.2 35.0 16.9 20.7 17.0 25.6 22.8 18.1 29.0 25.1 35.7 21.4 19.7 29.0 21.7 38.8 27.4 32.6 24.1 19.0 19.3 31.6 28.6 15.9 25.4 26.1 30.5 16.4 28.3 20.4 32.2 26.7 40.5 18.3 20.2 29.2 23.8 19.0 30.0 26.8 23.7 15.4 23.0 28.9 25.3 34.2 12.9 22.8 28.9 29.7 22.5 17.9 18.8 12.7 13.9 28.2 16.5 23.2 19.6 3.8 13.8 18.3 11.2 14.9 13.2 12.0 12.5 13.0 13.6 15.7 11.8 12.3 14.5 15.0 16.4 12.2 11.1 9.2 21.7 30.8 32.7 25.3 24.3 21.4 32.4 21.8 24.9 32.3 104.2 66.6 34.3 45.4 14.0 26.6 62.9 25.5 52.2 72.8 15.7 25.5 33.4 16.6 32.9 6.5 24.3 27.5 0.0 22.1 44.1 25.5 45.0 39.5 22.2 23.7 20.6 27.0 20.3 16.5 6.2 36.2 28.8 10.1 35.1 19.7 28.4 33.6 21.5 29.7 17.7 43.7 32.3 38.3 56.6 54.1 14.9 77.6 32.4 22.5 80.0 JADE2 "JADE-2, KIAA0239, PHF15" ENSG00000043143 "Jade family PHD finger 2" Q9NQC1 5 134524312-134583230 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025959, HPA055789" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA025959: AB_1855289, HPA055789: AB_2682922" "unprognostic (8.98e-2)" "unprognostic (1.38e-1)" "unprognostic (1.10e-2)" "unprognostic (1.29e-1)" "unprognostic (3.46e-2)" "unprognostic (2.14e-1)" "unprognostic (7.69e-2)" "unprognostic (5.56e-2)" "unprognostic (8.25e-2)" "prognostic unfavorable (4.42e-4)" "unprognostic (1.58e-2)" "unprognostic (3.49e-2)" "prognostic favorable (5.36e-6)" "unprognostic (3.73e-1)" "unprognostic (1.76e-3)" "unprognostic (2.68e-1)" "unprognostic (2.87e-2)" 15.6 19.8 16.7 16.1 22.0 9.7 13.9 22.8 21.7 16.0 13.4 15.3 9.2 12.7 13.9 8.4 11.8 20.6 13.2 13.4 17.8 14.5 14.8 4.7 15.0 25.8 30.8 16.0 28.4 14.0 30.9 14.4 8.5 20.1 12.8 8.2 16.4 15.0 16.9 12.0 11.5 17.8 13.0 16.8 22.9 12.9 8.1 30.8 13.0 20.6 6.0 19.2 20.0 22.7 7.3 2.0 6.8 3.0 3.1 6.2 2.4 28.7 20.5 0.6 0.8 7.2 8.7 9.4 5.2 13.7 9.6 11.3 15.6 22.4 31.7 11.6 6.7 9.7 6.1 3.6 27.5 4.8 19.1 1.4 7.4 14.3 4.2 7.2 8.1 1.1 5.8 13.3 11.7 14.8 7.6 7.2 9.5 4.6 11.9 5.8 10.3 14.0 7.3 6.8 8.8 10.7 12.6 0.6 12.4 9.0 8.0 4.4 2.9 12.8 0.4 18.4 5.8 5.6 10.1 10.1 6.8 6.1 19.1 12.9 5.5 23.0 29.3 10.5 14.6 9.5 6.8 1.2 4.4 6.2 1.1 6.0 7.3 5.7 5.6 2.0 5.5 5.6 5.6 1.3 3.1 3.0 1.2 5.8 2.4 16.7 22.0 22.8 21.7 17.8 14.5 30.8 16.0 20.1 30.8 8.9 9.1 20.8 6.1 3.8 21.4 10.1 10.2 6.7 4.5 7.0 33.4 6.4 6.6 4.6 0.2 9.2 8.4 0.0 14.6 8.4 8.1 4.3 2.3 3.0 4.0 9.5 11.1 15.4 30.1 0.0 19.0 8.0 1.7 22.6 9.7 6.0 8.8 3.5 18.0 9.1 21.8 0.0 10.8 0.2 1.5 3.1 6.1 20.2 11.9 3.4 JADE3 "JADE-3, KIAA0215, PHF16" ENSG00000102221 "Jade family PHD finger 3" Q92613 X 46912276-47061242 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Spermatogonia: 26.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "memory B-cell: 4.8;naive B-cell: 3.7;plasmacytoid DC: 1.7" "Group enriched" "Detected in many" 9 "B-cells: 4.8;dendritic cells: 1.7" "Cell line enhanced" "Detected in many" "BEWO: 36.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA006007, HPA064697" Uncertain Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA006007: AB_1079605, HPA064697: AB_2685326" "unprognostic (1.39e-1)" "unprognostic (2.53e-1)" "unprognostic (2.24e-1)" "unprognostic (1.52e-3)" "unprognostic (1.18e-2)" "unprognostic (3.01e-2)" "unprognostic (1.05e-3)" "unprognostic (1.59e-1)" "unprognostic (6.83e-3)" "unprognostic (4.55e-2)" "unprognostic (8.97e-3)" "unprognostic (2.82e-1)" "unprognostic (4.25e-2)" "unprognostic (4.42e-2)" "unprognostic (2.69e-1)" "unprognostic (8.18e-2)" "unprognostic (9.70e-2)" 4.9 12.6 3.5 2.7 5.1 1.5 6.2 3.3 4.9 5.7 4.5 7.1 14.0 1.9 9.5 16.3 4.7 4.3 3.2 5.2 3.9 3.3 3.7 7.7 4.3 4.1 9.2 1.4 7.2 8.7 3.0 2.1 15.9 4.7 5.4 3.2 2.1 4.3 12.2 3.3 3.8 3.5 6.0 8.5 9.8 4.7 14.5 8.4 8.4 4.2 1.4 7.5 7.6 13.1 4.8 1.7 0.0 0.3 0.2 0.2 0.4 6.4 5.8 9.5 6.5 3.5 2.6 36.4 3.8 3.2 4.3 4.9 6.6 5.6 0.0 2.7 2.8 6.4 2.5 11.5 3.1 6.3 17.1 7.5 5.1 6.5 6.4 5.7 3.8 2.7 2.0 4.3 3.0 9.9 2.6 8.1 9.8 3.5 3.0 3.3 6.6 13.8 4.6 7.4 4.1 4.9 14.2 10.7 8.9 3.6 5.9 8.2 7.3 11.0 10.2 6.0 16.4 6.8 4.0 5.0 4.6 8.0 6.4 2.5 2.3 2.0 12.2 1.2 3.3 4.4 0.0 0.1 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.1 3.7 0.0 0.0 0.0 0.2 0.3 1.7 0.0 0.4 3.5 5.1 3.3 4.9 3.9 3.3 9.2 1.4 4.7 8.4 0.0 8.5 0.5 2.3 3.8 1.5 3.3 2.5 0.0 1.2 5.2 0.0 7.9 0.0 2.1 0.3 4.5 0.9 0.0 3.2 8.1 2.2 3.8 0.0 11.1 1.5 0.0 8.1 3.7 1.2 2.0 4.4 0.8 3.3 4.6 1.9 1.2 2.9 0.0 3.5 2.1 1.6 6.5 1.9 9.2 26.6 7.0 11.9 0.5 2.3 3.3 JAK2 JTK10 ENSG00000096968 "Janus kinase 2" O60674 9 4984390-5128183 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity, Innate immunity" "Chromatin regulator, Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 36.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 40.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 40.8" "Group enriched" "Detected in many" 5 "ASC diff: 19.4;HDLM-2: 27.4;HEL: 56.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013089, HPA040820, HPA043870" Approved Supported "Nucleoplasm,Plasma membrane,Focal adhesion sites" No No Nucleoplasm "Plasma membrane, Focal adhesion sites" "CAB013089: AB_2533647, HPA040820: AB_2677151, HPA043870: AB_2678708" "unprognostic (2.24e-3)" "unprognostic (2.76e-2)" "unprognostic (1.50e-2)" "unprognostic (7.67e-2)" "unprognostic (5.50e-2)" "unprognostic (3.09e-2)" "unprognostic (1.48e-1)" "unprognostic (7.36e-2)" "unprognostic (1.09e-1)" "unprognostic (5.49e-3)" "unprognostic (1.58e-1)" "unprognostic (1.72e-2)" "unprognostic (3.85e-1)" "unprognostic (4.53e-2)" "unprognostic (3.43e-2)" "unprognostic (1.96e-1)" "unprognostic (7.37e-3)" 19.8 8.8 11.5 19.0 10.5 19.0 17.7 14.7 14.4 17.8 10.6 7.0 10.3 7.2 14.8 13.6 12.4 13.4 14.6 27.6 10.3 6.7 7.7 5.6 16.1 19.4 7.0 10.5 15.9 6.7 10.1 7.5 12.0 10.0 12.0 7.4 9.4 7.2 7.4 14.4 19.0 12.3 10.4 11.7 21.5 14.1 10.1 9.0 13.6 8.6 6.5 13.5 13.9 15.6 2.1 9.6 40.8 7.5 3.4 2.1 2.5 2.5 1.5 1.5 2.5 19.4 5.0 0.4 3.5 3.0 2.7 1.8 0.1 0.8 0.1 0.8 2.1 2.2 0.9 1.6 2.1 2.0 27.4 0.5 56.1 3.0 0.7 4.0 3.8 2.9 4.1 0.9 1.1 1.8 3.3 2.5 2.0 4.0 6.5 4.8 0.9 0.9 5.4 1.3 1.3 1.7 1.9 2.8 0.8 2.0 1.3 1.7 0.9 1.0 1.5 1.1 1.6 0.8 6.7 5.1 4.1 1.4 4.2 2.4 1.2 2.3 0.5 5.3 1.9 2.0 40.8 7.5 13.4 2.1 7.3 1.7 2.1 1.6 1.2 9.6 1.9 0.9 1.1 7.1 3.4 5.8 3.6 1.6 2.5 11.5 10.5 14.7 14.4 10.3 6.7 7.0 10.5 10.0 9.0 14.9 6.4 6.9 2.8 8.7 7.4 22.0 0.0 5.3 7.9 7.0 7.9 1.8 1.7 3.0 7.4 8.7 3.9 23.3 3.4 0.8 7.0 1.7 13.9 1.6 11.9 7.9 2.9 4.9 36.0 5.3 21.9 27.7 5.0 16.2 4.2 12.2 5.4 14.4 31.5 2.5 11.1 0.0 5.0 14.9 5.7 7.3 2.9 5.0 3.3 4.1 JAM2 "C21orf43, CD322, JAM-B, JAMB, VE-JAM" ENSG00000154721 "Junctional adhesion molecule 2" P57087 21 25639272-25717562 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 66.7" "Cell type enhanced" "Detected in many" 20 "Cardiomyocytes: 31.9;Endothelial cells: 151.0;Ito cells: 49.7" "Cancer enriched" "Detected in all" 9 "glioma: 27.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 18.2;BJ hTERT+: 11.6;HDLM-2: 11.3;hTERT-RPE1: 16.2;U-138 MG: 13.1;U-87 MG: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028789, HPA077346" Supported "Nucleoplasm,Plasma membrane" NA NA 17000 "Plasma membrane" Nucleoplasm "HPA028789: AB_2732443, HPA077346: AB_2732341" "unprognostic (1.42e-1)" "unprognostic (6.39e-2)" "unprognostic (1.23e-1)" "unprognostic (1.73e-1)" "unprognostic (2.02e-2)" "unprognostic (1.53e-2)" "unprognostic (7.51e-4)" "unprognostic (2.61e-2)" "unprognostic (4.55e-1)" "unprognostic (1.02e-1)" "unprognostic (3.46e-2)" "unprognostic (3.81e-1)" "unprognostic (8.86e-2)" "unprognostic (5.71e-3)" "unprognostic (2.18e-1)" "unprognostic (2.20e-1)" "unprognostic (4.85e-3)" 16.6 17.2 13.8 8.4 18.9 1.5 14.6 9.9 23.4 18.1 14.7 14.5 8.0 7.5 20.5 13.5 13.3 12.0 14.4 21.9 13.5 12.5 6.5 3.5 17.1 4.6 17.6 13.5 18.9 3.9 5.8 7.7 66.7 18.5 12.0 9.7 11.1 5.5 18.0 8.4 6.9 9.2 21.8 23.0 2.8 9.7 25.8 12.2 0.6 9.5 10.1 6.3 13.5 15.1 3.1 1.9 1.9 0.7 2.8 1.1 0.4 0.0 0.0 18.2 0.1 0.7 0.2 0.4 0.5 11.6 1.5 5.5 0.0 0.0 0.1 0.0 0.2 7.0 0.0 1.6 0.0 3.4 11.3 0.5 0.1 0.0 0.0 0.0 0.0 0.1 1.0 0.0 1.3 0.0 16.2 0.0 0.4 0.0 0.2 5.6 0.1 0.3 0.1 5.7 0.1 0.0 2.1 3.7 0.0 0.0 0.0 0.3 2.7 0.1 0.2 0.0 0.2 0.6 0.1 0.0 13.1 1.2 0.1 1.8 1.5 0.0 0.0 9.6 0.1 0.5 1.4 0.7 0.3 0.4 0.5 0.6 0.3 0.4 0.9 0.4 3.1 0.7 1.1 1.9 2.8 0.6 1.9 0.2 0.4 13.8 18.9 9.9 20.5 13.5 12.5 17.6 13.5 18.5 12.2 0.0 2.9 1.4 1.4 6.6 1.5 31.9 0.0 1.4 0.0 3.5 13.7 0.3 0.0 0.3 12.9 151.0 0.0 0.0 0.2 2.2 18.5 1.2 0.0 0.0 1.0 0.0 0.0 49.7 2.2 13.2 9.2 1.4 15.1 0.0 0.0 0.9 0.1 0.0 23.0 0.0 3.6 0.0 7.6 4.8 3.9 5.8 0.7 0.0 0.0 0.7 JAML "AMICA, AMICA1, Gm638" ENSG00000160593 "Junction adhesion molecule like" Q86YT9 11 118193740-118225094 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "blood: 202.6" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 2: 48.3;Kupffer cells: 117.5;Macrophages: 185.0;T-cells: 45.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 202.6" "Group enriched" "Detected in many" 4 "dendritic cells: 60.5;granulocytes: 202.6;monocytes: 59.0" "Cell line enriched" "Detected in some" 5 "HMC-1: 24.9" "Region enriched" "Detected in single" 9 "cerebellum: 7.0" "Region enriched" "Detected in many" 12 "cerebellum: 113.6" "HPA005854, HPA047919" Approved Supported "Nucleoplasm,Plasma membrane" NA NA 1400000 "Plasma membrane" Nucleoplasm "HPA005854: , HPA047919: AB_2680209" "unprognostic (3.91e-3)" "unprognostic (1.55e-3)" "unprognostic (3.00e-2)" "unprognostic (1.28e-3)" "unprognostic (2.87e-3)" "prognostic favorable (3.11e-4)" "unprognostic (2.80e-1)" "prognostic favorable (3.92e-4)" "unprognostic (1.14e-1)" "unprognostic (3.17e-1)" "unprognostic (8.69e-2)" "unprognostic (5.08e-1)" "unprognostic (6.43e-3)" "unprognostic (8.96e-2)" "unprognostic (3.12e-2)" "unprognostic (4.10e-2)" "unprognostic (1.58e-2)" 6.7 2.1 0.9 23.1 1.1 6.6 2.1 5.3 0.8 4.1 8.4 0.7 1.3 6.1 3.8 9.6 4.0 3.1 8.9 3.1 0.9 0.9 3.4 4.3 34.4 43.2 3.7 0.5 2.1 1.8 0.0 2.7 4.2 2.3 3.4 8.3 6.7 6.7 1.1 1.0 2.2 14.0 4.7 1.8 43.4 3.9 1.9 0.6 14.3 2.6 5.9 25.0 9.8 3.0 0.3 60.5 202.6 59.0 1.4 25.2 40.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.1 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.7 0.0 0.0 24.9 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.3 2.3 0.3 2.7 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.2 0.0 5.8 59.0 202.6 3.9 36.6 25.2 0.3 7.0 7.4 60.5 0.1 8.3 6.7 126.6 1.4 17.1 46.6 11.1 40.1 0.9 1.1 5.3 0.8 0.9 0.9 3.7 0.5 2.3 0.6 6.0 48.3 15.4 0.1 0.0 0.0 0.0 0.0 4.0 10.3 1.8 0.0 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.3 0.2 0.4 0.1 14.0 2.1 29.9 0.0 0.0 8.0 117.5 0.9 0.0 185.0 0.0 11.8 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.1 1.4 0.0 0.3 45.3 0.0 0.1 JARID2 JMJ ENSG00000008083 "Jumonji and AT-rich interaction domain containing 2" Q92833 6 15246296-15522040 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 53.3" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 146.2;Muller glia cells: 167.6;Suprabasal keratinocytes: 132.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 40.6" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "JURKAT: 32.2;SuSa: 36.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063889, CAB069890" Approved Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "CAB069890: AB_10000529, HPA063889: AB_2685143" "unprognostic (5.06e-2)" "unprognostic (1.82e-1)" "unprognostic (1.08e-1)" "unprognostic (1.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.43e-1)" "unprognostic (4.87e-3)" "unprognostic (6.35e-2)" "unprognostic (2.57e-2)" "unprognostic (1.30e-2)" "unprognostic (2.18e-1)" "unprognostic (3.60e-2)" "unprognostic (3.26e-3)" "unprognostic (7.04e-2)" "unprognostic (4.48e-2)" "unprognostic (2.78e-2)" "unprognostic (1.99e-1)" 10.2 5.3 6.9 11.5 8.8 53.3 7.2 40.6 9.3 6.3 8.3 11.4 9.4 6.9 8.8 8.4 15.4 5.0 7.9 5.9 6.8 7.1 4.6 4.4 8.2 12.8 6.8 3.8 7.2 4.4 6.1 8.2 8.4 8.4 5.5 5.9 15.1 10.7 11.9 12.5 14.9 12.5 5.3 6.6 14.2 8.2 17.5 6.5 41.3 5.0 8.9 19.2 6.5 7.7 4.2 4.6 14.4 4.0 4.9 3.9 2.0 5.2 3.6 15.0 8.6 1.8 1.8 14.9 1.5 3.6 2.0 2.5 3.8 4.1 2.8 5.4 3.0 3.0 2.7 3.5 8.7 1.8 5.4 5.3 9.8 4.3 4.8 2.0 9.9 11.5 2.6 5.5 2.9 11.7 6.0 2.1 32.2 12.7 4.7 1.1 5.2 19.7 18.7 16.0 2.6 1.6 8.8 4.6 7.8 1.8 5.5 11.6 6.6 3.1 10.9 13.7 36.6 3.8 10.7 3.6 9.2 5.1 5.0 5.2 3.0 7.2 4.9 3.1 9.3 11.5 9.6 4.0 3.2 3.9 2.6 3.3 2.6 1.9 2.3 3.3 4.2 2.4 3.3 14.4 4.9 2.7 4.6 1.5 2.0 6.9 8.8 40.6 7.9 6.8 7.1 6.8 3.8 8.4 6.5 6.0 10.9 22.2 9.5 71.4 71.0 8.9 10.2 4.0 11.4 5.2 82.5 23.3 1.7 6.8 59.2 24.1 12.3 0.0 3.9 19.3 18.6 5.7 24.3 12.9 21.4 146.2 25.7 14.1 48.4 29.9 8.1 37.2 25.3 20.8 16.0 167.6 11.0 11.5 8.1 2.6 91.1 6.5 25.0 7.0 67.9 132.5 21.1 30.5 13.4 13.6 JAZF1 "DKFZp761K2222, TIP27, ZNF802" ENSG00000153814 "JAZF zinc finger 1" Q86VZ6 7 27830573-28180743 "Disease related genes, Predicted intracellular proteins" "Lipid metabolism, Transcription, Transcription regulation" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 85.4;Late spermatids: 64.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019271, HPA066967" Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "CAB019271: , HPA066967: AB_2685758" "unprognostic (1.19e-1)" "unprognostic (2.14e-1)" "unprognostic (2.18e-2)" "unprognostic (7.48e-2)" "unprognostic (9.08e-2)" "unprognostic (1.14e-1)" "unprognostic (2.74e-1)" "unprognostic (8.88e-2)" "unprognostic (2.50e-1)" "unprognostic (1.44e-1)" "unprognostic (8.27e-3)" "unprognostic (2.32e-2)" "unprognostic (1.26e-2)" "unprognostic (7.18e-3)" "unprognostic (2.10e-1)" "unprognostic (1.95e-1)" "unprognostic (1.01e-2)" 11.9 65.2 18.7 13.4 13.1 16.7 17.7 26.9 19.2 50.1 23.0 8.5 12.8 3.4 34.1 18.4 8.4 11.9 9.9 17.0 14.0 14.8 4.8 12.2 9.9 10.8 8.9 16.9 11.6 5.7 5.6 19.0 12.3 11.1 23.6 7.3 4.8 4.2 28.1 5.6 5.9 6.7 29.7 12.2 11.0 7.4 14.3 10.0 6.3 12.1 5.5 11.9 18.7 24.3 4.6 12.5 17.6 3.7 4.3 4.6 2.4 0.7 0.6 2.4 0.6 18.6 22.7 0.0 5.8 14.7 9.7 11.8 0.0 3.8 16.8 11.8 11.7 6.5 0.3 3.2 4.2 7.7 2.5 5.1 6.0 4.2 0.0 12.7 2.5 1.7 10.2 5.2 7.2 4.8 7.3 5.9 1.3 0.1 27.5 5.2 0.7 0.7 8.7 5.2 0.1 3.9 1.8 1.1 5.1 3.4 0.1 1.5 2.6 4.6 0.1 6.0 7.7 1.7 3.0 5.8 15.3 6.0 4.1 6.4 5.0 1.4 6.5 4.9 6.2 8.4 17.6 3.7 5.5 4.6 3.0 1.3 2.9 1.4 3.1 3.3 4.6 0.6 3.1 3.2 4.3 3.2 12.5 2.9 2.4 18.7 13.1 26.9 18.7 14.0 14.8 8.9 16.9 11.1 10.0 3.0 6.5 8.0 2.6 13.1 7.4 23.4 10.2 14.7 3.4 1.8 5.9 0.5 6.6 12.7 85.4 8.0 0.0 23.3 2.1 1.0 21.1 2.5 24.2 4.2 9.1 15.9 5.2 2.5 22.5 64.7 50.9 27.7 21.9 17.2 0.7 3.9 4.3 0.0 32.5 1.4 3.9 12.9 15.5 8.4 15.8 9.8 1.1 13.4 0.2 1.4 JDP2 JUNDM2 ENSG00000140044 "Jun dimerization protein 2" Q8WYK2 14 75427716-75474111 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Kupffer cells: 71.9;Muller glia cells: 43.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 11.0;granulocytes: 6.9;monocytes: 10.5" "Cell line enhanced" "Detected in many" "HHSteC: 50.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059511 Supported Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA059511: AB_2684046" "unprognostic (3.19e-2)" "unprognostic (5.58e-2)" "prognostic unfavorable (8.58e-5)" "unprognostic (1.64e-2)" "unprognostic (2.13e-1)" "unprognostic (1.20e-1)" "unprognostic (2.99e-2)" "unprognostic (2.81e-1)" "unprognostic (5.06e-2)" "unprognostic (1.91e-1)" "unprognostic (3.25e-2)" "unprognostic (1.86e-1)" "unprognostic (8.11e-3)" "unprognostic (2.20e-1)" "unprognostic (1.92e-1)" "unprognostic (2.13e-1)" "unprognostic (9.30e-3)" 27.0 14.4 11.2 19.3 12.5 46.0 59.6 10.6 15.1 16.3 15.3 13.7 6.5 15.3 12.7 10.5 17.1 14.8 21.3 20.7 13.5 9.0 9.7 14.3 24.8 13.2 14.0 8.7 21.8 15.8 7.4 10.1 12.0 11.2 13.9 8.1 16.6 19.5 11.4 13.3 15.2 22.4 17.8 15.7 39.7 15.8 4.7 11.8 1.4 20.7 18.7 9.7 14.2 60.4 11.0 2.1 6.9 10.5 0.1 0.2 1.1 4.4 3.9 0.7 7.8 24.7 18.4 26.8 13.8 15.0 9.0 11.4 9.5 3.9 3.5 7.0 26.2 1.6 17.4 4.9 4.7 3.9 4.7 0.5 4.8 7.3 3.4 50.8 6.8 0.3 32.4 28.3 3.7 9.1 3.5 0.4 4.0 0.6 6.8 8.1 21.7 0.3 11.2 2.7 8.6 2.5 2.4 0.1 9.5 4.3 2.4 0.6 3.1 14.2 20.4 15.8 9.2 19.5 14.9 1.8 11.4 17.7 0.7 2.0 5.7 1.6 8.3 3.4 25.8 5.6 0.1 4.1 3.8 0.0 7.0 0.0 11.0 0.2 0.0 2.1 5.1 0.0 0.0 6.9 0.1 10.5 1.8 0.2 1.1 11.2 12.5 10.6 15.1 13.5 9.0 14.0 8.7 11.2 11.8 11.9 31.0 5.6 5.5 14.5 14.3 16.9 12.7 6.7 7.9 8.7 9.8 1.6 0.0 2.3 0.3 11.3 14.9 0.0 5.7 4.7 22.2 3.7 2.3 7.4 8.9 7.9 5.2 11.1 71.9 0.2 16.7 9.4 11.8 2.8 12.7 43.2 6.9 8.6 15.6 2.2 30.5 6.5 7.1 0.1 0.4 7.9 0.2 0.0 8.0 9.1 JHY "C11orf63, FLJ23554, Jhy" ENSG00000109944 "Junctional cadherin complex regulator" Q6NUN7 11 122882528-122959798 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 51.0" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 1: 11.9;Ciliated cells: 34.8;Club cells: 13.6;Proximal tubular cells: 8.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 13.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039612, HPA040344, HPA077658, HPA077748" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA039612: AB_10674424, HPA040344: AB_2676931, HPA077658: AB_2732355, HPA077748: AB_2732360" "unprognostic (5.27e-2)" "unprognostic (1.12e-1)" "unprognostic (3.93e-2)" "prognostic favorable (7.94e-5)" "unprognostic (9.97e-5)" "unprognostic (1.64e-1)" "unprognostic (2.02e-3)" "unprognostic (1.94e-3)" "unprognostic (1.77e-1)" "unprognostic (1.49e-1)" "unprognostic (4.13e-2)" "unprognostic (2.97e-1)" "prognostic favorable (8.77e-4)" "unprognostic (6.46e-3)" "unprognostic (2.54e-1)" "prognostic unfavorable (2.58e-4)" "unprognostic (7.79e-2)" 3.6 0.9 1.9 1.6 2.1 0.2 2.3 1.6 2.2 2.1 2.4 1.2 1.0 0.7 1.5 2.5 1.0 5.1 1.5 1.6 1.5 2.6 5.3 1.0 2.8 1.0 1.7 1.4 2.1 1.5 6.3 4.2 2.3 1.7 2.3 0.8 1.9 1.0 1.5 2.4 1.0 1.2 1.0 2.2 1.3 1.0 51.0 1.3 1.4 3.4 1.5 1.2 1.7 1.2 2.4 4.9 0.3 0.6 4.3 4.1 1.1 2.6 3.7 2.2 0.1 0.6 0.4 0.7 5.7 6.6 2.4 1.0 0.2 9.9 0.0 1.4 8.8 13.4 2.3 2.6 1.3 1.1 8.8 2.7 0.1 1.8 0.1 0.9 1.5 4.6 2.8 7.3 0.4 0.6 6.2 3.6 3.9 0.0 0.0 1.8 1.6 0.0 0.6 0.3 7.7 3.4 0.9 0.0 1.2 6.9 3.0 5.7 4.0 6.8 3.7 2.4 2.9 4.5 0.6 1.2 7.8 1.0 0.2 4.5 0.1 0.0 0.0 2.0 2.0 5.2 0.3 0.6 0.1 2.9 0.1 4.1 2.4 3.0 3.9 4.9 1.4 2.1 2.1 0.3 4.3 0.0 1.1 0.6 1.1 1.9 2.1 1.6 2.2 1.5 2.6 1.7 1.4 1.7 1.3 11.9 4.1 0.0 0.0 0.0 0.0 0.0 0.0 34.8 13.6 5.2 0.0 0.0 3.3 4.9 0.0 0.0 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 2.9 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 JKAMP "C14orf100, CDA06, HSPC213, HSPC327, JAMP" ENSG00000050130 "JNK1/MAPK8 associated membrane protein" Q9P055 14 59484443-59505410 "Cancer-related genes, Predicted membrane proteins" "Unfolded protein response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031172, HPA071650" Supported Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA031172: AB_10670563, HPA071650: AB_2686429" "unprognostic (1.48e-1)" "unprognostic (2.19e-2)" "unprognostic (4.95e-2)" "unprognostic (5.88e-2)" "unprognostic (2.54e-1)" "unprognostic (1.49e-3)" "prognostic unfavorable (3.09e-6)" "unprognostic (2.68e-1)" "unprognostic (3.52e-1)" "unprognostic (1.16e-1)" "unprognostic (3.09e-1)" "unprognostic (3.14e-1)" "prognostic favorable (1.36e-4)" "unprognostic (1.76e-1)" "unprognostic (2.27e-1)" "unprognostic (1.36e-1)" "unprognostic (1.73e-1)" 19.0 29.5 19.3 13.0 25.5 15.7 24.2 16.7 28.4 17.5 21.3 25.0 18.1 13.8 22.8 19.6 18.6 23.2 21.7 18.3 18.8 29.4 38.9 26.1 22.2 16.2 29.5 19.5 19.7 18.7 42.3 44.5 24.1 36.9 22.9 22.5 22.8 24.9 20.3 15.9 17.5 25.0 20.7 30.3 22.1 18.7 24.6 27.0 18.6 24.6 18.0 14.7 21.0 16.7 14.9 29.0 37.0 31.7 18.0 18.3 21.5 19.9 23.6 20.3 16.6 15.2 20.1 15.5 31.3 26.8 18.5 22.1 7.4 36.6 9.9 28.1 28.9 21.3 14.5 14.9 19.3 25.0 29.7 8.5 10.0 15.2 14.7 20.2 16.6 19.7 21.9 21.9 17.3 11.9 29.7 18.8 13.8 9.0 19.9 34.7 18.0 9.1 12.8 11.1 16.9 20.8 10.7 24.7 9.1 31.9 19.8 8.7 15.2 28.4 22.8 16.6 15.5 23.0 12.8 24.7 19.5 25.6 17.8 20.5 9.3 16.5 11.5 27.6 11.3 24.5 28.2 25.2 32.5 15.1 29.8 14.6 14.9 16.5 15.9 21.2 13.6 17.7 16.6 37.0 18.0 31.7 29.0 18.3 21.5 19.3 25.5 16.7 28.4 18.8 29.4 29.5 19.5 36.9 27.0 20.8 28.2 18.6 27.3 26.7 28.5 9.4 48.4 64.3 19.4 43.6 17.7 52.1 6.6 41.7 127.9 21.5 16.0 70.0 47.9 55.4 37.6 25.8 34.6 34.4 51.7 27.0 30.0 31.9 57.1 50.5 32.8 38.3 45.5 31.5 24.3 40.3 41.2 21.0 29.7 46.2 24.2 12.9 28.6 93.1 41.2 25.5 24.9 26.6 23.5 13.7 JMJD1C "DKFZp761F0118, FLJ14374, KDM3C, KIAA1380, TRIP8" ENSG00000171988 "Jumonji domain containing 1C" Q15652 10 63167221-63521850 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 15.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056175, HPA066195" Approved Supported Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA056175: AB_2683057, HPA066195: AB_2685634" "unprognostic (7.72e-2)" "unprognostic (5.57e-2)" "unprognostic (9.44e-2)" "unprognostic (1.63e-1)" "unprognostic (2.87e-2)" "unprognostic (6.91e-2)" "unprognostic (3.85e-1)" "unprognostic (2.54e-2)" "unprognostic (1.17e-1)" "unprognostic (1.29e-2)" "unprognostic (2.22e-3)" "unprognostic (1.27e-1)" "unprognostic (3.39e-3)" "unprognostic (7.51e-2)" "unprognostic (2.53e-1)" "unprognostic (4.18e-2)" "unprognostic (1.13e-1)" 31.7 10.9 8.7 26.0 10.9 25.9 16.2 43.0 11.1 21.8 16.6 5.4 11.8 12.2 18.1 17.4 16.4 13.1 18.5 11.7 10.8 8.1 14.1 16.7 29.9 20.9 9.6 6.5 19.2 12.6 27.1 18.6 10.3 14.1 14.1 9.2 13.8 15.3 15.6 13.4 11.0 22.2 11.7 17.6 29.1 12.9 10.9 13.3 27.2 15.6 20.1 15.3 21.9 11.8 4.8 4.2 15.2 2.8 1.7 3.1 1.1 11.0 5.6 13.2 10.1 7.0 13.0 4.6 7.7 16.0 7.0 9.6 9.5 11.9 15.0 4.7 7.2 6.3 9.1 3.7 7.4 12.5 4.0 4.7 5.7 5.8 6.9 8.6 12.2 2.1 12.9 7.7 12.3 36.1 15.9 12.5 10.8 10.0 11.4 16.3 3.0 9.3 6.6 14.1 2.5 19.8 16.2 28.7 7.1 7.1 8.0 7.2 11.8 11.6 7.3 11.1 10.1 7.2 22.2 14.9 6.5 9.2 5.6 9.6 10.2 8.1 14.3 7.9 7.3 5.8 0.6 2.8 3.1 2.0 1.9 3.1 4.7 2.2 2.1 2.4 4.8 3.1 2.6 15.2 1.7 1.6 4.2 1.9 1.1 8.7 10.9 43.0 11.1 10.8 8.1 9.6 6.5 14.1 13.3 104.2 81.3 88.7 263.2 135.0 89.5 52.3 45.9 113.8 121.7 52.4 143.3 28.1 11.6 51.6 31.8 129.1 72.6 0.0 41.5 23.6 115.8 122.0 90.2 30.6 51.0 111.2 82.5 89.6 79.2 32.2 96.1 141.3 72.6 41.5 51.6 62.3 60.4 56.1 84.1 23.1 170.7 71.1 102.3 135.2 137.3 117.1 27.8 76.7 33.1 223.6 JMJD6 "KIAA0585, PTDSR, PTDSR1" ENSG00000070495 "Arginine demethylase and lysine hydroxylase" Q6NYC1 17 76712832-76726799 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, Dioxygenase, Oxidoreductase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 80.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004548, HPA059156" Supported Supported Nucleoplasm No No Nucleoplasm "CAB004548: AB_628185, HPA059156: AB_2683934" "unprognostic (1.26e-1)" "unprognostic (6.27e-2)" "unprognostic (8.06e-2)" "unprognostic (9.46e-2)" "unprognostic (5.95e-2)" "unprognostic (4.14e-3)" "prognostic unfavorable (5.75e-6)" "unprognostic (4.88e-2)" "unprognostic (2.16e-1)" "unprognostic (2.56e-2)" "prognostic favorable (5.71e-4)" "unprognostic (5.66e-2)" "prognostic unfavorable (7.59e-7)" "unprognostic (1.15e-1)" "unprognostic (1.31e-1)" "unprognostic (8.86e-2)" "unprognostic (3.82e-1)" 14.9 15.9 10.7 12.6 14.9 80.6 14.3 20.5 18.7 9.9 17.5 8.5 10.5 11.7 12.2 6.6 12.2 11.5 14.7 26.0 11.9 7.3 9.7 11.1 14.6 11.0 17.8 7.8 16.7 13.7 10.6 13.3 12.3 16.9 11.9 8.6 8.3 9.7 10.2 19.6 8.6 10.5 13.7 13.8 12.7 14.7 11.2 18.6 5.4 11.0 8.6 10.0 16.1 57.5 13.4 17.3 25.2 24.8 8.6 20.4 12.8 16.4 22.7 8.0 10.4 10.4 9.0 7.8 15.2 11.8 22.1 21.6 22.9 8.2 10.8 6.7 16.4 32.5 12.6 25.3 7.5 21.4 7.7 20.1 16.1 15.9 23.1 16.7 8.4 24.7 10.6 11.9 24.3 8.2 14.1 18.4 5.9 23.9 20.2 16.4 10.3 14.5 12.0 7.0 15.9 27.5 11.5 15.1 16.7 7.5 5.2 13.9 13.7 13.2 19.6 18.1 14.4 17.5 12.5 11.8 25.9 15.1 13.3 28.1 22.4 11.9 10.0 25.0 7.4 14.3 25.1 19.4 25.2 17.6 24.8 17.0 13.4 20.4 19.5 17.3 9.2 17.0 15.8 15.4 8.6 23.7 14.9 19.5 12.8 10.7 14.9 20.5 18.7 11.9 7.3 17.8 7.8 16.9 18.6 23.8 25.1 29.2 77.6 73.8 14.6 19.8 20.4 12.0 22.7 8.7 47.1 25.1 14.9 26.0 22.7 26.3 38.4 0.0 23.8 37.8 34.9 35.0 63.6 8.6 28.6 6.4 37.7 27.0 17.6 8.6 15.0 33.2 55.6 37.9 18.1 14.1 24.5 19.9 16.6 6.7 34.5 12.9 62.8 45.9 25.9 64.4 25.5 38.3 20.4 33.1 JMY "FLJ37870, WHAMM2" ENSG00000152409 "Junction mediating and regulatory protein, p53 cofactor" Q8N9B5 5 79236189-79327215 "Predicted intracellular proteins" "DNA damage, DNA repair" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 17.4;Karpas-707: 29.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037508, HPA043308" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA037508: , HPA043308: AB_10806502" "unprognostic (1.87e-2)" "unprognostic (2.12e-3)" "unprognostic (4.28e-1)" "unprognostic (1.79e-1)" "unprognostic (4.30e-2)" "unprognostic (5.28e-3)" "unprognostic (2.10e-2)" "unprognostic (1.16e-2)" "unprognostic (2.66e-1)" "prognostic unfavorable (1.12e-4)" "unprognostic (5.24e-2)" "unprognostic (1.23e-1)" "prognostic favorable (3.03e-5)" "unprognostic (7.21e-2)" "unprognostic (3.22e-1)" "unprognostic (1.85e-1)" "unprognostic (4.15e-1)" 8.6 9.2 13.4 5.8 17.0 14.8 10.3 21.7 15.8 13.6 17.8 10.1 13.0 5.8 20.3 12.9 10.0 9.2 8.4 8.5 11.2 8.9 11.5 9.1 7.1 7.6 13.6 13.4 24.7 15.9 24.8 12.5 5.8 11.7 13.5 7.9 9.2 11.9 11.0 15.4 11.9 8.2 13.0 9.7 8.1 9.5 12.0 14.1 10.4 17.7 5.1 7.2 13.5 10.2 0.9 0.8 0.4 0.4 3.7 1.7 0.1 2.4 2.4 1.8 4.8 5.2 4.7 6.5 2.4 6.1 2.2 3.6 1.1 2.7 1.7 17.4 2.6 2.5 2.7 6.5 3.1 3.5 7.5 6.0 3.4 3.8 2.4 7.9 1.5 2.2 4.4 8.5 1.0 9.6 4.5 2.7 4.7 2.0 29.8 1.8 3.3 3.2 3.2 3.0 0.5 1.6 3.2 5.9 7.2 4.7 2.6 7.4 4.0 3.0 3.3 5.5 3.3 2.7 3.2 2.8 0.9 1.6 0.5 1.5 8.5 7.3 1.7 1.9 1.5 1.6 0.0 0.4 0.1 1.4 0.4 0.9 0.9 1.4 1.4 0.1 0.8 1.7 1.2 0.4 3.7 0.3 0.8 1.2 0.1 13.4 17.0 21.7 15.8 11.2 8.9 13.6 13.4 11.7 14.1 8.9 12.2 7.5 10.3 26.6 32.0 32.7 17.8 20.1 14.8 15.7 41.2 5.1 1.7 6.5 23.3 13.0 4.7 0.0 8.5 4.7 16.9 16.5 8.1 13.9 4.0 38.1 23.0 4.9 5.4 15.4 22.5 9.9 21.9 1.0 8.4 17.3 13.0 10.4 33.6 6.5 38.4 12.9 25.5 22.9 41.1 34.8 16.9 17.0 7.3 9.2 JPH1 JP-1 ENSG00000104369 "Junctophilin 1" Q9HDC5 8 74234700-74321328 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 97.2" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 35.7;Basal glandular cells: 27.1;Cardiomyocytes: 31.6;Glandular cells: 24.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MOLT-4: 10.1;OE19: 12.1;SK-BR-3: 24.2;T-47d: 17.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008996, HPA009413, CAB013461" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB013461: , HPA008996: AB_1852023, HPA009413: AB_1079163" "unprognostic (2.91e-3)" "unprognostic (3.01e-1)" "unprognostic (8.85e-2)" "unprognostic (8.73e-6)" "unprognostic (2.07e-1)" "unprognostic (1.86e-1)" "unprognostic (3.63e-2)" "prognostic favorable (5.77e-5)" "unprognostic (8.97e-2)" "unprognostic (1.30e-1)" "unprognostic (2.38e-1)" "unprognostic (5.99e-2)" "unprognostic (9.80e-2)" "unprognostic (6.87e-2)" "unprognostic (3.03e-1)" "unprognostic (4.88e-2)" "unprognostic (1.08e-2)" 1.7 0.6 1.8 0.7 5.7 0.5 0.8 13.7 3.1 0.8 1.9 0.8 0.4 0.8 1.5 1.7 1.8 0.6 0.6 3.3 2.1 0.7 0.8 0.5 2.2 0.5 1.0 4.2 0.5 3.5 1.1 0.4 1.1 2.4 1.8 2.8 0.0 1.3 0.8 97.2 0.7 0.9 1.4 2.4 0.5 0.9 0.9 2.3 2.4 1.2 21.5 1.4 1.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.4 0.1 3.1 0.0 1.0 0.0 0.7 4.5 3.9 3.1 1.0 0.0 5.9 0.0 3.6 0.0 0.5 2.0 0.2 0.6 2.6 0.0 2.9 0.0 0.0 7.8 0.5 0.0 0.2 2.8 10.1 0.0 6.8 12.1 2.0 5.1 3.9 0.0 0.1 9.0 5.2 0.7 0.0 24.2 1.2 1.2 17.2 0.1 0.0 1.2 1.7 0.4 1.0 0.0 0.0 0.0 2.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 5.7 13.7 3.1 2.1 0.7 1.0 4.2 2.4 2.3 35.7 8.0 0.0 27.1 2.5 0.0 31.6 0.0 8.1 15.9 1.8 5.9 0.0 0.0 0.2 2.1 0.4 1.3 0.0 1.2 0.0 2.1 24.9 0.0 0.0 0.1 0.0 12.1 0.0 0.0 0.4 0.9 0.2 1.7 0.0 10.1 0.2 3.4 8.0 0.0 0.7 0.0 0.0 2.3 0.1 3.6 1.8 0.0 0.0 5.6 16.6 JPH3 "CAGL237, HDL2, JP-3, JP3, TNRC22" ENSG00000154118 "Junctophilin 3" Q8WXH2 16 87601835-87698156 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 44.2" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 25.0;Cone photoreceptor cells: 21.6;Early spermatids: 44.0;Horizontal cells: 47.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Lineage enhanced" "Detected in single" "dendritic cells: 1.1" "Cell line enhanced" "Detected in some" "MCF7: 6.5;NTERA-2: 5.8;SH-SY5Y: 7.5;SiHa: 4.9;U-2 OS: 23.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076304 Approved Nucleoplasm,Cytosol Yes No "Nucleoplasm, Cytosol" "HPA076304: AB_2686793" "unprognostic (8.97e-3)" "unprognostic (3.17e-2)" "unprognostic (1.57e-3)" "unprognostic (4.82e-3)" "unprognostic (3.43e-1)" "unprognostic (9.12e-2)" "unprognostic (1.68e-2)" "unprognostic (8.10e-2)" "unprognostic (5.53e-2)" "unprognostic (1.48e-1)" "unprognostic (5.61e-3)" "unprognostic (2.80e-2)" "unprognostic (1.28e-4)" "unprognostic (3.01e-2)" "unprognostic (2.09e-1)" "unprognostic (1.87e-2)" "unprognostic (1.36e-2)" 1.3 3.6 27.2 1.6 24.1 1.1 1.2 18.9 44.2 1.5 1.4 1.2 0.0 1.4 1.3 1.2 2.4 1.4 1.2 1.2 30.9 14.6 1.2 1.2 1.2 1.2 8.3 12.2 1.1 1.5 1.2 4.4 1.2 6.4 1.3 1.3 0.8 1.2 1.7 1.1 1.2 1.7 1.3 3.3 1.2 1.5 1.8 3.5 0.0 1.2 0.0 1.2 1.1 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.8 0.0 1.0 0.0 1.5 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 6.5 0.0 0.0 5.8 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 7.5 4.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 27.2 24.1 18.9 30.3 30.9 14.6 8.3 12.2 6.4 3.5 0.0 0.0 0.0 0.0 0.0 25.0 2.8 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 44.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 47.7 0.0 0.0 0.0 9.9 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.9 3.4 0.0 0.1 0.0 0.0 0.0 JPH4 "JPHL1, KIAA1831" ENSG00000092051 "Junctophilin 4" Q96JJ6 14 23568035-23578800 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.7;seminal vesicle: 37.8" "Group enriched" "Detected in many" 19 "Bipolar cells: 144.6;Horizontal cells: 387.7" "Cancer enhanced" "Detected in some" "glioma: 6.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 5.4;myeloid DC: 5.9" "Group enriched" "Detected in many" 14 "dendritic cells: 5.9;monocytes: 5.4" "Group enriched" "Detected in some" 6 "SCLC-21H: 10.1;SH-SY5Y: 25.2;U-2 OS: 19.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013492 Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB013492: " "unprognostic (3.30e-2)" "unprognostic (1.91e-3)" "unprognostic (5.05e-3)" "unprognostic (7.41e-2)" "unprognostic (2.04e-1)" "unprognostic (1.84e-1)" "unprognostic (3.77e-3)" "unprognostic (5.98e-4)" "unprognostic (1.58e-1)" "unprognostic (1.16e-1)" "unprognostic (3.89e-3)" "unprognostic (1.15e-2)" "unprognostic (3.15e-2)" "unprognostic (2.10e-2)" "unprognostic (1.91e-1)" "unprognostic (2.13e-2)" "unprognostic (4.96e-3)" 1.9 12.3 33.6 2.0 43.8 1.3 1.6 45.3 63.7 3.4 1.9 2.1 8.0 1.8 17.1 6.2 1.5 5.1 1.6 1.3 32.3 16.8 2.7 1.3 3.4 2.0 8.3 27.6 6.2 1.5 3.1 23.2 1.6 9.8 11.6 1.7 0.8 1.2 37.8 1.2 1.6 2.2 13.9 4.2 2.9 1.7 2.2 10.9 0.0 1.3 0.0 1.7 1.7 1.8 0.0 5.9 0.4 5.4 0.0 0.0 1.0 0.0 0.0 0.5 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.5 10.1 25.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 5.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 33.6 43.8 45.3 42.6 32.3 16.8 8.3 27.6 9.8 10.9 0.0 1.1 0.0 0.1 0.0 144.6 1.1 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 1.6 387.7 1.7 2.5 1.3 0.0 10.0 1.8 0.0 0.0 0.0 1.5 0.0 0.0 13.8 0.0 7.7 12.9 0.3 0.4 2.7 0.0 0.0 0.0 0.0 0.8 JPT1 "ARM2, HN1, HN1A" ENSG00000189159 "Jupiter microtubule associated homolog 1" Q9UK76 17 75135248-75168281 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 109.4;testis: 101.3" "Cell type enhanced" "Detected in many" 13 "Ductal cells: 365.7;Exocrine glandular cells: 382.5;Extravillous trophoblasts: 1210.3;monocytes: 655.6;Pancreatic endocrine cells: 967.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 109.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059729 Approved Supported "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA Nucleoplasm "Nuclear membrane, Nucleoli" "HPA059729: AB_2684114" "unprognostic (1.13e-2)" "unprognostic (1.81e-1)" "unprognostic (1.31e-3)" "unprognostic (3.57e-3)" "unprognostic (6.71e-2)" "unprognostic (2.51e-3)" "prognostic unfavorable (1.58e-7)" "unprognostic (3.58e-2)" "unprognostic (1.37e-1)" "prognostic favorable (4.91e-4)" "unprognostic (1.25e-3)" "unprognostic (8.24e-2)" "prognostic unfavorable (1.77e-7)" "unprognostic (1.83e-1)" "unprognostic (8.99e-2)" "unprognostic (4.84e-2)" "unprognostic (1.51e-1)" 8.0 18.5 15.6 25.9 22.2 23.0 8.1 30.7 25.4 9.4 43.3 4.6 7.7 37.5 6.1 5.4 52.8 4.3 23.7 6.1 17.9 19.6 15.5 12.8 13.9 26.3 11.1 15.0 5.6 6.5 1.2 6.6 29.2 13.7 7.0 23.7 3.3 15.9 17.6 23.7 9.3 51.3 7.3 8.3 26.2 42.5 101.3 4.9 32.6 5.8 28.9 28.7 17.9 17.0 15.4 14.5 109.4 28.4 10.2 28.7 14.6 92.5 92.3 48.6 48.2 10.3 10.6 38.8 48.7 14.5 47.9 36.9 75.5 55.6 26.1 31.3 39.0 50.4 55.4 45.3 60.7 36.2 26.0 57.0 41.9 36.7 74.7 24.2 31.4 40.5 16.2 29.1 39.0 40.1 14.1 87.1 49.7 23.6 53.7 43.8 67.0 100.7 30.7 28.3 76.6 121.7 64.4 58.0 40.4 51.2 58.2 60.4 49.1 69.8 37.0 25.9 53.6 99.1 19.3 50.1 27.5 77.6 38.5 56.6 21.0 33.9 39.0 23.9 29.5 31.3 27.5 18.5 51.6 12.4 26.6 8.9 15.4 17.2 14.9 14.5 8.0 8.2 12.0 109.4 10.2 28.4 9.6 28.7 14.6 15.6 22.2 30.7 25.4 17.9 19.6 11.1 15.0 13.7 4.9 23.8 17.8 0.0 0.0 0.0 0.0 0.0 0.0 30.8 33.0 233.8 0.0 95.9 84.6 365.7 0.0 0.0 0.0 0.0 382.5 1210.3 0.0 0.0 7.0 0.0 299.4 0.0 0.0 0.0 0.0 0.0 0.0 40.7 0.0 655.6 0.0 0.0 967.6 0.0 0.0 121.9 0.0 0.0 0.0 0.0 0.0 0.0 81.0 0.0 0.0 0.0 JRK "jerky, JH8" ENSG00000234616 "Jrk helix-turn-helix protein" 8 142657460-142681968 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 23.3;Spermatogonia: 21.3" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052675 Approved "Nucleoplasm,Nucleoli,Nuclear bodies" No No "Nucleoplasm, Nucleoli" "Nuclear bodies" "HPA052675: AB_2681910" "unprognostic (3.65e-2)" "unprognostic (5.30e-2)" "unprognostic (9.67e-2)" "unprognostic (3.90e-3)" "unprognostic (1.27e-1)" "unprognostic (1.84e-2)" "unprognostic (6.58e-6)" "unprognostic (1.05e-1)" "unprognostic (3.87e-1)" "unprognostic (6.90e-2)" "unprognostic (1.84e-1)" "unprognostic (1.11e-1)" "unprognostic (7.50e-2)" "unprognostic (2.07e-1)" "unprognostic (2.53e-1)" "unprognostic (1.22e-2)" "unprognostic (1.69e-2)" 2.6 3.3 6.4 4.0 6.5 1.6 3.7 11.1 7.1 2.8 2.8 6.1 6.8 2.9 5.4 3.6 3.1 4.7 2.6 3.7 4.4 2.9 0.7 2.6 5.3 5.2 5.2 9.6 4.6 5.6 4.4 3.0 4.3 4.5 2.8 5.4 4.1 4.5 6.2 6.5 3.2 4.9 3.5 4.8 4.3 6.1 5.3 4.3 4.2 2.6 6.1 2.6 7.9 4.5 2.3 3.3 2.3 2.0 4.4 1.2 5.5 6.0 7.0 5.7 6.8 10.0 4.4 8.6 3.6 10.6 6.1 5.3 11.5 9.5 3.7 7.1 7.3 7.5 6.2 5.3 5.4 7.2 10.5 9.5 19.0 6.2 2.8 7.3 6.7 6.4 4.7 6.7 3.9 5.3 5.9 11.2 10.1 4.2 8.9 9.5 8.4 4.1 6.0 3.9 8.5 11.1 4.4 5.3 3.7 9.5 12.9 8.6 15.8 6.5 3.7 4.6 6.4 4.6 7.0 8.3 17.7 8.1 4.7 5.6 6.2 5.6 6.2 9.2 7.9 3.3 2.3 2.9 3.1 1.6 1.8 1.4 3.5 3.1 2.3 4.5 4.4 3.5 2.5 2.0 0.8 2.2 2.0 1.2 6.0 0.6 5.1 1.9 0.0 12.9 9.6 7.6 1.4 1.2 7.0 19.6 3.6 3.3 2.7 1.3 6.2 2.3 23.3 2.2 2.1 1.1 3.6 1.1 2.4 2.6 9.5 8.7 10.4 5.6 1.1 10.6 1.9 0.0 1.8 3.1 5.4 4.1 0.0 11.0 2.4 10.2 0.0 1.4 9.8 21.3 0.0 1.8 0.0 4.5 4.1 JRKL HHMJG ENSG00000183340 "JRK like" Q9Y4A0 11 96389989-96507574 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Ciliated cells: 36.1;Early spermatids: 121.0;Late spermatids: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046184, HPA060341" Uncertain Approved "Nucleoplasm,Cytokinetic bridge" Yes No Nucleoplasm "Cytokinetic bridge" "HPA046184: AB_10963576, HPA060341: AB_2732646" "unprognostic (4.59e-3)" "unprognostic (9.21e-2)" "unprognostic (3.42e-1)" "unprognostic (1.80e-2)" "unprognostic (6.90e-2)" "unprognostic (2.44e-1)" "unprognostic (5.00e-3)" "unprognostic (4.94e-2)" "unprognostic (7.55e-3)" "unprognostic (6.12e-2)" "unprognostic (3.99e-3)" "unprognostic (1.31e-1)" "unprognostic (3.20e-3)" "unprognostic (6.21e-2)" "unprognostic (1.21e-1)" "unprognostic (2.97e-1)" "unprognostic (9.57e-3)" 11.5 7.8 10.4 10.2 12.3 1.4 10.3 11.1 9.8 12.5 10.1 6.2 7.9 8.2 13.0 9.1 9.7 12.3 8.7 8.4 9.2 6.8 9.1 5.9 8.0 9.7 10.0 7.8 16.4 7.0 13.4 15.6 12.0 10.0 13.5 10.7 6.0 9.7 11.7 9.9 8.9 12.4 12.8 17.9 10.4 9.9 17.9 13.1 11.6 14.0 6.3 10.3 12.4 14.8 5.3 9.0 6.0 5.7 3.9 7.6 3.4 6.8 4.3 9.0 6.6 18.2 20.2 6.5 11.6 8.0 8.4 11.0 7.3 16.6 9.4 17.0 10.7 10.7 10.7 4.4 7.9 9.8 10.1 4.1 8.7 11.1 5.5 14.6 4.9 5.6 9.6 12.6 12.1 15.2 15.6 7.5 10.9 4.6 4.1 13.5 1.4 6.3 14.1 1.3 12.3 5.9 6.5 8.7 7.6 10.3 7.2 3.6 6.5 6.7 4.7 5.1 8.8 5.7 6.7 9.2 16.2 7.2 14.1 4.6 3.5 7.7 5.5 7.5 7.9 6.9 6.0 5.7 5.5 3.8 4.5 5.3 5.3 6.0 4.7 5.7 4.1 7.6 6.8 2.1 3.9 5.2 9.0 2.8 3.4 10.4 12.3 11.1 9.8 9.2 6.8 10.0 7.8 10.0 13.1 8.9 4.3 5.0 9.5 4.1 7.1 5.5 12.7 36.1 15.9 0.0 3.9 5.3 1.7 9.6 121.0 5.5 5.7 0.0 4.5 4.6 7.1 6.7 3.5 2.1 4.3 7.9 5.8 7.4 4.1 37.3 7.8 5.2 1.7 4.6 8.8 4.5 6.4 5.5 8.9 5.4 11.5 0.0 9.0 9.5 4.3 5.3 3.3 3.8 7.3 6.4 JUN "AP-1, c-Jun" ENSG00000177606 "Jun proto-oncogene, AP-1 transcription factor subunit" P05412 1 58780788-58784327 "Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 71.6" "Low region specificity" "Detected in all" "CAB003801, CAB007780, HPA031174, HPA059474" Enhanced Enhanced Nucleoplasm Yes No Nucleoplasm "CAB003801: AB_365485, CAB007780: AB_562268, HPA031174: , HPA059474: AB_2684030" "unprognostic (2.06e-2)" "unprognostic (1.76e-2)" "unprognostic (1.34e-1)" "unprognostic (7.85e-2)" "unprognostic (1.60e-1)" "unprognostic (1.70e-1)" "unprognostic (4.11e-2)" "unprognostic (5.21e-2)" "unprognostic (1.24e-1)" "unprognostic (5.00e-2)" "unprognostic (2.14e-1)" "unprognostic (2.82e-1)" "unprognostic (5.15e-2)" "unprognostic (1.45e-1)" "unprognostic (2.83e-1)" "unprognostic (2.37e-1)" "unprognostic (2.81e-3)" 64.5 29.4 26.7 33.7 17.2 68.4 61.7 19.5 20.6 60.0 32.7 30.8 28.4 13.3 40.5 21.8 34.1 72.6 48.5 31.3 20.2 12.4 21.2 39.3 55.1 14.3 15.3 12.0 49.8 48.7 15.0 16.7 21.6 24.1 48.6 16.7 40.5 59.4 39.3 32.2 51.3 28.6 40.7 17.6 22.9 47.0 18.2 18.1 9.0 61.0 35.2 23.3 41.5 33.1 7.4 1.3 4.0 5.1 3.2 2.5 1.2 16.1 2.3 5.2 1.0 8.3 9.5 0.1 20.6 7.5 14.6 8.9 4.2 1.2 0.6 9.9 12.8 31.6 5.6 0.4 6.7 9.3 12.8 37.5 0.2 0.9 4.7 6.9 1.1 3.7 10.2 17.3 18.8 7.9 6.6 10.9 0.7 5.7 9.4 5.6 3.0 1.0 9.0 4.2 7.8 14.7 0.4 71.6 3.2 13.7 1.5 14.5 4.2 14.3 15.0 6.0 5.9 5.3 0.6 19.1 33.3 15.1 12.0 25.8 20.9 3.3 1.2 34.8 2.1 9.5 1.2 5.1 2.0 2.4 1.1 1.3 4.1 1.2 2.5 1.3 7.4 0.3 1.7 4.0 3.2 0.4 0.2 0.9 1.2 26.7 17.2 19.5 20.6 20.2 12.4 15.3 12.0 24.1 18.1 500.2 627.8 505.0 717.3 1097.5 107.5 1349.5 494.3 76.3 282.1 99.5 247.4 529.1 43.1 569.2 40.2 960.8 1411.6 46.7 449.9 86.5 867.7 1920.0 529.9 118.4 560.4 82.6 1440.1 352.4 430.2 18.1 1136.5 481.3 718.7 237.2 1907.1 688.6 543.7 1520.1 243.3 25.0 400.6 1513.4 1714.3 15.6 13.8 843.0 347.6 518.9 938.7 449.9 JUNB ENSG00000171223 "JunB proto-oncogene, AP-1 transcription factor subunit" P17275 19 12791496-12793315 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Smooth muscle cells: 2844.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 101.1" "Group enriched" "Detected in all" 5 "granulocytes: 101.1;monocytes: 27.0" "Cell line enhanced" "Detected in many" "HDLM-2: 106.6;U-266/70: 45.7;U-266/84: 67.8" "Group enriched" "Detected in many" 5 "amygdala: 25.2;basal ganglia: 16.8;cerebral cortex: 31.3;hippocampal formation: 24.3;olfactory region: 15.1" "Region enriched" "Detected in single" 20 "cerebellum: 17.1" "CAB004464, HPA019149" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB004464: AB_2130023, HPA019149: AB_1852053" "unprognostic (1.03e-2)" "unprognostic (1.10e-1)" "unprognostic (2.11e-1)" "unprognostic (1.04e-1)" "unprognostic (7.17e-2)" "unprognostic (1.77e-2)" "unprognostic (2.19e-1)" "unprognostic (2.13e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (3.65e-4)" "unprognostic (1.79e-1)" "unprognostic (9.78e-2)" "prognostic unfavorable (1.05e-4)" "unprognostic (7.20e-2)" "unprognostic (7.06e-2)" "unprognostic (3.77e-1)" "unprognostic (1.02e-1)" 83.4 95.3 8.7 57.2 16.6 153.1 29.0 8.3 16.0 57.6 33.1 29.2 13.0 20.7 26.6 23.7 84.8 128.6 103.5 46.4 10.2 9.9 20.4 54.5 76.2 23.1 10.3 7.1 108.1 25.0 10.5 43.8 44.4 21.5 63.8 9.7 47.3 37.8 84.3 54.3 66.0 32.9 33.6 15.7 25.7 39.7 15.3 11.6 12.2 27.1 71.9 53.3 71.7 37.9 4.7 12.7 101.1 27.0 2.6 6.5 12.7 8.9 1.8 0.5 1.1 2.0 5.0 1.8 3.9 3.4 1.9 1.8 1.1 5.3 3.1 13.8 1.4 5.9 17.0 0.4 5.9 0.2 106.6 1.7 3.0 6.8 1.5 2.7 4.1 14.3 6.3 17.4 1.7 1.3 3.9 0.9 2.2 8.0 5.7 0.6 26.9 2.8 24.9 0.3 6.1 7.0 3.8 1.3 6.4 1.3 11.3 4.2 6.4 17.1 10.5 4.9 0.3 1.8 4.6 3.0 5.7 3.3 11.4 4.9 45.7 67.8 2.8 6.7 10.6 1.5 3.5 17.4 18.5 5.2 27.0 5.3 4.7 5.7 6.5 12.7 4.4 4.1 4.3 101.1 2.6 24.7 1.1 5.5 12.7 8.7 16.6 8.3 16.0 10.2 9.9 10.3 7.1 21.5 11.6 107.2 621.9 699.4 682.5 1300.3 80.0 296.2 231.8 71.0 126.3 146.5 37.3 100.9 41.4 570.4 6.9 1195.0 682.0 70.0 486.4 175.7 1823.6 1011.1 495.7 64.4 1063.7 20.6 1445.6 268.2 528.1 10.3 754.8 1027.7 848.6 461.7 904.4 381.1 718.1 736.4 247.5 63.6 159.5 1144.8 2844.2 7.1 9.8 1577.0 368.2 643.4 570.8 396.1 JUND AP-1 ENSG00000130522 "JunD proto-oncogene, AP-1 transcription factor subunit" P17535 19 18279760-18281622 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 204.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005268, HPA063029" Supported Supported Nucleoplasm No No Nucleoplasm "CAB005268: AB_2130177, HPA063029: AB_2684925" "prognostic favorable (6.15e-5)" "unprognostic (4.18e-3)" "unprognostic (8.89e-2)" "unprognostic (2.52e-1)" "unprognostic (3.70e-1)" "unprognostic (6.39e-2)" "unprognostic (1.63e-2)" "unprognostic (6.35e-2)" "unprognostic (3.48e-2)" "unprognostic (2.00e-1)" "unprognostic (3.37e-3)" "unprognostic (4.09e-2)" "unprognostic (3.35e-2)" "unprognostic (1.22e-1)" "unprognostic (3.99e-1)" "unprognostic (5.37e-2)" "unprognostic (1.49e-1)" 75.7 52.7 35.4 38.9 32.4 204.7 51.5 34.7 56.5 42.4 49.5 42.6 21.1 35.7 43.4 31.0 31.7 55.7 43.5 35.9 31.5 32.1 26.9 66.5 55.7 17.2 21.6 22.6 78.1 64.3 21.7 47.8 80.3 27.0 45.5 21.0 35.2 39.0 33.3 29.2 44.5 61.8 34.4 31.5 39.3 46.2 34.9 19.2 32.0 27.2 33.7 23.1 41.7 30.8 8.6 10.7 19.0 7.8 4.5 6.3 1.7 22.3 9.5 9.5 10.6 7.5 8.4 41.9 9.4 11.3 5.3 7.2 10.2 20.2 11.6 11.1 9.6 8.9 12.2 2.3 2.2 2.7 23.0 20.6 17.1 7.8 22.2 16.8 8.0 22.3 8.1 9.6 5.7 7.4 12.8 4.2 5.2 23.3 33.9 1.4 29.8 23.5 24.9 19.7 6.2 13.7 8.7 5.9 24.4 7.7 3.5 51.6 21.2 11.6 12.8 30.5 11.2 10.7 12.0 14.6 3.2 15.4 20.7 5.7 47.5 18.8 9.3 11.5 12.1 7.6 8.0 6.4 5.8 4.9 7.8 3.8 7.4 6.3 4.4 4.6 8.6 4.7 4.9 19.0 4.5 7.4 10.7 5.1 1.7 35.4 32.4 34.7 56.5 31.5 32.1 21.6 22.6 27.0 19.2 166.7 583.1 114.2 384.1 281.7 132.7 131.9 277.7 40.2 80.8 244.3 74.6 62.1 26.6 75.1 45.5 195.4 591.7 0.0 119.6 99.8 176.3 381.2 256.9 414.0 90.7 131.9 546.1 198.2 227.2 34.1 114.2 233.6 236.2 46.9 344.1 497.9 140.1 270.0 83.4 55.0 167.8 129.4 254.4 4.4 18.5 344.5 137.4 102.3 148.5 185.6 KALRN "ARHGEF24, DUET, duo, HAPIP, Hs.8004, Kalirin, TRAD" ENSG00000160145 "Kalirin RhoGEF kinase" O60229 3 124080023-124726325 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.2;retina: 31.2" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 71.2;Early spermatids: 45.5;Ito cells: 50.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 4.3" "Lineage enriched" "Detected in single" 5 "T-cells: 4.3" "Cell line enhanced" "Detected in many" "CACO-2: 32.4;HEL: 19.8;OE19: 11.2;SH-SY5Y: 9.3" "Low region specificity" "Detected in many" "HPA011913, CAB026456" Approved Approved Nucleoplasm,Cytosol NA NA 110000 "Nucleoplasm, Cytosol" "CAB026456: , HPA011913: AB_1850494" "unprognostic (2.54e-2)" "unprognostic (3.43e-1)" "unprognostic (2.08e-1)" "unprognostic (3.12e-4)" "unprognostic (2.54e-1)" "unprognostic (1.74e-1)" "unprognostic (1.52e-1)" "unprognostic (1.53e-1)" "unprognostic (3.41e-2)" "unprognostic (8.58e-2)" "unprognostic (1.65e-1)" "unprognostic (1.04e-1)" "unprognostic (2.26e-3)" "unprognostic (5.58e-2)" "unprognostic (2.67e-1)" "unprognostic (3.70e-2)" "unprognostic (2.81e-3)" 5.5 4.3 12.7 2.4 14.1 0.6 4.2 1.8 35.2 4.0 3.8 3.7 0.5 2.7 5.6 2.3 9.6 4.2 3.1 12.1 17.6 3.9 2.6 7.3 2.9 1.1 4.1 15.8 2.3 11.9 2.5 14.4 6.8 9.4 3.1 2.1 31.2 2.2 5.4 23.5 1.5 7.2 6.4 3.6 8.0 11.5 2.2 2.4 0.0 5.3 6.7 3.1 2.9 4.1 0.1 0.0 0.9 0.0 0.1 4.3 1.2 0.3 0.6 3.6 0.7 0.5 0.1 4.7 1.4 0.9 1.4 0.6 32.4 2.5 0.1 0.4 3.6 2.2 0.2 0.8 0.0 1.1 0.0 0.3 19.8 0.3 4.9 0.0 0.0 0.0 0.2 0.0 0.3 0.0 1.5 1.6 0.0 4.5 0.1 0.4 2.4 0.0 0.0 2.0 11.2 3.2 1.0 1.6 0.0 0.1 0.3 1.2 9.3 0.4 0.3 0.3 3.6 0.7 0.1 8.2 4.1 1.6 0.6 0.6 0.0 0.3 0.0 0.5 0.0 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.1 1.8 0.3 0.0 0.0 2.4 0.7 0.9 0.1 0.0 0.0 4.3 1.2 12.7 14.1 1.8 35.2 17.6 3.9 4.1 15.8 9.4 2.4 3.0 3.8 0.0 1.4 1.4 71.2 33.4 17.8 8.1 0.0 15.7 5.9 7.3 1.7 4.7 45.5 26.9 30.6 0.0 7.2 0.7 4.8 2.8 3.5 17.4 0.8 0.0 9.2 50.3 2.6 34.6 3.4 0.7 3.3 0.0 12.2 5.4 3.9 20.4 31.1 2.4 2.7 19.4 14.6 1.9 1.7 1.0 11.9 0.7 10.0 1.4 KANSL1 "CENP-36, DKFZP727C091, KIAA1267, MSL1v1, NSL1" ENSG00000120071 "KAT8 regulatory NSL complex subunit 1" Q7Z3B3 17 46029916-46225389 "Predicted intracellular proteins" "Chromatin regulator" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 157.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006874, HPA007208" Approved Supported Nucleoplasm No No Nucleoplasm "HPA006874: AB_1852393, HPA007208: AB_1852395" "unprognostic (2.46e-1)" "unprognostic (2.55e-1)" "unprognostic (2.11e-1)" "unprognostic (1.37e-1)" "unprognostic (2.33e-2)" "unprognostic (4.45e-2)" "prognostic unfavorable (3.74e-4)" "unprognostic (1.54e-2)" "unprognostic (9.28e-2)" "unprognostic (7.79e-3)" "unprognostic (2.01e-1)" "unprognostic (1.16e-1)" "unprognostic (2.84e-2)" "unprognostic (6.13e-2)" "unprognostic (1.29e-1)" "unprognostic (5.76e-2)" "unprognostic (1.33e-2)" 14.2 11.0 8.9 11.3 12.6 18.2 17.2 24.6 12.1 15.3 11.7 19.6 7.7 6.5 20.3 14.9 14.7 14.0 11.0 9.7 8.1 8.3 13.9 7.8 13.0 18.8 13.2 6.5 19.5 16.8 13.9 11.4 13.4 14.7 13.7 13.3 13.6 12.6 7.8 15.9 17.8 15.6 16.2 18.2 18.8 13.3 25.6 14.6 42.8 14.2 5.5 14.2 16.8 26.6 2.1 1.1 1.8 0.6 1.7 2.6 0.7 1.7 1.4 6.5 3.2 0.9 2.5 4.2 1.4 2.5 3.2 3.8 6.5 0.5 6.3 2.5 6.9 9.7 3.8 13.2 4.8 6.4 7.1 6.5 0.9 2.7 8.2 10.7 0.7 2.3 2.5 10.2 7.1 10.9 3.4 7.9 11.0 2.5 7.2 6.9 2.5 23.7 1.2 2.0 0.5 8.4 13.7 11.9 11.4 4.5 4.1 3.3 8.1 8.8 0.3 5.7 19.9 10.1 13.0 6.8 14.0 8.2 5.4 1.7 12.4 8.2 10.0 3.8 3.5 9.7 0.1 0.6 1.7 1.6 0.4 1.6 2.1 1.6 2.6 0.2 1.0 1.6 1.3 1.8 1.7 0.6 1.1 1.8 0.7 8.9 12.6 24.6 12.1 8.1 8.3 13.2 6.5 14.7 14.6 29.8 36.7 32.2 16.0 24.2 64.8 10.4 15.3 12.0 12.5 45.4 96.2 13.0 1.7 34.3 157.2 31.5 27.5 0.0 22.2 16.9 22.4 23.4 23.1 18.7 18.2 65.2 30.6 31.3 37.1 106.7 32.2 26.2 20.3 43.3 28.8 31.9 35.1 24.6 28.3 7.9 84.7 25.8 19.4 24.0 44.5 26.3 12.2 30.5 26.9 23.3 KANSL2 "C12orf41, FLJ20436, NSL2" ENSG00000139620 "KAT8 regulatory NSL complex subunit 2" Q9H9L4 12 48653401-48682238 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038497, HPA038498" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA038497: AB_10674685, HPA038498: AB_2676046" "unprognostic (3.87e-3)" "unprognostic (6.18e-2)" "unprognostic (3.67e-1)" "unprognostic (8.89e-2)" "unprognostic (5.37e-2)" "unprognostic (4.73e-2)" "prognostic unfavorable (4.98e-4)" "unprognostic (5.46e-2)" "unprognostic (1.35e-3)" "unprognostic (6.16e-2)" "unprognostic (6.75e-3)" "unprognostic (4.19e-3)" "unprognostic (8.05e-2)" "unprognostic (2.92e-1)" "unprognostic (1.38e-1)" "unprognostic (1.18e-1)" "prognostic favorable (4.32e-4)" 11.4 12.3 9.8 9.0 14.0 41.3 14.5 19.7 14.7 12.0 10.7 15.6 8.9 8.9 14.9 14.3 13.7 12.0 9.0 12.8 8.6 8.6 13.8 10.2 11.0 16.8 13.0 11.2 17.4 14.3 10.6 21.0 18.2 11.3 12.5 11.3 14.1 13.2 10.4 36.3 13.1 11.6 13.5 11.2 14.0 10.8 16.5 12.7 20.1 16.4 12.6 16.5 11.8 12.8 23.6 21.3 28.2 18.4 19.8 26.8 18.7 9.5 13.0 11.7 5.6 13.1 11.6 24.6 10.9 8.7 17.8 10.2 22.8 12.4 15.6 19.4 12.9 7.5 9.7 19.0 12.7 14.9 14.0 11.3 18.2 11.6 6.4 14.7 20.1 7.1 12.1 16.1 13.5 23.7 9.8 8.6 13.5 21.1 10.4 12.9 8.9 19.7 15.4 15.1 14.1 13.1 17.0 11.5 17.8 9.6 13.3 13.3 9.2 21.1 15.7 12.9 13.1 20.6 19.7 7.4 13.6 10.0 5.8 9.9 15.8 23.3 22.8 6.7 45.9 6.9 28.2 16.8 19.3 23.0 17.4 22.0 23.6 22.9 23.8 21.3 21.1 26.8 25.5 7.7 19.8 18.4 17.3 25.1 18.7 9.8 14.0 19.7 14.7 8.6 8.6 13.0 11.2 11.3 12.7 3.0 11.0 11.3 11.5 10.5 13.7 8.9 7.6 12.0 14.8 14.0 27.5 18.9 8.3 10.4 20.7 12.1 9.3 0.0 8.7 9.9 12.8 9.0 11.5 8.7 10.5 14.3 8.6 14.7 13.9 11.8 11.5 13.8 15.1 13.6 8.4 6.6 9.4 3.5 9.6 12.2 21.4 25.8 15.9 26.4 33.2 9.8 21.2 22.3 11.4 8.6 KANSL3 "FLJ10081, KIAA1310, NSL3, Rcd1" ENSG00000114982 "KAT8 regulatory NSL complex subunit 3" Q9P2N6 2 96593170-96642787 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035017, HPA035018" Approved Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA035017: AB_2674414, HPA035018: AB_10601763" "unprognostic (2.19e-1)" "unprognostic (6.94e-2)" "unprognostic (5.62e-2)" "unprognostic (8.72e-3)" "unprognostic (3.28e-1)" "unprognostic (4.35e-3)" "prognostic unfavorable (5.34e-4)" "unprognostic (6.34e-2)" "unprognostic (1.41e-1)" "unprognostic (2.02e-1)" "unprognostic (3.01e-2)" "unprognostic (2.99e-2)" "unprognostic (2.04e-3)" "unprognostic (3.28e-1)" "unprognostic (1.92e-1)" "unprognostic (8.30e-3)" "unprognostic (4.99e-3)" 15.3 15.2 8.2 15.4 10.8 15.9 16.9 10.6 13.3 16.6 14.0 13.6 17.8 9.9 21.5 15.3 12.7 17.2 12.1 9.2 7.5 4.8 13.2 9.8 13.7 9.9 10.9 7.3 20.1 17.5 17.0 13.7 12.4 9.6 16.5 9.3 20.2 16.6 19.8 15.7 14.2 15.7 18.0 6.1 15.0 13.4 36.0 8.4 14.8 18.1 10.5 11.0 20.1 14.8 3.6 1.4 4.2 2.6 5.7 5.9 2.8 9.3 5.7 19.1 14.5 8.0 4.3 8.6 7.5 11.9 15.0 16.3 10.6 6.2 13.8 10.9 11.7 11.5 6.1 13.4 7.1 13.0 9.1 10.7 18.9 5.8 11.9 10.7 12.9 7.5 11.0 5.0 10.0 8.5 9.1 8.3 14.8 13.1 9.8 9.3 5.3 23.2 10.3 9.3 4.8 9.7 18.5 13.0 7.5 8.8 9.5 20.4 12.5 8.9 9.8 8.7 11.6 8.5 4.8 12.3 10.4 9.1 7.7 6.7 8.2 5.0 11.6 5.5 14.6 9.6 4.2 2.6 0.8 5.8 2.6 4.3 3.1 3.5 5.9 1.2 3.6 2.6 4.5 0.2 5.7 2.2 1.4 2.5 2.8 8.2 10.8 10.6 13.3 7.5 4.8 10.9 7.3 9.6 8.4 41.7 25.0 4.7 9.1 4.0 14.0 23.7 15.3 12.0 25.0 10.4 41.2 6.6 3.3 8.3 10.9 11.4 10.7 0.0 8.3 3.6 6.6 9.7 17.4 10.6 7.2 14.3 12.6 17.2 8.8 22.8 9.2 8.4 6.8 11.8 16.7 11.4 10.5 5.8 12.0 3.8 29.4 12.9 9.2 23.2 10.5 5.6 9.3 12.5 13.8 9.2 KAT2B "GCN5, GCN5L, P/CAF, PCAF" ENSG00000114166 "Lysine acetyltransferase 2B" Q92831 3 20040023-20154404 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Activator, Acyltransferase, Transferase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 56.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002470, CAB004526, HPA055839, HPA073897" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004526: AB_2128417, HPA002470: , HPA055839: AB_2682938, HPA073897: " "unprognostic (2.91e-2)" "unprognostic (6.85e-3)" "unprognostic (9.05e-2)" "unprognostic (2.25e-1)" "unprognostic (2.66e-2)" "unprognostic (3.01e-3)" "unprognostic (2.44e-1)" "unprognostic (3.83e-3)" "unprognostic (2.44e-2)" "unprognostic (1.03e-1)" "unprognostic (5.23e-3)" "unprognostic (7.13e-2)" "unprognostic (7.03e-2)" "unprognostic (2.26e-2)" "unprognostic (1.59e-1)" "unprognostic (5.16e-2)" "unprognostic (4.63e-2)" 10.6 6.6 30.1 9.4 27.5 24.9 6.8 22.0 20.1 10.2 9.4 27.6 7.9 10.9 7.8 5.4 17.3 7.7 8.0 21.9 24.7 18.0 10.8 24.0 10.1 12.7 26.8 15.9 18.2 11.6 38.1 8.7 8.5 24.2 9.5 8.1 10.7 20.9 9.2 33.4 8.9 13.0 8.7 21.4 11.7 9.0 1.8 31.1 8.7 10.0 7.4 12.0 8.7 11.0 2.1 2.7 5.5 1.5 1.1 4.8 0.8 1.5 4.0 2.2 3.6 9.1 8.6 5.2 5.1 7.6 5.4 7.9 1.2 2.6 13.7 2.1 9.6 6.8 1.1 5.5 1.6 4.5 12.4 5.2 12.0 6.3 0.4 4.3 1.8 15.6 3.7 3.0 4.7 3.0 9.5 5.1 3.4 7.7 19.4 7.6 1.9 3.9 3.6 0.9 3.8 3.9 5.1 4.2 2.9 7.3 8.1 1.1 2.4 2.8 4.6 17.3 3.6 4.8 8.1 4.9 9.1 3.7 3.4 5.8 7.4 15.4 3.3 8.3 7.9 19.2 1.3 1.1 2.8 3.6 1.5 3.4 1.0 3.1 2.5 0.9 2.1 1.1 2.1 5.5 1.1 1.1 2.7 4.8 0.8 30.1 27.5 22.0 20.1 24.7 18.0 26.8 15.9 24.2 31.1 29.8 17.3 4.7 10.0 7.6 11.9 56.5 2.5 17.4 14.8 5.2 3.9 5.4 10.0 2.8 2.3 10.5 13.6 23.3 3.8 1.1 9.3 10.0 10.4 26.1 6.5 14.3 11.1 18.4 21.9 1.3 6.1 15.7 16.9 5.4 5.7 12.6 3.7 0.0 4.9 5.3 11.2 6.5 9.9 0.9 0.9 11.3 8.2 13.8 3.1 7.1 KAT5 "cPLA2, ESA1, HTATIP, HTATIP1, PLIP, TIP60, ZC2HC5" ENSG00000172977 "Lysine acetyltransferase 5" Q92993 11 65711996-65719604 "Enzymes, Predicted intracellular proteins, Transcription factors" "Growth regulation, Host-virus interaction, Transcription, Transcription regulation" "Activator, Acyltransferase, Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016953 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA016953: AB_1851277" "unprognostic (2.20e-1)" "unprognostic (3.58e-1)" "unprognostic (3.59e-2)" "unprognostic (2.74e-1)" "unprognostic (9.61e-2)" "unprognostic (7.16e-2)" "unprognostic (1.29e-3)" "unprognostic (1.20e-1)" "unprognostic (2.01e-1)" "unprognostic (2.74e-1)" "unprognostic (2.13e-1)" "unprognostic (2.54e-1)" "prognostic favorable (1.10e-13)" "unprognostic (1.37e-1)" "unprognostic (2.55e-1)" "unprognostic (1.85e-1)" "unprognostic (8.54e-2)" 18.5 19.5 21.2 16.0 27.4 34.3 21.6 29.4 37.1 22.1 24.1 28.2 22.3 16.5 30.1 24.8 21.2 32.9 24.5 21.1 18.3 19.2 22.6 16.1 20.8 18.3 19.0 25.7 29.5 23.2 38.8 22.0 32.7 24.6 21.2 19.4 29.3 23.6 27.5 24.6 27.6 19.2 25.2 20.1 22.0 21.9 30.7 22.8 26.9 26.5 19.1 22.1 24.4 22.0 25.0 24.0 40.4 23.6 24.8 28.6 23.3 19.1 23.4 21.3 16.2 16.9 17.9 22.4 13.9 22.7 23.3 20.3 17.0 22.9 17.6 19.9 24.3 25.7 16.2 26.5 23.3 14.1 22.9 17.0 25.8 19.3 20.1 24.3 28.1 31.0 19.0 26.1 15.3 31.5 18.0 14.6 20.7 26.6 27.6 22.0 34.9 23.8 32.9 18.6 13.7 15.1 19.6 14.1 32.2 21.3 29.1 19.9 21.0 13.2 25.0 26.5 11.6 24.5 18.2 18.7 18.9 16.7 14.9 14.9 21.2 21.8 25.9 16.3 13.8 15.4 23.4 23.6 40.4 25.7 22.3 22.1 21.1 22.5 25.5 24.0 25.0 28.6 23.3 26.1 24.8 23.3 14.5 21.5 23.3 21.2 27.4 29.4 37.1 18.3 19.2 19.0 25.7 24.6 22.8 11.9 13.7 18.8 38.6 18.8 41.0 0.6 17.8 24.1 14.8 27.9 29.5 43.8 29.9 35.7 7.2 16.8 22.2 0.0 44.9 35.8 24.2 20.6 33.4 9.3 32.0 36.5 29.1 16.5 14.9 9.4 25.9 18.3 40.5 53.3 18.0 36.1 31.7 25.9 36.4 25.6 34.3 45.3 33.0 35.4 22.7 18.6 85.7 25.5 24.7 24.6 KAT6B "Morf, MOZ2, MYST4, qkf, querkopf, ZC2HC6B" ENSG00000156650 "Lysine acetyltransferase 6B" Q8WYB5 10 74825582-75032622 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 22.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006104 Supported Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA006104: AB_1079445" "unprognostic (4.17e-1)" "unprognostic (1.98e-1)" "unprognostic (1.82e-1)" "unprognostic (2.32e-2)" "unprognostic (7.83e-2)" "unprognostic (2.85e-2)" "unprognostic (3.56e-1)" "unprognostic (2.62e-1)" "unprognostic (2.54e-1)" "unprognostic (1.09e-1)" "unprognostic (9.47e-2)" "unprognostic (8.78e-2)" "prognostic favorable (4.82e-4)" "unprognostic (2.52e-1)" "unprognostic (3.70e-1)" "unprognostic (2.59e-2)" "unprognostic (3.15e-1)" 11.6 9.5 11.1 13.2 11.9 15.1 12.4 19.0 11.6 16.7 12.2 13.3 15.3 7.2 25.1 13.0 12.0 13.2 12.0 10.0 10.6 9.5 9.0 7.3 9.2 9.0 9.0 9.9 24.6 13.3 24.8 31.1 9.4 8.9 13.5 9.6 10.1 17.9 12.0 15.3 10.6 11.3 16.2 9.3 10.4 13.0 12.8 12.1 26.6 13.0 8.9 12.5 14.3 12.7 3.2 1.9 1.6 1.1 5.3 3.7 1.5 3.9 4.1 7.4 6.3 5.9 8.7 3.6 3.5 7.0 3.0 3.4 2.7 4.6 8.5 1.9 6.4 3.2 3.1 3.9 3.1 5.0 3.6 5.7 3.1 3.3 3.9 4.4 7.4 2.1 5.6 5.0 4.2 6.7 9.9 3.5 6.7 3.3 7.3 3.8 4.3 7.1 3.4 4.1 4.3 22.9 11.1 3.8 1.8 2.2 2.0 3.7 6.2 3.6 6.6 3.2 2.8 3.7 2.9 4.2 4.3 5.1 2.8 3.3 5.4 6.3 5.7 4.6 7.8 0.9 0.7 1.1 1.6 3.2 0.9 3.4 2.4 2.4 2.7 1.2 3.2 3.7 3.4 0.9 5.3 0.8 1.9 2.4 1.5 11.1 11.9 19.0 11.6 10.6 9.5 9.0 9.9 8.9 12.1 41.7 50.1 23.2 20.4 17.6 50.8 43.1 10.2 38.8 35.2 8.7 64.8 8.7 8.3 8.6 4.4 18.6 17.3 23.3 15.8 8.8 28.2 22.8 39.4 14.4 9.7 41.3 22.8 13.5 11.0 6.7 39.1 13.9 13.5 4.6 18.3 49.8 10.2 14.4 37.8 8.0 53.6 25.8 24.0 25.6 21.2 15.3 19.0 34.6 15.5 17.1 KAT7 "HBO1, HBOA, MYST2, ZC2HC7" ENSG00000136504 "Lysine acetyltransferase 7" O95251 17 49788555-49835030 "Enzymes, Predicted intracellular proteins, Transcription factors" "DNA damage, DNA repair, DNA replication, Transcription, Transcription regulation" "Acyltransferase, Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044470, HPA071116" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044470: AB_10965785, HPA071116: " "unprognostic (1.30e-1)" "unprognostic (3.15e-2)" "unprognostic (6.20e-3)" "unprognostic (2.20e-2)" "unprognostic (7.99e-2)" "unprognostic (1.53e-1)" "unprognostic (1.35e-2)" "unprognostic (1.72e-2)" "unprognostic (1.36e-1)" "unprognostic (6.26e-2)" "unprognostic (1.44e-2)" "unprognostic (2.52e-1)" "unprognostic (1.33e-3)" "unprognostic (2.75e-1)" "unprognostic (5.03e-2)" "unprognostic (6.23e-2)" "unprognostic (7.68e-2)" 15.8 14.3 16.9 16.2 25.9 44.4 17.5 37.0 35.0 19.5 17.3 23.8 17.9 13.1 27.3 18.6 18.8 19.5 14.6 25.3 16.8 21.8 18.7 11.3 13.9 15.3 17.0 23.6 21.9 13.6 44.4 19.8 19.8 21.9 20.4 14.9 20.8 18.9 23.3 31.7 22.7 14.7 21.8 17.9 15.8 15.5 63.7 19.1 25.9 28.6 14.5 20.6 22.7 17.4 13.0 12.7 15.2 11.4 20.6 20.7 14.2 13.0 18.3 17.8 12.4 8.4 11.1 21.5 11.3 13.2 20.4 14.6 28.3 9.3 14.9 18.4 12.0 17.8 11.4 16.9 11.8 24.1 16.2 16.7 17.7 13.3 11.7 12.5 18.1 14.8 10.6 11.9 18.3 22.9 11.8 15.0 16.6 19.6 14.9 19.1 19.8 25.7 13.0 44.1 27.9 16.0 16.2 28.4 12.9 9.5 14.7 19.3 16.4 11.6 6.9 10.6 28.1 25.5 16.0 9.0 25.9 14.0 11.3 14.7 21.8 23.8 17.5 11.7 10.9 16.1 15.2 11.0 15.1 16.9 8.9 20.7 13.0 16.3 17.1 12.7 12.2 20.6 16.2 13.1 20.6 11.4 6.6 14.3 14.2 16.9 25.9 37.0 35.0 16.8 21.8 17.0 23.6 21.9 19.1 23.8 17.6 14.7 9.0 14.9 30.8 23.6 20.4 24.1 20.5 26.2 29.5 18.8 8.3 9.4 17.4 18.6 10.4 0.0 6.5 13.0 11.4 13.2 23.1 9.0 11.5 42.9 24.1 12.3 16.1 11.0 15.5 11.1 13.5 12.6 12.1 15.3 8.2 8.6 17.3 8.7 25.3 38.8 13.9 69.0 33.2 17.6 28.3 20.2 11.4 7.2 KAT8 "FLJ14040, hMOF, MOF, MYST1, ZC2HC8" ENSG00000103510 "Lysine acetyltransferase 8" Q9H7Z6 16 31115754-31131393 "Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Late spermatids: 102.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 17.8;neutrophil: 17.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066324 Supported Nucleoplasm NA NA Nucleoplasm "HPA066324: AB_2685658" "unprognostic (8.58e-2)" "unprognostic (9.53e-2)" "unprognostic (7.83e-2)" "unprognostic (1.12e-2)" "unprognostic (8.59e-2)" "unprognostic (1.06e-1)" "unprognostic (3.22e-1)" "prognostic favorable (6.34e-4)" "unprognostic (3.13e-2)" "unprognostic (3.05e-1)" "unprognostic (5.50e-2)" "unprognostic (9.77e-2)" "unprognostic (7.33e-2)" "unprognostic (2.97e-1)" "unprognostic (1.29e-1)" "unprognostic (5.00e-1)" "unprognostic (1.41e-1)" 18.4 21.7 22.7 29.4 23.6 26.6 29.7 48.9 30.8 28.0 24.8 18.3 27.5 15.7 29.8 48.3 16.7 35.0 28.2 32.7 23.0 21.2 20.8 18.9 26.3 29.0 20.2 21.0 52.8 31.4 38.0 22.2 31.5 16.8 21.2 17.7 22.1 35.1 26.2 39.8 22.1 19.7 25.9 20.5 27.4 18.6 27.3 18.4 30.2 31.7 22.6 22.2 20.2 26.6 2.1 4.1 17.8 4.6 1.7 2.9 1.9 7.7 12.0 15.0 4.5 17.8 13.4 15.4 6.9 13.3 11.2 12.3 6.0 17.0 18.3 11.0 8.6 10.2 9.3 23.9 11.6 11.1 15.3 16.2 7.9 8.8 19.0 16.0 13.1 14.4 12.6 23.4 8.3 24.2 14.7 10.6 19.4 21.1 15.1 5.7 22.6 20.2 24.8 16.9 18.8 7.3 32.6 12.3 21.5 9.0 4.6 15.8 16.1 4.2 11.7 5.8 9.6 12.7 21.8 6.3 4.7 10.1 5.3 5.0 14.4 14.5 10.4 7.2 17.5 7.1 3.9 4.4 17.8 1.9 2.4 2.4 2.1 2.2 2.6 4.1 1.8 2.9 2.1 17.4 1.7 4.6 1.4 1.3 1.9 22.7 23.6 48.9 30.8 23.0 21.2 20.2 21.0 16.8 18.4 17.9 15.6 17.9 35.9 18.4 17.8 15.2 12.7 4.0 14.8 8.7 13.7 25.5 18.3 19.6 99.8 18.5 18.6 23.3 23.2 17.7 24.7 25.4 27.6 11.1 26.6 30.2 23.6 16.5 29.2 102.1 49.8 22.4 23.6 22.6 19.7 36.9 14.8 17.5 50.9 12.4 23.7 25.8 17.5 30.4 18.8 13.7 38.0 20.0 20.7 22.1 KATNA1 ENSG00000186625 "Katanin catalytic subunit A1" O75449 6 149594873-149648972 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 12 "Early spermatids: 312.3;Late spermatids: 142.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036207 Approved Supported "Nucleoplasm,Centriolar satellite" NA NA "Centriolar satellite" Nucleoplasm "HPA036207: AB_10672238" "unprognostic (1.57e-1)" "unprognostic (2.41e-2)" "unprognostic (2.95e-2)" "unprognostic (3.57e-2)" "unprognostic (1.21e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (3.57e-7)" "unprognostic (9.78e-2)" "unprognostic (8.89e-2)" "unprognostic (7.40e-2)" "unprognostic (2.70e-2)" "unprognostic (4.50e-2)" "unprognostic (3.92e-2)" "unprognostic (2.10e-1)" "unprognostic (3.37e-1)" "unprognostic (1.74e-3)" "unprognostic (8.85e-2)" 12.5 7.8 9.3 11.9 9.8 14.2 11.7 13.0 9.5 13.8 12.1 15.0 6.0 7.6 15.3 10.3 12.5 10.9 10.1 11.3 9.1 6.7 13.7 8.4 10.8 11.8 10.4 7.9 18.7 9.6 5.7 12.1 11.0 15.0 12.7 9.5 17.5 10.1 10.5 21.2 12.0 10.8 12.4 8.9 12.2 10.4 36.7 12.0 22.5 13.9 10.3 14.0 15.1 12.7 19.6 19.4 23.5 20.8 12.7 24.2 14.9 11.5 4.1 9.5 20.7 11.5 18.4 14.7 14.5 12.3 15.3 20.3 9.9 6.1 16.1 8.4 14.4 11.1 9.1 18.6 9.5 20.0 14.7 15.7 21.4 8.9 13.7 15.9 29.9 8.1 11.6 11.3 17.5 13.9 14.2 14.0 21.7 22.1 11.8 13.5 16.0 20.5 19.5 9.3 12.9 7.0 14.1 17.3 7.8 10.9 6.5 7.7 10.9 26.4 7.6 10.1 13.9 7.8 29.2 12.0 8.0 12.2 21.0 16.7 11.0 10.1 22.1 10.5 21.3 13.0 23.5 15.2 21.0 19.9 20.8 17.5 19.6 20.2 20.0 19.4 14.2 17.2 17.3 7.0 12.7 18.0 16.7 24.2 14.9 9.3 9.8 13.0 9.5 9.1 6.7 10.4 7.9 15.0 12.0 14.9 9.9 13.7 31.3 26.1 8.6 15.9 10.2 24.1 13.6 14.0 27.5 18.4 14.9 16.5 312.3 15.5 9.7 23.3 10.9 15.9 23.8 16.3 19.7 6.6 15.3 12.7 5.8 10.4 11.8 142.0 19.5 18.0 10.1 22.6 8.4 10.9 12.0 10.5 15.6 16.6 34.9 6.5 18.9 100.5 54.7 25.1 21.4 17.5 8.9 15.2 KATNAL1 MGC2599 ENSG00000102781 "Katanin catalytic subunit A1 like 1" Q9BW62 13 30202630-30307484 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 107.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 30.6" "Low region specificity" "Detected in all" HPA046205 Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA046205: AB_10965325" "unprognostic (3.34e-1)" "unprognostic (6.44e-3)" "unprognostic (2.08e-2)" "unprognostic (6.91e-2)" "unprognostic (2.53e-1)" "unprognostic (1.52e-1)" "unprognostic (1.57e-2)" "unprognostic (2.84e-2)" "unprognostic (3.43e-1)" "unprognostic (4.68e-3)" "unprognostic (4.54e-2)" "unprognostic (2.17e-2)" "unprognostic (1.84e-3)" "unprognostic (7.41e-2)" "unprognostic (6.42e-2)" "unprognostic (5.12e-2)" "unprognostic (1.83e-3)" 11.0 5.7 12.2 6.4 12.5 7.6 12.0 11.0 14.4 14.1 11.4 10.4 4.6 2.2 12.7 4.2 8.1 6.6 5.4 22.6 8.5 9.8 5.9 5.4 6.7 8.2 10.3 14.9 6.3 2.9 3.2 11.9 4.2 11.9 6.7 5.9 4.1 3.5 8.5 7.1 3.8 4.2 19.7 10.8 4.5 4.7 25.1 7.8 12.0 4.4 3.3 9.1 7.7 7.9 5.2 6.9 3.4 1.0 9.5 7.1 1.4 5.5 4.6 8.1 4.3 6.2 13.2 0.2 23.0 7.4 12.3 9.7 0.9 5.6 8.9 2.7 30.6 15.5 1.5 5.7 5.9 18.8 7.7 2.1 6.4 5.7 2.1 3.3 3.1 4.3 5.1 3.0 13.8 3.4 11.6 12.9 5.0 3.4 3.9 15.0 1.1 7.0 2.9 3.5 0.1 3.0 7.9 9.6 0.9 4.4 0.4 3.4 7.1 6.1 1.2 4.3 7.1 2.0 1.9 11.7 10.9 16.6 5.9 9.2 2.1 3.8 12.3 4.3 3.1 15.6 1.9 0.9 3.4 5.8 0.5 2.9 2.6 4.6 5.8 2.3 5.2 1.1 2.6 0.3 9.5 1.0 6.9 7.1 1.4 12.2 12.5 11.0 14.4 8.5 9.8 10.3 14.9 11.9 7.8 8.9 2.6 1.9 3.5 5.3 9.0 35.3 2.5 16.0 2.3 5.2 25.5 0.2 3.3 5.4 107.1 6.4 0.0 0.0 1.3 0.7 9.4 1.6 9.3 9.0 2.8 20.6 9.8 6.7 2.1 42.6 8.3 3.4 16.9 35.1 0.5 8.5 4.5 0.0 4.9 5.7 17.6 6.5 11.2 41.6 21.5 5.0 0.2 7.5 0.6 1.3 KATNAL2 "DKFZP667C165, MGC33211" ENSG00000167216 "Katanin catalytic subunit A1 like 2" Q8IYT4 18 46917492-47102243 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 30.3;testis: 33.2" "Group enriched" "Detected in many" 4 "Ciliated cells: 46.8;Early spermatids: 59.9;Late spermatids: 47.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 19.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040712, HPA042029" Approved Approved "Nucleoplasm,Intermediate filaments" No No "Nucleoplasm, Intermediate filaments" "HPA040712: AB_2677092, HPA042029: AB_2677807" "unprognostic (3.40e-1)" "unprognostic (7.75e-2)" "unprognostic (9.00e-3)" "unprognostic (9.28e-2)" "unprognostic (1.74e-2)" "unprognostic (6.55e-3)" "unprognostic (6.97e-2)" "unprognostic (1.28e-2)" "unprognostic (3.90e-2)" "unprognostic (5.36e-2)" "unprognostic (9.52e-6)" "unprognostic (1.28e-1)" "prognostic favorable (1.24e-7)" "unprognostic (1.64e-1)" "unprognostic (7.14e-4)" "unprognostic (1.06e-3)" "unprognostic (1.61e-1)" 5.5 2.9 8.2 4.1 9.7 2.8 7.1 4.0 7.5 2.5 2.4 11.3 2.5 1.8 2.8 7.1 2.7 8.6 5.1 4.3 8.1 7.6 9.5 5.2 4.6 3.4 9.6 6.2 3.1 3.3 30.3 7.0 2.2 9.0 3.4 3.1 6.4 3.4 3.7 6.0 8.0 1.5 2.3 8.7 3.3 2.0 33.2 6.3 2.4 15.5 1.1 3.0 2.3 2.5 3.1 0.6 2.7 1.3 0.8 1.5 0.3 1.9 4.3 2.4 15.0 4.9 5.9 1.1 1.8 1.6 1.5 1.9 0.2 5.1 19.8 1.5 2.8 1.9 0.6 4.7 0.5 1.1 2.0 2.5 0.8 1.3 0.3 2.0 1.2 1.9 12.2 1.8 2.5 0.6 3.4 0.5 9.1 0.7 1.6 8.5 1.9 1.2 2.6 5.4 2.5 2.7 5.5 1.1 0.0 4.7 0.4 5.4 6.0 1.9 0.4 0.6 8.8 11.4 11.0 1.0 5.0 0.5 2.0 1.2 1.3 1.0 13.3 2.7 12.5 9.6 1.7 0.7 0.5 1.1 1.3 0.9 2.2 0.9 0.5 0.3 3.1 1.5 1.4 2.7 0.8 0.9 0.6 0.2 0.3 8.2 9.7 4.0 7.5 8.1 7.6 9.6 6.2 9.0 6.3 0.0 1.4 0.0 2.6 1.3 10.4 2.2 0.0 46.8 6.8 3.5 5.9 0.0 11.6 0.4 59.9 1.4 0.8 0.0 0.2 0.0 1.5 1.2 0.0 3.9 2.8 11.1 0.0 3.1 1.0 47.0 1.4 0.6 3.3 1.0 0.3 2.4 0.2 0.0 2.1 5.2 2.1 0.0 0.8 11.2 4.3 1.0 0.1 0.0 1.5 1.4 KATNBL1 "C15orf29, FLJ22557" ENSG00000134152 "Katanin regulatory subunit B1 like 1" Q9H079 15 34140674-34210096 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 75.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 46.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 46.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062573 Approved Supported "Nucleoplasm,Midbody,Cleavage furrow,Mitotic spindle" Yes No "Midbody, Mitotic spindle" "Nucleoplasm, Cleavage furrow" "HPA062573: AB_2684796" "unprognostic (5.02e-1)" "unprognostic (1.67e-1)" "unprognostic (1.35e-2)" "unprognostic (2.91e-2)" "unprognostic (2.01e-2)" "unprognostic (1.38e-1)" "unprognostic (1.14e-1)" "unprognostic (1.75e-1)" "unprognostic (1.01e-1)" "unprognostic (5.16e-2)" "unprognostic (3.94e-3)" "unprognostic (8.00e-3)" "prognostic unfavorable (4.60e-5)" "unprognostic (2.71e-2)" "unprognostic (7.23e-2)" "unprognostic (2.42e-1)" "unprognostic (1.43e-1)" 13.2 7.9 16.2 14.0 22.6 9.1 22.7 16.7 26.0 11.7 12.2 10.7 10.5 9.6 13.5 12.5 28.8 10.9 10.2 9.0 11.2 9.0 9.1 10.9 20.2 10.7 13.8 10.3 10.9 14.3 8.7 10.4 75.0 15.0 11.9 13.6 8.9 10.5 9.0 7.4 19.7 9.4 16.1 17.8 12.0 11.0 11.0 12.8 7.5 8.3 8.6 12.3 10.2 19.1 9.1 10.2 46.0 6.8 4.3 8.9 4.5 17.7 15.6 24.9 16.6 20.2 20.2 18.5 24.2 14.7 19.4 19.4 8.8 9.9 8.7 15.9 15.7 27.4 23.5 12.1 13.9 23.0 17.8 6.5 15.3 16.5 10.4 14.0 16.0 16.7 12.0 20.5 13.1 26.0 20.2 34.7 22.4 16.3 18.3 26.4 8.7 10.0 13.2 18.2 22.9 12.4 15.5 15.1 8.1 17.9 24.0 14.1 12.6 14.8 10.9 7.1 25.8 13.5 19.2 19.9 26.4 13.6 23.4 19.1 11.4 15.3 17.9 23.7 17.5 19.6 16.5 6.8 10.3 7.0 6.3 8.9 8.5 7.7 7.2 7.4 9.1 8.6 7.6 46.0 4.3 4.0 10.2 6.3 4.5 16.2 22.6 16.7 26.0 11.2 9.0 13.8 10.3 15.0 12.8 35.7 25.1 24.1 50.0 36.7 53.1 11.8 28.1 44.2 34.2 24.4 49.1 52.9 28.2 51.7 63.2 41.9 19.0 0.0 47.3 69.4 32.9 72.1 42.8 18.4 34.4 63.5 23.0 32.5 28.5 42.2 29.4 37.7 30.4 56.9 30.5 52.5 80.0 38.6 31.1 34.2 40.0 58.2 43.0 37.0 44.8 47.4 150.1 31.6 35.9 104.3 KAZN "FLJ43806, KAZRIN, KIAA1026" ENSG00000189337 "Kazrin, periplakin interacting protein" Q674X7 1 13892792-15118043 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 64.9" "Cell type enhanced" "Detected in many" 6 "Muller glia cells: 72.8;Suprabasal keratinocytes: 79.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 21 "neutrophil: 6.9" "Lineage enriched" "Detected in single" 21 "granulocytes: 6.9" "Cell line enhanced" "Detected in many" "AN3-CA: 40.6;SK-BR-3: 22.0" "HPA032095, HPA032096" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA Nucleoplasm "Nuclear speckles, Cytosol" "HPA032095: AB_2674146, HPA032096: AB_10670826" "unprognostic (2.81e-1)" "unprognostic (5.82e-2)" "unprognostic (1.12e-1)" "unprognostic (2.42e-3)" "unprognostic (5.34e-2)" "unprognostic (2.15e-3)" "unprognostic (6.57e-3)" "unprognostic (7.88e-3)" "unprognostic (3.21e-1)" "unprognostic (4.96e-3)" "unprognostic (1.10e-1)" "unprognostic (5.55e-2)" "prognostic favorable (1.20e-6)" "unprognostic (3.61e-2)" "unprognostic (7.93e-2)" "unprognostic (3.21e-1)" "unprognostic (1.06e-2)" 8.0 11.0 13.4 3.0 17.4 1.2 7.6 41.1 21.9 8.0 3.8 27.5 5.7 4.6 3.1 11.1 18.8 11.0 7.0 4.1 12.4 12.4 13.2 5.2 8.5 1.5 25.1 12.1 10.4 8.0 22.9 2.7 11.0 15.0 4.1 4.0 10.5 16.8 7.2 1.7 14.2 4.9 3.7 25.0 64.9 4.9 4.1 18.9 0.0 6.6 7.0 6.3 7.9 9.4 0.3 0.0 6.9 0.0 0.0 0.0 0.0 8.0 1.4 8.8 40.6 3.8 4.0 3.0 3.8 3.2 7.2 5.2 1.8 4.3 0.0 10.1 8.2 1.3 2.9 2.0 6.3 3.6 0.2 3.9 4.6 4.8 12.0 2.8 0.0 2.4 5.6 8.5 1.6 1.1 3.2 0.0 1.1 1.8 9.4 5.7 5.9 0.0 0.4 2.4 3.6 1.2 2.7 0.2 4.9 12.1 2.5 4.7 3.4 0.7 22.0 15.1 5.3 1.3 3.1 0.0 6.0 5.6 9.4 4.6 1.6 1.3 0.0 5.6 8.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 13.4 17.4 41.1 21.4 12.4 12.4 25.1 12.1 15.0 18.9 3.0 2.6 0.9 12.5 44.8 9.3 3.0 5.1 12.0 6.8 47.1 7.9 1.1 14.9 1.8 4.5 8.1 3.0 0.0 1.4 5.8 10.8 8.1 3.5 0.0 0.7 0.0 6.8 40.5 1.2 5.8 17.5 2.1 43.9 0.0 3.7 72.8 1.4 0.0 16.3 11.4 2.4 6.5 21.7 0.1 4.0 79.0 38.8 2.9 2.8 24.0 KBTBD2 "BKLHD1, DKFZP566C134" ENSG00000170852 "Kelch repeat and BTB domain containing 2" Q8IY47 7 32868172-32894131 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021133 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA Yes "Nucleoplasm, Nucleoli fibrillar center" "HPA021133: AB_1852093" "unprognostic (1.01e-1)" "prognostic unfavorable (1.89e-4)" "unprognostic (3.17e-2)" "unprognostic (9.19e-2)" "unprognostic (1.16e-1)" "unprognostic (3.70e-2)" "prognostic unfavorable (5.69e-4)" "unprognostic (3.96e-3)" "unprognostic (1.05e-1)" "unprognostic (2.61e-1)" "unprognostic (2.80e-3)" "unprognostic (5.05e-1)" "unprognostic (6.79e-3)" "unprognostic (3.81e-3)" "unprognostic (1.42e-2)" "unprognostic (8.69e-2)" "unprognostic (2.96e-1)" 20.9 12.3 13.9 15.0 15.7 34.4 16.4 18.3 18.0 13.6 12.2 12.9 10.2 11.3 17.3 8.1 12.8 12.0 18.5 17.0 13.8 14.3 11.2 15.3 17.5 24.9 18.2 13.4 13.9 9.6 16.2 13.8 18.4 17.5 12.5 14.6 12.1 11.7 11.6 36.5 12.2 13.4 18.3 21.1 21.1 10.9 12.5 13.8 26.3 15.2 18.2 16.8 13.6 20.4 6.9 3.5 25.1 8.6 6.8 7.4 2.3 18.3 9.2 23.9 11.8 14.4 14.6 8.6 16.5 16.8 15.7 19.1 9.1 14.3 15.5 11.5 17.0 26.5 13.6 12.1 12.9 19.9 6.1 8.7 13.1 15.2 11.7 14.9 14.0 17.3 15.4 13.6 17.1 16.7 14.6 17.3 14.2 23.7 23.1 23.1 15.1 11.7 23.0 19.3 12.8 8.8 11.3 20.9 13.0 13.9 11.1 12.5 23.5 10.6 14.5 18.2 20.9 10.3 24.0 14.9 15.3 19.8 14.2 22.5 19.2 18.9 28.4 15.0 17.0 38.1 9.2 4.2 13.0 7.4 7.7 6.2 4.5 3.6 6.5 3.5 6.9 2.8 4.7 25.1 6.8 8.6 1.8 4.7 2.3 13.9 15.7 18.3 18.0 13.8 14.3 18.2 13.4 17.5 13.8 26.8 19.2 12.7 14.0 35.8 14.2 16.5 15.3 4.0 31.8 1.8 9.8 5.5 0.0 10.3 3.9 43.6 14.7 0.0 10.5 7.5 19.3 14.5 42.7 13.2 11.6 7.9 14.3 32.5 21.6 4.3 12.0 20.7 23.6 4.6 11.9 9.0 12.8 13.1 5.6 3.6 7.9 19.4 18.1 15.8 7.0 31.6 6.3 13.8 10.5 13.9 KBTBD4 "BKLHD4, FLJ10450, HSPC252" ENSG00000123444 "Kelch repeat and BTB domain containing 4" Q9NVX7 11 47572197-47579015 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037792, HPA037793" Uncertain Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA037792: AB_10671633, HPA037793: AB_2675671" "unprognostic (5.52e-2)" "unprognostic (2.23e-1)" "unprognostic (8.36e-3)" "unprognostic (1.15e-1)" "unprognostic (3.30e-2)" "unprognostic (7.32e-2)" "unprognostic (1.21e-1)" "unprognostic (2.09e-1)" "unprognostic (8.73e-3)" "unprognostic (2.78e-1)" "unprognostic (4.04e-2)" "unprognostic (7.22e-2)" "prognostic favorable (2.70e-7)" "unprognostic (4.18e-1)" "unprognostic (1.32e-1)" "unprognostic (2.07e-1)" "unprognostic (4.25e-2)" 8.4 13.4 7.9 6.7 15.9 11.7 9.0 16.2 25.8 9.0 9.7 13.6 13.3 6.5 12.3 13.7 8.0 15.5 7.6 9.5 7.5 8.7 12.0 9.4 8.6 10.7 7.0 7.1 13.2 8.4 23.0 11.9 10.0 11.7 12.1 9.2 13.6 8.6 10.5 19.1 10.8 10.3 10.0 6.2 9.9 9.0 11.6 4.6 13.5 12.4 9.4 14.2 10.9 8.1 12.4 6.6 11.8 5.3 12.3 14.7 10.4 5.1 10.6 11.4 9.6 7.0 9.4 4.0 8.6 10.2 11.2 9.7 4.4 9.5 9.3 4.9 9.8 9.0 8.4 6.3 11.3 9.5 12.1 10.2 6.8 14.7 4.9 5.2 14.1 13.7 8.6 7.9 4.5 6.1 8.6 11.3 6.9 5.4 7.3 8.7 12.7 10.3 4.5 6.2 12.4 7.6 10.3 15.5 5.9 11.9 10.7 15.9 10.5 7.4 9.9 6.5 4.4 16.6 4.5 10.3 8.1 9.0 11.1 8.5 11.3 17.4 12.9 11.2 4.1 8.3 10.7 5.3 11.8 13.7 4.3 14.7 12.4 11.0 12.6 6.6 11.0 11.7 12.5 8.0 12.3 4.1 3.1 12.8 10.4 7.9 15.9 16.2 25.8 7.5 8.7 7.0 7.1 11.7 4.6 6.0 2.2 2.4 5.9 4.2 14.7 0.1 7.6 12.0 6.8 10.4 7.9 10.2 19.9 11.8 9.0 5.2 4.4 23.3 11.9 5.9 6.4 4.0 10.4 7.7 7.1 12.7 6.9 7.4 3.7 13.8 4.6 4.3 1.7 13.6 4.8 22.8 7.7 3.5 8.9 9.1 10.4 12.9 4.2 18.0 16.4 4.0 11.8 11.7 5.0 2.8 KCMF1 "DEBT91, DKFZP434L1021, PCMF, ZZZ1" ENSG00000176407 "Potassium channel modulatory factor 1" Q9P0J7 2 84971093-85059472 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030383, HPA030384" Enhanced Enhanced Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA030383: AB_10599977, HPA030384: AB_10601230" "unprognostic (8.01e-2)" "unprognostic (1.98e-2)" "unprognostic (9.95e-2)" "unprognostic (7.42e-3)" "unprognostic (1.24e-2)" "unprognostic (8.54e-2)" "prognostic unfavorable (2.33e-7)" "unprognostic (5.68e-3)" "unprognostic (1.43e-1)" "unprognostic (9.81e-2)" "prognostic unfavorable (6.10e-5)" "unprognostic (4.98e-2)" "prognostic unfavorable (4.18e-6)" "unprognostic (6.11e-2)" "unprognostic (2.66e-1)" "unprognostic (4.42e-1)" "unprognostic (1.01e-1)" 19.2 13.3 17.9 20.2 16.0 23.6 26.1 13.4 18.6 15.0 20.2 10.7 20.3 15.4 16.3 18.8 28.5 12.8 17.9 30.4 16.5 12.0 14.8 20.7 16.4 18.8 13.7 11.1 17.2 48.6 14.7 18.7 20.5 14.4 17.5 21.4 14.0 19.4 15.7 67.2 17.6 20.6 25.7 10.3 16.7 16.8 29.0 11.5 19.7 18.7 21.8 22.5 23.9 34.0 4.0 4.2 8.1 3.4 2.8 8.8 1.5 27.6 21.7 19.4 14.9 20.5 19.9 33.1 29.6 27.5 28.4 19.0 26.5 29.9 30.1 29.8 40.1 28.4 18.4 15.1 28.6 37.6 22.5 10.5 19.2 16.4 27.0 40.2 21.1 18.3 20.5 45.3 27.8 77.2 25.4 21.4 16.3 19.0 24.0 28.4 25.5 20.3 11.7 21.2 35.2 18.3 14.7 27.3 18.8 25.7 24.3 18.7 14.0 17.2 22.0 28.7 23.3 10.2 13.5 18.2 29.1 28.3 27.1 30.7 27.4 33.8 30.5 21.9 15.6 21.7 5.0 2.6 8.1 4.5 2.2 3.6 3.5 3.2 3.4 2.2 4.0 2.8 3.1 7.5 2.8 3.4 4.2 8.8 1.5 17.9 16.0 13.4 18.6 16.5 12.0 13.7 11.1 14.4 11.5 29.8 28.2 27.9 82.6 63.0 31.1 41.6 20.4 10.7 25.0 12.2 13.7 22.2 21.6 33.1 65.6 24.8 41.1 23.3 45.9 22.3 26.3 94.5 17.3 29.8 18.4 68.3 18.5 25.8 25.1 87.4 23.9 22.8 25.3 23.4 27.6 31.3 46.8 35.9 27.3 28.6 27.5 25.8 36.8 31.0 29.4 69.1 34.1 19.1 28.1 106.5 KCNA10 Kv1.8 ENSG00000143105 "Potassium voltage-gated channel subfamily A member 10" Q16322 1 110517217-110519175 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-2 OS: 1.4;U-87 MG: 1.2" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "basal ganglia: 0.2" "HPA015061, CAB022564" Uncertain Nucleoplasm,Cytosol No NA "Nucleoplasm, Cytosol" "CAB022564: , HPA015061: AB_1855573" "unprognostic (2.96e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNAB1 "AKR6A3, hKvb3, hKvBeta3, KCNA1B, Kvb1.3" ENSG00000169282 "Potassium voltage-gated channel subfamily A member regulatory beta subunit 1" Q14722 3 156037701-156539138 "Predicted intracellular proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Oxidoreductase, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.1;thyroid gland: 25.7" "Group enriched" "Detected in many" 5 "Bipolar cells: 54.8;Cone photoreceptor cells: 29.5;Sertoli cells: 77.6;Smooth muscle cells: 66.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 7.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 5.9;hTEC/SVTERT24-B: 9.2" "Region enhanced" "Detected in many" "basal ganglia: 300.5" "Low region specificity" "Detected in all" "HPA036110, HPA044550" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA Vesicles "Nucleoplasm, Plasma membrane" "HPA036110: , HPA044550: AB_10797032" "unprognostic (1.52e-1)" "unprognostic (3.73e-1)" "unprognostic (1.33e-1)" "unprognostic (2.98e-4)" "unprognostic (1.24e-2)" "unprognostic (1.64e-1)" "unprognostic (1.81e-1)" "unprognostic (2.83e-2)" "unprognostic (8.51e-2)" "unprognostic (3.72e-2)" "unprognostic (5.87e-2)" "unprognostic (9.70e-2)" "unprognostic (2.17e-3)" "unprognostic (2.60e-1)" "unprognostic (1.95e-1)" "unprognostic (1.06e-1)" "unprognostic (4.00e-1)" 12.6 5.9 7.5 1.1 41.1 1.4 3.5 10.7 16.4 5.7 2.9 4.6 2.5 1.6 3.4 11.9 2.1 2.7 2.7 4.8 12.3 4.3 1.8 2.3 3.1 0.9 3.7 10.3 2.8 3.7 1.8 1.2 1.3 3.0 21.1 1.8 7.2 3.4 17.9 1.7 1.3 1.9 2.6 2.6 4.3 1.3 2.7 12.3 0.0 25.7 1.0 0.5 2.0 3.0 1.0 4.3 2.4 1.2 0.9 2.7 0.4 0.9 0.8 1.3 0.3 0.1 0.0 2.5 2.2 0.0 0.0 0.2 1.7 0.2 0.6 1.2 0.0 0.5 0.6 0.0 0.0 0.0 0.7 1.7 5.9 1.1 2.7 0.0 1.7 0.5 0.0 0.0 9.2 0.0 2.1 3.7 0.9 0.2 0.5 0.4 0.2 0.5 1.0 1.9 2.6 0.5 0.9 1.3 4.7 0.0 0.4 1.4 1.4 0.5 1.1 1.2 0.9 1.5 0.9 3.8 1.5 0.9 2.5 2.0 3.2 0.7 0.7 4.5 1.9 1.7 2.4 0.6 0.2 1.5 0.7 2.7 0.9 1.4 1.3 0.9 1.0 1.2 1.3 0.1 0.9 1.2 4.3 1.7 0.4 7.5 41.1 10.7 16.4 12.3 4.3 3.7 10.3 3.0 12.3 0.0 0.0 0.5 0.1 0.7 54.8 4.1 0.0 0.0 1.2 0.0 29.5 0.1 0.0 0.4 11.9 1.4 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 3.6 0.0 0.0 1.3 9.3 4.7 0.0 1.1 1.7 0.0 0.0 1.6 0.0 0.0 2.5 0.0 6.1 77.6 66.2 0.1 0.9 0.6 0.1 0.0 0.0 0.1 KCNC1 Kv3.1 ENSG00000129159 "Potassium voltage-gated channel subfamily C member 1" P48547 11 17734774-17856804 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 67.5" "Cell type enriched" "Detected in some" 4 "Bipolar cells: 36.6" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Region enhanced" "Detected in all" "cerebellum: 67.5" "Cell type enhanced" "Detected in some" "basophil: 5.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RH-30: 7.5;SCLC-21H: 7.1;SH-SY5Y: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047634, HPA048249" Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" NA NA "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "HPA047634: AB_2680109, HPA048249: " "unprognostic (1.79e-2)" "unprognostic (2.68e-1)" "unprognostic (1.33e-1)" "unprognostic (4.09e-3)" "unprognostic (1.12e-1)" "unprognostic (8.02e-2)" "unprognostic (2.40e-1)" "unprognostic (1.27e-1)" "unprognostic (8.37e-2)" "unprognostic (2.14e-1)" "unprognostic (7.04e-5)" "unprognostic (5.89e-2)" "unprognostic (7.32e-4)" "unprognostic (1.29e-1)" "unprognostic (5.44e-2)" "unprognostic (1.05e-2)" "unprognostic (7.83e-2)" 0.7 2.3 8.2 1.0 10.0 2.9 0.9 67.5 33.3 3.0 1.0 1.0 0.0 1.4 1.5 0.6 1.1 0.9 1.3 0.6 5.6 4.9 0.9 1.1 1.0 1.2 3.3 12.6 1.1 0.9 0.6 1.4 0.7 19.5 1.2 0.8 0.7 1.2 0.7 1.7 1.8 1.2 0.8 1.9 1.0 1.3 2.9 2.0 0.0 1.5 0.0 0.8 2.4 0.5 1.7 0.8 5.8 0.8 0.7 1.1 0.3 0.4 0.1 3.1 1.2 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.2 1.0 0.0 0.2 0.0 0.9 1.1 1.8 0.0 0.3 0.3 2.1 0.6 3.0 0.2 0.4 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.5 1.4 0.0 0.5 0.5 1.2 1.5 0.0 0.0 0.8 7.5 0.9 0.0 0.4 7.1 4.4 0.4 0.5 0.0 0.4 0.6 0.5 0.1 0.2 2.3 0.3 0.3 0.5 0.6 1.0 0.5 0.3 1.0 5.8 0.7 1.1 1.1 0.7 0.7 0.7 0.9 0.5 0.2 1.7 0.7 0.8 3.8 0.7 0.8 0.8 0.4 0.3 8.2 10.0 67.5 33.3 5.6 4.9 3.3 12.6 19.5 2.0 0.0 0.0 0.0 0.0 0.0 36.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 7.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 7.5 0.0 0.0 8.4 0.3 0.0 0.0 1.0 0.0 1.5 0.2 0.0 0.0 0.1 7.4 0.0 0.4 5.4 4.5 0.0 0.0 0.0 0.0 0.0 KCND1 Kv4.1 ENSG00000102057 "Potassium voltage-gated channel subfamily D member 1" Q9NSA2 X 48961378-48971569 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.8" "Cell type enhanced" "Detected in some" 8 "Collecting duct cells: 1.8;Distal tubular cells: 1.7;Intestinal endocrine cells: 3.4;Leydig cells: 1.7;Peritubular cells: 3.5;Rod photoreceptor cells: 2.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HSkMC: 13.2;NB-4: 10.5;SuSa: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000524, HPA001066" Supported Uncertain Nucleoplasm Yes No Nucleoplasm "HPA000524: AB_2666013, HPA001066: AB_1079662" "unprognostic (6.00e-2)" "unprognostic (2.58e-1)" "unprognostic (1.01e-4)" "unprognostic (2.19e-4)" "unprognostic (1.41e-1)" "unprognostic (3.79e-2)" "unprognostic (2.79e-1)" "unprognostic (8.13e-3)" "unprognostic (1.13e-2)" "unprognostic (2.41e-3)" "prognostic favorable (2.66e-6)" "unprognostic (2.61e-1)" "unprognostic (4.30e-11)" "unprognostic (3.13e-2)" "unprognostic (3.49e-1)" "unprognostic (7.64e-2)" "unprognostic (2.22e-3)" 4.9 2.4 4.2 3.4 4.7 6.0 2.2 16.8 7.8 5.1 2.2 6.3 1.9 2.0 5.0 3.8 1.4 7.4 6.3 2.9 6.9 2.5 2.5 1.8 3.0 3.1 3.1 3.5 4.6 1.4 1.8 3.0 2.5 10.4 3.3 2.1 2.6 1.2 6.0 0.7 1.6 2.6 6.6 6.5 4.2 2.5 3.0 2.7 1.1 2.3 0.5 3.6 3.0 3.0 0.6 1.3 1.4 0.1 0.0 0.8 0.1 0.4 1.9 0.8 4.7 6.4 5.1 1.6 1.0 4.0 2.8 1.9 1.2 0.6 1.6 3.4 3.1 0.8 0.6 0.8 0.4 2.7 2.6 3.1 1.4 1.9 0.1 2.4 0.4 2.9 13.2 1.8 5.2 0.6 4.7 0.9 2.2 1.1 3.6 2.0 3.5 0.4 10.5 2.5 0.3 0.7 1.3 0.9 1.5 3.1 1.5 0.5 2.1 0.9 0.0 2.1 10.2 2.0 1.5 2.4 0.6 2.6 0.6 0.2 2.9 3.8 3.8 1.7 3.7 2.1 0.0 0.1 0.0 0.5 0.0 0.3 0.6 0.2 0.8 0.0 0.1 0.2 0.0 1.4 0.0 0.0 1.3 0.0 0.1 4.2 4.7 16.8 7.8 6.9 2.5 3.1 3.5 10.4 2.7 0.0 1.4 0.0 0.0 0.7 0.2 0.4 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 3.4 0.6 0.8 0.0 1.7 0.0 0.0 0.0 0.2 0.3 0.1 0.0 3.5 0.0 2.8 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.1 KCNF1 "IK8, KCNF, kH1, Kv5.1" ENSG00000162975 "Potassium voltage-gated channel modifier subfamily F member 1" Q9H3M0 2 10911937-10914225 "Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "brain: 36.9" "Group enriched" "Detected in some" 4 "Extravillous trophoblasts: 10.2;Syncytiotrophoblasts: 6.4" "Cancer enriched" "Detected in many" 7 "glioma: 27.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 16.9;MCF7: 6.0;T-47d: 7.3" "Group enriched" "Detected in many" 4 "amygdala: 70.7;basal ganglia: 55.9;cerebral cortex: 78.2;hippocampal formation: 69.5;olfactory region: 141.1" "Low region specificity" "Detected in all" "HPA014738, HPA062278" Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA014738: AB_1852114, HPA062278: AB_2732679" "unprognostic (2.54e-1)" "unprognostic (6.06e-3)" "unprognostic (1.37e-1)" "unprognostic (3.07e-2)" "unprognostic (4.39e-2)" "unprognostic (7.41e-4)" "unprognostic (1.54e-3)" "unprognostic (4.83e-5)" "unprognostic (1.57e-1)" "unprognostic (6.95e-2)" "unprognostic (1.60e-2)" "unprognostic (1.40e-1)" "unprognostic (2.96e-1)" "unprognostic (3.10e-4)" "unprognostic (2.37e-1)" "unprognostic (4.28e-2)" "unprognostic (4.08e-2)" 0.9 0.9 11.5 1.0 25.5 0.8 1.2 0.8 36.9 0.9 1.2 2.4 0.0 1.2 1.9 0.8 1.6 1.1 1.0 1.1 13.1 4.7 1.1 0.9 1.0 1.0 3.1 10.5 0.9 2.2 0.8 0.2 0.9 3.6 1.0 1.2 0.0 0.8 1.4 0.8 0.8 1.1 1.0 1.0 1.5 1.1 1.0 3.1 0.5 0.8 0.0 0.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 16.9 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.2 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.0 0.0 0.0 2.6 0.1 1.8 0.0 0.1 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.2 7.3 0.8 0.0 0.0 2.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 11.5 25.5 0.8 28.5 13.1 4.7 3.1 10.5 3.6 3.1 0.0 0.0 0.0 0.0 0.0 1.0 1.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 KCNH3 "BEC1, elk2, Kv12.2" ENSG00000135519 "Potassium voltage-gated channel subfamily H member 3" Q9ULD8 12 49539157-49558308 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.7" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 9.4;Early spermatids: 4.1;Late spermatids: 3.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 9.8" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.6" "Lineage enriched" "Detected in single" 5 "T-cells: 3.6" "Cell line enhanced" "Detected in some" "A549: 9.6;AN3-CA: 4.5;HMC-1: 4.6;RPTEC TERT1: 11.8;U-2 OS: 12.5" "Group enriched" "Detected in many" 11 "amygdala: 60.0;basal ganglia: 42.5;cerebral cortex: 73.6;hippocampal formation: 46.6;olfactory region: 50.0" "Low region specificity" "Detected in many" HPA051088 Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA051088: AB_2681340" "unprognostic (5.69e-3)" "unprognostic (1.36e-1)" "unprognostic (8.87e-4)" "unprognostic (8.24e-3)" "unprognostic (7.54e-2)" "unprognostic (2.38e-2)" "unprognostic (3.63e-2)" "unprognostic (2.66e-1)" "unprognostic (9.91e-3)" "unprognostic (5.28e-2)" "unprognostic (6.39e-5)" "unprognostic (1.68e-1)" "unprognostic (1.07e-4)" "unprognostic (5.52e-3)" "unprognostic (2.67e-1)" "unprognostic (1.27e-1)" "unprognostic (2.86e-1)" 0.9 3.8 24.3 1.5 18.5 1.4 1.0 5.8 30.7 0.9 0.8 0.5 0.0 0.9 1.3 0.9 0.7 8.7 1.7 1.2 22.0 3.0 1.6 0.7 1.2 1.9 1.9 13.0 0.8 1.4 6.3 9.3 0.8 0.0 1.2 0.7 0.0 1.1 1.6 0.8 1.1 1.0 1.0 0.6 1.4 1.4 2.6 2.1 0.0 1.7 0.0 1.4 0.9 0.0 0.0 0.1 0.6 0.8 0.4 3.6 0.5 1.0 9.6 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.6 0.0 0.3 2.3 0.7 0.2 0.0 0.1 0.4 0.0 0.5 0.1 0.1 0.0 4.6 0.0 0.0 0.1 0.0 1.8 0.0 0.2 0.0 0.3 0.0 1.6 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.6 11.8 0.0 1.8 0.3 0.3 0.0 0.3 0.0 1.1 0.2 0.1 0.0 12.5 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 1.7 0.0 3.6 0.0 0.3 1.1 0.1 0.0 1.1 2.6 0.6 0.4 0.1 0.0 0.4 0.5 24.3 18.5 5.8 30.7 22.0 3.0 1.9 13.0 0.0 2.1 0.0 0.3 0.0 0.2 0.1 0.0 0.6 2.5 9.4 0.0 0.0 0.0 0.0 0.0 0.1 4.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 1.6 2.4 1.3 0.8 3.6 0.3 0.0 0.0 0.0 0.0 0.4 0.2 0.0 1.1 0.0 0.2 0.0 0.0 0.9 2.5 0.3 0.0 1.0 0.0 0.0 KCNH5 "eag2, H-EAG2, Kv10.2" ENSG00000140015 "Potassium voltage-gated channel subfamily H member 5" Q8NCM2 14 62699454-63102037 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 4.6;brain: 9.2;retina: 5.7" "Cell type enriched" "Detected in some" 15 "Bipolar cells: 64.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HeLa: 10.1;RT4: 13.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030487, HPA072351" Uncertain Approved Nucleoplasm,Centrosome,Cytosol NA NA Centrosome "Nucleoplasm, Cytosol" "HPA030487: AB_10609995, HPA072351: " "unprognostic (1.16e-1)" "unprognostic (7.23e-2)" "unprognostic (1.25e-1)" "unprognostic (4.23e-2)" "unprognostic (2.70e-1)" "unprognostic (1.12e-1)" "unprognostic (1.50e-1)" "unprognostic (1.76e-2)" "unprognostic (8.45e-2)" "unprognostic (2.66e-1)" "unprognostic (1.70e-3)" "unprognostic (3.11e-1)" 0.9 4.6 1.7 0.5 3.6 0.3 0.4 0.2 9.2 0.3 0.4 0.4 0.0 0.3 0.4 0.5 0.3 0.3 0.3 0.3 1.3 3.0 0.4 0.3 0.3 0.3 1.2 4.2 0.3 0.3 0.3 1.5 1.2 6.5 0.7 0.3 5.7 0.3 0.3 0.3 0.3 0.3 0.3 1.6 0.3 0.3 1.7 0.0 0.0 0.3 0.0 0.3 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.8 1.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.1 0.0 1.7 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 3.6 0.2 9.2 1.3 3.0 1.2 4.2 6.5 0.0 0.0 0.0 0.0 0.1 0.0 64.7 0.4 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.5 0.0 0.0 1.4 0.7 0.0 1.0 0.0 0.0 0.0 KCNJ12 "hIRK1, IRK2, KCNJN1, Kir2.2, Kir2.2v" ENSG00000184185 "Potassium voltage-gated channel subfamily J member 12" Q14500 17 21376197-21419872 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 39.4;skeletal muscle: 47.8" "Cell type enriched" "Detected in some" 7 "Horizontal cells: 84.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 39.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 3.6;HeLa: 5.9;PC-3: 6.3;SCLC-21H: 7.3;SiHa: 3.7;SuSa: 8.0;U-2197: 6.3" "Low region specificity" "Detected in all" HPA027021 Approved Uncertain "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA027021: AB_10602912" "unprognostic (3.81e-3)" "unprognostic (2.69e-2)" "unprognostic (8.60e-2)" "prognostic unfavorable (7.84e-5)" "unprognostic (2.29e-1)" "unprognostic (1.73e-2)" "unprognostic (3.80e-2)" "unprognostic (1.54e-2)" "unprognostic (4.39e-2)" "unprognostic (4.91e-2)" "unprognostic (8.12e-2)" "unprognostic (1.16e-1)" "unprognostic (4.22e-2)" "unprognostic (2.23e-1)" "unprognostic (1.51e-1)" "unprognostic (5.90e-2)" "unprognostic (9.70e-3)" 1.2 1.3 1.9 0.9 2.9 0.7 0.9 39.4 5.8 1.2 0.8 1.1 0.5 0.5 0.8 1.4 1.5 2.1 0.7 5.1 0.9 1.4 1.2 0.5 1.3 0.4 1.3 3.4 0.7 0.5 10.6 0.7 0.7 4.0 0.9 0.6 1.7 0.6 0.9 47.8 6.0 0.6 1.0 0.9 1.3 0.9 1.3 0.9 0.0 1.0 7.5 1.1 0.8 1.5 0.0 0.9 0.0 0.5 0.0 0.1 0.0 0.0 1.1 0.4 2.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 3.6 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.2 5.9 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.1 0.0 1.5 0.0 6.3 0.0 1.0 1.6 0.0 0.0 7.3 0.4 3.7 0.0 1.5 8.0 0.0 0.0 2.8 0.0 0.5 6.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.1 0.0 1.9 2.9 39.4 5.8 0.9 1.4 1.3 3.4 4.0 0.9 0.0 0.0 0.0 0.0 1.3 0.8 12.5 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.0 0.4 1.4 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.2 84.2 1.2 5.5 0.0 0.2 6.9 0.0 0.0 0.0 0.4 11.2 0.0 0.0 3.9 0.6 1.4 0.0 0.5 0.5 1.3 1.9 0.1 0.0 0.6 0.0 KCNJ18 "KIR2.6, TTPP2" ENSG00000260458 "Potassium voltage-gated channel subfamily J member 18" B7U540 17 21692523-21704612 "Disease related genes, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "lymphoid tissue: 3.5;skin 1: 8.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "cervical cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.0;HDLM-2: 2.1;HeLa: 1.7;RPMI-8226: 1.0;U-266/70: 3.3" "Region enhanced" "Detected in many" "cerebellum: 75.1" HPA027021 Uncertain Uncertain "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA027021: AB_10602912" "unprognostic (2.41e-1)" "unprognostic (3.90e-5)" "unprognostic (2.56e-1)" "unprognostic (1.95e-1)" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.3 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.4 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 KCNK17 "K2p17.1, TALK-2, TALK2, TASK-4, TASK4" ENSG00000124780 "Potassium two pore domain channel subfamily K member 17" Q96T54 6 39299001-39314553 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 29.1;retina: 20.0" "Group enriched" "Detected in some" 4 "Exocrine glandular cells: 7.3;granulocytes: 5.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 34 "plasmacytoid DC: 29.1" "Lineage enriched" "Detected in single" 34 "dendritic cells: 29.1" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 42.5" "Not detected" "Not detected" HPA043892 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA043892: AB_10962838" "unprognostic (5.33e-3)" "unprognostic (6.42e-2)" "unprognostic (1.33e-1)" "unprognostic (1.04e-1)" "unprognostic (1.54e-1)" "unprognostic (3.70e-2)" "unprognostic (3.85e-2)" "unprognostic (4.09e-2)" "unprognostic (4.95e-1)" "unprognostic (2.35e-1)" "unprognostic (1.71e-2)" "unprognostic (2.54e-1)" "unprognostic (3.77e-11)" "unprognostic (5.89e-2)" "unprognostic (5.36e-1)" "unprognostic (2.82e-1)" "unprognostic (3.86e-3)" 0.7 0.4 0.3 0.6 1.1 1.4 3.3 0.3 0.8 0.7 1.3 0.8 1.9 3.0 1.9 0.5 1.0 1.3 6.5 7.9 0.6 0.6 0.3 4.6 10.4 0.9 2.6 0.8 0.4 6.1 0.4 2.7 6.3 1.9 1.1 0.6 20.0 2.9 1.0 0.2 0.1 1.7 1.5 0.6 1.1 5.4 0.6 0.1 3.4 9.3 2.6 2.4 0.9 0.5 0.0 29.1 0.1 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 42.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 29.1 0.0 0.1 0.3 1.1 0.3 0.8 0.6 0.6 2.6 0.8 1.9 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 5.8 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNK5 "K2p5.1, TASK-2" ENSG00000164626 "Potassium two pore domain channel subfamily K member 5" O95279 6 39188973-39229450 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 48.4;intestine: 74.2;kidney: 46.3" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 43.3;Enterocytes: 50.9;Proximal tubular cells: 29.1;Syncytiotrophoblasts: 38.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 18.8;HEL: 19.3;HMC-1: 17.8;K-562: 18.0;OE19: 14.7;T-47d: 14.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA059148 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA059148: AB_2683929" "unprognostic (1.46e-1)" "prognostic favorable (3.29e-4)" "unprognostic (1.08e-1)" "unprognostic (2.92e-3)" "unprognostic (8.09e-4)" "unprognostic (3.97e-2)" "unprognostic (2.33e-1)" "unprognostic (9.57e-3)" "unprognostic (7.14e-2)" "unprognostic (3.43e-1)" "prognostic unfavorable (5.85e-4)" "unprognostic (2.98e-1)" "prognostic favorable (4.98e-7)" "unprognostic (2.34e-1)" "unprognostic (7.13e-2)" "unprognostic (1.03e-2)" "prognostic favorable (4.45e-4)" 2.2 1.3 0.3 4.5 0.4 4.5 3.9 0.4 0.5 4.3 25.5 0.8 2.6 16.1 5.6 4.0 4.3 1.4 48.4 1.5 0.3 0.0 46.3 12.6 3.6 1.1 0.8 0.4 4.0 15.3 1.2 1.0 15.2 0.8 2.3 4.7 3.6 16.0 1.6 0.5 15.8 74.2 1.3 0.6 1.2 9.4 0.9 0.3 2.0 9.0 2.2 4.1 2.2 3.8 0.0 0.9 0.2 0.1 0.0 1.4 0.5 3.4 3.2 4.3 1.6 0.0 0.0 3.7 0.0 0.0 0.0 0.0 18.8 7.8 0.0 5.7 0.0 0.4 7.2 3.3 0.1 0.0 0.0 2.4 19.3 1.5 0.1 0.0 3.9 17.8 0.0 0.0 0.1 0.0 0.0 0.0 4.3 18.0 0.0 0.0 6.1 8.7 4.3 7.9 14.7 0.0 0.0 0.8 7.3 3.0 2.9 1.0 0.8 3.1 4.0 0.0 1.7 14.3 6.5 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.3 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.9 1.4 0.0 0.0 0.1 0.4 0.2 0.0 0.1 0.9 0.2 0.5 0.3 0.4 0.4 0.5 0.3 0.0 0.8 0.4 0.8 0.3 0.0 19.2 0.0 1.8 3.3 0.0 0.4 43.3 0.0 6.8 1.8 0.0 22.6 5.0 13.0 0.0 0.2 50.9 0.0 10.8 3.9 1.9 1.8 0.0 23.1 1.8 0.0 0.0 0.0 0.3 0.0 0.6 0.7 1.7 1.0 10.8 0.0 7.5 10.5 0.0 29.1 0.0 0.0 0.4 0.0 0.7 2.4 38.1 1.0 6.4 10.7 KCNMB3 "KCNMB2, KCNMBL" ENSG00000171121 "Potassium calcium-activated channel subfamily M regulatory beta subunit 3" Q9NPA1 3 179236691-179267002 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 13.7;Late spermatids: 10.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 11.2;NB-4: 7.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015665, HPA019185" Approved Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA015665: AB_1852142, HPA019185: AB_1852144" "unprognostic (2.50e-1)" "unprognostic (1.32e-1)" "unprognostic (6.76e-5)" "unprognostic (2.65e-2)" "unprognostic (2.22e-2)" "unprognostic (2.08e-1)" "unprognostic (4.59e-3)" "unprognostic (1.14e-1)" "unprognostic (9.15e-3)" "unprognostic (5.09e-2)" "unprognostic (1.87e-2)" "unprognostic (1.95e-5)" "unprognostic (5.93e-10)" "unprognostic (7.22e-2)" "unprognostic (4.72e-1)" "unprognostic (8.69e-2)" "unprognostic (3.49e-2)" 3.0 2.0 0.7 2.9 0.7 1.2 3.3 0.2 0.6 1.8 2.0 1.9 2.0 2.3 0.7 1.0 2.4 1.8 1.0 0.9 2.2 4.0 1.2 2.9 1.1 1.6 5.3 3.7 2.1 6.6 2.9 2.2 2.7 1.4 0.5 0.6 2.2 1.9 1.5 5.9 2.6 4.5 2.4 2.6 1.9 1.5 3.5 0.3 2.3 0.4 3.6 1.0 0.0 3.0 0.7 1.2 0.0 1.4 1.1 1.9 0.8 0.5 1.3 0.6 6.5 2.6 0.1 3.0 0.6 2.7 1.1 0.0 0.2 1.5 3.8 0.4 11.2 2.9 2.5 1.2 0.2 3.7 1.9 0.6 0.9 0.0 1.0 1.1 0.1 0.4 0.1 1.5 1.8 0.1 7.6 0.0 1.2 2.3 3.3 0.0 0.1 1.0 2.1 1.5 0.4 1.0 1.2 0.7 1.1 3.1 6.1 0.7 0.6 1.1 0.3 0.9 1.0 0.4 3.6 0.6 4.3 0.8 2.3 0.4 0.5 1.0 0.3 0.6 3.5 0.6 0.8 0.1 2.1 0.4 0.7 1.9 3.6 0.1 0.3 0.9 0.0 0.0 2.2 0.8 1.8 0.2 2.3 0.6 2.5 1.4 2.3 0.0 13.7 1.0 0.0 4.3 8.0 2.7 1.5 0.0 3.1 1.0 1.2 1.6 2.3 1.5 1.0 0.0 4.7 1.8 1.6 10.9 2.6 0.8 0.0 1.0 1.3 1.9 2.7 0.0 2.8 0.0 5.3 6.5 1.4 1.6 1.4 0.1 1.0 0.0 1.1 0.7 KCNN2 "hSK2, KCa2.2" ENSG00000080709 "Potassium calcium-activated channel subfamily N member 2" Q9H2S1 5 114360945-114496500 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Transport" "Calmodulin-binding, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 25.3;brain: 23.1;liver: 33.2" "Cell type enhanced" "Detected in some" 12 "Cardiomyocytes: 10.8;Hepatocytes: 14.7;Melanocytes: 20.3;Rod photoreceptor cells: 7.2" "Group enriched" "Detected in some" 7 "glioma: 3.5;melanoma: 3.2;prostate cancer: 12.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 15.0;NTERA-2: 5.7;SK-MEL-30: 10.6;THP-1: 18.7;U-937: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038221 Uncertain Uncertain "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA038221: AB_10673044" "unprognostic (9.22e-3)" "unprognostic (1.90e-1)" "unprognostic (2.04e-1)" "unprognostic (5.65e-2)" "unprognostic (1.43e-1)" "unprognostic (1.40e-1)" "unprognostic (2.94e-1)" "unprognostic (1.42e-1)" "unprognostic (1.11e-2)" "unprognostic (1.56e-1)" "unprognostic (1.09e-1)" "unprognostic (1.15e-1)" "unprognostic (1.66e-1)" "unprognostic (1.23e-2)" "unprognostic (4.61e-1)" "unprognostic (3.16e-1)" "unprognostic (4.25e-1)" 0.8 25.3 12.6 0.8 7.3 0.6 1.1 21.7 15.0 1.7 1.2 9.5 0.0 0.9 3.9 0.9 0.8 1.0 1.0 7.7 23.1 3.6 4.8 33.2 2.5 0.9 4.5 16.9 1.4 3.8 1.0 16.0 0.6 9.1 11.7 1.3 4.2 1.1 5.4 9.9 2.1 0.9 2.8 8.4 1.1 1.1 3.8 6.5 0.0 0.9 0.0 0.8 2.4 1.1 0.3 0.3 0.8 0.3 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 15.0 2.3 0.3 0.1 0.0 0.2 0.0 0.5 0.0 2.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.3 0.0 0.1 0.0 0.2 0.0 1.2 5.7 0.0 0.0 0.1 0.0 0.7 0.3 0.1 1.8 0.0 0.0 0.2 10.6 0.3 0.2 18.7 0.2 0.0 0.4 1.7 0.0 0.1 0.0 0.1 1.8 6.7 0.5 0.5 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.3 0.3 0.1 0.3 0.8 0.1 0.3 0.3 0.1 0.0 12.6 7.3 21.7 15.0 23.1 3.6 4.5 16.9 9.1 6.5 0.0 0.6 0.0 0.1 0.2 6.8 10.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.7 5.2 0.0 0.0 0.8 0.0 0.9 4.5 0.0 14.7 0.0 0.0 0.0 6.2 1.0 0.0 0.0 0.0 20.3 0.0 0.5 0.3 1.4 0.0 0.0 0.5 7.2 0.0 0.5 0.5 3.2 0.3 0.0 0.0 0.4 0.1 KCNN3 "hSK3, KCa2.3, SKCA3" ENSG00000143603 "Potassium calcium-activated channel subfamily N member 3" Q9UGI6 1 154697455-154870280 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Transport" "Calmodulin-binding, Ion channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.7" "Cell type enhanced" "Detected in many" 16 "Alveolar cells type 1: 11.9;Ciliated cells: 32.1;Endothelial cells: 16.9" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.8;memory B-cell: 4.8" "Group enriched" "Detected in many" 9 "B-cells: 4.8;granulocytes: 5.8;monocytes: 2.7" "Cell line enhanced" "Detected in some" "Daudi: 18.1;HMC-1: 12.5;Karpas-707: 31.0;RPMI-8226: 8.4;U-266/70: 29.9;U-698: 10.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057127 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA057127: AB_2683345" "unprognostic (2.09e-1)" "unprognostic (2.91e-2)" "unprognostic (3.41e-2)" "unprognostic (1.04e-1)" "unprognostic (7.22e-2)" "unprognostic (4.06e-2)" "unprognostic (2.19e-2)" "unprognostic (2.03e-1)" "unprognostic (3.43e-2)" "unprognostic (9.51e-2)" "unprognostic (4.07e-3)" "unprognostic (4.89e-2)" "prognostic unfavorable (1.97e-4)" "unprognostic (1.71e-2)" "unprognostic (1.54e-1)" "unprognostic (6.93e-2)" "unprognostic (1.80e-2)" 1.7 2.5 20.6 6.5 21.7 1.0 1.8 5.7 26.7 9.3 9.1 12.4 1.1 5.4 12.6 1.7 3.5 10.3 3.1 4.0 21.6 8.0 3.5 1.0 3.1 5.8 12.0 10.9 2.1 1.0 1.5 2.6 0.7 13.3 3.4 4.6 0.1 2.7 2.7 8.5 1.1 3.9 10.6 8.1 5.0 4.4 1.3 15.5 0.2 3.7 3.5 9.2 8.3 4.9 4.8 0.4 5.8 2.7 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 1.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.5 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 31.0 0.3 0.0 0.1 0.0 0.4 0.0 1.2 0.0 7.7 8.4 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.5 0.0 0.0 0.0 29.9 3.9 10.0 0.3 0.0 2.9 5.8 0.0 0.0 0.0 0.2 0.0 4.8 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.4 20.6 21.7 5.7 10.3 21.6 8.0 12.0 10.9 13.3 15.5 11.9 2.4 0.0 0.5 1.1 0.2 2.2 0.0 32.1 3.4 0.0 2.0 0.0 3.3 0.2 2.6 16.9 0.0 0.0 0.2 0.0 2.3 0.4 0.0 0.0 0.4 0.0 4.1 5.5 0.0 6.2 0.3 0.8 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.5 0.1 1.5 0.0 0.0 0.0 0.1 KCTD1 C18orf5 ENSG00000134504 "Potassium channel tetramerization domain containing 1" Q719H9 18 26454910-26657401 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 99.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 35.9;HaCaT: 37.3;hTCEpi: 33.7;RPTEC TERT1: 32.8" "HPA057808, HPA062486" Approved "Nucleoplasm,Nucleoli,Cytokinetic bridge,Centriolar satellite" NA NA Nucleoplasm "Nucleoli, Cytokinetic bridge, Centriolar satellite" "HPA057808: , HPA062486: " "unprognostic (1.15e-3)" "unprognostic (5.66e-2)" "unprognostic (2.35e-4)" "prognostic unfavorable (2.22e-4)" "unprognostic (3.65e-3)" "unprognostic (7.43e-2)" "unprognostic (2.03e-3)" "unprognostic (6.77e-2)" "unprognostic (2.74e-1)" "unprognostic (1.88e-3)" "unprognostic (5.68e-3)" "unprognostic (1.77e-2)" "prognostic favorable (4.60e-8)" "unprognostic (3.87e-3)" "unprognostic (7.39e-2)" "unprognostic (1.50e-1)" "unprognostic (8.02e-2)" 3.9 11.8 15.9 2.1 37.3 0.7 22.2 13.7 29.0 12.6 5.0 6.9 6.2 3.2 10.0 15.8 32.8 33.8 5.8 12.9 16.7 6.7 20.1 2.6 4.0 2.0 6.6 18.4 11.1 5.2 7.4 6.1 17.2 6.8 15.3 7.3 8.4 12.5 16.4 2.8 39.3 2.2 8.7 6.0 2.9 7.0 4.1 10.7 5.7 13.6 20.1 11.7 8.5 18.3 0.3 0.7 0.7 0.3 0.0 1.8 0.2 5.5 19.1 35.9 3.8 21.1 3.4 4.6 4.6 7.0 7.4 7.4 1.8 6.4 1.1 17.9 9.8 6.1 37.3 6.8 10.1 7.0 1.0 3.3 1.2 4.2 3.0 4.0 0.6 1.8 5.7 33.7 2.1 14.0 9.5 7.0 8.2 0.4 0.5 5.2 7.9 5.5 1.7 3.6 18.4 8.8 2.9 2.1 0.8 32.8 8.2 3.7 14.2 6.8 9.2 3.1 21.6 8.4 1.5 3.8 8.3 2.6 1.6 5.1 1.7 1.4 0.1 3.1 3.7 12.3 0.0 0.1 0.7 0.8 0.1 1.6 0.0 1.8 0.6 0.7 0.3 0.7 0.5 0.0 0.0 0.3 0.3 0.0 0.2 15.9 37.3 13.7 29.0 16.7 6.7 6.6 18.4 6.8 10.7 3.0 2.6 0.0 39.9 28.2 3.9 10.1 5.1 29.4 14.8 24.4 7.9 41.6 99.5 7.7 26.4 2.4 1.3 0.0 3.2 5.2 2.6 13.8 0.0 1.8 3.9 20.6 1.2 2.5 1.0 6.7 4.9 1.0 21.9 0.0 4.3 19.5 8.6 0.0 2.8 6.8 6.3 0.0 3.1 1.9 3.7 38.9 27.8 0.0 4.7 35.3 KCTD10 "BTBD28, MSTP028" ENSG00000110906 "Potassium channel tetramerization domain containing 10" Q9H3F6 12 109448656-109477544 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014273 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA014273: AB_1852159" "unprognostic (7.21e-3)" "unprognostic (3.04e-1)" "unprognostic (2.45e-1)" "unprognostic (1.34e-1)" "unprognostic (1.93e-3)" "unprognostic (2.31e-1)" "prognostic unfavorable (5.32e-4)" "unprognostic (1.84e-2)" "unprognostic (1.85e-1)" "unprognostic (7.01e-2)" "unprognostic (9.33e-2)" "unprognostic (3.45e-1)" "unprognostic (7.72e-2)" "unprognostic (5.76e-2)" "unprognostic (3.26e-1)" "unprognostic (3.05e-1)" "unprognostic (1.70e-3)" 29.1 16.2 10.4 16.3 17.1 8.4 21.3 10.6 20.0 25.3 26.9 14.1 15.1 8.5 30.5 15.6 24.4 18.1 23.2 16.1 11.0 16.4 23.2 9.3 20.5 13.9 11.7 8.4 16.7 7.9 14.6 12.7 19.2 16.9 19.8 22.2 29.4 14.4 29.8 9.9 19.3 14.1 36.4 9.6 17.5 19.4 13.5 12.6 12.8 30.8 15.4 17.5 27.8 19.0 6.2 10.4 7.9 14.0 20.8 12.7 11.8 9.2 9.8 28.7 9.5 23.2 33.2 6.4 20.2 26.6 13.4 13.4 9.2 7.6 9.0 11.9 46.1 6.8 7.3 10.2 16.7 12.9 8.7 6.9 10.4 6.3 5.8 14.9 7.6 9.1 31.6 10.3 17.7 9.7 19.6 31.4 8.8 6.9 3.9 23.4 4.8 9.8 10.3 17.0 4.1 12.2 9.7 12.5 7.0 13.5 16.0 10.2 15.3 12.2 12.6 12.7 18.0 15.5 6.2 23.1 14.3 5.5 8.1 11.1 8.8 16.6 12.5 16.1 6.7 21.0 7.9 8.1 5.4 12.7 12.4 9.3 6.2 7.6 9.2 10.4 6.2 8.4 10.5 5.9 20.8 14.0 7.9 8.4 11.8 10.4 17.1 10.6 20.0 11.0 16.4 11.7 8.4 16.9 12.6 14.9 34.6 5.7 16.8 13.1 5.2 10.5 15.3 8.1 9.1 5.2 15.7 7.3 5.0 14.0 8.4 22.7 13.6 0.0 11.3 10.5 16.9 12.3 13.9 4.0 10.5 7.9 11.1 26.4 12.3 7.8 10.6 10.4 15.1 19.0 12.5 2.6 17.7 11.5 17.7 8.4 4.6 25.8 28.8 9.1 5.6 14.4 11.3 10.2 13.3 16.5 KCTD11 "C17orf36, KCASH1, REN" ENSG00000213859 "Potassium channel tetramerization domain containing 11" Q693B1 17 7351889-7354944 "Predicted intracellular proteins" "Cell cycle, Growth regulation, Ubl conjugation pathway" "Developmental protein, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 29.2;hTCEpi: 21.5" "Not detected" "Not detected" HPA052035 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA052035: AB_2681704" "unprognostic (1.98e-1)" "unprognostic (5.67e-2)" "unprognostic (1.08e-1)" "prognostic favorable (9.55e-4)" "unprognostic (6.78e-3)" "unprognostic (1.92e-2)" "unprognostic (2.38e-2)" "unprognostic (1.59e-3)" "unprognostic (3.91e-1)" "prognostic unfavorable (5.02e-4)" "unprognostic (7.93e-2)" "unprognostic (3.62e-1)" "unprognostic (1.99e-1)" "unprognostic (2.03e-1)" "unprognostic (8.03e-2)" "unprognostic (1.27e-1)" "unprognostic (1.01e-2)" 7.4 5.7 4.7 5.3 6.5 0.9 16.2 5.8 5.7 20.1 6.9 7.6 5.1 5.2 8.9 7.5 32.9 8.0 9.8 4.9 3.6 3.6 5.2 5.1 8.6 9.4 10.2 3.4 8.6 10.5 8.2 5.2 15.2 6.0 10.5 5.2 6.5 11.1 9.8 4.3 23.0 6.5 7.1 5.0 8.1 7.9 4.0 5.5 1.5 17.2 23.3 17.0 19.2 22.0 1.8 2.5 8.8 6.0 1.6 2.3 2.5 10.2 4.1 3.1 2.3 13.3 7.8 3.3 6.6 10.7 7.2 6.3 3.7 4.5 1.5 3.7 11.2 6.7 17.9 0.4 29.2 6.1 6.1 1.2 0.1 2.9 0.6 7.0 0.1 5.9 6.1 21.5 7.7 4.2 14.4 2.2 1.2 1.3 1.7 5.3 4.4 0.9 1.4 1.0 4.5 2.4 1.3 2.8 1.4 7.3 4.0 0.1 1.7 4.7 4.7 0.7 4.0 6.7 0.6 4.3 5.8 5.2 3.9 3.4 1.2 0.6 0.4 7.1 3.3 4.3 8.8 3.6 2.4 2.3 6.0 0.8 1.8 1.1 1.0 2.5 1.4 0.6 1.6 0.5 1.6 4.3 0.1 0.2 2.5 4.7 6.5 5.8 5.7 3.6 3.6 10.2 3.4 6.0 5.5 8.9 0.6 1.7 16.0 1.5 3.3 0.4 2.5 10.7 4.5 5.2 2.0 4.2 3.3 11.3 12.7 2.7 7.7 0.0 8.4 5.3 11.4 7.7 4.6 2.4 4.2 1.6 6.9 6.7 3.7 5.3 16.4 5.4 1.7 8.2 4.3 3.9 21.3 4.8 20.5 2.7 1.4 19.4 17.2 0.7 1.0 3.9 8.2 4.3 3.3 17.4 KCTD13 "FKSG86, PDIP1, POLDIP1" ENSG00000174943 "Potassium channel tetramerization domain containing 13" Q8WZ19 16 29905012-29927035 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Autism, Autism spectrum disorder, Disease mutation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043524 Enhanced Supported "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA043524: AB_2678528" "unprognostic (6.97e-2)" "unprognostic (9.06e-3)" "prognostic unfavorable (8.54e-4)" "unprognostic (4.00e-2)" "unprognostic (2.39e-1)" "unprognostic (3.13e-2)" "unprognostic (1.02e-1)" "unprognostic (1.45e-2)" "unprognostic (3.59e-2)" "unprognostic (1.97e-2)" "prognostic favorable (9.05e-4)" "unprognostic (3.92e-3)" "prognostic unfavorable (8.17e-4)" "unprognostic (1.16e-2)" "unprognostic (2.22e-1)" "unprognostic (3.56e-1)" "unprognostic (5.49e-3)" 5.7 5.4 20.4 12.3 28.4 9.5 5.6 11.4 26.0 6.0 6.6 16.0 6.2 11.5 7.2 13.2 5.8 6.3 13.1 3.8 24.4 11.4 6.1 4.2 4.3 13.5 15.7 14.7 8.0 5.7 9.2 11.9 5.3 10.5 7.4 10.6 6.1 6.9 9.6 3.1 15.1 9.9 4.3 9.7 9.7 9.2 33.9 15.7 6.4 10.5 3.6 11.0 5.6 5.7 3.9 2.5 8.8 2.8 2.9 5.7 1.6 6.0 11.0 3.5 7.4 1.8 2.7 7.9 3.2 0.6 0.9 3.2 4.8 11.5 12.1 3.9 2.7 5.8 10.1 3.2 3.5 2.3 5.1 7.4 2.7 7.8 2.6 0.8 4.3 6.8 4.3 5.5 6.2 1.4 2.5 2.2 7.2 5.8 6.5 4.0 6.9 5.2 4.9 4.1 2.9 2.5 9.5 3.7 3.2 2.5 6.7 9.4 3.2 3.5 4.9 8.6 4.0 5.2 2.7 5.4 4.5 3.3 8.7 5.0 6.2 2.3 4.6 3.6 8.1 6.3 4.9 2.8 7.4 3.0 2.3 3.5 2.2 5.7 4.6 2.5 3.9 5.0 4.0 8.8 2.9 2.7 2.1 4.0 1.6 20.4 28.4 11.4 26.0 24.4 11.4 15.7 14.7 10.5 15.7 0.0 11.9 5.7 4.5 5.4 7.7 3.0 7.6 4.0 2.3 0.0 7.9 4.8 3.3 6.3 14.1 3.3 4.5 0.0 3.8 4.3 5.0 6.0 2.3 1.6 6.7 4.8 7.5 5.5 3.2 6.0 5.8 4.9 8.5 5.4 7.0 4.8 8.4 7.8 6.0 2.1 5.6 0.0 6.1 21.6 15.1 8.0 5.6 7.7 5.5 6.1 KCTD14 MGC2376 ENSG00000151364 "Potassium channel tetramerization domain containing 14" Q9BQ13 11 78015715-78046191 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 40.8;pancreas: 42.8;salivary gland: 43.9;seminal vesicle: 47.8" "Cell type enhanced" "Detected in many" 5 "Exocrine glandular cells: 14.8;Mucus-secreting cells: 15.2;Pancreatic endocrine cells: 12.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 4 "cerebellum: 5.5" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 15.4;Hep G2: 16.8;RPTEC TERT1: 27.3;U-2 OS: 12.4" "HPA041118, HPA042181" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA041118: AB_10963117, HPA042181: AB_10968059" "unprognostic (7.37e-3)" "unprognostic (4.27e-2)" "unprognostic (7.03e-2)" "unprognostic (6.93e-2)" "unprognostic (1.59e-2)" "unprognostic (2.28e-2)" "unprognostic (2.04e-3)" "unprognostic (3.26e-1)" "prognostic unfavorable (3.96e-5)" "prognostic favorable (8.01e-4)" "prognostic unfavorable (1.05e-4)" "unprognostic (3.19e-1)" "prognostic favorable (6.92e-5)" "unprognostic (2.42e-2)" "unprognostic (2.05e-1)" "prognostic favorable (5.93e-4)" "unprognostic (1.63e-1)" 2.6 18.9 1.2 1.5 0.8 0.0 11.6 5.5 0.8 6.5 4.8 1.2 40.8 2.5 2.3 10.8 2.1 6.8 10.3 0.7 1.0 1.3 10.7 14.4 9.6 0.3 0.9 0.5 2.4 42.8 6.2 2.5 5.1 1.3 5.3 6.9 5.8 43.9 47.8 0.7 1.5 6.1 0.9 0.8 0.7 12.1 1.9 0.8 0.7 12.4 2.9 3.6 1.4 1.1 0.4 1.4 0.6 1.1 1.1 1.8 0.4 0.0 2.1 0.3 0.3 0.8 0.5 2.1 1.1 1.0 2.1 5.1 8.0 5.2 0.0 5.7 0.6 0.2 0.6 0.3 15.4 5.4 0.2 7.8 0.0 1.8 16.8 3.1 0.1 0.1 2.4 0.4 8.4 6.6 1.5 0.5 0.1 0.1 0.0 0.8 0.1 0.2 0.4 3.9 0.2 0.3 0.2 0.0 0.0 27.3 2.0 1.4 0.1 0.0 0.1 2.5 0.5 0.8 0.6 0.4 0.1 12.4 0.4 0.2 0.1 0.1 0.1 0.1 0.1 2.2 0.0 0.7 0.6 0.7 0.9 0.5 0.0 0.7 1.8 1.4 0.4 0.8 1.8 0.2 1.1 1.1 1.3 0.0 0.4 1.2 0.8 5.5 0.8 1.0 1.3 0.9 0.5 1.3 0.8 3.0 9.6 0.0 9.5 0.3 0.0 0.0 2.5 0.0 5.7 5.2 0.0 0.6 3.3 2.0 0.1 0.0 2.5 0.0 14.8 1.2 0.8 10.5 1.1 4.0 0.2 0.0 4.6 0.0 0.0 0.0 3.1 0.0 1.7 0.0 15.2 1.7 12.8 7.0 4.9 11.3 0.0 0.0 1.9 0.2 0.2 0.1 0.6 0.0 8.5 5.8 KCTD15 MGC25497 ENSG00000153885 "Potassium channel tetramerization domain containing 15" Q96SI1 19 33795933-33815763 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 47.3" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 14.1;Ito cells: 25.8;Suprabasal keratinocytes: 16.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 2.5;eosinophil: 7.7;intermediate monocyte: 4.6;myeloid DC: 3.4;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 5 "dendritic cells: 3.4;granulocytes: 7.7;monocytes: 6.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050822 Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA050822: AB_2681250" "unprognostic (1.26e-2)" "unprognostic (1.93e-1)" "unprognostic (2.41e-1)" "unprognostic (6.62e-3)" "unprognostic (1.67e-2)" "unprognostic (2.66e-2)" "unprognostic (3.09e-2)" "unprognostic (5.60e-2)" "unprognostic (6.33e-2)" "unprognostic (5.58e-2)" "unprognostic (2.76e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (3.65e-8)" "unprognostic (1.40e-1)" "unprognostic (1.89e-3)" "unprognostic (6.13e-2)" "unprognostic (7.30e-2)" 8.7 4.0 10.5 7.1 7.9 3.4 7.7 7.7 11.0 15.5 13.6 8.6 4.6 4.7 20.3 6.2 14.6 12.7 9.4 6.8 13.0 5.1 6.2 7.1 13.3 4.1 5.8 8.4 14.3 15.6 1.6 3.4 7.3 9.4 9.0 4.2 12.4 3.7 13.7 4.8 47.3 5.8 13.8 9.3 8.3 8.1 10.6 8.9 1.0 8.9 5.1 4.6 9.4 13.0 0.0 3.4 7.7 6.3 0.0 1.2 0.9 5.8 13.4 12.1 18.5 4.0 2.1 9.6 7.7 1.4 4.3 2.2 7.5 4.0 0.0 17.6 10.8 2.0 6.9 8.8 6.0 1.6 6.3 15.4 24.1 8.3 7.2 11.2 4.6 4.4 4.2 25.5 1.6 9.8 0.0 8.4 3.5 5.9 0.1 0.7 14.8 0.1 13.2 11.1 9.8 22.7 11.2 6.5 2.2 4.8 2.7 9.4 32.4 15.1 21.5 28.0 5.4 15.9 12.3 13.7 20.3 18.2 0.4 1.3 15.0 0.7 9.5 0.0 8.1 24.7 0.6 2.5 7.7 0.0 4.6 0.1 0.0 1.2 0.2 3.4 0.0 0.1 0.0 0.0 0.0 6.3 0.0 0.7 0.9 10.5 7.9 7.7 9.2 13.0 5.1 5.8 8.4 9.4 8.9 0.0 1.7 0.0 3.2 14.1 2.9 2.0 0.0 0.0 3.4 0.0 9.8 0.2 3.3 0.8 0.5 8.0 0.8 0.0 7.2 0.2 4.9 2.2 8.1 1.6 1.2 1.6 1.2 25.8 3.5 1.4 4.0 4.7 5.0 0.0 2.9 2.8 3.0 0.0 8.5 0.2 10.7 0.0 5.2 0.0 0.4 16.9 0.2 0.0 0.9 2.5 KCTD9 "BTBD27, FLJ20038" ENSG00000104756 "Potassium channel tetramerization domain containing 9" Q7L273 8 25427847-25458476 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042468, HPA047902" Supported "Nucleoplasm,Intermediate filaments,Cytosol" No No Nucleoplasm "Intermediate filaments, Cytosol" "HPA042468: , HPA047902: AB_2680205" "unprognostic (4.18e-2)" "unprognostic (3.90e-2)" "prognostic favorable (7.88e-4)" "unprognostic (7.04e-2)" "unprognostic (7.41e-2)" "unprognostic (1.05e-2)" "unprognostic (2.20e-2)" "unprognostic (6.01e-2)" "unprognostic (4.33e-1)" "unprognostic (2.43e-2)" "unprognostic (4.49e-3)" "unprognostic (2.30e-1)" "unprognostic (1.48e-1)" "unprognostic (6.62e-2)" "unprognostic (1.35e-1)" "unprognostic (1.31e-2)" "unprognostic (4.97e-3)" 14.4 5.8 7.4 17.3 7.7 11.5 14.6 17.7 10.1 15.7 14.1 5.4 16.8 12.4 15.6 12.2 18.2 11.3 12.8 48.4 5.9 5.2 9.6 6.6 10.3 6.9 7.4 5.3 12.4 8.3 7.3 11.2 7.4 14.6 11.8 14.8 9.4 14.6 18.4 19.0 15.0 10.9 16.7 10.8 8.6 10.6 11.2 6.6 11.8 8.7 11.7 8.7 19.1 14.8 2.2 3.2 3.7 2.9 0.9 3.8 1.5 18.1 12.9 14.1 4.9 18.4 24.5 11.6 27.6 24.9 18.2 18.5 9.2 13.4 11.9 11.8 27.5 25.7 12.3 12.3 13.0 22.0 6.1 7.3 13.9 12.6 8.5 22.4 4.8 10.4 18.8 15.8 16.5 13.8 11.1 15.3 12.0 14.6 9.4 20.6 4.8 18.7 8.4 6.9 14.1 6.9 7.3 16.4 4.4 18.5 10.4 3.6 4.7 21.2 9.4 14.3 13.3 7.2 5.6 16.9 20.1 11.7 38.5 14.9 2.7 4.9 15.7 14.1 8.6 14.4 2.6 1.7 3.7 3.4 2.5 3.8 2.2 3.6 3.6 1.1 1.2 2.2 3.6 1.8 0.9 2.9 3.2 3.5 1.5 7.4 7.7 17.7 10.1 5.9 5.2 7.4 5.3 14.6 6.6 29.8 11.5 4.5 33.0 66.1 13.0 55.7 5.1 16.0 22.7 26.2 23.6 8.1 11.6 15.4 3.8 15.4 29.0 0.0 23.8 14.2 32.6 43.6 19.7 8.3 8.1 3.2 9.8 12.3 8.1 2.1 28.4 15.1 28.7 7.2 12.4 7.8 24.5 22.1 52.3 8.4 18.3 6.5 26.5 24.6 30.7 47.8 9.4 15.2 16.5 40.5 KDELC1 "EP58, MGC5302" ENSG00000134901 "KDEL motif containing 1" Q6UW63 13 102784281-102799007 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 20.1;Peritubular cells: 10.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 6.5" "Group enriched" "Detected in many" 4 "NK-cells: 6.5;T-cells: 4.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020780, HPA043946, HPA064398" Approved Supported Nucleoplasm "Intracellular and membrane" NA NA 7400 Nucleoplasm "CAB020780: , HPA043946: AB_2678743, HPA064398: AB_2685256" "unprognostic (1.97e-2)" "unprognostic (2.34e-1)" "unprognostic (3.21e-1)" "unprognostic (2.04e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (2.24e-4)" "unprognostic (6.68e-3)" "prognostic unfavorable (4.81e-4)" "unprognostic (4.34e-3)" "unprognostic (2.75e-2)" "unprognostic (7.26e-2)" "unprognostic (1.50e-2)" "prognostic unfavorable (4.73e-4)" "unprognostic (1.11e-2)" "unprognostic (1.17e-1)" "unprognostic (2.46e-1)" "unprognostic (2.60e-3)" 7.0 4.6 6.7 4.0 8.2 1.9 7.1 14.8 8.6 8.8 5.6 4.5 6.1 1.8 18.8 5.9 4.9 7.0 10.9 8.4 6.1 2.6 10.0 10.1 5.8 2.9 8.4 3.2 9.8 3.2 2.5 10.5 15.8 5.7 6.0 3.9 5.7 3.4 7.1 1.7 3.3 3.5 16.4 6.3 4.7 4.4 2.6 7.1 3.0 5.2 1.9 2.5 9.0 6.2 0.4 1.2 0.0 0.0 6.5 4.5 0.5 3.8 2.8 18.2 17.4 18.7 14.5 4.4 10.3 8.0 9.7 16.8 8.2 5.5 0.0 8.3 8.5 4.9 6.4 12.9 5.3 9.8 1.6 10.8 4.7 8.7 8.8 16.3 11.9 17.1 13.7 6.1 7.3 7.1 14.5 21.0 5.9 7.6 0.0 5.1 4.2 5.3 9.6 11.6 5.5 8.7 0.0 13.0 4.5 26.5 0.3 2.7 16.8 10.2 2.7 5.7 15.8 7.9 5.2 6.4 6.4 4.7 7.2 10.3 3.6 6.6 0.0 12.5 0.0 11.0 0.0 0.0 0.0 2.7 0.0 4.5 0.4 1.5 2.2 1.2 0.0 0.5 1.4 0.0 6.5 0.0 0.0 1.7 0.5 6.7 8.2 14.8 8.6 6.1 2.6 8.4 3.2 5.7 7.1 3.0 0.3 0.0 0.6 1.0 0.6 0.8 2.5 0.0 0.0 0.0 2.0 4.8 0.0 2.1 0.0 3.4 0.0 0.0 0.3 20.1 7.0 0.2 6.9 2.8 2.7 0.0 1.2 6.2 0.6 0.0 4.6 0.2 0.0 0.0 0.3 0.9 0.5 0.0 10.3 1.0 0.7 6.5 3.1 0.0 1.1 0.9 3.1 1.5 0.5 0.1 KDELC2 MGC33424 ENSG00000178202 "KDEL motif containing 2" Q7Z4H8 11 108472105-108498432 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 65.0" "Cell type enhanced" "Detected in many" 4 "Fibroblasts: 35.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039315, HPA039817, HPA066134" Approved Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA Nucleoplasm Vesicles "HPA039315: AB_10960861, HPA039817: AB_10966564, HPA066134: AB_2685624" "unprognostic (1.29e-1)" "unprognostic (2.80e-1)" "unprognostic (3.62e-1)" "unprognostic (7.65e-3)" "unprognostic (6.56e-3)" "unprognostic (1.02e-2)" "prognostic unfavorable (1.45e-4)" "unprognostic (6.04e-2)" "unprognostic (3.49e-3)" "unprognostic (1.49e-1)" "unprognostic (6.00e-3)" "unprognostic (4.08e-3)" "unprognostic (1.66e-3)" "unprognostic (1.85e-2)" "unprognostic (1.31e-1)" "unprognostic (1.90e-1)" "prognostic unfavorable (6.27e-5)" 20.8 7.8 4.2 12.7 4.7 2.7 19.7 3.6 3.2 27.2 11.1 4.8 9.7 4.1 21.8 21.1 16.1 17.6 18.0 13.3 4.1 4.2 11.4 13.5 12.5 10.0 4.6 2.7 25.6 9.5 19.8 5.1 65.0 4.6 20.6 8.0 13.4 13.0 14.5 8.1 6.9 7.3 24.4 5.0 9.9 8.9 9.5 4.4 10.0 9.2 8.7 6.5 19.5 20.0 0.9 2.0 0.2 1.5 4.5 4.6 1.0 3.1 3.6 14.2 14.5 24.0 27.9 13.7 14.2 13.2 20.3 22.1 17.3 23.6 0.0 8.8 18.4 22.5 2.4 10.7 0.3 21.5 5.6 8.3 5.3 4.0 8.0 9.7 13.9 0.0 16.0 4.5 10.7 0.3 12.4 17.1 0.0 11.9 0.1 30.6 2.3 8.9 8.0 6.2 3.4 10.5 0.4 22.2 0.0 3.7 8.9 3.0 9.1 26.7 1.8 3.9 6.8 12.8 5.3 17.0 39.3 7.8 3.3 14.7 0.1 0.0 0.0 10.1 14.6 31.1 0.1 0.3 0.0 4.6 1.5 3.9 0.5 2.3 3.8 1.1 0.9 2.4 3.6 0.2 4.5 0.7 2.0 1.9 1.0 4.2 4.7 3.6 3.2 4.1 4.2 4.6 2.7 4.6 4.4 3.0 10.1 3.2 5.2 10.3 9.9 5.0 2.5 10.7 9.1 15.7 5.9 21.7 1.7 2.2 0.9 11.2 1.5 0.0 6.3 13.2 35.1 7.9 3.5 9.7 14.2 0.0 1.7 14.7 2.4 0.0 26.2 6.9 5.0 3.6 8.3 3.8 4.2 3.5 29.4 5.2 6.0 12.9 16.7 0.5 1.0 8.3 17.7 8.5 6.8 2.3 KDF1 "C1orf172, FLJ34633, RP11-344H11.3" ENSG00000175707 "Keratinocyte differentiation factor 1" Q8NAX2 1 26949562-26960406 "Disease related genes, Predicted intracellular proteins" Differentiation "Developmental protein" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 8.6" "Group enriched" "Detected in many" 36 "B-cells: 3.7;T-cells: 8.6" "Cell line enhanced" "Detected in some" "A-431: 13.3;BEWO: 11.7;CAPAN-2: 12.5;HaCaT: 11.8;HBEC3-KT: 16.2;hTCEpi: 21.3;OE19: 20.5;SK-BR-3: 13.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028639, HPA068312" Uncertain Supported "Nucleoplasm,Cell Junctions,Mitotic spindle" NA NA "Cell Junctions" "Nucleoplasm, Mitotic spindle" "HPA028639: AB_10599191, HPA068312: AB_2685972" "unprognostic (2.58e-1)" "unprognostic (1.23e-1)" "unprognostic (6.46e-2)" "unprognostic (1.50e-2)" "unprognostic (1.15e-2)" "unprognostic (1.05e-1)" "unprognostic (1.64e-1)" "unprognostic (8.45e-2)" "unprognostic (9.09e-2)" "unprognostic (9.01e-2)" "unprognostic (2.73e-1)" "unprognostic (3.91e-1)" "prognostic favorable (3.04e-13)" "unprognostic (1.38e-3)" "unprognostic (7.83e-2)" "unprognostic (8.03e-2)" "prognostic favorable (4.40e-4)" 0.2 1.1 0.6 3.8 0.7 0.0 7.9 1.5 3.6 2.9 11.9 0.4 13.6 9.3 1.0 17.3 16.1 5.5 4.2 0.5 0.8 0.1 7.9 3.5 7.5 6.7 0.2 0.6 1.0 23.8 6.6 9.0 12.4 0.8 6.0 5.1 2.0 14.3 11.5 0.2 13.3 12.5 0.2 0.2 1.0 7.7 5.8 0.5 1.6 14.5 7.2 8.6 5.2 6.0 3.7 0.1 0.0 0.0 0.0 8.6 2.4 13.3 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 6.6 12.5 0.0 0.5 0.0 0.0 11.8 0.0 16.2 0.0 0.0 0.2 0.0 0.0 2.3 0.1 0.0 0.0 0.0 21.3 0.0 1.7 0.0 0.0 0.0 0.7 0.0 0.0 7.9 0.0 0.0 0.9 20.5 0.1 0.0 0.0 1.9 2.9 6.3 8.2 0.0 0.1 13.9 0.0 1.5 9.0 0.2 0.1 0.0 0.0 0.0 0.0 1.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 4.5 3.5 5.9 4.2 0.1 3.7 8.6 5.1 0.0 0.0 0.0 0.0 0.3 2.4 0.6 0.7 1.5 3.6 0.8 0.1 0.2 0.6 0.8 0.5 11.9 9.1 0.5 10.7 0.0 0.4 0.3 12.7 9.4 4.5 14.0 0.0 28.2 21.6 24.5 0.3 0.1 17.1 0.0 20.6 20.1 0.8 11.8 0.0 2.9 2.4 0.0 7.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 14.1 1.0 18.2 22.9 0.0 7.3 2.1 0.0 0.2 5.8 7.0 0.0 24.8 1.5 17.2 16.2 KDM1A "AOF2, BHC110, KDM1, KIAA0601, LSD1" ENSG00000004487 "Lysine demethylase 1A" O60341 1 23019443-23083689 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, Oxidoreductase, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 100.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005884, HPA053660" Supported Supported Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "CAB005884: AB_443964, HPA053660: AB_2682220" "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "prognostic favorable (6.31e-4)" "unprognostic (1.50e-1)" "unprognostic (6.83e-2)" "unprognostic (3.95e-2)" "prognostic unfavorable (4.47e-12)" "unprognostic (1.80e-2)" "unprognostic (1.99e-2)" "unprognostic (9.41e-2)" "unprognostic (3.34e-3)" "unprognostic (2.13e-1)" "unprognostic (2.61e-1)" "unprognostic (1.41e-1)" "unprognostic (3.73e-2)" "unprognostic (7.74e-2)" "unprognostic (1.39e-1)" 15.1 19.0 19.7 16.8 23.2 24.9 19.3 28.0 26.6 20.0 20.6 15.1 21.0 16.2 28.9 30.6 20.9 22.0 15.7 18.6 16.4 18.9 15.9 14.8 15.1 19.5 13.8 25.4 27.4 21.4 24.6 28.7 19.3 20.3 20.9 21.6 16.4 21.3 19.9 24.8 23.3 16.9 19.1 10.7 16.2 17.1 78.4 12.1 48.1 20.9 19.1 22.1 18.7 21.9 9.1 9.7 5.7 6.9 3.8 7.4 1.9 30.3 15.7 44.9 39.6 11.9 15.2 32.0 12.9 16.3 26.4 23.6 14.7 29.5 22.6 18.6 21.2 13.4 34.1 41.6 24.6 33.6 20.5 25.2 31.7 26.2 35.7 15.2 24.4 14.0 14.1 17.7 28.0 19.8 23.3 32.9 42.0 34.7 10.7 18.7 18.0 53.2 18.7 29.2 16.9 22.9 51.1 29.6 15.3 22.1 19.6 56.2 42.5 58.3 15.4 19.2 32.9 15.4 18.3 26.6 11.8 19.9 21.8 17.6 13.9 10.9 26.3 12.3 29.0 16.7 2.8 3.7 5.7 5.9 5.9 5.2 9.1 5.4 5.7 4.4 3.3 7.1 7.4 0.3 3.8 6.9 9.7 5.8 1.9 19.7 23.2 28.0 26.6 16.4 18.9 13.8 25.4 20.3 12.1 17.9 26.1 9.0 22.9 16.6 27.5 21.6 15.3 26.8 17.0 22.7 25.5 25.8 14.9 30.7 32.2 12.8 14.4 0.0 21.5 47.0 17.4 18.6 11.5 13.9 13.3 14.3 21.9 14.1 13.9 16.3 19.8 15.0 11.8 28.9 20.5 19.3 25.4 14.0 21.5 12.6 20.0 0.0 15.9 100.4 63.4 11.2 13.8 8.7 24.7 17.5 KDM1B "AOF1, bA204B7.3, C6orf193, dJ298J15.2, FLJ33898, FLJ34109, FLJ43328, LSD2" ENSG00000165097 "Lysine demethylase 1B" Q8NB78 6 18155329-18223853 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, Oxidoreductase, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 30.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 4.2;granulocytes: 7.6;monocytes: 9.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031269, HPA055597" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA031269: AB_10601587, HPA055597: " "unprognostic (1.93e-1)" "unprognostic (7.53e-2)" "prognostic favorable (6.94e-4)" "unprognostic (2.57e-2)" "unprognostic (7.25e-2)" "unprognostic (1.08e-1)" "unprognostic (5.57e-3)" "unprognostic (1.32e-2)" "unprognostic (8.41e-2)" "unprognostic (6.84e-2)" "unprognostic (2.16e-1)" "unprognostic (3.17e-2)" "unprognostic (6.68e-2)" "unprognostic (3.02e-2)" "unprognostic (2.90e-1)" "unprognostic (7.36e-2)" "unprognostic (3.53e-1)" 7.3 10.5 19.1 12.2 17.8 27.9 13.4 13.5 14.6 8.6 15.6 10.6 7.2 9.8 7.5 8.2 11.7 17.5 7.5 8.1 13.8 9.6 10.0 8.9 12.1 11.4 15.1 12.0 8.8 7.8 3.9 9.8 5.5 13.5 7.0 15.9 7.1 7.6 6.4 19.1 13.3 10.3 10.0 13.0 10.5 7.1 18.7 13.8 16.0 33.5 7.6 11.5 9.2 10.0 1.6 4.2 7.6 9.6 0.3 0.8 1.2 8.4 5.1 7.2 14.9 9.5 15.3 14.2 7.9 8.4 5.2 7.4 8.7 4.9 21.4 19.3 13.1 16.3 10.3 12.1 14.4 11.6 17.9 9.6 10.4 5.6 9.0 4.8 14.5 11.5 7.5 16.8 13.2 12.5 8.5 5.5 10.7 24.7 3.0 9.0 7.7 8.3 6.2 2.2 21.6 8.4 16.6 14.0 15.5 7.5 11.2 19.8 7.6 6.4 15.6 14.8 8.7 15.4 11.8 4.2 10.5 5.5 7.6 9.2 3.0 8.4 12.0 4.2 11.0 24.3 1.3 5.3 7.6 0.6 9.6 0.4 1.3 0.6 0.6 4.2 1.6 0.6 0.2 5.6 0.3 7.5 1.8 0.8 1.2 19.1 17.8 13.5 14.6 13.8 9.6 15.1 12.0 13.5 13.8 0.0 8.0 4.7 3.6 11.3 4.6 9.4 5.1 17.4 14.8 1.8 9.8 2.3 1.7 4.9 0.6 2.4 14.4 0.0 3.8 4.4 3.8 5.9 2.3 6.0 6.8 4.8 6.4 4.9 30.8 0.2 3.4 16.9 6.8 7.2 9.9 6.6 4.9 15.6 6.3 9.1 14.4 0.0 4.7 0.4 12.4 13.9 1.1 4.5 9.7 5.2 KDM2A "CXXC8, DKFZP434M1735, FBL11, FBL7, FBXL11, FLJ00115, JHDM1A, KIAA1004, LILINA" ENSG00000173120 "Lysine demethylase 2A" Q9Y2K7 11 67119269-67258087 "Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 129.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012272, HPA044251" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB012272: , HPA044251: " "unprognostic (7.43e-2)" "unprognostic (1.84e-1)" "unprognostic (4.09e-1)" "unprognostic (8.66e-2)" "unprognostic (1.67e-1)" "unprognostic (2.30e-2)" "unprognostic (6.05e-2)" "unprognostic (2.84e-1)" "unprognostic (4.46e-1)" "unprognostic (2.04e-3)" "unprognostic (3.27e-2)" "unprognostic (5.08e-2)" "unprognostic (2.67e-2)" "unprognostic (3.30e-1)" "unprognostic (1.05e-1)" "unprognostic (5.61e-2)" "unprognostic (9.45e-3)" 19.6 14.6 18.6 25.3 23.9 38.1 21.0 36.5 22.8 20.0 21.9 17.8 20.7 15.3 32.0 18.6 32.7 20.2 19.3 18.8 17.4 12.7 16.8 20.3 24.3 30.1 17.9 14.9 27.4 15.3 26.1 21.1 26.0 17.5 23.3 17.1 21.0 22.2 20.5 32.8 28.7 24.1 25.0 14.6 29.0 19.8 27.6 18.6 32.2 19.9 20.3 37.3 24.9 25.9 7.2 1.9 5.0 1.9 4.6 5.2 2.8 25.5 15.4 9.4 14.6 9.3 13.6 7.1 11.2 13.0 20.1 13.8 24.1 13.4 19.7 19.7 15.7 12.4 25.0 15.5 11.1 16.3 33.0 6.9 14.5 18.4 6.0 9.9 12.3 20.1 11.2 13.6 19.7 13.8 11.1 14.6 11.5 13.4 27.8 9.7 17.0 15.9 8.9 19.0 15.9 13.2 20.3 15.8 11.0 8.4 16.1 12.8 10.2 35.9 20.7 21.3 11.6 31.1 12.6 19.5 13.5 9.1 18.5 9.5 15.5 17.0 12.5 11.9 8.9 9.3 0.6 1.9 0.5 4.8 1.5 5.2 6.4 3.6 4.2 1.2 7.2 3.8 3.5 5.0 4.6 1.0 1.9 4.3 2.8 18.6 23.9 36.5 22.8 17.4 12.7 17.9 14.9 17.5 18.6 35.7 36.8 25.7 19.5 36.6 73.1 27.1 38.2 25.4 28.4 15.7 129.6 18.9 0.0 15.1 20.3 31.6 30.8 0.0 12.5 11.7 30.7 26.1 26.5 32.7 19.2 90.6 30.5 27.0 41.3 10.2 19.8 42.0 18.6 31.5 24.9 25.1 20.3 23.0 21.5 9.1 113.7 19.4 25.9 56.1 34.8 41.8 27.0 45.7 23.2 39.3 KDM2B "CXXC2, Fbl10, FBXL10, JHDM1B, PCCX2" ENSG00000089094 "Lysine demethylase 2B" Q8NHM5 12 121429097-121581015 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 64.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071257 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA071257: " "unprognostic (7.67e-2)" "unprognostic (3.72e-3)" "unprognostic (2.15e-1)" "unprognostic (1.69e-1)" "unprognostic (1.37e-1)" "prognostic favorable (6.74e-6)" "unprognostic (1.16e-1)" "unprognostic (5.45e-2)" "unprognostic (1.01e-2)" "unprognostic (1.95e-1)" "prognostic favorable (8.64e-4)" "unprognostic (1.77e-1)" "unprognostic (4.44e-3)" "unprognostic (1.44e-2)" "unprognostic (3.90e-2)" "unprognostic (7.07e-2)" "unprognostic (4.82e-2)" 6.2 6.3 13.9 20.1 15.7 14.9 7.0 31.1 25.1 9.2 7.6 12.3 5.2 8.2 9.9 7.3 14.4 10.8 7.9 5.8 11.8 7.2 6.6 10.2 9.5 21.3 14.3 15.1 14.1 8.2 13.0 8.2 7.2 12.2 6.6 7.7 8.1 9.1 6.8 11.7 18.9 13.1 8.1 13.2 16.3 7.4 9.8 14.5 27.0 8.2 5.5 20.9 11.1 11.6 11.5 5.0 4.2 3.6 2.6 8.3 4.0 6.7 8.6 17.0 5.2 4.7 4.9 17.4 6.7 9.1 9.8 8.3 11.7 3.8 33.1 9.9 6.1 5.2 5.9 18.1 6.6 7.4 13.7 11.7 19.1 7.8 10.4 5.2 22.3 14.8 3.9 4.0 8.8 6.7 9.8 7.0 16.6 14.4 4.7 5.0 10.0 24.2 26.8 27.3 5.4 7.0 27.9 8.6 16.3 5.4 13.1 18.6 11.0 11.5 6.8 6.8 14.8 12.8 24.5 8.8 10.2 7.6 9.7 6.5 11.0 9.7 32.3 9.3 17.5 6.3 4.2 3.6 2.8 8.3 3.2 6.3 11.5 6.6 4.8 5.0 10.6 5.9 7.5 0.5 2.6 1.9 4.8 5.5 4.0 13.9 15.7 31.1 25.1 11.8 7.2 14.3 15.1 12.2 14.5 0.0 11.7 22.7 5.0 15.0 19.7 13.0 15.3 2.7 4.5 10.4 11.8 5.7 10.0 6.6 41.3 7.3 4.7 0.0 5.0 9.1 9.4 5.4 13.9 12.2 21.8 14.3 5.2 8.0 16.4 37.2 7.2 21.0 15.1 64.1 4.7 3.9 5.1 5.9 6.7 3.3 13.8 19.4 9.9 5.1 13.9 13.2 5.5 17.8 6.6 5.4 KDM3A "JHMD2A, JMJD1, JMJD1A, KIAA0742, TSGA" ENSG00000115548 "Lysine demethylase 3A" Q9Y4C1 2 86440647-86492716 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055543, HPA065162" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA055543: AB_2682842, HPA065162: AB_2685424" "unprognostic (1.97e-2)" "unprognostic (3.03e-3)" "unprognostic (1.32e-2)" "unprognostic (4.04e-2)" "unprognostic (5.06e-2)" "unprognostic (5.24e-2)" "prognostic unfavorable (2.15e-6)" "unprognostic (2.01e-1)" "unprognostic (3.35e-3)" "unprognostic (9.50e-3)" "unprognostic (4.44e-2)" "unprognostic (5.64e-2)" "prognostic unfavorable (5.25e-4)" "unprognostic (2.17e-1)" "unprognostic (2.24e-1)" "unprognostic (1.24e-1)" "unprognostic (2.66e-2)" 21.5 12.5 21.5 14.6 27.2 52.9 18.5 17.2 18.7 18.9 25.9 19.6 17.3 17.0 21.2 24.8 20.3 16.8 14.7 21.3 22.7 11.4 13.2 11.9 17.2 14.8 17.8 15.2 20.6 15.7 16.3 20.3 19.5 17.8 19.7 14.9 14.6 19.2 19.1 20.7 34.7 19.1 21.0 22.1 15.7 14.5 42.9 23.6 30.1 18.6 12.8 17.3 29.0 22.1 4.8 4.9 14.4 3.4 4.9 9.1 4.1 18.4 7.4 17.6 4.6 9.1 9.3 16.5 9.0 8.9 8.5 10.5 9.4 7.9 10.8 17.1 7.5 17.5 11.8 13.1 9.0 16.6 14.5 10.9 17.4 6.8 13.3 6.8 13.8 11.1 10.2 13.7 7.6 14.1 29.3 10.4 10.2 11.1 17.8 8.9 4.7 19.2 19.4 15.8 11.1 11.3 13.1 23.8 23.3 7.6 10.5 13.7 14.5 11.9 8.6 16.4 16.2 5.0 9.1 11.6 17.3 7.2 17.8 10.2 18.6 17.5 16.1 21.9 14.4 21.1 11.9 3.2 5.9 7.6 3.4 8.0 4.8 8.4 7.3 4.9 4.1 9.1 7.8 14.4 4.9 2.3 4.4 8.6 4.1 21.5 27.2 17.2 18.7 22.7 11.4 17.8 15.2 17.8 23.6 32.8 13.4 6.9 20.9 27.1 22.7 22.6 10.2 36.1 23.9 5.2 49.1 3.7 0.0 12.1 58.0 19.8 15.9 23.3 8.6 5.9 16.9 16.0 37.0 6.8 9.0 52.4 15.0 14.7 11.3 20.1 16.1 15.1 20.3 5.4 11.4 35.1 10.0 9.7 16.3 4.2 33.6 6.5 14.4 32.1 10.2 35.0 9.7 17.0 9.3 11.7 KDM3B "C5orf7, JMJD1B, KIAA1082, NET22" ENSG00000120733 "Lysine demethylase 3B" Q7LBC6 5 138352596-138437028 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016610, HPA057202" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA016610: AB_1852004, HPA057202: AB_2683367" "unprognostic (1.21e-1)" "unprognostic (1.42e-1)" "unprognostic (1.63e-3)" "unprognostic (1.34e-1)" "unprognostic (6.72e-2)" "unprognostic (1.72e-1)" "unprognostic (5.21e-2)" "unprognostic (1.68e-1)" "unprognostic (2.64e-1)" "unprognostic (4.68e-2)" "unprognostic (1.11e-1)" "unprognostic (4.48e-2)" "prognostic favorable (6.67e-4)" "unprognostic (1.73e-1)" "unprognostic (3.05e-1)" "unprognostic (1.43e-1)" "unprognostic (7.60e-2)" 13.5 12.8 10.0 10.9 12.6 12.2 14.9 20.2 14.9 14.0 14.2 18.4 13.5 9.9 20.0 18.0 13.0 14.7 12.5 11.8 14.7 8.6 12.8 8.4 11.4 11.5 12.0 9.6 19.8 17.4 27.9 15.1 11.7 11.3 13.6 14.4 18.5 16.3 16.3 29.6 16.5 14.0 21.5 10.7 13.3 12.6 10.4 12.2 25.2 16.1 9.0 16.4 21.9 19.4 4.1 5.1 9.3 4.6 7.4 5.7 2.2 10.6 15.0 28.3 25.9 13.1 10.9 21.9 7.4 12.0 13.2 14.8 16.7 11.8 21.3 13.4 14.0 18.1 11.0 23.0 16.5 15.1 14.0 14.1 18.3 13.3 12.6 11.7 14.7 20.0 13.0 18.0 10.2 12.2 10.4 15.7 12.4 14.3 11.4 15.8 13.7 19.2 18.2 14.0 14.5 6.2 23.4 21.8 13.9 18.9 14.8 15.0 16.4 12.6 12.4 10.9 43.9 11.8 18.6 15.1 7.9 8.2 8.3 12.8 15.8 7.5 18.9 5.2 20.8 11.2 0.3 4.6 6.5 4.2 3.6 5.7 4.1 5.0 5.2 4.1 3.9 4.4 4.2 9.3 7.4 3.6 5.1 2.8 2.2 10.0 12.6 20.2 14.9 14.7 8.6 12.0 9.6 11.3 12.2 14.9 14.9 8.8 12.1 14.2 19.4 29.7 25.5 10.7 13.6 21.0 27.5 10.5 0.0 12.9 5.9 12.7 15.8 0.0 14.4 8.0 12.8 16.3 12.7 18.3 15.1 22.3 20.2 17.8 45.4 2.2 19.5 16.7 15.1 17.2 28.8 20.6 16.4 26.8 21.5 12.6 29.9 25.8 12.7 12.3 13.9 18.9 9.2 11.4 23.0 17.3 KDM4A "JHDM3A, JMJD2, JMJD2A, KIAA0677, TDRD14A" ENSG00000066135 "Lysine demethylase 4A" O75164 1 43650158-43705515 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA007610 Uncertain Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA007610: AB_1852006" "unprognostic (7.01e-2)" "unprognostic (1.50e-1)" "unprognostic (3.22e-2)" "unprognostic (6.18e-2)" "unprognostic (3.54e-2)" "unprognostic (5.40e-3)" "prognostic unfavorable (1.39e-5)" "unprognostic (4.88e-3)" "unprognostic (1.13e-1)" "unprognostic (5.47e-1)" "unprognostic (2.70e-1)" "unprognostic (7.95e-2)" "unprognostic (2.81e-1)" "unprognostic (2.32e-3)" "unprognostic (2.02e-1)" "unprognostic (1.92e-1)" "unprognostic (1.28e-1)" 12.8 29.5 12.7 15.4 19.7 11.2 14.5 23.4 22.3 17.5 18.8 20.7 17.6 29.0 18.2 14.6 19.1 19.7 15.4 10.7 11.9 11.5 13.9 18.5 15.3 14.8 14.8 16.3 22.1 15.1 22.3 22.4 13.8 19.1 15.3 20.0 21.6 17.9 12.9 13.2 23.4 23.3 16.1 13.8 18.6 15.2 6.9 14.1 29.7 18.5 11.3 22.3 17.2 15.5 6.7 5.9 12.8 7.2 6.2 7.7 4.6 10.6 9.9 16.0 28.4 15.8 15.0 11.4 10.1 11.6 15.5 15.4 11.3 9.6 14.0 10.5 10.1 11.8 11.2 19.8 12.0 16.1 9.8 16.3 19.8 14.9 9.1 15.1 14.2 16.0 16.3 19.5 15.2 19.2 11.9 16.1 12.2 9.8 20.1 11.2 8.4 11.1 12.1 26.7 9.2 10.0 14.9 18.8 9.9 11.0 21.4 14.4 13.0 22.1 15.3 27.8 24.9 8.9 48.2 12.3 9.3 15.0 8.3 13.7 9.2 11.0 12.6 9.7 12.0 17.5 11.1 6.8 12.8 6.9 5.6 7.7 6.7 6.7 5.6 5.9 5.1 4.6 4.0 4.5 6.2 7.2 5.3 7.1 4.6 12.7 19.7 23.4 22.3 11.9 11.5 14.8 16.3 19.1 14.1 8.9 21.1 2.2 4.2 8.1 20.8 6.8 7.6 26.8 4.5 1.8 35.3 7.1 5.0 7.9 9.2 7.1 13.8 0.0 5.9 4.7 8.3 4.8 12.7 8.6 7.5 30.2 11.5 9.8 6.4 4.4 11.5 7.7 1.7 10.0 19.3 10.6 8.9 10.5 13.8 5.7 23.4 6.5 6.2 0.7 1.0 4.1 6.8 5.7 14.0 5.0 KDM4B "JMJD2B, KIAA0876, TDRD14B" ENSG00000127663 "Lysine demethylase 4B" O94953 19 4969113-5153595 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 67.3;Cone photoreceptor cells: 92.3;Horizontal cells: 69.9;Rod photoreceptor cells: 74.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 7.1;dendritic cells: 2.5;granulocytes: 6.9" "Cell line enhanced" "Detected in all" "T-47d: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062872 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA062872: AB_2684890" "prognostic favorable (7.39e-4)" "unprognostic (1.99e-1)" "prognostic unfavorable (2.74e-4)" "prognostic favorable (4.25e-7)" "unprognostic (5.95e-2)" "unprognostic (7.96e-3)" "unprognostic (2.72e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.13e-4)" "unprognostic (3.89e-2)" "unprognostic (8.24e-3)" "unprognostic (5.14e-3)" "unprognostic (8.66e-2)" "unprognostic (1.98e-1)" "unprognostic (3.82e-1)" "unprognostic (4.14e-2)" "unprognostic (5.44e-2)" 13.3 16.0 14.8 15.1 13.4 22.0 20.0 26.1 18.7 19.4 12.6 18.3 24.3 12.1 24.2 18.1 15.9 18.4 12.0 12.6 13.3 9.2 10.4 18.2 11.8 19.2 13.8 12.9 18.5 19.0 12.1 17.9 29.4 11.2 24.8 6.0 18.8 16.5 22.6 38.0 21.1 12.9 16.2 13.3 21.2 12.0 19.9 13.8 14.6 28.9 8.8 13.7 13.3 21.9 7.1 2.5 6.9 0.9 1.3 0.8 0.5 8.9 3.1 7.4 8.9 4.3 4.3 15.0 4.5 3.4 4.0 5.0 5.3 2.5 12.5 4.8 5.1 3.2 5.1 4.5 5.3 2.5 5.6 11.4 4.2 5.4 4.4 8.1 4.2 9.8 6.6 5.7 3.3 2.7 7.2 5.3 7.1 10.3 7.7 3.5 4.6 4.8 6.4 6.5 3.2 7.8 8.2 5.6 10.4 4.0 5.9 13.8 10.6 5.8 6.5 7.1 7.5 35.5 11.1 7.7 6.0 3.4 7.2 4.5 21.3 8.8 9.6 11.7 8.5 3.4 1.6 0.9 2.6 0.5 0.3 0.3 6.1 0.4 0.4 0.4 7.1 0.6 0.8 6.9 1.3 0.4 2.5 0.5 0.5 14.8 13.4 26.1 18.7 13.3 9.2 13.8 12.9 11.2 13.8 6.0 7.2 13.7 11.9 6.5 67.3 12.7 15.3 2.7 5.7 7.0 92.3 21.3 6.6 9.5 13.7 10.5 8.4 0.0 6.6 19.1 10.3 19.8 8.1 23.7 8.0 69.9 8.1 12.3 11.8 8.8 17.0 9.1 10.1 9.0 16.5 20.7 14.6 13.3 21.9 5.2 74.4 6.5 8.1 18.4 7.7 13.4 20.1 10.2 8.4 10.8 KDM4C "GASC1, JMJD2C, KIAA0780, TDRD14C" ENSG00000107077 "Lysine demethylase 4C" Q9H3R0 9 6720863-7175648 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 73.8;Late spermatids: 64.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 32.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069357 Approved Nucleoplasm NA NA Nucleoplasm "HPA069357: AB_2686128" "unprognostic (1.56e-2)" "unprognostic (1.91e-2)" "unprognostic (4.38e-2)" "unprognostic (1.38e-1)" "unprognostic (3.52e-1)" "unprognostic (4.36e-2)" "unprognostic (2.50e-2)" "unprognostic (6.89e-3)" "unprognostic (2.37e-1)" "unprognostic (2.34e-2)" "unprognostic (3.65e-2)" "unprognostic (2.03e-2)" "unprognostic (1.92e-1)" "unprognostic (7.87e-3)" "unprognostic (1.21e-1)" "unprognostic (2.23e-2)" "unprognostic (1.64e-3)" 12.1 12.1 13.3 21.5 15.0 27.5 12.7 51.2 14.3 12.4 14.9 18.0 14.6 14.2 14.7 13.9 12.5 12.0 11.9 10.0 11.1 11.9 9.9 12.2 16.1 21.1 15.1 10.5 13.5 18.9 26.0 24.0 10.6 13.7 11.5 18.5 15.3 15.1 13.9 9.7 16.9 16.6 15.4 13.8 15.2 16.2 10.4 16.0 29.0 14.9 7.9 25.7 13.5 14.2 13.8 8.4 13.0 11.1 10.8 11.8 6.9 9.4 5.6 2.4 3.5 8.2 9.2 6.8 4.3 5.9 5.2 5.0 6.6 5.4 11.1 2.7 6.0 5.1 2.9 5.2 7.5 6.7 32.0 3.8 15.5 8.0 8.9 7.8 5.9 10.7 7.9 5.2 4.1 8.8 13.1 6.2 9.7 2.4 7.6 5.4 4.9 9.7 23.1 4.0 10.4 2.1 5.8 2.1 6.8 7.6 5.6 8.2 4.9 4.0 7.8 3.8 6.9 3.8 10.2 6.6 5.1 2.4 5.8 4.1 5.7 4.1 11.2 5.0 5.7 1.9 7.2 6.4 13.0 9.8 6.9 10.8 11.9 10.9 10.7 8.4 13.8 11.8 8.8 1.5 10.8 11.1 3.4 9.2 6.9 13.3 15.0 51.2 14.3 11.1 11.9 15.1 10.5 13.7 16.0 6.0 11.8 5.3 5.9 17.6 22.2 7.0 12.7 8.1 6.8 7.0 43.2 4.3 3.3 5.7 73.8 7.9 11.1 0.0 5.5 4.6 6.2 5.5 8.1 9.0 5.8 11.1 9.4 8.0 9.1 64.8 8.9 15.0 6.8 8.2 13.0 5.6 6.5 12.4 8.9 3.1 30.6 12.9 7.6 5.4 3.7 20.8 4.9 17.3 9.3 6.5 KDM4D "FLJ10251, JMJD2D" ENSG00000186280 "Lysine demethylase 4D" Q6B0I6 11 94973681-94999518 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 37.5" "Group enriched" "Detected in many" 4 "Early spermatids: 69.2;Late spermatids: 28.4;Spermatocytes: 52.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "non-classical monocyte: 5.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA055854, HPA064037" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA055854: AB_2682944, HPA064037: AB_2685180" "unprognostic (1.98e-1)" "unprognostic (5.71e-2)" "unprognostic (1.83e-1)" "unprognostic (9.65e-3)" "unprognostic (3.19e-1)" "unprognostic (5.12e-2)" "unprognostic (2.84e-2)" "unprognostic (3.16e-1)" "unprognostic (3.11e-1)" "unprognostic (1.36e-1)" "unprognostic (1.37e-2)" "unprognostic (5.62e-2)" "unprognostic (4.49e-2)" "unprognostic (8.14e-2)" "unprognostic (1.84e-1)" "unprognostic (2.45e-1)" "unprognostic (2.88e-1)" 0.6 0.8 1.2 0.4 2.0 0.1 0.8 1.4 2.1 0.6 0.3 1.2 1.7 0.2 0.6 0.9 0.4 1.0 0.5 1.0 0.7 0.7 0.6 0.4 0.4 0.7 0.6 1.3 1.3 0.4 1.4 2.1 0.5 1.1 0.6 0.4 1.2 0.7 0.7 1.0 0.7 0.5 0.6 0.9 0.7 0.4 37.5 1.0 0.3 0.8 0.6 0.6 0.6 0.4 1.3 1.2 0.0 5.1 0.1 1.4 0.2 0.9 1.4 5.6 4.1 1.2 1.4 2.6 1.9 2.1 5.2 4.6 1.5 1.8 2.1 6.1 1.6 5.0 1.7 3.6 3.9 4.0 2.3 3.7 1.8 0.6 2.1 1.1 0.9 0.6 2.7 2.1 5.2 4.7 0.8 2.0 7.4 2.0 1.0 2.0 1.7 3.1 2.1 2.5 1.4 6.8 4.3 2.4 1.5 1.2 0.6 3.3 4.0 2.2 2.0 1.5 3.2 2.1 0.6 1.5 3.6 2.1 5.5 2.8 1.3 4.1 0.3 1.2 1.1 3.9 0.0 0.3 0.0 0.3 0.2 0.2 1.3 0.6 1.0 0.0 0.2 0.8 0.1 0.0 0.1 5.1 1.2 1.4 0.2 1.2 2.0 1.4 2.1 0.7 0.7 0.6 1.3 1.1 1.0 0.0 0.0 0.0 0.2 0.0 6.6 0.8 2.5 1.4 0.0 0.0 2.0 0.8 3.3 0.6 69.2 0.4 0.0 0.0 0.5 0.7 0.3 0.1 0.0 1.0 0.5 3.2 0.0 1.8 0.3 28.4 2.0 0.7 0.0 1.0 0.0 4.3 0.2 0.0 1.1 1.0 2.9 0.0 0.9 52.0 12.4 0.0 0.2 0.0 0.2 0.1 KDM5B "CT31, JARID1B, PLU-1, PPP1R98, RBBP2H1A" ENSG00000117139 "Lysine demethylase 5B" Q9UGL1 1 202724491-202809470 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 74.0" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 181.0;Spermatocytes: 261.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027179, HPA053723, CAB068193" Enhanced Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "CAB068193: AB_2665696, HPA027179: AB_1851987, HPA053723: AB_2682241" "unprognostic (1.19e-1)" "unprognostic (1.74e-2)" "unprognostic (1.03e-1)" "unprognostic (4.67e-2)" "unprognostic (1.92e-2)" "unprognostic (2.31e-1)" "unprognostic (3.49e-3)" "unprognostic (3.02e-2)" "unprognostic (3.23e-2)" "unprognostic (6.12e-2)" "unprognostic (1.61e-2)" "unprognostic (4.79e-2)" "unprognostic (8.25e-3)" "unprognostic (2.56e-2)" "unprognostic (1.61e-1)" "unprognostic (5.56e-2)" "unprognostic (4.13e-1)" 7.7 7.1 5.9 8.2 7.8 14.8 12.3 12.7 9.0 12.9 9.6 5.1 9.7 5.0 13.6 9.4 17.6 8.6 8.4 5.7 6.1 4.5 6.0 4.6 9.0 5.4 3.7 7.3 13.3 9.0 9.8 8.6 23.1 5.0 11.3 9.0 16.0 11.1 8.8 4.3 19.5 7.3 10.1 4.9 6.9 8.2 74.0 5.2 25.8 9.1 6.2 10.4 12.2 12.6 4.1 3.0 16.0 5.2 7.3 4.4 2.6 10.6 4.3 28.9 13.9 13.7 12.4 24.4 7.3 11.3 7.7 8.2 3.6 11.3 0.0 5.0 11.4 5.7 16.4 13.6 12.0 9.9 0.1 5.2 5.8 4.1 5.8 11.7 18.0 7.7 12.9 20.0 11.0 14.5 20.8 17.1 7.2 18.0 0.0 7.7 10.8 5.0 21.5 19.6 7.4 7.6 21.2 0.0 0.0 11.1 18.4 8.8 19.5 15.5 9.5 12.9 39.6 19.5 12.9 12.6 6.8 5.1 0.8 4.2 1.1 0.7 4.5 6.0 6.7 2.8 16.0 2.9 6.4 3.7 3.4 3.1 2.8 3.3 2.7 3.0 4.1 4.2 1.8 9.5 7.3 5.2 2.1 4.4 2.6 5.9 7.8 12.7 9.0 6.1 4.5 3.7 7.3 5.0 5.2 83.4 33.4 5.4 32.8 57.2 30.9 7.3 10.2 54.9 40.9 15.7 58.9 35.8 5.0 41.9 155.3 25.3 16.1 0.0 19.5 25.5 34.2 40.2 25.5 9.6 7.0 14.3 41.9 19.0 17.8 181.0 33.6 10.8 25.3 10.0 31.3 68.3 38.0 17.3 30.8 5.9 133.9 32.3 21.7 261.1 71.6 101.6 68.9 12.5 27.0 45.7 KDM5C "DXS1272E, JARID1C, MRX13, SMCX, XE169" ENSG00000126012 "Lysine demethylase 5C" P41229 X 53191321-53225422 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038244, HPA046147" Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038244: AB_2675911, HPA046147: AB_2679555" "unprognostic (1.19e-1)" "unprognostic (1.13e-1)" "unprognostic (1.56e-2)" "unprognostic (7.10e-2)" "unprognostic (9.75e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (2.08e-2)" "unprognostic (2.11e-1)" "unprognostic (1.24e-1)" "unprognostic (5.45e-2)" "unprognostic (1.58e-2)" "unprognostic (5.05e-3)" "unprognostic (1.96e-2)" "unprognostic (6.91e-2)" "unprognostic (1.30e-1)" "unprognostic (1.00e-1)" 19.5 22.9 22.4 22.6 24.7 26.3 17.9 43.0 31.7 25.9 19.5 23.4 16.7 22.2 29.2 13.3 26.9 24.8 15.2 17.6 21.6 15.3 17.0 18.8 20.6 25.8 24.6 21.8 33.1 22.5 37.7 31.8 34.0 22.8 18.7 13.5 17.0 25.6 17.1 36.6 28.4 22.2 23.6 16.0 25.0 19.4 10.6 26.2 29.0 22.2 11.3 24.5 21.5 26.4 4.5 4.3 4.8 4.0 2.8 6.1 3.8 16.9 23.1 24.8 19.0 17.2 15.7 17.6 10.6 12.4 14.4 13.4 15.6 11.1 15.8 13.8 13.9 40.6 15.2 28.0 22.7 11.0 11.8 41.4 15.3 24.7 11.0 21.2 18.1 30.6 12.4 16.7 28.1 34.7 20.6 21.2 13.2 29.7 10.5 10.5 21.7 13.2 20.4 21.0 8.8 21.7 15.0 14.8 17.1 9.1 16.3 18.7 24.1 32.2 29.9 12.1 23.8 20.9 16.0 14.5 16.1 13.9 14.4 10.3 15.3 12.4 12.0 20.9 21.5 11.9 3.0 3.8 2.7 6.1 3.6 5.1 4.5 3.7 5.7 3.1 3.2 4.5 2.9 4.8 2.8 4.0 4.3 4.3 3.8 22.4 24.7 43.0 31.7 21.6 15.3 24.6 21.8 22.8 26.2 11.9 12.2 11.9 9.7 10.8 25.0 7.7 17.8 12.0 12.5 7.0 23.6 10.6 3.3 13.4 0.6 14.3 21.7 0.0 18.7 11.4 11.3 12.4 12.7 19.8 12.4 23.8 30.0 18.4 14.6 1.7 13.6 9.4 13.5 10.0 27.8 10.9 20.8 24.6 14.9 4.2 16.1 0.0 10.3 7.0 14.6 13.9 17.4 10.2 15.6 15.9 KDM6A UTX ENSG00000147050 "Lysine demethylase 6A" O15550 X 44873177-45112602 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000568, HPA001165, HPA002111" Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim" "Intracellular and membrane" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA000568: AB_1858705, HPA001165: AB_1080541, HPA002111: AB_1858704" "unprognostic (1.73e-3)" "unprognostic (6.86e-3)" "unprognostic (1.45e-2)" "unprognostic (1.36e-1)" "unprognostic (1.72e-1)" "unprognostic (2.65e-2)" "unprognostic (2.58e-3)" "unprognostic (8.22e-3)" "unprognostic (3.23e-1)" "unprognostic (2.44e-1)" "unprognostic (2.56e-1)" "unprognostic (1.07e-1)" "unprognostic (2.73e-1)" "unprognostic (2.24e-2)" "unprognostic (5.18e-2)" "unprognostic (1.26e-1)" "unprognostic (3.16e-2)" 12.3 12.1 16.5 17.6 24.5 47.9 21.4 26.1 22.0 16.9 11.8 16.7 12.0 13.1 22.6 11.3 15.4 16.9 15.2 9.1 18.2 6.5 11.6 13.5 19.7 15.1 28.8 11.3 23.8 14.9 21.3 20.2 13.3 18.3 10.3 11.3 10.3 16.1 12.6 15.1 21.3 17.6 13.5 14.9 18.1 15.0 17.7 26.1 19.1 14.5 6.9 13.6 14.9 22.8 5.5 7.1 15.7 7.5 6.2 7.9 3.5 8.7 7.6 11.3 11.4 8.1 8.4 24.2 6.8 4.8 8.2 8.6 17.9 7.5 5.7 3.7 6.3 17.0 18.8 14.5 12.0 7.6 8.3 15.5 7.1 9.6 6.7 5.7 3.8 20.2 4.5 9.9 13.5 14.1 8.8 6.3 7.0 9.8 14.2 5.1 5.7 7.8 11.2 9.4 6.7 8.8 8.7 10.9 1.0 4.7 16.3 9.7 5.2 21.7 10.9 9.2 24.8 10.6 0.1 5.3 7.8 6.0 7.8 3.5 9.0 10.8 8.6 5.4 4.0 4.5 15.7 3.8 3.5 5.3 7.5 6.0 5.5 7.2 7.9 7.1 3.8 7.0 6.3 7.3 6.2 7.2 3.8 5.6 3.5 16.5 24.5 26.1 22.0 18.2 6.5 28.8 11.3 18.3 26.1 6.0 8.8 5.2 11.3 23.2 6.5 11.4 10.2 5.3 7.9 7.0 13.7 3.8 0.0 6.5 1.0 9.4 18.8 0.0 6.6 4.9 8.9 11.4 2.3 13.9 6.1 23.8 12.6 6.2 8.9 1.1 6.1 9.7 10.1 7.2 14.2 7.4 7.7 14.4 6.7 3.3 8.4 6.5 10.3 5.6 11.7 23.1 9.2 10.1 11.0 16.3 KDM7A "JHDM1D, KIAA1718" ENSG00000006459 "Lysine demethylase 7A" Q6ZMT4 7 140084746-140177035 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012114 Uncertain Approved Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA012114: AB_1852429" "unprognostic (1.55e-1)" "unprognostic (1.44e-1)" "unprognostic (2.54e-1)" "unprognostic (4.08e-3)" "unprognostic (3.52e-1)" "unprognostic (1.69e-2)" "unprognostic (4.00e-1)" "unprognostic (3.44e-2)" "unprognostic (2.56e-1)" "unprognostic (3.84e-2)" "unprognostic (9.74e-2)" "unprognostic (1.29e-1)" "unprognostic (9.55e-2)" "unprognostic (3.42e-1)" "unprognostic (2.59e-1)" "unprognostic (2.10e-1)" "unprognostic (1.18e-1)" 20.1 3.2 6.6 15.2 4.7 18.7 10.4 8.7 6.1 13.2 12.0 4.7 4.6 10.3 8.9 5.8 13.0 5.8 6.0 8.0 5.7 3.5 4.9 8.5 9.7 10.1 4.8 2.8 5.0 6.4 7.0 6.7 15.5 6.7 6.9 12.2 3.7 11.4 4.5 24.6 15.0 16.3 9.3 6.0 6.7 11.9 9.4 5.9 10.8 6.4 10.3 15.2 13.1 9.1 2.8 3.0 6.1 2.3 1.8 1.6 0.8 0.9 0.4 2.9 3.1 2.7 2.3 5.9 1.3 1.9 0.5 0.6 0.3 0.4 2.0 2.0 1.3 1.6 1.1 4.1 2.5 0.9 11.3 2.5 0.1 0.4 5.3 2.7 1.9 2.1 2.7 5.6 1.6 8.8 1.4 2.8 5.4 6.4 8.9 0.5 0.8 3.5 3.1 4.7 6.5 1.6 4.0 0.2 4.0 1.0 1.2 5.2 6.3 3.0 7.0 3.0 4.9 9.6 0.7 4.9 0.6 1.1 1.9 0.8 3.1 0.4 6.6 1.6 5.2 1.1 1.6 2.3 0.9 1.1 1.3 0.9 1.5 1.6 1.5 3.0 2.8 1.5 1.0 6.1 1.8 0.5 1.2 1.3 0.8 6.6 4.7 8.7 6.1 5.7 3.5 4.8 2.8 6.7 5.9 14.9 27.5 13.2 37.9 44.3 12.4 12.1 10.2 26.8 25.0 15.7 25.5 7.1 1.7 6.4 4.1 20.3 28.2 23.3 8.2 2.5 15.4 28.1 8.1 16.9 9.7 6.4 50.6 24.5 36.3 3.4 7.2 33.7 3.3 3.6 38.6 3.7 10.2 26.8 3.9 2.6 9.5 6.5 17.6 24.7 10.0 40.7 31.7 13.1 21.9 43.9 KDM8 "FLJ13798, JMJD5" ENSG00000155666 "Lysine demethylase 8" Q8N371 16 27203495-27221768 "Enzymes, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Transcription, Transcription regulation" "Aminopeptidase, Chromatin regulator, Dioxygenase, Hydrolase, Oxidoreductase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 44.9" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026545 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA026545: AB_1852015" "unprognostic (1.39e-1)" "unprognostic (1.37e-3)" "unprognostic (2.80e-1)" "unprognostic (2.16e-2)" "unprognostic (3.21e-1)" "unprognostic (1.22e-2)" "unprognostic (2.41e-3)" "unprognostic (1.33e-2)" "unprognostic (7.95e-2)" "unprognostic (3.41e-1)" "prognostic favorable (1.75e-4)" "unprognostic (1.22e-1)" "unprognostic (2.75e-2)" "unprognostic (5.33e-2)" "unprognostic (2.71e-1)" "unprognostic (2.04e-1)" "unprognostic (3.92e-3)" 1.9 3.2 2.7 3.6 3.5 1.4 2.1 5.9 5.9 2.2 4.2 3.7 3.2 12.0 3.1 2.2 2.1 2.5 2.5 2.0 2.7 3.2 2.3 44.9 2.0 3.3 2.3 5.1 3.0 4.5 2.8 3.3 1.7 3.7 2.9 1.9 2.1 2.6 2.5 4.0 1.9 16.8 1.9 2.2 3.7 2.3 2.2 2.2 5.9 2.9 2.0 3.7 2.8 2.2 5.6 6.5 1.3 3.4 2.2 8.2 3.5 1.6 3.7 6.4 3.3 1.6 1.9 3.4 2.1 2.4 4.8 4.3 3.1 2.9 9.6 3.7 3.5 2.4 1.9 3.7 3.2 2.8 11.0 5.5 6.1 4.1 7.3 3.4 4.3 7.3 2.5 2.6 3.2 2.1 2.8 3.7 4.6 7.7 5.9 2.9 2.8 4.3 7.7 11.1 1.3 2.2 6.3 3.9 8.6 1.8 1.9 6.0 3.8 0.9 3.0 2.3 2.2 3.2 5.7 4.1 5.7 3.0 2.1 2.2 3.7 3.8 7.7 2.3 4.0 0.5 0.4 3.2 1.3 4.2 3.4 3.6 3.2 6.2 6.0 3.0 5.6 6.0 8.2 0.1 2.2 2.9 6.5 3.6 3.5 2.7 3.5 5.9 5.9 2.7 3.2 2.3 5.1 3.7 2.2 0.0 1.7 0.5 0.2 0.2 1.0 1.0 0.0 9.4 2.3 0.0 2.0 1.3 3.3 0.9 0.4 1.0 1.6 0.0 0.6 0.4 0.8 0.4 0.0 46.0 1.6 0.0 5.2 1.3 1.3 0.0 0.3 1.2 0.0 1.0 1.3 1.6 0.7 0.0 1.1 1.2 2.5 0.0 0.8 0.9 2.5 0.0 1.1 0.5 1.1 0.1 KEAP1 "INrf2, KIAA0132, KLHL19, MGC10630, MGC1114, MGC20887, MGC4407, MGC9454" ENSG00000079999 "Kelch like ECH associated protein 1" Q14145 19 10486120-10503741 "Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005558, CAB025337" Approved Supported "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Nucleoplasm, Centriolar satellite" Cytosol "CAB025337: , HPA005558: AB_1079175" "unprognostic (1.98e-1)" "prognostic favorable (3.28e-4)" "unprognostic (1.61e-1)" "unprognostic (1.02e-1)" "unprognostic (1.42e-1)" "unprognostic (1.63e-2)" "unprognostic (2.64e-2)" "unprognostic (1.46e-1)" "unprognostic (1.48e-1)" "unprognostic (5.22e-3)" "unprognostic (2.04e-1)" "unprognostic (9.99e-2)" "unprognostic (1.29e-1)" "unprognostic (7.71e-3)" "unprognostic (5.06e-1)" "unprognostic (8.18e-2)" "unprognostic (1.60e-2)" 16.0 13.7 13.5 10.4 14.3 9.1 12.4 13.2 15.1 13.1 15.7 15.4 13.8 13.6 11.0 12.7 26.3 15.1 12.7 19.7 13.9 13.7 13.2 22.0 10.8 15.5 16.7 7.4 11.8 14.3 11.1 10.2 11.5 14.3 13.9 8.8 11.8 11.3 13.9 63.9 16.8 13.8 11.6 16.5 11.3 10.6 12.2 13.8 13.1 14.5 29.1 16.1 14.5 11.2 14.6 23.7 21.3 19.8 21.0 30.8 19.6 17.3 31.8 8.8 11.7 18.2 15.5 9.4 14.8 11.0 15.2 13.6 22.6 17.5 24.7 39.0 16.4 11.3 15.6 17.5 11.5 7.5 23.9 19.2 37.3 9.5 26.7 17.6 19.5 20.3 16.0 15.6 17.1 8.0 12.7 14.4 7.4 22.8 45.8 13.2 24.0 14.1 53.6 25.7 16.6 26.8 25.7 11.0 28.9 9.8 20.8 24.3 12.7 20.6 13.8 12.8 8.1 11.9 26.1 17.7 24.5 13.2 27.4 17.9 26.7 33.4 24.2 18.9 23.3 17.9 16.1 19.8 21.3 30.8 17.0 29.3 14.6 21.5 28.3 23.7 5.7 13.5 19.1 10.9 21.0 16.6 16.3 25.4 19.6 13.5 14.3 13.2 12.8 13.9 13.7 16.7 7.4 14.3 13.8 26.8 17.3 19.6 22.6 19.5 21.5 20.3 20.4 13.4 17.0 10.4 7.9 22.5 11.6 29.0 22.3 24.1 31.5 0.0 31.3 21.0 19.7 21.7 11.5 28.8 25.7 25.4 25.8 27.0 14.8 34.6 27.0 14.9 10.1 57.7 20.6 39.6 26.7 21.0 24.4 19.1 11.1 12.9 15.6 19.5 17.3 19.3 22.4 22.4 27.9 21.7 KEL "CD238, ECE3" ENSG00000197993 "Kell blood group, metallo-endopeptidase" P23276 7 142941114-142962681 "Blood group antigen proteins, Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen, Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 21.1;testis: 36.4" "Cell type enriched" "Detected in some" 14 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 7 "intermediate monocyte: 1.4" "Lineage enriched" "Detected in single" 14 "monocytes: 1.4" "Group enriched" "Detected in some" 12 "HEL: 15.3;K-562: 12.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA064442 Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA064442: " "unprognostic (5.78e-3)" "unprognostic (1.08e-5)" "unprognostic (5.29e-3)" "unprognostic (4.85e-3)" "unprognostic (9.68e-2)" "unprognostic (1.96e-2)" "unprognostic (1.03e-1)" "unprognostic (1.54e-2)" "unprognostic (5.18e-2)" "unprognostic (1.08e-2)" "unprognostic (3.71e-2)" "unprognostic (3.57e-2)" "unprognostic (2.29e-3)" "unprognostic (9.24e-2)" "unprognostic (7.05e-2)" "unprognostic (3.32e-2)" "unprognostic (3.25e-3)" 0.2 0.0 0.9 2.5 1.1 21.1 0.2 0.2 0.4 0.4 0.2 0.3 0.2 0.0 0.2 0.2 0.6 0.1 0.2 0.2 1.4 0.7 0.4 0.2 1.4 5.0 2.0 0.2 0.2 0.2 0.0 0.2 1.1 0.3 0.2 0.0 0.3 2.5 0.2 0.2 0.0 0.5 0.2 4.4 3.8 0.0 36.4 0.3 0.4 0.2 0.2 3.7 0.2 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 12.4 0.1 0.0 0.0 0.5 0.3 0.3 0.0 0.0 0.1 0.0 0.1 0.0 1.2 0.0 0.1 0.2 0.0 0.5 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 1.1 0.2 0.4 1.4 0.7 2.0 0.2 0.3 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 2.3 3.5 0.0 0.0 1.7 0.2 1.9 0.0 0.0 46.7 0.0 0.2 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 1.0 KHDC4 "BLOM7, KIAA0907, SNORA80EHG" ENSG00000132680 "KH domain containing 4, pre-mRNA splicing factor" Q7Z7F0 1 155913043-155934400 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 22.7;Club cells: 22.7;Collecting duct cells: 54.1;monocytes: 23.4;Syncytiotrophoblasts: 25.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008796 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA008796: AB_1079369" "unprognostic (6.31e-2)" "unprognostic (1.32e-1)" "unprognostic (4.52e-2)" "unprognostic (5.22e-3)" "unprognostic (7.68e-3)" "unprognostic (1.61e-1)" "prognostic unfavorable (1.01e-6)" "unprognostic (3.79e-2)" "unprognostic (2.44e-2)" "unprognostic (7.88e-2)" "unprognostic (3.66e-2)" "prognostic unfavorable (3.87e-4)" "prognostic unfavorable (2.78e-10)" "unprognostic (1.04e-1)" "unprognostic (2.37e-1)" "unprognostic (9.10e-2)" "prognostic favorable (4.36e-5)" 15.6 17.9 22.5 18.4 24.6 9.3 20.0 42.2 26.7 23.0 19.0 19.5 25.2 20.4 24.4 42.5 16.3 17.2 17.4 15.8 22.7 11.0 20.1 16.2 19.1 23.5 25.0 13.3 29.8 18.8 19.5 39.4 20.5 20.2 23.1 25.0 18.9 22.3 19.9 21.9 25.7 20.4 23.8 21.7 22.3 24.3 15.8 24.8 21.8 20.4 7.1 25.6 21.5 20.8 6.5 3.6 7.6 6.1 5.1 7.2 2.4 12.3 9.5 20.2 12.2 10.9 15.3 12.6 10.7 8.5 16.3 16.9 9.8 27.5 15.4 12.0 6.0 11.7 23.0 18.5 7.5 16.2 12.2 38.7 13.8 28.9 11.7 7.6 16.2 12.0 9.9 20.0 11.4 8.9 19.3 11.7 17.6 16.6 17.8 14.8 5.9 15.5 16.0 22.3 11.7 13.7 18.5 11.0 13.6 14.4 6.8 14.1 14.1 7.9 8.4 11.4 17.4 17.6 27.4 9.8 15.9 11.0 5.1 14.3 29.0 12.5 13.7 11.4 15.2 11.9 7.6 3.5 6.5 5.3 4.6 6.8 6.1 5.6 6.8 3.4 6.5 7.2 6.5 4.5 5.1 6.1 3.6 4.6 2.4 22.5 24.6 42.2 26.7 22.7 11.0 25.0 13.3 20.2 24.8 11.9 16.3 0.0 0.0 0.0 0.0 0.0 0.0 22.7 22.7 54.1 0.0 20.8 3.3 9.5 0.0 0.0 0.0 0.0 6.2 17.7 0.0 0.0 5.8 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 23.4 0.0 0.0 13.6 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.0 KHDRBS1 "FLJ34027, p62, Sam68" ENSG00000121774 "KH RNA binding domain containing, signal transduction associated 1" Q07666 1 32013829-32060850 "Predicted intracellular proteins" "Cell cycle, mRNA processing, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005355, HPA051280, HPA056813" Supported Enhanced Nucleoplasm NA NA 20000 Nucleoplasm "CAB005355: AB_631869, HPA051280: AB_2681417, HPA056813: AB_2683240" "unprognostic (1.31e-1)" "unprognostic (3.01e-2)" "unprognostic (1.22e-2)" "unprognostic (1.55e-1)" "unprognostic (2.09e-1)" "unprognostic (6.55e-2)" "prognostic unfavorable (3.68e-5)" "unprognostic (5.01e-2)" "unprognostic (2.51e-3)" "unprognostic (4.03e-2)" "unprognostic (2.17e-2)" "unprognostic (1.91e-3)" "prognostic unfavorable (9.32e-4)" "unprognostic (1.08e-1)" "unprognostic (1.45e-1)" "unprognostic (1.26e-1)" "unprognostic (7.03e-2)" 34.5 31.7 31.1 49.7 34.2 42.0 35.9 56.6 41.5 42.0 38.8 35.1 30.1 33.3 51.5 37.8 37.0 39.5 51.2 34.9 29.7 30.1 30.0 30.9 38.3 52.5 27.3 35.9 63.2 31.3 40.4 29.5 33.9 25.9 36.5 31.7 32.2 31.1 35.5 39.0 30.6 32.4 44.2 31.4 36.0 31.0 42.7 23.7 69.9 35.1 41.0 50.0 40.2 34.4 11.4 10.2 6.4 10.2 8.2 14.4 3.5 44.4 27.1 62.1 45.6 21.6 27.2 36.5 27.0 34.4 50.8 42.9 30.1 40.0 66.7 30.3 34.1 29.5 31.2 50.0 37.0 52.1 39.7 42.7 42.0 26.7 41.0 28.5 55.6 28.3 29.8 21.2 38.6 30.7 33.4 47.9 41.1 54.1 30.6 38.9 29.0 81.8 47.6 63.0 28.1 32.6 65.7 52.6 56.3 35.4 45.2 42.5 55.6 39.3 33.7 33.9 46.2 40.1 40.5 35.9 33.1 35.9 35.3 45.1 32.2 34.8 65.6 34.4 44.5 25.2 4.6 6.7 6.4 9.6 10.2 14.4 11.4 11.5 9.9 9.0 9.3 12.5 11.8 5.9 8.2 8.2 10.2 10.3 3.5 31.1 34.2 56.6 41.5 29.7 30.1 27.3 35.9 25.9 23.7 35.7 61.9 121.1 181.3 131.1 88.3 92.4 79.0 108.4 116.0 66.3 47.1 161.4 71.3 89.2 18.7 98.3 69.3 23.3 88.7 198.7 113.7 105.9 126.8 57.1 105.8 60.4 113.1 87.8 125.1 11.5 102.9 123.6 102.9 84.8 92.4 126.7 86.6 57.5 116.7 98.2 71.0 90.5 113.7 152.3 117.7 114.2 145.1 101.2 124.2 156.2 KHDRBS3 "Etle, etoile, SALP, SLM-2, SLM2, T-STAR" ENSG00000131773 "KH RNA binding domain containing, signal transduction associated 3" O75525 8 135457457-135656722 "Predicted intracellular proteins" "Host-virus interaction, mRNA processing, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.4;testis: 79.1" "Group enriched" "Detected in many" 7 "Bipolar cells: 168.5;Early spermatids: 282.4;Late spermatids: 91.3;Spermatocytes: 308.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "eosinophil: 4.1" "Lineage enriched" "Detected in single" 25 "granulocytes: 4.1" "Cell line enhanced" "Detected in many" "REH: 31.4;RPTEC TERT1: 28.3;WM-115: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000275, HPA000500, HPA000981" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA000275: AB_1079183, HPA000500: AB_1079184, HPA000981: AB_2666164" "unprognostic (1.36e-1)" "unprognostic (1.61e-1)" "unprognostic (1.98e-1)" "unprognostic (6.55e-3)" "unprognostic (2.75e-1)" "unprognostic (2.43e-1)" "unprognostic (1.31e-3)" "unprognostic (9.36e-2)" "unprognostic (2.00e-2)" "unprognostic (2.66e-1)" "unprognostic (1.91e-2)" "unprognostic (1.21e-1)" "prognostic favorable (7.16e-6)" "unprognostic (6.63e-2)" "unprognostic (7.85e-2)" "unprognostic (1.07e-1)" "unprognostic (1.33e-3)" 8.0 9.6 16.4 3.3 16.6 1.7 5.8 7.1 34.4 10.3 5.3 8.0 0.9 2.7 4.3 13.4 3.9 4.2 6.8 5.6 16.7 9.8 11.0 7.0 4.5 1.9 11.1 21.7 5.8 5.4 3.5 4.2 1.6 8.7 5.2 5.4 2.6 6.4 7.6 14.7 3.1 3.6 5.1 12.5 1.9 3.7 79.1 7.9 0.9 3.1 1.5 2.7 6.8 4.5 0.1 0.0 4.1 0.0 0.0 0.1 0.0 0.1 0.6 11.5 0.6 2.4 4.6 4.6 7.5 10.5 7.2 3.7 4.0 1.6 0.0 4.1 7.2 0.1 1.0 7.2 7.6 9.8 1.5 12.4 0.0 4.2 8.2 1.9 2.0 26.2 1.0 1.0 3.9 6.0 8.7 5.8 13.5 0.9 19.0 12.7 2.6 0.7 0.4 2.3 6.1 12.5 31.4 15.7 8.1 28.3 0.2 14.8 12.5 0.5 1.6 8.1 7.6 0.5 0.6 0.4 8.9 15.3 0.1 16.2 6.7 0.0 0.0 5.4 0.0 31.3 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 16.6 7.1 34.4 16.7 9.8 11.1 21.7 8.7 7.9 26.8 4.0 1.4 11.3 13.4 168.5 11.4 5.1 1.4 6.8 7.0 0.0 0.4 21.6 11.4 282.4 14.6 2.4 0.0 19.1 1.0 19.3 16.7 4.6 16.3 0.7 6.4 22.5 6.2 2.4 91.3 15.0 2.8 13.5 2.8 7.8 5.3 25.6 2.9 8.1 21.6 13.0 0.0 26.9 308.0 29.7 8.2 1.1 0.0 5.2 6.5 KHNYN KIAA0323 ENSG00000100441 "KH and NYN domain containing" O15037 14 24429286-24441834 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003402 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003402: AB_1079190" "unprognostic (2.95e-1)" "prognostic unfavorable (4.38e-4)" "unprognostic (1.03e-1)" "unprognostic (8.03e-2)" "prognostic unfavorable (5.10e-4)" "unprognostic (4.11e-2)" "unprognostic (1.65e-1)" "unprognostic (2.01e-1)" "unprognostic (1.28e-1)" "unprognostic (1.05e-2)" "unprognostic (5.75e-2)" "unprognostic (1.88e-1)" "unprognostic (1.47e-1)" "unprognostic (8.43e-2)" "unprognostic (1.41e-1)" "unprognostic (6.08e-2)" "unprognostic (2.73e-1)" 18.3 16.7 8.3 24.2 12.8 21.1 18.1 18.9 9.4 21.6 22.4 14.3 25.2 16.9 18.7 19.5 24.3 18.3 28.8 11.2 8.6 5.9 11.8 12.5 16.8 19.2 12.9 7.2 30.7 23.2 17.6 12.8 31.5 11.3 21.5 16.1 10.8 17.0 20.0 15.1 16.9 21.2 24.5 13.6 22.7 24.6 9.3 12.5 20.1 16.1 16.6 26.0 19.7 30.7 6.6 4.5 7.0 5.8 4.5 5.8 3.7 12.6 15.3 12.7 10.1 14.1 13.9 13.5 12.4 14.4 14.4 11.2 9.5 21.8 17.9 7.2 11.0 11.9 12.0 11.2 19.6 10.3 27.2 5.6 8.0 13.7 17.2 15.1 11.6 17.0 14.1 44.2 15.4 19.2 18.6 16.1 13.0 10.3 15.9 8.3 17.0 4.0 7.0 3.4 22.6 13.3 6.4 0.1 8.8 8.7 18.2 9.4 9.9 10.5 6.6 16.3 13.3 7.7 13.1 16.2 12.6 11.3 14.9 7.0 30.7 16.5 11.9 6.9 6.2 11.7 4.7 4.1 7.0 5.8 5.8 3.4 4.6 4.5 4.9 3.1 6.6 3.5 3.3 5.7 4.5 4.8 4.5 4.4 3.7 8.3 12.8 18.9 9.4 8.6 5.9 12.9 7.2 11.3 12.5 11.9 12.3 7.8 20.6 7.9 2.5 2.9 17.8 1.4 7.9 7.0 2.0 17.5 1.7 15.2 0.3 13.4 27.4 0.0 36.6 11.0 8.5 26.7 13.9 7.6 12.3 0.0 10.4 9.2 10.8 2.0 13.0 9.0 11.8 14.4 22.1 8.3 32.5 14.4 10.6 3.3 7.6 12.9 15.6 1.4 1.5 11.2 22.4 12.5 15.3 26.9 KHSRP "FBP2, FUBP2, KSRP" ENSG00000088247 "KH-type splicing regulatory protein" Q92945 19 6413348-6424794 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034739, HPA056518" Supported Enhanced Nucleoplasm NA NA 740000 Nucleoplasm "HPA034739: AB_10601582, HPA056518: AB_2683162" "unprognostic (2.16e-1)" "unprognostic (3.98e-2)" "unprognostic (2.41e-1)" "unprognostic (4.27e-1)" "unprognostic (4.57e-2)" "unprognostic (1.77e-2)" "unprognostic (2.55e-2)" "unprognostic (1.25e-1)" "unprognostic (2.25e-1)" "unprognostic (7.12e-2)" "unprognostic (1.74e-2)" "unprognostic (2.79e-2)" "prognostic unfavorable (2.56e-4)" "unprognostic (1.45e-2)" "unprognostic (1.50e-1)" "unprognostic (9.38e-2)" "unprognostic (2.84e-2)" 40.3 34.3 31.4 34.5 37.2 49.9 27.6 53.8 54.2 38.9 35.6 51.4 23.9 49.5 48.0 27.5 41.5 39.2 33.3 27.4 31.3 27.7 31.0 49.2 27.0 39.3 31.7 29.8 51.0 45.3 18.4 31.4 43.4 28.1 35.0 25.6 39.2 44.4 35.9 43.7 41.8 44.8 30.3 30.3 37.9 36.1 56.3 29.2 73.9 37.8 35.0 33.4 37.7 33.7 8.9 11.5 4.9 7.6 3.1 6.3 3.5 72.0 36.3 34.7 33.7 15.1 16.5 60.4 29.7 19.6 35.2 36.3 73.6 19.7 71.5 46.5 17.2 21.1 39.0 39.5 28.0 28.1 0.3 74.1 46.1 22.5 50.9 26.4 51.6 44.5 21.3 12.7 28.9 23.7 14.6 27.3 33.0 85.6 30.3 21.2 46.0 63.3 51.0 67.5 17.9 51.3 66.9 34.0 45.8 16.3 37.1 41.1 45.5 36.5 25.4 32.2 24.2 30.3 48.2 29.7 28.9 36.2 61.1 58.2 60.6 47.1 54.6 25.4 73.5 33.9 3.2 6.9 4.5 5.7 7.6 6.0 5.9 6.0 6.3 6.4 8.9 4.2 4.5 4.9 3.1 6.3 11.5 4.1 3.5 31.4 37.2 53.8 54.2 31.3 27.7 31.7 29.8 28.1 29.2 8.9 20.3 40.4 19.2 52.2 42.6 12.6 40.8 12.0 25.0 29.6 47.1 31.6 5.0 24.6 57.0 30.1 34.2 23.3 26.5 36.8 31.4 26.2 18.4 39.5 33.0 47.7 55.3 38.1 29.9 19.6 46.9 22.9 25.3 16.2 44.5 35.1 29.9 24.6 43.5 20.3 58.4 25.8 22.3 68.6 52.6 63.2 33.4 16.0 55.7 28.8 KIAA0040 ENSG00000235750 KIAA0040 Q15053 1 175156987-175192999 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Syncytiotrophoblasts: 315.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 32.8;RPMI-8226: 23.3;U-698: 42.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA016895, HPA068812" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA016895: AB_2669476, HPA068812: AB_2686041" "unprognostic (5.98e-2)" "unprognostic (1.43e-1)" "unprognostic (1.77e-1)" "unprognostic (2.99e-2)" "unprognostic (1.01e-2)" "unprognostic (8.54e-3)" "unprognostic (2.91e-1)" "unprognostic (2.87e-2)" "unprognostic (3.83e-1)" "unprognostic (1.21e-1)" "unprognostic (2.66e-2)" "unprognostic (1.63e-1)" "unprognostic (2.53e-2)" "unprognostic (1.49e-1)" "unprognostic (2.57e-1)" "unprognostic (2.28e-2)" "unprognostic (3.05e-1)" 25.7 4.0 2.7 18.4 7.4 5.1 16.0 2.0 3.9 8.0 7.7 1.8 3.5 5.2 8.6 7.9 7.0 9.2 11.0 16.3 3.2 2.9 17.8 12.1 25.3 16.1 6.9 1.0 5.0 17.9 4.6 13.6 45.6 7.6 7.9 5.6 12.2 15.2 4.1 11.1 5.1 10.2 6.0 5.4 27.6 9.8 3.4 3.5 14.8 9.6 7.2 18.6 6.6 10.7 16.5 5.4 26.4 6.1 3.3 9.6 5.4 3.1 0.1 0.1 0.0 0.0 0.0 0.0 1.4 3.8 0.0 0.0 1.6 4.6 32.8 7.8 0.0 0.1 13.2 2.3 15.4 0.0 11.1 1.9 3.5 7.2 0.2 0.4 0.2 0.4 0.0 4.2 0.0 5.9 0.0 5.1 4.8 2.8 5.5 0.0 0.7 4.1 0.0 1.0 2.7 2.8 3.5 1.7 23.3 5.0 7.9 0.2 1.2 2.4 12.9 0.3 8.4 8.2 0.7 2.0 0.0 1.5 0.0 0.3 13.6 16.5 42.2 0.6 0.0 3.5 12.8 6.1 1.0 5.9 3.3 5.3 16.2 6.5 4.9 5.4 16.5 6.9 5.9 26.4 3.3 1.2 1.2 9.6 5.4 2.7 7.4 2.0 3.9 3.2 2.9 6.9 1.0 7.6 3.5 35.7 5.6 53.8 61.7 23.7 0.0 3.1 12.7 20.1 15.9 12.2 0.0 57.4 11.6 11.3 0.5 20.2 11.2 0.0 20.8 5.6 39.4 46.5 10.5 6.0 10.4 0.0 4.1 13.5 10.6 1.2 15.5 16.9 6.8 10.0 5.5 4.3 17.8 14.2 9.9 4.7 0.0 25.8 65.9 0.3 3.3 9.7 315.3 25.4 10.3 30.7 KIAA0141 DELE ENSG00000081791 KIAA0141 Q14154 5 141923808-141942047 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036548, HPA061490" Uncertain Uncertain "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA036548: AB_10673356, HPA061490: " "unprognostic (1.97e-1)" "unprognostic (1.65e-1)" "unprognostic (2.78e-3)" "unprognostic (1.00e-1)" "unprognostic (1.80e-1)" "unprognostic (7.77e-2)" "unprognostic (2.72e-2)" "unprognostic (7.99e-2)" "unprognostic (2.63e-1)" "prognostic unfavorable (6.89e-4)" "unprognostic (1.91e-2)" "unprognostic (1.80e-1)" "unprognostic (2.15e-3)" "unprognostic (7.86e-2)" "unprognostic (1.89e-1)" "unprognostic (4.02e-1)" "unprognostic (2.28e-3)" 26.2 35.7 17.9 28.5 21.0 31.0 27.4 39.6 26.8 24.8 27.2 28.1 33.5 27.3 32.9 29.0 23.5 26.1 29.4 66.5 17.9 16.2 27.0 35.2 28.9 35.6 21.7 25.8 26.2 28.4 25.2 25.2 28.2 22.0 26.2 28.6 23.1 22.1 38.8 40.9 20.1 24.6 27.5 23.2 43.0 26.0 19.0 21.2 19.9 26.9 26.5 24.8 27.6 24.9 10.2 26.2 8.8 28.8 10.9 12.3 10.7 10.0 13.6 20.0 29.3 15.8 21.0 13.3 13.2 21.5 23.1 25.7 19.5 23.7 23.8 15.2 14.3 13.4 15.7 12.0 27.7 12.9 13.6 10.6 14.4 15.8 15.1 20.1 20.4 28.5 25.5 13.9 20.2 16.6 20.8 24.1 5.1 9.1 32.5 11.9 13.1 5.4 11.2 7.7 12.5 21.2 18.6 13.3 26.4 16.7 15.0 11.3 14.3 15.3 24.1 31.2 13.6 31.1 18.4 19.3 17.7 10.8 9.2 11.7 9.1 9.7 14.5 14.4 16.4 19.4 7.7 20.3 6.5 10.4 26.4 9.8 10.2 8.4 10.2 26.2 9.4 7.2 9.2 8.8 10.9 28.8 10.6 12.3 10.7 17.9 21.0 39.6 26.8 17.9 16.2 21.7 25.8 22.0 21.2 11.9 27.4 12.8 15.2 7.2 7.4 0.0 28.1 14.7 10.3 0.0 27.5 22.7 0.0 0.0 0.7 29.7 19.2 0.0 0.0 11.4 12.3 13.8 18.5 25.9 24.6 33.4 20.8 28.3 26.1 1.1 14.7 18.7 15.1 0.0 20.9 4.8 0.0 10.5 8.5 0.0 19.5 12.9 7.2 3.0 5.5 9.4 21.5 15.2 25.0 17.2 KIAA0355 ENSG00000166398 KIAA0355 O15063 19 34254537-34355586 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Ito cells: 122.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 23.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014570 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA014570: AB_1852307" "unprognostic (1.88e-2)" "unprognostic (8.90e-2)" "unprognostic (1.08e-1)" "unprognostic (1.75e-2)" "unprognostic (2.17e-2)" "unprognostic (1.48e-3)" "unprognostic (9.05e-2)" "unprognostic (8.27e-2)" "prognostic unfavorable (2.82e-4)" "unprognostic (2.98e-2)" "unprognostic (3.83e-2)" "unprognostic (1.34e-1)" "unprognostic (7.73e-3)" "unprognostic (2.96e-2)" "unprognostic (1.86e-1)" "unprognostic (1.16e-1)" "unprognostic (1.67e-1)" 19.8 7.2 9.3 10.8 14.7 4.4 19.5 16.3 15.0 12.3 8.5 22.1 9.3 7.5 16.6 9.4 11.3 11.8 13.1 14.0 9.0 8.9 10.2 8.8 14.9 11.7 15.6 11.1 12.5 14.5 18.9 21.8 31.0 15.7 11.2 8.1 16.6 9.4 9.7 17.4 12.2 9.8 12.3 16.2 20.7 8.2 22.2 13.5 8.4 14.1 5.4 12.7 10.7 12.1 6.3 2.0 4.4 3.4 2.6 5.8 1.4 2.3 6.9 6.2 3.2 4.3 4.1 8.2 5.2 4.3 4.0 6.0 5.5 2.8 5.2 11.6 4.8 5.0 1.6 4.6 2.4 4.4 7.4 4.0 3.2 2.7 4.2 5.5 1.4 2.6 4.8 4.3 5.2 7.8 15.9 16.3 2.9 9.5 2.6 4.3 1.2 0.9 1.2 4.7 3.1 2.6 2.3 4.3 2.7 3.3 2.6 7.2 5.9 6.0 23.5 7.6 9.5 1.8 2.6 13.5 13.8 5.2 3.5 5.4 4.5 6.2 1.6 2.6 0.5 6.7 0.0 1.2 0.0 1.8 2.7 2.7 4.7 3.8 1.6 1.5 6.3 3.2 2.0 4.4 2.6 3.4 2.0 5.8 1.4 9.3 14.7 16.3 15.0 9.0 8.9 15.6 11.1 15.7 13.5 23.8 18.8 27.0 6.6 16.5 44.8 10.9 30.6 10.7 7.9 26.2 37.3 18.8 11.6 15.4 3.0 69.9 15.4 23.3 14.6 22.0 19.0 14.8 13.9 29.8 9.5 25.4 60.6 122.2 18.6 3.1 13.8 10.8 18.6 10.8 22.6 16.9 15.1 24.5 14.9 6.9 78.9 12.9 16.5 29.2 43.4 17.1 28.5 20.3 18.0 8.6 KIAA0391 "MRPP3, PRORP" ENSG00000100890 KIAA0391 O15091 14 35121846-35277614 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA020459 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA020459: AB_2670449" "unprognostic (6.44e-3)" "unprognostic (8.10e-2)" "unprognostic (7.71e-3)" "unprognostic (4.90e-2)" "unprognostic (3.42e-2)" "unprognostic (1.74e-1)" "unprognostic (2.76e-2)" "unprognostic (8.67e-2)" "unprognostic (1.94e-2)" "unprognostic (3.25e-4)" "unprognostic (1.75e-1)" "unprognostic (1.80e-1)" "unprognostic (9.67e-5)" "unprognostic (2.56e-1)" "unprognostic (1.67e-1)" "unprognostic (2.10e-2)" "unprognostic (6.65e-2)" 13.9 26.1 18.8 17.6 20.1 12.5 17.5 23.1 21.9 17.4 22.4 20.6 15.6 16.6 13.0 19.4 26.1 14.7 13.2 16.7 17.6 16.3 31.1 29.5 20.9 29.5 20.2 17.7 10.8 16.5 29.8 27.4 13.4 19.2 14.1 24.9 15.8 18.0 21.8 22.2 23.0 16.5 15.0 23.0 18.7 15.8 17.1 20.9 31.2 18.9 21.3 24.8 18.2 16.0 10.0 9.7 10.9 5.4 12.1 25.5 12.4 22.8 18.3 12.7 16.8 13.9 16.5 11.2 15.4 13.8 19.7 17.1 17.3 14.2 25.1 20.1 14.6 5.6 17.8 23.3 26.6 22.3 19.7 7.2 11.3 14.1 36.9 14.4 13.9 12.4 17.6 20.5 18.6 17.2 17.0 28.5 21.6 18.2 7.3 24.0 25.9 21.0 15.3 13.6 19.8 18.1 20.2 21.1 14.5 27.7 23.4 11.8 13.4 19.9 22.1 12.8 17.1 32.2 11.5 21.6 15.2 13.7 11.7 13.2 8.0 18.6 26.3 7.7 15.1 15.9 10.9 5.4 3.4 15.4 5.2 22.4 10.0 23.8 16.6 7.2 7.0 21.2 15.6 6.3 12.1 4.3 9.7 25.5 12.4 18.8 20.1 23.1 21.9 17.6 16.3 20.2 17.7 19.2 20.9 3.0 1.3 1.3 0.5 0.0 1.3 1.5 0.0 1.4 2.3 0.0 0.0 0.8 1.7 1.0 0.0 1.0 1.4 0.0 0.8 0.5 0.8 1.0 2.3 1.6 1.0 0.0 0.0 1.8 0.8 0.0 0.6 0.8 0.0 0.0 0.9 1.2 1.5 0.0 0.4 1.4 1.5 0.0 0.3 0.5 1.1 0.0 0.6 0.0 1.6 0.9 KIAA0408 ENSG00000189367 KIAA0408 Q6ZU52 6 127440343-127459391 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 38.6;smooth muscle: 37.2" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 1: 86.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 12.5;GAMG: 10.9;SCLC-21H: 31.5;SH-SY5Y: 15.6;U-138 MG: 8.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044035, HPA053341" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044035: AB_10964274, HPA053341: AB_2732578" "unprognostic (1.06e-1)" "unprognostic (4.36e-2)" "unprognostic (3.06e-1)" "unprognostic (1.09e-1)" "unprognostic (8.56e-4)" "unprognostic (1.00e-1)" "unprognostic (4.95e-2)" "unprognostic (6.05e-3)" "unprognostic (2.29e-1)" "unprognostic (5.94e-2)" "unprognostic (3.20e-2)" 22.9 3.1 9.1 3.4 6.9 0.0 2.8 12.4 21.0 7.4 12.0 0.6 1.9 1.1 2.6 4.7 16.7 1.1 2.9 2.6 10.2 9.7 0.6 0.7 15.3 0.5 11.5 0.7 3.3 0.5 0.0 6.8 1.1 0.9 20.4 5.0 0.7 1.9 1.7 38.6 0.4 6.7 37.2 13.1 2.0 3.7 3.4 1.2 0.7 1.5 15.4 0.8 25.2 11.3 0.0 0.0 0.0 0.2 0.0 0.9 0.1 0.0 2.9 12.5 0.0 1.1 3.0 0.0 0.3 2.2 1.9 4.5 0.0 0.0 0.0 0.0 0.4 10.9 0.0 1.2 0.0 2.9 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.7 0.0 8.1 0.0 1.4 0.0 1.2 0.0 0.3 2.3 0.0 4.3 0.0 4.2 0.0 0.1 0.0 2.1 0.0 0.7 0.0 31.5 15.6 0.0 0.0 0.3 0.0 0.0 0.9 0.0 8.6 1.4 0.0 2.0 0.0 0.0 0.0 5.0 0.2 6.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.1 6.9 12.4 11.8 10.2 9.7 11.5 0.7 0.9 1.2 86.4 19.0 0.0 0.1 0.0 3.3 0.0 0.0 6.7 5.7 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.2 7.9 0.0 1.3 0.8 0.0 0.9 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.2 0.9 0.1 0.0 0.1 0.0 0.0 0.0 KIAA0513 ENSG00000135709 KIAA0513 O60268 16 85027751-85094230 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 57.6" "Cell type enhanced" "Detected in many" 15 "Horizontal cells: 46.1;Late spermatids: 149.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 15.9;monocytes: 13.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012866, HPA014431" Enhanced Uncertain Nucleoplasm,Cytosol NA NA 8400 "Nucleoplasm, Cytosol" "HPA012866: AB_1852321, HPA014431: AB_1852322" "unprognostic (1.98e-2)" "unprognostic (2.47e-2)" "unprognostic (2.35e-1)" "unprognostic (1.69e-2)" "unprognostic (1.49e-2)" "unprognostic (9.37e-3)" "unprognostic (2.90e-2)" "unprognostic (8.56e-2)" "unprognostic (1.38e-1)" "unprognostic (4.85e-2)" "prognostic favorable (1.72e-5)" "unprognostic (7.52e-2)" "unprognostic (1.94e-3)" "unprognostic (7.88e-2)" "unprognostic (4.00e-1)" "unprognostic (2.33e-2)" "unprognostic (2.34e-1)" 5.2 11.0 20.8 8.8 30.8 14.3 2.8 57.6 57.6 6.9 8.1 4.6 1.8 4.7 3.3 3.1 7.6 2.3 4.9 4.5 19.7 14.9 3.0 1.9 6.7 5.2 11.3 27.6 2.9 13.0 4.1 14.8 4.0 17.6 6.2 6.1 2.9 8.3 5.2 5.6 9.9 6.0 5.6 6.9 7.4 10.1 5.7 4.6 0.5 2.8 1.0 6.2 8.3 3.5 0.0 3.6 15.9 13.6 0.7 0.9 3.1 5.7 6.2 4.2 6.1 7.9 5.9 1.0 5.8 9.3 8.4 4.9 2.8 2.7 2.0 2.6 7.0 5.1 5.1 3.9 9.2 5.2 4.3 3.2 3.7 1.9 1.5 3.8 0.4 5.3 10.9 4.9 9.6 1.2 3.6 4.4 4.1 16.2 4.8 7.4 9.0 0.7 1.5 4.1 6.7 5.0 0.7 5.4 1.2 7.8 4.2 12.4 1.9 6.8 11.4 2.8 4.4 9.2 1.2 8.9 5.2 3.9 7.8 2.0 7.6 1.3 4.1 6.8 2.9 5.6 11.0 7.2 10.6 0.9 8.3 0.3 0.0 0.6 0.6 2.6 0.0 0.6 0.6 15.9 0.7 13.6 3.6 0.2 3.1 20.8 30.8 57.6 45.9 19.7 14.9 11.3 27.6 17.6 4.6 6.0 7.2 3.0 6.5 3.5 13.4 5.8 2.5 1.4 2.3 1.8 5.9 0.4 0.0 2.0 38.3 3.2 5.9 0.0 4.1 0.6 3.9 11.1 2.3 2.4 6.7 46.1 10.9 5.5 18.3 149.1 15.0 8.8 3.3 5.4 8.4 2.5 6.6 7.0 25.1 1.3 5.9 0.0 3.1 3.6 4.9 3.9 2.9 4.4 3.5 26.5 KIAA0586 "JBTS23, Talpid3" ENSG00000100578 KIAA0586 Q9BVV6 14 58427385-58551289 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 76.6;Early spermatids: 97.7;Late spermatids: 81.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000846, HPA050249" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA000846: AB_2234167, HPA050249: " "unprognostic (1.90e-1)" "unprognostic (7.85e-2)" "unprognostic (2.98e-2)" "unprognostic (6.88e-2)" "unprognostic (4.99e-2)" "unprognostic (1.76e-3)" "unprognostic (4.82e-3)" "unprognostic (1.13e-1)" "unprognostic (2.80e-1)" "unprognostic (2.39e-1)" "unprognostic (2.67e-2)" "unprognostic (5.65e-2)" "prognostic favorable (7.20e-4)" "unprognostic (8.10e-3)" "unprognostic (1.77e-1)" "unprognostic (3.41e-1)" "unprognostic (1.13e-1)" 9.5 9.9 10.2 9.2 14.7 9.8 9.9 23.9 13.0 9.9 8.3 7.5 8.0 6.1 9.4 10.7 9.4 7.5 8.3 8.0 12.4 9.6 7.4 11.1 7.9 11.2 15.3 10.7 13.5 8.2 14.6 33.2 6.7 14.5 9.7 11.0 7.0 8.1 8.6 10.4 9.1 8.3 15.8 19.8 9.5 7.6 25.0 14.8 24.5 9.0 7.4 12.7 10.0 8.6 9.1 5.0 13.5 3.6 13.1 10.9 3.1 14.3 10.7 17.8 7.4 12.2 11.0 6.6 13.4 9.5 11.4 10.4 4.3 8.0 17.9 8.5 8.8 5.2 9.2 16.5 8.0 19.6 15.8 6.0 14.6 9.2 12.4 7.2 19.8 10.8 7.0 3.4 9.4 12.4 6.1 13.4 16.4 14.8 9.5 18.4 9.0 10.7 8.5 7.1 9.0 17.4 15.3 20.1 10.8 8.2 6.7 11.1 6.9 13.8 8.3 6.5 9.1 10.6 10.5 12.7 16.9 14.6 9.5 10.6 4.8 8.6 14.3 11.2 14.6 10.5 13.5 2.8 6.1 9.3 2.4 8.6 7.3 9.0 7.1 3.2 9.1 10.9 8.7 3.2 13.1 3.6 5.0 8.5 3.1 10.2 14.7 23.9 13.0 12.4 9.6 15.3 10.7 14.5 14.8 11.9 12.6 13.0 5.3 2.9 27.5 11.3 10.2 29.4 12.5 8.7 76.6 5.9 5.0 5.7 97.7 11.7 3.3 0.0 4.6 6.5 5.6 3.5 19.8 4.3 7.9 30.2 10.3 8.0 7.3 81.1 9.5 6.9 8.5 4.6 6.5 21.5 5.6 2.9 11.3 5.4 50.2 0.0 6.6 51.5 21.3 4.0 4.0 13.8 6.5 3.1 KIAA0895 ENSG00000164542 KIAA0895 Q8NCT3 7 36324221-36390125 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 69.3;Late spermatids: 54.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021036, HPA061066" Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cell Junctions, Cytosol" "HPA021036: AB_2670571, HPA061066: AB_2684423" "unprognostic (4.94e-2)" "unprognostic (9.59e-2)" "unprognostic (2.93e-1)" "unprognostic (1.39e-1)" "unprognostic (8.85e-2)" "unprognostic (1.15e-3)" "unprognostic (3.79e-3)" "unprognostic (3.43e-1)" "unprognostic (3.74e-1)" "unprognostic (4.71e-3)" "unprognostic (1.46e-1)" "unprognostic (3.49e-1)" "unprognostic (4.51e-2)" "unprognostic (6.68e-2)" "unprognostic (3.06e-2)" "unprognostic (2.35e-2)" "unprognostic (5.24e-2)" 1.5 9.9 8.1 1.3 11.0 2.8 5.2 28.9 13.5 3.7 3.0 5.8 6.0 3.0 4.6 9.1 3.6 8.6 4.6 2.6 6.2 8.1 13.1 10.4 4.2 0.7 4.2 8.2 12.7 12.4 18.6 14.7 2.0 8.0 4.6 2.1 6.6 4.1 4.7 2.1 7.8 1.7 4.4 4.7 1.2 14.3 27.1 4.9 2.1 5.5 1.5 0.9 2.3 2.7 0.6 0.5 1.3 0.1 0.5 1.5 0.4 7.3 4.5 9.3 9.1 0.2 0.2 2.1 2.0 2.3 4.4 5.4 1.9 3.8 0.0 2.0 0.4 7.7 4.2 12.0 3.9 3.9 0.6 7.6 0.1 7.0 1.7 1.6 1.2 0.2 1.0 7.1 3.9 5.0 5.4 0.1 4.0 2.9 0.1 0.5 2.4 3.6 2.6 0.4 1.9 1.1 1.4 0.4 0.0 10.1 0.8 28.4 9.9 3.6 8.6 2.6 6.6 8.6 1.3 0.0 0.6 2.2 1.3 2.9 4.2 9.4 0.0 1.8 0.3 2.1 0.8 0.1 0.3 0.1 0.1 1.3 0.3 0.9 0.2 0.1 0.6 1.4 0.6 1.3 0.5 0.1 0.5 1.5 0.4 8.1 11.0 28.9 13.5 6.2 8.1 4.2 8.2 8.0 4.9 6.0 2.4 0.0 4.2 8.7 17.4 2.6 5.1 16.0 3.4 3.5 25.5 1.9 5.0 4.7 69.3 1.1 0.4 0.0 2.5 1.3 0.9 3.6 1.1 5.0 0.4 11.1 8.1 0.0 0.0 54.0 2.6 0.2 3.3 0.0 1.0 5.0 3.7 1.4 0.4 9.4 15.7 6.5 1.0 21.6 12.4 7.5 0.6 0.0 1.0 1.4 KIAA0895L LOC653319 ENSG00000196123 "KIAA0895 like" Q68EN5 16 67175602-67184040 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Bipolar cells: 69.1;Cone photoreceptor cells: 41.2;Early spermatids: 91.4;Horizontal cells: 101.7;Late spermatids: 145.2;Rod photoreceptor cells: 68.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 2.3;plasmacytoid DC: 2.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065996 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA065996: AB_2685593" "unprognostic (8.71e-2)" "unprognostic (1.54e-1)" "unprognostic (8.11e-3)" "unprognostic (2.89e-2)" "unprognostic (2.15e-1)" "unprognostic (4.98e-2)" "unprognostic (1.79e-2)" "unprognostic (4.78e-2)" "unprognostic (4.89e-3)" "unprognostic (2.90e-1)" "prognostic favorable (3.16e-4)" "unprognostic (3.74e-2)" "unprognostic (2.67e-3)" "unprognostic (3.93e-2)" "unprognostic (2.82e-1)" "unprognostic (3.61e-1)" "unprognostic (1.00e-3)" 9.5 20.7 18.1 8.1 19.8 5.2 5.9 46.3 25.0 8.8 6.8 11.5 11.5 10.7 15.4 13.4 6.6 15.0 10.0 7.7 15.1 10.6 9.8 4.6 8.7 3.6 13.0 27.7 21.8 7.6 18.0 24.1 9.5 18.5 10.5 8.8 13.2 8.4 10.3 5.9 9.8 9.5 11.7 16.2 11.0 13.7 13.5 12.4 4.4 13.2 4.3 3.2 7.2 6.8 0.0 2.8 0.0 0.8 0.2 1.1 0.3 2.3 4.1 14.7 9.2 2.7 6.5 9.8 6.4 1.6 2.8 2.6 4.0 2.4 4.4 4.2 2.4 2.5 9.2 4.1 3.5 1.7 4.3 5.7 6.5 10.5 3.8 2.2 2.8 13.3 3.6 1.5 3.5 1.3 10.2 4.6 9.5 6.6 4.3 3.6 3.7 6.7 4.9 3.3 2.2 6.7 18.6 7.2 8.3 4.8 5.6 17.5 14.7 7.2 3.7 1.8 7.0 8.1 4.7 5.4 10.0 7.1 4.6 2.6 5.7 4.6 4.6 12.6 4.3 5.2 0.0 0.8 0.0 0.2 0.7 0.0 0.0 0.9 1.1 2.3 0.0 0.1 0.2 0.0 0.2 0.4 2.8 0.0 0.3 18.1 19.8 46.3 24.1 15.1 10.6 13.0 27.7 18.5 12.4 3.0 9.3 1.7 3.6 2.6 69.1 2.8 5.1 2.7 11.4 7.0 41.2 3.3 3.3 4.8 91.4 3.8 4.2 0.0 2.2 5.4 3.7 5.3 4.6 3.6 3.5 101.7 12.6 9.8 0.6 145.2 6.4 1.7 5.0 1.0 4.4 18.9 3.6 4.5 10.3 1.1 68.7 19.4 3.9 4.7 10.2 2.0 2.5 0.9 5.4 3.7 KIAA1109 "FLJ21404, FSA, KIAA1371, Tweek" ENSG00000138688 KIAA1109 Q2LD37 4 122152333-122362758 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Rod photoreceptor cells: 143.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038076 Approved Approved Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA038076: AB_10670652" "unprognostic (2.53e-1)" "unprognostic (2.04e-2)" "unprognostic (3.52e-2)" "unprognostic (1.09e-1)" "unprognostic (1.63e-1)" "unprognostic (2.63e-3)" "unprognostic (1.04e-1)" "unprognostic (6.62e-2)" "unprognostic (7.61e-2)" "unprognostic (3.65e-2)" "unprognostic (2.38e-1)" "unprognostic (7.97e-2)" "prognostic favorable (4.33e-8)" "unprognostic (2.04e-1)" "unprognostic (3.55e-1)" "unprognostic (2.28e-2)" "unprognostic (2.29e-2)" 18.4 17.1 25.6 18.0 34.1 42.9 26.1 33.4 34.2 22.9 18.7 24.1 17.9 15.6 20.9 25.4 12.3 16.8 16.4 15.3 25.5 22.0 24.0 17.4 19.5 14.8 26.4 26.2 34.3 16.6 68.2 33.1 14.3 33.6 19.1 18.8 22.6 16.6 21.5 40.1 23.1 20.8 18.6 29.3 20.0 15.2 20.4 24.2 15.3 25.4 12.6 13.6 18.0 18.5 3.1 2.3 7.7 3.6 1.7 3.5 0.7 16.4 5.4 12.5 8.3 21.0 27.3 6.5 7.5 14.1 7.7 8.5 4.0 8.7 8.7 4.4 17.6 10.4 6.2 7.7 9.2 12.6 6.5 4.9 9.5 9.8 7.4 10.9 8.9 5.3 15.7 11.1 9.2 12.8 21.1 16.4 9.4 6.2 10.5 15.8 5.5 7.7 7.0 4.2 7.9 5.9 4.4 17.5 2.2 13.6 12.4 7.4 6.6 4.7 5.4 10.5 21.2 5.9 7.3 21.9 9.6 9.6 7.9 7.6 10.2 6.5 6.3 10.2 7.9 7.0 3.3 1.4 7.7 3.3 3.6 3.5 2.5 2.3 2.3 1.4 3.1 2.0 2.3 6.6 1.7 1.7 2.3 2.9 0.7 25.6 34.1 33.4 34.2 25.5 22.0 26.4 26.2 33.6 24.2 80.4 33.9 13.7 17.7 18.5 114.9 62.7 7.6 37.5 44.3 40.1 117.8 8.9 1.7 11.4 26.6 33.8 40.9 23.3 15.1 5.7 21.1 21.2 20.8 21.5 11.1 87.4 20.7 36.2 31.0 20.3 47.5 20.1 15.1 17.2 25.2 59.6 17.8 25.9 47.7 10.5 143.8 32.3 29.9 49.5 31.9 21.3 10.9 32.4 23.9 23.0 KIAA1143 ENSG00000163807 KIAA1143 Q96AT1 3 44737661-44761662 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 149.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045018, HPA061799" Approved Enhanced "Nucleoplasm,Cytokinetic bridge" Yes No Nucleoplasm "Cytokinetic bridge" "HPA045018: AB_10964578, HPA061799: AB_2684614" "unprognostic (1.31e-1)" "unprognostic (2.74e-1)" "prognostic favorable (3.65e-4)" "unprognostic (2.25e-1)" "unprognostic (6.00e-2)" "unprognostic (3.01e-3)" "unprognostic (2.23e-3)" "unprognostic (6.17e-2)" "unprognostic (6.42e-2)" "unprognostic (1.57e-3)" "unprognostic (3.71e-1)" "unprognostic (4.08e-2)" "prognostic favorable (3.26e-6)" "unprognostic (1.82e-1)" "unprognostic (1.85e-1)" "unprognostic (3.19e-2)" "unprognostic (6.46e-2)" 21.7 14.6 19.8 13.2 16.9 9.0 18.8 17.2 21.7 18.9 15.7 13.6 11.9 10.4 19.9 13.3 17.9 16.5 12.8 22.0 19.9 17.9 16.2 11.4 13.6 13.8 21.4 12.7 26.0 16.2 22.2 15.2 14.5 18.8 20.9 12.2 9.1 13.3 15.3 28.9 16.0 14.2 17.9 21.7 16.7 12.7 9.4 16.7 25.0 19.4 16.5 15.8 23.3 17.8 6.6 5.5 9.5 8.7 7.6 7.4 4.5 6.6 4.3 12.4 8.6 8.4 13.2 6.2 7.7 10.8 9.9 10.1 4.4 5.9 16.4 5.9 8.0 4.7 4.7 14.5 8.1 13.1 9.0 4.9 11.9 8.1 5.3 5.8 14.9 8.4 9.4 9.9 10.1 9.6 11.0 8.2 10.2 16.8 9.0 9.6 3.8 16.5 10.5 11.6 7.1 5.6 6.8 11.8 9.2 6.3 5.7 6.2 10.6 8.9 7.0 6.1 8.6 11.6 12.8 9.4 5.5 5.0 14.4 8.7 5.8 16.5 10.0 10.2 14.5 8.0 5.3 5.7 9.5 7.4 6.3 6.5 6.6 6.4 5.9 5.5 6.3 6.8 6.2 5.7 7.6 8.7 3.7 5.3 4.5 19.8 16.9 17.2 21.7 19.9 17.9 21.4 12.7 18.8 16.7 35.7 29.6 39.6 25.1 30.7 17.4 23.8 30.6 32.1 45.5 22.7 7.9 37.2 58.0 37.7 149.2 31.5 17.6 0.0 53.7 48.7 27.7 35.1 37.0 22.9 30.8 14.3 15.0 30.7 39.1 61.4 34.8 35.6 13.5 26.2 22.9 41.7 40.6 23.5 46.3 29.3 12.2 0.0 25.5 46.8 40.9 24.3 47.8 34.8 24.1 36.6 KIAA1191 "FLJ21022, p33MONOX, p60MONOX" ENSG00000122203 KIAA1191 Q96A73 5 176346061-176361968 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Proximal tubular cells: 207.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044701, HPA048145" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA044701: AB_2679053, HPA048145: AB_2680283" "unprognostic (7.59e-3)" "unprognostic (1.08e-1)" "unprognostic (3.85e-2)" "unprognostic (4.94e-2)" "unprognostic (2.27e-2)" "unprognostic (1.32e-2)" "unprognostic (2.46e-1)" "unprognostic (1.48e-2)" "unprognostic (4.39e-1)" "unprognostic (7.10e-2)" "unprognostic (8.93e-2)" "unprognostic (1.73e-1)" "prognostic favorable (9.94e-5)" "unprognostic (5.02e-3)" "unprognostic (1.69e-1)" "unprognostic (2.52e-1)" "unprognostic (1.73e-2)" 16.7 22.0 31.3 11.0 35.5 12.0 19.6 32.4 43.0 22.5 20.6 21.2 19.2 20.8 22.3 24.1 26.6 29.5 17.8 34.3 25.9 28.1 84.1 29.3 20.4 10.9 24.6 28.8 41.6 25.1 24.0 22.9 16.1 30.5 24.5 20.0 24.0 29.3 29.1 29.1 17.8 23.1 24.0 18.9 14.0 25.5 7.5 18.6 10.8 28.5 14.0 17.5 26.4 18.4 17.9 16.1 22.3 19.7 19.1 27.7 19.1 17.1 16.7 30.8 40.1 27.3 20.5 23.6 24.9 24.0 27.7 30.2 33.1 17.4 6.5 33.2 29.7 41.3 15.1 18.8 43.9 33.1 34.5 20.7 7.6 11.7 17.4 31.2 6.7 13.9 20.2 31.3 24.4 20.8 31.3 33.7 10.8 11.5 14.8 29.9 21.9 9.6 4.0 13.3 17.5 21.8 7.2 19.4 5.6 25.9 16.9 23.8 25.7 26.6 13.0 29.5 28.0 18.8 7.1 31.6 25.5 11.7 18.1 29.7 9.6 13.0 7.8 20.4 12.8 19.7 20.1 16.7 22.3 21.8 19.7 24.2 17.9 20.8 20.9 16.1 14.6 22.1 23.1 8.0 19.1 19.0 13.2 27.7 19.1 31.3 35.5 32.4 43.0 25.9 28.1 24.6 28.8 30.5 18.6 50.6 37.1 20.7 37.8 30.2 29.8 54.8 30.6 33.5 39.8 31.4 23.6 18.8 79.6 31.8 1.9 28.9 32.5 0.0 23.9 12.1 24.7 29.2 17.3 41.4 13.8 46.1 41.5 22.1 19.1 5.9 28.7 20.9 20.3 36.1 28.0 25.8 29.8 33.7 36.0 207.7 29.3 12.9 29.2 7.5 6.4 27.7 27.9 17.5 27.1 40.6 KIAA1211 ENSG00000109265 KIAA1211 Q6ZU35 4 56049073-56328625 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 39.9;testis: 27.0" "Group enriched" "Detected in some" 15 "Early spermatids: 102.6;Late spermatids: 87.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.2" "Lineage enhanced" "Detected in single" "B-cells: 1.2" "Cell line enhanced" "Detected in many" "SCLC-21H: 16.0;SH-SY5Y: 34.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043249, HPA048148" Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA043249: AB_2678388, HPA048148: AB_2680286" "unprognostic (1.65e-1)" "unprognostic (1.98e-1)" "unprognostic (7.74e-3)" "unprognostic (1.31e-1)" "unprognostic (6.04e-1)" "unprognostic (6.44e-2)" "unprognostic (1.98e-2)" "unprognostic (3.24e-2)" "unprognostic (1.34e-1)" "unprognostic (3.12e-2)" "unprognostic (1.11e-1)" "unprognostic (1.09e-1)" "unprognostic (8.05e-6)" "unprognostic (1.02e-1)" "unprognostic (6.54e-2)" "unprognostic (2.79e-2)" "unprognostic (2.93e-1)" 1.0 2.1 4.5 4.2 3.7 3.0 0.8 4.2 6.8 2.3 12.6 3.3 3.2 11.8 3.7 3.9 1.0 2.7 14.4 1.6 5.7 7.0 1.6 1.0 1.4 1.8 5.3 3.0 2.2 1.6 7.6 1.9 2.3 13.4 1.6 7.2 4.7 0.9 5.5 0.7 0.9 39.9 4.0 4.8 2.1 2.4 27.0 1.5 0.2 0.8 0.0 1.6 1.5 2.2 1.2 0.3 0.0 0.0 0.0 0.0 0.5 0.0 1.7 6.7 0.5 0.2 0.0 2.4 0.0 0.2 0.3 0.7 1.9 0.2 5.9 0.1 0.0 5.4 0.0 5.6 0.1 0.2 0.5 3.3 3.2 3.0 0.3 0.9 2.7 0.5 0.3 0.1 0.0 0.1 2.2 3.1 5.3 0.0 5.8 0.0 0.8 4.0 0.2 3.6 5.0 4.3 3.9 3.7 0.1 0.0 1.5 16.0 34.2 0.6 0.2 4.1 5.9 1.4 0.3 1.2 0.1 1.7 0.4 1.5 5.8 3.9 0.0 1.7 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.5 3.7 4.2 6.8 5.7 7.0 5.3 3.0 13.4 1.5 0.0 0.0 0.0 0.0 0.1 2.3 2.2 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 102.6 0.0 5.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 6.4 4.7 0.6 0.0 87.5 0.6 0.0 0.0 0.0 0.7 2.7 1.8 0.9 0.4 0.0 0.0 0.0 0.0 1.6 0.7 0.0 0.1 0.0 1.1 0.0 KIAA1217 "DKFZP761L0424, ETL4, SKT" ENSG00000120549 KIAA1217 Q5T5P2 10 23694746-24547848 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 91.1" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 107.7;Club cells: 95.5;Muller glia cells: 121.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.8" "Lineage enhanced" "Detected in single" "T-cells: 2.8" "Cell line enhanced" "Detected in many" "BEWO: 34.0;Karpas-707: 30.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004941 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA004941: AB_2130659" "unprognostic (3.60e-2)" "unprognostic (7.55e-3)" "unprognostic (1.20e-1)" "unprognostic (2.73e-2)" "unprognostic (1.27e-1)" "unprognostic (4.45e-3)" "unprognostic (1.60e-3)" "unprognostic (2.03e-3)" "unprognostic (1.87e-2)" "unprognostic (4.62e-2)" "prognostic unfavorable (7.63e-4)" "unprognostic (2.69e-1)" "unprognostic (1.84e-3)" "unprognostic (5.27e-2)" "unprognostic (2.44e-1)" "unprognostic (2.97e-1)" "unprognostic (1.22e-1)" 24.9 12.7 3.3 6.6 8.7 0.0 21.6 5.5 16.2 10.2 15.1 2.7 18.0 7.5 7.2 16.5 22.6 10.4 11.9 8.6 5.1 3.7 13.5 10.4 8.6 1.4 4.3 8.1 8.4 10.1 34.1 5.5 12.2 8.8 15.1 8.9 16.9 28.8 26.6 91.1 12.0 13.7 4.1 3.8 5.7 10.1 16.8 1.8 3.3 20.5 20.4 8.8 10.1 13.0 0.0 0.0 0.0 0.0 0.9 2.8 0.0 7.6 3.9 1.5 0.0 1.0 2.8 34.0 1.5 2.4 3.5 7.6 6.6 12.3 0.4 7.7 3.0 7.2 12.8 1.9 14.5 3.9 2.8 1.4 0.1 8.9 7.7 1.7 0.0 0.1 10.7 9.4 7.8 2.1 1.6 0.0 0.7 0.0 30.9 1.8 2.7 4.2 0.2 3.5 7.5 3.5 0.3 9.1 6.3 8.3 10.1 1.0 0.5 3.8 12.9 0.0 16.6 6.2 0.0 8.1 5.4 5.9 21.7 1.9 13.8 11.6 0.0 18.1 0.2 0.2 0.0 0.0 0.0 0.5 0.0 2.8 0.0 0.1 0.8 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 3.3 8.7 5.5 16.2 5.1 3.7 4.3 8.1 8.8 1.8 35.7 24.2 0.8 63.7 107.7 12.4 33.1 17.8 32.1 95.5 31.4 7.9 43.5 3.3 26.0 24.9 10.8 21.2 0.0 23.1 16.7 14.6 36.0 1.1 21.2 4.6 0.0 23.0 25.8 10.5 7.0 16.4 2.7 1.7 0.0 21.3 121.7 20.1 22.0 31.1 4.5 2.7 12.9 19.6 0.5 0.7 44.5 54.5 0.7 16.6 47.2 KIAA1468 "FLJ33841, HsT3308, HsT885" ENSG00000134444 KIAA1468 Q9P260 18 62187255-62310217 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039708, HPA040038" Approved Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Nucleoplasm, Centriolar satellite, Cytosol" "HPA039708: AB_10794753, HPA040038: AB_10793860" "unprognostic (1.33e-1)" "unprognostic (2.22e-1)" "unprognostic (3.98e-2)" "unprognostic (2.48e-1)" "unprognostic (1.18e-1)" "unprognostic (4.03e-2)" "unprognostic (1.98e-3)" "unprognostic (2.44e-2)" "unprognostic (6.30e-2)" "unprognostic (3.00e-1)" "unprognostic (5.12e-2)" "unprognostic (2.36e-1)" "unprognostic (4.84e-3)" "unprognostic (2.47e-2)" "unprognostic (6.86e-2)" "unprognostic (3.54e-1)" "unprognostic (1.71e-2)" 11.7 13.3 14.8 15.7 31.6 18.3 17.8 25.7 25.9 14.3 16.5 14.3 16.6 13.8 13.9 18.3 36.5 11.8 13.9 10.3 12.5 14.4 14.8 11.5 11.8 15.8 13.7 16.0 12.8 12.6 20.2 20.0 11.9 22.8 18.5 21.7 13.5 18.8 14.1 11.8 29.6 15.5 11.1 11.4 17.1 18.0 8.0 16.8 18.3 14.4 16.6 22.0 15.5 21.7 3.7 3.5 6.0 3.5 4.0 4.7 1.9 7.7 7.1 8.7 8.3 9.3 11.0 9.3 14.0 11.7 12.6 14.0 3.7 7.3 5.4 7.3 12.3 8.3 16.3 12.4 8.4 15.5 4.9 7.7 4.5 8.0 8.3 8.3 8.6 6.3 8.0 10.3 10.7 6.6 10.4 8.6 5.2 3.4 5.5 13.2 4.5 5.3 7.4 5.1 5.3 6.1 6.6 11.0 6.3 14.4 15.7 12.4 6.6 8.4 12.4 7.2 11.8 6.4 9.4 10.9 13.5 4.2 5.9 6.9 16.1 3.0 5.3 9.5 9.3 10.7 5.0 3.5 4.1 4.1 3.0 3.3 3.0 3.8 3.9 3.5 3.7 4.1 4.7 6.0 4.0 2.5 2.4 4.4 1.9 14.8 31.6 25.7 25.9 12.5 14.4 13.7 16.0 22.8 16.8 14.9 16.3 7.5 6.2 7.6 23.5 8.1 5.1 8.1 14.8 0.0 9.8 5.5 0.0 5.8 0.4 8.3 12.9 23.3 7.4 3.4 5.4 9.4 7.0 7.8 6.3 20.6 12.1 7.4 15.3 0.0 6.9 14.5 10.1 7.2 16.0 5.2 7.1 5.8 7.4 5.0 13.9 6.5 4.7 9.9 4.9 18.7 5.5 9.5 14.3 9.7 KIAA1522 ENSG00000162522 KIAA1522 Q9P206 1 32741885-32774970 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 90.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 38.4;hTCEpi: 32.0;RT4: 35.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA032050, HPA032051, HPA064839" Approved Supported "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "HPA032050: AB_10601764, HPA032051: AB_2674126, HPA064839: AB_2685366" "unprognostic (7.98e-2)" "unprognostic (1.14e-2)" "unprognostic (1.44e-2)" "unprognostic (3.09e-2)" "unprognostic (6.41e-2)" "unprognostic (3.63e-3)" "prognostic unfavorable (6.29e-7)" "unprognostic (1.58e-1)" "unprognostic (1.13e-1)" "unprognostic (5.06e-2)" "prognostic unfavorable (8.25e-5)" "unprognostic (4.55e-2)" "prognostic favorable (1.29e-5)" "unprognostic (1.35e-2)" "unprognostic (1.35e-1)" "unprognostic (3.98e-1)" "unprognostic (2.12e-1)" 3.7 39.4 12.1 8.6 8.7 0.7 14.1 1.6 15.8 8.7 25.9 2.7 27.8 28.1 5.4 8.7 33.8 13.5 28.8 2.3 6.4 4.5 23.1 5.9 13.4 0.8 2.4 6.6 18.0 32.8 21.7 4.8 19.3 7.3 18.5 17.4 10.0 36.9 44.6 1.8 33.4 36.0 6.8 1.6 1.1 25.5 2.9 3.0 3.1 19.2 17.9 20.3 15.0 22.3 0.0 2.1 0.0 1.0 0.0 0.4 0.2 19.4 10.2 1.6 2.8 0.7 1.5 7.6 2.4 4.7 2.8 2.7 11.1 38.4 0.0 10.1 3.5 8.2 29.0 3.1 20.6 1.4 0.0 4.1 4.0 14.5 9.0 1.2 0.0 10.4 0.5 32.0 7.3 8.8 12.5 5.7 0.8 5.8 0.1 1.3 16.1 0.1 0.1 3.4 16.8 6.4 2.6 2.1 4.9 26.5 35.5 1.4 1.4 15.0 21.6 2.9 10.9 23.0 1.3 5.3 4.6 12.6 4.2 5.1 0.2 0.1 0.1 4.7 0.7 5.3 0.0 0.6 0.0 0.0 1.0 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 12.1 8.7 1.6 15.8 6.4 4.5 2.4 6.6 7.3 3.0 11.9 49.9 0.5 31.7 65.7 0.5 3.3 76.5 20.1 23.9 26.2 2.0 12.1 8.3 38.3 3.6 6.7 90.1 0.0 57.6 3.7 5.6 56.0 26.6 8.6 2.5 0.0 27.9 1.3 0.3 3.6 8.1 2.5 6.8 3.6 55.5 0.8 52.7 49.1 4.6 12.5 0.0 6.5 5.0 1.8 2.5 72.6 6.6 1.9 54.5 60.9 KIAA1549L "C11orf41, C11orf69, G2, MGC34830" ENSG00000110427 "KIAA1549 like" Q6ZVL6 11 33376466-33674102 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 24 "brain: 30.4;parathyroid gland: 64.4" "Cell type enriched" "Detected in some" 4 "Melanocytes: 16.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "TIME: 23.0;U-138 MG: 30.4;WM-115: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010132, HPA051594" Approved Nucleoplasm,Vesicles NA NA 27000 Nucleoplasm Vesicles "HPA010132: AB_1078313, HPA051594: " "unprognostic (3.02e-1)" "unprognostic (1.18e-1)" "unprognostic (2.70e-2)" "unprognostic (1.34e-5)" "unprognostic (2.63e-1)" "unprognostic (7.92e-2)" "unprognostic (2.89e-2)" "unprognostic (5.27e-3)" "unprognostic (1.55e-2)" "unprognostic (2.59e-4)" "unprognostic (8.88e-2)" "unprognostic (1.44e-1)" "unprognostic (3.62e-3)" "unprognostic (1.08e-3)" "unprognostic (8.46e-2)" "unprognostic (4.04e-1)" "unprognostic (1.09e-1)" 0.8 0.9 8.2 0.7 20.5 0.6 1.2 6.2 30.4 0.7 0.7 1.7 0.0 0.6 0.7 0.6 0.9 0.6 0.8 0.6 5.3 2.4 0.9 0.6 0.6 0.7 1.6 17.1 0.7 0.8 64.4 1.0 1.4 2.3 0.7 0.7 0.0 0.7 0.6 0.6 1.9 0.6 0.7 1.1 0.6 0.7 1.3 1.6 0.0 0.6 0.0 1.1 0.9 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 3.3 0.1 0.5 3.7 0.0 13.3 7.8 2.1 1.2 0.0 0.3 10.2 0.1 11.7 10.2 0.7 0.4 3.8 3.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 3.3 5.8 7.6 9.5 0.2 0.0 9.7 8.3 0.0 0.1 0.0 0.7 0.0 4.9 0.0 0.8 0.0 0.0 5.1 1.1 1.2 0.1 0.0 3.2 0.1 0.0 0.0 23.0 30.4 6.4 0.7 10.6 0.0 0.0 0.0 8.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.2 20.5 6.2 30.4 5.3 2.4 1.6 17.1 2.3 1.6 0.0 0.0 0.0 0.3 1.8 4.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.6 0.4 0.5 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.3 3.2 0.0 1.8 0.0 0.4 0.0 0.2 16.9 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.3 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.5 KIAA1586 ENSG00000168116 KIAA1586 Q9HCI6 6 57046532-57055239 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 45.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA036370 Approved Approved "Nucleoplasm,Nuclear membrane" No No "Nucleoplasm, Nuclear membrane" "HPA036370: AB_10672219" "unprognostic (7.17e-2)" "unprognostic (3.05e-1)" "unprognostic (1.79e-1)" "unprognostic (1.29e-2)" "unprognostic (2.50e-2)" "unprognostic (1.03e-1)" "unprognostic (3.51e-2)" "unprognostic (1.08e-1)" "unprognostic (2.46e-2)" "unprognostic (4.96e-3)" "unprognostic (2.62e-2)" "unprognostic (1.55e-1)" "unprognostic (1.36e-3)" "unprognostic (5.64e-2)" "unprognostic (8.25e-2)" "unprognostic (1.54e-2)" "unprognostic (1.07e-1)" 7.2 8.7 11.9 5.7 19.7 11.7 9.0 33.8 15.7 9.1 6.8 2.9 6.5 3.6 10.4 6.5 5.7 6.1 7.8 6.0 10.4 8.7 6.1 8.0 5.9 6.9 10.9 9.3 13.3 5.4 9.8 19.7 15.3 12.4 9.1 4.5 2.6 5.0 6.5 4.1 4.3 5.3 7.5 8.4 7.4 4.7 12.5 10.4 6.2 9.6 3.6 6.4 9.0 6.6 5.5 6.3 3.1 4.2 8.2 7.1 3.2 4.9 2.1 13.1 14.9 5.3 8.6 7.3 8.3 6.9 7.3 8.7 3.4 1.6 1.9 6.9 6.1 6.4 2.5 10.0 4.9 10.0 6.2 7.6 20.6 4.8 7.8 6.9 16.5 7.7 6.2 3.6 6.4 7.1 5.2 6.8 5.4 28.3 1.6 8.5 3.9 7.9 10.1 8.5 1.7 3.1 7.3 9.6 4.7 4.8 10.3 11.1 10.3 5.4 1.8 6.2 9.4 4.3 15.0 5.5 11.2 4.7 10.7 5.9 6.6 8.7 9.7 6.9 12.2 4.5 0.3 4.2 3.1 3.9 3.0 4.3 5.5 5.7 4.9 5.9 4.4 7.1 6.0 0.3 8.2 2.8 6.3 6.5 3.2 11.9 19.7 33.8 15.7 10.4 8.7 10.9 9.3 12.4 10.4 8.9 4.6 9.0 4.2 9.3 14.8 20.8 2.5 12.0 7.9 7.0 2.0 36.3 10.0 5.7 45.2 7.1 0.7 0.0 4.7 25.6 16.5 1.6 12.7 3.9 10.7 9.5 5.2 8.0 7.3 18.2 11.8 5.6 3.3 7.2 2.3 8.9 3.2 0.0 13.8 12.4 7.8 19.4 10.3 18.1 18.9 3.9 8.9 7.4 3.3 1.6 KIAA1841 ENSG00000162929 KIAA1841 Q6NSI8 2 61065871-61138034 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 69.6;Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 45.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051240 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA051240: AB_2681401" "unprognostic (1.01e-1)" "unprognostic (1.62e-1)" "unprognostic (2.35e-3)" "unprognostic (1.08e-1)" "unprognostic (1.19e-1)" "unprognostic (1.18e-2)" "unprognostic (5.71e-8)" "unprognostic (1.13e-1)" "unprognostic (5.06e-3)" "unprognostic (7.53e-2)" "unprognostic (6.09e-2)" "unprognostic (8.92e-2)" "unprognostic (7.85e-6)" "unprognostic (8.54e-2)" "unprognostic (1.04e-2)" "unprognostic (3.51e-1)" "unprognostic (2.25e-1)" 5.1 3.6 9.8 3.9 8.9 2.3 4.3 13.3 12.4 10.0 7.1 7.0 1.0 5.5 4.4 6.8 3.8 7.5 3.6 5.2 9.6 11.6 2.6 2.3 8.0 3.2 8.8 12.1 2.4 3.6 3.9 8.2 3.5 20.6 9.6 8.3 3.6 3.6 3.1 3.7 8.5 5.9 5.4 10.1 3.3 5.6 7.5 6.2 3.3 4.0 2.7 3.5 4.3 3.7 1.5 1.2 4.8 2.5 1.4 3.7 0.6 4.6 9.0 11.8 5.1 6.8 7.7 3.7 8.9 2.2 4.6 4.3 2.7 3.0 1.9 2.4 6.8 9.5 5.9 7.5 3.0 6.5 8.1 1.8 1.7 6.2 7.5 3.7 2.1 1.7 3.6 4.9 8.3 2.9 5.3 6.4 2.7 1.7 1.5 12.8 0.4 1.8 1.4 3.7 5.4 1.8 6.0 9.7 0.4 5.8 9.5 7.0 4.4 10.7 2.4 3.2 9.2 1.8 2.5 8.4 7.5 2.8 6.0 6.0 0.8 2.4 2.8 5.4 1.5 5.1 0.8 1.4 4.8 1.3 1.5 1.2 1.5 1.2 0.6 1.2 0.6 0.2 1.0 3.0 1.4 2.5 0.8 3.7 0.6 9.8 8.9 13.3 12.4 9.6 11.6 8.8 12.1 20.6 6.2 6.0 4.3 0.0 2.9 2.3 12.4 6.5 2.5 69.6 15.9 3.5 53.0 0.9 0.0 3.1 2.4 3.8 5.1 0.0 5.4 2.2 6.6 4.4 1.1 1.0 5.0 7.9 7.5 5.5 4.0 1.7 3.4 4.2 3.3 9.0 4.3 4.8 7.6 7.0 1.8 0.5 45.8 0.0 3.6 10.4 19.2 2.9 0.3 2.2 4.5 2.6 KIAA2026 FLJ20375 ENSG00000183354 KIAA2026 Q5HYC2 9 5881596-6007901 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 22.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002109 Uncertain Approved Nucleoplasm,Vesicles,Cytosol No No "Vesicles, Cytosol" Nucleoplasm "HPA002109: AB_1078071" "unprognostic (7.42e-2)" "unprognostic (2.79e-1)" "unprognostic (3.67e-2)" "unprognostic (1.52e-1)" "unprognostic (5.97e-3)" "unprognostic (1.61e-1)" "unprognostic (8.74e-2)" "unprognostic (6.86e-2)" "unprognostic (9.19e-2)" "unprognostic (8.41e-3)" "unprognostic (6.49e-2)" "unprognostic (1.52e-1)" "prognostic favorable (8.34e-4)" "unprognostic (2.41e-1)" "unprognostic (2.07e-1)" "unprognostic (1.76e-1)" "unprognostic (9.00e-2)" 7.0 6.3 10.3 13.7 11.1 6.6 6.7 21.4 12.4 10.2 7.5 8.6 5.7 5.5 9.7 7.0 7.2 6.7 7.4 6.2 11.7 9.0 7.5 5.4 6.4 7.0 16.7 7.1 13.0 6.0 13.9 14.5 8.1 9.9 8.0 5.9 5.9 12.8 15.6 15.3 9.4 6.7 7.7 11.2 9.1 7.8 13.3 12.9 11.0 10.3 3.7 7.5 8.0 17.8 7.0 4.1 9.4 5.9 7.0 7.5 1.2 5.9 2.9 6.0 3.9 4.6 7.4 2.9 4.1 5.7 3.7 3.5 1.9 3.3 7.5 1.5 4.9 4.6 3.0 3.5 3.1 5.6 17.2 2.9 22.4 6.5 2.9 3.6 7.9 10.4 4.5 4.2 3.2 5.4 7.0 5.8 4.7 2.4 13.4 4.7 1.7 4.2 13.6 3.4 3.3 2.5 4.7 3.9 3.8 4.0 3.8 8.3 4.9 3.8 3.3 3.1 4.3 3.4 10.1 6.8 7.1 4.3 3.6 4.4 10.4 8.2 7.5 3.6 3.7 2.0 5.2 3.4 9.4 6.4 2.6 7.3 7.0 6.2 5.7 1.3 6.1 6.8 7.5 8.8 7.0 5.9 4.1 3.6 1.2 10.3 11.1 21.4 12.4 11.7 9.0 16.7 7.1 9.9 12.9 41.7 31.3 33.5 27.5 39.6 86.1 47.2 25.5 16.0 17.0 36.6 74.6 12.9 6.6 15.8 25.2 35.7 26.7 23.3 11.7 8.8 23.6 29.1 18.6 14.5 14.8 42.9 37.0 29.4 26.4 11.5 65.3 26.1 21.9 29.7 28.8 49.5 15.0 30.8 71.8 8.6 74.2 45.3 32.0 129.1 110.7 45.8 25.1 37.4 25.6 35.9 KIDINS220 ARMS ENSG00000134313 "Kinase D interacting substrate 220" Q9ULH0 2 8721081-8837630 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014790 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA014790: AB_1852460" "unprognostic (3.58e-1)" "unprognostic (1.27e-2)" "unprognostic (1.23e-1)" "unprognostic (1.78e-3)" "unprognostic (2.05e-1)" "unprognostic (2.01e-1)" "unprognostic (1.33e-2)" "prognostic favorable (9.64e-4)" "unprognostic (1.68e-1)" "unprognostic (9.21e-2)" "unprognostic (9.74e-2)" "unprognostic (7.39e-2)" "prognostic favorable (9.29e-6)" "unprognostic (4.12e-2)" "unprognostic (1.47e-1)" "unprognostic (9.27e-2)" "unprognostic (1.15e-1)" 16.5 16.4 21.6 9.4 26.9 14.7 14.7 35.3 30.3 16.9 17.2 21.9 7.2 7.8 23.2 11.2 13.0 15.7 12.3 14.7 16.6 8.1 16.0 10.7 16.1 8.2 25.6 15.9 27.5 12.8 45.8 20.2 14.5 25.5 14.5 11.7 11.1 14.8 13.3 17.4 12.7 11.6 17.5 30.3 11.1 14.0 7.1 24.3 11.2 14.9 6.3 8.3 19.6 16.7 3.6 5.1 10.0 8.1 5.7 7.2 3.7 7.1 11.6 23.2 14.8 29.3 19.4 12.2 14.3 11.8 9.1 8.5 11.5 7.4 13.5 14.6 21.3 17.6 12.3 20.8 8.8 13.5 19.3 14.1 12.0 9.0 12.1 20.7 12.4 16.7 20.1 13.9 14.5 19.0 14.1 14.2 11.8 23.4 16.9 16.1 7.9 12.6 6.7 12.6 11.9 10.3 12.1 17.1 6.7 12.1 13.8 19.7 33.2 11.3 11.4 12.8 12.7 7.3 14.3 18.7 20.3 10.7 20.2 15.3 12.5 10.9 18.3 11.8 16.8 15.4 7.4 6.2 7.5 7.2 7.4 5.4 3.6 5.3 6.0 5.1 3.6 5.5 6.1 10.0 5.7 8.1 3.4 4.3 3.7 21.6 26.9 35.3 30.3 16.6 8.1 25.6 15.9 25.5 24.3 92.3 90.8 17.1 22.8 29.1 86.9 34.8 17.8 34.8 60.3 27.9 131.6 14.0 0.0 28.3 1.0 42.5 22.2 46.7 20.3 8.6 44.1 27.7 33.6 26.8 24.5 146.2 41.6 47.9 43.5 3.9 64.5 42.8 23.6 19.0 21.7 76.6 23.5 27.7 61.5 10.9 56.2 6.5 32.3 23.7 25.5 25.7 9.2 27.4 21.8 32.3 KIF12 ENSG00000136883 "Kinesin family member 12" Q96FN5 9 114086126-114099291 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 33.1;kidney: 51.5;pancreas: 42.1" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 101.9;Collecting duct cells: 85.5;Distal tubular cells: 68.0;Intestinal endocrine cells: 61.7;Proximal tubular cells: 57.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 6.5;OE19: 11.2;RPTEC TERT1: 30.9;SCLC-21H: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA020192, HPA024127" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA020192: AB_1852467, HPA024127: AB_1852469" "unprognostic (5.29e-2)" "unprognostic (5.03e-2)" "unprognostic (3.34e-1)" "unprognostic (1.84e-2)" "unprognostic (5.80e-2)" "unprognostic (8.38e-2)" "unprognostic (9.81e-2)" "unprognostic (4.41e-2)" "unprognostic (1.90e-1)" "unprognostic (3.98e-2)" "unprognostic (1.69e-2)" "unprognostic (3.33e-2)" "unprognostic (1.10e-2)" "unprognostic (4.51e-2)" "unprognostic (2.38e-1)" "unprognostic (2.00e-1)" "unprognostic (1.12e-2)" 0.4 0.0 0.8 0.8 1.2 0.0 9.1 0.8 0.6 3.3 5.8 0.4 3.3 11.8 4.7 18.0 0.5 3.8 33.1 0.4 0.4 0.2 51.5 9.8 1.0 0.4 0.4 0.5 1.1 42.1 0.0 0.6 1.3 0.4 2.4 1.7 0.8 1.8 4.2 0.4 0.4 7.3 0.4 0.4 0.4 5.5 1.5 0.4 1.0 11.6 0.4 0.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 6.5 0.1 0.0 3.6 0.0 0.4 0.0 0.1 0.1 0.2 0.0 0.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.3 0.1 11.2 0.4 0.0 0.0 0.0 30.9 0.1 4.5 0.1 0.0 0.6 0.0 0.1 3.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.2 0.8 0.6 0.4 0.2 0.4 0.5 0.4 0.4 0.0 4.1 0.8 0.8 0.0 0.0 0.4 101.9 0.0 0.0 85.5 0.0 0.1 68.0 28.9 5.4 0.0 7.1 0.0 10.4 6.4 0.2 2.2 0.0 7.4 0.3 0.0 61.7 0.0 0.0 9.5 0.6 0.0 0.0 1.8 22.5 0.0 8.1 20.9 0.0 57.8 0.0 0.0 0.0 1.5 4.5 0.0 0.5 0.0 23.4 0.1 KIF17 "KIAA1405, KIF17B, KIF3X, KLP-2, OSM-3" ENSG00000117245 "Kinesin family member 17" Q9P2E2 1 20664014-20718017 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.2;testis: 19.4" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 35.8;Ito cells: 16.5;Late spermatids: 60.3;Sertoli cells: 19.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 2.4;basal ganglia: 5.2;cerebral cortex: 3.6;hippocampal formation: 1.8;hypothalamus: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.8;hTERT-HME1: 8.4;U-2 OS: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA032085 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA032085: AB_10669917" "unprognostic (4.15e-3)" "unprognostic (8.60e-3)" "unprognostic (6.43e-2)" "unprognostic (1.12e-2)" "unprognostic (7.68e-2)" "unprognostic (3.70e-1)" "unprognostic (1.07e-2)" "unprognostic (1.04e-1)" "unprognostic (7.11e-2)" "unprognostic (1.08e-1)" "unprognostic (7.34e-3)" "unprognostic (8.73e-2)" "unprognostic (3.63e-3)" "unprognostic (1.08e-2)" "unprognostic (2.26e-1)" "unprognostic (1.22e-1)" "unprognostic (1.20e-2)" 0.1 0.4 2.4 0.2 5.2 0.1 0.1 0.0 3.9 0.4 0.2 0.4 0.0 0.3 0.4 0.8 0.1 3.1 0.2 0.2 1.8 3.5 0.2 0.1 0.4 0.1 0.4 0.7 0.6 0.1 0.2 1.5 0.7 0.5 0.4 0.1 0.0 0.1 0.8 0.1 0.1 0.2 0.9 0.3 0.1 0.1 19.4 0.0 0.0 0.9 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.5 0.9 0.0 0.0 0.1 0.2 2.7 3.8 1.5 0.9 0.4 1.0 0.0 1.2 2.0 0.7 0.0 1.3 0.9 1.1 0.0 0.3 0.0 0.0 0.4 1.6 0.0 0.0 0.3 0.8 1.0 8.4 1.0 0.0 0.1 0.6 0.0 1.8 0.1 0.0 0.0 2.5 0.1 1.8 0.0 0.1 0.0 0.6 0.0 0.7 1.5 0.5 0.0 0.3 1.6 0.0 0.0 0.0 0.6 5.1 0.5 0.4 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 5.2 0.0 3.6 1.8 3.5 0.4 0.7 0.5 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.6 0.0 2.7 0.0 1.8 3.9 0.1 0.0 0.0 35.8 12.6 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.4 4.0 0.0 0.0 16.5 1.5 60.3 1.1 3.3 1.7 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.3 19.4 1.4 1.5 4.2 1.1 1.4 0.0 0.0 0.1 KIF18B ENSG00000186185 "Kinesin family member 18B" Q86Y91 17 44924709-44947711 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 12.3;lymphoid tissue: 34.7" "Cell type enhanced" "Detected in some" 10 "Cardiomyocytes: 1.6;Extravillous trophoblasts: 3.6;Hofbauer cells: 1.9;Kupffer cells: 1.8;Spermatogonia: 2.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA024205 Enhanced Supported "Nucleoplasm,Nuclear bodies,Microtubule ends,Cytosol" Yes Yes "Nucleoplasm, Microtubule ends" "Nuclear bodies, Cytosol" "HPA024205: AB_1852472" "unprognostic (1.88e-1)" "unprognostic (9.92e-2)" "unprognostic (4.61e-2)" "unprognostic (1.13e-2)" "unprognostic (4.17e-1)" "unprognostic (7.27e-3)" "prognostic unfavorable (2.44e-6)" "unprognostic (3.34e-3)" "prognostic unfavorable (6.90e-4)" "unprognostic (1.98e-1)" "prognostic unfavorable (2.16e-4)" "unprognostic (8.18e-2)" "unprognostic (0.00e+0)" "unprognostic (4.69e-3)" "unprognostic (1.93e-1)" "unprognostic (3.08e-1)" "unprognostic (1.68e-2)" 0.7 0.6 0.5 8.2 0.4 12.3 0.4 0.4 0.5 0.9 1.6 0.3 0.7 2.9 0.5 0.6 3.2 0.3 1.3 1.5 0.5 0.5 0.5 0.7 0.8 5.9 0.6 0.1 0.6 0.4 0.0 0.4 1.9 0.2 0.5 1.5 0.1 0.7 0.1 0.4 2.9 2.5 0.8 0.4 1.7 1.5 3.8 0.1 34.7 0.4 2.7 7.6 0.7 1.1 1.1 0.8 2.0 0.6 1.0 1.4 0.4 14.4 18.8 16.2 15.1 0.4 1.4 13.6 12.4 4.6 15.6 12.3 15.6 12.5 12.8 5.3 4.7 10.0 15.9 11.1 5.0 7.9 26.3 16.6 16.5 21.2 9.6 0.0 13.6 14.5 0.3 0.2 13.5 5.4 2.1 7.9 13.3 12.4 21.8 8.0 11.2 25.3 13.4 11.9 13.1 13.0 19.4 24.7 8.5 2.5 7.9 12.2 11.8 8.3 7.5 4.6 7.8 14.1 9.7 5.2 23.3 23.1 13.7 26.0 7.0 6.9 15.7 7.5 10.4 15.0 1.8 0.6 0.4 0.5 0.3 0.4 0.8 0.7 0.5 0.3 1.1 0.4 0.5 2.0 1.0 0.3 0.8 1.4 0.4 0.5 0.4 0.4 0.4 0.5 0.5 0.6 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.4 0.1 0.0 0.0 1.9 0.0 0.0 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.6 2.5 0.4 0.7 0.5 0.6 0.1 KIF20A RAB6KIFL ENSG00000112984 "Kinesin family member 20A" O95235 5 138178719-138187715 "Predicted intracellular proteins" "Protein transport, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 47.7;testis: 18.2" "Cell type enhanced" "Detected in some" 23 "Erythroid cells: 46.7;Extravillous trophoblasts: 10.5;Spermatocytes: 17.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "NK-cell: 10.0;T-reg: 3.2" "Group enriched" "Detected in many" 64 "NK-cells: 10.0;T-cells: 3.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA036909, HPA036910" Approved Enhanced "Nucleoplasm,Cytokinetic bridge,Cleavage furrow" Yes Yes "Nucleoplasm, Cleavage furrow" "Cytokinetic bridge" "HPA036909: AB_10670245, HPA036910: AB_10671716" "unprognostic (7.50e-2)" "unprognostic (2.43e-1)" "unprognostic (1.39e-3)" "unprognostic (1.21e-2)" "unprognostic (3.47e-2)" "unprognostic (2.60e-2)" "prognostic unfavorable (2.14e-12)" "prognostic unfavorable (6.79e-4)" "unprognostic (2.86e-2)" "unprognostic (3.16e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (9.73e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (9.05e-2)" "unprognostic (2.61e-1)" "unprognostic (1.09e-1)" "unprognostic (3.16e-1)" 2.3 1.7 0.3 3.6 0.4 10.4 0.7 0.3 0.7 1.7 2.7 0.4 0.3 2.7 1.6 2.2 10.7 0.3 0.3 0.8 0.3 0.3 1.2 1.2 2.3 6.7 0.6 0.4 0.8 0.5 0.0 0.3 6.6 0.5 1.0 4.2 0.4 2.0 0.3 0.5 3.5 2.7 4.4 0.5 3.8 2.1 18.2 0.3 47.7 0.5 6.1 11.7 1.8 3.0 0.1 0.0 0.0 0.0 10.0 3.2 0.4 22.2 15.0 33.2 22.0 1.7 3.3 14.3 19.3 17.7 42.1 31.8 28.2 20.8 9.6 10.4 24.3 15.8 22.1 31.1 36.1 42.2 14.0 14.7 14.2 26.8 17.9 0.1 6.9 6.6 1.2 0.6 22.4 12.9 7.1 27.2 13.7 5.9 18.4 29.1 20.4 11.6 6.8 21.0 13.1 16.4 12.8 33.3 9.9 11.5 11.0 9.9 9.8 36.5 12.4 8.5 44.5 15.8 7.2 12.9 11.0 16.4 9.9 32.2 9.5 9.1 10.7 7.1 20.5 21.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.5 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 3.2 0.4 0.3 0.4 0.3 0.7 0.3 0.3 0.6 0.4 0.5 0.3 0.0 1.7 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.6 0.0 0.4 46.7 0.0 10.5 0.4 0.1 4.6 0.0 4.9 0.0 0.0 3.7 1.0 1.0 0.3 0.6 0.0 0.0 0.1 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.0 17.9 4.6 0.4 0.8 0.0 1.6 0.0 KIF20B "CT90, KRMP1, MPHOSPH1, MPP1" ENSG00000138182 "Kinesin family member 20B" Q96Q89 10 89701610-89774939 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 26.2" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 70.0;Spermatocytes: 149.9;Spermatogonia: 96.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA050214 Supported Supported "Nucleoplasm,Cytokinetic bridge,Midbody,Cytosol" Yes Yes "Nucleoplasm, Cytokinetic bridge" "Midbody, Cytosol" "HPA050214: AB_2681053" "unprognostic (2.13e-1)" "unprognostic (3.01e-2)" "unprognostic (1.72e-2)" "unprognostic (3.20e-2)" "unprognostic (2.65e-1)" "unprognostic (7.39e-2)" "unprognostic (8.95e-5)" "unprognostic (3.32e-3)" "unprognostic (2.01e-2)" "unprognostic (8.14e-2)" "prognostic unfavorable (1.21e-4)" "unprognostic (1.62e-2)" "prognostic unfavorable (3.06e-6)" "unprognostic (4.22e-3)" "unprognostic (2.70e-1)" "unprognostic (2.51e-2)" "unprognostic (6.43e-2)" 3.9 2.3 1.3 5.9 6.6 11.1 3.2 12.8 3.0 4.1 3.8 0.7 1.1 4.3 3.4 2.2 7.0 3.3 1.5 2.2 2.1 1.3 2.4 3.2 2.8 9.5 1.6 2.6 4.3 2.0 2.1 3.2 4.0 3.6 2.3 5.1 1.5 3.4 2.0 2.1 4.9 5.5 3.0 3.0 8.0 3.0 10.2 2.6 26.2 2.8 3.9 9.1 2.8 3.8 13.3 4.8 8.3 3.9 2.4 8.6 1.9 36.0 7.4 10.8 9.6 2.1 3.7 9.0 14.8 13.6 15.6 16.4 9.7 16.7 14.0 4.7 7.5 5.8 18.4 12.0 8.3 21.0 16.8 8.2 14.2 12.9 8.4 0.6 24.1 11.8 1.5 1.2 15.0 15.4 5.5 10.0 7.4 13.5 16.2 13.8 6.2 14.1 4.6 11.1 5.9 7.1 9.8 21.3 6.1 4.8 4.8 3.4 6.2 10.6 4.8 5.6 8.1 12.6 7.0 7.8 10.0 10.1 13.0 23.8 4.5 12.2 18.8 9.5 21.5 7.4 8.3 2.3 3.7 5.5 3.9 6.7 11.5 7.4 5.9 1.2 13.3 8.6 8.0 0.1 2.4 3.8 4.8 8.6 1.9 1.3 6.6 12.8 3.0 2.1 1.3 1.6 2.6 3.6 2.6 3.0 15.7 46.6 7.4 15.8 11.8 7.1 2.5 6.7 7.9 0.0 9.8 9.8 3.3 5.1 8.6 7.8 5.9 70.0 4.0 30.5 12.7 3.4 43.8 3.8 17.2 12.7 1.2 8.6 11.6 9.6 7.5 16.4 5.0 9.0 5.4 6.4 2.9 5.7 8.1 2.4 9.1 6.5 15.5 149.9 96.9 12.3 4.3 26.1 13.0 2.2 KIF23 "KNSL5, MKLP-1, MKLP1" ENSG00000137807 "Kinesin family member 23" Q02241 15 69414246-69448427 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 41.8;testis: 20.4" "Cell type enhanced" "Detected in many" 12 "Extravillous trophoblasts: 31.4;Spermatocytes: 47.9;Spermatogonia: 18.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "eosinophil: 7.7" "Group enriched" "Detected in many" 12 "granulocytes: 7.7;monocytes: 2.2;T-cells: 2.1" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB010414, HPA045208, HPA068831" Uncertain Enhanced "Nucleoplasm,Midbody ring,Mitotic spindle" Yes Yes Nucleoplasm "Midbody ring, Mitotic spindle" "CAB010414: AB_631959, HPA045208: AB_2679254, HPA068831: AB_2686045" "unprognostic (1.29e-1)" "unprognostic (2.40e-1)" "unprognostic (5.57e-2)" "prognostic unfavorable (8.62e-4)" "unprognostic (1.86e-1)" "unprognostic (7.99e-3)" "prognostic unfavorable (3.18e-5)" "unprognostic (1.43e-3)" "unprognostic (4.25e-3)" "unprognostic (2.60e-1)" "prognostic unfavorable (3.69e-5)" "unprognostic (5.85e-3)" "unprognostic (0.00e+0)" "unprognostic (1.15e-2)" "unprognostic (2.59e-1)" "unprognostic (1.17e-1)" "unprognostic (9.17e-2)" 1.8 2.6 1.8 12.7 1.3 16.3 3.2 0.3 0.9 2.2 3.3 0.3 1.4 3.5 3.3 1.2 8.8 1.8 2.4 2.2 0.7 0.5 4.9 0.8 2.5 6.7 0.9 0.5 1.6 0.9 0.0 0.3 10.8 1.3 1.9 4.3 0.6 2.1 0.9 0.3 3.0 3.9 3.4 1.4 4.5 3.1 20.4 0.2 41.8 0.6 6.3 8.8 1.8 3.3 0.3 0.1 7.7 2.2 0.1 2.1 0.6 25.2 22.0 16.3 15.6 1.0 1.9 9.9 27.7 15.0 40.2 31.3 13.3 19.8 14.8 8.4 14.3 21.4 29.2 33.6 10.3 40.9 13.7 15.7 13.9 20.6 8.2 0.6 14.3 12.9 0.9 1.1 19.2 16.2 5.1 13.6 12.0 9.2 18.5 25.2 11.1 8.0 7.7 20.2 9.4 8.8 9.1 36.3 8.2 10.6 13.1 8.3 6.9 32.2 14.2 12.1 21.4 13.5 6.5 8.8 24.3 32.4 16.8 40.7 7.2 19.5 13.3 8.6 19.3 21.4 0.0 2.2 7.7 0.0 1.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.1 1.0 0.1 2.1 0.6 1.8 1.3 0.3 0.9 0.7 0.5 0.9 0.5 1.3 0.2 0.0 0.3 0.0 2.6 1.6 0.2 0.8 7.6 1.4 6.8 7.0 2.0 5.9 3.3 1.8 6.3 0.1 1.1 0.0 0.0 31.4 3.1 0.5 2.3 0.0 6.8 0.0 1.7 6.2 3.2 3.2 0.9 2.9 0.0 10.0 2.2 0.1 0.4 0.0 1.8 0.5 0.0 6.5 2.3 47.9 18.3 0.9 2.1 0.8 2.3 1.0 KIF26A "DKFZP434N178, KIAA1236" ENSG00000066735 "Kinesin family member 26A" Q9ULI4 14 104138723-104180894 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 12 "Horizontal cells: 17.5;Intestinal endocrine cells: 7.5;Ito cells: 11.1;Spermatogonia: 7.5" "Group enriched" "Detected in many" 5 "stomach cancer: 3.8;testis cancer: 14.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 17.2;MCF7: 14.6;NTERA-2: 12.8;REH: 11.1;SCLC-21H: 11.9;SH-SY5Y: 24.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA046882, HPA060346" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA046882: AB_2679856, HPA060346: AB_2684259" "unprognostic (3.01e-1)" "unprognostic (3.20e-1)" "unprognostic (3.95e-1)" "unprognostic (1.77e-2)" "unprognostic (2.79e-1)" "unprognostic (1.12e-1)" "unprognostic (5.49e-3)" "unprognostic (1.69e-1)" "unprognostic (1.21e-2)" "unprognostic (3.31e-3)" "unprognostic (5.24e-3)" "unprognostic (7.01e-2)" "prognostic unfavorable (7.78e-4)" "unprognostic (7.96e-2)" "unprognostic (1.72e-1)" "unprognostic (9.12e-2)" "unprognostic (4.68e-3)" 12.0 6.8 1.8 4.9 2.1 5.0 15.9 1.3 3.9 8.9 3.3 1.5 4.9 1.7 5.9 3.9 2.1 3.7 4.9 10.1 1.6 2.6 3.4 2.5 8.5 2.5 1.9 2.8 23.5 9.4 1.6 4.4 6.8 2.0 2.5 1.6 6.9 2.5 4.0 9.1 3.9 2.5 2.3 1.0 9.3 2.5 4.1 0.9 1.9 2.3 5.6 0.9 2.6 8.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.6 2.4 0.0 0.0 4.1 0.2 0.0 0.0 0.0 1.9 0.0 0.0 3.3 0.0 0.4 1.5 1.9 0.0 0.0 0.0 3.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 4.1 0.0 0.0 0.0 14.6 0.0 0.0 12.8 0.1 1.2 11.1 4.9 1.2 0.0 0.0 11.9 24.3 2.6 0.4 0.0 1.6 0.2 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.1 1.3 3.5 1.6 2.6 1.9 2.8 2.0 0.9 0.0 0.0 0.0 0.0 1.0 1.2 2.2 0.0 0.0 0.0 1.8 0.0 0.8 1.7 0.8 0.2 5.4 0.0 0.0 0.2 0.8 3.1 0.1 0.0 0.0 1.9 17.5 7.5 11.1 0.0 0.0 0.0 0.0 1.7 0.0 1.0 0.3 0.2 0.0 0.7 0.0 0.0 0.0 0.2 0.1 7.5 1.5 0.3 0.0 3.3 0.0 KIF2A "HK2, KIF2" ENSG00000068796 "Kinesin family member 2A" O00139 5 62306162-62537249 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis" "Developmental protein, Motor protein" "Cancer-related genes, Disease mutation, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 152.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004715, HPA004716" Approved Enhanced Nucleoplasm,Nucleoli,Centrosome Yes No 2100000 "Nucleoplasm, Nucleoli, Centrosome" "HPA004715: AB_2667215, HPA004716: AB_1079211" "unprognostic (2.40e-2)" "unprognostic (3.43e-1)" "prognostic favorable (1.70e-4)" "unprognostic (2.74e-2)" "unprognostic (1.43e-1)" "prognostic favorable (5.45e-4)" "prognostic unfavorable (3.17e-6)" "unprognostic (8.77e-3)" "unprognostic (4.69e-2)" "unprognostic (9.10e-2)" "unprognostic (1.85e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (3.81e-5)" "unprognostic (3.53e-2)" "unprognostic (2.95e-2)" "unprognostic (1.65e-1)" "unprognostic (1.58e-1)" 11.3 9.3 25.4 21.9 26.4 12.4 15.5 15.4 40.1 19.7 13.5 19.4 8.0 10.3 12.9 7.6 14.3 17.5 13.7 7.2 26.2 24.1 8.2 5.8 10.6 29.4 24.9 24.6 13.0 12.3 15.2 14.3 27.8 37.0 10.2 14.5 6.8 10.7 11.9 7.4 7.9 15.8 13.5 34.3 17.4 9.6 39.2 26.4 28.7 13.0 5.6 26.7 17.4 14.8 9.0 8.4 7.1 3.0 15.8 25.4 9.7 17.3 17.4 29.1 25.8 11.0 15.5 23.8 18.6 15.4 20.3 25.8 18.7 19.1 43.1 20.6 16.4 24.0 11.0 22.0 14.9 27.1 43.2 15.4 43.2 16.3 10.2 13.0 23.5 16.5 12.8 9.9 19.7 17.9 11.9 18.5 24.9 30.6 26.3 16.9 13.1 39.4 11.7 16.9 4.2 11.0 29.0 23.0 23.8 9.1 21.1 26.1 21.7 25.3 10.6 13.1 22.5 13.9 13.3 16.0 12.1 20.0 14.0 18.5 24.9 35.9 45.5 14.0 28.4 14.8 7.1 3.0 3.4 20.2 2.6 22.8 9.0 20.3 20.6 4.0 7.8 17.9 18.4 5.3 15.8 1.8 8.4 25.4 9.7 25.4 26.4 15.4 31.2 26.2 24.1 24.9 24.6 37.0 26.4 14.9 13.1 22.3 22.3 14.9 41.8 7.0 7.6 71.0 25.0 19.2 98.2 16.2 11.6 30.0 88.3 17.5 11.4 0.0 27.0 18.7 10.4 29.9 16.3 3.4 13.1 49.3 20.2 14.7 10.2 90.3 12.0 18.7 11.8 152.3 5.1 22.4 23.3 7.4 12.4 13.5 88.2 25.8 13.3 80.2 42.1 8.3 36.7 39.6 9.5 40.0 KIF2C "CT139, KNSL6, MCAK" ENSG00000142945 "Kinesin family member 2C" Q99661 1 44739818-44767767 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 39.9;testis: 61.4" "Group enriched" "Detected in many" 18 "Early spermatids: 430.2;Late spermatids: 1559.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 5.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA006219, HPA079172" Enhanced Supported Nucleoplasm,Midbody,Centrosome Yes Yes "Nucleoplasm, Centrosome" Midbody "HPA006219: AB_2667540, HPA079172: " "unprognostic (3.29e-2)" "unprognostic (1.35e-2)" "unprognostic (1.03e-2)" "unprognostic (1.71e-3)" "unprognostic (2.77e-1)" "unprognostic (5.17e-2)" "prognostic unfavorable (3.07e-7)" "unprognostic (7.49e-3)" "unprognostic (3.33e-3)" "unprognostic (3.66e-1)" "prognostic unfavorable (6.86e-4)" "unprognostic (4.27e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.33e-3)" "unprognostic (1.49e-1)" "unprognostic (1.86e-2)" "unprognostic (2.41e-1)" 1.1 0.7 0.4 8.7 0.4 12.7 0.8 0.5 0.5 1.2 2.4 0.4 0.2 2.1 1.3 1.4 4.6 0.6 0.7 0.9 0.6 0.5 0.7 0.6 1.6 6.7 0.4 0.2 0.7 0.4 0.3 0.6 2.2 0.6 0.6 3.2 0.4 1.1 0.2 0.4 2.3 2.2 1.1 0.4 3.3 1.4 61.4 0.2 39.9 0.8 4.7 12.0 0.9 1.7 1.3 1.5 0.0 0.2 3.9 5.8 1.0 29.0 11.3 25.3 20.2 1.4 2.9 17.0 21.8 15.6 44.7 39.0 19.1 21.1 33.5 10.5 10.7 30.9 13.9 25.7 14.7 40.9 21.6 11.1 39.6 20.0 15.9 0.1 29.2 18.4 0.7 1.4 31.8 15.6 4.1 14.4 23.8 31.2 28.8 28.2 11.3 30.7 17.7 24.7 14.3 14.2 24.7 38.2 21.0 7.5 10.6 17.4 12.4 29.0 20.7 18.3 19.1 11.9 22.2 8.5 16.2 32.3 17.6 38.2 15.2 15.5 48.3 10.4 28.5 31.2 0.0 0.0 0.0 1.9 0.0 0.1 1.3 3.4 2.6 0.3 0.2 0.7 0.5 0.0 3.9 0.2 1.5 5.8 1.0 0.4 0.4 0.5 0.5 0.6 0.5 0.4 0.2 0.6 0.2 0.0 0.3 0.8 0.5 1.5 1.0 0.8 0.0 0.0 2.3 1.8 2.0 1.1 1.7 0.3 430.2 0.1 0.0 23.3 0.3 20.1 0.7 0.6 0.0 0.0 7.4 0.0 0.0 4.3 1.0 1559.3 8.6 1.3 0.0 7.2 0.9 0.3 0.1 0.0 6.3 0.0 0.2 6.5 0.3 55.1 28.0 0.4 3.1 0.7 1.6 0.4 KIF3A "FLA10, KLP-20" ENSG00000131437 "Kinesin family member 3A" Q9Y496 5 132692628-132737638 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.5" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 131.2;Cone photoreceptor cells: 117.8;Horizontal cells: 174.8;Spermatocytes: 129.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 27.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 27.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB037085 Approved Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA "Nucleoplasm, Intermediate filaments, Cytosol" "CAB037085: AB_477147" "unprognostic (8.22e-3)" "unprognostic (2.58e-1)" "unprognostic (2.29e-3)" "unprognostic (3.59e-2)" "unprognostic (2.51e-1)" "unprognostic (3.80e-1)" "unprognostic (8.21e-4)" "unprognostic (1.30e-1)" "unprognostic (4.71e-2)" "unprognostic (1.46e-1)" "unprognostic (1.44e-2)" "unprognostic (7.64e-2)" "unprognostic (6.08e-3)" "unprognostic (8.62e-2)" "unprognostic (1.92e-1)" "unprognostic (1.17e-1)" "unprognostic (1.23e-1)" 3.4 9.9 19.6 5.0 21.0 2.5 6.6 23.8 54.5 6.2 3.6 8.1 3.2 3.5 6.5 7.1 4.5 8.7 5.3 7.0 28.0 22.9 7.6 2.5 5.7 4.8 18.7 25.5 6.9 4.0 15.8 18.5 4.3 37.7 6.6 3.8 3.8 3.8 6.6 3.5 5.1 3.0 5.7 15.0 3.8 4.9 23.9 11.1 3.5 6.9 0.1 4.7 5.3 3.5 3.4 0.7 27.1 1.1 2.4 4.3 1.1 7.0 8.8 7.8 14.1 5.2 5.2 6.2 5.9 4.6 5.6 7.9 8.5 5.7 19.3 8.2 6.8 16.8 4.6 6.1 11.7 11.7 5.7 7.1 2.8 4.4 3.2 5.2 3.6 7.6 4.0 6.0 8.1 9.1 7.6 7.0 12.4 2.9 11.2 6.8 5.1 22.7 2.7 3.8 2.6 3.3 6.4 6.2 2.3 5.6 6.0 24.2 7.6 8.9 2.9 8.9 13.2 8.9 1.1 7.3 7.0 12.3 5.1 7.1 8.1 11.8 11.1 8.6 2.9 7.7 27.1 0.4 1.1 3.9 0.8 4.1 3.4 4.0 3.6 0.7 2.1 3.9 4.3 0.3 2.4 1.1 0.7 3.0 1.1 19.6 21.0 23.8 32.3 28.0 22.9 18.7 25.5 37.7 11.1 50.6 33.1 5.4 13.8 12.0 70.6 23.3 7.6 131.2 38.7 36.6 117.8 13.0 24.9 16.7 49.7 8.5 0.9 0.0 11.3 9.8 12.6 8.0 12.8 2.4 5.5 174.8 19.0 9.2 3.3 16.3 15.3 5.0 40.5 6.4 3.4 51.3 11.4 2.3 23.0 7.3 94.7 12.9 10.8 129.4 94.9 13.9 8.2 16.0 1.7 6.0 KIF3B "FLA8, KIAA0359, KLP-11" ENSG00000101350 "Kinesin family member 3B" O15066 20 32277664-32335011 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 100.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007119 Approved Uncertain "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA Nucleoplasm "Nucleoli, Golgi apparatus" "HPA007119: AB_1852498" "unprognostic (1.74e-2)" "unprognostic (2.25e-1)" "unprognostic (5.14e-2)" "unprognostic (1.84e-1)" "unprognostic (2.73e-1)" "unprognostic (2.89e-1)" "unprognostic (1.49e-2)" "unprognostic (2.14e-1)" "unprognostic (9.01e-3)" "unprognostic (9.30e-2)" "unprognostic (1.41e-1)" "unprognostic (1.18e-1)" "prognostic favorable (1.44e-12)" "unprognostic (2.41e-2)" "unprognostic (2.68e-1)" "unprognostic (5.11e-2)" "unprognostic (4.42e-2)" 8.4 11.0 22.9 7.7 30.2 5.5 9.1 17.6 24.6 11.6 13.4 13.3 7.7 14.3 8.8 13.5 5.8 15.4 11.0 6.2 19.9 15.1 26.4 17.8 9.3 7.7 15.1 18.7 10.5 16.9 38.5 18.1 6.4 13.2 9.0 14.2 11.8 8.4 8.6 5.3 5.8 17.1 9.0 16.0 6.8 12.7 15.3 13.7 4.3 14.3 4.1 8.4 8.5 6.5 6.5 3.1 3.7 5.9 2.6 6.6 1.8 22.9 15.6 10.9 13.9 14.5 23.1 11.1 11.4 16.0 13.9 10.9 26.5 12.7 12.4 13.8 21.5 19.8 14.9 13.9 16.9 17.7 5.8 6.3 10.7 12.5 13.0 9.2 9.0 8.2 14.1 12.2 23.9 9.5 11.4 11.2 5.0 6.6 4.9 11.1 10.5 4.1 4.1 5.8 12.3 13.7 3.8 17.9 4.5 14.2 17.0 17.9 15.1 29.8 8.0 11.4 9.5 17.6 7.0 13.6 26.1 17.8 15.1 14.1 8.3 11.9 6.4 25.9 15.8 10.5 1.3 3.1 3.7 6.6 4.2 5.5 6.1 5.0 6.1 1.7 6.5 3.1 4.6 3.2 2.6 5.9 3.1 3.9 1.8 22.9 30.2 17.6 24.6 19.9 15.1 15.1 18.7 13.2 13.7 20.8 25.5 9.3 7.3 6.0 31.6 7.0 35.7 53.5 14.8 12.2 100.1 6.5 3.3 29.6 52.5 12.5 61.3 0.0 33.7 5.2 11.0 13.5 8.1 20.4 7.0 30.2 37.8 13.5 7.3 61.7 12.4 5.9 0.0 4.6 25.9 20.6 28.0 33.1 19.1 19.9 58.5 0.0 6.2 30.1 6.9 4.4 5.5 8.6 21.8 7.8 KIF4A "FLJ12530, FLJ12655, FLJ14204, FLJ20631, HSA271784, KIF4, KIF4-G1, MRX100" ENSG00000090889 "Kinesin family member 4A" O95239 X 70290090-70420832 "Predicted intracellular proteins" "DNA-binding, Motor protein" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 11.1;lymphoid tissue: 19.3" "Cell type enriched" "Detected in some" 5 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Lineage enriched" "Detected in single" 5 "T-cells: 3.2" "Low cell line specificity" "Detected in many" "HPA034745, HPA034746, HPA061583" Approved Supported Nucleoplasm,Midbody Yes Yes "Nucleoplasm, Midbody" "HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564" "unprognostic (8.17e-3)" "unprognostic (2.78e-2)" "unprognostic (1.02e-2)" "unprognostic (3.46e-3)" "unprognostic (3.20e-1)" "unprognostic (1.64e-1)" "prognostic unfavorable (7.37e-6)" "unprognostic (2.18e-3)" "unprognostic (5.06e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (9.44e-6)" "unprognostic (3.79e-2)" "unprognostic (0.00e+0)" "unprognostic (3.09e-2)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (1.47e-1)" 0.9 0.6 0.8 3.3 1.0 11.1 0.5 0.4 3.4 1.2 4.1 0.4 0.4 3.4 0.8 0.4 7.4 1.5 2.5 2.0 0.8 1.3 0.7 0.7 1.5 5.8 0.5 0.9 0.4 0.4 0.0 1.3 2.4 0.8 0.7 5.2 0.4 1.2 0.4 0.8 2.3 3.6 1.2 0.5 4.9 2.1 7.5 1.1 19.3 0.4 0.4 7.2 1.1 2.0 0.7 0.0 0.0 0.2 0.2 3.2 0.3 22.5 15.8 23.9 11.7 1.1 2.0 9.4 17.2 9.2 23.5 20.5 17.7 13.3 13.9 10.8 8.4 18.2 13.6 25.8 9.3 26.6 15.9 13.0 15.7 19.3 12.5 0.2 17.4 10.9 0.7 0.5 19.5 11.2 2.8 14.3 10.7 19.9 30.9 22.1 14.5 15.9 8.6 24.1 24.1 16.8 17.7 32.3 13.0 5.6 8.9 15.8 13.2 28.0 11.9 7.3 12.6 9.5 6.8 9.9 15.6 20.3 16.7 20.4 8.9 15.3 20.1 8.2 19.1 23.4 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.4 1.3 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 3.2 0.3 0.8 1.0 0.4 3.4 0.8 1.3 0.5 0.9 0.8 1.1 0.0 0.3 0.0 0.2 1.5 0.0 0.4 2.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.1 0.1 46.7 0.0 10.3 1.0 0.1 0.0 0.0 4.3 0.0 1.2 1.8 0.6 0.5 0.0 0.9 0.0 0.0 1.2 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.2 7.2 5.8 0.3 1.5 0.5 2.1 0.3 KIF4B ENSG00000226650 "Kinesin family member 4B" Q2VIQ3 5 155013755-155018132 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 9.0" "Group enriched" "Detected in some" 7 "Cone photoreceptor cells: 2.0;Early spermatids: 4.7;Late spermatids: 3.1;Spermatocytes: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 2.4" "HPA034745, HPA034746, HPA061583" Uncertain Uncertain Nucleoplasm,Midbody Yes NA "Nucleoplasm, Midbody" "HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564" "unprognostic (9.87e-3)" "unprognostic (1.17e-1)" "unprognostic (3.91e-3)" "unprognostic (1.71e-1)" "unprognostic (9.14e-2)" "unprognostic (1.71e-1)" "unprognostic (4.76e-2)" "unprognostic (1.94e-1)" "unprognostic (1.06e-1)" "unprognostic (4.37e-2)" "unprognostic (6.48e-9)" "unprognostic (7.24e-2)" "unprognostic (5.10e-2)" "unprognostic (1.71e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.3 0.4 0.1 0.0 0.1 0.6 0.0 0.1 0.3 0.0 0.9 0.0 0.5 0.0 0.2 0.5 0.1 0.0 0.1 0.7 0.1 0.4 1.0 0.4 0.0 0.4 0.7 0.0 0.3 0.2 0.0 0.0 1.1 0.6 0.2 2.4 0.4 0.0 0.8 0.5 0.5 0.1 0.5 0.7 1.2 1.0 0.0 0.7 0.5 0.6 1.3 0.2 0.3 0.0 0.5 0.5 0.2 0.8 1.3 0.7 1.2 0.4 0.6 0.5 0.4 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.4 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 KIF5A "D12S1889, MY050, NKHC, SPG10" ENSG00000155980 "Kinesin family member 5A" Q12840 12 57549998-57586632 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Amyotrophic lateral sclerosis, Disease mutation, Epilepsy, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "brain: 138.6" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 36.9;Horizontal cells: 25.4;Late spermatids: 11.4;Spermatogonia: 9.3" "Cancer enriched" "Detected in some" 5 "glioma: 26.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.4;naive CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 20 "T-cells: 2.0" "Cell line enhanced" "Detected in some" "HDLM-2: 20.4;K-562: 8.6;NTERA-2: 10.6;SCLC-21H: 21.8;U-87 MG: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004469, HPA073448" Enhanced Approved "Nucleoplasm,Mitotic spindle,Cytosol" Yes No "Nucleoplasm, Cytosol" "Mitotic spindle" "HPA004469: AB_1079212, HPA073448: AB_2686601" "unprognostic (7.94e-2)" "unprognostic (4.95e-3)" "unprognostic (3.87e-1)" "unprognostic (3.34e-3)" "unprognostic (7.12e-2)" "unprognostic (4.22e-2)" "unprognostic (3.22e-5)" "unprognostic (2.82e-1)" "unprognostic (2.01e-1)" "unprognostic (1.52e-2)" "prognostic favorable (5.23e-4)" "unprognostic (7.61e-2)" "unprognostic (2.26e-4)" "unprognostic (4.75e-2)" "unprognostic (1.46e-1)" "unprognostic (4.12e-1)" "unprognostic (1.51e-1)" 1.8 7.6 85.4 3.0 47.6 1.9 1.9 15.2 138.6 2.1 2.8 4.0 0.0 2.4 3.4 2.1 1.9 2.0 1.9 1.7 52.4 18.3 2.0 1.7 1.8 1.8 12.9 43.6 1.8 2.3 6.0 2.5 1.7 21.6 1.9 2.8 0.6 2.0 2.0 1.7 1.7 3.0 2.8 9.0 1.8 2.1 4.4 12.9 0.0 2.8 0.0 1.8 1.8 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 3.8 3.3 0.0 0.0 0.1 0.2 0.7 1.3 1.7 0.0 0.0 1.6 0.0 0.7 0.6 0.1 2.0 0.0 1.0 20.4 1.5 0.1 0.1 1.6 0.6 0.0 0.1 0.2 0.1 1.0 0.0 0.0 0.2 1.8 8.6 4.5 0.0 0.0 0.3 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 21.8 4.9 0.0 0.2 0.0 0.6 0.4 0.0 0.0 0.0 2.4 0.0 0.9 2.9 3.5 0.3 8.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.4 0.8 0.0 0.0 0.8 2.0 0.0 0.0 0.0 0.0 0.3 0.0 85.4 47.6 15.2 112.0 52.4 18.3 12.9 43.6 21.6 12.9 0.0 0.0 0.0 0.1 0.0 36.9 1.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 25.4 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 5.8 0.2 0.0 0.4 0.0 8.7 0.0 0.9 2.3 9.3 0.1 0.0 0.0 0.0 0.0 KIFC2 ENSG00000167702 "Kinesin family member C2" Q96AC6 8 144466043-144474202 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 36.2;skin 1: 48.2" "Cell type enhanced" "Detected in many" 4 "Intestinal endocrine cells: 22.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "T-47d: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029264 Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA029264: AB_10609999" "unprognostic (2.03e-1)" "unprognostic (1.28e-3)" "unprognostic (3.87e-3)" "unprognostic (4.12e-3)" "unprognostic (4.28e-2)" "unprognostic (1.48e-1)" "unprognostic (2.20e-2)" "unprognostic (3.41e-2)" "unprognostic (2.12e-1)" "unprognostic (9.95e-2)" "unprognostic (2.39e-2)" "unprognostic (4.48e-2)" "unprognostic (1.52e-1)" "unprognostic (1.06e-1)" "unprognostic (2.05e-1)" "unprognostic (8.13e-2)" "unprognostic (2.71e-2)" 4.2 5.1 18.7 4.2 28.4 4.5 3.4 36.2 35.0 3.1 6.3 2.3 6.6 8.8 2.7 5.2 7.0 2.9 4.4 2.2 13.5 7.2 4.7 2.8 3.8 4.8 4.4 16.8 2.1 7.9 9.8 7.9 2.5 8.3 7.2 4.8 2.2 7.5 6.5 2.3 48.2 7.9 2.1 2.6 8.1 8.7 5.2 6.6 1.6 4.1 1.3 3.5 5.0 4.9 0.8 0.1 0.1 0.1 0.0 0.8 0.1 8.0 6.9 3.3 7.4 4.9 2.9 7.9 4.9 3.5 2.6 2.6 2.7 10.0 8.4 2.8 2.7 4.4 16.5 3.3 4.4 1.1 8.5 2.9 5.1 17.0 3.5 6.3 1.4 15.0 3.8 15.7 2.6 3.4 12.5 1.7 8.3 5.5 8.8 2.0 13.8 6.1 4.3 0.5 8.9 10.3 15.3 0.2 5.0 11.0 12.7 10.6 9.7 3.5 10.7 3.9 2.8 28.4 2.8 4.7 5.2 15.7 5.5 4.9 4.3 2.1 2.3 10.1 7.1 2.8 0.0 0.1 0.0 0.5 0.0 0.8 0.0 0.3 0.6 0.1 0.8 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.1 18.7 28.4 36.2 35.0 13.5 7.2 4.4 16.8 8.3 6.6 8.9 9.9 2.2 2.6 5.4 8.9 0.8 7.6 2.7 6.8 14.0 5.9 1.6 1.7 3.2 5.2 0.6 17.3 0.0 1.2 1.5 2.6 3.1 8.1 5.4 2.4 14.3 22.4 2.5 6.2 6.9 7.2 4.8 3.3 1.0 9.9 7.2 2.7 14.0 2.8 4.3 3.3 0.0 1.9 5.1 5.5 9.9 2.5 5.7 9.9 2.6 KIN "KIN17, Rts2" ENSG00000151657 "Kin17 DNA and RNA binding protein" O60870 10 7750962-7787981 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, DNA replication, Host-virus interaction, mRNA processing, Stress response" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016339, HPA038700" Enhanced Nucleoplasm NA NA Nucleoplasm "CAB016339: AB_627860, HPA038700: AB_2676159" "unprognostic (4.33e-3)" "unprognostic (1.24e-2)" "unprognostic (1.66e-2)" "unprognostic (1.40e-2)" "unprognostic (2.94e-2)" "unprognostic (1.31e-1)" "unprognostic (3.17e-3)" "unprognostic (1.30e-2)" "unprognostic (2.58e-1)" "unprognostic (5.59e-2)" "unprognostic (1.11e-1)" "unprognostic (5.40e-3)" "prognostic unfavorable (1.44e-7)" "unprognostic (3.98e-2)" "unprognostic (1.17e-1)" "unprognostic (4.65e-1)" "prognostic favorable (3.23e-5)" 8.5 8.6 9.0 8.2 9.7 9.4 9.0 19.8 11.9 9.5 7.0 10.2 9.1 7.8 11.3 9.9 6.5 8.1 7.2 8.6 7.5 7.8 10.1 12.9 7.4 10.4 9.7 8.2 10.8 10.2 7.7 15.5 10.0 10.6 10.0 7.7 8.4 8.4 8.6 9.1 11.5 10.0 9.1 9.0 10.8 8.1 6.9 9.7 13.6 11.1 7.7 9.7 8.8 8.3 7.0 6.9 13.8 5.1 5.9 5.0 1.8 6.9 4.4 6.8 4.3 5.6 6.8 5.5 6.2 2.8 7.5 8.1 8.5 7.0 5.4 3.3 3.8 2.3 6.7 5.7 3.8 8.7 6.1 6.6 8.5 4.5 8.1 8.0 3.0 6.9 5.6 4.3 5.7 3.8 6.3 5.6 6.9 8.4 5.2 5.8 6.2 6.0 4.7 6.6 7.2 2.7 7.7 4.9 4.9 6.3 3.9 3.0 6.4 4.9 5.0 9.9 6.8 9.1 6.1 4.0 4.9 5.5 8.6 5.0 6.8 7.3 6.7 6.2 4.7 3.3 13.8 4.8 8.0 4.7 5.1 4.7 6.5 4.2 3.9 3.6 7.0 4.8 5.0 10.8 5.9 4.6 6.9 3.4 1.8 9.0 9.7 19.8 11.9 7.5 7.8 9.7 8.2 10.6 9.7 32.8 25.6 13.0 13.7 15.3 52.4 11.1 22.9 30.8 18.2 17.4 37.3 31.0 11.6 26.4 4.2 24.1 15.8 23.3 18.7 21.8 20.6 11.9 15.1 12.4 27.3 60.4 22.3 24.5 18.0 4.3 25.6 22.4 15.1 19.0 17.1 29.5 18.4 20.1 29.0 14.6 53.1 12.9 17.6 28.6 16.7 12.5 32.2 25.4 13.3 13.3 KLC1 "hKLC1B, hKLC1G, hKLC1J, hKLC1N, hKLC1P, hKLC1R, hKLC1S, KLC, KNS2, KNS2A" ENSG00000126214 "Kinesin light chain 1" Q07866 14 103561896-103714249 "Predicted intracellular proteins" "Host-virus interaction" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 117.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB009798, HPA044617, HPA052450" Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "CAB009798: AB_2280879, HPA044617: AB_2679024, HPA052450: AB_2681838" "unprognostic (6.93e-3)" "unprognostic (1.20e-1)" "unprognostic (2.21e-3)" "unprognostic (7.94e-2)" "unprognostic (2.60e-1)" "unprognostic (1.19e-1)" "unprognostic (1.21e-3)" "unprognostic (2.67e-2)" "unprognostic (9.21e-2)" "unprognostic (5.62e-2)" "prognostic favorable (6.75e-4)" "unprognostic (6.84e-3)" "prognostic unfavorable (7.17e-4)" "unprognostic (6.58e-2)" "unprognostic (8.69e-2)" "unprognostic (4.05e-1)" "unprognostic (1.49e-1)" 19.5 20.4 61.3 15.7 45.6 17.6 16.6 103.0 117.9 15.2 14.8 22.4 11.5 10.5 21.1 18.7 19.7 16.0 15.7 27.1 61.0 65.1 8.6 8.9 20.0 15.9 66.2 47.9 19.8 14.8 25.2 17.0 17.9 50.7 16.3 14.1 14.1 16.9 19.7 28.2 22.4 12.8 23.1 56.0 18.3 13.8 14.3 23.2 7.9 13.8 13.0 18.1 15.7 14.9 7.3 10.4 12.4 8.6 4.1 10.9 3.1 16.4 22.1 42.7 23.3 28.9 31.6 19.7 38.8 31.9 36.5 24.9 18.9 18.0 21.8 20.2 41.8 16.2 27.5 26.0 20.5 34.6 26.3 13.1 12.2 26.1 19.1 32.9 23.9 24.3 22.9 33.3 27.5 33.5 38.9 31.3 15.5 18.2 25.1 31.7 27.7 16.0 21.1 13.7 26.3 40.9 15.4 18.0 10.7 22.7 36.5 50.4 28.2 31.5 16.0 25.6 27.6 14.1 11.8 45.5 27.1 13.4 37.1 21.5 20.1 14.0 24.2 31.0 13.8 29.0 7.6 5.8 12.4 10.3 6.0 9.5 6.4 9.3 10.9 6.8 7.3 7.9 7.2 7.0 4.1 8.6 10.4 8.4 3.1 61.3 45.6 103.0 90.3 61.0 65.1 66.2 47.9 50.7 23.2 41.7 27.5 24.9 39.0 23.1 133.1 34.0 22.9 16.0 14.8 19.2 49.1 19.5 8.3 42.1 4.2 42.8 13.0 0.0 26.7 27.4 32.1 34.5 32.4 15.6 26.3 130.3 43.0 31.9 18.1 11.4 35.6 24.1 37.1 46.9 20.2 42.5 49.1 14.4 45.3 3.4 89.3 25.8 40.6 36.8 78.0 15.4 35.2 28.9 14.7 31.8 KLC2 FLJ12387 ENSG00000174996 "Kinesin light chain 2" Q9H0B6 11 66257294-66267860 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 51.7" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 4.6;MAIT T-cell: 6.2;memory B-cell: 3.6;memory CD4 T-cell: 2.2;memory CD8 T-cell: 3.1;naive B-cell: 4.7;naive CD4 T-cell: 2.2;naive CD8 T-cell: 2.7;NK-cell: 2.3;plasmacytoid DC: 4.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040416, HPA040434" Approved Supported "Nucleoplasm,Plasma membrane,Mitochondria,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Mitochondria" "HPA040416: AB_10795524, HPA040434: AB_10795367" "unprognostic (1.29e-1)" "unprognostic (4.95e-3)" "unprognostic (2.99e-1)" "unprognostic (3.24e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (3.16e-4)" "unprognostic (2.43e-3)" "unprognostic (2.45e-2)" "unprognostic (6.27e-3)" "unprognostic (1.60e-1)" "unprognostic (3.49e-2)" "unprognostic (1.64e-3)" "unprognostic (4.57e-3)" "unprognostic (1.96e-2)" "unprognostic (1.81e-1)" "unprognostic (1.72e-2)" "unprognostic (8.08e-2)" 7.5 12.5 15.9 7.9 20.7 2.9 6.6 51.7 49.4 7.4 7.8 7.5 6.5 8.5 11.3 6.0 8.8 9.0 8.0 15.3 20.0 17.4 6.7 2.4 6.6 7.5 13.8 26.0 11.3 11.2 15.4 15.4 6.4 29.0 13.6 4.4 8.2 8.4 15.5 23.8 9.3 7.7 10.1 8.6 6.6 9.8 17.4 10.0 13.5 6.3 4.5 5.6 8.8 8.5 4.7 4.1 0.8 0.4 2.3 6.2 1.5 20.4 25.1 12.2 7.3 7.4 6.0 9.5 14.5 10.4 14.9 11.5 13.6 6.1 9.3 14.0 10.7 19.2 17.3 12.5 14.0 5.0 14.8 15.8 1.8 19.8 9.2 14.3 4.1 9.9 6.0 18.6 17.4 14.2 9.6 6.9 11.2 9.9 12.5 11.8 28.8 23.2 6.2 12.1 5.9 20.9 8.9 6.3 12.6 11.6 11.5 33.4 16.1 10.6 9.5 17.3 7.1 15.7 2.8 11.3 24.5 21.9 29.6 19.0 13.1 10.9 5.0 17.3 2.8 9.8 0.0 0.4 0.8 4.6 0.1 6.2 3.6 2.2 3.1 0.6 4.7 2.2 2.7 0.7 2.3 0.3 4.1 0.6 1.5 15.9 20.7 51.7 49.4 20.0 17.4 13.8 26.0 29.0 10.0 3.0 1.0 5.6 8.0 7.9 32.1 1.4 0.0 5.3 1.2 12.2 11.8 8.8 11.6 15.0 8.9 4.5 2.9 0.0 7.2 16.4 4.8 12.0 0.0 2.1 2.7 52.4 35.6 4.3 4.6 3.4 8.1 2.8 11.8 10.0 5.8 14.1 13.4 3.6 13.1 9.1 26.5 0.0 16.2 24.4 25.6 8.4 10.6 3.3 3.7 7.1 KLC3 "KLC2L, KLCt, KNS2B" ENSG00000104892 "Kinesin light chain 3" Q6P597 19 45333434-45351520 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 39.5;tongue: 25.3" "Cell type enhanced" "Detected in many" 17 "Basal keratinocytes: 126.0;Ductal cells: 38.6;Suprabasal keratinocytes: 160.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 25.8;HaCaT: 12.0;HBEC3-KT: 7.7;hTCEpi: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052797, HPA056508" Approved Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA "Actin filaments" "Nucleoplasm, Cytosol" "HPA052797: AB_2681954, HPA056508: AB_2683159" "unprognostic (4.11e-2)" "unprognostic (3.71e-1)" "unprognostic (3.07e-4)" "prognostic unfavorable (1.46e-4)" "unprognostic (3.47e-3)" "unprognostic (1.13e-1)" "unprognostic (4.42e-2)" "unprognostic (2.29e-1)" "unprognostic (2.53e-1)" "unprognostic (1.75e-2)" "unprognostic (1.49e-1)" "unprognostic (2.74e-2)" "unprognostic (4.79e-3)" "unprognostic (1.94e-1)" "unprognostic (3.55e-3)" "unprognostic (4.14e-1)" "unprognostic (2.37e-1)" 0.1 0.2 0.0 0.2 1.2 1.9 1.9 0.0 0.5 4.0 0.1 0.0 0.0 0.1 0.6 2.9 10.6 0.1 0.2 0.1 0.2 0.0 1.9 0.1 0.7 0.2 0.0 0.0 0.3 4.5 1.5 1.1 0.9 0.5 1.7 0.2 4.0 7.8 2.2 0.6 39.5 0.3 0.0 0.0 0.2 0.2 2.8 0.2 0.3 1.1 25.3 9.2 0.2 7.9 1.5 1.0 3.3 0.9 1.0 1.3 0.6 25.8 0.2 0.1 0.3 0.1 0.1 2.1 0.2 0.0 0.0 0.1 2.6 4.8 0.2 2.1 0.0 2.8 12.0 1.7 7.7 0.1 0.6 3.9 0.1 0.7 0.5 0.0 0.2 1.7 0.0 9.8 0.1 1.9 0.3 0.0 0.4 0.4 0.3 0.1 3.4 0.1 0.4 0.6 0.4 0.8 4.0 0.0 0.2 0.2 0.9 3.4 0.6 0.2 5.5 0.7 0.3 4.8 0.1 0.0 0.3 2.8 0.2 0.3 0.6 0.5 0.2 0.1 0.1 0.3 3.3 0.7 0.6 0.8 0.5 0.7 0.9 1.0 0.9 0.3 1.5 1.0 1.3 2.6 1.0 0.9 1.0 0.8 0.6 0.0 1.2 0.0 0.5 0.2 0.0 0.0 0.0 0.5 0.2 0.0 3.7 0.0 35.4 126.0 0.9 0.4 2.5 2.7 2.3 1.8 0.0 0.2 8.3 38.6 3.0 0.0 0.0 0.0 2.6 0.4 1.2 9.3 0.0 0.0 0.3 1.6 0.0 0.6 0.0 8.5 1.7 1.4 13.5 1.0 0.0 0.8 11.5 0.0 0.4 1.4 1.9 0.0 4.1 0.5 8.3 160.2 0.6 0.0 0.0 19.7 KLF1 EKLF ENSG00000105610 "Kruppel like factor 1" Q13351 19 12884422-12887199 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 30.6;lymphoid tissue: 7.0;placenta: 9.0" "Cell type enriched" "Detected in some" 146 "Erythroid cells: 350.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "classical monocyte: 1.7;intermediate monocyte: 4.7;non-classical monocyte: 2.9" "Lineage enriched" "Detected in single" 8 "monocytes: 4.7" "Group enriched" "Detected in some" 28 "HEL: 23.1;K-562: 55.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA051850 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA051850: AB_2616460" "unprognostic (1.17e-1)" "unprognostic (1.38e-4)" "unprognostic (2.96e-1)" "unprognostic (1.17e-3)" "unprognostic (7.13e-2)" "unprognostic (3.90e-4)" "unprognostic (3.25e-2)" "unprognostic (3.19e-2)" "unprognostic (1.97e-1)" "unprognostic (1.08e-2)" "unprognostic (6.51e-2)" "unprognostic (7.71e-2)" "unprognostic (2.69e-3)" "unprognostic (1.05e-1)" "unprognostic (1.06e-1)" "unprognostic (3.76e-1)" "unprognostic (2.44e-1)" 0.0 0.0 0.5 0.0 0.3 30.6 0.0 0.1 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 1.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.2 9.0 0.3 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 7.0 0.0 0.1 0.0 0.0 0.8 1.2 0.0 0.6 0.0 0.3 0.5 0.5 4.7 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 23.1 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.4 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.3 0.0 0.0 1.7 0.0 0.2 4.7 0.0 0.3 0.0 0.1 0.5 0.1 0.1 0.2 0.5 0.0 2.9 0.0 0.0 1.6 0.5 0.3 0.1 0.4 0.2 0.1 0.2 0.0 0.3 0.0 0.0 0.0 2.2 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 350.4 0.0 1.2 0.0 0.2 0.0 0.0 2.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 KLF11 "MODY7, TIEG2, Tieg3" ENSG00000172059 "Kruppel like factor 11" O14901 2 10042849-10054836 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 120.7;Suprabasal keratinocytes: 75.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058276 Supported "Nucleoplasm,Nuclear bodies,Focal adhesion sites,Cytosol" Yes No Nucleoplasm "Nuclear bodies, Focal adhesion sites, Cytosol" "HPA058276: AB_2683664" "unprognostic (9.66e-3)" "unprognostic (1.87e-1)" "unprognostic (1.59e-1)" "unprognostic (1.06e-2)" "unprognostic (3.02e-3)" "unprognostic (2.63e-3)" "unprognostic (6.34e-2)" "unprognostic (1.04e-2)" "unprognostic (1.67e-1)" "unprognostic (1.04e-1)" "unprognostic (3.17e-3)" "unprognostic (3.08e-2)" "unprognostic (2.48e-3)" "unprognostic (8.96e-2)" "unprognostic (3.44e-1)" "unprognostic (1.07e-2)" "unprognostic (9.24e-2)" 28.7 9.1 2.5 7.0 3.5 11.8 33.1 8.2 4.4 12.9 13.0 5.1 10.8 3.5 12.8 11.7 8.3 11.2 11.6 19.4 2.9 2.3 12.7 27.9 14.6 15.9 5.5 2.4 13.7 38.3 7.3 2.4 9.9 3.4 13.9 4.7 9.2 11.3 10.9 14.0 19.1 7.7 30.4 3.5 16.1 10.2 16.7 2.7 1.5 9.1 8.5 5.6 11.1 42.7 2.9 6.6 1.7 12.7 5.4 2.7 3.8 3.7 1.8 4.4 0.4 3.1 5.5 10.7 4.4 4.5 2.5 2.6 4.3 8.8 0.0 8.0 5.3 10.2 0.9 3.8 3.4 1.7 25.9 2.9 1.9 5.4 0.8 3.0 7.9 12.6 8.6 12.7 4.8 1.3 6.5 2.2 0.7 5.2 17.5 2.5 4.4 0.0 1.4 7.1 3.0 3.8 4.2 0.1 7.3 6.1 4.7 5.7 3.5 6.7 13.9 12.9 7.3 3.2 10.8 6.2 11.1 9.3 8.3 1.4 15.9 18.9 10.2 2.9 2.1 5.9 0.0 6.9 1.7 2.6 11.0 0.8 2.8 1.7 1.8 6.6 2.9 0.5 1.0 0.2 5.4 12.7 0.3 2.7 3.8 2.5 3.5 8.2 4.4 2.9 2.3 5.5 2.4 3.4 2.7 6.0 5.8 3.2 13.5 53.8 5.2 2.8 7.6 5.3 7.9 7.0 5.9 2.4 24.9 7.7 120.7 16.6 3.1 0.0 7.4 3.3 9.7 13.1 8.1 34.1 11.6 3.2 6.8 43.0 29.9 21.5 13.6 21.1 28.7 3.6 6.8 2.3 8.2 0.0 15.6 5.3 4.7 32.3 44.3 14.1 35.0 75.4 6.9 5.7 7.4 9.5 KLF12 "AP-2rep, AP2REP, HSPC122" ENSG00000118922 "Kruppel like factor 12" Q9Y4X4 13 73686089-73995056 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 35.3;Peritubular cells: 26.9;T-cells: 26.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064146, HPA075652" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA064146: AB_2685198, HPA075652: " "unprognostic (1.49e-1)" "unprognostic (7.65e-2)" "unprognostic (7.79e-2)" "prognostic unfavorable (5.03e-6)" "unprognostic (1.35e-1)" "unprognostic (3.01e-1)" "unprognostic (9.22e-2)" "unprognostic (8.59e-2)" "unprognostic (5.19e-2)" "unprognostic (3.70e-2)" "unprognostic (2.60e-2)" "unprognostic (3.47e-2)" "unprognostic (1.01e-3)" "unprognostic (1.07e-1)" "unprognostic (2.18e-1)" "unprognostic (1.02e-1)" "unprognostic (6.67e-3)" 2.1 0.9 0.4 2.9 0.4 0.9 1.9 0.6 3.4 2.1 1.5 0.1 1.7 7.1 0.7 1.1 1.1 3.2 0.4 0.5 2.9 5.8 2.0 6.1 0.5 2.8 0.6 0.0 3.5 0.0 1.2 1.1 0.9 1.4 1.9 1.4 1.2 1.4 1.3 3.9 1.4 1.5 2.1 5.5 1.7 2.1 1.7 0.9 0.9 0.6 2.6 5.1 1.4 0.0 1.0 10.2 0.0 5.7 12.7 0.1 4.0 2.0 4.5 4.7 0.8 2.5 7.6 1.9 6.0 1.8 2.7 2.7 3.1 12.0 4.9 3.7 0.2 4.5 0.0 1.9 5.0 1.9 11.0 0.8 6.3 5.1 8.6 8.8 5.9 0.0 1.9 13.4 0.8 9.6 0.0 1.4 0.3 2.0 5.3 3.7 0.0 2.5 0.2 2.4 10.5 2.8 1.3 4.6 4.0 0.3 0.8 0.0 8.7 2.7 3.9 1.9 5.3 6.7 2.4 15.4 0.0 4.4 0.9 0.1 0.1 4.2 0.4 5.1 1.7 3.7 4.7 0.5 1.4 2.6 4.0 0.0 2.6 0.6 0.9 1.9 1.4 6.0 2.6 10.8 1.3 3.8 16.4 14.6 5.1 4.0 4.5 3.5 35.3 0.0 3.3 1.8 0.5 3.6 0.9 0.0 0.0 0.1 5.1 2.5 0.0 18.1 0.1 7.9 0.0 2.5 6.0 1.1 19.2 3.5 3.3 5.4 0.7 11.7 0.3 2.9 26.9 6.0 12.5 0.0 10.3 0.4 0.4 5.8 0.1 26.6 4.6 1.0 KLF15 KKLF ENSG00000163884 "Kruppel like factor 15" Q9UIH9 3 126342635-126357442 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 25.6;Distal tubular cells: 24.9;Erythroid cells: 23.3;Hepatocytes: 54.2;Peritubular cells: 18.7;Proximal tubular cells: 19.2" "Cancer enhanced" "Detected in many" "liver cancer: 30.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC diff: 33.4;HHSteC: 20.3;RPMI-8226: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003286, HPA028866" Uncertain Supported "Nucleoplasm,Nuclear speckles,Vesicles" NA NA "Nucleoplasm, Nuclear speckles" Vesicles "HPA003286: , HPA028866: AB_10600819" "unprognostic (3.77e-3)" "unprognostic (1.08e-1)" "unprognostic (1.99e-2)" "unprognostic (1.07e-2)" "unprognostic (2.72e-3)" "unprognostic (2.11e-1)" "unprognostic (4.63e-2)" "unprognostic (1.09e-2)" "unprognostic (2.91e-1)" "unprognostic (1.32e-1)" "unprognostic (3.58e-2)" "unprognostic (1.10e-1)" "prognostic favorable (3.27e-7)" "unprognostic (6.75e-2)" "unprognostic (7.65e-2)" "unprognostic (1.91e-2)" "unprognostic (5.58e-3)" 35.0 7.7 11.8 2.3 19.8 1.5 13.8 10.0 14.2 6.1 6.2 11.6 4.4 2.8 7.4 6.0 7.3 10.4 5.1 16.9 15.7 6.0 20.1 32.5 7.1 2.9 24.8 7.0 40.6 46.3 3.2 6.1 3.2 14.6 9.3 2.4 7.0 23.1 7.5 41.0 3.7 3.6 5.8 10.5 4.0 11.1 4.7 22.3 0.0 8.6 4.5 2.3 11.9 22.0 12.2 9.4 18.6 10.4 13.9 12.0 9.1 0.4 0.0 1.2 5.2 33.4 0.6 5.7 0.3 0.8 0.4 0.7 0.6 0.0 1.8 0.5 0.0 1.0 0.0 3.0 0.1 0.1 0.1 1.2 0.1 0.4 4.2 20.3 0.0 0.1 3.1 0.2 0.0 0.7 0.0 0.3 2.5 2.3 4.1 0.1 0.4 0.0 0.7 3.7 0.7 0.1 2.6 0.1 10.9 0.1 0.4 0.4 4.4 0.1 0.2 5.4 1.9 0.3 2.5 0.1 0.1 0.2 0.2 0.1 2.7 0.3 0.4 0.1 0.8 0.7 18.6 7.4 10.2 7.7 10.4 9.3 12.2 8.2 8.1 8.4 11.8 10.7 12.0 17.9 13.9 9.1 9.4 10.7 9.1 11.8 19.8 10.0 14.2 15.7 6.0 24.8 7.0 14.6 22.3 6.0 2.9 1.9 2.3 0.0 1.6 25.6 10.2 1.4 1.2 0.0 0.0 0.1 24.9 0.0 0.1 1.1 0.0 23.3 0.0 0.2 0.9 3.9 0.0 54.2 0.1 0.0 0.0 5.5 2.2 0.6 11.2 0.0 1.7 0.0 0.0 11.0 0.6 0.0 18.7 19.2 3.2 0.0 0.9 0.0 0.1 0.0 0.2 0.0 0.0 1.4 KLF16 "BTEB4, DRRF, NSLP2" ENSG00000129911 "Kruppel like factor 16" Q9BXK1 19 1852399-1863568 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 56.1;Rod photoreceptor cells: 50.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052481 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA052481: AB_2681845" "unprognostic (3.24e-2)" "unprognostic (4.66e-2)" "unprognostic (2.48e-1)" "unprognostic (3.74e-2)" "unprognostic (4.12e-2)" "unprognostic (1.37e-1)" "unprognostic (9.68e-3)" "unprognostic (1.46e-1)" "unprognostic (2.92e-3)" "unprognostic (7.15e-2)" "unprognostic (3.23e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (2.93e-5)" "unprognostic (5.85e-3)" "unprognostic (2.31e-1)" "unprognostic (1.98e-1)" "unprognostic (3.76e-2)" 10.5 9.2 19.5 11.8 32.2 20.3 5.7 7.0 20.8 3.9 12.9 6.2 5.0 15.8 5.8 4.1 9.9 5.1 10.1 4.8 20.6 8.8 7.1 15.1 8.6 14.8 7.8 10.2 10.8 10.1 6.2 10.2 7.0 7.3 5.0 5.6 5.3 6.0 4.7 4.9 9.2 14.2 6.2 6.6 15.9 12.8 6.4 5.8 7.7 3.5 10.1 11.8 4.4 4.2 2.5 9.1 4.8 2.3 0.2 2.1 1.1 16.6 8.9 4.5 9.4 2.7 3.2 9.9 12.8 2.9 5.4 4.8 7.1 7.4 12.4 11.1 8.3 4.9 15.4 6.9 11.6 3.4 18.9 12.1 12.9 4.6 8.4 6.1 12.3 21.9 4.9 7.0 8.8 11.1 6.6 4.6 8.3 15.8 9.7 4.5 12.6 11.4 15.2 14.8 11.0 12.8 17.8 4.2 13.4 5.6 5.7 19.8 16.7 4.5 6.9 14.5 4.4 6.5 15.5 11.2 8.8 13.3 19.9 17.4 13.7 15.6 13.9 9.0 10.7 9.2 1.7 2.3 2.2 1.5 1.9 1.8 2.2 1.8 0.9 1.8 2.5 1.6 1.1 4.8 0.2 1.8 9.1 2.1 1.1 19.5 32.2 7.0 19.3 20.6 8.8 7.8 10.2 7.3 5.8 0.0 7.2 8.7 10.0 23.8 56.1 1.5 5.1 4.0 4.5 3.5 21.6 3.2 1.7 6.2 38.5 10.5 23.9 23.3 7.0 2.5 5.2 8.9 4.6 14.1 11.5 14.3 31.6 10.4 11.4 26.9 4.6 7.5 11.8 5.4 20.1 9.6 9.4 24.6 3.2 4.8 50.1 0.0 4.2 0.9 4.3 23.7 3.3 2.5 15.8 12.3 KLF2 LKLF ENSG00000127528 "Kruppel like factor 2" Q9Y5W3 19 16324817-16327874 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Endothelial cells: 353.6;Ito cells: 251.0;Smooth muscle cells: 179.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 33.3;U-266/70: 22.9;U-266/84: 22.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055964 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA055964: AB_2682989" "unprognostic (3.22e-3)" "unprognostic (1.89e-2)" "unprognostic (3.13e-2)" "unprognostic (1.72e-3)" "unprognostic (1.04e-1)" "unprognostic (7.91e-3)" "prognostic favorable (8.55e-4)" "unprognostic (1.74e-1)" "unprognostic (3.09e-2)" "unprognostic (4.28e-2)" "unprognostic (4.90e-1)" "unprognostic (1.52e-1)" "unprognostic (9.76e-3)" "unprognostic (7.80e-2)" "unprognostic (1.76e-1)" "unprognostic (3.50e-1)" "unprognostic (7.56e-2)" 59.2 17.9 4.4 35.3 6.4 51.2 33.6 3.1 8.7 33.7 16.3 8.5 15.6 6.4 46.3 30.8 28.2 35.3 35.9 29.5 5.2 4.3 12.3 8.1 58.9 64.6 6.3 4.2 54.4 6.6 5.4 9.4 15.9 10.2 26.8 4.9 38.3 10.3 11.1 43.7 19.5 14.4 42.6 7.6 35.6 46.1 23.2 2.5 10.9 16.7 39.4 24.1 50.2 36.1 19.4 1.3 32.0 12.4 10.6 23.5 7.1 3.4 1.1 0.1 0.8 0.2 0.5 1.4 8.3 1.2 3.1 1.3 0.1 11.5 0.3 1.8 4.3 0.6 1.2 0.3 0.0 1.0 0.3 1.4 0.0 0.6 0.1 3.0 0.0 6.0 0.8 0.1 1.0 0.1 4.8 6.9 7.3 0.2 7.5 1.6 0.2 0.7 1.5 0.1 4.9 1.1 0.2 2.2 12.2 0.1 0.2 0.2 0.1 0.6 6.0 4.5 0.0 0.2 4.0 33.3 6.3 4.5 0.4 11.2 22.9 22.0 0.8 2.8 0.0 2.8 21.6 3.3 9.4 17.8 12.4 14.4 17.4 23.5 18.0 1.3 19.4 22.7 18.6 32.0 10.6 10.5 0.2 22.1 7.1 4.4 6.4 3.1 8.7 5.2 4.3 6.3 4.2 10.2 2.5 32.8 89.9 111.6 9.0 21.2 4.3 39.3 7.6 4.0 7.9 3.5 7.9 3.9 0.0 6.4 1.8 353.6 13.6 0.0 5.1 6.9 75.5 10.2 32.4 7.6 71.7 0.0 44.5 251.0 130.3 3.5 82.8 76.1 60.8 0.0 41.9 5.2 38.7 3.5 68.6 1.3 5.9 64.7 179.5 0.9 1.3 23.1 5.5 58.6 4.9 13.1 KLF3 BKLF ENSG00000109787 "Kruppel like factor 3" P57682 4 38664196-38701042 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Urothelial cells: 244.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049512, HPA065054" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA049512: AB_2680799, HPA065054: AB_2685415" "unprognostic (4.20e-1)" "unprognostic (2.08e-2)" "unprognostic (4.70e-3)" "unprognostic (3.77e-2)" "unprognostic (1.36e-1)" "unprognostic (3.02e-2)" "unprognostic (3.20e-2)" "unprognostic (2.33e-1)" "unprognostic (2.57e-2)" "unprognostic (2.15e-1)" "unprognostic (1.02e-3)" "unprognostic (4.10e-2)" "prognostic favorable (4.36e-4)" "unprognostic (9.01e-2)" "unprognostic (1.70e-1)" "unprognostic (1.99e-1)" "unprognostic (3.10e-3)" 23.0 14.3 11.1 14.7 14.4 41.7 25.6 8.9 13.7 20.2 31.2 21.7 10.4 21.0 20.0 14.1 51.9 14.6 39.3 12.0 11.9 8.1 13.2 25.2 21.4 16.6 16.2 8.2 36.1 18.6 21.6 11.4 20.4 13.8 19.0 27.6 12.4 24.0 17.6 12.5 43.1 40.3 18.7 16.7 22.3 25.6 7.9 18.2 6.5 16.4 25.7 34.9 26.1 28.3 4.0 3.1 14.3 10.9 2.7 9.4 2.1 9.5 6.6 25.0 5.0 11.5 17.2 7.9 5.3 15.5 3.6 4.5 6.2 17.7 0.0 7.5 11.5 10.4 10.5 7.1 9.3 5.8 0.1 5.2 9.1 9.7 13.0 11.8 2.2 0.0 15.5 25.8 5.2 9.7 6.8 13.8 3.6 25.9 4.5 5.7 2.2 2.4 4.0 5.8 19.8 4.8 3.2 12.1 10.4 12.8 23.1 7.2 9.3 5.8 4.6 11.1 10.5 2.8 3.2 21.8 12.0 6.8 20.3 5.7 6.3 2.0 0.0 4.9 6.9 5.1 8.8 4.0 14.3 6.3 6.9 4.3 3.7 7.0 5.6 3.1 4.0 9.4 5.6 12.8 2.7 10.9 0.7 7.2 2.1 11.1 14.4 8.9 13.7 11.9 8.1 16.2 8.2 13.8 18.2 20.8 25.6 15.7 113.6 107.8 41.2 15.3 63.7 21.4 23.9 29.6 29.5 23.5 10.0 75.6 0.6 80.0 132.1 140.2 75.2 17.8 67.1 127.0 19.6 48.4 47.0 33.4 83.1 51.0 71.6 1.9 48.1 51.1 47.2 34.3 132.6 51.1 83.4 132.3 45.3 18.4 36.2 25.8 29.9 0.7 0.9 194.5 22.9 35.8 87.7 244.9 KLF4 "EZF, GKLF" ENSG00000136826 "Kruppel like factor 4" O43474 9 107484852-107490482 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 92.1" "Cell type enhanced" "Detected in many" 6 "Mucus-secreting cells: 685.3;Suprabasal keratinocytes: 589.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "classical monocyte: 5.2;intermediate monocyte: 7.4;myeloid DC: 4.4;non-classical monocyte: 2.9" "Group enriched" "Detected in many" 12 "dendritic cells: 4.4;monocytes: 7.4" "Cell line enhanced" "Detected in many" "hTCEpi: 32.8;hTERT-HME1: 20.3;OE19: 17.5;U-2197: 49.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA002926 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA002926: AB_1852541" "unprognostic (2.06e-1)" "unprognostic (1.42e-2)" "unprognostic (1.14e-2)" "unprognostic (2.45e-1)" "unprognostic (1.55e-1)" "unprognostic (6.58e-3)" "unprognostic (3.44e-2)" "unprognostic (6.49e-2)" "unprognostic (3.45e-1)" "unprognostic (1.29e-2)" "unprognostic (1.18e-2)" "unprognostic (1.08e-1)" "prognostic favorable (3.93e-5)" "unprognostic (2.55e-1)" "unprognostic (1.67e-1)" "unprognostic (8.13e-2)" "unprognostic (8.32e-2)" 29.2 8.5 2.7 23.8 3.9 14.4 23.7 1.8 3.5 39.1 28.9 5.6 5.5 10.2 17.8 18.6 34.9 22.0 32.4 18.6 2.4 2.2 4.8 5.1 35.6 4.4 2.7 2.2 18.6 2.3 2.7 2.8 41.0 6.2 11.3 29.6 11.7 11.9 6.5 13.6 92.1 39.4 16.0 3.3 21.8 22.2 11.2 2.0 1.9 7.8 81.1 30.7 16.8 24.1 0.0 4.4 0.4 7.4 0.1 0.0 1.3 5.7 2.3 0.2 0.0 6.0 15.5 2.2 2.0 10.6 2.7 3.2 0.8 7.3 0.0 0.3 2.6 9.4 4.2 2.6 1.5 1.0 0.0 1.1 0.0 4.0 0.1 9.0 0.0 0.0 2.0 32.8 5.5 20.3 0.6 0.2 0.1 0.2 0.0 1.5 3.7 0.0 0.7 1.8 17.5 11.5 0.1 0.6 0.1 0.8 1.6 0.1 0.1 1.6 4.8 6.0 4.8 0.7 2.5 1.2 1.6 0.0 49.8 0.8 0.0 0.0 0.0 1.6 1.0 2.8 0.0 5.2 0.0 0.0 7.4 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.4 0.1 2.9 0.4 0.0 1.3 2.7 3.9 1.8 3.5 2.4 2.2 2.7 2.2 6.2 2.0 11.9 47.4 12.3 228.3 387.3 0.4 56.5 17.8 18.7 29.6 1.8 7.9 33.0 1.7 21.1 201.9 242.7 430.0 0.0 34.8 55.7 240.7 170.1 55.2 3.9 80.6 0.0 118.8 142.4 148.1 123.4 133.2 214.3 195.7 12.6 685.3 1.7 32.1 447.5 57.0 1.2 1.8 38.8 108.2 4.1 15.1 589.1 90.3 5.3 253.4 169.8 KLF5 "BTEB2, CKLF, IKLF" ENSG00000102554 "Kruppel like factor 5" Q13887 13 73054976-73077542 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 88.4;intestine: 88.1" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 1017.1;Suprabasal keratinocytes: 599.6;Urothelial cells: 1225.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "basal ganglia: 22.2" "Cell type enriched" "Detected in single" 18 "basophil: 16.3" "Lineage enriched" "Detected in single" 106 "granulocytes: 16.3" "Cell line enhanced" "Detected in many" "CAPAN-2: 27.5;HaCaT: 31.5;HBEC3-KT: 27.5;hTCEpi: 39.3;OE19: 59.4;RT4: 33.2;SiHa: 28.0" "Group enriched" "Detected in many" 4 "amygdala: 5.6;basal ganglia: 9.3;cerebral cortex: 6.9;hippocampal formation: 8.8;hypothalamus: 4.3" "Low region specificity" "Detected in some" HPA040398 Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "HPA040398: AB_10673267" "unprognostic (7.90e-3)" "unprognostic (5.11e-2)" "unprognostic (2.03e-2)" "unprognostic (1.56e-1)" "unprognostic (4.69e-2)" "unprognostic (2.75e-1)" "unprognostic (1.18e-1)" "unprognostic (3.97e-2)" "unprognostic (5.82e-1)" "unprognostic (1.47e-2)" "prognostic unfavorable (2.55e-4)" "unprognostic (4.43e-2)" "unprognostic (1.42e-3)" "unprognostic (3.56e-3)" "unprognostic (3.98e-1)" "unprognostic (5.09e-2)" "unprognostic (1.54e-2)" 2.3 1.5 4.1 24.3 22.2 12.9 8.1 0.7 1.2 19.6 74.4 0.4 4.3 28.7 4.8 3.7 88.4 8.3 48.4 1.3 1.4 1.2 3.9 1.2 12.8 0.1 0.9 1.1 5.0 3.5 0.0 7.3 22.8 4.3 17.6 32.9 1.8 26.4 5.4 10.0 59.4 88.1 4.1 2.4 0.8 17.9 12.2 1.4 3.0 20.7 64.4 61.8 23.4 34.1 0.0 0.0 16.3 0.0 0.0 0.1 0.0 5.3 7.4 0.0 0.1 0.2 0.4 8.5 3.1 7.3 1.4 1.7 6.9 27.5 0.1 16.7 2.7 0.5 31.5 9.6 27.5 2.2 0.2 2.5 0.1 15.7 0.6 2.0 2.5 0.4 2.0 39.3 0.4 15.4 1.4 0.0 0.9 0.3 0.5 6.3 1.8 0.5 0.1 0.3 59.4 10.6 0.4 7.0 0.6 21.8 33.2 0.7 0.3 28.0 4.5 1.9 3.6 0.6 0.6 0.0 1.9 5.7 0.0 1.3 0.9 0.4 0.9 2.7 0.5 2.3 16.3 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 4.1 22.2 0.7 1.2 1.4 1.2 0.9 1.1 4.3 1.4 151.8 97.6 0.5 1017.1 460.9 0.4 5.6 79.0 128.5 151.2 34.9 2.0 57.7 18.3 30.8 305.6 1.1 308.2 0.0 40.2 87.3 46.1 522.9 3.5 2.9 5.4 9.5 195.2 0.6 0.0 162.5 6.1 6.1 55.6 5.4 327.8 0.0 63.9 284.0 1.4 2.6 0.0 0.0 28.8 7.2 25.9 599.6 48.5 0.7 397.9 1225.4 KLF6 "BCD1, COPEB, CPBP, GBF, PAC1, ST12, Zf9" ENSG00000067082 "Kruppel like factor 6" Q99612 10 3775996-3785281 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Basal glandular cells: 1442.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013529, HPA069585" Supported Supported Nucleoplasm,Nucleoli,Vesicles,Cytosol No No Nucleoplasm "Nucleoli, Vesicles, Cytosol" "CAB013529: AB_2533431, HPA069585: AB_2686157" "unprognostic (1.23e-1)" "unprognostic (1.53e-2)" "unprognostic (1.47e-3)" "unprognostic (4.53e-2)" "unprognostic (1.47e-1)" "unprognostic (7.55e-2)" "unprognostic (2.00e-1)" "unprognostic (1.08e-3)" "unprognostic (1.61e-1)" "unprognostic (2.83e-2)" "unprognostic (1.36e-2)" "unprognostic (2.35e-2)" "prognostic favorable (2.28e-4)" "unprognostic (8.07e-3)" "unprognostic (4.85e-2)" "unprognostic (6.87e-2)" "unprognostic (1.37e-2)" 69.8 10.0 8.4 26.3 10.6 80.6 101.1 7.4 10.1 28.6 31.7 10.3 9.7 11.0 24.9 28.8 38.6 28.0 38.6 18.6 7.8 5.1 32.2 32.5 46.0 35.8 13.8 4.2 20.2 23.8 7.5 4.7 26.1 11.2 20.1 21.0 13.2 26.9 16.5 57.8 60.2 44.8 42.8 17.0 20.3 26.7 14.3 10.0 12.5 41.0 28.8 21.5 44.7 30.7 15.6 29.8 77.8 18.7 13.0 30.8 23.2 13.2 3.6 6.9 2.2 40.3 40.4 4.3 22.8 11.7 24.4 16.6 9.3 17.9 3.8 5.3 24.7 19.0 8.1 4.2 21.1 20.5 18.6 2.5 0.5 4.1 8.7 17.3 2.5 13.1 13.3 40.3 17.4 33.2 8.7 24.9 2.5 4.1 29.7 31.0 0.9 4.6 3.8 2.6 7.1 6.5 3.0 7.1 13.4 24.0 13.2 3.0 2.9 5.6 16.3 34.2 19.6 8.0 2.1 32.4 33.1 4.6 19.5 10.4 5.7 18.5 7.0 8.9 3.3 10.2 50.9 17.0 43.7 27.1 14.2 23.9 15.6 30.8 26.8 13.1 12.5 9.6 14.8 77.8 13.0 18.7 29.8 22.2 23.2 8.4 10.6 7.4 10.1 7.8 5.1 13.8 4.2 11.2 10.0 1158.3 540.6 237.0 1442.7 520.2 42.2 53.1 293.0 254.3 251.4 130.9 31.4 113.5 18.3 616.6 54.4 455.0 961.8 70.0 474.3 369.8 410.0 832.0 597.5 234.2 510.8 35.0 381.0 212.4 420.1 42.4 120.8 593.9 458.9 839.6 556.8 32.1 706.5 466.4 125.9 61.9 78.0 135.8 372.0 6.2 13.6 549.2 163.8 409.2 300.8 382.6 KLF7 UKLF ENSG00000118263 "Kruppel like factor 7" O75840 2 207074137-207167267 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ito cells: 86.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003423, HPA030490" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003423: , HPA030490: AB_10601922" "unprognostic (5.93e-2)" "unprognostic (2.49e-3)" "unprognostic (2.98e-1)" "unprognostic (3.99e-3)" "unprognostic (2.56e-1)" "unprognostic (2.85e-3)" "unprognostic (5.44e-2)" "unprognostic (1.24e-2)" "unprognostic (6.75e-2)" "unprognostic (8.78e-2)" "unprognostic (3.67e-2)" "unprognostic (1.47e-1)" "prognostic favorable (4.26e-4)" "unprognostic (3.27e-3)" "unprognostic (1.23e-1)" "unprognostic (1.73e-1)" "unprognostic (3.47e-2)" 22.2 10.1 10.3 15.1 12.0 40.7 17.3 30.2 12.0 12.2 12.1 14.6 9.3 5.7 19.7 13.4 11.6 10.2 13.8 12.1 10.3 8.0 9.9 8.4 17.1 15.7 12.9 9.1 17.1 6.1 3.0 6.4 7.0 17.4 10.2 6.7 7.0 8.9 9.3 6.2 7.9 11.9 24.2 25.7 11.3 10.7 7.9 14.7 14.4 10.8 8.5 8.3 18.4 18.2 4.5 3.0 24.0 11.7 12.9 9.0 3.5 4.5 3.2 8.7 0.6 3.0 8.0 1.8 5.3 4.2 8.2 3.6 0.0 3.7 0.0 3.4 10.7 14.3 11.3 7.4 24.2 4.4 3.1 0.4 0.1 8.9 1.8 5.3 2.3 3.6 10.6 8.2 5.7 19.0 11.9 9.5 2.4 0.0 4.3 6.3 0.1 2.8 0.8 5.1 0.5 1.6 1.2 2.3 3.2 2.0 3.5 13.5 16.5 4.5 6.4 4.3 7.3 1.0 3.6 18.8 16.4 7.9 6.9 6.2 3.3 2.2 0.0 14.5 2.0 3.2 11.5 5.4 6.8 0.9 6.8 0.4 3.0 5.1 1.0 3.0 4.5 9.0 6.1 24.0 12.9 11.7 1.4 4.1 3.5 10.3 12.0 30.2 12.0 10.3 8.0 12.9 9.1 17.4 14.7 38.7 7.0 15.0 23.7 19.5 5.6 12.5 20.4 8.1 15.9 8.7 11.8 0.4 1.7 20.8 4.5 58.3 0.9 0.0 44.8 0.2 12.4 9.7 11.5 13.5 13.1 11.1 5.8 86.0 44.8 3.3 12.7 20.0 3.3 17.2 0.7 8.2 55.3 0.3 9.6 4.5 8.5 45.3 20.2 0.5 7.5 13.4 0.9 4.9 0.6 7.4 KLF8 "BKLF3, DXS741, ZNF741" ENSG00000102349 "Kruppel like factor 8" O95600 X 56232421-56287889 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Ito cells: 18.4;Leydig cells: 34.8;Peritubular cells: 25.8;Sertoli cells: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "hTCEpi: 12.1;RT4: 10.5;SK-BR-3: 9.3;SuSa: 6.0;T-47d: 17.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071740 Supported Nucleoplasm NA NA Nucleoplasm "HPA071740: AB_2686440" "unprognostic (2.32e-1)" "unprognostic (1.56e-1)" "unprognostic (3.60e-2)" "unprognostic (1.50e-8)" "unprognostic (2.96e-1)" "prognostic favorable (3.32e-4)" "unprognostic (6.56e-2)" "unprognostic (6.93e-2)" "unprognostic (1.05e-1)" "unprognostic (6.13e-2)" "unprognostic (3.15e-1)" "unprognostic (6.83e-2)" "unprognostic (1.03e-1)" "unprognostic (2.62e-3)" "unprognostic (3.15e-1)" "unprognostic (7.68e-2)" "unprognostic (2.60e-2)" 15.1 2.0 2.9 7.9 7.4 0.4 15.0 6.7 5.5 12.9 5.0 0.8 5.2 1.2 19.2 8.6 24.8 6.8 4.8 4.3 2.4 1.8 8.8 0.9 8.3 2.7 1.3 3.3 10.3 2.0 4.0 2.0 7.9 2.9 5.3 4.0 5.2 8.8 4.7 3.3 28.4 4.9 11.6 1.9 5.0 3.4 5.3 0.9 0.7 5.5 16.6 14.3 9.7 14.3 5.0 2.1 0.6 0.2 4.1 1.4 0.5 2.2 0.0 0.1 0.0 1.9 0.5 1.3 0.2 2.3 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 5.2 0.0 0.0 0.0 4.0 5.0 1.4 0.0 0.0 0.1 0.0 0.0 0.1 12.1 0.0 1.8 0.0 0.0 0.0 1.3 0.6 0.4 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 5.7 10.5 0.0 0.0 4.5 9.3 0.0 6.0 17.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.2 0.3 0.3 0.2 0.4 5.0 1.2 1.4 2.1 4.6 0.3 0.3 0.5 4.1 0.1 0.8 0.5 0.5 2.9 7.4 6.7 5.5 2.4 1.8 1.3 3.3 2.9 0.9 0.0 2.6 9.7 4.4 6.2 0.1 1.4 0.0 1.4 1.2 14.0 2.0 4.2 0.0 0.8 0.1 5.5 0.5 0.0 0.9 12.7 5.0 5.2 1.1 0.0 1.2 0.0 0.0 18.4 1.2 1.5 34.8 7.0 5.0 3.6 0.9 0.5 0.6 0.0 25.8 5.0 0.0 19.4 8.9 0.9 0.7 10.2 3.8 0.7 0.8 4.8 KLF9 BTEB1 ENSG00000119138 "Kruppel like factor 9" Q13886 9 70384597-70414624 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Smooth muscle cells: 214.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 22.7;ASC TERT1: 31.6;HHSteC: 40.6;HSkMC: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029308 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA029308: AB_10601923" "unprognostic (2.12e-2)" "unprognostic (2.56e-1)" "unprognostic (3.12e-1)" "unprognostic (2.69e-2)" "unprognostic (5.86e-2)" "unprognostic (1.37e-1)" "unprognostic (3.64e-3)" "unprognostic (4.34e-1)" "unprognostic (5.55e-1)" "unprognostic (9.47e-2)" "unprognostic (7.86e-2)" "unprognostic (3.44e-1)" "prognostic favorable (6.59e-6)" "unprognostic (1.43e-3)" "unprognostic (1.75e-1)" "unprognostic (3.17e-2)" "unprognostic (1.02e-2)" 35.9 15.3 6.8 8.8 25.8 6.1 25.7 42.6 21.4 10.2 20.0 9.7 16.1 6.0 19.6 13.2 17.0 22.2 17.8 18.2 8.4 4.0 26.2 36.7 22.6 5.1 26.3 8.0 22.1 21.3 13.0 8.6 3.9 14.7 12.4 11.0 20.4 31.4 10.7 38.9 12.6 17.6 25.0 12.0 8.6 16.7 5.5 25.2 1.9 24.0 20.3 5.4 15.4 11.9 2.8 1.7 2.8 0.7 0.7 2.8 0.6 0.1 0.2 0.0 2.8 22.7 31.6 0.3 1.4 9.8 0.5 1.1 0.0 1.3 0.0 1.1 2.6 0.7 0.0 4.3 6.6 1.0 0.0 3.4 1.5 4.8 0.8 40.6 0.7 4.0 27.0 6.8 0.4 9.6 13.7 8.7 0.6 2.9 6.0 3.7 0.4 0.1 2.1 0.2 0.4 1.4 0.0 1.3 3.7 1.8 0.0 0.4 1.9 13.4 7.8 15.4 0.9 2.6 2.3 11.8 2.6 1.9 3.0 0.7 4.3 4.6 0.2 2.3 2.3 13.0 2.8 0.5 0.3 1.6 0.3 2.3 2.8 2.1 1.6 1.2 2.5 2.8 1.6 0.0 0.7 0.7 1.7 2.2 0.6 6.8 25.8 42.6 21.4 8.4 4.0 26.3 8.0 14.7 25.2 38.7 21.0 13.2 56.7 42.7 40.6 62.7 48.4 18.7 28.4 14.0 19.6 0.1 26.6 7.4 17.2 139.1 35.5 0.0 11.6 0.2 78.1 86.9 7.0 140.6 3.5 76.3 13.3 97.6 59.8 11.6 84.0 36.1 37.1 4.6 29.3 151.3 10.9 28.5 79.9 29.8 8.8 77.6 214.2 1.0 3.9 29.9 0.0 24.5 27.3 22.8 KLHDC10 "KIAA0265, slim" ENSG00000128607 "Kelch domain containing 10" Q6PID8 7 130070510-130135720 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020119 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA020119: AB_2249467" "unprognostic (2.83e-1)" "unprognostic (6.26e-2)" "unprognostic (1.13e-1)" "unprognostic (8.16e-3)" "unprognostic (3.22e-1)" "unprognostic (1.80e-2)" "unprognostic (5.55e-2)" "unprognostic (8.70e-2)" "unprognostic (7.97e-2)" "unprognostic (1.42e-2)" "unprognostic (8.69e-2)" "unprognostic (2.43e-1)" "unprognostic (1.24e-2)" "unprognostic (8.22e-2)" "unprognostic (2.04e-1)" "unprognostic (2.23e-1)" "unprognostic (1.64e-2)" 11.7 18.6 15.5 9.1 21.1 7.2 14.8 27.1 24.1 13.4 12.6 16.9 13.6 11.0 13.4 14.4 13.0 15.5 9.7 14.9 14.2 24.8 21.3 22.8 11.8 7.9 17.0 18.6 15.2 15.3 37.4 25.1 13.6 23.4 13.4 13.0 15.0 10.7 17.1 23.2 13.1 11.7 11.9 14.1 11.0 11.9 35.3 10.2 9.8 18.3 8.9 11.6 9.6 12.3 3.3 1.9 1.8 2.5 0.6 3.4 0.6 11.3 10.6 7.3 40.0 9.7 10.8 3.4 10.8 8.3 8.2 8.6 5.7 8.6 9.6 7.7 9.9 13.8 8.9 11.7 6.9 10.4 7.8 7.0 5.6 11.9 6.7 7.7 10.3 6.9 6.7 11.9 12.7 8.0 10.3 11.5 6.7 27.2 6.1 9.2 9.5 8.9 10.0 1.2 8.3 6.9 7.3 13.8 6.9 11.3 7.8 11.9 9.5 17.4 31.1 8.8 9.4 7.6 7.7 13.0 10.6 4.6 14.1 12.9 8.0 10.4 8.9 22.2 10.0 14.3 0.0 1.8 1.8 2.4 2.5 2.0 1.7 1.7 2.8 1.9 3.3 1.5 2.8 1.6 0.6 1.9 1.6 3.4 0.6 15.5 21.1 27.1 24.1 14.2 24.8 17.0 18.6 23.4 10.2 17.9 13.2 6.0 6.4 20.6 19.5 19.4 33.1 16.0 20.5 33.2 37.3 10.1 3.3 15.5 51.3 15.6 11.8 23.3 20.5 7.9 20.1 11.2 5.8 37.5 10.8 33.4 19.1 32.5 22.9 12.4 14.1 11.7 16.9 13.6 15.5 18.1 18.9 3.5 23.0 23.2 21.6 0.0 10.3 29.7 4.5 25.5 9.4 7.5 18.2 11.5 KLHDC2 "HCLP-1, LCP" ENSG00000165516 "Kelch domain containing 2" Q9Y2U9 14 49767608-49786385 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000628 Approved Supported "Nucleoplasm,Nuclear membrane,Nuclear bodies" NA NA "Nucleoplasm, Nuclear membrane" "Nuclear bodies" "HPA000628: AB_2666051" "unprognostic (2.65e-1)" "unprognostic (8.29e-2)" "unprognostic (1.30e-2)" "unprognostic (9.01e-2)" "unprognostic (2.57e-2)" "unprognostic (5.52e-3)" "unprognostic (4.54e-2)" "unprognostic (9.72e-3)" "unprognostic (7.43e-2)" "unprognostic (1.24e-1)" "unprognostic (4.81e-3)" "unprognostic (6.77e-3)" "prognostic favorable (2.75e-10)" "unprognostic (2.20e-2)" "unprognostic (2.08e-1)" "unprognostic (1.32e-2)" "unprognostic (9.34e-2)" 17.0 20.2 18.2 9.6 18.0 7.6 20.7 21.0 22.3 15.4 22.0 10.8 16.2 15.9 18.4 14.3 13.6 13.4 15.2 47.1 16.0 14.3 29.7 41.7 12.6 13.1 17.6 16.8 22.9 43.2 16.2 15.5 11.1 17.6 16.9 16.1 18.5 16.2 18.8 40.7 14.9 22.5 20.7 13.5 10.2 20.3 21.7 18.3 15.0 24.8 13.1 9.5 23.9 13.0 13.1 7.0 15.0 7.0 12.5 19.9 8.7 8.5 7.2 13.6 6.6 19.6 17.2 14.3 9.0 17.2 11.4 11.6 4.2 11.7 17.2 12.7 16.1 6.6 7.7 8.3 8.2 9.7 11.8 9.4 5.3 5.4 9.8 14.3 11.3 4.7 17.7 14.2 5.2 10.3 14.1 10.4 14.6 6.8 12.9 9.0 10.1 11.6 4.9 10.0 9.9 21.2 9.2 14.6 10.3 5.2 18.3 16.9 13.4 15.1 28.0 9.8 10.9 10.7 4.3 8.8 10.6 8.4 8.3 4.6 17.7 11.4 10.1 5.9 5.9 5.5 8.8 7.0 15.0 9.2 4.5 11.5 13.0 14.0 14.5 7.0 13.1 19.9 13.3 6.8 12.5 4.4 5.4 13.3 8.7 18.2 18.0 21.0 22.3 16.0 14.3 17.6 16.8 17.6 18.3 38.7 44.9 30.4 46.5 43.5 61.9 8.0 63.7 8.1 29.6 45.4 47.1 79.2 91.2 47.8 50.9 38.7 75.6 0.0 75.6 56.4 54.1 49.6 30.0 84.4 29.0 62.0 54.9 39.9 21.1 13.6 75.4 27.9 37.1 35.1 73.9 61.3 50.5 92.2 72.9 135.2 91.2 64.7 53.4 224.0 88.8 58.1 68.9 41.5 79.2 42.7 KLHDC3 "dJ20C7.3, hPeas, PEAS" ENSG00000124702 "Kelch domain containing 3" Q9BQ90 6 43014103-43021298 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 122.7" "Group enriched" "Detected in all" 9 "Early spermatids: 436.9;Late spermatids: 1305.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030131, HPA030132, HPA030133, HPA030134" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA030131: AB_10599712, HPA030132: AB_10600880, HPA030133: AB_10611532, HPA030134: AB_10601350" "unprognostic (3.85e-2)" "prognostic favorable (9.15e-4)" "unprognostic (5.31e-2)" "prognostic unfavorable (4.52e-4)" "unprognostic (9.97e-3)" "unprognostic (2.80e-1)" "unprognostic (2.09e-3)" "unprognostic (1.05e-2)" "unprognostic (5.09e-2)" "unprognostic (1.58e-3)" "prognostic favorable (9.08e-4)" "unprognostic (6.34e-2)" "unprognostic (2.88e-2)" "unprognostic (8.73e-2)" "unprognostic (9.78e-2)" "unprognostic (2.88e-1)" "unprognostic (1.52e-1)" 16.1 19.0 37.2 11.6 41.6 14.7 17.6 38.0 68.2 15.2 16.7 14.6 15.4 14.4 12.8 21.2 16.1 19.9 13.6 34.0 34.2 25.7 14.8 20.2 14.4 14.4 26.7 41.6 20.3 15.2 15.6 17.6 20.9 29.6 16.3 15.0 13.5 21.3 18.5 122.7 15.1 14.7 15.9 14.6 14.1 15.4 47.0 15.3 17.4 19.3 17.6 15.6 13.7 11.2 19.5 39.4 41.6 36.3 21.6 31.5 29.8 26.4 8.2 27.3 45.6 18.8 14.2 19.6 12.0 15.5 23.5 25.8 23.5 13.9 26.3 13.7 17.5 8.8 14.1 29.0 15.5 16.1 14.0 39.5 32.7 23.6 24.4 18.5 19.2 23.4 22.8 15.6 18.1 10.6 18.3 22.7 30.1 39.7 18.8 8.8 32.9 31.4 33.1 35.5 66.8 8.8 30.6 20.0 31.5 14.4 15.4 50.6 39.5 12.7 14.6 20.4 18.5 25.4 55.7 13.4 10.7 20.0 11.8 11.8 20.6 25.8 38.2 4.7 27.6 9.0 14.9 36.3 41.6 28.5 33.8 24.0 19.2 23.8 25.8 39.4 19.5 31.5 24.5 17.7 21.6 25.8 21.8 25.1 29.8 37.2 41.6 38.0 68.2 34.2 25.7 26.7 41.6 29.6 15.3 11.9 17.1 31.9 30.7 16.7 29.1 32.5 30.6 5.3 6.8 17.4 13.7 84.7 72.9 52.9 436.9 20.2 33.8 23.3 48.1 97.9 40.2 39.5 13.8 24.5 56.1 30.2 50.3 24.5 35.6 1305.6 41.4 26.0 32.1 61.3 43.7 33.2 40.4 43.6 55.5 45.1 21.9 51.8 26.8 102.4 30.2 18.1 89.5 30.2 50.7 28.0 KLHDC9 KARCA1 ENSG00000162755 "Kelch domain containing 9" Q8NEP7 1 161098361-161100346 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.3" "Group enriched" "Detected in many" 6 "Early spermatids: 336.6;Late spermatids: 352.6;Spermatocytes: 259.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "EFO-21: 5.0;HDLM-2: 3.5;HEK 293: 3.7;MCF7: 3.4;T-47d: 3.3;U-266/70: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032058, HPA043197" Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes NA "Nucleoplasm, Nucleoli, Nucleoli rim, Mitotic chromosome" "HPA032058: AB_10601439, HPA043197: AB_2678359" "unprognostic (1.79e-1)" "unprognostic (2.26e-1)" "unprognostic (4.71e-2)" "unprognostic (1.04e-3)" "unprognostic (2.53e-2)" "unprognostic (1.52e-1)" "unprognostic (1.62e-1)" "unprognostic (4.87e-3)" "unprognostic (6.31e-2)" "prognostic favorable (4.20e-6)" "unprognostic (1.81e-3)" "unprognostic (1.71e-1)" "unprognostic (1.12e-1)" "unprognostic (3.53e-1)" "unprognostic (5.51e-2)" "unprognostic (6.36e-2)" "unprognostic (6.88e-2)" 1.0 3.7 4.0 1.0 8.4 0.9 1.4 3.1 9.5 1.8 2.4 2.3 5.6 1.6 2.4 3.9 1.1 5.7 2.4 1.7 3.3 4.9 5.9 2.6 1.7 1.0 3.6 7.4 2.5 3.6 4.1 4.8 1.0 5.6 3.2 1.6 3.5 2.9 2.4 2.5 0.8 1.6 1.1 1.6 1.1 2.4 24.3 2.2 0.0 5.0 0.0 1.1 1.5 0.6 0.9 0.1 0.0 0.2 0.0 1.1 0.1 0.4 2.7 1.0 2.9 0.0 0.3 0.3 0.0 0.7 0.1 0.0 0.0 0.2 0.0 5.0 0.0 0.0 1.6 0.0 0.0 0.0 3.5 3.7 0.0 1.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.4 0.5 0.0 1.5 0.5 2.4 2.6 0.0 1.9 0.6 0.0 2.5 1.1 0.0 1.0 0.0 0.8 3.3 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 1.1 0.0 0.1 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 4.0 8.4 3.1 9.5 3.3 4.9 3.6 7.4 5.6 2.2 0.0 4.1 0.0 11.1 0.8 13.0 8.5 7.6 53.5 9.1 27.9 2.0 2.3 48.0 6.8 336.6 3.3 3.2 0.0 4.9 2.8 3.5 10.5 1.1 7.3 0.5 3.2 5.2 1.8 0.3 352.6 7.5 0.3 6.8 1.0 12.5 27.9 4.2 7.0 7.8 29.8 16.9 12.9 1.9 259.8 11.1 0.6 0.7 0.0 7.6 5.6 KLHL11 FLJ10572 ENSG00000178502 "Kelch like family member 11" Q9NVR0 17 41853545-41865431 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 8 "Early spermatids: 91.3;Late spermatids: 33.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023021, HPA052403, HPA054269" Uncertain Approved "Nucleoplasm,Nuclear membrane" "Intracellular and membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA023021: AB_1852568, HPA052403: , HPA054269: AB_2682432" "unprognostic (9.90e-2)" "unprognostic (2.00e-2)" "unprognostic (1.00e-1)" "unprognostic (3.82e-1)" "unprognostic (2.07e-1)" "unprognostic (1.84e-2)" "unprognostic (1.32e-1)" "unprognostic (3.11e-2)" "unprognostic (1.50e-1)" "unprognostic (1.83e-2)" "unprognostic (3.25e-1)" "unprognostic (1.38e-1)" "unprognostic (2.21e-3)" "unprognostic (4.05e-1)" "unprognostic (2.79e-1)" "unprognostic (3.09e-2)" "unprognostic (5.07e-2)" 4.0 4.6 7.0 3.5 10.6 15.5 5.1 10.4 13.3 4.7 6.3 6.4 3.4 3.0 6.0 3.3 4.2 6.1 3.2 7.1 5.8 5.5 4.5 3.6 4.4 4.4 5.9 9.3 7.0 5.4 9.2 7.7 4.0 10.9 5.4 3.8 5.1 4.7 6.0 12.2 5.0 5.2 4.2 3.9 4.6 4.8 25.0 5.9 5.7 8.4 2.8 5.4 6.1 4.0 3.7 2.0 0.3 1.3 1.2 3.1 1.0 2.8 7.6 4.2 8.9 3.6 2.3 6.6 2.9 3.0 3.4 3.7 6.0 1.8 9.0 3.2 3.5 3.1 8.8 11.1 4.1 6.2 4.5 5.6 3.4 10.0 4.6 2.7 4.2 3.9 2.5 1.8 4.6 7.6 2.7 3.4 5.9 3.5 9.5 3.6 2.8 7.0 1.9 3.2 1.5 1.8 6.3 9.8 5.7 1.2 6.9 10.3 4.5 5.7 18.0 2.1 4.2 9.8 1.6 4.7 4.7 6.8 4.7 4.8 5.8 5.0 7.8 5.1 3.2 4.7 0.0 1.3 0.0 1.4 0.2 3.1 2.4 2.0 1.1 2.0 3.7 1.7 1.3 0.3 1.2 1.2 0.3 1.2 1.0 7.0 10.6 10.4 13.3 5.8 5.5 5.9 9.3 10.9 5.9 0.0 0.3 0.0 1.0 0.5 2.7 0.1 0.0 0.0 2.3 0.0 3.9 0.4 0.0 0.3 91.3 0.6 0.3 0.0 0.2 0.3 0.4 0.6 0.0 0.0 0.2 7.9 0.0 0.0 0.0 33.4 0.3 1.1 1.7 1.0 0.3 2.3 0.5 0.0 0.0 0.0 3.4 6.5 0.8 2.6 2.0 0.3 0.3 1.0 0.2 0.9 KLHL17 ENSG00000187961 "Kelch like family member 17" Q6TDP4 1 960587-965715 "Predicted intracellular proteins" "Ubl conjugation pathway" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031251 Approved Uncertain "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA031251: AB_10601539" "unprognostic (1.28e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (1.18e-1)" "unprognostic (8.55e-2)" "unprognostic (1.41e-1)" "unprognostic (1.38e-2)" "prognostic unfavorable (1.89e-6)" "unprognostic (3.09e-2)" "unprognostic (1.51e-1)" "unprognostic (8.53e-2)" "unprognostic (1.06e-2)" "unprognostic (1.19e-2)" "prognostic unfavorable (2.70e-6)" "unprognostic (1.61e-1)" "unprognostic (1.92e-1)" "unprognostic (1.70e-1)" "unprognostic (7.73e-2)" 4.7 7.0 9.9 8.7 8.9 8.2 8.8 14.0 10.0 6.2 5.1 4.9 4.1 8.4 6.5 4.8 9.9 4.6 5.8 4.2 8.4 4.2 7.2 6.1 5.6 8.1 6.7 3.4 1.5 9.5 5.4 12.4 5.7 6.3 6.8 2.3 6.0 11.6 5.6 5.2 19.1 6.1 6.6 4.2 9.8 7.7 9.8 8.2 5.6 5.4 4.0 7.6 6.5 6.7 0.4 1.0 0.0 1.2 0.0 1.7 0.4 4.6 5.2 6.5 15.5 2.3 2.4 7.1 9.1 2.5 5.1 5.0 6.8 7.0 1.7 6.4 3.9 4.9 9.9 6.0 3.7 0.8 9.3 14.4 3.0 18.9 9.6 1.5 3.4 9.5 2.0 1.8 5.0 1.4 6.4 3.1 9.7 9.9 3.0 2.2 5.4 5.6 12.0 7.1 1.8 7.7 9.1 2.6 3.2 2.7 1.8 15.8 14.9 2.6 8.2 8.3 2.1 4.5 6.1 5.4 9.8 13.2 8.5 7.5 6.0 2.1 3.9 5.6 7.8 4.5 0.0 1.2 0.0 1.7 0.1 0.4 0.4 0.3 0.4 0.0 0.4 0.7 0.4 0.0 0.0 0.6 1.0 0.0 0.4 9.9 8.9 14.0 10.0 8.4 4.2 6.7 3.4 6.3 8.2 0.0 1.9 2.0 0.9 2.3 4.5 2.5 0.0 0.0 0.0 3.5 2.0 1.1 0.0 0.9 1.1 0.7 0.9 0.0 0.7 1.6 1.1 0.8 0.0 0.6 1.1 6.4 2.9 4.3 1.8 1.5 0.3 1.9 3.3 0.0 1.6 1.0 1.6 0.0 1.4 1.0 6.4 0.0 1.0 3.7 5.5 2.6 0.7 0.9 1.0 1.0 KLHL18 "FLJ13703, KIAA0795" ENSG00000114648 "Kelch like family member 18" O94889 3 47282917-47346816 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 66.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035027, HPA035028" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA035027: AB_10602340, HPA035028: AB_10669899" "unprognostic (1.96e-1)" "unprognostic (1.61e-1)" "unprognostic (1.20e-1)" "unprognostic (3.82e-2)" "unprognostic (2.26e-1)" "unprognostic (3.47e-2)" "prognostic unfavorable (3.13e-4)" "unprognostic (1.22e-1)" "unprognostic (9.01e-2)" "unprognostic (3.05e-1)" "unprognostic (9.60e-2)" "unprognostic (3.23e-3)" "unprognostic (2.88e-3)" "unprognostic (3.13e-2)" "unprognostic (2.61e-1)" "unprognostic (1.07e-1)" "unprognostic (4.67e-1)" 9.1 9.0 11.5 9.7 12.2 21.1 7.1 16.7 15.7 7.8 8.2 10.4 11.7 6.8 9.1 8.4 13.8 7.7 8.5 9.3 8.8 9.4 7.2 5.8 9.6 9.7 7.7 13.5 6.6 8.5 13.9 9.8 8.6 10.6 8.2 7.4 16.0 7.2 10.7 23.7 20.0 8.4 10.3 6.3 13.9 7.6 9.6 9.9 7.0 11.3 9.3 11.2 9.5 10.1 3.5 6.7 4.6 14.0 1.1 3.7 4.5 7.4 9.6 7.4 10.9 8.2 5.9 5.3 10.2 5.3 10.4 8.5 10.1 4.6 14.5 5.8 8.5 9.5 4.6 22.2 10.8 10.8 11.4 7.4 21.3 13.8 9.2 8.4 11.3 9.8 6.8 8.4 14.9 14.0 5.8 11.5 8.0 25.7 6.1 8.3 6.1 8.6 6.6 13.5 6.0 19.3 6.0 4.9 8.5 9.8 14.1 5.1 6.8 7.1 8.8 5.1 7.9 5.1 6.3 12.0 9.7 9.9 11.0 12.8 6.9 13.2 12.7 6.2 13.2 10.1 4.6 10.2 3.2 1.9 9.2 2.9 3.5 1.5 3.7 6.7 2.1 1.3 1.8 4.5 1.1 14.0 1.8 1.5 4.5 11.5 12.2 16.7 15.7 8.8 9.4 7.7 13.5 10.6 9.9 11.9 10.7 16.7 8.4 10.1 66.8 53.4 2.5 5.3 5.7 3.5 19.6 9.3 18.3 13.9 2.4 13.5 11.0 23.3 12.8 10.4 6.6 8.2 34.7 16.3 25.5 12.7 9.1 16.5 25.7 2.1 5.5 16.7 0.0 10.8 8.2 12.5 14.5 10.5 7.8 19.2 47.9 6.5 11.7 10.1 15.0 18.3 11.8 10.0 8.9 9.5 KLHL2 MAV ENSG00000109466 "Kelch like family member 2" O95198 4 165207618-165323156 "Predicted intracellular proteins" "Ubl conjugation pathway" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.6" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 10.8" "Lineage enriched" "Detected in many" 6 "granulocytes: 10.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051637 Uncertain Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA051637: " "unprognostic (1.14e-1)" "unprognostic (8.11e-2)" "unprognostic (1.46e-1)" "unprognostic (8.31e-3)" "unprognostic (1.46e-1)" "unprognostic (1.56e-1)" "unprognostic (1.79e-1)" "unprognostic (3.11e-3)" "unprognostic (4.42e-2)" "unprognostic (2.06e-1)" "unprognostic (4.67e-1)" "unprognostic (4.88e-2)" "prognostic favorable (3.77e-4)" "unprognostic (4.21e-2)" "unprognostic (1.83e-1)" "unprognostic (2.30e-2)" "unprognostic (1.81e-1)" 10.5 11.2 25.1 10.4 36.0 16.4 12.1 9.7 41.6 6.1 5.8 19.6 4.0 5.0 7.0 13.4 15.8 8.9 9.5 5.0 37.2 17.7 13.3 23.8 10.6 9.4 25.7 14.7 3.8 6.6 5.3 18.4 6.9 15.1 7.8 6.5 4.0 16.3 9.7 3.2 4.7 5.6 9.6 25.7 11.1 7.4 5.4 25.0 1.6 11.3 3.4 8.4 10.9 7.2 1.3 1.2 10.8 1.9 0.3 1.6 0.6 8.7 8.1 5.6 5.8 8.7 7.8 6.0 11.9 9.4 6.2 6.7 4.8 6.6 9.1 3.0 6.0 11.0 6.1 9.1 6.3 8.0 14.8 3.5 7.6 7.2 7.5 7.6 7.8 11.1 6.5 18.0 5.6 21.2 10.9 14.8 3.4 3.4 19.2 9.5 3.3 0.2 2.5 3.4 5.0 3.6 3.1 4.2 2.8 11.3 8.5 28.8 4.8 7.5 2.7 7.2 10.9 1.8 8.9 20.4 4.9 10.1 5.6 8.0 12.5 8.7 7.3 6.0 5.6 9.6 1.9 1.4 1.9 0.8 1.4 0.5 0.4 0.6 0.5 1.2 1.3 1.4 1.6 10.8 0.3 1.9 0.7 0.7 0.6 25.1 36.0 9.7 24.7 37.2 17.7 25.7 14.7 15.1 25.0 6.0 14.1 5.6 11.1 5.4 8.3 4.0 7.6 5.3 7.9 21.0 13.7 3.5 23.2 6.7 1.1 13.4 4.1 0.0 11.3 8.3 5.4 10.1 9.2 30.8 7.4 30.2 14.9 17.2 40.5 1.3 3.7 20.7 5.0 4.6 4.7 3.2 8.8 4.8 4.2 14.7 6.4 0.0 6.8 2.1 7.1 6.6 3.1 7.0 3.1 16.1 KLHL23 "FLJ37812, MGC22679, MGC2610" ENSG00000213160 "Kelch like family member 23" Q8NBE8 2 169694488-169776989 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 108.6;Cone photoreceptor cells: 84.4;Sertoli cells: 168.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 6.6" "Group enriched" "Detected in many" 4 "dendritic cells: 2.0;NK-cells: 6.6;T-cells: 2.3" "Cell line enhanced" "Detected in many" "SCLC-21H: 32.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047593 Approved "Nucleoplasm,Actin filaments" NA NA "Nucleoplasm, Actin filaments" "HPA047593: " "unprognostic (4.77e-2)" "unprognostic (2.65e-2)" "unprognostic (7.48e-2)" "unprognostic (4.12e-3)" "unprognostic (1.66e-2)" "unprognostic (2.13e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (4.19e-2)" "unprognostic (3.64e-3)" "unprognostic (1.05e-2)" "unprognostic (4.09e-1)" "unprognostic (4.21e-2)" "prognostic unfavorable (2.43e-5)" "unprognostic (2.61e-1)" "unprognostic (1.45e-1)" "unprognostic (2.70e-1)" "unprognostic (4.87e-3)" 6.8 2.5 14.1 6.1 13.6 1.8 8.3 16.4 16.4 11.9 26.0 6.9 7.5 11.3 26.7 5.8 12.7 11.4 8.7 10.8 12.7 10.7 7.1 6.3 7.8 3.2 8.9 14.3 19.3 7.9 8.8 17.2 13.0 8.1 14.6 14.7 8.6 8.1 13.8 11.0 2.5 11.8 25.4 8.7 2.9 8.6 20.1 7.9 9.1 10.3 4.5 3.3 11.0 6.2 0.8 2.0 0.1 0.1 6.6 2.3 0.7 6.2 3.2 24.6 6.9 1.4 0.5 16.8 3.0 2.3 5.5 6.1 6.8 5.4 3.9 2.5 0.3 8.0 1.0 25.5 2.1 8.4 13.7 12.5 11.5 6.5 11.0 2.1 16.0 1.8 1.0 1.8 2.3 3.9 3.6 4.2 14.4 15.6 0.5 1.8 3.0 23.4 6.5 20.1 3.3 2.5 7.5 21.0 0.4 5.0 18.6 32.0 22.0 4.7 0.4 2.8 8.1 4.0 5.2 1.5 2.2 7.2 2.1 5.0 1.8 1.7 17.5 1.7 4.8 3.4 0.0 0.1 0.0 1.6 0.0 2.2 0.6 1.4 1.2 0.2 0.8 2.3 2.2 0.1 6.6 0.0 2.0 1.6 0.7 14.1 13.6 16.4 13.1 12.7 10.7 8.9 14.3 8.1 7.9 3.0 5.4 0.0 5.8 1.3 108.6 41.9 17.8 6.7 6.8 0.0 84.4 3.7 3.3 15.1 3.0 5.6 8.0 0.0 27.4 7.4 3.9 14.9 0.0 10.2 0.8 38.1 30.6 8.6 1.0 2.7 2.3 1.0 0.0 0.0 19.5 12.9 16.7 14.1 8.1 13.4 35.6 168.1 38.7 3.2 9.8 0.9 1.0 4.3 20.2 3.9 KLHL25 "ENC-2, ENC2, FLJ12587" ENSG00000183655 "Kelch like family member 25" Q9H0H3 15 85759323-85795030 "Predicted intracellular proteins" "Translation regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 31.5" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 12.1;Horizontal cells: 12.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "monocytes: 6.1;NK-cells: 5.1;T-cells: 3.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "cerebral cortex: 36.7;hippocampal formation: 25.8" HPA023450 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA023450: AB_1852583" "unprognostic (1.18e-1)" "unprognostic (1.06e-2)" "unprognostic (2.78e-2)" "unprognostic (1.99e-2)" "unprognostic (1.30e-1)" "unprognostic (1.42e-1)" "unprognostic (2.94e-2)" "unprognostic (8.98e-2)" "unprognostic (6.60e-2)" "unprognostic (9.29e-3)" "unprognostic (4.25e-2)" "unprognostic (5.18e-2)" "unprognostic (2.22e-2)" "unprognostic (3.57e-2)" "unprognostic (1.80e-1)" "unprognostic (2.08e-1)" "unprognostic (2.66e-2)" 10.6 4.2 5.2 6.8 12.1 1.5 12.7 3.9 21.5 4.7 4.8 7.5 7.7 9.9 7.9 7.2 8.2 6.2 5.2 4.2 5.7 5.9 4.3 18.3 4.8 4.0 5.3 5.8 4.4 3.6 4.4 4.6 2.8 5.4 5.7 2.9 3.8 6.2 7.6 7.8 9.7 7.0 6.2 3.0 2.6 7.5 16.3 4.3 3.7 4.7 2.5 3.9 4.1 31.5 0.6 1.2 0.5 6.1 5.1 3.5 1.0 2.3 7.2 10.5 5.1 2.1 1.2 5.4 3.0 1.4 4.3 3.2 9.6 4.0 1.5 1.6 2.5 2.7 5.9 11.3 5.7 0.9 1.4 5.2 0.4 3.0 7.3 2.5 0.4 1.9 2.2 1.9 4.1 1.4 1.9 2.3 5.2 0.6 1.4 1.8 4.4 3.7 2.3 9.5 4.1 3.8 7.6 6.3 2.4 1.6 5.0 14.7 10.2 4.4 5.1 1.9 4.5 9.3 0.6 1.9 4.5 8.2 2.9 5.4 1.5 3.1 1.5 2.0 2.6 2.5 0.0 0.2 0.5 2.0 2.3 1.1 0.1 2.1 1.5 0.5 0.6 3.5 2.2 0.0 5.1 6.1 1.2 1.8 1.0 5.2 12.1 3.9 11.1 5.7 5.9 5.3 5.8 5.4 4.3 0.0 3.4 0.0 4.2 2.4 1.9 2.5 2.5 1.4 1.2 0.0 0.0 0.7 1.7 1.8 12.1 2.1 3.8 0.0 2.3 1.2 1.9 3.4 0.0 9.6 0.7 12.7 10.3 3.1 1.5 3.1 0.9 0.7 6.8 1.0 6.6 2.2 3.8 2.9 1.4 1.7 0.9 6.5 2.3 3.2 3.9 4.1 1.5 1.5 2.8 3.5 KLHL35 FLJ33790 ENSG00000149243 "Kelch like family member 35" Q6PF15 11 75422394-75430629 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.1;testis: 11.2" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 33.0;Early spermatids: 21.7;Late spermatids: 21.4;Spermatogonia: 37.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.4" "Group enriched" "Detected in many" 4 "granulocytes: 5.4;T-cells: 2.1" "Cell line enhanced" "Detected in some" "CACO-2: 14.2;HMC-1: 9.5;PC-3: 8.2;SiHa: 16.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039864, HPA070736" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Centrosome" NA NA "Nucleoplasm, Centrosome" "Nucleoli fibrillar center" "HPA039864: AB_10794204, HPA070736: " "unprognostic (3.53e-2)" "prognostic favorable (4.63e-4)" "unprognostic (5.40e-2)" "unprognostic (1.97e-1)" "unprognostic (6.88e-2)" "unprognostic (4.15e-3)" "unprognostic (4.98e-2)" "unprognostic (3.92e-2)" "unprognostic (6.52e-2)" "unprognostic (2.87e-1)" "unprognostic (2.67e-1)" "unprognostic (4.39e-2)" "unprognostic (8.68e-3)" "unprognostic (1.59e-1)" "unprognostic (1.05e-1)" "unprognostic (3.11e-2)" "unprognostic (1.28e-1)" 1.1 3.4 4.5 0.7 14.1 0.7 3.5 1.8 8.2 3.2 1.0 3.0 0.2 0.7 0.5 1.0 1.0 2.0 1.1 1.1 3.7 6.2 0.6 0.6 2.7 0.7 3.1 3.3 0.5 4.5 0.5 0.8 0.8 6.2 0.7 0.6 0.7 1.3 1.0 0.9 1.2 0.5 1.1 4.3 1.0 2.3 11.2 2.4 0.0 1.4 0.0 0.7 0.7 0.2 0.2 0.8 5.4 0.3 0.0 2.1 1.2 0.0 0.3 0.1 0.0 0.2 1.3 0.0 0.8 0.0 0.8 0.1 14.2 1.2 0.0 4.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.8 3.6 9.5 0.2 0.2 0.0 0.0 0.1 0.4 2.5 0.0 0.0 1.0 0.6 0.3 0.1 0.1 2.8 8.2 0.0 0.0 0.8 0.7 0.1 1.1 0.9 16.7 3.1 0.0 0.0 3.2 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 2.1 0.0 0.5 0.0 1.2 0.7 0.8 0.2 0.3 0.5 0.1 0.0 0.3 0.0 0.0 1.2 4.5 14.1 1.8 7.1 3.7 6.2 3.1 3.3 6.2 2.4 8.9 4.3 0.0 1.5 1.1 33.0 0.8 0.0 2.7 4.5 3.5 7.9 1.3 3.3 1.7 21.7 1.0 0.2 0.0 2.7 1.4 2.5 0.9 4.6 0.0 1.1 1.6 4.1 3.7 0.0 21.4 2.6 2.1 1.7 2.8 1.0 2.0 2.6 0.0 1.1 0.1 11.0 6.5 1.4 7.5 37.1 1.9 2.1 0.0 0.6 0.7 KLHL38 C8ORFK36 ENSG00000175946 "Kelch like family member 38" Q2WGJ6 8 123645527-123652950 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 72.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "melanoma: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.3;HHSteC: 1.9;SK-BR-3: 5.5;SK-MEL-30: 1.7;U-2197: 9.7" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA024770, HPA027115" Uncertain Approved Nucleoplasm,Cytosol Yes NA Nucleoplasm Cytosol "HPA024770: AB_10599286, HPA027115: AB_10599950" "unprognostic (8.62e-3)" "unprognostic (3.86e-3)" "unprognostic (1.02e-2)" "unprognostic (8.94e-2)" "unprognostic (4.68e-1)" "unprognostic (2.09e-2)" "unprognostic (8.20e-2)" "unprognostic (2.13e-1)" "unprognostic (1.54e-1)" "unprognostic (4.02e-1)" "unprognostic (1.19e-1)" "unprognostic (5.77e-2)" "unprognostic (5.73e-6)" "unprognostic (8.46e-3)" "unprognostic (3.82e-2)" "unprognostic (6.52e-2)" "unprognostic (2.84e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.5 0.7 0.6 0.1 0.1 16.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.2 0.1 72.0 0.0 0.1 0.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.8 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 1.7 0.0 1.0 0.0 0.0 0.0 0.2 9.7 0.1 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KLHL41 "KBTBD10, Krp1, SARCOSIN" ENSG00000239474 "Kelch like family member 41" O60662 2 169509702-169526262 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 20 "skeletal muscle: 564.4;tongue: 157.3" "Cell type enriched" "Detected in some" 12 "Cardiomyocytes: 97.4" "Group enriched" "Detected in some" 9 "head and neck cancer: 10.8;prostate cancer: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HSkMC: 12.8;LHCN-M2: 20.3;RH-30: 32.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA021165, HPA021753, HPA021760" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA021165: AB_1852087, HPA021753: AB_1852089, HPA021760: AB_1852091" "unprognostic (2.44e-2)" "unprognostic (6.12e-2)" "unprognostic (9.01e-2)" "unprognostic (2.94e-2)" "unprognostic (2.90e-1)" "unprognostic (1.36e-3)" "unprognostic (2.05e-1)" "unprognostic (5.46e-3)" "unprognostic (1.88e-1)" "unprognostic (5.38e-2)" "unprognostic (6.65e-4)" "unprognostic (9.64e-2)" "unprognostic (1.50e-1)" "unprognostic (1.69e-3)" "unprognostic (1.19e-1)" "unprognostic (1.12e-2)" "unprognostic (1.52e-1)" 12.0 0.1 0.2 0.1 0.2 0.1 0.2 0.3 0.2 0.1 0.2 0.0 0.0 0.1 0.1 17.8 9.8 0.2 0.6 10.2 0.2 0.3 0.1 0.1 0.2 0.1 0.2 0.0 0.2 0.2 0.1 0.5 0.1 0.0 3.9 0.1 0.0 6.6 0.1 564.4 0.2 0.1 2.3 0.2 0.1 0.2 0.5 0.0 0.0 2.0 157.3 5.0 2.1 0.1 0.2 0.5 0.0 0.2 0.0 0.8 0.0 0.0 0.1 0.0 0.3 0.2 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.1 0.0 12.8 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 32.6 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.2 0.3 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 2.2 97.4 0.0 4.0 3.4 0.0 7.9 0.0 0.0 0.4 3.7 0.0 0.0 0.0 0.5 0.0 0.3 0.4 0.0 0.0 0.2 0.0 1.2 0.6 0.0 2.1 0.9 0.0 0.0 0.0 0.0 0.7 0.7 0.0 1.1 0.2 5.7 0.0 0.6 3.3 0.5 0.0 0.0 0.0 0.0 0.0 KLHL7 "KLHL6, RP42, SBBI26" ENSG00000122550 "Kelch like family member 7" Q8IXQ5 7 23105758-23177914 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 452.0;Late spermatids: 236.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029491, HPA029492" Uncertain Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA029491: AB_10599605, HPA029492: AB_10600881" "unprognostic (1.24e-2)" "unprognostic (4.45e-1)" "unprognostic (1.77e-1)" "unprognostic (4.55e-2)" "unprognostic (1.29e-2)" "unprognostic (1.65e-2)" "prognostic unfavorable (7.96e-4)" "unprognostic (3.78e-1)" "unprognostic (6.10e-2)" "unprognostic (6.41e-3)" "unprognostic (1.30e-1)" "unprognostic (1.51e-1)" "prognostic favorable (8.98e-5)" "unprognostic (2.46e-2)" "unprognostic (3.55e-3)" "unprognostic (3.23e-2)" "unprognostic (2.27e-2)" 7.5 14.6 9.2 5.6 13.0 8.2 10.3 12.6 15.1 8.8 5.7 7.9 4.7 5.9 9.1 9.9 7.7 7.4 7.6 37.1 8.1 8.7 9.2 7.7 6.4 5.8 8.3 9.7 9.6 5.9 7.1 6.1 6.5 15.9 8.1 6.3 8.6 7.2 6.8 7.4 8.6 5.8 8.1 10.6 5.8 5.2 40.7 6.2 9.6 7.2 5.1 6.7 6.9 7.1 5.5 5.5 32.0 8.7 4.2 8.0 6.0 10.9 9.4 25.9 30.6 12.7 11.1 9.5 9.7 14.4 14.3 16.7 11.4 8.0 10.8 7.9 11.8 23.7 11.9 9.9 6.8 12.1 2.8 7.1 7.1 8.1 14.6 9.5 14.3 5.6 9.8 8.9 16.4 13.5 11.4 18.2 13.4 12.4 11.8 23.3 12.6 11.9 22.8 35.7 7.5 11.2 10.6 14.5 9.8 13.4 9.5 15.6 15.3 21.1 10.5 9.9 16.6 8.7 7.5 7.7 12.1 12.6 26.5 11.5 18.6 15.2 25.7 8.0 15.2 14.4 18.7 7.8 32.0 6.8 8.7 7.1 4.5 7.3 6.4 5.5 5.5 5.5 5.4 7.4 4.2 7.5 4.0 8.0 6.0 9.2 13.0 12.6 15.1 8.1 8.7 8.3 9.7 15.9 6.2 20.8 5.6 13.3 15.2 20.9 19.9 85.8 5.1 16.0 9.1 8.7 27.5 18.6 10.0 15.7 452.0 14.1 4.9 0.0 15.3 24.1 17.0 11.5 20.8 5.9 16.7 35.0 10.4 14.1 15.3 236.4 15.5 14.1 11.8 12.6 7.6 23.5 14.7 0.0 19.4 9.8 15.0 6.5 19.1 94.0 10.6 29.5 19.8 15.2 6.4 22.7 KLHL8 KIAA1378 ENSG00000145332 "Kelch like family member 8" Q9P2G9 4 87160103-87240314 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 56.2" "Cell type enriched" "Detected in many" 5 "Muller glia cells: 205.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013856, HPA017762" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA013856: AB_1852594, HPA017762: AB_2669660" "unprognostic (2.93e-2)" "unprognostic (4.91e-3)" "unprognostic (3.44e-2)" "unprognostic (4.66e-2)" "unprognostic (1.18e-1)" "unprognostic (3.27e-2)" "unprognostic (2.12e-1)" "unprognostic (4.46e-3)" "unprognostic (3.27e-2)" "unprognostic (2.06e-2)" "unprognostic (1.13e-1)" "unprognostic (3.46e-1)" "prognostic favorable (1.53e-5)" "unprognostic (4.24e-3)" "unprognostic (3.05e-1)" "unprognostic (3.57e-3)" "unprognostic (1.57e-3)" 6.8 7.3 6.9 5.6 8.1 3.0 12.0 10.0 10.7 9.2 7.5 5.3 3.8 7.3 8.3 56.2 5.3 5.4 5.0 7.4 7.7 7.2 11.4 10.3 9.0 8.1 6.3 5.6 6.1 6.3 7.1 14.2 6.6 7.3 5.7 8.5 4.6 6.5 7.7 23.4 4.8 8.2 6.6 8.0 6.9 5.5 4.2 6.5 7.0 17.3 2.9 4.7 6.8 10.9 3.8 10.3 8.6 12.1 8.7 4.9 5.0 6.5 5.8 10.5 4.7 9.6 7.0 5.6 8.4 4.5 5.6 6.6 9.2 5.0 9.5 6.8 6.2 4.6 2.8 11.1 8.3 12.2 9.1 7.0 11.6 4.4 5.4 8.2 19.0 7.3 8.8 6.0 8.6 8.7 5.5 6.7 7.3 14.9 8.7 5.8 7.2 22.7 9.6 2.6 14.8 2.3 8.6 9.0 5.8 9.5 6.8 22.0 7.7 5.5 13.5 6.2 4.1 4.7 14.1 6.2 7.2 8.8 7.6 7.0 13.1 8.5 16.9 5.4 9.1 7.8 1.9 12.1 7.3 3.0 9.2 4.9 3.3 2.4 2.5 10.3 3.8 4.4 4.3 8.6 8.7 9.0 2.7 0.9 5.0 6.9 8.1 10.0 10.7 7.7 7.2 6.3 5.6 7.3 6.5 3.0 18.5 11.3 9.5 12.2 18.4 11.7 5.1 6.7 10.3 41.8 39.3 3.2 10.0 4.5 2.8 9.5 12.2 0.0 3.9 4.6 8.6 10.5 7.0 17.1 8.6 22.3 8.6 5.5 30.8 2.4 8.9 13.4 10.1 2.8 12.0 205.6 5.0 8.6 7.8 16.5 44.7 12.9 9.2 11.2 19.4 12.9 19.9 7.7 13.3 9.8 KLK6 "Bssp, Klk7, neurosin, PRSS18, PRSS9" ENSG00000167755 "Kallikrein related peptidase 6" Q92876 19 50958631-50969673 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.6;esophagus: 48.9" "Cell type enhanced" "Detected in some" 22 "Collecting duct cells: 10.4;Early spermatids: 2.0;Late spermatids: 2.1;Pancreatic endocrine cells: 4.6;Urothelial cells: 2.7" "Cancer enhanced" "Detected in many" "ovarian cancer: 131.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "A-431: 70.0;CAPAN-2: 167.5" "Region enhanced" "Detected in many" "pons and medulla: 175.6" "Group enriched" "Detected in many" 8 "midbrain: 106.3;pons and medulla: 164.1;thalamus: 62.4" HPA051837 Supported "Nucleoplasm,Nuclear membrane,Cytokinetic bridge" "Secreted in other tissues" Yes No 6800000 Nucleoplasm "Nuclear membrane, Cytokinetic bridge" "HPA051837: " "unprognostic (7.30e-2)" "unprognostic (3.32e-1)" "unprognostic (6.58e-2)" "prognostic unfavorable (1.38e-5)" "unprognostic (1.10e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (8.85e-4)" "unprognostic (3.02e-1)" "unprognostic (2.46e-1)" "prognostic unfavorable (7.82e-4)" "unprognostic (4.45e-1)" "unprognostic (2.72e-2)" "unprognostic (1.31e-1)" "unprognostic (2.46e-1)" "unprognostic (9.07e-2)" "prognostic unfavorable (1.27e-4)" 0.9 0.9 9.7 0.9 23.5 0.9 6.5 3.3 42.2 10.0 1.0 82.0 0.0 1.1 2.0 1.2 48.9 24.6 3.8 0.9 20.1 11.8 9.0 0.9 0.9 0.9 46.1 14.9 0.9 0.9 0.9 0.2 0.9 44.3 1.0 0.9 0.0 5.9 2.8 0.9 2.9 0.9 1.0 97.6 5.1 1.0 1.5 32.6 0.0 0.9 15.7 28.1 0.9 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.3 167.5 0.0 1.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 15.4 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.6 2.3 0.1 0.2 0.0 0.1 6.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 23.5 3.3 23.1 20.1 11.8 46.1 14.9 44.3 32.6 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.1 0.3 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 2.7 KLLN killin ENSG00000227268 "Killin, p53 regulated DNA replication inhibitor" B2CW77 10 87859161-87863437 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 6.3;skeletal muscle: 7.4" "Cell type enhanced" "Detected in many" 7 "granulocytes: 5.7;Sertoli cells: 6.5" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 8.1;Karpas-707: 8.4" "Low region specificity" "Detected in many" HPA074502 Supported Nucleoplasm,Nucleoli No No Nucleoplasm Nucleoli "HPA074502: AB_2686695" "unprognostic (4.53e-2)" "unprognostic (1.19e-1)" "unprognostic (1.82e-1)" "unprognostic (1.68e-2)" "unprognostic (3.71e-1)" "unprognostic (6.53e-2)" "unprognostic (1.37e-1)" "unprognostic (3.59e-1)" "unprognostic (1.09e-1)" "unprognostic (2.07e-1)" "unprognostic (3.12e-3)" "unprognostic (1.57e-2)" "unprognostic (4.79e-4)" "unprognostic (1.38e-2)" "unprognostic (1.00e-1)" "unprognostic (9.02e-4)" "unprognostic (1.60e-1)" 1.7 1.5 1.2 0.8 1.9 0.6 1.4 2.0 1.4 1.3 1.6 0.7 1.2 2.0 0.6 2.9 0.6 0.7 1.0 1.8 1.7 1.7 0.5 1.3 1.1 0.7 0.6 1.3 1.9 0.9 0.6 1.6 0.4 0.8 7.4 0.4 0.7 0.8 0.9 1.7 0.9 2.4 1.3 1.4 0.9 0.9 1.7 1.4 6.3 1.6 1.7 1.2 0.5 1.4 1.6 1.9 1.4 1.0 0.6 1.5 1.2 1.5 0.9 1.2 0.9 4.3 3.3 0.6 0.5 0.9 1.6 1.2 1.3 0.6 0.8 0.5 1.1 2.5 1.0 1.1 2.4 0.9 1.1 1.4 1.1 1.5 1.6 0.5 8.1 0.7 8.4 0.9 2.8 6.4 2.6 0.8 1.0 0.8 4.2 0.3 4.1 0.8 1.4 0.8 1.6 1.4 1.1 0.2 1.4 2.7 1.9 0.5 1.0 0.5 1.6 0.6 4.9 5.0 4.7 1.7 4.7 1.0 3.1 1.0 1.5 0.7 1.4 1.1 1.2 0.9 0.9 0.8 1.7 1.2 1.1 6.3 1.7 1.6 1.4 0.7 0.5 0.0 0.0 0.0 0.1 0.1 1.5 2.0 0.0 2.7 2.3 0.0 0.0 0.6 0.0 0.2 2.7 0.5 1.6 0.0 0.2 0.3 0.5 0.2 5.7 0.4 0.3 3.2 0.0 0.6 0.3 1.1 0.0 0.0 0.0 0.0 1.6 2.4 0.2 0.9 0.0 1.3 1.1 6.5 0.5 0.2 1.4 0.4 0.5 0.0 1.0 0.1 KLRB1 "CD161, CLEC5B, hNKR-P1A, NKR, NKR-P1, NKR-P1A" ENSG00000111796 "Killer cell lectin like receptor B1" Q12918 12 9594551-9607886 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "blood: 178.9" "Cell type enriched" "Detected in many" 21 "T-cells: 765.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "MAIT T-cell: 178.9" "Group enriched" "Detected in many" 133 "NK-cells: 53.0;T-cells: 178.9" "Cell line enhanced" "Detected in some" "HEL: 3.0;Karpas-707: 2.2" "Low region specificity" "Detected in all" HPA039113 Approved Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039113: AB_10674979" "prognostic favorable (3.51e-5)" "unprognostic (1.23e-3)" "unprognostic (7.03e-3)" "prognostic favorable (1.42e-5)" "unprognostic (1.69e-1)" "prognostic favorable (6.99e-5)" "unprognostic (1.54e-3)" "unprognostic (7.15e-3)" "unprognostic (4.12e-1)" "unprognostic (8.23e-3)" "unprognostic (3.57e-2)" "unprognostic (1.65e-1)" "unprognostic (1.17e-2)" "unprognostic (2.45e-1)" "unprognostic (1.34e-1)" "prognostic favorable (5.61e-4)" "unprognostic (1.17e-2)" 3.8 0.8 0.8 22.8 0.8 18.6 2.1 0.5 0.6 2.9 9.1 0.0 1.3 5.0 1.8 3.7 2.6 1.8 7.3 1.3 0.7 0.8 3.8 4.9 11.8 23.7 1.1 0.2 2.0 1.0 0.0 0.9 2.1 0.8 1.8 3.9 0.9 4.8 1.4 0.9 0.8 20.4 0.6 1.8 25.2 4.4 1.3 0.2 6.2 1.9 2.9 17.7 5.5 2.0 0.1 0.3 0.8 0.2 53.0 178.9 18.5 0.1 0.0 1.5 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.1 0.0 0.9 0.2 1.9 0.0 0.0 0.2 0.0 3.0 0.0 0.4 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.2 2.2 0.0 0.8 0.8 0.6 0.5 0.5 0.0 1.1 0.3 0.9 0.0 0.5 0.4 0.6 0.6 0.7 0.1 1.7 0.3 0.2 0.0 1.6 0.0 0.4 0.7 0.6 0.4 1.5 0.0 1.8 1.0 0.5 0.1 0.0 43.1 0.1 178.9 0.1 25.6 28.1 0.1 0.1 1.5 8.7 0.8 53.0 0.2 0.3 5.7 18.5 0.8 0.8 0.5 0.6 0.7 0.8 1.1 0.2 0.8 0.2 0.0 12.8 14.5 0.6 8.7 0.0 0.8 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 5.1 1.3 0.0 5.5 0.9 0.0 0.0 35.6 22.5 0.0 0.0 3.0 23.6 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 2.5 0.0 0.0 7.8 0.8 765.3 0.3 1.3 KLRG2 "CLEC15B, FLJ44186" ENSG00000188883 "Killer cell lectin like receptor G2" A4D1S0 7 139452690-139483712 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 9.7;thyroid gland: 22.1" "Group enriched" "Detected in some" 6 "Collecting duct cells: 7.0;Extravillous trophoblasts: 1.8;Syncytiotrophoblasts: 6.4" "Cancer enriched" "Detected in many" 11 "testis cancer: 42.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 11.2;HAP1: 11.8;NTERA-2: 6.2;SCLC-21H: 5.6;SK-BR-3: 23.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018199 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA018199: AB_2133260" "unprognostic (2.50e-2)" "unprognostic (3.05e-2)" "unprognostic (9.82e-2)" "unprognostic (5.38e-8)" "unprognostic (2.41e-1)" "unprognostic (1.97e-2)" "unprognostic (3.13e-2)" "prognostic favorable (8.61e-4)" "unprognostic (2.14e-2)" "unprognostic (2.92e-1)" "unprognostic (5.19e-2)" "unprognostic (8.83e-2)" "unprognostic (1.10e-3)" "unprognostic (5.66e-2)" "unprognostic (1.71e-1)" "unprognostic (1.14e-2)" "unprognostic (2.34e-2)" 0.2 0.1 0.0 0.0 0.3 0.0 2.4 0.0 0.8 1.0 0.0 0.2 0.0 0.0 0.2 0.7 7.3 0.2 0.0 0.0 0.0 0.0 4.5 0.0 6.2 0.0 0.1 0.0 0.0 0.2 6.5 0.9 0.7 0.3 0.2 0.1 0.3 9.7 0.3 0.1 4.7 0.0 1.5 1.4 0.0 0.2 2.3 0.0 0.9 22.1 2.6 2.3 0.8 2.4 0.4 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 3.3 0.0 0.0 1.7 11.8 0.0 0.0 0.0 2.9 0.0 0.4 0.0 0.1 0.0 0.2 0.0 5.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.0 1.8 0.0 6.2 0.0 0.1 0.0 0.0 0.0 0.4 0.1 5.6 0.3 1.7 23.9 0.0 4.8 5.3 1.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.3 0.0 0.0 0.0 7.0 0.0 0.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 6.4 0.0 0.0 0.3 KMT2A "ALL-1, CXXC7, HRX, HTRX1, MLL, MLL1A, TRX1" ENSG00000118058 "Lysine methyltransferase 2A" Q03164 11 118436490-118526832 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Apoptosis, Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017794, CAB024270, HPA044910" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB017794: , CAB024270: , HPA044910: AB_2679141" "unprognostic (6.80e-2)" "unprognostic (8.93e-2)" "unprognostic (1.83e-1)" "unprognostic (4.56e-1)" "unprognostic (4.96e-2)" "unprognostic (1.72e-3)" "unprognostic (4.52e-3)" "unprognostic (6.07e-2)" "unprognostic (1.61e-1)" "unprognostic (8.46e-2)" "unprognostic (3.21e-1)" "unprognostic (1.16e-1)" "unprognostic (5.91e-3)" "unprognostic (7.90e-2)" "unprognostic (3.73e-1)" "unprognostic (1.67e-1)" "unprognostic (1.02e-1)" 14.4 11.3 17.7 17.0 19.2 28.6 16.8 43.8 21.2 17.3 14.6 19.8 18.1 8.5 21.8 17.1 10.6 15.7 14.1 10.2 17.3 13.4 13.1 9.3 15.3 19.6 16.6 18.7 35.6 16.8 28.9 21.8 10.2 15.4 15.6 12.4 14.4 14.2 19.2 11.1 16.8 14.2 15.2 12.1 15.7 12.3 7.9 23.4 16.6 16.6 7.8 19.4 18.8 24.6 6.7 3.5 8.3 2.0 6.5 5.3 0.8 12.1 5.6 15.2 11.4 9.3 11.1 4.5 5.5 8.0 5.8 6.7 11.3 8.8 15.0 11.3 8.0 10.3 10.6 16.1 6.1 11.6 16.5 6.2 29.4 5.2 6.1 5.2 17.5 5.7 5.3 6.2 12.7 17.0 7.3 9.0 9.8 19.1 12.8 7.3 9.5 11.6 10.3 9.2 5.0 8.4 8.8 14.6 5.0 8.5 9.2 12.5 8.1 13.8 4.5 2.9 8.3 7.8 5.9 13.2 9.9 9.0 7.2 9.8 3.7 2.9 10.1 3.7 12.9 5.9 8.3 2.0 4.6 5.3 1.3 4.3 6.2 4.8 4.6 0.8 6.7 4.9 4.8 1.3 6.5 1.4 3.5 3.9 0.8 17.7 19.2 43.8 21.2 17.3 13.4 16.6 18.7 15.4 23.4 65.5 59.8 31.5 64.8 77.2 147.8 34.4 38.2 53.5 35.2 36.6 143.3 12.2 3.3 26.8 6.6 70.1 19.7 0.0 22.3 8.1 43.5 71.4 26.7 23.1 14.2 184.3 63.8 45.4 32.6 4.7 61.9 26.1 40.5 33.3 29.3 117.0 23.2 14.4 73.9 6.9 144.6 64.7 59.7 11.1 14.9 70.4 5.0 50.7 27.3 49.9 KMT2B "CXXC10, HRX2, KIAA0304, MLL1B, MLL2, MLL4, TRX2, WBP7" ENSG00000272333 "Lysine methyltransferase 2B" Q9UMN6 19 35718019-35738878 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Cancer-related genes, Disease mutation, Dystonia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 61.2;Rod photoreceptor cells: 74.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006487 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA006487: AB_1080587" "unprognostic (1.09e-2)" "unprognostic (3.53e-2)" "unprognostic (3.41e-2)" "unprognostic (7.95e-2)" "unprognostic (9.92e-2)" "unprognostic (3.53e-3)" "unprognostic (2.33e-2)" "unprognostic (4.57e-2)" "unprognostic (7.28e-2)" "unprognostic (2.07e-2)" "unprognostic (3.13e-3)" "unprognostic (2.63e-3)" "unprognostic (9.47e-3)" "unprognostic (2.10e-1)" "unprognostic (2.37e-1)" "unprognostic (3.77e-2)" "unprognostic (2.24e-2)" 10.2 9.3 11.4 14.2 13.1 18.4 10.4 23.9 11.4 10.0 12.0 14.2 12.9 13.8 13.0 7.1 11.4 11.6 12.6 7.5 11.0 5.3 9.9 8.9 10.6 14.7 14.7 6.8 15.3 19.6 10.8 13.3 9.3 11.2 12.1 5.6 13.8 14.7 10.0 13.3 19.9 12.3 12.2 12.4 15.8 12.1 21.5 14.9 14.1 14.9 7.0 14.2 12.4 14.2 0.4 0.7 3.2 0.7 2.1 0.7 0.2 11.5 19.5 9.0 9.9 4.7 4.6 9.4 5.6 4.1 5.7 4.4 13.0 5.9 10.3 8.8 4.6 6.1 7.6 8.1 4.8 2.5 15.2 9.0 18.5 9.1 6.5 4.6 11.2 21.2 6.2 6.5 5.8 6.4 5.1 5.5 10.7 15.4 12.9 3.7 11.8 9.5 9.7 8.3 10.0 6.9 15.0 5.9 5.6 3.1 10.3 10.2 8.2 8.5 13.8 5.9 5.0 8.4 12.0 7.7 11.4 12.4 7.6 11.8 17.8 10.9 8.2 6.2 10.4 7.9 1.0 0.7 0.6 0.7 0.4 0.4 0.3 0.2 0.3 0.2 0.4 0.3 0.4 3.2 2.1 0.3 0.7 0.2 0.2 11.4 13.1 23.9 11.4 11.0 5.3 14.7 6.8 11.2 14.9 8.9 19.1 13.3 8.5 11.3 61.2 7.7 10.2 4.0 5.7 8.7 49.1 5.2 0.0 5.5 2.1 11.7 14.0 0.0 6.7 4.9 8.1 13.1 4.7 9.7 7.3 33.4 19.4 11.6 8.7 4.1 7.5 6.4 5.0 6.4 10.4 27.2 7.1 11.4 11.7 4.2 74.2 0.0 8.2 28.1 36.4 11.3 7.9 10.2 11.3 12.8 KMT2C "HALR, KIAA1506, MLL3" ENSG00000055609 "Lysine methyltransferase 2C" Q8NEZ4 7 152134922-152436005 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Acyltransferase, Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074736 Approved Nucleoplasm NA NA Nucleoplasm "HPA074736: AB_2686709" "unprognostic (7.75e-2)" "unprognostic (3.10e-1)" "unprognostic (2.83e-1)" "unprognostic (1.33e-2)" "unprognostic (1.31e-1)" "unprognostic (5.23e-3)" "unprognostic (1.09e-1)" "unprognostic (1.59e-2)" "unprognostic (1.01e-1)" "unprognostic (1.17e-1)" "unprognostic (3.45e-1)" "unprognostic (1.06e-1)" "prognostic favorable (8.01e-6)" "unprognostic (1.78e-1)" "unprognostic (3.83e-1)" "unprognostic (3.04e-2)" "unprognostic (2.64e-1)" 13.9 12.6 11.7 16.7 18.6 29.7 14.5 24.8 14.1 18.4 12.6 15.5 21.4 9.7 20.2 20.6 14.4 12.8 12.7 10.8 13.4 9.5 10.3 11.4 13.0 12.1 17.7 9.4 18.8 18.4 18.8 18.9 38.0 12.6 14.0 11.8 12.6 15.8 22.9 30.3 25.2 13.1 13.6 16.0 14.6 14.9 13.6 19.6 22.6 16.9 9.3 16.8 17.8 31.6 5.6 3.5 16.1 3.9 5.5 2.9 0.6 9.7 4.9 9.1 9.7 16.5 10.0 10.7 5.1 3.9 4.1 5.0 9.3 5.9 15.5 7.4 9.2 5.6 5.6 9.8 7.4 6.9 9.8 5.0 9.2 7.4 6.4 8.0 15.5 11.3 8.4 10.3 5.8 7.8 6.6 5.8 8.1 14.8 13.4 8.9 13.6 11.2 14.1 5.5 7.6 4.9 7.6 8.3 8.1 7.0 10.0 13.3 10.5 8.4 15.0 5.5 9.9 4.9 12.8 7.3 6.8 3.6 7.3 7.2 14.1 6.9 16.7 8.9 12.8 7.0 8.8 3.5 4.3 2.1 2.2 2.9 5.6 1.7 1.7 1.7 3.8 2.7 1.8 16.1 5.5 3.9 3.5 1.3 0.6 11.7 18.6 24.8 14.1 13.4 9.5 17.7 9.4 12.6 19.6 71.5 66.6 54.7 36.1 79.1 82.8 58.2 45.9 44.2 92.1 43.6 163.0 29.7 5.0 30.2 18.6 49.2 41.0 23.3 28.7 45.7 47.0 48.1 62.5 36.6 29.6 76.3 65.1 41.7 48.8 11.0 62.5 61.0 40.5 25.2 44.5 62.2 33.0 43.8 56.6 15.7 75.2 25.8 50.1 33.5 31.5 84.2 106.4 50.4 30.3 55.0 KMT2D "ALR, CAGL114, MLL2, MLL4, TNRC21" ENSG00000167548 "Lysine methyltransferase 2D" O14686 12 49018975-49059774 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 49.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 5.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035977 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Yes No "Plasma membrane, Cytosol" Nucleoplasm "HPA035977: AB_10670673" "unprognostic (8.33e-2)" "unprognostic (1.49e-1)" "unprognostic (9.14e-2)" "unprognostic (2.52e-1)" "unprognostic (8.07e-2)" "unprognostic (6.91e-3)" "unprognostic (7.35e-2)" "unprognostic (2.29e-1)" "unprognostic (3.57e-1)" "unprognostic (5.14e-2)" "unprognostic (7.23e-2)" "unprognostic (3.07e-1)" "unprognostic (1.68e-2)" "unprognostic (7.10e-2)" "unprognostic (1.87e-1)" "unprognostic (3.20e-2)" "unprognostic (7.60e-2)" 12.1 7.6 4.9 6.7 10.8 26.1 6.8 11.7 10.5 9.5 6.5 5.8 13.0 5.5 15.7 7.4 8.8 8.9 5.8 9.1 6.1 3.5 6.2 6.5 22.9 9.6 6.7 3.3 9.7 11.6 13.3 9.2 12.9 13.7 6.7 6.6 9.8 7.6 8.0 16.1 13.6 9.4 7.1 9.1 13.6 8.3 7.3 5.7 6.2 11.0 6.1 7.6 7.0 6.3 2.0 2.2 5.9 0.5 1.5 0.8 0.6 17.1 16.3 16.5 13.3 17.1 11.5 17.7 9.1 9.5 11.8 6.3 28.6 7.3 17.8 11.8 12.7 8.5 11.6 21.7 10.0 9.8 10.4 17.4 22.6 17.1 15.3 11.7 26.8 22.7 9.7 14.4 16.5 17.1 14.1 17.5 18.5 28.3 9.9 13.3 18.9 13.3 25.0 15.6 23.7 14.1 20.0 10.2 6.4 9.9 19.0 13.8 11.7 14.0 13.8 9.5 15.0 13.7 23.5 23.3 9.3 16.6 8.1 15.2 14.1 9.1 17.3 10.7 13.9 6.9 0.6 0.5 3.0 0.8 0.2 0.4 0.3 0.3 0.5 0.3 2.0 0.3 0.8 5.9 1.5 0.1 2.2 0.0 0.6 4.9 10.8 11.7 10.5 6.1 3.5 6.7 3.3 13.7 5.7 8.9 18.4 11.1 6.5 12.5 25.2 4.7 12.7 5.3 9.1 17.4 49.1 6.6 1.7 5.8 2.5 12.6 11.1 0.0 5.2 4.6 8.5 8.3 8.1 12.3 8.3 20.6 12.6 17.2 19.7 1.1 8.9 9.6 10.1 4.6 10.5 5.2 7.2 8.6 10.3 4.3 38.9 6.5 3.3 3.7 3.2 15.4 9.5 10.4 10.1 8.4 KMT2E "HDCMC04P, MLL5" ENSG00000005483 "Lysine methyltransferase 2E" Q8IZD2 7 105014179-105114361 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Growth arrest, Transcription, Transcription regulation" "Chromatin regulator" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042866, HPA056125" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA042866: , HPA056125: AB_2683044" "unprognostic (1.05e-1)" "unprognostic (6.33e-2)" "unprognostic (6.49e-2)" "unprognostic (4.34e-1)" "unprognostic (1.94e-1)" "unprognostic (4.77e-2)" "unprognostic (2.20e-1)" "unprognostic (3.98e-3)" "unprognostic (2.03e-2)" "unprognostic (3.16e-2)" "unprognostic (3.53e-2)" "unprognostic (6.45e-2)" "prognostic unfavorable (3.80e-5)" "unprognostic (1.68e-1)" "unprognostic (1.53e-1)" "unprognostic (3.57e-2)" "unprognostic (1.06e-1)" 22.7 11.8 18.6 24.5 23.5 44.8 20.9 41.6 22.4 26.4 20.9 18.6 21.7 14.7 25.3 15.8 16.5 18.6 18.2 16.8 20.6 15.1 14.2 11.6 22.8 20.1 22.7 17.4 33.5 15.6 20.5 20.1 18.7 18.6 21.2 20.5 17.6 19.6 19.2 21.3 25.7 18.5 26.2 23.1 21.6 17.9 12.9 27.2 24.6 21.7 15.1 22.7 26.6 21.4 38.2 24.7 72.9 20.8 20.3 30.6 14.7 15.1 10.7 22.7 19.5 14.1 16.9 5.8 11.6 17.4 9.8 12.1 8.7 13.9 12.6 11.6 13.6 13.2 11.8 12.5 11.5 16.3 20.3 7.2 12.7 14.0 7.4 13.3 17.0 16.0 11.8 10.8 13.6 14.6 17.9 17.7 14.1 17.3 36.1 13.8 11.9 27.1 14.6 7.9 8.3 8.6 23.4 14.0 14.6 9.7 15.4 13.0 15.7 16.1 13.9 8.8 15.9 6.0 10.2 21.8 23.2 16.2 26.5 11.5 27.6 21.8 29.1 15.2 13.0 15.9 48.5 18.0 39.4 30.6 13.6 30.3 35.6 28.4 26.1 12.8 38.2 28.0 26.0 72.9 20.3 20.8 24.7 23.6 14.7 18.6 23.5 41.6 22.4 20.6 15.1 22.7 17.4 18.6 27.2 131.0 136.3 133.9 100.8 130.3 219.2 86.5 76.5 84.3 142.1 109.9 237.6 33.5 29.9 70.0 19.2 197.7 91.8 93.5 59.6 38.6 151.9 115.7 236.2 33.7 53.7 174.8 96.0 86.5 76.0 18.6 130.6 138.7 133.3 110.0 88.5 114.4 63.9 84.2 123.8 28.6 269.1 122.9 222.6 98.9 71.7 117.7 54.6 186.4 107.4 119.5 KMT5A "PR-Set7, SET07, SET8, SETD8" ENSG00000183955 "Lysine methyltransferase 5A" Q9NQR1 12 123383773-123409358 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064495 Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA064495: AB_2685273" "unprognostic (5.62e-2)" "unprognostic (4.45e-2)" "unprognostic (3.90e-1)" "unprognostic (3.04e-1)" "unprognostic (2.20e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (6.21e-7)" "unprognostic (3.88e-3)" "unprognostic (1.06e-2)" "unprognostic (1.64e-2)" "unprognostic (6.13e-2)" "unprognostic (3.44e-1)" "unprognostic (4.75e-3)" "unprognostic (4.27e-2)" "unprognostic (1.30e-1)" "unprognostic (4.39e-2)" "unprognostic (1.06e-1)" 7.6 5.4 8.9 14.0 7.5 20.2 7.9 9.8 14.1 13.9 9.1 9.9 21.4 7.3 15.7 9.5 22.3 12.3 8.3 10.9 8.1 5.5 6.7 7.4 8.7 8.4 7.8 10.6 7.2 13.1 6.8 7.4 9.9 12.8 18.6 9.1 7.9 19.3 12.5 13.6 15.6 9.1 11.0 10.3 13.3 9.0 5.2 8.6 42.2 17.2 8.9 19.7 12.3 14.2 3.5 3.8 7.8 3.8 4.1 5.4 0.6 12.4 7.9 9.5 14.6 6.1 10.9 13.0 18.6 8.9 10.8 9.5 9.0 7.3 28.7 10.8 12.3 4.0 11.6 13.6 6.8 11.6 12.1 14.1 24.1 8.3 4.5 9.1 18.7 6.1 4.6 8.6 11.7 10.9 10.4 8.8 12.3 43.6 13.4 8.8 9.0 18.9 27.9 4.4 11.3 9.0 22.5 8.1 7.8 7.5 15.2 13.0 10.2 18.5 9.4 8.5 8.8 13.1 23.9 11.2 12.2 8.9 14.5 13.3 7.5 7.8 26.3 8.4 9.8 10.2 4.1 2.5 7.8 2.8 3.8 5.4 3.5 3.3 4.3 2.0 2.3 1.8 2.3 3.4 4.1 3.6 3.8 2.7 0.6 8.9 7.5 9.8 14.1 8.1 5.5 7.8 10.6 12.8 8.6 11.9 12.6 0.0 14.2 0.0 19.6 0.0 5.1 21.4 12.5 26.2 5.9 10.7 6.6 8.0 7.4 11.3 8.5 0.0 8.1 13.9 8.7 20.1 2.3 13.4 15.1 3.2 4.7 28.8 17.1 2.1 15.0 10.3 0.0 1.0 28.5 22.4 11.3 10.5 40.3 8.3 16.8 6.5 0.0 8.9 11.7 0.0 11.9 8.2 12.4 19.3 KMT5B "CGI-85, SUV420H1" ENSG00000110066 "Lysine methyltransferase 5B" Q4FZB7 11 68154863-68213828 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Myogenesis, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 52.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063648 Supported Nucleoplasm NA NA Nucleoplasm "HPA063648: AB_2685073" "unprognostic (5.82e-2)" "unprognostic (4.25e-2)" "unprognostic (2.54e-1)" "unprognostic (5.36e-3)" "unprognostic (3.52e-1)" "unprognostic (2.94e-1)" "unprognostic (1.83e-2)" "unprognostic (1.08e-1)" "unprognostic (3.16e-2)" "unprognostic (1.71e-1)" "unprognostic (5.54e-2)" "unprognostic (1.21e-1)" "unprognostic (3.79e-3)" "unprognostic (2.62e-1)" "unprognostic (4.26e-2)" "unprognostic (3.21e-2)" "prognostic favorable (9.30e-4)" 17.6 19.1 20.9 23.4 22.5 23.7 27.3 38.8 26.7 22.4 21.2 19.9 32.3 21.8 26.2 22.7 19.7 20.4 18.2 15.1 23.8 15.3 19.1 21.5 17.4 16.9 18.6 22.2 27.4 24.0 27.4 28.1 26.6 17.0 24.9 21.5 15.4 25.2 30.4 18.8 20.8 24.0 23.4 18.4 19.6 19.7 19.1 23.6 38.0 30.9 17.5 19.1 20.5 22.5 4.5 5.5 16.0 5.2 8.9 5.9 2.7 10.3 7.8 16.0 10.3 3.7 9.4 17.3 7.5 5.2 9.3 5.5 24.6 16.6 8.5 13.0 10.1 9.2 5.4 11.0 8.6 13.6 9.5 6.4 8.0 9.2 10.1 13.6 11.2 11.0 9.3 17.8 11.2 11.8 8.6 9.2 8.5 11.8 9.9 7.9 21.3 7.9 11.8 17.1 20.7 5.9 13.1 12.5 22.6 6.9 10.0 14.0 16.7 11.5 11.6 52.3 9.1 14.9 7.4 9.6 12.6 16.8 9.6 7.5 12.7 5.5 17.9 7.9 7.1 13.4 7.8 3.7 16.0 4.7 5.2 3.3 3.4 5.1 5.7 3.6 4.5 5.9 5.2 11.3 8.9 4.8 5.5 4.0 2.7 20.9 22.5 38.8 26.7 23.8 15.3 18.6 22.2 17.0 23.6 56.6 48.3 13.8 31.8 0.0 45.8 0.0 22.9 58.9 46.6 24.4 11.8 24.2 18.3 24.2 13.7 24.8 22.7 0.0 28.3 24.3 18.6 34.9 20.9 32.7 15.6 60.4 24.6 25.2 31.0 17.2 25.9 18.9 0.0 34.3 38.9 26.9 30.1 24.6 29.7 19.2 39.1 32.3 0.0 34.9 59.5 0.0 43.3 17.5 31.2 40.1 KMT5C "MGC2705, SUV420H2" ENSG00000133247 "Lysine methyltransferase 5C" Q86Y97 19 55339853-55348120 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 47.4;Cone photoreceptor cells: 47.1;Horizontal cells: 63.5;Rod photoreceptor cells: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEK 293: 16.6;SCLC-21H: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052294 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA052294: AB_2681788" "unprognostic (4.02e-2)" "unprognostic (3.45e-2)" "unprognostic (2.92e-3)" "unprognostic (6.77e-3)" "unprognostic (2.48e-1)" "unprognostic (8.27e-2)" "unprognostic (2.29e-2)" "unprognostic (1.27e-1)" "unprognostic (8.69e-2)" "unprognostic (3.04e-1)" "unprognostic (9.48e-3)" "unprognostic (1.49e-2)" "prognostic unfavorable (1.05e-8)" "unprognostic (7.39e-2)" "unprognostic (2.96e-1)" "unprognostic (9.41e-2)" "unprognostic (2.39e-2)" 5.0 5.6 8.5 7.3 15.7 13.4 5.4 20.0 10.7 5.1 7.5 11.2 4.9 11.9 7.0 5.4 4.6 11.0 7.4 4.2 11.2 4.5 5.1 4.4 5.5 4.6 17.1 5.3 6.1 8.5 6.2 11.7 6.5 9.6 6.6 3.8 6.3 7.7 6.3 6.6 13.5 8.5 3.6 6.2 6.2 9.8 7.0 14.7 10.1 5.1 2.3 3.5 6.3 4.6 0.3 0.8 0.9 0.6 1.1 0.8 0.3 5.0 3.5 3.3 2.8 0.7 0.9 9.3 1.4 0.6 0.5 1.3 2.2 4.3 5.0 1.8 1.1 0.2 2.8 2.1 1.8 0.6 4.5 16.6 4.0 2.5 2.2 1.2 2.3 4.8 0.8 2.5 1.7 0.9 0.7 1.1 5.5 9.8 2.8 0.6 5.8 6.6 5.2 6.0 3.0 5.2 9.8 3.9 4.9 0.8 1.3 16.2 6.9 0.7 3.7 2.0 1.9 4.2 2.9 1.2 1.6 4.0 0.5 1.0 8.3 4.1 3.2 0.8 5.6 2.2 0.3 0.6 0.3 0.7 0.4 0.0 0.1 0.5 0.7 0.6 0.3 0.3 0.8 0.9 1.1 0.0 0.8 0.2 0.3 8.5 15.7 20.0 10.7 11.2 4.5 17.1 5.3 9.6 14.7 6.0 5.5 1.9 11.9 0.0 47.4 0.0 10.2 6.7 5.7 3.5 47.1 25.7 1.7 5.8 1.6 2.2 8.4 23.3 2.6 16.4 3.1 9.2 2.3 1.0 8.3 63.5 7.0 4.9 3.1 1.5 6.9 4.9 0.0 1.0 14.9 28.9 6.1 15.3 6.0 2.1 46.0 6.5 0.0 8.4 11.1 0.0 16.6 9.6 13.3 9.8 KNL1 "AF15Q14, CASC5, CT29, D40, hKNL-1, hSpc105, KIAA1570, MCPH4, PPP1R55, Spc7" ENSG00000137812 "Kinetochore scaffold 1" Q8NG31 15 40594020-40664342 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "lymphoid tissue: 54.7;testis: 35.6" "Cell type enhanced" "Detected in some" 12 "Club cells: 3.4;Extravillous trophoblasts: 9.3;Hofbauer cells: 5.6;Proximal tubular cells: 8.4;Syncytiotrophoblasts: 3.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA026624, HPA049647" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" Yes Yes Nucleoplasm "Nuclear bodies" "HPA026624: AB_10601696, HPA049647: AB_2680840" "unprognostic (5.35e-2)" "unprognostic (1.01e-1)" "unprognostic (5.59e-3)" "unprognostic (4.22e-2)" "unprognostic (1.59e-2)" "unprognostic (5.66e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (2.06e-2)" "unprognostic (1.43e-1)" "unprognostic (3.20e-4)" "unprognostic (2.22e-2)" "unprognostic (1.93e-12)" "unprognostic (3.07e-2)" "unprognostic (3.08e-1)" "unprognostic (8.45e-2)" "unprognostic (7.36e-2)" 0.7 0.5 0.3 7.1 0.4 5.4 0.7 0.3 0.3 0.6 4.0 0.1 0.0 1.5 0.4 0.8 3.9 0.4 0.9 0.5 0.4 0.4 0.9 1.0 1.3 4.7 0.3 0.0 0.5 0.5 0.0 0.4 2.8 0.1 0.5 1.5 0.0 0.8 0.0 0.4 0.8 3.9 0.5 0.4 3.3 0.8 35.6 0.0 54.7 0.5 4.1 3.7 0.7 0.9 2.9 1.2 0.7 0.5 0.7 2.5 0.0 10.9 5.6 11.5 8.3 0.3 1.7 5.1 12.8 5.2 10.0 8.5 6.9 4.4 7.3 4.1 5.5 7.6 13.7 10.8 6.0 10.6 12.6 3.0 21.4 9.6 2.0 0.0 16.3 10.8 0.3 0.2 6.7 4.2 1.3 8.5 13.0 13.7 12.2 11.7 3.7 13.9 3.3 5.6 6.6 6.0 12.7 16.5 3.6 1.5 9.7 9.9 4.6 11.1 6.3 1.3 3.8 6.8 5.0 7.9 11.7 10.4 13.4 7.1 4.7 15.9 14.2 4.7 11.1 11.1 0.4 0.2 0.1 0.1 0.1 0.0 2.9 1.1 0.1 1.2 2.2 0.0 0.7 0.7 0.7 0.5 0.1 2.5 0.0 0.3 0.4 0.3 0.3 0.4 0.4 0.3 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 3.4 1.8 0.0 2.4 1.7 0.2 0.0 0.0 0.0 0.0 0.5 9.3 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 KPNA1 "IPOA5, NPI-1, RCH2, SRP1" ENSG00000114030 "Karyopherin subunit alpha 1" P52294 3 122421949-122514945 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 89.4" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 145.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053627, HPA063426" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA053627: AB_2682211, HPA063426: AB_2685013" "unprognostic (6.23e-2)" "unprognostic (3.83e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (5.81e-5)" "unprognostic (1.82e-1)" "unprognostic (1.56e-1)" "unprognostic (1.30e-1)" "unprognostic (4.02e-3)" "unprognostic (2.86e-1)" "unprognostic (1.40e-1)" "unprognostic (6.77e-3)" "unprognostic (7.89e-3)" "unprognostic (5.22e-2)" "unprognostic (9.09e-2)" "unprognostic (5.43e-1)" "unprognostic (4.02e-1)" "unprognostic (4.77e-1)" 15.4 16.9 15.1 14.4 15.5 7.6 17.8 14.6 19.3 11.8 13.6 12.0 9.0 9.9 14.4 12.3 17.2 10.8 9.6 18.7 13.9 11.6 13.1 24.6 12.5 11.2 14.4 16.8 10.8 14.5 19.6 13.8 13.6 16.5 12.3 12.3 8.6 13.2 15.1 89.4 13.1 11.3 17.7 15.8 10.9 12.3 15.2 13.5 12.4 14.1 10.9 15.3 14.5 13.6 11.4 17.3 29.3 18.2 13.5 13.9 10.9 29.9 17.8 30.7 15.5 20.0 22.1 9.7 23.2 19.7 25.5 23.1 21.4 14.7 21.9 21.4 25.5 20.2 15.8 24.0 19.8 37.7 5.9 9.1 26.9 16.0 11.9 11.7 23.8 12.4 15.3 25.8 18.3 25.8 12.5 27.8 11.9 18.8 12.7 23.1 14.0 17.2 5.7 13.3 21.2 19.2 17.7 25.5 14.0 11.1 21.1 21.2 12.8 24.9 13.6 20.2 25.1 18.0 14.1 23.7 16.0 17.6 7.8 17.9 12.2 12.3 40.7 22.4 16.7 16.2 15.7 13.1 12.5 12.6 13.4 13.5 11.4 11.2 13.9 17.3 8.8 11.6 11.8 29.3 13.5 18.2 5.5 11.8 10.9 15.1 15.5 14.6 16.7 13.9 11.6 14.4 16.8 16.5 13.5 14.9 28.5 15.2 21.0 36.9 27.4 26.5 25.5 46.8 42.1 14.0 29.5 18.8 11.6 21.1 89.9 29.2 15.5 46.7 28.8 20.9 21.6 27.0 38.1 43.9 20.5 19.1 15.6 26.4 29.7 145.2 20.8 25.2 16.9 25.2 17.0 23.9 27.4 17.5 23.3 16.7 47.9 12.9 33.5 30.1 16.6 39.6 20.8 27.3 10.7 24.2 KPNA2 "IPOA1, QIP2, RCH1, SRP1alpha" ENSG00000182481 "Karyopherin subunit alpha 2" P52292 17 68035519-68046842 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 103.9" "Cell type enhanced" "Detected in all" 10 "Early spermatids: 663.6;Spermatocytes: 296.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015460, HPA041270" Enhanced Enhanced Nucleoplasm,Cytosol Yes Yes 38000 Nucleoplasm Cytosol "CAB015460: AB_831493, HPA041270: AB_2677385" "unprognostic (2.78e-2)" "unprognostic (1.54e-1)" "prognostic favorable (3.83e-4)" "unprognostic (2.14e-2)" "unprognostic (1.64e-1)" "unprognostic (5.16e-3)" "prognostic unfavorable (2.12e-10)" "prognostic unfavorable (5.77e-4)" "unprognostic (3.34e-2)" "unprognostic (7.59e-2)" "unprognostic (3.72e-3)" "unprognostic (3.08e-2)" "prognostic unfavorable (1.26e-13)" "unprognostic (3.07e-2)" "unprognostic (1.78e-1)" "unprognostic (9.50e-2)" "prognostic unfavorable (2.19e-4)" 10.6 8.3 10.2 19.5 12.0 38.6 11.9 6.1 13.2 7.4 11.5 6.6 4.3 10.1 8.3 10.4 21.1 6.3 7.9 8.9 11.6 13.2 10.9 11.8 9.1 25.5 10.3 10.3 5.3 4.7 4.5 8.4 16.4 11.4 4.6 14.5 4.0 8.2 4.7 7.2 8.7 10.2 13.2 8.5 14.8 9.7 103.9 9.0 56.6 5.9 20.3 36.8 10.0 8.3 24.6 28.1 16.4 22.6 20.3 17.7 15.0 62.2 81.9 78.2 31.3 11.6 11.3 49.7 55.0 42.7 88.9 69.4 56.3 29.2 58.5 17.4 31.7 44.3 34.5 86.4 42.9 102.4 23.5 50.9 51.8 39.6 53.7 12.2 44.5 35.7 7.0 8.1 51.1 31.5 12.5 85.5 25.0 41.1 42.3 78.8 58.1 55.5 28.7 52.8 50.8 42.5 30.7 71.4 32.0 35.0 29.2 31.1 34.6 30.9 99.8 32.3 74.7 58.1 22.4 33.3 49.3 61.0 34.7 73.9 35.1 50.2 58.4 24.0 38.3 52.9 16.4 16.1 6.6 14.1 22.6 10.9 24.6 10.3 14.4 28.1 19.7 7.9 12.3 1.2 20.3 18.9 21.4 17.7 15.0 10.2 12.0 6.1 13.2 11.6 13.2 10.3 10.3 11.4 9.0 11.9 32.3 47.6 33.0 97.4 19.1 12.6 7.6 8.1 18.2 17.4 7.9 59.0 13.3 31.3 663.6 49.2 9.8 70.0 22.3 244.0 94.4 18.1 43.8 15.3 104.7 30.2 41.1 16.0 36.5 186.9 17.8 52.4 50.6 104.6 9.7 29.4 18.3 10.5 13.8 26.9 17.8 32.3 72.6 296.7 211.0 77.3 99.4 34.5 15.8 20.4 KPNA3 "hSRP1, IPOA4, SRP1gamma, SRP4" ENSG00000102753 "Karyopherin subunit alpha 3" O00505 13 49699307-49792921 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport, Viral penetration into host nucleus, Virus entry into host cell" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 71.8" "Cell type enhanced" "Detected in all" 7 "Early spermatids: 254.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046852, HPA077643" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA046852: AB_2679840, HPA077643: " "unprognostic (4.20e-2)" "prognostic unfavorable (2.80e-4)" "unprognostic (3.69e-2)" "unprognostic (1.23e-1)" "prognostic favorable (2.03e-4)" "unprognostic (6.27e-3)" "unprognostic (6.79e-2)" "unprognostic (9.40e-3)" "unprognostic (1.56e-2)" "unprognostic (4.57e-3)" "unprognostic (3.93e-3)" "unprognostic (4.66e-2)" "prognostic unfavorable (3.81e-4)" "unprognostic (9.78e-2)" "unprognostic (7.83e-2)" "unprognostic (5.68e-3)" "unprognostic (4.60e-3)" 12.4 8.0 15.2 9.1 11.8 14.1 12.4 10.9 14.4 8.5 11.4 7.5 8.1 7.0 9.5 6.8 14.5 7.3 8.4 17.2 12.3 11.4 8.0 13.6 9.6 9.4 11.1 11.4 8.1 6.3 9.1 8.1 8.3 13.0 9.4 9.7 5.9 8.3 11.4 71.8 9.0 8.5 14.3 13.2 8.1 8.3 15.1 11.8 11.4 10.9 14.6 10.8 15.0 16.3 6.0 5.0 7.6 6.8 8.1 12.1 4.1 14.1 9.8 18.9 15.8 19.4 21.3 9.5 25.8 21.4 22.7 16.6 29.8 13.2 30.6 5.3 30.0 15.3 16.7 22.5 20.7 38.0 18.3 15.8 22.4 9.7 34.6 18.9 33.4 14.6 15.6 15.1 19.0 25.1 15.0 28.0 12.9 12.3 8.3 31.2 6.5 17.9 18.2 21.8 19.8 6.9 23.5 18.6 9.3 13.9 11.8 7.9 12.6 9.4 11.8 10.2 16.4 7.0 13.5 25.4 16.8 13.7 15.3 17.1 6.7 9.4 27.0 10.2 15.5 16.6 7.6 4.6 4.3 8.6 5.5 12.1 6.0 8.8 8.4 5.0 4.0 8.8 7.9 2.8 8.1 6.8 2.9 10.1 4.1 15.2 11.8 10.9 14.4 12.3 11.4 11.1 11.4 13.0 11.8 62.5 29.8 19.7 23.8 38.2 22.9 70.2 10.2 37.5 25.0 12.2 31.4 13.2 14.9 42.7 254.1 35.9 17.7 23.3 46.6 15.0 28.3 24.7 32.3 33.4 29.7 49.3 29.2 35.0 34.0 136.0 20.4 32.3 18.6 37.9 17.6 46.9 45.4 10.5 47.0 20.9 62.4 25.8 29.3 52.1 29.9 43.5 8.8 27.7 20.2 28.7 KPNA4 "IPOA3, MGC12217, MGC26703, QIP1, SRP3" ENSG00000186432 "Karyopherin subunit alpha 4" O00629 3 160494995-160565588 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 66.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034336, HPA043154, HPA045500" Enhanced Enhanced Nucleoplasm NA NA 250000 Nucleoplasm "CAB034336: AB_2281054, HPA043154: AB_2678343, HPA045500: AB_2679351" "unprognostic (1.58e-1)" "unprognostic (7.65e-2)" "unprognostic (2.75e-2)" "prognostic unfavorable (8.59e-4)" "unprognostic (7.56e-2)" "unprognostic (4.46e-2)" "prognostic unfavorable (6.24e-7)" "unprognostic (7.71e-3)" "unprognostic (1.57e-1)" "unprognostic (1.22e-2)" "prognostic unfavorable (1.03e-6)" "unprognostic (1.20e-1)" "unprognostic (1.21e-1)" "unprognostic (3.98e-2)" "unprognostic (2.21e-1)" "unprognostic (2.17e-3)" "unprognostic (1.48e-1)" 18.0 9.4 12.6 12.9 12.7 15.2 25.1 13.1 14.1 14.8 14.4 8.6 11.1 7.3 13.1 10.8 22.1 8.9 13.9 45.0 12.0 12.1 11.0 12.6 11.4 12.4 11.6 10.8 15.0 10.7 12.5 6.9 17.5 11.1 11.0 9.7 7.1 10.9 13.1 66.1 10.6 9.5 20.4 10.4 12.1 10.8 13.5 6.3 13.8 11.4 22.2 10.2 21.8 25.2 2.9 2.9 6.8 11.5 8.3 5.6 3.2 33.8 12.0 12.4 16.7 14.3 13.2 16.3 21.1 15.1 15.5 13.2 15.3 17.8 18.0 25.3 21.6 23.2 15.8 13.9 13.6 23.4 22.3 7.8 15.2 10.7 9.1 18.6 21.2 13.7 13.5 14.4 15.0 30.6 12.5 20.4 8.9 11.4 14.6 22.0 9.5 19.1 8.8 25.2 15.3 11.2 12.8 18.5 18.2 12.5 13.0 10.1 9.8 20.4 20.5 29.3 14.4 17.8 11.6 22.7 17.8 15.3 17.7 33.9 26.8 17.7 41.3 16.2 22.2 15.7 6.8 3.6 6.0 3.1 6.7 5.6 2.9 4.5 4.5 2.7 2.5 3.6 4.7 5.4 8.3 11.5 2.9 4.2 3.2 12.6 12.7 13.1 13.3 12.0 12.1 11.6 10.8 11.1 6.3 35.7 24.3 27.5 63.0 109.9 56.4 153.2 20.4 40.2 43.3 10.4 74.6 22.7 29.9 33.3 19.9 45.0 51.2 0.0 32.4 20.6 50.3 69.0 30.1 26.1 35.0 50.9 27.5 29.4 41.9 14.3 31.4 45.8 42.2 26.2 29.9 52.1 57.1 33.4 32.5 31.4 60.8 32.3 42.2 40.3 21.8 110.2 34.0 29.9 30.5 94.6 KPNA6 "FLJ11249, IPOA7, KPNA7, MGC17918" ENSG00000025800 "Karyopherin subunit alpha 6" O60684 1 32108038-32176568 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 204.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018863 Supported Approved Nucleoplasm,Cytosol NA NA 11000 Cytosol Nucleoplasm "HPA018863: AB_1852632" "unprognostic (8.58e-2)" "unprognostic (1.13e-1)" "unprognostic (1.95e-1)" "unprognostic (3.30e-2)" "unprognostic (8.35e-2)" "unprognostic (7.34e-2)" "prognostic unfavorable (9.28e-5)" "unprognostic (1.11e-1)" "unprognostic (1.24e-1)" "unprognostic (5.51e-2)" "unprognostic (3.18e-1)" "unprognostic (5.32e-2)" "unprognostic (1.73e-2)" "unprognostic (1.35e-1)" "unprognostic (1.76e-1)" "unprognostic (1.80e-1)" "unprognostic (1.57e-2)" 16.1 18.7 24.6 14.6 19.0 22.9 18.1 23.9 25.2 16.3 18.8 15.7 23.0 11.5 21.3 17.5 21.4 15.9 12.1 23.4 22.7 18.2 18.3 18.0 17.3 13.2 15.4 19.8 16.9 17.1 40.9 18.0 23.5 29.7 17.6 17.3 14.1 16.2 19.8 54.0 20.5 14.2 23.1 29.2 14.8 17.4 22.2 17.6 12.6 17.8 14.5 18.3 17.9 17.8 9.1 9.3 9.5 12.5 5.0 11.2 6.4 17.0 13.5 12.1 15.5 18.6 16.4 14.2 13.8 16.3 20.2 19.6 15.0 18.7 14.3 16.4 24.8 12.2 14.8 18.5 21.1 25.9 14.4 10.2 14.7 20.8 12.1 16.5 16.1 12.1 16.5 20.1 25.0 24.0 17.1 21.0 11.3 14.2 13.2 19.1 9.4 13.0 9.2 28.1 11.1 10.1 13.1 17.4 11.7 17.6 15.7 11.6 9.8 25.1 15.1 13.4 30.9 10.6 8.6 24.4 18.8 13.0 24.4 19.8 9.5 10.8 11.3 20.5 15.1 17.9 4.0 10.2 9.5 11.2 12.5 11.0 7.8 9.7 8.7 8.3 9.1 11.2 10.8 6.0 5.0 12.5 9.3 9.6 6.4 24.6 19.0 23.9 25.2 22.7 18.2 15.4 19.8 29.7 17.6 38.7 37.4 43.4 31.3 56.4 47.6 28.5 33.1 40.2 21.6 27.9 55.0 38.1 14.9 32.5 204.0 37.9 20.6 0.0 27.4 36.4 38.2 41.3 12.8 56.3 26.8 49.3 44.3 35.6 32.3 48.0 31.7 26.8 23.6 28.9 37.1 29.8 38.9 17.5 38.2 28.3 40.5 32.3 29.9 55.9 52.6 74.4 113.5 32.6 29.2 51.1 KPNB1 "IMB1, Impnb, IPO1, IPOB, MGC2155, MGC2156, MGC2157, NTF97" ENSG00000108424 "Karyopherin subunit beta 1" Q14974 17 47649476-47685505 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 28.2" "Lineage enriched" "Detected in all" 4 "granulocytes: 28.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029878, CAB034449, HPA050302" Supported Enhanced "Nucleoplasm,Nuclear membrane,Cytosol" Yes No 5500000 "Nuclear membrane" "Nucleoplasm, Cytosol" "CAB034449: AB_2133993, HPA029878: AB_10670041, HPA050302: AB_2681079" "unprognostic (2.57e-1)" "unprognostic (1.15e-1)" "unprognostic (4.33e-3)" "unprognostic (2.81e-2)" "unprognostic (1.18e-1)" "unprognostic (8.15e-2)" "prognostic unfavorable (2.55e-7)" "unprognostic (7.18e-3)" "unprognostic (9.52e-2)" "unprognostic (5.47e-3)" "unprognostic (4.37e-2)" "unprognostic (8.41e-3)" "prognostic unfavorable (8.43e-6)" "unprognostic (1.34e-2)" "unprognostic (1.20e-1)" "unprognostic (1.41e-2)" "unprognostic (3.44e-2)" 38.0 42.1 31.9 46.1 30.7 22.1 33.3 32.9 33.5 37.6 37.9 29.7 39.9 24.5 39.3 35.4 51.2 33.1 35.0 43.5 28.1 30.5 33.8 48.8 35.8 50.5 31.6 35.3 47.2 32.3 42.3 29.4 34.6 34.9 36.1 39.3 23.7 35.2 45.9 74.6 31.7 32.1 40.7 36.6 50.3 35.7 62.4 34.8 47.6 37.0 34.3 62.8 50.8 47.5 5.4 4.0 28.2 3.9 3.7 6.3 2.8 43.7 74.6 47.5 43.1 23.0 40.0 47.7 52.2 46.8 68.5 53.9 130.2 26.1 56.5 35.7 48.7 48.3 31.0 85.7 48.1 104.1 34.7 52.3 62.4 60.2 40.7 23.7 70.6 41.1 32.4 21.2 78.6 77.1 29.2 45.1 31.5 70.5 38.7 52.9 47.6 65.4 21.2 45.2 29.9 47.2 40.6 84.0 32.9 28.1 62.7 41.8 38.8 35.7 19.2 30.2 59.2 41.5 27.3 37.5 74.9 46.5 38.9 63.2 47.4 54.7 81.0 31.9 34.2 54.9 4.3 3.5 7.1 4.9 3.6 6.3 5.4 5.5 5.5 2.1 5.1 5.2 4.9 28.2 3.7 3.9 4.0 4.0 2.8 31.9 30.7 32.9 33.3 28.1 30.5 31.6 35.3 34.9 34.8 119.1 66.6 108.8 81.6 111.6 93.4 119.7 66.2 52.2 73.9 41.8 64.8 98.4 34.9 106.8 32.0 100.4 53.1 46.7 102.8 118.0 87.0 86.2 75.0 80.5 109.7 76.3 118.8 122.8 99.2 31.1 89.8 89.3 57.3 151.5 71.7 76.6 115.8 60.4 114.2 42.9 82.7 97.0 78.3 276.1 166.5 125.5 132.3 92.4 98.1 114.9 KPTN 2E4 ENSG00000118162 "Kaptin, actin binding protein" Q9Y664 19 47475144-47484268 "Disease related genes, Predicted intracellular proteins" Actin-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 18.5" "Lineage enriched" "Detected in many" 5 "dendritic cells: 18.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041710, HPA041796" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Vesicles" "HPA041710: AB_10961904, HPA041796: AB_10962832" "unprognostic (4.80e-3)" "unprognostic (2.22e-1)" "unprognostic (7.24e-2)" "unprognostic (1.53e-1)" "unprognostic (5.54e-2)" "unprognostic (3.47e-2)" "prognostic unfavorable (7.91e-6)" "unprognostic (9.30e-2)" "unprognostic (2.24e-1)" "unprognostic (2.21e-2)" "unprognostic (5.51e-2)" "unprognostic (2.59e-2)" "prognostic unfavorable (7.82e-4)" "unprognostic (1.40e-1)" "unprognostic (8.72e-2)" "unprognostic (2.04e-1)" "unprognostic (2.34e-1)" 6.0 5.8 7.1 5.3 15.6 8.9 6.2 17.2 11.0 4.6 5.4 5.7 3.4 6.0 4.5 3.0 7.3 3.6 4.4 6.5 9.5 7.1 5.8 6.8 4.5 5.5 13.0 6.3 2.7 5.5 9.2 8.9 6.3 8.9 6.5 4.2 3.7 17.6 3.9 8.7 5.4 5.1 4.8 8.5 5.0 3.9 3.9 9.6 12.5 4.8 6.2 3.9 5.1 4.7 1.4 18.5 2.6 3.8 0.9 1.3 1.7 6.3 11.1 8.7 5.4 9.0 7.1 6.1 3.5 6.7 19.4 12.2 8.0 7.6 7.6 2.7 6.3 7.0 7.3 7.4 12.8 5.4 7.1 11.5 3.2 7.5 7.1 8.1 6.4 9.3 8.1 8.3 6.4 6.0 4.9 7.4 10.3 6.4 7.4 5.6 4.9 11.4 27.5 7.8 6.9 6.8 8.3 4.4 3.2 6.0 9.5 18.7 14.4 5.9 6.8 4.4 4.5 5.6 9.4 4.2 4.6 5.3 2.5 7.9 1.9 2.9 3.3 4.2 4.2 6.9 0.0 3.0 1.2 1.2 2.5 0.4 1.3 0.8 1.0 3.6 1.4 1.1 0.9 2.6 0.9 3.8 18.5 1.3 1.7 7.1 15.6 17.2 11.0 9.5 7.1 13.0 6.3 8.9 9.6 3.0 2.4 5.6 6.1 2.5 5.6 2.8 7.6 0.0 5.7 5.2 5.9 12.8 8.3 8.7 0.6 2.3 3.5 0.0 3.5 10.6 4.1 5.5 2.3 5.5 7.5 9.5 2.9 3.7 5.1 1.9 1.1 5.3 1.7 1.8 1.5 6.5 5.3 1.9 0.7 5.8 4.1 0.0 2.1 3.2 18.5 2.8 12.8 2.5 2.8 5.8 KRBA1 KIAA1862 ENSG00000133619 "KRAB-A domain containing 1" A5PL33 7 149714781-149734575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 30.6" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 8.9;Muller glia cells: 11.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021237, HPA050448" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA021237: AB_2134145, HPA050448: AB_2681129" "unprognostic (2.19e-2)" "unprognostic (9.01e-2)" "unprognostic (8.06e-2)" "unprognostic (7.48e-3)" "unprognostic (6.75e-3)" "unprognostic (5.59e-2)" "unprognostic (1.01e-5)" "unprognostic (3.41e-2)" "unprognostic (1.51e-2)" "unprognostic (1.42e-1)" "prognostic favorable (2.77e-4)" "unprognostic (2.55e-1)" "unprognostic (6.33e-3)" "unprognostic (9.62e-2)" "unprognostic (4.29e-2)" "unprognostic (1.47e-1)" "unprognostic (9.31e-2)" 3.8 4.6 5.6 6.2 8.1 4.7 5.6 8.7 12.8 5.2 5.2 7.6 11.0 2.2 7.8 4.9 5.5 5.2 5.8 30.6 6.7 5.2 5.3 2.2 4.5 5.7 6.3 9.0 7.9 7.0 9.7 16.9 3.1 7.1 6.0 1.9 9.4 17.2 9.5 7.4 6.4 3.6 8.5 5.1 6.4 5.0 5.7 6.5 2.5 4.3 5.5 4.8 5.0 5.3 4.1 3.7 1.3 3.7 0.3 4.2 1.7 6.2 3.9 7.8 16.2 3.5 3.5 6.8 3.3 4.2 5.4 6.2 0.4 1.7 1.9 7.1 4.2 11.0 6.2 5.8 11.2 2.7 8.7 11.0 3.5 5.0 3.6 4.4 0.0 9.8 7.7 5.3 3.7 2.0 6.4 4.9 10.5 14.1 2.0 2.7 2.4 9.0 5.3 9.3 2.9 3.8 9.5 3.1 1.0 4.1 5.0 6.2 10.4 5.1 14.9 3.5 3.7 2.6 5.4 5.0 6.6 2.9 0.0 4.6 9.6 3.1 8.4 3.9 6.0 6.8 0.0 1.8 0.4 3.8 1.7 2.6 1.8 1.9 2.2 2.6 4.1 3.4 2.9 1.3 0.3 3.7 3.7 4.2 1.7 5.6 8.1 8.7 12.8 6.7 5.2 6.3 9.0 7.1 6.5 0.0 2.7 1.5 2.1 1.5 6.3 8.9 0.0 0.0 0.0 3.5 3.9 0.9 0.0 4.5 0.5 0.9 0.0 0.0 2.3 1.9 2.3 2.2 0.0 0.8 4.2 7.9 0.0 0.6 3.0 0.9 3.7 1.1 0.0 1.0 0.0 11.2 1.2 0.0 3.2 1.5 4.4 6.5 1.7 0.7 3.6 1.6 1.0 1.0 0.0 1.5 KRBA2 ENSG00000184619 "KRAB-A domain containing 2" Q6ZNG9 17 8368637-8376711 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 15.7;Rod photoreceptor cells: 28.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA022849 Approved Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA022849: AB_1852996" "unprognostic (9.17e-2)" "unprognostic (1.81e-1)" "unprognostic (1.92e-1)" "unprognostic (3.10e-2)" "unprognostic (2.98e-2)" "unprognostic (8.35e-3)" "unprognostic (7.44e-2)" "unprognostic (1.07e-1)" "unprognostic (2.80e-2)" "unprognostic (2.13e-1)" "unprognostic (7.61e-4)" "unprognostic (6.14e-2)" "unprognostic (5.02e-7)" "unprognostic (1.82e-1)" "unprognostic (2.55e-1)" "unprognostic (3.52e-2)" "unprognostic (1.08e-1)" 10.2 6.5 7.2 3.9 9.7 1.6 6.1 7.8 7.6 6.4 4.5 9.9 4.1 3.7 6.6 5.1 3.9 5.0 3.9 27.5 8.2 4.4 9.6 2.7 4.0 4.0 9.9 6.4 7.1 5.0 11.2 8.8 4.7 7.6 6.9 4.0 11.0 7.7 4.9 11.0 6.4 4.2 4.6 9.1 3.9 4.5 6.2 8.7 6.3 7.5 6.0 3.4 7.5 5.7 5.0 2.8 12.7 3.8 1.8 6.0 0.7 0.6 6.2 7.1 6.6 3.9 5.8 3.9 0.9 2.6 3.1 3.8 0.1 2.4 0.6 4.5 1.0 1.8 1.5 2.6 1.0 4.1 3.1 2.2 1.0 4.0 2.8 1.4 0.4 1.8 4.5 0.0 2.6 1.3 2.1 4.8 4.0 0.0 0.8 2.3 1.0 2.7 0.3 0.7 0.2 2.2 5.0 4.5 0.6 2.0 4.3 2.4 4.9 6.3 2.1 1.6 5.8 3.1 0.4 2.9 2.2 3.8 0.9 0.9 2.6 1.5 0.4 2.8 0.0 5.1 12.7 2.3 3.5 3.4 1.8 3.2 2.9 3.4 2.6 1.2 5.0 6.0 3.3 2.2 1.8 3.8 2.8 3.2 0.7 7.2 9.7 7.8 7.6 8.2 4.4 9.9 6.4 7.6 8.7 0.0 0.6 0.0 1.2 0.2 2.0 0.4 0.0 4.0 0.0 1.8 15.7 2.0 3.3 2.4 0.3 1.5 1.0 0.0 1.0 0.5 0.9 0.5 4.7 0.0 0.8 3.2 4.1 2.5 1.0 0.0 1.4 1.1 1.7 0.0 1.0 2.4 1.6 0.0 2.8 0.9 28.5 0.0 1.2 1.8 1.5 0.6 1.0 1.3 1.2 0.3 KRBOX1 ENSG00000240747 "KRAB box domain containing 1" C9JBD0 3 42809483-42942792 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 8 "placenta: 78.4;testis: 68.5" "Cell type enriched" "Detected in many" 7 "Spermatocytes: 1048.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "NK-cell: 9.0" "Lineage enriched" "Detected in many" 5 "NK-cells: 9.0" "Cell line enhanced" "Detected in some" "BJ hTERT+: 10.6;CAPAN-2: 22.9;EFO-21: 11.2;GAMG: 17.6;hTEC/SVTERT24-B: 16.1;hTERT-HME1: 10.8;U-2197: 31.8" HPA046901 Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA046901: AB_2797232" "unprognostic (2.62e-1)" "unprognostic (1.19e-1)" "unprognostic (1.82e-1)" "unprognostic (1.53e-3)" "unprognostic (7.63e-3)" "unprognostic (1.24e-2)" "unprognostic (1.05e-1)" "unprognostic (1.11e-1)" "unprognostic (3.46e-2)" "unprognostic (2.27e-1)" "unprognostic (5.64e-2)" "unprognostic (2.95e-2)" "unprognostic (9.66e-2)" "unprognostic (2.27e-2)" "unprognostic (1.04e-1)" "unprognostic (1.31e-1)" "unprognostic (2.28e-1)" 1.1 1.8 1.6 0.3 2.1 0.3 1.4 2.1 2.3 1.9 1.6 1.8 1.2 0.8 2.6 5.4 2.1 1.9 1.2 2.3 1.4 1.2 1.4 0.3 0.7 0.7 1.4 1.2 3.2 2.3 0.3 1.9 78.4 1.6 1.6 1.0 2.3 2.1 2.7 0.5 2.5 1.0 2.3 1.8 0.7 1.1 68.5 0.6 0.2 2.5 1.1 0.8 1.2 1.1 0.8 1.7 1.2 1.2 9.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.1 10.6 0.0 0.0 0.0 22.9 0.0 11.2 0.8 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 4.5 0.0 16.1 10.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 8.2 0.0 31.8 0.0 3.4 1.1 0.0 1.7 0.0 0.6 0.0 0.6 1.2 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.8 0.3 0.9 0.0 9.0 1.2 1.7 0.5 0.2 1.6 2.1 2.1 2.3 1.4 1.2 1.4 1.2 1.6 0.6 0.0 1.6 0.0 2.5 0.0 6.5 4.8 5.1 1.4 3.4 5.2 2.0 9.4 16.6 4.1 134.8 0.4 0.7 0.0 10.5 8.6 1.6 1.5 0.0 0.5 2.0 1.6 0.0 1.3 0.0 72.9 18.7 0.0 0.0 0.0 0.8 12.4 6.2 1.9 12.7 1.7 7.4 12.9 3.3 1048.9 159.2 0.0 7.6 0.0 1.7 0.8 KRBOX4 "FLJ20344, ZNF673" ENSG00000147121 "KRAB box domain containing 4" Q5JUW0 X 46446857-46497422 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA065295 Approved Nucleoplasm NA NA Nucleoplasm "HPA065295: AB_2685456" "unprognostic (4.12e-1)" "unprognostic (6.40e-2)" "unprognostic (1.74e-2)" "unprognostic (1.64e-2)" "unprognostic (1.17e-1)" "unprognostic (2.25e-1)" "prognostic unfavorable (2.87e-6)" "prognostic favorable (4.67e-5)" "unprognostic (1.73e-2)" "unprognostic (2.61e-3)" "unprognostic (3.27e-2)" "unprognostic (4.75e-3)" "prognostic unfavorable (1.98e-7)" "unprognostic (7.94e-2)" "unprognostic (1.08e-1)" "unprognostic (1.00e-1)" "prognostic favorable (2.17e-4)" 17.8 11.3 16.9 10.5 22.3 6.8 17.0 24.9 21.0 14.4 14.2 19.9 11.7 7.9 25.6 27.9 8.5 16.0 14.1 10.6 13.6 16.6 12.0 16.4 13.5 15.5 16.1 16.8 22.4 14.0 17.3 24.5 20.3 22.2 16.8 11.1 13.2 9.8 14.6 8.7 13.4 10.5 18.1 17.2 19.7 10.3 6.4 19.0 12.6 17.0 9.3 14.5 14.3 12.9 17.4 12.5 13.7 8.8 13.8 17.8 8.2 14.8 8.5 13.7 10.4 13.5 14.2 8.3 14.5 13.3 13.5 12.4 7.5 13.7 8.5 9.7 12.4 22.1 10.6 16.9 8.1 16.0 8.3 7.2 7.0 17.6 7.1 14.6 10.3 11.5 15.8 9.0 18.5 15.4 12.0 12.6 13.1 7.5 9.4 12.1 8.6 10.6 5.2 12.3 5.8 15.6 7.5 12.7 10.5 8.7 6.2 5.0 9.7 12.5 6.1 13.9 24.3 10.1 10.4 11.3 15.2 15.1 19.7 11.8 10.3 11.6 12.2 13.0 0.5 13.6 12.2 6.7 13.7 12.7 8.2 13.3 13.2 13.7 12.2 6.6 17.4 17.8 12.7 5.1 13.8 8.8 12.5 11.6 8.2 16.9 22.3 24.9 21.0 13.6 16.6 16.1 16.8 22.2 19.0 6.0 6.7 12.3 3.7 1.9 5.7 6.3 10.2 5.3 4.5 5.2 3.9 11.8 8.3 7.0 0.2 12.3 2.0 0.0 4.0 6.6 7.5 4.3 7.0 4.0 8.1 9.5 1.2 16.5 6.5 0.9 7.2 4.6 6.8 3.6 3.6 10.1 3.1 4.3 10.6 4.5 7.8 12.9 5.1 1.9 5.1 2.4 11.3 8.7 4.3 1.4 KREMEN1 "KREMEN, KRM1" ENSG00000183762 "Kringle containing transmembrane protein 1" Q96MU8 22 29073078-29168333 "Disease related genes, Predicted membrane proteins" "Wnt signaling pathway" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "neutrophil: 9.0" "Lineage enriched" "Detected in many" 7 "granulocytes: 9.0" "Cell line enhanced" "Detected in many" "RH-30: 18.3;U-2197: 31.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058513 Approved "Nucleoplasm,Nuclear bodies,Cytosol" No No 400000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA058513: AB_2683739" 5.2 11.8 7.1 6.8 17.8 2.7 5.8 5.0 6.9 9.6 9.6 7.6 25.7 4.9 6.0 13.2 27.8 8.6 5.0 16.8 8.3 3.6 10.5 3.2 8.3 9.1 5.2 4.3 17.4 3.4 16.3 8.0 7.2 4.2 7.1 8.5 21.2 35.4 20.6 18.9 26.5 8.1 4.7 3.0 13.9 6.4 14.5 6.8 19.0 17.1 33.4 20.0 5.9 10.0 0.7 1.2 9.0 0.6 0.8 0.4 0.2 2.6 1.8 6.2 3.2 2.1 6.4 5.3 0.7 6.2 2.0 3.0 8.4 1.2 0.1 2.4 2.9 5.1 12.8 12.8 5.1 2.2 3.1 8.1 0.7 0.9 7.9 2.2 0.1 0.7 6.2 10.4 2.2 1.2 0.9 0.3 5.2 2.7 0.2 2.5 2.2 0.0 0.8 0.3 17.3 1.4 0.4 18.3 0.2 2.2 4.9 12.5 7.0 7.3 2.6 9.6 2.1 9.7 0.4 0.2 8.4 2.6 31.2 0.9 0.6 0.2 0.2 5.3 1.1 9.7 2.1 0.6 0.3 0.3 0.5 0.3 0.3 0.3 0.2 0.1 0.7 0.4 0.4 9.0 0.8 0.4 1.2 0.2 0.2 7.1 17.8 5.0 6.9 8.3 3.6 5.2 4.3 4.2 6.8 14.9 20.2 0.0 11.3 13.6 3.3 19.9 7.6 16.0 26.1 7.0 0.0 11.2 1.7 4.8 2.5 4.1 2.6 0.0 3.6 1.2 9.9 8.7 18.5 2.4 2.3 0.0 0.0 6.7 17.9 7.7 16.4 3.9 0.0 2.8 16.3 29.9 3.3 5.5 9.9 4.4 2.7 12.9 4.2 7.7 6.4 16.9 4.5 2.2 7.3 8.9 KRR1 "HRB2, RIP-1" ENSG00000111615 "KRR1, small subunit processome component homolog" Q13601 12 75490861-75511636 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043433, HPA051690" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "HPA043433: AB_10960988, HPA051690: AB_2681574" "unprognostic (2.77e-1)" "unprognostic (1.02e-1)" "unprognostic (8.21e-2)" "unprognostic (1.71e-1)" "unprognostic (2.02e-1)" "unprognostic (4.71e-2)" "unprognostic (6.01e-3)" "unprognostic (1.78e-1)" "unprognostic (1.00e-1)" "unprognostic (1.38e-1)" "unprognostic (5.85e-2)" "unprognostic (1.88e-1)" "unprognostic (2.32e-2)" "unprognostic (1.69e-1)" "unprognostic (1.61e-1)" "unprognostic (3.26e-1)" "unprognostic (1.12e-2)" 22.5 18.4 14.2 15.1 22.0 38.0 17.8 29.1 23.3 21.2 14.3 6.7 14.6 12.6 18.3 15.2 24.2 14.7 10.5 12.5 12.6 10.8 23.7 25.0 13.5 18.2 12.8 16.4 21.7 15.0 17.8 33.5 21.4 19.8 20.9 11.8 6.3 20.7 14.2 28.8 16.6 15.2 15.7 16.1 19.8 15.1 12.3 17.3 24.3 20.5 22.4 18.1 19.6 16.4 15.8 10.8 8.9 4.6 8.6 14.7 5.6 25.4 21.1 13.3 11.8 10.5 9.6 24.3 22.3 14.2 17.6 11.3 15.4 13.4 27.1 18.2 11.0 17.6 13.4 17.8 19.6 19.9 22.3 18.1 26.2 11.7 17.9 12.7 46.1 16.6 9.9 16.8 20.2 19.3 17.8 12.0 25.9 28.9 8.7 17.2 16.8 26.8 13.1 19.6 14.1 19.3 21.3 25.6 16.3 19.6 32.2 16.0 13.3 21.1 15.0 26.3 13.3 24.9 18.8 14.9 16.3 10.8 16.8 23.1 17.4 21.8 17.0 8.8 16.3 29.3 7.7 2.4 8.9 10.1 4.6 12.4 15.8 14.1 11.4 3.9 14.4 14.7 13.8 1.1 8.6 3.7 10.8 12.5 5.6 14.2 22.0 29.1 23.3 12.6 10.8 12.8 16.4 19.8 17.3 65.5 42.2 31.8 91.0 43.6 53.3 22.4 15.3 48.2 54.6 38.4 31.4 56.6 49.7 37.5 4.0 32.2 15.1 0.0 42.7 45.8 41.4 40.8 36.9 36.7 26.1 69.9 17.2 22.1 18.8 5.3 48.6 29.3 11.8 32.5 23.2 65.0 33.7 27.9 50.2 37.3 53.6 12.9 36.3 55.6 54.8 38.8 58.9 48.4 29.3 62.9 KRT15 "CK15, K15, K1CO" ENSG00000171346 "Keratin 15" P19012 17 41513743-41522529 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "breast: 37.4;esophagus: 115.3;skin 1: 119.3;vagina: 38.6" "Cell type enhanced" "Detected in many" 19 "Basal glandular cells: 1816.1;Basal keratinocytes: 1163.5;Urothelial cells: 567.2" "Cancer enhanced" "Detected in many" "cervical cancer: 178.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "HaCaT: 123.1;hTCEpi: 95.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023910, HPA024554" Enhanced Supported "Nucleoplasm,Intermediate filaments" No No 580000000 "Intermediate filaments" Nucleoplasm "HPA023910: AB_1852205, HPA024554: AB_1852207" "prognostic favorable (4.50e-4)" "unprognostic (9.14e-2)" "unprognostic (3.28e-2)" "unprognostic (1.19e-3)" "unprognostic (3.57e-2)" "unprognostic (8.84e-2)" "unprognostic (6.12e-3)" "unprognostic (1.70e-1)" "unprognostic (2.13e-1)" "unprognostic (8.65e-3)" "unprognostic (9.91e-3)" "unprognostic (2.09e-1)" "unprognostic (2.24e-11)" "unprognostic (6.91e-3)" "unprognostic (2.62e-1)" "unprognostic (1.33e-5)" "unprognostic (5.35e-2)" 0.6 0.0 1.4 0.6 1.5 0.0 37.4 0.6 1.1 14.6 1.1 0.6 0.6 0.0 0.6 0.6 115.3 2.7 10.6 0.6 1.3 0.0 1.1 0.6 2.1 0.6 0.6 0.6 0.6 0.6 0.0 0.6 3.0 1.1 16.4 0.0 1.4 15.1 0.6 0.6 119.3 3.5 0.6 0.6 0.6 0.0 0.6 0.6 0.6 0.6 1.9 6.2 0.8 38.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 6.1 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.6 2.2 0.0 0.2 0.0 1.3 123.1 0.0 4.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.4 0.0 95.2 0.2 0.7 0.3 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.6 0.0 0.0 10.4 0.3 0.7 0.2 0.0 0.1 1.8 0.1 0.0 2.3 0.0 2.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.4 1.5 0.6 1.1 1.3 0.0 0.6 0.6 1.1 0.6 11.9 10.1 0.0 1816.1 1163.5 0.6 0.7 7.6 22.7 230.9 1.8 0.0 0.4 1.7 6.9 90.0 0.5 4.7 0.0 6.8 6.5 13.4 221.8 2.3 0.0 0.3 0.0 4.6 0.0 0.0 35.8 1.4 5.1 303.7 0.0 10.4 0.0 8.6 9.7 0.4 0.0 0.6 0.0 22.7 0.6 0.7 169.3 1.0 0.5 6.0 567.2 KRT34 "Ha-4, KRTHA4" ENSG00000131737 "Keratin 34" O76011 17 41377650-41382403 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 10.3;skin 1: 36.0;tongue: 18.2" "Group enriched" "Detected in some" 17 "Early spermatids: 4.5;Late spermatids: 11.4" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "BJ: 66.1" "HPA055194, HPA072208" Enhanced Approved Nucleoplasm,Vesicles NA NA 170000000 "Nucleoplasm, Vesicles" "HPA055194: AB_2682733, HPA072208: AB_2686494" "unprognostic (2.52e-1)" "unprognostic (2.14e-1)" "unprognostic (9.03e-2)" "unprognostic (2.94e-1)" "unprognostic (2.25e-1)" "unprognostic (1.19e-1)" "unprognostic (2.86e-3)" "unprognostic (5.12e-7)" "unprognostic (3.84e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 10.3 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 18.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 66.1 2.9 7.9 15.6 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 2.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.0 8.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 KRT79 "K6L, KRT6L" ENSG00000185640 "Keratin 79" Q5XKE5 12 52821410-52834295 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 11.3;skin 1: 34.3" "Group enriched" "Detected in some" 5 "granulocytes: 4.6;Melanocytes: 3.3" "Group enriched" "Detected in some" 5 "breast cancer: 1.4;cervical cancer: 2.6;head and neck cancer: 2.7;melanoma: 1.6;urothelial cancer: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 20 "HMC-1: 99.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA059347 Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA 950000000 "Nucleoplasm, Nuclear membrane, Cytosol" "HPA059347: AB_2683986" "unprognostic (5.19e-3)" "unprognostic (1.56e-3)" "unprognostic (5.24e-2)" "unprognostic (2.38e-2)" "unprognostic (6.85e-2)" "unprognostic (6.36e-2)" "unprognostic (3.17e-1)" "unprognostic (7.92e-2)" "unprognostic (1.88e-2)" "unprognostic (1.60e-2)" "unprognostic (1.32e-1)" "unprognostic (2.72e-1)" "unprognostic (3.99e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 4.2 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 34.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 11.3 0.1 0.1 0.2 0.1 2.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 99.9 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 KRTCAP3 KCP3 ENSG00000157992 "Keratinocyte associated protein 3" Q53RY4 2 27442366-27446481 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 34.8" "Cell type enhanced" "Detected in many" 5 "Exocrine glandular cells: 157.5;Undifferentiated cells: 162.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "MAIT T-cell: 6.9;memory B-cell: 5.4;memory CD4 T-cell: 6.2;memory CD8 T-cell: 3.2;naive B-cell: 4.6;naive CD4 T-cell: 7.0;naive CD8 T-cell: 3.3;T-reg: 4.8" "Group enriched" "Detected in many" 19 "B-cells: 5.4;T-cells: 7.0" "Cell line enhanced" "Detected in some" "A-431: 28.1;CAPAN-2: 32.2;HaCaT: 10.3;OE19: 14.3;SCLC-21H: 15.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047136, HPA060203" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA047136: AB_2679949, HPA060203: AB_2684221" "prognostic favorable (2.67e-5)" "unprognostic (5.93e-2)" "unprognostic (5.03e-2)" "unprognostic (3.41e-1)" "unprognostic (1.29e-1)" "unprognostic (7.83e-2)" "unprognostic (1.44e-1)" "unprognostic (1.14e-1)" "unprognostic (9.43e-2)" "unprognostic (1.60e-2)" "unprognostic (1.44e-2)" "unprognostic (4.63e-2)" "unprognostic (1.04e-1)" "unprognostic (3.73e-3)" "unprognostic (3.79e-2)" "unprognostic (8.21e-2)" "unprognostic (9.42e-3)" 0.9 1.0 0.5 10.0 0.8 0.5 6.3 1.3 1.7 4.6 24.4 0.7 13.3 16.2 1.5 3.2 8.5 9.8 16.5 1.7 0.7 0.3 4.8 6.5 11.8 1.9 0.7 1.4 2.7 28.8 3.3 6.9 1.5 1.5 9.7 6.2 1.9 17.4 22.6 1.0 4.9 34.8 0.9 0.9 1.0 16.7 1.8 0.8 2.3 12.3 6.9 5.4 7.6 4.5 5.4 0.0 0.1 0.0 0.3 7.0 1.8 28.1 0.2 0.7 0.5 0.0 0.0 5.9 0.0 0.0 0.0 0.1 9.0 32.2 0.2 0.2 0.0 0.0 10.3 0.2 7.3 0.0 0.2 0.2 0.0 0.2 0.6 0.0 0.0 0.3 0.0 0.6 0.0 0.2 0.1 0.0 0.7 0.3 0.1 0.0 7.5 0.3 1.9 6.1 14.3 0.1 0.1 0.2 0.7 0.0 0.0 15.1 0.5 0.4 9.4 0.6 0.5 0.2 0.2 0.0 0.3 0.7 0.3 0.2 1.6 1.1 0.1 0.5 0.2 0.1 0.0 0.0 0.1 0.6 0.0 6.9 5.4 6.2 3.2 0.0 4.6 7.0 3.3 0.0 0.3 0.0 0.0 4.8 1.8 0.5 0.8 1.3 1.7 0.7 0.3 0.7 1.4 1.5 0.8 20.8 18.0 3.7 106.9 20.7 2.6 0.2 86.6 56.2 43.3 40.1 7.9 15.0 5.0 85.6 4.7 0.8 81.3 0.0 157.5 26.3 1.5 101.7 4.6 12.1 1.8 1.6 59.7 1.3 0.6 3.6 0.3 1.8 6.8 4.6 108.5 1.5 121.7 98.2 0.0 4.9 5.9 0.0 1.0 2.7 33.8 13.6 6.6 1.0 162.2 123.8 KY FLJ33207 ENSG00000174611 "Kyphoscoliosis peptidase" Q8NBH2 3 134603138-134651636 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease" "Myofibrillar myopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 19.5;tongue: 36.2" "Cell type enhanced" "Detected in some" 19 "Early spermatids: 3.0;Late spermatids: 5.2;Muller glia cells: 2.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "basophil: 7.4" "Lineage enriched" "Detected in single" 75 "granulocytes: 7.4" "Cell line enhanced" "Detected in some" "Karpas-707: 3.4;U-2197: 4.6;U-87 MG: 13.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA036492, HPA036668" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA036492: AB_10672222, HPA036668: AB_2675239" "unprognostic (1.40e-2)" "unprognostic (2.05e-2)" "unprognostic (4.24e-2)" "unprognostic (2.81e-2)" "unprognostic (2.72e-2)" "unprognostic (1.65e-2)" "unprognostic (2.42e-2)" "unprognostic (2.42e-1)" "unprognostic (1.27e-1)" "unprognostic (3.86e-2)" "unprognostic (9.87e-2)" "unprognostic (2.83e-2)" "unprognostic (3.82e-1)" "unprognostic (4.62e-2)" "unprognostic (2.29e-1)" "unprognostic (8.98e-2)" "unprognostic (1.47e-1)" 0.3 5.7 3.5 0.4 2.3 0.5 1.4 2.5 4.6 2.2 1.7 2.1 1.7 0.9 3.9 2.3 3.1 3.7 0.9 4.8 4.9 2.1 0.7 0.2 0.3 0.2 1.7 6.9 1.7 0.2 8.5 6.8 0.2 3.2 3.6 0.6 3.3 1.7 2.8 19.5 12.6 0.5 7.4 2.0 0.3 1.7 0.7 3.6 0.5 5.2 36.2 1.1 1.3 1.4 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 13.9 0.7 0.0 7.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 3.5 2.3 2.5 4.6 4.9 2.1 1.7 6.9 3.2 3.6 0.0 0.0 0.0 0.0 0.6 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 2.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 KYNU ENSG00000115919 Kynureninase Q16719 2 142877498-143055832 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 35.9;liver: 41.1;placenta: 34.3" "Cell type enhanced" "Detected in many" 18 "Macrophages: 94.5;monocytes: 360.7;Syncytiotrophoblasts: 87.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 18 "classical monocyte: 28.7;intermediate monocyte: 35.9;memory B-cell: 19.7;myeloid DC: 28.4;naive B-cell: 12.7;non-classical monocyte: 29.2;plasmacytoid DC: 19.9" "Group enriched" "Detected in many" 21 "B-cells: 19.7;dendritic cells: 28.4;monocytes: 35.9" "Cell line enhanced" "Detected in some" "A549: 37.9;GAMG: 62.8;HeLa: 42.3;Hep G2: 25.7;hTEC/SVTERT24-B: 22.2;U-87 MG: 66.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA031686 Enhanced Supported Nucleoplasm,Cytosol NA NA 360000 Cytosol Nucleoplasm "HPA031686: AB_2673995" "unprognostic (2.58e-2)" "unprognostic (3.39e-3)" "unprognostic (1.21e-2)" "unprognostic (5.94e-2)" "unprognostic (1.65e-2)" "unprognostic (9.04e-2)" "unprognostic (5.36e-3)" "unprognostic (3.58e-3)" "unprognostic (4.88e-2)" "unprognostic (3.35e-2)" "unprognostic (2.87e-3)" "unprognostic (1.51e-1)" "unprognostic (1.40e-3)" "unprognostic (3.33e-3)" "unprognostic (3.65e-2)" "unprognostic (5.24e-2)" "unprognostic (1.64e-1)" 9.0 3.7 2.2 11.0 3.7 3.9 15.4 0.6 1.7 3.0 1.2 1.3 0.8 0.2 1.1 2.6 5.6 1.5 4.4 3.8 1.4 1.1 8.4 41.1 12.7 13.7 2.9 0.4 1.7 1.0 0.2 1.6 34.3 2.7 1.9 1.2 1.5 3.0 0.8 0.7 1.5 2.7 2.0 6.3 16.0 2.4 7.0 2.6 2.7 2.2 1.7 13.0 12.4 2.6 19.7 28.4 1.3 35.9 0.4 0.1 11.1 0.0 37.9 0.1 0.1 0.0 0.1 0.1 0.0 1.0 0.0 0.0 0.6 0.5 2.2 0.1 0.0 62.8 0.1 0.0 0.0 0.0 0.1 0.0 0.8 42.3 25.7 0.5 0.1 0.2 3.6 3.1 22.2 0.1 0.0 0.0 0.0 0.1 0.2 0.3 19.3 0.0 2.3 0.1 0.0 0.1 0.0 0.2 0.1 0.6 19.6 0.1 0.0 21.0 3.1 0.2 0.2 10.5 5.4 0.3 1.2 0.1 18.5 0.0 0.1 0.0 0.0 66.4 4.4 0.1 0.1 28.7 0.5 0.1 35.9 0.1 19.7 0.1 0.1 28.4 12.7 0.1 0.0 1.3 0.4 29.2 19.9 0.1 11.1 2.2 3.7 0.6 1.7 1.4 1.1 2.9 0.4 2.7 2.6 3.0 2.4 22.6 0.5 3.5 0.1 1.2 5.1 2.7 10.3 3.5 3.9 2.8 5.0 12.1 34.6 2.9 0.0 0.0 7.8 1.5 3.3 0.8 0.0 44.8 38.5 9.5 0.0 3.1 59.7 39.6 1.7 94.5 1.7 360.7 0.0 0.2 37.4 0.0 0.4 23.0 0.5 6.5 1.3 40.0 8.0 2.8 87.5 0.0 0.0 4.2 L1CAM "CD171, HSAS, HSAS1, MASA, MIC5, S10, SPG1" ENSG00000198910 "L1 cell adhesion molecule" P32004 X 153861514-153886174 "CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein" "Disease mutation, Hereditary spastic paraplegia, Hirschsprung disease, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 29.6;brain: 54.5" "Group enriched" "Detected in some" 6 "Collecting duct cells: 80.3;Horizontal cells: 31.8;Melanocytes: 42.2" "Cancer enhanced" "Detected in many" "melanoma: 34.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 1.0;naive B-cell: 2.2" "Lineage enriched" "Detected in single" 7 "B-cells: 2.2" "Cell line enhanced" "Detected in many" "BJ hTERT+: 73.5;BJ hTERT+ SV40 Large T+ RasG12V: 40.4;HeLa: 53.0;RH-30: 32.2;RPTEC TERT1: 43.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010896 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 59000000 "Nucleoplasm, Plasma membrane" "CAB010896: AB_609903" "unprognostic (1.33e-3)" "unprognostic (3.43e-2)" "unprognostic (2.75e-1)" "prognostic unfavorable (8.51e-10)" "unprognostic (2.04e-2)" "prognostic unfavorable (3.81e-4)" "unprognostic (9.44e-2)" "prognostic unfavorable (2.36e-6)" "unprognostic (1.13e-1)" "unprognostic (9.12e-2)" "unprognostic (8.52e-3)" "unprognostic (8.02e-2)" "prognostic unfavorable (1.17e-4)" "unprognostic (3.07e-1)" "unprognostic (6.31e-2)" "unprognostic (1.69e-1)" "unprognostic (7.47e-3)" 4.4 29.6 19.9 8.0 21.9 1.2 1.7 54.5 43.6 2.8 16.3 1.5 2.0 4.9 1.7 3.0 5.3 2.6 3.2 5.2 11.2 20.6 12.3 1.3 1.3 3.7 7.3 22.4 1.4 3.0 1.0 6.1 1.4 19.3 3.5 5.7 6.2 5.9 10.8 1.6 9.9 7.6 6.1 3.5 1.7 4.8 1.5 3.4 0.0 1.2 1.3 2.6 2.3 3.9 2.2 0.0 0.0 0.0 0.0 0.3 0.2 17.9 1.4 5.4 0.0 0.0 0.0 2.3 25.5 73.5 24.6 40.4 7.3 0.1 0.0 24.3 0.1 20.6 0.7 0.6 0.4 12.9 0.0 0.1 0.0 53.0 1.1 0.0 0.0 4.0 0.1 0.3 3.7 2.5 0.0 0.0 0.0 0.0 0.0 0.1 24.4 0.0 0.5 1.2 0.0 0.9 0.0 32.2 0.1 43.2 0.3 16.2 10.6 14.3 12.7 10.3 12.7 1.3 0.3 0.0 0.0 10.8 1.1 12.1 0.2 0.3 0.1 0.1 0.2 20.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 19.9 21.9 54.5 30.2 11.2 20.6 7.3 22.4 19.3 3.4 0.0 0.0 0.8 0.0 1.0 8.5 0.8 0.0 0.0 0.0 80.3 3.9 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.1 31.8 0.0 1.8 0.0 0.0 0.9 0.0 42.2 0.0 0.0 0.8 0.0 0.0 0.0 0.2 8.6 0.0 0.4 0.0 0.1 1.1 0.1 0.0 0.0 0.1 L3MBTL1 "dJ138B7.3, DKFZp586P1522, KIAA0681, L3MBTL, ZC2HC3" ENSG00000185513 "L3MBTL1, histone methyl-lysine binding protein" Q9Y468 20 43507680-43550950 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 16.2;Cone photoreceptor cells: 13.7;Spermatocytes: 15.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 10.7;SuSa: 11.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA068051 Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA068051: AB_2732778" "unprognostic (2.32e-1)" "unprognostic (2.77e-1)" "unprognostic (5.66e-2)" "unprognostic (7.19e-3)" "unprognostic (1.28e-1)" "unprognostic (1.50e-2)" "unprognostic (7.65e-4)" "unprognostic (6.02e-2)" "unprognostic (6.00e-2)" "unprognostic (2.23e-2)" "unprognostic (1.15e-3)" "unprognostic (1.20e-2)" "unprognostic (1.44e-3)" "unprognostic (2.01e-1)" "unprognostic (1.65e-1)" "unprognostic (2.89e-1)" "unprognostic (1.56e-4)" 3.3 5.7 12.6 4.3 11.7 6.4 5.2 25.0 14.3 5.6 4.9 10.5 8.3 4.3 8.2 10.7 4.0 10.4 3.9 5.7 13.8 16.4 4.5 1.8 4.2 4.7 16.3 9.6 11.2 3.3 7.1 14.6 5.1 10.1 6.6 4.4 7.5 8.1 8.0 9.0 9.7 4.7 6.0 7.4 5.6 4.2 13.3 14.5 4.6 7.2 0.7 5.5 4.3 5.4 0.5 1.3 1.5 0.2 2.5 1.8 1.4 0.2 2.0 5.5 3.7 0.1 0.0 10.7 1.2 1.5 1.8 3.1 0.5 5.7 3.1 2.0 2.0 2.4 4.8 0.0 1.1 1.5 0.0 4.9 2.5 4.9 3.8 1.4 0.0 2.9 2.2 2.5 1.2 0.0 5.1 1.1 4.3 2.9 2.1 1.0 0.6 1.3 3.2 2.7 2.0 2.9 2.4 1.3 0.8 4.1 1.3 2.0 6.2 2.0 1.3 0.3 11.1 2.7 3.2 2.0 1.0 3.7 0.0 0.9 4.0 1.0 1.1 3.9 3.9 1.1 0.0 0.2 0.6 0.8 0.2 1.3 0.5 1.0 1.0 0.9 0.4 1.8 0.6 1.5 2.5 0.1 1.3 0.3 1.4 12.6 11.7 25.0 14.3 13.8 16.4 16.3 9.6 10.1 14.5 3.0 2.7 0.0 1.9 0.8 16.2 1.6 0.0 6.7 5.7 5.2 13.7 1.9 1.7 1.1 1.6 1.0 1.1 0.0 0.2 2.8 1.1 2.0 4.7 0.8 1.1 6.4 1.2 1.3 1.9 2.1 4.6 2.4 3.3 0.0 1.1 6.4 0.6 1.9 5.6 0.3 11.7 0.0 1.4 15.1 10.2 1.0 1.6 1.5 1.7 1.4 L3MBTL2 "dJ756G23.3, DKFZP761I141, H-l(3)mbt-l" ENSG00000100395 "L3MBTL2, polycomb repressive complex 1 subunit" Q969R5 22 41205205-41231271 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000815 Approved Nucleoplasm NA NA Nucleoplasm "HPA000815: AB_1079220" "unprognostic (2.42e-1)" "prognostic favorable (6.39e-5)" "unprognostic (3.98e-2)" "prognostic favorable (4.37e-4)" "unprognostic (3.48e-1)" "unprognostic (1.19e-2)" "unprognostic (4.16e-3)" "unprognostic (1.03e-2)" "unprognostic (2.19e-1)" "unprognostic (2.26e-1)" "unprognostic (7.95e-3)" "unprognostic (1.05e-1)" "unprognostic (2.10e-2)" "unprognostic (2.07e-3)" "unprognostic (1.81e-1)" "unprognostic (2.70e-2)" "unprognostic (2.19e-1)" 10.8 15.8 15.2 13.5 26.4 11.1 12.9 20.6 32.7 15.5 12.8 16.8 17.9 10.1 15.0 15.2 12.6 24.0 11.4 14.3 15.6 16.6 12.4 16.9 13.9 18.5 14.5 19.2 18.7 15.9 23.6 22.6 12.4 15.4 15.1 12.5 15.2 15.8 17.9 11.6 15.6 11.8 16.9 12.6 16.9 13.2 14.5 16.0 16.7 14.7 9.3 20.4 13.8 10.9 13.1 13.2 7.2 13.3 14.5 17.7 15.2 9.8 9.9 8.3 17.2 10.6 7.9 9.9 9.5 11.2 18.7 15.5 6.2 7.2 16.1 7.6 13.0 11.3 9.7 20.2 12.7 12.0 20.0 25.7 6.3 17.9 15.0 11.2 30.7 15.0 10.8 4.9 14.9 14.0 8.0 13.3 12.7 11.4 13.3 8.8 17.3 15.3 10.3 11.7 36.2 11.6 15.8 6.7 19.0 9.3 10.1 7.0 4.9 16.7 12.4 9.9 8.8 8.2 17.2 10.6 9.9 9.3 7.9 10.5 10.8 19.8 13.5 11.6 14.1 12.7 6.5 10.4 7.2 17.7 12.9 16.3 13.1 14.1 13.9 13.2 9.3 16.9 15.9 1.1 14.5 13.3 9.8 13.5 15.2 15.2 26.4 20.6 32.7 15.6 16.6 14.5 19.2 15.4 16.0 14.9 18.7 6.0 5.1 2.4 23.9 9.2 17.8 26.8 22.7 10.4 15.7 14.9 10.0 8.4 10.3 6.8 7.1 23.3 6.7 16.3 5.7 5.8 10.5 12.3 11.1 15.9 14.5 8.0 9.1 23.9 6.6 9.9 3.3 10.8 7.5 14.1 7.2 5.8 8.9 6.7 14.2 6.5 8.2 18.4 12.4 3.3 14.3 12.5 8.0 5.3 L3MBTL3 KIAA1798 ENSG00000198945 "L3MBTL3, histone methyl-lysine binding protein" Q96JM7 6 130013699-130141451 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "granulocytes: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 31.5;HUVEC TERT2: 30.6;TIME: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044382, HPA053035" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim" Yes No "Nucleoli, Nucleoli rim" Nucleoplasm "HPA044382: AB_2678920, HPA053035: AB_2682021" "unprognostic (2.33e-1)" "unprognostic (9.92e-2)" "unprognostic (1.40e-1)" "unprognostic (7.82e-2)" "unprognostic (4.22e-3)" "unprognostic (1.28e-2)" "unprognostic (4.51e-2)" "unprognostic (1.48e-2)" "unprognostic (2.90e-1)" "unprognostic (2.63e-1)" "unprognostic (7.56e-3)" "unprognostic (1.07e-1)" "unprognostic (8.44e-2)" "unprognostic (3.94e-3)" "unprognostic (2.88e-1)" "unprognostic (2.45e-2)" "unprognostic (1.60e-2)" 8.8 16.7 5.2 16.4 8.2 7.5 7.5 2.4 7.7 17.1 5.6 3.6 9.3 3.1 17.5 14.1 5.7 7.4 6.0 4.1 5.4 5.8 6.1 6.4 7.4 11.4 5.2 5.9 12.1 3.8 8.1 17.0 6.5 5.7 10.3 5.7 4.8 5.8 7.5 5.3 4.3 7.6 9.9 5.4 18.5 4.6 7.5 3.9 25.5 10.2 4.3 12.8 10.4 11.6 10.7 10.8 3.9 14.1 1.7 4.2 0.6 0.8 3.2 7.4 1.1 5.1 6.9 1.5 3.7 7.7 1.5 2.7 3.8 4.0 1.3 5.4 4.8 4.6 3.2 4.2 6.6 2.3 2.9 4.3 8.6 1.6 1.0 2.6 5.1 31.5 4.3 4.8 1.7 5.1 7.6 30.6 4.1 6.2 3.5 3.8 0.3 10.8 0.9 3.5 0.7 1.6 4.0 2.1 0.0 4.9 1.2 0.2 1.0 1.4 0.3 3.0 9.5 7.8 4.5 20.9 2.5 3.5 0.4 2.4 0.6 0.0 2.3 1.2 2.1 2.5 3.9 3.5 3.5 2.7 4.0 2.7 7.6 2.7 3.8 1.3 10.7 2.4 3.0 3.7 1.7 14.1 10.8 4.2 0.6 5.2 8.2 2.4 7.7 5.4 5.8 5.2 5.9 5.7 3.9 3.0 9.2 7.5 4.8 4.5 2.9 2.9 2.5 5.3 3.4 8.7 2.0 10.2 1.7 4.3 18.5 5.6 0.7 0.0 4.9 6.0 6.7 4.2 38.3 4.9 3.3 0.0 3.5 7.4 8.2 1.6 8.9 3.6 1.7 4.6 7.2 5.6 7.5 3.5 5.6 4.3 0.7 6.5 5.1 5.4 6.1 3.9 5.1 10.0 4.1 5.2 L3MBTL4 "FLJ35936, HsT1031" ENSG00000154655 "L3MBTL4, histone methyl-lysine binding protein" Q8NA19 18 5954706-6415237 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 50.7;Late spermatids: 66.8;monocytes: 45.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive B-cell: 5.3;NK-cell: 6.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 4.3;Karpas-707: 5.9;RPMI-8226: 13.8;SCLC-21H: 6.7;SH-SY5Y: 7.3;U-2 OS: 4.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA064194, HPA069042" Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA064194: AB_2685208, HPA069042: AB_2686071" "unprognostic (1.33e-3)" "unprognostic (8.98e-2)" "unprognostic (6.31e-2)" "unprognostic (1.10e-1)" "unprognostic (3.56e-2)" "unprognostic (1.40e-1)" "unprognostic (1.70e-2)" "unprognostic (1.73e-1)" "unprognostic (4.68e-2)" "unprognostic (1.94e-1)" "unprognostic (1.92e-1)" "unprognostic (1.91e-1)" "unprognostic (1.20e-2)" "unprognostic (5.08e-2)" "unprognostic (1.00e-1)" "unprognostic (2.14e-3)" "unprognostic (6.08e-2)" 6.3 6.9 8.4 3.7 12.8 2.1 6.8 0.8 8.1 6.2 3.4 12.3 4.8 4.2 4.9 5.4 5.9 6.2 4.3 8.6 9.6 3.5 9.9 12.0 5.9 2.7 13.7 5.5 12.3 14.2 18.8 8.2 1.1 4.6 3.4 3.0 6.0 5.9 9.6 1.4 9.9 4.8 2.0 3.6 4.0 4.4 17.0 13.4 0.6 8.2 2.5 2.3 3.1 7.1 5.3 1.3 0.4 2.2 6.4 1.4 0.8 0.0 0.3 0.3 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.0 0.2 0.6 0.0 0.0 4.3 0.2 0.0 0.0 0.1 0.0 2.0 0.1 0.2 2.9 2.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.1 0.3 0.0 1.8 3.8 0.0 13.8 0.0 2.4 6.7 7.3 0.0 0.1 0.3 0.5 0.0 0.0 0.1 0.1 4.4 0.1 1.7 0.2 0.0 0.1 1.7 0.1 2.1 0.4 2.2 0.1 1.4 0.6 0.1 1.1 0.2 0.2 1.3 5.3 0.3 0.4 0.3 6.4 1.4 0.3 0.1 0.8 8.4 12.8 0.8 8.1 9.6 3.5 13.7 5.5 4.6 13.4 3.0 9.8 0.0 5.5 6.9 0.8 4.5 12.7 1.4 6.8 5.2 15.7 0.1 3.3 7.1 50.7 3.6 0.9 0.0 4.5 0.0 2.8 4.9 1.1 8.5 3.3 0.0 10.9 1.3 2.5 66.8 9.5 2.6 1.7 45.1 1.3 1.0 3.8 1.9 12.0 6.0 0.3 6.5 6.2 11.8 1.3 7.2 0.1 1.0 3.8 3.9 LACTB2 CGI-83 ENSG00000147592 "Lactamase beta 2" Q53H82 8 70635318-70669174 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 70.1;liver: 58.8" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 194.5;Proximal tubular cells: 262.2;Spermatocytes: 198.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 99.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044391, HPA053040" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 24000 Cytosol "Nucleoplasm, Golgi apparatus" "HPA044391: AB_10965168, HPA053040: AB_2682022" "unprognostic (6.33e-3)" "unprognostic (3.13e-1)" "unprognostic (1.96e-1)" "unprognostic (1.23e-2)" "unprognostic (1.82e-1)" "unprognostic (4.29e-2)" "unprognostic (1.61e-1)" "unprognostic (2.34e-1)" "unprognostic (8.10e-2)" "unprognostic (3.95e-1)" "unprognostic (7.73e-3)" "unprognostic (1.96e-1)" "prognostic favorable (5.60e-4)" "unprognostic (3.70e-1)" "unprognostic (7.49e-2)" "unprognostic (2.93e-1)" "unprognostic (5.93e-2)" 9.3 31.4 6.8 6.7 10.0 1.2 8.9 2.0 7.1 5.5 13.5 9.0 5.3 17.8 5.7 8.3 7.6 5.2 14.6 19.3 7.2 7.2 70.1 58.8 9.7 8.9 11.5 7.5 5.5 10.6 6.2 12.6 6.3 10.1 7.5 10.0 6.2 7.8 8.6 12.0 6.1 19.1 7.2 11.6 8.0 7.7 45.7 11.7 6.0 9.8 10.9 5.9 8.2 7.4 14.0 18.2 13.4 17.3 11.0 13.8 6.4 14.3 15.0 4.7 1.9 8.3 12.7 2.9 8.0 4.7 8.7 6.6 7.1 16.2 0.0 3.3 3.9 17.5 10.3 5.7 8.5 6.9 8.6 6.4 6.7 2.0 3.9 17.4 6.5 5.8 15.3 10.4 4.3 6.5 4.1 2.2 5.3 11.6 13.6 11.4 4.3 3.7 1.2 5.1 19.4 14.2 3.3 2.8 3.0 33.2 7.6 6.8 2.4 17.9 99.3 8.9 6.4 16.6 8.8 3.6 0.6 4.8 15.4 6.5 11.1 8.3 0.0 4.9 11.2 6.4 11.1 15.2 13.4 9.9 17.3 12.5 14.0 10.4 9.7 18.2 13.2 10.1 10.6 6.4 11.0 16.4 12.8 13.8 6.4 6.8 10.0 2.0 7.1 7.2 7.2 11.5 7.5 10.1 11.7 53.6 33.1 13.5 17.8 14.5 13.8 31.9 25.5 20.1 30.7 17.4 7.9 19.6 64.6 43.6 194.5 15.3 25.3 0.0 101.8 11.7 10.3 12.0 9.2 70.0 40.7 7.9 11.6 22.1 31.8 14.1 19.0 23.7 15.1 11.8 21.3 33.2 68.2 19.2 14.2 262.2 14.8 6.5 11.3 198.5 24.5 14.6 16.2 23.0 26.4 8.1 LAGE3 "CVG5, DXS9879E, DXS9951E, ESO3, ITBA2, Pcc1" ENSG00000196976 "L antigen family member 3" Q14657 X 154477769-154479257 "Disease related genes, Predicted intracellular proteins" "tRNA processing" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA036122, HPA036123" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA036122: AB_2674951, HPA036123: AB_10601926" "unprognostic (1.70e-1)" "prognostic favorable (5.29e-6)" "unprognostic (1.09e-2)" "prognostic unfavorable (7.60e-4)" "unprognostic (2.28e-1)" "unprognostic (9.65e-2)" "prognostic unfavorable (8.63e-5)" "unprognostic (1.99e-2)" "unprognostic (2.08e-1)" "unprognostic (3.04e-2)" "unprognostic (4.88e-3)" "unprognostic (6.73e-2)" "prognostic unfavorable (5.42e-5)" "unprognostic (7.37e-2)" "unprognostic (3.57e-2)" "unprognostic (2.31e-1)" "unprognostic (1.80e-1)" 10.9 18.3 24.6 9.1 23.0 20.1 7.9 12.4 27.4 10.0 9.7 9.4 5.3 8.5 6.1 11.1 6.8 7.3 7.9 11.0 22.3 15.6 6.7 12.3 7.3 11.3 16.3 20.7 11.3 20.2 5.1 16.6 6.9 12.1 9.7 6.2 8.6 17.5 9.0 22.0 12.2 7.5 7.4 12.3 10.9 11.2 5.0 10.4 16.7 6.2 8.1 10.8 8.4 6.3 14.5 27.5 10.8 10.8 18.4 36.5 15.6 12.6 12.1 4.5 9.5 4.9 4.0 13.3 3.9 2.7 5.9 6.6 7.8 6.9 27.1 35.6 5.1 10.5 5.5 11.1 3.8 2.0 15.4 17.7 9.8 11.3 4.4 8.3 13.1 14.7 6.2 2.6 8.8 2.3 4.5 4.1 13.2 9.6 13.2 8.0 29.9 17.4 38.2 8.5 17.1 29.4 15.4 7.7 30.2 3.4 3.5 12.5 11.6 9.0 21.8 15.7 3.2 9.4 9.6 4.6 4.2 12.6 17.7 14.7 31.2 32.4 40.8 7.5 23.5 9.8 10.8 10.8 4.2 11.7 9.8 14.8 14.5 16.2 17.1 14.8 12.2 36.5 18.7 1.2 18.4 8.0 27.5 12.3 15.6 24.6 23.0 12.4 27.4 22.3 15.6 16.3 20.7 12.1 10.4 8.9 14.3 71.5 41.6 51.5 53.2 30.2 63.7 14.7 4.5 33.2 7.9 50.3 107.8 40.4 1.7 41.3 31.9 23.3 81.3 104.5 43.3 40.6 46.1 41.5 106.6 22.3 54.2 29.4 37.2 4.7 38.6 58.8 87.7 76.7 44.6 51.0 42.4 23.0 34.6 60.2 15.4 6.5 45.3 15.7 103.1 48.9 47.5 40.6 51.3 36.1 LAMA5 ENSG00000130702 "Laminin subunit alpha 5" O15230 20 62307955-62367312 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 71.5;Cytotrophoblasts: 73.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A549: 30.9;CACO-2: 42.6;EFO-21: 31.8;HaCaT: 29.0;HeLa: 27.8;TIME: 37.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA054609, CAB078157" Enhanced Approved Nucleoplasm,Vesicles "Secreted to extracellular matrix" NA NA 1200000 Vesicles Nucleoplasm "CAB078157: AB_2665809, HPA054609: AB_2682540" "unprognostic (8.01e-2)" "unprognostic (2.47e-1)" "unprognostic (1.92e-2)" "unprognostic (3.42e-3)" "unprognostic (1.17e-1)" "unprognostic (9.90e-3)" "unprognostic (4.01e-3)" "unprognostic (5.45e-2)" "unprognostic (8.99e-2)" "unprognostic (1.34e-2)" "unprognostic (5.98e-3)" "unprognostic (2.98e-3)" "unprognostic (4.04e-2)" "unprognostic (9.86e-3)" "unprognostic (2.07e-1)" "unprognostic (9.76e-2)" "unprognostic (1.33e-2)" 22.6 5.9 5.6 8.1 5.9 2.5 16.8 24.0 6.6 16.7 28.0 3.1 18.6 7.6 23.2 13.8 18.0 14.2 27.4 13.7 4.7 2.9 17.0 7.3 19.7 4.4 3.7 2.3 6.9 13.9 8.3 6.0 33.3 5.5 17.4 2.6 18.6 12.7 25.0 9.4 45.2 9.0 25.0 4.5 8.8 13.3 4.4 3.4 2.0 18.4 11.8 10.4 19.4 24.9 0.9 1.2 0.2 0.0 0.0 0.0 0.0 3.9 30.9 0.6 4.0 0.7 8.8 23.8 1.1 0.6 0.9 0.1 42.6 16.0 0.3 31.8 0.0 0.9 29.0 0.8 12.4 0.0 0.1 1.7 1.0 27.8 12.1 2.8 0.0 4.6 0.4 8.2 2.1 2.2 1.5 4.1 0.0 1.8 0.4 0.0 5.9 0.0 0.1 2.0 5.1 18.0 0.0 0.3 3.3 8.0 18.9 0.3 12.3 17.1 17.1 0.3 3.3 17.0 0.2 37.3 0.4 11.8 0.2 5.0 0.2 0.0 0.1 8.8 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 5.6 5.9 24.0 6.6 4.7 2.9 3.7 2.3 5.5 3.4 71.5 26.6 8.3 15.9 15.1 1.3 15.3 22.9 13.4 35.2 36.6 7.9 73.3 0.0 28.3 4.3 36.5 0.0 0.0 3.8 24.9 7.8 13.3 2.3 9.4 11.6 3.2 2.4 17.8 0.0 1.1 9.2 2.5 1.7 1.8 0.0 8.2 10.9 0.0 18.4 10.2 1.7 25.8 31.9 0.7 1.9 11.0 47.9 1.0 0.2 24.5 LAMTOR2 "ENDAP, MAPBPIP, MAPKSP1AP, p14, Ragulator2, ROBLD3" ENSG00000116586 "Late endosomal/lysosomal adaptor, MAPK and MTOR activator 2" Q9Y2Q5 1 156054752-156058510 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004126 Approved Approved Nucleoplasm,Vesicles No No 17000 "Nucleoplasm, Vesicles" "HPA004126: AB_1849916" "unprognostic (2.09e-1)" "unprognostic (1.23e-1)" "unprognostic (2.07e-1)" "unprognostic (1.58e-1)" "unprognostic (8.14e-2)" "unprognostic (4.52e-2)" "unprognostic (8.64e-2)" "unprognostic (3.90e-2)" "unprognostic (3.79e-1)" "unprognostic (1.66e-2)" "unprognostic (2.06e-1)" "unprognostic (3.41e-2)" "prognostic unfavorable (1.10e-6)" "unprognostic (2.47e-1)" "unprognostic (1.34e-1)" "unprognostic (8.65e-2)" "unprognostic (1.35e-1)" 24.3 33.5 30.3 18.8 27.2 23.4 35.3 14.2 30.6 22.5 27.5 13.8 34.3 24.5 17.0 38.1 27.6 25.4 25.7 37.2 25.8 24.9 31.7 63.5 27.7 37.9 26.4 22.8 11.4 75.2 16.6 18.0 21.1 23.4 18.8 27.5 16.4 35.9 34.3 35.5 20.4 26.2 26.2 19.3 26.0 27.3 12.1 20.3 20.2 20.9 30.2 23.6 21.9 17.0 47.2 89.8 60.4 80.6 32.6 47.6 56.7 15.1 34.5 16.4 22.4 33.3 27.1 18.0 13.6 23.1 17.0 19.5 15.8 26.0 22.5 23.7 26.2 15.0 22.4 16.6 36.7 9.6 18.7 25.2 13.1 23.4 20.8 26.4 18.5 21.4 31.9 23.0 18.1 23.3 23.8 34.6 33.8 11.8 16.9 24.4 30.6 19.1 26.4 17.2 60.3 51.9 16.2 12.2 32.9 37.3 22.3 6.3 36.5 17.3 48.2 27.5 27.2 33.9 54.5 23.4 14.4 13.3 20.9 12.7 25.6 37.5 13.1 25.7 20.6 15.4 41.8 80.6 60.4 30.9 71.6 30.2 47.2 34.2 33.5 89.8 38.3 26.2 28.2 39.6 32.6 56.5 47.5 47.6 56.7 30.3 27.2 14.2 30.6 25.8 24.9 26.4 22.8 23.4 20.3 53.6 42.8 84.0 54.8 42.9 27.7 101.0 124.9 48.2 29.6 102.9 5.9 124.2 328.3 164.5 35.9 83.1 242.4 23.3 156.0 159.6 83.8 73.9 107.1 259.1 359.6 6.4 121.0 78.0 197.4 46.6 43.7 177.6 150.1 338.2 124.1 62.7 171.6 238.4 47.7 425.0 20.8 32.3 55.6 21.8 36.0 69.9 64.5 60.9 143.9 71.1 LANCL2 "GPR69B, TASP" ENSG00000132434 "LanC like 2" Q9NS86 7 55365448-55433742 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 38.4;Late spermatids: 42.1" "Cancer enhanced" "Detected in all" "glioma: 52.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in all" 7 "A-431: 58.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019711, HPA029535" Uncertain Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA019711: AB_1852699, HPA029535: AB_10602342" "unprognostic (1.11e-1)" "unprognostic (6.89e-2)" "unprognostic (7.28e-2)" "unprognostic (1.28e-2)" "unprognostic (1.20e-1)" "unprognostic (1.76e-2)" "unprognostic (1.01e-1)" "unprognostic (1.31e-1)" "unprognostic (2.56e-1)" "prognostic favorable (1.89e-4)" "unprognostic (1.35e-3)" "unprognostic (5.58e-2)" "prognostic favorable (1.03e-6)" "unprognostic (4.58e-3)" "unprognostic (1.04e-2)" "unprognostic (3.94e-1)" "unprognostic (1.45e-1)" 3.1 4.9 20.4 2.3 17.0 3.1 5.9 9.9 28.5 6.1 4.6 19.8 1.8 5.0 9.6 5.3 3.5 5.6 3.8 3.9 17.2 11.3 6.0 4.8 3.0 4.0 12.9 21.1 9.6 3.4 10.4 4.2 3.9 10.1 5.9 4.7 2.4 3.3 6.9 5.7 5.3 4.2 7.0 10.8 2.8 3.5 5.7 13.1 3.3 6.6 0.3 2.7 2.8 2.7 2.7 4.7 0.7 4.5 3.6 6.0 2.6 58.4 2.0 4.1 2.7 1.2 2.2 2.3 2.7 3.2 4.1 3.5 2.0 1.7 4.1 2.5 3.8 4.1 2.6 2.2 1.5 2.5 1.8 4.3 1.4 1.6 2.0 2.2 4.5 2.7 3.9 1.6 3.1 1.0 2.1 2.0 1.9 2.5 2.7 3.8 1.7 1.1 2.1 7.9 1.6 2.5 1.7 1.9 2.0 2.7 4.7 7.2 6.8 3.8 5.7 1.5 1.6 2.3 4.8 3.3 2.6 3.5 4.9 5.1 2.6 3.1 4.4 2.0 1.0 4.9 0.4 3.6 0.7 2.6 4.5 4.5 2.7 3.4 3.9 4.7 2.6 3.1 2.7 0.5 3.6 3.0 3.7 6.0 2.6 20.4 17.0 9.9 28.5 17.2 11.3 12.9 21.1 10.1 13.1 3.0 6.2 7.6 5.5 3.5 8.0 7.5 7.6 8.1 4.5 10.4 5.9 10.6 5.0 6.7 38.4 4.8 6.6 23.3 10.4 11.1 9.3 4.3 11.5 7.3 6.6 14.3 12.1 9.2 6.3 42.1 8.3 5.0 0.0 9.0 8.6 10.6 6.7 7.0 7.1 19.5 8.2 0.0 3.1 12.0 10.9 3.3 15.9 4.4 10.3 4.7 LAP3 "LAP, LAPEP, PEPS" ENSG00000002549 "Leucine aminopeptidase 3" P28838 4 17577192-17607972 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 227.4;monocytes: 251.5;Proximal tubular cells: 217.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029606, HPA029607" Enhanced Supported Nucleoplasm,Midbody,Cytosol Yes No 4100000 Cytosol "Nucleoplasm, Midbody" "HPA029606: AB_10599288, HPA029607: AB_10611381" "unprognostic (2.10e-2)" "unprognostic (1.01e-1)" "unprognostic (6.95e-3)" "unprognostic (1.46e-1)" "unprognostic (1.26e-1)" "unprognostic (2.87e-1)" "unprognostic (2.16e-1)" "unprognostic (1.55e-1)" "unprognostic (5.33e-2)" "unprognostic (1.44e-3)" "unprognostic (2.61e-3)" "unprognostic (1.17e-1)" "unprognostic (4.29e-3)" "unprognostic (1.73e-1)" "unprognostic (3.28e-2)" "unprognostic (3.06e-1)" "unprognostic (8.79e-2)" 42.5 29.7 23.2 43.9 38.5 18.1 30.7 8.5 23.5 13.3 21.0 23.5 12.3 27.5 17.2 20.8 19.3 18.7 24.3 25.4 24.4 17.0 71.7 70.3 39.4 54.2 33.7 16.1 13.5 14.7 23.5 13.2 25.0 34.9 15.3 22.7 15.0 23.0 12.1 33.3 20.9 30.6 26.9 35.0 54.9 20.8 19.3 30.7 19.9 29.4 21.7 32.1 24.4 23.7 7.5 45.7 9.5 46.1 11.8 12.9 25.3 10.9 9.6 9.2 8.7 18.3 22.3 0.1 17.3 19.5 62.9 76.5 17.5 20.9 43.2 11.5 13.3 37.5 6.8 34.5 12.2 24.0 16.4 9.9 23.9 10.6 22.8 21.3 21.5 15.4 22.7 7.8 20.6 10.9 7.2 21.8 11.4 23.1 30.9 14.8 11.8 19.1 29.5 19.2 20.6 18.4 29.7 8.8 21.8 16.4 12.9 13.6 11.2 15.8 9.8 33.8 13.3 8.3 8.3 14.1 16.0 10.8 16.8 30.0 28.4 43.4 37.3 21.6 35.9 15.4 8.4 43.4 9.5 8.0 46.1 7.4 7.5 7.5 8.5 45.7 5.2 6.5 6.8 6.2 11.8 31.9 25.9 12.9 25.3 23.2 38.5 8.5 23.5 24.4 17.0 33.7 16.1 34.9 30.7 26.8 44.7 44.2 21.0 19.6 8.0 43.2 10.2 46.8 26.1 26.2 2.0 31.2 99.5 46.8 71.4 104.1 38.5 0.0 96.6 44.5 25.9 23.1 63.4 92.3 227.4 6.4 15.6 68.2 96.6 22.8 21.3 135.7 40.5 251.5 30.0 93.7 42.5 30.2 32.9 217.2 12.6 32.3 24.7 46.4 13.2 19.9 46.6 30.5 39.9 21.7 LARP1 "KIAA0731, LARP, MGC19556" ENSG00000155506 "La ribonucleoprotein domain family member 1" Q6PKG0 5 154712902-154817607 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015222, HPA051397, HPA054819" Approved Supported "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA "Nucleoplasm, Endoplasmic reticulum, Cytosol" "CAB015222: , HPA051397: AB_2681467, HPA054819: AB_2682612" "unprognostic (1.44e-3)" "unprognostic (1.21e-1)" "unprognostic (7.69e-2)" "unprognostic (1.76e-3)" "unprognostic (3.95e-2)" "unprognostic (3.08e-3)" "unprognostic (2.72e-2)" "unprognostic (3.34e-3)" "unprognostic (4.12e-1)" "unprognostic (1.51e-1)" "unprognostic (1.70e-1)" "unprognostic (6.83e-2)" "unprognostic (2.07e-1)" "unprognostic (2.20e-1)" "unprognostic (1.22e-1)" "unprognostic (1.45e-2)" "unprognostic (1.83e-1)" 24.9 30.1 30.5 21.9 31.9 18.9 20.3 25.7 46.5 21.3 20.4 27.3 23.2 21.0 26.5 23.0 29.2 25.4 18.5 28.5 27.8 29.1 25.6 22.6 19.9 23.1 26.8 29.7 28.4 81.2 55.9 23.6 25.1 29.2 18.2 21.3 18.9 38.8 21.4 41.7 24.7 22.3 23.8 22.2 21.5 24.4 27.8 27.4 26.1 33.5 16.4 25.8 22.1 28.7 5.2 6.4 2.8 7.9 10.1 5.8 2.5 26.2 36.7 28.7 32.9 25.0 20.3 31.8 26.7 27.3 31.3 30.6 57.7 31.6 69.3 37.9 33.3 45.8 26.4 52.3 49.1 36.2 22.9 29.5 50.1 38.2 26.6 31.8 67.0 23.3 25.1 28.5 38.9 49.7 17.8 27.5 31.3 41.1 48.1 29.0 25.9 39.6 26.2 30.5 22.8 18.5 44.4 27.3 33.0 19.2 32.7 52.1 28.0 36.2 58.2 32.1 30.8 34.6 31.7 36.4 39.4 24.7 29.7 47.8 43.0 30.9 59.1 26.1 37.1 27.5 2.8 4.0 1.1 4.5 4.9 5.8 4.3 5.4 5.3 4.0 5.2 4.3 4.7 2.4 10.1 7.9 6.4 3.4 2.5 30.5 31.9 25.7 46.5 27.8 29.1 26.8 29.7 29.2 27.4 41.7 26.0 38.9 30.3 69.5 60.5 94.4 40.8 37.5 26.1 38.4 35.3 37.5 24.9 38.5 9.8 50.1 45.7 23.3 70.6 28.5 46.8 41.1 17.3 58.2 49.0 82.6 42.2 50.3 51.5 7.7 64.5 38.5 35.4 31.5 52.6 32.3 54.8 28.1 75.3 40.9 38.4 12.9 41.1 37.6 41.4 73.9 20.0 24.9 61.7 53.6 LARP7 "DKFZP564K112, HDCMA18P, PIP7S" ENSG00000174720 "La ribonucleoprotein domain family member 7" Q4G0J3 4 112636964-112657592 "Disease related genes, Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, Spermatogenesis, Transcription, Transcription regulation" RNA-binding "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026842, HPA027930" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA026842: AB_10611116, HPA027930: AB_10601233" "unprognostic (3.01e-1)" "unprognostic (6.63e-2)" "unprognostic (5.72e-2)" "unprognostic (2.65e-1)" "unprognostic (1.07e-1)" "unprognostic (1.13e-1)" "unprognostic (2.28e-2)" "unprognostic (1.68e-1)" "unprognostic (1.82e-2)" "unprognostic (1.12e-2)" "unprognostic (1.72e-1)" "unprognostic (1.98e-2)" "unprognostic (1.40e-2)" "unprognostic (1.26e-1)" "unprognostic (1.51e-1)" "unprognostic (2.28e-2)" "prognostic favorable (4.33e-4)" 22.9 20.2 26.5 24.2 37.0 23.9 23.9 32.5 33.2 26.8 24.7 15.0 24.5 20.7 26.8 23.3 26.4 21.9 20.0 38.3 34.3 21.3 38.8 26.9 18.1 25.6 33.3 26.5 26.3 14.4 21.4 42.6 23.1 34.7 27.3 23.9 11.5 19.2 19.9 35.5 19.1 35.2 31.1 46.9 32.4 20.0 16.0 41.2 27.5 26.4 21.2 25.2 30.1 20.9 23.8 34.6 30.7 27.8 17.8 19.2 10.4 11.2 11.2 23.6 11.9 16.2 18.9 11.9 14.3 12.0 13.3 12.7 7.7 17.9 27.6 12.7 13.7 12.6 7.6 22.2 12.9 18.0 23.1 15.7 15.8 9.4 12.1 12.0 37.4 23.5 15.1 15.3 11.9 7.0 18.6 12.5 13.4 19.2 14.2 17.2 9.7 30.0 13.9 60.8 19.2 8.4 16.9 18.9 12.0 20.6 12.3 13.0 17.9 9.2 22.8 14.1 41.2 10.0 14.7 12.0 12.6 12.7 12.7 15.2 9.5 15.9 28.0 16.2 14.0 13.3 30.7 15.0 25.3 18.5 20.7 16.5 23.8 18.8 19.2 12.3 22.8 18.4 17.8 18.3 17.8 27.8 34.6 18.1 10.4 26.5 37.0 32.5 33.2 34.3 21.3 33.3 26.5 34.7 41.2 89.3 68.1 68.6 56.9 22.0 61.3 101.6 96.8 136.5 94.4 45.4 27.5 68.0 94.5 57.3 9.9 57.6 66.6 0.0 56.1 62.9 53.2 37.8 100.6 146.5 61.4 55.6 37.3 81.6 89.8 8.5 87.5 66.9 23.6 73.1 66.9 107.4 53.1 75.9 94.0 93.8 47.4 116.4 44.3 77.9 66.8 18.2 84.0 66.0 67.8 40.9 LARS2 "KIAA0028, LEURS, MGC26121, mtLeuRS" ENSG00000011376 "Leucyl-tRNA synthetase 2, mitochondrial" Q15031 3 45388506-45549421 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035951, HPA045450, HPA066085" Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA035951: AB_10672997, HPA045450: AB_2679328, HPA066085: AB_2685612" "unprognostic (3.89e-1)" "unprognostic (3.89e-1)" "prognostic favorable (1.71e-4)" "unprognostic (3.02e-2)" "unprognostic (3.77e-1)" "unprognostic (1.45e-1)" "unprognostic (2.21e-3)" "unprognostic (9.19e-2)" "unprognostic (6.13e-2)" "unprognostic (2.86e-1)" "unprognostic (4.98e-1)" "unprognostic (4.37e-2)" "prognostic favorable (1.32e-11)" "unprognostic (2.81e-1)" "unprognostic (5.74e-2)" "unprognostic (9.90e-2)" "unprognostic (9.07e-2)" 9.6 14.3 18.8 9.6 21.8 6.7 8.1 11.9 17.9 9.2 14.8 13.1 8.3 9.6 9.8 8.9 10.4 11.2 8.4 14.2 14.6 13.6 18.9 17.2 7.0 10.3 15.7 9.5 10.2 8.2 20.0 14.0 10.6 12.3 10.8 15.3 10.0 8.7 9.8 14.1 7.8 8.8 11.0 8.8 10.0 8.9 7.3 11.8 16.1 10.5 8.3 12.8 11.3 7.8 5.1 5.9 2.4 3.3 8.4 6.0 3.7 6.4 8.0 9.4 8.9 8.6 9.7 10.1 10.0 10.3 18.7 13.9 14.2 8.9 13.3 8.6 11.6 13.7 7.0 34.9 20.9 14.2 11.6 8.8 14.4 13.0 13.8 9.0 20.8 5.3 12.5 12.9 17.8 9.4 9.7 11.6 16.1 22.3 7.5 11.6 7.0 14.9 7.6 23.5 10.8 14.9 8.5 9.3 14.8 16.6 15.5 7.4 9.3 15.9 9.0 8.3 11.2 14.3 12.2 10.2 11.4 8.5 9.5 12.0 6.0 10.8 14.2 13.5 14.1 10.1 0.6 2.8 2.4 6.0 3.3 5.8 5.1 4.4 5.4 5.9 4.0 4.8 5.4 1.2 8.4 3.0 4.5 3.9 3.7 18.8 21.8 11.9 17.9 14.6 13.6 15.7 9.5 12.3 11.8 0.0 1.3 2.7 1.1 1.0 5.0 7.8 2.5 2.7 1.2 5.2 3.9 4.1 5.0 2.5 0.6 3.8 2.3 0.0 2.4 4.2 1.6 2.2 1.1 6.7 4.4 1.6 4.6 2.5 3.7 1.1 1.1 1.6 1.7 2.8 4.3 3.6 2.8 6.6 2.1 2.1 4.4 0.0 1.2 0.7 2.4 1.1 2.4 1.8 6.3 1.6 LAS1L FLJ12525 ENSG00000001497 "LAS1 like, ribosome biogenesis factor" Q9Y4W2 X 65512582-65534775 "Disease related genes, Predicted intracellular proteins" "rRNA processing" "Disease mutation, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 108.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044431, HPA061463" Supported Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA Nucleoplasm "Centriolar satellite, Cytosol" "HPA044431: AB_10965695, HPA061463: AB_2684530" "unprognostic (9.71e-2)" "unprognostic (1.62e-3)" "unprognostic (1.57e-1)" "unprognostic (1.47e-1)" "unprognostic (3.39e-2)" "unprognostic (2.38e-1)" "unprognostic (7.15e-3)" "unprognostic (2.83e-2)" "unprognostic (3.16e-1)" "unprognostic (2.76e-2)" "unprognostic (2.14e-1)" "unprognostic (5.06e-2)" "unprognostic (6.00e-3)" "unprognostic (1.26e-1)" "unprognostic (1.17e-3)" "unprognostic (2.00e-3)" "unprognostic (1.53e-1)" 16.4 14.7 22.6 17.8 26.4 27.9 21.4 38.3 26.1 18.0 17.9 30.1 14.1 11.1 21.9 17.4 17.1 23.8 14.2 14.0 24.2 22.0 15.7 24.4 15.5 23.2 26.4 23.4 26.2 19.8 29.0 13.8 16.3 26.0 17.8 17.2 19.7 19.5 22.5 20.4 23.9 13.4 20.4 29.7 17.8 14.6 23.7 25.7 26.7 16.4 15.4 26.7 15.3 16.2 20.7 22.0 12.4 20.8 17.8 22.5 17.3 20.3 33.8 16.1 13.4 7.0 9.0 15.7 12.3 7.9 19.2 17.0 16.5 15.2 31.8 17.7 9.2 14.2 14.5 32.4 21.6 21.7 12.1 26.5 14.3 29.6 16.2 8.5 36.6 13.0 9.2 12.8 19.2 13.7 8.4 12.7 19.8 33.5 33.2 11.3 24.2 27.8 28.1 23.8 24.0 31.3 24.0 22.5 35.2 13.2 9.2 12.8 14.7 19.6 14.4 8.9 14.3 10.8 19.5 9.1 11.9 23.6 36.2 18.5 12.1 14.2 35.0 11.6 38.8 6.3 12.4 15.7 7.8 18.8 20.8 20.8 20.2 17.6 22.3 22.0 20.7 22.5 18.5 1.7 17.8 15.0 16.4 17.6 17.3 22.6 26.4 38.3 26.1 24.2 22.0 26.4 23.4 26.0 25.7 11.9 18.2 15.2 17.8 16.3 32.6 8.3 15.3 32.1 28.4 3.5 27.5 27.9 13.3 18.3 44.1 14.8 7.4 0.0 23.0 25.7 15.1 11.9 17.4 12.9 14.3 42.9 16.0 11.6 7.1 108.3 16.1 12.3 10.1 20.8 7.9 15.2 17.5 7.0 14.5 12.9 33.2 12.9 20.2 20.5 20.0 16.3 14.9 11.8 12.8 14.4 LBHD1 "C11orf48, MGC2477" ENSG00000162194 "LBH domain containing 1" Q9BQE6 11 62662817-62672255 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "heart muscle: 67.7" "Cell type enhanced" "Detected in some" 16 "Ciliated cells: 16.0;Club cells: 4.5;Cone photoreceptor cells: 3.9;Rod photoreceptor cells: 7.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 19.1;JURKAT: 33.3" "HPA012127, HPA023592" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA012127: AB_1845527, HPA023592: AB_1845528" "unprognostic (4.34e-4)" "unprognostic (1.25e-1)" "unprognostic (7.38e-2)" "unprognostic (7.90e-3)" "unprognostic (1.02e-1)" "unprognostic (2.33e-1)" "unprognostic (2.18e-8)" "unprognostic (2.75e-1)" "unprognostic (1.03e-1)" "unprognostic (1.52e-2)" "unprognostic (2.81e-1)" "unprognostic (6.79e-2)" "unprognostic (2.78e-8)" "unprognostic (3.69e-2)" "unprognostic (1.62e-1)" "unprognostic (5.79e-2)" "unprognostic (4.72e-3)" 4.7 14.7 1.7 6.2 3.9 6.9 4.2 3.4 3.6 3.8 4.0 3.9 7.6 4.0 2.3 5.4 4.0 4.1 5.3 67.7 3.4 2.1 4.1 8.3 4.4 8.3 1.8 3.3 3.3 4.1 7.5 4.4 2.3 3.7 4.6 4.1 4.5 4.2 10.0 4.8 2.6 6.0 2.5 3.1 10.4 4.6 6.7 2.3 6.2 4.6 3.0 6.5 4.8 2.6 4.9 7.1 5.7 6.2 8.0 7.0 4.3 1.6 2.8 1.7 1.3 2.7 5.1 3.9 2.2 3.3 3.7 2.9 2.3 19.1 5.7 4.9 2.7 3.8 7.4 1.9 5.2 2.9 7.7 5.9 4.8 7.8 1.6 4.0 4.4 6.3 7.0 0.6 6.5 2.0 4.1 2.0 33.3 4.9 5.2 2.3 2.8 2.8 6.7 2.2 3.9 2.5 6.8 4.3 10.4 4.8 3.3 1.9 2.9 2.5 3.5 7.1 2.5 6.3 6.7 1.5 2.3 1.4 2.3 2.4 8.6 7.4 5.4 2.1 4.5 2.4 2.2 6.2 5.7 6.6 4.5 5.7 4.6 3.7 7.0 5.4 4.9 5.1 4.1 1.8 8.0 3.4 7.1 2.2 4.3 1.7 3.9 3.4 3.6 3.4 2.1 1.8 3.3 3.7 2.3 3.0 2.4 0.0 0.1 0.0 1.9 0.8 0.0 16.0 4.5 0.0 3.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 2.3 0.2 0.2 1.6 0.0 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 1.3 0.2 0.0 0.4 0.3 7.3 0.0 0.0 0.6 0.9 0.0 0.2 0.0 0.0 0.3 LBX1 "HPX6, LBX1H" ENSG00000138136 "Ladybird homeobox 1" P52954 10 101226195-101229794 "Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 76 "brain: 11.8;skeletal muscle: 25.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 7 "cerebellum: 11.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEK 293: 5.0;RH-30: 6.4;SCLC-21H: 13.6" "Group enriched" "Detected in some" 24 "cerebellum: 1.8;pons and medulla: 3.2" "Group enriched" "Detected in some" 21 "cerebellum: 2.9;pons and medulla: 2.8" "HPA002016, HPA002086, CAB079927" Uncertain Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nucleoli, Nuclear bodies, Cytosol" "CAB079927: , HPA002016: AB_2666518, HPA002086: AB_1079242" "unprognostic (4.13e-1)" "unprognostic (3.86e-2)" "unprognostic (2.25e-2)" "unprognostic (2.29e-1)" "unprognostic (7.28e-3)" "unprognostic (3.31e-1)" "unprognostic (9.76e-2)" "unprognostic (1.45e-1)" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 11.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 6.4 0.0 0.0 0.0 13.6 0.0 0.4 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 11.8 0.8 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LBX2 ENSG00000179528 "Ladybird homeobox 2" Q6XYB7 2 74497517-74503316 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 13.8" "Cell type enhanced" "Detected in some" 11 "Hepatocytes: 2.8;Ito cells: 2.5;Proximal tubular cells: 6.3;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 9.3;Hep G2: 19.3;SK-MEL-30: 8.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "cerebellum: 1.3;olfactory region: 0.9" HPA044257 Uncertain Approved Nucleoplasm,Midbody Yes No Nucleoplasm Midbody "HPA044257: AB_2678880" "unprognostic (5.24e-2)" "unprognostic (7.97e-2)" "unprognostic (2.35e-5)" "unprognostic (8.22e-4)" "unprognostic (2.95e-1)" "unprognostic (2.94e-1)" "unprognostic (1.34e-2)" "unprognostic (1.34e-1)" "unprognostic (2.02e-1)" "unprognostic (2.76e-2)" "unprognostic (1.85e-1)" "unprognostic (3.25e-2)" "unprognostic (1.43e-5)" "unprognostic (5.77e-2)" "unprognostic (1.69e-1)" "unprognostic (1.78e-1)" "unprognostic (1.87e-2)" 4.4 0.4 1.5 1.0 0.5 0.3 1.3 0.5 0.5 1.1 6.8 0.0 1.5 8.3 2.2 2.6 0.5 0.6 3.9 1.8 0.3 0.3 1.9 13.8 3.7 0.4 0.3 0.6 0.6 3.4 0.0 0.3 2.6 0.5 0.6 0.0 0.2 1.5 0.4 0.8 1.3 7.3 0.1 0.4 1.9 4.9 1.3 0.0 0.3 1.1 1.7 2.1 0.8 0.6 0.2 2.1 1.6 4.8 2.5 1.0 1.5 3.8 1.4 0.0 0.1 1.7 1.4 6.5 0.3 0.2 0.4 0.4 9.3 5.7 0.2 1.6 0.7 0.6 1.5 0.0 0.3 0.0 8.0 1.7 4.1 0.5 19.3 1.3 0.2 2.6 1.8 1.4 1.4 0.3 0.2 1.6 0.1 2.7 2.0 0.3 2.0 0.1 0.8 0.4 1.6 0.2 0.4 0.4 0.2 0.2 1.2 0.2 1.1 2.3 0.3 8.4 0.1 0.2 0.3 3.6 1.4 6.1 7.4 0.1 2.6 2.0 0.2 1.4 0.7 4.3 0.8 4.0 0.3 0.8 1.9 0.5 0.2 0.2 1.0 2.1 0.2 0.2 0.7 1.6 2.5 4.8 0.6 0.1 1.5 1.5 0.5 0.5 0.5 0.3 0.3 0.3 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.8 0.0 0.4 0.0 0.5 0.0 0.0 1.6 0.0 0.6 0.4 0.3 0.0 0.0 2.8 0.9 0.0 2.4 2.5 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 6.3 0.0 6.5 0.2 0.0 0.0 0.1 0.5 0.0 0.8 0.1 LCA5L "C21orf13, MGC33295" ENSG00000157578 "LCA5L, lebercilin like" O95447 21 39405844-39445805 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 57.2" "Cell type enhanced" "Detected in many" 28 "Early spermatids: 967.3;Late spermatids: 347.9;Spermatocytes: 191.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "MCF7: 6.9;T-47d: 7.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA019790, HPA032010" Enhanced Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA019790: AB_1845690, HPA032010: AB_2674110" "unprognostic (1.02e-1)" "unprognostic (3.81e-1)" "unprognostic (2.43e-1)" "unprognostic (2.54e-3)" "unprognostic (4.69e-2)" "unprognostic (1.68e-1)" "unprognostic (3.15e-2)" "unprognostic (6.34e-2)" "unprognostic (1.27e-2)" "unprognostic (1.85e-2)" "unprognostic (5.50e-2)" "unprognostic (2.37e-1)" "unprognostic (7.53e-3)" "unprognostic (1.40e-1)" "unprognostic (1.04e-2)" "unprognostic (9.68e-3)" "unprognostic (1.95e-1)" 0.4 1.3 1.4 0.3 3.7 0.3 1.2 1.1 1.6 1.2 0.6 2.3 2.7 0.4 0.9 4.6 0.4 4.4 1.0 0.5 1.9 1.2 1.6 1.3 1.0 0.3 0.7 1.2 0.8 1.1 1.7 9.1 0.3 3.1 0.7 0.4 2.2 0.8 1.8 1.7 0.7 0.4 0.5 0.7 0.4 0.6 57.2 1.1 0.3 2.9 0.4 0.3 0.5 0.5 0.3 0.7 0.2 0.5 0.0 1.1 0.0 1.7 1.8 1.0 3.2 1.6 1.4 0.2 0.5 0.8 1.0 0.1 1.0 1.9 1.2 1.5 1.7 0.4 0.5 0.1 1.0 0.6 0.6 1.5 0.9 1.9 0.2 1.3 2.0 0.0 1.2 4.2 3.0 3.4 2.2 0.6 1.9 3.1 1.2 1.1 6.9 0.6 0.7 6.2 1.3 1.9 0.4 0.4 1.2 3.3 0.6 2.1 0.9 3.8 1.6 2.5 0.6 7.4 0.3 0.1 0.6 0.4 1.8 0.5 3.7 1.9 0.4 2.8 0.7 1.2 0.0 0.3 0.0 0.6 0.0 0.4 0.0 0.5 0.6 0.2 0.3 0.0 1.1 0.2 0.0 0.5 0.7 0.0 0.0 1.4 3.7 1.1 1.6 1.9 1.2 0.7 1.2 3.1 1.1 3.0 0.3 0.0 0.8 0.5 2.0 1.7 2.5 84.3 27.3 7.0 5.9 0.8 16.6 2.7 967.3 1.0 0.0 0.0 2.0 0.1 1.5 0.5 0.0 1.5 0.5 1.6 4.1 1.8 0.6 347.9 6.1 1.0 1.7 1.0 1.3 3.1 1.7 0.0 7.4 9.1 15.3 19.4 0.9 191.0 27.7 0.5 0.2 0.0 0.8 0.5 LCAT ENSG00000213398 "Lecithin-cholesterol acyltransferase" P04180 16 67939750-67944131 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Acyltransferase, Hydrolase, Transferase" "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "brain: 64.4;liver: 154.2" "Cell type enriched" "Detected in many" 16 "Hepatocytes: 204.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 64.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 35.6;Hep G2: 27.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044767 Approved Nucleoplasm "Secreted to blood" NA NA 6470000000 9500000000 Nucleoplasm "HPA044767: AB_2756312" "unprognostic (3.34e-2)" "unprognostic (3.56e-2)" "prognostic unfavorable (8.50e-4)" "unprognostic (5.43e-3)" "unprognostic (1.25e-2)" "unprognostic (2.16e-1)" "prognostic favorable (4.21e-8)" "unprognostic (6.42e-2)" "unprognostic (4.26e-1)" "unprognostic (4.12e-1)" "unprognostic (1.50e-2)" "unprognostic (7.21e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (9.93e-2)" "unprognostic (1.83e-1)" "unprognostic (2.85e-1)" "unprognostic (1.90e-3)" 4.4 3.6 6.3 2.2 3.7 0.9 4.3 64.4 9.6 4.5 4.4 7.3 1.4 1.3 5.3 3.0 1.8 3.5 3.5 4.5 8.4 1.8 3.9 154.2 5.6 1.9 5.5 6.3 4.7 2.5 5.9 2.7 5.5 9.2 6.4 1.3 1.8 2.4 6.2 3.4 9.9 2.4 3.8 7.5 3.9 2.3 2.2 6.1 1.4 7.6 1.6 1.4 2.6 4.5 1.8 0.8 5.0 1.1 1.3 1.4 0.1 2.5 4.0 6.0 6.8 5.2 7.4 35.6 9.9 4.3 6.7 4.7 13.3 3.1 1.3 1.9 14.3 2.4 8.8 1.4 13.6 4.2 0.6 3.6 1.7 8.9 27.7 7.2 0.3 4.7 12.8 12.9 13.9 4.8 9.1 4.9 4.0 3.8 0.6 4.7 4.1 1.6 4.2 3.9 0.4 2.2 1.7 6.5 1.4 1.9 4.3 0.2 3.1 15.0 0.7 1.7 12.9 8.5 2.7 9.3 8.7 13.6 9.5 3.5 8.2 2.2 3.7 4.1 1.1 7.5 2.4 1.1 5.0 0.9 0.1 1.3 1.2 0.7 0.8 0.2 1.8 1.4 0.4 2.8 1.3 0.5 0.8 0.0 0.1 6.3 3.7 64.4 9.6 8.4 1.8 5.5 6.3 9.2 6.1 8.9 4.5 0.0 4.1 8.4 0.2 4.2 7.6 2.7 3.4 3.5 2.0 6.0 0.0 1.6 0.0 4.3 0.0 0.0 0.9 2.7 7.1 2.9 1.1 204.0 2.1 0.0 1.2 12.3 3.2 0.5 8.1 1.6 6.8 2.8 0.0 7.5 1.4 0.0 8.1 0.0 0.5 12.9 7.1 1.0 1.5 2.3 10.2 0.0 0.0 1.4 LCMT1 "CGI-68, PPMT1" ENSG00000205629 "Leucine carboxyl methyltransferase 1" Q9UIC8 16 25111729-25178231 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 149.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041559, HPA043530" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041559: AB_2677548, HPA043530: AB_2678532" "unprognostic (9.08e-2)" "prognostic favorable (2.78e-4)" "unprognostic (1.18e-1)" "unprognostic (3.71e-1)" "unprognostic (3.15e-1)" "unprognostic (1.73e-1)" "prognostic unfavorable (5.85e-4)" "unprognostic (1.41e-2)" "unprognostic (7.41e-2)" "unprognostic (4.45e-2)" "unprognostic (4.62e-2)" "unprognostic (1.16e-1)" "prognostic favorable (7.53e-6)" "unprognostic (1.23e-1)" "unprognostic (8.99e-2)" "unprognostic (1.84e-3)" "unprognostic (6.71e-2)" 9.8 18.0 27.9 11.6 30.6 13.9 18.1 27.5 36.4 15.4 17.1 15.5 17.5 13.1 16.2 26.7 13.4 16.8 14.1 25.3 22.8 27.5 17.8 7.5 10.8 11.9 21.7 26.7 23.8 31.4 25.3 20.5 18.9 24.8 15.7 17.2 15.0 14.4 18.3 31.6 16.5 12.7 15.1 18.9 10.1 12.6 29.8 14.4 16.9 15.5 14.3 15.3 11.7 12.1 19.7 17.6 21.6 18.9 15.8 38.9 19.5 17.0 16.1 15.0 20.8 13.5 19.8 15.4 10.7 17.7 15.6 20.6 20.3 15.7 10.4 15.3 16.2 19.9 8.8 15.5 14.7 21.2 10.6 23.7 5.6 16.4 32.9 30.9 13.4 9.3 22.4 16.3 17.8 18.6 23.0 14.2 23.7 8.9 13.7 17.2 43.6 16.0 25.8 22.9 10.8 16.7 19.0 13.8 20.2 17.7 12.1 24.5 15.2 12.8 19.9 24.4 18.4 20.1 6.2 8.4 15.6 10.9 10.1 10.5 17.9 18.1 11.0 19.1 11.8 11.4 12.7 18.9 21.6 20.6 16.7 22.6 19.7 25.6 22.3 17.6 14.3 23.1 21.1 7.4 15.8 17.5 9.1 38.9 19.5 27.9 30.6 27.5 36.4 22.8 27.5 21.7 26.7 24.8 14.4 14.9 13.7 23.2 24.4 21.4 25.3 30.5 15.3 22.7 7.9 31.4 2.0 149.0 41.4 46.1 60.5 21.8 58.0 0.0 58.2 63.7 29.6 28.2 9.2 9.0 41.1 22.3 49.3 17.8 33.7 98.3 24.2 25.1 32.1 33.3 47.4 20.7 45.5 40.3 22.6 69.2 18.9 25.8 18.4 50.2 46.6 27.9 137.0 33.1 48.4 31.3 LCMT2 "KIAA0547, MGC9534, PPM2, TYW4" ENSG00000168806 "Leucine carboxyl methyltransferase 2" O60294 15 43323649-43330605 "Enzymes, Plasma proteins, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039401, HPA048176" Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA039401: AB_10805478, HPA048176: AB_2680299" "unprognostic (4.32e-2)" "unprognostic (1.44e-1)" "unprognostic (1.55e-1)" "unprognostic (4.11e-2)" "unprognostic (1.99e-1)" "unprognostic (2.27e-1)" "unprognostic (9.08e-2)" "unprognostic (5.14e-2)" "unprognostic (3.52e-2)" "unprognostic (2.20e-1)" "unprognostic (3.33e-3)" "unprognostic (9.57e-2)" "prognostic favorable (5.69e-9)" "unprognostic (2.28e-1)" "unprognostic (3.21e-2)" "unprognostic (1.62e-2)" "unprognostic (1.57e-1)" 7.9 10.9 6.5 8.3 8.1 2.5 25.9 11.4 10.1 10.8 7.4 7.2 10.6 5.2 10.3 12.7 11.0 10.2 6.7 8.4 6.7 8.4 11.9 9.2 6.2 9.9 6.1 7.6 13.0 8.2 13.7 10.1 6.4 9.6 10.2 7.5 8.9 10.3 13.8 7.9 6.2 8.4 8.6 4.8 9.6 8.7 7.1 9.6 12.2 9.8 11.2 13.9 7.4 9.6 6.3 6.9 5.5 4.0 3.3 10.5 5.0 6.0 4.9 11.5 9.9 12.3 3.8 5.6 7.5 9.0 9.8 10.8 7.2 2.8 5.2 15.3 8.5 10.3 14.4 0.0 9.9 7.5 8.0 5.3 9.3 13.0 4.2 7.5 0.0 7.0 5.8 9.6 7.2 6.7 6.6 3.1 12.1 11.7 7.0 11.8 9.5 10.4 4.4 4.9 13.5 4.1 12.3 10.1 5.0 17.1 7.0 15.4 13.1 9.9 8.3 4.3 9.4 10.2 14.3 2.6 11.6 5.2 13.1 12.2 4.7 11.1 2.2 7.2 7.7 11.9 2.4 4.0 5.5 4.0 3.8 5.5 5.0 6.7 4.8 6.9 6.3 10.5 6.8 1.3 3.3 3.5 3.9 5.3 5.0 6.5 8.1 11.4 10.1 6.7 8.4 6.1 7.6 9.6 9.6 0.0 1.9 3.2 3.5 2.7 6.9 2.8 7.6 6.7 7.9 3.5 7.9 3.6 3.3 5.4 1.4 2.8 1.3 0.0 3.5 2.1 2.2 2.8 1.1 3.4 2.3 3.2 5.2 5.5 1.6 1.3 4.6 1.5 0.0 2.8 2.7 8.6 3.2 2.3 1.4 4.2 6.6 6.5 3.1 7.5 8.3 2.5 2.1 2.5 3.4 2.0 LCOR "C10orf12, DKFZP564P1916, FLJ13022, FLJ38026, KIAA1795, MLR2" ENSG00000196233 "Ligand dependent nuclear receptor corepressor" Q96JN0 10 96832282-96995959 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031429, HPA057621, HPA077000" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA031429: AB_2673879, HPA057621: AB_2732616, HPA077000: AB_2686824" "unprognostic (5.61e-2)" "unprognostic (1.59e-1)" "unprognostic (2.11e-1)" "unprognostic (2.23e-1)" "unprognostic (1.49e-1)" "unprognostic (1.20e-1)" "unprognostic (2.87e-3)" "unprognostic (2.19e-1)" "unprognostic (2.40e-1)" "unprognostic (1.54e-1)" "unprognostic (4.93e-2)" "unprognostic (5.61e-3)" "unprognostic (1.20e-1)" "unprognostic (1.96e-2)" "unprognostic (4.40e-2)" "unprognostic (1.24e-1)" "prognostic favorable (2.16e-4)" 7.5 6.4 9.9 9.2 11.6 35.5 8.6 25.7 10.5 7.8 13.8 12.6 9.4 17.4 8.9 8.1 12.9 8.3 8.3 7.8 7.3 6.9 9.1 10.0 9.4 9.7 13.6 7.5 13.1 16.9 10.3 20.3 25.9 10.8 8.7 14.1 9.5 12.1 7.4 11.9 7.1 24.2 9.4 11.4 9.9 10.9 7.6 11.7 13.2 10.5 6.6 13.2 12.5 9.7 6.8 4.8 12.2 4.2 3.4 5.4 1.9 11.2 7.4 13.0 6.0 3.7 4.2 6.7 5.7 5.0 6.5 7.1 10.0 7.8 11.9 6.0 5.5 5.5 6.5 12.6 6.9 11.5 5.6 6.5 12.2 4.3 11.8 7.3 11.5 7.1 3.8 5.9 9.6 16.7 6.5 7.0 6.4 10.2 6.2 9.5 5.4 6.7 6.1 4.3 5.8 3.4 9.1 10.3 3.5 6.5 25.1 6.0 5.2 5.5 3.4 7.3 6.2 7.4 5.1 9.7 5.3 10.7 4.2 9.3 5.9 5.1 13.9 5.1 11.9 2.4 2.1 3.8 6.4 4.8 4.2 4.6 3.8 4.0 5.4 3.1 6.8 4.7 4.7 12.2 3.4 2.5 4.8 2.4 1.9 9.9 11.6 25.7 10.5 7.3 6.9 13.6 7.5 10.8 11.7 17.9 23.2 11.8 15.3 13.7 43.1 12.4 48.4 50.9 29.6 29.6 72.6 11.6 10.0 25.1 0.8 17.3 59.9 0.0 29.4 6.5 12.3 29.5 25.5 19.5 12.0 38.1 45.1 24.5 25.9 1.1 9.5 27.5 20.3 19.0 30.3 10.3 34.4 42.1 13.1 21.3 55.5 19.4 20.8 19.2 25.0 11.3 32.3 23.0 29.6 29.7 LCORL "FLJ30696, MLR1" ENSG00000178177 "Ligand dependent nuclear receptor corepressor like" Q8N3X6 4 17841199-18021876 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028794, HPA028795, HPA060033" Uncertain Approved "Nucleoplasm,Nuclear membrane" "Intracellular and membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA028794: AB_10600664, HPA028795: AB_10600882, HPA060033: AB_2684192" "unprognostic (1.06e-1)" "unprognostic (4.95e-2)" "prognostic favorable (9.65e-4)" "unprognostic (3.22e-3)" "unprognostic (3.62e-2)" "unprognostic (2.54e-4)" "unprognostic (8.90e-4)" "unprognostic (3.46e-1)" "unprognostic (3.52e-2)" "unprognostic (7.59e-2)" "unprognostic (2.10e-1)" "unprognostic (1.22e-1)" "unprognostic (7.39e-2)" "unprognostic (1.70e-2)" "unprognostic (6.06e-2)" "unprognostic (1.32e-1)" "unprognostic (7.27e-4)" 8.3 7.8 11.3 5.7 11.9 5.1 6.6 21.9 10.4 7.0 9.2 6.9 4.7 14.2 6.3 5.1 7.3 4.6 7.1 3.9 10.3 9.8 9.6 7.2 7.5 8.0 14.8 6.5 7.6 6.4 8.4 11.3 8.7 8.9 5.9 8.8 5.0 7.0 5.3 7.9 8.6 22.3 5.8 16.2 12.6 9.1 12.2 15.3 17.1 8.1 2.7 5.7 6.5 5.4 4.4 3.8 8.2 4.6 2.4 3.2 1.5 4.8 3.2 13.0 4.0 6.9 10.8 3.3 6.0 5.9 5.2 6.8 1.6 6.5 9.4 3.2 4.0 8.0 2.2 6.2 2.5 7.3 2.6 3.9 7.5 5.7 3.9 4.4 6.0 6.1 5.9 3.0 3.5 7.3 7.6 7.0 6.1 4.5 15.0 7.0 1.3 5.8 12.3 4.5 4.3 4.7 5.8 8.0 5.2 8.4 2.6 9.7 9.3 4.3 2.2 4.2 5.1 3.9 5.8 4.7 8.2 4.1 5.1 9.4 12.2 4.6 7.9 6.7 8.1 6.5 8.2 4.5 4.9 2.9 4.6 2.4 4.4 2.0 1.8 3.8 3.0 2.3 2.7 2.2 2.4 3.6 2.6 3.2 1.5 11.3 11.9 21.9 10.4 10.3 9.8 14.8 6.5 8.9 15.3 11.9 10.4 17.9 3.8 21.2 18.3 8.1 40.8 17.4 6.8 7.0 39.3 7.3 8.3 9.7 26.0 20.2 18.1 0.0 9.7 7.4 8.7 8.5 18.5 11.9 13.9 19.1 34.0 9.2 11.7 15.2 13.6 22.6 3.3 8.2 17.8 9.8 10.0 14.1 7.1 14.0 20.9 19.4 6.1 40.8 15.6 16.7 8.2 6.9 14.9 4.2 LDB1 "CLIM2, NLI" ENSG00000198728 "LIM domain binding 1" Q86U70 10 102107560-102120453 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 29.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034488 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA034488: AB_10669783" "unprognostic (8.83e-2)" "unprognostic (3.71e-2)" "unprognostic (1.97e-3)" "unprognostic (4.54e-2)" "unprognostic (1.35e-1)" "unprognostic (5.01e-3)" "unprognostic (1.55e-2)" "unprognostic (1.04e-3)" "unprognostic (2.33e-1)" "unprognostic (1.63e-1)" "unprognostic (1.09e-3)" "unprognostic (8.25e-2)" "unprognostic (2.54e-1)" "unprognostic (3.19e-1)" "unprognostic (1.33e-1)" "unprognostic (8.60e-2)" "unprognostic (1.26e-2)" 18.6 18.7 20.6 20.7 31.1 46.3 21.3 23.2 43.0 35.5 30.4 26.5 24.5 14.0 37.4 19.4 25.2 31.8 27.3 26.9 20.1 13.1 20.7 9.5 21.1 25.1 19.5 24.5 58.0 13.5 24.6 25.5 22.0 20.4 27.6 12.7 36.3 28.8 37.5 21.1 64.3 23.3 31.2 13.9 29.0 20.5 15.3 22.0 27.4 24.2 20.5 27.4 32.2 33.9 4.6 2.4 8.5 7.8 3.0 4.4 2.0 11.4 14.1 27.4 34.0 10.7 12.4 14.2 11.9 19.1 13.4 11.6 9.6 9.9 17.8 17.4 14.7 6.3 22.9 13.0 22.8 7.2 15.4 11.9 53.0 14.4 9.4 13.0 14.5 18.8 26.1 18.1 10.8 12.6 47.0 13.8 15.4 32.4 19.4 10.3 10.7 26.3 20.8 13.9 5.1 6.9 29.8 18.0 12.5 12.1 12.3 11.4 28.1 7.8 9.5 13.4 19.1 46.0 9.4 13.6 8.3 17.5 7.3 9.9 17.0 14.4 12.0 13.6 31.9 7.5 3.1 4.1 3.3 4.4 4.8 2.7 3.4 3.0 4.1 2.3 4.6 4.0 3.0 8.5 3.0 7.8 2.4 2.4 2.0 20.6 31.1 23.2 43.0 20.1 13.1 19.5 24.5 20.4 22.0 29.8 8.3 11.6 2.8 20.3 17.8 7.3 2.5 5.3 9.1 3.5 3.9 4.0 0.0 7.1 1.7 4.2 1.8 23.3 4.9 5.1 5.8 2.4 9.2 2.0 7.9 14.3 7.9 3.1 3.8 2.0 5.8 5.9 3.3 1.8 1.3 10.4 6.0 2.0 6.0 1.4 5.7 0.0 5.3 6.7 6.6 18.4 6.5 6.9 1.9 1.8 LDB2 "CLIM1, LDB1" ENSG00000169744 "LIM domain binding 2" O43679 4 16501541-16898809 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 21 "Endothelial cells: 120.7;Ito cells: 249.8" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 5 "amygdala: 14.5;basal ganglia: 30.3;cerebral cortex: 45.3;hippocampal formation: 16.6;olfactory region: 21.7" "Cell type enriched" "Detected in single" 13 "NK-cell: 5.1" "Lineage enriched" "Detected in single" 13 "NK-cells: 5.1" "Cell line enhanced" "Detected in some" "AF22: 9.7;ASC TERT1: 9.3;fHDF/TERT166: 9.8;HAP1: 18.0;HUVEC TERT2: 34.0;U-138 MG: 13.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB017544, HPA068634" Supported Supported "Nucleoplasm,Nucleoli,Plasma membrane" No NA "Nucleoplasm, Nucleoli" "Plasma membrane" "CAB017544: AB_2137013, HPA068634: AB_2686012" "unprognostic (3.43e-1)" "unprognostic (2.77e-1)" "unprognostic (9.10e-2)" "unprognostic (4.37e-1)" "unprognostic (7.25e-2)" "unprognostic (4.62e-3)" "unprognostic (2.10e-3)" "unprognostic (1.57e-1)" "unprognostic (2.94e-2)" "unprognostic (2.82e-1)" "unprognostic (2.67e-2)" "unprognostic (1.96e-2)" "unprognostic (2.05e-3)" "unprognostic (1.26e-3)" "unprognostic (1.60e-1)" "unprognostic (9.63e-2)" "unprognostic (7.10e-3)" 27.9 9.5 14.5 4.6 30.3 0.4 26.8 1.1 45.3 27.1 6.8 2.7 8.0 4.0 54.9 14.4 9.5 15.6 18.3 18.5 16.6 4.8 14.9 15.0 31.3 6.9 5.5 21.7 11.9 4.6 15.2 5.6 33.7 3.4 10.4 5.4 15.4 6.1 8.6 7.5 5.4 6.8 32.8 4.2 32.9 6.7 6.4 3.4 0.7 17.8 7.5 3.0 14.7 13.3 0.2 0.0 0.3 0.0 5.1 0.0 0.6 0.0 0.0 9.7 0.0 5.6 9.3 0.0 5.3 4.1 0.6 1.5 0.0 0.0 0.0 0.0 9.8 0.0 0.0 18.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 5.2 0.0 6.7 0.0 1.4 34.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 4.5 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 2.8 0.0 0.0 8.9 13.7 0.0 0.7 0.0 4.4 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.1 0.0 0.0 0.0 0.6 14.5 30.3 1.1 45.3 16.6 4.8 5.5 21.7 3.4 3.4 0.0 8.5 1.9 0.2 7.7 21.5 9.2 5.1 1.4 0.0 0.0 0.0 0.2 0.0 1.7 1.1 120.7 0.0 0.0 0.2 0.2 22.0 0.3 5.7 1.3 0.3 0.0 0.0 249.8 20.4 1.5 35.4 2.3 8.5 0.0 0.0 9.8 0.3 0.0 47.4 0.0 1.7 6.5 13.4 0.0 0.6 5.9 0.1 5.4 0.0 0.1 LDB3 "CMD1C, KIAA0613, PDLIM6, ZASP" ENSG00000122367 "LIM domain binding 3" O75112 10 86668449-86736068 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cardiomyopathy, Disease mutation, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 21 "heart muscle: 213.9;skeletal muscle: 329.7;tongue: 110.3" "Cell type enriched" "Detected in some" 41 "Cardiomyocytes: 1579.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HSkMC: 5.9;hTERT-RPE1: 5.8;SCLC-21H: 9.6;SK-MEL-30: 4.6" "Low region specificity" "Detected in all" HPA048955 Enhanced Supported "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA 450000 "Focal adhesion sites, Cytosol" Nucleoplasm "HPA048955: AB_2680568" "unprognostic (1.60e-1)" "unprognostic (9.01e-2)" "unprognostic (4.87e-2)" "unprognostic (6.92e-2)" "unprognostic (5.55e-2)" "unprognostic (1.50e-2)" "unprognostic (2.57e-2)" "unprognostic (1.36e-1)" "unprognostic (2.79e-2)" "unprognostic (7.61e-2)" "unprognostic (2.54e-3)" "unprognostic (3.55e-2)" "unprognostic (4.72e-4)" "unprognostic (3.07e-2)" "unprognostic (1.60e-1)" "unprognostic (1.62e-2)" "unprognostic (3.16e-1)" 6.4 0.4 0.9 1.3 1.6 0.2 0.5 0.1 1.3 2.8 2.3 0.0 4.9 0.4 4.2 9.9 9.9 1.3 1.0 213.9 1.7 1.0 0.3 0.2 0.4 0.2 2.6 0.0 1.5 0.3 0.3 0.1 0.5 0.0 4.4 0.8 4.7 7.6 3.1 329.7 0.3 1.2 3.6 6.7 0.2 0.7 0.5 0.0 0.0 2.8 110.3 10.2 1.9 0.9 0.9 0.6 1.8 0.4 0.6 0.6 0.0 0.3 0.2 0.4 3.1 0.4 0.1 0.3 0.4 0.3 0.1 0.2 0.3 0.3 0.2 0.6 0.0 0.7 0.4 0.2 0.0 0.1 0.9 0.7 0.7 0.9 0.1 0.1 0.1 1.6 5.9 0.5 0.1 0.0 5.8 0.0 0.7 0.2 1.8 0.3 1.5 0.4 0.2 0.4 0.4 0.3 0.0 2.0 0.1 0.0 1.1 9.6 1.8 0.3 0.2 4.6 1.4 0.3 0.2 0.0 0.3 0.5 0.4 0.1 0.2 0.6 0.4 0.7 0.3 0.5 1.8 0.4 0.4 0.4 0.3 0.4 0.3 0.3 0.3 0.2 0.9 0.5 0.6 1.4 0.6 0.4 0.6 0.3 0.0 0.9 1.6 0.1 0.6 1.7 1.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 1.7 1579.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 18.3 0.7 0.0 0.0 1.0 0.0 0.7 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.2 10.3 0.4 1.7 0.0 0.0 1.0 0.1 0.0 6.3 0.0 3.4 38.8 33.0 0.6 1.0 0.0 0.0 0.0 0.0 0.1 LDLRAD1 ENSG00000203985 "Low density lipoprotein receptor class A domain containing 1" Q5T700 1 54007299-54018186 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "fallopian tube: 64.2;lung: 16.1;ovary: 20.5" "Cell type enriched" "Detected in some" 15 "Ciliated cells: 499.2" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "CAPAN-2: 3.7;Hep G2: 15.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA052489 Enhanced Uncertain "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA052489: AB_2681850" "unprognostic (6.53e-3)" "unprognostic (2.05e-2)" "unprognostic (2.51e-1)" "prognostic favorable (9.21e-4)" "unprognostic (1.59e-2)" "unprognostic (1.67e-1)" "unprognostic (1.97e-1)" "unprognostic (1.32e-1)" "unprognostic (8.07e-3)" "unprognostic (2.43e-1)" "unprognostic (2.86e-1)" "unprognostic (5.23e-1)" "unprognostic (4.27e-2)" 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.1 0.1 0.0 0.0 0.6 2.1 0.4 64.2 1.1 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 20.5 0.1 0.0 1.5 0.1 0.2 0.5 0.0 0.0 2.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.8 4.8 0.0 0.0 0.7 0.5 2.1 0.4 0.4 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.1 3.7 0.0 1.9 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.1 0.3 0.8 15.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 1.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.6 0.3 0.0 0.1 1.0 0.0 0.1 0.8 0.1 0.0 0.3 0.2 0.1 0.1 0.4 0.0 0.1 0.3 0.0 0.2 2.1 0.4 0.3 0.4 0.2 0.3 0.5 0.3 0.4 0.1 0.7 0.4 0.5 2.1 0.4 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.0 7.4 0.0 0.2 0.0 0.0 0.0 0.0 499.2 34.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.6 4.7 0.0 0.1 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 LDOC1 "BCUR1, Mar7, Mart7, RTL7, SIRH7" ENSG00000182195 "LDOC1, regulator of NFKB signaling" O95751 X 141175745-141177125 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 36.5;Peritubular cells: 36.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 19.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 29.8;MCF7: 40.1;PC-3: 50.3;U-251 MG: 29.9" "Region enriched" "Detected in many" 5 "cerebellum: 21.5" "Low region specificity" "Detected in all" "HPA051768, HPA061842" Approved Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA051768: AB_2681599, HPA061842: AB_2684624" "unprognostic (4.09e-1)" "unprognostic (4.72e-2)" "unprognostic (1.88e-1)" "unprognostic (1.73e-3)" "unprognostic (2.47e-1)" "unprognostic (2.42e-1)" "unprognostic (4.51e-2)" "unprognostic (2.08e-2)" "unprognostic (8.92e-2)" "unprognostic (1.21e-1)" "unprognostic (6.40e-3)" "unprognostic (1.21e-1)" "unprognostic (1.27e-2)" "unprognostic (1.98e-2)" "unprognostic (3.06e-2)" "unprognostic (4.38e-3)" "unprognostic (2.76e-2)" 21.1 24.2 24.4 5.9 31.8 2.0 9.9 18.3 51.2 24.2 5.5 21.0 11.0 5.1 17.3 12.1 10.0 30.3 10.4 6.7 27.3 25.6 15.6 3.1 9.7 5.5 23.2 23.3 31.8 18.3 13.0 54.9 1.8 30.2 23.1 3.5 13.5 47.9 36.4 3.8 17.9 5.2 12.5 19.5 9.3 7.8 6.6 16.6 1.8 22.6 3.7 5.7 11.2 9.9 8.2 4.8 8.2 0.0 19.2 8.9 3.0 0.0 29.8 4.6 12.8 8.0 9.8 0.0 7.1 8.8 9.7 13.6 0.0 11.7 0.0 5.6 11.6 9.6 14.0 5.0 10.4 6.9 0.0 9.2 0.0 16.1 0.0 3.1 0.0 2.8 17.3 5.4 8.4 4.5 7.8 8.2 0.0 0.2 0.0 8.7 40.1 0.0 0.0 4.8 0.0 50.3 0.0 4.1 0.0 11.9 7.0 0.0 4.0 0.0 6.2 0.0 2.6 7.9 0.0 14.8 0.0 9.6 0.0 29.9 0.0 0.0 0.0 5.0 0.0 0.0 8.2 0.0 0.1 4.3 0.0 3.1 3.3 8.9 3.3 0.8 8.2 7.9 5.1 0.2 19.2 0.0 4.8 8.1 3.0 24.4 31.8 18.3 47.4 27.3 25.6 23.2 23.3 30.2 16.6 0.0 4.0 0.0 15.7 5.4 25.2 1.6 22.9 5.3 10.3 22.7 7.9 1.9 36.5 12.0 0.5 11.3 0.0 0.0 12.3 1.6 11.7 14.6 2.3 0.0 0.8 19.1 5.2 11.1 0.8 0.9 20.4 1.6 3.3 0.0 0.2 20.6 11.6 0.0 36.4 26.8 9.6 12.9 19.4 0.9 7.7 5.9 1.3 5.7 0.0 14.0 LEF1 "TCF10, TCF1ALPHA, TCF7L3" ENSG00000138795 "Lymphoid enhancer binding factor 1" Q9UJU2 4 108047545-108168956 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 231.5" "Cell type enhanced" "Detected in many" 12 "Distal tubular cells: 11.6;Melanocytes: 32.1;Spermatocytes: 21.3;T-cells: 13.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 42.2" "Lineage enriched" "Detected in many" 5 "T-cells: 42.2" "Group enriched" "Detected in many" 5 "JURKAT: 98.3;MOLT-4: 93.3;REH: 72.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002087, CAB019405" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "CAB019405: AB_823558, HPA002087: AB_1079245" "unprognostic (1.03e-3)" "unprognostic (7.36e-3)" "unprognostic (2.97e-2)" "prognostic favorable (1.37e-5)" "unprognostic (9.08e-2)" "unprognostic (5.24e-2)" "unprognostic (3.81e-2)" "unprognostic (1.10e-2)" "unprognostic (1.77e-1)" "unprognostic (5.21e-2)" "unprognostic (9.99e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (2.47e-6)" "unprognostic (1.12e-1)" "unprognostic (5.22e-2)" "unprognostic (7.88e-2)" "unprognostic (8.91e-2)" 0.9 13.5 3.5 9.3 5.4 7.6 2.0 1.6 3.4 3.6 1.0 2.9 0.8 0.4 6.0 3.5 3.4 5.0 2.8 0.5 4.7 5.2 2.7 0.3 2.4 25.3 4.9 1.9 1.8 0.8 0.0 1.1 7.8 3.1 2.8 1.0 1.6 3.1 0.7 0.5 2.4 3.9 2.9 4.4 7.0 0.9 8.2 2.3 231.5 2.7 1.3 20.6 4.8 3.2 0.3 0.1 0.5 0.0 8.9 42.2 9.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.7 4.1 0.0 0.0 0.0 0.0 0.4 0.0 1.2 0.0 0.5 0.0 2.9 1.0 0.0 0.0 0.0 3.6 0.5 0.0 0.1 0.0 0.1 0.6 0.0 98.3 2.1 0.0 0.4 0.1 93.3 0.0 0.2 1.0 0.2 72.0 1.4 0.0 0.3 0.2 0.4 0.8 0.0 0.0 13.8 1.1 0.3 0.0 0.0 1.9 1.6 0.0 2.4 6.0 2.5 16.5 1.2 0.0 7.9 0.0 0.0 0.0 2.6 0.0 0.5 0.1 19.7 8.8 0.0 0.3 42.2 29.2 0.5 8.9 0.0 0.1 25.7 9.5 3.5 5.4 1.6 3.4 4.7 5.2 4.9 1.9 3.1 2.3 3.0 3.4 0.0 1.1 3.0 0.0 1.2 0.0 4.0 1.2 0.0 0.0 0.1 11.6 0.0 3.1 3.6 0.0 0.0 0.0 0.1 1.8 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.9 0.6 0.8 32.1 0.0 0.0 0.4 0.2 0.0 0.0 0.3 0.0 0.0 5.9 21.3 9.6 1.1 0.3 13.1 0.1 0.3 LEKR1 FLJ16641 ENSG00000197980 "Leucine, glutamate and lysine rich 1" Q6ZMV7 3 156825481-157046129 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 29.8" "Group enriched" "Detected in many" 10 "Ciliated cells: 34.8;Early spermatids: 63.2;Late spermatids: 32.2;Spermatocytes: 49.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 6.6;U-266/70: 6.2" "Low region specificity" "Detected in all" "HPA044039, HPA047774" Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA044039: AB_10794288, HPA047774: " "unprognostic (5.42e-2)" "unprognostic (1.17e-1)" "unprognostic (3.22e-2)" "unprognostic (8.64e-2)" "unprognostic (1.67e-1)" "unprognostic (1.94e-1)" "unprognostic (2.29e-3)" "unprognostic (1.98e-2)" "unprognostic (7.55e-2)" "unprognostic (2.20e-1)" "unprognostic (5.66e-3)" "unprognostic (3.50e-2)" "unprognostic (5.99e-2)" "unprognostic (6.59e-2)" "unprognostic (3.28e-1)" "unprognostic (2.17e-3)" "unprognostic (1.80e-2)" 1.4 1.7 1.4 2.5 4.6 0.6 2.7 1.4 2.2 1.5 1.0 1.6 3.5 1.7 1.3 8.2 0.9 6.3 1.7 1.4 1.5 2.0 2.8 1.3 3.0 1.6 1.1 1.4 2.9 2.7 4.8 4.5 0.5 2.2 1.7 1.1 2.5 1.6 4.9 0.7 0.9 1.6 0.8 1.9 1.8 1.5 29.8 0.7 4.4 4.0 0.7 1.4 1.2 1.8 3.2 1.9 2.5 0.3 2.5 2.0 0.4 6.6 2.7 0.1 1.6 1.2 0.6 0.4 0.4 1.0 1.4 1.1 0.3 3.8 0.1 2.0 1.1 2.6 2.5 0.0 0.5 2.7 1.2 0.6 2.5 0.5 0.0 0.0 2.1 0.6 3.1 1.6 0.5 1.9 0.8 0.6 0.1 1.5 1.6 2.4 2.4 0.0 1.9 2.2 1.9 1.5 0.0 1.8 1.5 2.1 0.6 4.2 1.7 2.2 1.5 0.1 0.5 4.6 3.6 0.0 0.4 0.7 0.5 1.0 6.2 1.0 0.0 1.2 1.5 2.3 2.5 0.3 0.3 0.7 0.1 1.4 3.1 1.6 0.6 1.2 3.2 1.8 0.9 0.3 2.5 0.2 1.9 2.0 0.4 1.4 4.6 1.4 2.2 1.5 2.0 1.1 1.4 2.2 0.7 0.0 1.4 0.0 1.1 1.1 1.3 0.8 2.5 34.8 3.4 3.5 2.0 0.2 3.3 0.6 63.2 0.4 1.3 0.0 1.4 0.1 0.5 0.7 1.1 1.6 0.2 3.2 0.0 0.0 1.8 32.2 1.4 1.1 1.7 1.8 0.6 1.4 0.7 0.0 1.8 3.3 4.5 0.0 0.3 49.4 3.2 0.6 0.1 1.3 0.8 0.8 LENG1 ENSG00000105617 "Leukocyte receptor cluster member 1" Q96BZ8 19 54155161-54159882 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AF22: 5.7;HaCaT: 8.3;HDLM-2: 5.1;HSkMC: 3.9;LHCN-M2: 4.8;U-87 MG: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043541 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA043541: AB_10961190" "unprognostic (8.75e-2)" "unprognostic (4.36e-2)" "unprognostic (2.72e-2)" "unprognostic (2.30e-1)" "unprognostic (5.69e-2)" "unprognostic (1.91e-1)" "unprognostic (1.10e-1)" "unprognostic (8.73e-2)" "unprognostic (6.42e-2)" "unprognostic (5.22e-2)" "prognostic favorable (8.12e-4)" "unprognostic (7.51e-2)" "prognostic favorable (3.72e-4)" "unprognostic (2.21e-1)" "unprognostic (2.84e-1)" "unprognostic (4.82e-2)" "unprognostic (1.14e-2)" 9.6 8.0 8.2 8.0 11.1 6.1 7.3 10.1 9.5 7.5 10.8 11.5 10.8 7.6 13.4 8.7 6.1 11.9 9.6 12.7 8.2 7.9 7.6 7.2 8.9 6.3 11.2 7.6 10.3 9.7 7.3 8.5 7.3 10.3 9.3 10.7 6.6 21.6 10.4 13.1 9.9 14.8 7.5 10.8 21.8 8.8 12.3 13.1 10.1 10.8 7.6 6.8 8.2 15.8 3.8 3.2 4.1 3.3 2.8 3.8 0.8 0.1 0.4 5.7 0.2 0.6 0.2 0.4 0.8 0.1 0.6 0.3 0.2 0.0 0.0 0.2 0.0 0.5 8.3 0.3 0.2 0.2 5.1 1.3 0.0 0.5 0.1 0.0 0.0 0.5 3.9 0.7 0.2 0.5 0.2 0.1 0.5 0.1 0.0 4.8 0.6 0.4 0.5 0.0 0.2 0.6 0.0 0.1 0.8 0.5 0.5 0.2 0.2 0.3 0.0 0.3 0.0 0.2 0.1 0.7 0.4 0.4 0.2 0.4 0.1 0.2 0.0 5.6 0.1 2.7 1.0 2.7 4.1 2.5 3.3 2.8 1.6 3.7 3.8 2.2 3.8 3.7 2.9 3.7 2.8 1.6 3.2 2.7 0.8 8.2 11.1 10.1 9.5 8.2 7.9 11.2 7.6 10.3 13.1 17.9 9.1 29.1 20.5 18.3 10.2 6.4 15.3 18.7 6.8 17.4 0.0 24.4 19.9 18.7 76.0 20.3 33.5 0.0 24.7 12.4 18.9 14.1 54.2 15.5 26.7 6.4 25.9 25.8 16.2 6.4 20.8 26.0 20.3 26.2 20.4 14.5 21.8 17.8 14.2 21.2 13.9 38.8 26.8 23.1 29.4 18.7 35.8 35.5 16.6 14.7 LENG8 "KIAA1932, MGC40108, pp13842" ENSG00000167615 "Leukocyte receptor cluster member 8" Q96PV6 19 54448887-54462037 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "Rod photoreceptor cells: 564.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 102.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042004, HPA042056, HPA061571" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042004: AB_10794642, HPA042056: AB_10795389, HPA061571: AB_2684562" "unprognostic (2.09e-2)" "unprognostic (3.24e-3)" "unprognostic (5.14e-3)" "unprognostic (2.19e-1)" "unprognostic (4.42e-2)" "prognostic favorable (7.59e-4)" "unprognostic (1.38e-2)" "unprognostic (1.77e-1)" "unprognostic (1.92e-2)" "unprognostic (4.45e-3)" "unprognostic (5.11e-3)" "unprognostic (8.85e-3)" "prognostic unfavorable (3.30e-7)" "unprognostic (3.64e-2)" "unprognostic (6.92e-2)" "unprognostic (1.71e-1)" "prognostic favorable (2.73e-6)" 58.7 37.3 45.7 53.2 47.3 48.4 30.7 81.5 55.3 37.9 32.9 48.1 54.4 78.1 56.3 66.3 22.9 44.8 39.2 24.1 42.2 21.6 35.0 22.7 36.2 45.8 52.1 30.2 50.3 62.7 13.8 46.4 27.4 38.1 41.9 22.1 48.9 66.7 59.1 36.5 37.2 75.5 35.6 34.3 80.0 53.2 32.6 57.5 24.8 42.2 18.7 33.5 31.5 32.0 4.0 5.6 8.0 1.9 1.7 1.6 0.6 14.5 11.4 14.6 7.4 4.6 7.5 7.8 12.2 1.9 2.3 4.5 9.2 21.1 11.4 5.3 9.9 0.6 19.3 4.7 5.6 1.7 19.2 102.5 17.4 31.4 6.4 5.0 2.6 14.0 16.8 8.7 1.4 5.8 20.0 3.5 8.8 13.2 16.5 2.9 5.0 10.7 13.6 3.4 3.3 2.6 17.3 4.3 16.1 6.0 4.3 11.8 6.1 1.3 9.0 2.8 7.8 8.8 3.8 16.9 10.3 10.7 1.6 12.9 15.6 7.3 4.6 8.4 18.6 6.7 3.9 1.9 2.3 1.6 1.2 1.6 1.4 0.8 1.5 1.0 4.0 1.5 1.1 8.0 1.7 0.9 5.6 1.0 0.6 45.7 47.3 81.5 55.3 42.2 21.6 52.1 30.2 38.1 57.5 17.9 30.7 24.9 18.7 25.5 123.6 1.7 45.9 21.4 29.6 38.4 106.0 15.1 1.7 17.8 25.8 24.8 65.9 23.3 27.1 10.2 22.7 34.5 10.5 37.6 22.3 90.6 100.9 44.2 43.7 9.1 40.3 25.1 23.6 18.0 78.8 36.3 27.0 52.6 34.6 5.3 564.9 19.4 19.6 16.7 13.6 33.6 17.6 19.5 50.5 29.3 LEO1 ENSG00000166477 "LEO1 homolog, Paf1/RNA polymerase II complex component" Q8WVC0 15 51938025-51971806 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "granulocytes: 262.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040741, HPA040941" Enhanced Enhanced "Nucleoplasm,Nucleoli fibrillar center,Centrosome" No No "Nucleoplasm, Nucleoli fibrillar center" Centrosome "HPA040741: AB_10794859, HPA040941: AB_10805832" "unprognostic (2.76e-2)" "unprognostic (2.14e-2)" "unprognostic (2.44e-1)" "unprognostic (1.81e-3)" "unprognostic (2.85e-2)" "unprognostic (1.03e-1)" "unprognostic (1.09e-2)" "unprognostic (1.04e-2)" "unprognostic (1.83e-2)" "unprognostic (2.10e-1)" "unprognostic (1.20e-1)" "unprognostic (1.02e-2)" "unprognostic (1.30e-1)" "unprognostic (1.04e-1)" "unprognostic (8.48e-2)" "unprognostic (2.10e-2)" "unprognostic (1.08e-1)" 10.7 15.2 15.0 15.3 27.9 8.3 17.0 42.6 24.4 13.4 17.8 14.1 9.7 13.9 12.6 11.2 24.4 9.7 14.2 10.6 14.0 14.0 21.4 27.8 10.2 17.2 14.8 14.9 10.6 10.3 25.2 22.4 12.7 22.7 13.8 21.0 9.1 21.2 12.5 13.5 21.8 19.8 12.6 15.3 14.3 13.9 9.8 18.5 23.4 12.0 9.4 18.2 16.9 15.7 12.3 15.3 9.6 15.3 18.9 19.7 10.0 9.6 22.6 14.6 11.7 15.1 13.1 10.5 15.8 13.1 13.6 12.4 15.6 6.4 19.6 9.3 16.2 15.1 19.0 19.4 14.1 13.1 13.0 8.8 30.9 18.4 27.3 11.9 27.8 43.2 14.0 11.1 10.6 13.8 12.9 13.2 16.6 18.7 10.8 16.1 41.2 14.7 21.1 6.3 28.9 9.7 16.5 25.3 20.5 11.9 27.2 10.4 15.9 12.0 18.5 12.3 16.7 15.4 25.4 15.7 13.5 9.3 12.4 18.8 8.5 26.5 18.1 11.8 39.9 14.3 5.4 9.4 9.6 18.7 14.6 17.5 12.3 18.7 15.2 15.3 10.1 19.5 17.5 2.3 18.9 15.3 11.5 19.7 10.0 15.0 27.9 42.6 24.4 14.0 14.0 14.8 14.9 22.7 18.5 32.8 27.7 10.4 12.9 23.2 35.2 17.1 20.4 45.5 39.8 7.0 9.8 21.3 13.3 21.4 1.6 15.0 19.3 0.0 21.0 22.3 16.2 9.1 262.5 12.3 16.9 25.4 7.5 8.6 12.3 2.1 7.5 7.8 3.3 14.4 16.3 20.9 17.2 14.0 12.7 17.9 20.8 6.5 9.2 15.6 9.0 21.7 14.8 15.4 13.9 20.1 LETM2 "FLJ25409, SLC55A2" ENSG00000165046 "Leucine zipper and EF-hand containing transmembrane protein 2" Q2VYF4 8 38386207-38409527 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 16.8;testis: 28.6" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 41.6;Late spermatids: 34.7;Pancreatic endocrine cells: 29.9;Spermatocytes: 24.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 16.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 16.8" "Cell line enhanced" "Detected in many" "HBEC3-KT: 16.8;hTERT-HME1: 15.3" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 50.6" HPA025032 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" Yes No Nucleoplasm "Nuclear bodies, Cytosol" "HPA025032: AB_1852808" "unprognostic (3.37e-2)" "unprognostic (2.73e-1)" "unprognostic (3.14e-1)" "unprognostic (2.05e-2)" "unprognostic (2.27e-4)" "unprognostic (3.20e-2)" "unprognostic (3.96e-2)" "unprognostic (1.43e-1)" "unprognostic (8.27e-2)" "unprognostic (3.80e-2)" "unprognostic (1.39e-1)" "unprognostic (1.35e-1)" "unprognostic (3.40e-2)" "unprognostic (4.09e-3)" "unprognostic (2.49e-1)" "unprognostic (1.16e-1)" "unprognostic (9.25e-2)" 2.3 1.3 3.3 1.7 7.9 6.8 1.5 9.9 6.6 2.6 1.3 2.9 0.5 1.5 2.1 2.1 2.1 2.1 2.0 1.4 4.3 4.1 3.5 1.4 3.2 1.7 3.1 4.2 2.6 1.4 3.6 5.5 6.7 3.3 1.9 1.5 3.0 1.4 1.4 0.8 1.8 1.1 1.2 3.2 2.3 4.1 28.6 1.6 3.8 1.6 1.0 2.2 3.1 1.7 1.4 1.3 16.8 3.8 1.2 4.0 1.2 13.8 2.5 1.9 1.8 1.5 4.3 1.4 4.7 5.6 6.7 4.1 1.0 5.5 1.7 11.1 1.0 2.0 1.5 3.8 16.8 7.0 0.8 1.6 2.0 1.9 2.5 1.9 0.3 1.9 1.2 4.7 7.1 15.3 3.6 7.0 2.2 1.7 2.7 5.9 2.9 5.0 1.2 0.4 1.0 11.8 1.7 3.1 1.0 11.0 0.6 1.6 1.6 1.6 0.3 0.5 1.3 1.6 0.8 12.1 2.1 14.8 3.8 1.1 1.8 1.0 1.3 3.3 2.2 1.6 0.9 3.4 0.5 0.9 1.3 1.5 1.4 0.8 1.3 1.3 1.4 1.6 1.5 16.8 1.2 3.8 0.6 4.0 1.2 3.3 7.9 9.9 6.6 4.3 4.1 3.1 4.2 3.3 1.6 3.0 5.4 0.5 11.6 0.5 7.0 1.6 5.1 4.0 2.3 5.2 5.9 1.4 1.7 3.5 41.6 2.6 0.2 0.0 17.9 4.8 2.2 2.1 9.2 0.0 1.3 6.4 0.0 1.3 1.5 34.7 2.0 2.5 1.7 1.0 1.4 3.5 29.9 0.0 1.4 2.2 8.2 0.0 2.8 24.4 1.5 0.6 6.8 3.8 1.0 4.4 LETMD1 "HCCR, HCCR-1, HCCR-2, HCCR1, HCCR2, SLC55A3" ENSG00000050426 "LETM1 domain containing 1" Q6P1Q0 12 51047962-51060424 "Predicted intracellular proteins, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074361 Supported Nucleoplasm,Nucleoli,Mitochondria NA NA Mitochondria "Nucleoplasm, Nucleoli" "HPA074361: AB_2686682" "unprognostic (2.16e-1)" "unprognostic (1.47e-1)" "unprognostic (1.08e-1)" "unprognostic (6.55e-2)" "unprognostic (1.25e-1)" "unprognostic (2.11e-1)" "unprognostic (2.20e-2)" "unprognostic (3.05e-3)" "unprognostic (1.48e-2)" "unprognostic (5.05e-2)" "unprognostic (7.86e-2)" "unprognostic (6.57e-2)" "prognostic favorable (3.26e-4)" "unprognostic (4.07e-1)" "unprognostic (7.79e-2)" "unprognostic (2.58e-1)" "prognostic favorable (3.16e-4)" 25.7 27.5 23.0 18.1 31.2 17.1 27.1 23.1 37.5 18.6 26.8 18.8 21.5 31.9 22.9 22.4 16.2 30.0 23.5 16.4 21.2 19.0 29.3 35.1 16.6 18.5 20.6 21.3 34.3 38.6 28.5 20.2 12.3 21.6 19.1 26.1 22.6 28.2 24.0 23.8 18.5 28.5 18.7 21.4 17.5 22.6 15.5 14.3 19.9 34.1 10.7 20.1 20.3 14.8 11.3 7.2 2.9 11.6 8.6 17.1 9.3 7.4 6.7 5.0 13.5 22.8 37.4 5.1 7.7 12.8 8.1 9.2 16.2 15.4 19.7 9.6 8.3 5.9 13.9 10.3 10.4 9.4 7.1 12.9 14.1 9.3 12.7 15.1 12.7 10.3 31.5 33.7 9.6 22.8 24.8 8.2 19.1 14.6 14.3 11.1 11.6 8.9 12.3 3.4 9.3 18.3 7.6 6.1 10.7 10.2 11.4 15.0 6.9 5.8 13.1 17.6 5.3 20.7 11.6 6.2 5.1 5.5 8.4 4.4 13.0 20.2 8.4 9.5 8.3 3.6 2.5 7.3 2.9 8.6 7.8 12.5 11.3 14.2 10.6 7.2 8.1 17.1 15.5 2.4 8.6 11.6 6.4 12.6 9.3 23.0 31.2 23.1 37.5 21.2 19.0 20.6 21.3 21.6 14.3 20.8 22.7 30.4 41.1 44.1 20.2 12.5 22.9 25.4 11.4 22.7 9.8 40.0 77.9 12.6 6.3 19.6 22.0 23.3 28.4 18.9 32.4 29.0 25.3 16.3 26.2 17.5 26.7 20.3 41.0 11.9 30.2 21.2 37.1 17.2 34.4 24.4 16.0 28.1 28.7 31.5 16.5 25.8 38.1 20.6 19.4 38.8 23.3 42.4 49.8 24.8 LEUTX ENSG00000213921 "Leucine twenty homeobox" A8MZ59 19 39776595-39786167 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "CACO-2: 1.0;HDLM-2: 2.3" HPA041498 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA041498: AB_10796346" "unprognostic (6.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LGALS1 GBP ENSG00000100097 "Galectin 1" P09382 22 37675608-37679806 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Fibroblasts: 4031.4;Hofbauer cells: 3788.4;monocytes: 10290.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000646, HPA000687, HPA001130, CAB002157" Enhanced Approved Nucleoplasm,Cytosol "Secreted to blood" No No 19000000 Cytosol Nucleoplasm "CAB002157: AB_563734, HPA000646: AB_1078935, HPA000687: AB_2756309, HPA001130: AB_2756311" "unprognostic (1.65e-1)" "unprognostic (8.13e-2)" "unprognostic (5.13e-2)" "prognostic favorable (2.36e-5)" "unprognostic (6.38e-2)" "unprognostic (2.67e-3)" "prognostic unfavorable (3.06e-4)" "unprognostic (3.22e-3)" "unprognostic (4.91e-3)" "unprognostic (2.51e-1)" "unprognostic (6.16e-3)" "unprognostic (8.06e-2)" "prognostic unfavorable (1.18e-10)" "unprognostic (2.24e-2)" "unprognostic (8.13e-2)" "unprognostic (9.47e-2)" "prognostic unfavorable (5.10e-4)" 167.5 49.3 23.0 56.0 22.9 29.8 213.7 7.6 30.9 158.6 94.5 20.1 44.2 22.0 150.9 80.3 74.0 66.8 78.8 108.6 18.9 29.3 24.0 20.8 55.8 45.4 41.4 28.9 105.1 18.2 5.1 17.5 80.1 53.6 85.9 23.4 35.7 34.9 89.6 117.1 29.2 29.2 145.8 88.3 40.3 40.0 42.4 20.5 16.7 19.6 59.1 20.4 99.8 81.7 29.0 185.2 44.0 149.1 19.6 73.1 180.2 94.5 55.8 1.2 49.5 116.0 227.9 1.1 219.9 258.2 162.9 162.4 6.2 12.5 0.1 22.6 222.0 56.2 10.1 1.9 144.6 57.0 97.1 1.0 8.3 58.6 25.6 75.7 4.8 110.9 141.1 9.9 129.9 55.6 149.1 178.8 0.0 6.0 40.1 126.0 42.2 0.1 67.3 0.4 21.0 132.4 0.1 83.0 25.9 67.0 0.2 0.1 29.4 43.9 7.7 54.9 2.4 40.9 56.9 241.8 217.7 108.9 96.6 112.2 24.6 16.4 0.4 255.8 25.1 86.6 44.0 149.1 5.3 40.8 114.2 6.1 29.0 38.0 39.8 185.2 10.8 6.6 26.8 6.3 19.6 120.0 45.7 73.1 180.2 23.0 22.9 7.6 30.9 18.9 29.3 41.4 28.9 53.6 20.5 154.9 138.0 222.9 146.3 648.8 7.2 914.1 63.7 54.9 94.4 155.3 5.9 84.3 14.9 558.2 21.5 662.6 6.4 23.3 75.7 807.6 4031.4 43.7 528.7 472.3 3788.4 7.9 2.9 939.1 2674.9 59.6 903.3 2724.8 2709.5 10290.5 1.7 156.0 264.8 1.7 1222.7 15.1 31.2 1623.4 2845.4 14.7 12.1 513.9 126.7 373.6 0.9 48.4 LGALS13 "PLAC8, PP13" ENSG00000105198 "Galectin 13" Q9UHV8 19 39602501-39607476 "Predicted intracellular proteins" Apoptosis Hemagglutinin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "placenta: 58.9" "Cell type enriched" "Detected in some" 19 "Syncytiotrophoblasts: 267.5" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.5" "Group enriched" "Detected in some" 7 "cerebellum: 1.5;hypothalamus: 1.2;midbrain: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 73 "SuSa: 7.3" HPA046803 Supported Nucleoplasm NA NA Nucleoplasm "HPA046803: AB_10965990" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 58.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.5 0.2 0.0 1.2 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 4.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 14.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 267.5 0.0 0.0 0.0 LGALS14 "CLC2, PPL13" ENSG00000006659 "Galectin 14" Q8TCE9 19 39704306-39709444 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 34 "placenta: 110.8" "Cell type enriched" "Detected in some" 72 "Syncytiotrophoblasts: 74.1" "Cancer enriched" "Detected in single" 16 "liver cancer: 5.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 3.2" "Lineage enriched" "Detected in single" 5 "T-cells: 3.2" "Group enriched" "Detected in some" 5 "EFO-21: 5.5;U-266/70: 12.8" HPA065180 Supported Nucleoplasm NA NA Nucleoplasm "HPA065180: " "unprognostic (1.95e-1)" 0.0 0.2 0.1 0.1 0.1 0.2 1.1 0.1 0.3 1.5 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.2 0.0 0.2 110.8 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.6 0.2 0.0 0.3 0.3 0.1 1.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.6 0.0 0.0 3.2 0.6 0.3 0.0 0.4 0.7 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.3 0.5 0.0 5.5 0.1 0.1 0.8 0.1 0.0 0.3 1.9 0.2 0.1 1.0 0.4 0.0 0.2 1.2 0.0 0.3 0.3 0.4 0.7 0.0 0.5 0.1 1.4 0.0 0.5 0.2 0.3 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.2 0.4 0.3 0.1 0.4 0.2 0.8 0.1 0.2 0.0 0.6 0.8 1.0 0.3 12.8 0.7 0.1 0.4 0.3 0.3 0.6 0.0 0.2 0.1 0.0 0.1 0.0 0.9 0.0 0.0 0.1 3.2 0.2 0.6 0.0 0.0 0.3 0.0 0.6 0.1 0.1 0.1 0.3 0.1 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.1 0.0 0.0 0.0 LGALS2 HL14 ENSG00000100079 "Galectin 2" P05162 22 37570246-37582616 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "blood: 129.0;gallbladder: 91.7;intestine: 43.0;kidney: 35.3;pancreas: 87.3" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 800.0;Enterocytes: 838.5;Pancreatic endocrine cells: 476.7;Proximal tubular cells: 1320.5;Undifferentiated cells: 571.4" "Cancer enhanced" "Detected in all" "renal cancer: 54.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 31 "classical monocyte: 129.0;intermediate monocyte: 47.0;myeloid DC: 100.5" "Group enriched" "Detected in many" 51 "dendritic cells: 100.5;monocytes: 129.0" "Group enriched" "Detected in some" 4 "CACO-2: 46.8;Hep G2: 26.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA003536, CAB025198" Enhanced Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB025198: , HPA003536: AB_1078936" "unprognostic (1.37e-3)" "unprognostic (4.11e-3)" "unprognostic (1.32e-3)" "unprognostic (4.32e-2)" "unprognostic (1.74e-1)" "unprognostic (2.91e-3)" "unprognostic (3.19e-1)" "unprognostic (9.92e-2)" "unprognostic (8.07e-2)" "unprognostic (2.58e-1)" "unprognostic (6.15e-2)" "unprognostic (5.19e-1)" "unprognostic (2.33e-3)" "unprognostic (1.80e-1)" "unprognostic (6.70e-2)" "unprognostic (5.01e-3)" "unprognostic (1.21e-1)" 3.1 0.4 0.6 4.3 0.5 1.8 0.6 0.4 0.5 0.5 12.6 0.5 0.4 6.1 1.0 1.9 0.8 0.6 91.7 0.7 0.4 0.4 35.3 1.0 2.3 7.9 0.5 0.4 0.6 87.3 0.0 0.4 0.9 0.5 0.5 13.0 0.5 1.8 0.4 0.4 0.9 43.0 0.4 0.5 8.3 1.5 0.6 0.4 4.5 0.5 1.0 9.6 0.7 0.6 0.6 100.5 2.2 129.0 0.1 0.2 70.1 1.1 0.6 0.4 0.4 0.0 0.0 0.5 0.7 0.0 0.0 0.0 46.8 0.0 0.1 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 26.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.4 0.2 9.0 0.1 0.0 0.4 0.5 0.0 0.0 0.0 0.1 0.7 0.8 1.1 0.2 0.7 0.7 2.7 0.9 0.4 1.9 0.3 0.0 0.1 0.1 1.2 0.0 0.5 0.6 129.0 0.6 0.1 47.0 0.2 0.6 0.1 0.2 100.5 0.2 0.2 0.1 2.2 0.1 2.9 0.8 0.2 70.1 0.6 0.5 0.4 0.5 0.4 0.4 0.5 0.4 0.5 0.4 6.0 4.6 32.7 0.1 15.1 0.0 0.1 800.0 1.4 2.3 27.9 0.0 0.1 107.8 20.9 0.0 0.1 838.5 0.0 175.0 0.2 3.5 0.1 2.3 0.6 27.7 0.0 70.9 0.6 23.7 0.0 0.6 71.1 23.6 13.6 374.8 0.0 476.7 354.2 0.0 1320.5 0.0 0.0 6.2 0.0 0.2 10.8 0.2 2.5 571.4 0.1 LGALS3 "GALIG, LGALS2, MAC-2" ENSG00000131981 "Galectin 3" P17931 14 55124110-55145413 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Immunity, Innate immunity, mRNA processing, mRNA splicing" "IgE-binding protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 3145.4;Paneth cells: 2942.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 67.4;intermediate monocyte: 55.4;myeloid DC: 41.7;non-classical monocyte: 44.2;T-reg: 25.9" "Group enriched" "Detected in all" 12 "dendritic cells: 41.7;monocytes: 67.4;T-cells: 25.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 90.9;CAPAN-2: 72.2;OE19: 119.2;SK-MEL-30: 169.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA003162, CAB005191" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" NA NA 2300000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB005191: AB_2136784, HPA003162: AB_1078937" "unprognostic (1.42e-1)" "unprognostic (9.79e-2)" "unprognostic (1.14e-1)" "unprognostic (3.15e-1)" "unprognostic (2.46e-2)" "unprognostic (3.34e-2)" "unprognostic (1.73e-3)" "unprognostic (1.00e-1)" "unprognostic (2.13e-2)" "unprognostic (1.28e-1)" "unprognostic (1.08e-3)" "unprognostic (5.97e-2)" "unprognostic (8.52e-2)" "unprognostic (1.44e-1)" "unprognostic (2.96e-2)" "unprognostic (2.65e-3)" "unprognostic (7.60e-3)" 95.7 11.0 10.4 50.9 13.6 29.8 53.2 6.5 11.7 54.1 127.1 6.1 42.4 75.7 50.3 30.7 76.1 26.1 83.9 42.3 8.4 5.7 19.9 3.9 65.5 16.6 8.5 9.4 58.9 24.2 0.5 11.0 78.7 5.5 51.7 93.7 25.7 78.3 51.7 31.3 76.1 182.4 48.2 8.7 11.1 36.9 20.4 5.7 5.5 18.0 65.7 41.7 41.1 44.4 1.3 41.7 3.6 67.4 2.5 25.9 37.2 21.7 6.9 0.2 0.1 45.3 90.9 26.5 17.4 36.7 4.8 8.6 15.0 72.2 0.0 9.2 20.3 8.8 21.8 0.4 18.2 2.7 25.7 0.3 0.0 7.7 6.9 34.4 0.0 0.0 28.3 27.8 5.6 11.7 11.0 7.5 0.0 0.0 21.0 10.9 14.7 0.0 5.3 0.3 119.2 19.6 0.0 0.9 1.5 45.3 29.1 0.6 1.7 40.7 0.0 169.5 1.2 17.9 2.4 13.7 23.0 3.2 8.5 0.3 11.7 37.1 0.1 33.0 1.4 2.4 1.7 67.4 3.4 1.8 55.4 11.4 1.3 6.8 5.1 41.7 0.4 0.3 1.0 3.6 2.5 44.2 1.1 25.9 37.2 10.4 13.6 6.5 11.7 8.4 5.7 8.5 9.4 5.5 5.7 670.0 300.6 39.7 543.1 560.7 2.0 183.5 254.8 1263.4 586.9 113.4 0.0 565.8 570.3 541.1 17.4 423.0 3145.4 116.8 951.7 754.6 506.8 590.1 552.4 0.9 1164.5 1.6 166.8 50.3 236.1 23.5 514.6 722.3 804.8 642.0 1587.7 215.8 859.9 2942.3 361.0 42.5 11.3 142.3 241.1 7.7 3.6 697.2 404.6 52.2 1480.8 936.7 LGALSL "GRP, HSPC159" ENSG00000119862 "Galectin like" Q3ZCW2 2 64453969-64461381 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 50.8;tongue: 90.3" "Cell type enhanced" "Detected in many" 7 "Rod photoreceptor cells: 124.1;Suprabasal keratinocytes: 119.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "eosinophil: 3.7;MAIT T-cell: 1.9;neutrophil: 4.1" "Group enriched" "Detected in many" 8 "granulocytes: 4.1;T-cells: 1.9" "Cell line enhanced" "Detected in many" "AN3-CA: 25.0;HAP1: 36.4" "Low region specificity" "Detected in all" HPA046079 Approved Approved Nucleoplasm NA NA 9700000 Nucleoplasm "HPA046079: AB_10967075" "unprognostic (1.34e-1)" "unprognostic (3.43e-1)" "unprognostic (7.18e-2)" "unprognostic (3.77e-2)" "unprognostic (3.12e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.16e-4)" "unprognostic (1.25e-2)" "unprognostic (8.43e-2)" "unprognostic (3.57e-3)" "unprognostic (2.77e-1)" "unprognostic (2.24e-2)" "unprognostic (4.34e-2)" "unprognostic (6.57e-2)" "unprognostic (6.20e-2)" "unprognostic (9.19e-2)" "unprognostic (2.77e-2)" 6.5 9.2 4.8 3.4 6.2 3.5 12.0 11.0 7.2 6.9 11.5 2.7 2.4 5.0 4.2 6.4 12.7 3.5 4.9 8.1 4.6 5.0 5.6 4.8 18.0 2.9 3.8 3.9 5.7 5.5 10.0 6.3 5.3 4.3 8.2 6.1 14.7 6.4 3.9 30.7 50.8 13.4 5.2 2.8 4.0 4.4 4.0 1.2 0.8 3.1 90.3 13.6 5.1 6.2 0.3 0.1 4.1 0.3 0.0 1.9 3.8 5.8 3.7 10.6 25.0 0.3 0.1 3.1 1.6 4.0 3.1 3.0 17.4 1.2 0.0 2.4 0.8 6.1 7.0 36.4 6.7 2.5 6.6 9.5 0.1 1.9 8.5 3.2 1.6 2.4 1.6 4.3 1.3 4.8 2.8 1.9 3.9 0.0 1.7 0.0 4.5 2.4 0.3 8.3 3.4 4.4 2.7 6.5 1.9 3.7 4.2 1.7 7.0 5.2 3.5 3.0 6.6 2.5 0.2 0.8 2.0 6.4 1.3 3.1 7.4 3.5 4.9 0.0 1.0 2.7 0.0 0.3 3.7 0.0 0.0 1.9 0.3 0.4 0.4 0.1 0.2 0.0 0.0 4.1 0.0 0.0 0.0 0.0 3.8 4.8 6.2 11.0 7.2 4.6 5.0 3.8 3.9 4.3 1.2 20.8 55.7 0.8 19.8 60.0 27.5 11.8 5.1 0.0 3.4 10.4 31.4 1.2 13.3 5.6 9.7 11.7 35.4 0.0 11.7 2.3 9.3 20.9 1.1 9.5 0.9 12.7 8.7 12.9 4.8 1.5 7.5 2.8 10.1 1.8 29.0 68.8 14.0 20.1 4.2 10.2 124.1 19.4 32.3 4.7 1.3 119.7 1.3 0.0 16.6 28.5 LGMN "LGMN1, PRSC1" ENSG00000100600 Legumain Q99538 14 92703807-92748702 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Hofbauer cells: 1236.6;Ito cells: 365.8;Syncytiotrophoblasts: 348.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 11 "plasmacytoid DC: 54.2" "Lineage enriched" "Detected in many" 11 "dendritic cells: 54.2" "Cell line enhanced" "Detected in many" "RPMI-8226: 129.9;U-266/70: 71.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001426 Enhanced Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 1200000 Vesicles Nucleoplasm "HPA001426: AB_1079247" "unprognostic (1.19e-1)" "unprognostic (1.16e-1)" "unprognostic (2.37e-1)" "unprognostic (1.52e-1)" "unprognostic (1.99e-1)" "unprognostic (3.29e-2)" "unprognostic (4.52e-2)" "unprognostic (1.31e-1)" "unprognostic (5.03e-2)" "unprognostic (3.50e-2)" "unprognostic (4.70e-2)" "unprognostic (2.47e-1)" "prognostic favorable (4.70e-4)" "unprognostic (8.06e-2)" "unprognostic (3.64e-2)" "unprognostic (7.18e-3)" "unprognostic (7.24e-2)" 42.9 16.3 8.6 17.4 10.7 3.5 19.9 5.8 17.9 13.3 22.3 11.7 13.9 24.2 12.1 48.1 17.4 14.1 32.7 38.8 10.3 10.1 87.6 44.6 31.5 42.4 8.3 10.1 20.5 14.6 54.4 9.7 113.6 9.9 22.0 24.5 23.2 22.6 8.4 17.3 11.9 37.1 23.3 11.5 58.3 23.7 14.0 7.9 17.2 36.8 19.2 17.3 31.4 18.2 4.7 54.2 0.7 0.8 1.0 4.3 1.7 4.9 7.1 4.8 8.7 14.9 12.0 16.7 10.6 10.2 11.1 13.1 5.5 8.9 2.7 15.8 17.4 6.9 12.3 0.0 9.2 5.3 0.2 5.5 0.1 3.9 6.3 4.4 0.1 0.4 8.5 4.5 10.7 6.2 3.3 13.1 5.1 1.0 23.0 0.8 6.6 1.3 0.2 2.3 31.1 4.9 1.2 4.2 129.9 12.0 19.3 5.2 3.5 14.8 9.1 7.7 11.0 6.7 0.0 7.1 5.5 7.0 9.9 3.2 71.5 8.4 3.7 3.1 0.1 10.5 0.7 0.4 0.1 0.2 0.8 0.4 4.7 1.4 0.4 5.0 3.4 4.3 2.5 0.5 1.0 0.2 54.2 2.6 1.7 8.6 10.7 5.8 17.9 10.3 10.1 8.3 10.1 9.9 7.9 53.6 113.7 33.9 33.3 20.5 9.9 25.0 45.9 18.7 34.2 29.6 88.4 130.6 8.3 49.8 0.8 31.3 68.2 0.0 45.2 121.5 45.8 47.6 8.1 36.1 1236.6 12.7 35.1 365.8 242.3 2.3 28.1 82.0 45.5 62.3 31.1 25.8 41.2 52.6 54.5 101.8 15.3 19.4 64.6 22.3 17.7 15.3 348.2 8.5 40.4 39.9 LGR5 "FEX, GPR49, GPR67, HG38" ENSG00000139292 "Leucine rich repeat containing G protein-coupled receptor 5" O75473 12 71439770-71586310 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.3;fallopian tube: 19.9;placenta: 21.6;skeletal muscle: 26.6" "Cell type enhanced" "Detected in some" 23 "Cytotrophoblasts: 46.3;Syncytiotrophoblasts: 22.1;Undifferentiated cells: 11.5" "Group enriched" "Detected in many" 7 "colorectal cancer: 16.8;endometrial cancer: 26.8;ovarian cancer: 9.8;stomach cancer: 6.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Lineage enriched" "Detected in single" 10 "B-cells: 1.1" "Group enriched" "Detected in some" 5 "Hep G2: 16.2;SH-SY5Y: 47.7" "Region enriched" "Detected in some" 8 "olfactory region: 41.8" "Low region specificity" "Detected in many" HPA012530 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA012530: AB_1849329" "unprognostic (5.19e-2)" "unprognostic (3.79e-1)" "unprognostic (3.30e-1)" "unprognostic (1.02e-2)" "unprognostic (1.59e-1)" "unprognostic (2.49e-3)" "unprognostic (1.52e-1)" "prognostic favorable (5.09e-4)" "unprognostic (1.46e-1)" "unprognostic (2.60e-1)" "unprognostic (3.71e-1)" "unprognostic (8.10e-2)" "unprognostic (2.01e-5)" "unprognostic (1.50e-1)" "unprognostic (1.69e-1)" "unprognostic (2.28e-2)" "unprognostic (6.25e-3)" 2.3 2.2 3.5 0.8 18.1 0.4 2.1 0.9 9.5 2.2 4.2 24.5 0.0 6.1 4.9 1.7 0.6 19.9 0.8 0.8 5.0 3.4 0.9 1.4 1.4 0.4 32.3 5.1 1.5 0.6 1.0 2.0 21.6 10.8 1.8 4.6 0.9 3.1 9.0 26.6 4.0 6.5 0.7 15.0 0.6 2.9 0.7 25.7 0.0 0.9 0.9 2.1 0.7 1.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 5.3 0.0 0.4 16.2 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 5.3 0.7 1.0 0.0 0.0 0.0 6.5 0.1 47.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 18.1 0.9 9.5 5.0 3.4 32.3 5.1 10.8 25.7 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 46.3 0.0 0.0 0.3 0.1 0.4 0.0 0.0 1.7 1.7 0.0 0.0 0.4 5.5 0.0 4.7 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 22.1 0.0 11.5 0.0 LGR6 FLJ14471 ENSG00000133067 "Leucine rich repeat containing G protein-coupled receptor 6" Q9HBX8 1 202193901-202319781 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "G-protein coupled receptor, Receptor, Transducer" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 49.6" "Cell type enhanced" "Detected in some" 12 "Basal glandular cells: 2.8;Cardiomyocytes: 8.3;Late spermatids: 3.2;Spermatocytes: 6.0;Spermatogonia: 3.3" "Cancer enhanced" "Detected in many" "ovarian cancer: 17.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "gdT-cell: 14.3;memory CD8 T-cell: 8.3;naive CD8 T-cell: 4.7" "Lineage enriched" "Detected in single" 41 "T-cells: 14.3" "Cell line enhanced" "Detected in some" "A549: 16.6;CAPAN-2: 14.8;HaCaT: 8.0;HeLa: 4.0" "Region enriched" "Detected in some" 9 "olfactory region: 30.0" HPA008556 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA008556: " "unprognostic (4.72e-3)" "unprognostic (5.29e-2)" "unprognostic (1.21e-1)" "unprognostic (2.89e-2)" "prognostic unfavorable (4.35e-4)" "unprognostic (1.08e-1)" "unprognostic (5.13e-2)" "unprognostic (9.23e-2)" "unprognostic (1.12e-1)" "unprognostic (2.54e-2)" "unprognostic (4.01e-2)" "unprognostic (7.89e-2)" "unprognostic (1.00e-2)" "unprognostic (1.17e-3)" "unprognostic (2.08e-1)" "unprognostic (1.70e-1)" "unprognostic (7.83e-2)" 1.1 0.1 0.9 0.8 3.2 1.8 7.9 6.0 2.4 2.6 2.2 1.5 0.5 0.2 1.6 7.3 4.4 13.8 49.6 12.3 0.7 3.3 0.9 1.4 6.9 1.1 6.8 0.2 2.2 0.5 0.1 15.9 0.9 9.3 6.7 1.1 0.8 8.5 2.5 0.3 3.2 1.6 2.6 1.6 5.3 0.7 4.9 3.9 0.2 4.1 2.6 3.4 3.2 2.9 0.0 0.0 0.0 0.0 0.3 14.3 2.5 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 1.7 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.9 0.0 1.7 8.3 0.0 0.0 0.7 4.7 0.0 0.3 0.0 0.0 0.4 2.5 0.9 3.2 6.0 2.4 0.7 3.3 6.8 0.2 9.3 3.9 0.0 0.0 0.0 2.8 1.1 0.0 8.3 0.0 0.0 1.2 0.0 0.0 0.5 0.0 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 3.2 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 6.0 3.3 0.1 0.7 0.5 1.7 0.3 LGSN "GLULD1, LGS" ENSG00000146166 "Lengsin, lens protein with glutamine synthetase domain" Q5TDP6 6 63275951-63319977 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 5.2;liver: 9.3" "Cell type enhanced" "Detected in some" 9 "Ciliated cells: 4.0;Club cells: 3.4;Late spermatids: 2.2;Proximal tubular cells: 2.4" "Cancer enhanced" "Detected in some" "lung cancer: 2.2" "Region enriched" "Detected in single" 7 "pons and medulla: 2.9" "Cell type enhanced" "Detected in some" "neutrophil: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 10.6;BEWO: 5.7;CACO-2: 3.4;HeLa: 3.9;Karpas-707: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030957, HPA039983" Enhanced Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA030957: AB_10670149, HPA039983: AB_2676784" "unprognostic (1.94e-1)" "unprognostic (1.72e-1)" "unprognostic (1.12e-1)" "unprognostic (9.03e-2)" "unprognostic (2.81e-1)" "unprognostic (1.01e-1)" "unprognostic (5.05e-4)" "unprognostic (1.26e-1)" "unprognostic (1.74e-1)" "unprognostic (1.08e-1)" "unprognostic (2.13e-1)" "unprognostic (2.53e-2)" "unprognostic (4.51e-3)" "unprognostic (1.64e-3)" "unprognostic (1.31e-1)" "unprognostic (2.19e-1)" 0.2 0.0 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 5.2 9.3 0.7 0.2 0.4 0.2 0.2 0.5 0.0 0.2 2.3 2.9 0.5 0.1 0.2 0.2 0.2 0.3 0.1 0.4 0.2 1.6 0.3 0.8 0.7 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.7 1.0 3.4 0.7 0.3 0.5 0.1 0.1 10.6 0.1 0.1 0.0 0.0 5.7 0.1 0.1 0.0 0.0 3.4 0.1 0.1 0.0 0.0 0.3 0.1 0.6 0.4 0.0 0.0 0.0 0.1 3.9 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 2.6 0.0 0.3 0.1 0.1 0.2 0.0 0.0 0.1 0.2 0.2 0.0 0.1 1.9 0.1 0.4 0.1 0.1 0.4 0.1 0.0 0.2 0.3 0.2 0.0 0.1 1.2 0.0 0.1 0.1 0.1 0.1 1.6 0.7 0.3 0.5 0.3 0.2 0.7 0.5 0.3 0.1 0.7 0.4 0.5 3.4 0.3 0.3 1.0 0.1 0.1 0.2 0.2 0.2 0.2 0.2 0.1 0.4 0.2 2.9 0.2 0.0 0.3 0.0 0.4 0.0 0.0 0.4 0.0 4.0 3.4 0.0 0.0 1.7 1.7 0.0 0.8 0.0 0.2 0.0 0.2 0.3 0.0 0.2 0.0 0.5 0.2 0.0 0.0 0.0 0.3 2.2 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.5 0.0 LHFPL4 ENSG00000156959 "LHFPL tetraspan subfamily member 4" Q7Z7J7 3 9498361-9553802 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 29.1;pituitary gland: 9.0" "Group enriched" "Detected in some" 4 "Bipolar cells: 39.8;Cone photoreceptor cells: 17.7;Horizontal cells: 14.3;Rod photoreceptor cells: 16.4" "Group enriched" "Detected in some" 13 "glioma: 6.8;pancreatic cancer: 1.3;testis cancer: 5.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "GAMG: 13.5;NTERA-2: 4.3;SCLC-21H: 10.1;SH-SY5Y: 12.5;U-266/84: 10.5;WM-115: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041421 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA041421: AB_10796673" "unprognostic (6.81e-2)" "unprognostic (3.65e-2)" "unprognostic (4.50e-1)" "unprognostic (6.62e-3)" "unprognostic (1.82e-1)" "unprognostic (1.45e-1)" "unprognostic (2.08e-1)" "unprognostic (1.60e-1)" "unprognostic (5.65e-2)" "unprognostic (6.59e-2)" "unprognostic (1.12e-2)" "unprognostic (3.77e-1)" "unprognostic (1.90e-2)" "unprognostic (6.78e-2)" "unprognostic (2.99e-1)" "unprognostic (3.03e-3)" "unprognostic (8.21e-2)" 0.9 4.9 8.0 1.0 11.4 0.9 0.9 16.0 29.1 0.9 1.4 1.5 0.0 1.2 0.9 0.8 0.9 0.9 0.9 0.8 8.4 8.5 0.9 0.8 1.0 0.8 4.2 8.6 0.8 1.8 1.2 9.0 0.8 9.2 0.9 1.4 1.7 0.9 0.9 0.8 0.9 1.3 0.9 4.2 0.8 1.3 1.6 1.8 0.0 0.9 0.0 0.8 0.8 0.1 0.0 1.2 0.6 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 10.1 12.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 2.8 0.0 10.5 0.0 0.5 0.0 3.8 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 1.2 0.0 0.0 8.0 11.4 16.0 15.6 8.4 8.5 4.2 8.6 9.2 1.8 0.0 0.0 0.0 2.6 0.0 39.8 0.6 0.0 0.0 0.0 0.0 17.7 0.5 0.0 0.3 0.4 0.0 0.5 0.0 0.2 0.8 0.3 1.5 1.1 0.0 0.2 14.3 1.2 4.9 0.3 0.4 0.0 0.0 0.0 0.0 0.6 1.3 0.3 1.4 0.0 0.1 16.4 0.0 0.1 1.7 1.0 0.0 1.1 0.0 1.0 2.5 LHX1 "LIM-1, LIM1" ENSG00000273706 "LIM homeobox 1" P48742 17 36936785-36944612 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 15.0;kidney: 5.7;seminal vesicle: 7.1" "Cell type enriched" "Detected in some" 9 "Horizontal cells: 341.7" "Cancer enhanced" "Detected in some" "ovarian cancer: 8.1" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.1" "Lineage enhanced" "Detected in single" "T-cells: 1.1" "Cell line enhanced" "Detected in some" "HAP1: 6.3;HMC-1: 2.7;WM-115: 11.7" "Region enhanced" "Detected in many" "cerebellum: 21.5" "Region enriched" "Detected in many" 4 "cerebellum: 20.4" "HPA044307, HPA073521, HPA074382" Enhanced Supported "Nucleoplasm,Nuclear membrane,Golgi apparatus" NA NA Nucleoplasm "Nuclear membrane, Golgi apparatus" "HPA044307: , HPA073521: AB_2732226, HPA074382: " "unprognostic (3.86e-5)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.63e-5)" "unprognostic (3.85e-2)" "unprognostic (1.06e-4)" "unprognostic (2.67e-2)" "unprognostic (2.72e-1)" "unprognostic (1.52e-1)" "unprognostic (4.20e-3)" "unprognostic (1.74e-5)" "unprognostic (1.33e-1)" "unprognostic (8.62e-2)" "unprognostic (3.05e-2)" 0.1 0.0 0.0 0.1 0.0 0.0 0.0 15.0 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 1.1 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.2 0.0 6.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 2.7 0.0 0.1 0.0 2.0 0.7 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 1.9 0.0 1.5 0.0 0.0 0.0 0.1 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.0 40.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 341.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 9.2 1.7 0.0 0.0 0.9 1.2 0.0 0.3 0.0 0.0 0.0 LHX2 "hLhx2, LH-2" ENSG00000106689 "LIM homeobox 2" P50458 9 124001670-124033301 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 44.7;retina: 17.0" "Cell type enriched" "Detected in some" 9 "Muller glia cells: 245.9" "Group enriched" "Detected in many" 5 "cervical cancer: 3.2;glioma: 10.7;melanoma: 3.5" "Group enriched" "Detected in many" 6 "amygdala: 30.7;basal ganglia: 20.5;cerebral cortex: 26.6;hippocampal formation: 23.6;olfactory region: 16.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 15.7;GAMG: 12.3;HAP1: 15.7;HeLa: 10.9;NTERA-2: 19.5;U-138 MG: 10.2" "Group enriched" "Detected in many" 5 "amygdala: 41.7;basal ganglia: 25.3;cerebral cortex: 46.8;hippocampal formation: 47.4;olfactory region: 19.7" "Group enriched" "Detected in many" 6 "amygdala: 55.6;basal ganglia: 46.4;cerebral cortex: 70.9;hippocampal formation: 73.5;olfactory region: 35.5" HPA000838 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA000838: AB_2666109" "unprognostic (3.60e-3)" "prognostic favorable (9.52e-4)" "unprognostic (3.52e-1)" "unprognostic (9.97e-2)" "unprognostic (1.29e-1)" "unprognostic (1.12e-2)" "unprognostic (6.37e-3)" "unprognostic (1.07e-1)" "unprognostic (4.59e-2)" "unprognostic (3.24e-1)" "unprognostic (2.96e-1)" "unprognostic (1.32e-2)" "unprognostic (4.66e-15)" "unprognostic (1.72e-1)" "unprognostic (2.92e-1)" "unprognostic (2.46e-2)" "unprognostic (1.77e-1)" 0.9 1.0 30.7 1.1 20.5 0.9 1.1 0.0 44.7 0.8 0.9 4.7 0.0 1.0 0.8 0.8 0.8 0.8 1.0 0.8 23.6 2.4 0.8 6.1 0.9 1.1 1.5 16.1 1.1 0.8 0.8 4.6 5.1 0.0 0.8 1.1 17.0 1.1 0.8 0.8 2.2 0.9 0.8 0.2 0.9 0.9 4.0 4.2 0.0 0.8 0.0 1.1 0.9 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 4.9 0.1 15.7 0.0 0.2 1.6 0.4 0.2 1.2 0.1 4.9 0.0 0.1 2.1 0.9 12.3 0.1 15.7 0.0 0.6 0.0 3.4 0.0 10.9 0.2 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 7.8 0.0 0.1 19.5 0.0 4.6 4.2 0.0 0.0 0.0 0.0 6.4 0.0 4.0 0.0 0.0 0.1 5.6 2.0 0.0 10.2 0.4 2.9 0.7 0.2 3.2 0.0 0.6 2.2 1.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 30.7 20.5 0.0 26.6 23.6 2.4 1.5 16.1 0.0 4.2 0.0 0.0 0.0 0.0 0.0 2.7 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 3.0 7.9 0.0 6.7 0.0 16.0 0.0 0.0 0.0 0.0 0.0 245.9 0.0 0.0 0.0 0.0 6.2 0.0 0.0 1.0 0.6 0.0 0.1 0.0 0.0 0.0 LHX5 ENSG00000089116 "LIM homeobox 5" Q9H2C1 12 113462034-113472280 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.0;stomach 1: 2.1;testis: 2.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 5 "cerebellum: 4.8;hypothalamus: 6.7;pons and medulla: 9.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.7;HMC-1: 4.6;K-562: 1.2;SiHa: 3.3;U-2 OS: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA053908 Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Cytosol "Nucleoplasm, Nuclear bodies" "HPA053908: AB_2682304" "unprognostic (5.20e-2)" "unprognostic (4.04e-3)" "unprognostic (1.73e-1)" "unprognostic (1.21e-1)" "unprognostic (2.19e-2)" "unprognostic (1.06e-2)" "unprognostic (1.95e-1)" "unprognostic (4.56e-1)" "unprognostic (1.10e-1)" "unprognostic (1.81e-1)" "unprognostic (5.10e-2)" "unprognostic (7.54e-3)" 0.0 0.1 0.0 0.0 0.3 0.0 0.0 4.8 4.9 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 9.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 2.1 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.8 0.0 0.0 6.7 1.2 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 LHX8 Lhx7 ENSG00000162624 "LIM homeobox 8" Q68G74 1 75128434-75161533 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.5;lymphoid tissue: 5.3;salivary gland: 6.1;tongue: 4.9" "Cell type enhanced" "Detected in single" 26 "Spermatogonia: 2.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "basal ganglia: 9.5;thalamus: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "SCLC-21H: 23.8;U-266/70: 8.0" "Region enhanced" "Detected in some" "basal ganglia: 9.9" "Group enriched" "Detected in some" 32 "basal ganglia: 15.3;hypothalamus: 4.4" HPA071806 Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA071806: AB_2686449" "unprognostic (2.28e-2)" "unprognostic (6.23e-2)" "unprognostic (3.85e-3)" "unprognostic (1.52e-9)" "unprognostic (1.64e-1)" "unprognostic (2.13e-1)" "unprognostic (1.06e-2)" 0.0 0.0 0.1 0.0 9.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.8 0.0 2.1 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.3 0.0 3.9 0.0 0.2 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.3 0.0 0.5 4.9 5.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.2 0.0 0.0 8.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.5 0.0 0.5 0.0 1.1 0.0 0.6 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.8 0.0 0.0 0.0 0.0 0.0 LHX9 ENSG00000143355 "LIM homeobox 9" Q9NQ69 1 197911902-197935478 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "ovary: 22.1;retina: 24.3;testis: 17.5" "Group enriched" "Detected in some" 10 "Leydig cells: 145.9;Peritubular cells: 47.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "fHDF/TERT166: 78.9" "Group enriched" "Detected in many" 4 "hippocampal formation: 6.9;midbrain: 20.7;thalamus: 13.3" "Group enriched" "Detected in many" 5 "midbrain: 38.1;pons and medulla: 11.9;thalamus: 24.4" HPA009695 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA009695: AB_1079251" "unprognostic (8.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.38e-4)" "unprognostic (1.43e-1)" "unprognostic (5.68e-3)" "unprognostic (3.55e-1)" "unprognostic (1.12e-2)" "unprognostic (5.52e-2)" "unprognostic (2.63e-2)" "unprognostic (3.26e-2)" "unprognostic (5.15e-2)" "unprognostic (2.62e-3)" "unprognostic (6.35e-3)" "unprognostic (1.42e-1)" "unprognostic (1.88e-1)" 0.3 0.2 1.7 0.1 1.0 0.1 0.1 0.1 0.5 1.1 0.3 0.7 0.4 0.2 0.8 4.1 0.1 0.4 0.2 1.5 0.7 2.6 0.1 1.2 2.7 0.1 0.8 0.0 22.1 0.1 0.1 1.4 0.1 3.1 0.1 0.2 24.3 0.1 0.2 0.9 0.1 0.2 0.1 0.5 0.1 0.1 17.5 0.5 0.0 0.1 0.0 0.1 0.1 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 1.2 2.2 0.1 0.0 0.0 0.0 0.0 78.9 0.0 0.0 1.9 0.0 0.6 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 2.4 2.3 0.9 0.0 0.0 0.0 0.0 1.9 0.0 0.7 0.4 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 1.0 0.1 0.5 0.7 2.6 0.8 0.0 3.1 0.5 3.0 9.6 0.0 0.0 0.0 0.0 1.4 0.0 1.4 1.2 0.0 0.0 0.0 1.7 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.8 145.9 0.0 0.0 0.0 0.0 2.6 0.0 0.0 47.4 0.0 0.3 0.0 0.0 2.3 0.3 0.0 0.1 0.0 0.0 0.0 LIAS LAS ENSG00000121897 "Lipoic acid synthetase" O43766 4 39458587-39485109 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 82.3;Late spermatids: 80.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018842, HPA019076" Approved Supported Approved Nucleoplasm,Mitochondria Yes No "Nucleoplasm, Mitochondria" "HPA018842: AB_1852864, HPA019076: AB_1852866" "unprognostic (3.61e-1)" "unprognostic (1.89e-1)" "unprognostic (8.44e-2)" "unprognostic (2.33e-1)" "unprognostic (4.87e-2)" "unprognostic (1.49e-1)" "unprognostic (8.31e-2)" "unprognostic (1.57e-1)" "unprognostic (4.19e-2)" "unprognostic (3.68e-2)" "unprognostic (2.46e-3)" "unprognostic (3.80e-2)" "prognostic favorable (4.11e-7)" "unprognostic (9.41e-3)" "unprognostic (2.35e-1)" "unprognostic (5.45e-2)" "unprognostic (6.98e-2)" 9.8 12.9 9.9 7.0 12.7 10.2 11.3 10.2 13.3 7.0 10.7 12.9 8.1 10.4 9.1 10.7 11.6 11.9 7.4 14.0 10.6 10.6 15.7 15.5 5.7 9.0 12.3 10.5 19.2 12.4 10.0 11.5 6.8 15.7 8.2 12.4 9.0 7.8 7.0 42.7 8.8 9.9 13.6 12.4 8.9 9.9 20.1 13.2 8.7 8.8 13.5 8.3 10.0 7.9 9.6 5.8 3.7 7.1 6.9 16.7 4.3 4.0 3.1 4.0 3.8 8.4 8.2 3.4 4.6 2.6 4.3 2.9 5.0 5.5 14.6 5.3 1.7 10.9 3.6 11.3 6.3 5.8 1.6 2.8 6.1 1.6 5.0 7.7 13.2 4.0 7.9 10.5 5.1 16.2 9.6 4.9 9.1 14.4 3.6 5.2 2.5 7.4 17.0 5.3 10.6 10.1 6.5 10.8 8.8 5.1 2.1 4.4 3.8 2.7 3.6 14.9 5.8 4.0 6.1 1.8 3.5 7.7 4.5 10.7 7.1 10.8 10.2 5.4 15.4 3.0 2.0 6.2 3.7 6.1 7.1 12.6 9.6 8.3 8.0 5.8 8.5 16.7 11.5 3.3 6.9 5.1 5.4 5.2 4.3 9.9 12.7 10.2 13.3 10.6 10.6 12.3 10.5 15.7 13.2 8.9 9.3 13.4 11.9 8.7 24.0 16.5 10.2 20.1 13.6 17.4 9.8 21.5 18.3 10.7 82.3 7.1 13.1 0.0 5.5 12.9 8.0 5.2 17.3 17.0 15.4 9.5 17.4 5.5 11.7 80.7 9.5 10.9 1.7 17.2 12.1 15.2 9.0 10.5 11.7 23.2 23.3 0.0 9.5 47.0 20.9 8.2 8.0 12.9 18.1 8.4 LIG1 ENSG00000105486 "DNA ligase 1" P18858 19 48115445-48170603 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037015, HPA041431, HPA048071" Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" Yes No Nucleoplasm "Golgi apparatus, Vesicles" "CAB037015: , HPA041431: AB_2677476, HPA048071: AB_2680248" "unprognostic (1.83e-1)" "unprognostic (1.48e-3)" "unprognostic (6.45e-2)" "unprognostic (9.76e-2)" "unprognostic (9.47e-2)" "unprognostic (9.24e-3)" "unprognostic (1.17e-3)" "unprognostic (2.28e-1)" "unprognostic (6.03e-3)" "unprognostic (4.26e-1)" "unprognostic (1.78e-2)" "unprognostic (1.10e-3)" "prognostic unfavorable (5.75e-5)" "unprognostic (3.59e-2)" "unprognostic (4.09e-2)" "unprognostic (1.59e-2)" "unprognostic (1.55e-2)" 4.1 5.6 8.1 25.2 10.4 37.8 6.4 17.2 10.6 6.5 9.2 6.5 8.7 12.0 6.8 6.1 11.0 7.8 6.9 2.6 6.3 5.3 6.0 6.2 5.9 18.6 7.7 7.4 10.8 10.3 9.1 9.7 11.7 8.1 7.5 6.0 4.6 7.2 7.9 6.1 12.5 12.8 3.6 7.1 11.2 6.7 15.1 11.5 34.7 10.7 12.1 16.9 6.6 8.6 10.4 1.3 2.0 5.6 10.9 11.5 4.8 15.8 20.4 21.9 14.1 0.9 1.1 15.8 9.2 6.8 14.8 16.4 11.5 15.6 28.7 5.7 3.9 4.1 10.7 9.0 9.0 6.4 15.4 15.5 17.7 14.4 14.9 0.3 22.0 14.7 2.0 0.7 7.9 1.2 1.9 7.9 17.5 15.0 10.8 7.5 12.7 35.1 32.7 12.4 17.1 4.7 30.3 17.1 14.1 4.6 24.2 13.8 13.8 11.1 13.0 3.1 5.2 8.4 16.9 7.8 11.8 20.0 9.9 14.3 10.7 16.8 29.2 4.8 12.4 13.1 0.0 1.4 2.0 7.6 5.6 6.8 10.3 8.4 7.6 1.3 10.4 11.5 8.0 1.1 10.9 2.7 1.2 8.9 4.8 8.1 10.4 17.2 10.6 6.3 5.3 7.7 7.4 8.1 11.5 3.0 9.9 14.6 6.7 7.3 17.6 3.9 2.5 25.4 12.5 3.5 9.8 16.2 6.6 5.1 17.7 5.5 4.5 0.0 4.5 29.3 5.0 2.8 5.8 3.9 13.9 7.9 0.0 4.3 5.2 6.4 2.0 5.8 3.3 10.8 6.8 11.9 3.5 5.8 1.8 3.7 11.6 12.9 4.9 9.8 28.5 8.0 8.4 11.4 8.1 5.5 LIG3 LIG2 ENSG00000005156 "DNA ligase 3" P49916 17 34980494-35009743 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 51.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006723 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA006723: AB_1847781" "unprognostic (6.05e-3)" "unprognostic (2.98e-1)" "unprognostic (1.24e-1)" "unprognostic (2.83e-1)" "unprognostic (1.57e-1)" "unprognostic (8.76e-2)" "unprognostic (2.40e-2)" "unprognostic (2.78e-1)" "unprognostic (2.25e-1)" "unprognostic (1.02e-2)" "unprognostic (8.77e-3)" "unprognostic (1.31e-1)" "unprognostic (6.67e-3)" "unprognostic (3.39e-1)" "unprognostic (3.28e-1)" "unprognostic (3.29e-2)" "unprognostic (4.71e-2)" 8.8 11.5 10.7 9.8 17.0 9.2 12.5 15.9 18.3 14.7 11.5 15.8 11.4 8.4 21.5 12.3 14.2 17.3 7.9 11.0 14.2 8.0 9.8 11.8 9.8 9.6 9.1 11.7 17.8 15.4 22.9 13.3 16.5 9.3 16.5 13.1 11.8 14.3 13.9 17.0 13.9 9.8 14.7 8.0 14.3 11.6 27.8 10.9 20.8 14.5 9.7 13.9 13.6 12.7 4.6 10.1 4.8 6.3 11.1 8.4 4.5 7.9 15.8 19.1 16.8 3.8 4.7 14.6 7.7 5.6 10.4 10.5 7.6 4.3 13.0 6.4 10.0 10.3 7.4 21.6 9.9 13.5 6.1 14.5 13.6 7.6 11.0 6.0 21.2 24.1 3.5 8.7 7.7 12.1 5.2 12.6 20.0 21.3 14.9 7.5 8.9 26.7 6.8 18.3 9.9 6.7 14.5 17.5 13.7 5.1 8.6 15.6 11.2 11.5 9.4 7.4 29.3 17.0 10.7 6.0 6.8 8.5 8.3 12.3 13.4 14.4 16.8 4.9 10.1 13.0 0.6 3.8 4.8 5.9 6.3 8.4 4.6 4.0 5.2 10.1 4.0 5.4 3.8 0.3 11.1 3.2 6.0 2.5 4.5 10.7 17.0 15.9 18.3 14.2 8.0 9.1 11.7 9.3 10.9 3.0 10.1 1.5 8.9 4.4 16.2 8.7 10.2 4.0 13.6 12.2 15.7 12.3 8.3 5.8 35.6 3.9 6.2 0.0 5.2 15.3 5.4 10.6 9.2 7.3 7.0 15.9 6.4 3.7 5.9 51.3 6.6 4.5 3.3 3.6 8.2 8.5 3.7 7.0 7.4 5.7 16.8 6.5 3.9 29.6 15.8 4.5 18.1 4.9 9.7 8.4 LIG4 ENSG00000174405 "DNA ligase 4" P49917 13 108207439-108218368 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication" Ligase "Cancer-related genes, Disease mutation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ciliated cells: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001334, HPA057325" Approved Supported "Nucleoplasm,Cytoplasmic bodies" NA NA Nucleoplasm "Cytoplasmic bodies" "HPA001334: AB_1078689, HPA057325: AB_2732608" "unprognostic (9.93e-2)" "unprognostic (1.56e-1)" "unprognostic (2.35e-1)" "unprognostic (2.00e-2)" "unprognostic (1.40e-1)" "unprognostic (1.97e-1)" "unprognostic (1.56e-1)" "unprognostic (7.97e-2)" "unprognostic (2.43e-1)" "unprognostic (4.87e-1)" "unprognostic (1.96e-2)" "unprognostic (4.21e-3)" "unprognostic (1.94e-2)" "unprognostic (3.04e-1)" "unprognostic (1.82e-1)" "unprognostic (1.50e-2)" "unprognostic (9.03e-3)" 8.8 12.4 11.6 10.4 15.9 4.3 9.1 14.2 20.6 5.4 7.1 10.2 7.8 8.9 5.8 11.4 8.1 5.9 8.7 8.8 15.6 14.4 11.2 16.7 8.7 12.7 15.5 10.6 7.9 8.3 17.0 20.3 8.3 19.6 7.5 8.7 3.8 6.7 7.1 9.5 6.6 8.6 8.4 14.4 12.6 9.7 11.7 13.6 18.6 10.0 5.4 10.2 8.1 5.3 3.3 2.1 6.8 10.7 2.7 2.7 1.5 8.9 3.4 9.2 6.1 7.7 8.3 3.3 8.8 6.7 6.7 8.1 4.0 4.0 15.2 7.2 5.8 8.3 3.7 6.1 5.9 11.8 8.9 5.8 7.1 7.8 2.1 9.2 9.5 7.6 7.5 9.9 6.5 5.9 6.5 8.0 28.1 2.5 2.8 10.4 4.8 15.8 7.0 2.3 7.3 2.1 14.5 3.6 2.4 8.9 5.7 5.8 6.0 1.9 5.4 6.6 7.5 4.6 14.8 11.9 4.0 4.4 4.5 7.9 7.5 4.9 24.7 15.5 5.5 9.1 0.8 2.3 6.8 1.8 3.8 2.5 2.6 2.0 1.9 2.1 3.3 2.0 2.7 3.2 2.7 10.7 1.4 2.7 1.5 11.6 15.9 14.2 20.6 15.6 14.4 15.5 10.6 19.6 13.6 8.9 7.4 2.4 2.3 2.4 9.6 10.1 0.0 26.8 11.4 1.8 7.9 1.9 8.3 4.6 9.5 3.6 4.1 0.0 6.5 1.0 2.3 3.0 3.5 7.8 5.0 17.5 9.2 4.3 7.3 3.6 2.6 5.0 1.7 8.2 4.6 6.9 6.8 5.3 5.6 5.6 12.6 12.9 2.5 16.4 2.7 5.0 1.5 2.5 2.8 2.0 LIMD1 ENSG00000144791 "LIM domains containing 1" Q9UGP4 3 45555394-45686338 "Plasma proteins, Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation" Repressor "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 35.7;B-cells: 31.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064220, HPA071736" Approved Supported "Nucleoplasm,Focal adhesion sites" NA NA "Nucleoplasm, Focal adhesion sites" "HPA064220: AB_2685216, HPA071736: " "unprognostic (2.77e-1)" "unprognostic (3.22e-2)" "unprognostic (5.43e-2)" "unprognostic (7.78e-2)" "unprognostic (6.53e-2)" "unprognostic (2.07e-2)" "unprognostic (9.44e-2)" "unprognostic (1.53e-2)" "unprognostic (1.11e-1)" "unprognostic (2.42e-1)" "unprognostic (6.88e-2)" "unprognostic (2.11e-3)" "prognostic favorable (6.73e-5)" "unprognostic (8.02e-2)" "unprognostic (3.06e-2)" "unprognostic (2.86e-2)" "unprognostic (6.61e-3)" 12.6 7.0 4.8 14.9 5.5 6.2 13.9 2.5 6.0 10.2 9.7 8.1 13.0 8.4 14.4 12.0 10.4 9.6 10.9 11.5 5.1 4.1 8.3 16.6 24.8 17.1 9.2 2.2 7.6 24.5 11.3 5.5 11.7 9.4 12.1 9.2 20.2 19.1 8.2 25.2 8.3 12.2 12.5 6.8 16.4 11.4 6.2 6.4 20.3 17.9 10.7 24.9 12.9 18.9 6.7 8.8 4.1 5.5 1.1 1.6 1.0 7.4 14.2 5.2 7.0 4.6 9.0 10.4 7.2 10.1 7.7 6.7 6.7 3.9 0.9 4.8 6.6 15.7 5.1 11.0 5.9 6.4 15.7 6.7 8.3 11.2 5.5 4.7 7.4 10.7 3.7 4.9 11.4 6.0 5.6 6.7 8.6 6.9 23.5 7.6 4.9 9.0 4.7 8.4 6.0 13.7 4.5 6.0 11.3 4.0 13.3 2.4 4.7 6.1 11.1 7.2 5.6 6.7 6.7 11.9 8.5 7.7 8.5 7.6 22.5 28.9 3.7 18.5 6.8 9.2 4.1 1.4 1.4 1.6 3.1 1.0 3.9 1.3 1.4 1.4 6.7 1.4 1.4 1.6 1.1 5.5 8.8 1.3 1.0 4.8 5.5 2.5 6.0 5.1 4.1 9.2 2.2 9.4 6.4 35.7 20.6 31.3 5.1 2.6 1.5 14.2 12.7 10.7 13.6 7.0 2.0 5.1 1.7 6.0 1.0 4.3 5.9 0.0 4.6 10.3 4.8 9.5 3.5 16.3 14.1 6.4 6.4 9.8 15.3 0.2 10.9 9.0 5.0 1.0 16.0 7.0 5.6 3.5 3.2 3.0 1.0 6.5 8.0 0.7 4.1 1.9 4.5 7.4 8.8 3.6 LIMD2 MGC10986 ENSG00000136490 "LIM domain containing 2" Q9BT23 17 63695902-63701172 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 175.1;lymphoid tissue: 98.4" "Cell type enhanced" "Detected in many" 13 "B-cells: 358.9;Hofbauer cells: 123.5;Kupffer cells: 178.4;T-cells: 223.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 54.7;NB-4: 38.1;SH-SY5Y: 38.1;THP-1: 28.6;U-698: 57.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062432, HPA075172" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA062432: , HPA075172: " "unprognostic (2.90e-3)" "unprognostic (2.89e-3)" "unprognostic (6.34e-2)" "unprognostic (6.53e-2)" "unprognostic (8.72e-2)" "unprognostic (2.00e-3)" "unprognostic (1.81e-1)" "unprognostic (2.67e-2)" "unprognostic (6.68e-2)" "unprognostic (2.01e-2)" "unprognostic (1.20e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (5.36e-11)" "unprognostic (1.21e-1)" "unprognostic (2.21e-1)" "unprognostic (2.26e-2)" "unprognostic (6.08e-2)" 3.6 2.0 6.5 54.8 14.8 28.7 2.3 1.2 8.5 2.7 2.9 3.0 1.3 3.9 2.6 3.2 3.0 2.6 5.1 2.7 9.6 3.3 3.7 5.1 8.1 63.5 3.6 3.7 2.8 1.7 0.8 3.5 6.4 2.8 4.1 2.8 5.0 11.3 1.7 1.1 1.8 12.9 2.6 3.0 51.1 5.5 6.1 1.7 98.4 2.5 2.2 79.7 7.4 2.6 81.9 55.1 175.1 65.1 46.6 67.5 73.0 0.1 1.7 21.6 5.3 0.2 0.5 0.5 0.5 0.3 2.2 1.5 0.9 0.4 54.7 4.8 2.6 2.2 0.8 4.7 0.2 0.6 18.8 1.9 16.2 0.3 4.6 4.2 21.0 1.7 5.4 0.2 2.2 0.0 2.5 5.8 3.8 1.4 3.2 2.4 0.2 18.5 38.1 11.6 0.0 1.0 7.7 8.7 9.6 3.0 0.2 26.0 38.1 2.7 0.0 5.0 5.8 0.1 28.6 7.3 3.0 6.6 0.1 0.7 0.6 0.2 57.0 0.3 3.0 5.2 175.1 54.6 122.9 35.7 63.3 35.1 64.6 49.4 41.5 55.1 81.9 67.5 48.1 112.7 46.6 65.1 20.8 58.1 73.0 6.5 14.8 1.2 8.5 9.6 3.3 3.6 3.7 2.8 1.7 0.0 5.8 358.9 7.5 6.6 0.8 0.8 2.5 1.4 3.4 10.4 3.9 1.3 5.0 15.9 14.6 16.3 0.5 0.0 8.0 2.7 7.3 13.6 53.0 1.5 123.5 3.2 21.4 27.0 178.4 36.6 3.1 84.5 35.4 24.4 2.0 5.0 22.0 5.9 4.6 1.7 1.0 6.5 7.3 4.9 6.8 5.3 1.3 223.7 2.1 3.1 LIMK2 ENSG00000182541 "LIM domain kinase 2" P53671 22 31212239-31280080 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 96.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 14.7;neutrophil: 37.2" "Lineage enriched" "Detected in all" 7 "granulocytes: 37.2" "Cell line enhanced" "Detected in all" "BEWO: 37.6;hTCEpi: 69.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008183, CAB019313, HPA053882" Approved Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "CAB019313: , HPA008183: AB_1079252, HPA053882: AB_2682291" "unprognostic (1.79e-1)" "unprognostic (1.95e-1)" "unprognostic (1.04e-2)" "unprognostic (2.59e-2)" "unprognostic (1.39e-1)" "unprognostic (2.42e-2)" "unprognostic (4.02e-2)" "unprognostic (5.99e-2)" "unprognostic (1.21e-1)" "unprognostic (2.95e-1)" "unprognostic (3.96e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (4.57e-6)" "unprognostic (4.48e-2)" "unprognostic (1.48e-2)" "unprognostic (5.72e-2)" "unprognostic (1.37e-1)" 9.4 6.6 23.5 23.6 26.2 29.4 17.0 9.9 16.8 11.0 20.9 15.6 10.7 13.1 12.9 8.7 33.7 22.1 28.7 6.0 15.4 10.7 15.4 19.9 21.6 18.1 20.8 7.2 11.4 19.9 20.0 12.8 64.3 23.3 17.1 22.1 10.1 25.7 16.2 9.7 36.7 13.3 10.1 28.3 17.4 18.5 16.8 17.9 12.4 25.8 15.6 15.3 13.1 20.0 1.0 1.6 37.2 1.9 2.4 5.6 1.6 7.0 1.1 4.9 2.7 2.1 2.5 37.6 4.6 2.2 4.7 4.0 6.0 3.3 6.9 8.3 7.0 2.2 14.3 5.7 24.5 2.9 5.0 6.2 5.0 5.5 6.5 3.2 9.2 9.2 4.0 69.7 3.8 11.5 32.0 11.9 5.6 2.7 5.0 6.4 5.5 5.6 3.1 4.6 18.2 1.8 7.4 8.3 3.8 5.4 16.7 6.3 5.6 3.5 22.6 9.3 15.9 18.8 3.7 7.2 4.2 6.6 2.3 4.3 2.8 4.1 6.0 2.6 4.3 1.8 2.1 1.9 14.7 1.3 1.3 2.4 0.8 2.3 1.7 0.7 1.0 2.3 1.8 37.2 2.4 0.5 1.6 5.6 1.6 23.5 26.2 9.9 16.8 15.4 10.7 20.8 7.2 23.3 17.9 29.8 17.0 3.0 42.2 31.9 7.0 19.8 12.7 33.5 28.4 5.2 19.6 59.9 3.3 10.9 1.0 19.3 16.9 0.0 38.9 46.0 10.8 19.1 23.1 6.8 15.7 3.2 12.7 12.9 7.9 1.3 4.0 11.8 3.3 2.8 41.8 15.6 22.5 10.5 4.2 8.1 23.2 19.4 4.1 9.8 10.4 34.3 96.6 8.7 49.0 20.7 LIN28B "CSDD2, FLJ16517" ENSG00000187772 "Lin-28 homolog B" Q6ZN17 6 104936616-105083332 "Predicted intracellular proteins" "RNA-mediated gene silencing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "placenta: 51.9" "Cell type enhanced" "Detected in some" 13 "Cytotrophoblasts: 66.0;Extravillous trophoblasts: 67.8;Syncytiotrophoblasts: 46.7" "Cancer enriched" "Detected in single" 25 "testis cancer: 12.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 14.1;BEWO: 73.1;Hep G2: 12.2;K-562: 23.6;NTERA-2: 12.9;SuSa: 13.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA036630, HPA061745" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA036630: AB_10669911, HPA061745: AB_2684601" "unprognostic (2.00e-4)" "unprognostic (6.75e-2)" "unprognostic (2.02e-1)" "unprognostic (2.57e-2)" "unprognostic (1.59e-2)" "unprognostic (4.10e-2)" 0.1 0.1 1.2 0.0 0.8 0.3 0.0 0.1 1.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.3 0.0 0.1 0.1 0.1 0.5 0.8 0.0 0.0 0.0 1.0 51.9 1.2 0.0 0.0 0.4 0.1 0.0 0.1 0.2 0.1 0.0 0.2 0.1 0.1 5.8 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.7 2.1 0.4 0.2 0.5 0.3 0.0 0.9 14.1 2.8 0.0 0.0 73.1 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.8 0.0 8.8 0.0 0.0 0.0 6.8 10.1 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.3 0.0 0.0 1.5 1.7 12.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.3 0.0 0.0 1.1 13.5 0.0 2.9 0.3 0.0 1.5 0.0 0.0 4.3 6.0 0.0 0.0 0.0 0.0 1.6 0.4 0.2 0.5 0.4 0.3 0.5 0.3 0.1 0.2 0.7 0.1 0.2 2.1 0.2 0.4 0.7 0.2 0.3 1.2 0.8 0.1 1.3 0.9 1.3 0.5 0.8 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 5.9 66.0 0.0 0.0 15.5 0.0 0.0 0.0 0.0 67.8 0.0 0.0 0.0 0.0 8.0 1.6 0.0 0.0 0.0 17.9 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.4 6.5 0.0 5.8 9.2 0.0 46.7 0.0 0.0 0.0 LIN37 "F25965, lin-37, ZK418.4" ENSG00000267796 "Lin-37 DREAM MuvB core complex component" Q96GY3 19 35748361-35754519 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 9.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043253, HPA047809" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA043253: AB_2678391, HPA047809: AB_2680162" "unprognostic (7.10e-2)" "unprognostic (1.32e-1)" "unprognostic (7.07e-2)" "unprognostic (2.45e-3)" "unprognostic (7.77e-3)" "unprognostic (5.85e-3)" "unprognostic (1.62e-2)" "unprognostic (1.07e-1)" "unprognostic (2.93e-1)" "unprognostic (2.56e-1)" "prognostic favorable (1.67e-4)" "unprognostic (9.88e-3)" "prognostic unfavorable (1.62e-6)" "unprognostic (2.53e-2)" "unprognostic (8.89e-2)" "unprognostic (4.35e-1)" "unprognostic (5.14e-2)" 12.0 13.1 15.7 6.4 18.6 13.5 10.0 22.9 20.6 12.9 11.4 10.1 9.4 8.4 15.3 11.5 10.5 15.5 10.2 17.3 12.2 12.7 8.8 9.3 10.6 11.4 10.6 13.1 21.5 13.5 7.9 13.5 15.3 11.9 9.7 7.1 10.3 10.3 13.5 16.8 15.2 8.5 11.8 10.4 10.0 8.7 13.7 13.4 11.2 11.1 7.4 11.2 10.6 10.7 11.5 11.3 16.9 4.3 9.2 13.7 7.2 5.6 13.8 4.5 5.6 9.7 7.4 6.4 6.4 8.1 12.1 13.8 4.9 1.9 4.4 6.7 9.1 8.1 2.0 4.2 6.4 4.2 12.4 6.1 5.1 5.9 5.7 23.6 3.8 6.8 6.4 11.9 10.3 19.8 7.1 8.5 11.6 5.1 5.0 7.7 13.5 4.9 4.5 1.3 11.7 6.6 2.3 3.5 3.3 8.1 3.4 4.4 4.7 6.9 11.2 5.6 4.2 5.0 6.4 7.1 5.8 3.4 6.6 8.7 7.8 8.3 3.5 6.9 5.5 4.7 7.9 4.3 13.8 11.2 4.1 10.4 10.9 12.7 13.2 4.9 11.5 13.7 12.4 16.9 9.2 4.3 11.3 13.1 7.2 15.7 18.6 22.9 20.6 12.2 12.7 10.6 13.1 11.9 13.4 0.0 0.6 3.2 0.6 3.4 1.7 0.1 2.5 0.0 0.0 3.5 2.0 4.0 3.3 1.0 4.7 0.6 3.2 0.0 1.0 2.5 2.5 0.6 4.6 0.9 1.6 1.6 1.2 0.0 3.4 3.1 3.7 2.1 5.0 1.8 0.5 0.8 2.0 1.7 3.2 2.7 2.2 6.5 2.2 6.5 1.9 4.6 9.6 2.5 1.3 0.1 LIN9 TGS ENSG00000183814 "Lin-9 DREAM MuvB core complex component" Q5TKA1 1 226231149-226309869 "Predicted intracellular proteins" "Cell cycle, DNA synthesis" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Spermatocytes: 34.4;Spermatogonia: 15.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030241 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA030241: AB_10601542" "unprognostic (9.90e-2)" "unprognostic (8.00e-2)" "unprognostic (1.23e-1)" "unprognostic (8.82e-3)" "unprognostic (1.21e-1)" "unprognostic (1.42e-2)" "unprognostic (3.51e-5)" "unprognostic (2.80e-2)" "unprognostic (9.84e-3)" "unprognostic (2.65e-2)" "unprognostic (3.59e-3)" "unprognostic (1.17e-1)" "unprognostic (1.09e-3)" "unprognostic (8.08e-2)" "unprognostic (1.79e-1)" "unprognostic (3.22e-1)" "unprognostic (8.26e-2)" 3.7 3.0 3.9 5.9 3.9 6.9 4.3 17.5 5.6 5.0 7.9 2.6 3.3 5.1 4.1 2.1 6.0 3.2 2.9 15.9 4.2 2.8 4.3 2.4 5.1 5.8 2.4 1.9 6.6 3.1 2.3 3.1 5.0 4.5 4.6 5.0 2.3 3.8 3.0 4.6 4.7 7.8 3.6 3.7 5.0 4.0 11.6 4.6 22.0 4.8 5.8 5.8 4.3 4.3 4.3 1.3 6.2 5.1 2.9 6.8 2.0 9.0 5.7 9.6 6.9 0.9 2.5 18.9 6.7 4.3 11.7 10.6 6.3 12.0 8.6 8.7 2.9 5.2 8.5 9.2 3.4 10.6 8.1 16.6 5.4 7.4 4.5 0.8 10.3 5.8 0.9 2.5 6.0 6.2 2.8 5.8 8.0 18.4 10.4 7.1 3.2 11.0 7.1 15.6 11.5 10.5 10.8 16.6 11.3 3.8 4.6 8.6 12.2 11.9 14.2 8.7 6.2 7.9 13.8 2.7 6.8 10.1 9.3 17.1 4.9 11.3 18.2 4.0 9.7 15.9 6.2 2.0 1.8 2.5 2.6 3.7 4.3 4.3 5.5 0.8 3.7 6.8 5.0 0.3 2.9 5.1 1.3 5.5 2.0 3.9 3.9 17.5 5.6 4.2 2.8 2.4 1.9 4.5 4.6 8.9 3.2 0.0 1.1 3.0 0.8 12.7 0.0 5.3 2.3 0.0 0.0 11.3 1.7 1.7 9.0 3.0 1.6 0.0 2.7 5.9 2.1 1.0 1.1 0.8 2.3 3.2 2.4 1.8 3.4 2.2 4.0 0.6 0.0 0.0 2.2 1.7 2.6 3.5 4.2 1.0 0.9 0.0 2.8 34.4 15.6 1.6 12.9 1.3 3.9 1.3 LINS1 "LINS, WINS1" ENSG00000140471 "Lines homolog 1" Q8NG48 15 100559369-100603230 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038578, HPA038579" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA038578: AB_2676095, HPA038579: AB_10697393" "unprognostic (9.87e-2)" "unprognostic (3.32e-3)" "unprognostic (2.93e-1)" "unprognostic (2.00e-1)" "unprognostic (7.37e-2)" "unprognostic (6.16e-2)" "unprognostic (7.14e-2)" "unprognostic (1.06e-1)" "unprognostic (2.48e-2)" "unprognostic (3.36e-2)" "unprognostic (1.65e-1)" "unprognostic (1.71e-3)" "unprognostic (1.14e-2)" "unprognostic (2.93e-1)" "unprognostic (2.08e-1)" "unprognostic (1.47e-1)" "unprognostic (1.28e-2)" 10.0 10.2 12.2 13.2 13.4 8.1 13.6 16.9 13.8 13.7 10.2 10.1 13.3 6.8 13.5 16.7 14.9 12.0 7.7 8.6 11.2 6.8 10.4 9.2 10.3 17.6 8.2 11.1 13.1 9.4 12.8 19.8 11.4 9.6 10.9 12.1 10.2 14.1 13.2 11.4 15.7 11.6 10.6 10.7 13.4 10.4 11.8 10.4 16.6 14.7 9.2 15.9 13.3 12.8 7.7 5.1 6.9 5.0 9.0 23.3 6.6 4.1 6.6 8.2 8.1 6.1 8.2 7.1 6.8 7.3 7.5 8.2 6.0 8.2 11.1 4.0 6.1 5.7 18.2 7.6 8.5 8.0 3.8 11.0 10.0 10.0 4.7 4.9 8.4 6.1 7.3 7.4 5.8 9.3 7.5 8.9 6.3 15.9 8.9 4.7 5.5 5.0 7.2 9.3 16.1 8.1 7.5 13.1 10.4 6.5 11.6 4.2 5.5 6.4 6.1 9.9 10.8 10.3 6.5 6.4 9.6 8.7 6.7 8.6 9.7 12.4 10.0 6.1 11.0 7.6 6.9 5.0 6.9 10.9 4.6 15.2 7.7 17.0 11.6 5.1 6.8 23.3 16.6 6.4 9.0 3.8 4.1 10.2 6.6 12.2 13.4 16.9 13.8 11.2 6.8 8.2 11.1 9.6 10.4 17.9 5.1 2.4 8.9 0.0 15.5 0.0 5.1 13.4 4.5 12.2 17.7 6.7 5.0 4.9 5.4 2.9 7.8 0.0 4.5 4.5 3.1 7.3 1.1 7.4 12.3 15.9 4.7 4.9 5.7 1.1 11.2 3.2 0.0 4.6 7.0 10.0 4.0 0.0 6.7 3.6 14.0 12.9 0.0 16.4 11.1 0.0 10.4 10.2 5.3 6.8 LIPA "CESD, LAL" ENSG00000107798 "Lipase A, lysosomal acid type" P38571 10 89213569-89414557 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 139.0" "Group enriched" "Detected in many" 7 "Hofbauer cells: 503.3;Kupffer cells: 514.1;Macrophages: 167.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 31.8;intermediate monocyte: 68.4;myeloid DC: 23.3;non-classical monocyte: 35.6" "Group enriched" "Detected in all" 5 "dendritic cells: 23.3;monocytes: 68.4" "Cell line enhanced" "Detected in many" "AN3-CA: 61.6;ASC TERT1: 77.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034892, HPA057052" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" "Intracellular and membrane" NA NA 150000 "Vesicles, Cytosol" "Nucleoplasm, Nucleoli fibrillar center" "CAB034892: AB_784329, HPA057052: AB_2683322" "unprognostic (1.27e-1)" "unprognostic (3.23e-1)" "unprognostic (1.17e-1)" "unprognostic (1.07e-1)" "unprognostic (1.61e-1)" "unprognostic (2.55e-2)" "unprognostic (7.14e-2)" "unprognostic (1.66e-1)" "unprognostic (1.19e-1)" "unprognostic (4.28e-2)" "unprognostic (1.08e-1)" "unprognostic (7.30e-3)" "unprognostic (1.39e-2)" "unprognostic (1.40e-1)" "unprognostic (4.42e-2)" "unprognostic (3.42e-2)" "unprognostic (5.71e-2)" 139.0 16.3 15.8 14.4 22.7 7.8 19.9 8.8 21.4 13.4 28.1 61.3 3.4 37.4 10.2 5.2 9.5 9.0 19.4 8.7 22.5 13.8 10.8 49.3 38.5 45.7 41.6 13.4 10.4 9.5 17.5 6.3 17.8 28.4 7.4 16.7 5.7 11.0 8.8 4.1 6.8 65.8 11.3 55.1 87.3 7.9 3.1 37.2 7.0 8.3 4.7 10.0 15.1 8.6 7.0 23.3 3.2 68.4 5.5 8.3 25.5 55.0 8.5 5.6 61.6 58.1 77.3 1.6 29.2 34.2 12.2 21.9 3.2 29.7 10.2 5.7 45.7 13.1 55.2 2.4 15.8 9.1 14.3 5.7 4.2 3.6 13.1 15.3 8.1 8.4 34.3 11.4 13.0 7.0 14.8 2.4 7.7 0.0 19.0 9.5 4.6 7.0 5.5 3.6 9.8 9.6 4.6 6.6 9.4 11.3 8.7 1.9 3.9 7.1 9.2 21.5 3.9 10.5 10.5 4.4 10.4 2.7 22.2 7.1 9.9 10.5 4.2 12.4 18.0 13.0 0.8 31.8 3.2 8.2 68.4 8.2 6.5 7.3 7.8 23.3 7.0 7.7 8.3 1.4 5.5 35.6 4.7 7.1 25.5 15.8 22.7 8.8 21.4 22.5 13.8 41.6 13.4 28.4 37.2 38.7 42.2 50.6 22.0 15.8 5.2 8.5 45.9 14.7 13.6 31.4 0.0 28.4 18.3 29.7 4.4 53.1 3.9 23.3 31.7 28.0 34.8 15.2 27.7 46.5 503.3 15.9 20.9 52.8 514.1 1.8 10.6 167.0 45.5 27.9 9.4 29.4 17.5 5.9 20.5 14.6 1.3 6.5 21.8 4.8 10.9 10.9 16.7 33.0 8.7 20.1 LITAF "FLJ38636, PIG7, SIMPLE, TP53I7" ENSG00000189067 "Lipopolysaccharide induced TNF factor" Q99732 16 11547722-11636381 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 202.5" "Cell type enhanced" "Detected in many" 5 "monocytes: 551.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 202.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 202.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006960 Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "HPA006960: AB_1079254" "unprognostic (2.26e-1)" "unprognostic (4.96e-2)" "unprognostic (2.32e-3)" "unprognostic (1.03e-1)" "prognostic unfavorable (2.02e-4)" "unprognostic (4.07e-2)" "unprognostic (8.75e-3)" "unprognostic (3.60e-1)" "unprognostic (6.15e-3)" "unprognostic (1.04e-1)" "unprognostic (4.61e-2)" "unprognostic (5.01e-1)" "unprognostic (1.85e-2)" "unprognostic (9.49e-2)" "prognostic unfavorable (6.25e-4)" "unprognostic (3.57e-2)" "unprognostic (1.60e-1)" 55.0 14.1 18.0 49.2 42.4 53.3 65.7 5.0 18.5 50.4 36.4 45.2 20.2 13.9 42.7 28.8 19.6 34.0 35.3 31.5 20.7 15.7 48.9 66.3 73.0 80.6 28.6 13.2 43.1 26.3 15.9 17.1 46.2 42.8 36.2 36.7 26.0 57.3 32.2 18.6 28.5 24.1 41.6 52.1 57.9 26.3 11.0 19.0 18.7 53.3 18.8 36.4 47.4 41.6 14.1 16.9 202.5 10.3 20.2 37.6 35.6 13.9 26.1 16.5 7.9 2.5 1.9 16.7 18.2 56.1 17.4 25.9 10.8 37.7 7.0 23.3 15.3 20.2 17.3 6.9 30.5 16.6 53.6 7.2 0.5 22.7 54.7 38.7 2.1 2.4 5.8 59.3 14.2 38.9 15.6 0.0 0.4 4.3 27.3 0.2 13.3 0.3 32.3 26.8 18.6 0.1 2.1 3.6 40.3 14.5 19.8 4.1 12.4 31.5 40.3 32.4 26.6 22.5 11.9 0.1 7.2 12.2 4.2 4.2 10.7 23.5 18.0 8.3 17.1 41.3 32.2 10.3 20.8 37.6 9.8 22.8 14.1 23.5 33.5 13.6 13.9 26.8 31.7 202.5 20.2 5.7 16.9 26.2 35.6 18.0 42.4 5.0 18.5 20.7 15.7 28.6 13.2 42.8 19.0 41.7 81.4 104.3 281.2 139.8 1.8 51.2 129.9 133.8 114.9 155.3 0.0 57.9 411.1 191.6 1.7 48.8 46.4 0.0 64.4 335.4 125.8 223.3 202.9 35.5 219.5 0.0 16.8 61.4 140.8 7.9 52.0 294.8 148.5 551.0 130.0 207.3 91.3 203.2 64.3 66.5 3.5 51.8 174.1 0.0 4.7 115.6 31.0 220.6 89.7 303.0 LKAAEAR1 C20orf201 ENSG00000171695 "LKAAEAR motif containing 1" Q8TD35 20 64083380-64084359 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 12.5;testis: 18.0" "Group enriched" "Detected in some" 36 "Early spermatids: 401.3;Late spermatids: 525.6" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in some" 9 "intermediate monocyte: 7.9;non-classical monocyte: 12.5" "Lineage enriched" "Detected in many" 11 "monocytes: 12.5" "Group enriched" "Detected in some" 4 "REH: 9.3;SCLC-21H: 9.6" "Low region specificity" "Detected in many" HPA056463 Approved Nucleoplasm NA NA Nucleoplasm "HPA056463: AB_2683139" "unprognostic (5.47e-3)" "unprognostic (1.18e-1)" "unprognostic (1.20e-1)" "unprognostic (4.08e-1)" "unprognostic (1.66e-1)" "unprognostic (3.56e-1)" "unprognostic (4.19e-1)" "unprognostic (2.58e-1)" "unprognostic (7.93e-2)" "unprognostic (3.78e-3)" "unprognostic (6.74e-2)" "unprognostic (3.16e-4)" "unprognostic (3.07e-2)" "unprognostic (1.41e-1)" "unprognostic (3.12e-1)" "unprognostic (2.30e-2)" 0.5 0.0 3.4 0.3 2.9 0.6 0.1 1.5 2.9 0.0 0.2 0.6 0.1 0.0 0.0 1.8 0.0 0.0 1.7 3.1 0.1 0.0 0.3 0.2 1.2 0.0 0.7 0.7 0.1 0.0 0.2 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.3 0.5 0.3 18.0 0.1 0.0 0.0 0.0 0.1 1.0 0.8 12.5 0.0 0.8 0.8 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.3 1.8 0.7 0.3 0.0 1.5 9.3 0.0 0.2 0.0 0.0 9.6 2.3 0.0 0.1 0.1 0.0 0.2 0.5 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.8 0.1 7.9 0.6 0.1 0.7 0.2 1.0 0.0 0.8 0.2 0.0 0.0 12.5 0.2 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 401.3 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 1.5 0.0 0.0 1.3 2.4 525.6 3.4 0.0 0.0 0.0 0.0 0.4 0.1 0.0 2.8 0.0 0.7 12.9 0.5 3.7 5.5 0.0 0.1 0.0 0.0 0.0 LMBRD2 DKFZp434H2226 ENSG00000164187 "LMBR1 domain containing 2" Q68DH5 5 36098412-36151961 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "basophil: 11.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 11.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012165 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA012165: AB_2136131" "unprognostic (9.43e-3)" "unprognostic (3.03e-1)" "unprognostic (1.80e-2)" "unprognostic (7.09e-2)" "unprognostic (1.79e-1)" "unprognostic (9.53e-3)" "unprognostic (6.58e-2)" "unprognostic (8.46e-3)" "unprognostic (6.45e-3)" "unprognostic (2.80e-1)" "unprognostic (8.61e-2)" "unprognostic (6.94e-2)" "unprognostic (2.30e-3)" "unprognostic (7.53e-2)" "unprognostic (1.11e-1)" "unprognostic (1.65e-2)" "unprognostic (5.35e-2)" 6.2 9.7 12.1 6.6 21.4 2.2 8.8 12.8 25.5 7.3 8.7 9.5 7.6 9.6 5.3 7.2 6.8 4.8 5.8 8.2 14.2 11.4 10.5 14.2 5.7 7.6 9.9 15.6 5.0 7.7 16.9 16.9 8.4 14.1 9.7 9.1 4.8 7.6 6.8 11.1 7.7 9.6 5.5 10.5 6.7 10.1 5.2 8.6 8.4 12.8 2.9 7.4 7.6 6.1 1.5 1.2 11.0 1.2 1.0 2.3 0.8 4.9 3.7 4.5 7.4 9.4 8.3 15.9 10.3 5.4 7.6 7.6 4.6 10.8 8.9 5.2 5.4 7.8 6.8 5.9 3.6 12.5 12.7 3.6 6.9 12.6 0.8 6.0 8.3 9.2 4.9 6.4 6.5 6.5 5.7 4.1 6.9 8.1 9.4 9.1 3.3 7.1 5.5 2.5 7.7 4.7 5.4 10.5 5.4 6.5 4.4 8.5 6.6 14.8 8.8 3.6 4.6 10.0 10.1 5.4 9.1 2.4 11.5 5.4 7.7 11.3 7.8 8.6 9.5 6.2 11.0 1.2 2.0 1.6 1.2 1.1 1.5 1.4 1.4 1.0 1.3 1.9 1.9 0.8 1.0 1.2 1.2 2.3 0.8 12.1 21.4 12.8 25.5 14.2 11.4 9.9 15.6 14.1 8.6 8.9 9.8 5.6 4.2 6.2 10.8 22.2 10.2 9.4 2.3 12.2 7.9 8.0 3.3 4.4 1.3 5.8 11.8 0.0 6.6 5.6 6.6 8.8 6.9 25.2 9.7 14.3 6.4 9.8 13.2 1.4 4.4 7.7 6.8 6.4 14.8 11.6 5.6 3.5 6.7 10.2 10.7 12.9 7.9 21.2 8.1 8.8 16.2 6.7 10.4 2.5 LMCD1 ENSG00000071282 "LIM and cysteine rich domains 1" Q9NZU5 3 8501707-8574673 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 189.9" "Cell type enhanced" "Detected in many" 8 "Ductal cells: 99.6;Horizontal cells: 92.2;Smooth muscle cells: 171.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "T-reg: 17.0" "Lineage enriched" "Detected in many" 6 "T-cells: 17.0" "Cell line enhanced" "Detected in many" "HHSteC: 30.4;HSkMC: 42.6;hTEC/SVTERT24-B: 31.3;U-2197: 27.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA024059 Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol" No No "Nucleoplasm, Cytosol" "Plasma membrane, Cell Junctions" "HPA024059: AB_1852950" "unprognostic (2.46e-1)" "unprognostic (1.79e-1)" "unprognostic (5.13e-3)" "unprognostic (1.30e-1)" "unprognostic (2.28e-2)" "unprognostic (2.10e-1)" "unprognostic (1.56e-1)" "unprognostic (1.38e-1)" "unprognostic (2.96e-1)" "unprognostic (8.21e-3)" "unprognostic (4.29e-1)" "unprognostic (2.54e-2)" "prognostic unfavorable (8.66e-5)" "unprognostic (3.80e-2)" "unprognostic (1.33e-1)" "unprognostic (1.01e-3)" "unprognostic (3.68e-3)" 38.6 3.3 1.6 10.1 1.8 0.0 36.4 3.9 1.9 11.7 4.4 3.8 5.2 1.9 22.3 20.8 8.3 11.9 15.4 15.9 2.3 1.7 5.5 2.2 25.9 3.8 2.4 1.7 17.9 8.5 5.8 2.0 14.1 4.5 16.1 1.6 4.6 19.2 7.0 189.9 5.7 3.3 72.9 3.7 14.3 10.6 9.3 1.3 0.8 4.6 34.3 7.1 29.4 15.7 1.8 2.7 0.0 0.3 0.0 17.0 0.2 2.9 16.9 2.8 2.1 21.1 11.9 2.9 12.4 6.4 6.8 16.9 12.5 3.8 0.0 1.4 14.3 2.9 0.2 1.6 3.2 2.8 5.1 1.1 3.7 1.1 2.4 30.4 0.0 0.3 42.6 0.0 31.3 0.2 4.0 3.3 0.0 0.0 0.0 8.8 2.1 0.0 0.0 5.5 3.8 0.7 0.0 9.4 0.0 6.3 1.1 0.1 7.1 2.0 10.3 6.4 8.4 13.4 0.0 1.6 6.9 13.8 27.6 8.3 1.7 1.9 0.8 1.4 0.9 8.8 0.0 0.0 0.0 0.0 0.3 0.1 1.8 2.6 0.5 2.7 0.3 0.0 0.0 0.0 0.0 0.0 0.9 17.0 0.2 1.6 1.8 3.9 1.9 2.3 1.7 2.4 1.7 4.5 1.3 8.9 15.4 0.0 47.6 28.0 13.3 13.7 20.4 20.1 15.9 5.2 9.8 2.6 3.3 99.6 0.9 70.2 0.5 0.0 42.3 3.5 58.2 6.1 10.3 11.3 3.1 92.2 11.6 36.2 0.6 1.5 10.6 4.0 50.6 15.4 2.2 34.8 83.3 0.0 30.4 29.2 7.9 0.0 171.0 5.0 7.0 23.7 3.7 2.2 3.3 5.2 LMNA "CMD1A, HGPS, LGMD1B, LMN1, LMNL1, MADA, PRO1" ENSG00000160789 "Lamin A/C" P02545 1 156082573-156140089 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Cardiomyopathy, Charcot-Marie-Tooth disease, Congenital muscular dystrophy, Disease mutation, Emery-Dreifuss muscular dystrophy, Limb-girdle muscular dystrophy, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "granulocytes: 1139.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 10.4;memory CD4 T-cell: 8.9;myeloid DC: 34.8;T-reg: 35.4" "Group enriched" "Detected in all" 8 "dendritic cells: 34.8;granulocytes: 10.4;T-cells: 35.4" "Cell line enhanced" "Detected in many" "WM-115: 137.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004022, HPA006523, HPA006660, HPA012078" Supported Supported "Nucleoplasm,Nuclear speckles" NA NA 3200000 "Nucleoplasm, Nuclear speckles" "CAB004022: AB_2136278, HPA006523: , HPA006660: AB_1079231, HPA012078: " "unprognostic (2.22e-2)" "unprognostic (1.89e-1)" "unprognostic (1.04e-2)" "unprognostic (5.75e-2)" "unprognostic (7.43e-3)" "unprognostic (1.47e-1)" "unprognostic (5.23e-3)" "unprognostic (3.27e-2)" "unprognostic (8.33e-2)" "unprognostic (5.90e-2)" "unprognostic (5.10e-2)" "unprognostic (6.34e-2)" "unprognostic (1.41e-2)" "unprognostic (1.24e-1)" "unprognostic (2.89e-1)" "unprognostic (3.08e-2)" "unprognostic (1.44e-2)" 64.0 37.3 7.4 51.4 11.8 21.3 88.6 9.0 10.8 62.8 32.6 21.9 27.2 28.6 69.1 52.3 62.2 40.1 77.7 62.5 8.8 7.5 25.9 26.6 51.8 39.6 15.7 11.2 60.3 30.9 15.2 17.4 73.3 18.1 34.0 15.2 32.7 37.5 26.4 36.3 68.7 29.9 63.0 10.3 22.4 36.7 30.2 12.9 9.4 31.5 140.0 35.6 46.4 51.2 1.1 34.8 10.4 3.5 1.7 35.4 6.4 59.1 58.7 6.5 17.4 32.9 57.1 20.0 64.0 81.5 48.3 33.4 14.8 58.6 0.5 38.0 98.4 24.9 69.3 9.5 49.6 12.6 20.1 5.6 18.7 47.2 34.3 29.7 3.2 55.2 34.1 21.6 39.2 27.0 25.0 43.1 0.0 10.0 4.5 52.9 46.7 0.1 10.3 4.8 68.6 74.8 0.2 22.7 17.3 47.8 28.4 6.6 13.3 43.2 46.9 59.4 10.0 39.6 15.4 76.8 46.1 29.3 56.9 51.6 4.4 1.2 1.2 75.3 3.1 137.4 10.4 3.5 0.1 1.2 0.8 1.0 1.1 8.9 3.4 34.8 0.0 0.1 0.3 0.8 1.7 0.1 0.3 35.4 6.4 7.4 11.8 9.0 10.8 8.8 7.5 15.7 11.2 18.1 12.9 244.2 393.4 23.4 924.2 542.3 8.1 85.2 119.8 93.7 315.1 153.5 45.2 422.7 92.9 335.7 28.0 269.0 358.5 46.7 313.5 336.4 599.3 268.8 1139.0 91.5 324.9 12.7 414.0 194.0 35.3 30.8 267.2 305.5 814.9 19.0 337.1 35.8 392.9 289.2 270.1 93.5 18.0 200.5 784.5 74.2 30.2 526.5 569.5 18.5 345.1 767.5 LMNTD1 "FLJ36004, IFLTD1, Pas1c1" ENSG00000152936 "Lamin tail domain containing 1" Q8N9Z9 12 25409307-25648579 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.4;fallopian tube: 19.0;pituitary gland: 21.3;testis: 15.0" "Group enriched" "Detected in some" 15 "Ciliated cells: 26.8;Early spermatids: 38.5;Late spermatids: 35.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.5;RT4: 6.7;SH-SY5Y: 6.9;U-2197: 24.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA038640 Approved Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA038640: AB_2676127" "unprognostic (8.92e-3)" "unprognostic (3.21e-1)" "unprognostic (2.41e-1)" "unprognostic (1.19e-2)" "unprognostic (9.57e-2)" "unprognostic (1.68e-1)" "unprognostic (6.18e-2)" "unprognostic (2.42e-1)" "unprognostic (7.80e-2)" "unprognostic (3.89e-2)" 0.4 0.3 4.3 0.7 6.7 0.4 1.1 3.3 1.6 1.4 3.9 7.1 0.0 1.5 0.8 6.0 0.3 19.0 0.9 0.5 8.5 2.8 0.8 0.2 4.1 0.4 1.1 3.0 4.0 0.7 0.1 21.3 0.3 13.4 0.4 3.8 1.3 0.2 0.3 0.2 0.6 0.6 1.2 4.1 0.6 0.6 15.0 6.5 0.0 1.1 0.0 0.2 0.4 0.3 2.6 2.2 2.7 0.9 0.7 1.6 0.6 0.3 0.3 0.1 0.2 0.2 1.6 2.4 3.1 5.5 1.2 0.2 0.0 0.3 0.2 0.1 0.0 3.5 0.1 0.2 0.1 0.3 0.9 0.1 1.0 0.8 2.0 0.3 0.1 0.1 0.5 0.2 1.6 0.4 0.1 0.1 0.1 1.9 0.3 0.0 0.4 0.0 0.3 1.7 0.1 0.5 0.4 0.2 0.2 0.2 6.7 0.1 6.9 0.2 0.4 3.9 0.8 0.3 1.5 0.3 0.2 0.9 24.0 0.2 0.8 1.3 1.7 0.3 1.6 2.6 1.9 0.9 0.6 1.4 0.3 0.5 2.1 1.0 1.3 0.4 2.6 1.4 1.6 2.7 0.7 0.4 2.2 0.5 0.6 4.3 6.7 3.3 1.6 8.5 2.8 1.1 3.0 13.4 6.5 0.0 0.0 0.5 1.1 0.0 0.0 0.4 0.0 26.8 2.3 0.0 0.0 0.2 1.7 0.0 38.5 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.8 35.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.2 0.0 0.0 0.7 LMO2 "RBTN2, RBTNL1, RHOM2, TTG2" ENSG00000135363 "LIM domain only 2" P25791 11 33858576-33892289 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Endothelial cells: 121.0;Erythroid cells: 46.7;Ito cells: 110.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 1.5;classical monocyte: 1.1;eosinophil: 3.0;intermediate monocyte: 3.1;myeloid DC: 4.3;neutrophil: 1.6;non-classical monocyte: 3.6" "Group enriched" "Detected in many" 7 "dendritic cells: 4.3;granulocytes: 3.0;monocytes: 3.6" "Cell line enhanced" "Detected in some" "HEL: 23.3;HL-60: 23.2;K-562: 23.6;NB-4: 9.9;THP-1: 30.8;U-937: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016258, HPA029285, HPA070901, HPA070910" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB016258: AB_2136572, HPA029285: AB_2672978, HPA070901: , HPA070910: " "unprognostic (1.60e-1)" "unprognostic (1.47e-2)" "unprognostic (6.03e-2)" "unprognostic (1.71e-3)" "unprognostic (1.89e-1)" "unprognostic (1.14e-3)" "prognostic favorable (3.12e-4)" "unprognostic (1.73e-3)" "unprognostic (8.95e-2)" "unprognostic (5.76e-2)" "unprognostic (7.86e-3)" "unprognostic (3.69e-1)" "unprognostic (7.10e-2)" "unprognostic (9.65e-2)" "unprognostic (3.90e-1)" "unprognostic (1.45e-1)" "unprognostic (4.46e-2)" 18.2 6.1 13.8 13.6 15.6 28.8 14.5 5.2 18.4 9.4 5.5 10.3 6.4 6.2 9.7 9.9 6.9 8.6 9.1 6.4 15.8 12.2 12.9 5.5 15.9 22.2 14.2 7.2 5.1 3.9 4.2 8.3 8.5 11.9 8.3 2.7 14.6 4.5 4.0 25.0 4.2 5.5 6.6 13.9 22.0 4.4 3.6 11.1 1.0 10.7 8.1 13.3 11.1 14.8 0.5 4.3 3.0 3.6 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.9 0.5 5.7 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 23.3 0.0 0.0 0.1 23.2 8.1 0.0 0.0 0.0 0.0 0.0 4.5 0.0 23.6 0.0 0.0 0.1 2.1 9.9 0.4 0.0 0.0 6.6 0.3 0.0 0.0 0.3 1.9 0.0 0.1 0.2 0.0 0.1 0.0 30.8 0.3 0.0 0.1 0.7 0.0 0.0 0.1 0.2 2.1 10.9 0.1 1.5 1.1 3.0 0.0 3.1 0.1 0.5 0.0 0.0 4.3 0.0 0.0 0.0 1.6 0.0 3.6 0.3 0.0 0.5 13.8 15.6 5.2 9.5 15.8 12.2 14.2 7.2 11.9 11.1 3.0 10.3 7.6 7.8 7.4 1.4 1.7 7.6 5.3 0.0 5.2 2.0 0.3 0.0 2.9 0.2 121.0 0.0 46.7 1.7 1.7 8.4 4.1 7.0 1.0 33.2 0.0 0.0 110.5 41.7 0.7 3.7 42.5 10.1 0.0 0.0 1.0 0.9 0.0 0.0 5.6 1.9 0.0 2.8 0.2 2.7 5.3 18.0 0.5 0.4 19.5 LMO4 ENSG00000143013 "LIM domain only 4" P61968 1 87328468-87348923 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 102.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 105.3;T-47d: 67.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022345, HPA045877, HPA061638" Approved Supported "Nucleoplasm,Midbody ring" Yes No Nucleoplasm "Midbody ring" "CAB022345: , HPA045877: AB_2679480, HPA061638: AB_2684572" "unprognostic (5.39e-2)" "unprognostic (4.62e-3)" "unprognostic (2.67e-2)" "unprognostic (4.33e-3)" "unprognostic (1.37e-1)" "unprognostic (2.05e-2)" "prognostic unfavorable (5.25e-4)" "unprognostic (3.97e-3)" "unprognostic (7.44e-2)" "prognostic favorable (1.47e-4)" "unprognostic (3.46e-2)" "unprognostic (6.82e-2)" "unprognostic (1.14e-2)" "unprognostic (2.86e-2)" "unprognostic (2.87e-2)" "prognostic favorable (1.42e-4)" "unprognostic (1.70e-1)" 19.3 7.5 39.8 11.7 36.4 8.0 13.9 10.3 102.4 22.7 16.2 9.8 10.9 11.5 19.4 18.1 22.2 13.7 21.0 17.2 62.3 18.0 12.8 14.5 16.6 11.5 21.0 50.9 18.4 10.4 11.6 13.3 27.5 13.0 26.0 14.3 11.2 36.2 37.9 18.4 17.1 21.1 15.3 16.5 15.8 38.6 12.0 11.0 4.4 14.2 12.5 36.3 15.4 21.4 7.8 7.2 18.9 8.2 15.3 6.9 3.6 9.4 7.4 5.8 105.3 17.9 21.3 14.8 8.6 6.8 8.1 9.1 18.2 6.0 22.2 11.0 10.0 13.2 7.9 2.3 6.0 8.1 11.8 5.8 20.2 16.2 5.6 17.2 10.9 27.5 11.1 13.9 12.6 7.2 14.7 5.5 8.6 4.5 19.7 4.3 3.8 0.3 7.1 21.3 10.2 7.0 12.6 8.1 4.8 10.0 36.4 4.8 0.3 34.6 5.1 25.5 11.6 67.0 30.0 3.5 38.2 7.2 9.1 28.1 18.1 11.9 5.0 4.7 2.4 5.4 18.9 6.8 13.0 6.0 8.2 6.9 7.8 5.4 6.1 5.0 4.4 1.4 3.5 10.9 15.3 7.7 7.2 1.4 3.6 39.8 36.4 10.3 102.4 62.3 18.0 21.0 50.9 13.0 11.0 41.7 27.4 50.6 46.8 87.3 192.0 49.2 163.1 29.4 48.9 34.9 68.7 270.0 53.0 48.7 1.6 54.7 57.7 23.3 112.7 251.2 186.2 38.4 292.9 75.1 64.5 104.9 29.9 81.6 115.9 4.5 88.1 61.6 62.4 25.2 66.7 78.4 77.9 34.8 221.3 42.6 34.0 32.3 148.3 3.9 34.7 81.2 214.1 67.1 38.3 32.9 LMTK3 "KIAA1883, LMR3, PPP1R101, TYKLM3" ENSG00000142235 "Lemur tyrosine kinase 3" Q96Q04 19 48485271-48513189 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 38.1" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 21.6;Ductal cells: 19.4;Horizontal cells: 17.5;Urothelial cells: 44.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 8.6;SK-BR-3: 10.2;U-266/70: 9.5;U-266/84: 7.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040203, HPA077070" Enhanced Supported Uncertain "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA040203: AB_10671690, HPA077070: AB_2732330" "unprognostic (2.41e-1)" "unprognostic (1.48e-1)" "unprognostic (5.37e-2)" "unprognostic (5.45e-2)" "unprognostic (2.95e-1)" "unprognostic (1.71e-2)" "unprognostic (5.67e-2)" "unprognostic (2.46e-1)" "unprognostic (2.09e-1)" "unprognostic (2.51e-3)" "unprognostic (5.71e-2)" "unprognostic (1.47e-1)" "prognostic favorable (3.18e-8)" "unprognostic (1.38e-1)" "unprognostic (3.22e-2)" "unprognostic (3.24e-1)" "unprognostic (6.11e-2)" 1.3 4.4 19.8 2.3 28.6 2.0 2.0 20.0 38.1 2.0 1.5 6.0 0.2 6.2 1.4 1.5 2.3 1.6 1.9 1.7 17.2 11.1 2.5 1.3 3.2 2.2 6.5 23.8 1.3 2.1 8.5 6.1 2.1 12.5 3.5 1.2 1.6 5.2 3.1 1.2 2.4 4.0 1.2 6.6 1.8 2.9 1.5 10.3 0.0 2.3 0.0 2.2 1.6 1.2 0.0 0.0 0.0 0.2 0.0 0.4 0.1 4.6 3.1 0.4 0.0 0.0 0.0 4.5 0.0 0.3 0.0 0.1 2.2 3.7 1.7 1.3 0.0 1.2 2.2 0.3 1.6 0.0 0.0 1.2 0.2 0.3 0.7 0.0 0.0 8.6 0.2 0.9 0.0 0.0 2.0 0.1 2.8 1.4 2.9 0.0 3.1 0.6 0.8 1.1 2.4 0.9 3.9 0.0 1.3 1.1 0.8 0.7 2.9 0.1 10.2 0.0 0.6 3.9 0.2 0.1 0.0 0.8 0.1 0.0 9.5 7.7 0.4 0.2 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 19.8 28.6 20.0 38.1 17.2 11.1 6.5 23.8 12.5 10.3 3.0 1.7 0.8 9.2 0.5 16.4 2.2 2.5 4.0 4.5 7.0 0.0 4.3 21.6 19.4 0.1 0.0 0.7 0.0 0.4 2.5 0.9 15.7 0.0 0.0 1.0 17.5 0.0 1.3 0.3 0.0 0.6 0.3 3.3 0.0 1.0 7.3 10.7 0.0 0.0 0.6 1.9 0.0 0.7 2.4 1.3 1.6 5.7 0.0 0.6 44.3 LMX1A "LMX1, LMX1.1" ENSG00000162761 "LIM homeobox transcription factor 1 alpha" Q8TE12 1 165201867-165356715 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.3;pituitary gland: 8.0" "Group enriched" "Detected in some" 33 "Early spermatids: 29.1;Intestinal endocrine cells: 40.3;Late spermatids: 14.3" "Not detected" "Not detected" "Region enhanced" "Detected in many" "pons and medulla: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "SCLC-21H: 4.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA028051, HPA030088" Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus, Vesicles" "HPA028051: AB_10599731, HPA030088: AB_10601106" "unprognostic (1.73e-1)" "unprognostic (9.57e-2)" "unprognostic (7.58e-2)" "unprognostic (1.59e-1)" "unprognostic (2.17e-1)" "unprognostic (2.82e-1)" "unprognostic (2.63e-1)" "unprognostic (3.22e-2)" "unprognostic (2.10e-3)" "unprognostic (1.51e-1)" "unprognostic (9.82e-3)" 2.2 0.0 0.0 2.0 0.0 0.0 1.2 2.6 0.5 0.5 1.7 3.4 3.1 4.0 0.1 1.3 1.1 0.5 0.2 0.2 0.9 1.5 0.0 0.1 0.1 0.0 2.2 0.0 0.0 0.0 0.1 8.0 0.0 7.3 0.2 2.1 0.5 1.5 0.3 1.4 0.3 2.2 0.9 0.1 0.0 0.2 4.3 0.3 0.0 0.3 3.5 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.5 0.9 1.5 2.2 0.0 7.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.3 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 LMX1B NPS1 ENSG00000136944 "LIM homeobox transcription factor 1 beta" O60663 9 126614443-126701032 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 16.5;salivary gland: 35.3" "Cell type enhanced" "Detected in some" 16 "Cardiomyocytes: 1.4;Early spermatids: 1.1" "Cancer enriched" "Detected in some" 14 "breast cancer: 12.9" "Region enriched" "Detected in single" 4 "pons and medulla: 2.9" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "MCF7: 17.2;OE19: 10.9;T-47d: 10.6" "Region enhanced" "Detected in some" "pons and medulla: 2.4" "Region enhanced" "Detected in some" "midbrain: 7.9" HPA073716 Approved Nucleoplasm NA NA Nucleoplasm "HPA073716: AB_2686630" "unprognostic (4.17e-1)" "unprognostic (4.72e-2)" "unprognostic (2.81e-2)" "unprognostic (2.53e-4)" "unprognostic (1.73e-1)" "unprognostic (1.50e-4)" "unprognostic (1.86e-1)" "unprognostic (2.20e-2)" "unprognostic (3.41e-1)" "unprognostic (2.26e-1)" "unprognostic (1.34e-2)" "unprognostic (3.51e-3)" "unprognostic (1.63e-5)" "unprognostic (1.69e-1)" "unprognostic (1.23e-1)" "unprognostic (1.56e-6)" "unprognostic (1.13e-2)" 1.3 0.1 0.0 0.1 0.0 0.1 7.5 0.0 0.1 0.1 0.5 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.3 1.9 0.1 0.2 1.4 0.0 0.1 0.0 0.6 0.0 0.1 0.8 0.0 0.6 0.0 2.9 0.1 0.0 16.5 35.3 0.0 0.4 1.5 0.2 0.0 2.4 0.0 0.1 3.1 0.0 0.0 0.9 0.1 0.0 0.2 0.1 0.6 0.4 1.2 0.3 0.9 0.5 0.0 2.4 1.1 0.4 3.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 2.2 1.3 0.0 0.5 0.0 2.8 1.2 3.8 0.0 0.0 0.0 4.6 0.0 0.0 0.4 0.0 0.0 2.3 0.0 0.5 0.0 2.0 0.0 0.0 0.3 0.0 0.0 0.0 17.2 0.0 0.0 0.0 10.9 0.2 0.0 3.2 0.0 0.0 0.3 0.0 1.5 0.3 0.1 0.4 0.1 10.6 0.2 0.0 0.0 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.3 0.3 0.3 0.1 0.2 0.3 0.3 0.2 0.1 0.6 0.5 0.4 1.2 0.9 0.2 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 LNPK "KIAA1715, LNP, LNP1, Ul" ENSG00000144320 "Lunapark, ER junction formation factor" Q9C0E8 2 175923892-176002839 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 17.9;Ciliated cells: 16.0;Collecting duct cells: 15.7;Extravillous trophoblasts: 15.2;Hofbauer cells: 20.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-138 MG: 60.1" "Low region specificity" "Detected in all" HPA014205 Approved Supported "Nucleoplasm,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" Nucleoplasm "HPA014205: AB_2234186" "unprognostic (4.93e-2)" "unprognostic (3.35e-2)" "unprognostic (1.20e-1)" "unprognostic (7.45e-2)" "unprognostic (2.92e-1)" "unprognostic (3.85e-2)" "unprognostic (1.08e-2)" "unprognostic (8.73e-2)" "unprognostic (1.27e-1)" "unprognostic (3.15e-1)" "unprognostic (2.72e-2)" "unprognostic (3.13e-1)" "unprognostic (4.17e-3)" "unprognostic (1.63e-1)" "unprognostic (9.27e-2)" "unprognostic (2.35e-3)" "unprognostic (3.43e-2)" 14.2 10.8 13.4 8.4 16.0 29.4 11.3 12.9 26.5 15.0 13.3 13.4 7.1 8.6 11.9 7.7 15.1 8.2 9.1 13.6 13.8 16.1 9.8 16.3 8.1 7.6 19.9 14.2 12.8 6.4 16.8 22.8 9.4 21.1 12.0 11.9 10.1 8.6 10.1 33.5 13.5 8.4 11.3 26.2 6.6 8.9 25.4 14.6 16.4 10.3 14.8 8.7 12.2 15.1 7.1 6.7 11.6 7.3 9.7 11.6 5.2 8.7 4.4 10.6 14.9 22.3 13.9 5.3 25.9 12.5 12.1 17.1 6.1 10.4 8.8 14.8 11.4 15.9 9.7 9.9 6.9 16.9 13.3 10.1 9.9 5.7 5.4 5.3 16.7 12.3 11.4 6.6 11.7 5.8 9.9 2.2 7.0 10.1 11.7 16.5 5.7 11.0 6.7 3.4 9.0 8.6 11.2 10.7 6.4 5.1 8.0 12.2 12.4 11.4 6.5 8.6 10.4 9.7 5.5 3.3 60.1 8.9 20.0 12.1 6.9 12.6 7.3 18.6 5.5 11.2 5.7 6.6 11.6 8.1 7.3 9.5 7.1 7.2 8.9 6.0 5.0 7.2 11.2 5.6 9.7 6.7 6.7 11.6 5.2 13.4 16.0 12.9 23.3 13.8 16.1 19.9 14.2 21.1 14.6 17.9 9.9 0.0 0.0 0.0 0.0 0.0 0.0 16.0 11.4 15.7 0.0 4.3 5.0 14.3 0.0 0.0 0.0 0.0 8.3 15.2 0.0 0.0 10.5 0.0 20.8 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 3.6 0.0 0.0 11.1 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 LONP1 "hLON, LonHS, PIM1, PRSS15" ENSG00000196365 "Lon peptidase 1, mitochondrial" P36776 19 5691834-5720572 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA-binding, Hydrolase, Protease, Serine protease" "Cataract, Deafness, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 78.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002034, HPA002192" Supported Enhanced Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA002034: AB_2756304, HPA002192: AB_1079695" "unprognostic (6.52e-2)" "unprognostic (1.12e-1)" "unprognostic (2.43e-1)" "unprognostic (2.43e-2)" "unprognostic (2.84e-1)" "unprognostic (2.38e-1)" "unprognostic (1.66e-3)" "unprognostic (5.56e-2)" "unprognostic (2.71e-1)" "unprognostic (7.57e-2)" "unprognostic (4.04e-2)" "unprognostic (1.26e-1)" "unprognostic (1.76e-2)" "unprognostic (1.09e-2)" "unprognostic (1.24e-1)" "unprognostic (1.11e-1)" "unprognostic (2.11e-1)" 15.8 78.3 16.4 12.8 19.8 12.5 13.9 16.1 22.8 11.3 13.6 15.8 13.3 13.7 10.5 13.8 12.7 12.7 15.7 27.3 15.4 15.3 19.9 49.6 10.3 14.5 17.7 14.9 15.5 17.7 17.6 16.8 16.6 16.2 11.7 8.5 12.7 18.5 14.7 38.0 14.7 13.9 11.5 12.7 15.5 13.5 9.8 13.3 13.8 21.2 15.3 11.8 14.7 12.5 6.7 6.5 6.0 6.2 4.0 7.2 3.0 23.0 23.9 7.9 25.3 9.4 6.7 24.7 14.7 11.7 15.9 19.5 20.4 8.3 28.9 20.6 15.4 15.3 9.8 20.4 17.8 7.7 17.1 16.8 16.0 20.9 26.7 43.7 36.4 16.8 12.6 25.6 15.1 29.9 7.7 12.7 40.6 42.3 57.8 7.3 15.3 18.0 21.7 28.3 9.4 31.6 19.0 11.4 31.2 8.8 13.7 21.1 21.1 12.9 18.9 51.6 5.8 11.1 45.7 8.9 8.1 8.9 22.5 21.4 60.9 37.5 25.7 36.5 39.9 14.6 6.0 4.1 0.8 6.4 6.2 4.1 6.0 5.6 6.1 4.3 6.7 7.2 4.8 0.5 4.0 2.4 6.5 4.0 3.0 16.4 19.8 16.1 22.8 15.4 15.3 17.7 14.9 16.2 13.3 6.0 13.3 13.7 8.7 7.3 24.7 17.9 15.3 9.4 10.3 26.2 5.9 24.8 39.7 28.3 5.3 9.8 24.8 0.0 23.9 27.0 10.5 12.9 5.7 44.0 28.2 20.6 10.9 14.1 11.3 4.0 11.8 15.2 13.5 24.4 21.6 20.9 25.6 14.4 16.3 36.0 22.0 19.4 10.3 9.1 13.4 9.4 29.3 9.2 22.2 9.4 LONRF2 "FLJ45273, RNF192" ENSG00000170500 "LON peptidase N-terminal domain and ring finger 2" Q1L5Z9 2 100273291-100322733 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.9;epididymis: 32.6" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 74.2;Cardiomyocytes: 34.4;Horizontal cells: 104.9" "Cancer enhanced" "Detected in many" "thyroid cancer: 15.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 6.5;GAMG: 8.1;HAP1: 6.4;HEK 293: 6.9;HMC-1: 5.7;PC-3: 5.9;SCLC-21H: 14.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057366 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA057366: AB_2683420" "unprognostic (9.81e-2)" "unprognostic (4.97e-2)" "unprognostic (2.68e-2)" "unprognostic (3.20e-2)" "unprognostic (7.10e-2)" "unprognostic (7.72e-2)" "unprognostic (9.50e-2)" "unprognostic (9.86e-3)" "unprognostic (6.33e-2)" "unprognostic (1.32e-1)" "prognostic favorable (6.42e-5)" "unprognostic (1.14e-1)" "unprognostic (6.06e-2)" "unprognostic (3.45e-2)" "unprognostic (2.50e-2)" "unprognostic (2.66e-3)" "unprognostic (6.34e-2)" 1.6 23.0 8.4 0.6 32.9 0.2 2.2 21.1 15.4 5.1 1.7 1.3 2.3 0.5 19.0 32.6 2.0 17.8 1.7 4.3 5.6 9.9 1.3 0.7 1.5 0.5 3.9 7.0 10.5 4.4 9.6 7.8 0.6 6.4 3.2 0.7 1.6 1.5 3.2 4.6 0.4 0.5 19.8 4.5 0.5 1.5 1.8 4.3 0.4 3.5 0.8 0.4 1.4 1.3 0.7 0.5 1.7 0.4 0.7 0.5 0.1 0.0 6.5 2.0 2.4 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 1.2 0.0 1.1 0.0 8.1 0.0 6.4 0.0 0.0 0.5 6.9 0.0 0.4 0.0 0.2 0.1 5.7 0.0 0.0 0.3 0.0 0.4 0.0 1.8 3.7 0.1 0.0 4.2 0.0 0.3 0.4 1.2 5.9 0.0 0.0 0.0 1.6 0.2 14.0 3.8 0.0 0.0 1.0 2.3 3.5 0.1 0.1 0.1 0.8 0.0 0.4 0.0 0.0 0.0 2.8 0.0 0.3 1.1 0.4 0.4 0.3 0.3 0.3 0.4 0.3 0.3 0.2 0.7 0.4 0.5 1.7 0.7 0.3 0.5 0.2 0.1 8.4 32.9 21.1 9.7 5.6 9.9 3.9 7.0 6.4 4.3 0.0 13.2 0.0 1.2 0.7 74.2 34.4 5.1 5.3 5.7 5.2 29.5 1.7 5.0 2.4 0.4 1.0 0.0 0.0 1.8 0.2 1.5 5.8 5.7 0.5 0.4 104.9 10.9 0.0 0.0 1.5 3.1 0.3 1.7 0.0 0.1 10.0 2.1 0.0 11.0 0.3 18.2 6.5 3.3 0.5 0.2 0.1 2.4 0.0 0.4 0.5 LONRF3 "FLJ22612, RNF127" ENSG00000175556 "LON peptidase N-terminal domain and ring finger 3" Q496Y0 X 118974614-119018355 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 14.9;Basal glandular cells: 13.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 7.4" "Lineage enriched" "Detected in single" 8 "T-cells: 7.4" "Cell line enhanced" "Detected in many" "GAMG: 9.9;K-562: 10.6;OE19: 12.0;PC-3: 12.1;SiHa: 11.0;SK-MEL-30: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050422, HPA061162" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA050422: AB_2681122, HPA061162: AB_2732658" "unprognostic (1.80e-2)" "unprognostic (1.48e-1)" "unprognostic (1.24e-1)" "unprognostic (1.92e-1)" "unprognostic (4.24e-2)" "unprognostic (1.64e-1)" "unprognostic (6.06e-3)" "unprognostic (1.29e-2)" "unprognostic (3.21e-1)" "unprognostic (8.01e-2)" "prognostic unfavorable (4.32e-4)" "unprognostic (4.29e-2)" "unprognostic (2.31e-3)" "unprognostic (6.34e-2)" "unprognostic (6.16e-2)" "unprognostic (1.70e-1)" "unprognostic (1.27e-3)" 3.8 3.9 4.2 2.1 3.4 4.6 10.8 15.8 6.1 1.9 4.1 2.0 1.6 2.9 2.4 3.1 1.7 2.5 3.9 3.9 5.0 1.9 3.6 15.4 11.8 0.8 1.7 3.7 2.0 8.1 0.4 3.5 0.9 4.4 3.0 5.5 4.1 8.1 3.0 13.8 1.4 2.3 10.8 2.7 1.1 4.5 2.7 2.5 0.0 9.9 1.9 1.1 4.7 6.6 0.0 0.1 0.8 0.8 0.0 7.4 0.7 3.7 5.5 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 4.6 0.0 2.7 0.0 9.9 0.0 1.1 0.0 0.0 0.1 3.1 4.7 9.0 5.3 3.1 4.0 0.6 0.0 0.0 0.0 0.0 1.7 1.4 0.4 10.6 0.0 0.8 4.5 0.0 1.8 0.0 12.0 12.1 0.0 2.5 0.0 3.3 1.5 0.2 0.0 11.0 0.3 9.6 0.1 0.0 3.5 0.2 0.1 0.2 0.0 5.8 1.2 4.7 0.0 2.6 4.1 2.4 0.0 0.8 0.0 4.5 0.0 7.4 0.0 2.0 1.5 0.1 0.0 1.1 1.6 0.8 0.0 0.0 0.0 0.7 0.7 4.2 3.4 15.8 6.1 5.0 1.9 1.7 3.7 4.4 2.5 6.0 14.9 0.0 13.8 1.3 3.6 3.2 0.0 0.0 10.3 1.8 0.0 0.5 1.7 2.4 1.3 1.9 5.8 0.0 3.8 0.0 2.8 4.7 5.8 4.0 2.9 1.6 1.2 3.1 3.7 0.4 0.9 3.8 3.3 0.0 2.3 6.1 4.6 3.1 1.4 0.7 0.2 0.0 3.1 1.7 4.1 0.1 0.3 1.3 2.5 9.8 LOXL2 "LOR, WS9-14" ENSG00000134013 "Lysyl oxidase like 2" Q9Y4K0 8 23297189-23425328 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Transcription, Transcription regulation" "Chromatin regulator, Oxidoreductase, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Endothelial cells: 15.5;Extravillous trophoblasts: 20.1;Fibroblasts: 16.6;Ito cells: 23.4;Sertoli cells: 25.8;Smooth muscle cells: 22.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 8 "pons and medulla: 22.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 109.9;BJ hTERT+ SV40 Large T+ RasG12V: 63.6;fHDF/TERT166: 71.2;TIME: 59.3;U-87 MG: 110.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025848, HPA036257, HPA056542" Approved Enhanced Nucleoplasm "Secreted to extracellular matrix" NA NA Nucleoplasm "CAB025848: , HPA036257: AB_2675025, HPA056542: AB_2683168" "unprognostic (9.48e-2)" "prognostic unfavorable (9.83e-6)" "unprognostic (2.03e-1)" "unprognostic (2.81e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (5.55e-2)" "unprognostic (1.42e-2)" "prognostic unfavorable (1.46e-7)" "unprognostic (2.91e-2)" "unprognostic (3.63e-3)" "prognostic unfavorable (9.05e-4)" "unprognostic (1.25e-1)" "prognostic unfavorable (2.91e-7)" "unprognostic (1.51e-2)" "unprognostic (7.07e-2)" "unprognostic (4.93e-2)" "unprognostic (3.68e-3)" 37.8 2.7 1.2 14.5 1.6 0.6 22.4 2.9 1.6 16.9 18.4 1.0 12.2 5.8 11.8 9.1 11.5 4.1 5.4 7.2 1.2 1.3 4.3 4.1 6.2 7.5 1.9 0.7 15.6 4.4 1.3 2.2 38.0 22.7 8.4 3.8 1.6 5.6 9.7 6.2 4.3 10.7 27.3 10.9 8.3 7.7 4.1 0.7 1.6 4.3 8.0 8.6 19.1 6.4 1.9 1.3 3.0 0.7 2.1 2.8 0.7 6.3 17.0 5.1 4.1 14.0 23.1 2.2 109.9 35.6 50.4 63.6 0.1 0.4 1.2 0.8 71.2 23.4 5.3 0.2 9.4 26.7 0.2 0.9 0.0 2.3 0.1 28.3 0.0 0.4 20.4 0.4 18.8 2.5 33.6 42.1 0.2 0.0 0.2 16.6 3.4 0.0 0.1 3.3 0.0 2.6 0.2 4.2 0.0 14.6 0.0 0.1 1.4 13.7 0.7 1.0 16.8 0.1 0.1 59.3 46.9 12.4 19.1 14.4 0.4 0.0 3.3 110.2 0.1 48.8 1.9 0.7 3.0 1.6 0.3 0.8 1.9 0.6 1.3 0.5 0.9 0.8 2.8 1.6 2.1 0.6 1.3 0.2 0.7 1.2 1.6 2.9 1.0 1.2 1.3 1.9 0.7 22.7 0.7 0.0 4.0 0.5 0.4 2.3 1.7 1.7 0.0 1.4 0.0 0.0 0.0 2.0 0.0 1.5 0.5 15.5 0.0 0.0 1.3 20.1 16.6 0.5 0.0 0.0 1.1 1.6 0.0 23.4 0.3 0.0 0.9 0.5 3.3 0.0 0.0 0.8 3.4 0.0 0.4 0.0 3.1 25.8 22.6 0.9 0.9 2.8 0.8 0.0 0.0 0.1 LRCH4 "LRN, LRRN1" ENSG00000077454 "Leucine rich repeats and calponin homology domain containing 4" O75427 7 100574011-100586153 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 153.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 45.7;NB-4: 70.7" "Low region specificity" "Detected in all" "HPA037667, HPA037668" Enhanced Approved "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA "Nucleoplasm, Focal adhesion sites, Cytosol" "HPA037667: AB_10671882, HPA037668: AB_10672910" "unprognostic (2.41e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (1.61e-7)" "unprognostic (8.32e-3)" "unprognostic (2.76e-2)" "unprognostic (3.96e-3)" "unprognostic (8.98e-3)" "unprognostic (3.72e-2)" "unprognostic (2.52e-1)" "unprognostic (5.51e-2)" "unprognostic (2.63e-3)" "unprognostic (7.81e-2)" "unprognostic (1.95e-1)" "unprognostic (1.77e-1)" "unprognostic (1.40e-2)" "unprognostic (7.96e-2)" "unprognostic (1.26e-2)" 11.4 15.2 14.5 32.0 25.7 52.7 13.8 19.7 22.2 12.0 14.0 16.4 11.8 22.0 12.3 9.6 14.4 14.0 15.9 10.2 16.2 9.1 16.1 12.2 20.8 39.1 25.8 13.1 23.7 17.3 8.9 22.8 26.4 19.2 14.6 7.2 18.3 23.5 13.0 15.8 15.0 27.8 8.1 25.7 54.5 14.9 43.3 23.1 31.1 20.0 6.8 25.2 9.9 12.0 5.9 6.2 24.2 8.4 1.4 7.3 2.9 7.9 4.5 4.5 4.0 2.7 2.1 8.6 7.7 3.5 4.5 3.7 7.5 11.7 5.8 8.7 2.3 4.8 6.9 2.2 3.2 1.3 5.7 6.0 6.6 5.3 3.5 8.6 11.4 45.7 3.5 3.5 3.8 2.1 2.9 4.6 15.2 8.2 11.9 3.2 15.0 13.1 70.7 4.7 7.4 5.3 14.6 3.7 7.1 3.5 2.8 5.9 8.8 3.7 11.8 9.0 6.1 7.9 24.9 7.2 6.2 11.3 8.6 4.6 12.1 5.7 5.2 4.8 28.3 10.6 12.6 8.4 11.9 5.2 6.8 4.7 4.7 5.1 5.9 6.2 5.9 7.3 5.9 24.2 1.4 4.7 5.9 5.2 2.9 14.5 25.7 19.7 22.2 16.2 9.1 25.8 13.1 19.2 23.1 8.9 16.7 24.7 13.8 10.6 13.6 0.7 25.5 6.7 6.8 21.0 39.3 33.4 13.3 27.1 153.1 9.5 22.2 0.0 21.3 11.2 9.5 12.1 18.5 11.3 30.3 12.7 5.8 15.4 53.4 19.7 23.0 33.3 13.5 52.3 12.9 15.5 23.1 14.0 9.6 6.2 29.9 19.4 12.2 42.6 28.7 10.0 86.4 42.9 11.0 14.2 LRIF1 "C1orf103, FLJ11269, RIF1" ENSG00000121931 "Ligand dependent nuclear receptor interacting factor 1" Q5T3J3 1 110947185-110964079 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044515 Uncertain Supported "Nucleoplasm,Centriolar satellite" NA NA Nucleoplasm "Centriolar satellite" "HPA044515: AB_10796800" "unprognostic (5.06e-2)" "unprognostic (4.82e-2)" "unprognostic (4.74e-1)" "unprognostic (3.66e-2)" "unprognostic (2.20e-2)" "unprognostic (2.72e-1)" "unprognostic (1.27e-3)" "unprognostic (1.85e-1)" "unprognostic (1.64e-1)" "prognostic favorable (1.73e-4)" "unprognostic (5.14e-2)" "unprognostic (9.23e-3)" "unprognostic (3.94e-2)" "unprognostic (2.82e-1)" "unprognostic (2.48e-1)" "unprognostic (3.88e-2)" "unprognostic (2.70e-1)" 9.0 11.2 13.7 15.4 15.5 5.9 20.7 15.6 14.7 7.9 7.5 6.6 7.8 7.0 8.1 23.9 8.1 9.6 6.7 16.1 12.7 13.3 9.6 16.7 11.9 17.6 10.5 7.5 18.4 6.9 5.8 17.5 25.1 10.3 9.9 7.6 7.3 8.6 9.2 20.5 10.6 8.4 6.0 12.4 14.0 8.1 27.7 10.1 16.8 12.6 10.2 19.0 10.0 28.5 21.0 11.4 21.4 8.2 18.0 19.4 8.4 12.0 5.3 10.2 6.9 4.7 7.7 11.5 7.4 8.6 13.1 10.6 13.4 15.3 9.2 10.7 5.6 14.0 7.9 4.8 4.4 15.9 16.7 5.7 10.2 5.4 13.8 14.0 19.2 12.5 4.8 12.4 9.0 15.9 5.5 7.0 9.9 31.8 42.6 8.7 4.0 1.9 15.3 15.3 7.4 12.3 12.8 16.7 11.2 3.4 6.3 8.5 9.4 0.0 12.9 21.6 6.5 10.6 31.3 4.9 11.6 0.4 13.6 6.0 19.8 6.8 17.4 6.6 22.0 20.0 13.0 5.7 12.3 15.3 6.3 19.4 21.0 12.1 15.8 11.4 15.5 13.5 18.5 21.4 18.0 8.2 10.3 11.1 8.4 13.7 15.5 15.6 14.7 12.7 13.3 10.5 7.5 10.3 10.1 11.9 6.7 21.2 56.0 12.8 19.8 20.2 10.2 21.4 10.3 8.7 17.7 16.2 13.3 13.9 9.9 18.0 11.4 0.0 17.5 26.9 16.6 45.6 8.1 25.1 12.1 14.3 10.9 13.5 8.5 8.9 14.7 18.8 30.4 19.0 10.4 26.9 17.0 13.9 13.1 7.9 30.3 12.9 23.0 32.1 49.1 15.4 31.6 28.7 9.8 43.3 LRIG2 KIAA0806 ENSG00000198799 "Leucine rich repeats and immunoglobulin like domains 2" O94898 1 113073209-113132260 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015538 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA 510000 "Golgi apparatus" Nucleoplasm "HPA015538: AB_2250170" "unprognostic (1.68e-2)" "unprognostic (1.13e-1)" "unprognostic (9.08e-2)" "prognostic unfavorable (9.37e-4)" "unprognostic (4.72e-2)" "unprognostic (1.27e-3)" "unprognostic (2.33e-2)" "unprognostic (6.62e-3)" "unprognostic (3.27e-2)" "unprognostic (5.95e-2)" "unprognostic (1.03e-2)" "unprognostic (1.03e-2)" "unprognostic (1.27e-2)" "unprognostic (2.34e-1)" "unprognostic (8.83e-2)" "unprognostic (1.29e-1)" "unprognostic (1.25e-1)" 8.3 7.7 10.1 11.4 10.6 4.7 10.7 15.6 10.0 11.6 9.2 16.1 6.0 10.8 15.1 14.9 7.8 9.2 8.2 7.3 9.3 9.1 9.2 6.3 8.0 9.7 13.0 6.7 15.0 8.5 13.4 11.6 10.1 9.2 9.3 8.6 14.6 9.0 11.2 13.1 16.6 9.5 8.9 11.6 10.1 8.1 9.4 13.4 10.4 12.6 5.0 10.7 8.6 10.7 4.4 2.6 4.9 2.5 4.8 3.9 1.7 4.3 2.4 6.7 5.0 6.4 6.6 3.8 2.8 4.2 3.4 5.8 3.5 2.8 4.5 5.0 3.5 1.9 5.0 4.6 3.0 5.7 3.1 2.7 4.8 4.5 1.7 6.5 5.7 2.3 6.5 5.5 5.4 7.1 5.3 4.4 6.3 5.7 4.3 4.2 3.2 5.7 6.1 6.2 1.8 4.0 5.3 8.4 2.2 3.3 2.9 4.8 3.8 5.0 3.3 6.4 5.7 2.5 6.4 6.6 6.4 3.4 8.7 4.5 4.7 2.2 4.6 6.8 3.6 5.9 4.9 2.5 1.5 3.1 2.0 3.5 3.1 3.4 3.2 1.9 4.4 3.9 3.6 1.7 4.8 2.1 2.6 2.6 1.7 10.1 10.6 15.6 10.0 9.3 9.1 13.0 6.7 9.2 13.4 0.0 13.3 5.9 2.5 7.4 19.1 8.1 12.7 12.0 6.8 14.0 35.3 5.8 0.0 3.2 0.9 6.3 9.9 0.0 2.3 3.7 5.7 4.7 5.7 4.3 4.1 17.5 5.2 6.2 8.5 0.0 17.0 5.9 6.8 1.8 7.1 27.0 2.7 7.0 15.2 4.1 21.3 0.0 4.2 8.6 14.9 5.8 4.5 7.0 8.3 3.4 LRIT3 "CSNB1F, FIGLER4, FLJ44691" ENSG00000183423 "Leucine rich repeat, Ig-like and transmembrane domains 3" Q3SXY7 4 109848202-109872315 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 17.1" "Group enriched" "Detected in some" 11 "Cone photoreceptor cells: 31.4;Muller glia cells: 15.4;Rod photoreceptor cells: 9.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA013454 Enhanced Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA013454: AB_1853277" "unprognostic (5.41e-2)" "unprognostic (6.82e-2)" "unprognostic (4.20e-2)" "unprognostic (6.50e-2)" "unprognostic (3.42e-1)" "unprognostic (7.67e-3)" "unprognostic (1.54e-1)" "unprognostic (5.25e-2)" "unprognostic (3.16e-2)" "unprognostic (4.49e-2)" "unprognostic (6.92e-3)" "unprognostic (3.34e-3)" "unprognostic (2.14e-1)" "unprognostic (4.01e-2)" "unprognostic (1.69e-1)" "unprognostic (1.35e-1)" "unprognostic (1.14e-2)" 0.6 0.6 0.7 0.6 1.2 0.4 1.7 2.0 1.3 1.2 0.6 0.6 0.6 0.3 0.7 1.8 0.6 1.0 0.6 0.6 0.8 0.7 4.4 0.7 0.6 0.6 0.6 0.6 0.6 0.7 0.7 0.6 0.6 0.6 0.9 0.5 17.1 0.8 0.6 1.6 3.2 0.6 0.6 0.6 0.8 0.2 1.3 0.6 0.6 0.8 0.6 0.6 0.6 0.6 0.1 0.3 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.8 0.0 0.4 0.1 0.1 0.0 0.0 0.2 0.2 0.3 0.0 0.6 0.6 0.0 0.0 0.1 1.3 0.1 0.2 0.3 1.6 0.3 0.4 0.2 0.1 1.3 0.0 0.0 2.0 0.1 0.3 0.2 0.1 1.3 0.3 0.6 0.0 0.0 0.9 1.0 0.2 0.8 0.2 0.6 0.0 0.2 1.0 0.3 0.5 0.0 0.0 0.4 0.0 0.3 0.1 1.2 0.0 0.3 0.3 0.6 0.3 0.6 1.0 0.0 0.3 0.9 0.3 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.9 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.7 1.2 2.0 1.3 0.8 0.7 0.6 0.6 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 31.4 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.1 0.0 0.0 0.0 9.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 LRMDA "C10orf11, CDA017, OCA7" ENSG00000148655 "Leucine rich melanocyte differentiation associated" Q9H2I8 10 75431453-76560167 "Disease related genes, Predicted intracellular proteins" Differentiation Albinism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 13 "Distal tubular cells: 28.2;Hofbauer cells: 48.4;Proximal tubular cells: 72.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 23.6;myeloid DC: 27.3" "Group enriched" "Detected in many" 8 "dendritic cells: 27.3;granulocytes: 8.7;monocytes: 23.6" "Cell line enhanced" "Detected in many" "Hep G2: 18.4;HMC-1: 14.3;NB-4: 26.5;SK-MEL-30: 37.3;THP-1: 19.8;U-937: 17.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA047446, HPA050419" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA047446: AB_2680050, HPA050419: AB_2756316" "unprognostic (1.04e-1)" "unprognostic (8.03e-2)" "unprognostic (2.40e-1)" "unprognostic (7.97e-2)" "unprognostic (2.03e-1)" "unprognostic (1.58e-2)" "unprognostic (1.31e-1)" "unprognostic (8.57e-3)" "unprognostic (5.86e-2)" "unprognostic (6.80e-2)" "unprognostic (8.34e-2)" "unprognostic (1.26e-1)" "unprognostic (7.34e-3)" "unprognostic (7.26e-2)" "unprognostic (6.50e-2)" "unprognostic (4.98e-3)" "unprognostic (3.64e-2)" 12.7 35.3 4.6 4.7 6.4 13.2 6.1 2.6 3.6 7.1 4.6 8.2 12.5 3.1 12.5 34.9 5.3 5.7 8.9 13.2 3.7 5.1 11.5 19.1 13.1 5.6 7.4 3.1 8.6 21.0 6.8 9.7 6.9 6.7 8.3 4.0 19.8 10.7 8.8 2.2 2.3 4.5 5.3 8.1 7.8 8.6 5.8 5.0 0.1 13.2 6.9 3.9 5.5 5.3 0.0 27.3 8.7 23.6 2.6 0.1 6.7 0.1 2.6 0.1 0.0 1.2 1.5 0.0 0.3 0.0 0.1 0.2 3.1 5.5 0.0 10.9 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.6 0.6 1.3 18.4 0.5 3.7 14.3 0.7 0.5 0.3 0.0 2.3 0.5 0.0 0.0 0.6 0.0 0.4 0.0 26.5 0.1 1.6 1.1 0.0 0.1 0.0 0.2 3.4 0.1 0.2 3.3 0.0 37.3 0.1 0.2 19.8 0.3 0.1 1.4 1.0 2.1 0.2 0.0 0.0 9.6 17.7 4.7 2.6 23.6 8.7 0.0 11.2 0.1 0.0 0.0 0.0 27.3 0.0 0.0 0.0 1.3 2.6 6.4 0.2 0.0 6.7 4.6 6.4 2.6 3.6 3.7 5.1 7.4 3.1 6.7 5.0 20.8 17.5 0.0 0.0 0.0 0.0 0.0 0.0 12.0 6.8 12.2 0.0 0.9 28.2 17.1 0.0 0.0 0.0 0.0 13.8 0.8 0.0 0.0 7.0 0.0 48.4 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 11.8 0.0 0.0 15.2 0.0 0.0 72.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 LRMP JAW1 ENSG00000118308 "Lymphoid restricted membrane protein" Q12912 12 25004342-25108334 "Predicted intracellular proteins, Predicted membrane proteins" "Fertilization, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.8;lymphoid tissue: 69.5" "Cell type enhanced" "Detected in many" 9 "B-cells: 52.5;granulocytes: 24.4;Kupffer cells: 29.4;T-cells: 40.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 51.8" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Daudi: 96.3;REH: 33.5;U-698: 110.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA002967, HPA018505" Enhanced Uncertain Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA002967: AB_1079161, HPA018505: AB_1851988" "unprognostic (3.78e-2)" "unprognostic (2.59e-3)" "unprognostic (7.54e-2)" "unprognostic (7.08e-3)" "unprognostic (2.36e-1)" "unprognostic (1.48e-3)" "unprognostic (7.98e-2)" "unprognostic (4.08e-2)" "unprognostic (7.32e-2)" "unprognostic (1.15e-1)" "unprognostic (3.59e-2)" "unprognostic (7.97e-2)" "unprognostic (7.25e-3)" "unprognostic (7.72e-2)" "unprognostic (9.25e-2)" "unprognostic (1.31e-1)" "unprognostic (7.59e-2)" 5.5 1.4 15.1 51.7 2.9 19.2 4.6 0.4 5.6 1.9 3.6 2.1 0.9 3.2 1.4 1.8 3.9 2.3 3.0 1.7 8.1 1.8 5.5 2.3 5.6 57.8 3.5 4.7 2.3 15.1 0.4 2.1 1.7 7.4 2.8 3.5 1.3 4.1 2.1 0.8 2.7 13.2 1.8 5.3 27.6 3.6 0.7 2.8 67.0 3.6 1.7 69.5 10.4 5.7 17.4 5.7 51.8 12.2 12.0 7.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.3 0.0 5.7 0.0 0.0 0.0 7.4 8.5 0.0 0.0 0.1 0.0 0.0 0.0 4.9 1.1 6.4 0.0 0.0 8.1 13.7 0.0 0.0 0.0 33.5 0.0 9.5 0.1 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.2 0.0 0.0 6.3 1.1 110.1 0.0 3.3 0.0 17.0 5.4 51.8 6.5 10.5 5.4 17.4 4.1 6.6 5.7 13.3 7.1 6.9 39.3 12.0 12.2 5.4 0.7 4.7 15.1 2.9 0.4 5.6 8.1 1.8 3.5 4.7 7.4 2.8 0.0 7.4 52.5 2.5 0.8 0.2 0.4 0.0 9.4 15.9 0.0 0.0 0.1 0.0 0.2 1.5 2.1 0.0 0.0 7.5 0.1 0.5 0.2 24.4 1.0 11.5 0.0 8.5 4.9 29.4 0.4 0.9 20.0 5.0 1.8 0.0 0.0 1.6 3.5 4.6 13.0 0.2 0.0 0.2 0.2 0.0 4.8 0.1 40.3 0.2 14.4 LRP1 "A2MR, APOER, APR, CD91, IGFBP-3R, IGFBP3R1, LRP, LRP1A" ENSG00000123384 "LDL receptor related protein 1" Q07954 12 57128493-57213351 "Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis "Developmental protein, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 153.3;Leydig cells: 216.0;Peritubular cells: 173.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 18 "classical monocyte: 7.6;intermediate monocyte: 4.0;myeloid DC: 2.8;non-classical monocyte: 3.7" "Group enriched" "Detected in many" 20 "dendritic cells: 2.8;monocytes: 7.6" "Cell line enhanced" "Detected in many" "ASC diff: 83.1;ASC TERT1: 84.4;fHDF/TERT166: 36.2;HSkMC: 54.7;hTERT-RPE1: 42.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004182, CAB018621, HPA022903" Supported Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 88000000 Vesicles Nucleoplasm "CAB018621: AB_627893, HPA004182: AB_2667163, HPA022903: AB_10602426" "unprognostic (1.65e-1)" "unprognostic (1.61e-1)" "unprognostic (1.76e-1)" "unprognostic (2.71e-1)" "unprognostic (5.00e-2)" "unprognostic (4.33e-2)" "unprognostic (3.98e-1)" "unprognostic (8.68e-2)" "unprognostic (1.70e-1)" "unprognostic (3.37e-3)" "unprognostic (1.48e-1)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.52e-5)" "unprognostic (2.81e-3)" "unprognostic (6.13e-2)" "unprognostic (2.80e-2)" "prognostic unfavorable (1.29e-5)" 77.8 12.0 19.8 21.5 21.3 6.1 27.7 28.1 25.3 31.4 19.7 11.9 9.0 17.8 26.9 18.2 19.2 21.0 24.1 26.0 18.6 10.4 6.3 31.4 24.7 5.5 13.9 15.6 56.9 8.8 8.5 8.0 29.4 17.1 21.4 9.5 20.0 14.8 17.0 11.3 15.7 14.2 22.4 14.3 11.3 11.8 11.1 15.4 0.3 13.2 9.3 3.1 22.9 39.4 0.0 2.8 0.1 7.6 0.0 0.2 1.9 1.2 2.3 5.1 4.0 83.1 84.4 15.3 14.0 18.1 4.6 4.5 4.3 2.0 0.0 1.7 36.2 1.0 5.5 0.8 1.4 1.6 0.1 0.2 0.0 2.7 9.0 11.4 0.0 2.4 54.7 0.5 10.3 1.2 42.1 0.2 0.1 0.0 0.2 14.4 0.2 0.0 0.0 5.8 1.7 1.4 0.5 28.8 0.2 0.3 0.3 0.2 2.8 3.1 0.1 2.2 7.4 0.4 0.2 0.2 16.2 6.0 9.0 0.8 0.1 0.0 0.0 28.4 0.0 3.1 0.0 7.6 0.0 0.0 4.0 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.2 0.1 0.0 3.7 0.0 0.0 1.9 19.8 21.3 28.1 19.7 18.6 10.4 13.9 15.6 17.1 15.4 11.9 9.6 3.7 11.4 21.3 25.5 12.1 20.4 5.3 11.4 1.8 0.0 65.3 0.0 7.8 1.6 5.8 72.1 0.0 1.6 42.2 117.6 4.4 5.8 153.3 72.0 7.9 4.1 16.0 118.9 3.6 216.0 50.7 27.0 3.6 14.3 130.1 9.9 18.6 173.2 2.2 3.8 38.8 44.2 1.4 2.2 14.1 105.3 0.9 20.9 10.2 LRP10 "DKFZP564C1940, LRP9, MGC8675, MST087, MSTP087" ENSG00000197324 "LDL receptor related protein 10" Q7Z4F1 14 22871613-22881580 "Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 29.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 29.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000932 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA000932: AB_2281523" "unprognostic (1.08e-1)" "unprognostic (1.52e-2)" "unprognostic (3.72e-2)" "unprognostic (4.59e-2)" "unprognostic (1.72e-1)" "unprognostic (5.01e-2)" "prognostic unfavorable (3.54e-7)" "prognostic unfavorable (9.17e-4)" "unprognostic (8.32e-2)" "unprognostic (1.48e-2)" "unprognostic (1.97e-2)" "unprognostic (4.55e-2)" "prognostic favorable (6.31e-5)" "unprognostic (3.06e-2)" "unprognostic (8.81e-2)" "unprognostic (2.27e-1)" "unprognostic (4.14e-2)" 33.1 20.1 12.7 26.0 13.1 23.7 37.2 5.8 10.3 32.0 52.4 16.2 41.0 31.7 39.0 46.8 66.1 27.1 65.1 27.7 13.6 6.0 46.5 63.3 34.1 30.0 14.2 8.1 30.7 36.6 31.4 11.7 32.0 14.4 36.9 19.0 22.6 36.1 41.1 21.2 32.9 65.9 32.0 11.2 26.1 37.9 19.1 12.9 20.7 46.9 34.1 36.2 43.3 42.8 3.8 2.3 29.7 2.6 2.4 6.3 3.4 15.4 18.9 4.1 10.8 56.7 32.9 14.1 24.5 46.6 15.5 21.5 5.8 55.1 8.1 12.3 55.1 17.7 22.2 2.7 28.0 6.1 13.2 2.9 2.8 10.4 4.0 25.3 6.4 25.9 35.9 32.8 23.1 12.0 43.0 28.2 3.7 3.4 31.4 20.8 17.8 1.8 1.9 0.9 15.0 25.5 4.1 4.2 8.1 16.6 27.6 0.3 4.5 13.5 26.0 10.6 3.2 13.6 4.6 29.3 23.9 6.8 12.3 10.0 14.7 8.7 3.7 12.3 2.6 10.2 5.9 2.2 15.8 5.1 2.3 5.0 3.8 6.3 6.0 2.3 2.7 5.5 3.1 29.7 2.4 2.6 1.9 6.0 3.4 12.7 13.1 5.8 10.3 13.6 6.0 14.2 8.1 14.4 12.9 98.3 51.7 60.9 74.0 34.2 2.2 27.2 107.0 37.5 59.1 78.5 0.0 55.7 8.3 146.7 9.9 50.6 243.0 46.7 208.6 82.1 65.3 100.3 34.6 35.4 52.6 0.0 63.9 69.3 49.2 11.4 52.6 36.1 52.3 101.0 99.6 89.2 227.5 199.9 68.6 40.8 8.3 64.7 65.9 2.6 6.7 41.5 110.6 62.3 73.3 132.4 LRP4 "CLSS, LRP-4, MEGF7, SOST2" ENSG00000134569 "LDL receptor related protein 4" O75096 11 46856868-46918642 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Endocytosis, Wnt signaling pathway" "Developmental protein, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7;skin 1: 33.0" "Cell type enriched" "Detected in many" 4 "Cone photoreceptor cells: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 17.0;SuSa: 13.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011934, HPA012300" Approved Uncertain Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoplasm, Nucleoli, Mitochondria" "HPA011934: AB_1853286, HPA012300: AB_1853288" "unprognostic (1.46e-1)" "unprognostic (4.07e-2)" "unprognostic (2.86e-1)" "unprognostic (1.33e-2)" "unprognostic (4.39e-2)" "unprognostic (9.73e-3)" "unprognostic (5.29e-4)" "unprognostic (8.61e-2)" "unprognostic (2.29e-2)" "unprognostic (2.77e-1)" "unprognostic (1.92e-1)" "unprognostic (1.33e-1)" "unprognostic (7.59e-2)" "unprognostic (7.95e-2)" "unprognostic (2.76e-2)" "unprognostic (9.90e-3)" "unprognostic (6.79e-2)" 1.2 1.9 16.0 1.3 20.3 0.5 2.1 7.3 23.7 3.0 5.4 11.6 0.6 3.9 2.1 1.3 2.4 2.0 2.5 7.2 20.4 5.8 1.2 0.7 3.4 0.5 9.6 12.6 5.4 2.7 9.3 3.3 3.1 14.5 2.7 4.1 1.3 2.1 3.0 4.4 33.0 5.3 2.0 9.7 4.2 9.6 1.6 19.0 0.0 2.9 1.0 0.8 1.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.5 17.0 5.2 10.6 2.9 3.9 0.7 1.5 2.3 2.5 2.2 0.0 0.0 1.1 8.7 2.4 3.0 9.5 5.8 1.8 0.0 7.9 0.8 3.0 5.2 2.2 0.1 1.5 3.6 3.4 3.5 0.9 2.0 1.9 2.1 0.7 0.0 1.3 0.6 0.1 0.2 9.2 0.0 0.7 1.2 5.8 0.0 0.2 2.2 0.0 11.2 0.9 0.0 2.8 13.6 0.2 0.4 0.1 4.6 2.9 5.2 1.6 0.0 0.0 0.3 3.4 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 20.3 7.3 17.3 20.4 5.8 9.6 12.6 14.5 19.0 0.0 3.4 0.0 2.5 7.2 0.4 4.8 0.0 0.0 2.3 1.8 39.3 1.8 1.7 0.0 0.4 0.7 6.3 0.0 0.3 0.4 4.3 0.3 4.7 0.0 0.2 0.0 0.0 1.3 0.0 0.0 1.7 0.0 1.7 1.0 2.2 8.7 0.5 2.3 1.1 0.2 2.6 0.0 1.2 0.1 0.7 9.5 1.1 0.0 1.8 0.7 LRP5L DKFZp434O0213 ENSG00000100068 "LDL receptor related protein 5 like" A4QPB2 22 25351418-25405377 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Sertoli cells: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 6.3;NK-cell: 10.7" "Group enriched" "Detected in many" 7 "granulocytes: 6.3;NK-cells: 10.7" "Low cell line specificity" "Detected in many" HPA028717 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA028717: AB_10601767" "unprognostic (5.90e-2)" "unprognostic (2.54e-1)" "unprognostic (1.04e-1)" "unprognostic (1.34e-3)" "unprognostic (2.22e-1)" "unprognostic (5.98e-2)" "unprognostic (1.13e-1)" "unprognostic (5.98e-3)" "unprognostic (5.11e-1)" "unprognostic (9.64e-2)" "unprognostic (9.78e-2)" "unprognostic (4.38e-2)" "unprognostic (8.51e-2)" "unprognostic (1.15e-1)" "unprognostic (1.59e-1)" "unprognostic (3.44e-1)" "prognostic favorable (6.93e-6)" 6.0 4.7 4.8 8.0 3.8 17.6 18.5 1.5 6.2 10.0 7.0 4.1 11.4 4.1 8.2 8.1 3.9 6.3 8.0 5.3 3.9 2.0 9.1 17.4 5.9 8.5 8.1 1.7 7.7 8.0 6.3 3.8 2.1 4.1 8.9 4.7 6.5 11.0 12.2 2.7 6.1 5.7 7.7 3.4 8.4 4.8 5.0 3.6 3.7 15.5 4.3 6.7 6.3 7.5 1.1 0.2 6.3 0.5 10.7 1.0 0.3 2.0 3.1 1.2 6.2 2.3 1.0 2.2 1.8 2.8 2.4 2.6 2.9 1.0 0.8 2.4 2.0 1.9 4.0 2.2 3.1 1.5 2.9 7.0 4.0 5.1 7.3 2.8 7.7 8.2 4.1 3.0 2.7 11.5 3.9 1.0 3.6 2.5 2.5 1.6 6.9 1.4 7.2 2.8 6.5 4.5 6.9 2.7 3.0 2.8 4.8 4.0 4.7 1.4 2.2 2.2 1.3 2.6 2.8 1.8 2.7 11.7 1.8 3.0 6.4 1.3 1.7 1.6 4.7 1.4 6.3 0.5 2.1 1.0 0.4 0.9 0.2 0.3 0.3 0.1 1.1 0.1 0.3 0.2 10.7 0.2 0.2 0.0 0.3 4.8 3.8 1.5 6.2 3.9 2.0 8.1 1.7 4.1 3.6 0.0 2.7 0.9 3.4 6.0 1.7 1.4 2.5 2.7 6.8 1.8 0.0 0.4 0.0 2.5 0.5 2.9 2.6 0.0 1.0 0.4 1.1 3.7 0.0 4.4 2.2 9.5 3.5 2.5 4.3 0.0 3.7 4.0 1.7 1.8 5.2 1.5 2.6 5.8 1.8 0.3 1.5 12.9 5.2 0.9 3.4 3.4 0.2 4.4 4.3 2.8 LRR1 "LRR-1, MGC20689, PPIL5" ENSG00000165501 "Leucine rich repeat protein 1" Q96L50 14 49598697-49614672 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 43.9" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 77.7;Erythroid cells: 70.0;Spermatocytes: 63.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA065703, HPA069364" Approved Approved "Nucleoplasm,Nuclear membrane,Vesicles" No No "Nucleoplasm, Nuclear membrane" Vesicles "HPA065703: AB_2685537, HPA069364: AB_2686129" "unprognostic (2.73e-2)" "unprognostic (1.21e-2)" "unprognostic (3.17e-2)" "unprognostic (2.26e-2)" "unprognostic (2.85e-2)" "unprognostic (9.34e-2)" "prognostic unfavorable (2.97e-4)" "unprognostic (7.34e-2)" "unprognostic (2.50e-2)" "unprognostic (8.30e-2)" "unprognostic (4.64e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (4.90e-7)" "unprognostic (6.86e-2)" "unprognostic (1.21e-1)" "unprognostic (1.86e-1)" "unprognostic (4.04e-2)" 5.7 6.0 1.7 7.8 2.5 14.2 5.0 2.4 2.8 3.2 8.5 2.5 2.6 7.8 4.2 2.8 7.2 3.7 4.6 6.9 1.5 1.1 4.3 5.6 4.5 9.6 2.5 1.6 3.1 6.5 1.3 1.6 4.8 2.3 3.3 6.2 4.3 6.0 5.5 7.5 4.8 7.9 3.5 3.3 8.1 4.9 43.9 2.0 28.0 3.8 7.7 9.2 4.7 4.6 12.5 14.6 20.3 18.8 7.3 12.7 8.5 22.3 16.0 12.8 12.7 2.9 2.1 14.8 12.1 11.1 27.6 24.9 14.3 18.8 20.3 8.4 7.2 8.0 14.6 15.3 11.0 19.4 20.7 12.1 9.8 11.6 9.1 2.3 23.2 12.9 2.2 3.8 12.3 5.6 1.9 13.0 17.5 9.9 13.7 13.6 20.1 27.0 19.4 7.7 10.7 20.9 19.1 21.6 14.6 9.3 9.2 12.8 7.2 11.6 13.9 8.3 3.4 17.9 15.1 5.0 19.1 31.7 8.4 14.9 7.5 10.7 22.2 9.8 16.3 14.3 16.9 12.3 20.3 9.3 18.8 11.8 12.5 11.9 12.6 12.7 9.2 9.5 10.7 6.6 7.3 13.1 14.6 12.7 8.5 1.7 2.5 2.4 2.8 1.5 1.1 2.5 1.6 2.3 2.0 3.0 6.2 3.0 4.9 13.9 3.6 2.8 10.2 2.7 7.9 3.5 2.0 8.3 1.7 11.3 77.7 8.4 10.5 70.0 19.7 27.5 7.5 7.5 13.9 5.6 18.9 1.6 4.6 6.2 11.1 26.3 6.9 12.4 10.1 14.4 8.4 4.5 10.8 0.0 3.2 6.2 5.0 6.5 7.1 63.9 10.0 13.0 6.4 6.4 12.4 5.9 LRRC10B ENSG00000204950 "Leucine rich repeat containing 10B" A6NIK2 11 61508800-61511018 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in many" 7 "brain: 27.8;fallopian tube: 36.2;pituitary gland: 14.8" "Cell type enhanced" "Detected in some" 13 "Ciliated cells: 20.1;Muller glia cells: 7.8;Sertoli cells: 19.4;Smooth muscle cells: 11.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 27.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 12.2;RH-30: 13.2;SCLC-21H: 6.8" "Region enriched" "Detected in many" 7 "basal ganglia: 202.0" "Group enriched" "Detected in many" 5 "basal ganglia: 39.3;hippocampal formation: 35.0" HPA047619 Uncertain Approved Nucleoplasm,Nucleoli No NA Nucleoplasm Nucleoli "HPA047619: AB_2680106" "unprognostic (9.95e-2)" "unprognostic (2.67e-2)" "unprognostic (4.92e-2)" "unprognostic (1.26e-2)" "unprognostic (2.11e-1)" "unprognostic (1.32e-1)" "unprognostic (6.10e-2)" "unprognostic (9.22e-2)" "unprognostic (4.88e-3)" "unprognostic (1.62e-1)" "unprognostic (9.21e-3)" "unprognostic (2.52e-2)" "unprognostic (5.27e-4)" "unprognostic (5.07e-2)" "unprognostic (1.43e-1)" "unprognostic (2.38e-1)" "unprognostic (6.63e-2)" 2.4 1.6 4.8 0.9 27.8 0.5 1.9 0.2 5.8 3.4 1.6 1.2 1.0 0.9 2.2 3.7 1.1 36.2 0.8 1.2 5.2 1.9 0.9 0.6 3.7 0.5 1.1 4.3 3.0 1.5 2.1 14.8 1.2 1.2 0.9 1.0 0.0 1.1 1.2 0.7 0.5 0.9 2.5 0.2 0.6 1.0 2.4 8.3 0.9 0.8 0.2 0.5 0.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.9 0.0 0.3 0.0 0.0 0.0 13.2 0.0 0.0 0.0 6.8 0.6 0.3 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 27.8 0.2 5.8 5.2 1.9 1.1 4.3 1.2 8.3 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 20.1 4.5 1.8 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 7.8 0.1 0.0 0.0 0.0 0.0 19.4 11.8 0.5 0.9 0.3 0.1 0.0 0.0 0.0 LRRC14 "KIAA0014, LRRC14A" ENSG00000160959 "Leucine rich repeat containing 14" Q15048 8 144517992-144525178 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021047 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021047: AB_1853298" "unprognostic (7.57e-2)" "unprognostic (1.50e-1)" "unprognostic (1.20e-1)" "unprognostic (7.05e-3)" "unprognostic (1.83e-1)" "unprognostic (7.58e-2)" "unprognostic (6.39e-3)" "unprognostic (1.93e-1)" "unprognostic (3.96e-2)" "unprognostic (2.28e-1)" "prognostic favorable (1.78e-4)" "unprognostic (3.31e-1)" "unprognostic (1.52e-1)" "unprognostic (7.25e-2)" "unprognostic (1.77e-1)" "unprognostic (6.93e-2)" "unprognostic (1.04e-3)" 9.4 10.3 11.9 15.0 11.9 9.5 26.5 14.3 22.3 10.4 10.5 15.1 5.0 11.0 13.7 8.9 11.5 10.6 11.3 9.7 12.4 8.2 9.4 8.9 10.0 12.2 15.3 16.0 11.2 17.5 16.9 13.5 8.4 12.7 15.6 7.9 9.4 16.8 12.9 9.8 17.6 10.6 12.7 9.2 11.9 11.0 9.6 12.1 9.7 13.8 6.2 9.8 11.9 9.4 10.6 9.8 4.7 8.6 13.1 10.3 8.7 9.6 19.9 5.4 8.7 5.8 4.7 7.7 8.7 3.8 7.0 6.0 8.8 11.8 7.9 9.2 6.4 4.3 10.6 8.4 8.6 3.2 10.5 19.4 11.7 21.2 3.6 5.4 5.0 9.7 5.7 7.4 7.0 3.5 5.8 6.0 9.1 15.4 9.5 6.8 11.9 18.3 6.5 4.4 8.5 28.8 15.7 4.5 11.1 4.2 8.5 14.7 8.2 13.3 10.7 6.2 3.3 16.4 5.5 6.4 12.0 21.3 10.6 12.7 5.3 3.1 9.8 11.3 11.6 7.3 1.9 8.6 1.8 10.3 8.1 10.2 9.0 7.7 9.6 8.4 10.6 8.6 7.0 4.7 13.1 6.7 9.8 7.2 8.7 11.9 11.9 14.3 22.3 12.4 8.2 15.3 16.0 12.7 12.1 6.0 1.9 12.4 4.6 5.7 11.7 3.5 12.7 5.3 5.7 8.7 2.0 5.7 5.0 4.8 1.1 4.5 7.9 0.0 7.0 5.8 3.9 6.7 6.9 9.0 6.6 11.1 5.2 10.4 5.2 2.4 6.9 3.7 1.7 7.2 6.6 8.9 5.7 3.5 7.4 6.0 7.6 6.5 5.2 27.9 24.3 5.1 4.6 6.9 11.4 3.5 LRRC14B ENSG00000185028 "Leucine rich repeat containing 14B" A6NHZ5 5 191511-195353 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 30.6;skeletal muscle: 45.2;tongue: 14.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "renal cancer: 1.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 19 "plasmacytoid DC: 4.8" "Lineage enriched" "Detected in single" 19 "dendritic cells: 4.8" "Cell line enriched" "Detected in some" 4 "U-266/84: 29.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA038046, HPA038047" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA038046: AB_10672504, HPA038047: AB_2675806" "unprognostic (7.63e-4)" "unprognostic (4.25e-3)" "unprognostic (8.50e-3)" "unprognostic (7.63e-4)" "unprognostic (4.95e-2)" "unprognostic (3.79e-2)" "unprognostic (6.07e-3)" "unprognostic (9.68e-2)" "unprognostic (6.43e-2)" "unprognostic (6.43e-3)" "unprognostic (2.78e-2)" "unprognostic (6.19e-2)" "unprognostic (3.60e-3)" "unprognostic (2.19e-1)" 0.1 0.0 0.0 0.2 0.5 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.4 0.0 0.0 30.6 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.9 0.4 0.0 45.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.2 14.3 0.7 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 3.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 7.1 29.2 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.5 0.2 0.2 0.0 0.3 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC2 ENSG00000163827 "Leucine rich repeat containing 2" Q9BYS8 3 46515423-46580099 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 53.9;skeletal muscle: 70.3;tongue: 20.0" "Cell type enriched" "Detected in many" 17 "Cardiomyocytes: 175.7" "Cancer enhanced" "Detected in some" "thyroid cancer: 5.6" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 10.8;HEL: 6.2;LHCN-M2: 6.2;TIME: 4.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA039138, HPA064844" Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA039138: AB_10795461, HPA064844: " "unprognostic (1.32e-4)" "unprognostic (3.44e-3)" "unprognostic (2.29e-2)" "unprognostic (3.38e-2)" "unprognostic (4.17e-2)" "unprognostic (1.44e-1)" "unprognostic (7.38e-3)" "unprognostic (1.61e-1)" "unprognostic (7.42e-2)" "unprognostic (1.45e-1)" "unprognostic (3.72e-3)" "unprognostic (2.17e-1)" "unprognostic (2.23e-2)" "unprognostic (1.09e-1)" "unprognostic (2.53e-1)" "unprognostic (1.96e-2)" "unprognostic (1.24e-1)" 1.8 0.5 1.9 0.4 1.4 0.4 1.0 1.4 3.0 2.6 1.1 0.2 0.0 0.4 3.9 1.4 1.1 1.1 1.4 53.9 1.3 0.4 2.2 2.5 0.6 0.3 0.5 2.3 2.8 0.7 0.1 2.2 0.5 1.0 1.2 0.8 0.4 1.4 0.2 70.3 1.2 0.6 2.3 0.4 1.3 1.0 0.4 0.0 1.4 10.1 20.0 1.2 1.7 1.8 1.2 0.8 2.6 0.7 1.1 2.5 0.3 0.2 0.1 0.2 0.3 1.0 2.3 0.1 0.8 1.5 0.6 0.8 0.0 0.2 0.3 0.2 10.8 0.1 0.2 3.8 0.0 1.4 0.5 0.1 6.2 0.4 0.2 0.3 0.2 0.1 0.2 0.1 4.3 0.0 3.6 0.2 0.8 0.1 0.4 6.2 0.1 0.8 0.1 1.5 0.5 0.2 0.1 0.1 0.3 0.1 0.3 0.5 1.2 0.8 0.2 1.6 1.3 0.2 0.8 4.9 0.3 0.6 2.5 1.6 0.4 0.3 2.9 0.2 0.1 1.4 2.2 0.7 0.6 0.6 0.4 0.4 0.7 1.6 0.3 0.2 1.2 0.8 0.6 2.6 1.1 0.5 0.8 2.5 0.3 1.9 1.4 1.4 3.0 1.3 0.4 0.5 2.3 1.0 0.0 8.9 0.6 0.0 0.8 1.6 0.0 175.7 2.5 1.4 0.0 1.8 0.0 0.1 8.3 0.2 2.0 1.5 0.0 0.0 0.8 0.0 4.3 0.4 10.3 8.9 1.5 0.0 2.9 5.5 0.0 1.7 0.6 1.1 10.1 0.0 1.5 0.3 1.5 0.0 0.0 0.5 0.1 0.0 3.9 0.6 0.2 2.0 0.1 0.7 1.7 0.4 LRRC20 "FLJ10751, FLJ10844" ENSG00000172731 "Leucine rich repeat containing 20" Q8TCA0 10 70298970-70382650 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "skeletal muscle: 111.8" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 28.5;Early spermatids: 20.2;Hepatocytes: 14.5;Late spermatids: 32.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-2 OS: 34.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039630 Approved Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA039630: AB_10795467" "unprognostic (3.14e-1)" "unprognostic (1.78e-1)" "unprognostic (3.01e-1)" "unprognostic (1.60e-1)" "unprognostic (7.17e-2)" "unprognostic (1.94e-2)" "unprognostic (1.31e-1)" "unprognostic (1.38e-2)" "unprognostic (3.18e-1)" "unprognostic (2.16e-1)" "unprognostic (9.43e-2)" "unprognostic (1.30e-1)" "prognostic favorable (1.41e-4)" "unprognostic (1.50e-3)" "unprognostic (1.60e-1)" "unprognostic (1.32e-1)" "unprognostic (1.30e-1)" 1.3 2.5 5.6 1.4 7.2 1.6 1.4 5.2 11.2 3.3 3.2 2.5 0.0 1.4 2.7 3.1 7.1 2.4 2.1 15.8 5.0 3.9 1.2 8.3 2.2 1.7 3.7 6.3 2.2 1.3 2.1 3.6 1.1 4.9 2.6 2.0 1.8 1.8 2.4 111.8 1.6 1.4 3.5 2.0 1.4 1.6 3.5 1.9 1.6 2.6 14.3 3.1 2.2 4.8 0.9 2.6 0.0 1.0 1.1 4.1 1.1 14.6 11.3 7.3 15.6 4.1 3.3 0.0 1.9 6.6 5.0 4.7 9.6 15.3 2.9 7.8 1.4 15.6 5.3 7.1 10.6 3.5 8.2 2.3 1.7 2.5 22.0 4.5 4.2 1.4 1.3 3.2 6.9 2.3 4.9 9.7 19.4 2.1 4.7 4.6 2.3 16.0 3.5 2.4 11.0 25.7 13.4 4.2 8.3 6.5 1.5 18.5 8.0 1.2 1.3 5.1 1.9 1.9 4.3 5.9 4.0 34.6 5.3 4.5 7.6 13.4 4.8 6.5 17.4 0.8 0.0 0.9 0.0 1.7 1.0 1.4 0.9 1.3 1.9 2.6 0.0 4.1 1.5 0.0 1.1 0.7 0.4 0.2 1.1 5.6 7.2 5.2 11.2 5.0 3.9 3.7 6.3 4.9 1.9 0.0 5.8 0.0 0.5 1.3 8.0 28.5 2.5 0.0 1.2 0.0 3.9 0.1 0.0 3.5 20.2 2.7 0.4 0.0 4.2 0.1 2.0 0.7 0.0 14.5 0.4 1.6 5.2 1.3 0.3 32.8 2.8 0.0 1.7 1.0 1.3 7.8 4.1 1.7 1.4 1.4 1.7 0.0 1.7 4.3 4.5 0.5 0.0 0.8 1.9 0.6 LRRC27 KIAA1674 ENSG00000148814 "Leucine rich repeat containing 27" Q9C0I9 10 132332154-132379918 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in all" 5 "testis: 52.9" "Group enriched" "Detected in many" 8 "Early spermatids: 394.8;Late spermatids: 739.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 14.5;hTERT-RPE1: 18.9" "Low region specificity" "Detected in all" "HPA037595, HPA067395" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA037595: , HPA067395: AB_2732766" "unprognostic (1.97e-1)" "unprognostic (5.76e-4)" "unprognostic (1.48e-3)" "unprognostic (1.94e-3)" "unprognostic (6.76e-2)" "unprognostic (6.61e-3)" "unprognostic (1.41e-1)" "unprognostic (1.04e-2)" "unprognostic (8.26e-2)" "unprognostic (1.75e-2)" "unprognostic (5.94e-3)" "unprognostic (1.47e-1)" "unprognostic (2.18e-1)" "unprognostic (5.74e-2)" "unprognostic (1.72e-1)" "unprognostic (4.49e-2)" "unprognostic (9.27e-4)" 2.1 2.8 8.1 1.5 8.4 1.0 4.1 2.2 8.9 3.6 2.1 6.1 7.5 2.0 3.8 5.6 1.6 10.5 3.5 2.2 6.6 5.4 4.4 2.4 3.1 1.9 4.3 7.3 5.4 3.1 7.5 5.8 2.1 6.5 4.1 2.1 4.8 3.1 4.0 1.2 2.1 2.6 3.4 3.5 3.3 3.0 52.9 4.5 0.7 5.1 1.0 1.2 2.5 1.8 4.7 7.8 4.4 6.8 3.1 2.8 2.7 2.5 4.7 10.3 14.5 9.1 9.3 1.0 2.5 8.1 4.2 3.8 0.8 5.2 1.4 1.5 5.8 3.2 1.8 2.3 1.2 2.6 2.9 2.0 0.3 3.3 2.4 6.5 1.1 1.7 4.0 8.0 4.2 5.7 18.9 3.0 3.6 0.8 1.0 3.2 4.3 2.2 3.2 2.9 1.8 1.6 1.9 1.7 0.8 7.5 0.6 1.8 5.2 1.2 0.8 3.3 2.2 2.3 2.6 3.9 1.7 2.1 3.8 1.5 0.7 0.3 0.8 7.7 2.2 1.0 4.4 6.8 1.1 1.7 5.7 1.3 3.4 1.1 1.0 7.3 4.7 2.8 1.6 0.5 3.1 3.6 7.8 0.7 2.7 8.1 8.4 2.2 8.9 6.6 5.4 4.3 7.3 6.5 4.5 8.9 10.9 1.3 2.4 2.5 7.8 4.4 7.6 48.2 7.9 3.5 9.8 3.1 16.6 5.9 394.8 4.5 1.7 0.0 4.6 1.0 5.2 2.9 8.1 2.1 6.6 7.9 5.2 14.7 8.0 739.5 4.4 7.1 6.8 7.2 1.9 8.9 3.3 0.0 11.0 11.9 17.7 6.5 2.3 75.2 20.4 2.8 1.1 4.9 3.3 1.4 LRRC28 "FLJ34269, FLJ45242, MGC24976" ENSG00000168904 "Leucine rich repeat containing 28" Q86X40 15 99251362-99390729 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 131.5;Late spermatids: 330.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039378, HPA040784, HPA066130" Approved Approved "Nucleoplasm,Golgi apparatus,Mitochondria" No No Nucleoplasm "Golgi apparatus, Mitochondria" "HPA039378: AB_2676476, HPA040784: AB_2677135, HPA066130: AB_2685623" "unprognostic (4.84e-2)" "prognostic favorable (1.41e-4)" "unprognostic (2.82e-3)" "unprognostic (9.86e-2)" "unprognostic (2.20e-1)" "unprognostic (1.47e-1)" "unprognostic (8.02e-2)" "unprognostic (1.02e-1)" "unprognostic (1.22e-1)" "prognostic favorable (9.97e-5)" "unprognostic (2.62e-1)" "unprognostic (1.21e-1)" "unprognostic (5.89e-2)" "unprognostic (8.37e-2)" "unprognostic (3.95e-1)" "unprognostic (1.65e-3)" "unprognostic (1.41e-1)" 9.1 9.5 7.5 5.3 12.7 7.4 7.3 12.7 15.4 7.7 10.4 8.1 6.1 15.8 6.9 7.6 9.9 5.0 8.8 10.8 7.5 6.5 17.7 42.3 6.2 6.3 6.9 8.4 5.8 18.1 9.1 10.8 5.9 9.8 6.3 9.5 9.3 8.6 6.9 18.0 12.1 18.2 7.8 6.7 6.3 9.1 24.1 5.2 17.7 7.4 8.2 8.6 7.9 7.3 4.8 6.0 21.8 6.9 3.4 7.0 4.2 2.9 7.1 7.1 9.1 10.2 14.4 3.0 3.1 8.7 5.3 6.3 5.5 6.3 5.9 5.7 7.3 6.6 6.5 5.1 9.8 7.8 3.6 7.5 4.0 3.3 5.5 9.0 3.9 6.5 8.5 13.6 5.0 10.0 12.0 16.7 9.5 3.5 5.9 11.0 5.6 10.6 6.5 2.9 22.4 2.5 6.5 6.0 5.3 11.3 9.3 3.2 4.1 7.3 4.0 11.4 11.2 6.2 7.4 6.0 5.2 3.6 4.0 6.0 12.1 16.7 3.6 6.7 3.8 9.7 15.6 6.9 21.8 5.5 5.5 4.3 4.8 5.2 5.7 6.0 4.1 4.8 4.1 3.6 3.4 5.3 5.0 7.0 4.2 7.5 12.7 12.7 15.4 7.5 6.5 6.9 8.4 9.8 5.2 14.9 2.6 9.7 11.4 12.2 20.0 13.3 10.2 10.7 6.8 10.4 21.6 15.0 23.2 11.2 131.5 10.5 25.7 23.3 25.7 18.2 9.3 9.5 2.3 32.1 16.9 20.6 8.7 11.1 19.8 330.3 11.8 8.6 13.5 17.2 15.4 14.3 13.6 20.1 8.1 54.9 19.0 0.0 12.0 42.3 35.8 13.8 10.9 15.0 13.6 11.9 LRRC29 "FBL9, FBXL9" ENSG00000125122 "Leucine rich repeat containing 29" Q8WV35 16 67207139-67227048 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034998 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA034998: AB_10601938" "unprognostic (5.16e-3)" "unprognostic (1.55e-1)" "unprognostic (2.55e-3)" "prognostic favorable (4.33e-4)" "unprognostic (1.80e-1)" "unprognostic (2.49e-1)" "unprognostic (2.10e-1)" "unprognostic (5.29e-2)" "unprognostic (1.92e-1)" "unprognostic (2.45e-1)" "prognostic favorable (5.20e-4)" "unprognostic (1.88e-1)" "unprognostic (4.32e-3)" "unprognostic (3.44e-3)" "unprognostic (4.92e-2)" "unprognostic (1.00e-1)" "unprognostic (1.21e-1)" 2.4 4.9 8.2 1.6 10.3 2.7 3.0 7.4 8.2 2.0 1.7 7.1 3.6 3.1 2.4 2.7 1.5 4.5 3.8 2.4 8.3 4.2 5.6 3.8 3.7 2.7 7.0 6.0 3.1 5.1 4.2 8.1 2.7 5.0 5.4 1.4 3.9 6.6 4.1 4.0 5.0 3.8 3.2 5.0 2.5 2.9 4.3 5.9 2.6 6.3 0.6 1.8 2.1 1.6 1.4 2.3 3.6 2.9 3.9 4.5 2.3 1.0 3.0 0.9 0.4 1.8 1.3 0.2 0.8 1.7 1.6 1.8 0.4 0.6 0.8 2.4 2.2 0.8 0.2 0.4 2.0 0.6 1.0 0.8 0.7 0.2 1.6 2.0 0.1 2.7 1.7 2.1 2.4 1.4 1.2 1.0 0.5 0.6 0.4 3.2 0.1 0.3 1.6 0.4 0.0 1.1 1.4 0.8 2.2 2.0 0.1 1.1 1.4 1.1 1.1 1.8 0.4 3.0 1.3 0.4 3.1 0.9 0.6 0.2 4.4 0.9 1.3 2.2 0.8 0.9 0.0 2.6 3.6 0.9 2.9 1.0 0.8 2.5 3.6 2.3 1.4 4.5 1.9 3.4 3.9 2.7 1.6 0.5 2.3 8.2 10.3 7.4 8.2 8.3 4.2 7.0 6.0 5.0 5.9 0.0 1.3 0.8 2.7 0.5 2.9 1.0 5.1 1.4 0.0 8.7 3.9 3.1 3.3 2.0 4.0 2.4 2.4 0.0 0.8 0.9 3.1 2.8 1.1 0.8 3.4 6.4 2.9 0.0 3.1 6.7 0.9 2.2 3.3 4.6 1.1 1.4 1.2 0.3 1.4 7.7 1.8 0.0 1.9 7.7 2.3 1.3 0.8 0.0 0.7 0.8 LRRC32 "D11S833E, GARP" ENSG00000137507 "Leucine rich repeat containing 32" Q14392 11 76657524-76670747 "Predicted intracellular proteins, Predicted membrane proteins" "Growth factor binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Endothelial cells: 91.0;Extravillous trophoblasts: 149.6;Fibroblasts: 48.9;Ito cells: 70.6;Sertoli cells: 38.8;Smooth muscle cells: 74.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "neutrophil: 1.0;T-reg: 3.1" "Group enriched" "Detected in many" 7 "granulocytes: 1.0;T-cells: 3.1" "Group enriched" "Detected in some" 6 "ASC diff: 42.0;ASC TERT1: 25.9;HSkMC: 16.1;HUVEC TERT2: 18.2;U-2197: 38.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA055775, HPA058434" Enhanced Nucleoplasm "Intracellular and membrane" NA NA 19000 Nucleoplasm "HPA055775: AB_2732600, HPA058434: AB_2732622" "unprognostic (3.18e-1)" "unprognostic (1.38e-1)" "unprognostic (2.60e-2)" "unprognostic (4.19e-3)" "unprognostic (1.16e-1)" "unprognostic (8.84e-2)" "unprognostic (1.39e-2)" "unprognostic (2.24e-2)" "unprognostic (6.29e-2)" "unprognostic (1.83e-2)" "unprognostic (1.58e-1)" "unprognostic (9.86e-2)" "prognostic unfavorable (3.93e-5)" "unprognostic (7.99e-3)" "unprognostic (1.15e-2)" "unprognostic (5.22e-3)" "prognostic unfavorable (2.64e-4)" 50.5 16.5 5.4 8.0 11.3 1.9 35.1 4.6 9.1 19.8 12.4 4.4 3.5 7.0 15.2 10.4 11.1 10.8 22.6 18.0 7.6 3.5 19.5 8.5 51.8 4.7 10.2 4.3 19.9 8.7 7.9 7.0 40.5 10.1 12.6 5.1 16.6 5.2 9.4 29.0 9.9 7.7 13.0 5.7 21.2 8.1 8.6 8.7 0.6 16.6 9.7 2.1 19.8 25.1 0.2 0.0 1.0 0.0 0.0 3.1 9.6 0.0 0.0 0.4 0.0 42.0 25.9 0.5 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.2 0.0 0.8 0.0 0.0 16.1 0.0 1.4 0.0 0.3 18.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.0 4.8 2.7 0.3 38.6 0.0 0.0 0.0 0.6 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 3.1 9.6 5.4 11.3 4.6 9.1 7.6 3.5 10.2 4.3 10.1 8.7 0.0 7.0 3.4 0.2 12.9 0.0 3.4 0.0 1.4 2.3 0.0 0.0 1.3 0.0 0.1 1.3 91.0 0.0 0.0 0.0 149.6 48.9 1.2 2.3 0.8 3.3 0.0 0.0 70.6 4.4 1.1 8.3 5.2 16.9 0.0 0.2 0.4 0.0 2.9 8.5 0.1 0.0 38.8 74.8 0.5 2.7 10.9 7.0 1.3 0.0 1.1 LRRC41 MUF1 ENSG00000132128 "Leucine rich repeat containing 41" Q15345 1 46261196-46303608 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Syncytiotrophoblasts: 119.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051941 Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA051941: AB_2681669" "unprognostic (1.57e-2)" "prognostic unfavorable (5.50e-4)" "unprognostic (7.80e-3)" "unprognostic (2.23e-2)" "unprognostic (2.11e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (1.66e-9)" "unprognostic (6.09e-2)" "unprognostic (2.96e-2)" "unprognostic (3.38e-2)" "unprognostic (5.34e-2)" "unprognostic (2.34e-1)" "prognostic unfavorable (6.34e-4)" "unprognostic (8.11e-2)" "unprognostic (1.80e-1)" "unprognostic (6.31e-2)" "unprognostic (1.73e-2)" 24.2 27.6 19.7 14.6 20.3 14.1 23.3 26.0 31.9 29.9 23.6 25.7 32.6 18.4 35.0 25.1 29.1 36.2 25.2 25.7 19.5 17.3 21.8 27.6 21.5 16.4 17.5 20.2 38.3 30.6 37.4 29.4 45.2 17.7 28.8 16.6 25.4 27.0 36.7 32.2 26.3 25.1 29.4 15.3 19.1 22.6 26.1 17.9 30.4 31.7 21.8 24.1 29.5 25.1 14.8 29.1 16.4 20.1 19.4 16.9 17.0 14.3 10.5 18.2 19.7 24.6 30.9 17.1 14.9 27.7 21.7 14.6 8.8 4.8 9.1 19.9 35.3 29.1 11.2 17.7 21.1 11.1 11.0 19.2 14.8 12.1 12.8 34.6 9.1 7.9 37.8 28.5 20.3 24.5 31.3 27.7 17.3 14.7 9.4 23.7 9.1 12.1 12.2 27.2 9.4 10.3 10.1 9.4 14.7 24.3 17.6 17.0 19.3 20.1 20.0 24.0 29.3 11.8 27.8 18.2 19.1 8.7 15.9 14.2 15.5 7.2 4.0 17.9 7.0 13.2 16.4 20.1 9.2 14.3 19.0 15.1 12.7 15.4 15.9 29.1 14.8 16.9 13.0 2.0 19.4 12.7 16.6 14.9 17.0 19.7 20.3 26.0 31.9 19.5 17.3 17.5 20.2 17.7 17.9 17.9 24.3 13.3 31.1 25.2 23.2 10.9 17.8 14.7 14.8 33.2 23.6 74.9 33.2 37.3 20.8 17.5 29.6 23.3 26.2 40.3 30.1 28.8 6.9 25.6 31.5 44.5 35.2 27.0 17.7 13.8 32.2 15.8 10.1 23.4 26.7 27.3 26.9 20.1 31.1 24.0 26.3 38.8 32.0 27.4 33.6 25.3 119.2 19.8 26.6 28.1 LRRC42 MGC8974 ENSG00000116212 "Leucine rich repeat containing 42" Q9Y546 1 53946077-53968168 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047458, HPA050537, HPA064581" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA047458: , HPA050537: AB_2681161, HPA064581: AB_2685292" "unprognostic (3.13e-1)" "unprognostic (1.32e-1)" "unprognostic (5.88e-2)" "unprognostic (9.97e-3)" "unprognostic (4.01e-2)" "unprognostic (7.95e-3)" "prognostic unfavorable (3.88e-5)" "prognostic unfavorable (6.02e-4)" "unprognostic (1.05e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-2)" "unprognostic (1.11e-1)" "unprognostic (1.13e-1)" "unprognostic (2.24e-2)" "unprognostic (9.08e-2)" "unprognostic (7.36e-3)" "unprognostic (1.67e-2)" 12.0 27.1 11.8 9.8 14.7 8.7 20.3 8.8 10.5 15.1 13.1 7.9 18.5 10.7 17.5 19.4 18.8 15.1 16.6 14.0 9.1 8.3 16.1 23.1 13.1 12.9 7.7 10.0 17.9 11.5 12.4 23.1 32.3 10.5 15.8 11.9 17.9 15.0 21.2 14.9 18.0 10.2 16.1 13.6 10.2 14.4 24.0 9.9 16.6 21.8 14.9 13.1 18.3 17.8 6.5 10.5 7.6 4.5 6.4 8.9 4.1 25.3 9.5 24.0 14.1 12.6 17.2 16.3 20.1 28.2 26.9 36.8 31.2 17.2 14.2 16.2 24.7 32.0 22.5 20.3 28.8 31.5 11.3 12.2 13.2 15.2 20.2 23.0 8.2 12.7 15.5 40.1 23.2 25.7 19.9 17.1 13.4 16.5 3.9 26.1 8.8 15.1 11.5 20.4 18.8 14.8 26.2 25.4 10.0 19.4 19.2 14.4 15.4 26.9 15.4 22.1 39.6 22.7 9.9 13.8 20.6 26.3 18.2 12.5 10.7 12.3 21.4 20.0 8.6 10.9 0.1 4.5 7.6 7.6 4.4 6.4 6.5 6.5 8.9 5.6 4.1 6.9 5.0 6.8 6.4 3.3 10.5 7.0 4.1 11.8 14.7 8.8 10.5 9.1 8.3 7.7 10.0 10.5 9.9 11.9 4.3 5.6 28.2 45.8 3.6 8.3 20.4 12.0 11.4 10.4 3.9 38.1 16.6 32.6 2.2 8.7 8.5 0.0 14.7 26.4 20.6 35.2 0.0 11.9 15.2 9.5 65.5 8.6 5.6 2.7 22.2 8.6 10.1 10.8 8.5 20.7 26.6 13.5 16.6 12.2 3.2 12.9 14.1 24.6 45.1 34.3 48.1 6.5 13.6 35.8 LRRC45 MGC20806 ENSG00000169683 "Leucine rich repeat containing 45" Q96CN5 17 82023302-82031151 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 22.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023372, HPA023382, HPA024768" Enhanced Supported "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" NA NA "Centrosome, Cytosol" "Nucleoplasm, Plasma membrane" "HPA023372: AB_1853317, HPA023382: AB_1853318, HPA024768: AB_10602348" "unprognostic (6.69e-2)" "unprognostic (6.10e-2)" "unprognostic (6.86e-2)" "unprognostic (1.38e-2)" "unprognostic (6.92e-2)" "unprognostic (4.41e-3)" "unprognostic (4.70e-3)" "unprognostic (1.23e-1)" "unprognostic (6.10e-2)" "unprognostic (1.78e-3)" "unprognostic (6.17e-3)" "unprognostic (7.46e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (1.22e-3)" "unprognostic (1.24e-1)" "unprognostic (4.79e-2)" "unprognostic (3.58e-1)" 5.1 4.9 7.1 7.0 9.3 12.0 4.5 20.3 10.8 4.6 7.0 5.7 9.5 11.1 4.4 5.0 8.0 10.5 5.8 3.1 7.7 3.9 5.9 12.9 5.6 6.5 8.3 4.7 3.7 15.5 4.5 4.8 4.9 6.5 6.6 3.6 4.9 13.6 5.0 4.3 10.2 9.4 5.2 3.3 7.6 10.4 3.1 9.9 7.1 9.8 6.8 6.5 5.0 5.1 2.3 3.3 5.0 3.2 2.8 4.6 3.1 9.8 11.2 3.4 7.0 1.4 1.9 13.4 6.9 2.9 4.2 3.5 10.0 6.8 7.4 6.2 1.4 4.3 11.6 3.3 4.1 0.9 4.5 21.3 4.7 20.5 13.5 1.2 5.5 11.8 1.9 1.7 2.5 0.6 1.7 6.1 7.2 3.3 3.3 1.1 16.7 12.3 18.4 3.5 8.0 15.1 10.1 6.7 4.1 2.7 9.2 10.6 10.4 3.1 16.5 5.8 1.8 13.5 6.4 3.5 7.3 9.3 11.6 11.7 6.4 1.6 1.1 3.9 4.8 7.6 5.0 3.2 3.6 3.9 2.4 4.0 1.5 4.5 4.6 2.2 2.3 2.4 3.1 0.2 2.8 1.0 3.3 3.8 3.1 7.1 9.3 20.3 10.8 7.7 3.9 8.3 4.7 6.5 9.9 6.0 2.1 1.9 4.2 3.9 4.5 2.4 10.2 14.7 7.9 3.5 0.0 8.9 5.0 6.8 1.1 3.1 9.1 0.0 4.2 22.5 4.0 3.5 4.6 11.1 7.4 4.8 4.6 8.6 5.9 1.1 6.6 2.5 8.5 2.8 9.8 5.0 5.0 8.6 6.0 6.5 4.0 0.0 3.8 1.4 11.0 2.0 2.5 5.3 10.3 2.0 LRRC58 ENSG00000163428 "Leucine rich repeat containing 58" Q96CX6 3 120324509-120349339 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057574 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA057574: AB_2683474" "unprognostic (7.87e-3)" "unprognostic (6.84e-3)" "unprognostic (3.20e-1)" "unprognostic (2.67e-3)" "unprognostic (8.73e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (4.98e-4)" "unprognostic (4.41e-2)" "unprognostic (1.30e-2)" "unprognostic (3.67e-2)" "unprognostic (2.73e-3)" "unprognostic (1.48e-1)" "unprognostic (1.66e-2)" "unprognostic (6.43e-2)" "unprognostic (1.94e-1)" "prognostic unfavorable (6.18e-4)" "unprognostic (1.06e-1)" 15.8 30.1 12.7 10.7 14.3 10.0 15.4 13.9 14.8 15.4 13.3 16.3 11.3 9.6 14.5 11.3 14.6 11.0 9.7 9.6 12.9 9.6 19.2 14.1 10.9 12.7 15.9 10.5 19.7 13.1 21.0 9.8 12.1 14.4 15.1 9.9 13.2 11.6 12.1 9.2 13.8 12.2 15.5 22.9 14.6 10.0 7.9 15.5 27.9 18.3 9.0 11.0 17.2 16.1 5.7 6.4 3.5 5.8 3.7 8.4 3.4 24.8 8.8 6.0 7.7 14.0 13.4 9.6 8.9 7.8 9.6 12.0 8.2 7.7 16.3 11.2 9.6 13.6 10.9 11.1 8.8 18.3 6.3 6.9 17.4 12.0 9.5 9.4 28.1 9.0 9.8 11.3 11.6 15.0 6.2 5.6 10.5 9.8 21.0 10.3 11.3 22.0 9.0 6.1 11.0 16.1 4.9 16.2 10.5 7.3 9.2 7.7 10.3 15.7 10.8 22.3 4.4 11.8 12.8 8.3 16.1 17.9 10.7 11.3 18.1 20.8 34.6 16.2 21.3 13.4 2.4 5.8 2.3 4.4 5.1 6.4 5.4 5.5 5.6 5.5 5.7 8.4 6.2 3.5 3.7 3.9 6.4 5.4 3.4 12.7 14.3 13.9 13.5 12.9 9.6 15.9 10.5 14.4 15.5 68.5 57.6 28.8 17.3 45.2 28.0 15.5 28.1 37.5 38.7 17.4 53.0 14.2 10.0 19.4 6.7 20.4 18.0 23.3 26.5 21.7 39.0 27.8 33.6 31.0 24.2 23.8 16.1 25.2 43.8 4.0 51.8 30.3 32.1 8.2 22.2 43.2 26.4 14.4 68.6 33.1 20.4 25.8 33.5 17.4 24.0 49.8 11.3 27.7 29.0 14.4 LRRC61 "FLJ31392, HSPC295, MGC3036" ENSG00000127399 "Leucine rich repeat containing 61" Q9BV99 7 150322639-150338150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 41.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 31.1;Hep G2: 20.7;NTERA-2: 27.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019355 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA019355: AB_1853339" "unprognostic (4.05e-2)" "unprognostic (9.50e-2)" "unprognostic (1.61e-3)" "unprognostic (5.91e-3)" "prognostic unfavorable (1.11e-5)" "unprognostic (1.46e-2)" "unprognostic (4.43e-3)" "unprognostic (1.82e-1)" "unprognostic (1.76e-2)" "unprognostic (4.22e-2)" "unprognostic (2.53e-2)" "unprognostic (1.56e-1)" "unprognostic (1.66e-2)" "prognostic favorable (2.85e-4)" "unprognostic (1.21e-1)" "unprognostic (3.27e-1)" "unprognostic (1.69e-3)" 2.8 14.7 6.7 9.0 9.3 2.3 4.1 7.5 7.3 6.7 6.0 3.5 4.5 5.8 7.0 4.0 6.4 20.8 8.0 3.3 5.4 13.1 10.8 18.3 4.8 9.1 5.0 3.4 18.5 12.7 12.2 10.9 7.3 5.1 6.4 2.9 10.6 6.2 6.7 3.0 5.4 7.9 3.8 3.0 10.1 6.6 6.6 3.9 41.0 16.4 3.0 11.8 4.2 9.0 9.5 15.1 11.6 2.4 6.5 10.5 4.2 7.8 0.2 0.2 0.0 0.0 0.0 3.7 0.0 0.0 1.0 3.2 14.8 7.8 2.4 3.3 0.1 0.0 7.1 0.0 0.0 0.5 31.1 10.1 2.8 9.5 20.7 5.7 0.0 1.5 0.6 3.2 0.0 0.0 0.2 0.0 16.2 9.8 4.6 0.0 14.2 14.3 1.2 27.3 5.3 0.0 0.0 0.0 6.4 2.3 5.1 14.1 13.8 13.2 2.9 5.4 2.3 2.2 1.7 0.0 0.0 0.0 0.0 0.0 5.1 1.6 0.0 0.0 0.0 0.0 2.3 2.4 6.7 9.5 1.0 7.6 8.0 6.8 7.3 2.6 9.5 6.7 7.7 11.6 6.5 1.0 15.1 10.5 4.2 6.7 9.3 7.5 7.3 5.4 13.1 5.0 3.4 5.1 3.9 6.0 1.0 6.5 4.0 1.0 7.7 2.1 10.2 20.1 4.5 15.7 0.0 22.6 16.6 22.1 4.7 2.1 9.6 0.0 24.7 21.2 2.4 4.0 1.1 18.3 5.5 12.7 18.6 1.3 1.3 12.9 9.5 1.8 3.3 24.4 7.6 13.0 27.0 13.9 5.3 27.2 4.7 0.0 0.8 20.4 22.8 2.4 22.5 8.7 9.5 2.6 LRRC7 "densin-180, KIAA1365" ENSG00000033122 "Leucine rich repeat containing 7" Q96NW7 1 69568398-70151945 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 29.1" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 37.9;Early spermatids: 20.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "eosinophil: 1.4;naive CD4 T-cell: 1.7;naive CD8 T-cell: 1.3" "Group enriched" "Detected in many" 14 "granulocytes: 1.4;T-cells: 1.7" "Group enriched" "Detected in some" 6 "HaCaT: 10.5;HEL: 31.3" "Low region specificity" "Detected in many" HPA005625 Supported "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Centrosome" "HPA005625: AB_1853340" "unprognostic (2.81e-2)" "unprognostic (1.62e-2)" "unprognostic (1.51e-1)" "unprognostic (2.98e-3)" "unprognostic (2.47e-1)" "unprognostic (1.73e-1)" "unprognostic (1.04e-1)" "unprognostic (3.50e-2)" "unprognostic (4.84e-3)" "unprognostic (2.92e-2)" "unprognostic (1.06e-3)" "unprognostic (1.46e-1)" "unprognostic (5.64e-6)" "unprognostic (1.31e-2)" "unprognostic (1.74e-2)" "unprognostic (5.13e-3)" "unprognostic (2.08e-3)" 1.0 1.3 20.2 1.0 29.1 1.0 0.8 0.5 21.9 1.2 1.9 5.0 0.0 1.0 1.2 1.0 1.3 0.8 3.2 2.8 15.4 5.8 2.8 1.2 0.8 0.9 4.4 17.6 1.0 2.7 0.7 0.4 1.2 2.4 1.5 2.4 0.2 0.9 1.1 2.8 1.1 1.3 1.2 2.5 0.8 0.8 5.8 7.6 0.0 6.7 0.0 0.8 0.9 0.5 0.0 0.1 1.4 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 3.3 0.0 0.0 10.5 0.2 0.0 0.0 0.0 0.5 31.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 3.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.7 1.3 0.0 0.0 0.0 0.0 0.0 0.1 20.2 29.1 0.5 19.2 15.4 5.8 4.4 17.6 2.4 7.6 0.0 0.0 5.1 0.5 0.7 37.9 5.8 2.5 0.0 0.0 0.0 2.0 0.4 0.0 0.0 20.2 1.4 0.0 0.0 0.0 0.4 2.1 0.7 0.0 5.5 0.3 6.4 0.0 1.8 1.5 4.6 0.6 0.7 5.0 0.0 0.0 0.5 0.0 0.0 2.8 1.3 7.9 0.0 1.4 7.4 2.7 1.1 0.1 2.5 0.0 0.1 LRRC75A "C17orf76, FAM211A, FLJ35696" ENSG00000181350 "Leucine rich repeat containing 75A" Q8NAA5 17 16441577-16492153 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 42.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 12.0;HUVEC TERT2: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028528, HPA065840" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA028528: AB_10600755, HPA065840: " "unprognostic (1.09e-1)" "unprognostic (5.60e-2)" "unprognostic (5.79e-2)" "unprognostic (3.85e-5)" "unprognostic (3.93e-2)" "unprognostic (3.23e-2)" "unprognostic (3.44e-1)" "unprognostic (7.66e-3)" "unprognostic (7.74e-2)" "unprognostic (2.84e-1)" "prognostic favorable (7.46e-5)" "unprognostic (8.36e-2)" "unprognostic (4.28e-3)" "unprognostic (8.84e-2)" "unprognostic (1.82e-1)" "unprognostic (1.17e-3)" "unprognostic (2.06e-1)" 1.0 8.9 5.2 2.8 3.7 1.7 0.6 0.7 6.3 2.2 26.3 1.5 1.4 15.0 1.9 0.5 0.4 0.9 0.5 0.4 4.1 2.4 0.8 0.2 1.6 1.9 1.6 3.2 1.8 1.6 3.7 4.1 1.5 2.1 1.1 10.4 1.9 0.3 1.7 0.4 0.4 42.3 3.0 0.8 6.4 1.3 8.5 0.4 0.5 1.2 0.0 1.9 1.3 0.7 0.8 0.0 0.3 0.6 0.3 0.6 0.2 1.2 1.0 1.2 0.8 0.3 0.5 0.1 0.3 0.8 2.8 2.3 1.1 0.3 0.0 0.8 0.1 0.5 0.4 0.3 0.2 0.1 0.4 0.9 12.0 0.6 0.0 0.4 0.2 0.9 0.0 0.0 0.6 0.0 0.4 3.9 1.3 0.5 0.2 0.0 2.0 1.9 0.8 0.2 2.8 0.1 0.7 0.7 0.1 0.6 0.2 2.3 0.6 0.0 0.2 2.8 0.5 0.2 0.1 0.0 0.3 1.4 0.9 1.5 1.5 0.3 0.2 0.1 0.7 1.0 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.6 0.3 0.3 0.6 0.0 0.0 0.2 5.2 3.7 0.7 6.3 4.1 2.4 1.6 3.2 2.1 0.4 38.7 51.3 11.9 7.2 0.0 8.7 0.3 7.6 16.0 36.4 1.8 5.9 13.7 16.6 3.8 5.3 6.0 49.1 23.3 6.1 16.9 3.9 6.4 27.8 8.1 10.5 3.2 23.7 9.2 10.7 5.9 15.3 6.7 0.0 1.8 44.8 16.7 5.7 23.0 10.6 15.2 16.4 12.9 2.3 3.8 6.7 0.0 14.0 8.9 47.2 6.2 LRRC75B "C22orf36, FAM211B, MGC131773" ENSG00000178026 "Leucine rich repeat containing 75B" Q2VPJ9 22 24585620-24593208 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 22.2;Muller glia cells: 39.6;Proximal tubular cells: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 2.7;NK-cell: 2.0" "Group enriched" "Detected in many" 5 "granulocytes: 2.7;NK-cells: 2.0" "Cell line enhanced" "Detected in many" "Hep G2: 8.3;MCF7: 7.4;SH-SY5Y: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002540 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA002540: AB_1079263" "unprognostic (1.21e-1)" "unprognostic (2.00e-1)" "unprognostic (2.47e-1)" "unprognostic (2.34e-1)" "unprognostic (2.74e-2)" "unprognostic (5.21e-2)" "unprognostic (4.52e-2)" "unprognostic (2.48e-2)" "unprognostic (2.49e-1)" "unprognostic (2.48e-2)" "unprognostic (2.67e-2)" "unprognostic (1.35e-1)" "unprognostic (1.47e-1)" "unprognostic (1.74e-1)" "unprognostic (1.28e-1)" "unprognostic (7.40e-2)" "unprognostic (9.69e-2)" 4.2 1.9 7.5 1.4 6.0 3.0 2.6 3.8 6.6 3.5 3.8 2.6 11.5 1.4 2.4 5.8 3.4 3.3 9.8 4.3 5.5 9.1 6.0 3.4 1.7 1.7 7.8 4.0 7.3 7.2 1.4 1.5 2.3 4.1 6.9 2.0 4.9 7.5 15.0 10.7 4.3 8.2 6.7 7.0 2.7 2.6 8.3 0.5 0.0 8.6 3.0 2.1 5.5 2.7 0.0 0.3 2.7 0.4 2.0 0.2 0.0 0.1 4.2 0.0 2.3 0.6 1.7 0.4 0.6 0.7 1.5 1.6 3.1 0.0 0.0 1.0 1.2 1.2 4.7 0.4 2.3 0.0 1.3 2.8 0.3 0.6 8.3 4.2 0.0 0.0 0.0 1.8 1.5 0.2 0.9 1.1 0.0 0.4 0.0 0.1 7.4 0.0 1.5 2.1 5.0 1.7 0.0 0.2 0.0 1.9 0.4 2.2 6.6 2.2 0.7 0.6 0.5 0.0 0.7 2.4 2.5 1.6 0.9 0.8 0.1 0.0 0.0 1.3 0.1 0.0 0.0 0.3 2.7 0.0 0.4 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.0 0.0 7.5 6.0 3.8 5.6 5.5 9.1 7.8 4.0 4.1 0.5 11.9 5.1 0.0 2.0 0.0 2.2 3.1 17.8 0.0 0.0 7.0 0.0 1.7 10.0 8.0 1.1 0.8 14.2 0.0 7.9 0.3 1.8 7.4 0.0 22.2 1.0 1.6 1.2 1.3 1.6 5.8 11.8 0.5 0.0 0.0 5.5 39.6 4.2 3.4 9.2 38.2 0.9 0.0 4.1 0.5 0.7 0.0 0.9 0.0 4.5 1.0 LRRC9 FLJ46156 ENSG00000131951 "Leucine rich repeat containing 9" Q6ZRR7 14 59919713-60063559 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 16.4;pituitary gland: 13.9;testis: 14.3" "Group enriched" "Detected in some" 9 "Early spermatids: 98.5;Late spermatids: 64.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 7.3;pons and medulla: 16.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.3;CACO-2: 2.0;GAMG: 1.1;NTERA-2: 4.2;SCLC-21H: 1.9;SH-SY5Y: 1.3;SuSa: 1.7;U-2 OS: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040965, HPA041381, HPA077675" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "Nucleoplasm, Nuclear bodies" "HPA040965: AB_2677225, HPA041381: AB_2677444, HPA077675: " "unprognostic (1.01e-2)" "unprognostic (2.00e-1)" "unprognostic (4.45e-2)" "unprognostic (2.12e-3)" "unprognostic (2.80e-1)" "unprognostic (2.95e-3)" "unprognostic (1.93e-1)" "unprognostic (3.11e-2)" "unprognostic (1.91e-2)" "unprognostic (4.82e-2)" "unprognostic (3.45e-3)" "unprognostic (6.06e-2)" "unprognostic (2.62e-3)" "unprognostic (8.54e-3)" "unprognostic (8.30e-2)" "unprognostic (1.67e-2)" "unprognostic (2.29e-2)" 0.6 0.4 0.6 0.1 7.3 0.2 0.1 0.2 1.1 0.3 0.1 3.2 0.0 0.1 0.2 1.4 0.1 3.4 0.1 0.1 1.4 1.2 0.2 0.2 0.1 0.1 0.5 1.3 1.0 0.2 4.8 13.9 0.1 16.4 1.3 0.1 0.0 0.1 0.2 0.1 0.1 0.7 0.1 0.9 0.1 0.2 14.3 2.2 0.0 0.1 0.0 0.1 0.2 0.1 0.6 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 4.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 7.3 0.2 1.1 1.4 1.2 0.5 1.3 16.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 98.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.6 0.0 0.0 0.0 64.1 0.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 8.8 0.9 0.0 0.1 0.0 0.0 0.0 LRRIQ3 "LRRC44, MGC22773" ENSG00000162620 "Leucine rich repeats and IQ motif containing 3" A6PVS8 1 74026015-74198187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 34.1" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 144.3;Late spermatids: 74.3;Spermatocytes: 156.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 12.2;JURKAT: 7.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA030799 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA030799: AB_10601337" "unprognostic (5.94e-3)" "unprognostic (6.00e-2)" "unprognostic (6.49e-3)" "unprognostic (1.63e-1)" "unprognostic (6.62e-2)" "unprognostic (2.78e-1)" "unprognostic (2.27e-2)" "unprognostic (2.27e-1)" "unprognostic (8.17e-2)" "unprognostic (2.44e-1)" "unprognostic (1.12e-3)" "unprognostic (1.71e-1)" "unprognostic (1.41e-1)" "unprognostic (1.05e-1)" "unprognostic (1.13e-1)" "unprognostic (1.88e-2)" "unprognostic (4.65e-2)" 1.8 1.3 0.9 0.9 2.7 0.2 0.9 0.3 1.5 0.8 0.4 1.1 0.1 0.3 0.4 1.2 0.6 2.8 0.6 0.6 1.0 1.1 3.5 1.7 1.6 0.9 2.5 1.4 2.5 0.6 2.1 7.2 0.3 2.4 0.6 0.3 0.6 0.8 0.6 0.4 0.3 0.4 0.2 1.3 1.6 0.5 34.1 1.0 1.4 1.9 0.0 0.8 0.5 0.4 3.9 1.1 1.9 1.1 1.1 4.0 0.9 0.3 1.5 0.2 0.6 1.6 0.6 1.0 0.9 0.6 1.3 1.4 0.2 2.1 2.1 1.9 0.2 12.2 0.2 3.3 3.0 1.6 5.2 0.0 1.9 0.5 1.0 0.2 3.4 1.1 1.1 1.6 2.2 0.8 0.5 0.6 7.3 1.6 3.0 2.1 0.0 1.3 0.5 1.7 3.7 1.0 1.6 1.2 2.1 1.9 0.2 1.6 1.1 0.2 0.2 4.6 0.3 1.3 1.9 0.2 0.2 1.1 0.8 1.8 3.1 1.1 1.7 2.3 0.3 1.6 0.0 0.2 1.9 2.3 1.1 2.9 3.9 2.6 2.9 0.3 2.0 2.5 3.5 0.0 1.1 0.3 1.1 4.0 0.9 0.9 2.7 0.3 1.5 1.0 1.1 2.5 1.4 2.4 1.0 0.0 1.0 0.0 1.0 1.0 0.8 0.4 0.0 36.1 1.2 0.0 3.9 1.4 11.6 1.4 144.3 0.1 0.0 0.0 1.6 1.5 0.2 1.2 0.0 1.0 1.1 0.0 2.9 0.0 0.6 74.3 1.7 0.4 0.0 1.0 0.9 1.1 0.7 0.0 1.4 4.2 0.6 0.0 0.4 156.8 22.6 0.1 0.2 0.7 0.6 0.7 LRRN3 "FIGLER5, FLJ11129, NLRR3" ENSG00000173114 "Leucine rich repeat neuronal 3" Q9H3W5 7 111091006-111125454 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 26.5;brain: 23.8" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 33.5;Leydig cells: 52.0;Peritubular cells: 15.2" "Group enriched" "Detected in many" 7 "glioma: 17.5;thyroid cancer: 4.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "naive CD4 T-cell: 20.3;naive CD8 T-cell: 18.4" "Lineage enriched" "Detected in single" 98 "T-cells: 20.3" "Cell line enhanced" "Detected in some" "AF22: 14.7;BJ: 8.3;BJ hTERT+: 18.2;GAMG: 9.3;SH-SY5Y: 26.4;SuSa: 8.5;T-47d: 14.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043820, HPA046792" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043820: AB_2678687, HPA046792: AB_2679810" "unprognostic (4.93e-2)" "unprognostic (4.55e-2)" "unprognostic (5.92e-2)" "unprognostic (1.96e-2)" "unprognostic (1.27e-2)" "unprognostic (4.78e-3)" "unprognostic (1.13e-1)" "unprognostic (1.07e-2)" "unprognostic (1.51e-1)" "unprognostic (5.84e-2)" "unprognostic (4.85e-3)" "unprognostic (1.08e-2)" "unprognostic (3.29e-4)" "unprognostic (1.37e-1)" "unprognostic (1.69e-1)" "unprognostic (1.29e-2)" "unprognostic (7.23e-2)" 7.8 26.5 12.7 1.6 21.2 1.1 2.1 20.0 23.8 3.6 1.4 1.9 0.8 1.0 1.0 3.1 1.9 1.3 1.6 9.0 10.4 10.7 0.9 2.7 8.7 3.6 7.7 13.0 7.9 1.5 0.7 4.9 6.7 9.0 4.7 1.6 0.8 1.9 6.4 4.0 0.8 2.1 1.0 2.9 2.0 0.9 16.4 6.3 8.8 22.3 0.0 4.4 1.6 1.3 0.2 0.0 0.1 0.0 0.0 20.3 4.0 0.0 0.0 14.7 1.8 6.8 2.9 0.0 8.3 18.2 0.8 0.7 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.9 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.2 0.1 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 26.4 0.0 0.0 0.0 8.5 14.4 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.6 1.2 0.0 0.0 20.3 18.4 0.1 0.0 0.0 0.0 0.2 4.0 12.7 21.2 20.0 23.8 10.4 10.7 7.7 13.0 9.0 6.3 0.0 7.0 0.0 0.0 0.0 33.5 12.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.3 9.6 0.0 1.1 0.0 0.7 3.2 1.7 1.3 0.0 3.4 52.0 0.0 1.7 0.0 0.0 10.8 0.0 0.0 15.2 0.0 3.9 0.0 1.2 0.9 0.5 0.1 0.3 3.2 0.0 0.1 LRRN4CL ENSG00000177363 "LRRN4 C-terminal like" Q8ND94 11 62686402-62689899 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Fibroblasts: 17.2;Leydig cells: 25.0;Melanocytes: 32.1;Peritubular cells: 16.3" "Cancer enriched" "Detected in many" 5 "melanoma: 26.5" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "neutrophil: 3.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 5.7;ASC TERT1: 19.1;HHSteC: 14.9;HSkMC: 8.0;LHCN-M2: 9.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA050317 Enhanced Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA050317: AB_2681084" "unprognostic (1.28e-1)" "unprognostic (2.74e-2)" "unprognostic (2.84e-1)" "unprognostic (9.95e-3)" "unprognostic (2.61e-2)" "unprognostic (4.03e-3)" "unprognostic (1.18e-1)" "unprognostic (1.41e-1)" "unprognostic (3.04e-1)" "unprognostic (2.05e-1)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (1.35e-7)" "unprognostic (2.73e-2)" "unprognostic (6.12e-2)" "unprognostic (4.53e-3)" "unprognostic (1.86e-2)" 15.7 4.8 0.2 5.0 0.6 0.6 11.6 0.6 0.9 27.2 12.1 0.1 3.5 2.1 27.0 14.0 19.1 11.4 6.7 9.3 0.3 0.2 0.8 0.2 3.1 1.8 0.3 0.6 24.9 2.1 0.4 1.2 4.4 2.2 10.8 2.5 17.8 3.2 6.7 17.0 6.8 4.3 15.1 1.9 0.3 5.7 8.5 0.0 0.0 3.5 10.4 2.4 18.2 11.2 0.9 0.6 3.3 0.8 0.8 0.6 0.1 0.0 0.1 0.2 0.2 5.7 19.1 0.2 2.0 2.9 0.2 1.0 0.2 0.1 0.1 0.2 3.2 0.0 0.3 0.1 0.0 0.3 0.1 0.2 0.3 0.1 0.1 14.9 0.2 0.1 8.0 0.2 0.4 0.0 0.1 0.0 0.3 0.2 0.1 9.7 0.1 0.2 0.4 0.4 0.1 0.1 0.1 1.3 0.3 0.0 0.1 0.6 0.2 0.3 0.2 0.6 0.1 0.1 0.2 0.2 1.8 0.1 2.0 0.1 0.2 0.2 0.2 1.1 0.2 0.0 0.9 0.8 0.3 0.4 0.3 0.3 0.4 0.4 0.3 0.1 0.9 0.5 0.6 3.3 0.8 0.4 0.6 0.2 0.1 0.2 0.6 0.6 0.9 0.3 0.2 0.3 0.6 2.2 0.0 0.0 2.6 0.0 1.9 6.0 1.9 1.1 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.0 0.9 1.0 0.0 0.0 0.0 0.1 17.2 0.8 1.1 0.0 0.3 1.6 1.2 1.3 1.2 0.0 25.0 1.5 32.1 0.0 0.1 0.3 0.0 0.0 16.3 0.1 0.7 0.0 1.7 0.4 0.2 6.0 0.1 0.0 0.0 1.0 LRRTM3 ENSG00000198739 "Leucine rich repeat transmembrane neuronal 3" Q86VH5 10 66926006-67099830 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 7.3;brain: 29.1;ovary: 8.0;pituitary gland: 26.6" "Group enriched" "Detected in some" 11 "Early spermatids: 137.5;Late spermatids: 100.5" "Cancer enriched" "Detected in single" 7 "glioma: 2.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.8;Daudi: 2.3;HAP1: 10.8;NTERA-2: 2.3;RPMI-8226: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA070444, HPA078598" Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA070444: , HPA078598: " "unprognostic (1.21e-2)" "unprognostic (4.85e-2)" "unprognostic (1.12e-1)" "unprognostic (4.02e-2)" "unprognostic (1.15e-4)" "unprognostic (8.11e-2)" "unprognostic (4.77e-1)" 0.9 7.3 12.9 1.0 18.7 0.9 0.9 19.7 29.1 1.7 0.9 3.2 0.0 1.0 1.2 0.9 1.4 0.9 0.9 0.9 7.0 6.5 1.0 0.9 1.4 0.9 3.7 16.0 8.0 3.7 0.9 26.6 0.9 4.5 1.2 0.9 0.0 1.0 1.2 1.0 0.9 1.1 1.0 2.8 0.9 0.9 1.9 5.9 0.0 0.9 0.0 0.9 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.3 0.0 0.5 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 18.7 19.7 21.3 7.0 6.5 3.7 16.0 4.5 5.9 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 137.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 100.5 8.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 11.3 0.0 0.3 0.0 0.0 1.5 1.3 0.0 0.0 0.0 0.0 0.0 LRWD1 "CENP-33, DKFZp434K1815, ORCA" ENSG00000161036 "Leucine rich repeats and WD repeat domain containing 1" Q9UFC0 7 102464929-102473168 "Predicted intracellular proteins" "DNA replication" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 10 "testis: 129.9" "Group enriched" "Detected in many" 8 "Early spermatids: 733.2;Spermatocytes: 397.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021320 Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Vesicles" "HPA021320: AB_1853372" "unprognostic (1.50e-1)" "unprognostic (1.25e-1)" "unprognostic (1.31e-2)" "unprognostic (7.66e-3)" "unprognostic (1.60e-2)" "unprognostic (2.08e-3)" "unprognostic (1.72e-3)" "unprognostic (4.97e-2)" "unprognostic (3.34e-1)" "unprognostic (3.04e-2)" "prognostic favorable (8.71e-5)" "unprognostic (1.00e-1)" "prognostic unfavorable (1.25e-4)" "unprognostic (1.46e-2)" "unprognostic (4.14e-2)" "unprognostic (7.82e-2)" "unprognostic (9.20e-2)" 2.7 4.6 3.6 3.8 5.0 7.6 1.9 7.9 5.8 2.5 2.5 3.4 3.4 2.9 2.8 2.8 2.1 7.1 2.5 2.6 4.3 4.0 4.0 5.1 2.6 4.4 3.4 3.7 3.1 3.4 3.4 4.9 2.0 4.2 2.2 1.6 1.7 3.3 4.0 3.6 2.2 4.3 2.7 2.4 6.6 3.3 129.9 3.8 3.9 2.7 1.6 4.2 2.3 1.8 12.6 9.8 9.2 4.0 9.9 10.4 5.8 7.4 10.3 5.6 15.7 4.3 3.2 8.7 7.9 5.2 13.6 9.4 9.9 4.3 18.4 11.4 6.0 16.0 7.9 8.2 7.1 4.0 6.4 15.9 3.8 4.7 6.1 5.7 7.1 7.4 3.0 4.3 15.7 3.3 4.6 7.1 14.4 17.8 5.7 7.3 22.4 21.3 16.9 11.9 9.4 15.0 11.3 5.2 19.8 4.0 4.7 7.4 21.1 8.7 8.4 7.7 6.8 4.8 5.9 4.1 7.5 16.1 23.2 12.6 20.9 36.0 17.6 8.3 6.6 13.0 9.1 2.5 9.2 10.4 4.0 9.9 11.1 9.1 9.1 2.8 12.6 5.8 7.4 5.9 9.9 3.5 9.8 9.0 5.8 3.6 5.0 7.9 5.8 4.3 4.0 3.4 3.7 4.2 3.8 0.0 0.6 5.2 5.8 9.3 11.7 0.7 2.5 16.0 6.8 12.2 2.0 7.7 6.6 12.2 733.2 5.8 7.9 0.0 9.2 9.8 5.7 3.5 0.0 6.8 7.8 4.8 7.5 5.5 5.7 71.5 17.5 3.9 5.0 10.0 6.3 8.6 9.9 6.0 14.9 11.5 8.1 0.0 5.1 397.6 39.9 8.5 5.1 7.0 6.3 3.3 LSG1 FLJ11301 ENSG00000041802 "Large 60S subunit nuclear export GTPase 1" Q9H089 3 194640788-194672477 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037704, HPA037705" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No "Nuclear bodies, Cytosol" Nucleoplasm "HPA037704: AB_10672912, HPA037705: AB_2675621" "unprognostic (5.72e-3)" "unprognostic (9.38e-3)" "unprognostic (2.63e-1)" "unprognostic (1.23e-2)" "unprognostic (3.74e-2)" "unprognostic (3.03e-1)" "prognostic unfavorable (3.21e-7)" "unprognostic (4.63e-2)" "unprognostic (1.59e-1)" "unprognostic (2.07e-1)" "unprognostic (1.60e-2)" "unprognostic (4.86e-3)" "unprognostic (1.42e-1)" "unprognostic (3.00e-2)" "unprognostic (2.70e-1)" "unprognostic (6.77e-2)" "unprognostic (2.07e-1)" 20.4 17.8 14.2 17.9 20.7 28.8 21.8 14.5 18.9 17.7 18.5 19.2 16.6 20.4 21.6 24.8 22.5 18.3 15.3 17.8 13.3 15.1 20.4 30.6 18.2 20.2 19.9 13.3 21.9 25.6 20.6 24.4 24.2 23.8 21.0 22.3 15.9 19.8 22.2 30.1 26.0 20.0 18.0 16.3 22.2 18.5 18.6 15.9 25.0 23.5 15.8 28.1 18.7 20.3 13.2 14.0 10.7 10.6 17.0 14.9 8.2 20.3 13.5 8.2 13.8 12.9 7.0 16.7 12.2 11.8 16.8 14.9 17.8 9.4 16.1 36.8 11.2 29.4 14.9 25.9 13.9 20.5 20.8 12.5 17.2 14.0 10.1 9.2 18.9 16.7 6.8 12.1 17.4 16.2 6.2 18.2 11.4 14.3 17.9 13.8 28.3 17.0 11.3 22.4 27.5 24.9 20.7 13.5 18.2 9.0 17.7 15.6 10.8 15.9 14.6 14.9 16.2 34.3 12.4 13.9 12.8 14.6 18.0 25.0 19.7 25.9 38.2 10.3 24.4 19.8 2.8 8.1 10.7 13.5 10.6 14.9 13.2 11.0 11.9 14.0 11.0 12.9 11.5 1.1 17.0 7.1 7.4 12.2 8.2 14.2 20.7 14.5 18.9 13.3 15.1 19.9 13.3 23.8 15.9 17.9 26.4 14.6 12.3 14.3 17.0 13.4 25.5 49.5 39.8 8.7 11.8 20.5 5.0 16.5 8.6 13.5 11.5 23.3 19.4 16.2 10.6 9.4 51.0 12.4 11.2 14.3 7.5 9.8 4.5 6.5 14.4 13.1 11.8 10.8 11.2 18.2 16.1 9.9 13.8 10.2 17.4 19.4 9.8 18.1 33.3 14.1 23.8 13.8 14.5 7.1 LSM10 MGC15749 ENSG00000181817 "LSM10, U7 small nuclear RNA associated" Q969L4 1 36391238-36397892 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 82.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048469 Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA048469: AB_2756307" "unprognostic (2.15e-2)" "unprognostic (4.10e-2)" "unprognostic (1.76e-1)" "unprognostic (2.64e-1)" "unprognostic (6.21e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (1.83e-4)" "unprognostic (1.22e-1)" "unprognostic (1.12e-1)" "unprognostic (1.90e-2)" "prognostic favorable (4.89e-4)" "unprognostic (1.04e-1)" "prognostic unfavorable (6.40e-6)" "unprognostic (1.84e-1)" "unprognostic (2.80e-1)" "unprognostic (3.59e-2)" "unprognostic (8.54e-2)" 15.0 11.9 19.8 17.7 20.2 12.6 21.1 11.1 20.9 12.3 20.8 9.5 16.7 11.9 14.2 19.1 15.0 11.4 15.7 28.2 18.6 19.7 17.3 21.3 11.8 27.3 17.7 14.4 14.6 18.6 12.1 16.4 13.2 17.0 16.2 11.0 13.8 16.9 19.5 82.0 10.1 13.0 17.8 12.5 21.1 14.5 12.1 10.3 10.3 18.9 22.0 26.8 19.1 25.0 73.8 45.9 66.7 50.5 19.1 31.0 49.9 18.9 29.0 10.9 29.2 25.8 25.3 11.3 17.1 25.1 27.5 21.1 12.9 18.2 44.9 23.7 23.1 20.4 10.5 18.5 22.2 18.3 30.4 22.1 22.5 17.2 30.3 31.4 16.9 33.1 21.2 19.8 24.7 17.6 15.0 28.1 25.8 20.7 22.0 19.3 33.7 18.8 19.3 28.1 23.6 30.1 14.3 10.5 30.3 26.5 11.6 14.0 10.5 13.9 17.8 41.5 18.4 9.2 14.6 18.6 12.6 17.4 32.7 26.6 29.1 39.1 35.1 25.2 26.0 28.3 35.7 50.5 61.4 25.6 48.7 27.8 70.6 25.5 26.5 36.0 73.8 23.1 25.0 66.7 19.1 44.9 45.9 31.0 49.9 19.8 20.2 11.1 20.9 18.6 19.7 17.7 14.4 17.0 10.3 11.9 15.6 88.7 31.6 28.6 15.4 45.2 15.3 5.3 11.4 43.6 5.9 48.1 119.3 34.9 7.6 35.4 23.8 46.7 41.3 51.7 42.8 37.2 40.4 54.6 93.0 17.5 27.1 30.1 72.9 16.5 35.9 85.7 49.0 44.1 20.4 20.9 37.9 34.5 44.2 91.1 12.7 12.9 49.5 8.4 23.0 35.0 33.4 57.3 25.4 24.3 LSM11 FLJ38273 ENSG00000155858 "LSM11, U7 small nuclear RNA associated" P83369 5 157743695-157760709 "Predicted intracellular proteins" "mRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039587 Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA039587: AB_10796330" "unprognostic (3.99e-2)" "unprognostic (2.05e-1)" "unprognostic (2.38e-2)" "unprognostic (6.90e-2)" "unprognostic (2.32e-2)" "unprognostic (1.90e-1)" "unprognostic (6.61e-3)" "unprognostic (9.68e-3)" "unprognostic (1.70e-1)" "unprognostic (2.89e-2)" "unprognostic (3.77e-2)" "unprognostic (3.57e-1)" "unprognostic (1.62e-3)" "unprognostic (1.44e-1)" "unprognostic (1.07e-1)" "unprognostic (6.11e-2)" "unprognostic (3.01e-2)" 3.4 3.7 10.8 3.6 4.7 2.9 6.4 13.6 11.8 5.3 8.9 1.9 4.9 4.6 9.1 3.2 4.7 4.6 4.7 2.4 5.1 6.1 2.8 2.7 3.1 3.9 4.7 9.2 7.3 3.7 5.0 4.2 4.2 5.8 9.2 5.4 2.7 3.4 10.2 2.5 4.4 3.8 21.0 3.3 3.1 4.1 9.0 1.4 1.9 2.6 2.6 4.2 15.0 8.0 1.0 0.6 1.6 0.9 2.7 1.8 0.5 3.7 2.7 7.6 8.0 3.5 4.4 6.6 5.2 2.3 4.4 5.8 8.2 3.8 8.3 6.1 3.0 3.1 4.4 9.7 5.7 4.8 5.9 9.2 3.4 9.8 5.2 1.2 10.1 4.3 2.0 3.8 5.3 5.4 5.0 7.1 6.9 6.4 4.5 4.7 3.6 5.6 5.9 2.3 3.1 8.4 9.1 9.5 3.4 2.2 3.5 4.5 7.1 3.4 4.6 4.6 5.9 3.9 6.3 5.1 8.6 3.4 5.0 8.1 3.7 2.4 8.3 3.4 10.6 3.8 1.6 0.9 0.5 1.4 0.7 1.8 0.7 1.8 1.4 0.6 1.0 1.6 1.5 0.7 2.7 0.4 0.4 1.2 0.5 10.8 4.7 13.6 11.8 5.1 6.1 4.7 9.2 5.8 1.4 6.0 5.5 1.3 3.2 3.2 29.9 2.0 0.0 2.7 4.5 3.5 5.9 1.4 0.0 1.5 9.0 2.7 2.1 0.0 0.7 3.6 3.3 2.9 1.1 1.8 1.9 7.9 2.9 4.9 3.7 11.1 1.4 4.5 0.0 0.0 1.7 2.0 1.5 3.5 3.9 1.3 7.3 0.0 3.4 7.2 9.1 3.8 1.0 2.9 3.9 3.7 LSM2 "C6orf28, G7b, YBL026W" ENSG00000204392 "LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated" Q9Y333 6 31797396-31806984 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052805, HPA066718" Supported Enhanced Nucleoplasm NA NA 26000 Nucleoplasm "HPA052805: , HPA066718: AB_2685710" "unprognostic (1.69e-1)" "unprognostic (7.78e-2)" "unprognostic (5.65e-2)" "unprognostic (1.24e-1)" "unprognostic (5.10e-2)" "unprognostic (1.50e-1)" "unprognostic (1.36e-3)" "unprognostic (6.14e-2)" "unprognostic (1.03e-1)" "unprognostic (2.34e-3)" "unprognostic (1.51e-1)" "unprognostic (2.64e-1)" "prognostic unfavorable (5.59e-9)" "unprognostic (2.23e-1)" "unprognostic (8.48e-2)" "unprognostic (4.49e-2)" "unprognostic (9.59e-2)" 20.3 17.4 15.7 21.7 19.4 21.0 18.7 14.4 17.7 21.1 19.5 14.0 11.8 17.9 23.6 15.2 21.8 21.5 20.7 17.5 14.4 12.8 17.5 15.1 18.0 33.5 20.7 17.5 19.4 20.3 9.6 15.1 17.9 20.3 19.7 21.3 10.8 12.8 14.0 19.5 17.1 15.3 21.5 26.7 22.1 16.7 16.5 19.4 51.8 23.4 19.5 26.9 21.8 20.9 18.2 10.8 8.7 5.7 12.3 15.3 10.1 10.2 5.0 8.8 11.3 5.0 6.9 9.3 6.4 4.1 9.2 8.2 5.7 3.9 10.9 9.0 5.3 8.5 4.1 11.6 10.9 8.3 11.5 14.9 12.5 3.1 5.8 6.1 12.4 4.5 5.2 5.0 8.5 8.8 4.3 9.6 11.2 16.3 7.1 6.5 7.4 14.9 28.4 8.1 7.7 10.9 9.2 7.0 16.0 7.6 3.0 8.9 7.7 6.9 6.2 12.5 4.8 6.8 9.9 5.0 5.5 9.6 6.3 10.3 7.4 12.6 13.9 2.8 14.8 8.5 8.7 5.7 3.6 9.4 5.2 12.4 18.2 10.1 10.6 9.5 16.1 9.7 11.9 1.2 12.3 4.4 10.8 15.3 10.1 15.7 19.4 14.4 17.7 14.4 12.8 20.7 17.5 20.3 19.4 20.8 23.4 106.9 62.3 51.7 30.5 12.2 40.8 18.7 22.7 52.4 5.9 114.2 96.2 89.8 18.3 82.4 26.4 70.0 118.6 172.4 68.7 55.0 82.9 52.9 122.6 28.6 51.9 62.0 59.2 20.0 46.1 69.2 87.7 110.0 89.7 34.6 82.0 49.1 46.3 86.4 26.4 45.3 57.7 49.6 178.0 56.1 57.7 108.4 103.8 39.9 LSM3 "SMX4, USS2, YLR438C" ENSG00000170860 "LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated" P62310 3 14178358-14201119 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044966 Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA044966: AB_2679159" "unprognostic (3.84e-3)" "unprognostic (7.00e-3)" "unprognostic (3.61e-2)" "unprognostic (2.87e-2)" "unprognostic (2.27e-1)" "unprognostic (2.19e-1)" "unprognostic (2.94e-3)" "unprognostic (5.01e-2)" "unprognostic (2.70e-2)" "unprognostic (1.23e-1)" "unprognostic (2.73e-2)" "unprognostic (8.07e-3)" "unprognostic (4.93e-3)" "unprognostic (5.57e-2)" "unprognostic (2.88e-1)" "unprognostic (1.46e-1)" "unprognostic (1.89e-3)" 14.1 13.6 18.2 12.5 17.1 18.9 15.5 13.2 17.3 11.5 15.6 11.8 7.6 15.0 11.6 13.4 19.1 10.3 11.3 20.1 15.1 12.5 27.6 26.7 10.1 14.2 14.2 13.5 12.4 15.6 7.3 12.4 16.5 14.4 14.2 13.9 12.3 13.3 11.0 31.9 12.1 17.6 15.8 15.0 16.3 12.5 21.5 13.9 24.4 19.7 21.4 13.9 12.9 11.1 21.3 23.1 27.2 18.3 17.1 17.7 18.7 14.6 11.9 12.8 13.2 6.0 7.0 32.7 12.2 8.1 15.6 15.0 13.4 11.6 16.2 10.1 8.4 11.0 6.9 14.4 11.8 15.4 15.3 17.9 17.1 17.2 12.8 3.1 19.1 12.5 5.2 8.6 15.6 6.7 7.0 8.0 14.2 18.4 13.0 11.5 16.8 20.2 26.1 22.2 16.5 16.2 11.2 15.9 17.8 14.5 15.2 7.2 11.7 13.9 19.5 11.3 15.4 22.5 24.4 7.2 10.0 16.0 12.1 20.7 9.2 26.9 30.5 12.7 18.8 14.2 27.2 15.9 23.3 12.8 18.3 15.0 21.3 15.0 14.9 14.6 17.1 16.5 17.3 15.2 17.1 15.3 23.1 17.7 18.7 18.2 17.1 13.2 17.3 15.1 12.5 14.2 13.5 14.4 13.9 62.5 87.7 130.3 102.5 86.8 44.5 230.9 170.7 87.0 91.0 120.4 17.7 322.3 411.1 178.6 266.0 108.5 137.9 70.0 230.7 336.7 102.8 94.5 135.1 199.8 207.0 52.4 100.7 114.8 112.2 107.8 129.8 142.9 92.8 201.0 161.2 94.1 180.4 182.4 131.5 513.1 53.0 103.5 91.2 226.0 285.5 88.3 266.3 100.1 174.8 132.7 LSM8 YJR022W ENSG00000128534 "LSM8 homolog, U6 small nuclear RNA associated" O95777 7 118184032-118192824 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020116 Uncertain Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA020116: AB_1853385" "unprognostic (1.02e-2)" "unprognostic (6.58e-2)" "unprognostic (1.36e-1)" "prognostic unfavorable (9.85e-4)" "unprognostic (3.33e-2)" "unprognostic (7.34e-2)" "unprognostic (1.13e-3)" "unprognostic (1.87e-2)" "unprognostic (1.79e-2)" "unprognostic (9.90e-2)" "unprognostic (5.14e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (7.46e-6)" "unprognostic (4.82e-2)" "unprognostic (1.42e-1)" "unprognostic (7.80e-2)" "unprognostic (3.00e-3)" 27.5 20.8 16.8 30.8 19.7 39.7 27.1 33.1 25.9 18.5 20.1 12.8 18.8 20.6 23.0 25.4 26.2 19.3 16.2 25.1 19.1 10.1 20.2 19.9 23.1 34.1 19.8 17.2 22.9 27.0 13.2 28.3 16.8 20.1 22.3 22.8 13.6 24.5 21.2 21.4 21.9 26.2 23.6 28.3 33.8 22.3 21.0 20.2 30.0 24.6 23.2 38.2 22.1 21.6 29.8 40.6 22.0 28.2 18.2 35.3 16.2 14.7 9.8 22.5 17.1 8.2 13.3 9.2 16.1 14.0 11.1 14.5 8.0 15.5 30.6 33.6 8.3 21.6 10.5 13.5 10.4 11.8 15.8 14.5 20.4 20.6 15.9 18.3 26.5 23.6 12.0 12.7 13.6 12.7 10.8 11.3 23.2 21.2 30.5 13.8 6.7 46.8 66.8 20.4 12.9 15.0 14.8 13.3 21.2 11.6 9.9 13.4 17.1 14.3 36.4 30.8 19.4 7.6 29.7 9.3 17.8 10.1 20.9 20.0 26.1 18.5 35.4 13.1 32.5 22.7 22.0 21.0 19.1 29.0 28.2 28.1 29.8 32.2 35.3 22.4 26.5 31.2 31.7 7.0 18.2 26.6 40.6 31.4 16.2 16.8 19.7 33.1 25.9 19.1 10.1 19.8 17.2 20.1 20.2 23.8 61.2 138.3 86.7 0.0 39.3 40.2 61.1 66.9 64.8 59.3 45.2 106.7 76.3 84.3 27.9 60.3 67.5 70.0 148.8 162.8 58.6 85.5 99.3 65.7 119.9 39.7 83.0 72.4 145.9 11.0 90.0 92.8 0.0 140.7 82.5 44.7 124.3 90.0 71.5 76.7 38.2 84.1 22.3 105.0 109.7 0.0 101.0 138.4 90.9 91.2 LSMEM2 "C3orf45, FLJ38608" ENSG00000179564 "Leucine rich single-pass membrane protein 2" Q8N112 3 50279027-50288114 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 26.6;skeletal muscle: 16.3;tongue: 7.2" "Cell type enriched" "Detected in some" 5 "Late spermatids: 197.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 13 "T-cells: 1.2" "Cell line enhanced" "Detected in some" "HeLa: 3.7;WM-115: 3.5" "Low region specificity" "Detected in many" HPA079523 Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA079523: " "unprognostic (2.84e-3)" "unprognostic (6.54e-2)" "unprognostic (2.36e-2)" "unprognostic (1.09e-1)" "unprognostic (1.03e-1)" "unprognostic (2.30e-1)" "unprognostic (8.96e-2)" "unprognostic (1.02e-1)" "unprognostic (1.55e-2)" "unprognostic (2.65e-1)" "unprognostic (3.17e-2)" "unprognostic (2.82e-1)" "unprognostic (1.82e-1)" "unprognostic (2.46e-2)" "unprognostic (2.48e-1)" "unprognostic (6.49e-3)" "unprognostic (1.71e-1)" 0.6 0.3 1.2 0.2 2.1 0.4 0.2 0.7 1.9 1.1 0.3 2.1 0.1 0.4 1.4 0.4 0.7 0.8 0.4 26.6 1.4 0.7 0.3 0.1 0.3 0.1 1.3 0.6 0.9 0.3 0.1 0.1 0.2 1.3 0.4 0.3 1.6 1.4 0.5 16.3 0.1 0.5 0.5 1.6 0.2 0.2 3.0 0.9 0.1 0.2 7.2 0.2 0.3 0.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.3 0.2 0.3 0.0 0.0 0.4 0.4 0.4 0.4 0.2 0.3 0.5 0.1 0.1 0.0 0.5 0.1 0.1 1.1 0.1 0.0 0.5 0.2 3.7 0.2 0.0 0.3 0.2 0.2 0.0 0.1 0.2 0.5 0.0 1.1 0.0 1.0 0.0 0.2 0.1 0.7 0.5 0.4 0.0 0.0 0.3 0.0 0.3 0.3 0.1 0.5 0.0 0.8 1.0 0.4 0.0 0.0 0.0 0.2 1.3 0.4 0.4 0.9 0.6 0.6 0.1 0.9 3.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.3 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.1 0.7 1.9 1.4 0.7 1.3 0.6 1.3 0.9 0.0 1.1 0.0 0.1 0.9 0.1 3.0 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.1 41.7 0.0 0.9 0.0 0.2 0.1 0.3 0.3 4.7 0.0 0.1 0.0 0.0 0.0 0.0 197.4 1.1 0.0 1.7 0.0 0.4 0.5 0.1 0.0 0.7 0.0 0.2 0.0 0.7 1.6 1.0 1.1 0.1 0.0 0.6 0.1 LTA4H ENSG00000111144 "Leukotriene A4 hydrolase" P09960 12 96000828-96043520 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Leukotriene biosynthesis" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 215.6;Kupffer cells: 278.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008399, CAB015221, HPA017017" Supported Approved Nucleoplasm,Cytosol NA NA 85000000 "Nucleoplasm, Cytosol" "CAB015221: , HPA008399: AB_1852816, HPA017017: AB_1852818" "prognostic favorable (9.79e-4)" "unprognostic (6.62e-2)" "unprognostic (6.04e-2)" "unprognostic (1.87e-1)" "unprognostic (1.38e-2)" "unprognostic (2.59e-2)" "unprognostic (4.25e-3)" "prognostic favorable (8.96e-4)" "unprognostic (1.72e-1)" "unprognostic (1.75e-2)" "unprognostic (3.38e-2)" "unprognostic (1.34e-1)" "unprognostic (1.73e-1)" "unprognostic (1.74e-1)" "unprognostic (1.04e-1)" "unprognostic (3.50e-2)" "unprognostic (1.34e-1)" 27.9 33.2 11.2 21.5 16.7 55.7 19.0 24.1 15.6 27.2 29.1 13.1 16.7 27.6 27.6 14.1 53.4 22.7 14.5 19.2 10.6 12.2 27.2 19.4 68.0 33.4 12.3 11.3 49.9 28.2 21.2 31.8 11.3 13.3 29.6 17.8 20.7 21.1 16.1 20.6 23.6 41.2 21.5 13.3 44.3 22.1 13.7 11.5 29.2 38.8 22.3 43.1 30.1 25.2 20.6 35.3 6.1 84.2 14.2 9.0 54.6 21.0 22.6 31.8 18.9 27.6 30.9 13.9 8.8 26.1 17.4 20.3 16.5 18.2 47.1 11.1 13.1 13.7 27.7 26.0 35.9 23.8 16.1 25.2 17.3 14.5 20.0 16.3 9.1 10.5 29.4 30.3 24.0 29.5 79.5 34.5 27.6 10.5 8.3 25.1 14.4 23.9 28.0 37.0 25.1 30.7 22.4 23.7 27.1 32.0 26.8 16.5 19.5 17.8 20.8 19.1 25.5 25.9 11.2 12.3 7.4 12.5 10.5 9.5 11.2 19.4 21.8 5.2 16.5 5.8 0.4 76.0 2.2 4.5 84.2 8.4 15.1 6.3 5.8 35.3 20.6 9.0 6.7 6.1 14.2 73.2 8.7 6.3 54.6 11.2 16.7 24.1 15.6 10.6 12.2 12.3 11.3 13.3 11.5 35.7 107.1 87.8 57.2 46.0 19.4 23.4 17.8 48.2 91.0 36.6 31.4 27.0 63.0 34.2 44.9 33.1 22.4 0.0 24.3 24.3 27.5 27.6 7.0 18.1 215.6 11.1 20.7 47.3 278.8 8.1 33.9 139.0 20.3 38.7 40.9 32.1 23.4 24.6 38.5 53.1 58.0 6.5 18.5 45.1 12.5 65.5 17.4 34.8 53.6 42.1 LTB4R2 "BLT2, BLTR2, JULF2, NOP9" ENSG00000213906 "Leukotriene B4 receptor 2" Q9NPC1 14 24305734-24312053 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 38.9;lymphoid tissue: 26.8;skin 1: 21.4;tongue: 43.6" "Cell type enhanced" "Detected in some" 7 "Basal glandular cells: 3.0;Horizontal cells: 3.2;Kupffer cells: 2.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 15.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB022689, HPA029680, HPA072921" Uncertain Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB022689: , HPA029680: AB_10603013, HPA072921: AB_2686557" "unprognostic (2.01e-1)" "unprognostic (1.04e-1)" "unprognostic (9.53e-2)" "unprognostic (8.82e-2)" "unprognostic (1.42e-1)" "unprognostic (1.12e-2)" "unprognostic (1.40e-1)" "unprognostic (7.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.37e-1)" "unprognostic (1.48e-3)" "unprognostic (7.18e-2)" "unprognostic (7.05e-11)" "unprognostic (1.84e-1)" "unprognostic (1.04e-1)" "unprognostic (4.23e-2)" "unprognostic (1.19e-1)" 1.5 1.2 0.4 1.8 0.5 4.8 1.1 0.4 0.6 7.9 0.4 0.6 0.8 2.4 1.0 4.7 38.9 0.8 0.7 0.4 0.5 0.1 6.1 0.5 1.1 1.8 0.4 0.7 0.7 0.5 0.3 0.7 0.8 0.5 1.8 0.3 0.5 4.7 1.1 0.9 21.4 1.8 0.4 0.4 3.5 1.0 1.4 0.4 3.1 0.9 43.6 26.8 0.6 9.0 0.3 2.2 1.4 2.0 0.9 2.7 1.1 2.5 4.4 1.9 1.8 0.4 0.6 7.7 0.9 0.4 1.3 0.9 3.4 1.5 3.2 1.6 0.6 1.9 15.9 1.3 2.7 1.0 4.0 4.9 2.2 3.5 1.6 0.5 3.6 4.2 0.5 3.6 2.0 2.3 1.2 0.6 5.8 2.8 3.6 0.6 4.8 1.9 3.8 1.0 0.1 5.4 7.9 1.7 1.8 0.4 3.1 3.4 1.6 1.6 2.0 1.3 2.1 3.7 2.7 1.6 2.6 3.2 4.0 1.3 7.9 2.3 5.2 0.5 6.1 2.0 0.0 2.0 1.4 2.7 1.6 1.6 0.1 2.2 2.0 2.2 0.3 1.7 0.9 1.3 0.9 0.8 0.6 0.4 1.1 0.4 0.5 0.4 0.6 0.5 0.1 0.4 0.7 0.5 0.4 0.0 0.0 0.0 3.0 0.2 0.2 0.0 0.0 1.4 0.0 1.8 0.0 0.1 0.0 0.2 0.0 0.9 0.3 0.0 1.2 0.1 0.0 0.2 0.0 0.8 0.6 3.2 1.7 1.3 2.2 0.0 0.3 0.2 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.2 0.5 0.0 0.0 0.7 0.2 0.1 0.2 0.0 0.6 0.9 LTBP2 "C14orf141, LTBP3" ENSG00000119681 "Latent transforming growth factor beta binding protein 2" Q14767 14 74498170-74612378 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor binding, Heparin-binding" "Disease mutation, Dwarfism, Glaucoma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 18 "Fibroblasts: 19.4;Peritubular cells: 77.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 44.9;HUVEC TERT2: 24.5;LHCN-M2: 24.4;TIME: 107.9" "Group enriched" "Detected in some" 10 "cerebellum: 5.9;olfactory region: 3.0" "Region enriched" "Detected in some" 5 "olfactory region: 31.6" HPA003415 Approved Approved Nucleoplasm "Secreted to extracellular matrix" NA NA 13000000 Nucleoplasm "HPA003415: AB_1079284" "unprognostic (1.24e-1)" "unprognostic (3.09e-2)" "unprognostic (5.10e-2)" "unprognostic (3.92e-3)" "unprognostic (2.08e-3)" "unprognostic (2.10e-1)" "unprognostic (2.69e-1)" "unprognostic (4.43e-2)" "unprognostic (1.08e-1)" "unprognostic (1.61e-1)" "unprognostic (2.80e-2)" "unprognostic (3.77e-1)" "unprognostic (1.98e-3)" "unprognostic (2.22e-3)" "unprognostic (1.11e-1)" "unprognostic (1.07e-1)" "prognostic unfavorable (3.94e-4)" 25.0 1.7 0.8 8.0 1.3 0.0 21.5 1.0 1.0 50.3 5.0 1.2 4.8 1.2 18.0 11.8 16.2 6.2 20.1 20.3 0.8 0.8 2.4 1.4 29.5 4.8 1.6 1.9 32.1 3.9 0.4 4.2 19.0 3.1 15.7 0.9 51.8 13.6 9.7 20.5 6.0 3.2 8.6 2.6 2.5 4.3 12.2 0.4 2.2 44.8 14.4 6.0 14.7 11.6 0.4 1.7 0.3 0.2 0.0 1.2 0.2 0.5 0.9 0.2 0.0 7.2 13.3 0.0 9.0 3.1 1.7 1.1 0.0 3.3 0.0 2.7 44.9 0.8 0.9 0.0 3.3 0.7 0.0 0.1 0.1 0.4 0.3 1.7 0.0 0.1 13.7 1.4 9.6 5.6 13.3 24.5 0.0 0.0 0.0 24.4 0.2 0.0 0.0 0.0 0.0 0.8 0.1 0.2 0.0 2.1 1.2 0.2 0.6 6.4 0.0 0.2 0.6 0.2 0.0 107.9 0.6 10.8 3.3 3.3 0.1 0.1 0.0 2.4 0.0 0.3 0.1 0.1 0.1 1.2 0.1 1.0 0.2 0.6 0.2 0.2 0.4 0.7 0.6 0.3 0.0 0.2 1.7 0.0 0.2 0.8 1.3 1.0 1.0 0.8 0.8 1.6 1.9 3.1 0.4 0.0 2.1 0.0 14.7 4.9 2.3 5.0 0.0 0.0 10.3 0.0 0.0 0.3 5.0 1.2 1.2 3.5 0.0 0.0 0.3 0.4 19.4 1.6 1.1 0.2 4.1 3.2 0.0 12.9 0.0 4.5 15.3 1.5 0.0 0.0 0.0 0.4 2.8 0.0 77.4 0.0 0.6 6.5 6.2 0.7 2.7 0.9 1.0 0.0 0.0 1.7 LTC4S MGC33147 ENSG00000213316 "Leukotriene C4 synthase" Q16873 5 179793980-179796647 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Leukotriene biosynthesis, Lipid biosynthesis, Lipid metabolism" "Lyase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 31.3" "Cell type enriched" "Detected in many" 6 "granulocytes: 332.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 8.5;eosinophil: 31.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 31.3" "Cell line enriched" "Detected in some" 10 "HMC-1: 52.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA044688 Approved "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA Nucleoplasm "Endoplasmic reticulum, Cytosol" "HPA044688: " "unprognostic (8.94e-2)" "unprognostic (2.40e-2)" "unprognostic (9.35e-3)" "unprognostic (3.57e-2)" "unprognostic (1.24e-2)" "unprognostic (9.40e-2)" "unprognostic (4.53e-5)" "unprognostic (2.27e-2)" "unprognostic (1.06e-1)" "unprognostic (9.99e-2)" "unprognostic (2.65e-1)" "unprognostic (1.98e-2)" "unprognostic (4.62e-1)" 9.0 6.7 3.5 2.8 3.5 8.6 4.6 1.7 5.0 6.9 5.0 9.4 5.4 3.6 8.7 10.4 4.2 13.0 15.7 11.3 3.9 3.1 6.2 2.3 28.3 8.0 6.8 4.2 5.8 2.4 2.0 3.2 2.9 4.3 5.6 1.9 3.3 7.4 11.6 2.7 3.5 5.7 4.5 6.3 6.7 5.0 3.3 3.9 0.8 5.3 5.6 3.2 3.6 3.9 0.1 4.5 31.3 0.3 2.2 1.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.4 5.3 0.0 0.2 0.2 0.3 52.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 8.5 0.2 31.3 0.5 0.3 1.7 0.1 1.2 0.8 4.5 0.1 0.2 0.5 0.1 2.2 0.0 0.2 0.1 0.3 3.5 3.5 1.7 5.0 3.9 3.1 6.8 4.2 4.3 3.9 0.0 5.6 2.2 7.5 8.9 0.2 0.0 12.7 4.0 3.4 14.0 0.0 6.9 1.7 4.1 0.3 11.3 0.4 0.0 2.1 1.5 4.7 3.1 332.3 0.8 33.8 0.0 2.9 53.4 8.9 0.0 15.3 23.5 1.7 1.0 1.6 0.0 2.1 0.0 44.6 40.2 0.3 0.0 0.9 0.0 0.7 6.0 2.5 5.0 2.6 5.0 LTV1 "C6orf93, dJ468K18.4, FLJ14909" ENSG00000135521 "LTV1 ribosome biogenesis factor" Q96GA3 6 143843344-143863812 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA030159, HPA030160, HPA030161" Approved Enhanced Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA030159: AB_10600770, HPA030160: AB_10600056, HPA030161: AB_10602001" "unprognostic (2.26e-2)" "unprognostic (1.52e-1)" "unprognostic (3.88e-2)" "unprognostic (5.45e-2)" "unprognostic (1.11e-1)" "unprognostic (1.99e-2)" "prognostic unfavorable (4.95e-5)" "unprognostic (7.09e-2)" "unprognostic (2.16e-1)" "unprognostic (1.55e-2)" "unprognostic (1.26e-1)" "unprognostic (4.70e-2)" "prognostic unfavorable (6.01e-13)" "unprognostic (2.94e-1)" "unprognostic (6.83e-2)" "unprognostic (8.62e-3)" "unprognostic (1.41e-1)" 20.0 20.6 15.6 19.5 26.2 39.3 26.7 19.4 26.0 14.6 16.5 11.1 17.9 13.8 21.2 14.7 21.2 18.0 11.3 15.7 25.1 10.9 14.4 29.0 18.9 21.2 21.0 17.1 20.6 20.9 13.3 19.7 17.3 17.4 16.3 18.9 8.0 16.6 18.5 52.0 23.5 17.2 20.7 18.5 20.8 18.3 17.5 18.1 15.0 16.1 26.4 21.8 16.6 25.5 17.3 18.4 4.1 12.9 21.2 16.1 8.3 11.7 11.0 13.1 29.1 9.7 11.9 15.2 18.3 13.5 20.3 16.2 17.8 6.1 24.8 14.8 16.5 22.3 13.3 21.8 17.9 28.4 14.2 21.3 49.0 12.6 27.3 17.2 60.2 28.5 13.3 13.2 22.5 24.8 8.4 14.0 14.5 46.5 16.5 15.6 19.8 20.5 25.7 15.5 13.5 12.2 17.8 24.8 11.1 15.0 16.4 11.6 14.0 18.7 15.5 17.0 12.5 8.7 38.6 12.6 13.0 15.0 28.9 33.5 20.6 25.3 33.7 13.0 31.6 18.2 1.2 10.1 4.1 12.1 12.9 13.1 17.3 12.7 13.0 15.2 14.3 14.1 16.1 0.3 21.2 11.0 18.4 10.9 8.3 15.6 26.2 19.4 26.0 25.1 10.9 21.0 17.1 17.4 18.1 6.0 28.5 25.1 16.5 22.8 9.2 21.2 10.2 29.4 30.7 7.0 2.0 22.4 11.6 22.5 19.1 16.8 7.4 0.0 24.9 25.7 22.1 9.1 24.3 17.3 24.9 11.1 18.9 11.1 11.1 6.2 23.9 21.1 5.0 37.9 11.7 9.9 24.3 8.6 25.8 12.4 8.7 6.5 15.6 50.2 65.1 28.1 13.6 16.6 16.4 15.6 LUC7L "hLuc7B1, Luc7, LUC7B1" ENSG00000007392 "LUC7 like" Q9NQ29 16 188969-229463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056424, HPA069321" Supported Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA056424: AB_2683126, HPA069321: AB_2686119" "unprognostic (9.55e-3)" "unprognostic (2.01e-1)" "unprognostic (3.23e-2)" "unprognostic (5.61e-2)" "unprognostic (7.81e-2)" "unprognostic (2.60e-2)" "unprognostic (8.01e-3)" "unprognostic (4.31e-2)" "unprognostic (7.60e-2)" "unprognostic (2.35e-1)" "prognostic favorable (1.30e-4)" "unprognostic (1.57e-2)" "prognostic unfavorable (2.59e-4)" "unprognostic (1.33e-1)" "unprognostic (2.48e-1)" "unprognostic (2.02e-1)" "unprognostic (2.02e-3)" 23.8 24.5 30.4 26.5 30.9 25.3 24.0 42.6 30.0 21.9 20.1 29.9 25.8 21.3 29.4 37.7 15.5 19.2 24.5 12.7 34.1 26.5 26.9 19.9 18.8 31.0 33.1 24.3 29.3 24.2 31.2 40.3 23.1 25.4 35.2 18.2 24.3 25.1 25.2 20.3 28.8 23.9 24.4 29.2 32.1 22.6 29.8 33.1 23.2 40.2 15.9 21.0 16.6 26.3 6.5 11.1 3.5 11.7 3.9 6.9 5.6 5.4 24.4 25.9 9.7 10.0 7.7 11.4 10.1 7.7 16.5 12.0 25.4 6.4 9.9 13.3 5.8 8.7 6.9 30.8 9.2 16.6 17.7 21.1 12.1 16.6 29.7 11.2 14.0 13.6 6.9 10.7 13.3 5.3 14.3 12.7 8.6 14.3 6.4 13.2 26.2 23.0 24.4 38.6 12.3 11.8 19.8 11.3 10.4 23.6 5.8 15.4 17.3 10.9 7.6 9.4 16.0 9.8 7.6 10.3 12.0 18.1 5.0 12.1 7.0 9.3 10.5 3.6 10.0 10.7 0.3 9.1 3.5 6.7 10.4 5.2 6.5 6.3 6.5 9.8 3.0 3.7 2.8 1.2 3.9 11.7 11.1 6.9 5.6 30.4 30.9 42.6 30.0 34.1 26.5 33.1 24.3 25.4 33.1 47.6 61.1 29.6 38.6 47.3 48.4 18.3 12.7 40.2 58.0 22.7 35.3 24.9 10.0 29.4 34.2 45.0 22.2 0.0 18.2 33.5 35.8 31.0 39.4 10.0 21.2 42.9 40.6 25.2 14.5 14.7 30.2 28.9 37.1 35.1 16.5 30.8 22.7 28.1 30.4 11.3 61.8 25.8 46.4 62.1 51.9 47.4 41.8 27.7 17.1 27.1 LUC7L2 "CGI-59, CGI-74, FLJ10657, H_NH0792N18.3, hLuc7B2, LUC7B2" ENSG00000146963 "LUC7 like 2, pre-mRNA splicing factor" Q9Y383 7 139340359-139423457 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051631 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA051631: AB_2681558" "unprognostic (1.07e-3)" "unprognostic (2.71e-2)" "unprognostic (8.26e-3)" "unprognostic (2.91e-1)" "unprognostic (2.84e-1)" "unprognostic (1.00e-2)" "unprognostic (4.54e-3)" "unprognostic (2.05e-2)" "unprognostic (1.12e-2)" "unprognostic (1.48e-3)" "unprognostic (3.54e-1)" "unprognostic (2.20e-2)" "prognostic unfavorable (4.92e-4)" "unprognostic (1.23e-2)" "unprognostic (1.97e-1)" "unprognostic (1.39e-1)" "unprognostic (4.28e-3)" 27.2 24.7 32.2 34.7 35.0 59.3 41.3 35.6 33.9 35.1 34.7 41.6 28.0 22.6 35.7 36.8 33.1 32.7 29.3 35.0 33.3 30.4 29.7 33.3 26.6 39.0 33.2 30.5 41.3 34.7 47.7 29.0 31.6 33.8 39.8 31.4 27.3 29.5 40.1 58.4 41.8 27.5 35.2 37.3 32.0 29.0 37.0 32.4 66.3 53.3 23.6 44.8 34.0 33.7 14.3 11.3 15.0 13.7 13.5 20.8 10.6 18.9 10.9 22.8 21.4 15.9 13.1 17.6 21.7 20.8 20.8 21.9 12.1 18.0 31.3 13.3 17.0 13.1 13.7 27.7 21.6 29.7 14.8 27.4 26.8 16.6 12.0 13.4 42.8 22.5 11.3 27.6 19.6 24.2 14.5 16.6 16.2 34.0 16.6 22.6 17.6 50.9 39.0 18.7 24.7 15.8 30.9 23.3 28.2 23.8 21.0 20.2 19.7 23.8 24.1 20.9 17.8 16.8 16.8 16.3 16.4 9.8 18.4 20.0 26.1 24.3 68.5 18.0 41.4 22.0 8.0 8.1 15.0 16.7 12.5 18.7 14.3 16.3 17.5 11.1 13.1 20.8 17.4 8.2 13.5 13.7 11.3 16.3 10.6 32.2 35.0 35.6 33.9 33.3 30.4 33.2 30.5 33.8 32.4 50.6 46.2 14.9 66.6 0.0 52.0 0.0 38.2 68.3 72.8 36.6 49.1 65.1 46.4 37.4 8.6 43.3 25.3 0.0 33.9 61.0 40.1 52.5 55.8 49.7 38.8 41.3 21.1 33.2 38.6 4.2 49.2 33.4 0.0 42.3 38.2 40.5 31.1 21.0 63.6 30.1 47.3 58.2 0.0 57.2 71.0 0.1 68.9 66.1 33.4 47.7 LURAP1L "bA3L8.2, C9orf150, FLJ38505, MGC46502" ENSG00000153714 "Leucine rich adaptor protein 1 like" Q8IV03 9 12775021-12822131 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 48.7" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 80.1;Glandular cells: 116.6;Paneth cells: 77.2;Urothelial cells: 93.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "eosinophil: 1.2" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.2" "Cell line enhanced" "Detected in many" "HHSteC: 45.3;hTERT-HME1: 36.3;T-47d: 52.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA024407 Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA024407: AB_10603780" "unprognostic (1.20e-1)" "unprognostic (2.15e-1)" "unprognostic (7.45e-2)" "unprognostic (1.73e-2)" "unprognostic (2.08e-2)" "unprognostic (5.61e-3)" "unprognostic (1.48e-1)" "unprognostic (1.69e-1)" "unprognostic (2.92e-1)" "unprognostic (1.06e-2)" "unprognostic (1.56e-2)" "unprognostic (3.67e-2)" "unprognostic (5.68e-3)" "unprognostic (4.38e-1)" "unprognostic (5.67e-2)" "unprognostic (1.53e-1)" "unprognostic (1.02e-2)" 10.6 7.2 2.9 7.9 9.2 0.1 13.0 23.4 5.5 11.5 13.7 7.1 2.9 4.0 5.0 7.9 8.5 4.1 14.7 3.5 3.5 3.3 4.1 48.7 17.8 5.3 7.7 4.0 4.5 19.9 0.2 7.3 21.0 5.9 8.0 9.6 4.7 21.6 7.3 2.4 8.8 6.6 13.2 8.1 11.0 9.9 3.7 7.9 0.9 8.6 2.8 5.3 10.3 9.4 0.0 0.1 1.2 0.0 0.0 0.0 1.6 0.9 3.2 0.0 1.0 4.9 6.8 0.0 1.7 9.1 2.2 2.5 0.0 1.1 0.0 0.6 8.7 10.8 1.3 0.0 0.1 1.7 0.0 0.4 0.4 3.0 1.7 45.3 0.0 0.0 2.6 4.3 8.1 36.3 3.8 1.5 0.0 0.0 11.9 1.2 0.7 0.0 0.0 0.0 4.1 3.5 0.0 0.6 0.0 8.9 0.5 6.9 0.6 1.9 1.2 1.5 0.8 52.1 0.1 0.5 2.0 0.3 5.0 1.2 0.0 0.0 0.0 3.3 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.9 9.2 23.4 5.5 3.5 3.3 7.7 4.0 5.9 7.9 8.9 17.3 0.0 29.2 80.1 4.1 5.3 15.3 5.3 17.0 1.8 2.0 0.4 6.6 56.6 2.6 6.3 32.8 0.0 10.3 1.2 27.7 116.6 10.4 28.7 0.5 17.5 25.6 1.8 0.0 0.8 8.6 0.6 25.3 0.0 8.9 3.6 22.9 77.2 2.8 4.1 9.3 38.8 40.0 0.1 0.3 56.2 0.9 0.0 13.4 93.3 LUZP2 ENSG00000187398 "Leucine zipper protein 2" Q86TE4 11 24496970-25082631 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 11.1;brain: 32.7" "Group enriched" "Detected in some" 4 "Early spermatids: 18.8;Paneth cells: 21.8" "Group enriched" "Detected in some" 7 "glioma: 3.5;prostate cancer: 4.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 14.2;HAP1: 7.1;HeLa: 2.5;hTERT-RPE1: 6.1" "Low region specificity" "Detected in all" "HPA039007, HPA046161" Enhanced Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted in brain" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA039007: AB_2676307, HPA046161: AB_2679564" "unprognostic (4.49e-2)" "unprognostic (2.74e-2)" "unprognostic (8.63e-2)" "unprognostic (3.50e-1)" "unprognostic (5.22e-3)" "unprognostic (3.38e-1)" "unprognostic (4.88e-2)" "unprognostic (5.67e-4)" "unprognostic (2.40e-1)" "unprognostic (5.66e-2)" "unprognostic (6.16e-3)" "unprognostic (4.09e-2)" "unprognostic (5.18e-3)" "unprognostic (9.41e-3)" "unprognostic (4.18e-2)" "unprognostic (2.17e-1)" "unprognostic (9.64e-2)" 1.2 11.1 14.5 0.9 10.8 0.9 1.6 2.6 32.7 0.9 2.1 5.9 0.0 0.9 1.0 0.8 0.9 0.8 1.0 1.0 10.3 13.8 1.0 2.3 1.1 0.8 13.7 5.6 0.8 0.8 0.7 1.9 0.8 26.7 4.5 1.7 0.0 1.0 0.9 0.8 0.9 1.1 1.2 30.0 0.9 0.9 1.6 14.5 0.0 0.8 0.9 0.8 1.6 0.3 0.5 0.4 1.9 0.3 0.3 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 14.2 7.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 6.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.6 0.0 0.3 0.0 0.2 0.2 0.0 1.5 0.1 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 1.5 0.3 0.4 0.2 0.1 0.2 0.2 0.1 0.3 0.1 0.5 0.3 0.2 1.9 0.3 0.2 0.4 0.1 0.0 14.5 10.8 2.6 9.3 10.3 13.8 13.7 5.6 26.7 14.5 0.0 0.0 0.0 0.1 0.6 2.3 0.4 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.6 4.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.0 0.9 0.0 0.0 0.0 1.8 0.2 0.1 21.8 0.0 0.6 0.6 0.0 0.0 0.2 0.2 0.3 0.1 0.0 0.9 0.7 LXN ENSG00000079257 Latexin Q9BS40 3 158645822-158672693 "Predicted intracellular proteins" "Inflammatory response" "Heparin-binding, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 129.8;granulocytes: 113.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "hTERT-RPE1: 161.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014179, CAB025128" Approved Approved Nucleoplasm,Cytosol No NA 4200000 "Nucleoplasm, Cytosol" "CAB025128: , HPA014179: AB_1853404" "unprognostic (4.46e-2)" "unprognostic (2.59e-1)" "unprognostic (1.80e-2)" "unprognostic (2.42e-2)" "unprognostic (1.36e-1)" "unprognostic (3.20e-2)" "unprognostic (3.20e-1)" "unprognostic (5.82e-3)" "unprognostic (4.70e-3)" "unprognostic (1.98e-1)" "unprognostic (7.13e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (1.86e-5)" "unprognostic (8.45e-2)" "unprognostic (3.48e-2)" "unprognostic (3.18e-1)" "unprognostic (8.84e-2)" 32.3 31.5 2.8 13.6 3.3 9.4 35.8 11.7 3.5 11.8 20.9 1.2 12.7 12.4 9.8 17.7 14.0 15.2 17.2 24.4 5.7 3.6 13.6 4.0 16.9 17.8 3.0 2.1 37.1 15.0 7.9 20.6 15.5 4.4 34.0 18.6 11.1 29.3 11.3 7.8 4.8 24.1 22.8 2.6 10.0 7.0 8.5 1.3 12.4 15.8 6.6 7.3 29.3 31.5 5.9 4.5 22.2 3.6 5.2 17.0 4.2 0.0 5.3 0.4 0.0 2.3 8.0 0.4 4.1 10.5 1.0 2.0 0.0 12.0 0.0 3.8 1.1 0.0 1.8 1.0 1.6 1.5 0.0 5.2 2.5 4.6 0.0 2.6 0.6 0.0 17.9 0.3 1.9 0.3 161.2 38.9 0.0 0.0 0.1 0.0 21.2 0.2 0.0 0.4 0.9 1.3 0.7 0.0 5.0 3.6 14.7 0.6 0.0 0.0 5.6 1.3 1.3 0.0 0.0 5.5 0.0 0.0 5.6 0.0 0.1 0.0 0.0 2.0 0.2 0.0 13.8 3.6 5.0 3.7 3.4 3.6 5.9 7.6 5.9 4.3 4.1 8.5 4.7 22.2 5.2 2.1 4.5 17.0 4.2 2.8 3.3 11.7 3.5 5.7 3.6 3.0 2.1 4.4 1.3 14.9 8.6 7.5 61.6 4.9 0.2 3.4 2.5 129.8 31.8 15.7 3.9 11.7 13.3 14.9 2.9 28.6 33.3 23.3 23.6 13.4 20.3 29.5 113.9 0.4 21.7 0.0 33.7 49.1 4.0 7.2 7.8 14.2 18.6 27.9 63.3 8.3 13.1 69.1 2.5 11.5 1.4 12.9 3.7 0.4 8.8 7.2 3.3 7.7 25.5 71.1 LY6G5C "C6orf20, G5c, NG33" ENSG00000204428 "Lymphocyte antigen 6 family member G5C" Q5SRR4 6 31676684-31684040 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.6" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 17.4;Spermatocytes: 12.9;Spermatogonia: 13.4" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 3.1;HDLM-2: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038690 Approved Approved Nucleoplasm,Cytosol "Secreted - unknown location" NA NA Nucleoplasm Cytosol "HPA038690: AB_10673286" "unprognostic (1.51e-2)" "unprognostic (7.26e-2)" "unprognostic (7.19e-2)" "prognostic favorable (1.07e-4)" "unprognostic (4.83e-1)" "unprognostic (6.91e-2)" "unprognostic (1.33e-1)" "unprognostic (1.57e-2)" "unprognostic (4.27e-2)" "unprognostic (5.63e-2)" "unprognostic (3.74e-5)" "unprognostic (5.84e-2)" "unprognostic (3.78e-4)" "unprognostic (1.53e-1)" "unprognostic (2.07e-1)" "unprognostic (5.88e-2)" "unprognostic (1.39e-2)" 0.4 0.0 0.5 2.1 2.5 1.1 0.3 4.6 3.8 0.0 0.0 0.2 0.3 0.4 0.0 0.5 2.0 0.8 0.4 0.7 0.0 0.9 0.5 1.2 0.3 0.4 2.5 0.0 1.0 0.4 0.1 0.0 0.2 0.0 1.3 0.3 0.3 0.0 0.4 0.8 1.2 2.1 0.2 0.0 0.3 0.0 0.0 0.8 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.4 2.1 3.1 0.1 0.1 0.1 0.3 0.3 0.8 0.0 2.4 1.5 0.1 0.1 0.0 0.6 0.0 0.0 0.9 2.7 1.4 1.1 0.0 0.5 0.0 0.3 1.2 0.0 0.0 0.7 1.7 0.1 0.0 0.9 0.0 1.5 0.1 0.0 2.3 0.4 0.1 0.1 0.0 1.0 0.4 0.8 0.1 0.5 0.3 0.2 0.9 0.0 0.5 0.0 0.1 1.8 0.0 0.2 1.1 1.8 0.1 0.4 0.5 0.5 2.3 1.5 0.6 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.1 1.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.8 0.0 0.0 3.0 1.0 0.0 1.7 1.4 3.1 0.8 2.5 17.4 1.2 1.8 2.0 0.4 3.3 1.5 9.4 4.3 2.9 0.0 4.3 0.1 1.2 2.4 4.7 1.7 5.2 0.0 3.4 7.4 6.5 4.4 1.1 2.2 1.7 1.8 1.7 5.7 3.7 2.5 1.4 3.8 0.9 0.0 1.9 12.9 13.4 0.6 0.2 4.4 2.5 0.9 LY6G6E "C6orf22, G6e" ENSG00000255552 "Lymphocyte antigen 6 family member G6E" 6 31711771-31714065 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 4.3;brain: 5.2;lung: 3.9;skin 1: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "amygdala: 2.9;cerebral cortex: 5.2;hippocampal formation: 1.7" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 111 "HEL: 23.1" HPA056234 Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA056234: AB_2732601" "unprognostic (1.77e-1)" "unprognostic (1.58e-2)" "unprognostic (2.25e-1)" "unprognostic (6.88e-2)" 0.3 0.0 2.9 0.0 0.5 4.3 0.0 0.0 5.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.3 0.2 1.7 0.1 0.0 0.3 3.9 0.0 0.0 0.0 0.6 0.0 0.2 0.2 0.6 0.7 0.2 0.0 0.0 0.3 0.0 0.0 4.0 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.6 2.2 0.0 0.1 0.2 0.4 0.4 0.8 1.1 0.4 0.1 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.6 0.2 0.4 0.4 0.4 0.7 0.4 0.0 0.2 0.3 0.4 1.1 0.1 0.3 0.8 0.7 1.0 2.9 0.5 0.0 5.2 1.7 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LY6K "CT97, FLJ35226, HSJ001348" ENSG00000160886 "Lymphocyte antigen 6 family member K" Q17RY6 8 142700111-142705127 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 39.3" "Cell type enhanced" "Detected in many" 18 "Extravillous trophoblasts: 132.9;Glandular cells: 88.0;Spermatocytes: 359.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 10 "neutrophil: 5.3" "Lineage enriched" "Detected in single" 11 "granulocytes: 5.3" "Cell line enhanced" "Detected in many" "A-431: 28.8;BJ: 31.3;HeLa: 34.1;SiHa: 49.0;U-2197: 66.2" "HPA017770, CAB075742, CAB075743" Enhanced Approved "Nucleoplasm,Plasma membrane" "Secreted in male reproductive system" NA NA "Plasma membrane" Nucleoplasm "CAB075742: AB_2665748, CAB075743: AB_2665749, HPA017770: AB_1853414" "unprognostic (1.25e-1)" "unprognostic (1.95e-2)" "unprognostic (1.48e-1)" "unprognostic (7.23e-3)" "unprognostic (3.47e-2)" "unprognostic (2.39e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (9.17e-5)" "unprognostic (4.18e-2)" "unprognostic (6.89e-2)" "unprognostic (9.75e-2)" "unprognostic (1.40e-1)" "unprognostic (5.27e-5)" "unprognostic (1.71e-1)" "unprognostic (1.46e-1)" "unprognostic (2.03e-1)" "unprognostic (4.61e-2)" 6.6 0.4 1.4 0.3 1.8 0.4 7.6 0.9 3.8 1.8 1.6 0.1 9.8 0.5 0.7 0.8 10.9 0.8 1.2 1.2 1.5 1.9 2.0 0.2 0.6 1.9 1.7 0.0 0.7 0.4 0.0 0.3 6.3 1.0 1.1 0.1 0.1 1.4 7.0 6.3 4.3 0.2 0.6 1.1 0.3 0.4 39.3 0.2 0.2 1.1 4.5 6.8 1.0 3.2 0.1 0.1 5.3 0.2 0.4 0.2 0.0 28.8 0.5 0.0 1.5 0.6 1.9 0.3 31.3 3.7 9.7 5.9 0.0 0.2 0.0 2.6 3.5 3.4 2.6 0.0 1.7 8.2 0.3 0.0 0.0 34.1 0.0 0.4 0.0 0.0 2.9 5.1 7.2 9.3 0.0 0.8 0.0 0.0 0.1 18.2 0.2 0.0 0.0 1.0 0.9 0.5 0.0 0.1 0.0 1.6 0.4 0.9 0.1 49.0 0.6 9.5 1.7 0.1 0.0 1.2 0.4 2.8 66.2 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.5 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 5.3 0.4 0.1 0.1 0.0 0.0 1.4 1.8 0.9 1.7 1.5 1.9 1.7 0.0 1.0 0.2 3.0 0.3 0.0 65.7 34.6 0.3 0.1 10.2 1.4 7.9 24.4 0.0 11.3 0.0 0.5 5.0 3.3 0.0 0.0 0.0 132.9 2.9 88.0 0.0 0.0 5.3 0.0 0.0 1.3 0.0 10.1 3.7 2.8 11.8 0.0 0.0 0.5 3.9 0.0 2.8 0.0 0.7 0.0 13.3 359.5 76.0 39.3 21.2 0.0 0.0 76.5 LYAR "ZC2HC2, ZLYAR" ENSG00000145220 "Ly1 antibody reactive" Q9NX58 4 4267701-4290169 "Predicted intracellular proteins, Transcription factors" "Immunity, Innate immunity, rRNA processing, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 60.2" "Cell type enhanced" "Detected in many" 12 "Spermatocytes: 435.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035880, HPA035881" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA035880: , HPA035881: AB_10669980" "unprognostic (2.81e-1)" "unprognostic (3.79e-1)" "unprognostic (2.64e-2)" "unprognostic (6.22e-3)" "unprognostic (1.44e-1)" "unprognostic (2.97e-2)" "prognostic unfavorable (3.20e-5)" "unprognostic (1.08e-3)" "unprognostic (2.92e-2)" "prognostic favorable (8.82e-4)" "unprognostic (5.05e-2)" "unprognostic (1.59e-2)" "prognostic unfavorable (4.36e-10)" "unprognostic (4.94e-2)" "unprognostic (1.61e-1)" "unprognostic (5.90e-2)" "unprognostic (2.72e-1)" 11.1 5.7 6.8 11.9 10.1 10.9 8.2 7.3 8.0 6.6 6.9 4.3 4.1 5.7 6.9 5.5 11.2 7.1 5.4 10.1 7.0 4.6 5.0 9.9 7.7 13.8 10.9 4.5 11.1 6.3 4.4 15.6 7.1 8.4 7.8 6.8 3.7 5.4 6.4 15.1 5.9 6.2 9.1 7.9 18.2 5.8 60.2 12.0 10.0 6.3 11.9 10.9 10.1 10.4 7.3 7.1 8.9 12.9 10.7 32.8 10.3 13.3 7.0 6.3 9.2 5.5 6.3 10.8 12.2 4.2 12.7 8.8 22.0 17.6 35.9 8.8 5.2 20.5 8.5 23.5 12.7 16.7 6.4 17.3 36.0 6.7 24.6 9.4 41.5 9.8 4.9 8.1 14.6 24.9 3.3 10.9 20.5 48.1 12.0 8.8 13.5 14.1 53.5 31.3 14.2 23.0 21.7 11.5 17.3 5.7 9.3 15.0 6.4 6.6 7.3 12.4 8.4 7.5 12.4 10.2 12.7 10.1 16.5 38.4 8.5 12.8 57.4 8.6 35.1 10.2 8.9 9.7 8.5 28.6 9.6 32.8 7.3 18.9 30.8 7.1 5.7 8.9 19.0 2.8 10.7 12.9 5.3 8.8 10.3 6.8 10.1 7.3 8.0 7.0 4.6 10.9 4.5 8.4 12.0 14.9 30.0 19.7 34.4 106.7 9.4 21.6 12.7 26.8 36.4 1.8 7.9 43.0 8.3 15.1 74.2 29.5 2.8 0.0 17.0 43.6 29.4 25.4 20.8 10.6 32.5 14.3 10.3 8.6 30.8 61.9 31.7 32.1 20.3 19.0 16.0 9.6 22.6 13.9 25.1 5.1 28.7 38.8 35.0 435.9 39.2 101.3 16.9 130.7 24.0 62.3 LYPD1 "LYPDC1, MGC29643" ENSG00000150551 "LY6/PLAUR domain containing 1" Q8N2G4 2 132644853-132671579 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8;fallopian tube: 74.6" "Group enriched" "Detected in many" 5 "Ductal cells: 49.4;Exocrine glandular cells: 65.7;monocytes: 108.2;Pancreatic endocrine cells: 67.6" "Cancer enhanced" "Detected in many" "ovarian cancer: 57.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "eosinophil: 10.9" "Lineage enriched" "Detected in single" 36 "granulocytes: 10.9" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 17.4;HUVEC TERT2: 14.8;SK-MEL-30: 15.2;SuSa: 13.7;U-251 MG: 31.7;WM-115: 63.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA068333 Approved "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA Nucleoplasm "Vesicles, Plasma membrane" "HPA068333: " "unprognostic (9.25e-2)" "unprognostic (7.45e-2)" "unprognostic (1.03e-1)" "unprognostic (1.44e-2)" "unprognostic (1.15e-1)" "unprognostic (2.07e-2)" "unprognostic (6.40e-3)" "unprognostic (5.60e-2)" "unprognostic (8.36e-3)" "unprognostic (1.05e-2)" "unprognostic (6.70e-2)" "unprognostic (2.86e-2)" "unprognostic (1.51e-2)" "unprognostic (1.43e-2)" "unprognostic (1.55e-1)" "unprognostic (1.03e-1)" "unprognostic (6.78e-2)" 1.5 2.5 16.4 1.7 27.8 1.2 1.4 3.8 16.8 1.3 2.5 4.6 0.0 1.4 2.5 1.8 1.4 74.6 3.6 1.8 18.9 19.0 3.2 1.6 1.4 3.5 16.9 5.4 8.4 3.5 2.0 12.4 1.2 11.8 1.4 1.4 5.4 21.7 1.4 1.2 1.5 1.4 1.8 7.0 1.3 1.4 1.5 3.4 1.2 1.3 1.1 2.5 1.4 0.0 0.3 0.0 10.9 0.0 0.0 0.0 0.0 0.2 4.8 5.4 0.0 0.0 0.0 0.0 1.1 0.6 2.4 0.5 0.4 0.6 0.0 10.1 2.0 1.6 5.2 0.0 0.0 1.2 0.0 1.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 1.0 14.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.3 0.1 2.1 0.0 0.0 0.0 7.1 0.1 0.7 1.3 0.6 0.0 15.2 13.7 0.0 0.1 0.7 0.3 7.6 3.2 31.7 0.0 0.0 0.0 6.2 0.0 63.9 1.3 0.0 10.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 27.8 3.8 11.0 18.9 19.0 16.9 5.4 11.8 3.4 0.0 0.0 0.0 0.0 0.1 0.8 0.2 5.1 0.0 0.0 5.2 0.0 0.0 1.7 49.4 4.4 0.0 0.0 0.0 65.7 0.0 0.1 0.1 0.0 0.0 0.1 14.3 1.7 0.6 0.3 6.3 3.7 0.0 0.0 108.2 0.0 1.5 67.6 0.0 0.0 2.2 0.8 0.0 5.3 1.1 1.8 0.0 0.0 0.0 0.0 0.0 LYPD5 FLJ30469 ENSG00000159871 "LY6/PLAUR domain containing 5" Q6UWN5 19 43795929-43827206 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "placenta: 39.6;skin 1: 39.8;tongue: 34.7" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 25.8;Late spermatids: 48.7;Melanocytes: 16.9;Syncytiotrophoblasts: 18.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 8.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.8" "Group enriched" "Detected in many" 4 "monocytes: 3.8;T-cells: 1.2" "Cell line enhanced" "Detected in some" "A-431: 5.9;BEWO: 9.1;HaCaT: 9.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042511, HPA054670" Approved Approved Nucleoplasm,Cytosol No NA "Nucleoplasm, Cytosol" "HPA042511: AB_10794279, HPA054670: AB_2682567" "unprognostic (4.27e-3)" "prognostic favorable (5.84e-4)" "unprognostic (4.63e-2)" "unprognostic (8.42e-3)" "unprognostic (4.80e-2)" "unprognostic (2.91e-3)" "unprognostic (3.96e-1)" "unprognostic (7.93e-3)" "unprognostic (1.37e-1)" "unprognostic (1.18e-1)" "unprognostic (1.40e-3)" "unprognostic (1.19e-1)" "unprognostic (1.83e-3)" "unprognostic (8.30e-2)" "unprognostic (2.02e-1)" "unprognostic (7.53e-3)" "unprognostic (4.08e-2)" 1.5 1.2 3.4 2.1 7.9 0.7 4.2 2.4 8.8 5.7 1.4 3.5 0.5 1.2 1.3 2.4 7.8 1.6 1.9 1.3 3.9 4.8 0.9 1.0 3.4 1.4 4.5 4.0 0.8 0.9 1.1 1.4 39.6 9.3 1.3 1.5 0.7 2.1 1.5 0.7 39.8 1.1 1.9 3.3 5.9 1.3 7.4 2.7 0.6 1.4 34.7 3.4 2.4 5.4 0.4 0.0 0.5 3.8 0.0 1.2 0.5 5.9 0.0 0.3 0.0 0.1 0.0 9.1 0.5 0.0 0.8 1.0 0.7 2.1 0.3 1.1 0.7 2.3 9.5 0.0 1.1 0.5 1.0 0.0 0.2 0.6 0.0 2.5 0.1 0.1 2.9 2.6 0.4 1.1 0.0 0.3 0.2 0.1 0.3 0.0 0.3 0.2 0.1 0.6 3.1 1.9 0.0 0.1 0.1 0.6 0.9 0.7 0.2 1.2 1.4 0.0 1.9 0.6 0.2 0.8 0.0 1.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.7 0.0 1.2 0.0 0.0 3.8 0.3 0.0 0.8 0.1 0.0 0.4 0.4 1.2 0.5 0.0 1.4 0.0 0.0 0.5 3.4 7.9 2.4 8.8 3.9 4.8 4.5 4.0 9.3 2.7 0.0 0.0 0.0 2.6 3.2 1.5 0.6 0.0 1.4 0.0 0.0 0.0 0.9 3.3 0.4 25.8 1.7 0.0 0.0 0.8 7.4 0.2 1.4 0.0 0.0 2.0 0.0 0.0 0.6 0.0 48.7 0.3 0.7 16.9 0.0 1.8 1.0 0.4 0.2 1.1 0.0 0.6 0.0 0.1 1.1 2.6 2.5 18.1 0.0 0.4 5.1 LYPLA1 LPL1 ENSG00000120992 "Lysophospholipase I" O75608 8 54046367-54102017 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 729.6;Late spermatids: 528.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050941, HPA063151" Enhanced Approved Nucleoplasm,Cytosol NA NA 1700000 "Nucleoplasm, Cytosol" "HPA050941: AB_2681284, HPA063151: " "unprognostic (2.62e-2)" "unprognostic (1.28e-2)" "unprognostic (3.25e-3)" "unprognostic (9.42e-2)" "unprognostic (9.48e-2)" "unprognostic (3.56e-1)" "unprognostic (9.58e-2)" "unprognostic (2.05e-2)" "unprognostic (6.52e-3)" "unprognostic (3.76e-2)" "prognostic unfavorable (2.34e-4)" "unprognostic (2.58e-1)" "unprognostic (2.15e-1)" "unprognostic (1.01e-1)" "unprognostic (1.11e-1)" "unprognostic (1.41e-1)" "unprognostic (2.56e-3)" 14.1 17.7 7.2 12.2 8.9 13.4 16.4 10.8 15.2 10.7 14.6 6.9 4.7 15.4 8.0 11.1 30.4 8.0 11.9 27.1 6.8 6.8 31.1 37.3 13.6 23.4 7.3 4.9 12.3 24.3 9.0 7.4 51.1 12.0 15.3 15.2 17.0 23.3 7.1 26.4 22.1 17.6 10.4 6.3 14.0 14.9 64.8 4.1 21.3 13.3 19.3 19.7 24.6 17.3 29.1 37.1 42.7 40.4 27.1 29.2 35.1 30.2 17.1 22.3 20.0 8.1 13.2 28.1 18.1 10.4 16.8 15.8 12.3 29.4 53.0 21.2 11.7 18.5 20.3 31.3 30.1 23.4 19.2 17.1 36.9 10.9 19.8 13.3 22.5 50.1 11.6 26.6 13.0 29.4 14.4 43.3 23.1 37.4 16.1 23.2 8.0 34.3 17.2 33.1 50.7 7.9 20.8 11.8 24.2 25.8 41.0 11.7 20.0 12.7 23.8 27.8 22.1 34.7 20.2 20.8 10.1 14.8 17.5 16.7 22.5 33.8 47.8 13.7 24.0 19.8 31.4 33.1 42.7 19.1 31.1 19.0 29.1 18.2 18.4 37.1 23.9 18.4 17.8 19.5 27.1 40.4 23.8 29.2 35.1 7.2 8.9 10.8 15.2 6.8 6.8 7.3 4.9 12.0 4.1 26.8 44.0 77.0 68.7 54.8 33.9 58.1 45.9 38.8 33.0 59.3 49.1 180.5 257.0 74.6 729.6 72.2 62.9 0.0 77.4 255.5 43.3 142.6 49.5 102.9 105.0 17.5 55.2 78.0 108.6 528.5 26.2 78.4 70.9 59.5 73.4 26.2 94.9 67.1 21.5 145.1 62.5 45.3 42.2 70.4 176.9 70.9 279.5 61.2 78.8 160.0 LYPLA2 APT-2 ENSG00000011009 "Lysophospholipase II" O95372 1 23790970-23795539 "Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063151 Uncertain Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA063151: " "unprognostic (8.84e-2)" "unprognostic (6.87e-2)" "unprognostic (2.65e-1)" "unprognostic (7.81e-3)" "unprognostic (2.12e-2)" "unprognostic (2.22e-2)" "prognostic unfavorable (5.84e-5)" "unprognostic (3.06e-1)" "unprognostic (1.80e-1)" "unprognostic (5.18e-2)" "unprognostic (2.52e-1)" "unprognostic (2.40e-1)" "prognostic favorable (4.99e-4)" "unprognostic (6.10e-2)" "unprognostic (1.47e-1)" "unprognostic (1.71e-3)" "unprognostic (1.24e-1)" 12.4 13.6 14.8 13.3 34.8 20.6 13.5 10.7 17.7 9.9 21.2 12.3 5.6 21.3 10.9 17.2 25.4 19.2 21.6 14.4 9.9 9.5 33.2 34.5 14.3 19.0 7.6 12.8 10.3 18.3 32.0 12.0 31.6 35.4 14.8 12.7 11.3 21.1 11.2 14.2 17.7 24.0 9.5 5.4 22.1 19.1 9.9 6.9 27.7 16.5 9.5 16.5 15.3 13.5 29.5 32.3 50.0 40.6 32.0 48.0 42.4 25.5 15.8 19.3 22.3 9.8 11.9 26.6 15.8 15.1 15.0 12.8 21.8 41.6 13.9 22.3 14.9 10.6 24.3 13.9 41.0 6.4 26.0 19.6 17.5 26.0 35.8 15.2 16.4 23.1 14.7 25.4 22.6 8.6 19.3 35.3 15.9 24.4 14.0 16.4 25.3 22.0 26.7 39.3 21.5 22.3 24.4 11.1 25.6 35.3 19.6 28.0 48.6 17.9 28.7 26.8 14.7 23.3 17.3 30.3 15.1 20.0 18.2 13.1 38.0 32.1 19.4 24.9 37.9 19.0 28.9 40.6 50.0 48.0 39.6 38.7 27.6 40.1 41.6 32.3 29.5 35.2 36.0 48.4 32.0 31.2 24.6 35.6 42.4 14.8 34.8 10.7 17.7 9.9 9.5 7.6 12.8 35.4 6.9 8.9 26.4 19.0 29.7 34.6 31.0 13.7 35.7 37.5 20.5 34.9 17.7 93.7 58.0 104.5 13.5 26.9 80.5 23.3 98.3 88.0 17.6 27.9 36.8 28.8 60.5 22.3 42.6 17.8 16.8 9.9 9.8 20.4 18.6 82.0 39.0 26.1 99.3 53.5 6.0 76.2 20.4 25.8 12.4 6.8 19.0 36.3 96.9 32.4 45.1 36.5 LYRM1 A211C6.1 ENSG00000102897 "LYR motif containing 1" O43325 16 20899868-20925006 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 101.6" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 144.2;Late spermatids: 327.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059840 Supported Nucleoplasm,Midbody Yes No Nucleoplasm Midbody "HPA059840: AB_2684137" "unprognostic (4.44e-2)" "unprognostic (1.03e-1)" "unprognostic (1.66e-2)" "prognostic favorable (7.48e-7)" "unprognostic (3.04e-1)" "unprognostic (1.10e-1)" "unprognostic (3.47e-1)" "unprognostic (8.60e-2)" "unprognostic (1.20e-1)" "unprognostic (1.04e-2)" "unprognostic (1.49e-2)" "unprognostic (3.39e-1)" "prognostic unfavorable (4.80e-4)" "unprognostic (1.57e-1)" "unprognostic (6.18e-2)" "unprognostic (3.86e-1)" "prognostic favorable (9.50e-4)" 25.4 18.9 19.1 15.0 17.4 12.8 25.5 12.6 17.8 17.5 16.6 9.6 14.0 9.5 17.1 21.1 16.2 24.9 17.0 34.2 15.4 18.2 30.6 101.6 11.2 19.2 18.8 13.8 25.3 26.1 20.5 13.9 9.0 24.9 21.1 14.0 13.1 14.1 19.1 28.7 10.6 12.6 27.6 17.9 11.5 15.7 22.9 9.0 16.2 19.4 14.9 12.9 25.3 19.7 12.7 7.2 47.4 10.2 8.4 14.2 10.1 12.1 13.0 12.1 9.6 32.9 26.2 4.0 10.1 16.9 5.8 8.8 14.6 15.2 8.5 39.5 12.1 8.5 8.5 5.3 10.6 9.5 15.9 8.3 3.9 3.6 37.6 24.5 12.7 7.7 19.0 9.4 16.3 46.8 16.5 24.1 12.7 8.5 15.1 25.2 16.1 12.5 8.6 12.6 18.1 6.9 17.2 6.7 10.2 21.0 7.1 11.9 11.4 6.3 10.5 16.8 7.0 10.8 7.4 6.4 8.4 6.1 13.2 6.9 14.9 20.9 13.3 21.9 13.7 7.3 47.4 7.2 23.3 8.6 9.1 11.8 12.7 13.2 10.6 5.9 11.2 10.7 10.8 26.8 8.4 10.2 7.2 14.2 10.1 19.1 17.4 12.6 17.8 15.4 18.2 18.8 13.8 24.9 9.0 17.9 13.9 29.7 49.4 18.7 29.4 53.1 25.5 24.1 10.3 22.7 13.7 23.9 64.6 36.2 144.2 28.7 7.0 0.0 38.2 7.9 24.2 36.6 15.1 41.4 13.8 14.3 28.8 11.1 11.6 327.6 26.7 12.7 16.9 55.9 15.3 26.4 29.5 14.0 35.7 98.2 27.2 12.9 22.0 66.8 24.3 18.2 12.5 26.1 25.2 44.5 LYSMD1 "MGC35223, RP11-68I18.5, SB145" ENSG00000163155 "LysM domain containing 1" Q96S90 1 151159748-151165948 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028055, HPA064537" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA028055: AB_10601912, HPA064537: AB_2685281" "unprognostic (1.71e-1)" "unprognostic (1.45e-2)" "unprognostic (1.19e-2)" "unprognostic (3.60e-3)" "unprognostic (2.59e-3)" "unprognostic (8.26e-2)" "unprognostic (7.24e-3)" "unprognostic (7.31e-3)" "unprognostic (1.77e-1)" "unprognostic (1.53e-2)" "unprognostic (1.88e-1)" "unprognostic (2.24e-2)" "unprognostic (8.72e-3)" "unprognostic (1.80e-1)" "unprognostic (2.07e-1)" "unprognostic (8.47e-3)" "unprognostic (6.33e-2)" 8.2 11.2 9.0 4.7 11.2 2.1 10.0 20.8 13.4 11.0 9.3 13.0 10.7 10.6 12.1 7.9 8.6 11.4 8.7 13.2 8.8 9.1 9.4 9.3 5.9 5.2 8.5 9.9 19.8 10.9 13.8 14.8 13.2 11.0 10.6 9.8 11.1 9.0 15.4 20.6 9.2 8.7 12.4 9.3 6.3 8.2 7.3 10.6 8.2 11.1 6.4 5.7 10.0 8.8 3.6 3.3 7.2 2.1 3.1 3.5 0.7 4.1 4.5 9.7 7.6 5.7 6.4 7.6 6.1 5.3 7.2 6.5 2.8 5.0 5.5 7.4 3.9 3.7 7.3 7.6 4.2 5.3 10.5 8.4 3.1 7.4 3.0 9.0 3.2 5.1 8.9 9.4 6.7 9.7 9.8 3.0 12.6 6.2 5.3 5.0 6.6 8.3 4.1 6.2 4.2 5.8 6.0 7.1 3.2 5.3 1.9 11.8 14.4 4.5 13.9 7.8 12.9 8.5 11.2 3.0 5.6 3.1 3.5 7.8 16.9 12.9 2.6 4.8 1.3 5.2 3.8 2.1 3.0 2.1 1.3 2.4 1.7 2.5 1.4 1.6 3.6 3.3 3.5 7.2 3.1 1.7 3.3 3.3 0.7 9.0 11.2 20.8 13.2 8.8 9.1 8.5 9.9 11.0 10.6 0.0 0.3 0.0 0.8 0.8 4.1 7.5 0.0 4.0 4.5 5.2 5.9 3.4 3.3 1.8 0.3 0.9 3.4 0.0 0.5 2.3 2.7 1.0 0.0 3.2 0.5 1.6 4.1 2.5 0.0 0.0 4.0 0.0 1.7 0.0 1.9 3.4 1.9 0.0 5.6 4.3 7.9 0.0 3.0 1.6 2.5 1.0 2.4 0.0 2.7 0.9 LYST "CHS, CHS1" ENSG00000143669 "Lysosomal trafficking regulator" Q99698 1 235661041-235883640 "Disease related genes, Predicted intracellular proteins" "Phagocytosis, Protein transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 38.8" "Cell type enhanced" "Detected in many" 6 "monocytes: 236.3;Rod photoreceptor cells: 167.4" "Cancer enhanced" "Detected in all" "melanoma: 11.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.0" "Group enriched" "Detected in all" 5 "granulocytes: 13.0;monocytes: 5.9" "Cell line enhanced" "Detected in many" "HDLM-2: 13.7;SK-MEL-30: 12.7;THP-1: 44.9;U-937: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053366, HPA055725" Supported "Nucleoplasm,Plasma membrane,Centriolar satellite" Yes No Nucleoplasm "Plasma membrane, Centriolar satellite" "HPA053366: AB_2682129, HPA055725: AB_2682898" "unprognostic (1.56e-2)" "unprognostic (1.54e-1)" "unprognostic (9.92e-2)" "unprognostic (8.85e-2)" "unprognostic (1.96e-2)" "unprognostic (4.32e-2)" "unprognostic (4.11e-2)" "unprognostic (7.79e-2)" "unprognostic (4.08e-2)" "unprognostic (1.95e-1)" "unprognostic (1.55e-1)" "unprognostic (9.31e-2)" "prognostic unfavorable (5.27e-5)" "unprognostic (1.59e-1)" "unprognostic (1.54e-1)" "unprognostic (6.29e-2)" "unprognostic (1.99e-1)" 10.3 5.2 6.4 9.0 8.8 31.3 10.6 10.5 7.1 8.8 5.3 3.8 3.4 3.4 6.8 4.3 6.6 5.6 5.8 4.7 4.3 2.4 5.0 6.1 10.9 7.8 4.2 6.0 6.2 5.0 9.1 12.6 5.5 5.3 6.0 5.0 9.6 8.2 4.8 3.9 11.7 6.3 9.8 9.2 11.3 8.4 6.4 6.3 38.8 8.5 4.0 7.6 9.3 10.6 1.6 1.7 13.0 5.9 1.7 1.0 0.7 3.8 0.9 0.4 0.9 6.0 6.9 0.6 1.4 5.7 1.5 1.4 0.0 1.0 0.5 0.6 3.1 3.6 1.8 0.5 0.7 1.3 13.7 1.2 1.2 0.8 0.3 1.1 1.8 1.7 2.3 3.6 1.9 4.7 2.2 1.2 0.6 0.1 0.8 1.2 0.2 2.3 3.9 0.1 0.7 0.4 0.1 0.5 0.0 4.4 4.2 2.5 0.5 1.5 0.0 12.7 0.5 0.5 44.9 2.6 1.1 0.5 1.3 1.2 0.9 0.0 0.0 1.9 17.2 3.2 0.4 3.1 5.7 0.6 3.5 1.0 1.1 0.3 0.7 1.7 1.6 0.2 0.5 13.0 1.7 5.9 0.2 0.2 0.7 6.4 8.8 10.5 7.1 4.3 2.4 4.2 6.0 5.3 6.3 17.9 50.4 48.0 71.9 63.1 61.8 9.2 10.2 24.1 39.8 10.4 88.4 5.4 10.0 5.6 9.9 41.7 11.5 0.0 10.7 4.0 23.9 49.0 106.6 14.5 28.2 49.3 9.2 15.4 73.1 13.4 25.9 70.4 114.7 236.3 11.3 23.7 24.4 14.2 20.5 9.0 167.4 12.9 28.6 79.6 22.6 57.0 7.3 65.4 6.3 82.9 LYZ ENSG00000090382 Lysozyme P61626 12 69348341-69354234 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase" "Amyloidosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 490.0;salivary gland: 1017.8" "Cell type enhanced" "Detected in many" 16 "Kupffer cells: 3040.5;Macrophages: 4386.3;Pancreatic endocrine cells: 1930.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 490.0;myeloid DC: 308.1" "Group enriched" "Detected in all" 18 "dendritic cells: 308.1;monocytes: 490.0" "Cell line enriched" "Detected in some" 13 "OE19: 521.4" "Not detected" "Not detected" "CAB000055, HPA048284, HPA066182" Enhanced Approved "Nucleoplasm,Golgi apparatus,Actin filaments" "Secreted to blood" NA NA 1500000000 2600000000 "Golgi apparatus, Actin filaments" Nucleoplasm "CAB000055: AB_2341230, HPA048284: AB_2680339, HPA066182: AB_2732741" "unprognostic (8.52e-2)" "unprognostic (6.12e-3)" "unprognostic (2.83e-1)" "unprognostic (7.29e-2)" "unprognostic (7.91e-2)" "prognostic favorable (7.45e-4)" "unprognostic (1.21e-1)" "unprognostic (7.40e-2)" "unprognostic (1.41e-1)" "unprognostic (2.08e-2)" "unprognostic (1.44e-1)" "unprognostic (3.13e-1)" "unprognostic (2.50e-1)" "unprognostic (2.37e-1)" "unprognostic (3.65e-2)" "unprognostic (5.78e-2)" "unprognostic (3.62e-2)" 19.1 2.4 1.7 42.1 1.8 187.0 2.9 1.6 1.6 2.9 52.5 2.0 0.1 72.4 2.3 6.9 3.9 3.4 105.0 15.4 1.8 1.8 4.8 4.8 81.0 57.2 2.1 0.0 4.5 5.0 0.0 1.8 8.3 0.9 2.4 5.0 2.7 1017.8 2.8 1.8 2.1 95.0 1.8 2.5 34.2 212.1 1.6 0.5 24.5 2.4 207.7 75.7 6.6 2.4 1.6 308.1 21.9 490.0 2.3 1.1 407.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 39.8 0.0 4.6 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 4.5 0.1 521.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 20.5 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 22.3 0.0 7.5 490.0 5.9 0.7 102.3 1.1 1.6 0.4 0.5 308.1 0.4 0.4 0.4 21.9 2.3 17.6 6.5 0.6 407.9 1.7 1.8 1.6 1.6 1.8 1.8 2.1 0.0 0.9 0.5 80.4 424.7 79.8 2.3 50.8 0.1 0.0 815.3 52.2 87.6 26.2 0.0 4.1 0.0 46.7 1.4 10.8 19.6 0.0 484.8 7.4 19.7 4.1 113.9 7.3 924.7 0.0 12.0 37.4 3040.5 3.7 3.7 4386.3 50.6 757.4 61.5 0.0 1930.3 401.2 2.1 5.0 1.1 38.8 3.9 0.6 2.3 33.4 7.1 13.8 38.3 2.2 LZIC MGC15436 ENSG00000162441 "Leucine zipper and CTNNBIP1 domain containing" Q8WZA0 1 9922113-9943407 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 240.8;Spermatocytes: 162.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028184, HPA058614" Approved Approved Nucleoplasm,Cytosol NA NA 110000 Nucleoplasm Cytosol "HPA028184: AB_10602706, HPA058614: AB_2683779" "unprognostic (1.56e-1)" "unprognostic (2.41e-1)" "unprognostic (1.76e-2)" "unprognostic (1.62e-1)" "unprognostic (6.26e-2)" "unprognostic (8.37e-2)" "prognostic unfavorable (2.47e-5)" "unprognostic (2.89e-1)" "unprognostic (3.79e-3)" "unprognostic (7.84e-2)" "unprognostic (1.70e-3)" "unprognostic (1.23e-1)" "prognostic favorable (3.56e-5)" "unprognostic (1.19e-1)" "unprognostic (3.76e-3)" "unprognostic (1.50e-2)" "unprognostic (1.95e-2)" 13.6 14.2 21.4 12.8 18.0 11.4 17.7 13.6 21.6 18.2 19.2 24.5 15.1 19.5 18.3 13.5 17.6 16.9 14.1 21.0 19.8 16.5 20.0 20.4 11.5 13.6 24.3 10.3 25.5 15.3 26.1 15.9 14.9 20.5 15.8 19.4 13.0 16.6 14.6 21.7 13.9 23.7 21.3 28.2 11.0 12.2 44.3 20.1 20.2 17.2 13.2 15.6 14.9 23.1 13.9 28.1 28.3 22.7 16.8 21.0 12.9 16.1 10.7 20.6 14.6 12.8 21.3 9.2 14.7 12.5 20.8 20.2 13.3 28.4 19.6 16.8 18.5 13.1 12.3 19.4 21.3 31.3 18.1 13.3 28.5 13.9 21.8 12.4 26.0 14.8 13.9 30.6 29.1 27.6 14.9 16.3 26.0 35.3 11.2 19.1 11.4 21.3 12.7 10.4 20.4 17.5 22.8 27.3 15.7 11.2 7.3 10.3 16.3 18.0 7.9 34.6 20.5 13.1 13.4 14.8 14.5 19.8 20.5 15.4 9.2 21.0 33.6 14.8 38.9 19.2 22.0 18.8 28.3 16.0 20.7 14.0 13.9 16.3 15.5 18.1 13.8 16.3 16.9 18.9 16.8 22.7 28.1 21.0 12.9 21.4 18.0 13.6 21.6 19.8 16.5 24.3 10.3 20.5 20.1 6.0 12.9 11.9 18.9 11.3 8.9 52.1 10.2 33.5 11.4 7.0 5.9 24.8 41.4 22.9 240.8 16.9 27.5 0.0 18.4 37.8 16.2 18.9 30.0 19.2 37.4 39.7 8.7 11.6 21.1 51.9 24.5 26.4 13.5 28.9 17.2 47.0 20.3 25.9 25.8 42.9 14.5 19.4 17.6 162.6 67.1 14.6 28.8 17.5 20.6 18.3 LZTR1 "BTBD29, LZTR-1" ENSG00000099949 "Leucine zipper like transcription regulator 1" Q8N653 22 20982013-20999038 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067852, HPA068772, HPA071248" Approved Approved Nucleoplasm,Centrosome,Cytosol No No Nucleoplasm "Centrosome, Cytosol" "HPA067852: , HPA068772: AB_2686031, HPA071248: AB_2686372" "unprognostic (1.88e-2)" "unprognostic (1.01e-1)" "unprognostic (1.90e-1)" "unprognostic (1.08e-1)" "unprognostic (1.06e-1)" "unprognostic (2.44e-2)" "prognostic unfavorable (5.15e-4)" "unprognostic (9.81e-2)" "unprognostic (3.55e-1)" "unprognostic (3.78e-2)" "unprognostic (1.01e-2)" "unprognostic (2.64e-1)" "unprognostic (1.16e-3)" "unprognostic (4.29e-2)" "unprognostic (1.65e-1)" "unprognostic (6.25e-2)" "unprognostic (1.25e-2)" 21.2 16.9 17.3 15.6 17.4 10.3 17.9 20.7 24.7 18.5 18.3 25.3 20.6 18.9 24.9 14.0 16.5 18.3 21.2 15.8 15.4 10.9 17.2 13.1 16.2 12.8 19.6 16.5 21.7 16.2 24.9 26.0 18.8 19.0 16.9 12.9 18.9 17.5 18.0 17.2 15.0 15.7 21.9 14.0 19.3 14.5 10.8 19.2 10.8 19.6 12.6 12.5 18.5 16.4 1.6 2.2 0.2 3.4 1.8 3.0 1.5 6.3 5.2 7.8 9.4 17.9 12.4 6.3 13.0 9.1 7.4 10.2 3.0 2.6 6.7 4.8 14.5 6.9 8.6 5.8 10.6 3.0 12.5 13.6 7.2 6.8 4.5 9.6 3.9 9.6 11.4 5.4 9.4 6.8 11.8 14.4 6.3 30.0 11.7 8.4 3.8 6.9 3.7 2.4 7.7 5.7 8.2 11.3 2.6 5.9 8.6 7.7 11.4 7.1 12.3 7.6 4.9 5.7 7.2 12.8 17.4 8.9 7.8 7.0 5.1 4.4 2.0 7.8 3.8 8.4 0.0 2.5 0.2 3.0 3.1 1.6 1.6 1.5 2.8 2.2 1.0 2.1 1.5 0.1 1.8 3.4 1.2 0.5 1.5 17.3 17.4 20.7 24.7 15.4 10.9 19.6 16.5 19.0 19.2 11.9 10.4 9.7 1.4 1.9 8.1 11.2 2.5 6.7 5.7 8.7 5.9 3.6 1.7 6.6 0.8 9.5 7.8 0.0 4.3 3.2 5.4 2.0 5.7 6.2 6.9 3.2 8.7 12.3 11.6 1.3 8.1 4.9 6.8 4.6 9.1 6.6 5.7 5.9 9.2 6.1 9.3 0.0 7.2 2.6 1.7 3.1 3.0 6.9 5.8 0.9 MAB21L1 CAGR1 ENSG00000180660 "Mab-21 like 1" Q13394 13 35474182-35477209 "Predicted intracellular proteins" "Developmental protein, Nucleotidyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 24.0;skeletal muscle: 8.5" "Group enriched" "Detected in some" 38 "Bipolar cells: 51.8;Cone photoreceptor cells: 47.1;Horizontal cells: 82.6;Muller glia cells: 136.9;Rod photoreceptor cells: 120.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 12.9;BJ hTERT+: 10.5;BJ hTERT+ SV40 Large T+: 14.9;HBF TERT88: 16.2;hTERT-RPE1: 31.2;SH-SY5Y: 48.0" "Group enriched" "Detected in some" 9 "cerebellum: 45.8;midbrain: 22.3;pons and medulla: 12.9" "Low region specificity" "Detected in all" "HPA049324, HPA059864" Approved Nucleoplasm NA NA Nucleoplasm "HPA049324: AB_2680712, HPA059864: AB_2684147" "unprognostic (4.44e-2)" "unprognostic (2.82e-2)" "unprognostic (2.79e-3)" "unprognostic (3.87e-4)" "unprognostic (5.67e-2)" "unprognostic (5.26e-2)" "unprognostic (1.71e-1)" "unprognostic (4.12e-3)" "unprognostic (1.64e-1)" "unprognostic (1.56e-1)" "unprognostic (1.12e-1)" "unprognostic (1.55e-1)" "unprognostic (3.19e-2)" "unprognostic (6.93e-3)" "unprognostic (1.14e-1)" "unprognostic (3.72e-1)" "unprognostic (2.86e-1)" 2.9 6.4 0.3 0.5 0.0 0.0 6.3 24.0 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.8 0.6 1.1 0.0 0.0 0.0 0.0 1.8 0.5 3.7 0.2 8.5 1.2 1.1 0.0 0.8 0.0 0.3 0.0 0.6 0.2 0.2 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.9 10.5 14.9 8.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 16.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 31.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 1.2 48.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 51.8 0.3 0.0 0.0 0.0 0.0 47.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.5 0.2 2.3 0.0 0.1 82.6 0.0 1.3 0.0 0.0 0.3 0.0 1.7 0.0 0.0 136.9 0.0 0.0 0.4 0.0 120.3 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.2 MAB21L2 ENSG00000181541 "Mab-21 like 2" Q9Y586 4 150581922-150584693 "Disease related genes, Predicted intracellular proteins" "Developmental protein" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 19.2;intestine: 59.8;smooth muscle: 15.2" "Cell type enhanced" "Detected in some" 24 "Cholangiocytes: 12.7;Horizontal cells: 23.8;Muller glia cells: 5.1" "Cancer enhanced" "Detected in some" "colorectal cancer: 3.3" "Region enriched" "Detected in some" 18 "pons and medulla: 19.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "hTERT-RPE1: 46.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA049324, HPA059864" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA049324: AB_2680712, HPA059864: AB_2684147" "unprognostic (1.12e-1)" "unprognostic (3.67e-2)" "unprognostic (4.03e-2)" "unprognostic (2.63e-1)" "unprognostic (2.32e-1)" "unprognostic (3.85e-2)" "unprognostic (8.99e-2)" "unprognostic (2.76e-2)" "unprognostic (2.75e-1)" "unprognostic (6.60e-2)" "unprognostic (4.78e-3)" "unprognostic (1.18e-1)" "unprognostic (6.81e-2)" "unprognostic (1.68e-1)" 0.6 3.1 0.2 8.6 0.4 0.0 0.1 0.2 0.2 0.2 59.8 0.1 0.0 6.8 0.1 0.9 0.9 0.2 0.5 0.7 0.2 0.6 0.1 0.5 0.1 0.6 1.0 0.0 0.1 0.2 0.0 0.3 0.0 19.2 0.2 8.1 9.0 2.2 0.0 0.3 0.2 14.7 15.2 4.5 0.1 0.3 0.1 0.0 0.2 1.4 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.2 0.0 0.0 0.0 46.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.2 0.2 0.6 1.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.1 3.3 0.8 12.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 23.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 5.1 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 MAB21L3 "C1orf161, FLJ38716" ENSG00000173212 "Mab-21 like 3" Q8N8X9 1 116111755-116135240 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 9.9;skin 1: 8.7" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 41.7;Alveolar cells type 2: 51.9;Ciliated cells: 24.1;Club cells: 33.0;granulocytes: 16.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 5.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 15.7;RT4: 15.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039551 Approved Nucleoplasm NA NA Nucleoplasm "HPA039551: AB_2676565" "unprognostic (9.25e-3)" "unprognostic (3.47e-3)" "unprognostic (1.44e-3)" "unprognostic (5.23e-5)" "unprognostic (2.22e-1)" "unprognostic (2.06e-2)" "unprognostic (5.36e-2)" "unprognostic (3.75e-3)" "unprognostic (1.21e-1)" "unprognostic (7.01e-2)" "unprognostic (2.49e-1)" "unprognostic (4.84e-2)" "unprognostic (1.16e-2)" "unprognostic (1.84e-1)" "unprognostic (1.69e-1)" "unprognostic (2.52e-1)" "unprognostic (4.61e-2)" 0.3 0.0 0.3 2.7 0.3 0.8 0.5 0.3 0.3 2.8 2.1 0.3 0.3 0.2 0.3 0.3 9.9 0.0 0.3 0.3 0.3 0.2 2.0 3.1 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.3 2.2 0.3 1.1 1.8 0.3 1.3 0.7 0.6 8.7 3.4 0.3 0.3 0.3 0.4 0.7 0.3 0.3 0.3 2.5 1.7 2.1 4.2 2.6 1.3 5.5 1.2 4.4 0.7 0.0 3.4 0.1 0.8 0.6 0.1 0.0 5.3 0.6 0.2 0.0 0.0 0.3 1.3 2.1 15.7 0.1 0.3 2.9 0.1 0.1 0.1 0.7 0.1 0.9 0.4 2.8 0.0 0.9 0.5 0.0 0.4 0.1 0.3 0.1 0.0 0.5 0.9 2.4 0.0 0.3 0.5 0.5 2.2 0.7 1.0 0.8 0.8 0.4 0.6 15.1 0.5 0.8 2.4 2.0 0.6 2.5 2.5 0.4 0.5 1.0 2.5 0.7 0.6 2.3 4.0 1.0 0.5 0.3 1.0 2.6 1.2 0.3 0.6 0.6 0.5 0.8 0.4 0.5 0.3 2.6 0.7 0.7 5.5 4.4 0.7 1.3 0.2 0.0 0.3 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.3 0.3 41.7 51.9 0.0 2.3 0.6 0.0 0.4 0.0 24.1 33.0 3.5 0.0 3.8 1.7 0.0 0.1 0.0 0.7 0.0 0.2 0.5 0.0 0.7 16.3 0.6 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 1.5 11.4 0.0 1.0 0.6 MACROD1 LRP16 ENSG00000133315 "MACRO domain containing 1" Q9BQ69 11 63998558-64166106 "Disease related genes, Predicted intracellular proteins" "DNA damage" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 142.5" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 116.0;Proximal tubular cells: 164.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 27.0;RPMI-8226: 51.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041031, HPA071075" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA041031: AB_10794435, HPA071075: AB_2686341" "unprognostic (1.19e-2)" "unprognostic (2.15e-1)" "unprognostic (1.38e-1)" "unprognostic (3.14e-2)" "unprognostic (3.88e-2)" "unprognostic (6.03e-2)" "unprognostic (1.95e-2)" "unprognostic (2.82e-1)" "unprognostic (2.44e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.15e-1)" "prognostic favorable (4.68e-6)" "unprognostic (2.45e-2)" "unprognostic (9.92e-2)" "unprognostic (2.36e-1)" "unprognostic (2.86e-2)" 4.9 3.0 2.9 2.8 3.3 2.5 3.9 6.2 4.6 3.6 6.9 2.8 7.0 4.3 3.4 6.5 7.8 3.2 3.9 29.0 2.2 3.4 10.6 10.4 3.0 1.8 3.0 3.1 5.2 16.6 2.5 2.7 2.1 3.1 6.1 1.9 4.6 16.4 8.1 142.5 5.5 3.9 6.2 2.4 2.7 5.6 1.9 2.7 0.8 12.7 25.0 3.3 4.6 4.5 0.6 0.7 0.0 1.2 0.0 2.0 0.4 4.0 2.1 0.6 3.8 0.6 0.4 3.7 2.3 1.1 1.9 1.8 2.0 11.0 15.4 8.5 0.2 0.6 10.4 0.5 0.0 0.1 1.1 7.2 5.5 8.8 10.9 2.3 4.6 0.6 0.9 1.2 0.2 0.5 1.3 0.7 4.8 5.0 3.1 0.3 27.0 6.4 15.9 1.8 1.4 8.2 5.7 4.3 51.0 0.6 0.2 5.3 11.0 2.1 15.9 14.5 0.0 11.4 0.1 1.0 1.7 2.6 2.6 0.2 6.2 0.9 2.5 1.2 4.7 1.6 0.0 0.2 0.0 2.0 1.2 1.9 0.6 1.8 1.1 0.4 0.4 0.9 0.8 0.0 0.0 0.0 0.7 0.0 0.4 2.9 3.3 6.2 4.6 2.2 3.4 3.0 3.1 3.1 2.7 0.0 5.8 10.9 30.6 24.8 13.1 30.8 30.6 0.0 4.5 40.1 0.0 25.1 116.0 16.5 5.8 9.0 17.2 0.0 34.7 10.9 13.7 23.2 0.0 42.3 9.7 11.1 22.0 7.4 2.5 15.9 23.0 1.8 37.1 2.8 52.9 14.3 17.6 28.8 13.4 164.4 15.8 19.4 18.4 2.9 28.5 32.4 20.0 6.1 65.5 30.1 MACROD2 "C20orf133, dJ631M13.5" ENSG00000172264 "MACRO domain containing 2" A1Z1Q3 20 13995369-16053197 "Predicted intracellular proteins" "DNA damage" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.5" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 2: 151.9;Bipolar cells: 89.0;Club cells: 67.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 7.4;naive B-cell: 14.1;neutrophil: 3.8" "Group enriched" "Detected in many" 5 "B-cells: 14.1;granulocytes: 3.8" "Cell line enhanced" "Detected in many" "EFO-21: 14.7;Karpas-707: 18.2;RT4: 8.0;SCLC-21H: 10.0" "Low region specificity" "Detected in all" HPA049076 Enhanced Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA049076: " "unprognostic (1.70e-1)" "unprognostic (7.36e-2)" "unprognostic (1.59e-1)" "unprognostic (5.68e-3)" "unprognostic (2.03e-1)" "unprognostic (1.63e-3)" "unprognostic (1.24e-1)" "unprognostic (2.32e-2)" "unprognostic (3.02e-1)" "unprognostic (2.96e-2)" "unprognostic (4.02e-1)" "unprognostic (7.83e-2)" "unprognostic (4.15e-5)" "unprognostic (9.80e-2)" "unprognostic (9.91e-3)" "unprognostic (3.23e-1)" "unprognostic (2.02e-2)" 2.8 5.1 15.2 3.0 47.5 2.0 4.2 20.8 13.6 6.4 2.7 3.7 2.0 1.4 12.1 3.9 2.3 10.3 4.1 1.9 10.5 8.2 5.6 2.7 15.7 5.5 7.6 8.9 4.5 4.2 5.4 12.0 1.8 10.5 7.1 2.1 4.0 2.4 14.9 3.1 3.9 1.8 5.8 6.9 6.9 3.4 7.9 9.9 0.0 4.1 0.1 7.2 10.6 3.1 14.1 0.5 3.8 1.8 0.3 0.6 0.5 1.0 0.6 2.8 0.9 0.9 0.8 0.5 0.5 2.0 1.1 0.6 1.0 0.7 1.9 14.7 1.4 2.6 1.4 0.4 0.7 1.9 1.0 0.9 1.1 1.1 1.9 3.6 0.3 0.3 1.6 1.1 0.0 0.8 1.0 1.1 0.3 1.3 18.2 3.1 0.4 0.5 0.7 1.0 6.3 0.4 1.1 0.5 3.5 2.1 8.0 10.0 4.3 1.5 0.1 0.7 1.3 1.0 1.6 0.8 1.5 3.1 0.2 0.1 1.5 0.5 1.8 0.9 1.0 1.8 0.3 0.6 0.6 0.4 1.3 0.4 7.4 0.3 0.4 0.5 14.1 0.4 0.6 3.8 0.3 1.8 0.2 0.2 0.5 15.2 47.5 20.8 12.8 10.5 8.2 7.6 8.9 10.5 9.9 47.6 151.9 14.5 37.6 3.9 89.0 4.0 12.7 12.0 67.1 12.2 37.3 4.4 8.3 9.1 28.4 2.1 1.1 0.0 1.4 0.2 2.6 4.4 1.1 3.9 0.8 7.9 1.2 2.5 0.3 46.6 3.1 1.0 3.3 0.0 3.7 9.3 4.6 1.1 16.6 5.1 18.6 6.5 4.1 17.9 16.4 5.8 1.7 0.0 2.4 3.8 MAD1L1 "HsMAD1, MAD1, PIG9, TP53I9, TXBP181" ENSG00000002822 "Mitotic arrest deficient 1 like 1" Q9Y6D9 7 1815793-2233243 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 9 "Early spermatids: 225.4;Late spermatids: 498.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003635, CAB015338" Supported Supported "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "CAB015338: AB_627901, HPA003635: AB_1853472" "unprognostic (1.85e-1)" "unprognostic (3.76e-2)" "unprognostic (4.26e-3)" "unprognostic (8.32e-2)" "unprognostic (1.42e-2)" "unprognostic (3.83e-2)" "unprognostic (2.70e-2)" "unprognostic (1.18e-2)" "unprognostic (4.78e-2)" "unprognostic (5.76e-2)" "unprognostic (1.89e-1)" "unprognostic (2.48e-1)" "unprognostic (2.33e-3)" "unprognostic (5.18e-2)" "unprognostic (1.33e-1)" "unprognostic (2.36e-1)" "unprognostic (4.57e-1)" 11.8 7.6 11.4 17.3 29.7 19.1 9.0 15.7 15.0 10.0 9.3 12.1 6.1 8.8 10.4 8.5 12.3 9.2 10.9 11.4 12.3 10.0 7.9 17.6 13.3 23.2 14.8 13.3 10.3 10.7 7.8 10.7 9.3 10.5 9.4 6.8 12.0 10.3 8.3 16.8 17.4 9.8 10.3 11.9 21.2 9.8 15.4 11.0 25.9 10.5 7.2 19.1 11.3 11.3 25.4 21.9 25.8 21.6 6.7 46.8 18.2 17.0 6.8 8.5 12.9 6.0 5.2 11.2 12.6 7.9 13.6 11.0 13.4 10.3 10.6 4.8 7.5 19.8 13.6 7.9 9.2 7.8 5.4 8.0 11.8 10.4 20.8 7.9 8.1 23.3 6.6 7.6 14.8 7.6 3.0 6.7 6.1 13.5 8.2 7.2 17.1 3.4 32.0 14.0 2.8 8.1 18.3 9.1 7.9 7.5 9.8 5.9 16.2 10.0 10.2 28.9 6.5 7.8 28.0 8.3 9.8 27.6 27.8 12.6 12.9 12.0 13.0 8.6 25.7 33.4 25.8 12.1 8.6 27.9 21.6 26.0 19.7 27.2 27.1 21.9 25.4 37.7 26.2 3.4 6.7 19.6 8.1 46.8 18.2 11.4 29.7 15.7 15.0 12.3 10.0 14.8 13.3 10.5 11.0 3.0 7.2 29.6 12.2 15.7 6.9 7.5 0.0 6.7 9.1 7.0 9.8 13.5 13.3 10.9 225.4 10.8 7.0 0.0 9.9 13.5 13.2 7.9 40.5 28.0 35.1 22.3 31.2 4.3 18.6 498.1 11.5 30.9 35.4 29.7 7.7 17.4 12.6 6.0 9.9 8.6 11.6 19.4 9.8 28.6 33.1 18.7 20.5 41.5 6.5 9.5 MAD2L1 "HSMAD2, MAD2" ENSG00000164109 "Mitotic arrest deficient 2 like 1" Q13257 4 120055608-120067074 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 27.3" "Group enriched" "Detected in many" 5 "Extravillous trophoblasts: 100.5;Spermatocytes: 142.5;Spermatogonia: 91.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003348 Uncertain Approved Nucleoplasm NA Yes Nucleoplasm "HPA003348: AB_10603014" "unprognostic (4.08e-3)" "unprognostic (7.31e-2)" "unprognostic (5.17e-3)" "unprognostic (1.10e-2)" "unprognostic (1.27e-1)" "unprognostic (5.54e-2)" "prognostic unfavorable (5.15e-5)" "prognostic unfavorable (2.17e-4)" "unprognostic (6.74e-3)" "unprognostic (1.47e-1)" "unprognostic (3.20e-3)" "unprognostic (3.87e-3)" "prognostic unfavorable (3.07e-11)" "unprognostic (3.06e-2)" "unprognostic (4.05e-1)" "unprognostic (1.03e-1)" "unprognostic (9.70e-2)" 1.4 1.8 2.4 4.2 5.7 10.3 2.4 4.4 4.1 1.9 4.4 1.2 0.3 3.8 1.7 1.4 6.5 2.9 1.1 1.7 2.7 2.7 1.2 1.2 1.5 7.6 2.3 3.6 1.7 1.2 0.7 1.0 3.5 2.4 1.6 5.5 0.7 2.4 1.2 1.2 2.3 4.2 1.8 2.8 3.8 1.9 13.7 1.2 27.3 1.2 8.2 7.3 2.1 2.4 1.8 2.2 2.0 0.8 2.5 3.9 1.7 14.7 6.4 15.2 9.9 1.6 2.0 6.5 11.7 6.6 12.2 9.5 8.6 9.1 21.7 3.9 4.2 5.4 4.0 15.1 8.9 17.2 10.2 10.6 12.0 6.3 8.1 0.5 19.5 6.9 1.1 1.3 8.3 5.2 3.1 7.0 9.3 14.3 12.4 6.4 6.5 18.7 8.5 10.4 7.7 7.4 9.7 20.4 8.9 5.0 5.7 16.2 11.5 5.8 7.2 3.6 7.8 4.8 7.2 4.4 8.3 9.4 8.3 14.7 11.6 12.4 14.2 7.7 10.1 10.8 2.0 0.5 0.4 1.6 0.5 2.1 1.8 3.8 3.0 0.4 1.4 3.5 3.5 1.3 2.5 0.8 2.2 3.9 1.7 2.4 5.7 4.4 4.1 2.7 2.7 2.3 3.6 2.4 1.2 0.0 2.2 6.0 6.3 15.3 8.5 3.0 2.5 6.7 2.3 7.0 2.0 18.3 0.0 2.9 1.8 3.1 2.9 23.3 1.4 100.5 6.1 4.5 15.0 1.6 23.3 19.1 1.7 2.5 6.3 3.6 4.4 6.2 8.5 4.6 8.1 10.6 1.7 2.9 1.4 4.3 3.6 12.9 6.6 142.5 91.0 7.9 9.0 17.9 16.2 4.5 MAD2L1BP "CMT2, dJ261G23.1, KIAA0110" ENSG00000124688 "MAD2L1 binding protein" Q15013 6 43629540-43640952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 66.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028729 Supported "Nucleoplasm,Nuclear membrane,Nucleoli" Yes No Nucleoplasm "Nuclear membrane, Nucleoli" "HPA028729: AB_2672752" "unprognostic (2.60e-1)" "unprognostic (2.06e-1)" "unprognostic (3.92e-2)" "unprognostic (6.97e-2)" "unprognostic (6.91e-2)" "unprognostic (6.92e-2)" "unprognostic (5.74e-3)" "unprognostic (2.67e-3)" "unprognostic (3.60e-1)" "unprognostic (7.18e-2)" "unprognostic (1.71e-1)" "unprognostic (6.64e-2)" "unprognostic (4.61e-2)" "unprognostic (1.18e-1)" "unprognostic (3.34e-1)" "unprognostic (1.16e-1)" "unprognostic (3.25e-3)" 12.1 16.6 11.0 13.3 14.4 35.7 13.8 16.5 24.4 12.2 21.3 10.1 6.3 18.1 12.9 14.1 17.0 13.4 13.2 19.2 11.9 12.1 18.3 18.9 11.4 18.2 11.0 12.6 11.3 18.5 11.5 12.8 12.6 14.0 12.6 22.0 13.6 24.2 11.3 25.1 11.9 22.0 12.4 9.8 17.5 16.8 17.6 7.9 29.0 18.9 13.9 19.9 14.3 13.2 27.9 27.6 39.7 22.2 26.8 39.8 21.4 15.9 7.4 11.7 13.0 10.2 11.1 7.1 9.6 15.6 21.4 20.1 15.1 6.5 12.5 5.5 11.3 19.5 10.5 18.2 13.4 16.5 11.4 14.1 15.4 8.2 13.0 11.0 9.0 9.3 11.2 16.5 15.9 9.7 10.8 16.0 10.1 19.7 6.7 14.8 15.0 8.0 16.8 7.2 66.4 9.6 9.3 9.1 11.8 15.2 12.8 14.0 14.2 6.9 10.7 45.4 9.3 12.5 24.2 8.7 11.5 9.6 7.5 15.3 8.7 7.4 29.3 10.4 15.3 12.6 39.7 22.2 25.0 25.7 22.1 25.8 27.9 30.8 28.4 27.6 25.6 32.3 29.0 18.6 26.8 19.9 18.3 39.8 21.4 11.0 14.4 16.5 24.4 11.9 12.1 11.0 12.6 14.0 7.9 23.8 10.1 16.1 16.9 12.8 12.1 10.4 10.2 21.4 21.6 3.5 11.8 18.1 23.2 24.8 36.4 11.3 26.9 23.3 18.5 17.9 15.3 9.1 30.1 11.3 15.5 9.5 16.7 14.7 10.8 27.8 11.2 13.0 27.0 20.8 15.1 12.4 20.4 25.9 11.3 16.5 12.0 25.8 12.2 18.4 18.8 8.4 5.1 15.4 19.2 21.6 MAEA "EMP, GID9" ENSG00000090316 "Macrophage erythroblast attacher" Q7L5Y9 4 1289851-1340147 "Predicted intracellular proteins" "Cell cycle, Cell division, Erythrocyte maturation, Ubl conjugation pathway" "Actin-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036886, HPA058185" Approved Enhanced Nucleoplasm Yes No Nucleoplasm "HPA036886: , HPA058185: AB_2683633" "unprognostic (2.70e-2)" "unprognostic (1.52e-1)" "unprognostic (1.78e-2)" "unprognostic (1.11e-1)" "unprognostic (2.03e-2)" "prognostic favorable (5.34e-4)" "unprognostic (3.10e-3)" "unprognostic (3.89e-2)" "unprognostic (1.78e-1)" "unprognostic (2.50e-1)" "unprognostic (6.94e-3)" "unprognostic (4.65e-3)" "prognostic favorable (1.90e-4)" "unprognostic (1.17e-2)" "unprognostic (2.49e-1)" "unprognostic (1.97e-1)" "unprognostic (4.51e-2)" 23.6 35.4 25.5 26.3 28.4 19.5 20.9 34.0 35.8 24.4 33.3 21.7 26.8 39.9 27.3 23.8 34.7 26.0 29.2 36.6 23.7 33.1 33.2 27.9 19.1 26.1 23.3 32.0 33.4 32.0 21.9 30.3 27.6 34.0 23.6 17.2 22.3 36.7 28.0 27.3 29.0 38.2 20.9 17.7 31.0 30.3 23.3 26.7 26.5 26.1 28.5 26.5 26.3 25.4 19.7 18.9 48.2 28.0 17.0 35.8 21.9 22.7 27.0 19.2 19.0 12.8 12.8 25.0 23.3 12.2 18.8 17.3 28.0 29.3 20.7 18.2 16.7 34.9 16.9 18.4 28.5 7.8 16.6 20.5 19.5 29.8 26.7 15.3 21.9 21.0 15.9 15.6 15.2 9.6 13.1 15.2 20.0 27.1 16.6 16.5 24.1 32.5 33.6 25.3 24.7 29.1 31.7 15.4 18.7 20.1 27.5 34.5 24.1 20.8 15.7 15.8 11.2 29.0 19.1 21.3 35.1 15.1 16.0 38.5 20.9 32.0 22.8 24.5 20.2 19.3 23.9 20.2 27.2 25.5 20.7 35.8 19.7 20.5 24.1 18.9 16.5 18.3 18.8 48.2 17.0 28.0 13.3 23.1 21.9 25.5 28.4 34.0 35.8 23.7 33.1 23.3 32.0 34.0 26.7 17.9 23.5 19.1 12.9 16.7 25.9 30.8 12.7 14.7 21.6 15.7 19.6 42.4 39.7 39.2 5.8 20.4 33.8 0.0 26.5 43.0 21.1 18.9 10.4 15.3 34.2 20.6 19.5 18.4 22.3 8.2 32.8 16.9 27.0 55.9 30.8 20.6 33.1 32.0 35.0 28.1 18.6 12.9 16.5 25.9 41.2 17.3 79.6 27.4 32.9 18.6 MAF1 DKFZp586G1123 ENSG00000179632 "MAF1 homolog, negative regulator of RNA polymerase III" Q9H063 8 144104499-144107611 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024821, HPA058548" Uncertain Supported Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA024821: AB_2671696, HPA058548: AB_2683751" "unprognostic (2.26e-1)" "unprognostic (3.05e-1)" "unprognostic (2.71e-2)" "unprognostic (2.21e-1)" "unprognostic (8.51e-2)" "unprognostic (9.67e-2)" "prognostic unfavorable (7.09e-4)" "unprognostic (6.12e-2)" "unprognostic (4.92e-2)" "unprognostic (5.90e-3)" "unprognostic (9.42e-2)" "unprognostic (6.48e-2)" "unprognostic (9.40e-3)" "unprognostic (9.02e-2)" "unprognostic (2.59e-1)" "unprognostic (2.38e-1)" "unprognostic (3.99e-2)" 26.8 23.2 17.5 18.4 17.5 43.6 35.7 20.5 26.3 27.3 47.2 23.7 22.8 19.5 33.0 22.5 34.4 26.1 33.6 72.5 17.3 15.5 24.1 21.4 21.2 28.2 19.7 18.6 36.3 39.8 25.2 20.8 23.8 14.9 36.8 18.9 23.8 28.7 32.3 114.3 18.7 29.8 50.9 17.2 27.7 28.9 30.2 16.2 35.5 40.4 38.7 22.8 35.2 46.7 48.0 39.9 45.1 34.5 33.2 46.2 32.6 24.2 39.1 18.1 18.1 49.6 24.8 14.7 19.1 31.6 29.9 30.6 14.3 27.1 27.0 32.6 31.9 16.6 15.0 24.6 27.0 22.1 23.8 29.8 29.5 26.9 22.3 33.5 12.5 20.3 21.8 31.7 23.9 45.3 33.5 32.2 19.8 22.7 18.4 17.8 57.9 46.6 23.0 13.6 44.2 105.0 18.7 25.4 28.7 18.7 18.3 26.5 22.1 25.4 33.1 30.9 17.7 22.5 19.2 19.3 14.0 31.9 24.6 24.0 22.3 16.9 12.6 23.2 23.4 9.2 15.8 34.5 45.1 28.5 26.8 32.3 40.1 41.0 46.2 39.9 48.0 44.2 41.4 19.9 33.2 27.0 29.8 29.2 32.6 17.5 17.5 20.5 26.3 17.3 15.5 19.7 18.6 14.9 16.2 14.9 17.0 89.7 75.9 82.5 41.2 46.4 7.6 4.0 3.4 41.8 13.7 87.2 89.5 88.1 49.3 67.4 88.9 70.0 94.2 87.3 63.4 114.9 33.3 25.2 87.3 35.0 89.6 44.8 58.6 27.8 81.7 78.7 74.2 166.9 77.1 55.4 88.3 79.3 87.7 90.2 29.0 97.0 72.8 85.0 43.7 78.4 120.7 94.5 78.4 80.6 MAFB KRML ENSG00000204103 "MAF bZIP transcription factor B" Q9Y5Q3 20 40685848-40689240 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 87.6;parathyroid gland: 154.1" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 322.7;Kupffer cells: 488.8;Macrophages: 252.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "intermediate monocyte: 27.4;non-classical monocyte: 36.7" "Lineage enriched" "Detected in many" 14 "monocytes: 36.7" "Cell line enhanced" "Detected in some" "HSkMC: 16.2;hTCEpi: 34.0;SCLC-21H: 9.3;SiHa: 8.4;U-138 MG: 9.2;U-2197: 13.4;U-87 MG: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA005653 Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" Yes NA Nucleoplasm "Nucleoli, Golgi apparatus, Cytosol" "HPA005653: AB_1079293" "unprognostic (1.55e-1)" "unprognostic (1.17e-2)" "unprognostic (1.16e-3)" "prognostic unfavorable (5.64e-4)" "unprognostic (9.16e-2)" "unprognostic (3.92e-2)" "unprognostic (1.10e-1)" "unprognostic (2.10e-1)" "unprognostic (2.57e-2)" "unprognostic (6.09e-2)" "unprognostic (5.45e-3)" "unprognostic (9.92e-2)" "unprognostic (3.95e-2)" "unprognostic (1.05e-1)" "unprognostic (3.21e-3)" "unprognostic (3.49e-2)" "unprognostic (2.30e-2)" 38.3 7.9 3.2 13.0 4.0 17.0 19.5 1.0 9.7 10.6 6.9 3.0 1.2 3.3 5.6 8.9 16.8 7.0 9.2 12.4 3.6 2.3 10.9 14.0 21.9 28.9 4.7 3.4 7.0 6.1 154.1 2.3 9.4 5.0 7.6 3.3 5.6 10.4 2.7 11.0 41.6 7.6 5.5 7.7 87.6 4.7 7.5 3.8 6.9 18.2 20.5 11.4 8.2 10.9 0.0 2.5 0.7 36.7 0.0 0.0 2.5 0.0 0.0 0.0 1.4 0.8 0.1 0.2 0.2 0.0 0.1 0.0 0.2 0.1 0.0 1.1 0.2 0.0 2.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.1 0.5 0.0 0.1 16.2 34.0 0.1 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 3.9 1.4 3.3 0.0 0.0 0.0 0.0 0.3 0.2 9.3 0.7 8.4 0.8 2.0 3.1 0.8 0.1 0.2 9.2 0.1 13.4 0.0 0.0 0.0 0.0 8.9 0.3 0.0 0.1 7.3 0.0 0.0 27.4 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.7 0.0 36.7 0.0 0.0 2.5 3.2 4.0 1.0 9.7 3.6 2.3 4.7 3.4 5.0 3.8 20.8 32.3 6.7 25.3 60.9 14.6 153.6 7.6 0.0 13.6 48.8 23.6 7.5 1.7 2.0 0.6 19.9 50.9 0.0 3.0 2.1 61.9 37.1 10.4 32.6 322.7 3.2 55.5 34.4 488.8 0.7 27.3 252.1 20.3 0.0 13.7 25.8 5.4 24.6 23.0 0.8 8.2 12.9 44.3 0.5 0.9 77.0 10.4 4.4 8.1 17.7 MAFF hMafF ENSG00000185022 "MAF bZIP transcription factor F" Q9ULX9 22 38200767-38216511 "Predicted intracellular proteins, Transcription factors" "Stress response, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 114.6" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 289.5;Glandular cells: 257.7;Syncytiotrophoblasts: 400.7;Urothelial cells: 321.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 16.9;neutrophil: 5.9;NK-cell: 14.1" "Group enriched" "Detected in many" 7 "granulocytes: 16.9;NK-cells: 14.1" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 31.3;SK-MEL-30: 37.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB025341, HPA055371" Approved Approved Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "CAB025341: , HPA055371: AB_2682797" "prognostic favorable (4.32e-4)" "unprognostic (2.54e-1)" "unprognostic (1.07e-1)" "unprognostic (2.67e-1)" "unprognostic (1.99e-2)" "unprognostic (2.13e-3)" "unprognostic (5.06e-3)" "unprognostic (3.42e-3)" "unprognostic (7.83e-3)" "unprognostic (5.36e-3)" "unprognostic (1.23e-3)" "unprognostic (2.44e-1)" "unprognostic (3.24e-2)" "unprognostic (2.84e-1)" "unprognostic (4.08e-2)" "unprognostic (1.07e-1)" "unprognostic (2.68e-2)" 45.8 15.4 5.0 10.7 10.7 18.8 32.9 4.1 10.4 16.5 14.7 5.1 6.4 5.1 17.1 4.9 21.5 18.3 27.2 17.2 5.2 5.4 8.6 16.5 31.5 2.9 9.8 1.5 24.5 12.4 3.5 6.2 114.6 12.6 20.1 6.9 5.9 8.8 34.0 60.7 14.3 8.6 15.0 6.5 4.2 13.9 6.9 8.4 0.9 11.3 10.3 8.2 28.6 34.4 0.6 0.9 16.9 2.2 14.1 2.2 1.2 7.5 1.2 1.7 2.6 2.7 8.7 7.9 15.3 21.2 7.8 8.4 2.2 6.2 0.2 1.5 6.5 11.8 5.1 0.4 6.1 13.3 1.4 0.2 0.8 0.8 1.9 7.3 0.5 2.7 3.7 10.2 31.3 17.4 7.0 16.4 0.8 1.5 7.3 6.1 1.7 0.3 2.0 1.2 8.4 6.2 0.5 1.4 1.5 7.9 11.6 0.9 1.4 2.3 6.1 37.2 4.4 1.3 0.6 21.4 9.9 7.3 7.3 5.1 2.7 2.8 0.3 15.0 0.6 6.2 16.9 0.3 0.2 2.2 0.5 2.1 0.6 1.2 1.5 0.9 0.4 1.6 1.2 5.9 14.1 2.2 0.1 0.5 1.2 5.0 10.7 4.1 10.4 5.2 5.4 9.8 1.5 12.6 8.4 50.6 43.7 7.5 289.5 111.8 2.2 13.7 33.1 29.4 33.0 10.4 0.0 30.6 6.6 37.6 0.4 35.0 98.6 0.0 21.5 52.9 80.2 257.7 21.9 5.0 23.2 0.0 100.5 14.7 7.8 0.0 9.2 26.4 55.6 17.2 43.3 16.8 51.3 62.0 3.5 2.4 2.0 19.4 116.4 0.9 1.0 90.2 400.7 27.7 35.7 321.4 MAFK "NFE2U, P18" ENSG00000198517 "MAF bZIP transcription factor K" O60675 7 1530714-1543043 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 62.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2 OS: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026820, HPA060841" Enhanced Enhanced Nucleoplasm No No Nucleoplasm "CAB026820: , HPA060841: AB_2684377" "unprognostic (6.82e-2)" "unprognostic (3.71e-3)" "unprognostic (1.49e-2)" "unprognostic (2.55e-1)" "unprognostic (6.44e-3)" "unprognostic (1.19e-1)" "unprognostic (9.44e-2)" "unprognostic (2.28e-2)" "unprognostic (1.22e-2)" "unprognostic (1.45e-2)" "unprognostic (2.81e-1)" "unprognostic (1.40e-1)" "unprognostic (2.83e-2)" "unprognostic (1.08e-2)" "unprognostic (1.24e-1)" "unprognostic (5.59e-2)" "unprognostic (2.14e-1)" 15.7 14.3 12.6 12.4 20.1 16.3 13.0 4.2 12.5 9.3 18.0 13.5 6.7 18.2 14.7 5.0 10.1 10.2 12.7 30.9 13.2 11.8 10.5 10.9 18.7 8.7 19.7 11.0 7.2 34.9 6.0 8.7 62.4 14.5 16.1 5.1 6.7 11.0 12.0 26.8 12.8 16.8 26.1 12.1 11.3 13.2 4.1 13.1 22.8 9.1 9.7 7.5 13.7 19.0 1.9 5.1 3.6 1.7 1.5 2.6 1.4 20.0 14.4 0.5 2.1 1.6 2.0 11.0 13.3 7.6 3.2 2.3 10.3 5.5 4.7 4.9 3.3 21.9 15.6 1.2 3.8 1.4 7.2 10.5 2.7 18.4 7.5 3.7 6.4 8.7 2.0 5.0 5.4 4.1 4.0 2.9 14.8 7.0 2.6 1.5 13.2 7.2 23.1 4.6 4.9 14.6 10.9 0.5 7.9 3.0 8.3 6.2 2.3 8.0 23.8 5.8 3.3 9.2 8.6 6.9 5.0 34.8 25.0 7.2 5.0 1.5 7.8 6.6 8.9 7.0 1.7 1.6 3.6 2.1 0.8 2.3 1.4 1.2 2.5 0.7 1.9 2.6 2.0 2.2 1.5 1.7 5.1 2.2 1.4 12.6 20.1 4.2 12.5 13.2 11.8 19.7 11.0 14.5 13.1 38.7 21.2 5.1 38.8 56.7 1.8 2.4 12.7 9.4 15.9 29.6 2.0 7.9 1.7 12.6 2.8 17.5 32.5 0.0 12.9 7.1 20.6 51.3 9.2 11.6 9.5 11.1 22.2 10.4 16.3 3.8 4.4 14.9 18.6 5.4 21.7 7.5 30.7 26.8 2.8 2.1 0.6 12.9 22.7 0.5 4.7 50.4 65.2 8.6 13.4 64.3 MAGEA10 "CT1.10, MAGE10, MGC10599" ENSG00000124260 "MAGE family member A10" P43363 X 152133310-152138578 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "placenta: 48.7" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 4.0;Sertoli cells: 6.5;Spermatocytes: 12.1;Spermatogonia: 8.9;Syncytiotrophoblasts: 9.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "GAMG: 42.1" "HPA003333, HPA070780" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003333: AB_10962837, HPA070780: AB_2686310" "unprognostic (1.92e-1)" "unprognostic (1.06e-1)" "unprognostic (2.02e-1)" "unprognostic (6.95e-2)" "unprognostic (9.91e-2)" "unprognostic (5.97e-3)" "unprognostic (1.11e-1)" "unprognostic (1.25e-1)" 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 48.7 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.6 0.1 0.0 0.0 0.1 0.0 6.6 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.9 0.8 2.6 0.8 1.2 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 42.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.9 0.0 0.2 0.0 7.0 2.6 0.8 0.7 0.4 0.7 0.4 0.7 0.5 0.4 0.3 0.9 0.6 0.7 2.6 1.2 0.5 0.8 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 12.1 8.9 0.0 9.4 0.0 0.0 0.0 MAGEA11 "CT1.11, MAGE-11, MAGE11, MAGEA-11, MGC10511" ENSG00000185247 "MAGE family member A11" P43364 X 149688228-149717266 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 36.5;testis: 9.3" "Cell type enhanced" "Detected in some" 22 "Spermatocytes: 9.3;Spermatogonia: 14.3;Syncytiotrophoblasts: 4.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "U-2 OS: 23.4" HPA052687 Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA052687: AB_2681915" "unprognostic (4.06e-3)" "unprognostic (2.05e-1)" "unprognostic (7.21e-2)" "unprognostic (1.09e-2)" "unprognostic (9.64e-2)" "unprognostic (1.32e-1)" "unprognostic (6.13e-2)" "unprognostic (1.16e-1)" "unprognostic (6.67e-4)" "unprognostic (1.14e-1)" "unprognostic (1.33e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 36.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.0 23.4 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 14.3 0.0 4.9 0.0 0.0 0.0 MAGEA9 "CT1.9, MAGE9, MGC8421" ENSG00000123584 "MAGE family member A9" P43362 X 149781930-149787737 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 15 "testis: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "U-266/70: 29.6;U-266/84: 20.1" "HPA045401, HPA051687" Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA045401: AB_2679315, HPA051687: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.6 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 MAGEA9B ENSG00000267978 "MAGE family member A9B" P43362 X 149581653-149587453 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 35 "testis: 14.2" "Group enriched" "Detected in some" 22 "Sertoli cells: 6.5;Spermatocytes: 10.7;Spermatogonia: 4.8" "Cancer enhanced" "Detected in some" "urothelial cancer: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "OE19: 29.3;RT4: 47.2;U-266/70: 20.4;U-266/84: 25.2" "HPA045401, HPA051687" Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA045401: AB_2679315, HPA051687: " "unprognostic (6.12e-3)" "unprognostic (3.26e-1)" 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 29.3 0.0 0.0 0.0 2.2 0.0 47.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 20.4 25.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 10.7 4.8 0.0 0.1 0.0 0.0 0.0 MAGEB16 ENSG00000189023 "MAGE family member B16" A2A368 X 35798342-35803735 "Predicted intracellular proteins" "Tumor antigen" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 44 "testis: 9.0" "Group enriched" "Detected in some" 25 "Spermatocytes: 4.7;Spermatogonia: 9.7" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-266/70: 37.0" "HPA055743, HPA076456" Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA055743: AB_2682902, HPA076456: " "unprognostic (2.12e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 9.7 0.0 0.0 0.0 0.0 0.0 MAGEB17 ENSG00000182798 "MAGE family member B17" A8MXT2 X 16167481-16171464 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 4.4;testis: 5.4" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-138 MG: 3.3;U-2 OS: 7.2;U-266/70: 17.8" HPA003756 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA003756: AB_2250114" "unprognostic (1.94e-2)" "unprognostic (2.23e-1)" "unprognostic (3.57e-1)" "unprognostic (4.04e-4)" "unprognostic (2.75e-1)" "unprognostic (5.11e-1)" "unprognostic (3.56e-2)" "unprognostic (1.40e-1)" "unprognostic (3.10e-1)" "unprognostic (1.57e-2)" "unprognostic (1.88e-2)" "unprognostic (2.49e-2)" "unprognostic (1.50e-1)" "unprognostic (7.05e-2)" "unprognostic (2.88e-1)" "unprognostic (5.45e-2)" "unprognostic (6.44e-2)" 0.1 0.0 0.1 0.4 0.0 0.0 0.6 0.1 0.0 0.6 0.4 0.0 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.5 0.0 0.1 0.4 0.0 0.0 1.2 5.4 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 1.8 0.0 0.0 3.3 7.2 0.0 0.2 17.8 0.9 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEC1 "CT7, CT7.1, MAGE-C1, MGC39366" ENSG00000155495 "MAGE family member C1" O60732 X 141903894-141909388 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 23.5" "Group enriched" "Detected in some" 7 "Sertoli cells: 6.5;Spermatocytes: 5.9;Spermatogonia: 14.9" "Cancer enhanced" "Detected in many" "melanoma: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 22.9;Karpas-707: 22.9;U-2 OS: 15.4;U-2197: 29.1;U-266/70: 20.9;U-266/84: 18.4" "HPA004622, CAB015452" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB015452: AB_784404, HPA004622: AB_1853495" "unprognostic (5.63e-2)" "unprognostic (1.59e-1)" "unprognostic (1.68e-1)" "unprognostic (4.52e-2)" "unprognostic (9.96e-2)" "unprognostic (3.47e-1)" "unprognostic (8.56e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 15.4 29.1 0.0 20.9 18.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 5.9 14.9 0.0 0.0 0.0 0.0 0.0 MAGEC2 "CT10, HCA587, MAGE-C2, MAGEE1" ENSG00000046774 "MAGE family member C2" Q9UBF1 X 142202345-142205290 "Cancer-related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 319 "testis: 31.8" "Group enriched" "Detected in some" 9 "Spermatocytes: 30.7;Spermatogonia: 86.6" "Cancer enhanced" "Detected in many" "melanoma: 19.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "K-562: 35.8;U-266/84: 40.4" HPA062230 Enhanced Supported Nucleoplasm,Cytosol Yes NA Nucleoplasm Cytosol "HPA062230: AB_2684718" "unprognostic (1.25e-1)" "unprognostic (5.68e-2)" "unprognostic (3.99e-1)" "unprognostic (2.82e-1)" "unprognostic (1.04e-1)" "unprognostic (4.00e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 1.5 0.0 0.0 0.0 0.1 2.5 0.4 4.9 0.0 0.0 40.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 6.5 0.0 30.7 86.6 0.0 0.0 0.0 0.0 0.0 MAGED2 "11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386" ENSG00000102316 "MAGE family member D2" Q9UNF1 X 54807599-54816012 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Tumor antigen" "Bartter syndrome, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Peritubular cells: 301.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031572, HPA031573" Approved Enhanced Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli, Cytosol" "HPA031572: AB_10599819, HPA031573: AB_10602181" "unprognostic (1.33e-1)" "unprognostic (8.60e-2)" "unprognostic (3.32e-1)" "unprognostic (1.69e-3)" "unprognostic (4.79e-2)" "unprognostic (3.52e-1)" "unprognostic (2.41e-3)" "unprognostic (1.39e-1)" "unprognostic (2.97e-1)" "prognostic favorable (2.88e-4)" "prognostic favorable (2.82e-4)" "unprognostic (6.34e-2)" "unprognostic (3.55e-3)" "prognostic unfavorable (9.43e-4)" "unprognostic (1.58e-1)" "unprognostic (9.77e-2)" "unprognostic (3.58e-1)" 22.1 38.4 26.9 14.8 26.5 8.2 50.2 24.4 43.0 55.7 27.3 27.8 21.4 16.2 41.1 31.8 21.9 45.9 28.5 40.7 23.8 38.2 42.7 17.3 24.0 13.5 30.3 36.0 79.7 23.5 34.5 57.6 58.6 57.1 63.9 16.4 43.1 32.0 53.7 25.6 16.5 17.6 41.6 24.7 17.5 22.5 21.8 18.3 23.4 45.1 17.3 22.0 31.9 29.2 17.1 11.7 43.1 37.0 28.5 35.5 32.5 5.4 10.0 60.2 18.3 28.7 39.1 11.1 22.5 40.2 17.9 31.8 10.0 13.9 7.6 59.1 45.3 14.7 7.4 17.1 17.0 12.9 13.5 14.2 15.7 11.9 19.5 24.6 4.0 12.1 51.1 7.1 18.1 9.2 36.9 33.9 8.9 3.8 9.3 34.1 15.0 8.9 6.7 22.2 9.5 12.0 5.9 21.6 10.8 24.5 4.1 9.5 24.5 8.9 10.4 52.0 73.5 42.9 6.8 29.2 15.3 23.8 22.7 6.3 6.0 5.0 5.4 22.3 10.6 77.7 43.1 9.1 35.5 35.5 22.4 27.3 16.3 29.4 33.1 11.7 17.1 29.7 34.1 3.4 28.5 37.0 7.2 29.2 32.5 26.9 26.5 24.4 43.0 23.8 38.2 30.3 36.0 57.1 18.3 41.7 33.9 29.8 80.0 37.7 72.3 51.6 53.5 66.9 30.7 73.3 27.5 185.2 208.9 88.2 2.4 76.6 14.7 0.0 47.8 117.1 94.0 95.1 100.4 13.2 60.7 130.3 56.0 66.9 12.9 8.5 216.0 36.3 150.1 64.9 42.6 178.6 48.5 32.3 301.2 111.7 49.9 155.2 150.8 13.5 12.4 30.6 141.5 45.4 24.9 55.9 MAGI1 "AIP3, BAIAP1, BAP1, MAGI-1, TNRC19, WWP3" ENSG00000151276 "Membrane associated guanylate kinase, WW and PDZ domain containing 1" Q96QZ7 3 65353525-66038834 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 219.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031851, HPA031852, HPA031853, HPA077002" Supported Supported "Nucleoplasm,Cell Junctions" NA NA "Cell Junctions" Nucleoplasm "HPA031851: AB_10599289, HPA031852: AB_2674074, HPA031853: AB_10602095, HPA077002: " "unprognostic (5.00e-2)" "unprognostic (9.84e-2)" "unprognostic (6.00e-3)" "unprognostic (1.73e-3)" "unprognostic (1.64e-1)" "unprognostic (2.17e-2)" "unprognostic (1.46e-3)" "unprognostic (9.46e-3)" "unprognostic (8.59e-2)" "unprognostic (2.19e-1)" "unprognostic (6.58e-2)" "unprognostic (2.05e-3)" "prognostic favorable (4.55e-8)" "unprognostic (3.51e-2)" "unprognostic (1.34e-1)" "unprognostic (1.68e-2)" "unprognostic (8.03e-2)" 18.0 6.0 10.1 6.4 9.8 1.0 16.5 38.6 16.8 6.9 11.2 10.1 25.7 10.7 11.6 7.6 9.4 12.6 19.7 11.1 9.4 11.8 14.3 17.6 13.3 2.9 8.8 10.4 4.3 16.7 18.7 13.1 11.1 9.6 9.2 9.5 7.7 17.4 37.9 7.7 13.0 11.6 7.9 8.3 13.9 19.8 10.7 7.7 0.6 23.2 5.8 4.4 6.9 13.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 2.8 1.5 8.8 0.9 1.8 1.3 3.9 4.9 4.2 1.9 2.9 10.5 2.5 0.0 0.7 5.8 1.5 0.9 2.4 1.7 3.0 0.0 1.4 24.8 3.0 7.0 1.1 0.0 0.8 1.9 1.5 6.4 1.3 4.9 4.2 3.3 10.5 0.0 1.9 2.1 0.0 0.0 11.8 8.4 1.5 0.0 2.5 0.6 2.3 9.4 2.8 7.7 1.9 2.3 0.0 6.0 4.5 0.0 1.1 6.0 4.4 1.5 2.0 0.0 0.0 0.0 3.5 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 9.8 38.6 15.5 9.4 11.8 8.8 10.4 9.6 7.7 71.5 24.3 2.2 16.9 19.8 93.8 31.3 91.7 37.5 30.7 22.7 70.7 11.8 3.3 33.9 112.5 42.5 30.4 0.0 28.1 2.1 7.3 19.7 1.1 50.5 3.7 219.3 35.1 72.4 7.8 11.8 6.1 1.9 5.0 1.0 37.8 13.0 33.5 25.1 8.1 12.4 23.8 32.3 13.0 16.9 9.7 16.4 4.2 1.0 22.1 10.8 MAGIX "FLJ21687, JM10, PDZX" ENSG00000269313 "MAGI family member, X-linked" X 49162564-49168483 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 39.7;Proximal tubular cells: 31.6" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 7.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 6.7;RT4: 15.5;SK-BR-3: 7.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA007390, HPA035302" Uncertain Approved "Nucleoplasm,Mitotic chromosome" NA NA Nucleoplasm "Mitotic chromosome" "HPA007390: , HPA035302: AB_10603015" "unprognostic (1.11e-1)" "unprognostic (1.34e-2)" "unprognostic (6.24e-2)" "unprognostic (1.08e-1)" "unprognostic (2.55e-3)" "unprognostic (2.64e-6)" "unprognostic (6.75e-2)" "unprognostic (1.91e-3)" "unprognostic (3.38e-1)" "unprognostic (1.55e-3)" "unprognostic (1.16e-1)" "unprognostic (2.33e-2)" "prognostic favorable (6.91e-9)" "unprognostic (4.35e-2)" "unprognostic (2.70e-1)" "unprognostic (1.73e-1)" "prognostic favorable (2.10e-4)" 0.5 0.3 0.0 0.9 1.2 0.5 0.0 3.9 1.2 1.6 1.2 0.5 8.0 1.0 1.5 4.0 0.7 1.8 6.2 2.6 1.8 5.0 4.2 1.1 0.0 0.0 0.0 0.5 5.9 3.1 0.0 0.4 1.0 2.0 0.4 1.1 9.0 5.7 1.2 0.8 0.6 0.0 0.8 0.3 4.5 0.0 0.0 0.3 0.7 0.8 0.7 0.8 0.0 1.2 2.6 7.9 2.0 1.2 1.1 1.1 0.3 2.4 0.5 0.6 0.7 0.2 1.8 0.3 0.4 0.4 0.3 1.4 6.7 0.7 0.6 0.7 0.9 1.5 0.4 1.5 0.0 1.9 2.2 2.8 3.8 0.8 0.3 0.7 5.9 0.7 0.2 0.5 0.1 0.7 0.6 1.0 0.4 2.5 0.5 0.8 0.6 2.0 0.6 1.8 1.2 0.4 0.1 1.2 1.2 15.5 3.0 0.7 1.3 7.1 0.6 0.4 5.6 0.6 0.3 0.8 1.8 0.7 0.5 1.7 0.9 0.5 2.9 0.9 2.2 4.3 2.0 3.3 0.2 1.8 0.8 1.1 0.9 0.1 1.3 1.2 0.6 1.1 7.9 1.2 1.8 2.6 0.1 1.1 3.0 4.8 0.9 6.6 2.9 7.2 6.5 10.2 10.7 3.4 12.2 2.0 1.8 39.7 9.3 0.2 2.2 29.3 0.0 18.2 3.7 1.9 6.2 0.0 29.9 4.4 7.9 16.8 3.1 1.6 0.0 0.6 4.7 1.7 6.4 17.6 7.3 10.6 22.1 0.4 31.6 9.2 0.0 2.3 2.1 1.5 3.9 3.2 2.2 12.3 8.9 MAGOH "MAGOH1, MAGOHA" ENSG00000162385 "Mago homolog, exon junction complex core component" P61326 1 53226892-53238610 "Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015425, HPA043036, HPA047754" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB015425: AB_629914, HPA043036: AB_2678279, HPA047754: AB_2680148" "prognostic favorable (1.85e-4)" "unprognostic (2.61e-2)" "unprognostic (5.39e-2)" "unprognostic (2.33e-1)" "unprognostic (3.59e-1)" "unprognostic (6.34e-3)" "unprognostic (3.07e-3)" "unprognostic (2.18e-1)" "unprognostic (5.17e-2)" "unprognostic (1.46e-2)" "unprognostic (8.54e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (1.45e-5)" "unprognostic (2.01e-2)" "unprognostic (1.63e-1)" "unprognostic (3.60e-2)" "unprognostic (6.75e-3)" 31.5 31.3 25.7 32.9 28.9 70.7 33.8 23.0 36.8 26.9 33.9 17.4 33.5 30.2 37.5 33.7 37.5 31.4 25.6 27.6 30.3 25.6 35.9 42.5 33.2 43.2 23.5 28.8 36.7 35.6 18.9 46.6 43.4 31.4 24.6 31.9 22.8 31.2 31.1 40.9 30.7 35.7 35.3 32.6 36.9 28.5 28.1 24.3 50.3 37.4 37.2 46.0 28.0 30.0 29.8 35.2 31.3 30.9 29.8 33.0 18.2 33.1 16.0 28.2 24.5 14.6 9.4 32.6 24.9 14.6 32.9 33.4 36.5 15.9 47.4 29.1 14.5 41.7 20.5 36.8 21.8 39.3 31.4 40.9 43.2 20.9 39.4 23.4 74.9 24.2 10.1 15.7 29.9 24.6 12.9 21.7 43.8 43.3 10.9 17.8 25.8 61.4 52.0 52.1 27.3 35.2 42.0 53.9 25.1 17.5 33.2 24.2 19.6 33.3 27.1 39.0 35.3 14.0 53.9 19.9 20.5 28.1 28.9 56.9 16.0 28.6 74.0 18.6 47.7 20.9 17.0 21.6 31.3 32.3 30.9 31.1 29.8 31.2 33.0 30.5 29.0 28.8 29.5 26.0 29.8 28.1 35.2 32.3 18.2 25.7 28.9 23.0 36.8 30.3 25.6 23.5 28.8 31.4 24.3 47.6 37.5 73.4 102.0 128.2 31.7 45.8 56.0 76.3 62.6 54.1 13.7 170.1 150.9 70.5 11.4 70.8 46.6 0.0 74.0 157.5 82.2 60.3 80.9 46.1 101.6 22.3 52.2 54.6 49.1 8.4 69.9 77.4 77.6 102.8 70.6 51.5 72.6 70.2 64.0 112.9 28.8 58.2 90.6 80.9 69.2 105.6 202.3 78.8 80.9 86.6 MAMDC4 "AEGP, DKFZp434M1411" ENSG00000177943 "MAM domain containing 4" Q6UXC1 9 136850943-136860799 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 14.9;liver: 48.9" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 19.8;Hepatocytes: 16.6;Horizontal cells: 15.9;Mucus-secreting cells: 19.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 10 "cerebellum: 14.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 18.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB026377, HPA059977" Approved Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "CAB026377: , HPA059977: AB_2684186" "unprognostic (2.79e-1)" "unprognostic (7.90e-2)" "unprognostic (4.09e-3)" "unprognostic (6.86e-2)" "unprognostic (8.33e-2)" "unprognostic (2.66e-4)" "unprognostic (3.20e-2)" "unprognostic (2.39e-1)" "unprognostic (1.31e-1)" "unprognostic (7.37e-2)" "prognostic favorable (1.88e-6)" "unprognostic (8.22e-3)" "unprognostic (1.58e-2)" "unprognostic (1.22e-3)" "unprognostic (9.22e-2)" "unprognostic (2.18e-1)" "unprognostic (1.08e-2)" 2.0 1.6 1.2 1.9 1.5 1.4 1.2 14.9 1.2 1.2 2.3 1.2 1.2 5.0 1.2 1.2 1.2 1.7 1.2 1.6 1.2 0.4 2.6 48.9 1.2 2.5 1.2 1.2 1.2 3.4 0.5 7.2 1.2 1.2 3.2 0.9 1.2 3.5 1.4 1.7 1.5 6.1 1.2 1.2 5.1 2.3 6.5 1.2 1.2 5.1 1.2 1.2 1.2 1.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 1.6 2.6 1.5 2.9 0.6 0.1 18.9 2.7 0.3 0.3 0.6 2.0 1.6 1.4 0.6 0.7 0.8 2.2 0.3 1.3 0.0 2.1 0.9 0.8 5.3 2.3 1.2 0.2 4.9 0.8 1.7 1.4 0.6 1.4 0.6 2.5 2.7 1.2 0.2 4.2 1.0 3.7 1.4 1.1 0.7 1.6 0.4 2.5 0.9 1.4 1.7 2.1 0.6 1.3 1.1 1.0 4.4 0.9 0.8 7.6 4.8 1.5 0.4 3.1 1.6 0.4 1.7 2.0 1.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.5 14.9 1.2 1.2 0.4 1.2 1.2 1.2 1.2 0.0 4.3 0.0 0.8 0.7 5.4 6.2 12.7 2.7 0.0 1.8 0.0 2.2 1.7 0.8 1.7 1.4 19.8 0.0 4.4 2.8 2.6 1.3 0.0 16.6 2.4 15.9 0.0 2.5 2.4 1.9 1.7 2.2 0.0 1.0 19.5 2.6 0.9 12.5 1.4 2.1 7.4 0.0 1.4 1.2 2.2 0.4 1.9 1.3 10.3 0.7 MAML1 "KIAA0200, Mam-1" ENSG00000161021 "Mastermind like transcriptional coactivator 1" Q92585 5 179732850-179777286 "Predicted intracellular proteins" "Notch signaling pathway, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "granulocytes: 57.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.6;BJ hTERT+ SV40 Large T+: 8.9;hTCEpi: 9.0;SK-MEL-30: 15.6;SuSa: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037687, HPA057531" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA037687: AB_10672604, HPA057531: AB_2683458" "unprognostic (2.64e-1)" "unprognostic (2.06e-1)" "unprognostic (3.01e-2)" "unprognostic (5.41e-3)" "unprognostic (5.79e-2)" "unprognostic (2.45e-1)" "unprognostic (1.75e-3)" "unprognostic (3.01e-1)" "prognostic unfavorable (9.70e-4)" "unprognostic (1.49e-1)" "unprognostic (1.59e-1)" "unprognostic (2.83e-2)" "prognostic unfavorable (1.84e-5)" "unprognostic (3.44e-1)" "unprognostic (6.05e-2)" "unprognostic (1.06e-1)" "unprognostic (6.69e-2)" 8.5 8.9 8.5 9.5 9.6 15.8 8.2 27.2 9.3 35.4 9.3 10.6 3.9 12.5 11.2 18.8 8.8 9.5 6.8 6.4 7.9 3.3 7.5 5.8 11.9 9.7 9.9 5.8 13.0 8.8 2.3 9.2 11.7 8.6 9.2 10.9 10.4 7.8 4.7 13.1 9.2 25.1 13.4 6.4 10.1 8.0 5.6 10.6 20.8 10.8 3.4 9.1 9.9 9.6 2.4 0.8 3.3 2.0 1.1 1.7 0.9 0.0 0.0 0.0 0.0 7.6 7.5 0.0 4.6 8.6 8.9 6.6 0.0 0.0 5.5 6.6 0.0 0.0 0.3 0.0 0.0 5.6 0.0 0.0 0.0 6.6 0.0 6.7 0.0 0.1 0.0 9.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.5 0.2 0.1 0.0 0.0 0.1 15.6 8.5 7.1 0.0 7.0 0.1 1.1 0.2 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 3.3 1.7 1.2 0.8 2.4 0.9 1.4 0.6 2.4 1.0 0.8 3.0 1.1 2.0 0.8 0.5 0.9 8.5 9.6 27.2 9.3 7.9 3.3 9.9 5.8 8.6 10.6 14.9 9.4 3.9 11.0 22.1 12.9 6.2 17.8 4.0 3.4 8.7 17.7 8.9 1.7 6.0 1.8 20.3 6.7 23.3 5.7 9.5 10.8 9.5 57.4 8.6 11.1 20.6 8.6 31.9 21.5 1.6 16.1 11.4 5.0 10.0 13.5 10.0 5.8 7.0 23.7 3.3 9.3 12.9 10.3 5.7 9.4 26.1 7.8 13.1 13.3 12.7 MAML2 "KIAA1819, MAM3" ENSG00000184384 "Mastermind like transcriptional coactivator 2" Q8IZL2 11 95976598-96343180 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Notch signaling pathway, Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 86.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 27.9" "Low region specificity" "Detected in all" HPA035223 Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA035223: AB_10671101" "unprognostic (8.11e-2)" "unprognostic (2.51e-1)" "unprognostic (7.08e-2)" "unprognostic (9.07e-2)" "unprognostic (3.57e-3)" "unprognostic (3.32e-2)" "unprognostic (3.66e-2)" "unprognostic (2.33e-1)" "unprognostic (3.99e-2)" "unprognostic (8.05e-2)" "prognostic unfavorable (3.89e-4)" "unprognostic (9.11e-2)" "prognostic favorable (1.90e-4)" "unprognostic (9.76e-2)" "unprognostic (1.73e-2)" "unprognostic (1.99e-1)" "unprognostic (7.19e-2)" 26.3 5.5 10.2 16.1 8.1 4.2 19.7 27.8 13.4 15.8 9.2 10.4 8.4 4.3 11.2 8.5 9.3 11.7 10.8 8.9 10.5 6.9 13.8 3.5 15.0 10.9 6.9 3.4 11.7 8.2 13.3 15.2 18.8 9.3 12.3 8.9 10.8 16.6 12.3 4.4 14.2 8.9 10.2 14.4 16.8 6.5 4.3 10.6 21.2 11.8 4.8 13.6 16.0 15.3 2.1 1.2 4.7 1.1 4.2 6.4 2.0 5.6 1.1 9.8 2.6 10.2 11.8 2.1 6.5 9.8 4.3 4.5 0.7 12.0 1.2 15.5 15.1 2.3 5.2 2.0 6.3 6.0 27.9 0.7 0.7 2.0 2.1 6.0 0.0 0.0 17.2 0.6 7.7 4.5 8.0 2.4 0.1 3.1 1.8 7.6 0.4 0.1 1.5 1.0 2.9 1.8 1.9 1.8 6.5 6.4 8.0 0.1 0.9 2.4 1.0 2.7 3.3 0.9 0.3 10.6 7.6 1.8 2.6 4.1 1.2 0.2 1.8 3.6 1.1 13.9 0.1 1.1 0.0 1.5 0.6 2.6 1.9 3.2 4.1 1.2 2.1 6.4 4.3 4.7 4.2 0.7 0.9 1.2 2.0 10.2 8.1 27.8 7.0 10.5 6.9 6.9 3.4 9.3 10.6 14.9 7.5 12.1 17.3 17.3 40.8 4.1 12.7 18.7 19.4 12.2 86.4 10.3 10.0 14.8 1.1 20.5 18.4 0.0 0.4 20.6 19.5 17.4 1.1 0.2 16.3 0.0 6.4 6.7 12.6 1.4 8.1 15.7 11.8 16.2 6.2 24.7 9.5 14.4 8.1 11.8 21.9 32.3 17.3 0.5 0.6 11.8 10.9 16.0 11.8 13.1 MAMLD1 "CG1, CXorf6, F18" ENSG00000013619 "Mastermind like domain containing 1" Q13495 X 150361422-150514178 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Horizontal cells: 12.7;Leydig cells: 31.4;Peritubular cells: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 15.6;U-2197: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003923 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA003923: AB_10602034" "unprognostic (4.18e-3)" "unprognostic (1.74e-1)" "unprognostic (1.63e-1)" "unprognostic (4.29e-2)" "unprognostic (4.16e-2)" "unprognostic (5.09e-2)" "unprognostic (2.31e-1)" "unprognostic (7.68e-2)" "unprognostic (2.08e-2)" "unprognostic (9.74e-2)" "unprognostic (9.86e-3)" "unprognostic (4.82e-2)" "unprognostic (1.86e-1)" "unprognostic (3.33e-2)" "unprognostic (3.58e-2)" "unprognostic (1.41e-3)" "unprognostic (9.76e-3)" 7.6 4.6 9.1 2.6 15.5 2.6 10.0 5.2 11.7 5.8 3.7 5.7 5.7 1.8 9.0 5.9 3.2 7.8 4.2 3.9 9.3 9.5 2.6 3.2 5.9 2.8 3.5 6.9 21.8 6.0 3.0 6.0 3.2 5.7 5.6 2.3 6.4 3.2 11.7 6.6 2.4 1.8 5.6 5.6 2.5 2.6 15.3 5.2 0.0 1.6 1.7 2.1 2.9 3.5 2.2 0.1 0.8 0.1 0.6 3.0 0.8 4.6 1.8 2.5 5.0 7.3 2.7 0.0 4.4 9.3 6.8 15.6 0.0 0.2 0.0 2.3 10.5 5.4 0.1 2.8 2.1 9.3 7.0 0.2 0.1 5.9 0.1 5.4 0.2 0.0 3.7 0.5 7.7 0.9 3.4 1.4 0.4 0.1 0.1 6.4 0.9 0.0 0.1 0.5 0.0 3.5 0.3 9.7 0.2 1.1 0.1 0.7 0.5 1.5 0.1 2.5 0.6 0.1 0.0 1.8 3.6 4.5 24.2 7.8 0.3 0.3 0.1 10.1 1.8 4.9 0.0 0.0 0.2 1.1 0.0 1.6 2.2 1.8 1.5 0.1 0.9 1.7 3.0 0.8 0.6 0.1 0.1 2.0 0.8 9.1 15.5 5.2 11.0 9.3 9.5 3.5 6.9 5.7 5.2 0.0 0.3 0.0 0.8 3.1 1.0 2.0 5.1 0.0 0.0 0.0 9.8 0.0 1.7 2.8 1.1 4.5 0.0 0.0 2.2 0.0 1.1 1.2 0.0 3.4 0.5 12.7 3.5 3.7 0.6 2.4 31.4 2.6 3.3 1.0 0.4 2.0 2.1 0.0 22.6 0.1 0.4 6.5 8.0 0.0 0.4 3.6 0.0 0.0 0.0 0.4 MAN1C1 HMIC ENSG00000117643 "Mannosidase alpha class 1C member 1" Q9NR34 1 25617468-25786207 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 51.1;Ito cells: 82.9" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 8.3" "Lineage enriched" "Detected in many" 5 "T-cells: 8.3" "Cell line enhanced" "Detected in many" "AF22: 12.7;HSkMC: 47.0;U-266/70: 14.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048352 Uncertain Uncertain Nucleoplasm,Vesicles NA NA 1200000 "Nucleoplasm, Vesicles" "HPA048352: AB_2680368" "unprognostic (2.75e-1)" "unprognostic (5.45e-3)" "unprognostic (5.71e-3)" "unprognostic (2.05e-2)" "unprognostic (1.95e-1)" "unprognostic (8.90e-3)" "unprognostic (4.78e-2)" "prognostic favorable (7.55e-4)" "unprognostic (1.80e-1)" "unprognostic (5.70e-2)" "prognostic favorable (4.79e-4)" "unprognostic (2.51e-1)" "unprognostic (9.09e-3)" "unprognostic (3.18e-2)" "unprognostic (7.23e-2)" "unprognostic (7.44e-2)" "unprognostic (5.18e-2)" 4.6 4.5 4.2 3.0 3.8 0.0 2.2 9.9 8.8 8.6 3.6 1.2 6.6 2.5 2.4 3.9 7.3 3.4 5.2 3.2 10.3 12.1 3.2 4.0 4.2 7.1 0.7 4.4 7.8 8.3 7.2 1.2 1.8 7.5 0.9 2.7 1.9 8.0 6.0 7.0 3.1 1.0 10.7 3.2 4.3 4.0 1.0 0.6 1.1 1.6 0.8 8.3 1.1 0.0 0.1 12.7 2.7 9.5 7.4 3.7 0.1 2.4 0.6 0.2 0.2 0.0 0.1 0.1 0.9 1.7 0.1 1.2 0.1 0.2 4.0 0.5 0.2 0.2 0.0 1.1 2.1 5.3 47.0 0.2 0.2 0.0 0.2 0.0 0.5 0.0 0.5 0.0 0.6 0.0 2.3 3.3 0.0 0.1 0.2 7.8 0.2 0.1 0.2 7.5 0.2 0.3 2.0 0.6 2.4 1.0 1.5 0.0 0.0 0.7 8.6 0.3 14.0 0.0 0.0 1.9 4.5 0.6 0.4 1.6 0.7 0.6 1.0 0.8 0.4 3.6 1.6 0.6 1.0 8.3 4.8 1.1 0.8 1.3 0.4 0.8 1.1 3.0 2.7 1.9 2.9 6.0 19.1 6.4 5.1 2.7 7.9 21.0 51.1 8.3 8.3 0.5 0.3 11.1 0.0 0.0 3.4 1.0 9.9 2.6 2.3 37.6 19.1 20.6 2.9 82.9 16.5 0.9 25.0 3.6 1.7 0.0 0.0 20.6 2.2 0.0 20.8 12.8 4.5 6.5 3.1 0.2 2.0 4.5 35.7 5.3 0.0 1.3 MAN2B1 "LAMAN, MANB" ENSG00000104774 "Mannosidase alpha class 2B member 1" O00754 19 12646511-12666742 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 23.3;Macrophages: 18.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 42.1;intermediate monocyte: 39.4;myeloid DC: 35.2;non-classical monocyte: 28.4;plasmacytoid DC: 41.9" "Group enriched" "Detected in all" 5 "dendritic cells: 41.9;monocytes: 42.1" "Low cell line specificity" "Detected in all" "HPA041530, HPA053404" Supported Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 3400000 "Nucleoplasm, Vesicles" "HPA041530: AB_10795639, HPA053404: " "unprognostic (6.63e-2)" "unprognostic (3.61e-1)" "unprognostic (2.20e-2)" "unprognostic (5.48e-2)" "unprognostic (3.81e-1)" "unprognostic (1.04e-1)" "unprognostic (1.61e-1)" "unprognostic (1.84e-2)" "unprognostic (9.55e-2)" "unprognostic (1.95e-1)" "unprognostic (2.79e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (1.94e-5)" "unprognostic (4.00e-1)" "unprognostic (4.17e-2)" "unprognostic (2.22e-1)" "unprognostic (1.51e-1)" 25.2 15.6 7.9 26.7 11.0 33.4 24.4 4.4 7.0 10.5 15.0 14.0 8.6 14.2 15.3 16.5 12.2 13.4 16.4 19.4 6.4 4.4 13.6 16.3 30.2 68.6 10.0 4.7 12.2 21.7 9.1 7.2 15.8 8.6 13.7 10.6 12.0 22.0 8.1 7.7 18.0 20.0 10.2 11.7 51.3 19.5 6.3 8.2 22.1 11.3 7.8 30.0 18.7 11.2 7.7 41.9 6.5 42.1 2.7 8.4 26.0 16.5 8.5 8.7 10.2 29.0 19.5 24.6 12.3 26.0 11.0 10.8 6.8 7.0 18.2 15.0 9.7 3.1 13.0 4.4 8.2 5.3 9.0 13.5 6.3 4.2 11.0 14.8 41.5 43.3 23.2 16.2 6.1 7.8 11.9 10.4 6.9 8.0 13.8 5.8 12.9 5.6 23.4 7.2 8.3 10.8 13.0 11.9 9.0 13.0 19.2 2.7 8.5 12.2 10.5 20.0 5.5 16.2 25.7 13.6 15.0 6.2 14.5 11.5 18.4 20.2 9.0 10.1 40.9 16.7 2.2 42.1 6.2 7.5 39.4 8.4 7.7 6.9 6.7 35.2 6.5 3.8 3.8 6.5 2.7 28.4 41.9 6.8 26.0 7.9 11.0 4.4 7.0 6.4 4.4 10.0 4.7 8.6 8.2 6.0 6.9 14.4 1.6 3.2 2.6 0.7 2.5 5.3 1.2 1.8 0.0 2.0 1.7 1.6 2.0 1.0 2.5 23.3 2.0 2.3 2.8 2.2 1.1 0.8 7.9 0.0 1.7 2.5 10.2 8.1 3.4 18.6 1.7 5.4 0.9 1.3 1.0 2.9 4.2 1.1 3.0 12.9 1.2 0.5 1.5 2.9 2.3 5.4 1.7 1.6 MAN2C1 "MANA, MANA1" ENSG00000140400 "Mannosidase alpha class 2C member 1" Q9NTJ4 15 75355207-75368630 "Enzymes, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040627, HPA067407" Uncertain Enhanced Nucleoplasm NA NA 9000 Nucleoplasm "HPA040627: AB_10795490, HPA067407: AB_2685834" "unprognostic (4.68e-2)" "unprognostic (1.95e-1)" "unprognostic (3.84e-3)" "unprognostic (3.48e-2)" "unprognostic (3.85e-1)" "unprognostic (3.00e-2)" "unprognostic (1.26e-2)" "unprognostic (6.26e-2)" "unprognostic (2.47e-1)" "unprognostic (5.02e-2)" "unprognostic (1.06e-2)" "unprognostic (3.40e-2)" "unprognostic (4.87e-3)" "unprognostic (9.56e-2)" "unprognostic (1.33e-1)" "unprognostic (2.91e-1)" "unprognostic (1.39e-3)" 29.9 28.8 22.6 20.4 26.0 30.0 24.6 27.5 25.5 25.1 25.1 26.8 23.8 22.9 27.8 27.5 20.2 24.2 23.3 28.2 18.3 12.9 22.9 21.4 25.2 17.0 23.0 28.3 32.8 22.3 28.2 30.6 22.4 18.3 24.9 14.2 30.8 25.6 20.2 37.9 30.9 27.7 20.0 15.0 28.1 23.0 28.8 19.9 21.0 34.7 15.3 19.5 21.1 21.3 2.3 15.7 2.6 16.2 3.9 7.3 8.5 5.5 13.3 11.1 8.0 12.7 11.0 13.8 12.9 12.2 6.8 5.7 9.2 19.1 2.7 7.6 9.4 6.2 17.2 6.1 8.7 4.4 15.2 13.4 17.5 25.2 9.1 18.8 11.2 2.8 13.1 8.8 6.4 8.1 14.4 15.8 8.0 10.0 14.4 5.5 10.8 5.5 12.7 4.7 6.6 5.6 7.8 5.6 16.6 8.9 25.9 6.6 12.0 8.2 12.5 5.8 8.3 12.4 13.1 30.9 14.3 10.0 9.9 12.7 14.4 3.5 4.4 9.2 12.9 14.2 2.6 13.3 2.0 7.2 16.2 6.8 2.3 5.3 5.2 15.7 2.0 7.3 5.1 1.4 3.9 12.4 6.4 7.0 8.5 22.6 26.0 27.5 25.5 18.3 12.9 23.0 28.3 18.3 19.9 20.8 52.5 12.9 13.4 11.9 32.1 2.0 5.1 16.0 18.2 8.7 51.1 14.5 3.3 9.4 8.2 17.2 21.3 0.0 7.7 8.8 15.0 13.8 31.1 21.5 17.5 27.0 32.8 33.2 37.8 10.6 21.6 24.1 15.1 19.8 21.0 18.6 9.2 14.4 11.7 12.3 52.0 25.8 10.4 18.6 10.9 7.4 17.7 12.7 20.7 11.9 MANBAL dJ1141E15.2 ENSG00000101363 "Mannosidase beta like" Q9NQG1 20 37289638-37317260 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052348 Uncertain Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA052348: AB_2681795" "unprognostic (1.86e-2)" "unprognostic (9.15e-2)" "unprognostic (1.85e-1)" "unprognostic (2.45e-2)" "unprognostic (3.12e-1)" "unprognostic (2.21e-3)" "prognostic unfavorable (7.07e-4)" "unprognostic (2.37e-1)" "unprognostic (1.23e-1)" "unprognostic (9.61e-2)" "unprognostic (2.83e-1)" "unprognostic (3.43e-1)" "prognostic favorable (3.62e-4)" "unprognostic (1.06e-1)" "unprognostic (1.86e-1)" "unprognostic (8.03e-2)" "unprognostic (2.70e-2)" 17.3 25.2 19.6 10.7 27.6 2.9 29.8 11.4 32.7 22.5 22.1 15.9 21.9 17.0 26.7 29.7 22.1 28.9 23.3 13.9 20.8 20.1 19.0 14.5 15.1 19.3 18.9 23.2 28.5 21.4 15.1 16.9 16.1 22.1 24.0 20.3 27.5 16.6 32.9 7.1 19.8 15.6 33.5 13.4 11.1 18.7 17.6 11.2 9.8 23.2 13.7 13.7 20.5 28.3 18.0 21.7 25.4 19.3 14.5 17.3 11.1 17.2 33.9 17.3 17.4 28.4 20.7 15.0 24.1 25.2 23.4 18.5 39.9 23.6 4.4 29.0 29.3 23.9 23.8 16.3 37.7 16.1 3.3 16.9 4.7 14.2 35.4 30.7 4.9 3.0 22.5 26.8 21.7 36.1 23.6 16.3 5.9 7.5 4.9 23.3 20.3 6.2 6.5 13.7 29.0 31.8 3.7 22.7 5.2 22.2 24.1 16.6 19.0 24.5 36.9 19.8 15.5 24.8 8.0 17.8 43.2 16.2 24.2 18.5 6.6 8.9 3.7 31.0 2.7 22.2 9.2 17.0 23.7 11.8 19.3 13.6 18.0 14.2 14.0 15.5 17.8 17.3 16.6 25.4 14.5 15.1 21.7 9.3 11.1 19.6 27.6 11.4 32.7 20.8 20.1 18.9 23.2 22.1 11.2 23.8 31.4 8.3 66.3 26.8 21.0 16.9 33.1 13.4 25.0 41.8 3.9 82.3 33.2 65.8 4.1 25.8 22.5 0.0 96.6 107.8 49.0 70.0 7.0 18.7 26.4 19.1 29.3 30.7 12.6 5.7 43.4 19.2 43.9 21.6 32.4 50.8 77.2 44.8 64.3 47.6 11.3 19.4 44.2 23.2 48.1 26.6 64.3 10.7 32.7 98.7 MAP1LC3B ATG8F ENSG00000140941 "Microtubule associated protein 1 light chain 3 beta" Q9GZQ8 16 87383995-87404779 "Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037216, HPA042824, HPA052474, HPA052484, HPA053767" Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "CAB037216: AB_796155, HPA042824: , HPA052474: AB_2681844, HPA052484: AB_2681846, HPA053767: AB_2682253" "unprognostic (4.70e-3)" "unprognostic (2.89e-1)" "unprognostic (3.21e-1)" "unprognostic (9.70e-3)" "unprognostic (4.28e-1)" "unprognostic (1.79e-2)" "unprognostic (4.98e-3)" "unprognostic (2.50e-2)" "unprognostic (1.20e-1)" "unprognostic (7.26e-2)" "unprognostic (1.04e-1)" "unprognostic (1.70e-1)" "prognostic favorable (2.77e-7)" "prognostic unfavorable (8.97e-4)" "unprognostic (9.66e-2)" "unprognostic (1.14e-1)" "unprognostic (1.60e-1)" 35.8 36.4 37.4 15.3 34.6 89.0 35.9 58.5 46.6 21.2 18.7 25.8 22.9 11.1 22.7 20.0 19.5 17.5 24.5 41.0 35.6 40.5 24.7 22.2 20.6 22.3 49.0 40.2 19.6 15.9 27.9 20.5 31.2 46.7 19.6 20.4 18.6 19.6 22.4 67.4 22.9 13.6 28.3 43.1 18.0 15.8 27.5 28.8 13.6 27.2 23.1 20.9 22.0 31.9 15.5 15.8 50.0 18.6 20.8 21.8 19.9 10.5 6.1 12.0 10.9 36.2 28.1 8.0 20.9 24.0 16.5 11.4 9.9 7.7 6.8 16.1 28.3 18.3 9.6 17.5 13.2 23.5 8.9 15.4 7.1 7.8 16.7 60.1 5.1 8.0 37.3 44.0 25.6 61.3 24.9 19.5 10.6 19.0 14.6 27.8 10.9 9.0 11.4 12.6 4.8 14.9 14.3 8.0 6.7 22.0 5.0 9.8 11.3 32.2 5.4 40.3 16.7 8.9 6.2 24.6 17.9 11.5 16.2 11.7 19.4 23.7 24.9 25.4 12.3 12.8 48.1 18.6 42.0 17.5 16.5 17.8 15.5 16.9 17.7 14.4 12.8 13.1 13.8 50.0 20.8 17.2 15.8 21.8 19.9 37.4 34.6 58.5 46.6 35.6 40.5 49.0 40.2 46.7 28.8 83.4 75.1 94.3 175.2 196.3 67.1 164.8 63.7 120.5 68.2 73.3 49.1 124.6 222.2 290.4 163.3 131.2 195.1 256.9 117.1 101.7 121.4 182.7 127.1 55.7 184.9 82.6 126.6 77.3 139.1 218.9 84.0 179.4 178.8 251.5 103.4 145.6 263.3 235.0 83.8 141.7 98.8 58.2 173.1 309.4 159.5 186.7 528.2 136.3 87.6 216.2 MAP1LC3B2 ATG8G ENSG00000258102 "Microtubule associated protein 1 light chain 3 beta 2" A6NCE7 12 116548105-116576448 "Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "blood: 33.1" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 31.3" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 11.2" "HPA042824, HPA052474, HPA052484, HPA053767" Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA042824: , HPA052474: AB_2681844, HPA052484: AB_2681846, HPA053767: AB_2682253" "unprognostic (1.50e-1)" "unprognostic (6.94e-2)" "unprognostic (9.14e-2)" "unprognostic (3.89e-3)" "unprognostic (1.62e-1)" "unprognostic (1.22e-1)" "unprognostic (2.43e-3)" "unprognostic (3.15e-1)" "unprognostic (2.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.33e-1)" "unprognostic (1.84e-1)" "unprognostic (1.11e-3)" "unprognostic (6.66e-3)" "unprognostic (1.65e-1)" "unprognostic (1.53e-2)" "unprognostic (3.42e-1)" 0.4 3.5 0.4 0.4 0.4 2.0 0.4 0.4 1.8 0.4 0.7 0.4 0.4 2.2 1.0 0.4 0.5 0.0 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.4 0.9 0.0 0.4 0.4 2.6 0.4 0.2 0.4 0.8 0.4 3.9 1.1 0.8 0.6 0.4 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.5 0.7 0.4 7.0 8.0 33.1 10.1 7.2 11.4 8.5 2.7 0.0 0.7 3.0 0.4 1.5 1.6 3.0 0.6 0.2 0.4 3.7 2.6 0.2 3.7 0.7 2.2 1.6 1.1 0.8 1.2 0.7 0.0 0.0 0.6 3.2 2.3 1.9 1.8 0.4 1.0 2.3 1.9 0.7 0.5 0.3 1.6 4.7 0.7 0.9 1.4 2.9 1.7 0.1 0.7 2.0 0.4 0.6 0.4 1.4 0.9 4.4 1.2 1.1 11.2 0.4 1.5 0.2 0.9 4.1 1.1 3.6 2.6 3.8 3.0 4.7 4.7 1.2 2.4 22.7 9.3 25.1 6.6 8.9 6.2 7.0 7.4 6.3 7.7 6.1 5.1 5.6 33.1 7.2 10.1 8.0 11.4 8.5 0.0 1.7 1.4 17.3 21.5 1.1 31.3 0.0 1.4 3.4 0.0 0.0 2.2 6.6 0.2 9.2 8.2 3.5 0.0 0.0 1.9 8.9 10.1 6.9 1.5 3.9 12.7 1.7 3.1 8.1 13.4 4.4 10.2 10.1 0.0 1.0 0.5 0.3 3.5 3.5 1.3 1.2 0.0 14.4 20.0 8.4 18.7 9.5 6.9 0.8 18.6 MAP1S "BPY2IP1, C19orf5, FLJ10669, MAP8, VCY2IP1" ENSG00000130479 "Microtubule associated protein 1S" Q66K74 19 17719242-17734516 "Predicted intracellular proteins" Apoptosis DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 78.9;Late spermatids: 220.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050934, HPA054637" Approved Supported "Nucleoplasm,Nucleoli,Cell Junctions,Cytosol" NA NA Cytosol "Nucleoplasm, Nucleoli, Cell Junctions" "HPA050934: AB_2681281, HPA054637: AB_2682552" "unprognostic (8.47e-2)" "unprognostic (2.39e-2)" "unprognostic (1.60e-1)" "unprognostic (2.72e-1)" "unprognostic (3.70e-1)" "unprognostic (8.23e-2)" "prognostic unfavorable (5.29e-4)" "unprognostic (2.53e-1)" "unprognostic (6.17e-2)" "unprognostic (4.39e-2)" "prognostic favorable (2.65e-4)" "unprognostic (6.33e-2)" "unprognostic (1.19e-1)" "unprognostic (1.36e-1)" "unprognostic (1.72e-1)" "unprognostic (2.09e-1)" "unprognostic (8.65e-2)" 14.7 7.1 18.9 14.0 27.0 14.9 13.4 15.4 42.1 12.3 11.5 15.5 4.9 12.5 13.4 9.8 11.6 11.1 13.1 9.3 17.2 12.9 8.3 6.9 17.6 13.2 11.4 18.1 16.8 13.8 8.9 11.9 16.1 14.3 10.0 4.7 8.4 12.6 12.1 21.2 6.0 10.5 8.8 10.3 14.2 16.0 34.1 13.1 13.2 8.5 4.3 8.6 12.6 7.6 13.1 20.7 24.9 17.7 9.4 13.3 12.5 13.0 20.5 6.2 8.1 5.2 7.8 15.7 8.6 4.4 5.5 6.2 27.9 7.5 7.7 15.9 5.5 6.4 7.2 5.0 7.0 2.3 9.6 28.7 6.9 18.2 18.2 11.1 7.6 10.0 8.5 4.0 8.3 5.2 3.9 10.9 5.9 10.7 4.4 2.9 18.3 9.3 19.3 13.6 8.2 24.0 15.1 4.8 7.8 7.1 20.0 11.0 12.1 4.8 7.4 8.6 4.7 4.7 8.4 16.8 10.1 8.7 19.5 12.9 8.3 10.0 7.8 11.6 12.2 11.8 13.3 17.0 19.2 13.3 17.7 12.8 13.1 10.4 13.1 20.7 13.1 8.8 11.7 24.9 9.4 13.1 16.7 9.5 12.5 18.9 27.0 15.4 42.1 17.2 12.9 11.4 18.1 14.3 13.1 3.0 6.9 9.5 12.3 9.2 10.0 4.8 10.2 0.0 4.5 3.5 7.9 17.5 3.3 18.4 78.9 12.8 21.7 0.0 14.9 13.7 10.1 12.1 10.3 3.9 23.4 38.1 19.5 25.8 19.1 220.0 20.8 18.7 1.7 16.2 12.9 7.8 17.9 14.0 29.7 5.2 5.9 12.9 11.4 16.3 26.4 2.9 28.3 10.9 13.1 12.3 MAP2K3 "MAPKK3, MEK3, MKK3, PRKMK3" ENSG00000034152 "Mitogen-activated protein kinase kinase 3" P46734 17 21284672-21315240 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018548 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB018548: AB_631927" "unprognostic (2.31e-1)" "unprognostic (6.39e-2)" "unprognostic (4.63e-2)" "unprognostic (3.68e-1)" "unprognostic (3.54e-3)" "unprognostic (1.60e-1)" "unprognostic (2.97e-2)" "unprognostic (1.35e-2)" "unprognostic (5.25e-3)" "unprognostic (1.88e-2)" "unprognostic (3.16e-2)" "unprognostic (2.18e-2)" "unprognostic (1.33e-1)" "unprognostic (6.48e-2)" "unprognostic (1.22e-2)" "unprognostic (2.92e-1)" "unprognostic (1.77e-1)" 16.1 12.1 5.5 14.8 7.3 66.9 29.0 12.4 8.9 10.2 12.4 6.3 10.3 18.1 7.6 11.1 24.2 11.6 25.1 26.8 5.6 5.3 15.8 37.1 25.5 34.0 7.4 3.9 10.1 26.3 9.6 15.8 26.7 9.5 12.2 9.3 12.7 18.5 9.2 46.4 20.9 23.8 18.1 7.6 26.7 16.3 5.3 4.1 16.4 11.5 45.0 21.4 16.0 17.3 13.2 17.3 49.2 33.3 5.4 16.2 10.0 21.4 21.7 2.9 13.2 17.6 11.3 11.0 33.2 36.1 26.5 24.4 24.1 13.8 19.4 13.6 52.0 22.4 21.3 9.2 29.5 18.9 20.1 16.8 11.2 12.5 21.8 5.5 14.7 23.1 8.7 8.4 36.1 10.9 8.3 11.8 11.4 2.1 9.7 22.1 21.3 7.4 14.0 8.3 38.6 12.5 15.3 18.7 14.3 15.0 22.6 7.9 2.8 12.3 13.3 23.1 30.1 6.6 5.0 10.8 25.2 20.6 26.9 21.4 12.1 6.1 25.0 24.3 12.7 13.0 14.5 16.0 25.2 14.6 24.0 12.6 13.2 12.1 13.6 17.3 10.6 7.8 10.1 49.2 5.4 33.3 12.7 16.2 10.0 5.5 7.3 12.4 8.9 5.6 5.3 7.4 3.9 9.5 4.1 35.7 59.6 38.8 149.8 229.1 5.9 17.0 45.9 29.4 45.5 21.0 3.9 51.1 63.0 81.6 1.1 21.1 72.0 210.2 69.2 75.4 38.0 143.0 94.4 63.8 45.6 17.5 115.4 21.5 64.9 0.7 11.2 56.1 82.7 15.4 50.2 16.4 93.5 56.1 15.6 27.9 6.9 0.0 70.0 0.9 4.4 190.7 56.1 56.1 31.9 222.1 MAP2K4 "JNKK1, MEK4, MKK4, PRKMK4, SERK1" ENSG00000065559 "Mitogen-activated protein kinase kinase 4" P45985 17 12020824-12143830 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.2" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "SuSa: 67.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007751, HPA060074" Enhanced Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "CAB007751: , HPA060074: AB_2684197" "unprognostic (1.55e-1)" "unprognostic (1.85e-1)" "unprognostic (4.47e-2)" "unprognostic (1.02e-2)" "unprognostic (1.04e-1)" "unprognostic (2.70e-1)" "unprognostic (2.89e-1)" "unprognostic (2.16e-1)" "unprognostic (1.93e-3)" "unprognostic (2.53e-1)" "unprognostic (2.76e-3)" "unprognostic (4.82e-2)" "unprognostic (5.32e-3)" "unprognostic (3.13e-1)" "unprognostic (2.30e-1)" "unprognostic (7.00e-2)" "unprognostic (1.79e-1)" 10.7 13.2 23.7 9.4 21.0 3.1 14.4 25.0 42.7 12.5 11.5 7.9 8.5 9.6 12.1 17.8 18.5 11.5 10.7 14.9 31.7 29.3 15.8 20.6 11.4 14.6 24.5 27.1 13.0 11.1 19.6 16.7 15.1 23.4 14.5 13.1 6.5 9.8 13.2 20.6 14.4 9.9 13.5 16.3 10.7 10.7 10.3 9.8 10.3 16.5 11.6 13.4 11.1 11.2 2.8 1.8 13.2 4.3 3.5 3.3 2.3 10.6 9.2 12.1 6.2 6.7 8.7 7.7 7.3 9.6 8.3 8.0 5.4 3.7 4.4 5.9 11.3 5.4 7.1 10.5 10.1 12.5 7.8 12.3 4.9 5.4 10.2 7.9 4.7 7.4 7.2 10.0 9.7 10.2 8.6 7.5 6.3 5.2 2.6 10.4 3.9 5.6 4.4 7.0 11.5 4.5 7.0 13.6 3.0 11.4 6.9 2.4 7.2 8.4 4.5 7.0 67.1 5.7 3.4 6.8 4.1 6.3 5.6 8.6 5.1 5.7 3.5 7.7 3.7 5.9 0.6 2.7 2.0 3.0 1.5 2.7 2.8 2.4 2.4 1.8 2.7 2.0 3.3 13.2 3.5 4.3 1.8 2.6 2.3 23.7 21.0 25.0 42.7 31.7 29.3 24.5 27.1 23.4 9.8 8.9 14.2 10.8 26.3 36.9 14.2 21.2 10.2 2.7 21.6 14.0 7.9 10.7 21.6 11.2 6.3 8.7 11.8 0.0 12.4 8.6 12.9 32.3 1.1 16.3 10.2 17.5 11.5 10.4 17.7 5.8 10.9 11.7 11.8 19.0 13.8 10.3 14.7 11.5 12.0 17.7 9.7 12.9 12.0 7.9 8.1 34.4 21.2 9.5 10.6 40.3 MAP2K6 "MAPKK6, MEK6, MKK6, PRKMK6, SAPKK3" ENSG00000108984 "Mitogen-activated protein kinase kinase 6" P52564 17 69414698-69553861 "Enzymes, Predicted intracellular proteins" "Apoptosis, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 31.9;skeletal muscle: 55.6" "Cell type enhanced" "Detected in many" 7 "Intestinal endocrine cells: 43.8;Muller glia cells: 32.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 9.3;neutrophil: 19.3;plasmacytoid DC: 31.9" "Group enriched" "Detected in all" 9 "dendritic cells: 31.9;granulocytes: 19.3;monocytes: 9.3" "Cell line enhanced" "Detected in many" "A549: 24.4;AN3-CA: 13.3;HUVEC TERT2: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007744, HPA031134" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB007744: AB_562318, HPA031134: AB_10603016" "prognostic favorable (2.27e-6)" "unprognostic (2.24e-1)" "unprognostic (8.46e-2)" "unprognostic (4.10e-2)" "unprognostic (3.75e-2)" "unprognostic (1.23e-1)" "unprognostic (7.61e-3)" "unprognostic (9.52e-2)" "unprognostic (3.67e-1)" "unprognostic (4.09e-3)" "prognostic favorable (7.52e-4)" "unprognostic (3.61e-2)" "unprognostic (2.29e-2)" "unprognostic (7.48e-2)" "unprognostic (9.43e-2)" "unprognostic (1.39e-1)" "unprognostic (2.03e-2)" 4.5 2.0 3.2 8.6 5.9 10.1 14.0 13.7 7.5 19.8 21.5 6.2 4.7 7.2 4.7 3.1 3.4 3.3 5.1 2.5 3.9 3.5 4.1 8.6 2.6 10.3 5.4 4.1 2.7 8.5 0.0 3.2 1.1 5.3 2.8 22.8 5.3 4.0 4.6 55.6 2.3 7.3 2.3 6.2 5.9 5.4 2.1 5.4 13.7 2.8 4.8 5.1 3.0 2.5 2.3 31.9 19.3 9.3 1.8 2.1 2.6 0.1 24.4 11.0 13.3 4.7 2.6 1.6 0.1 3.6 1.0 1.5 0.7 1.1 0.6 9.0 0.5 0.8 1.2 3.8 0.5 0.3 0.8 2.0 0.1 6.9 6.8 4.7 1.0 1.0 12.1 0.3 0.3 0.0 1.0 17.5 3.3 0.0 1.7 0.0 0.1 12.7 0.5 7.8 0.5 4.5 4.6 1.1 0.3 4.9 3.4 4.9 7.4 1.0 0.9 2.2 6.1 3.4 1.3 3.1 1.3 1.6 1.1 0.4 1.2 1.3 0.3 1.0 1.5 1.0 0.8 9.3 1.6 1.2 1.1 2.1 1.6 1.4 1.5 2.9 2.3 1.6 1.5 19.3 1.8 0.4 31.9 1.9 2.6 3.2 5.9 13.7 7.5 3.9 3.5 5.4 4.1 5.3 5.4 3.0 7.9 4.7 3.2 2.4 4.9 1.4 2.5 6.7 5.7 0.0 2.0 7.5 19.9 1.2 8.5 2.4 17.0 0.0 3.6 5.4 2.8 1.9 1.1 2.0 5.1 3.2 43.8 4.9 8.9 1.9 4.0 7.0 3.3 0.0 22.4 32.9 1.2 8.6 3.5 1.1 3.8 0.0 3.1 0.0 0.2 3.8 0.7 11.5 23.7 2.3 MAP3K10 "MEKK10, MLK2, MST" ENSG00000130758 "Mitogen-activated protein kinase kinase kinase 10" Q02779 19 40191744-40215575 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.0" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 13.9;Horizontal cells: 22.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007039 Approved Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA "Nucleoplasm, Actin filaments, Cytosol" "HPA007039: AB_1079357" "unprognostic (2.09e-1)" "unprognostic (3.77e-2)" "unprognostic (1.42e-3)" "unprognostic (2.03e-2)" "unprognostic (2.04e-1)" "prognostic favorable (8.69e-4)" "unprognostic (4.50e-3)" "unprognostic (1.80e-1)" "unprognostic (3.94e-2)" "unprognostic (6.13e-2)" "unprognostic (1.34e-3)" "unprognostic (4.62e-3)" "unprognostic (6.88e-2)" "unprognostic (1.53e-2)" "unprognostic (1.51e-2)" "unprognostic (4.77e-3)" "prognostic favorable (2.13e-4)" 7.7 7.0 29.6 4.7 22.8 3.7 2.2 14.3 32.0 3.3 3.4 5.3 1.8 4.4 4.5 1.8 3.7 3.1 4.0 8.2 28.2 11.2 4.7 2.1 4.2 4.6 11.5 9.4 4.3 8.1 4.7 5.2 3.7 9.0 4.6 2.0 2.4 6.9 4.8 22.9 5.6 5.0 4.0 5.3 6.7 6.2 6.6 7.1 2.3 3.3 2.6 2.4 3.8 5.4 0.8 0.0 0.0 0.2 0.0 0.9 0.0 6.3 7.6 2.4 5.6 2.2 1.3 6.5 4.4 2.2 2.0 2.1 1.7 1.8 5.8 4.6 1.5 5.1 2.1 0.9 2.3 0.3 11.0 7.2 1.5 3.2 1.7 4.2 1.3 3.7 1.2 5.5 2.2 1.5 2.3 1.9 8.2 5.5 9.9 0.6 3.8 4.8 2.3 2.8 2.1 5.0 5.9 2.5 3.4 1.8 4.0 7.9 11.4 5.1 1.9 10.4 1.5 2.5 2.3 3.1 5.4 5.2 7.8 8.5 13.1 7.5 2.6 6.2 2.4 7.8 0.0 0.1 0.0 0.4 0.2 0.0 0.8 0.2 0.9 0.0 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 29.6 22.8 14.3 28.7 28.2 11.2 11.5 9.4 9.0 7.1 0.0 0.0 2.2 1.5 1.3 13.9 2.4 0.0 0.0 0.0 7.0 7.9 0.6 0.0 2.3 2.6 2.3 2.6 0.0 3.6 0.7 1.9 2.0 0.0 2.6 2.2 22.3 4.1 3.7 2.2 6.5 2.8 1.1 1.7 1.0 1.9 5.2 3.4 1.9 4.6 3.7 7.3 6.5 2.6 2.6 1.7 2.4 1.1 1.9 2.1 1.7 MAP3K12 "DLK, MEKK12, MUK, ZPK, ZPKP1" ENSG00000139625 "Mitogen-activated protein kinase kinase kinase 12" Q12852 12 53479669-53500063 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.3" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 35.3;Rod photoreceptor cells: 81.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 3.4;monocytes: 1.7;T-cells: 2.8" "Cell line enhanced" "Detected in many" "ASC diff: 26.4;HHSteC: 25.2;HSkMC: 25.1;hTERT-RPE1: 33.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039936, HPA071996" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA039936: AB_10795239, HPA071996: AB_2686481" "unprognostic (4.01e-1)" "unprognostic (3.30e-1)" "unprognostic (8.89e-3)" "unprognostic (6.40e-3)" "unprognostic (1.10e-1)" "unprognostic (2.22e-1)" "unprognostic (6.97e-2)" "unprognostic (3.61e-2)" "unprognostic (2.39e-1)" "unprognostic (2.70e-1)" "prognostic favorable (1.51e-4)" "unprognostic (8.50e-3)" "prognostic unfavorable (5.43e-10)" "unprognostic (1.65e-2)" "unprognostic (2.44e-1)" "unprognostic (1.32e-1)" "unprognostic (1.18e-1)" 8.0 8.7 12.3 5.8 16.0 3.0 5.1 40.3 20.6 14.1 6.1 7.0 7.8 3.6 15.1 5.8 4.6 11.5 16.1 4.2 9.4 7.7 4.5 1.4 8.8 4.5 6.4 14.7 13.7 1.8 3.0 12.7 7.3 10.8 5.9 4.6 9.5 2.4 13.5 1.2 4.5 4.1 16.9 5.3 5.3 3.9 6.5 7.4 2.7 4.3 1.4 3.2 11.3 6.4 0.3 0.6 3.4 1.7 0.6 2.8 0.5 0.2 7.0 4.4 6.8 26.4 14.1 0.5 4.7 8.9 5.2 5.3 0.1 0.8 1.5 2.7 5.1 4.2 0.0 2.0 3.1 2.1 2.3 2.4 1.7 3.6 0.0 25.2 0.0 1.7 25.1 2.3 7.1 3.7 33.3 8.1 3.5 0.0 7.5 4.9 3.0 1.7 0.3 1.5 0.0 2.6 2.4 2.9 0.4 2.6 0.0 4.4 6.0 2.5 3.2 6.7 1.0 2.2 4.4 5.9 5.0 5.4 2.3 1.2 3.0 3.4 0.0 8.1 3.0 4.9 0.0 1.7 0.0 1.5 1.3 2.8 0.3 2.1 2.3 0.6 0.0 0.9 1.2 3.4 0.6 0.4 0.3 0.4 0.5 12.3 16.0 40.3 20.6 9.4 7.7 6.4 14.7 10.8 7.4 6.0 13.4 5.6 1.9 0.7 26.7 0.7 10.2 8.1 11.4 1.8 35.3 1.6 8.3 5.4 1.2 3.7 4.6 0.0 1.6 1.8 3.8 2.7 12.7 7.7 3.6 28.6 3.4 7.4 12.7 1.4 7.5 5.9 0.0 7.2 2.5 17.4 4.5 2.6 7.8 7.0 81.9 6.5 4.9 2.3 1.9 0.9 1.8 7.5 3.5 2.0 MAP3K13 "LZK, MEKK13" ENSG00000073803 "Mitogen-activated protein kinase kinase kinase 13" O43283 3 185282941-185489097 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 456.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016497, HPA036691, HPA036692" Uncertain Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA016497: AB_10670027, HPA036691: AB_10673661, HPA036692: AB_10670845" "unprognostic (8.95e-2)" "unprognostic (6.72e-3)" "unprognostic (9.46e-2)" "prognostic unfavorable (1.28e-5)" "unprognostic (5.16e-2)" "unprognostic (2.81e-1)" "unprognostic (2.61e-1)" "unprognostic (1.23e-2)" "unprognostic (9.04e-2)" "prognostic favorable (1.11e-4)" "prognostic unfavorable (7.27e-5)" "unprognostic (2.70e-3)" "unprognostic (1.54e-2)" "unprognostic (2.94e-2)" "unprognostic (2.82e-1)" "unprognostic (6.64e-2)" "unprognostic (9.31e-3)" 9.8 24.8 21.7 8.7 22.2 9.5 15.1 16.4 26.1 12.9 16.9 18.4 10.5 16.8 12.9 42.1 15.2 14.6 13.1 8.1 19.2 18.6 21.9 20.7 15.2 7.4 23.2 17.1 16.5 24.9 20.9 24.5 9.1 21.8 14.5 18.9 18.6 26.2 11.4 3.3 9.8 23.4 12.1 26.4 8.7 16.4 12.9 15.8 4.4 18.6 8.3 10.3 12.5 11.5 23.7 21.5 21.1 13.2 11.5 17.4 7.8 29.1 5.8 11.3 0.3 10.3 12.7 6.7 6.7 4.6 10.9 13.2 11.2 11.0 0.2 23.0 12.2 18.2 16.7 0.3 15.5 19.4 32.5 15.0 0.1 7.9 9.2 11.2 15.3 8.4 11.5 13.6 9.3 11.7 11.3 12.1 0.3 0.3 23.7 9.7 9.1 1.8 7.2 13.0 22.5 13.7 0.2 13.5 16.0 19.2 7.6 18.6 12.4 11.3 17.1 23.2 12.9 25.8 8.6 8.0 9.0 11.7 16.2 14.5 12.1 15.6 9.6 13.2 7.8 14.7 6.4 13.2 5.1 10.3 12.2 15.8 23.7 12.4 12.8 21.5 19.0 17.4 16.8 21.1 11.5 8.6 9.4 4.8 7.8 21.7 22.2 16.4 26.1 19.2 18.6 23.2 17.1 21.8 15.8 50.6 76.2 44.7 172.9 125.7 111.5 22.1 104.4 64.3 84.2 75.0 86.4 120.9 243.7 92.5 109.7 52.6 82.0 0.0 111.2 29.4 48.3 249.1 28.9 83.1 55.4 42.9 102.2 83.4 50.4 168.4 40.0 59.4 81.0 456.3 109.9 93.7 112.0 96.2 50.9 224.8 81.3 45.3 74.0 119.3 28.8 127.2 170.1 31.2 98.7 249.0 MAP3K14 "FTDCR1B, HS, HSNIK, NIK" ENSG00000006062 "Mitogen-activated protein kinase kinase kinase 14" Q99558 17 45263121-45317040 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "monocytes: 49.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 22.4;HDLM-2: 23.0;U-251 MG: 22.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027269, HPA027270" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" NA NA "Vesicles, Cytosol" "Nucleoplasm, Nucleoli fibrillar center" "HPA027269: AB_2732436, HPA027270: AB_2732437" "unprognostic (1.05e-2)" "prognostic favorable (5.27e-5)" "unprognostic (2.71e-2)" "unprognostic (9.42e-2)" "unprognostic (5.31e-2)" "unprognostic (2.61e-3)" "unprognostic (2.70e-2)" "unprognostic (1.72e-1)" "unprognostic (3.40e-1)" "unprognostic (3.45e-1)" "unprognostic (1.07e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (2.78e-4)" "unprognostic (8.82e-2)" "unprognostic (3.49e-2)" "unprognostic (1.03e-2)" "unprognostic (2.28e-1)" 3.7 3.4 3.0 14.7 4.0 3.4 2.7 4.9 3.6 5.0 7.3 4.5 3.5 6.0 5.5 3.3 6.8 4.2 6.2 4.5 3.0 4.4 5.1 4.9 12.0 3.0 0.6 3.5 5.7 3.5 7.7 1.5 4.6 5.2 3.5 4.3 7.5 4.8 14.5 6.1 9.6 5.2 4.1 8.4 4.0 4.5 4.5 7.1 2.2 6.9 18.0 4.9 2.8 9.5 4.8 7.7 3.6 5.6 5.2 2.3 9.5 22.4 2.3 4.0 1.6 3.8 5.7 2.6 1.8 8.5 5.2 3.4 11.9 4.2 13.6 2.8 8.5 6.8 1.0 3.6 4.4 23.0 1.7 0.9 6.1 1.5 4.1 0.7 4.5 5.9 2.3 4.2 2.2 9.0 1.6 2.0 1.8 18.3 4.3 3.5 4.0 1.5 1.2 5.9 3.1 5.2 6.9 9.6 6.2 1.9 2.4 1.9 4.1 2.7 2.9 3.4 1.7 0.4 3.6 3.9 6.0 3.3 22.5 17.5 6.5 2.2 2.2 2.5 5.2 1.5 3.4 1.6 3.5 3.6 2.0 7.6 2.4 2.5 2.3 9.5 2.6 2.5 7.7 5.6 2.2 4.8 5.2 2.3 3.0 13.8 9.7 13.7 0.0 3.6 2.0 15.3 9.4 4.5 0.0 3.9 0.7 0.0 4.2 3.7 1.6 11.2 0.0 2.3 1.2 1.8 6.5 1.1 8.1 4.4 1.6 12.6 4.9 7.8 4.5 4.4 6.2 0.0 49.5 6.4 2.2 3.3 7.8 1.1 2.5 2.7 0.0 0.6 4.5 2.4 0.0 0.0 5.1 6.7 5.0 MAP3K2 "MEKK2, MEKK2B" ENSG00000169967 "Mitogen-activated protein kinase kinase kinase 2" Q9Y2U5 2 127298730-127388465 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 13.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021540 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021540: AB_2670742" "unprognostic (5.81e-2)" "unprognostic (2.76e-1)" "unprognostic (1.58e-1)" "unprognostic (9.46e-2)" "unprognostic (1.02e-1)" "unprognostic (5.76e-2)" "unprognostic (7.19e-2)" "unprognostic (4.50e-1)" "unprognostic (1.27e-1)" "unprognostic (4.00e-1)" "unprognostic (1.25e-1)" "unprognostic (1.39e-1)" "unprognostic (4.97e-3)" "unprognostic (7.56e-2)" "unprognostic (8.93e-2)" "unprognostic (8.88e-2)" "unprognostic (2.11e-1)" 18.5 14.5 13.7 20.1 14.5 41.0 22.6 20.1 16.3 16.6 19.6 12.7 18.9 18.8 19.8 18.0 13.4 15.9 18.6 13.3 12.5 10.2 15.5 27.6 20.0 28.5 17.9 13.0 20.3 15.4 23.8 21.2 13.9 12.3 13.6 13.1 12.2 18.1 25.5 24.5 19.4 22.5 18.1 14.9 17.0 18.0 14.9 14.3 25.8 22.5 13.7 16.8 17.1 20.3 3.1 5.1 13.6 2.9 2.3 2.1 1.1 16.4 7.0 5.6 5.7 7.9 10.5 9.4 10.3 11.2 10.2 8.3 8.4 7.3 10.9 17.8 14.7 9.4 14.0 9.0 6.9 11.5 27.3 7.0 10.1 12.8 7.3 9.2 10.1 21.9 9.4 7.6 12.3 15.2 9.0 4.7 8.2 4.7 21.8 10.0 6.0 11.9 7.2 5.8 4.6 9.2 7.8 10.6 8.1 4.1 15.5 11.2 6.0 15.0 9.2 9.3 4.8 6.0 7.8 10.7 20.0 18.8 9.2 13.9 22.7 16.3 11.2 9.6 6.7 8.6 4.0 2.9 2.0 1.7 1.8 2.1 3.1 1.6 1.7 2.4 2.6 1.9 2.0 13.6 2.3 2.2 5.1 1.4 1.1 13.7 14.5 20.1 16.3 12.5 10.2 17.9 13.0 12.3 14.3 77.4 39.5 24.5 32.1 64.0 51.3 27.5 38.2 57.6 46.6 27.9 100.1 16.2 11.6 17.3 3.2 38.8 49.0 23.3 29.5 16.3 51.8 41.5 60.0 61.1 46.1 68.3 43.6 22.1 61.3 3.8 39.1 76.0 54.0 23.4 36.2 25.5 35.7 24.6 48.8 27.2 56.9 19.4 48.6 31.4 55.2 68.6 22.0 30.5 24.4 35.7 MAP3K3 "MAPKKK3, MEKK3" ENSG00000198909 "Mitogen-activated protein kinase kinase kinase 3" Q99759 17 63622415-63696303 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007764, HPA035410, HPA035411" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB007764: AB_562314, HPA035410: AB_2674614, HPA035411: AB_2674615" "unprognostic (9.65e-3)" "unprognostic (1.33e-1)" "unprognostic (5.14e-2)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.16e-1)" "unprognostic (4.12e-2)" "unprognostic (1.03e-2)" "unprognostic (1.33e-1)" "unprognostic (1.36e-1)" "unprognostic (9.37e-2)" "unprognostic (1.46e-3)" "unprognostic (5.51e-2)" "unprognostic (2.35e-1)" "unprognostic (2.79e-2)" "unprognostic (4.68e-2)" "unprognostic (1.09e-1)" "unprognostic (3.08e-2)" 23.9 11.8 10.5 20.5 15.0 24.8 19.1 26.8 14.9 22.2 21.8 15.0 14.0 8.0 24.5 13.2 16.6 18.3 20.6 37.4 11.3 8.4 17.1 12.4 23.1 21.4 14.4 9.6 21.6 11.4 16.9 12.3 21.0 11.9 18.4 8.3 21.7 12.8 18.5 19.6 15.4 14.7 20.4 13.2 30.4 16.4 26.5 12.3 12.9 15.5 12.8 15.4 19.0 26.8 1.9 3.5 18.3 8.5 1.1 2.6 2.3 10.2 7.7 9.8 9.6 18.9 15.2 4.5 10.2 11.2 12.7 10.3 3.5 2.1 11.1 7.2 19.9 9.3 3.8 6.4 7.2 8.1 9.7 14.1 9.0 10.5 5.0 9.9 6.9 9.7 10.9 5.0 15.8 8.3 8.1 30.8 8.2 5.5 14.7 10.1 7.3 12.4 7.3 6.1 2.1 8.3 6.6 25.2 7.2 4.6 4.7 5.0 12.1 6.9 8.3 8.5 12.9 8.3 6.9 27.7 32.5 8.6 17.6 12.3 14.7 14.8 4.1 7.0 5.6 8.4 8.8 8.5 10.4 2.2 8.3 2.3 1.5 2.6 2.1 3.5 1.9 2.5 2.5 18.3 1.1 8.2 1.3 1.9 2.3 10.5 15.0 26.8 14.9 11.3 8.4 14.4 9.6 11.9 12.3 17.9 12.6 8.8 5.9 6.9 13.9 9.9 2.5 4.0 5.7 15.7 13.7 2.7 8.3 3.7 7.1 33.7 2.1 0.0 6.9 2.9 7.4 8.9 3.5 8.3 13.8 17.5 4.1 39.3 38.3 4.4 13.8 15.3 21.9 8.2 3.3 7.5 4.9 0.0 12.4 2.1 15.0 19.4 11.4 18.0 6.1 9.8 1.1 8.7 4.4 3.7 MAP3K6 "ASK2, MAPKKK6, MEKK6" ENSG00000142733 "Mitogen-activated protein kinase kinase kinase 6" O95382 1 27355184-27366892 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 63.9" "Cell type enhanced" "Detected in many" 4 "Ito cells: 28.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA051192 Approved Approved "Nucleoplasm,Plasma membrane,Actin filaments,Cytosol" NA NA Nucleoplasm "Plasma membrane, Actin filaments, Cytosol" "HPA051192: AB_2681380" "unprognostic (1.19e-2)" "unprognostic (2.77e-3)" "unprognostic (2.62e-2)" "unprognostic (1.97e-2)" "prognostic unfavorable (2.13e-4)" "prognostic favorable (7.26e-4)" "prognostic unfavorable (8.76e-4)" "unprognostic (9.10e-2)" "unprognostic (2.79e-1)" "unprognostic (6.91e-2)" "unprognostic (6.56e-2)" "unprognostic (1.25e-1)" "unprognostic (4.65e-3)" "unprognostic (4.95e-2)" "unprognostic (2.79e-1)" "unprognostic (7.07e-3)" "unprognostic (1.50e-1)" 37.5 6.3 7.4 6.9 8.6 1.3 22.1 12.6 8.3 19.9 9.0 2.7 8.9 3.3 13.1 10.3 25.7 12.8 12.4 14.9 6.2 2.6 13.6 5.0 21.7 5.5 11.4 1.9 11.7 8.3 8.2 15.8 7.3 9.8 13.9 5.9 15.7 11.5 9.7 6.3 63.9 6.2 16.0 11.7 8.7 9.0 6.7 7.0 0.6 12.0 16.1 14.3 14.3 18.3 2.7 3.3 5.1 6.9 1.1 7.6 2.4 7.5 7.0 6.3 7.0 8.8 15.4 1.6 9.4 5.4 7.1 5.4 2.1 10.2 0.1 8.4 14.2 2.8 11.9 2.1 6.5 3.6 6.2 5.2 0.5 16.2 3.1 2.7 0.5 0.6 12.4 16.1 7.4 2.6 7.9 4.8 0.5 2.3 4.1 11.3 18.7 0.3 8.6 2.0 7.5 5.8 2.7 4.2 1.7 10.6 7.9 2.3 3.5 9.9 8.7 7.4 2.7 4.6 6.4 9.9 17.9 7.5 19.9 4.9 3.4 4.2 0.1 15.8 6.1 5.2 1.8 1.5 5.1 5.3 3.3 7.6 2.7 5.5 5.9 3.3 2.3 4.4 3.6 2.4 1.1 6.9 0.0 5.6 2.4 7.4 8.6 12.6 8.3 6.2 2.6 11.4 1.9 9.8 7.0 17.9 16.2 4.7 10.4 11.1 0.5 8.9 10.2 1.4 11.4 3.5 0.0 0.9 3.3 2.3 0.4 15.8 1.7 0.0 3.8 1.7 7.7 7.3 2.3 0.8 2.5 4.8 0.0 28.8 12.5 1.1 15.0 5.1 5.0 13.6 4.9 5.2 8.9 0.0 14.2 1.5 0.4 6.5 10.5 8.7 2.1 12.9 0.1 10.2 4.3 14.4 MAP3K7CL "C21orf7, TAK1L, TAKL, TAKL-1, TAKL-2, TAKL-4" ENSG00000156265 "MAP3K7 C-terminal like" P57077 21 29077471-29175889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 37.9;skeletal muscle: 50.4;tongue: 28.8" "Cell type enhanced" "Detected in many" 8 "Kupffer cells: 17.1;Sertoli cells: 19.4;Smooth muscle cells: 26.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 7.6;granulocytes: 12.0;monocytes: 5.7" "Cell line enhanced" "Detected in many" "HBF TERT88: 17.4;LHCN-M2: 18.5;RH-30: 74.0" "HPA030079, HPA042439" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA030079: AB_2673299, HPA042439: AB_10794422" "unprognostic (2.23e-1)" "unprognostic (2.06e-1)" "unprognostic (9.36e-2)" "unprognostic (1.99e-3)" "unprognostic (4.98e-2)" "unprognostic (7.00e-3)" "unprognostic (3.40e-3)" "unprognostic (1.38e-1)" "unprognostic (6.22e-2)" "unprognostic (1.93e-2)" "unprognostic (1.28e-3)" "unprognostic (4.39e-3)" "prognostic unfavorable (8.31e-6)" "unprognostic (2.68e-3)" "unprognostic (1.57e-1)" "unprognostic (1.12e-1)" "unprognostic (8.10e-2)" 6.9 5.1 1.6 4.6 2.2 1.4 2.5 1.2 1.7 4.0 4.6 2.4 1.7 0.9 8.6 11.7 3.4 3.0 5.2 16.2 1.4 1.9 4.4 3.2 6.6 5.2 1.8 1.9 4.7 4.3 2.5 2.9 1.7 2.7 4.4 1.8 2.4 1.8 2.6 50.4 2.7 3.1 3.8 3.1 3.9 1.7 3.2 1.4 2.3 2.7 28.8 7.8 3.6 2.1 7.6 0.8 12.0 5.7 0.6 1.5 37.9 0.9 0.2 0.1 0.3 0.1 5.7 0.1 1.3 3.7 3.4 9.3 1.5 0.4 8.0 0.5 5.3 0.1 0.0 0.1 4.2 17.4 1.6 0.0 0.8 0.6 0.1 0.8 0.0 0.0 2.0 8.1 11.9 11.3 1.7 0.6 0.2 0.5 3.3 18.5 0.2 0.1 0.0 0.4 0.7 0.3 0.0 74.0 0.2 0.5 0.2 0.5 0.3 0.0 0.0 0.4 1.5 0.0 0.4 0.6 7.3 6.2 1.6 0.2 1.4 0.2 0.3 1.1 0.6 1.5 12.0 5.7 1.1 0.6 4.2 1.5 7.6 0.4 0.6 0.7 5.3 0.7 1.1 8.6 0.6 1.9 0.8 1.1 37.9 1.6 2.2 1.2 1.7 1.4 1.9 1.8 1.9 2.7 1.4 0.0 4.0 3.7 5.5 7.6 2.3 1.4 2.5 1.4 0.0 0.0 2.0 0.2 0.0 1.1 1.1 3.6 1.3 0.0 1.4 0.2 3.4 3.0 1.1 4.0 3.3 0.0 4.6 1.3 17.1 0.6 0.6 5.5 5.0 1.8 2.2 1.3 2.6 2.9 4.2 2.1 1.2 19.4 26.7 1.1 1.4 8.3 0.3 2.6 1.3 2.1 MAP3K9 "MEKK9, MLK1, PRKE1" ENSG00000006432 "Mitogen-activated protein kinase kinase kinase 9" P80192 14 70722526-70809534 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.1" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 28.6;Urothelial cells: 25.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 18.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000942 Approved Approved Nucleoplasm,Nucleoli "Intracellular and membrane" NA NA "Nucleoplasm, Nucleoli" "HPA000942: AB_1079360" "unprognostic (1.20e-1)" "unprognostic (3.75e-1)" "unprognostic (4.01e-2)" "unprognostic (1.43e-2)" "unprognostic (3.16e-3)" "unprognostic (2.45e-2)" "unprognostic (3.75e-5)" "unprognostic (2.58e-1)" "unprognostic (4.20e-2)" "unprognostic (4.38e-2)" "unprognostic (1.53e-2)" "unprognostic (2.48e-2)" "unprognostic (4.23e-6)" "unprognostic (5.71e-3)" "unprognostic (6.86e-3)" "unprognostic (1.79e-1)" "unprognostic (2.35e-1)" 0.5 2.2 5.8 2.0 9.2 1.4 2.8 20.1 16.5 2.4 3.1 1.8 0.4 3.0 1.1 3.4 10.1 2.2 1.5 1.2 5.7 7.1 3.1 2.4 3.9 2.6 5.9 5.9 1.4 4.3 6.8 4.7 2.8 12.8 2.0 3.1 3.1 3.2 1.3 1.9 7.8 2.9 0.7 1.6 1.9 3.4 10.1 1.8 0.6 5.3 3.2 6.8 2.0 3.9 2.3 0.5 1.3 0.2 1.1 1.4 0.3 18.1 8.4 1.6 2.0 0.0 0.0 5.6 0.4 0.2 1.7 1.6 6.0 7.0 3.7 2.5 0.1 3.7 8.6 5.3 10.2 1.9 2.4 1.5 0.2 2.9 4.0 0.3 0.4 0.8 0.1 5.6 1.2 10.6 3.1 0.0 3.3 1.3 0.8 0.4 7.3 2.8 0.4 3.5 7.2 3.9 1.0 3.2 0.7 3.9 8.3 11.6 2.5 5.2 6.2 1.0 3.2 5.6 0.6 0.0 0.0 7.4 0.0 2.8 1.9 4.4 1.9 2.8 0.3 1.1 0.5 0.2 0.8 0.6 0.1 0.1 1.0 0.6 1.0 0.0 2.3 1.0 0.7 1.3 1.1 0.2 0.5 1.4 0.3 5.8 9.2 20.1 16.5 5.7 7.1 5.9 5.9 12.8 1.8 6.0 14.9 0.9 10.9 7.7 15.8 1.8 15.3 0.0 10.3 7.0 11.8 2.5 1.7 5.5 13.2 0.7 3.1 0.0 4.0 1.3 0.8 9.0 1.1 4.9 1.0 28.6 8.1 0.6 0.8 15.9 0.6 1.4 3.3 0.0 3.4 3.4 7.4 3.5 0.0 1.9 12.3 0.0 1.0 5.4 8.5 8.0 3.3 2.9 5.0 25.4 MAP4K3 "GLK, MAPKKKK3, RAB8IPL1" ENSG00000011566 "Mitogen-activated protein kinase kinase kinase kinase 3" Q8IVH8 2 39249266-39437312 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 80.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 41.6;RT4: 38.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030380 Approved Approved "Nucleoplasm,Centriolar satellite" NA NA "Centriolar satellite" Nucleoplasm "HPA030380: AB_10601132" "unprognostic (4.82e-2)" "unprognostic (7.22e-2)" "unprognostic (5.87e-3)" "unprognostic (7.34e-3)" "unprognostic (6.77e-2)" "unprognostic (2.57e-1)" "unprognostic (1.05e-2)" "unprognostic (6.73e-2)" "unprognostic (1.66e-1)" "unprognostic (6.73e-2)" "unprognostic (4.33e-3)" "unprognostic (4.26e-2)" "unprognostic (2.12e-1)" "unprognostic (3.08e-2)" "unprognostic (3.30e-1)" "unprognostic (2.43e-1)" "unprognostic (5.08e-2)" 19.7 18.9 17.6 15.4 17.6 9.6 17.8 37.1 19.6 19.2 16.9 14.6 9.8 13.7 23.5 14.8 11.1 15.3 18.7 19.5 15.4 12.5 26.2 15.4 15.6 5.8 15.4 13.4 24.6 14.0 25.7 24.6 30.8 14.4 18.6 14.1 17.9 13.3 15.7 33.0 17.8 17.2 18.6 15.3 11.5 26.1 21.0 16.5 9.4 25.9 11.3 7.5 18.8 32.6 0.7 0.5 2.5 1.9 1.0 1.3 0.4 9.9 6.2 41.6 6.6 6.8 13.6 11.4 8.8 11.3 8.8 7.5 5.2 5.0 2.1 10.0 6.0 9.1 5.4 15.6 7.8 13.4 2.4 6.4 3.6 4.4 12.1 17.7 1.6 5.9 12.2 7.8 11.4 12.4 9.3 7.5 2.0 4.6 4.1 11.7 5.4 3.4 2.3 12.5 9.4 9.4 3.8 13.5 1.6 11.6 38.5 7.4 8.5 5.2 8.3 23.0 13.7 5.6 2.2 6.1 6.8 8.1 6.1 4.7 6.2 3.5 0.7 8.4 2.6 7.9 2.5 0.7 0.0 1.2 1.1 0.1 0.1 1.2 0.9 0.1 0.7 1.1 1.3 0.0 1.0 1.9 0.5 0.6 0.4 17.6 17.6 37.1 19.6 15.4 12.5 15.4 13.4 14.4 16.5 3.0 6.7 5.1 15.6 15.7 23.8 32.7 17.8 13.4 15.9 21.0 23.6 9.2 16.6 9.0 38.6 10.3 11.9 0.0 10.7 5.5 15.6 20.0 2.3 16.2 9.1 6.4 9.2 15.4 9.5 80.0 19.2 12.2 5.0 1.8 12.5 15.2 12.8 7.0 16.6 10.9 41.2 19.4 12.7 19.5 20.8 16.8 8.7 4.4 9.3 29.0 MAP7D2 FLJ14503 ENSG00000184368 "MAP7 domain containing 2" Q96T17 X 20006713-20116917 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.8;epididymis: 38.7" "Cell type enhanced" "Detected in many" 15 "Cytotrophoblasts: 80.1;Spermatocytes: 34.1;Spermatogonia: 117.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "basophil: 5.5" "Lineage enriched" "Detected in single" 6 "granulocytes: 5.5" "Cell line enhanced" "Detected in some" "A549: 8.8;CACO-2: 12.7;HEK 293: 17.4;HeLa: 15.1;Hep G2: 7.5;SCLC-21H: 20.0;SiHa: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051508, HPA059537" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051508: AB_2681513, HPA059537: AB_2684054" "unprognostic (1.51e-1)" "unprognostic (9.19e-2)" "unprognostic (3.76e-1)" "unprognostic (1.45e-5)" "unprognostic (5.65e-2)" "unprognostic (9.77e-3)" "unprognostic (1.50e-1)" "unprognostic (1.50e-1)" "unprognostic (5.95e-2)" "unprognostic (7.77e-3)" "unprognostic (3.58e-4)" "unprognostic (2.21e-2)" "prognostic unfavorable (7.27e-5)" "unprognostic (9.12e-3)" "unprognostic (3.60e-2)" "unprognostic (2.54e-3)" "unprognostic (3.19e-1)" 0.7 3.6 11.1 0.9 18.5 1.3 1.0 12.9 30.8 0.7 1.3 0.8 0.7 1.3 1.2 38.7 0.9 3.0 1.1 0.9 16.5 10.3 4.1 0.7 0.9 0.8 10.4 15.0 0.8 1.7 0.7 3.0 8.1 24.2 1.5 1.5 0.8 0.8 2.8 1.0 1.5 1.8 1.0 7.1 0.7 8.9 9.7 2.1 0.0 0.6 0.0 0.9 0.7 0.5 0.0 0.8 5.5 0.1 0.0 0.3 0.0 0.0 8.8 0.8 0.0 0.0 0.2 0.0 0.9 0.0 0.1 0.1 12.7 0.3 1.5 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.6 17.4 0.0 15.1 7.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 3.5 0.6 0.0 0.2 0.0 0.0 1.0 0.0 20.0 3.4 8.5 3.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 1.0 0.0 0.9 5.5 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 11.1 18.5 12.9 21.7 16.5 10.3 10.4 15.0 24.2 2.1 3.0 0.0 0.0 0.4 1.5 29.4 1.1 0.0 9.4 1.2 0.0 2.0 80.1 3.3 1.1 10.2 0.5 2.0 0.0 0.7 5.5 1.0 0.6 0.0 0.0 5.1 17.5 9.2 0.0 0.0 16.3 0.6 0.7 0.0 0.0 0.3 1.9 0.6 3.2 1.8 13.3 7.3 0.0 0.1 34.1 117.0 1.4 25.6 0.0 1.4 0.4 MAPK13 "p38delta, PRKM13, SAPK4" ENSG00000156711 "Mitogen-activated protein kinase 13" O15264 6 36127809-36144524 "Enzymes, Predicted intracellular proteins" "Cell cycle, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 143.1;Late spermatids: 214.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 16.5;T-cells: 27.8" "Cell line enhanced" "Detected in many" "HBEC3-KT: 46.2;RPMI-8226: 27.9;RT4: 28.9" "Region enhanced" "Detected in some" "cerebellum: 6.5" "Region enriched" "Detected in some" 15 "cerebellum: 59.9" "HPA007667, CAB025854" Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim, Cytosol" "CAB025854: , HPA007667: AB_1079867" "unprognostic (6.36e-2)" "unprognostic (6.88e-2)" "unprognostic (2.93e-1)" "unprognostic (6.64e-3)" "unprognostic (1.13e-2)" "unprognostic (4.80e-2)" "unprognostic (4.30e-3)" "unprognostic (5.28e-2)" "unprognostic (1.77e-1)" "unprognostic (2.14e-2)" "unprognostic (1.57e-1)" "unprognostic (7.21e-2)" "prognostic favorable (9.00e-4)" "unprognostic (3.12e-2)" "unprognostic (1.70e-1)" "unprognostic (2.21e-2)" "unprognostic (1.41e-1)" 6.5 22.0 2.2 5.4 4.0 2.9 6.8 2.8 7.3 6.8 18.9 0.5 36.8 18.8 1.9 10.3 41.1 2.4 12.0 1.2 1.7 1.8 6.5 2.8 9.6 11.2 0.8 3.8 3.9 24.6 18.8 12.4 10.5 2.5 6.8 16.0 2.4 20.7 26.3 0.9 28.6 37.7 2.1 0.8 5.9 12.2 23.7 1.1 5.0 13.8 16.0 18.5 7.3 13.9 16.5 0.1 5.2 0.3 2.8 27.8 6.7 19.6 0.1 0.3 0.2 1.2 5.7 2.7 1.6 0.2 0.2 0.5 16.3 19.4 4.7 1.2 1.5 2.8 15.2 0.0 46.2 0.4 12.0 5.2 0.1 0.5 16.2 2.0 0.1 1.2 4.9 16.4 3.0 0.6 2.3 3.0 0.5 0.3 5.3 0.5 10.3 0.1 1.2 0.1 19.4 0.3 11.6 0.2 27.9 9.0 28.9 19.6 0.3 1.7 0.3 0.1 0.6 22.0 2.5 4.1 1.4 0.2 0.5 0.3 0.3 7.0 1.4 0.0 0.5 0.1 5.2 0.3 4.5 16.2 0.0 10.5 10.8 11.6 13.0 0.1 16.5 10.6 11.9 3.9 2.8 0.0 0.0 27.8 6.7 2.2 4.0 2.8 7.3 1.7 1.8 0.8 3.8 2.5 1.1 26.8 24.1 11.5 34.8 24.3 0.8 1.6 22.9 1.4 22.7 27.9 5.9 41.4 13.3 48.4 89.5 2.3 143.1 0.0 102.6 8.3 3.2 28.0 2.3 1.6 35.8 0.0 63.0 0.6 6.1 214.3 6.6 6.4 16.9 22.6 80.8 1.5 76.0 89.2 9.2 7.9 2.2 0.0 1.0 6.1 1.5 46.5 27.0 20.2 93.7 47.8 MAPK15 "ERK7, ERK8" ENSG00000181085 "Mitogen-activated protein kinase 15" Q8TD08 8 143716259-143722458 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.9;epididymis: 27.6;fallopian tube: 29.5" "Cell type enriched" "Detected in some" 6 "Ciliated cells: 85.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 26.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.2;HaCaT: 5.4;HeLa: 14.3;MCF7: 13.9;T-47d: 12.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA002704 Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cytosol" "Cell Junctions" "HPA002704: AB_1079307" "unprognostic (9.11e-2)" "unprognostic (1.38e-1)" "unprognostic (8.04e-3)" "unprognostic (2.94e-1)" "unprognostic (2.54e-2)" "unprognostic (1.14e-2)" "unprognostic (1.22e-1)" "unprognostic (6.09e-2)" "unprognostic (2.59e-2)" "unprognostic (1.48e-1)" "unprognostic (3.88e-1)" "unprognostic (9.51e-2)" "unprognostic (2.64e-2)" "unprognostic (1.54e-2)" "unprognostic (5.78e-1)" "unprognostic (6.35e-2)" "unprognostic (1.62e-2)" 0.6 0.1 3.6 0.3 8.1 0.1 1.1 0.2 2.1 4.5 0.4 8.7 5.2 0.5 2.2 27.6 1.3 29.5 0.4 1.1 5.4 4.6 3.9 0.2 7.4 0.5 0.2 1.5 4.7 2.0 9.1 4.2 0.6 26.9 0.9 0.4 1.6 3.0 2.4 0.2 4.9 0.7 0.5 0.4 0.5 0.9 7.3 2.4 0.1 8.4 0.5 0.4 0.5 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 1.7 0.0 0.0 0.0 0.6 1.3 0.0 0.0 0.0 0.2 7.2 0.0 1.3 0.0 0.0 5.4 0.1 0.2 0.0 1.1 1.6 0.0 14.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.3 2.7 0.0 0.0 13.9 0.0 0.0 2.0 1.2 1.1 0.0 3.0 0.4 0.9 1.3 4.0 4.0 0.0 2.8 0.0 0.2 12.5 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 8.1 0.2 2.1 5.4 4.6 0.2 1.5 26.9 2.4 0.0 8.3 0.0 0.2 0.3 0.0 0.8 0.0 85.6 13.6 0.0 0.0 0.0 0.0 0.6 12.6 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.0 2.7 0.7 0.3 0.1 0.0 0.1 0.0 MAPK1IP1L C14orf32 ENSG00000168175 "Mitogen-activated protein kinase 1 interacting protein 1 like" Q8NDC0 14 55051631-55070192 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034506 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA034506: AB_10669784" "unprognostic (3.27e-2)" "unprognostic (1.30e-1)" "unprognostic (2.83e-1)" "unprognostic (2.68e-2)" "unprognostic (1.43e-1)" "unprognostic (1.28e-1)" "unprognostic (6.86e-3)" "unprognostic (8.17e-3)" "unprognostic (3.32e-1)" "unprognostic (2.91e-2)" "unprognostic (1.70e-1)" "unprognostic (4.65e-1)" "prognostic favorable (4.82e-5)" "unprognostic (7.96e-2)" "unprognostic (1.71e-1)" "unprognostic (2.45e-1)" "unprognostic (5.40e-2)" 37.7 27.1 22.9 23.9 23.7 65.9 27.9 25.7 29.3 26.3 24.7 24.2 20.0 17.3 32.1 28.6 28.6 31.5 24.9 32.6 20.1 25.8 41.9 32.6 27.6 33.6 21.3 18.0 41.1 21.2 25.7 32.8 36.4 22.8 23.9 23.6 28.5 33.8 30.6 38.5 26.7 29.5 32.8 19.9 33.3 26.7 30.8 17.4 37.7 25.9 26.6 39.1 32.9 24.2 27.5 30.8 28.8 30.4 21.4 30.7 19.6 19.6 17.4 30.7 19.5 24.9 24.6 23.9 22.1 23.6 27.6 32.1 13.9 17.5 22.8 18.9 29.5 16.6 21.8 33.0 33.6 38.8 20.6 21.1 22.0 17.0 20.9 27.3 26.8 24.3 31.7 25.3 23.0 36.7 20.2 36.5 14.7 20.3 20.4 39.8 23.7 22.5 20.8 22.3 18.7 29.4 19.4 33.9 13.7 37.8 22.2 20.1 23.3 21.4 15.4 20.0 28.8 27.4 15.6 27.5 28.4 37.3 17.5 19.7 12.6 18.1 30.2 22.7 14.1 20.3 28.8 22.2 25.7 21.4 30.4 28.2 27.5 25.5 23.1 23.9 23.6 23.8 23.4 16.5 21.4 28.1 30.8 30.7 19.6 22.9 23.7 25.7 29.3 20.1 25.8 21.3 18.0 22.8 17.4 65.5 67.1 61.8 149.4 63.8 21.0 62.4 25.5 29.4 52.4 45.4 35.3 104.9 59.7 58.1 17.0 57.5 43.4 46.7 60.7 94.2 53.6 91.3 81.9 48.3 65.8 36.5 55.6 41.7 57.7 6.7 47.5 53.4 47.2 65.9 50.1 56.2 70.4 41.2 50.9 82.4 22.3 32.3 53.6 84.9 56.9 62.6 126.5 57.4 37.9 127.6 MAPK3 "ERK1, p44erk1, p44mapk, PRKM3" ENSG00000102882 "Mitogen-activated protein kinase 3" P27361 16 30114105-30123506 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Cell cycle, Host-virus interaction" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 255.2;Enterocytes: 275.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "eosinophil: 25.1;neutrophil: 11.3" "Lineage enriched" "Detected in many" 8 "granulocytes: 25.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002683, HPA003995, HPA005700, HPA030069" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB002683: , HPA003995: AB_1078751, HPA005700: AB_1078750, HPA030069: AB_10602035" "unprognostic (5.03e-2)" "unprognostic (4.62e-2)" "unprognostic (3.46e-2)" "unprognostic (1.60e-1)" "unprognostic (4.70e-3)" "unprognostic (2.75e-1)" "prognostic unfavorable (1.11e-4)" "unprognostic (2.09e-2)" "unprognostic (3.59e-2)" "unprognostic (1.12e-1)" "unprognostic (1.55e-1)" "unprognostic (3.51e-2)" "unprognostic (8.78e-2)" "unprognostic (1.45e-1)" "unprognostic (3.01e-2)" "unprognostic (2.38e-1)" "unprognostic (1.19e-2)" 24.9 18.5 63.3 15.3 43.2 15.6 21.1 24.8 52.0 21.3 45.1 30.4 6.3 39.7 24.2 11.4 44.1 28.7 25.6 21.2 37.1 34.0 13.4 8.8 23.3 13.1 33.8 27.4 32.7 13.0 26.1 15.2 27.6 27.6 20.1 36.7 26.2 17.1 18.3 13.9 18.7 49.2 24.0 27.8 15.9 33.7 11.6 19.5 8.4 20.5 18.7 26.0 18.2 22.2 1.4 1.5 25.1 2.7 0.8 3.1 1.4 14.0 7.7 16.4 9.2 41.2 54.6 9.2 10.5 26.0 16.6 19.9 9.1 28.2 14.1 10.4 29.3 19.2 5.2 13.7 12.3 16.3 26.7 15.9 4.3 8.5 15.3 41.4 3.2 12.1 33.7 7.2 19.0 8.6 25.3 42.2 15.5 5.9 18.2 22.0 36.8 14.5 5.0 4.3 28.6 6.7 17.2 9.7 31.7 15.2 8.9 14.5 10.3 6.0 21.1 6.1 13.8 13.8 7.7 29.9 11.0 9.5 12.5 3.6 20.7 9.4 7.2 22.0 6.8 7.7 2.4 2.7 25.1 0.9 1.9 1.4 1.3 2.1 1.6 1.4 1.4 1.5 1.6 11.3 0.8 1.0 1.5 3.1 1.4 63.3 43.2 24.8 52.0 37.1 34.0 33.8 27.4 27.6 19.5 20.8 20.3 9.0 19.0 8.8 28.0 12.7 15.3 20.1 7.9 8.7 21.6 66.6 19.9 31.0 255.2 49.5 275.3 0.0 54.5 107.4 25.7 11.8 2.3 6.4 38.5 7.9 52.6 52.8 25.3 107.0 30.0 18.9 21.9 27.9 135.6 38.1 77.0 98.1 25.8 18.2 32.7 19.4 18.6 10.5 17.5 11.5 28.3 13.1 63.5 18.0 MAPK4 "Erk3-related, Erk4, PRKM4" ENSG00000141639 "Mitogen-activated protein kinase 4" P31152 18 50560078-50731824 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 26.4;brain: 33.4;parathyroid gland: 43.5" "Cell type enhanced" "Detected in some" 15 "Cardiomyocytes: 20.1;Early spermatids: 20.2;Late spermatids: 42.4;Muller glia cells: 55.0" "Group enriched" "Detected in many" 5 "glioma: 15.2;melanoma: 3.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.0;HeLa: 4.5;NTERA-2: 3.0;SCLC-21H: 15.7;SH-SY5Y: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007461 Approved "Nucleoplasm,Golgi apparatus,Midbody" NA NA "Nucleoplasm, Golgi apparatus" Midbody "HPA007461: AB_1079308" "unprognostic (4.12e-2)" "unprognostic (3.24e-2)" "unprognostic (3.60e-1)" "unprognostic (1.42e-3)" "unprognostic (5.17e-2)" "unprognostic (1.84e-2)" "unprognostic (6.32e-2)" "unprognostic (2.08e-2)" "unprognostic (8.24e-2)" "unprognostic (1.61e-1)" "unprognostic (4.38e-3)" "unprognostic (2.16e-1)" "unprognostic (3.44e-7)" "unprognostic (1.96e-4)" "unprognostic (5.99e-4)" "unprognostic (2.31e-2)" "unprognostic (1.82e-1)" 1.9 26.4 16.9 1.1 33.4 0.9 1.8 15.9 23.9 1.4 2.6 9.5 3.8 1.6 1.8 4.5 3.5 1.5 3.0 16.9 13.0 14.3 4.5 7.0 3.5 0.9 17.1 9.1 4.2 2.5 43.5 8.3 3.7 20.5 5.3 1.8 4.1 1.8 12.4 1.7 1.0 1.9 5.2 11.8 1.1 1.3 3.5 12.4 1.7 7.8 0.0 0.9 2.2 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.8 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 1.5 1.4 4.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.9 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 15.7 3.8 0.1 1.1 2.6 0.9 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 33.4 15.9 14.5 13.0 14.3 17.1 9.1 20.5 12.4 8.9 0.0 0.0 0.1 0.0 11.0 20.1 2.5 0.0 0.0 0.0 0.0 3.6 5.0 1.0 20.2 0.0 0.0 0.0 0.0 0.3 0.4 0.8 0.0 0.8 0.3 4.8 0.0 0.0 0.0 42.4 0.9 0.0 0.0 0.0 0.0 55.0 0.5 0.0 1.4 0.0 0.6 0.0 1.0 0.6 0.6 0.0 1.5 0.0 0.0 0.0 MAPK7 "BMK1, ERK5, PRKM7" ENSG00000166484 "Mitogen-activated protein kinase 7" Q13164 17 19377721-19383544 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Differentiation" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Sertoli cells: 25.8;Spermatocytes: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 24.1;SuSa: 29.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018561, HPA031031" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB018561: AB_2140544, HPA031031: AB_2673706" "unprognostic (1.63e-1)" "unprognostic (2.75e-2)" "unprognostic (1.72e-1)" "unprognostic (2.90e-2)" "unprognostic (4.38e-2)" "unprognostic (1.20e-3)" "prognostic unfavorable (1.86e-4)" "unprognostic (5.67e-3)" "unprognostic (1.62e-2)" "unprognostic (1.16e-1)" "unprognostic (1.83e-2)" "unprognostic (4.75e-2)" "unprognostic (1.23e-2)" "unprognostic (1.90e-1)" "unprognostic (5.71e-1)" "unprognostic (1.55e-1)" "unprognostic (3.78e-2)" 11.5 15.0 6.4 7.3 7.6 9.2 11.8 12.5 7.9 13.4 15.3 7.2 6.0 9.2 13.1 14.1 17.3 9.4 11.8 8.2 5.9 4.7 10.8 4.8 9.9 9.2 8.2 5.2 25.4 5.7 7.3 7.5 12.5 6.7 14.0 6.9 10.5 7.8 12.3 7.5 13.1 11.2 13.8 7.1 13.2 8.0 13.3 7.5 4.5 8.6 11.3 10.6 12.7 15.9 2.2 2.6 11.5 7.4 5.5 4.7 3.0 3.6 5.8 4.8 3.7 24.1 10.1 5.6 5.0 4.6 6.9 6.4 6.7 0.6 2.2 4.0 8.6 5.1 4.1 5.6 4.6 4.3 3.8 4.3 1.0 4.1 2.9 10.4 0.9 3.7 10.6 3.2 10.5 3.7 6.0 5.1 4.3 1.9 0.8 6.9 2.4 7.4 3.9 5.5 3.7 3.8 4.0 7.0 1.5 2.3 2.0 2.2 6.4 5.1 0.5 2.5 29.6 3.1 1.2 2.8 7.4 5.5 8.2 3.4 1.4 2.1 0.6 8.6 0.9 4.5 1.0 3.6 11.5 4.7 7.4 2.5 2.2 2.2 4.1 2.6 1.4 2.1 2.6 1.3 5.5 6.5 1.7 1.0 3.0 6.4 7.6 12.5 7.9 5.9 4.7 8.2 5.2 6.7 7.5 6.0 3.5 6.2 5.5 4.8 2.0 1.7 0.0 1.4 2.3 5.2 2.0 4.8 5.0 7.1 6.3 7.1 9.0 0.0 5.3 6.9 8.3 5.5 2.3 1.3 6.7 0.0 10.3 6.7 6.7 5.9 10.6 6.3 3.3 2.8 5.7 14.5 6.2 13.5 11.0 3.0 2.0 25.8 8.6 31.4 10.6 3.8 4.2 4.4 6.1 5.2 MAPKAP1 "MGC2745, MIP1, SIN1" ENSG00000119487 "Mitogen-activated protein kinase associated protein 1" Q9BPZ7 9 125437393-125707234 "Predicted intracellular proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029091, HPA029092" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029091: AB_10599732, HPA029092: AB_10601568" "unprognostic (6.65e-2)" "unprognostic (1.56e-1)" "unprognostic (1.31e-2)" "unprognostic (1.33e-1)" "unprognostic (2.11e-1)" "unprognostic (1.09e-1)" "unprognostic (5.11e-2)" "unprognostic (2.57e-2)" "unprognostic (1.68e-1)" "unprognostic (8.94e-2)" "unprognostic (2.59e-1)" "unprognostic (8.08e-2)" "prognostic favorable (7.23e-6)" "unprognostic (1.66e-1)" "unprognostic (2.04e-1)" "unprognostic (2.98e-1)" "unprognostic (4.27e-2)" 27.2 33.9 35.0 24.4 41.4 20.4 22.6 20.3 30.4 27.0 30.1 21.0 20.6 20.1 26.4 25.6 30.3 20.5 21.3 44.9 29.5 24.9 37.5 37.5 20.1 21.3 28.3 20.4 29.1 24.8 29.8 24.1 31.3 27.1 21.7 26.7 22.8 29.7 26.2 60.7 18.2 23.3 33.2 28.5 27.0 25.1 24.9 22.1 24.1 32.7 23.2 24.7 27.2 25.7 7.6 7.1 18.8 6.1 5.4 7.5 2.5 23.7 27.0 18.2 19.3 25.2 24.1 30.4 30.1 30.9 23.4 16.5 27.3 26.8 24.4 18.5 42.0 25.7 33.2 28.2 35.4 31.9 27.6 11.5 17.5 32.6 25.8 28.4 31.3 20.5 23.6 32.7 33.4 35.1 26.2 34.5 24.1 27.8 19.3 49.6 49.6 23.1 12.6 29.0 56.1 33.9 19.6 43.2 32.4 25.7 17.3 22.2 21.8 30.2 28.5 18.9 25.9 33.0 18.4 22.2 33.3 22.0 39.9 50.0 24.2 59.4 24.9 47.5 14.5 35.9 3.6 6.1 5.3 4.6 5.8 6.2 7.5 5.0 5.0 4.8 7.6 4.4 7.5 18.8 5.4 5.2 7.1 5.4 2.5 35.0 41.4 20.3 30.4 29.5 24.9 28.3 20.4 27.1 22.1 11.9 14.2 27.4 23.3 14.1 24.1 59.7 30.6 14.7 36.4 14.0 39.3 28.8 46.4 43.0 56.5 22.7 24.3 23.3 57.0 40.4 18.6 34.5 17.3 28.8 47.0 30.2 9.2 14.1 24.3 91.3 17.5 38.5 21.9 66.7 20.1 28.1 47.7 20.1 16.6 60.6 25.2 6.5 23.4 54.5 81.3 16.9 42.6 24.5 23.4 26.9 MAPKAPK2 ENSG00000162889 "Mitogen-activated protein kinase-activated protein kinase 2" P49137 1 206684944-206734283 "Cancer-related genes, Enzymes, Predicted membrane proteins" "DNA damage" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "plasmacytoid DC: 18.7" "Lineage enriched" "Detected in all" 6 "dendritic cells: 18.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010297, HPA045556, HPA063708, HPA064435" Approved Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "CAB010297: AB_2250405, HPA045556: AB_2679367, HPA063708: AB_2685100, HPA064435: AB_2685263" "unprognostic (7.93e-2)" "unprognostic (1.83e-1)" "unprognostic (5.27e-2)" "unprognostic (5.12e-2)" "unprognostic (1.80e-1)" "unprognostic (1.32e-2)" "prognostic unfavorable (1.93e-4)" "unprognostic (9.85e-2)" "unprognostic (1.68e-1)" "unprognostic (2.00e-1)" "unprognostic (1.01e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (4.58e-6)" "unprognostic (2.12e-1)" "unprognostic (1.37e-1)" "unprognostic (6.96e-2)" "unprognostic (3.29e-2)" 23.0 25.3 11.6 21.2 15.7 58.6 23.9 11.1 14.5 19.3 25.6 17.2 14.5 25.7 20.0 18.5 23.5 17.3 26.0 89.2 12.3 8.7 33.7 26.7 26.7 21.5 16.7 6.5 23.3 19.1 16.9 22.8 13.6 15.7 20.2 14.4 17.8 19.8 14.4 62.9 18.3 32.9 18.3 14.6 37.7 23.1 21.3 14.6 26.9 24.3 25.2 28.2 22.9 46.1 1.1 18.7 3.2 1.1 2.3 1.6 0.5 21.2 8.4 11.7 13.2 34.6 20.3 14.6 14.8 33.7 22.7 21.4 16.1 10.4 10.2 10.4 29.9 14.2 16.1 8.7 15.8 16.3 11.9 6.6 17.2 10.5 10.3 26.7 25.4 57.6 28.0 20.2 21.8 24.1 18.9 18.5 13.9 19.8 46.7 18.3 26.4 10.2 18.4 13.5 7.5 11.8 26.2 24.6 3.3 17.1 13.1 9.4 12.1 17.5 29.6 20.5 22.8 14.4 24.7 17.6 20.5 17.3 23.7 20.2 60.9 54.0 8.3 23.2 15.5 6.7 1.1 0.7 1.4 1.6 1.1 1.5 1.0 1.2 1.5 0.6 1.1 0.6 1.1 3.2 2.3 1.0 18.7 1.4 0.5 11.6 15.7 11.1 14.5 12.3 8.7 16.7 6.5 15.7 14.6 50.6 53.7 28.9 47.2 75.9 11.3 97.2 40.8 6.7 29.6 29.6 19.6 5.0 13.3 28.0 71.3 26.3 27.4 23.3 50.4 7.0 28.6 55.9 34.6 34.4 22.4 0.0 59.3 21.5 27.7 20.1 21.0 27.9 32.1 12.6 32.0 17.7 50.5 21.2 16.3 21.0 14.8 25.8 48.7 11.8 4.1 63.0 13.8 37.4 24.1 68.1 MAPKAPK3 "3pK, MAPKAP3" ENSG00000114738 "Mitogen-activated protein kinase-activated protein kinase 3" Q16644 3 50611520-50649297 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 86.7;skeletal muscle: 70.1" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 193.9;Hofbauer cells: 91.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 30.2;eosinophil: 23.0;intermediate monocyte: 50.0;myeloid DC: 27.1;neutrophil: 20.5;non-classical monocyte: 61.4;plasmacytoid DC: 16.9" "Group enriched" "Detected in all" 5 "dendritic cells: 27.1;granulocytes: 23.0;monocytes: 61.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058275 Supported Nucleoplasm NA NA Nucleoplasm "HPA058275: AB_2683663" "unprognostic (6.46e-3)" "unprognostic (1.84e-1)" "prognostic favorable (8.08e-5)" "unprognostic (1.17e-1)" "unprognostic (1.93e-1)" "unprognostic (9.96e-2)" "unprognostic (8.77e-3)" "unprognostic (7.68e-3)" "unprognostic (1.11e-1)" "unprognostic (5.87e-2)" "unprognostic (2.19e-3)" "unprognostic (1.01e-1)" "prognostic favorable (1.90e-8)" "unprognostic (2.15e-2)" "unprognostic (1.22e-1)" "unprognostic (1.86e-1)" "unprognostic (1.69e-1)" 8.9 16.1 5.6 9.3 7.2 30.4 6.3 1.9 6.2 5.5 9.5 7.1 7.5 9.9 5.5 8.6 16.8 5.1 8.5 86.7 4.8 3.7 17.9 11.9 11.0 15.1 7.2 4.1 8.7 24.2 11.2 9.0 9.0 6.0 7.6 6.7 10.9 12.4 9.2 70.1 17.6 12.0 5.2 5.9 12.5 9.0 4.0 5.2 25.9 22.6 40.9 14.3 6.1 7.5 3.0 27.1 23.0 61.4 7.3 6.4 19.5 23.4 7.3 3.0 8.6 4.6 11.7 6.9 5.7 8.2 8.8 7.5 11.3 21.9 9.4 5.8 19.1 21.9 8.4 20.9 22.5 7.9 20.8 5.0 49.5 10.3 10.2 9.3 35.6 26.4 9.3 14.0 20.5 28.0 8.8 7.8 16.8 13.9 6.2 18.5 9.5 15.1 35.9 11.4 8.2 30.0 6.7 7.3 14.2 41.0 13.5 5.7 4.0 5.1 14.5 6.5 5.3 9.1 22.1 5.6 7.0 16.0 36.0 14.1 4.2 7.7 7.8 37.0 56.1 2.8 6.4 30.2 23.0 5.5 50.0 5.4 3.0 6.2 6.4 27.1 1.8 4.9 5.5 20.5 7.3 61.4 16.9 5.2 19.5 5.6 7.2 1.9 6.2 4.8 3.7 7.2 4.1 6.0 5.2 8.9 9.4 7.5 19.5 10.1 0.9 193.9 10.2 6.7 6.8 10.4 0.0 5.0 54.7 35.3 28.4 6.7 23.1 0.0 26.4 5.7 11.0 21.5 35.7 10.9 91.5 0.0 5.8 4.9 48.9 60.2 6.6 40.9 6.8 46.9 13.9 10.8 54.8 8.6 3.2 28.5 2.3 25.8 11.7 3.4 4.3 17.7 4.2 18.7 27.9 30.1 MAPKAPK5 PRAK ENSG00000089022 "Mitogen-activated protein kinase-activated protein kinase 5" Q8IW41 12 111841978-111902238 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004546, HPA015515" Supported Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB004546: AB_627910, HPA015515: AB_1853569" "unprognostic (6.45e-2)" "unprognostic (7.29e-2)" "unprognostic (1.27e-3)" "unprognostic (1.09e-2)" "unprognostic (5.52e-2)" "unprognostic (3.76e-2)" "prognostic unfavorable (2.98e-8)" "unprognostic (1.88e-1)" "unprognostic (3.09e-2)" "unprognostic (1.22e-1)" "unprognostic (1.75e-1)" "unprognostic (1.25e-2)" "unprognostic (3.20e-1)" "unprognostic (6.03e-2)" "unprognostic (3.39e-2)" "unprognostic (9.41e-2)" "unprognostic (3.25e-2)" 20.7 26.2 21.4 17.5 26.4 24.1 21.7 23.7 28.3 17.3 28.8 26.1 21.9 26.3 25.8 22.8 20.8 17.5 22.7 20.7 17.7 15.2 21.7 21.5 18.9 19.4 22.3 20.4 21.3 24.5 19.8 20.4 21.0 17.3 18.7 32.9 23.6 23.3 20.5 33.2 23.0 28.4 21.1 18.0 18.4 19.8 16.7 22.0 19.3 20.5 15.1 19.3 19.9 16.5 4.9 4.1 3.2 11.4 3.9 6.8 2.5 14.9 19.8 19.2 16.1 13.9 14.1 29.3 15.0 18.1 23.0 16.0 25.6 12.3 22.6 11.1 17.6 13.7 14.9 25.2 15.7 21.6 15.0 13.8 20.1 13.8 20.5 16.8 25.2 14.2 14.8 22.6 22.0 26.2 17.5 16.9 20.6 27.7 8.9 16.8 16.8 25.0 39.9 27.3 36.8 14.0 24.8 14.0 21.7 18.3 21.7 23.7 20.1 17.0 29.0 20.8 18.3 23.5 28.9 14.7 13.1 13.2 13.4 18.7 18.3 22.4 26.7 15.9 18.4 18.5 1.3 4.8 3.2 6.5 3.5 3.5 4.9 4.3 4.7 3.3 4.0 6.8 5.1 2.5 3.9 11.4 4.1 6.6 2.5 21.4 26.4 23.7 28.3 17.7 15.2 22.3 20.4 17.3 22.0 3.0 17.2 13.8 19.4 18.2 45.9 15.7 22.9 9.4 15.9 3.5 39.3 26.2 11.6 25.6 11.1 15.5 36.7 0.0 25.7 28.0 17.4 20.5 2.3 11.1 17.5 22.3 35.2 16.5 15.8 5.6 14.4 16.6 8.5 24.4 39.9 19.2 27.7 28.8 16.6 16.8 34.7 19.4 17.9 18.0 36.8 18.6 25.2 22.3 30.8 24.3 MAPKBP1 KIAA0596 ENSG00000137802 "Mitogen-activated protein kinase binding protein 1" O60336 15 41774434-41827855 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 48.1" "Cell type enhanced" "Detected in many" 18 "Basal keratinocytes: 48.5;Cone photoreceptor cells: 192.4;Suprabasal keratinocytes: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030832, HPA030833" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoli, Nucleoli rim" Nucleoplasm "HPA030832: AB_10601869, HPA030833: AB_2673628" "unprognostic (2.53e-1)" "unprognostic (9.18e-2)" "unprognostic (6.56e-2)" "prognostic favorable (1.47e-4)" "unprognostic (1.16e-1)" "unprognostic (2.22e-1)" "unprognostic (9.84e-3)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (6.80e-4)" "unprognostic (1.08e-3)" "unprognostic (6.03e-3)" "unprognostic (7.94e-2)" "unprognostic (1.68e-1)" "unprognostic (8.98e-2)" "unprognostic (1.72e-1)" "unprognostic (2.28e-2)" 4.7 6.0 10.6 5.0 13.8 4.4 5.7 48.1 13.9 6.1 5.7 8.8 4.4 10.6 9.3 5.4 12.5 8.0 5.3 4.2 8.6 6.7 3.9 2.3 4.7 4.0 8.6 9.2 15.4 4.3 5.8 9.5 6.1 9.3 5.9 4.3 7.0 5.1 7.1 4.9 26.3 10.5 10.2 6.8 5.7 5.4 19.5 10.7 4.4 8.7 5.2 7.4 8.4 6.6 1.9 1.9 4.3 2.1 2.2 3.3 1.6 4.9 2.6 7.1 6.7 7.9 7.8 4.8 7.1 17.7 6.4 4.7 5.2 1.8 1.2 5.8 5.7 8.9 12.0 6.8 19.7 4.6 4.5 2.0 5.0 8.1 1.7 3.4 3.2 10.3 4.0 15.8 10.2 18.5 10.6 9.4 8.3 3.1 2.3 9.0 1.0 2.6 2.8 0.8 2.9 5.4 2.9 5.1 0.5 3.7 5.6 8.0 4.6 4.1 4.1 3.1 7.6 4.9 2.5 7.4 9.2 4.5 8.9 6.9 5.2 8.5 2.9 6.2 4.3 7.7 4.3 1.3 1.1 3.3 0.7 2.4 1.9 1.9 1.4 1.9 1.8 2.4 2.0 0.7 2.2 2.1 0.7 0.8 1.6 10.6 13.8 48.1 13.9 8.6 6.7 8.6 9.2 9.3 10.7 6.0 13.0 2.2 7.6 48.5 11.4 2.8 2.5 10.7 9.1 3.5 192.4 5.0 0.0 2.7 11.7 7.0 4.0 0.0 3.0 3.5 5.5 3.6 1.1 1.8 3.3 14.3 4.6 4.9 2.1 19.1 6.6 4.6 8.5 4.6 1.4 6.1 3.3 1.5 7.4 0.3 8.2 12.9 3.9 8.1 4.1 46.9 4.5 4.4 2.0 12.1 MAPRE2 "EB1, EB2, RP1" ENSG00000166974 "Microtubule associated protein RP/EB family member 2" Q15555 18 34976928-35143470 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 71.4" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 93.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 42.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016738, HPA016739" Enhanced Uncertain Nucleoplasm NA NA 24000000 Nucleoplasm "HPA016738: AB_1853571, HPA016739: AB_1853570" "unprognostic (2.01e-1)" "unprognostic (3.48e-1)" "unprognostic (2.55e-2)" "unprognostic (5.30e-3)" "unprognostic (1.75e-1)" "unprognostic (1.05e-1)" "unprognostic (1.13e-2)" "unprognostic (8.53e-2)" "unprognostic (1.09e-2)" "unprognostic (2.29e-1)" "unprognostic (2.93e-2)" "unprognostic (5.40e-2)" "unprognostic (2.22e-3)" "unprognostic (5.83e-2)" "unprognostic (1.34e-1)" "unprognostic (3.16e-2)" "unprognostic (3.99e-3)" 12.3 33.8 38.9 15.3 35.5 10.4 9.6 34.6 61.8 11.6 13.4 30.4 3.1 8.3 8.1 11.3 10.1 6.5 22.7 47.9 43.7 29.8 10.6 18.5 15.1 18.4 39.0 43.3 14.8 7.3 7.6 8.6 15.7 32.1 9.4 14.0 8.7 10.5 10.2 24.6 12.8 10.7 14.4 71.4 14.6 16.7 3.8 22.1 31.9 12.3 8.6 17.5 15.7 8.4 27.4 23.1 25.1 22.8 34.0 32.8 32.8 0.2 8.8 9.9 5.2 6.0 5.6 0.7 6.3 15.0 7.5 13.0 0.6 3.3 28.9 7.4 13.8 8.1 11.9 7.7 5.1 13.9 16.9 7.2 29.4 9.6 16.9 4.4 16.1 24.7 6.7 1.4 10.5 3.6 7.1 42.1 20.8 9.1 13.0 9.8 0.5 34.1 5.4 7.7 9.6 1.7 13.7 12.1 6.6 3.9 0.1 12.4 8.2 4.7 0.2 5.2 9.7 1.0 9.5 7.0 8.3 4.7 4.9 4.2 6.8 16.2 17.0 14.4 21.7 12.9 25.1 14.7 22.2 32.8 18.2 25.4 27.4 23.2 29.8 16.0 25.9 26.8 32.6 10.6 34.0 22.8 23.1 23.5 32.8 38.9 35.5 34.6 41.2 43.7 29.8 39.0 43.3 32.1 22.1 20.8 19.4 20.7 4.8 21.1 74.9 93.6 17.8 9.4 6.8 5.2 23.6 0.4 5.0 7.3 8.0 22.0 9.6 0.0 11.4 8.9 21.6 2.9 26.5 22.2 22.9 49.3 28.2 36.2 41.5 5.5 17.8 20.3 28.7 4.6 27.1 43.5 8.6 19.2 19.8 4.6 10.1 77.6 52.6 1.5 11.3 24.1 0.7 35.5 9.9 3.0 MARCKS "80K-L, MACS, PKCSL" ENSG00000277443 "Myristoylated alanine rich protein kinase C substrate" P29966 6 113857362-113863471 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "monocytes: 652.8" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 10.1;neutrophil: 15.0" "Group enriched" "Detected in many" 10 "B-cells: 3.9;granulocytes: 15.0;monocytes: 10.1" "Cell line enhanced" "Detected in many" "AF22: 74.7;TIME: 58.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022062, HPA054820, HPA067595, HPA069443" Enhanced Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA 17000000 "Plasma membrane" "Nucleoplasm, Endoplasmic reticulum, Cytosol" "CAB022062: AB_309681, HPA054820: AB_2682613, HPA067595: AB_2732772, HPA069443: AB_2732133" "unprognostic (4.71e-1)" "unprognostic (1.91e-2)" "unprognostic (2.46e-1)" "unprognostic (5.51e-3)" "unprognostic (8.22e-3)" "unprognostic (2.38e-2)" "prognostic unfavorable (2.78e-8)" "unprognostic (7.82e-2)" "unprognostic (2.57e-1)" "unprognostic (6.92e-2)" "unprognostic (2.27e-1)" "unprognostic (3.56e-2)" "prognostic unfavorable (4.85e-4)" "unprognostic (1.36e-3)" "unprognostic (2.77e-2)" "unprognostic (8.07e-2)" "unprognostic (2.70e-2)" 13.0 5.0 11.2 17.0 12.9 26.9 16.0 18.5 43.3 12.1 23.2 17.9 0.9 11.6 9.7 4.0 17.0 8.4 10.9 9.7 10.5 5.3 8.7 12.9 13.3 8.8 15.9 12.6 11.2 1.2 6.5 39.5 13.8 14.1 21.6 11.4 8.2 5.6 5.0 9.5 12.9 9.1 42.3 20.9 18.8 5.2 8.5 30.0 4.9 7.9 13.6 23.5 7.8 3.9 0.9 15.0 10.1 0.0 0.0 0.4 6.8 4.0 74.7 4.0 25.3 16.5 0.4 22.2 31.2 15.7 26.2 7.2 9.8 0.0 4.7 40.9 12.4 21.3 12.3 6.4 20.5 0.0 7.3 0.0 4.3 9.4 16.9 1.8 0.1 17.0 12.7 15.1 14.4 43.1 44.2 0.0 0.8 19.7 22.2 0.0 0.2 0.0 9.6 7.7 5.3 0.0 7.5 0.7 4.9 13.2 10.4 30.3 14.2 7.2 15.2 18.4 0.3 2.0 58.7 14.6 0.1 23.9 37.8 53.3 3.8 2.0 11.2 9.9 27.9 0.0 3.4 0.0 0.0 10.1 0.0 3.9 0.0 0.0 0.9 1.6 0.0 0.0 15.0 0.0 5.5 0.0 0.0 0.4 8.9 19.9 84.3 477.4 447.8 131.4 10.5 56.0 99.0 62.6 36.6 27.5 5.0 31.5 120.8 46.4 214.9 254.5 0.0 195.2 5.5 224.2 281.9 2.3 4.3 324.8 79.4 322.8 234.5 223.1 24.8 111.7 249.4 259.8 652.8 331.8 330.7 220.9 241.8 62.9 3.4 33.7 38.8 128.7 20.0 15.6 558.1 24.6 7.5 259.9 481.3 MARCKSL1 "F52, MacMARCKS, MLP, MLP1" ENSG00000175130 "MARCKS like 1" P49006 1 32333832-32336379 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 166.5" "Cell type enhanced" "Detected in many" 9 "monocytes: 1596.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "eosinophil: 54.9" "Lineage enriched" "Detected in many" 8 "granulocytes: 54.9" "Cell line enhanced" "Detected in many" "AF22: 108.3;NTERA-2: 104.4" "Low region specificity" "Detected in all" "CAB020787, HPA030528" Enhanced Supported "Nucleoplasm,Actin filaments,Cytosol" NA Yes 120000 Cytosol "Nucleoplasm, Actin filaments" "CAB020787: , HPA030528: AB_2673514" "unprognostic (8.08e-2)" "unprognostic (1.28e-1)" "unprognostic (1.11e-1)" "unprognostic (1.04e-2)" "unprognostic (1.38e-1)" "unprognostic (3.16e-3)" "prognostic unfavorable (1.78e-6)" "unprognostic (3.65e-1)" "unprognostic (1.72e-1)" "unprognostic (8.41e-3)" "unprognostic (2.91e-1)" "unprognostic (1.76e-2)" "prognostic unfavorable (1.20e-4)" "unprognostic (1.50e-1)" "unprognostic (8.16e-3)" "unprognostic (1.08e-1)" "unprognostic (3.22e-2)" 9.9 12.7 59.9 22.1 45.4 10.9 27.7 22.0 58.0 22.3 27.5 126.3 5.3 15.9 25.8 42.3 3.6 15.9 24.9 10.7 64.2 47.2 6.4 9.7 9.0 41.5 83.6 35.4 74.1 4.8 1.3 4.9 11.0 56.6 22.5 30.7 5.2 19.9 14.2 2.0 5.3 13.9 11.3 166.5 12.5 34.8 30.3 52.3 41.4 29.0 2.2 49.2 17.0 5.5 6.4 2.2 54.9 6.7 0.2 3.9 1.2 8.4 7.6 108.3 44.2 2.4 0.9 19.2 3.5 2.2 10.6 7.0 18.0 6.2 19.0 13.3 2.4 0.0 4.5 34.9 0.4 7.8 0.4 25.8 1.0 2.9 39.7 7.5 4.9 0.1 12.4 1.4 7.9 0.2 16.5 30.9 32.8 29.1 0.2 14.2 20.0 61.7 20.9 104.4 27.4 17.6 77.1 11.6 9.0 15.9 16.8 67.2 63.9 18.6 20.6 58.5 46.0 14.3 8.8 9.1 4.5 26.3 0.4 6.7 2.9 0.2 49.9 0.5 7.5 23.7 0.7 1.0 54.9 0.9 5.4 0.3 4.6 1.9 1.2 1.5 6.4 3.9 1.6 4.4 0.2 6.7 2.2 1.0 1.2 59.9 45.4 22.0 54.9 64.2 47.2 83.6 35.4 56.6 52.3 0.0 2.2 147.6 95.4 83.2 17.7 7.3 163.1 2.7 4.5 57.6 5.9 9.9 69.6 353.9 21.7 181.6 54.0 0.0 269.1 98.8 68.7 341.5 23.0 3.8 20.1 9.5 716.9 486.2 57.0 35.8 567.8 77.4 285.1 1596.0 443.0 406.9 517.8 228.0 602.9 1.2 12.4 129.4 72.9 6.2 129.4 72.6 11.2 47.2 387.2 506.2 MARK2 "EMK1, PAR-1, PAR-1B, Par1b" ENSG00000072518 "Microtubule affinity regulating kinase 2" Q7KZI7 11 63838928-63911019 "Enzymes, Predicted intracellular proteins" "Differentiation, Wnt signaling pathway" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038790, HPA074905" Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA038790: AB_10674840, HPA074905: AB_2686722" "unprognostic (1.33e-2)" "unprognostic (2.45e-2)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.21e-4)" "unprognostic (7.13e-2)" "unprognostic (3.82e-2)" "prognostic unfavorable (1.30e-4)" "unprognostic (2.73e-3)" "unprognostic (4.41e-1)" "unprognostic (5.79e-2)" "unprognostic (3.94e-3)" "unprognostic (3.77e-1)" "unprognostic (5.20e-3)" "unprognostic (5.15e-3)" "unprognostic (6.78e-2)" "unprognostic (1.03e-1)" "unprognostic (2.40e-1)" 9.7 11.6 16.5 16.3 21.4 18.5 13.8 24.7 26.1 15.2 20.5 20.0 11.1 21.3 13.6 7.5 48.4 13.6 14.4 14.7 17.0 10.1 11.9 12.4 15.4 16.3 18.1 13.7 11.0 17.3 21.8 22.4 21.1 15.0 14.9 19.8 10.6 20.7 14.3 15.7 35.8 26.9 13.3 13.3 21.6 16.8 9.8 18.7 22.9 15.9 13.6 23.5 14.8 21.3 2.9 1.9 9.8 1.9 3.3 4.5 1.2 22.7 15.2 12.5 13.1 6.9 9.0 17.3 9.3 8.9 13.4 10.4 16.3 24.1 16.8 16.4 9.7 14.5 29.5 12.0 14.5 11.6 11.6 9.4 18.5 12.0 10.6 7.7 20.1 24.5 4.9 19.8 12.3 10.7 6.3 11.0 15.9 15.7 19.4 8.8 28.0 21.0 14.3 14.2 18.4 11.1 17.4 9.3 18.6 10.0 18.8 17.2 11.6 16.0 41.1 10.7 14.0 29.9 12.0 10.4 14.2 8.9 18.3 10.3 11.8 12.2 16.5 9.7 10.6 11.3 2.7 1.7 4.4 2.9 1.5 4.5 2.3 3.2 3.1 1.9 2.9 2.6 2.4 9.8 3.3 1.9 1.7 1.5 1.2 16.5 21.4 24.7 26.1 17.0 10.1 18.1 13.7 15.0 18.7 6.0 5.0 13.9 16.2 22.3 26.0 10.9 35.7 6.7 6.8 19.2 7.9 19.2 1.7 18.5 0.4 11.9 59.3 0.0 18.5 16.8 10.6 28.8 17.3 12.1 15.7 19.1 28.7 13.5 19.5 0.7 11.8 11.3 3.3 8.2 35.1 19.1 20.0 35.9 10.3 6.9 17.8 19.4 9.2 8.4 21.8 30.1 54.3 23.6 28.2 30.9 MAS1L "dJ994E9.2, MAS-L, MRG" ENSG00000204687 "MAS1 proto-oncogene like, G protein-coupled receptor" P35410 6 29486697-29487956 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "cervix, uterine: 7.5;epididymis: 4.0" "Cell type enriched" "Detected in single" 58 "granulocytes: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 40 "HEL: 3.9" HPA017983 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA017983: AB_1849332" "unprognostic (3.66e-2)" "unprognostic (2.51e-1)" "unprognostic (2.30e-2)" "unprognostic (5.22e-2)" "unprognostic (1.65e-1)" 2.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 7.5 1.3 0.4 1.2 4.0 2.1 0.2 1.2 0.4 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 1.1 1.5 0.3 0.2 1.7 1.5 1.1 0.0 0.0 0.5 0.3 0.0 0.5 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MASP1 "CRARF, MASP, PRSS5" ENSG00000127241 "Mannan binding lectin serine peptidase 1" P48740 3 187217285-187292022 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Complement activation lectin pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 43.4;liver: 80.1" "Cell type enhanced" "Detected in some" 15 "Cardiomyocytes: 32.5;Cholangiocytes: 28.1;Hepatocytes: 57.1;Ito cells: 30.7" "Group enriched" "Detected in some" 9 "glioma: 6.8;liver cancer: 7.7;prostate cancer: 3.0;renal cancer: 3.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "BJ: 27.1;BJ hTERT+: 103.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001617, HPA009641" Supported Enhanced Nucleoplasm,Cytosol "Secreted to blood" No NA 8670000000 1800000000 "Nucleoplasm, Cytosol" "HPA001617: AB_1079314, HPA009641: AB_1079313" "unprognostic (1.67e-1)" "unprognostic (1.02e-2)" "unprognostic (1.99e-1)" "unprognostic (5.20e-2)" "unprognostic (1.02e-2)" "unprognostic (1.25e-6)" "prognostic favorable (2.20e-4)" "unprognostic (9.92e-2)" "unprognostic (3.22e-1)" "unprognostic (2.29e-1)" "unprognostic (4.18e-1)" "unprognostic (1.29e-1)" "unprognostic (2.82e-3)" "unprognostic (3.56e-3)" "unprognostic (1.97e-1)" "unprognostic (7.85e-2)" "unprognostic (4.29e-1)" 2.1 1.4 3.6 1.2 3.8 0.1 1.2 1.9 10.2 43.4 19.1 14.8 2.4 0.8 34.9 7.1 4.1 6.7 3.3 39.6 6.1 2.5 1.6 80.1 2.2 0.4 6.4 3.0 1.7 0.2 0.2 0.5 3.2 13.0 17.4 2.1 0.1 0.9 19.4 12.2 2.5 2.6 17.1 21.8 0.4 0.6 1.5 6.7 0.0 1.3 6.3 3.5 4.4 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 3.7 0.0 27.1 103.4 0.4 0.1 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 3.8 1.9 3.5 6.1 2.5 6.4 3.0 13.0 6.7 0.0 2.6 0.0 0.1 2.6 0.0 32.5 28.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.6 0.7 0.0 0.0 0.0 0.2 11.0 0.0 0.0 57.1 0.4 0.0 0.0 30.7 2.4 3.8 2.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.7 2.2 0.0 0.0 5.9 0.0 0.0 1.5 0.1 0.5 0.0 0.1 MAST4 KIAA0303 ENSG00000069020 "Microtubule associated serine/threonine kinase family member 4" O15021 5 66596361-67169595 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 428.6;Basal keratinocytes: 327.4;Glandular cells: 324.3;Suprabasal keratinocytes: 348.9;Urothelial cells: 641.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 12.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 17.8;HDLM-2: 22.6;HEL: 18.7;RT4: 22.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000544 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA000544: AB_1079315" "unprognostic (1.77e-2)" "unprognostic (6.24e-2)" "unprognostic (1.80e-1)" "unprognostic (4.99e-3)" "unprognostic (2.83e-2)" "prognostic favorable (5.18e-5)" "unprognostic (9.01e-2)" "unprognostic (1.00e-1)" "unprognostic (2.79e-2)" "unprognostic (9.47e-2)" "unprognostic (5.03e-2)" "unprognostic (3.01e-2)" "unprognostic (1.01e-2)" "unprognostic (1.37e-2)" "unprognostic (2.63e-1)" "unprognostic (2.63e-1)" "unprognostic (3.08e-2)" 16.2 12.9 10.2 6.9 11.8 2.5 12.6 6.2 19.4 13.9 6.9 6.3 6.3 6.3 14.4 8.9 31.2 11.6 9.7 24.5 9.9 8.1 14.2 9.5 13.1 5.0 6.5 9.2 20.2 5.9 35.6 16.7 18.4 11.1 10.1 5.3 5.7 13.7 8.7 12.7 16.9 6.8 11.4 5.6 6.0 8.2 10.7 5.0 37.5 8.1 21.8 20.6 13.6 22.3 3.4 1.1 12.1 0.9 2.4 7.5 1.4 7.6 4.2 2.1 0.1 6.9 6.2 5.0 1.7 2.6 0.6 0.5 3.8 2.1 0.5 3.6 1.4 1.6 6.9 6.4 17.8 0.7 22.6 2.1 18.7 2.4 1.6 0.5 0.0 6.6 10.3 9.8 3.9 7.9 7.3 14.1 1.7 1.8 2.1 4.8 6.6 2.7 0.1 1.4 0.6 3.4 0.6 1.8 0.4 1.7 22.9 3.0 2.4 2.3 0.9 0.1 1.5 1.5 0.1 13.5 1.6 2.3 2.5 2.9 5.5 2.4 0.1 4.3 0.0 1.3 12.1 0.4 0.8 1.2 0.5 2.9 3.4 4.7 1.2 0.4 2.1 5.0 2.1 4.1 2.4 0.9 1.1 7.5 1.4 10.2 11.8 6.2 19.4 9.9 8.1 6.5 9.2 11.1 5.0 29.8 44.7 9.0 428.6 327.4 18.2 114.6 17.8 29.4 59.1 17.4 2.0 33.2 31.5 46.4 104.5 72.0 17.3 0.0 103.5 42.2 34.0 324.3 92.3 37.2 4.6 7.9 30.9 60.2 6.0 92.7 38.3 9.8 45.5 2.8 14.9 56.5 55.6 15.6 30.8 73.9 3.5 38.8 35.8 11.4 8.5 348.9 114.8 15.2 15.0 641.7 MASTL "FLJ14813, Gwl, THC2" ENSG00000120539 "Microtubule associated serine/threonine kinase like" Q96GX5 10 27154824-27186924 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 20.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027175, HPA054273" Approved Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA027175: AB_1853591, HPA054273: AB_2682433" "unprognostic (4.10e-2)" "unprognostic (6.89e-2)" "unprognostic (1.22e-2)" "unprognostic (3.14e-3)" "unprognostic (3.67e-1)" "unprognostic (1.97e-2)" "prognostic unfavorable (2.52e-6)" "unprognostic (2.19e-2)" "unprognostic (4.00e-2)" "unprognostic (4.05e-2)" "prognostic unfavorable (4.81e-5)" "unprognostic (3.78e-2)" "prognostic unfavorable (1.71e-6)" "unprognostic (1.55e-3)" "unprognostic (2.27e-1)" "unprognostic (2.66e-1)" "unprognostic (1.79e-1)" 9.1 7.0 3.6 8.9 6.1 21.1 8.3 4.0 7.5 7.4 7.6 3.8 5.7 5.7 6.0 6.7 12.3 5.4 5.3 5.6 6.8 4.5 6.5 7.1 10.2 14.8 5.4 5.7 7.0 12.7 6.7 6.3 14.2 6.7 5.5 7.1 5.6 8.0 4.7 4.0 10.1 10.0 6.1 5.6 8.7 6.2 11.3 2.3 21.1 6.5 4.3 12.3 8.7 7.5 3.9 2.6 5.6 4.9 2.3 4.0 1.8 11.9 9.6 18.4 6.8 2.8 4.2 10.9 17.9 7.5 29.7 36.6 11.6 12.0 9.6 6.8 7.5 14.4 11.6 11.7 7.1 21.1 8.1 11.3 11.3 6.7 6.7 1.6 4.3 8.5 2.5 3.2 17.9 3.5 3.9 6.4 7.8 8.6 21.6 18.0 7.9 14.0 4.7 13.7 6.7 3.9 9.0 30.7 7.9 7.3 4.5 8.2 11.8 11.3 7.6 7.9 12.7 7.6 9.1 5.5 7.4 15.6 18.9 15.7 2.6 4.2 14.1 8.1 13.1 6.1 0.1 4.4 3.8 2.0 4.3 3.0 2.6 2.5 1.8 2.5 3.9 2.5 2.3 5.6 2.3 4.9 2.6 4.0 1.8 3.6 6.1 4.0 7.5 6.8 4.5 5.4 5.7 6.7 2.3 6.0 8.5 7.2 4.0 9.7 1.9 1.6 0.0 4.0 9.1 1.8 0.0 3.3 0.0 3.2 1.7 3.6 3.0 0.0 2.2 20.7 5.8 3.3 12.7 1.7 5.1 3.2 4.1 2.5 12.0 1.5 2.8 5.6 0.0 1.8 3.4 1.5 3.6 1.9 2.5 1.4 0.9 0.0 5.9 11.2 16.4 8.7 5.1 8.7 3.5 5.9 MAT2A "MATA2, MATII, SAMS2" ENSG00000168906 "Methionine adenosyltransferase 2A" P31153 2 85539165-85545280 "Enzymes, Plasma proteins, Predicted intracellular proteins" "One-carbon metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 205.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009968, HPA043028" Approved Approved Nucleoplasm,Cytosol NA NA 950000 Nucleoplasm Cytosol "CAB009968: AB_675710, HPA043028: AB_10960707" "unprognostic (1.38e-3)" "unprognostic (2.58e-2)" "unprognostic (3.96e-2)" "prognostic unfavorable (5.29e-5)" "unprognostic (9.89e-3)" "unprognostic (5.90e-3)" "prognostic unfavorable (4.87e-4)" "prognostic favorable (8.94e-4)" "prognostic unfavorable (5.94e-5)" "unprognostic (4.07e-2)" "unprognostic (2.02e-1)" "unprognostic (2.59e-2)" "unprognostic (9.63e-3)" "unprognostic (1.04e-1)" "unprognostic (2.02e-1)" "unprognostic (4.39e-2)" "unprognostic (1.77e-2)" 55.9 68.9 37.4 35.3 54.1 20.4 30.3 37.5 50.0 28.6 35.3 74.5 39.7 33.6 35.8 59.8 33.5 44.9 51.6 35.0 41.7 28.5 52.3 26.4 32.9 27.0 74.8 37.6 44.2 205.8 38.8 60.5 29.3 48.9 40.6 36.8 35.0 28.2 31.3 51.4 33.7 35.8 47.6 57.7 24.7 44.6 34.9 69.4 22.7 94.0 34.1 30.8 46.9 33.4 13.8 15.3 4.9 17.2 16.9 22.8 14.9 30.0 44.6 52.4 32.5 36.1 44.1 31.0 37.8 34.9 39.8 42.5 36.4 101.4 70.5 24.9 45.9 32.5 46.9 65.9 56.4 51.2 35.7 48.4 42.1 64.6 31.5 66.0 62.4 47.1 39.9 57.2 42.9 30.0 50.7 37.7 41.0 47.3 55.5 90.3 25.8 56.9 68.8 34.8 25.9 57.5 60.6 49.6 45.7 60.1 47.7 41.3 38.1 34.2 33.0 60.9 27.7 27.9 33.5 36.6 48.9 29.5 26.9 45.1 34.3 27.2 51.0 31.9 78.4 25.6 4.8 15.2 4.9 15.4 17.2 22.8 13.8 17.5 16.2 15.3 12.2 16.4 14.3 1.6 16.9 13.7 10.9 15.3 14.9 37.4 54.1 37.5 50.0 41.7 28.5 74.8 37.6 48.9 69.4 44.7 76.0 36.8 172.0 127.5 81.9 4.5 86.6 34.8 63.7 68.0 64.8 30.7 16.6 50.4 46.3 49.1 61.0 23.3 49.9 34.3 63.9 55.3 83.1 40.6 57.5 25.4 79.9 36.2 106.8 20.7 66.7 92.6 64.1 35.1 55.5 59.7 55.5 42.1 78.8 119.6 80.9 109.9 101.9 51.4 57.7 103.4 31.9 36.2 51.7 86.6 MATR3 "KIAA0723, MGC9105, MPD2, VCPDM" ENSG00000015479 "Matrin 3" P43243 5 139293648-139331677 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity" RNA-binding "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 12 "Cytotrophoblasts: 1.0;Hofbauer cells: 1.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB033552, HPA036564, HPA036565" Supported Approved Nucleoplasm "Intracellular and membrane" NA NA 140000 Nucleoplasm "CAB033552: AB_2281755, HPA036564: AB_10669907, HPA036565: AB_10673623" "unprognostic (9.33e-2)" "unprognostic (6.57e-2)" "unprognostic (8.37e-2)" "unprognostic (7.53e-2)" "unprognostic (7.20e-2)" "unprognostic (4.32e-3)" "unprognostic (1.03e-1)" "unprognostic (3.56e-2)" "unprognostic (2.96e-2)" "unprognostic (1.93e-1)" "unprognostic (1.23e-1)" "unprognostic (9.36e-2)" "unprognostic (1.08e-3)" "unprognostic (1.73e-1)" "unprognostic (1.93e-1)" "unprognostic (3.86e-2)" "unprognostic (7.90e-2)" 32.9 39.7 62.4 25.8 77.3 82.2 49.0 103.4 81.6 46.9 32.2 35.3 27.1 22.4 50.6 38.6 31.4 40.5 34.6 36.1 61.5 62.0 46.3 33.3 34.0 42.0 50.1 58.5 62.6 30.2 61.7 61.0 36.1 59.0 40.7 32.6 28.8 28.4 43.3 44.3 23.7 27.5 43.5 51.3 35.0 25.5 32.7 36.8 64.8 58.0 23.9 48.5 36.7 30.4 36.6 28.3 45.5 30.4 45.4 44.8 42.9 36.9 34.7 104.5 47.9 36.7 40.7 52.9 31.6 55.5 56.2 65.6 49.4 38.6 62.4 44.2 44.1 53.2 24.6 69.0 49.1 75.8 49.3 33.8 42.3 41.1 51.6 35.0 45.9 32.5 41.9 37.8 45.6 42.4 46.3 54.3 39.9 38.0 31.4 57.6 33.6 87.3 51.4 56.4 37.0 33.1 54.0 78.2 38.9 52.1 57.7 52.3 65.8 45.5 33.1 46.4 83.5 36.2 45.4 35.0 51.5 33.7 33.7 44.2 32.0 52.0 76.0 35.9 40.3 49.5 45.5 20.9 33.9 36.3 25.1 44.8 36.6 38.2 40.9 28.3 30.7 42.3 38.8 10.4 45.4 30.4 15.7 40.8 42.9 62.4 77.3 103.4 81.6 61.5 62.0 50.1 58.5 59.0 36.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 MATR3 ENSG00000280987 "Matrin 3" 5 139273752-139331671 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 101.8;Ciliated cells: 112.4;Club cells: 72.8;granulocytes: 100.2;Intestinal endocrine cells: 79.9;Melanocytes: 97.8;Suprabasal keratinocytes: 97.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA036564, HPA036565" Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA036564: AB_10669907, HPA036565: AB_10673623" "unprognostic (3.08e-1)" "unprognostic (1.96e-1)" "unprognostic (1.15e-2)" "unprognostic (2.37e-2)" "unprognostic (3.64e-1)" "unprognostic (1.10e-1)" "unprognostic (8.69e-9)" "unprognostic (1.10e-1)" "unprognostic (9.33e-3)" "unprognostic (3.09e-1)" "unprognostic (2.08e-1)" "unprognostic (5.51e-2)" "unprognostic (9.91e-10)" "unprognostic (2.91e-2)" "unprognostic (9.21e-3)" "unprognostic (2.24e-1)" "unprognostic (9.89e-2)" 1.9 3.5 4.4 5.4 11.1 4.3 5.5 3.0 14.5 2.0 4.4 3.9 1.2 3.6 3.6 5.3 3.0 4.4 1.6 9.6 4.6 1.9 2.0 1.1 7.6 3.8 6.8 4.0 4.2 1.8 1.1 2.1 10.1 3.7 6.3 0.7 6.1 1.8 12.8 3.1 2.4 3.2 3.3 4.0 3.9 4.7 4.5 2.2 1.5 5.2 6.7 2.8 5.3 5.8 4.9 0.5 1.8 1.6 4.3 2.2 14.5 10.7 6.9 32.8 17.5 19.8 12.3 9.6 7.6 13.4 16.4 16.5 13.4 56.3 14.1 13.8 9.4 17.5 51.4 27.3 25.6 11.3 23.7 33.7 14.4 12.8 14.2 33.6 14.2 21.4 19.3 17.3 21.6 9.7 13.4 21.2 28.7 9.7 15.3 6.3 21.8 9.4 27.0 7.6 7.5 43.2 21.7 23.4 6.9 8.9 21.8 12.3 12.3 13.1 24.7 16.8 10.9 17.3 10.3 11.3 17.2 9.3 13.6 5.0 5.3 31.0 9.5 29.0 13.8 0.1 1.4 0.2 0.9 1.8 2.1 5.8 2.9 3.4 4.9 3.6 4.3 3.3 0.5 1.6 0.8 0.2 1.5 2.2 41.7 33.3 0.0 0.6 101.8 1.8 0.0 0.0 112.4 72.8 0.0 2.0 0.3 0.0 0.0 0.2 0.7 2.3 0.0 0.0 0.2 0.8 0.7 100.2 0.0 0.7 1.6 79.9 0.0 0.0 0.4 0.6 23.2 97.8 0.0 2.0 0.5 0.1 0.8 0.7 0.0 0.9 0.0 0.3 1.4 0.4 97.2 0.2 0.0 1.5 0.9 MAU2 "KIAA0892, mau-2, MAU2L, MGC75361, SCC4" ENSG00000129933 "MAU2 sister chromatid cohesion factor" Q9Y6X3 19 19320681-19358755 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059897 Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" NA NA Nucleoplasm "Nuclear bodies" "HPA059897: AB_2684154" "unprognostic (3.53e-1)" "unprognostic (2.94e-2)" "unprognostic (1.18e-1)" "unprognostic (9.57e-3)" "unprognostic (1.87e-1)" "prognostic favorable (3.90e-5)" "unprognostic (1.68e-2)" "unprognostic (3.49e-3)" "unprognostic (5.56e-3)" "unprognostic (3.56e-1)" "unprognostic (3.98e-3)" "unprognostic (1.28e-1)" "unprognostic (4.27e-3)" "unprognostic (2.42e-2)" "unprognostic (1.10e-1)" "unprognostic (6.67e-3)" "unprognostic (2.96e-2)" 15.3 15.2 17.5 17.4 23.6 24.5 15.8 30.5 21.1 15.7 15.0 28.2 18.9 16.9 18.9 21.6 20.8 20.1 16.9 19.9 15.7 14.4 14.8 12.7 19.5 26.5 28.3 13.1 25.2 19.3 17.8 20.9 15.9 18.3 16.6 10.5 17.2 16.8 20.4 43.6 25.0 15.9 17.8 19.7 22.0 14.1 18.0 25.9 20.6 16.6 12.2 18.6 15.3 16.0 7.0 6.8 14.1 13.4 8.2 9.8 7.4 8.5 6.6 11.8 10.5 9.8 10.3 16.4 8.1 8.3 11.0 10.0 9.5 12.1 10.6 17.6 8.7 5.5 10.1 10.0 8.3 5.1 5.5 25.7 8.3 10.3 8.2 11.4 14.7 13.0 11.3 9.4 7.9 9.1 11.6 10.5 9.7 11.1 13.2 7.3 9.8 15.1 20.5 10.2 11.9 19.0 17.0 7.6 11.4 7.8 11.2 17.2 15.7 10.0 10.5 10.5 6.3 9.1 20.8 9.3 17.2 3.9 16.9 12.2 17.3 14.5 10.7 8.4 15.6 12.9 4.1 7.7 5.5 8.7 6.5 9.8 6.9 7.5 8.0 6.8 7.0 8.3 7.6 14.1 8.2 13.4 6.8 7.1 7.4 17.5 23.6 30.5 21.1 15.7 14.4 28.3 13.1 18.3 25.9 17.9 19.4 10.2 5.7 5.6 29.6 15.7 20.4 20.1 9.1 10.4 51.1 8.3 3.3 7.3 8.2 9.2 10.7 23.3 8.0 6.2 7.6 8.0 9.3 7.2 7.5 47.7 13.8 12.9 14.5 9.0 14.1 10.5 10.1 3.6 14.1 12.8 10.1 7.0 13.1 4.8 31.4 6.5 8.3 31.2 13.2 8.4 12.7 12.1 13.0 6.4 MAX "bHLHd4, bHLHd5, bHLHd6, bHLHd7, bHLHd8" ENSG00000125952 "MYC associated factor X" P61244 14 65006174-65102695 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 94.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000328, HPA003474" Supported Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "CAB000328: AB_2281783, HPA003474: AB_1079317" "unprognostic (4.50e-3)" "unprognostic (1.51e-3)" "unprognostic (4.08e-2)" "unprognostic (2.87e-1)" "unprognostic (8.37e-2)" "unprognostic (2.42e-2)" "unprognostic (1.13e-3)" "unprognostic (1.30e-3)" "unprognostic (1.53e-2)" "unprognostic (7.36e-3)" "unprognostic (7.19e-2)" "unprognostic (1.66e-2)" "prognostic unfavorable (5.57e-4)" "unprognostic (2.99e-1)" "unprognostic (4.68e-2)" "prognostic favorable (2.12e-4)" "unprognostic (6.03e-2)" 33.4 25.5 31.3 31.5 38.6 68.7 25.8 59.0 38.2 34.6 29.4 37.2 26.3 31.5 34.3 24.0 47.6 38.2 27.9 30.1 29.9 28.4 26.3 21.8 31.4 43.4 37.1 21.6 39.7 20.0 17.4 23.7 30.2 32.7 31.9 25.0 26.8 33.6 37.7 27.8 32.1 40.2 30.7 34.8 42.9 24.8 15.7 40.9 41.3 30.2 22.5 40.7 35.1 40.7 18.7 19.1 87.5 23.6 19.2 30.0 44.8 28.9 11.3 7.0 11.3 18.4 14.4 9.1 10.2 15.6 12.7 15.7 7.2 20.4 24.1 8.6 12.2 11.3 14.5 17.5 14.2 9.6 24.3 10.6 37.5 7.5 7.9 21.6 14.1 94.4 17.2 10.1 11.7 13.0 16.6 14.1 16.3 17.6 9.8 12.9 16.0 32.6 48.6 9.3 17.1 18.6 18.5 11.0 10.8 11.8 9.7 15.1 9.8 13.4 14.3 13.1 6.5 14.0 18.0 17.6 11.7 14.2 10.8 8.1 12.1 10.2 15.3 14.6 13.6 11.7 87.5 23.6 80.6 21.7 20.1 23.7 18.7 25.4 22.1 19.1 17.6 26.6 22.3 49.5 19.2 17.4 18.3 30.0 44.8 31.3 38.6 59.0 38.2 29.9 28.4 37.1 21.6 32.7 40.9 26.8 27.2 50.6 55.5 151.2 22.4 25.5 22.9 21.4 27.3 17.4 19.6 34.8 44.7 33.9 34.8 46.7 63.2 0.0 27.8 36.5 43.0 52.7 62.2 19.1 53.4 44.5 42.5 68.2 78.5 71.7 72.2 46.3 54.0 34.3 40.5 43.3 45.6 87.7 56.6 49.1 15.0 135.8 55.6 40.5 26.6 157.8 45.2 59.0 24.2 65.0 MAZ "Pur-1, ZF87, Zif87, ZNF801" ENSG00000103495 "MYC associated zinc finger protein" P56270 16 29806106-29811164 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Intestinal endocrine cells: 128.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048315, HPA059495, HPA065930" Approved Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA048315: AB_2680353, HPA059495: AB_2684039, HPA065930: AB_2685579" "unprognostic (1.05e-1)" "unprognostic (2.11e-1)" "unprognostic (1.15e-1)" "unprognostic (1.03e-1)" "unprognostic (1.25e-1)" "unprognostic (3.83e-1)" "unprognostic (3.25e-3)" "unprognostic (6.16e-2)" "unprognostic (1.27e-1)" "unprognostic (5.12e-2)" "unprognostic (2.00e-1)" "unprognostic (6.39e-3)" "prognostic unfavorable (5.15e-4)" "unprognostic (1.20e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.22e-4)" "unprognostic (7.08e-2)" 23.9 32.2 49.3 34.0 37.9 86.3 62.2 57.3 49.0 31.7 51.5 25.5 30.8 34.8 33.1 26.5 31.1 34.9 31.4 21.3 43.3 30.1 22.8 33.0 31.3 52.5 30.5 32.4 38.4 39.8 44.5 30.2 24.2 22.1 48.1 38.8 29.0 32.3 31.2 41.0 35.8 34.6 29.1 22.9 34.5 28.7 28.4 25.4 141.5 30.2 26.7 40.8 30.6 39.4 5.7 8.4 9.5 9.9 16.4 28.6 8.7 28.1 37.6 38.9 42.3 21.1 20.1 35.1 20.6 16.9 32.2 23.4 48.0 40.7 50.6 26.9 40.2 15.9 25.7 63.8 26.9 11.5 41.2 102.1 33.5 81.7 65.4 29.7 82.8 41.8 21.4 38.1 27.0 30.6 30.1 32.1 71.6 49.0 44.6 15.2 116.4 79.3 70.6 39.4 30.9 29.4 78.5 36.7 58.9 26.2 30.7 59.8 46.6 19.7 42.8 25.8 26.1 36.8 80.0 22.0 35.5 28.6 13.5 32.0 32.6 41.0 55.9 17.4 54.8 29.3 6.8 6.3 9.5 26.1 9.9 28.6 5.7 17.5 24.8 8.0 4.2 14.6 21.4 5.0 16.4 6.2 8.4 18.4 8.7 49.3 37.9 57.3 49.0 43.3 30.1 30.5 32.4 22.1 25.4 6.0 4.8 31.8 14.3 29.2 60.4 0.3 33.1 9.4 6.8 10.4 11.8 21.0 24.9 29.7 2.1 30.0 41.1 0.0 35.5 46.9 42.8 30.2 33.4 34.2 49.7 44.5 128.1 28.8 32.4 3.4 25.9 25.0 43.9 13.6 101.5 21.1 32.8 59.6 34.6 17.0 30.3 32.3 47.4 17.7 20.5 31.0 14.0 40.1 104.1 11.3 MBD1 "CXXC3, PCM1" ENSG00000141644 "Methyl-CpG binding domain protein 1" Q9UIS9 18 50266882-50281774 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 96.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009017, CAB036003, HPA068850" Approved Enhanced Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB009017: AB_2095559, CAB036003: , HPA068850: AB_2732121" "unprognostic (2.12e-2)" "unprognostic (5.05e-2)" "unprognostic (6.88e-2)" "unprognostic (5.01e-3)" "unprognostic (9.20e-2)" "unprognostic (6.85e-2)" "prognostic unfavorable (5.08e-6)" "unprognostic (5.91e-2)" "unprognostic (2.61e-2)" "unprognostic (4.65e-2)" "unprognostic (1.96e-3)" "prognostic unfavorable (1.70e-6)" "unprognostic (7.06e-3)" "unprognostic (7.70e-2)" "unprognostic (7.05e-2)" "unprognostic (4.61e-2)" "unprognostic (1.31e-1)" 14.7 21.7 18.0 18.8 20.8 29.4 15.7 27.1 29.4 15.3 17.2 18.8 16.2 18.7 18.4 16.6 21.1 16.4 16.8 19.7 19.2 14.0 17.4 18.9 16.0 20.9 21.8 23.1 20.7 19.7 28.2 24.2 19.4 18.2 18.0 13.9 15.0 19.6 19.5 25.9 24.2 18.3 18.3 15.2 22.6 18.0 72.3 21.5 19.1 19.9 20.0 18.2 19.1 20.0 13.1 11.7 22.2 11.6 14.3 17.4 12.1 10.4 9.9 11.1 12.6 12.0 9.8 12.0 12.6 14.5 17.5 13.5 7.4 8.3 16.6 9.2 12.2 10.2 18.9 12.7 22.0 10.2 18.5 8.1 10.4 14.0 7.8 23.2 25.2 22.1 11.4 35.6 19.9 45.7 11.1 14.3 16.6 13.1 26.0 13.4 9.7 21.1 13.2 10.5 5.5 7.9 19.6 8.2 18.0 8.6 4.7 14.8 14.0 9.3 9.0 11.5 9.4 11.4 23.1 15.5 19.0 8.7 6.1 12.7 48.3 20.4 17.4 12.3 19.4 17.1 15.2 11.6 22.2 17.4 10.1 16.4 13.0 15.2 14.4 11.7 13.1 15.9 12.8 15.6 14.3 7.9 10.7 13.9 12.1 18.0 20.8 27.1 29.4 19.2 14.0 21.8 23.1 18.2 21.5 8.9 24.0 8.2 12.0 20.1 15.2 24.2 12.7 13.4 19.4 15.7 17.7 24.4 11.6 13.0 58.6 18.8 17.5 0.0 11.9 19.1 14.4 10.8 8.1 16.3 16.1 14.3 12.5 14.7 14.3 75.6 14.4 15.2 15.1 12.6 19.9 16.3 16.7 17.0 18.0 8.4 19.0 12.9 17.6 96.5 17.9 25.6 43.0 14.6 17.1 15.6 MBD2 ENSG00000134046 "Methyl-CpG binding domain protein 2" Q9UBB5 18 54151601-54224788 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Kupffer cells: 111.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 8.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037282, HPA067582, HPA067615" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB037282: AB_477234, HPA067582: AB_2685866, HPA067615: AB_2685872" "unprognostic (4.86e-2)" "unprognostic (7.21e-2)" "prognostic favorable (6.49e-4)" "unprognostic (1.19e-1)" "unprognostic (3.36e-2)" "unprognostic (2.47e-1)" "unprognostic (2.38e-3)" "unprognostic (2.35e-2)" "unprognostic (2.71e-2)" "unprognostic (2.36e-3)" "unprognostic (8.04e-3)" "unprognostic (1.10e-2)" "unprognostic (1.08e-1)" "unprognostic (8.70e-2)" "unprognostic (1.67e-1)" "unprognostic (2.51e-3)" "unprognostic (5.19e-2)" 29.8 11.9 8.5 27.9 9.8 15.3 24.0 9.9 9.0 17.5 22.5 7.4 20.1 10.5 12.5 14.8 33.1 11.3 18.7 17.9 7.9 8.1 23.3 23.2 21.3 33.7 10.0 5.3 15.3 19.3 13.1 12.5 38.1 8.6 18.3 15.0 12.1 23.3 17.3 13.9 24.1 26.7 15.7 11.7 36.9 12.5 26.1 9.4 31.0 31.0 25.4 32.2 22.8 27.1 2.0 1.5 2.2 8.2 0.4 2.6 0.8 12.7 5.8 10.8 5.3 12.7 10.8 10.6 12.1 15.2 14.0 12.3 3.7 7.1 30.2 6.2 18.6 6.2 20.5 9.1 16.3 15.4 22.5 5.0 4.4 9.1 8.0 13.2 14.1 8.2 9.4 18.4 10.7 15.7 9.3 16.1 9.3 3.4 28.1 12.6 6.1 14.2 7.9 11.3 5.0 7.8 9.6 6.3 12.2 20.1 13.2 11.8 5.0 9.4 9.5 6.3 14.9 4.9 7.2 13.9 14.3 6.6 4.9 10.7 30.5 16.6 23.3 12.6 12.0 8.5 0.1 2.6 1.2 1.2 4.6 1.6 1.4 1.3 1.9 1.5 2.0 0.7 1.2 2.2 0.4 8.2 1.2 2.6 0.8 8.5 9.8 9.9 9.0 7.9 8.1 10.0 5.3 8.6 9.4 26.8 16.0 24.2 25.1 43.8 17.7 28.8 20.4 24.1 20.5 31.4 15.7 11.3 6.6 23.6 1.7 25.3 29.7 23.3 49.8 45.1 20.5 42.9 8.1 17.9 28.1 20.6 15.6 24.5 111.1 3.3 23.3 44.3 25.3 33.3 38.0 36.6 44.0 20.1 24.8 19.0 23.2 25.8 18.1 5.2 4.3 54.6 15.3 17.5 33.1 78.0 MBD3 ENSG00000071655 "Methyl-CpG binding domain protein 3" O95983 19 1573596-1592801 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Syncytiotrophoblasts: 101.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013265 Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB013265: " "unprognostic (1.41e-1)" "unprognostic (2.12e-2)" "unprognostic (3.44e-2)" "prognostic favorable (5.08e-4)" "unprognostic (1.85e-1)" "unprognostic (1.00e-2)" "prognostic unfavorable (2.99e-4)" "unprognostic (2.50e-1)" "unprognostic (3.12e-1)" "unprognostic (1.40e-1)" "prognostic favorable (1.76e-5)" "unprognostic (1.59e-1)" "unprognostic (1.19e-1)" "unprognostic (4.42e-2)" "unprognostic (5.89e-2)" "unprognostic (3.17e-1)" "unprognostic (4.24e-2)" 19.4 14.8 27.3 18.2 21.0 19.9 19.7 18.9 25.1 11.8 14.9 12.7 18.8 17.1 14.4 12.0 14.8 13.4 18.3 21.5 26.5 16.5 17.2 19.1 13.1 18.2 18.2 16.9 17.2 25.4 17.7 18.1 27.3 13.1 19.5 7.5 12.5 28.0 17.1 41.4 28.5 14.5 11.4 14.9 18.3 14.1 21.1 11.0 23.9 17.2 14.3 15.4 12.3 26.8 3.1 7.0 2.3 3.7 1.2 3.7 2.0 27.5 31.3 13.1 22.5 10.8 9.4 19.5 17.0 10.3 18.2 17.0 29.2 12.6 27.8 13.4 12.4 6.3 22.9 14.6 16.4 4.9 37.2 30.2 16.3 33.8 21.6 15.6 20.8 23.2 13.4 14.0 17.6 8.0 9.1 16.6 20.4 30.0 23.8 8.9 31.3 25.0 28.9 21.9 8.4 20.7 29.8 16.3 20.8 9.2 26.8 36.8 29.9 17.0 14.9 12.7 4.7 16.7 25.7 16.5 25.6 18.7 37.9 40.1 23.2 19.3 25.4 20.7 29.1 26.2 1.2 3.7 2.3 3.7 2.0 3.3 1.6 3.0 2.0 3.4 3.1 3.3 2.8 1.5 1.2 1.7 7.0 0.7 2.0 27.3 21.0 18.9 25.1 26.5 16.5 18.2 16.9 13.1 11.0 11.9 28.2 15.2 7.7 9.6 22.9 17.3 7.6 2.7 10.3 10.4 13.7 42.8 5.0 14.0 2.5 16.5 27.6 46.7 22.3 36.6 14.2 12.7 3.5 37.6 23.2 17.5 14.3 28.8 26.1 4.7 20.8 11.9 5.0 10.0 22.7 30.6 17.9 14.7 24.1 15.8 10.7 38.8 11.6 5.7 11.0 11.2 101.6 7.5 25.3 7.4 MBD5 "FLJ11113, KIAA1461" ENSG00000204406 "Methyl-CpG binding domain protein 5" Q9P267 2 148021011-148516971 "Disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035964 Supported Nucleoplasm,Midbody NA NA "Nucleoplasm, Midbody" "HPA035964: AB_2674891" "unprognostic (1.10e-2)" "unprognostic (1.02e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (3.72e-4)" "unprognostic (5.81e-2)" "unprognostic (2.12e-1)" "unprognostic (2.22e-2)" "unprognostic (1.65e-1)" "unprognostic (9.86e-2)" "unprognostic (7.72e-2)" "unprognostic (2.00e-1)" "unprognostic (1.94e-1)" "unprognostic (2.39e-2)" "unprognostic (9.12e-2)" "unprognostic (1.12e-1)" "unprognostic (6.59e-2)" "unprognostic (1.82e-1)" 8.5 11.3 13.9 14.1 13.7 6.8 9.0 26.1 14.7 13.7 16.3 10.1 8.9 7.2 12.6 8.7 9.9 9.6 13.4 10.3 11.7 10.6 13.7 6.9 8.2 8.7 9.3 9.9 14.2 5.7 25.5 24.7 10.4 11.3 11.5 8.1 10.8 7.5 11.6 9.9 6.6 8.2 15.7 11.8 9.8 9.1 11.0 12.5 17.3 12.8 6.0 8.6 15.1 10.1 1.3 1.1 3.6 1.2 1.0 2.2 0.7 1.4 1.5 9.0 6.5 6.5 7.4 4.0 6.7 7.3 4.5 3.8 3.4 4.5 2.5 1.7 5.7 2.2 1.0 4.7 7.4 6.4 2.2 2.2 5.4 4.9 1.7 2.7 0.7 0.8 5.6 6.5 6.0 4.0 9.3 7.5 4.5 2.0 6.1 7.6 3.4 2.9 3.9 3.0 4.0 2.4 2.9 1.5 0.9 6.0 7.2 5.2 7.3 4.3 2.3 4.5 5.5 2.9 4.5 5.5 5.3 2.2 0.7 2.9 4.4 1.7 2.2 9.0 2.5 6.1 3.6 0.4 1.9 1.6 0.3 1.1 0.7 1.8 1.5 0.9 1.3 1.4 2.2 0.6 1.0 1.2 1.1 0.6 0.7 13.9 13.7 26.1 14.7 11.7 10.6 9.3 9.9 11.3 12.5 14.9 10.7 3.9 10.8 3.4 23.3 8.7 12.7 12.0 23.9 12.2 35.3 6.1 3.3 16.7 52.0 9.0 4.6 0.0 13.8 7.3 7.9 8.0 3.5 7.4 6.0 12.7 11.1 11.6 14.9 28.9 16.7 14.6 0.0 10.8 5.5 9.0 16.2 3.5 9.9 11.6 16.8 6.5 5.2 5.1 7.3 2.9 7.1 13.8 6.9 10.7 MBD6 KIAA1887 ENSG00000166987 "Methyl-CpG binding domain protein 6" Q96DN6 12 57520710-57530148 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 67.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 10 "neutrophil: 14.7" "Lineage enriched" "Detected in many" 10 "granulocytes: 14.7" "Cell line enhanced" "Detected in all" "RH-30: 46.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038948, HPA038949" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA038948: AB_2676285, HPA038949: AB_10671868" "unprognostic (2.56e-1)" "unprognostic (4.15e-2)" "unprognostic (1.64e-2)" "unprognostic (3.12e-2)" "unprognostic (1.13e-1)" "unprognostic (2.84e-1)" "unprognostic (2.84e-2)" "unprognostic (6.96e-2)" "unprognostic (2.74e-2)" "unprognostic (3.19e-1)" "unprognostic (1.83e-2)" "unprognostic (6.65e-2)" "unprognostic (1.28e-3)" "unprognostic (1.13e-1)" "unprognostic (1.73e-1)" "unprognostic (2.24e-1)" "unprognostic (1.01e-2)" 16.0 21.1 15.2 22.1 18.4 35.0 18.7 20.2 15.2 22.3 22.1 19.6 35.2 27.9 24.9 22.6 18.0 21.7 25.2 13.1 15.2 7.6 21.0 21.6 17.6 16.3 18.0 11.1 24.3 22.4 24.2 60.6 35.1 14.0 19.9 14.3 34.8 23.7 37.0 22.5 25.1 22.8 14.6 16.1 34.4 28.6 31.1 18.7 16.1 48.2 14.0 21.9 19.0 20.3 1.4 0.5 14.7 1.1 0.7 1.3 0.6 8.7 12.5 9.7 10.3 6.7 4.8 13.6 10.1 6.1 6.5 4.9 12.9 13.9 8.8 7.8 5.4 6.5 12.3 8.8 7.6 4.6 17.4 8.9 15.5 12.1 8.7 8.2 9.2 40.2 8.4 13.4 7.0 10.0 10.2 8.7 7.5 9.8 23.4 5.2 9.0 9.5 9.2 9.3 6.4 9.2 9.5 46.8 6.7 5.6 17.3 13.4 8.1 8.1 16.2 9.9 6.1 18.2 14.9 8.6 7.2 11.9 7.3 6.8 24.4 8.2 6.1 9.4 5.8 12.1 0.0 1.1 0.4 1.3 0.9 0.6 1.4 0.2 0.4 0.5 1.0 0.6 0.6 14.7 0.7 0.4 0.4 0.2 0.6 15.2 18.4 20.2 15.2 15.2 7.6 18.0 11.1 14.0 18.7 6.0 16.2 6.7 12.6 9.7 56.0 5.2 33.1 12.0 10.3 8.7 25.5 9.5 5.0 7.2 6.7 12.7 14.9 0.0 10.4 6.7 8.2 11.5 18.5 24.3 12.2 23.8 15.0 15.4 20.2 7.8 13.6 15.0 11.8 1.0 19.5 28.3 8.8 17.5 12.0 3.7 67.0 19.4 7.6 39.1 29.6 10.8 18.9 13.1 15.7 14.9 MBIP ENSG00000151332 "MAP3K12 binding inhibitory protein 1" Q9NS73 14 36298558-36320676 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 61.2" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 202.5;Alveolar cells type 2: 218.5;Club cells: 169.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003388 Supported Supported Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA003388: AB_1079322" "unprognostic (8.79e-2)" "unprognostic (9.92e-2)" "unprognostic (5.07e-2)" "unprognostic (8.66e-2)" "unprognostic (9.85e-2)" "unprognostic (4.71e-2)" "unprognostic (2.71e-1)" "prognostic favorable (1.52e-4)" "unprognostic (5.24e-2)" "prognostic favorable (1.14e-4)" "unprognostic (4.65e-1)" "unprognostic (9.27e-2)" "prognostic favorable (1.25e-4)" "unprognostic (2.95e-1)" "unprognostic (1.12e-1)" "unprognostic (1.74e-3)" "unprognostic (1.09e-1)" 10.4 11.7 11.4 5.7 17.0 15.4 12.9 16.4 14.9 15.4 12.2 11.5 3.6 8.6 14.0 11.3 14.0 9.1 8.6 7.2 10.7 13.0 19.5 15.0 46.2 8.1 9.9 8.9 20.0 9.0 10.4 25.1 9.8 13.3 13.8 11.7 10.1 7.7 8.9 6.0 14.3 13.2 11.0 13.6 9.8 19.0 8.8 11.8 14.4 61.2 4.0 7.9 12.4 9.3 12.0 10.4 5.1 9.3 8.3 17.9 9.6 16.6 8.7 18.7 18.8 18.8 18.2 14.1 14.3 17.8 19.0 20.0 17.8 16.8 15.8 21.9 18.4 10.0 12.8 19.6 13.2 23.4 22.8 14.7 9.2 8.7 30.3 20.5 18.8 10.3 18.6 20.4 12.4 16.1 19.7 11.8 22.2 15.8 19.8 14.0 16.0 18.0 15.3 15.8 14.3 26.0 8.7 16.3 11.0 21.4 12.9 28.0 11.1 11.8 11.4 18.9 16.7 18.6 12.3 9.2 21.2 13.8 15.5 14.7 16.4 18.9 24.8 8.1 9.7 14.6 1.4 9.3 2.0 11.2 6.8 14.1 12.0 13.7 13.8 9.2 8.7 17.9 14.5 5.1 8.3 5.3 10.4 16.1 9.6 11.4 17.0 16.4 14.9 10.7 13.0 9.9 8.9 13.3 11.8 202.5 218.5 10.4 31.7 80.1 24.3 9.4 2.5 50.9 169.5 24.4 2.0 20.7 49.7 17.7 2.7 17.7 14.6 0.0 16.6 17.7 24.9 20.7 12.7 21.2 15.9 87.4 30.2 15.4 9.9 2.5 29.7 14.5 20.3 9.0 12.1 23.6 16.8 17.5 25.5 38.3 22.5 12.9 21.2 42.9 36.4 57.2 16.6 14.9 17.7 12.9 MBLAC2 "DKFZp686P15118, MGC46734" ENSG00000176055 "Metallo-beta-lactamase domain containing 2" Q68D91 5 90458203-90474768 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037757, HPA037758" Uncertain Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA037757: AB_10670528, HPA037758: " "unprognostic (6.32e-2)" "unprognostic (2.48e-1)" "unprognostic (9.22e-3)" "unprognostic (1.21e-2)" "unprognostic (9.27e-2)" "unprognostic (1.96e-3)" "unprognostic (9.98e-3)" "unprognostic (1.82e-2)" "unprognostic (3.33e-2)" "unprognostic (4.00e-3)" "unprognostic (4.16e-2)" "unprognostic (1.95e-1)" "unprognostic (1.83e-2)" "unprognostic (1.44e-1)" "unprognostic (3.34e-1)" "unprognostic (6.31e-2)" "unprognostic (1.63e-2)" 5.2 7.4 11.2 5.7 16.8 2.7 9.5 16.7 14.7 8.7 5.7 7.4 7.4 6.1 9.6 6.6 7.2 7.5 5.0 5.2 12.7 14.2 9.3 11.1 5.5 11.1 10.6 9.8 16.3 7.4 21.8 10.0 5.4 9.7 8.6 6.2 4.8 7.8 7.8 4.3 9.5 5.4 7.1 10.7 6.6 4.8 6.1 7.0 8.1 9.7 3.1 7.0 6.5 6.9 5.3 2.9 1.1 3.8 3.3 4.8 2.3 5.8 2.5 4.4 5.5 5.8 7.9 5.4 4.6 4.3 4.0 4.3 1.9 4.4 13.7 2.8 4.1 5.6 6.0 5.7 7.0 6.3 7.7 3.9 6.1 4.1 4.4 6.1 6.0 2.7 6.8 9.4 2.9 11.2 4.7 5.1 7.4 9.2 7.6 6.8 3.6 5.8 8.3 2.8 1.2 12.3 6.3 7.3 18.6 6.1 2.2 7.6 8.9 4.2 6.2 11.2 2.7 5.1 4.5 6.3 5.0 3.5 6.1 6.0 5.4 6.0 6.1 4.3 12.7 6.8 0.0 1.5 1.1 3.2 3.8 3.9 3.1 3.6 3.5 2.9 5.3 4.8 3.7 0.1 3.3 1.9 1.0 1.3 2.3 11.2 16.8 16.7 14.7 12.7 14.2 10.6 9.8 9.7 7.0 3.0 2.2 1.4 0.8 2.4 6.4 4.0 5.1 2.7 1.2 1.8 7.9 3.0 1.7 1.6 0.3 4.4 2.0 0.0 1.1 2.7 2.2 0.8 0.0 4.9 2.2 3.2 4.1 3.7 5.3 0.6 3.7 1.2 1.7 1.0 2.8 5.6 2.0 0.0 4.9 3.9 6.2 0.0 2.7 2.8 4.6 2.9 0.7 2.1 3.5 0.7 MBNL1 "EXP, EXP35, EXP40, EXP42, KIAA0428, MBNL" ENSG00000152601 "Muscleblind like splicing regulator 1" Q9NR56 3 152243828-152465780 "Disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016398, HPA035098" Enhanced Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB016398: AB_784435, HPA035098: AB_2674461" "unprognostic (5.46e-3)" "unprognostic (6.01e-3)" "unprognostic (1.94e-3)" "unprognostic (1.99e-1)" "unprognostic (3.44e-2)" "unprognostic (5.82e-3)" "unprognostic (2.75e-2)" "unprognostic (9.49e-3)" "unprognostic (5.18e-2)" "unprognostic (1.70e-2)" "unprognostic (2.78e-3)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.90e-7)" "unprognostic (7.53e-3)" "unprognostic (6.15e-2)" "unprognostic (1.77e-1)" "unprognostic (2.98e-1)" 55.9 17.5 14.5 50.8 17.0 28.5 43.8 11.8 14.5 46.4 44.0 10.8 18.0 15.2 41.1 23.6 33.3 22.3 27.5 29.9 14.3 12.9 18.6 16.5 39.6 45.6 18.0 9.1 30.5 12.5 12.5 16.0 10.4 12.6 30.5 26.0 12.7 18.3 25.1 87.6 22.8 29.5 59.8 22.1 39.6 23.1 14.6 17.4 71.9 18.5 34.5 46.0 64.4 29.3 25.0 30.7 38.2 27.4 33.6 39.9 40.2 27.8 23.0 3.7 8.4 29.6 30.6 2.8 35.0 28.4 23.1 19.4 10.1 16.4 28.7 17.9 49.0 7.2 12.8 6.9 20.2 34.3 22.3 9.4 31.3 11.7 4.7 16.5 37.4 22.9 14.2 11.0 26.6 20.8 17.8 47.4 11.6 15.9 39.2 22.4 9.6 34.8 13.7 1.5 8.2 18.4 35.7 11.6 35.9 11.7 14.1 3.0 3.4 15.2 8.3 14.8 1.4 11.5 57.1 39.8 31.7 12.2 21.0 30.1 41.0 23.4 33.0 18.5 46.8 17.0 32.6 22.7 38.2 37.2 27.4 39.9 25.0 30.5 30.9 30.7 24.1 38.9 33.3 35.4 33.6 22.8 11.1 27.0 40.2 14.5 17.0 11.8 14.5 14.3 12.9 18.0 9.1 12.6 17.4 140.0 156.6 98.0 41.0 189.8 25.7 160.6 45.9 78.9 139.9 36.6 60.9 20.0 18.3 32.5 2.1 146.2 138.0 70.0 54.4 8.3 91.5 50.3 155.2 83.5 55.2 30.2 45.4 75.5 193.7 5.9 82.8 171.1 97.8 129.0 61.7 16.0 47.0 71.9 67.1 29.9 84.3 97.0 113.3 4.9 10.9 213.0 12.4 228.4 54.7 46.0 MBNL2 "MBLL, MBLL39" ENSG00000139793 "Muscleblind like splicing regulator 2" Q5VZF2 13 97221434-97394120 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062685 Supported Nucleoplasm NA NA Nucleoplasm "HPA062685: AB_2684834" "unprognostic (8.02e-2)" "unprognostic (7.78e-2)" "unprognostic (6.37e-2)" "unprognostic (5.46e-2)" "unprognostic (1.37e-1)" "unprognostic (1.58e-1)" "unprognostic (3.54e-1)" "unprognostic (1.44e-3)" "unprognostic (1.08e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (1.99e-4)" "unprognostic (1.00e-1)" "unprognostic (5.26e-3)" "unprognostic (1.01e-2)" "unprognostic (1.48e-1)" "unprognostic (2.73e-1)" "unprognostic (9.17e-2)" 38.4 43.3 26.5 12.9 38.6 5.0 23.2 31.2 41.0 27.8 21.6 45.9 9.5 13.8 23.9 11.2 25.6 14.8 29.7 23.4 31.0 22.6 24.6 59.6 19.3 12.3 46.5 22.4 40.8 28.9 16.9 35.9 33.5 49.8 21.8 16.4 16.6 24.6 27.0 28.9 13.3 12.2 27.4 52.3 12.4 19.0 9.7 46.9 11.1 24.2 17.2 15.3 25.6 28.0 9.2 6.5 13.3 8.4 5.5 12.9 7.1 11.0 3.9 4.3 4.5 23.9 12.7 0.3 25.4 12.8 11.8 12.0 4.5 16.5 3.7 10.6 35.0 13.2 15.7 2.0 11.2 15.4 9.9 1.9 4.6 8.9 11.2 35.2 0.5 4.1 13.0 19.2 9.6 18.6 13.5 22.3 5.1 5.6 2.0 5.9 2.8 2.6 1.6 0.1 1.3 6.7 1.2 9.3 3.1 15.7 12.5 5.5 9.4 14.5 15.0 25.1 10.6 6.1 0.6 7.0 1.7 5.5 3.3 5.3 5.4 1.3 1.0 11.3 1.3 31.1 13.3 6.2 8.9 10.1 8.4 12.9 9.2 9.2 9.0 6.5 7.6 8.1 10.8 1.0 5.5 5.8 5.5 9.6 7.1 26.5 38.6 31.2 41.0 31.0 22.6 46.5 22.4 49.8 46.9 77.4 33.1 17.2 23.5 62.4 22.9 62.9 28.1 78.9 59.1 27.9 45.2 19.3 16.6 21.2 2.1 46.8 13.1 0.0 36.5 66.4 35.8 27.2 17.3 61.0 12.9 44.5 46.7 42.4 25.3 6.4 65.3 18.4 54.0 7.2 27.1 73.1 48.9 10.5 42.1 24.9 104.0 45.3 43.8 0.5 0.7 42.4 20.9 22.7 16.6 26.3 MBTD1 "FLJ20055, SA49P01" ENSG00000011258 "Mbt domain containing 1" Q05BQ5 17 51177425-51260163 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.1" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021876 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA021876: AB_2140367" "unprognostic (1.95e-1)" "unprognostic (1.85e-1)" "unprognostic (6.91e-3)" "unprognostic (3.39e-2)" "unprognostic (1.81e-2)" "unprognostic (2.52e-3)" "unprognostic (1.48e-1)" "unprognostic (1.32e-2)" "unprognostic (3.30e-2)" "unprognostic (5.45e-2)" "unprognostic (2.11e-1)" "unprognostic (1.61e-2)" "unprognostic (7.90e-3)" "unprognostic (1.50e-2)" "unprognostic (3.03e-1)" "unprognostic (1.15e-1)" "unprognostic (8.25e-3)" 9.0 6.8 8.8 10.6 14.2 11.0 13.5 21.2 12.0 10.7 8.8 13.2 8.6 9.2 14.3 9.6 9.3 8.3 7.1 5.8 9.9 5.8 7.4 11.2 7.2 9.3 12.6 8.1 15.4 11.0 8.8 9.6 10.0 8.8 8.9 9.3 8.3 9.0 8.8 7.9 16.7 9.8 11.9 7.7 11.7 9.5 27.9 11.7 32.4 10.1 4.8 9.0 9.5 10.5 0.9 1.1 5.1 0.4 0.4 0.9 0.1 3.7 3.5 19.0 7.6 4.6 5.3 10.0 2.9 3.6 3.1 3.9 4.2 4.9 14.8 6.9 2.1 2.2 3.7 8.6 2.1 5.9 4.1 7.9 15.3 4.0 6.4 3.1 10.2 4.6 4.6 4.1 2.3 4.3 6.2 5.5 13.1 11.8 3.7 2.4 3.8 13.9 10.7 10.8 8.1 3.2 16.1 11.5 7.3 4.8 7.2 12.1 18.4 2.6 5.1 6.1 16.7 7.3 20.2 3.3 3.4 3.4 2.5 3.1 9.2 5.8 13.3 2.0 6.8 1.9 5.1 0.4 1.9 0.7 0.3 0.2 0.9 0.7 0.5 0.7 0.6 0.4 0.9 0.9 0.4 0.4 1.1 0.8 0.1 8.8 14.2 21.2 12.0 9.9 5.8 12.6 8.1 8.8 11.7 14.9 12.9 8.2 5.9 15.2 7.9 6.2 15.3 5.3 6.8 7.0 15.7 6.4 1.7 4.3 44.2 8.9 7.3 0.0 4.5 4.2 7.6 8.0 4.7 10.0 5.0 9.5 13.2 9.8 13.1 11.1 13.6 8.4 10.1 7.2 14.7 5.6 5.7 10.5 9.9 3.9 11.4 0.0 8.0 28.1 14.5 19.3 7.2 8.2 11.6 6.8 MBTPS2 "KFSD, S2P" ENSG00000012174 "Membrane bound transcription factor peptidase, site 2" O43462 X 21839636-21885424 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Hydrolase, Metalloprotease, Protease" "Disease mutation, Ichthyosis, Osteogenesis imperfecta, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005494, CAB009486" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "CAB009486: AB_2140370, HPA005494: AB_1079329" "unprognostic (7.97e-3)" "unprognostic (9.12e-2)" "unprognostic (5.38e-2)" "unprognostic (1.18e-2)" "unprognostic (2.65e-1)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (7.22e-2)" "unprognostic (3.32e-1)" "unprognostic (9.30e-2)" "unprognostic (1.99e-1)" "unprognostic (1.77e-1)" "unprognostic (8.38e-2)" "unprognostic (7.76e-2)" "unprognostic (1.07e-1)" "unprognostic (3.61e-1)" "unprognostic (3.05e-2)" 12.0 17.4 9.3 7.2 13.9 2.5 12.7 20.8 18.5 11.8 9.3 13.4 6.9 7.6 14.7 9.1 9.3 10.9 10.1 11.6 9.9 10.7 13.9 26.0 8.6 6.6 10.6 13.0 18.7 12.2 17.9 15.6 22.3 17.4 15.7 9.1 12.4 14.1 13.1 14.5 8.2 8.1 14.6 14.6 7.5 9.1 6.9 7.0 7.1 13.1 7.4 6.7 11.4 9.1 3.9 6.9 1.5 4.8 4.6 5.9 3.3 8.9 18.6 8.9 9.1 11.3 14.0 4.3 13.3 13.6 12.7 11.1 7.4 12.3 7.8 6.9 14.2 24.8 8.4 12.3 7.6 15.7 5.8 9.8 3.8 11.8 6.1 15.5 8.2 3.8 13.2 8.3 19.1 14.1 12.9 9.7 4.6 10.6 8.7 14.4 5.6 3.3 4.3 8.3 4.7 13.8 4.2 16.6 8.7 8.8 4.6 2.2 18.3 18.7 11.9 16.4 12.4 15.9 7.1 11.5 16.0 3.7 23.2 9.9 10.7 13.5 3.8 17.8 3.4 15.3 0.1 4.3 1.5 4.5 4.8 4.2 3.9 3.5 4.1 6.9 3.8 4.7 5.6 0.5 4.6 4.8 4.8 5.9 3.3 9.3 13.9 20.8 18.5 9.9 10.7 10.6 13.0 17.4 7.0 8.9 7.8 3.0 3.4 4.8 11.7 12.0 7.6 10.7 6.8 7.0 17.7 5.6 0.0 5.1 0.3 4.6 3.3 0.0 7.7 5.4 8.9 6.6 10.4 16.1 8.0 28.6 2.4 10.4 9.5 0.9 9.8 4.4 10.1 3.6 3.3 7.7 5.3 3.1 12.4 7.5 14.0 0.0 6.9 2.8 1.7 2.4 4.0 4.3 4.2 4.1 MCC ENSG00000171444 "Mutated in colorectal cancers" P23508 5 113022099-113488830 "Predicted intracellular proteins" "Wnt signaling pathway" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 49.4" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 97.8;Cone photoreceptor cells: 53.0;Hepatocytes: 50.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 6.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 28.2;hTCEpi: 19.0;RT4: 17.6" "Low region specificity" "Detected in all" "HPA037390, HPA037391" Approved Approved Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA "Nucleoplasm, Cytosol" "Cytoplasmic bodies" "HPA037390: AB_2675451, HPA037391: AB_10671248" "unprognostic (6.60e-2)" "unprognostic (1.23e-1)" "unprognostic (1.44e-1)" "unprognostic (1.23e-1)" "unprognostic (8.40e-2)" "unprognostic (1.06e-1)" "unprognostic (1.20e-1)" "unprognostic (5.21e-2)" "unprognostic (9.59e-2)" "unprognostic (8.02e-3)" "unprognostic (1.56e-1)" "unprognostic (1.74e-1)" "prognostic favorable (6.19e-4)" "unprognostic (1.70e-3)" "unprognostic (3.34e-1)" "unprognostic (2.47e-2)" "unprognostic (2.90e-1)" 7.1 2.3 6.9 3.2 6.1 0.5 7.8 11.4 8.1 11.8 3.2 3.4 5.9 1.7 12.5 4.7 9.1 7.4 4.4 8.4 9.2 5.0 3.9 12.7 4.6 3.0 7.6 5.1 49.4 4.5 28.9 5.2 7.1 7.8 7.7 2.4 15.1 6.7 9.5 5.0 13.9 2.6 9.1 5.8 3.4 3.6 6.5 5.2 1.3 3.2 6.1 4.3 9.3 11.8 0.2 6.3 1.3 0.2 0.1 1.6 0.1 0.4 0.1 7.2 0.7 6.2 5.8 7.9 1.2 3.2 1.3 1.6 0.2 6.5 0.0 7.6 0.5 3.6 8.7 4.3 28.2 0.6 2.3 2.7 0.0 2.5 1.9 1.8 0.3 0.1 7.7 19.0 3.5 13.4 7.2 8.4 0.9 0.0 10.7 2.9 0.6 0.1 0.1 3.9 0.0 0.5 0.1 6.3 1.9 0.1 17.6 3.1 6.8 5.8 0.0 15.4 2.6 2.3 0.0 10.0 4.9 4.6 7.6 2.2 3.1 0.0 0.0 13.1 0.0 5.1 0.0 0.2 0.1 0.5 0.2 1.6 0.2 0.5 0.6 0.0 0.2 0.4 0.5 1.3 0.1 0.1 6.3 1.5 0.1 6.9 6.1 11.4 8.1 9.2 5.0 7.6 5.1 7.8 5.2 0.0 0.6 0.5 24.4 33.4 97.8 13.9 7.6 0.0 3.4 3.5 53.0 0.7 0.0 2.9 10.6 23.9 0.0 0.0 1.2 1.7 27.7 5.4 0.0 50.6 2.0 35.0 4.6 25.2 4.0 24.2 19.5 0.5 15.1 5.4 0.2 7.4 3.0 0.2 25.5 1.4 8.2 0.0 10.3 8.2 8.5 41.3 1.0 2.9 0.0 14.9 MCM10 "CNA43, DNA43, PRO2249" ENSG00000065328 "Minichromosome maintenance 10 replication initiation factor" Q7L590 10 13161554-13211104 "Predicted intracellular proteins" "DNA damage, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 10.8;lymphoid tissue: 31.4" "Cell type enhanced" "Detected in many" 13 "Erythroid cells: 23.3;Extravillous trophoblasts: 17.2;Spermatogonia: 14.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA045899, HPA071952" Approved Supported Nucleoplasm,Nucleoli Yes Yes "Nucleoplasm, Nucleoli" "HPA045899: AB_10960529, HPA071952: AB_2686477" "unprognostic (9.76e-3)" "unprognostic (1.60e-1)" "unprognostic (2.31e-1)" "unprognostic (2.29e-3)" "unprognostic (1.41e-1)" "unprognostic (6.58e-3)" "unprognostic (1.78e-8)" "unprognostic (2.42e-3)" "unprognostic (3.51e-2)" "unprognostic (6.26e-2)" "unprognostic (2.78e-4)" "unprognostic (7.81e-2)" "unprognostic (0.00e+0)" "unprognostic (8.87e-2)" "unprognostic (1.29e-1)" "unprognostic (9.73e-2)" "unprognostic (1.05e-1)" 3.0 0.5 0.3 5.6 0.3 10.8 2.1 0.3 0.5 1.4 2.6 0.4 0.3 1.8 1.1 0.6 5.9 0.2 0.7 0.7 0.3 0.3 0.6 0.9 1.4 6.0 0.3 0.6 0.7 0.3 0.3 0.4 3.6 0.5 0.6 2.9 0.4 1.1 0.3 1.5 1.3 1.8 0.9 0.7 2.9 1.1 4.3 0.3 31.4 0.9 3.3 6.9 0.9 1.8 0.5 1.0 1.5 0.4 0.8 3.4 1.5 13.7 15.5 18.4 13.9 0.6 1.1 8.0 14.4 2.2 16.2 16.9 15.1 9.8 20.7 6.5 3.6 6.0 16.1 25.8 8.5 15.0 10.8 12.3 25.8 6.9 10.0 0.0 13.2 11.7 0.2 0.3 16.4 1.5 1.3 5.2 16.8 30.4 14.2 8.8 12.3 31.3 5.7 10.9 13.2 3.8 24.8 16.3 12.8 3.7 5.0 3.7 14.0 11.6 8.3 2.2 10.0 10.4 9.1 3.2 10.3 19.4 15.5 15.5 4.4 17.1 27.2 6.6 14.6 8.0 0.2 0.3 0.2 1.1 0.1 0.2 0.5 1.6 3.4 1.0 0.4 0.4 2.8 1.5 0.8 0.4 0.2 1.6 1.5 0.3 0.3 0.3 0.5 0.3 0.3 0.3 0.6 0.5 0.3 0.0 0.0 1.5 0.2 1.4 0.0 1.2 0.0 0.0 1.2 0.0 0.0 4.1 0.0 0.4 1.1 0.1 0.0 23.3 0.2 17.2 1.0 0.2 0.0 0.0 4.3 0.0 0.0 0.0 0.3 1.1 0.0 0.2 0.0 0.0 0.3 0.0 0.6 0.0 0.4 0.0 0.0 0.0 1.9 5.9 14.0 0.4 2.9 1.0 1.8 0.0 MCM2 "BM28, CCNL1, cdc19, CDCL1, D3S3194, DFNA70, KIAA0030" ENSG00000073111 "Minichromosome maintenance complex component 2" P49736 3 127598223-127622436 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 69.9" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 45.7;Extravillous trophoblasts: 22.4;Spermatogonia: 27.1;Syncytiotrophoblasts: 28.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB000303, HPA031450, HPA031495, HPA031496" Enhanced Enhanced Nucleoplasm Yes Yes 8600 Nucleoplasm "CAB000303: AB_322519, HPA031450: , HPA031495: AB_2673904, HPA031496: AB_2673905" "unprognostic (2.43e-1)" "prognostic favorable (4.66e-4)" "unprognostic (4.44e-2)" "unprognostic (3.12e-3)" "unprognostic (1.68e-1)" "unprognostic (2.25e-2)" "prognostic unfavorable (1.51e-7)" "unprognostic (8.43e-3)" "unprognostic (1.92e-2)" "unprognostic (1.79e-1)" "unprognostic (1.41e-3)" "unprognostic (1.21e-2)" "unprognostic (1.16e-2)" "unprognostic (8.16e-3)" "unprognostic (1.56e-1)" "unprognostic (3.29e-2)" "unprognostic (2.82e-1)" 2.9 3.7 2.1 24.3 4.0 32.5 3.5 6.7 3.2 4.7 7.1 3.3 2.2 4.7 4.7 5.9 11.2 4.8 5.4 3.6 2.0 2.3 3.9 3.4 3.4 14.6 2.2 3.5 5.1 3.0 2.4 2.4 26.4 3.0 3.2 6.0 2.5 4.7 1.9 7.0 6.0 7.1 2.9 2.9 13.3 3.8 20.3 3.9 69.9 4.1 16.6 20.7 3.4 5.1 10.4 3.6 0.9 1.4 5.8 10.6 3.4 25.1 21.4 23.5 20.5 1.4 3.0 23.0 13.2 8.5 26.6 29.0 35.5 16.7 27.1 12.9 6.5 22.8 20.3 41.9 15.2 16.6 22.4 26.2 44.9 28.7 25.8 0.9 41.9 19.6 1.6 1.7 18.0 2.7 3.2 8.3 29.6 22.3 24.9 9.8 33.3 38.8 30.7 34.4 21.6 18.9 43.6 33.7 38.8 5.5 19.5 29.3 22.2 33.9 10.1 3.5 9.9 21.7 32.9 4.2 20.7 17.7 25.5 17.8 25.8 29.2 67.4 14.3 31.7 7.9 0.0 0.6 0.2 4.7 1.4 5.9 10.4 4.1 5.5 2.8 9.2 3.9 5.0 0.9 5.8 0.3 3.6 10.6 3.4 2.1 4.0 6.7 3.2 2.0 2.3 2.2 3.5 3.0 3.9 3.0 1.3 6.7 1.7 4.0 2.2 7.6 0.0 10.7 5.7 0.0 0.0 45.7 0.0 4.1 0.7 1.7 1.0 0.0 1.6 22.4 3.3 0.7 1.1 1.7 15.2 0.0 3.5 1.3 1.6 0.7 1.7 1.6 1.7 15.4 5.1 1.5 1.7 0.0 1.4 0.5 1.7 0.0 2.8 6.2 27.1 2.6 28.0 3.2 12.0 0.6 MCM3 ENSG00000112118 "Minichromosome maintenance complex component 3" P25205 6 52264009-52284881 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 82.5" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 85.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002162, HPA004789, HPA004790" Supported Supported Nucleoplasm NA Yes 29000 Nucleoplasm "CAB002162: AB_564115, HPA004789: AB_1079336, HPA004790: AB_1079335" "unprognostic (9.14e-2)" "prognostic favorable (1.89e-4)" "unprognostic (2.37e-1)" "unprognostic (1.53e-2)" "unprognostic (2.14e-1)" "unprognostic (5.48e-3)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.36e-1)" "prognostic unfavorable (4.40e-5)" "unprognostic (1.01e-3)" "unprognostic (2.96e-2)" "unprognostic (1.15e-1)" "unprognostic (8.35e-2)" "unprognostic (1.16e-2)" "unprognostic (1.00e-1)" "prognostic favorable (3.13e-5)" "unprognostic (1.34e-2)" 17.3 10.9 8.5 29.7 10.5 22.3 15.3 10.7 9.7 15.9 17.2 9.5 20.2 9.0 21.2 13.0 21.7 15.5 15.8 15.4 7.4 6.6 16.1 12.6 13.7 30.1 8.9 5.8 20.0 13.8 16.0 7.4 24.7 10.0 15.9 19.2 12.7 12.6 23.4 12.1 15.0 17.8 17.7 9.5 23.2 15.3 16.1 10.5 82.5 12.9 20.1 35.7 19.1 15.3 21.1 12.9 11.4 13.3 22.2 29.4 18.6 30.2 20.1 35.1 33.0 7.6 6.8 23.0 22.5 17.3 38.4 39.4 41.1 16.5 33.0 22.6 13.1 25.1 24.1 46.2 27.5 38.8 37.1 43.7 62.4 40.4 57.9 2.0 61.2 25.6 4.1 6.4 28.2 7.9 9.4 19.5 40.0 50.7 76.2 19.7 19.9 61.6 47.3 29.1 60.3 14.2 54.7 53.7 44.1 17.0 32.2 35.6 27.3 23.6 13.6 20.4 51.4 26.8 43.4 10.0 26.2 28.2 27.1 33.5 22.6 25.8 58.8 22.5 53.1 30.7 11.1 8.0 11.4 22.9 13.3 19.7 21.1 23.3 23.0 12.9 19.2 22.6 24.0 1.1 22.2 7.4 8.3 29.4 18.6 8.5 10.5 10.7 9.7 7.4 6.6 8.9 5.8 10.0 10.5 20.8 10.5 30.5 14.0 17.1 13.8 13.9 12.7 22.7 20.5 21.0 3.9 85.3 11.6 21.3 0.6 24.8 4.9 23.3 17.7 53.2 16.0 7.5 36.9 9.3 30.8 0.0 7.0 14.7 8.9 2.3 25.0 13.8 6.8 10.8 16.7 19.0 13.0 10.5 19.8 6.5 11.2 6.5 24.7 21.7 59.4 8.8 22.9 27.7 31.0 11.2 MCM3AP "GANP, KIAA0572, Map80, SAC3" ENSG00000160294 "Minichromosome maintenance complex component 3 associated protein" O60318 21 46235126-46286297 "Predicted intracellular proteins, Transporters" "Immunity, mRNA transport, Protein transport, Translocation, Transport" "Acyltransferase, Transferase" "Mental retardation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021527, HPA032103" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" Nucleoplasm "HPA021527: AB_1853626, HPA032103: AB_2674152" "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (2.31e-1)" "unprognostic (2.20e-1)" "unprognostic (1.72e-1)" "unprognostic (6.31e-3)" "unprognostic (1.48e-2)" "unprognostic (2.06e-1)" "unprognostic (4.17e-2)" "unprognostic (4.76e-3)" "prognostic favorable (2.05e-4)" "unprognostic (1.96e-1)" "unprognostic (2.81e-3)" "unprognostic (1.04e-1)" "unprognostic (1.05e-1)" "unprognostic (3.85e-3)" "unprognostic (2.28e-1)" 19.4 16.7 14.2 21.5 25.3 19.5 19.0 26.6 29.2 18.3 17.2 27.7 19.3 15.4 24.8 18.0 18.1 21.1 16.3 17.9 14.4 13.2 15.5 13.3 18.2 21.9 16.5 14.6 23.7 17.5 25.7 20.6 18.2 18.2 17.7 17.6 21.3 22.1 21.4 52.9 18.2 19.9 19.5 15.1 20.7 18.7 15.7 15.7 31.8 19.6 15.7 26.0 21.1 16.4 4.8 4.8 3.8 4.9 3.0 6.9 4.1 16.0 15.8 18.6 20.0 15.2 19.0 16.9 17.7 21.7 16.8 13.7 14.4 9.6 22.9 14.6 18.7 18.1 9.6 24.5 14.9 14.8 23.5 22.2 37.5 15.1 11.2 13.7 17.0 21.2 14.8 13.0 22.9 15.9 11.5 17.8 13.9 44.7 17.5 19.3 9.2 18.2 11.5 31.9 17.5 13.2 23.8 11.7 20.7 8.2 14.9 15.7 16.7 22.6 15.0 17.3 14.7 20.4 17.8 22.5 17.6 13.4 14.6 13.2 31.9 35.3 14.2 15.9 16.5 22.8 1.5 4.7 3.8 6.1 4.9 6.5 2.9 3.7 6.9 4.8 4.8 3.3 3.4 2.9 3.0 2.7 4.2 4.4 4.1 14.2 25.3 26.6 29.2 14.4 13.2 16.5 14.6 18.2 15.7 8.9 17.6 16.7 6.1 6.3 21.7 3.6 15.3 10.7 12.5 10.4 19.6 9.8 1.7 9.7 2.5 7.8 12.3 0.0 12.4 9.8 8.9 11.6 8.1 15.3 13.5 15.9 11.5 13.5 20.6 3.6 17.0 12.4 10.1 21.6 18.4 8.9 12.8 7.0 13.4 5.2 21.0 19.4 6.6 18.9 13.4 9.2 7.8 8.5 14.5 5.5 MCM4 "CDC21, CDC54, hCdc21, MGC33310, P1-Cdc21" ENSG00000104738 "Minichromosome maintenance complex component 4" P33991 8 47960185-47978160 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 56.6" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 117.9;Late spermatids: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004497, HPA004873, HPA031052" Enhanced Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB004497: AB_627916, HPA004873: AB_1079337, HPA031052: AB_2673712" "unprognostic (4.55e-2)" "unprognostic (3.16e-3)" "prognostic favorable (2.19e-4)" "prognostic unfavorable (2.84e-5)" "unprognostic (7.71e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (1.23e-4)" "unprognostic (1.12e-3)" "prognostic unfavorable (1.15e-4)" "unprognostic (2.65e-2)" "prognostic unfavorable (2.38e-4)" "unprognostic (5.16e-2)" "prognostic unfavorable (2.61e-4)" "unprognostic (3.53e-2)" "unprognostic (2.90e-1)" "unprognostic (1.70e-2)" "unprognostic (1.40e-1)" 4.9 8.7 6.7 18.4 12.6 33.1 9.3 13.9 14.8 6.7 11.9 6.9 3.6 8.3 4.7 7.8 21.6 5.9 6.8 8.3 6.6 7.1 8.0 6.6 4.4 20.3 5.9 7.7 5.3 5.5 4.3 4.1 29.2 7.7 4.2 13.2 5.3 9.0 3.1 8.7 16.2 10.3 5.9 6.4 10.1 6.3 39.0 4.1 56.6 4.0 21.8 23.7 8.0 9.5 5.1 4.9 3.4 4.3 4.9 12.9 4.5 34.5 21.5 39.9 14.6 3.9 6.9 17.6 26.4 17.3 33.3 37.7 22.8 31.5 37.5 14.8 13.1 25.0 25.5 50.3 21.4 37.6 11.8 33.2 64.3 25.8 25.3 1.1 34.3 14.1 4.1 4.3 26.5 9.5 5.1 11.7 25.3 35.4 31.2 22.9 21.4 75.8 25.0 43.3 41.1 9.3 48.2 31.3 24.4 12.0 31.0 38.4 18.4 53.4 22.3 7.9 23.8 26.6 18.1 7.8 25.4 24.7 28.5 24.2 10.3 24.6 76.5 20.4 31.9 22.7 3.4 2.1 1.5 5.5 3.7 2.7 5.1 5.0 6.8 4.9 2.1 4.6 3.4 0.1 4.9 4.3 1.7 12.9 4.5 6.7 12.6 13.9 14.8 6.6 7.1 5.9 7.7 7.7 4.1 0.0 4.6 3.0 9.5 19.3 11.6 22.4 0.0 17.4 10.3 5.2 9.8 26.7 3.3 6.0 117.9 5.2 5.0 46.7 5.2 33.9 7.4 4.3 1.1 3.4 10.4 15.9 6.4 1.3 3.5 57.7 4.9 9.9 3.3 2.8 9.6 6.5 4.1 3.5 2.8 2.2 15.3 0.0 8.0 45.2 31.3 16.7 24.9 3.8 20.2 8.2 MCM5 CDC46 ENSG00000100297 "Minichromosome maintenance complex component 5" P33992 22 35400063-35425430 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 57.0;lymphoid tissue: 60.6" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 115.2;monocytes: 225.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000101, HPA000845, HPA052880" Enhanced Enhanced Nucleoplasm Yes Yes Nucleoplasm "CAB000101: AB_2235163, HPA000845: AB_1079338, HPA052880: AB_2681979" "unprognostic (6.71e-2)" "prognostic favorable (2.81e-6)" "unprognostic (5.29e-3)" "unprognostic (7.94e-2)" "unprognostic (1.83e-2)" "unprognostic (1.46e-2)" "prognostic unfavorable (1.78e-4)" "prognostic unfavorable (3.95e-4)" "unprognostic (1.29e-1)" "unprognostic (3.34e-2)" "unprognostic (1.37e-1)" "unprognostic (8.07e-2)" "prognostic unfavorable (3.58e-5)" "unprognostic (3.26e-2)" "unprognostic (1.01e-1)" "unprognostic (1.77e-3)" "unprognostic (1.53e-1)" 12.1 4.9 6.1 27.5 9.0 57.0 9.1 6.7 5.7 10.4 11.5 12.3 5.0 9.5 10.8 10.8 15.8 8.7 9.4 5.2 4.4 3.4 6.8 8.0 9.3 31.1 8.8 3.7 17.9 10.8 6.2 3.6 19.3 5.8 7.2 8.3 6.5 8.9 5.1 8.8 10.3 16.7 6.0 7.8 31.2 8.4 16.4 8.8 60.6 9.0 17.7 33.0 8.7 9.6 46.8 30.9 19.0 26.0 21.3 32.9 24.0 39.3 28.6 22.6 23.0 2.2 4.5 19.9 26.3 14.0 39.4 37.5 19.0 19.7 26.1 15.3 13.4 16.3 19.7 22.6 20.9 12.6 21.0 41.5 37.2 28.7 38.0 0.8 76.8 33.7 2.4 1.9 23.5 6.4 3.6 17.4 23.9 23.0 39.0 14.9 32.5 62.5 25.6 30.1 26.9 17.0 70.8 32.1 32.8 7.7 22.9 17.5 18.6 36.2 14.5 8.1 12.4 15.2 29.4 10.3 39.8 30.2 24.7 27.1 21.7 26.8 49.1 25.8 29.1 30.3 19.0 20.7 14.5 18.4 24.1 13.1 46.8 16.1 19.4 27.1 37.0 13.1 14.8 9.9 21.3 26.0 30.9 32.9 24.0 6.1 9.0 6.7 5.7 4.4 3.4 8.8 3.7 5.8 8.8 6.0 8.2 53.6 8.0 9.4 1.5 3.4 12.7 5.3 4.5 7.0 0.0 115.2 5.0 14.8 1.9 7.5 3.8 70.0 11.1 61.5 6.2 3.3 15.0 5.1 47.1 1.6 3.4 13.5 21.1 3.6 10.0 25.5 6.8 225.4 9.2 4.5 9.4 7.0 5.6 3.7 3.2 19.4 6.4 11.2 52.2 5.5 68.8 20.8 32.2 4.7 MCM6 Mis5 ENSG00000076003 "Minichromosome maintenance complex component 6" Q14566 2 135839626-135876426 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 66.3" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 46.7;Spermatogonia: 41.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004818, CAB009577" Enhanced Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB009577: AB_2266309, HPA004818: AB_1079339" "unprognostic (6.73e-2)" "unprognostic (6.68e-3)" "unprognostic (1.22e-3)" "unprognostic (3.60e-3)" "unprognostic (8.98e-2)" "unprognostic (4.34e-2)" "prognostic unfavorable (5.70e-7)" "unprognostic (1.71e-2)" "prognostic unfavorable (1.09e-5)" "unprognostic (2.36e-2)" "unprognostic (1.36e-2)" "unprognostic (3.53e-2)" "prognostic unfavorable (8.29e-12)" "unprognostic (2.84e-1)" "unprognostic (9.02e-2)" "unprognostic (7.42e-2)" "unprognostic (1.68e-1)" 11.3 6.3 7.2 17.7 8.4 23.1 9.5 12.3 9.4 9.1 11.9 5.1 2.9 8.7 10.4 8.8 12.6 8.7 7.6 6.0 5.0 5.5 6.8 7.0 8.5 23.9 4.9 8.0 10.9 4.3 6.2 3.4 10.9 5.9 8.6 12.2 6.2 6.9 6.7 8.2 8.9 16.7 10.4 7.2 14.1 8.0 13.2 3.7 66.3 5.1 11.4 27.5 10.8 9.8 5.5 9.4 5.3 4.0 7.0 13.9 5.6 23.3 14.3 31.3 19.9 6.7 8.8 12.3 17.0 12.9 19.8 22.1 29.3 17.9 40.8 12.5 12.3 8.7 13.9 31.6 15.5 21.2 20.9 21.8 40.5 21.3 9.2 3.1 48.5 18.1 5.2 2.0 14.4 4.4 4.0 13.4 32.2 28.9 34.5 14.5 23.8 59.2 35.7 28.2 20.6 14.4 29.4 37.5 37.3 9.9 20.6 19.7 16.8 22.4 10.7 10.7 23.4 12.3 30.6 6.6 13.8 11.5 14.8 12.8 20.7 33.7 53.7 19.3 37.2 16.4 5.3 1.4 0.9 7.6 4.0 7.1 5.5 10.5 9.2 4.6 3.2 9.6 11.8 0.8 7.0 3.6 9.4 13.9 5.6 7.2 8.4 12.3 9.4 5.0 5.5 4.9 8.0 5.9 3.7 0.0 2.4 2.2 3.8 6.0 2.2 3.2 2.5 4.0 6.8 3.5 0.0 26.1 0.0 4.4 2.1 7.1 1.3 46.7 5.8 20.9 11.3 1.5 9.2 3.0 20.4 3.2 2.4 9.8 4.0 1.6 8.6 5.8 5.0 3.6 9.2 2.3 2.8 3.5 15.9 1.0 0.5 0.0 4.2 15.6 41.4 3.6 8.9 17.5 9.7 1.0 MCM7 "CDC47, MCM2, PPP1R104" ENSG00000166508 "Minichromosome maintenance complex component 7" P33993 7 100092728-100101940 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002163, HPA003898, CAB016312" Enhanced Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB002163: AB_564113, CAB016312: AB_627235, HPA003898: AB_1853632" "unprognostic (1.87e-1)" "prognostic favorable (1.28e-4)" "unprognostic (1.36e-1)" "unprognostic (5.20e-2)" "unprognostic (1.94e-1)" "unprognostic (7.03e-2)" "prognostic unfavorable (2.18e-4)" "unprognostic (2.08e-2)" "unprognostic (5.79e-3)" "unprognostic (2.16e-2)" "unprognostic (2.42e-1)" "unprognostic (9.34e-3)" "unprognostic (3.83e-2)" "unprognostic (5.41e-2)" "unprognostic (1.76e-1)" "unprognostic (1.32e-2)" "unprognostic (2.38e-1)" 8.6 5.2 17.5 13.6 21.7 37.3 11.2 20.0 20.6 8.2 14.2 19.2 15.0 10.4 16.0 6.3 10.7 8.6 9.9 5.1 18.1 12.4 5.5 8.5 7.4 22.4 23.7 9.5 12.6 13.1 7.5 10.3 10.7 15.5 10.0 15.7 7.2 9.2 9.2 11.5 10.1 10.3 11.7 23.5 10.7 7.8 14.9 22.3 7.5 9.4 4.1 28.2 10.3 10.0 7.3 5.7 1.9 5.7 7.6 9.0 6.0 24.9 28.8 31.8 24.0 3.1 4.1 16.3 15.2 18.4 42.5 45.3 22.0 26.4 42.3 14.5 10.8 27.1 19.8 46.7 22.1 35.9 21.6 39.9 26.9 16.2 15.2 1.7 45.7 17.5 2.8 4.2 31.1 18.7 5.4 16.1 24.4 51.5 34.7 21.5 53.3 77.6 18.7 27.9 23.2 20.9 41.8 46.7 51.6 8.2 15.1 20.8 31.7 24.0 22.3 7.5 18.6 10.2 19.2 6.8 16.0 29.1 31.4 30.1 14.5 24.8 76.1 11.1 36.7 28.6 1.8 2.5 1.9 8.1 4.1 6.2 5.3 5.7 7.9 5.5 7.3 5.9 5.7 1.6 7.6 5.7 5.7 9.0 6.0 17.5 21.7 20.0 20.6 18.1 12.4 23.7 9.5 15.5 22.3 8.9 17.0 23.7 20.7 41.4 8.7 7.9 15.3 24.1 9.1 3.5 13.7 90.8 8.3 17.6 40.0 14.5 15.8 70.0 22.4 78.1 17.3 11.3 24.2 10.4 34.4 6.4 16.7 8.0 10.8 22.7 19.5 16.5 18.6 17.2 34.7 10.1 16.0 20.1 14.5 9.1 11.9 12.9 22.7 83.2 67.3 30.9 60.2 28.7 60.9 12.3 MCM8 "C20orf154, dJ967N21.5, MGC119522, MGC119523, MGC12866, MGC4816, REC" ENSG00000125885 "Minichromosome maintenance 8 homologous recombination repair factor" Q9UJA3 20 5950652-5998977 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, DNA replication" "DNA-binding, Helicase, Hydrolase" "Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 43.2;Spermatogonia: 32.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045141, HPA066433" Supported Nucleoplasm NA NA Nucleoplasm "HPA045141: AB_2679230, HPA066433: " "unprognostic (6.55e-2)" "unprognostic (2.46e-2)" "unprognostic (4.43e-1)" "unprognostic (2.22e-3)" "unprognostic (1.90e-1)" "unprognostic (5.78e-2)" "prognostic unfavorable (9.30e-8)" "unprognostic (5.21e-2)" "unprognostic (5.14e-2)" "unprognostic (2.50e-1)" "prognostic unfavorable (7.50e-4)" "unprognostic (6.74e-2)" "unprognostic (1.11e-2)" "unprognostic (5.53e-2)" "unprognostic (2.76e-1)" "unprognostic (2.66e-2)" "unprognostic (3.47e-1)" 4.9 5.4 7.3 11.0 7.6 11.2 9.3 17.9 12.7 5.4 6.2 3.1 12.0 5.4 5.9 3.9 6.6 4.3 2.7 11.3 4.8 2.2 4.3 3.1 6.3 9.6 10.6 5.1 5.0 5.6 5.1 4.8 5.4 7.1 5.9 6.0 3.5 5.1 7.2 11.2 6.1 6.1 7.0 8.3 6.1 5.6 21.9 7.7 8.8 4.4 7.0 9.5 6.0 6.1 1.8 1.7 3.3 0.7 1.9 3.0 0.4 19.1 15.0 12.9 13.0 3.4 4.2 11.5 15.7 6.4 12.4 14.9 16.3 12.1 19.5 4.7 5.2 22.3 20.6 21.4 12.4 22.3 5.3 8.7 21.6 7.2 15.9 0.5 22.7 3.4 1.9 2.0 20.8 8.6 3.2 5.7 12.5 22.0 19.3 12.6 5.4 11.7 11.9 17.3 11.8 8.8 14.3 21.9 7.9 3.1 7.6 9.6 10.2 16.0 17.9 9.6 14.5 11.5 8.1 3.8 21.9 18.3 11.8 22.8 8.3 20.7 33.2 4.4 14.7 18.0 3.3 0.5 1.7 1.8 0.5 3.0 1.8 1.1 2.1 0.1 1.7 1.1 1.7 2.1 1.9 0.7 1.7 2.0 0.4 7.3 7.6 17.9 12.7 4.8 2.2 10.6 5.1 7.1 7.7 0.0 4.1 10.0 2.6 2.1 6.9 8.5 7.6 4.0 2.3 12.2 15.7 5.2 0.0 1.2 6.5 3.0 3.8 0.0 2.3 4.7 2.7 4.2 1.1 1.6 3.6 6.4 4.1 1.8 2.1 2.3 3.4 3.5 1.7 0.0 2.9 4.0 2.7 3.5 2.8 2.4 10.7 6.5 2.7 43.2 32.6 2.3 3.3 3.9 5.2 1.8 MCM9 "C6orf61, dJ329L24.3, FLJ20170, MCMDC1, MGC35304" ENSG00000111877 "Minichromosome maintenance 9 homologous recombination repair factor" Q9NXL9 6 118813442-118935162 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031137 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA031137: AB_10602027" "unprognostic (3.11e-2)" "unprognostic (1.99e-1)" "unprognostic (4.33e-3)" "unprognostic (2.90e-1)" "unprognostic (2.78e-2)" "unprognostic (2.82e-1)" "unprognostic (3.00e-2)" "unprognostic (2.29e-1)" "unprognostic (3.61e-2)" "unprognostic (7.76e-2)" "unprognostic (1.53e-1)" "unprognostic (2.99e-1)" "unprognostic (8.30e-2)" "unprognostic (2.16e-1)" "unprognostic (3.95e-1)" "unprognostic (2.26e-1)" "unprognostic (8.79e-2)" 8.6 7.2 5.9 11.9 8.4 14.5 17.7 5.2 6.9 9.4 11.2 8.2 9.8 7.3 9.0 16.0 10.2 8.6 8.2 6.6 5.9 4.0 9.3 7.6 15.6 12.1 11.5 4.7 8.7 12.2 11.9 11.2 13.8 6.3 10.5 8.4 7.0 11.8 8.7 4.2 9.8 12.6 10.9 5.7 10.2 7.3 7.9 8.1 27.0 13.1 7.1 9.9 9.6 10.5 3.1 5.2 8.0 5.3 10.2 6.4 3.9 4.6 7.4 11.9 12.8 5.4 5.3 9.1 4.4 7.9 6.5 8.3 6.1 8.4 14.1 5.5 7.6 4.3 14.0 8.3 4.8 9.2 8.3 11.4 11.2 8.8 5.9 3.2 12.0 7.6 5.8 5.7 6.7 7.7 4.1 6.2 8.8 13.5 6.5 4.3 9.8 10.6 9.7 5.8 7.7 3.4 8.4 7.5 3.7 6.6 9.3 10.3 7.4 7.8 5.7 4.1 3.2 8.5 17.0 6.3 5.2 4.6 3.7 6.5 8.7 7.2 16.7 6.6 9.8 6.0 7.2 4.5 8.0 4.9 5.3 3.8 3.1 3.0 5.0 5.2 3.0 3.6 3.5 5.4 10.2 3.2 3.7 6.4 3.9 5.9 8.4 5.2 6.9 5.9 4.0 11.5 4.7 6.3 8.1 6.0 4.1 4.4 3.1 2.6 3.5 3.9 2.5 12.0 4.5 7.0 9.8 9.1 3.3 2.3 1.5 4.4 5.1 0.0 2.5 2.9 2.8 3.4 6.9 2.4 3.0 1.6 6.9 3.7 5.3 1.9 3.4 4.5 0.0 2.8 5.9 2.1 2.1 5.8 3.9 2.9 5.4 0.0 2.1 4.8 2.7 1.8 6.1 5.3 4.1 4.1 MCMBP "C10orf119, FLJ13081, MCM-BP" ENSG00000197771 "Minichromosome maintenance complex binding protein" Q9BTE3 10 119829404-119892556 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013792, HPA038481" Uncertain Enhanced "Nucleoplasm,Cell Junctions,Cytosol" NA NA Nucleoplasm "Cell Junctions, Cytosol" "CAB013792: , HPA038481: AB_10794620" "unprognostic (1.26e-1)" "unprognostic (7.92e-2)" "unprognostic (4.62e-2)" "unprognostic (2.31e-2)" "unprognostic (1.72e-2)" "unprognostic (4.64e-2)" "unprognostic (1.31e-3)" "unprognostic (5.61e-2)" "unprognostic (2.28e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (7.32e-2)" "prognostic unfavorable (6.18e-4)" "unprognostic (2.23e-2)" "unprognostic (8.24e-2)" "unprognostic (2.51e-1)" "unprognostic (4.87e-2)" 33.6 15.3 11.7 23.2 13.8 14.6 35.5 17.2 13.8 27.0 26.3 16.9 11.4 15.5 28.0 14.9 26.4 23.0 18.7 26.3 12.0 10.2 18.7 23.7 28.5 38.6 17.4 8.5 29.2 18.2 23.2 17.6 35.4 14.2 22.5 21.4 15.7 21.0 17.4 30.1 23.8 20.7 26.0 16.8 26.0 20.7 15.4 15.5 38.0 24.5 28.2 24.7 32.5 28.6 4.5 6.9 12.1 9.7 4.1 5.1 2.4 31.0 22.1 31.0 21.4 15.7 19.3 18.2 28.8 31.6 36.7 38.0 28.8 25.5 36.2 13.3 23.0 16.7 29.0 37.0 29.0 43.0 26.5 27.3 18.6 17.6 22.0 24.4 34.3 45.0 15.8 16.4 33.2 43.8 20.2 25.1 23.7 17.1 27.3 24.0 23.0 43.0 20.7 15.6 23.1 16.0 27.2 60.0 18.4 15.7 21.4 13.4 17.2 21.0 17.5 24.0 24.3 11.9 24.5 19.4 18.1 17.8 18.3 34.3 19.7 21.9 40.1 21.6 23.1 11.1 12.1 5.3 3.6 4.2 9.7 5.1 4.5 3.9 4.4 6.9 1.8 4.2 3.8 6.4 4.1 6.1 3.5 3.9 2.4 11.7 13.8 17.2 13.8 12.0 10.2 17.4 8.5 14.2 15.5 14.9 13.9 20.1 27.2 38.0 10.0 16.2 12.7 10.7 18.2 19.2 3.9 30.7 11.6 9.6 3.3 32.4 15.1 0.0 11.5 42.5 26.3 18.7 17.4 23.1 33.4 30.2 10.4 30.1 35.7 4.9 27.9 31.3 21.9 8.2 18.5 16.9 12.8 7.0 21.2 17.5 17.1 19.4 29.9 27.6 61.5 37.4 33.2 27.4 26.9 24.5 MCOLN1 "ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1" ENSG00000090674 "Mucolipin 1" Q9GZU1 19 7522626-7534009 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport" "Ion channel" "Disease mutation, Mucolipidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Hofbauer cells: 91.8;Kupffer cells: 81.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 5 "granulocytes: 30.9;monocytes: 28.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031763, CAB032637, HPA069495" Uncertain Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "CAB032637: AB_2142964, HPA031763: AB_10600822, HPA069495: " "unprognostic (5.51e-2)" "unprognostic (1.31e-2)" "unprognostic (1.35e-2)" "unprognostic (3.30e-2)" "unprognostic (2.66e-1)" "unprognostic (4.07e-2)" "unprognostic (8.38e-3)" "unprognostic (1.57e-1)" "unprognostic (1.79e-2)" "unprognostic (1.47e-1)" "prognostic favorable (5.60e-5)" "unprognostic (1.36e-1)" "prognostic favorable (5.67e-4)" "unprognostic (2.58e-1)" "unprognostic (1.66e-1)" "unprognostic (1.07e-1)" "unprognostic (1.83e-1)" 18.9 27.5 10.1 10.3 11.9 10.0 10.3 8.2 19.7 7.7 9.6 11.2 7.2 9.6 8.8 9.5 11.2 8.4 11.7 11.7 9.0 9.2 11.5 20.6 17.9 20.6 10.6 10.0 7.8 10.5 9.8 26.0 17.9 13.6 8.8 6.9 9.7 9.2 8.0 14.2 13.9 8.0 9.5 10.4 38.3 8.9 6.5 9.4 7.0 6.2 7.6 5.1 12.5 8.7 1.3 6.2 30.9 28.9 2.8 2.7 4.4 6.4 6.6 3.2 11.0 18.9 6.1 9.3 12.0 9.7 14.6 12.6 5.0 5.7 3.6 14.8 8.1 12.9 3.0 5.4 4.1 4.3 7.0 12.0 3.2 6.5 4.0 16.6 3.6 14.2 8.6 9.7 13.9 2.4 4.6 6.1 8.1 5.9 16.1 8.4 2.1 4.9 3.6 7.2 3.4 14.2 6.9 5.4 7.7 5.5 5.6 8.4 10.3 5.1 9.1 15.2 3.7 5.5 6.4 7.6 7.0 4.0 28.1 8.9 12.4 19.0 2.5 11.2 5.1 10.4 30.9 13.7 29.7 2.3 27.5 2.0 1.1 2.0 1.9 5.6 1.3 1.9 2.0 12.2 2.8 28.9 6.2 2.7 4.4 10.1 11.9 8.2 19.7 9.0 9.2 10.6 10.0 13.6 9.4 3.0 1.6 10.4 6.1 11.8 26.9 2.0 17.8 4.0 1.2 29.6 21.6 10.4 1.7 20.9 4.9 11.9 19.5 46.7 19.9 15.2 17.9 4.5 1.1 12.4 91.8 55.6 16.1 11.1 81.2 10.8 15.3 42.0 20.3 5.4 8.6 23.6 17.7 20.1 14.9 9.2 37.0 6.5 9.2 10.2 11.9 15.2 24.7 10.2 8.6 4.1 MCPH1 "BRIT1, FLJ12847" ENSG00000147316 "Microcephalin 1" Q8NEM0 8 6406592-6648504 "Disease related genes, Predicted intracellular proteins" "Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008238, HPA012064, CAB012177" Supported Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB012177: AB_303207, HPA008238: AB_1853655, HPA012064: " "unprognostic (1.00e-1)" "unprognostic (2.17e-2)" "prognostic favorable (8.52e-4)" "unprognostic (6.45e-2)" "unprognostic (1.16e-2)" "unprognostic (1.19e-2)" "unprognostic (1.14e-2)" "unprognostic (1.34e-1)" "unprognostic (1.95e-1)" "unprognostic (1.13e-1)" "unprognostic (1.07e-1)" "unprognostic (4.79e-2)" "unprognostic (5.55e-3)" "unprognostic (4.24e-2)" "unprognostic (2.48e-1)" "unprognostic (4.79e-2)" "unprognostic (2.94e-1)" 13.5 10.0 11.6 10.7 14.6 35.0 14.0 19.9 16.8 13.6 11.7 12.4 15.1 9.1 17.2 10.0 12.2 12.5 9.4 11.9 12.2 10.0 11.4 11.0 10.8 15.0 11.0 11.3 14.3 13.4 13.2 19.4 14.4 13.9 13.6 10.6 10.2 14.4 15.4 24.9 11.9 11.2 12.3 14.2 15.3 11.7 17.1 12.5 21.6 14.0 10.7 17.0 14.3 17.6 6.9 4.1 11.7 4.1 6.0 6.2 3.0 4.6 4.1 7.5 5.2 3.7 6.7 6.4 7.0 6.2 9.0 6.7 5.2 3.5 8.9 1.9 5.7 8.2 5.4 9.4 6.7 10.7 3.7 5.2 11.4 4.2 6.9 6.2 5.7 9.0 6.4 7.0 6.1 8.8 6.3 6.5 9.7 13.8 9.0 6.8 3.0 15.3 6.2 12.9 8.5 4.1 9.2 7.1 5.4 5.2 8.5 5.2 6.9 5.2 5.5 7.6 8.7 4.8 8.1 5.4 7.0 3.8 2.3 6.6 4.2 5.7 13.3 6.4 6.6 9.5 2.2 3.0 11.7 4.8 3.4 6.2 6.0 4.2 5.5 3.0 6.9 5.4 5.6 0.5 6.0 4.1 4.1 4.2 3.0 11.6 14.6 19.9 16.8 12.2 10.0 11.0 11.3 13.9 12.5 3.0 10.7 14.5 11.1 4.0 12.6 12.4 17.8 40.2 25.0 14.0 15.7 9.3 3.3 9.4 34.4 10.8 4.2 46.7 9.2 8.6 6.2 7.7 19.6 6.4 6.1 28.6 0.0 9.8 12.9 20.9 11.2 6.7 0.0 10.8 5.9 14.2 8.6 8.0 12.4 6.5 9.5 6.5 9.6 17.0 10.9 5.3 10.3 17.0 6.4 9.1 MCRS1 "ICP22BP, INO80Q, MCRS2, MSP58, P78" ENSG00000187778 "Microspherule protein 1" Q96EZ8 12 49556544-49568153 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039057 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA039057: AB_10794085" "unprognostic (2.60e-3)" "unprognostic (5.23e-2)" "unprognostic (1.46e-1)" "unprognostic (1.89e-2)" "unprognostic (1.68e-1)" "unprognostic (4.60e-2)" "prognostic unfavorable (2.30e-4)" "unprognostic (2.26e-2)" "unprognostic (2.83e-3)" "unprognostic (6.11e-2)" "unprognostic (9.94e-3)" "unprognostic (1.23e-1)" "prognostic favorable (2.70e-4)" "unprognostic (2.28e-1)" "unprognostic (1.69e-1)" "unprognostic (4.35e-2)" "unprognostic (3.26e-2)" 16.3 20.3 20.2 19.5 23.3 24.4 16.0 20.1 41.7 19.8 21.0 28.3 16.5 19.1 21.7 20.6 22.5 23.2 22.7 47.6 20.0 15.5 25.0 21.5 17.3 19.7 19.0 24.7 17.8 25.3 23.8 16.6 25.7 21.6 19.7 19.4 24.1 26.8 21.0 32.3 19.9 29.0 20.4 21.8 22.2 20.6 33.2 23.1 30.2 29.9 30.2 22.7 19.4 17.6 22.8 38.6 38.6 39.0 41.0 34.8 31.7 15.6 23.3 24.2 22.9 13.0 15.1 27.7 15.2 15.0 35.7 19.9 39.2 27.9 27.2 29.8 27.1 16.3 18.7 38.8 34.9 15.9 21.8 35.1 28.5 17.3 13.2 24.6 32.3 30.2 18.9 26.0 26.6 21.8 22.1 28.0 25.4 34.5 18.9 21.1 22.4 21.3 18.2 36.2 15.9 18.1 27.3 20.5 31.9 25.4 11.5 24.9 24.6 16.3 20.2 13.1 18.2 33.8 32.8 20.6 18.6 22.4 16.8 21.0 18.9 18.7 26.7 24.7 17.3 11.8 38.6 29.9 34.7 33.0 39.0 25.3 22.7 28.6 34.8 38.6 22.8 25.5 27.1 15.4 41.0 29.2 26.5 28.7 31.7 20.2 23.3 20.1 41.7 20.0 15.5 19.0 24.7 21.6 23.1 32.8 14.4 21.6 19.8 9.5 12.0 21.6 28.1 18.7 6.8 22.7 7.9 43.3 44.7 33.3 22.1 14.6 30.2 0.0 31.4 42.6 16.5 23.3 27.6 9.6 35.7 22.3 26.4 12.9 19.2 31.3 25.3 19.4 27.0 45.9 22.8 19.7 32.7 29.6 25.5 31.9 14.0 6.5 15.5 38.5 60.3 11.0 49.5 34.5 30.6 22.5 MCTP1 FLJ22344 ENSG00000175471 "Multiple C2 and transmembrane domain containing 1" Q6DN14 5 94703741-95284575 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 49.2;brain: 42.4" "Cell type enhanced" "Detected in many" 10 "Endothelial cells: 29.9;granulocytes: 61.2;Kupffer cells: 33.5;Macrophages: 35.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 41 "basophil: 11.5;classical monocyte: 12.9;eosinophil: 5.8;intermediate monocyte: 19.2;myeloid DC: 10.1;neutrophil: 18.7;non-classical monocyte: 17.6;plasmacytoid DC: 5.3" "Group enriched" "Detected in many" 52 "dendritic cells: 10.1;granulocytes: 18.7;monocytes: 19.2" "Cell line enhanced" "Detected in many" "Karpas-707: 28.3;RPMI-8226: 28.0;RPTEC TERT1: 21.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019018 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA019018: AB_1853665" "unprognostic (1.20e-2)" "unprognostic (6.70e-4)" "unprognostic (1.77e-2)" "unprognostic (1.03e-2)" "unprognostic (1.16e-4)" "unprognostic (1.88e-1)" "unprognostic (1.16e-2)" "unprognostic (2.47e-2)" "unprognostic (1.86e-1)" "unprognostic (6.99e-2)" "unprognostic (5.31e-2)" "unprognostic (1.35e-1)" "unprognostic (1.91e-6)" "unprognostic (5.38e-2)" "unprognostic (3.65e-2)" "unprognostic (2.89e-3)" "unprognostic (4.43e-2)" 49.2 2.7 6.5 11.4 42.4 36.9 18.3 18.3 16.5 6.9 7.2 0.3 4.4 5.0 11.1 9.2 6.5 4.1 16.7 4.6 8.5 7.4 3.0 3.8 11.3 5.5 4.1 3.8 3.3 3.4 3.1 5.2 7.1 3.9 5.9 7.3 1.0 4.3 2.7 5.1 4.5 4.8 10.9 5.7 8.2 5.3 4.0 8.1 5.5 5.0 21.2 4.3 17.3 12.6 0.3 10.1 18.7 19.2 0.2 0.2 3.3 0.1 2.0 1.3 0.0 20.0 8.0 0.0 0.1 9.8 0.9 3.2 0.0 5.2 7.2 7.7 0.0 20.5 0.0 0.1 0.1 1.1 0.0 1.4 4.3 4.9 0.0 2.6 8.9 5.8 2.9 0.0 3.6 13.1 8.5 20.7 3.0 0.1 28.3 7.4 0.2 0.5 6.8 1.6 0.1 8.2 0.3 0.0 28.0 21.3 11.3 4.0 0.2 0.6 0.0 14.6 0.6 0.0 8.4 0.1 3.6 5.6 0.1 1.6 2.0 0.0 0.0 16.9 14.9 3.6 11.5 12.9 5.8 0.0 19.2 0.0 0.3 0.0 0.1 10.1 0.1 0.2 0.0 18.7 0.2 17.6 5.3 0.0 3.3 6.5 42.4 18.3 12.2 8.5 7.4 4.1 3.8 3.9 8.1 3.0 9.6 0.0 0.1 16.1 2.0 2.5 0.0 4.0 6.8 3.5 0.0 0.3 0.0 0.0 20.6 29.9 0.0 0.0 0.2 0.1 3.0 0.6 61.2 0.5 10.7 3.2 0.0 1.8 33.5 12.2 0.6 35.3 11.8 0.0 0.0 3.6 0.8 0.0 0.0 0.0 3.7 0.0 2.2 1.4 1.4 11.7 0.2 2.2 0.0 0.4 MCTP2 "FLJ11175, FLJ33303" ENSG00000140563 "Multiple C2 and transmembrane domain containing 2" Q6DN12 15 94231538-94483952 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 41.6" "Cell type enhanced" "Detected in many" 5 "granulocytes: 35.7;Mucus-secreting cells: 42.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 21.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 14.5;HMC-1: 12.0;U-698: 15.9;U-87 MG: 18.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA051176, HPA070541" Uncertain Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA051176: AB_2681373, HPA070541: AB_2686277" "unprognostic (1.70e-2)" "unprognostic (4.32e-2)" "unprognostic (5.63e-2)" "unprognostic (7.15e-4)" "unprognostic (3.57e-2)" "unprognostic (2.66e-3)" "unprognostic (3.45e-2)" "unprognostic (3.68e-3)" "unprognostic (2.83e-1)" "unprognostic (1.45e-1)" "unprognostic (2.97e-1)" "unprognostic (1.80e-1)" "prognostic unfavorable (2.18e-5)" "unprognostic (5.87e-2)" "unprognostic (4.36e-1)" "unprognostic (1.76e-3)" "unprognostic (9.41e-2)" 5.3 4.1 0.8 19.7 1.7 12.6 2.7 0.7 1.5 5.4 12.3 0.0 6.9 5.6 4.0 9.5 5.7 4.5 10.3 4.6 1.0 2.2 3.6 2.3 12.4 18.4 2.5 0.8 3.8 10.0 5.3 24.4 17.1 0.6 6.8 10.2 2.5 16.8 9.6 0.8 4.0 10.9 4.0 0.9 41.6 3.7 1.7 0.4 3.0 8.7 4.1 12.9 6.2 14.8 2.7 0.1 21.2 0.5 6.8 4.4 1.1 2.5 0.0 0.0 0.0 0.0 0.0 1.8 1.3 0.8 0.2 0.1 1.7 3.1 7.3 0.3 0.0 0.0 5.7 0.1 4.7 0.0 1.4 0.5 14.5 2.0 0.8 1.0 3.0 12.0 0.8 5.8 0.1 6.0 0.0 0.0 2.5 0.5 4.1 0.0 0.0 1.4 8.0 0.6 2.4 2.6 3.3 0.1 2.7 0.3 7.6 1.4 0.3 0.1 2.4 0.9 0.5 0.0 0.2 0.0 0.0 1.2 0.0 0.0 8.7 0.1 15.9 18.0 7.9 0.9 3.2 0.5 7.7 4.4 0.1 2.1 2.2 1.2 1.9 0.0 2.7 0.5 1.9 21.2 6.8 0.5 0.1 0.0 1.1 0.8 1.7 0.7 1.5 1.0 2.2 2.5 0.8 0.6 0.4 3.0 24.7 20.4 10.8 3.8 0.8 0.8 5.1 5.3 15.9 3.5 0.0 13.2 0.0 2.7 3.2 2.1 18.6 0.0 4.1 5.9 7.2 13.7 35.7 1.3 7.5 0.0 15.0 1.3 12.7 3.9 0.3 2.1 1.7 0.0 42.4 0.2 4.0 21.0 0.0 1.7 0.5 0.0 0.8 0.1 2.0 1.9 20.5 19.7 18.7 14.9 MCUB "CCDC109B, FLJ20647" ENSG00000005059 "Mitochondrial calcium uniporter dominant negative beta subunit" Q9NWR8 4 109560205-109688726 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 39.3;lymphoid tissue: 45.3" "Cell type enhanced" "Detected in some" 9 "Cytotrophoblasts: 107.3;Exocrine glandular cells: 99.3;Extravillous trophoblasts: 82.0;Hofbauer cells: 95.7;Pancreatic endocrine cells: 50.6;Syncytiotrophoblasts: 61.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 36.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA048776 Enhanced Approved Nucleoplasm,Vesicles,Mitochondria NA NA "Nucleoplasm, Vesicles, Mitochondria" "HPA048776: AB_2680518" "unprognostic (6.12e-3)" "unprognostic (1.70e-2)" "unprognostic (3.12e-2)" "unprognostic (1.60e-1)" "unprognostic (1.42e-1)" "unprognostic (1.70e-1)" "unprognostic (1.70e-2)" "unprognostic (3.06e-1)" "unprognostic (2.35e-1)" "unprognostic (1.14e-2)" "unprognostic (1.26e-3)" "unprognostic (3.40e-1)" "prognostic unfavorable (7.35e-6)" "unprognostic (2.48e-1)" "unprognostic (5.21e-2)" "unprognostic (1.21e-1)" "unprognostic (1.42e-2)" 11.6 2.2 4.1 21.0 3.2 8.3 16.6 0.4 3.7 8.2 4.9 4.6 1.4 3.5 12.3 5.5 9.2 6.3 7.3 14.9 4.5 4.7 3.9 2.1 7.8 44.2 3.5 2.6 7.5 2.1 2.3 5.1 9.9 6.5 5.4 6.1 4.1 6.5 2.2 4.3 7.6 8.8 8.4 8.5 13.8 4.2 3.6 1.9 45.3 4.7 9.5 24.8 7.3 9.0 14.0 15.7 1.1 16.0 20.0 39.3 25.7 10.4 4.5 2.5 12.8 2.8 7.4 9.7 9.0 5.5 9.9 8.9 0.2 8.5 36.7 1.9 7.7 5.5 3.0 9.4 5.5 8.8 23.3 7.4 4.4 5.0 0.6 4.9 8.9 0.1 4.7 1.5 6.0 5.1 7.0 13.2 13.6 1.3 23.4 7.5 12.8 20.4 0.1 11.6 1.8 6.5 7.8 19.4 4.1 11.6 4.6 10.3 4.5 9.7 28.9 3.0 2.1 3.6 0.4 9.4 3.9 5.1 20.6 15.6 9.1 6.3 8.9 12.0 1.9 2.7 0.0 16.0 0.2 6.3 9.7 9.0 13.5 26.7 19.0 15.7 14.0 39.3 22.2 1.1 20.0 7.2 11.0 22.4 25.7 4.1 3.2 0.4 3.7 4.5 4.7 3.5 2.6 6.5 1.9 8.9 6.9 0.0 0.0 0.0 0.0 0.0 0.0 4.0 4.5 5.2 0.0 107.3 0.0 22.4 0.0 0.0 0.0 0.0 99.3 82.0 0.0 0.0 1.1 0.0 95.7 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 25.2 0.0 0.0 50.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 61.4 0.0 0.0 0.0 MDC1 "Em:AB023051.5, KIAA0170, NFBD1" ENSG00000137337 "Mediator of DNA damage checkpoint 1" Q14676 6 30699807-30717889 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Spermatocytes: 75.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 3.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 15.7;AN3-CA: 12.3;HEK 293: 29.8" "Low region specificity" "Detected in all" HPA006915 Enhanced Supported "Nucleoplasm,Nuclear bodies" No No "Nuclear bodies" Nucleoplasm "HPA006915: AB_1853669" "unprognostic (8.52e-2)" "unprognostic (4.32e-1)" "unprognostic (4.11e-2)" "unprognostic (2.66e-2)" "unprognostic (1.60e-1)" "unprognostic (1.61e-1)" "unprognostic (5.40e-3)" "unprognostic (1.13e-1)" "unprognostic (1.09e-2)" "unprognostic (9.44e-2)" "unprognostic (2.74e-3)" "unprognostic (1.31e-1)" "unprognostic (1.62e-2)" "unprognostic (3.86e-2)" "unprognostic (2.99e-1)" "unprognostic (4.39e-3)" "unprognostic (3.23e-1)" 10.8 3.6 5.7 9.5 5.9 4.9 5.5 10.2 8.0 6.9 6.3 8.5 3.8 3.8 9.9 5.1 3.7 8.3 5.0 5.0 5.2 2.4 5.1 6.2 5.1 5.4 4.9 3.7 11.3 5.7 3.1 12.5 3.1 6.0 6.4 2.9 9.4 5.5 3.5 11.1 11.7 6.4 6.1 5.5 7.1 7.7 26.7 5.3 11.4 11.9 2.4 13.0 5.2 5.4 2.0 1.8 0.4 0.2 3.8 1.2 0.3 15.7 1.1 1.2 12.3 3.9 3.9 1.0 1.3 0.7 2.7 1.1 1.0 1.7 2.6 6.7 7.8 6.4 1.6 2.4 4.5 2.5 2.2 29.8 1.9 3.0 0.7 0.5 1.1 1.4 1.0 0.9 4.2 2.0 0.3 0.4 6.4 3.9 2.9 0.4 1.5 0.7 0.2 0.9 0.8 0.8 2.2 1.3 2.9 4.5 3.4 2.6 1.3 0.6 3.2 0.5 2.2 2.9 2.2 1.0 1.0 1.5 2.0 1.5 1.9 7.3 6.8 0.3 4.4 2.1 0.4 0.1 0.3 1.1 0.2 0.9 0.8 0.9 1.2 0.2 2.0 1.0 0.8 0.1 3.8 0.1 1.8 0.0 0.3 5.7 5.9 10.2 8.0 5.2 2.4 4.9 3.7 6.0 5.3 14.9 15.4 9.7 4.8 3.9 10.7 6.3 7.6 8.1 6.8 5.2 7.9 4.4 3.3 3.8 3.4 5.6 1.0 0.0 5.4 9.5 7.3 2.5 16.2 11.4 5.6 4.8 6.4 5.5 5.9 2.1 7.2 4.5 1.7 8.2 2.6 10.0 4.8 0.0 5.6 2.8 17.0 12.9 5.0 75.3 17.2 3.1 1.6 6.9 4.4 0.8 MDFI I-mfa ENSG00000112559 "MyoD family inhibitor" Q99750 6 41636882-41654246 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Cytotrophoblasts: 196.5;Extravillous trophoblasts: 103.1;Pancreatic endocrine cells: 86.6;Syncytiotrophoblasts: 116.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 23.6;HBEC3-KT: 29.3;OE19: 24.7;REH: 77.3" "Region enriched" "Detected in single" 8 "cerebellum: 19.0" "Low region specificity" "Detected in all" HPA049973 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA049973: AB_2680975" "unprognostic (9.74e-3)" "unprognostic (4.25e-2)" "unprognostic (6.82e-2)" "unprognostic (6.26e-3)" "unprognostic (9.18e-2)" "unprognostic (1.07e-1)" "unprognostic (1.69e-1)" "prognostic unfavorable (1.32e-5)" "prognostic unfavorable (9.11e-4)" "unprognostic (1.66e-1)" "unprognostic (3.27e-2)" "unprognostic (4.04e-2)" "prognostic unfavorable (2.85e-6)" "unprognostic (2.66e-2)" "unprognostic (6.06e-2)" "unprognostic (1.57e-1)" "unprognostic (8.22e-2)" 29.5 2.1 2.9 5.3 3.1 0.4 10.5 0.9 10.8 14.0 3.2 2.5 3.5 1.9 4.8 4.6 20.5 4.1 12.3 4.0 2.3 2.1 2.5 2.3 10.1 4.5 2.4 1.3 15.7 1.6 0.9 4.2 17.8 3.4 13.3 0.6 6.3 10.1 4.7 1.0 6.7 1.3 2.9 2.0 0.7 3.2 4.6 1.3 0.8 7.0 31.0 19.6 8.4 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 12.9 0.0 0.0 0.0 23.6 0.0 0.0 0.0 0.0 0.0 7.1 0.0 5.4 0.0 0.0 13.6 3.5 29.3 0.0 0.0 0.0 0.1 0.0 0.6 0.5 0.0 0.0 0.9 13.6 0.1 6.4 0.0 9.7 4.0 0.0 0.0 0.0 0.0 10.1 0.1 8.8 24.7 0.5 77.3 7.4 0.1 0.8 2.2 2.4 5.9 0.1 11.0 0.0 9.3 0.0 0.9 10.7 0.0 12.6 0.1 0.4 0.0 0.0 0.0 0.1 0.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 3.1 0.9 2.0 2.3 2.1 2.4 1.3 3.4 1.3 0.0 0.0 0.0 26.4 21.8 0.0 0.8 0.0 0.0 0.0 5.2 0.0 196.5 0.0 24.1 0.5 3.0 0.0 0.0 44.9 103.1 11.5 36.3 0.0 0.0 16.7 0.0 0.0 3.7 0.0 0.0 36.2 0.5 0.0 1.0 0.0 0.0 86.6 0.0 5.6 0.0 0.0 0.0 1.9 0.1 1.5 8.0 116.0 0.0 0.0 51.1 MDFIC "HIC, MDFIC1" ENSG00000135272 "MyoD family inhibitor domain containing" Q9P1T7 7 114922154-115019202 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Muller glia cells: 111.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2197: 38.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA030716 Approved Supported "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA "Nucleoplasm, Golgi apparatus" "HPA030716: AB_10671364" "unprognostic (1.24e-3)" "unprognostic (4.15e-1)" "unprognostic (2.38e-2)" "unprognostic (2.29e-2)" "unprognostic (1.39e-1)" "unprognostic (3.13e-3)" "unprognostic (1.73e-2)" "unprognostic (1.62e-1)" "unprognostic (1.47e-1)" "unprognostic (8.02e-2)" "unprognostic (6.38e-3)" "unprognostic (3.68e-2)" "prognostic unfavorable (3.65e-4)" "unprognostic (6.13e-3)" "unprognostic (7.10e-2)" "unprognostic (1.42e-1)" "unprognostic (3.55e-1)" 39.4 21.1 4.6 29.3 4.6 5.1 62.4 2.5 4.0 18.4 15.5 5.1 13.9 3.7 22.8 8.8 18.2 7.7 9.7 15.9 4.4 4.7 8.3 8.6 17.5 48.0 4.7 4.1 11.2 5.9 15.2 6.6 11.2 13.6 11.9 5.8 11.2 14.4 19.4 13.7 8.1 9.4 16.7 13.7 28.3 6.6 4.0 3.4 17.8 16.1 11.2 24.1 18.0 25.4 3.6 8.1 1.1 2.5 2.7 6.9 1.2 0.0 4.8 6.4 0.0 13.7 19.0 2.7 24.4 29.4 5.6 7.1 0.1 14.5 3.4 0.3 16.0 9.0 2.8 2.0 4.2 9.7 12.0 5.7 0.0 6.0 0.0 7.0 7.4 5.0 15.8 4.1 12.7 4.0 14.4 3.7 3.3 0.0 23.6 19.0 0.0 0.0 0.6 5.2 0.3 5.5 0.0 18.9 7.3 5.7 5.9 0.2 0.0 10.6 10.0 11.0 9.2 3.1 6.7 10.4 20.9 5.9 38.6 11.7 9.6 0.0 0.0 14.6 0.0 17.8 0.2 1.5 1.1 3.0 1.9 4.6 3.6 6.9 6.4 2.4 3.2 4.0 3.4 0.1 2.7 2.5 8.1 5.6 1.2 4.6 4.6 2.5 4.0 4.4 4.7 4.7 4.1 13.6 3.4 14.9 25.0 24.0 5.8 8.4 0.5 23.2 10.2 20.1 17.0 14.0 0.0 6.9 8.3 2.0 1.3 27.3 0.0 0.0 2.5 4.5 13.4 6.6 2.3 13.9 22.0 0.0 0.0 48.5 50.6 0.9 4.0 28.8 35.4 5.4 2.1 111.3 6.0 2.0 2.5 4.1 3.4 6.5 8.3 0.0 0.5 12.0 3.1 40.1 4.2 6.4 MDM2 "HDM2, MGC5370" ENSG00000135679 "MDM2 proto-oncogene" Q00987 12 68808176-68850686 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" Transferase "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 95.6;U-698: 91.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000086, CAB016303" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB000086: AB_563872, CAB016303: AB_627920" "unprognostic (1.16e-1)" "prognostic favorable (3.23e-4)" "unprognostic (6.16e-2)" "prognostic favorable (4.51e-7)" "unprognostic (7.25e-2)" "unprognostic (6.91e-2)" "unprognostic (3.77e-2)" "unprognostic (1.72e-1)" "unprognostic (2.45e-2)" "unprognostic (3.23e-1)" "unprognostic (1.80e-3)" "unprognostic (2.36e-1)" "unprognostic (4.22e-2)" "unprognostic (4.59e-2)" "unprognostic (1.81e-1)" "unprognostic (2.68e-1)" "unprognostic (8.95e-2)" 16.6 15.3 11.1 12.5 10.8 23.1 12.5 12.0 11.3 13.1 16.6 13.6 11.9 5.2 8.8 9.4 14.2 12.6 12.3 9.0 8.8 8.6 11.2 25.7 15.9 13.3 14.2 7.1 11.0 21.4 11.4 10.4 24.5 11.9 12.6 21.5 7.8 10.5 11.1 19.5 9.8 7.2 10.8 10.8 15.3 9.8 6.5 11.5 29.5 13.6 10.8 14.1 13.5 12.6 4.9 4.0 19.3 6.4 3.6 4.4 3.0 3.1 7.5 7.9 3.9 10.2 9.5 40.2 8.9 8.9 4.7 7.6 4.5 1.4 33.3 2.5 5.8 1.3 1.9 5.4 95.6 7.6 8.8 3.7 6.1 6.3 20.2 10.0 5.4 5.6 14.6 8.2 18.7 12.8 4.7 13.2 5.8 6.2 8.1 9.0 5.1 7.1 1.8 6.6 1.6 1.4 25.3 5.4 2.7 2.9 26.6 6.0 3.5 5.6 4.4 1.9 16.7 10.4 3.6 14.1 3.6 6.8 2.9 3.1 12.3 7.8 91.9 5.5 2.1 14.7 5.3 5.4 4.8 4.4 4.0 3.9 4.7 3.7 4.1 2.8 4.9 4.0 3.7 19.3 3.6 6.4 4.0 3.8 3.0 11.1 10.8 12.0 11.3 8.8 8.6 14.2 7.1 11.9 11.5 29.8 48.8 22.9 24.5 13.9 27.9 17.8 25.5 97.7 62.6 24.4 31.4 43.9 11.6 18.1 1.1 20.2 16.6 0.0 20.8 23.6 22.4 34.7 31.3 38.4 16.5 28.6 24.1 22.1 44.9 1.8 17.8 21.8 11.8 31.5 23.5 26.4 19.8 20.1 14.2 15.3 34.5 19.4 21.7 13.9 20.6 19.3 78.8 25.4 19.7 74.5 MDM4 "HDMX, MDMX" ENSG00000198625 "MDM4, p53 regulator" O15151 1 204516379-204558120 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 34.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018919, HPA048821" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA018919: AB_1853694, HPA048821: AB_2680531" "unprognostic (4.63e-2)" "unprognostic (3.73e-1)" "unprognostic (6.38e-2)" "unprognostic (1.50e-1)" "unprognostic (3.84e-2)" "unprognostic (1.68e-3)" "unprognostic (2.33e-1)" "unprognostic (1.29e-1)" "unprognostic (1.51e-2)" "unprognostic (2.34e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (9.87e-4)" "prognostic unfavorable (7.06e-6)" "unprognostic (1.20e-1)" "unprognostic (1.73e-1)" "unprognostic (2.49e-2)" "prognostic favorable (2.49e-4)" 12.7 8.8 14.4 21.1 18.0 59.1 14.6 19.7 16.4 12.2 10.6 20.4 15.8 7.6 12.5 23.6 10.4 12.3 10.3 11.3 13.7 8.0 11.1 12.3 15.4 21.0 20.5 9.5 19.0 16.7 11.1 19.0 12.4 13.4 13.1 12.4 14.2 11.3 15.4 12.0 23.7 15.2 18.5 13.5 19.9 11.9 19.6 19.4 55.8 15.1 9.5 21.0 13.9 12.7 15.1 9.0 8.1 4.8 4.9 7.8 2.4 3.6 7.1 7.2 9.9 5.0 5.6 34.0 2.7 2.8 3.5 5.2 3.7 4.9 12.4 2.6 3.8 2.9 3.9 4.8 4.0 4.7 3.7 3.4 9.8 15.8 4.3 3.8 7.7 9.8 5.7 2.6 5.7 10.2 3.7 3.4 8.0 5.6 18.1 3.0 12.0 4.7 6.8 9.9 1.3 3.0 5.6 5.9 4.1 3.4 17.5 3.2 7.2 2.7 5.4 5.1 7.5 10.2 4.5 3.4 4.0 7.1 2.6 4.4 9.1 3.2 10.3 2.8 3.3 5.7 8.1 4.7 6.2 7.2 4.8 6.0 9.0 5.4 5.0 4.1 15.1 7.8 6.5 7.8 4.9 4.3 9.0 3.0 2.4 14.4 18.0 19.7 16.4 13.7 8.0 20.5 9.5 13.4 19.4 26.8 49.9 72.9 46.9 54.7 91.7 33.5 40.8 20.1 61.4 66.3 159.0 39.1 11.6 25.4 65.9 50.6 37.1 93.5 23.0 23.0 48.1 52.9 63.6 48.4 30.6 39.7 62.4 94.5 85.6 124.4 74.2 75.3 40.5 23.4 44.0 44.1 23.4 40.8 50.9 12.8 196.4 51.8 36.2 60.6 71.3 59.7 50.9 73.9 39.6 40.0 MDN1 "KIAA0301, Rea1" ENSG00000112159 "Midasin AAA ATPase 1" Q9NU22 6 89642499-89819723 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 50.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 27.1;NTERA-2: 26.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029666, HPA029667, HPA029668, HPA029669" Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol" NA NA "Nucleoli, Cytosol" "Nucleoplasm, Intermediate filaments" "HPA029666: AB_10600888, HPA029667: AB_10696207, HPA029668: AB_10669868, HPA029669: AB_10670429" "unprognostic (2.00e-1)" "unprognostic (4.46e-2)" "unprognostic (7.62e-2)" "unprognostic (2.26e-2)" "unprognostic (6.14e-3)" "unprognostic (3.46e-1)" "unprognostic (6.68e-2)" "unprognostic (1.40e-1)" "unprognostic (3.51e-1)" "unprognostic (1.75e-1)" "unprognostic (1.77e-2)" "unprognostic (9.07e-2)" "unprognostic (2.54e-3)" "unprognostic (6.28e-3)" "unprognostic (9.22e-2)" "unprognostic (2.02e-1)" "unprognostic (6.09e-2)" 10.0 8.8 8.6 10.1 18.2 16.1 14.9 19.2 18.7 9.1 7.5 14.8 8.6 5.9 14.1 10.0 9.2 10.2 6.4 8.6 9.4 9.6 9.4 15.1 7.3 10.9 13.1 12.4 22.3 10.7 19.0 10.9 5.9 15.9 8.1 8.6 9.4 9.3 8.3 16.2 19.6 8.8 9.2 12.7 9.0 8.2 14.0 13.7 8.4 12.8 8.2 12.7 7.5 7.8 3.8 8.9 6.7 1.0 3.3 4.2 0.3 4.6 4.6 4.8 4.5 7.9 7.5 4.8 3.2 2.4 3.6 4.5 10.6 1.7 14.0 3.7 3.3 3.9 4.1 12.4 4.3 6.5 5.5 8.2 15.2 5.9 6.9 3.0 19.6 3.8 4.6 3.7 9.7 9.0 2.2 6.4 6.4 27.1 3.4 3.5 5.6 3.0 7.4 26.4 3.9 4.0 6.1 9.1 3.5 3.2 6.6 8.7 3.9 4.5 2.7 2.9 6.6 1.9 8.7 8.2 2.4 4.5 3.2 7.4 3.9 4.3 6.9 3.3 11.2 4.2 6.7 1.0 1.9 2.4 0.8 2.1 3.0 3.3 2.6 0.6 3.8 4.2 3.3 0.2 3.3 1.0 8.9 1.3 0.3 8.6 18.2 19.2 18.7 9.4 9.6 13.1 12.4 15.9 13.7 26.8 15.5 8.5 5.2 26.1 24.4 30.7 7.6 13.4 25.0 14.0 23.6 4.9 0.0 5.9 6.0 13.3 4.6 23.3 6.9 5.7 10.0 7.3 5.8 41.4 5.9 17.5 7.5 9.2 3.3 2.5 6.6 6.6 11.8 2.8 6.9 7.8 5.6 3.5 8.1 1.8 19.5 0.0 9.5 21.7 50.0 26.3 2.9 9.6 9.3 8.7 MDP1 "FN6Pase, MGC5987" ENSG00000213920 "Magnesium dependent phosphatase 1" Q86V88 14 24213937-24216070 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "monocytes: 29.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003064, HPA070338" Uncertain Approved Nucleoplasm NA NA 34000 Nucleoplasm "HPA003064: AB_10602350, HPA070338: AB_2686256" "unprognostic (2.70e-1)" "unprognostic (3.68e-1)" "unprognostic (2.51e-1)" "unprognostic (2.11e-1)" "unprognostic (3.09e-1)" "unprognostic (5.46e-2)" "unprognostic (5.48e-2)" "unprognostic (1.12e-1)" "unprognostic (6.27e-2)" "unprognostic (8.02e-2)" "unprognostic (2.00e-3)" "unprognostic (1.02e-1)" "prognostic favorable (5.96e-4)" "unprognostic (6.39e-2)" "unprognostic (1.32e-1)" "unprognostic (3.82e-1)" "unprognostic (3.19e-2)" 12.2 17.6 18.5 8.3 15.0 8.1 18.7 18.6 18.3 13.3 10.2 13.1 21.0 6.7 10.6 19.0 8.9 14.3 12.0 17.8 13.8 13.9 16.6 14.7 8.7 13.5 15.1 14.5 12.9 20.2 14.8 18.3 9.4 16.6 13.3 8.6 13.5 14.3 16.3 11.4 10.6 9.8 10.9 13.9 10.4 10.0 6.6 17.0 14.3 14.6 10.6 10.8 10.0 9.6 10.1 23.0 12.2 11.1 9.0 11.9 7.9 3.1 7.9 6.0 3.9 6.0 5.6 0.2 3.4 7.4 6.9 7.2 4.2 9.1 12.8 8.8 3.5 2.1 3.1 2.9 6.8 4.3 4.3 3.2 4.9 2.9 9.6 5.8 6.2 3.6 3.9 6.3 4.2 8.0 7.1 4.9 9.3 1.5 9.6 6.2 17.2 8.8 10.2 1.7 6.3 14.2 6.3 4.2 10.1 6.7 4.6 7.4 7.2 5.4 11.6 7.2 3.4 7.0 3.3 2.9 7.6 7.3 3.2 3.4 15.6 6.2 9.3 7.1 3.1 5.8 3.1 10.9 12.2 6.3 11.1 5.9 10.1 8.1 7.3 12.4 9.5 9.9 8.2 3.8 9.0 9.4 23.0 11.9 7.9 18.5 15.0 18.6 18.3 13.8 13.9 15.1 14.5 16.6 17.0 6.0 11.7 7.5 2.8 4.0 3.4 0.0 5.1 21.4 0.0 5.2 0.0 3.1 11.6 10.4 3.0 5.2 8.1 0.0 17.0 4.4 5.6 2.4 4.7 5.0 7.0 3.2 11.1 6.2 2.2 2.9 5.8 11.0 16.9 29.7 11.1 3.1 12.6 2.9 7.1 15.7 2.7 12.9 7.2 1.9 3.2 4.0 2.1 5.1 10.7 2.0 ME1 ENSG00000065833 "Malic enzyme 1" P48163 6 83210389-83431071 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Kupffer cells: 57.7;Muller glia cells: 93.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "MAIT T-cell: 15.6" "Lineage enriched" "Detected in many" 11 "T-cells: 15.6" "Cell line enhanced" "Detected in many" "CACO-2: 42.9;OE19: 48.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006493 Enhanced Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA 3800000 "Nucleoplasm, Plasma membrane" Cytosol "HPA006493: AB_1078272" "unprognostic (7.21e-2)" "unprognostic (3.99e-2)" "unprognostic (2.24e-1)" "unprognostic (3.12e-3)" "prognostic unfavorable (7.73e-4)" "unprognostic (7.98e-3)" "prognostic unfavorable (4.57e-5)" "unprognostic (3.24e-1)" "unprognostic (4.44e-3)" "unprognostic (1.41e-3)" "unprognostic (7.10e-3)" "unprognostic (2.43e-1)" "prognostic unfavorable (1.81e-7)" "unprognostic (4.07e-2)" "unprognostic (2.49e-1)" "unprognostic (1.85e-2)" "unprognostic (4.51e-2)" 30.7 35.3 16.3 4.6 17.7 0.8 27.1 5.5 13.1 5.9 6.7 5.4 39.2 18.1 3.8 7.4 24.5 4.2 13.5 21.3 10.5 14.0 3.6 12.4 7.7 6.0 16.8 11.8 10.0 3.3 30.0 11.1 2.9 16.3 7.9 10.1 9.3 7.8 30.2 25.7 10.1 8.7 18.7 17.2 6.3 20.0 13.4 7.2 1.4 6.3 20.9 4.5 13.7 14.9 0.0 0.0 0.0 1.4 0.0 15.6 0.5 8.8 18.3 0.4 0.0 15.6 14.6 0.0 5.7 14.7 6.1 11.9 42.9 7.8 0.0 15.0 13.4 12.2 9.3 13.6 5.1 6.7 0.0 7.6 0.0 11.7 0.0 20.0 4.3 16.1 15.9 10.3 12.3 8.4 10.3 9.5 0.0 6.1 0.0 8.3 9.9 0.0 4.9 0.0 48.5 7.2 0.0 15.4 8.5 18.1 4.2 1.8 4.7 9.7 14.4 0.3 8.3 0.0 10.6 10.0 3.8 4.6 1.2 0.0 3.4 3.9 0.0 0.0 0.0 11.2 0.0 1.4 0.0 0.8 0.3 15.6 0.0 0.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 16.3 17.7 5.5 13.1 10.5 14.0 16.8 11.8 16.3 7.2 17.9 8.9 0.0 4.2 1.6 16.7 35.8 5.1 1.4 6.8 5.2 2.0 0.5 1.7 10.0 4.4 1.9 8.0 0.0 8.4 0.6 7.1 5.6 0.0 12.4 6.8 12.7 0.0 4.9 57.7 4.2 23.9 9.5 0.0 5.4 4.0 93.9 12.7 5.8 35.0 2.6 6.4 0.0 3.3 4.9 1.5 3.0 0.7 0.9 5.5 1.8 MEA1 MEA ENSG00000124733 "Male-enhanced antigen 1" Q16626 6 43011143-43016868 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 109.4" "Group enriched" "Detected in many" 5 "Early spermatids: 615.5;Late spermatids: 1508.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017921, HPA073087" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA017921: AB_1853708, HPA073087: " "unprognostic (1.30e-2)" "unprognostic (1.07e-2)" "unprognostic (1.42e-1)" "unprognostic (2.15e-1)" "unprognostic (2.45e-1)" "unprognostic (2.08e-1)" "unprognostic (1.18e-2)" "unprognostic (1.10e-2)" "unprognostic (2.74e-2)" "prognostic favorable (3.37e-4)" "unprognostic (8.56e-2)" "unprognostic (2.12e-2)" "prognostic unfavorable (1.29e-6)" "unprognostic (2.07e-1)" "unprognostic (8.62e-2)" "unprognostic (1.89e-2)" "unprognostic (5.58e-2)" 16.8 17.4 26.6 13.9 23.4 11.8 17.4 13.1 29.9 16.2 14.3 17.2 14.0 12.7 20.1 25.2 16.8 20.5 17.2 12.5 20.9 25.4 16.5 18.7 15.2 14.2 21.9 20.8 22.7 26.7 13.2 17.7 17.3 17.5 20.9 17.0 19.6 16.6 20.3 14.6 15.2 13.1 19.5 15.7 12.8 13.0 109.4 8.7 19.1 15.8 13.4 21.2 21.5 14.1 61.2 40.9 70.6 51.0 46.6 51.7 59.9 38.7 22.4 33.6 26.6 30.8 20.6 13.4 26.0 27.7 32.5 35.7 33.3 10.2 20.3 27.3 31.7 47.5 19.7 25.9 35.3 30.6 23.2 35.1 37.7 24.5 35.9 15.9 27.4 19.8 16.4 17.6 43.1 28.2 33.1 19.5 33.3 25.4 22.8 35.5 74.3 36.7 31.8 15.8 110.3 19.8 18.0 20.0 20.2 22.4 36.8 32.5 22.8 20.0 17.2 29.5 28.3 26.2 30.0 14.4 35.9 28.9 23.2 44.8 26.0 21.5 33.9 18.0 20.6 29.1 64.5 39.2 70.6 46.7 44.5 42.9 61.2 42.9 45.6 40.9 56.8 43.2 45.8 35.9 46.6 51.0 40.0 51.7 59.9 26.6 23.4 13.1 29.9 20.9 25.4 21.9 20.8 17.5 8.7 23.8 11.8 43.2 62.1 58.8 20.2 24.9 43.3 58.9 39.8 52.4 3.9 94.6 142.6 74.9 615.5 56.2 55.4 0.0 80.2 87.3 55.2 61.8 46.1 39.4 95.1 15.9 28.7 41.7 31.9 1508.8 58.7 50.6 64.1 93.8 42.8 52.2 71.4 49.1 56.3 121.5 14.8 116.4 68.9 194.8 94.1 60.9 71.1 58.2 45.3 74.3 MECP2 "MRX16, MRX79, RTT" ENSG00000169057 "Methyl-CpG binding protein 2" P51608 X 154021573-154137103 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Autism, Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 194.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000593, HPA001341, CAB037264" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "CAB037264: AB_477252, HPA000593: AB_1079348, HPA001341: AB_1079347" "unprognostic (1.27e-3)" "unprognostic (2.60e-3)" "unprognostic (2.16e-3)" "prognostic unfavorable (8.35e-5)" "unprognostic (2.35e-1)" "unprognostic (3.66e-1)" "unprognostic (6.12e-2)" "unprognostic (1.18e-2)" "unprognostic (8.81e-2)" "unprognostic (1.53e-1)" "unprognostic (1.84e-3)" "unprognostic (4.22e-1)" "prognostic favorable (7.32e-9)" "unprognostic (7.63e-2)" "unprognostic (1.00e-1)" "unprognostic (9.08e-2)" "unprognostic (6.05e-2)" 18.6 21.4 29.2 17.0 27.1 33.8 17.6 39.1 33.5 20.2 19.2 17.6 15.9 13.9 20.0 15.1 18.8 21.1 19.5 23.1 22.5 14.0 17.1 16.4 22.8 19.7 22.5 26.7 29.0 21.2 24.3 22.9 13.9 25.4 23.0 8.0 20.8 18.7 23.7 31.6 14.1 15.3 16.2 21.1 23.3 15.0 9.7 24.4 13.8 19.1 8.7 14.3 18.7 28.6 5.6 4.2 22.4 4.9 2.9 6.8 1.8 19.4 11.6 9.8 12.2 8.4 6.0 8.3 9.8 11.0 12.0 19.6 8.9 9.5 23.4 23.2 8.6 19.0 9.3 14.7 11.5 6.1 17.7 17.7 9.0 10.6 5.6 10.3 11.3 18.9 6.1 6.5 11.2 13.2 9.5 9.3 11.5 9.7 20.0 7.2 11.6 13.6 13.0 7.6 14.7 13.0 11.8 10.7 7.7 8.5 8.9 13.8 8.0 7.6 8.9 18.7 5.5 5.8 14.7 9.7 9.1 18.1 18.5 19.7 24.0 17.8 26.6 13.2 22.3 15.6 22.4 3.5 13.3 6.8 3.2 4.8 5.6 4.8 5.5 2.4 4.9 4.6 4.4 16.9 2.9 4.9 4.2 5.0 1.8 29.2 27.1 39.1 33.5 22.5 14.0 22.5 26.7 25.4 24.4 6.0 33.8 38.3 36.3 27.4 82.7 40.4 30.6 17.4 33.0 43.6 194.4 13.1 56.3 31.6 0.5 36.8 24.4 0.0 27.0 13.6 26.3 29.6 50.8 30.8 23.4 93.8 35.1 60.8 37.0 2.1 49.5 41.8 28.7 60.5 17.4 46.1 29.3 28.1 69.3 21.9 81.7 32.3 40.0 7.7 36.0 25.3 15.4 82.9 16.4 29.4 MED1 "CRSP1, CRSP200, DRIP230, PBP, PPARBP, PPARGBP, RB18A, TRAP220, TRIP2" ENSG00000125686 "Mediator complex subunit 1" Q15648 17 39404285-39451286 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 87.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017696, HPA052818" Approved Supported Nucleoplasm NA NA 170000 Nucleoplasm "CAB017696: AB_1128703, HPA052818: AB_2681962" "unprognostic (1.77e-1)" "unprognostic (1.63e-1)" "unprognostic (9.26e-2)" "unprognostic (1.21e-1)" "unprognostic (2.18e-2)" "unprognostic (1.67e-1)" "unprognostic (1.21e-2)" "unprognostic (4.50e-1)" "unprognostic (7.86e-2)" "unprognostic (1.95e-3)" "unprognostic (4.09e-2)" "unprognostic (1.04e-1)" "unprognostic (1.78e-2)" "unprognostic (2.00e-1)" "unprognostic (5.94e-2)" "unprognostic (9.40e-2)" "unprognostic (5.79e-2)" 16.4 13.8 11.8 14.8 13.7 15.5 15.1 19.8 16.5 16.9 14.6 18.8 9.3 10.3 17.9 9.7 15.0 14.3 10.9 12.8 11.6 10.5 13.0 13.3 12.3 17.7 12.0 10.3 22.2 16.2 34.5 21.1 16.5 14.5 12.5 14.2 16.5 13.4 11.6 19.5 16.1 14.1 17.1 14.0 20.4 13.0 15.1 12.1 34.1 13.2 12.1 22.5 16.6 13.4 6.6 4.9 4.4 4.0 5.0 6.1 2.7 8.1 11.0 13.8 9.4 10.1 10.3 11.1 10.0 10.9 13.8 13.5 10.5 8.1 22.0 11.4 12.4 15.8 16.2 16.5 9.9 21.9 21.2 13.8 13.8 10.4 10.5 10.9 24.6 14.6 9.7 10.1 16.9 24.7 8.5 11.7 12.6 17.7 11.9 11.2 4.6 22.9 9.3 8.9 7.9 6.5 17.2 18.6 9.4 8.1 9.5 8.8 10.0 13.2 87.5 11.5 12.3 16.2 14.1 10.4 10.7 13.4 11.9 17.6 10.9 14.6 22.7 10.6 12.1 13.1 3.2 4.0 4.4 5.2 3.9 5.8 6.6 5.5 5.8 4.0 6.4 5.4 6.1 3.3 5.0 2.6 4.9 3.3 2.7 11.8 13.7 19.8 16.5 11.6 10.5 12.0 10.3 14.5 12.1 23.8 11.5 11.9 11.5 24.2 13.6 16.9 10.2 17.4 26.1 8.7 13.7 14.5 3.3 10.8 5.0 19.6 9.5 0.0 10.3 10.6 16.0 13.2 9.2 17.0 12.9 11.1 13.2 17.8 21.9 6.6 13.6 14.7 20.3 10.0 14.1 12.3 11.8 10.5 17.0 7.2 10.5 19.4 13.7 18.4 18.1 28.5 18.5 20.0 16.0 14.0 MED10 "L6, MGC5309, NUT2, TRG20" ENSG00000133398 "Mediator complex subunit 10" Q9BTT4 5 6371881-6378594 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042795, HPA054188" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA042795: AB_10796679, HPA054188: AB_2682410" "unprognostic (2.33e-3)" "unprognostic (3.31e-1)" "unprognostic (1.50e-2)" "unprognostic (1.06e-3)" "prognostic unfavorable (2.65e-5)" "unprognostic (3.38e-2)" "prognostic unfavorable (1.62e-6)" "unprognostic (3.26e-1)" "unprognostic (5.16e-2)" "unprognostic (4.92e-3)" "unprognostic (4.32e-2)" "unprognostic (2.16e-2)" "prognostic unfavorable (2.19e-5)" "unprognostic (3.85e-2)" "unprognostic (3.78e-2)" "unprognostic (3.11e-1)" "unprognostic (2.14e-1)" 19.8 15.8 28.8 16.9 23.2 37.2 16.2 20.6 31.4 13.9 22.7 19.3 17.1 15.8 15.1 20.3 22.2 16.7 16.6 24.6 29.9 31.2 14.7 17.2 16.2 25.1 27.7 21.1 17.7 31.4 10.6 13.8 16.5 23.9 15.9 10.4 13.7 17.1 19.6 21.5 21.3 18.7 24.0 26.6 17.4 16.9 21.1 17.5 15.1 16.4 12.3 21.6 19.6 22.9 34.4 24.4 37.4 17.2 24.9 40.0 35.2 17.5 19.5 7.8 14.4 12.4 13.7 22.2 22.2 20.0 23.6 17.3 29.5 14.1 22.7 18.0 18.5 34.2 13.1 13.4 16.4 21.2 37.6 15.6 15.0 30.5 14.7 38.3 18.0 13.3 15.6 21.6 22.4 32.1 14.5 18.7 13.1 22.0 13.5 18.0 22.0 26.2 27.2 13.3 12.2 51.3 15.1 13.8 9.5 16.0 18.5 14.9 22.2 42.3 17.5 33.6 10.1 12.2 16.2 20.6 23.6 26.1 21.6 23.4 22.0 21.7 32.6 21.2 28.5 17.5 37.4 15.8 33.1 28.7 16.4 35.2 34.4 36.2 30.9 13.3 31.5 40.0 33.6 11.4 24.9 17.2 24.4 31.8 35.2 28.8 23.2 20.6 31.4 29.9 31.2 27.7 21.1 23.9 17.5 20.8 20.0 57.8 71.8 81.7 63.0 37.5 28.1 26.8 20.5 43.6 27.5 70.4 49.7 97.6 4.0 72.4 44.3 23.3 79.7 67.2 66.6 65.2 50.7 21.5 57.0 69.9 42.4 66.9 26.4 8.0 65.0 44.9 59.1 114.6 40.5 50.4 108.8 43.2 42.5 39.7 47.1 32.3 76.8 57.9 89.6 61.6 66.4 95.9 40.4 66.0 MED11 "HSPC296, MGC88387" ENSG00000161920 "Mediator complex subunit 11" Q9P086 17 4731428-4733610 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056669 Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA056669: AB_2683204" "unprognostic (4.01e-2)" "unprognostic (2.34e-2)" "unprognostic (7.91e-2)" "prognostic favorable (1.86e-5)" "unprognostic (8.24e-2)" "unprognostic (5.47e-2)" "unprognostic (1.27e-1)" "unprognostic (1.36e-1)" "unprognostic (3.82e-2)" "unprognostic (3.86e-2)" "unprognostic (2.10e-3)" "unprognostic (1.09e-1)" "unprognostic (1.12e-3)" "unprognostic (4.84e-2)" "unprognostic (1.16e-1)" "unprognostic (1.68e-1)" "unprognostic (8.61e-2)" 12.8 30.8 15.5 16.5 26.4 7.0 16.2 14.5 19.3 16.6 20.9 16.4 22.3 20.7 14.7 22.8 20.5 19.7 21.5 22.0 16.9 13.2 29.5 35.4 16.4 19.6 25.0 19.7 13.8 30.6 24.3 14.4 19.0 22.8 17.5 18.4 13.7 27.7 16.4 24.7 20.8 26.8 18.8 21.9 25.4 20.3 11.7 23.3 13.9 22.8 25.9 19.9 16.4 14.7 23.8 18.6 51.3 23.3 14.2 21.5 13.0 12.2 35.9 13.3 13.7 14.4 17.7 10.4 8.8 15.1 13.2 16.3 12.4 9.7 17.1 9.5 10.9 8.7 18.9 13.4 25.1 9.7 20.3 30.7 8.3 20.1 18.9 9.0 6.0 10.2 15.3 17.7 14.0 8.8 14.3 14.8 17.8 8.5 13.1 11.4 17.9 11.7 7.6 7.9 19.0 11.5 11.6 9.7 11.1 26.7 12.8 5.4 9.0 11.5 15.6 8.6 11.4 13.9 7.2 8.7 7.1 7.1 13.5 14.1 6.2 5.4 6.5 12.2 10.5 9.2 14.7 11.8 28.0 16.8 16.6 17.9 22.8 16.5 16.8 11.6 23.8 19.6 21.5 51.3 14.2 23.3 18.6 12.4 13.0 15.5 26.4 14.5 19.3 16.9 13.2 25.0 19.7 22.8 23.3 6.0 16.8 45.4 26.9 10.9 21.7 11.5 35.7 36.1 21.6 14.0 9.8 37.6 54.7 29.5 1.1 10.8 45.9 0.0 31.1 29.4 14.7 21.4 27.8 23.1 29.5 28.6 10.4 20.9 18.3 2.1 16.1 26.6 10.1 54.1 26.4 17.5 22.4 48.9 13.1 52.6 25.3 19.4 18.6 31.6 30.4 16.4 20.9 25.9 26.5 27.1 MED12 "CAGH45, FGS1, HOPA, KIAA0192, OKS, OPA1, TNRC11, TRAP230" ENSG00000184634 "Mediator complex subunit 12" Q93074 X 71118556-71142454 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003184, HPA003185" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA003184: AB_1079349, HPA003185: AB_1079350" "unprognostic (1.39e-1)" "unprognostic (2.23e-1)" "unprognostic (5.42e-2)" "unprognostic (2.07e-1)" "unprognostic (6.89e-3)" "unprognostic (7.14e-2)" "unprognostic (1.68e-2)" "unprognostic (1.15e-2)" "unprognostic (2.10e-1)" "unprognostic (1.53e-1)" "unprognostic (2.45e-1)" "unprognostic (2.50e-1)" "unprognostic (1.22e-3)" "unprognostic (1.28e-1)" "unprognostic (1.02e-1)" "unprognostic (3.67e-1)" "unprognostic (5.16e-2)" 18.2 31.3 12.3 15.3 14.7 16.6 18.1 18.0 15.1 16.8 12.8 19.8 21.3 10.2 21.7 16.5 13.1 17.7 14.2 12.9 12.9 8.5 13.3 9.8 14.0 15.3 15.7 10.7 28.8 14.2 20.1 17.9 23.0 11.6 16.5 11.8 18.6 14.6 20.3 14.9 17.6 14.8 16.4 11.2 27.3 14.2 15.3 12.9 33.1 17.8 12.6 15.9 15.4 16.4 4.0 5.1 9.7 3.7 5.0 7.4 3.6 8.7 10.3 16.3 9.7 12.0 10.7 24.1 6.2 8.9 9.9 7.1 12.4 8.3 11.5 8.2 10.7 6.8 8.7 19.0 7.8 7.9 12.1 14.7 19.1 23.2 16.7 9.4 17.5 16.9 12.4 8.5 12.9 15.0 12.7 15.2 14.7 17.7 20.2 9.7 14.7 18.4 10.0 9.3 11.2 13.5 17.3 18.2 8.7 7.5 17.4 9.1 11.0 14.3 7.3 8.1 17.5 8.8 8.7 13.2 10.8 12.8 9.9 4.3 10.0 5.5 8.4 6.3 9.8 7.2 9.7 3.7 7.2 5.9 3.6 5.0 4.0 4.1 5.4 3.9 4.0 4.6 3.9 7.7 5.0 2.4 5.1 7.4 3.6 12.3 14.7 18.0 15.1 12.9 8.5 15.7 10.7 11.6 12.9 8.9 3.4 5.2 5.2 5.4 7.1 8.1 15.3 2.7 6.8 8.7 5.9 17.0 1.7 5.4 0.2 8.7 6.8 0.0 5.4 6.2 7.8 5.7 9.2 3.4 8.0 12.7 7.5 14.1 6.7 0.9 13.0 9.2 5.0 6.4 7.8 5.8 8.6 8.4 12.7 2.2 4.5 0.0 5.0 6.4 7.4 5.0 22.8 6.4 6.4 6.8 MED13 "KIAA0593, THRAP1, TRAP240" ENSG00000108510 "Mediator complex subunit 13" Q9UHV7 17 61942605-62065282 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067939 Supported Nucleoplasm NA NA Nucleoplasm "HPA067939: AB_2685928" "unprognostic (7.26e-2)" "unprognostic (4.50e-2)" "prognostic favorable (1.43e-4)" "unprognostic (8.79e-2)" "unprognostic (1.69e-2)" "unprognostic (3.56e-1)" "unprognostic (1.33e-1)" "unprognostic (5.69e-2)" "unprognostic (1.18e-1)" "unprognostic (1.97e-1)" "unprognostic (1.88e-1)" "unprognostic (3.92e-2)" "unprognostic (2.63e-2)" "unprognostic (2.53e-1)" "unprognostic (1.21e-1)" "unprognostic (4.51e-3)" "unprognostic (2.30e-1)" 10.4 7.6 6.3 6.6 9.1 19.3 8.8 8.8 7.5 8.7 9.0 13.8 6.8 7.1 13.6 9.0 9.7 6.8 8.2 8.4 12.6 5.3 9.0 14.3 12.7 7.3 8.2 3.5 9.9 8.6 15.3 5.9 9.6 15.6 7.1 8.3 6.4 21.6 5.9 31.8 10.0 8.1 12.0 13.8 6.7 7.4 11.9 8.3 15.1 10.4 12.4 8.9 10.7 8.4 3.2 5.6 7.9 5.0 2.7 3.5 0.7 13.1 15.8 12.2 9.9 11.2 12.3 9.3 7.3 10.6 14.8 14.4 11.9 7.2 14.1 6.9 11.4 11.2 8.2 15.5 9.5 20.8 9.1 9.1 23.0 11.5 7.6 11.8 20.1 10.8 9.5 11.1 16.1 18.4 10.7 11.1 11.1 18.8 24.3 10.1 22.3 18.1 6.1 6.5 15.5 8.1 15.0 31.3 8.6 10.4 15.6 9.6 18.2 15.2 4.4 9.5 12.7 15.9 14.3 13.9 17.0 25.1 8.8 13.7 11.8 13.4 19.4 9.0 9.0 9.6 1.6 2.1 2.5 2.8 1.0 3.5 2.0 2.7 2.9 2.1 3.2 1.9 3.5 7.9 2.7 5.0 5.6 3.0 0.7 6.3 9.1 8.8 7.5 12.6 5.3 8.2 3.5 15.6 8.3 59.6 43.0 14.7 44.8 69.3 52.4 21.4 68.8 17.4 40.9 22.7 43.2 15.6 8.3 15.0 36.5 37.9 41.2 46.7 17.2 9.5 48.8 53.4 25.4 34.1 16.6 58.8 42.5 35.0 34.5 46.0 28.4 34.0 30.4 18.0 37.0 37.9 22.3 34.5 30.8 15.6 39.0 32.3 40.6 39.0 13.6 71.4 36.3 22.4 25.2 74.9 MED13L "KIAA1025, THRAP2, TRAP240L" ENSG00000123066 "Mediator complex subunit 13 like" Q71F56 12 115953872-116277338 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 13.1" "Lineage enriched" "Detected in all" 5 "granulocytes: 13.1" "Cell line enhanced" "Detected in all" "T-47d: 50.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039445 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA039445: AB_10673532" "unprognostic (1.81e-2)" "unprognostic (1.87e-2)" "unprognostic (3.32e-1)" "unprognostic (4.60e-2)" "unprognostic (5.69e-2)" "unprognostic (1.74e-2)" "unprognostic (2.55e-2)" "unprognostic (1.96e-1)" "unprognostic (1.78e-1)" "unprognostic (8.62e-3)" "unprognostic (1.54e-1)" "unprognostic (5.08e-2)" "unprognostic (1.83e-2)" "unprognostic (6.82e-2)" "unprognostic (1.54e-1)" "unprognostic (4.56e-2)" "unprognostic (4.64e-1)" 21.3 7.9 9.8 14.7 10.6 39.1 22.0 29.7 11.1 17.3 13.6 12.1 12.3 7.8 21.6 11.1 13.2 13.9 12.2 9.4 11.0 7.0 9.0 7.3 15.2 16.7 11.5 9.1 20.5 15.6 14.3 13.6 13.4 9.6 14.6 10.9 11.7 14.2 14.2 18.1 21.9 13.1 15.3 11.9 14.3 12.8 14.9 11.2 55.9 14.0 10.8 15.4 13.8 22.7 2.5 1.9 13.1 1.1 1.4 1.1 0.7 6.4 15.4 7.2 8.1 9.7 16.0 7.7 6.8 9.0 9.4 6.7 15.3 2.3 4.4 5.7 12.2 5.9 4.7 8.2 5.4 12.4 10.0 5.3 9.1 4.6 5.7 10.7 8.1 12.2 12.8 9.3 10.3 15.8 7.3 6.8 11.9 9.9 4.4 8.1 14.5 15.9 17.1 4.0 2.3 3.6 11.3 7.8 10.7 6.1 5.9 7.4 6.4 6.1 3.2 6.0 16.8 50.7 17.9 8.4 10.7 7.1 7.8 8.1 8.4 3.8 8.1 5.0 8.9 5.6 13.1 1.1 3.6 1.0 0.9 1.1 2.5 1.0 1.1 1.5 1.3 0.8 0.9 4.1 1.4 1.1 1.9 0.7 0.7 9.8 10.6 29.7 11.1 11.0 7.0 11.5 9.1 9.6 11.2 59.6 40.0 33.7 33.5 88.0 49.8 29.5 20.4 28.1 45.5 24.4 51.1 8.0 3.3 11.3 48.2 59.1 24.3 0.0 22.2 18.4 39.9 36.4 13.9 25.2 18.1 54.0 30.1 55.9 55.0 39.2 85.4 26.9 30.4 13.6 34.1 23.6 22.2 14.4 62.9 11.7 43.8 45.3 53.1 19.1 18.8 88.8 11.9 22.7 25.1 43.3 MED14 "CRSP150, CRSP2, CSRP, CXorf4, EXLM1, RGR1, TRAP170" ENSG00000180182 "Mediator complex subunit 14" O60244 X 40648306-40735858 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064182 Approved Nucleoplasm NA NA Nucleoplasm "HPA064182: AB_2685204" "unprognostic (5.21e-2)" "unprognostic (2.82e-1)" "unprognostic (8.88e-2)" "unprognostic (1.14e-1)" "unprognostic (3.07e-1)" "unprognostic (2.34e-1)" "unprognostic (2.08e-3)" "unprognostic (2.16e-1)" "unprognostic (7.95e-3)" "unprognostic (4.38e-2)" "unprognostic (5.05e-2)" "unprognostic (7.78e-2)" "unprognostic (1.16e-1)" "unprognostic (4.89e-2)" "unprognostic (8.54e-2)" "unprognostic (2.32e-1)" "unprognostic (1.64e-1)" 11.0 11.4 12.0 18.5 14.7 19.6 10.5 19.2 16.8 12.9 17.7 20.5 11.4 18.1 14.4 21.9 15.0 10.0 11.1 14.6 13.8 12.5 13.0 15.5 12.4 16.2 12.4 11.5 14.9 12.9 21.5 15.9 13.5 15.1 12.0 15.6 14.7 10.6 12.2 53.8 16.7 19.8 16.2 12.8 13.5 12.8 5.7 11.7 31.7 16.2 18.4 20.9 17.5 12.8 4.0 5.7 6.0 7.3 7.7 5.2 2.4 22.2 11.0 17.8 15.7 7.9 10.3 3.6 8.8 11.1 12.8 16.3 10.1 11.1 12.9 6.0 11.1 27.4 17.0 30.1 14.0 19.2 11.7 22.7 13.0 13.5 9.1 8.5 13.6 13.5 7.4 8.6 18.6 16.3 15.1 15.3 8.6 8.8 12.6 13.3 11.5 12.5 12.2 19.6 14.2 12.9 6.3 19.0 12.9 12.2 10.3 11.5 10.1 20.9 9.6 9.7 34.7 14.0 8.2 13.9 13.1 13.7 16.4 10.8 11.8 12.0 12.8 12.7 9.4 9.4 4.3 3.6 6.0 4.5 7.3 5.2 3.9 4.3 4.4 5.7 4.0 4.9 3.8 1.9 7.7 3.9 3.1 3.9 2.4 12.0 14.7 19.2 16.8 13.8 12.5 12.4 11.5 15.1 11.7 14.9 11.8 11.3 8.1 21.1 15.3 12.9 12.7 2.7 11.4 12.2 17.7 5.5 5.0 7.0 0.4 8.3 15.8 0.0 8.7 4.4 10.9 12.9 10.4 18.7 8.0 17.5 19.7 8.0 16.7 0.8 8.1 14.9 11.8 11.8 20.8 6.5 10.3 14.4 8.1 8.6 15.6 25.8 11.4 11.4 3.2 26.5 5.5 8.7 15.3 25.3 MED15 "Arc105, CAG7A, PCQAP, TIG-1, TNRC7" ENSG00000099917 "Mediator complex subunit 15" Q96RN5 22 20495913-20587632 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 71.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003179 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA003179: AB_1079581" "unprognostic (7.98e-2)" "unprognostic (2.26e-1)" "unprognostic (1.70e-1)" "prognostic favorable (7.30e-5)" "unprognostic (2.53e-1)" "unprognostic (1.76e-3)" "prognostic unfavorable (3.71e-4)" "unprognostic (3.73e-2)" "unprognostic (1.12e-3)" "unprognostic (3.46e-1)" "prognostic unfavorable (9.09e-4)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.61e-4)" "unprognostic (1.32e-2)" "unprognostic (2.50e-1)" "unprognostic (3.60e-2)" "unprognostic (5.57e-2)" 26.2 28.3 26.4 29.5 32.0 41.6 23.4 28.5 31.4 23.9 25.3 27.4 17.6 34.8 35.6 15.0 25.8 23.4 25.9 21.9 23.4 15.4 20.6 12.2 28.6 31.4 22.8 22.4 23.6 24.9 17.9 24.1 32.2 22.0 22.0 13.8 29.5 22.7 23.2 40.7 27.9 30.1 20.8 19.3 32.9 24.5 19.9 23.9 19.2 20.3 16.4 29.2 29.7 24.3 4.9 6.8 9.1 13.9 13.6 19.8 8.8 22.1 11.9 7.6 9.2 8.0 7.9 14.0 22.6 16.6 17.9 16.6 18.1 10.1 9.0 10.4 15.9 8.1 22.9 6.9 16.8 7.2 12.8 12.3 17.1 12.8 13.1 13.4 15.5 15.8 9.6 13.2 14.1 14.4 10.2 13.8 6.9 71.5 8.5 11.3 14.9 6.5 8.8 8.2 9.8 8.1 11.4 17.3 3.6 10.8 16.2 7.2 12.4 17.0 17.3 24.0 5.2 9.7 8.7 24.8 28.9 21.8 15.4 18.1 11.2 9.9 6.9 20.9 9.6 25.7 4.1 7.6 6.5 17.8 8.4 8.4 4.2 12.2 19.8 6.8 4.9 7.2 12.0 9.1 13.6 13.9 6.1 19.0 8.8 26.4 32.0 28.5 31.4 23.4 15.4 22.8 22.4 22.0 23.9 47.6 28.6 11.2 22.3 26.6 19.3 3.9 7.6 26.8 25.0 24.4 17.7 42.4 13.3 28.7 32.9 22.4 35.0 0.0 24.9 35.8 18.8 29.4 19.7 7.4 27.6 14.3 17.2 23.9 25.0 18.1 13.3 27.1 23.6 31.5 22.7 12.8 47.2 23.2 13.8 10.1 14.7 45.3 24.7 20.4 15.4 24.1 51.7 31.2 19.6 31.9 MED18 "FLJ20045, p28b, SRB5" ENSG00000130772 "Mediator complex subunit 18" Q9BUE0 1 28329002-28335967 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027429 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA027429: AB_10610137" "unprognostic (2.72e-2)" "unprognostic (2.00e-1)" "unprognostic (2.78e-3)" "prognostic favorable (3.93e-4)" "unprognostic (2.40e-1)" "unprognostic (1.38e-1)" "prognostic unfavorable (1.52e-4)" "unprognostic (4.30e-2)" "unprognostic (1.53e-1)" "unprognostic (3.54e-1)" "unprognostic (7.49e-2)" "unprognostic (2.13e-1)" "prognostic favorable (8.38e-5)" "prognostic favorable (6.72e-4)" "unprognostic (9.20e-2)" "unprognostic (3.08e-2)" "unprognostic (7.69e-2)" 9.8 11.2 6.2 9.2 6.7 5.9 7.9 5.5 12.1 7.7 11.4 7.1 8.9 9.7 8.1 9.1 13.3 9.9 9.5 8.4 6.6 6.7 11.6 19.2 6.7 11.8 8.5 6.6 7.0 12.3 5.7 7.1 12.4 8.6 8.6 10.3 7.8 10.2 7.3 10.9 9.1 13.0 6.9 6.0 14.3 9.9 8.5 6.9 17.0 11.0 6.1 18.5 8.4 6.6 8.3 8.3 11.6 8.3 5.4 7.5 7.1 13.2 6.6 6.6 5.6 8.9 8.6 7.4 7.9 9.5 10.4 9.0 3.7 12.5 16.5 8.2 8.1 6.3 8.3 10.5 9.8 8.1 11.2 7.4 12.7 6.0 8.2 12.3 7.6 13.6 9.2 12.1 8.1 12.5 6.2 8.9 8.3 12.0 4.4 9.6 6.4 9.6 9.7 7.8 7.4 3.8 7.0 9.5 8.7 9.1 6.7 6.7 6.7 8.0 8.1 11.0 7.3 6.9 7.3 10.7 6.3 7.2 10.4 8.2 7.6 10.1 9.2 9.3 16.2 4.5 6.2 7.5 10.4 7.5 7.4 5.5 8.3 5.9 6.2 6.2 6.7 7.4 7.3 11.6 5.4 8.3 8.3 7.5 7.1 6.2 6.7 5.5 12.1 6.6 6.7 8.5 6.6 8.6 6.9 8.9 4.5 6.0 3.4 0.7 3.2 4.1 2.5 4.0 5.7 1.8 11.8 9.8 6.6 6.2 0.4 2.3 6.3 23.3 5.2 11.1 2.1 2.5 1.1 3.4 6.8 9.5 3.4 4.3 3.2 0.7 4.4 3.3 1.7 6.4 4.8 4.6 5.0 6.8 4.9 6.4 4.6 19.4 3.1 7.2 6.3 1.1 12.4 5.1 4.1 5.3 MED20 "DKFZp586D2223, PRO0213, SRB2, TRFP" ENSG00000124641 "Mediator complex subunit 20" Q9H944 6 41905354-41921139 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040717 Uncertain Approved Nucleoplasm,Centrosome NA NA Centrosome Nucleoplasm "HPA040717: AB_10794146" "unprognostic (1.45e-1)" "unprognostic (1.99e-1)" "unprognostic (2.58e-3)" "unprognostic (8.32e-2)" "unprognostic (9.86e-3)" "unprognostic (1.72e-1)" "unprognostic (1.16e-3)" "unprognostic (1.22e-1)" "prognostic unfavorable (1.48e-5)" "unprognostic (1.58e-3)" "unprognostic (4.23e-2)" "unprognostic (5.10e-2)" "prognostic favorable (1.17e-4)" "unprognostic (1.71e-2)" "unprognostic (4.63e-1)" "unprognostic (4.13e-3)" "unprognostic (2.31e-1)" 11.8 22.1 12.4 12.1 14.2 7.0 14.2 17.0 15.4 15.3 14.0 16.4 17.4 13.1 16.1 17.8 17.0 13.2 9.9 15.3 12.7 9.5 17.5 14.7 10.4 11.4 14.8 9.3 12.8 17.6 14.5 23.5 17.4 13.8 16.3 15.4 13.2 15.3 14.0 23.0 12.1 15.4 15.3 9.6 13.3 12.9 14.6 11.5 20.9 15.5 13.1 16.4 16.0 12.9 15.0 20.0 13.6 22.1 11.6 10.8 11.5 13.5 11.5 12.4 14.8 11.7 13.0 15.3 8.6 8.3 12.3 9.9 14.6 9.3 18.4 17.1 10.1 7.0 10.3 21.1 11.6 15.6 10.6 6.7 16.5 8.9 12.8 11.2 14.0 10.4 10.1 18.2 11.7 17.6 9.8 15.2 17.8 22.3 8.9 14.7 12.1 15.6 10.0 16.1 43.1 9.3 21.7 14.9 6.6 17.6 8.7 11.5 9.1 12.3 5.8 11.6 15.4 11.7 14.7 14.8 8.7 19.0 5.3 10.6 9.2 12.3 38.9 4.8 15.6 12.3 13.0 19.6 13.6 8.7 22.1 10.8 14.2 5.8 9.8 20.0 15.0 7.9 9.3 7.3 11.6 14.8 17.8 10.2 11.5 12.4 14.2 17.0 15.4 12.7 9.5 14.8 9.3 13.8 11.5 8.9 3.8 7.7 3.5 3.3 2.1 4.0 0.0 4.0 5.7 7.0 0.0 19.8 6.6 5.5 0.4 2.8 5.1 0.0 2.9 15.6 5.3 4.1 6.9 7.3 7.2 1.6 9.2 8.6 6.0 0.0 3.1 3.0 1.7 1.8 6.4 4.0 4.1 3.5 6.3 8.0 3.7 0.0 3.4 4.1 13.4 5.0 20.8 2.5 6.6 4.7 MED21 "SRB7, SURB7" ENSG00000152944 "Mediator complex subunit 21" Q13503 12 27022546-27066343 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 190.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017177 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA017177: AB_1857665" "unprognostic (3.02e-1)" "unprognostic (7.33e-2)" "unprognostic (2.66e-1)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" "unprognostic (2.10e-1)" "unprognostic (7.18e-3)" "unprognostic (1.01e-1)" "unprognostic (4.78e-3)" "unprognostic (7.32e-2)" "unprognostic (1.03e-2)" "unprognostic (1.54e-1)" "prognostic favorable (3.74e-8)" "unprognostic (3.18e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-2)" "unprognostic (1.42e-2)" 20.7 31.5 20.7 13.3 32.4 31.9 23.9 25.9 31.9 24.8 21.9 18.0 18.8 14.9 25.9 21.7 30.4 20.8 19.6 31.3 19.5 21.9 34.1 18.8 20.8 15.7 21.1 26.2 30.8 17.1 30.3 26.0 19.8 23.6 27.6 20.6 18.3 25.3 24.5 30.7 19.3 17.4 27.3 20.2 16.0 19.6 28.9 22.1 22.1 28.2 28.7 19.9 31.6 27.2 20.1 15.8 35.5 18.6 12.8 28.0 19.1 16.6 17.6 9.3 14.8 20.8 21.0 15.4 19.0 14.3 16.1 21.0 18.4 19.0 11.0 12.1 14.5 23.4 13.8 19.8 17.6 27.8 9.6 17.7 15.8 18.2 11.3 11.6 19.3 11.4 14.8 25.8 19.9 23.9 26.1 23.3 14.9 12.8 14.7 18.1 12.5 16.9 35.6 28.5 21.2 23.3 14.6 59.7 12.4 16.7 19.1 7.1 10.4 23.2 10.0 15.0 37.3 17.7 12.9 16.8 18.0 14.0 22.3 19.2 4.5 9.3 18.1 17.1 21.6 12.1 35.5 17.5 23.9 20.4 18.6 20.8 20.1 24.6 23.9 15.8 16.6 28.0 25.3 14.0 12.8 16.5 12.9 23.8 19.1 20.7 32.4 25.9 31.9 19.5 21.9 21.1 26.2 23.6 22.1 14.9 16.5 22.6 105.7 87.8 9.2 30.8 7.6 12.0 29.6 50.6 0.0 52.6 79.6 36.3 190.1 33.7 16.5 23.3 33.3 49.3 57.0 71.3 18.4 20.0 27.5 12.7 17.1 22.1 17.5 59.3 44.8 27.0 67.4 36.9 17.6 15.1 29.2 17.3 44.6 72.5 13.1 19.4 58.7 92.2 54.3 88.5 51.0 27.7 17.2 125.9 MED22 "Med24, SRB6, SURF5" ENSG00000148297 "Mediator complex subunit 22" Q15528 9 133338323-133348131 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020391, HPA063694" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA020391: AB_1857668, HPA063694: AB_2685093" "unprognostic (2.62e-2)" "unprognostic (1.15e-1)" "unprognostic (2.68e-1)" "unprognostic (7.53e-2)" "unprognostic (5.56e-1)" "unprognostic (2.98e-2)" "prognostic unfavorable (5.16e-6)" "unprognostic (4.99e-3)" "unprognostic (3.23e-2)" "unprognostic (1.66e-1)" "prognostic favorable (6.46e-4)" "unprognostic (3.99e-1)" "prognostic favorable (3.76e-11)" "unprognostic (9.25e-3)" "unprognostic (2.66e-1)" "unprognostic (1.66e-2)" "unprognostic (1.62e-1)" 12.6 14.4 15.2 15.9 16.5 11.9 11.3 19.6 26.0 19.0 16.6 15.5 12.6 14.3 18.4 12.6 13.4 16.2 14.3 15.4 13.7 14.3 14.0 10.6 13.8 15.6 14.5 16.2 19.7 15.0 19.3 13.0 16.2 15.7 18.1 8.7 14.6 14.7 21.7 14.5 14.9 14.4 20.4 15.4 16.9 12.2 8.3 12.7 11.4 20.4 7.5 13.4 14.5 12.3 4.6 4.8 6.3 4.9 1.6 2.9 2.4 7.0 8.3 13.0 9.3 2.9 4.9 15.2 8.6 6.0 10.7 7.2 18.1 6.6 14.2 5.1 6.1 9.4 14.0 9.7 8.3 4.4 11.1 5.6 7.5 18.1 5.0 4.9 9.6 7.8 3.8 6.6 9.6 6.4 5.0 5.2 8.3 10.9 6.9 5.1 9.7 13.6 8.1 18.2 8.8 10.0 18.7 10.5 13.0 4.4 5.2 10.6 8.6 10.0 12.7 7.5 5.6 14.4 3.4 6.8 14.0 9.8 9.5 11.2 4.7 6.3 13.7 8.0 7.5 11.5 2.2 3.9 6.3 2.0 3.7 2.6 3.4 2.4 2.6 3.0 4.6 2.9 2.2 6.0 1.6 4.9 4.8 2.0 2.4 15.2 16.5 19.6 26.0 13.7 14.3 14.5 16.2 15.7 12.7 20.8 13.2 5.1 9.2 7.3 12.8 7.5 10.2 0.0 2.3 15.7 0.0 5.2 3.3 5.2 1.7 7.2 7.4 0.0 4.5 4.4 10.1 7.1 7.0 5.0 6.7 12.7 6.4 5.5 6.9 1.6 10.9 7.5 1.7 1.0 6.7 8.4 6.1 0.0 15.6 4.9 10.9 25.8 21.5 7.1 10.4 5.6 4.6 5.0 5.6 3.6 MED23 "CRSP130, CRSP3, DRIP130, Sur2" ENSG00000112282 "Mediator complex subunit 23" Q9ULK4 6 131573966-131628229 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070341 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA070341: AB_2686257" "unprognostic (1.11e-2)" "unprognostic (4.66e-2)" "unprognostic (5.51e-3)" "unprognostic (1.80e-1)" "unprognostic (3.06e-2)" "unprognostic (1.14e-2)" "unprognostic (6.62e-3)" "unprognostic (4.47e-1)" "unprognostic (1.64e-1)" "unprognostic (6.81e-3)" "unprognostic (1.44e-2)" "unprognostic (3.59e-1)" "unprognostic (1.64e-1)" "unprognostic (1.82e-2)" "unprognostic (2.21e-1)" "unprognostic (2.44e-2)" "unprognostic (2.53e-2)" 14.0 17.1 12.1 19.7 12.7 21.8 16.3 23.0 17.6 14.7 12.3 12.1 17.8 12.7 21.6 13.3 14.9 14.6 10.2 10.2 11.7 8.3 12.2 9.6 13.1 15.4 15.9 12.3 20.5 18.7 23.9 16.1 12.3 11.3 13.9 14.4 12.3 19.8 16.8 14.8 15.0 15.4 14.3 11.0 13.7 14.9 13.1 13.3 22.7 18.0 7.4 16.7 16.2 20.7 6.0 6.8 8.8 5.7 15.0 10.9 4.6 5.2 5.9 14.0 17.6 17.4 13.3 12.9 13.3 15.0 12.3 17.9 6.1 7.4 11.7 9.7 13.6 11.8 9.5 7.5 8.6 19.2 13.3 10.5 12.3 10.7 10.3 12.6 20.2 20.9 11.7 10.3 13.6 13.9 14.4 15.2 12.8 15.7 12.3 12.9 8.1 15.3 12.8 6.6 9.1 5.9 13.9 8.7 7.0 9.5 7.8 10.5 9.5 9.4 13.3 8.6 16.9 3.6 14.3 15.3 9.2 10.4 14.6 12.0 13.1 8.8 16.9 11.3 9.3 12.2 4.5 5.3 8.8 7.3 5.7 10.9 6.0 7.2 8.0 6.8 5.2 7.4 6.7 4.5 15.0 3.9 3.6 7.8 4.6 12.1 12.7 23.0 17.6 11.7 8.3 15.9 12.3 11.3 13.3 17.9 8.1 15.2 5.3 8.1 21.1 5.7 5.1 5.3 12.5 22.7 15.7 7.2 3.3 6.7 1.4 9.8 12.5 0.0 6.6 5.7 9.0 11.5 13.9 10.6 7.1 11.1 13.8 12.3 15.4 0.9 13.3 9.1 5.0 6.4 17.6 8.9 7.4 17.3 9.6 7.3 20.5 12.9 6.9 13.0 4.8 7.5 6.5 15.4 13.2 6.3 MED25 "ACID1, ARC92, DKFZp434K0512, TCBAP0758" ENSG00000104973 "Mediator complex subunit 25" Q71SY5 19 49818279-49840383 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Charcot-Marie-Tooth disease, Disease mutation, Mental retardation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Late spermatids: 84.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 19.8" "Lineage enriched" "Detected in all" 5 "granulocytes: 19.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068802 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA068802: AB_2686039" "unprognostic (1.72e-1)" "unprognostic (5.22e-3)" "unprognostic (6.67e-2)" "unprognostic (8.16e-2)" "unprognostic (2.20e-1)" "prognostic favorable (9.85e-4)" "unprognostic (1.02e-3)" "unprognostic (2.10e-1)" "unprognostic (3.59e-2)" "unprognostic (2.57e-1)" "unprognostic (1.72e-2)" "unprognostic (1.38e-2)" "unprognostic (1.04e-2)" "unprognostic (9.85e-2)" "unprognostic (1.65e-1)" "unprognostic (1.39e-1)" "unprognostic (3.04e-3)" 13.2 45.2 16.3 17.0 16.5 30.4 13.1 22.7 25.1 15.1 18.1 19.3 14.2 14.8 21.0 18.2 20.6 28.6 20.5 24.9 16.1 15.6 16.8 13.9 18.2 16.3 16.3 16.0 29.3 21.6 15.9 25.3 22.1 16.5 13.4 14.2 20.9 15.1 22.7 49.3 20.0 14.9 15.6 14.0 18.2 21.2 58.8 16.4 24.9 23.9 21.1 17.9 17.7 14.3 4.2 3.1 19.8 2.6 1.0 2.2 1.7 23.7 32.2 19.3 21.1 13.4 13.3 17.4 15.5 17.4 24.1 24.4 27.3 29.5 26.9 9.6 19.7 15.2 21.1 22.8 17.7 19.0 16.4 33.0 18.1 28.5 21.2 14.8 20.8 27.1 14.6 17.2 19.5 14.3 22.1 20.2 16.8 33.1 21.0 16.2 13.0 17.7 39.5 14.8 23.5 24.2 22.8 19.5 27.3 24.5 35.8 34.0 31.2 21.8 25.9 9.9 17.7 15.9 17.1 22.8 24.9 18.2 11.9 16.7 22.3 32.1 28.4 20.4 18.5 13.7 1.1 2.6 3.9 2.2 2.4 1.9 3.0 1.7 2.1 2.3 4.2 1.6 1.2 19.8 1.0 1.7 3.1 1.8 1.7 16.3 16.5 22.7 25.1 16.1 15.6 16.3 16.0 16.5 16.4 32.8 18.5 7.0 12.0 4.9 10.9 4.9 7.6 78.9 15.9 19.2 41.2 22.6 1.7 20.2 42.0 7.1 27.9 46.7 21.3 19.4 8.2 7.8 7.0 5.4 18.8 7.9 42.5 5.5 13.8 84.9 14.7 13.7 3.3 26.2 16.6 10.1 24.3 16.7 10.6 14.6 25.2 12.9 7.2 40.9 34.9 4.5 28.3 13.1 15.6 13.9 MED26 "CRSP7, CRSP70" ENSG00000105085 "Mediator complex subunit 26" O95402 19 16574907-16629062 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 34.7" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 45.5;Late spermatids: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA057997, HPA071835" Enhanced Approved Nucleoplasm,Vesicles,Cytosol Yes No Nucleoplasm "Vesicles, Cytosol" "HPA057997: AB_2732618, HPA071835: AB_2686455" "unprognostic (2.02e-2)" "prognostic favorable (2.46e-4)" "unprognostic (2.47e-2)" "unprognostic (2.57e-3)" "unprognostic (1.42e-1)" "unprognostic (3.60e-3)" "unprognostic (5.03e-2)" "unprognostic (3.77e-2)" "unprognostic (1.34e-2)" "unprognostic (1.17e-2)" "unprognostic (2.99e-3)" "unprognostic (2.60e-2)" "prognostic unfavorable (5.50e-5)" "unprognostic (9.43e-3)" "unprognostic (1.64e-1)" "unprognostic (5.14e-2)" "unprognostic (5.98e-3)" 5.5 4.6 5.9 8.3 6.2 14.0 7.3 8.7 6.2 6.0 5.1 4.2 5.2 4.0 5.7 6.0 6.2 4.3 4.4 4.0 5.1 4.5 3.7 5.9 9.0 7.6 4.8 4.5 6.2 6.8 6.8 5.4 7.9 4.9 5.4 3.3 3.8 7.2 7.9 9.9 7.1 4.8 4.2 4.5 6.8 5.1 34.7 4.6 8.5 5.0 6.0 6.9 4.8 5.7 2.6 4.4 2.3 1.0 1.2 2.3 0.4 9.1 3.6 3.3 7.1 4.3 3.4 9.7 5.4 3.8 5.8 5.3 5.3 5.5 14.7 5.7 3.4 1.9 6.9 5.1 5.4 4.0 10.8 10.5 5.8 3.3 4.2 4.2 6.5 5.5 4.1 5.3 4.9 5.2 3.5 3.1 7.8 9.4 17.8 3.6 9.1 6.9 6.2 7.8 4.4 11.5 7.2 5.0 16.0 3.4 3.6 8.8 4.6 4.7 4.6 5.3 2.4 3.4 8.6 3.7 7.4 5.9 9.0 7.1 12.4 10.0 11.8 5.2 8.7 4.3 2.3 0.4 0.4 1.6 1.0 0.3 1.4 0.2 0.7 0.8 2.6 1.0 0.2 1.2 1.2 0.4 4.4 2.3 0.4 5.9 6.2 8.7 6.2 5.1 4.5 4.8 4.5 4.9 4.6 3.0 10.1 12.7 3.9 12.6 3.9 0.7 2.5 1.4 1.2 5.2 9.8 5.8 3.3 3.7 45.5 4.7 4.3 0.0 3.4 8.8 6.2 4.9 1.1 4.0 4.3 4.8 2.4 3.7 9.4 52.0 6.1 4.7 1.7 2.8 4.3 5.2 5.1 3.5 3.5 1.9 5.7 0.0 6.4 21.0 16.9 9.4 14.1 4.9 5.0 7.6 MED27 "CRSP34, CRSP8, MED3, TRAP37" ENSG00000160563 "Mediator complex subunit 27" Q6P2C8 9 131860107-132079908 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 45.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007002 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA007002: AB_1078574" "unprognostic (8.81e-2)" "prognostic favorable (1.59e-4)" "unprognostic (2.42e-2)" "unprognostic (2.21e-2)" "unprognostic (9.57e-2)" "unprognostic (1.32e-2)" "unprognostic (1.55e-2)" "unprognostic (6.07e-2)" "unprognostic (6.63e-3)" "unprognostic (1.63e-1)" "unprognostic (8.59e-3)" "unprognostic (5.93e-2)" "unprognostic (7.45e-3)" "unprognostic (9.16e-2)" "unprognostic (1.19e-1)" "unprognostic (1.32e-1)" "unprognostic (4.60e-2)" 11.1 12.1 18.0 9.5 18.1 15.5 11.5 14.0 21.4 10.9 11.7 19.5 10.1 7.8 18.6 23.5 15.5 13.9 9.5 17.5 17.5 11.2 10.4 7.5 10.9 13.5 18.6 19.1 12.7 7.9 10.6 17.8 12.7 17.4 12.7 10.7 16.0 17.7 14.4 15.2 15.7 8.6 16.3 16.1 11.7 10.2 14.7 14.0 17.9 13.2 9.6 15.8 12.3 10.5 12.9 19.8 13.4 18.6 18.0 19.7 11.8 16.1 15.9 18.4 14.6 13.2 12.2 15.5 16.8 22.4 33.8 26.5 23.8 13.1 16.0 11.4 17.5 22.6 29.4 25.4 23.9 22.2 17.2 15.0 12.0 16.7 14.1 19.8 21.5 15.2 13.4 16.5 26.6 27.3 10.7 17.6 23.5 17.5 13.4 24.6 25.7 23.1 12.5 18.7 15.9 27.1 20.4 26.0 19.6 13.6 9.0 34.4 13.9 21.7 11.2 11.2 12.3 17.8 10.1 14.7 34.4 15.1 25.4 25.3 5.4 16.6 28.4 19.1 15.0 23.4 3.5 12.2 13.4 18.9 18.6 15.3 11.6 14.8 18.5 19.2 12.9 12.7 15.5 4.8 18.0 16.0 19.8 19.7 11.8 18.0 18.1 14.0 21.4 17.5 11.2 18.6 19.1 17.4 14.0 14.9 8.5 3.0 11.2 5.4 24.5 5.9 5.1 6.7 10.3 12.2 17.7 28.2 11.6 13.9 12.9 10.6 2.1 0.0 14.5 17.3 8.9 5.1 10.4 4.9 15.2 20.6 5.1 5.5 3.7 5.4 13.3 8.8 6.8 11.8 4.2 23.3 12.9 0.0 15.9 6.0 17.8 6.5 8.3 20.7 22.2 4.4 45.8 10.2 4.7 10.7 MED28 "DKFZP434N185, EG1, magicin" ENSG00000118579 "Mediator complex subunit 28" Q9H204 4 17614631-17634105 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Actin-binding, Activator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035900, HPA035901" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA035900: AB_10673223, HPA035901: AB_2674853" "unprognostic (1.14e-3)" "unprognostic (6.97e-2)" "unprognostic (1.95e-1)" "unprognostic (6.08e-3)" "unprognostic (8.22e-3)" "unprognostic (3.90e-1)" "unprognostic (1.55e-2)" "unprognostic (5.47e-2)" "unprognostic (5.71e-2)" "unprognostic (2.43e-1)" "unprognostic (2.27e-2)" "unprognostic (7.00e-2)" "unprognostic (1.16e-2)" "unprognostic (6.30e-2)" "unprognostic (8.46e-2)" "unprognostic (1.14e-1)" "unprognostic (5.07e-3)" 12.8 12.4 16.5 15.3 18.2 22.7 20.1 23.6 19.4 18.9 15.8 20.2 17.4 13.1 25.1 22.0 15.0 19.7 11.9 11.3 16.4 15.7 13.0 10.9 16.7 21.4 18.7 17.4 30.2 16.5 14.1 20.4 18.3 15.1 18.5 15.6 17.0 16.5 17.1 27.8 22.0 16.5 16.4 16.1 20.0 15.0 16.7 17.9 27.3 18.9 14.9 23.2 16.4 17.7 9.5 10.1 14.9 10.7 8.4 11.2 10.7 3.3 2.1 17.1 8.6 7.6 6.0 7.0 4.8 5.6 6.4 5.8 5.8 8.0 9.0 3.3 4.3 5.6 3.3 10.3 5.1 6.5 3.5 5.1 15.8 6.9 8.7 5.3 11.0 8.0 5.7 7.1 3.9 3.4 6.7 5.5 13.1 13.9 8.3 5.6 3.2 16.2 19.1 11.8 6.5 3.5 12.6 6.3 4.1 6.1 4.9 12.3 6.2 4.1 3.6 4.0 10.5 6.8 11.4 6.7 4.2 3.0 3.0 4.4 6.3 2.8 11.7 3.8 10.7 4.4 6.7 10.7 9.8 7.6 8.0 7.5 9.0 8.4 7.0 10.1 9.5 11.2 8.6 14.9 8.4 6.5 7.0 6.5 10.7 16.5 18.2 23.6 19.4 16.4 15.7 18.7 17.4 15.1 17.9 17.9 25.9 61.1 99.1 81.9 38.0 16.5 33.1 24.1 37.5 21.0 15.7 101.0 71.3 52.8 8.7 68.0 25.0 23.3 46.6 148.4 70.1 83.1 58.8 24.9 81.0 31.8 42.5 41.1 73.2 17.0 52.3 65.7 57.3 101.0 38.4 49.8 50.1 40.3 44.2 44.5 33.7 32.3 50.1 82.8 93.7 81.8 112.6 68.2 42.3 82.7 MED29 "DKFZp434H247, IXL, MED2" ENSG00000063322 "Mediator complex subunit 29" Q9NX70 19 39391303-39400637 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055956 Supported Nucleoplasm NA NA Nucleoplasm "HPA055956: AB_2682986" "unprognostic (3.30e-2)" "unprognostic (3.51e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (7.27e-4)" "unprognostic (2.68e-1)" "unprognostic (1.92e-1)" "unprognostic (2.85e-2)" "unprognostic (1.71e-1)" "unprognostic (5.36e-3)" "unprognostic (1.46e-2)" "unprognostic (1.10e-1)" "unprognostic (2.70e-2)" "prognostic favorable (5.15e-5)" "unprognostic (9.51e-2)" "unprognostic (4.84e-2)" "unprognostic (2.17e-1)" "unprognostic (1.87e-2)" 17.4 22.2 39.7 15.0 39.1 15.7 17.8 24.8 38.1 21.1 16.0 25.7 15.8 17.0 18.3 22.5 15.9 29.9 20.1 21.1 34.4 35.4 22.2 22.0 17.6 17.4 36.4 31.9 34.6 23.9 41.9 21.5 17.1 28.5 21.4 13.5 19.3 22.6 25.8 25.7 16.0 16.5 18.7 32.6 18.5 16.9 15.1 17.9 16.4 30.8 14.2 16.3 18.0 13.1 28.2 22.2 35.7 41.9 21.8 27.8 25.8 14.5 38.6 11.7 11.9 17.3 13.4 9.4 15.8 17.5 15.1 12.1 19.0 14.2 10.8 21.2 14.5 13.0 7.7 10.9 13.7 8.8 21.0 19.8 13.9 15.3 12.8 14.0 13.2 12.3 14.0 11.0 15.7 17.3 15.9 12.1 21.2 9.2 13.7 14.9 19.0 12.9 4.0 8.9 17.9 13.6 21.3 16.0 15.2 14.1 24.7 18.1 16.3 32.2 21.2 13.8 7.4 16.5 14.5 13.2 12.8 13.1 15.6 15.9 17.6 19.9 18.4 17.7 10.0 20.4 26.0 28.6 24.0 24.5 34.4 23.9 28.2 22.8 21.9 22.2 26.2 27.8 26.1 35.7 21.8 41.9 17.8 26.3 25.8 39.7 39.1 24.8 38.1 34.4 35.4 36.4 31.9 28.5 17.9 26.8 35.0 25.3 26.4 19.7 21.9 29.7 30.6 28.1 25.0 29.6 11.8 31.6 44.7 23.3 42.3 29.3 65.9 23.3 24.7 25.8 28.9 19.9 42.7 41.4 35.2 22.3 31.4 32.5 37.8 44.0 35.6 33.2 27.0 39.7 30.7 32.2 23.2 60.4 30.4 46.2 15.8 51.8 25.9 24.4 15.1 17.8 24.1 32.0 23.6 16.2 MED30 "THRAP6, TRAP25" ENSG00000164758 "Mediator complex subunit 30" Q96HR3 8 117520713-117540262 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 151.0;Suprabasal keratinocytes: 133.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045767 Approved Nucleoplasm NA NA Nucleoplasm "HPA045767: AB_2679446" "unprognostic (1.15e-1)" "unprognostic (1.90e-1)" "unprognostic (3.86e-2)" "unprognostic (1.57e-2)" "unprognostic (1.46e-1)" "unprognostic (3.20e-2)" "unprognostic (2.00e-2)" "unprognostic (3.33e-2)" "unprognostic (8.41e-2)" "unprognostic (4.02e-2)" "unprognostic (1.51e-2)" "unprognostic (7.73e-2)" "prognostic unfavorable (1.70e-6)" "unprognostic (5.38e-3)" "unprognostic (2.80e-1)" "unprognostic (1.05e-1)" "unprognostic (4.62e-2)" 18.5 12.5 10.8 16.1 12.1 46.7 18.8 12.9 14.8 16.8 14.9 15.4 12.0 11.9 17.8 21.0 15.8 18.3 9.2 14.9 11.1 10.0 9.9 19.0 16.2 19.7 13.7 8.6 23.0 10.1 4.2 14.5 14.3 12.1 16.1 15.2 10.5 11.1 14.2 12.2 16.9 12.9 15.8 14.1 17.0 12.4 18.9 13.1 34.3 19.3 12.9 18.5 17.5 16.1 28.7 34.8 45.4 27.3 16.9 24.3 17.5 22.2 2.3 9.0 5.9 6.3 5.9 9.9 6.7 7.3 10.3 12.9 4.2 11.1 17.8 10.8 3.6 7.9 10.1 7.9 5.2 13.3 23.7 9.8 14.4 1.4 5.5 6.9 11.4 12.5 5.4 6.0 5.3 12.0 3.8 6.3 25.9 8.0 10.9 4.8 5.2 35.0 29.3 5.0 21.1 16.6 13.0 11.3 7.8 5.2 3.9 12.7 10.8 7.9 18.3 10.1 8.5 4.4 14.6 3.0 5.0 13.2 9.2 11.6 9.5 6.4 20.5 4.7 13.0 8.4 24.7 16.7 45.4 21.3 18.8 22.3 24.0 21.6 20.9 18.1 28.7 24.3 23.0 38.8 16.9 27.3 34.8 22.8 17.5 10.8 12.1 12.9 14.8 11.1 10.0 13.7 8.6 12.1 13.1 8.9 17.1 45.0 68.1 151.0 5.5 5.1 17.8 60.2 15.9 8.7 5.9 43.1 10.0 19.7 20.7 26.7 20.8 0.0 19.7 56.3 56.7 49.8 20.8 20.4 27.1 0.0 36.1 33.2 28.6 10.4 55.3 33.3 38.8 17.2 32.4 7.8 16.3 30.8 35.0 14.3 4.5 32.3 41.0 32.1 36.6 133.1 51.5 58.0 37.7 53.3 MED31 "CGI-125, Soh1" ENSG00000108590 "Mediator complex subunit 31" Q9Y3C7 17 6643315-6651634 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035947 Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA035947: AB_10696646" "unprognostic (1.42e-1)" "unprognostic (4.39e-1)" "unprognostic (6.87e-2)" "unprognostic (4.40e-3)" "unprognostic (1.71e-1)" "unprognostic (3.99e-1)" "unprognostic (6.99e-2)" "unprognostic (1.01e-1)" "unprognostic (1.03e-2)" "unprognostic (1.39e-2)" "unprognostic (5.79e-2)" "unprognostic (6.46e-3)" "unprognostic (1.58e-2)" "unprognostic (1.54e-1)" "unprognostic (1.30e-1)" "unprognostic (2.22e-3)" "unprognostic (1.89e-1)" 9.7 19.7 18.7 9.6 21.6 9.4 16.2 25.3 25.5 12.1 10.0 10.2 8.9 9.4 11.9 30.5 20.8 14.3 13.9 16.0 19.0 21.4 15.4 15.9 10.1 14.1 16.0 15.1 14.0 9.5 9.1 22.3 12.5 19.4 11.3 9.7 10.5 14.3 10.4 11.4 21.8 11.3 13.6 13.7 14.5 10.0 17.6 11.5 17.5 16.3 13.4 15.4 16.9 11.9 12.5 13.4 33.3 12.2 11.8 15.7 11.0 18.0 20.3 18.3 11.6 16.6 14.2 6.5 14.2 14.6 21.9 28.7 10.0 9.5 2.4 18.0 6.9 16.3 19.9 14.4 17.3 19.1 13.1 24.2 4.4 18.6 15.4 12.5 5.0 9.5 7.6 19.1 19.8 6.8 11.8 16.2 9.6 7.8 4.7 15.8 6.6 9.6 13.1 6.5 8.2 11.8 7.2 8.1 6.6 18.2 9.0 7.1 8.0 7.2 5.9 15.4 9.0 6.1 5.5 7.3 10.9 9.4 13.7 14.1 4.3 5.5 6.0 15.0 6.0 7.7 28.6 12.2 19.5 14.7 8.3 13.9 12.0 13.6 14.1 10.4 12.5 12.4 13.1 33.3 11.8 10.0 13.4 15.7 11.0 18.7 21.6 25.3 25.5 19.0 21.4 16.0 15.1 19.4 11.5 14.9 19.3 37.2 41.8 94.9 7.5 4.5 43.3 61.6 19.4 31.4 9.8 37.0 46.4 32.6 26.3 32.3 17.8 0.0 27.5 35.1 31.5 42.1 26.5 51.9 29.6 12.7 12.1 38.6 27.8 40.6 41.1 29.6 38.8 27.9 17.2 16.7 35.8 14.0 24.8 41.8 10.6 38.8 32.0 75.1 83.7 105.0 40.0 35.4 18.3 56.1 MED4 "DRIP36, HSPC126, TRAP36, VDRIP" ENSG00000136146 "Mediator complex subunit 4" Q9NPJ6 13 48053323-48095131 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006232 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA006232: AB_1079351" "unprognostic (1.10e-1)" "unprognostic (2.14e-1)" "unprognostic (3.03e-1)" "unprognostic (2.80e-1)" "unprognostic (5.79e-1)" "unprognostic (2.56e-2)" "unprognostic (4.09e-1)" "unprognostic (7.97e-2)" "unprognostic (7.34e-3)" "unprognostic (3.21e-1)" "unprognostic (2.35e-1)" "unprognostic (2.45e-1)" "unprognostic (1.28e-1)" "unprognostic (1.86e-3)" "unprognostic (6.54e-3)" "unprognostic (1.94e-2)" "unprognostic (1.84e-1)" 31.3 25.9 29.1 23.1 33.4 43.8 31.8 28.9 31.8 27.4 32.3 23.2 24.3 26.4 32.1 30.3 31.5 24.4 21.9 36.6 28.5 24.1 28.6 33.3 24.1 27.7 29.4 34.1 26.0 21.2 18.0 27.8 40.2 29.5 27.9 31.6 19.0 26.3 27.2 58.8 29.2 33.3 35.6 30.7 29.2 25.2 34.7 26.7 39.7 28.9 29.7 35.0 26.4 26.4 33.9 32.8 52.1 35.3 41.4 50.0 41.7 13.7 9.0 31.0 17.1 20.7 26.7 21.5 20.2 25.3 24.3 17.4 17.1 23.8 22.8 5.8 21.3 15.0 21.1 22.7 19.4 31.8 29.4 18.6 29.8 17.7 26.7 19.2 43.9 27.6 18.4 27.4 14.3 21.3 23.8 22.5 23.1 21.1 14.6 27.1 13.9 41.2 41.9 30.7 44.8 12.0 30.1 21.0 18.3 31.5 21.5 13.7 22.3 16.5 20.8 21.4 21.1 17.7 33.2 18.1 13.6 15.8 17.0 18.3 14.2 20.7 34.9 11.7 23.1 25.8 42.9 34.6 52.1 41.0 35.2 45.2 33.9 46.6 41.3 32.8 30.7 45.3 42.9 36.5 41.4 35.3 29.8 50.0 41.7 29.1 33.4 28.9 31.8 28.5 24.1 29.4 34.1 29.5 26.7 89.3 48.5 58.1 61.8 81.1 51.2 87.3 58.6 60.2 102.4 54.1 15.7 104.5 129.3 69.3 65.3 77.3 49.0 46.7 55.2 88.3 76.1 49.7 94.8 58.7 61.5 35.0 25.8 46.1 48.8 142.9 71.1 63.1 74.2 169.5 41.9 46.1 53.9 60.4 72.9 63.7 43.3 51.8 73.1 126.5 140.6 85.1 112.8 80.4 51.2 61.0 MED6 NY-REN-28 ENSG00000133997 "Mediator complex subunit 6" O75586 14 70581257-70600690 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030764, HPA069039" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA030764: AB_2673601, HPA069039: AB_2686070" "unprognostic (1.65e-2)" "unprognostic (1.93e-1)" "unprognostic (1.09e-1)" "unprognostic (2.22e-3)" "unprognostic (1.04e-1)" "unprognostic (1.72e-2)" "prognostic unfavorable (1.04e-4)" "unprognostic (1.74e-1)" "prognostic unfavorable (2.75e-4)" "unprognostic (2.23e-2)" "unprognostic (1.54e-1)" "unprognostic (1.48e-1)" "unprognostic (6.93e-2)" "unprognostic (2.86e-1)" "unprognostic (3.32e-1)" "unprognostic (1.01e-1)" "unprognostic (3.15e-2)" 16.7 19.7 20.3 16.5 30.7 22.7 21.9 42.0 30.4 17.6 15.7 19.3 16.6 14.2 23.6 22.9 24.5 19.7 14.8 17.1 20.1 19.5 14.7 20.2 15.5 26.9 17.4 23.0 25.7 15.6 13.5 30.0 22.9 21.9 15.2 16.5 20.5 17.4 17.4 29.9 24.1 16.2 18.9 19.6 21.6 16.4 16.6 20.5 21.0 19.4 18.9 30.2 18.5 18.8 19.9 18.5 23.5 21.1 21.3 24.8 14.2 36.9 20.7 26.8 11.6 14.7 15.5 21.4 18.8 19.9 28.9 28.3 20.3 23.0 28.4 11.1 15.9 17.3 17.9 31.3 18.9 31.2 19.8 16.6 20.6 16.0 27.4 18.0 18.0 16.6 17.6 22.2 20.7 19.2 12.8 22.1 21.7 18.9 18.0 20.9 27.6 25.7 24.4 19.9 26.3 25.2 21.5 25.0 14.7 18.0 19.8 18.3 19.8 19.6 21.0 21.8 16.3 32.8 22.7 17.5 23.8 34.6 12.0 17.2 19.1 28.4 39.8 20.8 15.7 16.5 17.4 16.2 23.5 18.7 18.2 22.2 18.9 24.8 21.3 18.5 19.9 23.1 23.3 15.8 21.3 21.1 13.9 23.1 14.2 20.3 30.7 42.0 30.4 20.1 19.5 17.4 23.0 21.9 20.5 17.9 21.7 37.3 31.2 17.2 71.1 5.6 10.2 25.4 18.2 17.4 74.6 34.1 5.0 27.0 5.8 22.4 13.9 23.3 20.3 35.6 20.0 28.9 45.1 12.5 22.6 25.4 21.2 26.4 19.2 4.4 25.0 20.6 16.9 27.1 10.5 47.4 22.6 17.6 27.6 12.5 92.2 25.8 18.6 20.6 39.9 17.6 41.0 40.8 14.6 27.6 MED8 "ARC32, MGC17544, MGC19641" ENSG00000159479 "Mediator complex subunit 8" Q96G25 1 43383917-43389808 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028377, HPA028438" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA028377: AB_10600112, HPA028438: AB_10600057" "unprognostic (1.23e-1)" "unprognostic (1.13e-1)" "unprognostic (8.41e-2)" "unprognostic (1.49e-2)" "unprognostic (2.37e-2)" "unprognostic (8.58e-3)" "prognostic unfavorable (2.04e-7)" "unprognostic (2.60e-2)" "unprognostic (1.82e-2)" "unprognostic (1.87e-2)" "unprognostic (5.17e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (1.11e-7)" "unprognostic (7.08e-2)" "unprognostic (3.28e-1)" "unprognostic (3.05e-2)" "unprognostic (1.36e-1)" 22.7 21.9 19.0 18.3 22.0 22.0 22.9 30.0 25.8 20.4 21.1 21.9 19.0 21.7 18.4 24.8 33.4 15.0 16.1 15.9 18.5 19.0 22.1 34.6 19.4 18.3 21.0 17.2 19.2 25.6 17.7 34.5 26.8 20.3 19.3 24.5 19.2 25.0 21.1 16.5 27.3 21.2 23.5 21.3 20.9 22.5 18.5 20.6 14.2 27.0 19.3 25.9 24.9 20.6 27.0 34.6 32.5 35.0 18.4 25.5 22.1 22.2 14.0 13.2 15.7 20.4 20.5 17.4 22.4 20.6 27.0 28.6 26.6 16.4 13.5 16.1 28.1 17.8 14.2 20.7 19.0 26.3 18.7 20.3 22.2 24.3 33.3 34.8 19.5 23.6 20.0 25.2 28.5 35.1 16.2 21.5 12.5 19.6 23.1 17.3 14.3 10.2 16.0 12.6 20.9 16.3 12.0 15.2 20.7 18.0 14.6 13.9 10.4 13.3 21.8 44.0 19.1 14.8 39.3 15.9 11.8 21.5 23.1 31.7 27.6 31.8 15.8 25.1 24.4 15.7 25.3 35.0 32.5 22.0 31.3 20.9 27.0 20.2 24.8 34.6 21.1 20.7 21.5 28.0 18.4 27.3 16.0 25.5 22.1 19.0 22.0 30.0 25.8 18.5 19.0 21.0 17.2 20.3 20.6 14.9 8.0 15.6 20.0 16.7 28.3 11.8 25.5 8.1 11.4 14.0 13.7 44.7 28.2 39.6 9.7 21.0 24.2 93.5 65.5 56.4 27.8 21.2 31.1 23.1 52.8 15.9 18.6 18.4 20.8 18.1 22.7 29.1 18.6 38.7 19.9 27.7 46.2 19.3 20.5 41.8 47.9 25.8 17.9 66.2 30.9 22.2 73.9 24.9 19.6 25.5 MED9 "FLJ10193, MED25" ENSG00000141026 "Mediator complex subunit 9" Q9NWA0 17 17476986-17493226 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056415 Uncertain Approved Nucleoplasm,Midbody Yes No Nucleoplasm Midbody "HPA056415: AB_2683120" "unprognostic (1.81e-2)" "unprognostic (4.58e-2)" "unprognostic (2.65e-1)" "unprognostic (3.48e-3)" "unprognostic (1.27e-1)" "unprognostic (2.18e-1)" "unprognostic (1.89e-1)" "unprognostic (3.21e-2)" "unprognostic (4.23e-1)" "unprognostic (7.65e-2)" "prognostic favorable (4.18e-5)" "unprognostic (3.96e-2)" "prognostic favorable (2.83e-9)" "unprognostic (2.26e-3)" "unprognostic (2.29e-1)" "unprognostic (3.09e-1)" "unprognostic (1.39e-1)" 10.2 12.7 16.0 6.5 23.5 12.3 14.1 16.3 29.1 13.0 11.2 9.2 10.9 11.2 11.7 17.3 8.2 11.7 6.6 30.0 14.3 13.6 13.9 19.1 8.2 11.5 13.6 14.5 12.4 10.2 20.3 11.3 7.9 12.6 11.4 10.5 8.9 15.8 14.9 34.4 11.3 10.5 8.6 10.3 9.5 10.1 12.9 8.6 14.9 13.4 15.2 9.1 7.5 7.8 11.4 12.8 11.8 11.4 10.3 13.4 7.4 7.3 9.4 8.1 8.7 6.6 5.9 7.0 6.0 7.4 9.3 8.4 13.7 3.7 9.1 6.9 6.2 5.6 9.6 10.3 8.3 8.8 5.7 16.4 5.5 6.2 9.8 7.0 4.4 4.8 9.6 7.9 7.8 8.1 7.0 6.3 13.3 6.5 4.2 6.2 6.2 19.7 9.1 7.5 15.3 9.7 15.3 18.4 5.9 8.1 5.2 5.3 8.4 7.9 6.3 13.3 32.1 7.4 5.8 4.3 6.9 8.0 11.8 9.4 8.0 5.6 5.0 8.6 7.8 7.2 2.7 7.0 11.8 10.3 9.6 13.4 11.4 10.7 10.6 7.8 10.4 11.6 12.8 2.4 10.3 11.4 12.8 10.3 7.4 16.0 23.5 16.3 29.1 14.3 13.6 13.6 14.5 12.6 8.6 3.0 4.1 0.9 8.0 4.0 14.2 17.7 7.6 5.3 4.5 8.7 13.7 7.7 10.0 5.6 5.3 3.7 6.6 0.0 4.0 4.5 5.5 7.3 0.0 4.5 5.3 15.9 15.1 5.5 2.4 5.2 5.2 3.8 1.7 3.6 9.3 22.1 2.9 5.8 8.9 4.5 22.8 0.0 6.1 8.8 25.4 4.3 8.0 5.0 7.3 7.4 MEF2A "RSRFC4, RSRFC9" ENSG00000068305 "Myocyte enhancer factor 2A" Q02078 15 99565417-99716466 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004499, HPA046597" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB004499: AB_627921, HPA046597: AB_2679714" "unprognostic (1.89e-1)" "unprognostic (8.82e-2)" "unprognostic (5.91e-2)" "unprognostic (8.04e-2)" "unprognostic (8.68e-2)" "unprognostic (2.05e-1)" "unprognostic (2.25e-1)" "unprognostic (6.26e-2)" "unprognostic (1.93e-2)" "unprognostic (1.91e-2)" "unprognostic (7.08e-3)" "unprognostic (1.46e-1)" "prognostic favorable (6.93e-4)" "prognostic unfavorable (7.96e-4)" "unprognostic (4.69e-2)" "unprognostic (1.32e-1)" "unprognostic (1.69e-3)" 28.9 17.4 17.4 19.1 24.3 12.0 20.1 22.9 31.6 21.9 19.7 20.1 18.2 9.5 30.5 24.7 16.6 20.5 16.6 62.0 14.9 12.7 18.8 17.5 26.0 16.7 14.0 21.9 23.0 11.7 32.0 10.2 18.8 16.1 19.9 11.4 14.5 15.5 18.4 46.1 38.4 16.3 31.2 23.6 22.2 16.3 10.7 15.8 17.6 15.2 19.6 17.3 25.2 15.9 12.8 10.7 11.3 14.2 5.6 4.5 4.3 8.5 4.8 8.2 4.1 10.5 13.5 4.1 8.7 20.0 7.1 9.8 4.9 11.9 10.7 12.3 18.6 11.0 9.4 8.3 6.8 9.3 7.2 12.2 21.6 10.9 4.5 18.0 8.5 10.6 8.9 11.5 9.6 19.9 29.8 13.0 8.9 7.6 20.6 13.3 3.5 13.9 12.7 4.5 5.7 7.1 20.5 18.0 8.7 14.7 12.1 5.3 7.4 13.2 5.7 24.4 9.1 5.4 7.8 21.2 20.0 11.0 9.8 10.4 11.3 12.8 23.4 13.9 9.5 19.0 6.2 10.3 11.3 3.4 12.8 2.9 12.8 3.2 3.0 10.7 10.4 4.5 3.4 10.2 5.6 14.2 6.6 2.1 4.3 17.4 24.3 22.9 31.6 14.9 12.7 14.0 21.9 16.1 15.8 74.5 34.5 30.5 27.2 78.8 48.1 137.9 20.4 69.6 51.2 27.9 47.1 6.7 21.6 16.0 6.0 83.9 18.4 23.3 16.2 2.9 42.7 21.5 30.1 37.6 35.1 28.6 12.2 52.8 98.7 3.6 51.8 62.9 33.7 33.3 16.2 25.2 20.7 23.0 60.8 15.3 40.4 71.1 67.0 25.6 25.6 44.2 7.7 19.7 12.4 21.3 MEF2B RSRFR2 ENSG00000213999 "Myocyte enhancer factor 2B" Q02080 19 19145568-19170289 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "lymphoid tissue: 81.2" "Cell type enriched" "Detected in single" 16 "Sertoli cells: 6.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 12 "Daudi: 50.9;U-266/70: 51.2;U-698: 67.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA004734 Supported Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cytosol" "Cell Junctions" "HPA004734: AB_10963939" "unprognostic (7.31e-3)" "unprognostic (4.06e-2)" "unprognostic (9.44e-5)" "unprognostic (5.07e-2)" "unprognostic (2.01e-1)" "unprognostic (7.19e-3)" "unprognostic (1.64e-1)" "unprognostic (1.78e-1)" "unprognostic (2.76e-1)" "unprognostic (1.98e-2)" "unprognostic (8.66e-3)" "unprognostic (1.92e-2)" "unprognostic (1.56e-11)" "unprognostic (2.40e-1)" "unprognostic (1.92e-1)" "unprognostic (3.68e-1)" "unprognostic (8.98e-3)" 2.0 1.0 0.8 81.2 1.2 1.4 1.9 0.6 1.4 2.7 3.0 0.9 0.6 1.5 2.2 1.1 1.5 2.3 2.2 1.9 1.0 0.6 1.8 2.9 2.0 32.3 1.1 0.9 3.7 0.8 0.8 2.1 0.8 1.0 3.7 1.0 1.8 3.5 1.1 1.4 2.3 3.1 1.1 1.2 6.7 1.7 1.7 0.8 1.6 3.0 3.5 58.7 1.9 2.9 0.1 0.2 1.1 0.9 0.0 0.2 0.0 0.2 0.1 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.3 50.9 0.1 0.2 0.1 0.4 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.2 0.2 0.4 0.1 0.2 0.1 0.1 0.1 0.0 0.4 0.1 0.5 0.0 0.2 0.3 0.3 0.0 0.0 0.9 0.4 0.0 1.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.4 0.5 0.1 51.2 4.7 67.3 0.1 0.3 0.0 0.0 0.9 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.1 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.8 1.2 0.6 1.4 1.0 0.6 1.1 0.9 1.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MEF2C ENSG00000081189 "Myocyte enhancer factor 2C" Q06413 5 88717117-88904257 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 154.8" "Cell type enhanced" "Detected in many" 6 "B-cells: 255.0;Ito cells: 239.4;Sertoli cells: 329.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 17.2;intermediate monocyte: 19.5;memory B-cell: 32.6;myeloid DC: 22.3;naive B-cell: 48.2;non-classical monocyte: 15.9;plasmacytoid DC: 23.8" "Group enriched" "Detected in many" 5 "B-cells: 48.2;dendritic cells: 23.8;monocytes: 19.5" "Cell line enhanced" "Detected in many" "Daudi: 24.2;HEL: 53.4;Karpas-707: 29.4;REH: 60.8;U-266/70: 22.3;WM-115: 34.8" "Group enriched" "Detected in many" 7 "amygdala: 209.9;basal ganglia: 138.6;cerebral cortex: 403.6;hippocampal formation: 331.6;olfactory region: 196.3" "Group enriched" "Detected in all" 4 "amygdala: 103.2;cerebral cortex: 309.8;hippocampal formation: 290.6;olfactory region: 138.8" "HPA005533, CAB068196, CAB068197" Enhanced Supported Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB068196: AB_2665646, CAB068197: AB_2665645, HPA005533: AB_1079352" "unprognostic (2.74e-1)" "unprognostic (1.64e-2)" "unprognostic (2.37e-2)" "unprognostic (8.78e-2)" "unprognostic (9.75e-2)" "unprognostic (1.69e-1)" "unprognostic (1.06e-1)" "unprognostic (3.19e-2)" "unprognostic (3.52e-2)" "unprognostic (8.73e-2)" "unprognostic (1.15e-1)" "unprognostic (1.38e-1)" "prognostic unfavorable (1.01e-4)" "unprognostic (7.18e-3)" "unprognostic (1.58e-1)" "unprognostic (4.42e-2)" "unprognostic (1.42e-2)" 13.9 10.8 17.0 15.0 26.7 3.8 10.7 4.3 52.8 8.2 6.8 6.1 1.5 2.8 10.9 5.4 5.0 6.4 9.8 11.2 11.1 6.8 4.5 4.0 8.3 19.3 6.6 28.0 12.3 2.9 5.2 6.5 14.8 4.8 7.1 5.7 4.6 6.6 6.6 154.8 3.9 7.4 10.8 8.3 16.0 4.5 3.6 4.4 1.6 9.6 3.5 24.0 8.9 5.8 48.2 23.8 5.8 19.5 4.0 0.1 7.2 0.3 0.0 1.7 0.0 1.9 1.1 0.0 0.5 1.0 0.0 0.2 0.0 0.2 24.2 0.1 2.8 0.6 0.7 2.3 2.1 0.0 7.3 3.0 53.4 3.2 0.0 0.6 2.3 0.1 5.3 0.0 0.0 0.0 0.3 8.4 0.0 2.8 29.4 2.1 0.0 0.0 0.0 0.5 0.0 2.0 60.8 15.3 11.6 0.0 0.3 0.0 2.0 0.0 0.1 7.0 1.0 0.0 13.5 9.6 1.3 0.2 0.1 1.2 22.3 2.5 14.6 0.3 16.5 34.8 0.1 17.2 0.0 0.0 19.5 0.0 32.6 0.0 0.0 22.3 48.2 0.0 0.0 5.8 4.0 15.9 23.8 0.1 7.2 17.0 26.7 4.3 52.8 11.1 6.8 6.6 28.0 4.8 4.4 29.8 48.3 255.0 4.7 9.5 22.0 80.9 12.7 6.7 39.8 1.8 202.2 0.8 23.2 0.8 6.9 155.1 1.6 70.0 11.1 1.1 13.9 1.6 4.7 3.0 134.1 4.8 1.2 239.4 207.6 5.3 27.6 138.9 64.1 28.9 0.3 65.1 0.4 2.9 67.5 0.5 196.7 329.8 171.0 1.2 16.6 7.3 1.4 7.9 1.9 1.6 MEF2D ENSG00000116604 "Myocyte enhancer factor 2D" Q14814 1 156463727-156500828 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 97.8" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 163.0;Sertoli cells: 97.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "THP-1: 55.0;U-266/70: 48.3;U-266/84: 49.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004807, HPA007114" Enhanced Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA004807: AB_1079354, HPA007114: AB_1079353" "unprognostic (3.17e-2)" "unprognostic (7.31e-2)" "unprognostic (3.35e-2)" "unprognostic (3.45e-2)" "unprognostic (1.95e-1)" "unprognostic (8.99e-2)" "unprognostic (2.02e-1)" "unprognostic (1.29e-1)" "unprognostic (9.96e-2)" "unprognostic (1.96e-2)" "unprognostic (1.97e-1)" "unprognostic (2.50e-1)" "prognostic unfavorable (7.53e-4)" "unprognostic (9.27e-2)" "unprognostic (1.66e-1)" "unprognostic (8.09e-3)" "unprognostic (1.45e-1)" 18.1 19.6 14.9 15.7 27.5 47.6 15.5 27.0 40.3 23.8 21.1 12.1 10.5 11.0 28.6 12.9 13.8 19.5 16.6 26.3 11.8 9.6 10.4 10.6 20.0 13.9 8.6 21.1 26.7 22.4 21.4 15.0 16.2 11.6 17.2 10.6 22.3 11.3 18.8 97.8 17.5 14.8 22.0 8.4 17.2 16.1 9.9 9.9 17.2 14.7 19.4 15.6 21.9 19.3 1.7 8.5 8.1 2.0 1.5 2.3 0.8 4.6 8.6 1.8 2.8 4.4 6.1 2.8 6.1 8.0 3.2 3.5 2.7 6.3 10.8 7.1 8.2 3.2 4.6 2.1 3.5 1.9 14.7 2.8 2.6 10.7 1.5 5.4 6.3 8.6 6.8 5.9 5.6 7.7 6.8 6.1 3.4 1.9 19.1 5.1 4.4 4.2 14.6 2.6 2.6 4.4 20.8 3.9 12.4 2.8 2.3 3.0 4.7 5.9 12.9 10.2 3.7 3.5 55.0 10.2 7.7 7.2 5.6 4.5 48.3 49.9 20.7 6.5 5.0 4.1 1.3 2.0 2.3 1.9 1.1 2.3 1.7 1.4 1.7 1.4 1.7 0.7 1.3 8.1 1.5 1.9 8.5 1.6 0.8 14.9 27.5 27.0 40.3 11.8 9.6 8.6 21.1 11.6 9.9 6.0 18.1 14.4 10.3 33.1 78.1 35.2 20.4 2.7 15.9 1.8 163.0 3.9 0.0 7.0 1.3 21.1 33.9 0.0 9.7 4.3 21.3 16.3 3.5 11.3 15.8 66.7 20.6 18.4 22.5 4.6 29.1 18.3 13.5 10.0 29.7 16.8 18.5 28.1 30.4 2.6 80.6 97.0 38.1 5.1 9.8 33.2 12.8 12.9 11.0 14.9 MEFV "FMF, MEF, TRIM20" ENSG00000103313 "MEFV, pyrin innate immunity regulator" O15553 16 3242028-3256627 "Disease related genes, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" Actin-binding "Amyloidosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 23.3" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 7.0;Kupffer cells: 14.8;Macrophages: 7.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 10.0" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "THP-1: 12.1" HPA077497 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA077497: " "unprognostic (2.67e-1)" "unprognostic (1.06e-1)" "unprognostic (4.96e-2)" "unprognostic (2.01e-1)" "unprognostic (2.49e-2)" "unprognostic (3.10e-1)" "unprognostic (7.06e-2)" "unprognostic (3.35e-2)" "unprognostic (2.97e-2)" "unprognostic (1.09e-1)" "unprognostic (8.89e-2)" "unprognostic (3.27e-1)" "unprognostic (7.58e-7)" "unprognostic (1.08e-1)" "unprognostic (7.16e-4)" "unprognostic (1.73e-3)" "unprognostic (1.48e-1)" 4.2 1.2 0.5 9.8 1.0 9.7 0.9 0.4 0.9 1.1 1.4 0.3 0.0 1.0 0.6 2.7 1.2 1.6 1.8 4.2 0.5 0.5 1.3 1.5 11.4 14.8 2.8 0.1 1.2 1.8 0.2 0.7 1.8 0.8 0.9 0.6 1.7 0.8 0.7 1.7 0.6 1.3 1.6 2.2 23.3 1.0 2.2 1.3 1.2 1.7 0.2 1.4 2.7 4.1 0.4 2.1 10.0 6.5 0.5 0.3 1.3 0.1 0.1 0.1 0.3 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.2 0.2 1.1 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.1 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.2 0.2 0.2 0.3 0.1 12.1 0.1 0.3 0.1 0.1 0.1 0.5 0.4 0.2 0.4 2.1 0.0 2.5 3.8 0.2 0.1 4.2 0.1 0.2 0.2 0.1 2.1 0.4 0.1 0.3 10.0 0.5 6.5 0.3 0.1 1.3 0.5 1.0 0.4 0.9 0.5 0.5 2.8 0.1 0.8 1.3 0.0 2.2 0.0 0.0 0.2 0.0 7.0 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.9 0.0 0.0 0.6 14.8 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.1 0.0 0.0 0.0 0.0 MEGF9 EGFL5 ENSG00000106780 "Multiple EGF like domains 9" Q9H1U4 9 120600813-120714470 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 80.4;Cone photoreceptor cells: 200.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 19.1" "Group enriched" "Detected in many" 5 "granulocytes: 19.1;monocytes: 5.7" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014319, HPA050238" Approved Approved Nucleoplasm,Cytosol NA NA 32000000 Nucleoplasm Cytosol "HPA014319: AB_1848035, HPA050238: AB_2681060" "unprognostic (1.18e-1)" "unprognostic (5.33e-2)" "unprognostic (1.84e-1)" "unprognostic (1.75e-2)" "unprognostic (3.30e-1)" "unprognostic (3.68e-1)" "unprognostic (2.31e-1)" "unprognostic (2.29e-2)" "unprognostic (3.63e-2)" "unprognostic (1.13e-2)" "unprognostic (5.92e-2)" "unprognostic (4.97e-2)" "prognostic favorable (5.48e-11)" "unprognostic (1.90e-2)" "unprognostic (1.50e-1)" "unprognostic (6.78e-2)" "unprognostic (1.41e-1)" 15.0 9.6 22.4 9.9 21.7 15.4 12.8 27.9 26.2 11.7 6.7 29.3 2.1 6.4 6.1 5.5 12.8 12.8 7.9 6.1 24.6 16.4 12.5 33.8 17.9 7.0 28.6 16.0 9.3 5.4 15.6 6.8 4.8 22.6 8.4 5.8 21.4 7.8 6.6 6.0 19.0 6.5 8.1 21.1 12.9 7.2 3.1 25.8 3.2 25.5 4.6 5.6 11.3 9.6 0.3 2.2 19.1 5.7 0.3 0.6 1.3 2.7 10.7 9.4 2.9 13.1 8.1 3.0 2.8 2.4 0.7 1.0 0.6 1.6 10.1 4.2 2.6 3.4 11.8 13.5 4.8 2.0 8.2 3.9 1.4 20.1 4.4 5.6 4.0 8.7 3.8 14.8 4.6 3.7 26.3 6.6 5.5 3.2 4.8 7.8 7.8 7.9 1.4 0.4 6.0 2.9 6.0 10.5 4.3 19.3 8.9 9.3 7.9 3.3 2.7 7.9 1.6 8.1 4.1 7.7 2.8 1.6 10.4 4.2 8.8 10.3 3.3 4.0 4.8 16.1 0.4 5.7 3.6 0.6 1.9 0.2 0.3 0.6 0.5 2.2 0.3 0.5 0.4 19.1 0.3 3.0 0.2 0.5 1.3 22.4 21.7 27.9 21.5 24.6 16.4 28.6 16.0 22.6 25.8 80.4 47.6 4.9 4.8 24.4 27.8 23.0 15.3 6.7 21.6 22.7 200.3 0.3 0.0 3.9 0.6 7.3 6.5 23.3 4.7 1.1 6.1 8.8 6.9 41.0 5.9 12.7 6.3 10.4 54.2 0.9 10.6 18.5 25.3 2.8 3.3 28.2 11.0 6.8 11.0 5.0 70.5 12.9 9.9 8.4 6.1 38.3 1.0 9.6 6.0 5.7 MEIS1 ENSG00000143995 "Meis homeobox 1" O00470 2 66433452-66573869 "Disease related genes, Predicted intracellular proteins, Transcription factors" Transcription "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 104.1;Horizontal cells: 77.9;Paneth cells: 51.8;Rod photoreceptor cells: 125.2" "Cancer enhanced" "Detected in many" "ovarian cancer: 18.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 3.3;plasmacytoid DC: 2.9" "Group enriched" "Detected in many" 4 "dendritic cells: 2.9;granulocytes: 1.9;NK-cells: 3.3" "Cell line enhanced" "Detected in many" "BJ hTERT+: 25.4;HeLa: 15.9;HHSteC: 19.0;SH-SY5Y: 16.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB011521, HPA056000" Approved Approved Nucleoplasm NA NA Nucleoplasm "CAB011521: AB_776272, HPA056000: AB_2683004" "unprognostic (6.84e-2)" "unprognostic (1.08e-1)" "unprognostic (3.43e-2)" "unprognostic (1.34e-1)" "unprognostic (4.22e-1)" "prognostic favorable (2.70e-5)" "unprognostic (2.45e-2)" "unprognostic (7.78e-3)" "unprognostic (2.36e-2)" "unprognostic (5.91e-2)" "unprognostic (1.07e-1)" "unprognostic (1.92e-1)" "prognostic unfavorable (1.69e-4)" "unprognostic (6.52e-2)" "unprognostic (9.71e-2)" "unprognostic (4.13e-2)" "unprognostic (2.01e-2)" 7.9 21.2 2.5 14.1 5.1 1.1 9.0 27.5 5.1 52.6 24.0 6.8 13.1 3.0 49.3 15.6 18.2 30.5 15.5 9.0 2.0 1.5 4.7 1.8 14.7 5.3 8.9 3.6 25.4 33.8 4.4 1.4 8.0 9.4 14.8 7.0 10.8 26.4 20.2 2.6 4.8 7.7 31.9 7.7 7.2 14.1 5.9 5.6 0.7 2.7 6.6 6.2 20.6 22.7 0.1 2.9 1.9 0.4 3.3 0.6 5.3 0.1 0.9 7.5 1.5 9.8 6.4 1.0 9.8 25.4 8.4 8.8 0.8 7.1 0.0 2.5 7.5 0.5 1.2 4.4 4.4 8.4 0.0 4.3 12.4 15.9 1.8 19.0 0.0 3.3 5.8 5.1 3.4 1.5 6.8 3.9 2.0 1.1 0.0 0.3 0.5 0.9 0.2 0.2 0.9 1.0 0.0 2.0 1.8 0.7 2.3 2.4 16.2 1.8 0.5 0.7 5.9 0.7 1.4 1.2 1.8 3.0 1.3 2.7 1.9 0.6 0.1 1.6 10.9 0.5 1.9 0.1 0.0 0.5 0.4 0.0 0.1 0.0 0.1 0.7 0.0 0.0 0.6 1.4 3.3 0.0 2.9 0.2 5.3 2.5 5.1 27.5 5.1 2.0 1.5 8.9 3.6 9.4 5.6 0.0 0.3 0.0 11.4 2.9 10.6 16.1 0.0 2.7 6.8 0.0 104.1 4.1 0.0 16.5 8.7 3.8 0.9 0.0 15.3 1.6 11.0 1.7 0.0 1.6 2.0 77.9 1.2 16.5 1.9 10.4 31.9 0.5 3.3 0.0 0.3 19.9 16.8 51.8 26.5 2.9 125.2 19.4 10.6 1.4 0.9 1.9 1.6 0.0 0.9 13.7 MEIS2 "HsT18361, MRG1" ENSG00000134138 "Meis homeobox 2" O14770 15 36889204-37101299 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 108.0;Cone photoreceptor cells: 239.5;Ito cells: 148.5;Rod photoreceptor cells: 121.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 49 "basophil: 4.8;eosinophil: 4.9" "Lineage enriched" "Detected in single" 49 "granulocytes: 4.9" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 41.7;SH-SY5Y: 39.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 83.2;olfactory region: 364.7" "HPA003256, CAB004999" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004999: AB_425545, HPA003256: AB_1079356" "unprognostic (4.33e-2)" "unprognostic (1.94e-2)" "unprognostic (6.71e-4)" "unprognostic (2.47e-3)" "unprognostic (1.65e-1)" "unprognostic (2.24e-1)" "unprognostic (5.23e-2)" "unprognostic (1.23e-1)" "unprognostic (3.66e-1)" "unprognostic (4.73e-2)" "unprognostic (7.97e-2)" "unprognostic (1.11e-1)" "prognostic unfavorable (2.64e-7)" "unprognostic (6.47e-2)" "unprognostic (8.15e-2)" "unprognostic (8.79e-5)" "unprognostic (1.15e-1)" 6.3 16.5 9.6 6.5 36.8 0.4 7.7 7.4 12.4 26.4 17.0 4.3 12.0 15.1 35.6 6.3 10.6 17.8 16.9 11.3 6.7 3.9 7.3 5.9 7.5 5.2 3.9 6.9 16.4 10.0 2.8 19.8 6.4 10.7 28.8 5.2 6.4 39.0 16.7 1.0 2.9 5.2 34.6 6.2 5.6 11.3 2.6 8.6 2.2 3.5 4.6 3.2 19.5 16.9 0.0 0.0 4.9 0.0 0.0 0.0 0.0 4.7 4.4 5.7 16.2 6.5 8.0 1.3 10.3 5.8 12.3 6.9 6.2 3.9 2.7 0.2 41.7 7.9 8.3 10.0 2.6 6.9 3.9 6.4 21.0 5.9 5.1 11.0 6.2 21.5 10.6 2.3 8.3 2.5 16.4 7.0 1.0 7.0 0.0 2.5 5.0 0.0 2.4 0.0 5.7 1.4 0.0 4.2 1.5 0.0 9.3 4.4 39.4 3.9 2.7 3.0 6.6 1.2 4.9 9.9 14.2 1.7 3.7 4.4 2.8 2.8 5.3 16.8 3.5 3.5 4.8 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 36.8 7.4 8.0 6.7 3.9 3.9 6.9 10.7 8.6 0.0 8.2 2.9 108.0 15.5 14.5 21.8 66.2 25.4 6.8 1.8 239.5 21.3 0.0 42.0 11.8 23.5 0.9 0.0 24.0 5.7 46.8 24.7 61.2 7.9 2.8 3.2 1.7 148.5 6.6 4.4 44.3 1.7 8.5 1.0 0.0 11.8 22.0 0.0 38.9 0.0 121.2 32.3 43.2 1.8 2.7 5.4 3.8 1.9 0.6 43.1 MEIS3 "DKFZp547H236, MRG2" ENSG00000105419 "Meis homeobox 3" Q99687 19 47403124-47419523 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 35.3;endometrium 1: 28.8" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 22.3;Horizontal cells: 42.9;Late spermatids: 47.6;Muller glia cells: 18.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 28.4;HMC-1: 24.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046699 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA046699: AB_2616456" "unprognostic (3.27e-3)" "unprognostic (2.98e-1)" "unprognostic (2.13e-2)" "unprognostic (4.49e-1)" "unprognostic (3.16e-1)" "unprognostic (4.67e-2)" "unprognostic (2.12e-2)" "unprognostic (5.93e-3)" "unprognostic (1.21e-1)" "unprognostic (2.73e-2)" "unprognostic (1.58e-2)" "unprognostic (9.76e-2)" "prognostic unfavorable (1.78e-6)" "unprognostic (9.29e-3)" "unprognostic (9.21e-3)" "unprognostic (4.36e-2)" "unprognostic (3.80e-3)" 5.6 3.9 35.3 4.7 10.6 0.0 5.0 11.0 25.3 8.4 4.7 2.4 3.8 3.5 28.8 2.2 6.0 14.2 6.0 3.7 23.2 11.6 1.5 1.1 3.1 1.2 2.6 14.6 7.4 1.7 1.1 4.9 7.4 3.8 7.0 2.1 4.1 3.6 6.4 1.4 1.6 3.8 22.5 1.7 2.4 2.6 3.3 2.0 0.5 3.4 1.6 1.4 6.1 4.7 0.0 0.2 0.5 0.7 0.0 0.1 0.4 0.3 12.1 28.4 0.1 15.4 13.3 0.4 12.7 19.4 9.9 17.5 1.1 1.9 0.0 1.4 20.8 8.2 1.4 2.9 3.5 3.4 18.9 4.3 0.0 4.4 0.1 10.0 0.2 24.6 9.8 0.7 3.9 2.1 3.5 0.0 0.0 0.2 2.8 1.1 11.5 0.0 0.1 8.3 0.3 0.7 0.0 2.1 0.3 0.6 0.9 1.1 23.0 10.9 0.9 5.2 11.8 0.6 3.5 0.0 7.6 19.3 5.5 1.7 0.0 0.0 0.0 21.2 1.1 15.2 0.1 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.2 0.1 0.4 35.3 10.6 11.0 25.3 23.2 11.6 2.6 14.6 3.8 2.0 0.0 2.7 0.0 1.0 0.7 4.8 0.8 0.0 2.7 3.4 3.5 5.9 0.1 0.0 0.0 22.3 0.5 0.0 0.0 0.0 0.2 9.9 3.2 0.0 0.0 0.5 42.9 0.0 1.8 0.0 47.6 10.6 1.1 6.8 0.0 0.0 18.0 0.1 0.0 3.9 0.0 2.7 12.9 6.9 2.6 4.7 0.9 0.7 0.0 0.0 0.7 MEN1 ENSG00000133895 "Menin 1" O00255 11 64803510-64811294 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030342 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030342: AB_10610138" "unprognostic (2.06e-1)" "unprognostic (1.76e-1)" "unprognostic (3.78e-2)" "unprognostic (2.31e-2)" "unprognostic (1.05e-1)" "unprognostic (8.41e-2)" "prognostic unfavorable (1.08e-4)" "unprognostic (2.66e-1)" "unprognostic (2.59e-1)" "unprognostic (1.42e-2)" "unprognostic (4.96e-2)" "unprognostic (1.36e-1)" "unprognostic (7.39e-2)" "prognostic favorable (6.31e-5)" "unprognostic (1.40e-1)" "unprognostic (3.03e-1)" "unprognostic (3.76e-1)" 12.1 20.6 13.2 15.6 17.7 11.8 12.5 25.8 26.9 15.5 14.9 16.4 22.2 16.9 14.8 18.4 18.9 17.6 14.7 9.0 12.4 11.5 15.9 23.0 12.8 22.1 12.5 15.6 19.7 25.9 16.8 18.0 16.1 16.0 15.9 11.6 16.6 23.3 19.9 8.4 21.6 15.8 11.0 9.8 20.6 15.3 21.2 12.3 33.2 23.9 6.2 20.3 13.7 15.5 5.2 2.9 3.4 1.5 1.8 4.8 1.0 16.3 22.0 14.1 22.1 15.8 10.2 16.6 11.8 11.7 18.4 12.4 12.7 16.2 23.3 19.3 9.1 15.4 23.4 19.1 16.3 11.1 19.9 28.2 19.3 17.7 16.9 14.0 12.4 13.1 11.7 12.3 15.5 12.8 11.1 17.0 30.0 28.0 8.9 10.2 30.6 31.3 25.1 18.4 13.8 33.1 24.3 16.0 22.3 11.9 15.2 19.9 17.5 13.9 19.7 14.3 10.5 29.3 13.8 10.7 17.4 16.7 20.8 9.9 14.0 16.2 11.8 13.8 9.7 11.0 0.9 1.3 3.4 3.7 1.5 4.8 3.7 2.6 4.6 1.3 5.2 4.5 2.6 0.2 1.8 0.5 2.9 1.9 1.0 13.2 17.7 25.8 26.9 12.4 11.5 12.5 15.6 16.0 12.3 3.0 4.8 19.3 3.8 5.0 8.3 3.7 2.5 1.4 1.2 3.5 5.9 15.7 3.3 7.3 0.9 4.4 8.4 0.0 6.2 18.5 4.6 4.9 1.1 9.4 7.9 3.2 4.1 8.0 0.3 0.6 11.2 2.6 8.5 6.4 8.7 8.4 7.1 10.1 3.5 6.2 5.7 12.9 2.7 16.6 15.5 6.0 13.6 6.7 9.5 3.0 MEOX1 MOX1 ENSG00000005102 "Mesenchyme homeobox 1" P50221 17 43640388-43661954 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 25 "Basal keratinocytes: 3.7;Endothelial cells: 15.5;Melanocytes: 5.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 17.9" "Lineage enriched" "Detected in single" 66 "T-cells: 17.9" "Cell line enriched" "Detected in some" 13 "HeLa: 24.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA045214, HPA063788" Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" NA NA Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA045214: AB_10959299, HPA063788: " "unprognostic (1.36e-3)" "unprognostic (2.15e-4)" "unprognostic (1.25e-1)" "unprognostic (2.58e-3)" "unprognostic (2.01e-2)" "unprognostic (5.65e-3)" "unprognostic (1.25e-1)" "unprognostic (4.55e-3)" "unprognostic (6.71e-2)" "unprognostic (2.64e-1)" "unprognostic (1.46e-1)" "unprognostic (9.36e-2)" "unprognostic (3.44e-6)" "unprognostic (2.40e-2)" "unprognostic (2.66e-1)" "unprognostic (1.82e-1)" "unprognostic (7.47e-3)" 24.3 0.3 0.1 7.4 0.1 0.0 17.3 0.1 0.1 12.4 3.2 0.1 2.3 1.2 11.6 5.7 10.9 6.7 6.5 17.8 0.1 0.1 0.2 0.3 1.2 5.4 0.1 0.1 4.8 1.2 1.5 0.5 0.3 0.1 8.2 1.9 0.8 5.8 2.0 19.8 4.6 3.5 8.6 0.1 8.9 2.4 3.5 0.1 3.2 1.7 15.4 7.1 6.1 16.7 0.0 0.0 0.0 0.0 0.2 17.9 0.9 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.4 0.1 0.0 0.0 1.7 0.1 0.5 0.0 0.1 0.0 0.0 0.1 0.1 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 4.6 3.0 0.0 0.0 1.8 0.5 0.0 0.2 0.0 0.0 17.9 0.9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 3.7 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 15.5 0.0 0.0 0.0 0.1 0.7 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 1.6 0.1 0.0 0.0 0.0 MEPCE "BCDIN3, FLJ20257, MePCE" ENSG00000146834 "Methylphosphate capping enzyme" Q7L2J0 7 100428790-100434126 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026384, HPA051587" Supported Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "CAB026384: , HPA051587: AB_2681544" "unprognostic (8.59e-2)" "unprognostic (1.23e-2)" "unprognostic (3.77e-2)" "prognostic unfavorable (6.01e-6)" "unprognostic (1.09e-1)" "unprognostic (1.53e-2)" "unprognostic (3.83e-2)" "unprognostic (2.19e-1)" "unprognostic (1.69e-2)" "unprognostic (2.95e-1)" "unprognostic (1.65e-3)" "unprognostic (1.09e-1)" "prognostic favorable (1.01e-10)" "unprognostic (9.66e-2)" "unprognostic (9.31e-2)" "unprognostic (4.57e-1)" "unprognostic (9.50e-3)" 17.5 24.1 17.7 13.9 22.8 18.5 15.0 24.1 24.1 15.7 14.0 16.7 26.9 14.1 18.8 22.5 16.1 18.6 22.9 12.4 20.1 13.7 18.7 20.8 13.5 19.7 19.7 16.4 29.2 18.3 32.5 15.0 19.0 19.3 15.8 10.2 17.2 18.5 24.2 21.4 26.1 15.8 15.7 17.7 34.9 14.4 63.1 20.4 21.7 25.7 17.1 17.9 16.3 20.4 8.4 8.7 9.3 3.6 7.3 9.1 10.6 13.5 17.6 13.1 14.0 12.7 12.8 9.7 15.2 22.3 16.5 12.8 14.3 20.0 28.0 25.4 9.5 13.0 12.6 14.2 11.5 10.9 12.5 16.2 14.4 13.6 10.8 10.7 18.4 17.9 13.2 13.8 18.8 23.9 9.0 13.7 9.0 28.5 20.8 15.7 50.5 21.0 42.0 24.1 11.4 19.6 17.0 10.5 25.4 11.0 8.4 19.7 17.0 23.8 46.7 15.9 6.8 11.9 16.9 11.7 27.8 21.6 18.7 20.0 13.8 13.1 31.2 15.6 23.1 24.3 2.5 3.6 4.8 5.6 3.2 6.5 8.0 6.4 6.0 4.4 8.4 9.1 8.0 9.3 7.3 2.6 8.7 5.7 10.6 17.7 22.8 24.1 24.1 20.1 13.7 19.7 16.4 19.3 20.4 8.9 20.5 18.0 14.7 26.9 8.9 19.8 17.8 9.4 7.9 21.0 7.9 13.3 13.3 9.0 21.7 18.0 26.9 0.0 10.4 7.0 12.5 12.5 17.4 17.9 10.9 11.1 10.3 33.2 27.3 44.1 16.1 14.2 8.5 18.0 18.8 16.7 8.8 24.6 14.5 11.7 9.1 6.5 12.8 34.9 13.7 22.0 17.7 15.8 15.5 8.6 MESP1 "bHLHc5, MGC10676" ENSG00000166823 "Mesoderm posterior bHLH transcription factor 1" Q9BRJ9 15 89748661-89751310 "Predicted intracellular proteins, Transcription factors" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 14.1;prostate: 10.9" "Cell type enhanced" "Detected in many" 6 "Exocrine glandular cells: 37.0;Glandular cells: 36.0;Spermatocytes: 42.6" "Group enriched" "Detected in many" 5 "endometrial cancer: 6.3;prostate cancer: 26.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 5.7;HDLM-2: 5.0;HEK 293: 5.0;PC-3: 9.5;SCLC-21H: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA069981 Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA069981: AB_2686225" "unprognostic (4.17e-2)" "unprognostic (1.52e-2)" "unprognostic (1.49e-1)" "unprognostic (1.27e-1)" "unprognostic (4.83e-2)" "unprognostic (7.21e-2)" "unprognostic (2.68e-2)" "unprognostic (4.95e-3)" "unprognostic (2.26e-2)" "unprognostic (2.47e-1)" "unprognostic (8.38e-2)" "unprognostic (2.06e-1)" "unprognostic (2.24e-3)" "unprognostic (2.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.10e-1)" "unprognostic (7.03e-2)" 14.1 1.6 6.8 1.4 4.3 1.1 3.8 7.3 8.8 2.5 1.9 1.1 0.1 1.3 1.0 1.0 0.9 1.0 2.9 3.9 4.9 5.0 1.3 1.2 1.1 1.1 3.3 4.3 1.0 1.2 1.1 1.1 0.8 2.4 10.9 1.0 1.3 3.0 1.2 7.0 0.9 1.1 0.9 1.4 0.9 1.0 1.4 1.9 0.0 1.0 2.2 0.9 0.9 0.4 0.0 0.1 0.0 0.1 0.0 0.8 0.1 5.7 2.1 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.3 0.1 0.0 0.3 0.0 2.3 0.0 0.7 0.0 0.4 0.0 0.0 5.0 5.0 0.2 0.9 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 1.5 0.0 0.2 0.0 0.1 0.8 1.4 0.0 0.0 9.5 0.2 0.0 1.3 0.1 0.0 4.4 0.1 1.1 1.9 1.2 0.0 0.1 0.7 0.0 0.0 0.3 3.4 1.1 2.3 0.8 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.1 6.8 4.3 7.3 8.8 4.9 5.0 3.3 4.3 2.4 1.9 0.0 0.6 0.8 2.6 0.2 10.5 5.2 12.7 0.0 0.0 1.8 9.8 1.8 10.0 16.5 3.7 0.7 17.0 0.0 37.0 0.1 1.0 36.0 4.6 11.5 2.0 7.9 5.8 3.1 2.2 1.0 1.1 2.1 6.8 2.8 4.6 12.7 7.1 10.5 0.0 11.1 15.3 0.0 1.0 42.6 14.3 0.3 0.2 4.4 11.0 5.0 METAP1 "KIAA0094, MAP1A, MetAP1A" ENSG00000164024 "Methionyl aminopeptidase 1" P53582 4 98995620-99062813 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 14 "Early spermatids: 345.0;Late spermatids: 1171.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025485, HPA037997, HPA037998" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 11000 Cytosol "Nucleoplasm, Plasma membrane" "CAB025485: , HPA037997: AB_2675777, HPA037998: AB_2675778" "unprognostic (1.79e-1)" "unprognostic (3.39e-1)" "prognostic favorable (7.22e-4)" "unprognostic (1.58e-2)" "unprognostic (6.53e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (3.08e-5)" "unprognostic (1.09e-1)" "unprognostic (1.51e-3)" "unprognostic (2.05e-1)" "prognostic unfavorable (2.28e-5)" "unprognostic (2.00e-1)" "prognostic favorable (1.72e-4)" "unprognostic (5.50e-2)" "unprognostic (8.51e-2)" "unprognostic (1.15e-3)" "prognostic favorable (9.31e-4)" 12.1 8.3 10.0 16.0 10.1 11.8 18.6 9.2 13.8 16.0 17.9 7.0 22.9 13.4 24.1 25.9 37.2 14.0 12.3 27.9 9.5 7.1 14.3 13.7 10.7 12.6 7.9 9.8 11.3 13.0 7.8 14.4 9.2 9.9 19.1 19.3 7.5 19.0 21.5 27.2 16.4 15.2 27.8 10.1 13.9 11.6 46.8 8.1 27.0 10.8 21.8 19.1 36.6 22.6 12.7 11.7 10.4 11.1 12.5 19.2 10.8 21.7 21.5 18.9 20.3 15.0 24.1 21.0 31.2 20.1 26.7 25.5 24.1 32.5 32.3 12.5 25.2 16.0 21.9 33.1 31.2 37.1 22.5 15.8 28.8 15.7 25.9 16.3 38.9 24.2 17.3 22.8 22.7 24.1 20.8 21.9 18.3 22.5 19.5 28.5 16.6 34.1 18.6 23.2 37.1 17.5 22.4 29.5 17.2 42.9 28.2 25.9 15.3 10.4 32.4 12.3 22.1 12.4 14.9 17.8 21.6 27.5 19.8 27.2 14.2 19.9 25.5 18.6 20.0 21.4 10.4 9.4 4.2 14.9 11.1 19.2 12.7 15.4 14.5 11.7 10.1 15.1 13.5 2.3 12.5 10.7 5.8 13.4 10.8 10.0 10.1 9.2 13.8 9.5 7.1 7.9 9.8 9.9 8.1 38.7 10.5 13.7 44.1 37.7 4.6 49.8 20.4 18.7 17.0 14.0 2.0 22.0 11.6 26.9 345.0 13.5 29.0 0.0 25.4 55.9 12.3 21.8 3.5 16.4 15.6 3.2 7.5 16.5 19.6 1171.9 17.8 14.6 15.1 6.4 25.2 8.3 22.3 34.2 21.2 22.9 3.5 25.8 22.1 15.1 46.4 33.9 6.4 15.2 32.6 39.6 METRN "C16orf23, MGC2601" ENSG00000103260 "Meteorin, glial cell differentiation regulator" Q9UJH8 16 715115-719655 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 58.9" "Cell type enriched" "Detected in many" 8 "Muller glia cells: 554.6" "Cancer enhanced" "Detected in all" "glioma: 69.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 53.4;PC-3: 41.3" "Region enriched" "Detected in all" 5 "cerebellum: 549.1" "Low region specificity" "Detected in all" HPA051164 Approved Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Secreted in brain" NA NA "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA051164: AB_2681369" "unprognostic (1.60e-2)" "unprognostic (3.49e-1)" "unprognostic (4.47e-2)" "unprognostic (2.96e-1)" "unprognostic (1.45e-1)" "unprognostic (7.49e-2)" "unprognostic (1.82e-1)" "unprognostic (2.59e-1)" "unprognostic (8.13e-2)" "unprognostic (2.35e-1)" "unprognostic (2.12e-2)" "unprognostic (3.32e-1)" "unprognostic (5.03e-3)" "unprognostic (3.62e-2)" "unprognostic (1.26e-1)" "unprognostic (3.09e-1)" "unprognostic (2.17e-2)" 7.7 14.9 44.7 5.1 58.9 2.6 4.6 14.2 45.4 4.1 7.0 24.1 19.8 5.6 5.3 7.8 3.1 27.4 6.4 12.4 39.6 31.6 10.5 8.5 6.0 4.2 45.7 15.1 2.7 43.1 5.2 15.1 5.3 15.3 7.4 2.5 9.2 27.3 16.8 21.5 3.9 5.9 4.4 39.5 5.4 8.3 4.6 19.0 2.5 6.6 3.4 3.0 3.9 5.0 3.2 0.9 0.8 1.0 1.7 2.9 0.5 2.6 22.5 4.4 22.5 7.9 4.4 7.2 5.3 2.7 2.1 1.4 3.3 6.6 0.4 12.5 3.7 8.2 9.9 0.6 5.2 0.3 1.4 9.9 0.9 4.1 17.0 4.8 1.9 2.9 10.7 5.7 0.6 1.3 6.7 0.7 6.3 1.5 0.5 1.6 53.4 0.7 6.5 1.6 2.9 41.3 7.3 5.1 7.3 5.5 0.7 7.0 8.9 2.1 5.9 27.4 0.5 8.9 3.8 2.4 6.1 11.7 7.1 4.6 3.4 0.9 0.4 9.6 1.4 14.4 0.0 0.3 0.8 2.9 1.0 1.7 3.2 1.5 2.7 0.2 0.5 0.9 1.9 0.0 1.7 1.0 0.9 2.8 0.5 44.7 58.9 14.2 27.4 39.6 31.6 45.7 15.1 15.3 19.0 0.0 2.1 4.2 14.7 3.4 38.6 14.0 50.9 2.7 0.0 15.7 13.7 0.6 43.1 6.3 6.5 12.6 15.0 0.0 4.2 1.8 8.7 28.3 0.0 27.2 5.2 66.7 26.2 19.0 5.1 14.5 10.3 4.8 10.1 0.0 8.1 554.6 5.4 14.7 8.9 43.5 29.1 25.8 15.3 3.9 11.3 2.6 0.3 6.4 8.6 14.2 METTL1 "C12orf1, TRM8, TRMT8" ENSG00000037897 "Methyltransferase like 1" Q9UBP6 12 57768471-57772793 "Enzymes, Plasma proteins, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Proximal tubular cells: 53.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in all" 6 "RH-30: 78.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020914, HPA050450" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA020914: AB_1853830, HPA050450: AB_2681130" "unprognostic (5.24e-2)" "unprognostic (2.60e-1)" "unprognostic (9.43e-2)" "unprognostic (3.46e-1)" "unprognostic (9.01e-2)" "unprognostic (1.41e-2)" "prognostic unfavorable (4.25e-6)" "unprognostic (5.67e-2)" "unprognostic (6.19e-2)" "unprognostic (1.14e-3)" "unprognostic (1.78e-1)" "unprognostic (2.32e-1)" "prognostic unfavorable (3.55e-6)" "unprognostic (7.75e-2)" "unprognostic (1.96e-1)" "unprognostic (5.01e-2)" "unprognostic (2.22e-1)" 12.2 16.6 6.7 13.8 8.8 8.4 12.3 2.2 6.9 7.6 7.6 4.5 10.8 3.3 9.4 21.2 10.3 9.0 10.7 8.1 5.8 5.0 20.9 15.3 7.7 8.8 7.4 4.6 17.6 34.9 10.9 10.6 8.3 6.5 11.0 10.3 5.3 17.9 17.2 20.4 8.5 5.7 10.5 5.0 8.2 7.3 11.4 5.4 4.5 15.1 15.6 9.8 8.8 7.8 6.1 12.6 0.7 6.7 7.3 18.6 5.1 6.1 11.2 4.7 4.3 6.4 4.4 6.4 6.6 6.0 11.1 6.0 7.8 8.6 7.4 12.3 8.0 6.3 7.3 7.2 10.2 10.8 4.4 8.4 8.6 4.3 9.5 4.5 9.3 4.5 3.9 9.3 12.4 8.7 5.4 5.9 4.8 7.9 7.4 5.6 11.9 6.5 11.1 11.1 8.2 11.3 5.8 78.7 10.9 9.7 7.7 5.0 4.5 6.9 7.6 6.1 4.9 10.0 8.8 4.4 4.5 5.0 7.9 8.7 3.4 2.5 9.0 6.4 6.7 9.3 0.0 4.7 0.0 5.3 6.7 18.6 4.7 6.9 6.5 10.3 6.1 9.5 9.2 0.7 7.3 1.1 12.6 3.3 5.1 6.7 8.8 2.2 6.9 5.8 5.0 7.4 4.6 6.5 5.4 8.9 3.5 8.9 11.4 9.3 2.9 3.6 2.5 1.4 17.0 5.2 0.0 15.0 21.6 15.2 11.3 7.1 1.3 0.0 20.6 19.6 12.0 7.7 12.7 9.0 22.2 3.2 6.3 4.3 1.0 8.6 10.3 9.0 6.8 27.1 5.6 1.6 12.8 0.0 4.6 53.6 5.5 0.0 14.7 4.8 14.7 9.2 8.1 4.3 9.1 10.5 METTL14 KIAA1627 ENSG00000145388 "Methyltransferase like 14" Q9HCE5 4 118685368-118715433 "Cancer-related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 64.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038002 Supported Supported Nucleoplasm Yes No Nucleoplasm "HPA038002: AB_10672401" "unprognostic (4.48e-1)" "unprognostic (5.13e-2)" "unprognostic (5.98e-3)" "unprognostic (3.44e-2)" "unprognostic (1.33e-1)" "unprognostic (1.83e-1)" "unprognostic (3.75e-2)" "unprognostic (4.40e-1)" "unprognostic (9.97e-2)" "unprognostic (2.40e-2)" "unprognostic (3.64e-2)" "unprognostic (3.33e-3)" "prognostic favorable (1.46e-5)" "unprognostic (1.05e-1)" "unprognostic (1.32e-1)" "unprognostic (1.76e-3)" "unprognostic (7.76e-3)" 17.3 16.4 15.5 12.4 19.2 25.8 18.0 25.9 19.4 21.8 16.1 12.8 11.7 13.4 19.1 17.2 16.4 15.9 12.0 12.3 13.3 11.3 17.4 22.0 13.9 15.9 16.4 16.0 22.6 14.6 17.1 34.5 13.6 16.0 20.0 13.0 12.3 13.7 14.9 13.5 16.4 15.4 14.5 17.3 17.3 14.2 26.6 18.4 24.1 18.7 10.6 16.2 23.0 16.1 18.9 12.3 24.1 17.5 17.1 18.4 10.7 14.7 6.8 14.9 14.0 9.4 11.9 10.9 13.2 10.1 10.0 11.5 9.8 17.7 16.8 7.9 9.2 10.0 7.3 12.6 10.9 12.8 13.2 7.7 14.0 8.6 10.9 10.8 22.6 16.8 10.5 12.6 11.5 7.7 13.1 9.0 13.5 14.9 14.3 13.6 9.9 22.1 19.0 12.8 12.7 6.0 12.7 18.7 8.4 10.8 9.8 12.3 13.8 9.3 17.3 12.5 14.3 7.8 21.6 12.1 14.5 13.3 12.9 10.4 12.0 12.5 19.1 10.3 12.7 11.7 24.1 10.6 22.3 14.7 15.6 16.6 18.9 15.4 15.1 12.3 18.1 18.4 16.6 8.5 17.1 17.5 9.8 16.2 10.7 15.5 19.2 25.9 19.4 13.3 11.3 16.4 16.0 16.0 18.4 23.8 23.4 4.8 15.3 9.6 15.8 13.7 15.3 13.4 27.3 22.7 21.6 15.0 10.0 9.5 64.5 14.8 10.9 0.0 13.6 8.9 10.1 14.5 20.9 29.7 10.5 7.9 11.6 14.7 15.5 9.0 17.3 12.0 6.8 7.2 14.1 12.0 12.0 15.0 13.1 18.2 24.7 12.9 11.7 18.9 16.8 10.5 12.8 17.5 13.0 13.2 METTL16 "METT10D, MGC3329" ENSG00000127804 "Methyltransferase like 16" Q86W50 17 2405562-2511891 "Enzymes, Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020352, HPA059798" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA020352: AB_1853828, HPA059798: AB_2684128" "unprognostic (4.94e-3)" "unprognostic (2.86e-2)" "unprognostic (2.29e-2)" "unprognostic (5.66e-3)" "unprognostic (1.50e-1)" "unprognostic (5.47e-2)" "unprognostic (3.35e-2)" "unprognostic (1.88e-1)" "unprognostic (1.25e-1)" "unprognostic (3.46e-1)" "prognostic favorable (3.06e-4)" "unprognostic (5.35e-2)" "unprognostic (4.85e-3)" "unprognostic (2.91e-2)" "unprognostic (2.32e-1)" "unprognostic (1.61e-1)" "unprognostic (2.68e-2)" 12.7 14.0 13.1 11.0 15.2 13.1 14.1 22.5 14.4 14.9 13.1 19.8 11.2 8.6 21.6 10.6 11.0 16.5 9.6 12.4 12.6 9.7 11.5 6.9 12.2 13.1 18.3 9.7 22.5 13.5 19.7 22.8 7.5 13.6 13.5 10.4 18.3 12.1 13.1 14.2 14.7 10.4 16.5 14.6 11.1 11.2 11.0 17.5 15.7 16.5 8.8 17.5 15.3 12.7 5.7 3.1 2.3 3.2 2.0 8.1 2.0 6.1 16.4 9.3 8.9 7.0 8.9 8.7 7.8 6.8 8.9 7.4 21.8 4.0 19.3 8.5 7.1 9.5 8.9 21.4 10.7 12.2 7.3 13.6 9.9 13.5 9.9 7.6 9.1 8.0 7.5 10.2 12.3 18.2 6.1 9.2 11.3 12.9 10.4 6.0 6.7 13.0 5.4 10.6 7.6 6.9 21.7 9.8 8.7 6.5 5.6 4.9 7.7 11.7 6.4 6.9 10.0 8.1 5.8 6.7 8.2 5.3 11.6 11.3 6.1 7.5 13.8 11.1 7.6 11.1 2.3 3.2 1.2 5.7 2.1 7.2 5.7 5.6 5.5 2.2 5.0 8.1 5.9 0.1 2.0 1.5 3.1 3.5 2.0 13.1 15.2 22.5 14.4 12.6 9.7 18.3 9.7 13.6 17.5 11.9 31.0 7.0 19.7 10.2 26.4 14.0 15.3 34.8 36.4 7.0 43.2 7.3 11.6 8.4 12.4 12.9 15.8 0.0 9.2 7.9 8.9 15.5 24.3 7.3 8.9 25.4 19.5 19.6 9.2 5.4 13.8 8.2 8.5 9.0 12.7 25.1 8.0 3.5 12.0 7.0 38.8 6.5 13.2 11.4 17.4 11.2 5.0 20.8 14.0 13.5 METTL17 "FLJ20859, METT11D1" ENSG00000165792 "Methyltransferase like 17" Q9H7H0 14 20989770-20997035 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002955, HPA059802" Uncertain Enhanced Nucleoplasm "Intracellular and membrane" No No Nucleoplasm "HPA002955: AB_2144183, HPA059802: AB_2684129" "unprognostic (1.90e-2)" "unprognostic (1.21e-1)" "unprognostic (2.17e-1)" "unprognostic (2.53e-1)" "unprognostic (2.88e-1)" "unprognostic (1.28e-1)" "unprognostic (1.00e-2)" "unprognostic (2.23e-3)" "unprognostic (1.90e-1)" "unprognostic (1.33e-1)" "unprognostic (1.39e-1)" "unprognostic (4.02e-2)" "unprognostic (3.06e-2)" "unprognostic (1.39e-2)" "unprognostic (1.35e-1)" "unprognostic (2.11e-1)" "unprognostic (3.29e-2)" 11.4 35.7 15.8 15.8 18.4 25.4 14.4 24.9 16.6 16.4 22.1 14.2 25.6 19.7 14.9 15.8 23.4 15.2 12.2 20.6 17.3 10.0 20.7 20.4 17.5 18.5 21.1 11.8 15.6 19.8 11.6 18.9 16.0 16.1 13.4 25.0 14.2 23.1 26.1 20.2 16.0 21.6 21.0 16.3 25.0 17.6 21.9 20.2 17.9 15.1 22.1 22.3 12.7 15.2 7.9 10.3 17.6 5.3 6.2 9.2 4.3 14.4 17.9 18.8 7.1 11.6 5.2 14.5 9.6 13.5 29.3 24.2 14.1 18.9 31.0 9.8 12.5 18.1 24.2 23.8 18.8 21.2 10.9 19.7 16.2 13.2 18.4 10.9 27.1 18.8 10.8 16.6 15.0 11.2 10.4 11.7 27.8 14.9 14.9 13.9 10.7 18.0 28.2 18.7 23.1 22.7 23.1 16.5 20.4 15.6 14.2 13.5 15.9 12.7 16.7 9.6 14.4 11.6 23.9 6.5 10.2 29.9 9.9 13.1 12.9 20.9 22.1 5.9 19.5 12.3 17.6 5.3 5.0 8.6 4.9 4.8 7.3 9.1 8.4 10.3 7.9 8.9 9.2 0.0 6.2 3.2 6.2 7.1 4.3 15.8 18.4 24.9 16.6 17.3 10.0 21.1 11.8 16.1 20.2 8.9 12.4 26.4 18.4 16.8 36.1 4.8 17.8 24.1 12.5 10.4 41.2 27.0 5.0 17.2 37.8 9.0 22.4 0.0 13.4 14.1 13.0 10.5 27.8 22.7 16.0 20.6 11.7 12.3 9.9 5.6 31.1 17.5 3.3 19.8 20.1 26.1 13.4 30.0 20.1 13.6 49.5 12.9 13.9 18.2 14.0 15.6 10.6 18.7 30.4 24.6 METTL18 "AsTP2, C1orf156, HPM1, MGC9084" ENSG00000171806 "Methyltransferase like 18" O95568 1 169792529-169794966 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035314 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA035314: AB_10601146" "unprognostic (6.63e-2)" "unprognostic (1.46e-1)" "unprognostic (3.34e-1)" "unprognostic (1.01e-1)" "unprognostic (1.69e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.01e-4)" "unprognostic (1.41e-1)" "unprognostic (1.05e-2)" "unprognostic (2.39e-2)" "unprognostic (5.67e-2)" "unprognostic (2.14e-2)" "prognostic unfavorable (4.06e-4)" "unprognostic (3.65e-1)" "unprognostic (3.06e-2)" "unprognostic (3.03e-2)" "prognostic favorable (3.28e-4)" 8.7 7.3 12.1 9.9 9.0 3.8 11.5 13.5 11.8 6.5 6.8 3.5 8.4 5.6 7.7 9.8 7.8 8.2 5.2 10.2 8.5 6.8 8.6 8.5 5.9 16.5 11.1 10.1 10.4 9.4 31.9 9.4 6.3 9.2 11.2 6.8 3.4 8.4 7.5 5.0 6.5 9.2 6.3 12.7 14.3 8.2 6.7 11.2 9.8 10.0 8.0 11.8 7.8 8.9 13.4 5.4 12.2 5.8 12.4 19.3 9.8 9.0 5.2 8.5 5.8 5.0 9.3 5.9 4.2 4.9 5.4 4.7 6.6 14.7 15.4 11.8 5.6 7.9 10.4 8.5 9.6 7.3 9.2 6.8 11.0 4.7 5.4 10.3 11.6 5.1 4.2 10.1 5.5 6.0 5.5 10.3 11.9 11.6 7.3 7.2 4.4 12.2 7.9 10.7 19.5 13.1 9.1 8.4 11.6 8.7 9.1 6.3 9.7 9.0 10.2 12.4 13.2 13.5 12.8 4.6 6.8 6.5 6.8 9.8 14.3 18.6 20.8 5.0 9.3 6.8 9.3 5.2 12.2 14.6 5.8 18.5 12.1 16.3 17.0 5.4 13.4 19.3 18.3 3.0 12.4 3.4 4.2 18.4 9.8 12.1 9.0 13.5 11.8 8.5 6.8 11.1 10.1 9.2 11.2 3.0 5.8 1.5 5.6 1.3 7.5 5.3 5.1 13.4 5.7 5.2 0.0 11.5 21.6 9.3 13.7 7.8 3.9 0.0 6.9 4.9 5.6 3.4 6.9 2.6 6.5 6.4 2.9 2.5 4.7 3.6 5.8 2.8 5.0 1.0 4.9 8.5 5.3 5.8 4.9 7.0 6.1 0.0 2.8 14.4 9.4 0.6 9.6 10.0 4.9 2.1 METTL21A "FAM119A, HCA557b, HSPA-KMT, LOC151194" ENSG00000144401 "Methyltransferase like 21A" Q8WXB1 2 207580631-207625928 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034712 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034712: AB_10670160" "unprognostic (1.41e-1)" "unprognostic (1.50e-1)" "unprognostic (4.56e-2)" "unprognostic (2.09e-3)" "unprognostic (2.00e-1)" "unprognostic (1.64e-2)" "prognostic unfavorable (1.87e-5)" "unprognostic (4.80e-2)" "unprognostic (2.30e-2)" "unprognostic (2.47e-3)" "unprognostic (6.65e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (5.43e-4)" "unprognostic (5.01e-2)" "unprognostic (3.05e-1)" "unprognostic (1.52e-2)" "unprognostic (2.05e-1)" 10.4 9.1 16.5 13.8 18.2 20.2 14.6 14.0 16.9 9.0 9.3 8.7 3.8 8.1 10.0 8.4 6.7 8.3 7.1 13.2 16.3 15.4 11.1 20.9 8.9 15.4 25.8 10.6 12.0 10.6 11.6 10.1 12.7 20.2 8.8 9.2 8.8 8.4 7.1 19.5 9.0 8.3 8.3 19.2 15.4 12.3 7.1 18.8 18.5 15.2 6.2 14.8 10.1 24.3 25.2 14.8 25.9 20.6 7.5 14.4 8.3 8.0 7.6 12.6 9.5 5.6 5.9 24.5 4.5 5.6 7.3 7.4 14.4 13.0 11.7 10.0 3.5 12.9 4.7 18.0 5.9 6.1 6.8 12.4 13.6 12.2 23.7 9.9 17.8 13.8 5.2 7.9 3.6 6.1 9.1 8.2 19.6 19.6 6.9 4.8 13.1 17.9 30.5 20.9 11.0 5.4 13.2 5.3 16.9 10.5 6.8 14.9 12.3 9.7 3.4 9.4 18.3 4.7 26.4 4.2 6.4 14.0 5.9 7.9 10.2 12.8 24.1 10.5 14.0 9.5 13.8 14.4 25.9 5.0 13.9 8.3 25.2 7.6 7.1 11.8 21.6 14.4 9.2 5.0 7.5 20.6 14.8 5.9 8.3 16.5 18.2 14.0 16.9 16.3 15.4 25.8 10.6 20.2 18.8 14.9 22.3 43.0 29.8 14.2 19.9 23.8 15.3 25.4 21.6 10.4 7.9 32.6 24.9 21.2 24.4 14.8 9.7 0.0 22.0 25.1 20.5 35.0 46.1 10.9 26.1 17.5 5.2 12.3 20.6 28.4 9.2 39.1 42.2 19.0 14.2 15.6 18.5 61.9 7.1 19.3 19.9 12.9 12.5 9.8 17.2 11.0 8.8 18.3 16.6 16.6 METTL22 "C16orf68, FLJ12433, MGC2654" ENSG00000067365 "Methyltransferase like 22" Q9BUU2 16 8621683-8649654 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Early spermatids: 86.1;Late spermatids: 289.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 12.6" "Lineage enriched" "Detected in all" 4 "granulocytes: 12.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040803, HPA059882, HPA074173" Uncertain Supported "Nucleoplasm,Nucleoli rim" Yes No "Nucleoli rim" Nucleoplasm "HPA040803: AB_10795479, HPA059882: AB_2684150, HPA074173: AB_2686672" "unprognostic (1.74e-1)" "unprognostic (6.50e-2)" "unprognostic (3.02e-1)" "unprognostic (1.41e-1)" "unprognostic (7.83e-2)" "unprognostic (1.52e-1)" "unprognostic (1.39e-1)" "unprognostic (2.58e-2)" "unprognostic (1.80e-2)" "unprognostic (1.10e-1)" "unprognostic (1.94e-3)" "unprognostic (3.82e-2)" "prognostic unfavorable (2.79e-8)" "unprognostic (1.78e-2)" "unprognostic (2.81e-1)" "unprognostic (1.15e-2)" "unprognostic (8.90e-2)" 8.4 10.6 5.4 10.5 8.8 12.5 8.0 17.1 10.2 9.6 10.9 10.9 13.6 9.2 13.0 12.2 7.6 8.6 9.8 15.0 7.0 7.3 7.1 9.5 6.5 10.8 7.9 6.8 10.8 10.6 7.3 7.6 9.4 9.3 10.5 7.9 10.2 9.5 15.6 45.2 15.7 6.4 11.4 6.3 8.1 9.8 27.8 9.3 10.4 10.1 10.0 9.1 9.7 9.9 1.1 2.8 12.6 3.0 1.8 1.6 1.4 3.7 7.7 8.8 8.3 3.3 8.5 7.6 6.4 3.4 7.7 8.7 7.5 8.7 5.8 5.8 5.6 2.8 7.1 5.5 10.2 5.1 8.5 7.5 6.0 13.4 21.2 10.0 6.1 4.6 8.5 7.4 8.4 9.2 4.7 6.1 8.1 8.0 6.0 5.8 13.2 6.3 14.8 4.7 1.7 7.6 9.6 6.6 12.1 3.7 4.0 10.8 7.2 5.6 6.6 4.2 5.0 7.2 5.1 4.7 9.1 7.9 7.4 2.9 8.1 4.3 9.1 3.3 8.2 4.2 1.4 3.0 2.4 1.3 2.3 1.2 1.1 1.1 1.3 2.8 1.1 1.5 0.7 12.6 1.8 2.5 1.6 1.6 1.4 5.4 8.8 17.1 10.2 7.0 7.3 7.9 6.8 9.3 9.3 8.9 6.4 9.7 6.4 3.0 13.1 16.7 5.1 2.7 5.7 0.0 3.9 10.3 10.0 8.1 86.1 6.7 5.6 0.0 8.3 8.2 4.3 8.9 8.1 6.2 26.1 1.6 6.9 5.5 27.8 289.3 10.0 22.9 1.7 2.8 5.1 5.4 7.7 8.2 13.1 6.8 12.2 0.0 4.7 22.1 12.9 2.4 11.1 5.7 5.9 6.5 METTL9 DREV1 ENSG00000197006 "Methyltransferase like 9" Q9H1A3 16 21597218-21657473 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Proximal tubular cells: 326.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053588, HPA056347" Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" "Secreted to blood" NA NA "Nucleoplasm, Cell Junctions" Cytosol "HPA053588: AB_2682203, HPA056347: " "unprognostic (1.55e-1)" "unprognostic (2.18e-2)" "unprognostic (1.98e-3)" "unprognostic (5.43e-2)" "unprognostic (5.81e-2)" "unprognostic (3.13e-1)" "prognostic unfavorable (8.71e-4)" "unprognostic (3.44e-2)" "unprognostic (1.11e-2)" "unprognostic (7.57e-3)" "unprognostic (1.73e-2)" "unprognostic (3.18e-1)" "unprognostic (1.49e-3)" "unprognostic (2.14e-1)" "unprognostic (3.28e-1)" "unprognostic (5.17e-2)" "unprognostic (1.65e-1)" 24.0 45.5 29.6 18.8 34.9 50.0 45.1 12.2 31.9 34.2 19.1 18.7 15.5 14.9 23.4 35.6 30.2 23.8 19.4 32.0 22.2 20.0 61.0 8.7 24.0 38.8 26.8 8.4 22.8 28.8 37.2 25.0 25.4 17.7 23.8 20.3 32.5 22.1 19.3 30.6 21.5 20.6 21.1 25.0 29.6 18.8 10.8 18.1 39.8 37.8 20.0 25.9 24.9 24.6 4.9 14.1 30.5 24.5 5.6 7.3 7.6 13.6 10.4 26.4 22.8 27.3 49.5 9.5 21.9 31.4 17.3 21.0 7.5 24.9 24.0 18.7 38.3 16.7 8.6 17.5 19.6 23.7 18.2 14.3 10.4 10.5 27.9 19.6 8.1 21.6 29.1 20.9 17.9 23.4 32.6 33.1 26.9 15.3 19.8 34.2 15.1 21.1 13.6 23.7 17.0 10.8 30.8 20.5 21.8 28.5 13.4 15.3 27.6 18.6 12.9 46.7 20.7 13.1 4.2 18.7 28.8 12.6 17.6 13.4 16.8 27.0 19.3 28.3 20.2 20.3 30.5 24.5 10.7 4.0 4.5 4.8 4.6 6.8 7.3 14.1 4.9 7.3 5.4 12.5 5.6 3.9 4.4 5.4 7.6 29.6 34.9 12.2 31.9 22.2 20.0 26.8 8.4 17.7 18.1 17.9 25.0 67.7 73.4 63.7 38.7 50.8 28.1 17.4 25.0 82.0 43.2 62.9 238.8 101.7 6.4 91.1 45.1 0.0 107.0 99.3 82.6 115.4 48.3 10.4 80.8 42.9 81.5 80.4 211.5 4.5 58.7 86.5 99.5 101.8 76.5 49.9 98.9 45.6 61.2 326.8 37.5 64.7 68.4 13.2 20.0 67.2 116.4 146.0 75.0 107.4 MEX3B "DKFZp434J0617, RKHD3, RNF195" ENSG00000183496 "Mex-3 RNA binding family member B" Q6ZN04 15 82041778-82046141 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 15.6;testis: 33.3" "Group enriched" "Detected in many" 21 "Early spermatids: 185.8;Late spermatids: 144.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "myeloid DC: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 33.5;HEL: 24.6;SH-SY5Y: 13.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041093 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041093: AB_10793868" "unprognostic (2.42e-1)" "unprognostic (1.76e-1)" "unprognostic (2.74e-2)" "unprognostic (6.84e-2)" "unprognostic (1.43e-1)" "unprognostic (1.64e-1)" "unprognostic (5.22e-2)" "unprognostic (7.56e-2)" "unprognostic (4.98e-2)" "unprognostic (1.18e-1)" "unprognostic (2.31e-1)" "unprognostic (9.31e-3)" "unprognostic (5.93e-8)" "unprognostic (1.24e-2)" "unprognostic (9.05e-2)" "unprognostic (4.09e-2)" "unprognostic (1.51e-2)" 2.0 0.6 1.5 1.8 1.6 2.0 1.6 3.8 4.5 15.6 2.8 1.6 2.5 0.8 7.9 0.6 1.1 1.2 2.8 2.0 2.0 1.4 1.0 1.0 1.4 2.8 2.2 3.3 6.8 0.7 0.2 0.9 3.3 1.0 3.7 0.9 1.2 3.0 3.8 1.6 1.1 1.1 4.0 1.0 1.2 1.0 33.3 0.7 8.4 1.0 1.8 1.2 3.1 4.2 0.0 1.3 0.0 0.1 0.4 0.1 0.0 0.1 1.2 8.8 33.5 0.7 1.0 2.5 1.0 0.5 1.8 1.6 0.2 0.2 1.5 0.6 1.9 0.5 0.2 4.1 0.1 1.3 0.3 2.7 24.6 1.4 1.1 1.4 0.3 7.8 0.5 0.7 1.0 2.0 4.3 3.8 3.1 1.2 0.0 3.1 0.8 4.0 2.1 11.4 0.0 0.3 5.6 5.4 0.8 0.0 0.0 7.0 13.7 1.7 0.3 1.1 2.6 0.1 0.4 3.5 4.6 5.4 2.5 1.5 3.2 1.6 1.8 1.5 2.4 3.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 1.5 1.6 3.8 4.5 2.0 1.4 2.2 3.3 1.0 0.7 0.0 1.1 0.0 0.4 2.5 3.3 3.7 0.0 0.0 0.0 0.0 2.0 7.7 0.0 0.8 185.8 1.9 0.0 0.0 0.2 7.2 4.3 0.9 1.1 0.0 1.5 0.0 1.2 3.7 1.0 144.1 6.1 3.6 6.8 0.0 1.6 5.7 0.6 0.0 4.2 0.0 2.8 6.5 4.0 2.6 4.3 1.8 2.1 0.0 1.1 0.3 MFAP1 AMP ENSG00000140259 "Microfibril associated protein 1" P55081 15 43804492-43824802 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015583, HPA042370" Uncertain Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA015583: , HPA042370: AB_10796904" "unprognostic (1.05e-1)" "unprognostic (5.94e-2)" "unprognostic (2.56e-2)" "unprognostic (1.23e-2)" "unprognostic (2.06e-1)" "unprognostic (5.28e-2)" "prognostic unfavorable (2.50e-4)" "unprognostic (4.08e-1)" "unprognostic (1.48e-1)" "unprognostic (1.66e-2)" "unprognostic (3.12e-1)" "unprognostic (7.02e-2)" "prognostic favorable (1.04e-9)" "unprognostic (1.66e-2)" "unprognostic (9.68e-2)" "unprognostic (3.82e-3)" "unprognostic (1.54e-2)" 23.7 32.9 23.8 25.4 25.0 12.5 24.3 35.5 29.2 22.5 19.5 17.7 20.0 15.9 25.2 27.2 28.0 21.2 16.8 21.9 24.6 21.2 28.1 20.0 16.8 26.7 21.5 30.9 29.2 20.0 38.5 33.0 25.2 24.0 26.3 20.7 15.5 21.9 21.8 33.3 24.4 19.3 21.5 26.7 23.9 21.0 21.7 27.3 33.9 28.2 19.2 34.1 24.1 28.2 21.2 20.3 34.3 21.5 29.6 26.0 15.1 15.5 16.2 28.2 18.5 24.0 15.2 17.4 25.1 17.5 20.4 23.9 25.2 10.2 16.7 24.0 15.5 20.8 28.3 25.1 20.5 24.2 28.2 15.0 40.5 29.2 18.8 18.9 24.0 21.7 14.1 22.5 19.5 17.7 19.7 19.9 19.3 36.6 14.4 24.4 11.6 19.5 18.2 19.9 29.1 14.2 28.7 28.3 10.7 21.2 23.3 17.9 17.6 22.1 19.0 10.2 23.5 28.5 15.5 18.8 20.8 14.8 22.8 20.2 17.7 42.6 36.6 17.5 23.0 15.2 21.4 15.8 34.3 23.4 21.5 22.9 21.2 23.4 22.0 20.3 18.6 24.1 23.5 14.4 29.6 17.1 16.7 26.0 15.1 23.8 25.0 35.5 29.2 24.6 21.2 21.5 30.9 24.0 27.3 32.8 24.6 22.3 53.2 27.0 43.5 27.8 22.9 76.3 37.5 48.8 5.9 80.4 48.0 35.7 4.6 33.8 18.8 0.0 25.6 46.4 25.7 30.0 46.1 16.3 30.6 30.2 10.9 19.0 22.6 4.7 25.9 22.6 25.3 32.5 19.6 45.9 21.9 28.1 33.6 32.8 30.7 19.4 23.5 42.6 76.1 24.2 123.1 30.6 18.8 39.7 MFAP3 ENSG00000037749 "Microfibril associated protein 3" P55082 5 154038906-154220478 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015883, HPA049198" Approved Approved "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" Nucleoplasm "HPA015883: AB_1853840, HPA049198: AB_2680672" "unprognostic (6.02e-2)" "prognostic unfavorable (4.28e-4)" "unprognostic (1.58e-3)" "unprognostic (2.40e-2)" "unprognostic (1.60e-1)" "unprognostic (1.21e-1)" "unprognostic (6.33e-2)" "unprognostic (6.58e-3)" "unprognostic (1.21e-1)" "unprognostic (3.07e-2)" "unprognostic (1.53e-2)" "unprognostic (7.00e-2)" "unprognostic (1.30e-1)" "unprognostic (1.33e-2)" "unprognostic (2.05e-1)" "unprognostic (7.16e-3)" "unprognostic (9.35e-3)" 21.3 7.6 5.8 8.0 12.2 7.9 11.3 12.6 11.4 11.1 8.3 6.3 7.8 7.2 14.1 7.3 11.6 7.5 8.9 9.2 7.2 6.8 9.5 9.4 10.9 6.8 6.4 7.1 9.4 6.3 27.2 9.6 15.0 8.8 7.8 8.4 9.5 8.8 6.4 13.2 6.4 9.5 11.7 8.9 7.9 7.4 8.3 7.0 9.1 11.3 6.3 9.2 12.2 10.1 3.0 10.6 14.6 10.3 7.7 9.6 5.4 9.7 12.7 21.6 22.7 19.5 18.3 21.2 17.6 18.9 18.4 23.8 19.1 22.2 14.0 20.5 16.6 18.3 22.0 20.3 22.0 29.5 6.3 13.3 9.2 19.5 6.9 18.6 16.4 10.8 19.7 21.9 22.0 18.7 15.2 25.7 12.7 10.4 15.2 16.0 6.4 9.1 3.7 11.2 10.4 7.5 8.7 25.6 12.8 11.9 13.8 22.3 24.9 19.3 21.8 17.4 20.0 22.9 8.1 23.3 24.0 16.8 13.2 17.9 15.3 19.6 13.2 12.2 11.3 18.8 8.1 10.3 14.6 6.5 9.8 9.6 3.0 5.6 4.9 10.6 3.0 7.4 5.4 8.4 7.7 7.0 3.8 4.9 5.4 5.8 12.2 12.6 11.4 7.2 6.8 6.4 7.1 8.8 7.0 0.0 0.3 0.0 0.9 5.4 3.3 2.0 0.0 0.0 0.0 5.2 5.9 3.5 1.7 0.9 4.5 4.8 2.0 0.0 1.0 2.4 2.7 1.1 4.6 1.6 1.6 3.2 0.0 0.0 1.2 3.3 1.7 2.5 8.5 1.0 0.6 7.8 0.9 0.0 0.0 1.1 4.3 0.0 3.0 2.1 2.1 4.8 5.0 1.3 0.6 1.4 MFAP3L "KIAA0626, NYD-sp9" ENSG00000198948 "Microfibril associated protein 3 like" O75121 4 169986597-170033031 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 32.9" "Group enriched" "Detected in many" 20 "Early spermatids: 409.5;Late spermatids: 1347.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 7.9;eosinophil: 2.1;neutrophil: 4.9" "Lineage enriched" "Detected in single" 9 "granulocytes: 7.9" "Cell line enhanced" "Detected in many" "HMC-1: 14.4;RT4: 23.5;SK-BR-3: 21.6;SuSa: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017986, HPA062306, HPA077490" Enhanced Supported "Nucleoplasm,Cell Junctions" "Intracellular and membrane" NA NA Nucleoplasm "Cell Junctions" "HPA017986: AB_1853842, HPA062306: , HPA077490: AB_2686842" "unprognostic (8.04e-3)" "unprognostic (8.67e-3)" "unprognostic (3.74e-1)" "unprognostic (1.28e-2)" "unprognostic (4.51e-2)" "unprognostic (7.92e-2)" "unprognostic (3.50e-2)" "unprognostic (3.14e-2)" "unprognostic (2.67e-1)" "unprognostic (2.33e-1)" "unprognostic (3.96e-1)" "unprognostic (7.58e-2)" "prognostic favorable (1.42e-8)" "unprognostic (6.59e-3)" "unprognostic (2.12e-1)" "unprognostic (1.62e-4)" "unprognostic (2.40e-3)" 2.1 3.4 15.0 1.3 19.6 2.7 10.2 4.9 19.4 11.4 2.1 21.1 4.2 1.0 4.9 32.9 1.2 4.0 2.6 1.9 15.4 11.1 25.6 29.5 2.7 1.2 21.8 10.0 1.1 1.6 5.7 3.3 5.5 21.1 2.9 2.2 17.5 2.0 11.7 4.2 19.7 1.1 3.9 16.4 1.7 1.3 30.6 20.8 0.0 2.8 0.2 1.0 11.9 1.5 0.0 0.7 7.9 0.8 0.0 0.8 6.9 0.2 3.5 1.9 2.0 1.6 0.8 0.7 3.8 0.5 1.8 1.6 1.2 0.2 0.0 0.1 5.9 3.4 1.8 6.9 0.8 0.8 0.0 2.6 0.0 3.7 1.4 0.9 0.0 14.4 1.2 2.1 0.2 0.6 1.0 0.2 2.2 0.5 0.7 3.6 2.0 0.6 0.5 2.0 0.4 3.0 0.0 1.1 0.0 5.2 23.5 1.6 3.5 3.2 21.6 6.9 12.8 1.2 0.0 0.1 1.9 7.1 3.5 7.3 0.3 0.0 0.0 4.8 0.7 7.1 7.9 0.2 2.1 0.8 0.8 0.4 0.0 0.7 0.2 0.3 0.0 0.3 0.1 4.9 0.0 0.0 0.7 0.1 6.9 15.0 19.6 4.9 15.4 15.4 11.1 21.8 10.0 21.1 20.8 0.0 6.4 0.0 0.2 2.3 9.2 2.5 0.0 0.0 0.0 34.9 19.6 2.9 5.0 0.4 409.5 2.3 0.4 23.3 1.0 0.9 0.5 0.5 4.6 43.3 0.9 3.2 2.4 4.9 1.0 1347.3 4.9 0.6 6.8 0.0 0.1 2.3 1.3 0.0 8.5 17.3 14.7 19.4 3.4 18.0 13.6 7.3 7.9 0.0 0.4 2.1 MFHAS1 "LRRC65, MASL1, ROCO4" ENSG00000147324 "Malignant fibrous histiocytoma amplified sequence 1" Q9Y4C4 8 8783354-8893645 "Disease related genes, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Signal transduction inhibitor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 2.5;MAIT T-cell: 2.1;memory B-cell: 1.1;memory CD4 T-cell: 3.9;memory CD8 T-cell: 2.2;naive B-cell: 1.0;naive CD4 T-cell: 1.9;naive CD8 T-cell: 1.7;T-reg: 3.1" "Group enriched" "Detected in many" 5 "B-cells: 1.1;T-cells: 3.9" "Cell line enhanced" "Detected in many" "MOLT-4: 51.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051213, HPA054471" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051213: AB_2681391, HPA054471: AB_2682498" "unprognostic (1.33e-1)" "unprognostic (4.46e-3)" "unprognostic (1.22e-3)" "unprognostic (3.60e-1)" "unprognostic (1.95e-1)" "unprognostic (8.91e-3)" "unprognostic (2.70e-2)" "unprognostic (2.68e-3)" "unprognostic (9.23e-3)" "unprognostic (7.18e-2)" "unprognostic (1.83e-1)" "unprognostic (1.81e-1)" "unprognostic (2.01e-3)" "unprognostic (5.93e-2)" "unprognostic (4.91e-1)" "unprognostic (1.82e-1)" "unprognostic (1.81e-1)" 8.0 2.7 10.1 14.9 10.2 12.5 5.8 10.3 10.0 8.7 16.6 5.0 5.0 7.6 7.7 4.8 7.6 9.9 10.7 7.6 10.0 6.5 15.8 10.5 12.5 12.1 6.2 4.7 6.8 6.3 6.2 3.3 11.1 7.4 8.9 14.9 5.4 7.6 6.1 4.4 8.5 9.5 10.4 3.6 13.5 9.0 7.6 5.2 24.9 10.8 3.6 10.6 9.3 15.0 1.1 0.5 0.0 0.3 0.4 3.9 0.9 7.9 6.0 3.6 2.7 3.4 4.4 12.0 3.3 7.1 2.4 3.2 9.5 1.5 11.6 4.1 3.1 6.9 2.7 3.8 3.0 2.1 15.0 3.4 0.8 2.2 6.1 4.1 3.3 1.2 2.4 6.4 3.2 3.2 2.6 5.2 14.5 5.3 0.0 1.9 2.8 51.2 2.9 7.1 10.5 2.5 7.0 5.6 1.8 16.7 8.3 5.8 4.7 1.9 3.0 5.2 6.5 2.0 4.5 2.2 2.9 4.3 11.5 6.3 0.6 2.7 9.1 5.4 4.4 1.7 0.0 0.3 0.0 2.5 0.1 2.1 1.1 3.9 2.2 0.5 1.0 1.9 1.7 0.0 0.4 0.0 0.1 3.1 0.9 10.1 10.2 10.3 10.0 10.0 6.5 6.2 4.7 7.4 5.2 50.6 44.0 7.4 22.5 33.3 17.4 14.0 22.9 5.3 25.0 29.6 3.9 2.5 11.6 10.6 1.9 16.1 8.6 23.3 13.2 2.5 21.6 32.3 21.9 15.3 25.5 3.2 18.1 27.0 25.7 1.9 10.6 10.6 10.1 2.8 28.4 21.8 21.5 5.8 7.8 14.6 8.1 0.0 42.2 1.9 20.2 43.7 1.9 20.8 24.0 15.4 MFSD10 "IT10C3, TETRAN" ENSG00000109736 "Major facilitator superfamily domain containing 10" Q14728 4 2930561-2934859 "Predicted membrane proteins" "Apoptosis, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 71.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043209 Uncertain Approved "Nucleoplasm,Nuclear membrane" No No "Nuclear membrane" Nucleoplasm "HPA043209: AB_2678364" "unprognostic (1.44e-1)" "unprognostic (2.26e-2)" "unprognostic (7.06e-2)" "unprognostic (2.11e-3)" "unprognostic (7.76e-2)" "unprognostic (9.43e-2)" "prognostic unfavorable (4.49e-4)" "unprognostic (6.82e-3)" "unprognostic (4.70e-3)" "unprognostic (3.21e-1)" "unprognostic (1.91e-2)" "unprognostic (5.42e-3)" "prognostic unfavorable (5.68e-5)" "unprognostic (8.32e-2)" "unprognostic (2.30e-1)" "unprognostic (8.03e-2)" "unprognostic (1.00e-2)" 21.6 9.1 10.3 15.2 10.7 62.9 34.4 20.2 13.0 17.1 18.1 8.9 17.5 13.8 16.0 17.1 18.0 16.3 23.5 13.5 9.6 10.1 15.7 6.0 16.8 17.6 9.1 10.1 20.6 20.9 4.2 13.3 13.5 8.4 22.0 5.2 7.1 27.1 14.5 10.3 10.0 19.0 10.9 7.7 16.3 18.7 11.1 7.4 8.3 29.9 15.0 14.9 15.2 16.7 18.4 22.2 42.5 33.1 16.1 33.2 15.0 12.9 12.3 3.5 9.0 6.0 4.3 9.8 12.0 5.9 5.9 6.8 6.5 31.4 2.3 6.4 7.5 10.9 12.2 3.2 17.3 1.6 14.6 11.1 4.9 10.5 6.7 10.1 15.5 7.2 6.5 10.2 6.6 4.2 9.1 6.7 5.2 6.8 4.8 4.4 14.0 4.4 71.8 11.7 10.2 14.8 5.4 1.7 10.8 8.7 8.0 9.3 11.1 2.8 8.4 12.5 3.8 22.1 29.5 9.8 4.7 8.3 5.9 9.5 3.2 1.4 3.5 13.7 39.7 7.5 21.0 21.4 42.5 29.9 26.4 25.3 18.4 19.3 33.2 22.2 14.8 9.9 17.3 16.8 16.1 33.1 17.4 12.6 15.0 10.3 10.7 20.2 13.0 9.6 10.1 9.1 10.1 8.4 7.4 35.7 29.0 29.6 60.0 27.8 6.7 4.6 28.1 29.4 21.6 43.6 7.9 55.4 3.3 85.0 10.1 33.1 37.5 0.0 39.9 70.0 33.4 67.6 32.3 2.9 65.2 14.3 27.1 38.6 37.6 12.2 33.6 46.5 40.5 72.1 34.1 9.8 74.5 42.1 21.2 17.3 9.4 90.5 37.6 14.3 16.0 23.5 70.0 69.2 41.7 89.7 MFSD12 "C19orf28, MGC20700, PP3501" ENSG00000161091 "Major facilitator superfamily domain containing 12" Q6NUT3 19 3538261-3574290 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 101.3;Extravillous trophoblasts: 117.0;Melanocytes: 185.5" "Cancer enriched" "Detected in all" 7 "melanoma: 124.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SK-MEL-30: 59.6;WM-115: 113.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042149, HPA043088" Uncertain Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA042149: AB_2677875, HPA043088: AB_2678308" "unprognostic (1.22e-1)" "unprognostic (2.92e-1)" "unprognostic (1.65e-1)" "prognostic favorable (5.66e-6)" "unprognostic (1.56e-2)" "unprognostic (6.51e-2)" "prognostic unfavorable (6.61e-4)" "prognostic unfavorable (2.34e-4)" "unprognostic (3.19e-2)" "unprognostic (9.12e-3)" "unprognostic (1.56e-2)" "unprognostic (2.76e-2)" "unprognostic (1.13e-1)" "prognostic favorable (7.70e-4)" "unprognostic (1.95e-1)" "unprognostic (3.90e-2)" "unprognostic (1.73e-1)" 25.9 13.0 15.4 19.0 14.4 23.5 9.3 10.4 22.9 8.1 8.9 24.3 11.2 12.5 10.2 12.7 11.1 14.3 10.0 7.6 23.9 12.8 38.0 21.5 13.8 15.2 20.7 10.0 9.7 19.8 15.7 11.9 46.6 15.6 10.2 5.7 13.5 23.7 10.5 8.1 43.6 13.8 9.9 18.6 19.7 14.1 7.5 16.1 37.0 9.1 6.1 11.8 7.9 7.8 2.4 12.9 2.6 7.9 0.5 3.1 1.6 17.0 13.8 3.4 8.9 7.1 5.5 12.3 10.5 5.7 12.3 13.5 5.9 5.8 4.8 8.0 5.5 19.6 10.7 4.4 5.4 4.4 10.5 12.5 2.8 44.2 6.0 8.9 6.0 9.5 4.9 8.2 12.6 2.9 4.7 3.3 7.2 13.4 7.0 3.1 10.2 5.9 10.8 6.4 7.5 11.2 4.3 4.9 20.3 5.1 7.3 12.9 6.5 20.7 9.7 59.6 4.4 3.3 12.6 13.5 5.6 8.2 22.7 11.8 8.0 4.5 4.4 24.6 15.6 113.8 0.1 4.0 2.6 2.1 7.9 2.1 2.4 3.1 1.6 2.8 1.7 2.7 2.1 1.3 0.5 7.6 12.9 0.5 1.6 15.4 14.4 10.4 22.9 23.9 12.8 20.7 10.0 15.6 16.1 6.0 3.2 15.2 3.8 23.6 15.8 1.6 12.7 4.0 4.5 19.2 5.9 10.7 0.0 19.3 101.3 10.8 13.8 0.0 26.4 117.0 8.0 13.6 0.0 19.2 73.9 35.0 26.9 8.6 19.6 20.9 2.3 32.4 185.5 19.8 9.3 8.3 29.4 17.3 3.2 33.8 11.5 12.9 5.0 4.2 9.1 22.2 77.5 7.5 8.6 13.2 MFSD14B "FLJ14753, HIATL1" ENSG00000148110 "Major facilitator superfamily domain containing 14B" Q5SR56 9 94374551-94461042 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 86.0" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 63.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017978 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA017978: AB_2116836" "unprognostic (3.03e-2)" "unprognostic (2.28e-1)" "unprognostic (3.96e-3)" "unprognostic (5.95e-3)" "unprognostic (1.39e-1)" "unprognostic (3.29e-2)" "unprognostic (4.13e-3)" "unprognostic (3.27e-2)" "unprognostic (1.01e-1)" "unprognostic (9.64e-2)" "unprognostic (1.16e-2)" "unprognostic (3.11e-3)" "unprognostic (1.15e-1)" "unprognostic (9.12e-2)" "unprognostic (6.63e-2)" "unprognostic (1.93e-1)" "unprognostic (9.01e-2)" 15.1 18.9 13.3 14.3 14.7 9.0 20.2 11.6 12.8 14.9 14.2 19.7 15.5 9.9 18.6 16.1 28.1 14.4 12.5 13.4 13.3 12.4 14.7 9.0 25.7 21.5 14.6 7.8 15.9 21.5 86.0 9.2 24.2 28.3 14.5 15.4 21.6 15.9 14.2 7.3 21.8 16.0 12.8 19.1 19.3 13.0 9.2 13.2 24.0 16.7 14.2 23.9 14.1 18.8 4.6 7.8 10.4 11.4 3.6 7.1 3.6 25.9 16.7 13.1 10.2 28.8 20.7 20.9 25.3 22.0 22.5 22.1 8.4 31.1 31.3 15.1 21.7 26.1 57.4 15.6 16.1 22.0 22.3 8.4 10.7 16.1 12.6 20.5 33.8 20.0 18.9 24.4 23.8 18.3 12.6 19.2 17.2 20.3 18.6 29.9 19.7 24.7 19.4 19.2 38.0 13.5 12.4 30.1 10.1 24.0 20.0 12.6 16.6 21.5 25.5 26.7 16.4 11.6 20.0 20.6 23.6 16.7 36.2 23.3 20.6 25.5 8.6 21.0 16.6 21.1 0.6 7.9 5.9 5.6 11.4 5.1 4.6 5.1 5.6 7.8 2.9 5.1 7.1 10.4 3.6 7.7 7.7 5.1 3.6 13.3 14.7 11.6 12.8 13.3 12.4 14.6 7.8 28.3 13.2 6.0 21.9 13.7 20.2 0.0 11.2 0.0 17.8 13.4 12.5 41.8 3.9 12.4 6.6 15.2 2.6 11.3 7.1 0.0 16.4 22.4 13.2 30.5 3.5 10.4 25.8 4.8 7.0 27.0 63.5 2.1 15.5 18.5 0.0 10.8 26.6 18.1 22.0 15.8 15.2 5.7 9.1 12.9 0.0 10.4 17.5 0.0 16.0 13.8 14.9 41.4 MFSD6 FLJ20160 ENSG00000151690 "Major facilitator superfamily domain containing 6" Q6ZSS7 2 190408355-190509205 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 108.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022274 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA022274: AB_2142776" "unprognostic (9.47e-2)" "unprognostic (7.01e-3)" "unprognostic (1.42e-1)" "unprognostic (3.15e-2)" "unprognostic (2.49e-1)" "unprognostic (4.13e-3)" "unprognostic (1.78e-2)" "unprognostic (3.08e-2)" "unprognostic (3.92e-1)" "unprognostic (3.77e-1)" "unprognostic (9.54e-2)" "unprognostic (2.08e-1)" "prognostic favorable (1.05e-4)" "unprognostic (3.46e-2)" "unprognostic (3.27e-1)" "unprognostic (9.14e-2)" "unprognostic (9.18e-2)" 12.3 26.9 20.8 9.3 23.3 4.2 13.8 19.4 33.1 15.3 20.0 29.0 29.0 12.6 7.1 22.3 26.6 13.0 10.3 11.1 25.4 26.5 7.4 2.0 16.9 8.7 36.2 22.9 3.5 10.9 28.2 35.7 5.6 43.1 15.7 19.0 12.2 19.2 29.6 3.8 18.9 15.4 9.5 36.7 12.7 20.2 4.9 18.3 13.0 25.5 10.8 12.7 13.3 13.6 2.4 2.6 8.1 2.0 3.3 5.6 1.2 10.6 6.6 0.2 2.3 4.8 6.2 9.1 5.5 11.1 3.7 4.7 2.4 13.6 16.7 2.6 11.4 7.0 18.2 3.2 9.6 4.2 33.9 5.0 8.9 6.5 1.2 1.9 3.5 2.8 0.9 17.5 5.5 3.6 12.2 1.3 13.3 2.2 18.6 0.9 4.1 16.3 0.7 1.5 11.6 7.1 3.6 0.5 14.3 7.1 19.5 21.2 5.4 7.8 18.4 10.6 0.7 6.0 4.1 5.5 0.6 1.3 7.3 8.4 8.6 3.5 6.0 6.1 7.3 3.0 8.1 2.0 0.6 2.6 0.6 2.7 2.4 3.5 3.6 2.6 1.3 1.6 3.6 0.1 3.3 0.9 1.3 5.6 1.2 20.8 23.3 19.4 33.1 25.4 26.5 36.2 22.9 43.1 18.3 29.8 21.2 3.9 9.9 5.7 8.3 17.9 5.1 108.4 37.5 22.7 7.9 0.1 0.0 12.6 37.9 12.8 13.4 0.0 17.7 0.1 2.3 15.4 22.1 0.6 4.2 27.0 34.0 11.1 2.1 9.9 5.2 9.2 8.5 4.6 38.6 7.1 20.1 17.5 4.9 1.3 7.7 0.0 3.1 0.9 1.1 15.9 0.0 10.2 14.4 19.0 MFSD8 "CLN7, MGC33302" ENSG00000164073 "Major facilitator superfamily domain containing 8" Q8NHS3 4 127917732-127966034 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044802 Approved Supported Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA044802: AB_10963221" "unprognostic (1.67e-1)" "unprognostic (1.95e-1)" "unprognostic (4.47e-2)" "unprognostic (8.10e-2)" "unprognostic (1.57e-1)" "unprognostic (4.12e-2)" "unprognostic (1.18e-1)" "unprognostic (8.99e-2)" "unprognostic (2.19e-2)" "unprognostic (8.69e-2)" "unprognostic (4.51e-2)" "unprognostic (3.44e-2)" "unprognostic (3.93e-3)" "unprognostic (1.70e-1)" "unprognostic (5.61e-3)" "unprognostic (3.14e-1)" "prognostic favorable (2.21e-4)" 8.9 9.6 9.1 11.7 15.4 5.3 13.0 19.6 15.4 12.2 12.1 14.6 9.4 17.1 19.0 11.9 10.3 9.8 9.2 7.5 8.9 10.1 12.6 19.1 9.1 9.7 9.3 11.8 13.2 14.5 16.7 21.5 18.0 15.8 10.2 15.6 14.8 10.9 9.7 7.2 11.0 15.0 12.4 11.8 13.5 12.0 9.4 10.2 12.9 13.6 7.1 15.0 9.9 10.5 7.0 5.8 7.1 8.2 5.4 8.3 4.1 8.3 6.9 7.2 4.0 6.4 5.7 6.2 6.2 8.1 8.2 8.2 4.3 11.9 3.9 12.2 11.2 13.2 6.9 8.4 6.3 11.8 9.1 6.7 4.8 7.8 6.6 7.2 5.0 5.9 6.2 2.1 7.7 5.8 4.1 8.7 6.1 8.1 5.3 11.6 7.7 4.3 1.7 1.4 8.6 4.6 4.6 0.5 4.5 5.8 11.9 7.3 2.6 7.8 8.0 3.3 5.7 4.7 3.4 4.5 2.7 2.8 10.1 5.9 11.5 18.9 8.8 8.7 4.3 7.3 4.6 5.6 7.1 7.1 6.2 6.2 7.0 7.9 6.6 4.5 3.6 8.3 8.3 6.3 5.4 8.2 5.8 8.0 4.1 9.1 15.4 19.6 15.4 8.9 10.1 9.3 11.8 15.8 10.2 11.9 13.1 8.1 4.7 2.9 16.3 2.8 2.5 10.7 13.6 15.7 19.6 9.8 1.7 7.4 9.5 5.6 7.0 0.0 6.1 6.5 5.6 4.3 12.7 9.4 6.6 11.1 4.1 8.0 7.5 10.7 8.6 6.0 3.3 6.4 6.8 11.0 6.3 9.7 8.9 5.7 21.2 6.5 3.8 11.4 4.3 5.0 18.4 14.4 6.8 3.5 MGA "FLJ12634, KIAA0518, MAD5, MXD5" ENSG00000174197 "MGA, MAX dimerization protein" Q8IWI9 15 41621224-41773081 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042278, HPA058183" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA042278: AB_10794647, HPA058183: AB_2683632" "unprognostic (5.78e-2)" "unprognostic (7.97e-2)" "unprognostic (2.97e-1)" "unprognostic (7.20e-2)" "unprognostic (6.26e-3)" "unprognostic (5.82e-3)" "unprognostic (8.61e-3)" "unprognostic (1.70e-1)" "unprognostic (1.90e-2)" "unprognostic (3.96e-3)" "unprognostic (3.71e-1)" "unprognostic (3.80e-2)" "unprognostic (1.43e-2)" "unprognostic (1.57e-1)" "unprognostic (3.93e-1)" "unprognostic (2.50e-1)" "unprognostic (3.89e-1)" 9.3 11.3 13.8 13.6 15.3 14.3 13.0 28.2 16.9 14.5 10.1 13.3 12.2 6.8 14.2 11.5 9.8 11.3 7.8 10.1 11.2 7.7 10.1 8.5 8.5 12.7 18.7 10.5 22.7 12.0 18.0 27.6 12.4 13.7 11.0 9.7 7.2 10.3 10.8 11.8 11.2 10.6 11.8 16.1 12.5 9.8 16.4 14.7 22.4 13.9 5.3 13.4 11.6 11.5 5.0 4.1 4.9 4.9 9.8 5.0 1.5 1.4 8.5 10.7 7.0 8.4 6.7 8.6 4.2 4.3 5.1 5.0 9.0 5.0 10.0 7.7 4.9 9.2 5.9 16.5 3.7 7.0 4.7 5.4 21.3 14.0 8.0 7.5 19.5 10.6 5.1 4.6 7.0 7.0 2.1 6.5 9.8 24.7 4.6 4.5 4.1 11.8 7.6 6.6 4.3 4.4 13.4 10.9 5.2 2.7 6.1 10.2 9.9 15.1 5.3 2.7 8.2 4.3 12.5 6.9 6.1 8.7 6.3 5.0 6.3 9.4 9.8 3.9 7.5 3.0 4.9 2.3 2.5 4.7 1.8 4.6 4.8 3.7 5.0 2.4 5.0 3.9 4.3 1.2 9.8 4.9 4.1 1.8 1.5 13.8 15.3 28.2 16.9 11.2 7.7 18.7 10.5 13.7 14.7 20.8 17.5 20.6 9.5 7.0 24.2 25.5 5.1 20.1 21.6 12.2 31.4 14.6 6.6 10.4 11.7 15.0 7.0 23.3 4.6 10.4 12.5 11.4 13.9 8.1 10.1 12.7 7.5 15.4 11.0 4.6 19.2 11.8 8.5 2.8 9.2 13.5 7.3 11.5 19.4 4.2 21.2 38.8 13.4 27.3 40.0 9.8 21.7 17.5 10.5 8.7 MGAT4B GnT-Ivb ENSG00000161013 "Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B" Q9UQ53 5 179797597-179806952 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 125.6;liver: 100.0" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 212.8;Paneth cells: 114.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "eosinophil: 8.5" "Lineage enriched" "Detected in single" 9 "granulocytes: 8.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012804, HPA052134" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" "Intracellular and membrane" NA NA Nucleoplasm "Golgi apparatus, Vesicles, Cytosol" "HPA012804: , HPA052134: AB_2681741" "unprognostic (2.01e-2)" "unprognostic (8.68e-3)" "unprognostic (1.40e-1)" "unprognostic (3.83e-2)" "prognostic unfavorable (6.15e-5)" "unprognostic (3.61e-3)" "unprognostic (7.57e-3)" "unprognostic (1.22e-2)" "unprognostic (2.02e-1)" "unprognostic (5.13e-2)" "unprognostic (2.26e-2)" "unprognostic (2.27e-2)" "prognostic favorable (5.78e-4)" "unprognostic (1.52e-1)" "unprognostic (2.54e-1)" "unprognostic (1.72e-2)" "unprognostic (1.42e-1)" 13.2 22.8 9.1 19.5 8.2 9.5 18.7 15.3 13.5 8.7 77.3 5.9 10.1 61.7 9.2 10.4 16.8 10.7 26.0 20.6 9.5 5.4 31.9 100.0 17.1 15.6 6.3 5.2 9.1 13.4 10.3 8.3 14.4 6.3 8.8 30.9 10.1 19.2 8.2 8.4 12.1 125.6 7.5 4.9 12.5 22.3 11.2 5.6 7.0 16.6 14.6 10.0 9.5 13.7 0.9 0.6 8.5 0.7 0.0 0.6 0.2 20.8 21.1 10.4 24.1 32.0 17.2 18.1 12.4 24.9 11.3 8.9 23.1 58.2 3.5 31.9 28.6 50.4 15.8 15.2 27.9 8.6 29.2 8.1 10.7 19.2 20.1 22.6 13.5 3.3 18.6 19.6 11.5 14.3 44.4 23.2 4.2 6.9 9.6 19.0 23.3 2.0 11.2 6.4 31.9 8.5 5.2 8.3 9.9 33.9 40.6 17.2 10.1 18.6 19.3 33.4 9.2 13.2 13.7 28.3 28.6 12.7 16.0 19.8 8.2 9.4 8.8 34.3 17.0 20.6 0.0 0.7 8.5 0.3 0.1 0.1 0.0 0.5 0.2 0.6 0.9 0.4 0.6 0.3 0.0 0.5 0.5 0.0 0.2 9.1 8.2 15.3 13.5 9.5 5.4 6.3 5.2 6.3 5.6 11.9 8.6 8.5 16.0 11.1 15.5 21.6 25.5 0.0 5.7 26.2 3.9 6.8 3.3 60.0 0.5 14.3 212.8 0.0 46.0 9.9 10.4 29.2 4.7 75.0 15.1 28.6 22.0 31.9 17.0 1.6 14.1 11.7 10.1 18.0 64.6 23.5 79.0 114.3 15.9 20.7 10.4 12.9 8.6 1.6 4.8 10.5 11.7 5.0 102.6 39.7 MGAT5B "FLJ25132, GnT-IX, GnT-VB" ENSG00000167889 "Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B" Q3V5L5 17 76868456-76950393 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 28.1" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 5.1;Early spermatids: 6.3;Extravillous trophoblasts: 2.8;Late spermatids: 6.8" "Group enriched" "Detected in many" 5 "glioma: 2.6;melanoma: 7.1;testis cancer: 2.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 21.8;SCLC-21H: 11.2;U-138 MG: 13.2;U-2 OS: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011082 Approved "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" Yes No "Nucleoplasm, Mitotic spindle" "Cytokinetic bridge" "HPA011082: AB_2668423" "unprognostic (6.37e-2)" "unprognostic (9.16e-3)" "unprognostic (8.51e-2)" "unprognostic (1.43e-3)" "unprognostic (5.68e-3)" "unprognostic (1.33e-1)" "unprognostic (2.28e-3)" "unprognostic (1.52e-3)" "unprognostic (5.30e-2)" "unprognostic (3.89e-2)" "unprognostic (1.68e-1)" "unprognostic (5.67e-2)" "unprognostic (1.46e-7)" "unprognostic (1.66e-1)" "unprognostic (8.09e-3)" "unprognostic (1.04e-1)" "unprognostic (3.01e-1)" 1.1 1.2 9.3 1.1 13.4 1.0 0.9 4.4 28.1 1.0 0.9 1.1 0.0 0.8 1.1 0.7 0.9 1.0 0.9 0.8 5.5 2.8 0.9 0.7 1.0 0.9 2.3 8.1 1.2 0.8 1.0 0.6 1.1 2.6 0.8 0.8 1.1 0.8 0.8 0.7 0.9 0.9 0.8 0.7 1.4 1.0 2.3 1.7 0.0 0.8 0.0 0.9 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 21.8 4.4 2.2 0.0 0.0 2.3 0.3 0.9 8.0 4.7 0.0 0.5 0.0 1.7 1.0 9.4 0.1 1.0 0.2 2.1 0.0 0.3 0.0 1.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 1.3 3.6 1.4 0.4 0.1 0.0 0.0 1.0 0.0 0.0 1.2 0.5 2.3 3.0 3.9 4.5 6.2 0.0 11.2 4.3 3.8 1.7 3.4 0.2 0.1 0.1 4.0 13.2 14.3 0.2 4.1 0.0 0.0 0.5 0.4 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 13.4 4.4 27.4 5.5 2.8 2.3 8.1 2.6 1.7 0.0 0.0 0.0 0.1 0.1 5.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 2.8 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 6.8 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 2.1 0.0 0.2 0.9 2.2 0.0 0.1 0.0 0.0 0.0 MGLL "HU-K5, MGL" ENSG00000074416 "Monoglyceride lipase" Q99685 3 127689062-127823250 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid degradation, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "monocytes: 404.8;Pancreatic endocrine cells: 322.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 11.6;intermediate monocyte: 28.5;non-classical monocyte: 18.3;plasmacytoid DC: 30.4" "Group enriched" "Detected in many" 13 "dendritic cells: 30.4;granulocytes: 11.6;monocytes: 28.5" "Cell line enhanced" "Detected in many" "BJ: 46.5;BJ hTERT+: 53.6;LHCN-M2: 42.8;RPTEC TERT1: 38.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011348, HPA011993, HPA011994" Enhanced Enhanced Nucleoplasm NA NA 4300000 Nucleoplasm "HPA011348: AB_2668490, HPA011993: AB_1853914, HPA011994: AB_1853916" "unprognostic (1.84e-2)" "unprognostic (1.80e-2)" "unprognostic (2.14e-1)" "unprognostic (8.19e-2)" "unprognostic (1.15e-2)" "unprognostic (1.69e-1)" "unprognostic (5.83e-2)" "unprognostic (3.61e-2)" "unprognostic (1.45e-1)" "unprognostic (8.83e-2)" "prognostic unfavorable (6.41e-4)" "unprognostic (7.63e-3)" "unprognostic (1.44e-1)" "unprognostic (1.68e-1)" "unprognostic (1.90e-2)" "unprognostic (2.51e-1)" "unprognostic (2.11e-3)" 72.2 6.7 29.4 22.6 29.7 7.5 39.0 32.8 36.9 13.3 36.3 8.3 8.4 16.5 8.7 10.8 63.8 16.3 24.1 35.5 23.6 10.2 22.6 32.1 32.4 6.0 15.4 17.8 3.9 3.6 1.7 5.0 18.9 10.2 10.6 27.6 10.0 31.4 13.6 40.9 11.9 22.3 13.6 12.2 19.2 17.5 3.2 15.5 2.4 6.4 33.4 19.7 14.4 14.5 1.8 30.4 11.6 28.5 0.6 0.9 6.0 11.2 10.1 0.0 0.0 17.8 21.0 1.3 46.5 53.6 10.3 16.6 0.3 4.6 2.9 12.9 15.7 3.1 0.4 0.0 6.1 5.7 5.0 0.1 0.3 7.2 0.0 6.4 0.0 0.3 7.8 3.6 19.3 21.1 5.8 21.8 0.1 0.0 0.5 42.8 1.1 0.0 0.1 0.0 7.3 16.0 0.0 5.5 23.8 38.6 1.2 6.0 0.4 8.0 15.8 2.7 0.4 0.7 0.4 27.9 11.3 3.3 27.2 6.3 0.0 0.0 9.5 23.4 0.6 35.0 4.2 2.8 11.6 0.2 28.5 0.9 1.8 0.2 0.3 3.1 0.2 0.0 0.0 0.5 0.6 18.3 30.4 0.0 6.0 29.4 29.7 32.8 36.9 23.6 10.2 15.4 17.8 10.2 15.5 181.7 90.0 5.2 8.0 20.3 16.7 42.0 119.8 56.2 34.2 40.1 0.0 68.4 142.6 90.3 3.6 101.2 167.0 23.3 144.8 129.8 47.2 9.2 8.1 126.2 122.7 0.0 85.0 14.7 24.4 4.0 30.2 33.6 20.3 404.8 177.1 46.3 322.3 129.8 65.4 60.0 6.1 84.1 176.1 0.2 1.1 19.4 60.8 10.2 49.8 4.2 MGMT ENSG00000170430 "O-6-methylguanine-DNA methyltransferase" P16455 10 129467184-129768007 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Methyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Hepatocytes: 419.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002786, HPA032135, HPA032136, HPA069497, CAB069881" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB002786: , CAB069881: AB_10002128, HPA032135: AB_2674171, HPA032136: AB_2674172, HPA069497: AB_2732134" "unprognostic (1.10e-1)" "prognostic favorable (9.42e-4)" "unprognostic (1.48e-1)" "unprognostic (5.81e-2)" "unprognostic (7.84e-3)" "unprognostic (1.67e-1)" "prognostic favorable (1.54e-4)" "unprognostic (6.54e-3)" "unprognostic (4.71e-2)" "unprognostic (2.03e-1)" "unprognostic (1.26e-1)" "unprognostic (6.32e-1)" "unprognostic (4.89e-1)" "unprognostic (2.75e-1)" "unprognostic (1.95e-1)" "unprognostic (1.66e-1)" "unprognostic (1.08e-1)" 11.7 11.3 7.4 15.5 7.6 7.1 11.3 3.5 9.1 8.3 12.2 10.0 19.6 10.8 15.3 17.1 9.9 15.2 14.1 10.5 7.1 7.1 12.6 45.6 7.5 11.6 8.6 6.6 12.3 16.5 5.7 5.8 4.5 9.2 11.2 3.4 11.8 14.9 24.5 14.4 9.2 9.6 10.9 8.1 8.6 9.9 11.7 3.9 16.0 10.2 14.9 14.7 12.6 13.0 20.3 17.7 6.5 15.3 18.2 21.2 16.6 0.0 2.5 2.7 13.0 5.7 11.8 10.2 5.7 6.4 4.2 4.1 15.8 16.9 11.8 9.2 7.4 0.0 7.7 1.7 6.1 1.9 0.0 1.0 2.3 5.8 10.1 8.8 0.2 6.8 7.5 0.0 2.4 0.0 0.0 0.0 20.0 0.0 8.3 5.1 21.3 9.3 12.1 0.6 10.9 10.2 10.8 0.0 4.6 7.8 5.8 2.7 6.8 6.9 2.8 0.0 2.2 11.2 9.2 0.0 5.5 2.8 0.0 0.0 0.0 0.0 6.0 0.0 3.8 0.0 2.6 15.3 6.5 19.1 14.8 18.6 20.3 17.5 17.8 15.8 19.9 17.6 18.9 1.8 18.2 13.7 17.7 21.2 16.6 7.4 7.6 3.5 9.1 7.1 7.1 8.6 6.6 9.2 3.9 11.9 14.7 57.0 56.4 45.4 15.7 37.8 86.6 57.6 15.9 97.7 7.9 41.1 107.8 40.8 70.9 48.0 68.8 23.3 51.1 53.2 48.9 49.8 64.5 419.1 76.3 14.3 52.4 98.2 75.3 90.6 62.5 39.9 62.4 45.9 56.4 33.9 74.4 47.0 51.9 227.8 39.0 45.3 55.7 43.1 97.3 37.3 22.4 67.1 59.6 48.8 MGST3 GST-III ENSG00000143198 "Microsomal glutathione S-transferase 3" O14880 1 165630861-165661796 "Enzymes, Predicted membrane proteins" "Lyase, Oxidoreductase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cytotrophoblasts: 1846.4;Syncytiotrophoblasts: 1983.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 88.9;HDLM-2: 94.3;OE19: 97.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053311, HPA077929" Enhanced Approved Nucleoplasm NA NA 40000 Nucleoplasm "HPA053311: AB_2682108, HPA077929: " "unprognostic (1.21e-1)" "unprognostic (1.44e-1)" "unprognostic (1.65e-2)" "unprognostic (1.22e-2)" "unprognostic (2.67e-1)" "unprognostic (7.78e-2)" "unprognostic (3.09e-1)" "unprognostic (2.06e-2)" "unprognostic (2.16e-1)" "unprognostic (1.90e-1)" "unprognostic (3.96e-1)" "unprognostic (3.34e-2)" "unprognostic (1.12e-2)" "unprognostic (7.60e-2)" "unprognostic (8.88e-2)" "unprognostic (1.89e-1)" "unprognostic (1.90e-1)" 42.8 30.8 52.5 9.7 30.5 19.0 51.2 17.9 56.0 18.4 39.7 18.4 19.1 65.2 19.5 101.8 19.7 20.6 26.5 133.6 38.1 33.9 45.2 29.5 20.8 11.0 44.2 37.6 22.7 17.7 11.1 18.3 30.9 39.6 21.2 40.4 20.3 29.8 20.6 87.2 15.6 53.4 24.7 38.7 12.4 29.8 19.4 23.3 2.7 25.7 41.8 8.2 19.9 17.3 21.3 35.1 20.7 47.0 15.7 38.0 40.7 22.2 16.3 17.7 13.9 62.1 37.3 88.9 18.6 30.0 14.5 25.3 17.0 29.0 1.4 14.7 22.7 14.3 27.2 4.3 18.2 14.7 94.3 11.1 3.4 12.8 7.7 17.5 5.3 7.5 31.8 14.7 20.0 7.7 28.6 23.6 6.1 8.3 8.5 27.1 4.9 5.9 12.3 38.7 97.4 21.0 5.6 7.6 2.8 76.5 20.9 13.7 16.8 18.7 24.3 37.0 37.1 18.5 26.2 21.4 18.0 10.7 12.4 13.4 6.3 4.3 0.7 33.4 14.1 11.6 10.4 45.7 20.7 30.1 37.0 30.3 21.3 38.0 33.5 35.1 19.9 24.4 26.7 9.8 15.7 47.0 15.1 32.3 40.7 52.5 30.5 17.9 56.0 38.1 33.9 44.2 37.6 39.6 23.3 95.3 125.6 83.1 202.5 202.9 129.1 591.8 331.2 242.2 134.2 528.7 251.3 1846.4 848.8 339.3 13.2 253.1 716.8 630.8 371.6 1154.8 298.4 174.8 89.0 248.3 760.5 123.9 146.8 184.8 114.8 21.3 359.3 238.2 492.6 405.8 197.9 162.7 335.4 599.7 375.8 841.2 122.6 498.0 374.9 15.6 33.3 203.4 1983.2 87.4 339.8 197.4 MICAL2 KIAA0750 ENSG00000133816 "Microtubule associated monooxygenase, calponin and LIM domain containing 2" "O94851, Q6ZW33" 11 12094008-12359144 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Actin-binding, Developmental protein, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 138.4" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 73.9;Late spermatids: 128.9;Peritubular cells: 106.1" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 4 "cerebellum: 138.4;cerebral cortex: 39.8" "Cell type enhanced" "Detected in many" "neutrophil: 12.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-138 MG: 40.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030437, HPA039895, HPA040438" Approved Uncertain "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Cytosol" "Nucleoplasm, Plasma membrane" "HPA030437: AB_10601873, HPA039895: AB_2676731, HPA040438: AB_10672896" "unprognostic (2.68e-2)" "unprognostic (1.77e-2)" "unprognostic (5.77e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (6.88e-4)" "unprognostic (2.20e-2)" "unprognostic (3.60e-2)" "unprognostic (9.32e-2)" "unprognostic (2.86e-1)" "unprognostic (1.36e-1)" "unprognostic (1.15e-2)" "unprognostic (6.47e-2)" "prognostic unfavorable (3.63e-5)" "unprognostic (4.61e-2)" "unprognostic (1.97e-1)" "unprognostic (1.21e-1)" "unprognostic (1.67e-1)" 4.1 3.3 15.4 7.3 15.1 6.8 2.9 138.4 39.8 6.6 14.7 2.7 2.9 7.2 14.7 7.7 11.5 5.4 11.1 24.8 22.0 6.9 2.9 3.9 12.8 2.3 5.6 17.9 3.9 4.4 0.7 2.4 5.0 5.5 3.3 15.1 2.8 2.9 8.4 14.6 9.3 10.8 22.7 7.6 2.6 5.9 24.6 0.6 0.0 4.5 1.9 2.2 7.8 3.2 0.2 5.5 12.2 6.7 3.7 3.5 2.1 11.8 6.3 0.3 1.4 1.6 3.0 7.5 18.9 21.4 7.4 11.6 13.2 8.5 0.3 4.1 13.2 21.2 8.4 2.3 30.4 18.4 13.7 1.5 11.2 1.2 0.9 14.2 2.1 1.4 5.3 5.4 32.6 31.9 13.8 16.9 0.8 19.5 0.5 11.9 0.7 0.1 1.0 0.4 8.4 5.9 0.1 7.5 7.9 1.5 14.9 6.1 0.5 6.2 17.3 1.2 4.7 1.7 0.6 30.1 40.3 15.2 6.6 16.4 0.4 0.9 0.4 24.5 3.0 0.8 0.1 6.7 0.5 2.8 1.7 3.5 0.2 1.7 1.7 5.5 0.2 0.2 0.9 12.2 3.7 0.5 1.0 2.1 2.1 15.4 15.1 138.4 39.8 22.0 6.9 5.6 17.9 5.5 0.6 38.7 29.6 4.2 6.7 9.0 2.8 28.1 7.6 5.3 11.4 3.5 0.0 2.1 0.0 9.6 73.9 7.1 31.5 23.3 12.4 9.5 4.5 7.0 1.1 17.8 3.0 0.0 21.7 11.1 11.1 128.9 19.5 8.9 5.0 8.2 10.0 0.2 29.0 14.1 106.1 0.6 1.6 12.9 27.6 0.9 0.9 8.3 1.9 9.2 9.9 9.7 MICAL3 KIAA0819 ENSG00000243156 "Microtubule associated monooxygenase, calponin and LIM domain containing 3" Q7RTP6 22 17787649-18024559 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Exocytosis" "Actin-binding, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Muller glia cells: 59.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 10.0;memory B-cell: 3.3;naive B-cell: 5.2" "Group enriched" "Detected in many" 6 "B-cells: 5.2;granulocytes: 10.0" "Cell line enhanced" "Detected in many" "WM-115: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000639, HPA003421, HPA034882" Approved Supported "Nucleoplasm,Plasma membrane,Midbody ring,Cytosol" Yes No "Nucleoplasm, Midbody ring" "Plasma membrane, Cytosol" "HPA000639: AB_10301319, HPA003421: AB_10601134, HPA034882: AB_2674371" "unprognostic (1.65e-1)" "unprognostic (1.02e-1)" "unprognostic (3.67e-2)" "unprognostic (2.00e-2)" "unprognostic (7.68e-2)" "unprognostic (2.06e-1)" "unprognostic (4.71e-2)" "unprognostic (3.07e-3)" "unprognostic (3.41e-1)" "unprognostic (1.01e-1)" "unprognostic (4.58e-1)" "unprognostic (3.82e-1)" "unprognostic (8.86e-3)" "unprognostic (1.36e-2)" "unprognostic (1.23e-1)" "unprognostic (2.03e-2)" "unprognostic (6.64e-2)" 10.1 9.0 15.4 20.7 19.2 10.2 9.6 62.2 25.0 12.8 22.4 30.0 8.8 8.3 30.3 14.0 13.8 28.6 9.5 23.7 15.4 13.8 8.7 16.8 6.1 15.2 21.6 15.6 20.2 10.2 30.4 11.0 11.9 19.4 11.8 16.5 14.2 8.0 14.8 28.0 14.7 13.2 26.1 20.9 12.2 11.1 15.7 22.6 3.0 10.4 7.8 20.8 14.7 15.1 5.2 0.3 10.0 0.1 1.3 1.1 0.2 13.9 15.4 8.2 13.2 6.1 7.9 9.8 12.3 13.4 17.5 13.8 14.6 2.0 15.6 6.3 16.8 20.1 16.2 12.0 14.2 17.0 15.1 11.4 16.2 16.3 6.1 4.1 7.2 8.7 6.3 11.4 18.3 19.5 11.1 10.1 4.5 17.8 10.1 6.4 12.5 6.8 4.5 5.5 10.3 10.0 9.5 12.2 0.7 14.0 9.9 21.5 8.4 17.4 11.0 26.2 13.0 4.4 3.1 17.8 18.0 11.6 12.3 25.6 6.6 11.7 20.9 15.6 3.2 51.4 10.0 0.0 0.1 0.5 0.1 0.8 3.3 0.6 0.5 0.1 5.2 0.3 0.2 0.2 1.3 0.0 0.3 1.1 0.2 15.4 19.2 62.2 25.0 15.4 13.8 21.6 15.6 19.4 22.6 3.0 15.1 14.3 10.9 10.0 13.4 13.4 12.7 20.1 15.9 12.2 49.1 11.8 0.0 19.8 9.4 14.0 21.9 23.3 8.4 29.4 9.6 10.5 18.5 33.0 2.7 1.6 9.8 6.2 2.7 10.5 3.7 3.7 8.5 8.2 18.5 59.7 22.3 20.1 6.0 3.9 11.6 0.0 9.2 19.3 12.6 10.3 9.4 7.7 15.7 6.7 MICB PERB11.2 ENSG00000204516 "MHC class I polypeptide-related sequence B" Q29980 6 31494881-31511124 "Disease related genes, Predicted membrane proteins" "Adaptive immunity, Cytolysis, Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "vagina: 26.5" "Cell type enhanced" "Detected in many" 10 "Erythroid cells: 23.3;Hofbauer cells: 9.9;Kupffer cells: 12.9;monocytes: 10.0;T-cells: 10.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 11.6;U-266/84: 26.5" HPA064618 Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA064618: AB_2685301" "unprognostic (3.63e-3)" "unprognostic (8.81e-2)" "unprognostic (3.19e-1)" "unprognostic (1.51e-2)" "unprognostic (8.44e-2)" "unprognostic (5.94e-2)" "prognostic unfavorable (7.04e-5)" "unprognostic (2.05e-1)" "unprognostic (2.61e-1)" "unprognostic (1.67e-3)" "unprognostic (2.28e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (4.94e-9)" "unprognostic (1.91e-3)" "unprognostic (2.80e-2)" "unprognostic (9.72e-2)" "unprognostic (1.21e-2)" 3.3 1.2 0.8 9.1 0.8 6.1 3.5 3.0 1.0 1.8 1.6 0.9 0.0 1.0 2.1 1.3 2.1 1.1 1.7 2.2 1.0 0.6 2.9 1.3 6.9 7.8 1.2 0.8 1.3 2.9 0.2 0.6 0.8 1.2 1.1 1.9 1.1 1.9 0.7 0.8 1.0 5.0 1.7 1.5 11.7 1.4 2.3 1.1 8.1 2.4 0.7 8.1 3.2 26.5 2.2 2.1 4.1 4.8 1.9 4.4 1.9 2.4 0.8 0.0 0.0 1.5 2.5 0.0 1.7 1.7 2.2 2.9 0.0 0.3 2.8 6.2 3.2 7.1 0.6 0.7 2.9 0.8 2.4 2.6 3.2 0.5 1.1 0.5 1.0 2.7 3.1 0.6 3.8 2.2 2.3 1.4 4.4 3.3 5.9 2.6 0.0 0.9 4.2 0.3 0.0 0.4 3.4 0.0 5.9 2.6 0.1 0.0 0.0 1.1 0.0 0.5 0.9 1.5 1.2 1.4 1.7 0.0 1.5 0.0 11.6 26.5 6.2 0.4 8.7 3.7 4.1 3.1 4.0 2.9 3.6 3.6 2.2 2.9 3.9 2.1 2.0 1.6 3.1 3.1 1.9 4.8 1.3 4.4 1.9 0.8 0.8 3.0 1.0 1.0 0.6 1.2 0.8 1.2 1.1 3.0 1.0 5.1 0.6 2.6 0.0 0.3 2.5 0.0 1.2 0.0 0.0 0.1 1.7 1.2 0.0 1.9 0.3 23.3 0.6 0.2 3.3 1.7 0.0 0.0 9.9 0.0 0.0 3.1 12.9 0.0 0.3 8.1 1.7 10.0 0.7 0.0 1.5 2.0 0.4 0.3 0.0 0.0 3.9 0.7 1.5 1.0 0.1 10.0 1.7 1.1 MICU2 EFHA1 ENSG00000165487 "Mitochondrial calcium uptake 2" Q8IYU8 13 21492691-21604214 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045511, HPA058790" Approved Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA045511: AB_10959894, HPA058790: AB_2683821" "unprognostic (4.32e-3)" "unprognostic (1.50e-2)" "unprognostic (2.00e-1)" "unprognostic (7.01e-2)" "unprognostic (9.80e-2)" "unprognostic (4.11e-2)" "unprognostic (1.47e-2)" "unprognostic (8.01e-2)" "unprognostic (4.79e-3)" "unprognostic (1.63e-3)" "unprognostic (1.58e-1)" "unprognostic (1.56e-1)" "prognostic favorable (1.40e-7)" "unprognostic (3.81e-2)" "unprognostic (8.94e-2)" "unprognostic (5.15e-2)" "unprognostic (3.50e-1)" 14.8 32.4 23.9 23.5 23.2 20.9 22.9 28.6 25.4 19.5 25.4 17.3 16.1 18.0 16.7 21.1 19.9 17.8 16.3 41.7 22.9 24.1 52.8 24.5 15.6 16.8 23.4 25.6 17.0 16.9 19.5 30.3 31.2 20.6 20.3 23.9 14.5 16.9 23.6 39.6 15.5 21.0 14.7 28.1 19.4 20.1 17.5 22.6 25.2 26.3 25.6 19.4 15.6 15.4 33.2 21.8 26.5 23.5 22.8 30.7 17.2 11.8 6.8 16.2 10.3 14.5 19.5 14.0 20.1 16.5 21.5 15.0 9.9 19.2 18.5 13.1 19.1 11.1 15.9 15.9 16.9 29.7 18.7 16.5 31.9 7.4 11.4 17.5 23.9 18.6 16.8 16.8 12.1 8.6 19.3 14.3 17.5 11.2 8.3 35.0 10.2 15.9 22.8 11.0 41.9 10.8 17.5 41.4 12.3 42.3 9.7 13.1 10.1 13.7 16.2 13.0 14.8 15.8 22.6 17.6 9.4 8.4 19.0 16.5 6.2 8.2 13.5 9.2 20.0 23.2 22.1 20.1 26.5 26.1 23.5 24.1 33.2 23.0 26.0 21.8 20.8 20.9 26.0 18.7 22.8 19.3 20.1 30.7 17.2 23.9 23.2 28.6 25.4 22.9 24.1 23.4 25.6 20.6 22.6 35.7 23.2 29.6 35.2 26.7 24.7 68.6 30.6 50.9 37.5 48.8 21.6 50.6 122.7 36.4 20.1 21.0 30.6 23.3 23.9 37.2 35.7 25.7 24.3 21.3 32.4 39.7 29.2 19.6 34.1 10.0 31.4 30.0 45.5 39.7 26.0 60.5 29.6 54.7 33.9 82.6 49.4 58.2 27.8 59.5 48.0 22.3 58.8 35.4 29.2 26.8 MIDN ENSG00000167470 Midnolin Q504T8 19 1248553-1259140 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "neutrophil: 13.5" "Lineage enriched" "Detected in many" 9 "granulocytes: 13.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042018, HPA049432" Uncertain Approved Nucleoplasm Yes No Nucleoplasm "HPA042018: AB_2677800, HPA049432: AB_2680765" "unprognostic (1.82e-2)" "unprognostic (6.21e-2)" "unprognostic (2.27e-2)" "unprognostic (2.18e-2)" "unprognostic (2.40e-1)" "unprognostic (2.24e-3)" "unprognostic (1.06e-2)" "unprognostic (2.04e-2)" "unprognostic (2.29e-2)" "unprognostic (1.33e-1)" "unprognostic (3.03e-1)" "unprognostic (1.71e-1)" "unprognostic (1.49e-2)" "unprognostic (1.21e-1)" "unprognostic (1.33e-1)" "unprognostic (3.56e-1)" "unprognostic (1.19e-2)" 28.0 32.6 9.7 22.7 16.1 59.4 16.6 8.9 19.5 19.5 24.7 17.6 12.6 19.0 14.1 14.2 38.7 28.3 40.8 27.8 10.4 9.8 17.9 19.3 28.7 19.9 10.2 6.5 36.7 20.0 8.2 32.7 19.7 22.3 20.1 11.1 19.5 18.8 22.2 48.2 26.6 31.6 14.6 14.6 30.7 21.9 10.5 9.2 28.6 14.0 31.3 34.5 19.4 20.1 0.4 0.5 13.5 1.2 1.4 1.2 0.6 5.2 11.6 19.9 9.2 4.2 7.3 14.6 9.1 5.5 4.7 3.3 15.1 5.9 8.4 10.0 6.8 2.5 10.8 6.0 9.7 1.8 11.7 11.0 11.7 7.6 11.8 8.7 11.8 17.5 11.2 9.1 5.6 5.4 7.3 7.7 10.0 15.0 8.8 4.9 21.0 15.7 4.8 43.7 10.3 7.7 24.5 5.6 3.8 8.8 6.2 16.0 20.9 19.3 18.6 12.0 10.8 7.4 13.5 9.5 8.6 9.6 39.5 9.8 8.4 4.5 11.4 16.5 5.3 29.2 1.1 1.2 1.2 1.2 1.2 0.8 0.3 0.4 0.8 0.5 0.4 0.2 0.6 13.5 1.4 1.2 0.5 0.1 0.6 9.7 16.1 8.9 15.5 10.4 9.8 10.2 6.5 22.3 9.2 35.7 74.9 43.3 105.5 87.8 56.5 71.4 104.4 30.8 33.0 127.4 29.5 12.3 16.6 100.6 27.2 122.8 266.9 0.0 134.4 37.6 65.2 167.2 60.0 71.2 67.2 20.6 157.9 183.5 91.3 20.0 46.1 71.9 40.5 13.6 163.9 48.5 185.5 221.8 31.1 33.6 32.7 38.8 178.2 2.7 14.0 129.5 68.0 56.7 123.5 150.3 MIEN1 "C17orf37, C35, MGC14832, ORB3, Rdx12, XTP4" ENSG00000141741 "Migration and invasion enhancer 1" Q9BRT3 17 39728496-39730787 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in all" 14 "OE19: 214.8;SK-BR-3: 64.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056650, HPA061344" Approved Supported "Nucleoplasm,Plasma membrane,Centriolar satellite,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Centriolar satellite, Cytosol" "HPA056650: , HPA061344: AB_2684484" "unprognostic (2.48e-1)" "unprognostic (3.18e-2)" "unprognostic (3.04e-1)" "unprognostic (1.13e-2)" "unprognostic (3.04e-1)" "unprognostic (1.17e-1)" "unprognostic (4.47e-2)" "unprognostic (8.37e-2)" "unprognostic (6.72e-2)" "unprognostic (2.03e-1)" "unprognostic (1.90e-1)" "unprognostic (3.17e-1)" "unprognostic (2.99e-2)" "unprognostic (3.70e-1)" "unprognostic (2.00e-1)" "unprognostic (3.88e-3)" "unprognostic (2.22e-3)" 16.9 18.6 27.0 16.7 38.6 23.2 19.8 14.9 26.1 12.4 25.2 18.0 37.5 30.2 13.6 19.1 26.3 17.2 19.4 37.2 25.8 21.8 32.2 40.6 16.1 19.7 27.1 17.5 11.7 26.3 14.1 18.9 27.0 18.3 23.5 13.9 12.5 45.6 30.1 24.5 16.0 26.8 11.5 27.2 17.3 32.8 18.6 20.9 21.4 34.5 17.5 14.9 15.6 19.6 41.2 37.8 59.2 45.4 23.7 40.4 48.1 4.6 9.1 1.9 4.4 3.2 2.1 2.1 4.9 3.7 4.5 4.2 2.4 3.6 3.5 6.8 2.6 5.0 5.9 2.1 2.5 1.0 6.8 10.0 3.1 4.3 5.4 5.9 4.2 5.0 2.4 4.5 2.0 1.7 2.5 3.0 8.0 4.7 6.3 2.4 3.7 9.1 4.9 1.5 214.8 4.4 3.9 3.0 7.2 2.0 3.1 5.8 5.4 5.1 64.0 8.7 1.4 8.3 5.5 5.1 2.0 5.2 9.8 5.5 7.8 7.1 6.7 9.0 5.2 4.0 51.7 37.3 47.1 38.0 43.9 21.6 41.2 27.0 33.8 25.9 35.7 20.5 30.2 59.2 23.7 45.4 37.8 40.4 48.1 27.0 38.6 14.9 26.1 25.8 21.8 27.1 17.5 18.3 20.9 41.7 48.6 67.4 114.7 53.3 25.2 45.2 58.6 85.6 33.0 94.2 3.9 131.8 257.0 122.9 87.4 56.2 154.8 46.7 153.4 61.5 51.5 183.7 80.7 101.9 128.4 33.4 181.2 58.3 96.9 55.5 39.1 66.0 131.6 84.8 136.7 78.2 163.9 235.0 46.7 153.1 13.5 45.3 67.4 80.7 70.9 61.5 222.5 83.1 110.2 164.5 MIER1 "hMI-ER1, KIAA1610, MI-ER1" ENSG00000198160 "MIER1 transcriptional regulator" Q8N108 1 66924895-66988619 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019589, HPA050306" Enhanced Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA019589: AB_1853953, HPA050306: AB_2681080" "unprognostic (3.38e-3)" "unprognostic (1.34e-1)" "prognostic favorable (4.96e-4)" "unprognostic (1.63e-1)" "prognostic favorable (3.44e-8)" "unprognostic (1.61e-1)" "unprognostic (3.15e-3)" "unprognostic (1.32e-1)" "unprognostic (1.05e-1)" "unprognostic (3.92e-3)" "unprognostic (4.48e-3)" "unprognostic (2.57e-2)" "unprognostic (2.81e-2)" "unprognostic (2.25e-2)" "unprognostic (2.73e-1)" "unprognostic (5.15e-2)" "unprognostic (2.45e-2)" 23.5 20.0 13.9 23.2 14.8 70.3 19.9 15.9 14.9 22.2 22.9 10.8 18.8 13.2 19.3 17.9 16.0 15.0 19.0 12.5 13.3 12.9 16.0 20.7 19.4 22.2 14.8 10.9 22.9 11.8 11.2 20.2 18.5 13.3 19.9 20.7 10.8 12.6 22.5 14.0 14.1 22.3 25.6 15.0 23.0 16.1 15.9 13.9 30.4 17.4 13.9 16.3 23.9 34.3 8.5 7.6 24.3 12.2 9.6 14.9 5.3 14.1 8.4 10.3 18.4 21.2 14.6 11.5 15.0 17.0 15.4 16.7 6.8 8.9 14.3 5.7 16.9 13.7 9.5 12.7 16.2 22.0 16.8 9.8 31.4 22.5 10.5 17.2 24.7 18.7 14.5 12.3 17.1 17.8 17.6 16.5 17.9 16.5 13.0 17.6 4.4 35.8 9.0 14.4 6.5 5.4 15.7 24.8 9.9 12.8 16.3 6.2 11.9 22.4 13.8 14.6 10.4 7.4 16.4 19.3 17.6 12.5 17.2 13.8 16.1 14.9 20.9 14.3 10.9 10.6 21.6 7.4 16.6 12.8 8.0 14.9 7.5 11.6 11.3 5.5 8.5 12.0 11.7 24.3 9.6 12.2 7.6 9.5 5.3 13.9 14.8 15.9 14.9 13.3 12.9 14.8 10.9 13.3 13.9 14.9 43.7 34.7 30.9 42.8 36.6 29.9 20.4 36.1 34.2 26.2 23.6 32.0 38.1 31.5 37.6 46.8 73.5 0.0 35.1 21.8 47.2 42.0 89.1 45.1 20.1 38.1 40.5 35.0 36.9 40.6 75.4 43.8 13.5 51.3 46.9 62.0 40.3 63.2 87.7 24.9 46.9 77.6 49.2 49.7 56.8 30.4 28.7 56.8 35.4 56.7 MIER2 KIAA1193 ENSG00000105556 "MIER family member 2" Q8N344 19 301444-344815 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041439 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041439: AB_2677481" "unprognostic (1.48e-1)" "unprognostic (1.45e-3)" "prognostic unfavorable (2.89e-4)" "prognostic favorable (1.72e-5)" "unprognostic (6.71e-2)" "unprognostic (2.96e-1)" "unprognostic (6.95e-3)" "unprognostic (1.96e-2)" "unprognostic (1.43e-1)" "unprognostic (4.24e-1)" "unprognostic (1.18e-2)" "unprognostic (7.24e-2)" "prognostic unfavorable (7.22e-6)" "unprognostic (8.05e-2)" "unprognostic (4.28e-2)" "unprognostic (4.94e-3)" "unprognostic (1.68e-2)" 15.5 6.8 9.1 9.3 11.8 4.3 9.7 14.4 12.5 8.6 7.5 10.0 6.6 9.8 12.0 7.8 9.4 7.9 8.5 9.1 9.8 6.7 6.4 3.4 12.5 8.5 9.1 7.8 8.5 11.6 3.7 9.8 13.5 9.1 10.9 3.3 8.3 12.9 10.9 17.0 18.4 9.3 6.4 6.4 17.2 10.3 31.5 12.1 4.6 8.3 7.1 6.6 9.1 16.5 2.2 6.6 6.4 5.8 1.6 3.3 3.0 8.9 5.7 5.1 5.9 1.9 2.8 11.1 7.4 3.5 5.6 5.9 8.8 2.9 4.7 4.0 3.8 2.2 7.7 3.3 4.3 1.7 11.2 15.8 2.8 4.5 6.6 5.6 0.0 22.2 3.6 3.3 4.5 1.6 3.7 6.3 6.4 7.8 0.0 3.1 9.5 7.3 10.0 13.2 2.7 0.0 6.4 1.7 1.2 2.7 5.1 8.2 7.4 4.3 3.2 7.3 3.2 3.7 5.0 6.6 7.6 5.3 11.6 8.2 13.6 6.7 3.8 7.2 4.0 7.5 6.4 5.8 4.2 2.0 5.2 1.8 0.9 2.7 3.0 6.6 2.2 3.3 2.2 0.5 1.6 5.8 3.7 1.1 3.0 9.1 11.8 14.4 12.5 9.8 6.7 9.1 7.8 9.1 12.1 0.0 4.8 6.0 10.5 10.0 6.4 1.1 7.6 2.7 3.4 3.5 15.7 19.2 1.7 7.9 4.7 8.7 3.5 0.0 4.8 14.6 4.7 8.4 0.0 1.6 9.0 3.2 10.3 9.8 7.0 13.3 5.8 6.5 5.0 4.6 4.2 6.6 6.4 6.2 5.3 1.0 11.5 6.5 4.2 17.7 25.6 9.4 24.6 5.2 4.9 11.3 MIER3 "DKFZp686L09111, DKFZp781I1119, FLJ35954" ENSG00000155545 "MIER family member 3" Q7Z3K6 5 56919602-56971675 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058349, HPA065946" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA058349: AB_2683688, HPA065946: AB_2685583" "unprognostic (1.01e-1)" "unprognostic (2.71e-1)" "unprognostic (4.07e-3)" "unprognostic (1.81e-1)" "unprognostic (2.22e-2)" "unprognostic (1.29e-1)" "unprognostic (2.82e-2)" "unprognostic (2.47e-1)" "unprognostic (1.61e-2)" "unprognostic (3.36e-1)" "unprognostic (1.88e-2)" "unprognostic (5.66e-2)" "unprognostic (9.31e-3)" "unprognostic (5.53e-2)" "unprognostic (3.76e-1)" "unprognostic (2.63e-2)" "unprognostic (4.84e-3)" 7.5 7.3 5.6 8.0 7.7 8.0 10.9 23.0 10.7 10.9 25.9 7.7 5.4 19.4 15.3 8.0 7.1 8.4 5.5 6.5 5.9 5.4 6.7 9.5 6.1 6.6 9.2 7.4 13.5 14.7 12.1 12.5 8.7 9.2 8.2 19.5 9.6 7.9 8.7 8.2 6.2 14.1 8.0 8.5 6.4 6.9 15.0 8.1 12.4 8.6 7.7 6.6 7.4 12.2 4.1 4.4 4.4 4.1 3.8 6.0 3.4 6.4 9.4 13.2 24.8 8.8 7.0 18.3 6.1 7.9 11.6 13.0 14.9 5.5 7.0 7.4 7.1 10.5 8.2 16.5 6.5 12.5 3.6 7.6 6.0 11.3 7.1 6.6 8.1 12.4 8.1 8.2 8.6 7.2 7.2 7.5 8.6 7.7 12.1 6.7 7.1 12.2 9.3 10.4 2.9 5.5 20.6 12.4 7.2 5.5 12.9 11.0 17.6 18.5 6.9 9.1 11.0 10.0 7.7 7.2 3.3 10.4 5.9 10.9 7.5 10.1 17.6 6.3 6.3 7.2 0.6 2.4 4.4 3.3 4.1 4.9 4.1 2.6 6.0 3.8 4.0 4.8 3.3 2.3 3.8 3.3 4.4 2.5 3.4 5.6 7.7 23.0 10.7 5.9 5.4 9.2 7.4 9.2 8.1 14.9 4.8 1.9 4.4 11.9 7.1 7.1 10.2 4.0 6.8 3.5 13.7 3.2 5.0 3.5 11.5 5.8 44.2 0.0 5.0 2.9 8.2 7.4 4.6 8.5 3.5 9.5 11.5 8.0 5.1 5.6 5.5 4.8 1.7 7.2 14.2 6.6 6.3 12.7 8.1 4.2 13.2 12.9 6.6 11.7 4.1 8.5 5.7 4.9 8.9 5.4 MIF "GIF, GLIF" ENSG00000240972 "Macrophage migration inhibitory factor" P14174 22 23894004-23895227 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Cytokine, Isomerase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 1397.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 129.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003868, CAB005284" Approved Supported Nucleoplasm,Cytosol "Secreted to blood" No No 13800000 14000000 Cytosol Nucleoplasm "CAB005284: AB_648587, HPA003868: AB_1079290" "unprognostic (1.68e-1)" "unprognostic (7.79e-3)" "unprognostic (2.49e-1)" "unprognostic (1.46e-1)" "unprognostic (1.33e-1)" "unprognostic (1.36e-2)" "unprognostic (9.48e-2)" "unprognostic (1.22e-3)" "unprognostic (2.17e-2)" "unprognostic (1.78e-2)" "unprognostic (1.52e-1)" "unprognostic (2.28e-2)" "unprognostic (2.19e-2)" "unprognostic (1.20e-1)" "unprognostic (1.55e-1)" "unprognostic (2.56e-1)" "unprognostic (1.02e-1)" 30.6 49.8 43.9 42.0 39.9 46.0 71.6 19.0 66.1 23.0 42.7 10.4 55.6 39.9 22.5 113.3 51.9 23.3 42.5 60.7 42.8 40.3 71.8 58.8 46.2 113.9 33.5 43.7 24.5 80.2 16.2 41.1 30.5 45.2 54.8 11.6 15.0 57.3 101.2 36.0 63.3 50.6 26.7 78.3 42.5 56.2 24.9 19.2 19.0 28.9 43.7 16.7 21.4 44.6 56.8 42.5 17.6 23.8 38.3 52.7 66.0 49.8 11.0 2.4 11.2 0.9 2.3 18.7 18.8 3.1 6.1 7.8 8.3 8.2 23.7 14.9 1.3 2.8 22.2 2.6 11.4 0.7 19.9 129.4 8.9 10.1 17.2 4.9 34.6 21.1 4.7 6.8 3.6 1.7 4.5 4.8 17.8 13.8 12.1 2.0 25.1 23.5 64.2 14.3 9.8 60.3 30.2 4.1 66.5 4.7 3.4 32.5 37.8 12.0 12.7 31.0 0.6 16.4 10.4 13.7 5.3 35.6 3.2 0.4 52.3 18.4 24.4 21.5 12.9 10.8 16.3 23.8 17.6 37.4 22.3 52.7 56.8 51.8 40.4 31.6 49.1 46.1 38.0 7.1 38.3 14.6 42.5 48.3 66.0 43.9 39.9 19.0 66.1 42.8 40.3 33.5 43.7 45.2 19.2 145.9 147.8 297.7 257.6 597.1 25.5 0.3 433.1 384.1 354.8 657.8 2.0 427.6 1397.6 643.7 166.1 220.2 275.4 0.0 324.9 742.0 370.2 224.8 172.4 900.8 252.9 20.6 335.5 293.4 221.5 97.3 311.3 223.0 733.9 288.6 378.1 30.6 687.0 340.1 284.6 1307.4 25.0 135.8 432.6 7.9 117.5 663.2 573.7 251.6 418.6 198.5 MIIP "FLJ12438, IIp45" ENSG00000116691 "Migration and invasion inhibitory protein" Q5JXC2 1 12019466-12032045 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Extravillous trophoblasts: 82.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 7 "HDLM-2: 90.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044948 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044948: AB_10795887" "unprognostic (1.36e-2)" "unprognostic (1.95e-2)" "unprognostic (5.02e-3)" "unprognostic (3.59e-2)" "unprognostic (1.82e-1)" "unprognostic (1.16e-1)" "unprognostic (4.65e-3)" "unprognostic (7.16e-2)" "unprognostic (2.97e-1)" "unprognostic (4.03e-2)" "unprognostic (3.73e-3)" "unprognostic (6.56e-2)" "prognostic unfavorable (8.26e-7)" "unprognostic (8.02e-3)" "unprognostic (5.09e-2)" "unprognostic (1.05e-1)" "unprognostic (1.15e-2)" 13.2 9.4 12.2 17.0 17.3 53.4 10.8 13.7 15.3 11.1 11.4 11.9 11.6 11.0 16.5 8.8 11.1 13.0 8.9 13.3 12.9 10.1 9.2 11.7 13.3 18.3 15.9 10.6 20.4 13.5 5.8 7.1 14.6 17.0 11.3 4.5 8.5 18.1 14.2 26.3 14.8 12.7 12.3 11.0 20.4 10.0 18.2 15.2 10.5 22.5 9.7 12.5 12.3 11.9 14.8 45.0 18.3 27.1 10.6 19.0 12.5 5.0 3.4 2.7 5.2 1.4 1.6 9.4 2.7 1.4 5.4 4.1 6.6 8.1 6.4 6.6 1.4 3.8 5.3 2.0 3.1 0.7 90.6 7.5 4.0 5.4 7.0 3.1 6.1 12.4 2.2 4.0 4.7 2.1 0.9 3.0 8.8 11.9 5.9 1.6 5.1 6.0 9.1 4.8 3.7 5.1 8.6 3.4 9.8 2.3 1.5 5.0 5.3 4.0 5.1 9.8 1.5 3.4 10.6 3.2 5.0 5.3 9.9 4.2 5.0 6.3 8.6 3.2 10.7 5.0 4.9 23.2 7.1 9.0 25.9 8.4 14.8 9.3 7.8 14.2 13.0 5.8 4.5 18.3 10.6 27.1 45.0 19.0 12.5 12.2 17.3 13.7 15.3 12.9 10.1 15.9 10.6 17.0 15.2 11.9 7.7 14.7 6.9 11.6 14.2 5.0 2.5 6.7 2.3 8.7 7.9 31.4 21.6 13.8 26.0 9.8 14.7 23.3 15.9 82.3 17.4 10.1 17.3 12.5 36.1 7.9 16.0 9.2 17.8 38.7 7.8 20.3 15.1 64.1 9.7 14.2 13.7 14.4 6.3 10.1 14.5 12.9 14.7 14.7 41.9 15.1 27.7 20.8 13.4 5.9 MINDY1 "FAM63A, FLJ11280, MINDY-1" ENSG00000143409 "MINDY lysine 48 deubiquitinase 1" Q8N5J2 1 150996086-151008375 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 15 "Distal tubular cells: 33.2;Ductal cells: 11.3;Proximal tubular cells: 10.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 26.3;eosinophil: 19.1;neutrophil: 30.4" "Lineage enriched" "Detected in many" 7 "granulocytes: 30.4" "Cell line enhanced" "Detected in many" "T-47d: 27.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028351, HPA028358, HPA061086" Approved Enhanced Nucleoplasm NA NA 240000 Nucleoplasm "HPA028351: AB_10611110, HPA028358: AB_10601102, HPA061086: AB_2684425" "unprognostic (5.73e-2)" "unprognostic (2.86e-1)" "unprognostic (5.47e-2)" "unprognostic (3.14e-1)" "unprognostic (3.39e-2)" "unprognostic (6.90e-2)" "unprognostic (1.47e-2)" "unprognostic (1.64e-1)" "unprognostic (1.02e-1)" "unprognostic (1.88e-1)" "unprognostic (9.22e-3)" "unprognostic (1.06e-1)" "prognostic favorable (3.43e-8)" "unprognostic (2.30e-1)" "unprognostic (7.95e-2)" "unprognostic (2.50e-2)" "unprognostic (6.06e-2)" 9.2 9.7 14.0 6.7 31.1 5.6 13.0 18.4 21.2 13.1 13.5 53.8 14.8 14.0 14.7 6.5 24.1 14.4 11.8 24.5 17.6 10.1 26.6 12.2 10.9 5.2 37.5 13.5 19.3 37.3 26.2 12.3 5.9 25.0 11.7 14.8 16.9 25.3 21.0 11.9 17.1 12.1 13.7 34.1 10.7 15.9 14.7 35.7 0.9 39.9 7.9 10.3 12.3 13.0 0.6 4.0 30.4 3.2 1.5 2.2 3.4 6.1 4.0 4.3 6.1 7.8 6.5 3.6 2.0 5.1 2.8 4.5 8.6 14.7 0.4 4.8 2.6 0.9 3.1 3.4 3.7 1.3 4.6 5.1 6.0 7.4 7.3 1.7 1.8 2.4 5.3 3.4 5.1 1.4 9.6 7.2 2.1 3.7 15.5 2.9 9.5 0.3 4.0 2.0 1.9 1.4 4.5 0.8 18.9 13.4 12.2 7.5 5.5 3.8 7.0 4.2 2.1 27.9 6.1 6.7 2.4 3.2 1.2 1.7 5.7 5.2 20.6 5.8 4.0 11.4 26.3 3.2 19.1 0.1 1.5 0.1 0.3 1.3 0.3 4.0 0.6 2.2 0.7 30.4 1.5 0.9 0.6 1.6 3.4 14.0 31.1 18.4 21.2 17.6 10.1 37.5 13.5 25.0 35.7 8.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 4.0 6.8 3.5 0.0 3.4 33.2 11.3 0.0 0.0 0.0 0.0 6.1 0.6 0.0 0.0 3.5 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 7.3 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 MINDY2 "FAM63B, KIAA1164" ENSG00000128923 "MINDY lysine 48 deubiquitinase 2" Q8NBR6 15 58771192-58861900 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 137.0;Collecting duct cells: 78.5;Extravillous trophoblasts: 84.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2197: 40.6" "Low region specificity" "Detected in all" "HPA051103, HPA063669" Approved Enhanced Nucleoplasm No No Nucleoplasm "HPA051103: AB_2681345, HPA063669: AB_2685082" "unprognostic (4.71e-2)" "unprognostic (8.92e-3)" "unprognostic (4.63e-2)" "unprognostic (4.13e-2)" "unprognostic (1.32e-1)" "unprognostic (1.06e-1)" "unprognostic (2.14e-1)" "unprognostic (8.60e-2)" "unprognostic (7.23e-2)" "unprognostic (7.09e-2)" "unprognostic (2.36e-3)" "unprognostic (4.74e-2)" "prognostic favorable (3.00e-8)" "unprognostic (2.53e-1)" "unprognostic (3.59e-1)" "unprognostic (6.76e-2)" "unprognostic (4.77e-2)" 14.0 9.2 15.5 8.8 14.7 5.6 11.1 41.0 15.4 12.4 8.8 12.4 11.8 5.8 13.0 8.0 11.8 11.7 10.4 16.7 14.6 12.6 16.9 5.8 12.5 6.1 16.2 15.5 11.7 6.4 15.5 12.5 21.9 14.9 15.0 6.6 11.7 7.7 11.8 6.1 11.4 6.5 13.6 16.9 9.4 7.8 6.2 15.8 8.6 15.8 5.4 6.0 13.1 9.1 4.6 2.9 5.5 3.1 1.9 5.5 1.4 5.8 2.9 4.1 2.5 6.2 11.4 6.5 5.4 11.5 1.7 2.4 4.6 2.9 3.0 5.9 6.5 3.0 5.7 7.5 4.3 2.6 3.0 2.7 4.2 3.2 4.1 3.8 3.1 3.9 5.0 7.3 2.0 4.5 6.4 4.1 3.2 7.2 3.4 3.9 0.7 3.9 2.4 8.7 0.8 1.5 1.7 11.8 3.2 5.0 6.6 3.7 2.8 3.9 5.5 9.8 9.1 1.7 6.7 4.8 2.4 2.1 40.6 2.3 3.0 4.3 3.0 5.3 5.2 5.7 5.5 1.8 3.3 3.2 1.6 5.5 2.7 2.8 3.5 0.6 4.6 2.4 3.3 3.9 1.9 3.1 2.9 2.2 1.4 15.5 14.7 41.0 15.4 14.6 12.6 16.2 15.5 14.9 15.8 137.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 52.2 33.0 78.5 0.0 54.4 39.7 36.7 0.0 0.0 0.0 0.0 18.8 84.1 0.0 0.0 10.5 0.0 28.7 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 16.2 0.0 0.0 23.8 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 44.5 0.0 0.0 0.0 MINDY3 "C10orf97, CARP, DERP5, FAM188A, FLJ13397, my042" ENSG00000148481 "MINDY lysine 48 deubiquitinase 3" Q9H8M7 10 15778170-15860520 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 20.8;Ciliated cells: 21.4;Hofbauer cells: 31.6;Syncytiotrophoblasts: 27.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038400, HPA038406" Uncertain Supported "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA038400: AB_10669724, HPA038406: AB_2676001" "unprognostic (9.20e-2)" "unprognostic (5.84e-2)" "unprognostic (3.09e-1)" "unprognostic (3.26e-1)" "unprognostic (1.99e-2)" "unprognostic (3.67e-1)" "unprognostic (8.29e-2)" "unprognostic (2.81e-2)" "unprognostic (3.85e-2)" "unprognostic (9.63e-2)" "unprognostic (6.48e-3)" "unprognostic (6.50e-2)" "unprognostic (1.32e-1)" "unprognostic (2.97e-1)" "unprognostic (1.04e-2)" "unprognostic (1.76e-1)" "unprognostic (3.19e-1)" 14.6 22.0 17.9 10.0 22.2 15.2 18.4 22.0 32.0 19.1 13.7 19.7 11.4 8.2 18.6 20.0 13.4 15.3 13.3 8.9 20.1 18.8 16.0 15.8 15.5 11.9 22.9 14.0 18.1 12.8 16.3 14.4 20.1 25.8 18.9 18.0 13.5 11.8 16.5 4.1 15.3 11.4 16.7 32.0 11.8 14.6 18.8 16.1 10.5 17.2 7.7 12.6 17.8 14.1 3.4 4.2 5.7 8.0 3.4 6.2 2.9 6.6 6.2 12.1 12.8 18.0 17.1 10.0 21.3 10.8 16.3 19.1 5.4 10.5 5.0 4.1 23.0 11.3 6.2 10.3 12.7 14.6 15.3 14.4 16.3 8.8 5.8 22.6 3.3 13.7 12.9 11.1 14.5 10.3 16.0 12.8 12.2 9.9 4.2 16.1 7.2 7.1 4.0 4.4 10.8 11.9 3.5 7.1 3.5 18.2 5.1 10.0 11.1 10.4 10.1 8.5 11.3 11.3 8.1 13.4 10.6 8.2 17.8 6.2 23.1 9.8 8.6 12.2 7.4 8.4 5.7 3.6 3.1 4.9 7.1 4.1 3.1 3.4 5.2 4.0 3.4 2.3 4.4 3.1 3.4 8.0 4.2 6.2 2.9 17.9 22.2 22.0 32.0 20.1 18.8 22.9 14.0 25.8 16.1 20.8 11.8 0.0 0.0 0.0 0.0 0.0 0.0 21.4 6.8 14.0 0.0 16.7 16.6 10.4 0.0 0.0 0.0 0.0 7.3 13.3 0.0 0.0 1.1 0.0 31.6 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 2.8 0.0 0.0 7.1 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 MIOS "FLJ20323, MIO, Sea4" ENSG00000164654 "Meiosis regulator for oocyte development" Q9NXC5 7 7566872-7608929 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 67.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042928, HPA052223" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042928: AB_10795610, HPA052223: AB_2681768" "unprognostic (8.09e-3)" "unprognostic (1.25e-2)" "unprognostic (6.93e-2)" "prognostic favorable (6.51e-4)" "unprognostic (3.42e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (9.14e-4)" "unprognostic (5.03e-2)" "unprognostic (6.06e-2)" "unprognostic (1.44e-2)" "unprognostic (2.27e-1)" "unprognostic (2.09e-1)" "prognostic favorable (3.28e-6)" "unprognostic (1.03e-1)" "unprognostic (1.10e-2)" "unprognostic (7.67e-3)" "unprognostic (2.72e-1)" 9.9 7.8 6.7 14.4 9.5 10.3 9.6 11.7 10.3 9.9 7.0 7.3 10.3 5.5 8.8 8.7 17.1 8.1 6.4 8.0 7.3 5.6 12.0 11.2 7.4 13.9 5.7 7.2 9.0 16.2 24.6 14.9 11.0 16.8 14.7 8.7 10.9 12.3 14.3 67.7 15.3 8.9 8.0 8.8 15.2 10.6 11.9 7.8 14.0 6.8 14.6 19.0 9.3 12.2 10.5 8.3 8.9 11.0 6.4 7.5 4.2 18.9 8.5 10.3 12.3 8.1 17.5 8.6 14.9 11.9 9.5 9.6 10.5 7.5 16.8 4.7 8.8 25.6 17.2 10.4 10.9 12.7 6.8 9.1 4.1 10.2 7.0 11.4 18.0 4.7 14.5 13.7 8.5 21.4 9.4 8.5 5.7 20.9 13.8 40.2 13.2 4.0 8.2 20.8 9.6 9.1 12.5 15.7 16.1 8.6 9.7 10.8 17.5 7.9 22.7 8.8 19.8 12.3 16.2 7.4 14.9 16.0 8.2 12.6 12.3 13.5 15.0 13.0 10.5 17.3 0.0 5.9 8.9 5.1 11.0 4.3 10.5 5.5 4.7 8.3 9.5 7.5 5.8 0.6 6.4 5.3 5.0 5.4 4.2 6.7 9.5 11.7 10.3 7.3 5.6 5.7 7.2 16.8 7.8 8.9 11.0 15.3 12.4 10.8 7.9 16.5 10.2 12.0 9.1 7.0 11.8 14.7 14.9 11.0 29.5 6.4 6.3 0.0 15.2 7.3 5.7 25.8 9.2 15.1 13.8 11.1 4.1 6.7 20.9 40.8 5.5 13.5 6.8 5.4 8.1 7.8 11.3 9.0 7.1 8.4 15.6 12.9 6.6 24.4 28.0 16.6 17.7 12.5 9.3 16.5 MIS18A "B28, C21orf45, C21orf46, FASP1, hMis18alpha" ENSG00000159055 "MIS18 kinetochore protein A" Q9NYP9 21 32268219-32279069 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Spermatocytes: 118.1;Spermatogonia: 79.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA018286, HPA020585" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA018286: AB_1845693, HPA020585: AB_1845694" "unprognostic (1.19e-1)" "unprognostic (1.55e-2)" "unprognostic (4.44e-2)" "unprognostic (1.98e-3)" "unprognostic (3.45e-2)" "unprognostic (2.29e-2)" "unprognostic (1.64e-2)" "unprognostic (2.35e-2)" "unprognostic (1.19e-2)" "unprognostic (4.39e-3)" "unprognostic (1.01e-2)" "unprognostic (1.52e-1)" "unprognostic (3.34e-2)" "unprognostic (1.85e-2)" "unprognostic (1.07e-1)" "unprognostic (6.57e-2)" "unprognostic (1.28e-1)" 5.5 7.5 7.8 6.6 10.7 13.8 7.4 16.4 8.3 6.1 8.9 5.4 1.9 7.9 6.6 6.3 11.4 5.6 5.3 3.9 6.8 4.7 6.7 5.7 3.7 9.7 6.8 9.3 9.8 5.8 3.3 4.3 7.1 6.6 5.5 10.6 4.4 6.0 4.1 4.0 7.8 8.5 7.7 6.2 7.3 6.1 26.6 5.4 19.3 3.9 6.8 11.3 5.3 6.5 18.5 13.2 8.2 11.7 10.4 15.5 6.4 21.1 5.3 15.3 14.6 2.3 4.0 23.5 11.2 5.8 11.0 9.6 10.5 11.8 23.2 8.3 4.2 13.3 7.2 15.0 8.5 13.3 13.2 16.6 26.6 5.6 13.5 1.5 22.7 9.0 1.7 3.7 9.2 6.7 3.6 7.7 23.7 30.9 19.6 10.7 14.5 26.0 20.7 31.6 14.7 15.5 22.8 22.9 21.7 7.6 7.3 18.4 9.1 17.1 14.6 10.5 11.5 17.6 13.9 4.5 13.9 25.7 10.8 11.5 10.6 16.8 29.3 8.9 36.6 12.5 2.4 5.3 8.2 10.2 6.8 10.2 18.2 11.2 11.7 4.9 18.5 15.5 11.5 1.7 10.4 11.7 13.2 14.6 6.4 7.8 10.7 16.4 8.3 6.8 4.7 6.8 9.3 6.6 5.4 17.9 6.2 11.5 6.8 13.9 10.1 5.2 5.1 10.7 5.7 10.4 3.9 29.4 11.6 9.4 4.3 6.8 2.0 0.0 10.7 41.8 12.1 4.6 3.5 7.3 14.5 7.9 5.8 14.1 5.4 5.3 9.8 6.3 5.0 6.4 17.5 9.7 8.2 7.8 9.6 13.7 7.4 19.4 6.6 118.1 79.0 12.9 12.2 8.9 15.3 3.5 MIXL1 "MILD1, MIXL" ENSG00000185155 "Mix paired-like homeobox" Q9H2W2 1 226223618-226227054 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 23.9;lymphoid tissue: 8.9" "Cell type enhanced" "Detected in single" 17 "Melanocytes: 1.7" "Cancer enriched" "Detected in some" 9 "testis cancer: 6.3" "Group enriched" "Detected in some" 5 "cerebellum: 5.1;cerebral cortex: 1.8" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HAP1: 2.7;Hep G2: 13.3;SuSa: 3.1;U-698: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA005662 Approved Nucleoplasm NA NA Nucleoplasm "HPA005662: AB_2667382" "unprognostic (4.09e-2)" "unprognostic (2.84e-2)" "unprognostic (2.15e-2)" "unprognostic (1.00e-1)" "unprognostic (6.34e-2)" "unprognostic (1.03e-2)" "unprognostic (3.18e-2)" "unprognostic (5.66e-2)" "unprognostic (5.05e-2)" "unprognostic (7.40e-3)" "unprognostic (2.78e-2)" "unprognostic (2.70e-1)" "unprognostic (2.71e-13)" "unprognostic (1.54e-1)" "unprognostic (1.29e-2)" "unprognostic (1.67e-1)" "unprognostic (8.47e-2)" 0.6 0.2 0.6 8.9 0.4 0.3 0.3 5.1 1.8 0.7 1.4 0.4 0.0 2.7 0.4 0.1 0.6 0.3 0.2 0.4 0.6 0.6 0.3 0.6 0.5 8.2 0.6 0.0 1.2 0.2 2.3 0.3 0.3 0.6 1.0 1.1 0.2 4.9 0.4 0.2 0.3 1.3 0.0 0.5 7.8 1.4 2.2 0.0 1.0 0.4 0.7 7.0 2.6 0.3 7.5 7.7 23.9 12.2 14.6 9.5 4.0 0.1 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.1 0.1 0.1 0.3 0.1 0.0 0.1 2.7 0.0 0.2 0.0 0.1 0.2 0.2 13.3 0.7 0.0 0.1 0.2 0.1 0.7 0.0 0.0 0.2 1.9 0.0 0.1 0.1 0.0 0.1 0.1 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.0 3.1 0.1 0.7 0.2 0.1 0.0 0.1 0.0 0.4 0.0 3.5 0.0 0.0 0.0 23.9 4.7 8.4 4.8 7.1 9.5 7.5 5.6 5.4 4.8 7.2 7.4 7.3 12.9 14.6 12.2 7.7 7.1 4.0 0.6 0.4 5.1 1.8 0.6 0.6 0.6 0.0 0.6 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 MKI67 "MIB-, PPP1R105" ENSG00000148773 "Marker of proliferation Ki-67" P46013 10 128096659-128126385 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 25.2;lymphoid tissue: 81.5" "Cell type enhanced" "Detected in many" 19 "Erythroid cells: 163.5;Extravillous trophoblasts: 71.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.4;T-reg: 1.3" "Group enriched" "Detected in many" 13 "NK-cells: 1.1;T-cells: 1.4" "Low cell line specificity" "Detected in many" "CAB000058, HPA000451, HPA001164, CAB068198" Enhanced Enhanced "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes Yes "Nucleoplasm, Nucleoli rim" "Mitotic chromosome" "CAB000058: AB_2142367, CAB068198: AB_2665702, HPA000451: AB_1079186, HPA001164: AB_1079187" "unprognostic (2.54e-1)" "unprognostic (1.29e-1)" "unprognostic (3.37e-1)" "unprognostic (9.92e-3)" "unprognostic (3.17e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (3.61e-6)" "unprognostic (7.16e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-1)" "prognostic unfavorable (9.47e-5)" "unprognostic (2.45e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.42e-2)" "unprognostic (2.10e-1)" "unprognostic (2.50e-1)" "unprognostic (4.61e-1)" 1.8 1.2 0.2 9.9 0.5 25.2 1.8 0.3 0.5 1.5 5.0 0.6 0.2 3.6 0.7 1.4 13.4 0.3 1.2 1.3 0.2 0.2 1.2 1.0 1.9 8.8 0.2 0.2 0.5 0.4 0.0 0.4 2.9 0.5 0.7 5.8 0.5 2.2 0.6 0.5 3.9 6.2 1.3 0.8 6.5 3.5 2.5 0.2 81.5 0.4 5.2 10.0 1.3 3.5 0.0 0.0 0.0 0.0 1.1 1.4 0.4 48.1 24.5 25.5 18.0 1.0 2.2 7.9 18.3 13.5 17.4 15.6 20.0 20.0 36.3 5.3 12.5 11.5 29.4 26.7 13.7 26.2 38.2 12.9 31.1 18.1 12.5 0.0 43.6 16.9 0.5 0.6 17.8 18.3 4.3 17.0 16.9 14.2 34.9 17.2 19.1 26.0 13.3 10.1 12.5 11.2 19.4 33.4 4.8 6.3 13.5 8.9 9.6 25.9 9.3 4.4 8.8 7.7 9.3 15.7 9.2 18.5 13.0 49.4 15.9 12.6 44.0 7.7 20.0 7.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 1.4 1.0 0.0 1.1 0.0 0.0 1.3 0.4 0.2 0.5 0.3 0.5 0.2 0.2 0.2 0.2 0.5 0.2 0.0 4.8 10.7 0.5 5.7 0.0 1.2 2.5 2.7 7.9 0.0 0.0 2.7 0.0 0.4 2.5 0.0 2.7 163.5 0.0 71.7 3.4 1.4 1.1 1.0 34.1 0.0 6.4 3.7 8.0 0.5 0.3 12.7 3.3 0.0 4.8 0.0 0.1 2.9 0.4 0.0 0.0 0.0 0.4 8.8 14.6 2.6 6.5 13.4 20.7 4.1 MKL1 "BSAC, KIAA1438, MAL, MKL, MRTF-A" ENSG00000196588 "Megakaryoblastic leukemia (translocation) 1" Q969V6 22 40410281-40636702 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Actin-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 87.5;Late spermatids: 76.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 50.9" "Group enriched" "Detected in all" 5 "dendritic cells: 26.4;granulocytes: 50.9;monocytes: 15.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030782 Approved Supported Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA030782: AB_10600930" "unprognostic (7.90e-3)" "unprognostic (4.51e-2)" "unprognostic (2.99e-1)" "unprognostic (1.29e-1)" "unprognostic (9.04e-2)" "unprognostic (9.37e-2)" "unprognostic (4.38e-3)" "unprognostic (1.02e-3)" "unprognostic (1.30e-1)" "unprognostic (1.35e-2)" "unprognostic (1.51e-1)" "unprognostic (3.74e-2)" "prognostic unfavorable (1.58e-7)" "unprognostic (9.05e-2)" "unprognostic (8.15e-2)" "unprognostic (1.30e-2)" "unprognostic (3.98e-1)" 18.1 11.1 15.4 25.4 19.1 69.2 15.8 16.2 26.1 17.6 14.2 13.5 10.1 11.3 27.6 12.9 12.3 17.5 13.2 16.3 14.2 11.1 11.3 8.9 17.4 25.6 11.8 16.6 16.9 14.5 10.2 10.5 18.9 12.6 14.2 9.4 13.3 16.9 15.7 14.3 18.0 13.6 15.7 11.0 23.9 14.3 25.4 10.8 28.2 17.3 9.0 25.5 15.5 14.6 4.9 26.4 50.9 15.0 3.8 5.6 7.5 10.9 14.8 6.5 7.7 8.2 6.2 12.7 10.7 7.0 9.9 9.6 7.0 3.3 11.7 4.4 11.3 8.5 14.4 5.4 13.2 6.4 13.0 9.5 19.4 16.6 10.3 8.1 22.4 38.2 6.7 15.9 9.5 6.6 7.3 7.2 6.9 5.4 5.3 4.6 10.7 8.7 25.2 5.1 5.6 5.2 14.2 7.2 5.9 7.8 8.2 3.6 3.8 17.5 8.9 6.5 8.7 6.0 25.4 11.8 6.7 18.1 8.9 9.2 7.1 6.3 16.9 5.5 11.4 13.0 12.0 15.0 50.9 4.4 11.6 4.1 3.2 4.0 3.4 17.8 4.9 5.6 4.7 14.5 3.8 15.0 26.4 5.2 7.5 15.4 19.1 16.2 26.1 14.2 11.1 11.8 16.6 12.6 10.8 6.0 8.3 7.8 6.0 13.9 11.5 7.3 2.5 8.1 2.3 8.7 21.6 7.0 3.3 9.5 87.5 7.1 7.4 0.0 12.0 6.9 9.1 8.9 16.1 3.9 10.9 3.2 6.4 6.7 17.0 76.0 10.3 13.9 6.8 16.2 6.5 3.7 14.1 2.9 7.4 2.6 12.0 25.8 12.1 9.2 9.5 11.2 6.5 10.1 3.7 8.0 MKNK1 MNK1 ENSG00000079277 "MAP kinase interacting serine/threonine kinase 1" Q9BUB5 1 46557408-46616843 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Translation regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 72.3" "Cell type enhanced" "Detected in all" 6 "Hofbauer cells: 113.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB027355, CAB037310, HPA071293" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB027355: AB_2266303, CAB037310: AB_1854049, HPA071293: AB_2686382" "unprognostic (4.05e-3)" "prognostic favorable (7.05e-4)" "unprognostic (5.28e-2)" "unprognostic (3.47e-2)" "unprognostic (1.64e-1)" "unprognostic (7.38e-2)" "prognostic unfavorable (1.24e-5)" "unprognostic (3.50e-2)" "unprognostic (1.77e-1)" "unprognostic (2.60e-1)" "unprognostic (1.50e-1)" "unprognostic (2.14e-2)" "prognostic unfavorable (1.51e-5)" "unprognostic (7.02e-2)" "unprognostic (3.19e-2)" "unprognostic (4.67e-1)" "unprognostic (5.67e-3)" 17.6 12.0 10.7 16.2 10.5 16.8 12.1 13.7 12.3 9.2 12.6 11.0 9.6 9.7 11.9 13.3 12.2 11.1 11.4 12.3 10.8 7.0 9.4 10.8 16.1 16.3 9.9 9.8 10.7 72.3 8.6 11.3 15.4 11.0 9.9 13.3 11.9 10.6 7.7 12.8 10.2 12.7 13.3 8.1 25.6 11.7 7.6 8.7 12.5 8.8 15.8 10.9 10.9 14.5 4.9 6.0 33.3 12.1 5.0 22.0 6.1 19.5 13.2 8.8 9.7 7.9 11.7 11.7 9.9 9.9 12.0 16.4 15.3 8.0 12.9 12.2 9.9 13.5 23.7 14.7 16.2 12.9 22.2 13.0 27.3 15.2 13.0 12.3 14.6 22.2 15.4 11.2 15.6 8.6 6.5 14.0 15.9 14.2 9.5 6.5 12.8 10.4 13.0 6.0 11.3 15.7 9.6 18.4 12.9 12.9 20.5 6.2 5.5 19.1 17.3 16.0 18.3 11.7 16.3 11.4 4.4 0.9 13.6 11.0 8.1 13.5 11.0 8.5 18.8 8.0 3.9 12.1 14.3 7.5 11.5 22.0 4.6 6.6 6.8 6.0 4.9 4.8 7.0 33.3 5.0 8.1 4.4 4.4 6.1 10.7 10.5 13.7 12.3 10.8 7.0 9.9 9.8 11.0 8.7 11.9 22.1 17.5 15.7 12.4 17.9 15.5 15.3 10.7 18.2 21.0 2.0 19.4 6.6 16.1 13.0 14.3 23.5 23.3 32.1 29.7 19.5 15.8 11.5 20.2 113.5 17.5 16.1 18.4 71.2 17.5 19.8 58.2 10.1 16.2 11.9 6.5 28.0 14.0 34.3 10.2 4.6 6.5 14.4 16.8 15.5 9.7 15.4 24.9 14.7 19.5 MKRN1 RNF61 ENSG00000133606 "Makorin ring finger protein 1" Q9UHC7 7 140453040-140479569 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000567 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA000567: AB_1079299" "unprognostic (9.97e-2)" "unprognostic (1.50e-1)" "unprognostic (1.27e-1)" "unprognostic (7.60e-3)" "unprognostic (1.65e-2)" "unprognostic (2.41e-1)" "unprognostic (4.87e-3)" "unprognostic (1.24e-2)" "unprognostic (8.02e-2)" "unprognostic (2.97e-2)" "unprognostic (2.52e-1)" "unprognostic (1.35e-1)" "unprognostic (2.89e-3)" "unprognostic (5.76e-2)" "unprognostic (2.42e-1)" "unprognostic (1.22e-1)" "unprognostic (1.22e-2)" 16.8 17.6 26.8 20.8 28.8 69.9 20.1 37.2 32.6 20.4 39.6 16.1 19.7 28.4 20.1 18.6 23.3 22.2 22.4 38.5 24.9 29.8 20.6 17.5 23.6 18.3 25.7 23.3 24.9 27.3 28.2 21.5 31.7 29.4 21.0 33.7 19.4 24.8 23.1 38.5 24.4 26.6 26.3 20.5 22.5 21.7 95.4 20.2 21.0 23.6 18.8 22.3 25.3 36.4 13.1 7.5 39.3 10.5 12.8 17.8 6.4 28.4 22.0 17.2 25.5 27.3 23.9 24.3 19.6 25.5 15.5 17.9 9.0 30.0 20.7 30.8 19.1 31.0 13.9 19.3 21.6 19.7 40.9 16.7 21.5 13.2 16.6 22.0 18.4 33.2 23.8 32.6 17.4 16.5 25.6 15.4 14.3 16.9 26.1 14.8 24.5 21.5 32.9 44.2 24.0 16.3 15.6 14.7 31.6 24.8 33.0 23.8 24.6 24.6 33.4 35.1 26.5 16.4 16.0 21.8 10.9 8.7 26.5 17.9 62.3 45.6 18.1 31.2 28.9 22.4 19.4 9.2 39.3 6.7 8.7 8.0 13.1 13.0 10.1 7.5 10.9 17.8 11.3 18.1 12.8 10.5 2.5 14.0 6.4 26.8 28.8 37.2 32.6 24.9 29.8 25.7 23.3 29.4 20.2 47.6 30.4 57.3 58.0 72.9 58.8 51.3 63.7 33.5 43.3 40.1 33.4 63.4 87.9 55.8 227.6 33.8 112.4 256.9 59.7 76.6 47.0 74.5 36.9 38.9 53.2 112.8 93.6 40.5 91.7 263.0 61.5 68.3 65.8 87.4 100.7 52.1 52.9 123.8 58.7 39.1 43.2 45.3 49.5 153.2 47.1 83.4 115.4 66.0 96.2 100.8 MKRN2 "HSPC070, RNF62" ENSG00000075975 "Makorin ring finger protein 2" Q9H000 3 12557014-12583713 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 10 "Early spermatids: 562.3;Late spermatids: 587.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037559, HPA037560" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA037559: AB_10672460, HPA037560: AB_10696936" "unprognostic (4.17e-2)" "unprognostic (1.08e-1)" "unprognostic (1.59e-2)" "unprognostic (5.99e-2)" "unprognostic (3.89e-2)" "unprognostic (1.47e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (4.38e-1)" "unprognostic (8.49e-2)" "unprognostic (2.86e-1)" "unprognostic (1.42e-1)" "unprognostic (2.56e-3)" "prognostic favorable (6.04e-4)" "unprognostic (3.26e-1)" "unprognostic (2.22e-1)" "unprognostic (1.33e-2)" "unprognostic (3.32e-2)" 13.7 10.4 15.1 11.1 18.3 16.4 11.6 29.3 19.5 13.7 12.7 12.4 16.1 12.5 15.2 12.3 16.2 13.1 10.9 26.3 14.0 15.1 13.7 12.5 12.1 12.6 15.2 14.8 20.8 26.6 17.3 11.9 14.4 16.0 11.3 11.5 13.2 12.8 13.1 24.5 12.8 10.9 15.9 16.2 10.1 11.7 46.1 14.7 15.4 18.2 17.0 13.7 13.0 12.6 21.3 19.0 30.0 20.3 25.3 26.2 18.7 10.7 12.5 14.9 11.2 23.3 22.7 28.8 16.7 17.9 21.3 17.9 12.0 10.7 15.3 9.6 18.4 9.8 6.6 19.3 16.4 19.0 17.3 16.3 21.8 14.3 16.1 26.9 21.4 9.9 25.2 15.3 24.8 15.6 19.1 17.4 21.3 20.3 21.7 18.3 15.2 26.2 11.1 9.9 10.5 22.0 25.3 14.4 17.2 14.9 14.3 8.7 14.8 14.5 7.4 14.8 11.0 16.8 19.0 17.6 14.6 14.3 17.3 22.6 16.5 33.7 32.8 15.8 25.7 21.9 18.9 17.2 30.0 21.5 15.6 26.2 21.3 22.1 22.0 19.0 16.4 23.9 22.3 15.0 25.3 20.3 15.1 23.4 18.7 15.1 18.3 29.3 19.2 14.0 15.1 15.2 14.8 16.0 14.7 17.9 8.1 9.3 8.8 8.5 14.5 12.1 2.5 17.4 11.4 5.2 3.9 16.1 16.6 13.6 562.3 11.6 7.3 0.0 14.7 16.7 10.4 6.8 18.5 5.4 13.3 11.1 2.4 6.7 9.8 587.8 19.0 7.9 15.1 24.4 11.9 18.1 12.7 12.9 19.4 8.1 12.4 12.9 14.7 60.0 42.8 8.2 13.5 9.6 11.4 7.9 MKRN3 "D15S9, MGC88288, RNF63, ZFP127, ZNF127" ENSG00000179455 "Makorin ring finger protein 3" Q13064 15 23565678-23630075 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.4" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 12.6;Cone photoreceptor cells: 23.6;Horizontal cells: 6.4;Rod photoreceptor cells: 6.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 5.7" "Lineage enriched" "Detected in many" 4 "T-cells: 5.7" "Cell line enhanced" "Detected in many" "JURKAT: 16.0;K-562: 17.1" "Low region specificity" "Detected in many" HPA029494 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA029494: AB_10603873" "unprognostic (3.18e-1)" "unprognostic (1.26e-1)" "unprognostic (4.26e-1)" "unprognostic (1.86e-3)" "unprognostic (1.04e-3)" "unprognostic (1.15e-2)" "unprognostic (6.27e-4)" "unprognostic (1.51e-1)" "unprognostic (8.52e-2)" "unprognostic (7.05e-2)" "unprognostic (4.97e-3)" "unprognostic (2.86e-1)" "unprognostic (1.05e-4)" "unprognostic (5.37e-2)" "unprognostic (1.52e-1)" "unprognostic (8.91e-2)" "unprognostic (9.78e-2)" 1.0 0.7 5.1 1.2 10.4 4.0 1.2 1.0 11.1 0.5 1.1 8.4 0.0 1.3 1.3 3.2 5.6 0.9 0.8 0.8 6.4 3.4 1.1 0.7 1.0 1.9 14.4 3.0 1.2 1.7 0.5 3.8 8.5 5.1 1.2 0.8 3.1 5.2 1.0 1.4 1.2 1.9 0.8 8.2 1.5 0.9 5.7 13.3 5.0 0.9 1.1 1.7 0.7 0.6 1.0 0.9 1.3 0.5 0.4 5.7 0.7 4.6 3.3 3.0 3.1 0.0 0.0 7.0 0.3 0.0 2.8 1.9 8.3 0.0 0.2 0.1 0.0 6.2 8.0 1.3 0.0 0.7 0.0 0.3 6.7 8.9 0.3 0.1 7.8 6.0 0.1 0.0 5.8 0.0 1.2 0.0 16.0 17.1 7.3 0.8 0.0 8.2 3.4 0.0 4.4 10.1 5.9 1.1 4.1 0.0 0.1 0.7 2.4 0.0 3.4 0.0 0.2 2.6 2.3 0.0 7.8 6.6 0.4 5.5 9.2 11.3 5.5 4.5 0.1 0.1 1.3 0.5 0.4 1.8 0.2 1.0 1.0 0.6 1.4 0.2 0.9 2.0 5.7 1.3 0.4 0.3 0.9 0.4 0.7 5.1 10.4 1.0 6.8 6.4 3.4 14.4 3.0 5.1 13.3 0.0 0.0 0.0 1.1 0.5 12.6 0.4 0.0 0.0 0.0 0.0 23.6 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.9 0.3 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 3.4 0.0 0.0 0.4 0.0 6.4 0.0 1.2 2.4 1.0 0.0 0.5 0.0 0.0 0.4 MKX "C10orf48, IRXL1, MGC39616" ENSG00000150051 "Mohawk homeobox" Q8IYA7 10 27672875-27746060 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 21.3;prostate: 24.3" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 2: 3.4;Ciliated cells: 6.7;Club cells: 2.3;Peritubular cells: 6.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "myeloid DC: 1.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.2" "Cell line enhanced" "Detected in some" "BJ: 19.3;BJ hTERT+: 11.1;BJ hTERT+ SV40 Large T+: 12.7;BJ hTERT+ SV40 Large T+ RasG12V: 8.7;fHDF/TERT166: 55.2;SiHa: 8.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA006927 Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA006927: AB_1853981" "unprognostic (2.04e-1)" "unprognostic (2.59e-2)" "unprognostic (1.17e-1)" "unprognostic (3.62e-2)" "unprognostic (3.74e-1)" "unprognostic (5.23e-2)" "unprognostic (9.09e-2)" "unprognostic (6.07e-2)" "unprognostic (8.37e-2)" "unprognostic (2.16e-1)" "unprognostic (3.49e-1)" "unprognostic (1.41e-1)" "unprognostic (1.09e-2)" "unprognostic (7.62e-2)" "unprognostic (1.91e-1)" "unprognostic (1.14e-1)" "unprognostic (6.38e-3)" 3.7 3.2 1.6 1.4 2.1 0.3 3.0 2.6 5.9 4.9 4.3 1.4 0.9 0.5 1.8 3.4 1.8 7.1 2.7 0.8 1.4 2.5 0.6 1.9 1.2 0.5 2.7 1.4 21.3 1.0 0.3 13.9 0.3 6.7 24.3 1.5 2.9 0.9 7.7 0.5 1.0 0.7 10.6 2.7 0.8 3.4 1.3 0.1 0.0 4.5 0.5 0.3 8.7 1.6 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 19.3 11.1 12.7 8.7 0.0 0.0 0.0 0.0 55.2 0.5 0.0 0.1 0.0 3.4 0.0 1.2 0.0 3.5 0.0 0.5 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 1.2 0.0 2.4 0.3 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.2 0.0 8.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.1 2.6 5.9 1.4 2.5 2.7 1.4 6.7 0.1 0.0 3.4 0.0 0.0 0.0 0.1 1.4 0.0 6.7 2.3 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.7 0.0 0.0 0.0 2.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 MLF1 ENSG00000178053 "Myeloid leukemia factor 1" P58340 3 158571163-158607252 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, Differentiation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 41.4;skeletal muscle: 53.6;testis: 101.1" "Group enriched" "Detected in many" 15 "Early spermatids: 4250.8;Late spermatids: 9284.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 10.4" "Lineage enriched" "Detected in single" 12 "T-cells: 10.4" "Cell line enhanced" "Detected in many" "A-431: 33.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA069479, HPA079339" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA069479: AB_2686140, HPA079339: " "unprognostic (6.49e-2)" "unprognostic (1.98e-3)" "unprognostic (1.98e-1)" "prognostic unfavorable (2.15e-5)" "unprognostic (1.72e-2)" "unprognostic (2.65e-2)" "unprognostic (8.55e-2)" "unprognostic (4.11e-2)" "unprognostic (2.01e-1)" "unprognostic (2.07e-1)" "unprognostic (7.21e-2)" "unprognostic (1.07e-1)" "unprognostic (7.82e-2)" "prognostic unfavorable (5.54e-4)" "unprognostic (9.34e-3)" "unprognostic (2.47e-3)" "unprognostic (3.36e-2)" 3.5 2.6 6.0 1.8 11.9 0.9 5.3 3.4 7.1 3.1 2.7 6.5 0.5 0.8 4.9 5.6 3.5 18.3 4.9 41.4 6.3 6.3 5.7 1.2 5.2 1.0 4.9 6.3 6.2 3.1 5.2 10.4 1.0 20.1 2.0 1.7 2.8 2.2 1.6 53.6 1.8 1.3 4.5 4.7 1.2 1.9 101.1 5.7 0.0 5.3 18.9 1.4 4.2 1.5 0.6 0.3 0.4 0.3 0.8 10.4 2.3 33.7 4.4 11.4 0.0 6.0 7.1 3.4 3.5 3.3 12.8 11.7 0.0 19.2 0.0 13.4 6.0 18.7 6.6 0.1 5.9 17.1 0.0 7.4 2.0 3.3 0.3 4.1 0.0 2.5 4.4 8.7 6.1 3.4 13.4 3.0 0.0 2.5 0.0 8.4 4.9 0.0 0.1 2.7 18.0 9.9 0.0 6.4 0.4 9.8 2.4 14.7 8.7 15.9 5.6 16.7 11.7 16.2 3.4 1.1 12.0 12.2 14.1 13.6 6.1 3.8 0.0 8.7 0.0 8.6 0.0 0.0 0.0 3.6 0.0 1.6 0.6 8.3 8.7 0.3 0.3 2.1 4.4 0.4 0.8 0.3 0.2 10.4 2.3 6.0 11.9 3.4 7.1 6.3 6.3 4.9 6.3 20.1 5.7 23.8 26.2 2.2 109.9 39.8 12.6 168.2 0.0 238.3 60.3 19.2 31.4 0.6 61.3 22.4 4250.8 23.3 4.2 0.0 6.9 3.5 36.8 26.1 43.8 0.0 6.4 9.5 32.5 8.0 2.7 9284.2 64.7 13.2 21.9 1.8 14.3 25.9 7.6 14.4 47.4 27.5 58.5 19.4 36.9 440.7 150.0 29.9 1.4 8.9 10.3 65.9 MLF2 NTN4 ENSG00000089693 "Myeloid leukemia factor 2" Q15773 12 6747996-6767475 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010811, HPA010859" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA010811: AB_1079389, HPA010859: AB_1079388" "unprognostic (1.65e-1)" "unprognostic (6.55e-2)" "unprognostic (4.42e-1)" "unprognostic (9.88e-3)" "unprognostic (1.76e-1)" "unprognostic (4.19e-2)" "unprognostic (1.52e-1)" "unprognostic (4.15e-2)" "unprognostic (1.31e-1)" "unprognostic (9.11e-2)" "unprognostic (3.37e-1)" "unprognostic (6.23e-2)" "unprognostic (1.38e-1)" "unprognostic (5.83e-2)" "unprognostic (4.72e-1)" "unprognostic (8.44e-2)" "unprognostic (3.63e-1)" 31.4 45.6 55.8 23.3 65.4 36.9 24.9 50.5 100.5 28.6 30.9 44.0 23.9 36.5 32.1 30.5 39.3 31.7 28.6 44.1 54.4 47.2 37.9 77.4 24.8 21.5 40.2 42.5 28.3 33.4 43.3 31.1 32.5 44.8 38.4 27.6 28.2 43.1 36.7 45.3 33.6 35.1 35.9 33.7 21.8 27.7 21.0 30.7 26.0 36.3 28.9 29.4 29.3 23.6 17.0 38.9 86.7 20.1 11.8 14.8 16.9 39.1 64.9 33.4 58.7 31.3 31.9 51.3 38.6 46.4 66.4 58.3 62.7 38.9 28.3 10.2 50.2 43.4 32.9 41.0 55.8 41.3 44.5 38.0 20.0 34.4 35.9 34.6 21.2 27.6 29.8 45.6 51.3 39.3 48.8 27.0 27.0 25.1 11.8 46.2 55.6 29.1 32.8 107.8 42.5 22.4 18.6 30.7 25.1 55.4 49.5 21.3 42.2 34.8 61.6 37.3 73.7 17.9 35.1 26.6 39.6 52.8 41.8 56.3 14.4 16.3 37.6 52.9 18.5 46.6 35.4 20.1 73.9 14.8 18.0 14.3 15.3 11.5 13.9 22.6 17.0 12.2 13.5 86.7 11.8 19.5 38.9 11.2 16.9 55.8 65.4 50.5 100.5 54.4 47.2 40.2 42.5 44.8 30.7 35.7 25.7 57.9 127.1 121.2 102.4 55.8 104.4 45.5 36.4 104.7 39.3 229.6 237.1 156.1 7.9 68.0 134.5 0.0 110.6 175.2 95.0 155.3 83.1 146.5 129.4 76.3 96.6 62.0 41.9 7.0 105.6 62.0 97.8 201.0 116.3 120.9 125.1 111.0 100.8 262.4 48.7 51.8 117.9 51.9 90.7 109.8 357.4 59.8 120.9 152.3 MLH1 "COCA2, FCC2, HNPCC, HNPCC2" ENSG00000076242 "MutL homolog 1" P40692 3 36993332-37050918 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013294, HPA052707, HPA060714, CAB070868" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB013294: AB_2533406, CAB070868: , HPA052707: AB_2681923, HPA060714: AB_2684348" "unprognostic (1.26e-2)" "unprognostic (3.88e-3)" "unprognostic (2.36e-2)" "unprognostic (1.82e-1)" "unprognostic (3.33e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (8.24e-5)" "unprognostic (3.36e-2)" "unprognostic (2.18e-1)" "unprognostic (1.32e-1)" "unprognostic (8.54e-2)" "unprognostic (8.63e-3)" "unprognostic (2.10e-3)" "unprognostic (4.37e-2)" "unprognostic (1.38e-1)" "unprognostic (1.02e-2)" "unprognostic (8.86e-2)" 16.3 20.7 18.2 19.4 21.4 24.4 18.7 19.7 19.6 15.3 17.3 28.8 19.6 12.4 18.7 23.6 15.1 16.2 14.4 32.0 17.3 17.7 18.8 20.5 17.8 22.8 19.9 16.0 17.6 18.1 26.0 29.4 17.3 19.2 18.5 17.7 16.7 15.6 18.1 46.4 14.2 14.1 21.1 21.6 20.7 16.5 27.6 21.5 29.0 22.2 19.5 24.5 16.9 21.4 12.0 12.9 13.2 23.2 6.7 13.4 9.0 14.2 22.5 28.1 0.0 12.5 15.7 12.6 21.3 17.0 24.8 26.4 17.0 15.9 35.3 10.6 17.3 14.0 9.8 24.2 18.0 26.6 16.0 12.5 24.7 20.8 23.8 13.9 30.3 17.2 11.7 12.7 23.1 28.8 9.8 15.3 23.9 31.6 16.9 25.1 11.5 31.6 12.4 20.6 14.5 12.4 3.1 34.4 14.9 15.7 15.5 6.0 14.2 21.6 23.0 14.2 16.4 33.2 21.6 12.1 19.5 21.0 19.1 25.0 13.4 36.6 33.1 15.1 28.7 17.5 10.9 11.7 13.2 13.4 19.5 9.7 12.0 8.4 10.7 12.9 10.3 9.6 9.7 3.4 6.7 23.2 6.1 12.5 9.0 18.2 21.4 19.7 19.6 17.3 17.7 19.9 16.0 19.2 21.5 23.8 12.0 16.0 10.7 6.4 19.2 37.1 15.3 16.0 13.6 10.4 9.8 27.1 16.6 12.5 20.3 11.2 5.3 0.0 13.0 23.0 13.4 8.0 7.0 14.5 17.5 3.2 5.2 12.3 14.3 9.5 10.3 11.4 8.5 19.8 7.2 14.3 8.6 7.0 13.1 9.2 17.9 12.9 9.5 37.0 25.4 4.8 16.7 13.1 7.6 3.4 MLH3 ENSG00000119684 "MutL homolog 3" Q9UHC1 14 75013764-75051532 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Disease mutation, Hereditary nonpolyposis colorectal cancer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060570 Approved Nucleoplasm NA NA Nucleoplasm "HPA060570: AB_2684323" "unprognostic (2.94e-1)" "unprognostic (6.70e-3)" "unprognostic (7.14e-3)" "unprognostic (7.35e-2)" "unprognostic (7.38e-2)" "unprognostic (1.55e-1)" "unprognostic (1.49e-2)" "unprognostic (1.62e-2)" "unprognostic (3.77e-2)" "unprognostic (6.68e-2)" "unprognostic (1.93e-2)" "unprognostic (8.42e-2)" "unprognostic (3.53e-1)" "unprognostic (2.89e-1)" "unprognostic (1.68e-1)" "unprognostic (1.64e-1)" "unprognostic (7.11e-2)" 13.6 15.6 10.3 9.0 14.4 3.3 13.4 15.2 18.6 13.7 11.8 17.3 17.0 8.4 13.1 12.9 9.4 10.9 10.7 11.0 11.2 10.6 12.8 11.7 8.6 10.3 18.5 15.4 13.3 9.4 24.6 33.6 10.3 16.6 13.4 11.0 8.4 9.2 19.4 13.6 8.0 13.3 12.0 15.6 9.9 7.9 10.7 18.5 7.7 19.2 5.7 12.6 12.0 9.6 8.1 4.1 4.6 3.8 9.8 7.0 8.3 10.4 10.4 7.4 1.3 8.3 13.9 7.9 3.3 3.2 6.2 5.5 8.1 12.5 12.1 3.2 4.0 7.2 7.7 0.1 3.8 8.8 11.5 0.1 7.4 6.8 5.0 6.8 3.4 5.1 5.6 7.8 6.1 0.4 6.4 10.0 0.0 7.5 9.4 13.4 7.9 4.8 3.2 6.8 7.8 5.8 9.3 4.9 2.3 13.4 10.9 12.0 9.2 11.2 8.1 0.6 8.4 10.9 6.8 5.3 2.6 4.9 3.5 3.6 11.1 10.9 11.7 9.2 0.3 11.4 4.6 3.8 2.4 7.0 2.9 5.8 4.8 4.1 6.4 4.1 8.1 6.4 5.1 1.9 9.8 2.0 3.5 4.5 8.3 10.3 14.4 15.2 18.6 11.2 10.6 18.5 15.4 16.6 18.5 23.8 15.9 16.4 20.6 7.0 53.7 15.9 20.4 20.1 17.0 34.9 41.2 12.8 6.6 12.4 5.2 13.7 11.6 0.0 9.6 5.6 12.6 11.4 23.1 13.7 8.8 33.4 12.6 12.9 6.5 4.7 36.8 9.4 15.1 6.4 13.1 35.6 11.0 13.1 48.1 13.2 58.1 45.3 14.6 21.5 8.9 7.5 8.5 12.2 16.4 10.0 MLIP "C6orf142, CIP, MGC18257" ENSG00000146147 "Muscular LMNA interacting protein" Q5VWP3 6 53929982-54266280 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 61.7;liver: 47.4;skeletal muscle: 101.9;tongue: 31.6" "Cell type enriched" "Detected in some" 10 "Cardiomyocytes: 190.6" "Cancer enhanced" "Detected in some" "liver cancer: 1.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HUVEC TERT2: 18.1;SK-MEL-30: 17.4" "Low region specificity" "Detected in many" "HPA029252, HPA046654" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA029252: AB_2732446, HPA046654: " "unprognostic (7.95e-3)" "unprognostic (4.39e-2)" "unprognostic (2.36e-1)" "unprognostic (1.06e-4)" "unprognostic (2.38e-2)" "unprognostic (1.26e-2)" "unprognostic (5.60e-2)" "unprognostic (2.74e-2)" "unprognostic (1.89e-2)" "unprognostic (1.78e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (1.91e-5)" "unprognostic (7.49e-2)" "unprognostic (2.65e-2)" "unprognostic (5.27e-2)" "unprognostic (3.29e-3)" 5.7 1.9 4.2 0.2 5.2 0.1 1.6 0.8 11.5 0.8 0.5 0.0 0.0 0.3 0.4 3.5 4.9 0.5 0.8 61.7 1.8 0.8 0.5 47.4 0.4 0.2 7.2 8.3 0.4 0.6 0.3 0.5 0.2 1.8 0.8 0.4 1.3 2.6 0.3 101.9 6.5 1.1 0.3 2.9 0.3 0.4 0.5 0.0 0.0 2.7 31.6 2.2 0.6 1.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.4 2.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.7 2.2 0.0 0.0 0.0 18.1 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.3 0.0 0.3 1.2 0.0 0.1 0.6 1.3 0.0 0.0 0.5 17.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.2 5.2 0.8 11.5 1.8 0.8 7.2 8.3 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 190.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 11.7 0.5 0.0 0.0 0.0 0.0 0.3 0.1 0.0 18.3 0.0 12.7 0.0 0.6 1.5 8.2 0.3 0.0 6.8 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.2 0.1 1.8 0.0 0.0 0.0 0.1 MLLT1 "ENL, LTG19, YEATS1" ENSG00000130382 "MLLT1, super elongation complex subunit" Q03111 19 6210379-6279948 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 13 "Cytotrophoblasts: 494.9;Syncytiotrophoblasts: 951.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031166 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA031166: AB_10601874" "unprognostic (3.21e-1)" "unprognostic (2.75e-3)" "unprognostic (4.84e-2)" "unprognostic (3.36e-2)" "unprognostic (2.47e-1)" "prognostic favorable (6.03e-5)" "unprognostic (1.30e-3)" "unprognostic (1.44e-2)" "unprognostic (1.56e-1)" "unprognostic (1.98e-1)" "unprognostic (3.93e-3)" "unprognostic (4.76e-2)" "unprognostic (3.65e-3)" "unprognostic (1.14e-2)" "unprognostic (2.01e-1)" "unprognostic (1.66e-2)" "unprognostic (7.99e-3)" 20.1 13.7 21.8 17.1 23.4 8.8 12.9 32.7 28.6 17.7 16.8 16.8 17.7 13.4 22.1 15.5 13.1 25.5 19.3 18.2 16.9 14.3 10.7 12.8 16.7 10.9 13.0 18.5 29.8 22.4 26.2 10.7 45.2 14.6 17.2 6.8 18.7 21.7 18.8 23.5 18.8 13.1 15.0 10.6 13.9 15.1 10.7 13.7 10.8 18.9 12.1 10.2 20.6 23.6 1.5 5.2 4.9 3.5 1.9 2.5 1.6 24.6 12.1 15.0 17.7 11.7 10.2 17.5 15.3 10.0 12.9 13.3 20.0 8.3 17.9 20.1 20.1 14.5 15.4 11.9 15.0 7.8 15.1 18.6 22.3 32.9 15.0 22.7 14.4 20.5 16.5 13.2 12.3 10.1 14.3 14.6 16.2 21.5 21.0 8.5 13.6 24.6 13.9 18.2 12.4 25.6 21.2 11.2 14.3 7.0 15.3 26.1 23.7 15.8 17.6 19.0 7.8 15.8 17.1 15.2 18.1 14.1 28.0 21.1 25.8 19.9 14.1 21.0 24.8 25.7 0.2 1.9 0.4 1.8 3.0 2.5 1.5 1.3 1.7 1.4 1.4 1.1 1.5 4.9 1.9 3.5 5.2 0.5 1.6 21.8 23.4 32.7 28.6 16.9 14.3 13.0 18.5 14.6 13.7 20.8 37.8 0.0 10.7 0.1 27.3 17.8 5.1 8.1 15.9 12.2 17.7 494.9 6.6 11.4 24.3 22.4 5.5 0.0 14.2 17.8 8.9 15.8 9.3 16.8 52.2 55.6 4.7 18.4 16.7 43.4 17.5 7.0 0.0 5.4 11.7 31.9 12.0 0.0 17.3 5.6 14.4 25.8 7.3 8.2 5.5 0.1 951.9 4.3 11.7 11.9 MLLT10 AF10 ENSG00000078403 "MLLT10, histone lysine methyltransferase DOT1L cofactor" P55197 10 21524675-21743630 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 71.2" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 158.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005747 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA005747: AB_1079393" "unprognostic (6.58e-2)" "unprognostic (1.57e-1)" "unprognostic (7.32e-2)" "unprognostic (1.47e-2)" "unprognostic (1.31e-2)" "prognostic favorable (8.75e-4)" "unprognostic (1.03e-3)" "unprognostic (9.56e-3)" "unprognostic (9.29e-2)" "unprognostic (1.78e-1)" "unprognostic (2.69e-2)" "unprognostic (7.85e-2)" "unprognostic (6.57e-2)" "unprognostic (1.26e-1)" "unprognostic (1.50e-1)" "unprognostic (1.07e-1)" "unprognostic (1.67e-1)" 16.3 12.1 11.7 18.4 14.3 21.9 12.8 25.4 13.6 19.0 17.0 12.0 13.6 8.5 26.3 12.8 14.7 14.5 13.7 15.8 10.2 8.5 12.3 13.5 12.3 11.6 10.5 9.9 21.4 12.3 16.6 23.2 20.3 11.8 12.6 11.3 14.6 13.2 16.3 13.4 18.7 12.1 18.7 11.2 10.6 11.4 71.2 14.3 14.6 18.1 9.7 15.2 18.5 19.6 5.5 6.9 12.0 6.8 5.3 7.2 2.8 14.5 12.4 19.1 13.2 12.1 15.3 21.0 9.2 5.8 11.6 11.3 13.1 15.5 17.4 5.1 10.2 10.0 13.7 21.0 12.4 11.6 12.0 12.2 27.0 10.8 18.9 15.0 0.6 17.4 11.4 14.8 9.6 11.1 11.8 15.3 18.3 28.8 13.6 9.1 11.3 20.9 12.6 7.8 8.1 3.9 18.3 10.2 14.6 11.1 6.9 6.7 18.6 12.2 14.7 20.7 17.7 6.9 18.7 13.8 7.3 12.7 14.5 9.1 11.8 13.6 19.5 8.4 10.4 5.6 10.6 6.8 12.0 5.3 4.6 5.2 5.0 6.2 5.7 5.6 5.5 7.2 6.7 5.8 5.3 5.2 6.9 4.6 2.8 11.7 14.3 25.4 13.6 10.2 8.5 10.5 9.9 11.8 14.3 26.8 36.0 13.7 13.7 33.5 31.4 23.5 20.4 17.4 20.5 17.4 41.2 28.7 11.6 12.4 52.7 20.3 15.5 0.0 11.2 48.3 23.9 18.2 23.3 17.8 25.1 28.6 3.4 27.0 30.5 78.0 36.5 23.5 45.5 20.8 15.6 19.7 11.6 14.0 45.3 17.5 50.9 38.8 19.4 158.1 57.1 38.3 42.0 23.5 18.3 10.1 MLLT11 AF1Q ENSG00000213190 "MLLT11, transcription factor 7 cofactor" Q13015 1 151057758-151068497 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.1" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 72.1;Late spermatids: 161.6;monocytes: 56.9" "Cancer enhanced" "Detected in all" "glioma: 29.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 38.6;EFO-21: 29.3;SH-SY5Y: 42.4;U-698: 36.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000540 Uncertain Supported Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA000540: AB_2666024" "unprognostic (2.96e-2)" "unprognostic (1.98e-2)" "unprognostic (1.08e-2)" "prognostic unfavorable (4.26e-5)" "unprognostic (1.69e-1)" "unprognostic (1.96e-2)" "unprognostic (5.80e-2)" "unprognostic (1.17e-1)" "unprognostic (1.01e-2)" "unprognostic (2.49e-2)" "unprognostic (1.44e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (4.25e-12)" "unprognostic (5.66e-3)" "unprognostic (1.42e-1)" "unprognostic (1.29e-1)" "unprognostic (3.94e-3)" 1.9 7.5 13.6 3.4 9.1 1.1 1.2 16.3 42.1 1.9 2.1 5.1 1.2 0.8 3.7 1.2 1.3 0.8 11.1 11.8 11.3 16.4 1.2 1.2 5.3 2.3 10.3 1.2 4.2 1.3 8.4 1.8 1.2 3.2 1.3 1.1 1.2 1.5 1.2 2.6 1.0 2.0 4.2 5.8 2.1 0.9 1.2 1.2 2.0 1.2 1.2 2.6 3.2 1.2 2.4 1.0 6.5 1.0 4.2 9.2 2.8 1.2 5.3 38.6 6.1 0.6 1.0 0.6 2.4 2.6 2.3 4.2 0.5 2.5 1.9 29.3 1.8 6.5 1.5 9.3 2.2 1.3 11.3 2.6 5.0 3.8 0.1 1.2 0.3 0.8 1.7 0.3 12.7 0.5 8.0 17.0 7.6 5.3 0.9 7.4 0.4 17.7 3.3 16.8 0.1 0.8 16.9 5.1 0.1 4.4 1.1 23.3 42.4 0.2 0.4 1.2 26.5 1.4 0.6 11.8 5.0 5.5 1.8 4.4 0.9 0.8 36.0 12.5 0.3 9.4 1.6 0.6 1.6 5.9 0.7 2.7 2.4 3.9 6.0 0.8 2.1 5.3 9.2 6.5 4.2 1.0 1.0 3.6 2.8 13.6 9.1 16.3 21.0 11.3 16.4 10.3 1.2 3.2 1.2 0.0 0.6 1.5 4.0 3.2 38.5 10.1 0.0 0.0 0.0 3.5 7.9 2.0 14.9 2.6 72.1 3.6 0.0 0.0 1.1 2.1 12.7 1.7 4.6 0.0 5.6 35.0 10.3 5.5 4.8 161.6 2.0 7.6 5.0 56.9 0.0 12.4 2.9 0.0 3.5 1.1 18.5 0.0 35.9 4.7 8.8 3.0 6.2 7.5 0.1 4.1 MLLT3 "AF-9, AF9, YEATS3" ENSG00000171843 "MLLT3, super elongation complex subunit" P42568 9 20341665-20622543 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Mucus-secreting cells: 101.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 14.4" "Group enriched" "Detected in many" 5 "NK-cells: 3.8;T-cells: 14.4" "Cell line enhanced" "Detected in many" "HEL: 73.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001824 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA001824: AB_1079394" "unprognostic (3.31e-1)" "unprognostic (2.22e-1)" "unprognostic (1.23e-3)" "unprognostic (1.27e-2)" "unprognostic (1.99e-1)" "unprognostic (7.57e-2)" "unprognostic (3.83e-2)" "unprognostic (1.01e-3)" "unprognostic (2.12e-1)" "unprognostic (3.92e-3)" "unprognostic (1.05e-1)" "unprognostic (2.03e-2)" "prognostic favorable (1.84e-4)" "unprognostic (1.85e-1)" "unprognostic (4.81e-2)" "unprognostic (1.40e-2)" "unprognostic (1.68e-1)" 8.6 17.3 18.0 10.4 25.8 19.7 11.4 34.6 20.3 12.3 20.9 7.2 10.6 7.2 13.6 7.9 10.2 11.5 12.7 8.6 18.0 12.8 10.1 2.1 10.7 9.1 14.8 13.8 10.5 4.6 18.3 24.7 10.3 13.2 11.7 22.8 7.4 21.3 12.1 9.1 7.9 12.3 13.5 12.0 5.9 15.3 3.6 21.4 22.1 22.5 6.1 6.5 12.9 10.4 1.4 0.7 1.6 0.3 3.8 14.4 2.8 2.6 7.2 2.6 2.9 6.0 3.7 1.6 6.8 11.5 3.1 3.5 7.0 2.5 10.0 3.7 3.2 0.9 1.3 2.4 11.8 2.8 20.6 6.3 73.6 22.3 3.3 4.3 1.3 6.2 2.8 4.5 1.1 7.4 10.4 3.0 4.2 0.0 12.9 6.4 2.0 7.2 4.3 1.6 14.4 2.1 0.0 4.7 2.7 14.1 3.9 8.3 2.9 5.5 2.8 3.0 2.6 2.9 1.9 2.0 0.0 1.7 1.7 2.4 5.8 5.3 4.1 0.0 3.2 1.4 1.6 0.3 0.5 3.9 0.2 3.6 0.5 7.0 5.3 0.7 1.4 14.4 8.3 0.1 3.8 0.3 0.4 7.3 2.8 18.0 25.8 34.6 20.3 18.0 12.8 14.8 13.8 13.2 21.4 26.8 23.0 7.3 15.3 7.3 5.5 12.1 7.6 9.4 38.7 21.0 31.4 0.9 11.6 23.0 2.7 8.6 13.6 0.0 7.3 5.3 16.7 15.6 11.5 1.7 2.0 4.8 31.7 6.7 2.6 4.2 12.7 3.2 21.9 1.0 101.9 37.2 18.7 17.3 8.9 7.0 1.0 0.0 16.5 0.1 5.6 7.3 1.4 25.4 28.6 13.2 MLLT6 "AF17, FLJ23480" ENSG00000275023 "MLLT6, PHD finger containing" 17 38705542-38729803 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 244.7;Cone photoreceptor cells: 192.4;Rod photoreceptor cells: 215.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004021 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA004021: AB_1853995" "prognostic favorable (4.18e-4)" "unprognostic (1.50e-1)" "unprognostic (2.53e-1)" "unprognostic (1.44e-2)" "unprognostic (1.29e-1)" "prognostic favorable (3.98e-4)" "unprognostic (4.98e-2)" "unprognostic (1.79e-2)" "unprognostic (1.77e-1)" "unprognostic (7.12e-3)" "prognostic favorable (7.41e-4)" "unprognostic (1.78e-1)" "unprognostic (1.84e-2)" "unprognostic (9.12e-2)" "unprognostic (1.12e-1)" "unprognostic (2.05e-1)" "unprognostic (2.46e-3)" 6.5 7.6 10.0 10.3 10.6 7.3 6.3 14.1 16.9 6.2 6.8 7.2 11.1 7.2 9.2 8.6 5.5 10.3 9.2 7.5 9.7 5.8 1.2 8.5 11.8 8.5 9.6 13.0 9.0 12.8 10.1 4.8 7.2 7.3 5.7 10.0 10.3 12.5 22.3 8.5 8.9 8.2 8.1 11.7 6.7 4.1 9.2 6.3 7.2 4.8 10.1 5.5 11.5 1.4 0.9 2.0 0.8 2.8 6.0 1.7 5.8 6.5 6.6 14.4 7.3 6.6 3.4 3.6 6.7 4.5 5.4 2.4 11.5 16.6 5.3 4.3 6.4 15.2 4.2 7.5 4.0 17.7 11.5 6.1 10.8 10.6 3.5 9.3 8.3 6.7 7.7 3.9 8.9 10.9 7.3 12.6 10.1 14.0 3.8 4.9 18.2 9.0 0.8 5.0 3.4 10.8 9.0 15.3 5.2 13.5 14.8 16.4 3.8 12.6 10.7 4.3 12.4 6.8 9.6 5.2 7.8 7.3 6.6 23.9 7.8 11.2 7.7 8.6 5.5 1.7 0.8 0.4 6.0 0.5 4.6 1.4 3.2 4.2 0.4 1.4 3.1 4.1 2.0 2.8 0.3 0.9 1.7 1.7 44.7 51.0 32.0 22.5 27.1 244.7 23.4 30.6 14.7 36.4 31.4 192.4 15.0 10.0 20.0 2.7 38.7 26.1 0.0 35.9 4.1 20.2 29.7 35.9 9.4 12.0 112.8 47.7 31.9 18.3 3.1 43.4 18.1 18.6 23.4 30.0 32.6 28.3 21.0 39.6 13.5 215.1 32.3 25.4 16.1 23.5 25.5 32.0 48.9 37.7 23.0 MLST8 "GbetaL, GBL, Lst8, Pop3" ENSG00000167965 "MTOR associated protein, LST8 homolog" Q9BVC4 16 2204248-2209416 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019935, HPA041841" Approved Approved "Nucleoplasm,Golgi apparatus,Cell Junctions" NA NA Nucleoplasm "Golgi apparatus, Cell Junctions" "CAB019935: AB_561447, HPA041841: AB_2677701" "unprognostic (2.19e-1)" "unprognostic (7.68e-2)" "unprognostic (1.34e-1)" "unprognostic (1.52e-1)" "unprognostic (3.35e-3)" "unprognostic (1.74e-1)" "unprognostic (8.17e-3)" "unprognostic (1.52e-1)" "unprognostic (5.77e-2)" "unprognostic (5.70e-3)" "unprognostic (4.62e-2)" "unprognostic (1.65e-1)" "prognostic favorable (7.60e-4)" "unprognostic (8.74e-2)" "unprognostic (1.20e-1)" "unprognostic (2.29e-1)" "unprognostic (5.48e-2)" 12.4 18.6 24.0 11.9 22.8 15.7 10.4 23.1 39.1 11.6 14.4 15.7 12.5 16.6 9.9 14.0 15.9 17.4 12.6 18.4 23.9 18.5 15.5 17.9 9.1 13.3 20.7 20.0 16.0 32.3 11.1 12.6 15.5 16.1 14.4 6.8 17.3 25.5 13.0 36.6 13.5 13.9 8.7 14.1 10.5 15.6 25.5 13.3 13.4 20.8 13.9 11.8 13.2 9.0 8.5 14.8 2.5 18.6 7.4 9.6 11.5 7.2 20.7 8.6 21.9 11.3 8.0 14.2 5.9 8.1 10.4 9.6 28.0 10.1 18.6 15.0 7.1 4.3 8.8 8.7 18.0 1.2 14.1 39.7 12.6 20.5 18.0 16.4 19.3 17.8 11.4 12.9 12.1 15.7 8.5 11.1 25.8 18.1 12.9 5.5 30.3 18.3 25.8 16.6 6.2 19.3 19.2 8.6 32.6 7.8 4.3 27.2 13.9 9.8 22.2 15.8 3.3 13.1 18.9 7.8 12.2 13.8 9.8 8.0 14.8 8.9 20.3 6.0 17.1 10.2 0.0 15.2 2.5 8.5 18.6 6.6 8.5 7.5 9.6 14.8 7.2 9.0 9.0 1.7 7.4 16.9 8.2 7.2 11.5 24.0 22.8 23.1 39.1 23.9 18.5 20.7 20.0 16.1 13.3 6.0 13.6 23.8 14.5 13.1 30.3 3.0 10.2 10.7 6.8 15.7 19.6 58.4 29.9 30.2 39.4 11.9 36.0 23.3 37.0 37.8 20.1 13.3 8.1 14.5 41.0 28.6 27.6 19.6 22.1 78.3 13.8 14.5 16.9 34.3 26.7 26.0 26.7 37.4 14.2 30.7 24.7 19.4 15.5 24.7 25.4 13.6 44.1 18.7 37.1 11.1 MLX "bHLHd13, MAD7, MXD7, TCFL4" ENSG00000108788 "MLX, MAX dimerization protein" Q9UH92 17 42567068-42573239 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025329, HPA052766, HPA064438" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "CAB025329: , HPA052766: AB_2681940, HPA064438: AB_2685265" "unprognostic (2.28e-2)" "unprognostic (1.13e-1)" "unprognostic (1.19e-3)" "unprognostic (1.21e-3)" "unprognostic (3.88e-1)" "unprognostic (2.46e-2)" "unprognostic (8.55e-3)" "unprognostic (2.49e-1)" "unprognostic (4.87e-2)" "unprognostic (8.66e-2)" "unprognostic (9.66e-2)" "unprognostic (2.89e-1)" "unprognostic (1.61e-2)" "unprognostic (7.43e-2)" "unprognostic (4.67e-2)" "unprognostic (2.05e-1)" "unprognostic (3.25e-1)" 21.3 19.2 10.4 12.6 11.9 8.3 22.5 10.3 14.3 12.3 32.2 10.8 15.4 27.5 11.0 15.1 18.8 10.5 19.2 38.1 9.8 9.8 23.5 34.7 19.0 18.6 11.3 6.6 10.4 36.8 8.5 13.0 13.7 9.4 13.4 23.1 11.6 18.5 14.8 43.3 15.6 42.5 12.1 10.2 18.7 20.6 7.4 8.9 20.3 23.5 24.9 19.7 16.5 13.1 14.6 26.3 34.7 33.5 12.8 18.2 23.0 15.8 18.3 14.4 14.6 22.0 25.4 10.0 23.8 21.1 25.7 23.3 16.5 16.5 19.1 16.8 20.2 23.4 24.0 26.2 15.4 22.6 15.1 24.6 19.7 13.2 18.3 25.9 26.4 28.5 22.0 17.2 20.6 18.9 17.4 18.9 23.1 21.5 17.1 29.3 21.0 37.0 13.0 10.2 39.3 16.6 16.8 29.9 20.4 20.8 19.6 22.5 11.2 10.6 13.7 26.7 20.0 28.1 31.3 13.4 22.9 14.8 25.0 35.1 17.4 19.7 18.0 25.7 16.9 26.9 14.2 25.0 34.7 14.3 30.8 15.8 14.6 14.8 14.3 26.3 11.8 13.1 13.1 32.3 12.8 33.5 14.1 18.2 23.0 10.4 11.9 10.3 14.3 9.8 9.8 11.3 6.6 9.4 8.9 62.5 76.9 37.4 23.4 37.3 27.5 22.9 40.8 30.8 50.0 26.2 23.6 33.1 51.4 35.7 17.8 23.2 101.9 0.0 60.3 38.8 28.7 21.1 44.1 46.0 60.8 23.8 24.8 23.4 50.2 21.2 32.5 61.4 30.4 50.5 40.2 12.3 61.7 61.4 29.4 44.4 24.5 51.8 33.9 8.4 38.4 43.5 36.8 35.8 48.8 32.5 MLXIPL "bHLHd14, CHREBP, MIO, MONDOB, WBSCR14, WS-bHLH" ENSG00000009950 "MLX interacting protein like" Q9NP71 7 73593194-73624543 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 103.6" "Group enriched" "Detected in many" 6 "Cholangiocytes: 71.4;Hepatocytes: 220.3;Intestinal endocrine cells: 86.4" "Cancer enriched" "Detected in many" 6 "liver cancer: 60.9" "Region enhanced" "Detected in many" "cerebellum: 20.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 30.1;K-562: 9.0;SCLC-21H: 16.2;T-47d: 7.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA064640 Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA064640: AB_2685309" "unprognostic (1.11e-1)" "unprognostic (1.14e-1)" "unprognostic (2.18e-2)" "unprognostic (4.86e-2)" "unprognostic (5.04e-1)" "unprognostic (1.06e-3)" "unprognostic (3.46e-3)" "unprognostic (9.12e-2)" "unprognostic (1.30e-1)" "unprognostic (1.43e-1)" "unprognostic (6.13e-3)" "unprognostic (4.91e-2)" "unprognostic (2.25e-2)" "unprognostic (1.12e-1)" "unprognostic (3.46e-2)" "unprognostic (2.46e-2)" "unprognostic (7.72e-3)" 30.0 18.0 4.2 0.8 3.9 0.5 10.9 20.4 6.8 1.1 16.5 0.4 2.6 33.2 0.4 22.1 1.0 3.5 5.5 1.8 3.2 1.7 11.6 103.6 0.9 0.4 1.2 4.0 2.0 6.5 4.0 3.9 0.4 5.0 0.9 1.3 1.1 2.7 0.9 24.7 1.2 27.1 0.7 1.2 0.4 3.5 5.7 0.0 0.0 2.0 7.7 0.4 0.8 1.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.6 0.0 3.7 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 4.3 0.0 0.1 0.0 0.3 0.7 0.0 0.0 0.0 0.1 4.6 0.0 2.5 30.1 0.8 0.1 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 3.5 0.0 0.0 0.4 4.8 0.7 0.0 0.0 0.7 0.0 0.0 16.2 0.4 0.5 2.5 0.0 0.0 7.3 3.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.2 3.9 20.4 6.8 3.2 1.7 1.2 4.0 5.0 0.0 0.0 14.4 0.0 4.4 1.0 3.5 2.1 71.4 5.3 7.9 3.5 19.6 0.1 1.7 1.8 1.7 1.5 5.2 0.0 0.9 0.1 2.5 2.1 0.0 220.3 0.4 1.6 86.4 12.3 11.6 0.2 2.6 1.7 6.8 0.0 7.7 2.8 2.2 4.2 1.1 9.9 7.4 0.0 1.9 3.6 0.9 0.6 0.5 2.9 10.3 2.5 MMACHC "cblC, DKFZP564I122" ENSG00000132763 "Methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria" Q9Y4U1 1 45500053-45513382 "Disease related genes, Predicted intracellular proteins" "Oxidoreductase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 30.1" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 21.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027394, HPA027399, HPA027402" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA027394: AB_10601669, HPA027399: AB_10601987, HPA027402: AB_2672255" "unprognostic (3.34e-1)" "unprognostic (1.63e-1)" "unprognostic (7.03e-3)" "unprognostic (3.14e-2)" "unprognostic (4.05e-1)" "unprognostic (1.16e-2)" "unprognostic (9.04e-2)" "unprognostic (1.03e-2)" "unprognostic (1.90e-1)" "unprognostic (1.05e-2)" "unprognostic (3.88e-2)" "unprognostic (6.81e-2)" "unprognostic (2.61e-3)" "unprognostic (2.08e-3)" "unprognostic (8.83e-2)" "unprognostic (2.50e-2)" "unprognostic (2.58e-2)" 3.5 7.4 5.8 3.3 10.2 2.2 6.1 3.6 12.2 5.4 6.3 11.8 3.2 5.6 4.1 5.6 4.0 6.2 2.9 11.1 6.2 5.1 7.6 30.1 2.7 3.1 7.3 6.9 6.4 9.8 9.5 5.4 2.9 8.5 3.9 7.6 4.0 11.9 7.5 14.7 3.8 4.1 4.2 6.7 3.6 4.5 7.3 5.7 4.1 4.4 3.7 3.6 3.9 3.1 2.1 3.6 5.0 6.1 2.6 3.9 1.1 6.8 3.5 6.1 9.2 5.8 3.5 7.6 5.3 3.5 9.7 8.8 7.3 4.2 10.7 6.9 4.4 1.8 5.7 11.2 12.7 8.9 2.9 10.2 8.3 5.9 8.2 5.5 11.8 3.0 5.0 7.2 10.7 11.8 3.5 4.6 11.3 9.4 6.1 7.4 7.3 7.9 3.8 10.0 7.8 8.3 9.8 2.5 11.9 5.6 5.4 9.8 5.0 8.0 13.3 17.3 4.8 7.6 4.3 2.1 6.8 9.3 7.6 2.8 9.2 7.4 6.2 4.9 5.7 6.3 5.0 1.6 1.6 1.7 2.4 2.8 2.0 2.0 1.4 1.7 2.1 3.9 2.0 3.5 2.6 6.1 3.6 1.4 1.1 5.8 10.2 3.6 12.2 6.2 5.1 7.3 6.9 8.5 5.7 3.0 5.6 1.5 1.7 0.1 0.9 8.7 2.5 1.4 3.4 1.8 0.0 3.1 5.0 1.1 0.6 0.7 1.6 0.0 1.2 3.7 1.8 1.3 2.3 21.9 2.9 3.2 4.1 2.5 3.1 0.0 1.7 0.9 0.0 0.0 2.6 1.0 1.8 0.0 1.4 3.2 4.4 0.0 1.7 8.1 2.0 0.1 2.3 1.3 6.0 1.6 MMP15 "MT2-MMP, MTMMP2, SMCP-2" ENSG00000102996 "Matrix metallopeptidase 15" P51511 16 58025566-58046901 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 43.2" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 56.0;Enterocytes: 81.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 30 "plasmacytoid DC: 2.9" "Lineage enriched" "Detected in single" 30 "dendritic cells: 2.9" "Cell line enhanced" "Detected in many" "BEWO: 37.1;Hep G2: 19.3;SK-BR-3: 18.6;WM-115: 30.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002611, HPA040390" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "CAB002611: , HPA040390: AB_2676956" "unprognostic (1.76e-2)" "unprognostic (7.32e-2)" "unprognostic (2.69e-1)" "unprognostic (6.85e-2)" "unprognostic (3.09e-1)" "unprognostic (1.68e-1)" "unprognostic (6.88e-3)" "unprognostic (1.40e-1)" "unprognostic (3.02e-2)" "unprognostic (1.24e-2)" "unprognostic (4.81e-2)" "unprognostic (1.81e-1)" "prognostic favorable (8.54e-8)" "unprognostic (3.63e-2)" "unprognostic (1.36e-1)" "unprognostic (1.28e-1)" "prognostic favorable (3.08e-4)" 5.9 2.3 2.0 5.5 3.0 0.1 7.7 3.7 7.2 3.3 19.5 4.2 16.3 22.6 2.9 1.7 2.5 3.6 15.9 17.6 2.3 3.7 8.4 26.4 6.1 2.0 2.5 2.2 2.1 10.3 7.3 5.2 28.5 10.4 3.6 8.2 9.5 4.7 14.7 3.4 2.3 43.2 3.4 3.4 5.2 14.7 28.0 2.1 1.1 26.8 2.5 2.2 3.3 4.2 0.0 2.9 0.0 0.0 0.0 0.0 0.0 5.7 4.4 2.3 11.9 2.4 0.1 37.1 0.5 0.3 2.1 0.5 3.5 14.9 0.0 7.0 0.6 1.6 8.1 2.0 1.7 0.6 0.0 3.9 0.0 1.9 19.3 3.1 0.1 7.7 1.2 3.1 0.3 0.9 3.3 1.4 3.3 4.8 0.0 0.7 2.9 0.2 0.9 6.8 17.0 1.2 2.9 0.3 3.1 6.5 2.1 0.6 4.1 7.7 18.6 3.5 5.5 2.0 3.1 1.3 0.1 3.7 1.4 0.5 0.0 0.0 0.1 0.7 0.9 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 2.0 3.0 3.7 7.2 2.3 3.7 2.5 2.2 10.4 2.1 17.9 11.8 0.9 1.0 2.3 1.9 19.3 56.0 5.3 9.1 17.4 15.7 33.4 1.7 33.5 2.2 6.0 81.1 0.0 10.5 19.6 2.8 1.6 0.0 29.0 10.2 1.6 10.9 19.6 3.5 4.8 0.9 0.1 1.7 0.0 31.8 1.7 13.5 40.7 3.2 5.4 1.4 0.0 0.8 0.9 4.9 1.9 40.5 1.5 28.3 1.4 MMP28 "EPILYSIN, MM28, MMP-25, MMP-28" ENSG00000271447 "Matrix metallopeptidase 28" Q9H239 17 35756249-35795707 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 34.2;Enterocytes: 39.1;Mucus-secreting cells: 31.9;Paneth cells: 47.6;Urothelial cells: 34.5" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 7.2;naive CD8 T-cell: 5.9" "Lineage enriched" "Detected in many" 5 "T-cells: 7.2" "Cell line enriched" "Detected in some" 7 "HaCaT: 28.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057288, HPA057890" Approved "Nucleoplasm,Focal adhesion sites" "Secreted to extracellular matrix" NA NA Nucleoplasm "Focal adhesion sites" "HPA057288: , HPA057890: " "unprognostic (7.99e-3)" "unprognostic (3.27e-1)" "unprognostic (2.20e-1)" "unprognostic (1.01e-1)" "unprognostic (7.52e-2)" "unprognostic (1.63e-1)" "unprognostic (6.90e-2)" "unprognostic (1.09e-2)" "unprognostic (1.51e-1)" "unprognostic (1.99e-1)" "prognostic unfavorable (6.28e-6)" "unprognostic (9.37e-2)" "unprognostic (1.31e-1)" "unprognostic (8.87e-2)" "unprognostic (1.74e-1)" "unprognostic (1.76e-2)" "unprognostic (3.27e-3)" 8.0 1.6 1.8 2.7 3.7 0.5 4.3 0.0 5.1 1.7 7.3 1.6 1.4 3.0 3.2 4.8 4.3 1.5 12.3 0.5 2.8 0.8 0.2 10.3 0.4 0.0 2.9 0.1 1.3 0.5 0.0 0.7 1.3 2.9 4.1 2.7 0.1 2.1 0.6 4.5 9.3 4.3 0.2 0.6 7.2 13.4 0.2 0.0 4.2 4.4 2.5 5.5 2.2 1.1 1.5 0.1 0.2 1.3 7.2 0.9 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.1 0.7 0.0 0.1 28.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.2 0.2 0.0 0.1 0.0 0.2 0.1 0.2 0.0 3.9 0.2 0.6 0.0 0.0 0.0 1.6 0.2 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 2.0 1.1 0.4 1.7 0.1 0.9 7.2 5.9 0.1 1.3 0.2 1.5 0.0 0.9 26.8 20.8 0.0 5.1 34.2 0.4 1.0 2.5 5.3 5.7 7.0 0.0 0.0 0.0 0.1 5.0 8.1 39.1 0.0 0.3 0.0 1.6 1.8 0.0 0.0 0.1 1.6 3.5 6.2 0.0 7.1 1.1 0.9 3.3 0.0 31.9 9.1 9.7 47.6 2.8 0.7 0.5 6.5 2.0 0.5 2.5 29.0 0.0 0.7 18.5 34.5 MMP7 "MPSL1, PUMP-1" ENSG00000137673 "Matrix metallopeptidase 7" P09237 11 102520508-102530753 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 93.0;kidney: 129.5;salivary gland: 79.3" "Cell type enriched" "Detected in many" 6 "Ductal cells: 5335.6" "Cancer enhanced" "Detected in all" "pancreatic cancer: 352.1" "Region enriched" "Detected in single" 5 "pons and medulla: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 23.2;CAPAN-2: 129.5;EFO-21: 30.7;RPTEC TERT1: 56.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025869, HPA051358" Supported Approved Nucleoplasm,Vesicles "Secreted to extracellular matrix" NA NA 2810000 "Nucleoplasm, Vesicles" "CAB025869: , HPA051358: AB_2681452" "unprognostic (1.06e-3)" "unprognostic (9.51e-2)" "unprognostic (4.15e-2)" "unprognostic (1.38e-1)" "unprognostic (7.70e-3)" "unprognostic (7.28e-2)" "prognostic unfavorable (2.53e-4)" "prognostic unfavorable (3.38e-4)" "unprognostic (3.96e-2)" "unprognostic (5.63e-2)" "unprognostic (6.59e-3)" "unprognostic (1.51e-1)" "unprognostic (6.36e-3)" "unprognostic (1.42e-2)" "unprognostic (5.54e-2)" "unprognostic (1.48e-1)" "unprognostic (1.46e-1)" 6.8 0.2 0.2 1.2 0.2 0.0 28.8 0.2 0.2 5.2 0.2 0.2 2.1 0.0 17.2 12.3 3.3 16.4 93.0 0.2 0.2 0.2 129.5 1.4 5.0 0.9 0.2 0.2 3.9 23.5 0.0 0.7 2.7 1.3 42.0 0.0 0.2 79.3 6.7 0.2 7.8 0.3 0.5 0.2 0.2 0.9 9.4 0.2 1.2 0.3 1.4 4.5 19.9 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 129.5 0.0 30.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 56.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 1.3 0.2 80.4 30.5 0.0 310.5 0.9 0.0 0.6 119.8 113.8 646.0 964.8 0.0 0.3 0.0 5335.6 3.9 0.3 0.0 0.0 184.1 0.2 0.4 323.2 2.3 0.0 103.8 0.0 0.0 0.0 0.0 6.5 10.9 7.3 0.0 113.6 0.0 0.0 723.2 0.0 0.0 6.0 0.0 0.0 0.4 0.0 0.1 2.0 0.7 0.0 0.0 640.3 MMS19 "hMMS19, MET18, MMS19L" ENSG00000155229 "MMS19 homolog, cytosolic iron-sulfur assembly component" Q96T76 10 97458324-97498794 "Predicted intracellular proteins" "Chromosome partition, DNA damage, DNA repair, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA051936, HPA056299" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA051936: AB_2681668, HPA056299: AB_2683091" "unprognostic (8.57e-2)" "unprognostic (2.38e-3)" "unprognostic (9.34e-3)" "unprognostic (1.84e-1)" "unprognostic (2.04e-1)" "unprognostic (1.29e-2)" "prognostic unfavorable (6.88e-4)" "unprognostic (4.40e-1)" "unprognostic (1.99e-2)" "unprognostic (4.90e-2)" "unprognostic (1.17e-1)" "unprognostic (9.06e-3)" "unprognostic (6.79e-2)" "unprognostic (6.49e-2)" "unprognostic (4.06e-1)" "unprognostic (3.51e-2)" "prognostic unfavorable (3.39e-4)" 17.5 16.4 26.5 16.6 25.5 17.1 23.0 38.0 35.7 18.9 18.2 26.2 17.1 16.8 20.8 23.4 23.1 23.7 15.9 25.6 24.8 18.4 22.8 16.2 20.2 24.2 21.0 24.8 28.3 20.6 19.3 31.4 24.5 22.3 17.3 21.8 23.1 19.5 20.6 26.7 38.2 18.4 22.0 18.6 23.7 17.8 33.7 24.7 27.6 19.2 19.4 26.4 18.0 21.9 8.1 11.0 9.8 8.5 6.7 12.7 7.7 15.2 14.7 17.8 24.8 17.5 21.1 10.7 12.4 25.0 18.9 22.3 19.5 20.1 23.7 13.6 16.8 12.6 17.5 29.1 33.5 17.9 10.2 22.1 12.4 12.2 20.3 13.2 16.4 12.2 17.4 14.6 16.7 35.7 36.8 31.8 17.9 17.7 13.3 18.3 13.9 15.6 30.2 10.0 15.6 12.1 12.6 13.6 10.6 22.4 11.1 7.2 11.9 7.1 9.6 18.4 23.2 19.4 15.0 18.0 8.6 11.0 5.9 13.9 12.0 13.4 13.7 13.0 24.8 7.0 9.8 7.2 5.8 7.5 8.5 12.7 8.1 10.1 9.4 11.0 7.0 12.2 9.5 1.6 6.7 6.5 8.3 10.0 7.7 26.5 25.5 38.0 35.7 24.8 18.4 21.0 24.8 22.3 24.7 20.8 16.5 8.0 5.3 9.3 10.5 15.3 7.6 4.0 5.7 5.2 17.7 11.8 10.0 9.9 7.2 10.8 8.7 0.0 6.9 15.6 8.7 5.0 3.5 12.8 11.1 9.5 9.8 14.7 13.8 6.4 14.4 7.8 13.5 17.2 13.1 5.6 8.4 2.9 10.6 5.5 22.4 12.9 9.2 20.9 29.6 10.0 7.3 7.0 12.0 4.1 MMS22L "C6orf167, dJ39B17.2" ENSG00000146263 "MMS22 like, DNA repair protein" Q6ZRQ5 6 97142161-97283217 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 21.4" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 39.3;Early spermatids: 45.4;Spermatocytes: 34.8;Spermatogonia: 44.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA067042 Supported Nucleoplasm NA NA Nucleoplasm "HPA067042: AB_2685768" "unprognostic (3.61e-2)" "unprognostic (2.80e-1)" "unprognostic (2.26e-2)" "unprognostic (1.97e-3)" "unprognostic (1.70e-1)" "unprognostic (1.52e-1)" "unprognostic (1.00e-5)" "unprognostic (9.63e-2)" "unprognostic (5.81e-3)" "unprognostic (8.21e-3)" "unprognostic (9.39e-2)" "unprognostic (6.58e-2)" "unprognostic (1.34e-6)" "unprognostic (3.48e-2)" "unprognostic (2.00e-1)" "unprognostic (1.66e-1)" "unprognostic (1.29e-1)" 3.1 3.3 3.0 8.0 4.6 12.7 7.1 2.0 3.2 4.2 3.4 5.5 3.6 2.7 5.2 2.8 4.9 3.1 3.0 3.7 3.6 3.3 2.7 2.1 6.0 11.0 5.1 1.8 3.7 3.2 5.0 4.3 4.1 4.0 4.6 5.0 4.6 3.9 3.5 1.6 5.9 5.1 3.9 8.1 4.5 2.8 13.1 3.1 21.4 2.5 4.0 6.8 3.5 4.0 3.0 4.1 3.1 4.8 2.1 3.9 1.4 4.9 5.6 9.4 10.2 1.5 2.9 7.4 10.2 4.7 9.7 14.2 7.7 5.9 11.0 6.3 3.8 11.2 9.1 11.8 5.6 19.3 9.4 8.8 11.1 8.1 4.8 0.9 17.0 7.9 1.5 3.0 13.6 6.3 2.0 4.1 10.4 15.1 17.7 9.0 5.9 6.2 6.9 3.6 8.1 4.2 10.5 8.9 3.9 4.1 6.6 5.3 4.6 6.7 3.4 2.8 5.5 5.2 10.5 3.1 9.8 9.4 8.1 13.9 2.2 6.6 12.4 5.6 10.8 10.8 1.6 1.5 3.1 2.4 2.4 3.6 1.8 3.2 3.5 3.6 3.0 3.0 3.9 1.5 2.1 4.8 4.1 2.8 1.4 3.0 4.6 2.0 3.2 3.6 3.3 5.1 1.8 4.0 3.1 3.0 7.5 10.7 4.6 8.1 10.7 3.6 5.1 4.0 9.1 3.5 39.3 7.5 1.7 2.3 45.4 5.3 2.6 0.0 3.6 9.4 6.4 2.3 7.0 2.6 5.3 3.2 1.2 11.1 8.7 11.8 9.2 5.2 6.8 1.8 7.5 6.9 2.1 0.0 5.3 0.3 29.7 6.5 3.1 34.8 44.9 7.2 3.0 12.1 7.0 1.8 MN1 "MGCR, MGCR1, MGCR1-PEN" ENSG00000169184 "MN1 proto-oncogene, transcriptional regulator" Q10571 22 27748277-27801498 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Developmental protein" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 62.7" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 9.8;Early spermatids: 22.6;Fibroblasts: 10.0;Late spermatids: 12.6;Peritubular cells: 9.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "non-classical monocyte: 1.7" "Lineage enriched" "Detected in single" 8 "monocytes: 1.7" "Cell line enhanced" "Detected in some" "AF22: 22.1;HeLa: 8.9;hTERT-RPE1: 9.9;RH-30: 8.9;TIME: 14.0;U-2 OS: 12.1;U-2197: 12.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003072 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA003072: AB_1079399" "unprognostic (5.64e-2)" "unprognostic (2.48e-2)" "unprognostic (1.09e-2)" "unprognostic (1.26e-1)" "unprognostic (2.88e-2)" "unprognostic (2.52e-2)" "unprognostic (7.01e-2)" "unprognostic (3.03e-2)" "unprognostic (4.17e-2)" "unprognostic (1.64e-1)" "unprognostic (4.00e-2)" "unprognostic (7.33e-2)" "unprognostic (5.13e-7)" "unprognostic (3.84e-2)" "unprognostic (2.00e-1)" "unprognostic (5.28e-3)" "unprognostic (2.21e-4)" 3.7 2.0 3.4 4.2 17.3 2.4 1.9 1.3 5.6 5.9 4.2 2.6 2.5 2.1 3.0 9.0 7.0 3.4 11.1 5.1 2.5 2.7 1.6 1.4 4.3 1.3 3.3 3.5 12.4 1.5 1.3 2.3 2.6 4.5 3.1 2.2 10.8 2.1 2.7 62.7 2.9 2.1 5.8 1.0 1.5 3.5 2.0 5.4 0.0 1.8 14.8 2.1 5.0 4.7 0.0 0.2 0.0 1.7 0.0 0.1 0.0 0.0 1.0 22.1 0.6 0.4 0.9 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 2.2 3.9 0.9 1.8 1.1 1.3 0.0 0.0 0.6 0.0 8.9 0.0 0.5 0.0 0.2 0.0 2.5 0.5 2.2 9.9 0.2 0.0 0.0 0.1 0.7 0.0 0.0 0.2 2.9 0.0 2.0 3.6 8.9 0.0 0.3 0.0 0.0 0.3 1.9 0.0 0.0 5.6 0.2 0.0 14.0 0.7 12.1 12.7 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 3.4 17.3 1.3 4.2 2.5 2.7 3.3 3.5 4.5 5.4 3.0 2.9 0.5 0.1 3.8 9.8 3.9 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 22.6 4.1 0.0 0.0 0.9 0.1 10.0 0.1 0.0 0.4 0.2 0.0 0.0 0.6 0.3 12.6 4.6 0.7 0.0 0.0 0.0 4.3 1.7 0.0 9.6 0.0 0.6 0.0 2.1 0.5 0.9 2.4 0.0 0.0 0.0 0.1 MNAT1 "MAT1, RNF66" ENSG00000020426 "MNAT1, CDK activating kinase assembly factor" P51948 14 60734742-60969953 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000701, HPA001154, CAB004495" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004495: AB_670057, HPA000701: AB_1079400, HPA001154: AB_2666212" "unprognostic (4.10e-2)" "unprognostic (1.52e-1)" "unprognostic (1.39e-1)" "unprognostic (6.11e-2)" "unprognostic (2.05e-1)" "prognostic unfavorable (2.45e-4)" "unprognostic (1.17e-2)" "unprognostic (2.73e-1)" "unprognostic (2.62e-2)" "unprognostic (3.52e-2)" "unprognostic (3.48e-2)" "unprognostic (6.34e-2)" "prognostic favorable (3.46e-4)" "unprognostic (2.68e-1)" "unprognostic (1.53e-1)" "unprognostic (1.53e-1)" "unprognostic (7.14e-3)" 15.3 14.9 14.6 10.1 18.9 9.4 19.6 29.2 20.2 16.9 11.4 11.8 12.2 6.8 17.3 15.0 13.7 18.9 10.8 15.2 14.0 14.2 19.8 17.0 10.7 9.4 13.8 15.4 16.2 10.3 42.8 33.2 13.7 18.7 16.3 9.9 11.6 18.4 12.8 53.0 8.4 7.1 14.6 15.0 9.2 11.5 8.8 11.8 11.8 14.0 15.9 12.5 13.6 12.3 14.7 25.7 11.6 5.1 18.9 10.8 3.9 60.9 11.8 14.7 10.4 17.2 19.0 16.1 22.5 24.3 27.5 22.3 9.4 21.5 14.7 17.1 16.4 14.9 19.5 16.4 25.8 39.6 18.3 17.1 9.9 11.5 13.8 21.4 22.9 5.3 11.5 19.0 17.7 19.7 26.6 26.2 21.5 14.6 14.1 30.6 20.9 14.2 14.4 8.0 11.6 26.4 14.8 40.2 9.2 32.3 28.8 13.2 9.0 17.2 14.5 20.8 17.8 22.5 11.2 19.9 21.2 22.4 9.9 16.8 6.2 5.2 21.1 17.1 3.9 15.3 4.7 3.6 11.6 8.5 4.6 8.8 14.7 9.1 8.9 6.6 11.3 10.8 10.7 0.3 18.9 5.1 25.7 7.5 3.9 14.6 18.9 29.2 20.2 14.0 14.2 13.8 15.4 18.7 11.8 29.8 18.0 15.9 49.9 22.0 39.8 44.5 28.1 66.9 35.2 27.9 29.5 43.5 68.0 30.1 2.7 27.0 2.9 0.0 38.3 30.0 22.1 39.3 31.3 19.1 17.5 22.3 16.7 15.4 4.5 4.9 27.9 11.3 13.5 13.6 13.8 46.7 45.6 11.8 28.7 46.9 58.0 51.8 35.9 54.6 50.7 15.8 30.1 25.5 14.2 38.2 MNDA PYHIN3 ENSG00000163563 "Myeloid cell nuclear differentiation antigen" P41218 1 158831317-158849506 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 289.8;bone marrow: 83.3" "Group enriched" "Detected in many" 4 "Hofbauer cells: 203.8;Kupffer cells: 493.3;Macrophages: 520.9;Muller glia cells: 130.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 289.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 289.8" "Group enriched" "Detected in some" 15 "NB-4: 36.7;THP-1: 69.4;U-937: 45.4" "Low region specificity" "Detected in all" "HPA034532, HPA073215" Enhanced Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles,Cytosol" NA NA 110000 Nucleoplasm "Nucleoli, Nucleoli rim, Vesicles, Cytosol" "HPA034532: AB_10669677, HPA073215: AB_2686582" "unprognostic (1.53e-2)" "unprognostic (7.84e-3)" "unprognostic (2.45e-2)" "unprognostic (1.03e-1)" "unprognostic (1.42e-1)" "unprognostic (1.41e-2)" "unprognostic (2.02e-2)" "unprognostic (7.99e-3)" "unprognostic (1.58e-2)" "unprognostic (1.46e-1)" "unprognostic (1.65e-1)" "unprognostic (9.89e-2)" "unprognostic (1.96e-2)" "unprognostic (1.07e-1)" "unprognostic (4.95e-2)" "unprognostic (2.81e-2)" "unprognostic (1.02e-1)" 17.6 6.3 5.4 24.4 7.9 83.3 3.0 1.4 5.8 2.1 2.1 3.2 0.2 1.1 1.7 3.4 2.3 4.7 8.4 6.3 4.9 3.2 3.9 4.2 31.3 32.2 10.7 2.6 3.4 2.4 1.1 2.2 9.9 6.8 2.6 2.5 5.0 3.6 1.2 2.0 1.9 3.6 6.2 18.6 57.3 2.6 4.0 6.3 5.5 2.1 1.4 4.2 9.1 4.9 1.6 29.7 289.8 60.9 0.1 0.1 40.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.4 0.0 7.1 60.9 11.1 0.1 25.4 0.1 1.6 0.0 0.1 29.7 0.6 0.0 0.0 289.8 0.1 12.0 0.4 0.0 40.2 5.4 7.9 1.4 5.8 4.9 3.2 10.7 2.6 6.8 6.3 32.8 82.3 20.5 0.0 2.2 0.6 0.7 10.2 14.7 17.0 0.0 0.0 0.8 0.0 0.0 0.2 2.1 0.0 0.0 0.3 0.9 2.3 0.0 40.7 1.3 203.8 0.0 0.0 6.2 493.3 0.9 1.1 520.9 1.7 25.2 0.0 130.5 0.0 0.0 0.0 1.1 4.7 12.9 9.2 0.3 0.2 1.9 0.8 1.0 0.0 0.0 MNS1 "FLJ11222, SPATA40" ENSG00000138587 "Meiosis specific nuclear structural 1" Q8NEH6 15 56421544-56465137 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.2;testis: 36.4" "Group enriched" "Detected in many" 5 "Ciliated cells: 285.0;Early spermatids: 279.9;Spermatocytes: 128.6" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 35.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039975, HPA040382" Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA039975: AB_10793858, HPA040382: AB_10794740" "unprognostic (7.78e-2)" "unprognostic (2.54e-2)" "unprognostic (1.19e-1)" "unprognostic (5.07e-2)" "unprognostic (2.25e-1)" "unprognostic (6.62e-2)" "unprognostic (1.15e-1)" "unprognostic (3.45e-2)" "unprognostic (1.13e-2)" "unprognostic (2.05e-2)" "unprognostic (6.63e-2)" "unprognostic (1.06e-1)" "unprognostic (1.12e-3)" "unprognostic (8.20e-3)" "unprognostic (1.15e-1)" "unprognostic (2.72e-2)" "unprognostic (7.71e-2)" 1.6 1.4 3.2 2.7 4.9 3.2 2.6 35.2 6.7 4.3 2.0 2.1 0.6 2.0 3.2 5.4 2.4 17.6 2.9 2.1 4.1 4.0 7.9 1.8 2.9 1.2 2.1 4.9 4.0 2.1 0.8 10.7 1.4 11.4 3.8 1.9 1.1 1.8 1.7 1.2 1.3 1.8 1.9 3.2 1.3 1.9 36.4 2.4 3.3 2.6 1.4 1.1 1.6 2.2 0.1 0.8 0.0 0.4 0.0 0.0 0.0 19.2 4.5 2.4 7.1 2.0 4.3 0.4 4.7 2.7 5.6 11.9 6.4 9.3 10.8 6.0 2.0 8.1 7.6 2.9 2.7 11.4 0.0 1.2 13.9 5.0 1.1 0.7 4.7 1.5 1.7 0.1 11.3 1.6 2.3 1.0 4.2 3.1 0.0 4.7 2.5 0.1 5.9 0.7 10.0 2.7 9.0 14.2 0.1 5.4 3.8 18.7 5.7 7.8 2.4 8.2 0.6 5.7 7.3 0.4 7.6 8.7 7.3 11.4 2.2 7.1 0.2 8.5 11.2 8.7 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 3.2 4.9 35.2 6.7 4.1 4.0 2.1 4.9 11.4 2.4 0.0 6.6 0.8 7.2 3.0 9.7 5.2 5.1 285.0 42.1 33.2 23.6 0.5 10.0 7.1 279.9 1.4 0.0 0.0 1.7 3.1 10.3 2.0 0.0 0.0 5.6 14.3 1.2 7.4 1.0 16.7 11.8 3.0 0.0 1.0 0.7 12.0 1.2 0.0 8.1 9.1 31.9 0.0 3.6 128.6 20.6 1.3 0.5 0.0 3.7 0.9 MNT "bHLHd3, MAD6, MXD6, ROX" ENSG00000070444 "MAX network transcriptional repressor" Q99583 17 2384060-2401118 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059532, HPA067578" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059532: AB_2684053, HPA067578: AB_2685864" "unprognostic (3.72e-1)" "unprognostic (3.42e-2)" "unprognostic (1.57e-1)" "unprognostic (2.39e-1)" "unprognostic (1.29e-1)" "unprognostic (5.30e-3)" "unprognostic (1.31e-2)" "unprognostic (4.49e-2)" "unprognostic (1.27e-1)" "unprognostic (4.97e-2)" "unprognostic (3.47e-3)" "unprognostic (2.27e-3)" "unprognostic (1.81e-2)" "unprognostic (3.52e-2)" "unprognostic (5.09e-1)" "unprognostic (9.32e-2)" "unprognostic (1.98e-2)" 18.0 14.7 12.6 15.2 15.2 29.8 11.8 13.3 22.8 17.3 16.8 12.1 9.9 14.9 16.9 11.3 19.5 15.9 14.4 9.0 12.1 11.6 11.2 9.1 11.9 13.2 8.6 13.6 17.9 15.8 14.2 18.9 15.1 12.0 13.8 8.4 15.8 12.4 17.2 10.7 15.3 13.6 13.4 11.4 14.5 13.1 16.2 9.3 14.2 13.3 11.5 14.4 25.5 13.8 1.0 1.1 4.1 1.7 0.6 1.2 0.6 7.2 9.0 7.8 9.9 9.8 11.1 7.1 4.8 6.4 2.7 3.1 5.9 7.1 10.0 5.1 7.4 6.0 11.5 5.6 10.6 2.1 5.4 8.1 7.1 14.8 5.0 6.4 3.0 13.2 17.6 10.0 5.8 7.8 8.8 4.7 8.0 6.0 9.2 3.1 5.2 7.0 5.2 3.7 5.3 5.9 8.1 3.7 6.6 5.1 10.3 8.3 12.0 5.6 5.5 12.9 4.2 4.5 5.8 8.5 6.7 4.6 10.5 3.9 7.9 3.9 4.0 13.6 6.1 4.3 1.5 1.2 2.9 0.6 1.7 1.2 1.0 0.8 1.0 0.5 0.7 1.0 1.0 4.1 0.6 1.3 1.1 0.1 0.6 12.6 15.2 13.3 21.6 12.1 11.6 8.6 13.6 12.0 9.3 6.0 25.0 11.3 14.7 16.6 15.7 5.6 5.1 8.1 15.9 14.0 21.6 5.6 1.7 8.7 6.8 10.5 16.7 0.0 8.9 7.9 12.4 16.5 12.8 8.9 12.2 25.4 19.0 12.9 24.0 12.2 10.3 15.4 10.1 1.8 20.9 10.6 10.9 20.1 12.4 2.4 10.6 6.5 12.2 10.4 19.6 22.5 7.8 12.8 22.3 51.0 MNX1 "HB9, HLXB9, HOXHB9, SCRA1" ENSG00000130675 "Motor neuron and pancreas homeobox 1" P50219 7 156994051-157010651 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pancreas: 43.3" "Cell type enhanced" "Detected in some" 15 "Intestinal endocrine cells: 24.1;Mucus-secreting cells: 18.0;Paneth cells: 9.0;Undifferentiated cells: 12.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 11.8;BEWO: 8.8;EFO-21: 11.3;HEK 293: 9.0;RPMI-8226: 24.7;SCLC-21H: 13.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA071717 Approved Nucleoplasm,Nucleoli,Cytosol No NA Nucleoplasm "Nucleoli, Cytosol" "HPA071717: AB_2686437" "unprognostic (2.01e-1)" "unprognostic (1.21e-1)" "unprognostic (1.87e-2)" "unprognostic (3.72e-3)" "unprognostic (8.85e-2)" "unprognostic (1.08e-2)" "unprognostic (2.07e-1)" "unprognostic (4.07e-2)" "unprognostic (5.06e-2)" "unprognostic (8.62e-4)" "unprognostic (1.00e-2)" "unprognostic (3.35e-2)" "unprognostic (2.23e-5)" "unprognostic (1.67e-3)" "unprognostic (5.80e-2)" "unprognostic (5.58e-2)" "unprognostic (1.08e-1)" 0.1 0.0 0.1 0.4 0.2 0.0 0.1 0.2 0.1 0.1 6.0 0.2 0.1 9.0 0.1 0.1 0.3 0.0 7.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 43.3 0.0 3.2 0.1 0.2 0.8 3.7 0.1 1.9 0.1 0.1 0.1 7.3 0.1 0.2 0.1 2.7 1.0 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 3.9 0.0 11.8 0.0 0.0 8.8 0.0 0.0 0.1 0.0 5.1 1.7 0.9 11.3 0.0 0.3 0.2 2.0 1.6 0.9 1.4 9.0 0.0 0.8 2.3 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 4.1 3.7 1.9 0.0 6.6 0.6 0.1 0.0 1.1 0.7 0.0 1.7 24.7 4.4 0.4 13.3 0.0 1.7 1.5 0.2 0.1 3.7 2.9 0.0 0.0 0.0 0.0 0.0 3.7 1.9 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.7 0.0 4.3 0.0 2.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 24.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 18.0 0.0 2.5 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 12.4 0.0 MOAP1 "MAP-1, PNMA4" ENSG00000165943 "Modulator of apoptosis 1" Q96BY2 14 93182196-93184928 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 69.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000939, HPA076948" Enhanced Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA000939: AB_1079402, HPA076948: " "unprognostic (9.40e-3)" "unprognostic (1.26e-1)" "unprognostic (1.57e-1)" "unprognostic (7.52e-2)" "unprognostic (1.21e-1)" "unprognostic (8.75e-2)" "unprognostic (1.01e-1)" "prognostic favorable (7.37e-9)" "unprognostic (1.98e-1)" "unprognostic (6.52e-2)" "unprognostic (1.05e-3)" "unprognostic (1.58e-2)" "prognostic favorable (3.15e-6)" "unprognostic (6.93e-2)" "unprognostic (1.21e-1)" "unprognostic (1.61e-1)" "unprognostic (9.27e-2)" 6.9 14.5 21.9 5.7 30.0 15.9 8.6 30.5 69.5 12.8 10.1 7.1 7.7 7.1 9.3 12.0 8.0 11.1 8.2 23.9 24.2 35.9 14.2 9.0 9.7 7.9 22.9 27.8 8.6 9.0 25.0 12.0 7.1 27.8 15.0 7.4 10.1 8.2 14.9 13.9 5.2 7.0 10.1 11.2 7.8 8.3 4.4 7.8 5.9 10.6 3.6 7.5 8.4 3.8 6.3 4.2 16.4 4.4 8.8 14.3 7.5 3.8 3.0 7.3 9.8 6.3 2.4 4.9 4.5 5.2 4.7 5.3 3.2 3.8 11.6 8.3 5.2 3.3 6.0 5.2 4.5 5.2 5.3 6.6 6.5 6.1 4.3 8.2 5.8 11.8 4.3 6.8 2.8 5.7 11.2 5.7 14.1 2.3 7.1 5.3 15.9 9.1 5.5 3.4 7.7 3.9 5.6 9.9 7.0 11.9 10.9 16.9 14.6 4.6 6.5 18.4 6.1 10.0 4.3 6.2 1.8 2.9 4.2 2.2 13.4 13.7 7.0 4.8 3.7 3.2 16.4 4.0 10.3 11.3 4.4 12.6 6.0 10.5 11.5 4.2 6.3 14.3 12.2 3.7 8.8 4.4 4.0 9.8 7.5 21.9 30.0 30.5 69.5 24.2 35.9 22.9 27.8 27.8 7.8 29.8 27.2 31.3 16.6 14.3 94.0 64.3 12.7 6.7 12.5 19.2 47.1 23.2 34.9 26.8 3.8 15.8 10.7 0.0 13.3 4.8 12.5 23.4 26.6 6.4 14.5 79.4 46.6 11.6 10.8 0.9 16.4 10.1 11.8 18.0 18.8 76.4 16.9 10.2 25.8 13.9 85.3 19.4 26.1 9.6 21.3 13.6 39.9 31.9 13.1 18.6 MOB1A "C2orf6, FLJ10788, FLJ11595, Mats1, MOB1, Mob4B, MOBK1B, MOBKL1B" ENSG00000114978 "MOB kinase activator 1A" Q9H8S9 2 74152528-74178898 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "monocytes: 381.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047088, HPA071690" Supported Approved Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA047088: AB_2679927, HPA071690: AB_2686432" "unprognostic (5.32e-2)" "unprognostic (2.45e-1)" "unprognostic (5.38e-2)" "unprognostic (2.62e-1)" "unprognostic (2.19e-1)" "unprognostic (8.19e-2)" "prognostic unfavorable (3.34e-4)" "unprognostic (9.36e-2)" "unprognostic (3.91e-2)" "unprognostic (1.13e-1)" "unprognostic (2.05e-3)" "unprognostic (1.04e-1)" "unprognostic (2.20e-3)" "unprognostic (5.10e-2)" "unprognostic (2.00e-1)" "unprognostic (1.10e-1)" "unprognostic (5.11e-3)" 32.2 18.0 12.2 41.5 16.3 36.6 36.2 10.8 11.3 24.5 21.5 12.6 16.1 19.7 27.1 19.8 28.9 22.0 19.9 20.9 11.0 10.4 34.7 21.4 28.4 65.1 14.7 6.9 28.4 12.6 13.8 11.5 20.9 15.9 21.0 20.7 14.3 18.1 18.8 12.8 22.9 30.2 31.6 21.8 51.1 18.7 17.9 12.8 57.0 25.4 16.9 42.4 29.2 24.6 22.3 22.2 32.3 42.8 20.6 15.9 25.2 21.0 12.1 15.2 16.4 25.1 27.5 18.0 17.0 22.9 22.2 21.9 16.5 15.4 43.3 14.6 21.3 16.5 17.7 19.4 19.4 33.7 30.4 11.6 39.1 8.4 17.4 20.1 33.8 63.2 23.2 19.0 17.7 15.0 16.7 23.2 16.8 16.7 16.1 21.5 11.4 42.4 28.8 14.1 18.1 9.9 29.3 52.4 23.0 19.1 26.4 7.7 10.1 24.1 17.9 15.5 12.0 14.3 16.1 22.0 28.9 15.2 20.2 26.9 12.0 10.6 33.3 19.4 28.9 15.4 30.8 24.0 32.3 14.8 39.0 15.9 22.3 13.3 15.7 22.2 17.2 12.3 14.6 24.0 20.6 42.8 15.5 13.4 25.2 12.2 16.3 10.8 11.3 11.0 10.4 14.7 6.9 15.9 12.8 47.6 54.3 138.1 70.9 121.6 12.3 37.0 43.3 80.3 58.0 78.5 5.9 57.5 77.9 53.0 5.0 60.8 83.6 46.7 46.0 83.4 58.3 90.4 109.5 38.0 153.8 25.4 36.1 63.3 177.0 8.5 57.8 185.9 64.1 381.5 63.9 22.4 63.0 74.8 64.3 137.3 13.0 71.1 74.1 87.4 46.2 115.4 55.5 96.5 62.4 139.8 MOB1B "MOB4A, MOBKL1A" ENSG00000173542 "MOB kinase activator 1B" Q7L9L4 4 70902326-71022449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 70.0;monocytes: 52.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEL: 34.3" "Low region specificity" "Detected in all" "HPA047088, HPA071690" Supported Approved Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA047088: AB_2679927, HPA071690: AB_2686432" "unprognostic (1.05e-1)" "unprognostic (1.48e-2)" "unprognostic (1.84e-1)" "unprognostic (2.96e-2)" "unprognostic (1.99e-1)" "unprognostic (3.96e-1)" "prognostic unfavorable (4.92e-4)" "unprognostic (2.94e-1)" "unprognostic (1.36e-1)" "unprognostic (3.45e-1)" "unprognostic (1.42e-2)" "unprognostic (1.07e-1)" "unprognostic (1.09e-3)" "unprognostic (2.70e-1)" "unprognostic (1.71e-1)" "unprognostic (1.25e-1)" "unprognostic (7.53e-3)" 9.8 10.1 15.7 17.8 13.0 30.9 11.1 10.4 20.0 10.5 9.7 17.3 4.8 6.1 13.9 8.6 9.9 11.8 9.1 11.1 19.8 10.6 29.3 8.3 20.6 13.4 15.5 18.6 13.8 11.0 18.0 10.9 11.2 12.8 12.7 8.5 8.0 11.1 8.6 10.8 11.2 8.4 14.1 17.4 10.6 10.1 7.6 15.4 52.3 14.4 8.2 12.8 10.8 9.8 0.6 5.3 2.5 3.1 0.7 1.4 1.2 3.9 3.2 12.2 9.9 6.6 8.4 10.0 11.9 6.5 6.7 5.9 4.2 7.6 22.0 5.7 10.5 4.5 2.8 7.5 10.0 16.2 11.6 2.6 34.3 3.6 3.3 6.6 7.5 6.9 6.9 5.5 7.5 6.1 7.5 7.9 11.4 21.0 7.2 10.5 4.2 23.2 4.6 4.0 2.6 4.2 7.5 11.8 3.0 11.1 6.9 4.2 8.1 5.1 2.3 15.9 6.8 5.4 4.8 9.4 18.6 9.5 8.4 4.8 4.6 1.5 9.4 6.5 5.5 8.5 0.8 3.1 2.5 1.3 1.6 1.1 0.5 0.6 0.6 4.0 0.6 0.8 0.7 0.4 0.7 0.9 5.3 1.4 1.2 15.7 13.0 10.4 20.0 19.8 10.6 15.5 18.6 12.8 15.4 23.8 15.5 2.2 5.2 15.9 2.0 14.7 7.6 21.4 12.5 41.8 17.7 4.6 8.3 4.9 0.4 9.5 0.9 70.0 4.0 4.9 11.2 9.8 10.4 6.4 9.9 6.4 36.4 9.8 34.3 1.4 4.0 21.6 10.1 52.3 8.4 6.0 8.0 0.0 8.1 15.9 4.3 25.8 21.7 7.2 9.8 14.9 4.8 5.4 5.6 8.4 MOB2 HCCA2 ENSG00000182208 "MOB kinase activator 2" Q70IA6 11 1469457-1501247 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 57.3;urinary bladder: 51.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046313 Uncertain Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA046313: AB_10959882" "unprognostic (5.02e-1)" "unprognostic (5.71e-2)" "unprognostic (6.24e-3)" "unprognostic (4.42e-3)" "prognostic unfavorable (4.64e-4)" "unprognostic (8.30e-2)" "unprognostic (1.06e-3)" "unprognostic (3.06e-2)" "unprognostic (1.77e-1)" "unprognostic (2.80e-2)" "unprognostic (5.30e-2)" "unprognostic (2.87e-1)" "prognostic favorable (2.02e-4)" "unprognostic (2.67e-1)" "unprognostic (8.56e-2)" "unprognostic (9.78e-2)" "unprognostic (1.15e-1)" 9.2 4.2 2.4 17.0 2.5 3.0 12.1 2.5 3.2 14.9 30.9 1.8 6.7 2.5 12.5 8.7 17.3 13.8 26.8 8.1 2.8 1.9 3.2 3.0 4.1 8.2 2.1 2.1 8.6 5.8 6.8 1.8 4.2 2.9 21.2 6.7 4.3 12.9 20.1 7.1 9.4 10.6 57.3 2.5 3.7 9.9 4.2 2.0 2.0 4.3 3.2 4.4 51.8 21.2 10.6 10.8 11.2 12.5 11.6 17.3 9.0 13.9 15.2 9.4 7.6 23.5 16.6 8.7 11.0 16.1 21.2 16.8 9.7 19.2 10.3 8.5 25.9 13.2 17.1 14.5 24.7 13.0 13.8 21.7 7.8 5.5 12.3 15.9 10.2 12.3 13.4 29.8 11.3 13.3 17.1 22.5 13.4 12.6 10.7 10.7 9.9 13.2 17.4 11.6 26.7 14.2 9.6 9.6 10.7 17.7 13.3 17.6 18.7 13.7 17.1 13.2 12.5 7.9 10.2 18.5 13.0 6.6 4.2 6.9 10.6 10.3 10.7 9.0 9.9 9.9 8.2 8.6 11.2 17.3 8.7 14.6 8.2 14.9 13.8 10.8 10.6 12.5 10.5 7.1 11.6 12.5 6.9 12.8 9.0 2.4 2.5 2.5 2.5 2.8 1.9 2.1 2.1 2.9 2.0 6.0 7.7 13.7 25.1 73.0 17.7 11.3 12.7 6.7 5.7 7.0 11.8 26.7 23.2 29.5 22.2 55.0 43.9 70.0 33.6 25.8 27.0 36.5 25.3 7.4 23.5 41.3 20.1 25.8 15.2 9.0 22.2 20.7 54.0 32.5 29.1 18.0 31.2 63.1 48.1 18.3 17.2 84.1 54.6 22.2 39.4 71.6 49.7 45.0 24.3 28.6 MOCS2 MOCO1 ENSG00000164172 "Molybdenum cofactor synthesis 2" "O96007, O96033" 5 53095679-53110063 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Molybdenum cofactor biosynthesis" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Distal tubular cells: 485.7;Proximal tubular cells: 194.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037679, HPA037680" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA Cytosol "Nucleoplasm, Nuclear speckles" "HPA037679: AB_2675604, HPA037680: AB_10673635" "unprognostic (3.27e-1)" "unprognostic (3.11e-2)" "unprognostic (2.82e-1)" "unprognostic (8.37e-3)" "unprognostic (2.12e-1)" "unprognostic (3.48e-2)" "unprognostic (1.60e-2)" "unprognostic (1.33e-1)" "unprognostic (6.66e-2)" "unprognostic (7.59e-2)" "unprognostic (2.41e-3)" "unprognostic (1.85e-1)" "prognostic favorable (3.68e-6)" "unprognostic (1.04e-1)" "unprognostic (1.04e-2)" "unprognostic (2.04e-1)" "unprognostic (5.86e-2)" 18.1 34.6 41.5 9.8 38.0 4.0 19.6 21.7 41.8 16.0 17.1 20.7 10.4 17.6 14.8 28.2 17.0 12.9 15.9 39.9 36.7 32.1 49.7 52.0 13.1 11.4 30.0 22.4 21.2 18.4 30.4 23.3 16.2 28.7 18.6 14.9 17.2 21.2 20.8 38.3 8.9 17.6 16.1 27.1 10.7 16.6 11.0 20.0 8.2 31.5 19.4 11.2 16.9 15.4 16.9 12.5 6.3 10.9 17.3 25.8 12.9 20.2 16.6 12.0 28.7 24.6 22.7 15.2 24.9 26.2 22.2 26.4 22.6 15.2 20.7 37.5 19.6 34.4 12.3 24.0 25.5 35.0 5.2 23.4 15.9 16.3 20.4 25.3 17.2 12.0 18.1 12.8 25.2 22.5 22.0 23.8 26.7 15.4 11.3 37.0 30.0 18.5 9.8 10.6 8.7 34.6 9.4 25.8 18.8 38.4 15.4 8.9 10.3 18.1 14.8 18.6 15.9 28.6 4.4 15.2 21.3 22.1 18.9 32.0 13.3 19.7 23.4 30.5 4.9 32.9 5.2 9.2 6.3 16.9 10.9 20.2 16.5 19.0 19.2 12.5 16.9 25.8 22.2 1.7 17.3 9.8 11.4 18.3 12.9 41.5 38.0 21.7 41.8 36.7 32.1 30.0 22.4 28.7 20.0 50.6 20.6 25.2 32.7 11.8 27.0 111.0 66.2 36.1 19.4 66.3 25.5 82.4 485.7 34.6 5.6 32.8 17.8 0.0 38.2 28.9 48.8 44.5 9.3 99.9 36.5 6.4 25.3 19.0 25.0 10.1 46.9 27.4 21.9 7.2 17.9 36.8 23.4 19.3 64.7 194.9 18.1 32.3 50.3 40.7 54.7 13.7 27.0 26.1 22.9 30.2 MON2 KIAA1040 ENSG00000061987 "MON2 homolog, regulator of endosome-to-Golgi trafficking" Q7Z3U7 12 62466817-62600479 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038697, HPA057607" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA038697: AB_10697396, HPA057607: AB_2683482" "unprognostic (1.09e-1)" "unprognostic (1.98e-1)" "unprognostic (9.91e-2)" "unprognostic (1.94e-1)" "unprognostic (1.71e-2)" "prognostic favorable (2.03e-4)" "unprognostic (7.69e-2)" "unprognostic (5.99e-2)" "unprognostic (2.24e-2)" "unprognostic (6.20e-2)" "unprognostic (5.57e-2)" "unprognostic (1.58e-2)" "unprognostic (1.93e-1)" "unprognostic (1.77e-1)" "unprognostic (2.91e-1)" "unprognostic (1.80e-3)" "unprognostic (4.36e-2)" 16.4 14.8 12.1 16.9 20.7 13.3 16.8 28.6 20.6 20.8 14.4 25.8 21.3 13.3 22.3 16.8 16.2 16.8 15.6 14.5 14.2 13.0 17.5 22.6 14.3 14.3 20.4 18.7 22.8 24.0 36.7 31.9 17.8 22.6 16.9 17.3 16.7 22.4 24.3 15.7 16.4 15.0 15.2 17.4 15.7 17.0 11.2 18.1 21.8 21.3 10.9 17.6 15.8 17.2 6.2 5.5 8.9 6.2 3.7 7.2 3.6 10.4 16.2 12.2 6.4 15.9 14.8 11.2 11.4 9.6 10.5 10.5 7.2 4.2 7.4 8.9 11.0 8.2 10.1 12.0 8.3 14.5 9.5 9.4 11.7 11.9 7.3 6.8 10.1 8.3 10.0 6.4 11.4 14.1 14.1 10.1 6.9 11.0 18.0 9.2 12.1 8.9 4.8 7.2 6.4 9.0 8.3 11.0 10.2 5.9 14.2 5.3 5.8 19.2 10.4 7.8 13.1 22.6 7.5 14.1 10.2 7.5 12.8 7.3 10.0 9.2 8.4 10.9 6.4 11.4 2.0 6.1 6.3 5.5 6.2 7.0 5.0 4.4 7.2 5.5 6.2 6.2 6.9 8.9 3.7 4.6 3.2 5.0 3.6 12.1 20.7 28.6 20.6 14.2 13.0 20.4 18.7 22.6 18.1 32.8 18.5 10.7 12.5 14.9 35.8 12.0 15.3 21.4 25.0 26.2 55.0 11.1 0.0 6.5 2.2 15.5 15.3 0.0 9.4 6.0 17.5 19.3 16.2 31.0 9.4 20.6 13.8 23.9 17.6 1.5 20.1 16.2 8.5 8.2 19.8 17.0 8.8 17.3 17.0 4.8 57.6 25.8 20.8 7.9 9.7 17.1 17.0 15.4 13.3 14.1 MORC2 "AC004542.C22.1, KIAA0852, ZCW3, ZCWCC1" ENSG00000133422 "MORC family CW-type zinc finger 2" Q9Y6X9 22 30925130-30968298 "Disease related genes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Hydrolase "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 50.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 10.3;MAIT T-cell: 9.1;memory CD4 T-cell: 14.3;memory CD8 T-cell: 8.3;naive CD4 T-cell: 14.7;naive CD8 T-cell: 8.9;T-reg: 17.7" "Lineage enriched" "Detected in many" 8 "T-cells: 17.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000436 Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA000436: AB_1079404" "unprognostic (3.43e-2)" "unprognostic (1.71e-2)" "unprognostic (1.60e-3)" "unprognostic (1.44e-2)" "unprognostic (6.15e-2)" "unprognostic (3.56e-3)" "unprognostic (2.89e-3)" "unprognostic (4.63e-1)" "unprognostic (6.76e-2)" "unprognostic (1.60e-1)" "unprognostic (5.46e-3)" "unprognostic (1.32e-1)" "prognostic unfavorable (6.54e-8)" "unprognostic (5.64e-2)" "unprognostic (2.38e-1)" "unprognostic (1.02e-2)" "unprognostic (6.66e-3)" 6.7 5.3 4.6 6.0 7.0 5.2 16.9 6.4 7.5 6.8 7.1 6.5 14.8 4.7 7.4 5.9 6.1 6.3 4.7 7.7 4.7 5.0 5.3 9.6 6.3 8.8 4.8 4.1 8.1 7.5 9.4 8.1 7.7 7.7 8.0 4.5 7.7 11.0 7.9 9.8 10.4 5.6 6.7 5.3 7.3 5.9 50.5 5.0 5.5 6.6 6.1 6.6 6.8 9.7 1.7 2.2 0.8 2.0 1.2 17.7 3.9 18.6 17.0 20.2 22.3 21.1 15.7 15.3 13.8 10.8 14.2 14.6 22.2 9.0 16.7 12.4 12.0 10.0 16.0 18.1 8.6 11.8 13.1 21.9 17.4 13.6 26.0 18.2 14.2 18.0 14.9 12.6 14.9 19.3 11.8 14.2 9.8 22.8 17.3 14.8 30.3 15.1 29.0 18.7 22.0 12.6 29.0 11.8 21.5 13.7 17.0 18.0 14.2 14.6 23.9 10.5 16.9 12.8 24.2 14.2 17.2 17.0 12.1 12.2 15.5 19.1 18.8 12.6 10.1 12.2 0.5 1.1 0.8 10.3 1.9 9.1 1.5 14.3 8.3 1.2 1.7 14.7 8.9 0.3 1.2 2.0 2.2 17.7 3.9 4.6 7.0 6.4 7.5 4.7 5.0 4.8 4.1 7.7 5.0 0.0 2.9 5.2 6.2 6.5 7.0 4.5 2.5 2.7 6.8 10.4 9.8 7.0 3.3 6.4 23.5 7.1 4.0 0.0 7.0 9.6 6.6 7.4 1.1 7.8 4.5 12.7 8.6 4.9 4.0 7.4 7.2 3.7 6.8 2.8 5.8 3.5 9.1 3.5 9.6 2.8 9.9 19.4 6.2 20.9 18.8 8.2 5.3 4.4 6.4 4.9 MORC3 "KIAA0136, NXP2, ZCW5, ZCWCC3" ENSG00000159256 "MORC family CW-type zinc finger 3" Q14149 21 36320189-36386148 "Predicted intracellular proteins" "Host-virus interaction" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018406, HPA034848" Approved Enhanced Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA018406: AB_1858988, HPA034848: AB_2674359" "unprognostic (4.01e-3)" "unprognostic (4.86e-2)" "unprognostic (4.25e-2)" "unprognostic (1.38e-1)" "unprognostic (1.16e-1)" "unprognostic (6.29e-2)" "unprognostic (6.56e-2)" "unprognostic (1.40e-1)" "unprognostic (1.17e-1)" "unprognostic (2.53e-1)" "unprognostic (6.40e-2)" "unprognostic (8.61e-2)" "unprognostic (1.18e-3)" "unprognostic (1.38e-2)" "unprognostic (3.91e-1)" "unprognostic (1.87e-1)" "unprognostic (1.13e-1)" 18.0 11.2 15.6 15.4 16.4 28.0 17.5 30.9 16.3 20.3 15.3 10.1 14.1 10.6 22.5 10.6 23.0 17.9 13.5 12.5 14.6 7.9 11.6 13.0 17.0 20.6 17.5 12.1 29.3 11.3 14.8 25.1 20.6 16.6 16.1 12.1 7.3 20.6 14.2 28.1 20.1 14.8 21.4 21.0 19.1 14.0 10.8 18.2 25.5 15.0 17.6 20.0 22.9 23.5 11.2 7.6 21.9 10.7 8.2 11.9 6.6 12.2 4.7 11.4 7.5 11.8 12.8 16.1 11.6 20.3 13.4 11.1 7.6 8.0 5.9 4.5 13.3 13.3 6.2 8.9 11.6 14.1 11.1 7.0 24.4 5.1 5.6 7.7 12.5 21.8 8.0 14.5 12.8 17.7 14.0 10.7 9.3 19.5 15.1 10.8 4.0 8.0 6.8 9.4 15.0 5.7 9.9 5.7 10.6 5.9 12.8 4.7 12.3 13.5 8.8 13.8 9.2 9.9 10.5 14.3 13.0 3.2 8.7 10.0 6.7 5.9 5.7 8.4 19.9 9.3 21.9 7.5 16.1 8.4 9.4 8.3 10.0 9.2 7.9 7.6 11.2 11.9 8.5 11.7 8.2 10.7 4.9 11.3 6.6 15.6 16.4 30.9 16.3 14.6 7.9 17.5 12.1 16.6 18.2 26.8 20.8 20.5 44.0 60.8 20.0 17.6 12.7 32.1 25.0 21.0 7.9 13.4 3.3 14.1 38.2 20.4 10.1 23.3 10.9 15.8 35.2 39.4 46.2 13.6 15.7 15.9 10.9 12.9 25.7 13.5 17.3 33.9 23.6 21.6 14.7 15.5 17.4 14.4 25.1 5.3 11.9 12.9 20.2 24.7 32.9 71.4 21.1 24.5 9.0 52.9 MORC4 "FLJ11565, ZCW4, ZCWCC2" ENSG00000133131 "MORC family CW-type zinc finger 4" Q8TE76 X 106813871-107000244 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "placenta: 94.5" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 122.1;Alveolar cells type 2: 98.4;Ciliated cells: 111.1;Club cells: 109.2;Cytotrophoblasts: 213.9;granulocytes: 61.5;Syncytiotrophoblasts: 215.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 44.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA000395, HPA015547, HPA050250" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA000395: AB_1079405, HPA015547: AB_2669216, HPA050250: AB_2681063" "prognostic unfavorable (3.56e-5)" "unprognostic (3.30e-3)" "unprognostic (1.09e-1)" "unprognostic (1.13e-1)" "unprognostic (1.40e-1)" "unprognostic (6.29e-3)" "unprognostic (1.39e-1)" "unprognostic (1.43e-1)" "unprognostic (1.47e-1)" "unprognostic (2.30e-2)" "unprognostic (5.56e-2)" "unprognostic (8.59e-2)" "unprognostic (1.60e-1)" "unprognostic (1.60e-2)" "unprognostic (6.57e-2)" "unprognostic (4.89e-2)" "unprognostic (8.69e-2)" 8.7 20.0 3.2 6.0 4.8 5.1 6.2 4.9 3.6 8.0 5.3 4.6 12.7 4.6 8.8 8.5 6.8 7.3 6.7 5.3 4.3 2.8 4.9 9.7 6.0 2.2 4.9 2.2 12.3 9.1 6.0 4.9 94.5 5.8 7.7 4.9 4.2 8.7 8.8 9.4 8.6 4.9 7.4 5.4 2.6 5.6 12.5 5.0 2.3 7.6 7.5 5.2 6.3 15.1 6.0 4.6 10.5 3.8 2.8 4.0 0.7 11.0 44.0 4.4 10.1 13.4 15.5 22.9 10.7 11.4 5.4 7.0 23.3 5.0 1.7 5.6 11.0 9.3 8.7 14.7 9.4 6.5 2.5 8.5 2.7 14.9 9.8 9.9 1.9 5.6 8.2 9.1 7.4 10.8 32.3 4.8 1.7 1.5 16.7 12.1 9.7 4.0 2.7 3.9 29.5 16.7 1.9 8.8 1.9 17.5 8.8 3.8 4.8 13.0 12.8 8.4 6.5 7.6 1.9 5.0 8.7 8.8 17.2 5.9 4.7 6.1 4.3 9.3 1.7 6.3 10.5 3.8 3.1 3.7 3.0 3.2 3.3 3.6 2.8 1.6 6.0 4.0 3.4 8.2 2.8 3.6 4.6 2.6 0.7 3.2 4.8 4.9 3.6 4.3 2.8 4.9 2.2 5.8 5.0 122.1 98.4 2.2 12.9 15.5 4.5 2.2 7.6 111.1 109.2 5.2 3.9 213.9 18.3 8.8 0.8 5.0 3.9 0.0 6.4 21.9 23.8 19.4 61.5 16.2 20.2 1.6 1.7 8.6 1.3 0.9 10.3 4.8 11.8 0.0 8.8 5.8 6.7 4.9 11.0 9.0 7.5 25.8 8.6 5.4 24.3 14.1 215.6 6.4 8.4 11.7 MORF4L2 "KIAA0026, MRGX" ENSG00000123562 "Mortality factor 4 like 2" Q15014 X 103675496-103688158 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Extravillous trophoblasts: 931.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031872, HPA054102" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA031872: AB_2674081, HPA054102: AB_2682379" "prognostic unfavorable (9.83e-4)" "unprognostic (2.04e-1)" "unprognostic (1.81e-1)" "unprognostic (7.14e-3)" "unprognostic (2.59e-1)" "prognostic unfavorable (4.29e-5)" "unprognostic (5.27e-2)" "unprognostic (6.34e-3)" "unprognostic (2.41e-1)" "unprognostic (4.49e-3)" "unprognostic (1.88e-1)" "unprognostic (1.10e-2)" "prognostic unfavorable (7.86e-7)" "unprognostic (8.54e-2)" "unprognostic (2.65e-2)" "unprognostic (1.78e-1)" "unprognostic (4.05e-1)" 33.3 51.4 50.4 26.6 53.5 23.9 51.6 52.8 66.8 76.2 32.9 29.7 62.9 25.8 74.0 63.4 40.2 55.2 39.5 38.5 50.0 71.2 44.0 76.5 34.3 19.3 45.5 48.8 99.8 36.2 38.6 81.8 77.4 63.5 47.4 40.3 23.4 35.2 57.8 44.9 27.4 27.8 93.7 46.1 25.9 31.5 33.5 34.7 21.5 46.8 35.6 29.9 55.5 45.3 21.6 40.7 24.7 24.7 25.4 29.1 21.9 61.5 41.8 56.2 24.8 83.8 63.0 75.5 82.5 72.2 68.6 70.7 42.8 55.5 42.1 67.7 78.4 84.4 41.9 70.3 61.1 86.0 19.3 31.9 22.4 71.9 48.4 91.9 30.6 21.3 68.4 54.5 58.4 77.1 58.7 75.2 21.9 36.7 58.2 83.9 62.3 27.3 30.2 53.4 74.4 47.6 27.7 52.8 44.5 68.5 37.5 53.7 41.8 62.2 46.2 61.5 62.5 30.6 29.8 62.7 40.1 26.9 69.4 44.0 29.0 35.4 37.4 71.7 62.2 60.0 24.7 23.3 18.4 25.4 24.7 29.1 21.6 24.3 23.9 24.3 19.1 26.9 23.1 9.5 25.4 24.6 40.7 19.7 21.9 50.4 53.5 52.8 66.8 50.0 71.2 45.5 48.8 63.5 34.7 116.1 147.5 88.8 414.6 322.8 43.3 119.2 122.3 420.3 177.5 104.7 9.8 369.7 208.9 242.9 24.0 127.8 101.6 93.5 114.3 931.5 289.9 258.5 150.3 162.2 144.9 55.6 171.3 128.3 54.0 17.4 306.3 110.7 178.8 79.4 116.9 105.8 160.2 115.2 540.3 206.2 33.5 142.3 300.8 27.0 40.2 277.8 488.0 71.4 94.4 332.6 MORN1 FLJ13941 ENSG00000116151 "MORN repeat containing 1" Q5T089 1 2321253-2391707 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 34.8;Rod photoreceptor cells: 21.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005858, HPA070703" Uncertain Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA005858: AB_1848709, HPA070703: AB_2686299" "unprognostic (1.39e-3)" "unprognostic (6.49e-2)" "unprognostic (1.58e-1)" "unprognostic (8.21e-3)" "unprognostic (9.12e-2)" "unprognostic (5.87e-3)" "unprognostic (1.87e-1)" "unprognostic (2.65e-1)" "unprognostic (3.61e-2)" "unprognostic (5.97e-2)" "unprognostic (1.11e-2)" "unprognostic (2.60e-1)" "unprognostic (8.88e-3)" "unprognostic (2.53e-1)" "unprognostic (6.29e-2)" "unprognostic (1.09e-1)" "unprognostic (1.70e-1)" 4.2 4.0 6.9 5.6 15.1 2.5 4.9 25.8 6.6 7.3 4.4 6.1 14.4 4.5 9.3 13.9 3.7 23.5 7.4 3.0 5.5 5.7 7.8 4.1 5.8 3.5 3.9 8.0 15.2 8.6 4.9 11.6 2.5 11.7 6.7 3.1 8.8 9.1 11.7 4.7 6.4 4.3 6.0 4.9 4.6 5.4 17.3 4.8 5.8 15.0 3.3 3.8 3.5 4.6 2.1 3.7 4.2 4.3 0.8 2.6 1.0 6.4 7.8 5.4 4.9 1.9 0.9 5.6 2.0 1.4 3.2 2.7 3.7 7.3 1.7 4.2 1.2 2.4 8.0 1.1 3.1 3.1 3.9 8.3 1.7 14.3 4.2 1.6 2.1 0.9 1.1 0.7 3.0 2.7 2.4 2.2 3.4 2.7 2.0 1.1 8.9 2.1 0.8 3.2 3.4 6.9 2.2 5.0 2.7 2.5 2.9 8.9 4.3 5.2 9.5 4.1 2.5 5.0 0.6 0.7 3.7 5.3 2.6 2.3 4.8 1.7 1.1 7.4 1.3 2.5 0.0 0.8 0.2 1.4 0.3 0.8 1.0 1.5 1.1 1.0 2.1 2.6 1.2 4.2 0.8 4.3 3.7 0.1 1.0 6.9 15.1 25.8 6.6 5.5 5.7 3.9 8.0 11.7 4.8 3.0 2.7 1.5 3.6 1.4 8.5 3.2 5.1 34.8 4.5 14.0 19.6 3.1 3.3 1.8 16.8 1.0 2.1 0.0 1.2 1.4 2.1 2.7 5.7 1.0 2.3 9.5 5.2 1.8 0.6 19.5 2.3 0.6 1.7 1.0 0.6 8.4 1.4 0.0 2.8 7.9 21.9 0.0 2.0 19.2 5.9 1.9 1.6 0.8 1.9 2.3 MORN2 MOPT ENSG00000188010 "MORN repeat containing 2" Q502X0 2 38875962-38929072 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 88.7" "Cell type enhanced" "Detected in many" 21 "Ciliated cells: 638.4;Early spermatids: 1599.5;Late spermatids: 2860.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057815 Approved Nucleoplasm NA NA Nucleoplasm "HPA057815: AB_2683537" "unprognostic (7.28e-3)" "unprognostic (3.84e-2)" "unprognostic (8.65e-2)" "unprognostic (1.24e-2)" "unprognostic (1.84e-1)" "unprognostic (1.48e-1)" "unprognostic (1.24e-3)" "unprognostic (1.66e-2)" "unprognostic (6.01e-2)" "unprognostic (2.60e-2)" "unprognostic (2.93e-1)" "unprognostic (2.21e-1)" "unprognostic (8.37e-3)" "unprognostic (2.35e-1)" "unprognostic (1.09e-2)" "unprognostic (3.55e-1)" "unprognostic (8.80e-2)" 5.9 14.4 20.5 3.1 22.7 4.1 10.2 6.8 14.8 14.9 6.5 10.3 13.8 3.4 8.3 34.6 5.0 43.7 9.1 10.7 16.4 18.6 31.4 8.6 8.6 2.9 16.5 12.7 9.6 9.5 22.7 27.1 4.0 30.1 8.4 6.8 8.3 11.4 9.7 7.1 3.6 3.3 5.7 11.1 3.1 6.9 88.7 9.5 2.0 21.9 7.2 2.9 6.1 4.4 3.6 7.5 2.0 11.0 3.1 4.8 4.8 23.4 12.4 15.2 18.5 16.7 25.2 8.5 10.9 17.2 17.5 16.9 7.2 13.4 1.5 9.2 16.2 17.5 6.5 6.8 14.1 26.0 9.9 13.1 5.1 14.0 19.1 14.6 8.2 3.7 15.0 17.4 21.4 7.8 22.0 16.0 4.7 8.7 3.5 14.3 23.5 3.7 15.8 11.6 15.6 13.0 2.0 16.0 5.3 32.6 14.1 15.3 20.1 16.2 10.8 23.1 9.2 14.8 11.4 10.7 12.2 12.2 19.3 17.3 6.9 9.9 0.9 28.2 2.4 21.9 2.0 11.0 1.5 2.2 8.4 4.1 3.4 2.6 3.3 7.5 3.6 4.4 4.6 0.9 3.1 6.9 3.8 4.8 4.8 20.5 22.7 6.8 14.8 16.4 18.6 16.5 12.7 30.1 9.5 14.9 16.4 6.4 23.2 8.7 14.8 36.7 38.2 638.4 66.0 57.6 9.8 13.2 228.8 53.3 1599.5 11.8 8.3 0.0 38.9 19.6 23.9 32.1 9.2 17.9 21.0 15.9 22.0 14.1 7.8 2860.4 49.5 14.9 21.9 5.4 18.5 60.4 35.0 28.8 48.4 323.7 28.1 25.8 13.4 365.9 74.1 9.3 6.4 4.1 23.9 21.4 MORN3 ENSG00000139714 "MORN repeat containing 3" Q6PF18 12 121648742-121672631 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "placenta: 30.1;testis: 51.5" "Cell type enriched" "Detected in many" 5 "Late spermatids: 1766.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 9 "BEWO: 12.6;CACO-2: 6.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA038709, HPA038710" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA038709: AB_2676164, HPA038710: AB_2676165" "prognostic favorable (1.16e-4)" "unprognostic (2.70e-3)" "unprognostic (5.56e-2)" "unprognostic (5.13e-2)" "unprognostic (7.38e-3)" "unprognostic (3.46e-3)" "unprognostic (7.44e-2)" "unprognostic (3.70e-2)" "unprognostic (4.31e-2)" "unprognostic (3.09e-2)" "unprognostic (3.65e-3)" "unprognostic (3.11e-2)" "unprognostic (1.39e-2)" "unprognostic (3.06e-1)" "unprognostic (2.21e-1)" "unprognostic (8.85e-2)" "unprognostic (1.18e-1)" 0.3 0.2 1.2 0.5 1.4 0.9 0.3 0.3 1.6 0.4 0.3 0.3 0.3 0.2 0.3 1.4 0.3 5.6 0.4 0.3 1.4 1.2 0.4 0.3 1.0 1.4 0.3 0.3 0.3 0.4 3.4 0.7 30.1 0.3 0.3 0.0 0.3 0.3 0.3 0.3 2.5 0.3 0.3 0.3 0.8 0.8 51.5 0.3 0.3 0.5 0.3 0.6 0.3 0.3 1.2 1.2 3.1 0.6 2.2 2.3 0.6 0.1 0.2 0.4 0.2 0.0 0.3 12.6 0.2 0.0 0.1 0.1 6.8 0.3 0.2 0.2 0.1 0.2 0.4 0.1 0.1 0.1 0.1 0.1 0.5 0.3 0.4 0.3 0.4 0.9 0.1 0.3 0.3 0.0 0.1 0.2 0.8 0.2 0.3 0.1 0.2 0.8 0.6 0.2 0.0 0.1 0.3 0.0 0.1 0.4 0.2 1.1 1.1 0.1 0.2 0.0 0.5 0.9 0.1 0.1 0.2 0.2 0.3 0.1 0.2 0.1 0.4 0.9 0.3 0.1 2.3 0.6 0.4 2.1 0.3 2.0 0.8 2.3 1.3 0.2 1.2 2.1 1.4 3.1 2.2 0.5 1.2 2.0 0.6 1.2 1.4 0.3 1.2 1.4 1.2 0.3 0.3 0.3 0.3 3.0 2.2 0.5 1.1 2.9 1.1 1.1 5.1 50.9 11.4 1.8 0.0 0.2 6.6 3.3 357.0 1.5 0.0 0.0 1.2 0.4 1.3 0.3 2.3 0.0 0.8 0.0 0.0 0.6 0.0 1766.8 8.6 0.1 0.0 1.8 0.0 3.7 1.7 0.0 8.9 0.8 1.7 0.0 0.0 7.0 5.6 3.4 6.1 3.3 0.1 1.0 MOSPD1 dJ473B4 ENSG00000101928 "Motile sperm domain containing 1" Q9UJG1 X 134887626-134915267 "Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 80.8;Late spermatids: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031158 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA031158: AB_10603874" "unprognostic (2.23e-3)" "unprognostic (3.37e-3)" "unprognostic (1.34e-1)" "unprognostic (2.30e-1)" "unprognostic (1.77e-1)" "unprognostic (3.36e-1)" "unprognostic (6.78e-3)" "unprognostic (5.15e-2)" "unprognostic (1.58e-1)" "unprognostic (1.25e-1)" "unprognostic (6.20e-3)" "unprognostic (4.27e-2)" "unprognostic (6.45e-3)" "unprognostic (2.92e-2)" "unprognostic (2.01e-1)" "unprognostic (5.71e-2)" "unprognostic (1.15e-1)" 11.0 19.7 6.2 6.5 8.0 12.3 7.9 7.8 10.4 11.1 6.9 8.8 5.5 5.4 19.3 12.5 20.5 25.1 6.6 17.4 7.3 6.2 11.8 10.3 8.0 5.5 9.9 7.4 12.9 8.9 10.3 8.1 23.2 21.2 8.1 7.0 10.3 14.6 7.6 17.6 14.5 6.9 10.7 9.0 8.3 7.5 16.4 7.5 10.2 9.1 13.5 10.1 9.5 12.0 6.2 8.3 12.3 6.8 6.0 14.3 5.1 7.7 6.1 5.2 3.6 8.2 4.8 11.3 13.1 23.8 12.6 12.3 15.0 3.1 2.6 18.3 8.3 22.9 2.8 8.0 6.8 16.7 8.7 4.7 2.2 16.2 6.0 34.9 6.1 3.8 8.7 8.3 14.2 6.1 14.4 9.2 5.4 2.7 10.7 15.2 10.8 4.3 2.8 5.3 4.1 13.9 3.3 9.2 4.8 5.4 22.3 3.1 3.8 6.6 6.7 22.5 26.3 2.7 3.8 4.6 6.2 3.8 23.2 11.6 8.3 11.1 4.2 8.5 10.6 8.1 6.0 6.8 12.3 7.6 5.0 10.0 6.2 9.0 8.3 7.5 5.1 10.2 9.8 4.0 6.0 5.5 8.3 14.3 5.1 6.2 8.0 7.8 10.4 7.3 6.2 9.9 7.4 21.2 7.5 6.0 4.3 6.7 9.8 18.9 9.0 42.3 5.1 16.0 6.8 10.4 2.0 6.1 18.3 21.3 80.8 12.7 5.7 46.7 10.7 12.5 9.1 9.7 5.7 4.9 13.2 4.8 4.1 13.5 11.4 57.7 6.4 7.2 28.7 5.4 7.2 8.3 17.9 11.5 10.3 20.2 9.0 6.5 15.3 3.0 5.3 17.9 21.9 10.1 6.6 8.1 MOSPD3 "CDS3, NET30" ENSG00000106330 "Motile sperm domain containing 3" O75425 7 100612102-100615384 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Late spermatids: 1149.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 33.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041137, HPA048240" Uncertain Approved Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA041137: AB_10803996, HPA048240: AB_2680325" "unprognostic (1.24e-1)" "unprognostic (8.98e-2)" "unprognostic (1.06e-2)" "unprognostic (1.08e-1)" "unprognostic (1.25e-2)" "unprognostic (1.80e-2)" "unprognostic (1.19e-1)" "unprognostic (5.94e-2)" "unprognostic (9.88e-2)" "unprognostic (1.66e-1)" "unprognostic (2.46e-2)" "unprognostic (8.65e-2)" "unprognostic (2.24e-2)" "unprognostic (7.55e-2)" "unprognostic (2.25e-1)" "unprognostic (1.09e-1)" "unprognostic (3.20e-2)" 13.8 22.3 13.0 7.7 12.8 17.4 9.8 9.0 16.9 14.7 9.1 14.5 13.9 9.9 12.0 12.9 22.5 12.0 14.9 10.2 11.2 10.8 19.3 29.8 11.1 18.5 10.6 11.6 13.1 17.1 6.7 9.8 7.8 12.0 12.9 4.8 14.9 19.1 11.3 11.3 24.4 10.6 10.3 9.5 11.8 14.7 37.0 9.9 16.6 12.2 13.6 16.8 12.4 13.4 11.6 17.9 22.2 16.7 20.9 29.7 8.0 6.0 8.2 6.6 11.4 3.5 2.6 4.7 4.6 5.5 4.8 4.9 7.6 8.1 3.8 10.2 4.2 6.8 4.7 3.8 6.6 0.9 9.8 5.1 3.9 6.1 11.4 4.5 3.0 15.1 7.4 5.7 4.1 2.4 4.2 8.2 6.4 9.1 7.8 4.9 17.9 8.4 23.0 6.0 7.9 12.4 7.9 6.9 9.1 7.6 9.1 3.6 21.7 8.6 13.4 4.6 2.8 8.1 8.9 9.2 9.3 14.7 19.3 4.4 6.2 5.8 2.6 9.3 33.7 11.4 18.5 16.7 22.2 18.8 12.4 22.2 11.6 21.8 21.8 17.9 11.3 13.0 13.5 12.3 20.9 8.5 12.0 29.7 8.0 13.0 12.8 9.0 16.9 11.2 10.8 10.6 11.6 12.0 9.9 8.9 6.5 11.9 14.9 10.8 6.6 3.2 17.8 9.4 4.5 19.2 5.9 6.0 36.5 33.9 271.2 15.7 8.7 0.0 37.6 23.2 22.0 20.1 3.5 26.2 25.2 6.4 20.7 19.0 23.0 1149.7 25.6 15.1 25.3 14.4 14.9 11.4 39.0 17.5 20.5 35.7 3.4 12.9 20.0 17.7 21.5 17.1 5.1 29.3 16.9 17.8 MPG MDG ENSG00000103152 "N-methylpurine DNA glycosylase" P29372 16 77007-85853 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006531 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA006531: AB_1854075" "unprognostic (1.78e-2)" "unprognostic (8.48e-2)" "unprognostic (9.99e-2)" "prognostic favorable (2.82e-5)" "unprognostic (8.54e-2)" "unprognostic (3.27e-1)" "unprognostic (2.75e-2)" "unprognostic (1.63e-1)" "unprognostic (2.14e-1)" "unprognostic (1.44e-1)" "unprognostic (1.85e-2)" "unprognostic (1.83e-2)" "unprognostic (1.39e-2)" "unprognostic (1.86e-3)" "unprognostic (3.88e-2)" "unprognostic (1.86e-2)" "unprognostic (3.26e-1)" 20.8 32.1 18.4 21.1 18.4 25.3 33.2 18.3 32.1 19.5 20.4 12.6 24.6 21.0 22.6 30.5 21.5 18.5 28.5 37.4 16.7 15.1 16.1 32.0 20.1 39.7 15.8 18.2 23.8 36.5 8.0 21.7 19.0 16.5 23.2 7.2 15.2 47.1 24.2 33.6 19.0 19.4 19.2 13.6 25.6 27.3 10.9 11.2 18.3 29.2 22.4 22.8 27.2 25.2 33.5 38.8 27.2 27.4 41.2 31.1 22.4 14.0 20.5 5.6 17.1 10.3 23.5 14.0 20.1 27.8 13.1 14.4 12.9 18.9 10.0 17.6 11.4 6.5 18.0 3.9 8.8 2.0 17.1 14.9 6.5 10.4 19.2 29.8 6.7 40.2 22.6 12.2 14.7 6.1 17.5 22.8 11.3 14.2 18.0 17.0 48.4 11.7 31.1 10.1 8.1 22.4 22.3 6.7 38.0 10.9 5.1 4.6 11.7 10.6 11.5 25.3 2.7 16.4 34.9 19.9 10.7 13.6 14.5 9.9 17.6 5.9 12.7 19.8 19.5 38.1 14.2 27.4 27.2 22.7 19.2 20.6 33.5 21.8 22.6 28.5 30.6 16.8 17.2 14.0 41.2 15.7 38.8 31.1 22.4 18.4 18.4 18.3 32.1 16.7 15.1 15.8 18.2 16.5 11.2 3.0 24.6 65.6 62.0 31.8 13.4 1.1 30.6 20.1 22.7 38.4 3.9 68.9 28.2 68.7 6.3 43.1 60.4 0.0 99.2 74.2 79.8 90.4 54.4 44.9 80.7 9.5 47.8 47.3 65.5 3.6 60.9 47.4 54.0 72.1 66.3 38.4 109.6 66.2 54.5 52.3 9.1 84.1 64.9 18.8 43.7 35.9 51.7 62.9 63.6 97.9 MPHOSPH6 MPP6 ENSG00000135698 "M-phase phosphoprotein 6" Q99547 16 82147798-82170226 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003674, HPA026948" Approved Supported Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "CAB003674: , HPA026948: AB_1854077" "unprognostic (2.58e-2)" "unprognostic (1.38e-1)" "unprognostic (1.65e-2)" "unprognostic (2.01e-1)" "unprognostic (3.57e-1)" "unprognostic (2.97e-3)" "prognostic unfavorable (4.36e-5)" "unprognostic (2.00e-2)" "unprognostic (2.29e-3)" "prognostic favorable (3.41e-5)" "unprognostic (7.52e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (3.05e-1)" "unprognostic (2.95e-1)" "unprognostic (2.11e-1)" "unprognostic (1.17e-1)" "unprognostic (9.43e-2)" 13.7 15.5 32.0 17.5 25.1 12.3 54.1 37.1 32.6 18.5 16.0 9.3 7.0 9.9 18.9 17.1 26.5 11.9 12.3 9.4 25.4 22.2 12.0 11.5 13.6 16.1 17.5 21.9 10.4 7.2 13.6 43.5 17.4 24.0 11.3 18.7 10.8 18.1 10.3 15.4 28.4 11.0 16.8 31.7 12.7 11.2 9.9 17.9 10.8 8.7 12.9 18.2 19.6 18.5 18.6 24.6 19.4 25.2 17.1 28.3 15.6 19.6 10.7 24.1 11.7 11.7 16.6 13.3 21.2 25.5 18.5 9.0 17.3 11.5 16.2 12.9 11.6 13.7 20.7 22.9 22.0 24.9 12.0 15.0 13.0 9.0 31.1 11.7 32.3 20.2 10.4 19.8 11.0 31.7 9.4 21.2 22.7 30.5 4.6 28.1 15.9 24.8 38.2 22.0 24.5 14.9 30.8 11.1 10.7 16.7 20.7 16.5 7.1 35.7 15.9 15.2 10.3 27.9 20.1 16.6 17.4 17.3 15.3 15.0 6.8 16.4 64.4 15.7 26.6 22.0 13.0 22.0 19.4 22.3 25.2 28.3 18.6 23.1 23.2 24.6 14.6 24.8 23.6 2.7 17.1 17.4 14.7 23.0 15.6 32.0 25.1 37.1 32.6 25.4 22.2 17.5 21.9 24.0 17.9 17.9 37.6 25.3 34.6 34.5 13.8 29.0 12.7 34.8 35.2 19.2 9.8 52.1 43.1 41.7 4.8 14.3 15.1 46.7 24.5 35.8 39.3 21.5 17.4 13.0 43.1 19.1 8.6 19.0 33.6 7.6 10.3 56.9 30.4 71.3 17.4 31.2 42.3 28.1 9.6 33.9 22.5 19.4 25.8 30.3 54.8 47.2 27.5 22.9 28.6 40.1 MPHOSPH8 "HSMPP8, mpp8" ENSG00000196199 "M-phase phosphoprotein 8" Q99549 13 19633681-19673459 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039701, HPA040035" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA039701: AB_10805484, HPA040035: AB_10794207" "unprognostic (4.22e-1)" "unprognostic (5.58e-2)" "unprognostic (2.66e-1)" "unprognostic (4.01e-3)" "unprognostic (3.05e-2)" "unprognostic (1.86e-1)" "unprognostic (2.81e-3)" "unprognostic (4.90e-2)" "unprognostic (4.55e-2)" "unprognostic (1.59e-1)" "unprognostic (3.52e-3)" "unprognostic (3.40e-2)" "unprognostic (6.49e-2)" "unprognostic (3.86e-2)" "unprognostic (4.93e-2)" "unprognostic (2.10e-1)" "unprognostic (1.02e-1)" 20.6 27.1 37.7 33.4 37.1 19.2 21.4 48.9 45.0 32.0 26.6 13.2 31.7 17.8 29.4 26.7 19.1 22.3 18.8 27.9 31.0 27.2 18.9 16.5 22.9 28.4 28.8 32.8 43.6 22.0 20.9 44.3 20.0 28.4 26.1 20.1 11.9 24.5 38.8 25.7 26.6 23.9 31.3 37.1 30.0 22.5 16.6 33.5 16.5 26.8 11.7 20.4 31.3 37.9 21.7 13.8 39.4 9.9 11.5 17.6 3.6 12.9 8.3 12.5 20.2 16.2 20.6 22.1 19.5 14.2 12.3 10.6 12.7 22.9 20.5 15.6 11.8 19.2 21.7 22.9 13.6 15.9 25.5 11.7 33.0 13.7 15.4 14.4 23.7 26.9 12.1 17.7 9.7 13.7 18.8 16.2 16.7 15.9 13.2 11.4 12.6 18.1 19.9 12.2 24.1 9.3 14.6 28.8 16.2 21.4 10.1 17.1 10.5 18.2 16.8 17.7 21.8 10.2 19.7 19.0 9.6 8.6 18.1 9.8 9.0 9.3 20.4 7.3 22.0 14.8 39.4 9.5 15.4 13.0 6.9 11.5 21.5 14.6 12.5 4.3 21.7 17.6 14.4 27.5 11.5 9.9 13.8 11.3 3.6 37.7 37.1 48.9 45.0 31.0 27.2 28.8 32.8 28.4 33.5 86.4 100.8 102.7 102.3 61.2 189.0 78.6 81.5 60.2 84.2 97.7 78.5 107.7 41.4 45.8 58.1 101.2 89.2 23.3 47.7 70.1 98.0 73.8 137.8 68.9 64.6 198.6 56.6 106.2 53.3 25.9 166.0 79.7 64.1 91.0 71.4 105.7 42.2 94.7 147.8 48.2 208.1 174.6 116.5 181.6 204.0 64.6 49.1 124.6 63.9 55.3 MPHOSPH9 MPP9 ENSG00000051825 "M-phase phosphoprotein 9" Q99550 12 123152320-123244014 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 48.9" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 108.0;Rod photoreceptor cells: 64.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037485 Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA037485: AB_10672792" "unprognostic (2.98e-2)" "unprognostic (5.00e-1)" "unprognostic (4.36e-3)" "unprognostic (1.45e-2)" "unprognostic (1.62e-1)" "unprognostic (2.81e-1)" "unprognostic (5.81e-3)" "unprognostic (1.64e-1)" "unprognostic (1.58e-2)" "unprognostic (1.88e-1)" "unprognostic (8.34e-2)" "unprognostic (1.08e-2)" "unprognostic (6.53e-3)" "unprognostic (1.31e-2)" "unprognostic (2.75e-1)" "unprognostic (5.14e-3)" "unprognostic (1.17e-1)" 5.3 9.8 11.0 10.5 14.6 24.8 5.6 21.6 14.9 5.5 6.7 7.7 4.9 7.9 6.4 12.8 5.9 6.1 4.0 8.8 8.8 6.0 7.1 12.7 6.1 12.0 7.1 8.0 6.9 6.3 9.9 20.4 5.7 9.9 5.8 7.6 7.7 5.9 5.2 7.2 5.4 8.0 5.9 9.1 10.2 5.9 14.4 11.0 48.9 6.2 3.2 10.8 5.5 5.0 6.2 4.9 8.3 3.7 8.5 12.1 3.0 8.5 9.1 14.6 16.4 6.5 6.1 5.5 8.8 4.5 11.1 8.9 8.6 4.2 16.8 6.5 5.8 10.6 6.1 18.8 7.2 15.5 10.7 12.2 17.1 10.1 8.4 5.0 15.9 14.9 6.6 2.7 10.5 10.5 9.8 11.3 25.6 11.8 7.4 10.1 7.2 18.1 25.2 10.0 5.6 9.9 16.2 14.7 10.9 8.6 8.4 18.7 8.8 13.7 5.5 8.6 15.3 10.3 12.0 6.4 9.1 13.1 10.5 12.5 11.6 18.7 14.0 7.3 15.3 18.8 8.3 3.7 5.1 10.9 3.6 7.7 5.6 8.6 9.8 3.5 6.2 12.1 11.8 0.7 8.5 3.1 4.9 7.4 3.0 11.0 14.6 21.6 14.9 8.8 6.0 7.1 8.0 9.9 11.0 8.9 7.4 13.8 3.9 3.9 36.9 12.6 10.2 14.7 9.1 7.0 108.0 8.9 5.0 4.1 46.8 4.5 3.3 0.0 1.6 5.6 8.1 2.8 2.3 27.6 7.3 50.9 13.7 5.5 12.0 48.4 6.6 7.2 3.3 14.4 5.1 17.7 1.6 0.0 10.6 7.1 64.2 0.0 4.1 30.0 19.6 1.9 1.4 22.3 7.5 2.4 MPIG6B "C6orf25, G6b, G6b-B, NG31" ENSG00000204420 "Megakaryocyte and platelet inhibitory receptor G6b" O95866 6 31718594-31726714 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Heparin-binding, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 33.2" "Cell type enriched" "Detected in single" 30 "granulocytes: 9.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 4 "NK-cell: 3.0;plasmacytoid DC: 1.8" "Group enriched" "Detected in many" 4 "dendritic cells: 1.8;NK-cells: 3.0" "Cell line enriched" "Detected in single" 17 "HEL: 11.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA054404, HPA073017" Approved "Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 7400000 "Golgi apparatus" "Nucleoplasm, Endoplasmic reticulum, Plasma membrane, Cytosol" "HPA054404: , HPA073017: AB_2686566" "unprognostic (1.45e-1)" "unprognostic (1.25e-1)" "unprognostic (2.93e-1)" "unprognostic (1.77e-2)" "unprognostic (1.23e-1)" "unprognostic (6.53e-2)" "unprognostic (3.53e-2)" "unprognostic (2.71e-2)" "unprognostic (1.19e-1)" "unprognostic (1.43e-2)" "unprognostic (2.70e-1)" "unprognostic (1.71e-2)" "unprognostic (1.82e-2)" "unprognostic (1.02e-1)" "unprognostic (1.34e-1)" "unprognostic (2.55e-2)" "unprognostic (1.71e-2)" 0.8 0.2 0.0 1.2 0.5 5.3 0.7 0.1 0.4 1.0 0.9 0.0 0.0 0.9 1.0 0.8 2.0 0.7 1.5 7.4 0.2 0.0 0.4 0.5 7.6 2.8 1.0 0.0 2.7 0.2 0.2 0.2 1.4 0.7 0.9 0.2 1.1 1.8 0.3 1.2 10.5 0.8 1.9 0.6 33.2 0.4 2.7 0.1 1.2 1.0 1.4 0.8 1.6 1.6 0.2 1.8 0.5 0.1 3.0 0.1 5.7 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.3 0.2 0.4 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.3 0.0 0.5 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.5 3.0 0.1 1.8 0.0 5.7 0.0 0.5 0.1 0.4 0.2 0.0 1.0 0.0 0.7 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 MPLKIP "C7orf11, ORF20, TTDN1" ENSG00000168303 "M-phase specific PLK1 interacting protein" Q8TAP9 7 40126023-40134652 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA058457, HPA065463" Uncertain Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "HPA058457: AB_2683724, HPA065463: AB_2685493" "unprognostic (5.59e-2)" "unprognostic (1.74e-1)" "unprognostic (9.40e-2)" "unprognostic (2.39e-2)" "unprognostic (5.55e-2)" "unprognostic (1.34e-3)" "unprognostic (2.73e-1)" "unprognostic (3.40e-2)" "unprognostic (3.94e-2)" "unprognostic (1.65e-1)" "unprognostic (3.16e-3)" "unprognostic (8.89e-2)" "unprognostic (1.61e-2)" "unprognostic (8.44e-2)" "unprognostic (2.91e-2)" "unprognostic (1.91e-2)" "unprognostic (6.08e-2)" 13.7 15.2 11.6 9.3 12.7 8.7 14.8 13.9 12.1 12.7 14.5 12.6 9.5 11.9 11.0 13.6 12.9 10.0 9.3 9.3 11.8 11.4 20.5 52.1 8.7 13.3 15.0 8.8 12.0 17.3 10.1 16.1 13.8 10.4 11.5 11.6 11.1 14.4 10.5 10.1 11.3 13.4 9.2 11.9 12.7 10.8 11.0 12.0 25.5 19.2 7.9 12.8 11.3 12.6 53.8 41.9 52.9 38.0 30.7 45.0 40.9 24.1 7.1 13.3 16.7 13.4 15.8 14.7 8.7 10.3 13.9 14.1 9.7 11.8 19.7 12.9 9.0 26.5 29.7 8.0 16.3 17.4 15.1 29.0 15.0 10.5 20.4 16.1 17.8 14.4 14.8 22.6 9.9 12.9 13.9 16.7 21.6 39.3 15.1 14.1 12.4 18.0 60.4 18.4 20.2 24.2 26.4 9.2 25.9 15.4 5.7 19.4 24.1 14.3 13.6 20.9 19.5 17.5 26.7 15.1 7.5 22.7 9.1 13.5 24.6 29.1 33.4 12.8 30.6 22.1 43.4 38.0 52.9 28.0 34.3 31.3 53.8 35.9 32.8 39.4 47.0 40.0 35.1 20.4 30.7 31.5 41.9 45.0 40.9 11.6 12.7 13.9 12.1 11.8 11.4 15.0 8.8 10.4 12.0 47.6 34.6 54.8 74.2 97.8 44.2 15.9 53.5 53.5 39.8 55.8 23.6 94.3 99.5 60.1 107.2 61.3 51.0 0.0 47.7 63.7 58.5 51.4 49.7 109.9 60.4 50.9 46.7 45.4 55.0 29.2 70.2 56.9 55.6 52.3 57.8 42.0 52.6 70.6 51.9 148.0 42.4 51.8 48.1 54.9 49.5 117.2 80.0 48.0 77.3 91.3 MPND FLJ14981 ENSG00000008382 "MPN domain containing" Q8N594 19 4343527-4360086 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 65.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043274, HPA045475" Approved Approved "Nucleoplasm,Nucleoli rim" No No "Nucleoli rim" Nucleoplasm "HPA043274: AB_2678403, HPA045475: AB_2679339" "unprognostic (3.16e-2)" "prognostic favorable (2.99e-4)" "unprognostic (4.85e-2)" "prognostic favorable (6.12e-4)" "unprognostic (8.60e-2)" "unprognostic (5.37e-3)" "unprognostic (3.16e-2)" "prognostic favorable (1.55e-4)" "unprognostic (1.23e-1)" "unprognostic (2.87e-2)" "unprognostic (3.94e-3)" "unprognostic (5.18e-2)" "prognostic favorable (7.04e-4)" "unprognostic (2.22e-3)" "unprognostic (3.22e-1)" "unprognostic (5.44e-2)" "unprognostic (9.04e-2)" 7.7 13.7 18.9 14.1 12.3 11.5 8.0 12.1 21.6 6.5 19.9 6.6 15.7 25.9 8.5 7.8 13.8 8.2 11.8 12.1 14.2 11.3 12.8 25.1 14.3 8.5 12.7 20.0 8.7 20.7 14.5 7.2 7.0 11.9 12.1 13.9 11.5 14.3 9.0 17.4 12.5 20.7 9.3 8.9 10.1 12.5 4.2 6.7 13.5 8.6 8.3 10.1 9.3 11.0 3.1 4.5 10.3 6.0 2.4 5.6 1.9 7.9 6.7 11.1 12.7 7.0 3.3 11.3 3.9 3.8 3.2 4.0 12.9 4.1 7.2 12.2 5.0 9.5 8.2 5.0 6.7 1.8 8.1 11.3 5.5 9.5 20.9 5.6 7.4 10.0 5.0 4.9 3.5 3.7 5.0 9.9 19.2 2.9 18.8 4.0 23.0 17.4 6.3 5.1 13.5 9.7 14.3 3.4 10.4 8.2 14.1 12.4 12.7 7.1 10.0 5.3 6.6 6.7 9.1 3.7 5.2 5.6 31.4 7.7 15.7 9.6 4.8 5.7 4.1 5.9 10.3 5.1 2.4 2.2 6.0 3.4 1.8 2.6 3.1 4.5 3.1 1.7 1.9 1.2 2.4 2.7 4.5 5.6 1.9 18.9 12.3 12.1 21.6 14.2 11.3 12.7 20.0 11.9 6.7 0.0 3.0 4.5 6.6 4.7 7.2 11.5 10.2 1.4 3.4 10.4 2.0 11.3 0.0 4.3 0.5 4.9 65.9 0.0 4.4 9.3 3.9 9.1 4.6 21.2 13.6 6.4 16.0 6.7 23.8 2.2 5.8 10.2 3.3 6.4 27.9 3.9 4.9 32.5 3.5 11.4 3.4 6.5 5.1 0.0 5.3 7.3 8.7 5.3 28.8 7.1 MPO ENSG00000005381 Myeloperoxidase P05164 17 58269856-58280935 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrogen peroxide" "Oxidoreductase, Peroxidase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "bone marrow: 315.2" "Cell type enhanced" "Detected in some" 11 "Distal tubular cells: 1.7;Kupffer cells: 1.2" "Cancer enhanced" "Detected in single" "stomach cancer: 1.1" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 5 "classical monocyte: 7.6;intermediate monocyte: 3.8;myeloid DC: 3.2;neutrophil: 2.0" "Group enriched" "Detected in many" 30 "dendritic cells: 3.2;granulocytes: 2.0;monocytes: 7.6" "Group enriched" "Detected in some" 93 "HL-60: 218.1;NB-4: 285.8" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000059, HPA021147, HPA061464" Enhanced Supported Nucleoplasm,Vesicles "Intracellular and membrane" No NA 576000000 15000000 Vesicles Nucleoplasm "CAB000059: AB_2335676, HPA021147: AB_1854083, HPA061464: AB_2684531" "unprognostic (1.91e-1)" "unprognostic (9.08e-2)" "unprognostic (4.62e-2)" "unprognostic (2.90e-2)" "unprognostic (2.13e-3)" "unprognostic (2.78e-1)" "unprognostic (3.23e-1)" "unprognostic (2.91e-1)" "unprognostic (2.56e-1)" "unprognostic (1.68e-1)" "unprognostic (6.92e-2)" "unprognostic (8.34e-3)" "unprognostic (4.91e-2)" "unprognostic (3.07e-3)" "unprognostic (2.83e-1)" "unprognostic (1.14e-2)" "unprognostic (8.05e-2)" 0.2 0.1 0.5 0.1 0.8 315.2 0.1 0.4 1.0 0.1 0.1 1.4 0.0 0.1 0.2 0.2 0.1 0.1 0.1 21.5 0.6 0.8 0.1 1.4 6.9 0.8 0.6 0.0 0.6 0.1 0.1 1.0 2.9 0.4 0.2 0.1 0.2 6.3 0.1 0.7 0.5 0.1 0.1 0.4 17.8 0.1 0.4 0.2 19.7 0.6 0.0 0.5 0.1 0.0 0.0 3.2 2.0 7.6 0.0 0.1 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 218.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 285.8 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.6 0.0 0.0 3.8 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 2.0 0.0 0.8 0.0 0.1 7.2 0.5 0.8 0.4 1.0 0.6 0.8 0.6 0.0 0.4 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.6 1.2 0.9 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 MPP3 DLG3 ENSG00000161647 "Membrane palmitoylated protein 3" Q13368 17 43800799-43833170 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.7" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 24.5;Early spermatids: 39.4;Late spermatids: 56.6" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 6 "cerebellum: 46.7;pons and medulla: 13.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-HME1: 6.6;SCLC-21H: 13.3;T-47d: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021818, HPA024742" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021818: AB_1854086, HPA024742: AB_1854087" "unprognostic (1.94e-1)" "unprognostic (1.38e-1)" "unprognostic (2.30e-2)" "unprognostic (2.23e-5)" "unprognostic (4.59e-3)" "unprognostic (5.63e-2)" "unprognostic (5.07e-6)" "unprognostic (2.01e-1)" "unprognostic (1.03e-2)" "unprognostic (3.43e-2)" "unprognostic (1.77e-1)" "unprognostic (1.84e-3)" "unprognostic (8.02e-11)" "unprognostic (9.98e-3)" "unprognostic (1.50e-2)" "unprognostic (1.66e-1)" "unprognostic (1.75e-2)" 5.1 2.0 4.8 2.1 2.9 0.6 5.1 46.7 5.2 3.3 1.7 2.2 4.5 1.4 3.5 4.0 3.0 2.7 5.4 12.3 2.7 5.0 2.1 1.2 7.4 1.3 3.0 1.5 1.7 5.9 3.0 2.6 2.1 13.0 3.0 1.1 1.7 1.6 4.3 1.5 2.4 1.3 3.5 2.5 2.2 4.3 3.7 1.1 0.0 1.7 0.9 1.4 1.6 4.2 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.6 3.1 0.8 0.8 1.8 1.4 0.0 1.6 0.6 1.2 0.7 1.2 1.9 0.0 0.6 1.3 0.8 1.5 1.2 2.3 1.8 0.0 1.6 1.5 3.7 0.7 0.1 0.0 0.1 0.9 3.1 2.1 6.6 3.7 1.6 0.3 0.9 0.0 0.6 0.9 0.0 0.0 0.8 0.7 1.2 0.0 1.0 0.4 4.4 0.6 13.3 3.5 0.8 2.8 0.5 1.1 7.1 1.6 1.4 3.5 3.3 0.9 3.0 0.9 0.4 0.0 0.8 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.8 2.9 46.7 3.3 2.7 5.0 3.0 1.5 13.0 1.1 11.9 2.6 0.0 5.5 3.5 1.9 24.5 7.6 0.0 6.8 1.8 0.0 0.1 0.0 3.4 39.4 2.7 0.7 0.0 1.2 0.5 2.6 4.8 1.1 0.9 0.9 9.5 1.2 1.3 0.0 56.6 3.4 2.8 1.7 2.8 0.9 0.8 2.2 3.1 2.5 0.3 1.9 6.5 4.1 0.7 1.9 2.4 0.1 0.0 1.7 2.5 MPP5 "FLJ12615, PALS1" ENSG00000072415 "Membrane palmitoylated protein 5" Q8N3R9 14 67241109-67335819 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 54.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000993, HPA063890" Enhanced Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA000993: AB_1079407, HPA063890: AB_2732707" "unprognostic (3.65e-1)" "unprognostic (3.82e-3)" "unprognostic (4.56e-2)" "unprognostic (9.20e-2)" "unprognostic (9.86e-2)" "unprognostic (1.36e-1)" "prognostic unfavorable (5.62e-4)" "unprognostic (1.48e-1)" "unprognostic (1.02e-1)" "unprognostic (1.37e-1)" "unprognostic (1.93e-3)" "unprognostic (9.89e-3)" "prognostic favorable (1.71e-12)" "unprognostic (2.28e-1)" "unprognostic (1.82e-1)" "unprognostic (6.90e-2)" "unprognostic (6.87e-2)" 7.1 9.2 14.8 6.8 29.2 7.0 10.1 9.4 18.0 9.0 12.5 15.9 13.7 18.5 6.9 20.8 14.4 7.2 9.0 7.3 16.4 17.0 28.8 17.2 11.5 4.5 30.6 10.2 6.4 8.6 22.9 11.4 27.9 20.5 15.8 11.6 7.6 15.9 18.6 14.6 8.6 18.7 11.9 23.3 6.2 9.7 8.2 25.4 6.8 24.1 6.9 5.8 9.1 9.1 3.6 2.4 3.7 2.8 6.7 4.4 1.2 54.9 8.8 8.9 7.2 5.2 4.7 7.9 16.8 8.8 12.3 8.3 8.7 16.9 4.7 8.0 13.6 4.3 11.5 5.1 9.7 18.9 2.2 3.5 4.3 9.3 6.0 6.0 1.6 3.3 5.0 3.7 7.1 9.1 8.9 6.8 5.4 4.5 2.1 19.6 7.4 5.2 2.0 3.0 8.0 6.0 4.7 14.2 5.6 11.2 13.7 5.0 3.6 10.4 10.2 5.8 8.2 10.5 3.3 10.6 15.7 33.4 5.5 7.3 3.2 2.9 7.2 10.5 3.7 5.4 0.4 2.2 3.7 1.7 2.8 1.4 3.6 2.0 1.9 2.4 1.9 4.4 2.4 0.8 6.7 2.3 2.4 1.1 1.2 14.8 29.2 9.4 18.0 16.4 17.0 30.6 10.2 20.5 25.4 59.6 21.6 6.0 21.7 18.7 9.4 22.4 12.7 9.4 17.0 21.0 41.2 18.5 11.6 19.2 4.4 14.3 41.0 0.0 23.5 8.9 16.6 25.6 4.7 16.8 14.2 3.2 5.2 16.5 9.6 3.9 7.5 7.2 3.3 7.2 18.4 24.1 20.2 31.6 10.6 28.4 34.5 6.5 19.6 8.3 33.8 15.2 14.6 4.4 19.5 31.5 MPP7 FLJ32798 ENSG00000150054 "Membrane palmitoylated protein 7" Q5T2T1 10 28050993-28334486 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 33.2" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 55.2;Suprabasal keratinocytes: 53.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 11.0;CACO-2: 20.7;CAPAN-2: 12.9;T-47d: 41.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037597, HPA037598" Approved Supported "Nucleoplasm,Cell Junctions" NA NA "Cell Junctions" Nucleoplasm "HPA037597: AB_2675569, HPA037598: AB_10696941" "unprognostic (1.12e-1)" "unprognostic (1.24e-1)" "unprognostic (1.59e-3)" "unprognostic (1.49e-1)" "unprognostic (6.64e-2)" "unprognostic (7.78e-2)" "unprognostic (9.31e-3)" "prognostic favorable (5.88e-4)" "unprognostic (2.15e-1)" "unprognostic (1.70e-1)" "unprognostic (1.88e-1)" "unprognostic (2.26e-1)" "prognostic favorable (2.79e-14)" "unprognostic (2.46e-1)" "unprognostic (1.88e-1)" "unprognostic (4.66e-2)" "unprognostic (1.03e-2)" 1.9 1.2 1.9 3.2 1.9 2.6 3.7 3.2 3.0 2.3 6.3 1.9 1.9 1.8 1.9 3.7 16.3 4.6 2.0 2.0 1.9 0.6 4.9 1.9 3.7 4.6 1.9 1.9 1.9 11.3 1.8 7.8 4.2 2.2 2.8 3.5 2.6 5.0 1.9 4.7 11.2 3.3 3.0 1.9 2.4 5.9 33.2 1.9 1.9 5.7 1.9 3.0 3.4 5.4 0.7 8.1 9.0 8.2 4.9 9.2 5.3 2.6 0.0 0.2 0.0 0.0 0.0 11.0 0.5 0.4 2.2 3.5 20.7 12.9 0.0 0.1 1.5 1.6 4.8 1.8 3.4 5.2 0.0 3.5 0.0 0.6 1.2 0.0 0.0 0.0 0.1 5.5 0.3 0.2 0.0 0.0 1.0 0.5 0.0 2.9 4.9 1.0 0.0 0.6 4.0 1.0 0.5 6.2 0.0 0.2 8.7 0.5 0.0 1.1 5.3 0.0 1.8 41.8 0.5 0.0 0.8 6.0 0.0 0.4 0.1 0.0 0.0 0.0 4.9 0.0 0.0 8.2 9.0 4.3 2.7 6.3 0.7 4.7 2.9 8.1 0.6 9.2 6.4 3.3 4.9 1.4 0.1 1.1 5.3 1.9 1.9 3.2 3.0 1.9 0.6 1.9 1.9 2.2 1.9 41.7 38.7 0.0 9.3 20.5 1.2 9.0 12.7 16.0 23.9 14.0 15.7 38.9 8.3 3.5 55.2 2.8 10.9 0.0 10.9 2.0 2.1 11.1 1.1 2.6 4.7 3.2 6.4 1.8 5.6 13.5 0.9 2.5 6.8 0.0 8.9 22.1 7.6 7.0 0.4 7.3 7.0 0.0 4.7 2.5 9.3 53.3 38.9 8.7 10.7 12.8 MPPE1 PGAP5 ENSG00000154889 "Metallophosphoesterase 1" Q53F39 18 11882622-11909223 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, GPI-anchor biosynthesis, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 22.1;neutrophil: 66.2" "Lineage enriched" "Detected in all" 7 "granulocytes: 66.2" "Cell line enhanced" "Detected in all" "OE19: 34.0" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 10 "basal ganglia: 104.4" HPA012639 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA012639: AB_1854088" "unprognostic (9.23e-2)" "unprognostic (1.54e-1)" "unprognostic (1.38e-2)" "unprognostic (1.84e-1)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (4.51e-1)" "unprognostic (7.92e-3)" "prognostic unfavorable (1.35e-4)" "unprognostic (1.00e-2)" "unprognostic (4.46e-1)" "unprognostic (1.61e-1)" "prognostic favorable (6.45e-7)" "unprognostic (1.26e-1)" "unprognostic (1.38e-1)" "unprognostic (7.79e-2)" "unprognostic (6.15e-2)" 15.0 13.7 11.8 16.5 16.0 19.9 15.2 11.4 20.9 14.1 16.4 20.1 18.2 13.5 18.7 22.1 13.4 15.8 23.6 17.2 11.5 14.4 23.7 20.8 24.7 29.0 19.8 12.2 11.7 24.6 22.2 16.5 15.2 14.1 13.1 17.2 14.8 16.8 26.6 19.3 22.4 19.7 14.0 15.1 17.5 17.7 6.7 14.8 22.7 37.1 14.6 17.6 14.9 13.9 4.5 8.5 66.2 9.5 6.3 6.0 6.7 3.9 5.7 4.3 10.5 12.5 14.8 4.1 9.4 13.7 5.6 8.9 10.6 11.3 7.8 20.8 9.1 5.6 4.3 3.0 5.3 5.3 8.6 5.2 2.2 11.5 2.4 17.6 10.1 16.3 21.9 7.0 4.9 3.6 8.4 3.3 7.1 2.8 7.6 9.3 9.3 7.4 6.8 3.0 34.0 1.5 3.0 2.7 9.5 9.2 6.0 6.2 3.5 8.8 6.9 8.2 5.0 5.1 13.2 6.8 11.4 4.4 10.9 5.2 11.9 10.5 9.9 8.5 5.3 11.2 4.1 9.5 22.1 6.0 7.7 4.3 4.0 3.7 5.6 8.5 4.5 4.5 5.7 66.2 6.3 5.2 6.7 5.8 6.7 11.8 16.0 11.4 20.9 11.5 14.4 19.8 12.2 14.1 14.8 53.6 33.6 15.2 11.9 16.0 17.3 1.6 20.4 28.1 18.2 21.0 11.8 22.8 18.3 24.9 15.7 14.7 31.5 23.3 36.6 26.4 17.4 11.4 26.6 23.6 22.2 7.9 9.2 9.8 29.2 25.1 11.8 25.8 18.6 10.0 18.0 19.8 30.1 15.9 14.2 23.0 17.9 12.9 13.7 3.4 7.2 17.6 14.0 30.5 13.7 16.6 MRE11 "ATLD, MRE11A" ENSG00000020922 "MRE11 homolog, double strand break repair nuclease" P49959 11 94415578-94493908 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Meiosis" "Endonuclease, Exonuclease, Hydrolase, Nuclease" "Cancer-related genes, Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 26.8;Ciliated cells: 21.4;Cytotrophoblasts: 31.8;Syncytiotrophoblasts: 23.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002691, CAB004081" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004081: AB_2145100, HPA002691: AB_1079409" "unprognostic (5.59e-3)" "unprognostic (4.35e-2)" "unprognostic (8.55e-2)" "unprognostic (2.76e-2)" "unprognostic (9.82e-2)" "unprognostic (5.17e-2)" "prognostic unfavorable (7.14e-4)" "unprognostic (2.85e-1)" "unprognostic (1.03e-2)" "unprognostic (1.34e-1)" "unprognostic (8.66e-3)" "unprognostic (6.96e-3)" "unprognostic (1.57e-3)" "unprognostic (1.39e-1)" "unprognostic (1.77e-1)" "unprognostic (1.22e-1)" "unprognostic (8.06e-3)" 14.7 11.0 10.7 15.2 12.5 24.0 16.6 21.2 12.0 17.5 11.0 10.8 13.9 8.0 17.4 11.2 13.9 13.2 8.9 9.4 8.7 6.5 8.8 8.9 11.4 13.8 13.3 7.9 16.7 15.5 8.2 12.8 14.2 9.8 12.7 14.1 10.4 14.1 10.8 9.3 18.3 12.8 12.8 13.5 17.2 11.8 9.9 13.0 25.3 12.7 7.4 18.4 14.3 13.3 8.7 14.8 7.9 13.1 10.3 11.8 7.9 10.0 10.3 19.3 2.4 6.6 9.2 11.1 14.2 9.2 12.8 15.2 18.7 20.7 26.4 23.1 7.4 16.0 19.4 16.4 10.6 17.0 17.4 9.7 23.0 14.7 10.7 3.0 15.0 16.6 6.4 6.6 16.6 10.4 5.8 11.2 12.9 16.0 17.1 10.2 7.3 15.2 14.3 6.2 23.4 11.3 13.6 17.3 13.2 8.4 14.1 6.8 9.8 19.6 12.3 3.8 17.1 21.1 9.1 8.1 19.2 14.1 16.6 10.1 4.3 15.2 25.9 5.1 24.0 15.3 5.4 11.1 7.9 11.2 13.1 11.0 8.5 8.4 11.8 14.8 8.7 7.1 11.5 4.8 10.3 9.8 10.5 10.9 7.9 10.7 12.5 21.2 12.0 8.7 6.5 13.3 7.9 9.8 13.0 26.8 14.7 0.0 0.0 0.0 0.0 0.0 0.0 21.4 17.0 8.7 0.0 31.8 3.3 10.1 0.0 0.0 0.0 0.0 6.9 13.1 0.0 0.0 16.3 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 16.2 0.0 0.0 8.6 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 MRFAP1 "PAM14, PGR1" ENSG00000179010 "Morf4 family associated protein 1" Q9Y605 4 6640091-6642745 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB042447, HPA056367" Approved Supported Nucleoplasm No No Nucleoplasm "CAB042447: AB_2145271, HPA056367: AB_2683107" "unprognostic (1.28e-1)" "unprognostic (1.67e-1)" "unprognostic (3.82e-2)" "unprognostic (1.31e-2)" "unprognostic (7.03e-2)" "unprognostic (9.55e-2)" "unprognostic (1.14e-3)" "unprognostic (1.86e-3)" "unprognostic (1.30e-1)" "unprognostic (5.51e-2)" "unprognostic (7.78e-3)" "unprognostic (1.02e-1)" "prognostic favorable (2.90e-7)" "unprognostic (1.24e-1)" "unprognostic (9.93e-2)" "unprognostic (2.27e-1)" "unprognostic (1.79e-1)" 52.8 77.4 88.5 32.3 81.7 24.6 51.2 64.5 87.7 53.9 43.6 57.8 42.4 39.3 57.5 59.3 41.5 54.0 36.6 67.1 77.3 83.7 60.7 65.9 40.2 31.3 87.2 95.9 69.0 39.9 64.2 65.6 52.0 59.7 54.5 37.0 38.4 43.0 60.5 82.3 33.0 39.2 59.1 91.6 45.9 37.7 51.0 69.1 19.1 54.2 57.2 34.4 45.5 58.4 34.3 62.7 71.1 65.3 46.4 49.6 58.2 52.6 58.6 49.9 57.4 61.4 55.7 39.4 69.6 64.5 64.6 64.7 57.7 57.3 33.0 54.1 64.3 73.4 30.2 67.2 72.7 78.4 13.4 48.7 49.2 68.4 62.4 57.6 36.7 24.8 57.6 66.8 59.3 60.4 61.5 71.6 29.3 64.5 21.7 63.6 66.4 27.6 86.6 62.1 46.0 75.3 36.1 90.4 27.9 78.0 40.0 78.7 61.6 45.1 32.6 64.5 45.6 90.8 45.0 63.8 56.9 38.2 42.2 91.3 32.2 39.7 54.9 58.9 78.6 55.0 60.1 65.3 55.3 47.4 52.8 47.8 33.0 47.4 47.4 62.7 34.3 49.3 48.1 71.1 46.4 49.6 50.5 49.6 58.2 88.5 81.7 64.5 87.0 77.3 83.7 87.2 95.9 59.7 69.1 148.9 130.0 79.5 227.3 167.4 108.6 201.1 155.4 147.2 116.0 83.7 15.7 451.0 185.6 196.0 36.0 186.5 82.1 70.0 177.2 244.5 165.5 214.4 148.7 169.8 172.2 104.9 170.8 146.1 121.9 44.4 290.8 105.8 119.8 143.3 103.2 214.1 184.1 109.1 286.4 178.7 82.2 213.4 216.5 343.0 235.0 151.9 269.5 109.0 123.5 202.6 MRGBP "C20orf20, Eaf7, FLJ10914, MRG15BP" ENSG00000101189 "MRG domain binding protein" Q9NV56 20 62796453-62801738 "Plasma proteins, Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Activator, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 55.3" "Group enriched" "Detected in many" 8 "Early spermatids: 101.9;Late spermatids: 283.4;Spermatocytes: 115.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017012 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA017012: AB_1845679" "unprognostic (1.90e-1)" "unprognostic (1.60e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (2.33e-4)" "unprognostic (8.56e-2)" "unprognostic (1.80e-3)" "prognostic unfavorable (3.80e-6)" "unprognostic (2.02e-2)" "unprognostic (3.06e-1)" "unprognostic (1.45e-1)" "unprognostic (1.17e-1)" "unprognostic (8.79e-2)" "prognostic unfavorable (2.48e-6)" "unprognostic (1.36e-1)" "unprognostic (1.28e-1)" "unprognostic (2.25e-1)" "unprognostic (6.01e-3)" 5.7 6.7 6.3 6.1 6.6 6.6 5.8 7.8 9.1 5.4 7.7 6.8 4.4 9.2 5.7 4.6 6.2 5.2 5.4 8.9 5.6 5.3 6.5 9.4 5.6 8.0 6.5 5.5 10.5 10.6 5.9 6.6 8.4 5.1 5.7 4.9 6.5 8.4 7.3 8.5 6.3 9.7 8.4 4.0 8.5 6.7 55.3 6.0 8.3 6.2 6.2 6.1 6.6 7.5 1.7 2.0 2.8 3.7 0.6 3.8 1.2 14.3 9.1 7.5 11.5 4.1 6.3 7.3 8.3 10.8 32.5 14.2 32.4 11.5 13.2 16.7 6.4 16.1 12.2 8.5 14.1 18.4 4.1 7.3 9.6 9.8 18.6 6.5 11.2 18.2 5.4 10.4 8.8 9.4 6.9 7.7 12.8 13.0 7.3 8.1 21.8 21.1 21.3 6.3 15.1 16.5 19.0 14.3 9.8 4.9 5.9 10.6 8.6 11.9 10.7 15.0 4.3 13.1 16.4 7.9 20.3 21.2 13.7 17.6 9.8 6.0 15.7 20.0 11.2 11.3 0.0 2.2 2.8 2.0 3.7 2.7 1.5 2.5 2.7 1.5 1.7 1.9 3.8 2.4 0.6 1.5 2.0 2.7 1.2 6.3 6.6 7.8 9.1 5.6 5.3 6.5 5.5 5.1 6.0 0.0 2.1 8.2 13.4 13.1 10.5 8.1 7.6 1.4 3.4 12.2 7.9 9.6 16.6 19.6 101.9 10.3 9.8 0.0 19.2 21.5 10.4 13.1 1.1 12.7 12.6 12.7 2.4 7.4 8.4 283.4 11.2 12.2 6.8 14.4 10.2 10.6 18.6 7.0 7.4 13.8 12.6 0.0 8.9 115.6 17.2 11.4 12.2 10.9 11.8 16.5 MRI1 "MGC3207, MRDI, mtnA, Ypr118w" ENSG00000037757 "Methylthioribose-1-phosphate isomerase 1" Q9BV20 19 13764532-13774282 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042744, CAB045988" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" No No 2600000 "Nucleoplasm, Cytosol" "Nucleoli fibrillar center" "CAB045988: AB_2145566, HPA042744: AB_2678141" "unprognostic (1.16e-1)" "unprognostic (1.20e-1)" "unprognostic (2.14e-1)" "unprognostic (7.36e-2)" "unprognostic (4.14e-2)" "unprognostic (1.05e-1)" "unprognostic (3.24e-1)" "unprognostic (1.57e-2)" "unprognostic (4.27e-3)" "unprognostic (1.61e-1)" "unprognostic (8.98e-2)" "unprognostic (1.50e-3)" "unprognostic (1.75e-2)" "unprognostic (1.18e-2)" "unprognostic (1.67e-1)" "unprognostic (1.77e-1)" "unprognostic (1.28e-1)" 14.5 18.5 12.5 21.8 18.3 16.6 16.8 24.5 21.8 21.5 17.2 23.6 23.5 19.0 24.2 21.3 20.7 19.9 17.6 13.5 14.6 12.1 24.4 20.1 15.4 19.5 16.5 14.3 24.0 20.5 21.3 17.3 24.2 17.2 17.8 13.4 18.5 23.4 21.6 13.0 28.6 18.5 13.3 16.6 22.0 19.8 5.0 16.7 20.0 21.8 10.5 18.2 18.1 20.6 5.7 8.9 6.9 5.8 5.0 6.6 3.6 10.7 8.0 4.0 9.6 4.4 8.2 9.8 12.8 7.4 11.6 10.6 8.4 8.6 5.8 5.1 4.7 5.5 18.1 18.6 13.2 7.1 10.1 32.2 4.6 12.7 9.0 3.9 13.9 10.8 8.2 7.3 5.9 4.7 10.5 10.7 5.7 8.8 0.3 5.0 15.8 15.4 8.9 6.6 3.9 22.9 14.5 5.4 13.1 5.9 8.4 8.0 7.2 4.6 10.5 10.0 5.6 8.2 5.1 6.5 6.0 5.5 21.2 6.2 7.9 8.3 1.7 5.1 16.1 7.1 6.9 5.5 1.9 6.2 5.8 6.0 5.0 5.3 6.6 4.7 5.7 4.3 3.3 4.1 5.0 3.2 8.9 4.8 3.6 12.5 18.3 24.5 21.8 14.6 12.1 16.5 14.3 17.2 16.7 8.9 16.6 10.8 9.0 9.8 3.1 0.8 5.1 20.1 14.8 15.7 7.9 10.1 5.0 8.2 0.6 6.0 9.1 0.0 11.0 7.7 8.5 6.0 12.7 9.0 6.3 1.6 8.7 12.3 8.9 1.4 16.1 8.5 1.7 6.4 9.4 3.3 5.8 11.0 14.2 8.1 6.3 25.8 5.5 0.4 3.9 9.9 4.5 14.4 9.1 8.0 MROH1 "HEATR7A, KIAA1833" ENSG00000179832 "Maestro heat like repeat family member 1" Q8NDA8 8 144148016-144261940 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024287, HPA044465" Approved Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA024287: , HPA044465: AB_10960985" "unprognostic (1.25e-1)" "unprognostic (4.85e-2)" "unprognostic (1.38e-1)" "prognostic favorable (6.74e-4)" "unprognostic (2.97e-2)" "unprognostic (2.42e-2)" "unprognostic (2.46e-1)" "unprognostic (4.17e-1)" "unprognostic (1.17e-1)" "unprognostic (1.48e-2)" "unprognostic (6.64e-2)" "unprognostic (1.92e-1)" "prognostic favorable (3.65e-6)" "unprognostic (1.61e-3)" "unprognostic (1.97e-1)" "unprognostic (1.68e-1)" "unprognostic (1.48e-2)" 5.7 7.5 11.9 7.6 10.0 19.7 6.1 17.8 16.0 6.0 8.5 4.5 13.0 16.7 5.4 7.3 9.2 6.8 7.0 5.4 7.0 6.0 8.3 5.8 9.4 8.1 5.2 11.7 5.1 17.3 5.4 11.1 8.3 10.3 9.0 4.5 6.9 14.3 9.8 5.2 13.4 14.3 6.5 3.9 11.5 14.0 7.5 5.0 5.2 33.3 3.9 7.5 8.5 6.6 1.9 5.5 4.4 9.5 1.1 5.6 2.8 9.8 4.1 0.5 4.0 1.9 2.1 18.0 4.4 3.1 2.4 3.4 6.9 17.9 5.3 6.4 2.5 6.0 9.5 0.6 6.7 1.1 3.0 5.8 6.3 12.0 6.2 4.9 2.8 6.7 3.8 7.0 3.9 5.7 2.9 3.5 4.3 2.6 2.4 2.7 21.2 4.8 5.9 1.5 6.8 19.4 6.3 1.3 5.4 3.6 19.7 4.5 3.9 11.0 10.6 3.3 1.6 7.8 3.9 8.7 5.0 9.5 10.1 3.6 4.2 2.0 5.6 9.8 8.5 2.9 4.4 7.4 1.9 2.4 9.5 1.9 1.1 2.1 2.5 5.5 1.9 2.0 1.4 1.5 1.1 7.9 1.7 5.6 2.8 11.9 10.0 17.8 16.0 7.0 6.0 5.2 11.7 10.3 5.0 8.9 29.5 3.9 7.0 5.6 34.8 9.5 2.5 9.4 15.9 5.2 11.8 23.8 3.3 10.4 3.8 5.8 32.2 0.0 14.2 16.8 5.9 13.3 13.9 7.6 17.4 35.0 22.5 3.1 11.3 9.9 2.8 12.0 1.7 8.2 20.3 6.7 14.9 14.4 2.5 4.9 3.5 6.5 5.8 9.3 14.5 5.1 41.9 5.7 18.1 10.6 MROH6 C8orf73 ENSG00000204839 "Maestro heat like repeat family member 6" A6NGR9 8 143566187-143572971 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 10.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 1.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 11.8;HaCaT: 10.0;OE19: 10.2;SK-BR-3: 21.4;U-937: 12.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA068049 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA068049: AB_2685945" "unprognostic (2.10e-2)" "unprognostic (1.96e-2)" "unprognostic (1.07e-3)" "unprognostic (2.26e-3)" "unprognostic (8.04e-2)" "unprognostic (8.96e-2)" "unprognostic (2.28e-1)" "unprognostic (1.73e-1)" "unprognostic (5.97e-2)" "unprognostic (2.81e-2)" "unprognostic (1.09e-2)" "unprognostic (9.04e-2)" "unprognostic (1.05e-3)" "unprognostic (1.32e-1)" "unprognostic (1.44e-1)" "unprognostic (9.16e-3)" "unprognostic (1.18e-1)" 1.8 2.3 3.4 2.3 2.8 15.8 1.5 7.6 3.9 5.8 2.7 2.0 3.6 5.7 1.9 2.6 17.4 1.6 11.0 1.3 2.4 0.9 3.1 5.3 2.8 5.4 1.1 1.2 2.6 1.2 2.1 1.4 8.7 2.4 3.7 1.2 4.8 3.1 3.3 1.2 10.1 4.7 4.1 2.6 3.6 6.7 4.1 1.5 0.7 1.2 7.8 15.0 3.2 6.3 0.1 0.8 1.6 1.0 0.0 0.4 0.1 11.8 2.7 0.2 0.5 0.6 0.5 1.3 0.3 0.3 0.2 0.1 0.8 6.5 1.2 0.6 0.1 0.1 10.0 0.3 3.4 0.0 1.6 2.0 1.2 3.7 0.4 0.4 0.4 1.6 0.6 0.9 0.3 0.2 0.0 0.1 1.3 0.9 1.0 0.0 6.7 0.5 1.1 0.3 10.2 2.0 1.1 0.2 2.0 0.5 1.2 0.5 0.2 0.4 21.4 1.0 0.1 2.3 0.8 0.0 0.2 7.5 0.8 1.8 1.0 0.7 0.2 0.4 12.2 0.3 0.0 1.0 0.0 0.1 0.4 0.1 0.0 0.2 0.1 0.8 0.1 0.3 0.4 1.6 0.0 0.6 0.4 0.0 0.1 3.4 2.8 7.6 3.9 2.4 0.9 1.1 1.2 2.4 1.5 0.0 6.6 1.4 1.9 2.5 1.5 1.2 5.1 0.0 2.3 8.7 0.0 0.8 1.7 1.2 0.0 2.1 8.3 0.0 0.6 2.7 2.1 1.4 1.1 10.4 4.6 1.6 1.7 1.3 9.1 0.5 4.4 3.0 3.3 1.0 4.0 3.8 4.3 4.0 2.5 1.9 0.2 0.0 2.3 0.7 2.1 2.3 0.8 1.9 4.9 2.1 MROH8 "C20orf131, C20orf132, dJ621N11.3, dJ621N11.4" ENSG00000101353 "Maestro heat like repeat family member 8" Q9H579 20 37101226-37179588 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 33.7" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 27.0;Late spermatids: 25.0;Spermatocytes: 18.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" HPA060298 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA060298: AB_2684246" "unprognostic (1.16e-2)" "unprognostic (6.65e-3)" "unprognostic (5.88e-3)" "unprognostic (1.04e-2)" "unprognostic (2.17e-2)" "unprognostic (6.92e-2)" "unprognostic (3.31e-3)" "unprognostic (2.50e-4)" "unprognostic (1.98e-1)" "unprognostic (3.00e-2)" "unprognostic (1.11e-3)" "unprognostic (9.70e-3)" "unprognostic (5.00e-9)" "unprognostic (1.39e-1)" "unprognostic (1.01e-1)" "unprognostic (3.10e-2)" "unprognostic (1.62e-1)" 3.6 3.1 4.0 1.8 5.9 2.7 2.9 6.6 7.7 3.4 3.4 4.6 2.4 2.1 4.3 9.5 2.0 4.0 2.2 4.9 3.6 5.0 3.6 4.0 1.7 5.5 3.8 5.0 3.7 4.5 4.8 7.3 1.9 4.1 3.4 2.1 6.2 4.7 5.9 12.0 3.4 1.9 4.1 3.4 2.6 2.5 33.7 2.7 3.1 4.8 2.4 3.7 2.8 2.0 2.6 7.2 8.0 2.2 1.0 2.0 1.1 1.3 3.6 8.9 2.2 3.5 3.6 1.4 1.3 5.0 3.1 3.8 2.3 1.8 7.7 0.4 1.3 5.8 2.2 2.3 1.0 2.5 1.3 0.2 2.4 1.9 1.9 3.1 2.5 3.8 2.1 2.2 1.2 0.1 2.6 2.4 3.6 3.2 1.6 2.0 0.7 6.9 7.0 1.0 1.0 2.2 5.9 1.9 1.5 1.7 1.4 3.1 4.2 2.3 0.9 1.5 2.5 2.2 2.7 2.8 9.5 1.5 0.5 0.6 2.9 2.2 4.8 3.2 1.6 3.1 1.9 2.1 0.7 1.8 2.2 2.0 2.6 1.2 2.0 1.0 2.5 0.6 1.4 8.0 1.0 1.0 7.2 0.7 1.1 4.0 5.9 6.6 7.7 3.6 5.0 3.8 5.0 4.1 2.7 3.0 1.1 0.0 0.8 0.6 5.7 2.8 0.0 1.4 0.0 0.0 7.9 3.5 0.0 0.1 27.0 2.4 1.3 0.0 0.2 0.9 3.1 0.8 0.0 3.4 2.4 0.0 1.2 1.3 2.6 25.0 1.4 0.2 1.7 1.0 1.0 3.3 0.1 0.8 2.8 1.7 4.2 0.0 1.0 18.2 3.7 0.4 1.1 0.7 1.3 0.3 MRPL2 "CGI-22, MRP-L14, RPML14" ENSG00000112651 "Mitochondrial ribosomal protein L2" Q5T653 6 43054029-43059806 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007455, HPA064814" Approved Supported Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA Mitochondria Nucleoplasm "HPA007455: AB_1079410, HPA064814: AB_2685358" "unprognostic (2.31e-1)" "unprognostic (1.49e-2)" "unprognostic (3.06e-1)" "unprognostic (1.48e-2)" "unprognostic (3.34e-1)" "unprognostic (1.62e-2)" "unprognostic (1.99e-1)" "unprognostic (1.01e-1)" "unprognostic (3.17e-1)" "prognostic favorable (6.01e-4)" "unprognostic (3.07e-1)" "unprognostic (1.79e-1)" "unprognostic (3.24e-2)" "unprognostic (6.42e-2)" "unprognostic (2.33e-2)" "unprognostic (3.13e-1)" "unprognostic (2.78e-1)" 16.9 19.9 17.4 13.1 22.5 16.0 14.2 13.6 21.8 13.0 15.6 13.3 16.4 20.3 14.1 16.9 13.6 16.2 15.5 31.7 16.0 16.8 20.9 55.0 12.9 16.2 18.8 20.3 15.7 17.4 25.8 17.8 11.7 15.3 12.9 15.0 12.6 21.1 19.6 53.2 13.8 15.2 13.4 12.4 11.5 13.4 21.0 13.2 17.5 15.7 25.5 12.3 12.4 11.9 21.0 26.9 14.3 18.5 17.5 16.9 13.6 10.9 12.6 6.3 11.0 7.7 6.2 9.8 4.9 7.0 12.8 11.5 24.1 3.8 15.5 12.3 6.8 9.5 11.6 13.6 13.1 8.0 9.0 28.2 12.5 10.2 29.1 15.2 10.4 6.1 8.1 13.9 14.8 20.1 6.7 9.0 19.8 20.9 10.4 6.8 21.3 13.4 37.0 5.7 42.2 14.9 15.6 6.3 19.8 9.6 6.9 15.2 7.9 4.8 8.5 15.0 5.6 9.6 18.7 8.1 7.5 10.1 9.9 13.6 12.1 11.0 32.0 5.5 16.8 7.3 6.8 18.5 14.3 13.5 17.2 16.9 20.4 15.6 16.0 25.2 21.0 15.9 16.1 5.5 17.5 13.4 26.9 16.6 13.6 17.4 22.5 13.6 21.8 16.0 16.8 18.8 20.3 15.3 13.2 20.8 15.2 33.7 27.7 21.6 18.7 34.1 35.7 29.4 27.3 57.6 25.5 66.2 157.5 45.9 72.1 31.5 50.7 46.7 46.7 41.8 35.6 25.5 27.7 68.6 44.0 4.8 29.4 30.1 23.0 24.4 50.9 27.0 50.6 45.1 37.0 29.6 38.4 49.5 48.4 109.4 17.2 25.8 39.1 33.4 34.3 23.7 53.1 27.7 57.2 21.0 MRPL21 ENSG00000197345 "Mitochondrial ribosomal protein L21" Q7Z2W9 11 68891276-68903835 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051657 Approved Approved Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA "Nucleoplasm, Mitochondria" "HPA051657: AB_2681565" "unprognostic (1.80e-1)" "unprognostic (6.09e-2)" "unprognostic (4.80e-2)" "unprognostic (8.96e-3)" "unprognostic (9.25e-3)" "prognostic unfavorable (5.97e-4)" "unprognostic (3.23e-2)" "unprognostic (1.51e-1)" "unprognostic (1.09e-1)" "unprognostic (1.06e-1)" "unprognostic (4.84e-2)" "unprognostic (7.36e-2)" "unprognostic (1.26e-2)" "unprognostic (3.73e-2)" "unprognostic (1.72e-1)" "unprognostic (4.36e-2)" "unprognostic (3.12e-1)" 16.5 18.0 30.5 21.4 29.7 25.5 26.5 27.7 28.0 19.6 24.0 13.3 26.8 18.9 20.4 25.2 24.2 23.0 28.3 47.3 24.6 26.1 33.1 33.7 12.4 30.0 27.6 21.0 21.4 23.8 13.2 17.7 16.1 25.6 18.0 21.8 14.4 56.9 39.4 56.6 17.9 25.0 17.6 16.4 14.9 19.3 18.7 21.9 21.3 22.2 40.3 20.4 17.2 16.5 49.1 42.2 20.3 39.3 29.1 36.4 34.6 23.1 32.2 19.6 18.7 13.8 15.1 23.3 16.2 17.4 30.6 21.1 65.9 29.9 35.9 36.2 17.5 28.1 28.9 32.7 30.8 24.1 23.5 24.6 25.3 24.8 39.5 27.6 43.5 19.2 22.2 15.9 30.5 36.3 14.9 21.0 25.6 49.1 27.3 18.2 42.7 20.5 46.1 17.9 68.0 47.5 29.2 23.7 55.8 30.1 26.8 31.9 25.4 20.6 41.4 64.1 16.6 42.8 25.2 17.5 21.0 21.0 45.9 29.5 20.4 31.4 50.5 28.0 26.8 28.4 20.3 39.3 19.4 25.9 39.3 27.2 49.1 34.1 28.7 42.2 33.4 32.7 27.0 10.8 29.1 36.1 31.0 36.4 34.6 30.5 29.7 27.7 28.0 24.6 26.1 27.6 21.0 25.6 21.9 32.8 37.1 55.8 62.8 44.6 34.3 172.9 79.0 53.5 53.4 76.8 7.9 109.3 253.7 83.0 140.3 46.6 123.2 70.0 91.4 93.2 51.5 65.5 62.5 89.7 95.9 11.1 59.3 38.1 59.5 153.5 69.3 54.4 74.2 72.1 93.9 45.9 78.4 86.8 67.8 152.2 34.6 25.8 64.9 54.9 57.3 45.4 68.0 41.5 111.2 58.8 MRPL43 bMRP36a ENSG00000055950 "Mitochondrial ribosomal protein L43" Q8N983 10 100969458-100987515 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073022 Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA073022: " "unprognostic (2.65e-1)" "unprognostic (1.10e-2)" "unprognostic (2.01e-2)" "unprognostic (4.11e-3)" "unprognostic (6.07e-2)" "unprognostic (3.74e-1)" "unprognostic (1.97e-1)" "unprognostic (2.12e-1)" "unprognostic (1.84e-1)" "unprognostic (1.13e-1)" "unprognostic (1.33e-2)" "unprognostic (2.03e-1)" "unprognostic (6.04e-3)" "unprognostic (3.02e-1)" "unprognostic (3.53e-2)" "unprognostic (7.29e-2)" "unprognostic (2.53e-2)" 34.6 34.5 25.9 20.1 24.2 22.5 25.0 24.0 32.9 26.0 26.1 32.5 25.5 28.5 24.7 29.9 31.8 25.9 30.2 25.0 24.4 20.9 37.2 39.6 20.5 20.3 26.5 19.3 32.7 62.2 16.7 21.4 26.6 22.9 31.9 8.3 30.1 61.4 34.4 100.4 26.8 30.1 25.5 32.1 24.8 32.0 28.6 20.3 23.5 45.2 35.2 25.6 27.6 22.6 36.2 36.6 41.3 32.3 36.4 39.4 33.4 30.1 34.3 7.2 12.7 7.5 9.7 22.4 21.1 19.2 16.4 16.7 19.5 23.7 26.0 28.8 8.8 8.9 18.9 2.6 17.6 2.2 19.6 44.6 20.5 24.9 30.2 16.2 16.1 16.5 15.1 13.8 13.9 6.1 7.8 15.4 16.6 10.1 13.3 4.9 31.9 15.0 36.7 11.6 8.2 32.4 16.2 24.1 17.4 9.1 15.6 8.1 20.9 15.4 7.5 23.6 2.4 40.1 7.8 18.8 15.4 20.6 16.5 22.1 27.9 21.2 13.1 19.7 30.2 11.1 41.3 32.3 35.1 32.3 30.0 33.2 36.2 35.7 32.1 36.6 33.3 34.7 30.9 11.0 36.4 28.8 28.6 39.4 33.4 25.9 24.2 24.0 32.9 24.4 20.9 26.5 19.3 22.9 20.3 41.7 35.1 68.5 70.1 49.5 43.4 32.2 84.1 78.9 51.2 71.5 39.3 112.8 152.5 84.3 53.4 47.0 56.3 70.0 110.7 118.6 57.0 57.6 45.1 59.7 86.2 17.5 58.7 51.5 39.7 31.5 79.1 47.5 60.8 68.5 68.0 64.2 77.6 84.2 69.3 155.7 46.0 51.8 80.4 138.2 73.5 59.8 86.7 61.0 79.0 55.9 MRPL44 "FLJ12701, FLJ13990" ENSG00000135900 "Mitochondrial ribosomal protein L44" Q9H9J2 2 223957404-223967714 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, Ribosomal protein, RNA-binding" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038147, HPA038148" Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Mitochondria" NA NA Mitochondria "Nucleoplasm, Nuclear bodies, Plasma membrane" "HPA038147: AB_10671521, HPA038148: AB_2675863" "unprognostic (5.21e-2)" "unprognostic (3.48e-1)" "unprognostic (3.38e-2)" "unprognostic (3.00e-1)" "unprognostic (7.05e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (2.16e-2)" "unprognostic (3.32e-1)" "unprognostic (7.65e-2)" "unprognostic (8.33e-2)" "unprognostic (6.65e-2)" "prognostic favorable (2.02e-4)" "unprognostic (2.47e-2)" "unprognostic (1.14e-1)" "unprognostic (9.93e-2)" "unprognostic (2.49e-1)" 16.4 29.2 15.3 16.8 16.4 32.7 26.7 15.1 24.2 11.7 17.9 12.8 9.2 16.0 13.9 12.6 18.3 14.1 14.8 29.0 14.6 16.9 31.0 38.9 13.0 24.1 15.2 17.0 13.5 26.1 11.0 12.7 17.3 13.8 13.3 19.6 11.8 14.1 13.9 35.3 14.7 15.5 12.3 15.6 18.8 14.9 18.4 12.8 23.6 16.2 22.9 21.0 14.1 11.3 31.5 28.2 39.8 30.1 21.2 26.9 23.3 12.1 10.3 15.4 17.7 14.5 17.3 24.4 13.7 15.4 22.3 23.6 36.5 15.3 18.4 14.9 11.7 20.5 16.2 25.0 18.9 20.7 17.3 17.7 20.0 11.9 28.6 21.4 22.1 15.5 20.2 23.7 13.5 18.2 18.9 21.8 18.9 19.1 14.6 17.9 14.1 16.5 28.1 23.0 24.5 10.8 19.5 18.9 11.3 29.7 10.3 21.0 12.1 10.1 22.7 33.0 23.7 19.1 32.0 14.3 14.9 11.6 12.7 11.0 16.1 11.2 26.3 15.1 21.2 16.3 31.5 30.1 22.6 20.5 29.1 25.9 31.5 22.1 24.4 28.2 27.0 26.9 23.5 39.8 21.2 25.6 22.6 22.2 23.3 15.3 16.4 15.1 24.2 14.6 16.9 15.2 17.0 13.8 12.8 6.0 12.5 45.0 23.7 15.9 18.2 9.7 28.1 22.7 12.5 26.2 0.0 79.5 69.6 38.7 3.8 18.8 20.4 23.3 30.7 52.2 18.6 18.3 18.4 47.4 42.1 11.1 12.6 20.3 28.6 5.9 16.7 21.2 32.1 33.3 21.1 13.5 34.8 17.5 17.0 71.1 10.4 19.4 10.3 34.2 56.9 14.4 40.7 18.4 24.3 31.4 MRPL46 "C15orf4, LIECG2, P2ECSL" ENSG00000259494 "Mitochondrial ribosomal protein L46" Q9H2W6 15 88459476-88467419 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050166 Uncertain Supported "Nucleoplasm,Cell Junctions,Mitochondria" NA NA Mitochondria "Nucleoplasm, Cell Junctions" "HPA050166: AB_2681039" "unprognostic (1.42e-1)" "unprognostic (6.94e-3)" "unprognostic (1.02e-1)" "unprognostic (1.21e-2)" "unprognostic (3.28e-2)" "unprognostic (5.16e-2)" "unprognostic (6.22e-2)" "unprognostic (1.84e-1)" "unprognostic (1.79e-1)" "unprognostic (4.64e-3)" "unprognostic (7.78e-2)" "unprognostic (5.65e-2)" "prognostic favorable (2.09e-6)" "unprognostic (7.73e-2)" "unprognostic (9.18e-2)" "unprognostic (6.96e-3)" "unprognostic (1.63e-1)" 11.0 28.3 14.2 11.9 14.7 5.4 13.2 15.8 15.6 7.3 12.4 8.5 10.0 11.1 9.6 11.5 13.3 10.5 8.3 40.8 11.8 11.3 19.3 38.7 7.4 10.4 13.2 13.0 11.4 8.9 8.1 9.2 13.7 13.8 9.0 13.8 7.8 9.3 9.5 57.0 8.2 9.3 11.1 11.4 9.7 12.0 13.7 11.7 12.2 10.0 17.9 11.0 11.1 13.4 31.8 24.6 13.2 24.5 24.3 31.9 25.1 10.0 32.2 10.6 11.3 15.2 11.1 19.6 14.4 13.5 21.8 19.5 39.6 22.2 23.9 14.8 13.0 19.5 24.6 40.7 17.7 17.6 9.7 32.4 19.9 23.2 41.3 9.5 19.4 15.5 12.8 21.6 16.4 11.4 11.0 18.8 23.7 21.8 10.2 15.8 21.5 16.3 24.6 16.4 18.6 19.6 18.8 14.6 18.1 16.9 32.3 16.1 10.5 13.7 21.6 29.5 18.6 24.3 24.2 11.6 17.0 16.1 9.0 20.7 9.5 19.6 19.4 18.7 21.4 12.8 9.9 19.6 13.2 26.8 24.5 30.5 31.8 28.7 26.1 24.6 28.4 31.9 28.4 3.5 24.3 17.6 20.9 26.9 25.1 14.2 14.7 15.8 15.6 11.8 11.3 13.2 13.0 13.8 11.7 0.0 6.4 19.3 18.4 12.2 20.3 64.9 30.6 16.0 10.3 34.9 25.5 77.8 101.2 30.3 48.5 15.4 23.1 0.0 32.9 37.0 13.4 13.1 21.9 82.5 31.2 14.3 27.2 17.2 12.6 6.8 13.3 9.2 6.8 63.1 17.9 17.8 28.5 17.5 17.7 80.1 22.7 25.8 10.5 30.3 24.5 20.5 67.5 22.7 28.6 26.5 MRPL52 ENSG00000172590 "Mitochondrial ribosomal protein L52" Q86TS9 14 22829879-22835037 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012319 Approved Supported Nucleoplasm,Mitochondria Yes No Mitochondria Nucleoplasm "HPA012319: AB_1854118" "unprognostic (8.98e-2)" "unprognostic (9.07e-2)" "unprognostic (1.36e-1)" "unprognostic (3.18e-1)" "unprognostic (1.36e-1)" "unprognostic (4.74e-2)" "unprognostic (4.01e-3)" "unprognostic (1.29e-1)" "unprognostic (6.52e-2)" "unprognostic (8.05e-3)" "unprognostic (8.07e-2)" "unprognostic (2.87e-1)" "unprognostic (7.46e-2)" "unprognostic (2.19e-1)" "unprognostic (1.40e-1)" "unprognostic (3.16e-1)" "unprognostic (1.41e-1)" 24.3 29.4 31.8 31.8 36.8 27.8 54.5 18.8 34.7 22.7 35.5 13.5 31.4 43.7 21.3 23.5 37.5 20.8 39.2 73.7 28.3 31.0 34.1 41.9 36.9 55.9 35.5 27.8 17.2 58.5 21.6 20.7 20.9 40.1 22.4 22.4 12.7 41.6 43.0 79.5 24.3 35.1 22.9 37.0 27.6 39.9 30.6 24.0 27.8 27.4 38.4 25.2 15.6 31.6 43.9 50.6 25.4 39.0 21.9 30.7 29.7 43.9 34.6 18.9 23.4 11.8 13.9 46.1 30.7 22.2 27.5 26.2 42.4 61.7 33.5 33.9 21.1 28.0 40.1 15.5 42.5 20.7 35.4 25.5 24.9 13.8 96.1 35.9 39.1 35.9 20.8 29.4 35.6 30.4 21.8 43.6 42.7 25.5 33.4 20.1 61.7 31.6 59.5 34.8 54.8 76.5 39.2 23.6 39.5 28.7 26.3 18.9 24.4 23.8 23.3 32.6 14.1 22.4 37.5 33.5 28.8 33.7 36.0 46.5 33.1 39.0 40.8 26.2 26.9 45.9 25.4 36.0 18.0 25.4 39.0 23.2 43.9 27.9 22.9 50.6 37.7 26.4 25.3 6.1 21.9 28.7 41.9 30.7 29.7 31.8 36.8 18.8 34.7 28.3 31.0 35.5 27.8 40.1 24.0 68.5 78.6 124.3 65.2 107.6 20.6 96.4 201.2 95.0 89.9 129.1 17.7 163.2 235.4 222.3 47.9 83.9 246.5 93.5 272.5 246.5 72.7 86.6 121.1 226.4 208.7 19.1 132.6 105.6 152.4 44.5 51.8 104.0 118.1 247.9 188.7 49.5 303.7 207.0 46.3 360.5 27.7 64.7 84.5 124.7 106.0 130.4 105.4 86.1 183.5 87.8 MRPL58 "DS-1, ICT1" ENSG00000167862 "Mitochondrial ribosomal protein L58" Q14197 17 75012670-75021261 "Enzymes, Predicted intracellular proteins, Ribosomal proteins" "Protein biosynthesis" "Hydrolase, Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 56.1;Distal tubular cells: 48.0;Exocrine glandular cells: 52.2;Proximal tubular cells: 104.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003634 Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA003634: AB_1851388" "unprognostic (2.04e-1)" "unprognostic (1.57e-2)" "unprognostic (1.94e-3)" "unprognostic (7.12e-2)" "unprognostic (3.16e-2)" "unprognostic (4.35e-2)" "unprognostic (1.38e-3)" "unprognostic (1.52e-1)" "unprognostic (2.57e-1)" "unprognostic (3.79e-3)" "unprognostic (4.98e-2)" "unprognostic (2.43e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (1.10e-1)" "unprognostic (1.12e-1)" "unprognostic (2.66e-2)" "unprognostic (1.71e-1)" 12.4 23.4 13.9 18.4 14.8 13.7 17.6 18.1 15.7 10.6 15.2 9.8 17.5 13.1 12.5 15.1 19.4 12.5 16.3 31.2 12.2 12.0 25.7 41.7 10.2 15.2 14.3 14.0 10.5 24.2 13.5 9.1 13.9 14.0 13.6 16.3 10.1 17.7 22.5 57.3 16.5 13.4 14.8 12.9 14.6 15.1 7.6 14.0 13.2 14.8 31.2 15.7 14.3 11.6 18.3 28.9 11.2 22.0 20.0 33.5 20.9 26.1 36.9 12.3 14.1 13.3 13.2 17.2 15.5 16.9 32.4 27.6 28.3 16.5 18.2 12.8 15.4 20.0 18.7 25.2 26.7 34.3 9.3 29.9 14.3 17.5 23.5 25.1 29.8 9.8 14.2 12.8 21.5 34.5 11.0 24.6 18.9 23.0 13.3 18.3 32.7 25.7 20.5 9.3 40.8 50.0 13.3 21.9 26.5 23.8 19.4 11.5 22.0 13.4 24.5 30.1 16.5 32.8 24.6 10.4 17.5 19.2 18.4 29.2 13.9 11.0 20.1 20.0 33.4 14.4 11.2 22.0 10.5 17.3 20.7 14.9 18.3 21.1 17.2 28.9 14.8 15.7 17.6 2.0 20.0 17.4 19.4 33.5 20.9 13.9 14.8 18.1 15.7 12.2 12.0 14.3 14.0 14.0 14.0 29.8 8.3 0.0 0.0 0.0 0.0 0.0 0.0 38.8 14.8 24.4 0.0 56.1 48.0 41.8 0.0 0.0 0.0 0.0 52.2 30.7 0.0 0.0 1.1 0.0 42.2 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 26.2 0.0 0.0 44.8 0.0 0.0 104.5 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.0 0.0 MRPS26 "C20orf193, dJ534B8.3, MRP-S13, MRP-S26, RPMS13" ENSG00000125901 "Mitochondrial ribosomal protein S26" Q9BYN8 20 3045945-3048254 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045472, HPA054610" Supported Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA045472: AB_10962052, HPA054610: AB_2682541" "unprognostic (1.53e-1)" "unprognostic (2.18e-1)" "unprognostic (3.71e-1)" "unprognostic (4.41e-2)" "unprognostic (1.21e-1)" "unprognostic (1.68e-1)" "unprognostic (8.13e-3)" "unprognostic (3.14e-1)" "unprognostic (6.83e-2)" "unprognostic (8.21e-2)" "unprognostic (9.65e-3)" "unprognostic (2.14e-1)" "unprognostic (1.14e-2)" "unprognostic (3.77e-1)" "unprognostic (4.11e-2)" "unprognostic (2.95e-1)" "unprognostic (3.93e-3)" 20.2 30.4 27.1 14.4 29.2 13.4 20.9 25.9 31.7 19.2 19.8 15.3 32.3 22.5 18.1 30.6 19.6 24.4 21.2 25.8 24.4 28.2 28.8 39.6 14.7 15.4 24.6 27.0 28.9 43.4 21.0 28.1 16.4 20.0 31.0 16.4 15.2 32.3 27.9 37.1 22.3 20.1 27.8 19.0 16.2 22.1 13.3 20.7 12.3 28.9 23.0 16.9 18.4 19.2 36.5 28.4 10.3 24.4 29.2 30.8 23.0 26.8 36.2 8.2 14.9 9.0 6.8 21.5 10.5 7.1 12.1 9.3 31.6 12.4 26.7 13.4 5.4 16.0 25.5 16.2 21.7 7.1 6.8 34.6 12.2 13.1 52.4 12.5 19.2 6.0 7.7 16.9 10.0 15.2 8.5 8.9 16.1 19.6 6.3 7.2 23.2 19.8 33.8 40.5 20.5 35.8 22.0 14.2 28.5 11.8 18.0 25.8 33.5 12.1 40.5 24.3 8.5 18.2 10.9 8.4 7.9 12.6 14.2 19.4 28.7 36.9 16.2 5.1 16.1 8.8 7.6 21.4 10.3 24.0 24.4 30.0 36.5 26.6 25.6 28.4 34.9 30.8 26.4 1.7 29.2 19.0 17.2 20.6 23.0 27.1 29.2 25.9 31.7 24.4 28.2 24.6 27.0 20.0 20.7 14.9 23.2 55.8 62.3 72.8 37.0 58.1 63.7 30.8 29.6 52.4 33.4 157.2 177.4 69.1 3.0 39.5 65.6 46.7 47.8 88.9 56.4 71.2 13.9 99.1 71.1 44.5 52.9 30.7 23.5 7.5 63.9 31.3 64.1 32.5 77.7 64.3 51.7 49.1 58.0 189.5 37.6 58.2 67.0 32.2 73.4 80.7 65.7 38.5 105.3 45.7 MRTO4 "C1orf33, dJ657E11.4, MRT4" ENSG00000053372 "MRT4 homolog, ribosome maturation factor" Q9UKD2 1 19251539-19260128 "Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026446 Approved Approved "Nucleoplasm,Nuclear membrane,Nucleoli" Yes No "Nucleoplasm, Nuclear membrane" Nucleoli "HPA026446: AB_10601441" "unprognostic (3.99e-1)" "unprognostic (1.75e-1)" "unprognostic (2.18e-2)" "unprognostic (2.94e-1)" "unprognostic (4.12e-1)" "unprognostic (4.22e-2)" "prognostic unfavorable (1.56e-8)" "unprognostic (7.46e-2)" "unprognostic (5.58e-2)" "unprognostic (2.61e-2)" "unprognostic (2.69e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (4.11e-8)" "unprognostic (5.87e-2)" "unprognostic (1.16e-1)" "unprognostic (2.50e-1)" "unprognostic (3.23e-2)" 17.2 16.5 20.4 16.9 18.5 12.0 21.6 10.7 21.7 12.1 13.8 12.4 10.2 17.5 15.6 15.2 21.6 18.8 11.8 11.7 19.1 15.9 13.6 23.7 10.5 23.0 16.1 19.1 18.7 41.2 10.2 8.8 12.5 15.1 12.2 17.6 10.6 13.2 11.9 22.8 15.3 19.3 17.3 10.0 14.5 13.7 21.6 11.6 14.5 12.9 29.3 22.7 11.4 12.4 14.7 12.8 1.0 8.2 10.6 15.7 7.2 24.3 17.3 14.4 18.8 7.0 11.2 12.7 19.1 10.8 32.7 21.6 24.9 25.3 36.0 16.0 15.8 14.3 19.4 39.7 28.8 33.0 12.8 30.3 26.6 15.5 21.4 8.8 35.1 11.2 9.8 19.1 36.9 19.2 8.7 18.3 16.4 40.2 11.6 19.3 17.8 28.5 25.4 18.4 25.6 26.4 26.8 17.5 27.8 17.8 8.3 23.1 17.0 14.6 20.1 20.1 10.7 14.3 20.7 12.0 17.9 22.2 27.4 32.4 9.5 16.5 47.4 17.4 45.1 28.5 0.7 7.5 0.7 7.9 8.2 15.7 14.7 9.6 10.8 11.4 13.1 13.0 11.6 1.0 10.6 6.2 12.8 6.7 7.2 20.4 18.5 10.7 21.7 19.1 15.9 16.1 19.1 15.1 11.6 6.0 12.6 26.1 38.7 33.2 19.2 9.0 35.7 17.4 23.9 7.0 9.8 42.2 34.9 44.9 14.5 23.3 5.4 0.0 47.2 51.2 28.2 15.4 25.4 14.4 42.9 14.3 20.7 11.6 12.1 27.6 21.3 21.7 18.6 39.7 19.8 19.2 44.4 14.0 19.1 30.1 13.8 19.4 28.8 37.0 43.7 29.4 21.7 14.6 31.2 31.2 MS4A14 "DKFZp434H092, FLJ32856, MS4A16, NYD-SP21" ENSG00000166928 "Membrane spanning 4-domains A14" Q96JA4 11 60378530-60417756 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 79.3;testis: 53.6" "Group enriched" "Detected in some" 41 "Early spermatids: 207.0;Late spermatids: 514.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 6.8;non-classical monocyte: 9.2" "Lineage enriched" "Detected in many" 5 "monocytes: 9.2" "Cell line enriched" "Detected in single" 24 "THP-1: 14.6" HPA058973 Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA058973: " "unprognostic (1.78e-1)" "unprognostic (1.76e-1)" "unprognostic (5.75e-2)" "unprognostic (1.77e-1)" "unprognostic (1.27e-1)" "unprognostic (1.79e-2)" "unprognostic (1.24e-1)" "unprognostic (3.45e-2)" "unprognostic (4.00e-2)" "unprognostic (1.05e-1)" "unprognostic (1.77e-1)" "unprognostic (2.14e-1)" "unprognostic (4.50e-6)" "unprognostic (3.73e-2)" "unprognostic (7.16e-3)" "unprognostic (8.40e-2)" "unprognostic (7.11e-2)" 14.5 4.4 2.0 4.6 2.3 1.5 5.4 0.8 1.5 2.4 3.9 1.9 1.1 1.5 1.9 6.4 1.8 1.3 2.3 6.4 2.5 2.3 3.5 13.3 18.0 11.3 2.4 0.1 1.3 1.5 1.2 3.2 6.0 2.4 3.0 2.2 4.5 2.1 1.6 1.3 1.3 4.0 2.4 5.5 79.3 1.5 53.6 1.5 3.7 1.7 0.7 3.0 2.4 1.7 0.5 1.8 0.1 9.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 4.3 0.0 0.0 6.8 0.0 0.0 0.0 0.0 1.8 0.5 0.0 0.0 0.1 0.0 9.2 0.0 0.0 0.9 2.0 2.3 0.8 1.5 2.5 2.3 2.4 0.1 2.4 1.5 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 207.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 7.5 514.6 3.7 8.8 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 6.5 0.0 5.7 2.4 0.3 0.1 0.0 0.0 0.0 MSANTD2 "C11orf61, FLJ23342" ENSG00000120458 "Myb/SANT DNA binding domain containing 2" Q6P1R3 11 124766498-124800673 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038694, HPA038695" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA038694: AB_2676155, HPA038695: AB_10674693" "unprognostic (2.20e-1)" "unprognostic (1.86e-1)" "unprognostic (7.06e-2)" "unprognostic (2.31e-1)" "unprognostic (2.06e-1)" "unprognostic (6.19e-2)" "unprognostic (7.77e-4)" "unprognostic (4.77e-3)" "unprognostic (3.32e-2)" "unprognostic (3.91e-1)" "unprognostic (1.14e-1)" "unprognostic (2.60e-3)" "prognostic unfavorable (2.50e-4)" "unprognostic (5.67e-2)" "unprognostic (1.64e-1)" "unprognostic (1.85e-1)" "prognostic favorable (2.65e-4)" 12.4 7.3 12.4 11.8 20.3 2.7 13.0 20.8 12.8 13.8 9.4 14.8 14.1 7.7 15.7 17.8 7.7 11.7 10.0 6.4 9.2 7.3 12.8 7.8 9.2 10.4 16.4 7.6 15.8 13.9 12.1 19.9 12.9 12.3 13.3 9.7 8.6 11.0 12.1 7.7 17.5 9.7 9.4 9.2 13.6 10.7 6.2 19.6 8.6 26.2 5.2 10.1 7.7 17.0 2.4 1.3 1.6 1.9 0.5 4.4 1.0 2.9 1.9 15.8 11.4 7.5 9.8 6.4 6.5 7.0 4.6 6.0 6.4 6.7 3.9 6.1 4.7 4.9 5.9 7.3 3.9 7.7 5.5 4.2 3.5 3.7 5.5 4.6 2.8 2.9 4.4 4.3 5.9 5.4 9.9 8.4 3.9 4.0 6.0 7.0 3.3 1.7 9.4 10.0 7.2 14.9 4.5 4.4 3.1 6.3 3.1 4.4 12.9 3.5 5.5 2.7 11.3 9.0 2.9 7.2 17.3 4.4 4.8 6.8 2.9 2.0 2.9 3.5 3.8 9.5 0.0 1.2 1.6 2.2 1.9 1.1 1.5 2.3 3.3 1.3 2.4 2.4 2.0 0.0 0.5 1.9 1.2 4.4 1.0 12.4 20.3 20.8 12.8 9.2 7.3 16.4 7.6 12.3 19.6 3.0 10.1 3.4 4.2 7.8 7.9 2.7 2.5 2.7 1.2 7.0 2.0 2.6 3.3 4.0 3.5 8.4 1.6 0.0 0.9 3.8 8.5 4.2 1.1 2.6 2.5 12.7 1.2 8.6 3.8 1.1 8.9 4.0 1.7 1.0 2.9 6.7 4.3 4.0 6.7 3.3 5.6 12.9 8.5 1.4 1.1 3.6 1.6 4.4 4.1 2.8 MSANTD3 "C9orf30, MGC17337" ENSG00000066697 "Myb/SANT DNA binding domain containing 3" Q96H12 9 100427156-100451711 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "monocytes: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062662 Approved Nucleoplasm NA NA Nucleoplasm "HPA062662: AB_2684826" "unprognostic (1.58e-1)" "unprognostic (1.96e-1)" "unprognostic (5.51e-2)" "unprognostic (1.51e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (6.66e-5)" "prognostic unfavorable (3.23e-6)" "prognostic unfavorable (3.56e-4)" "unprognostic (1.51e-1)" "unprognostic (2.61e-3)" "unprognostic (5.52e-2)" "unprognostic (3.38e-1)" "prognostic unfavorable (3.22e-7)" "unprognostic (1.95e-1)" "unprognostic (1.18e-1)" "unprognostic (2.28e-1)" "unprognostic (2.16e-2)" 11.4 12.5 17.0 16.8 17.5 14.7 21.2 22.7 22.6 15.1 13.2 15.8 5.5 8.8 16.4 12.2 12.6 8.6 19.3 21.5 16.9 14.9 13.0 15.1 15.5 9.3 19.6 18.2 11.1 15.0 10.4 11.3 16.7 20.1 11.6 10.1 9.7 10.9 14.9 21.5 10.9 7.9 20.4 17.6 7.2 11.6 7.8 14.5 5.4 18.2 11.6 11.0 17.3 13.0 3.7 1.5 9.0 0.6 5.7 6.2 2.7 14.9 13.6 9.9 9.7 15.5 18.2 11.2 21.7 24.5 21.3 16.0 8.5 14.1 9.0 11.1 21.3 47.7 17.1 6.7 22.8 25.1 13.2 4.6 4.2 10.9 7.1 16.2 6.0 5.3 8.0 9.8 19.1 37.8 20.1 24.3 7.7 7.5 3.4 31.5 10.7 8.0 4.4 14.6 16.3 23.6 9.5 26.1 2.7 22.0 4.2 11.7 14.6 7.8 6.9 18.5 12.0 2.9 6.8 26.4 27.5 34.8 21.4 32.3 4.9 9.1 4.1 38.4 4.1 20.7 9.0 0.6 3.3 4.2 0.3 6.2 3.6 3.6 5.0 1.5 3.7 4.4 4.0 0.5 5.7 0.2 0.8 2.9 2.7 17.0 17.5 22.7 22.6 16.9 14.9 19.6 18.2 20.1 14.5 14.9 3.4 1.4 7.5 5.3 16.0 13.3 10.2 9.4 9.1 7.0 2.0 28.2 26.6 24.5 1.5 10.5 1.3 0.0 21.1 11.6 8.9 7.2 3.5 8.3 9.9 19.1 9.2 8.0 1.6 3.0 6.9 6.6 6.8 39.7 4.4 6.3 36.9 5.7 8.1 5.3 7.9 6.5 8.2 2.3 11.7 3.8 9.0 6.9 5.8 4.3 MSANTD4 KIAA1826 ENSG00000170903 "Myb/SANT DNA binding domain containing 4 with coiled-coils" Q8NCY6 11 105995623-106022403 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Muller glia cells: 124.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014411 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA014411: AB_2668995" "prognostic unfavorable (4.95e-4)" "unprognostic (1.64e-1)" "unprognostic (1.74e-1)" "unprognostic (1.30e-1)" "unprognostic (7.04e-3)" "unprognostic (8.21e-3)" "unprognostic (1.41e-2)" "unprognostic (2.13e-2)" "unprognostic (8.84e-3)" "unprognostic (1.09e-1)" "unprognostic (3.14e-2)" "unprognostic (1.83e-1)" "prognostic favorable (1.26e-5)" "unprognostic (2.30e-1)" "unprognostic (1.73e-1)" "unprognostic (2.78e-2)" "unprognostic (2.90e-1)" 8.5 11.3 15.4 8.5 16.5 2.9 9.0 21.6 20.7 13.8 8.6 12.6 6.0 5.4 12.8 7.7 9.6 8.3 7.7 17.0 19.2 14.2 10.6 7.4 9.0 9.6 17.1 18.2 12.4 10.2 12.1 20.6 7.7 15.9 10.9 6.9 7.8 7.3 13.9 14.6 4.8 6.9 11.6 13.1 8.5 7.5 10.6 17.9 7.2 14.7 6.0 10.4 10.9 9.0 8.9 8.5 3.6 10.0 9.2 11.8 6.1 4.3 6.5 14.6 0.1 16.0 17.7 0.1 12.5 17.2 9.8 12.6 11.3 8.6 9.6 21.2 10.5 10.8 11.3 16.3 8.0 12.2 17.5 7.9 18.8 7.6 6.9 24.1 14.6 14.9 11.9 9.9 13.2 26.3 12.2 8.7 10.4 8.7 6.2 14.3 1.8 13.9 7.3 5.6 6.5 13.3 9.3 19.0 13.7 13.5 5.4 9.7 18.6 3.3 11.4 9.1 9.5 9.0 7.5 12.4 14.5 11.4 7.5 12.5 6.2 7.1 4.9 6.7 5.8 10.5 2.8 6.9 3.6 10.7 10.0 10.5 8.3 10.0 7.7 8.5 8.9 11.8 10.1 1.7 9.2 5.9 7.3 7.1 6.1 15.4 16.5 21.6 20.7 19.2 14.2 17.1 18.2 15.9 17.9 14.9 12.5 2.2 2.9 4.7 41.7 20.2 15.3 10.7 22.7 3.5 19.6 1.4 1.7 5.8 26.9 8.3 1.7 0.0 5.1 1.2 8.5 1.1 5.8 5.7 4.5 35.0 8.1 6.2 6.9 11.1 13.0 7.1 11.8 6.4 2.7 124.6 5.9 0.0 9.2 7.3 19.5 0.0 6.3 9.1 5.6 5.1 0.2 5.0 2.9 1.4 MSC "ABF-1, bHLHa22" ENSG00000178860 Musculin O60682 8 71841549-71844468 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 56.3" "Cell type enhanced" "Detected in many" 12 "Exocrine glandular cells: 35.3;Leydig cells: 39.4;monocytes: 88.4;Peritubular cells: 38.9;Smooth muscle cells: 40.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory CD8 T-cell: 18.5" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 14 "HDLM-2: 132.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA062878 Supported Nucleoplasm NA NA Nucleoplasm "HPA062878: AB_2684891" "unprognostic (2.58e-2)" "unprognostic (1.62e-1)" "unprognostic (1.86e-1)" "unprognostic (1.35e-3)" "prognostic unfavorable (5.21e-4)" "unprognostic (3.70e-2)" "prognostic unfavorable (4.83e-5)" "unprognostic (3.95e-2)" "unprognostic (7.92e-2)" "unprognostic (3.75e-2)" "unprognostic (3.73e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (1.07e-13)" "unprognostic (1.65e-2)" "unprognostic (1.45e-1)" "unprognostic (7.48e-2)" "unprognostic (1.40e-2)" 9.9 7.6 2.0 10.1 1.3 2.8 56.3 0.6 4.4 4.8 1.6 0.8 0.4 1.9 4.8 2.9 3.3 3.4 10.5 16.3 5.5 0.2 5.2 3.0 6.6 14.1 0.8 1.2 7.3 4.7 0.0 2.6 15.1 1.9 4.8 0.9 15.9 3.7 3.1 2.6 3.0 3.8 3.8 0.9 5.6 3.8 3.1 0.6 1.8 3.6 3.4 4.8 10.3 6.5 5.0 4.3 0.1 0.2 0.0 18.5 2.1 0.0 1.0 0.0 0.0 4.8 0.8 0.0 0.2 3.9 0.1 0.2 0.0 0.0 0.0 0.0 0.7 4.8 0.2 0.0 0.2 0.0 132.2 0.0 0.0 0.0 0.0 8.6 0.0 0.4 1.9 0.0 8.3 5.1 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.1 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 7.2 0.0 0.0 0.9 0.0 0.0 0.0 1.3 0.0 0.8 0.0 0.0 3.5 0.0 5.7 0.0 0.0 0.0 3.9 0.0 5.2 5.0 6.8 18.5 0.1 2.8 0.1 6.4 0.1 0.0 0.2 4.3 8.6 2.1 2.0 1.3 0.6 4.4 5.5 0.2 0.8 1.2 1.9 0.6 0.0 0.0 1.5 0.1 4.5 0.0 1.6 0.0 0.0 0.0 1.8 0.0 0.1 0.0 14.0 0.3 2.2 0.0 0.0 35.3 0.1 17.8 0.4 0.0 0.0 1.9 0.0 0.0 1.8 0.8 0.6 39.4 3.8 25.3 88.4 0.0 0.0 22.7 0.0 38.9 0.8 0.0 25.8 40.6 0.2 0.2 2.9 0.0 5.0 0.0 0.2 MSH2 "COCA1, HNPCC, HNPCC1" ENSG00000095002 "MutS homolog 2" P43246 2 47402969-47663146 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 59.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009572, HPA066845, CAB070867" Approved Supported Nucleoplasm,Vesicles NA Yes Nucleoplasm Vesicles "CAB009572: AB_2144828, CAB070867: , HPA066845: AB_2732752" "unprognostic (2.35e-1)" "unprognostic (1.54e-2)" "unprognostic (2.89e-3)" "prognostic unfavorable (4.44e-4)" "unprognostic (2.23e-1)" "unprognostic (6.31e-3)" "prognostic unfavorable (1.72e-9)" "unprognostic (1.77e-1)" "unprognostic (7.09e-3)" "unprognostic (8.57e-2)" "prognostic unfavorable (4.63e-4)" "unprognostic (5.38e-2)" "unprognostic (3.29e-3)" "unprognostic (1.20e-3)" "unprognostic (5.74e-1)" "unprognostic (8.46e-2)" "unprognostic (1.48e-1)" 7.3 9.8 14.2 12.2 25.5 11.4 14.1 22.6 18.1 9.4 11.6 7.6 5.6 6.5 10.5 13.3 10.8 11.1 4.9 8.4 13.0 14.0 7.3 5.5 7.1 19.7 12.5 17.0 7.9 8.4 15.3 9.1 9.9 18.5 7.9 13.8 12.3 9.4 7.3 6.7 10.3 8.0 7.8 13.8 9.4 6.7 13.4 13.5 37.0 13.9 6.6 21.4 8.5 7.6 7.4 2.9 3.9 4.2 12.2 12.6 6.2 28.3 9.7 26.5 14.3 2.0 5.6 16.1 16.9 8.4 21.0 20.3 18.2 12.3 34.9 22.8 5.9 14.8 12.1 19.8 9.6 31.7 18.0 14.8 25.1 11.2 16.5 2.0 24.5 8.8 3.1 2.8 17.8 4.8 4.7 11.5 0.8 41.8 8.1 16.0 11.3 28.4 18.5 49.9 17.2 11.5 38.1 47.4 20.4 9.1 15.0 22.0 23.9 14.9 11.6 11.9 22.3 11.6 9.6 4.6 13.9 18.3 14.4 18.8 5.2 18.5 48.9 8.5 18.1 8.6 2.8 1.0 3.9 7.9 4.2 8.6 6.3 7.4 9.5 2.3 7.4 12.6 11.9 0.7 12.2 3.2 2.9 10.1 6.2 14.2 25.5 22.6 18.1 13.0 14.0 12.5 17.0 18.5 13.5 8.9 11.5 13.7 5.7 7.3 16.8 13.8 5.1 25.4 13.6 8.7 43.2 14.2 3.3 9.6 13.1 11.7 4.6 23.3 7.3 16.3 8.7 3.4 11.5 1.0 9.6 11.1 3.4 3.7 4.0 17.6 4.9 4.0 8.5 6.4 9.1 20.0 6.0 5.8 6.0 3.5 38.3 0.0 5.5 34.2 59.5 5.6 4.2 8.7 9.8 2.7 MSH6 GTBP ENSG00000116062 "MutS homolog 6" P52701 2 47695530-47810101 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" DNA-binding "Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009091, HPA028376, HPA028446, CAB070870" Enhanced Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA Yes Nucleoplasm "Golgi apparatus, Vesicles" "CAB009091: AB_670083, CAB070870: AB_2144959, HPA028376: AB_10598909, HPA028446: AB_10602182" "unprognostic (5.10e-2)" "unprognostic (5.87e-3)" "unprognostic (3.29e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (1.98e-1)" "unprognostic (3.09e-2)" "prognostic unfavorable (7.86e-4)" "unprognostic (1.79e-1)" "unprognostic (2.35e-3)" "unprognostic (1.01e-1)" "unprognostic (1.74e-3)" "unprognostic (8.99e-2)" "prognostic unfavorable (1.06e-7)" "unprognostic (1.22e-1)" "unprognostic (2.31e-1)" "unprognostic (9.68e-2)" "unprognostic (3.48e-2)" 13.0 20.5 9.7 13.1 18.8 13.6 13.0 20.5 13.1 17.9 13.3 17.6 10.7 6.1 28.2 11.0 12.4 18.3 8.4 8.6 11.4 8.8 9.5 14.6 11.0 21.7 23.9 9.6 43.2 27.6 16.2 17.3 14.9 15.0 14.6 10.3 8.7 12.0 13.2 10.4 10.3 10.5 22.1 14.9 11.6 11.1 25.1 22.0 40.4 13.4 10.4 25.8 14.2 16.4 8.4 8.4 7.6 9.8 9.7 15.1 5.7 27.5 20.6 38.3 9.1 11.6 12.2 17.3 15.3 13.5 15.9 16.7 15.1 9.6 45.5 23.0 16.6 21.9 11.6 34.5 19.5 20.8 19.8 17.2 29.1 16.3 15.3 7.1 29.2 10.7 9.9 6.2 16.2 10.8 14.9 9.9 1.1 25.3 16.7 15.5 19.9 31.1 13.8 33.6 18.6 9.5 73.8 50.2 20.5 9.7 17.9 21.5 23.3 21.3 10.2 9.3 35.1 12.2 10.3 6.0 18.5 22.6 14.0 19.8 15.7 21.2 76.2 15.6 18.7 11.3 7.6 5.8 4.9 8.4 9.8 10.4 8.4 9.5 8.3 8.4 8.1 15.1 7.6 3.9 9.7 9.3 4.2 9.5 5.7 9.7 18.8 20.5 13.1 11.4 8.8 23.9 9.6 15.0 22.0 26.8 18.4 9.7 20.1 22.3 26.4 6.9 0.0 28.1 31.8 7.0 33.4 24.9 3.3 12.8 25.7 15.3 2.6 0.0 8.4 16.9 17.4 11.4 17.3 8.5 11.1 14.3 4.6 12.3 5.1 11.5 23.6 12.1 3.3 7.2 7.9 27.0 8.8 3.5 21.2 5.3 29.7 6.5 17.2 40.0 40.2 15.3 8.0 13.3 9.3 10.7 MSI1 ENSG00000135097 "Musashi RNA binding protein 1" O43347 12 120341330-120369180 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 27.3;skeletal muscle: 23.2" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 51.1;Early spermatids: 46.0;Late spermatids: 40.7;Muller glia cells: 68.3;Rod photoreceptor cells: 92.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 43.8;HAP1: 20.0;NTERA-2: 22.8;SCLC-21H: 32.5;SH-SY5Y: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA074923, HPA075573" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA074923: , HPA075573: " "unprognostic (1.21e-1)" "unprognostic (3.46e-3)" "unprognostic (1.85e-1)" "unprognostic (1.09e-1)" "unprognostic (3.89e-1)" "unprognostic (3.18e-2)" "unprognostic (1.20e-1)" "unprognostic (1.46e-1)" "unprognostic (1.90e-2)" "unprognostic (2.75e-2)" "prognostic favorable (5.99e-4)" "unprognostic (3.66e-1)" "unprognostic (1.46e-3)" "unprognostic (7.61e-2)" "unprognostic (7.35e-2)" "unprognostic (2.70e-2)" "unprognostic (1.19e-1)" 0.8 6.8 8.7 0.6 7.4 0.4 1.2 3.9 14.2 1.9 1.5 8.6 2.2 7.8 4.3 2.7 1.5 3.1 1.4 4.0 11.3 5.9 0.7 1.0 1.0 0.6 4.7 6.1 2.9 7.3 1.3 12.8 1.4 4.6 4.5 1.5 27.3 1.3 2.5 23.2 0.5 5.2 2.2 4.7 0.7 3.1 12.5 5.4 0.0 1.3 0.0 0.4 0.9 0.9 0.1 0.4 0.6 0.2 0.2 0.3 0.0 0.0 0.5 43.8 11.1 0.0 0.0 5.6 0.0 0.0 0.3 0.5 7.7 0.2 0.0 0.6 0.0 0.2 0.1 20.0 0.0 0.1 0.2 4.5 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.0 0.1 22.8 0.2 0.2 0.1 0.0 0.1 0.0 0.0 32.5 15.8 0.0 0.3 0.3 4.4 6.7 0.0 0.0 0.1 6.0 0.0 0.0 0.5 0.1 0.0 0.1 0.1 0.4 0.3 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.3 0.1 0.6 0.2 0.2 0.4 0.1 0.0 8.7 7.4 3.9 7.2 11.3 5.9 4.7 6.1 4.6 5.4 0.0 0.0 0.0 1.0 0.9 20.9 2.6 0.0 0.0 0.0 0.0 51.1 0.0 1.7 1.0 46.0 0.3 0.5 0.0 4.5 0.5 0.5 5.5 0.0 0.0 0.1 3.2 9.7 0.0 0.0 40.7 0.3 0.0 0.0 1.0 0.7 68.3 2.0 5.5 0.4 0.0 92.6 12.9 2.1 7.0 1.3 0.0 0.3 0.0 2.5 0.3 MSL1 "DKFZp686P24239, hMSL1, MSL-1" ENSG00000188895 "Male specific lethal 1 homolog" Q68DK7 17 40122298-40136916 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 11.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 11.7" "Cell line enhanced" "Detected in all" "SK-BR-3: 95.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022800, HPA023567" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA022800: AB_1853057, HPA023567: AB_1853059" "unprognostic (1.94e-1)" "unprognostic (6.28e-2)" "unprognostic (1.82e-1)" "unprognostic (1.45e-1)" "unprognostic (4.71e-2)" "unprognostic (5.39e-2)" "unprognostic (2.33e-2)" "unprognostic (1.60e-1)" "unprognostic (1.06e-2)" "unprognostic (2.24e-1)" "unprognostic (3.46e-1)" "unprognostic (7.48e-3)" "prognostic unfavorable (3.06e-6)" "unprognostic (2.92e-2)" "unprognostic (7.91e-2)" "unprognostic (5.80e-2)" "unprognostic (2.61e-2)" 27.2 26.0 31.4 26.6 31.6 29.9 56.5 36.0 45.1 44.6 31.7 25.8 42.7 30.2 39.3 35.1 29.6 38.7 31.9 22.2 31.6 20.3 27.5 21.7 29.3 27.2 31.4 36.7 32.0 28.6 40.5 39.9 28.4 27.2 32.6 28.7 20.3 27.2 32.9 29.2 35.4 28.7 32.5 24.5 43.6 27.0 32.8 33.8 22.1 39.3 23.9 29.4 34.0 52.7 1.7 1.9 11.7 1.3 0.9 2.3 0.8 9.1 10.9 23.5 15.3 21.4 18.6 12.1 16.1 17.2 20.4 18.5 10.9 9.9 20.3 12.4 16.9 13.0 17.1 19.7 10.6 21.1 17.3 15.9 11.2 15.0 12.9 11.2 15.1 21.9 15.5 17.0 15.0 12.5 20.8 18.7 12.4 17.6 16.6 16.2 5.7 24.0 16.8 10.0 10.1 7.2 19.8 13.0 18.3 14.8 10.1 21.8 12.9 15.1 95.0 12.0 22.4 22.2 21.0 15.3 13.8 15.4 10.0 13.5 26.5 14.8 20.3 14.0 11.3 16.0 0.0 1.3 1.0 2.3 0.7 1.2 1.7 1.3 1.8 0.9 1.1 1.3 1.2 11.7 0.9 1.0 1.9 0.8 0.8 31.4 31.6 36.0 45.1 31.6 20.3 31.4 36.7 27.2 33.8 26.8 38.4 15.6 33.7 44.4 55.0 22.6 22.9 26.8 22.7 10.4 11.8 12.6 3.3 16.7 12.4 38.4 28.0 0.0 18.0 11.4 35.5 45.8 3.5 31.4 21.1 49.3 30.0 38.6 33.5 19.8 54.1 27.8 30.4 5.4 31.8 34.6 19.9 23.0 37.4 6.0 28.4 38.8 36.3 69.6 48.1 57.5 14.2 15.2 28.5 42.5 MSL2 "FLJ10546, KIAA1585, msl-2, MSL2L1, RNF184" ENSG00000174579 "MSL complex subunit 2" Q9HCI7 3 136148922-136197241 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003413 Uncertain Approved Nucleoplasm,Cytosol NA No "Nucleoplasm, Cytosol" "HPA003413: AB_1848659" "unprognostic (9.86e-2)" "prognostic favorable (4.80e-4)" "unprognostic (1.30e-1)" "unprognostic (2.32e-1)" "unprognostic (4.41e-2)" "unprognostic (8.11e-3)" "unprognostic (1.37e-2)" "unprognostic (4.62e-2)" "unprognostic (7.01e-2)" "unprognostic (1.36e-1)" "unprognostic (1.71e-1)" "unprognostic (2.54e-2)" "unprognostic (2.23e-1)" "unprognostic (5.79e-3)" "unprognostic (4.54e-2)" "unprognostic (3.52e-2)" "unprognostic (1.76e-3)" 13.1 10.1 13.3 16.2 15.6 40.2 13.5 31.0 15.8 13.7 11.3 14.8 9.9 11.1 15.5 8.2 12.2 14.1 10.0 9.8 12.4 9.0 10.0 14.1 13.4 23.7 12.6 11.2 18.3 12.7 19.9 19.8 15.9 12.0 13.0 10.1 10.6 13.2 9.8 14.9 14.1 18.2 9.6 14.2 24.2 12.3 13.6 15.6 59.3 13.8 7.4 23.9 13.4 12.9 7.6 3.8 8.7 3.9 6.6 13.3 5.4 12.6 4.2 8.7 9.9 6.0 6.8 15.9 7.7 6.5 6.1 6.2 8.4 6.7 23.7 10.6 5.7 7.5 9.1 10.0 6.6 9.7 12.5 7.7 25.8 8.4 4.7 6.2 21.2 13.5 5.3 7.3 5.0 14.2 6.0 6.1 20.8 9.2 20.6 5.1 7.7 38.3 12.4 11.6 6.0 7.4 17.9 14.8 15.1 3.1 9.0 11.3 8.1 17.5 7.2 11.6 7.0 6.4 13.9 9.6 8.3 7.3 7.7 7.1 24.5 12.7 35.5 7.1 9.0 5.5 5.2 3.7 5.0 7.0 3.9 8.8 4.5 6.6 8.2 3.8 7.6 13.3 8.9 8.7 6.6 2.8 2.5 5.0 5.4 13.3 15.6 31.0 15.8 12.4 9.0 12.6 11.2 12.0 15.6 17.9 9.1 20.4 14.9 24.8 12.8 13.4 10.2 4.0 6.8 12.2 3.9 7.2 3.3 4.6 2.3 10.7 6.9 0.0 4.7 5.4 8.2 10.7 6.9 17.8 7.6 15.9 17.2 19.0 22.8 1.6 8.6 10.5 20.3 9.0 14.4 7.2 5.5 3.5 8.1 5.6 10.1 6.5 12.3 12.6 10.5 23.3 4.0 25.4 10.9 11.2 MSL3 MSL3L1 ENSG00000005302 "MSL complex subunit 3" Q8N5Y2 X 11758159-11775753 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034535, HPA034536" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA034535: AB_10603878, HPA034536: AB_10670973" "unprognostic (2.58e-1)" "unprognostic (1.76e-3)" "unprognostic (1.04e-1)" "unprognostic (9.56e-2)" "unprognostic (5.36e-2)" "prognostic favorable (3.28e-4)" "prognostic unfavorable (4.93e-4)" "unprognostic (8.36e-2)" "unprognostic (2.48e-2)" "unprognostic (4.88e-3)" "unprognostic (2.13e-1)" "unprognostic (5.04e-2)" "prognostic unfavorable (3.14e-9)" "unprognostic (1.20e-1)" "unprognostic (2.06e-1)" "unprognostic (4.35e-1)" "prognostic favorable (2.17e-4)" 11.4 8.1 11.7 23.4 13.3 19.0 10.7 11.9 18.8 7.8 9.3 10.0 6.4 8.6 9.6 7.5 11.9 9.4 10.9 7.7 11.1 11.2 9.9 9.2 14.4 32.5 11.8 10.5 8.6 7.5 7.0 7.9 12.3 15.7 9.7 10.5 4.6 9.9 8.9 24.0 13.7 16.2 10.1 11.3 34.1 9.5 10.5 10.0 49.1 10.1 9.4 30.2 13.9 15.5 25.7 27.1 39.0 33.4 24.5 37.1 30.9 11.5 12.5 16.6 14.5 13.8 19.1 7.1 14.8 13.3 16.2 19.5 7.7 11.7 16.5 15.3 14.1 11.4 9.6 19.7 12.1 19.7 10.6 13.9 8.8 14.3 3.9 12.6 13.4 17.1 11.8 15.5 19.5 8.5 15.2 27.6 21.2 16.0 10.5 16.2 11.8 10.7 15.2 13.6 12.2 20.7 7.8 16.9 20.0 11.3 14.4 10.9 13.1 16.0 6.9 9.6 16.7 11.6 8.8 26.4 15.7 11.0 25.5 13.6 8.3 9.9 19.1 11.4 7.6 13.0 26.7 31.1 22.4 24.2 27.5 23.0 25.7 28.6 27.8 24.0 25.3 37.1 34.5 39.0 24.5 33.4 27.1 33.6 30.9 11.7 13.3 11.9 18.8 11.1 11.2 11.8 10.5 15.7 10.0 8.9 16.3 29.8 12.1 11.7 9.9 13.3 22.9 26.8 13.6 7.0 7.9 18.5 8.3 14.7 38.4 20.4 9.2 0.0 14.8 27.4 15.3 10.0 25.5 14.1 20.2 7.9 6.4 27.0 54.7 16.2 11.5 37.3 13.5 14.4 14.3 7.2 19.6 11.5 15.6 9.8 7.3 6.5 13.7 32.0 11.7 16.2 9.8 32.0 12.4 10.9 MSLN "CAK1, MPF" ENSG00000102854 Mesothelin Q13421 16 760762-768865 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 85.5;lung: 88.5" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 175.7;Alveolar cells type 2: 67.0;Club cells: 66.0;Paneth cells: 190.0" "Cancer enhanced" "Detected in many" "ovarian cancer: 343.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 9.0" "Group enriched" "Detected in many" 59 "dendritic cells: 9.0;monocytes: 2.6" "Cell line enhanced" "Detected in some" "CAPAN-2: 104.2;EFO-21: 16.1;HeLa: 31.8;hTCEpi: 23.1;OE19: 19.3" "Low region specificity" "Detected in many" "CAB002216, HPA017172" Enhanced Supported Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 14000000 Vesicles Nucleoplasm "CAB002216: AB_563874, HPA017172: AB_1853819" "unprognostic (1.73e-1)" "unprognostic (1.77e-1)" "unprognostic (2.06e-2)" "unprognostic (1.33e-1)" "unprognostic (3.43e-2)" "unprognostic (3.95e-2)" "unprognostic (2.46e-1)" "unprognostic (9.47e-2)" "unprognostic (8.57e-2)" "unprognostic (4.69e-2)" "prognostic unfavorable (6.66e-4)" "unprognostic (2.63e-1)" "prognostic favorable (5.91e-4)" "unprognostic (2.00e-2)" "unprognostic (1.60e-1)" "unprognostic (2.14e-2)" "unprognostic (3.35e-2)" 36.5 0.0 0.4 6.7 0.5 0.7 0.3 0.1 0.4 5.4 5.4 0.8 26.8 2.1 4.8 18.9 3.1 85.5 9.6 4.3 0.4 0.3 2.6 0.2 88.5 0.4 0.6 0.0 22.3 0.4 0.0 0.6 13.7 0.9 1.9 1.2 0.2 14.4 33.1 0.0 0.5 0.7 1.0 0.8 0.1 3.7 2.1 0.0 0.1 0.1 0.6 7.8 1.4 1.3 0.0 9.0 0.0 2.6 0.0 0.0 0.4 0.0 0.4 0.0 0.2 0.0 0.0 0.4 0.0 1.5 1.8 0.4 1.5 104.2 0.0 16.1 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 31.8 1.2 0.9 0.0 0.0 0.0 23.1 0.0 0.4 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 19.3 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 2.6 0.2 0.0 0.4 0.4 0.5 0.1 0.4 0.4 0.3 0.6 0.0 0.9 0.0 175.7 67.0 0.0 1.3 0.2 1.3 1.2 50.9 25.4 66.0 24.4 0.0 0.1 0.0 1.6 1.1 0.0 1.9 0.0 0.7 0.0 0.6 1.2 0.0 0.0 2.9 0.0 2.9 0.0 0.6 4.5 4.4 2.6 1.7 7.2 1.3 0.0 19.2 190.0 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.1 0.1 0.0 2.5 37.2 MSRA ENSG00000175806 "Methionine sulfoxide reductase A" Q9UJ68 8 10054268-10428891 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.4" "Cell type enriched" "Detected in many" 6 "Proximal tubular cells: 597.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 78.4" "Cell type enhanced" "Detected in many" "eosinophil: 9.0" "Group enriched" "Detected in many" 4 "dendritic cells: 2.3;granulocytes: 9.0;monocytes: 3.2" "Cell line enhanced" "Detected in many" "HMC-1: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023804, HPA075766" Approved Supported "Nucleoplasm,Plasma membrane,Actin filaments,Cytosol" "Intracellular and membrane" No No 25000 "Nucleoplasm, Plasma membrane, Cytosol" "Actin filaments" "HPA023804: AB_1853826, HPA075766: " "unprognostic (1.55e-1)" "unprognostic (4.30e-3)" "unprognostic (1.45e-3)" "unprognostic (1.00e-2)" "unprognostic (4.21e-2)" "unprognostic (1.62e-2)" "unprognostic (1.49e-2)" "unprognostic (6.40e-2)" "unprognostic (9.69e-2)" "unprognostic (1.08e-1)" "unprognostic (1.80e-1)" "unprognostic (4.58e-2)" "unprognostic (1.07e-3)" "unprognostic (6.43e-3)" "unprognostic (4.02e-1)" "unprognostic (6.36e-3)" "unprognostic (3.07e-1)" 7.0 8.1 8.0 5.2 7.5 36.1 5.9 78.4 13.7 3.6 5.9 4.3 2.2 5.9 4.8 3.7 5.5 4.2 4.4 8.5 8.9 5.5 32.4 22.9 5.7 6.8 6.8 9.5 4.2 10.2 2.9 3.4 4.6 8.1 3.4 4.0 3.9 6.0 5.0 4.7 3.8 12.7 4.9 6.7 7.2 4.9 8.5 5.5 3.5 4.4 2.6 3.8 3.9 2.7 1.1 2.3 9.0 3.2 1.1 0.8 0.3 0.1 1.1 1.8 5.4 1.6 1.8 0.6 3.3 0.7 0.5 2.2 0.7 2.7 0.0 0.8 3.0 7.2 2.9 0.5 0.2 1.7 0.4 0.0 0.5 1.7 2.5 5.3 1.0 15.2 0.5 3.9 0.4 0.0 1.8 0.9 0.3 0.5 0.3 5.9 0.2 0.0 0.3 0.8 3.9 1.0 1.8 1.7 2.3 1.3 1.3 3.1 2.0 5.4 0.2 0.7 0.6 2.8 3.3 3.2 2.2 2.6 0.5 1.6 0.2 0.1 0.9 5.9 1.0 4.1 0.8 3.2 9.0 0.7 2.2 0.6 1.1 0.8 0.5 2.3 0.4 0.6 0.5 3.8 1.1 1.6 0.3 0.5 0.3 8.0 7.5 78.4 13.7 8.9 5.5 6.8 9.5 8.1 5.5 0.0 9.0 10.0 24.1 14.5 10.7 18.1 17.8 5.3 4.5 24.4 29.5 5.8 77.9 27.0 64.1 26.4 29.0 0.0 41.4 4.5 11.3 16.9 81.6 82.9 42.3 15.9 9.2 16.5 31.0 107.2 8.6 33.1 28.7 14.4 19.7 13.4 40.7 28.8 9.2 597.4 5.8 12.9 17.6 27.7 18.8 12.3 7.0 15.3 17.4 28.6 MSRB1 "SelR, SelX, SepR, SEPX1" ENSG00000198736 "Methionine sulfoxide reductase B1" Q9NZV6 16 1938210-1943326 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 195.6;liver: 94.8;pancreas: 107.2" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 236.4;monocytes: 165.9;Proximal tubular cells: 237.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 85.8;neutrophil: 195.6" "Lineage enriched" "Detected in all" 7 "granulocytes: 195.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008650, HPA043463, HPA069557" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB008650: AB_1619225, HPA043463: AB_2678489, HPA069557: AB_2686153" "unprognostic (3.93e-2)" "unprognostic (3.68e-1)" "unprognostic (1.32e-1)" "unprognostic (9.61e-2)" "unprognostic (1.76e-2)" "unprognostic (1.15e-1)" "unprognostic (2.19e-1)" "unprognostic (1.49e-1)" "unprognostic (2.88e-2)" "unprognostic (4.90e-2)" "unprognostic (5.29e-2)" "unprognostic (3.60e-1)" "unprognostic (4.27e-2)" "unprognostic (8.46e-2)" "unprognostic (4.92e-2)" "unprognostic (7.31e-2)" "unprognostic (4.59e-3)" 7.9 4.0 5.2 9.0 6.3 27.3 5.1 3.2 6.1 5.2 13.1 5.6 7.5 8.7 7.9 13.5 16.9 9.6 13.5 13.7 4.7 4.1 24.9 94.8 9.6 15.6 5.5 4.1 7.3 107.2 2.9 3.9 11.6 4.1 11.0 5.1 6.2 4.7 9.4 20.5 8.0 17.0 14.3 4.3 18.2 9.6 8.1 3.6 3.7 5.5 19.8 4.5 14.8 4.8 1.7 10.9 195.6 26.2 2.4 2.8 12.2 6.8 17.3 6.4 15.2 12.0 5.3 11.0 8.4 10.6 12.3 10.7 27.7 7.5 6.6 27.5 9.7 10.8 11.2 10.7 7.4 3.8 37.0 12.2 5.1 6.4 44.1 11.0 14.4 12.2 9.8 6.5 8.9 1.7 3.9 12.3 8.6 8.0 3.7 6.5 37.5 8.1 23.6 8.8 12.3 9.9 11.8 8.9 31.0 19.2 11.4 6.2 8.2 9.5 10.6 5.1 4.3 11.5 25.5 7.3 3.7 10.4 7.4 4.9 9.8 15.5 12.6 3.9 13.6 6.5 26.0 26.2 85.8 2.2 12.0 2.1 1.7 1.8 1.8 10.9 1.7 1.4 1.6 195.6 2.4 10.7 4.6 2.8 12.2 5.2 6.3 3.2 6.1 4.7 4.1 5.5 4.1 4.1 3.6 8.9 14.9 11.5 10.5 5.8 6.0 32.4 38.2 20.1 3.4 31.4 3.9 30.0 79.6 56.2 3.3 12.0 75.5 23.3 97.0 102.6 13.1 12.7 4.6 236.4 55.0 7.9 57.8 19.0 79.6 10.4 8.6 26.2 15.1 165.9 31.9 17.1 66.7 63.3 21.5 237.9 3.0 0.0 19.8 35.7 9.1 8.3 32.3 20.3 27.8 18.7 MSX1 "HOX7, HYD1, OFC5" ENSG00000163132 "Msh homeobox 1" P28360 4 4859666-4863936 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 47.2" "Cell type enhanced" "Detected in some" 11 "Endothelial cells: 14.6;Fibroblasts: 22.2;Melanocytes: 15.1;Smooth muscle cells: 26.1" "Cancer enriched" "Detected in all" 17 "endometrial cancer: 246.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 29.5;EFO-21: 13.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB026198, HPA063895, HPA073604" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB026198: , HPA063895: AB_2685145, HPA073604: AB_2686617" "unprognostic (1.12e-1)" "unprognostic (1.93e-2)" "unprognostic (3.39e-2)" "prognostic favorable (1.64e-7)" "unprognostic (9.13e-2)" "unprognostic (1.16e-3)" "unprognostic (4.07e-3)" "unprognostic (3.81e-2)" "unprognostic (1.48e-2)" "unprognostic (2.21e-3)" "unprognostic (4.78e-2)" "unprognostic (1.17e-1)" "prognostic unfavorable (1.18e-5)" "unprognostic (4.35e-2)" "unprognostic (2.06e-1)" "unprognostic (2.34e-3)" "unprognostic (1.33e-2)" 9.0 3.8 4.6 1.5 2.9 1.0 11.4 1.4 8.6 47.2 1.4 6.0 1.0 1.4 17.9 1.2 1.5 4.5 2.2 2.5 8.7 2.2 1.4 1.3 2.1 1.4 4.2 1.6 2.5 2.0 1.2 11.5 5.1 14.0 3.9 0.9 1.7 3.7 4.9 18.3 2.5 1.2 4.3 3.6 3.3 1.3 1.4 3.8 0.0 4.7 2.6 1.2 5.9 18.8 0.5 0.4 1.9 0.8 0.7 0.6 0.2 1.5 0.9 0.3 1.8 5.2 3.3 5.6 3.8 1.8 2.2 1.1 29.5 9.6 0.1 13.7 2.7 10.9 0.0 6.6 0.0 0.8 1.2 7.7 0.0 5.1 10.5 0.4 0.1 0.9 0.6 0.5 1.7 0.5 0.7 0.5 2.5 4.7 0.2 1.1 0.7 0.8 1.5 0.1 0.4 7.0 3.9 4.1 0.3 0.1 0.9 0.3 0.1 3.4 0.1 2.3 0.5 0.6 1.3 1.2 2.6 5.8 8.3 6.0 0.6 0.5 3.4 1.7 1.9 2.5 1.9 0.4 0.5 0.3 0.5 0.4 0.5 0.3 0.4 0.3 0.4 0.6 0.4 1.4 0.7 0.8 0.4 0.5 0.2 4.6 2.9 1.4 8.6 8.7 2.2 4.2 1.6 14.0 3.8 0.0 0.0 0.0 1.9 6.4 0.7 4.0 0.0 0.0 0.0 0.0 3.9 0.2 0.0 0.2 0.4 14.6 0.7 0.0 0.8 0.1 22.2 3.2 0.0 0.0 0.4 0.0 0.0 6.7 0.6 0.0 1.1 0.9 15.1 0.0 0.1 0.3 0.4 0.0 0.4 0.4 0.8 0.0 26.1 0.7 1.5 4.1 0.2 0.0 1.5 1.5 MT1E "MT1, MTD" ENSG00000169715 "Metallothionein 1E" P04732 16 56625475-56627112 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 248.5" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 3009.6;Hepatocytes: 2806.6;Mucus-secreting cells: 2755.2;Paneth cells: 3720.3;Proximal tubular cells: 4546.8;Undifferentiated cells: 2435.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 3.9;T-cells: 14.2" "Cell line enhanced" "Detected in many" "HBEC3-KT: 124.0;LHCN-M2: 94.5;RPTEC TERT1: 107.0;U-2 OS: 60.4" HPA041152 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA041152: AB_2732490" "unprognostic (1.12e-1)" "unprognostic (2.02e-1)" "unprognostic (3.59e-1)" "unprognostic (1.55e-1)" "unprognostic (2.77e-2)" "unprognostic (1.19e-2)" "unprognostic (3.63e-1)" "unprognostic (9.80e-2)" "unprognostic (7.85e-2)" "unprognostic (3.45e-2)" "unprognostic (2.78e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (5.06e-5)" "unprognostic (1.86e-1)" "unprognostic (9.53e-2)" "unprognostic (1.97e-1)" "unprognostic (3.78e-2)" 68.4 71.5 38.0 18.4 104.6 2.5 47.7 13.8 42.3 10.1 75.3 20.0 10.7 36.2 7.3 18.4 27.1 33.1 44.2 19.6 40.0 27.0 66.1 248.5 21.1 13.7 66.0 27.4 13.4 145.0 4.5 5.1 7.8 94.3 22.6 64.3 13.9 9.1 9.1 28.0 16.4 114.5 29.8 58.6 5.4 47.0 4.1 24.5 0.0 110.7 21.3 4.9 9.4 11.8 0.3 3.9 0.0 2.0 0.1 14.2 1.9 11.2 0.0 0.0 0.0 18.2 21.1 0.1 29.8 32.0 8.2 9.6 0.1 15.1 0.0 2.3 10.3 1.2 24.5 27.5 124.0 11.3 11.3 0.0 0.4 16.4 1.9 8.2 0.0 0.0 14.5 42.1 21.4 24.7 49.8 4.9 0.0 0.0 0.0 94.5 0.0 0.0 7.4 10.8 0.0 0.1 0.0 0.0 0.3 107.0 0.0 1.6 0.0 0.0 0.0 0.1 2.1 0.0 13.8 12.2 0.0 60.4 9.5 5.7 0.0 0.2 0.2 34.7 18.9 0.1 0.0 2.0 0.0 10.5 1.4 3.7 0.3 5.9 14.2 3.9 0.0 2.7 10.7 0.0 0.1 1.2 0.2 13.7 1.9 38.0 104.6 13.8 42.3 40.0 27.0 66.0 27.4 94.3 24.5 366.3 115.6 55.5 220.6 158.7 0.0 67.5 448.4 238.3 298.0 471.1 0.0 12.9 1188.7 375.5 1.5 49.3 3009.6 93.5 167.4 775.1 142.5 750.7 27.7 2806.6 30.0 0.0 233.0 171.2 56.5 2.4 138.4 87.0 104.6 99.2 2755.2 0.0 423.2 3720.3 48.1 4546.8 0.0 213.4 278.2 0.2 2.7 129.5 66.7 38.7 2435.9 51.9 MTA1 ENSG00000182979 "Metastasis associated 1" Q13330 14 105419820-105470729 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004508, HPA005544" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004508: AB_627969, HPA005544: AB_1079420" "unprognostic (6.79e-3)" "unprognostic (4.22e-2)" "unprognostic (1.06e-1)" "unprognostic (6.36e-2)" "unprognostic (2.91e-2)" "unprognostic (7.74e-2)" "prognostic unfavorable (4.62e-4)" "unprognostic (6.59e-2)" "unprognostic (1.47e-1)" "unprognostic (6.72e-3)" "prognostic favorable (9.48e-5)" "unprognostic (4.57e-3)" "unprognostic (1.39e-2)" "unprognostic (2.88e-2)" "unprognostic (1.48e-1)" "unprognostic (1.75e-1)" "unprognostic (1.18e-1)" 23.4 20.1 22.4 24.7 24.3 22.0 22.9 33.8 23.4 17.9 18.9 21.9 22.5 22.3 22.1 21.3 14.9 22.5 20.0 27.7 22.1 17.3 14.8 15.1 20.1 22.3 22.8 18.4 31.4 31.1 15.7 26.5 16.1 19.4 21.9 10.6 22.2 28.7 24.8 29.1 20.0 19.8 27.1 15.0 23.6 18.9 31.4 24.1 27.3 21.1 16.1 16.3 19.3 20.5 1.8 3.7 2.8 0.9 1.8 1.8 0.6 13.3 10.7 19.9 19.8 7.6 13.0 17.6 10.7 8.1 10.6 10.2 13.8 18.1 26.2 11.1 7.8 7.5 18.4 14.4 10.2 7.2 17.1 24.2 13.6 9.7 14.1 16.9 17.1 10.5 14.6 12.9 7.5 17.3 14.8 15.0 19.6 15.4 11.4 5.5 24.0 30.8 33.9 28.7 19.1 22.7 29.1 12.1 8.5 8.4 10.5 32.2 33.5 14.4 16.7 15.3 10.6 15.1 16.3 10.8 8.6 9.1 14.1 11.1 23.4 11.2 16.6 10.7 11.6 14.9 0.5 0.9 2.8 1.4 0.9 1.2 1.5 1.2 1.1 1.1 1.8 1.5 1.8 0.2 1.8 0.5 3.7 0.9 0.6 22.4 24.3 33.8 23.4 22.1 17.3 22.8 18.4 19.4 24.1 3.0 13.6 15.6 26.8 13.9 0.0 8.1 15.3 2.7 7.9 33.2 0.0 10.1 14.9 11.4 24.8 18.0 14.8 23.3 17.3 6.9 18.4 25.2 5.7 11.5 9.4 0.0 17.9 12.9 12.5 9.1 33.4 11.0 11.8 8.2 18.6 0.0 14.9 7.0 30.1 7.7 0.0 19.4 23.4 21.9 11.6 16.7 7.8 15.7 21.8 39.4 MTA2 "MTA1-L1, MTA1L1" ENSG00000149480 "Metastasis associated 1 family member 2" O94776 11 62593214-62601840 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005315, HPA006214, CAB017522, HPA072727" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB005315: AB_2146965, CAB017522: AB_831564, HPA006214: AB_1079421, HPA072727: " "unprognostic (5.97e-3)" "unprognostic (1.63e-2)" "unprognostic (1.23e-1)" "unprognostic (3.04e-2)" "unprognostic (3.48e-1)" "unprognostic (3.66e-2)" "prognostic unfavorable (4.82e-5)" "unprognostic (3.32e-3)" "unprognostic (1.95e-1)" "unprognostic (5.38e-3)" "unprognostic (3.09e-2)" "unprognostic (1.59e-1)" "unprognostic (1.16e-3)" "unprognostic (3.16e-3)" "unprognostic (9.84e-2)" "unprognostic (2.23e-1)" "unprognostic (2.50e-2)" 26.3 20.4 16.6 28.0 17.9 28.7 20.5 21.6 24.8 23.9 22.0 31.5 15.6 17.1 23.8 16.9 45.1 19.9 23.7 18.8 15.8 12.4 19.0 23.6 21.8 35.5 19.7 12.7 35.0 13.7 22.5 19.8 22.3 20.9 21.9 27.3 21.2 22.3 22.1 12.7 41.1 23.5 25.0 23.8 39.4 19.9 25.7 18.9 64.6 19.3 20.3 49.1 21.7 27.8 12.9 12.0 8.4 13.2 10.4 17.3 4.4 24.8 21.8 34.8 45.5 15.6 14.7 24.0 21.1 29.7 42.4 31.1 20.6 21.8 35.5 22.8 27.7 22.7 33.6 46.9 58.4 36.1 35.1 23.5 37.8 23.6 20.7 24.3 42.6 48.7 16.4 32.9 29.8 44.6 20.2 39.2 37.1 41.7 28.3 30.3 48.3 54.0 54.4 30.0 23.7 25.5 51.9 24.8 41.5 30.0 37.4 27.8 25.5 22.0 31.5 17.8 28.8 36.9 29.3 27.4 23.9 22.0 26.9 24.3 21.2 27.4 50.2 17.4 31.2 23.0 5.6 6.4 8.4 17.3 11.0 14.6 12.9 14.4 12.5 10.2 9.8 13.7 13.5 2.9 10.4 13.2 12.0 11.6 4.4 16.6 17.9 21.6 24.8 15.8 12.4 19.7 12.7 20.9 18.9 3.0 3.8 13.4 3.6 11.8 0.0 3.4 2.5 0.0 5.7 1.8 0.0 11.3 5.0 4.9 0.4 6.2 7.9 23.3 8.1 8.8 6.6 3.3 10.4 8.2 7.3 0.0 11.5 14.1 16.4 0.4 4.6 5.3 1.7 7.2 10.5 0.0 6.9 5.8 3.9 2.1 0.0 0.0 5.7 5.1 5.3 9.8 15.8 7.5 11.5 3.9 MTA3 KIAA1266 ENSG00000057935 "Metastasis associated 1 family member 3" Q9BTC8 2 42494569-42756947 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 74.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039433 Approved Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA039433: AB_10794747" "unprognostic (5.40e-2)" "unprognostic (4.89e-2)" "unprognostic (5.28e-2)" "prognostic unfavorable (2.30e-4)" "unprognostic (4.13e-2)" "unprognostic (2.88e-1)" "prognostic unfavorable (4.69e-4)" "unprognostic (7.55e-2)" "unprognostic (2.04e-1)" "unprognostic (5.43e-2)" "unprognostic (2.27e-1)" "unprognostic (1.58e-1)" "unprognostic (2.64e-2)" "unprognostic (9.03e-2)" "unprognostic (2.05e-1)" "unprognostic (3.47e-1)" "unprognostic (1.28e-2)" 8.8 35.0 19.2 16.7 21.0 1.6 14.6 11.4 23.7 14.5 12.5 10.2 16.8 9.0 17.2 25.0 16.7 14.1 11.3 11.1 18.3 14.0 14.5 7.6 8.3 11.5 12.3 14.6 33.3 15.0 18.3 15.8 16.1 12.5 15.0 14.1 12.6 10.6 20.8 9.8 15.4 8.7 14.3 10.4 6.4 12.5 21.0 9.3 74.3 13.0 7.7 15.0 13.5 13.4 2.9 3.2 7.7 1.9 3.3 8.8 3.3 7.6 8.0 12.0 7.2 9.6 13.4 23.8 4.8 8.7 10.8 9.3 10.1 13.3 25.1 8.3 10.4 8.2 4.8 25.4 11.4 15.9 9.3 8.6 4.5 4.7 15.9 10.4 2.7 15.3 14.2 12.8 7.3 7.9 14.8 14.5 12.7 8.2 2.9 11.8 11.3 17.5 8.4 42.9 10.2 4.9 10.1 10.5 0.0 10.8 6.3 6.4 20.8 7.4 23.3 9.8 32.7 12.6 3.4 9.0 5.2 8.5 3.8 4.6 6.0 2.8 36.8 6.9 2.8 6.6 7.7 1.9 0.0 4.1 0.7 5.7 2.5 4.4 6.2 3.2 2.9 8.8 5.9 0.3 3.3 1.2 1.0 2.2 3.3 19.2 21.0 11.4 23.7 18.3 14.0 12.3 14.6 12.5 9.3 11.9 12.2 9.0 18.9 13.6 0.0 10.6 10.2 9.4 12.5 21.0 0.0 48.3 14.9 20.3 8.2 11.1 20.0 0.0 24.6 35.3 15.4 16.9 11.5 12.3 10.4 0.0 9.2 16.0 7.3 17.2 31.4 5.9 16.9 8.2 20.7 0.0 18.5 23.5 37.4 26.2 0.0 12.9 14.4 20.0 42.4 15.9 50.1 6.9 19.7 15.3 MTAP "c86fus, MSAP" ENSG00000099810 "Methylthioadenosine phosphorylase" Q13126 9 21802543-21937651 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Purine salvage" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046915 Supported Nucleoplasm,Cytosol NA NA 3100000 Cytosol Nucleoplasm "HPA046915: AB_2679862" "unprognostic (1.40e-2)" "unprognostic (1.83e-1)" "unprognostic (2.21e-1)" "unprognostic (2.58e-3)" "unprognostic (2.78e-1)" "unprognostic (6.16e-2)" "prognostic unfavorable (4.68e-4)" "unprognostic (9.47e-2)" "unprognostic (2.03e-1)" "unprognostic (8.63e-2)" "unprognostic (4.76e-3)" "unprognostic (4.27e-2)" "unprognostic (6.28e-3)" "unprognostic (2.18e-1)" "unprognostic (1.29e-1)" "unprognostic (1.18e-1)" "unprognostic (1.85e-1)" 17.0 12.6 7.8 12.6 10.4 8.4 13.9 4.6 10.2 17.3 14.5 12.8 13.4 8.0 21.2 11.6 19.6 12.2 16.9 11.4 7.9 7.7 13.0 17.5 11.4 13.0 12.0 6.2 20.5 17.2 17.6 14.4 17.5 12.3 17.0 13.1 14.3 14.6 15.9 10.8 11.8 10.3 19.9 14.3 17.9 11.7 7.9 10.1 19.1 11.7 14.3 16.2 19.7 17.2 9.3 8.4 1.4 6.9 8.5 8.2 3.5 14.4 2.2 11.7 9.9 9.7 10.0 13.2 21.2 10.4 10.7 12.4 9.9 6.8 7.2 6.6 10.0 8.8 6.7 12.0 29.9 18.3 0.1 9.8 0.1 27.4 13.1 9.4 11.5 12.9 12.0 0.0 19.8 21.7 12.4 11.1 0.2 0.1 9.7 11.2 2.0 13.2 0.3 13.7 6.7 17.7 0.2 8.9 12.7 9.3 0.1 6.7 7.6 6.9 8.1 10.5 8.9 5.2 0.2 12.1 0.1 7.6 0.1 16.8 6.5 11.4 15.1 0.1 11.5 6.2 1.4 6.9 0.3 5.0 5.4 8.2 7.7 7.2 5.6 8.4 9.3 6.5 5.9 1.0 8.5 3.4 8.0 4.1 3.5 7.8 10.4 4.6 10.2 7.9 7.7 12.0 6.2 12.3 10.1 20.8 16.6 17.1 39.8 12.6 0.0 21.0 25.5 16.0 28.4 14.0 0.0 42.6 13.3 34.0 42.8 11.2 6.9 0.0 24.4 68.9 13.3 17.2 10.4 19.8 23.3 0.0 9.2 16.5 21.0 8.8 13.8 17.0 10.1 12.6 13.2 0.0 37.3 0.0 13.8 15.3 0.0 12.9 13.2 0.9 16.0 11.4 18.9 13.4 18.8 44.6 MTBP ENSG00000172167 "MDM2 binding protein" Q96DY7 8 120445400-120542133 "Predicted intracellular proteins" "Cell cycle, Growth arrest, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Erythroid cells: 23.3;Spermatocytes: 9.2;Spermatogonia: 7.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 30.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA025694, HPA050594" Uncertain Approved "Nucleoplasm,Nuclear bodies" Yes No Nucleoplasm "Nuclear bodies" "HPA025694: AB_1854169, HPA050594: AB_2681185" "unprognostic (1.92e-2)" "unprognostic (1.07e-1)" "unprognostic (4.47e-1)" "unprognostic (3.53e-4)" "unprognostic (1.20e-1)" "unprognostic (5.40e-3)" "unprognostic (2.77e-6)" "unprognostic (3.99e-3)" "unprognostic (1.50e-2)" "unprognostic (7.86e-3)" "unprognostic (3.38e-3)" "unprognostic (3.29e-1)" "unprognostic (5.20e-10)" "unprognostic (3.41e-3)" "unprognostic (2.51e-1)" "unprognostic (3.02e-2)" "unprognostic (5.86e-2)" 3.7 2.4 4.9 8.3 6.9 7.1 5.4 16.8 7.3 3.8 3.4 4.1 3.2 3.0 5.8 5.2 4.2 3.6 2.5 2.2 3.6 3.2 2.3 1.8 2.6 8.2 4.8 3.3 5.3 2.7 2.6 3.9 4.2 5.1 3.2 5.5 3.2 3.6 2.3 2.0 6.0 3.2 4.2 4.6 4.6 2.7 11.0 4.8 12.6 2.3 3.4 8.0 2.9 3.5 2.7 0.6 0.6 2.0 1.7 3.2 1.1 9.8 2.9 9.8 4.0 1.4 2.4 4.8 7.5 4.3 11.1 14.4 3.1 5.5 9.0 7.7 2.5 3.3 8.5 9.2 4.5 13.7 7.4 7.0 7.5 4.2 3.7 0.7 7.9 5.8 0.9 2.0 8.5 5.5 1.7 4.9 8.3 4.8 6.8 6.4 4.4 12.6 4.9 4.4 7.8 5.9 7.3 10.1 6.4 2.6 3.5 5.1 5.9 5.1 30.1 4.5 5.6 5.6 5.8 2.9 4.8 8.7 6.1 12.1 2.7 5.6 5.2 4.5 9.9 5.4 0.0 0.4 0.6 1.3 2.0 2.0 2.7 1.9 2.3 0.6 1.9 3.2 2.7 0.2 1.7 1.0 0.0 2.2 1.1 4.9 6.9 16.8 7.3 3.6 3.2 4.8 3.3 5.1 4.8 0.0 1.0 0.0 1.3 0.7 0.0 1.1 0.0 2.7 1.2 1.8 0.0 1.6 0.0 0.7 0.6 0.0 0.0 23.3 1.5 2.6 1.1 0.9 2.3 0.8 1.4 0.0 0.0 1.3 0.8 0.0 1.4 1.6 1.7 1.0 1.3 0.0 0.3 0.0 1.1 0.0 0.0 0.0 1.6 9.2 7.0 0.5 0.6 2.2 1.0 0.8 MTCP1 "P13MTCP1, p8MTCP1" ENSG00000214827 "Mature T cell proliferation 1" P56278 X 155061622-155147937 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 9 "Ciliated cells: 4.0;Club cells: 2.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HeLa: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032040 Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA032040: AB_2674122" "unprognostic (2.42e-2)" "unprognostic (2.07e-2)" "unprognostic (1.14e-1)" "unprognostic (6.29e-3)" "unprognostic (8.30e-2)" "unprognostic (4.10e-1)" "unprognostic (2.40e-5)" "unprognostic (9.30e-2)" "unprognostic (1.17e-1)" "unprognostic (4.94e-2)" "unprognostic (5.72e-2)" "unprognostic (1.15e-2)" "prognostic unfavorable (4.52e-8)" "unprognostic (1.55e-3)" "unprognostic (1.06e-2)" "unprognostic (1.39e-2)" "unprognostic (1.75e-2)" 6.4 7.1 4.1 5.3 5.3 7.2 15.8 4.4 4.8 6.0 6.2 3.4 7.7 5.7 6.0 8.2 7.0 6.1 4.4 30.1 4.7 2.9 6.7 12.8 8.5 15.5 4.5 2.7 9.1 20.7 3.9 6.5 3.5 6.4 5.8 6.1 3.9 7.3 7.0 11.4 12.0 6.7 8.7 7.2 6.7 6.2 16.1 3.8 2.5 8.2 5.4 7.2 6.9 4.0 0.2 0.0 0.8 0.7 0.5 2.0 0.1 1.4 4.9 2.4 3.9 1.6 1.3 2.7 3.0 1.5 1.9 4.8 4.3 7.5 2.7 3.1 0.6 3.0 4.8 3.2 3.5 2.4 1.8 3.2 1.2 14.3 2.3 1.4 2.9 3.3 2.4 1.7 3.2 3.0 2.3 1.8 4.7 1.1 4.9 1.3 2.0 3.7 6.1 1.1 1.8 0.8 4.0 2.6 6.1 2.4 2.1 1.2 1.8 2.2 1.2 2.1 1.7 2.2 1.3 1.8 2.2 3.9 2.1 2.2 10.7 4.6 5.2 4.3 3.5 3.1 0.0 0.6 0.8 1.1 0.0 2.0 0.2 1.2 0.4 0.0 0.1 0.2 1.4 0.0 0.5 0.7 0.0 0.0 0.1 4.1 5.3 4.4 4.8 4.7 2.9 4.5 2.7 6.4 3.8 0.0 1.0 0.0 0.2 0.2 0.0 0.6 0.0 4.0 2.3 0.0 0.0 0.1 0.0 0.5 0.0 0.3 0.0 0.0 1.1 0.2 0.3 0.3 0.0 1.0 0.4 0.0 1.7 0.0 1.0 0.2 1.1 0.5 1.7 1.0 0.0 0.0 1.1 0.0 0.4 0.2 0.0 0.0 0.3 0.5 0.2 0.6 0.2 0.0 0.5 0.0 MTF1 ENSG00000188786 "Metal regulatory transcription factor 1" Q14872 1 37809567-37859620 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028604, HPA028689" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA028604: AB_10600304, HPA028689: AB_10611384" "unprognostic (5.74e-2)" "unprognostic (2.10e-1)" "unprognostic (2.56e-2)" "unprognostic (2.89e-1)" "unprognostic (8.33e-2)" "unprognostic (8.15e-3)" "unprognostic (1.34e-2)" "unprognostic (5.07e-2)" "unprognostic (1.91e-1)" "unprognostic (4.58e-2)" "unprognostic (3.20e-2)" "unprognostic (2.30e-2)" "unprognostic (3.70e-2)" "unprognostic (4.37e-3)" "unprognostic (2.98e-1)" "unprognostic (6.32e-2)" "unprognostic (2.19e-1)" 7.8 7.1 9.9 8.1 11.8 28.4 6.9 12.4 10.8 8.4 7.2 10.0 6.7 4.8 9.6 4.8 16.1 9.5 6.0 4.9 9.4 6.5 6.5 5.3 7.3 8.2 10.7 7.0 9.5 8.6 12.7 12.1 10.5 8.3 6.4 7.7 5.3 7.1 8.3 10.5 7.7 6.2 7.8 8.9 8.4 6.4 10.5 13.4 4.9 6.5 7.1 10.0 6.8 7.8 2.9 3.9 6.3 9.1 1.6 3.1 2.7 6.6 4.1 4.1 3.6 10.5 7.3 7.8 6.6 6.8 7.9 7.5 4.4 3.8 7.1 5.1 7.4 5.1 6.2 6.9 5.5 9.2 24.4 4.3 6.7 5.6 3.4 6.0 7.8 7.5 6.7 9.7 11.1 11.3 5.6 5.0 5.1 4.3 5.8 5.8 3.8 3.9 4.0 5.8 3.5 4.0 4.2 9.7 4.3 5.2 6.6 6.3 4.6 7.9 6.4 5.7 5.9 3.9 6.6 7.0 4.9 5.6 5.6 8.6 10.6 12.0 4.1 6.7 8.2 4.3 4.4 6.1 3.9 3.1 5.9 2.7 2.4 2.7 2.4 3.9 2.9 2.9 2.4 6.3 1.6 9.1 1.4 1.8 2.7 9.9 11.8 12.4 10.8 9.4 6.5 10.7 7.0 8.3 13.4 8.9 9.3 12.9 9.3 18.3 0.0 10.9 5.1 25.4 3.4 7.0 0.0 8.4 1.7 9.7 42.8 11.7 10.2 0.0 13.7 20.3 7.8 10.8 16.1 5.5 9.3 0.0 22.8 12.3 17.3 15.0 8.9 16.2 6.8 11.8 7.8 0.0 10.7 7.0 11.0 5.6 0.0 6.5 7.6 28.7 21.3 26.0 14.3 12.5 8.1 12.7 MTF2 "M96, PCL2, TDRD19A" ENSG00000143033 "Metal response element binding transcription factor 2" Q9Y483 1 93079235-93139081 "Predicted intracellular proteins" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 43.4" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 122.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 42.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069047, HPA069066" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA069047: AB_2686073, HPA069066: AB_2686078" "unprognostic (1.84e-2)" "unprognostic (1.45e-1)" "unprognostic (5.56e-2)" "unprognostic (7.88e-3)" "unprognostic (7.12e-2)" "unprognostic (2.26e-3)" "prognostic unfavorable (8.90e-7)" "unprognostic (1.26e-2)" "unprognostic (9.22e-3)" "unprognostic (3.98e-2)" "unprognostic (4.55e-2)" "prognostic unfavorable (1.05e-4)" "prognostic unfavorable (2.47e-7)" "unprognostic (7.19e-3)" "unprognostic (2.48e-1)" "unprognostic (2.48e-1)" "unprognostic (1.26e-2)" 6.8 8.0 8.5 19.7 18.4 21.9 10.3 24.3 12.2 9.8 8.0 8.6 4.9 8.0 9.0 8.5 7.2 7.6 7.4 5.3 9.0 8.2 7.6 7.3 8.6 19.9 8.1 9.8 12.0 7.0 6.7 13.9 13.0 9.2 7.0 8.4 6.7 6.7 6.8 7.1 8.1 9.5 6.8 8.5 12.7 7.2 17.3 9.2 43.4 9.6 7.1 19.4 7.9 8.3 11.7 12.0 14.7 10.6 13.0 14.3 6.2 7.4 3.6 12.5 8.2 2.2 2.1 14.5 4.8 3.8 8.3 10.4 6.1 4.1 24.1 8.8 3.0 7.1 4.0 11.5 5.0 12.3 9.3 8.4 16.6 5.5 8.2 3.3 21.6 7.1 2.6 2.7 7.8 4.7 3.8 7.9 18.8 18.7 7.6 5.1 3.1 31.0 18.0 21.3 3.3 4.8 25.2 15.4 6.5 7.7 8.1 7.8 9.5 7.9 9.4 9.6 13.8 5.6 15.3 4.5 5.5 8.2 5.2 7.1 5.9 6.7 42.8 1.1 12.9 3.5 9.4 9.4 14.7 11.3 10.6 12.9 10.0 11.7 14.3 12.0 11.7 13.9 12.4 7.2 13.0 6.3 11.4 12.9 6.2 8.5 18.4 24.3 12.2 9.0 8.2 8.1 9.8 9.2 9.2 26.8 27.2 56.4 25.5 41.3 0.0 11.7 7.6 17.4 28.4 36.6 0.0 60.2 6.6 29.9 3.7 39.3 25.4 23.3 16.9 56.8 29.0 28.2 57.8 13.4 30.0 0.0 30.9 35.0 26.7 5.0 30.2 40.6 16.9 42.3 29.2 0.0 27.2 31.6 22.3 12.9 0.0 38.8 23.6 122.6 74.3 37.8 50.8 48.4 30.8 32.0 MTFMT FMT1 ENSG00000103707 "Mitochondrial methionyl-tRNA formyltransferase" Q96DP5 15 65001512-65029639 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" Transferase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040710 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040710: AB_10794879" "unprognostic (1.20e-1)" "unprognostic (2.72e-2)" "unprognostic (9.28e-3)" "unprognostic (4.35e-2)" "unprognostic (1.28e-1)" "unprognostic (1.42e-2)" "unprognostic (6.63e-2)" "unprognostic (2.02e-1)" "unprognostic (6.95e-2)" "unprognostic (2.18e-2)" "unprognostic (2.41e-2)" "unprognostic (1.78e-1)" "prognostic favorable (3.31e-8)" "unprognostic (2.75e-2)" "unprognostic (4.06e-2)" "unprognostic (3.26e-1)" "unprognostic (1.85e-2)" 8.7 10.2 7.9 10.0 11.5 11.6 7.5 13.5 12.7 9.5 12.7 6.8 8.0 9.7 11.8 10.6 9.5 10.9 9.7 13.8 8.0 7.8 12.8 13.4 8.4 8.6 6.8 9.4 14.0 5.9 7.3 9.3 7.5 10.3 10.8 10.8 12.2 8.7 9.8 13.3 11.6 13.9 12.0 5.7 9.2 8.7 7.2 5.2 9.2 11.7 4.6 8.8 12.0 9.1 5.0 9.6 16.9 3.6 4.6 5.9 1.9 2.5 3.5 3.4 6.0 4.9 3.4 3.0 2.4 4.2 3.1 3.0 2.2 3.0 9.0 3.2 4.3 5.1 7.6 6.4 4.2 3.0 3.4 4.7 3.8 3.4 2.5 5.7 5.2 1.2 4.9 5.3 1.7 3.7 4.4 2.8 8.0 4.0 4.3 4.7 3.5 4.1 5.5 4.7 7.3 6.1 3.8 5.0 4.1 5.1 3.0 3.5 3.6 5.7 5.3 4.3 4.7 3.3 3.7 5.2 3.7 3.8 4.3 4.7 3.7 5.3 3.5 3.3 8.4 3.8 3.1 3.6 2.4 4.9 2.9 4.9 4.7 4.9 5.2 5.6 5.0 5.5 5.9 16.9 4.6 2.0 9.6 4.9 1.9 7.9 11.5 13.5 12.7 8.0 7.8 6.8 9.4 10.3 5.2 3.0 8.9 11.5 12.6 3.0 0.0 15.0 7.6 5.3 9.1 3.5 0.0 9.0 21.6 10.4 1.6 6.5 11.9 0.0 8.5 10.3 10.0 11.7 8.1 9.5 14.2 0.0 7.5 10.4 10.8 1.4 14.4 11.1 8.5 2.8 9.0 0.0 9.2 16.4 14.5 15.3 0.0 0.0 10.3 10.9 21.6 4.0 7.4 9.6 15.3 13.2 MTHFSD FLJ12998 ENSG00000103248 "Methenyltetrahydrofolate synthetase domain containing" Q2M296 16 86530176-86555235 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 28.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041333 Uncertain Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA041333: AB_10795006" "unprognostic (4.09e-2)" "unprognostic (2.52e-2)" "prognostic unfavorable (9.88e-5)" "unprognostic (2.66e-2)" "unprognostic (7.71e-2)" "unprognostic (1.66e-1)" "unprognostic (4.90e-2)" "unprognostic (6.24e-2)" "unprognostic (3.29e-1)" "unprognostic (4.05e-2)" "unprognostic (2.96e-2)" "unprognostic (3.90e-3)" "unprognostic (1.94e-3)" "unprognostic (1.00e-1)" "unprognostic (1.05e-1)" "unprognostic (4.77e-1)" "unprognostic (5.85e-3)" 12.6 12.6 10.9 10.0 11.4 7.1 13.1 17.1 16.5 12.1 10.8 19.3 18.2 9.1 17.5 15.6 14.4 16.8 11.9 10.0 11.1 7.9 12.2 11.9 10.4 13.3 13.4 13.6 14.8 14.2 24.0 15.8 10.1 14.4 15.9 13.4 16.2 17.2 15.7 14.7 15.6 12.5 14.1 9.5 15.9 12.1 21.5 12.8 14.7 14.7 13.3 14.9 13.3 18.7 8.3 9.9 10.1 7.6 9.3 9.3 7.2 9.5 9.2 8.9 7.8 7.8 11.9 11.0 9.6 7.1 12.2 6.1 8.0 16.3 8.6 10.4 8.3 6.5 13.3 9.9 9.4 11.5 5.7 8.1 7.6 12.0 7.5 10.4 6.0 4.4 7.5 15.2 15.6 13.5 10.6 7.3 12.9 16.2 0.0 8.8 12.2 7.6 9.2 5.9 8.0 11.5 23.2 5.3 6.8 7.1 5.9 8.8 6.0 21.8 4.3 8.0 9.4 21.8 6.4 7.4 11.8 10.2 7.8 9.2 7.1 8.7 25.3 10.8 9.9 11.5 10.1 7.6 3.8 8.5 5.8 8.8 8.3 9.3 8.5 9.9 6.8 7.8 8.8 3.1 9.3 7.1 4.5 7.6 7.2 10.9 11.4 17.1 16.5 11.1 7.9 13.4 13.6 14.4 12.8 6.0 5.1 5.1 2.5 1.0 0.0 3.5 2.5 8.1 3.4 5.2 0.0 6.1 10.0 4.4 28.8 3.6 5.3 0.0 3.7 4.2 3.0 2.4 4.6 2.8 5.2 0.0 4.1 4.3 5.3 11.9 6.1 3.3 3.3 4.6 4.8 0.0 3.1 3.5 7.8 3.3 0.0 6.5 4.7 9.9 3.2 1.3 6.4 2.9 4.7 1.7 MTIF3 "IF-3mt, IF3(mt)" ENSG00000122033 "Mitochondrial translational initiation factor 3" Q9H2K0 13 27435643-27450591 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 461.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039791 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA039791: AB_10795296" "unprognostic (1.82e-1)" "unprognostic (1.44e-2)" "unprognostic (2.59e-1)" "unprognostic (3.26e-3)" "unprognostic (1.49e-2)" "unprognostic (8.01e-2)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (2.49e-1)" "unprognostic (3.77e-1)" "unprognostic (1.64e-2)" "unprognostic (1.62e-1)" "unprognostic (2.40e-1)" "unprognostic (3.24e-2)" "unprognostic (1.13e-1)" "unprognostic (9.27e-2)" "prognostic favorable (8.41e-4)" 36.9 30.4 29.8 21.9 26.3 8.5 28.4 22.8 26.7 21.5 24.8 16.9 25.9 23.7 15.1 38.5 25.5 16.5 20.5 55.7 27.5 22.8 41.5 38.7 15.1 22.2 28.9 19.7 23.1 28.3 14.5 40.3 20.2 28.3 22.7 24.8 17.4 43.3 28.1 46.1 21.6 29.7 18.2 28.7 24.9 22.7 28.3 26.2 29.7 22.9 38.5 24.0 27.8 16.4 25.3 44.3 35.9 26.5 18.5 24.1 19.4 12.6 8.8 19.9 10.0 22.3 33.5 10.1 18.7 20.5 13.8 14.0 11.7 15.7 13.8 12.7 20.3 9.6 10.9 10.7 14.7 19.0 14.5 13.2 17.5 8.1 14.5 21.8 18.1 16.7 18.8 27.1 11.3 14.4 31.2 23.9 13.7 10.0 5.6 20.8 22.3 15.8 22.1 10.3 40.0 10.0 9.3 10.8 15.8 28.4 13.0 14.6 8.9 11.3 16.7 21.2 22.5 13.0 27.3 16.3 9.3 5.5 24.0 12.7 4.3 6.0 8.0 9.7 18.2 13.3 34.2 26.5 35.9 17.1 25.5 18.4 25.3 21.8 17.2 27.9 21.7 19.3 19.6 17.7 18.5 22.1 44.3 24.1 19.4 29.8 26.3 22.8 26.7 27.5 22.8 28.9 19.7 28.3 26.2 26.8 39.6 74.4 31.9 30.2 0.0 153.3 114.7 80.3 53.4 109.9 0.0 82.5 276.8 69.3 461.6 70.4 109.5 70.0 91.1 54.9 56.4 44.1 70.4 186.6 88.5 0.0 61.7 75.5 115.6 139.9 129.5 86.8 101.3 78.5 97.0 0.0 94.2 104.0 117.4 273.1 0.0 122.9 55.6 149.2 77.3 37.1 47.5 55.4 92.5 39.3 MTMR10 FLJ20313 ENSG00000166912 "Myotubularin related protein 10" Q9NXD2 15 30938941-30991607 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 84.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 14.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006081 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" No No "Nucleoplasm, Nuclear bodies" Cytosol "HPA006081: AB_2667508" "unprognostic (1.60e-1)" "unprognostic (6.09e-2)" "unprognostic (1.21e-1)" "unprognostic (1.36e-1)" "unprognostic (2.18e-1)" "unprognostic (7.36e-2)" "unprognostic (4.43e-2)" "unprognostic (7.26e-2)" "unprognostic (1.24e-1)" "unprognostic (3.31e-2)" "unprognostic (6.43e-2)" "unprognostic (2.54e-1)" "prognostic favorable (7.77e-12)" "unprognostic (9.92e-2)" "unprognostic (1.15e-1)" "unprognostic (1.79e-1)" "unprognostic (1.01e-1)" 13.9 7.3 19.9 7.8 22.8 12.0 16.3 8.4 19.3 10.0 8.4 32.9 4.2 9.6 7.4 8.1 17.1 6.4 7.5 10.2 22.5 13.3 25.9 19.2 10.6 9.6 30.9 11.9 9.5 9.8 14.8 4.3 32.7 29.4 9.2 8.5 9.5 11.1 10.0 24.3 7.6 8.9 8.3 84.0 10.7 10.0 6.6 24.9 8.9 11.7 6.0 8.3 9.5 7.2 3.4 3.8 14.1 6.9 1.4 1.6 1.6 5.5 6.3 5.8 3.1 12.9 7.0 4.2 8.0 16.8 6.8 6.7 4.0 1.9 2.3 11.0 10.7 6.7 8.2 4.5 4.8 6.4 8.3 1.2 2.9 4.1 5.9 7.5 5.5 5.9 9.4 3.8 4.3 4.8 8.0 16.7 6.8 3.1 6.5 6.1 1.6 5.8 1.6 2.9 6.9 2.6 4.4 5.0 13.1 25.3 8.8 2.1 5.4 3.8 4.6 1.6 8.4 2.9 10.4 7.9 7.9 5.0 4.1 4.9 5.9 5.0 6.0 4.6 2.0 8.8 3.3 3.2 3.0 0.8 4.2 0.8 2.1 0.9 0.6 3.2 3.4 1.6 1.3 14.1 1.4 6.9 3.8 1.3 1.6 19.9 22.8 8.4 19.3 22.5 13.3 30.9 11.9 29.4 24.9 23.8 14.6 5.9 3.7 7.9 0.0 20.2 5.1 4.0 7.9 31.4 0.0 14.7 1.7 2.9 11.5 11.7 10.0 0.0 3.2 2.6 7.6 7.4 16.2 28.7 10.3 0.0 5.8 10.4 21.9 17.8 9.8 17.2 8.5 2.8 9.0 0.0 4.2 8.6 7.1 13.3 0.0 0.0 5.3 12.1 6.6 9.7 32.2 5.7 6.8 5.2 MTMR3 "FYVE-DSP1, KIAA0371, ZFYVE10" ENSG00000100330 "Myotubularin related protein 3" Q13615 22 29883155-30030866 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid metabolism" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034515, HPA034516, HPA061399" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034515: AB_10669726, HPA034516: AB_10669727, HPA061399: " "unprognostic (4.39e-3)" "unprognostic (7.84e-2)" "unprognostic (2.46e-2)" "unprognostic (1.76e-2)" "unprognostic (5.61e-2)" "unprognostic (4.51e-3)" "unprognostic (2.25e-2)" "unprognostic (3.20e-2)" "unprognostic (3.42e-1)" "unprognostic (4.39e-1)" "unprognostic (8.33e-4)" "unprognostic (1.28e-1)" "unprognostic (5.35e-4)" "unprognostic (7.96e-2)" "unprognostic (7.64e-2)" "unprognostic (2.49e-1)" "unprognostic (8.38e-2)" 15.8 17.2 15.7 12.6 20.6 66.7 16.0 24.2 18.0 13.7 12.6 18.9 14.8 10.6 18.8 13.5 20.1 16.7 13.0 14.4 13.0 11.7 12.4 9.9 18.3 12.6 14.7 11.4 20.3 15.8 22.1 20.6 20.6 15.8 15.1 12.9 18.1 15.9 14.7 30.7 22.5 13.1 16.0 17.0 20.7 14.1 23.7 14.6 14.0 16.6 11.9 14.9 14.0 19.3 2.6 3.9 16.5 6.6 3.9 4.1 3.5 8.5 6.7 11.7 12.4 11.8 8.6 8.6 7.6 11.6 10.5 12.2 6.3 5.2 6.5 5.1 14.7 8.4 10.6 12.3 9.7 10.6 12.9 10.2 11.8 6.8 6.7 10.9 10.0 30.2 9.1 16.1 10.2 18.6 10.3 10.5 7.1 7.3 11.8 6.5 10.7 6.7 7.3 4.3 9.2 5.0 8.0 15.8 6.6 9.9 16.0 12.9 8.9 14.7 13.3 7.9 10.3 7.4 10.1 11.1 17.2 11.7 3.5 5.4 10.2 6.9 6.1 7.5 5.0 7.9 6.4 6.6 10.0 3.1 4.6 4.1 2.2 2.5 3.4 3.9 2.6 3.1 2.7 16.5 3.9 4.7 1.5 2.7 3.5 15.7 20.6 24.2 18.0 13.0 11.7 14.7 11.4 15.8 14.6 3.0 11.3 4.3 8.7 14.8 0.0 2.8 10.2 6.7 14.8 12.2 0.0 10.4 1.7 9.3 11.6 8.9 12.4 0.0 7.6 5.5 9.4 14.8 7.0 8.5 9.8 0.0 12.0 13.5 24.0 12.1 12.7 12.9 13.5 2.8 11.1 0.0 9.9 8.6 10.6 5.7 0.0 6.5 5.0 20.9 24.0 12.0 11.4 7.0 9.3 11.6 MTMR7 ENSG00000003987 "Myotubularin related protein 7" Q9Y216 8 17298030-17413528 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8;parathyroid gland: 17.9" "Cell type enhanced" "Detected in some" 16 "Early spermatids: 9.5;Intestinal endocrine cells: 3.5;Late spermatids: 3.1;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "NTERA-2: 5.4;SCLC-21H: 14.3;SH-SY5Y: 8.3" "Low region specificity" "Detected in all" HPA075682 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA075682: " "unprognostic (1.01e-1)" "unprognostic (6.10e-2)" "unprognostic (1.05e-2)" "unprognostic (1.44e-1)" "unprognostic (1.67e-1)" "unprognostic (1.31e-2)" "unprognostic (4.15e-2)" "unprognostic (1.41e-2)" "unprognostic (1.92e-1)" "unprognostic (2.45e-1)" "unprognostic (2.07e-4)" "unprognostic (1.46e-2)" "unprognostic (1.97e-7)" "unprognostic (1.12e-1)" "unprognostic (1.42e-1)" "unprognostic (4.17e-2)" "unprognostic (2.66e-3)" 1.4 4.9 10.9 1.9 16.7 3.4 0.9 16.2 25.8 1.2 1.3 16.0 0.0 2.0 1.8 0.8 1.5 1.5 1.6 1.7 7.5 7.8 2.4 2.2 1.4 1.7 9.2 9.5 3.5 2.6 17.9 10.3 1.8 19.5 1.2 1.3 4.7 1.4 1.1 2.1 2.6 1.9 1.1 11.2 1.4 1.8 2.9 9.4 0.0 6.5 0.0 0.8 1.4 0.7 0.7 0.2 0.8 0.2 0.3 1.4 0.1 0.8 0.7 1.2 1.0 0.0 0.0 0.9 1.8 0.0 0.0 0.0 0.9 0.2 0.9 0.5 0.0 0.8 0.4 4.1 0.1 0.0 0.1 3.0 1.2 1.6 0.5 1.0 0.7 0.9 0.2 0.0 0.1 0.0 0.8 0.2 0.4 0.6 0.7 0.0 0.6 1.3 1.7 5.4 0.7 0.6 0.4 1.8 0.5 0.0 3.4 14.3 8.3 0.6 0.8 0.9 2.0 0.4 0.9 1.5 0.9 0.5 2.0 1.1 0.4 0.4 0.7 2.6 1.3 0.7 0.0 0.1 0.7 0.2 0.2 0.1 0.7 0.1 0.2 0.1 0.0 0.5 0.3 0.8 0.3 0.2 0.2 1.4 0.1 10.9 16.7 16.2 15.2 7.5 7.8 9.2 9.5 19.5 9.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 9.5 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.3 0.0 3.5 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.5 0.5 0.6 1.6 0.1 1.1 0.0 0.0 0.0 MTO1 ENSG00000135297 "Mitochondrial tRNA translation optimization 1" Q9Y2Z2 6 73461578-73509236 "Disease related genes, Predicted intracellular proteins" "tRNA processing" "Cardiomyopathy, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Early spermatids: 108.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030230, HPA030232" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030230: AB_10598910, HPA030232: AB_10600891" "unprognostic (2.17e-2)" "unprognostic (5.29e-2)" "unprognostic (1.05e-2)" "unprognostic (3.22e-2)" "unprognostic (6.47e-2)" "unprognostic (8.58e-2)" "unprognostic (6.28e-2)" "unprognostic (5.48e-2)" "unprognostic (2.97e-1)" "unprognostic (2.12e-3)" "unprognostic (9.01e-3)" "unprognostic (1.55e-1)" "unprognostic (9.17e-2)" "unprognostic (1.11e-1)" "unprognostic (1.67e-1)" "unprognostic (8.08e-3)" "unprognostic (1.64e-1)" 10.4 11.0 11.1 13.5 13.7 14.7 11.5 21.8 13.6 14.0 14.0 11.3 12.4 12.7 12.6 11.2 12.1 10.0 8.1 13.3 10.0 10.9 19.7 28.4 9.8 15.8 19.3 10.0 14.5 12.1 24.6 15.6 8.7 13.9 12.2 12.7 10.1 10.7 12.3 15.8 9.8 13.6 11.9 12.1 18.6 11.9 20.5 15.0 13.0 14.0 11.0 16.6 12.1 15.0 10.4 7.4 5.3 7.8 10.5 14.0 8.7 5.1 4.7 6.5 5.3 9.4 11.0 5.9 10.7 9.8 10.5 12.8 9.7 3.9 13.5 8.4 10.0 8.2 8.8 11.9 8.6 16.1 7.8 7.8 10.3 11.4 10.5 12.4 18.5 7.0 9.5 13.6 11.3 12.7 7.4 7.9 12.0 17.6 13.0 10.9 8.9 5.1 16.0 4.8 7.7 4.8 8.5 18.7 22.4 8.4 8.1 5.5 3.3 5.5 9.3 9.6 6.2 6.1 19.6 5.0 6.2 6.1 3.5 10.1 8.5 13.1 5.4 3.2 13.8 8.2 1.7 6.4 5.3 9.7 7.2 11.9 10.4 11.7 9.8 7.4 7.9 12.9 10.5 1.8 10.5 7.8 5.5 14.0 8.7 11.1 13.7 21.8 13.6 10.0 10.9 19.3 10.0 13.9 15.0 14.9 17.0 14.3 13.5 6.9 0.0 12.9 7.6 6.7 11.4 10.4 0.0 10.2 18.3 6.5 108.3 9.0 9.0 0.0 6.4 6.5 6.9 10.3 5.8 18.4 7.8 0.0 8.1 9.2 5.9 11.0 10.3 10.8 0.0 8.2 8.1 0.0 6.1 7.0 9.2 12.6 0.0 6.5 10.2 21.7 10.2 8.8 8.6 24.2 9.8 9.7 MTREX "Dob1, fSAP118, KIAA0052, Mtr4, SKIV2L2" ENSG00000039123 "Mtr4 exosome RNA helicase" P42285 5 55307760-55425581 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, rRNA processing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 39.4;Ciliated cells: 48.2;Club cells: 39.8;Exocrine glandular cells: 35.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037379 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA037379: AB_10601713" "unprognostic (7.71e-2)" "unprognostic (1.21e-1)" "unprognostic (1.33e-3)" "unprognostic (1.32e-1)" "unprognostic (1.50e-1)" "unprognostic (2.08e-1)" "unprognostic (1.79e-2)" "unprognostic (5.08e-1)" "unprognostic (4.17e-2)" "unprognostic (1.46e-2)" "unprognostic (5.05e-2)" "unprognostic (7.67e-2)" "unprognostic (1.11e-2)" "unprognostic (2.09e-1)" "unprognostic (3.98e-1)" "unprognostic (2.86e-1)" "unprognostic (2.11e-1)" 23.6 23.6 26.1 24.9 24.0 18.7 24.1 40.6 31.2 22.0 19.3 15.2 28.8 27.6 26.2 17.8 23.3 20.0 22.4 24.3 22.0 16.0 21.2 22.7 19.7 24.7 21.1 21.5 25.9 25.8 35.8 45.0 19.0 26.6 25.6 21.7 10.4 21.8 28.7 71.3 23.8 24.3 20.9 37.5 20.9 20.6 22.3 21.5 29.7 29.3 19.2 21.7 24.4 23.4 9.8 10.9 5.8 10.3 5.9 10.4 4.0 14.2 20.0 14.6 15.5 12.4 13.1 19.6 13.1 10.0 14.8 18.9 21.4 18.7 27.7 15.5 11.5 19.6 9.9 28.4 18.0 22.2 4.9 23.5 18.9 18.9 16.3 11.4 11.1 12.6 10.3 12.3 15.6 19.1 11.6 12.8 10.4 22.3 16.0 14.3 13.0 11.9 14.7 13.2 5.9 19.4 14.6 16.3 12.2 16.0 20.9 18.0 11.1 14.9 8.5 12.8 14.6 20.4 16.1 11.5 3.8 9.7 10.7 22.0 11.8 12.4 23.9 9.7 25.5 14.7 4.9 6.6 5.8 10.4 6.1 10.0 8.8 7.7 9.7 7.9 9.8 8.1 8.3 1.9 5.9 10.3 10.9 7.5 4.0 26.1 24.0 40.6 31.2 22.0 16.0 21.1 21.5 26.6 21.5 29.8 39.4 0.0 0.0 0.0 0.0 0.0 0.0 48.2 39.8 19.2 0.0 21.8 10.0 23.4 0.0 0.0 0.0 0.0 35.5 18.3 0.0 0.0 23.3 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 24.4 0.0 0.0 29.8 0.0 0.0 17.0 0.0 0.0 0.0 0.0 0.0 0.0 29.2 0.0 0.0 0.0 MTRR cblE ENSG00000124275 "5-methyltetrahydrofolate-homocysteine methyltransferase reductase" Q9UBK8 5 7851186-7906025 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 57.4;Late spermatids: 61.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038113 Supported Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA "Nucleoplasm, Cytosol" "Intermediate filaments" "HPA038113: AB_10671520" "unprognostic (1.06e-1)" "unprognostic (1.08e-1)" "unprognostic (5.32e-2)" "unprognostic (1.17e-2)" "unprognostic (1.63e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (6.60e-4)" "unprognostic (2.56e-2)" "unprognostic (5.82e-2)" "unprognostic (7.43e-2)" "unprognostic (1.29e-1)" "unprognostic (9.11e-3)" "unprognostic (3.44e-2)" "unprognostic (1.30e-1)" "unprognostic (2.60e-1)" "unprognostic (1.56e-1)" "unprognostic (1.12e-1)" 12.2 12.3 11.2 10.5 13.8 5.4 9.7 15.6 14.3 10.8 10.4 24.1 11.5 10.3 17.3 15.9 10.5 11.3 13.3 15.8 14.2 12.9 22.0 23.9 14.9 11.4 18.1 9.6 13.6 13.6 9.4 13.1 11.6 16.6 10.8 11.9 13.6 11.3 7.4 34.6 10.5 11.5 14.2 22.1 9.3 9.2 8.4 12.5 8.1 14.7 9.9 13.5 13.6 8.8 4.6 4.8 4.6 6.8 3.4 11.4 4.2 9.4 8.9 4.7 10.5 18.2 5.9 13.5 14.7 8.7 7.3 8.4 13.4 7.6 15.9 14.1 11.8 14.0 6.1 7.3 7.2 13.9 10.1 8.2 7.6 31.0 7.1 11.1 11.6 3.3 9.5 6.6 12.4 9.1 10.4 4.7 4.1 9.9 12.1 4.3 1.8 7.4 5.9 3.6 14.0 9.9 6.1 5.1 6.7 7.9 7.4 7.4 1.0 25.8 18.8 16.2 9.7 5.8 9.0 7.3 17.1 10.8 13.1 11.5 18.0 5.9 13.1 12.4 25.6 9.1 4.6 5.1 4.1 5.5 6.8 9.5 4.6 9.2 7.9 4.8 4.1 5.4 5.1 0.1 3.4 5.4 2.7 11.4 4.2 11.2 13.8 15.6 14.3 14.2 12.9 18.1 9.6 16.6 12.5 14.9 57.4 8.2 7.5 14.4 0.0 10.1 2.5 9.4 11.4 8.7 0.0 8.3 18.3 8.0 40.0 7.0 8.5 0.0 4.9 7.5 10.2 9.9 10.3 16.6 6.7 0.0 9.2 10.4 12.5 61.7 9.8 8.7 1.7 5.4 9.6 0.0 5.8 7.0 11.0 23.3 0.0 6.5 13.3 16.9 11.9 18.1 9.4 12.9 8.9 7.0 MUC20 "FLJ14408, KIAA1359" ENSG00000176945 "Mucin 20, cell surface associated" Q8N307 3 195720882-195741123 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 50.6" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 60.2;Urothelial cells: 102.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.2" "Cell line enriched" "Detected in some" 7 "SK-BR-3: 25.3" HPA042249 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 11000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042249: " "unprognostic (1.85e-1)" "unprognostic (4.64e-2)" "unprognostic (1.05e-2)" "unprognostic (1.83e-3)" "unprognostic (2.12e-1)" "unprognostic (1.59e-2)" "unprognostic (2.06e-1)" "unprognostic (2.41e-1)" "unprognostic (3.99e-4)" "unprognostic (7.66e-2)" "unprognostic (2.84e-2)" "unprognostic (1.14e-1)" "prognostic favorable (1.57e-4)" "unprognostic (2.05e-1)" "unprognostic (2.56e-1)" "unprognostic (3.98e-3)" "unprognostic (1.17e-1)" 1.7 1.2 1.1 3.4 2.1 1.2 1.8 2.5 1.2 6.3 15.2 1.1 4.7 3.2 1.5 5.2 15.9 5.7 8.7 1.1 1.1 0.7 50.6 4.8 6.4 1.1 1.1 1.1 4.6 7.6 1.0 4.6 13.3 1.1 4.9 7.6 1.2 10.6 1.8 2.5 2.1 4.1 2.0 1.1 1.6 2.3 1.8 1.1 3.0 3.9 1.9 14.9 10.6 26.6 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.2 0.6 0.2 0.0 0.6 0.0 0.1 0.0 0.0 0.0 3.0 0.1 0.5 0.0 0.2 1.3 0.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.4 0.0 0.5 3.4 0.1 0.8 0.1 0.8 0.0 1.9 1.0 0.3 0.0 25.3 0.2 0.4 0.1 0.0 0.0 0.2 0.7 0.9 0.1 1.1 1.3 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.2 0.0 0.0 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.1 2.5 1.2 1.1 0.7 1.1 1.1 1.1 1.1 32.8 14.7 0.0 8.8 1.5 20.2 0.5 10.2 60.2 37.5 21.0 33.4 0.0 1.7 32.3 0.0 1.3 15.6 0.0 8.7 0.1 1.5 12.8 1.1 6.4 0.4 11.1 13.3 1.8 0.6 0.0 4.9 0.9 3.3 0.0 7.2 5.6 13.7 18.6 6.0 1.4 22.0 0.0 1.6 1.1 0.7 1.6 0.0 0.5 13.5 102.7 MUL1 "C1orf166, FLJ12875, GIDE, MAPL, MULAN, RNF218" ENSG00000090432 "Mitochondrial E3 ubiquitin protein ligase 1" Q969V5 1 20499448-20508161 "Enzymes, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026827 Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA026827: AB_10601137" "unprognostic (1.39e-1)" "unprognostic (2.73e-2)" "unprognostic (1.32e-2)" "unprognostic (1.51e-1)" "unprognostic (4.82e-3)" "unprognostic (1.85e-3)" "unprognostic (6.05e-3)" "unprognostic (1.01e-1)" "unprognostic (6.31e-2)" "unprognostic (5.86e-3)" "unprognostic (4.05e-1)" "unprognostic (9.10e-2)" "prognostic favorable (6.15e-14)" "unprognostic (1.59e-2)" "unprognostic (1.10e-1)" "unprognostic (1.05e-2)" "unprognostic (2.37e-1)" 13.3 15.9 10.3 12.9 12.3 20.6 20.4 9.2 22.2 13.1 15.8 19.0 8.0 11.6 18.2 10.7 17.2 17.0 18.5 26.2 11.7 12.5 20.5 20.1 16.3 12.1 16.8 9.5 17.5 26.8 21.9 13.0 21.6 17.6 13.9 13.3 14.3 15.3 18.1 26.7 17.4 19.5 17.0 11.7 13.6 15.2 14.1 11.6 18.5 15.1 14.6 14.0 16.3 13.6 23.2 26.0 31.9 30.4 25.2 32.1 27.5 17.1 16.6 9.6 19.8 20.8 11.7 10.4 17.0 20.4 21.2 20.5 10.2 28.5 12.9 19.1 24.0 16.1 26.1 17.2 24.6 15.5 12.8 13.6 9.9 11.2 14.8 24.5 13.5 17.0 19.1 32.5 21.7 22.6 12.5 13.8 11.7 12.9 15.8 23.0 8.7 8.1 9.1 9.8 14.3 15.9 8.0 12.1 16.7 25.0 9.6 9.8 14.5 15.3 16.4 20.9 8.1 11.5 13.0 15.6 20.7 11.9 18.0 15.2 18.5 16.1 13.9 16.2 18.4 19.1 26.3 26.5 31.9 30.9 30.4 32.1 23.2 23.6 31.4 26.0 21.5 27.1 26.3 24.0 25.2 25.4 20.1 32.1 27.5 10.3 12.3 9.2 22.2 11.7 12.5 16.8 9.5 17.6 11.6 20.8 9.3 11.7 7.8 4.6 12.5 14.6 12.7 9.4 6.8 17.4 5.9 33.7 10.0 21.4 1.6 9.7 12.0 0.0 20.3 20.8 12.1 8.1 3.5 11.9 19.7 12.7 8.2 10.4 11.4 2.8 12.0 7.7 18.6 21.6 11.8 15.6 19.7 11.5 14.5 8.7 10.5 19.4 8.5 10.6 13.4 6.1 31.5 10.8 10.1 9.0 MUM1 "EXPAND1, MUM-1" ENSG00000160953 "Melanoma associated antigen (mutated) 1" Q2TAK8 19 1354711-1378431 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 192.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048063 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA048063: AB_2680243" "unprognostic (2.50e-2)" "unprognostic (4.67e-1)" "unprognostic (1.72e-1)" "prognostic favorable (4.82e-4)" "unprognostic (1.14e-1)" "unprognostic (4.21e-3)" "unprognostic (4.84e-2)" "unprognostic (2.77e-2)" "unprognostic (1.21e-1)" "unprognostic (2.24e-2)" "prognostic favorable (2.25e-6)" "unprognostic (1.60e-1)" "unprognostic (6.05e-3)" "unprognostic (5.34e-2)" "unprognostic (1.57e-1)" "unprognostic (1.79e-1)" "unprognostic (7.29e-3)" 6.7 5.3 14.4 3.6 20.9 2.1 5.6 21.9 19.2 7.0 5.8 13.6 4.5 3.7 10.4 5.6 4.3 13.0 5.4 5.3 13.6 9.1 4.9 8.3 6.8 3.6 14.2 11.5 18.4 4.0 7.7 7.5 6.0 11.5 6.7 4.8 5.8 6.7 8.7 5.5 8.1 4.8 11.5 10.5 6.0 4.8 19.9 13.1 1.9 6.0 0.9 4.5 5.6 11.5 4.3 3.9 11.8 2.6 3.8 4.5 1.3 7.2 9.3 13.0 13.8 10.6 14.1 15.9 12.6 7.9 11.6 8.6 6.4 4.8 14.7 5.9 16.2 4.1 8.2 13.1 8.2 8.8 15.8 8.3 7.9 9.5 9.6 10.2 6.1 17.8 9.2 5.1 6.5 4.7 14.9 11.8 9.9 12.2 7.4 11.0 8.1 10.4 6.5 14.7 8.1 5.3 16.8 10.9 6.1 7.7 10.5 9.4 21.5 11.1 13.1 8.4 11.8 6.4 14.0 11.3 10.5 14.6 8.5 11.6 15.0 12.6 6.7 14.0 9.9 14.2 11.8 1.1 6.8 4.5 2.6 3.8 3.9 2.5 3.3 2.1 4.3 3.7 4.0 2.2 3.8 2.2 3.9 1.6 1.3 14.4 20.9 21.9 19.2 13.6 9.1 14.2 11.5 11.5 13.1 32.8 18.3 29.6 30.8 15.0 192.5 23.6 48.4 30.8 14.8 17.4 133.5 16.7 10.0 30.8 84.4 21.8 35.5 0.0 19.1 20.1 33.2 18.7 32.4 72.0 15.3 151.0 36.8 28.8 14.8 101.3 53.8 14.7 28.7 20.8 26.2 51.9 24.8 28.3 53.0 11.0 82.1 116.4 31.5 168.6 74.1 12.9 11.9 20.8 29.5 16.6 MUS81 "FLJ44872, SLX3" ENSG00000172732 "MUS81 structure-specific endonuclease subunit" Q96NY9 11 65857126-65867653 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 97.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059530 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA059530: AB_2684052" "unprognostic (2.34e-3)" "unprognostic (2.52e-1)" "unprognostic (8.68e-2)" "unprognostic (1.35e-1)" "unprognostic (6.31e-2)" "unprognostic (1.87e-1)" "prognostic unfavorable (6.05e-4)" "unprognostic (2.06e-1)" "unprognostic (7.18e-2)" "unprognostic (5.24e-2)" "unprognostic (9.64e-2)" "unprognostic (4.27e-2)" "unprognostic (1.05e-3)" "unprognostic (5.37e-2)" "unprognostic (2.98e-1)" "unprognostic (1.20e-1)" "unprognostic (8.86e-2)" 15.6 14.3 17.2 21.4 19.5 13.6 24.7 21.6 19.5 19.3 22.2 19.1 18.3 22.1 28.2 12.4 14.4 20.4 19.5 18.4 16.6 12.3 17.7 13.8 17.9 22.2 24.0 14.1 23.5 17.0 19.5 17.2 16.6 17.2 19.4 9.8 13.4 14.9 23.2 28.1 18.2 26.5 19.4 17.5 21.6 17.7 11.3 22.4 32.2 17.8 15.6 17.7 18.2 21.7 12.5 13.2 23.2 15.2 10.8 20.0 11.2 10.8 6.9 11.8 11.6 5.2 6.4 15.0 11.7 9.5 15.2 10.2 9.1 17.9 10.5 16.0 9.3 18.9 10.6 10.5 10.5 3.4 22.6 7.7 19.0 18.6 5.5 16.0 13.4 20.3 10.1 19.5 19.2 15.2 11.2 12.8 19.1 11.4 29.6 10.0 7.3 19.1 20.8 8.4 7.3 15.5 18.9 5.6 20.0 11.6 6.9 11.8 13.5 8.0 14.6 25.4 7.6 17.0 14.1 11.2 11.4 9.7 14.5 12.7 19.9 13.2 15.1 12.9 9.0 18.9 16.2 12.4 23.2 20.0 14.3 19.6 12.5 15.1 17.2 13.0 10.6 12.0 14.7 8.5 10.8 15.2 13.2 12.8 11.2 17.2 19.5 21.6 19.5 16.6 12.3 24.0 14.1 17.2 22.4 11.9 17.3 13.7 18.5 7.1 18.0 6.7 15.3 18.7 15.9 7.0 19.6 18.3 5.0 21.3 50.1 11.3 25.7 0.0 19.4 19.4 11.8 9.8 13.9 8.3 16.9 22.3 16.1 14.1 14.6 97.2 20.1 15.3 10.1 36.1 20.9 13.8 21.1 21.0 25.5 12.1 22.2 38.8 16.7 23.6 13.8 6.5 16.5 21.9 18.9 11.2 MUTYH MYH ENSG00000132781 "MutY DNA glycosylase" Q9UIF7 1 45329163-45340470 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Glycosidase, Hydrolase" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA008732 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA008732: AB_1854219" "unprognostic (6.30e-3)" "unprognostic (7.12e-2)" "unprognostic (6.29e-2)" "unprognostic (8.80e-2)" "unprognostic (3.43e-1)" "unprognostic (5.16e-3)" "prognostic unfavorable (4.76e-8)" "unprognostic (2.80e-2)" "unprognostic (7.12e-3)" "unprognostic (3.05e-2)" "unprognostic (7.80e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (7.25e-5)" "unprognostic (3.50e-3)" "unprognostic (1.62e-1)" "unprognostic (5.57e-2)" "unprognostic (5.49e-3)" 7.7 8.4 10.3 12.7 14.8 11.1 8.3 31.6 12.4 10.5 10.1 15.1 11.0 11.1 11.5 9.8 8.3 11.0 10.0 6.1 10.9 7.3 9.7 9.0 7.2 14.0 13.6 10.1 12.9 8.4 7.5 12.5 12.5 11.6 9.1 11.0 12.6 9.5 11.7 8.5 11.1 9.8 7.5 12.6 12.8 11.8 4.9 16.6 14.1 11.9 7.4 12.0 9.3 9.2 7.2 6.5 1.9 8.9 6.6 15.4 6.3 4.9 4.3 10.1 6.9 7.2 5.4 17.6 3.4 4.7 7.4 6.1 9.1 7.0 13.9 6.1 2.3 5.9 7.6 5.3 6.3 3.4 11.5 4.0 6.8 6.9 6.5 6.7 5.8 5.0 3.6 6.5 9.9 16.6 1.9 5.3 18.3 10.5 5.4 3.1 8.0 15.9 5.5 25.5 11.7 5.3 21.6 7.8 7.5 3.8 9.3 9.2 7.2 7.4 5.8 11.5 13.6 4.6 6.7 3.3 6.5 4.0 5.0 5.4 8.2 9.4 8.5 5.6 8.8 4.9 1.5 5.6 1.9 9.8 8.9 15.4 7.2 10.2 9.9 6.5 7.2 11.3 11.0 0.9 6.6 6.8 5.5 10.3 6.3 10.3 14.8 31.6 12.4 10.9 7.3 13.6 10.1 11.6 16.6 0.0 6.4 7.0 10.7 6.2 14.7 3.1 0.0 9.4 6.8 7.0 2.0 33.3 3.3 5.7 0.8 5.2 13.7 0.0 4.6 11.1 7.0 7.0 10.4 3.9 8.7 4.8 7.5 6.7 6.4 0.6 10.0 6.9 6.8 9.0 12.3 11.8 3.3 14.0 11.3 7.0 18.5 12.9 7.1 7.1 11.1 4.6 18.5 12.9 12.5 6.4 MVB12A "FAM125A, FLJ32495" ENSG00000141971 "Multivesicular body subunit 12A" Q96EY5 19 17405722-17433724 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041885, HPA042231" Approved Supported "Nucleoplasm,Golgi apparatus" No No Nucleoplasm "Golgi apparatus" "HPA041885: AB_10964218, HPA042231: AB_10961043" "unprognostic (1.34e-2)" "prognostic favorable (3.26e-4)" "unprognostic (1.48e-1)" "unprognostic (2.35e-2)" "unprognostic (1.12e-1)" "unprognostic (1.52e-2)" "unprognostic (5.96e-3)" "unprognostic (8.49e-2)" "unprognostic (1.80e-1)" "unprognostic (1.77e-1)" "unprognostic (9.93e-2)" "unprognostic (3.87e-2)" "unprognostic (2.29e-1)" "unprognostic (2.54e-1)" "unprognostic (2.89e-1)" "unprognostic (1.75e-1)" "unprognostic (1.33e-2)" 18.4 24.6 9.4 16.2 9.8 14.1 21.1 10.1 12.3 13.4 16.3 13.3 22.2 19.0 16.4 15.2 24.0 16.8 17.1 10.4 8.2 6.1 17.4 16.6 12.4 21.1 11.8 7.1 33.8 16.8 9.6 7.2 15.1 8.8 12.5 9.5 15.6 17.0 17.3 11.4 20.0 20.4 9.0 9.2 17.7 14.2 10.7 11.3 19.6 29.5 12.4 22.8 15.6 15.3 13.8 28.2 24.6 30.6 17.7 26.3 17.4 16.6 9.4 4.3 13.1 6.1 9.8 24.0 5.2 10.4 14.1 17.4 8.6 24.8 13.3 17.3 11.4 10.0 8.1 8.5 12.7 3.8 14.1 23.8 3.0 19.4 20.1 18.9 5.3 12.8 10.7 9.9 10.9 6.8 9.2 15.5 10.5 9.3 26.0 5.6 12.5 9.4 8.3 6.3 13.2 26.4 12.0 4.8 19.5 11.5 9.2 8.4 12.4 7.6 11.2 26.9 4.5 14.8 11.1 7.5 10.6 5.6 11.4 6.2 18.5 23.0 14.5 11.1 18.7 13.0 24.6 30.1 19.2 17.3 30.6 16.2 11.9 17.5 16.3 28.2 13.8 14.7 14.4 17.6 17.7 23.8 25.5 26.3 17.4 9.4 9.8 10.1 12.3 8.2 6.1 11.8 7.1 8.8 11.3 8.9 8.0 13.4 34.3 34.7 5.6 5.2 50.9 24.1 6.8 43.6 5.9 48.6 46.4 68.9 9.1 33.7 66.4 0.0 42.2 82.3 43.2 18.8 21.8 25.5 61.9 3.2 25.4 59.5 39.5 12.8 40.3 24.2 30.4 44.1 43.8 29.5 52.9 66.6 44.2 47.1 13.2 6.5 36.3 13.6 10.4 38.3 34.0 23.5 54.2 41.4 MXD1 "bHLHc58, MAD, MAD1" ENSG00000059728 "MAX dimerization protein 1" Q05195 2 69897688-69942945 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 81.1;bone marrow: 72.8;esophagus: 64.8" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 212.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 81.1" "Lineage enriched" "Detected in many" 49 "granulocytes: 81.1" "Cell line enhanced" "Detected in many" "hTERT-HME1: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001599 Enhanced Uncertain Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA001599: AB_1079434" "unprognostic (1.59e-1)" "unprognostic (5.11e-2)" "unprognostic (1.63e-2)" "prognostic unfavorable (8.14e-6)" "unprognostic (1.49e-1)" "unprognostic (1.76e-1)" "unprognostic (4.36e-2)" "unprognostic (8.73e-3)" "unprognostic (3.39e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (8.50e-4)" "unprognostic (8.72e-2)" "unprognostic (3.24e-2)" "unprognostic (1.59e-1)" "unprognostic (1.61e-1)" "unprognostic (1.56e-3)" "unprognostic (1.77e-2)" 6.9 2.2 2.7 18.7 3.8 72.8 3.7 5.7 4.1 15.8 19.6 4.7 0.9 13.6 2.9 2.6 64.8 3.8 4.9 10.8 3.0 2.9 3.0 5.5 17.0 14.3 5.9 2.4 3.3 2.5 3.6 4.0 15.8 3.1 3.3 14.0 5.1 8.8 1.4 3.1 5.9 50.2 4.6 4.3 15.8 8.2 3.6 3.7 9.4 4.0 20.8 34.0 6.3 21.6 0.2 0.8 81.1 1.6 0.4 0.4 0.6 3.5 1.5 2.2 1.6 5.0 2.5 8.4 3.9 2.2 1.9 1.3 4.9 2.8 2.0 2.0 1.5 1.9 12.6 4.2 7.8 2.0 1.1 5.1 4.2 4.5 4.9 16.8 5.0 4.2 2.8 13.3 4.4 20.4 2.4 2.4 2.1 7.3 8.1 1.2 2.8 2.4 10.1 0.6 5.2 2.5 1.1 2.3 5.0 2.5 4.2 7.3 3.1 5.2 7.0 2.7 2.7 1.0 3.0 9.6 2.8 0.8 3.0 3.7 5.5 9.3 0.8 2.9 8.9 1.0 17.0 1.6 16.8 0.3 1.0 0.4 0.1 0.2 0.2 0.8 0.2 0.2 0.3 81.1 0.4 0.8 0.2 0.2 0.6 2.7 3.8 5.7 4.1 3.0 2.9 5.9 2.4 3.1 3.7 35.7 30.8 18.2 23.9 22.9 27.8 4.8 7.6 10.7 11.4 1.8 51.1 7.9 6.6 10.8 12.4 9.0 212.1 0.0 14.8 5.1 13.6 61.3 26.5 6.7 26.9 9.5 93.4 6.2 48.3 15.3 4.4 71.5 15.1 20.8 115.5 40.4 44.4 91.2 2.5 5.1 17.8 0.0 28.7 8.1 2.0 49.3 88.6 20.8 26.6 110.0 MXD3 "bHLHc13, MAD3" ENSG00000213347 "MAX dimerization protein 3" Q9BW11 5 177301461-177312757 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.1;lymphoid tissue: 59.4" "Cell type enriched" "Detected in many" 7 "Erythroid cells: 116.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 14.1" "Group enriched" "Detected in many" 6 "granulocytes: 14.1;monocytes: 8.7" "Cell line enhanced" "Detected in many" "HDLM-2: 59.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA070111 Approved Nucleoplasm,Nucleoli NA Yes "Nucleoplasm, Nucleoli" "HPA070111: AB_2686228" "unprognostic (2.78e-1)" "unprognostic (1.32e-2)" "unprognostic (2.11e-1)" "unprognostic (3.63e-1)" "unprognostic (8.26e-2)" "unprognostic (6.18e-3)" "prognostic unfavorable (3.60e-4)" "unprognostic (3.32e-1)" "unprognostic (6.84e-2)" "unprognostic (3.12e-2)" "unprognostic (4.97e-2)" "unprognostic (2.84e-2)" "unprognostic (3.33e-16)" "unprognostic (8.55e-3)" "unprognostic (2.22e-1)" "unprognostic (1.61e-1)" "unprognostic (3.22e-3)" 2.5 1.8 1.3 28.2 1.9 32.1 5.4 1.2 3.4 2.4 6.8 1.2 2.8 6.9 2.7 6.2 6.6 3.6 2.8 2.4 1.6 0.8 2.7 6.6 5.4 7.3 2.2 1.2 2.6 5.8 0.7 4.3 4.5 2.1 5.0 0.9 1.1 4.7 2.1 3.6 10.3 5.6 1.4 1.3 10.3 3.8 3.1 2.9 59.4 3.5 3.7 13.5 2.7 3.6 2.0 1.6 14.1 8.7 0.7 0.8 1.1 8.1 5.6 3.5 9.5 0.2 0.5 5.8 10.6 3.5 4.8 4.6 3.7 8.5 4.3 4.4 1.4 2.6 4.0 0.4 1.2 0.2 59.2 7.2 2.4 8.1 5.4 0.5 2.3 7.5 0.3 0.6 0.3 0.2 0.4 4.4 19.2 1.5 13.6 0.9 10.4 21.6 6.5 1.2 2.5 9.8 10.6 10.8 6.2 1.0 1.1 8.6 7.1 6.8 6.9 3.7 0.5 10.9 6.2 3.2 5.8 15.0 4.6 5.6 18.0 5.9 4.7 4.5 8.1 3.3 3.5 2.6 7.7 0.7 7.2 0.0 1.6 0.1 0.1 1.6 2.0 0.0 0.3 14.1 0.7 8.7 1.0 0.8 1.1 1.3 1.9 1.2 3.4 1.6 0.8 2.2 1.2 2.1 2.9 3.0 2.2 0.0 1.5 4.9 2.8 1.2 5.1 5.3 4.5 5.2 0.0 4.5 0.0 1.3 16.3 2.3 4.0 116.8 3.5 7.2 3.4 2.4 9.2 3.9 8.8 3.2 1.7 4.3 4.9 1.9 1.7 5.1 3.3 1.0 5.0 1.0 1.9 3.1 1.4 0.3 2.2 0.0 3.1 0.7 5.9 5.0 11.0 5.1 6.9 1.8 MXI1 "bHLHc11, MAD2, MXD2, MXI" ENSG00000119950 "MAX interactor 1, dimerization protein" P50539 10 110207605-110287365 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 32.0;SK-MEL-30: 52.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035319, HPA035320, HPA056762" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" Yes No Nucleoplasm "Nucleoli, Nucleoli rim, Cytosol" "HPA035319: AB_10670588, HPA035320: , HPA056762: AB_2683229" "unprognostic (1.77e-2)" "unprognostic (2.02e-1)" "unprognostic (3.34e-1)" "unprognostic (3.03e-2)" "unprognostic (1.11e-1)" "unprognostic (1.71e-2)" "unprognostic (1.08e-2)" "unprognostic (1.03e-1)" "unprognostic (1.37e-2)" "unprognostic (1.59e-1)" "unprognostic (9.26e-3)" "prognostic unfavorable (9.17e-4)" "prognostic unfavorable (1.02e-5)" "unprognostic (3.05e-2)" "unprognostic (1.36e-2)" "unprognostic (2.29e-1)" "unprognostic (2.96e-1)" 16.9 19.4 37.2 7.5 34.9 32.7 26.5 56.4 36.9 20.3 26.4 33.9 20.1 12.0 26.0 23.8 39.5 19.1 17.4 36.0 35.1 26.6 23.9 30.5 16.5 7.1 37.0 25.9 46.4 23.1 25.6 12.1 14.4 26.2 24.5 22.1 15.8 41.2 32.7 22.8 25.4 22.5 18.2 44.7 7.8 14.7 13.5 38.1 7.0 29.2 13.4 9.8 32.8 33.9 4.5 2.2 11.0 4.7 1.4 8.6 2.3 5.4 2.2 5.6 11.2 8.8 6.7 2.4 3.2 10.8 2.1 6.6 0.9 9.8 7.2 5.2 5.5 3.5 7.1 6.7 7.6 5.6 3.6 9.0 1.9 4.4 4.1 5.8 3.8 4.3 7.1 29.0 3.7 14.8 32.0 2.0 5.7 7.1 15.6 3.5 3.5 2.5 7.8 2.4 8.9 6.7 1.6 7.3 11.4 7.3 0.5 9.5 15.7 3.1 2.3 52.2 7.3 2.6 12.5 2.0 3.7 6.4 4.0 1.6 12.9 6.8 2.6 10.0 14.2 3.9 2.2 3.1 11.0 3.1 2.5 5.8 3.9 6.7 3.6 1.7 4.5 8.6 2.2 7.8 1.4 4.7 2.2 5.0 2.3 37.2 34.9 56.4 36.9 35.1 26.6 37.0 25.9 26.2 38.1 14.9 15.6 8.3 48.3 51.5 37.3 78.1 28.1 21.4 31.8 31.4 45.2 3.4 39.7 15.1 4.1 38.3 50.6 116.8 12.7 13.2 31.9 46.8 3.5 46.4 10.1 49.3 16.3 19.6 18.4 7.0 41.7 19.0 99.5 18.0 20.8 127.5 14.4 35.1 52.3 53.0 43.0 45.3 88.6 8.6 26.0 58.8 8.1 21.3 15.6 33.1 MYB c-myb ENSG00000118513 "MYB proto-oncogene, transcription factor" P10242 6 135181315-135219173 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 104.9" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 44.2;granulocytes: 25.4;Intestinal endocrine cells: 16.9;Mucus-secreting cells: 26.5;Undifferentiated cells: 37.5" "Cancer enhanced" "Detected in many" "breast cancer: 17.7" "Region enhanced" "Detected in some" "basal ganglia: 4.7" "Group enriched" "Detected in some" 4 "basophil: 5.6;eosinophil: 10.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 10.0" "Cell line enhanced" "Detected in many" "HL-60: 39.5;MOLT-4: 72.0;NB-4: 37.5;REH: 44.5;THP-1: 62.8;U-937: 34.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB017704, HPA071605" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB017704: , HPA071605: " "unprognostic (1.69e-1)" "unprognostic (5.82e-2)" "unprognostic (1.82e-3)" "unprognostic (1.37e-2)" "unprognostic (4.06e-1)" "unprognostic (8.35e-3)" "unprognostic (1.13e-3)" "unprognostic (2.48e-2)" "unprognostic (6.44e-2)" "unprognostic (1.00e-1)" "unprognostic (3.71e-2)" "prognostic favorable (9.65e-4)" "unprognostic (2.41e-11)" "prognostic favorable (9.87e-4)" "unprognostic (8.35e-2)" "unprognostic (3.04e-2)" "unprognostic (9.40e-2)" 0.5 0.7 1.3 9.1 4.7 18.9 13.2 0.3 0.6 1.4 15.4 0.5 0.3 6.5 0.9 1.0 3.7 5.0 1.7 0.6 0.7 0.7 0.4 0.5 1.8 3.3 0.3 0.5 1.0 0.3 0.4 0.3 0.6 0.5 1.6 16.7 0.5 0.8 1.5 1.0 3.5 5.9 0.7 0.4 1.4 0.9 2.0 0.6 104.9 0.4 2.0 4.7 0.7 1.5 0.1 1.7 10.0 0.8 0.0 0.5 0.1 0.3 0.0 0.3 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.2 1.8 0.0 0.0 0.0 0.1 1.0 0.0 0.1 3.1 0.4 25.2 0.1 0.0 0.0 39.5 20.0 0.0 0.0 0.1 0.0 0.0 0.0 24.8 20.4 3.8 0.2 2.0 72.0 37.5 0.2 3.5 0.3 44.5 1.0 6.1 0.0 0.2 1.9 1.2 0.0 2.0 0.0 0.1 1.5 62.8 0.0 0.0 0.3 1.5 0.4 4.8 1.2 12.2 0.0 34.2 0.4 5.6 0.8 10.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 1.7 0.5 0.1 1.3 4.7 0.3 0.6 0.7 0.7 0.3 0.5 0.5 0.6 0.0 2.2 2.9 1.1 2.4 0.6 0.4 2.5 44.2 10.3 0.0 0.0 0.7 0.0 0.0 0.1 0.0 2.9 0.0 0.7 0.6 0.4 2.7 25.4 0.0 0.9 0.0 16.9 0.0 1.2 0.0 0.0 1.5 8.5 0.0 26.5 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 6.0 0.2 1.9 37.5 2.0 MYBL1 "A-myb, AMYB" ENSG00000185697 "MYB proto-oncogene like 1" P10243 8 66562175-66614247 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 25.6" "Cell type enhanced" "Detected in many" 14 "Erythroid cells: 23.3;Spermatocytes: 32.1;T-cells: 50.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 4.9;MAIT T-cell: 3.5" "Group enriched" "Detected in many" 32 "NK-cells: 1.4;T-cells: 4.9" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 29.1;BJ hTERT+ SV40 Large T+ RasG12V: 24.7;Daudi: 29.7;HBF TERT88: 40.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA008791 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA008791: AB_1078540" "unprognostic (1.11e-1)" "unprognostic (2.47e-2)" "unprognostic (2.57e-1)" "unprognostic (7.23e-4)" "unprognostic (2.26e-1)" "unprognostic (1.89e-2)" "unprognostic (6.67e-3)" "unprognostic (2.38e-1)" "unprognostic (1.25e-1)" "unprognostic (3.78e-2)" "unprognostic (1.13e-2)" "unprognostic (3.74e-3)" "prognostic unfavorable (2.03e-8)" "unprognostic (2.04e-1)" "unprognostic (1.55e-1)" "unprognostic (1.75e-1)" "unprognostic (5.87e-2)" 2.1 1.1 2.6 25.6 5.1 2.5 2.2 6.5 3.8 1.6 2.1 4.0 2.6 1.7 1.6 2.9 1.5 1.8 3.3 3.9 3.4 2.2 1.4 2.4 4.5 21.7 6.4 2.8 1.2 0.7 1.3 1.2 4.1 6.3 2.6 1.9 1.8 1.2 2.2 1.3 1.6 3.9 2.7 6.5 11.0 2.2 12.7 4.4 4.7 1.5 1.0 18.0 2.2 1.9 0.0 0.0 0.0 0.0 1.4 4.9 0.3 11.8 4.1 1.3 3.5 0.3 0.7 0.9 16.4 7.6 29.1 24.7 0.5 12.1 29.7 1.5 13.8 10.9 3.4 1.2 1.3 40.3 3.5 1.9 0.6 4.5 0.5 0.0 0.2 1.2 0.2 0.1 8.0 6.7 5.2 0.9 2.2 0.1 9.9 17.7 1.0 1.9 0.4 1.0 1.1 5.5 0.6 4.9 0.7 6.8 0.4 2.9 1.1 2.9 1.0 2.9 2.1 17.6 0.8 5.0 17.5 4.0 3.9 15.0 2.9 3.9 8.8 4.6 1.8 6.9 0.0 0.0 0.0 4.9 0.0 3.5 0.0 0.9 2.0 0.0 0.0 0.1 0.8 0.0 1.4 0.0 0.0 0.0 0.3 2.6 5.1 6.5 3.8 3.4 2.2 6.4 2.8 6.3 4.4 0.0 2.9 0.9 0.4 1.5 9.2 8.1 0.0 2.7 0.0 0.0 2.0 1.2 0.0 0.6 3.0 0.7 0.0 23.3 0.0 0.6 1.3 0.2 0.0 0.8 0.5 4.8 0.0 3.1 0.6 3.2 0.9 1.4 1.7 1.0 0.1 10.3 0.1 0.0 0.0 0.6 9.3 0.0 2.1 32.1 5.7 0.4 1.3 50.3 0.2 0.1 MYBL2 "B-MYB, BMYB" ENSG00000101057 "MYB proto-oncogene like 2" P10244 20 43667019-43716496 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 35.9;bone marrow: 33.0;lymphoid tissue: 49.2" "Cell type enhanced" "Detected in many" 22 "Erythroid cells: 93.5;Extravillous trophoblasts: 28.3;Spermatogonia: 25.7" "Cancer enriched" "Detected in all" 5 "testis cancer: 295.8" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 30 "plasmacytoid DC: 35.9" "Lineage enriched" "Detected in many" 30 "dendritic cells: 35.9" "Cell line enhanced" "Detected in many" "MCF7: 103.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB017114, HPA030530, HPA055416" Uncertain Supported Nucleoplasm,Cytosol Yes Yes Nucleoplasm Cytosol "CAB017114: , HPA030530: AB_2673515, HPA055416: AB_2682811" "unprognostic (9.75e-3)" "unprognostic (1.29e-2)" "unprognostic (3.20e-1)" "prognostic unfavorable (9.73e-4)" "unprognostic (2.35e-1)" "unprognostic (1.67e-1)" "prognostic unfavorable (2.11e-7)" "unprognostic (2.66e-3)" "unprognostic (9.23e-3)" "unprognostic (1.78e-1)" "unprognostic (2.38e-3)" "unprognostic (1.32e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.42e-1)" "unprognostic (2.27e-1)" "unprognostic (1.19e-1)" "unprognostic (1.84e-1)" 1.7 0.7 0.2 48.3 0.2 33.0 1.0 0.2 0.2 1.0 4.4 0.2 0.1 2.7 1.1 1.1 8.4 0.3 1.7 0.9 0.2 0.2 1.0 1.2 1.8 22.3 0.3 0.1 0.8 9.4 0.0 0.4 4.0 0.2 0.7 2.7 0.3 2.9 0.1 0.3 1.8 6.4 0.6 0.3 43.9 2.9 12.6 0.1 49.2 0.6 6.4 33.8 1.9 2.1 1.1 35.9 0.0 0.0 0.0 0.4 0.3 26.3 16.8 14.9 15.4 0.1 0.5 19.3 11.9 4.0 37.8 27.9 82.4 16.6 53.3 6.9 5.2 7.9 16.1 26.9 8.2 14.2 9.9 17.2 24.9 16.8 22.2 0.0 22.7 17.3 0.3 0.7 14.4 3.2 0.8 10.1 26.5 24.8 66.3 3.3 103.7 46.1 32.0 17.1 21.2 14.7 32.1 30.6 30.5 7.0 5.4 13.7 20.0 35.5 35.7 3.6 16.4 23.5 24.9 4.7 2.3 38.0 16.7 20.5 23.0 47.4 83.8 4.9 19.5 14.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 35.9 0.4 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.1 0.2 0.1 0.0 0.0 13.4 0.2 3.8 0.0 1.7 2.5 0.0 0.0 0.0 0.0 2.4 0.0 0.0 4.3 0.0 0.5 93.5 0.8 28.3 0.4 0.1 0.0 0.0 11.2 0.0 0.0 1.3 1.6 10.0 0.0 0.5 1.7 0.0 1.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 3.4 25.7 2.0 3.1 2.1 2.2 0.9 MYBPH ENSG00000133055 "Myosin binding protein H" Q13203 1 203167811-203175813 "Predicted intracellular proteins" "Cell adhesion" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 53.8" "Cell type enhanced" "Detected in single" 33 "Alveolar cells type 2: 2.2" "Group enriched" "Detected in many" 7 "glioma: 4.9;head and neck cancer: 20.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 6.1" "Lineage enriched" "Detected in many" 6 "dendritic cells: 6.1" "Group enriched" "Detected in some" 5 "CACO-2: 17.6;HSkMC: 34.5;THP-1: 8.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA061383 Enhanced Approved Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoplasm, Mitochondria" Nucleoli "HPA061383: AB_2684497" "unprognostic (2.26e-4)" "unprognostic (2.04e-1)" "unprognostic (3.50e-1)" "unprognostic (1.06e-1)" "unprognostic (3.82e-2)" "unprognostic (1.32e-3)" "unprognostic (3.42e-1)" "unprognostic (6.84e-2)" "unprognostic (1.18e-1)" "unprognostic (2.96e-1)" "unprognostic (2.86e-1)" "unprognostic (1.75e-1)" "unprognostic (7.62e-4)" "unprognostic (1.51e-1)" "unprognostic (3.34e-2)" "unprognostic (1.14e-1)" "unprognostic (1.74e-1)" 0.8 0.1 1.1 0.8 0.8 0.3 0.4 0.4 0.6 0.1 0.1 0.0 0.0 0.1 0.4 4.4 3.9 0.2 0.1 0.2 0.4 0.3 1.1 1.5 0.2 0.3 1.3 0.0 0.1 0.2 0.1 0.6 0.3 1.0 4.2 0.1 0.0 8.8 0.1 53.8 0.2 0.1 0.1 0.4 0.4 0.1 0.2 2.1 0.9 3.9 12.7 2.0 0.3 0.8 0.0 6.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 4.4 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 34.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 6.1 0.0 0.1 1.1 0.8 0.4 0.6 0.4 0.3 1.3 0.0 1.0 2.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 MYC "bHLHe39, c-Myc, MYCC" ENSG00000136997 "MYC proto-oncogene, bHLH transcription factor" P01106 8 127735434-127741434 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 812.6;Basal keratinocytes: 900.0;Smooth muscle cells: 529.5;Suprabasal keratinocytes: 935.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 132.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000084, CAB010307, HPA055893, HPA066556" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB000084: , CAB010307: AB_631274, HPA055893: AB_2682960, HPA066556: AB_2685691" "unprognostic (1.45e-2)" "unprognostic (4.00e-3)" "unprognostic (3.94e-3)" "unprognostic (2.41e-3)" "unprognostic (8.14e-2)" "unprognostic (3.36e-3)" "unprognostic (5.80e-2)" "unprognostic (4.94e-3)" "unprognostic (1.59e-1)" "prognostic unfavorable (7.52e-4)" "unprognostic (5.19e-3)" "unprognostic (9.86e-3)" "prognostic unfavorable (5.49e-8)" "unprognostic (7.85e-2)" "unprognostic (4.66e-2)" "unprognostic (2.48e-1)" "prognostic unfavorable (4.96e-5)" 67.4 20.8 3.2 46.6 7.1 16.3 36.0 1.2 5.0 23.9 23.3 3.8 11.8 11.1 23.8 14.4 47.6 59.5 32.4 23.7 5.8 2.2 11.2 36.6 16.0 40.5 5.8 1.2 38.7 64.6 2.1 7.4 14.9 9.8 20.6 11.3 6.1 14.4 21.8 69.6 78.5 17.2 21.3 12.0 38.3 24.7 16.3 3.8 40.2 9.0 48.4 27.1 28.9 37.3 25.5 8.8 1.0 10.3 20.9 55.2 22.0 7.2 14.0 1.2 12.5 20.4 24.1 3.7 8.7 3.8 10.9 9.1 19.2 19.1 74.3 12.3 5.2 10.7 15.8 65.1 28.3 7.2 17.5 22.7 44.7 23.8 25.0 18.8 31.2 7.2 16.8 62.6 7.3 58.0 8.8 12.5 26.2 66.0 39.3 5.4 20.8 51.0 68.1 3.5 31.3 28.1 28.4 5.3 132.1 9.1 7.5 86.4 8.2 4.0 34.1 22.6 2.1 13.9 20.5 15.2 8.2 9.8 6.3 10.9 0.7 1.2 35.9 7.2 35.0 4.1 0.7 10.3 0.1 8.6 9.1 43.4 25.5 31.1 18.6 8.8 20.6 55.2 34.8 1.0 20.9 6.1 0.3 24.8 22.0 3.2 7.1 1.2 3.6 5.8 2.2 5.8 1.2 9.8 3.8 53.6 68.5 50.1 812.6 900.0 0.0 10.2 28.1 18.7 83.0 12.2 0.0 20.0 1.7 71.3 0.9 89.5 6.3 0.0 37.0 51.5 149.4 176.0 54.4 27.1 25.9 0.0 12.0 96.3 42.9 1.1 91.5 19.1 160.3 3.6 66.1 1.0 60.5 11.5 63.3 5.3 0.2 45.3 529.5 0.5 0.7 935.3 4.9 39.5 82.4 301.8 MYCBP AMY-1 ENSG00000214114 "MYC binding protein" Q99417 1 38862964-38874105 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 163.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041188, HPA078331" Supported Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA041188: AB_10794405, HPA078331: AB_2686882" "unprognostic (2.42e-2)" "unprognostic (6.60e-2)" "unprognostic (3.85e-3)" "unprognostic (9.46e-3)" "unprognostic (8.77e-2)" "unprognostic (2.16e-1)" "prognostic unfavorable (6.03e-6)" "unprognostic (7.59e-2)" "unprognostic (3.00e-3)" "unprognostic (5.03e-3)" "unprognostic (4.41e-3)" "unprognostic (2.34e-3)" "unprognostic (5.81e-3)" "unprognostic (8.02e-3)" "unprognostic (1.30e-1)" "unprognostic (1.20e-2)" "unprognostic (2.41e-2)" 8.6 10.5 4.8 13.6 7.4 9.0 14.5 4.6 4.9 11.6 14.9 3.6 21.3 10.5 9.6 18.2 23.4 17.7 15.6 16.8 5.2 4.9 26.5 21.1 16.1 20.7 4.6 3.1 9.3 20.0 13.9 12.5 24.8 11.2 13.6 15.6 6.6 22.9 17.3 11.8 12.0 24.4 14.6 4.9 16.8 13.1 28.9 5.2 16.8 24.3 18.1 19.6 13.0 11.9 9.0 21.7 32.1 15.1 11.0 12.9 8.1 18.5 8.1 7.2 5.2 4.2 7.4 28.7 14.9 4.9 15.1 11.9 9.5 22.3 15.3 16.6 6.8 2.4 13.9 11.2 19.4 18.3 19.2 18.6 16.3 11.6 10.0 1.1 40.4 14.8 6.6 15.5 12.5 7.9 5.8 11.0 17.6 23.6 14.2 15.8 10.9 12.9 19.4 18.2 28.1 20.4 12.4 21.2 21.4 19.7 15.7 13.6 9.3 14.3 19.0 9.6 17.2 13.0 19.5 8.7 7.9 13.3 12.1 17.0 9.5 17.0 16.9 7.9 23.8 10.3 14.8 12.6 32.1 7.8 15.1 8.9 9.0 9.7 9.3 16.0 6.4 8.4 9.3 25.1 11.0 13.5 21.7 12.9 8.1 4.8 7.4 4.6 4.9 5.2 4.9 4.6 3.1 11.2 5.2 8.9 13.3 18.6 14.6 9.4 0.6 7.3 22.9 163.3 36.4 26.2 0.0 96.0 54.7 19.6 63.4 10.8 26.5 23.3 23.9 75.4 7.3 14.2 26.4 13.4 19.0 9.5 9.2 6.2 15.1 16.8 6.6 15.9 18.6 23.4 25.1 3.8 23.0 38.6 8.5 34.2 4.5 6.5 12.2 22.9 68.8 15.6 73.7 21.5 26.9 20.0 MYCBP2 "FLJ10106, KIAA0916, PAM" ENSG00000005810 "MYC binding protein 2, E3 ubiquitin protein ligase" O75592 13 77044655-77327050 "Enzymes, Predicted intracellular proteins" "Biological rhythms, Ubl conjugation pathway" "Guanine-nucleotide releasing factor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 40.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058807 Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA058807: AB_2732627" "unprognostic (1.79e-1)" "unprognostic (1.25e-1)" "unprognostic (1.60e-1)" "unprognostic (1.06e-1)" "unprognostic (1.75e-1)" "unprognostic (2.03e-2)" "unprognostic (8.36e-2)" "unprognostic (1.21e-1)" "unprognostic (1.09e-1)" "unprognostic (1.80e-1)" "unprognostic (1.48e-1)" "unprognostic (6.42e-2)" "prognostic favorable (5.01e-5)" "unprognostic (2.63e-1)" "unprognostic (9.84e-2)" "unprognostic (4.04e-2)" "unprognostic (1.00e-1)" 28.0 13.4 31.0 26.1 28.8 24.1 22.4 31.3 32.7 15.5 10.9 8.1 11.5 8.0 16.2 26.7 18.9 11.7 11.1 13.5 24.1 18.6 12.3 13.2 12.4 29.8 15.3 31.1 22.8 12.6 14.5 17.2 9.6 20.0 17.9 11.5 9.6 12.9 12.4 13.7 57.6 13.6 13.2 14.0 24.1 10.3 14.1 16.2 18.6 11.6 12.6 30.7 13.3 34.0 8.3 4.6 3.3 3.7 4.2 7.3 2.5 7.8 4.0 4.9 5.3 24.5 10.9 2.8 5.0 7.4 4.4 5.7 3.5 4.1 22.5 3.2 9.8 4.3 7.3 8.4 9.2 6.0 8.9 8.3 19.1 8.2 7.3 8.3 40.0 6.8 12.2 7.7 4.0 8.0 4.3 9.9 8.3 4.0 7.1 7.8 4.7 10.9 27.0 2.6 10.5 5.1 12.5 5.0 5.4 7.4 7.8 7.7 3.6 6.0 8.7 4.5 5.2 3.2 30.7 13.0 4.2 3.5 2.7 4.8 7.7 5.3 16.1 8.5 33.0 4.2 2.0 3.5 3.2 5.8 3.7 5.1 7.9 6.5 5.0 3.2 8.3 7.3 5.8 3.3 4.2 2.5 4.6 7.3 2.5 31.0 28.8 31.3 32.7 24.1 18.6 15.3 31.1 20.0 16.2 35.7 43.3 79.8 35.8 73.2 212.4 65.7 30.6 17.4 26.1 33.2 98.2 33.8 1.7 22.3 46.1 82.8 12.8 23.3 28.6 26.5 62.0 42.9 47.3 46.5 37.4 206.6 31.4 39.3 93.9 20.0 60.9 48.5 30.4 37.9 18.1 141.3 26.4 17.5 90.5 11.2 95.1 103.5 74.0 61.5 64.3 131.7 36.7 68.3 24.7 36.1 MYCL "bHLHe38, LMYC, MYCL1" ENSG00000116990 "MYCL proto-oncogene, bHLH transcription factor" P12524 1 39895426-39902256 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 46.4;skin 1: 26.0" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 21.7;Hepatocytes: 21.9;Mucus-secreting cells: 22.7;Urothelial cells: 22.1" "Cancer enhanced" "Detected in all" "urothelial cancer: 28.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 11.5;intermediate monocyte: 5.5;myeloid DC: 12.9;plasmacytoid DC: 15.4" "Group enriched" "Detected in many" 75 "dendritic cells: 15.4;monocytes: 11.5" "Group enriched" "Detected in some" 7 "U-266/70: 96.4;U-266/84: 70.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA063132, HPA074515" Enhanced "Nucleoplasm,Mitotic chromosome" NA NA Nucleoplasm "Mitotic chromosome" "HPA063132: AB_2684946, HPA074515: " "unprognostic (7.45e-2)" "unprognostic (6.91e-2)" "unprognostic (7.36e-2)" "unprognostic (1.83e-3)" "unprognostic (1.61e-2)" "unprognostic (2.92e-3)" "unprognostic (6.72e-3)" "prognostic favorable (4.49e-4)" "unprognostic (1.24e-1)" "unprognostic (1.77e-2)" "unprognostic (5.44e-2)" "unprognostic (1.12e-1)" "unprognostic (5.01e-3)" "unprognostic (2.75e-2)" "unprognostic (5.21e-2)" "unprognostic (1.53e-2)" "unprognostic (5.80e-2)" 0.3 0.3 1.2 4.4 2.1 0.1 1.7 0.8 1.7 3.6 7.5 1.8 8.5 2.6 1.0 4.0 17.8 1.6 2.3 0.7 1.1 0.9 0.8 6.4 1.9 2.9 0.6 1.4 0.5 46.4 0.0 2.1 11.2 1.8 5.3 3.6 1.8 4.6 16.6 0.6 26.0 7.3 1.2 1.1 4.0 3.3 1.5 0.6 6.4 4.2 3.1 6.0 18.4 7.3 0.0 15.4 0.1 11.5 0.0 0.1 3.8 0.2 0.0 2.9 0.7 0.0 0.0 7.1 0.1 0.0 0.2 0.1 0.1 0.1 0.4 0.3 0.0 0.0 0.7 2.0 0.5 0.1 0.4 1.1 0.1 0.0 0.1 0.0 0.0 1.7 0.2 2.4 0.0 0.2 0.0 0.2 1.1 0.7 0.0 0.1 0.2 0.0 0.0 2.8 0.4 0.1 0.2 3.4 0.6 0.2 11.6 0.5 0.7 0.2 0.4 0.1 1.1 0.7 3.7 0.0 0.0 1.1 1.3 0.1 96.4 70.7 0.2 0.0 0.4 0.0 0.0 11.5 0.0 0.0 5.5 0.0 0.0 0.0 0.1 12.9 0.0 0.0 0.0 0.1 0.0 2.3 15.4 0.0 3.8 1.2 2.1 0.8 1.7 1.1 0.9 0.6 1.4 1.8 0.6 0.0 0.6 0.0 9.0 6.0 0.2 3.3 0.0 1.4 4.5 8.7 0.0 21.7 0.0 1.1 0.1 0.5 9.5 0.0 5.1 11.3 0.7 4.8 0.0 21.9 4.9 0.0 16.6 2.5 6.9 0.2 0.0 9.6 1.7 0.0 22.7 1.1 2.4 8.5 0.0 0.0 0.0 0.0 0.3 0.0 0.7 10.3 14.6 0.0 10.5 22.1 MYCN "bHLHe37, MYCNOT, N-myc, NMYC" ENSG00000134323 "MYCN proto-oncogene, bHLH transcription factor" P04198 2 15940564-15947007 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 16.8" "Cell type enriched" "Detected in some" 8 "Extravillous trophoblasts: 75.4" "Cancer enhanced" "Detected in many" "testis cancer: 45.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.9;BEWO: 70.2;HMC-1: 16.9;NTERA-2: 26.6;RH-30: 18.6;SuSa: 12.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057420 Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA057420: AB_2683434" "unprognostic (8.04e-2)" "unprognostic (1.96e-1)" "unprognostic (1.29e-1)" "unprognostic (2.07e-2)" "unprognostic (4.11e-1)" "unprognostic (2.46e-2)" "unprognostic (1.23e-2)" "unprognostic (3.03e-2)" "unprognostic (1.81e-1)" "unprognostic (3.35e-3)" "unprognostic (3.09e-2)" "unprognostic (2.09e-1)" "unprognostic (1.12e-3)" "unprognostic (8.89e-2)" "unprognostic (2.47e-1)" "unprognostic (4.90e-2)" "unprognostic (1.23e-1)" 0.9 1.9 5.1 1.8 5.5 1.6 1.2 1.4 8.4 3.1 1.2 12.1 0.0 3.0 1.9 0.8 1.3 1.4 2.6 2.3 7.0 4.7 6.0 1.5 1.6 2.9 6.0 2.2 10.3 0.7 0.4 0.7 16.8 6.8 0.6 1.3 1.1 6.6 0.7 1.0 2.4 1.7 0.9 8.9 0.9 8.5 6.5 4.0 5.7 5.1 2.3 3.5 2.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 70.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 26.6 0.6 0.0 0.0 18.6 3.5 0.0 0.9 0.2 4.7 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 5.5 1.4 7.0 7.0 4.7 6.0 2.2 6.8 4.0 0.0 0.0 0.0 0.1 0.5 2.6 0.7 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 1.2 0.2 0.0 0.0 0.0 75.4 0.6 0.0 0.0 0.5 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.2 0.0 0.4 2.1 0.1 0.0 0.0 0.5 3.6 0.0 9.6 0.0 0.2 0.0 MYCT1 "FLJ21269, MTLC" ENSG00000120279 "MYC target 1" Q8N699 6 152697895-152724567 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Endothelial cells: 121.1;Ito cells: 178.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 39 "eosinophil: 20.4" "Lineage enriched" "Detected in single" 190 "granulocytes: 20.4" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 46.9;TIME: 38.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047992 Approved Nucleoplasm,Vesicles NA NA 69000 Nucleoplasm Vesicles "HPA047992: " "unprognostic (2.92e-1)" "unprognostic (1.82e-1)" "unprognostic (5.95e-2)" "unprognostic (2.06e-1)" "unprognostic (6.73e-2)" "unprognostic (6.80e-2)" "unprognostic (4.64e-3)" "unprognostic (6.78e-2)" "unprognostic (9.90e-2)" "unprognostic (2.10e-1)" "unprognostic (2.66e-2)" "unprognostic (2.18e-2)" "prognostic unfavorable (4.73e-4)" "unprognostic (1.26e-3)" "unprognostic (1.08e-1)" "unprognostic (1.25e-1)" "unprognostic (3.36e-2)" 37.3 3.1 4.1 4.4 6.3 1.1 27.5 3.0 7.7 16.2 8.4 1.5 5.2 3.1 14.5 9.4 14.4 6.8 9.1 17.2 5.1 4.2 6.9 11.1 24.1 4.9 5.8 1.9 8.2 2.5 3.4 2.7 17.4 6.6 8.8 5.3 8.3 4.0 3.7 14.2 4.8 5.5 10.8 5.4 39.4 4.6 7.7 5.2 0.6 12.5 11.0 2.8 17.0 12.3 0.1 0.0 20.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 6.8 0.1 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 46.9 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 38.8 0.2 0.3 0.5 0.0 0.4 0.0 5.8 0.0 0.0 0.0 0.4 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 4.1 6.3 3.0 7.7 5.1 4.2 5.8 1.9 6.6 5.2 0.0 6.9 0.0 0.1 6.4 0.0 2.8 5.1 29.4 1.2 0.0 0.0 0.0 0.0 0.1 6.0 121.1 0.0 0.0 0.2 0.0 2.4 0.4 1.1 1.0 0.1 0.0 0.0 178.6 9.1 2.9 0.3 0.8 13.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.1 0.1 0.1 4.8 0.0 0.0 0.0 0.2 MYEF2 "FLJ11213, HsT18564, KIAA1341, MEF-2" ENSG00000104177 "Myelin expression factor 2" 15 48134631-48178517 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 75.7;Cone photoreceptor cells: 74.6;Horizontal cells: 77.9;Spermatocytes: 104.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 34.5;SCLC-21H: 30.8;SK-MEL-30: 30.1" "Low region specificity" "Detected in all" HPA004883 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA004883: AB_1079436" "unprognostic (4.30e-2)" "unprognostic (8.59e-2)" "unprognostic (5.01e-2)" "unprognostic (2.17e-1)" "unprognostic (2.02e-2)" "unprognostic (7.18e-3)" "unprognostic (2.76e-3)" "unprognostic (6.81e-2)" "unprognostic (2.35e-1)" "unprognostic (4.09e-2)" "unprognostic (1.55e-5)" "unprognostic (1.32e-2)" "unprognostic (3.76e-3)" "unprognostic (7.94e-2)" "unprognostic (2.51e-2)" "unprognostic (7.26e-2)" "unprognostic (4.05e-1)" 5.2 17.0 18.7 6.5 18.7 2.0 8.7 23.1 31.9 2.6 9.6 12.7 15.7 4.3 6.7 11.6 3.3 13.6 7.9 9.5 18.3 17.8 19.9 1.1 6.6 7.3 19.0 18.5 2.6 15.3 19.3 26.5 2.1 19.3 10.3 5.9 8.6 6.9 14.9 2.0 5.1 4.6 8.8 20.8 6.6 8.7 28.2 11.4 7.6 6.4 0.9 8.3 5.0 2.2 1.8 1.1 0.0 0.0 1.9 1.4 0.2 0.1 9.9 34.5 21.4 0.3 0.0 0.0 10.4 2.8 5.3 2.3 3.9 4.2 7.2 13.7 2.3 3.7 0.0 14.4 0.6 7.1 19.5 5.5 4.4 0.0 1.6 1.8 5.0 3.5 0.1 0.4 0.0 0.7 16.2 9.5 10.1 0.7 10.2 4.3 5.6 7.6 0.0 14.8 2.4 1.7 0.0 2.7 0.2 17.3 1.9 30.8 23.7 0.0 3.1 30.1 16.9 16.5 6.4 6.1 1.7 8.3 6.4 24.1 4.6 17.3 0.0 3.2 0.0 6.7 0.0 0.0 0.0 0.8 0.0 0.0 1.8 0.5 0.5 1.0 0.2 1.4 0.5 0.0 1.9 0.0 1.1 1.0 0.2 18.7 18.7 23.1 24.0 18.3 17.8 19.0 18.5 19.3 11.4 11.9 12.6 6.1 1.9 0.7 75.7 6.5 10.2 50.9 19.4 47.1 74.6 0.3 26.6 18.1 69.2 6.1 0.5 0.0 9.8 0.1 1.1 11.2 4.6 0.0 0.4 77.9 50.1 4.3 1.3 27.3 2.0 5.4 10.1 6.4 7.8 34.0 12.9 7.0 1.1 18.2 56.1 0.0 6.2 104.9 27.4 0.9 0.0 7.9 6.0 1.4 MYEOV OCIM ENSG00000172927 "Myeloma overexpressed" Q96EZ4 11 69294138-69367726 "Predicted membrane proteins" Proto-oncogene "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 29.4;breast: 16.9;esophagus: 17.3" "Cell type enriched" "Detected in some" 8 "Pancreatic endocrine cells: 116.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 59.2;A549: 28.4;CAPAN-2: 8.7;U-2 OS: 13.1" HPA012949 Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA012949: AB_1854241" "unprognostic (1.42e-2)" "unprognostic (8.56e-2)" "unprognostic (7.07e-2)" "unprognostic (3.36e-1)" "unprognostic (5.60e-2)" "unprognostic (7.28e-3)" "unprognostic (7.58e-3)" "prognostic unfavorable (2.00e-4)" "unprognostic (3.49e-1)" "unprognostic (6.33e-2)" "prognostic unfavorable (1.54e-7)" "unprognostic (2.83e-1)" "prognostic unfavorable (1.48e-5)" "unprognostic (2.08e-1)" "unprognostic (1.16e-1)" "unprognostic (3.35e-1)" "unprognostic (3.69e-2)" 29.4 0.2 0.0 2.4 0.0 0.2 16.9 0.1 0.0 2.6 1.1 0.0 0.4 0.4 0.5 8.1 17.3 0.0 1.3 0.1 0.0 0.2 0.2 8.6 0.1 0.2 0.0 0.1 0.1 2.1 0.0 0.1 0.0 0.0 0.1 0.6 0.9 2.0 0.0 0.6 4.9 0.8 0.1 0.0 0.3 10.7 0.4 0.0 0.1 0.1 5.3 13.6 0.2 4.7 0.5 0.0 0.0 0.1 1.0 0.3 2.1 59.2 28.4 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.2 8.7 0.2 2.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 1.0 2.3 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.8 0.1 0.0 1.0 0.1 0.8 0.0 13.1 0.0 0.6 0.1 0.6 0.1 0.0 0.2 1.1 0.0 0.1 0.0 0.2 0.0 0.3 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.3 0.0 0.0 0.0 3.5 0.0 0.0 0.0 15.5 10.5 0.0 0.4 0.0 8.4 0.2 0.2 1.2 0.0 0.0 2.4 0.0 0.0 0.0 0.0 4.7 0.3 0.0 0.0 0.0 1.0 0.0 116.0 12.5 0.0 0.0 0.0 0.0 1.4 0.0 0.4 1.1 0.1 0.0 0.5 6.8 MYF5 bHLHc2 ENSG00000111049 "Myogenic factor 5" P13349 12 80716912-80719673 "Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "skeletal muscle: 23.1;tongue: 13.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 22 "LHCN-M2: 104.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA041691 Supported Nucleoplasm NA NA Nucleoplasm "HPA041691: AB_10796780" "unprognostic (2.65e-2)" 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 13.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 104.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYH14 "DFNA4, FLJ13881, KIAA2034, MHC16, MYH17" ENSG00000105357 "Myosin heavy chain 14" Q7Z406 19 50188186-50310544 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell shape" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Deafness, Disease mutation, Neuropathy, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 78.6;skeletal muscle: 53.1" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 373.2;Paneth cells: 214.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 15.2;CAPAN-2: 19.2;HaCaT: 38.2;MCF7: 18.5;OE19: 19.5;RT4: 47.4;SK-BR-3: 16.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062391, HPA067889, HPA070260" Enhanced Approved Nucleoplasm NA NA 59000000 Nucleoplasm "HPA062391: AB_2684748, HPA067889: AB_2685917, HPA070260: AB_2686243" "unprognostic (2.52e-1)" "unprognostic (5.81e-2)" "unprognostic (9.63e-2)" "unprognostic (3.73e-3)" "unprognostic (1.44e-1)" "unprognostic (1.40e-1)" "unprognostic (1.39e-1)" "unprognostic (1.79e-1)" "unprognostic (1.71e-1)" "unprognostic (3.48e-2)" "unprognostic (1.93e-2)" "unprognostic (1.01e-1)" "prognostic favorable (3.97e-8)" "prognostic favorable (7.83e-4)" "unprognostic (8.50e-2)" "unprognostic (3.12e-1)" "unprognostic (2.77e-1)" 5.5 0.5 6.1 8.4 6.1 0.1 2.7 4.6 9.4 3.4 63.9 10.5 3.5 38.7 1.1 4.6 14.7 7.5 9.2 16.2 6.4 5.4 4.3 8.7 11.5 0.2 8.5 3.9 1.1 7.5 7.3 4.5 0.7 7.8 3.2 9.4 4.6 12.0 3.1 53.1 20.3 78.6 0.8 11.1 0.2 21.0 0.7 4.2 0.4 16.7 11.4 9.5 4.9 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 1.6 0.0 8.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 10.5 19.2 0.0 9.9 0.0 1.2 38.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 8.0 0.0 0.0 5.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 18.5 0.0 0.1 0.2 19.5 0.2 0.0 9.6 0.2 0.0 47.4 0.0 0.0 0.9 16.9 0.0 0.0 3.1 0.5 0.0 0.0 3.9 0.0 0.0 0.3 3.4 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 6.1 4.6 9.4 6.4 5.4 8.5 3.9 7.8 4.2 74.5 32.2 4.7 15.0 3.0 4.6 18.6 50.9 42.8 37.5 54.1 2.0 0.0 0.0 46.2 0.9 0.7 373.2 0.0 24.4 0.1 0.9 28.7 14.9 41.5 0.1 15.9 49.7 3.7 1.2 0.4 0.3 1.7 5.0 0.0 88.8 19.2 45.9 214.0 0.0 6.4 10.8 0.0 2.8 0.4 4.1 18.3 0.0 0.8 86.0 79.7 MYL12A "MLCB, MRCL3, MRLC3, MYL2B" ENSG00000101608 "Myosin light chain 12A" P19105 18 3247481-3256236 "Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 245.4;heart muscle: 248.0;skeletal muscle: 423.8" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 5937.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB004503, HPA039262, HPA045244, HPA059197" Supported Approved "Nucleoplasm,Nucleoli fibrillar center" NA Yes 70000000 "Nucleoplasm, Nucleoli fibrillar center" "CAB004503: AB_2282358, HPA039262: AB_2676418, HPA045244: AB_2679269, HPA059197: AB_2683944" "unprognostic (2.14e-3)" "unprognostic (5.30e-2)" "unprognostic (1.80e-1)" "unprognostic (5.31e-2)" "unprognostic (3.03e-2)" "unprognostic (7.95e-2)" "unprognostic (1.41e-1)" "unprognostic (1.57e-3)" "unprognostic (2.02e-1)" "unprognostic (2.53e-2)" "unprognostic (1.49e-3)" "unprognostic (2.30e-1)" "unprognostic (9.86e-2)" "unprognostic (1.30e-1)" "unprognostic (4.98e-2)" "unprognostic (4.58e-3)" "unprognostic (7.13e-2)" 60.9 19.9 7.1 31.1 13.1 21.7 63.9 5.1 7.6 25.1 31.2 7.4 22.5 15.6 24.1 29.0 43.6 22.8 32.4 248.0 8.2 6.8 52.7 43.1 58.3 58.4 14.6 5.7 28.6 24.8 24.9 11.1 49.5 18.9 24.3 27.2 14.7 26.5 18.6 423.8 24.2 41.5 27.9 22.1 68.6 22.5 20.4 10.3 40.3 38.6 80.1 42.0 30.6 31.2 103.4 166.8 173.4 91.9 104.2 168.7 245.4 31.3 20.0 45.6 19.1 53.9 56.8 27.9 71.6 94.5 68.1 74.3 30.2 39.8 15.2 18.9 103.9 47.6 13.7 26.4 44.9 61.1 21.4 9.4 15.5 23.8 26.5 90.3 44.1 30.3 88.8 63.7 52.8 32.0 62.5 106.8 20.4 19.4 53.2 139.6 53.7 20.5 44.4 18.7 36.4 14.8 11.9 23.9 26.7 149.3 50.9 6.4 15.6 56.6 24.4 49.5 44.0 17.2 65.2 114.2 16.9 38.5 46.2 56.5 12.1 17.5 24.6 50.7 17.7 60.4 173.4 74.5 154.6 166.4 77.4 166.7 103.4 156.8 168.7 109.0 80.4 142.5 167.0 122.8 104.2 91.9 166.8 133.2 245.4 7.1 13.1 5.1 7.6 8.2 6.8 14.6 5.7 18.9 10.3 684.9 287.2 341.2 723.8 564.8 28.8 5937.2 466.2 370.7 324.2 485.1 11.8 673.0 399.6 1177.4 18.9 908.8 703.7 0.0 1306.6 996.1 418.1 441.5 501.9 258.7 758.2 54.0 101.2 852.6 651.0 20.6 309.8 806.5 420.1 2189.4 519.0 67.5 1678.2 662.9 372.7 509.4 40.9 562.7 473.8 61.2 173.0 476.5 557.0 1044.7 325.5 594.7 MYL12B MRLC2 ENSG00000118680 "Myosin light chain 12B" O14950 18 3261909-3278284 "Plasma proteins, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039262, HPA045244, HPA059197" Supported Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA039262: AB_2676418, HPA045244: AB_2679269, HPA059197: AB_2683944" "unprognostic (2.55e-2)" "unprognostic (7.31e-2)" "unprognostic (5.69e-2)" "unprognostic (4.05e-2)" "unprognostic (3.66e-1)" "unprognostic (2.85e-3)" "unprognostic (1.38e-2)" "unprognostic (7.65e-2)" "unprognostic (2.89e-2)" "unprognostic (1.27e-2)" "prognostic unfavorable (9.69e-4)" "unprognostic (1.18e-1)" "prognostic favorable (8.17e-5)" "unprognostic (3.38e-1)" "unprognostic (3.77e-1)" "prognostic favorable (6.62e-6)" "unprognostic (1.27e-2)" 64.1 82.2 38.7 46.1 38.2 41.9 66.1 27.0 48.9 63.9 84.8 21.4 58.7 67.6 52.9 86.8 106.9 49.6 65.2 53.0 37.8 34.0 150.0 105.3 85.9 68.7 36.0 31.9 53.4 48.9 48.4 37.5 139.8 46.8 56.8 75.0 37.1 69.8 52.8 71.8 59.6 129.4 54.7 30.9 62.2 52.8 42.8 26.0 65.1 107.2 89.8 61.1 58.6 61.5 46.7 83.6 151.5 78.1 47.6 77.7 109.0 49.0 26.0 23.1 22.2 67.3 57.4 39.8 74.9 65.9 70.1 72.2 54.5 39.4 24.6 33.0 101.7 52.8 24.9 38.1 86.1 72.0 14.3 16.1 24.8 29.5 43.7 69.4 55.5 39.1 49.4 82.7 46.6 29.8 61.2 104.8 25.3 21.2 24.2 90.8 99.6 31.7 40.1 15.4 58.9 22.3 15.8 29.1 19.7 147.6 91.0 19.0 19.8 74.4 45.3 45.1 39.9 38.7 33.3 126.2 68.1 101.7 59.4 90.6 13.5 12.9 30.0 41.4 22.6 52.9 123.3 51.4 151.5 72.2 68.0 61.4 46.7 70.7 77.7 60.9 37.8 58.0 66.8 120.5 47.6 78.1 83.6 75.2 109.0 38.7 38.2 27.0 48.9 37.8 34.0 36.0 31.9 46.8 26.0 750.4 480.3 216.3 748.4 563.6 73.7 716.9 471.3 642.4 558.4 514.7 23.6 919.9 888.6 1342.8 114.5 450.9 1252.4 93.5 1292.5 904.2 420.1 592.5 429.2 253.2 547.6 62.0 234.2 683.2 403.1 161.2 413.3 509.2 327.3 1202.0 540.9 131.6 1740.8 831.1 407.3 1106.8 72.8 349.3 305.9 216.8 195.5 496.8 1173.0 496.0 458.6 860.6 MYL5 ENSG00000215375 "Myosin light chain 5" Q02045 4 673580-682033 "Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 61.5" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 71.2;Rod photoreceptor cells: 78.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 34.0;ASC TERT1: 23.4" "Low region specificity" "Detected in many" "HPA037381, HPA039262" Uncertain Uncertain Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA037381: AB_10672484, HPA039262: AB_2676418" "unprognostic (6.30e-3)" "unprognostic (1.42e-2)" "unprognostic (5.67e-2)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (5.53e-2)" "unprognostic (1.33e-1)" "unprognostic (4.77e-3)" "unprognostic (2.38e-1)" "unprognostic (8.39e-2)" "unprognostic (1.61e-3)" "unprognostic (1.05e-1)" "unprognostic (2.80e-1)" "unprognostic (2.95e-2)" "unprognostic (3.01e-1)" "unprognostic (1.10e-2)" "unprognostic (1.91e-2)" 9.9 11.4 14.5 10.1 12.7 8.5 12.6 13.4 14.6 6.1 10.9 14.7 14.6 18.0 7.1 19.5 10.6 7.1 8.0 4.9 13.9 11.4 9.7 11.3 7.8 19.5 10.8 10.0 7.5 15.4 13.2 7.7 5.3 10.5 9.8 11.8 10.0 61.5 10.7 18.6 16.2 15.4 10.1 9.3 8.8 7.3 15.5 3.9 7.5 7.5 24.2 9.9 6.5 6.9 11.0 12.6 8.2 9.5 15.4 6.5 4.5 2.2 3.7 13.6 7.2 34.0 23.4 6.5 5.5 7.4 5.6 5.2 4.5 9.6 2.6 2.6 8.9 4.0 3.3 2.1 3.7 1.6 4.8 2.7 3.9 5.1 4.1 11.9 5.9 3.6 17.6 3.6 4.4 4.7 8.2 3.4 5.6 4.0 3.5 6.9 4.2 3.1 4.1 2.8 4.7 5.7 2.8 2.9 1.5 9.2 10.6 6.2 3.5 1.8 4.6 3.7 4.6 7.4 5.4 5.6 4.8 0.9 4.1 3.1 13.6 2.6 1.6 5.3 5.3 2.4 8.2 7.4 1.1 3.1 4.7 3.9 7.9 5.1 1.8 6.6 11.0 6.5 6.3 5.0 15.4 9.5 12.6 2.3 4.5 14.5 12.7 13.4 14.6 13.9 11.4 10.8 10.0 10.5 3.9 0.0 11.0 9.5 6.0 10.6 5.7 1.2 7.6 6.7 2.3 7.0 19.6 5.7 10.0 8.8 16.6 4.5 31.5 0.0 4.0 4.3 6.6 7.4 12.8 14.9 18.5 11.1 5.2 9.2 16.2 71.2 6.6 7.5 6.8 20.8 8.8 16.6 6.2 10.5 3.5 30.0 78.4 6.5 5.0 14.4 3.1 11.7 4.6 6.1 13.3 8.9 MYL9 "LC20, MLC2, MRLC1, MYRL2" ENSG00000101335 "Myosin light chain 9" P24844 20 36541484-36551447 "Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 717.2;urinary bladder: 496.7" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 1565.8;Peritubular cells: 1778.4;Sertoli cells: 2108.4;Smooth muscle cells: 1718.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 2.6;neutrophil: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 85.3;BJ: 110.6;fHDF/TERT166: 87.8;hTERT-RPE1: 70.2" "Low region specificity" "Detected in single" "HPA039262, HPA045244, HPA059197" Supported Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA 92000000 "Nucleoplasm, Nucleoli fibrillar center" "HPA039262: AB_2676418, HPA045244: AB_2679269, HPA059197: AB_2683944" "unprognostic (1.15e-1)" "unprognostic (5.05e-2)" "unprognostic (2.67e-3)" "unprognostic (5.38e-2)" "unprognostic (7.17e-2)" "unprognostic (5.06e-2)" "unprognostic (1.94e-1)" "unprognostic (1.82e-1)" "unprognostic (1.34e-1)" "unprognostic (2.59e-1)" "unprognostic (9.06e-2)" "unprognostic (8.90e-2)" "prognostic unfavorable (7.92e-7)" "unprognostic (1.90e-2)" "unprognostic (8.41e-2)" "unprognostic (1.20e-1)" "unprognostic (1.92e-2)" 61.9 46.0 2.0 58.1 5.8 0.2 64.8 1.4 6.4 123.3 361.6 6.0 162.9 22.7 278.8 102.0 242.7 80.3 199.0 169.8 1.9 2.1 27.7 6.8 36.0 14.9 4.7 8.7 107.8 5.4 2.8 4.8 31.7 10.5 218.9 30.4 71.8 22.6 203.9 22.2 14.7 70.3 717.2 5.2 22.8 120.7 55.1 1.4 1.4 48.8 21.9 8.7 496.7 107.7 1.2 0.5 2.7 0.2 0.3 0.1 10.8 8.0 0.1 6.4 0.1 85.3 32.8 28.4 110.6 47.9 58.0 37.6 63.8 0.9 0.0 58.0 87.8 12.7 3.0 0.0 0.2 13.7 0.0 0.0 1.6 12.5 5.9 55.1 0.0 1.9 45.9 5.8 38.3 0.1 70.2 2.0 0.0 0.2 2.9 48.6 0.0 0.0 0.8 2.5 1.6 0.5 0.0 0.0 0.5 0.4 0.6 0.0 0.4 1.1 2.8 0.0 29.2 24.7 1.6 14.2 55.4 23.4 8.0 0.1 0.0 0.4 0.2 21.0 0.0 0.0 0.0 0.2 2.6 0.0 0.0 0.1 1.2 0.0 0.1 0.3 0.2 0.0 0.0 2.7 0.3 0.0 0.5 0.0 10.8 2.0 5.8 1.4 6.4 1.9 2.1 4.7 8.7 10.5 1.4 366.3 53.6 10.5 235.7 53.9 0.8 1565.8 30.6 20.1 50.0 85.5 0.0 24.0 23.2 211.4 5.9 105.7 0.0 0.0 105.2 66.4 237.6 45.8 15.0 1.1 29.4 1.6 0.0 219.1 4.8 25.6 307.2 19.2 69.2 26.2 0.1 179.9 56.1 0.0 1778.4 24.0 5.5 2108.4 1718.3 4.2 6.9 46.7 22.4 10.2 0.6 57.0 MYLK3 "caMLCK, MLCK" ENSG00000140795 "Myosin light chain kinase 3" Q32MK0 16 46703369-46790407 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 62.2;skeletal muscle: 20.8;tongue: 31.1" "Cell type enriched" "Detected in some" 10 "Cardiomyocytes: 162.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "pons and medulla: 6.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 9.7;HEL: 29.1;K-562: 4.5;SK-BR-3: 6.1" "Group enriched" "Detected in some" 7 "cerebral cortex: 9.8;hippocampal formation: 5.7" "Region enriched" "Detected in single" 5 "hippocampal formation: 5.2" HPA073447 Enhanced Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA073447: AB_2732225" "unprognostic (6.01e-4)" "unprognostic (2.19e-1)" "unprognostic (2.64e-1)" "unprognostic (1.77e-2)" "unprognostic (1.84e-1)" "unprognostic (2.94e-3)" "unprognostic (2.60e-1)" "unprognostic (4.73e-2)" "unprognostic (3.33e-2)" "unprognostic (2.41e-2)" "unprognostic (6.58e-3)" "unprognostic (1.83e-1)" "unprognostic (4.16e-2)" "unprognostic (2.57e-2)" "unprognostic (2.52e-1)" "unprognostic (1.08e-2)" "unprognostic (2.97e-1)" 0.0 0.1 0.7 0.0 1.7 0.1 0.0 0.1 0.2 0.2 0.0 3.8 0.0 0.0 0.1 3.4 2.0 0.8 0.1 62.2 1.5 1.4 0.4 0.0 0.2 0.1 0.1 0.4 0.2 0.1 0.1 0.5 0.2 6.6 1.0 0.0 0.0 1.3 0.0 20.8 0.0 0.0 0.0 0.3 0.0 0.0 2.9 0.3 0.0 0.1 31.1 1.1 0.1 0.0 1.2 0.9 2.6 0.7 1.2 0.7 0.2 0.0 0.1 0.1 0.1 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.7 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.1 1.6 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.3 0.0 6.1 0.2 2.9 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.4 0.0 0.3 0.0 0.1 0.0 2.5 0.7 0.6 0.6 0.4 0.4 0.7 0.5 0.5 0.3 1.2 0.7 0.7 2.6 1.2 0.5 0.9 0.3 0.2 0.7 1.7 0.1 0.2 1.5 1.4 0.1 0.4 6.6 0.3 0.0 3.5 0.0 0.7 0.0 0.5 162.4 0.0 16.0 6.8 0.0 2.0 1.4 0.0 0.0 7.4 0.0 0.0 0.0 0.2 0.4 1.4 0.6 1.1 0.0 0.4 0.0 0.0 0.6 0.0 3.2 0.6 0.5 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.9 0.2 0.0 0.2 0.0 0.0 0.2 MYNN "SBBIZ1, ZBTB31, ZNF902" ENSG00000085274 Myoneurin Q9NPC7 3 169772831-169789716 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045149 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA045149: AB_10960839" "unprognostic (7.13e-2)" "unprognostic (2.28e-2)" "unprognostic (3.67e-2)" "unprognostic (2.19e-2)" "unprognostic (1.17e-2)" "unprognostic (2.02e-1)" "unprognostic (3.09e-2)" "unprognostic (1.20e-1)" "unprognostic (1.03e-2)" "unprognostic (2.77e-1)" "unprognostic (8.25e-3)" "unprognostic (1.25e-3)" "unprognostic (1.34e-3)" "unprognostic (1.05e-1)" "unprognostic (1.52e-1)" "unprognostic (2.04e-1)" "unprognostic (1.36e-3)" 20.3 10.3 10.3 10.6 13.3 22.4 16.4 29.7 15.3 18.4 12.3 8.9 17.7 8.8 17.7 10.9 15.4 15.1 10.5 12.1 13.0 9.0 13.5 13.7 11.4 13.6 12.9 13.7 22.4 15.8 16.2 18.4 17.5 16.0 16.7 12.0 7.7 12.5 11.6 17.9 13.0 16.4 14.3 12.4 16.3 14.3 16.1 15.8 17.5 15.4 13.1 15.9 15.3 12.9 8.2 5.2 19.0 5.0 10.0 10.6 7.6 9.5 4.3 5.3 10.3 10.8 9.3 6.7 6.8 9.2 9.8 10.9 5.4 9.9 14.7 11.8 6.9 8.0 7.7 9.3 8.0 13.0 13.2 7.3 13.9 6.4 5.2 9.3 12.4 10.0 8.2 10.4 6.0 17.5 8.0 8.6 6.4 5.7 14.8 9.6 8.0 7.3 6.4 7.9 11.7 5.0 8.0 7.3 15.2 6.4 16.4 7.4 8.9 7.9 17.7 10.7 7.1 21.7 9.0 6.6 9.0 4.4 8.5 12.3 17.5 12.1 20.0 7.3 7.8 8.9 19.0 5.0 11.9 7.6 5.0 10.2 8.2 8.7 7.2 5.1 8.1 10.6 8.4 13.5 10.0 4.1 5.2 8.4 7.6 10.3 13.3 29.7 15.3 13.0 9.0 12.9 13.7 16.0 15.8 26.8 16.3 8.3 27.3 36.7 10.7 10.9 17.8 20.1 19.4 10.4 21.6 13.1 11.6 8.7 32.8 15.7 8.8 0.0 8.2 14.2 14.2 14.5 7.0 6.4 7.1 9.5 13.7 11.1 9.1 8.9 15.8 9.1 15.1 10.8 7.6 12.0 9.1 9.3 17.7 10.4 30.3 6.5 15.7 28.4 16.8 33.5 17.4 15.4 8.3 23.0 MYO18B BK125H2.1 ENSG00000133454 "Myosin XVIIIB" 22 25742144-26031041 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skeletal muscle: 141.2" "Group enriched" "Detected in some" 45 "Cardiomyocytes: 88.1;Early spermatids: 50.3;Late spermatids: 28.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 7.8;REH: 11.2;RH-30: 23.8;U-2 OS: 10.5;U-266/70: 7.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA000953 Uncertain Supported Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA000953: AB_1079440" "unprognostic (3.28e-2)" "unprognostic (1.79e-1)" "unprognostic (1.86e-2)" "unprognostic (1.23e-1)" "unprognostic (1.66e-2)" "unprognostic (1.01e-2)" "unprognostic (5.93e-4)" "unprognostic (2.46e-1)" "unprognostic (1.22e-1)" "unprognostic (7.14e-2)" "unprognostic (4.36e-3)" "unprognostic (2.96e-3)" "unprognostic (3.93e-7)" "unprognostic (1.14e-1)" "unprognostic (3.12e-1)" "unprognostic (5.06e-2)" "unprognostic (1.65e-1)" 3.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.4 0.0 0.0 30.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 1.0 0.0 141.2 0.1 0.0 1.5 0.0 0.0 0.3 2.4 0.0 0.3 1.1 16.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 4.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.7 2.9 0.0 0.3 1.2 0.0 0.0 0.0 11.2 23.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.5 0.0 0.0 7.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 88.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 28.5 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.0 0.0 MYO1A "DFNA48, MYHL" ENSG00000166866 "Myosin IA" Q9UBC5 12 57028517-57051198 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "intestine: 148.0" "Cell type enhanced" "Detected in some" 25 "Enterocytes: 221.7;Mucus-secreting cells: 59.5;Paneth cells: 51.8;Undifferentiated cells: 76.4" "Group enriched" "Detected in many" 13 "colorectal cancer: 17.8;pancreatic cancer: 4.8;stomach cancer: 9.8" "Region enhanced" "Detected in single" "pons and medulla: 1.3" "Group enriched" "Detected in some" 5 "classical monocyte: 1.2;intermediate monocyte: 1.1;myeloid DC: 2.9" "Group enriched" "Detected in many" 6 "dendritic cells: 2.9;monocytes: 1.2" "Cell line enriched" "Detected in some" 5 "OE19: 30.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA053490 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA053490: AB_2682168" "unprognostic (2.77e-2)" "unprognostic (2.00e-3)" "unprognostic (1.04e-1)" "unprognostic (1.20e-1)" "unprognostic (7.31e-2)" "unprognostic (7.11e-2)" "unprognostic (4.57e-2)" "unprognostic (1.57e-1)" "unprognostic (6.04e-2)" "unprognostic (4.26e-2)" "unprognostic (8.96e-2)" "unprognostic (2.14e-1)" "unprognostic (2.38e-2)" "unprognostic (6.89e-2)" "unprognostic (5.01e-1)" "unprognostic (5.81e-2)" "unprognostic (8.72e-2)" 0.1 0.1 0.1 5.2 0.2 0.0 0.1 0.1 0.2 0.1 57.2 0.3 0.1 70.0 0.1 0.1 0.1 0.1 5.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.1 0.2 1.3 0.1 14.1 0.1 0.2 0.1 0.1 0.1 148.0 0.4 4.7 0.1 3.3 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 2.9 0.0 1.2 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 5.8 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 3.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 1.1 0.0 30.9 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.1 0.3 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.5 0.1 1.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.4 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 221.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 23.7 0.0 0.3 0.2 0.0 0.9 0.0 0.0 59.5 0.0 0.2 51.8 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.1 0.0 0.0 76.4 0.0 MYO1E "HuncM-IC, MGC104638, MYO1C" ENSG00000157483 "Myosin IE" Q12965 15 59132434-59372900 "Disease related genes, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 16.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 51.5;HaCaT: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003003, HPA023886" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "HPA003003: , HPA023886: AB_1854253" "unprognostic (7.90e-2)" "unprognostic (1.35e-1)" "unprognostic (1.52e-1)" "prognostic favorable (4.19e-4)" "unprognostic (1.49e-1)" "unprognostic (3.59e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (1.57e-6)" "unprognostic (1.89e-1)" "unprognostic (5.38e-3)" "prognostic unfavorable (7.99e-4)" "unprognostic (2.41e-1)" "unprognostic (7.92e-2)" "unprognostic (7.31e-2)" "unprognostic (9.71e-2)" "unprognostic (1.15e-1)" "unprognostic (5.62e-2)" 25.9 4.6 7.9 18.4 19.0 0.7 13.3 2.3 12.6 13.6 28.5 40.6 26.5 13.6 18.1 17.0 22.1 10.0 21.5 6.8 12.6 7.6 22.4 33.4 11.6 18.9 27.2 7.6 6.8 8.8 23.7 6.6 18.7 17.2 15.6 19.4 13.0 12.4 43.5 7.2 28.8 25.9 12.3 25.5 11.4 17.1 4.7 22.4 2.6 9.9 10.6 21.7 15.6 16.2 7.0 16.9 0.4 3.4 2.5 0.4 1.6 29.6 51.5 2.8 1.9 22.1 18.1 14.6 12.1 5.9 6.7 7.9 12.7 11.6 11.8 8.7 9.4 27.7 47.8 4.3 18.7 9.0 5.4 2.4 0.1 43.0 11.2 20.5 0.0 1.6 24.7 11.5 8.6 25.4 21.4 11.0 0.2 0.0 0.1 11.4 2.7 0.1 0.2 6.8 4.8 11.5 0.0 12.5 7.2 36.4 14.0 1.5 5.1 26.9 5.6 10.4 8.9 3.7 1.3 13.3 13.6 3.9 41.3 11.8 0.0 0.7 0.2 24.9 0.1 12.2 0.0 3.1 0.0 0.1 3.4 0.0 6.6 0.0 0.0 11.0 7.0 0.0 0.0 0.4 2.5 1.2 16.9 0.4 1.6 7.9 19.0 2.3 12.6 12.6 7.6 27.2 7.6 17.2 22.4 6.0 7.7 0.0 21.2 22.0 0.0 3.2 20.4 34.8 6.8 24.4 0.0 3.3 3.3 39.7 3.4 16.1 46.1 0.0 15.8 17.7 9.9 27.4 4.6 9.4 29.8 0.0 18.9 4.3 3.3 5.2 8.6 16.2 18.6 7.2 21.7 11.7 42.3 31.6 11.3 3.0 0.9 12.9 23.0 1.0 3.8 21.0 10.8 1.0 19.6 34.4 MYO1G HA-2 ENSG00000136286 "Myosin IG" B0I1T2 7 44962662-44979098 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 37.9;bone marrow: 27.4;lymphoid tissue: 46.8" "Cell type enriched" "Detected in many" 7 "monocytes: 573.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 20.2;HEL: 24.5;HL-60: 14.0;JURKAT: 30.5;MOLT-4: 31.0;NB-4: 13.1;THP-1: 27.5;U-937: 20.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA021252 Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA 120000 "Plasma membrane" Nucleoplasm "HPA021252: AB_1854254" "unprognostic (2.74e-2)" "prognostic favorable (8.26e-4)" "unprognostic (5.20e-3)" "unprognostic (9.91e-3)" "unprognostic (1.27e-2)" "unprognostic (1.27e-3)" "unprognostic (1.74e-1)" "unprognostic (1.35e-1)" "unprognostic (4.54e-3)" "unprognostic (6.47e-2)" "unprognostic (6.40e-2)" "unprognostic (6.24e-2)" "prognostic unfavorable (8.71e-8)" "unprognostic (3.20e-1)" "unprognostic (2.04e-1)" "unprognostic (1.85e-1)" "unprognostic (7.92e-2)" 2.5 1.2 1.6 11.0 3.0 27.4 1.5 0.4 2.0 1.0 1.9 0.7 0.0 1.8 1.2 2.1 2.4 1.9 3.6 3.2 1.0 0.9 1.9 1.9 13.0 18.6 4.5 0.0 0.9 0.8 0.0 0.9 1.5 2.7 1.5 1.1 1.5 5.8 0.5 0.6 1.2 8.3 1.9 2.6 22.3 2.1 0.9 1.8 46.8 2.1 2.2 26.6 4.7 1.3 9.9 14.0 9.4 37.9 6.7 24.4 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.0 24.5 0.8 0.0 0.0 14.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 30.5 0.0 0.0 0.0 0.0 31.0 13.1 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 20.2 0.0 9.4 17.0 5.2 19.9 29.6 12.6 9.9 12.7 17.4 14.0 6.6 4.6 9.0 1.7 6.7 37.9 1.2 24.4 19.3 1.6 3.0 0.4 2.0 1.0 0.9 4.5 0.0 2.7 1.8 3.0 11.4 56.6 0.3 2.5 0.0 1.1 0.0 1.4 2.3 0.0 0.0 0.1 0.0 0.1 0.3 0.6 0.0 0.0 0.9 0.2 1.7 0.4 30.0 0.9 10.8 3.2 0.0 2.5 71.9 1.2 0.0 51.5 3.3 573.5 0.0 0.2 0.2 0.0 0.4 0.3 0.0 6.5 1.6 0.4 0.2 1.5 0.1 86.3 0.0 0.1 MYO5C MGC74969 ENSG00000128833 "Myosin VC" Q9NQX4 15 52192322-52295798 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 122.1;Alveolar cells type 2: 62.6;Ciliated cells: 60.2;Club cells: 64.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 2.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 12.8;MCF7: 22.9;OE19: 20.7;RT4: 13.3;SK-BR-3: 17.5;T-47d: 21.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB020790, HPA032115, HPA032116" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB020790: , HPA032115: AB_2674158, HPA032116: AB_2674159" "unprognostic (1.85e-1)" "unprognostic (1.29e-1)" "unprognostic (3.49e-2)" "prognostic favorable (5.18e-5)" "unprognostic (2.94e-1)" "unprognostic (4.01e-2)" "unprognostic (2.07e-1)" "unprognostic (1.53e-1)" "unprognostic (4.53e-3)" "unprognostic (1.02e-1)" "unprognostic (4.04e-3)" "unprognostic (4.82e-2)" "prognostic favorable (2.47e-5)" "prognostic favorable (5.82e-4)" "unprognostic (9.15e-2)" "unprognostic (2.34e-1)" "unprognostic (2.32e-1)" 11.2 1.5 2.7 4.0 4.0 0.4 10.7 14.7 3.4 11.1 10.0 3.4 9.5 3.7 3.7 9.8 6.6 8.6 12.2 1.7 2.5 1.7 6.4 2.7 11.4 1.2 2.6 3.0 2.6 33.9 18.5 7.8 2.1 7.5 7.8 13.2 6.5 22.6 12.8 2.1 4.3 4.1 4.2 4.3 2.7 14.2 4.7 3.4 0.5 15.1 3.7 3.8 4.5 18.4 1.2 1.6 1.5 0.0 0.0 2.9 0.1 10.6 12.8 1.8 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 1.9 4.5 0.6 2.7 0.0 0.1 1.7 2.7 3.7 0.0 0.5 4.3 0.0 9.1 7.8 0.0 0.0 0.1 0.0 3.7 0.0 3.6 1.9 2.8 0.4 0.0 0.2 0.0 22.9 0.6 0.1 0.7 20.7 6.1 8.7 1.1 5.3 10.2 13.3 1.8 2.0 0.8 17.5 0.0 2.9 21.1 0.0 0.0 0.0 0.1 0.0 1.6 0.3 0.3 1.0 0.1 0.1 0.3 0.0 0.0 0.0 0.7 0.0 0.0 1.2 0.2 0.2 1.0 0.4 0.4 0.3 1.5 0.0 0.0 1.6 2.9 0.1 2.7 4.0 14.7 3.4 2.5 1.7 2.6 3.0 7.5 3.4 122.1 62.6 0.5 13.4 0.6 0.0 5.8 15.3 60.2 64.8 21.0 0.0 2.2 3.3 17.6 2.0 14.0 14.6 0.0 25.7 1.2 0.6 32.8 3.5 4.2 0.7 0.0 5.2 0.0 0.3 1.8 1.7 0.7 6.8 0.0 44.0 4.9 30.1 23.0 0.4 0.8 0.4 0.0 1.0 6.5 4.7 1.3 0.6 0.0 22.4 35.7 MYO6 "DFNA22, DFNB37, KIAA0389" ENSG00000196586 "Myosin VI" Q9UM54 6 75749192-75919537 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Endocytosis, Hearing, Protein transport, Transport" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Cardiomyopathy, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 333.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "gdT-cell: 8.6;MAIT T-cell: 4.0;memory CD4 T-cell: 2.7;memory CD8 T-cell: 4.9;naive CD8 T-cell: 4.8;NK-cell: 3.3" "Group enriched" "Detected in many" 20 "NK-cells: 3.3;T-cells: 8.6" "Cell line enhanced" "Detected in many" "RT4: 43.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010762, HPA035482, HPA035483" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB010762: AB_477166, HPA035482: , HPA035483: AB_2674647" "unprognostic (6.29e-2)" "unprognostic (6.34e-2)" "unprognostic (3.63e-3)" "unprognostic (1.30e-1)" "unprognostic (8.98e-2)" "unprognostic (2.73e-2)" "unprognostic (3.41e-3)" "unprognostic (1.23e-2)" "unprognostic (1.23e-2)" "unprognostic (2.66e-2)" "unprognostic (7.78e-2)" "unprognostic (2.78e-2)" "prognostic favorable (1.27e-12)" "unprognostic (1.57e-1)" "unprognostic (1.72e-1)" "unprognostic (1.41e-1)" "unprognostic (2.49e-2)" 8.4 9.1 18.2 9.0 27.0 0.9 26.9 17.1 24.1 16.2 18.9 26.8 28.7 30.0 7.5 25.9 28.1 10.0 23.1 4.9 19.1 12.2 44.0 13.8 20.5 4.5 24.0 17.9 4.6 18.5 42.2 24.2 7.1 19.0 16.0 17.3 11.9 23.3 33.7 4.2 14.1 27.7 8.0 21.2 6.7 23.9 14.3 28.2 0.9 13.4 9.1 10.9 16.1 13.1 0.2 0.0 0.1 0.1 3.3 8.6 1.2 22.7 6.1 4.9 3.5 11.9 9.6 19.6 8.1 8.6 6.0 7.8 9.2 20.5 0.0 7.9 9.1 6.9 18.0 5.8 11.6 6.9 9.6 11.9 6.5 2.0 5.6 10.2 0.0 9.5 6.8 8.4 8.1 6.4 10.0 16.6 3.3 8.5 3.3 6.1 21.9 0.0 0.2 3.3 17.1 1.6 0.4 11.8 0.4 22.3 43.4 10.2 6.7 2.0 20.4 3.5 11.6 8.7 13.3 24.3 6.6 5.7 0.3 7.3 6.9 7.0 0.0 4.1 0.0 2.3 0.1 0.0 0.0 8.6 0.0 4.0 0.2 2.7 4.9 0.0 0.0 0.6 4.8 0.1 3.3 0.1 0.0 0.1 1.2 18.2 27.0 17.1 24.1 19.1 12.2 24.0 17.9 19.0 28.2 131.0 218.3 7.6 88.9 26.8 74.9 7.3 35.7 75.0 79.6 143.1 113.9 27.1 46.4 104.1 3.9 45.8 95.7 0.0 104.0 18.4 24.2 142.1 25.4 28.2 5.5 90.6 81.6 42.4 3.8 5.6 27.9 6.0 28.7 4.6 66.2 333.7 145.6 80.7 40.7 83.4 184.9 12.9 16.9 10.9 13.8 29.7 65.6 12.1 54.2 164.0 MYOCD MYCD ENSG00000141052 Myocardin Q8IZQ8 17 12665890-12768949 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 63.4" "Group enriched" "Detected in some" 6 "Cardiomyocytes: 26.6;Peritubular cells: 94.7;Sertoli cells: 25.8;Smooth muscle cells: 30.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 6.3;BJ hTERT+: 6.4;HBF TERT88: 10.6;hTEC/SVTERT24-B: 11.7;REH: 8.0;SuSa: 13.5" "Low region specificity" "Detected in single" "Region enhanced" "Detected in single" "cerebellum: 6.4" "CAB046485, HPA071528, HPA072582" Approved Approved Nucleoplasm NA NA Nucleoplasm "CAB046485: AB_10600720, HPA071528: , HPA072582: " "unprognostic (2.82e-1)" "unprognostic (1.69e-1)" "unprognostic (2.36e-2)" "unprognostic (1.90e-1)" "unprognostic (3.79e-2)" "unprognostic (5.33e-2)" "unprognostic (2.15e-4)" "unprognostic (2.71e-2)" "unprognostic (1.61e-2)" "unprognostic (2.31e-1)" "unprognostic (1.76e-1)" "unprognostic (4.83e-2)" "unprognostic (1.01e-4)" "unprognostic (2.88e-2)" "unprognostic (1.07e-1)" "unprognostic (5.45e-2)" "unprognostic (1.91e-2)" 3.1 0.8 0.6 5.1 1.0 0.0 1.9 0.3 0.5 19.6 19.9 0.2 17.6 2.1 16.6 10.9 14.4 7.4 12.2 18.6 0.4 0.4 0.9 0.4 2.5 0.0 0.5 0.8 10.6 0.4 0.0 0.5 2.6 0.6 17.2 4.2 5.1 0.4 18.7 1.2 1.5 6.6 63.4 0.6 0.5 6.7 3.7 0.1 0.0 1.0 1.2 0.0 33.4 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.3 6.4 2.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.3 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 8.0 1.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 13.5 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.3 0.5 0.4 0.4 0.5 0.8 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 26.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.1 1.1 0.1 0.0 0.0 0.1 0.0 7.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.7 0.0 0.0 25.8 30.6 0.2 0.7 0.6 0.5 0.0 0.0 0.0 MYOD1 "bHLHc1, MYF3, MYOD, PUM" ENSG00000129152 "Myogenic differentiation 1" P15172 11 17719568-17722131 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skeletal muscle: 31.8" "Cell type enriched" "Detected in single" 7 "Spermatogonia: 3.0" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "RH-30: 103.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA055436, HPA078647" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA055436: , HPA078647: " "unprognostic (1.07e-3)" "unprognostic (2.10e-1)" "unprognostic (1.01e-1)" 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.5 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 4.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 103.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.0 0.0 0.0 0.0 0.0 0.0 MYOG "bHLHc3, MYF4" ENSG00000122180 Myogenin P15173 1 203083132-203086036 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cell cycle, Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skeletal muscle: 60.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "head and neck cancer: 3.9;testis cancer: 1.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 200 "HSkMC: 18.0;RH-30: 34.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA028336 Supported Nucleoplasm NA NA Nucleoplasm "HPA028336: AB_2672562" "unprognostic (1.71e-1)" "unprognostic (1.64e-1)" "unprognostic (1.05e-3)" "unprognostic (2.22e-1)" "unprognostic (2.79e-9)" "unprognostic (3.96e-1)" "unprognostic (2.56e-1)" 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.3 0.0 0.0 2.4 0.0 60.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 1.7 13.3 1.7 0.0 0.0 0.8 0.8 2.3 1.3 1.8 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 34.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.4 0.8 0.4 0.7 1.0 0.8 0.5 0.6 0.3 0.6 0.9 1.0 1.4 1.8 1.3 0.8 0.8 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYOZ2 "C4orf5, CS-1" ENSG00000172399 "Myozenin 2" Q9NPC6 4 119135784-119187789 "Disease related genes, Predicted intracellular proteins" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "heart muscle: 219.1;skeletal muscle: 188.6" "Cell type enriched" "Detected in some" 343 "Cardiomyocytes: 2214.4" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 3.3;HSkMC: 3.7;SK-MEL-30: 9.5;U-87 MG: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035763, HPA035764" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA035763: AB_2674770, HPA035764: AB_10696509" "unprognostic (2.53e-1)" "unprognostic (9.20e-2)" "unprognostic (6.94e-2)" "unprognostic (2.14e-1)" "unprognostic (2.57e-1)" "unprognostic (2.34e-2)" "unprognostic (5.71e-1)" "unprognostic (2.18e-1)" "unprognostic (4.77e-2)" "unprognostic (4.04e-1)" "unprognostic (8.25e-2)" "unprognostic (5.07e-2)" "unprognostic (6.19e-7)" "unprognostic (6.66e-4)" "unprognostic (2.43e-1)" "unprognostic (3.06e-1)" "unprognostic (2.83e-2)" 3.7 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.4 2.4 2.6 0.2 0.1 219.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 1.9 0.1 188.6 0.0 0.1 0.2 0.0 0.1 0.1 0.6 0.0 0.0 2.0 13.9 3.2 0.2 0.1 0.1 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.2 3.3 0.0 0.4 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 3.7 0.0 0.6 0.0 0.1 0.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 9.5 1.7 0.0 0.0 0.2 0.1 0.2 0.5 0.0 0.0 0.0 0.0 10.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2214.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 1.9 0.0 0.2 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.7 0.7 0.0 6.5 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 MYPN MYOP ENSG00000138347 Myopalladin Q86TC9 10 68106117-68212017 "Disease related genes, Predicted intracellular proteins" Actin-binding "Cardiomyopathy, Disease mutation, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 23.6;skeletal muscle: 114.9;tongue: 46.3" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 94.6" "Cancer enriched" "Detected in single" 7 "head and neck cancer: 0.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 3.8" "Lineage enriched" "Detected in single" 12 "granulocytes: 3.8" "Cell line enhanced" "Detected in some" "BJ: 16.6;fHDF/TERT166: 46.6;GAMG: 9.2;HBF TERT88: 11.0;LHCN-M2: 20.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA036299, HPA061494" Enhanced Approved Nucleoplasm,Vesicles,Cytosol No No "Nucleoplasm, Vesicles" Cytosol "HPA036299: , HPA061494: AB_2684539" "unprognostic (4.75e-2)" "unprognostic (2.20e-1)" "unprognostic (8.14e-3)" "unprognostic (8.62e-3)" "unprognostic (3.91e-1)" "unprognostic (3.36e-3)" "unprognostic (4.62e-2)" "unprognostic (3.86e-2)" "unprognostic (2.82e-1)" "unprognostic (2.26e-3)" "unprognostic (3.94e-3)" "unprognostic (3.10e-1)" "unprognostic (2.88e-8)" "unprognostic (4.63e-5)" "unprognostic (9.94e-2)" "unprognostic (2.01e-1)" "unprognostic (3.47e-1)" 4.5 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 2.1 0.0 0.0 23.6 0.4 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.5 0.0 0.1 2.1 0.0 114.9 0.1 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.9 46.3 3.4 0.0 0.0 0.3 0.1 3.8 0.1 0.2 0.1 0.0 1.2 0.5 0.0 0.0 0.3 1.8 0.0 16.6 8.3 6.3 2.3 0.0 0.0 0.0 0.0 46.6 9.2 0.3 0.0 0.1 11.0 0.1 0.0 0.0 5.9 0.0 0.1 0.0 0.0 0.8 0.0 3.3 0.4 1.5 0.1 0.0 0.0 0.1 20.1 3.5 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 2.3 0.4 0.0 0.0 0.0 0.0 0.4 0.3 0.0 1.7 0.0 0.0 0.0 0.0 2.0 0.0 1.8 3.8 0.1 0.5 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.3 0.1 0.1 0.9 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.5 94.6 0.0 0.0 0.0 0.0 23.6 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 MYPOP P42pop ENSG00000176182 "Myb related transcription factor, partner of profilin" Q86VE0 19 45890020-45902604 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 36.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HDLM-2: 19.2;NB-4: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065307 Approved Nucleoplasm NA NA Nucleoplasm "HPA065307: AB_2685460" "unprognostic (5.13e-2)" "unprognostic (2.68e-2)" "unprognostic (1.70e-1)" "unprognostic (4.52e-2)" "unprognostic (2.68e-2)" "unprognostic (4.87e-3)" "prognostic unfavorable (1.21e-4)" "unprognostic (1.94e-1)" "unprognostic (2.10e-1)" "prognostic unfavorable (8.67e-5)" "unprognostic (1.28e-3)" "unprognostic (1.42e-2)" "unprognostic (4.08e-2)" "unprognostic (8.19e-3)" "unprognostic (3.09e-1)" "unprognostic (1.12e-1)" "unprognostic (1.10e-3)" 7.6 9.4 15.7 7.9 14.3 4.2 8.0 15.1 25.9 6.5 7.5 6.8 5.9 11.4 7.2 7.0 6.4 6.1 7.1 8.0 15.9 9.2 9.5 6.1 5.9 8.3 8.5 7.7 6.5 8.5 7.0 12.9 6.1 11.3 7.7 6.0 6.3 9.5 8.2 36.4 10.1 10.1 6.5 9.0 12.3 8.5 6.8 8.7 5.3 5.0 4.3 7.0 6.8 10.7 1.0 1.5 2.7 1.4 0.6 1.1 0.4 4.2 6.8 2.6 5.3 3.4 2.2 5.2 3.2 3.3 3.5 4.6 2.7 2.7 4.1 3.1 1.6 3.4 3.6 1.9 1.4 2.5 19.2 11.1 1.9 3.8 4.4 3.7 1.9 6.2 2.1 4.1 1.9 1.8 3.7 2.8 7.0 2.6 3.7 2.2 1.8 10.1 26.2 2.9 5.5 6.9 8.1 1.1 2.3 2.0 2.4 5.4 4.1 3.1 3.4 3.3 2.0 2.3 7.1 3.6 3.3 5.5 3.0 5.0 10.9 7.8 2.7 4.8 5.2 3.9 0.0 1.4 2.7 1.1 0.6 0.3 1.0 0.8 0.6 1.5 0.3 0.6 0.7 1.6 0.6 0.7 1.0 0.7 0.4 15.7 14.3 15.1 25.9 15.9 9.2 8.5 7.7 11.3 8.7 3.0 1.3 3.7 4.4 10.2 10.1 11.8 5.1 1.4 0.0 5.2 7.9 4.5 19.9 7.0 5.2 3.8 7.8 0.0 7.9 14.2 6.6 2.9 0.0 3.2 5.1 6.4 8.6 3.7 4.9 1.0 6.6 5.3 3.3 6.4 4.5 3.2 6.0 5.9 7.1 5.1 11.4 19.4 4.5 2.4 4.9 8.5 4.5 6.9 4.6 2.0 MYRF "C11orf9, MRF, Ndt80, pqn-47" ENSG00000124920 "Myelin regulatory factor" Q9Y2G1 11 61752642-61788518 "Plasma proteins, Predicted membrane proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Hydrolase, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 96.7;stomach 1: 57.2" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 44.7;Cholangiocytes: 58.6;Ductal cells: 29.2;Exocrine glandular cells: 31.5;Pancreatic endocrine cells: 47.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 17.5;CACO-2: 29.3;CAPAN-2: 16.9;EFO-21: 22.9;Hep G2: 12.4;HHSteC: 13.1;OE19: 25.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018310 Approved Nucleoplasm,Cytosol NA NA 550000 Nucleoplasm Cytosol "HPA018310: AB_1845534" "unprognostic (3.51e-2)" "unprognostic (3.34e-1)" "unprognostic (1.56e-1)" "unprognostic (5.39e-2)" "unprognostic (1.54e-1)" "unprognostic (3.65e-2)" "unprognostic (1.34e-1)" "unprognostic (9.34e-3)" "unprognostic (2.44e-1)" "unprognostic (1.27e-1)" "unprognostic (1.01e-2)" "unprognostic (2.54e-2)" "prognostic unfavorable (2.01e-4)" "unprognostic (8.91e-3)" "unprognostic (1.11e-1)" "unprognostic (2.67e-1)" "unprognostic (6.73e-2)" 4.6 1.3 16.4 2.1 42.9 1.4 1.5 3.3 38.5 3.7 4.3 96.7 0.0 12.8 6.9 1.6 2.0 8.0 22.4 1.5 29.2 13.9 4.5 5.8 15.8 1.2 54.3 19.9 5.8 19.7 1.2 0.2 2.6 35.7 1.2 4.0 11.6 1.7 1.6 1.0 1.4 11.4 5.4 53.8 1.3 57.2 3.0 51.4 0.0 1.2 0.0 1.2 1.3 0.3 0.0 0.0 0.2 0.3 0.5 2.1 0.5 1.3 17.5 3.1 1.0 0.0 0.0 0.1 0.1 0.0 0.6 0.7 29.3 16.9 0.6 22.9 0.0 0.8 0.7 1.0 0.1 1.2 0.0 0.3 0.1 0.3 12.4 13.1 0.0 0.3 0.3 0.1 0.4 0.0 7.7 0.1 0.9 5.4 0.2 0.1 0.3 0.0 0.6 0.8 25.8 2.3 0.0 0.1 1.1 7.8 0.1 0.1 0.6 0.1 1.2 0.3 10.9 0.3 0.1 0.6 0.2 10.2 0.2 0.3 0.3 0.1 0.1 0.1 1.2 0.2 0.0 0.0 0.2 2.1 0.3 1.2 0.0 0.7 1.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.5 16.4 42.9 3.3 29.3 29.2 13.9 54.3 19.9 35.7 51.4 44.7 6.1 0.0 0.0 0.1 0.1 0.8 58.6 0.0 2.3 3.5 0.0 0.2 0.0 29.2 0.3 0.0 8.4 0.0 31.5 0.2 4.9 0.2 0.0 5.3 0.8 0.0 1.2 0.6 0.0 0.2 5.5 0.6 3.3 1.8 3.2 3.7 47.6 11.5 3.5 1.0 0.0 0.0 0.3 1.0 3.2 0.0 0.7 0.0 5.2 0.7 MYRIP "DKFZp586F1018, exophilin-8, MyRIP, SLAC2-C, SLAC2C" ENSG00000170011 "Myosin VIIA and Rab interacting protein" Q8NFW9 3 39808914-40260321 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.0;retina: 36.3" "Cell type enhanced" "Detected in many" 17 "Hepatocytes: 14.7;Ito cells: 44.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.5;HUVEC TERT2: 17.0;REH: 3.9;SCLC-21H: 3.6;SH-SY5Y: 10.5;T-47d: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006433 Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Nucleoplasm, Nucleoli fibrillar center, Golgi apparatus" "HPA006433: AB_10603023" "unprognostic (1.87e-2)" "unprognostic (5.46e-2)" "unprognostic (2.66e-2)" "unprognostic (7.89e-2)" "unprognostic (2.36e-1)" "unprognostic (6.03e-2)" "unprognostic (2.57e-3)" "unprognostic (1.34e-3)" "unprognostic (1.04e-1)" "unprognostic (1.49e-1)" "unprognostic (3.85e-2)" "unprognostic (1.91e-1)" "prognostic favorable (3.96e-8)" "unprognostic (7.12e-2)" "unprognostic (2.40e-1)" "unprognostic (8.92e-2)" "unprognostic (6.16e-2)" 4.8 2.0 31.0 2.2 7.8 0.5 3.4 23.7 19.4 9.0 4.2 3.9 1.3 2.9 6.0 3.8 2.4 3.3 4.3 2.8 13.9 9.6 2.7 16.7 1.7 2.6 8.5 11.0 5.3 13.1 2.1 8.4 0.6 10.8 3.4 4.4 36.3 16.0 1.8 2.7 1.8 2.8 3.9 5.5 10.2 7.7 1.7 4.2 0.0 2.1 1.6 2.9 2.8 2.7 0.8 0.1 0.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.3 0.2 0.7 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.5 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 1.1 0.0 0.1 3.9 0.0 0.0 0.4 2.2 3.6 10.5 0.0 0.0 0.0 0.0 4.2 0.0 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.0 31.0 7.8 23.7 18.4 13.9 9.6 8.5 11.0 10.8 4.2 0.0 5.6 0.0 0.1 0.7 2.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 9.9 0.0 0.0 2.3 0.0 0.2 1.7 2.3 14.7 0.0 4.8 0.0 44.8 4.3 3.6 0.9 0.0 0.0 0.0 9.6 6.3 1.0 0.0 0.0 0.8 4.3 0.0 0.5 2.7 0.2 0.5 0.0 0.0 0.6 0.0 MYSM1 KIAA1915 ENSG00000162601 "Myb like, SWIRM and MPN domains 1" Q5VVJ2 1 58654739-58700092 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Chromatin regulator, DNA-binding, Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054291, HPA057306" Approved Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA054291: AB_2682438, HPA057306: " "unprognostic (2.95e-3)" "unprognostic (3.64e-2)" "unprognostic (3.20e-2)" "unprognostic (8.68e-2)" "unprognostic (2.08e-2)" "prognostic favorable (5.09e-5)" "unprognostic (8.12e-3)" "unprognostic (9.63e-3)" "unprognostic (5.72e-3)" "unprognostic (3.74e-1)" "unprognostic (2.25e-1)" "unprognostic (4.56e-2)" "unprognostic (2.38e-3)" "unprognostic (4.22e-2)" "unprognostic (1.83e-1)" "unprognostic (8.45e-2)" "unprognostic (1.44e-2)" 13.2 12.3 14.1 14.4 15.7 24.4 17.3 16.9 24.3 14.3 13.7 11.4 11.9 12.5 17.5 14.3 13.5 13.0 9.9 14.1 11.7 8.1 11.0 11.0 12.9 14.3 14.0 13.3 18.1 14.0 16.5 19.2 11.3 18.0 14.4 11.6 9.3 15.5 15.2 23.2 20.4 14.6 13.7 15.2 14.2 11.5 8.3 14.7 11.9 15.5 10.6 12.9 13.3 14.7 1.1 0.7 2.2 2.1 0.2 2.3 0.5 8.3 2.4 6.2 6.6 5.7 7.3 8.9 5.0 5.6 5.0 4.3 4.2 3.7 8.7 1.5 3.8 5.9 6.4 6.8 2.9 9.6 5.8 4.6 10.5 1.1 4.6 6.9 15.8 8.0 5.2 5.0 6.4 3.3 6.6 1.2 5.6 11.1 5.6 5.7 2.8 7.7 13.2 9.8 3.4 4.5 6.6 14.9 5.3 4.1 3.2 5.1 5.0 4.2 8.3 11.7 11.7 2.5 9.0 4.0 8.9 4.0 6.8 9.5 10.2 4.8 11.6 5.2 11.5 9.7 0.8 0.7 0.5 2.0 1.0 1.4 0.9 1.4 1.6 0.6 1.1 2.3 1.1 2.2 0.2 2.1 0.7 1.4 0.5 14.1 15.7 16.9 24.3 11.7 8.1 14.0 13.3 18.0 14.7 20.8 28.9 12.6 19.3 16.9 20.3 24.6 10.2 22.7 48.9 10.4 23.6 7.0 13.3 7.0 3.2 17.3 18.0 0.0 8.1 4.8 11.6 20.1 54.4 12.4 9.7 17.5 15.5 31.3 13.2 4.0 11.8 14.6 8.5 15.4 16.2 12.0 10.3 14.4 16.3 6.3 26.3 25.8 14.1 13.0 20.4 16.2 9.5 25.5 13.6 22.6 MYT1 "MTF1, MYTI, NZF2, PLPB1, ZC2H2C1, ZC2HC4A" ENSG00000196132 "Myelin transcription factor 1" Q01538 20 64102394-64242253 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 69.5" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 28.8;Cone photoreceptor cells: 56.9;Horizontal cells: 25.4;Rod photoreceptor cells: 27.0" "Cancer enhanced" "Detected in some" "glioma: 3.2" "Region enriched" "Detected in all" 13 "cerebellum: 69.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.8;REH: 13.3;SCLC-21H: 16.6;SH-SY5Y: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006303 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA006303: AB_1079446" "unprognostic (1.09e-1)" "unprognostic (4.65e-2)" "unprognostic (3.68e-2)" "unprognostic (2.05e-7)" "unprognostic (1.28e-1)" "unprognostic (8.34e-2)" "unprognostic (1.20e-1)" "unprognostic (7.10e-2)" "unprognostic (9.33e-3)" "unprognostic (2.28e-2)" "unprognostic (8.45e-4)" "unprognostic (9.73e-2)" "unprognostic (1.01e-1)" "unprognostic (5.45e-2)" "unprognostic (9.68e-2)" "unprognostic (2.91e-3)" "unprognostic (1.23e-1)" 0.4 7.4 4.3 0.5 5.0 2.4 0.4 69.5 11.0 0.3 0.7 2.7 0.0 0.9 0.4 0.5 0.3 0.6 0.5 0.8 4.2 5.3 0.6 0.4 0.4 0.4 3.7 2.2 0.4 4.7 0.4 3.7 0.4 5.1 0.6 0.6 3.7 0.3 0.4 0.3 0.4 0.6 0.4 2.0 0.5 1.0 2.1 4.8 0.0 1.4 0.0 0.8 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.6 0.6 0.0 0.5 0.0 4.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 1.0 0.0 0.0 1.4 0.0 0.7 0.0 0.3 13.3 0.0 0.0 0.0 0.0 16.6 4.3 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 2.9 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 4.3 5.0 69.5 3.1 4.2 5.3 3.7 2.2 5.1 4.8 0.0 0.0 0.0 0.2 0.0 28.8 1.1 5.1 0.0 0.0 0.0 56.9 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 25.4 2.4 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.5 9.8 0.0 0.0 0.0 0.0 0.0 MZF1 "MZF-1, MZF1B, Zfp98, ZNF42, ZSCAN6" ENSG00000099326 "Myeloid zinc finger 1" P28698 19 58561931-58573575 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 46.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 27.9;HeLa: 21.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001757 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA001757: AB_1080718" "unprognostic (8.25e-3)" "unprognostic (2.33e-1)" "unprognostic (5.12e-2)" "unprognostic (5.16e-3)" "unprognostic (7.15e-2)" "unprognostic (4.29e-3)" "unprognostic (1.84e-2)" "unprognostic (4.62e-1)" "unprognostic (8.10e-2)" "unprognostic (7.03e-2)" "prognostic favorable (7.97e-4)" "unprognostic (2.87e-2)" "prognostic unfavorable (2.83e-8)" "unprognostic (1.47e-1)" "unprognostic (1.80e-1)" "unprognostic (4.64e-2)" "prognostic favorable (4.09e-5)" 7.8 14.2 16.9 10.9 17.4 9.4 8.1 20.3 18.8 12.5 9.4 12.4 24.8 19.6 13.6 13.4 8.7 16.6 13.5 6.7 15.4 9.7 11.7 9.8 12.5 9.9 13.9 14.8 15.9 15.2 17.5 26.0 6.8 13.7 13.8 7.8 12.4 16.7 21.5 9.7 11.6 17.0 9.6 9.6 11.7 14.7 9.0 16.1 8.3 18.1 5.2 9.4 11.0 9.8 3.5 2.3 2.3 1.2 6.6 9.0 3.4 4.7 12.4 5.1 3.2 3.0 2.7 6.1 4.3 2.3 0.8 1.6 2.6 5.9 3.4 2.1 1.2 3.7 5.4 1.3 3.1 0.4 5.9 27.9 3.6 21.4 1.4 1.8 2.7 6.3 1.8 8.0 1.1 3.5 5.0 2.7 4.0 3.0 4.4 1.1 5.3 1.5 1.5 1.8 2.9 4.9 4.2 1.2 6.1 2.7 10.4 4.9 6.9 2.1 4.2 2.7 1.0 4.3 3.6 3.0 8.2 2.6 1.4 2.2 7.5 8.5 2.8 6.5 2.9 1.9 0.0 1.2 0.6 3.3 0.9 4.9 3.2 5.4 3.8 2.3 3.5 9.0 5.6 2.3 6.6 0.9 0.6 3.2 3.4 16.9 17.4 20.3 18.8 15.4 9.7 13.9 14.8 13.7 16.1 11.9 14.2 12.3 10.5 7.1 36.2 5.5 12.7 13.4 2.3 10.4 31.4 5.0 3.3 6.8 16.9 6.4 15.4 0.0 4.8 3.0 6.1 9.5 4.6 8.3 4.1 28.6 16.1 7.4 3.5 19.1 9.8 3.3 10.1 1.0 10.7 18.1 5.6 8.5 12.4 7.9 46.3 19.4 3.2 8.9 3.4 7.2 5.4 12.8 10.5 6.0 N4BP2 B3BP ENSG00000078177 "NEDD4 binding protein 2" Q86UW6 4 40056826-40158252 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 35.6" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 68.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 20.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036770, HPA042607, HPA072549" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA036770: AB_10672477, HPA042607: AB_2678074, HPA072549: " "unprognostic (5.03e-2)" "unprognostic (3.42e-1)" "unprognostic (7.94e-3)" "unprognostic (1.15e-1)" "unprognostic (1.50e-1)" "unprognostic (3.99e-3)" "unprognostic (2.88e-1)" "unprognostic (1.01e-1)" "unprognostic (3.66e-2)" "unprognostic (2.65e-2)" "unprognostic (9.55e-3)" "unprognostic (4.49e-2)" "unprognostic (2.14e-2)" "unprognostic (1.24e-1)" "unprognostic (9.31e-2)" "unprognostic (6.85e-3)" "unprognostic (1.45e-1)" 3.5 3.1 3.4 7.4 5.1 7.0 5.8 6.1 3.2 5.5 4.3 1.2 7.1 4.7 7.0 6.6 5.2 4.8 3.8 3.5 2.5 3.6 3.2 11.3 7.5 9.2 1.9 1.6 7.0 13.1 2.5 14.3 11.9 2.8 4.9 4.5 4.3 10.7 11.0 2.9 5.4 5.3 3.2 3.1 4.3 3.8 3.5 2.1 35.6 7.2 3.5 7.8 5.6 5.2 2.4 8.1 5.7 1.2 10.6 4.5 1.2 1.5 1.6 9.4 1.5 0.6 3.1 7.7 1.8 1.9 1.0 2.2 3.0 3.1 8.3 3.5 1.7 1.7 1.2 6.0 1.9 2.5 2.6 1.9 3.7 1.4 1.4 1.6 10.0 8.9 3.5 2.7 1.7 3.7 0.3 2.7 7.9 8.2 3.6 2.0 1.5 20.2 4.3 4.7 1.2 1.3 11.8 11.1 1.9 0.8 3.7 3.8 6.7 1.6 1.3 1.5 6.3 1.1 2.7 3.7 1.1 5.9 0.7 1.3 5.9 6.0 5.7 1.2 3.6 2.3 5.7 1.1 0.5 2.3 1.2 2.4 1.7 3.0 1.7 1.7 2.4 4.5 2.5 0.3 10.6 1.0 8.1 1.3 1.2 3.4 5.1 6.1 3.2 2.5 3.6 1.9 1.6 2.8 2.1 20.8 19.5 2.9 12.0 10.6 30.6 12.3 12.7 6.7 18.2 21.0 25.5 34.4 0.0 5.4 2.6 6.6 6.0 23.3 10.7 11.4 12.3 12.2 4.7 15.5 10.4 68.3 18.6 4.9 16.3 2.7 9.2 17.8 6.8 9.0 15.0 11.8 9.7 8.6 3.5 3.1 20.2 12.9 5.7 13.6 27.0 11.4 22.5 13.8 8.0 8.4 N4BP2L1 CG018 ENSG00000139597 "NEDD4 binding protein 2 like 1" Q5TBK1 13 32400723-32428311 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "monocytes: 143.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 13.1;JURKAT: 12.5;NB-4: 33.0" "Low region specificity" "Detected in all" HPA038971 Approved Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038971: AB_10673408" "unprognostic (2.66e-3)" "unprognostic (2.38e-3)" "unprognostic (3.63e-2)" "unprognostic (5.32e-2)" "unprognostic (5.09e-2)" "unprognostic (3.40e-2)" "prognostic favorable (3.11e-4)" "unprognostic (6.91e-3)" "unprognostic (2.30e-1)" "unprognostic (9.37e-2)" "unprognostic (2.30e-2)" "unprognostic (1.20e-3)" "unprognostic (4.56e-2)" "unprognostic (1.04e-1)" "unprognostic (2.30e-1)" "unprognostic (3.29e-2)" "unprognostic (2.57e-3)" 12.1 9.4 19.6 10.5 22.2 29.5 22.1 24.5 21.8 12.3 11.0 9.4 4.2 11.6 14.6 12.8 8.3 14.0 9.6 6.3 15.0 16.6 7.4 57.8 17.3 17.6 12.1 18.8 30.1 11.0 7.3 21.2 10.0 11.0 11.3 11.3 7.3 7.6 9.5 11.0 17.5 13.4 11.3 10.6 19.2 7.2 3.6 15.5 14.2 10.4 5.1 12.9 13.5 16.5 15.9 28.0 24.2 25.5 15.2 13.5 17.4 0.5 0.1 0.7 0.2 2.9 2.3 0.2 0.3 1.2 0.7 1.2 2.1 2.9 5.6 0.8 0.6 2.1 0.0 2.1 0.2 0.9 8.5 1.3 13.1 0.6 6.2 4.6 4.9 0.8 1.6 0.5 0.5 0.6 5.2 0.4 12.5 0.0 10.5 0.5 0.4 10.0 33.0 1.1 0.0 0.3 9.6 0.3 4.7 2.8 1.0 2.0 2.4 2.1 0.0 0.9 1.5 0.3 9.3 0.2 0.2 0.1 0.1 0.1 5.9 3.5 0.3 0.3 1.8 0.4 24.2 25.5 6.6 9.8 23.1 8.5 14.0 9.5 11.9 21.9 15.9 13.1 11.3 6.2 15.2 15.8 28.0 13.5 17.4 19.6 22.2 24.5 21.8 15.0 16.6 12.1 18.8 11.0 15.5 41.7 25.1 28.7 27.2 26.8 7.4 3.4 10.2 5.3 22.7 5.2 0.0 17.0 8.3 8.8 17.8 35.7 4.5 0.0 7.4 0.9 15.9 22.7 8.1 57.2 20.1 0.0 36.5 11.6 41.3 15.5 25.3 44.8 28.7 143.3 11.5 10.0 6.2 10.7 20.8 8.4 1.6 77.6 56.7 0.7 0.2 30.9 8.7 43.1 13.3 12.8 N4BP2L2 "CG005, PFAAP5" ENSG00000244754 "NEDD4 binding protein 2 like 2" Q92802 13 32432417-32538885 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039338, HPA039434, HPA059327" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA039338: AB_2676453, HPA039434: AB_10673143, HPA059327: AB_2683981" "unprognostic (1.13e-1)" "unprognostic (1.72e-1)" "unprognostic (3.15e-1)" "unprognostic (5.81e-2)" "unprognostic (6.83e-2)" "unprognostic (6.51e-2)" "unprognostic (8.95e-2)" "unprognostic (6.29e-3)" "unprognostic (6.04e-2)" "unprognostic (1.87e-1)" "unprognostic (2.71e-3)" "unprognostic (2.67e-2)" "unprognostic (4.73e-3)" "unprognostic (1.49e-1)" "unprognostic (1.97e-1)" "unprognostic (1.45e-1)" "unprognostic (4.03e-3)" 24.4 22.6 22.8 27.3 28.0 17.4 29.7 43.4 34.0 34.1 25.2 18.0 31.6 13.9 38.3 25.8 19.5 26.3 22.1 30.3 23.7 18.8 23.7 25.4 26.2 20.1 30.2 23.3 38.5 19.5 19.1 75.7 20.6 24.6 28.1 23.3 15.5 22.4 27.3 49.3 23.0 21.4 28.7 39.8 24.3 23.1 14.7 29.6 31.4 27.8 21.1 20.4 29.4 27.1 12.7 10.2 23.0 12.5 14.2 17.7 7.7 7.7 5.4 17.6 12.4 14.8 18.5 14.4 15.0 14.7 12.5 11.7 10.0 20.4 9.8 8.5 15.1 21.3 13.4 17.1 14.0 15.9 20.8 7.6 19.6 12.1 10.9 22.6 21.0 9.5 19.4 18.7 10.9 14.0 21.8 18.7 16.0 14.1 9.8 18.2 9.1 17.7 18.4 17.2 34.6 7.2 13.4 16.4 9.6 15.4 9.7 6.8 14.8 10.9 12.0 21.4 18.9 12.7 24.7 14.8 7.9 8.1 7.2 7.5 7.5 7.8 8.0 9.1 14.7 11.8 23.0 8.6 19.7 12.4 9.6 17.0 12.7 14.4 12.4 7.7 11.4 17.7 15.2 15.4 14.2 12.5 10.2 13.3 7.7 22.8 28.0 43.4 34.0 23.7 18.8 30.2 23.3 24.6 29.6 160.8 148.3 169.0 254.9 122.5 229.6 159.8 99.3 147.2 134.2 205.9 233.7 140.7 77.9 107.5 102.8 157.2 207.2 93.5 65.1 67.9 132.2 215.5 205.8 114.9 103.8 235.2 168.7 154.7 146.4 89.3 342.6 171.5 118.1 247.1 126.1 127.5 94.1 273.5 283.5 60.3 318.6 310.4 155.5 171.9 86.9 120.3 160.2 246.8 107.6 246.1 N4BP3 LZTS4 ENSG00000145911 "NEDD4 binding protein 3" O15049 5 178113443-178126087 "Predicted intracellular proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 31.5" "Cell type enriched" "Detected in many" 4 "Extravillous trophoblasts: 120.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 4.0;naive B-cell: 4.0;naive CD8 T-cell: 2.6;plasmacytoid DC: 4.4" "Group enriched" "Detected in many" 18 "B-cells: 4.0;dendritic cells: 4.4;T-cells: 2.6" "Cell line enhanced" "Detected in many" "BEWO: 8.0;MCF7: 10.9;RH-30: 10.9;SK-BR-3: 38.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030972, HPA030973, HPA061387" Approved Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA030972: AB_2673680, HPA030973: AB_10603574, HPA061387: " "unprognostic (1.84e-1)" "unprognostic (1.70e-2)" "unprognostic (4.96e-3)" "unprognostic (6.64e-3)" "unprognostic (2.06e-1)" "unprognostic (3.18e-3)" "unprognostic (1.88e-6)" "unprognostic (1.45e-1)" "unprognostic (1.61e-1)" "unprognostic (1.92e-2)" "unprognostic (3.28e-3)" "unprognostic (9.55e-2)" "prognostic favorable (2.38e-4)" "unprognostic (2.62e-1)" "unprognostic (1.16e-1)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" 6.6 1.3 1.9 2.6 2.1 3.5 13.9 6.5 4.3 2.5 1.8 0.7 0.5 0.8 1.1 0.6 16.2 1.5 1.3 3.2 1.8 2.6 2.5 0.2 8.4 4.0 2.1 1.2 1.4 1.1 10.1 2.5 31.5 3.1 2.0 0.6 1.5 9.5 1.3 5.7 7.8 1.9 1.3 1.2 5.9 3.1 1.4 1.3 0.4 2.0 4.7 11.2 4.9 3.8 4.0 4.4 0.0 0.0 0.2 2.6 0.5 0.0 0.0 1.2 0.9 0.1 0.0 8.0 0.0 0.0 0.0 0.0 1.7 0.6 0.7 1.1 0.0 0.1 2.5 0.2 0.0 0.0 1.2 0.4 2.1 0.8 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 6.4 0.7 1.3 0.5 0.0 10.9 0.1 0.1 6.0 1.8 0.0 6.0 10.9 2.7 0.6 1.2 0.9 0.4 0.3 38.8 2.5 1.6 1.4 0.0 1.2 0.0 0.9 0.0 0.0 1.7 1.2 6.8 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.3 4.0 0.2 0.2 0.0 4.0 0.9 2.6 0.0 0.2 0.0 4.4 0.0 0.5 1.9 2.1 6.5 4.3 1.8 2.6 2.1 1.2 3.1 1.3 3.0 1.1 5.9 11.5 8.4 27.3 1.5 2.5 0.0 0.0 1.8 11.8 1.7 11.6 3.4 0.1 4.0 2.6 0.0 0.7 120.1 0.9 9.9 4.6 0.0 2.0 1.6 4.1 0.0 0.0 0.4 0.6 1.1 11.8 1.8 1.8 1.9 4.7 5.3 1.8 0.3 8.9 0.0 0.9 0.1 6.9 5.9 19.3 1.0 1.9 10.6 N6AMT1 "C21orf127, HEMK2, MTQ2, N6AMT, PRED28" ENSG00000156239 "N-6 adenine-specific DNA methyltransferase 1" Q9Y5N5 21 28872191-28885371 "Predicted intracellular proteins" "Chromatin regulator, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034133, CAB034135, HPA059242" Approved Approved Nucleoplasm,Centrosome Yes No Centrosome Nucleoplasm "CAB034133: AB_2147189, CAB034135: AB_2250945, HPA059242: AB_2683957" "unprognostic (2.20e-2)" "unprognostic (4.93e-2)" "unprognostic (5.06e-2)" "unprognostic (2.82e-1)" "unprognostic (7.46e-2)" "unprognostic (1.56e-1)" "unprognostic (1.09e-1)" "unprognostic (3.67e-1)" "unprognostic (2.64e-1)" "unprognostic (1.04e-1)" "unprognostic (1.94e-2)" "unprognostic (2.67e-1)" "unprognostic (1.03e-1)" "unprognostic (5.24e-2)" "unprognostic (6.99e-2)" "unprognostic (5.43e-2)" "unprognostic (5.51e-3)" 5.4 10.9 10.1 6.0 18.6 2.0 10.5 7.4 14.8 9.9 7.0 17.0 6.0 6.7 13.8 13.7 5.6 9.3 6.2 10.8 10.8 9.2 9.0 6.3 5.5 6.7 21.3 8.4 18.3 6.6 14.6 15.6 13.1 14.1 10.1 7.4 8.4 6.5 9.0 11.3 8.0 6.2 7.8 14.5 7.9 6.7 7.6 19.3 3.9 12.1 4.0 6.9 8.7 9.2 2.2 2.0 1.6 2.1 4.1 4.8 1.8 3.4 3.1 7.8 10.8 6.5 7.2 6.0 7.4 3.1 4.4 2.6 3.8 6.2 3.8 3.8 4.0 7.8 4.1 6.6 3.7 5.4 4.8 5.1 8.0 4.7 4.8 5.8 4.8 3.1 3.7 8.0 4.4 3.1 8.2 3.2 4.7 9.9 6.8 9.0 3.4 2.3 3.9 9.8 7.2 4.3 3.4 7.4 2.9 8.0 5.0 5.9 8.3 6.7 2.4 2.7 7.3 3.3 4.2 7.5 3.7 6.6 6.7 4.5 4.1 4.6 2.1 5.8 12.6 6.8 1.1 1.5 1.6 1.8 2.1 2.0 2.2 3.4 2.3 2.0 2.2 4.8 3.4 0.5 4.1 1.6 1.7 1.4 1.8 10.1 18.6 7.4 14.8 10.8 9.2 21.3 8.4 14.1 19.3 3.0 4.8 1.4 5.3 1.6 11.1 14.0 7.6 21.4 6.8 12.2 7.9 15.0 6.6 9.7 2.5 4.9 0.9 23.3 5.5 9.8 6.1 3.4 1.1 2.8 6.2 9.5 0.0 4.9 1.2 3.4 8.9 2.6 1.7 2.8 2.6 10.3 6.4 4.8 9.6 7.3 10.0 0.0 8.2 2.6 8.1 3.1 12.5 2.5 3.3 4.8 NAA11 "ARD1B, ARD2, hARD2" ENSG00000156269 "N(alpha)-acetyltransferase 11, NatA catalytic subunit" Q9BSU3 4 79225694-79326050 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 166 "placenta: 32.1;testis: 30.5" "Group enriched" "Detected in some" 11 "Cytotrophoblasts: 16.7;Early spermatids: 21.1;Extravillous trophoblasts: 13.6;Late spermatids: 20.7;Spermatocytes: 14.4;Spermatogonia: 15.0;Syncytiotrophoblasts: 11.1" "Cancer enhanced" "Detected in some" "testis cancer: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "GAMG: 14.7;K-562: 8.8;U-266/70: 25.1;U-266/84: 8.0" "Not detected" "Not detected" HPA035922 Approved Supported "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Centrosome, Cytosol" "HPA035922: AB_10673490" "unprognostic (7.37e-2)" "unprognostic (7.58e-2)" "unprognostic (1.36e-1)" "unprognostic (1.20e-1)" "unprognostic (4.67e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 32.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 30.5 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 25.1 8.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 21.1 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 20.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 14.4 15.0 0.0 11.1 0.0 0.0 0.0 NAA35 "bA379P1.1, FLJ21613, FLJ22643, MAK10" ENSG00000135040 "N(alpha)-acetyltransferase 35, NatC auxiliary subunit" Q5VZE5 9 85941146-86022298 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021547 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA021547: AB_1853505" "unprognostic (5.87e-2)" "unprognostic (2.41e-1)" "unprognostic (4.71e-3)" "unprognostic (9.25e-3)" "unprognostic (2.37e-2)" "unprognostic (6.39e-2)" "prognostic unfavorable (1.16e-7)" "unprognostic (1.86e-1)" "unprognostic (5.22e-3)" "unprognostic (1.56e-1)" "unprognostic (8.30e-2)" "unprognostic (1.09e-1)" "unprognostic (2.36e-3)" "unprognostic (1.88e-1)" "unprognostic (4.34e-2)" "unprognostic (9.18e-2)" "unprognostic (1.07e-2)" 11.3 19.5 15.2 16.4 14.6 9.7 17.1 20.1 17.6 13.4 16.5 12.5 22.9 14.9 20.5 21.0 16.8 13.5 14.4 14.2 16.6 14.0 16.0 14.3 10.8 10.2 14.6 16.2 16.2 16.4 19.1 25.5 16.9 14.4 17.4 19.5 13.0 16.3 20.0 28.7 13.4 17.4 16.4 14.1 10.3 13.4 25.7 15.1 10.0 19.8 15.8 12.7 14.4 13.5 12.2 5.8 8.9 4.7 5.9 9.6 4.4 22.9 16.0 16.0 12.5 9.4 11.3 25.1 14.5 14.2 16.3 13.8 11.0 15.9 7.8 8.5 14.7 13.7 32.2 14.6 17.0 17.5 19.5 10.5 17.2 17.4 15.0 17.5 26.3 15.6 11.7 14.8 17.4 25.8 11.4 15.3 16.2 21.0 15.3 15.4 15.8 14.7 15.3 16.1 27.7 16.4 12.6 22.7 12.1 17.8 20.9 14.6 13.0 16.5 14.6 12.8 17.3 11.7 11.1 12.1 10.5 13.2 17.5 13.4 20.5 25.1 5.3 13.4 11.4 10.7 2.0 4.6 8.9 7.0 4.7 9.3 12.2 7.7 6.5 5.8 12.2 9.6 7.7 2.1 5.9 3.2 3.8 6.4 4.4 15.2 14.6 20.1 17.6 16.6 14.0 14.6 16.2 14.4 15.1 3.0 13.1 12.0 17.1 14.4 24.0 19.6 10.2 32.1 21.6 10.4 21.6 18.4 1.7 16.5 5.9 11.9 11.1 0.0 22.5 15.1 13.4 18.4 11.5 8.9 10.6 20.6 20.1 8.6 9.5 3.6 8.6 12.9 13.5 11.8 15.0 22.0 15.4 14.0 11.0 7.1 32.7 12.9 16.5 58.6 33.7 14.4 26.0 12.8 14.6 17.4 NAA38 "LSMD1, MGC14151, PFAAP2" ENSG00000183011 "N(alpha)-acetyltransferase 38, NatC auxiliary subunit" Q9BRA0 17 7856685-7885238 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Late spermatids: 1093.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059189 Supported Nucleoplasm "Intracellular and membrane" No No Nucleoplasm "HPA059189: " "unprognostic (6.84e-2)" "unprognostic (1.65e-3)" "unprognostic (1.30e-2)" "unprognostic (1.85e-3)" "unprognostic (2.76e-2)" "unprognostic (3.35e-1)" "unprognostic (4.72e-2)" "unprognostic (1.05e-1)" "unprognostic (2.27e-1)" "unprognostic (7.28e-3)" "unprognostic (1.48e-3)" "unprognostic (3.31e-1)" "unprognostic (5.83e-3)" "unprognostic (1.58e-1)" "unprognostic (6.02e-2)" "unprognostic (2.66e-1)" "unprognostic (9.75e-2)" 24.4 38.7 55.9 20.5 51.0 41.8 23.8 25.1 60.7 22.1 27.0 18.7 16.2 20.1 17.2 22.9 19.8 30.1 28.1 34.2 41.4 37.2 26.1 27.6 18.4 26.3 45.9 36.2 15.8 33.3 17.9 21.3 15.0 32.1 26.7 18.1 19.7 37.5 33.2 74.5 16.5 18.2 23.8 34.2 22.3 22.2 26.6 25.6 14.6 18.7 39.8 20.0 18.0 15.9 66.0 84.4 68.7 71.8 35.5 52.1 70.5 27.7 51.1 28.7 29.3 16.0 17.9 9.9 13.0 15.1 24.1 20.2 19.2 11.9 19.2 22.0 13.7 15.4 22.9 15.3 24.0 6.0 28.4 69.8 29.2 57.9 27.7 15.6 8.1 22.7 25.9 13.4 15.7 10.3 16.7 23.3 44.1 6.0 21.0 13.9 33.5 29.3 19.4 6.4 21.1 59.6 30.2 13.2 12.7 22.0 15.7 12.8 24.6 10.1 24.5 18.4 4.3 15.1 21.5 12.5 16.2 11.7 13.1 36.3 8.7 8.8 7.0 27.3 33.9 15.8 68.7 71.8 47.6 47.7 59.1 43.6 66.0 50.9 48.6 84.4 57.1 46.1 47.8 51.7 35.5 56.4 76.8 52.1 70.5 55.9 51.0 25.1 60.7 41.4 37.2 45.9 36.2 32.1 25.6 71.5 116.4 99.9 74.2 83.6 100.6 294.9 109.5 131.2 75.1 240.8 47.1 142.9 439.3 87.9 575.0 132.2 186.5 70.0 137.1 98.8 70.4 99.2 97.1 325.3 181.0 38.1 217.8 193.3 210.1 1093.0 108.1 113.0 72.6 165.1 179.4 108.6 125.9 144.0 106.4 289.2 88.8 109.9 82.5 94.0 121.8 86.9 76.9 96.9 261.5 96.2 NAA40 "FLJ13848, NAT11" ENSG00000110583 "N(alpha)-acetyltransferase 40, NatD catalytic subunit" Q86UY6 11 63938959-63957328 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Horizontal cells: 96.9;Late spermatids: 100.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037816, HPA056142" Uncertain Supported "Nucleoplasm,Centriolar satellite,Cytosol" NA NA Nucleoplasm "Centriolar satellite, Cytosol" "HPA037816: AB_10672289, HPA056142: " "unprognostic (3.52e-1)" "unprognostic (4.12e-1)" "unprognostic (1.40e-1)" "unprognostic (6.88e-3)" "unprognostic (1.50e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (1.43e-7)" "unprognostic (1.45e-1)" "unprognostic (1.13e-2)" "unprognostic (1.58e-1)" "unprognostic (7.01e-3)" "unprognostic (6.29e-3)" "unprognostic (3.42e-2)" "unprognostic (6.43e-3)" "unprognostic (2.49e-1)" "unprognostic (1.55e-1)" "unprognostic (5.25e-2)" 4.9 12.4 9.8 10.0 11.6 4.1 7.6 16.7 13.5 7.1 7.3 12.2 10.8 9.2 5.0 7.7 9.2 11.2 7.6 13.8 9.8 10.0 10.0 5.1 6.1 10.7 8.3 8.6 4.2 8.9 28.0 22.7 10.5 8.9 6.0 7.9 12.2 9.7 11.3 7.5 4.5 9.8 5.4 7.6 12.5 6.3 19.2 8.9 10.1 10.1 4.1 11.7 8.1 4.9 4.1 5.0 3.5 0.8 6.7 10.1 2.8 10.7 12.6 15.7 8.4 4.4 4.3 10.0 8.0 8.6 19.9 14.0 10.4 13.7 6.6 10.0 7.2 13.9 9.7 13.1 5.8 14.8 8.7 8.1 9.1 8.0 11.7 5.9 14.3 7.8 4.5 5.3 12.3 3.4 7.8 12.8 11.6 15.3 5.0 9.2 8.1 15.2 11.3 14.6 10.0 8.5 15.1 14.2 8.4 13.3 8.3 20.9 11.1 12.5 11.0 6.5 11.9 18.0 6.4 8.2 11.1 13.5 6.4 6.5 6.0 3.8 11.7 6.6 6.2 8.5 3.3 0.8 3.5 10.1 0.6 3.6 4.1 2.7 4.8 3.6 3.9 1.7 4.1 0.3 6.7 0.3 5.0 0.8 2.8 9.8 11.6 16.7 13.5 9.8 10.0 8.3 8.6 8.9 8.9 3.0 3.7 5.1 1.9 2.5 27.2 12.8 7.6 22.7 12.5 17.4 31.4 8.4 0.0 5.2 38.5 7.1 10.5 0.0 4.7 10.2 4.6 1.9 1.1 4.5 7.8 96.9 16.8 10.4 9.4 100.4 4.4 8.4 1.7 3.6 6.5 9.4 4.8 3.5 6.7 3.0 24.2 0.0 3.1 19.1 16.8 2.5 3.4 8.2 6.8 1.0 NAALAD2 "GCPIII, NAALADASE2" ENSG00000077616 "N-acetylated alpha-linked acidic dipeptidase 2" Q9Y3Q0 11 90131515-90192894 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 44.1" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 15.8;Early spermatids: 37.5;Horizontal cells: 66.7" "Cancer enhanced" "Detected in some" "testis cancer: 1.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "non-classical monocyte: 2.4" "Lineage enriched" "Detected in single" 12 "monocytes: 2.4" "Cell line enhanced" "Detected in some" "CACO-2: 20.0;SH-SY5Y: 6.7;SuSa: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060820, HPA065419" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA060820: AB_2684373, HPA065419: AB_2685487" "unprognostic (1.68e-1)" "unprognostic (2.66e-3)" "unprognostic (1.49e-1)" "unprognostic (4.52e-3)" "unprognostic (4.73e-3)" "unprognostic (2.97e-1)" "unprognostic (3.82e-3)" "unprognostic (1.77e-2)" "unprognostic (2.44e-1)" "unprognostic (2.30e-1)" "unprognostic (3.30e-2)" "unprognostic (8.00e-2)" "unprognostic (9.97e-4)" "unprognostic (1.52e-2)" "unprognostic (2.54e-1)" "unprognostic (1.63e-2)" "unprognostic (2.93e-1)" 7.7 13.0 5.3 1.8 9.9 1.1 3.1 2.1 9.8 7.8 2.1 3.7 2.8 1.3 10.3 5.4 1.8 4.7 3.7 2.5 5.5 7.4 2.7 1.7 2.8 1.6 6.5 5.0 12.9 2.5 0.9 44.1 8.8 11.9 5.2 2.2 5.8 1.9 3.7 2.1 1.5 2.1 3.5 6.2 4.4 1.8 16.6 7.4 0.0 1.7 1.7 1.2 1.8 3.8 0.0 0.1 0.0 2.4 0.0 0.1 0.1 0.1 0.2 1.9 0.1 0.6 0.1 2.4 0.1 0.1 0.1 0.0 20.0 0.7 0.3 0.2 0.0 0.3 0.3 1.4 0.0 0.0 0.0 0.4 1.9 0.4 1.8 0.2 0.1 0.1 2.3 0.0 0.0 0.0 0.6 0.4 0.2 0.1 0.0 0.0 0.0 0.3 0.3 1.9 0.5 0.2 0.3 0.0 0.2 0.0 0.0 0.2 6.7 0.0 0.2 0.0 4.9 0.2 0.4 2.6 0.1 1.6 0.4 0.3 1.1 0.3 0.3 0.7 0.3 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.1 0.1 5.3 9.9 2.1 9.8 5.5 7.4 6.5 5.0 11.9 7.4 0.0 0.0 0.0 0.1 0.2 15.8 0.8 2.5 0.0 1.2 0.0 0.0 0.8 0.0 0.0 37.5 0.7 0.0 0.0 0.0 0.5 3.4 0.2 0.0 0.0 0.3 66.7 0.0 1.3 5.4 13.2 10.3 0.2 0.0 0.0 0.0 10.1 0.0 0.0 13.8 0.0 2.3 0.0 4.7 0.3 4.4 0.0 0.7 0.0 0.0 0.0 NAALADL2 ENSG00000177694 "N-acetylated alpha-linked acidic dipeptidase like 2" Q58DX5 3 174438573-175810552 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 29.3" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 60.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 11.7;BJ hTERT+: 4.2;fHDF/TERT166: 4.9;WM-115: 4.5" "Low region specificity" "Detected in many" "HPA012413, HPA017425, CAB025586" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB025586: , HPA012413: AB_1854274, HPA017425: AB_1854275" "unprognostic (7.28e-3)" "unprognostic (1.10e-1)" "unprognostic (6.28e-2)" "unprognostic (1.60e-1)" "unprognostic (2.56e-1)" "unprognostic (2.56e-1)" "unprognostic (2.29e-4)" "unprognostic (3.44e-3)" "unprognostic (5.70e-2)" "unprognostic (7.42e-2)" "unprognostic (7.85e-3)" "unprognostic (9.49e-2)" "unprognostic (3.66e-6)" "unprognostic (7.11e-2)" "unprognostic (1.48e-1)" "unprognostic (9.05e-2)" "unprognostic (2.22e-2)" 4.9 2.3 2.2 4.6 3.7 0.8 7.0 1.9 2.7 8.3 8.3 5.4 23.8 2.4 9.7 10.5 2.3 5.0 8.9 5.4 2.5 1.8 7.0 3.7 3.3 1.3 2.3 2.0 5.4 3.9 20.6 3.0 6.4 4.0 9.6 3.3 4.4 17.0 29.3 1.8 3.2 6.6 6.0 3.6 2.6 4.5 1.9 2.9 4.9 3.5 2.6 1.7 8.7 5.0 0.1 1.7 0.2 0.1 0.1 0.8 0.0 0.0 0.0 0.2 0.0 3.5 11.7 0.1 2.3 4.2 0.6 0.7 0.2 1.3 0.0 0.5 4.9 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 3.2 0.6 0.1 0.0 3.0 0.4 0.0 0.0 0.1 2.3 0.4 0.2 0.0 0.0 1.6 0.0 0.0 0.2 0.1 1.7 0.2 0.0 0.0 0.2 0.2 0.9 0.3 3.1 0.1 0.5 2.3 0.1 0.1 0.5 0.0 0.0 0.0 1.5 0.0 4.5 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.1 0.0 1.7 0.0 0.0 2.2 3.7 1.9 2.7 2.5 1.8 2.3 2.0 4.0 2.9 0.0 11.5 0.0 7.2 2.1 7.6 2.8 10.2 18.7 6.8 12.2 11.8 16.3 6.6 6.8 60.1 2.1 11.1 0.0 2.3 1.5 7.8 18.3 4.6 2.4 1.6 0.0 8.6 3.1 0.3 28.0 14.1 0.7 3.3 0.0 1.1 7.7 2.5 3.5 11.3 1.7 6.6 0.0 2.3 3.2 1.9 1.6 10.3 0.0 14.9 13.7 NAB1 ENSG00000138386 "NGFI-A binding protein 1" Q13506 2 190646746-190692766 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 90.6;Suprabasal keratinocytes: 121.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002738 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "Golgi apparatus" "HPA002738: AB_1079447" "unprognostic (1.44e-1)" "unprognostic (2.65e-2)" "unprognostic (6.02e-3)" "unprognostic (4.04e-3)" "unprognostic (9.05e-2)" "unprognostic (9.45e-2)" "unprognostic (7.12e-3)" "unprognostic (6.41e-2)" "unprognostic (2.13e-2)" "unprognostic (1.79e-2)" "prognostic unfavorable (1.01e-4)" "unprognostic (3.52e-1)" "unprognostic (7.23e-3)" "unprognostic (1.71e-1)" "unprognostic (1.90e-1)" "unprognostic (1.13e-1)" "unprognostic (3.85e-2)" 19.1 10.3 12.1 12.5 13.7 7.6 28.3 28.2 15.7 18.5 19.9 10.4 7.2 7.4 16.2 26.4 32.3 14.1 13.9 21.2 12.1 9.7 10.6 18.6 12.5 13.8 14.5 12.0 15.7 9.3 16.4 20.2 12.8 12.4 16.3 12.9 19.8 15.9 17.5 6.9 33.2 10.9 13.3 14.3 9.3 18.4 12.3 12.4 13.6 19.0 15.7 13.0 13.0 25.8 1.4 1.7 5.4 6.1 4.6 6.0 1.4 12.2 9.1 23.2 8.1 9.1 15.8 40.2 12.5 19.7 9.4 10.8 22.1 13.6 13.7 14.7 9.8 17.6 31.4 13.2 16.1 18.8 43.7 11.2 16.1 32.5 10.5 5.9 6.7 8.1 9.1 25.8 20.0 6.2 13.5 14.6 8.4 15.7 11.8 14.5 6.0 9.7 7.0 8.2 13.2 12.6 12.0 16.7 5.4 7.2 12.0 21.0 17.0 14.7 5.0 13.1 31.0 4.0 10.6 10.1 19.9 15.8 11.2 7.4 9.4 10.1 10.2 21.0 6.2 15.5 0.0 2.6 1.1 2.7 2.0 4.0 1.4 2.8 3.5 1.7 0.9 2.9 3.1 5.4 4.6 6.1 1.6 6.0 1.4 12.1 13.7 28.2 15.7 12.1 9.7 14.5 12.0 12.4 12.4 6.0 23.4 2.2 21.8 90.6 15.9 15.7 17.8 21.4 31.8 12.2 11.8 3.8 3.3 8.7 1.1 28.6 7.3 0.0 6.9 8.3 21.6 24.1 19.7 23.7 6.0 6.4 13.8 35.0 19.5 3.2 12.4 18.1 37.1 6.4 15.0 11.5 7.4 28.8 13.8 3.6 14.1 45.3 59.7 1.4 36.3 121.5 1.0 12.8 13.6 26.5 NAB2 MADER ENSG00000166886 "NGFI-A binding protein 2" Q15742 12 57088894-57095476 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 47.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004510, HPA027464" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB004510: AB_627982, HPA027464: AB_10601138" "prognostic favorable (7.41e-4)" "unprognostic (4.04e-2)" "unprognostic (2.20e-3)" "unprognostic (2.43e-2)" "unprognostic (4.74e-2)" "unprognostic (2.10e-1)" "unprognostic (1.88e-3)" "unprognostic (1.80e-1)" "unprognostic (5.85e-2)" "unprognostic (1.19e-1)" "unprognostic (2.13e-1)" "unprognostic (6.98e-2)" "prognostic unfavorable (9.38e-6)" "unprognostic (1.95e-1)" "unprognostic (9.76e-2)" "unprognostic (5.67e-3)" "unprognostic (6.19e-3)" 9.5 12.6 11.7 9.9 14.2 4.8 7.9 33.3 20.4 18.7 13.7 5.3 9.6 8.2 22.8 18.9 10.5 15.6 14.5 9.6 8.6 6.8 8.4 18.7 12.8 9.1 4.4 14.6 29.2 8.5 14.5 17.0 13.4 6.8 15.0 4.4 8.5 5.6 14.5 7.1 18.6 7.1 14.5 4.1 8.0 8.2 11.8 7.0 12.4 9.8 7.7 8.6 14.5 26.5 4.2 1.2 0.9 5.4 0.9 2.5 1.2 5.5 3.6 18.9 17.3 17.0 22.3 2.0 16.8 15.2 10.6 8.9 5.8 3.3 3.5 6.9 16.5 3.2 10.1 6.5 12.4 5.7 1.5 1.7 4.2 2.8 5.9 12.9 3.4 10.1 24.7 13.7 12.6 4.3 16.9 2.8 2.6 9.5 3.7 12.3 26.0 5.1 16.3 3.8 4.8 6.3 3.8 24.9 1.8 4.5 2.2 2.1 5.0 8.1 4.7 35.2 5.1 10.6 7.4 3.2 15.7 13.1 11.1 4.9 8.7 2.1 1.8 15.3 2.2 9.4 0.0 2.3 0.3 1.2 5.3 1.4 2.1 2.0 1.5 1.2 4.2 2.5 2.5 0.9 0.9 5.4 0.0 1.9 1.2 11.7 14.2 33.3 20.4 8.6 6.8 4.4 14.6 6.8 7.0 11.9 15.4 9.0 20.1 26.3 18.7 2.4 0.0 1.4 13.6 8.7 2.0 2.7 6.6 7.2 0.4 10.5 2.6 0.0 1.2 8.8 23.4 12.6 16.2 13.0 10.6 9.5 6.3 16.5 13.7 2.1 18.1 18.0 20.3 0.0 0.5 7.5 3.3 0.0 17.7 4.4 3.8 19.4 16.0 1.6 15.0 28.4 47.0 5.1 1.3 8.4 NABP1 "DKFZp667M1322, FLJ13624, FLJ22833, hSSB2, MGC111163, OBFC2A, SOSS-B2, SSB2" ENSG00000173559 "Nucleic acid binding protein 1" Q96AH0 2 191678068-191696659 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 40.0" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 2: 620.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054978, HPA067802" Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA054978: AB_2682660, HPA067802: AB_2685899" "unprognostic (5.43e-2)" "unprognostic (5.33e-2)" "unprognostic (2.80e-1)" "unprognostic (4.73e-2)" "unprognostic (1.48e-1)" "unprognostic (6.89e-2)" "unprognostic (8.07e-4)" "unprognostic (1.33e-1)" "unprognostic (2.89e-2)" "unprognostic (2.99e-1)" "unprognostic (2.82e-2)" "unprognostic (6.17e-2)" "prognostic unfavorable (8.20e-7)" "unprognostic (5.64e-2)" "unprognostic (7.50e-2)" "unprognostic (1.48e-1)" "unprognostic (6.02e-2)" 20.8 4.9 2.4 26.0 2.3 4.2 22.2 1.1 2.1 4.4 14.1 1.9 1.6 13.3 6.7 9.2 12.1 4.9 8.1 6.9 4.7 2.0 8.8 8.7 18.6 39.6 3.9 1.3 4.9 6.3 0.8 4.4 28.0 6.1 4.7 5.2 2.6 6.2 3.9 3.1 4.3 30.6 4.7 5.3 40.0 4.6 18.4 1.5 7.4 3.6 12.1 23.0 8.7 8.8 3.8 2.2 18.6 7.7 1.6 14.2 1.9 14.8 2.3 0.3 0.4 11.3 13.7 3.9 23.2 19.0 14.4 8.7 12.3 8.4 0.8 18.4 14.0 11.7 4.2 2.1 9.9 16.0 7.7 1.9 7.4 4.7 3.1 8.2 3.4 8.4 18.0 12.5 20.7 14.9 17.2 5.4 2.2 10.4 32.9 22.5 1.2 1.1 4.0 1.3 3.1 11.7 2.5 2.6 7.0 21.6 11.0 0.5 0.1 8.0 2.8 6.5 14.1 0.7 2.2 13.8 12.1 10.2 6.3 14.5 10.9 4.5 3.1 10.0 4.1 2.1 2.5 4.0 1.9 6.4 6.7 8.7 3.8 8.6 6.6 2.2 0.6 2.2 3.8 18.6 1.6 7.7 1.4 14.2 1.9 2.4 2.3 1.1 1.9 4.7 2.0 3.9 1.3 6.1 1.5 199.5 620.7 29.6 104.4 47.2 3.0 6.7 12.7 85.6 168.4 10.4 2.0 20.0 3.3 17.5 161.5 9.3 94.3 0.0 4.6 34.8 18.6 41.1 131.1 6.7 49.8 3.2 4.1 11.6 96.8 54.0 9.5 125.6 38.8 147.9 15.3 1.1 20.2 31.6 3.5 17.7 3.8 6.5 28.6 21.1 18.0 39.5 122.3 52.2 21.7 106.4 NABP2 "hSSB1, MGC2731, OBFC2B, SOSS-B1, SSB1" ENSG00000139579 "Nucleic acid binding protein 2" Q9BQ15 12 56222015-56229854 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 187.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044615, HPA057213" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA044615: AB_10795884, HPA057213: AB_2683371" "unprognostic (1.45e-1)" "prognostic favorable (8.35e-6)" "unprognostic (1.44e-1)" "unprognostic (1.14e-1)" "unprognostic (1.80e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (7.44e-6)" "unprognostic (4.00e-1)" "unprognostic (1.11e-1)" "unprognostic (6.96e-3)" "unprognostic (6.52e-2)" "unprognostic (4.72e-2)" "prognostic unfavorable (2.69e-5)" "unprognostic (1.28e-1)" "unprognostic (1.92e-1)" "unprognostic (1.28e-1)" "unprognostic (3.01e-2)" 14.0 26.7 27.7 16.7 33.3 16.2 15.7 23.6 32.6 16.2 19.5 17.6 14.9 22.8 16.3 19.4 15.0 16.0 23.0 16.2 25.8 25.2 21.0 17.7 11.7 18.0 26.4 24.4 23.1 25.8 17.2 17.0 8.6 24.0 15.8 19.9 17.6 15.9 19.6 51.8 14.0 22.4 16.7 20.2 14.9 17.0 18.6 20.5 10.6 20.6 21.7 18.7 15.9 14.7 17.1 13.5 15.3 14.9 25.9 21.0 10.2 25.4 26.4 25.1 27.9 10.9 11.9 4.8 15.4 12.9 22.4 13.4 15.8 23.0 19.6 31.4 14.1 16.0 20.4 23.3 19.4 17.1 36.9 21.9 32.7 18.5 12.1 11.8 23.3 31.9 10.1 15.5 26.7 21.7 19.2 14.3 24.3 16.8 33.8 16.1 23.1 31.5 26.1 18.4 15.2 25.3 28.6 23.5 29.2 10.6 10.6 32.0 23.7 24.7 30.6 20.9 4.1 35.0 20.8 10.1 15.8 15.0 33.1 28.2 22.9 34.9 12.5 29.4 21.8 29.2 15.3 9.9 8.6 17.5 13.8 19.4 17.1 14.7 15.8 13.4 12.6 9.2 15.3 1.9 25.9 14.9 13.5 21.0 10.2 27.7 33.3 23.6 32.6 25.8 25.2 26.4 24.4 24.0 20.5 14.9 17.6 19.2 18.9 16.6 15.5 8.1 12.7 12.0 3.4 22.7 2.0 25.5 41.4 27.1 73.7 17.5 25.1 0.0 61.7 33.3 19.1 11.3 17.3 18.5 27.5 14.3 17.3 16.5 16.1 187.0 21.9 20.4 30.4 36.9 24.4 24.4 31.4 24.6 32.2 28.4 11.8 19.4 19.4 9.9 24.7 14.9 12.7 27.7 34.4 9.3 NACAD KIAA0363 ENSG00000136274 "NAC alpha domain containing" O15069 7 45080438-45088914 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 45.0" "Cell type enhanced" "Detected in many" 16 "Horizontal cells: 30.2;Peritubular cells: 11.3" "Group enriched" "Detected in many" 7 "glioma: 12.1;testis cancer: 16.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.4;non-classical monocyte: 1.8" "Group enriched" "Detected in many" 12 "monocytes: 1.8;T-cells: 1.4" "Cell line enhanced" "Detected in many" "GAMG: 24.1;SCLC-21H: 18.5;SH-SY5Y: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020981, HPA079208" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA020981: AB_2670549, HPA079208: " "unprognostic (5.54e-6)" "unprognostic (1.89e-1)" "unprognostic (8.55e-4)" "unprognostic (7.06e-3)" "prognostic unfavorable (1.38e-4)" "unprognostic (1.61e-1)" "unprognostic (6.91e-2)" "unprognostic (1.16e-1)" "unprognostic (4.17e-2)" "unprognostic (3.17e-2)" "unprognostic (8.17e-3)" "unprognostic (2.76e-2)" "unprognostic (7.72e-3)" "unprognostic (2.72e-3)" "unprognostic (9.22e-2)" "unprognostic (1.54e-1)" "unprognostic (2.87e-2)" 4.7 8.9 11.5 2.7 19.4 1.1 2.1 16.7 45.0 4.8 3.5 43.1 0.1 2.1 6.9 2.3 3.9 4.8 3.7 5.1 16.7 15.9 2.2 1.2 3.0 1.9 30.2 12.9 10.4 2.4 3.2 11.7 3.8 26.7 4.7 2.3 1.1 3.2 5.7 2.0 2.1 2.7 7.4 30.8 2.7 2.5 4.5 21.5 0.0 1.4 0.0 1.5 3.2 2.3 0.1 0.0 0.0 1.8 0.0 1.4 0.1 0.0 0.0 1.8 0.0 1.1 0.5 0.0 2.0 2.5 5.6 3.5 0.1 0.1 0.0 1.6 3.6 24.1 0.1 1.6 1.3 2.0 0.0 0.5 0.0 1.2 0.0 1.3 0.0 0.0 1.2 0.0 2.4 0.2 2.9 1.7 0.0 0.0 2.5 1.4 0.0 0.0 0.0 1.6 0.0 1.5 0.0 0.7 0.0 0.2 0.0 18.5 12.8 0.0 0.0 0.1 5.0 0.0 0.0 0.6 0.0 0.0 0.1 0.3 1.3 0.7 0.0 1.1 0.0 3.7 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.4 0.0 0.0 1.8 0.0 0.0 0.1 11.5 19.4 16.7 24.1 16.7 15.9 30.2 12.9 26.7 21.5 0.0 0.0 0.0 2.7 0.6 5.1 4.2 0.0 1.4 0.0 1.8 0.0 0.0 0.0 0.4 2.0 1.0 0.0 0.0 0.2 0.0 3.8 1.7 1.1 0.0 0.1 30.2 1.2 0.6 0.0 3.6 6.4 0.0 1.7 1.8 0.0 1.9 0.1 0.0 11.3 0.0 1.4 6.5 2.2 1.5 0.6 0.1 0.1 0.0 0.0 0.6 NACC1 "BEND8, BTBD14B, BTBD30, NAC-1, NAC1" ENSG00000160877 "Nucleus accumbens associated 1" Q96RE7 19 13118103-13141141 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021238, HPA062245, CAB069927" Enhanced Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB069927: AB_1082966, HPA021238: AB_1845475, HPA062245: AB_2684724" "unprognostic (2.19e-1)" "unprognostic (9.20e-3)" "unprognostic (2.67e-2)" "unprognostic (2.84e-2)" "unprognostic (2.62e-1)" "unprognostic (7.75e-2)" "unprognostic (8.46e-3)" "unprognostic (1.10e-1)" "unprognostic (1.93e-1)" "unprognostic (8.46e-2)" "unprognostic (2.40e-2)" "unprognostic (3.04e-2)" "unprognostic (7.35e-2)" "unprognostic (2.80e-2)" "unprognostic (1.02e-1)" "unprognostic (1.97e-1)" "unprognostic (9.74e-2)" 12.5 13.7 27.2 18.2 22.3 10.0 6.7 19.8 38.7 10.8 16.6 20.1 11.7 16.6 12.8 10.0 17.9 10.5 9.4 13.2 23.6 14.2 10.8 15.6 11.3 14.9 17.1 14.2 7.8 16.8 10.5 10.6 15.4 16.0 11.9 8.4 7.8 15.3 15.6 17.6 10.9 18.3 9.2 17.2 15.2 16.1 18.8 15.4 10.7 9.8 9.6 9.9 13.2 7.9 0.7 0.9 1.8 0.8 0.6 1.3 0.5 28.3 34.5 8.0 17.8 4.5 5.7 21.8 13.9 10.5 13.5 10.5 34.7 12.1 14.2 31.2 11.6 10.6 14.1 10.3 25.3 5.0 25.1 16.4 9.1 28.2 24.3 10.8 14.2 25.5 8.6 8.4 13.2 7.2 10.6 15.3 12.8 19.7 5.7 6.6 58.5 22.8 11.3 35.7 8.0 31.9 14.0 9.2 14.2 8.2 31.1 17.5 11.0 13.5 19.8 12.3 8.7 17.6 13.1 21.7 28.7 17.9 21.1 24.4 15.7 24.5 11.8 30.7 14.3 17.8 0.1 0.5 0.0 0.8 0.8 0.6 0.7 1.3 0.8 0.9 0.4 0.4 0.7 1.8 0.6 0.6 0.8 0.2 0.5 27.2 22.3 19.8 38.7 23.6 14.2 17.1 14.2 16.0 15.4 0.0 1.7 11.2 5.7 10.8 15.6 2.0 15.3 0.0 2.3 15.7 2.0 16.1 6.6 11.8 1.6 6.8 16.0 0.0 7.5 16.9 5.4 11.3 10.3 14.5 18.9 25.4 4.7 9.8 8.8 1.6 4.0 8.0 5.0 7.2 14.5 8.3 16.0 10.5 8.9 13.6 7.8 6.5 4.2 10.6 14.0 12.2 22.7 12.1 14.3 16.0 NADK FLJ13052 ENSG00000008130 "NAD kinase" O95544 1 1751232-1780457 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 80.4" "Group enriched" "Detected in many" 7 "granulocytes: 80.4;monocytes: 24.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048909, HPA053368" Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA048909: AB_2680553, HPA053368: AB_2682130" "unprognostic (1.29e-1)" "unprognostic (4.29e-1)" "unprognostic (7.07e-2)" "unprognostic (6.82e-2)" "unprognostic (1.98e-1)" "unprognostic (1.58e-2)" "unprognostic (3.32e-1)" "unprognostic (9.03e-2)" "unprognostic (7.81e-2)" "unprognostic (1.11e-1)" "unprognostic (1.49e-1)" "unprognostic (1.68e-1)" "unprognostic (4.54e-3)" "unprognostic (1.40e-1)" "unprognostic (5.36e-2)" "unprognostic (1.50e-2)" "unprognostic (1.16e-1)" 24.7 34.3 11.1 19.0 11.9 49.0 25.5 9.9 12.6 12.4 18.2 10.8 14.1 20.3 13.9 14.5 12.5 14.3 17.1 11.9 9.9 7.9 12.7 52.3 17.5 27.0 15.8 8.6 16.9 32.2 8.3 11.9 22.5 10.3 13.7 14.1 13.9 21.4 14.5 10.6 11.7 19.4 14.4 8.3 39.4 22.1 17.3 9.6 10.8 14.0 12.0 19.2 13.7 28.3 1.8 7.2 80.4 24.7 0.5 1.4 10.4 15.1 14.6 13.1 19.2 18.7 13.6 16.9 15.3 13.4 17.5 15.6 15.6 27.9 20.1 11.7 11.3 5.6 12.9 14.0 12.1 7.8 19.5 22.3 16.4 22.9 26.9 18.1 23.0 27.6 15.9 11.0 10.8 15.5 9.5 16.9 16.0 20.1 28.8 13.0 17.3 17.3 20.0 8.9 25.5 16.5 22.0 11.2 41.1 15.1 12.6 17.7 13.5 17.1 37.7 15.7 8.1 12.9 16.1 16.3 12.8 9.2 13.1 13.7 25.7 11.6 45.0 12.6 25.5 6.6 11.8 21.1 49.5 1.2 24.7 1.4 1.8 0.7 0.9 7.2 1.7 0.5 0.7 80.4 0.5 23.8 5.9 1.0 10.4 11.1 11.9 9.9 12.6 9.9 7.9 15.8 8.6 10.3 9.6 11.9 30.7 29.2 12.9 8.8 7.3 5.6 28.1 9.4 18.2 14.0 15.7 22.0 13.3 18.5 13.2 18.0 35.4 23.3 25.3 21.4 15.7 25.2 2.3 80.8 33.4 6.4 21.9 14.7 54.6 20.0 34.8 30.2 8.5 40.5 34.0 5.1 24.7 33.1 32.5 18.2 15.9 12.9 17.0 10.8 20.5 11.2 35.8 13.8 26.2 19.2 NAE1 "APP-BP1, APPBP1, ula-1" ENSG00000159593 "NEDD8 activating enzyme E1 subunit 1" Q13564 16 66802875-66873256 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Spermatogonia: 205.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041178, HPA042041" Enhanced Approved Nucleoplasm,Microtubules,Centrosome NA NA 53000 Nucleoplasm "Microtubules, Centrosome" "HPA041178: AB_10964773, HPA042041: AB_10964772" "unprognostic (3.22e-2)" "unprognostic (1.73e-1)" "unprognostic (1.79e-2)" "unprognostic (1.13e-1)" "unprognostic (2.00e-2)" "unprognostic (1.06e-2)" "prognostic unfavorable (3.92e-8)" "unprognostic (2.31e-1)" "unprognostic (5.58e-2)" "unprognostic (3.12e-3)" "unprognostic (5.34e-2)" "unprognostic (3.85e-2)" "unprognostic (7.09e-3)" "unprognostic (2.50e-1)" "unprognostic (1.84e-1)" "prognostic favorable (9.44e-5)" "unprognostic (1.97e-1)" 23.6 27.4 25.3 20.2 31.8 27.2 27.3 36.7 41.7 26.0 25.8 24.4 23.7 26.2 27.9 31.0 27.5 23.9 20.2 23.6 25.4 29.0 24.3 25.9 18.3 27.0 27.7 31.9 31.0 26.6 38.8 42.2 26.4 34.9 24.9 30.0 22.1 24.3 23.5 33.2 26.9 27.6 25.4 25.3 18.4 22.2 36.9 25.9 28.9 27.9 28.0 24.9 24.7 22.4 9.4 6.4 6.7 3.2 8.6 19.4 9.4 23.0 17.8 31.8 31.2 12.7 18.1 26.4 17.6 17.9 26.1 31.8 21.6 18.0 25.6 20.2 13.2 16.9 23.4 23.9 21.2 37.1 9.4 27.2 18.1 12.3 33.5 14.6 33.7 22.8 14.7 15.7 20.8 18.3 13.9 18.2 31.2 42.9 9.0 20.1 8.1 35.2 38.6 44.0 18.1 32.2 37.8 37.8 34.1 20.1 20.3 34.2 25.1 52.7 11.3 20.3 20.4 12.1 22.8 14.2 18.3 18.3 19.0 20.3 17.1 26.4 92.1 16.5 22.4 22.1 1.3 3.1 6.7 15.4 3.0 19.4 9.4 16.4 16.6 4.2 7.9 17.8 17.7 1.4 8.6 3.2 6.4 14.0 9.4 25.3 31.8 36.7 41.7 25.4 29.0 27.7 31.9 34.9 25.9 29.8 25.1 24.4 55.4 29.3 47.7 26.2 15.3 37.5 40.9 29.6 11.8 87.4 33.2 58.5 2.8 22.8 26.7 23.3 52.6 55.3 37.2 37.1 33.6 18.8 25.1 47.7 22.0 20.9 11.6 10.1 45.1 15.5 47.2 33.3 27.8 58.9 51.8 82.6 50.9 40.7 33.6 19.4 49.5 120.6 205.2 28.1 43.8 31.6 33.7 41.4 NAF1 ENSG00000145414 "Nuclear assembly factor 1 ribonucleoprotein" Q96HR8 4 163110073-163166921 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036241, HPA036242, HPA066090" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036241: AB_2675017, HPA036242: AB_10673616, HPA066090: AB_2685614" "unprognostic (6.24e-2)" "unprognostic (1.20e-2)" "unprognostic (1.20e-2)" "unprognostic (2.58e-1)" "unprognostic (8.99e-2)" "unprognostic (2.00e-2)" "unprognostic (1.18e-2)" "unprognostic (1.56e-2)" "unprognostic (1.33e-1)" "unprognostic (1.32e-1)" "unprognostic (1.64e-3)" "unprognostic (1.45e-1)" "unprognostic (8.73e-3)" "unprognostic (2.04e-1)" "unprognostic (1.77e-1)" "unprognostic (3.17e-2)" "unprognostic (3.05e-1)" 13.3 12.3 8.6 9.6 19.8 8.7 11.9 10.7 18.9 12.9 10.6 14.7 6.4 6.2 18.8 8.6 11.0 17.3 10.9 11.7 10.5 7.8 9.5 10.5 10.9 10.7 7.2 9.1 20.1 11.1 15.7 18.7 8.8 10.1 12.0 11.4 13.4 10.4 12.5 36.4 14.3 8.3 12.7 7.4 10.0 11.3 17.2 7.5 12.3 14.0 12.2 12.2 12.5 10.4 2.5 2.4 0.1 1.6 1.2 3.5 1.4 9.1 7.7 10.0 10.2 5.9 9.4 11.7 10.8 7.2 9.5 9.5 8.7 10.9 23.7 3.1 6.6 7.6 7.7 20.2 11.6 12.5 10.4 12.5 25.1 6.9 7.4 10.3 16.2 9.0 8.9 10.4 11.5 9.4 9.9 8.4 7.7 28.1 12.6 12.6 8.9 18.7 9.2 13.0 6.9 7.7 15.6 7.4 12.4 9.4 4.2 10.9 8.2 7.1 13.0 7.7 9.2 7.0 7.1 8.8 11.4 9.8 8.8 12.1 7.9 11.0 18.3 10.8 9.4 11.2 0.0 1.5 0.1 2.2 1.6 0.9 1.9 2.5 3.3 2.4 2.5 3.5 2.3 0.0 1.2 1.5 2.4 0.7 1.4 8.6 19.8 10.7 18.9 10.5 7.8 7.2 9.1 10.1 7.5 6.0 14.7 11.5 15.4 28.7 11.4 3.1 10.2 36.1 7.9 8.7 17.7 12.3 3.3 7.0 37.3 8.5 2.7 0.0 5.9 13.9 10.6 10.3 10.4 4.4 10.8 7.9 18.4 14.1 15.7 16.6 6.4 9.3 8.5 6.4 5.3 9.3 6.7 3.5 4.9 6.9 13.7 32.3 14.4 17.6 14.3 35.9 17.8 10.0 8.4 10.5 NAGK GNK ENSG00000124357 "N-acetylglucosamine kinase" Q9UJ70 2 71064344-71079805 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 191.3;Syncytiotrophoblasts: 266.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035206, HPA035207" Enhanced Approved Nucleoplasm,Cytosol NA NA 690000 Cytosol Nucleoplasm "HPA035206: AB_2674517, HPA035207: AB_10602031" "unprognostic (6.15e-2)" "unprognostic (4.23e-3)" "unprognostic (2.97e-2)" "prognostic unfavorable (6.88e-4)" "unprognostic (2.44e-1)" "prognostic favorable (5.87e-4)" "unprognostic (4.65e-3)" "unprognostic (2.18e-2)" "unprognostic (2.31e-1)" "unprognostic (9.99e-2)" "unprognostic (4.32e-2)" "unprognostic (1.59e-1)" "prognostic unfavorable (4.35e-4)" "unprognostic (8.60e-2)" "unprognostic (1.45e-2)" "unprognostic (5.50e-3)" "unprognostic (2.13e-2)" 20.0 17.6 21.8 30.9 24.5 9.8 15.7 13.9 18.8 23.6 15.5 23.7 17.4 11.4 16.4 19.7 67.0 13.7 20.0 14.0 17.6 20.4 16.9 20.2 18.3 30.6 31.1 20.3 15.0 25.8 27.5 21.8 43.9 26.2 15.8 15.8 14.7 49.0 17.8 11.3 29.5 14.6 22.8 21.6 43.4 15.5 24.8 26.7 20.2 13.0 27.2 39.9 24.5 26.1 14.3 53.0 37.4 79.3 8.5 7.1 52.2 19.0 15.5 8.7 8.9 34.8 21.3 34.3 42.5 18.4 28.5 25.9 18.1 10.0 10.6 10.1 29.4 33.6 9.2 6.6 12.6 17.7 15.1 5.2 6.0 5.1 11.2 26.1 3.7 15.2 19.0 13.2 30.6 4.8 20.6 29.9 9.3 2.7 12.0 39.4 17.4 9.4 13.3 9.3 15.2 12.0 7.4 24.4 5.4 17.2 34.1 9.0 5.0 12.8 20.2 13.3 15.6 10.5 4.8 26.2 34.0 13.2 13.1 14.8 8.4 7.3 6.2 23.2 10.2 18.6 10.3 79.3 31.5 5.4 69.8 5.5 14.3 6.4 5.2 53.0 13.3 5.5 4.5 37.4 8.5 46.6 42.4 7.1 52.2 21.8 24.5 13.9 18.8 17.6 20.4 31.1 20.3 26.2 26.7 35.7 38.8 52.2 25.0 23.9 42.8 14.8 22.9 24.1 28.4 36.6 21.6 111.0 34.9 60.8 114.8 28.1 13.8 0.0 39.8 106.9 36.8 15.4 49.8 12.1 191.3 44.5 22.4 30.7 107.2 16.6 27.9 97.6 37.1 45.1 18.1 42.9 52.7 22.6 35.3 46.9 53.5 19.4 33.0 33.7 22.6 36.4 266.6 23.8 13.8 37.2 NAIF1 "bA379C10.2, C9orf90, DKFZp762G199" ENSG00000171169 "Nuclear apoptosis inducing factor 1" Q69YI7 9 128061233-128068206 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054898, HPA064931" Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA054898: AB_2682633, HPA064931: AB_2732725" "unprognostic (7.09e-2)" "unprognostic (5.92e-2)" "unprognostic (1.20e-2)" "unprognostic (5.56e-3)" "unprognostic (1.58e-1)" "unprognostic (2.17e-1)" "prognostic unfavorable (1.61e-4)" "unprognostic (1.60e-1)" "unprognostic (6.15e-2)" "unprognostic (9.41e-2)" "prognostic favorable (1.02e-5)" "unprognostic (3.08e-1)" "prognostic favorable (8.30e-5)" "unprognostic (8.48e-2)" "unprognostic (2.47e-1)" "unprognostic (6.67e-2)" "unprognostic (3.92e-2)" 7.1 7.2 4.5 5.1 4.5 11.3 10.3 5.6 5.5 6.0 4.5 2.4 10.9 6.0 6.3 5.1 7.1 5.4 6.6 7.4 5.5 3.4 5.2 8.3 9.3 8.3 3.8 4.2 5.4 7.3 3.4 4.5 7.3 5.3 6.0 3.7 5.5 6.5 9.5 7.1 5.5 6.2 5.2 4.8 9.0 5.5 15.6 2.9 12.5 6.2 6.1 7.8 5.5 16.3 3.4 2.2 4.5 3.0 1.6 3.4 1.5 4.8 4.2 2.7 6.9 2.5 2.3 6.1 3.7 2.2 3.2 2.6 3.3 3.9 5.9 3.3 2.3 4.5 3.6 2.8 2.8 2.6 18.0 3.7 4.4 5.0 1.9 4.2 6.0 12.4 2.1 3.4 2.4 4.0 2.5 2.9 6.7 10.3 3.8 2.9 5.6 5.8 7.3 2.9 6.6 7.2 5.6 4.3 5.3 2.4 3.0 3.9 4.5 3.6 5.1 3.8 2.0 3.9 6.0 1.9 3.8 11.9 3.1 4.2 6.2 12.9 3.9 3.6 3.9 5.0 0.0 2.2 3.3 1.7 2.0 1.4 1.1 3.4 2.5 2.2 3.4 2.6 2.2 4.5 1.6 3.0 1.7 0.9 1.5 4.5 4.5 5.6 5.5 5.5 3.4 3.8 4.2 5.3 2.9 0.0 4.0 8.8 4.0 4.2 3.3 3.9 5.1 0.0 2.3 5.2 0.0 5.0 3.3 3.1 5.9 4.7 5.1 0.0 5.8 5.0 3.3 3.0 8.1 2.4 4.8 9.5 5.2 5.5 4.7 9.2 5.8 4.4 0.0 4.6 2.5 4.1 3.4 4.0 2.8 3.4 5.0 0.0 3.3 10.8 7.6 3.3 3.9 7.2 3.1 2.0 NANOG "FLJ12581, FLJ40451" ENSG00000111704 "Nanog homeobox" Q9H9S0 12 7787794-7799141 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 4.9;testis: 3.8" "Cell type enhanced" "Detected in some" 12 "Cone photoreceptor cells: 7.9;Spermatocytes: 5.7" "Cancer enriched" "Detected in single" 1164 "testis cancer: 58.1" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.9" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "NTERA-2: 52.1" "CAB019380, HPA072117" Supported Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB019380: , HPA072117: " "unprognostic (1.76e-1)" "unprognostic (1.86e-1)" "unprognostic (1.01e-1)" "unprognostic (1.78e-1)" "unprognostic (8.59e-3)" "unprognostic (3.50e-1)" "unprognostic (3.46e-2)" "unprognostic (6.35e-2)" "unprognostic (1.10e-1)" "unprognostic (3.87e-1)" "unprognostic (4.51e-7)" "unprognostic (3.46e-2)" "unprognostic (2.09e-1)" "unprognostic (1.51e-1)" "unprognostic (3.85e-2)" 0.4 0.9 0.4 0.4 1.0 1.8 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.5 0.5 0.4 0.4 0.6 0.4 0.4 0.4 0.1 0.5 0.7 1.7 0.5 0.4 0.4 0.5 0.5 0.0 0.6 0.4 0.4 0.5 0.0 0.4 0.4 0.4 1.1 1.7 0.4 0.4 0.4 1.0 0.7 3.8 0.4 0.4 0.4 0.4 0.4 0.4 0.4 1.1 4.9 3.2 0.7 1.1 0.8 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 52.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.2 0.7 0.5 0.6 0.4 0.4 0.6 0.5 0.4 0.2 1.1 0.7 0.8 2.3 1.1 0.5 4.9 0.3 0.2 0.4 1.0 0.4 0.4 0.4 0.1 0.4 0.4 0.4 0.4 0.0 0.0 0.5 1.6 1.4 1.9 0.4 0.0 0.0 0.0 0.0 7.9 1.2 0.0 0.3 1.0 0.3 0.0 0.0 0.3 0.2 0.4 0.8 0.0 0.5 0.4 0.0 0.0 0.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.7 0.3 0.0 1.4 0.2 1.2 0.0 0.0 5.7 0.4 0.5 0.6 0.0 0.3 1.4 NANOGP8 ENSG00000255192 "Nanog homeobox retrogene P8" 15 35084193-35085110 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 1.5;skin 1: 1.7;testis: 2.3" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 415 "testis cancer: 20.7" "Cell type enriched" "Detected in single" 15 "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 15 "dendritic cells: 1.5" "Group enriched" "Detected in some" 85 "NTERA-2: 32.7;SuSa: 15.4" HPA072117 Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA072117: " "unprognostic (1.58e-1)" "unprognostic (9.05e-3)" "unprognostic (1.48e-1)" "unprognostic (2.37e-1)" 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.8 0.0 0.3 0.1 0.0 0.2 0.0 1.7 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NANOS1 "NOS1, ZC2HC12A" ENSG00000188613 "Nanos C2HC-type zinc finger 1" Q8WY41 10 119029716-119033732 "Disease related genes, Predicted intracellular proteins" "Translation regulation" "Repressor, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 40.7" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 10.9;Cone photoreceptor cells: 9.8;Muller glia cells: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.2" "Cell line enhanced" "Detected in many" "SH-SY5Y: 39.6;SK-BR-3: 22.7;SK-MEL-30: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB012219 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB012219: " "prognostic unfavorable (1.52e-4)" "unprognostic (1.17e-1)" "unprognostic (1.50e-3)" "unprognostic (1.59e-3)" "unprognostic (7.07e-3)" "unprognostic (2.01e-1)" "unprognostic (2.19e-2)" "unprognostic (4.76e-3)" "unprognostic (1.97e-1)" "unprognostic (2.70e-1)" "unprognostic (8.22e-3)" "unprognostic (8.79e-2)" "unprognostic (2.64e-4)" "unprognostic (7.89e-2)" "unprognostic (6.99e-2)" "unprognostic (2.78e-2)" "unprognostic (2.52e-3)" 8.5 10.5 8.1 1.0 7.1 1.0 6.4 6.5 4.8 4.9 2.1 4.5 1.3 1.2 2.1 4.4 2.1 1.5 1.0 16.7 5.0 6.7 3.5 1.0 1.3 1.1 3.4 2.4 0.9 3.3 0.9 2.2 8.2 6.0 3.5 1.2 8.8 1.5 2.5 40.7 1.7 1.4 3.4 6.7 0.9 3.1 2.9 3.0 0.1 9.3 0.3 1.0 3.3 9.8 0.6 0.5 3.2 0.3 0.6 0.3 0.1 7.6 0.6 1.1 0.2 3.7 0.5 4.7 0.1 0.2 0.2 0.1 0.9 2.7 4.1 1.0 0.0 0.0 2.8 1.3 1.3 0.3 1.2 3.2 0.1 1.9 0.8 1.7 0.4 0.0 0.7 5.7 0.0 0.8 1.2 0.2 1.4 0.7 0.5 0.2 1.1 1.0 1.3 3.5 1.6 0.6 0.0 1.3 2.7 1.5 0.6 3.0 39.6 2.2 22.7 17.2 6.2 3.6 2.2 0.2 0.0 1.7 0.0 0.3 1.2 3.9 1.4 0.3 1.0 0.0 3.2 0.3 0.4 0.2 0.1 0.1 0.2 0.2 0.2 0.0 0.6 0.3 0.2 1.3 0.6 0.2 0.5 0.1 0.1 8.1 7.1 6.5 4.8 5.0 6.7 3.4 2.4 6.0 3.0 6.0 0.6 0.0 3.5 0.7 3.3 10.9 0.0 0.0 1.2 1.8 9.8 5.3 0.0 0.5 0.1 0.6 0.4 0.0 0.2 0.2 4.1 3.2 0.0 0.0 0.5 1.6 2.9 0.6 0.0 0.0 1.7 0.0 0.0 0.0 1.0 8.5 0.2 0.0 0.7 0.2 1.7 0.0 0.5 0.2 0.7 1.1 0.8 0.0 0.6 0.9 NANS SAS ENSG00000095380 "N-acetylneuraminate synthase" Q9NR45 9 98056739-98083075 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019223 Approved Enhanced Nucleoplasm No No 200000 Nucleoplasm "HPA019223: AB_1854298" "unprognostic (2.95e-1)" "unprognostic (5.10e-3)" "unprognostic (2.24e-2)" "prognostic favorable (1.71e-4)" "unprognostic (7.31e-3)" "unprognostic (1.23e-1)" "prognostic unfavorable (6.42e-4)" "unprognostic (2.08e-1)" "unprognostic (7.98e-2)" "unprognostic (2.28e-1)" "unprognostic (1.54e-2)" "unprognostic (1.12e-1)" "unprognostic (1.31e-2)" "unprognostic (1.64e-1)" "unprognostic (7.36e-2)" "unprognostic (3.62e-3)" "unprognostic (1.79e-1)" 17.2 10.1 8.8 20.2 11.4 22.2 16.4 7.0 11.7 20.2 47.6 6.4 17.0 19.4 11.0 15.1 18.6 10.4 25.0 20.9 14.4 12.4 15.0 49.6 17.1 20.1 11.5 10.6 14.1 59.2 6.1 16.3 15.8 12.1 37.2 49.6 9.4 80.0 18.3 11.9 10.3 18.9 11.0 9.0 22.2 28.3 11.5 9.8 10.6 19.7 15.2 25.0 15.7 14.8 12.3 41.9 16.4 49.8 7.4 12.1 18.3 73.9 21.9 6.5 18.7 13.1 14.2 14.1 23.7 18.6 19.4 15.9 26.1 10.6 22.8 11.5 26.0 20.5 26.3 12.0 20.3 16.2 18.3 18.0 13.5 24.5 52.1 36.3 15.2 11.1 11.9 13.9 20.6 23.6 22.6 20.6 11.4 24.5 23.8 14.1 50.8 10.2 22.0 11.2 53.6 28.4 19.8 17.8 23.2 15.4 22.7 13.2 6.9 15.2 82.5 20.1 7.5 27.3 16.5 53.6 15.1 14.7 38.7 24.2 22.2 18.4 8.7 17.9 18.5 11.7 5.3 42.1 6.0 8.0 49.8 12.1 12.3 10.5 8.3 41.9 10.1 11.5 7.8 16.4 7.4 43.0 38.4 11.9 18.3 8.8 11.4 7.0 11.7 14.4 12.4 11.5 10.6 12.1 9.8 26.8 52.4 47.0 107.6 62.3 8.1 21.5 53.5 151.3 77.3 21.0 17.7 73.6 59.7 41.8 35.3 57.3 177.1 0.0 89.0 121.2 62.1 166.7 43.8 28.6 139.8 9.5 62.4 25.2 52.6 53.6 30.0 94.4 123.2 58.7 195.9 13.3 63.2 189.8 24.8 47.7 7.0 12.9 96.2 7.2 16.9 54.0 126.1 27.7 245.2 195.9 NAP1L4 NAP2 ENSG00000205531 "Nucleosome assembly protein 1 like 4" Q99733 11 2944431-2992377 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB011567 Approved Supported Nucleoplasm NA NA 5700000 Nucleoplasm "CAB011567: AB_776638" "unprognostic (1.61e-1)" "prognostic favorable (9.77e-4)" "unprognostic (8.99e-2)" "unprognostic (9.64e-3)" "unprognostic (2.96e-3)" "unprognostic (2.24e-2)" "prognostic unfavorable (1.68e-7)" "unprognostic (1.80e-1)" "unprognostic (6.44e-2)" "unprognostic (1.77e-1)" "unprognostic (6.73e-2)" "unprognostic (2.31e-1)" "unprognostic (6.10e-3)" "unprognostic (1.19e-1)" "unprognostic (1.29e-1)" "prognostic favorable (1.55e-4)" "unprognostic (1.54e-1)" 21.6 17.2 36.4 21.9 41.0 27.5 21.1 31.7 34.8 22.9 23.4 37.8 19.1 13.3 23.3 18.7 29.8 18.7 21.8 58.2 34.6 40.1 30.8 22.2 20.3 37.7 50.5 28.7 26.7 18.9 63.0 25.3 24.1 33.7 22.7 22.8 22.3 27.2 22.4 51.5 19.3 24.8 27.5 49.5 23.5 25.1 36.6 34.9 32.2 23.6 32.1 46.8 29.8 21.6 12.3 12.4 28.2 13.1 24.7 30.6 19.4 17.7 11.9 19.5 15.4 20.3 22.6 8.9 37.1 24.3 34.5 31.7 29.7 48.6 34.0 22.8 22.6 3.6 32.4 5.1 31.6 40.1 36.0 12.7 24.3 36.0 38.2 14.0 19.8 26.3 18.8 15.4 18.6 13.5 2.8 20.8 15.6 31.1 35.5 29.9 16.8 46.0 0.8 47.1 22.6 17.3 21.3 23.2 26.6 3.0 30.4 29.0 24.9 18.7 27.8 17.9 20.1 1.7 1.6 15.7 27.0 25.1 36.0 3.2 18.9 30.0 45.8 1.9 14.2 17.6 28.2 10.3 13.4 19.7 11.2 19.4 11.7 24.8 25.5 12.4 12.3 22.0 25.4 7.0 24.7 13.1 11.2 30.6 19.4 36.4 41.0 31.7 34.8 34.6 40.1 50.5 28.7 33.7 34.9 41.7 36.7 40.2 54.8 62.3 78.5 179.1 53.5 109.7 70.5 71.5 43.2 87.0 82.9 68.3 75.9 55.4 32.8 70.0 44.0 90.2 52.2 59.8 70.7 42.9 41.1 62.0 43.6 45.4 20.1 108.1 44.5 38.9 33.7 73.9 37.6 64.0 62.3 21.0 47.0 52.8 59.4 45.3 37.9 136.3 123.0 58.5 76.3 103.8 47.2 75.7 NAP1L5 DRLM ENSG00000177432 "Nucleosome assembly protein 1 like 5" Q96NT1 4 88695915-88697829 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 53.4" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 32.4;granulocytes: 31.1;Muller glia cells: 32.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 29.5" "Low region specificity" "Detected in all" HPA058227 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA058227: AB_2683644" "unprognostic (1.92e-2)" "unprognostic (3.35e-3)" "unprognostic (4.33e-1)" "unprognostic (1.53e-1)" "unprognostic (1.26e-1)" "unprognostic (2.61e-2)" "unprognostic (1.96e-2)" "unprognostic (5.62e-2)" "unprognostic (2.65e-1)" "unprognostic (1.45e-1)" "unprognostic (1.65e-3)" "unprognostic (2.65e-1)" "unprognostic (8.54e-3)" "unprognostic (1.82e-2)" "unprognostic (1.49e-1)" "unprognostic (2.57e-2)" "unprognostic (1.39e-1)" 7.3 21.8 24.5 3.6 23.3 4.9 4.9 25.8 53.4 6.2 3.1 4.2 2.1 1.9 6.4 10.5 4.1 4.9 5.4 5.6 23.9 52.8 6.1 5.0 3.1 3.0 28.4 33.6 8.2 2.8 7.9 12.9 4.7 35.6 6.7 3.1 3.6 2.5 8.7 1.8 1.7 2.4 6.4 11.5 3.5 2.8 4.9 5.4 0.5 9.3 1.3 2.4 5.2 2.0 0.7 0.9 0.6 0.8 1.5 3.9 1.0 0.0 1.1 7.3 4.4 10.7 6.9 0.0 7.8 4.8 4.0 6.3 0.0 0.9 0.0 3.2 4.5 1.7 1.5 12.9 3.1 7.3 2.4 0.0 13.5 4.7 1.1 9.3 6.9 8.9 10.8 1.0 4.7 0.7 5.2 7.1 7.6 3.8 0.0 11.8 0.1 8.5 0.5 3.0 3.7 0.0 4.6 2.1 0.8 2.7 3.3 9.7 29.5 0.0 1.4 5.7 8.2 0.0 2.0 5.1 4.6 1.1 2.9 3.9 2.0 0.0 0.0 9.8 0.0 3.5 0.0 0.2 0.4 3.9 0.4 2.6 0.0 1.9 3.0 0.9 0.7 3.5 3.3 0.6 1.5 0.8 0.7 1.7 1.0 24.5 23.3 25.8 41.9 23.9 52.8 28.4 33.6 35.6 5.4 3.0 7.0 2.4 3.4 1.5 32.4 4.8 0.0 1.4 6.8 5.2 13.7 12.6 13.3 1.7 0.6 5.4 0.0 0.0 2.2 1.6 8.5 2.9 31.1 2.9 4.8 14.3 16.6 10.4 0.0 0.4 10.0 1.2 5.0 2.8 1.4 32.8 1.0 0.2 17.0 3.4 17.3 19.4 9.8 5.6 2.1 1.3 18.5 7.9 0.9 1.7 NAPRT "NAPRT1, PP3856" ENSG00000147813 "Nicotinate phosphoribosyltransferase" Q6XQN6 8 143574785-143578649 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Ligase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 22.3;SK-BR-3: 23.9;U-937: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023739, HPA024017, CAB068206, CAB068207" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 2000000 "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB068206: AB_2665644, CAB068207: AB_2665681, HPA023739: AB_1854308, HPA024017: AB_1854309" "unprognostic (7.08e-2)" "unprognostic (1.55e-1)" "unprognostic (5.76e-3)" "unprognostic (2.94e-2)" "unprognostic (1.06e-1)" "unprognostic (2.30e-1)" "unprognostic (7.65e-2)" "unprognostic (2.19e-1)" "unprognostic (2.84e-1)" "unprognostic (1.08e-2)" "unprognostic (1.75e-1)" "unprognostic (4.13e-2)" "prognostic favorable (6.28e-4)" "unprognostic (6.02e-2)" "unprognostic (3.97e-1)" "unprognostic (2.28e-2)" "unprognostic (1.61e-2)" 9.7 6.4 4.9 9.7 6.2 21.1 13.2 10.7 5.4 6.7 25.2 2.3 9.9 33.0 4.7 4.7 16.4 4.8 15.5 4.9 3.9 2.1 10.7 28.3 8.3 12.1 3.7 0.1 5.9 6.5 2.4 2.8 8.6 4.1 6.9 3.8 5.2 12.8 3.8 7.1 12.4 34.4 5.2 2.2 9.8 11.8 5.5 4.0 3.0 6.8 8.9 9.5 7.6 8.1 0.8 4.7 4.6 8.4 0.5 1.6 2.4 3.4 4.0 0.4 0.8 0.3 1.2 2.6 0.8 0.4 1.3 0.8 3.3 22.3 0.9 6.3 0.2 0.0 7.7 0.2 6.3 0.0 4.1 6.4 5.3 10.5 0.9 2.8 1.3 2.8 0.1 2.2 0.1 0.0 0.0 1.4 4.4 4.9 4.1 0.1 4.3 2.6 2.7 1.0 4.7 2.5 4.6 0.1 11.0 0.9 1.3 1.8 0.4 10.0 23.9 3.0 0.1 0.9 3.1 4.2 0.7 6.4 4.7 1.7 0.5 0.2 1.1 1.1 18.5 3.3 0.0 4.4 4.6 1.6 8.4 0.5 0.8 0.7 1.5 4.7 0.2 0.8 0.7 2.7 0.5 8.4 1.5 0.2 2.4 4.9 6.2 10.7 5.4 3.9 2.1 3.7 0.1 4.1 4.0 32.8 29.7 8.2 53.6 0.0 11.6 7.8 50.9 2.7 17.0 71.5 17.7 41.1 58.0 56.8 30.9 28.6 149.9 23.3 48.4 46.0 12.4 35.0 7.0 99.2 70.9 15.9 10.5 37.4 86.2 46.4 29.7 44.6 0.0 92.0 73.3 27.1 82.3 117.4 20.5 160.6 12.5 12.9 11.5 15.6 17.6 0.0 47.0 17.5 111.6 67.7 NARF "DKFZp434G0420, FLJ10067, IOP2" ENSG00000141562 "Nuclear prelamin A recognition factor" Q9UHQ1 17 82458180-82490537 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Late spermatids: 375.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053006 Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA053006: AB_2682013" "unprognostic (1.84e-1)" "prognostic favorable (1.15e-4)" "unprognostic (2.00e-1)" "unprognostic (1.10e-2)" "unprognostic (4.14e-1)" "unprognostic (6.52e-2)" "unprognostic (6.62e-3)" "unprognostic (2.37e-2)" "unprognostic (1.51e-1)" "unprognostic (1.54e-1)" "unprognostic (3.42e-3)" "unprognostic (3.80e-3)" "prognostic unfavorable (1.48e-10)" "unprognostic (3.57e-1)" "unprognostic (7.72e-2)" "unprognostic (2.47e-2)" "unprognostic (1.83e-2)" 13.7 10.6 21.2 15.7 20.2 35.0 17.4 24.2 23.5 8.2 13.1 10.1 11.1 13.8 9.5 11.0 13.1 11.2 10.6 28.5 15.7 12.3 10.1 21.3 11.8 15.1 16.4 15.0 11.2 13.8 9.0 11.9 10.2 16.3 10.9 9.0 14.7 13.6 12.0 44.4 15.4 11.0 9.8 10.6 17.7 13.6 35.4 18.1 12.4 11.7 11.2 11.5 11.7 12.4 11.6 10.1 50.6 10.6 15.9 13.6 11.5 8.7 8.2 14.0 22.1 6.6 6.5 7.9 5.2 5.5 9.0 9.3 9.5 3.1 5.6 5.9 4.2 10.3 7.8 10.2 6.6 6.2 5.9 22.7 11.8 11.8 11.7 5.9 12.0 21.0 9.7 11.0 7.1 2.4 9.1 17.0 18.5 26.8 4.2 4.0 7.5 21.0 19.4 5.9 6.8 17.9 17.5 14.2 8.9 4.2 9.1 17.1 24.3 13.7 9.3 16.0 9.5 8.0 9.8 8.5 11.7 10.0 9.6 8.9 38.7 14.6 12.4 10.7 8.5 6.9 24.4 10.6 29.5 11.6 9.4 12.7 11.6 11.4 11.2 10.1 11.0 13.1 10.9 50.6 15.9 7.0 8.3 13.6 11.5 21.2 20.2 24.2 23.5 15.7 12.3 16.4 15.0 16.3 18.1 11.9 21.0 45.4 29.2 33.2 32.8 37.2 17.8 30.8 12.5 5.2 51.1 27.5 33.2 47.7 143.2 38.3 36.0 93.5 57.8 48.2 29.1 28.2 52.9 17.3 29.6 47.7 54.6 43.0 21.3 375.7 23.3 29.7 59.1 68.5 24.8 23.0 67.6 26.0 17.0 18.3 34.2 12.9 37.1 136.6 75.4 30.9 25.6 45.7 31.0 25.5 NARS2 "DFNB94, FLJ23441, SLM5" ENSG00000137513 "Asparaginyl-tRNA synthetase 2, mitochondrial" Q96I59 11 78435961-78574874 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Deafness, Disease mutation, Leigh syndrome, Non-syndromic deafness, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026793 Supported Approved Nucleoplasm,Mitochondria,Cytosol No No "Nucleoplasm, Mitochondria" Cytosol "HPA026793: AB_1848833" "unprognostic (1.80e-1)" "unprognostic (1.95e-1)" "unprognostic (5.73e-3)" "unprognostic (1.79e-3)" "unprognostic (1.40e-2)" "unprognostic (2.05e-1)" "unprognostic (1.28e-1)" "unprognostic (5.62e-2)" "unprognostic (4.62e-3)" "prognostic favorable (1.39e-5)" "unprognostic (1.96e-1)" "unprognostic (1.56e-1)" "prognostic favorable (1.22e-6)" "unprognostic (8.57e-2)" "unprognostic (1.45e-1)" "unprognostic (2.93e-1)" "unprognostic (1.60e-1)" 10.9 16.0 11.8 9.3 11.2 6.4 13.4 19.4 11.8 11.6 13.0 13.1 13.5 12.0 17.6 13.9 10.8 12.0 9.9 12.7 11.3 12.2 22.3 26.8 9.0 10.2 13.4 8.4 15.9 20.0 14.0 17.3 9.4 13.8 13.3 13.3 23.2 12.7 13.2 24.4 9.1 11.1 10.6 10.8 12.6 11.3 11.8 10.3 17.3 16.0 7.7 14.1 9.7 10.7 14.6 13.5 6.7 9.4 16.2 16.6 8.7 7.3 10.3 10.8 7.1 7.6 6.4 9.0 6.1 6.0 9.5 7.9 17.7 7.9 18.2 15.9 3.9 9.2 9.7 18.2 11.9 13.3 11.9 9.8 12.8 8.0 15.0 6.3 13.7 4.8 4.5 7.7 8.4 15.0 8.6 8.1 15.4 19.3 5.0 10.6 8.6 14.2 22.2 11.8 30.0 12.5 14.9 17.7 24.6 12.7 10.4 12.9 8.1 9.1 11.7 15.7 12.2 11.0 5.5 4.9 13.0 15.3 14.8 10.3 8.4 14.1 40.1 2.5 12.4 8.8 6.7 7.9 3.5 9.8 8.3 12.0 14.6 11.3 10.8 13.5 12.6 16.6 14.8 1.7 16.2 9.4 10.3 8.2 8.7 11.8 11.2 19.4 11.8 11.3 12.2 13.4 8.4 13.8 10.3 17.9 17.1 9.0 12.7 11.9 5.3 8.3 2.5 10.7 7.9 5.2 2.0 17.3 24.9 8.2 11.0 6.3 5.0 0.0 6.5 20.2 10.4 14.0 8.1 16.3 10.6 0.0 11.5 2.5 6.5 3.9 7.2 6.1 16.9 1.0 7.7 5.7 6.1 13.3 4.6 22.1 8.7 6.5 8.3 7.4 18.1 12.0 12.8 5.1 13.7 7.5 NASP "DKFZp547F162, FLB7527, FLJ31599, FLJ35510, MGC19722, MGC20372, MGC2297, PRO1999" ENSG00000132780 "Nuclear autoantigenic sperm protein" P49321 1 45583846-45618904 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Spermatocytes: 344.6;Spermatogonia: 575.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028136, HPA030518, HPA030520" Enhanced Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA028136: AB_2672497, HPA030518: AB_2673509, HPA030520: AB_2673510" "unprognostic (5.59e-2)" "unprognostic (1.34e-3)" "unprognostic (5.02e-1)" "unprognostic (2.24e-1)" "unprognostic (1.23e-1)" "unprognostic (5.36e-3)" "prognostic unfavorable (4.96e-6)" "unprognostic (2.59e-1)" "prognostic unfavorable (3.67e-4)" "unprognostic (1.56e-2)" "unprognostic (1.15e-1)" "unprognostic (1.78e-2)" "prognostic unfavorable (1.91e-8)" "unprognostic (1.62e-2)" "unprognostic (4.83e-2)" "unprognostic (7.73e-2)" "unprognostic (5.32e-2)" 20.7 15.2 19.3 33.4 32.0 64.0 21.2 20.1 24.0 22.8 21.9 30.2 26.4 15.9 22.3 19.8 20.1 23.0 12.5 18.1 22.4 17.3 17.5 21.0 17.6 39.0 40.2 17.8 28.3 17.4 21.9 22.9 28.5 24.2 18.9 24.7 12.6 17.8 21.8 14.3 16.1 20.5 21.3 30.3 31.7 17.5 35.8 40.2 49.1 17.7 28.2 43.0 18.5 19.6 16.9 11.8 8.1 9.7 7.3 17.5 6.9 24.6 14.6 70.1 24.8 11.8 6.2 33.0 20.0 14.9 31.1 39.1 26.9 17.9 46.5 14.1 8.6 34.2 23.9 46.7 21.3 39.9 21.2 29.6 60.1 26.3 42.1 4.1 62.7 25.3 7.2 5.2 34.3 11.9 8.1 21.2 39.2 50.5 27.5 21.0 16.8 71.4 57.5 101.9 24.6 12.4 90.3 61.5 44.7 15.4 24.9 26.9 32.6 32.9 18.8 20.3 55.3 13.5 49.1 11.4 14.4 44.2 27.6 32.5 16.9 31.8 80.7 14.7 40.1 14.3 4.9 7.3 8.1 12.3 9.7 14.2 13.5 13.9 14.0 11.5 16.9 12.3 11.8 3.1 7.3 5.7 11.8 17.5 6.9 19.3 32.0 20.1 24.0 22.4 17.3 40.2 17.8 24.2 40.2 53.6 89.6 88.0 115.5 69.4 46.4 46.2 35.7 160.6 146.7 34.9 35.3 265.5 26.6 48.1 12.2 85.7 26.9 23.3 32.6 179.3 75.1 49.2 111.0 32.6 90.0 41.3 49.2 76.1 37.0 19.1 87.8 52.1 38.8 54.1 39.4 64.0 29.7 41.2 73.6 27.1 77.6 84.1 71.5 344.6 575.6 49.8 224.3 87.3 90.3 75.0 NAT16 "C7orf52, FLJ39237" ENSG00000167011 "N-acetyltransferase 16 (putative)" Q8N8M0 7 101170493-101180276 "Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.1;pancreas: 6.0;pituitary gland: 5.8;thyroid gland: 4.6" "Cell type enriched" "Detected in some" 45 "Horizontal cells: 276.5" "Cancer enhanced" "Detected in some" "melanoma: 2.1" "Group enriched" "Detected in many" 4 "amygdala: 3.1;basal ganglia: 9.1;cerebral cortex: 2.9;hypothalamus: 4.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RPMI-8226: 4.6;SH-SY5Y: 6.9;SK-MEL-30: 5.2;U-2 OS: 6.1;U-87 MG: 3.4" HPA021918 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA021918: AB_1848922" "unprognostic (4.32e-2)" "unprognostic (1.75e-1)" "unprognostic (2.69e-3)" "unprognostic (4.58e-3)" "unprognostic (2.93e-2)" "unprognostic (2.61e-2)" "unprognostic (6.14e-2)" "unprognostic (1.40e-2)" "unprognostic (2.25e-3)" "unprognostic (2.35e-2)" "unprognostic (4.23e-2)" "unprognostic (2.62e-2)" "unprognostic (5.53e-5)" "unprognostic (7.65e-2)" "unprognostic (2.48e-1)" "unprognostic (5.02e-5)" "unprognostic (1.59e-1)" 0.2 0.4 3.1 0.2 9.1 0.7 0.1 0.4 8.2 0.1 0.2 0.0 0.0 0.2 0.0 0.3 0.1 0.2 0.1 0.1 0.9 4.8 0.1 0.5 0.1 0.2 0.7 0.6 0.1 6.0 0.2 5.8 0.1 0.8 0.2 0.3 0.5 0.3 0.1 0.3 0.4 0.2 0.2 0.4 0.3 1.2 0.4 1.2 0.0 4.6 0.0 0.0 0.1 0.0 1.2 0.7 2.2 0.6 1.3 0.8 0.0 0.5 0.0 0.1 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.2 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.7 0.3 0.0 0.0 0.1 0.2 0.0 0.1 0.0 1.3 0.5 0.5 0.1 0.1 0.8 0.0 0.6 0.2 0.1 4.6 0.1 0.5 0.1 6.9 0.0 0.3 5.2 0.5 0.3 0.0 0.0 0.4 6.1 0.5 0.1 0.1 0.0 0.1 3.4 0.0 1.6 0.4 0.6 0.3 0.3 0.4 0.3 0.2 0.2 0.1 0.2 1.2 0.8 0.4 2.2 1.3 0.3 0.7 0.3 0.0 3.1 9.1 0.4 2.9 0.9 4.8 0.7 0.6 0.8 1.2 0.0 0.0 0.0 0.0 0.0 1.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 276.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 NAT9 DKFZP564C103 ENSG00000109065 "N-acetyltransferase 9 (putative)" Q9BTE0 17 74770547-74776367 "Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021820, HPA057149" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA021820: AB_1847958, HPA057149: AB_2683350" "unprognostic (7.53e-2)" "unprognostic (1.27e-1)" "unprognostic (1.91e-1)" "unprognostic (1.40e-1)" "unprognostic (2.18e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (3.25e-5)" "unprognostic (1.27e-1)" "unprognostic (5.77e-2)" "unprognostic (1.41e-1)" "prognostic favorable (3.21e-5)" "unprognostic (6.50e-3)" "prognostic unfavorable (6.26e-6)" "prognostic favorable (7.80e-4)" "unprognostic (8.50e-2)" "unprognostic (8.64e-2)" "unprognostic (1.03e-3)" 9.4 31.6 20.1 11.3 17.8 11.8 13.5 20.0 20.6 13.6 11.2 9.9 21.7 8.0 11.6 24.5 9.1 16.8 12.9 11.3 18.4 12.1 12.9 16.6 10.5 12.0 18.1 17.8 21.5 14.5 18.5 25.1 13.8 23.1 15.8 9.9 11.6 18.1 13.2 9.5 10.9 8.5 11.2 17.0 12.1 11.2 12.2 20.7 7.9 14.9 7.0 10.8 11.3 10.3 19.6 13.7 9.7 16.7 10.9 21.5 8.4 9.5 13.9 8.9 8.1 14.6 18.3 10.7 18.1 16.2 19.4 16.8 24.0 10.6 26.1 7.0 14.5 12.5 10.5 12.0 20.1 12.5 5.4 18.0 16.7 10.3 21.3 17.0 8.6 10.8 16.7 15.0 19.3 29.5 16.2 21.1 16.9 20.8 8.3 14.1 9.1 17.2 7.0 6.9 18.6 20.4 11.5 26.2 15.1 14.0 15.6 12.8 17.1 7.6 22.5 35.1 12.8 20.9 11.6 12.1 22.4 18.2 9.7 17.1 11.5 4.1 14.6 9.3 5.9 14.2 9.7 11.5 4.6 6.9 16.7 13.7 14.0 12.3 10.1 13.7 19.6 21.5 15.5 2.9 10.9 9.4 10.3 6.5 8.4 20.1 17.8 20.0 20.6 18.4 12.1 18.1 17.8 23.1 20.7 6.0 12.6 22.2 30.8 31.1 35.9 5.0 5.1 5.3 6.8 17.4 45.2 18.9 6.6 13.9 4.5 17.4 10.0 0.0 17.0 16.5 18.5 26.9 1.1 8.5 15.7 42.9 25.3 7.4 8.3 2.9 27.3 15.2 10.1 19.0 12.9 12.4 16.5 16.9 15.9 9.8 39.2 6.5 18.6 17.9 24.3 26.0 18.5 12.9 16.4 31.4 NAV2 "FLJ10633, FLJ11030, FLJ23707, HELAD1, KIAA1419, POMFIL2, RAINB1" ENSG00000166833 "Neuron navigator 2" Q8IVL1 11 19350724-20121598 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 64.6" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-HME1: 34.8;SH-SY5Y: 31.8;TIME: 24.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011755, HPA011891" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA011755: AB_1854319, HPA011891: AB_1854318" "unprognostic (7.71e-2)" "unprognostic (2.37e-1)" "unprognostic (1.29e-1)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (1.76e-3)" "unprognostic (3.01e-2)" "unprognostic (3.86e-2)" "unprognostic (1.54e-1)" "unprognostic (1.00e-1)" "unprognostic (3.53e-3)" "unprognostic (1.84e-1)" "unprognostic (2.83e-2)" "unprognostic (3.85e-2)" "unprognostic (1.08e-1)" "unprognostic (6.43e-2)" "unprognostic (3.28e-2)" 14.8 3.1 7.9 4.7 12.5 3.1 13.8 13.8 16.1 10.2 17.6 16.1 8.6 5.1 9.3 13.4 7.8 5.7 3.2 64.6 9.9 7.0 12.3 18.7 11.2 3.0 16.5 11.5 4.7 10.8 10.1 6.6 16.2 23.5 7.9 6.3 8.6 16.5 11.8 3.4 7.9 4.7 13.0 32.2 2.5 9.9 2.1 12.6 0.0 20.1 1.8 5.3 6.0 8.6 0.3 1.9 0.0 0.5 0.0 0.3 0.0 5.9 1.7 3.9 0.4 13.2 8.5 4.2 5.0 8.6 6.6 5.0 6.7 0.8 0.0 0.2 7.5 10.8 0.7 0.2 3.9 7.8 1.0 0.4 0.1 8.8 7.6 2.4 0.0 0.2 5.5 10.2 3.1 34.8 4.9 8.8 0.0 0.7 3.0 19.1 6.3 0.0 0.0 9.2 1.6 5.0 0.0 18.0 0.9 5.7 1.7 6.8 31.8 3.8 3.0 5.7 21.5 0.1 0.0 24.5 15.5 2.3 18.3 4.7 1.0 0.5 0.0 5.3 0.3 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.5 0.2 0.0 0.0 0.0 0.0 0.5 1.9 0.0 0.0 7.9 12.5 13.8 16.1 9.9 7.0 16.5 11.5 23.5 12.6 59.6 16.9 0.8 19.9 3.8 1.7 12.3 10.2 25.4 25.0 19.2 0.0 22.2 11.6 17.9 2.4 10.8 1.0 0.0 18.3 18.1 14.6 23.3 1.1 33.0 8.6 25.4 10.4 11.1 1.5 5.6 0.9 2.3 15.1 1.8 7.7 32.7 26.8 0.0 3.9 0.4 2.1 0.0 9.0 1.5 0.5 3.1 12.2 0.0 8.0 15.2 NAXE "AIBP, APOA1BP, MGC119143, MGC119144, MGC119145, YJEFN1" ENSG00000163382 "NAD(P)HX epimerase" Q8NCW5 1 156591762-156594299 "Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins" "Lipid transport, Transport" Isomerase "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 120.4;Distal tubular cells: 170.8;Proximal tubular cells: 189.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043766, HPA048164" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" NA NA 3300000 Nucleoplasm "Vesicles, Cytosol" "HPA043766: AB_2678660, HPA048164: AB_2680294" "unprognostic (1.27e-1)" "unprognostic (2.34e-2)" "unprognostic (2.49e-1)" "prognostic unfavorable (4.94e-4)" "unprognostic (7.38e-2)" "unprognostic (5.32e-2)" "unprognostic (2.46e-3)" "unprognostic (2.60e-1)" "unprognostic (1.72e-1)" "unprognostic (3.08e-3)" "unprognostic (3.23e-2)" "unprognostic (3.14e-2)" "unprognostic (2.15e-2)" "unprognostic (8.05e-2)" "unprognostic (7.43e-2)" "unprognostic (2.09e-1)" "unprognostic (3.81e-1)" 19.1 29.9 31.6 14.4 28.5 12.1 22.6 17.6 42.5 23.0 30.0 31.0 17.4 28.4 28.5 57.9 23.4 29.4 25.8 46.3 28.5 25.0 41.6 41.0 17.2 16.9 33.2 29.3 29.3 37.3 36.3 29.0 21.8 28.8 27.9 26.6 23.0 29.5 36.3 30.9 20.2 25.9 25.0 29.1 17.4 25.0 29.5 22.2 17.7 32.4 19.5 20.4 20.8 18.3 52.4 53.8 12.4 26.5 31.6 32.5 40.6 31.6 42.0 13.4 24.0 17.9 12.3 16.0 10.9 16.7 18.7 19.8 34.9 21.3 21.5 33.2 13.9 16.2 30.9 13.4 26.1 13.3 22.7 29.3 17.8 24.0 23.1 20.5 22.3 18.3 12.3 33.8 23.8 22.2 15.0 25.4 29.0 18.1 19.6 19.1 56.3 24.5 27.2 16.6 43.8 32.8 24.7 12.6 56.8 25.3 26.3 32.5 31.0 26.2 50.1 38.5 19.8 48.6 32.9 14.8 13.5 21.1 19.1 23.8 50.8 30.7 20.5 18.6 13.3 20.8 4.9 24.1 12.4 31.6 26.5 31.3 52.4 29.2 32.2 21.7 41.7 32.5 30.9 2.9 31.6 20.6 53.8 25.5 40.6 31.6 28.5 17.6 42.5 28.5 25.0 33.2 29.3 28.8 22.2 38.7 23.3 0.0 0.0 0.0 0.0 0.0 0.0 21.4 43.3 64.6 0.0 120.4 170.8 89.3 0.0 0.0 0.0 0.0 87.1 28.1 0.0 0.0 4.7 0.0 80.7 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 71.3 0.0 0.0 83.0 0.0 0.0 189.4 0.0 0.0 0.0 0.0 0.0 0.0 68.0 0.0 0.0 0.0 NBEA "BCL8B, FLJ10197, KIAA1544, LYST2" ENSG00000172915 Neurobeachin Q8NFP9 13 34942287-35673022 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 130.3;Cone photoreceptor cells: 137.4;Rod photoreceptor cells: 84.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 16.5;SH-SY5Y: 41.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039730, HPA040385" Enhanced Supported "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli, Cytosol" "HPA039730: AB_10794202, HPA040385: AB_10795523" "unprognostic (1.80e-2)" "unprognostic (2.90e-1)" "unprognostic (4.99e-2)" "unprognostic (3.89e-4)" "unprognostic (3.59e-1)" "unprognostic (2.04e-1)" "unprognostic (8.75e-2)" "unprognostic (6.95e-3)" "unprognostic (5.01e-1)" "unprognostic (7.43e-2)" "unprognostic (1.03e-3)" "unprognostic (2.45e-1)" "prognostic favorable (7.86e-8)" "unprognostic (2.28e-2)" "unprognostic (9.35e-2)" "unprognostic (1.17e-1)" "unprognostic (6.46e-2)" 3.9 11.9 12.2 2.7 20.6 1.0 8.2 32.6 28.5 7.4 9.8 3.9 10.9 2.7 10.3 6.2 6.2 9.4 5.4 11.7 13.5 10.6 6.6 1.7 3.6 2.6 6.9 22.2 10.4 5.7 9.3 25.0 1.5 14.2 11.9 4.8 13.3 7.0 14.2 8.5 2.0 3.8 11.4 4.7 5.1 4.8 7.7 6.0 6.1 9.6 0.7 2.4 7.1 6.4 1.1 1.3 0.0 0.5 0.4 1.4 0.1 0.0 2.3 5.3 3.0 0.4 0.0 0.1 3.4 5.2 4.0 3.3 0.0 0.5 1.4 0.0 5.8 2.2 0.1 1.8 0.7 8.4 0.6 1.8 0.0 1.6 0.5 0.3 0.9 2.2 0.9 0.6 0.0 0.4 16.5 0.7 0.6 0.0 9.7 0.5 1.0 0.5 0.0 2.3 2.9 0.9 0.6 2.3 0.4 4.6 1.0 3.1 41.0 2.5 0.0 1.7 4.3 0.9 0.2 0.0 1.0 0.6 0.0 0.7 0.9 0.2 0.7 2.5 0.3 2.1 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.1 0.2 0.0 1.1 1.4 1.3 0.0 0.4 0.0 1.3 0.0 0.1 12.2 20.6 32.6 18.4 13.5 10.6 6.9 22.2 14.2 6.0 26.8 8.6 0.5 5.0 0.9 130.3 43.7 12.7 61.6 14.8 8.7 137.4 0.1 1.7 7.3 14.9 6.3 0.0 0.0 1.5 0.1 8.3 8.7 23.3 0.0 0.7 44.5 22.0 9.2 2.4 11.0 16.4 2.9 6.8 1.0 1.4 66.5 2.3 0.0 18.0 7.1 84.5 6.5 12.2 4.9 5.9 0.6 0.0 0.0 0.8 13.1 NBEAL1 "ALS2CR16, ALS2CR17, MGC164581" ENSG00000144426 "Neurobeachin like 1" Q6ZS30 2 203014879-203226378 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 915.3;Suprabasal keratinocytes: 1140.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA049189, HPA049447" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA049189: AB_2680669, HPA049447: AB_2680771" "unprognostic (3.66e-2)" "unprognostic (5.26e-2)" "unprognostic (2.86e-2)" "unprognostic (1.11e-1)" "unprognostic (4.52e-4)" "unprognostic (1.16e-1)" "unprognostic (1.92e-1)" "unprognostic (1.20e-1)" "unprognostic (4.40e-2)" "unprognostic (6.77e-3)" "unprognostic (2.01e-3)" "unprognostic (7.20e-2)" "unprognostic (2.56e-3)" "unprognostic (2.12e-1)" "unprognostic (2.22e-1)" "unprognostic (7.98e-3)" "unprognostic (7.59e-2)" 11.2 7.8 5.2 7.3 7.9 2.7 13.4 7.5 6.0 9.2 14.5 6.5 8.4 9.9 19.1 7.0 8.7 7.9 8.9 8.2 4.8 2.9 14.4 12.3 14.7 3.3 5.1 2.7 8.8 8.5 9.2 13.6 10.2 7.0 6.7 14.4 9.7 8.1 10.6 6.9 6.6 11.7 11.9 7.3 5.0 14.7 9.9 6.2 2.8 10.1 6.4 5.3 9.8 9.5 0.9 0.7 0.9 0.6 0.6 3.0 0.2 4.9 4.7 2.0 1.7 12.2 9.5 2.8 4.8 3.5 2.6 3.9 5.2 2.6 1.1 4.0 8.1 5.0 4.1 3.9 5.6 6.0 2.2 1.7 1.9 7.0 2.9 2.9 1.7 2.3 3.6 3.7 4.2 5.3 6.2 4.0 2.0 3.3 1.8 5.8 3.5 0.7 0.9 1.0 2.1 4.3 0.8 3.2 1.1 7.2 9.4 1.3 1.0 4.1 3.1 3.1 5.1 3.6 1.7 6.8 6.8 5.8 3.2 2.2 2.9 2.2 1.5 4.1 0.8 2.3 0.0 0.5 0.9 0.8 0.4 1.0 0.4 0.9 0.5 0.4 0.9 0.7 0.5 0.3 0.6 0.6 0.7 3.0 0.2 5.2 7.9 7.5 6.0 4.8 2.9 5.1 2.7 7.0 6.2 35.7 64.5 271.2 252.7 915.3 18.0 15.9 229.3 49.5 45.5 36.6 25.5 175.9 71.3 47.8 23.3 102.0 184.3 0.0 85.7 226.2 143.2 257.6 106.1 170.8 139.2 77.9 282.5 298.9 603.4 33.7 254.0 131.4 597.2 39.7 387.3 18.1 70.0 210.5 121.6 72.5 26.3 116.4 186.6 37.7 34.6 1140.0 191.8 258.9 547.2 252.4 NBN "AT-V1, AT-V2, ATV, NBS, NBS1" ENSG00000104320 Nibrin O60934 8 89933336-90003228 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, Host-virus interaction, Meiosis" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 78.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001429, CAB003836" Supported Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "CAB003836: AB_562172, HPA001429: AB_1854460" "unprognostic (1.52e-1)" "unprognostic (1.72e-1)" "unprognostic (2.32e-3)" "unprognostic (7.46e-2)" "unprognostic (2.49e-2)" "unprognostic (1.28e-1)" "unprognostic (1.05e-2)" "prognostic unfavorable (5.46e-5)" "unprognostic (5.05e-2)" "unprognostic (4.61e-2)" "prognostic unfavorable (4.20e-4)" "unprognostic (1.15e-1)" "unprognostic (6.68e-2)" "unprognostic (3.14e-2)" "unprognostic (3.28e-1)" "unprognostic (2.84e-2)" "unprognostic (1.03e-1)" 19.2 16.1 17.9 23.6 29.5 41.3 23.0 17.4 21.0 19.3 22.6 12.2 16.9 13.3 33.2 16.6 19.7 17.5 20.2 14.2 19.4 16.7 25.9 19.3 17.9 26.7 16.9 18.1 19.3 17.1 21.0 29.4 13.2 18.4 17.6 20.9 7.1 18.4 17.6 15.7 11.2 18.0 22.2 18.1 26.5 14.7 13.9 18.9 23.4 20.8 14.7 22.8 17.5 16.0 10.1 12.0 21.8 18.5 9.7 8.6 7.6 15.4 8.7 8.8 4.6 4.8 12.0 5.6 11.0 14.6 14.0 15.3 5.0 11.8 23.4 12.9 10.0 5.7 5.2 10.6 10.3 18.0 10.9 6.1 19.8 5.4 7.0 9.4 11.8 10.5 9.0 5.5 7.9 17.5 6.9 11.3 9.5 14.5 13.6 15.9 13.7 18.0 7.5 2.5 11.5 9.5 12.1 7.6 13.8 18.1 21.3 2.5 8.1 6.9 78.3 6.5 5.1 14.7 8.8 8.4 12.2 8.7 7.4 10.8 6.3 7.2 13.0 12.3 11.2 11.3 14.1 11.1 20.3 8.1 12.5 8.6 10.1 5.9 5.9 12.0 6.1 5.7 6.2 21.8 9.7 18.5 6.6 3.7 7.6 17.9 29.5 17.4 21.0 19.4 16.7 16.9 18.1 18.4 18.9 44.7 13.9 32.5 12.1 10.5 23.3 25.0 17.8 42.8 42.1 26.2 2.0 18.9 36.5 30.4 10.9 17.9 8.9 0.0 27.9 17.4 18.4 8.7 76.4 27.6 22.9 12.7 11.6 17.2 22.4 5.9 17.5 30.7 11.8 52.3 15.1 27.1 19.1 5.8 24.8 31.1 10.3 6.5 20.6 11.2 43.3 11.8 9.0 23.2 17.4 8.6 NBPF1 "FLJ20719, KIAA1693" ENSG00000219481 "NBPF member 1" 1 16562319-16613562 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 52.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (8.16e-3)" "unprognostic (6.96e-2)" "unprognostic (1.33e-2)" "unprognostic (6.09e-2)" "unprognostic (3.49e-1)" "unprognostic (4.76e-2)" "unprognostic (1.15e-5)" "unprognostic (2.16e-2)" "unprognostic (5.40e-2)" "unprognostic (2.99e-1)" "unprognostic (4.90e-2)" "unprognostic (2.14e-2)" "prognostic favorable (1.06e-4)" "unprognostic (1.57e-1)" "unprognostic (1.05e-1)" "unprognostic (5.18e-2)" "unprognostic (1.68e-1)" 6.8 23.3 14.2 6.4 18.3 4.5 7.4 32.7 13.1 11.7 11.6 21.5 6.0 7.5 9.5 6.2 6.6 13.9 7.9 5.2 13.4 9.3 8.1 7.7 7.3 3.2 32.8 4.2 18.6 5.5 22.3 12.3 9.7 18.4 9.0 11.3 9.3 6.5 9.6 4.5 5.9 16.6 12.2 21.3 6.7 7.3 22.3 21.5 3.7 9.5 3.3 4.3 10.4 8.5 2.0 0.9 4.3 1.0 0.4 1.7 0.5 5.4 7.8 8.0 4.8 2.2 2.6 1.5 3.8 4.9 7.2 6.5 2.8 2.3 4.3 1.1 10.6 2.9 5.1 3.8 2.3 8.5 2.7 4.2 1.4 2.6 2.7 3.5 2.1 3.4 2.8 2.9 10.4 3.1 3.8 3.2 10.2 4.6 2.5 2.8 4.3 9.3 1.6 1.5 0.9 15.5 8.0 4.3 0.4 2.0 1.1 9.8 9.7 9.7 4.0 5.4 2.4 6.2 1.5 3.8 6.4 3.5 8.6 3.3 1.3 5.9 2.4 1.5 3.2 2.6 0.4 0.7 4.3 1.2 0.8 1.4 1.1 1.1 1.5 0.5 2.0 1.3 1.7 0.2 0.4 1.0 0.9 0.0 0.5 14.2 18.3 32.7 13.1 13.4 9.3 32.8 4.2 18.4 21.5 14.9 11.3 0.0 2.8 7.2 7.6 9.6 12.7 13.4 10.3 10.4 7.9 5.4 3.3 4.7 4.6 7.1 27.6 0.0 2.9 7.4 10.3 5.7 5.8 4.4 10.4 9.5 2.9 4.3 4.5 5.4 6.4 8.1 8.5 2.8 23.2 4.5 4.6 12.9 6.7 7.7 5.7 6.5 17.0 52.6 23.0 6.8 2.6 2.9 10.1 1.8 NBPF10 AG1 ENSG00000271425 "NBPF member 10" 1 146064699-146144804 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 71.5;Basal keratinocytes: 50.6;Suprabasal keratinocytes: 92.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (2.05e-1)" "unprognostic (8.84e-2)" "unprognostic (5.84e-2)" "unprognostic (5.61e-3)" "unprognostic (1.06e-1)" "unprognostic (5.16e-3)" "unprognostic (3.26e-1)" "unprognostic (2.17e-1)" "unprognostic (9.49e-2)" "unprognostic (6.64e-5)" "unprognostic (1.60e-1)" "unprognostic (6.01e-2)" "unprognostic (1.11e-3)" "unprognostic (2.19e-1)" "unprognostic (1.61e-1)" "unprognostic (9.61e-2)" "unprognostic (6.68e-2)" 1.5 0.0 0.9 3.3 2.3 0.0 3.0 0.9 0.0 1.6 1.9 1.0 1.3 0.5 0.0 0.4 1.2 1.3 0.6 3.2 1.1 1.5 0.7 1.1 1.1 0.3 1.3 0.0 4.2 0.0 1.5 2.0 0.1 1.2 0.7 0.6 0.2 1.3 2.4 3.7 1.5 0.4 0.4 0.2 5.3 1.4 3.2 2.3 11.3 13.4 2.8 3.1 4.1 3.1 3.2 1.4 2.5 2.5 0.6 6.0 2.7 2.6 3.8 4.1 6.4 2.8 2.4 5.4 3.8 0.7 4.5 2.5 1.7 12.3 4.0 8.3 8.5 10.4 3.7 1.4 1.7 7.6 6.7 6.7 1.0 2.1 1.5 1.5 4.4 1.3 2.0 3.2 2.4 3.6 0.3 0.4 4.7 4.7 1.6 5.5 3.8 3.1 11.3 3.1 2.7 2.8 3.8 4.7 1.9 3.0 2.8 2.7 2.4 0.8 1.5 1.8 0.4 1.1 0.2 1.1 0.2 0.3 0.7 1.3 0.4 0.3 3.7 0.4 1.2 2.4 0.3 0.2 71.5 40.3 0.5 3.4 50.6 0.5 7.2 0.0 14.7 12.5 0.0 0.0 0.6 0.0 4.1 6.4 3.6 1.3 0.0 2.3 4.1 26.7 1.3 18.6 1.3 1.3 0.0 0.0 1.3 4.6 1.3 6.1 18.6 28.7 1.8 2.6 1.7 4.4 28.3 7.8 0.0 2.2 0.0 30.9 9.0 4.3 92.5 0.5 1.8 3.0 3.4 NBPF11 NBPF24 ENSG00000263956 "NBPF member 11" Q86T75 1 148102046-148152322 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA038748, HPA038752, HPA042595, HPA043105, HPA044023, HPA046971, HPA058050" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (2.27e-1)" "unprognostic (6.10e-2)" "unprognostic (8.01e-2)" "unprognostic (8.20e-2)" "unprognostic (3.70e-1)" "unprognostic (1.37e-2)" "unprognostic (1.60e-1)" "prognostic favorable (6.87e-4)" "unprognostic (8.93e-2)" "unprognostic (6.48e-2)" "unprognostic (1.72e-3)" "unprognostic (4.78e-2)" "unprognostic (6.67e-6)" "unprognostic (2.75e-1)" "unprognostic (1.15e-1)" "unprognostic (2.68e-1)" "prognostic favorable (3.20e-5)" 1.5 2.1 3.4 2.1 3.9 3.0 3.8 5.7 5.3 4.6 1.5 3.1 9.6 1.4 5.7 9.6 1.2 3.0 1.5 0.7 3.0 1.4 3.7 3.3 3.0 6.0 1.1 5.3 3.2 5.4 1.6 3.3 4.4 2.9 2.4 3.4 3.2 5.6 0.6 5.7 2.0 3.0 5.7 3.1 2.1 1.5 3.1 1.5 3.0 0.0 3.5 1.3 0.0 5.2 3.9 6.1 3.5 1.0 4.1 1.0 5.5 4.4 8.8 8.4 6.1 5.2 5.9 5.0 4.6 4.3 4.5 3.4 5.6 9.2 3.9 5.9 3.9 7.2 5.5 1.8 5.2 5.1 6.0 4.0 13.8 3.7 4.3 5.8 14.9 4.4 5.1 5.4 10.2 6.3 3.1 8.0 6.6 0.6 4.3 10.8 6.6 10.5 7.6 12.3 5.7 8.9 5.1 3.5 4.2 10.7 3.5 9.3 7.9 5.4 7.4 12.1 7.9 9.9 7.6 5.6 4.6 8.6 6.3 5.5 4.5 6.4 5.3 3.7 3.1 6.1 1.9 5.7 4.1 1.3 2.9 3.3 3.4 2.4 1.9 5.2 3.8 2.9 0.3 1.0 3.5 3.9 1.3 1.0 11.9 11.8 0.8 2.0 1.0 4.8 5.1 2.5 6.7 9.1 3.5 9.8 3.9 0.0 2.5 3.5 5.8 3.9 0.0 2.9 2.8 4.1 1.6 12.8 16.6 2.9 4.8 3.4 5.5 7.3 1.0 4.9 3.1 6.8 2.8 6.3 2.7 3.4 7.0 2.5 1.9 7.0 6.5 1.4 6.2 4.5 1.3 2.4 5.0 9.0 1.1 NBPF12 "COAS1, KIAA1245" ENSG00000268043 "NBPF member 12" 1 146938744-146996202 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "pancreas: 29.8" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 43.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (5.48e-2)" "unprognostic (3.97e-1)" "unprognostic (1.74e-1)" "unprognostic (8.96e-3)" "unprognostic (4.57e-2)" "unprognostic (5.00e-3)" "unprognostic (2.03e-2)" "unprognostic (5.76e-3)" "unprognostic (4.57e-2)" "unprognostic (2.90e-1)" "prognostic favorable (9.01e-7)" "unprognostic (2.23e-1)" "unprognostic (1.69e-3)" "unprognostic (2.96e-2)" "unprognostic (2.86e-1)" "unprognostic (2.08e-1)" "prognostic favorable (2.47e-5)" 2.7 1.7 2.2 4.0 3.9 5.1 3.2 4.4 4.7 2.6 1.9 5.8 2.2 2.4 6.0 3.6 1.5 2.4 3.1 0.9 2.3 1.7 6.1 2.8 3.4 4.2 4.2 4.3 29.8 4.2 5.0 1.8 3.8 2.5 1.8 4.2 3.5 4.0 0.9 2.5 1.9 3.0 3.2 3.1 5.3 7.0 1.1 3.3 2.9 0.9 2.9 1.2 3.9 3.8 2.6 6.1 2.3 0.9 3.5 0.8 6.7 5.4 11.4 9.8 5.4 5.0 7.4 7.0 5.3 5.0 5.1 4.9 6.4 15.1 4.4 6.0 5.3 5.0 8.1 4.0 4.8 5.6 5.7 6.6 11.7 4.2 4.5 4.9 9.8 5.3 7.2 4.9 11.4 6.5 4.5 10.9 10.4 2.6 4.0 10.3 10.6 6.2 6.6 8.2 7.1 10.3 4.2 3.6 3.8 14.9 5.7 12.0 9.2 8.2 4.6 17.8 6.9 14.9 5.3 4.4 7.3 10.0 9.7 9.2 6.8 6.3 4.8 3.5 5.0 6.1 2.3 1.8 3.5 1.1 2.0 3.4 2.3 1.9 1.0 3.8 2.6 2.0 0.7 0.9 1.4 2.6 2.2 0.8 29.8 20.0 11.1 2.6 3.4 16.0 7.2 0.0 9.4 11.4 5.2 43.2 3.3 0.0 9.6 5.2 4.5 6.5 0.0 7.5 3.0 5.0 1.4 23.2 11.3 3.3 9.5 10.3 8.6 14.3 2.5 5.2 7.1 1.7 9.0 9.9 9.5 10.0 14.0 9.9 0.8 17.2 6.5 5.0 12.2 5.7 3.8 1.6 10.9 11.5 0.9 NBPF14 DJ328E19.C1.1 ENSG00000270629 "NBPF member 14" 1 148531385-148679751 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.2" "Cell type enhanced" "Detected in many" 9 "Paneth cells: 190.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in all" 5 "basophil: 9.8;classical monocyte: 17.2;eosinophil: 25.2;intermediate monocyte: 11.5;memory B-cell: 21.8;myeloid DC: 14.9;naive B-cell: 15.1;neutrophil: 22.9;non-classical monocyte: 13.1;plasmacytoid DC: 16.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (5.28e-2)" "unprognostic (3.88e-2)" "unprognostic (7.92e-3)" "unprognostic (7.13e-2)" "unprognostic (2.46e-1)" "unprognostic (1.37e-3)" "unprognostic (1.66e-1)" "unprognostic (1.04e-1)" "unprognostic (2.02e-2)" "unprognostic (7.69e-4)" "unprognostic (7.23e-3)" "unprognostic (5.20e-2)" "unprognostic (5.15e-4)" "unprognostic (2.28e-2)" "unprognostic (2.61e-1)" "unprognostic (3.73e-1)" "unprognostic (2.52e-2)" 4.4 0.7 2.5 3.2 4.6 6.7 4.3 2.1 4.3 5.4 2.4 2.1 0.9 0.4 4.3 11.2 3.9 3.4 2.9 6.7 4.2 3.4 3.4 3.4 4.0 2.6 2.8 7.7 6.3 3.1 0.9 1.8 4.6 3.6 2.7 6.9 3.2 1.9 1.2 8.5 1.9 4.1 3.8 4.5 0.8 5.2 5.1 2.8 2.6 9.1 4.7 1.8 4.7 21.8 16.5 25.2 17.2 3.4 3.1 3.5 26.7 5.1 10.1 7.4 21.1 29.5 5.0 10.0 10.2 6.9 8.0 4.1 8.9 5.0 2.6 10.3 9.5 8.1 6.7 10.5 10.1 9.8 7.6 13.2 16.4 1.0 8.3 10.4 5.4 29.5 8.7 18.5 24.7 32.9 10.7 4.6 4.4 27.1 16.4 16.0 2.7 7.5 4.3 5.6 12.3 4.3 9.1 15.8 8.6 11.1 0.1 0.1 20.4 11.3 4.8 10.1 14.1 9.0 42.8 7.9 8.8 9.5 16.6 47.8 15.3 12.3 14.3 9.1 11.8 9.8 17.2 25.2 2.3 11.5 1.7 21.8 2.4 2.1 14.9 15.1 3.1 2.6 22.9 3.4 13.1 16.5 3.1 3.5 83.4 73.1 16.4 35.4 1.9 2.0 17.3 10.2 16.0 27.3 12.2 3.9 1.1 0.0 29.4 29.3 0.8 7.7 0.0 13.9 12.6 12.9 19.5 49.9 8.1 12.9 0.0 3.5 3.7 40.0 30.3 26.2 27.4 1.7 20.8 5.3 17.1 21.9 190.4 15.9 4.4 9.8 12.9 11.4 57.2 10.2 5.5 1.3 6.9 16.2 27.9 NBPF15 "MGC8902, NBPF16" ENSG00000266338 "NBPF member 15" Q8N660 1 144421386-144461674 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 41.7;Club cells: 22.7;Paneth cells: 30.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "B-cells: 3.1;NK-cells: 2.7;T-cells: 5.5" "Low cell line specificity" "Detected in many" "HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (1.38e-1)" "unprognostic (1.23e-2)" "unprognostic (2.03e-1)" "unprognostic (7.10e-2)" "unprognostic (1.96e-1)" "unprognostic (4.82e-3)" "unprognostic (1.84e-3)" "unprognostic (3.50e-3)" "unprognostic (8.16e-3)" "unprognostic (1.19e-1)" "unprognostic (4.73e-2)" "unprognostic (2.69e-2)" "prognostic unfavorable (4.11e-5)" "unprognostic (1.36e-1)" "unprognostic (1.91e-1)" "unprognostic (6.67e-2)" "unprognostic (6.26e-2)" 2.2 1.1 1.3 2.7 3.3 0.0 4.9 6.1 3.6 3.2 1.1 1.8 2.9 0.4 4.0 7.7 1.7 2.4 1.9 0.5 7.1 1.5 4.9 2.8 5.0 1.4 1.5 3.4 1.7 3.6 3.2 2.7 4.2 2.8 2.1 3.0 5.2 3.1 0.7 2.2 0.7 3.8 6.3 3.6 0.9 0.9 4.8 1.0 3.0 1.9 3.7 1.4 0.5 3.1 0.2 0.6 0.4 2.7 5.5 1.8 7.5 4.9 8.9 16.7 10.6 16.7 11.0 13.6 13.3 8.3 8.6 4.2 8.1 3.8 3.8 9.9 9.7 5.9 9.8 4.3 13.3 12.5 5.3 0.3 11.1 5.3 8.0 0.3 3.7 13.6 7.6 9.9 20.7 12.0 11.6 1.5 1.7 11.5 20.1 16.1 0.2 3.4 3.6 2.7 11.1 3.3 5.3 5.9 9.2 6.8 0.8 20.2 5.7 8.9 9.4 12.0 8.9 3.4 12.4 13.5 8.9 11.9 12.6 10.2 11.0 6.4 0.2 0.4 6.2 0.2 0.3 0.1 1.3 0.0 1.9 3.1 3.5 2.4 0.2 1.8 4.2 1.6 0.6 2.7 0.4 0.2 5.5 1.8 41.7 21.0 0.9 0.8 1.8 2.5 7.5 5.1 8.1 22.7 1.8 5.9 1.3 0.0 5.3 1.6 3.8 1.0 0.0 3.7 2.6 3.9 1.2 14.0 7.8 1.4 3.2 5.8 6.2 9.2 0.5 8.1 1.8 1.7 3.6 3.7 2.7 6.0 30.2 9.9 0.9 7.0 0.0 6.2 2.6 1.7 1.1 0.2 2.5 5.0 0.3 NBPF19 ENSG00000271383 "NBPF member 19" A0A087WUL8 1 149390623-149556361 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Paneth cells: 94.8" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (7.92e-3)" "unprognostic (9.12e-2)" "unprognostic (2.95e-2)" "unprognostic (8.53e-2)" "unprognostic (1.12e-1)" "unprognostic (1.36e-3)" "unprognostic (5.59e-2)" "unprognostic (2.87e-1)" "unprognostic (1.20e-4)" "unprognostic (3.54e-3)" "unprognostic (2.12e-1)" "unprognostic (1.76e-2)" "unprognostic (1.92e-5)" "unprognostic (1.10e-1)" "unprognostic (3.32e-1)" "unprognostic (8.93e-2)" "unprognostic (4.61e-2)" 6.8 0.9 3.2 10.4 2.7 9.5 8.4 1.7 4.5 6.6 3.7 4.0 10.1 1.1 8.8 8.0 5.3 6.0 7.3 4.8 3.4 2.3 3.1 12.1 6.0 3.2 4.7 10.6 6.2 4.0 0.9 7.0 5.5 5.0 3.9 7.5 7.7 8.6 6.2 13.0 1.7 6.0 2.6 6.7 1.7 9.5 2.9 2.5 6.3 5.2 5.2 3.9 7.4 6.2 11.7 18.0 16.7 6.9 7.0 1.5 23.8 6.4 13.9 7.1 27.1 23.5 6.5 11.8 9.1 8.3 8.2 5.6 8.7 7.0 2.9 18.2 10.7 11.0 19.0 11.0 12.9 12.6 10.6 20.0 17.8 1.9 5.6 19.9 7.3 16.3 4.9 23.8 31.1 11.0 5.3 10.4 4.8 11.4 17.4 17.5 10.9 11.9 12.0 6.7 9.9 9.9 15.1 11.5 5.2 12.1 1.2 2.9 27.9 9.8 5.3 20.1 18.1 27.3 31.6 16.6 12.3 10.3 18.2 9.5 5.4 22.1 19.0 13.9 4.9 9.8 16.7 5.3 7.0 6.4 4.7 2.3 3.8 2.5 3.2 6.2 5.2 6.5 18.0 6.9 5.2 11.7 1.4 1.5 47.6 49.9 6.4 15.8 0.0 7.8 21.2 2.5 21.4 18.2 3.5 25.5 1.3 1.7 14.5 16.9 1.9 1.1 23.3 5.3 5.4 5.3 6.2 18.6 7.4 6.5 3.2 1.2 0.6 29.4 4.2 30.0 33.9 0.0 15.4 3.4 25.4 8.8 94.8 28.3 0.3 51.8 19.4 4.2 26.5 6.0 0.0 1.1 7.5 7.7 8.6 NBPF20 ENSG00000162825 "NBPF member 20" 1 145289900-145405778 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 13.3" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 27.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 13.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (6.25e-3)" "unprognostic (4.74e-2)" "unprognostic (1.23e-1)" "unprognostic (8.05e-2)" "unprognostic (1.20e-2)" "unprognostic (1.40e-1)" "unprognostic (2.25e-2)" "unprognostic (5.37e-2)" "unprognostic (3.22e-3)" "unprognostic (3.54e-1)" "unprognostic (4.26e-4)" "unprognostic (1.69e-1)" "unprognostic (1.45e-4)" "unprognostic (9.74e-2)" "unprognostic (5.21e-2)" "unprognostic (1.00e-1)" "unprognostic (1.70e-1)" 1.1 1.2 1.1 1.2 1.2 1.0 1.5 2.5 1.2 1.4 1.1 0.0 1.3 1.8 1.1 1.2 0.7 1.1 1.1 1.1 1.1 2.6 1.1 1.2 1.0 2.2 1.3 5.9 1.1 0.0 1.5 1.1 1.6 2.1 1.1 2.4 1.1 1.7 1.0 1.1 1.1 3.6 1.1 1.5 1.4 1.1 4.0 13.3 1.0 1.8 2.9 1.0 0.3 14.7 7.5 2.1 5.9 13.2 23.2 5.4 7.2 1.8 2.6 2.7 8.1 1.8 3.5 2.8 7.4 4.1 4.5 7.3 8.5 7.3 7.0 9.0 2.3 9.4 5.9 2.7 4.0 4.0 6.9 6.6 14.2 12.1 4.8 6.8 1.9 9.2 5.2 10.5 9.6 0.6 1.8 2.0 3.3 12.0 3.5 6.1 2.2 3.8 2.7 3.8 6.7 14.7 7.6 4.1 5.7 5.8 5.6 12.4 12.7 15.9 6.7 16.7 3.1 2.6 8.0 6.9 1.7 1.8 0.5 1.5 0.5 1.0 0.9 0.8 1.5 0.7 1.0 0.4 4.0 1.0 0.9 1.0 2.9 1.8 13.3 0.9 0.3 20.8 27.1 1.9 1.4 2.6 4.3 3.3 0.0 8.1 3.4 0.0 17.7 1.2 0.0 6.7 13.7 2.4 0.6 0.0 9.6 4.0 3.1 1.1 7.0 14.5 1.6 1.6 5.8 2.5 3.7 1.1 5.2 3.8 3.3 5.4 2.8 1.3 8.9 10.5 3.5 0.0 7.5 0.0 2.2 12.7 9.8 2.8 0.6 0.7 4.0 0.9 NBPF26 ENSG00000273136 "NBPF member 26" 1 120723923-120841481 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.7" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 50.6;Alveolar cells type 2: 23.7;granulocytes: 15.1;Paneth cells: 23.2" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in all" "neutrophil: 17.7" "Group enriched" "Detected in all" 4 "granulocytes: 17.7;monocytes: 10.0" "Low cell line specificity" "Detected in many" "HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (2.42e-1)" "unprognostic (2.11e-1)" "unprognostic (2.24e-1)" "unprognostic (7.64e-3)" "unprognostic (4.21e-1)" "unprognostic (1.34e-3)" "unprognostic (1.69e-1)" "unprognostic (1.26e-2)" "unprognostic (6.31e-5)" "unprognostic (9.78e-3)" "unprognostic (3.01e-1)" "unprognostic (1.27e-1)" "unprognostic (2.82e-5)" "unprognostic (1.05e-1)" "unprognostic (2.08e-1)" "unprognostic (8.11e-2)" "unprognostic (1.65e-1)" 2.7 0.8 2.3 4.3 2.2 2.1 1.8 1.1 2.5 3.2 1.9 1.1 1.1 0.0 3.0 5.6 4.8 2.4 3.1 1.1 1.1 3.5 1.7 2.3 2.0 1.1 1.1 3.6 1.1 1.1 1.1 1.1 2.0 2.5 1.4 1.7 1.6 1.3 1.1 9.9 1.1 6.0 2.4 10.6 0.5 3.4 1.1 1.1 1.8 3.3 1.8 2.0 1.1 3.4 2.8 17.7 10.0 2.4 2.1 1.0 27.0 0.1 8.1 8.9 11.5 9.4 0.6 9.6 4.9 6.0 6.5 5.8 1.0 1.9 9.1 11.1 10.7 8.0 13.1 13.8 8.4 12.8 0.5 18.5 2.9 2.3 5.2 7.6 5.6 5.7 6.0 15.7 17.4 19.4 0.3 4.9 1.5 16.7 15.8 15.1 2.1 12.3 2.9 1.0 11.0 3.0 9.2 4.9 4.7 11.0 0.8 0.5 11.2 16.4 8.4 9.6 0.6 3.4 8.2 7.2 19.2 23.8 7.6 7.4 2.0 7.9 6.8 11.5 1.0 7.7 6.4 7.2 1.9 5.2 1.7 1.2 2.0 1.9 2.8 3.4 1.7 2.1 17.7 2.4 10.0 2.1 1.1 1.0 50.6 23.7 1.4 1.3 0.0 0.6 1.4 0.0 6.7 6.8 0.0 0.0 0.4 3.3 3.5 2.2 0.0 0.0 0.0 2.6 1.7 1.0 0.7 15.1 1.3 0.2 0.0 0.0 1.3 3.7 0.0 6.1 1.8 0.0 1.0 0.6 0.8 3.2 23.2 4.2 0.6 1.6 0.0 0.5 4.3 2.6 0.0 0.3 0.0 2.5 0.4 NBPF3 AE2 ENSG00000142794 "NBPF member 3" Q9H094 1 21440128-21485005 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "testis: 29.5" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 9.4;Early spermatids: 10.3;Spermatocytes: 14.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 15.4;HHSteC: 14.9" "HPA042595, HPA043692, HPA044023, HPA046971, HPA058050" Supported Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA042595: , HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (5.49e-2)" "unprognostic (1.19e-2)" "unprognostic (5.09e-3)" "unprognostic (2.57e-2)" "unprognostic (3.11e-1)" "unprognostic (2.01e-1)" "unprognostic (2.82e-2)" "unprognostic (2.10e-1)" "unprognostic (2.22e-3)" "unprognostic (1.09e-1)" "unprognostic (3.11e-3)" "unprognostic (1.63e-1)" "unprognostic (5.31e-5)" "unprognostic (8.35e-2)" "unprognostic (1.23e-2)" "unprognostic (2.69e-2)" "unprognostic (1.66e-2)" 3.2 5.1 4.5 2.6 4.6 2.3 6.5 12.7 5.3 4.1 3.5 3.7 4.2 1.5 3.7 4.6 3.7 3.6 2.9 2.8 4.7 3.5 4.0 4.6 3.0 3.0 5.0 3.8 4.7 4.3 2.6 9.4 11.7 4.5 4.5 3.6 3.3 4.9 4.0 2.2 6.2 4.0 5.3 4.6 3.2 4.7 29.5 4.9 2.4 4.8 1.3 4.5 5.1 5.6 1.1 0.3 2.3 0.7 1.1 5.3 1.6 1.8 2.5 0.2 5.7 3.8 1.3 4.8 3.2 15.4 4.5 3.8 3.4 5.8 2.9 1.3 8.4 1.3 0.2 2.7 3.8 0.5 1.5 2.9 2.0 0.1 1.2 14.9 1.2 2.0 1.0 1.1 4.1 0.7 2.2 0.4 0.0 0.8 1.0 1.0 6.4 0.0 2.8 0.8 2.6 3.6 0.0 0.0 2.7 0.7 2.4 3.9 4.1 5.0 1.3 3.9 1.4 1.8 2.4 3.7 1.9 2.2 5.6 1.3 0.0 1.6 4.5 0.4 2.5 2.5 0.0 0.5 2.3 3.8 0.7 5.3 1.1 1.6 3.0 0.3 0.5 2.8 3.5 0.2 1.1 0.0 0.0 1.5 1.6 4.5 4.6 12.7 5.3 4.7 3.5 5.0 3.8 4.5 4.9 0.0 3.0 0.8 2.2 1.1 1.4 2.6 2.5 9.4 1.2 1.8 5.9 2.5 0.0 1.0 10.3 1.4 0.0 0.0 2.2 1.0 3.1 1.5 2.3 1.0 0.8 0.0 0.0 3.7 0.6 1.6 2.6 2.2 0.0 0.0 3.3 1.0 2.0 0.0 1.8 1.6 1.8 0.0 1.0 14.4 7.0 2.6 2.1 1.3 1.2 1.6 NBPF4 FLJ32833 ENSG00000196427 "NBPF member 4" Q96M43 1 108223341-108244081 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 3.1;testis: 8.8" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "breast cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 8.2;K-562: 11.8;Karpas-707: 3.5;MCF7: 13.9;THP-1: 4.2" "HPA045044, HPA046411, HPA047447, HPA058050" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA045044: AB_2679196, HPA046411: AB_2679657, HPA047447: AB_2680051, HPA058050: " "unprognostic (6.33e-2)" "unprognostic (2.08e-1)" "unprognostic (2.18e-2)" "unprognostic (8.29e-2)" "unprognostic (2.90e-1)" "unprognostic (8.73e-2)" 0.0 0.0 0.0 0.0 1.0 0.0 1.3 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.4 0.0 0.8 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 11.8 3.5 0.0 13.9 0.0 0.0 0.7 0.0 0.0 0.0 2.0 0.6 0.0 0.0 0.3 0.0 0.0 0.2 1.7 0.0 0.2 4.2 0.0 0.0 0.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NBPF6 ENSG00000186086 "NBPF member 6" Q5VWK0 1 108450282-108471002 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 1.9;testis: 7.1" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "breast cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 8.9;K-562: 14.0;SK-BR-3: 3.3;SK-MEL-30: 2.5" "HPA045044, HPA046411, HPA047447, HPA058050" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA045044: AB_2679196, HPA046411: AB_2679657, HPA047447: AB_2680051, HPA058050: " "unprognostic (4.36e-2)" "unprognostic (5.87e-2)" "unprognostic (4.62e-2)" "unprognostic (2.39e-1)" "unprognostic (2.61e-1)" "unprognostic (8.02e-2)" 0.0 0.0 0.0 0.0 1.7 0.0 1.1 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 1.4 0.0 0.9 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 7.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 1.5 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 3.3 2.5 0.0 0.0 1.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NBPF9 AE01 ENSG00000269713 "NBPF member 9" 1 149054027-149103561 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.9" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 35.7" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 21.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (1.25e-2)" "unprognostic (1.02e-2)" "unprognostic (3.75e-1)" "unprognostic (2.13e-1)" "unprognostic (1.96e-1)" "unprognostic (1.53e-1)" "unprognostic (3.33e-3)" "unprognostic (1.94e-1)" "unprognostic (2.15e-2)" "unprognostic (2.93e-1)" "unprognostic (2.10e-1)" "unprognostic (6.90e-2)" "unprognostic (9.42e-6)" "unprognostic (6.23e-2)" "unprognostic (2.76e-1)" "unprognostic (6.63e-3)" "unprognostic (8.80e-2)" 3.3 2.0 5.6 6.5 5.3 2.4 2.6 12.3 5.0 4.2 3.3 2.1 4.5 1.7 4.9 7.2 2.8 2.9 4.7 3.8 5.3 3.6 5.4 8.3 4.6 2.8 1.8 4.9 6.3 4.4 1.9 2.2 4.3 3.0 3.1 6.8 2.2 2.4 1.7 4.5 3.2 4.4 2.0 2.7 1.8 2.9 2.0 1.8 5.2 2.5 4.0 2.3 0.0 4.2 5.2 21.9 7.6 5.6 1.8 0.8 22.2 9.8 12.2 16.5 11.1 13.5 9.7 20.6 15.0 10.9 11.8 7.3 9.7 5.3 5.7 10.5 13.1 6.7 8.5 9.6 18.7 13.5 8.9 1.7 16.5 4.4 12.9 2.2 6.5 13.3 7.2 11.9 20.9 20.1 9.5 4.1 6.2 14.0 13.3 17.6 0.7 3.6 4.6 4.0 13.4 6.0 7.6 8.1 8.9 10.3 7.9 16.5 6.7 16.6 9.1 8.0 12.3 4.2 22.2 24.6 7.2 17.9 31.6 17.2 9.1 10.6 9.0 1.6 8.6 21.9 7.6 0.3 0.4 3.6 0.7 1.9 1.3 0.4 1.3 4.2 1.8 1.0 5.8 5.6 1.2 5.2 1.6 0.8 35.7 13.6 5.4 6.7 4.8 4.3 3.9 7.6 8.1 19.4 5.2 5.9 2.3 0.0 2.9 2.8 2.4 0.7 0.0 1.6 3.4 9.1 4.1 17.4 24.5 3.2 0.0 1.7 2.5 9.5 2.1 6.6 14.0 3.3 1.8 0.4 3.7 2.5 7.8 3.9 0.4 11.4 6.5 3.9 9.7 4.1 12.4 1.1 2.2 0.6 5.8 NBR1 "1A1-3B, CA125, KIAA0049, M17S2" ENSG00000188554 "NBR1, autophagy cargo receptor" Q14596 17 43170481-43211689 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 246.4;Late spermatids: 675.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022944, HPA022999, HPA023999" Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles" NA NA Vesicles "Nucleoplasm, Nuclear bodies" "HPA022944: AB_2671001, HPA022999: AB_1859532, HPA023999: AB_1859533" "unprognostic (1.85e-1)" "unprognostic (1.78e-1)" "unprognostic (3.26e-2)" "unprognostic (3.28e-2)" "unprognostic (3.27e-1)" "unprognostic (1.58e-1)" "unprognostic (1.15e-1)" "unprognostic (2.98e-1)" "unprognostic (2.18e-1)" "unprognostic (1.02e-2)" "unprognostic (1.03e-1)" "unprognostic (1.54e-2)" "prognostic favorable (2.00e-5)" "unprognostic (1.65e-1)" "unprognostic (4.88e-2)" "unprognostic (2.10e-1)" "unprognostic (1.39e-1)" 26.3 29.5 27.1 17.2 27.3 7.7 28.0 27.3 29.4 25.6 32.9 33.3 29.0 31.0 28.4 25.5 23.1 25.6 20.7 29.8 26.0 22.0 38.3 39.6 21.1 25.4 27.2 21.8 34.1 26.5 55.8 25.0 31.2 22.8 30.1 32.1 20.7 25.5 29.5 62.9 23.9 37.7 24.2 34.2 23.3 23.2 57.0 31.7 29.8 32.1 24.5 19.8 32.5 23.7 9.6 12.6 25.2 21.5 15.5 17.1 14.4 12.6 15.4 13.2 14.0 30.1 31.3 12.7 23.8 47.3 19.8 16.4 8.0 20.1 6.7 24.8 33.1 19.7 13.9 15.0 30.8 28.8 21.0 16.0 8.0 19.6 17.2 28.8 6.7 12.4 35.5 34.9 21.7 42.8 40.4 30.8 15.6 17.1 18.1 26.2 7.1 14.4 4.9 4.2 14.7 10.0 4.8 20.8 22.0 25.1 14.3 8.0 14.2 16.4 8.1 23.8 23.2 22.1 11.1 25.5 29.1 10.9 13.3 9.4 21.7 17.6 8.8 19.7 9.3 20.0 23.5 16.1 25.2 14.2 15.3 14.6 9.6 12.9 13.7 12.6 6.7 12.4 11.9 23.1 15.5 21.5 8.0 17.1 14.4 27.1 27.3 27.3 29.4 26.0 22.0 27.2 21.8 22.8 31.7 38.7 36.1 13.0 29.2 21.2 32.9 75.1 40.8 54.9 43.3 34.9 37.3 22.6 16.6 20.6 246.4 37.9 79.4 0.0 19.1 15.5 24.6 46.9 24.4 55.7 18.8 19.1 38.7 46.1 53.8 675.8 54.4 30.1 25.3 7.2 58.7 45.6 24.4 63.7 41.8 46.8 51.6 38.8 23.9 41.7 27.0 23.8 13.2 29.6 48.7 29.1 NCAPD2 "CAP-D2, CNAP1, hCAP-D2, KIAA0159" ENSG00000010292 "Non-SMC condensin I complex subunit D2" Q15021 12 6493356-6531955 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "lymphoid tissue: 84.1" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012423, HPA036947, HPA037363" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA Yes Cytosol "Nucleoplasm, Nucleoli" "CAB012423: , HPA036947: AB_10671367, HPA037363: AB_10672483" "unprognostic (1.51e-1)" "unprognostic (1.88e-1)" "unprognostic (2.20e-1)" "unprognostic (1.31e-2)" "unprognostic (1.03e-2)" "unprognostic (7.84e-2)" "prognostic unfavorable (1.79e-8)" "unprognostic (2.73e-3)" "unprognostic (1.45e-2)" "unprognostic (5.00e-2)" "unprognostic (5.41e-3)" "unprognostic (4.53e-1)" "prognostic unfavorable (1.13e-7)" "unprognostic (4.80e-3)" "unprognostic (1.18e-1)" "unprognostic (4.53e-1)" "unprognostic (8.75e-2)" 6.8 8.8 6.5 24.6 12.7 16.7 7.7 7.7 9.0 8.0 11.3 16.2 7.0 10.6 11.5 8.8 17.7 8.1 6.5 6.2 7.5 5.4 7.0 5.1 7.7 20.4 16.5 6.2 7.7 7.2 9.6 6.3 13.9 8.7 8.2 12.4 8.1 10.5 8.3 7.0 14.8 13.0 8.2 12.7 16.4 9.9 17.2 11.4 84.1 11.4 12.4 24.3 10.9 9.5 5.0 4.8 7.2 2.8 7.8 7.4 3.2 22.1 20.5 22.1 16.0 5.8 6.0 25.8 15.3 12.3 24.8 20.1 18.5 23.6 23.3 4.6 10.0 21.0 19.6 36.4 17.9 47.4 42.2 20.4 21.3 23.5 10.5 2.4 26.4 15.4 3.8 6.7 19.3 19.8 11.4 16.3 15.0 13.5 9.5 21.9 11.0 29.9 17.4 34.5 20.9 16.0 25.6 50.3 12.4 8.3 12.4 9.1 9.6 22.8 10.8 8.1 36.0 4.7 16.6 10.2 16.3 26.8 11.0 29.7 7.4 10.0 33.2 9.6 15.3 20.2 7.2 2.0 3.6 6.3 2.8 5.6 5.0 6.2 7.3 3.0 3.8 7.4 7.2 1.9 7.8 1.9 4.8 7.2 3.2 6.5 12.7 7.7 9.0 7.5 5.4 16.5 6.2 8.7 11.4 6.0 6.1 13.0 3.2 3.2 3.6 2.9 7.6 5.3 3.4 1.8 7.9 6.8 0.0 4.1 14.9 2.6 5.2 46.7 3.3 16.2 3.1 2.8 3.5 2.6 8.6 4.8 1.2 9.2 10.8 20.4 5.5 5.4 0.0 5.4 6.3 10.0 4.5 5.7 5.6 2.0 7.6 0.0 3.6 17.7 10.0 3.0 5.3 6.9 8.0 3.0 NCAPD3 "CAP-D3, FLJ42888, hCAP-D3, hcp-6, hHCP-6, KIAA0056" ENSG00000151503 "Non-SMC condensin II complex subunit D3" P42695 11 134150119-134225454 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 82.1" "Low cell type specificity" "Detected in many" "Cancer enriched" "Detected in all" 8 "prostate cancer: 50.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040286 Supported Nucleoplasm NA NA Nucleoplasm "HPA040286: AB_2676918" "unprognostic (4.27e-2)" "unprognostic (6.05e-2)" "unprognostic (7.78e-3)" "unprognostic (8.22e-3)" "unprognostic (2.79e-1)" "unprognostic (4.29e-2)" "unprognostic (2.15e-3)" "unprognostic (2.56e-1)" "unprognostic (4.32e-2)" "unprognostic (4.75e-1)" "unprognostic (2.79e-3)" "unprognostic (1.16e-1)" "unprognostic (1.95e-1)" "unprognostic (1.93e-2)" "unprognostic (3.35e-2)" "unprognostic (3.94e-1)" "unprognostic (3.48e-1)" 4.9 6.4 4.9 8.3 7.4 13.7 5.4 8.9 6.2 4.0 5.4 8.5 5.0 5.4 4.7 5.9 7.8 4.2 5.4 4.5 5.5 4.3 4.3 12.1 5.3 7.6 9.0 3.3 4.1 5.9 6.8 9.2 6.0 6.1 82.1 6.1 4.9 6.0 6.6 3.8 9.0 5.6 5.4 6.8 8.5 5.3 14.8 7.1 30.7 6.6 5.3 9.8 4.5 5.4 6.9 11.2 2.6 5.6 5.8 10.4 3.8 13.1 11.7 12.9 19.4 5.2 3.9 8.5 15.5 9.9 14.3 15.8 22.8 20.8 24.4 20.9 7.9 14.8 22.0 24.0 13.4 15.6 22.1 20.8 41.9 11.8 10.1 2.5 25.9 22.8 2.7 2.2 18.9 6.2 4.1 9.3 23.2 22.3 14.5 10.7 11.0 29.8 16.8 8.8 24.7 20.7 17.5 15.2 14.1 5.5 16.9 25.8 12.1 22.5 18.0 3.6 10.5 28.5 14.8 7.4 18.5 7.8 12.5 19.3 6.2 6.2 23.0 5.3 30.9 15.5 1.7 5.6 2.6 9.5 5.0 5.6 3.7 6.4 7.2 5.1 6.9 8.9 10.4 2.2 5.8 4.1 11.2 9.4 3.8 4.9 7.4 8.9 6.2 5.5 4.3 9.0 3.3 6.1 7.1 3.0 7.2 9.0 3.7 8.1 18.5 7.0 5.1 4.0 9.1 12.2 9.8 8.7 0.0 2.5 5.0 4.2 2.4 0.0 2.3 8.8 5.9 9.1 2.3 8.9 7.6 11.1 7.5 4.9 5.1 7.5 4.4 7.7 1.7 20.8 4.3 10.6 2.7 0.0 3.9 2.8 22.1 0.0 6.4 17.4 13.7 8.0 3.8 7.9 7.1 2.5 NCAPG2 "CAP-G2, FLJ20311, hCAP-G2, LUZP5, MTB" ENSG00000146918 "Non-SMC condensin II complex subunit G2" Q86XI2 7 158631311-158704829 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 39.1" "Cell type enhanced" "Detected in many" 10 "Spermatocytes: 40.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026631, HPA049637" Approved Supported "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA026631: AB_1845983, HPA049637: " "unprognostic (2.73e-2)" "unprognostic (1.77e-1)" "unprognostic (6.81e-2)" "prognostic unfavorable (7.94e-4)" "unprognostic (1.66e-1)" "prognostic favorable (1.91e-4)" "prognostic unfavorable (3.00e-5)" "unprognostic (5.33e-3)" "prognostic unfavorable (3.21e-4)" "unprognostic (7.79e-2)" "prognostic unfavorable (8.50e-4)" "unprognostic (5.19e-2)" "prognostic unfavorable (4.06e-5)" "unprognostic (2.58e-3)" "unprognostic (1.28e-1)" "unprognostic (8.21e-2)" "unprognostic (7.37e-2)" 5.9 4.0 4.4 8.6 4.2 20.1 5.4 9.0 5.1 4.4 6.6 5.8 3.5 4.2 5.1 5.1 9.9 3.7 3.1 4.0 4.3 3.5 3.3 3.9 4.4 11.4 6.2 4.2 4.4 4.4 6.0 5.8 6.9 4.9 4.5 7.7 3.9 5.3 4.2 4.5 6.5 5.5 4.6 6.2 6.1 5.3 14.6 5.1 39.1 3.6 7.6 13.0 4.8 5.5 1.8 2.8 6.9 5.4 6.1 9.3 2.5 30.0 16.0 19.5 12.5 2.9 4.8 7.7 22.0 14.2 27.3 30.6 14.1 15.8 18.6 13.8 9.0 29.0 15.5 16.2 10.1 36.5 19.8 12.0 16.8 19.9 11.1 1.3 20.7 19.0 2.0 1.1 22.2 6.4 5.0 15.1 21.8 20.6 28.0 25.0 32.0 34.4 14.0 19.2 17.1 13.0 20.2 20.5 17.7 6.7 13.5 21.3 16.5 27.2 10.6 6.0 13.0 9.6 13.5 7.9 18.7 14.3 50.4 35.3 18.5 13.6 22.6 19.8 26.5 35.4 6.9 1.0 1.2 6.5 1.4 9.3 1.8 6.6 4.5 2.8 1.2 2.2 2.4 0.6 6.1 5.4 1.4 8.3 2.5 4.4 4.2 9.0 5.1 4.3 3.5 6.2 4.2 4.9 5.1 6.0 1.0 1.5 1.1 3.5 3.8 3.4 2.5 8.1 6.8 1.8 0.0 2.6 0.0 2.3 9.3 2.2 0.4 0.0 2.9 8.4 2.7 0.9 1.1 2.1 6.1 7.9 0.0 4.3 2.7 4.0 2.6 4.7 1.7 2.8 1.7 1.9 1.6 0.0 3.9 1.1 2.8 6.5 4.1 40.1 15.6 1.8 2.2 5.1 1.8 2.3 NCAPH "BRRN1, CAP-H, hCAP-H" ENSG00000121152 "Non-SMC condensin I complex subunit H" Q15003 2 96335787-96373845 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 17.2;lymphoid tissue: 41.3;testis: 60.4" "Cell type enhanced" "Detected in many" 22 "Spermatocytes: 77.0;Spermatogonia: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "basophil: 5.6;T-reg: 8.7" "Group enriched" "Detected in many" 5 "granulocytes: 5.6;T-cells: 8.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA002647, HPA003008" Enhanced Supported Nucleoplasm,Cytosol Yes Yes Cytosol Nucleoplasm "HPA002647: AB_1078300, HPA003008: AB_1078301" "unprognostic (5.52e-2)" "unprognostic (7.37e-2)" "unprognostic (2.93e-2)" "unprognostic (2.85e-3)" "unprognostic (1.92e-1)" "unprognostic (7.51e-2)" "prognostic unfavorable (9.53e-6)" "prognostic unfavorable (6.73e-4)" "unprognostic (1.50e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.02e-4)" "unprognostic (3.16e-2)" "unprognostic (0.00e+0)" "unprognostic (3.00e-2)" "unprognostic (2.38e-1)" "unprognostic (2.14e-1)" "unprognostic (2.30e-2)" 1.3 1.1 0.8 13.2 0.9 17.2 1.7 0.7 1.2 1.5 3.9 0.7 0.4 2.9 0.7 1.1 7.4 0.4 1.0 0.8 0.8 0.7 0.9 0.9 1.5 10.6 1.0 0.6 0.8 0.6 0.1 0.5 3.4 1.0 0.7 5.1 0.6 1.9 0.4 0.6 2.7 3.5 1.4 1.2 6.7 2.1 60.4 0.8 41.3 0.6 6.4 12.2 1.7 2.2 1.3 0.5 5.6 1.0 0.1 8.7 0.8 31.2 11.9 30.2 15.6 1.1 1.6 20.0 14.8 10.4 28.7 30.3 21.9 17.5 29.2 10.5 6.5 26.2 14.1 25.8 10.1 30.8 25.6 17.1 30.1 12.4 19.8 0.2 27.8 25.7 0.5 1.1 22.2 9.4 2.7 11.3 23.4 20.8 21.6 13.6 14.7 40.7 29.0 21.6 13.8 15.1 31.7 27.5 23.7 5.7 12.1 17.9 13.7 8.6 12.1 5.2 11.9 8.9 20.6 6.5 21.2 32.4 19.8 23.9 11.6 16.5 31.0 9.1 27.9 23.9 5.6 0.0 0.3 1.3 1.0 0.2 1.3 1.9 1.5 0.5 0.9 0.0 0.7 0.3 0.1 0.0 0.0 8.7 0.8 0.8 0.9 0.7 1.2 0.8 0.7 1.0 0.6 1.0 0.8 0.0 0.0 0.8 0.2 0.6 0.4 0.4 0.0 2.7 2.3 0.0 7.9 1.1 0.0 0.4 3.9 0.5 0.0 0.0 0.0 14.1 0.4 0.5 1.1 0.5 6.8 0.0 0.0 0.6 3.2 4.0 0.9 3.0 1.7 0.0 1.0 4.7 0.2 0.0 0.4 0.0 2.3 0.0 0.9 77.0 26.2 0.6 1.6 5.4 1.2 0.6 NCAPH2 "384D8-2, CAP-H2, hCAP-H2" ENSG00000025770 "Non-SMC condensin II complex subunit H2" Q6IBW4 22 50508216-50523472 "Predicted intracellular proteins" "DNA condensation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 86.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067932, HPA069056" Enhanced Supported "Nucleoplasm,Cytokinetic bridge" Yes No Nucleoplasm "Cytokinetic bridge" "HPA067932: AB_2685926, HPA069056: AB_2686076" "unprognostic (2.01e-1)" "prognostic favorable (2.24e-8)" "unprognostic (3.65e-2)" "unprognostic (2.81e-1)" "unprognostic (5.04e-2)" "unprognostic (1.57e-2)" "prognostic unfavorable (8.25e-4)" "unprognostic (2.92e-2)" "unprognostic (8.66e-2)" "unprognostic (1.10e-1)" "unprognostic (2.26e-2)" "unprognostic (6.31e-2)" "unprognostic (2.04e-3)" "unprognostic (2.64e-2)" "unprognostic (1.80e-1)" "unprognostic (1.41e-1)" "unprognostic (3.00e-1)" 15.7 12.4 24.5 17.8 18.8 57.4 14.7 33.5 29.4 14.5 14.2 17.4 14.6 15.6 17.5 15.7 18.0 17.2 11.4 18.2 20.0 19.6 14.5 13.8 17.0 22.2 17.8 19.2 22.8 22.6 16.3 22.0 20.0 19.0 15.2 10.8 16.8 22.4 16.6 20.2 23.2 15.7 20.5 15.7 18.4 15.7 26.1 20.4 25.2 16.3 16.8 21.0 12.0 14.5 13.7 10.1 14.5 11.6 11.3 20.9 12.8 19.9 10.8 18.9 19.3 5.6 6.5 24.5 15.8 11.0 28.6 31.2 22.0 13.8 23.1 8.7 11.3 16.0 15.9 17.2 15.1 8.3 13.2 28.5 13.3 27.4 19.7 6.9 29.4 24.0 5.9 9.5 22.6 7.6 4.3 9.2 20.2 16.7 45.0 11.5 27.5 20.1 33.6 13.4 12.0 13.0 33.8 24.6 25.4 8.3 13.1 12.3 16.1 12.4 18.5 14.8 6.3 12.7 29.0 5.9 22.4 27.0 18.3 23.4 23.5 13.1 34.2 16.8 15.1 21.0 10.6 8.4 14.5 17.1 10.4 20.9 13.7 17.7 17.4 7.0 13.2 18.7 15.5 10.2 11.3 11.6 10.1 16.8 12.8 24.5 18.8 33.5 29.4 20.0 19.6 17.8 19.2 19.0 20.4 20.8 26.9 14.1 20.2 16.8 17.5 17.1 15.3 4.0 6.8 8.7 3.9 24.7 13.3 11.3 30.7 11.3 15.5 0.0 20.2 48.4 17.3 13.7 16.2 9.5 16.9 7.9 12.6 11.1 7.2 86.8 16.1 10.9 11.8 19.8 15.5 14.5 14.9 11.5 16.3 7.0 12.9 19.4 21.2 29.6 36.4 16.2 26.3 15.8 15.6 17.6 NCBP1 "CBP80, NCBP, Sto1" ENSG00000136937 "Nuclear cap binding protein subunit 1" Q09161 9 97633626-97673748 "Predicted intracellular proteins, Transporters" "mRNA capping, mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042411, HPA049031" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA042411: AB_2677985, HPA049031: AB_2680606" "unprognostic (4.76e-3)" "unprognostic (2.16e-1)" "prognostic favorable (5.28e-4)" "unprognostic (4.63e-2)" "unprognostic (2.19e-1)" "unprognostic (1.13e-1)" "unprognostic (2.14e-3)" "unprognostic (1.53e-2)" "unprognostic (3.26e-2)" "unprognostic (9.46e-2)" "unprognostic (3.16e-1)" "prognostic unfavorable (4.17e-4)" "unprognostic (4.11e-2)" "unprognostic (3.84e-1)" "unprognostic (1.61e-1)" "unprognostic (1.17e-1)" "unprognostic (7.04e-2)" 18.5 17.2 19.8 27.4 26.2 37.2 23.6 25.5 27.1 17.0 21.9 18.7 19.8 18.0 19.2 15.3 21.7 15.9 16.3 20.4 23.7 17.8 17.9 22.7 17.3 25.9 16.6 23.8 22.8 22.0 17.1 26.9 20.3 22.6 18.4 25.7 18.1 18.3 17.7 25.5 22.4 19.3 16.3 18.7 20.5 19.4 26.8 17.8 36.1 22.5 15.1 25.0 18.5 19.4 7.6 13.7 12.9 14.6 14.9 10.0 7.7 24.3 16.8 18.9 17.6 13.3 13.4 18.4 18.7 10.9 17.1 16.1 22.4 12.8 21.0 8.1 16.8 16.3 27.6 30.0 21.3 24.6 14.0 9.7 19.4 25.3 14.0 13.0 25.8 20.2 10.1 10.7 19.9 15.4 12.3 17.7 16.1 28.6 11.8 28.6 17.6 18.7 13.7 20.4 34.8 18.2 18.0 43.8 8.4 13.9 18.2 24.1 16.2 18.7 16.4 9.7 16.8 10.2 15.8 14.8 13.4 12.5 26.6 19.2 11.5 14.0 10.9 12.3 20.1 17.6 12.9 11.4 11.0 8.7 14.6 9.9 6.5 9.9 9.1 13.7 7.6 8.7 10.0 3.5 14.9 14.3 5.9 8.6 7.7 19.8 26.2 25.5 27.1 23.7 17.8 16.6 23.8 22.6 17.8 6.0 12.0 5.8 5.1 12.0 20.2 21.7 2.5 14.7 14.8 8.7 19.6 11.5 3.3 7.8 12.7 8.7 10.7 0.0 6.0 12.8 9.3 6.9 8.1 14.8 10.5 20.6 8.7 8.0 13.7 6.8 6.1 9.5 5.0 14.4 11.4 10.1 8.6 8.6 7.1 4.5 23.7 6.5 9.2 16.8 15.2 6.5 12.0 8.5 8.9 7.4 NCBP2 "Cbc2, CBP20, NIP1" ENSG00000114503 "Nuclear cap binding protein subunit 2" P52298 3 196935402-196942597 "Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044850, HPA062483" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA044850: AB_10961012, HPA062483: AB_2684779" "unprognostic (1.82e-2)" "unprognostic (1.09e-1)" "unprognostic (4.04e-2)" "unprognostic (5.12e-3)" "unprognostic (3.17e-1)" "unprognostic (5.13e-3)" "prognostic unfavorable (2.37e-7)" "unprognostic (2.86e-2)" "unprognostic (9.63e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (4.75e-4)" "prognostic unfavorable (2.27e-4)" "unprognostic (3.28e-3)" "unprognostic (6.38e-2)" "unprognostic (1.97e-1)" "unprognostic (4.30e-2)" "unprognostic (5.04e-3)" 27.6 34.5 39.4 26.8 42.1 11.4 35.6 33.4 37.8 28.0 25.4 17.9 25.2 21.8 26.6 32.1 23.1 24.9 22.5 22.6 37.5 33.3 31.9 21.6 20.3 37.6 33.5 28.9 30.8 27.8 28.3 30.4 25.4 31.4 28.3 26.1 18.7 19.8 27.8 41.8 20.1 19.9 33.7 39.0 24.3 21.3 20.4 31.3 24.9 29.8 19.3 30.5 27.5 23.7 26.1 19.1 9.7 20.8 19.6 28.9 17.6 35.7 11.6 26.9 34.0 30.8 27.0 19.3 27.0 20.1 17.1 17.8 25.4 13.0 23.9 60.4 18.8 22.1 21.8 34.5 29.3 26.7 12.6 22.7 31.2 13.5 21.1 27.3 36.4 21.8 21.6 25.3 12.4 35.0 25.6 26.2 26.3 17.6 25.5 28.6 41.6 27.0 22.4 34.3 33.9 37.6 21.3 20.6 22.6 24.8 25.0 15.2 40.3 16.9 32.5 47.1 22.4 72.1 29.0 24.8 17.7 18.8 21.8 48.5 39.3 36.3 41.1 24.1 41.2 26.9 3.8 18.1 9.7 19.2 20.8 28.9 26.1 23.5 22.5 19.1 20.5 27.3 24.4 2.3 19.6 20.1 15.5 20.8 17.6 39.4 42.1 33.4 35.7 37.5 33.3 33.5 28.9 31.4 31.3 23.8 35.0 86.4 59.4 46.6 55.7 35.2 20.4 37.5 50.0 40.1 55.0 50.6 82.9 57.9 91.7 48.0 33.3 0.0 43.2 65.3 43.0 45.0 51.9 29.2 58.3 42.9 43.3 31.9 50.5 46.4 34.8 49.6 30.4 71.3 40.2 72.8 56.6 43.0 48.4 59.3 55.3 25.8 53.0 32.3 58.0 39.1 44.5 49.8 42.2 83.5 NCL "C23, Nsr1" ENSG00000115053 Nucleolin P19338 2 231453531-231483641 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004210, HPA023981, HPA071110" Supported Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes Yes 600000 "Nucleoplasm, Nucleoli, Nucleoli rim" "Mitotic chromosome" "CAB004210: AB_670270, HPA023981: AB_1854688, HPA071110: " "unprognostic (1.91e-1)" "unprognostic (2.53e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (2.28e-4)" "unprognostic (1.63e-2)" "unprognostic (2.72e-3)" "prognostic unfavorable (1.41e-6)" "unprognostic (3.74e-2)" "unprognostic (4.31e-3)" "unprognostic (9.78e-2)" "unprognostic (6.70e-3)" "unprognostic (6.07e-2)" "unprognostic (1.66e-2)" "unprognostic (2.57e-2)" "unprognostic (9.70e-2)" "unprognostic (2.84e-2)" "unprognostic (1.42e-2)" 71.2 68.2 59.6 67.7 77.0 96.6 71.0 72.8 69.2 72.1 63.0 79.2 46.0 48.1 80.3 63.7 85.2 65.7 45.9 55.9 57.7 53.3 66.7 94.7 55.6 78.4 67.4 51.8 93.9 77.5 94.8 83.4 69.5 79.8 64.6 75.4 47.1 58.1 51.8 120.6 70.3 56.9 70.9 88.4 80.2 59.4 41.7 76.4 118.9 67.8 82.6 105.5 79.9 60.6 40.8 41.3 20.4 36.4 52.6 53.9 40.8 63.3 59.3 71.9 52.7 42.5 46.2 74.0 71.7 48.7 67.7 60.0 97.9 45.6 84.2 61.8 55.3 90.9 62.2 143.9 96.3 116.1 49.2 60.3 140.5 56.3 131.9 46.6 160.1 53.3 43.8 55.9 84.5 89.0 38.9 71.0 76.8 125.1 28.9 59.5 86.2 140.1 99.4 107.1 66.9 42.6 104.6 129.7 73.9 49.7 84.2 62.3 44.4 48.0 55.1 63.3 61.3 41.4 81.1 60.3 54.3 56.2 63.4 94.2 54.8 53.8 181.3 39.5 104.5 56.2 9.5 27.9 20.4 47.4 33.2 53.9 40.8 41.7 42.6 41.3 38.9 46.6 42.1 6.0 52.6 36.4 35.5 34.4 40.8 59.6 77.0 72.8 69.2 57.7 53.3 67.4 51.8 79.8 76.4 271.0 357.6 280.1 370.4 408.5 137.1 290.7 137.6 385.4 589.2 184.9 45.2 333.3 195.6 173.5 15.4 228.8 106.1 210.2 218.7 336.0 249.6 218.4 431.8 217.9 213.5 76.3 191.8 122.8 135.8 18.9 201.0 194.7 156.9 238.1 192.5 194.0 213.8 138.2 150.3 209.2 125.5 148.8 282.2 390.1 563.8 385.9 316.9 226.1 268.8 321.5 NCLN "NET59, NICALIN" ENSG00000125912 Nicalin Q969V3 19 3185563-3209575 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006625 Approved Approved "Nucleoplasm,Lipid droplets" NA NA 12000 "Lipid droplets" Nucleoplasm "HPA006625: AB_1079453" "unprognostic (4.32e-2)" "unprognostic (1.88e-1)" "unprognostic (1.89e-1)" "prognostic favorable (1.19e-4)" "unprognostic (8.55e-2)" "unprognostic (2.79e-1)" "prognostic unfavorable (2.15e-4)" "unprognostic (9.27e-2)" "unprognostic (1.22e-1)" "unprognostic (9.38e-2)" "unprognostic (2.02e-2)" "unprognostic (1.26e-3)" "prognostic unfavorable (8.37e-5)" "prognostic favorable (8.82e-5)" "unprognostic (1.75e-1)" "unprognostic (1.25e-1)" "unprognostic (7.38e-2)" 15.8 27.4 10.2 18.2 15.3 31.1 10.2 21.2 23.6 9.3 20.4 14.7 14.9 32.9 12.7 7.2 14.1 11.0 15.5 10.5 12.2 8.5 13.3 48.3 15.5 19.8 9.7 9.0 12.1 41.3 9.5 11.5 11.3 10.8 13.3 9.7 13.0 18.7 9.9 16.3 14.9 27.8 9.5 8.0 20.6 18.9 17.2 12.1 11.8 11.8 11.8 13.2 9.4 11.8 5.3 17.8 8.8 12.2 4.3 7.7 7.1 27.0 31.6 7.9 24.4 7.8 6.4 20.5 29.8 12.5 22.5 18.3 42.8 15.7 16.3 26.0 19.5 14.4 32.1 9.3 22.7 5.0 21.4 21.4 11.4 19.5 29.1 15.5 20.3 21.3 11.2 14.4 18.1 9.9 5.7 12.4 16.2 29.2 18.3 10.2 24.0 17.6 21.7 22.2 16.1 22.4 28.6 8.4 26.0 13.3 18.6 17.0 16.8 12.0 22.5 18.9 4.0 16.3 23.4 16.7 19.5 17.0 31.8 35.9 23.0 20.8 12.6 20.6 26.1 29.9 1.1 11.9 8.8 6.9 12.2 6.1 5.3 4.2 7.7 8.7 4.4 4.6 6.1 7.3 4.3 4.9 17.8 3.8 7.1 10.2 15.3 21.2 23.6 12.2 8.5 9.7 9.0 10.8 12.1 14.9 17.1 21.6 7.6 7.3 14.5 8.7 17.8 5.3 9.1 10.4 9.8 17.5 3.3 30.0 12.3 11.3 71.0 0.0 31.8 38.3 11.6 13.6 16.1 39.4 37.7 22.3 12.1 14.7 22.2 39.2 8.6 12.5 13.5 14.4 38.1 5.0 30.8 40.3 8.5 10.3 12.2 12.9 10.3 12.5 18.3 10.9 14.2 12.8 53.7 13.3 NCOA1 "bHLHe74, F-SRC-1, KAT13A, NCoA-1, RIP160, SRC1" ENSG00000084676 "Nuclear receptor coactivator 1" Q15788 2 24491914-24770702 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 41.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019402, HPA070213, HPA070520" Supported Enhanced "Nucleoplasm,Plasma membrane,Cytosol" No No Nucleoplasm "Plasma membrane, Cytosol" "CAB019402: AB_2196189, HPA070213: AB_2686235, HPA070520: AB_2686276" "unprognostic (2.73e-1)" "unprognostic (5.82e-2)" "unprognostic (2.46e-2)" "unprognostic (9.89e-3)" "unprognostic (7.60e-2)" "unprognostic (2.36e-2)" "unprognostic (7.06e-3)" "unprognostic (1.45e-1)" "unprognostic (1.43e-1)" "unprognostic (1.72e-1)" "unprognostic (2.93e-3)" "unprognostic (1.16e-1)" "unprognostic (2.10e-2)" "unprognostic (7.15e-2)" "unprognostic (3.08e-1)" "unprognostic (1.29e-1)" "unprognostic (2.92e-2)" 9.8 10.0 15.3 7.3 18.0 8.9 10.5 15.9 17.1 13.7 8.9 13.5 4.9 12.5 13.0 11.5 10.8 10.0 8.3 8.8 20.8 12.2 11.9 8.8 9.4 8.2 10.8 9.9 17.2 10.3 23.9 16.0 10.1 14.2 9.6 10.1 19.9 10.6 13.0 42.5 9.3 10.9 11.6 9.7 9.6 7.6 11.4 10.7 8.5 7.0 12.2 9.3 9.7 10.8 2.5 5.5 14.2 3.5 3.4 4.1 1.8 6.7 5.0 8.9 4.6 9.8 9.0 13.6 3.6 7.3 4.6 4.1 4.7 2.9 4.9 1.5 6.6 8.8 1.6 5.3 3.1 5.0 23.3 7.7 17.6 2.0 1.9 6.2 8.0 14.7 14.3 4.7 4.4 3.6 5.7 4.6 6.4 10.7 8.2 6.9 4.5 7.1 2.9 4.2 4.0 3.4 5.7 41.0 2.5 5.0 9.2 8.1 6.4 8.4 5.1 3.7 4.9 6.1 4.1 5.0 7.7 6.1 5.2 3.6 9.5 8.2 8.6 4.4 5.1 3.8 11.0 3.5 6.9 3.8 2.7 4.1 1.8 3.4 4.1 2.6 2.5 3.3 4.0 14.2 3.4 2.8 5.5 3.7 1.8 15.3 18.0 15.9 17.1 20.8 12.2 10.8 9.9 14.2 10.7 35.7 29.8 13.6 10.7 27.1 97.2 33.1 15.3 20.1 31.8 14.0 49.1 11.2 6.6 12.0 13.1 29.2 24.6 23.3 23.0 14.9 31.2 14.1 18.6 20.3 15.3 58.8 24.2 33.2 25.2 3.8 43.7 26.2 18.6 10.0 22.7 63.8 17.7 35.1 40.7 11.4 67.4 38.8 35.4 32.1 36.8 27.0 4.5 25.4 23.0 14.6 NCOA2 "bHLHe75, GRIP1, KAT13C, NCoA-2, TIF2" ENSG00000140396 "Nuclear receptor coactivator 2" Q15596 8 70109762-70403805 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060243 Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA060243: AB_2684229" "unprognostic (9.79e-3)" "unprognostic (1.40e-1)" "unprognostic (2.72e-1)" "unprognostic (4.94e-3)" "unprognostic (1.91e-2)" "unprognostic (2.18e-3)" "unprognostic (1.30e-1)" "unprognostic (6.77e-2)" "unprognostic (2.06e-1)" "unprognostic (7.00e-2)" "unprognostic (2.20e-2)" "unprognostic (2.63e-2)" "prognostic favorable (5.08e-4)" "unprognostic (2.52e-1)" "unprognostic (3.35e-1)" "unprognostic (1.07e-1)" "unprognostic (1.76e-1)" 13.6 13.2 16.9 13.1 14.0 22.5 14.9 19.2 14.0 13.9 17.3 10.1 49.7 12.4 16.6 33.6 20.0 12.5 12.6 15.8 13.9 13.0 16.4 25.5 15.5 16.9 10.8 11.4 18.5 9.7 23.4 17.1 16.2 10.0 14.8 11.8 15.3 14.8 21.7 13.2 14.9 28.8 19.2 9.6 14.5 11.7 15.5 12.9 15.3 13.4 10.3 13.8 18.9 17.2 3.8 2.5 9.4 7.8 2.1 3.8 1.6 8.8 11.0 12.2 6.9 11.1 11.4 12.5 5.1 5.1 3.9 3.8 5.6 10.3 10.5 2.1 9.3 6.5 5.2 14.9 7.0 4.4 24.8 11.8 18.3 5.6 8.9 5.8 3.7 4.9 9.9 7.9 5.3 7.6 6.2 2.7 7.7 5.8 16.0 4.5 8.8 9.1 3.7 6.4 10.1 5.2 9.0 5.1 6.5 6.3 14.7 9.3 6.8 8.8 4.7 7.2 8.9 11.1 6.8 3.5 5.7 7.3 7.2 2.7 21.1 10.8 10.2 5.8 4.9 8.3 4.5 2.5 3.5 3.8 3.9 2.8 2.2 2.3 3.3 2.5 3.8 2.8 2.7 9.4 2.1 7.8 1.1 3.2 1.6 16.9 14.0 19.2 13.5 13.9 13.0 10.8 11.4 10.0 12.9 11.9 24.3 16.7 7.9 14.3 23.6 31.3 33.1 9.4 34.2 24.4 49.1 16.2 10.0 6.0 4.0 14.5 20.6 23.3 10.7 10.2 16.2 17.2 21.9 57.7 14.7 69.9 24.2 22.7 43.2 5.7 18.4 19.9 20.3 4.6 17.5 14.7 10.9 11.5 20.8 15.7 29.6 25.8 15.6 11.2 15.4 18.7 26.5 25.4 16.0 12.2 NCOA3 "ACTR, AIB1, bHLHe42, CAGH16, KAT13B, p/CIP, RAC3, SRC-3, SRC3, TNRC16, TRAM-1" ENSG00000124151 "Nuclear receptor coactivator 3" Q9Y6Q9 20 47501902-47656877 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 38.1;MCF7: 63.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009800, HPA024210" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB009800: AB_2251314, HPA024210: AB_10602011" "unprognostic (7.26e-3)" "unprognostic (1.00e-1)" "unprognostic (2.69e-1)" "unprognostic (3.23e-2)" "unprognostic (5.78e-2)" "unprognostic (4.33e-2)" "prognostic unfavorable (8.09e-4)" "unprognostic (2.83e-2)" "unprognostic (1.47e-1)" "unprognostic (5.22e-3)" "unprognostic (2.09e-2)" "unprognostic (2.10e-1)" "unprognostic (2.05e-1)" "unprognostic (1.95e-1)" "unprognostic (2.04e-2)" "unprognostic (4.18e-1)" "unprognostic (1.63e-1)" 20.1 8.9 6.6 34.0 7.4 11.1 15.7 11.9 9.9 12.3 10.1 8.1 9.0 6.7 15.5 8.8 16.7 12.0 8.6 11.5 6.7 4.8 9.1 9.3 17.4 25.8 7.9 4.7 13.3 10.7 13.5 13.5 54.7 7.9 9.7 9.0 10.8 13.5 10.0 32.5 15.0 17.1 11.3 9.5 30.8 11.4 9.2 7.2 17.6 13.5 10.5 33.3 15.1 17.7 13.0 6.7 6.0 7.3 2.7 4.0 3.5 5.9 19.2 5.4 7.3 12.8 15.0 38.1 5.7 8.6 9.8 5.2 9.2 6.5 20.5 3.8 9.8 13.8 14.4 4.2 7.0 7.5 10.8 2.2 2.8 5.4 12.7 7.6 2.2 15.3 6.8 20.2 9.3 10.8 7.9 6.9 3.4 6.3 4.8 5.4 63.9 3.2 3.8 1.9 4.5 7.4 6.1 3.8 8.8 5.4 13.8 1.0 1.9 14.4 17.9 6.1 6.5 8.3 5.6 12.0 5.8 5.1 7.0 2.5 13.2 12.0 21.1 6.8 2.2 3.9 3.4 5.2 4.0 3.5 7.3 3.2 13.0 3.2 3.1 6.7 10.0 3.7 4.0 6.0 2.7 7.0 5.5 4.0 3.5 6.6 7.4 11.9 9.9 6.7 4.8 7.9 4.7 7.9 7.2 11.9 21.3 77.0 14.2 30.7 16.1 22.0 20.4 22.7 17.0 14.0 7.9 56.2 5.0 11.0 9.0 39.0 7.8 0.0 16.8 23.2 22.6 21.3 8.1 18.4 20.1 12.7 14.3 66.9 49.4 3.6 23.0 45.5 32.1 22.6 11.4 9.7 15.9 14.0 25.8 5.1 22.4 19.4 26.8 22.7 17.8 45.2 74.6 22.4 11.7 56.9 NCOA5 "bA465L10.6, CIA" ENSG00000124160 "Nuclear receptor coactivator 5" Q9HCD5 20 46060985-46089952 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050231 Uncertain Supported "Nucleoplasm,Actin filaments" NA NA "Nucleoplasm, Actin filaments" "HPA050231: AB_2681058" "unprognostic (1.78e-1)" "unprognostic (1.54e-1)" "unprognostic (2.43e-2)" "unprognostic (7.93e-2)" "unprognostic (2.30e-1)" "unprognostic (1.43e-2)" "prognostic unfavorable (1.41e-5)" "prognostic favorable (8.07e-4)" "unprognostic (2.32e-1)" "unprognostic (7.75e-2)" "prognostic favorable (1.09e-4)" "unprognostic (7.46e-2)" "unprognostic (4.40e-1)" "unprognostic (2.06e-2)" "unprognostic (1.07e-1)" "unprognostic (8.78e-2)" "unprognostic (1.91e-2)" 16.0 15.0 20.9 25.8 18.5 8.1 55.1 31.2 25.6 19.3 17.7 12.0 18.5 14.0 23.4 20.3 16.5 21.1 15.8 13.8 19.3 13.1 14.1 12.9 21.7 23.0 14.6 16.2 29.8 27.0 23.4 26.2 18.4 15.7 19.2 16.5 14.7 18.5 23.6 22.8 19.4 18.1 19.8 13.6 23.3 16.5 44.4 16.7 23.8 19.2 14.2 23.8 18.2 42.5 17.4 18.5 10.7 8.6 7.4 14.0 5.4 19.4 17.3 24.5 25.1 11.7 12.4 19.6 13.5 12.2 22.0 18.2 23.9 15.6 32.0 22.9 13.0 18.8 26.1 20.2 16.9 19.1 19.3 10.2 19.2 17.3 20.1 12.4 26.3 18.7 8.9 22.6 11.6 10.6 11.6 15.6 16.8 17.8 26.2 17.3 25.2 36.1 20.4 22.2 16.5 21.4 27.5 16.2 14.0 12.9 22.2 22.0 20.0 21.7 26.5 19.0 14.6 21.1 31.1 14.4 23.4 17.8 13.9 21.0 17.1 24.1 21.6 16.2 15.5 14.8 3.3 8.3 10.7 12.2 8.5 14.0 11.6 12.8 12.3 8.3 17.4 12.3 11.1 6.0 7.4 8.6 18.5 8.2 5.4 20.9 18.5 31.2 25.6 19.3 13.1 14.6 16.2 15.7 16.7 8.9 13.0 7.5 2.8 5.7 12.0 3.9 10.2 9.4 6.8 8.7 21.6 9.3 0.0 7.6 6.0 6.9 6.0 0.0 10.5 8.7 6.7 3.6 1.1 6.8 6.7 3.2 9.1 8.6 8.8 2.7 12.7 6.3 3.3 6.4 9.7 6.8 10.1 2.9 14.5 4.4 9.0 6.5 5.3 23.0 13.6 4.6 5.6 5.7 9.3 3.1 NCOA6 "AIB3, ASC2, KIAA0181, NRC, PRIP, RAP250, TRBP" ENSG00000198646 "Nuclear receptor coactivator 6" Q14686 20 34689097-34825649 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004198, HPA050211" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA004198: AB_1078228, HPA050211: AB_2681052" "unprognostic (2.48e-1)" "unprognostic (4.81e-2)" "unprognostic (1.72e-1)" "unprognostic (1.37e-2)" "unprognostic (1.23e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (4.65e-4)" "unprognostic (2.05e-1)" "unprognostic (2.16e-1)" "unprognostic (1.40e-1)" "unprognostic (3.87e-2)" "unprognostic (1.51e-1)" "prognostic favorable (8.78e-5)" "unprognostic (9.04e-2)" "unprognostic (1.59e-1)" "unprognostic (1.12e-1)" "unprognostic (4.42e-2)" 13.7 13.4 14.7 12.8 23.0 15.8 17.7 31.9 17.3 14.9 16.9 28.5 17.5 16.4 16.7 16.3 17.1 14.9 14.2 11.8 16.2 11.7 13.6 10.8 13.2 10.8 18.7 12.6 15.5 15.8 35.1 17.7 18.1 14.4 13.1 18.8 14.4 16.4 18.4 17.6 18.4 21.2 19.8 21.8 11.2 14.6 22.6 22.6 16.9 17.7 9.7 13.2 16.6 14.6 2.7 3.1 6.5 2.1 2.1 2.7 1.3 14.3 8.6 19.5 11.7 10.7 12.0 12.7 7.0 9.0 12.7 10.2 21.9 10.1 10.2 7.8 12.5 15.5 17.6 17.3 11.8 14.5 5.1 7.8 23.9 9.5 12.9 11.8 13.3 17.7 9.0 21.9 11.9 14.8 8.8 11.9 11.8 12.1 14.1 10.4 9.3 21.2 8.4 4.0 12.1 12.5 14.2 23.5 9.1 9.3 9.6 16.3 11.1 12.8 31.2 12.0 9.4 13.1 10.8 11.6 20.6 12.6 15.2 11.6 16.2 13.5 11.8 13.6 7.9 9.1 3.0 1.7 6.5 2.7 1.6 2.6 2.7 2.5 2.3 3.1 2.1 2.3 1.5 4.4 2.1 2.1 2.8 1.4 1.3 14.7 23.0 31.9 17.3 16.2 11.7 18.7 12.6 14.4 22.6 23.8 13.6 9.7 8.2 15.0 26.7 16.7 22.9 16.0 9.1 15.7 27.5 9.8 5.0 11.3 21.4 11.1 16.8 23.3 10.7 10.0 11.1 13.7 5.8 11.4 9.4 31.8 10.4 13.5 12.9 13.4 16.7 10.1 10.1 9.0 18.4 10.0 12.8 8.6 12.7 8.1 27.6 25.8 13.2 22.1 23.7 18.2 13.3 11.7 16.2 13.9 NCOA7 "dJ187J11.3, ERAP140, TLDC4" ENSG00000111912 "Nuclear receptor coactivator 7" Q8NI08 6 125781161-125932030 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 348.4;Ciliated cells: 413.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030289, HPA030290, HPA030291, HPA030292" Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" No No "Nucleoplasm, Nuclear bodies" "Golgi apparatus" "HPA030289: AB_10670031, HPA030290: AB_10601971, HPA030291: AB_10669597, HPA030292: AB_10670834" "unprognostic (1.01e-2)" "unprognostic (3.21e-2)" "unprognostic (7.32e-3)" "unprognostic (7.27e-3)" "unprognostic (1.54e-1)" "unprognostic (4.67e-2)" "unprognostic (1.26e-1)" "unprognostic (6.27e-2)" "unprognostic (2.73e-1)" "unprognostic (2.14e-1)" "unprognostic (6.08e-2)" "unprognostic (4.37e-2)" "prognostic favorable (1.78e-6)" "unprognostic (2.10e-1)" "unprognostic (2.58e-1)" "unprognostic (1.14e-1)" "unprognostic (8.10e-2)" 32.0 37.6 24.8 26.6 33.7 23.1 20.4 39.7 32.6 19.2 18.0 17.9 3.9 19.8 13.9 6.4 22.7 11.3 28.9 12.3 23.2 24.1 33.7 21.5 30.8 19.0 35.7 25.6 12.5 11.8 7.4 49.3 8.0 39.5 12.2 18.4 7.6 31.6 8.5 6.3 8.7 23.1 17.1 30.9 16.2 18.7 4.9 35.4 4.7 15.6 12.0 16.6 44.1 20.8 12.8 22.6 10.5 8.8 9.1 17.5 3.5 4.3 11.9 0.7 5.3 26.6 15.8 7.8 5.9 23.5 7.3 10.1 11.0 4.1 17.4 31.9 3.2 36.1 25.8 4.0 4.0 4.5 37.0 4.6 8.9 15.2 4.1 15.1 5.0 8.5 11.2 9.8 7.0 5.4 13.1 15.2 5.7 12.5 10.4 4.5 4.9 4.9 5.3 0.9 10.8 2.4 3.7 1.8 3.2 13.0 29.9 12.2 10.6 30.2 8.2 13.2 2.3 2.0 6.6 8.7 1.7 3.7 8.6 4.4 12.8 10.4 9.1 3.7 7.1 5.8 10.5 8.1 2.8 14.1 6.3 17.5 12.8 13.4 11.2 6.5 7.5 7.4 7.2 5.0 9.1 8.8 22.6 5.2 3.5 24.8 33.7 39.7 32.0 23.2 24.1 35.7 25.6 39.5 35.4 291.8 348.4 26.9 190.5 87.1 48.0 8.5 68.8 413.6 277.5 59.3 41.2 6.8 68.0 215.9 0.7 103.4 38.3 0.0 123.8 8.9 57.0 95.1 35.9 21.9 11.7 35.0 34.3 88.4 26.4 3.2 39.1 30.8 49.0 32.5 25.4 86.2 116.6 101.7 27.6 77.2 48.8 12.9 29.8 8.4 33.0 51.8 3.2 39.2 37.9 172.9 NCOR1 "hCIT529I10, hN-CoR, KIAA1047, MGC104216, N-CoR, PPP1R109, TRAC1" ENSG00000141027 "Nuclear receptor corepressor 1" O75376 17 16029157-16218185 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043246, HPA050288, HPA051168, CAB072830" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB072830: , HPA043246: AB_2678386, HPA050288: AB_2681073, HPA051168: AB_2681370" "unprognostic (1.83e-1)" "unprognostic (3.05e-1)" "unprognostic (9.17e-2)" "unprognostic (1.10e-1)" "unprognostic (7.38e-2)" "unprognostic (3.59e-2)" "unprognostic (2.55e-2)" "unprognostic (4.27e-2)" "unprognostic (4.87e-2)" "unprognostic (4.06e-2)" "unprognostic (7.07e-2)" "unprognostic (1.52e-2)" "prognostic favorable (7.92e-5)" "unprognostic (4.40e-2)" "unprognostic (2.52e-1)" "unprognostic (1.33e-1)" "unprognostic (5.42e-2)" 19.6 21.2 25.4 24.0 30.8 27.0 25.0 41.8 31.5 24.0 30.6 19.6 18.6 33.2 29.0 19.5 25.0 20.5 21.9 17.8 22.4 17.8 25.6 33.8 20.1 19.5 25.1 19.1 25.9 24.3 39.9 39.8 19.8 21.6 20.8 29.7 17.1 20.9 29.1 43.0 23.8 36.9 29.7 26.4 23.7 29.8 22.1 26.4 38.8 25.3 15.7 23.8 29.6 27.0 43.4 29.9 78.2 24.8 30.4 35.5 19.7 20.4 34.2 24.4 20.3 20.1 15.3 12.2 15.1 17.1 16.6 15.1 18.3 9.4 21.5 10.7 26.3 12.4 15.6 30.0 18.3 24.7 28.6 22.2 21.4 29.6 21.4 19.7 13.4 25.6 15.7 19.2 25.7 30.1 14.2 23.0 30.4 18.6 8.9 16.3 13.3 23.6 8.6 12.1 36.0 9.3 23.6 24.8 10.0 17.2 23.2 8.3 13.9 24.9 10.9 11.8 65.5 10.5 15.3 20.0 17.1 10.1 12.5 20.8 6.1 7.1 12.5 16.3 16.0 14.6 78.2 24.8 52.2 31.3 19.5 25.9 40.7 35.5 34.1 17.5 43.4 34.7 34.8 48.5 30.4 24.0 29.9 31.7 19.7 25.4 30.8 41.8 31.5 22.4 17.8 25.1 19.1 21.6 26.4 74.5 98.7 86.4 91.4 60.2 144.1 78.9 66.2 61.6 72.8 50.6 149.2 79.2 29.9 80.2 53.7 68.9 164.0 93.5 85.1 85.7 74.0 70.9 83.3 105.0 67.5 122.3 84.4 59.5 70.8 35.4 94.0 84.8 35.4 184.0 101.0 81.4 89.5 133.5 114.2 37.3 152.7 90.5 89.5 82.3 75.1 59.6 73.2 110.7 125.6 110.0 NCOR2 "CTG26, SMRT, SMRTE, TNRC14, TRAC-1" ENSG00000196498 "Nuclear receptor corepressor 2" Q9Y618 12 124324415-124567589 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 114.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001928 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA001928: AB_1079454" "unprognostic (9.51e-3)" "unprognostic (7.37e-3)" "unprognostic (4.66e-2)" "unprognostic (2.55e-3)" "unprognostic (2.14e-1)" "unprognostic (7.37e-2)" "unprognostic (3.19e-2)" "unprognostic (8.86e-2)" "unprognostic (2.21e-2)" "unprognostic (2.90e-3)" "unprognostic (6.42e-3)" "unprognostic (1.96e-1)" "unprognostic (9.86e-2)" "unprognostic (6.26e-2)" "unprognostic (1.59e-1)" "unprognostic (7.56e-2)" "unprognostic (8.90e-2)" 24.0 22.0 21.3 21.3 19.0 16.8 18.3 33.8 33.5 24.5 17.2 24.3 17.7 16.4 21.3 19.0 15.7 16.3 21.5 18.2 22.0 14.8 16.0 11.2 23.4 11.9 19.0 15.6 28.6 30.0 13.8 39.5 13.2 28.3 21.3 7.6 32.7 29.2 24.5 62.4 22.8 22.2 17.4 12.2 17.4 24.0 10.8 22.0 9.3 16.7 25.0 7.6 16.3 14.7 0.6 1.7 8.1 4.0 0.2 1.9 0.4 19.7 37.2 10.6 10.1 6.2 8.4 31.8 20.5 10.2 12.0 5.3 19.7 14.6 20.0 15.2 16.7 10.7 18.8 4.2 21.8 4.9 21.1 8.2 16.1 35.1 12.0 12.4 12.1 20.5 13.5 8.2 14.9 8.9 18.4 11.4 9.2 20.6 6.0 10.7 17.0 43.4 14.0 14.8 7.5 36.2 14.1 17.7 10.1 5.7 23.1 28.1 20.5 25.2 21.3 12.9 8.3 17.3 15.3 54.6 27.9 48.3 27.5 43.4 11.5 11.5 12.2 15.9 9.0 26.1 8.1 0.7 1.6 1.9 0.4 0.5 0.6 0.5 1.5 0.3 0.4 0.6 0.5 1.6 0.2 4.0 1.7 0.0 0.4 21.3 19.0 33.8 28.4 22.0 14.8 19.0 15.6 28.3 22.0 107.2 54.1 4.5 21.5 29.7 63.3 27.7 20.4 18.7 56.9 17.4 37.3 6.7 3.3 19.2 1.6 21.0 23.6 0.0 24.0 33.5 32.5 20.3 39.5 16.3 25.4 114.4 18.0 14.7 40.3 4.8 57.5 32.4 15.1 18.0 18.7 30.6 26.9 17.3 61.2 7.0 57.9 6.5 30.6 1.7 10.3 21.3 10.5 13.1 20.4 17.9 NDC80 "HEC, HEC1, hsNDC80, KNTC2, TID3" ENSG00000080986 "NDC80, kinetochore complex component" O14777 18 2571511-2616635 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 51.3" "Cell type enhanced" "Detected in many" 15 "Erythroid cells: 23.3;Spermatocytes: 84.6;Spermatogonia: 25.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 7.9;granulocytes: 9.3;T-cells: 11.5" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA066330 Supported Nucleoplasm,Centrosome NA Yes Nucleoplasm Centrosome "HPA066330: AB_2685661" "unprognostic (1.96e-1)" "unprognostic (5.38e-2)" "unprognostic (2.96e-1)" "unprognostic (2.21e-3)" "unprognostic (1.87e-1)" "unprognostic (3.63e-2)" "prognostic unfavorable (2.53e-8)" "unprognostic (1.16e-2)" "unprognostic (2.58e-3)" "unprognostic (2.86e-2)" "unprognostic (3.19e-3)" "unprognostic (7.74e-2)" "unprognostic (0.00e+0)" "unprognostic (9.69e-3)" "unprognostic (1.69e-1)" "unprognostic (3.50e-2)" "unprognostic (1.71e-1)" 2.9 1.3 0.8 15.3 0.8 14.6 0.9 0.7 0.9 2.9 3.8 0.8 0.6 2.7 4.2 3.8 8.3 1.3 1.8 2.7 0.6 0.4 1.6 1.4 2.9 10.1 0.6 0.8 1.2 0.8 0.0 0.6 6.0 1.1 4.3 5.1 0.8 1.9 7.6 0.6 4.0 4.8 2.2 0.6 7.9 3.0 15.9 0.6 51.3 0.9 8.1 9.9 2.2 6.7 7.9 1.6 9.3 0.7 2.2 11.5 1.4 21.9 5.0 24.8 11.0 1.3 3.0 12.8 25.8 13.9 33.8 28.9 13.6 12.5 24.0 11.7 10.0 14.3 13.6 27.7 11.1 35.8 9.0 7.0 18.9 14.2 10.4 0.5 36.2 15.9 1.5 1.0 19.4 13.8 3.5 15.3 14.9 15.4 30.6 29.5 9.9 17.6 15.8 12.8 14.2 7.3 19.5 25.4 19.2 8.8 10.6 20.1 9.0 23.6 6.2 9.4 10.3 10.4 14.5 9.3 22.1 49.2 17.4 34.0 13.4 21.1 32.2 9.7 16.8 18.6 3.7 0.7 2.8 2.2 0.6 2.0 7.9 3.7 4.3 0.3 5.7 2.4 2.4 9.3 2.2 0.5 1.6 11.5 1.4 0.8 0.8 0.7 0.9 0.6 0.4 0.6 0.8 1.1 0.6 0.0 1.1 3.7 0.8 2.1 0.0 17.3 0.0 1.4 3.4 0.0 0.0 1.7 0.0 0.9 9.7 0.3 0.2 23.3 0.3 20.1 1.9 0.1 0.0 0.0 9.3 0.0 0.0 6.2 2.5 3.6 6.9 2.2 0.0 0.0 0.9 0.0 0.2 0.0 21.9 0.1 0.0 19.4 3.1 84.6 25.0 0.5 1.7 6.9 2.3 0.9 NDN "HsT16328, PWCR" ENSG00000182636 "Necdin, MAGE family member" Q99608 15 23685400-23687330 "Plasma proteins, Predicted membrane proteins" "Growth regulation, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Leydig cells: 218.9;Peritubular cells: 195.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 2.5;plasmacytoid DC: 4.3" "Lineage enriched" "Detected in single" 5 "dendritic cells: 4.3" "Cell line enhanced" "Detected in many" "AF22: 20.6;ASC diff: 20.3;HSkMC: 27.3;NTERA-2: 16.4;SuSa: 22.6;U-2 OS: 30.6;U-266/70: 19.4;U-266/84: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074457 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA074457: AB_2686691" "unprognostic (3.49e-1)" "unprognostic (1.65e-1)" "unprognostic (4.20e-1)" "unprognostic (2.19e-2)" "unprognostic (2.71e-1)" "unprognostic (9.04e-2)" "unprognostic (6.79e-2)" "unprognostic (3.51e-1)" "unprognostic (3.11e-2)" "unprognostic (1.57e-1)" "unprognostic (1.03e-2)" "unprognostic (4.05e-2)" "prognostic unfavorable (4.52e-4)" "unprognostic (1.89e-2)" "unprognostic (8.10e-2)" "unprognostic (1.96e-1)" "unprognostic (6.81e-2)" 29.9 35.5 19.2 7.7 39.1 1.3 25.0 2.6 28.2 32.7 12.9 12.9 8.1 8.0 29.9 17.7 12.3 21.4 19.1 20.3 18.1 40.3 6.9 3.0 10.3 8.9 14.8 17.6 50.7 7.1 2.1 23.2 22.4 19.0 18.8 8.1 16.5 9.2 29.3 9.2 4.7 8.4 23.5 11.8 11.8 8.6 16.4 7.3 7.1 8.4 8.7 4.9 13.1 17.3 0.0 4.3 0.0 0.8 0.4 0.0 0.0 0.0 0.0 20.6 0.0 20.3 7.8 0.0 13.0 0.0 0.3 3.6 0.0 0.0 0.0 0.0 3.9 3.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 12.0 27.3 0.0 3.8 0.0 0.0 0.0 8.0 0.4 0.0 6.7 0.0 9.7 0.0 16.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.1 0.0 22.6 3.5 0.0 0.0 0.9 30.6 0.0 0.0 19.4 18.0 0.0 2.1 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.4 0.6 4.3 0.0 0.0 19.2 39.1 2.6 28.2 18.1 40.3 14.8 17.6 19.0 7.3 23.8 8.3 0.0 15.5 11.6 59.9 32.5 12.7 6.7 2.3 12.2 19.6 1.7 19.9 16.4 1.9 15.7 4.6 0.0 9.4 1.1 70.8 4.8 0.0 0.2 6.3 47.7 6.4 30.1 7.8 3.8 218.9 3.2 37.1 0.0 4.5 81.6 7.3 0.0 195.2 0.5 41.1 97.0 76.9 10.9 21.7 7.2 2.1 0.7 6.9 3.1 NDOR1 "bA350O14.9, NR1" ENSG00000188566 "NADPH dependent diflavin oxidoreductase 1" Q9UHB4 9 137205685-137217009 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024504 Approved Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA Cytosol "Nucleoplasm, Intermediate filaments" "HPA024504: AB_1854338" "unprognostic (1.67e-1)" "unprognostic (1.44e-2)" "unprognostic (3.55e-2)" "unprognostic (1.53e-1)" "unprognostic (1.55e-1)" "unprognostic (1.41e-2)" "unprognostic (5.89e-3)" "unprognostic (5.99e-2)" "unprognostic (9.30e-2)" "unprognostic (3.00e-1)" "unprognostic (2.61e-3)" "unprognostic (1.14e-1)" "unprognostic (1.07e-1)" "unprognostic (4.69e-3)" "unprognostic (2.05e-1)" "unprognostic (4.30e-2)" "unprognostic (6.74e-3)" 9.6 11.4 10.6 18.4 17.4 29.2 10.0 15.0 16.2 9.4 10.4 18.7 7.4 19.1 11.4 10.5 11.2 11.0 10.4 7.4 11.6 7.7 12.1 9.4 11.6 20.5 18.6 8.6 10.2 14.7 9.7 12.2 9.2 13.5 13.0 6.8 12.5 17.3 16.1 6.5 18.5 16.5 8.7 14.2 19.9 13.9 22.2 14.2 20.6 14.4 4.9 15.8 9.7 9.4 2.7 3.7 6.6 4.8 1.6 4.0 3.0 7.2 10.9 7.5 11.4 3.2 3.2 22.5 10.6 4.9 10.4 7.2 10.9 8.6 10.1 8.4 4.1 8.3 27.1 5.4 7.5 2.1 13.0 8.4 9.0 26.2 5.8 5.3 10.1 19.3 4.3 5.3 11.6 4.3 2.8 4.8 13.7 14.5 10.8 3.7 13.0 10.4 17.9 11.9 6.7 13.6 19.2 8.8 14.4 3.3 6.3 9.4 9.3 8.8 8.9 5.5 3.4 14.4 11.7 6.2 19.1 12.5 22.0 11.8 6.7 13.2 10.5 8.3 9.2 10.8 1.7 4.4 6.3 3.2 4.8 2.7 1.3 2.8 2.7 3.7 2.7 1.6 1.4 6.6 1.6 3.8 2.4 4.0 3.0 10.6 17.4 15.0 16.2 11.6 7.7 18.6 8.6 13.5 14.2 0.0 1.6 0.8 0.6 0.5 0.2 1.1 0.0 0.0 2.3 3.5 0.0 4.2 1.7 0.9 0.6 1.5 2.2 0.0 1.0 2.8 0.6 0.5 1.1 0.6 2.3 0.0 2.4 1.8 3.7 0.8 0.6 1.6 1.7 4.6 1.4 0.1 1.5 0.8 0.4 1.1 1.0 0.0 0.8 1.9 1.1 0.3 3.1 0.0 1.7 0.7 NDP "EVR2, norrin" ENSG00000124479 "NDP, norrin cystine knot growth factor" Q00604 X 43948776-43973504 "Disease related genes, Predicted secreted proteins" "Sensory transduction, Vision, Wnt signaling pathway" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 40.4" "Cell type enriched" "Detected in some" 8 "Muller glia cells: 100.6" "Cancer enhanced" "Detected in many" "glioma: 25.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "memory CD4 T-cell: 1.7" "Lineage enriched" "Detected in single" 14 "T-cells: 1.7" "Cell line enriched" "Detected in some" 17 "U-87 MG: 41.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003095 Supported Nucleoplasm,Nucleoli,Vesicles "Secreted to extracellular matrix" NA NA Vesicles "Nucleoplasm, Nucleoli" "HPA003095: AB_1079457" "unprognostic (1.12e-1)" "unprognostic (7.12e-2)" "unprognostic (2.27e-2)" "unprognostic (2.55e-3)" "unprognostic (6.84e-3)" "unprognostic (1.51e-1)" "unprognostic (9.09e-2)" "unprognostic (2.29e-1)" "unprognostic (1.22e-1)" "unprognostic (1.86e-1)" "unprognostic (1.40e-1)" "unprognostic (3.02e-2)" "unprognostic (2.22e-2)" "unprognostic (1.47e-1)" "unprognostic (1.13e-1)" "unprognostic (2.87e-3)" 0.9 0.6 17.3 0.6 18.6 0.5 3.6 14.6 15.0 19.1 0.7 12.6 0.2 0.6 13.6 19.9 0.6 18.0 0.9 1.4 14.0 7.8 0.7 0.5 0.6 0.7 11.0 10.9 40.4 0.6 0.8 0.2 5.3 13.1 6.8 0.7 1.4 0.6 12.4 1.5 1.1 0.6 10.7 7.5 0.6 0.7 1.4 12.2 0.0 1.2 0.0 0.7 1.0 1.7 0.1 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.9 0.0 0.0 0.1 1.1 0.7 0.0 0.0 1.1 0.0 2.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 1.2 0.0 0.0 0.0 41.2 0.4 2.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.3 18.6 14.6 15.0 14.0 7.8 11.0 10.9 13.1 12.2 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 12.4 0.0 0.0 0.0 0.0 100.6 0.7 0.0 9.2 0.0 3.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 NDRG2 "KIAA1248, SYLD" ENSG00000165795 "NDRG family member 2" Q9UN36 14 21016763-21070872 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis, Wnt signaling pathway" "Developmental protein" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 310.5;skeletal muscle: 253.0" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 411.1;Leydig cells: 322.7;Muller glia cells: 402.9;Sertoli cells: 588.6" "Cancer enhanced" "Detected in all" "glioma: 78.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 10 "myeloid DC: 54.5" "Lineage enriched" "Detected in many" 10 "dendritic cells: 54.5" "Cell line enhanced" "Detected in many" "Hep G2: 27.9;HMC-1: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002896, HPA003590, CAB017491" Enhanced Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA 150000 "Centriolar satellite" "Nucleoplasm, Cytosol" "CAB017491: AB_2298331, HPA002896: AB_1079459, HPA003590: AB_1079458" "unprognostic (9.27e-3)" "unprognostic (2.97e-3)" "unprognostic (1.26e-2)" "unprognostic (5.09e-3)" "unprognostic (2.00e-2)" "unprognostic (2.92e-2)" "prognostic favorable (6.71e-4)" "unprognostic (1.85e-3)" "unprognostic (5.57e-2)" "unprognostic (3.46e-2)" "unprognostic (1.69e-1)" "unprognostic (5.10e-2)" "prognostic favorable (1.43e-12)" "unprognostic (1.46e-1)" "unprognostic (5.56e-2)" "unprognostic (6.11e-2)" "unprognostic (4.19e-2)" 19.3 45.3 140.2 4.8 135.1 1.4 50.3 93.5 110.0 35.5 21.0 89.6 23.8 12.2 30.7 44.4 37.3 29.5 21.5 45.2 103.6 86.1 24.3 84.8 13.7 7.7 128.9 73.5 79.7 15.5 35.6 6.0 8.1 95.4 23.7 18.8 8.9 310.5 37.3 253.0 18.9 12.0 22.0 73.0 21.1 11.2 5.2 71.2 0.4 13.6 53.4 16.1 13.9 19.3 1.8 54.5 0.4 1.8 0.7 5.4 4.0 5.3 1.1 3.4 6.4 0.5 0.0 0.5 0.1 2.2 2.0 1.1 7.4 10.0 0.3 2.0 0.1 3.2 8.8 15.3 3.1 2.7 0.0 5.5 6.9 1.2 27.9 0.7 0.6 20.0 6.1 6.7 0.4 0.9 3.2 0.0 6.3 13.9 0.6 0.3 4.5 2.4 1.9 9.1 17.3 0.4 7.1 0.3 1.6 3.8 13.6 0.0 9.9 1.5 1.7 7.0 9.3 13.5 4.0 0.0 0.6 10.9 0.2 0.2 3.1 2.2 0.1 0.9 0.1 2.3 0.0 1.8 0.2 2.4 0.4 3.2 1.8 3.6 3.3 54.5 1.3 5.4 4.0 0.4 0.7 0.0 1.9 2.4 4.0 140.2 135.1 93.5 110.0 103.6 86.1 128.9 73.5 95.4 71.2 0.0 14.8 8.5 70.8 25.4 6.7 160.9 140.1 20.1 13.6 38.4 9.8 8.0 411.1 69.3 4.7 52.6 25.5 0.0 18.9 0.6 20.1 71.2 47.4 183.0 19.8 3.2 32.1 116.6 25.7 5.9 322.7 43.4 305.4 6.4 71.2 402.9 14.6 28.8 156.3 32.0 12.8 588.6 188.5 1.1 3.4 26.6 18.1 10.1 86.6 132.0 NDRG4 "KIAA1180, SMAP-8" ENSG00000103034 "NDRG family member 4" Q9ULP0 16 58462846-58513628 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 59.2;brain: 134.1;heart muscle: 112.6" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 389.7;Horizontal cells: 487.8" "Cancer enriched" "Detected in many" 6 "glioma: 23.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "EFO-21: 18.4;GAMG: 16.2;hTERT-RPE1: 15.2;SCLC-21H: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015313, HPA017587" Enhanced Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA015313: AB_1854343, HPA017587: AB_1854344" "unprognostic (1.52e-1)" "unprognostic (1.30e-1)" "unprognostic (9.03e-3)" "unprognostic (1.59e-2)" "unprognostic (3.97e-1)" "unprognostic (1.03e-1)" "unprognostic (1.82e-3)" "unprognostic (1.56e-1)" "unprognostic (6.07e-2)" "unprognostic (1.02e-1)" "unprognostic (4.84e-3)" "unprognostic (5.98e-2)" "unprognostic (2.27e-2)" "unprognostic (1.22e-2)" "unprognostic (8.51e-2)" "unprognostic (4.45e-2)" "unprognostic (7.17e-2)" 3.6 59.2 28.7 2.9 49.4 1.6 2.3 65.4 134.1 3.8 3.5 11.0 15.6 3.4 10.2 5.1 10.0 3.9 3.4 112.6 30.5 32.0 2.3 1.9 6.5 3.4 33.7 35.4 2.1 2.6 10.8 11.6 2.6 81.2 2.1 3.2 8.7 2.9 18.2 5.3 3.9 3.2 8.7 11.7 11.7 2.6 19.9 7.4 0.0 2.6 0.3 3.5 2.7 8.0 1.5 0.1 0.2 0.0 0.1 0.9 0.2 0.1 9.3 8.9 1.7 0.2 1.7 0.7 2.9 4.5 1.4 0.9 3.5 2.4 0.2 18.4 2.2 16.2 0.8 0.7 0.5 1.2 0.0 1.8 0.4 1.5 2.5 2.5 0.1 0.1 2.1 0.2 0.9 0.0 15.2 11.7 0.0 0.1 0.1 1.3 2.3 0.9 0.1 0.8 0.3 6.8 0.2 2.5 0.2 0.4 5.8 27.8 10.4 0.3 0.8 0.1 1.1 0.3 0.1 4.2 1.2 3.5 0.3 0.4 0.5 0.2 3.0 6.4 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.2 28.7 49.4 65.4 63.4 30.5 32.0 33.7 35.4 81.2 7.4 0.0 3.4 0.0 4.0 1.8 38.9 389.7 0.0 0.0 0.0 0.0 3.9 0.0 0.0 3.6 4.6 13.5 0.0 0.0 0.2 0.1 1.5 1.4 0.0 0.2 0.0 487.8 1.7 23.9 1.0 6.2 4.0 0.7 6.8 0.0 0.0 74.2 3.2 0.0 2.5 0.0 22.6 6.5 5.7 3.9 3.6 5.1 0.0 0.0 0.0 7.5 NDUFA9 "CI-39k, NDUFS2L, SDR22E1" ENSG00000139180 "NADH:ubiquinone oxidoreductase subunit A9" Q16795 12 4649095-4694317 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 66.6" "Cell type enhanced" "Detected in all" 7 "Late spermatids: 461.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042268, HPA073212" Supported Supported Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA042268: AB_2677922, HPA073212: AB_2686581" "unprognostic (2.26e-1)" "unprognostic (7.85e-3)" "unprognostic (3.67e-2)" "unprognostic (1.84e-1)" "unprognostic (2.41e-2)" "unprognostic (7.58e-2)" "unprognostic (9.64e-3)" "unprognostic (3.02e-1)" "unprognostic (2.06e-1)" "unprognostic (1.25e-1)" "unprognostic (3.45e-2)" "unprognostic (1.16e-1)" "prognostic favorable (2.57e-7)" "unprognostic (7.80e-2)" "unprognostic (1.71e-1)" "unprognostic (1.93e-2)" "prognostic favorable (5.75e-4)" 10.7 13.2 11.0 10.1 17.8 21.2 11.7 15.3 20.7 9.2 22.1 12.0 8.6 20.9 10.1 11.0 13.4 8.4 8.5 41.3 11.6 11.0 23.7 22.1 8.5 11.8 12.7 9.9 8.4 10.4 10.4 12.2 9.5 16.2 9.9 22.7 12.1 13.3 10.1 66.6 10.6 18.9 11.7 8.3 11.5 13.6 5.8 9.3 14.4 10.2 30.7 12.8 8.2 8.8 36.8 43.5 14.6 41.5 25.8 35.9 59.6 10.9 19.8 9.8 13.0 7.2 7.2 28.3 8.4 8.5 16.3 12.4 42.9 22.1 12.4 4.5 9.1 18.4 18.5 14.1 12.4 10.6 24.0 24.8 12.1 21.1 32.4 15.8 17.6 13.1 9.2 12.1 11.1 15.1 10.1 12.2 17.8 8.4 23.5 12.0 21.3 17.6 20.3 25.2 20.7 16.5 24.9 14.4 12.9 22.4 25.1 7.1 8.0 10.6 28.5 14.7 22.2 5.9 16.9 8.5 12.4 25.2 11.3 19.4 4.6 5.4 20.5 13.0 11.0 13.6 14.6 35.8 13.3 27.7 41.5 28.0 36.8 29.0 30.2 42.3 26.2 25.3 26.2 3.1 25.8 32.2 43.5 35.9 59.6 11.0 17.8 15.3 20.7 11.6 11.0 12.7 9.9 16.2 9.3 26.8 28.0 46.2 52.9 43.0 46.1 165.0 50.9 41.5 36.4 61.1 55.0 100.9 140.9 108.0 102.8 42.7 83.0 23.3 114.3 98.5 39.0 37.2 56.6 65.2 101.8 31.8 45.5 34.4 33.6 461.4 26.2 46.0 52.3 57.7 92.6 40.4 94.0 94.8 34.6 133.6 48.3 19.4 42.6 28.8 28.1 41.3 83.5 45.7 120.3 64.7 NDUFAB1 "ACP, ACP1, FASN2A, SDAP" ENSG00000004779 "NADH:ubiquinone oxidoreductase subunit AB1" O14561 16 23581002-23596356 "Predicted intracellular proteins" "Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 118.2;skeletal muscle: 112.0" "Cell type enhanced" "Detected in all" 7 "Cardiomyocytes: 1253.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054364, HPA076020" Approved Supported Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA054364: AB_2682463, HPA076020: " "unprognostic (3.33e-3)" "unprognostic (9.38e-2)" "unprognostic (1.14e-2)" "unprognostic (9.10e-2)" "unprognostic (2.33e-1)" "unprognostic (5.71e-2)" "unprognostic (1.22e-1)" "unprognostic (5.97e-2)" "unprognostic (1.97e-1)" "unprognostic (7.57e-2)" "unprognostic (3.89e-1)" "unprognostic (5.60e-2)" "prognostic favorable (1.94e-7)" "unprognostic (1.77e-1)" "unprognostic (1.07e-1)" "unprognostic (4.83e-2)" "unprognostic (3.16e-1)" 21.6 25.5 29.4 14.8 28.0 15.1 20.4 21.2 37.7 13.4 31.2 11.4 16.2 30.2 13.7 15.5 19.4 16.2 17.4 118.2 24.1 25.6 32.5 38.8 12.0 15.2 27.0 21.6 10.9 29.1 21.9 18.6 15.2 23.3 16.0 26.5 15.3 24.3 19.2 112.0 12.4 25.7 18.1 15.5 14.0 20.1 11.4 11.5 14.5 15.8 54.3 16.7 13.4 12.7 39.3 61.8 17.4 49.3 25.0 39.5 43.1 28.2 20.9 26.2 23.3 18.7 20.2 36.4 21.8 16.2 22.0 18.1 18.1 23.0 46.8 35.8 15.7 27.4 23.4 45.5 25.9 17.5 26.5 52.6 25.1 37.5 88.9 19.6 46.6 20.9 18.8 36.0 16.2 17.5 20.7 27.9 42.3 52.6 23.8 23.8 42.8 36.0 70.9 68.0 42.2 48.6 49.6 29.5 63.7 20.2 25.4 36.0 28.1 24.4 44.7 40.7 30.1 36.1 39.0 21.9 20.2 21.2 19.5 29.9 30.4 44.2 52.5 22.6 37.7 22.8 15.1 43.1 17.4 31.7 49.3 34.6 39.3 37.7 35.0 55.2 34.6 35.2 36.5 8.9 25.0 38.0 61.8 39.5 43.1 29.4 28.0 21.2 37.7 24.1 25.6 27.0 21.6 23.3 11.5 92.3 83.8 96.1 105.6 108.4 80.0 1253.7 109.5 175.3 81.9 106.4 43.2 246.2 600.2 140.5 81.4 113.0 204.9 70.0 182.7 251.9 115.6 117.8 83.1 281.9 233.1 49.3 194.3 96.3 110.6 24.0 89.8 100.2 148.5 155.9 210.6 118.9 192.1 168.4 114.2 541.1 90.3 90.5 123.0 114.6 115.3 124.3 187.8 90.6 317.0 150.7 NDUFB2 "AGGG, CI-AGGG" ENSG00000090266 "NADH:ubiquinone oxidoreductase subunit B2" O95178 7 140690777-140722790 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 153.5" "Cell type enhanced" "Detected in all" 7 "Cardiomyocytes: 3102.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051377 Approved Uncertain Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA051377: AB_2681460" "unprognostic (1.17e-2)" "unprognostic (4.63e-2)" "unprognostic (2.25e-1)" "unprognostic (4.83e-2)" "unprognostic (2.29e-2)" "unprognostic (2.07e-1)" "unprognostic (3.20e-2)" "unprognostic (3.30e-2)" "unprognostic (8.30e-2)" "unprognostic (1.95e-3)" "unprognostic (4.35e-3)" "unprognostic (1.23e-1)" "prognostic favorable (7.60e-7)" "unprognostic (2.05e-1)" "unprognostic (1.07e-1)" "unprognostic (8.28e-2)" "unprognostic (1.55e-1)" 25.1 31.2 45.1 19.9 52.5 20.2 27.3 29.1 43.3 21.5 39.0 26.0 25.1 28.3 20.1 29.5 27.7 22.0 25.7 105.5 37.0 36.0 46.6 41.2 18.4 23.8 46.0 35.6 14.5 47.0 26.5 23.9 17.7 33.3 20.7 30.8 28.1 37.6 27.4 127.2 17.2 28.1 38.1 37.7 19.7 26.9 14.3 25.2 15.6 57.6 48.1 21.1 25.5 17.5 94.7 116.5 55.2 108.5 75.9 87.8 153.5 41.1 67.0 24.0 52.4 38.6 39.2 34.9 29.9 26.2 31.0 29.6 51.7 41.1 31.3 44.8 36.2 58.7 20.4 21.4 42.1 24.7 52.2 73.6 22.9 57.3 58.1 30.6 35.3 30.9 43.6 36.5 29.4 18.1 26.6 46.1 44.5 38.7 37.9 42.9 122.0 55.3 91.1 55.6 84.7 76.6 31.9 23.4 72.2 62.1 81.8 48.9 48.3 41.0 67.2 35.9 28.6 29.2 40.5 38.4 41.0 24.1 48.4 51.5 36.2 67.2 54.9 62.4 56.8 51.3 55.2 108.5 48.1 83.5 107.8 71.3 94.7 82.1 81.4 116.5 72.9 87.8 87.7 9.0 75.9 97.1 92.8 73.9 153.5 45.1 52.5 29.1 43.3 37.0 36.0 46.0 35.6 33.3 25.2 175.7 232.0 217.4 229.1 201.1 175.8 3102.3 435.7 235.5 197.9 638.6 92.3 489.8 1692.7 343.0 795.3 237.8 727.9 70.0 273.3 377.8 291.6 360.2 272.6 944.1 632.0 131.9 411.8 215.5 261.6 154.7 206.2 385.8 411.7 381.5 493.4 197.7 268.8 531.3 229.1 1640.6 200.8 194.1 278.2 77.7 190.5 245.3 430.7 214.4 506.9 369.0 NDUFB4 B15 ENSG00000065518 "NADH:ubiquinone oxidoreductase subunit B4" O95168 3 120596309-120602500 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 195.7" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 1416.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051739, HPA064441" Enhanced Supported "Nucleoplasm,Nuclear membrane,Mitochondria" No No Mitochondria "Nucleoplasm, Nuclear membrane" "HPA051739: AB_2681585, HPA064441: " "unprognostic (1.75e-1)" "unprognostic (2.57e-3)" "unprognostic (6.95e-2)" "unprognostic (4.69e-2)" "unprognostic (1.59e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (1.62e-2)" "unprognostic (1.47e-1)" "unprognostic (4.35e-3)" "unprognostic (9.66e-3)" "unprognostic (7.97e-2)" "unprognostic (2.84e-1)" "unprognostic (3.69e-2)" "unprognostic (1.01e-1)" "unprognostic (1.12e-1)" "prognostic favorable (1.79e-4)" 25.5 68.2 37.6 20.1 37.7 22.4 59.4 40.7 51.6 25.6 37.2 19.1 25.6 33.6 23.2 32.2 30.2 24.3 27.8 130.2 32.5 30.8 53.3 46.9 25.4 42.0 37.3 29.4 25.8 36.5 34.1 32.8 18.5 36.7 26.8 34.8 24.6 33.9 29.5 195.7 27.3 30.6 37.6 32.4 22.6 28.7 26.6 25.6 31.1 25.9 64.8 25.4 32.3 29.1 64.5 73.4 52.1 60.5 39.1 79.7 49.0 51.3 37.5 44.9 44.9 28.3 33.8 36.5 28.9 38.4 37.6 41.6 36.4 39.5 26.1 58.7 32.3 47.2 49.8 34.6 36.8 28.4 40.0 39.8 40.3 39.4 36.6 17.2 35.4 47.8 30.5 49.1 18.3 24.1 45.6 46.9 49.7 23.8 40.2 40.3 40.3 70.0 51.3 35.7 84.6 102.8 40.6 25.6 57.4 60.9 32.1 50.6 51.8 33.9 38.0 61.5 31.3 64.0 56.5 36.0 33.3 43.9 14.1 40.2 49.6 44.7 78.9 52.6 49.9 45.1 46.2 46.2 52.1 45.5 60.5 47.4 64.5 63.5 51.3 58.4 47.2 54.8 53.4 28.1 39.1 60.5 73.4 79.7 49.0 37.6 37.7 40.7 51.6 32.5 30.8 37.3 29.4 36.7 25.6 151.8 116.9 147.4 227.4 197.5 114.3 1416.5 333.7 208.8 175.1 303.6 55.0 310.4 1039.5 474.7 797.6 248.2 436.8 93.5 541.7 349.0 180.0 247.2 169.9 411.5 288.6 79.4 286.7 153.4 221.7 73.1 254.9 235.4 411.7 399.5 378.0 175.1 503.3 436.8 260.6 758.9 123.5 252.2 270.2 329.1 90.3 219.8 294.7 162.0 391.3 307.0 NDUFB5 "CI-SGDH, MGC12314, SGDH" ENSG00000136521 "NADH:ubiquinone oxidoreductase subunit B5" O43674 3 179604690-179627647 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005640 Enhanced Supported Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA Mitochondria Nucleoplasm "HPA005640: AB_1079461" "unprognostic (6.76e-2)" "unprognostic (1.09e-2)" "unprognostic (6.33e-2)" "unprognostic (3.51e-3)" "unprognostic (1.38e-1)" "unprognostic (7.35e-3)" "unprognostic (1.33e-2)" "unprognostic (1.63e-1)" "unprognostic (4.46e-2)" "unprognostic (5.96e-3)" "unprognostic (4.83e-2)" "unprognostic (7.11e-2)" "prognostic favorable (3.32e-5)" "unprognostic (3.05e-1)" "unprognostic (1.36e-1)" "unprognostic (6.50e-2)" "unprognostic (1.95e-1)" 32.2 39.6 41.3 16.0 44.6 12.1 27.2 20.0 45.7 23.7 32.3 22.0 21.2 43.7 16.2 15.4 26.4 20.0 20.5 86.9 34.1 31.7 48.1 42.3 17.8 21.7 39.4 33.6 22.1 23.2 31.1 18.7 21.3 37.6 19.6 29.9 24.8 35.8 21.3 96.3 17.5 38.5 21.3 30.9 20.4 24.9 21.8 18.4 22.7 27.7 47.3 18.5 26.5 17.3 27.7 41.4 19.5 44.9 14.6 25.0 26.7 23.4 6.6 16.4 19.9 21.7 29.2 22.2 14.9 18.8 21.3 21.6 19.7 17.1 20.5 45.2 12.6 36.6 26.0 17.7 19.7 21.5 42.4 14.8 22.0 12.0 16.4 19.9 26.3 17.5 26.9 25.5 12.0 20.0 22.1 24.4 20.0 18.6 29.9 22.8 16.7 15.1 20.4 23.7 45.5 26.7 16.8 19.0 63.6 38.6 18.1 11.7 19.6 9.0 50.9 35.1 15.4 77.6 42.9 15.7 14.1 13.4 19.2 35.4 39.8 41.2 30.3 22.8 28.2 20.0 19.5 29.9 14.4 13.9 37.6 22.1 27.7 20.0 17.0 41.4 19.5 20.8 21.0 6.7 14.6 44.9 24.0 25.0 26.7 41.3 44.6 20.0 45.7 34.1 31.7 39.4 33.6 37.6 18.4 44.7 44.0 87.9 92.8 75.7 45.3 340.1 112.1 52.2 53.4 83.7 31.4 192.8 431.0 110.3 85.8 85.1 125.2 0.0 92.5 115.9 83.1 75.7 92.3 108.0 222.8 38.1 112.9 97.6 229.9 13.7 75.1 156.2 128.2 124.4 173.7 74.4 86.7 189.4 65.7 379.0 54.1 71.1 81.4 233.1 125.2 77.5 192.3 81.2 242.9 137.2 NDUFV2 CI-24k ENSG00000178127 "NADH:ubiquinone oxidoreductase core subunit V2" P19404 18 9102630-9134345 "Enzymes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003404, HPA077896" Supported Supported Nucleoplasm,Mitochondria,Cytosol No No Mitochondria "Nucleoplasm, Cytosol" "HPA003404: AB_1079466, HPA077896: AB_2686866" "unprognostic (1.18e-1)" "unprognostic (3.89e-2)" "unprognostic (2.89e-1)" "unprognostic (8.22e-2)" "unprognostic (1.32e-2)" "unprognostic (6.72e-3)" "unprognostic (1.36e-2)" "unprognostic (1.18e-1)" "unprognostic (6.72e-3)" "unprognostic (1.32e-3)" "unprognostic (2.39e-1)" "unprognostic (6.84e-2)" "unprognostic (1.70e-1)" "unprognostic (5.51e-2)" "unprognostic (1.31e-1)" "unprognostic (6.56e-2)" "unprognostic (1.95e-3)" 20.0 34.5 25.2 18.0 23.7 31.1 25.6 20.6 37.3 15.6 26.1 13.1 20.3 23.1 14.7 21.5 27.5 13.9 17.6 82.6 22.7 23.8 40.7 89.1 17.2 29.9 26.7 19.4 11.2 36.3 14.9 14.9 21.6 26.2 20.8 27.8 17.8 20.1 20.2 122.6 17.4 24.4 23.5 20.8 19.3 25.2 19.0 12.7 20.5 20.5 59.5 22.7 20.4 14.1 55.6 74.7 49.3 45.1 27.0 53.5 48.1 18.6 19.6 22.7 21.1 16.8 24.0 19.2 23.5 37.4 31.1 29.6 36.6 15.4 28.8 21.6 22.0 28.7 9.5 22.0 24.4 29.8 14.5 19.4 18.4 20.2 49.3 19.4 51.2 22.9 20.1 20.5 19.2 20.8 22.5 33.5 26.0 29.3 91.0 28.5 23.4 35.7 44.9 18.9 103.3 24.4 17.0 16.8 109.2 49.6 30.3 23.8 17.7 23.2 26.5 29.5 16.9 24.8 39.0 20.5 39.7 28.2 28.4 30.5 26.3 39.0 32.2 28.3 22.7 25.6 49.3 39.9 44.1 30.2 45.1 37.6 55.6 45.5 35.7 56.6 43.6 40.0 36.9 18.0 27.0 41.6 74.7 53.5 48.1 25.2 23.7 20.6 37.3 22.7 23.8 26.7 19.4 26.2 12.7 74.5 120.4 122.8 254.8 131.4 96.8 61.3 175.8 207.5 127.4 143.1 82.5 309.8 742.8 337.2 214.8 108.5 232.3 46.7 461.4 265.4 107.6 372.3 115.7 324.6 267.7 89.0 102.4 92.7 98.1 135.7 113.1 187.8 219.4 393.1 177.0 104.6 465.3 175.4 95.8 576.3 143.4 103.5 138.2 182.6 170.4 129.0 242.0 118.9 207.0 348.6 NECAB1 EFCBP1 ENSG00000123119 "N-terminal EF-hand calcium binding protein 1" Q8N987 8 90791550-90959408 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 56.4" "Cell type enhanced" "Detected in many" 15 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 54.2;Cardiomyocytes: 55.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEL: 6.1;hTERT-RPE1: 6.4;MOLT-4: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA023252, HPA023629, HPA025963, HPA031262, CAB068208, CAB068209, CAB068210" Enhanced Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB068208: AB_2665671, CAB068209: AB_2665672, CAB068210: AB_2665673, HPA023252: AB_1848013, HPA023629: AB_1848014, HPA025963: AB_1848015, HPA031262: AB_2673815" "unprognostic (8.09e-3)" "unprognostic (3.78e-1)" "unprognostic (8.17e-3)" "unprognostic (5.96e-5)" "unprognostic (2.51e-1)" "unprognostic (1.30e-1)" "unprognostic (3.83e-3)" "unprognostic (8.38e-2)" "unprognostic (1.78e-3)" "unprognostic (2.60e-1)" "unprognostic (2.25e-2)" "unprognostic (2.57e-2)" "unprognostic (2.19e-3)" "unprognostic (4.45e-3)" "unprognostic (1.68e-2)" "unprognostic (2.42e-3)" "unprognostic (5.39e-3)" 2.7 4.9 19.7 2.0 27.3 3.2 1.5 0.5 56.4 1.4 3.7 12.1 0.3 1.7 4.1 4.4 3.6 1.6 3.1 10.9 19.5 9.8 3.4 1.1 6.8 1.4 16.0 30.7 3.8 1.3 1.9 1.9 2.8 10.8 2.6 1.1 4.1 2.5 2.0 1.3 1.9 1.8 1.3 18.7 2.4 2.1 5.2 17.4 0.0 2.9 0.0 1.0 4.2 1.2 0.5 1.8 0.3 0.0 0.7 0.9 0.2 0.1 0.1 2.3 0.4 0.0 0.1 0.1 2.5 0.1 0.0 0.0 0.0 0.7 0.1 0.2 0.0 2.3 0.0 1.0 0.0 0.1 0.0 4.6 6.1 2.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.1 6.4 0.0 1.7 4.0 4.4 0.0 4.9 6.3 3.1 0.8 0.0 0.1 0.0 3.9 0.0 0.0 0.0 4.1 4.3 0.1 0.0 2.1 2.9 0.0 0.2 1.5 3.8 3.8 0.0 1.6 6.0 3.6 3.1 3.8 0.0 1.8 0.0 0.0 0.1 0.6 0.0 0.4 0.2 0.4 0.6 0.1 0.5 0.6 0.9 0.3 0.7 0.0 1.8 0.9 0.2 19.7 27.3 0.5 37.1 19.5 9.8 16.0 30.7 10.8 17.4 17.9 54.2 0.0 0.2 0.5 3.9 55.7 0.0 0.0 4.5 12.2 0.0 0.0 0.0 0.0 3.5 0.7 0.0 0.0 0.2 0.0 1.3 0.1 1.1 0.0 0.1 0.0 0.0 0.6 0.0 1.0 2.3 0.7 3.3 0.0 0.0 0.3 0.1 0.0 2.1 5.6 0.5 6.5 2.7 4.3 1.7 0.6 0.0 0.0 0.0 0.0 NEDD1 "GCP-WD, TUBGCP7" ENSG00000139350 "Neural precursor cell expressed, developmentally down-regulated 1" Q8NHV4 12 96907223-96953777 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 165.2;Late spermatids: 65.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038591 Approved Approved "Nucleoplasm,Plasma membrane,Centrosome" NA NA "Nucleoplasm, Centrosome" "Plasma membrane" "HPA038591: AB_10674688" "unprognostic (7.93e-2)" "unprognostic (3.18e-1)" "unprognostic (7.00e-2)" "unprognostic (1.19e-2)" "unprognostic (2.21e-1)" "unprognostic (5.92e-2)" "prognostic unfavorable (1.94e-4)" "prognostic unfavorable (3.70e-4)" "unprognostic (1.81e-2)" "unprognostic (9.29e-2)" "unprognostic (1.83e-2)" "unprognostic (1.56e-1)" "unprognostic (2.46e-3)" "unprognostic (7.29e-2)" "unprognostic (2.28e-1)" "unprognostic (1.34e-1)" "unprognostic (5.59e-2)" 10.7 6.2 5.7 10.0 6.6 9.8 9.8 2.5 7.1 10.8 9.3 7.1 1.7 4.9 13.5 8.3 11.6 10.0 5.5 8.3 6.0 4.4 12.6 5.4 9.4 10.3 7.0 3.7 13.3 7.7 14.9 13.5 7.9 6.5 11.9 7.2 6.3 8.5 6.3 25.5 7.8 10.3 15.4 8.4 14.5 7.2 17.8 8.3 30.6 11.9 24.3 10.7 15.1 9.6 9.4 5.9 19.9 11.1 15.6 14.0 7.3 13.7 9.1 15.8 9.6 7.8 7.1 11.2 47.8 17.0 22.1 19.1 6.0 5.1 8.5 4.6 38.2 10.3 12.4 10.6 11.0 29.8 16.3 9.1 10.6 6.0 5.3 6.5 14.4 9.6 5.2 9.1 13.4 10.4 14.6 10.8 14.7 6.1 6.3 15.8 5.6 26.2 6.6 8.7 7.2 29.2 13.9 16.0 8.4 9.0 9.0 4.9 8.7 13.4 7.6 8.3 12.9 10.2 5.1 7.7 13.9 10.7 9.9 11.2 6.2 7.5 11.4 4.3 7.3 16.8 10.0 6.9 19.9 12.1 11.1 13.7 9.4 13.4 12.9 5.9 8.1 14.0 10.9 5.4 15.6 7.8 4.6 14.0 7.3 5.7 6.6 2.5 7.1 6.0 4.4 7.0 3.7 6.5 8.3 8.9 8.6 11.3 24.7 17.2 8.1 8.9 7.6 25.4 15.9 15.7 0.0 7.5 8.3 8.1 165.2 9.1 5.3 0.0 7.0 11.4 8.4 20.9 16.1 4.9 7.5 17.5 5.8 12.3 4.3 65.3 11.5 9.3 6.8 3.6 7.0 12.9 6.8 7.0 9.6 10.5 8.4 19.4 8.2 26.7 24.6 12.3 3.3 18.1 6.6 16.3 NEDD8 Nedd-8 ENSG00000129559 "Neural precursor cell expressed, developmentally down-regulated 8" Q15843 14 24216852-24232454 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004082, HPA027583, HPA060254" Uncertain Enhanced Nucleoplasm,Cytosol NA NA 5700000 Nucleoplasm Cytosol "CAB004082: AB_10695300, HPA027583: AB_2732439, HPA060254: AB_2732644" "unprognostic (1.26e-2)" "unprognostic (2.55e-1)" "unprognostic (1.14e-1)" "unprognostic (1.08e-1)" "unprognostic (1.69e-1)" "unprognostic (3.34e-3)" "unprognostic (1.83e-3)" "unprognostic (9.19e-2)" "unprognostic (4.66e-1)" "unprognostic (1.35e-2)" "unprognostic (2.66e-2)" "unprognostic (1.41e-1)" "unprognostic (1.78e-3)" "unprognostic (2.76e-2)" "unprognostic (1.31e-1)" "unprognostic (2.79e-2)" "unprognostic (5.25e-3)" 38.2 48.1 55.5 30.7 58.1 34.6 42.2 34.1 62.4 41.0 36.3 26.8 32.6 25.0 32.2 59.9 40.3 34.3 31.3 50.7 47.1 49.5 46.5 48.4 30.5 31.5 49.4 54.6 34.3 33.4 101.1 31.3 39.7 45.5 31.6 40.0 27.4 37.2 40.7 70.7 36.5 28.4 43.0 36.0 34.9 29.9 25.7 34.3 26.9 37.5 44.7 46.8 30.7 32.0 60.2 76.1 90.2 60.1 43.2 64.1 89.9 26.0 45.7 37.1 26.2 42.2 36.9 27.0 35.6 37.8 42.0 38.8 31.5 31.9 22.5 20.9 50.1 35.4 27.5 37.0 55.6 59.1 31.7 22.4 24.0 42.1 107.3 36.6 39.7 25.2 39.2 37.0 35.3 27.8 39.6 50.1 26.4 21.4 26.4 64.7 57.9 31.6 37.7 27.4 48.1 53.5 22.5 29.4 22.9 48.4 49.6 15.7 36.6 30.8 31.4 25.6 39.6 19.0 31.6 37.5 23.9 24.0 30.5 31.5 31.4 47.3 32.6 17.2 22.9 22.6 73.5 57.9 90.2 46.8 60.1 50.7 60.2 54.4 51.9 56.9 51.1 51.2 52.0 62.2 43.2 59.0 76.1 64.1 89.9 55.5 58.1 34.1 62.4 47.1 49.5 49.4 54.6 45.5 34.3 134.0 147.7 239.7 188.0 246.8 91.4 436.0 229.3 136.5 126.3 294.8 45.2 457.7 504.0 309.5 46.7 283.5 261.3 163.5 353.5 526.2 324.5 205.0 213.6 344.7 501.8 100.1 204.1 216.7 303.8 60.6 252.0 280.5 254.8 432.0 208.2 154.8 360.0 256.1 259.2 606.3 68.0 207.0 308.8 113.9 219.0 337.9 350.8 243.7 228.6 222.9 NEDD8-MDP1 ENSG00000255526 "NEDD8-MDP1 readthrough" 14 24213955-24232352 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 24 "Alveolar cells type 2: 1.9;Ciliated cells: 4.0;granulocytes: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MOLT-4: 7.8;U-266/70: 5.0" "Low region specificity" "Detected in all" "HPA003064, HPA060254" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA003064: AB_10602350, HPA060254: AB_2732644" "unprognostic (2.72e-3)" "unprognostic (1.82e-1)" "unprognostic (3.64e-1)" "unprognostic (6.44e-2)" "unprognostic (2.64e-1)" "unprognostic (1.13e-1)" "unprognostic (6.04e-3)" "unprognostic (1.04e-1)" "unprognostic (1.92e-2)" "unprognostic (1.32e-3)" "unprognostic (2.33e-1)" "unprognostic (1.99e-2)" "unprognostic (1.64e-1)" "unprognostic (4.43e-2)" "unprognostic (2.60e-2)" "unprognostic (1.92e-1)" "unprognostic (1.83e-2)" 4.8 6.0 6.6 5.6 9.0 5.0 4.5 5.7 8.5 4.0 8.8 3.2 4.3 3.0 4.1 5.0 5.2 4.7 4.1 7.6 5.3 5.2 6.2 6.1 4.6 4.7 4.9 8.3 4.1 4.5 11.2 5.9 5.6 6.6 4.8 5.2 3.3 5.1 4.5 20.1 6.7 8.6 4.4 4.2 4.2 5.5 16.4 4.6 3.3 5.2 6.5 3.8 4.0 4.1 0.7 1.9 1.0 0.9 0.4 2.3 1.0 3.3 0.0 0.8 0.5 0.8 0.0 0.0 4.1 0.1 0.2 0.2 0.4 1.0 0.2 1.7 1.2 0.3 1.4 0.6 1.0 0.5 2.2 0.4 1.1 0.0 0.0 0.0 1.5 0.0 0.6 1.5 0.0 0.4 0.6 0.0 1.5 0.3 0.0 0.2 3.0 7.8 0.6 0.4 1.9 0.0 0.5 0.0 2.1 0.2 0.0 1.0 0.5 0.0 1.3 1.4 0.3 0.6 1.1 0.0 0.0 3.6 0.0 1.3 5.0 3.7 3.4 0.5 0.0 0.6 0.8 0.3 1.0 0.6 0.8 0.2 0.7 2.3 0.0 0.2 0.5 1.8 0.5 0.4 0.4 0.9 1.9 1.4 1.0 6.6 9.0 5.7 8.5 5.3 5.2 4.9 8.3 6.6 4.6 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NEDD9 "CAS-L, CASS2, HEF1" ENSG00000111859 "Neural precursor cell expressed, developmentally down-regulated 9" Q14511 6 11183298-11382348 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Cell cycle, Cell division, Growth regulation, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 72.8" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 437.7;Basal glandular cells: 247.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 49.8;HSkMC: 24.9" "Low region specificity" "Detected in all" "HPA009689, CAB009720, HPA038768, HPA039270, HPA072955" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB009720: , HPA009689: , HPA038768: AB_2676196, HPA039270: AB_2676422, HPA072955: " "unprognostic (2.83e-3)" "unprognostic (2.33e-2)" "unprognostic (1.08e-2)" "unprognostic (6.93e-2)" "unprognostic (2.12e-1)" "unprognostic (1.16e-1)" "unprognostic (1.62e-1)" "unprognostic (9.54e-2)" "unprognostic (3.05e-2)" "unprognostic (2.09e-1)" "unprognostic (2.90e-1)" "unprognostic (1.64e-1)" "unprognostic (5.59e-3)" "unprognostic (2.25e-2)" "unprognostic (2.37e-1)" "unprognostic (2.41e-1)" "unprognostic (1.05e-1)" 72.8 4.7 4.5 14.9 5.6 3.3 35.7 2.2 5.9 14.0 16.6 5.1 14.2 7.1 17.3 21.7 10.3 11.5 15.3 17.3 4.6 4.1 34.6 9.5 58.4 15.0 4.9 3.9 11.1 7.9 4.2 6.1 32.6 6.6 13.4 14.7 12.8 15.4 15.4 22.4 12.3 17.9 12.4 5.3 25.7 10.9 12.2 4.3 18.8 15.8 6.8 18.6 17.6 9.9 5.8 6.0 34.8 19.8 5.1 8.3 6.3 1.5 10.2 9.5 0.1 6.5 0.8 10.0 2.3 2.9 4.4 8.1 3.2 0.6 3.2 49.8 5.1 0.5 4.4 12.7 4.7 5.7 1.4 0.3 0.3 1.5 21.4 3.0 3.4 0.2 24.9 1.4 2.8 0.5 1.6 7.4 0.2 0.0 2.7 9.8 0.4 1.9 1.3 1.4 11.9 1.0 0.5 0.2 1.8 2.2 13.9 0.2 1.7 0.4 11.2 19.3 11.0 0.8 2.6 18.8 3.0 5.3 0.3 5.7 2.8 11.5 3.9 0.0 2.7 12.9 9.1 5.5 15.4 8.3 12.2 6.8 5.0 5.6 8.0 6.0 5.8 3.0 4.7 34.8 5.1 19.8 3.7 5.0 6.3 4.5 5.6 2.2 5.9 4.6 4.1 4.9 3.9 6.6 4.3 437.7 110.8 20.8 247.6 53.8 4.8 7.3 53.5 97.7 139.9 41.8 23.6 41.8 8.3 54.6 6.0 101.8 77.5 0.0 17.3 34.2 31.7 54.5 61.4 16.3 13.3 9.5 103.9 91.4 24.8 2.9 6.9 22.9 23.6 1.8 90.0 104.5 46.5 35.1 27.3 20.3 12.2 25.8 25.0 1.1 0.5 18.1 35.8 41.5 37.6 69.7 NEFL "CMT1F, CMT2E, NF68, NFL, PPP1R110" ENSG00000277586 "Neurofilament light" P07196 8 24950955-24957110 "Disease related genes, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 95.1" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 32.2;Distal tubular cells: 87.9;Horizontal cells: 28.6;Intestinal endocrine cells: 32.1;Muller glia cells: 29.9;Rod photoreceptor cells: 73.4" "Cancer enhanced" "Detected in many" "renal cancer: 24.0" "Cell type enriched" "Detected in some" 5 "memory CD4 T-cell: 13.7" "Lineage enriched" "Detected in single" 138 "T-cells: 13.7" "Group enriched" "Detected in some" 5 "HEK 293: 114.9;PC-3: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014850, HPA015021" Enhanced Supported Approved "Nucleoplasm,Intermediate filaments,Midbody" NA NA "Nucleoplasm, Intermediate filaments" Midbody "HPA014850: AB_1854397, HPA015021: AB_2669135" "unprognostic (7.63e-2)" "unprognostic (1.36e-2)" "unprognostic (9.53e-2)" "unprognostic (6.81e-2)" "unprognostic (2.82e-2)" "unprognostic (6.69e-2)" "unprognostic (3.69e-2)" "unprognostic (3.78e-3)" "unprognostic (3.06e-1)" "unprognostic (1.60e-1)" "unprognostic (1.46e-2)" "unprognostic (1.94e-1)" "prognostic unfavorable (4.91e-4)" "unprognostic (5.76e-3)" "unprognostic (7.88e-2)" "unprognostic (3.97e-3)" "unprognostic (3.17e-3)" 0.7 12.0 10.3 1.4 20.1 0.6 0.6 2.3 92.1 1.8 1.8 3.0 0.0 1.0 0.7 0.8 3.8 0.7 0.6 0.6 14.1 3.5 0.6 0.6 0.7 0.0 23.8 0.7 0.7 0.6 0.0 0.6 95.1 1.6 1.5 5.0 0.6 9.5 0.6 0.7 1.7 1.2 18.0 0.7 1.1 1.6 2.1 0.0 1.0 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 13.7 2.1 0.0 0.1 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.1 0.0 0.0 114.9 0.0 0.0 0.0 5.1 0.0 0.1 1.9 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.9 0.0 30.8 0.0 0.0 0.0 7.1 1.0 6.4 6.5 2.6 0.0 0.4 0.5 0.0 0.0 0.0 0.6 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.7 1.5 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 0.0 32.2 0.4 0.0 0.0 0.0 0.0 7.9 0.0 87.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.6 32.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.0 0.0 8.9 0.0 73.4 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 NEIL1 "FLJ22402, FPG1, hFPG1, NEI1" ENSG00000140398 "Nei like DNA glycosylase 1" Q96FI4 15 75346955-75357114 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 4.7;memory B-cell: 4.0;naive B-cell: 6.5;NK-cell: 14.1" "Group enriched" "Detected in many" 12 "B-cells: 6.5;NK-cells: 14.1;T-cells: 4.7" "Cell line enhanced" "Detected in many" "Daudi: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054084 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA054084: AB_2682372" "unprognostic (9.84e-3)" "unprognostic (1.19e-1)" "unprognostic (1.15e-2)" "unprognostic (4.62e-3)" "unprognostic (3.21e-2)" "unprognostic (1.81e-2)" "unprognostic (2.24e-2)" "unprognostic (1.17e-3)" "unprognostic (1.67e-1)" "unprognostic (1.33e-1)" "prognostic favorable (2.09e-4)" "unprognostic (3.50e-3)" "unprognostic (8.60e-2)" "unprognostic (9.24e-2)" "unprognostic (2.05e-1)" "unprognostic (3.03e-1)" "unprognostic (2.27e-3)" 7.1 14.8 12.9 28.2 14.5 6.8 9.3 24.4 15.4 10.8 8.3 4.9 23.2 10.1 8.4 11.6 6.4 10.0 10.2 5.3 12.8 5.7 7.9 9.1 9.3 9.8 6.0 9.8 11.0 10.8 9.1 9.0 4.6 8.0 10.4 2.4 7.1 25.0 24.2 13.6 11.7 9.5 4.3 5.9 6.8 9.9 3.8 7.0 15.4 8.2 5.2 13.3 7.5 8.5 6.5 0.2 0.7 0.5 14.1 4.7 1.0 2.2 3.7 2.4 1.5 0.7 0.8 4.6 1.3 0.0 0.5 0.1 0.6 4.0 11.6 2.2 0.2 1.1 6.4 1.4 0.4 0.0 5.6 9.5 1.9 10.0 1.8 1.0 2.2 2.7 0.3 1.8 0.6 0.0 6.0 1.5 1.1 1.2 3.4 0.4 2.9 0.4 6.3 2.1 0.4 0.9 2.2 1.5 0.5 2.2 2.4 1.4 2.8 2.3 1.0 3.2 1.3 4.3 3.3 6.3 1.3 2.5 1.9 1.1 5.4 5.2 9.4 1.2 9.4 1.2 0.0 0.5 0.0 4.7 0.1 1.3 4.0 0.8 1.0 0.2 6.5 1.4 1.4 0.7 14.1 0.1 0.2 0.2 1.0 12.9 14.5 24.4 15.4 12.8 5.7 6.0 9.8 8.0 7.0 20.8 19.2 9.3 14.9 5.7 20.2 2.5 2.5 38.8 23.9 14.0 9.8 8.7 1.7 7.2 21.8 13.4 15.5 0.0 7.4 3.1 7.8 12.0 10.5 10.5 2.8 9.5 20.7 24.5 6.9 1.1 17.5 5.8 8.5 0.0 18.2 21.4 6.1 14.7 12.7 5.8 5.9 6.5 4.1 1.4 0.7 5.1 4.0 13.1 11.3 5.8 NEIL2 "FLJ31644, MGC2832, MGC4505, NEH2" ENSG00000154328 "Nei like DNA glycosylase 2" Q969S2 8 11769639-11787346 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA073029, HPA073916" Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA073029: AB_2732216, HPA073916: AB_2732245" "unprognostic (1.52e-2)" "unprognostic (1.08e-2)" "unprognostic (1.03e-1)" "unprognostic (9.88e-2)" "unprognostic (2.18e-2)" "unprognostic (5.72e-2)" "unprognostic (2.70e-1)" "unprognostic (2.88e-2)" "unprognostic (5.46e-2)" "unprognostic (6.85e-2)" "unprognostic (1.99e-3)" "unprognostic (1.29e-1)" "unprognostic (1.12e-2)" "unprognostic (5.29e-2)" "unprognostic (1.91e-1)" "unprognostic (2.09e-1)" "unprognostic (4.05e-1)" 10.2 21.8 18.7 6.8 17.7 2.7 10.3 11.8 20.9 11.3 5.6 9.0 7.0 3.6 9.9 15.4 6.5 17.9 6.9 14.2 15.4 20.0 9.3 11.0 7.7 8.4 18.4 16.1 12.6 10.9 7.8 13.2 7.6 20.3 10.5 6.1 9.7 11.5 10.3 24.7 18.1 4.6 10.2 12.3 9.5 5.1 26.8 13.3 1.8 15.5 7.1 7.9 7.4 15.8 14.7 5.5 0.8 2.5 9.1 13.6 4.7 4.9 14.0 8.8 17.2 4.2 7.9 3.9 7.9 6.6 7.7 5.3 4.3 5.5 1.9 3.1 9.5 16.6 4.4 8.4 8.7 10.6 5.8 4.2 6.8 3.3 8.4 3.4 2.9 5.1 6.9 12.9 6.7 6.2 7.5 7.2 2.3 9.6 6.7 9.1 5.2 0.5 3.1 7.9 20.5 7.5 8.7 11.3 5.3 9.0 7.5 13.6 10.7 6.2 3.3 11.3 7.4 5.2 0.5 8.8 8.8 12.7 2.3 11.1 6.3 13.1 3.5 23.2 10.2 17.8 0.4 1.5 0.1 9.1 2.5 12.1 14.7 9.3 10.8 3.0 11.4 13.6 12.0 0.8 9.1 1.1 5.5 5.8 4.7 18.7 17.7 11.8 19.8 15.4 20.0 18.4 16.1 20.3 13.3 0.0 4.3 12.6 14.3 7.6 25.6 17.8 17.8 5.3 6.8 7.0 15.7 15.6 28.2 17.4 0.8 9.3 0.9 0.0 20.5 13.6 10.8 15.1 2.3 21.2 12.1 7.9 9.7 7.4 4.7 2.1 13.0 6.6 13.5 10.0 4.5 27.9 14.2 0.0 23.0 24.7 13.2 6.5 13.2 14.2 45.1 11.2 4.5 7.2 5.0 9.1 NEIL3 "FLJ10858, FPG2, hFPG2, hNEI3, ZGRF3" ENSG00000109674 "Nei like DNA glycosylase 3" Q8TAT5 4 177309836-177362943 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "lymphoid tissue: 70.8" "Cell type enhanced" "Detected in some" 8 "Club cells: 2.3;Extravillous trophoblasts: 2.9;Kupffer cells: 2.2;Spermatocytes: 1.9;Spermatogonia: 3.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 26.6;HL-60: 29.0;Karpas-707: 38.1;MOLT-4: 29.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA065761 Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA065761: AB_2685555" "unprognostic (6.03e-2)" "unprognostic (5.79e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (5.45e-4)" "unprognostic (4.91e-2)" "unprognostic (2.05e-1)" "unprognostic (3.64e-7)" "prognostic unfavorable (1.16e-4)" "unprognostic (6.09e-3)" "unprognostic (7.67e-2)" "unprognostic (6.51e-4)" "unprognostic (2.82e-3)" "unprognostic (0.00e+0)" "unprognostic (3.25e-2)" "unprognostic (8.13e-2)" "unprognostic (2.03e-1)" "unprognostic (1.04e-2)" 0.5 0.4 0.2 7.4 0.2 9.3 0.7 0.1 0.2 0.8 1.5 0.1 0.1 1.5 0.5 0.1 5.6 0.2 0.3 0.5 0.2 0.2 0.4 0.4 0.9 5.1 0.2 0.1 0.3 0.2 0.0 0.2 1.6 0.2 0.2 2.1 0.2 0.8 0.1 0.2 3.4 1.7 0.5 0.7 1.5 0.8 3.5 0.3 70.8 0.2 1.1 5.0 0.7 1.3 0.2 0.3 0.8 0.0 1.6 1.6 0.2 7.1 5.9 6.3 3.1 0.7 1.3 3.1 8.8 3.3 9.8 5.8 2.1 6.3 7.9 1.3 2.3 9.7 3.3 6.6 3.5 14.3 26.6 4.3 5.4 4.7 5.6 0.2 29.0 3.7 0.1 0.2 10.1 2.2 2.0 3.7 20.5 5.6 38.1 6.3 3.1 29.3 11.1 2.9 2.1 4.4 6.0 4.3 2.5 2.5 0.9 5.0 3.4 4.4 5.1 2.4 2.9 4.2 7.6 1.7 5.9 4.6 3.0 8.9 2.6 1.7 12.5 3.9 10.3 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.0 0.2 0.0 1.1 0.8 1.6 0.0 0.3 1.6 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 2.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.9 0.4 0.0 0.0 0.0 1.3 0.0 0.0 0.6 2.2 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.9 3.0 1.1 0.2 0.5 0.4 0.1 NEK1 "KIAA1901, NY-REN-55" ENSG00000137601 "NIMA related kinase 1" Q96PY6 4 169392857-169612629 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Amyotrophic lateral sclerosis, Ciliopathy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 85.6;Early spermatids: 83.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020873, HPA040413" Approved Supported "Nucleoplasm,Centriolar satellite,Cytosol" NA NA Cytosol "Nucleoplasm, Centriolar satellite" "HPA020873: AB_10671583, HPA040413: AB_10671169" "unprognostic (4.10e-2)" "unprognostic (2.97e-1)" "unprognostic (1.59e-2)" "unprognostic (1.97e-1)" "unprognostic (6.98e-2)" "unprognostic (3.10e-1)" "unprognostic (3.95e-1)" "unprognostic (3.29e-1)" "unprognostic (1.13e-1)" "unprognostic (2.78e-1)" "unprognostic (4.06e-3)" "unprognostic (2.21e-1)" "prognostic favorable (1.42e-4)" "unprognostic (1.07e-1)" "unprognostic (1.03e-1)" "unprognostic (2.10e-2)" "unprognostic (3.46e-1)" 9.6 10.5 13.5 9.2 15.8 6.0 8.7 20.7 14.5 13.6 8.4 12.5 7.1 5.4 12.4 9.1 7.9 15.7 10.2 11.4 13.7 13.2 10.2 6.9 7.7 8.0 15.9 11.3 16.3 6.6 15.3 16.5 7.2 16.0 11.6 7.7 8.9 6.4 10.6 7.1 4.7 5.7 11.1 18.2 8.0 8.1 18.3 14.8 14.7 13.3 6.4 7.4 10.0 8.2 4.5 3.3 6.7 3.3 2.2 5.3 1.3 4.2 1.8 7.8 8.4 12.1 13.5 2.5 8.9 8.0 7.2 6.8 2.4 5.0 11.3 1.7 7.8 6.9 1.4 7.3 7.6 8.2 12.4 5.0 7.6 7.7 2.9 7.1 7.6 6.1 10.8 4.3 7.3 12.8 14.7 7.0 10.9 13.4 21.5 9.2 2.7 9.8 3.4 2.5 2.7 4.5 6.1 5.1 3.6 7.6 5.0 8.5 9.7 6.5 3.2 6.0 6.2 4.0 3.4 8.4 4.6 4.2 4.7 6.0 8.7 13.3 8.6 7.6 3.8 8.0 6.7 2.1 1.8 4.4 3.3 4.8 4.4 3.4 2.7 1.5 4.5 5.1 5.3 1.1 2.2 1.6 3.3 3.2 1.3 13.5 15.8 20.7 12.9 13.7 13.2 15.9 11.3 16.0 14.8 11.9 13.1 13.3 12.5 8.5 20.5 31.9 0.0 85.6 22.7 17.4 27.5 17.5 14.9 8.5 83.6 9.0 5.4 23.3 5.5 6.7 16.2 7.0 17.4 6.6 9.1 17.5 6.9 8.6 6.9 39.7 21.9 8.9 5.0 2.8 5.0 23.4 6.9 4.2 29.7 8.1 24.4 12.9 18.6 59.1 27.4 5.5 24.7 8.6 6.8 9.5 NEK10 FLJ32685 ENSG00000163491 "NIMA related kinase 10" Q6ZWH5 3 27110085-27369460 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 31.4" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 97.7;Cone photoreceptor cells: 82.5;Early spermatids: 98.7;Late spermatids: 45.8" "Cancer enriched" "Detected in single" 5 "breast cancer: 1.8" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ: 7.7;LHCN-M2: 10.6;U-2 OS: 9.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038941 Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA038941: AB_10673600" "prognostic favorable (4.20e-4)" "unprognostic (2.17e-1)" "unprognostic (8.78e-2)" "unprognostic (2.15e-2)" "unprognostic (3.37e-2)" "unprognostic (3.02e-1)" "unprognostic (1.12e-1)" "unprognostic (1.83e-1)" "unprognostic (1.26e-1)" "unprognostic (1.93e-2)" "unprognostic (2.20e-3)" "unprognostic (1.37e-1)" "unprognostic (7.67e-2)" "unprognostic (1.33e-2)" "unprognostic (1.38e-2)" "unprognostic (1.57e-3)" "unprognostic (2.14e-1)" 0.4 0.5 4.5 0.5 14.6 0.4 14.2 0.6 6.8 1.6 2.0 1.1 2.0 2.5 0.9 8.3 2.0 10.5 2.1 3.1 8.4 3.8 1.4 2.5 4.5 0.6 0.8 6.7 2.7 0.8 0.5 9.0 0.3 3.4 1.9 0.7 1.3 0.5 1.4 10.5 0.4 1.0 1.2 0.8 0.6 1.1 31.4 1.3 0.3 0.8 0.3 0.7 1.4 0.4 0.4 0.2 1.9 0.1 0.1 0.6 0.1 1.0 2.1 1.1 1.2 0.9 2.1 0.4 7.7 1.2 2.1 1.9 0.0 0.5 0.7 1.9 3.2 1.5 0.1 0.5 0.5 2.3 1.4 0.8 0.2 4.1 3.7 0.2 0.4 1.0 2.5 0.5 3.3 0.1 2.7 1.5 4.4 0.1 0.7 10.6 0.1 0.8 0.5 0.7 0.2 0.3 1.0 0.4 0.3 4.1 0.6 0.2 0.2 1.2 0.5 0.6 0.8 6.2 0.4 0.9 5.7 9.0 0.3 0.8 0.3 0.2 0.5 4.8 0.9 2.1 0.1 0.1 0.2 0.6 0.1 0.1 0.1 0.5 0.4 0.0 0.4 0.1 0.5 1.9 0.1 0.0 0.2 0.0 0.1 4.5 14.6 0.6 6.8 8.4 3.8 0.8 6.7 3.4 1.3 6.0 0.0 0.0 0.2 0.2 4.0 10.2 2.5 97.7 13.6 1.8 82.5 0.0 0.0 0.3 98.7 0.7 0.7 0.0 0.0 0.2 2.9 1.5 0.0 0.5 0.2 0.0 0.0 0.6 1.3 45.8 1.7 0.4 0.0 0.0 0.1 1.4 0.2 0.6 1.1 0.0 19.6 0.0 1.1 25.4 1.7 0.4 0.0 0.0 0.1 0.1 NEK11 FLJ23495 ENSG00000114670 "NIMA related kinase 11" Q8NG66 3 131026850-131350465 "Enzymes, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 26.9" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 148.5;Early spermatids: 122.2;Late spermatids: 80.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016908 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA016908: AB_1854364" "unprognostic (9.15e-3)" "prognostic favorable (7.10e-4)" "unprognostic (1.05e-1)" "unprognostic (1.08e-1)" "unprognostic (9.96e-2)" "unprognostic (4.85e-3)" "unprognostic (2.48e-5)" "unprognostic (5.38e-2)" "unprognostic (1.86e-1)" "unprognostic (1.18e-1)" "unprognostic (2.27e-1)" "unprognostic (1.79e-1)" "prognostic favorable (5.92e-6)" "unprognostic (2.46e-2)" "unprognostic (1.60e-1)" "unprognostic (2.72e-2)" "unprognostic (1.58e-1)" 3.9 5.8 9.3 2.7 11.1 0.5 8.7 2.7 7.6 7.3 2.8 11.2 8.4 2.0 6.5 16.0 3.2 26.9 6.0 2.9 9.1 10.0 8.2 1.1 5.5 1.7 7.8 5.4 8.7 2.8 5.0 9.3 4.6 17.3 4.0 3.3 3.0 3.8 6.7 1.7 2.8 2.6 4.3 7.3 1.8 2.3 17.8 5.5 0.2 12.3 2.5 1.7 4.2 3.0 0.9 1.0 1.1 1.3 0.3 2.9 0.3 5.9 2.4 1.8 5.2 7.0 10.5 1.0 2.9 5.5 4.5 3.4 2.2 8.3 0.3 2.1 5.2 4.3 3.3 0.5 5.1 6.3 0.6 0.7 0.8 0.4 1.0 2.3 0.6 1.5 4.4 8.5 4.8 2.2 4.8 0.9 2.6 0.2 0.9 7.5 4.2 0.1 0.5 0.5 0.9 2.3 0.0 0.2 0.1 10.3 2.3 2.2 2.5 1.4 0.1 2.0 0.8 4.9 0.1 0.9 4.7 2.3 3.6 1.4 1.4 2.3 0.1 3.2 0.2 0.8 0.0 0.3 1.1 0.6 1.3 1.2 0.9 2.9 2.6 0.5 0.6 1.0 0.8 0.9 0.3 0.9 1.0 1.5 0.3 9.3 11.1 2.7 7.6 9.1 10.0 7.8 5.4 17.3 5.5 14.9 2.7 0.0 3.4 3.8 2.7 1.1 2.5 148.5 29.6 1.8 5.9 0.5 5.0 4.7 122.2 2.4 1.7 0.0 2.2 1.0 5.4 1.4 0.0 0.0 1.8 0.0 2.4 2.5 0.0 80.8 6.4 1.4 0.0 1.0 2.7 5.7 2.9 3.7 5.6 8.4 6.9 6.5 2.2 30.5 4.9 1.8 1.4 0.0 1.7 1.8 NEK2 "NEK2A, NLK1, PPP1R111, RP67" ENSG00000117650 "NIMA related kinase 2" P51955 1 211658657-211675630 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 14.0;testis: 41.0" "Cell type enhanced" "Detected in many" 22 "Early spermatids: 44.4;Erythroid cells: 93.5;Spermatocytes: 191.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebellum: 3.2" "Not detected" "Not detected" "CAB017530, HPA064967" Enhanced Supported Nucleoplasm,Centrosome NA Yes "Nucleoplasm, Centrosome" "CAB017530: AB_1126558, HPA064967: AB_2685393" "unprognostic (1.28e-1)" "unprognostic (2.33e-1)" "unprognostic (1.02e-1)" "unprognostic (8.51e-2)" "unprognostic (1.83e-1)" "unprognostic (1.35e-2)" "prognostic unfavorable (9.47e-6)" "prognostic unfavorable (9.11e-4)" "unprognostic (1.95e-2)" "unprognostic (2.00e-2)" "unprognostic (1.09e-3)" "unprognostic (8.49e-2)" "unprognostic (0.00e+0)" "unprognostic (8.21e-2)" "unprognostic (4.11e-2)" "unprognostic (1.25e-2)" "unprognostic (2.71e-1)" 1.1 0.7 0.6 6.7 0.5 7.4 1.3 0.3 0.9 0.9 2.5 0.3 0.3 3.4 0.3 1.2 4.2 0.7 1.4 0.9 1.0 0.3 0.6 0.6 1.0 3.9 0.3 0.3 0.6 0.3 0.0 0.3 1.2 0.4 0.9 3.6 0.4 1.0 0.3 0.3 1.8 3.0 0.6 0.6 1.6 1.1 41.0 0.4 14.0 0.3 1.5 4.8 0.6 1.6 1.8 0.9 2.7 0.5 3.9 4.3 0.9 30.7 22.2 17.0 12.2 1.0 1.7 18.8 11.9 11.2 21.0 18.1 11.8 30.3 16.4 5.7 9.2 13.3 16.5 14.8 8.9 26.5 25.0 12.3 7.8 19.4 15.9 0.1 15.4 10.7 0.5 1.1 16.1 17.4 5.1 13.5 16.7 21.4 28.8 21.0 8.6 16.8 10.4 16.1 19.9 11.4 16.6 26.1 24.9 7.3 8.8 15.4 17.1 17.2 19.2 14.9 15.2 29.6 9.2 7.0 10.5 20.8 20.6 31.9 11.9 22.0 21.7 9.1 11.9 17.4 2.7 0.5 0.4 0.5 0.3 0.2 1.5 0.6 0.3 0.1 1.8 1.1 0.7 2.4 3.9 0.4 0.9 4.3 0.9 0.6 0.5 0.3 0.9 1.0 0.3 0.3 0.3 0.4 0.4 0.0 0.3 0.8 0.5 2.6 0.7 0.4 0.0 2.7 3.4 0.0 0.0 0.9 0.0 0.1 44.4 0.1 1.1 93.5 0.2 11.4 0.2 0.3 0.0 0.0 4.7 3.2 0.0 2.5 2.8 28.5 2.3 1.1 0.0 0.0 1.2 0.8 0.0 0.8 0.7 0.0 1.9 6.5 0.0 191.1 25.4 1.5 1.1 0.7 2.3 0.9 NEK6 SID6-1512 ENSG00000119408 "NIMA related kinase 6" Q9HC98 9 124257606-124353307 "Enzymes, Predicted intracellular proteins, Transporters" "Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 103.8;Hofbauer cells: 99.7;monocytes: 90.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 62.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB045993, HPA056828" Approved Supported "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Nucleoplasm, Cytosol" "Centriolar satellite" "CAB045993: AB_2150651, HPA056828: AB_2683250" "unprognostic (6.27e-2)" "unprognostic (1.02e-2)" "unprognostic (4.15e-2)" "unprognostic (1.65e-2)" "unprognostic (5.22e-2)" "unprognostic (2.47e-2)" "unprognostic (3.13e-3)" "unprognostic (2.13e-2)" "unprognostic (2.38e-1)" "unprognostic (3.30e-2)" "unprognostic (1.38e-3)" "unprognostic (6.53e-2)" "unprognostic (5.03e-3)" "unprognostic (1.97e-1)" "prognostic unfavorable (7.66e-4)" "unprognostic (5.27e-2)" "unprognostic (4.77e-3)" 14.8 5.3 26.1 22.2 29.1 12.8 18.8 7.2 21.2 20.5 15.6 13.4 4.3 12.5 9.2 7.5 6.8 8.5 18.4 7.0 17.1 16.6 12.9 51.9 17.0 18.1 19.4 13.3 11.2 20.5 1.6 6.4 21.4 14.7 14.8 16.6 18.5 16.9 13.2 5.5 5.1 18.2 23.4 13.0 11.3 19.0 5.8 12.9 4.0 6.3 1.9 22.0 17.7 10.1 21.9 11.5 29.0 18.8 8.3 3.8 7.6 7.4 12.3 11.9 4.6 22.5 29.4 14.8 9.4 15.1 14.6 12.2 11.6 14.0 9.1 15.1 18.1 33.4 1.4 6.1 27.3 9.9 10.0 5.4 24.9 10.4 20.4 26.9 4.5 62.6 39.1 4.4 13.8 14.3 38.4 15.9 4.3 4.4 0.4 26.0 7.8 0.2 4.9 3.0 39.4 11.2 9.6 8.9 4.6 15.6 2.7 5.3 1.8 3.0 5.8 13.3 12.6 12.7 18.4 31.0 10.7 10.8 7.3 6.4 2.0 2.5 5.2 13.4 10.2 14.1 10.2 18.8 29.0 3.8 12.3 2.4 21.9 2.3 3.2 11.5 9.0 0.4 1.6 23.4 8.3 14.7 10.6 2.8 7.6 26.1 29.1 7.2 21.2 17.1 16.6 19.4 13.3 14.7 12.9 8.9 6.6 9.8 11.0 2.2 0.7 2.5 17.8 1.4 4.5 3.5 0.0 33.9 1.7 35.3 14.7 5.5 12.9 23.3 20.0 103.8 9.9 17.8 21.9 33.3 99.7 0.0 5.8 4.3 10.7 12.3 4.6 30.4 6.8 90.2 15.5 28.1 24.3 15.2 3.5 29.9 1.8 0.0 5.3 1.2 10.6 1.0 30.2 0.0 18.6 8.9 NEK7 ENSG00000151414 "NIMA related kinase 7" Q8TDX7 1 198156963-198322420 "Enzymes, Predicted intracellular proteins, Transporters" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 150.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 85.5;fHDF/TERT166: 115.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015520, HPA018193" Approved Supported Nucleoplasm Yes No Nucleoplasm "HPA015520: AB_1854371, HPA018193: AB_1854372" "unprognostic (2.08e-1)" "unprognostic (2.98e-2)" "unprognostic (1.65e-1)" "unprognostic (5.38e-2)" "unprognostic (4.26e-2)" "unprognostic (3.00e-2)" "unprognostic (2.14e-2)" "unprognostic (5.47e-2)" "unprognostic (4.77e-2)" "unprognostic (3.21e-1)" "unprognostic (1.46e-3)" "unprognostic (2.82e-1)" "unprognostic (1.13e-2)" "unprognostic (1.26e-2)" "unprognostic (1.74e-1)" "unprognostic (2.05e-2)" "unprognostic (1.56e-1)" 31.7 31.4 24.9 15.2 23.0 5.6 23.7 7.8 15.6 19.3 20.6 25.5 13.7 11.3 24.5 11.4 18.7 12.8 15.1 74.7 23.9 20.4 16.1 16.0 22.3 14.9 26.8 13.4 17.2 11.1 14.6 17.6 40.5 18.0 20.0 13.2 11.8 13.5 21.3 29.9 10.6 15.8 30.9 34.9 16.4 11.7 9.5 22.6 18.0 14.9 12.8 12.5 27.4 20.7 1.6 2.1 6.1 2.2 3.8 14.7 1.4 7.1 1.9 2.3 0.9 6.0 6.9 2.7 85.5 35.8 34.8 16.5 3.5 7.1 2.6 6.2 115.4 2.0 4.4 3.5 4.6 35.2 8.1 5.0 3.5 8.2 1.4 7.2 5.9 7.3 4.3 4.0 22.9 6.9 13.0 6.6 21.6 2.7 6.4 15.9 2.2 5.1 3.5 1.2 5.7 1.4 2.7 5.7 4.5 5.9 3.7 1.4 2.7 14.2 8.2 9.5 3.4 6.0 5.4 14.5 9.8 8.3 28.0 8.9 4.5 4.1 1.7 4.2 5.4 7.5 1.9 2.2 3.0 3.2 1.9 14.7 1.3 3.6 4.6 2.1 1.6 2.9 3.6 6.1 3.8 1.7 1.4 6.0 1.4 24.9 23.0 7.8 15.6 23.9 20.4 26.8 13.4 18.0 22.6 26.8 24.2 12.3 15.3 45.6 9.4 150.0 10.2 25.4 21.6 17.4 13.7 11.6 10.0 8.8 2.1 26.3 19.8 46.7 16.9 13.3 24.9 20.4 8.1 19.2 15.2 3.2 19.0 35.0 42.5 1.7 27.0 23.7 28.7 16.2 19.6 10.0 34.6 17.3 36.0 11.6 25.0 19.4 44.2 7.5 5.7 43.0 53.8 20.1 14.9 22.4 NELFA "NELF-A, WHSC2" ENSG00000185049 "Negative elongation factor complex member A" Q9H3P2 4 1982714-2041903 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009960, HPA039858, HPA043931" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB009960: AB_2288566, HPA039858: AB_2676711, HPA043931: AB_2678737" "unprognostic (1.66e-1)" "unprognostic (2.23e-1)" "unprognostic (3.01e-1)" "unprognostic (1.17e-1)" "unprognostic (3.32e-1)" "unprognostic (1.73e-2)" "prognostic unfavorable (4.35e-4)" "unprognostic (2.40e-1)" "unprognostic (1.12e-1)" "unprognostic (9.38e-2)" "unprognostic (2.74e-2)" "unprognostic (1.88e-3)" "unprognostic (1.58e-1)" "unprognostic (3.76e-2)" "unprognostic (2.77e-1)" "unprognostic (2.43e-1)" "unprognostic (3.05e-2)" 14.8 13.7 18.3 17.2 19.0 20.0 16.5 36.4 23.2 17.0 15.1 22.5 15.7 21.6 19.5 15.1 26.1 21.0 11.4 10.8 16.8 12.2 14.7 10.9 11.4 15.8 14.1 12.0 26.9 27.0 12.5 19.1 16.8 13.6 15.7 8.3 16.2 28.6 28.4 17.4 23.4 21.2 13.3 11.9 18.4 20.6 26.5 18.3 18.0 16.8 10.9 21.6 18.1 19.5 20.5 14.9 12.0 14.0 13.1 18.5 10.3 10.8 10.0 8.7 16.0 3.6 3.8 17.4 5.8 4.1 7.0 5.6 16.6 18.7 19.2 8.4 3.7 8.8 10.3 8.8 7.3 3.4 9.8 13.7 12.6 7.4 15.6 5.3 13.0 12.9 3.2 6.5 4.7 5.0 5.2 5.3 10.9 23.8 9.2 3.0 12.6 25.2 37.5 25.3 9.3 15.2 23.0 7.6 12.0 5.0 9.1 23.9 14.9 6.7 8.0 9.9 5.7 15.4 9.9 6.0 7.1 8.1 8.2 12.8 19.7 20.3 21.3 8.2 13.7 8.8 6.0 12.3 12.0 14.2 14.0 17.1 14.6 16.3 12.6 11.9 20.5 14.2 11.0 4.7 13.1 11.2 14.9 18.5 10.3 18.3 19.0 36.4 23.2 16.8 12.2 14.1 12.0 13.6 18.3 11.9 14.1 15.2 15.5 29.0 18.7 4.6 10.2 16.0 18.2 12.2 37.3 23.7 8.3 17.3 20.5 9.3 14.7 0.0 12.1 24.1 15.8 15.0 9.2 6.7 14.0 35.0 15.5 10.4 10.3 6.0 14.4 10.4 13.5 19.8 16.5 20.3 13.5 17.8 12.4 6.5 19.5 0.0 10.3 28.3 36.5 33.4 23.8 13.8 18.7 23.7 NELFB "COBRA1, KIAA1182, NELF-B" ENSG00000188986 "Negative elongation factor complex member B" Q8WX92 9 137255173-137273546 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020259 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA020259: AB_1847072" "unprognostic (2.56e-2)" "unprognostic (5.14e-2)" "unprognostic (1.26e-1)" "unprognostic (1.14e-2)" "unprognostic (3.27e-1)" "unprognostic (4.06e-1)" "unprognostic (5.58e-3)" "unprognostic (7.74e-3)" "unprognostic (2.04e-1)" "unprognostic (1.46e-1)" "unprognostic (5.03e-3)" "unprognostic (6.46e-2)" "prognostic favorable (4.31e-6)" "unprognostic (6.74e-3)" "unprognostic (1.01e-1)" "unprognostic (2.66e-2)" "unprognostic (4.04e-2)" 21.9 16.5 28.2 20.1 27.8 21.2 17.1 20.2 41.6 19.2 20.6 20.6 17.0 23.7 19.6 10.6 24.7 21.8 17.9 28.8 25.8 21.8 20.1 17.9 19.9 25.8 23.0 27.6 27.3 33.7 14.8 14.6 19.4 24.0 20.6 12.6 19.2 29.6 18.4 29.3 29.0 24.9 26.9 17.3 22.6 22.6 19.1 21.1 17.7 21.5 13.0 23.1 20.7 34.2 6.8 8.3 9.2 6.1 7.1 8.0 3.6 18.4 32.1 16.2 21.1 14.3 10.6 23.4 15.4 11.9 20.1 14.3 33.4 22.3 26.7 23.0 16.1 21.9 35.7 17.0 19.0 6.2 25.6 21.3 17.2 39.5 26.4 14.5 25.2 21.1 12.4 19.5 18.4 10.7 11.5 18.5 17.2 29.3 23.1 11.7 44.9 18.4 32.3 25.1 33.2 31.8 30.3 29.6 43.1 11.1 17.7 24.0 21.4 21.5 23.5 14.4 9.2 31.5 28.7 23.0 28.9 21.2 44.3 24.4 11.7 20.5 22.1 22.7 18.2 25.3 2.3 6.1 9.2 8.0 4.8 5.4 6.4 6.8 6.0 5.2 6.8 6.3 6.6 3.2 7.1 4.4 8.3 7.2 3.6 28.2 27.8 20.2 41.6 25.8 21.8 23.0 27.6 24.0 21.1 6.0 19.9 13.0 10.8 13.3 19.3 11.8 15.3 4.0 15.9 22.7 17.7 19.9 11.6 24.1 3.1 14.1 26.2 0.0 33.2 23.2 13.5 16.6 18.4 17.9 22.7 41.3 27.1 22.7 9.5 4.0 21.6 16.4 6.8 50.5 33.3 24.7 26.8 17.3 19.4 12.4 13.9 38.8 13.7 11.9 24.7 12.2 13.0 13.1 29.0 11.3 NELFCD "HSPC130, NELF-C, NELF-D, TH1, TH1L" ENSG00000101158 "Negative elongation factor complex member C/D" 20 58981208-58995133 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050641, HPA066262, HPA074936" Enhanced Supported "Nucleoplasm,Nuclear bodies,Vesicles,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" "Vesicles, Cytosol" "HPA050641: AB_2681198, HPA066262: AB_2685644, HPA074936: " "unprognostic (1.70e-2)" "unprognostic (1.27e-1)" "unprognostic (2.60e-1)" "prognostic unfavorable (4.98e-5)" "unprognostic (6.20e-2)" "unprognostic (2.42e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (1.47e-1)" "unprognostic (3.58e-1)" "unprognostic (1.02e-1)" "unprognostic (6.07e-3)" "prognostic unfavorable (3.37e-4)" "unprognostic (4.62e-2)" "unprognostic (2.96e-1)" "unprognostic (9.88e-2)" "unprognostic (1.34e-1)" "unprognostic (2.59e-1)" 9.1 11.1 10.2 9.4 13.0 8.8 12.7 18.1 13.7 10.2 10.8 15.2 9.2 8.4 11.2 8.2 14.6 12.5 8.6 9.2 10.9 8.2 16.4 15.9 7.9 11.2 16.7 13.4 15.4 10.3 19.1 18.1 12.1 12.5 10.2 8.9 9.4 14.7 9.1 12.0 11.9 8.8 8.1 11.8 9.2 8.9 26.1 12.4 17.4 14.4 10.0 13.6 9.8 11.3 22.7 29.6 9.4 27.7 19.4 24.6 20.5 12.5 14.5 17.4 18.6 6.0 10.7 11.2 10.2 10.0 31.0 18.0 48.0 18.1 16.5 16.1 10.2 16.1 22.0 23.4 25.8 25.1 5.1 16.6 21.8 18.1 37.5 7.2 15.6 15.0 11.3 8.3 11.3 7.9 8.1 17.8 13.4 29.0 12.7 14.1 49.9 33.7 23.6 10.1 39.1 32.2 18.9 14.5 30.7 13.0 19.5 19.2 28.7 31.9 38.5 21.2 10.4 41.5 18.3 7.1 23.9 22.7 9.2 16.9 10.0 18.6 16.9 14.2 13.9 20.6 7.2 20.4 9.4 20.3 22.8 23.9 22.7 19.3 24.6 29.6 20.0 18.9 19.9 2.2 19.4 27.7 15.0 17.6 20.5 10.2 13.0 18.1 13.7 10.9 8.2 16.7 13.4 12.5 12.4 8.9 25.1 37.2 47.8 26.9 66.4 9.8 22.9 12.0 13.6 21.0 39.3 113.3 43.1 46.4 10.6 25.5 19.3 23.3 27.3 56.4 21.7 32.6 16.1 21.3 33.3 52.4 22.4 17.8 14.5 18.1 34.2 21.7 25.3 58.7 19.2 42.7 32.2 14.0 24.8 35.6 57.2 38.8 32.5 57.5 97.9 27.5 86.2 40.8 33.2 48.7 NELFE "D6S45, NELF-E, RD, RDBP, RDP" ENSG00000204356 "Negative elongation factor complex member E" P18615 6 31952087-31959110 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 512.1;Late spermatids: 1326.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007187, HPA007594, HPA046502" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA007187: AB_1856161, HPA007594: AB_2667867, HPA046502: AB_2679677" "unprognostic (1.09e-1)" "unprognostic (3.28e-1)" "unprognostic (1.45e-1)" "unprognostic (6.33e-3)" "unprognostic (4.43e-2)" "unprognostic (4.25e-2)" "unprognostic (7.71e-3)" "unprognostic (1.34e-1)" "unprognostic (1.95e-1)" "unprognostic (1.46e-2)" "unprognostic (1.97e-1)" "unprognostic (7.78e-2)" "prognostic unfavorable (2.70e-4)" "unprognostic (5.21e-2)" "unprognostic (1.07e-1)" "unprognostic (2.21e-1)" "unprognostic (3.68e-2)" 19.4 21.1 18.5 17.6 20.4 18.4 26.8 10.2 18.2 22.8 20.4 19.0 23.5 15.8 20.7 30.2 21.7 30.4 20.4 22.6 18.5 17.0 19.2 13.5 17.0 20.9 18.5 18.7 21.2 46.1 12.4 18.0 23.7 27.5 14.4 17.9 12.7 24.9 22.4 40.4 19.6 18.1 19.5 28.0 16.3 18.1 58.1 18.2 28.3 20.8 16.9 14.7 15.3 18.8 23.6 25.2 28.8 33.4 20.7 22.5 23.4 17.3 12.4 17.4 13.5 6.2 10.2 13.9 12.9 14.0 11.8 6.5 18.7 9.9 13.4 14.5 13.5 29.3 12.7 6.1 6.4 6.9 11.3 13.6 8.0 13.4 23.5 10.2 15.6 9.1 9.1 17.3 10.4 19.5 21.9 10.9 12.1 12.9 16.0 13.4 28.8 22.9 10.2 6.7 21.3 4.3 20.4 13.8 21.0 14.8 16.2 11.1 18.3 10.1 11.2 24.3 12.6 16.8 29.8 10.0 10.8 22.0 11.4 24.0 26.2 27.1 14.9 7.0 9.9 21.0 20.0 25.4 28.8 21.6 30.5 21.8 23.6 22.2 22.5 25.2 23.6 20.1 20.4 14.5 20.7 33.4 18.5 20.5 23.4 18.5 20.4 10.2 18.2 18.5 17.0 18.5 18.7 27.5 18.2 14.9 27.5 38.2 55.6 41.9 14.9 41.2 76.5 119.1 33.0 31.4 11.8 84.5 112.7 75.5 512.1 48.4 82.2 0.0 118.3 93.8 44.0 50.5 43.9 30.6 74.9 11.1 32.8 41.1 50.2 1326.0 65.9 48.4 47.2 80.2 58.5 50.2 89.2 84.2 42.5 78.5 22.9 32.3 48.1 183.6 96.5 36.5 95.7 52.9 62.6 48.2 NEMF "FLJ10051, NY-CO-1, SDCCAG1" ENSG00000165525 "Nuclear export mediator factor" O60524 14 49782083-49853203 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004160 Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA004160: AB_1079884" "unprognostic (9.92e-2)" "unprognostic (6.03e-2)" "unprognostic (4.44e-2)" "unprognostic (3.37e-2)" "unprognostic (1.54e-1)" "unprognostic (1.65e-1)" "unprognostic (9.15e-3)" "unprognostic (7.62e-2)" "unprognostic (1.21e-2)" "unprognostic (2.32e-1)" "unprognostic (2.50e-1)" "unprognostic (1.12e-1)" "prognostic favorable (2.85e-4)" "unprognostic (3.61e-1)" "unprognostic (2.36e-1)" "unprognostic (8.98e-2)" "unprognostic (1.81e-2)" 13.6 12.2 15.0 14.8 20.9 30.9 12.5 28.0 22.1 15.0 14.4 14.6 14.4 8.1 14.3 12.2 18.2 11.6 11.2 15.0 16.9 15.0 14.6 11.2 11.6 13.4 21.1 17.2 15.2 13.1 26.4 30.9 15.5 27.9 13.9 12.4 10.7 14.8 14.8 17.4 11.5 15.1 13.9 24.8 14.7 13.7 8.4 23.2 17.0 15.7 9.8 14.5 13.5 13.4 36.1 33.0 28.4 21.9 20.3 26.8 7.8 18.8 21.1 20.2 13.4 22.9 18.5 18.1 23.8 15.8 15.7 15.5 10.8 20.3 5.2 18.3 19.6 12.3 27.0 19.0 14.9 25.4 21.0 10.9 20.9 20.1 16.3 13.4 27.3 19.2 16.4 11.0 16.6 15.5 21.3 22.4 12.1 25.8 19.8 21.5 17.3 16.2 9.0 12.1 15.1 21.3 16.8 20.0 11.9 18.6 25.0 13.4 12.5 22.1 23.8 22.1 22.8 20.5 17.8 26.4 23.1 20.3 15.0 16.3 14.1 25.1 22.4 8.6 12.9 20.6 27.6 18.2 20.1 20.5 16.3 19.5 32.8 21.0 19.2 15.2 36.1 24.8 26.8 28.4 20.3 21.9 33.0 17.9 7.8 15.0 20.9 28.0 22.1 16.9 15.0 21.1 17.2 27.9 23.2 38.7 66.5 52.5 59.9 30.6 90.1 88.4 30.6 92.3 58.0 41.8 94.2 66.4 31.5 48.3 7.7 60.9 51.0 23.3 34.1 50.5 56.0 46.7 86.6 27.6 51.0 123.9 51.9 44.2 43.5 8.9 60.9 57.0 23.6 64.1 43.0 55.4 40.2 57.5 63.3 24.8 92.1 71.1 53.6 79.2 54.9 29.7 90.6 62.3 45.2 79.7 NEMP1 "KIAA0286, TMEM194, TMEM194A" ENSG00000166881 "Nuclear envelope integral membrane protein 1" O14524 12 57055643-57088063 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 20.8;Sertoli cells: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014394 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA014394: AB_2204899" "unprognostic (9.24e-2)" "unprognostic (1.78e-1)" "unprognostic (1.18e-1)" "unprognostic (4.97e-2)" "unprognostic (1.43e-1)" "unprognostic (4.57e-3)" "prognostic unfavorable (1.93e-4)" "unprognostic (8.36e-2)" "unprognostic (2.42e-3)" "unprognostic (2.11e-1)" "unprognostic (1.64e-1)" "unprognostic (6.61e-2)" "prognostic unfavorable (1.09e-5)" "unprognostic (2.31e-2)" "unprognostic (9.51e-2)" "unprognostic (2.63e-2)" "unprognostic (7.05e-2)" 9.5 7.3 7.6 16.7 7.8 7.8 8.6 10.6 8.5 8.1 12.2 8.1 3.6 4.9 14.8 7.6 8.8 9.4 5.8 4.8 6.6 3.8 6.0 8.1 9.7 15.1 7.7 5.8 12.3 6.4 5.9 12.7 20.6 6.2 9.6 9.4 8.2 7.2 7.5 3.6 14.3 11.0 12.8 8.3 11.4 8.5 15.4 6.9 26.6 8.7 4.1 15.1 9.3 8.9 4.6 2.2 5.5 3.5 5.4 4.7 2.0 8.1 6.9 15.9 17.1 5.3 5.3 9.1 12.6 7.2 17.6 14.3 8.2 15.6 19.3 16.3 4.3 15.0 12.0 21.1 5.4 20.3 10.2 9.6 11.4 8.0 4.3 2.3 14.1 13.1 1.8 5.2 14.4 9.0 7.3 4.8 17.6 23.1 38.6 14.7 4.4 15.4 12.0 8.9 7.7 7.7 15.7 22.6 8.8 3.8 5.0 9.5 6.4 10.7 9.0 10.1 11.8 16.2 14.2 3.4 16.8 9.8 15.4 11.7 17.4 33.1 17.0 9.9 13.6 17.2 5.5 1.1 1.9 2.8 3.5 3.7 4.6 3.1 3.6 1.2 3.6 4.7 3.9 0.5 5.4 2.0 2.2 2.8 2.0 7.6 7.8 10.6 8.5 6.6 3.8 7.7 5.8 6.2 6.9 20.8 1.6 0.0 2.9 0.0 2.3 1.2 0.0 5.3 3.4 5.2 3.9 3.2 0.0 1.7 1.0 2.9 0.4 0.0 0.7 3.1 2.1 3.6 0.0 3.9 4.8 1.6 0.0 5.5 5.3 0.2 5.8 5.9 0.0 3.6 1.7 2.9 2.1 0.0 4.9 0.6 3.9 12.9 1.9 10.1 6.9 0.0 2.5 3.2 1.8 2.0 NEMP2 TMEM194B ENSG00000189362 "Nuclear envelope integral membrane protein 2" A6NFY4 2 190504342-190534722 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 27.3" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 16.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" HPA057719 Approved Nucleoplasm NA NA Nucleoplasm "HPA057719: AB_2683510" "unprognostic (3.51e-1)" "unprognostic (9.99e-2)" "unprognostic (1.11e-3)" "unprognostic (1.05e-2)" "unprognostic (2.06e-2)" "unprognostic (1.03e-1)" "unprognostic (8.65e-3)" "unprognostic (5.70e-2)" "unprognostic (1.06e-1)" "unprognostic (5.61e-3)" "unprognostic (2.19e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (6.42e-4)" "unprognostic (5.82e-2)" "unprognostic (7.76e-3)" "unprognostic (4.75e-3)" "unprognostic (1.32e-1)" 7.8 4.9 2.9 14.5 2.9 4.5 4.3 7.5 3.6 6.0 3.6 4.3 2.2 2.5 8.5 6.8 4.4 3.3 3.0 4.3 3.5 2.9 5.7 5.7 9.3 11.3 3.8 3.2 5.6 3.2 2.6 4.0 3.7 3.4 3.9 2.6 6.6 9.3 4.8 1.7 5.1 4.5 3.4 3.4 12.3 5.1 8.1 2.4 27.3 5.4 3.5 15.8 4.4 4.3 3.6 3.4 0.2 0.8 2.4 5.6 2.2 5.2 2.8 1.9 2.4 1.1 3.0 5.1 3.8 3.3 3.8 4.7 4.2 7.3 7.6 2.5 1.9 2.7 9.3 3.0 8.1 7.6 5.6 2.6 5.5 2.8 2.9 2.9 5.9 1.9 3.1 3.4 17.3 4.5 3.5 1.7 8.5 4.7 9.0 7.3 2.4 6.4 2.8 2.1 2.9 3.1 2.7 4.2 3.5 3.4 3.9 3.5 3.0 5.9 0.6 5.7 3.4 1.5 6.4 3.1 8.5 6.6 1.6 4.1 4.9 5.3 4.1 6.5 6.2 6.1 0.1 0.8 0.1 3.0 0.7 3.9 2.7 3.3 2.7 0.9 3.6 5.4 4.6 0.2 2.4 0.6 3.4 5.6 2.2 2.9 2.9 7.5 3.6 3.5 2.9 3.8 3.2 3.4 2.4 0.0 1.1 2.4 1.3 0.0 4.5 1.6 0.0 0.0 0.0 1.8 0.0 2.1 0.0 1.5 2.5 3.8 0.0 0.0 1.7 2.8 1.3 1.5 1.1 2.5 2.6 3.2 0.0 3.1 5.4 4.2 2.6 2.3 0.0 1.8 1.2 3.3 0.6 1.5 1.1 2.1 2.1 0.0 2.5 16.7 5.9 0.0 1.0 5.7 1.8 1.3 NEO1 "HsT17534, IGDCC2, NGN, NTN1R2" ENSG00000067141 "Neogenin 1" Q92859 15 73051710-73305206 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 57.8;Peritubular cells: 59.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009320, HPA027804, HPA027805, HPA027806" Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA 280000000 "Nucleoplasm, Plasma membrane" "Golgi apparatus" "CAB009320: AB_2150998, HPA027804: AB_10600771, HPA027805: AB_10601755, HPA027806: AB_10601006" "unprognostic (1.90e-1)" "unprognostic (2.38e-2)" "unprognostic (7.60e-3)" "unprognostic (3.76e-2)" "unprognostic (5.44e-1)" "unprognostic (3.83e-2)" "unprognostic (8.30e-2)" "unprognostic (2.31e-1)" "unprognostic (3.22e-1)" "unprognostic (3.30e-2)" "unprognostic (5.51e-2)" "unprognostic (8.05e-2)" "prognostic favorable (4.39e-4)" "unprognostic (1.51e-1)" "unprognostic (1.41e-1)" "unprognostic (1.33e-2)" "unprognostic (3.75e-1)" 7.3 5.8 19.2 6.2 22.4 1.2 11.4 12.7 23.9 13.4 30.0 44.5 14.8 17.9 14.2 7.2 8.0 15.4 13.4 6.8 20.1 14.1 16.2 5.9 10.7 2.7 27.1 15.7 17.5 11.5 44.4 6.9 1.5 19.3 23.1 36.9 16.0 11.5 25.5 17.9 24.6 19.0 16.0 22.3 3.6 15.1 9.0 22.5 2.1 12.5 3.8 4.7 10.1 9.5 0.0 0.3 1.4 0.3 0.8 3.1 0.3 3.7 18.3 21.9 14.4 13.3 3.9 5.5 1.4 1.8 3.6 0.7 2.7 18.5 1.0 2.2 4.0 13.6 0.8 15.3 8.4 1.5 6.6 11.3 12.3 0.2 2.5 3.8 0.3 0.4 9.6 15.6 0.7 7.2 4.2 0.0 9.6 0.0 23.5 0.8 11.2 4.3 0.2 20.9 2.8 1.5 10.0 11.7 2.4 7.0 10.1 10.0 14.1 17.2 7.7 9.1 18.4 8.1 2.2 0.0 16.9 9.0 5.4 3.9 10.1 18.6 2.6 3.6 3.5 4.7 0.0 0.3 0.4 1.8 0.0 3.1 0.0 1.1 1.4 0.0 0.0 0.6 0.5 1.4 0.8 0.0 0.3 0.0 0.3 19.2 22.4 12.7 23.9 20.1 14.1 27.1 15.7 19.3 22.5 8.9 7.2 1.7 6.9 12.6 14.6 4.2 22.9 4.0 6.8 21.0 13.7 0.5 1.7 8.7 3.0 2.9 34.1 0.0 5.5 0.6 7.9 14.5 0.0 5.9 0.7 9.5 57.8 8.0 0.3 4.1 29.4 0.5 10.1 0.0 37.7 10.4 9.4 38.6 59.1 14.3 21.5 6.5 8.6 5.7 18.1 22.2 0.2 4.5 47.7 6.1 NEPRO "C3orf17, DKFZP434F2021, NET17" ENSG00000163608 "Nucleolus and neural progenitor protein" Q6NW34 3 113002440-113019861 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Club cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069654 Supported Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "HPA069654: AB_2686164" "unprognostic (8.45e-3)" "unprognostic (3.84e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (1.13e-4)" "unprognostic (2.29e-2)" "unprognostic (2.43e-2)" "prognostic unfavorable (4.25e-4)" "unprognostic (2.04e-1)" "unprognostic (1.49e-2)" "unprognostic (4.98e-2)" "unprognostic (1.72e-2)" "unprognostic (9.29e-3)" "unprognostic (5.40e-2)" "unprognostic (1.69e-1)" "unprognostic (2.78e-1)" "unprognostic (1.69e-1)" "unprognostic (3.28e-2)" 15.1 12.3 12.6 12.9 19.8 15.9 15.5 22.8 21.3 14.4 12.8 15.3 11.6 12.3 15.4 19.0 12.7 12.8 13.0 14.0 13.2 12.5 12.4 10.3 11.3 19.3 14.2 13.7 14.8 16.5 13.4 18.2 12.4 15.6 12.4 9.8 11.5 13.5 15.1 28.1 18.2 13.6 16.0 17.5 17.5 14.2 19.1 12.8 21.9 20.0 16.4 15.5 17.5 10.9 3.8 3.4 2.9 3.0 7.9 6.4 2.7 10.0 8.4 13.4 10.0 4.4 8.0 7.2 9.7 6.1 5.4 3.6 7.6 6.6 13.3 5.3 3.1 7.6 10.6 9.8 4.3 7.5 2.6 6.2 20.4 7.4 5.6 8.0 12.9 7.5 12.6 7.8 4.4 11.2 14.7 4.7 13.2 6.9 10.7 3.9 6.4 11.1 7.6 13.9 8.9 10.8 9.1 10.6 6.9 6.1 8.9 9.3 13.6 5.5 7.0 15.9 10.4 8.0 11.1 9.4 7.5 7.5 2.7 6.8 10.6 8.2 15.7 12.0 10.3 5.3 2.9 2.3 2.7 4.4 3.0 4.5 3.8 5.1 3.7 3.4 3.1 6.4 6.3 1.5 7.9 1.2 2.4 2.2 2.7 12.6 19.8 22.8 21.3 13.2 12.5 14.2 13.7 15.6 12.8 8.9 10.9 0.0 0.0 0.0 0.0 0.0 0.0 16.0 19.4 17.4 0.0 15.4 14.9 12.5 0.0 0.0 0.0 0.0 11.1 12.4 0.0 0.0 16.3 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 16.2 0.0 0.0 12.4 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 NET1 "ARHGEF8, NET1A" ENSG00000173848 "Neuroepithelial cell transforming 1" Q7Z628 10 5412551-5458463 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Urothelial cells: 186.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 11.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 63.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020068 Uncertain Approved Nucleoplasm,Vesicles Yes No Nucleoplasm Vesicles "HPA020068: AB_2670348" "unprognostic (1.77e-2)" "unprognostic (1.87e-1)" "unprognostic (3.40e-1)" "unprognostic (4.05e-2)" "unprognostic (3.37e-3)" "unprognostic (2.15e-1)" "prognostic unfavorable (3.87e-5)" "unprognostic (6.31e-2)" "unprognostic (1.87e-1)" "unprognostic (2.77e-2)" "prognostic unfavorable (8.27e-4)" "unprognostic (2.26e-1)" "unprognostic (5.41e-2)" "unprognostic (1.20e-1)" "unprognostic (1.90e-1)" "unprognostic (3.01e-1)" "unprognostic (2.46e-1)" 19.4 4.8 14.2 25.8 16.7 15.0 39.8 11.8 15.2 30.2 39.3 21.0 32.1 24.1 19.4 25.7 38.2 20.7 25.9 8.4 16.5 12.7 21.3 19.0 9.5 10.5 19.0 9.4 15.2 19.4 2.9 6.6 51.8 20.8 23.0 38.9 20.3 43.0 23.2 16.7 21.8 54.7 33.4 19.9 3.9 33.5 11.8 10.9 14.8 18.1 26.8 20.2 28.0 31.8 1.8 5.9 2.7 1.2 1.0 11.5 2.4 27.9 16.7 11.6 12.9 6.8 3.1 63.7 17.0 9.3 13.7 13.1 9.1 53.3 10.3 7.1 10.3 3.0 45.8 14.0 25.6 16.5 9.6 10.1 18.6 5.6 20.3 1.8 5.3 8.1 4.6 15.3 13.5 3.2 12.0 7.9 10.8 32.8 16.3 7.5 13.3 17.9 7.4 15.6 38.6 12.7 11.3 21.4 8.0 8.4 14.1 10.0 5.5 14.9 27.7 5.0 20.2 9.2 15.9 7.2 5.2 8.2 8.0 13.7 10.0 5.4 13.5 4.7 8.1 10.8 2.7 0.8 1.8 0.9 1.2 0.0 1.8 1.6 0.5 5.9 0.9 11.5 2.1 0.1 1.0 0.6 2.5 5.1 2.4 14.2 16.7 11.8 15.2 16.5 12.7 19.0 9.4 20.8 10.9 29.8 38.9 8.2 74.8 35.7 7.7 10.1 45.9 77.6 83.0 12.2 3.9 84.2 5.0 11.3 2.0 33.2 153.4 0.0 21.4 96.0 33.1 71.1 15.0 45.0 12.6 3.2 77.6 14.1 12.4 1.7 20.1 13.0 33.7 83.0 146.5 3.4 41.8 114.6 82.4 21.2 3.1 109.9 58.2 24.9 18.6 28.2 98.2 7.0 102.0 186.5 NEU3 ENSG00000162139 "Neuraminidase 3" Q9UQ49 11 74988134-75018893 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Lipid degradation, Lipid metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 44.6" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 58.9;Spermatocytes: 32.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038729, HPA070381" Approved Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA038729: AB_2676179, HPA070381: " "unprognostic (1.67e-1)" "unprognostic (2.10e-1)" "unprognostic (2.55e-2)" "unprognostic (1.13e-3)" "unprognostic (2.95e-2)" "unprognostic (5.42e-2)" "unprognostic (1.63e-1)" "unprognostic (5.11e-2)" "unprognostic (3.91e-3)" "unprognostic (8.50e-2)" "prognostic favorable (5.98e-4)" "unprognostic (3.57e-3)" "unprognostic (3.80e-2)" "unprognostic (3.79e-1)" "unprognostic (2.38e-1)" "unprognostic (3.73e-1)" "unprognostic (1.84e-1)" 5.4 13.4 3.7 10.5 6.9 17.0 5.4 7.9 9.1 4.0 3.9 3.0 4.1 3.6 5.4 4.8 3.9 4.4 3.6 5.9 4.0 4.5 4.3 6.7 8.7 9.0 3.8 6.6 7.2 7.3 15.1 11.2 3.1 4.2 9.7 5.4 5.6 4.8 4.6 19.1 6.7 4.7 4.0 3.5 5.5 5.1 44.6 3.0 19.0 6.8 3.5 7.5 4.5 3.1 3.2 3.8 5.8 6.4 1.2 4.2 2.2 4.6 4.0 3.4 6.6 2.6 2.5 3.8 4.5 2.9 5.2 4.0 13.7 3.9 13.3 4.6 3.6 6.6 4.3 8.2 5.8 7.9 7.0 4.4 10.9 7.4 5.6 2.9 17.2 10.6 3.0 4.9 5.2 8.1 3.4 3.7 19.0 17.7 10.0 5.9 5.0 16.9 8.9 4.2 9.1 5.4 14.8 9.0 11.7 6.4 4.9 6.3 4.0 6.9 4.6 20.2 4.2 9.8 4.4 5.6 6.5 6.5 4.3 4.5 8.2 8.0 26.6 1.9 8.9 5.5 2.1 6.4 5.8 4.1 3.7 3.0 2.8 3.2 3.9 3.8 3.2 3.5 4.2 3.3 1.2 4.6 2.7 2.3 2.2 3.7 6.9 7.9 9.1 4.0 4.5 3.8 6.6 4.2 3.0 3.0 5.8 2.2 1.8 0.5 7.2 7.3 2.5 2.7 4.5 1.8 58.9 1.8 0.0 1.0 5.7 1.6 1.3 0.0 2.6 1.2 1.5 2.7 1.1 7.2 4.8 11.1 6.9 4.3 8.6 5.3 1.4 4.5 0.0 4.6 2.9 2.9 2.7 0.0 1.8 3.3 5.8 0.0 2.2 32.5 1.7 0.5 1.1 3.5 3.2 0.4 NEUROG1 "AKA, bHLHa6, Math4C, NEUROD3, ngn1" ENSG00000181965 "Neurogenin 1" Q92886 5 135534282-135535949 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 2.1;retina: 7.7;testis: 2.3" "Cell type enhanced" "Detected in single" 24 "Bipolar cells: 1.3" "Cancer enriched" "Detected in single" 12 "testis cancer: 1.1" "Region enhanced" "Detected in single" "midbrain: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "AF22: 1.3;SCLC-21H: 1.1;THP-1: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA072232 Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA072232: " "unprognostic (3.04e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.3 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 2.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 NEUROG3 "Atoh5, bHLHa7, Math4B, ngn3" ENSG00000122859 "Neurogenin 3" Q9Y4Z2 10 69571698-69573238 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.5;intestine: 8.4" "Group enriched" "Detected in some" 49 "Cardiomyocytes: 4.8;Intestinal endocrine cells: 5.1" "Cancer enhanced" "Detected in some" "stomach cancer: 1.4" "Region enriched" "Detected in single" 20 "hippocampal formation: 7.5" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.1;memory B-cell: 1.1" "Group enriched" "Detected in many" 7 "B-cells: 1.1;T-cells: 2.1" "Cell line enriched" "Detected in some" 5 "THP-1: 15.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA039785 Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Nuclear speckles" Nucleoplasm "HPA039785: AB_10795114" "unprognostic (1.22e-2)" "unprognostic (7.33e-2)" "unprognostic (3.04e-2)" "unprognostic (2.42e-1)" "unprognostic (1.10e-1)" "unprognostic (1.65e-2)" "unprognostic (5.85e-5)" "unprognostic (4.58e-2)" "unprognostic (4.19e-1)" 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 7.6 0.0 0.0 8.0 0.0 0.0 0.9 0.0 1.8 0.0 7.5 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 8.4 0.1 0.1 0.1 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.1 0.0 0.4 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.3 7.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NEXMIF "KIAA2022, KIDLIA, MRX98, XPN" ENSG00000050030 "Neurite extension and migration factor" Q5QGS0 X 74732856-74925485 "Disease related genes, Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.2;parathyroid gland: 9.0" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 2.2;Ciliated cells: 5.3;Club cells: 4.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HAP1: 6.7;Karpas-707: 10.8;SiHa: 9.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000407 Uncertain Supported "Nucleoplasm,Midbody,Mitotic spindle,Cytosol" Yes NA Nucleoplasm "Midbody, Mitotic spindle, Cytosol" "HPA000407: AB_2665984" "unprognostic (1.04e-3)" "unprognostic (6.07e-5)" "unprognostic (1.81e-2)" "unprognostic (2.07e-5)" "unprognostic (2.15e-1)" "unprognostic (2.18e-2)" "unprognostic (3.37e-1)" "unprognostic (1.74e-3)" "unprognostic (3.71e-1)" "unprognostic (1.79e-2)" "unprognostic (1.64e-3)" "unprognostic (8.25e-2)" "unprognostic (7.58e-3)" "unprognostic (1.37e-2)" "unprognostic (3.80e-2)" "unprognostic (2.79e-4)" "unprognostic (6.94e-4)" 0.6 3.0 5.4 0.7 6.2 0.4 1.3 10.2 9.4 1.7 1.9 0.7 1.0 0.6 1.7 0.9 1.8 1.3 0.5 0.3 5.0 6.2 2.4 0.2 0.9 0.5 1.8 5.0 1.7 4.4 9.0 7.5 0.5 1.9 3.2 1.1 1.1 2.5 2.5 0.4 1.8 1.1 2.6 1.2 0.6 1.6 0.9 1.5 0.0 1.5 0.0 0.5 0.7 2.8 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 10.8 0.0 0.2 0.3 0.1 0.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 9.5 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.2 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 5.4 6.2 10.2 6.8 5.0 6.2 1.8 5.0 1.9 1.5 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 5.3 4.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NF2 "ACN, BANF, merlin, SCH" ENSG00000186575 "Neurofibromin 2" P35240 22 29603556-29698598 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Deafness, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 61.9;Late spermatids: 86.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003097, CAB005385" Supported Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "CAB005385: AB_2298548, HPA003097: AB_1079473" "unprognostic (3.27e-1)" "unprognostic (1.34e-2)" "unprognostic (1.34e-1)" "unprognostic (1.76e-2)" "unprognostic (3.14e-1)" "unprognostic (1.62e-1)" "unprognostic (5.76e-3)" "unprognostic (1.61e-1)" "unprognostic (3.67e-2)" "unprognostic (2.16e-2)" "unprognostic (2.01e-3)" "unprognostic (4.66e-1)" "prognostic favorable (2.89e-5)" "unprognostic (7.73e-3)" "unprognostic (1.31e-1)" "unprognostic (2.24e-1)" "unprognostic (9.62e-2)" 11.8 12.4 23.6 11.1 20.1 10.0 15.4 20.8 28.1 10.8 9.7 9.0 11.8 7.8 10.5 11.3 14.2 11.3 8.0 19.7 26.6 16.4 13.5 11.1 11.9 24.1 18.0 13.5 11.0 12.9 46.8 8.6 6.9 11.4 10.2 8.7 9.5 9.3 15.4 25.7 12.1 8.5 11.9 10.7 10.4 8.8 21.6 10.1 14.9 15.6 11.5 9.9 10.6 10.2 8.5 13.6 6.6 17.3 11.6 15.0 9.8 26.6 10.8 3.8 24.6 7.4 7.4 3.6 21.7 12.2 23.8 20.6 10.6 6.6 7.1 18.0 22.3 16.5 9.5 7.8 12.6 21.3 10.3 6.1 8.4 8.1 7.6 7.9 12.0 10.0 6.8 5.7 16.9 20.6 8.1 16.7 4.6 4.1 6.6 23.1 11.2 7.3 4.8 2.8 6.3 10.2 7.6 20.3 6.8 24.2 12.5 5.8 4.0 12.4 8.4 4.9 4.0 5.4 4.8 31.0 35.5 40.5 15.4 36.6 10.3 8.2 8.5 9.4 4.7 22.6 6.6 9.5 3.6 15.0 13.5 12.8 8.2 11.3 10.1 13.6 8.5 9.8 9.2 2.3 11.6 17.3 9.3 9.4 9.8 23.6 20.1 20.8 28.1 26.6 16.4 18.0 13.5 11.4 10.1 6.0 16.1 9.0 9.6 12.6 16.5 19.9 17.8 6.7 7.9 14.0 9.8 9.9 18.3 42.9 61.9 9.8 8.4 0.0 21.5 6.3 12.6 9.5 23.0 12.5 12.4 28.6 12.6 10.4 10.0 86.8 6.6 7.2 8.5 6.4 7.5 17.3 28.7 15.6 11.7 16.2 8.5 6.5 14.9 21.4 7.2 12.5 3.2 10.9 9.8 8.6 NFAT5 "KIAA0827, NF-AT5, NFATL1, NFATZ, OREBP, TONEBP" ENSG00000102908 "Nuclear factor of activated T cells 5" O94916 16 69565094-69704666 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057304, HPA069711" Approved Supported Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA057304: AB_2683407, HPA069711: AB_2686180" "unprognostic (2.71e-1)" "unprognostic (1.50e-2)" "unprognostic (1.77e-1)" "unprognostic (3.57e-2)" "unprognostic (5.65e-3)" "unprognostic (2.08e-1)" "unprognostic (2.97e-2)" "unprognostic (1.26e-1)" "unprognostic (1.83e-1)" "unprognostic (3.56e-2)" "unprognostic (4.05e-3)" "unprognostic (1.87e-1)" "prognostic favorable (1.08e-4)" "unprognostic (1.62e-1)" "unprognostic (1.37e-1)" "unprognostic (6.32e-2)" "unprognostic (9.42e-2)" 15.4 19.1 19.0 17.0 17.1 25.1 15.8 22.4 18.0 19.3 11.9 11.9 12.5 7.7 18.7 19.5 15.7 15.0 11.7 11.6 15.6 8.2 15.7 10.2 15.6 10.5 13.0 12.7 15.6 13.8 35.6 24.2 30.8 13.1 14.7 12.8 13.9 20.1 15.6 12.1 26.5 14.0 12.5 10.5 11.6 12.0 10.1 14.4 10.3 21.9 7.7 10.8 19.6 30.4 2.1 2.9 5.5 4.6 1.1 2.6 0.5 11.1 14.6 7.2 8.9 10.8 13.1 7.9 11.6 13.9 12.3 9.0 11.0 9.2 5.1 6.9 14.0 4.9 9.7 6.4 6.6 13.0 2.9 2.5 4.0 5.3 13.5 8.8 3.9 7.6 9.1 4.5 9.3 11.4 10.2 12.0 3.0 7.8 2.7 11.4 4.9 3.0 5.7 4.2 2.3 1.7 5.3 3.2 2.8 11.8 19.2 3.9 2.4 25.0 2.7 6.9 9.2 5.5 3.1 14.9 10.8 6.6 5.8 3.9 5.9 4.5 8.9 7.2 3.4 6.4 3.5 1.3 1.4 2.2 0.8 1.6 2.1 1.1 2.6 0.6 1.9 0.9 0.8 5.5 1.1 4.6 2.9 1.6 0.5 19.0 17.1 22.4 18.0 15.6 8.2 13.0 12.7 13.1 14.4 44.7 38.8 29.6 89.1 131.5 50.5 7.8 35.7 17.4 37.5 137.9 80.5 49.6 5.0 15.7 6.5 62.4 23.8 0.0 11.1 13.9 39.1 74.1 19.6 23.1 15.6 57.2 23.5 47.3 21.8 4.7 55.0 41.6 55.6 38.7 30.3 54.8 18.7 24.6 51.6 7.0 64.7 25.8 65.5 64.9 26.2 122.5 42.6 32.0 18.1 90.9 NFATC1 "NF-ATC, NFAT2, NFATc" ENSG00000131196 "Nuclear factor of activated T cells 1" O95644 18 79395856-79529325 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "B-cells: 43.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 34.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB004513, HPA071732" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "CAB004513: AB_628011, HPA071732: AB_2686439" "unprognostic (3.53e-2)" "unprognostic (2.16e-3)" "unprognostic (3.08e-3)" "unprognostic (3.40e-2)" "unprognostic (4.54e-2)" "unprognostic (2.79e-2)" "unprognostic (1.92e-1)" "unprognostic (4.85e-3)" "unprognostic (7.02e-2)" "unprognostic (8.37e-2)" "unprognostic (1.90e-2)" "unprognostic (1.38e-1)" "unprognostic (5.87e-2)" "unprognostic (1.38e-1)" "unprognostic (4.54e-2)" "unprognostic (5.04e-2)" "unprognostic (3.11e-3)" 12.2 4.2 4.0 35.4 4.0 4.1 9.2 2.7 3.9 9.3 7.6 5.4 7.0 3.7 10.7 6.5 5.9 7.0 11.8 13.4 3.2 2.9 4.7 2.9 13.9 21.9 4.3 2.2 7.0 8.3 6.4 3.3 4.8 11.4 6.4 2.1 9.9 5.5 9.0 27.9 8.6 10.8 12.0 5.9 16.9 6.0 7.1 4.6 21.1 6.8 15.2 27.0 13.2 14.2 11.3 3.2 7.1 13.4 2.1 6.9 4.9 0.0 2.2 1.1 2.0 1.9 2.1 4.0 1.3 0.1 0.3 0.2 0.2 2.0 12.3 0.9 1.8 3.3 0.2 5.7 0.0 0.4 8.5 4.7 8.6 0.5 0.0 4.3 2.7 4.7 2.5 0.0 0.7 0.1 0.0 6.9 5.1 6.9 2.6 1.3 4.7 7.0 0.9 2.0 1.6 1.5 2.3 1.5 2.7 1.0 0.9 0.0 0.0 1.9 1.5 3.2 2.5 1.8 11.0 6.4 2.9 12.4 0.0 0.1 0.0 0.0 34.5 0.0 3.7 5.3 1.9 3.4 7.1 4.4 9.2 4.7 8.6 6.9 6.2 3.2 11.3 6.0 4.1 3.0 2.1 13.4 3.1 5.0 4.9 4.0 4.0 2.7 3.9 3.2 2.9 4.3 2.2 11.4 4.6 0.0 5.9 43.6 28.8 33.1 0.0 6.3 0.0 2.7 9.1 0.0 0.0 0.2 0.0 5.4 8.9 20.1 0.0 0.0 3.5 5.3 23.6 13.2 32.2 0.8 10.4 0.0 0.0 27.0 12.4 13.6 7.8 12.0 10.1 0.0 0.0 2.2 4.3 0.0 9.2 0.4 0.0 0.0 22.6 3.7 14.0 26.0 0.5 9.6 0.0 2.7 NFATC2 "NF-ATP, NFAT1, NFATp" ENSG00000101096 "Nuclear factor of activated T cells 2" Q13469 20 51386957-51562831 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 44.6" "Cell type enhanced" "Detected in many" 8 "Melanocytes: 59.1;T-cells: 40.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 14.4;HMC-1: 16.6;WM-115: 25.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA008789, CAB018567, HPA024369" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB018567: AB_628012, HPA008789: AB_1079474, HPA024369: AB_1854413" "unprognostic (2.69e-3)" "unprognostic (2.92e-2)" "unprognostic (2.31e-1)" "unprognostic (1.58e-2)" "unprognostic (1.15e-1)" "unprognostic (1.26e-2)" "unprognostic (3.94e-2)" "unprognostic (4.05e-2)" "unprognostic (9.26e-2)" "unprognostic (3.74e-3)" "unprognostic (2.17e-2)" "unprognostic (4.86e-2)" "prognostic unfavorable (1.57e-4)" "unprognostic (9.25e-2)" "unprognostic (1.02e-1)" "unprognostic (1.05e-2)" "unprognostic (6.59e-2)" 8.6 2.4 4.1 44.6 8.2 4.4 9.8 1.1 5.1 8.4 7.8 6.8 3.9 8.4 7.0 7.6 4.0 5.6 19.4 8.5 4.1 3.3 3.4 6.7 6.1 25.2 8.4 0.7 5.0 8.7 3.9 3.7 8.1 10.4 5.4 4.1 6.2 7.9 7.2 5.4 7.0 11.7 5.9 6.5 16.0 11.0 4.5 6.5 8.6 7.0 13.2 18.7 4.5 4.9 1.6 1.7 3.8 0.7 7.6 7.7 1.6 1.6 1.7 0.0 2.2 0.0 0.0 4.6 0.2 1.1 0.7 0.3 8.3 1.5 11.1 1.3 0.5 1.6 0.0 0.5 0.0 0.6 14.4 0.2 4.7 1.2 2.1 0.0 1.3 16.6 0.0 0.0 0.6 0.0 0.1 5.1 3.9 4.6 7.4 0.0 1.8 1.9 7.8 0.1 1.0 4.0 0.8 0.0 4.9 0.3 0.0 0.1 0.0 5.2 1.3 12.1 1.1 2.0 3.1 0.5 1.0 1.9 2.5 0.1 6.3 4.1 11.5 1.1 5.2 25.0 0.3 0.0 3.8 7.7 0.7 3.2 1.6 4.3 6.1 1.7 1.6 2.4 4.4 0.2 7.6 0.2 0.6 2.3 1.6 4.1 8.2 1.1 5.1 4.1 3.3 8.4 0.7 10.4 6.5 6.0 4.8 3.9 10.4 12.8 0.0 2.8 5.1 10.7 9.1 0.0 0.0 2.4 1.7 3.6 1.5 16.9 1.1 0.0 4.9 0.5 28.2 7.4 15.0 6.0 28.1 0.0 7.5 9.2 21.2 0.4 2.0 16.7 59.1 3.6 6.2 0.0 8.0 0.0 0.4 0.2 0.0 0.0 12.2 0.5 0.9 11.3 0.8 40.6 7.1 5.6 NFATC2IP "ESC2, FLJ14639, NIP45, RAD60" ENSG00000176953 "Nuclear factor of activated T cells 2 interacting protein" Q8NCF5 16 28950807-28967097 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053587 Approved Nucleoplasm NA NA Nucleoplasm "HPA053587: AB_2682202" "unprognostic (6.01e-2)" "unprognostic (1.41e-2)" "unprognostic (8.48e-2)" "unprognostic (1.33e-1)" "unprognostic (4.90e-1)" "unprognostic (7.09e-2)" "unprognostic (8.82e-3)" "unprognostic (1.15e-2)" "unprognostic (8.95e-2)" "unprognostic (5.80e-2)" "unprognostic (5.32e-2)" "prognostic unfavorable (5.23e-4)" "prognostic unfavorable (1.03e-5)" "unprognostic (8.00e-2)" "unprognostic (3.85e-2)" "unprognostic (3.25e-1)" "unprognostic (5.94e-2)" 14.0 11.9 16.6 26.5 15.0 32.5 16.1 29.9 16.8 14.6 23.6 12.7 19.0 16.1 17.8 11.8 20.4 17.5 15.8 15.6 13.0 7.8 15.9 18.9 18.1 26.0 16.5 18.0 18.6 16.2 21.9 11.2 14.0 12.0 17.1 25.7 15.7 17.1 12.9 20.7 24.8 25.1 19.4 12.2 32.7 17.8 27.1 15.3 37.7 16.3 6.9 28.6 19.8 16.0 3.5 6.3 8.7 3.7 5.8 4.9 1.3 18.0 13.1 17.8 17.9 10.9 11.5 22.6 17.6 13.3 20.7 26.6 15.1 22.6 19.3 13.4 12.5 12.6 21.5 21.4 19.3 28.2 16.4 15.7 17.6 34.0 18.7 6.9 15.9 27.0 8.1 15.8 22.5 13.7 10.3 16.5 19.7 15.9 24.1 18.3 22.4 20.6 28.2 17.5 14.6 15.5 36.1 15.9 17.7 14.8 16.3 13.8 9.8 11.8 18.4 6.8 15.2 19.0 11.9 18.2 23.0 13.0 17.9 13.2 17.9 23.4 23.6 12.7 26.3 13.4 8.7 3.2 3.2 4.1 3.7 3.8 3.2 3.1 4.7 1.8 3.5 4.9 4.4 2.4 5.8 2.3 6.3 4.5 1.3 16.6 15.0 29.9 16.8 13.0 7.8 16.5 18.0 12.0 15.3 32.8 50.0 43.4 20.5 28.2 62.9 14.8 22.9 17.4 35.2 27.9 94.2 24.6 16.6 19.0 3.9 28.0 38.7 70.0 20.0 25.0 22.1 29.7 34.8 17.9 20.3 41.3 39.3 39.3 30.1 4.3 27.3 31.4 21.9 35.1 53.9 16.0 32.1 31.7 19.1 14.0 87.9 38.8 18.4 64.9 95.4 26.5 21.9 40.1 47.3 40.4 NFATC3 "NFAT4, NFATX" ENSG00000072736 "Nuclear factor of activated T cells 3" Q12968 16 68084751-68229259 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "lymphoid tissue: 129.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 43.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050665 Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA050665: AB_2681210" "unprognostic (1.19e-1)" "unprognostic (1.56e-2)" "unprognostic (7.74e-2)" "unprognostic (7.25e-3)" "unprognostic (6.41e-2)" "unprognostic (1.28e-2)" "unprognostic (7.28e-3)" "unprognostic (2.97e-1)" "unprognostic (1.90e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (8.93e-2)" "unprognostic (9.07e-3)" "unprognostic (1.60e-1)" "unprognostic (1.58e-1)" "unprognostic (4.04e-2)" "unprognostic (1.30e-1)" 9.6 6.8 4.3 16.0 6.6 12.0 7.8 7.5 5.8 9.8 11.0 9.7 7.6 7.1 12.2 6.5 7.7 8.3 7.6 7.0 4.7 4.0 8.2 12.1 11.3 14.2 8.7 3.5 10.0 7.0 18.7 6.8 6.6 5.1 10.5 6.1 11.1 7.9 7.6 27.1 14.0 12.0 9.0 6.7 12.3 6.2 25.9 5.8 129.5 11.0 8.1 16.0 10.2 14.1 6.7 3.1 12.0 7.1 13.4 15.6 9.0 4.9 5.9 9.5 10.5 8.6 5.5 8.8 3.3 4.1 9.2 8.1 8.6 4.4 16.8 5.0 5.4 3.0 7.5 11.9 5.6 9.1 3.4 7.7 16.5 6.2 19.2 5.7 14.7 43.4 4.1 7.2 9.3 5.1 4.8 7.8 13.8 21.2 4.8 6.8 10.1 22.7 20.1 6.2 7.7 3.2 12.9 9.2 17.3 4.0 5.8 7.2 7.8 24.5 6.2 3.1 6.1 8.5 11.2 4.9 4.7 5.1 5.5 4.8 6.6 11.4 30.5 3.7 13.7 6.6 12.0 2.4 5.3 15.6 3.7 14.8 5.2 8.9 15.2 2.9 6.7 9.1 14.0 3.3 13.4 7.1 3.1 6.0 9.0 4.3 6.6 7.5 5.8 4.7 4.0 8.7 3.5 5.1 5.8 32.8 43.8 26.5 36.2 69.6 25.5 1.2 58.6 28.1 20.5 55.8 31.4 42.2 19.9 24.1 115.7 21.0 23.8 23.3 19.3 12.6 19.4 42.3 47.4 89.3 20.8 35.0 25.0 35.6 50.9 81.4 20.1 25.0 21.9 16.2 39.9 8.2 24.8 38.6 25.1 33.5 23.7 19.4 17.8 57.1 69.8 125.2 71.1 59.3 49.1 48.0 NFE2 NF-E2 ENSG00000123405 "Nuclear factor, erythroid 2" Q16621 12 54292111-54301121 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 119.7;bone marrow: 54.3;lymphoid tissue: 32.2" "Group enriched" "Detected in some" 6 "Erythroid cells: 93.5;Kupffer cells: 38.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basophil: 119.7;neutrophil: 80.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 119.7" "Group enriched" "Detected in some" 4 "HEL: 85.6;K-562: 37.0;NB-4: 26.1" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "olfactory region: 1.4" HPA001914 Enhanced Approved "Nucleoplasm,Actin filaments" NA NA "Nucleoplasm, Actin filaments" "HPA001914: AB_1079475" "unprognostic (2.68e-4)" "unprognostic (2.93e-2)" "unprognostic (2.20e-2)" "unprognostic (2.31e-2)" "unprognostic (2.33e-2)" "unprognostic (1.85e-1)" "unprognostic (1.20e-2)" "unprognostic (4.55e-2)" "unprognostic (4.12e-1)" "unprognostic (4.55e-2)" "unprognostic (3.47e-2)" "unprognostic (2.57e-3)" "unprognostic (9.90e-6)" "unprognostic (1.81e-2)" "unprognostic (8.99e-2)" "unprognostic (1.51e-2)" "unprognostic (3.46e-2)" 2.3 0.3 0.9 3.5 1.5 54.3 0.5 0.4 1.7 0.9 0.4 0.2 0.0 0.5 0.4 0.4 0.7 2.0 0.9 7.8 1.5 0.4 0.9 2.6 9.6 20.9 5.2 0.2 1.2 0.6 1.2 0.8 15.9 1.2 1.0 0.3 1.2 0.5 0.2 1.0 2.9 0.5 1.1 1.0 32.2 0.7 0.9 0.7 1.8 1.7 0.2 0.5 1.2 8.1 0.0 15.2 119.7 23.1 0.0 0.1 12.9 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 1.5 0.1 0.2 1.2 2.2 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 85.6 0.2 1.9 0.0 1.2 11.3 0.1 0.0 0.0 0.0 1.0 0.0 0.0 37.0 0.0 0.0 0.0 3.3 26.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.4 0.2 4.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 5.1 0.0 119.7 23.1 21.7 0.0 6.4 0.1 0.0 0.0 0.0 15.2 0.0 0.1 0.0 80.0 0.0 3.8 0.2 0.0 12.9 0.9 1.5 0.4 1.7 1.5 0.4 5.2 0.2 1.2 0.7 0.0 4.8 0.0 0.0 0.1 0.0 0.0 2.5 1.4 0.0 0.0 0.0 0.1 0.0 0.0 5.5 0.0 0.0 93.5 0.0 0.4 0.0 0.0 3.5 0.0 0.9 0.0 0.0 0.0 38.4 11.0 0.0 1.6 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.3 1.0 0.0 0.0 0.0 NFE2L1 "FLJ00380, LCR-F1, NRF1, TCF11" ENSG00000082641 "Nuclear factor, erythroid 2 like 1" Q14494 17 48048329-48061487 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 194.7" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 262.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 19.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063384, HPA065424" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA063384: AB_2684998, HPA065424: AB_2685488" "unprognostic (3.19e-1)" "unprognostic (2.41e-1)" "unprognostic (5.44e-2)" "prognostic favorable (8.20e-5)" "unprognostic (5.25e-2)" "prognostic unfavorable (2.73e-4)" "unprognostic (5.20e-2)" "unprognostic (5.58e-2)" "unprognostic (9.30e-2)" "unprognostic (2.61e-1)" "unprognostic (1.63e-2)" "unprognostic (1.08e-1)" "prognostic favorable (5.79e-6)" "unprognostic (2.20e-1)" "unprognostic (4.09e-2)" "unprognostic (6.19e-3)" "unprognostic (2.01e-2)" 24.2 25.7 15.5 13.1 15.5 4.6 50.3 9.1 19.8 18.8 17.5 17.4 32.3 17.4 31.4 30.5 21.4 22.7 16.3 85.5 18.2 19.2 27.9 18.4 13.9 12.6 21.7 21.2 26.2 11.1 16.6 16.3 16.6 25.0 16.5 13.6 22.6 17.7 26.1 194.7 19.9 18.3 24.3 27.5 17.7 13.9 18.8 16.5 5.8 22.4 58.9 10.7 17.3 24.2 4.1 9.4 19.7 9.4 2.1 2.6 0.9 19.2 43.0 28.2 23.8 59.2 28.9 21.2 31.5 43.8 22.4 25.0 52.4 22.3 22.2 64.0 39.7 29.1 40.1 19.9 25.1 24.1 38.0 16.6 12.5 29.1 17.5 70.3 27.8 20.2 39.4 62.8 40.7 45.8 37.5 34.9 15.0 22.1 61.6 27.5 16.5 17.6 8.7 18.2 17.4 16.4 12.5 39.9 21.1 24.7 28.9 17.4 26.3 21.5 14.5 44.4 38.3 28.6 19.1 46.7 54.9 23.8 18.5 31.5 103.1 69.0 20.8 52.1 11.8 31.1 7.9 9.4 2.7 2.6 4.8 1.5 3.8 2.5 2.6 1.9 4.1 1.9 2.1 19.7 2.1 5.6 9.4 0.9 0.9 15.5 15.5 9.1 19.8 18.2 19.2 21.7 21.2 25.0 16.5 53.6 49.6 9.7 17.8 49.5 67.0 262.2 61.1 40.2 31.8 73.3 33.4 18.6 21.6 36.9 6.0 55.4 91.6 0.0 31.5 17.7 25.0 31.4 26.7 111.7 30.3 68.3 28.9 55.9 33.7 7.9 94.6 19.5 20.3 41.5 46.8 24.4 46.3 54.1 78.8 38.4 33.8 58.2 41.2 22.3 20.4 42.3 18.7 14.4 38.2 19.7 NFE2L2 NRF2 ENSG00000116044 "Nuclear factor, erythroid 2 like 2" Q16236 2 177227595-177392697 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002990, CAB020317, HPA043438" Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "CAB020317: , HPA002990: AB_1079476, HPA043438: AB_2678482" "unprognostic (2.11e-1)" "unprognostic (3.12e-2)" "unprognostic (5.22e-2)" "unprognostic (1.41e-1)" "unprognostic (5.95e-2)" "unprognostic (3.90e-1)" "unprognostic (5.27e-2)" "unprognostic (9.58e-2)" "unprognostic (3.48e-2)" "unprognostic (9.86e-2)" "unprognostic (4.86e-2)" "unprognostic (1.83e-1)" "prognostic favorable (2.26e-4)" "unprognostic (1.97e-2)" "unprognostic (1.61e-1)" "unprognostic (1.26e-1)" "unprognostic (9.77e-3)" 30.9 24.4 25.4 19.3 34.7 15.0 24.6 36.4 29.7 31.7 28.3 25.8 22.2 28.1 27.7 30.9 82.5 27.0 28.9 32.3 28.0 16.9 44.8 49.3 29.0 19.7 49.0 18.7 53.1 16.3 21.7 52.5 29.4 33.5 39.0 25.4 21.7 34.7 28.1 25.9 48.1 29.2 42.1 42.7 26.8 45.9 21.9 41.6 21.1 49.5 35.8 25.5 43.7 47.1 23.5 41.1 42.4 35.6 25.8 43.2 22.6 10.6 12.3 11.2 12.0 37.8 40.8 12.8 18.2 25.3 16.6 18.8 16.2 20.4 10.5 19.8 20.6 31.6 19.8 13.1 27.7 23.3 8.1 8.0 13.5 21.6 31.6 48.4 8.0 12.8 28.1 65.2 23.6 35.1 39.4 16.4 8.3 14.0 20.6 22.8 10.6 8.1 21.1 12.2 55.2 11.6 6.7 9.8 10.6 25.4 40.1 14.6 9.5 41.2 13.3 43.1 33.7 10.3 21.6 24.7 17.2 11.5 19.1 11.1 14.5 8.7 8.8 17.2 8.9 33.0 42.4 35.6 21.4 23.0 34.1 26.6 23.5 26.9 23.6 41.1 19.9 43.2 28.2 39.9 25.8 31.9 15.5 25.0 22.6 25.4 34.7 36.4 29.7 28.0 16.9 49.0 18.7 33.5 41.6 145.9 85.8 49.5 216.1 262.7 59.6 57.4 96.8 143.2 127.4 146.5 15.7 88.4 333.2 126.2 58.6 116.1 96.6 0.0 147.7 27.7 204.6 118.5 212.0 76.9 78.0 54.0 72.6 97.6 100.1 19.8 266.3 164.9 91.1 213.8 57.7 176.6 122.9 89.2 201.2 56.4 47.1 38.8 169.0 50.5 33.8 275.8 155.7 62.3 90.2 201.5 NFE2L3 Nrf3 ENSG00000050344 "Nuclear factor, erythroid 2 like 3" Q9Y4A8 7 26152240-26187125 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 54.9" "Group enriched" "Detected in many" 14 "Cytotrophoblasts: 226.3;Syncytiotrophoblasts: 584.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 44.0;NTERA-2: 36.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055889 Enhanced Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Nucleoplasm, Vesicles" "HPA055889: AB_2682958" "unprognostic (4.99e-2)" "unprognostic (3.11e-1)" "unprognostic (4.36e-3)" "unprognostic (5.37e-2)" "unprognostic (8.41e-2)" "unprognostic (4.00e-3)" "unprognostic (7.29e-3)" "unprognostic (1.87e-1)" "unprognostic (2.12e-1)" "unprognostic (9.88e-2)" "prognostic unfavorable (6.62e-5)" "unprognostic (2.32e-1)" "prognostic unfavorable (7.58e-12)" "prognostic favorable (2.14e-4)" "unprognostic (2.40e-1)" "unprognostic (8.25e-2)" "unprognostic (4.13e-3)" 3.5 2.5 0.8 7.8 1.2 1.6 4.1 6.2 1.6 1.8 6.7 4.0 2.4 6.2 1.9 1.7 3.1 2.4 7.1 3.6 1.3 1.1 4.2 2.3 5.8 6.9 2.5 0.8 1.7 7.5 0.0 2.1 54.9 2.1 3.7 4.0 2.1 7.7 0.4 3.4 8.2 7.1 0.8 3.7 10.4 5.6 2.5 1.5 11.2 1.6 1.5 8.9 3.1 2.1 1.4 2.8 0.8 1.1 1.1 2.6 0.4 12.7 1.1 0.5 1.3 0.0 0.0 44.0 2.5 5.0 4.9 9.1 8.4 22.3 0.9 16.8 0.2 18.6 2.7 1.9 4.3 11.3 8.7 2.7 1.7 1.8 6.1 3.4 1.5 17.0 0.4 0.5 2.0 0.7 7.3 11.4 3.6 2.6 22.6 1.0 1.7 1.0 2.7 36.9 3.5 4.5 1.5 0.1 6.3 6.7 12.6 4.0 4.7 0.0 1.0 0.4 12.8 0.6 0.9 23.9 0.4 0.7 0.2 10.2 13.8 21.9 1.0 0.0 5.5 17.0 0.0 1.1 0.0 0.5 1.1 1.6 1.0 2.1 1.0 2.8 1.4 1.2 0.7 0.8 1.1 0.3 0.9 2.6 0.4 0.8 1.2 6.2 1.6 1.3 1.1 2.5 0.8 2.1 1.5 6.0 3.2 0.8 2.8 1.5 1.2 1.4 17.8 1.4 5.7 10.4 0.0 226.3 0.0 9.8 0.7 3.8 3.3 0.0 4.7 28.3 2.3 3.6 27.6 0.0 21.3 0.0 1.2 3.1 12.9 0.0 0.0 11.1 1.7 5.4 6.5 0.9 11.2 4.3 0.0 0.3 1.3 0.0 1.0 0.3 5.7 1.4 584.2 4.9 8.3 5.4 NFIA "KIAA1439, NFI-L" ENSG00000162599 "Nuclear factor I A" Q12857 1 60865259-61462793 "Disease related genes, Predicted intracellular proteins, Transcription factors" "DNA replication, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Leydig cells: 378.6;Peritubular cells: 412.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 37.8;T-47d: 20.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006111, HPA008884" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006111: AB_1854422, HPA008884: AB_1854421" "unprognostic (1.50e-3)" "unprognostic (1.32e-1)" "unprognostic (2.06e-1)" "unprognostic (1.05e-1)" "unprognostic (3.44e-2)" "prognostic favorable (7.30e-4)" "unprognostic (2.55e-1)" "unprognostic (1.22e-2)" "unprognostic (9.12e-2)" "unprognostic (9.38e-2)" "unprognostic (2.85e-2)" "unprognostic (5.20e-2)" "prognostic favorable (7.01e-4)" "unprognostic (2.11e-1)" "unprognostic (1.20e-1)" "unprognostic (2.23e-2)" "prognostic unfavorable (2.03e-4)" 29.1 17.7 21.9 17.0 19.1 15.9 28.5 42.1 16.9 23.1 20.1 17.1 19.2 9.1 17.1 16.3 27.9 20.4 18.7 25.7 18.2 13.7 13.7 48.4 11.3 8.7 16.9 13.0 22.1 17.2 24.5 14.1 6.5 21.9 26.0 12.8 16.4 25.3 26.5 30.8 11.6 12.3 44.0 25.8 11.7 14.9 11.1 15.9 2.9 36.6 14.9 8.8 35.6 30.9 1.3 2.4 5.2 5.0 0.7 5.6 2.8 3.4 3.3 0.4 37.8 15.9 10.5 0.1 0.8 2.6 0.8 1.6 0.2 2.6 5.8 2.7 1.6 0.8 4.5 1.4 9.3 0.4 13.4 3.0 0.3 8.5 2.7 3.6 0.7 1.2 13.2 7.6 3.7 15.4 2.8 9.9 1.8 3.6 10.9 0.7 1.7 0.1 0.1 1.7 3.5 3.3 0.5 3.9 9.6 2.0 6.9 3.7 2.8 2.0 15.9 5.2 0.5 20.1 0.2 9.4 0.6 5.4 8.7 1.6 0.9 1.6 0.0 0.9 0.0 0.8 5.2 5.0 2.3 3.7 3.4 5.5 1.3 4.5 5.6 2.4 0.5 4.4 5.3 0.2 0.7 4.3 1.7 0.1 2.8 21.9 19.1 42.1 16.9 18.2 13.7 16.9 13.0 21.9 15.9 32.8 33.6 5.4 59.0 75.6 33.8 159.5 142.7 66.9 62.6 45.4 2.0 4.7 23.2 26.4 20.8 92.6 15.2 140.2 42.1 1.3 154.1 78.8 26.5 273.8 12.6 39.7 24.2 171.2 52.2 9.9 378.6 13.7 43.9 16.2 43.1 155.3 21.3 31.6 412.3 88.5 5.8 142.3 149.4 6.0 8.1 66.7 1.4 11.4 64.6 44.8 NFIB "NFI-RED, NFIB2, NFIB3" ENSG00000147862 "Nuclear factor I B" O00712 9 14081843-14398983 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "DNA replication, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 55.0;HBEC3-KT: 22.3;HUVEC TERT2: 22.2;TIME: 21.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003956 Supported Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA003956: AB_1854424" "unprognostic (1.93e-1)" "unprognostic (3.18e-2)" "unprognostic (4.00e-1)" "unprognostic (2.16e-3)" "unprognostic (1.12e-1)" "unprognostic (2.55e-2)" "unprognostic (1.32e-1)" "unprognostic (4.72e-3)" "unprognostic (7.46e-2)" "unprognostic (9.35e-2)" "unprognostic (3.68e-1)" "unprognostic (1.12e-1)" "prognostic favorable (3.53e-4)" "unprognostic (4.69e-1)" "unprognostic (2.39e-1)" "unprognostic (1.87e-2)" "unprognostic (1.62e-1)" 29.3 9.5 22.6 9.2 12.9 1.0 39.7 30.0 22.9 14.8 17.0 13.6 34.1 11.3 16.8 22.3 11.5 17.0 18.0 24.1 22.0 9.3 18.8 22.3 16.3 9.8 10.8 15.5 18.7 17.5 8.2 6.0 14.7 13.7 21.3 10.4 9.2 40.0 41.3 20.8 23.6 16.8 24.2 14.9 10.4 14.2 7.6 15.6 2.7 18.8 13.9 7.7 27.4 23.4 0.3 0.3 2.4 0.4 0.5 1.0 1.3 6.4 4.6 2.9 55.0 13.9 8.1 0.1 0.1 0.0 1.3 4.8 0.0 2.6 0.1 4.3 0.4 4.2 1.4 2.7 22.3 2.4 0.9 2.6 19.8 10.4 0.6 4.6 0.5 0.1 7.0 3.1 5.0 18.5 5.2 22.2 0.0 0.6 0.1 1.8 3.0 0.0 0.1 1.0 2.9 5.4 0.0 2.6 0.0 4.1 2.4 4.6 17.2 4.7 5.8 1.9 0.1 11.7 0.0 21.7 4.3 6.4 3.3 4.0 0.5 0.4 1.6 3.8 0.1 5.4 1.3 0.1 0.2 0.3 0.2 1.0 0.2 0.2 0.2 0.1 0.3 0.2 0.1 2.4 0.5 0.4 0.3 0.5 1.3 22.6 12.9 30.0 18.8 22.0 9.3 10.8 15.5 13.7 15.6 47.6 31.8 8.5 155.7 238.9 30.8 173.3 203.8 49.5 63.7 43.6 0.0 4.1 33.2 58.5 2.9 193.3 44.6 0.0 108.3 1.6 65.3 158.3 3.5 91.3 1.9 0.0 21.9 176.8 10.2 2.3 124.0 9.2 89.4 2.8 28.6 261.1 66.5 55.8 45.6 159.0 8.8 84.1 186.4 0.7 0.9 147.9 1.4 2.2 68.3 55.3 NFIC "CTF, CTF5, NF-I, NFI" ENSG00000141905 "Nuclear factor I C" P08651 19 3314403-3469217 "Predicted intracellular proteins, Transcription factors" "DNA replication, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 101.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SiHa: 50.8;U-2197: 50.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004300, CAB004674, HPA052625" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "CAB004300: , CAB004674: AB_425564, HPA052625: AB_2681889" "unprognostic (2.59e-1)" "unprognostic (5.07e-3)" "unprognostic (2.11e-1)" "prognostic favorable (1.52e-6)" "unprognostic (8.38e-2)" "unprognostic (1.71e-3)" "unprognostic (1.14e-1)" "unprognostic (3.04e-1)" "unprognostic (9.66e-2)" "unprognostic (1.73e-1)" "unprognostic (6.81e-2)" "unprognostic (3.16e-2)" "unprognostic (2.03e-2)" "unprognostic (2.54e-1)" "unprognostic (9.65e-2)" "unprognostic (2.85e-2)" "unprognostic (1.80e-3)" 25.1 19.8 8.5 11.1 11.1 5.7 14.9 15.3 19.9 23.3 19.7 16.8 27.1 6.4 20.8 14.2 19.6 18.5 21.5 25.7 9.5 6.3 14.4 29.0 12.9 9.1 11.8 8.1 31.8 46.9 22.7 14.6 5.1 11.7 18.8 5.3 20.4 33.9 22.2 101.7 16.8 8.5 26.5 10.9 11.6 16.4 8.6 11.3 2.7 15.6 23.2 10.2 22.4 17.4 2.3 4.0 11.3 5.3 8.4 3.3 3.2 18.0 26.6 0.3 16.1 14.7 12.7 1.7 16.5 9.3 11.2 8.0 0.6 6.3 0.1 6.0 15.0 7.9 8.8 4.5 11.1 4.6 12.8 3.8 3.4 21.5 5.3 11.6 5.3 6.8 11.1 7.9 15.4 6.0 7.2 10.3 1.0 9.1 17.0 8.1 13.0 3.0 1.1 0.8 0.7 11.0 7.9 10.2 7.1 4.2 3.7 3.7 9.8 50.8 5.1 4.9 0.2 14.9 4.1 15.4 19.2 17.3 50.2 22.5 0.5 0.7 0.1 26.5 11.6 27.8 1.8 5.2 2.4 3.3 5.3 2.8 2.1 3.0 3.0 4.0 2.3 2.1 2.1 11.3 8.4 1.1 1.6 1.1 3.2 8.5 11.1 15.3 19.9 9.5 6.3 11.8 8.1 11.7 11.3 74.5 75.4 25.9 115.4 89.0 183.3 100.5 295.5 62.9 37.5 87.2 55.0 7.9 44.7 127.5 28.8 99.2 19.6 23.3 164.2 5.6 86.6 147.1 25.4 318.2 50.4 76.3 46.0 115.4 123.7 14.1 233.8 34.0 43.9 52.3 35.0 141.1 110.1 39.6 237.9 45.2 62.2 71.1 110.3 9.0 44.9 85.4 7.1 18.8 48.6 91.9 NFIX NF1A ENSG00000008441 "Nuclear factor I X" Q14938 19 12995608-13098796 "Disease related genes, Predicted intracellular proteins, Transcription factors" "DNA replication, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 139.7" "Cell type enhanced" "Detected in many" 5 "Leydig cells: 103.9;Peritubular cells: 118.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 37.3;fHDF/TERT166: 50.2;U-138 MG: 47.9;U-2197: 45.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007533 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA007533: AB_2667855" "unprognostic (3.32e-1)" "unprognostic (1.37e-2)" "unprognostic (2.84e-1)" "unprognostic (2.20e-1)" "unprognostic (2.29e-1)" "unprognostic (8.12e-2)" "prognostic favorable (4.66e-4)" "prognostic favorable (2.35e-4)" "unprognostic (1.26e-1)" "unprognostic (2.01e-2)" "unprognostic (3.25e-1)" "unprognostic (2.63e-2)" "unprognostic (1.08e-2)" "unprognostic (3.46e-2)" "unprognostic (2.92e-2)" "unprognostic (3.06e-2)" "unprognostic (4.38e-2)" 28.6 6.6 21.3 8.0 23.8 5.8 15.5 57.0 60.8 25.1 17.9 41.0 8.9 9.2 29.9 12.4 29.2 29.2 21.8 24.1 27.3 15.0 4.6 8.9 20.3 3.1 21.6 29.8 31.8 10.2 6.8 7.0 5.3 22.1 35.4 8.7 19.5 56.6 26.1 139.7 39.7 10.1 27.6 28.3 5.0 14.6 7.2 23.4 1.2 12.8 29.1 8.1 15.6 17.7 1.1 0.6 0.6 0.8 0.1 2.6 0.5 9.2 3.8 0.2 29.4 27.9 37.3 0.3 11.6 16.5 11.1 7.9 0.3 0.8 0.1 3.4 50.2 7.6 4.2 3.1 9.0 4.9 6.1 4.9 4.7 1.9 4.0 13.4 1.9 2.6 24.9 2.6 10.8 6.0 19.8 2.9 2.0 1.5 1.4 7.0 2.9 3.4 1.5 0.1 2.0 32.3 10.0 5.5 5.3 0.1 2.0 4.4 11.8 8.6 0.0 10.7 0.0 5.5 4.1 3.0 47.9 6.1 45.6 16.2 1.1 0.4 0.0 12.3 2.9 14.9 0.6 0.4 0.0 2.4 0.8 2.6 0.1 0.1 0.0 0.1 1.1 0.9 0.2 0.5 0.1 0.2 0.6 0.0 0.5 21.3 23.8 57.0 60.8 27.3 15.0 21.6 29.8 22.1 23.4 11.9 53.6 3.7 37.7 52.2 7.5 30.5 28.1 20.1 20.5 14.0 3.9 0.2 1.7 21.7 42.2 15.7 8.9 93.5 10.9 0.2 43.1 67.6 3.5 26.3 0.9 0.0 11.6 14.7 2.9 29.0 103.9 3.6 25.3 1.0 24.1 87.7 12.8 14.0 118.5 8.8 2.0 6.5 26.2 12.9 13.2 44.9 0.2 0.7 26.2 27.1 NFKB1 "KBF1, NF-kappaB, NF-kB1, NFkappaB, NFKB-p50, p105, p50" ENSG00000109320 "Nuclear factor kappa B subunit 1" P19838 4 102501329-102617302 "Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "monocytes: 303.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004031, HPA027305" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004031: AB_330564, HPA027305: AB_1854429" "unprognostic (1.06e-1)" "unprognostic (1.61e-2)" "unprognostic (4.37e-2)" "unprognostic (2.38e-2)" "unprognostic (1.60e-1)" "unprognostic (1.20e-1)" "unprognostic (2.04e-2)" "unprognostic (8.98e-2)" "unprognostic (1.96e-1)" "unprognostic (9.03e-3)" "unprognostic (2.28e-1)" "unprognostic (2.71e-1)" "prognostic favorable (1.76e-4)" "unprognostic (1.84e-2)" "unprognostic (6.75e-3)" "unprognostic (1.74e-1)" "unprognostic (6.92e-3)" 19.8 14.7 8.2 37.7 12.0 44.5 26.6 12.4 10.3 18.2 17.1 10.4 10.4 10.7 17.5 11.2 20.5 16.4 20.3 14.5 7.5 5.1 13.2 15.8 26.9 46.0 11.4 4.8 17.5 14.3 10.2 8.7 13.7 10.0 18.8 14.6 10.8 17.7 13.5 17.1 19.6 16.7 16.0 10.1 30.0 14.6 9.3 12.5 37.5 14.7 16.3 26.7 18.4 22.7 5.8 10.4 5.5 7.1 14.3 10.6 3.5 17.1 9.7 5.2 7.9 16.2 14.6 6.4 9.9 29.1 12.3 12.5 10.7 24.6 28.1 8.9 15.5 17.8 13.7 10.3 17.2 16.9 25.3 6.1 11.9 7.8 11.5 15.1 21.2 25.4 12.0 12.1 11.9 16.6 8.9 15.4 9.4 11.6 20.6 8.8 12.1 1.8 11.7 3.1 12.7 8.9 15.0 12.4 12.7 11.5 24.2 3.6 5.9 18.1 25.3 9.9 5.2 5.1 15.9 19.7 16.7 8.7 9.0 13.8 9.1 6.3 27.3 10.7 10.9 23.6 5.2 5.4 4.9 3.4 7.1 6.0 5.6 8.4 5.6 10.4 5.8 10.6 8.9 5.5 14.3 5.9 7.4 4.5 3.5 8.2 12.0 12.4 10.3 7.5 5.1 11.4 4.8 10.0 12.5 38.7 46.7 27.4 82.1 147.0 6.7 16.5 12.7 24.1 36.4 19.2 5.9 12.5 3.3 25.5 3.8 30.8 32.3 0.0 31.9 14.4 46.3 57.3 111.6 20.3 23.2 19.1 32.2 22.7 57.1 0.9 22.2 56.9 52.3 303.0 36.5 10.3 40.0 26.9 32.5 21.4 6.5 0.0 61.7 2.1 6.6 131.4 11.9 22.4 32.1 74.8 NFKB2 "LYT-10, NF-kB2, p105, p49/p100, p52" ENSG00000077150 "Nuclear factor kappa B subunit 2" Q00653 10 102394110-102402529 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "monocytes: 115.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 50.5;Karpas-707: 55.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008422, CAB022098, HPA023900" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB022098: , HPA008422: AB_1854434, HPA023900: AB_1854435" "unprognostic (1.10e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (3.86e-4)" "unprognostic (1.53e-2)" "unprognostic (8.08e-3)" "unprognostic (2.15e-1)" "unprognostic (2.38e-3)" "unprognostic (3.98e-2)" "prognostic favorable (8.45e-5)" "unprognostic (4.04e-1)" "unprognostic (8.34e-2)" "unprognostic (4.14e-2)" "prognostic unfavorable (6.69e-12)" "unprognostic (2.37e-3)" "unprognostic (1.63e-1)" "unprognostic (4.90e-2)" "unprognostic (1.56e-1)" 14.9 10.8 5.6 43.6 7.1 40.6 18.7 2.0 4.9 12.5 20.1 4.2 9.4 11.3 18.8 11.0 12.9 10.8 20.4 10.9 4.6 2.5 15.5 14.5 20.6 34.2 6.6 2.5 15.1 17.4 5.2 6.3 12.8 7.9 19.6 5.2 7.3 16.7 15.1 13.6 10.4 14.1 24.0 7.7 28.0 13.1 6.6 5.8 19.5 11.5 14.8 39.2 21.9 24.4 5.2 1.4 7.5 3.4 1.3 2.0 0.9 21.4 13.4 2.7 10.7 3.3 5.1 6.4 6.1 19.6 6.2 9.0 8.0 17.6 9.9 15.3 3.7 15.5 13.0 6.1 8.4 2.5 50.5 3.6 2.5 3.2 4.6 9.4 1.6 14.4 7.0 4.1 10.4 10.3 8.6 2.2 5.2 2.3 55.2 2.4 7.3 2.5 6.7 3.4 4.7 4.8 5.4 7.4 7.8 10.5 6.3 0.5 3.0 5.0 12.2 8.6 2.9 9.4 4.8 6.4 6.5 9.5 9.1 16.3 36.5 33.8 10.4 10.6 4.2 3.4 0.3 2.4 0.1 1.4 1.5 1.4 5.2 1.7 1.5 1.4 4.5 1.8 1.5 7.5 1.3 3.4 0.9 2.0 0.9 5.6 7.1 2.0 4.9 4.6 2.5 6.6 2.5 7.9 5.8 8.9 9.1 51.9 51.4 38.6 1.9 2.2 17.8 1.4 18.2 17.4 15.7 4.7 5.0 29.4 1.1 15.8 40.4 0.0 18.1 14.3 9.4 46.1 72.5 3.4 19.0 0.0 15.6 9.8 13.8 0.9 6.9 24.3 28.7 115.4 13.1 4.9 35.6 14.0 4.6 9.2 5.1 0.0 25.6 1.7 10.2 39.0 19.3 24.9 10.6 38.3 NFKBIB "IKBB, TRIP9" ENSG00000104825 "NFKB inhibitor beta" Q15653 19 38899700-38908893 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 80.2" "Group enriched" "Detected in all" 13 "Early spermatids: 932.5;Late spermatids: 859.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063734 Approved Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA063734: AB_2685107" "unprognostic (2.73e-1)" "unprognostic (3.24e-1)" "unprognostic (2.14e-1)" "unprognostic (9.16e-2)" "unprognostic (1.42e-1)" "unprognostic (4.35e-2)" "unprognostic (1.72e-1)" "unprognostic (2.79e-1)" "unprognostic (2.82e-1)" "unprognostic (8.84e-2)" "unprognostic (1.90e-1)" "unprognostic (4.51e-2)" "unprognostic (1.21e-2)" "unprognostic (2.19e-2)" "unprognostic (4.35e-1)" "unprognostic (2.08e-1)" "unprognostic (3.50e-3)" 7.9 7.1 7.0 12.5 9.8 22.0 6.8 2.9 7.3 3.9 7.6 8.1 7.6 10.8 5.8 5.7 8.6 5.1 7.6 7.1 7.3 5.8 7.9 14.6 6.7 8.7 11.2 5.2 4.3 9.7 4.0 3.9 7.2 7.2 5.0 3.6 5.1 8.6 6.6 13.9 8.0 11.7 5.1 9.9 9.2 12.4 80.2 9.3 6.0 6.6 8.7 8.7 6.6 5.1 3.8 5.4 12.4 5.8 8.7 7.2 2.9 8.1 10.2 1.5 3.6 1.5 0.9 4.8 5.5 2.2 3.0 3.4 7.2 4.4 9.0 6.2 1.2 2.8 4.5 3.8 2.7 0.9 27.5 4.9 6.0 1.9 4.1 5.3 6.9 12.8 1.2 3.0 3.3 4.2 0.8 1.6 6.7 7.0 8.3 1.1 5.3 8.5 6.8 5.1 6.9 4.2 12.0 6.3 8.2 1.4 3.2 8.9 5.3 3.5 5.1 3.9 0.9 3.0 5.9 3.9 5.1 6.5 8.7 8.4 17.3 15.3 19.2 3.3 7.2 6.2 1.5 4.3 12.4 5.3 5.8 4.1 3.6 3.1 4.5 3.8 3.8 2.3 3.4 9.0 8.7 4.7 5.4 7.2 2.9 7.0 9.8 2.9 7.3 7.3 5.8 11.2 5.2 7.2 9.3 8.9 22.4 22.8 35.7 28.0 10.9 6.5 10.2 4.0 11.4 12.2 3.9 24.4 6.6 26.6 932.5 20.4 53.1 23.3 27.0 21.6 13.5 31.8 66.8 18.7 21.9 23.8 21.2 8.0 14.6 859.8 12.7 18.6 16.9 37.9 17.0 13.0 38.2 17.5 14.2 19.2 11.5 19.4 18.9 20.1 14.9 21.1 49.4 29.9 18.2 31.5 NFKBIE IKBE ENSG00000146232 "NFKB inhibitor epsilon" O00221 6 44258166-44265788 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 85.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002692, HPA005941, CAB010272" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "CAB010272: AB_2235977, HPA002692: AB_1079479, HPA005941: AB_1079478" "prognostic favorable (1.72e-5)" "unprognostic (1.43e-1)" "unprognostic (1.39e-2)" "unprognostic (2.37e-2)" "unprognostic (6.32e-3)" "unprognostic (1.28e-1)" "prognostic unfavorable (3.50e-4)" "unprognostic (4.88e-2)" "unprognostic (1.09e-1)" "unprognostic (3.43e-2)" "unprognostic (3.36e-1)" "unprognostic (2.60e-1)" "prognostic unfavorable (1.37e-6)" "unprognostic (2.61e-2)" "unprognostic (8.83e-2)" "unprognostic (1.37e-2)" "prognostic favorable (8.07e-4)" 5.8 5.2 7.6 24.6 5.4 24.0 5.2 9.4 7.8 3.7 8.0 4.2 3.2 6.7 4.7 5.5 6.9 3.0 9.8 4.6 7.9 5.5 11.5 8.7 15.9 17.1 6.0 4.1 6.1 7.1 3.5 4.1 6.0 4.8 7.1 5.9 3.6 7.7 4.1 3.7 7.4 9.5 3.6 5.0 29.6 6.3 7.9 3.7 14.5 5.5 4.6 22.7 6.7 6.7 8.1 8.2 7.1 10.2 0.8 3.5 1.6 13.9 3.5 4.9 7.7 1.9 1.4 2.6 2.5 12.2 7.7 8.1 7.5 6.6 7.5 8.9 2.5 20.7 3.0 5.2 7.8 8.7 12.9 2.9 3.9 1.5 8.4 6.0 12.8 11.8 3.7 3.4 7.1 4.4 6.5 5.2 3.6 3.6 20.2 1.9 7.1 2.5 26.1 2.6 22.0 1.9 4.7 4.4 6.9 17.7 15.2 3.1 4.0 1.7 6.4 10.1 4.3 4.4 15.0 9.1 4.4 5.1 2.7 7.7 12.9 5.4 13.9 3.9 14.2 8.2 7.1 8.1 3.8 1.8 9.4 3.5 8.1 2.4 1.6 6.8 7.3 1.1 1.7 3.2 0.8 10.2 8.2 3.0 1.6 7.6 5.4 9.4 7.8 7.9 5.5 6.0 4.1 4.8 3.7 0.0 11.9 25.1 19.3 34.0 3.3 3.4 15.3 0.0 3.4 3.5 2.0 4.3 14.9 42.8 13.7 8.7 11.0 0.0 18.4 6.2 6.8 25.5 33.3 1.6 52.3 3.2 14.3 4.9 17.8 25.0 1.7 66.3 45.5 85.6 7.0 2.6 39.6 24.6 2.5 10.3 4.0 6.5 16.9 21.4 8.7 34.4 4.5 9.6 6.6 32.1 NFKBIL1 "IKBL, NFKBIL" ENSG00000204498 "NFKB inhibitor like 1" Q9UBC1 6 31546870-31558829 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 4.9;ASC TERT1: 5.1;HEK 293: 21.0;JURKAT: 8.6;U-266/70: 9.4;U-266/84: 7.8;U-698: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006298 Supported Nucleoplasm NA NA Nucleoplasm "HPA006298: AB_1079480" "unprognostic (1.11e-1)" "unprognostic (3.18e-1)" "unprognostic (2.01e-1)" "prognostic unfavorable (3.38e-4)" "unprognostic (1.21e-1)" "unprognostic (3.63e-1)" "unprognostic (2.51e-2)" "unprognostic (6.29e-2)" "unprognostic (5.41e-2)" "unprognostic (5.97e-3)" "unprognostic (5.54e-2)" "unprognostic (1.33e-1)" "unprognostic (2.16e-1)" "unprognostic (8.73e-2)" "unprognostic (9.92e-2)" "unprognostic (3.15e-1)" "unprognostic (7.50e-2)" 19.3 20.7 7.9 8.8 8.8 4.9 16.4 9.8 13.7 9.8 13.0 7.4 11.4 4.9 9.2 23.0 15.1 24.5 12.8 6.5 7.1 6.9 8.5 8.7 16.1 9.8 7.4 7.3 16.1 18.6 4.9 10.1 6.8 6.7 11.5 4.9 7.0 11.8 13.9 24.3 28.8 8.8 11.2 6.8 19.1 16.7 12.9 8.3 6.3 12.7 7.6 5.1 13.8 11.3 0.3 2.0 1.6 1.7 1.5 0.9 0.5 0.0 3.6 0.0 0.1 4.9 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 2.4 0.0 0.0 4.1 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 7.8 4.9 0.0 0.0 0.0 0.6 1.7 0.6 0.9 0.4 0.5 0.3 0.1 0.5 1.6 0.3 0.3 0.7 1.6 1.5 1.3 2.0 0.6 0.5 7.9 8.8 9.8 13.7 7.1 6.9 7.4 7.3 6.7 8.3 6.0 5.1 17.7 22.5 18.4 15.6 4.4 25.5 8.1 2.3 24.4 2.0 18.5 33.2 23.3 5.5 16.2 28.0 0.0 27.6 23.3 18.1 21.9 6.9 13.6 21.3 6.4 7.5 16.5 21.6 5.3 23.6 15.1 8.5 25.2 22.6 24.7 28.1 22.1 24.4 18.5 15.2 25.8 20.2 11.2 9.2 16.4 24.7 13.1 21.7 15.9 NFRKB "DKFZp547B2013, INO80G" ENSG00000170322 "Nuclear factor related to kappaB binding protein" Q6P4R8 11 129863636-129895590 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007082, HPA007128" Approved Enhanced Nucleoplasm Yes No Nucleoplasm "HPA007082: AB_1079481, HPA007128: AB_1079482" "unprognostic (1.22e-1)" "unprognostic (3.42e-2)" "unprognostic (2.12e-1)" "unprognostic (9.41e-2)" "unprognostic (6.56e-2)" "unprognostic (2.65e-2)" "prognostic unfavorable (5.78e-4)" "unprognostic (6.36e-3)" "unprognostic (1.68e-2)" "unprognostic (1.82e-1)" "unprognostic (2.00e-1)" "unprognostic (5.31e-2)" "unprognostic (9.22e-2)" "unprognostic (4.15e-2)" "unprognostic (6.57e-2)" "unprognostic (7.14e-2)" "unprognostic (3.93e-2)" 5.8 7.8 10.1 7.8 13.7 13.4 7.3 17.0 11.2 7.8 9.2 7.6 7.0 8.5 12.7 12.4 8.7 12.5 6.3 4.5 8.4 5.2 7.4 6.6 7.1 8.8 7.5 9.1 14.6 11.4 10.3 10.2 8.4 7.4 9.6 6.7 9.2 9.9 9.6 10.4 14.6 9.0 11.8 5.5 7.0 8.3 27.0 7.0 13.6 18.8 6.6 10.6 10.5 9.5 7.8 8.5 11.1 9.8 3.7 11.5 6.9 7.8 7.5 17.1 9.2 7.3 7.3 10.8 5.4 5.0 6.5 6.4 23.4 13.6 18.8 15.0 4.2 9.6 20.2 16.5 10.7 6.1 7.4 14.4 37.1 13.6 9.7 5.3 9.4 12.6 4.6 11.9 10.7 11.3 7.5 11.2 12.7 21.6 14.4 6.5 7.1 8.0 16.3 8.7 11.6 17.8 11.9 7.4 8.6 8.2 24.8 8.8 9.2 12.3 12.2 3.4 13.3 28.4 8.8 8.8 9.8 9.7 7.2 6.8 4.6 5.6 17.3 4.1 18.7 8.4 11.1 8.4 10.0 10.9 9.8 11.5 5.9 11.1 9.1 8.5 7.8 9.3 7.5 10.0 3.7 8.5 7.7 7.4 6.9 10.1 13.7 17.0 11.2 8.4 5.2 7.5 9.1 7.4 7.0 8.9 15.9 5.2 15.5 26.1 9.3 7.3 7.6 12.0 13.6 7.0 9.8 16.8 6.6 9.6 8.2 7.0 9.7 0.0 8.8 13.2 10.4 9.4 10.4 10.4 9.0 7.9 8.2 8.6 8.1 5.8 13.6 7.3 13.5 10.0 8.8 9.7 8.9 7.0 9.9 6.9 10.6 32.3 8.4 39.3 45.3 30.7 19.5 10.0 10.6 15.4 NFS1 "IscS, NifS" ENSG00000244005 "NFS1, cysteine desulfurase" Q9Y697 20 35668055-35699359 "Enzymes, Predicted intracellular proteins" "Molybdenum cofactor biosynthesis" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB034314, HPA051801, HPA054755" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB034314: AB_2235980, HPA051801: AB_2681616, HPA054755: AB_2682594" "unprognostic (1.72e-1)" "unprognostic (2.96e-1)" "unprognostic (1.27e-2)" "unprognostic (5.88e-3)" "unprognostic (1.05e-1)" "unprognostic (4.33e-2)" "unprognostic (1.14e-1)" "unprognostic (2.02e-1)" "unprognostic (9.00e-2)" "unprognostic (1.73e-1)" "unprognostic (6.52e-3)" "unprognostic (3.93e-2)" "prognostic favorable (4.72e-6)" "unprognostic (2.33e-2)" "unprognostic (1.97e-1)" "unprognostic (1.64e-2)" "unprognostic (5.54e-2)" 10.2 28.0 16.9 6.7 19.3 3.7 9.7 15.3 20.8 11.2 11.7 12.0 10.0 11.0 8.4 9.9 10.1 11.7 9.9 19.2 14.6 14.0 36.9 33.0 7.8 7.0 16.5 15.5 12.5 14.0 20.7 14.8 7.8 14.3 9.5 13.0 12.2 12.6 12.2 19.7 9.5 9.6 10.1 12.4 6.6 10.3 25.3 15.8 4.9 10.2 8.4 10.4 8.1 7.7 10.4 11.2 7.4 8.1 12.8 11.4 6.1 13.2 16.5 5.8 6.1 15.8 14.5 11.7 10.1 10.8 15.4 10.0 29.8 7.6 11.3 20.0 9.4 15.7 16.8 19.7 20.5 13.9 5.0 9.3 24.2 17.7 23.1 13.2 10.2 4.7 11.6 19.6 12.0 13.2 11.4 11.4 13.4 17.2 7.6 10.7 20.3 11.4 10.7 6.6 30.4 24.9 4.5 18.8 19.0 15.6 9.0 7.3 6.6 25.3 24.6 16.5 14.2 21.9 9.1 8.3 17.4 8.3 10.1 9.9 11.0 15.1 10.4 14.7 11.1 8.5 2.5 8.1 7.4 7.6 7.7 9.7 10.4 8.8 11.2 11.2 7.6 10.3 9.3 3.4 12.8 6.0 5.6 11.4 6.1 16.9 19.3 15.3 20.8 14.6 14.0 16.5 15.5 14.3 15.8 6.0 16.7 9.7 7.5 5.5 12.2 19.3 20.4 2.7 6.8 17.4 9.8 28.1 28.2 13.8 4.2 5.7 12.1 0.0 9.8 17.9 7.5 4.8 6.9 24.1 14.2 14.3 6.4 8.0 8.9 3.4 5.2 8.5 10.1 15.4 7.8 14.5 9.3 9.9 9.9 41.3 11.8 12.9 8.7 36.8 17.8 5.0 17.6 9.6 13.4 5.0 NFU1 "CGI-33, HIRIP5, NifU, NIFUC" ENSG00000169599 "NFU1 iron-sulfur cluster scaffold" Q9UMS0 2 69395750-69437628 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035826 Uncertain Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA035826: AB_2674803" "unprognostic (4.49e-3)" "unprognostic (5.62e-2)" "unprognostic (5.40e-2)" "unprognostic (1.84e-1)" "unprognostic (2.81e-1)" "unprognostic (2.16e-3)" "unprognostic (2.63e-2)" "unprognostic (1.76e-1)" "unprognostic (6.12e-2)" "unprognostic (1.55e-1)" "unprognostic (1.31e-1)" "unprognostic (2.12e-1)" "unprognostic (2.21e-3)" "unprognostic (2.63e-1)" "unprognostic (1.14e-1)" "unprognostic (1.91e-2)" "unprognostic (2.87e-1)" 32.3 26.0 24.9 14.7 23.5 14.9 59.9 19.7 40.4 14.7 20.0 12.1 16.0 15.9 17.1 31.8 13.9 17.6 15.9 83.2 21.4 23.6 32.8 20.0 23.0 20.8 24.1 29.7 18.5 21.7 22.9 23.0 19.1 23.7 17.5 20.8 12.2 19.1 19.8 69.3 9.7 16.3 28.9 24.8 13.9 18.7 16.5 16.8 7.8 21.4 28.3 14.4 19.0 19.4 18.2 17.7 16.0 17.5 12.9 18.2 8.0 20.3 18.8 19.7 19.7 25.1 23.8 21.5 22.0 19.4 19.3 14.5 40.9 17.9 12.3 11.5 18.1 30.6 9.2 20.2 20.6 27.0 25.9 19.8 13.8 16.1 37.2 25.7 25.1 21.0 19.9 12.1 20.8 14.3 22.0 24.6 14.5 23.7 15.1 34.7 4.3 13.2 43.1 18.0 21.8 21.3 14.6 30.9 5.0 29.5 21.5 15.9 12.6 12.0 11.0 34.2 21.8 13.3 17.6 24.2 24.6 17.6 19.1 29.4 19.9 16.8 8.1 18.5 25.5 18.9 13.5 8.5 16.0 12.1 12.4 11.8 15.9 12.3 14.4 8.6 18.2 12.8 14.4 2.8 12.9 17.5 17.7 18.2 8.0 24.9 23.5 19.7 40.4 21.4 23.6 24.1 29.7 23.7 16.8 29.8 16.1 41.2 30.6 14.3 22.2 90.1 35.7 50.9 15.9 36.6 11.8 101.7 160.8 46.6 83.4 32.3 30.2 23.3 53.3 58.8 29.6 33.8 57.7 33.6 71.3 17.5 51.2 28.3 33.0 20.9 32.2 38.6 37.1 88.4 43.8 34.7 48.9 45.6 34.6 134.1 25.7 45.3 49.1 77.4 52.4 13.0 51.3 35.0 49.8 27.4 NFX1 "MGC20369, NFX2, TEG-42, Tex42" ENSG00000086102 "Nuclear transcription factor, X-box binding 1" Q12986 9 33290511-33371157 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, DNA-binding, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056310, HPA061382, HPA073519" Approved Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA056310: AB_2683097, HPA061382: AB_2684496, HPA073519: AB_2686614" "unprognostic (3.90e-2)" "unprognostic (6.01e-2)" "unprognostic (1.19e-2)" "unprognostic (1.40e-1)" "unprognostic (3.07e-2)" "unprognostic (2.02e-2)" "unprognostic (9.11e-2)" "unprognostic (1.81e-2)" "unprognostic (8.71e-2)" "prognostic favorable (3.75e-4)" "unprognostic (3.40e-2)" "unprognostic (1.27e-1)" "unprognostic (1.13e-3)" "unprognostic (3.36e-2)" "unprognostic (1.14e-2)" "unprognostic (9.62e-2)" "unprognostic (3.20e-2)" 23.7 19.8 17.6 17.8 26.3 22.5 24.1 33.0 26.7 19.2 24.4 24.7 18.0 19.2 26.3 19.2 22.3 18.6 14.4 26.4 16.2 16.0 17.4 31.3 19.6 23.1 17.8 19.5 26.5 20.9 28.3 30.9 17.7 25.2 20.4 22.4 19.3 22.9 23.6 44.8 31.2 23.0 21.5 18.1 21.0 19.3 14.4 22.0 35.1 26.7 19.1 32.8 24.7 19.8 10.7 12.3 22.9 7.1 6.8 10.1 5.0 15.3 12.5 11.5 10.9 17.2 19.4 11.6 14.5 14.5 16.5 16.5 11.4 6.3 23.8 9.3 16.7 11.1 8.7 20.5 15.7 15.5 17.4 10.3 12.5 30.6 12.7 21.0 22.2 13.9 18.1 26.3 14.0 35.5 14.8 10.0 13.6 19.0 20.8 17.2 10.8 14.3 20.9 18.7 11.3 14.2 15.4 12.6 13.0 11.1 14.7 16.0 11.2 14.5 15.7 8.3 14.2 9.1 22.2 12.5 13.5 11.3 9.7 15.7 11.2 10.1 23.7 14.8 11.3 7.7 22.9 4.2 7.9 8.4 7.1 8.9 10.7 9.0 9.0 7.1 9.1 10.1 9.9 3.0 6.8 5.5 12.3 6.1 5.0 17.6 26.3 33.0 26.7 16.2 16.0 17.8 19.5 25.2 22.0 56.6 43.9 35.8 19.9 7.4 27.8 34.3 28.1 53.5 48.9 26.2 51.1 10.2 6.6 13.9 65.8 11.3 19.0 23.3 11.5 10.2 12.0 21.1 17.4 26.0 12.8 20.6 8.7 16.5 16.7 13.3 17.0 11.5 3.3 13.6 22.8 15.1 11.3 17.6 21.5 6.4 32.6 12.9 11.2 12.1 13.1 9.8 15.1 13.1 16.7 16.1 NFXL1 HOZFP ENSG00000170448 "Nuclear transcription factor, X-box binding like 1" Q6ZNB6 4 47847233-47914667 "Predicted membrane proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 100.7;Spermatocytes: 72.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059132 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA059132: AB_2683917" "unprognostic (5.37e-2)" "unprognostic (2.89e-1)" "unprognostic (5.14e-3)" "unprognostic (6.13e-2)" "unprognostic (1.81e-2)" "unprognostic (4.33e-2)" "prognostic unfavorable (9.28e-4)" "unprognostic (1.13e-2)" "unprognostic (6.26e-3)" "unprognostic (8.48e-3)" "unprognostic (8.34e-2)" "unprognostic (4.47e-2)" "unprognostic (4.72e-3)" "unprognostic (8.89e-2)" "unprognostic (3.15e-1)" "unprognostic (6.67e-2)" "unprognostic (8.01e-2)" 8.3 5.8 7.8 7.2 8.7 6.5 10.8 19.1 9.4 10.1 7.4 6.2 12.2 7.8 13.3 19.2 9.7 9.6 6.9 5.5 6.7 5.5 7.4 9.5 7.4 6.5 7.0 9.6 10.9 12.8 11.9 19.6 8.7 7.6 9.0 8.6 5.3 12.4 10.2 7.1 9.3 7.4 8.8 8.8 7.5 8.2 21.3 7.0 5.9 17.2 4.4 7.7 9.2 10.9 2.5 1.9 5.6 2.3 1.5 3.5 1.7 5.5 3.5 3.9 8.1 7.5 12.4 13.4 3.8 5.4 6.2 7.8 5.9 12.7 4.4 7.3 2.5 12.1 5.7 10.1 7.6 7.4 3.4 3.9 4.7 6.5 10.8 9.7 11.5 9.5 8.1 10.2 4.3 25.6 7.4 5.4 9.3 8.4 5.5 6.4 5.3 9.0 5.4 9.5 7.6 5.5 8.1 7.6 7.3 7.9 10.6 12.5 6.0 2.8 8.0 5.5 7.9 5.5 3.4 4.4 8.2 5.1 3.8 8.4 8.9 5.4 8.9 4.7 6.5 7.1 0.0 1.7 1.7 2.3 2.3 2.8 2.2 3.2 2.5 1.6 2.5 3.5 3.4 5.6 1.5 1.1 1.9 2.0 1.7 7.8 8.7 19.1 9.4 6.7 5.5 7.0 9.6 7.6 7.0 6.0 8.3 1.5 4.0 4.7 19.0 100.7 15.3 8.1 13.6 7.0 9.8 5.0 10.0 7.2 28.3 7.3 5.8 0.0 6.0 9.5 8.0 6.1 2.3 7.2 4.3 7.9 10.9 4.3 3.5 12.4 11.8 6.2 1.7 4.6 7.4 9.1 6.3 3.5 9.6 3.1 16.0 0.0 3.6 72.2 24.3 3.8 5.6 4.9 6.9 5.1 NFYA "CBF-B, HAP2, NF-YA" ENSG00000001167 "Nuclear transcription factor Y subunit alpha" P23511 6 41072945-41099976 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 34.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009250, HPA050779" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB009250: AB_2152107, HPA050779: AB_2681234" "unprognostic (2.56e-1)" "unprognostic (4.48e-2)" "unprognostic (1.33e-1)" "unprognostic (1.95e-2)" "unprognostic (4.57e-1)" "unprognostic (1.94e-2)" "prognostic unfavorable (8.74e-4)" "unprognostic (1.97e-2)" "unprognostic (2.24e-2)" "unprognostic (5.23e-3)" "unprognostic (5.62e-3)" "unprognostic (1.03e-1)" "unprognostic (1.92e-3)" "unprognostic (3.11e-1)" "unprognostic (5.98e-2)" "unprognostic (1.03e-1)" "unprognostic (1.92e-3)" 14.0 10.8 20.5 16.2 27.1 34.0 14.7 20.9 19.7 11.6 11.0 15.2 8.5 9.2 14.2 14.4 12.7 11.3 11.8 10.5 17.7 10.3 9.8 13.1 13.4 16.6 24.7 13.0 18.3 12.8 15.8 15.2 12.6 17.8 13.3 13.9 9.3 11.2 14.0 10.7 10.6 11.1 12.9 17.7 13.4 11.4 34.0 19.9 32.4 18.2 9.7 18.3 11.6 25.9 6.2 5.9 10.8 5.0 8.6 11.1 4.1 12.9 10.7 20.4 34.1 8.4 8.3 8.7 9.8 9.2 15.5 13.2 13.9 9.5 15.8 8.2 6.4 8.2 8.6 12.4 11.8 17.2 11.2 15.6 20.6 9.0 19.7 6.0 21.7 18.1 5.2 10.2 12.4 16.8 7.6 13.4 26.4 20.1 19.2 15.2 12.9 24.5 8.7 9.1 38.4 10.6 20.0 11.2 11.8 11.4 17.7 20.8 14.3 8.6 7.8 15.1 13.6 7.3 22.1 13.0 27.7 15.1 5.4 18.7 7.6 7.6 26.3 5.4 18.6 10.9 3.7 4.0 6.3 8.6 5.0 11.1 5.2 8.0 9.2 4.5 6.2 8.6 9.2 10.8 8.6 4.5 5.9 8.8 4.1 20.5 27.1 20.9 19.7 17.7 10.3 24.7 13.0 17.8 19.9 8.9 3.8 9.4 9.6 12.9 4.4 4.1 7.6 6.7 4.5 10.4 3.9 6.5 1.7 8.7 34.4 5.4 6.9 0.0 6.5 8.9 6.6 9.5 2.3 6.4 8.7 0.0 4.6 8.0 5.3 25.1 3.4 5.2 6.8 5.4 3.9 3.1 7.5 7.2 2.8 2.1 5.2 0.0 7.2 21.4 7.9 13.9 9.0 10.2 5.8 19.3 NFYB "CBF-A, HAP3, NF-YB" ENSG00000120837 "Nuclear transcription factor Y subunit beta" P25208 12 104117077-104138289 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 107.1" "Cell type enriched" "Detected in all" 4 "Syncytiotrophoblasts: 362.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 60.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004211, HPA065646" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB004211: AB_628018, HPA065646: " "unprognostic (5.82e-2)" "unprognostic (2.44e-3)" "unprognostic (4.90e-2)" "unprognostic (7.10e-3)" "unprognostic (2.67e-1)" "unprognostic (4.65e-2)" "unprognostic (2.10e-2)" "unprognostic (2.44e-1)" "unprognostic (7.36e-2)" "unprognostic (2.63e-1)" "unprognostic (9.39e-2)" "unprognostic (8.51e-2)" "prognostic unfavorable (9.28e-5)" "unprognostic (1.62e-3)" "unprognostic (4.98e-2)" "unprognostic (1.36e-1)" "unprognostic (4.81e-3)" 16.1 23.4 22.2 13.9 21.3 10.8 17.5 18.5 17.5 16.1 28.2 13.6 107.1 9.9 16.8 25.8 13.7 16.0 13.7 20.0 22.6 16.9 15.4 21.8 16.0 17.4 21.9 12.4 15.9 11.3 17.3 19.0 16.3 15.6 23.5 14.4 10.1 10.3 53.7 18.5 11.2 10.6 20.0 24.9 10.1 13.8 13.7 20.4 21.4 19.2 13.5 18.5 20.2 27.9 15.6 7.4 22.8 10.2 15.1 21.1 10.7 13.7 11.9 22.7 13.8 15.3 16.7 21.4 13.8 11.4 15.3 10.5 8.8 6.5 18.5 6.7 12.3 10.0 9.1 18.2 8.8 16.6 12.6 5.7 11.2 13.3 8.1 16.1 15.9 7.8 24.1 12.0 6.2 12.0 27.8 9.9 16.8 10.8 7.5 12.7 15.6 20.0 16.0 21.4 10.0 12.9 18.8 13.1 8.1 10.8 14.0 13.6 11.2 24.2 60.4 7.8 17.6 22.6 16.4 7.4 9.0 6.1 8.1 9.9 14.4 12.3 20.6 5.7 9.8 9.2 17.3 7.5 22.8 16.3 9.5 21.1 15.6 15.7 17.1 7.4 11.3 17.5 17.4 10.5 15.1 10.2 6.8 20.5 10.7 22.2 21.3 18.5 17.5 22.6 16.9 21.9 12.4 15.6 20.4 50.6 26.1 11.9 86.4 33.2 21.7 32.7 10.2 25.4 27.3 17.4 3.9 51.6 31.5 20.9 2.8 30.3 11.3 23.3 15.8 71.2 32.7 42.2 20.8 28.0 20.2 14.3 11.5 52.2 13.0 4.5 31.7 23.0 27.0 18.0 15.1 27.5 22.7 14.4 28.7 28.6 23.3 19.4 31.9 67.7 31.1 32.4 362.3 27.7 13.4 49.2 NFYC "CBF-C, NF-YC" ENSG00000066136 "Nuclear transcription factor Y subunit gamma" Q13952 1 40691648-40771603 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "THP-1: 90.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055011 Supported Nucleoplasm NA NA Nucleoplasm "HPA055011: AB_2682671" "unprognostic (1.20e-3)" "unprognostic (1.51e-2)" "unprognostic (9.77e-2)" "unprognostic (1.37e-3)" "unprognostic (8.53e-2)" "unprognostic (1.92e-2)" "prognostic unfavorable (7.24e-4)" "unprognostic (1.47e-2)" "unprognostic (5.66e-3)" "unprognostic (3.53e-3)" "unprognostic (2.75e-1)" "unprognostic (2.60e-2)" "prognostic favorable (1.24e-4)" "unprognostic (2.25e-2)" "unprognostic (3.63e-1)" "unprognostic (3.12e-1)" "unprognostic (7.75e-3)" 25.5 22.1 18.8 32.5 24.0 27.8 23.1 35.8 39.7 23.3 22.0 24.1 22.2 22.0 27.8 22.9 25.8 23.7 20.1 45.4 18.7 15.9 25.2 24.8 19.8 25.7 15.9 22.5 33.0 31.3 26.1 18.0 35.1 18.6 23.7 18.5 30.5 35.3 22.8 49.2 30.7 23.5 23.5 17.1 32.2 22.8 33.4 16.6 37.2 27.7 33.3 33.9 23.0 23.3 20.7 25.3 43.8 31.2 16.8 18.7 15.6 9.0 12.2 18.2 13.7 7.3 6.8 18.2 7.5 8.4 13.4 12.7 17.2 22.8 21.7 11.8 7.1 11.9 10.9 14.6 11.2 13.9 13.1 15.4 23.4 9.4 15.5 8.8 12.4 20.1 7.4 12.2 13.2 14.0 10.4 8.7 16.6 10.3 13.9 6.3 12.3 22.1 12.2 15.7 10.8 9.6 16.6 19.4 19.4 12.5 11.0 12.4 11.5 9.0 19.8 20.4 22.0 8.9 90.8 7.9 6.3 21.5 10.9 11.0 12.9 20.7 17.8 14.6 15.9 16.7 20.2 26.1 26.2 12.9 29.0 13.1 20.7 17.2 14.5 25.3 19.0 18.7 14.0 43.8 16.8 31.2 19.5 17.8 15.6 18.8 24.0 35.8 39.7 18.7 15.9 15.9 22.5 18.6 16.6 17.9 17.6 27.3 24.3 26.0 17.2 30.7 7.6 9.4 18.2 10.4 9.8 62.7 31.5 24.9 6.0 25.1 20.3 0.0 32.8 41.1 20.4 17.2 36.9 21.5 46.7 23.8 15.6 22.1 25.7 4.9 25.6 29.2 16.9 42.3 22.2 26.2 23.2 14.0 20.1 18.3 11.5 19.4 30.0 28.6 34.1 28.2 63.6 25.4 26.0 20.2 NGDN "C14orf120, CANu1, DKFZP564O092, LCP5, lpd-2, NGD" ENSG00000129460 Neuroguidin Q8NEJ9 14 23469688-23509862 "Predicted intracellular proteins" "Translation regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000944 Approved Approved Nucleoplasm,Nucleoli,Mitochondria Yes No "Nucleoli, Mitochondria" Nucleoplasm "HPA000944: AB_1079483" "unprognostic (2.63e-3)" "unprognostic (7.65e-2)" "unprognostic (2.84e-1)" "unprognostic (4.16e-3)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" "unprognostic (8.87e-2)" "unprognostic (1.72e-3)" "unprognostic (5.64e-2)" "unprognostic (3.87e-3)" "unprognostic (7.10e-2)" "unprognostic (1.65e-1)" "unprognostic (6.36e-2)" "unprognostic (9.83e-2)" "unprognostic (2.29e-2)" "unprognostic (2.58e-1)" "unprognostic (1.70e-1)" 20.1 17.6 17.2 19.3 23.6 35.7 26.9 28.9 25.8 17.8 17.8 21.2 18.7 15.0 29.1 22.3 17.4 21.7 12.1 14.8 17.6 15.7 20.6 21.0 15.5 20.4 23.5 17.4 27.2 16.6 20.9 20.7 19.7 19.1 19.7 19.4 17.4 24.0 19.9 32.8 22.7 17.9 21.0 21.6 19.7 17.5 19.0 25.2 19.6 23.7 17.2 22.8 17.3 19.7 42.0 26.7 18.9 23.4 35.2 44.6 28.2 11.0 21.9 16.8 15.7 16.3 11.8 22.2 14.6 15.3 31.3 25.4 21.6 20.2 27.4 10.8 13.3 22.2 19.2 33.2 18.1 36.9 18.2 17.5 24.5 13.3 66.7 22.2 32.4 17.5 14.7 23.1 24.6 29.4 12.4 15.8 21.2 27.1 19.6 15.2 26.2 24.1 24.5 21.2 25.4 29.5 19.7 20.1 14.0 20.0 21.0 17.2 19.4 17.3 20.8 23.9 17.8 12.9 20.8 11.9 14.8 17.6 13.9 21.2 24.5 42.5 39.8 6.4 16.6 15.8 17.5 21.5 18.9 31.6 23.4 33.5 42.0 34.3 32.1 25.3 36.6 44.6 35.1 6.6 35.2 22.4 26.7 37.4 28.2 17.2 23.6 28.9 25.8 17.6 15.7 23.5 17.4 19.1 25.2 32.8 26.9 41.2 49.3 62.7 21.0 17.7 17.8 28.1 29.6 26.2 15.7 50.7 28.2 31.1 4.1 34.3 17.4 23.3 31.3 36.0 37.0 25.4 43.9 18.1 26.5 23.8 23.6 16.0 16.4 4.5 32.5 29.5 30.4 36.1 18.8 20.7 28.1 19.9 26.5 27.0 24.7 19.4 38.7 57.2 69.0 59.1 47.8 41.5 22.0 44.2 NGFR "CD271, p75NTR, TNFRSF16" ENSG00000064300 "Nerve growth factor receptor" P08138 17 49495293-49515017 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Apoptosis, Biological rhythms, Differentiation, Neurogenesis" "Developmental protein, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 17 "Basal glandular cells: 33.8;Leydig cells: 88.9;Muller glia cells: 122.0;Sertoli cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "plasmacytoid DC: 4.2" "Lineage enriched" "Detected in single" 7 "dendritic cells: 4.2" "Group enriched" "Detected in some" 7 "RH-30: 56.0;WM-115: 62.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 13.1;hypothalamus: 8.2;pons and medulla: 3.7" "CAB000143, CAB001995, HPA004765" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 100000 "Nucleoplasm, Plasma membrane" "CAB000143: , CAB001995: , HPA004765: AB_1079233" "unprognostic (6.25e-3)" "unprognostic (1.06e-3)" "unprognostic (3.39e-3)" "unprognostic (6.67e-2)" "unprognostic (1.46e-2)" "unprognostic (2.26e-1)" "unprognostic (8.22e-2)" "unprognostic (4.94e-2)" "unprognostic (1.08e-2)" "unprognostic (4.10e-3)" "unprognostic (1.85e-2)" "unprognostic (1.25e-1)" "unprognostic (3.37e-2)" "unprognostic (4.01e-2)" "unprognostic (3.06e-2)" "unprognostic (2.77e-3)" "prognostic unfavorable (3.40e-4)" 30.9 24.0 1.2 9.2 7.4 1.0 11.7 6.1 4.5 7.6 9.4 10.4 7.9 3.2 6.8 15.0 11.3 12.6 10.8 22.2 2.4 2.9 4.8 29.1 1.4 11.6 13.8 1.3 7.6 6.2 2.8 6.7 16.7 15.9 17.7 3.4 20.2 17.2 9.7 4.8 8.4 5.0 10.7 22.4 18.9 4.9 12.2 4.4 0.4 25.8 7.4 7.0 13.1 6.8 0.0 4.2 0.0 0.4 0.0 0.5 0.2 0.0 0.0 1.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.9 1.3 0.4 1.2 0.0 0.1 0.2 0.1 0.0 1.0 0.1 0.0 0.1 6.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 8.1 0.1 0.0 0.0 1.0 0.0 0.0 1.0 56.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 3.7 2.2 0.1 0.0 0.0 0.0 1.0 0.1 2.7 0.0 0.0 0.0 0.0 0.5 62.2 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 4.2 0.0 0.2 1.2 7.4 6.1 4.0 2.4 2.9 13.8 1.3 15.9 4.4 0.0 0.0 0.5 33.8 3.2 6.1 0.5 0.0 1.4 2.3 0.0 3.9 0.2 0.0 0.0 0.6 1.3 0.0 0.0 0.0 0.4 3.3 2.4 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.9 88.9 1.8 15.1 0.0 0.0 122.0 0.0 0.0 26.2 0.0 5.7 32.3 9.5 0.5 0.9 1.5 0.1 1.0 0.0 2.0 NGRN DSC92 ENSG00000182768 "Neugrin, neurite outgrowth associated" Q9NPE2 15 90265659-90278141 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 103.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041367, HPA076267" Approved Supported "Nucleoplasm,Cytokinetic bridge,Mitochondria" "Intracellular and membrane" Yes No Mitochondria "Nucleoplasm, Cytokinetic bridge" "HPA041367: AB_10796668, HPA076267: " "unprognostic (2.82e-1)" "unprognostic (1.04e-2)" "unprognostic (1.66e-3)" "unprognostic (2.34e-1)" "unprognostic (2.21e-1)" "unprognostic (3.19e-2)" "unprognostic (2.94e-2)" "unprognostic (5.00e-2)" "unprognostic (7.78e-2)" "unprognostic (1.93e-2)" "unprognostic (5.22e-2)" "unprognostic (7.22e-2)" "unprognostic (3.31e-2)" "unprognostic (2.10e-1)" "unprognostic (2.05e-1)" "unprognostic (1.68e-3)" "unprognostic (3.21e-1)" 13.3 21.3 49.2 11.0 43.2 19.4 18.7 27.6 61.5 18.5 15.6 13.8 8.4 9.3 18.9 21.0 13.1 15.2 14.1 19.1 38.9 42.2 11.2 13.3 15.3 11.9 38.9 37.7 19.4 18.9 21.1 17.1 12.3 30.9 15.5 12.1 11.4 14.4 14.5 47.6 17.7 11.3 12.4 25.7 14.0 13.9 13.8 14.0 3.8 23.3 15.4 11.4 12.7 15.4 5.2 2.4 6.0 3.1 4.2 4.8 2.5 2.9 7.4 9.8 15.4 8.6 3.7 1.2 4.2 3.3 4.0 2.9 3.5 1.7 4.7 2.8 5.0 3.4 4.9 9.5 2.4 5.8 1.9 8.8 4.5 4.5 5.4 5.5 5.2 3.4 5.1 8.7 3.7 4.8 3.8 3.6 4.8 5.6 5.8 2.4 3.5 4.9 2.2 4.6 3.6 4.4 7.5 5.5 2.3 4.2 13.1 9.8 12.3 8.1 6.5 3.5 7.0 2.6 7.4 5.8 9.6 4.1 6.2 7.5 3.8 20.0 5.0 4.2 5.4 7.8 6.0 2.3 3.6 3.2 3.1 4.0 3.5 3.1 2.7 1.2 5.2 3.7 4.4 5.0 4.2 1.9 2.4 4.8 2.5 49.2 43.2 27.6 61.5 38.9 42.2 38.9 37.7 30.9 14.0 17.9 20.6 6.7 10.6 6.4 10.7 7.8 2.5 103.1 36.4 5.2 9.8 5.1 5.0 27.1 1.5 8.4 7.3 0.0 20.6 3.7 5.0 7.7 19.7 3.4 3.7 15.9 25.4 5.5 4.0 2.2 8.3 5.9 8.5 17.2 15.6 13.3 25.7 17.5 8.1 6.7 10.4 12.9 8.6 4.8 3.6 4.4 5.6 8.5 15.7 6.4 NHEJ1 "Cernunnos, FLJ12610, XLF" ENSG00000187736 "Non-homologous end joining factor 1" Q9H9Q4 2 219075317-219160865 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Disease mutation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 10 "Enterocytes: 2.5;Intestinal endocrine cells: 2.4;monocytes: 5.4;Mucus-secreting cells: 2.6;Paneth cells: 2.9;Undifferentiated cells: 3.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012334, HPA043869" Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "CAB012334: , HPA043869: AB_2678707" "unprognostic (5.66e-2)" "unprognostic (3.01e-2)" "unprognostic (3.16e-1)" "unprognostic (2.73e-2)" "unprognostic (2.28e-1)" "unprognostic (1.06e-2)" "unprognostic (5.92e-2)" "unprognostic (5.16e-2)" "unprognostic (6.04e-2)" "unprognostic (3.51e-2)" "unprognostic (6.87e-2)" "unprognostic (1.58e-3)" "unprognostic (4.52e-2)" "unprognostic (1.65e-1)" "unprognostic (1.82e-1)" "unprognostic (8.90e-2)" "unprognostic (8.29e-2)" 11.0 9.6 5.7 9.3 6.6 4.4 14.5 9.7 6.9 9.5 14.1 6.1 7.0 11.0 10.2 6.1 7.7 6.9 10.9 5.9 6.3 3.7 12.9 8.4 7.5 7.4 9.4 4.3 10.7 13.2 6.6 7.5 6.5 5.3 13.3 18.4 6.4 6.4 6.3 17.5 8.4 20.5 10.2 4.4 8.9 9.4 28.7 5.3 13.5 8.1 5.2 10.6 11.1 15.4 15.0 11.2 7.5 21.1 12.8 18.9 10.1 5.1 7.4 14.0 11.1 15.7 18.1 8.4 10.9 10.0 13.1 12.9 23.9 6.5 10.7 9.5 11.2 12.7 7.2 19.0 9.1 11.9 15.1 9.4 21.0 8.8 19.5 13.9 10.0 14.6 16.1 20.4 11.5 13.5 9.0 10.2 7.2 20.7 13.5 9.3 6.2 10.5 10.7 15.5 6.1 7.9 13.6 9.0 10.0 12.0 7.5 11.1 11.7 6.9 7.8 18.0 15.4 5.3 9.0 9.9 10.0 8.9 4.7 9.7 7.8 7.5 13.6 7.1 17.6 8.2 4.9 14.0 7.5 9.3 21.1 14.2 15.0 13.9 11.8 11.2 12.9 18.9 13.7 3.5 12.8 16.5 5.5 14.6 10.1 5.7 6.6 9.7 6.9 6.3 3.7 9.4 4.3 5.3 5.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 1.3 0.4 0.0 2.5 0.0 1.7 0.2 0.0 0.2 0.0 0.0 0.3 0.0 2.4 0.0 0.0 0.0 0.3 0.0 0.0 5.4 2.6 0.0 1.1 2.9 0.0 0.4 0.0 0.0 0.0 0.1 0.5 0.0 0.2 0.0 3.2 0.0 NHLH2 "bHLHa34, HEN2, NSCL2" ENSG00000177551 "Nescient helix-loop-helix 2" Q02577 1 115836377-115843917 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 16.6;skin 1: 10.5" "Group enriched" "Detected in some" 7 "Basal glandular cells: 2.1;Basal keratinocytes: 2.5;Cardiomyocytes: 2.6;Intestinal endocrine cells: 1.7;Spermatocytes: 4.9;Spermatogonia: 1.5;Suprabasal keratinocytes: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 36.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055238 Uncertain Approved "Nucleoplasm,Nuclear bodies" Yes NA "Nuclear bodies" Nucleoplasm "HPA055238: AB_2682752" "unprognostic (2.20e-2)" "unprognostic (2.28e-1)" "unprognostic (1.97e-1)" "unprognostic (1.82e-1)" "unprognostic (2.17e-1)" "unprognostic (1.58e-1)" "unprognostic (4.82e-2)" "unprognostic (1.11e-2)" "unprognostic (5.26e-2)" "unprognostic (9.55e-2)" "unprognostic (2.80e-3)" "unprognostic (1.53e-1)" "unprognostic (3.09e-1)" "unprognostic (2.25e-1)" 0.2 0.2 3.4 0.2 0.9 0.2 0.6 16.6 2.4 0.3 0.3 0.4 0.5 0.3 0.2 1.4 2.5 0.2 0.3 0.2 7.1 9.1 0.2 0.2 0.9 0.2 4.1 1.5 0.2 0.2 0.2 0.1 0.5 16.3 0.7 0.4 1.0 0.4 0.7 0.6 10.5 0.3 0.2 3.1 0.2 1.0 1.6 0.6 0.0 0.2 0.0 0.3 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.9 16.6 2.4 7.1 9.1 4.1 1.5 16.3 0.6 0.0 0.0 0.0 2.1 2.5 0.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 4.9 1.5 1.9 0.0 0.0 0.0 0.3 NHLRC2 "DKFZp779F115, FLJ20147, FLJ25621, FLJ33312, MGC45492" ENSG00000196865 "NHL repeat containing 2" Q8NBF2 10 113854661-113917194 "Predicted intracellular proteins" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 67.2;Sertoli cells: 64.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038493, HPA057564" Approved Approved Nucleoplasm NA NA 73000 Nucleoplasm "HPA038493: AB_10672519, HPA057564: AB_2683469" "unprognostic (7.09e-2)" "unprognostic (7.33e-2)" "unprognostic (3.00e-1)" "unprognostic (4.74e-2)" "unprognostic (5.15e-2)" "unprognostic (1.03e-1)" "unprognostic (9.70e-2)" "unprognostic (1.66e-1)" "unprognostic (3.49e-1)" "unprognostic (1.36e-1)" "unprognostic (4.88e-2)" "unprognostic (8.98e-2)" "unprognostic (1.05e-1)" "unprognostic (8.99e-2)" "unprognostic (2.52e-1)" "unprognostic (8.60e-2)" "unprognostic (1.68e-2)" 11.2 10.3 7.7 8.1 8.4 5.2 10.3 10.5 8.7 10.2 11.7 7.0 14.7 7.5 10.5 10.2 8.9 8.9 10.5 24.8 8.0 4.1 8.1 12.0 10.9 7.6 8.1 6.6 12.3 13.1 17.0 17.9 12.3 7.3 13.1 8.5 11.4 12.5 10.3 18.7 9.8 13.1 9.8 8.4 9.7 9.4 5.3 9.3 8.7 10.9 6.1 7.6 10.8 10.7 3.6 3.9 3.9 3.9 3.2 3.7 1.4 10.2 6.5 13.0 10.6 4.7 8.6 8.2 7.2 8.6 6.3 6.9 4.5 10.1 5.5 5.2 7.2 5.5 9.2 10.6 5.9 10.7 6.6 5.3 5.8 5.3 6.4 7.2 8.4 6.8 5.9 7.4 7.0 14.4 12.1 7.5 4.0 6.9 6.4 8.4 4.8 4.8 6.6 3.8 6.3 3.3 4.4 18.6 3.2 7.7 5.7 3.4 6.9 5.6 7.2 8.7 6.3 5.3 6.3 9.5 7.6 7.6 4.7 10.8 4.4 2.2 5.6 6.2 13.4 5.0 3.9 2.7 3.1 3.3 2.2 3.1 3.4 2.6 3.7 3.2 3.6 2.3 3.0 2.1 3.2 3.9 3.9 2.3 1.4 7.7 8.4 10.5 8.7 8.0 4.1 8.1 6.6 7.3 9.3 17.9 17.6 9.2 11.1 7.0 18.4 67.2 25.5 5.3 25.0 34.9 13.7 13.8 6.6 9.2 4.0 16.4 8.4 23.3 10.6 10.9 9.2 19.7 10.4 22.7 8.6 27.0 9.9 20.3 15.9 6.0 16.7 9.0 6.8 11.8 16.3 22.5 8.9 12.4 24.8 9.8 25.3 64.7 5.7 13.3 11.4 7.3 15.2 8.7 11.7 11.2 NHP2 "FLJ20479, NOLA2" ENSG00000145912 "NHP2 ribonucleoprotein" Q9NX24 5 178149460-178153967 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis, rRNA processing" "Ribonucleoprotein, RNA-binding" "Disease mutation, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044171, HPA050400" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044171: AB_2678844, HPA050400: AB_2681113" "unprognostic (1.19e-1)" "unprognostic (1.59e-1)" "unprognostic (3.71e-2)" "prognostic unfavorable (4.97e-4)" "unprognostic (4.05e-1)" "unprognostic (3.97e-2)" "prognostic unfavorable (5.24e-4)" "unprognostic (8.87e-2)" "unprognostic (9.12e-2)" "unprognostic (1.78e-2)" "unprognostic (4.20e-2)" "unprognostic (6.72e-2)" "unprognostic (1.67e-1)" "unprognostic (1.31e-1)" "unprognostic (1.13e-1)" "unprognostic (4.04e-2)" "unprognostic (8.63e-2)" 35.4 41.0 42.5 37.5 46.4 44.2 37.9 26.2 54.2 27.1 37.3 23.7 26.2 29.0 31.9 34.4 59.4 37.6 33.6 52.3 37.7 33.6 31.3 57.1 24.9 60.3 37.1 29.3 38.2 62.1 15.1 25.3 25.0 26.7 28.0 22.4 18.6 40.0 35.5 50.9 39.1 26.7 34.2 34.1 29.9 30.4 26.9 25.6 40.6 34.5 61.9 32.9 26.8 33.4 50.8 78.2 7.1 38.9 37.9 43.8 51.2 32.7 49.5 16.0 46.4 11.0 14.5 55.9 25.6 12.4 27.4 23.8 29.0 28.0 47.0 47.4 14.1 25.5 20.5 24.0 52.9 14.6 89.3 80.8 24.8 38.6 32.5 18.7 42.3 26.8 17.5 25.1 21.5 19.4 10.8 25.6 31.2 25.0 30.3 15.3 142.0 58.6 29.4 24.7 28.3 76.7 39.7 22.0 70.1 20.5 20.9 41.4 48.0 19.2 51.8 44.5 10.3 26.6 29.9 25.9 28.8 32.3 24.3 57.3 38.2 77.0 55.9 29.9 56.0 31.5 7.1 35.3 4.8 31.6 38.9 43.8 50.8 39.2 36.3 48.7 50.0 40.8 42.0 2.7 37.9 27.0 78.2 36.3 51.2 42.5 46.4 26.2 54.2 37.7 33.6 37.1 29.3 26.7 25.6 56.6 57.1 131.8 167.2 171.7 49.1 10.9 119.8 60.2 96.7 120.4 17.7 208.0 303.4 170.3 42.0 112.3 43.9 23.3 260.6 296.0 121.9 161.1 78.4 142.5 155.5 28.6 121.6 77.3 74.8 92.9 124.8 98.1 138.3 123.6 126.5 46.8 190.5 31.6 91.6 215.9 23.6 58.2 119.3 92.2 127.8 212.3 139.6 90.9 179.9 243.4 NHSL1 "bA43P8.1, C6orf63, KIAA1357" ENSG00000135540 "NHS like 1" Q5SYE7 6 138422043-138692571 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 93.0" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 65.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.8;non-classical monocyte: 3.8" "Group enriched" "Detected in many" 14 "dendritic cells: 1.2;granulocytes: 1.0;monocytes: 3.8" "Cell line enhanced" "Detected in many" "Hep G2: 22.4;TIME: 31.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029966, HPA029967" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "HPA029966: AB_10601972, HPA029967: AB_2673271" "unprognostic (1.85e-1)" "unprognostic (9.71e-2)" "unprognostic (6.19e-2)" "unprognostic (1.81e-1)" "unprognostic (1.01e-1)" "unprognostic (1.93e-1)" "unprognostic (3.27e-1)" "unprognostic (8.34e-2)" "unprognostic (5.21e-2)" "unprognostic (9.99e-2)" "unprognostic (1.10e-1)" "unprognostic (8.00e-2)" "unprognostic (4.19e-2)" "unprognostic (3.73e-2)" "unprognostic (1.52e-1)" "unprognostic (6.55e-2)" "unprognostic (4.06e-2)" 7.4 1.1 6.0 5.4 5.7 0.2 2.4 3.7 8.6 2.2 46.3 4.3 3.4 13.4 3.0 11.2 10.0 0.9 7.2 18.4 4.8 3.4 17.4 19.5 15.0 2.0 4.2 1.3 1.2 4.6 2.8 1.7 3.5 6.3 1.7 10.0 7.9 3.4 0.4 2.3 10.5 93.0 3.0 2.8 2.0 6.8 1.6 1.6 0.2 1.2 3.6 1.7 2.4 3.9 0.1 1.2 1.0 3.8 0.1 0.1 0.7 2.6 2.3 16.6 6.9 4.8 6.0 6.2 2.4 1.1 0.9 0.8 3.0 1.5 0.0 3.1 2.0 1.6 6.1 10.0 6.2 0.4 0.2 6.7 1.6 1.1 22.4 7.2 5.9 1.2 8.6 3.5 0.4 7.2 0.9 11.7 0.9 0.0 0.9 3.6 5.2 0.6 0.4 6.6 1.5 4.4 6.8 1.7 0.5 5.7 6.8 6.3 0.0 2.5 5.2 16.7 11.5 1.6 1.9 31.9 2.3 2.3 2.3 6.5 0.6 1.2 0.0 0.2 2.4 12.8 1.0 3.4 0.5 0.1 3.8 0.1 0.1 0.0 0.1 1.2 0.0 0.1 0.1 0.1 0.1 3.8 0.7 0.0 0.7 6.0 5.7 3.7 3.5 4.8 3.4 4.2 1.3 6.3 1.6 56.6 50.9 0.8 2.4 38.0 0.7 20.3 5.1 25.4 12.5 27.9 27.5 12.0 8.3 3.0 0.8 8.3 65.2 0.0 3.1 3.0 11.6 3.5 8.1 32.7 3.9 35.0 19.4 29.4 6.7 0.0 0.6 3.8 20.3 0.0 29.8 14.7 3.5 45.6 0.0 12.9 0.9 6.5 4.6 0.0 0.7 43.0 36.3 0.9 40.2 7.4 NICN1 MGC12936 ENSG00000145029 "Nicolin 1" Q9BSH3 3 49422946-49429326 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 25.0;Erythroid cells: 23.3;Late spermatids: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA058014 Supported Nucleoplasm NA NA Nucleoplasm "HPA058014: AB_2683579" "unprognostic (4.10e-2)" "unprognostic (1.08e-2)" "unprognostic (7.31e-2)" "unprognostic (1.33e-3)" "unprognostic (1.14e-1)" "unprognostic (1.31e-2)" "unprognostic (1.31e-2)" "unprognostic (4.50e-3)" "unprognostic (1.04e-2)" "unprognostic (2.88e-2)" "prognostic favorable (1.11e-4)" "unprognostic (2.46e-1)" "prognostic favorable (8.81e-7)" "unprognostic (3.11e-2)" "unprognostic (2.37e-1)" "unprognostic (1.03e-2)" "unprognostic (2.96e-2)" 9.6 12.1 19.3 5.7 23.4 3.6 10.5 21.5 27.9 9.2 9.7 8.4 12.8 7.8 12.0 12.8 5.3 10.7 8.7 16.9 12.7 10.9 16.8 10.9 10.4 8.5 9.6 21.6 13.7 12.6 10.1 10.2 6.1 12.5 10.9 5.8 10.3 13.0 10.2 14.4 8.6 8.3 9.7 8.1 9.7 10.0 13.5 10.6 7.0 13.7 7.0 8.8 9.5 8.9 9.2 8.1 8.1 8.5 6.7 10.9 7.3 2.5 8.5 8.8 6.2 3.7 4.5 3.3 3.0 2.9 2.9 3.5 1.9 7.9 8.2 3.2 6.6 6.3 2.3 5.1 4.0 2.8 14.7 3.2 7.9 8.8 9.5 6.9 3.5 5.3 9.2 4.8 6.4 2.1 14.0 4.0 17.0 4.9 0.2 3.2 2.6 5.7 5.6 3.4 3.3 2.6 4.2 2.8 10.3 5.3 1.4 2.1 3.5 2.3 2.5 6.1 19.1 4.4 2.3 10.5 2.0 2.3 2.1 1.6 9.1 3.7 2.8 7.1 8.6 3.8 8.1 7.3 6.9 8.0 5.4 5.3 9.2 5.0 9.4 5.9 5.6 6.2 7.6 2.1 6.7 8.5 8.1 10.9 7.3 19.3 23.4 21.5 26.2 12.7 10.9 9.6 21.6 12.5 10.6 0.0 0.6 0.5 5.0 3.7 6.1 10.7 5.1 1.4 1.2 0.0 9.8 5.3 0.0 0.0 25.0 3.8 4.0 23.3 0.0 1.7 4.6 2.6 1.1 4.5 4.9 3.2 11.6 1.8 4.7 27.9 8.9 1.5 3.3 0.0 3.4 5.8 0.0 1.4 5.6 0.0 6.3 6.5 3.1 12.2 2.3 2.9 2.7 5.2 2.3 4.2 NIN ENSG00000100503 Ninein Q8N4C6 14 50719763-50831121 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 87.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA005939, HPA070691" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Centrosome" NA NA Centrosome "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA005939: AB_2667474, HPA070691: AB_2686296" "unprognostic (1.98e-1)" "unprognostic (1.06e-1)" "unprognostic (3.54e-2)" "unprognostic (3.96e-1)" "unprognostic (1.52e-1)" "unprognostic (1.43e-2)" "unprognostic (3.41e-2)" "unprognostic (3.31e-1)" "unprognostic (5.81e-3)" "unprognostic (1.78e-2)" "unprognostic (2.07e-1)" "unprognostic (4.06e-1)" "unprognostic (2.46e-2)" "unprognostic (2.67e-1)" "unprognostic (1.28e-1)" "unprognostic (2.58e-2)" "unprognostic (7.66e-3)" 13.0 6.1 15.1 24.9 10.3 34.8 9.7 12.6 14.0 8.0 9.2 7.6 4.5 5.0 11.8 6.1 11.8 8.2 7.6 16.4 11.7 4.9 6.7 5.2 10.7 30.2 7.6 10.0 11.0 5.4 9.1 12.3 20.2 7.1 6.5 7.7 6.2 8.2 5.1 16.9 10.9 8.3 12.0 7.1 18.2 9.3 4.6 9.0 16.4 7.8 5.1 25.8 11.7 10.3 6.8 6.3 18.4 2.3 1.5 6.0 1.3 12.3 8.7 18.3 15.5 7.0 11.4 7.6 10.6 9.1 8.9 7.5 5.6 6.6 29.1 7.3 14.3 8.5 13.0 14.7 6.7 18.9 14.0 4.5 10.7 5.4 5.3 4.1 18.6 30.9 7.8 5.4 15.7 6.4 5.3 14.2 15.1 2.6 11.9 13.5 13.5 14.1 7.5 2.5 3.9 9.7 16.0 33.8 2.1 8.0 14.0 8.5 9.6 13.3 4.0 11.4 4.2 7.6 16.6 20.7 22.8 31.7 8.7 11.7 9.6 4.8 20.1 5.9 15.2 12.3 12.6 2.3 18.4 3.3 1.7 3.5 6.8 2.2 6.0 1.5 5.5 4.4 3.8 8.3 1.5 1.5 6.3 1.9 1.3 15.1 10.3 12.6 14.0 11.7 4.9 7.6 10.0 7.1 9.0 6.0 7.7 41.0 7.0 16.4 7.5 37.9 12.7 26.8 36.4 10.4 58.9 9.2 3.3 6.9 22.3 24.1 4.1 0.0 3.5 8.9 27.9 13.0 30.1 3.9 20.1 6.4 12.1 27.0 40.6 7.8 7.8 47.2 21.9 12.6 3.9 87.7 4.7 5.8 8.9 5.1 18.0 32.3 20.8 0.0 0.4 18.3 8.1 37.4 4.6 14.5 NINJ2 ENSG00000171840 "Ninjurin 2" Q9NZG7 12 564296-663779 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.7;brain: 43.6" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 32.8;Hofbauer cells: 25.9;Kupffer cells: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 41.4;MOLT-4: 70.0;THP-1: 14.8;U-698: 13.3" "Low region specificity" "Detected in many" "HPA058980, HPA067226" Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Centriolar satellite,Cytosol" NA NA "Endoplasmic reticulum" "Nucleoplasm, Plasma membrane, Centriolar satellite, Cytosol" "HPA058980: AB_2683869, HPA067226: " "unprognostic (1.16e-1)" "unprognostic (2.19e-1)" "unprognostic (9.51e-2)" "unprognostic (6.25e-3)" "unprognostic (1.37e-1)" "prognostic favorable (5.31e-4)" "unprognostic (5.72e-3)" "unprognostic (1.90e-3)" "unprognostic (4.60e-2)" "unprognostic (4.98e-3)" "unprognostic (5.88e-2)" "unprognostic (5.12e-2)" "unprognostic (2.68e-2)" "unprognostic (9.05e-2)" "unprognostic (1.03e-2)" "unprognostic (3.51e-3)" "unprognostic (1.23e-1)" 11.8 1.4 9.8 9.2 14.1 27.8 9.2 2.4 18.5 7.3 5.0 43.6 1.6 4.6 2.9 3.3 8.4 3.8 4.7 7.9 16.4 8.7 1.4 13.8 31.3 10.8 21.8 10.2 0.8 1.8 0.9 1.1 3.9 17.2 2.7 4.5 2.9 4.5 2.8 20.1 6.7 3.9 4.8 26.4 8.8 3.6 3.9 21.1 3.6 2.6 2.2 9.2 9.0 3.9 5.6 14.9 34.2 17.7 5.7 44.7 9.1 0.4 0.1 0.0 0.4 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.8 3.2 0.0 0.1 1.6 0.4 0.0 0.0 0.0 0.0 2.3 0.0 41.4 9.9 0.5 0.0 1.1 1.7 0.6 0.0 0.0 0.0 0.0 0.8 0.8 2.4 7.1 0.0 0.0 70.0 2.2 0.7 0.0 0.0 1.8 0.0 0.2 0.7 0.0 0.0 0.0 7.8 0.0 0.0 0.1 0.0 14.8 0.2 0.0 0.4 2.7 0.0 0.0 1.1 13.3 0.1 7.7 0.0 2.0 17.7 14.1 10.5 13.7 3.1 5.6 11.8 11.1 14.9 4.5 2.6 5.5 34.2 5.7 11.2 7.8 44.7 9.1 9.8 14.1 2.4 18.5 16.4 8.7 21.8 10.2 17.2 21.1 20.8 32.8 6.5 0.2 5.0 0.0 1.2 0.0 6.7 14.8 0.0 0.0 2.3 1.7 0.0 2.1 5.4 1.6 0.0 0.0 3.2 5.6 0.2 2.3 10.6 25.9 0.0 4.1 5.5 33.3 1.9 7.5 17.3 6.8 6.4 3.2 0.3 0.5 3.5 3.9 0.0 0.0 0.0 1.0 3.2 2.5 4.8 0.7 14.4 3.3 0.0 NIP7 "CGI-37, FLJ10296, HSPC031, KD93" ENSG00000132603 "NIP7, nucleolar pre-rRNA processing protein" Q9Y221 16 69339430-69343111 "Predicted intracellular proteins" "Ribosome biogenesis" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040856, HPA059850" Supported Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA040856: AB_2677171, HPA059850: AB_2684142" "unprognostic (2.14e-1)" "unprognostic (1.03e-1)" "unprognostic (2.76e-1)" "unprognostic (8.02e-2)" "unprognostic (6.47e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (1.04e-3)" "unprognostic (1.37e-3)" "unprognostic (5.72e-2)" "unprognostic (3.86e-2)" "prognostic unfavorable (6.69e-5)" "unprognostic (6.99e-2)" "unprognostic (1.18e-2)" "unprognostic (1.38e-1)" "unprognostic (1.28e-1)" "unprognostic (1.58e-1)" "unprognostic (3.33e-2)" 17.8 15.5 8.1 16.4 8.7 20.4 14.0 7.0 12.4 10.2 13.7 9.5 11.1 11.8 15.6 13.1 24.0 13.0 11.3 9.1 9.0 7.8 18.0 18.0 10.7 17.6 12.6 9.6 11.6 18.4 9.6 10.2 14.3 10.9 10.1 14.2 8.8 13.1 13.2 12.1 14.7 14.2 11.7 8.3 15.4 12.3 14.8 9.5 27.1 19.2 23.8 21.0 10.6 11.8 16.6 14.2 8.4 11.7 15.3 19.0 9.5 15.1 10.8 9.2 12.2 12.1 11.0 13.7 13.7 11.1 24.1 17.7 17.4 16.4 27.7 15.4 12.7 10.1 15.2 17.3 21.8 30.7 7.3 13.9 14.4 7.7 22.8 11.9 31.6 9.5 11.8 17.4 22.1 24.5 7.5 13.2 15.0 28.5 5.0 16.6 18.6 19.0 23.2 26.8 14.0 12.6 27.6 9.5 25.3 14.8 11.3 11.7 16.7 27.5 8.8 16.9 10.9 12.0 19.4 11.5 17.6 15.5 13.1 25.3 15.3 11.6 67.8 10.2 18.9 17.5 8.4 8.1 5.7 16.8 9.2 18.1 16.6 15.6 19.0 14.2 12.1 15.1 18.3 4.0 15.3 11.7 12.5 14.8 9.5 8.1 8.7 7.0 12.4 9.0 7.8 12.6 9.6 10.9 9.5 3.0 10.1 24.6 46.2 47.7 8.2 4.8 17.8 29.4 18.2 19.2 15.7 27.5 18.3 30.3 29.3 22.4 13.8 0.0 22.6 28.1 22.2 16.9 17.3 9.6 21.6 11.1 2.9 18.4 10.8 29.4 15.8 15.5 18.6 16.2 11.7 8.8 30.2 17.5 16.3 21.4 6.9 12.9 19.8 31.2 39.4 45.9 21.4 27.7 16.6 36.0 NIPAL3 "DJ462O23.2, NPAL3" ENSG00000001461 "NIPA like domain containing 3" Q6P499 1 24415794-24472976 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.4" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 104.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 41.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039978 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA039978: AB_10697712" "unprognostic (9.36e-2)" "unprognostic (7.63e-2)" "unprognostic (2.88e-2)" "unprognostic (1.19e-2)" "unprognostic (5.96e-2)" "unprognostic (5.38e-2)" "unprognostic (3.72e-3)" "unprognostic (3.60e-2)" "unprognostic (2.43e-1)" "unprognostic (6.66e-2)" "unprognostic (2.79e-1)" "unprognostic (3.14e-1)" "prognostic favorable (3.03e-7)" "unprognostic (1.46e-2)" "unprognostic (1.94e-1)" "prognostic favorable (3.95e-4)" "unprognostic (2.85e-1)" 5.3 5.1 21.4 5.2 21.8 4.9 8.3 41.2 29.4 6.9 8.9 42.4 5.6 7.1 4.2 7.4 10.3 10.4 6.3 9.2 25.5 21.3 9.4 2.3 9.2 7.1 32.9 14.7 5.5 11.3 14.0 6.5 2.8 31.5 38.4 9.3 7.1 9.9 5.7 3.5 7.7 8.5 8.1 34.8 4.8 9.6 3.1 22.5 5.8 20.7 2.3 7.9 7.8 5.4 12.9 8.4 8.9 3.6 9.2 26.0 9.7 12.8 5.2 0.5 1.7 7.9 8.8 1.9 41.7 29.9 15.3 11.3 1.8 14.7 6.0 13.4 23.0 3.1 12.6 5.1 15.5 15.0 12.2 15.9 6.6 8.7 2.1 7.3 5.8 6.0 8.8 14.4 10.1 30.9 13.9 5.2 11.8 3.8 3.8 9.2 2.8 4.7 2.4 3.2 6.2 14.7 2.2 0.0 6.8 16.2 4.1 19.4 1.8 5.6 7.9 11.2 3.6 10.8 4.4 7.5 13.7 2.9 4.5 9.1 11.9 9.7 2.1 9.2 10.6 12.2 8.9 3.6 4.7 10.8 3.4 10.7 12.9 18.2 14.0 6.5 10.9 26.0 16.1 1.6 9.2 2.3 8.4 17.6 9.7 21.4 21.8 41.2 24.6 25.5 21.3 32.9 14.7 31.5 22.5 44.7 28.0 14.5 11.0 8.1 52.0 21.5 17.8 9.4 19.4 38.4 104.1 3.0 3.3 11.5 2.8 8.5 24.1 46.7 13.4 4.0 8.5 26.1 12.7 3.2 4.2 12.7 18.0 7.4 3.8 5.6 3.7 7.1 13.5 6.4 14.9 15.3 17.2 14.4 4.9 3.6 53.0 0.0 6.2 2.4 5.5 14.3 3.5 20.8 16.3 16.1 NIPBL "DKFZp434L1319, FLJ11203, FLJ12597, FLJ13354, FLJ13648, IDN3, Scc2" ENSG00000164190 "NIPBL, cohesin loading factor" Q6KC79 5 36876759-37066413 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Activator, Developmental protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040834, HPA058239" Approved Supported Nucleoplasm,Vesicles,Cytosol No No Nucleoplasm "Vesicles, Cytosol" "HPA040834: AB_10796562, HPA058239: AB_2683650" "unprognostic (4.92e-2)" "unprognostic (9.77e-2)" "unprognostic (5.28e-2)" "unprognostic (8.10e-2)" "unprognostic (9.38e-2)" "unprognostic (6.02e-2)" "unprognostic (7.34e-2)" "unprognostic (3.04e-2)" "unprognostic (3.85e-2)" "unprognostic (1.33e-1)" "unprognostic (1.12e-1)" "unprognostic (6.39e-2)" "unprognostic (6.59e-2)" "unprognostic (2.33e-1)" "unprognostic (3.41e-1)" "unprognostic (1.04e-1)" "unprognostic (3.40e-2)" 16.8 13.9 13.3 21.9 15.7 22.7 15.8 22.9 15.9 17.3 19.2 10.8 20.1 10.4 18.7 16.5 16.6 14.3 15.9 12.4 13.5 7.1 12.6 13.2 16.0 16.0 17.2 11.1 21.2 14.6 30.0 20.9 17.4 13.5 15.1 13.2 8.5 17.1 24.7 18.9 18.2 18.4 13.2 11.9 18.5 14.7 14.1 19.0 42.5 18.1 14.0 16.9 17.6 29.2 4.8 4.6 11.1 4.3 3.8 4.9 1.9 10.3 6.1 16.0 7.5 10.2 11.2 11.8 8.3 9.3 9.2 7.7 8.6 10.7 15.7 5.4 10.3 10.6 9.1 13.6 7.7 13.3 12.9 7.1 19.1 27.2 6.3 7.0 22.3 12.8 8.2 9.5 10.3 13.6 8.8 11.5 9.9 18.1 11.8 8.6 5.0 15.2 8.5 7.6 6.1 5.3 13.0 25.2 6.0 6.5 14.8 11.9 8.4 40.3 10.8 8.5 13.2 11.0 13.0 12.5 12.2 13.3 10.3 6.2 8.6 11.4 18.6 6.7 15.3 9.1 10.0 4.1 5.7 4.8 3.2 4.4 4.0 3.9 4.2 3.3 4.8 4.3 4.9 11.1 3.8 4.3 4.6 2.9 1.9 13.3 15.7 22.9 15.9 13.5 7.1 17.2 11.1 13.5 19.0 122.1 90.0 21.9 65.0 42.9 59.8 76.5 43.3 84.3 83.0 31.4 72.6 34.3 5.0 46.3 10.9 63.8 39.1 70.0 40.4 27.0 34.9 58.3 78.9 22.9 32.7 38.1 39.9 33.7 44.3 10.2 61.5 61.2 23.6 64.9 38.5 49.5 45.0 45.6 53.0 10.2 67.9 51.8 44.3 162.2 75.4 41.0 63.5 61.8 38.0 88.6 NISCH "I-1, IRAS, KIAA0975" ENSG00000010322 Nischarin Q9Y2I1 3 52455118-52493071 "FDA approved drug targets, Predicted intracellular proteins" Apoptosis Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Intestinal endocrine cells: 162.6;Peritubular cells: 231.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023189 Approved Approved "Nucleoplasm,Vesicles,Microtubules,Cytokinetic bridge,Cytosol" NA NA "Nucleoplasm, Cytosol" "Vesicles, Microtubules, Cytokinetic bridge" "HPA023189: AB_1854495" "unprognostic (6.66e-2)" "unprognostic (1.58e-1)" "unprognostic (1.59e-3)" "unprognostic (4.11e-3)" "unprognostic (1.64e-1)" "unprognostic (8.08e-3)" "unprognostic (1.60e-2)" "unprognostic (6.56e-3)" "unprognostic (4.96e-2)" "unprognostic (8.33e-3)" "prognostic favorable (1.91e-4)" "unprognostic (1.40e-2)" "unprognostic (5.10e-2)" "unprognostic (1.19e-1)" "unprognostic (2.94e-2)" "unprognostic (1.47e-1)" "unprognostic (7.05e-3)" 16.5 24.9 29.7 14.3 36.1 18.1 16.7 84.5 47.5 24.1 16.4 21.4 22.1 12.9 24.4 19.5 14.1 20.9 16.4 14.1 24.7 18.8 14.9 11.8 17.1 15.9 13.2 35.6 30.7 21.8 23.3 55.3 21.0 20.8 29.8 11.4 27.0 26.5 30.2 12.2 42.5 14.8 20.9 13.3 16.8 14.8 27.3 13.9 16.3 17.1 7.8 12.6 21.9 19.5 5.8 6.6 6.5 8.3 6.1 8.1 6.4 7.4 7.9 24.6 20.0 18.4 20.4 20.2 16.2 10.7 13.0 13.3 11.8 11.3 10.5 4.5 22.4 10.7 10.1 13.0 17.6 7.7 10.6 14.0 18.9 27.5 11.4 16.8 11.1 17.0 32.0 14.2 14.0 12.0 27.5 20.9 21.1 10.0 11.7 12.1 10.7 19.8 24.6 15.0 9.6 13.5 11.8 6.7 12.2 14.8 15.0 10.4 18.2 17.5 4.6 11.2 22.4 14.5 18.7 22.8 18.3 17.6 18.5 11.5 19.5 11.1 13.3 12.6 18.1 11.1 6.3 8.3 6.5 6.4 7.6 6.3 4.7 5.4 8.1 4.5 5.8 6.5 6.5 2.9 6.1 1.1 6.6 5.8 6.4 29.7 36.1 84.5 47.5 24.7 18.8 13.2 35.6 20.8 13.9 23.8 28.8 12.0 14.1 24.5 39.6 18.2 7.6 10.7 18.2 14.0 7.9 26.9 8.3 11.4 7.2 20.2 15.8 0.0 8.2 11.6 19.3 13.0 24.3 12.4 25.4 27.0 162.6 52.2 62.2 16.8 81.7 22.2 18.6 5.4 16.3 10.6 9.2 13.9 231.3 11.0 23.3 25.8 23.1 31.1 15.6 19.4 20.3 13.8 15.0 10.8 NKAP FLJ22626 ENSG00000101882 "NFKB activating protein" Q8N5F7 X 119920672-119943772 "Predicted intracellular proteins" "Notch signaling pathway, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000916 Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA000916: AB_1079486" "prognostic unfavorable (4.20e-4)" "unprognostic (4.28e-3)" "unprognostic (9.14e-2)" "unprognostic (1.33e-3)" "unprognostic (2.66e-1)" "unprognostic (3.42e-2)" "unprognostic (3.49e-3)" "unprognostic (4.18e-3)" "unprognostic (3.70e-2)" "unprognostic (1.05e-2)" "unprognostic (1.05e-2)" "unprognostic (1.03e-1)" "unprognostic (4.14e-3)" "unprognostic (1.72e-1)" "unprognostic (1.53e-2)" "unprognostic (1.45e-1)" "unprognostic (1.49e-2)" 13.9 17.5 12.2 11.2 16.8 15.9 14.0 11.6 16.9 13.0 13.2 15.6 9.9 10.1 16.2 12.4 12.0 15.2 14.0 15.5 12.9 14.0 14.8 19.5 12.6 14.1 14.5 9.7 23.9 13.5 14.1 21.7 18.1 16.6 16.0 8.5 10.3 13.9 15.0 23.9 13.5 13.7 12.0 19.5 15.8 12.3 11.8 16.7 20.1 16.4 11.6 12.2 17.9 15.3 11.8 9.7 16.5 8.0 7.0 8.1 4.4 6.3 7.6 6.1 5.5 4.9 8.3 8.3 4.9 4.6 6.2 4.7 4.6 4.9 6.5 7.8 4.4 7.8 4.6 11.4 4.6 5.4 8.9 10.9 3.1 5.3 4.0 6.5 7.3 6.3 5.7 8.0 5.8 5.0 6.4 4.3 7.8 7.5 6.3 4.8 7.8 8.0 10.4 6.0 5.0 9.9 8.3 6.7 8.4 3.4 2.4 6.9 8.4 9.7 4.7 10.0 3.7 4.2 6.6 6.5 4.4 2.2 10.4 6.3 8.0 6.4 7.4 6.1 6.9 6.4 11.3 8.0 10.8 6.9 5.9 6.8 9.7 8.1 6.5 6.0 11.8 8.1 7.5 16.5 7.0 6.6 9.7 7.5 4.4 12.2 16.8 11.6 14.6 12.9 14.0 14.5 9.7 16.6 16.7 20.8 36.8 31.3 29.8 23.0 31.8 24.6 17.8 53.5 42.1 19.2 23.6 52.3 31.5 32.4 6.3 40.4 20.0 23.3 38.4 96.9 34.2 30.7 45.2 40.3 46.7 52.4 21.9 35.6 26.7 5.0 41.7 39.0 33.7 35.1 23.0 50.3 32.5 24.1 51.9 32.9 36.1 12.9 39.1 33.7 68.2 25.1 61.0 34.9 24.1 27.3 NKIRAS2 "DKFZP434N1526, kappaB-Ras2, KBRAS2" ENSG00000168256 "NFKB inhibitor interacting Ras like 2" Q9NYR9 17 42011382-42025644 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062861 Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA062861: AB_2684884" "unprognostic (2.53e-1)" "unprognostic (1.09e-3)" "unprognostic (2.31e-2)" "unprognostic (9.81e-2)" "unprognostic (2.55e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (5.56e-4)" "unprognostic (9.37e-3)" "unprognostic (2.89e-2)" "unprognostic (2.56e-1)" "unprognostic (6.96e-2)" "unprognostic (3.18e-2)" "prognostic unfavorable (1.23e-4)" "unprognostic (1.76e-1)" "unprognostic (2.70e-1)" "unprognostic (3.25e-2)" "unprognostic (5.42e-3)" 15.3 10.9 6.7 11.5 8.4 12.5 12.9 9.2 10.3 12.0 14.6 11.0 10.3 8.7 15.4 12.5 22.0 10.5 14.1 27.5 6.1 5.6 14.0 16.1 11.7 10.4 8.5 3.6 14.9 10.7 8.4 9.0 30.8 7.2 12.5 9.9 14.6 12.3 11.1 31.5 16.1 15.6 15.7 8.3 12.4 11.3 17.1 6.0 17.7 9.5 15.4 19.1 14.5 12.7 8.2 23.0 21.0 25.5 12.0 7.4 10.4 9.2 15.9 24.5 12.7 17.2 11.6 14.6 15.7 11.9 24.7 18.5 17.3 13.0 15.3 24.8 15.9 16.4 19.5 19.8 11.8 12.6 12.7 21.6 13.7 14.8 12.7 27.0 18.2 11.3 17.2 21.0 16.3 12.6 16.4 29.9 19.5 19.3 15.5 14.0 9.1 35.1 11.3 14.4 11.9 12.2 27.7 28.2 14.3 15.9 9.5 29.4 38.5 11.5 34.8 15.5 25.0 22.1 22.1 21.6 15.6 16.7 16.7 17.5 20.4 33.0 12.6 10.4 10.9 21.8 21.0 25.5 20.5 7.0 20.5 6.9 7.8 7.1 7.0 20.5 8.2 7.4 7.1 14.4 12.0 21.5 23.0 6.0 10.4 6.7 8.4 9.2 10.3 6.1 5.6 8.5 3.6 7.2 6.0 14.9 9.3 12.9 16.9 15.0 20.3 22.4 2.5 8.1 17.0 15.7 19.6 45.4 18.3 25.5 5.4 22.4 18.3 0.0 24.7 32.7 21.6 17.9 13.9 13.4 33.2 22.3 18.4 12.3 22.5 4.0 18.1 26.6 10.1 33.3 17.6 22.0 22.8 14.0 17.3 15.0 25.1 6.5 19.6 28.1 33.2 22.5 52.1 10.0 14.0 18.0 NKRF "ITBA4, NRF" ENSG00000186416 "NFKB repressing factor" O15226 X 119588337-119605895 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001476 Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA001476: AB_1079488" "unprognostic (6.12e-3)" "unprognostic (7.58e-2)" "unprognostic (8.10e-2)" "unprognostic (2.39e-1)" "unprognostic (9.92e-2)" "unprognostic (4.74e-3)" "prognostic unfavorable (4.92e-5)" "unprognostic (2.47e-1)" "unprognostic (1.20e-1)" "unprognostic (2.65e-1)" "unprognostic (1.33e-2)" "unprognostic (9.56e-3)" "unprognostic (2.62e-2)" "unprognostic (5.06e-2)" "unprognostic (1.04e-2)" "unprognostic (2.20e-3)" "unprognostic (3.08e-3)" 3.8 7.9 14.5 6.2 24.3 7.6 6.5 11.4 34.9 4.9 4.0 4.4 1.1 4.7 4.8 5.6 5.6 5.2 4.1 3.8 15.4 14.0 6.9 6.9 4.1 9.7 8.1 24.6 7.4 3.9 8.3 6.5 7.5 25.7 4.9 4.5 2.9 4.6 4.3 4.8 6.4 4.4 4.7 6.0 6.4 4.0 1.9 3.5 7.4 5.4 1.4 9.7 5.2 4.8 3.8 2.7 2.8 2.2 1.3 5.5 1.7 11.0 11.2 6.6 7.7 5.8 5.9 10.1 6.7 5.5 9.1 9.9 11.9 9.5 19.6 11.8 5.8 7.8 13.0 27.7 10.3 11.2 9.8 18.9 10.3 13.4 7.9 5.4 20.0 8.0 6.2 8.5 10.5 12.3 6.2 9.2 9.7 11.1 8.3 8.1 17.0 12.7 16.0 14.8 16.1 12.6 10.0 9.5 20.1 12.0 8.2 10.9 9.1 9.4 14.7 9.9 7.2 6.2 12.2 7.5 5.8 6.2 12.4 16.8 6.8 8.2 20.7 6.0 22.4 6.5 2.8 1.3 1.5 3.3 2.2 3.1 3.7 3.6 3.7 1.3 3.8 5.5 4.8 0.2 1.3 1.1 2.7 4.3 1.7 14.5 24.3 11.4 34.9 15.4 14.0 8.1 24.6 25.7 3.5 6.0 6.2 9.0 9.2 17.2 13.3 4.0 10.2 2.7 2.3 5.2 25.5 11.6 1.7 3.8 0.1 4.5 2.6 0.0 3.1 13.2 6.2 8.4 14.9 3.4 5.6 7.9 10.3 4.3 6.0 0.0 7.2 7.8 5.0 6.4 3.8 4.0 3.1 0.0 6.3 3.7 8.3 0.0 8.2 0.5 1.1 22.5 12.5 7.0 5.7 8.7 NKTR p104 ENSG00000114857 "Natural killer cell triggering receptor" P30414 3 42600614-42648741 "Enzymes, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022120, HPA051576" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" No No "Nucleoplasm, Plasma membrane, Cytosol" "HPA022120: AB_1854513, HPA051576: AB_2681540" "unprognostic (2.73e-3)" "unprognostic (3.11e-1)" "unprognostic (2.33e-1)" "unprognostic (2.06e-1)" "unprognostic (5.27e-3)" "prognostic favorable (1.26e-4)" "unprognostic (4.62e-2)" "unprognostic (5.65e-2)" "unprognostic (4.02e-2)" "unprognostic (1.61e-1)" "unprognostic (5.33e-2)" "prognostic unfavorable (6.01e-4)" "prognostic unfavorable (5.02e-4)" "unprognostic (3.82e-1)" "unprognostic (4.57e-1)" "unprognostic (1.40e-1)" "prognostic favorable (1.05e-5)" 12.9 14.4 9.8 18.8 22.2 16.3 15.9 42.0 12.3 18.8 10.4 18.5 15.4 11.8 27.2 17.4 11.0 12.0 13.1 11.2 10.9 10.5 9.5 9.7 14.6 15.5 14.5 11.3 22.7 18.4 19.2 26.9 11.1 14.1 12.9 11.1 20.4 13.2 19.5 12.0 20.0 13.3 19.4 15.0 18.5 10.1 17.8 13.8 20.6 14.9 10.9 19.4 12.9 13.9 9.3 8.5 11.7 10.0 11.1 10.2 3.6 8.9 5.2 17.2 7.0 10.3 12.6 9.7 14.6 3.7 6.1 8.3 9.0 7.2 14.2 7.0 4.4 6.0 7.9 10.1 3.7 12.5 7.1 8.5 18.2 16.3 14.6 4.4 14.0 12.0 5.1 7.2 12.0 4.6 11.1 10.7 3.4 18.3 11.0 11.5 3.7 9.5 13.7 14.8 4.8 7.6 10.1 7.7 5.8 8.5 6.9 6.1 3.6 15.7 6.5 2.4 8.0 9.6 10.2 17.1 10.9 8.0 11.9 14.0 9.5 13.3 9.9 5.8 17.2 6.7 9.2 6.2 11.7 10.2 7.7 9.4 8.9 9.8 8.5 4.7 9.3 10.0 8.7 9.1 11.1 10.0 8.5 8.3 3.6 9.8 22.2 42.0 12.3 10.9 10.5 14.5 11.3 14.1 13.8 101.3 122.0 67.1 53.1 52.4 190.3 63.1 50.9 45.5 75.1 83.7 231.7 56.8 14.9 39.7 13.6 120.9 75.7 23.3 34.0 42.2 62.5 58.7 92.6 44.7 39.4 125.5 69.0 103.2 49.9 13.7 155.3 72.2 49.0 62.3 51.5 160.2 38.7 44.6 126.2 9.7 283.7 90.5 58.5 210.1 183.7 50.1 26.2 126.8 54.0 42.1 NKX2-5 "CSX, CSX1, NKX2.5, NKX2E, NKX4-1" ENSG00000183072 "NK2 homeobox 5" P52952 5 173232109-173235357 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Atrial septal defect, Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "heart muscle: 95.6" "Cell type enriched" "Detected in some" 32 "Cardiomyocytes: 56.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 21.0;NTERA-2: 7.6;SK-MEL-30: 9.3;U-2 OS: 17.3;U-251 MG: 12.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA065034 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA065034: AB_2685409" "unprognostic (3.81e-1)" "unprognostic (8.53e-2)" "unprognostic (2.62e-2)" "unprognostic (9.57e-3)" "unprognostic (3.22e-3)" "unprognostic (6.63e-2)" "unprognostic (1.57e-1)" "unprognostic (2.72e-1)" "unprognostic (2.31e-1)" "unprognostic (5.80e-2)" "unprognostic (2.19e-1)" "unprognostic (1.77e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 95.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.1 0.0 0.0 0.2 4.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 3.0 1.1 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 4.9 21.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.1 0.3 4.2 0.0 9.3 2.9 0.0 0.0 0.0 4.0 17.3 5.3 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.7 0.1 0.1 0.0 0.0 0.0 NKX2-8 "Nkx2-9, NKX2.8, NKX2H" ENSG00000136327 "NK2 homeobox 8" O15522 14 36580579-36582607 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.6;lung: 7.7;testis: 22.9" "Cell type enhanced" "Detected in single" 18 "Basal glandular cells: 2.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.0;HaCaT: 10.0;HEK 293: 2.4;PC-3: 5.8;SiHa: 2.3" "Region enhanced" "Detected in single" "pons and medulla: 2.3" "Low region specificity" "Detected in many" HPA062879 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA062879: AB_2684892" "unprognostic (6.03e-2)" "unprognostic (1.75e-1)" "unprognostic (1.37e-3)" "unprognostic (2.27e-1)" "unprognostic (3.45e-4)" "unprognostic (2.36e-1)" "unprognostic (8.34e-2)" "unprognostic (7.80e-2)" "unprognostic (3.66e-1)" "unprognostic (3.11e-1)" "unprognostic (8.39e-3)" "unprognostic (4.60e-2)" "unprognostic (2.70e-1)" "unprognostic (6.13e-2)" 0.3 0.3 0.2 0.4 0.7 0.3 0.3 0.0 1.2 0.3 0.3 2.0 0.0 0.3 0.3 0.3 5.3 0.3 0.3 0.3 0.3 2.0 0.3 0.3 7.7 0.3 2.0 0.0 0.3 0.3 1.5 2.1 0.3 5.7 0.4 0.3 0.0 2.0 0.3 0.3 1.1 0.3 0.3 9.6 0.3 0.3 22.9 0.5 0.0 4.2 1.6 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.5 10.0 0.0 0.5 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.5 1.4 0.0 2.3 0.4 0.2 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 1.2 0.3 2.0 2.0 0.0 5.7 0.5 0.0 0.0 0.0 2.3 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.3 NKX3-1 "BAPX2, NKX3.1, NKX3A" ENSG00000167034 "NK3 homeobox 1" Q99801 8 23678693-23682927 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "prostate: 95.3" "Group enriched" "Detected in many" 6 "Basal glandular cells: 52.8;Glandular cells: 96.8" "Cancer enriched" "Detected in many" 65 "prostate cancer: 392.7" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 7 "eosinophil: 23.5;neutrophil: 23.4" "Lineage enriched" "Detected in many" 19 "granulocytes: 23.5" "Cell line enhanced" "Detected in many" "GAMG: 16.9;SiHa: 16.7;U-138 MG: 17.0;U-251 MG: 14.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA025693, HPA078571" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA025693: AB_1854522, HPA078571: AB_2732384" "unprognostic (1.47e-2)" "unprognostic (4.03e-2)" "unprognostic (2.67e-1)" "unprognostic (5.87e-2)" "unprognostic (2.56e-6)" "unprognostic (6.90e-3)" "unprognostic (1.13e-1)" "unprognostic (4.11e-3)" "unprognostic (9.42e-2)" "unprognostic (1.41e-1)" "unprognostic (3.00e-2)" "unprognostic (1.87e-1)" "unprognostic (4.37e-2)" "unprognostic (4.60e-2)" "unprognostic (3.88e-2)" "unprognostic (3.09e-2)" "unprognostic (1.69e-1)" 0.6 1.3 0.3 0.6 0.9 0.6 1.5 0.1 0.8 1.1 0.6 0.2 0.5 0.5 0.7 0.5 1.2 0.7 0.8 2.4 0.8 0.3 0.4 1.6 0.8 0.7 0.6 0.2 1.6 0.6 0.5 0.4 0.3 1.2 95.3 0.2 0.5 17.9 0.7 2.0 0.2 0.4 0.7 0.6 0.3 0.5 12.3 0.7 0.0 0.6 3.2 20.5 0.7 2.5 1.0 0.0 23.5 0.0 0.2 1.2 0.1 3.0 2.3 0.0 5.6 2.1 0.5 4.6 4.2 2.7 9.0 10.7 1.3 3.5 0.0 0.6 3.1 16.9 0.8 2.2 4.8 7.1 0.0 1.1 2.1 1.7 3.4 4.0 0.0 0.8 0.8 1.3 9.1 0.5 5.6 0.5 12.9 0.1 0.0 3.5 1.0 7.3 0.6 1.3 0.0 1.6 0.0 3.6 0.3 0.5 3.6 1.1 0.3 16.7 3.1 0.3 6.8 2.2 0.3 0.6 17.0 6.0 1.3 14.5 0.0 0.0 0.0 8.3 1.6 2.0 3.4 0.0 23.5 0.5 0.0 0.1 1.0 0.2 0.5 0.0 0.9 0.7 1.2 23.4 0.2 0.0 0.0 0.0 0.1 0.3 0.9 0.1 0.8 0.8 0.3 0.6 0.2 1.2 0.7 3.0 4.0 0.5 52.8 4.9 1.7 7.0 0.0 1.4 5.7 0.0 7.9 0.3 0.0 2.4 2.0 6.8 0.4 0.0 6.1 1.2 4.1 96.8 0.0 3.8 0.2 3.2 6.3 4.9 0.3 4.5 2.0 2.9 1.7 1.0 0.4 4.3 4.7 0.0 6.0 0.5 4.5 0.0 13.3 0.7 1.4 1.8 0.2 0.5 0.5 9.3 NKX3-2 "BAPX1, NKX3.2, NKX3B" ENSG00000109705 "NK3 homeobox 2" P78367 4 13540830-13545050 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 18.3;lymphoid tissue: 6.5" "Cell type enriched" "Detected in single" 31 "Cardiomyocytes: 3.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.6;NB-4: 12.7;NTERA-2: 7.2;THP-1: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA027564 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA027564: AB_10601973" "unprognostic (3.26e-2)" "unprognostic (1.26e-1)" "unprognostic (7.42e-3)" "unprognostic (5.97e-2)" "unprognostic (9.15e-3)" "unprognostic (5.72e-2)" "unprognostic (2.24e-5)" "unprognostic (3.49e-2)" "unprognostic (1.12e-1)" "unprognostic (4.06e-2)" "unprognostic (9.95e-2)" "unprognostic (1.80e-1)" "unprognostic (1.93e-8)" "unprognostic (5.81e-2)" "unprognostic (2.14e-1)" "unprognostic (3.08e-2)" "unprognostic (2.15e-1)" 1.7 0.0 0.1 6.5 0.1 0.0 0.1 0.1 0.1 1.1 18.3 0.1 0.1 1.6 0.9 0.1 2.3 0.2 0.4 1.8 0.1 0.0 0.4 0.1 0.1 2.0 0.1 0.1 2.9 0.2 0.0 0.9 0.1 0.1 0.6 2.4 0.1 1.5 0.6 0.1 0.1 2.0 3.2 0.1 5.3 2.8 0.9 0.1 0.1 0.3 0.9 0.1 0.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.3 1.9 0.1 0.0 1.4 0.0 0.0 0.0 0.1 0.8 0.8 0.0 0.0 0.0 1.0 0.0 4.6 0.0 0.0 0.0 2.6 0.6 1.7 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 1.9 0.0 0.7 1.7 0.0 0.7 0.0 0.4 12.7 7.2 0.0 0.5 0.0 0.7 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 2.3 1.0 7.6 0.0 0.5 3.0 0.1 0.5 2.2 0.0 0.0 0.4 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NKX6-1 "Nkx6.1, NKX6A" ENSG00000163623 "NK6 homeobox 1" P78426 4 84491987-84498450 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 6.0;esophagus: 11.0;pancreas: 10.8" "Cell type enhanced" "Detected in some" 19 "Ductal cells: 7.1;Early spermatids: 2.5;Spermatocytes: 3.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.6;HAP1: 8.1;HEK 293: 7.1;HMC-1: 5.5;PC-3: 4.8;U-2197: 9.0" "Region enhanced" "Detected in single" "pons and medulla: 1.7" "Low region specificity" "Detected in many" "HPA036774, CAB070169" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "CAB070169: AB_10011794, HPA036774: AB_10673664" "unprognostic (2.26e-1)" "unprognostic (2.12e-2)" "unprognostic (9.13e-2)" "unprognostic (3.19e-1)" "unprognostic (1.38e-2)" "unprognostic (1.30e-1)" "unprognostic (2.71e-2)" "unprognostic (2.46e-1)" "unprognostic (2.75e-2)" "unprognostic (3.82e-2)" "unprognostic (1.82e-3)" "unprognostic (1.85e-1)" "unprognostic (5.41e-2)" "unprognostic (7.13e-3)" "unprognostic (3.68e-1)" 0.2 0.0 0.3 0.2 2.2 0.0 6.0 1.0 1.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 11.0 0.0 0.2 0.2 0.4 1.3 0.2 0.2 0.2 0.2 2.5 0.2 0.2 10.8 0.0 0.2 0.2 0.9 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 1.3 0.2 1.5 2.1 0.2 0.2 3.7 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 5.6 0.9 0.1 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.5 0.2 2.3 0.0 8.1 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 1.1 0.0 0.1 0.0 0.0 0.1 4.8 0.0 2.4 0.0 0.0 0.3 1.5 0.0 0.7 0.0 0.0 1.5 0.0 0.8 0.1 0.0 2.5 9.0 2.3 0.0 0.0 0.0 1.5 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 1.0 1.1 0.4 1.3 2.5 0.2 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 2.5 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 3.8 1.0 0.0 0.0 0.0 0.0 0.0 NLE1 "FLJ10458, NLE" ENSG00000073536 "Notchless homolog 1" Q9NVX2 17 35128753-35142315 "Predicted intracellular proteins" "Notch signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 40.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018807 Approved Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA018807: AB_1848658" "unprognostic (9.19e-2)" "unprognostic (8.40e-2)" "unprognostic (4.69e-2)" "unprognostic (4.27e-2)" "unprognostic (2.52e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (8.64e-8)" "unprognostic (8.67e-3)" "unprognostic (1.98e-1)" "unprognostic (1.26e-2)" "unprognostic (6.49e-2)" "unprognostic (3.90e-2)" "unprognostic (2.00e-1)" "unprognostic (4.21e-2)" "unprognostic (1.75e-1)" "unprognostic (2.55e-1)" "prognostic unfavorable (6.39e-4)" 6.3 6.9 7.0 8.2 7.6 6.4 11.4 7.6 9.1 5.6 5.8 5.4 3.3 5.1 10.0 5.5 7.9 10.0 8.3 4.8 6.0 6.4 4.8 6.9 4.5 9.1 5.6 7.7 16.3 40.3 5.1 4.2 6.1 5.4 9.2 5.3 6.2 9.1 7.5 8.8 7.6 5.1 10.2 5.1 8.3 6.8 7.2 6.4 10.0 10.0 6.6 8.3 6.3 5.4 6.4 4.5 0.4 3.2 2.4 9.1 3.0 8.2 20.0 6.7 12.0 4.2 6.3 10.8 7.4 7.0 13.3 11.0 13.8 8.0 18.2 10.2 6.2 9.7 11.0 15.3 19.0 9.1 2.9 23.8 8.2 9.6 17.2 5.7 15.7 6.6 7.1 10.2 13.7 21.0 5.9 8.5 17.9 22.0 6.7 7.8 11.3 24.1 12.8 12.7 6.9 8.9 19.5 11.8 20.1 7.8 8.0 13.9 8.4 7.0 7.2 8.8 6.5 17.6 11.4 7.6 7.2 10.1 6.9 24.8 5.2 4.0 15.3 5.0 13.0 13.7 0.1 3.0 0.0 5.7 3.2 9.1 4.8 5.4 6.0 4.5 6.4 7.4 5.1 0.4 2.4 1.6 1.0 3.0 3.0 7.0 7.6 7.6 9.1 6.0 6.4 5.6 7.7 5.4 6.4 3.0 0.6 12.4 6.2 7.7 4.1 2.0 12.7 4.0 3.4 3.5 2.0 9.0 0.0 8.7 0.6 4.2 1.6 0.0 12.9 16.0 8.2 4.0 3.5 5.5 6.7 1.6 4.7 4.3 2.8 4.7 3.7 2.2 1.7 3.6 7.8 1.4 9.4 2.9 4.6 5.6 2.9 0.0 4.1 3.6 5.3 8.8 4.1 4.4 12.0 5.1 NLK ENSG00000087095 "Nemo like kinase" Q9UBE8 17 28041737-28196381 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Bipolar cells: 93.3;Cone photoreceptor cells: 145.3;Early spermatids: 243.8;Late spermatids: 250.1;Rod photoreceptor cells: 92.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 32 "basophil: 17.6" "Lineage enriched" "Detected in single" 32 "granulocytes: 17.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018192, HPA056511" Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions" NA NA Nucleoplasm "Nucleoli, Cell Junctions" "HPA018192: AB_1854525, HPA056511: AB_2683160" "unprognostic (7.19e-2)" "unprognostic (1.98e-1)" "unprognostic (5.54e-2)" "unprognostic (5.64e-3)" "unprognostic (2.11e-1)" "unprognostic (1.29e-1)" "unprognostic (1.67e-2)" "unprognostic (2.59e-3)" "unprognostic (2.72e-2)" "unprognostic (4.23e-3)" "unprognostic (1.07e-2)" "unprognostic (1.09e-2)" "unprognostic (5.29e-2)" "unprognostic (1.66e-1)" "unprognostic (3.92e-1)" "unprognostic (5.27e-2)" "unprognostic (6.57e-2)" 6.4 30.5 19.4 10.9 14.1 7.4 7.5 7.5 38.2 6.2 6.7 8.3 14.4 8.3 5.7 8.8 4.5 5.1 8.2 8.5 18.2 12.0 13.0 8.2 7.1 11.7 15.2 23.6 4.6 11.5 20.8 9.4 9.1 7.0 6.7 7.1 12.7 5.8 17.4 4.9 4.5 8.3 4.6 15.3 10.1 7.0 17.4 7.5 10.9 13.2 3.7 11.0 7.2 4.4 0.5 0.3 17.6 0.3 0.1 0.5 0.2 4.6 5.4 13.0 4.5 2.8 3.6 5.8 4.7 4.8 7.8 6.0 27.1 4.2 6.3 7.1 3.8 9.9 4.4 9.2 8.5 9.0 14.6 5.8 24.8 5.0 4.6 4.7 5.2 25.6 4.7 5.3 5.1 6.2 7.6 9.1 18.0 9.5 7.7 7.1 5.5 13.4 6.0 5.0 9.1 2.7 11.2 8.4 4.6 14.2 5.7 9.5 3.6 7.1 6.8 29.1 16.4 10.6 8.3 9.3 5.6 7.6 4.6 9.4 9.0 8.6 6.1 5.5 5.7 6.1 17.6 0.2 0.2 0.3 0.3 0.1 0.5 0.4 0.4 0.2 0.3 0.2 0.5 0.1 0.1 0.3 0.3 0.4 0.2 19.4 14.1 7.5 38.2 18.2 12.0 15.2 23.6 7.0 7.5 20.8 5.9 4.7 3.5 4.7 93.3 23.0 10.2 6.7 4.5 31.4 145.3 2.5 1.7 3.3 243.8 10.6 5.9 0.0 5.5 3.0 3.7 5.4 24.2 8.9 7.2 35.0 27.1 10.4 14.2 250.1 5.2 5.0 15.1 4.6 9.4 9.4 5.7 7.0 2.5 6.3 92.4 12.9 3.9 25.8 9.5 4.3 5.4 5.1 8.3 5.8 NLRP1 "CARD7, CLR17.1, DEFCAP, DKFZp586O1822, KIAA0926, NAC, NALP1, SLEV1, VAMAS1" ENSG00000091592 "NLR family pyrin domain containing 1" Q9C000 17 5499427-5619424 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Immunity, Inflammatory response, Innate immunity" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 371.4;Muller glia cells: 111.8" "Cancer enhanced" "Detected in all" "glioma: 20.2" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 23.7;Karpas-707: 42.0;U-266/70: 21.0" "CAB009189, HPA064431" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB009189: , HPA064431: AB_2685262" "unprognostic (4.40e-2)" "unprognostic (1.02e-1)" "unprognostic (3.16e-2)" "unprognostic (3.65e-2)" "unprognostic (4.00e-2)" "unprognostic (1.23e-3)" "unprognostic (4.13e-2)" "unprognostic (1.50e-2)" "unprognostic (1.02e-1)" "unprognostic (1.32e-1)" "prognostic favorable (7.57e-4)" "unprognostic (2.99e-1)" "prognostic unfavorable (1.60e-5)" "unprognostic (6.69e-2)" "unprognostic (1.26e-1)" "unprognostic (1.26e-1)" "unprognostic (1.34e-2)" 19.5 2.5 2.4 39.9 3.1 15.1 16.4 0.9 2.8 19.1 6.1 5.3 5.6 4.0 16.2 10.2 12.4 7.6 15.5 8.6 4.9 1.8 6.3 3.4 19.1 31.2 4.2 1.9 4.5 2.3 2.2 2.9 8.3 5.2 10.2 5.7 6.3 8.1 11.3 17.8 35.2 18.3 13.1 6.8 34.4 4.4 6.9 3.2 15.9 13.7 11.9 30.8 17.5 16.8 5.3 4.6 16.8 7.5 3.8 7.0 3.7 6.3 0.0 0.0 0.0 3.4 4.7 0.7 2.6 2.5 1.0 2.2 0.1 2.4 2.2 9.9 2.5 0.3 2.8 0.0 10.3 1.6 23.7 0.0 0.6 2.0 0.2 3.1 0.0 0.7 2.8 6.6 8.7 6.4 3.5 11.1 0.4 5.5 42.0 5.1 0.0 0.0 1.8 0.0 0.0 0.1 2.4 1.6 9.9 0.0 2.0 0.2 0.0 0.0 0.1 0.2 0.2 0.0 0.2 10.8 2.2 1.3 1.3 0.4 21.0 6.7 1.7 3.6 0.3 0.1 13.8 6.3 4.4 6.0 4.5 6.6 4.4 4.9 6.1 4.6 5.3 5.5 5.0 16.8 3.8 7.5 0.4 7.0 3.7 2.4 3.1 0.9 2.8 4.9 1.8 4.2 1.9 5.2 3.2 0.0 8.5 24.6 6.0 15.8 56.5 3.9 2.5 10.7 15.9 7.0 3.9 0.6 3.3 0.4 371.4 16.8 0.0 0.0 0.0 0.8 24.2 1.2 3.5 0.2 6.0 81.0 74.8 31.9 19.2 46.3 23.6 25.8 6.8 1.0 0.0 111.8 5.1 0.0 26.5 0.4 10.1 6.5 13.3 14.2 10.0 21.8 1.3 35.5 0.0 7.6 NLRP10 "CLR11.1, NALP10, NOD8, PAN5, Pynod" ENSG00000182261 "NLR family pyrin domain containing 10" Q86W26 11 7959424-7965426 "Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "placenta: 13.2;skin 1: 10.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 18.0;BJ: 5.5;HBF TERT88: 7.8;LHCN-M2: 3.4" "Region enhanced" "Detected in some" "olfactory region: 2.6" "HPA039498, HPA040101" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA039498: AB_10795679, HPA040101: AB_10795519" "unprognostic (4.06e-1)" "unprognostic (4.34e-1)" "unprognostic (9.78e-3)" "unprognostic (2.87e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 18.0 0.0 0.0 0.0 0.0 0.2 0.0 5.5 2.7 1.3 2.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 1.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.2 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NLRP12 "CLR19.3, Monarch1, NALP12, PAN6, PYPAF7, RNO2" ENSG00000142405 "NLR family pyrin domain containing 12" P59046 19 53793603-53824394 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 22.8;bone marrow: 11.0;lung: 6.5;lymphoid tissue: 13.5" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 9.0;Club cells: 6.8;granulocytes: 7.0;Kupffer cells: 12.3;Macrophages: 6.1" "Cancer enriched" "Detected in single" 5 "testis cancer: 2.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 22.8;neutrophil: 15.0" "Group enriched" "Detected in many" 4 "granulocytes: 22.8;monocytes: 8.7" "Group enriched" "Detected in some" 4 "HMC-1: 7.7;THP-1: 6.7;U-87 MG: 7.3;U-937: 6.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042099, HPA042981" Approved Uncertain "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA042099: , HPA042981: AB_10795712" "unprognostic (6.92e-2)" "unprognostic (3.11e-1)" "unprognostic (6.66e-3)" "unprognostic (9.82e-2)" "unprognostic (1.81e-4)" "unprognostic (3.90e-2)" "unprognostic (5.79e-2)" "unprognostic (6.26e-2)" "unprognostic (1.29e-1)" "unprognostic (1.60e-5)" "unprognostic (1.63e-1)" "unprognostic (1.68e-1)" "unprognostic (3.35e-2)" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "unprognostic (1.46e-2)" "unprognostic (4.48e-1)" 1.9 0.3 0.2 4.2 0.6 11.0 0.4 0.2 0.2 0.9 0.3 0.1 0.9 0.3 0.7 0.7 0.6 1.0 0.5 3.3 0.2 0.2 0.5 0.5 6.5 13.5 0.6 0.3 1.0 0.3 0.1 0.2 1.1 0.8 0.3 0.1 0.5 1.7 0.0 0.2 0.2 0.3 1.4 0.5 10.2 0.4 1.0 0.6 0.3 0.3 0.4 0.2 1.1 1.4 0.0 3.6 22.8 8.7 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 1.6 7.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 6.7 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 7.3 6.1 0.0 22.8 8.7 11.0 0.0 2.6 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 15.0 0.0 1.5 0.0 0.0 2.1 0.2 0.6 0.2 0.2 0.2 0.2 0.6 0.3 0.8 0.6 6.0 9.0 0.0 0.7 0.3 0.8 0.4 0.0 4.0 6.8 0.0 0.0 0.1 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.1 0.4 0.7 7.0 0.0 2.4 0.0 0.0 0.0 12.3 0.0 0.3 6.1 1.7 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.6 NMB "MGC17211, MGC2277, MGC3936" ENSG00000197696 "Neuromedin B" P08949 15 84655129-84658563 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "adipose tissue: 37.2;brain: 28.5;breast: 59.9" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 91.4" "Cancer enhanced" "Detected in all" "glioma: 93.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 28.0" "Region enriched" "Detected in many" 16 "olfactory region: 206.6" "Group enriched" "Detected in many" 6 "olfactory region: 80.6;pons and medulla: 17.5" CAB019302 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Secreted to blood" NA NA "Nucleoplasm, Vesicles" "Plasma membrane" "CAB019302: " "unprognostic (2.44e-2)" "unprognostic (1.10e-1)" "unprognostic (2.34e-3)" "unprognostic (3.79e-1)" "prognostic favorable (3.43e-4)" "unprognostic (3.81e-1)" "unprognostic (6.45e-2)" "unprognostic (1.45e-2)" "unprognostic (2.17e-1)" "unprognostic (4.36e-1)" "unprognostic (7.24e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (2.25e-4)" "unprognostic (7.92e-3)" "unprognostic (1.45e-1)" "unprognostic (1.71e-2)" "unprognostic (1.00e-1)" 37.2 8.0 4.6 2.8 7.5 3.3 59.9 2.4 28.5 4.0 6.5 13.7 1.0 2.3 3.1 3.2 2.5 5.0 4.5 7.0 7.0 12.2 4.4 1.9 3.8 3.6 6.6 3.5 3.4 3.3 2.7 4.2 1.4 5.6 1.9 2.1 2.6 4.6 1.8 2.0 1.8 1.4 2.9 9.9 2.0 2.5 6.4 4.8 2.2 8.9 4.9 1.9 4.7 8.5 7.0 10.4 5.9 0.8 1.3 6.4 2.6 28.0 10.7 2.0 0.4 5.5 2.5 0.2 1.7 3.3 3.8 5.2 3.7 7.7 1.2 4.5 4.4 0.0 5.0 10.7 2.2 2.2 10.5 13.5 4.3 4.2 17.4 1.4 2.9 4.7 2.5 0.9 5.9 2.3 2.5 5.5 7.7 0.0 0.4 2.1 16.4 2.7 9.5 7.9 5.9 3.1 8.4 0.0 12.4 3.6 2.2 1.1 12.2 2.8 1.6 12.7 2.1 1.9 11.2 1.4 0.7 3.7 3.5 2.7 0.2 3.0 2.6 8.7 16.2 4.5 0.0 0.8 5.9 6.3 0.6 2.3 4.9 5.0 6.4 3.5 7.0 4.8 3.6 1.2 1.3 0.3 10.4 5.6 2.6 4.6 7.5 2.4 8.5 7.0 12.2 6.6 3.5 5.6 4.8 3.0 2.4 14.3 22.9 13.9 1.6 2.2 7.6 10.7 7.9 29.6 0.0 1.7 11.6 91.4 24.0 11.3 1.7 0.0 50.2 7.5 17.3 30.7 5.7 2.9 30.9 4.8 17.9 4.9 4.8 7.5 4.0 28.4 32.1 29.7 4.9 7.0 39.2 7.0 3.5 22.5 2.3 12.9 29.9 11.1 21.2 11.2 2.6 11.4 8.0 39.6 NMD3 CGI-07 ENSG00000169251 "NMD3 ribosome export adaptor" Q96D46 3 161104696-161253532 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035019 Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA035019: AB_10600922" "unprognostic (1.37e-2)" "unprognostic (2.71e-1)" "unprognostic (9.50e-2)" "unprognostic (9.39e-3)" "unprognostic (1.95e-3)" "unprognostic (1.18e-2)" "unprognostic (1.03e-1)" "unprognostic (4.41e-2)" "unprognostic (2.00e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (2.03e-5)" "unprognostic (7.97e-2)" "unprognostic (5.57e-2)" "unprognostic (6.17e-2)" "unprognostic (8.71e-2)" "unprognostic (2.26e-2)" "unprognostic (5.86e-3)" 26.8 15.7 16.2 10.7 16.5 34.7 20.3 26.6 21.8 23.1 14.4 13.2 10.9 10.8 23.4 17.7 22.9 14.3 14.2 24.1 15.5 13.6 25.7 46.7 19.4 12.5 16.7 18.2 27.9 29.0 13.4 27.5 20.1 21.6 21.7 13.5 14.1 19.7 13.3 31.8 15.5 16.3 22.1 16.3 17.1 25.3 12.1 13.1 19.6 21.7 21.3 15.0 32.1 16.0 12.1 13.2 15.9 11.8 22.8 18.7 13.6 21.9 12.8 12.7 12.9 15.9 21.9 17.5 25.2 19.1 18.8 22.0 21.7 18.2 28.0 32.2 17.6 13.2 14.5 20.2 18.5 29.5 29.0 12.4 28.8 11.3 13.5 17.5 34.6 17.5 18.3 13.8 13.3 44.0 20.2 20.4 9.8 21.1 15.5 22.2 50.2 15.6 13.2 15.9 26.6 20.5 19.3 18.3 28.3 17.9 49.9 20.2 12.6 14.3 35.2 20.8 14.4 26.2 15.9 17.8 15.1 10.8 17.2 30.3 25.6 17.2 28.7 18.8 22.6 20.5 15.9 10.8 5.7 11.8 11.8 18.3 12.1 13.9 14.5 13.2 10.4 18.7 14.5 2.5 22.8 7.3 7.4 17.1 13.6 16.2 16.5 26.6 21.8 15.5 13.6 16.7 18.2 21.6 13.1 17.9 13.4 25.1 43.8 57.7 23.4 39.6 20.4 16.0 17.0 10.4 13.7 29.3 29.9 22.3 12.2 23.2 13.4 0.0 33.9 37.0 34.9 39.0 25.3 38.5 21.3 28.6 13.2 20.9 32.4 4.7 23.6 22.5 23.6 25.2 17.7 12.3 30.1 10.5 25.8 26.9 18.0 25.8 91.0 30.3 26.0 65.0 47.4 25.9 18.8 62.7 NME1 "NDPKA, NM23, NM23-H1" ENSG00000239672 "NME/NM23 nucleoside diphosphate kinase 1" P15531 17 51153536-51162428 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Endocytosis, Neurogenesis, Nucleotide metabolism" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008467, CAB040571, HPA041113" Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 28000000 Cytosol "Nucleoplasm, Plasma membrane" "CAB040571: , HPA008467: AB_1079492, HPA041113: AB_2677305" "unprognostic (2.24e-1)" "unprognostic (2.01e-1)" "unprognostic (3.48e-3)" "unprognostic (5.96e-2)" "unprognostic (9.71e-2)" "unprognostic (2.33e-3)" "prognostic unfavorable (2.60e-5)" "unprognostic (4.54e-2)" "unprognostic (3.35e-1)" "unprognostic (2.33e-3)" "unprognostic (2.90e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.07e-9)" "unprognostic (9.01e-2)" "unprognostic (1.51e-1)" "unprognostic (1.83e-1)" "unprognostic (9.46e-2)" 25.0 29.5 38.0 28.1 30.1 27.9 29.0 19.6 41.9 16.4 25.4 13.1 10.1 15.1 17.3 22.5 30.1 22.2 13.4 14.1 41.7 39.4 19.6 56.0 14.2 28.5 34.2 34.2 15.6 43.6 13.7 17.3 16.9 38.9 14.5 36.8 14.9 34.3 14.7 14.8 22.4 12.4 29.6 20.5 22.4 13.4 11.6 11.3 19.0 18.8 32.7 41.4 22.8 15.2 24.9 36.2 0.6 19.5 17.2 20.3 18.4 46.6 93.2 32.2 44.9 13.5 21.6 54.1 36.4 25.3 75.5 57.3 73.3 28.3 82.1 38.0 33.6 30.0 25.1 61.5 61.9 64.6 39.8 82.8 53.8 72.4 101.8 27.4 59.0 24.7 20.5 39.0 56.8 53.2 13.3 45.5 26.4 79.4 27.3 44.7 79.0 70.1 67.8 38.6 103.3 85.0 43.0 63.6 75.6 57.9 32.6 44.7 51.5 19.1 52.3 33.9 28.8 54.4 39.9 28.6 48.7 44.2 30.3 74.7 35.2 81.2 96.7 29.5 50.1 37.0 0.2 15.2 0.6 13.4 19.5 20.3 24.9 14.4 14.6 36.2 17.3 16.4 17.8 0.4 17.2 11.5 20.7 12.1 18.4 38.0 30.1 19.6 41.9 41.7 39.4 34.2 34.2 38.9 11.3 29.8 22.5 33.5 67.6 117.7 287.4 27.7 63.7 36.1 59.1 68.0 269.0 166.3 127.6 180.3 23.8 58.6 14.6 46.7 172.7 210.0 82.7 60.4 46.0 102.6 183.6 38.1 86.1 27.0 26.9 65.0 56.7 62.9 123.2 55.9 70.8 61.6 165.1 38.6 55.2 140.8 268.7 12.9 66.0 19.8 83.3 116.3 74.0 40.6 110.8 81.0 NME3 "DR-nm23, NDPKC, NM23-H3" ENSG00000103024 "NME/NM23 nucleoside diphosphate kinase 3" Q13232 16 1770286-1771730 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Nucleotide metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041113, HPA052733" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 7900000 Nucleoplasm Cytosol "HPA041113: AB_2677305, HPA052733: AB_2681930" "prognostic favorable (6.81e-5)" "unprognostic (1.41e-1)" "unprognostic (1.49e-1)" "unprognostic (1.15e-3)" "unprognostic (1.26e-1)" "unprognostic (1.61e-1)" "unprognostic (1.05e-1)" "unprognostic (4.54e-2)" "unprognostic (1.13e-1)" "unprognostic (6.22e-3)" "unprognostic (4.40e-2)" "unprognostic (4.43e-2)" "unprognostic (7.09e-3)" "unprognostic (1.79e-1)" "unprognostic (3.84e-1)" "unprognostic (3.64e-1)" "unprognostic (6.11e-3)" 20.6 45.6 18.0 12.9 19.8 6.6 20.0 21.9 18.2 16.6 18.0 11.0 31.6 25.7 14.4 19.1 12.9 14.3 21.5 11.8 17.5 16.1 17.7 11.2 17.3 11.3 18.4 15.9 22.1 26.8 15.1 24.1 9.7 14.4 26.9 6.4 13.8 34.3 41.4 15.2 9.2 24.6 14.6 14.1 20.4 17.5 7.2 14.6 5.1 24.1 11.7 8.8 11.5 17.9 19.3 34.1 15.5 25.6 20.1 24.4 20.0 0.7 11.7 0.2 9.6 2.7 1.4 1.1 6.8 2.0 1.2 0.9 0.0 14.0 0.1 19.2 0.9 1.2 10.0 0.6 3.8 0.1 13.7 31.3 0.0 5.5 5.5 5.2 2.3 4.4 6.4 3.5 1.2 0.7 2.3 2.5 0.1 4.7 1.9 1.2 17.0 0.2 4.6 12.5 2.3 9.5 6.5 0.1 18.3 2.0 0.5 13.7 10.6 20.7 15.6 1.7 0.5 14.9 5.6 8.7 2.6 9.7 8.3 4.6 5.0 1.5 1.0 3.5 0.4 5.8 4.9 25.6 15.5 17.5 22.9 17.1 19.3 24.4 16.4 22.0 16.3 21.4 16.8 5.3 20.1 24.5 34.1 21.8 20.0 18.0 19.8 21.9 18.2 17.5 16.1 18.4 15.9 14.4 14.6 32.8 63.8 51.1 124.1 64.5 115.4 25.8 76.5 58.9 55.7 120.4 56.9 65.8 51.4 53.1 16.8 69.7 85.0 0.0 33.3 35.7 82.8 109.1 50.7 52.9 65.1 62.0 130.1 72.4 57.8 13.2 138.4 78.5 77.6 175.9 94.2 102.4 38.5 89.7 119.9 123.2 117.3 116.4 86.4 1.4 41.7 57.3 38.6 61.8 96.6 69.8 NME5 "nm23-H5, RSPH23" ENSG00000112981 "NME/NM23 family member 5" P56597 5 138115172-138139443 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 28.1;testis: 36.2" "Group enriched" "Detected in many" 4 "Ciliated cells: 327.9;Early spermatids: 516.0;Late spermatids: 184.0;Spermatocytes: 142.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "RPTEC TERT1: 25.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035648, HPA044555, HPA058103" Enhanced Approved "Nucleoplasm,Nuclear bodies" Yes NA "Nucleoplasm, Nuclear bodies" "HPA035648: AB_2674719, HPA044555: AB_10960286, HPA058103: " "unprognostic (2.49e-2)" "unprognostic (7.63e-4)" "unprognostic (9.97e-2)" "prognostic favorable (7.24e-5)" "unprognostic (3.27e-2)" "unprognostic (2.27e-1)" "unprognostic (3.04e-3)" "unprognostic (3.06e-1)" "unprognostic (1.34e-1)" "unprognostic (2.39e-2)" "unprognostic (1.83e-2)" "unprognostic (2.14e-1)" "prognostic favorable (1.76e-4)" "unprognostic (9.14e-4)" "unprognostic (1.11e-3)" "unprognostic (3.45e-1)" "unprognostic (3.16e-2)" 1.3 5.2 12.3 0.6 18.4 0.3 3.7 3.5 13.9 7.1 1.2 3.9 4.7 0.5 4.1 18.2 1.0 28.1 6.8 2.9 12.0 10.7 15.4 0.6 3.6 0.6 9.4 9.9 4.5 3.5 12.1 8.9 0.4 13.1 4.2 1.1 4.8 3.1 3.9 0.4 0.4 0.5 2.6 4.2 0.4 2.2 36.2 4.8 0.0 9.6 0.3 0.4 2.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 3.7 0.0 0.0 0.0 0.6 0.4 0.6 0.2 0.1 1.5 0.0 0.9 0.1 0.6 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 1.4 0.0 0.0 1.9 0.0 0.8 0.0 3.3 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 1.2 0.0 0.0 0.0 25.6 0.0 5.9 2.2 0.0 0.7 3.8 1.5 0.5 1.3 0.0 0.6 0.0 0.0 0.8 0.4 0.6 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 18.4 3.5 13.9 12.0 10.7 9.4 9.9 13.1 4.8 6.0 6.9 0.0 9.1 0.6 11.4 2.8 2.5 327.9 26.1 31.4 13.7 0.4 72.9 18.8 516.0 3.4 0.0 0.0 3.6 0.0 3.2 7.9 0.0 0.5 0.1 6.4 5.2 1.3 0.0 184.0 8.3 0.7 10.1 1.0 2.5 15.8 5.2 0.0 13.1 66.5 21.6 0.0 1.0 142.0 20.4 0.3 0.0 0.0 1.1 5.6 NMI ENSG00000123609 "N-myc and STAT interactor" Q13287 2 151270465-151290057 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 75.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 75.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 42.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA008588 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA008588: AB_1079493" "unprognostic (5.28e-2)" "unprognostic (1.52e-1)" "unprognostic (1.54e-1)" "unprognostic (2.41e-2)" "unprognostic (9.25e-2)" "unprognostic (3.63e-2)" "prognostic unfavorable (1.15e-4)" "unprognostic (1.42e-2)" "unprognostic (1.08e-1)" "unprognostic (4.51e-3)" "prognostic unfavorable (3.54e-4)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.57e-7)" "unprognostic (1.91e-1)" "unprognostic (4.69e-2)" "unprognostic (1.52e-2)" "unprognostic (4.57e-2)" 12.0 14.2 5.0 18.6 7.1 26.4 14.0 1.3 5.8 8.9 15.0 3.4 11.1 13.2 8.6 10.4 16.1 9.8 14.7 8.7 5.9 3.8 13.0 20.4 18.5 26.9 5.1 2.7 14.8 8.4 2.9 6.5 24.6 6.9 13.6 10.5 5.0 9.8 7.9 5.1 7.3 26.0 13.1 7.7 30.2 10.2 5.3 6.4 36.7 14.9 10.2 14.2 10.4 10.3 10.8 17.0 75.1 26.9 14.3 12.5 14.9 10.9 5.4 0.3 0.0 3.1 8.5 10.7 3.2 7.5 15.4 23.5 1.1 25.0 10.7 11.9 4.8 5.1 6.3 1.1 2.8 3.9 22.7 0.6 30.1 5.6 0.6 13.2 28.5 8.7 5.5 3.8 9.2 2.1 6.8 19.0 11.9 14.9 2.6 2.9 8.4 23.9 42.6 6.3 2.2 8.1 25.8 0.6 9.2 12.7 9.5 1.5 0.0 6.7 7.3 4.1 1.1 1.2 32.5 10.3 2.2 5.0 7.2 4.6 0.4 0.4 0.6 5.3 34.3 2.4 31.6 19.7 21.6 10.8 26.9 12.5 10.8 11.3 10.7 17.0 9.1 9.2 9.4 75.1 14.3 24.4 6.9 9.7 14.9 5.0 7.1 1.3 5.8 5.9 3.8 5.1 2.7 6.9 6.4 23.8 19.8 16.0 18.1 14.8 0.2 3.1 15.3 38.8 27.3 12.2 0.0 62.5 13.3 54.5 2.6 35.8 24.2 0.0 36.0 53.3 19.2 13.1 34.7 16.0 71.3 0.0 17.3 17.2 39.1 0.0 18.1 53.0 1.7 45.9 20.9 5.8 34.1 23.0 13.1 20.9 0.0 6.5 14.7 3.3 1.7 15.6 45.5 40.7 19.5 19.2 NMNAT1 "LCA9, NMNAT, PNAT1" ENSG00000173614 "Nicotinamide nucleotide adenylyltransferase 1" Q9HAN9 1 9943428-9985501 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Nucleotidyltransferase, Transferase" "Disease mutation, Leber congenital amaurosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059447 Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA059447: AB_2684022" "unprognostic (1.94e-1)" "unprognostic (3.81e-3)" "unprognostic (7.54e-3)" "unprognostic (1.01e-1)" "unprognostic (3.50e-1)" "unprognostic (1.73e-1)" "unprognostic (1.56e-1)" "unprognostic (2.29e-1)" "unprognostic (4.45e-3)" "unprognostic (4.55e-2)" "unprognostic (1.12e-1)" "unprognostic (3.57e-1)" "prognostic favorable (3.85e-14)" "unprognostic (3.11e-3)" "unprognostic (1.17e-1)" "unprognostic (1.47e-3)" "unprognostic (5.16e-2)" 7.2 13.2 8.1 7.2 9.0 4.0 8.8 4.1 8.1 8.8 12.8 9.3 11.9 8.9 10.1 8.8 8.7 7.4 7.3 13.9 7.6 6.8 11.5 12.6 5.3 5.6 10.3 8.3 5.1 14.1 10.3 9.3 5.6 13.0 7.0 13.6 10.1 17.7 8.4 29.1 8.1 9.2 8.3 9.0 8.6 7.1 10.7 8.3 6.8 10.8 11.5 6.8 6.2 10.4 5.3 4.3 12.8 4.9 3.1 2.7 2.3 3.8 4.7 6.6 6.3 12.6 11.4 1.6 7.5 6.2 8.8 5.7 2.0 6.5 4.1 4.9 11.4 3.7 3.9 8.0 10.8 10.6 8.4 4.1 6.7 2.9 6.2 10.0 5.5 6.6 12.1 12.1 10.6 15.3 8.3 9.2 9.0 7.8 2.7 9.7 6.5 3.1 3.5 0.8 8.6 8.5 3.6 4.0 2.1 10.2 2.1 4.7 2.5 9.9 8.5 8.5 3.6 3.2 5.9 8.6 3.7 3.2 7.4 3.5 3.9 3.7 4.0 6.2 11.6 7.4 6.6 4.9 3.9 2.4 3.3 1.1 5.3 2.3 2.7 4.2 3.6 2.1 2.5 12.8 3.1 4.5 4.3 1.9 2.3 8.1 9.0 4.1 8.1 7.6 6.8 10.3 8.3 13.0 8.3 3.0 4.1 1.7 5.2 2.1 7.7 11.8 5.1 8.1 3.4 7.0 5.9 8.3 19.9 7.9 5.8 6.8 17.0 0.0 6.0 4.2 3.7 4.5 4.6 7.3 11.2 9.5 2.9 6.7 6.9 3.2 6.1 8.6 5.0 11.8 7.7 8.5 6.4 3.5 6.0 11.3 6.3 6.5 4.2 11.1 8.3 1.6 7.6 2.9 12.8 4.1 NMRAL1 "FLJ25918, HSCARG, SDR48A1" ENSG00000153406 "NmrA like redox sensor 1" Q9HBL8 16 4461680-4495763 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041353, HPA062287" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA041353: AB_10796343, HPA062287: AB_2684738" "unprognostic (2.56e-1)" "prognostic favorable (3.33e-7)" "unprognostic (4.16e-1)" "unprognostic (4.04e-3)" "unprognostic (1.15e-1)" "unprognostic (1.24e-1)" "unprognostic (1.05e-1)" "unprognostic (2.20e-1)" "unprognostic (3.90e-1)" "unprognostic (1.28e-1)" "unprognostic (2.86e-1)" "unprognostic (5.52e-2)" "unprognostic (8.48e-2)" "unprognostic (2.06e-2)" "unprognostic (1.13e-1)" "unprognostic (5.79e-2)" "unprognostic (2.21e-1)" 10.0 20.6 19.2 8.4 23.3 11.0 17.8 7.0 31.5 16.9 14.1 23.5 19.2 17.1 12.9 18.1 17.0 20.7 17.3 17.0 19.6 16.1 18.1 26.2 12.8 14.8 20.2 23.8 20.1 30.7 14.5 14.2 16.7 17.7 18.9 10.0 14.6 28.7 17.6 3.2 25.3 13.6 12.4 20.1 13.6 19.9 7.0 14.2 14.6 18.1 10.0 12.9 12.4 11.7 13.3 19.5 11.6 19.2 8.9 23.5 17.3 10.2 14.8 2.3 8.2 4.9 4.7 12.4 7.5 2.5 8.5 6.7 15.9 17.4 0.3 15.1 8.2 2.3 11.9 6.6 9.6 3.7 9.2 3.8 9.0 10.9 7.6 11.0 10.7 7.0 7.3 11.5 9.3 3.5 6.7 8.4 32.8 11.5 0.2 3.9 32.7 21.7 10.4 10.3 12.3 13.9 23.7 0.1 12.7 8.9 5.9 3.5 9.6 12.8 21.7 8.2 1.8 20.1 9.7 5.0 5.1 0.3 3.8 0.1 0.3 0.1 18.0 2.3 9.6 9.9 4.7 19.2 2.0 23.5 11.3 18.3 13.3 15.9 22.4 18.2 11.2 17.0 17.7 11.6 8.9 8.7 19.5 14.0 17.3 19.2 23.3 7.0 31.5 19.6 16.1 20.2 23.8 17.7 14.2 23.8 27.0 25.1 32.1 24.3 10.5 20.4 35.7 28.1 29.6 40.1 0.0 90.4 44.7 30.4 11.9 19.4 26.6 0.0 43.3 84.8 27.7 25.0 19.7 67.4 56.7 4.8 19.5 29.4 28.9 21.1 27.0 24.5 33.7 22.6 34.7 36.1 32.0 33.6 28.7 68.0 9.4 25.8 22.8 4.1 40.1 26.7 53.7 27.4 39.1 17.1 NMRK1 "bA235O14.2, C9orf95, FLJ20559, NRK1" ENSG00000106733 "Nicotinamide riboside kinase 1" Q9NWW6 9 75060573-75088217 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "monocytes: 102.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 29.9;Karpas-707: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049795 Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA049795: AB_2680886" "unprognostic (1.12e-1)" "unprognostic (4.13e-2)" "unprognostic (3.58e-2)" "prognostic favorable (3.70e-6)" "unprognostic (3.56e-2)" "unprognostic (2.35e-1)" "unprognostic (5.20e-3)" "unprognostic (2.21e-2)" "unprognostic (3.27e-2)" "unprognostic (2.43e-1)" "unprognostic (2.06e-2)" "unprognostic (1.78e-1)" "prognostic favorable (5.60e-4)" "unprognostic (9.25e-2)" "unprognostic (1.76e-1)" "unprognostic (5.28e-2)" "unprognostic (5.64e-2)" 15.5 7.7 11.1 15.9 10.7 6.9 14.3 21.5 14.6 13.2 15.2 5.8 20.1 12.2 8.1 15.6 24.6 9.4 10.9 9.4 10.2 9.7 22.1 40.3 15.4 19.9 10.8 9.7 15.2 30.6 45.8 18.1 19.7 10.2 15.9 10.3 10.9 29.5 17.7 15.0 15.6 26.6 8.3 8.7 18.8 13.6 6.7 8.9 14.4 31.6 11.2 22.0 12.6 14.8 6.7 8.8 7.3 6.7 8.2 24.2 10.1 5.1 1.1 1.5 3.5 12.2 16.5 8.3 7.5 11.8 1.9 3.1 0.0 13.6 3.0 4.5 7.2 3.6 9.0 1.7 5.0 6.0 29.9 1.8 2.1 2.4 2.6 10.9 2.0 0.4 11.4 12.9 3.1 6.4 11.4 13.0 5.2 0.2 36.8 13.2 3.8 1.9 1.8 1.9 19.4 4.7 0.6 13.5 19.3 15.3 9.2 1.0 0.2 3.2 3.3 4.2 10.3 8.5 2.2 8.9 6.5 1.2 5.9 2.0 16.3 13.0 1.8 10.6 2.2 6.6 7.3 2.7 4.5 13.9 2.5 16.7 6.7 24.2 16.0 3.1 3.9 22.1 16.7 5.2 8.2 6.7 8.8 15.4 10.1 11.1 10.7 21.5 14.6 10.2 9.7 10.8 9.7 10.2 8.9 35.7 17.1 17.1 33.3 18.7 8.5 15.1 15.3 20.1 22.7 22.7 7.9 52.7 44.7 25.5 14.0 20.7 33.3 0.0 31.3 65.3 17.5 21.3 1.1 34.4 51.6 11.1 4.1 39.3 19.7 24.5 21.9 10.5 25.3 102.8 28.0 9.6 23.2 24.6 11.7 75.6 7.6 12.9 15.2 6.6 3.8 23.6 38.1 29.9 22.4 26.0 NMRK2 "ITGB1BP3, MIBP, NRK2" ENSG00000077009 "Nicotinamide riboside kinase 2" Q9NPI5 19 3933103-3942416 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "heart muscle: 271.6;skeletal muscle: 103.2" "Cell type enriched" "Detected in single" 1346 "Cardiomyocytes: 751.9" "Cancer enhanced" "Detected in some" "renal cancer: 32.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 22.8;NTERA-2: 18.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA049909, HPA054792, HPA072450" Approved Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA049909: , HPA054792: AB_2682601, HPA072450: AB_2686522" "unprognostic (3.61e-1)" "unprognostic (5.92e-2)" "unprognostic (1.18e-2)" "unprognostic (2.54e-1)" "unprognostic (1.03e-1)" "unprognostic (7.61e-2)" "unprognostic (3.30e-2)" "prognostic favorable (1.19e-4)" "unprognostic (1.72e-1)" "unprognostic (3.29e-2)" "unprognostic (5.38e-1)" 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 1.0 0.0 0.0 271.6 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 1.0 1.9 0.1 103.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 18.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 751.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 NOC3L "AD24, C10orf117, FAD24, FLJ12820" ENSG00000173145 "NOC3 like DNA replication regulator" Q8WTT2 10 94333226-94362959 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 70.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063958, HPA067638, HPA070981" Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA063958: AB_2685160, HPA067638: AB_2685876, HPA070981: AB_2686331" "unprognostic (1.29e-1)" "unprognostic (2.25e-1)" "unprognostic (5.25e-2)" "unprognostic (2.49e-1)" "unprognostic (1.27e-3)" "unprognostic (4.58e-2)" "unprognostic (6.49e-3)" "unprognostic (3.34e-1)" "unprognostic (1.09e-1)" "unprognostic (1.34e-1)" "unprognostic (9.93e-2)" "unprognostic (5.50e-2)" "unprognostic (1.47e-2)" "unprognostic (3.24e-2)" "unprognostic (2.48e-1)" "unprognostic (1.09e-1)" "unprognostic (2.30e-1)" 16.7 13.2 9.2 11.2 14.5 3.7 14.4 10.8 12.7 13.5 8.9 6.0 8.4 6.7 14.1 8.5 14.3 12.1 7.3 8.8 9.3 6.6 11.0 15.0 9.7 14.9 16.4 7.7 15.4 7.8 12.5 18.2 11.0 14.5 12.5 8.2 6.3 9.7 8.9 18.8 11.6 8.4 9.8 16.6 19.8 8.1 14.1 13.1 12.8 15.7 13.6 16.0 16.1 10.6 13.7 4.3 0.5 4.1 7.5 5.8 3.1 17.9 9.8 6.7 21.5 7.0 11.4 7.9 14.4 11.4 19.8 23.0 16.7 12.7 19.5 10.6 7.2 10.2 13.0 19.0 8.6 32.1 13.3 14.2 13.2 8.2 10.7 14.0 20.9 6.0 6.5 8.5 20.8 21.0 12.9 8.8 7.3 20.5 9.9 19.4 6.0 13.1 15.6 14.1 10.5 10.9 5.9 15.3 10.7 11.7 5.6 4.8 11.9 10.3 5.2 15.9 7.8 13.4 8.1 8.5 12.7 12.8 11.5 24.1 9.4 18.8 27.1 11.6 20.3 9.4 0.0 2.4 0.5 4.3 3.9 5.4 13.7 4.4 5.4 4.3 12.6 5.8 5.1 0.1 7.5 4.1 3.8 4.0 3.1 9.2 14.5 10.8 12.7 9.3 6.6 16.4 7.7 14.5 13.1 17.9 10.7 18.7 20.6 21.1 20.3 20.0 10.2 28.1 47.8 21.0 7.9 18.3 21.6 16.6 2.2 24.1 2.0 0.0 11.8 11.5 13.4 12.0 28.8 9.2 11.3 12.7 5.2 13.5 14.5 3.6 17.0 13.1 11.8 25.2 6.0 21.0 12.3 2.9 23.3 18.0 20.6 12.9 21.8 59.0 70.2 19.1 12.7 13.8 8.6 13.5 NOC4L "MGC3162, NET49, Noc4, UTP19" ENSG00000184967 "Nucleolar complex associated 4 homolog" Q9BVI4 12 132144448-132152473 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053424 Supported Nucleoplasm,Nucleoli No No Nucleoli Nucleoplasm "HPA053424: AB_2682147" "unprognostic (9.44e-2)" "unprognostic (1.96e-2)" "unprognostic (5.44e-2)" "unprognostic (8.48e-2)" "unprognostic (1.13e-1)" "unprognostic (4.63e-2)" "unprognostic (4.79e-3)" "unprognostic (8.08e-2)" "unprognostic (1.06e-1)" "unprognostic (1.64e-1)" "unprognostic (8.36e-3)" "unprognostic (1.76e-1)" "unprognostic (3.85e-3)" "unprognostic (1.05e-1)" "unprognostic (2.51e-2)" "unprognostic (2.17e-1)" "unprognostic (1.61e-1)" 11.9 10.3 9.0 14.2 11.6 18.8 11.1 11.5 17.2 9.9 9.2 14.1 7.8 14.8 11.5 6.4 12.0 10.7 10.4 8.6 8.0 7.5 11.2 15.6 9.2 13.7 14.7 8.5 13.6 16.8 7.1 10.4 9.7 12.1 9.8 6.9 10.3 16.2 8.8 22.5 15.7 11.9 8.2 9.2 15.5 12.5 28.4 10.6 15.7 10.5 13.2 12.3 9.5 9.5 13.9 18.8 5.9 16.1 7.4 11.4 8.1 12.4 23.1 5.1 8.0 2.6 2.7 26.2 8.6 4.4 10.6 5.8 18.8 5.9 19.1 9.5 4.4 6.3 11.2 9.1 9.4 2.3 7.5 25.0 12.8 7.6 12.3 6.8 14.9 15.0 4.0 6.5 8.3 6.7 4.0 7.4 14.7 21.7 4.4 4.3 14.6 14.2 35.1 15.0 7.3 18.4 18.5 5.7 16.7 5.5 9.2 12.6 10.0 7.3 10.0 6.3 3.1 14.0 9.3 9.8 6.3 16.1 10.1 14.3 11.2 6.9 16.7 9.7 12.9 13.3 2.5 11.8 5.9 11.4 16.1 11.0 13.8 10.6 11.3 15.8 13.9 9.3 8.9 1.7 7.4 12.1 18.8 8.7 8.1 9.0 11.6 11.5 17.2 8.0 7.5 14.7 8.5 12.1 10.6 8.9 7.8 13.0 13.7 19.8 7.9 6.0 25.5 0.0 3.4 3.5 0.0 28.1 6.6 25.9 57.6 11.1 15.2 0.0 28.5 27.4 15.4 9.4 16.1 9.5 22.0 7.9 7.0 11.6 11.0 60.3 13.6 14.1 13.5 13.6 11.1 6.7 23.0 8.6 7.4 16.5 5.0 19.4 14.4 37.9 50.3 18.9 25.5 14.9 16.2 11.9 NOCT "Ccr4c, CCR4L, CCRN4L, NOC" ENSG00000151014 Nocturnin Q9UK39 4 139015789-139045939 "Enzymes, Predicted intracellular proteins" "Biological rhythms" "Hydrolase, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 38.7" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 8.9;Cone photoreceptor cells: 13.7;Extravillous trophoblasts: 7.7;Syncytiotrophoblasts: 10.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012287, HPA053714" Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA012287: AB_2668640, HPA053714: AB_2682238" "unprognostic (2.16e-1)" "unprognostic (2.16e-3)" "unprognostic (1.47e-1)" "unprognostic (2.29e-1)" "unprognostic (3.36e-3)" "unprognostic (2.00e-3)" "unprognostic (3.24e-1)" "prognostic unfavorable (5.28e-5)" "unprognostic (1.86e-1)" "unprognostic (5.64e-3)" "unprognostic (4.63e-2)" "unprognostic (1.01e-3)" "prognostic unfavorable (1.05e-5)" "unprognostic (2.54e-1)" "unprognostic (1.14e-1)" "unprognostic (3.52e-4)" "prognostic unfavorable (6.23e-4)" 17.5 3.9 3.3 4.9 8.0 38.7 7.4 3.2 7.3 2.7 3.1 2.7 0.0 2.2 2.8 1.5 4.0 2.5 7.9 5.4 4.9 3.7 6.9 25.8 5.1 3.1 3.0 3.1 1.7 4.4 4.0 4.7 9.3 3.7 2.0 2.8 1.8 10.8 1.4 12.0 3.9 10.5 4.5 2.3 3.2 3.0 4.9 2.6 3.7 2.9 11.8 3.9 3.7 4.6 1.9 1.5 6.3 3.1 1.4 2.4 0.2 4.7 5.5 2.2 4.1 5.0 2.1 13.5 7.1 5.1 10.1 7.3 7.3 2.0 15.8 5.7 5.3 14.3 3.4 11.4 6.2 9.6 7.0 4.6 7.3 3.3 6.4 4.5 10.7 4.3 2.4 3.1 11.2 7.6 2.0 4.4 3.2 13.1 5.2 4.5 5.4 7.3 5.6 7.0 2.1 5.9 6.0 6.4 5.6 6.8 3.1 8.2 5.5 4.5 5.1 4.0 8.9 3.7 8.3 6.6 5.5 7.1 5.2 8.4 4.3 4.0 10.0 5.1 21.2 6.9 1.5 1.4 0.8 2.4 1.5 1.4 1.1 1.1 1.3 0.6 1.9 0.8 1.6 6.3 1.4 3.1 1.5 0.7 0.2 3.3 8.0 3.2 7.3 4.9 3.7 3.0 3.1 3.7 2.6 8.9 0.6 0.0 2.6 0.0 4.7 0.0 2.5 1.4 1.2 0.0 13.7 4.3 1.7 1.9 0.6 0.0 0.3 0.0 0.2 7.7 0.5 2.0 2.3 1.5 1.4 1.6 0.0 0.6 2.2 0.0 0.9 0.7 0.0 0.0 0.1 0.3 1.8 0.0 0.0 3.1 4.6 0.0 0.0 0.9 3.2 0.0 10.1 0.0 0.0 1.7 NOL12 "MGC3731, Nop25, RRP17" ENSG00000273899 "Nucleolar protein 12" Q9UGY1 22 37681673-37693478 "Predicted intracellular proteins" "RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 31.1" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 77.4" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003547 Uncertain Approved "Nucleoplasm,Nucleoli,Mitotic chromosome,Vesicles" Yes No "Nucleoli, Mitotic chromosome" "Nucleoplasm, Vesicles" "HPA003547: AB_10602012" "unprognostic (3.37e-2)" "prognostic favorable (6.80e-5)" "unprognostic (2.65e-1)" "unprognostic (9.62e-2)" "unprognostic (2.13e-1)" "unprognostic (7.89e-2)" "unprognostic (3.23e-3)" "prognostic favorable (9.41e-4)" "unprognostic (9.96e-2)" "unprognostic (4.62e-2)" "unprognostic (2.18e-3)" "unprognostic (4.60e-2)" "prognostic unfavorable (2.56e-6)" "unprognostic (1.34e-2)" "unprognostic (8.40e-2)" "unprognostic (4.65e-2)" "prognostic favorable (3.24e-4)" 3.8 11.8 9.3 9.5 10.1 14.6 5.0 13.1 10.6 3.6 6.5 7.9 5.4 8.4 4.1 4.6 7.8 6.2 5.6 7.2 7.7 5.2 4.1 4.8 11.0 8.7 6.4 5.4 5.4 5.4 3.9 6.8 7.2 4.5 6.2 4.4 8.9 4.8 7.9 11.4 7.1 4.5 3.7 8.6 5.8 4.8 9.5 7.2 7.4 7.1 8.0 5.8 5.6 8.1 9.6 31.1 17.1 8.5 11.6 6.4 16.9 15.7 11.7 13.4 3.8 4.0 14.8 8.5 3.9 3.8 4.1 8.8 7.1 14.5 5.1 3.8 4.0 18.5 6.7 22.4 1.3 15.2 24.5 12.3 12.6 20.1 10.3 29.1 18.1 5.9 7.3 15.2 5.9 5.3 7.3 8.6 9.1 13.1 3.3 14.8 15.9 21.7 13.4 7.6 21.2 21.8 7.6 10.9 8.5 6.0 9.5 18.7 9.9 9.1 13.5 1.8 13.0 13.8 10.2 16.2 16.4 11.8 15.6 11.0 13.4 18.7 15.4 21.6 18.9 21.3 14.0 14.2 9.1 14.1 6.5 8.0 8.9 7.9 9.6 8.1 9.1 7.9 31.1 8.5 17.1 7.5 11.6 6.4 3.0 11.7 16.1 10.3 34.7 11.5 3.1 7.6 9.4 7.9 14.0 5.9 16.5 3.3 23.3 77.4 12.6 26.9 0.0 25.4 13.3 12.5 7.3 15.0 4.9 12.1 27.0 12.1 9.8 8.7 31.6 9.2 16.0 20.3 19.0 18.9 9.1 18.7 31.6 10.6 6.4 8.1 12.9 8.2 14.4 24.4 34.8 16.6 16.7 18.4 13.2 NOL3 "ARC, CARD2, MYP, NOP30" ENSG00000140939 "Nucleolar protein 3" O60936 16 67170154-67175735 "Disease related genes, Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 76.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 6.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 32.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009208 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB009208: AB_634091" "unprognostic (2.83e-2)" "unprognostic (1.63e-2)" "unprognostic (3.34e-3)" "unprognostic (1.07e-1)" "unprognostic (2.70e-3)" "unprognostic (2.83e-1)" "prognostic unfavorable (6.43e-5)" "unprognostic (5.74e-2)" "unprognostic (4.07e-2)" "unprognostic (1.83e-1)" "unprognostic (2.15e-1)" "unprognostic (8.08e-3)" "prognostic unfavorable (2.41e-4)" "unprognostic (1.39e-2)" "unprognostic (3.65e-2)" "unprognostic (3.90e-2)" "unprognostic (1.48e-2)" 16.3 22.6 13.0 3.2 19.6 1.3 9.4 7.3 14.1 8.4 7.1 10.8 19.7 5.3 7.5 10.5 15.4 7.8 15.7 29.1 11.1 8.3 10.1 12.8 10.1 2.6 15.9 12.3 6.8 12.3 22.8 14.8 8.6 12.7 19.8 6.1 13.8 18.0 13.3 76.1 39.7 5.2 10.6 11.6 3.7 11.1 2.7 15.8 0.6 9.6 27.7 6.3 9.4 9.2 0.0 2.1 1.5 6.8 0.7 3.4 2.5 6.2 10.2 1.7 9.6 8.6 6.5 9.6 5.0 5.4 5.5 3.3 2.2 16.5 0.1 16.8 5.9 1.4 10.5 2.3 7.8 1.3 5.6 3.6 0.2 8.1 3.2 5.4 0.5 1.3 4.0 14.5 4.3 3.1 15.8 2.3 2.2 2.2 6.6 10.3 16.2 0.1 0.8 1.6 5.7 25.2 5.6 3.6 12.4 9.3 1.9 13.6 7.3 21.2 15.4 2.2 2.3 32.8 1.7 5.3 7.3 6.2 7.1 4.3 9.7 3.0 1.7 20.6 1.6 2.4 0.0 6.8 0.0 0.3 0.6 0.1 0.0 3.4 0.3 2.1 0.0 0.0 0.5 1.5 0.7 0.2 2.1 0.0 2.5 13.0 19.6 7.3 14.1 11.1 8.3 15.9 12.3 12.7 15.8 26.8 25.2 2.2 26.4 12.2 16.6 45.2 33.1 8.1 13.6 3.5 15.7 7.0 13.3 54.2 0.9 10.5 15.3 0.0 30.2 9.9 15.1 25.5 2.3 27.7 9.5 52.4 21.5 8.0 5.1 0.4 23.3 3.1 20.3 20.8 17.6 28.3 36.8 10.5 28.3 17.3 46.0 12.9 36.2 0.2 1.1 17.2 9.3 2.2 13.7 21.4 NOL4 "CT125, HRIHFB2255, NOLP" ENSG00000101746 "Nucleolar protein 4" O94818 18 33851100-34224952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 12.5;testis: 14.5" "Cell type enhanced" "Detected in some" 25 "Early spermatids: 203.4;Intestinal endocrine cells: 70.9;Late spermatids: 68.6" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 28.9;SH-SY5Y: 7.7;U-698: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046740 Supported Nucleoplasm No NA Nucleoplasm "HPA046740: AB_10960527" "unprognostic (7.86e-2)" "unprognostic (1.58e-1)" "unprognostic (3.61e-1)" "unprognostic (5.43e-7)" "unprognostic (5.76e-2)" "unprognostic (1.56e-2)" "unprognostic (7.19e-2)" "unprognostic (3.45e-1)" "unprognostic (1.12e-2)" "unprognostic (4.78e-2)" "unprognostic (3.52e-2)" "unprognostic (1.23e-1)" "unprognostic (1.39e-1)" "unprognostic (7.77e-2)" "unprognostic (7.71e-2)" 0.0 2.4 3.3 0.0 6.2 0.0 0.0 8.9 12.5 0.7 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.8 5.3 1.0 2.8 0.2 0.2 1.2 0.0 2.0 0.0 3.2 0.0 0.3 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.0 14.5 2.1 0.2 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.6 0.1 0.0 0.0 0.0 28.9 7.7 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.4 0.0 0.0 0.0 0.0 2.0 0.1 1.7 0.0 203.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 30.2 70.9 0.0 0.0 68.6 2.3 0.0 0.0 0.0 0.0 12.9 0.2 0.0 2.1 2.2 2.0 0.0 0.0 1.0 1.5 0.0 0.0 0.0 0.2 0.0 NOL4L "C20orf112, C20orf113, dJ1184F4.2, dJ1184F4.4, DKFZP566G1424" ENSG00000197183 "Nucleolar protein 4 like" Q96MY1 20 32443059-32585074 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 78.2;Late spermatids: 112.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 32.2;HEL: 25.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041768, HPA043600" Enhanced Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA041768: AB_10964172, HPA043600: AB_10961001" "unprognostic (4.33e-2)" "unprognostic (1.71e-1)" "unprognostic (4.03e-1)" "prognostic unfavorable (1.01e-4)" "unprognostic (3.10e-1)" "unprognostic (7.88e-2)" "unprognostic (2.75e-3)" "unprognostic (1.65e-2)" "unprognostic (1.83e-1)" "unprognostic (1.41e-1)" "unprognostic (1.84e-1)" "unprognostic (1.72e-1)" "unprognostic (3.88e-2)" "unprognostic (9.32e-2)" "unprognostic (3.42e-1)" "unprognostic (6.08e-3)" "prognostic favorable (2.63e-4)" 7.7 8.0 13.1 9.0 14.9 18.9 8.7 19.4 14.8 6.5 16.3 35.6 8.7 19.9 6.5 13.8 2.8 9.9 11.0 5.0 13.9 11.7 9.8 5.7 10.6 8.0 20.5 8.7 3.7 12.1 5.0 19.9 12.1 16.3 7.5 15.0 12.5 11.0 9.8 1.9 3.8 20.7 7.4 17.9 11.3 14.3 33.2 20.1 16.7 8.5 2.6 6.5 10.0 8.7 1.9 2.2 7.2 11.7 8.9 8.7 4.7 3.9 12.1 7.6 5.2 1.6 2.5 1.0 2.5 2.1 3.2 2.2 32.2 9.2 0.2 7.5 3.3 5.0 1.1 2.4 7.0 1.4 0.9 1.9 25.3 5.9 23.0 4.3 0.3 1.5 6.3 1.0 2.3 1.5 7.3 19.2 5.5 7.5 3.4 1.5 2.2 8.2 7.7 4.4 12.0 11.3 3.5 0.9 1.3 5.3 0.7 10.1 8.2 7.9 0.2 4.3 8.2 1.6 7.7 20.1 3.0 10.5 2.7 2.6 2.5 0.8 1.7 3.3 13.7 9.0 3.0 2.2 1.1 6.6 4.9 5.8 1.9 4.4 3.8 2.2 1.4 8.7 7.1 7.2 8.9 11.7 0.3 7.0 4.7 13.1 14.9 19.4 14.8 13.9 11.7 20.5 8.7 16.3 20.1 6.0 3.5 1.7 9.0 0.0 34.0 7.4 5.1 4.0 2.3 12.2 62.8 0.2 8.3 6.4 78.2 21.3 50.9 0.0 6.9 1.6 5.0 14.5 11.5 3.9 8.2 7.9 16.8 26.4 3.0 112.0 5.2 4.7 0.0 5.4 33.1 14.8 10.1 34.5 4.6 17.7 55.8 19.4 6.3 53.6 3.9 0.0 0.3 12.8 28.2 20.1 NOL6 "bA311H10.1, FLJ21959, MGC14896, MGC14921, MGC20838, Nrap, UTP22" ENSG00000165271 "Nucleolar protein 6" Q9H6R4 9 33461441-33473930 "Predicted intracellular proteins, Predicted membrane proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055891, HPA061002" Supported Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA055891: AB_2682959, HPA061002: AB_2684410" "unprognostic (2.07e-2)" "unprognostic (6.63e-2)" "unprognostic (2.37e-1)" "unprognostic (5.23e-2)" "unprognostic (2.32e-1)" "unprognostic (2.67e-1)" "prognostic unfavorable (4.83e-5)" "unprognostic (7.37e-3)" "unprognostic (8.26e-2)" "unprognostic (3.03e-2)" "unprognostic (2.09e-1)" "unprognostic (4.24e-2)" "unprognostic (2.77e-1)" "unprognostic (2.92e-2)" "unprognostic (2.06e-1)" "prognostic unfavorable (9.49e-4)" "unprognostic (4.09e-1)" 15.3 14.9 13.3 17.7 19.7 21.0 14.9 16.8 30.8 16.0 11.4 14.6 9.0 10.3 15.3 11.9 21.1 12.8 18.2 13.1 12.4 10.6 13.8 41.6 13.5 15.8 10.1 11.4 20.5 20.5 22.7 18.2 15.4 19.2 17.5 14.8 12.5 15.5 15.5 23.4 23.5 11.3 17.0 7.3 17.6 13.0 19.0 7.8 13.8 13.2 19.7 20.9 12.4 14.5 4.2 7.1 0.3 8.4 3.9 6.0 3.4 15.6 22.6 8.6 19.5 13.5 9.3 14.8 17.5 13.1 20.5 17.2 24.9 5.8 27.3 8.0 19.6 9.0 11.0 25.0 25.1 21.7 17.3 10.4 14.0 26.3 13.8 13.3 31.9 20.6 10.3 20.8 27.1 26.2 8.5 13.4 10.1 22.8 10.5 16.2 13.8 17.8 32.1 31.2 17.5 20.6 15.4 8.5 14.2 15.8 18.8 10.2 14.1 14.6 18.9 6.2 9.6 7.6 18.6 14.9 12.6 17.0 15.8 30.4 10.0 14.0 23.1 11.2 16.9 14.4 0.0 4.0 0.3 5.4 8.4 6.0 4.2 4.1 5.2 7.1 3.6 5.1 4.8 0.2 3.9 7.9 3.8 4.0 3.4 13.3 19.7 16.8 30.8 12.4 10.6 10.1 11.4 19.2 7.8 3.0 14.6 4.5 5.1 17.7 4.5 5.5 7.6 4.0 11.4 3.5 5.9 3.4 3.3 6.7 17.3 6.0 2.3 0.0 3.4 4.8 4.1 6.5 3.5 6.7 4.4 3.2 9.8 3.7 1.2 17.9 5.5 2.7 5.0 1.8 4.1 4.2 4.9 0.0 5.6 2.1 3.5 0.0 5.1 2.3 6.1 22.6 2.5 5.0 6.8 7.4 NONO "NMT55, NRB54, P54, P54NRB, PPP1R114" ENSG00000147140 "Non-POU domain containing octamer binding" Q15233 X 71283192-71301168 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, RNA-binding" "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022069, HPA054094, HPA054559" Enhanced Enhanced "Nucleoplasm,Nucleoli fibrillar center,Nuclear speckles" NA NA 150000 Nucleoplasm "Nucleoli fibrillar center, Nuclear speckles" "CAB022069: , HPA054094: AB_2682376, HPA054559: AB_2682522" "unprognostic (2.39e-3)" "unprognostic (2.22e-2)" "unprognostic (2.64e-1)" "prognostic unfavorable (9.29e-4)" "unprognostic (8.87e-2)" "unprognostic (5.54e-2)" "unprognostic (1.02e-3)" "unprognostic (9.34e-2)" "unprognostic (2.32e-2)" "unprognostic (1.41e-2)" "unprognostic (3.12e-1)" "unprognostic (2.07e-1)" "unprognostic (7.29e-3)" "unprognostic (6.79e-2)" "unprognostic (5.73e-3)" "unprognostic (2.76e-2)" "unprognostic (3.04e-2)" 37.2 55.9 30.2 37.7 30.8 51.2 37.2 54.8 38.6 45.4 33.4 36.0 38.4 29.9 52.4 40.5 41.0 40.5 37.2 30.5 27.5 29.0 40.1 43.3 37.3 45.7 28.8 31.7 69.2 61.0 39.4 48.2 42.4 27.5 40.8 37.5 42.5 39.8 41.4 37.2 38.4 35.2 40.5 38.3 45.9 40.3 34.4 29.0 98.4 51.0 39.1 57.4 43.6 36.8 44.1 47.3 35.3 51.8 45.4 51.8 58.9 59.7 66.1 91.5 50.2 37.3 38.6 50.1 49.0 45.6 66.3 58.6 52.4 44.4 68.0 54.6 45.1 45.8 44.7 136.6 42.6 73.1 51.7 91.2 55.8 69.4 52.2 31.7 78.1 49.0 40.8 30.4 67.1 45.0 55.0 54.5 49.3 71.1 71.3 61.2 53.0 101.1 71.2 114.0 60.3 53.7 90.9 96.0 58.3 50.9 52.9 63.5 78.9 63.5 41.5 56.3 55.5 39.0 50.6 50.0 42.9 64.5 60.0 56.7 41.2 77.9 77.4 32.1 90.9 61.4 35.3 44.8 34.9 45.8 47.6 51.8 43.7 46.6 44.9 47.3 44.1 50.8 50.2 20.8 45.4 51.8 41.2 50.1 58.9 30.2 30.8 54.8 38.6 27.5 29.0 28.8 31.7 27.5 29.0 71.5 74.4 79.8 78.6 112.2 63.2 53.3 94.3 53.5 84.2 41.8 39.3 104.8 48.0 113.5 9.9 89.5 55.4 70.0 96.7 148.6 89.4 78.5 84.5 108.5 99.0 50.9 134.1 70.0 136.1 12.1 98.7 83.7 54.0 104.6 95.9 77.6 111.2 84.2 120.2 93.8 45.1 64.7 107.2 22.8 62.3 107.0 108.8 84.7 122.4 84.4 NOP14 "C4orf9, NOL14, RES4-25, UTP2" ENSG00000087269 "NOP14 nucleolar protein" P78316 4 2937933-2963385 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039596, HPA055652" Approved Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA039596: AB_2676590, HPA055652: AB_2682876" "unprognostic (4.70e-2)" "unprognostic (6.47e-2)" "prognostic favorable (3.93e-5)" "unprognostic (7.32e-2)" "unprognostic (3.28e-1)" "unprognostic (2.07e-2)" "prognostic unfavorable (9.10e-4)" "unprognostic (2.41e-2)" "unprognostic (8.62e-2)" "unprognostic (2.09e-1)" "unprognostic (1.30e-1)" "unprognostic (2.55e-3)" "unprognostic (1.16e-1)" "unprognostic (1.27e-3)" "unprognostic (1.44e-1)" "unprognostic (7.15e-2)" "unprognostic (4.77e-2)" 17.3 16.8 9.8 22.4 13.2 19.0 16.2 21.1 15.2 12.0 12.6 9.0 12.6 12.0 14.3 11.7 19.0 12.1 14.7 14.8 8.9 7.1 13.6 34.0 12.9 20.8 10.0 8.7 20.7 26.8 13.9 15.5 12.8 10.6 12.3 12.8 11.1 14.7 14.6 38.6 21.4 13.1 12.4 9.8 18.0 15.1 9.8 11.4 17.9 15.4 16.3 20.9 18.1 18.9 5.2 4.9 1.3 3.8 4.4 8.4 3.0 16.3 13.9 8.3 17.1 11.2 12.7 14.5 15.1 10.8 15.8 13.0 18.1 17.3 46.3 10.7 12.2 11.5 11.3 22.8 19.6 17.0 8.8 21.8 36.8 13.2 16.4 14.8 39.9 16.1 12.8 17.7 17.8 16.3 7.8 13.2 14.3 33.3 16.5 11.8 11.7 42.1 30.1 21.6 15.1 22.8 27.3 12.6 15.4 7.9 26.4 17.2 10.1 12.5 9.3 11.8 7.9 17.8 15.8 16.4 13.2 7.7 16.1 27.7 12.4 19.9 40.0 13.8 29.6 13.7 1.3 3.2 0.6 4.8 3.8 8.4 3.4 5.8 7.0 4.0 5.2 7.0 5.2 0.5 4.4 2.5 4.9 3.8 3.0 9.8 13.2 21.1 15.2 8.9 7.1 10.0 8.7 10.6 11.4 17.9 22.5 10.4 13.9 23.0 9.0 18.2 15.3 17.4 35.2 1.8 13.7 12.7 10.0 12.9 1.7 14.3 3.6 0.0 20.6 13.2 7.6 9.5 19.7 23.1 9.9 19.1 8.6 9.2 3.2 2.1 11.5 11.3 0.0 15.4 9.7 6.0 16.8 8.6 9.2 10.1 7.1 12.9 13.3 9.2 20.6 28.4 9.6 12.5 13.4 14.8 NOP58 "HSPC120, NOP5" ENSG00000055044 "NOP58 ribonucleoprotein" Q9Y2X3 2 202265716-202303666 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018472, HPA021062" Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center" NA Yes "Nucleoli fibrillar center" Nucleoplasm "HPA018472: AB_1854564, HPA021062: AB_1854565" "unprognostic (1.56e-2)" "unprognostic (1.61e-1)" "unprognostic (9.20e-2)" "unprognostic (2.15e-3)" "unprognostic (2.39e-1)" "unprognostic (3.94e-2)" "prognostic unfavorable (1.97e-6)" "unprognostic (6.64e-2)" "unprognostic (1.17e-2)" "prognostic favorable (9.86e-4)" "unprognostic (4.52e-3)" "unprognostic (5.20e-2)" "prognostic unfavorable (3.38e-9)" "unprognostic (1.79e-2)" "unprognostic (3.10e-1)" "unprognostic (1.33e-1)" "unprognostic (2.60e-1)" 25.1 26.5 16.7 41.6 24.6 47.1 32.2 30.2 24.2 28.8 21.6 13.7 19.5 20.3 31.0 25.9 31.9 26.4 17.7 21.7 21.4 20.3 23.4 36.2 21.7 40.4 16.9 19.1 32.9 31.5 22.3 47.8 24.0 21.9 26.7 27.0 17.1 25.5 29.5 36.9 22.7 25.2 24.1 19.3 33.0 23.5 17.5 17.8 40.0 24.6 32.8 41.4 31.1 41.3 23.5 22.2 4.3 15.2 21.2 26.7 13.5 26.9 19.2 19.0 23.6 14.2 12.8 45.0 26.0 14.0 20.1 18.8 42.3 24.4 41.8 21.7 15.7 25.1 25.1 37.6 32.0 35.5 16.3 34.5 50.4 28.8 41.6 21.1 49.8 24.3 16.5 19.1 28.0 64.3 10.9 18.0 24.9 55.0 31.9 25.1 28.7 45.4 55.1 47.4 30.1 33.3 38.4 28.7 55.1 23.7 32.7 29.3 21.7 24.1 34.7 29.9 31.8 23.7 39.4 15.5 25.7 30.2 22.9 44.4 26.0 47.4 59.8 19.0 35.5 30.5 4.3 10.2 3.1 16.8 15.2 24.5 23.5 24.0 22.7 15.9 18.7 26.4 26.7 1.0 21.2 10.9 22.2 23.7 13.5 16.7 24.6 30.2 24.2 21.4 20.3 16.9 19.1 21.9 17.8 101.3 103.5 73.0 102.7 76.2 27.1 68.8 38.2 96.4 150.2 38.4 39.3 67.7 24.9 45.7 11.5 57.0 15.0 23.3 58.3 76.0 49.7 70.7 131.9 44.1 43.1 23.8 33.8 29.4 17.4 7.9 40.0 46.4 23.6 73.1 32.3 17.7 45.7 10.5 28.0 32.1 43.5 25.8 81.9 59.1 54.7 65.4 56.9 61.8 56.1 83.8 NOP9 C14orf21 ENSG00000196943 "NOP9 nucleolar protein" Q86U38 14 24299862-24309124 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000850 Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA000850: AB_1078287" "unprognostic (1.39e-1)" "unprognostic (4.64e-2)" "unprognostic (4.57e-3)" "unprognostic (1.85e-1)" "unprognostic (8.28e-2)" "unprognostic (3.54e-1)" "unprognostic (1.69e-2)" "unprognostic (9.37e-2)" "unprognostic (7.22e-2)" "unprognostic (1.40e-1)" "unprognostic (1.09e-1)" "unprognostic (6.77e-2)" "prognostic favorable (9.39e-6)" "unprognostic (7.03e-3)" "unprognostic (3.80e-1)" "unprognostic (1.95e-1)" "unprognostic (1.59e-2)" 12.0 12.9 11.3 11.4 11.4 14.4 10.0 13.3 17.5 11.3 14.4 16.8 9.6 16.5 11.1 10.1 16.6 10.3 13.8 19.4 10.9 10.6 9.7 14.2 9.5 15.1 13.7 10.0 13.3 13.3 20.1 8.9 11.6 10.9 10.8 12.3 13.0 12.5 11.5 29.7 13.5 12.4 12.3 12.3 18.8 10.9 13.0 10.7 11.8 11.2 18.3 14.9 12.1 9.4 1.6 2.1 1.8 5.2 0.4 1.6 1.4 5.0 10.1 8.2 10.3 7.2 6.1 8.2 9.1 6.8 10.7 8.4 7.6 9.0 13.0 5.1 8.2 8.7 13.2 16.3 11.3 11.2 8.2 6.2 9.5 14.0 17.3 5.8 21.8 11.0 6.1 8.8 7.9 7.4 5.8 9.9 7.6 8.1 6.5 7.4 8.7 10.1 8.3 3.7 17.8 13.0 12.7 5.0 8.3 6.6 11.6 8.3 6.4 12.7 14.9 2.8 6.2 6.3 5.8 10.1 7.3 6.0 5.9 8.5 9.1 8.0 9.8 3.9 10.0 5.7 1.4 2.3 1.8 1.5 2.4 1.6 1.2 1.4 0.7 2.1 1.6 1.0 1.0 0.5 0.4 5.2 1.1 1.2 1.4 11.3 11.4 13.3 17.5 10.9 10.6 13.7 10.0 10.9 10.7 3.0 3.5 3.7 3.0 11.1 8.2 0.8 5.1 5.3 9.1 8.7 7.9 5.4 0.0 6.6 2.4 4.1 11.3 23.3 8.7 4.6 4.7 4.7 1.1 16.3 6.5 6.4 10.3 3.7 9.7 0.5 6.1 4.7 0.0 2.8 8.1 3.9 9.7 9.9 4.2 6.5 7.4 6.5 3.1 3.5 6.0 11.8 5.4 3.2 12.1 3.9 NOS1 "nNOS, NOS" ENSG00000089250 "Nitric oxide synthase 1" P29475 12 117208142-117452170 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Calmodulin-binding, Oxidoreductase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 13.4;skeletal muscle: 36.3" "Cell type enhanced" "Detected in some" 12 "Basal glandular cells: 7.9;Basal keratinocytes: 3.4;Glandular cells: 2.8;Ito cells: 8.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 6.3;RH-30: 13.1;RPTEC TERT1: 8.2;U-2 OS: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002167, HPA058312, HPA069509" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB002167: AB_564073, HPA058312: AB_2683676, HPA069509: " "unprognostic (1.63e-1)" "unprognostic (3.14e-2)" "unprognostic (2.18e-2)" "unprognostic (6.64e-3)" "unprognostic (4.91e-2)" "unprognostic (2.74e-1)" "unprognostic (2.54e-1)" "unprognostic (9.12e-3)" "unprognostic (2.51e-1)" "unprognostic (1.10e-1)" "unprognostic (1.07e-1)" "unprognostic (7.56e-2)" "unprognostic (1.01e-1)" "unprognostic (3.73e-2)" "unprognostic (1.34e-1)" "unprognostic (5.97e-4)" "unprognostic (1.87e-1)" 0.5 0.6 3.8 3.5 13.4 0.7 0.6 4.4 4.8 0.7 2.0 1.1 0.0 0.5 0.6 0.7 1.3 0.8 0.5 0.5 2.8 4.4 1.9 0.5 1.4 0.6 2.4 1.6 0.5 1.9 0.4 0.8 0.4 5.9 1.6 0.9 0.6 3.8 0.6 36.3 2.2 0.6 0.8 1.2 0.5 0.5 0.9 3.0 0.0 0.6 0.0 0.5 0.9 0.6 0.9 0.6 2.1 0.5 0.8 0.5 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 6.3 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 1.5 0.0 13.1 0.1 8.2 0.1 0.3 1.3 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 2.5 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.0 2.1 0.5 0.5 0.5 0.4 0.4 0.7 0.4 0.3 0.2 0.9 0.5 0.5 1.9 0.8 0.5 0.6 0.3 0.0 3.8 13.4 4.4 4.8 2.8 4.4 2.4 1.6 5.9 3.0 0.0 0.0 0.0 7.9 3.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.9 0.4 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.2 0.3 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.5 0.0 0.0 0.0 1.0 NOS1AP "CAPON, KIAA0464" ENSG00000198929 "Nitric oxide synthase 1 adaptor protein" O75052 1 162069774-162370475 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.1" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 192.4;Horizontal cells: 63.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 6.9;HaCaT: 5.2;HEL: 8.3" "Low region specificity" "Detected in all" "CAB018582, HPA030066, HPA055561" Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB018582: AB_2251417, HPA030066: AB_2673294, HPA055561: AB_2682851" "unprognostic (7.04e-3)" "unprognostic (2.20e-1)" "unprognostic (1.79e-2)" "unprognostic (3.93e-2)" "unprognostic (1.58e-2)" "unprognostic (4.75e-2)" "unprognostic (2.07e-1)" "unprognostic (1.89e-1)" "unprognostic (1.95e-1)" "unprognostic (1.54e-1)" "unprognostic (3.48e-1)" "unprognostic (1.71e-1)" "unprognostic (2.15e-5)" "unprognostic (1.82e-2)" "unprognostic (1.49e-1)" "unprognostic (1.62e-1)" "unprognostic (5.08e-3)" 2.1 7.9 10.2 1.6 7.0 4.8 6.2 23.1 34.1 2.4 3.7 3.1 7.1 2.7 2.4 1.7 2.2 2.6 7.4 2.3 19.0 10.1 2.9 7.6 2.3 1.4 6.5 13.0 1.6 3.5 2.0 2.7 2.2 5.5 2.5 3.9 2.7 4.6 9.7 1.7 2.4 3.1 2.1 4.4 1.3 3.8 4.0 3.1 0.0 1.6 0.2 1.8 1.8 2.2 0.0 0.1 1.1 0.5 0.0 0.3 0.1 6.9 0.0 3.2 1.9 0.1 0.0 0.5 0.6 0.8 0.9 0.8 1.5 1.7 0.0 4.4 0.2 1.1 5.2 1.1 0.2 0.3 0.1 3.2 8.3 1.2 1.7 0.0 0.0 0.1 0.3 0.2 0.0 0.3 0.9 1.7 1.0 0.6 0.1 0.1 3.6 0.6 0.0 2.4 1.1 3.1 0.1 1.3 0.2 1.5 2.3 2.6 1.8 1.6 0.3 1.2 0.9 1.9 0.4 0.8 0.1 0.8 0.0 1.2 4.7 0.0 0.0 1.1 0.1 0.9 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.1 10.2 7.0 23.1 21.1 19.0 10.1 6.5 13.0 5.5 3.1 0.0 0.3 0.0 5.3 2.6 8.5 1.9 2.5 1.4 1.2 21.0 192.4 0.0 8.3 0.9 24.7 1.6 3.8 0.0 1.0 0.2 1.2 9.9 0.0 19.5 0.1 63.5 6.4 2.5 0.6 8.0 4.0 0.0 0.0 0.0 7.3 20.7 0.6 5.5 6.7 0.2 2.2 6.5 0.3 1.9 1.3 1.8 0.5 0.0 4.4 6.4 NOSIP CGI-25 ENSG00000142546 "Nitric oxide synthase interacting protein" Q9Y314 19 49555711-49590262 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 119.4" "Cell type enhanced" "Detected in all" 8 "Late spermatids: 645.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043464, HPA062132" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA043464: AB_10794284, HPA062132: AB_2684693" "unprognostic (2.27e-1)" "unprognostic (4.69e-2)" "unprognostic (1.39e-1)" "unprognostic (4.17e-2)" "unprognostic (1.59e-2)" "unprognostic (9.46e-2)" "unprognostic (1.47e-2)" "unprognostic (9.42e-2)" "unprognostic (3.79e-1)" "unprognostic (1.25e-1)" "unprognostic (2.27e-2)" "unprognostic (9.73e-2)" "unprognostic (3.97e-2)" "unprognostic (2.15e-1)" "unprognostic (9.76e-2)" "unprognostic (1.02e-1)" "unprognostic (2.95e-3)" 13.4 13.9 14.2 14.0 14.0 14.3 11.5 12.1 14.2 11.3 15.9 12.3 13.1 17.3 12.5 8.1 12.7 11.1 11.7 14.9 12.3 11.4 13.2 14.5 12.6 24.6 18.3 10.8 12.9 39.7 7.1 13.6 15.6 14.3 11.6 7.9 11.3 19.2 11.4 66.9 11.9 16.5 11.0 13.1 18.0 13.9 40.2 16.3 20.6 15.5 17.6 16.3 11.7 15.0 20.4 21.5 31.8 16.8 29.7 119.4 69.2 66.5 36.1 14.1 31.0 12.6 9.2 13.5 15.7 13.9 26.5 24.4 25.2 11.8 17.9 27.6 13.2 11.1 14.9 13.8 27.6 11.6 20.4 39.9 22.6 20.8 28.0 19.9 18.3 19.1 12.0 19.2 20.1 10.9 10.8 15.9 28.8 25.0 14.3 13.8 17.8 18.6 39.4 19.1 25.0 31.4 24.4 23.4 15.9 12.3 20.1 17.6 22.9 21.2 18.1 15.8 6.7 14.7 19.4 23.5 23.0 19.5 8.0 30.0 26.9 50.8 24.2 8.7 25.2 17.7 28.0 16.8 23.5 35.1 15.7 45.4 20.4 71.4 40.2 16.6 19.8 119.4 65.8 31.8 29.7 14.3 21.5 37.5 69.2 14.2 14.0 12.1 14.2 12.3 11.4 18.3 10.8 14.3 16.3 17.9 37.0 70.7 51.2 64.7 22.7 33.5 58.6 30.8 14.8 48.8 21.6 81.7 72.9 76.5 286.4 75.9 124.9 46.7 245.7 72.4 65.6 38.9 66.9 45.0 63.5 11.1 56.3 82.3 64.5 645.6 66.4 58.6 59.1 85.6 76.3 39.5 185.4 94.7 67.8 92.9 31.4 58.2 62.7 203.6 46.2 66.7 114.0 101.0 98.9 47.7 NOTCH1 TAN1 ENSG00000148400 "Notch 1" P46531 9 136494433-136545786 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Angiogenesis, Differentiation, Notch signaling pathway, Transcription, Transcription regulation" "Activator, Developmental protein, Receptor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Endothelial cells: 41.3;Ito cells: 68.2;Muller glia cells: 50.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 8.8" "Group enriched" "Detected in many" 4 "granulocytes: 8.8;NK-cells: 2.7" "Cell line enhanced" "Detected in many" "HaCaT: 25.0;HMC-1: 21.7;hTCEpi: 24.0;MOLT-4: 38.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008112, CAB022466, HPA067168" Supported Approved Nucleoplasm NA NA 8100000 Nucleoplasm "CAB008112: AB_2153490, CAB022466: , HPA067168: AB_2685795" "unprognostic (1.77e-1)" "unprognostic (2.65e-2)" "unprognostic (2.16e-1)" "unprognostic (8.38e-3)" "unprognostic (3.04e-1)" "unprognostic (1.13e-1)" "unprognostic (7.56e-2)" "unprognostic (1.02e-1)" "unprognostic (5.74e-3)" "unprognostic (5.50e-3)" "unprognostic (8.78e-2)" "unprognostic (8.50e-2)" "prognostic unfavorable (5.45e-4)" "unprognostic (2.14e-2)" "unprognostic (1.92e-1)" "unprognostic (5.65e-2)" "unprognostic (8.84e-2)" 20.0 4.0 10.0 14.5 10.4 14.6 12.8 3.8 18.8 12.8 14.2 19.9 8.2 9.8 11.2 5.1 13.3 9.6 13.1 9.6 10.7 5.8 9.4 7.2 17.4 13.7 11.6 7.5 9.2 17.8 3.7 5.6 8.5 9.3 12.1 5.7 10.4 14.2 11.8 8.2 32.3 10.8 7.7 6.6 20.7 8.6 4.1 9.9 34.8 9.4 10.2 10.9 12.3 22.2 0.6 1.1 8.8 1.0 2.7 1.3 0.9 4.4 7.5 6.2 3.1 0.2 0.5 7.8 2.2 0.6 1.3 0.4 1.1 0.5 6.1 4.7 1.7 1.6 25.0 2.0 10.3 0.2 13.8 1.1 3.4 3.0 0.4 3.4 3.6 21.7 0.4 24.0 1.8 3.8 1.5 8.0 2.7 1.5 1.1 0.9 8.1 38.1 5.8 5.2 3.2 3.4 7.9 5.0 11.2 0.9 3.8 0.0 0.4 3.3 3.5 1.4 1.9 2.1 5.8 11.8 3.3 4.8 3.2 2.4 1.3 1.1 2.4 2.2 2.5 16.9 0.7 1.0 2.8 1.3 0.4 0.8 0.4 0.6 1.0 0.6 0.6 0.4 1.1 8.8 2.7 0.4 1.1 0.4 0.9 10.0 10.4 3.8 11.7 10.7 5.8 11.6 7.5 9.3 9.9 8.9 28.2 13.8 10.6 22.0 0.3 7.3 7.6 0.0 6.8 1.8 2.0 0.7 0.0 4.8 0.3 41.3 4.9 0.0 3.4 1.8 4.8 6.6 34.6 6.8 8.0 1.6 2.4 68.2 10.5 0.0 1.1 17.1 6.8 1.0 11.0 50.6 2.2 7.0 0.7 4.1 1.7 6.5 11.5 0.2 3.2 26.1 0.9 12.9 24.7 14.1 NOTCH2 ENSG00000134250 "Notch 2" Q04721 1 119911553-120069626 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway, Transcription, Transcription regulation" "Activator, Developmental protein, Receptor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Paneth cells: 129.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048743 Approved Supported "Nucleoplasm,Plasma membrane" NA NA 67000000 "Nucleoplasm, Plasma membrane" "HPA048743: AB_2680508" "unprognostic (1.33e-1)" "unprognostic (1.43e-2)" "unprognostic (2.66e-1)" "unprognostic (1.40e-3)" "unprognostic (7.98e-2)" "unprognostic (4.01e-2)" "unprognostic (1.22e-1)" "unprognostic (7.32e-2)" "unprognostic (1.18e-2)" "prognostic unfavorable (5.24e-4)" "prognostic unfavorable (9.48e-4)" "unprognostic (3.86e-2)" "unprognostic (6.12e-3)" "unprognostic (1.55e-2)" "unprognostic (2.65e-2)" "unprognostic (1.12e-2)" "unprognostic (7.35e-3)" 12.0 7.3 6.0 9.4 6.8 4.4 10.6 3.0 5.6 14.5 7.6 4.4 11.3 1.6 12.3 11.8 13.4 11.4 12.8 7.9 6.8 2.3 5.5 11.4 10.6 5.7 5.3 7.6 15.5 27.6 6.1 3.3 10.3 6.5 9.9 5.2 9.4 17.7 10.0 9.3 17.2 6.1 12.4 6.2 11.5 5.8 15.7 4.4 8.0 11.4 8.6 6.6 9.6 13.0 4.2 5.2 7.7 9.6 1.5 1.7 2.0 15.0 5.1 7.9 6.1 33.0 28.3 7.9 11.5 15.9 15.4 16.7 4.7 4.1 0.3 9.7 21.8 13.7 5.7 12.5 10.2 24.6 18.1 8.0 8.7 13.7 0.4 12.3 9.1 2.3 22.7 6.6 46.1 30.7 23.3 7.8 4.1 0.1 19.2 18.5 16.9 3.8 2.6 10.2 1.4 5.7 2.5 27.9 9.7 8.1 9.6 0.3 4.0 15.6 14.7 8.3 16.7 8.1 3.1 27.4 20.1 13.9 30.1 18.0 8.0 3.9 4.4 29.5 8.4 19.1 5.6 6.4 6.4 1.5 6.6 1.7 4.2 1.3 1.1 5.2 3.9 1.0 1.7 7.7 1.5 9.6 4.2 0.8 2.0 6.0 6.8 3.0 5.6 6.8 2.3 5.3 7.6 6.5 4.4 32.8 21.6 24.1 40.5 41.1 3.5 11.2 25.5 2.7 13.6 17.4 5.9 1.2 0.0 37.1 15.7 3.7 3.0 0.0 11.3 6.7 53.5 36.6 15.1 35.0 29.9 3.2 5.8 5.5 68.6 9.3 50.9 36.3 37.1 13.6 7.5 46.7 22.9 129.8 80.2 4.3 10.2 19.4 32.3 4.8 3.6 77.8 1.4 13.6 13.8 52.7 NOTCH3 "CADASIL, CASIL" ENSG00000074181 "Notch 3" Q9UM47 19 15159038-15200981 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway, Transcription, Transcription regulation" "Activator, Developmental protein, Receptor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Sertoli cells: 407.4;Smooth muscle cells: 286.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.4" "Group enriched" "Detected in many" 10 "dendritic cells: 2.4;granulocytes: 1.0" "Cell line enhanced" "Detected in many" "AF22: 28.4;MCF7: 28.0;U-87 MG: 19.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005393, HPA044392" Approved Supported "Nucleoplasm,Actin filaments,Cytosol" NA NA 18000000 "Nucleoplasm, Cytosol" "Actin filaments" "CAB005393: AB_2151246, HPA044392: AB_2678926" "unprognostic (4.97e-2)" "unprognostic (3.89e-2)" "unprognostic (7.06e-3)" "prognostic unfavorable (5.92e-4)" "unprognostic (9.20e-2)" "unprognostic (1.73e-2)" "unprognostic (2.72e-1)" "unprognostic (9.04e-2)" "unprognostic (3.90e-3)" "unprognostic (1.23e-1)" "unprognostic (1.19e-1)" "unprognostic (3.13e-1)" "prognostic unfavorable (2.53e-7)" "unprognostic (3.35e-2)" "unprognostic (8.34e-3)" "unprognostic (4.40e-2)" "unprognostic (2.00e-3)" 35.9 3.7 4.7 6.4 6.4 0.5 53.7 2.7 7.5 25.9 7.3 6.2 9.2 3.7 22.9 23.1 33.8 14.6 22.7 25.0 4.6 3.6 9.2 1.6 16.2 11.7 5.0 6.4 14.1 6.9 10.1 4.9 37.3 6.4 13.4 3.0 8.3 11.4 11.4 16.6 48.3 6.2 11.0 2.8 11.8 5.5 10.1 3.9 44.4 14.9 36.7 10.3 14.9 24.6 0.1 2.4 1.0 0.1 0.1 0.1 0.0 5.3 3.4 28.4 12.9 4.0 3.2 12.8 4.3 0.2 0.2 0.1 6.5 5.6 0.1 3.3 7.9 0.1 6.4 5.1 0.1 0.2 0.0 1.3 0.1 5.3 1.4 2.0 0.0 0.5 3.7 3.1 6.6 0.7 0.2 0.3 1.9 0.2 0.2 0.5 28.0 6.4 0.0 16.6 4.6 0.0 0.0 1.6 0.1 0.0 17.2 0.8 9.2 0.0 16.2 0.0 8.8 17.2 0.0 0.0 0.8 9.3 0.1 0.1 0.0 0.3 0.0 19.9 0.1 0.4 1.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.6 0.1 0.0 2.4 0.0 0.0 4.7 6.4 2.7 7.5 4.6 3.6 5.0 6.4 6.4 3.9 8.9 1.0 0.0 6.5 21.4 0.3 21.8 0.0 0.0 9.1 15.7 0.0 16.8 5.0 12.3 0.3 7.4 0.0 0.0 0.0 3.2 12.6 12.2 0.0 0.0 2.5 0.0 0.0 3.1 9.7 0.0 8.3 3.7 16.9 1.0 0.3 0.5 1.2 0.0 11.0 0.0 0.6 407.4 286.6 0.7 1.1 63.1 26.3 0.0 0.0 30.2 NOTO ENSG00000214513 "Notochord homeobox" A8MTQ0 2 73202258-73212513 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "HPA034660, HPA063906" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034660: AB_10601974, HPA063906: " "unprognostic (6.09e-2)" "unprognostic (9.77e-2)" "unprognostic (4.84e-2)" "unprognostic (1.09e-1)" "unprognostic (6.66e-2)" "unprognostic (1.68e-2)" 0.2 0.8 0.3 0.6 0.4 2.3 0.3 1.4 0.2 0.1 0.5 0.1 0.1 0.8 0.1 0.6 0.1 0.1 0.4 0.2 0.2 0.6 0.1 0.2 0.3 0.5 0.3 0.1 0.2 0.1 0.0 0.4 0.1 2.4 1.3 0.3 0.6 0.2 0.1 0.5 2.2 2.7 0.1 0.5 0.5 0.5 5.7 0.1 0.7 0.1 0.1 0.1 0.4 0.1 0.8 0.8 2.6 0.8 1.4 1.0 0.3 0.2 0.2 0.4 0.5 0.2 0.3 0.7 0.3 0.0 0.1 0.2 1.1 0.8 0.3 0.2 0.3 0.3 1.1 0.1 0.4 0.5 0.8 0.4 0.5 1.8 0.7 0.0 0.6 1.4 0.2 0.4 0.1 0.0 0.3 0.0 0.5 0.1 1.0 0.0 0.6 0.1 0.4 0.7 0.0 0.5 0.7 0.2 0.3 0.1 0.8 0.9 0.6 1.1 0.8 0.0 0.6 0.7 0.6 1.3 0.8 0.4 0.2 0.7 0.7 0.2 0.8 0.3 1.0 0.2 1.9 0.8 0.3 0.6 0.3 0.9 0.6 0.8 0.5 0.3 0.8 0.8 1.0 2.6 1.4 0.5 0.8 0.5 0.3 0.3 0.4 1.4 0.2 0.2 0.6 0.3 0.1 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 NOVA1 ENSG00000139910 "NOVA alternative splicing regulator 1" P51513 14 26443093-26597754 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.7" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 198.3;Horizontal cells: 128.7;Leydig cells: 139.2;Spermatocytes: 170.1" "Cancer enriched" "Detected in many" 5 "glioma: 14.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 25.9;ASC diff: 14.1;HAP1: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004155 Uncertain Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA004155: AB_1079497" "unprognostic (1.46e-1)" "unprognostic (4.43e-3)" "unprognostic (6.55e-3)" "unprognostic (4.00e-2)" "unprognostic (6.69e-3)" "unprognostic (4.29e-2)" "unprognostic (3.74e-3)" "unprognostic (2.41e-1)" "unprognostic (5.21e-1)" "unprognostic (4.32e-2)" "unprognostic (5.04e-4)" "unprognostic (2.40e-1)" "unprognostic (1.93e-3)" "unprognostic (9.27e-4)" "unprognostic (9.20e-2)" "unprognostic (5.62e-2)" "unprognostic (1.31e-4)" 17.8 6.7 17.5 3.4 17.4 1.3 32.9 54.7 49.2 12.2 6.3 13.3 5.0 2.5 9.4 6.9 4.0 6.2 6.2 3.0 17.1 25.1 7.0 2.2 2.7 4.4 19.2 17.8 6.3 2.7 4.4 14.1 1.3 26.4 5.4 6.5 4.0 2.8 17.5 6.9 3.1 3.4 9.9 22.5 2.1 3.3 10.3 14.9 0.0 4.1 2.7 5.2 5.6 9.4 0.3 0.3 0.6 0.4 2.2 0.5 0.0 0.0 6.1 25.9 0.0 14.1 7.6 0.1 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.4 0.4 4.2 0.1 12.7 0.1 0.0 0.0 1.0 0.0 0.0 0.2 5.3 0.0 1.2 9.4 0.0 1.9 1.9 9.4 5.4 5.4 0.0 0.0 4.1 0.0 5.3 0.1 7.6 0.0 6.1 0.7 8.6 0.1 3.6 4.9 8.3 4.8 0.0 0.0 0.0 2.6 0.7 0.0 0.0 3.6 4.2 3.1 0.7 0.0 0.0 0.0 5.1 0.0 3.8 0.6 0.0 0.2 0.3 0.1 0.3 0.2 0.2 0.2 0.1 0.3 0.2 0.5 0.6 2.2 0.4 0.3 0.4 0.0 17.5 17.4 54.7 26.9 17.1 25.1 19.2 17.8 26.4 14.9 0.0 1.0 0.0 6.8 4.6 198.3 0.8 2.5 8.1 0.0 14.0 3.9 0.0 8.3 0.0 14.7 6.2 0.5 0.0 0.3 0.0 12.1 2.1 0.0 0.2 0.2 128.7 63.4 35.0 1.2 11.2 139.2 1.9 3.3 0.0 2.3 26.6 3.1 10.5 61.9 20.4 13.0 6.5 19.8 170.1 57.9 2.8 0.0 0.0 3.7 0.6 NOVA2 "ANOVA, NOVA3" ENSG00000104967 "NOVA alternative splicing regulator 2" Q9UNW9 19 45933734-45973546 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.5" "Group enriched" "Detected in some" 11 "Bipolar cells: 50.9;Endothelial cells: 25.9;Horizontal cells: 20.6;Ito cells: 35.6" "Cancer enhanced" "Detected in many" "glioma: 5.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.3;HDLM-2: 8.8;HUVEC TERT2: 14.2;SH-SY5Y: 4.8;TIME: 21.2;U-2 OS: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045607 Enhanced Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" No No "Golgi apparatus" "Nucleoplasm, Nuclear bodies" "HPA045607: AB_10962628" "unprognostic (9.84e-2)" "unprognostic (2.07e-1)" "unprognostic (9.68e-2)" "unprognostic (2.01e-1)" "unprognostic (1.79e-1)" "unprognostic (3.04e-3)" "unprognostic (1.46e-1)" "unprognostic (6.21e-2)" "unprognostic (2.36e-1)" "unprognostic (3.02e-3)" "unprognostic (6.42e-5)" "unprognostic (1.16e-1)" "prognostic unfavorable (3.04e-4)" "unprognostic (5.05e-2)" "unprognostic (2.54e-1)" "unprognostic (1.41e-1)" "unprognostic (8.31e-2)" 11.8 4.5 23.9 2.7 22.7 1.3 5.7 13.0 33.5 3.9 2.5 7.2 0.0 2.5 5.6 2.7 2.4 3.6 4.2 5.8 17.1 10.9 3.2 2.7 9.4 2.2 7.1 17.3 2.0 2.5 3.3 5.7 9.7 11.1 2.6 2.4 2.5 2.4 3.1 5.5 2.7 2.0 5.7 5.5 2.4 2.5 4.3 8.7 0.0 4.5 0.4 1.8 3.9 3.5 0.0 0.0 0.4 0.1 0.4 0.1 0.0 0.0 0.1 8.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 1.1 0.0 0.0 8.8 0.3 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 4.8 0.0 0.0 0.0 0.0 0.0 0.0 21.2 0.0 5.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 23.9 22.7 13.0 29.3 17.1 10.9 7.1 17.3 11.1 8.7 0.0 0.0 0.0 0.1 0.6 50.9 3.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.3 25.9 0.0 0.0 0.2 0.0 0.4 0.2 0.0 0.4 0.1 20.6 0.0 35.6 2.6 2.4 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.4 0.0 3.1 0.0 0.0 2.3 1.9 0.1 0.0 0.0 0.0 0.3 NOX4 "KOX, KOX-1" ENSG00000086991 "NADPH oxidase 4" Q9NPH5 11 89324356-89498187 "Predicted membrane proteins, Transporters" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "kidney: 65.2" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 119.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 8.5;HUVEC TERT2: 15.6;TIME: 34.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA015475 Approved Nucleoplasm NA NA Nucleoplasm "HPA015475: AB_1854574" "unprognostic (2.91e-2)" "unprognostic (1.08e-1)" "unprognostic (1.74e-3)" "unprognostic (6.58e-3)" "unprognostic (1.92e-1)" "unprognostic (2.33e-1)" "unprognostic (8.83e-3)" "unprognostic (8.95e-3)" "unprognostic (3.80e-1)" "unprognostic (6.88e-2)" "unprognostic (1.56e-2)" "unprognostic (1.73e-1)" "prognostic favorable (6.14e-4)" "unprognostic (1.99e-4)" "unprognostic (9.71e-2)" "unprognostic (5.69e-2)" "unprognostic (3.03e-3)" 7.5 0.6 0.2 0.6 0.6 0.3 6.5 0.3 0.5 1.2 0.9 1.1 0.4 0.3 7.3 2.5 1.5 0.8 1.3 6.9 0.6 0.2 65.2 0.3 1.2 0.3 0.3 0.2 0.7 1.1 3.8 0.8 1.7 1.0 2.6 0.4 0.8 2.6 0.9 5.1 1.1 0.5 3.5 1.2 0.4 0.4 1.0 0.0 0.0 1.7 1.7 0.4 2.1 1.1 0.4 0.3 1.7 0.3 0.8 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.8 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 8.5 15.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 3.1 0.0 0.0 0.2 4.3 0.3 0.0 34.8 0.1 2.7 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.4 0.3 0.2 0.3 0.2 0.3 0.2 0.0 0.4 0.3 0.3 1.7 0.8 0.2 0.3 0.2 0.0 0.2 0.6 0.3 0.5 0.6 0.2 0.3 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.6 4.1 1.1 0.0 0.0 0.0 10.4 5.9 1.2 13.3 0.0 0.8 1.1 0.0 0.0 0.0 0.6 1.1 0.1 0.0 0.0 0.2 0.0 0.0 3.7 0.0 0.4 0.3 0.0 0.0 0.0 0.0 3.7 0.1 0.0 1.1 119.8 19.3 0.0 0.3 0.5 0.1 0.3 2.1 0.0 0.0 0.0 NPAS1 "bHLHe11, MOP5, PASD5" ENSG00000130751 "Neuronal PAS domain protein 1" Q99742 19 47019820-47045775 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 14.2;skin 1: 10.5;stomach 1: 8.0" "Cell type enhanced" "Detected in some" 17 "Cone photoreceptor cells: 15.7;Muller glia cells: 5.6;Rod photoreceptor cells: 5.1" "Cancer enhanced" "Detected in many" "testis cancer: 5.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 2.2" "Lineage enhanced" "Detected in single" "B-cells: 2.2" "Cell line enhanced" "Detected in many" "BJ: 8.9;Daudi: 9.1;HEK 293: 10.0;HMC-1: 8.3;NB-4: 15.9;U-266/84: 9.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA043364, HPA072259" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA043364: , HPA072259: AB_2686500" "unprognostic (2.34e-3)" "unprognostic (6.25e-2)" "unprognostic (7.32e-4)" "unprognostic (1.38e-1)" "unprognostic (6.24e-2)" "unprognostic (2.46e-2)" "unprognostic (2.76e-3)" "unprognostic (2.21e-2)" "unprognostic (1.09e-1)" "unprognostic (3.75e-1)" "unprognostic (5.91e-2)" "unprognostic (2.64e-1)" "unprognostic (2.14e-8)" "unprognostic (8.82e-2)" "unprognostic (2.07e-1)" "unprognostic (1.06e-1)" "unprognostic (4.20e-2)" 0.6 0.6 9.5 1.3 4.1 0.9 1.3 0.4 14.2 0.4 0.9 0.4 0.0 0.5 0.6 0.4 0.8 1.2 0.5 0.9 9.0 5.2 1.2 0.8 0.9 1.7 3.0 4.1 0.4 1.5 0.7 1.1 0.8 5.1 0.6 0.5 3.4 0.7 0.5 0.5 10.5 0.4 0.7 0.8 3.9 8.0 0.8 0.2 0.0 0.6 0.0 1.3 0.5 0.4 2.2 0.0 0.0 0.0 0.0 0.6 0.0 0.1 2.2 0.2 0.4 0.2 0.2 0.0 8.9 0.2 0.1 0.4 0.7 0.5 9.1 2.0 7.2 0.4 0.2 1.9 0.2 0.1 0.6 10.0 0.7 0.8 2.2 0.0 4.8 8.3 0.8 0.4 0.0 0.1 0.5 0.2 1.2 3.1 0.8 1.2 0.7 0.3 15.9 2.2 0.4 1.5 0.8 0.3 0.7 0.5 0.5 0.7 0.6 0.8 0.3 2.1 0.7 1.9 1.5 0.1 0.1 0.9 0.1 0.2 5.0 9.7 1.9 1.1 1.0 6.5 0.0 0.0 0.0 0.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 9.5 4.1 0.4 14.2 9.0 5.2 3.0 4.1 5.1 0.2 0.0 1.1 0.0 1.2 0.7 0.7 0.8 0.0 2.7 0.0 0.0 15.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.3 1.5 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 5.6 0.8 0.0 0.0 0.5 5.1 0.0 0.3 0.0 2.0 1.9 0.0 0.0 0.5 0.9 NPAS2 "bHLHe9, MOP4, PASD4" ENSG00000170485 "Neuronal PAS domain protein 2" Q99743 2 100820152-100996829 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, DNA damage, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 49.7;Urothelial cells: 36.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.0;naive CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 21 "T-cells: 2.0" "Cell line enhanced" "Detected in many" "GAMG: 45.0;PC-3: 34.2;RT4: 27.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019674 Uncertain Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA019674: AB_10601275" "unprognostic (2.74e-1)" "unprognostic (8.89e-2)" "unprognostic (4.66e-2)" "unprognostic (5.06e-3)" "unprognostic (4.39e-2)" "unprognostic (3.05e-1)" "prognostic unfavorable (2.07e-4)" "unprognostic (5.47e-3)" "unprognostic (4.48e-1)" "unprognostic (1.56e-1)" "unprognostic (1.59e-3)" "unprognostic (2.13e-1)" "prognostic unfavorable (3.55e-7)" "unprognostic (7.03e-2)" "unprognostic (6.58e-2)" "unprognostic (7.71e-3)" "unprognostic (1.34e-3)" 6.6 11.5 16.8 8.2 24.8 1.2 10.1 7.6 23.0 11.9 14.4 4.3 1.3 26.7 8.8 4.9 32.4 8.2 13.6 27.3 15.3 6.8 15.9 14.1 5.3 3.6 6.2 14.1 3.3 32.5 1.7 12.7 14.2 10.3 12.2 15.1 6.5 23.7 7.0 12.7 18.5 20.2 17.9 11.0 5.7 19.1 9.9 8.5 0.5 6.3 6.0 13.4 22.4 14.4 0.0 0.0 0.0 0.0 0.0 2.0 0.0 4.0 22.7 0.0 0.2 22.4 9.7 3.3 7.5 22.4 3.1 6.7 0.4 1.8 0.0 9.0 1.2 45.0 0.1 3.3 5.5 3.2 0.2 1.3 0.0 4.0 10.3 10.6 0.0 0.9 8.2 9.0 7.5 12.1 12.6 12.6 2.4 0.1 0.0 2.4 8.1 1.5 0.2 0.4 6.6 34.2 0.1 0.5 0.2 16.0 27.5 0.0 0.4 0.0 1.3 16.8 0.2 0.2 0.2 4.8 2.3 3.1 4.5 3.2 0.0 0.0 0.0 24.5 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 2.0 1.3 0.0 0.0 0.0 0.0 1.3 0.0 16.8 24.8 7.6 23.0 15.3 6.8 6.2 14.1 10.3 8.5 0.0 10.7 0.0 7.4 3.4 4.4 13.2 20.4 2.7 10.3 12.2 0.0 0.5 0.0 11.2 49.7 6.5 22.4 0.0 13.3 0.8 5.6 17.5 0.0 12.9 0.1 27.0 8.7 15.4 0.3 7.9 6.6 0.7 3.3 1.0 9.9 3.6 12.8 11.0 4.9 12.1 0.4 0.0 4.4 0.4 1.7 5.6 0.2 0.0 9.9 36.3 NPAS3 "bHLHe12, MOP6, PASD6" ENSG00000151322 "Neuronal PAS domain protein 3" Q8IXF0 14 32934933-33804176 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.8" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 7.8;Early spermatids: 16.1;Horizontal cells: 9.5;Late spermatids: 12.4" "Cancer enhanced" "Detected in some" "endometrial cancer: 6.4;glioma: 7.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "AF22: 9.0;U-266/70: 22.3;U-266/84: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075337 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA075337: " "unprognostic (6.02e-3)" "unprognostic (2.37e-1)" "unprognostic (1.75e-1)" "unprognostic (1.31e-2)" "unprognostic (3.24e-1)" "unprognostic (1.36e-1)" "unprognostic (1.14e-2)" "unprognostic (5.65e-2)" "unprognostic (2.74e-1)" "unprognostic (3.12e-3)" "unprognostic (5.29e-3)" "unprognostic (1.38e-1)" "unprognostic (3.18e-3)" "unprognostic (2.65e-3)" "unprognostic (1.50e-1)" "unprognostic (2.69e-3)" "unprognostic (3.27e-1)" 1.8 2.4 17.4 1.4 14.4 1.0 2.7 8.5 29.8 14.0 1.8 15.8 0.7 1.5 9.1 2.6 1.6 8.5 2.2 1.6 18.7 10.3 2.4 1.3 1.3 1.3 11.7 13.0 6.4 2.2 2.5 1.6 2.0 16.2 2.5 1.7 0.8 2.7 3.6 2.0 1.4 1.6 2.2 13.8 3.1 2.8 3.5 16.3 0.0 4.4 0.0 1.5 1.1 1.4 0.0 0.6 0.1 0.2 0.0 0.2 0.0 0.0 0.0 9.0 0.0 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.5 0.0 0.6 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.5 22.3 6.4 0.0 0.3 0.0 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.6 0.0 0.0 17.4 14.4 8.5 15.3 18.7 10.3 11.7 13.0 16.2 16.3 0.0 0.0 0.0 0.7 0.9 7.8 2.0 0.0 2.7 0.0 1.8 0.0 1.2 1.7 0.1 16.1 1.9 0.0 0.0 0.0 0.1 2.1 0.4 0.0 0.0 0.4 9.5 1.2 6.2 0.0 12.4 6.6 0.0 0.0 0.0 0.0 5.8 0.3 0.0 4.9 0.6 0.3 0.0 3.1 0.2 0.1 0.4 0.2 0.0 0.0 0.4 NPAT "E14, p220" ENSG00000149308 "Nuclear protein, coactivator of histone transcription" Q14207 11 108157215-108222642 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 34.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045908, HPA066370" Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA045908: AB_2679493, HPA066370: AB_2685665" "unprognostic (6.93e-2)" "unprognostic (5.81e-2)" "unprognostic (1.09e-2)" "unprognostic (3.82e-2)" "unprognostic (5.37e-2)" "unprognostic (2.60e-2)" "unprognostic (4.89e-2)" "unprognostic (7.38e-2)" "unprognostic (5.03e-3)" "unprognostic (1.26e-1)" "unprognostic (7.04e-2)" "unprognostic (4.14e-2)" "unprognostic (2.76e-3)" "unprognostic (1.97e-1)" "unprognostic (1.86e-1)" "unprognostic (5.76e-2)" "unprognostic (1.93e-1)" 15.7 9.8 8.5 18.6 11.5 7.1 12.0 24.6 12.8 13.1 9.3 7.5 8.9 7.1 12.0 10.7 10.3 10.7 8.2 9.4 7.8 8.7 10.1 9.5 11.5 23.1 10.7 8.9 15.2 9.1 14.6 21.5 18.3 13.1 10.7 11.0 7.9 11.6 8.4 8.8 12.2 12.2 9.0 13.7 17.1 10.0 11.3 11.1 26.7 14.4 7.5 21.6 15.4 10.7 5.2 2.2 7.4 3.1 5.8 11.6 3.6 5.0 4.1 6.4 8.0 8.0 5.9 5.2 7.5 9.6 6.7 10.1 8.4 11.0 8.7 10.2 4.7 7.5 9.5 8.8 7.7 12.1 7.7 3.5 14.4 4.5 4.3 3.4 10.8 9.6 5.5 4.5 11.8 7.6 5.2 9.4 10.2 13.3 4.3 9.3 2.5 13.2 5.8 5.3 8.1 5.7 9.1 9.1 11.9 4.4 7.4 6.9 6.3 9.7 5.8 7.5 7.1 6.6 5.3 7.7 11.7 6.2 6.9 6.8 3.0 3.7 34.0 2.9 8.0 9.0 7.4 1.7 3.2 6.2 3.1 6.9 4.9 7.2 7.8 2.2 5.2 11.6 9.2 2.2 5.8 3.0 1.7 5.2 3.6 8.5 11.5 24.6 12.8 7.8 8.7 10.7 8.9 13.1 11.1 17.9 10.4 14.6 16.1 14.4 16.6 12.5 2.5 10.7 14.8 12.2 27.5 8.3 1.7 7.3 2.6 17.4 5.4 0.0 5.9 7.4 13.6 12.2 18.5 8.5 6.2 9.5 9.9 20.9 11.2 2.6 14.7 12.4 8.5 8.2 8.2 11.4 5.5 7.0 15.9 4.1 17.4 6.5 8.5 24.1 30.6 11.5 11.8 25.3 8.6 11.9 NPC1 SLC65A1 ENSG00000141458 "NPC intracellular cholesterol transporter 1" O15118 18 23506184-23586898 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cholesterol metabolism, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Host cell receptor for virus entry, Receptor" "Disease mutation, Niemann-Pick disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 65.6" "Cell type enhanced" "Detected in many" 4 "Urothelial cells: 51.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 32.7" "Group enriched" "Detected in all" 4 "dendritic cells: 32.7;T-cells: 14.5" "Cell line enhanced" "Detected in all" "hTERT-HME1: 70.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026618, CAB070132, HPA077445" Approved Supported Nucleoplasm,Vesicles NA NA 27000 "Nucleoplasm, Vesicles" "CAB070132: AB_10001101, HPA026618: AB_1854580, HPA077445: " "unprognostic (1.74e-1)" "unprognostic (1.53e-3)" "unprognostic (2.67e-1)" "unprognostic (1.25e-1)" "unprognostic (3.20e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (2.26e-6)" "unprognostic (1.31e-1)" "unprognostic (1.01e-2)" "unprognostic (7.36e-3)" "unprognostic (1.07e-2)" "unprognostic (1.09e-3)" "unprognostic (2.78e-2)" "unprognostic (1.89e-1)" "unprognostic (2.73e-2)" "unprognostic (1.38e-1)" "unprognostic (2.08e-3)" 13.4 38.8 17.4 11.2 30.9 26.4 15.8 7.1 25.1 10.1 8.7 65.6 3.4 10.2 11.1 11.7 12.8 8.2 11.2 7.1 23.4 14.3 9.9 10.3 17.8 13.0 46.0 15.4 12.0 7.9 51.8 9.9 18.9 27.7 9.7 8.9 12.0 25.4 10.1 13.7 17.0 12.2 10.9 41.4 11.5 12.0 9.5 38.4 7.0 8.3 5.3 10.7 10.8 10.8 3.6 32.7 3.8 5.8 4.6 14.5 4.1 5.3 10.7 4.6 7.4 15.0 11.6 10.5 9.3 20.2 9.9 21.5 7.1 7.8 4.5 7.2 13.4 33.8 15.0 5.8 16.0 8.8 3.5 4.6 1.6 9.7 16.0 21.4 6.1 7.4 11.1 15.9 20.9 70.4 19.6 9.7 5.2 4.8 12.1 11.1 8.1 2.5 3.6 3.2 6.1 9.6 3.6 7.2 11.2 23.0 13.3 1.9 3.7 11.1 16.2 13.7 7.4 4.0 4.8 12.5 21.0 4.1 8.3 8.0 7.5 23.1 3.1 46.3 5.4 9.4 1.8 4.1 3.8 14.5 3.8 9.8 2.4 5.9 9.9 1.7 3.6 2.7 7.3 3.7 4.6 5.8 32.7 7.7 4.1 17.4 30.9 7.1 25.1 23.4 14.3 46.0 15.4 27.7 38.4 23.8 44.3 6.2 23.3 8.2 5.0 4.4 10.2 0.0 15.9 8.7 17.7 11.6 0.0 9.3 1.1 11.4 11.3 0.0 12.8 6.2 6.5 30.4 10.4 7.9 25.1 3.2 3.5 7.4 9.2 1.4 8.3 17.9 11.8 2.8 4.8 16.2 23.5 14.0 9.9 4.7 12.4 0.0 9.0 12.6 20.4 12.7 19.9 20.3 4.5 51.4 NPDC1 "CAB-, CAB1, DKFZp586J0523" ENSG00000107281 "Neural proliferation, differentiation and control 1" Q9NQX5 9 137039470-137046203 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Glandular cells: 329.4;Intestinal endocrine cells: 270.4;Ito cells: 337.0;Mucus-secreting cells: 535.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 8.4;MAIT T-cell: 10.7;memory CD4 T-cell: 13.2;memory CD8 T-cell: 13.6;T-reg: 10.4" "Lineage enriched" "Detected in many" 7 "T-cells: 13.6" "Cell line enhanced" "Detected in many" "T-47d: 39.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008189 Approved Approved Nucleoplasm,Cytosol NA NA 180000 Nucleoplasm Cytosol "HPA008189: AB_1854584" "unprognostic (6.94e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (2.01e-5)" "prognostic favorable (6.19e-5)" "unprognostic (2.06e-1)" "unprognostic (4.83e-3)" "unprognostic (1.24e-1)" "unprognostic (4.35e-2)" "unprognostic (8.65e-2)" "unprognostic (1.53e-1)" "prognostic favorable (3.18e-4)" "unprognostic (2.40e-1)" "unprognostic (2.65e-2)" "unprognostic (1.23e-2)" "unprognostic (2.35e-1)" "unprognostic (4.20e-2)" "unprognostic (8.84e-2)" 35.4 21.7 33.1 11.9 35.5 4.1 21.6 59.7 65.6 27.8 27.1 18.4 23.8 22.2 26.7 10.8 11.6 25.4 32.3 20.4 34.5 35.3 12.7 5.9 18.9 11.5 25.1 49.0 12.0 28.6 17.2 47.7 20.1 29.5 73.1 13.3 10.6 58.0 35.5 19.0 17.7 23.0 16.4 30.3 32.4 59.6 10.4 14.5 0.8 11.5 8.6 7.2 12.8 20.2 0.1 2.0 0.5 0.4 0.1 13.6 2.6 9.4 11.4 2.8 18.4 6.6 6.8 0.7 20.4 6.4 4.6 1.8 4.6 5.2 9.4 15.5 7.8 1.4 35.7 2.4 5.5 0.5 7.6 11.6 3.8 29.2 3.3 9.5 3.3 0.0 4.7 8.6 2.5 5.0 12.0 11.8 3.8 0.2 0.2 0.9 35.9 0.2 0.3 6.1 30.0 19.0 5.6 0.0 36.0 7.8 6.1 22.7 15.7 5.4 18.2 12.2 1.1 39.3 4.7 20.3 3.4 6.2 24.3 6.2 0.0 0.1 0.3 5.0 0.3 2.9 0.0 0.4 0.5 8.4 0.0 10.7 0.1 13.2 13.6 0.7 0.0 0.3 2.3 0.0 0.1 0.0 2.0 10.4 2.6 33.1 35.5 59.7 65.6 34.5 35.3 25.1 49.0 29.5 14.5 0.0 10.6 4.2 65.4 20.9 88.5 13.4 79.0 2.7 4.5 27.9 15.7 1.0 0.0 43.0 1.0 147.8 41.7 23.3 59.4 1.0 34.3 329.4 0.0 0.8 17.1 58.8 270.4 337.0 25.4 2.5 149.3 6.8 28.7 2.8 535.1 32.8 34.0 79.7 136.9 0.3 54.6 38.8 34.0 2.9 19.1 20.7 1.5 7.7 84.8 89.4 NPEPL1 "bA261P9.2, FLJ11583" ENSG00000215440 "Aminopeptidase like 1" Q8NDH3 20 58689131-58719238 "Enzymes, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 12.2;classical monocyte: 13.4;eosinophil: 4.9;intermediate monocyte: 8.9;myeloid DC: 8.2;neutrophil: 9.6;non-classical monocyte: 11.9" "Group enriched" "Detected in all" 5 "dendritic cells: 8.2;granulocytes: 12.2;monocytes: 13.4" "Cell line enhanced" "Detected in many" "MCF7: 43.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB004986, CAB017025, HPA036356" Approved Approved Nucleoplasm NA NA 16000 Nucleoplasm "CAB004986: AB_426073, CAB017025: , HPA036356: AB_2675082" "unprognostic (1.68e-1)" "unprognostic (5.87e-3)" "unprognostic (8.28e-2)" "unprognostic (2.78e-1)" "unprognostic (5.42e-2)" "unprognostic (1.47e-3)" "unprognostic (2.86e-3)" "unprognostic (3.11e-2)" "unprognostic (4.14e-1)" "unprognostic (1.08e-2)" "unprognostic (1.62e-3)" "unprognostic (3.78e-2)" "prognostic unfavorable (1.87e-9)" "unprognostic (7.97e-2)" "unprognostic (1.64e-1)" "unprognostic (2.21e-1)" "prognostic favorable (5.73e-4)" 17.2 10.3 9.9 9.7 15.3 15.8 25.0 24.2 10.1 9.6 14.9 10.2 17.2 14.4 11.9 23.5 17.9 12.5 24.5 19.4 10.1 8.6 16.7 11.9 14.5 12.6 12.9 7.2 12.5 15.6 13.6 11.4 11.2 13.1 15.0 4.5 15.7 19.1 17.2 51.8 15.2 13.7 25.8 10.0 16.5 12.8 13.0 9.0 5.6 16.5 20.4 11.8 15.3 20.4 1.0 8.2 12.2 13.4 2.0 2.3 4.1 9.3 13.1 2.4 1.9 5.3 9.8 0.7 3.4 0.3 11.8 6.6 7.5 7.1 0.4 19.6 6.7 0.1 10.1 3.2 4.4 1.1 8.2 2.9 3.1 10.0 3.3 13.4 3.3 5.6 9.6 14.0 4.1 0.0 4.3 9.9 2.6 0.4 1.5 4.6 43.7 1.3 8.8 3.5 5.5 13.7 2.7 1.1 5.1 4.8 6.0 4.4 1.4 9.5 2.6 17.6 1.4 10.2 6.5 10.4 3.0 2.4 5.9 1.8 4.5 1.6 0.3 4.3 6.4 1.2 12.2 13.4 4.9 1.9 8.9 2.3 1.0 1.1 1.3 8.2 0.7 0.7 1.3 9.6 2.0 11.9 0.4 2.3 4.1 9.9 15.3 24.2 10.1 10.1 8.6 12.9 7.2 13.1 9.0 8.9 14.1 0.8 7.2 8.1 14.8 13.3 7.6 14.7 12.5 26.2 23.6 11.6 11.6 13.1 1.3 12.2 10.9 0.0 8.0 6.9 9.0 5.9 2.3 7.3 10.0 7.9 11.5 14.7 15.1 6.4 20.4 9.9 6.8 8.2 9.9 20.9 8.6 15.3 13.8 17.3 8.6 19.4 11.8 2.1 3.3 9.8 7.4 10.1 12.0 4.7 NPHP4 "KIAA0673, POC10, SLSN4" ENSG00000131697 "Nephrocystin 4" O75161 1 5862811-5992473 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ciliopathy, Disease mutation, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 31.4;Rod photoreceptor cells: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063852, HPA065526" Approved Approved "Nucleoplasm,Nuclear bodies,Vesicles,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies, Vesicles" "HPA063852: , HPA065526: AB_2685505" "unprognostic (1.82e-1)" "unprognostic (1.57e-2)" "unprognostic (1.76e-1)" "unprognostic (7.30e-2)" "unprognostic (5.83e-2)" "unprognostic (2.53e-2)" "unprognostic (1.08e-2)" "unprognostic (1.95e-1)" "unprognostic (2.52e-1)" "unprognostic (1.23e-2)" "unprognostic (7.49e-3)" "unprognostic (9.00e-2)" "unprognostic (1.75e-2)" "unprognostic (2.96e-2)" "unprognostic (1.34e-1)" "unprognostic (2.54e-1)" "unprognostic (1.37e-1)" 5.6 4.7 7.3 4.7 11.2 7.2 4.9 6.3 12.0 5.4 3.5 4.9 8.9 4.4 5.2 11.9 3.7 17.4 5.7 3.7 6.6 3.9 4.5 2.5 6.7 4.6 2.8 6.4 7.0 4.9 7.1 17.8 3.7 5.4 4.5 2.9 8.3 4.1 5.7 3.7 9.6 4.5 5.3 3.5 4.6 4.3 11.4 3.7 5.8 14.9 3.7 2.6 4.3 4.5 0.5 0.4 2.6 1.0 0.5 0.8 0.4 7.6 4.2 5.7 4.4 5.1 7.4 4.4 4.0 4.1 5.6 4.4 4.0 6.7 4.0 10.1 4.5 3.8 7.2 2.8 6.8 2.8 4.9 6.5 3.4 7.7 3.6 3.5 6.6 5.2 6.0 3.4 6.6 4.2 3.4 3.9 9.7 6.1 4.3 2.5 5.6 8.0 6.6 1.0 4.0 4.5 6.9 3.6 6.5 2.5 1.0 18.0 5.5 6.3 4.6 6.6 2.6 6.1 7.2 3.5 8.1 3.4 13.4 4.9 5.2 6.9 4.0 3.4 8.4 2.1 2.6 1.0 0.0 0.5 0.2 0.8 0.3 0.5 0.0 0.4 0.5 0.4 0.0 1.4 0.5 0.8 0.3 0.2 0.4 7.3 11.2 6.3 12.0 6.6 3.9 2.8 6.4 5.4 3.7 0.0 0.6 0.0 1.0 3.5 6.4 2.5 5.1 5.3 5.7 3.5 31.4 0.5 1.7 0.8 1.5 2.2 1.6 0.0 1.6 0.4 1.8 1.5 0.0 1.5 1.7 4.8 3.5 1.3 4.3 1.0 3.7 2.6 10.1 1.0 2.3 5.4 1.9 2.6 2.1 1.4 19.4 6.5 2.1 11.2 6.0 4.5 0.9 0.7 1.2 0.9 NPIPA1 "morpheus, NPIP" ENSG00000183426 "Nuclear pore complex interacting protein family member A1" Q9UND3 16 14922802-14952060 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 33.1" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 54.9;Early spermatids: 43.7" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 16 "B-cells: 2.3;granulocytes: 1.7;T-cells: 1.3" "Cell line enhanced" "Detected in many" "HHSteC: 34.1" HPA053611 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (2.77e-2)" "unprognostic (1.25e-1)" "unprognostic (4.48e-2)" "unprognostic (2.52e-1)" "unprognostic (2.87e-2)" "unprognostic (2.29e-2)" "unprognostic (9.21e-2)" "unprognostic (1.65e-2)" "unprognostic (5.12e-2)" "unprognostic (1.08e-1)" "unprognostic (8.82e-3)" "unprognostic (3.65e-2)" "unprognostic (1.74e-7)" "unprognostic (2.28e-1)" "unprognostic (8.76e-2)" "unprognostic (1.73e-2)" "unprognostic (2.66e-5)" 5.1 6.0 5.9 3.8 4.9 4.2 4.8 33.1 8.3 5.0 5.8 1.8 15.6 0.0 3.0 16.3 2.7 4.6 7.0 6.2 6.6 3.0 4.3 5.4 3.7 25.2 4.7 1.1 13.6 3.0 7.8 3.3 2.5 11.7 7.9 16.3 3.0 12.4 3.8 5.0 3.2 6.5 6.1 4.1 5.0 4.0 2.3 0.0 1.7 0.1 0.1 1.3 0.7 0.1 5.3 24.6 9.5 0.0 0.4 4.2 9.3 6.5 8.6 7.7 3.7 5.8 1.5 13.4 12.9 10.3 4.3 11.3 1.3 8.9 4.8 4.3 0.0 8.3 19.6 34.1 11.7 2.8 18.9 18.5 7.2 13.1 5.1 4.1 8.1 1.3 6.5 9.7 11.3 0.0 6.3 0.2 0.0 0.2 4.6 0.1 2.1 13.8 11.3 1.0 9.3 5.0 0.6 10.6 3.1 1.9 10.3 0.8 11.5 0.5 0.2 2.9 3.9 2.8 3.1 0.4 0.7 5.8 1.7 0.0 0.0 0.8 0.0 1.3 2.3 0.3 1.2 0.0 1.3 0.6 0.4 0.0 0.1 0.1 0.0 0.7 0.7 6.0 18.3 0.0 1.1 8.2 7.4 2.0 0.0 54.9 29.6 8.7 5.9 1.8 0.0 5.2 43.7 3.6 2.6 0.0 1.7 1.2 6.2 1.3 20.9 2.9 2.0 6.4 4.7 6.7 5.2 17.6 19.8 4.0 0.0 6.4 4.5 3.0 4.9 3.5 18.0 1.0 4.8 19.4 3.9 12.2 10.4 3.4 1.0 5.0 7.5 0.9 NPIPA2 ENSG00000254852 "Nuclear pore complex interacting protein family member A2" E9PIF3 16 14748066-14765413 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "brain: 11.8" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 4.5;Club cells: 3.4;granulocytes: 9.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 12.2;NB-4: 4.1" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" 1.6 1.2 1.3 1.1 1.5 0.9 1.8 11.8 3.8 0.6 3.2 0.6 1.7 2.7 1.1 2.4 0.8 1.3 1.8 1.5 0.6 0.5 1.6 0.9 1.0 2.6 1.2 2.3 4.1 1.1 2.2 2.6 3.1 1.0 4.2 4.1 1.0 0.8 1.3 0.9 1.6 5.9 1.2 0.8 3.3 1.5 1.6 0.0 0.1 0.1 0.0 0.5 0.0 0.4 0.4 0.3 0.0 0.4 0.3 12.2 1.0 0.5 0.1 0.3 0.4 1.7 0.0 1.1 0.9 0.2 1.4 0.3 0.0 0.1 1.0 0.7 0.8 1.0 0.2 0.4 0.2 2.9 0.1 1.6 1.6 1.2 0.1 0.3 1.6 0.8 0.8 0.2 2.4 1.3 4.1 0.8 0.0 0.5 1.3 0.8 0.2 0.7 0.6 1.1 0.6 0.4 0.7 1.7 1.8 0.0 1.0 0.9 0.4 0.3 0.0 0.5 0.4 0.3 0.3 1.5 0.7 1.0 0.1 0.1 0.0 0.5 0.0 0.3 0.7 0.5 0.1 0.0 1.6 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.0 4.5 0.0 0.0 2.1 0.0 0.4 0.0 1.4 3.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 NPIPA3 ENSG00000224712 "Nuclear pore complex interacting protein family member A3" F8WFD2 16 14708944-14726338 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "brain: 13.2" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 3.0;Cardiomyocytes: 4.1;Ciliated cells: 4.0" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "basophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HSkMC: 5.0;hTERT-RPE1: 7.1;NB-4: 11.2;SK-MEL-30: 16.1" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (1.44e-1)" "unprognostic (7.83e-3)" "unprognostic (8.12e-3)" "unprognostic (1.87e-1)" "unprognostic (1.60e-1)" "unprognostic (5.69e-3)" "unprognostic (3.11e-2)" "unprognostic (4.58e-3)" "unprognostic (4.87e-1)" "unprognostic (2.69e-1)" "unprognostic (3.30e-2)" "unprognostic (2.04e-1)" "unprognostic (1.67e-3)" "unprognostic (1.20e-3)" "unprognostic (1.35e-1)" "unprognostic (1.79e-2)" "unprognostic (1.71e-2)" 1.3 1.4 1.8 2.3 1.3 1.9 1.2 13.2 5.0 0.8 2.9 0.5 2.4 2.2 1.1 2.8 6.4 1.0 2.2 1.8 1.1 0.8 1.2 1.0 1.1 2.8 1.5 7.2 4.1 1.3 2.3 2.6 1.9 2.9 5.3 3.2 3.4 1.2 1.0 1.0 1.3 1.8 1.4 1.0 1.9 1.6 0.1 0.0 1.6 0.0 0.0 0.6 0.0 0.0 0.6 0.1 0.3 0.0 0.1 1.5 0.5 0.0 0.4 0.4 0.0 2.1 3.5 0.2 1.3 0.8 0.1 0.1 2.3 0.3 0.1 0.0 0.4 0.7 0.4 0.2 0.1 0.5 5.0 0.7 1.3 0.2 7.1 0.1 0.7 0.1 0.3 0.3 1.3 0.0 11.2 0.9 0.0 0.0 0.1 0.0 0.0 3.1 1.0 0.5 0.5 0.0 0.2 16.1 0.7 0.2 0.0 0.5 0.6 0.1 0.0 0.1 0.0 0.2 0.1 1.9 0.1 2.0 1.6 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.3 0.0 0.0 0.5 0.0 4.1 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.2 0.1 0.3 0.0 1.1 0.0 0.1 0.0 1.2 0.0 0.3 0.2 0.6 0.0 0.0 0.0 0.6 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.2 0.0 0.5 0.0 NPIPA5 ENSG00000183793 "Nuclear pore complex interacting protein family member A5" E9PKD4 16 15363624-15381047 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 25.3" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 13.4;Early spermatids: 15.7;granulocytes: 10.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "THP-1: 15.7" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (1.20e-1)" "unprognostic (1.52e-2)" "unprognostic (1.94e-2)" "unprognostic (1.04e-1)" "unprognostic (1.01e-1)" "unprognostic (4.19e-4)" "unprognostic (5.85e-2)" "unprognostic (5.92e-2)" "unprognostic (7.85e-2)" "unprognostic (6.58e-2)" "unprognostic (9.02e-3)" "unprognostic (1.57e-2)" "unprognostic (4.34e-3)" "unprognostic (1.85e-1)" "unprognostic (2.85e-1)" "unprognostic (9.18e-2)" "unprognostic (4.02e-2)" 2.0 2.7 4.9 0.8 4.0 3.2 3.3 25.3 6.6 3.2 4.5 2.4 8.0 8.4 4.0 5.8 4.8 4.2 5.5 5.7 1.9 2.5 4.5 2.4 3.6 5.5 4.0 7.6 8.9 1.0 3.3 2.4 1.6 2.5 4.6 13.9 2.1 2.6 2.5 2.7 2.3 8.8 2.9 1.0 2.8 2.5 0.8 0.3 0.1 0.1 1.1 0.7 0.1 0.9 1.4 4.9 0.7 9.3 9.9 0.7 1.9 4.6 6.4 6.6 2.0 0.8 2.1 0.5 4.9 2.0 2.1 1.7 4.9 3.3 3.9 1.9 2.6 5.9 9.8 1.4 0.7 3.7 1.9 8.5 2.5 3.4 2.9 3.4 7.7 2.8 1.5 6.2 1.0 2.1 3.2 6.9 4.0 0.9 0.7 0.7 0.6 5.5 1.9 0.0 0.7 5.5 2.4 6.1 0.6 2.4 15.7 7.8 0.0 2.5 7.6 0.4 4.3 6.0 7.3 0.9 3.8 1.4 0.1 0.1 0.0 0.1 0.0 0.7 0.8 0.4 0.2 0.3 0.4 0.2 0.1 0.0 1.1 0.1 0.1 0.1 0.1 0.0 3.0 0.0 0.2 4.2 1.7 2.8 0.0 13.4 3.4 1.8 0.0 0.5 0.0 0.1 15.7 2.1 0.3 0.0 0.2 0.2 7.3 0.3 10.5 1.0 0.3 1.6 0.0 1.3 1.5 2.2 1.4 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 2.7 0.0 5.7 3.9 0.9 4.0 0.2 0.0 0.0 0.1 NPIPA7 ENSG00000214967 "Nuclear pore complex interacting protein family member A7" E9PJI5 16 16379055-16393954 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 1: 3.0;Cardiomyocytes: 13.4;Ciliated cells: 4.0;granulocytes: 5.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 4 "B-cells: 1.7;T-cells: 1.9" "Cell line enhanced" "Detected in all" "HMC-1: 39.4;THP-1: 33.7" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (1.17e-2)" 3.6 5.7 3.0 2.8 3.0 3.7 2.9 19.7 4.0 3.2 5.1 3.1 3.7 10.1 5.3 5.5 6.2 1.9 3.8 3.4 4.4 5.9 3.8 5.2 1.7 5.1 8.8 12.4 18.0 3.2 6.1 9.0 6.6 3.2 2.6 13.8 4.2 3.9 1.6 6.3 4.2 6.1 6.8 4.3 4.1 3.3 1.7 0.1 0.2 0.1 0.4 1.9 0.2 3.1 6.9 8.3 3.2 5.0 4.0 5.5 6.5 2.5 7.5 3.9 7.2 5.0 7.9 5.3 6.8 4.6 9.6 5.8 6.7 5.6 2.3 1.7 7.8 21.3 10.5 4.7 2.7 39.4 7.2 26.0 4.1 8.9 9.4 3.8 13.1 4.6 10.2 8.2 13.3 6.3 16.2 5.7 11.4 2.3 9.4 5.6 4.4 12.3 13.4 10.8 5.8 5.2 12.0 5.5 10.7 8.7 33.7 3.3 7.2 3.5 3.2 5.5 2.1 7.7 6.5 4.1 8.7 3.1 0.2 0.1 0.0 1.9 0.0 0.4 1.5 1.2 1.9 0.0 1.7 0.2 0.3 0.0 0.4 0.1 0.1 0.4 0.2 3.0 1.6 0.0 0.0 1.4 0.0 13.4 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 5.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 NPIPA8 LCR16a9 ENSG00000214940 "Nuclear pore complex interacting protein family member A8" P0DM63 16 18317942-18336736 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 14.1" "Cell type enhanced" "Detected in single" 28 "granulocytes: 1.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 18.2;EFO-21: 18.3;HMC-1: 67.5;SCLC-21H: 16.5;THP-1: 18.2" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (1.68e-1)" "unprognostic (3.60e-2)" "unprognostic (2.81e-1)" 2.6 7.9 2.0 1.3 2.8 3.9 2.3 14.1 10.8 1.4 5.5 0.0 0.6 0.0 0.9 5.1 0.0 2.6 3.4 1.9 1.1 1.0 2.4 1.5 0.5 6.0 1.1 7.6 6.6 4.8 2.3 1.3 1.5 6.5 1.5 4.6 1.7 0.0 0.2 4.4 1.4 2.1 1.6 0.0 3.8 0.5 1.8 0.5 1.7 0.6 0.1 1.1 0.3 0.0 0.7 0.1 0.1 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.1 3.2 18.2 18.3 0.1 0.0 0.0 7.2 2.1 0.0 0.0 0.0 0.0 0.5 0.5 3.0 0.0 67.5 0.1 0.0 0.0 0.0 0.0 1.3 4.4 7.1 0.0 0.0 0.0 0.0 0.0 5.0 7.4 0.0 0.7 11.2 0.5 0.1 0.0 16.5 5.2 0.0 0.1 0.1 3.6 0.0 18.2 0.0 0.3 0.0 0.0 4.1 0.0 0.0 0.0 5.8 5.0 0.4 0.0 0.6 0.0 0.6 0.0 1.1 1.8 0.5 0.2 0.3 0.2 0.7 0.4 1.7 0.1 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 NPIPB11 ENSG00000254206 "Nuclear pore complex interacting protein family member B11" E5RHQ5 16 29381354-29404029 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 8.9;Early spermatids: 12.3" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive B-cell: 3.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (6.82e-2)" "unprognostic (2.99e-1)" "unprognostic (1.93e-3)" "unprognostic (1.42e-1)" "unprognostic (1.14e-1)" "unprognostic (6.92e-3)" "unprognostic (3.06e-1)" "unprognostic (7.97e-2)" "unprognostic (2.84e-1)" "unprognostic (1.36e-1)" "unprognostic (5.57e-4)" "unprognostic (7.41e-2)" "unprognostic (2.94e-6)" "unprognostic (2.79e-1)" "unprognostic (1.98e-1)" "unprognostic (5.96e-3)" "unprognostic (4.79e-5)" 2.0 1.0 1.9 3.2 2.5 5.3 1.9 5.9 2.4 1.6 1.8 2.3 2.1 4.2 1.7 2.9 2.1 1.8 2.4 1.9 2.7 3.5 1.9 7.4 1.5 4.4 1.6 0.7 2.3 1.2 2.3 2.0 2.8 0.5 5.1 8.8 3.1 0.9 1.7 5.5 3.2 4.5 2.9 1.0 1.0 1.9 3.1 0.7 1.4 0.5 0.4 1.1 0.2 1.9 1.6 2.9 4.1 2.1 1.7 3.9 1.7 0.8 1.5 0.7 2.1 3.7 12.1 2.8 0.9 0.7 3.3 2.2 2.7 1.6 2.8 3.1 2.6 4.9 3.5 1.1 3.3 6.4 1.0 2.1 1.7 2.3 3.3 0.8 3.2 3.3 3.5 1.4 4.2 2.6 10.3 5.0 1.1 3.5 4.2 1.1 3.7 1.7 1.4 3.7 1.9 0.5 2.6 1.4 9.3 1.4 4.1 3.7 4.0 1.7 2.9 2.4 3.3 2.0 9.9 2.2 4.1 2.9 0.2 0.5 0.1 1.0 0.0 0.2 0.5 0.5 0.8 0.7 3.1 1.1 1.1 1.4 0.4 0.4 0.2 0.0 0.2 8.9 6.4 2.2 0.0 0.0 0.0 1.8 0.0 4.0 4.5 0.0 0.0 0.3 0.0 0.9 12.3 0.6 3.9 0.0 0.7 0.2 0.0 0.1 4.7 0.0 0.3 4.8 6.9 0.0 0.0 4.5 0.3 0.7 0.0 1.0 6.2 0.1 1.5 5.8 0.7 0.0 0.3 0.0 0.0 0.7 0.1 0.0 0.3 0.0 4.8 0.0 NPIPB12 ENSG00000169203 "Nuclear pore complex interacting protein family, member B12" 16 29483642-29505999 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 24 "Alveolar cells type 1: 3.0;Club cells: 1.2;granulocytes: 1.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 59.4" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (3.83e-2)" "unprognostic (1.08e-1)" "unprognostic (2.09e-2)" "unprognostic (1.77e-1)" "unprognostic (7.92e-2)" "unprognostic (1.50e-2)" "unprognostic (2.12e-1)" "unprognostic (2.37e-1)" "unprognostic (5.20e-2)" "unprognostic (2.42e-1)" "unprognostic (6.08e-2)" "unprognostic (1.28e-2)" "unprognostic (6.28e-7)" "unprognostic (3.32e-2)" "unprognostic (4.11e-2)" "unprognostic (2.33e-1)" "unprognostic (2.14e-4)" 4.4 2.8 3.2 7.5 4.2 11.3 3.7 10.1 6.3 4.1 5.0 4.4 4.3 7.9 2.9 3.3 4.7 4.3 3.9 3.4 4.7 8.2 5.3 10.8 2.9 5.6 3.8 4.7 5.8 3.5 4.6 4.9 7.8 3.7 8.1 23.7 6.2 3.5 4.0 9.0 4.2 5.3 6.7 5.3 3.1 4.0 9.0 2.2 14.5 3.0 12.6 3.7 0.9 9.3 9.5 7.6 19.8 9.3 5.5 14.4 5.7 1.6 2.9 2.5 8.1 19.5 15.7 10.4 4.6 5.7 12.3 13.0 9.1 3.9 10.1 9.7 11.7 10.9 16.0 8.6 12.6 23.0 8.7 7.2 6.3 6.8 7.4 3.2 8.8 11.7 13.6 4.6 15.5 9.0 59.4 11.8 6.3 6.9 22.0 3.3 15.2 7.0 6.8 8.4 5.8 3.2 14.1 8.2 3.4 6.9 15.9 8.2 19.1 7.2 13.1 10.7 7.5 7.2 15.5 7.8 22.9 8.7 14.5 3.0 1.1 3.7 1.0 0.9 3.4 2.1 2.4 2.0 9.0 2.9 1.9 8.1 12.6 2.3 2.2 1.5 0.9 3.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPIPB13 ENSG00000198064 "Nuclear pore complex interacting protein family, member B13" A6NJU9 16 30222937-30254510 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 8 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 8.8;Ciliated cells: 18.7;Club cells: 13.6;granulocytes: 11.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (7.11e-3)" "unprognostic (4.08e-2)" "unprognostic (1.83e-1)" "unprognostic (1.89e-3)" "unprognostic (4.87e-2)" "unprognostic (2.49e-2)" "unprognostic (2.56e-1)" "unprognostic (1.43e-1)" "unprognostic (6.17e-2)" "unprognostic (7.69e-2)" "unprognostic (3.67e-1)" "unprognostic (1.41e-1)" "unprognostic (3.09e-7)" "unprognostic (1.86e-2)" "unprognostic (2.98e-1)" "unprognostic (3.17e-1)" "unprognostic (2.58e-2)" 1.8 1.1 1.9 2.3 2.0 6.5 2.3 7.6 3.3 2.3 2.3 1.7 2.4 6.2 2.0 1.9 1.7 1.5 2.4 1.6 1.6 2.3 2.7 4.2 1.5 2.7 1.4 4.8 2.9 1.7 2.8 2.5 2.8 1.7 3.5 9.0 3.3 0.4 1.4 3.9 3.5 1.8 2.8 2.1 1.4 2.2 1.3 0.6 0.8 1.6 1.9 3.2 0.5 3.3 7.8 2.0 6.8 2.0 2.4 3.9 0.6 0.0 0.7 0.3 0.9 4.5 4.7 3.4 1.4 0.7 3.9 4.3 1.9 1.1 2.9 1.7 5.0 8.7 4.1 0.9 6.9 4.4 3.0 2.7 3.0 1.9 1.0 1.3 2.2 2.1 7.2 1.6 7.0 3.0 6.4 2.7 0.7 2.0 6.1 1.0 2.7 2.2 5.5 2.4 2.4 0.9 2.7 1.2 2.9 2.2 1.9 3.4 4.1 3.9 3.6 2.0 2.8 3.2 6.2 3.8 3.0 1.9 0.1 1.6 0.2 3.2 0.4 1.6 0.4 1.3 1.3 0.5 1.3 1.4 0.4 0.8 1.9 1.6 0.6 0.4 0.5 14.9 8.8 0.0 0.0 0.0 0.0 0.0 0.0 18.7 13.6 1.8 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 11.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 NPIPB15 "LOC440348, NPIPL2" ENSG00000196436 "Nuclear pore complex interacting protein family member B15" A6NHN6 16 74377878-74392080 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 18.6" "Group enriched" "Detected in many" 8 "Early spermatids: 335.7;Late spermatids: 195.5" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "memory B-cell: 4.0" "Lineage enriched" "Detected in single" 5 "B-cells: 4.0" "Cell line enhanced" "Detected in many" "T-47d: 13.5" "HPA011188, HPA053611" Supported Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA011188: AB_2668455, HPA053611: AB_2682206" "unprognostic (2.23e-2)" "unprognostic (3.48e-1)" "unprognostic (9.26e-2)" "unprognostic (2.56e-1)" "unprognostic (9.70e-2)" "unprognostic (2.02e-1)" "unprognostic (1.56e-2)" "unprognostic (5.53e-2)" "unprognostic (2.41e-2)" "unprognostic (7.73e-2)" "unprognostic (4.58e-3)" "unprognostic (1.53e-1)" "unprognostic (2.81e-2)" "unprognostic (1.97e-1)" "unprognostic (7.34e-3)" "unprognostic (2.53e-1)" "unprognostic (1.14e-3)" 1.8 1.2 0.8 0.5 1.3 2.9 3.8 4.5 1.5 2.1 6.2 4.1 1.1 0.0 3.0 2.1 2.1 1.1 1.1 0.8 3.1 8.4 2.4 2.6 0.8 1.8 6.1 4.4 5.2 2.7 7.1 11.2 6.1 1.1 3.0 4.1 5.3 1.5 0.9 3.1 4.3 18.6 4.4 2.2 1.4 1.8 4.0 0.2 0.8 0.3 0.6 0.6 0.5 2.8 0.1 2.7 1.6 3.3 2.3 0.6 1.9 2.6 2.1 5.9 1.6 0.1 4.7 0.0 3.7 0.0 5.3 0.0 2.2 1.7 0.0 3.0 0.1 6.2 2.7 1.5 1.9 9.5 3.2 4.8 4.3 3.3 3.2 0.0 0.1 0.4 1.9 1.8 4.3 1.0 0.0 0.6 1.4 0.0 1.0 2.7 3.1 0.0 1.8 3.8 0.0 7.0 0.0 4.5 0.0 13.5 2.2 0.2 2.0 5.6 0.0 1.0 6.5 1.8 1.1 2.7 1.3 1.4 0.0 0.3 0.2 0.6 0.0 0.0 4.0 0.2 0.6 0.2 0.7 0.2 0.0 0.8 0.6 0.1 0.1 0.0 0.5 3.0 5.1 3.7 1.6 1.8 2.8 1.1 7.6 4.0 7.9 7.0 7.9 1.0 0.0 1.2 335.7 2.9 12.4 0.0 3.3 0.9 3.4 5.9 0.0 2.1 1.0 0.0 16.8 3.1 4.0 195.5 10.6 1.2 3.3 1.0 35.4 1.1 2.1 28.1 7.1 0.5 1.7 0.0 2.8 7.2 5.3 2.4 2.1 4.5 15.8 5.5 NPIPB2 ENSG00000234719 "Nuclear pore complex interacting protein family, member B2" A6NJ64 16 11927373-11976643 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 5 "Ciliated cells: 4.0;Collecting duct cells: 1.8;Distal tubular cells: 5.0;granulocytes: 2.3;monocytes: 1.8;Proximal tubular cells: 2.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 12.5;U-266/70: 22.0" HPA053611 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (8.80e-2)" "unprognostic (4.83e-1)" "unprognostic (5.20e-2)" "unprognostic (8.24e-2)" "unprognostic (2.45e-1)" "unprognostic (4.34e-2)" "unprognostic (1.37e-1)" "unprognostic (2.73e-1)" "unprognostic (5.92e-2)" "unprognostic (3.01e-3)" "unprognostic (2.80e-2)" "unprognostic (2.21e-1)" "unprognostic (4.89e-3)" "unprognostic (4.39e-2)" "unprognostic (3.39e-2)" "unprognostic (2.25e-1)" "unprognostic (2.58e-2)" 3.4 3.8 3.8 3.6 5.0 1.8 3.0 4.6 8.2 3.6 2.7 4.9 13.8 3.4 4.9 10.3 1.6 3.3 4.2 2.7 8.2 2.9 4.9 2.3 4.0 4.9 3.0 1.7 4.5 6.6 11.0 3.5 2.4 3.6 3.3 2.9 3.8 6.1 13.2 3.1 6.8 3.9 4.8 3.5 2.7 2.2 17.4 2.4 10.2 6.1 1.8 1.9 2.1 2.8 2.7 2.2 0.7 3.1 3.5 2.7 1.0 0.1 1.4 1.7 1.0 3.7 6.5 2.4 1.9 3.1 0.8 0.4 1.0 1.4 0.9 0.6 1.8 0.3 0.3 1.1 1.4 1.7 0.9 1.5 0.5 1.4 1.5 6.5 0.9 0.4 0.3 3.3 1.8 4.0 0.3 0.2 0.2 0.1 4.2 0.5 2.0 0.2 0.5 0.4 1.1 1.3 1.8 0.1 12.5 0.6 0.8 2.3 0.0 4.3 0.2 0.0 1.7 0.3 2.7 0.4 0.3 0.2 0.4 0.2 22.0 7.1 1.0 2.6 0.3 1.0 0.0 3.1 0.6 1.0 0.2 0.2 2.7 1.7 1.3 2.2 1.6 2.7 0.6 0.7 3.5 0.5 2.2 0.0 1.0 3.8 5.0 4.6 8.2 8.2 2.9 3.0 1.7 3.6 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 1.8 0.0 0.6 5.0 0.4 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 2.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.5 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 NPIPB3 "KIAA0220, NPIPL3" ENSG00000169246 "Nuclear pore complex interacting protein family member B3" Q92617 16 21402237-21448567 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 10 "Basal keratinocytes: 2.5;Ciliated cells: 2.7;Club cells: 2.3;Melanocytes: 1.7;Suprabasal keratinocytes: 1.5" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 54.1" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (2.68e-2)" "unprognostic (5.08e-2)" "unprognostic (2.02e-1)" "unprognostic (1.38e-1)" "unprognostic (8.01e-2)" "unprognostic (9.97e-2)" "unprognostic (1.48e-1)" "unprognostic (1.31e-2)" "unprognostic (3.14e-1)" "unprognostic (3.91e-1)" "unprognostic (1.65e-1)" "unprognostic (4.66e-5)" "unprognostic (1.50e-7)" "unprognostic (1.30e-1)" "unprognostic (3.02e-2)" "unprognostic (5.94e-2)" "unprognostic (9.00e-4)" 7.3 5.0 8.2 8.6 9.8 32.4 8.8 15.5 8.8 6.4 7.6 6.9 5.2 12.4 6.2 6.4 6.8 5.5 9.6 7.2 8.2 9.6 7.9 18.1 6.7 6.7 5.9 4.0 9.5 5.0 9.8 8.2 11.7 5.6 19.7 36.9 9.6 6.1 7.6 14.6 7.1 7.3 9.7 7.9 5.2 6.6 5.3 9.0 6.5 3.6 3.4 5.7 0.4 13.7 12.5 8.6 14.9 11.5 6.6 25.5 9.5 3.4 5.1 5.7 19.3 17.0 20.0 9.6 13.0 6.2 15.7 5.6 14.1 4.7 11.2 7.9 8.8 17.2 54.1 10.4 16.0 16.9 3.5 6.1 12.2 15.6 7.3 6.7 18.2 15.9 26.6 6.9 24.7 16.9 39.2 15.8 7.5 14.7 26.9 8.9 11.8 10.2 8.0 10.9 8.3 5.5 13.1 10.0 16.4 12.9 7.8 11.0 24.2 13.3 2.3 13.8 14.1 9.9 18.1 9.6 14.1 12.7 6.5 3.6 2.6 5.7 2.7 2.3 4.4 3.0 2.9 2.2 5.3 3.9 2.6 3.9 3.4 2.0 9.0 2.0 0.4 0.0 0.0 0.0 0.4 2.5 0.0 0.8 0.0 2.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.1 NPIPB4 ENSG00000185864 "Nuclear pore complex interacting protein family member B4" C9JG80 16 21834569-21880827 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "skin 1: 31.2" "Cell type enriched" "Detected in many" 7 "Early spermatids: 92.2" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (3.09e-3)" "unprognostic (3.51e-3)" "unprognostic (4.01e-2)" "unprognostic (1.35e-1)" "unprognostic (1.02e-1)" "unprognostic (1.18e-3)" "unprognostic (2.03e-1)" "unprognostic (1.35e-1)" "unprognostic (6.82e-2)" "unprognostic (3.66e-1)" "unprognostic (1.76e-1)" "unprognostic (4.05e-3)" "unprognostic (6.04e-8)" "unprognostic (3.37e-1)" "unprognostic (7.78e-2)" "unprognostic (2.32e-1)" "unprognostic (5.46e-3)" 5.5 3.7 4.4 7.0 4.6 23.5 6.1 10.4 5.4 5.1 6.5 4.5 5.4 22.4 4.5 5.7 4.9 4.2 5.0 4.0 5.4 6.6 6.0 10.7 3.8 5.9 5.3 3.3 5.4 3.8 6.6 8.2 5.5 3.2 7.1 31.2 8.6 3.5 4.4 10.1 7.3 4.3 7.9 7.5 4.1 5.4 6.3 3.7 4.7 2.5 5.2 2.3 0.3 7.1 9.7 9.3 7.3 6.7 9.7 15.7 8.8 2.7 3.0 4.9 20.6 10.2 13.8 6.8 7.6 2.8 8.2 5.2 7.4 6.0 5.6 4.7 5.5 24.8 27.2 4.5 22.6 14.6 7.2 9.2 8.0 13.3 6.1 6.5 11.3 11.8 12.2 4.5 20.9 8.5 14.2 11.3 2.3 5.4 13.0 5.6 8.0 3.4 7.1 9.4 5.7 5.9 6.8 4.8 9.3 9.0 6.8 14.2 16.0 8.0 7.6 7.6 6.3 5.8 14.7 5.0 10.8 7.4 4.7 2.5 0.7 1.8 1.0 1.3 2.2 2.3 1.1 0.4 6.3 1.8 1.9 3.0 5.2 1.2 3.7 0.6 0.3 3.0 12.6 2.0 1.0 6.8 4.7 1.5 0.0 6.7 10.3 0.0 3.9 0.4 0.0 0.9 92.2 4.2 1.1 0.0 0.5 0.2 5.9 0.4 10.4 1.0 0.6 1.6 1.2 1.8 0.8 13.6 0.3 3.0 0.0 2.8 1.1 1.9 1.2 2.3 0.4 0.0 7.1 0.0 2.9 1.6 0.5 7.3 0.7 2.2 1.7 0.5 NPIPB5 ENSG00000243716 "Nuclear pore complex interacting protein family member B5" A8MRT5 16 22479121-22536521 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 44.9;Ciliated cells: 54.9;Club cells: 89.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (7.52e-4)" "unprognostic (2.08e-1)" "unprognostic (2.32e-2)" "unprognostic (9.43e-3)" "unprognostic (3.96e-1)" "unprognostic (2.64e-3)" "unprognostic (2.40e-3)" "unprognostic (4.20e-2)" "unprognostic (1.65e-1)" "unprognostic (4.19e-2)" "unprognostic (1.09e-1)" "unprognostic (3.87e-2)" "unprognostic (1.90e-10)" "unprognostic (1.10e-1)" "unprognostic (3.39e-2)" "unprognostic (3.86e-2)" "unprognostic (3.76e-5)" 10.8 7.0 13.4 34.7 12.0 30.6 10.4 18.3 13.4 9.6 10.8 9.6 12.5 7.7 8.6 33.3 7.2 8.4 6.6 8.4 24.1 6.1 8.7 6.1 13.6 19.3 17.5 16.7 9.9 10.1 6.4 8.7 7.2 13.7 10.5 12.1 14.6 12.2 22.9 17.8 54.2 17.1 6.8 9.7 16.3 8.9 10.6 11.8 7.0 14.4 6.8 14.2 8.0 10.0 11.7 7.0 8.3 3.5 4.4 5.9 1.3 10.9 9.6 6.1 7.8 10.4 9.8 14.5 6.7 2.4 4.2 5.3 13.5 18.5 15.1 12.5 8.9 4.0 9.8 14.2 9.6 7.5 18.6 5.2 5.8 25.2 26.0 10.1 31.6 9.8 11.9 7.3 10.3 19.0 7.7 7.4 17.5 16.1 24.6 5.1 18.6 14.0 42.3 17.0 2.0 4.1 15.3 4.4 18.0 7.6 6.4 6.8 5.7 8.3 11.7 5.6 15.1 6.9 10.9 25.2 13.5 6.1 11.2 11.3 13.6 6.4 19.7 5.6 23.0 6.0 6.7 3.5 2.7 5.5 1.7 2.3 8.6 5.2 3.7 2.0 11.7 5.9 4.9 8.3 4.4 3.2 7.0 2.4 1.3 13.4 12.0 18.3 13.4 24.1 6.1 17.5 16.7 13.7 11.8 26.8 44.9 3.7 11.4 12.8 13.0 28.7 2.5 54.9 89.9 5.2 9.8 3.6 0.0 3.1 4.7 11.9 2.6 0.0 1.2 2.3 8.9 9.1 9.3 1.6 3.7 6.4 1.2 6.7 4.6 1.8 9.5 11.0 5.0 9.0 3.0 5.0 4.0 4.9 6.0 0.7 24.7 0.0 17.6 3.0 2.6 10.0 4.9 11.4 3.9 9.2 NPIPB6 ENSG00000198156 "Nuclear pore complex interacting protein family member B6" E9PJ23 16 28342555-28363508 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "testis: 26.8" "Group enriched" "Detected in some" 15 "Early spermatids: 188.9;Late spermatids: 89.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory B-cell: 3.1;naive B-cell: 1.8" "Lineage enriched" "Detected in single" 5 "B-cells: 3.1" "Cell line enhanced" "Detected in many" "A549: 6.0;BEWO: 5.6;hTCEpi: 5.8;NB-4: 5.8;RPMI-8226: 6.0" "HPA011188, HPA053611" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA011188: AB_2668455, HPA053611: AB_2682206" "unprognostic (1.99e-1)" "unprognostic (1.81e-2)" "unprognostic (7.76e-3)" "unprognostic (1.06e-1)" "unprognostic (6.86e-2)" "unprognostic (2.43e-1)" "unprognostic (3.21e-1)" "unprognostic (1.02e-1)" "unprognostic (1.54e-1)" "unprognostic (1.31e-1)" "unprognostic (2.31e-1)" "unprognostic (1.97e-1)" "unprognostic (6.79e-4)" "unprognostic (3.20e-1)" "unprognostic (8.36e-2)" "unprognostic (4.78e-1)" "unprognostic (1.04e-3)" 0.2 0.0 0.9 0.3 1.4 0.5 0.6 1.8 0.9 0.4 0.5 0.3 0.7 1.0 0.1 0.9 0.1 0.1 1.1 0.7 0.1 0.1 0.2 0.4 0.7 1.2 0.2 0.4 0.9 0.2 0.7 0.6 0.2 0.5 0.6 1.8 0.3 0.4 0.9 0.6 0.6 26.8 0.6 0.2 0.2 0.3 3.1 0.1 0.1 0.0 0.1 0.6 0.5 0.2 6.0 2.9 0.6 1.4 0.3 5.6 0.3 0.5 0.1 0.5 0.2 2.4 1.9 0.5 0.2 0.6 0.7 0.3 0.5 0.3 1.3 0.5 1.4 1.1 0.0 0.0 1.7 0.4 1.0 5.8 0.4 1.3 1.0 0.1 3.2 0.2 4.8 0.0 1.4 0.5 5.8 1.6 0.5 0.3 3.1 2.5 6.0 0.1 0.1 0.7 1.3 0.2 0.3 0.6 3.4 1.2 0.4 0.6 0.7 2.3 0.5 0.4 2.2 2.3 0.7 0.2 0.9 0.2 0.0 0.0 0.0 0.3 0.0 0.0 3.1 0.6 0.5 0.0 1.8 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.0 0.6 0.0 0.2 0.5 0.3 0.4 0.0 9.4 1.2 0.0 0.0 0.5 0.0 0.0 188.9 0.1 0.2 0.0 0.2 0.1 0.2 0.3 0.0 0.0 0.2 0.0 0.0 0.6 0.0 89.0 1.1 0.1 0.0 0.0 0.1 1.0 0.1 0.3 1.8 0.0 0.1 0.0 0.0 4.4 1.1 1.1 1.1 0.0 0.5 0.4 NPIPB7 "LOC440350, NPIPL1" ENSG00000233232 "Nuclear pore complex interacting protein family member B7" O75200 16 28456372-28471175 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 14.9" "Cell type enriched" "Detected in some" 6 "Early spermatids: 117.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 6.2;hTCEpi: 2.5;U-266/70: 1.6" "HPA011188, HPA053611" Approved Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA011188: AB_2668455, HPA053611: AB_2682206" "unprognostic (1.18e-1)" "unprognostic (1.35e-1)" "unprognostic (8.35e-2)" "unprognostic (1.94e-1)" "unprognostic (1.94e-1)" "unprognostic (7.43e-2)" "unprognostic (3.07e-3)" "unprognostic (3.35e-2)" "unprognostic (3.44e-1)" "unprognostic (2.78e-2)" "unprognostic (3.62e-2)" "unprognostic (3.04e-2)" "unprognostic (4.40e-1)" "unprognostic (2.22e-1)" "unprognostic (7.73e-2)" "unprognostic (2.03e-2)" 0.0 0.0 0.5 0.2 0.9 0.1 0.1 2.3 0.5 0.1 0.3 0.3 0.3 0.3 0.0 0.2 0.1 0.1 0.5 0.8 0.0 0.0 0.2 0.4 0.3 0.5 0.4 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.8 0.2 0.1 0.2 0.1 0.1 14.9 0.4 0.1 0.1 0.0 1.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 6.2 0.0 0.2 0.0 0.1 0.4 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 2.5 0.4 0.2 0.1 0.0 1.2 0.0 0.1 0.0 0.9 0.1 1.0 0.6 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.4 0.1 0.0 1.6 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 117.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 NPIPB8 ENSG00000255524 "Nuclear pore complex interacting protein family member B8" E9PQR5 16 28637654-28658682 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 14.4" "Group enriched" "Detected in some" 12 "Early spermatids: 12.1;Late spermatids: 21.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 29 "hTCEpi: 22.2" "HPA011188, HPA053611" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA011188: AB_2668455, HPA053611: AB_2682206" "unprognostic (8.28e-2)" "unprognostic (1.88e-1)" "unprognostic (1.10e-1)" "unprognostic (5.78e-2)" "unprognostic (1.05e-2)" "unprognostic (2.64e-1)" "unprognostic (1.19e-1)" 0.4 0.7 0.0 0.6 0.3 0.5 0.5 1.6 0.4 0.3 0.9 2.2 0.6 0.7 0.5 0.3 0.1 0.1 0.1 0.0 0.3 1.1 0.6 0.3 0.1 1.1 1.1 0.1 1.3 0.2 1.1 0.4 1.3 0.4 0.9 0.7 2.2 0.2 0.1 0.6 0.7 14.4 1.0 0.4 0.5 0.6 0.6 0.3 0.1 0.1 0.5 0.8 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.0 0.6 0.3 22.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.1 0.3 0.4 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPIPB9 ENSG00000196993 "Nuclear pore complex interacting protein family member B9" F8W1W9 16 28751787-28772807 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "testis: 13.6" "Cell type enriched" "Detected in some" 5 "Ciliated cells: 5.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 8.0;U-266/70: 6.7" "HPA011188, HPA053611" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA011188: AB_2668455, HPA053611: AB_2682206" "unprognostic (7.38e-2)" "unprognostic (6.63e-4)" "unprognostic (6.63e-2)" "unprognostic (5.05e-2)" "unprognostic (5.53e-2)" "unprognostic (4.44e-2)" "unprognostic (1.53e-1)" "unprognostic (9.36e-2)" "unprognostic (7.52e-2)" "unprognostic (2.84e-1)" "unprognostic (2.86e-1)" "unprognostic (2.31e-1)" "unprognostic (4.71e-2)" 0.6 0.3 1.7 0.9 1.8 1.6 0.4 2.7 1.4 0.4 1.0 0.0 1.1 2.4 0.4 1.5 0.6 0.2 2.2 1.3 0.4 0.4 0.4 1.5 1.7 1.4 0.2 0.5 1.4 0.4 1.2 0.8 0.9 0.9 1.1 2.8 0.8 0.8 2.2 1.1 0.5 13.6 1.7 1.0 0.3 0.7 3.1 0.1 0.5 0.2 1.8 0.7 0.3 0.4 4.0 1.1 0.6 0.5 1.3 3.3 0.0 0.1 0.0 0.0 0.4 2.1 1.6 1.1 0.0 0.5 0.4 0.7 0.2 0.1 0.4 1.9 0.7 0.0 0.8 0.1 2.5 2.7 0.2 8.0 0.6 1.5 0.8 0.0 2.9 0.4 2.5 0.2 3.0 0.9 3.3 1.6 0.2 0.9 3.3 0.0 1.6 0.0 0.4 0.1 0.0 0.2 0.4 0.2 2.2 2.2 1.1 0.0 0.0 2.8 1.9 0.6 6.7 2.9 2.0 0.1 0.9 0.5 0.0 0.2 0.0 0.7 0.0 0.2 3.1 0.4 0.1 0.1 1.2 0.3 0.1 0.5 1.8 0.2 0.0 0.3 0.3 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.0 5.3 1.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.1 0.0 0.0 0.0 NPLOC4 "FLJ20657, KIAA1499, NPL4" ENSG00000182446 "NPL4 homolog, ubiquitin recognition factor" Q8TAT6 17 81556887-81648465 "Predicted intracellular proteins, Transporters" "Ubl conjugation pathway" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 89.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021560, HPA023295" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021560: AB_1854586, HPA023295: AB_1854587" "unprognostic (3.17e-1)" "unprognostic (2.98e-1)" "unprognostic (1.78e-1)" "unprognostic (1.00e-3)" "unprognostic (8.72e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (1.16e-5)" "unprognostic (1.06e-2)" "unprognostic (4.42e-1)" "unprognostic (2.97e-1)" "unprognostic (4.15e-3)" "unprognostic (1.21e-1)" "prognostic unfavorable (6.95e-7)" "unprognostic (1.01e-1)" "unprognostic (6.98e-2)" "unprognostic (6.51e-2)" "unprognostic (1.72e-1)" 21.7 23.0 15.3 18.7 16.1 22.0 15.4 14.7 24.1 13.2 15.9 18.6 14.2 14.7 18.9 16.3 25.1 14.7 14.4 35.4 16.2 13.5 20.2 28.2 18.4 18.3 16.4 15.5 13.9 18.2 17.8 17.1 25.6 17.2 16.7 13.3 21.0 16.4 14.9 89.8 24.2 16.4 19.4 14.9 22.0 17.6 31.0 13.4 19.7 14.7 17.1 20.6 15.7 16.6 4.6 5.9 5.7 18.1 2.5 4.6 7.8 29.0 38.3 15.3 23.8 18.9 15.7 19.0 24.1 26.9 40.1 37.2 29.0 26.3 21.6 19.4 28.1 29.4 23.6 15.0 20.2 34.9 13.5 19.8 25.0 31.0 25.7 18.1 26.3 31.9 15.5 19.6 37.4 13.4 19.4 40.9 20.2 26.3 32.9 24.2 18.8 35.4 14.3 17.9 14.5 24.2 23.4 24.6 17.6 14.4 28.1 20.5 23.7 30.3 42.3 27.3 30.5 33.1 19.4 29.2 52.7 36.6 28.6 38.6 25.1 17.7 26.6 42.0 17.7 33.8 3.0 18.1 3.9 4.6 4.6 2.8 4.6 3.2 3.6 5.9 3.7 2.9 3.8 5.7 2.5 2.8 4.6 3.0 7.8 15.3 16.1 14.7 24.1 16.2 13.5 16.4 15.5 17.2 13.4 11.9 17.8 16.0 14.4 15.7 22.7 39.6 12.7 8.1 18.2 19.2 27.5 16.5 1.7 17.6 91.1 20.1 26.2 46.7 32.2 17.3 15.5 19.7 3.5 46.4 16.9 19.1 29.2 29.4 24.0 71.7 16.4 19.3 11.8 19.8 15.0 18.4 36.6 20.1 12.0 20.4 35.3 19.4 16.4 22.3 23.3 21.1 31.0 15.0 15.3 23.7 NPM1 "B23, NPM" ENSG00000181163 "Nucleophosmin 1" P06748 5 171387116-171411137 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Host-virus interaction" "Chaperone, RNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011384, CAB012983" Supported Enhanced "Nucleoplasm,Nucleoli rim" Yes No 810000 "Nucleoli rim" Nucleoplasm "CAB012983: AB_2533084, HPA011384: AB_1854692" "unprognostic (1.84e-3)" "unprognostic (2.59e-1)" "unprognostic (2.23e-2)" "unprognostic (3.30e-2)" "unprognostic (2.65e-1)" "prognostic unfavorable (7.48e-4)" "prognostic unfavorable (4.82e-6)" "unprognostic (1.86e-2)" "unprognostic (5.25e-3)" "unprognostic (1.39e-1)" "unprognostic (2.26e-3)" "unprognostic (1.27e-1)" "prognostic unfavorable (2.89e-6)" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (1.52e-1)" "unprognostic (1.24e-2)" 56.8 44.7 29.9 61.1 33.6 76.0 67.0 37.7 34.6 113.5 57.8 24.8 39.3 36.7 78.2 50.5 81.6 65.0 44.0 48.5 28.8 31.6 64.9 78.8 59.5 128.1 36.1 27.9 177.4 102.0 27.1 57.9 65.2 36.1 87.2 49.3 29.5 47.3 48.2 67.9 42.7 52.8 92.4 43.2 85.9 54.0 56.7 31.3 111.3 112.6 66.5 82.1 116.8 65.7 85.3 54.1 12.3 29.1 59.0 126.6 91.4 119.9 81.3 98.8 139.9 60.4 110.3 147.3 109.2 99.8 148.0 133.3 193.9 84.8 321.2 86.8 63.1 99.7 70.4 137.0 248.2 192.8 100.0 108.7 113.3 79.7 142.8 89.5 228.2 94.0 97.3 87.5 100.4 198.1 116.7 110.3 74.8 137.8 73.9 107.4 149.0 148.9 162.3 123.6 64.0 99.9 133.7 109.0 164.6 126.2 84.6 77.9 62.6 65.2 106.8 197.6 72.0 131.0 101.3 68.9 49.5 109.2 56.9 183.8 59.2 107.6 193.2 74.9 185.8 98.7 12.3 26.9 8.4 45.7 29.1 84.6 85.3 85.1 66.2 54.1 62.8 126.6 99.0 4.0 59.0 23.1 48.7 73.2 91.4 29.9 33.6 37.7 34.6 28.8 31.6 36.1 27.9 36.1 31.3 321.6 347.3 775.5 994.0 1243.7 166.1 228.8 387.3 346.6 597.1 307.1 41.2 1400.5 630.0 839.1 64.3 646.8 150.8 116.8 796.2 1641.6 855.4 473.8 427.8 235.7 952.5 120.8 347.6 298.3 500.7 53.0 902.7 605.7 578.6 960.4 654.2 214.7 840.7 333.1 610.9 657.5 112.2 426.9 861.0 695.1 635.2 890.7 1286.9 674.9 783.2 797.7 NPM2 ENSG00000158806 "Nucleophosmin/nucleoplasmin 2" Q86SE8 8 22024125-22036897 "Predicted intracellular proteins" Fertilization "Chaperone, Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.6;parathyroid gland: 40.2;thyroid gland: 23.2" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 28.1;Cone photoreceptor cells: 19.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 10.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 4.1" "Group enriched" "Detected in many" 6 "granulocytes: 4.1;T-cells: 2.2" "Cell line enhanced" "Detected in many" "HaCaT: 13.3;HEL: 10.7;Hep G2: 23.7;JURKAT: 7.2;THP-1: 8.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA041070 Enhanced Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA041070: AB_2677285" "unprognostic (1.40e-2)" "unprognostic (3.30e-2)" "unprognostic (3.11e-2)" "unprognostic (2.49e-2)" "unprognostic (1.55e-1)" "unprognostic (2.06e-1)" "unprognostic (1.61e-1)" "unprognostic (3.03e-2)" "unprognostic (5.30e-3)" "unprognostic (1.01e-1)" "prognostic favorable (9.02e-4)" "unprognostic (2.23e-1)" "prognostic favorable (3.18e-6)" "unprognostic (8.05e-3)" "unprognostic (2.89e-1)" "unprognostic (1.42e-1)" "unprognostic (1.30e-1)" 0.8 15.6 14.4 0.5 11.4 1.3 2.3 20.4 27.6 1.9 1.4 0.8 0.3 2.4 4.9 1.3 1.4 2.8 2.2 1.5 13.0 13.8 2.9 1.3 2.0 1.0 14.9 15.7 0.8 7.4 40.2 7.8 0.9 7.2 4.7 1.4 3.7 3.1 1.8 0.8 2.0 1.4 4.0 3.0 7.5 2.0 3.1 2.4 0.1 23.2 0.0 0.8 1.4 0.8 0.4 0.0 4.1 0.0 0.0 2.2 0.1 2.9 0.4 0.1 0.2 0.7 0.0 1.2 0.3 0.4 1.9 3.8 1.2 2.8 0.0 0.9 0.0 0.2 13.3 0.3 0.0 1.1 0.1 0.3 10.7 0.7 23.7 2.4 1.4 1.0 0.4 1.8 0.0 0.2 2.9 0.0 7.2 0.3 0.0 0.1 0.0 0.1 2.8 0.6 4.7 0.3 0.2 1.0 0.6 4.4 0.0 2.9 0.2 0.0 0.0 3.5 0.0 0.5 8.4 0.0 0.0 0.2 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.9 0.0 2.2 0.0 0.9 2.1 0.0 0.4 0.3 0.4 0.0 0.0 0.0 0.0 1.4 0.1 14.4 11.4 20.4 27.6 13.0 13.8 14.9 15.7 7.2 2.4 0.0 1.4 0.5 8.2 0.1 28.1 2.0 2.5 9.4 11.4 0.0 19.6 0.1 3.3 6.3 15.2 0.3 0.4 0.0 7.0 0.2 0.4 3.3 0.0 0.4 3.5 6.4 10.9 2.5 0.0 10.4 0.6 1.2 10.1 1.8 1.5 0.9 5.4 0.0 0.4 9.8 3.9 0.0 1.4 0.5 0.3 1.0 0.2 4.3 0.6 5.8 NPNT "EGFL6L, POEM" ENSG00000168743 Nephronectin Q6UXI9 4 105894775-106004027 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 125.3" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 172.7;Alveolar cells type 2: 69.4;Club cells: 97.8" "Cancer enhanced" "Detected in all" "thyroid cancer: 104.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 15.2;CAPAN-2: 9.9;HeLa: 17.2;Hep G2: 13.7;MCF7: 12.2;RPTEC TERT1: 20.0;T-47d: 26.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA003711, HPA050203" Supported Approved "Nucleoplasm,Cell Junctions,Cytosol" "Secreted to extracellular matrix" NA NA "Nucleoplasm, Cell Junctions, Cytosol" "HPA003711: AB_1854591, HPA050203: AB_2681050" "unprognostic (1.24e-1)" "unprognostic (7.93e-2)" "unprognostic (1.59e-1)" "unprognostic (2.43e-2)" "unprognostic (3.92e-1)" "unprognostic (2.49e-1)" "unprognostic (1.87e-1)" "unprognostic (7.85e-3)" "unprognostic (4.78e-4)" "unprognostic (1.19e-2)" "unprognostic (1.57e-1)" "unprognostic (1.68e-1)" "prognostic favorable (8.28e-8)" "unprognostic (4.81e-2)" "unprognostic (1.21e-1)" "unprognostic (1.77e-1)" "unprognostic (2.31e-2)" 5.4 1.6 3.4 2.4 4.4 0.0 8.3 0.7 2.5 13.3 11.0 1.9 4.2 16.4 8.7 11.4 5.7 5.9 19.0 2.5 2.5 2.7 22.7 1.3 34.9 0.9 7.5 2.4 4.1 11.6 0.0 14.6 3.0 2.2 26.3 7.6 16.9 2.8 5.7 2.6 2.1 37.7 4.0 0.9 4.4 4.0 3.0 2.8 3.4 125.3 3.7 2.3 3.7 6.2 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 15.2 0.1 0.0 0.0 0.0 7.6 9.9 0.1 0.4 0.1 0.0 0.9 3.8 0.0 0.0 0.0 3.9 0.4 17.2 13.7 0.0 0.0 0.1 1.7 1.3 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 12.2 0.2 0.7 0.1 0.0 6.2 0.0 0.0 0.1 20.0 0.8 0.9 0.3 0.9 7.4 0.0 2.3 26.8 0.6 0.0 0.3 0.2 0.2 0.6 0.1 0.5 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 4.4 0.7 2.5 2.5 2.7 7.5 2.4 2.2 2.8 172.7 69.4 0.0 4.6 1.6 0.2 2.0 33.1 10.7 97.8 31.4 0.0 2.2 1.7 19.0 11.6 8.0 8.0 0.0 2.1 0.1 0.9 29.6 0.0 0.0 0.3 0.0 15.0 3.1 0.0 11.8 2.3 1.3 5.0 0.0 9.2 0.0 6.3 3.1 0.0 3.0 0.1 0.0 33.5 0.5 1.5 1.0 1.3 0.0 6.9 2.8 NPR1 "ANPa, ANPRA, GUCY2A, NPRA" ENSG00000169418 "Natriuretic peptide receptor 1" P16066 1 153678637-153693992 "Enzymes, FDA approved drug targets, Predicted membrane proteins" "cGMP biosynthesis" "Lyase, Receptor, Vasoactive" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 98.4" "Cell type enriched" "Detected in many" 10 "Ito cells: 136.2" "Cancer enhanced" "Detected in all" "ovarian cancer: 39.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "ASC diff: 60.5" "Region enriched" "Detected in many" 5 "olfactory region: 23.0" "Region enhanced" "Detected in single" "olfactory region: 11.1" HPA031087 Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA Nucleoli "Nucleoplasm, Plasma membrane" "HPA031087: AB_10601975" "unprognostic (2.54e-1)" "unprognostic (3.03e-3)" "unprognostic (6.31e-2)" "prognostic unfavorable (3.97e-4)" "unprognostic (1.55e-1)" "unprognostic (6.60e-2)" "unprognostic (1.54e-2)" "unprognostic (2.03e-1)" "unprognostic (2.46e-1)" "unprognostic (3.27e-2)" "prognostic favorable (2.49e-4)" "unprognostic (1.27e-1)" "unprognostic (6.69e-2)" "unprognostic (1.16e-2)" "unprognostic (1.09e-1)" "unprognostic (4.06e-1)" "unprognostic (1.74e-2)" 41.1 4.3 0.5 5.9 0.9 0.1 98.4 0.5 0.8 8.1 8.2 0.3 7.3 1.2 16.8 11.1 8.7 25.0 9.3 19.6 0.9 0.5 28.7 3.7 34.8 8.6 0.7 0.0 19.5 4.2 7.8 4.5 11.8 2.5 4.9 1.5 2.0 2.0 9.0 6.9 3.4 4.6 15.6 2.2 1.2 5.0 6.4 0.2 0.8 7.6 5.1 1.1 11.6 26.5 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 60.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 10.0 0.0 7.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.7 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.0 2.0 0.4 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.5 0.8 0.9 0.5 0.7 0.0 2.5 0.2 0.0 5.8 0.0 0.4 1.3 0.0 4.8 5.1 0.0 0.0 14.0 0.0 0.1 0.0 0.6 8.0 14.2 0.0 0.0 0.0 0.9 3.9 0.4 0.0 1.5 0.2 0.0 0.0 136.2 6.0 7.9 9.5 0.0 0.0 9.0 0.0 0.0 0.7 0.0 3.9 2.8 0.0 0.0 0.9 0.2 0.1 0.9 0.6 0.0 0.0 0.0 NPTXR ENSG00000221890 "Neuronal pentraxin receptor" O95502 22 38818452-38843982 "Plasma proteins, Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 73.6" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 14.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "GAMG: 11.4;SCLC-21H: 15.0;SiHa: 11.2;U-87 MG: 43.1" "Low region specificity" "Detected in all" HPA001079 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 280000 "Plasma membrane, Cytosol" Nucleoplasm "HPA001079: AB_1078414" "unprognostic (6.29e-2)" "prognostic favorable (3.93e-4)" "unprognostic (6.82e-3)" "prognostic unfavorable (2.85e-4)" "unprognostic (9.55e-2)" "unprognostic (6.93e-2)" "unprognostic (1.05e-1)" "unprognostic (1.51e-1)" "unprognostic (1.65e-2)" "unprognostic (1.71e-1)" "unprognostic (1.52e-3)" "unprognostic (1.37e-1)" "unprognostic (1.27e-1)" "unprognostic (1.49e-2)" "unprognostic (9.22e-2)" "unprognostic (8.65e-2)" "unprognostic (2.77e-2)" 2.3 3.8 39.1 1.8 17.5 0.8 1.9 16.2 73.6 5.8 2.6 4.3 0.5 1.5 5.6 3.3 2.7 6.1 2.0 10.5 57.4 15.2 1.3 0.8 1.7 1.6 5.6 20.7 6.2 3.6 5.9 2.0 0.9 4.5 6.2 1.7 1.0 3.2 5.6 0.9 1.2 1.4 5.7 3.3 2.1 2.0 1.6 4.0 0.0 2.5 0.0 1.6 2.5 1.9 0.3 0.2 0.6 0.2 0.6 2.3 0.4 0.4 2.9 0.1 0.8 6.0 0.6 0.0 1.9 0.4 3.8 1.3 2.9 0.6 0.0 3.5 0.5 11.4 0.4 0.8 0.1 1.3 0.2 1.0 0.0 0.1 4.5 0.6 0.0 0.1 1.9 0.1 3.5 0.0 5.6 0.1 0.0 3.6 0.1 0.1 4.5 0.0 0.2 3.5 1.4 1.0 0.7 0.0 7.0 1.0 8.1 15.0 0.9 11.2 0.0 0.3 0.8 4.8 1.1 0.2 6.9 4.2 0.0 0.3 1.0 0.0 0.0 43.1 8.7 3.5 0.5 0.2 0.1 1.8 0.0 1.3 0.1 1.0 2.3 0.0 0.3 1.5 1.2 0.6 0.6 0.1 0.2 0.0 0.4 39.1 17.5 16.2 49.0 57.4 15.2 5.6 20.7 4.5 4.0 0.0 0.0 0.0 1.9 1.0 5.4 14.2 5.1 2.7 3.4 3.5 2.0 0.0 0.0 5.7 1.6 4.2 0.0 0.0 3.3 0.0 0.8 4.6 0.0 0.2 0.2 0.0 1.7 5.5 0.3 0.4 1.7 0.3 1.7 0.0 0.0 6.5 3.1 0.0 2.1 0.5 3.1 0.0 2.6 0.0 0.8 0.9 0.0 0.0 0.0 3.3 NQO2 "DHQV, DIA6, NMOR2, QR2" ENSG00000124588 "N-ribosyldihydronicotinamide:quinone reductase 2" P16083 6 2987987-3028869 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 14 "monocytes: 212.8;Proximal tubular cells: 716.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 62.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021283, HPA021332" Enhanced Supported Nucleoplasm,Cytosol NA NA 6500000 Cytosol Nucleoplasm "HPA021283: AB_1854600, HPA021332: AB_1854601" "unprognostic (7.11e-3)" "unprognostic (1.43e-3)" "unprognostic (2.41e-1)" "unprognostic (3.01e-2)" "unprognostic (1.00e-2)" "unprognostic (3.58e-1)" "prognostic unfavorable (8.40e-4)" "unprognostic (1.77e-1)" "unprognostic (1.15e-1)" "unprognostic (4.90e-2)" "unprognostic (6.59e-2)" "unprognostic (3.60e-2)" "unprognostic (8.28e-2)" "unprognostic (2.03e-1)" "unprognostic (3.32e-2)" "unprognostic (3.96e-1)" "unprognostic (2.02e-1)" 24.7 45.6 18.2 11.0 17.6 27.2 21.9 44.3 28.1 12.9 11.5 8.9 8.8 15.6 10.4 15.4 12.1 11.2 12.8 38.2 16.0 13.3 82.9 47.0 11.7 17.5 17.0 23.5 13.5 18.4 12.1 9.3 12.1 24.5 12.7 9.0 18.0 24.5 13.5 41.3 20.2 15.5 10.7 11.8 15.3 12.8 7.7 12.5 7.0 11.9 13.9 7.9 10.4 11.0 3.2 16.6 62.1 25.2 7.3 9.3 13.1 12.7 21.6 13.2 29.0 23.3 13.8 14.2 12.4 15.9 11.5 12.9 22.7 4.9 11.2 45.3 21.3 26.9 9.8 13.5 8.6 9.0 26.1 11.5 6.9 26.5 22.7 19.0 6.9 22.1 8.5 10.3 13.9 13.0 16.5 11.1 14.6 39.2 6.7 9.5 28.4 7.9 12.8 17.9 26.9 18.0 14.7 15.7 32.7 17.3 6.8 2.8 5.1 18.8 8.0 39.4 24.7 11.0 4.8 19.1 10.8 4.2 14.4 5.4 14.6 33.1 3.4 12.7 21.0 21.3 5.6 25.2 13.5 9.2 15.7 6.6 3.2 8.3 8.3 16.6 2.1 5.0 5.7 62.1 7.3 13.9 1.7 9.3 13.1 18.2 17.6 44.3 28.1 16.0 13.3 17.0 23.5 24.5 12.5 8.9 17.3 8.1 35.0 31.3 32.4 60.5 50.9 22.7 10.3 24.4 9.8 36.3 137.6 19.8 39.2 32.9 25.6 23.3 55.3 41.3 45.4 32.3 12.8 167.7 66.5 39.7 4.6 20.3 34.6 38.3 33.1 71.3 64.1 212.8 19.0 47.3 40.8 17.3 38.5 716.7 18.8 25.8 46.2 7.0 10.1 36.0 26.1 17.3 20.9 42.3 NR1D2 "BD73, EAR-1r, Hs.37288, HZF2, RVR" ENSG00000174738 "Nuclear receptor subfamily 1 group D member 2" Q14995 3 23945260-23980618 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 90.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053868, HPA054798" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053868: AB_2682284, HPA054798: AB_2616453" "unprognostic (8.64e-2)" "unprognostic (9.96e-3)" "unprognostic (2.27e-1)" "unprognostic (2.46e-1)" "unprognostic (8.67e-2)" "unprognostic (2.09e-2)" "unprognostic (2.04e-1)" "unprognostic (3.61e-2)" "unprognostic (2.60e-1)" "unprognostic (6.79e-3)" "unprognostic (2.21e-1)" "unprognostic (5.73e-2)" "prognostic favorable (4.47e-7)" "unprognostic (2.36e-3)" "unprognostic (1.23e-1)" "unprognostic (1.08e-1)" "unprognostic (1.59e-1)" 15.2 12.5 15.2 7.9 17.1 9.5 15.9 40.9 31.9 21.1 13.3 14.0 20.9 10.0 19.0 11.0 12.2 13.3 11.0 22.5 15.0 13.4 16.8 22.1 10.6 9.6 14.4 16.1 24.3 12.7 41.6 15.8 10.0 16.1 15.1 9.0 16.3 22.2 23.1 35.4 14.2 10.4 15.6 14.6 13.1 10.9 5.6 15.1 5.5 40.7 23.2 10.5 13.0 14.3 2.4 0.9 0.2 2.5 1.1 6.1 1.0 9.9 2.2 5.3 5.0 5.6 6.0 3.3 14.8 19.5 8.2 9.2 1.7 9.8 7.1 5.0 20.7 12.9 6.7 6.6 9.7 17.3 2.5 7.7 1.1 5.3 2.0 11.7 3.7 1.1 8.0 10.3 10.0 25.9 15.4 5.6 4.2 2.5 25.9 6.5 5.7 2.0 1.2 5.7 8.1 11.3 1.8 8.6 4.8 4.6 13.8 5.5 12.2 10.8 6.2 12.8 9.0 5.5 3.3 11.1 21.6 22.0 14.0 16.8 12.7 17.1 3.3 12.3 5.7 12.5 0.0 0.8 0.1 3.3 2.5 6.1 2.4 3.7 3.1 0.9 1.9 2.6 2.6 0.2 1.1 1.4 0.9 2.2 1.0 15.2 17.1 40.9 31.9 15.0 13.4 14.4 16.1 16.1 15.1 11.9 6.9 16.2 30.6 29.7 80.4 32.7 15.3 6.7 17.0 19.2 37.3 8.9 6.6 10.1 8.3 26.1 10.7 0.0 12.9 2.0 40.4 34.0 8.1 27.7 8.5 90.6 27.3 8.6 9.9 9.0 31.7 16.9 27.0 5.4 16.8 58.7 15.8 8.6 40.0 8.8 48.7 32.3 40.9 7.7 10.4 29.4 5.7 18.5 12.4 26.4 NR1H2 "LXR-b, NER, NER-I, RIP15, UNR" ENSG00000131408 "Nuclear receptor subfamily 1 group H member 2" P55055 19 50329653-50382982 "Cancer-related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005446, HPA056838, HPA070212" Uncertain Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA005446: , HPA056838: AB_2683254, HPA070212: AB_2686234" "unprognostic (1.31e-1)" "unprognostic (5.35e-2)" "prognostic unfavorable (9.86e-4)" "unprognostic (1.34e-3)" "unprognostic (1.68e-1)" "unprognostic (5.24e-3)" "unprognostic (2.26e-2)" "unprognostic (9.69e-2)" "unprognostic (6.45e-2)" "unprognostic (5.23e-2)" "unprognostic (2.40e-1)" "unprognostic (1.88e-1)" "unprognostic (2.69e-2)" "unprognostic (1.86e-1)" "unprognostic (1.35e-1)" "unprognostic (5.12e-2)" "unprognostic (1.69e-3)" 30.1 27.5 24.5 24.7 27.5 98.0 24.4 20.6 33.5 25.1 30.9 23.1 25.2 30.9 31.2 23.1 27.9 26.9 28.7 36.8 23.8 19.4 27.1 31.4 28.3 23.3 31.7 25.9 26.5 37.6 22.0 18.6 30.5 28.1 27.9 10.5 23.2 33.8 33.8 76.2 25.3 30.3 29.9 22.9 29.9 26.7 21.2 29.1 20.4 27.1 24.4 21.7 33.2 27.6 34.1 34.2 63.0 37.7 22.3 28.6 32.5 16.1 42.5 4.1 10.4 12.2 12.9 13.3 22.3 19.0 13.2 15.2 8.8 15.7 10.4 20.0 13.4 10.6 15.1 2.6 12.2 3.2 25.8 22.9 9.9 14.3 9.1 23.4 16.4 27.3 13.5 16.7 13.6 9.2 13.4 12.0 8.3 16.2 21.6 7.4 17.9 11.7 13.5 8.3 10.3 36.5 7.0 10.8 18.0 11.4 18.1 4.6 16.2 14.5 18.0 14.0 2.4 12.4 13.7 15.2 17.8 14.5 18.2 19.8 27.1 22.3 7.6 35.5 10.8 17.9 39.1 35.9 63.0 27.7 35.0 27.0 34.1 27.4 25.9 34.2 34.1 28.6 24.9 55.4 22.3 37.7 29.5 24.4 32.5 24.5 27.5 20.6 33.5 23.8 19.4 31.7 25.9 28.1 29.1 26.8 27.8 34.4 74.6 38.1 39.5 23.4 25.5 9.4 7.9 29.6 13.7 57.0 54.7 54.4 5.2 46.6 78.1 0.0 63.6 44.7 33.4 68.0 50.6 17.4 46.9 35.0 20.0 20.9 26.7 6.8 42.0 44.5 57.3 84.8 39.8 39.5 60.4 87.7 50.2 46.2 21.7 38.8 58.5 32.5 30.0 40.0 117.1 47.8 32.6 81.4 NR1H3 "LXR-a, RLD-1" ENSG00000025434 "Nuclear receptor subfamily 1 group H member 3" Q13133 11 47248300-47269032 "Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 74.2" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 54.2;Hofbauer cells: 54.7;Kupffer cells: 70.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 14.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 22.9;HSkMC: 29.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036443, CAB037109" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB037109: AB_1840991, HPA036443: AB_10966142" "unprognostic (2.95e-3)" "unprognostic (5.31e-3)" "unprognostic (5.19e-2)" "prognostic favorable (5.05e-4)" "unprognostic (1.19e-1)" "unprognostic (2.65e-2)" "prognostic unfavorable (5.60e-4)" "unprognostic (1.51e-1)" "unprognostic (1.76e-1)" "unprognostic (7.73e-2)" "unprognostic (2.08e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.40e-5)" "unprognostic (3.56e-1)" "unprognostic (4.42e-2)" "unprognostic (2.84e-1)" "prognostic favorable (3.40e-4)" 74.2 9.4 4.8 12.7 6.9 1.2 22.8 7.0 5.5 10.2 17.9 4.4 7.2 23.1 6.7 10.0 6.6 8.1 9.2 8.5 4.0 2.9 10.3 35.7 13.7 29.4 6.8 5.6 7.5 7.8 4.3 3.5 16.1 4.3 10.1 5.9 6.4 7.1 9.0 6.1 5.1 19.0 7.1 3.4 40.2 7.6 13.7 4.1 6.3 9.7 2.6 10.7 10.8 12.9 1.1 4.5 6.5 14.6 6.1 3.8 2.1 1.6 6.8 3.1 3.0 20.9 22.9 14.7 1.7 8.6 2.8 4.4 8.3 21.5 2.9 3.3 1.4 1.0 4.5 3.7 2.9 1.9 2.7 3.0 3.9 9.0 12.4 8.6 1.4 0.5 29.9 1.8 4.4 2.6 4.9 2.4 4.6 4.8 1.2 1.9 7.1 2.7 7.9 3.4 9.1 2.3 4.0 4.2 1.9 2.5 15.3 3.0 1.0 6.1 4.0 5.1 3.2 9.7 3.7 0.6 2.3 3.1 4.5 1.0 6.0 8.7 3.5 4.2 1.8 1.1 6.5 2.9 2.4 1.5 14.6 2.1 1.1 1.7 1.4 4.5 0.9 1.8 1.5 1.5 6.1 4.5 0.8 3.8 2.1 4.8 6.9 7.0 5.5 4.0 2.9 6.8 5.6 4.3 4.1 0.0 9.9 6.1 6.3 3.0 2.1 4.5 22.9 1.4 5.7 5.2 2.0 9.7 10.0 4.4 23.5 12.0 39.9 0.0 7.5 11.4 9.9 3.2 12.7 54.2 54.7 1.6 1.7 21.5 70.5 33.3 8.3 7.9 3.3 6.4 9.7 4.8 4.0 10.5 5.6 19.2 0.9 19.4 6.4 27.2 16.3 2.0 5.5 2.9 12.1 4.1 NR1H4 "FXR, HRR-1, HRR1, RIP14" ENSG00000012504 "Nuclear receptor subfamily 1 group H member 4" Q96RI1 12 100473708-100564413 "Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters" "Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Disease mutation, FDA approved drug targets, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 109.4" "Cell type enhanced" "Detected in some" 15 "Cholangiocytes: 79.0;Distal tubular cells: 36.5;Hepatocytes: 90.4;Proximal tubular cells: 116.5" "Group enriched" "Detected in some" 11 "liver cancer: 18.7;renal cancer: 12.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 32 "Hep G2: 18.4;HHSteC: 11.1;RPTEC TERT1: 29.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA047699 Approved Nucleoplasm NA NA Nucleoplasm "HPA047699: AB_10965320" "unprognostic (1.78e-1)" "unprognostic (1.81e-1)" "unprognostic (6.68e-2)" "unprognostic (2.49e-1)" "unprognostic (1.60e-1)" "unprognostic (9.39e-2)" "unprognostic (2.01e-1)" "unprognostic (1.88e-2)" "unprognostic (1.16e-1)" "unprognostic (2.43e-1)" "unprognostic (3.77e-3)" 0.1 11.3 0.1 1.4 0.4 0.0 0.2 0.1 0.2 0.2 5.8 0.4 0.1 11.3 0.1 0.4 0.1 0.1 7.0 0.1 0.1 0.0 25.0 109.4 0.6 2.4 0.1 0.1 7.7 2.7 0.0 2.9 0.2 0.3 0.5 0.4 0.6 0.1 0.1 0.1 0.0 19.5 0.3 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.3 0.3 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.2 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 79.0 0.0 0.0 21.0 0.0 0.0 36.5 6.3 0.2 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 90.4 0.0 0.0 0.0 14.7 1.9 1.3 0.9 0.0 0.0 0.0 0.1 0.0 0.6 2.9 0.0 116.5 0.0 0.0 0.1 0.5 0.7 0.0 0.0 0.0 0.3 0.9 NR1I2 "BXR, ONR1, PAR2, PXR, SXR" ENSG00000144852 "Nuclear receptor subfamily 1 group I member 2" O75469 3 119780484-119818485 "FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 7.1;intestine: 15.4;liver: 22.2" "Group enriched" "Detected in some" 4 "Enterocytes: 29.0;Hepatocytes: 28.7" "Group enriched" "Detected in some" 24 "colorectal cancer: 9.0;liver cancer: 5.7;pancreatic cancer: 2.6;stomach cancer: 2.7" "Cell type enriched" "Detected in single" 18 "NK-cell: 7.1" "Lineage enriched" "Detected in single" 18 "NK-cells: 7.1" "Cell line enriched" "Detected in some" 4 "Hep G2: 17.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA029309, HPA055121, HPA073926" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA029309: AB_2672990, HPA055121: AB_2682703, HPA073926: AB_2686643" "unprognostic (6.76e-3)" "unprognostic (2.25e-1)" "unprognostic (5.84e-2)" "unprognostic (1.24e-4)" "unprognostic (4.51e-2)" "unprognostic (4.52e-2)" "unprognostic (4.03e-3)" "unprognostic (3.97e-2)" "unprognostic (5.78e-2)" "unprognostic (5.05e-2)" "unprognostic (5.21e-2)" "unprognostic (3.60e-2)" "unprognostic (5.51e-6)" "unprognostic (4.86e-1)" "unprognostic (6.95e-2)" "unprognostic (3.13e-1)" "unprognostic (6.12e-3)" 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 5.6 15.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.3 0.0 22.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 7.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.3 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.8 2.5 0.0 0.0 1.8 0.0 0.0 1.7 0.0 0.0 0.0 29.0 0.0 0.2 0.0 0.0 0.0 0.0 28.7 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.6 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 NR1I3 "CAR, CAR1, MB67" ENSG00000143257 "Nuclear receptor subfamily 1 group I member 3" Q14994 1 161229666-161238302 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "liver: 63.1" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 124.3" "Cancer enriched" "Detected in single" 67 "liver cancer: 17.6" "Region enriched" "Detected in single" 6 "basal ganglia: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA051365 Approved Nucleoplasm NA NA Nucleoplasm "HPA051365: AB_2616454" "unprognostic (2.59e-3)" "unprognostic (1.06e-2)" "unprognostic (9.33e-2)" "unprognostic (6.92e-4)" "unprognostic (2.55e-1)" "unprognostic (1.88e-2)" "unprognostic (1.91e-2)" "unprognostic (5.51e-2)" "unprognostic (8.69e-2)" "unprognostic (1.85e-1)" "unprognostic (6.23e-2)" "unprognostic (5.63e-3)" "unprognostic (2.71e-1)" "unprognostic (5.79e-2)" "unprognostic (6.44e-2)" "unprognostic (5.48e-3)" "unprognostic (2.62e-2)" 0.1 0.0 0.2 0.1 1.9 0.1 0.1 0.1 0.2 0.1 0.7 0.1 0.1 0.9 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 3.5 63.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.3 2.3 0.1 0.1 0.1 0.0 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.7 0.3 0.0 0.6 0.3 0.3 0.9 1.1 0.6 0.0 0.0 0.9 0.4 0.0 0.0 0.0 9.4 0.3 1.0 0.6 0.0 0.3 0.6 0.0 0.0 0.0 1.0 0.9 0.0 0.2 2.2 0.0 1.7 1.7 0.0 0.0 0.0 0.0 0.6 0.0 0.9 1.2 0.4 0.0 0.8 0.3 0.6 1.7 1.8 1.3 0.9 0.8 0.6 0.0 1.8 2.3 1.4 0.3 2.9 0.4 1.4 2.1 1.2 2.2 0.7 0.7 1.5 0.2 1.5 2.2 1.3 0.5 2.9 0.5 0.7 0.2 0.0 0.6 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.3 0.2 1.9 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.3 20.8 16.0 2.2 1.1 0.6 0.7 0.3 2.5 8.1 9.1 3.5 0.0 0.1 3.3 0.1 1.7 0.3 0.0 0.0 0.0 0.1 0.4 0.4 12.7 124.3 0.3 0.0 0.0 3.1 5.3 1.2 0.3 0.6 0.0 0.0 0.0 0.3 0.1 0.0 0.4 28.7 1.7 0.0 0.4 0.2 0.0 0.0 0.0 0.5 0.0 0.8 NR2C1 "TR2, TR2-11" ENSG00000120798 "Nuclear receptor subfamily 2 group C member 1" P13056 12 95020229-95073703 "Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035040, HPA035041, HPA067767" Supported Supported "Nucleoplasm,Cell Junctions,Cytosol" NA NA Nucleoplasm "Cell Junctions, Cytosol" "HPA035040: AB_2674426, HPA035041: AB_2674427, HPA067767: AB_2685898" "unprognostic (2.44e-1)" "unprognostic (8.04e-3)" "unprognostic (3.17e-2)" "unprognostic (2.51e-1)" "unprognostic (3.56e-3)" "unprognostic (3.01e-2)" "prognostic unfavorable (5.18e-5)" "unprognostic (1.30e-2)" "unprognostic (1.29e-2)" "unprognostic (1.86e-1)" "unprognostic (3.83e-2)" "unprognostic (4.56e-2)" "prognostic unfavorable (1.03e-6)" "unprognostic (2.31e-1)" "unprognostic (1.42e-1)" "unprognostic (2.16e-1)" "prognostic favorable (5.62e-5)" 11.6 15.8 15.9 11.8 14.7 15.5 12.4 38.3 23.9 12.5 11.2 12.5 12.9 11.2 17.6 20.2 8.3 15.5 11.1 14.8 14.6 9.3 10.3 14.0 14.2 9.9 11.7 15.2 16.3 12.5 16.4 15.4 11.2 13.7 10.7 12.7 14.6 8.0 17.4 19.6 11.0 11.2 15.7 14.2 14.3 10.5 22.2 14.9 12.3 18.0 9.0 10.2 12.3 10.7 4.5 6.2 3.5 4.2 3.5 9.0 3.9 8.1 10.1 16.1 7.6 3.7 6.7 22.9 8.0 5.8 8.0 7.5 8.9 4.6 9.9 2.9 5.3 5.1 8.7 7.9 6.2 6.1 4.3 16.8 12.0 8.2 10.6 8.5 8.0 5.2 7.7 5.1 5.5 6.8 8.9 8.5 12.4 9.1 3.9 9.3 5.4 8.7 18.6 10.9 6.6 17.8 8.4 11.3 5.9 9.0 9.4 8.3 6.6 12.8 5.5 5.9 9.3 9.6 5.1 8.0 6.5 6.4 7.9 4.5 5.7 9.3 9.5 1.6 9.4 3.0 0.5 4.1 3.5 7.1 4.2 9.0 3.7 5.7 6.0 6.2 4.5 7.2 5.0 2.6 3.5 3.7 6.2 3.7 3.9 15.9 14.7 38.3 23.9 14.6 9.3 11.7 15.2 13.7 14.9 32.8 12.5 7.0 12.2 7.3 39.9 16.1 10.2 22.7 1.2 10.4 17.7 12.6 3.3 10.1 14.3 14.6 8.5 0.0 8.2 10.9 11.3 8.0 9.3 10.6 8.3 23.8 6.9 12.9 10.5 3.8 40.6 10.2 13.5 10.8 10.9 14.6 14.3 11.5 28.3 6.8 50.7 6.5 9.8 54.9 23.8 6.5 6.5 10.9 10.9 17.1 NR2C2 "hTAK1, TAK1, TR2R1, TR4" ENSG00000177463 "Nuclear receptor subfamily 2 group C member 2" P49116 3 14947584-15053600 "Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006313 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006313: AB_1079503" "unprognostic (1.32e-1)" "unprognostic (3.87e-1)" "unprognostic (3.98e-2)" "unprognostic (1.30e-1)" "unprognostic (1.04e-1)" "prognostic favorable (1.51e-5)" "unprognostic (1.03e-2)" "unprognostic (1.34e-1)" "unprognostic (1.05e-1)" "unprognostic (1.20e-1)" "unprognostic (1.29e-1)" "unprognostic (5.95e-2)" "unprognostic (1.02e-1)" "unprognostic (2.26e-1)" "unprognostic (1.25e-1)" "unprognostic (2.82e-2)" "unprognostic (5.82e-3)" 13.2 13.1 22.5 17.0 17.5 17.1 16.1 30.5 26.4 11.9 14.0 12.8 14.1 18.5 17.8 11.0 13.6 12.6 12.3 14.5 18.3 12.0 12.4 12.6 18.7 16.9 12.6 20.4 18.8 14.2 18.0 23.2 11.9 13.1 12.3 12.2 13.7 13.0 21.5 31.5 19.6 18.1 15.7 13.5 18.8 14.7 29.2 13.3 26.0 19.4 9.0 15.5 15.5 17.8 5.1 4.2 6.2 3.4 2.7 4.9 1.5 10.1 11.5 13.2 10.2 9.4 11.3 30.3 14.7 11.9 11.9 12.4 7.4 10.0 15.7 7.7 13.1 10.5 10.2 12.1 7.5 12.4 20.6 17.2 20.5 24.6 6.6 7.9 15.0 15.9 8.9 10.0 15.0 7.9 10.0 13.4 15.5 14.5 10.8 10.5 9.0 23.0 11.8 8.7 4.8 11.9 18.5 15.7 10.4 5.7 15.4 8.4 21.1 13.3 11.2 13.5 10.9 11.2 15.0 17.3 18.5 22.1 16.8 20.0 16.5 21.3 17.0 13.3 14.4 16.2 6.2 2.5 1.9 4.9 3.4 4.4 2.3 2.7 2.9 2.6 5.1 3.9 3.5 3.5 2.7 3.0 4.2 2.5 1.5 22.5 17.5 30.5 26.4 18.3 12.0 12.6 20.4 13.1 13.3 20.8 9.8 10.9 9.5 3.3 15.5 5.1 12.7 24.1 7.9 7.0 13.7 6.7 5.0 6.1 46.1 6.4 10.7 0.0 6.3 6.3 5.8 13.8 9.2 7.8 6.7 12.7 24.1 20.3 20.9 49.4 17.8 7.7 5.0 7.2 10.7 13.3 9.4 11.8 19.4 5.7 16.3 0.0 4.8 30.9 16.3 2.8 12.5 13.6 10.6 10.7 NR2C2AP TRA16 ENSG00000184162 "Nuclear receptor 2C2 associated protein" Q86WQ0 19 19201416-19203424 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042054, HPA055653" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA042054: AB_10965022, HPA055653: AB_2682877" "unprognostic (9.54e-2)" "unprognostic (2.93e-3)" "prognostic unfavorable (8.53e-4)" "unprognostic (2.36e-2)" "unprognostic (6.81e-2)" "unprognostic (6.26e-3)" "prognostic unfavorable (5.63e-5)" "unprognostic (1.60e-2)" "unprognostic (1.53e-1)" "unprognostic (8.77e-2)" "unprognostic (3.65e-3)" "unprognostic (5.89e-2)" "unprognostic (7.62e-3)" "unprognostic (1.17e-2)" "unprognostic (5.99e-2)" "prognostic favorable (1.65e-4)" "unprognostic (2.10e-2)" 15.8 9.9 10.5 13.5 12.3 7.5 16.8 9.6 12.1 11.4 13.5 11.6 6.5 9.2 14.4 16.5 16.8 17.5 10.9 9.3 9.1 7.0 10.6 11.4 10.0 14.1 15.2 5.5 19.0 18.1 7.0 7.8 11.4 13.9 19.4 12.8 7.2 17.5 13.0 10.8 19.6 10.3 13.3 12.0 15.2 11.8 6.2 13.5 10.0 16.0 15.4 14.8 15.7 12.8 20.2 11.2 1.2 9.5 11.3 21.1 12.1 18.7 11.0 5.2 11.1 4.4 4.4 20.5 10.7 6.1 14.7 14.0 7.4 23.1 10.2 30.2 5.6 10.3 16.8 13.8 14.2 9.0 9.0 14.9 5.8 6.5 8.1 5.1 11.2 9.1 4.5 17.4 10.2 13.9 4.1 5.8 11.8 10.3 13.5 8.7 48.3 18.6 10.2 9.4 27.2 22.6 13.5 8.5 19.8 9.0 9.9 17.6 8.0 9.2 18.1 13.6 6.7 9.8 7.1 4.7 9.6 9.1 23.9 20.3 8.0 11.6 13.2 11.2 19.1 12.7 1.2 7.0 0.6 15.3 9.5 20.1 20.2 20.1 14.8 5.8 19.8 21.1 19.7 1.2 11.3 7.5 11.2 16.1 12.1 10.5 12.3 9.6 12.1 9.1 7.0 15.2 5.5 13.9 13.5 0.0 6.5 12.3 33.5 28.2 3.8 2.2 2.5 12.0 12.5 7.0 0.0 19.0 6.6 17.5 0.4 10.8 5.3 0.0 13.9 27.8 10.8 27.1 13.9 3.9 16.5 7.9 4.6 3.7 4.9 0.8 15.3 9.3 10.1 21.6 10.3 4.7 15.5 3.5 12.7 7.7 3.4 0.0 9.5 4.2 14.1 22.0 10.5 15.0 13.8 31.4 NR2F1 "COUP-TFI, EAR-3, ERBAL3, SVP44, TCFCOUP1, TFCOUP1" ENSG00000175745 "Nuclear receptor subfamily 2 group F member 1" P10589 5 93583224-93594615 "Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 16 "Ito cells: 216.7;Leydig cells: 86.6;Muller glia cells: 68.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 57.1;HHSteC: 43.9;hTERT-RPE1: 38.5;PC-3: 47.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019281, HPA058974" Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB019281: , HPA058974: AB_2732629" "unprognostic (8.07e-2)" "unprognostic (1.06e-2)" "unprognostic (3.86e-2)" "unprognostic (2.26e-1)" "unprognostic (4.75e-1)" "unprognostic (7.68e-3)" "unprognostic (3.18e-3)" "unprognostic (3.07e-2)" "unprognostic (2.21e-1)" "unprognostic (2.71e-3)" "unprognostic (5.24e-3)" "unprognostic (2.37e-1)" "prognostic unfavorable (3.47e-4)" "unprognostic (1.32e-2)" "unprognostic (1.61e-1)" "unprognostic (9.28e-2)" "prognostic unfavorable (1.47e-4)" 15.8 22.9 22.5 5.0 13.7 1.2 9.1 27.4 25.1 31.7 4.6 12.9 10.8 3.3 20.6 24.1 9.4 32.3 30.7 7.2 20.9 13.7 16.4 10.6 18.0 12.7 13.4 23.0 40.4 4.4 1.8 10.3 46.0 14.6 20.5 3.8 44.4 7.2 38.9 1.2 1.6 4.4 14.2 26.7 6.7 12.9 5.9 11.4 0.0 7.5 4.8 4.2 20.9 18.0 0.0 0.0 0.5 0.1 0.2 0.0 0.0 4.7 2.3 57.1 22.6 12.1 3.7 2.7 2.8 1.1 1.7 1.7 0.3 0.8 0.0 0.1 1.1 0.7 1.2 1.4 0.0 0.7 5.8 10.9 2.1 13.8 3.5 43.9 0.4 0.2 17.5 0.0 0.8 0.3 38.5 6.4 0.0 0.0 0.0 5.2 0.0 0.0 0.6 0.0 0.3 47.2 0.6 0.4 0.0 0.3 0.2 5.9 11.9 1.2 0.0 0.1 1.0 0.4 0.8 6.4 9.7 0.4 5.0 6.9 0.0 0.0 0.0 15.9 0.2 4.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.0 22.5 13.7 27.4 19.8 20.9 13.7 13.4 23.0 14.6 11.4 0.0 1.7 2.2 0.1 1.1 31.9 15.8 2.5 16.0 5.7 14.0 51.1 0.6 6.6 0.9 1.2 13.7 0.0 0.0 1.4 0.4 39.1 0.4 0.0 3.0 1.0 0.0 0.0 216.7 20.5 2.3 86.6 0.5 0.0 0.0 0.0 68.8 3.2 0.0 9.9 27.4 2.5 12.9 31.6 3.7 2.2 0.5 0.9 0.0 0.0 0.6 NR2F2 "ARP1, COUP-TFII, COUPTFB, NF-E3, SVP40, TFCOUP2" ENSG00000185551 "Nuclear receptor subfamily 2 group F member 2" P24468 15 96325938-96340263 "Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Ito cells: 273.8;Leydig cells: 472.6;Peritubular cells: 573.9;Sertoli cells: 478.6;Smooth muscle cells: 322.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "memory CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 11 "T-cells: 1.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058974 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA058974: AB_2732629" "unprognostic (9.28e-2)" "unprognostic (2.52e-2)" "unprognostic (2.34e-1)" "unprognostic (1.42e-2)" "unprognostic (8.96e-2)" "unprognostic (5.44e-2)" "unprognostic (3.38e-1)" "unprognostic (1.14e-1)" "unprognostic (2.61e-1)" "unprognostic (1.87e-1)" "unprognostic (1.89e-1)" "unprognostic (9.19e-2)" "unprognostic (5.14e-2)" "unprognostic (5.96e-2)" "unprognostic (1.72e-2)" "unprognostic (7.47e-2)" "unprognostic (1.28e-2)" 30.8 15.0 19.6 13.8 5.3 0.2 81.2 3.7 6.2 85.7 21.9 2.9 22.3 7.0 70.0 32.6 27.7 32.4 50.8 30.1 12.5 8.4 39.8 15.0 25.0 35.4 7.8 3.4 105.1 7.3 12.3 9.6 24.0 7.1 28.6 9.0 30.5 7.7 43.5 18.4 8.3 10.8 27.2 9.8 63.4 26.9 32.5 4.8 1.1 18.5 16.2 7.0 32.6 34.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 31.6 8.2 26.9 16.6 54.6 18.9 9.0 22.9 17.7 23.9 20.5 28.1 32.4 0.0 18.7 11.5 9.5 19.0 4.7 16.4 30.1 0.1 18.3 10.2 10.5 5.0 15.3 7.8 3.8 13.4 5.7 19.8 4.3 28.2 43.8 0.0 27.3 0.0 15.1 21.8 0.0 5.6 0.2 12.3 11.1 0.0 6.6 0.0 52.1 34.6 3.4 0.0 2.5 0.8 3.4 12.4 13.0 0.5 45.1 26.0 8.6 6.0 8.0 0.0 0.0 0.0 14.5 3.9 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.6 5.3 3.7 6.2 12.5 8.4 7.8 3.4 7.1 4.8 26.8 17.8 0.0 24.0 12.8 5.0 27.9 168.2 26.8 26.1 59.3 23.6 98.0 39.7 17.6 2.2 116.4 17.6 0.0 9.4 41.1 54.4 18.3 0.0 43.3 8.9 3.2 25.3 273.8 17.3 5.8 472.6 7.1 25.3 1.0 36.2 33.9 13.5 17.5 573.9 53.6 13.0 478.6 322.1 4.1 3.6 9.2 29.5 2.9 25.5 16.9 NR3C1 "GR, GRL" ENSG00000113580 "Nuclear receptor subfamily 3 group C member 1" P04150 5 143277931-143435512 "Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Receptor, RNA-binding" "Disease mutation, FDA approved drug targets, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004248, CAB010435" Supported Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "CAB010435: AB_2155784, HPA004248: AB_1078976" "unprognostic (1.38e-1)" "unprognostic (1.93e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.64e-5)" "unprognostic (1.43e-2)" "unprognostic (2.74e-1)" "unprognostic (4.19e-1)" "unprognostic (1.39e-1)" "unprognostic (2.46e-2)" "unprognostic (3.87e-2)" "unprognostic (2.15e-1)" "unprognostic (6.85e-2)" "prognostic unfavorable (1.72e-6)" "unprognostic (9.06e-3)" "unprognostic (1.02e-1)" "unprognostic (2.43e-3)" "unprognostic (2.45e-2)" 27.7 8.6 13.5 26.1 14.9 29.6 23.5 30.1 19.2 14.9 14.2 17.0 10.5 13.0 14.7 12.9 18.2 13.7 14.7 17.4 13.4 14.1 13.5 27.3 22.0 16.1 18.3 12.8 15.5 12.5 21.9 18.9 31.9 13.6 14.3 10.3 14.2 12.0 15.2 40.4 18.3 14.8 16.8 17.2 17.5 13.4 7.3 18.2 37.1 18.0 15.1 18.2 14.8 32.2 11.1 13.6 33.7 11.8 10.9 9.6 7.3 10.1 20.7 1.5 0.0 13.6 15.2 1.8 15.9 19.1 13.8 15.9 1.5 13.6 9.0 7.3 23.3 16.1 9.6 0.1 12.5 17.1 5.0 7.1 2.3 28.0 4.5 12.8 9.3 7.2 11.0 16.2 22.6 22.1 17.2 5.1 4.1 3.3 34.3 12.1 3.6 5.4 6.6 4.1 1.7 4.4 1.9 14.4 19.1 4.0 0.7 2.7 2.1 27.8 4.0 6.6 1.8 1.8 13.4 12.2 33.4 6.6 15.9 12.0 6.9 6.3 14.1 17.5 9.6 11.6 25.4 9.8 17.9 9.3 11.8 7.7 7.6 9.6 8.9 13.6 11.1 9.2 8.9 33.7 10.9 10.5 12.4 5.8 7.3 13.5 14.9 30.1 19.2 13.4 14.1 18.3 12.8 13.6 18.2 62.5 66.3 52.2 35.5 52.2 11.3 38.3 43.3 45.5 46.6 24.4 15.7 34.4 14.9 27.4 129.9 67.3 15.8 0.0 28.6 30.5 63.9 36.5 86.6 160.0 47.2 35.0 27.0 55.3 56.4 113.7 58.4 78.4 50.6 53.3 2.3 41.2 29.3 21.0 67.1 50.1 55.0 148.8 81.5 18.0 35.6 49.2 30.6 85.5 12.0 12.3 NR3C2 "MLR, MR" ENSG00000151623 "Nuclear receptor subfamily 3 group C member 2" P08235 4 148078762-148444698 "Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 47.2;Mucus-secreting cells: 43.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 4.8" "Lineage enriched" "Detected in single" 6 "T-cells: 4.8" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 11.1;HUVEC TERT2: 6.8;Karpas-707: 7.3;PC-3: 6.8;RPTEC TERT1: 9.1;TIME: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009155, HPA074979" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB009155: AB_2155949, HPA074979: AB_2686724" "unprognostic (2.75e-3)" "unprognostic (2.63e-2)" "unprognostic (6.70e-3)" "unprognostic (1.52e-1)" "unprognostic (4.09e-1)" "unprognostic (7.82e-3)" "unprognostic (1.04e-2)" "unprognostic (1.11e-2)" "unprognostic (1.14e-1)" "unprognostic (4.35e-2)" "unprognostic (4.97e-2)" "unprognostic (2.39e-1)" "prognostic favorable (3.10e-11)" "unprognostic (1.42e-1)" "unprognostic (1.87e-1)" "unprognostic (1.57e-1)" "unprognostic (1.27e-1)" 7.0 5.6 9.0 12.9 9.5 1.5 7.2 16.8 14.5 8.2 23.4 8.2 6.5 9.7 7.2 4.8 3.8 7.1 10.2 9.7 12.7 6.5 13.8 9.6 8.2 4.2 7.5 7.7 17.0 8.6 22.5 16.7 2.4 5.7 5.9 28.4 12.1 16.9 9.6 12.1 4.6 26.5 8.6 6.5 5.7 9.0 4.8 6.5 2.2 21.7 7.6 5.0 10.7 5.6 0.8 0.0 0.0 0.4 0.1 4.8 0.4 0.0 0.0 0.0 0.0 0.5 0.4 0.4 0.0 0.1 0.0 0.5 0.0 0.1 1.5 2.9 1.1 0.2 0.0 1.6 0.8 0.1 0.3 2.8 0.3 0.7 0.0 0.0 1.8 0.4 0.1 0.0 0.1 0.0 11.1 6.8 1.1 0.0 7.3 2.3 0.0 0.0 0.0 0.1 1.3 6.8 0.6 0.0 0.1 9.1 0.1 0.1 0.1 0.0 1.6 0.7 0.1 0.8 0.0 8.9 4.8 2.8 0.2 0.9 0.0 0.0 0.1 1.6 0.6 1.2 0.0 0.0 0.0 1.5 0.0 4.8 0.4 1.8 1.2 0.0 0.8 2.9 2.9 0.0 0.1 0.4 0.0 0.5 0.4 9.0 9.5 16.8 14.5 12.7 6.5 7.5 7.7 5.7 6.5 26.8 11.5 3.5 1.7 1.8 8.9 17.5 10.2 5.3 10.3 10.4 17.7 0.7 8.3 3.1 47.2 4.9 35.4 0.0 5.1 0.2 3.1 1.8 5.7 4.0 0.5 12.7 17.3 6.2 3.7 30.6 4.0 0.9 6.8 1.0 43.5 7.3 3.7 23.4 3.5 1.7 9.3 0.0 3.1 1.2 4.9 1.5 0.1 0.0 20.3 1.8 NR4A1 "GFRP1, HMR, N10, NAK-1, NGFIB, NUR77, TR3" ENSG00000123358 "Nuclear receptor subfamily 4 group A member 1" P22736 12 52022832-52059507 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 1121.0;granulocytes: 643.7;Smooth muscle cells: 682.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "intermediate monocyte: 18.2;non-classical monocyte: 24.4" "Lineage enriched" "Detected in many" 13 "monocytes: 24.4" "Cell line enhanced" "Detected in many" "HeLa: 25.8;MCF7: 29.4;SK-BR-3: 28.0;SK-MEL-30: 48.6" "Group enriched" "Detected in many" 5 "amygdala: 35.3;basal ganglia: 43.1;cerebral cortex: 77.4;hippocampal formation: 65.3;olfactory region: 79.3" "Low region specificity" "Detected in all" "HPA059742, HPA070142" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA059742: AB_2684119, HPA070142: AB_2732149" "unprognostic (2.40e-2)" "unprognostic (2.57e-1)" "unprognostic (1.29e-1)" "unprognostic (1.74e-1)" "unprognostic (1.65e-1)" "unprognostic (1.16e-1)" "unprognostic (1.26e-2)" "unprognostic (1.94e-1)" "unprognostic (1.92e-2)" "unprognostic (2.22e-3)" "unprognostic (1.90e-1)" "unprognostic (1.16e-1)" "prognostic favorable (6.99e-4)" "unprognostic (3.41e-2)" "unprognostic (2.71e-1)" "unprognostic (1.84e-2)" "unprognostic (8.89e-3)" 69.1 111.3 4.0 58.1 12.9 5.7 25.0 5.4 10.9 32.3 23.3 21.1 46.0 5.6 49.8 33.9 28.1 63.3 99.9 76.7 4.8 5.0 17.9 12.1 50.1 8.3 7.5 5.9 177.3 16.1 28.9 51.8 7.6 13.1 88.3 13.8 43.7 66.8 203.2 32.3 23.4 24.3 98.4 6.8 5.1 32.8 11.8 6.4 11.9 34.7 35.8 14.9 71.4 54.5 0.4 1.8 0.2 24.4 0.1 0.2 0.7 1.9 9.7 1.9 3.4 1.4 0.4 7.4 1.8 3.6 1.5 2.1 9.5 1.8 2.0 0.8 3.2 1.4 1.0 5.8 0.8 0.8 0.1 2.0 2.7 25.8 2.6 1.4 1.0 9.1 0.3 1.1 1.4 0.1 1.0 0.4 2.1 2.6 0.5 0.1 29.4 0.7 2.8 5.3 3.0 1.0 0.9 0.3 4.8 0.0 0.7 1.6 4.8 6.0 28.0 48.6 1.3 1.7 3.0 0.0 1.4 4.7 0.9 1.5 16.5 7.8 4.2 1.0 0.8 8.1 0.1 0.6 0.0 0.1 18.2 0.1 0.4 0.0 0.0 1.8 0.4 0.2 0.0 0.2 0.1 24.4 0.1 0.1 0.7 4.0 12.9 5.4 10.9 4.8 5.0 7.5 5.9 13.1 6.4 223.4 1121.0 24.4 132.4 396.0 36.6 7.8 15.3 111.1 143.3 82.0 117.8 62.1 5.0 12.1 16.2 91.9 82.8 0.0 11.1 32.1 293.0 212.1 643.7 7.4 47.6 15.9 331.5 135.7 50.1 4.5 28.1 257.6 352.6 8.2 251.3 24.1 5.1 265.7 22.3 0.7 70.9 122.9 682.6 1.5 12.4 413.3 92.5 20.2 184.5 44.7 NR5A1 "AD4BP, ELP, FTZ1, FTZF1, hSF-1, SF-1" ENSG00000136931 "Nuclear receptor subfamily 5 group A member 1" Q13285 9 124481236-124507430 "Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 47.7;lymphoid tissue: 50.8" "Group enriched" "Detected in some" 10 "Leydig cells: 10.9;Peritubular cells: 7.1;Sertoli cells: 12.9" "Group enriched" "Detected in some" 5 "head and neck cancer: 1.7;ovarian cancer: 2.4;testis cancer: 2.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "plasmacytoid DC: 1.3" "Lineage enriched" "Detected in single" 13 "dendritic cells: 1.3" "Cell line enhanced" "Detected in some" "HEL: 39.1;Hep G2: 25.3;K-562: 9.3" "Region enriched" "Detected in single" 20 "hypothalamus: 6.1" "Not detected" "Not detected" HPA079181 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA079181: " "unprognostic (1.66e-1)" "unprognostic (3.08e-1)" "unprognostic (6.13e-5)" "unprognostic (2.32e-7)" "unprognostic (3.95e-1)" "unprognostic (1.16e-1)" "unprognostic (1.13e-1)" "unprognostic (1.61e-1)" "unprognostic (1.60e-2)" "unprognostic (9.74e-2)" "unprognostic (4.14e-2)" "unprognostic (4.75e-3)" "unprognostic (1.14e-1)" "unprognostic (1.49e-2)" 0.2 47.7 0.2 0.2 0.5 0.0 0.2 0.2 0.4 0.2 0.2 1.3 0.2 0.0 0.2 0.4 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 13.1 0.2 0.0 5.8 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 50.8 0.0 9.4 0.2 0.2 0.2 0.2 0.2 0.2 0.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.1 0.0 25.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.5 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 12.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 NR6A1 "CT150, GCNF, GCNF1, RTR" ENSG00000148200 "Nuclear receptor subfamily 6 group A member 1" Q15406 9 124517275-124771310 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 28.2" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 112.0;Spermatocytes: 68.9;Spermatogonia: 111.8" "Cancer enriched" "Detected in many" 16 "testis cancer: 27.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "neutrophil: 8.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 8.6" "Cell line enhanced" "Detected in many" "BEWO: 47.8;CACO-2: 11.0;Hep G2: 10.7;K-562: 14.1;NTERA-2: 17.0;U-266/84: 10.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031461, HPA045145" Enhanced Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA031461: AB_2673894, HPA045145: AB_2679233" "unprognostic (1.73e-1)" "unprognostic (6.66e-2)" "unprognostic (4.53e-1)" "unprognostic (1.34e-6)" "unprognostic (4.40e-2)" "unprognostic (3.20e-2)" "unprognostic (2.52e-5)" "unprognostic (6.31e-2)" "unprognostic (8.01e-3)" "unprognostic (2.71e-2)" "unprognostic (1.58e-2)" "unprognostic (1.63e-1)" "unprognostic (7.26e-2)" "unprognostic (7.20e-3)" "unprognostic (1.71e-1)" "unprognostic (6.77e-3)" "unprognostic (1.09e-1)" 0.6 1.0 2.9 1.4 3.4 5.5 1.8 5.8 3.5 0.8 7.9 1.2 1.3 2.5 0.9 1.4 2.2 1.0 0.9 1.0 3.3 1.3 1.9 2.8 1.8 0.7 2.1 2.4 0.6 3.3 1.5 2.2 4.2 2.2 1.7 2.3 1.7 1.5 1.4 1.9 2.6 5.3 0.8 2.3 1.1 0.7 28.2 2.8 0.0 7.3 0.8 1.1 1.3 1.4 0.3 1.0 8.6 1.2 0.1 0.0 0.1 0.5 1.2 6.3 0.8 0.1 0.1 47.8 0.1 0.4 0.3 0.5 11.0 1.2 2.1 0.4 0.0 1.6 1.1 0.6 0.5 0.7 0.5 2.0 1.7 1.8 10.7 0.0 1.0 3.1 0.0 0.6 0.5 0.7 0.1 0.1 0.5 14.1 0.3 0.2 0.2 0.0 1.3 17.0 0.5 0.5 0.5 0.6 0.9 0.2 0.8 0.9 0.3 0.0 0.3 0.4 9.8 1.1 0.5 0.0 0.6 1.3 0.4 0.3 1.4 10.3 1.9 0.3 1.0 0.3 0.1 1.2 2.0 0.0 0.9 0.0 0.1 0.0 0.0 1.0 0.3 0.0 0.0 8.6 0.1 0.6 0.2 0.0 0.1 2.9 3.4 5.8 3.5 3.3 1.3 2.1 2.4 2.2 2.8 0.0 7.7 0.0 15.1 33.2 2.8 1.4 10.2 4.0 4.5 5.2 27.5 30.8 1.7 7.9 43.0 2.7 13.2 0.0 3.1 112.0 3.0 14.2 1.1 5.5 7.1 1.6 4.6 1.3 1.8 22.4 1.1 4.6 8.5 5.4 6.7 8.0 2.3 7.0 1.8 1.9 10.5 0.0 2.1 68.9 111.8 34.8 25.6 0.0 13.0 11.9 NRARP MGC61598 ENSG00000198435 "NOTCH regulated ankyrin repeat protein" Q7Z6K4 9 137300482-137302251 "Predicted intracellular proteins" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 41.7" "Group enriched" "Detected in many" 7 "Basal keratinocytes: 86.2;Suprabasal keratinocytes: 333.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 23.4;HEK 293: 11.8;NTERA-2: 17.2;OE19: 11.5;T-47d: 11.9;TIME: 17.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA025729 Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA025729: AB_1854633" "unprognostic (9.92e-2)" "unprognostic (1.75e-2)" "unprognostic (1.56e-1)" "unprognostic (7.17e-3)" "unprognostic (1.78e-1)" "unprognostic (1.15e-1)" "unprognostic (3.42e-2)" "unprognostic (1.89e-2)" "unprognostic (1.00e-2)" "unprognostic (6.42e-2)" "unprognostic (4.73e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (6.73e-6)" "unprognostic (2.85e-3)" "unprognostic (1.34e-1)" "unprognostic (4.90e-2)" "unprognostic (3.28e-3)" 7.9 1.6 6.5 8.4 7.8 1.7 13.8 3.9 11.7 5.6 41.7 6.1 1.1 17.1 5.2 1.9 17.4 3.2 26.0 7.1 5.0 6.5 3.2 2.9 7.0 1.8 6.0 3.0 5.6 14.2 3.1 7.1 8.9 7.4 11.8 22.8 5.6 1.9 2.8 4.4 19.7 15.7 4.5 3.2 7.7 8.7 6.0 3.4 2.3 4.2 14.0 14.4 7.6 10.2 0.2 0.0 0.0 0.3 0.4 0.0 0.0 2.5 0.5 3.5 4.2 0.0 0.0 1.6 0.1 0.1 0.0 0.0 2.8 1.4 0.0 6.4 0.0 0.1 23.4 6.4 0.2 0.1 0.2 11.8 0.7 1.0 2.6 0.4 0.9 2.3 0.0 1.1 0.0 0.2 0.0 5.3 0.1 6.9 0.1 0.0 7.7 0.1 2.7 17.2 11.5 3.5 4.6 0.7 8.4 0.6 0.2 2.4 4.4 0.7 1.2 0.0 0.7 11.9 1.9 17.1 0.0 0.0 0.1 1.0 0.1 0.1 1.4 0.0 2.3 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 6.5 7.8 3.9 6.8 5.0 6.5 6.0 3.0 7.4 3.4 0.0 0.0 0.5 2.8 86.2 0.3 2.8 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 11.7 6.0 10.7 0.0 1.0 0.0 0.6 6.0 0.0 0.0 0.4 0.0 9.8 5.5 0.8 2.9 0.0 0.0 16.9 0.0 15.3 9.4 0.6 31.1 0.4 0.0 2.5 6.5 23.4 0.0 0.8 333.1 0.0 0.0 19.6 5.5 NRBF2 "COPR1, COPR2, DKFZp564C1664, FLJ30395" ENSG00000148572 "Nuclear receptor binding factor 2" Q96F24 10 63133247-63155031 "Predicted intracellular proteins" "Autophagy, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 100.9" "Cell type enhanced" "Detected in many" 8 "Syncytiotrophoblasts: 238.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "neutrophil: 100.9" "Lineage enriched" "Detected in all" 8 "granulocytes: 100.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021670, HPA059477" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA021670: AB_2670803, HPA059477: AB_2684032" "unprognostic (7.71e-2)" "unprognostic (2.74e-1)" "unprognostic (1.71e-1)" "unprognostic (2.05e-2)" "unprognostic (1.47e-2)" "unprognostic (1.04e-1)" "unprognostic (1.21e-1)" "unprognostic (1.32e-2)" "unprognostic (2.33e-1)" "unprognostic (9.57e-2)" "unprognostic (2.42e-3)" "unprognostic (1.31e-2)" "prognostic unfavorable (2.36e-4)" "unprognostic (2.38e-1)" "unprognostic (3.21e-2)" "unprognostic (2.44e-2)" "unprognostic (1.59e-2)" 15.1 10.0 10.7 16.1 10.2 22.1 21.6 10.9 13.9 12.3 12.3 7.0 9.0 12.4 13.9 9.9 13.9 10.0 13.2 13.6 10.9 9.5 10.6 50.2 19.1 29.4 13.1 8.9 9.2 10.3 6.9 11.5 21.3 11.7 8.7 12.8 6.0 14.8 11.0 46.2 14.6 15.0 10.8 11.7 22.9 10.5 10.0 8.9 16.4 14.2 13.9 14.6 14.6 13.5 7.0 10.0 100.9 13.3 4.3 5.7 7.2 8.9 8.1 8.1 7.4 19.5 30.1 8.1 12.8 21.9 10.3 14.6 17.2 9.6 11.6 6.3 14.3 10.3 7.0 7.9 10.8 14.1 10.4 7.9 8.6 4.2 13.7 25.0 11.3 10.0 27.9 23.2 16.7 41.0 19.3 10.5 7.6 8.7 13.5 13.0 6.6 9.5 20.1 9.4 7.3 33.9 9.3 7.3 6.8 11.8 5.1 4.6 8.0 7.6 14.9 22.2 13.9 9.2 11.3 10.7 7.1 10.5 11.1 13.6 17.0 13.0 14.1 19.9 18.2 5.7 13.8 11.8 22.8 4.5 13.3 4.7 7.0 4.6 4.9 10.0 5.9 5.7 5.3 100.9 4.3 12.5 4.9 5.1 7.2 10.7 10.2 10.9 13.9 10.9 9.5 13.1 8.9 11.7 8.9 3.0 27.1 28.8 40.1 25.5 11.4 6.2 10.2 25.4 19.4 12.2 3.9 45.0 19.9 27.6 5.4 22.2 25.7 0.0 30.6 61.0 36.0 34.9 13.9 47.4 43.7 19.1 15.0 14.7 52.1 5.3 21.6 53.4 43.9 52.3 26.6 14.8 33.1 28.5 20.1 23.0 7.6 19.4 24.5 21.3 67.9 27.9 238.6 37.4 22.2 49.9 NRCAM "Bravo, KIAA0343" ENSG00000091129 "Neuronal cell adhesion molecule" Q92823 7 108147623-108456717 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 82.0" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 66.8;Cone photoreceptor cells: 96.2;Muller glia cells: 46.7" "Cancer enriched" "Detected in all" 7 "glioma: 57.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "naive CD8 T-cell: 5.5" "Lineage enriched" "Detected in single" 15 "T-cells: 5.5" "Cell line enhanced" "Detected in some" "A549: 26.4;AF22: 25.7;EFO-21: 47.9;HMC-1: 51.2;SH-SY5Y: 31.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012606 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 70000000 Nucleoplasm "Vesicles, Plasma membrane" "HPA012606: AB_1854636" "unprognostic (2.66e-1)" "unprognostic (2.65e-1)" "unprognostic (2.52e-3)" "unprognostic (2.18e-2)" "unprognostic (4.08e-3)" "unprognostic (1.01e-2)" "unprognostic (4.47e-3)" "unprognostic (1.66e-1)" "unprognostic (1.73e-1)" "unprognostic (4.81e-2)" "unprognostic (9.10e-3)" "unprognostic (4.33e-2)" "unprognostic (2.22e-2)" "unprognostic (9.70e-3)" "unprognostic (6.42e-2)" "unprognostic (6.51e-3)" "unprognostic (3.28e-2)" 2.5 28.7 24.5 2.3 23.7 1.2 1.6 16.6 82.0 5.0 1.6 10.5 9.5 1.5 2.6 26.6 1.5 3.7 6.3 1.1 19.1 15.9 5.8 1.3 2.7 1.6 11.8 21.2 2.1 21.5 1.2 14.6 6.4 21.7 1.6 1.6 0.7 2.4 12.1 1.0 1.6 1.5 1.6 10.8 4.2 2.3 2.2 9.9 0.0 4.0 0.0 2.9 1.5 0.8 0.1 0.0 0.3 0.0 0.0 5.5 0.6 0.0 26.4 25.7 0.0 3.1 0.6 0.5 0.1 0.1 0.2 0.4 10.6 0.0 0.0 47.9 0.2 0.4 0.1 0.6 0.4 0.2 0.0 3.4 0.0 0.2 0.2 0.0 0.2 51.2 4.3 0.0 0.0 0.1 0.0 16.5 0.0 0.0 0.2 0.4 9.9 0.1 0.0 3.5 15.7 0.0 0.0 7.5 8.6 5.9 0.0 5.0 31.5 0.3 0.0 0.5 0.9 0.0 0.0 17.5 1.1 0.2 0.0 4.3 0.0 0.1 0.2 0.2 0.0 14.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 5.5 0.0 0.0 0.0 0.0 0.0 0.6 24.5 23.7 16.6 34.7 19.1 15.9 11.8 21.2 21.7 9.9 0.0 0.0 0.0 0.0 0.3 66.8 0.5 2.5 0.0 0.0 5.2 96.2 2.1 3.3 1.3 25.4 0.9 0.0 0.0 10.2 0.2 0.9 0.7 22.0 0.0 0.7 12.7 0.0 2.5 1.5 4.7 0.9 0.0 3.3 1.0 0.0 46.7 5.7 0.0 0.4 2.1 7.9 0.0 0.9 1.0 1.1 0.1 3.7 0.0 0.0 0.0 NRDC "hNRD1, hNRD2, NRD1" ENSG00000078618 "Nardilysin convertase" O43847 1 51789191-51878937 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 96.4" "Group enriched" "Detected in many" 8 "Early spermatids: 492.5;Late spermatids: 1318.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053661 Approved Nucleoplasm NA NA Nucleoplasm "HPA053661: AB_2682221" "unprognostic (1.22e-1)" "unprognostic (6.52e-2)" "unprognostic (2.14e-2)" "unprognostic (5.62e-2)" "unprognostic (2.61e-1)" "unprognostic (3.25e-2)" "prognostic unfavorable (5.49e-6)" "unprognostic (1.42e-1)" "unprognostic (4.17e-2)" "unprognostic (1.67e-1)" "unprognostic (5.86e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (2.12e-9)" "unprognostic (2.75e-1)" "unprognostic (2.35e-2)" "unprognostic (9.54e-2)" "unprognostic (5.53e-3)" 16.4 15.9 13.4 15.8 17.5 14.5 11.7 14.7 16.9 12.2 13.7 11.0 9.9 11.2 11.8 12.1 14.4 10.9 10.9 25.7 13.1 13.3 12.4 28.5 12.0 13.6 16.2 10.6 11.7 15.9 19.3 21.4 14.2 15.7 13.8 12.1 9.8 11.9 11.3 96.4 19.1 10.3 13.3 14.0 13.6 11.9 32.3 14.5 19.4 11.7 21.5 15.1 13.0 16.0 13.8 18.5 36.3 19.1 15.8 15.1 16.2 46.9 26.5 26.6 38.1 28.0 43.3 30.9 47.5 41.1 34.6 36.7 18.5 18.6 31.0 25.4 35.7 46.4 27.4 39.0 36.8 43.8 36.7 19.2 37.0 36.0 16.1 28.7 32.3 28.2 34.4 28.2 50.4 46.8 29.8 35.9 33.0 48.7 20.8 43.2 17.2 29.2 11.2 47.2 19.4 28.5 28.6 31.8 34.2 25.5 27.3 25.5 19.2 43.3 34.9 25.7 53.9 23.3 39.3 29.8 30.4 28.2 33.1 40.3 31.1 46.9 29.0 35.9 40.7 34.8 19.3 18.1 26.0 13.7 19.1 13.7 13.8 12.7 15.1 18.5 9.3 12.5 13.4 36.3 15.8 14.5 15.0 14.4 16.2 13.4 17.5 14.7 16.9 13.1 13.3 16.2 10.6 15.7 14.5 32.8 55.9 17.8 35.3 0.0 67.0 0.0 17.8 108.4 63.7 26.2 76.6 47.3 26.6 38.1 492.5 33.3 18.8 70.0 55.1 37.0 33.6 42.0 32.5 52.9 39.9 58.8 17.5 28.3 38.2 1318.0 61.2 53.3 0.0 60.5 26.4 53.0 45.7 14.0 55.5 15.1 68.3 58.2 0.0 37.6 20.9 0.0 69.0 40.6 27.9 33.4 NRDE2 "C14orf102, FLJ14051" ENSG00000119720 "NRDE-2, necessary for RNA interference, domain containing" Q9H7Z3 14 90267856-90332137 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 104.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047050, HPA050583" Uncertain Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA047050: AB_2679917, HPA050583: AB_2681182" "unprognostic (1.24e-2)" "unprognostic (3.58e-1)" "unprognostic (1.24e-1)" "unprognostic (3.02e-1)" "unprognostic (4.51e-2)" "unprognostic (1.08e-2)" "unprognostic (9.60e-2)" "unprognostic (8.91e-3)" "unprognostic (1.10e-1)" "unprognostic (4.88e-3)" "unprognostic (3.26e-3)" "unprognostic (1.35e-2)" "unprognostic (2.31e-3)" "unprognostic (8.27e-2)" "unprognostic (6.56e-2)" "unprognostic (3.13e-2)" "unprognostic (3.49e-2)" 7.3 9.1 7.3 7.7 10.1 16.4 8.0 17.6 9.3 6.9 8.1 10.8 4.4 13.5 14.6 8.0 8.1 7.7 6.3 6.3 6.2 5.4 7.4 9.8 7.1 6.8 8.2 4.2 8.7 7.2 10.6 13.8 11.6 8.5 7.0 6.5 10.8 9.2 6.1 23.5 11.1 9.7 7.3 8.4 8.5 7.9 7.1 8.7 11.3 9.4 4.8 8.3 9.2 10.2 3.3 3.5 6.0 2.7 2.2 2.6 0.6 1.3 2.6 3.6 2.2 0.5 1.9 2.5 2.6 1.8 1.9 2.1 3.2 2.3 2.3 1.4 2.5 2.4 3.4 2.0 3.4 3.5 4.4 3.3 3.0 8.6 2.2 1.0 8.0 4.2 3.5 2.5 1.8 1.1 3.9 1.6 5.9 1.4 3.6 1.7 2.5 3.6 3.4 1.2 1.2 2.1 3.2 5.2 0.9 1.1 5.2 3.3 3.9 1.1 6.9 1.7 1.4 3.0 3.3 2.2 2.9 1.3 1.7 1.1 3.0 3.2 2.5 2.7 1.5 3.3 4.5 2.7 3.4 2.6 1.5 2.0 2.5 1.9 2.1 1.3 3.3 1.9 2.2 6.0 2.2 1.2 3.5 1.6 0.6 7.3 10.1 17.6 9.3 6.2 5.4 8.2 4.2 8.5 8.7 32.8 27.2 20.3 6.2 5.3 73.0 12.2 43.3 12.0 22.7 17.4 82.5 15.8 6.6 13.7 6.1 16.9 26.2 46.7 12.8 11.1 11.2 6.9 37.0 37.6 10.5 50.9 23.7 28.8 15.7 6.7 21.9 12.0 8.5 18.0 20.3 40.1 11.2 16.5 31.1 10.3 104.0 0.0 12.0 20.7 37.9 5.5 21.1 16.6 20.3 5.8 NRF1 "ALPHA-PAL, EWG" ENSG00000106459 "Nuclear respiratory factor 1" Q16656 7 129611714-129757082 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029329 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029329: AB_10601240" "unprognostic (2.80e-2)" "unprognostic (2.20e-3)" "unprognostic (4.51e-1)" "unprognostic (4.04e-2)" "unprognostic (2.01e-1)" "unprognostic (4.20e-3)" "prognostic unfavorable (6.02e-4)" "unprognostic (1.09e-1)" "unprognostic (2.13e-2)" "unprognostic (3.69e-2)" "unprognostic (1.18e-3)" "unprognostic (2.99e-3)" "unprognostic (1.83e-2)" "unprognostic (2.06e-1)" "unprognostic (6.52e-2)" "unprognostic (4.20e-1)" "unprognostic (2.06e-3)" 14.8 7.3 10.9 18.9 13.0 20.3 18.2 22.2 11.1 15.4 10.3 12.6 16.0 9.0 15.7 10.4 10.1 18.7 10.0 12.3 11.5 11.1 10.0 7.8 11.2 18.7 12.1 7.7 24.4 15.2 13.5 10.9 12.5 11.5 11.5 9.9 11.7 13.8 13.9 19.3 12.2 10.7 14.0 9.6 14.2 8.7 17.2 15.2 29.2 13.8 11.4 16.1 12.8 19.2 8.8 7.0 13.1 7.0 5.8 13.3 6.2 11.8 9.7 14.1 12.4 8.5 6.8 11.2 8.3 8.6 12.7 9.9 11.7 7.9 13.6 6.1 9.3 8.0 9.1 15.1 8.4 13.0 13.0 10.8 11.3 8.2 7.9 6.2 13.8 11.3 5.8 7.9 12.5 12.1 7.3 9.3 13.3 13.6 10.5 7.7 10.8 27.0 13.0 13.1 10.9 8.7 17.2 11.4 12.1 7.2 8.7 12.2 13.3 12.5 13.0 8.4 12.0 8.1 13.2 7.2 7.2 10.0 8.4 15.2 11.5 11.4 24.2 7.6 12.8 13.9 6.1 5.5 13.1 11.4 6.9 13.3 7.7 8.7 10.5 7.0 8.8 9.6 8.2 11.4 5.8 7.0 4.7 9.1 6.2 10.9 13.0 22.2 11.1 11.5 11.1 12.1 7.7 11.5 15.2 3.0 6.2 3.7 2.8 6.0 10.2 5.1 5.1 13.4 5.7 3.5 9.8 2.1 0.0 2.1 0.3 6.7 3.2 0.0 3.1 3.5 3.7 4.4 4.7 4.7 2.6 9.5 6.4 8.0 5.6 1.4 4.9 5.8 5.0 2.8 5.0 5.6 2.4 5.8 4.2 2.2 10.4 6.5 3.6 6.7 6.0 6.8 2.9 9.2 3.9 2.6 NRG1 "GGF, HGL, HRG, NDF, NRG1-IT2" ENSG00000157168 "Neuregulin 1" Q02297 8 31639386-32767959 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.3" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 35.7;Basal glandular cells: 36.6;Early spermatids: 31.2;Horizontal cells: 27.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "classical monocyte: 22.8" "Lineage enriched" "Detected in many" 5 "monocytes: 22.8" "Cell line enhanced" "Detected in many" "A549: 38.0;BJ: 26.0;fHDF/TERT166: 29.1;GAMG: 40.0;HBF TERT88: 25.6;hTEC/SVTERT24-B: 27.3;hTERT-HME1: 28.6" "Low region specificity" "Detected in all" HPA010964 Uncertain Approved Nucleoplasm "Secreted to blood" NA NA Nucleoplasm "HPA010964: AB_1854641" "unprognostic (5.76e-3)" "unprognostic (8.60e-2)" "unprognostic (1.96e-4)" "unprognostic (2.67e-1)" "unprognostic (1.94e-4)" "unprognostic (4.99e-2)" "unprognostic (6.69e-2)" "unprognostic (7.72e-2)" "unprognostic (2.98e-1)" "unprognostic (5.65e-2)" "unprognostic (7.99e-2)" "unprognostic (8.49e-2)" "unprognostic (4.47e-2)" "unprognostic (1.31e-1)" "unprognostic (2.88e-1)" "unprognostic (5.40e-2)" "unprognostic (7.83e-2)" 0.7 2.1 4.6 5.0 3.3 1.2 8.8 14.8 8.1 10.6 4.2 0.3 2.1 3.5 2.5 1.1 3.7 2.0 4.8 2.2 4.7 15.4 11.5 23.6 5.7 0.6 6.2 3.5 2.9 0.9 0.8 23.9 0.2 28.3 3.2 5.4 3.6 2.5 1.6 0.2 4.3 5.7 1.1 2.5 1.7 3.1 6.4 0.8 0.2 13.8 7.2 2.2 7.2 3.5 0.0 4.9 0.8 22.8 0.0 0.0 4.6 0.1 38.0 0.6 0.0 0.3 0.7 0.0 26.0 18.4 21.6 16.6 0.0 0.8 0.0 4.8 29.1 40.0 20.5 0.1 10.4 25.6 0.0 0.2 0.5 0.5 0.5 0.1 0.0 0.0 0.3 1.1 27.3 28.6 1.9 12.4 0.0 0.0 0.1 7.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 16.0 1.1 1.1 1.3 1.9 0.0 0.0 2.1 0.0 0.0 9.0 15.0 4.6 23.9 14.5 0.0 0.0 0.2 7.7 0.0 1.8 0.0 22.8 0.2 0.0 2.1 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 4.6 4.6 3.3 14.8 8.1 4.7 15.4 6.2 3.5 28.3 0.8 35.7 2.4 0.5 36.6 23.1 11.2 1.7 10.2 4.0 13.6 3.5 7.9 0.0 8.3 1.8 31.2 1.4 0.0 0.0 0.2 0.0 0.7 14.3 1.1 6.6 0.5 27.0 0.0 6.7 16.0 14.6 0.3 1.8 1.7 0.0 0.0 4.8 0.8 0.0 0.4 14.6 3.0 0.0 0.9 1.4 1.0 5.4 0.0 0.0 0.0 5.6 NRG2 "Don-1, HRG2, NTAK" ENSG00000158458 "Neuregulin 2" O14511 5 139846779-140043299 "Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.3" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 9.0;Bipolar cells: 15.1;Leydig cells: 8.9;Muller glia cells: 9.7;Peritubular cells: 9.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1" "Lineage enriched" "Detected in single" 4 "T-cells: 2.1" "Cell line enhanced" "Detected in some" "AN3-CA: 8.4;Karpas-707: 5.6;PC-3: 14.8;RPTEC TERT1: 7.5;SCLC-21H: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038935, HPA047973" Approved Supported Nucleoplasm,Nucleoli "Secreted to blood" No NA Nucleoplasm Nucleoli "HPA038935: AB_10672833, HPA047973: AB_2680226" "unprognostic (8.66e-4)" "unprognostic (2.17e-1)" "unprognostic (1.21e-1)" "unprognostic (6.04e-2)" "unprognostic (3.22e-1)" "unprognostic (2.96e-2)" "unprognostic (8.66e-3)" "unprognostic (1.11e-1)" "unprognostic (3.99e-1)" "unprognostic (1.88e-1)" "unprognostic (4.26e-3)" "unprognostic (4.00e-2)" "unprognostic (7.79e-3)" "unprognostic (3.64e-3)" "unprognostic (9.54e-2)" "unprognostic (2.23e-2)" "unprognostic (2.07e-2)" 4.5 4.5 4.0 1.4 7.0 0.6 4.4 27.3 5.1 13.1 2.3 3.8 2.6 1.0 3.0 2.9 3.7 7.6 7.6 1.5 4.2 3.5 1.3 0.6 1.2 2.1 5.2 3.4 15.9 3.2 15.8 7.7 1.1 4.1 4.5 0.9 2.9 13.6 4.7 6.0 5.0 1.0 5.1 3.6 3.3 1.1 2.7 4.9 0.0 0.8 1.0 1.5 4.8 3.7 0.4 0.1 0.0 0.1 0.0 2.1 0.1 0.0 2.0 0.2 8.4 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.1 0.0 0.4 0.0 4.0 2.4 0.4 0.2 0.1 4.8 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.5 0.9 0.2 0.2 0.0 5.6 0.0 0.4 0.0 0.0 0.1 0.0 14.8 0.1 0.0 0.0 7.5 1.8 5.6 3.4 0.0 3.2 3.3 0.0 0.0 0.0 0.2 2.6 0.4 0.0 1.6 1.1 0.0 0.0 3.7 0.0 0.7 0.0 0.0 0.0 2.1 0.1 0.5 0.1 0.2 0.4 0.0 0.4 0.4 1.2 0.0 0.0 0.0 0.1 0.0 0.1 4.0 7.0 27.3 5.1 4.2 3.5 5.2 3.4 4.1 4.9 0.0 0.0 0.0 9.0 2.5 15.1 1.4 0.0 0.0 0.0 1.8 0.0 0.1 1.7 0.3 0.5 0.9 0.0 0.0 1.9 0.0 1.8 1.3 0.0 0.0 0.1 6.4 0.0 0.0 0.0 0.6 8.9 0.0 3.3 0.0 0.0 9.7 0.8 0.0 9.6 1.5 0.7 6.5 1.1 3.0 4.3 0.3 0.0 0.8 0.0 5.9 NRIP1 RIP140 ENSG00000180530 "Nuclear receptor interacting protein 1" P48552 21 14961235-15065936 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 5.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 41.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029785, HPA046571, HPA060036" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA029785: , HPA046571: AB_2679704, HPA060036: AB_2684193" "unprognostic (5.60e-2)" "unprognostic (1.87e-1)" "unprognostic (5.20e-3)" "unprognostic (4.64e-3)" "unprognostic (7.98e-2)" "unprognostic (2.59e-2)" "unprognostic (2.74e-1)" "unprognostic (2.75e-3)" "unprognostic (8.94e-3)" "unprognostic (1.55e-1)" "unprognostic (2.64e-2)" "unprognostic (1.65e-1)" "unprognostic (1.80e-2)" "unprognostic (6.53e-2)" "unprognostic (1.07e-1)" "unprognostic (2.72e-1)" "unprognostic (2.80e-1)" 29.0 15.0 10.8 12.6 7.5 19.6 18.4 20.8 10.5 23.1 21.2 6.7 8.5 14.5 16.6 13.4 13.1 18.8 9.0 11.8 9.3 5.8 16.0 22.7 9.3 8.9 5.9 7.3 14.4 15.8 8.3 11.2 16.8 7.2 13.9 15.8 12.7 10.3 7.7 36.5 7.6 30.3 17.3 12.9 17.0 8.4 6.8 7.7 22.1 7.3 12.4 5.9 13.0 14.9 2.6 1.7 0.5 1.4 1.2 5.6 0.7 9.7 20.7 16.3 0.0 8.2 5.3 5.8 11.6 5.2 7.8 5.9 3.8 7.7 0.0 6.6 11.0 3.6 5.1 1.0 6.9 15.7 0.0 4.5 14.7 7.2 11.9 4.9 7.4 3.2 6.5 9.7 8.0 9.4 8.1 5.7 2.2 10.4 8.1 5.1 5.5 3.4 0.0 6.6 3.9 6.2 41.5 12.8 0.3 4.5 16.9 1.4 0.0 9.6 5.1 3.9 13.3 12.4 5.6 9.8 6.3 4.2 9.8 4.7 3.9 0.0 0.0 13.8 0.0 3.2 0.0 1.4 0.5 1.0 0.8 5.6 0.9 1.0 1.1 1.7 2.6 1.7 0.6 0.3 1.2 1.4 1.7 0.5 0.7 10.8 7.5 20.8 10.5 9.3 5.8 5.9 7.3 7.2 7.7 44.7 32.8 11.5 54.8 16.6 33.5 15.3 17.8 18.7 61.4 27.9 47.1 13.0 8.3 20.2 11.9 25.5 34.2 0.0 23.8 109.4 21.7 35.8 29.1 42.3 36.7 20.6 36.1 28.3 37.6 14.4 34.8 26.2 8.5 33.3 38.8 58.9 25.8 40.3 25.5 33.6 60.2 32.3 17.0 9.3 2.3 16.4 11.8 7.7 42.0 78.2 NRIP2 DKFZP761G1913 ENSG00000053702 "Nuclear receptor interacting protein 2" Q9BQI9 12 2825348-2835544 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 48.5" "Cell type enhanced" "Detected in some" 16 "Rod photoreceptor cells: 9.2;Sertoli cells: 25.8;Smooth muscle cells: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 5.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039197, HPA039860" Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" Yes No "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA039197: AB_10673416, HPA039860: AB_10794203" "unprognostic (3.28e-3)" "unprognostic (3.83e-1)" "prognostic unfavorable (8.05e-4)" "unprognostic (2.10e-2)" "unprognostic (8.11e-2)" "unprognostic (4.26e-3)" "unprognostic (5.66e-2)" "unprognostic (4.42e-3)" "unprognostic (2.89e-1)" "unprognostic (4.39e-2)" "prognostic favorable (8.69e-5)" "unprognostic (7.15e-2)" "unprognostic (2.82e-2)" "unprognostic (7.55e-2)" "unprognostic (5.23e-2)" "unprognostic (1.00e-1)" "unprognostic (8.97e-2)" 5.4 5.1 5.8 3.9 20.1 4.3 3.9 48.5 20.9 6.0 4.2 13.5 1.1 2.9 9.8 9.9 3.0 5.9 7.4 6.2 9.7 7.3 9.2 1.6 2.0 4.6 27.6 5.6 11.7 2.5 0.5 2.6 3.3 11.9 3.2 3.8 4.6 4.3 6.6 5.4 3.2 4.1 6.4 7.2 8.0 3.3 2.6 27.7 0.7 5.9 3.0 3.0 3.8 6.3 2.1 0.8 5.9 1.1 1.1 2.3 0.3 0.8 1.7 2.9 1.7 0.0 0.0 3.6 2.1 0.0 0.0 0.0 4.3 2.1 2.3 0.6 0.0 0.7 1.6 0.0 0.0 0.0 1.6 2.5 3.6 4.5 0.5 0.0 4.4 2.7 0.1 0.0 0.0 0.0 4.4 0.0 2.5 2.0 5.3 0.0 1.8 2.7 2.3 2.9 1.7 0.8 1.7 3.1 1.4 0.0 2.9 2.3 3.3 1.6 2.4 0.5 5.4 1.6 0.8 2.3 1.2 1.5 1.7 3.0 0.9 0.2 3.4 2.9 2.1 1.5 5.9 1.1 0.4 1.7 0.7 0.9 2.1 1.3 1.5 0.7 2.0 2.3 1.0 0.5 1.1 0.4 0.8 0.5 0.3 5.8 20.1 48.5 20.9 9.7 7.3 27.6 5.6 11.9 27.7 0.0 0.6 0.0 0.5 0.1 4.0 1.4 0.0 0.0 0.0 1.8 5.9 0.2 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.1 3.2 0.0 0.0 0.0 2.1 0.3 0.1 0.0 0.0 0.0 0.8 0.0 0.0 4.9 0.0 9.2 25.8 17.6 0.1 0.2 0.1 0.0 0.0 0.0 0.0 NRK DKFZp686A17109 ENSG00000123572 "Nik related kinase" Q7Z2Y5 X 105822543-105958610 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 42.2;placenta: 64.8" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 56.0;Leydig cells: 105.0;Syncytiotrophoblasts: 56.8" "Cancer enriched" "Detected in some" 8 "testis cancer: 6.1" "Region enriched" "Detected in single" 10 "cerebellum: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 30.7;HSkMC: 5.9;RH-30: 7.0;RPTEC TERT1: 18.9;SuSa: 23.1" "Region enriched" "Detected in single" 28 "cerebellum: 16.0" "Low region specificity" "Detected in many" HPA017238 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA017238: AB_1854645" "unprognostic (2.64e-4)" "unprognostic (9.82e-2)" "unprognostic (5.98e-3)" "unprognostic (5.52e-2)" "unprognostic (3.87e-2)" "unprognostic (2.29e-2)" "unprognostic (1.12e-1)" "unprognostic (2.86e-2)" "unprognostic (1.35e-2)" "unprognostic (6.08e-2)" "unprognostic (3.24e-2)" "unprognostic (5.28e-3)" "unprognostic (1.47e-3)" "unprognostic (1.14e-1)" "unprognostic (4.28e-2)" "unprognostic (6.80e-3)" 2.6 12.7 0.4 2.7 0.4 0.0 0.8 4.3 0.3 3.5 1.5 0.1 4.6 0.0 4.3 15.6 1.6 1.3 7.5 2.9 0.4 0.4 9.9 0.4 0.5 0.0 0.3 0.0 42.2 0.5 0.0 2.9 64.8 0.2 22.0 0.1 0.0 2.1 1.6 0.4 0.4 0.5 2.8 0.4 0.3 0.9 10.6 0.0 0.0 0.5 3.1 0.3 1.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 5.9 0.0 0.0 0.0 1.9 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 7.0 0.0 18.9 0.3 0.0 0.1 0.0 1.0 0.0 23.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 4.3 0.3 0.4 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 56.0 16.6 0.2 0.9 0.3 0.0 0.0 0.0 7.2 0.5 0.3 0.0 0.0 6.1 0.0 0.0 0.0 0.0 1.1 105.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.1 0.0 0.0 0.0 0.6 1.4 0.0 56.8 0.0 0.0 0.1 NRL "D14S46E, NRL-MAF, RP27" ENSG00000129535 "Neural retina leucine zipper" P54845 14 24080107-24115014 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Transcription regulation, Vision" "Activator, Developmental protein, DNA-binding" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "retina: 124.5" "Cell type enriched" "Detected in many" 6 "Rod photoreceptor cells: 2618.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026066, HPA064599" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB026066: , HPA064599: AB_2685295" "unprognostic (2.71e-2)" "unprognostic (8.17e-4)" "unprognostic (4.60e-2)" "unprognostic (1.80e-1)" "unprognostic (7.23e-2)" "unprognostic (1.99e-2)" "unprognostic (5.29e-2)" "unprognostic (1.88e-5)" "unprognostic (3.59e-2)" "unprognostic (7.84e-3)" "unprognostic (1.75e-3)" "unprognostic (3.49e-2)" "unprognostic (2.38e-5)" "unprognostic (2.56e-2)" "unprognostic (1.10e-1)" "unprognostic (1.73e-1)" "unprognostic (1.35e-3)" 1.5 2.7 4.4 2.3 4.1 1.0 1.8 2.1 2.8 1.9 1.3 1.7 1.7 3.2 1.4 7.9 1.3 1.4 1.2 2.7 3.8 3.1 3.5 3.9 1.7 1.9 3.9 1.4 1.8 3.4 5.4 2.8 1.8 2.1 1.8 1.0 124.5 1.6 2.4 4.1 0.9 1.9 1.0 4.4 2.6 1.3 4.3 1.2 3.3 4.3 1.8 1.6 1.5 2.2 3.8 1.4 4.1 1.3 2.0 2.7 1.2 0.8 1.7 0.5 1.8 0.5 0.5 1.6 0.4 0.4 2.2 1.0 1.1 0.8 2.5 0.8 1.0 1.6 1.0 1.0 1.2 0.3 1.8 1.5 0.7 0.5 3.7 1.2 1.9 3.3 0.7 1.0 0.6 1.2 0.4 1.1 3.1 1.6 3.0 0.8 2.6 2.2 1.8 0.6 3.4 1.8 2.2 2.1 0.7 1.2 1.7 2.0 2.0 1.3 1.5 1.6 0.7 1.1 2.6 0.4 1.4 0.8 0.6 1.2 7.6 3.2 2.7 0.2 1.6 1.5 0.0 1.1 4.1 1.1 1.2 0.7 3.8 1.1 1.6 1.3 2.4 2.7 2.3 0.2 2.0 1.3 1.4 1.0 1.2 4.4 4.1 2.1 2.8 3.8 3.1 3.9 1.4 2.1 1.2 0.0 0.3 4.4 1.7 0.7 340.0 1.6 0.0 0.0 1.2 7.0 406.4 1.0 11.6 0.5 1.7 0.6 2.1 23.3 1.0 0.8 0.5 2.4 0.0 2.6 1.7 236.8 1.7 0.0 0.6 2.8 1.1 0.2 1.7 1.0 1.8 381.3 0.4 0.9 1.8 6.8 2618.0 0.0 0.5 8.2 3.4 0.4 2.1 1.5 0.9 1.6 NRP2 VEGF165R2 ENSG00000118257 "Neuropilin 2" O60462 2 205681990-205798133 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Differentiation, Host-virus interaction, Neurogenesis" "Developmental protein, Heparin-binding, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Ito cells: 162.7;monocytes: 389.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.8;naive B-cell: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 34.5;HUVEC TERT2: 30.2;TIME: 28.8;U-251 MG: 58.9;U-87 MG: 27.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039980, HPA054974" Enhanced Approved "Nucleoplasm,Vesicles,Plasma membrane" "Secreted in other tissues" NA NA 15000000 "Vesicles, Plasma membrane" Nucleoplasm "HPA039980: AB_10795517, HPA054974: AB_2682657" "unprognostic (4.28e-2)" "unprognostic (1.17e-1)" "unprognostic (8.12e-3)" "unprognostic (3.38e-1)" "unprognostic (1.62e-1)" "unprognostic (1.57e-2)" "unprognostic (9.36e-2)" "unprognostic (3.70e-1)" "unprognostic (2.15e-3)" "unprognostic (2.90e-2)" "unprognostic (2.56e-3)" "unprognostic (4.17e-1)" "prognostic unfavorable (7.68e-7)" "unprognostic (2.22e-3)" "unprognostic (5.45e-2)" "unprognostic (6.41e-3)" "prognostic unfavorable (7.80e-5)" 24.3 14.5 8.7 11.4 7.4 2.6 7.8 1.2 7.0 34.4 35.4 3.9 8.4 3.5 33.7 4.6 24.8 13.1 25.8 4.4 11.5 8.3 3.4 6.2 15.8 4.9 8.9 3.9 33.0 1.4 2.5 6.6 29.9 9.0 18.6 7.0 27.7 2.6 21.0 2.5 3.3 8.2 44.7 8.6 4.7 17.1 3.4 5.2 2.6 7.3 6.0 3.0 39.3 24.6 1.4 0.5 0.0 1.8 0.0 0.0 0.5 0.7 14.2 9.1 0.0 8.2 2.6 2.7 2.2 4.3 2.8 2.7 13.4 34.5 0.0 3.4 7.1 5.6 5.5 0.4 4.4 4.7 0.0 1.9 0.1 0.6 0.1 22.4 0.0 0.5 19.7 3.4 3.9 3.5 17.4 30.2 0.0 0.0 0.0 1.9 0.0 0.0 0.0 11.4 0.0 2.5 0.0 0.5 3.1 5.7 0.0 8.2 0.3 0.3 0.0 20.3 24.3 0.0 0.1 28.8 12.5 0.1 3.2 58.9 0.0 0.0 0.8 27.8 0.0 26.1 0.0 1.8 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 8.7 7.4 1.2 3.8 11.5 8.3 8.9 3.9 9.0 5.2 83.4 48.1 3.9 13.9 17.2 25.2 4.8 7.6 64.3 72.8 1.8 0.0 68.2 0.0 2.1 5.6 84.5 0.0 0.0 3.3 4.0 46.3 4.7 3.5 0.9 113.5 0.0 1.2 162.7 27.7 10.2 2.6 22.5 18.6 389.5 0.1 4.3 31.6 0.0 4.6 0.6 2.4 0.0 10.3 1.7 0.7 11.0 21.5 0.7 0.0 44.5 NRSN2 "C20orf98, dJ1103G7.6" ENSG00000125841 "Neurensin 2" Q9GZP1 20 346782-359660 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 70.9" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015967 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA015967: AB_1854647" "unprognostic (5.67e-2)" "unprognostic (3.47e-1)" "unprognostic (7.50e-2)" "unprognostic (1.45e-1)" "unprognostic (1.30e-1)" "unprognostic (4.05e-2)" "unprognostic (4.48e-2)" "unprognostic (1.48e-1)" "unprognostic (4.96e-2)" "unprognostic (5.92e-2)" "prognostic favorable (1.61e-4)" "unprognostic (6.96e-2)" "unprognostic (1.96e-3)" "unprognostic (2.94e-2)" "unprognostic (1.96e-1)" "unprognostic (7.85e-3)" "unprognostic (1.73e-3)" 8.4 18.6 34.3 6.0 39.3 0.9 7.2 22.7 70.9 12.8 6.6 11.0 4.9 3.5 12.5 16.0 6.1 13.4 9.3 13.5 31.1 24.9 10.1 1.8 8.7 4.1 17.1 28.5 18.3 10.5 26.5 16.3 10.1 27.8 12.2 6.1 12.8 13.3 16.5 1.4 5.0 3.8 16.3 8.7 5.7 5.3 12.8 6.8 1.3 14.9 2.5 4.2 9.4 4.8 9.4 4.8 1.5 1.1 3.4 3.9 1.5 18.9 23.0 13.9 13.1 18.4 20.6 5.4 12.6 24.3 22.9 23.0 12.6 0.4 0.0 4.4 23.3 16.8 8.3 11.2 1.9 14.6 0.1 11.3 6.8 11.0 24.0 18.6 0.2 1.1 23.3 1.5 16.3 2.7 18.7 15.7 0.1 13.5 12.3 20.0 3.3 0.3 5.8 10.7 0.2 11.9 10.8 7.8 0.9 22.8 0.1 28.4 20.4 15.0 4.4 21.5 9.5 18.4 7.1 10.4 24.5 13.0 0.9 15.3 2.3 0.4 5.1 3.2 0.2 12.9 0.0 1.1 1.5 3.8 0.3 1.1 7.2 1.1 3.9 2.1 9.4 1.6 2.7 0.0 3.4 0.4 4.8 0.9 1.5 34.3 39.3 22.7 70.9 31.1 24.9 17.1 28.5 27.8 6.8 0.0 1.9 0.0 3.1 2.9 24.5 4.0 0.0 2.7 7.9 12.2 2.0 6.1 1.7 11.0 5.5 4.5 1.3 0.0 1.4 5.3 10.8 2.5 4.7 0.4 2.7 15.9 28.3 4.3 1.2 10.0 12.0 1.2 3.3 3.6 2.7 12.3 3.8 1.9 9.9 5.7 12.7 19.4 9.2 21.3 6.6 1.9 3.7 1.0 2.0 2.7 NSA2 "FLJ94393, HCLG1, HUSSY-29, TINP1" ENSG00000164346 "NSA2, ribosome biogenesis homolog" O95478 5 74766991-74780113 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis, rRNA processing" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA043487 Approved Enhanced Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA043487: AB_2678507" "unprognostic (4.79e-3)" "unprognostic (1.92e-1)" "unprognostic (5.49e-2)" "unprognostic (7.80e-2)" "unprognostic (1.54e-1)" "unprognostic (4.07e-2)" "unprognostic (6.14e-3)" "unprognostic (4.24e-1)" "unprognostic (2.15e-2)" "unprognostic (9.14e-2)" "unprognostic (8.66e-2)" "unprognostic (1.03e-1)" "unprognostic (4.92e-2)" "unprognostic (3.98e-1)" "unprognostic (1.64e-1)" "unprognostic (2.31e-2)" "unprognostic (1.44e-1)" 25.4 32.6 17.4 26.8 29.3 28.3 24.0 14.0 29.4 31.8 25.8 8.0 18.0 26.2 26.5 22.6 27.9 22.9 13.5 27.7 20.8 13.6 27.4 35.4 27.0 42.5 16.7 19.1 54.2 31.2 13.5 35.4 25.4 20.3 27.8 20.6 10.4 33.8 17.9 51.1 17.3 22.2 23.1 28.5 28.5 24.3 44.5 15.7 26.4 27.2 21.7 26.1 36.7 26.1 17.0 11.1 4.4 11.9 13.1 19.3 6.1 20.6 11.3 14.0 18.8 8.7 16.1 21.4 14.8 7.7 9.5 7.5 18.7 20.3 16.7 31.6 8.2 23.3 12.8 11.0 16.3 13.4 11.4 17.0 8.7 22.0 21.4 8.1 15.2 20.5 10.6 15.4 12.7 9.4 15.5 7.9 15.2 8.6 14.1 10.1 15.7 25.5 38.2 9.3 8.8 9.9 18.3 16.4 31.5 11.9 22.8 15.0 19.6 8.9 17.3 39.9 11.0 16.3 43.3 9.1 7.3 22.1 13.7 42.5 14.1 18.8 27.3 18.3 27.0 10.8 4.4 7.2 4.2 10.5 11.9 15.1 17.0 16.0 15.8 11.1 12.4 19.3 19.1 1.3 13.1 8.8 10.4 15.8 6.1 17.4 29.3 14.0 29.4 20.8 13.6 16.7 19.1 20.3 15.7 74.5 77.0 155.5 140.9 83.6 31.6 79.5 137.6 66.9 104.6 59.3 13.7 119.1 127.6 113.6 331.3 86.4 114.1 116.8 204.5 170.1 84.0 110.5 116.6 184.7 121.5 47.7 134.0 113.5 170.4 102.0 257.7 109.4 79.2 149.7 219.3 47.0 172.0 119.3 161.2 158.4 31.4 135.8 91.0 120.5 95.0 75.2 113.3 107.1 207.0 165.4 NSD1 "ARA267, FLJ22263, KMT3B, STO" ENSG00000165671 "Nuclear receptor binding SET domain protein 1" Q96L73 5 177133025-177300215 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Methyltransferase, Repressor, Transferase" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 141.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048431, HPA070333, HPA073705" Supported Supported "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA048431: AB_2680388, HPA070333: AB_2686255, HPA073705: AB_2732239" "unprognostic (3.48e-2)" "unprognostic (7.46e-2)" "unprognostic (7.14e-3)" "unprognostic (2.64e-3)" "unprognostic (1.38e-1)" "unprognostic (9.67e-2)" "unprognostic (2.29e-2)" "unprognostic (7.08e-2)" "unprognostic (1.68e-3)" "unprognostic (8.04e-2)" "unprognostic (1.48e-1)" "unprognostic (2.09e-1)" "unprognostic (7.77e-3)" "unprognostic (3.53e-2)" "unprognostic (1.01e-1)" "unprognostic (7.51e-2)" "unprognostic (7.32e-2)" 11.8 13.2 11.9 25.4 15.7 23.9 14.0 28.9 16.7 15.6 14.2 18.5 17.0 10.6 19.0 13.9 17.8 13.6 15.8 11.7 12.8 11.5 14.4 10.5 12.3 19.4 12.9 11.7 16.6 27.1 24.6 19.3 16.0 13.4 14.2 14.3 13.8 13.5 18.7 20.6 16.1 14.5 15.6 13.2 16.1 13.1 28.1 16.1 27.3 20.1 10.6 22.7 13.4 20.2 10.2 8.9 18.7 10.8 10.9 7.8 2.9 9.9 12.8 13.3 11.5 6.6 8.5 0.4 9.0 9.0 12.7 11.8 2.8 8.3 20.5 10.2 12.4 11.7 8.5 21.2 20.0 15.4 34.7 12.8 9.1 14.5 0.1 10.9 19.6 10.8 8.0 12.1 15.0 14.1 9.0 18.4 13.0 12.4 7.2 12.7 20.8 13.6 6.3 14.5 6.7 11.3 15.1 1.7 6.3 8.2 12.1 16.3 11.2 23.4 10.2 7.0 12.9 10.2 16.3 13.5 8.8 12.9 5.6 11.1 8.5 7.4 14.7 5.1 9.6 9.4 10.7 9.1 9.4 7.5 6.1 6.3 8.5 6.3 5.0 6.7 10.2 7.8 6.3 18.7 10.9 10.8 8.9 5.7 2.9 11.9 15.7 28.9 16.7 12.8 11.5 12.9 11.7 13.4 16.1 20.8 26.1 42.4 26.2 15.0 91.7 37.5 33.1 13.4 36.4 52.4 141.4 34.8 14.9 22.8 25.5 31.5 21.9 0.0 18.5 20.4 23.3 24.0 39.4 16.3 24.2 84.2 40.3 31.3 29.2 33.9 47.2 39.1 15.1 50.5 19.4 35.7 20.1 24.6 31.1 13.9 100.0 51.8 19.6 63.2 47.7 18.1 29.6 51.1 21.5 23.5 NSD2 "KMT3G, MMSET, WHSC1" ENSG00000109685 "Nuclear receptor binding SET domain protein 2" O96028 4 1871424-1982207 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 17.3;Ciliated cells: 13.4;Club cells: 14.8;Collecting duct cells: 12.2;Hofbauer cells: 11.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015801, CAB068246, CAB068247" Enhanced Supported Nucleoplasm No No Nucleoplasm "CAB068246: AB_2665690, CAB068247: AB_2665689, HPA015801: AB_1858830" "unprognostic (3.70e-1)" "unprognostic (9.80e-2)" "unprognostic (3.33e-2)" "unprognostic (1.77e-1)" "unprognostic (4.01e-1)" "unprognostic (1.31e-2)" "prognostic unfavorable (2.61e-4)" "unprognostic (3.24e-2)" "unprognostic (6.22e-2)" "unprognostic (7.66e-2)" "unprognostic (2.09e-1)" "unprognostic (9.25e-3)" "prognostic unfavorable (7.19e-4)" "unprognostic (3.89e-2)" "unprognostic (2.95e-1)" "unprognostic (1.31e-1)" "unprognostic (6.15e-2)" 8.7 7.6 17.6 11.5 16.2 35.1 8.5 20.6 18.2 7.0 14.8 12.4 6.3 14.0 9.5 7.4 12.7 6.8 6.9 11.9 15.1 10.9 8.4 7.5 11.1 18.8 14.7 16.1 7.0 11.7 10.7 11.8 9.8 14.6 8.7 17.7 9.4 10.2 7.4 11.8 12.1 14.6 10.5 15.3 13.5 11.0 26.3 13.4 46.7 13.8 5.5 17.7 8.6 9.4 4.9 3.9 4.1 1.8 2.7 4.3 0.6 27.7 14.0 42.3 18.5 4.6 6.8 12.3 22.4 19.9 27.5 30.8 12.4 33.0 29.9 7.7 18.5 36.0 12.1 27.3 18.5 47.3 14.3 11.3 35.6 19.4 7.3 5.8 21.8 18.7 2.6 4.7 24.1 23.2 15.2 21.6 30.2 19.3 31.4 22.5 10.9 58.1 22.9 17.8 14.1 16.2 33.2 27.6 10.3 11.3 13.2 26.3 21.0 18.4 6.9 8.4 19.2 16.3 14.6 16.7 27.5 20.5 17.4 45.1 14.7 15.5 27.1 16.5 21.6 25.5 2.1 1.7 1.7 2.9 1.8 3.2 1.8 3.2 3.2 1.5 4.9 2.8 2.3 4.1 2.7 1.4 3.9 4.3 0.6 17.6 16.2 20.6 18.2 15.1 10.9 14.7 16.1 14.6 13.4 11.9 17.3 0.0 0.0 0.0 0.0 0.0 0.0 13.4 14.8 12.2 0.0 10.0 3.3 10.2 0.0 0.0 0.0 0.0 6.1 7.3 0.0 0.0 2.3 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 10.0 0.0 0.0 10.2 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 NSD3 "FLJ20353, KMT3F, WHISTLE, WHSC1L1" ENSG00000147548 "Nuclear receptor binding SET domain protein 3" Q9BZ95 8 38269697-38382272 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 85.7;Extravillous trophoblasts: 142.9;monocytes: 86.6;Syncytiotrophoblasts: 109.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005659, CAB013721, HPA018893" Uncertain Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB013721: , HPA005659: AB_1080596, HPA018893: AB_1858833" "unprognostic (6.21e-2)" "unprognostic (3.73e-2)" "unprognostic (2.18e-2)" "unprognostic (4.12e-1)" "unprognostic (2.25e-1)" "unprognostic (1.53e-2)" "unprognostic (4.35e-2)" "unprognostic (1.97e-2)" "unprognostic (2.49e-1)" "unprognostic (5.72e-2)" "prognostic unfavorable (7.48e-4)" "unprognostic (5.06e-2)" "unprognostic (5.60e-3)" "unprognostic (6.69e-2)" "unprognostic (4.04e-1)" "unprognostic (1.05e-2)" "unprognostic (1.60e-2)" 19.2 11.3 31.1 15.8 31.4 36.3 20.1 51.5 37.7 18.5 15.5 16.7 14.0 16.2 16.0 12.5 17.0 16.8 17.0 12.7 24.4 16.6 14.2 11.2 17.9 22.3 25.0 26.8 26.5 16.3 21.0 24.2 22.5 21.9 16.4 18.7 12.3 18.3 17.9 12.3 16.2 17.7 16.0 15.3 17.2 19.7 9.3 25.6 16.7 19.2 6.9 20.4 19.6 23.3 26.7 5.6 26.2 5.1 8.6 18.0 2.9 24.1 13.9 23.9 16.1 16.8 19.3 17.7 20.3 22.4 17.6 20.5 7.4 13.4 28.8 18.7 13.8 17.1 14.6 18.9 16.2 25.2 11.4 11.1 36.7 11.2 8.6 17.2 16.1 13.3 10.3 16.5 15.9 32.4 16.5 20.1 31.9 26.0 19.2 16.7 8.7 47.1 13.7 16.2 18.8 6.6 21.6 26.1 9.1 12.5 18.7 13.5 18.2 16.5 14.5 14.1 16.0 18.2 12.3 19.2 18.3 19.0 27.2 11.9 17.1 20.4 27.8 15.5 16.3 13.2 13.9 5.1 9.1 8.0 2.4 5.3 16.5 12.0 7.1 4.1 26.7 15.0 6.3 26.2 8.6 1.5 5.6 18.0 2.9 31.1 31.4 51.5 37.7 24.4 16.6 25.0 26.8 21.9 25.6 62.5 52.3 0.0 0.0 0.0 0.0 0.0 0.0 62.9 55.7 48.8 0.0 85.7 19.9 60.6 0.0 0.0 0.0 0.0 53.3 142.9 0.0 0.0 8.1 0.0 39.1 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 86.6 0.0 0.0 50.3 0.0 0.0 28.5 0.0 0.0 0.0 0.0 0.0 0.0 109.4 0.0 0.0 0.0 NSFL1C "dJ776F14.1, p47, UBX1, UBXD10, UBXN2C" ENSG00000088833 "NSFL1 cofactor" Q9UNZ2 20 1442162-1473842 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047108, HPA050628" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" No No 920000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA047108: AB_2679935, HPA050628: AB_2681194" "unprognostic (7.55e-2)" "unprognostic (5.26e-2)" "unprognostic (2.51e-2)" "unprognostic (2.47e-1)" "unprognostic (5.96e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.10e-2)" "unprognostic (1.59e-1)" "unprognostic (4.67e-2)" "unprognostic (2.58e-1)" "unprognostic (4.97e-2)" "unprognostic (6.90e-2)" "unprognostic (5.46e-2)" "unprognostic (1.54e-1)" "unprognostic (7.44e-2)" "unprognostic (7.50e-3)" 15.7 22.7 20.2 10.2 23.5 15.8 15.3 18.2 26.5 16.6 14.7 17.1 9.3 11.1 17.4 21.2 19.8 19.9 12.2 21.9 16.7 18.2 14.8 19.8 12.7 9.6 17.1 22.4 22.7 10.8 12.4 9.9 21.5 24.2 16.8 13.9 20.1 13.6 21.8 49.7 25.6 12.4 18.9 15.8 12.2 12.6 11.1 15.3 12.8 13.1 14.8 12.4 15.9 13.7 14.5 12.0 32.4 10.9 5.9 11.0 9.4 21.3 24.8 15.9 15.1 14.4 13.4 11.8 10.0 18.0 24.5 18.2 20.9 17.4 11.9 8.1 18.1 23.3 20.3 9.7 26.2 18.9 4.4 10.6 12.0 4.4 24.0 15.2 11.6 7.3 11.4 9.6 25.5 8.5 14.2 17.4 8.6 15.5 10.7 17.1 10.2 12.1 22.2 17.1 16.5 27.5 5.8 19.8 11.6 28.5 15.0 9.2 11.3 12.1 24.1 10.9 9.7 14.7 8.0 16.1 19.0 14.0 11.0 16.3 8.6 15.3 9.9 14.1 16.3 13.4 10.7 8.9 32.4 8.5 10.6 8.5 13.9 9.2 8.3 12.0 14.5 10.5 9.2 29.1 5.9 10.9 9.5 11.0 9.4 20.2 23.5 18.2 26.5 16.7 18.2 17.1 22.4 24.2 15.3 20.8 21.0 25.3 52.2 79.2 58.7 30.5 20.4 25.4 30.7 29.6 21.6 128.5 48.0 77.9 14.8 36.0 52.0 0.0 82.5 121.5 43.5 44.6 39.3 35.8 71.3 66.7 41.9 25.2 37.6 26.4 36.2 39.7 40.5 47.7 29.3 44.2 95.4 52.6 43.5 54.7 37.5 77.6 53.6 80.7 105.4 66.1 126.8 34.5 37.5 81.7 NSMCE1 NSE1 ENSG00000169189 "NSE1 homolog, SMC5-SMC6 complex component" Q8WV22 16 27224991-27268794 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "granulocytes: 274.2;Late spermatids: 281.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041567, HPA043091" Supported Supported Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA041567: AB_10964260, HPA043091: AB_10962722" "unprognostic (6.27e-2)" "unprognostic (8.17e-2)" "unprognostic (2.52e-2)" "unprognostic (2.48e-3)" "unprognostic (4.17e-1)" "unprognostic (4.52e-3)" "unprognostic (1.59e-1)" "unprognostic (1.06e-1)" "unprognostic (1.79e-1)" "unprognostic (1.22e-1)" "unprognostic (1.93e-1)" "unprognostic (9.91e-2)" "unprognostic (1.40e-1)" "unprognostic (5.45e-3)" "unprognostic (3.58e-1)" "unprognostic (1.46e-1)" "unprognostic (1.29e-1)" 24.0 37.3 26.7 33.3 27.4 16.9 30.1 16.9 27.2 22.2 24.7 31.4 30.8 14.1 23.1 32.5 34.7 36.0 36.7 21.7 24.3 26.3 30.9 37.4 27.1 36.7 31.9 20.9 29.5 45.3 46.7 20.5 21.4 27.1 33.8 21.2 26.0 37.2 31.5 22.5 19.5 23.8 35.4 32.4 20.9 26.2 55.4 19.3 41.5 33.9 25.7 29.3 27.6 20.4 42.0 38.9 31.8 27.7 60.4 41.6 32.6 14.6 21.0 14.4 15.7 23.5 31.6 11.6 15.7 16.0 11.9 12.5 16.3 35.8 28.8 37.7 23.8 12.3 15.8 27.0 47.0 15.5 35.3 18.8 13.3 19.6 31.2 41.0 15.5 10.1 30.9 32.8 30.0 57.4 34.7 16.0 27.6 17.8 9.1 22.0 24.7 20.2 17.2 12.7 24.3 14.5 17.8 17.8 45.1 34.5 9.5 15.3 13.9 10.7 14.9 26.8 18.5 24.6 18.6 9.9 14.5 9.1 16.5 15.0 27.4 19.7 22.2 31.2 15.4 6.2 31.8 27.7 25.0 25.2 24.3 27.8 24.1 36.0 30.6 38.9 42.0 41.6 32.6 9.0 60.4 22.5 37.7 32.8 32.6 26.7 27.4 16.9 27.2 24.3 26.3 31.9 20.9 27.1 19.3 32.8 38.0 33.8 48.8 25.1 13.2 37.8 66.2 91.0 30.7 41.8 2.0 102.9 109.5 65.4 163.4 30.6 55.1 0.0 63.9 52.2 45.2 45.6 274.2 58.2 73.6 12.7 56.4 52.2 49.4 281.7 22.5 40.9 43.9 118.2 57.5 55.3 42.9 45.9 37.4 129.3 13.5 25.8 50.1 91.7 45.8 28.5 53.8 64.8 42.6 44.4 NSMCE2 "C8orf36, FLJ32440, MMS21, NSE2, ZMIZ7" ENSG00000156831 "NSE2/MMS21 homolog, SMC5-SMC6 complex SUMO ligase" Q96MF7 8 125091679-125367120 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis, Ubl conjugation pathway" Transferase "Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051614, HPA065734" Supported Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA051614: AB_2681551, HPA065734: AB_2685549" "unprognostic (1.14e-3)" "unprognostic (1.29e-1)" "unprognostic (6.56e-2)" "unprognostic (1.22e-3)" "unprognostic (8.65e-2)" "unprognostic (8.89e-3)" "prognostic unfavorable (7.54e-4)" "unprognostic (3.99e-2)" "unprognostic (2.48e-1)" "unprognostic (1.00e-1)" "unprognostic (1.53e-2)" "unprognostic (1.33e-1)" "unprognostic (3.09e-2)" "unprognostic (1.17e-1)" "unprognostic (7.53e-2)" "unprognostic (2.61e-2)" "unprognostic (6.85e-2)" 22.4 22.3 17.6 16.4 20.2 26.2 23.8 21.0 22.6 18.2 19.9 17.1 17.6 12.3 28.3 19.5 18.6 14.3 16.5 22.9 13.7 12.7 18.5 17.2 16.3 19.4 20.2 17.3 21.3 14.9 11.2 32.0 19.1 16.1 15.0 17.8 16.7 19.3 17.4 36.5 18.1 13.4 21.9 18.3 16.6 18.9 19.1 20.6 18.5 18.2 16.8 24.9 18.8 21.2 12.6 12.6 35.3 12.6 11.1 18.8 12.5 16.4 14.2 17.0 10.7 13.5 20.4 8.3 13.3 24.9 23.5 27.4 9.1 15.8 20.7 15.6 12.5 17.4 12.3 13.2 11.1 24.0 23.1 12.9 29.2 8.6 13.1 19.5 8.7 8.9 15.0 15.6 13.6 17.3 15.8 21.2 10.9 16.8 13.7 20.5 28.4 22.3 8.0 3.7 18.7 19.2 12.5 11.9 18.7 14.1 12.6 11.3 12.0 15.8 47.7 22.0 10.5 20.3 10.0 13.1 9.1 25.8 11.2 18.7 18.2 32.5 26.0 14.1 16.9 14.0 5.1 12.6 35.3 12.2 10.9 13.5 12.6 13.0 13.7 12.6 11.5 13.4 14.6 6.1 11.1 10.9 7.4 18.8 12.5 17.6 20.2 21.0 22.6 13.7 12.7 20.2 17.3 16.1 20.6 8.9 9.6 21.4 31.5 21.2 22.5 16.2 15.3 16.0 19.4 10.4 15.7 29.3 23.2 27.2 17.8 22.4 15.4 23.3 37.1 23.3 22.2 22.9 25.3 11.9 38.2 14.3 13.2 22.7 25.4 6.2 21.6 21.5 16.9 32.5 15.5 15.4 28.8 18.7 23.0 26.4 26.1 6.5 25.8 40.0 28.4 16.6 39.0 30.5 19.0 29.9 NSMCE4A "bA500G22.3, C10orf86, FLJ20003, NSE4A" ENSG00000107672 "NSE4 homolog A, SMC5-SMC6 complex component" Q9NXX6 10 121957088-121975217 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037459, HPA038412, HPA044872" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA037459: AB_10696932, HPA038412: AB_2676005, HPA044872: AB_2679124" "unprognostic (1.16e-3)" "unprognostic (2.86e-2)" "unprognostic (1.56e-1)" "unprognostic (3.73e-2)" "unprognostic (4.09e-3)" "unprognostic (2.18e-2)" "unprognostic (1.64e-1)" "prognostic favorable (2.72e-5)" "unprognostic (3.16e-2)" "unprognostic (7.47e-2)" "unprognostic (1.08e-1)" "unprognostic (6.44e-3)" "prognostic unfavorable (2.45e-4)" "unprognostic (1.64e-1)" "unprognostic (8.13e-2)" "unprognostic (1.35e-1)" "unprognostic (7.01e-3)" 21.8 17.7 11.1 27.1 17.6 16.2 26.0 14.0 12.5 23.7 26.6 14.0 14.3 22.8 20.8 17.1 22.3 18.0 16.7 17.8 11.0 8.2 15.4 23.0 22.3 22.2 18.5 12.6 20.0 24.3 13.3 10.5 15.5 12.2 21.1 20.3 15.2 24.5 23.0 15.9 14.6 26.1 26.9 12.2 20.0 23.7 6.5 16.8 23.3 21.8 15.8 20.6 26.7 16.8 24.0 24.9 8.8 17.6 18.7 22.4 17.2 16.8 20.8 22.3 19.9 7.9 10.4 16.5 9.5 17.1 16.4 22.9 16.0 13.2 22.5 7.4 7.5 9.0 14.7 13.1 10.4 13.0 27.0 30.9 14.8 7.1 29.9 6.7 16.6 10.4 7.0 8.0 9.6 15.7 9.2 17.3 20.7 13.5 16.3 9.1 13.7 30.2 24.5 11.7 12.1 16.4 26.1 17.4 24.2 11.2 14.1 6.1 12.0 10.8 7.4 14.7 9.4 8.1 15.9 14.0 6.5 11.7 10.9 19.6 21.8 23.1 34.7 8.1 22.7 6.9 0.1 15.4 8.8 15.3 17.6 17.7 24.0 20.6 19.8 15.9 21.7 21.8 17.7 1.4 18.7 17.1 24.9 22.4 17.2 11.1 17.6 14.0 12.5 11.0 8.2 18.5 12.6 12.2 16.8 20.8 27.8 29.6 39.9 15.0 20.2 17.1 25.5 17.4 20.5 12.2 31.4 41.8 29.9 24.3 0.3 29.5 27.6 46.7 53.2 31.1 22.0 38.1 11.5 31.4 31.1 25.4 20.7 17.2 18.3 0.4 32.8 19.0 20.3 55.1 31.7 29.1 29.2 37.6 31.5 30.2 36.0 25.8 24.5 6.1 11.7 18.9 55.4 25.8 40.3 43.9 NSMF NELF ENSG00000165802 "NMDA receptor synaptonuclear signaling and neuronal migration factor" Q6X4W1 9 137447573-137459334 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "brain: 96.4" "Cell type enhanced" "Detected in many" 6 "Peritubular cells: 67.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 12.1;non-classical monocyte: 10.5" "Group enriched" "Detected in many" 5 "dendritic cells: 6.0;granulocytes: 3.1;monocytes: 12.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044316 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA044316: AB_10964877" "unprognostic (1.48e-1)" "unprognostic (4.03e-2)" "unprognostic (5.40e-2)" "unprognostic (3.92e-2)" "unprognostic (8.54e-2)" "unprognostic (1.05e-1)" "unprognostic (1.52e-1)" "unprognostic (2.35e-1)" "unprognostic (7.96e-2)" "unprognostic (3.26e-2)" "unprognostic (2.38e-3)" "unprognostic (2.34e-3)" "prognostic favorable (1.85e-6)" "unprognostic (1.97e-2)" "unprognostic (4.14e-2)" "unprognostic (4.61e-2)" "unprognostic (3.97e-2)" 8.8 8.8 61.7 6.9 34.4 6.1 5.3 6.4 67.3 6.0 8.1 18.2 2.1 16.9 8.6 6.6 6.6 7.2 5.7 5.0 96.4 21.8 15.3 6.2 5.2 6.9 20.4 30.2 5.0 14.7 10.8 13.7 4.2 12.1 9.0 6.3 5.4 11.5 8.7 4.0 9.7 13.7 8.2 9.6 6.8 9.6 7.8 15.0 2.4 5.1 1.3 5.8 6.4 3.8 0.2 6.0 3.1 12.1 0.0 1.5 1.4 7.7 6.3 11.1 16.6 26.2 12.4 9.6 7.5 9.9 7.1 5.5 16.7 4.6 9.6 10.1 11.0 16.0 23.6 16.4 10.0 4.3 12.6 17.6 7.5 14.8 22.1 14.2 5.1 17.2 14.1 19.2 8.3 19.5 16.2 7.5 0.2 17.2 1.6 9.6 17.9 0.2 22.1 14.2 31.2 16.9 4.6 17.7 21.5 4.9 3.9 46.9 38.2 17.9 10.0 11.2 4.8 7.1 10.6 19.0 12.7 10.4 30.7 12.6 3.4 5.2 14.7 7.2 6.8 11.6 1.5 2.0 3.1 1.5 12.1 0.2 0.2 0.5 0.9 6.0 0.1 0.6 0.7 0.3 0.0 10.5 0.2 0.7 1.4 61.7 34.4 6.4 62.9 96.4 21.8 20.4 30.2 12.1 15.0 0.0 4.6 5.1 6.4 12.0 7.2 4.4 15.3 1.4 0.0 10.4 7.9 0.3 5.0 7.8 6.1 9.9 41.2 0.0 18.2 1.0 8.2 16.2 2.3 18.3 5.6 27.0 18.4 11.6 8.9 11.4 22.2 5.9 15.1 4.6 15.7 10.4 18.9 17.5 67.1 26.7 13.1 12.9 13.0 2.5 5.3 12.8 1.3 5.7 11.5 13.9 NSRP1 "CCDC55, DKFZP434K1421, NSrp70" ENSG00000126653 "Nuclear speckle splicing regulatory protein 1" Q9H0G5 17 30115521-30186475 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015593, HPA015603" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA015593: AB_2072217, HPA015603: AB_1846157" "unprognostic (3.96e-1)" "unprognostic (2.16e-2)" "unprognostic (5.45e-2)" "unprognostic (1.69e-1)" "unprognostic (1.34e-1)" "unprognostic (1.89e-1)" "unprognostic (7.76e-2)" "unprognostic (1.83e-1)" "unprognostic (5.93e-3)" "unprognostic (6.12e-2)" "unprognostic (2.21e-1)" "unprognostic (3.08e-2)" "unprognostic (1.31e-3)" "unprognostic (2.02e-1)" "unprognostic (1.98e-1)" "unprognostic (1.34e-1)" "unprognostic (2.43e-1)" 25.7 21.2 26.4 25.7 36.7 25.7 23.5 28.8 28.2 22.2 25.0 24.3 28.1 18.1 25.1 25.5 21.8 21.3 21.9 26.6 25.7 23.2 23.0 21.3 20.4 22.0 33.9 20.5 26.0 28.3 31.9 37.4 23.6 28.9 23.2 20.2 16.2 22.6 23.4 43.5 27.9 19.6 34.7 52.1 21.7 21.2 21.2 36.0 18.6 28.4 19.2 20.5 34.3 27.2 28.9 31.4 31.0 21.2 16.1 19.4 7.3 13.9 12.5 12.2 9.9 17.1 16.4 8.8 19.3 19.9 14.9 16.2 13.2 9.1 25.4 15.7 18.4 18.3 20.6 19.2 14.9 24.5 6.2 26.3 11.6 19.6 9.4 27.4 17.9 14.2 18.6 20.0 23.7 31.0 17.6 14.1 9.6 18.3 17.1 20.7 10.4 11.9 17.8 8.2 15.5 10.4 14.0 20.1 17.2 15.5 15.1 11.7 10.2 14.6 39.7 17.4 13.2 20.8 20.4 15.1 18.0 12.7 18.8 30.5 12.2 16.3 20.7 22.2 16.4 20.5 25.8 21.2 16.1 17.2 19.0 19.1 28.2 19.4 16.8 10.6 28.9 19.1 17.2 31.0 16.1 20.1 31.4 16.9 7.3 26.4 36.7 28.8 28.2 25.7 23.2 33.9 20.5 28.9 36.0 71.5 85.0 35.0 70.6 60.0 57.9 124.7 79.0 97.7 79.6 80.3 33.4 52.8 82.9 60.8 192.3 96.7 47.9 116.8 65.5 55.1 58.2 56.2 78.8 122.8 48.3 69.9 30.1 86.5 53.4 93.6 71.4 64.6 47.2 68.5 45.6 77.5 57.2 49.1 67.1 60.4 53.0 71.1 86.5 132.5 80.5 45.5 92.7 37.4 46.3 48.7 NSUN2 "FLJ20303, Misu, MRT5, TRM4" ENSG00000037474 "NOP2/Sun RNA methyltransferase family member 2" Q08J23 5 6599239-6633291 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis, tRNA processing" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037896 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA037896: AB_10670532" "unprognostic (3.99e-2)" "unprognostic (5.73e-2)" "unprognostic (1.44e-1)" "unprognostic (7.66e-3)" "unprognostic (8.56e-2)" "unprognostic (5.21e-2)" "unprognostic (1.44e-3)" "unprognostic (5.12e-2)" "unprognostic (4.48e-2)" "unprognostic (1.41e-1)" "unprognostic (1.84e-1)" "unprognostic (2.48e-2)" "prognostic unfavorable (5.69e-5)" "unprognostic (1.98e-1)" "unprognostic (1.47e-1)" "unprognostic (4.30e-3)" "unprognostic (1.70e-2)" 19.0 19.1 11.3 20.4 17.4 16.7 28.1 13.4 16.0 17.4 17.9 20.2 18.2 15.4 21.5 20.6 27.0 19.3 17.1 20.1 12.7 9.7 15.0 34.9 15.0 22.5 13.6 16.5 17.2 18.7 19.5 22.3 18.2 16.1 15.5 21.2 14.3 20.0 15.8 42.3 22.9 20.9 19.1 15.9 23.7 19.9 15.8 13.2 26.7 14.3 17.1 29.5 19.2 17.1 18.1 16.7 15.6 17.3 17.6 22.7 12.7 27.2 23.7 13.9 12.3 8.9 9.9 32.9 21.4 13.0 22.8 19.8 30.8 20.5 47.1 21.9 17.1 28.7 21.0 28.8 24.9 31.0 32.1 23.3 28.0 56.2 17.9 12.8 48.3 22.7 11.3 18.4 25.8 22.6 9.2 16.1 19.8 36.1 17.3 21.1 19.1 26.4 20.9 23.1 18.4 31.0 34.4 14.6 14.5 16.0 30.3 13.3 18.9 52.8 26.8 20.6 18.8 23.4 21.6 18.8 18.2 24.0 18.8 31.8 14.3 26.8 45.2 14.6 38.5 20.9 9.7 14.6 15.6 17.5 17.3 22.7 18.1 18.4 20.7 16.7 16.5 20.4 20.6 2.9 17.6 15.2 16.5 13.0 12.7 11.3 17.4 13.4 16.0 12.7 9.7 13.6 16.5 16.1 13.2 17.9 14.5 12.9 11.7 33.5 5.3 16.1 17.8 17.4 39.8 17.4 13.7 17.1 8.3 18.8 2.2 12.1 10.5 0.0 13.1 17.7 12.1 13.9 19.7 28.4 12.9 3.2 14.3 9.8 22.4 2.2 12.0 14.6 15.1 19.0 15.5 6.8 19.7 14.1 13.4 8.4 6.8 6.5 13.0 13.5 18.7 26.7 19.3 14.1 17.8 12.8 NSUN5 "FLJ10267, NOL1R, NSUN5A, p120(NOL1), WBSCR20, WBSCR20A, Ynl022cL" ENSG00000130305 "NOP2/Sun RNA methyltransferase family member 5" Q96P11 7 73302517-73308867 "Disease related genes, Predicted intracellular proteins" "rRNA processing" "Methyltransferase, RNA-binding, Transferase" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020536, HPA045590, HPA046867" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA020536: AB_1858789, HPA045590: AB_2679376, HPA046867: AB_2679847" "unprognostic (3.94e-1)" "unprognostic (1.12e-1)" "unprognostic (3.79e-2)" "unprognostic (1.01e-3)" "prognostic unfavorable (2.48e-4)" "unprognostic (1.92e-1)" "prognostic unfavorable (3.96e-4)" "unprognostic (3.54e-1)" "unprognostic (2.46e-1)" "unprognostic (2.72e-1)" "unprognostic (2.26e-1)" "unprognostic (1.14e-1)" "unprognostic (1.58e-2)" "unprognostic (3.21e-2)" "unprognostic (1.68e-1)" "unprognostic (1.39e-1)" "unprognostic (1.85e-2)" 9.0 7.7 11.2 13.1 12.8 40.9 8.7 12.9 14.4 8.5 10.3 15.0 4.8 12.6 12.3 6.9 10.8 12.0 8.1 9.4 10.8 9.3 9.4 9.8 8.0 16.1 19.4 11.9 10.6 19.6 9.5 8.3 8.3 13.6 9.7 6.2 7.7 13.6 9.7 27.1 11.8 12.1 10.9 11.6 15.8 9.6 14.6 13.6 23.5 10.6 11.2 12.1 10.6 8.9 33.5 21.2 18.7 14.4 16.8 22.3 15.3 12.2 17.0 4.8 10.5 2.0 2.5 18.2 5.9 3.4 9.1 9.8 22.9 9.1 20.2 4.0 2.9 13.4 10.6 9.0 5.9 3.0 13.3 20.9 7.6 12.4 13.1 7.8 16.8 10.4 3.4 9.9 7.8 6.6 2.1 1.2 15.2 24.9 4.8 4.3 29.5 14.2 34.6 19.3 9.0 13.1 17.4 3.6 28.9 3.9 6.1 12.4 20.7 10.3 27.6 13.3 5.4 17.7 13.4 1.9 0.1 13.3 13.2 3.9 19.3 24.9 28.8 0.2 23.6 0.9 14.2 14.4 15.0 14.0 12.5 11.0 21.5 15.9 14.3 16.5 33.5 22.3 18.8 18.7 16.8 9.3 21.2 17.3 15.3 11.2 12.8 12.9 14.4 10.8 9.3 19.4 11.9 13.6 13.6 6.0 6.1 51.6 17.1 15.0 25.1 17.1 25.5 10.7 12.5 34.9 11.8 33.4 31.5 36.0 12.8 7.3 18.6 0.0 28.6 37.8 16.9 12.9 26.5 20.3 30.9 30.2 3.5 6.7 17.4 16.3 27.0 19.4 20.3 46.9 16.4 13.8 24.0 17.5 19.4 19.5 21.4 6.5 14.1 60.6 58.5 18.6 18.2 25.4 19.9 15.5 NT5E "CALJA, CD73, eN, eNT, NT5" ENSG00000135318 "5'-nucleotidase ecto" P21589 6 85449584-85495791 "CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Ito cells: 45.4;Pancreatic endocrine cells: 72.9;Rod photoreceptor cells: 77.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 13.4;memory CD8 T-cell: 6.6;naive B-cell: 19.9;naive CD8 T-cell: 17.3" "Group enriched" "Detected in many" 47 "B-cells: 19.9;T-cells: 17.3" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 93.4;LHCN-M2: 105.7;TIME: 61.2;U-87 MG: 95.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA017357 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 1600000 "Plasma membrane" "Nucleoplasm, Cytosol" "HPA017357: AB_1846330" "unprognostic (1.92e-2)" "unprognostic (4.44e-3)" "unprognostic (1.54e-1)" "unprognostic (1.57e-3)" "unprognostic (9.33e-2)" "unprognostic (1.82e-3)" "unprognostic (1.20e-2)" "prognostic unfavorable (6.66e-4)" "unprognostic (5.45e-2)" "unprognostic (1.80e-1)" "prognostic unfavorable (1.32e-5)" "unprognostic (1.39e-1)" "unprognostic (3.11e-2)" "prognostic unfavorable (1.02e-4)" "unprognostic (3.49e-2)" "unprognostic (2.26e-1)" "unprognostic (2.78e-1)" 12.2 3.2 9.3 7.7 11.6 0.5 16.6 1.1 6.9 58.8 13.9 3.6 8.1 18.6 33.3 14.8 7.6 12.2 15.4 6.1 5.7 5.5 8.8 26.0 3.4 6.8 6.3 6.6 25.4 1.4 1.6 9.3 42.2 5.3 16.4 15.6 15.3 4.6 17.8 5.7 4.5 14.9 35.3 6.3 7.0 6.0 12.4 4.2 1.6 26.5 7.3 7.1 16.6 20.2 19.9 0.0 0.2 0.0 0.4 17.3 3.9 5.3 2.8 4.9 0.1 11.2 35.7 0.0 34.5 37.8 17.0 32.0 0.0 53.0 0.0 12.4 30.1 43.8 2.7 0.0 34.7 40.6 0.0 0.0 0.0 0.8 0.6 5.6 0.0 0.0 9.1 0.4 34.7 22.1 93.4 14.1 0.0 0.0 0.1 105.7 0.9 0.0 0.0 0.1 0.9 3.8 0.1 1.1 0.1 36.8 2.4 0.0 0.6 0.4 2.1 11.7 0.2 0.0 0.9 61.2 13.9 0.1 17.5 56.1 2.6 1.6 0.0 95.4 0.0 43.5 0.0 0.0 0.2 2.0 0.0 3.5 13.4 2.3 6.6 0.0 19.9 2.4 17.3 0.2 0.4 0.0 0.0 0.8 3.9 9.3 11.6 1.1 6.9 5.7 5.5 6.3 6.6 5.3 4.2 0.0 4.3 15.6 1.0 4.6 4.6 0.8 20.4 6.7 6.8 1.8 9.8 0.4 3.3 3.7 0.5 13.5 10.3 0.0 3.7 1.5 16.9 0.9 0.0 29.0 1.3 0.0 0.0 45.4 5.3 0.9 12.0 2.5 6.8 0.0 33.2 5.6 72.9 31.7 24.1 20.6 77.4 0.0 8.0 0.0 0.2 4.3 12.7 2.2 13.8 5.9 NTAN1 ENSG00000157045 "N-terminal asparagine amidase" Q96AB6 16 15037853-15056079 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 31.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051418 Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA051418: " "unprognostic (2.21e-2)" "unprognostic (2.31e-1)" "unprognostic (1.80e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (6.69e-4)" "unprognostic (1.87e-2)" "unprognostic (9.16e-2)" "unprognostic (8.11e-3)" "unprognostic (2.79e-1)" "unprognostic (1.75e-1)" "unprognostic (5.05e-2)" "unprognostic (1.65e-1)" "unprognostic (9.30e-3)" "prognostic unfavorable (9.07e-4)" "unprognostic (4.35e-1)" "unprognostic (2.12e-2)" "unprognostic (1.10e-1)" 24.2 8.3 11.7 8.1 11.7 11.9 48.2 5.2 12.1 16.1 18.0 5.4 8.6 6.8 14.4 24.5 14.6 10.2 12.2 23.2 8.0 6.0 10.6 16.9 13.5 12.4 7.4 8.0 13.0 13.3 7.6 5.0 7.8 9.8 15.9 15.7 17.9 11.1 7.7 14.4 13.6 9.7 19.8 7.4 13.7 12.9 14.0 6.4 8.1 10.5 12.7 11.7 18.8 19.9 9.4 12.0 31.2 5.7 5.3 12.3 5.2 10.0 7.3 8.8 7.6 11.3 21.8 3.3 12.2 16.6 12.5 21.6 3.4 7.5 6.9 9.7 23.2 9.8 4.2 7.0 14.3 17.5 6.6 9.7 4.0 6.6 18.8 11.6 2.9 2.2 11.3 8.5 12.0 4.6 7.9 28.3 10.3 4.7 7.9 23.2 8.4 5.9 12.3 6.4 11.7 8.2 11.8 12.0 9.3 9.0 13.9 2.7 10.0 5.0 1.8 8.6 17.9 3.3 4.5 15.9 18.1 7.2 7.6 10.7 7.7 15.3 9.1 10.9 6.5 8.2 2.5 4.1 31.2 5.5 5.7 6.5 9.4 7.2 7.3 3.8 6.1 5.9 3.7 1.9 5.3 5.5 12.0 12.3 5.2 11.7 11.7 5.2 12.1 8.0 6.0 7.4 8.0 9.8 6.4 3.0 4.6 27.4 13.7 29.9 5.6 2.5 10.2 4.0 13.6 17.4 9.8 62.9 38.1 42.6 39.3 51.7 10.5 0.0 20.6 15.7 22.3 22.4 8.1 16.4 96.7 23.8 6.4 46.1 47.3 19.7 76.8 45.7 55.6 55.9 8.1 7.8 42.1 11.8 70.7 27.1 7.4 38.8 29.7 26.5 27.7 19.1 47.6 28.4 14.2 19.2 NTMT1 "AD-003, C9orf32, HOMT1A, METTL11A, NRMT, NRMT1" ENSG00000148335 "N-terminal Xaa-Pro-Lys N-methyltransferase 1" Q9BV86 9 129608884-129636131 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 302.3;Late spermatids: 570.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020092, HPA058420" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA020092: AB_1853831, HPA058420: AB_2683713" "unprognostic (4.74e-3)" "unprognostic (1.77e-1)" "unprognostic (2.44e-1)" "unprognostic (1.48e-1)" "unprognostic (1.17e-1)" "unprognostic (1.24e-3)" "unprognostic (4.17e-3)" "unprognostic (4.92e-2)" "unprognostic (1.24e-1)" "unprognostic (8.57e-2)" "unprognostic (3.63e-1)" "unprognostic (4.35e-2)" "unprognostic (1.00e-3)" "unprognostic (1.11e-3)" "unprognostic (1.75e-1)" "unprognostic (5.58e-2)" "unprognostic (3.50e-3)" 10.2 25.7 11.9 11.5 13.1 13.8 10.0 13.2 15.3 8.9 10.7 9.0 14.4 11.7 8.8 13.6 10.2 7.8 16.6 31.8 11.5 11.5 11.7 16.8 8.9 11.5 15.7 11.3 8.8 19.5 9.4 10.8 12.1 13.8 10.2 7.4 9.4 13.0 11.4 54.6 10.7 10.2 13.6 10.3 13.1 10.5 56.2 10.7 10.8 12.3 22.1 9.8 12.3 14.5 27.1 28.4 20.3 34.2 14.8 26.6 19.4 16.7 34.8 14.4 24.4 9.2 13.7 15.5 31.9 18.9 32.3 28.0 28.5 22.0 21.6 16.4 22.7 23.3 32.7 30.2 28.1 20.4 16.6 16.2 9.0 31.3 28.7 29.5 18.1 13.7 14.6 14.3 33.8 16.9 10.4 17.6 19.3 33.0 16.2 16.8 55.4 20.4 24.5 18.8 31.2 30.4 19.4 17.0 43.2 13.0 9.6 29.3 15.3 15.7 29.5 21.8 9.6 24.5 9.5 11.9 38.9 19.7 36.0 33.4 12.8 15.2 32.8 17.7 18.8 22.2 15.1 27.3 20.3 25.2 28.7 24.8 23.4 25.5 26.6 26.4 27.1 26.4 22.0 7.6 14.8 34.2 28.4 23.4 19.4 11.9 13.1 13.2 15.3 11.5 11.5 15.7 11.3 13.8 10.7 3.0 11.5 55.2 60.7 88.7 16.0 2.8 20.4 10.7 18.2 21.0 21.6 61.3 82.9 57.5 302.3 31.5 59.1 0.0 48.7 71.0 52.7 55.2 30.0 42.9 59.3 39.7 19.4 20.3 27.3 570.1 32.5 46.3 52.3 28.9 25.6 18.8 57.3 24.6 23.3 72.8 22.1 25.8 84.4 60.3 47.2 86.8 113.4 40.1 37.2 65.8 NUAK1 "ARK5, KIAA0537, NuaK1" ENSG00000074590 "NUAK family kinase 1" O60285 12 106063340-106140033 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, DNA damage" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.3;parathyroid gland: 18.6" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 46.0;Endothelial cells: 46.6;Ito cells: 119.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.4;naive CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Cell line enhanced" "Detected in many" "AF22: 23.1;EFO-21: 23.1;RH-30: 33.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057143 Approved "Nucleoplasm,Nucleoli fibrillar center,Microtubules" Yes No "Nucleoli fibrillar center" "Nucleoplasm, Microtubules" "HPA057143: AB_2683349" "unprognostic (4.20e-2)" "unprognostic (8.42e-2)" "unprognostic (3.71e-2)" "prognostic unfavorable (9.83e-4)" "unprognostic (4.13e-2)" "unprognostic (2.34e-1)" "unprognostic (1.43e-1)" "unprognostic (4.80e-2)" "unprognostic (9.91e-2)" "unprognostic (4.06e-3)" "unprognostic (3.29e-1)" "unprognostic (1.31e-1)" "unprognostic (1.93e-3)" "prognostic unfavorable (4.27e-4)" "unprognostic (2.31e-1)" "unprognostic (8.70e-2)" "unprognostic (4.47e-2)" 8.2 1.8 4.2 2.0 13.0 0.0 5.5 9.9 20.1 4.6 1.7 24.3 1.1 1.0 5.8 1.6 1.9 3.6 2.7 11.3 5.1 3.3 2.5 2.4 4.9 1.5 8.7 8.4 3.2 1.2 18.6 1.9 2.5 7.6 3.6 2.2 2.3 1.8 3.7 9.4 11.6 1.5 6.3 5.5 1.1 1.5 1.3 9.3 1.1 1.8 1.1 1.4 3.4 3.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 5.0 3.4 23.1 0.2 9.3 1.0 10.7 5.7 3.9 4.4 3.3 1.7 0.8 0.0 23.1 10.4 1.9 4.8 4.8 4.6 2.1 0.0 1.3 0.0 3.7 1.8 1.9 0.0 0.0 4.8 3.1 2.5 0.8 7.6 8.4 0.0 0.0 16.8 3.1 0.5 0.1 0.2 4.5 0.0 1.4 0.0 33.2 4.0 2.5 5.9 2.7 0.1 2.6 0.8 0.2 15.9 1.2 0.1 6.2 3.8 12.9 1.4 6.8 0.0 0.0 0.3 1.1 0.0 3.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 4.2 13.0 9.9 17.5 5.1 3.3 8.7 8.4 7.6 9.3 0.0 3.7 0.0 32.0 11.9 30.8 46.0 2.5 0.0 5.7 7.0 0.0 0.4 3.3 5.0 0.3 46.6 0.0 23.3 8.3 4.1 9.2 4.4 0.0 10.5 6.1 38.1 0.0 119.1 9.7 1.7 3.7 1.3 10.1 1.0 2.0 1.7 11.7 0.0 2.8 1.4 2.6 0.0 14.4 0.7 5.5 13.9 0.2 0.9 0.9 3.7 NUAK2 "FLJ90349, SNARK" ENSG00000163545 "NUAK family kinase 2" Q9H093 1 205302059-205321791 "Enzymes, Predicted membrane proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 42.4" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 31.4;Ductal cells: 40.9;monocytes: 48.7;Mucus-secreting cells: 40.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 42.4" "Group enriched" "Detected in all" 4 "B-cells: 15.3;granulocytes: 42.4;T-cells: 10.7" "Cell line enhanced" "Detected in many" "BEWO: 22.8;RPMI-8226: 17.6;RPTEC TERT1: 20.9;SuSa: 24.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA008958 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA008958: AB_1080040" "unprognostic (2.24e-2)" "unprognostic (6.33e-2)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.01e-7)" "unprognostic (8.24e-3)" "unprognostic (1.58e-2)" "unprognostic (3.00e-2)" "unprognostic (1.08e-2)" "unprognostic (1.74e-1)" "unprognostic (9.19e-2)" "prognostic favorable (7.94e-6)" "unprognostic (3.71e-2)" "unprognostic (3.17e-2)" "unprognostic (4.90e-2)" "unprognostic (5.80e-2)" "unprognostic (4.54e-2)" "unprognostic (1.61e-1)" 1.4 2.8 0.8 12.5 2.4 8.3 0.9 9.2 1.5 18.9 10.4 3.9 2.4 13.6 2.7 3.8 31.3 3.4 1.3 1.1 1.7 1.0 14.5 3.6 16.2 20.3 5.5 1.5 3.3 13.2 0.1 2.3 7.2 2.0 1.5 7.5 9.8 9.7 2.0 0.7 12.9 15.4 0.9 2.7 10.4 2.0 5.6 2.4 5.5 14.5 20.1 31.7 2.8 24.6 15.3 3.6 42.4 5.6 5.7 10.7 5.4 2.1 11.6 7.1 0.3 0.1 0.3 22.8 2.8 2.9 7.6 3.1 12.2 0.4 3.4 1.7 0.7 12.5 4.2 1.6 4.2 3.3 0.0 0.2 0.0 0.7 2.1 4.9 0.0 0.0 1.3 3.1 4.4 2.6 1.7 0.3 0.0 0.4 0.9 1.4 0.5 0.0 0.0 4.5 1.5 0.3 0.0 0.5 17.6 20.9 0.0 1.1 0.1 0.8 3.3 0.3 24.7 3.3 0.0 0.8 2.7 1.3 0.3 4.3 6.2 0.9 2.1 0.4 0.0 1.0 3.4 5.6 13.2 3.9 4.2 2.8 14.2 4.8 4.6 3.6 15.3 10.7 8.1 42.4 5.7 4.1 1.4 2.8 5.4 0.8 2.4 9.2 1.5 1.7 1.0 5.5 1.5 2.0 2.4 6.0 5.0 9.1 0.8 1.0 0.8 1.4 20.4 2.7 0.0 31.4 0.0 6.5 5.0 40.9 1.7 2.2 20.3 0.0 1.5 27.7 4.0 1.8 0.0 2.9 4.6 0.0 10.4 1.3 11.7 1.2 0.0 6.5 6.8 48.7 40.0 1.7 7.2 2.9 0.0 15.0 0.5 6.5 2.5 0.5 0.9 4.6 3.4 4.5 18.7 0.2 NUB1 "BS4, NUB1L, NYREN18" ENSG00000013374 "Negative regulator of ubiquitin like proteins 1" Q9Y5A7 7 151341699-151378449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "monocytes: 930.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021220, HPA050722, HPA053648" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA021220: AB_2670630, HPA050722: AB_2681220, HPA053648: AB_2682217" "unprognostic (7.04e-3)" "unprognostic (2.47e-2)" "unprognostic (1.84e-1)" "unprognostic (1.01e-2)" "unprognostic (1.02e-2)" "unprognostic (3.22e-2)" "prognostic unfavorable (8.70e-4)" "unprognostic (1.42e-1)" "unprognostic (2.75e-1)" "unprognostic (2.67e-2)" "unprognostic (2.10e-1)" "unprognostic (8.76e-2)" "unprognostic (2.69e-2)" "unprognostic (9.44e-2)" "unprognostic (1.45e-1)" "unprognostic (2.64e-2)" "unprognostic (5.83e-3)" 20.1 17.3 17.1 22.1 15.5 13.2 20.5 20.5 20.0 22.2 25.0 17.6 17.3 30.9 24.4 17.6 18.1 19.8 17.0 16.5 14.8 12.9 17.1 18.9 21.2 28.7 14.3 15.4 25.4 21.7 28.0 26.4 23.7 18.5 21.6 15.3 16.2 19.8 15.7 30.3 16.9 38.3 20.8 19.8 26.5 17.7 56.0 16.0 32.3 26.5 15.9 19.8 25.3 22.3 21.1 18.9 28.9 24.0 24.5 24.7 17.1 27.0 12.3 16.6 9.8 17.3 21.2 13.8 21.8 20.1 16.6 19.2 12.0 24.0 29.2 28.9 13.6 21.3 13.7 9.9 14.2 10.7 25.8 16.7 10.6 11.7 7.6 24.3 24.6 13.8 13.5 16.7 11.9 11.3 20.6 10.9 14.9 27.7 0.8 13.3 14.5 43.5 18.7 26.0 27.7 16.2 24.2 17.2 4.4 12.3 13.4 15.6 26.0 40.9 17.6 20.8 12.1 12.0 14.2 22.0 14.1 5.0 18.7 20.6 28.5 21.7 25.7 28.5 21.2 23.0 10.4 15.7 20.7 20.9 20.3 24.7 21.1 18.3 21.1 13.6 19.9 20.4 19.0 28.9 24.5 24.0 18.9 14.3 17.1 17.1 15.5 20.5 20.0 14.8 12.9 14.3 15.4 18.5 16.0 68.5 57.3 44.2 28.5 22.0 35.4 51.7 30.6 72.3 71.7 24.4 11.8 39.1 51.4 43.6 181.4 36.0 42.1 0.0 60.6 37.7 28.4 41.4 69.4 33.4 27.3 46.1 28.2 30.7 34.8 15.4 40.9 42.6 15.1 930.6 41.4 52.7 51.5 17.5 38.5 30.5 40.1 25.8 38.7 96.0 12.7 25.3 41.9 48.0 21.9 30.6 NUBP2 CFD1 ENSG00000095906 "Nucleotide binding protein 2" Q9Y5Y2 16 1782901-1789191 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041704 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041704: AB_10804006" "unprognostic (1.94e-1)" "unprognostic (5.73e-3)" "unprognostic (2.83e-1)" "unprognostic (1.17e-1)" "unprognostic (2.16e-1)" "unprognostic (6.02e-2)" "unprognostic (8.44e-2)" "unprognostic (1.21e-1)" "unprognostic (3.42e-1)" "unprognostic (1.53e-1)" "unprognostic (8.64e-2)" "unprognostic (1.20e-1)" "prognostic favorable (9.63e-5)" "unprognostic (2.92e-2)" "unprognostic (1.82e-1)" "unprognostic (2.21e-1)" "unprognostic (5.83e-2)" 16.9 22.8 12.9 15.4 12.4 19.5 14.7 16.3 19.8 13.9 15.1 14.9 16.1 21.6 14.1 14.2 20.3 15.6 15.2 13.8 12.0 10.4 16.5 32.3 12.1 18.0 14.4 17.4 14.6 37.6 8.3 13.8 14.7 12.9 17.7 6.4 14.8 26.9 16.3 30.2 17.2 19.1 16.4 12.0 17.9 18.8 14.5 13.2 22.7 19.4 20.7 16.6 15.3 13.6 25.8 44.1 28.8 29.7 25.8 41.3 31.1 9.2 30.3 5.3 15.9 4.3 3.1 17.1 11.3 4.8 6.9 7.9 17.0 14.1 15.0 12.4 2.4 5.2 10.8 3.6 10.2 1.3 12.4 29.1 6.3 22.5 26.8 8.3 9.4 13.0 4.5 9.0 5.4 4.0 4.3 8.7 18.3 15.6 9.6 2.8 34.2 19.0 15.5 14.4 8.7 17.7 25.0 11.5 33.3 5.5 7.1 20.1 23.5 11.2 16.5 11.3 1.5 25.2 11.2 9.6 11.0 14.5 10.9 10.9 22.0 14.0 17.4 6.6 11.9 14.3 25.6 29.1 28.8 34.7 29.7 31.7 24.3 30.9 30.5 30.2 25.8 25.8 24.2 14.4 25.8 28.2 44.1 41.3 31.1 12.9 12.4 16.3 19.8 12.0 10.4 14.4 17.4 12.9 13.2 14.9 25.7 52.2 36.7 31.8 32.4 21.2 45.9 13.4 23.9 29.6 19.6 88.5 56.3 58.2 27.4 31.5 37.8 0.0 64.8 66.3 45.0 34.5 19.7 60.6 55.1 22.3 36.7 27.6 44.1 62.9 33.9 27.6 55.6 48.7 43.9 38.9 54.9 31.6 29.0 50.1 34.0 45.3 42.8 35.1 28.3 36.3 34.6 50.1 53.3 20.0 NUCKS1 NUCKS ENSG00000069275 "Nuclear casein kinase and cyclin dependent kinase substrate 1" Q9H1E3 1 205712819-205750276 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062351, HPA063843" Supported Supported Nucleoplasm,Nucleoli No No Nucleoplasm Nucleoli "HPA062351: AB_2684745, HPA063843: AB_2685134" "unprognostic (1.68e-1)" "unprognostic (3.92e-1)" "unprognostic (3.38e-1)" "prognostic unfavorable (1.41e-4)" "unprognostic (1.87e-1)" "unprognostic (2.93e-1)" "unprognostic (9.20e-2)" "unprognostic (1.79e-1)" "unprognostic (1.47e-2)" "unprognostic (5.16e-3)" "unprognostic (1.18e-3)" "unprognostic (1.37e-1)" "unprognostic (5.82e-3)" "unprognostic (7.45e-3)" "unprognostic (1.44e-1)" "unprognostic (2.25e-2)" "unprognostic (7.57e-2)" 25.6 25.3 46.9 17.3 55.5 12.1 31.3 45.0 49.2 33.0 24.2 38.3 18.8 12.5 36.5 27.8 25.3 32.1 22.5 40.6 43.8 35.6 30.9 43.9 20.6 29.4 43.6 47.6 49.1 17.4 50.3 21.0 20.8 32.8 31.9 21.1 21.9 19.0 32.7 43.1 21.7 14.6 42.9 49.1 22.6 17.9 14.2 38.9 35.3 42.5 20.6 24.8 32.0 22.6 7.8 7.4 4.5 4.9 10.7 11.8 4.0 40.6 25.0 67.5 26.6 18.7 25.9 31.8 29.4 30.3 41.3 33.3 13.7 47.0 45.2 17.1 28.6 13.1 30.1 51.2 24.6 47.4 21.6 25.6 29.4 22.1 14.9 13.8 46.1 10.5 20.5 22.3 24.5 42.8 22.2 32.2 29.3 47.1 14.5 32.2 47.0 41.8 23.3 68.9 16.3 18.7 43.7 83.2 25.9 23.1 25.1 28.1 52.0 43.3 34.7 23.5 54.6 53.1 34.8 32.1 31.7 28.2 36.1 51.9 13.4 15.7 36.5 21.8 26.0 42.6 4.5 3.4 3.7 9.9 4.9 9.6 5.8 9.2 8.6 4.7 7.8 11.5 11.8 0.6 10.7 4.0 7.4 5.5 4.0 46.9 55.5 45.0 36.6 43.8 35.6 43.6 47.6 32.8 38.9 199.5 245.2 149.9 252.8 229.2 349.8 365.7 310.8 239.6 291.2 287.9 68.7 230.3 326.6 177.1 41.7 224.6 54.9 233.6 148.6 321.5 312.0 255.4 201.9 550.1 225.1 298.8 172.0 219.1 173.7 32.2 474.1 194.8 165.4 192.0 193.2 516.1 113.3 94.7 456.1 297.2 177.2 310.4 243.6 46.5 115.0 213.3 148.2 154.5 216.0 173.7 NUDCD1 "CML66, FLJ14991" ENSG00000120526 "NudC domain containing 1" Q96RS6 8 109240919-109334385 "Predicted intracellular proteins" Immunity "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 72.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023183 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA023183: AB_1854695" "unprognostic (5.08e-3)" "unprognostic (3.73e-2)" "unprognostic (2.52e-2)" "unprognostic (9.03e-3)" "unprognostic (7.52e-2)" "unprognostic (3.62e-3)" "prognostic unfavorable (1.39e-5)" "prognostic unfavorable (4.37e-5)" "unprognostic (2.13e-1)" "unprognostic (9.49e-2)" "prognostic unfavorable (6.94e-4)" "unprognostic (8.22e-2)" "prognostic unfavorable (8.71e-6)" "unprognostic (1.95e-1)" "unprognostic (1.63e-1)" "unprognostic (3.35e-1)" "unprognostic (1.65e-1)" 22.1 9.2 9.4 10.2 12.7 3.2 17.1 16.4 12.2 14.0 9.1 4.4 9.0 5.0 14.4 9.8 10.9 12.3 9.0 10.9 9.9 8.4 13.6 10.8 12.3 14.1 12.6 8.9 12.0 13.1 9.1 15.2 25.4 9.7 10.7 12.1 4.8 11.4 12.7 10.9 7.5 8.6 13.8 8.6 19.0 10.3 20.1 8.4 19.5 15.6 11.0 14.0 13.8 13.4 4.4 4.4 1.2 4.2 5.1 5.2 2.3 13.1 7.9 11.3 6.4 6.5 8.8 6.2 9.7 11.5 27.1 25.7 8.8 10.3 8.9 6.2 10.2 7.6 7.9 17.1 15.7 37.8 11.3 6.1 13.6 5.4 8.9 13.1 5.9 5.1 5.8 8.7 13.4 18.9 8.4 24.5 10.6 14.9 4.6 22.9 11.2 15.8 6.9 8.0 26.5 10.8 10.0 9.4 8.6 16.7 6.9 9.4 8.3 4.3 11.6 9.2 12.3 9.2 4.6 6.7 13.4 8.1 6.2 8.3 3.5 4.4 10.4 5.1 10.1 11.3 0.0 1.9 1.2 3.3 4.1 4.4 4.4 3.7 4.9 4.4 3.8 4.6 5.2 0.1 5.1 4.2 3.2 4.0 2.3 9.4 12.7 16.4 12.2 9.9 8.4 12.6 8.9 9.7 8.4 3.0 10.6 12.6 15.2 15.8 5.1 7.7 0.0 18.7 27.3 3.5 5.9 22.1 6.6 15.9 72.7 22.5 2.6 0.0 9.4 19.1 11.5 9.5 17.3 5.0 8.7 4.8 8.6 7.4 4.9 13.1 12.0 9.0 6.8 21.6 4.5 4.3 12.3 5.9 6.3 11.0 8.5 0.0 12.8 44.7 31.3 14.6 6.9 8.7 9.0 17.2 NUDCD3 "KIAA1068, NudCL" ENSG00000015676 "NudC domain containing 3" Q8IVD9 7 44379121-44490880 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019136, HPA019528, HPA019529" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA019136: AB_1852370, HPA019528: AB_1852372, HPA019529: AB_1852374" "unprognostic (3.72e-2)" "unprognostic (9.28e-3)" "unprognostic (2.33e-2)" "unprognostic (2.05e-3)" "unprognostic (2.18e-3)" "unprognostic (2.05e-2)" "unprognostic (4.73e-2)" "unprognostic (2.30e-2)" "unprognostic (2.18e-1)" "unprognostic (3.96e-2)" "unprognostic (2.28e-1)" "unprognostic (5.62e-2)" "prognostic favorable (9.16e-4)" "unprognostic (3.51e-2)" "unprognostic (1.58e-2)" "unprognostic (1.45e-1)" "unprognostic (6.50e-2)" 8.3 6.3 15.3 5.4 20.8 7.3 7.2 10.9 26.0 7.8 5.8 7.7 6.4 4.0 6.9 7.3 8.0 10.3 6.7 19.5 15.2 13.0 6.0 5.8 7.2 6.2 12.5 16.8 9.3 6.8 12.8 4.7 5.3 10.1 8.4 5.7 6.1 7.1 9.9 18.3 7.0 5.0 8.8 10.1 5.8 5.9 9.9 7.1 4.1 8.1 4.8 6.6 6.3 5.3 4.7 2.8 3.2 3.1 2.5 4.7 3.5 3.1 5.9 4.3 7.8 5.4 4.5 1.7 5.2 5.0 6.0 6.3 4.0 2.2 10.1 3.9 6.7 8.4 3.7 5.9 6.8 3.5 5.8 6.3 2.9 3.6 2.9 5.0 4.8 1.8 4.0 4.6 4.5 5.2 3.6 7.3 3.4 7.2 3.3 4.4 2.8 2.1 4.5 5.5 3.1 7.9 3.3 4.7 3.7 3.4 4.9 4.7 13.5 3.0 5.6 2.3 4.5 4.3 6.9 7.1 4.3 4.4 2.7 4.1 9.2 9.6 5.1 4.5 5.8 7.4 2.0 2.8 3.2 4.6 2.7 4.7 3.5 4.4 3.8 2.6 4.7 4.6 4.0 1.8 2.5 3.1 2.8 4.4 3.5 15.3 20.8 10.9 26.0 15.2 13.0 12.5 16.8 10.1 7.1 11.9 19.2 17.2 11.6 10.1 37.9 38.9 12.7 21.4 13.6 36.6 51.1 17.0 19.9 27.0 56.9 21.1 21.5 0.0 18.7 15.8 15.0 14.2 9.2 28.8 15.6 46.1 16.7 21.5 19.8 67.6 28.1 11.6 15.1 19.8 21.4 25.5 23.6 21.2 26.5 21.3 40.2 32.3 15.5 52.1 13.7 14.2 12.0 15.8 25.0 10.8 NUDT13 DKFZp586P2219 ENSG00000166321 "Nudix hydrolase 13" Q86X67 10 73110375-73131828 "Predicted intracellular proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040636 Approved Approved Nucleoplasm Yes No Nucleoplasm "HPA040636: AB_10960360" "unprognostic (3.75e-1)" "unprognostic (3.85e-1)" "unprognostic (1.07e-1)" "unprognostic (2.48e-3)" "unprognostic (1.38e-1)" "unprognostic (1.32e-1)" "unprognostic (1.33e-1)" "unprognostic (2.03e-2)" "unprognostic (1.67e-1)" "unprognostic (2.60e-1)" "unprognostic (9.40e-2)" "unprognostic (5.07e-4)" "unprognostic (1.91e-1)" "unprognostic (3.82e-2)" "unprognostic (8.82e-2)" "unprognostic (2.92e-2)" "unprognostic (5.96e-2)" 4.3 7.4 3.7 9.9 8.9 5.0 6.3 3.5 5.1 3.4 8.1 7.2 9.5 7.0 6.5 13.8 3.8 4.5 7.0 7.0 5.9 3.0 7.1 12.8 5.1 5.3 7.3 4.5 4.4 7.8 7.4 4.1 3.6 5.8 5.2 4.7 3.7 5.0 8.8 8.6 7.2 5.8 5.2 11.8 5.8 6.0 5.6 7.2 2.4 4.6 2.8 4.8 6.8 3.7 6.2 1.9 2.5 3.4 4.9 3.7 1.1 5.1 3.7 6.0 7.5 3.8 3.2 1.3 4.6 4.1 2.4 2.7 9.7 10.8 2.5 2.3 2.8 3.9 6.1 0.6 4.3 2.4 1.9 10.5 7.0 6.0 5.3 0.3 3.9 2.9 2.3 4.7 3.1 1.7 6.4 1.8 4.6 5.9 4.0 2.4 2.4 2.3 5.6 2.3 3.3 11.9 5.1 1.0 0.2 3.3 2.4 2.7 3.9 2.5 6.2 2.0 2.7 3.4 2.5 3.4 2.1 8.2 0.8 1.7 2.9 3.3 3.4 5.9 7.2 2.0 0.1 2.6 2.5 1.8 2.5 2.1 3.0 1.5 1.6 1.9 6.2 2.3 2.4 1.0 4.9 3.4 0.6 3.7 1.1 3.7 8.9 3.5 5.1 5.9 3.0 7.3 4.5 5.8 7.2 6.0 1.3 2.2 2.3 0.8 1.3 6.2 0.0 6.7 2.3 3.5 3.9 3.0 3.3 1.6 2.6 1.0 1.2 0.0 0.6 0.7 1.3 1.4 0.0 3.2 1.5 0.0 1.2 0.6 1.3 3.4 0.9 1.5 0.0 1.8 1.8 0.8 1.2 2.9 0.7 4.1 1.7 0.0 1.0 3.2 0.5 1.3 0.9 0.0 1.3 0.9 NUDT15 "FLJ10956, MTH2" ENSG00000136159 "Nudix hydrolase 15" Q9NV35 13 48037567-48047222 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 67.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA038968, HPA038969" Approved Supported Nucleoplasm Yes No Nucleoplasm "HPA038968: AB_10697402, HPA038969: AB_2676295" "unprognostic (9.48e-2)" "unprognostic (5.91e-3)" "unprognostic (2.64e-2)" "unprognostic (9.00e-3)" "unprognostic (4.99e-2)" "unprognostic (2.50e-3)" "unprognostic (2.29e-2)" "unprognostic (7.47e-3)" "prognostic unfavorable (1.25e-5)" "unprognostic (1.04e-1)" "unprognostic (8.50e-2)" "unprognostic (3.69e-1)" "unprognostic (4.63e-2)" "unprognostic (1.84e-3)" "unprognostic (3.35e-1)" "unprognostic (9.58e-2)" "unprognostic (8.93e-3)" 15.0 15.2 11.4 16.6 14.6 16.5 18.0 14.1 17.7 14.8 21.1 9.5 14.3 22.1 11.1 15.5 23.8 12.8 13.5 13.3 10.5 15.7 20.3 21.3 11.1 7.4 12.8 11.1 13.0 13.8 6.1 18.6 14.2 15.8 16.9 24.1 8.2 14.1 12.6 15.9 10.8 20.5 11.3 11.9 9.6 13.9 22.2 10.6 11.6 22.3 24.1 12.0 12.1 14.2 4.7 7.0 4.6 9.9 3.8 9.2 4.1 19.6 11.9 22.4 9.9 9.2 13.4 16.5 16.0 15.1 17.7 17.2 17.6 19.1 14.6 9.1 12.6 15.9 23.2 21.7 23.5 27.4 7.6 18.7 14.2 11.7 19.1 8.6 21.2 13.6 9.2 15.1 14.3 20.2 8.0 19.1 14.7 12.5 5.8 28.4 9.6 16.7 20.1 35.9 30.1 14.2 11.5 14.5 9.5 19.7 15.0 13.6 14.5 10.9 18.8 12.4 20.1 9.6 16.1 9.8 12.5 15.2 15.6 22.0 3.1 5.1 18.3 6.5 16.7 20.1 2.1 7.3 4.6 4.6 9.9 4.5 4.7 7.4 5.8 7.0 4.7 8.8 9.2 1.6 3.8 6.7 5.6 5.0 4.1 11.4 14.6 14.1 17.7 10.5 15.7 12.8 11.1 15.8 10.6 11.9 11.2 7.5 29.2 14.7 7.3 10.8 15.3 12.0 20.5 7.0 2.0 29.2 41.4 15.1 13.5 11.7 22.0 0.0 15.4 67.2 13.0 26.5 9.2 14.7 14.6 36.5 8.1 8.0 6.7 7.2 15.5 9.6 10.1 10.8 19.4 7.7 12.6 11.5 11.7 33.4 7.1 0.0 21.2 5.8 30.2 17.9 31.8 5.7 29.5 30.3 NUDT16 FLJ31265 ENSG00000198585 "Nudix hydrolase 16" Q96DE0 3 131381671-131388830 "Enzymes, Predicted intracellular proteins" "Nucleotide metabolism" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Kupffer cells: 138.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 18.2;eosinophil: 18.8;intermediate monocyte: 21.9;myeloid DC: 13.6;neutrophil: 14.6;non-classical monocyte: 24.5" "Group enriched" "Detected in all" 4 "dendritic cells: 13.6;granulocytes: 18.8;monocytes: 24.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA060452, HPA062492" Uncertain Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA060452: AB_2684279, HPA062492: AB_2684781" "unprognostic (4.85e-3)" "prognostic favorable (9.39e-5)" "unprognostic (3.19e-3)" "unprognostic (9.21e-2)" "unprognostic (2.49e-1)" "unprognostic (1.22e-2)" "unprognostic (9.96e-2)" "unprognostic (1.15e-1)" "unprognostic (5.16e-2)" "unprognostic (1.94e-1)" "unprognostic (1.77e-1)" "unprognostic (5.88e-2)" "prognostic favorable (1.05e-7)" "unprognostic (3.29e-1)" "unprognostic (1.62e-1)" "unprognostic (2.00e-2)" "unprognostic (9.44e-2)" 25.9 13.4 22.1 13.1 22.0 8.7 13.1 13.5 20.5 11.1 32.8 23.9 13.9 20.2 11.7 11.6 8.7 14.0 13.6 22.2 21.1 19.6 25.9 23.1 16.2 31.1 27.7 16.9 23.0 18.3 32.9 9.7 7.6 20.1 13.4 18.4 13.6 11.7 13.6 20.3 6.8 37.5 18.5 30.4 22.2 13.8 9.5 21.6 2.2 17.1 11.5 9.1 12.4 8.4 4.3 13.6 18.8 24.5 3.7 4.3 6.7 12.6 6.8 11.2 5.8 22.5 20.5 5.2 10.4 9.6 7.0 7.3 10.4 5.7 2.1 9.1 9.6 13.9 9.3 9.9 6.5 11.2 6.3 7.2 5.4 8.7 10.0 14.4 9.0 9.9 18.2 5.8 4.6 12.7 6.3 10.9 0.0 6.1 11.0 6.8 13.2 0.0 2.4 8.7 12.7 10.1 7.1 8.1 16.0 7.0 10.3 5.5 9.6 6.2 6.3 9.5 9.9 13.8 7.2 10.7 11.5 5.0 21.0 8.0 11.0 10.8 0.3 7.4 7.0 6.3 2.2 18.2 18.8 2.6 21.9 2.7 4.3 2.7 2.4 13.6 4.2 2.4 2.4 14.6 3.7 24.5 1.8 4.3 6.7 22.1 22.0 13.5 20.5 21.1 19.6 27.7 16.9 20.1 21.6 14.9 31.3 19.1 10.7 7.4 22.7 83.1 40.8 16.0 18.2 19.2 7.9 18.7 58.0 20.4 59.4 30.8 62.9 23.3 32.8 21.8 21.4 14.7 18.5 95.7 54.0 41.3 24.3 84.1 138.2 27.2 24.5 46.3 16.9 14.4 61.2 10.0 23.8 50.3 37.1 92.4 18.3 25.8 23.7 17.6 5.1 4.6 6.1 20.8 42.4 14.7 NUDT18 "FLJ22494, MTH3" ENSG00000275074 "Nudix hydrolase 18" Q6ZVK8 8 22106872-22109419 "Enzymes, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028581, HPA030125" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA028581: AB_10601381, HPA030125: AB_2673324" "unprognostic (9.90e-3)" "prognostic favorable (1.43e-4)" "unprognostic (4.88e-3)" "prognostic favorable (2.49e-6)" "unprognostic (1.29e-2)" "unprognostic (6.82e-3)" "unprognostic (1.20e-1)" "unprognostic (1.54e-2)" "unprognostic (5.30e-2)" "unprognostic (1.67e-1)" "prognostic favorable (2.47e-4)" "unprognostic (1.43e-1)" "prognostic favorable (8.30e-4)" "unprognostic (3.59e-3)" "unprognostic (1.05e-1)" "unprognostic (6.84e-2)" "unprognostic (2.32e-1)" 3.6 2.7 2.9 4.4 6.4 2.9 3.6 5.3 6.8 2.0 6.1 4.3 5.4 5.3 1.6 11.9 3.7 4.3 3.8 2.5 1.7 2.9 2.9 4.5 6.3 3.2 3.3 1.2 8.6 2.1 5.2 1.8 3.7 3.6 3.8 3.8 5.6 11.0 1.0 3.6 5.4 2.7 2.5 6.0 5.6 2.8 3.4 7.1 5.0 2.3 5.8 3.2 0.0 3.6 3.6 5.0 3.2 7.8 4.7 1.5 6.8 14.5 0.5 3.2 11.5 4.3 8.0 4.0 11.1 5.5 6.2 3.4 5.4 5.1 6.6 4.9 13.8 12.0 2.1 6.7 1.8 6.3 2.0 4.3 4.1 3.3 7.6 1.3 13.5 7.9 6.4 2.2 5.7 7.1 6.9 11.3 3.1 8.6 5.1 7.2 5.7 3.9 0.8 4.2 3.5 2.6 1.3 5.5 7.9 6.0 1.6 2.4 2.9 3.5 3.5 3.6 8.2 7.2 5.5 3.5 1.9 4.7 2.1 3.8 0.4 1.6 6.2 3.9 8.6 0.1 2.9 5.0 4.7 3.2 4.3 2.6 3.7 2.7 2.0 3.6 4.0 2.2 0.7 7.8 2.3 3.6 1.4 1.5 3.0 2.1 5.2 3.9 1.8 3.0 1.6 12.7 2.7 1.2 5.2 0.0 5.5 5.0 6.8 10.6 3.0 15.0 0.0 11.8 8.3 3.9 3.7 0.0 2.5 12.8 3.2 2.9 4.9 19.5 10.0 2.8 3.0 5.0 12.6 7.0 3.7 8.6 11.5 3.2 8.8 1.3 0.0 2.8 2.6 2.0 1.6 2.6 8.5 6.3 2.2 NUDT19 RP2 ENSG00000213965 "Nudix hydrolase 19" A8MXV4 19 32691961-32713796 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042761 Uncertain Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli, Cytosol" "HPA042761: " "unprognostic (1.20e-1)" "unprognostic (2.90e-1)" "unprognostic (2.35e-3)" "unprognostic (6.61e-3)" "unprognostic (2.62e-2)" "unprognostic (2.44e-1)" "unprognostic (6.18e-3)" "unprognostic (1.97e-1)" "unprognostic (3.14e-2)" "unprognostic (2.19e-1)" "unprognostic (2.99e-1)" "unprognostic (1.85e-1)" "unprognostic (1.47e-1)" "unprognostic (2.64e-2)" "unprognostic (2.81e-1)" "unprognostic (1.23e-1)" "prognostic favorable (1.35e-4)" 9.9 18.7 7.2 11.1 7.0 10.8 10.7 7.4 7.6 5.6 12.8 6.1 8.4 10.2 6.6 8.8 16.9 6.3 7.6 19.3 6.1 6.5 10.5 16.4 15.9 9.2 6.2 5.5 8.5 18.9 9.5 9.3 6.6 6.1 11.2 10.7 9.4 14.7 11.8 29.5 13.2 12.9 6.9 5.6 8.9 11.3 6.8 6.6 6.8 5.9 13.1 13.0 9.9 8.4 8.4 11.9 9.0 23.6 18.7 14.8 6.5 13.7 16.0 1.8 15.9 5.5 7.2 0.3 7.8 2.9 5.8 5.5 9.0 7.6 0.2 9.4 9.0 4.5 9.0 11.0 9.1 7.7 15.8 6.6 17.8 6.4 3.3 7.6 13.3 5.5 5.8 12.1 4.9 12.0 6.8 8.5 2.8 13.7 10.2 10.4 9.1 0.1 12.3 1.9 3.8 7.6 0.1 3.5 7.7 9.6 10.3 7.2 10.3 13.9 11.9 9.8 3.3 6.5 16.3 6.8 8.1 5.2 8.0 13.9 12.0 10.1 4.5 9.7 12.8 7.4 6.6 17.3 9.0 11.9 21.7 12.8 8.4 12.5 14.8 11.9 5.9 10.0 13.8 3.3 18.7 23.6 9.5 13.8 6.5 7.2 7.0 7.4 7.6 6.1 6.5 6.2 5.5 6.1 6.6 11.9 12.6 8.2 6.5 19.5 12.8 18.7 5.1 4.0 4.5 7.0 11.8 9.8 23.2 2.6 7.7 4.5 9.7 0.0 9.9 9.4 9.4 8.5 1.1 9.3 12.6 3.2 11.6 12.3 12.1 3.1 3.7 10.8 11.8 7.2 13.0 5.5 9.5 14.0 8.9 14.8 26.4 0.0 6.6 1.4 1.9 27.6 6.5 13.3 15.8 7.9 NUDT2 APAH1 ENSG00000164978 "Nudix hydrolase 2" P50583 9 34329506-34343713 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004684, HPA044903, HPA058623, HPA067639" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB004684: AB_425306, HPA044903: AB_2679139, HPA058623: AB_2683780, HPA067639: AB_2685877" "unprognostic (2.74e-3)" "unprognostic (2.58e-2)" "unprognostic (3.37e-1)" "unprognostic (2.05e-3)" "unprognostic (3.08e-1)" "unprognostic (2.39e-1)" "unprognostic (1.24e-1)" "unprognostic (6.55e-2)" "unprognostic (7.06e-2)" "unprognostic (3.05e-3)" "unprognostic (1.18e-2)" "unprognostic (2.80e-1)" "unprognostic (2.77e-2)" "unprognostic (6.24e-2)" "unprognostic (1.72e-1)" "unprognostic (1.23e-1)" "unprognostic (1.91e-1)" 12.0 18.0 21.6 9.6 21.9 10.2 20.6 14.0 25.5 14.9 14.9 26.0 15.4 12.8 15.7 30.2 14.5 20.5 12.3 16.0 17.3 18.6 10.7 17.5 11.2 12.2 19.5 19.0 28.3 20.9 12.0 19.0 14.1 20.5 16.5 15.3 15.7 16.1 13.0 30.8 13.9 10.1 14.7 20.7 11.3 13.0 8.6 19.1 18.6 3.8 13.2 13.8 14.4 12.1 16.6 15.8 14.3 12.2 14.3 22.2 11.2 23.8 9.8 12.8 4.5 8.8 16.3 9.2 11.5 26.1 13.3 14.0 6.7 11.3 6.6 9.6 14.3 5.1 10.5 11.5 28.4 13.6 24.8 10.3 14.3 18.5 12.6 25.6 11.0 5.9 16.5 18.4 17.2 32.4 18.2 27.5 23.2 4.0 27.1 19.5 14.8 11.4 10.3 7.9 10.6 28.3 14.8 8.0 16.7 13.1 7.8 2.6 10.4 18.7 7.1 10.8 12.0 5.7 11.9 17.7 11.5 10.4 7.5 11.9 6.1 9.9 11.7 14.4 10.6 14.3 14.3 12.2 9.7 11.7 10.3 16.7 16.6 19.2 15.2 15.8 15.0 22.2 19.6 4.5 14.3 10.7 14.7 19.7 11.2 21.6 21.9 14.0 25.5 17.3 18.6 19.5 19.0 20.5 19.1 3.0 5.5 15.9 17.8 25.0 13.1 18.6 43.3 17.4 11.4 15.7 5.9 33.9 74.6 22.6 9.7 21.5 18.6 0.0 34.7 35.6 23.1 17.1 12.7 31.0 32.5 7.9 21.4 30.1 38.4 21.8 25.3 23.9 21.9 32.5 29.1 16.2 26.1 26.9 18.0 39.6 12.8 25.8 23.6 35.8 17.5 27.6 15.8 25.3 31.4 15.7 NUDT22 MGC13045 ENSG00000149761 "Nudix hydrolase 22" Q9BRQ3 11 64225941-64230686 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039334, HPA053464" Approved Enhanced Nucleoplasm No No Nucleoplasm "HPA039334: AB_10795174, HPA053464: AB_2682160" "unprognostic (2.72e-1)" "unprognostic (3.77e-1)" "unprognostic (1.86e-2)" "unprognostic (1.61e-1)" "unprognostic (2.36e-2)" "unprognostic (9.75e-2)" "unprognostic (1.73e-3)" "unprognostic (1.98e-1)" "unprognostic (1.15e-1)" "unprognostic (1.43e-1)" "unprognostic (7.65e-2)" "unprognostic (6.61e-2)" "prognostic favorable (2.18e-6)" "unprognostic (1.76e-2)" "unprognostic (1.50e-1)" "unprognostic (1.71e-1)" "unprognostic (8.54e-2)" 9.2 16.8 8.1 16.0 9.2 14.3 9.8 7.3 12.8 9.2 24.2 9.1 30.9 29.6 9.1 16.9 17.8 9.0 16.7 23.4 8.3 7.0 21.1 30.1 10.2 15.9 10.5 8.4 7.9 26.4 13.8 12.2 14.7 8.6 12.3 8.5 9.0 28.6 35.2 24.9 12.9 23.7 11.4 7.8 20.5 18.5 7.8 7.7 19.5 15.4 15.7 19.6 13.5 9.4 30.0 49.1 20.0 33.9 19.2 25.0 20.1 14.7 9.4 2.4 9.9 3.6 4.4 9.0 6.2 6.5 4.5 4.2 6.1 12.6 7.0 16.5 6.2 6.8 15.5 1.4 9.9 0.6 9.0 4.0 9.4 6.9 6.3 10.8 6.0 15.7 6.8 7.4 4.8 5.1 3.4 7.3 8.4 4.6 7.7 5.3 22.1 8.4 11.2 3.7 9.1 19.9 10.4 4.0 26.0 7.8 8.2 5.5 8.8 5.5 20.9 24.8 0.9 21.3 6.9 6.7 7.6 7.2 23.8 5.3 28.9 11.4 4.4 26.1 7.1 8.8 13.8 28.7 20.0 23.0 33.9 20.5 25.3 20.3 22.4 29.1 30.0 18.0 19.6 17.3 19.2 31.8 49.1 25.0 20.1 8.1 9.2 7.3 12.8 8.3 7.0 10.5 8.4 8.6 7.7 3.0 13.4 41.3 23.3 10.6 12.3 3.1 61.1 4.0 6.8 38.4 11.8 92.1 139.3 53.1 12.7 17.7 92.0 0.0 76.6 42.4 24.2 26.6 14.0 47.8 50.9 28.6 35.7 27.0 50.0 6.5 18.7 38.1 32.1 73.9 66.5 25.6 56.4 92.1 18.4 113.9 16.8 12.9 20.6 4.9 8.3 15.3 56.4 39.2 56.2 28.8 NUDT5 "hYSAH1, YSA1H" ENSG00000165609 "Nudix hydrolase 5" Q9UKK9 10 12165325-12196144 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019827 Approved Approved Nucleoplasm,Vesicles,Centrosome NA NA 660000 Vesicles "Nucleoplasm, Centrosome" "HPA019827: AB_1854704" "unprognostic (2.08e-2)" "unprognostic (2.10e-1)" "unprognostic (1.61e-1)" "unprognostic (2.09e-1)" "unprognostic (3.77e-3)" "unprognostic (4.91e-2)" "unprognostic (2.54e-2)" "unprognostic (4.60e-2)" "unprognostic (1.32e-1)" "unprognostic (6.39e-3)" "unprognostic (2.06e-1)" "unprognostic (9.97e-2)" "prognostic unfavorable (7.14e-12)" "unprognostic (1.61e-1)" "unprognostic (1.33e-1)" "unprognostic (3.12e-2)" "unprognostic (3.68e-2)" 19.6 22.0 17.4 18.6 21.2 13.5 20.2 15.4 21.4 16.7 20.4 16.1 15.2 17.3 10.0 16.5 25.8 16.3 12.1 10.0 16.2 14.3 26.0 57.1 16.8 22.7 21.7 12.8 12.5 16.9 19.1 35.7 19.9 18.5 13.4 24.2 13.2 16.7 19.7 5.1 20.6 15.9 11.6 17.9 22.4 14.1 8.0 21.5 28.2 19.1 16.5 29.5 16.2 18.6 22.4 45.9 50.1 19.5 16.2 37.0 20.4 35.6 26.3 31.5 29.3 30.5 30.2 27.9 26.4 16.9 31.1 33.4 37.7 34.1 35.7 23.0 21.4 19.5 35.9 43.9 40.9 28.7 29.2 42.9 29.7 32.3 55.4 31.8 19.7 20.9 31.7 24.5 33.9 17.3 24.1 39.7 57.2 39.7 24.4 28.3 32.7 36.8 23.1 27.4 57.3 16.4 33.7 11.4 41.4 29.1 12.3 15.2 22.8 32.0 24.7 36.7 38.5 42.3 20.3 24.8 13.3 25.5 37.0 32.3 20.6 36.2 48.0 27.9 25.7 9.8 8.1 19.1 33.5 22.8 19.5 26.2 22.4 24.6 26.8 27.0 18.3 17.0 23.0 50.1 16.2 14.8 45.9 37.0 20.4 17.4 21.2 15.4 21.4 16.2 14.3 21.7 12.8 18.5 21.5 23.8 37.8 33.5 51.1 38.1 19.2 2.8 25.5 60.2 39.8 22.7 15.7 73.5 63.0 74.1 27.1 31.4 34.2 23.3 72.2 127.8 35.8 30.5 31.1 116.5 105.0 20.6 36.8 40.5 41.3 6.6 36.5 39.3 28.7 110.0 34.5 32.9 64.5 28.1 27.3 95.7 22.5 32.3 25.6 20.2 27.5 52.9 48.6 51.7 51.0 40.6 NUDT7 ENSG00000140876 "Nudix hydrolase 7" P0C024 16 77722492-77742260 "Predicted intracellular proteins" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 45.1" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 49.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 16.9;THP-1: 27.9;U-698: 22.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042042 Supported Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA042042: AB_10806232" "unprognostic (1.92e-1)" "unprognostic (1.17e-2)" "unprognostic (6.64e-2)" "unprognostic (5.95e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (1.84e-4)" "unprognostic (2.48e-1)" "unprognostic (4.05e-2)" "unprognostic (2.11e-1)" "unprognostic (2.46e-2)" "unprognostic (4.74e-2)" "unprognostic (4.52e-1)" "prognostic favorable (5.36e-11)" "unprognostic (1.19e-1)" "unprognostic (8.96e-2)" "unprognostic (1.32e-1)" "unprognostic (3.42e-2)" 8.7 19.0 5.4 4.8 8.3 1.4 6.2 4.2 8.6 4.6 8.4 5.7 5.9 7.1 6.2 12.4 8.6 7.1 5.7 24.8 4.8 7.3 14.8 45.1 5.0 6.8 6.3 6.2 5.2 8.5 9.1 4.7 4.2 7.8 6.4 8.3 11.6 5.9 5.3 5.0 6.0 9.4 7.1 7.2 5.5 5.4 6.7 3.5 6.1 19.7 6.5 5.9 6.3 6.0 13.6 7.9 2.5 11.0 2.3 20.6 6.0 1.1 4.0 3.6 2.0 16.9 4.3 3.4 1.0 5.2 1.6 2.1 1.1 5.0 5.8 3.9 3.9 3.8 4.0 2.7 4.3 0.9 1.8 3.7 0.0 0.2 5.3 1.8 3.9 0.8 7.3 5.5 0.9 3.1 0.7 2.7 8.4 4.1 2.5 0.6 10.6 2.0 9.3 3.8 6.9 1.0 4.3 0.4 1.7 8.1 0.0 3.0 2.9 3.7 1.5 3.0 6.5 10.7 27.9 2.1 1.8 0.2 0.8 0.2 0.0 0.0 22.5 7.1 5.0 0.0 2.5 8.5 1.0 9.1 11.0 10.1 8.8 10.8 10.8 6.8 13.6 14.3 9.9 1.4 2.3 10.6 7.9 20.6 6.0 5.4 8.3 4.2 8.6 4.8 7.3 6.3 6.2 7.8 3.5 14.9 5.4 2.2 7.3 8.7 2.6 16.1 28.1 22.7 4.5 14.0 0.0 15.8 49.7 4.9 8.7 6.7 13.4 0.0 8.3 7.4 8.5 3.2 1.1 37.1 5.5 6.4 6.4 4.9 8.3 3.4 5.2 3.0 8.5 0.0 8.1 22.7 4.2 10.5 4.6 35.0 6.1 6.5 9.2 4.8 11.3 12.2 5.6 6.7 14.6 3.3 NUF2 "CDCA1, CT106, NUF2R" ENSG00000143228 "NUF2, NDC80 kinetochore complex component" Q9BZD4 1 163266576-163355764 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 38.6;testis: 29.0" "Cell type enriched" "Detected in many" 5 "Spermatocytes: 232.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA059692, HPA076604" Supported Nucleoplasm,Kinetochore,Cytosol Yes Yes Nucleoplasm "Kinetochore, Cytosol" "HPA059692: AB_2684103, HPA076604: " "unprognostic (9.41e-2)" "unprognostic (2.61e-1)" "unprognostic (2.56e-1)" "unprognostic (5.32e-3)" "unprognostic (6.20e-2)" "unprognostic (3.77e-2)" "prognostic unfavorable (1.04e-5)" "prognostic unfavorable (9.16e-4)" "prognostic unfavorable (4.83e-4)" "unprognostic (8.45e-2)" "prognostic unfavorable (9.75e-4)" "unprognostic (3.70e-2)" "unprognostic (0.00e+0)" "unprognostic (9.79e-2)" "unprognostic (7.88e-2)" "unprognostic (2.69e-1)" "unprognostic (5.96e-2)" 1.3 0.9 0.8 9.8 0.9 14.1 0.6 0.5 0.9 1.4 2.5 0.6 0.9 2.3 0.6 2.1 6.1 0.5 0.7 1.5 0.8 0.6 0.7 0.6 1.9 9.9 0.8 0.6 0.7 0.4 0.3 0.4 3.6 0.7 0.6 2.9 0.8 1.3 0.0 0.5 2.2 3.2 1.0 1.4 4.4 1.6 29.0 0.3 38.6 0.5 5.1 9.2 1.5 1.8 1.4 0.6 2.6 0.2 3.0 7.7 1.0 26.3 9.2 24.5 10.2 0.7 2.5 13.3 16.7 11.8 27.2 23.9 7.0 23.3 22.7 14.0 6.7 11.3 15.5 14.9 6.3 34.5 23.7 10.7 8.9 10.6 10.0 0.0 15.3 18.4 0.3 0.6 13.7 9.7 5.1 12.3 22.3 16.7 31.5 25.7 5.1 27.9 20.6 13.3 19.4 14.2 19.0 21.4 20.1 7.7 3.6 18.3 21.1 8.9 9.7 9.2 15.9 14.9 32.1 8.7 20.3 22.8 15.2 33.6 22.6 31.8 43.3 6.7 12.6 22.4 2.6 0.2 2.5 2.4 0.1 1.0 1.2 3.6 2.4 0.5 1.4 2.5 2.1 0.9 3.0 0.2 0.6 7.7 1.0 0.8 0.9 0.5 0.9 0.8 0.6 0.8 0.6 0.7 0.3 0.0 0.3 3.7 1.8 5.3 1.0 0.8 0.0 0.0 4.5 0.0 0.0 2.7 0.0 0.7 15.8 0.1 0.8 46.7 0.2 23.9 1.8 0.4 4.6 0.2 11.3 0.0 0.0 1.8 3.7 10.7 2.3 2.5 0.0 1.0 0.9 2.5 0.2 0.0 2.1 0.0 2.0 6.5 0.5 232.2 40.5 2.0 3.3 3.8 2.2 1.4 NUFIP1 NUFIP ENSG00000083635 "NUFIP1, FMR1 interacting protein 1" Q9UHK0 13 44939249-44989483 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 47.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029958, HPA029959" Approved Enhanced Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA029958: AB_10598911, HPA029959: AB_10602308" "unprognostic (2.01e-1)" "unprognostic (5.32e-3)" "unprognostic (1.58e-1)" "unprognostic (2.04e-1)" "unprognostic (1.70e-2)" "unprognostic (2.98e-3)" "unprognostic (2.32e-1)" "unprognostic (1.45e-2)" "unprognostic (2.91e-2)" "unprognostic (9.74e-3)" "unprognostic (4.52e-1)" "unprognostic (3.95e-2)" "unprognostic (3.73e-2)" "unprognostic (4.04e-2)" "unprognostic (4.89e-2)" "unprognostic (3.31e-1)" "unprognostic (5.24e-2)" 8.9 9.8 10.4 10.7 16.4 17.4 11.6 11.0 17.2 9.8 7.8 10.8 4.8 7.1 11.7 14.4 9.2 9.2 6.3 6.4 12.7 9.6 10.2 13.7 11.2 8.5 8.9 12.6 13.7 11.5 9.3 9.6 7.7 7.9 9.1 7.9 6.3 8.6 8.8 17.0 10.1 6.4 10.3 10.0 8.4 8.6 14.1 8.8 11.4 10.1 6.8 9.3 8.9 8.3 6.6 6.3 1.1 3.7 8.3 6.9 2.5 5.4 4.3 7.3 6.1 5.0 5.3 8.8 6.5 5.6 12.1 7.8 11.6 8.8 16.0 5.5 6.0 7.3 8.6 13.6 9.2 15.8 4.9 10.7 12.2 2.9 10.4 8.4 15.7 5.0 5.5 8.6 8.1 12.4 4.7 6.0 8.3 9.7 2.7 8.5 6.2 12.9 9.9 17.3 14.6 7.1 12.8 7.0 9.8 7.3 4.7 4.0 9.0 5.6 7.6 7.0 7.2 5.8 8.8 4.5 6.2 5.3 7.9 8.9 3.7 5.7 20.2 7.0 11.1 8.7 0.0 3.7 1.1 3.9 3.7 6.9 5.9 4.3 4.1 4.7 6.6 6.8 5.1 0.2 8.3 2.3 6.3 2.4 2.5 10.4 16.4 11.0 17.2 12.7 9.6 8.9 12.6 7.9 8.8 6.0 9.8 6.7 10.1 13.7 7.2 4.0 5.1 5.3 18.2 5.2 11.8 13.3 14.9 11.0 34.3 7.7 2.4 23.3 14.4 12.0 9.3 4.8 17.3 8.1 9.3 7.9 5.2 8.0 4.3 47.9 10.0 7.9 8.5 6.4 4.7 8.2 8.9 0.0 10.6 12.2 6.6 6.5 8.5 26.7 28.3 14.4 7.3 6.2 8.1 7.1 NUFIP2 "182-FIP, 82-FIP, FIP-82, KIAA1321, MGC117262, PIG1" ENSG00000108256 "NUFIP2, FMR1 interacting protein 2" Q7Z417 17 29255836-29294118 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067443 Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA067443: AB_2685841" "unprognostic (6.51e-2)" "unprognostic (6.96e-3)" "unprognostic (1.17e-1)" "unprognostic (2.95e-2)" "unprognostic (3.38e-1)" "unprognostic (2.12e-1)" "unprognostic (4.94e-3)" "unprognostic (1.40e-1)" "unprognostic (3.79e-2)" "unprognostic (9.42e-3)" "unprognostic (1.60e-3)" "unprognostic (5.24e-2)" "unprognostic (1.28e-3)" "unprognostic (3.45e-1)" "unprognostic (1.79e-1)" "unprognostic (7.18e-2)" "unprognostic (6.04e-3)" 21.6 20.6 25.0 25.4 28.6 83.5 25.1 38.8 39.0 17.3 18.0 15.5 17.4 19.6 17.8 15.9 27.1 17.0 17.7 21.8 24.1 15.6 16.9 28.9 31.5 22.2 24.2 15.5 20.0 19.8 26.2 40.8 44.4 28.9 18.4 16.6 13.9 25.4 27.5 43.7 17.9 20.3 13.3 30.5 24.6 22.0 17.0 27.2 18.3 20.2 15.6 22.9 19.0 42.6 6.9 9.8 21.2 6.9 4.1 6.1 1.6 15.2 24.9 14.6 10.1 12.6 14.8 24.5 15.2 9.2 11.7 10.8 27.4 8.4 24.8 22.8 10.4 10.5 21.6 11.6 10.6 15.0 26.5 20.8 18.7 22.7 7.1 11.7 23.8 20.3 12.7 13.1 12.9 14.0 13.6 8.6 9.2 30.5 18.5 12.0 12.6 25.0 10.8 15.0 11.7 9.2 20.6 25.1 10.6 9.9 25.1 14.0 8.9 27.2 51.2 16.6 20.4 17.6 16.1 14.1 22.5 22.5 13.1 25.9 25.9 23.8 28.8 14.9 12.7 19.1 8.8 5.2 6.2 4.9 5.0 3.7 6.8 4.7 5.2 4.1 6.9 6.1 5.0 21.2 4.1 6.9 9.8 2.4 1.6 25.0 28.6 38.8 39.0 24.1 15.6 24.2 15.5 28.9 27.2 74.5 64.2 22.8 72.9 88.5 53.5 62.1 45.9 93.7 81.9 29.6 90.3 51.9 13.3 28.1 31.3 71.7 45.3 0.0 24.0 25.9 79.0 66.2 44.0 49.9 37.9 54.0 46.3 54.0 64.2 19.1 32.8 71.6 38.8 19.8 49.9 42.9 31.3 40.1 32.9 24.5 57.0 19.4 63.4 26.4 24.5 85.4 152.2 34.6 41.7 98.3 NUMA1 ENSG00000137497 "Nuclear mitotic apparatus protein 1" Q14980 11 72002864-72080693 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019841, HPA019859, HPA029912" Enhanced Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA019841: AB_1854708, HPA019859: AB_1854709, HPA029912: AB_10602811" "unprognostic (1.60e-2)" "unprognostic (3.31e-1)" "unprognostic (2.06e-2)" "unprognostic (2.84e-1)" "unprognostic (1.14e-1)" "unprognostic (6.47e-2)" "unprognostic (5.75e-2)" "unprognostic (8.74e-3)" "unprognostic (5.91e-2)" "unprognostic (9.45e-2)" "unprognostic (1.60e-2)" "unprognostic (2.51e-2)" "prognostic favorable (7.92e-4)" "unprognostic (1.28e-1)" "unprognostic (1.37e-1)" "unprognostic (1.49e-1)" "unprognostic (1.39e-1)" 29.7 33.5 23.6 20.6 28.1 26.8 33.1 38.4 31.8 51.9 37.7 55.6 40.1 25.5 58.3 30.9 34.1 37.8 31.2 21.2 21.6 19.4 23.0 13.1 28.3 23.3 37.6 24.8 51.4 30.0 70.7 29.5 26.0 28.3 50.3 24.2 41.2 35.3 40.1 43.7 41.9 30.2 45.3 29.5 23.0 31.2 25.9 39.5 39.4 32.6 22.5 31.8 50.5 37.2 10.3 12.9 4.9 5.7 7.0 9.7 6.6 18.5 23.6 29.6 19.9 26.4 27.5 15.1 25.1 29.1 26.2 22.9 24.5 34.4 25.3 22.0 30.7 18.8 39.9 27.0 25.4 24.0 26.0 12.7 31.0 37.1 18.6 21.2 23.4 22.6 29.0 16.8 25.6 25.9 40.7 22.1 22.9 18.2 30.6 17.9 35.8 30.2 13.1 18.4 35.6 17.1 37.1 51.7 19.5 19.6 29.1 35.8 50.8 40.1 37.1 37.3 13.4 49.9 13.7 30.5 27.8 21.7 39.3 16.6 19.9 19.6 35.6 18.6 11.1 15.8 4.9 5.6 2.5 9.7 3.5 7.4 5.2 6.0 7.5 4.9 10.3 7.5 5.2 4.6 7.0 5.7 12.9 7.2 6.6 23.6 28.1 38.4 31.8 21.6 19.4 37.6 24.8 28.3 39.5 38.7 32.9 12.4 27.2 23.0 61.9 5.2 35.7 32.1 30.7 50.6 68.7 24.3 14.9 24.4 28.1 29.2 50.4 0.0 27.8 11.2 25.5 31.2 30.1 20.3 24.6 49.3 45.5 31.3 31.9 14.3 63.9 23.2 18.6 20.8 58.2 49.2 27.3 31.6 47.7 22.6 57.0 38.8 21.7 11.9 20.4 24.6 37.6 28.4 48.3 21.6 NUP107 NUP84 ENSG00000111581 "Nucleoporin 107" P57740 12 68686734-68745809 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031679 Uncertain "Nucleoplasm,Nuclear membrane,Centrosome" NA NA Nucleoplasm "Nuclear membrane, Centrosome" "HPA031679: AB_2673992" "unprognostic (2.89e-1)" "unprognostic (3.32e-1)" "unprognostic (4.10e-1)" "unprognostic (5.43e-2)" "unprognostic (1.60e-1)" "unprognostic (6.32e-2)" "prognostic unfavorable (3.12e-9)" "unprognostic (4.03e-2)" "unprognostic (1.23e-2)" "unprognostic (2.28e-1)" "unprognostic (1.17e-1)" "unprognostic (1.08e-2)" "prognostic unfavorable (1.28e-6)" "unprognostic (3.43e-2)" "unprognostic (2.05e-1)" "unprognostic (1.00e-1)" "unprognostic (1.96e-1)" 18.3 12.6 10.2 16.5 13.2 18.7 17.4 20.7 15.2 19.0 12.2 12.1 12.2 9.2 18.6 18.0 14.0 16.6 8.5 12.1 12.2 6.6 12.1 11.1 12.5 21.4 13.2 10.2 19.8 12.5 14.2 16.2 23.5 12.2 12.6 15.3 11.3 13.0 11.8 13.9 14.8 15.8 13.7 12.5 19.7 12.0 20.5 15.9 40.6 12.5 13.1 22.5 17.8 13.1 13.6 7.0 9.5 14.2 20.6 17.0 8.0 17.1 22.1 26.4 19.1 7.8 10.0 28.6 18.8 10.9 28.3 23.7 22.2 14.6 31.5 18.4 9.0 12.6 19.8 29.6 13.9 37.9 29.5 22.0 35.9 15.9 18.7 4.9 31.6 12.2 5.3 6.6 22.6 14.8 9.9 16.9 18.3 42.8 22.7 17.7 20.8 26.0 27.6 29.0 6.6 21.7 26.6 31.8 18.9 12.2 18.3 15.6 16.0 20.8 15.7 11.3 21.5 23.5 15.3 10.3 15.5 15.8 18.0 22.9 9.9 19.8 38.2 11.9 23.1 18.2 6.3 6.5 9.5 13.1 8.5 17.0 13.5 13.0 14.0 7.0 13.6 16.2 14.5 1.7 20.6 14.2 5.5 13.4 8.0 10.2 13.2 20.7 15.2 12.2 6.6 13.2 10.2 12.2 15.9 11.9 15.3 27.4 14.6 15.3 20.5 11.3 12.7 20.1 14.8 8.7 17.7 24.8 10.0 15.4 26.7 16.1 8.4 0.0 15.4 25.3 16.3 13.0 15.1 6.7 15.5 12.7 8.2 17.8 11.1 7.1 35.9 19.8 18.6 27.9 11.3 22.6 17.1 7.0 20.5 5.8 31.5 12.9 14.6 52.6 42.8 15.4 11.8 25.9 13.0 10.0 NUP188 KIAA0169 ENSG00000095319 "Nucleoporin 188" Q5SRE5 9 128947699-129007096 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 60.3" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 43.2;Spermatocytes: 41.6;Spermatogonia: 37.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061750, HPA063942" Approved Uncertain Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "HPA061750: AB_2684602, HPA063942: AB_2685156" "unprognostic (4.64e-1)" "unprognostic (6.91e-3)" "unprognostic (2.36e-1)" "prognostic favorable (5.20e-5)" "unprognostic (9.50e-2)" "unprognostic (4.41e-2)" "unprognostic (1.85e-3)" "unprognostic (1.91e-1)" "unprognostic (1.47e-1)" "unprognostic (1.63e-1)" "unprognostic (7.78e-2)" "unprognostic (4.53e-2)" "unprognostic (1.01e-1)" "unprognostic (4.68e-2)" "unprognostic (2.87e-1)" "unprognostic (2.81e-3)" "unprognostic (3.53e-3)" 10.2 11.1 7.6 12.6 9.2 14.3 14.0 13.3 8.7 9.2 9.3 10.1 9.6 5.8 9.8 6.7 16.6 8.3 7.6 9.2 5.6 6.3 8.1 9.6 13.1 16.6 6.5 6.7 10.8 13.3 12.6 13.6 9.1 7.3 9.5 9.3 11.2 9.9 8.3 10.9 16.4 9.0 11.0 7.7 12.2 9.5 60.3 7.3 26.5 9.2 11.3 17.3 8.5 10.5 6.1 7.9 6.3 10.7 6.0 12.0 7.0 10.9 21.0 17.4 23.7 13.2 13.1 15.6 15.4 12.2 28.3 18.9 25.3 8.8 19.2 5.8 16.9 18.3 32.6 39.0 19.1 21.2 15.4 18.8 17.1 39.2 19.9 8.4 29.2 17.3 9.1 9.0 29.7 15.2 8.3 16.2 25.0 37.5 13.7 19.9 27.8 24.9 11.9 23.3 21.1 20.2 22.9 37.7 19.6 8.7 12.4 24.5 11.8 39.9 15.2 5.9 13.4 16.7 10.8 13.1 23.5 16.7 23.6 27.5 11.7 21.6 26.0 13.7 18.7 17.3 6.3 5.3 1.9 9.3 10.7 12.0 6.1 7.9 9.0 7.9 5.9 8.1 8.6 0.8 6.0 5.9 3.3 9.5 7.0 7.6 9.2 13.3 8.7 5.6 6.3 6.5 6.7 7.3 7.3 0.0 13.0 7.5 5.2 5.8 14.9 2.7 7.6 4.0 2.3 5.2 43.2 6.4 1.7 5.5 10.1 6.8 3.2 0.0 5.6 5.9 6.9 7.5 5.8 3.8 7.4 19.1 8.7 12.9 4.9 3.1 8.9 7.2 1.7 4.6 6.7 7.5 7.5 0.0 11.0 1.9 25.0 25.8 4.2 41.6 37.7 9.8 7.2 7.0 6.0 7.2 NUP214 "CAIN, CAN, D9S46E, N214" ENSG00000126883 "Nucleoporin 214" P35658 9 131125561-131234670 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 131.5" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 225.7;Kupffer cells: 255.0;Late spermatids: 282.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 43.7;neutrophil: 131.5" "Group enriched" "Detected in many" 5 "granulocytes: 131.5;monocytes: 43.7" "Cell line enhanced" "Detected in all" "K-562: 73.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048789 Approved "Nucleoplasm,Vesicles,Focal adhesion sites" NA NA 100000 Nucleoplasm "Vesicles, Focal adhesion sites" "HPA048789: AB_2680521" "unprognostic (1.30e-1)" "unprognostic (9.51e-3)" "unprognostic (9.92e-3)" "unprognostic (1.15e-1)" "unprognostic (7.42e-2)" "unprognostic (8.31e-2)" "unprognostic (1.07e-3)" "unprognostic (2.10e-2)" "unprognostic (3.35e-1)" "unprognostic (4.95e-1)" "unprognostic (6.60e-3)" "unprognostic (1.08e-1)" "prognostic favorable (2.39e-5)" "unprognostic (5.49e-2)" "unprognostic (6.84e-2)" "unprognostic (1.82e-1)" "unprognostic (1.53e-1)" 16.9 10.3 11.5 13.8 13.9 29.4 12.9 13.0 14.4 10.2 11.4 19.8 10.4 9.0 15.0 13.7 16.1 12.1 10.2 9.7 9.5 8.1 19.0 15.1 11.7 13.3 13.2 8.8 14.2 17.0 16.7 16.9 13.0 11.3 11.1 10.8 15.3 13.0 11.1 15.5 17.5 11.7 11.1 14.3 35.8 12.3 63.7 13.3 27.4 11.8 7.6 16.8 10.7 11.2 1.2 16.8 131.5 43.7 1.2 0.8 17.9 6.8 9.8 8.4 5.0 6.8 6.6 8.8 6.1 6.3 8.0 6.5 8.0 5.0 11.1 4.9 8.4 8.3 15.7 11.3 8.0 7.8 8.0 5.5 6.9 14.0 15.6 6.0 10.8 7.5 7.1 7.4 10.2 8.3 5.1 8.1 7.4 73.0 6.4 8.2 12.8 14.2 16.4 9.1 9.9 8.6 5.0 10.6 11.1 9.2 6.3 7.1 7.4 10.2 9.4 5.3 6.3 12.4 27.0 7.0 14.1 7.9 9.2 9.9 5.6 10.9 10.8 6.9 6.5 8.5 3.5 43.7 17.3 0.7 18.4 0.8 1.2 0.7 0.6 16.8 1.1 0.7 0.7 131.5 1.2 15.0 1.5 0.4 17.9 11.5 13.9 13.0 14.4 9.5 8.1 13.2 8.8 11.3 13.3 17.9 19.9 15.2 9.5 7.7 29.6 24.0 15.3 16.0 15.9 22.7 43.2 10.9 8.3 9.1 225.7 14.6 13.6 0.0 13.1 9.3 11.4 11.4 8.1 11.9 75.5 15.9 19.5 18.4 255.0 282.5 21.6 77.0 10.1 15.4 14.3 14.8 12.0 5.8 19.1 6.7 31.6 6.5 8.1 90.1 44.5 9.5 9.2 11.8 16.3 9.3 NUP35 MP44 ENSG00000163002 "Nucleoporin 35" Q8NFH5 2 183117513-183161680 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 6 "Early spermatids: 131.7;Late spermatids: 308.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018401, HPA018410, HPA018441" Enhanced Supported "Nucleoplasm,Nuclear membrane,Plasma membrane" No No "Nucleoplasm, Nuclear membrane" "Plasma membrane" "HPA018401: AB_1854719, HPA018410: AB_1854721, HPA018441: AB_1854720" "unprognostic (6.18e-3)" "unprognostic (3.15e-1)" "unprognostic (1.83e-1)" "unprognostic (3.58e-3)" "unprognostic (1.37e-1)" "unprognostic (9.91e-2)" "prognostic unfavorable (5.02e-4)" "unprognostic (3.95e-1)" "unprognostic (6.21e-3)" "prognostic favorable (3.45e-4)" "unprognostic (2.32e-2)" "unprognostic (1.61e-3)" "unprognostic (1.78e-3)" "unprognostic (6.78e-2)" "unprognostic (3.47e-2)" "unprognostic (1.24e-1)" "unprognostic (3.96e-2)" 8.8 10.9 9.1 13.7 21.4 4.1 15.3 18.9 12.6 9.2 8.6 5.6 5.8 7.3 9.6 9.0 11.7 10.6 9.1 7.9 11.1 6.8 11.9 16.4 9.5 9.3 11.5 5.1 13.1 17.2 8.9 13.1 9.0 8.8 9.3 10.7 7.3 9.7 9.6 9.1 10.9 7.1 10.5 7.6 7.8 9.3 25.8 9.7 19.1 10.3 12.6 12.7 8.0 10.2 8.9 3.8 1.7 6.8 5.9 10.5 5.0 10.0 10.8 16.8 9.9 6.1 5.9 12.2 12.1 9.8 18.3 17.6 19.8 12.2 17.1 11.4 6.4 21.7 8.7 23.1 13.4 29.7 15.3 15.3 16.1 9.0 21.0 4.6 11.6 10.9 4.3 7.1 15.6 14.9 4.1 10.7 10.3 14.5 12.7 13.9 11.7 13.4 13.9 28.6 15.8 33.4 16.5 13.3 12.1 16.9 12.3 14.9 10.4 11.2 13.1 12.7 13.0 8.5 8.1 5.7 14.4 10.2 11.6 13.5 8.5 18.4 18.2 9.8 8.5 19.3 0.0 4.8 1.7 6.1 6.3 10.5 8.9 7.8 7.5 3.8 7.9 9.6 8.4 0.1 5.9 6.8 3.6 7.7 5.0 9.1 21.4 18.9 12.6 11.1 6.8 11.5 5.1 8.8 9.7 8.9 5.0 11.1 14.4 23.1 10.8 4.1 10.2 8.1 14.8 15.7 17.7 18.4 10.0 10.8 131.7 9.3 3.1 23.3 11.1 17.4 12.4 7.0 8.1 11.9 7.4 6.4 3.5 11.6 6.2 308.3 8.9 3.7 20.3 4.6 6.6 10.8 9.6 7.0 7.8 10.1 17.1 12.9 13.2 34.7 19.4 24.0 7.9 8.9 7.4 9.7 NUP37 "FLJ22618, MGC5585" ENSG00000075188 "Nucleoporin 37" Q8NFH4 12 102073103-102120124 "Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Extravillous trophoblasts: 79.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056300, HPA073708" Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA056300: AB_2683092, HPA073708: AB_2686629" "unprognostic (1.42e-3)" "unprognostic (5.39e-2)" "unprognostic (3.31e-2)" "unprognostic (1.03e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (6.72e-4)" "prognostic unfavorable (7.70e-6)" "unprognostic (2.48e-3)" "unprognostic (2.37e-3)" "unprognostic (7.77e-2)" "unprognostic (2.90e-3)" "unprognostic (1.67e-2)" "unprognostic (7.47e-2)" "unprognostic (5.55e-2)" "unprognostic (1.88e-1)" "unprognostic (3.06e-1)" "unprognostic (3.64e-1)" 11.1 18.4 6.0 17.5 7.7 12.6 12.8 8.1 7.4 12.4 12.8 8.7 14.9 8.1 13.0 14.7 22.0 12.6 7.8 12.3 5.7 5.4 11.4 8.6 9.0 16.4 6.0 5.1 12.6 11.7 12.6 15.2 17.6 10.6 13.7 16.0 11.2 11.7 9.6 18.0 11.3 14.5 11.4 9.3 16.5 11.5 17.8 6.2 28.4 16.4 18.5 20.8 13.6 11.0 19.4 18.1 30.6 17.2 13.2 26.7 13.0 32.0 23.7 20.9 9.5 17.3 23.0 46.3 20.7 19.5 32.7 22.4 30.2 17.5 21.8 14.8 16.0 22.6 23.8 36.5 32.0 41.1 30.7 20.8 23.4 12.8 27.0 22.1 33.0 7.4 17.7 14.1 25.4 18.9 21.9 26.6 29.1 41.4 8.3 30.2 22.3 24.5 27.4 20.6 30.2 37.9 16.2 29.6 16.5 25.7 24.2 10.9 7.8 15.6 16.8 14.8 24.6 29.4 19.2 8.6 11.8 12.9 16.5 28.3 12.6 23.8 37.4 13.5 27.0 19.7 30.6 14.7 16.4 13.8 17.2 15.0 19.4 16.9 14.0 18.1 17.7 15.3 17.3 4.3 13.2 14.2 15.3 26.7 13.0 6.0 7.7 8.1 7.4 5.7 5.4 6.0 5.1 10.6 6.2 6.0 11.0 22.6 21.0 10.1 7.4 7.9 22.9 28.1 11.4 15.7 7.9 61.2 21.6 20.4 2.3 14.2 9.2 23.3 17.3 79.0 11.7 10.2 7.0 8.6 31.3 3.2 5.8 10.4 14.3 4.0 18.1 16.9 6.8 19.8 15.7 17.6 16.1 10.5 17.7 18.0 17.2 19.4 10.3 50.2 37.0 8.3 33.6 17.3 20.7 10.6 NUP43 "bA350J20.1, FLJ13287" ENSG00000120253 "Nucleoporin 43" Q8NFH3 6 149724315-149749665 "Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 58.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027126, HPA027291, HPA028500" Enhanced Approved "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "HPA027126: AB_10599301, HPA027291: AB_10601851, HPA028500: AB_10602287" "prognostic unfavorable (2.08e-4)" "unprognostic (3.02e-1)" "unprognostic (3.86e-2)" "unprognostic (1.45e-3)" "unprognostic (2.29e-1)" "unprognostic (8.19e-3)" "prognostic unfavorable (7.13e-7)" "unprognostic (5.14e-2)" "unprognostic (2.45e-1)" "unprognostic (2.35e-1)" "unprognostic (1.11e-1)" "unprognostic (1.06e-2)" "unprognostic (2.74e-2)" "unprognostic (6.25e-3)" "unprognostic (2.02e-1)" "unprognostic (2.72e-2)" "unprognostic (3.60e-2)" 16.9 14.2 12.7 15.2 13.8 7.6 19.6 15.6 13.5 20.1 13.1 17.9 18.3 12.4 18.4 11.5 17.4 13.1 9.1 14.7 10.9 10.0 15.7 13.7 12.6 20.3 15.2 9.2 15.7 22.6 14.1 13.2 18.8 12.9 16.6 14.1 17.7 14.2 14.2 20.0 18.7 16.6 16.2 12.1 22.7 14.4 13.8 16.4 28.6 18.9 12.1 24.2 18.4 14.2 10.6 8.1 5.1 8.6 6.1 9.7 3.3 9.0 15.8 13.9 21.8 8.9 11.2 21.8 15.7 9.0 15.4 19.5 22.6 8.5 26.1 16.8 8.6 14.4 14.5 23.8 13.8 26.2 12.2 16.7 29.9 16.8 21.0 6.1 30.6 19.5 6.8 7.3 22.4 14.3 5.8 12.1 15.1 30.5 14.6 12.8 9.7 22.0 12.7 12.2 10.3 9.4 21.6 19.2 8.7 10.1 12.6 5.7 9.6 18.7 11.9 6.1 12.0 12.7 13.0 9.4 12.6 13.7 17.9 23.9 9.0 18.3 28.0 11.2 21.3 17.6 4.4 8.3 5.1 6.3 8.6 6.6 7.3 7.4 6.2 4.2 10.6 7.8 9.7 3.3 6.1 7.2 8.1 7.9 3.3 12.7 13.8 15.6 13.5 10.9 10.0 15.2 9.2 12.9 16.4 3.0 5.6 6.2 4.5 7.0 11.7 12.6 10.2 2.7 4.5 3.5 5.9 9.5 3.3 7.6 27.2 5.3 3.4 0.0 6.7 10.5 4.7 5.3 0.0 3.2 6.7 6.4 9.8 6.2 10.3 58.0 9.5 6.0 8.5 10.0 5.8 11.1 5.5 0.0 9.9 3.8 9.5 12.9 8.2 4.9 10.0 7.4 5.5 6.9 7.6 5.6 NUP50 NPAP60L ENSG00000093000 "Nucleoporin 50" Q9UKX7 22 45163841-45188015 "Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047162 Enhanced Supported "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA047162: AB_2679963" "unprognostic (2.64e-1)" "unprognostic (1.21e-2)" "unprognostic (4.96e-2)" "unprognostic (1.22e-1)" "unprognostic (2.17e-1)" "unprognostic (1.57e-1)" "unprognostic (5.46e-3)" "unprognostic (5.83e-3)" "unprognostic (4.94e-2)" "unprognostic (4.94e-2)" "unprognostic (7.22e-2)" "unprognostic (5.31e-2)" "unprognostic (1.97e-2)" "prognostic favorable (4.06e-4)" "unprognostic (1.43e-1)" "unprognostic (3.17e-2)" "unprognostic (3.63e-2)" 9.0 12.0 8.0 12.3 9.3 26.4 12.8 11.3 11.4 8.7 13.2 6.6 15.8 9.0 9.1 11.0 18.1 10.4 8.0 5.3 7.4 8.6 10.8 13.6 10.4 17.6 7.1 8.4 9.9 11.7 8.2 16.1 12.9 16.8 11.9 9.6 8.2 11.3 15.0 6.5 10.8 18.1 6.2 6.3 19.3 13.4 20.0 7.5 41.3 12.2 5.5 19.5 10.7 15.3 8.2 10.3 37.6 16.2 11.8 12.5 12.3 24.3 11.7 22.4 14.5 10.5 11.0 23.9 20.4 13.6 15.8 16.1 25.3 10.9 26.7 9.6 13.4 11.8 17.2 27.5 16.6 22.9 14.2 29.2 23.4 18.3 15.4 11.0 61.7 24.9 13.3 11.5 20.2 15.4 7.6 17.4 23.6 24.2 28.2 16.2 16.3 27.9 16.0 16.8 16.2 12.1 29.7 13.6 18.7 12.3 23.7 14.0 13.6 20.3 12.6 24.0 17.9 7.8 16.4 15.8 33.6 30.2 17.3 17.1 19.7 15.9 39.3 12.6 16.0 23.3 19.7 15.7 31.0 8.8 16.2 12.0 8.2 10.6 10.0 10.3 7.4 12.5 8.5 37.6 11.8 9.2 5.7 10.1 12.3 8.0 9.3 11.3 11.4 7.4 8.6 7.1 8.4 16.8 7.5 8.9 24.7 25.2 40.1 76.0 14.5 9.0 22.9 33.5 18.2 31.4 11.8 20.7 11.6 16.5 34.0 19.0 21.4 70.0 18.1 32.1 18.9 47.3 32.5 32.4 24.1 12.7 16.7 35.0 41.1 58.5 13.6 24.9 23.6 23.4 22.0 9.7 22.7 31.6 13.1 17.4 16.3 25.8 14.7 31.2 39.5 78.2 47.4 37.1 22.2 77.6 NUP54 ENSG00000138750 "Nucleoporin 54" Q7Z3B4 4 76114659-76148515 "Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035929, HPA058122" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA035929: AB_10671236, HPA058122: AB_2683613" "unprognostic (6.70e-2)" "unprognostic (3.51e-2)" "prognostic favorable (8.80e-4)" "unprognostic (3.02e-1)" "unprognostic (3.58e-2)" "unprognostic (4.24e-2)" "prognostic unfavorable (4.64e-4)" "unprognostic (1.51e-3)" "unprognostic (3.05e-2)" "unprognostic (1.62e-1)" "unprognostic (2.49e-3)" "unprognostic (3.36e-2)" "unprognostic (2.10e-2)" "unprognostic (1.22e-1)" "unprognostic (2.01e-1)" "unprognostic (1.83e-1)" "unprognostic (3.65e-3)" 23.7 14.5 13.5 18.2 15.2 28.4 25.7 26.0 17.2 23.1 20.0 14.6 17.9 15.3 22.9 18.2 21.4 22.5 15.1 17.0 12.2 10.8 16.4 20.3 17.8 22.8 20.5 13.1 25.3 19.3 13.3 16.8 22.8 14.9 19.8 19.7 12.2 20.0 24.1 17.8 21.2 18.4 24.7 14.7 23.6 19.2 19.6 20.0 36.1 19.8 18.1 22.1 24.1 21.8 10.0 11.4 7.7 10.0 21.6 16.5 7.5 17.1 6.8 21.8 15.7 18.6 17.8 19.2 17.4 25.1 25.8 26.6 16.0 24.6 26.0 14.7 17.3 14.0 11.6 23.4 19.4 32.4 17.1 13.7 15.7 8.5 15.2 17.6 30.4 19.0 16.2 14.0 20.4 21.7 11.4 22.1 17.1 26.9 16.4 18.6 15.0 32.0 14.3 34.9 20.9 6.1 25.1 34.4 9.9 15.3 16.5 13.2 11.0 16.1 19.1 14.0 17.8 8.1 18.7 14.7 20.8 18.6 24.7 21.1 10.7 3.9 24.8 14.8 17.9 18.2 6.5 7.5 7.7 12.2 9.0 16.5 9.0 12.9 11.7 11.4 10.0 13.8 13.0 3.5 21.6 10.0 8.4 12.5 7.5 13.5 15.2 26.0 17.2 12.2 10.8 20.5 13.1 14.9 20.0 20.8 11.8 23.1 37.0 31.3 13.7 9.9 7.6 18.7 12.5 10.4 19.6 36.3 24.9 18.9 7.9 20.4 11.5 0.0 24.2 38.9 30.9 23.1 23.1 11.9 19.3 7.9 13.8 18.4 18.3 5.6 25.3 17.0 16.9 30.7 18.4 11.8 15.9 21.0 24.4 17.2 19.1 32.3 26.8 38.4 40.1 25.5 32.7 27.7 21.7 29.4 NUP62 "DKFZp547L134, FLJ20822, FLJ43869, IBSN, MGC841, p62, SNDI" ENSG00000213024 "Nucleoporin 62" P37198 19 49906825-49929763 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Late spermatids: 254.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005435, CAB020724" Supported Supported "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "CAB020724: , HPA005435: AB_1079510" "unprognostic (2.26e-1)" "unprognostic (4.06e-2)" "unprognostic (9.92e-2)" "unprognostic (9.68e-2)" "unprognostic (7.83e-2)" "unprognostic (1.12e-2)" "prognostic unfavorable (2.50e-7)" "unprognostic (2.76e-2)" "unprognostic (3.61e-3)" "unprognostic (3.97e-2)" "unprognostic (4.06e-2)" "unprognostic (2.03e-2)" "prognostic unfavorable (5.71e-12)" "unprognostic (3.89e-3)" "unprognostic (3.62e-1)" "unprognostic (3.96e-1)" "unprognostic (3.27e-3)" 19.1 25.7 15.8 29.1 18.5 19.8 16.1 28.3 21.7 18.2 17.1 21.0 13.4 20.0 24.1 13.7 21.5 22.1 20.9 16.9 14.3 15.1 16.8 27.5 16.2 29.0 15.2 14.2 26.6 18.6 14.0 21.3 24.1 17.4 19.8 17.7 16.2 18.8 20.2 27.1 18.8 20.2 23.3 14.2 26.0 16.4 70.9 17.6 45.5 16.8 17.3 29.6 18.9 19.4 10.7 21.1 6.2 22.3 13.7 16.9 12.5 32.0 30.5 22.6 19.2 7.1 8.1 21.1 24.3 16.7 25.6 25.6 20.6 18.9 36.1 13.4 15.5 17.2 19.1 27.5 16.8 24.8 52.2 29.3 29.0 15.3 19.0 8.6 26.6 28.9 8.3 11.6 16.9 14.1 11.4 18.8 21.7 35.4 35.3 17.5 15.5 48.0 20.3 21.4 29.0 27.2 43.4 26.4 30.7 12.3 24.9 25.3 18.0 23.2 26.5 12.1 16.9 21.5 13.6 14.6 40.3 23.7 13.0 39.4 25.6 69.7 33.2 16.6 23.2 30.0 6.2 20.7 4.2 12.0 22.3 16.9 10.6 12.0 13.2 21.1 10.7 8.2 10.5 3.3 13.7 11.8 18.3 10.7 12.5 15.8 18.5 28.3 21.7 14.3 15.1 15.2 14.2 17.4 17.6 23.8 21.9 40.6 17.0 30.3 10.8 12.6 20.4 24.1 19.4 8.7 5.9 23.7 8.3 21.3 98.8 27.0 16.6 23.3 14.1 38.8 21.5 15.3 22.0 11.0 44.5 60.4 20.7 30.1 34.9 254.9 23.0 47.7 20.3 90.2 22.7 18.3 20.1 23.4 21.5 13.6 15.4 19.4 12.2 71.6 37.3 28.0 18.2 26.6 27.6 12.9 NUP85 "FLJ12549, NUP75" ENSG00000125450 "Nucleoporin 85" Q9BW27 17 75205659-75235758 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061910, HPA062595" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA061910: AB_2684634, HPA062595: AB_2684801" "unprognostic (2.30e-1)" "unprognostic (5.10e-2)" "unprognostic (5.12e-3)" "unprognostic (2.52e-3)" "unprognostic (2.25e-1)" "unprognostic (1.01e-2)" "prognostic unfavorable (1.73e-7)" "unprognostic (3.46e-1)" "unprognostic (1.09e-2)" "unprognostic (9.93e-2)" "unprognostic (2.94e-1)" "unprognostic (3.33e-2)" "prognostic unfavorable (3.32e-6)" "unprognostic (1.03e-3)" "unprognostic (2.16e-1)" "unprognostic (9.10e-3)" "unprognostic (2.11e-1)" 21.6 12.9 13.7 22.1 14.2 17.9 19.1 43.0 17.9 17.1 17.2 17.2 12.5 16.1 24.1 16.9 19.6 19.0 15.8 14.7 12.7 8.8 14.9 19.8 17.5 25.4 17.5 12.7 21.4 18.5 12.0 13.5 18.8 13.9 17.3 21.8 15.3 16.8 16.3 17.0 23.5 18.4 20.1 15.6 24.6 16.1 24.5 14.1 28.5 17.8 14.0 26.2 15.8 18.2 17.1 19.0 17.6 20.8 12.6 20.5 13.5 22.5 25.7 18.9 13.0 7.3 11.4 26.3 16.4 13.0 38.6 36.3 22.0 21.7 20.8 9.5 14.0 25.1 19.5 30.9 17.3 34.4 6.5 25.0 17.3 29.6 19.2 6.0 17.8 14.5 10.9 10.8 26.9 11.7 8.9 29.5 17.1 21.3 13.4 18.7 24.9 33.4 21.9 14.1 28.1 23.7 23.4 40.9 18.9 14.7 16.5 14.4 13.8 20.2 26.0 14.4 22.0 29.3 20.3 10.8 28.9 26.8 18.5 26.0 8.3 6.8 26.6 14.9 16.3 17.7 5.2 20.8 17.6 14.6 18.1 20.5 14.2 15.7 14.0 17.1 17.1 15.5 11.8 6.7 12.6 12.9 19.0 13.3 13.5 13.7 14.2 43.0 17.9 12.7 8.8 17.5 12.7 13.9 14.1 6.0 12.2 15.0 7.2 5.5 7.8 7.5 10.2 9.4 11.4 7.0 9.8 17.8 6.6 14.0 2.0 14.2 7.3 46.7 16.9 18.4 14.3 6.5 10.5 19.5 19.7 6.4 7.5 20.9 11.1 2.5 13.3 16.2 8.5 13.6 9.7 4.5 15.0 7.0 9.2 7.9 7.4 32.3 6.1 17.4 30.4 6.1 10.6 12.9 10.7 6.7 NUP88 MGC8530 ENSG00000108559 "Nucleoporin 88" Q99567 17 5360963-5420160 "Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 103.0;Spermatocytes: 115.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002209, HPA021816" Approved Approved Nucleoplasm NA NA Nucleoplasm "CAB002209: AB_564128, HPA021816: AB_1854725" "unprognostic (3.46e-2)" "unprognostic (1.66e-2)" "unprognostic (1.04e-2)" "unprognostic (8.83e-2)" "unprognostic (1.05e-1)" "unprognostic (2.03e-1)" "unprognostic (3.38e-2)" "unprognostic (3.94e-1)" "unprognostic (4.72e-2)" "unprognostic (4.94e-2)" "unprognostic (2.04e-2)" "unprognostic (5.75e-3)" "unprognostic (1.49e-1)" "unprognostic (1.10e-1)" "unprognostic (9.03e-2)" "unprognostic (1.14e-2)" "unprognostic (1.44e-2)" 10.8 12.4 8.1 17.2 8.8 13.2 14.1 15.0 9.2 9.0 12.5 6.6 8.1 7.4 10.1 12.2 13.1 10.5 7.7 15.3 8.0 5.6 11.3 25.7 9.1 17.8 6.9 6.9 9.9 11.1 11.9 12.4 10.0 7.5 9.6 14.3 6.9 11.7 12.5 33.4 11.8 12.4 10.2 7.7 20.0 11.4 34.4 8.4 28.9 15.8 10.3 23.1 10.9 10.5 24.2 7.4 3.5 8.6 12.2 10.5 7.4 20.6 22.8 18.4 15.5 8.8 9.0 19.9 15.8 14.2 29.2 26.7 19.5 8.7 37.6 6.5 15.4 16.8 20.9 31.7 18.7 32.5 10.4 21.8 16.4 20.4 14.2 12.4 13.4 17.3 6.7 13.6 21.6 33.3 10.4 19.9 15.1 18.7 9.9 20.3 10.0 20.5 9.2 19.4 19.6 11.5 20.2 20.8 18.0 13.4 9.5 8.0 15.5 19.4 9.4 11.8 15.2 10.5 15.6 12.2 12.4 14.1 13.0 28.8 6.4 8.4 18.6 14.7 15.1 19.1 3.5 4.9 2.2 8.2 7.3 8.1 24.2 9.1 9.8 6.9 23.2 9.5 10.1 0.5 12.2 8.6 7.4 10.5 7.4 8.1 8.8 15.0 9.2 8.0 5.6 6.9 6.9 7.5 8.4 11.9 16.2 36.6 23.6 19.7 12.9 8.9 12.7 13.4 19.4 15.7 15.7 27.0 10.0 20.2 103.0 8.5 8.8 0.0 22.2 20.9 10.1 18.0 7.0 15.8 10.5 9.5 13.2 8.0 4.1 21.6 14.1 11.5 3.3 18.0 9.1 8.9 19.4 14.0 10.3 7.0 10.4 12.9 13.2 115.8 53.5 14.9 30.1 18.1 16.8 38.1 NUP98 NUP96 ENSG00000110713 "Nucleoporin 98" P52948 11 3671083-3797792 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 93.4;Late spermatids: 116.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074810 Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA074810: AB_2686714" "unprognostic (1.11e-1)" "unprognostic (1.49e-1)" "unprognostic (7.41e-2)" "unprognostic (2.13e-1)" "unprognostic (7.71e-3)" "unprognostic (3.40e-1)" "unprognostic (4.08e-3)" "unprognostic (6.47e-2)" "unprognostic (1.04e-2)" "unprognostic (1.83e-2)" "unprognostic (7.76e-3)" "unprognostic (1.02e-1)" "unprognostic (1.23e-1)" "unprognostic (5.09e-1)" "unprognostic (1.91e-1)" "unprognostic (2.46e-1)" "unprognostic (1.21e-1)" 20.2 13.5 8.7 23.5 11.7 40.8 23.5 14.2 13.2 18.0 15.3 14.6 17.8 11.2 19.2 17.5 18.6 17.3 17.1 18.2 7.8 8.0 12.8 20.1 20.7 17.4 11.4 8.7 25.5 19.0 25.7 23.6 20.7 12.7 18.6 15.2 17.8 17.4 25.0 35.2 18.5 15.7 20.8 10.4 18.3 16.0 57.0 10.6 27.5 20.9 15.0 26.6 22.6 19.3 8.9 9.9 24.9 10.0 6.1 13.2 8.7 29.8 23.4 19.3 21.3 21.4 17.6 17.0 21.3 24.9 29.3 26.4 25.7 37.1 29.2 10.1 25.5 29.6 32.2 33.9 21.0 40.0 20.7 24.5 31.3 19.2 17.6 18.0 39.9 26.4 20.0 14.5 16.1 29.4 13.0 22.7 33.4 38.9 23.5 31.1 12.2 40.1 13.0 24.4 32.8 18.0 24.5 23.5 14.0 16.7 23.6 17.8 11.9 30.9 25.1 14.2 21.0 15.4 15.7 16.6 23.5 20.4 25.5 19.4 14.2 24.2 31.0 15.9 17.2 24.7 19.1 7.9 15.5 11.0 10.0 11.0 8.9 10.7 9.7 9.9 7.8 12.2 10.5 24.9 6.1 6.3 2.7 13.2 8.7 8.7 11.7 14.2 13.2 7.8 8.0 11.4 8.7 12.7 10.6 26.8 25.1 21.4 28.7 44.3 14.4 14.3 25.5 13.4 22.7 7.0 15.7 18.8 3.3 11.1 93.4 20.3 12.8 23.3 10.3 14.1 19.3 22.7 17.4 20.2 15.1 14.3 20.6 16.5 15.1 116.3 15.8 20.9 15.1 27.9 14.0 12.4 10.6 12.7 13.4 7.4 14.9 32.3 23.7 48.2 32.6 44.2 38.9 20.2 16.2 23.9 NUPL2 "CG1, H_RG271G13.9, hCG1, NLP_1" ENSG00000136243 "Nucleoporin like 2" O15504 7 23181827-23201011 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "Early spermatids: 230.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049036, HPA057251" Supported Nucleoplasm No No Nucleoplasm "HPA049036: , HPA057251: " "unprognostic (3.81e-2)" "unprognostic (2.53e-1)" "unprognostic (3.97e-1)" "unprognostic (3.87e-1)" "unprognostic (4.16e-1)" "unprognostic (1.10e-1)" "unprognostic (1.33e-3)" "unprognostic (2.16e-1)" "unprognostic (1.09e-2)" "unprognostic (1.42e-2)" "unprognostic (1.30e-3)" "unprognostic (2.07e-2)" "unprognostic (4.74e-3)" "unprognostic (1.32e-1)" "unprognostic (2.00e-3)" "unprognostic (3.59e-1)" "unprognostic (1.32e-2)" 13.3 21.1 19.4 27.0 17.1 23.3 14.4 25.9 30.4 15.4 16.4 12.3 26.8 15.4 19.5 26.5 17.9 17.7 18.7 24.3 16.1 16.1 17.8 16.2 14.7 23.2 14.9 19.9 16.7 14.6 22.3 19.7 10.8 15.2 16.5 16.9 12.5 20.3 20.8 16.9 21.6 14.9 19.1 14.6 20.1 15.2 32.2 16.9 19.7 20.8 16.8 19.6 17.7 16.7 16.4 13.8 22.9 8.7 13.9 12.3 9.8 12.1 7.0 9.0 17.0 8.9 11.4 6.6 10.1 7.6 10.8 11.4 9.0 13.6 20.4 9.0 7.0 24.3 14.7 15.5 8.8 13.5 5.9 16.4 14.1 14.9 8.9 11.1 28.7 17.2 5.5 10.7 10.3 6.6 8.3 11.3 11.5 23.7 14.4 10.7 3.5 13.7 16.7 17.1 14.9 10.0 12.6 8.1 15.3 11.9 9.3 11.9 11.4 10.6 5.6 15.6 15.1 7.1 31.4 11.5 7.8 9.8 13.4 16.2 19.0 28.6 22.5 7.3 21.5 17.8 22.9 8.7 7.6 11.4 8.4 10.2 16.4 12.2 11.3 11.5 14.0 11.5 12.3 8.5 13.9 7.1 13.8 12.3 9.8 19.4 17.1 25.9 30.4 16.1 16.1 14.9 19.9 15.2 16.9 14.9 8.6 15.3 14.1 11.9 20.9 15.4 5.1 17.4 12.5 22.7 19.6 14.9 33.2 19.5 230.4 12.2 7.4 0.0 11.6 11.0 12.2 10.0 13.9 5.0 23.6 22.3 15.0 14.1 16.5 25.9 23.3 16.2 8.5 24.4 10.9 16.0 15.1 14.4 19.4 22.3 23.0 12.9 19.8 24.4 11.8 11.8 5.5 20.2 16.8 11.9 NUPR1 "COM1, p8" ENSG00000176046 "Nuclear protein 1, transcriptional regulator" O60356 16 28532708-28539174 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 297.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 11.5;eosinophil: 4.2;neutrophil: 3.1" "Lineage enriched" "Detected in many" 10 "granulocytes: 11.5" "Cell line enhanced" "Detected in many" "HHSteC: 51.1;hTCEpi: 84.2;SK-MEL-30: 60.2;T-47d: 35.8;U-87 MG: 32.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA006349 Supported "Nucleoplasm,Cytokinetic bridge" NA NA Nucleoplasm "Cytokinetic bridge" "HPA006349: " "unprognostic (2.64e-2)" "unprognostic (2.77e-2)" "unprognostic (3.76e-2)" "unprognostic (1.86e-1)" "unprognostic (1.01e-1)" "unprognostic (4.40e-2)" "unprognostic (7.72e-3)" "unprognostic (5.77e-3)" "unprognostic (3.61e-2)" "unprognostic (2.77e-1)" "unprognostic (1.04e-2)" "unprognostic (2.32e-2)" "unprognostic (3.27e-2)" "unprognostic (1.51e-1)" "unprognostic (6.14e-2)" "unprognostic (6.36e-3)" "unprognostic (2.80e-2)" 26.9 38.6 13.1 8.9 20.0 1.7 24.4 13.4 10.1 30.0 28.6 10.4 114.1 4.5 19.9 36.6 31.2 16.5 19.3 16.2 14.8 12.2 19.3 47.1 33.7 7.5 20.5 8.2 41.0 297.9 2.2 5.8 16.1 23.1 46.5 16.5 23.5 89.5 128.3 22.2 27.5 8.9 35.3 23.9 7.6 17.4 18.6 17.6 4.2 146.4 14.4 11.5 47.9 79.1 0.8 0.8 11.5 0.6 1.1 0.5 0.1 0.2 1.6 0.0 13.2 19.7 17.3 10.3 11.5 10.0 0.4 9.3 0.0 0.0 0.0 6.4 17.7 1.1 0.3 0.0 0.3 0.3 0.0 0.5 0.0 0.7 8.3 51.1 0.0 0.0 16.4 84.2 5.4 24.0 12.7 0.0 0.0 0.0 0.5 5.8 2.3 0.0 0.2 0.0 0.0 6.4 0.0 0.0 0.4 0.0 1.1 0.1 0.0 3.3 13.8 60.2 0.2 35.8 1.9 0.0 3.7 9.2 9.8 1.6 0.0 0.0 0.1 32.1 0.0 0.4 11.5 0.6 4.2 0.4 0.4 0.5 0.4 0.4 0.3 0.2 0.8 0.5 0.5 3.1 1.1 0.5 0.8 0.3 0.1 13.1 20.0 13.4 10.1 14.8 12.2 20.5 8.2 23.1 17.6 268.0 266.9 12.9 284.3 281.4 2.7 143.0 84.1 203.4 100.1 307.1 2.0 116.3 18.3 217.4 9.2 223.9 44.6 0.0 489.4 49.3 360.2 373.9 19.7 654.2 297.7 1.6 58.7 232.7 44.1 22.4 489.5 65.6 146.8 10.8 319.6 165.4 272.9 60.4 662.3 199.5 3.2 200.5 420.6 5.8 4.3 464.9 591.9 17.5 358.7 334.3 NUSAP1 "ANKT, BM037, FLJ13421, LNP, NuSAP1, PRO0310p1, Q0310, SAPL" ENSG00000137804 "Nucleolar and spindle associated protein 1" Q9BXS6 15 41332694-41381050 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 38.3;lymphoid tissue: 123.4" "Cell type enhanced" "Detected in many" 19 "Erythroid cells: 350.4;Extravillous trophoblasts: 100.9;Spermatocytes: 103.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "T-reg: 16.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042904, HPA074847" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center" Yes Yes Nucleoplasm "Nucleoli fibrillar center" "HPA042904: AB_2678220, HPA074847: AB_2732269" "unprognostic (1.19e-1)" "unprognostic (9.53e-3)" "unprognostic (1.65e-1)" "unprognostic (8.78e-2)" "unprognostic (3.46e-2)" "unprognostic (2.97e-2)" "unprognostic (1.16e-3)" "unprognostic (1.74e-3)" "unprognostic (1.37e-2)" "unprognostic (4.14e-1)" "prognostic unfavorable (6.27e-4)" "unprognostic (8.49e-3)" "prognostic unfavorable (6.82e-14)" "unprognostic (4.76e-3)" "unprognostic (1.23e-1)" "unprognostic (2.18e-1)" "unprognostic (1.22e-1)" 3.2 12.9 0.7 20.3 1.3 38.3 3.8 0.7 0.9 2.9 5.4 1.1 4.4 5.8 1.5 2.8 16.1 0.9 2.5 2.7 0.7 0.7 2.5 4.2 5.7 16.5 0.9 0.5 4.2 3.0 0.0 0.6 9.2 0.9 1.8 6.5 0.8 3.6 5.6 4.4 6.0 6.3 2.2 1.2 7.4 4.1 8.6 0.6 123.4 0.8 9.7 19.4 2.9 5.3 2.7 3.1 6.4 1.4 1.7 16.3 3.1 37.4 12.6 41.8 19.9 2.2 3.6 13.9 30.0 17.7 33.1 32.1 17.0 19.6 19.4 16.7 11.3 26.6 36.2 32.2 14.7 31.8 34.9 15.8 49.4 31.3 16.0 0.6 31.4 22.2 1.1 1.7 17.6 13.6 6.5 19.8 30.1 27.0 66.3 25.6 10.0 38.8 21.1 21.5 38.5 15.6 41.9 44.6 21.0 11.8 11.7 30.3 20.8 41.3 24.3 8.6 15.9 36.6 23.3 12.0 25.7 32.3 29.0 52.7 24.7 47.7 62.1 13.5 47.2 44.1 6.4 1.4 4.4 0.7 0.9 0.4 2.7 3.5 2.6 3.1 2.1 0.2 1.9 0.8 1.7 1.2 2.9 16.3 3.1 0.7 1.3 0.7 0.9 0.7 0.7 0.9 0.5 0.9 0.6 0.0 1.0 6.7 5.9 34.2 0.8 0.8 22.9 0.0 4.5 0.0 0.0 10.7 3.3 2.1 20.6 0.7 1.8 350.4 0.4 100.9 8.5 4.1 6.9 3.8 30.5 0.0 2.9 9.2 13.2 8.5 0.3 16.4 3.3 6.4 3.4 1.5 1.6 0.0 1.8 3.9 0.9 0.0 4.1 103.5 65.4 21.8 16.1 13.4 10.2 4.7 NXF1 "DKFZp667O0311, Mex67, TAP" ENSG00000162231 "Nuclear RNA export factor 1" Q9UBU9 11 62792123-62806302 "Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016327, HPA061593" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB016327: AB_627608, HPA061593: AB_2684565" "unprognostic (2.45e-2)" "unprognostic (1.15e-3)" "unprognostic (2.34e-1)" "unprognostic (1.68e-3)" "unprognostic (2.36e-1)" "unprognostic (1.45e-2)" "unprognostic (5.40e-3)" "unprognostic (7.21e-3)" "unprognostic (2.54e-2)" "unprognostic (2.64e-1)" "prognostic favorable (4.08e-4)" "unprognostic (4.33e-3)" "unprognostic (8.08e-2)" "unprognostic (1.18e-1)" "unprognostic (3.38e-1)" "unprognostic (3.66e-3)" "unprognostic (1.25e-2)" 24.8 28.6 23.6 38.3 23.5 85.9 24.5 27.7 25.8 25.9 28.9 29.2 44.2 18.8 45.7 28.9 24.7 26.0 25.6 22.4 23.8 18.3 29.9 37.3 23.9 30.2 27.0 18.6 31.4 28.6 47.3 55.0 44.3 22.7 33.4 22.7 30.3 33.2 32.6 28.1 40.1 26.4 33.2 25.5 42.4 27.5 23.0 29.6 35.9 34.6 26.9 35.7 22.7 30.8 14.4 20.6 19.7 22.5 17.1 20.6 12.8 19.6 21.9 38.4 25.9 32.9 24.0 23.2 30.6 27.5 41.2 24.5 29.8 15.9 31.1 18.3 24.5 16.5 24.5 40.8 19.1 37.4 24.6 27.9 23.5 35.3 25.1 25.0 29.0 34.2 35.4 27.8 30.2 14.6 31.0 26.8 27.7 30.1 23.4 29.3 26.9 35.1 37.8 23.1 24.4 19.0 34.2 21.2 33.0 28.5 23.5 20.2 17.0 30.0 24.2 21.8 29.0 27.6 26.0 27.3 24.0 19.4 29.9 27.2 28.4 24.4 31.5 18.5 24.6 24.0 6.0 17.4 19.7 17.9 22.5 19.2 14.4 17.2 17.2 20.6 12.9 18.8 17.2 14.7 17.1 19.2 16.0 20.6 12.8 23.6 23.5 27.7 25.8 23.8 18.3 27.0 18.6 22.7 29.6 35.7 44.2 24.1 23.4 74.0 12.3 19.4 17.8 14.7 18.2 21.0 29.5 40.9 8.3 14.4 17.8 29.2 26.6 0.0 10.6 21.6 30.5 19.0 47.5 18.4 25.3 4.8 30.3 22.7 38.2 10.4 33.9 42.4 30.4 11.8 21.5 11.6 13.1 16.7 24.4 9.6 16.2 25.8 35.9 20.6 19.6 61.2 83.0 29.4 19.6 12.9 NXF3 ENSG00000147206 "Nuclear RNA export factor 3" Q9H4D5 X 103075810-103093125 "Predicted intracellular proteins" "mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 18.0;gallbladder: 16.4;testis: 50.0" "Cell type enhanced" "Detected in some" 11 "Cholangiocytes: 5.1;Ito cells: 2.5;Kupffer cells: 3.7;Late spermatids: 3.4;Paneth cells: 2.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 16.8;HL-60: 15.9;NB-4: 14.8;THP-1: 11.5;U-2197: 48.8;U-937: 35.6" "HPA003132, HPA046757" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA003132: AB_1079514, HPA046757: AB_2679789" "unprognostic (1.20e-3)" "unprognostic (6.72e-2)" "unprognostic (2.74e-1)" "unprognostic (3.05e-2)" "unprognostic (6.75e-4)" "unprognostic (1.72e-1)" "unprognostic (1.21e-1)" "unprognostic (8.86e-2)" "unprognostic (6.19e-2)" "unprognostic (3.13e-2)" "unprognostic (3.63e-2)" "unprognostic (1.88e-1)" "unprognostic (2.21e-10)" "unprognostic (1.90e-2)" "unprognostic (4.51e-2)" "unprognostic (3.99e-2)" "unprognostic (1.56e-1)" 1.3 0.5 0.1 0.0 0.3 2.4 0.2 0.1 0.2 0.9 0.3 0.0 1.0 0.2 0.2 8.2 0.6 18.0 16.4 1.1 0.2 0.1 0.7 2.1 5.7 1.3 0.3 0.0 4.4 0.7 0.0 0.1 0.2 0.1 0.3 0.6 0.4 4.2 0.3 0.1 0.1 1.9 0.2 0.3 0.4 0.2 50.0 0.0 0.0 0.2 0.9 0.2 0.2 0.3 0.0 0.0 0.5 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 16.8 0.1 0.0 0.0 15.9 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.7 0.0 3.0 0.3 0.0 0.0 14.8 0.0 0.1 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 48.8 0.0 0.0 0.0 0.0 0.2 35.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.9 0.1 0.3 0.1 0.2 0.2 0.1 0.3 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.5 3.7 3.4 0.3 0.0 0.0 0.0 0.3 0.0 0.3 2.9 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.8 0.0 NXPE3 "FAM55C, MGC15606" ENSG00000144815 "Neurexophilin and PC-esterase domain family member 3" Q969Y0 3 101779202-101827392 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 44.6" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 37.8;Horizontal cells: 46.1;Ito cells: 40.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 37.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036259 Uncertain Approved Nucleoplasm,Vesicles "Secreted - unknown location" NA NA 7600 Vesicles Nucleoplasm "HPA036259: AB_10671838" "unprognostic (3.30e-1)" "unprognostic (1.39e-1)" "unprognostic (1.53e-1)" "unprognostic (4.42e-5)" "unprognostic (4.98e-2)" "unprognostic (1.07e-1)" "unprognostic (1.81e-1)" "unprognostic (7.42e-2)" "unprognostic (1.89e-2)" "unprognostic (7.96e-2)" "unprognostic (1.57e-3)" "unprognostic (3.43e-1)" "prognostic unfavorable (7.76e-6)" "unprognostic (2.89e-1)" "unprognostic (5.23e-2)" "unprognostic (1.77e-1)" "unprognostic (8.75e-3)" 6.1 4.7 7.2 7.6 16.6 7.8 5.3 6.1 16.2 6.3 5.2 29.5 6.0 2.4 7.9 2.6 4.5 8.2 4.8 12.6 9.8 5.9 3.0 2.5 6.9 10.7 24.0 8.6 5.5 2.6 15.8 6.9 4.7 22.0 6.2 3.4 3.4 4.2 7.5 44.6 2.5 4.9 7.6 9.4 8.7 4.6 5.1 17.2 6.6 5.3 4.1 9.8 7.3 5.0 8.9 11.6 15.9 13.6 6.7 19.5 11.1 7.8 12.0 10.4 3.7 11.2 11.7 2.3 8.7 11.1 10.5 15.3 2.8 0.8 11.5 25.8 9.8 12.7 1.7 11.5 9.4 13.0 14.3 3.6 8.9 7.6 7.4 14.8 7.5 8.3 6.7 1.6 8.7 3.2 13.7 11.3 11.2 1.8 37.8 17.3 4.1 10.0 1.8 5.9 0.4 7.4 4.6 12.6 4.9 7.7 2.0 8.2 9.8 3.7 0.9 6.5 6.5 1.7 10.8 9.8 11.7 13.9 1.3 9.0 18.0 17.8 13.6 10.0 33.3 2.2 6.3 13.6 15.9 12.7 10.4 8.8 8.9 14.2 13.2 11.6 5.8 19.5 15.5 6.9 6.7 9.9 7.4 16.3 11.1 7.2 16.6 6.1 16.2 9.8 5.9 24.0 8.6 22.0 17.2 23.8 6.1 9.7 1.9 3.3 23.7 37.8 5.1 2.7 3.4 0.0 7.9 0.7 0.0 2.6 1.0 11.7 0.0 0.0 2.2 1.2 7.8 0.8 12.7 1.6 6.3 46.1 6.9 40.5 18.4 1.3 8.6 9.5 6.8 10.8 0.5 22.7 2.0 0.0 7.1 0.5 15.7 19.4 7.6 9.3 15.2 2.6 0.6 10.9 0.4 1.0 NXT1 "MTR2, P15" ENSG00000132661 "Nuclear transport factor 2 like export factor 1" Q9UKK6 20 23350736-23354777 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Basal keratinocytes: 208.9;Suprabasal keratinocytes: 221.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 61.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047471 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA047471: AB_2680061" "unprognostic (6.44e-2)" "unprognostic (2.89e-1)" "unprognostic (3.07e-2)" "unprognostic (1.02e-3)" "unprognostic (1.99e-1)" "unprognostic (2.57e-2)" "unprognostic (1.28e-3)" "unprognostic (5.89e-2)" "unprognostic (1.17e-1)" "unprognostic (6.89e-2)" "unprognostic (5.54e-2)" "unprognostic (1.17e-1)" "prognostic unfavorable (1.15e-7)" "unprognostic (2.07e-1)" "unprognostic (1.98e-1)" "unprognostic (9.11e-3)" "unprognostic (9.31e-2)" 16.0 9.7 6.2 11.9 6.8 35.0 16.7 5.9 7.1 14.0 11.1 6.0 11.9 6.2 14.0 15.8 16.7 16.7 11.6 15.1 5.7 6.4 12.8 18.0 13.7 15.4 8.1 5.2 23.8 15.0 5.8 13.9 17.6 7.5 19.2 9.4 11.0 12.7 14.0 18.1 14.9 9.5 13.6 7.6 17.4 11.1 17.2 5.7 18.3 24.7 15.9 16.3 20.5 24.1 41.8 34.2 9.9 19.9 30.5 32.0 25.6 14.1 15.8 9.6 10.0 6.7 6.6 8.9 8.7 9.7 14.2 14.3 10.4 13.9 16.9 13.0 8.6 23.6 16.6 11.2 22.7 13.9 8.1 10.5 12.5 3.5 18.4 10.1 13.3 9.5 5.8 15.2 13.7 19.5 5.6 11.2 12.5 16.5 16.7 10.9 18.3 27.4 23.4 8.0 25.4 35.0 19.0 15.5 19.7 8.5 11.9 15.6 9.1 7.9 21.3 16.1 6.1 11.9 15.4 7.1 14.5 11.9 12.0 16.6 11.6 11.0 19.2 4.1 61.8 10.7 9.7 14.5 9.9 25.7 19.9 31.4 41.8 26.0 26.7 20.8 37.2 32.0 28.9 3.5 30.5 14.2 34.2 17.7 25.6 6.2 6.8 5.9 7.1 5.7 6.4 8.1 5.2 7.5 5.7 14.9 13.3 51.6 95.5 208.9 10.2 6.9 10.2 17.4 18.2 19.2 3.9 59.8 34.9 30.3 19.6 43.0 5.5 46.7 27.1 61.1 67.7 54.5 76.0 12.8 40.7 11.1 18.0 29.4 12.1 10.0 47.8 37.4 102.9 27.9 21.2 17.6 31.6 7.0 37.8 18.2 16.0 6.5 78.3 63.1 77.2 221.6 33.6 44.0 27.7 89.4 NXT2 P15-2 ENSG00000101888 "Nuclear transport factor 2 like export factor 2" Q9NPJ8 X 109535781-109544690 "Predicted intracellular proteins" "mRNA transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 38.7" "Cell type enhanced" "Detected in many" 5 "monocytes: 45.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 48.9;U-937: 53.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024199, HPA072010" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA024199: AB_1854738, HPA072010: AB_2686483" "unprognostic (1.72e-1)" "unprognostic (1.39e-2)" "unprognostic (7.99e-2)" "unprognostic (5.31e-2)" "unprognostic (6.58e-2)" "unprognostic (3.69e-2)" "unprognostic (5.39e-2)" "unprognostic (3.14e-1)" "unprognostic (8.77e-2)" "unprognostic (3.36e-3)" "unprognostic (2.83e-3)" "unprognostic (1.14e-1)" "unprognostic (2.16e-3)" "unprognostic (2.59e-2)" "unprognostic (5.70e-2)" "unprognostic (2.56e-1)" "unprognostic (4.90e-2)" 10.1 6.5 10.4 6.0 9.7 12.3 12.9 3.7 8.4 8.1 6.2 9.0 1.3 7.4 4.7 6.1 10.1 5.8 5.0 3.3 9.9 6.9 7.7 9.6 6.4 9.2 10.1 6.3 5.5 7.9 5.5 2.6 17.4 10.6 6.9 7.0 3.8 8.8 3.6 2.6 10.0 9.1 5.9 11.4 7.6 6.7 38.7 9.1 14.0 7.3 6.3 11.1 7.4 7.2 7.4 11.4 4.2 11.6 12.3 11.6 9.3 4.4 3.9 3.8 6.6 5.7 4.6 8.4 2.8 4.8 3.7 4.8 3.0 6.3 5.7 9.0 3.5 10.0 3.4 5.0 4.4 5.6 7.4 3.1 4.8 3.8 5.0 2.3 48.9 20.1 3.3 3.9 3.5 2.2 2.7 3.2 6.0 5.0 23.6 3.6 4.6 7.4 5.2 6.1 6.3 5.9 2.9 5.4 6.8 3.4 4.4 1.5 4.8 12.2 6.9 3.8 3.5 2.9 16.6 2.4 5.3 3.0 7.0 2.9 4.9 6.0 8.7 4.6 53.7 5.4 3.9 8.5 4.2 11.6 11.6 7.5 7.4 8.7 9.5 11.4 6.8 8.6 8.4 1.8 12.3 9.2 7.0 9.9 9.3 10.4 9.7 3.7 8.4 9.9 6.9 10.1 6.3 10.6 9.1 3.0 6.2 5.6 17.9 17.1 1.3 25.0 0.0 8.1 12.5 3.5 0.0 13.0 18.3 10.9 10.7 4.7 5.5 0.0 12.3 20.9 7.8 17.5 5.7 4.4 10.2 0.0 1.2 3.7 7.5 4.0 4.4 9.0 1.7 45.9 5.0 7.1 7.8 8.4 4.2 12.5 0.9 12.9 6.8 17.7 31.4 20.5 24.4 9.5 5.9 19.2 NYNRIN "CGIN1, FLJ11811, KIAA1305" ENSG00000205978 "NYN domain and retroviral integrase containing" Q9P2P1 14 24398786-24419288 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 45.9" "Cell type enhanced" "Detected in many" 5 "Club cells: 12.5;Ito cells: 16.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 26.6" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.7" "Lineage enhanced" "Detected in single" "dendritic cells: 1.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 9.1;HEL: 9.1;HUVEC TERT2: 22.7;RT4: 18.7;TIME: 10.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018945 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA018945: AB_1859538" "unprognostic (9.41e-3)" "unprognostic (3.96e-2)" "unprognostic (2.02e-1)" "unprognostic (4.49e-3)" "unprognostic (5.08e-2)" "unprognostic (1.14e-2)" "unprognostic (2.56e-1)" "unprognostic (2.65e-2)" "unprognostic (1.44e-3)" "unprognostic (4.21e-1)" "unprognostic (1.01e-1)" "unprognostic (4.51e-2)" "unprognostic (3.59e-2)" "unprognostic (2.39e-2)" "unprognostic (1.86e-1)" "unprognostic (3.39e-1)" "unprognostic (2.43e-1)" 8.1 2.8 2.1 4.3 2.2 0.2 6.8 26.6 2.6 16.7 7.6 2.5 29.6 2.9 14.6 45.9 11.6 13.4 14.5 5.1 2.2 4.2 6.1 3.6 7.5 2.0 1.8 1.8 28.0 2.9 4.5 4.9 10.5 2.4 9.8 4.1 9.1 5.5 20.2 2.5 9.1 4.5 8.0 1.5 5.2 4.5 7.3 1.4 3.5 7.5 8.5 6.5 8.6 10.2 0.0 1.7 0.0 0.1 0.5 0.1 0.0 0.1 0.0 3.0 0.0 4.1 8.7 0.2 1.4 1.4 0.9 1.1 2.1 9.1 0.2 0.4 5.4 0.1 0.0 4.8 0.1 1.0 0.0 0.5 9.1 1.2 0.2 3.1 0.0 0.0 8.8 0.4 0.6 0.0 1.6 22.7 0.1 1.4 0.0 0.1 0.4 0.0 0.4 1.7 0.6 0.0 1.2 0.0 0.0 0.0 18.7 0.4 6.5 0.0 0.8 0.1 7.6 1.6 1.3 10.9 0.1 5.5 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.5 0.0 1.7 0.0 0.0 2.1 2.2 26.6 2.6 2.2 4.2 1.8 1.8 2.4 1.4 3.0 1.7 0.0 3.9 4.0 0.4 1.7 7.6 1.4 12.5 8.7 0.0 0.9 0.0 3.3 0.7 7.1 1.3 0.0 2.7 0.9 6.6 0.8 0.0 1.8 8.5 0.0 5.2 16.0 5.1 0.0 2.3 0.8 3.3 1.0 8.5 5.3 3.7 3.5 0.4 0.1 0.3 0.0 4.7 0.0 1.1 3.3 0.9 0.0 8.3 3.1 OAF MGC52117 ENSG00000184232 "Out at first homolog" Q86UD1 11 120210767-120230332 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 93.4" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 187.7;Muller glia cells: 261.4;Urothelial cells: 195.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 6.2;intermediate monocyte: 2.9;myeloid DC: 4.6" "Group enriched" "Detected in many" 12 "dendritic cells: 4.6;monocytes: 6.2" "Cell line enhanced" "Detected in many" "EFO-21: 35.0;Hep G2: 54.7;NB-4: 36.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047412 Uncertain Approved Nucleoplasm "Secreted - unknown location" NA NA 65000000 Nucleoplasm "HPA047412: AB_10960631" "unprognostic (1.59e-1)" "unprognostic (2.10e-2)" "unprognostic (1.40e-1)" "unprognostic (2.80e-1)" "unprognostic (5.69e-2)" "prognostic unfavorable (5.71e-5)" "unprognostic (2.11e-1)" "unprognostic (3.98e-3)" "unprognostic (5.09e-2)" "unprognostic (3.90e-2)" "unprognostic (3.28e-2)" "unprognostic (1.52e-2)" "unprognostic (1.07e-2)" "unprognostic (1.12e-2)" "unprognostic (7.15e-2)" "unprognostic (2.13e-1)" "unprognostic (1.95e-1)" 16.2 22.5 8.6 6.9 15.4 3.5 24.9 1.2 10.3 18.7 16.8 4.0 8.0 19.4 14.3 17.2 10.7 13.4 20.6 13.7 8.7 1.4 21.5 93.4 5.6 8.1 5.4 6.4 26.2 43.7 2.4 7.4 4.6 3.2 10.3 13.5 18.2 26.5 5.8 3.7 3.0 22.1 11.7 3.3 15.3 9.9 5.5 5.5 1.2 6.8 8.6 3.6 11.2 10.9 0.1 4.6 0.3 6.2 0.0 0.4 1.3 7.0 2.2 8.4 4.2 13.1 14.8 0.5 13.8 14.3 5.6 8.2 2.2 11.0 0.0 35.0 9.3 9.2 7.4 2.3 3.5 2.2 5.1 5.7 5.8 1.4 54.7 11.7 12.8 2.3 18.4 2.1 5.3 14.9 10.8 16.0 3.5 3.7 6.7 1.3 2.6 0.0 36.7 3.4 1.9 11.2 3.3 0.2 6.8 8.4 3.9 0.4 3.0 4.0 4.5 11.4 2.4 1.4 21.3 9.7 12.0 4.4 12.2 1.3 0.2 0.1 0.1 9.2 21.4 4.1 0.0 6.2 0.0 0.2 2.9 0.1 0.1 0.0 0.0 4.6 0.0 0.1 0.4 0.3 0.0 0.6 0.9 0.3 1.3 8.6 15.4 1.2 10.3 8.7 1.4 5.4 6.4 3.2 5.5 0.0 1.1 1.5 19.1 8.4 3.2 3.6 33.1 0.0 2.3 68.0 2.0 1.8 23.2 14.3 0.1 24.8 97.4 23.3 24.3 4.7 46.2 12.2 1.1 187.7 5.5 0.0 21.9 11.1 10.6 0.0 15.5 9.7 15.1 1.8 55.8 261.4 23.5 41.9 4.2 64.1 8.0 51.8 45.3 0.5 6.7 8.9 5.1 3.2 42.0 195.3 OARD1 "C6orf130, dJ34B21.3, MGC19570, TARG1" ENSG00000124596 "O-acyl-ADP-ribose deacylase 1" Q9Y530 6 41033627-41097787 "Predicted intracellular proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 72.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029036 Approved Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA029036: AB_10602336" "unprognostic (2.33e-2)" "unprognostic (5.23e-2)" "unprognostic (1.05e-1)" "unprognostic (1.92e-1)" "unprognostic (6.50e-2)" "unprognostic (1.45e-1)" "unprognostic (3.62e-2)" "unprognostic (7.06e-2)" "unprognostic (5.54e-2)" "unprognostic (3.99e-3)" "unprognostic (3.46e-2)" "unprognostic (2.15e-1)" "prognostic favorable (1.13e-4)" "unprognostic (4.78e-1)" "unprognostic (7.85e-2)" "unprognostic (1.70e-1)" "unprognostic (2.15e-1)" 14.6 19.1 19.1 15.8 19.3 15.3 19.3 13.2 20.2 13.6 17.4 18.8 30.3 19.1 12.6 26.6 15.8 20.1 15.9 13.5 19.1 18.6 27.8 35.4 16.2 24.8 21.4 19.6 22.5 25.3 21.6 22.4 13.8 20.9 16.8 20.4 17.6 15.9 24.2 16.7 14.9 17.9 15.8 21.4 16.2 22.7 44.7 20.9 21.4 24.6 14.2 20.7 16.0 14.1 27.6 16.5 23.4 16.2 27.4 24.4 13.2 11.4 7.4 16.0 10.8 9.2 10.6 9.5 7.0 10.1 8.4 9.4 11.1 8.4 15.8 7.8 4.3 9.2 8.5 9.9 9.5 12.5 13.9 5.4 19.2 7.8 20.8 8.7 13.2 12.6 8.3 14.0 8.1 27.9 7.6 5.8 20.5 24.4 13.6 9.0 17.1 21.4 15.5 15.1 72.4 4.9 10.0 14.0 15.4 16.6 6.3 16.8 11.3 6.6 6.7 23.0 12.8 11.8 12.2 6.0 8.7 10.3 5.6 12.1 18.0 17.9 35.3 7.2 13.4 7.4 20.4 13.8 23.4 17.2 14.2 21.6 27.6 19.7 17.0 16.5 25.8 24.4 23.2 13.4 27.4 16.2 16.0 21.8 13.2 19.1 19.3 13.2 20.2 19.1 18.6 21.4 19.6 20.9 20.9 14.9 40.0 42.2 37.8 25.3 59.8 37.9 43.3 57.6 34.2 57.6 43.2 77.5 72.9 37.0 142.4 30.6 31.5 0.0 42.0 52.6 25.1 27.9 47.3 57.2 39.6 39.7 21.2 19.6 46.1 120.0 26.2 34.7 33.7 36.9 47.2 59.6 29.7 43.8 24.4 76.7 60.3 25.8 35.0 186.5 159.6 25.6 38.1 48.9 57.7 23.1 OAS1 "IFI-4, OIAS, OIASI" ENSG00000089127 "2'-5'-oligoadenylate synthetase 1" P00973 12 112906777-112933222 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Nucleotidyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 83.9" "Cell type enhanced" "Detected in many" 9 "Hofbauer cells: 91.2;Urothelial cells: 142.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 83.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 50.8;BJ hTERT+ SV40 Large T+ RasG12V: 73.0;OE19: 48.0;U-266/70: 71.6;U-266/84: 54.4" "HPA003657, CAB021104" Uncertain Supported Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Nucleoplasm, Cytosol" "CAB021104: AB_10057722, HPA003657: AB_1854747" "unprognostic (1.03e-1)" "unprognostic (6.59e-2)" "unprognostic (8.56e-3)" "unprognostic (2.20e-3)" "unprognostic (2.78e-1)" "unprognostic (1.30e-1)" "unprognostic (2.00e-2)" "unprognostic (3.16e-2)" "unprognostic (1.37e-1)" "unprognostic (2.20e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (5.37e-2)" "unprognostic (1.63e-2)" "unprognostic (6.91e-2)" "unprognostic (3.68e-2)" "unprognostic (5.67e-2)" "prognostic favorable (6.12e-6)" 31.2 7.3 6.1 16.6 7.1 5.7 8.4 2.1 6.0 16.4 25.4 11.0 2.6 23.6 5.8 21.0 39.1 5.1 10.7 5.1 4.2 5.7 18.3 23.3 20.7 17.3 5.9 5.3 7.4 3.2 4.3 6.1 18.8 8.6 11.5 20.5 11.7 31.8 4.2 2.9 6.3 27.2 7.6 9.4 30.1 22.7 4.2 6.2 21.6 9.4 13.5 27.3 20.9 13.0 18.2 24.4 4.1 83.9 4.5 16.8 29.0 1.0 5.8 0.0 0.0 2.0 1.5 0.4 0.0 7.5 50.8 73.0 3.3 6.2 7.9 2.2 0.0 27.5 2.6 0.0 0.7 0.7 5.8 0.0 0.2 10.4 1.2 0.6 0.1 0.4 0.1 2.2 1.9 0.0 0.8 2.7 0.2 0.0 3.5 0.0 0.1 0.2 3.6 0.3 48.0 5.0 1.6 0.0 3.3 2.5 16.4 0.1 0.3 0.8 1.0 19.4 0.0 0.2 1.3 10.0 0.0 0.1 0.7 0.1 71.6 54.4 5.5 0.6 2.3 0.4 1.0 40.9 0.5 4.9 63.6 4.6 18.2 6.5 6.1 24.4 13.6 2.5 3.3 4.1 4.5 83.9 22.1 16.8 29.0 6.1 7.1 2.1 6.0 4.2 5.7 5.9 5.3 8.6 6.2 3.0 2.1 16.4 10.9 3.1 0.2 1.2 15.3 12.0 7.9 5.2 0.0 11.1 5.0 15.7 0.2 16.3 40.3 23.3 10.7 32.3 5.9 6.4 4.7 9.4 91.2 0.0 4.1 12.3 28.2 0.9 6.6 27.7 5.0 10.0 56.5 14.1 14.1 45.6 9.9 19.4 0.4 6.5 1.4 0.0 0.2 1.9 4.8 7.5 10.4 142.9 OAS3 ENSG00000111331 "2'-5'-oligoadenylate synthetase 3" Q9Y6K5 12 112938352-112973249 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Nucleotidyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Urothelial cells: 25.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 64.2;BJ hTERT+ SV40 Large T+ RasG12V: 70.2;GAMG: 31.4" "Not detected" "Not detected" "HPA041253, HPA041372" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" Yes No 21000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA041253: AB_10794990, HPA041372: AB_10795590" "unprognostic (8.47e-2)" "unprognostic (9.13e-2)" "unprognostic (1.27e-2)" "unprognostic (4.39e-3)" "unprognostic (2.59e-2)" "unprognostic (1.45e-1)" "unprognostic (4.14e-3)" "unprognostic (8.06e-3)" "unprognostic (3.19e-1)" "unprognostic (1.73e-2)" "unprognostic (2.29e-3)" "unprognostic (2.48e-1)" "prognostic unfavorable (2.23e-5)" "unprognostic (4.25e-2)" "unprognostic (1.37e-2)" "unprognostic (3.29e-2)" "unprognostic (2.93e-2)" 36.9 4.9 5.1 11.2 5.4 18.3 7.0 2.9 5.5 10.5 6.8 5.5 3.2 7.3 10.0 11.8 17.9 4.2 9.4 6.7 4.5 5.3 10.3 7.1 19.9 13.3 5.1 5.1 6.1 3.2 3.3 4.6 19.3 8.7 5.6 6.9 8.9 24.7 3.4 3.3 6.0 9.3 8.3 6.2 22.0 9.5 3.0 3.3 21.3 9.9 6.7 13.5 9.9 8.2 2.6 4.8 10.1 14.7 5.0 3.8 3.9 6.3 9.5 0.0 1.5 0.3 1.4 0.8 1.2 8.3 64.2 70.2 7.2 5.8 0.4 2.3 2.9 31.4 5.5 1.2 7.8 5.4 4.7 0.3 4.9 4.4 2.3 1.2 1.7 2.7 0.5 2.5 9.1 0.5 1.1 3.3 1.3 0.1 1.0 0.8 4.1 2.7 0.9 0.5 11.7 5.6 3.9 3.4 0.1 3.0 17.6 0.2 0.0 5.8 2.2 5.7 0.0 7.6 0.5 2.2 1.7 1.2 1.5 2.6 0.5 19.2 0.1 1.4 4.8 5.2 0.9 7.9 1.6 2.0 8.6 2.5 2.6 3.0 3.0 4.8 1.3 2.2 2.6 10.1 5.0 14.7 0.2 3.8 3.9 5.1 5.4 2.9 5.5 4.5 5.3 5.1 5.1 8.7 3.3 3.0 4.6 2.4 4.8 3.1 0.4 1.7 0.0 0.0 2.3 3.5 0.0 4.0 3.3 10.8 6.1 13.4 4.1 0.0 8.6 15.8 5.4 6.5 1.1 1.5 16.5 0.0 1.7 9.2 4.7 5.9 9.5 6.6 1.7 6.4 6.3 4.4 14.5 4.0 14.2 2.1 0.2 0.0 3.1 0.5 0.2 4.1 1.6 4.6 3.7 25.3 OASL "OASL1, p59OASL, TRIP14" ENSG00000135114 "2'-5'-oligoadenylate synthetase like" Q15646 12 121019111-121039242 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.5;bone marrow: 33.1" "Cell type enriched" "Detected in many" 4 "Urothelial cells: 72.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 52.2;BJ hTERT+ SV40 Large T+ RasG12V: 26.9;GAMG: 14.8;hTEC/SVTERT24-B: 20.9" "Not detected" "Not detected" HPA001474 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA001474: AB_1079518" "unprognostic (2.39e-2)" "unprognostic (7.50e-2)" "unprognostic (1.07e-1)" "unprognostic (2.47e-2)" "unprognostic (2.76e-1)" "unprognostic (1.50e-1)" "unprognostic (1.03e-1)" "unprognostic (1.62e-2)" "unprognostic (6.22e-2)" "unprognostic (5.93e-3)" "prognostic unfavorable (9.20e-4)" "unprognostic (4.61e-1)" "prognostic unfavorable (3.70e-9)" "unprognostic (2.52e-1)" "unprognostic (2.72e-2)" "unprognostic (1.18e-1)" "unprognostic (3.17e-2)" 20.5 0.5 1.0 8.3 1.4 33.1 2.7 0.4 1.9 3.6 5.9 1.7 0.1 1.6 1.7 1.3 4.7 0.6 3.1 2.2 0.7 0.9 4.0 22.6 16.5 1.9 1.3 1.2 1.4 0.4 0.2 0.8 3.6 2.3 2.5 3.0 2.3 3.4 0.3 1.1 0.8 2.0 1.1 1.9 5.2 15.7 2.1 0.6 6.0 3.2 3.7 7.6 2.9 1.5 0.8 3.2 44.5 10.8 6.9 23.6 10.8 1.0 0.2 0.0 0.3 0.4 0.9 0.0 0.1 0.5 52.2 26.9 0.0 5.0 0.3 1.5 0.0 14.8 2.7 0.0 0.3 3.8 9.2 0.0 0.0 5.2 0.0 0.3 0.0 0.7 0.3 0.2 20.9 0.0 0.1 0.1 0.3 0.0 1.8 0.2 0.5 0.0 2.7 0.0 1.8 1.1 0.0 0.1 0.6 0.2 4.9 0.0 0.0 0.4 0.2 8.2 0.0 0.1 0.8 0.0 0.2 0.4 0.6 0.1 2.0 3.7 0.0 7.8 0.4 0.1 4.2 10.3 22.4 20.4 10.8 5.3 0.8 14.1 23.6 3.2 0.3 4.0 15.7 44.5 6.9 7.4 0.1 9.9 10.8 1.0 1.4 0.4 1.9 0.7 0.9 1.3 1.2 2.3 0.6 0.0 6.2 0.0 3.8 1.9 0.0 0.3 0.0 4.0 3.4 0.0 0.0 0.2 0.0 2.7 3.1 2.1 4.2 0.0 3.4 0.6 0.5 1.1 11.5 3.9 12.3 0.0 1.7 0.0 4.0 2.5 0.3 6.8 0.0 4.6 15.9 0.0 7.4 3.5 0.0 0.3 0.0 0.0 2.2 1.9 0.1 0.9 0.1 17.3 1.2 72.1 OAT HOGA ENSG00000065154 "Ornithine aminotransferase" P04181 10 124397303-124418976 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Aminotransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 208.5" "Cell type enhanced" "Detected in all" 5 "Erythroid cells: 303.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB033576, HPA040098, HPA064742" Enhanced Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB033576: AB_2298892, HPA040098: AB_10793955, HPA064742: AB_2685343" "unprognostic (1.61e-2)" "unprognostic (1.70e-2)" "unprognostic (9.96e-2)" "unprognostic (1.02e-2)" "unprognostic (1.34e-1)" "unprognostic (1.05e-1)" "unprognostic (2.03e-1)" "unprognostic (4.43e-3)" "unprognostic (1.65e-1)" "unprognostic (2.37e-2)" "unprognostic (2.45e-1)" "unprognostic (7.62e-2)" "unprognostic (1.70e-2)" "unprognostic (2.21e-1)" "unprognostic (2.19e-1)" "unprognostic (2.72e-2)" "unprognostic (2.00e-2)" 13.5 37.1 25.9 9.1 26.7 20.3 33.8 17.2 39.8 24.7 71.9 22.8 33.9 164.0 21.6 15.5 26.1 14.9 16.0 12.7 25.6 29.8 25.6 36.8 11.6 9.3 27.9 30.1 21.8 12.3 12.1 18.0 14.8 37.8 17.9 15.8 13.3 55.2 29.1 13.7 16.3 208.5 22.5 25.5 8.4 17.3 14.6 19.4 4.9 15.9 23.1 15.2 15.5 18.2 10.2 26.5 23.0 23.6 9.6 20.1 16.3 42.0 7.6 5.0 17.9 51.0 49.3 17.1 25.5 52.1 22.8 25.0 19.5 5.5 0.0 18.6 43.0 21.7 44.8 22.8 47.7 24.8 7.4 31.6 47.1 5.3 14.5 26.3 0.0 31.1 32.2 24.6 20.5 24.0 37.8 26.5 8.7 81.0 9.1 31.8 10.9 12.4 2.6 10.0 12.9 10.8 11.6 19.1 11.4 21.8 0.7 10.5 11.2 16.0 42.8 35.9 30.1 14.2 11.6 20.4 13.0 12.2 21.5 15.8 7.8 8.1 11.4 18.0 12.7 6.2 18.6 23.6 20.7 18.5 20.7 20.1 9.6 15.6 19.4 26.5 10.2 19.6 19.1 23.0 9.6 20.8 5.7 14.4 16.3 25.9 26.7 17.2 39.8 25.6 29.8 27.9 30.1 37.8 19.4 17.9 38.8 36.2 123.3 134.4 27.8 14.0 22.9 44.2 75.1 33.2 25.5 97.9 76.3 32.5 16.9 35.8 49.1 303.7 12.0 67.3 125.7 58.3 43.8 69.3 56.5 41.3 41.3 35.6 32.6 9.0 96.4 49.4 81.0 20.8 48.6 32.0 11.7 36.8 112.8 114.0 21.3 77.6 123.8 32.5 27.0 110.2 40.3 40.6 67.9 76.5 OAZ3 ENSG00000143450 "Ornithine decarboxylase antizyme 3" Q9UMX2 1 151762899-151771334 "Predicted intracellular proteins" "Polyamine biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "testis: 102.2" "Cell type enriched" "Detected in many" 4 "Late spermatids: 9340.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030136, HPA045808" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA030136: AB_2673331, HPA045808: " "unprognostic (2.12e-1)" "unprognostic (3.86e-1)" "unprognostic (1.53e-1)" "unprognostic (5.44e-3)" "unprognostic (1.71e-1)" "unprognostic (1.01e-2)" "unprognostic (1.48e-3)" "unprognostic (1.08e-1)" "unprognostic (1.73e-2)" "unprognostic (1.01e-4)" "unprognostic (1.57e-2)" "unprognostic (2.89e-1)" "unprognostic (8.05e-6)" "unprognostic (3.94e-2)" "unprognostic (1.32e-1)" "unprognostic (2.50e-2)" "unprognostic (8.36e-2)" 0.4 0.3 0.5 0.7 0.5 0.0 0.6 0.6 0.6 0.3 0.4 0.4 0.7 0.1 0.3 2.0 0.4 0.2 0.3 0.6 0.5 0.5 0.5 0.8 0.6 0.8 0.5 0.5 0.3 0.6 1.4 0.6 0.3 0.4 4.0 0.5 0.3 3.1 0.7 1.0 0.3 0.3 0.5 0.6 0.6 0.2 102.2 0.2 0.3 0.8 0.7 0.4 0.4 0.6 1.4 3.2 2.2 5.0 2.6 2.4 1.6 1.2 2.3 1.4 3.3 1.1 3.3 2.9 2.3 0.6 2.2 1.0 1.3 3.1 1.0 2.0 0.7 1.6 1.2 1.3 2.3 0.7 7.3 6.9 1.1 4.4 1.8 1.3 0.6 1.3 5.1 1.4 2.6 3.5 1.4 3.4 3.0 1.4 3.7 2.3 9.7 0.9 1.6 3.3 4.6 2.5 0.4 1.1 1.7 0.4 2.9 1.5 3.6 1.0 5.2 4.6 3.2 10.4 2.7 3.0 1.3 0.7 2.6 1.3 5.1 9.5 2.6 1.7 1.6 3.5 2.2 3.0 0.6 1.4 1.5 1.3 1.4 1.3 2.4 3.2 1.2 1.5 2.2 2.1 2.6 5.0 1.3 2.2 1.6 0.5 0.5 0.6 0.4 0.5 0.5 0.5 0.5 0.4 0.2 0.0 1.7 0.0 2.1 0.7 0.6 1.2 0.0 2.7 1.2 0.0 2.0 1.4 1.7 1.8 2210.4 2.7 3.0 0.0 2.7 2.3 1.1 27.3 1.1 2.6 4.0 0.0 3.5 1.8 4.0 9340.9 42.6 1.1 1.7 2.8 7.2 1.6 2.5 4.2 40.0 2.8 1.6 0.0 0.8 57.9 27.9 0.5 1.3 0.0 1.8 3.1 ODAM "APin, FLJ20513" ENSG00000109205 "Odontogenic, ameloblast associated" A1E959 4 70196496-70204576 "Cancer-related genes, Predicted intracellular proteins" Biomineralization "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "salivary gland: 157.7" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 3.4;Ductal cells: 6.3;Exocrine glandular cells: 7.3;Pancreatic endocrine cells: 3.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "Hep G2: 24.2;OE19: 16.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036279, HPA036543, HPA070297" Supported Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA036279: , HPA036543: AB_10669797, HPA070297: " "unprognostic (2.34e-2)" "unprognostic (2.43e-1)" "unprognostic (1.26e-1)" "unprognostic (1.75e-1)" "unprognostic (3.34e-3)" "unprognostic (1.06e-1)" "unprognostic (1.88e-2)" "unprognostic (3.47e-1)" "unprognostic (3.08e-1)" "unprognostic (3.03e-1)" "unprognostic (2.72e-1)" "unprognostic (1.86e-2)" "unprognostic (2.50e-2)" 0.0 0.2 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.8 0.0 2.5 0.2 0.1 1.9 0.1 0.1 0.1 0.0 0.0 0.2 0.5 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.5 0.2 0.2 0.0 0.4 0.1 0.0 157.7 2.6 0.0 0.0 0.3 1.9 0.1 0.0 2.5 0.0 0.0 0.0 5.1 10.6 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 24.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.0 3.4 0.0 1.1 0.0 0.0 0.0 2.5 0.0 2.3 1.8 0.0 0.3 0.0 6.3 0.0 0.0 0.0 0.0 7.3 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 ODF3L2 "C19orf19, FLJ40059" ENSG00000181781 "Outer dense fiber of sperm tails 3 like 2" Q3SX64 19 463346-474983 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 26 "skeletal muscle: 12.5;testis: 16.7" "Cell type enriched" "Detected in some" 5 "Late spermatids: 894.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.5;BEWO: 2.2;EFO-21: 3.1;HMC-1: 2.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA067065, HPA067973" Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA Nucleoli "Nucleoplasm, Golgi apparatus" "HPA067065: , HPA067973: AB_2685937" "unprognostic (3.75e-4)" "unprognostic (1.79e-2)" "unprognostic (1.83e-3)" "unprognostic (9.69e-3)" "unprognostic (5.88e-2)" "unprognostic (5.65e-2)" "unprognostic (9.32e-2)" "unprognostic (1.35e-1)" "unprognostic (2.34e-2)" "unprognostic (1.77e-2)" "unprognostic (2.13e-2)" "unprognostic (4.06e-2)" "unprognostic (2.02e-5)" "unprognostic (3.13e-3)" "unprognostic (8.99e-2)" "unprognostic (3.05e-1)" "unprognostic (1.99e-1)" 0.4 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.3 0.5 0.0 16.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.5 0.0 0.0 2.2 0.0 0.1 0.1 0.1 0.0 0.0 0.1 3.1 0.0 0.5 0.1 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.3 2.3 0.0 0.3 0.0 0.2 1.1 0.0 0.0 0.6 0.1 0.6 1.0 0.1 0.0 0.8 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.9 0.0 0.5 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 187.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 894.9 7.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.6 0.0 0.7 0.0 0.1 6.4 5.2 0.0 0.0 0.0 0.0 0.0 ODR4 "C1orf27, FLJ20505, odr-4, TTG1" ENSG00000157181 "Odr-4 GPCR localization factor homolog" Q5SWX8 1 186375838-186421378 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 28.6;Ciliated cells: 28.1;Club cells: 54.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015988, HPA031352" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA015988: AB_1845644, HPA031352: AB_2673838" "unprognostic (1.19e-2)" "unprognostic (4.23e-2)" "unprognostic (1.12e-2)" "unprognostic (3.07e-2)" "unprognostic (1.08e-1)" "unprognostic (1.30e-2)" "unprognostic (2.11e-1)" "unprognostic (8.57e-2)" "unprognostic (8.11e-3)" "prognostic favorable (9.92e-4)" "unprognostic (1.15e-2)" "unprognostic (9.85e-2)" "unprognostic (2.18e-2)" "unprognostic (1.34e-1)" "unprognostic (3.50e-2)" "unprognostic (1.03e-2)" "unprognostic (4.20e-2)" 11.9 15.9 18.2 7.0 22.9 12.2 13.7 27.7 18.7 13.9 10.3 11.4 16.2 12.5 9.6 16.6 9.5 9.1 10.3 11.8 14.3 11.3 16.1 20.0 10.4 6.1 21.9 14.0 12.1 26.5 44.8 26.5 13.4 16.0 16.1 12.8 9.7 18.3 15.3 10.3 9.5 14.8 9.0 21.3 10.1 12.8 8.1 19.1 9.0 19.0 10.1 6.9 10.4 9.7 4.1 8.6 4.4 11.8 10.6 6.2 4.6 7.5 8.5 9.5 7.5 11.6 11.1 18.0 12.4 7.9 8.1 8.0 16.7 17.5 5.4 14.8 6.1 7.3 19.5 6.9 6.6 7.8 4.7 7.1 5.0 10.9 9.5 10.7 8.3 6.3 8.4 13.5 9.4 15.2 8.5 8.6 5.6 18.9 11.0 9.8 8.0 5.9 8.2 13.1 29.4 2.9 6.7 6.4 14.8 16.0 7.7 6.8 10.6 9.4 20.3 14.4 17.5 17.7 7.2 7.9 11.3 7.1 7.8 11.5 13.4 8.1 8.4 6.3 4.5 10.2 1.5 10.5 2.7 3.8 10.0 5.5 4.1 4.8 5.0 8.6 3.1 6.0 4.6 4.4 10.6 11.8 5.4 6.2 4.6 18.2 22.9 27.7 18.7 14.3 11.3 21.9 14.0 16.0 19.1 26.8 28.6 0.0 0.0 0.0 0.0 0.0 0.0 28.1 54.6 24.4 0.0 20.7 8.3 18.4 0.0 0.0 0.0 0.0 22.2 19.9 0.0 0.0 11.6 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 11.8 0.0 0.0 21.7 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 OGFOD1 "FLJ10826, KIAA1612, TPA1" ENSG00000087263 "2-oxoglutarate and iron dependent oxygenase domain containing 1" Q8N543 16 56451490-56479100 "Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 56.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003215, HPA003722" Approved Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003215: AB_1078881, HPA003722: " "unprognostic (1.13e-1)" "unprognostic (4.52e-2)" "unprognostic (3.80e-3)" "unprognostic (2.86e-2)" "unprognostic (2.48e-3)" "prognostic unfavorable (6.65e-4)" "prognostic unfavorable (7.02e-4)" "unprognostic (5.51e-2)" "unprognostic (6.87e-2)" "unprognostic (3.36e-2)" "unprognostic (1.58e-2)" "unprognostic (4.59e-2)" "unprognostic (7.49e-2)" "unprognostic (7.20e-2)" "unprognostic (6.11e-2)" "unprognostic (1.25e-1)" "unprognostic (1.84e-2)" 8.8 13.4 10.0 8.0 11.6 3.3 9.4 10.3 14.3 10.8 7.0 12.4 6.0 7.4 9.5 8.4 18.1 10.1 7.8 12.9 7.7 11.1 12.9 13.9 7.5 7.5 9.1 10.4 10.2 6.5 13.7 13.1 8.3 15.6 8.0 8.9 8.5 8.4 10.0 56.1 8.8 5.8 15.1 11.1 8.6 7.4 8.2 6.2 10.6 9.3 12.6 13.0 9.6 8.3 7.8 7.5 11.8 8.9 8.7 12.1 6.5 11.3 13.4 13.2 16.4 15.0 18.1 12.4 18.5 14.9 26.3 19.1 16.3 8.3 20.8 9.5 14.7 11.2 16.3 27.9 12.6 29.8 6.4 15.0 15.1 11.7 16.8 11.5 16.3 17.8 12.0 14.4 19.5 16.3 11.4 21.3 14.0 21.0 4.0 22.2 7.3 12.9 9.3 22.4 10.1 23.2 24.2 20.2 24.2 11.8 8.2 10.6 11.8 22.9 14.8 12.4 14.7 13.5 13.5 13.9 14.7 11.7 11.2 16.3 8.2 15.8 30.5 11.7 11.8 11.6 11.8 4.7 4.8 8.8 6.3 11.9 7.8 11.2 10.4 7.1 6.1 12.1 10.0 1.7 8.7 8.9 7.5 9.3 6.5 10.0 11.6 10.3 14.3 7.7 11.1 9.1 10.4 15.6 6.2 3.0 13.6 19.9 10.7 15.8 10.3 17.9 17.8 8.1 18.2 8.7 9.8 14.3 21.6 13.0 17.1 11.2 3.9 23.3 12.0 16.6 20.5 7.5 45.0 15.3 10.6 12.7 2.4 9.8 8.1 14.5 11.2 11.3 10.1 19.8 6.3 12.1 13.7 5.8 14.9 11.0 14.1 12.9 17.8 14.6 28.1 16.6 9.7 15.0 9.5 7.1 OGFOD2 "FLJ13491, FLJ37501" ENSG00000111325 "2-oxoglutarate and iron dependent oxygenase domain containing 2" Q6N063 12 122974580-122980043 "Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 8 "Early spermatids: 85.8;Late spermatids: 337.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039448, HPA040306" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA039448: AB_10795035, HPA040306: AB_10794026" "unprognostic (2.14e-1)" "unprognostic (2.47e-1)" "unprognostic (6.86e-2)" "unprognostic (3.36e-1)" "unprognostic (3.09e-2)" "unprognostic (1.57e-2)" "unprognostic (6.12e-3)" "unprognostic (1.14e-1)" "unprognostic (8.44e-2)" "unprognostic (1.33e-1)" "unprognostic (1.07e-3)" "unprognostic (2.48e-3)" "unprognostic (1.13e-3)" "unprognostic (1.88e-1)" "unprognostic (1.38e-1)" "unprognostic (2.60e-2)" "unprognostic (1.13e-1)" 6.2 15.0 8.9 11.7 11.7 10.0 7.5 13.4 10.6 7.5 13.4 11.6 14.1 18.5 9.6 14.9 11.2 12.8 13.1 8.5 8.0 8.8 12.9 18.9 8.0 13.4 14.5 9.3 11.6 24.3 10.9 13.5 10.6 13.4 11.4 7.8 9.7 20.1 14.6 13.2 15.9 17.9 8.7 8.0 14.4 11.5 25.1 13.8 10.9 13.3 10.8 12.0 7.4 8.0 16.4 13.4 18.0 16.6 8.8 15.6 9.3 7.2 11.8 4.9 8.0 3.4 3.7 13.3 4.4 4.6 6.2 5.6 11.0 6.5 8.1 9.2 3.8 3.6 10.5 3.5 6.0 2.3 5.6 7.7 12.9 10.0 11.4 7.4 12.8 10.1 5.4 9.1 5.7 5.1 9.0 6.5 15.8 14.9 6.0 3.1 13.9 10.7 24.2 3.0 5.0 15.1 12.0 4.7 14.3 4.7 6.5 6.3 5.8 6.0 8.7 8.3 3.4 21.9 11.0 4.1 8.5 8.7 10.0 4.5 15.2 9.1 7.7 11.7 6.7 8.2 12.5 12.2 18.0 10.1 13.1 8.7 16.4 8.2 9.8 13.4 11.4 9.3 8.5 10.0 8.8 16.6 8.0 15.6 9.3 8.9 11.7 13.4 10.6 8.0 8.8 14.5 9.3 13.4 13.8 0.0 6.5 8.4 5.1 2.6 3.3 0.3 7.6 28.1 6.8 12.2 2.0 21.9 8.3 9.9 85.8 5.4 10.7 0.0 13.0 12.2 4.3 4.0 0.0 18.7 11.3 11.1 2.4 6.2 11.4 337.1 8.1 5.2 6.8 5.4 9.6 7.3 11.3 7.0 4.2 23.7 5.8 12.9 2.7 25.1 15.2 4.0 13.7 7.2 11.0 2.4 OGFOD3 "C17orf101, FLJ22222" ENSG00000181396 "2-oxoglutarate and iron dependent oxygenase domain containing 3" Q6PK18 17 82389223-82418637 "Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052099 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA052099: AB_2681725" "unprognostic (1.12e-2)" "unprognostic (5.85e-2)" "unprognostic (9.66e-2)" "unprognostic (9.69e-2)" "unprognostic (4.11e-3)" "unprognostic (2.09e-1)" "unprognostic (2.80e-2)" "unprognostic (1.99e-1)" "unprognostic (5.41e-2)" "unprognostic (7.15e-2)" "unprognostic (8.05e-3)" "unprognostic (2.95e-1)" "prognostic favorable (5.72e-4)" "unprognostic (7.43e-2)" "unprognostic (1.40e-1)" "unprognostic (7.08e-2)" "unprognostic (1.02e-1)" 12.9 18.0 7.6 11.3 10.4 10.2 12.1 15.4 13.7 12.0 11.1 14.3 21.8 11.5 14.7 24.9 10.7 15.0 19.0 20.9 7.2 8.5 13.7 16.8 14.4 12.3 9.1 11.9 15.1 30.0 15.3 20.4 12.8 9.0 13.8 6.6 13.9 21.8 22.9 24.4 11.3 11.6 13.4 10.7 10.5 13.0 9.8 8.6 6.9 18.8 17.0 12.8 11.6 12.0 10.1 18.5 3.1 10.3 5.2 10.9 5.2 12.6 15.9 5.3 17.8 10.4 13.2 9.3 13.0 12.1 13.4 13.9 17.0 17.3 8.6 10.4 10.0 13.7 9.5 4.6 10.8 5.6 6.8 14.2 13.3 12.2 21.5 9.3 15.2 15.6 10.5 8.1 6.2 5.4 9.8 14.0 9.7 16.6 6.8 3.9 11.9 10.3 15.8 5.0 13.3 19.4 7.0 10.4 13.2 7.6 11.8 11.6 23.1 22.3 20.4 10.4 4.7 12.1 20.0 10.8 25.4 16.0 9.9 16.4 12.1 1.0 8.2 15.8 8.9 13.1 0.1 10.3 3.1 5.4 9.4 6.1 10.1 7.8 10.9 18.5 8.8 9.4 7.8 1.3 5.2 6.3 9.6 2.9 5.2 7.6 10.4 15.4 13.7 7.2 8.5 9.1 11.9 9.0 8.6 23.8 13.9 24.6 17.8 10.1 21.1 15.3 17.8 8.1 12.5 21.0 9.8 33.4 8.3 22.5 21.6 17.6 23.8 0.0 27.3 50.7 23.5 29.8 9.2 23.5 34.2 28.6 27.6 5.5 19.2 32.5 19.2 14.7 13.5 28.9 21.9 11.9 20.3 31.6 17.7 21.4 14.4 6.5 15.6 10.7 9.1 11.2 26.5 11.7 28.7 25.3 OGFR 7-60 ENSG00000060491 "Opioid growth factor receptor" Q9NZT2 20 62804835-62814000 "Predicted intracellular proteins" "Growth regulation" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 13.0;neutrophil: 3.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 13.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017899 Supported Approved Nucleoplasm NA NA 11000 Nucleoplasm "HPA017899: AB_1854774" "unprognostic (1.33e-2)" "unprognostic (3.28e-2)" "unprognostic (2.32e-2)" "unprognostic (1.71e-1)" "unprognostic (1.76e-1)" "unprognostic (3.04e-1)" "unprognostic (1.23e-2)" "unprognostic (5.87e-2)" "unprognostic (5.39e-3)" "unprognostic (2.16e-1)" "unprognostic (4.58e-2)" "unprognostic (4.21e-2)" "unprognostic (2.46e-3)" "unprognostic (1.60e-2)" "unprognostic (4.53e-2)" "unprognostic (3.49e-1)" "prognostic favorable (5.19e-4)" 21.8 15.9 25.9 30.4 18.4 33.0 16.8 18.7 34.6 18.2 24.4 13.9 22.1 30.5 17.8 16.3 14.1 17.8 22.4 21.0 23.6 19.3 19.7 38.8 27.4 27.9 14.5 18.1 23.4 23.0 15.1 20.8 22.3 17.5 22.0 11.3 15.1 31.3 18.3 25.6 23.2 29.2 19.5 13.1 38.7 23.4 10.3 16.3 21.0 22.2 12.6 20.2 18.3 29.3 1.6 1.1 13.0 1.8 0.7 1.1 0.4 18.6 12.6 7.7 10.0 7.7 8.6 21.4 11.9 12.5 44.9 19.8 28.5 13.9 23.0 21.9 9.7 22.9 21.8 9.0 14.3 11.0 7.0 14.1 11.2 15.9 25.7 12.7 13.9 26.6 10.7 10.5 10.9 4.6 12.5 9.5 14.2 10.4 11.7 7.1 27.8 28.8 25.4 5.0 9.6 24.5 22.8 13.7 10.1 6.2 10.1 7.7 11.5 16.4 22.6 17.9 7.4 11.4 20.9 12.9 23.8 20.9 18.4 16.8 14.8 4.2 12.3 19.0 14.7 9.1 1.8 1.8 13.0 0.8 1.6 0.5 1.1 1.1 1.0 1.1 1.6 1.1 0.7 3.8 0.7 1.5 0.9 0.6 0.4 25.9 18.4 18.7 34.6 23.6 19.3 14.5 18.1 17.5 16.3 8.9 16.7 30.8 28.9 24.0 59.6 4.1 35.7 6.7 6.8 15.7 88.4 23.2 10.0 31.3 1.7 20.7 32.0 0.0 28.4 42.5 25.4 26.6 0.0 43.1 51.9 41.3 17.2 23.4 71.5 1.9 30.2 39.0 15.1 42.3 24.4 31.6 29.0 31.7 17.7 21.2 39.1 19.4 20.6 1.4 4.1 20.5 23.3 37.0 21.0 27.5 OGFRL1 dJ331H24.1 ENSG00000119900 "Opioid growth factor receptor like 1" Q5TC84 6 71288803-71308950 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 52.2" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 79.5;Macrophages: 93.2;Muller glia cells: 83.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 12.8" "Lineage enriched" "Detected in many" 4 "granulocytes: 12.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027122 Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA027122: AB_2156775" "unprognostic (8.44e-3)" "unprognostic (1.41e-2)" "unprognostic (2.48e-1)" "unprognostic (1.95e-1)" "unprognostic (2.52e-1)" "unprognostic (4.24e-3)" "prognostic unfavorable (3.62e-4)" "unprognostic (9.62e-3)" "unprognostic (2.30e-2)" "unprognostic (2.49e-1)" "unprognostic (4.22e-2)" "unprognostic (2.11e-1)" "unprognostic (1.39e-2)" "unprognostic (1.27e-1)" "unprognostic (1.37e-1)" "unprognostic (3.25e-2)" "unprognostic (5.58e-3)" 16.9 8.7 20.2 11.3 26.8 16.9 36.0 22.3 33.3 6.7 7.2 29.1 2.8 2.9 8.3 10.7 24.5 5.2 8.3 5.8 30.2 17.6 5.7 4.8 8.5 9.6 27.7 18.3 5.4 6.0 5.8 10.0 9.9 37.8 6.7 4.3 3.3 31.8 10.3 4.1 14.6 5.7 24.1 52.2 11.7 5.4 2.4 29.1 3.2 4.8 4.3 17.8 5.4 9.4 0.7 2.4 12.8 3.0 0.5 0.5 0.6 3.8 1.1 4.1 0.0 11.2 10.3 1.5 17.4 10.8 7.0 7.2 1.4 0.7 23.7 24.0 7.5 6.5 1.9 3.1 12.0 25.0 5.0 2.5 5.2 4.2 0.6 9.1 2.4 1.8 10.3 10.3 5.2 16.4 5.9 5.6 0.0 0.3 1.9 24.1 3.2 0.0 3.8 1.7 1.5 1.0 1.6 12.6 5.4 16.3 0.3 14.1 6.4 5.1 3.2 1.1 6.2 5.5 19.2 8.6 17.3 8.7 1.8 5.7 2.5 0.1 3.1 5.8 16.5 3.0 3.1 3.0 0.1 0.5 2.0 0.5 0.4 0.4 0.5 2.4 0.7 0.1 0.3 12.8 0.5 1.4 0.9 0.2 0.6 20.2 26.8 22.3 27.4 30.2 17.6 27.7 18.3 37.8 29.1 6.0 21.8 14.3 18.0 34.6 15.3 7.8 5.1 1.4 11.4 10.4 23.6 19.2 1.7 12.9 0.4 21.0 0.0 0.0 27.8 10.1 31.4 13.9 5.8 4.0 53.5 36.5 13.8 8.6 79.5 1.1 15.3 93.2 30.4 27.9 2.4 83.6 18.3 0.0 31.1 3.1 5.0 25.8 18.6 0.4 1.1 40.7 15.9 12.1 4.3 14.9 OGG1 "HMMH, HOGG1, MUTM, OGH1" ENSG00000114026 "8-oxoguanine DNA glycosylase" O15527 3 9749944-9788219 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Glycosidase, Hydrolase, Lyase, Multifunctional enzyme" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Proximal tubular cells: 65.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027514, CAB047301" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB047301: , HPA027514: AB_10602189" "unprognostic (6.95e-2)" "unprognostic (7.82e-3)" "unprognostic (7.19e-2)" "unprognostic (1.24e-3)" "unprognostic (9.69e-2)" "unprognostic (1.97e-2)" "prognostic unfavorable (5.77e-5)" "unprognostic (7.83e-2)" "unprognostic (2.45e-2)" "unprognostic (3.43e-3)" "unprognostic (9.66e-3)" "unprognostic (4.23e-2)" "prognostic favorable (2.65e-4)" "unprognostic (2.06e-2)" "unprognostic (2.24e-1)" "unprognostic (1.65e-1)" "unprognostic (1.59e-1)" 10.4 12.9 15.4 28.5 16.2 12.7 11.5 22.0 17.7 16.7 18.8 16.2 10.5 22.0 16.2 13.1 10.0 14.7 12.1 10.7 14.7 10.8 30.1 17.8 9.9 28.5 12.3 14.1 22.5 12.0 5.8 10.2 10.3 15.3 14.4 10.2 14.6 14.3 13.2 7.4 11.5 28.2 12.1 13.6 14.1 10.8 7.3 15.6 19.8 12.2 6.3 25.5 12.2 13.3 12.2 11.9 15.4 8.5 19.4 15.4 8.3 5.7 10.8 10.9 6.8 10.7 12.3 20.2 7.5 7.8 11.6 13.9 10.3 5.7 35.2 5.0 9.5 18.5 5.6 6.4 8.2 4.9 12.5 9.2 17.5 17.4 14.8 11.3 6.8 11.2 12.2 10.6 20.0 8.5 9.4 14.3 5.0 5.5 5.7 11.0 10.8 5.4 6.7 5.8 5.2 15.5 4.0 7.4 11.4 6.5 2.9 4.9 8.6 9.7 7.9 5.8 5.9 12.4 11.6 9.2 11.8 12.4 9.2 12.3 5.7 8.2 18.1 9.5 19.6 7.2 11.3 8.5 15.4 15.1 6.6 14.6 10.4 13.0 12.3 7.6 12.2 10.2 9.6 2.1 19.4 5.3 11.9 15.4 8.3 15.4 16.2 22.0 17.7 14.7 10.8 12.3 14.1 15.3 15.6 0.0 4.3 24.5 8.6 4.8 19.3 2.0 7.6 4.0 2.3 8.7 33.4 5.4 10.0 7.2 0.6 8.3 10.4 23.3 5.9 8.2 9.7 5.0 2.3 8.5 15.7 7.9 17.2 6.7 6.7 0.9 13.3 8.2 6.8 12.6 7.6 10.3 7.1 10.1 12.7 65.4 29.4 25.8 9.0 8.3 15.3 4.0 3.3 13.8 12.2 4.3 OGT "FLJ23071, HRNT1, MGC22921, O-GLCNAC, OGT1" ENSG00000147162 "O-linked N-acetylglucosamine (GlcNAc) transferase" O15294 X 71533083-71575897 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Biological rhythms, Host-virus interaction, Ubl conjugation pathway" "Chromatin regulator, Glycosyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030751, HPA030752, HPA030753, HPA030754, CAB034099" Approved Supported "Nucleoplasm,Plasma membrane" Yes No Nucleoplasm "Plasma membrane" "CAB034099: AB_2157067, HPA030751: AB_10600217, HPA030752: AB_10601445, HPA030753: AB_2673594, HPA030754: AB_2673595" "unprognostic (1.37e-1)" "unprognostic (2.20e-1)" "unprognostic (2.32e-2)" "prognostic unfavorable (8.33e-4)" "unprognostic (3.40e-2)" "prognostic favorable (1.97e-4)" "unprognostic (9.56e-3)" "unprognostic (1.96e-3)" "unprognostic (5.58e-2)" "unprognostic (2.29e-1)" "unprognostic (1.06e-1)" "unprognostic (9.74e-3)" "prognostic unfavorable (2.36e-6)" "unprognostic (2.99e-3)" "unprognostic (2.28e-1)" "unprognostic (8.03e-3)" "prognostic favorable (6.85e-7)" 26.1 24.0 33.3 39.7 36.6 38.7 33.7 75.7 43.8 25.0 23.0 22.0 31.1 22.5 36.7 48.3 24.3 33.4 21.2 25.1 29.3 15.4 27.4 20.3 31.0 47.9 30.2 25.6 42.8 46.1 26.5 34.5 19.5 26.6 34.2 30.3 29.9 35.9 30.9 35.0 45.4 38.4 31.1 32.3 56.7 28.2 11.8 36.6 35.7 34.1 27.6 41.4 24.9 31.0 9.7 7.6 3.2 7.2 12.5 9.9 6.0 14.2 13.3 17.3 15.2 18.7 17.3 11.7 10.9 19.8 11.9 18.3 14.0 16.4 17.0 7.7 13.4 12.4 17.8 18.9 10.7 14.7 14.5 19.4 10.7 31.9 10.0 14.2 22.0 17.8 16.5 21.8 13.0 24.6 20.6 11.1 36.5 10.8 59.1 11.3 12.1 16.9 26.5 11.5 12.7 18.3 16.8 19.5 21.7 18.4 16.5 8.9 7.8 17.0 11.3 10.5 13.7 8.3 15.0 12.8 12.9 10.5 13.4 6.3 16.1 11.6 20.4 9.1 23.2 7.8 3.2 5.3 2.3 9.9 7.2 9.0 9.7 8.3 8.0 7.5 8.5 9.7 9.5 2.4 12.5 6.5 7.6 7.6 6.0 33.3 36.6 75.7 43.8 29.3 15.4 30.2 25.6 26.6 36.6 32.8 80.7 38.6 31.8 78.3 24.7 38.6 20.4 20.1 31.8 47.1 7.9 11.8 8.3 11.5 1.7 42.7 29.0 46.7 12.1 7.0 45.0 42.9 26.6 24.9 14.0 38.1 33.6 45.4 64.9 1.8 49.5 36.1 33.7 15.4 36.2 13.8 15.0 31.6 28.0 12.2 23.2 32.3 32.5 1.8 6.0 73.5 9.2 59.0 30.2 38.6 OLFM1 "AMY, NOE1, NOELIN, OlfA" ENSG00000130558 "Olfactomedin 1" Q99784 9 135075422-135121179 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 159.5" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 41.2;Horizontal cells: 36.5;Ito cells: 74.3;Leydig cells: 41.1" "Cancer enhanced" "Detected in all" "glioma: 18.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 38 "classical monocyte: 3.4;intermediate monocyte: 5.0;myeloid DC: 5.1;non-classical monocyte: 1.3" "Group enriched" "Detected in many" 51 "dendritic cells: 5.1;monocytes: 5.0" "Cell line enhanced" "Detected in some" "HeLa: 25.5;MCF7: 21.5;NTERA-2: 28.6;OE19: 20.3;SCLC-21H: 41.3;SiHa: 34.2;T-47d: 53.0;U-2197: 23.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057444 Approved Nucleoplasm,Nucleoli,Cytosol "Secreted in brain" NA NA 130000000 Nucleoli "Nucleoplasm, Cytosol" "HPA057444: AB_2683443" "unprognostic (6.77e-2)" "prognostic favorable (7.14e-4)" "unprognostic (1.01e-1)" "unprognostic (3.76e-2)" "prognostic unfavorable (6.58e-4)" "unprognostic (3.08e-1)" "unprognostic (1.30e-1)" "unprognostic (3.69e-3)" "unprognostic (2.67e-1)" "unprognostic (6.04e-2)" "unprognostic (1.58e-3)" "unprognostic (1.87e-1)" "unprognostic (9.46e-3)" "unprognostic (4.60e-2)" "unprognostic (1.51e-1)" "unprognostic (6.20e-2)" "unprognostic (7.53e-4)" 7.7 10.0 80.5 5.0 41.5 0.9 4.7 30.9 159.5 7.4 5.4 4.6 0.7 2.5 6.9 26.4 5.0 4.4 3.8 3.9 77.2 19.1 3.4 2.4 4.7 5.2 18.8 36.5 6.2 5.1 3.6 9.9 1.1 13.5 4.8 5.7 0.9 2.6 7.5 6.1 4.5 3.5 6.9 6.1 5.8 3.9 2.8 2.8 0.3 2.7 0.8 7.1 4.1 6.2 0.0 5.1 0.0 5.0 0.0 0.0 0.6 0.0 1.6 3.2 0.0 0.4 0.3 0.1 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.2 1.3 13.1 0.6 0.6 0.0 0.0 3.6 0.2 0.0 25.5 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 21.5 0.1 0.0 28.6 20.3 0.0 0.0 0.0 12.0 0.0 0.0 41.3 5.5 34.2 0.1 2.1 2.2 53.0 0.0 0.0 2.0 4.6 23.1 0.0 0.0 0.0 0.1 0.1 0.0 1.1 0.0 3.4 0.0 0.0 5.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.6 80.5 41.5 30.9 119.7 77.2 19.1 18.8 36.5 13.5 2.8 0.0 9.3 0.0 2.8 8.7 20.7 5.8 7.6 0.0 3.4 0.0 41.2 0.0 0.0 7.4 5.8 26.1 0.0 0.0 2.3 0.0 8.2 6.1 2.3 0.5 0.3 36.5 2.4 74.3 4.5 8.9 41.1 2.8 20.3 0.0 1.7 32.6 3.6 2.9 27.6 0.0 12.0 0.0 11.7 0.6 3.4 5.5 0.0 0.0 5.5 0.9 OLFM2 "NOE2, OlfC" ENSG00000105088 "Olfactomedin 2" O95897 19 9853718-9936552 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 51.4;skin 1: 60.2" "Group enriched" "Detected in many" 4 "Basal keratinocytes: 111.0;Late spermatids: 38.1;Muller glia cells: 72.1;Suprabasal keratinocytes: 103.3" "Cancer enhanced" "Detected in all" "glioma: 96.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 24.9" "Group enriched" "Detected in many" 27 "granulocytes: 24.9;T-cells: 8.9" "Cell line enhanced" "Detected in many" "AN3-CA: 15.7;ASC diff: 14.9;BJ hTERT+: 11.3;SH-SY5Y: 15.2;U-2 OS: 18.2;WM-115: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049961, HPA057771" Uncertain Approved Nucleoplasm "Secreted in other tissues" NA NA 2300000 Nucleoplasm "HPA049961: AB_2680972, HPA057771: AB_2683524" "unprognostic (1.42e-2)" "unprognostic (3.93e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.99e-2)" "unprognostic (5.91e-2)" "unprognostic (3.39e-2)" "unprognostic (8.78e-2)" "unprognostic (4.47e-2)" "unprognostic (8.04e-2)" "unprognostic (4.03e-2)" "unprognostic (1.41e-3)" "unprognostic (2.77e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (6.23e-2)" "unprognostic (5.67e-2)" "unprognostic (1.41e-2)" "unprognostic (1.23e-1)" 20.9 12.2 37.2 2.7 39.7 0.8 5.8 9.1 51.4 4.5 1.9 11.6 0.3 2.1 7.9 3.8 3.9 6.6 4.9 3.9 26.2 21.6 1.8 23.5 3.2 5.0 19.6 17.9 3.5 7.9 1.1 4.4 5.2 15.4 5.2 1.4 3.2 7.1 10.3 1.7 60.2 2.0 5.1 9.0 2.2 1.4 5.2 4.6 16.0 8.4 1.1 3.7 2.6 3.2 0.0 0.0 24.9 0.0 0.6 8.9 1.7 0.0 2.2 1.8 15.7 14.9 9.2 1.0 3.4 11.3 0.8 0.9 0.1 1.5 0.0 1.4 2.5 1.3 0.9 6.0 1.0 0.0 0.0 1.3 0.0 0.1 0.2 0.0 0.0 2.7 4.8 0.9 0.1 0.1 0.4 0.0 2.9 0.1 0.2 0.0 4.9 0.1 0.1 9.7 1.5 0.0 0.0 0.0 0.0 0.0 0.5 0.1 15.2 0.6 0.0 3.1 6.3 0.6 0.0 0.1 6.6 18.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 15.7 9.6 0.0 24.9 3.5 0.0 3.8 0.0 4.1 3.1 0.0 0.0 8.0 5.1 0.3 0.6 0.0 0.0 8.9 1.7 37.2 39.7 9.1 38.0 26.2 21.6 19.6 17.9 15.4 4.6 0.0 0.0 0.0 4.6 111.0 2.9 0.6 5.1 0.0 0.0 7.0 0.0 0.1 1.7 0.6 6.8 0.5 0.0 0.0 2.0 0.0 9.6 5.0 4.6 16.1 0.2 1.6 1.2 0.6 0.3 38.1 12.7 0.3 16.9 0.0 0.0 72.1 6.6 0.0 9.2 0.0 2.5 0.0 18.7 2.1 9.3 103.3 0.1 7.5 0.0 2.3 OLFM4 "GC1, GW112, OlfD" ENSG00000102837 "Olfactomedin 4" Q6UX06 13 53028759-53052057 "Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 280.2;pancreas: 105.8" "Group enriched" "Detected in many" 6 "Exocrine glandular cells: 804.6;Pancreatic endocrine cells: 1519.9;Undifferentiated cells: 937.7;Urothelial cells: 2045.0" "Group enriched" "Detected in many" 14 "colorectal cancer: 711.4;pancreatic cancer: 594.7;stomach cancer: 724.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.4" "Lineage enhanced" "Detected in single" "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "BEWO: 4.4;BJ hTERT+: 15.3;HaCaT: 21.4;OE19: 8.3;RPMI-8226: 4.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA077718 Enhanced Supported "Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol" "Secreted in other tissues" Yes NA "Nucleoplasm, Plasma membrane" "Cytokinetic bridge, Cytosol" "HPA077718: AB_2732358" "prognostic favorable (8.77e-4)" "unprognostic (4.84e-2)" "unprognostic (1.65e-3)" "unprognostic (2.33e-1)" "unprognostic (7.24e-2)" "unprognostic (1.34e-1)" "unprognostic (3.74e-2)" "unprognostic (5.16e-2)" "unprognostic (1.40e-1)" "unprognostic (1.22e-1)" "unprognostic (4.78e-2)" "unprognostic (1.28e-1)" "unprognostic (1.50e-1)" "unprognostic (1.29e-2)" "unprognostic (1.33e-1)" "unprognostic (4.37e-2)" "unprognostic (4.84e-3)" 0.3 0.0 0.3 18.1 0.3 11.4 2.5 0.3 0.5 50.3 132.5 0.4 0.2 121.4 0.8 3.3 0.5 0.9 6.0 1.1 0.3 0.1 7.5 0.3 1.6 0.4 0.3 0.2 0.7 105.8 0.0 0.2 0.9 0.3 16.2 58.9 0.2 2.9 0.2 0.3 0.1 280.2 5.6 0.2 2.2 2.4 1.4 0.3 1.8 0.3 0.4 0.3 18.4 40.9 0.0 0.0 1.4 0.6 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 4.4 1.9 15.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 21.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 8.3 0.0 0.0 0.7 4.7 0.1 0.0 0.9 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.5 0.7 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.6 0.0 0.0 0.9 0.3 0.3 0.3 0.5 0.3 0.1 0.3 0.2 0.3 0.3 0.0 0.0 0.0 149.7 0.1 0.0 0.4 0.0 0.0 0.0 132.6 0.0 0.0 1.7 216.4 0.2 0.0 104.8 0.0 804.6 0.0 0.0 16.5 0.0 0.0 0.1 0.0 88.9 0.0 0.0 0.0 0.0 0.0 0.0 18.0 135.9 3.2 1519.9 238.2 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 937.7 2045.0 OLFML2A FLJ00237 ENSG00000185585 "Olfactomedin like 2A" Q68BL7 9 124777158-124814885 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 12.1;Endothelial cells: 14.2;Fibroblasts: 13.1;Sertoli cells: 12.9;Smooth muscle cells: 28.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 58.3;GAMG: 12.1;HeLa: 14.7;hTERT-RPE1: 13.5;WM-115: 22.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA021180, HPA022254" Approved Approved Nucleoplasm,Cytosol "Secreted - unknown location" NA NA "Nucleoplasm, Cytosol" "HPA021180: AB_1854790, HPA022254: AB_1854791" "unprognostic (1.12e-1)" "unprognostic (3.07e-2)" "unprognostic (3.16e-1)" "unprognostic (2.45e-1)" "unprognostic (4.01e-2)" "unprognostic (1.27e-1)" "unprognostic (1.15e-1)" "unprognostic (3.00e-1)" "unprognostic (1.26e-3)" "unprognostic (7.53e-2)" "unprognostic (2.49e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (3.73e-5)" "unprognostic (5.72e-3)" "unprognostic (3.30e-2)" "unprognostic (7.91e-2)" "unprognostic (1.05e-2)" 17.3 2.1 1.0 7.4 1.7 0.1 10.9 1.9 3.4 34.2 18.9 3.1 6.3 2.3 29.2 8.3 11.8 4.2 7.6 12.5 1.2 1.0 3.0 0.6 10.3 1.5 2.1 1.5 13.2 3.4 3.6 2.1 5.0 4.0 16.1 4.6 18.9 4.7 9.5 9.8 11.6 5.0 33.7 1.6 23.8 4.0 3.1 0.6 3.7 20.0 11.9 5.0 22.0 10.4 1.4 0.7 2.6 0.9 0.6 0.6 0.4 0.3 5.2 0.4 0.1 6.1 58.3 0.0 0.8 2.9 1.2 1.2 0.0 0.7 0.0 1.5 0.0 12.1 9.7 0.1 0.3 1.4 0.0 0.0 0.0 14.7 0.0 0.3 0.0 0.0 4.1 0.9 3.6 0.5 13.5 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.1 1.3 0.0 0.5 0.0 3.5 0.0 0.0 0.4 0.0 0.0 1.2 0.0 1.5 10.6 1.4 0.1 0.0 1.8 1.9 2.0 0.2 0.7 0.0 0.0 5.6 0.3 22.8 1.9 0.9 0.4 0.4 0.3 0.3 0.5 0.3 0.3 0.7 1.4 0.4 0.6 2.6 0.6 0.3 0.6 0.3 0.4 1.0 1.7 1.9 3.4 1.2 1.0 2.1 1.5 4.0 0.6 0.0 2.2 0.0 3.7 10.6 0.5 12.1 0.0 1.4 0.0 0.0 2.0 0.2 0.0 0.1 0.6 14.2 0.0 0.0 0.6 0.2 13.1 1.0 0.0 0.0 0.1 0.0 0.0 3.1 2.4 1.2 2.6 0.5 10.1 0.0 0.0 0.2 0.0 0.0 1.4 0.0 3.9 12.9 28.8 0.2 0.7 7.3 0.0 0.0 0.0 1.6 OLIG2 "BHLHB1, bHLHe19, OLIGO2, PRKCBP2, RACK17" ENSG00000205927 "Oligodendrocyte transcription factor 2" Q13516 21 33025845-33029196 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 66.2" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 52 "glioma: 46.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "eosinophil: 15.4" "Lineage enriched" "Detected in single" 154 "granulocytes: 15.4" "Cell line enhanced" "Detected in some" "HMC-1: 30.0;NB-4: 21.7;THP-1: 18.8;WM-115: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003254, CAB019381" Enhanced Uncertain "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "CAB019381: , HPA003254: AB_1854795" "unprognostic (5.14e-1)" "unprognostic (4.56e-1)" "unprognostic (1.44e-2)" "unprognostic (8.27e-2)" "unprognostic (3.24e-2)" "unprognostic (4.34e-2)" "unprognostic (4.81e-2)" "unprognostic (5.41e-2)" "unprognostic (1.39e-1)" "unprognostic (5.78e-5)" "unprognostic (2.76e-1)" 1.3 1.3 24.1 1.4 19.1 1.4 1.3 4.2 66.2 1.3 1.3 41.4 0.0 1.7 1.3 1.3 1.3 1.3 1.3 1.3 23.6 15.6 1.3 1.3 1.3 1.3 20.9 15.5 1.3 1.3 1.3 0.0 1.3 17.1 1.3 1.3 0.0 1.3 1.3 1.3 1.3 1.5 1.3 16.8 1.3 1.4 1.3 16.6 0.0 1.3 0.0 1.3 1.4 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.5 0.0 0.0 0.0 0.6 4.3 0.0 0.0 0.0 0.8 30.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 21.7 1.9 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 18.8 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 6.1 1.8 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 19.1 4.2 27.6 23.6 15.6 20.9 15.5 17.1 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 OLR1 "CLEC8A, LOX-1, SCARE1" ENSG00000173391 "Oxidized low density lipoprotein receptor 1" P78380 12 10158301-10172138 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity, Inflammatory response" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5;lung: 46.8;placenta: 53.4" "Group enriched" "Detected in many" 7 "Cytotrophoblasts: 386.0;Hofbauer cells: 209.3;Macrophages: 102.1;Syncytiotrophoblasts: 387.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 5.9" "Group enriched" "Detected in many" 6 "dendritic cells: 5.9;granulocytes: 3.3;monocytes: 1.5" "Cell line enhanced" "Detected in some" "CACO-2: 32.7;HaCaT: 17.2;HHSteC: 34.6;hTCEpi: 15.9;SiHa: 65.9;SK-BR-3: 26.2" "Low region specificity" "Detected in all" HPA050798 Approved "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 1060000 "Nucleoplasm, Plasma membrane" Vesicles "HPA050798: AB_2756318" "unprognostic (2.30e-1)" "unprognostic (3.16e-2)" "unprognostic (1.58e-2)" "unprognostic (1.32e-1)" "unprognostic (7.81e-2)" "prognostic unfavorable (8.24e-5)" "unprognostic (6.34e-2)" "unprognostic (6.07e-3)" "unprognostic (5.40e-2)" "unprognostic (2.64e-1)" "unprognostic (1.97e-2)" "unprognostic (3.51e-1)" "unprognostic (1.08e-1)" "unprognostic (4.94e-3)" "unprognostic (3.47e-2)" "unprognostic (1.48e-2)" "unprognostic (1.42e-1)" 2.0 1.9 6.0 14.1 10.3 10.6 2.0 1.3 10.2 1.9 0.5 21.3 0.0 0.8 1.0 0.9 0.5 1.2 3.9 1.1 8.5 6.7 6.9 1.8 46.8 0.5 16.4 4.4 0.4 1.6 2.8 1.9 53.4 12.3 1.4 0.7 0.2 2.0 0.7 0.4 0.5 0.8 1.2 28.5 0.6 1.4 2.8 10.5 0.0 1.5 0.0 0.6 4.3 0.4 0.5 5.9 3.3 1.5 0.3 0.3 1.1 1.8 0.1 0.0 0.1 0.0 0.0 4.5 3.1 0.5 2.0 0.7 32.7 0.0 0.4 0.0 4.2 0.1 17.2 0.0 0.1 1.3 0.0 0.0 0.0 1.6 0.0 34.6 0.0 0.0 0.2 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.1 0.0 65.9 26.2 0.0 4.9 7.3 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.0 1.5 2.7 0.2 0.2 0.3 0.3 0.3 0.2 5.9 0.5 0.3 0.3 3.3 0.3 0.4 0.8 0.2 1.1 6.0 10.3 1.3 7.4 8.5 6.7 16.4 4.4 12.3 10.5 26.8 30.9 0.0 0.2 1.3 0.4 0.0 2.5 12.0 7.9 0.0 0.0 386.0 0.0 0.0 9.4 1.2 0.0 0.0 0.0 8.5 1.3 0.0 14.0 0.8 209.3 0.0 0.0 0.0 21.9 7.6 0.3 102.1 0.0 36.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 387.3 0.0 0.0 0.0 OMA1 "FLJ33782, MPRP-1, YKR087C, ZMPOMA1" ENSG00000162600 "OMA1 zinc metallopeptidase" Q96E52 1 58415384-58546802 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 54.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055120 Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA055120: AB_2682702" "prognostic favorable (1.63e-4)" "unprognostic (2.67e-2)" "prognostic favorable (7.70e-4)" "unprognostic (1.60e-3)" "unprognostic (1.61e-1)" "unprognostic (9.57e-2)" "unprognostic (3.94e-3)" "prognostic favorable (8.52e-4)" "unprognostic (8.22e-3)" "unprognostic (6.91e-2)" "unprognostic (4.10e-2)" "unprognostic (1.40e-1)" "unprognostic (9.54e-3)" "unprognostic (2.52e-2)" "unprognostic (3.93e-2)" "unprognostic (1.74e-2)" "unprognostic (5.24e-3)" 10.2 22.4 13.8 21.5 18.1 9.2 15.8 10.6 14.6 14.5 16.4 14.1 20.1 12.1 15.4 15.1 17.1 15.9 12.1 15.8 12.6 10.0 23.0 23.8 19.1 17.9 16.7 9.6 15.0 18.2 15.7 20.9 8.9 13.0 17.8 16.1 11.3 20.6 22.7 20.9 10.2 16.1 24.2 18.2 17.2 13.9 6.9 19.4 18.4 18.3 14.5 16.4 17.0 20.6 22.5 9.5 18.6 19.5 18.6 22.8 10.2 13.5 5.7 3.8 3.5 19.2 18.0 10.9 5.6 6.1 4.9 6.2 1.6 8.2 30.6 11.9 5.8 17.2 13.9 13.4 13.6 5.8 23.4 7.5 9.5 4.4 6.6 9.5 23.3 6.7 16.9 15.3 4.8 10.0 11.1 4.3 15.3 18.0 9.2 13.4 8.3 7.9 8.3 5.6 20.5 12.4 9.9 12.5 12.8 10.7 9.1 4.0 1.9 11.4 18.8 15.8 18.3 8.5 9.0 2.5 2.5 5.1 12.6 5.8 7.5 9.8 20.1 7.8 18.3 6.2 10.8 9.2 18.6 12.8 14.5 16.5 22.5 15.7 15.0 9.5 21.4 22.8 20.8 10.6 18.6 19.5 5.0 13.9 10.2 13.8 18.1 10.6 14.6 12.6 10.0 16.7 9.6 13.0 19.4 17.9 11.5 14.7 15.7 5.4 7.2 25.0 10.2 54.9 11.4 24.4 11.8 19.1 21.6 7.7 5.0 4.9 6.9 0.0 4.8 7.8 8.6 15.0 5.8 15.5 13.6 1.6 5.8 8.6 10.7 9.7 9.2 10.4 6.8 7.2 15.0 10.0 5.2 10.4 8.1 20.7 19.6 6.5 4.4 11.7 12.1 5.9 15.3 13.8 13.0 17.5 ONECUT2 OC-2 ENSG00000119547 "One cut homeobox 2" O95948 18 57435685-57491297 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.6;gallbladder: 60.7;intestine: 18.0" "Cell type enriched" "Detected in many" 6 "Horizontal cells: 910.5" "Group enriched" "Detected in many" 7 "liver cancer: 4.3;pancreatic cancer: 4.3;stomach cancer: 5.4" "Region enhanced" "Detected in many" "basal ganglia: 18.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 18.7;HeLa: 11.9;RT4: 6.3;SCLC-21H: 9.8" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "basal ganglia: 10.6;cerebellum: 9.9;cerebral cortex: 6.6;hippocampal formation: 4.3;hypothalamus: 4.3" HPA057058 Enhanced Supported "Nucleoplasm,Actin filaments" NA NA Nucleoplasm "Actin filaments" "HPA057058: AB_2683323" "unprognostic (3.02e-2)" "unprognostic (5.36e-2)" "unprognostic (9.06e-3)" "unprognostic (3.79e-5)" "unprognostic (1.13e-2)" "unprognostic (4.48e-4)" "unprognostic (2.10e-2)" "unprognostic (1.81e-1)" "unprognostic (3.75e-1)" "unprognostic (4.56e-3)" "unprognostic (8.66e-3)" "unprognostic (1.16e-2)" "unprognostic (5.34e-4)" "unprognostic (3.83e-2)" "unprognostic (2.58e-1)" "unprognostic (1.13e-1)" "unprognostic (3.21e-1)" 0.3 0.4 0.3 0.3 18.6 0.2 0.3 3.0 3.7 0.2 16.5 0.0 0.0 15.0 0.3 0.3 0.3 0.2 60.7 0.2 0.5 0.9 0.3 12.8 0.3 0.3 0.5 0.9 0.3 4.3 3.2 5.1 0.2 1.1 0.3 0.3 0.7 0.3 0.3 0.3 0.3 18.0 0.3 0.3 0.3 0.5 0.6 6.6 0.0 0.3 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 1.1 3.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 1.4 0.0 3.3 0.0 0.1 18.7 3.0 0.7 11.9 2.7 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 2.2 3.6 0.6 0.0 0.4 1.7 0.0 0.1 1.5 0.7 0.0 1.1 0.0 1.6 6.3 9.8 1.6 0.1 0.0 0.2 0.1 0.4 0.7 0.0 1.0 1.3 0.2 0.2 0.3 2.7 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 18.6 3.0 3.7 0.5 0.9 0.5 0.9 1.1 6.6 0.0 0.0 0.0 0.2 0.1 3.0 2.6 155.4 0.0 0.0 7.0 13.7 0.0 0.0 69.5 2.0 0.6 0.3 0.0 7.6 0.1 0.0 0.3 0.0 44.2 0.8 910.5 8.5 9.2 0.6 2.8 0.3 0.0 0.0 0.0 0.7 2.9 24.1 3.1 0.0 0.0 4.9 0.0 0.7 1.4 1.7 0.1 0.0 0.0 0.4 0.0 ONECUT3 ENSG00000205922 "One cut homeobox 3" O60422 19 1752373-1780988 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "stomach 1: 9.4;testis: 3.8" "Cell type enriched" "Detected in some" 4 "Horizontal cells: 295.6" "Group enriched" "Detected in some" 7 "pancreatic cancer: 3.5;stomach cancer: 3.9" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 8 "HaCaT: 7.6;OE19: 10.1;PC-3: 17.1" "Low region specificity" "Detected in single" "Region enhanced" "Detected in some" "hypothalamus: 1.3" HPA059936 Supported Nucleoplasm NA NA Nucleoplasm "HPA059936: AB_2684172" "unprognostic (9.43e-2)" "unprognostic (1.36e-1)" "unprognostic (6.28e-2)" "unprognostic (1.36e-3)" "unprognostic (2.27e-1)" "unprognostic (1.09e-2)" "unprognostic (2.21e-1)" "unprognostic (3.61e-3)" "unprognostic (2.02e-1)" "unprognostic (1.84e-1)" "unprognostic (3.87e-2)" "unprognostic (3.64e-1)" "unprognostic (3.08e-10)" "unprognostic (1.18e-1)" "unprognostic (9.86e-2)" "unprognostic (4.62e-1)" "unprognostic (1.21e-2)" 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.1 0.0 1.3 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.1 9.4 3.8 0.1 0.0 0.0 0.0 0.6 0.4 1.6 0.4 0.4 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.2 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.2 0.0 10.1 17.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.5 0.3 0.2 0.3 0.1 0.2 0.3 0.2 0.2 0.1 0.6 0.3 0.3 1.6 0.4 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.7 73.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.1 295.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 3.7 0.0 0.4 0.0 2.3 0.0 0.0 1.8 0.6 0.3 0.0 0.0 0.0 0.4 OPA1 "FLJ12460, KIAA0567, MGM1, NPG, NTG" ENSG00000198836 "OPA1, mitochondrial dynamin like GTPase" O60313 3 193593144-193697823 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Apoptosis, Sensory transduction, Vision" Hydrolase "Cardiomyopathy, Deafness, Disease mutation, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 130.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036926, HPA036927" Supported Supported Nucleoplasm,Mitochondria NA NA 13000 "Nucleoplasm, Mitochondria" "HPA036926: AB_10671247, HPA036927: AB_2675388" "unprognostic (2.10e-2)" "unprognostic (9.23e-3)" "unprognostic (7.98e-2)" "prognostic unfavorable (8.61e-4)" "unprognostic (1.62e-2)" "unprognostic (4.59e-2)" "unprognostic (2.24e-1)" "unprognostic (1.86e-2)" "unprognostic (1.57e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (8.44e-5)" "unprognostic (3.48e-2)" "prognostic favorable (1.84e-4)" "unprognostic (2.92e-1)" "unprognostic (4.75e-1)" "unprognostic (4.50e-3)" "unprognostic (3.21e-1)" 17.0 19.7 18.2 13.5 31.7 25.9 15.9 20.2 30.9 13.9 21.8 11.1 12.6 20.0 15.2 11.8 18.8 11.8 12.8 43.9 23.0 19.4 21.8 24.1 10.7 15.3 19.0 22.4 13.2 13.4 20.9 15.6 13.8 28.0 15.5 20.5 9.1 15.7 20.8 38.4 14.6 17.3 16.5 17.0 13.1 16.7 7.6 10.8 18.0 16.8 18.4 14.2 16.5 13.6 8.3 8.8 8.2 17.6 5.0 7.5 5.9 26.0 8.4 8.5 9.3 7.5 11.9 9.0 12.7 11.7 13.9 13.6 20.3 8.8 17.3 27.4 11.9 12.7 17.0 14.8 14.3 24.7 20.8 12.0 29.9 7.5 10.2 11.7 24.6 13.8 13.3 12.8 13.4 19.1 8.6 11.7 7.3 12.7 17.0 13.8 20.6 9.5 13.7 11.9 15.0 28.0 12.5 18.7 18.5 10.4 16.3 18.5 11.3 18.9 21.2 13.4 6.8 27.8 19.5 11.7 12.9 9.8 13.8 26.6 15.4 17.8 33.9 14.3 19.7 12.9 8.2 8.1 7.7 7.2 9.3 6.6 8.3 6.8 6.8 8.8 6.3 6.9 7.3 3.2 5.0 17.6 4.6 7.5 5.9 18.2 31.7 20.2 30.9 23.0 19.4 19.0 22.4 28.0 10.8 14.9 20.0 20.6 13.8 14.2 17.0 130.0 15.3 16.0 20.5 17.4 29.5 16.2 14.9 14.8 7.2 13.5 20.6 70.0 20.7 12.2 15.9 15.5 18.5 30.2 15.9 20.6 22.4 16.0 23.5 10.2 14.7 21.2 20.3 11.8 20.6 15.7 22.7 7.0 13.8 26.9 21.6 6.5 17.5 11.3 15.0 19.6 15.0 12.8 25.8 19.6 OPA3 "FLJ22187, MGA3" ENSG00000125741 "OPA3, outer mitochondrial membrane lipid metabolism regulator" Q9H6K4 19 45527427-45602212 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044881 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA044881: AB_10964052" "unprognostic (3.37e-1)" "unprognostic (3.89e-2)" "unprognostic (2.66e-1)" "unprognostic (5.71e-3)" "unprognostic (1.24e-2)" "unprognostic (2.87e-2)" "prognostic unfavorable (5.60e-4)" "unprognostic (3.14e-3)" "unprognostic (4.53e-2)" "unprognostic (8.06e-3)" "unprognostic (1.72e-3)" "unprognostic (8.73e-2)" "prognostic favorable (9.30e-12)" "unprognostic (5.85e-2)" "unprognostic (1.94e-1)" "unprognostic (3.82e-2)" "unprognostic (1.81e-1)" 21.6 14.8 8.5 9.4 15.9 7.9 21.8 8.5 13.1 6.2 8.9 7.2 5.7 8.4 10.5 7.7 11.3 7.6 9.8 21.8 9.8 9.6 15.9 16.4 19.3 9.7 11.0 4.5 8.9 9.3 23.9 12.3 11.4 18.4 7.9 8.7 12.1 8.2 9.4 19.7 12.5 9.7 10.2 12.4 12.0 9.2 15.7 11.1 5.3 11.8 9.7 9.6 9.5 30.3 6.7 7.8 7.4 13.0 10.9 6.2 4.5 11.5 14.7 5.9 5.9 3.9 4.8 9.0 7.6 7.0 8.1 8.6 6.8 8.3 10.0 5.5 7.5 9.3 9.3 9.9 10.3 7.1 18.1 10.0 15.4 8.2 7.0 7.1 10.8 20.1 7.3 8.1 8.9 9.8 4.7 5.7 6.0 13.1 11.2 5.5 7.1 8.4 4.5 5.2 9.7 10.1 8.5 5.3 5.4 6.3 20.9 4.5 5.3 9.7 8.9 4.1 5.5 5.0 6.2 12.3 6.9 7.9 5.7 12.8 7.6 14.0 8.3 6.7 7.8 10.3 6.0 7.4 3.8 5.3 10.5 5.6 6.7 4.8 4.5 7.8 5.6 6.0 5.9 7.4 10.9 13.0 7.3 6.2 4.5 8.5 15.9 8.5 13.1 9.8 9.6 11.0 4.5 18.4 11.1 11.9 9.4 14.3 16.9 16.7 22.0 21.8 22.9 10.7 9.1 10.4 49.1 23.1 21.6 16.0 12.7 14.1 19.6 0.0 18.5 25.8 9.8 12.5 16.1 19.4 14.5 19.1 13.2 14.1 11.6 15.7 5.8 15.3 13.5 19.0 10.4 13.8 14.0 17.3 6.0 13.4 35.6 0.0 18.6 13.0 14.0 17.1 30.3 13.1 12.1 13.9 OPHN1 "ARHGAP41, MRX60, OPN1" ENSG00000079482 "Oligophrenin 1" O60890 X 68042344-68433913 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Endocytosis, Neurogenesis" "GTPase activation" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Syncytiotrophoblasts: 56.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002919 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA002919: AB_1079526" "unprognostic (1.21e-1)" "unprognostic (3.21e-2)" "unprognostic (1.96e-1)" "unprognostic (7.31e-2)" "unprognostic (3.85e-3)" "unprognostic (4.32e-2)" "unprognostic (3.52e-2)" "unprognostic (3.09e-3)" "unprognostic (2.22e-1)" "unprognostic (6.62e-2)" "unprognostic (4.37e-2)" "unprognostic (2.30e-1)" "unprognostic (2.21e-4)" "unprognostic (1.98e-1)" "unprognostic (1.29e-2)" "unprognostic (2.08e-3)" "unprognostic (2.64e-3)" 5.8 8.2 21.9 2.4 22.6 3.6 7.1 12.3 21.6 9.9 4.9 10.7 3.2 3.5 9.7 4.8 6.1 5.3 4.5 4.1 19.5 9.7 7.0 1.7 6.6 2.0 9.6 12.2 7.1 4.0 6.6 4.8 20.7 9.1 16.2 5.1 7.9 7.2 8.0 7.8 8.6 4.1 6.3 6.2 2.9 5.9 2.9 12.4 0.1 7.2 2.0 2.3 3.9 6.2 2.7 3.3 4.1 1.7 1.7 1.2 0.3 15.1 3.8 2.4 5.9 5.5 5.7 3.9 2.8 3.9 5.3 6.4 2.4 3.1 0.7 10.8 3.4 2.4 4.1 2.1 1.2 8.2 0.4 1.5 3.2 4.3 2.4 1.8 0.8 3.8 3.3 3.9 4.9 4.8 8.9 4.3 0.6 2.1 1.4 3.1 7.8 0.5 0.8 4.6 7.6 3.2 0.4 4.8 0.7 6.9 5.9 0.9 2.3 5.5 7.0 12.4 5.9 4.7 1.3 4.7 3.6 5.8 12.7 3.6 2.1 2.5 0.5 2.8 1.9 2.6 1.1 1.7 0.6 1.2 0.9 1.0 1.3 1.0 0.8 0.7 2.7 1.1 1.2 4.1 1.7 1.2 3.3 0.7 0.3 21.9 22.6 12.3 18.6 19.5 9.7 9.6 12.2 9.1 12.4 14.9 13.4 0.0 4.9 2.9 5.3 3.1 2.5 17.4 7.9 17.4 5.9 18.1 0.0 0.9 1.6 4.5 3.4 0.0 0.7 9.5 11.0 11.1 8.1 0.0 3.9 0.0 4.1 3.7 1.9 0.2 19.5 6.3 8.5 0.0 2.8 18.4 1.0 3.2 11.3 1.6 5.2 0.0 5.1 0.2 1.3 4.4 56.0 0.0 3.4 3.1 OPN1SW "BCP, BOP, CBT" ENSG00000128617 "Opsin 1, short wave sensitive" P03999 7 128772491-128775790 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 11.4;retina: 23.9" "Cell type enriched" "Detected in some" 12 "Cone photoreceptor cells: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 37.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA013562, HPA014083" Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytokinetic bridge,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytokinetic bridge, Cytosol" "HPA013562: AB_2668850, HPA014083: AB_2668938" "unprognostic (2.88e-1)" "unprognostic (5.17e-2)" "unprognostic (2.22e-2)" "unprognostic (1.33e-2)" "unprognostic (2.55e-2)" "unprognostic (2.16e-1)" "prognostic unfavorable (8.50e-5)" "unprognostic (1.13e-1)" "unprognostic (1.27e-1)" "unprognostic (6.33e-2)" "unprognostic (3.79e-1)" "unprognostic (6.05e-2)" "prognostic unfavorable (2.26e-8)" "prognostic unfavorable (5.98e-8)" "unprognostic (2.53e-1)" "unprognostic (8.99e-2)" "prognostic unfavorable (9.33e-4)" 0.9 1.8 0.7 3.7 0.9 1.7 0.7 1.0 2.3 0.7 2.2 0.7 0.7 0.5 2.6 0.7 2.4 0.8 4.2 11.4 0.7 0.8 0.7 0.7 0.9 1.0 0.7 1.3 0.7 0.7 0.0 0.7 0.7 0.7 1.4 0.0 23.9 1.1 0.7 1.9 0.9 0.9 0.7 0.7 1.1 1.4 1.1 0.7 0.7 2.3 0.7 0.7 4.3 0.7 0.5 1.2 0.6 1.4 0.0 1.4 0.3 1.7 2.2 5.2 1.7 0.0 0.0 1.5 9.8 0.0 0.0 0.0 5.0 2.1 2.6 1.5 0.0 1.6 1.4 0.0 0.0 0.0 0.3 3.6 1.6 3.0 2.5 0.0 2.0 1.6 0.0 0.0 0.0 0.0 7.0 0.0 1.7 2.2 0.6 1.1 0.7 2.0 3.6 4.7 1.7 3.0 1.0 5.4 3.0 0.0 0.6 0.7 6.9 2.3 5.2 4.4 7.3 0.5 2.0 4.0 10.0 1.0 7.7 8.7 2.1 2.2 1.6 37.6 4.6 9.3 0.0 0.3 0.6 1.4 1.4 0.9 0.2 0.8 1.0 1.2 0.5 0.3 0.9 0.0 0.0 1.0 0.7 0.4 0.3 0.7 0.9 1.0 0.9 0.7 0.8 0.7 1.3 0.7 0.7 0.0 0.6 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 39.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 OPN3 "ECPN, encephalopsin, ERO, NMO-1, PPP1R116" ENSG00000054277 "Opsin 3" Q9H1Y3 1 241590102-241677376 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 211.3;Syncytiotrophoblasts: 143.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 12.1" "Lineage enriched" "Detected in many" 5 "dendritic cells: 12.1" "Cell line enhanced" "Detected in many" "ASC TERT1: 35.8" "Low region specificity" "Detected in all" "CAB013682, HPA064443" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB013682: , HPA064443: AB_2685267" "unprognostic (2.41e-2)" "prognostic unfavorable (3.17e-5)" "unprognostic (1.75e-2)" "unprognostic (1.93e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (7.12e-2)" "unprognostic (5.10e-3)" "unprognostic (1.24e-2)" "unprognostic (2.39e-1)" "unprognostic (4.96e-1)" "unprognostic (2.66e-2)" "unprognostic (3.44e-1)" "unprognostic (9.13e-2)" "unprognostic (9.15e-3)" "unprognostic (2.61e-2)" "unprognostic (7.12e-2)" "unprognostic (9.44e-3)" 5.3 4.2 5.1 4.5 8.8 1.7 6.4 1.9 22.1 4.4 9.0 2.4 1.0 2.6 6.2 6.7 7.9 6.7 4.6 3.5 5.2 4.9 6.2 18.1 11.8 8.4 5.0 11.1 6.8 4.2 1.8 6.9 26.4 3.4 2.3 8.0 1.4 4.1 2.3 2.6 4.1 4.4 2.9 3.2 7.8 5.6 4.7 1.7 12.5 9.3 1.7 7.1 6.2 5.1 2.5 12.1 0.9 1.4 0.5 0.5 0.6 2.1 7.0 5.1 0.4 18.8 35.8 3.9 3.7 2.8 2.7 2.7 0.5 5.8 0.3 0.2 4.5 3.0 12.2 1.6 2.6 2.7 7.6 0.4 0.0 1.6 4.3 9.5 1.7 4.0 18.1 7.4 1.6 4.1 18.2 5.4 6.3 3.5 1.0 4.3 1.1 0.6 2.2 13.9 8.9 3.8 2.9 0.3 6.7 18.3 3.1 1.4 5.2 2.4 7.4 2.0 10.8 0.4 6.8 6.5 0.6 0.5 1.0 3.9 2.5 3.9 0.3 2.0 5.7 7.8 0.0 1.1 0.9 0.1 1.4 0.1 2.2 0.2 0.2 2.7 2.5 0.3 0.5 0.3 0.5 1.2 12.1 0.2 0.6 5.1 8.8 1.9 22.1 5.2 4.9 5.0 11.1 3.4 1.7 6.0 4.8 15.9 11.0 13.1 2.3 0.6 15.3 1.4 3.4 12.2 0.0 62.4 11.6 13.0 80.4 5.8 7.3 0.0 8.9 211.3 7.6 6.9 2.3 20.3 25.1 0.0 4.1 6.7 25.6 64.2 10.3 41.2 27.0 30.7 9.0 2.1 20.4 8.2 15.6 15.4 2.1 0.0 9.0 7.7 9.1 10.8 143.5 2.6 8.2 11.6 OPRK1 "KOR, OPRK" ENSG00000082556 "Opioid receptor kappa 1" P41145 8 53225716-53251697 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.0;prostate: 6.7" "Group enriched" "Detected in some" 8 "Extravillous trophoblasts: 7.3;Leydig cells: 4.4" "Cancer enhanced" "Detected in some" "prostate cancer: 1.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "U-937: 22.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067549 Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA067549: AB_2732770" "unprognostic (1.01e-1)" "unprognostic (1.17e-2)" "unprognostic (8.70e-3)" "unprognostic (3.73e-2)" "unprognostic (6.74e-2)" "unprognostic (2.22e-3)" "unprognostic (8.09e-2)" "unprognostic (9.71e-2)" "unprognostic (4.28e-3)" "unprognostic (3.29e-1)" "unprognostic (3.35e-2)" "unprognostic (9.54e-4)" "unprognostic (1.61e-1)" 0.7 0.7 15.9 0.3 18.0 0.4 0.3 2.2 8.8 0.4 0.4 0.3 0.0 0.4 0.4 0.6 0.5 0.7 0.4 0.8 4.5 6.2 0.3 0.5 0.8 0.4 1.7 5.8 0.4 0.3 0.4 0.8 2.8 3.1 6.7 0.4 0.0 0.3 0.4 3.8 0.4 0.5 0.5 0.5 0.6 0.3 2.8 1.6 0.2 0.9 0.0 0.3 0.3 0.1 0.2 0.8 1.2 0.2 0.1 0.4 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 22.1 0.1 1.2 0.2 0.1 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.1 0.1 0.8 0.0 0.0 15.9 18.0 2.2 8.8 4.5 6.2 1.7 5.8 3.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.3 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 OR1N2 ENSG00000171501 "Olfactory receptor family 1 subfamily N member 2" Q8NGR9 9 122553112-122554214 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" 33 "Cardiomyocytes: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "RT4: 1.1" "Not detected" "Not detected" HPA060968 Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoli, Plasma membrane" Nucleoplasm "HPA060968: " 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 ORAI2 "C7orf19, CBCIP2, FLJ12474, FLJ14733, H_NH0514P08.8, TMEM142B" ENSG00000160991 "ORAI calcium release-activated calcium modulator 2" Q96SN7 7 102433106-102456821 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "B-cells: 169.1;Cone photoreceptor cells: 62.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 30.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 46.5;RPMI-8226: 45.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055137, HPA065937" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA055137: AB_2682712, HPA065937: AB_2685581" "unprognostic (5.09e-3)" "unprognostic (1.23e-1)" "unprognostic (1.13e-1)" "unprognostic (1.55e-2)" "unprognostic (5.07e-3)" "unprognostic (8.56e-2)" "unprognostic (3.82e-2)" "unprognostic (7.07e-2)" "unprognostic (7.61e-2)" "unprognostic (1.47e-1)" "prognostic favorable (8.49e-5)" "unprognostic (7.16e-2)" "unprognostic (1.57e-3)" "unprognostic (7.97e-2)" "unprognostic (1.88e-1)" "prognostic favorable (6.65e-4)" "unprognostic (2.46e-1)" 6.3 7.2 13.8 28.1 15.8 24.3 8.0 18.6 15.9 4.7 5.7 5.0 5.6 5.6 7.7 6.2 2.7 7.7 6.6 4.1 11.9 17.1 6.9 1.5 6.2 25.9 9.3 4.8 5.0 4.8 13.9 24.8 4.1 10.3 4.3 2.8 4.3 5.1 7.6 1.8 1.6 10.3 4.6 7.0 21.9 7.7 1.8 5.1 9.9 10.9 1.3 20.3 10.0 4.4 14.4 2.5 30.9 2.7 7.4 2.3 2.5 6.4 14.7 5.7 10.9 5.2 5.9 0.4 6.3 7.0 7.0 6.1 8.4 6.8 46.5 17.6 10.7 14.0 2.5 2.2 1.6 2.4 5.0 4.1 6.6 6.9 2.5 7.9 15.8 8.9 5.5 1.1 11.4 1.9 7.3 12.5 6.3 8.2 37.3 5.4 13.5 23.4 7.3 7.1 2.2 6.9 9.6 5.1 45.7 4.1 4.8 9.7 24.2 6.2 2.6 3.4 3.1 3.8 6.2 11.9 16.5 18.4 11.3 8.3 36.4 25.5 34.0 12.3 9.6 8.4 4.9 2.7 30.9 2.0 2.4 2.3 13.3 1.8 1.6 1.6 14.4 1.2 1.4 25.6 7.4 1.4 2.5 0.8 2.5 13.8 15.8 18.6 11.2 11.9 17.1 9.3 4.8 10.3 5.1 3.0 11.1 169.1 8.0 3.5 25.3 2.6 12.7 20.1 15.9 15.7 62.8 1.0 5.0 18.0 2.6 20.1 0.3 0.0 10.3 1.5 12.6 8.4 25.4 0.8 14.7 41.3 16.6 23.4 19.4 4.9 7.5 17.5 10.1 29.7 2.0 11.8 9.9 0.0 9.6 7.9 21.1 0.0 5.9 3.2 9.4 2.8 2.5 25.5 1.3 5.8 ORAI3 "MGC13024, TMEM142C" ENSG00000175938 "ORAI calcium release-activated calcium modulator 3" Q9BRQ5 16 30949066-30956461 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hofbauer cells: 77.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 36.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015022 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA015022: AB_1854807" "unprognostic (1.17e-1)" "unprognostic (3.88e-2)" "unprognostic (2.94e-3)" "unprognostic (1.15e-2)" "unprognostic (8.29e-2)" "unprognostic (1.46e-1)" "unprognostic (8.60e-2)" "unprognostic (8.54e-2)" "unprognostic (3.15e-1)" "unprognostic (1.33e-3)" "unprognostic (1.77e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (3.87e-5)" "unprognostic (2.30e-2)" "unprognostic (4.46e-2)" "unprognostic (6.43e-3)" "unprognostic (9.17e-3)" 13.4 22.9 5.5 13.0 5.6 12.4 14.8 6.0 8.1 17.0 12.8 9.1 13.3 7.5 12.4 16.9 19.9 13.6 16.5 10.8 4.9 5.1 16.5 39.6 15.4 20.7 5.9 3.6 16.9 14.5 13.5 12.1 14.8 5.8 26.2 7.3 13.3 10.3 15.3 9.4 10.2 9.9 16.4 5.1 20.0 10.4 19.7 5.2 14.2 25.6 6.3 13.7 29.1 15.2 5.1 6.8 17.9 8.5 8.1 2.8 2.2 1.0 5.8 3.0 4.0 26.1 23.5 0.2 3.3 23.0 2.5 6.5 0.5 9.6 1.4 7.8 6.5 10.3 4.7 0.5 6.4 1.7 4.4 1.9 3.7 1.8 5.7 36.5 4.0 11.5 25.2 17.2 4.9 9.7 24.2 4.3 0.8 4.1 7.7 8.2 3.8 0.2 15.0 2.4 3.2 1.6 3.1 2.3 10.8 9.7 2.5 0.7 5.0 3.1 0.9 5.2 7.7 7.3 16.5 3.1 1.9 1.3 4.2 0.7 18.9 1.3 1.1 9.6 9.4 2.9 14.1 6.5 17.9 2.5 6.3 2.8 5.1 1.4 2.0 6.1 4.8 1.7 2.3 10.9 8.1 8.5 6.8 1.9 2.2 5.5 5.6 6.0 8.1 4.9 5.1 5.9 3.6 5.8 5.2 6.0 9.6 31.2 20.7 7.0 1.7 5.6 5.1 8.1 3.4 15.7 2.0 19.6 11.6 14.8 48.3 11.6 5.1 0.0 10.1 2.1 16.0 14.7 6.9 65.7 77.4 33.4 14.5 17.2 29.5 24.4 49.2 21.5 20.3 28.9 12.9 22.3 8.7 16.9 40.7 47.0 3.4 25.8 6.6 24.5 1.5 4.0 3.7 15.0 6.2 19.2 ORAOV1 TAOS1 ENSG00000149716 "Oral cancer overexpressed 1" Q8WV07 11 69653076-69675416 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062696 Approved Nucleoplasm NA NA Nucleoplasm "HPA062696: AB_2684837" "unprognostic (2.15e-1)" "unprognostic (1.37e-2)" "unprognostic (3.63e-1)" "unprognostic (1.60e-1)" "unprognostic (2.20e-1)" "unprognostic (2.09e-2)" "unprognostic (6.76e-3)" "unprognostic (4.65e-2)" "unprognostic (9.87e-3)" "unprognostic (1.82e-1)" "unprognostic (6.51e-3)" "unprognostic (1.18e-2)" "prognostic unfavorable (1.51e-5)" "unprognostic (1.10e-1)" "unprognostic (1.54e-1)" "unprognostic (2.77e-1)" "unprognostic (5.19e-3)" 11.3 14.8 19.0 14.0 20.2 13.5 12.2 24.0 24.0 11.1 11.3 19.6 14.1 16.0 13.8 33.8 15.6 12.1 9.8 9.4 17.7 13.5 12.6 11.7 11.1 16.3 22.5 16.8 14.5 18.6 12.8 15.7 10.1 16.7 14.1 12.6 11.6 14.4 20.0 15.5 25.4 13.1 15.1 16.2 17.8 13.6 14.7 21.0 9.3 14.1 10.3 15.6 12.4 12.5 8.0 8.0 5.3 9.9 4.1 9.9 4.2 38.2 8.3 5.8 6.7 5.9 5.2 7.1 12.8 7.1 9.8 5.7 13.7 12.5 8.8 6.8 7.7 7.4 15.9 8.1 6.8 12.1 5.1 10.6 9.2 15.5 8.7 9.2 6.8 5.8 6.0 8.8 10.8 11.0 5.7 7.1 8.2 9.3 6.1 9.5 12.7 6.3 13.0 6.2 16.9 16.1 5.9 10.0 7.5 6.4 6.1 7.0 6.4 8.8 6.8 29.7 5.2 10.2 7.3 7.7 10.6 8.7 16.7 10.3 8.2 5.4 6.9 16.6 7.6 9.9 2.3 5.2 3.9 8.8 4.2 6.6 8.0 8.0 5.9 5.5 7.6 9.9 8.7 5.3 4.1 9.9 8.0 8.7 4.2 19.0 20.2 24.0 24.0 17.7 13.5 22.5 16.8 16.7 21.0 20.8 6.4 9.5 9.1 3.9 10.9 2.0 7.6 12.0 2.3 12.2 9.8 6.5 11.6 6.7 2.1 5.9 8.1 0.0 4.8 2.6 6.2 12.3 4.7 2.9 5.7 3.2 12.2 6.2 5.7 0.9 8.6 6.3 3.3 9.0 10.0 13.8 6.6 7.0 10.3 8.7 12.0 6.5 7.3 7.6 10.5 7.3 4.8 7.5 6.8 9.2 ORC1 "HSORC1, ORC1L, PARC1" ENSG00000085840 "Origin recognition complex subunit 1" Q13415 1 52372829-52404459 "Disease related genes, Predicted intracellular proteins" "DNA replication" DNA-binding "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 22.9;lymphoid tissue: 29.1" "Cell type enhanced" "Detected in some" 9 "Early spermatids: 4.6;Extravillous trophoblasts: 8.3;Spermatogonia: 7.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "NK-cell: 7.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027439, HPA027450" Approved Supported Nucleoplasm NA Yes Nucleoplasm "HPA027439: , HPA027450: AB_10602041" "unprognostic (3.28e-1)" "unprognostic (4.42e-3)" "prognostic favorable (1.74e-5)" "unprognostic (1.29e-2)" "unprognostic (7.29e-2)" "unprognostic (2.34e-3)" "prognostic unfavorable (3.22e-5)" "unprognostic (3.77e-3)" "prognostic unfavorable (3.69e-4)" "unprognostic (3.86e-2)" "unprognostic (2.70e-3)" "unprognostic (8.39e-2)" "unprognostic (1.25e-10)" "unprognostic (4.56e-3)" "unprognostic (1.05e-1)" "unprognostic (2.45e-1)" "unprognostic (1.57e-2)" 0.9 1.2 0.2 9.9 0.4 22.9 0.8 1.4 1.1 1.1 3.4 0.4 0.1 1.4 0.6 1.5 5.3 0.5 0.8 0.9 0.3 0.4 1.0 1.1 1.4 5.7 0.3 0.4 1.0 0.7 0.2 0.9 1.6 0.9 0.8 3.8 0.5 1.4 0.8 0.9 2.0 3.0 0.7 0.4 4.2 1.2 8.7 0.5 29.1 0.5 8.0 11.3 1.0 1.7 1.0 1.3 0.7 0.4 7.5 2.3 0.7 7.4 8.2 13.3 8.7 0.3 1.1 12.8 5.3 4.9 15.8 16.4 10.1 4.2 17.2 4.7 3.3 7.2 10.3 19.5 6.7 13.8 7.3 11.2 20.6 12.2 10.0 0.0 27.6 11.8 0.6 0.3 15.4 1.7 1.1 4.6 10.9 23.9 8.4 5.1 5.5 21.6 13.1 29.4 4.5 11.8 23.3 20.7 16.8 2.7 9.8 7.5 6.3 12.3 7.5 4.2 13.0 4.1 11.1 2.1 6.4 9.3 10.0 13.2 4.4 11.7 21.3 6.3 20.6 7.8 0.1 0.2 0.0 0.5 0.3 0.6 0.4 0.8 0.8 1.3 1.0 0.3 0.7 0.7 7.5 0.4 0.1 2.3 0.7 0.2 0.4 1.4 1.1 0.3 0.4 0.3 0.4 0.9 0.5 0.0 0.0 0.8 0.2 0.8 0.5 0.3 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.2 4.6 0.1 0.0 0.0 0.2 8.3 0.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 2.8 0.6 0.2 0.0 0.0 0.7 0.2 0.1 0.0 0.4 3.3 0.9 0.0 0.1 3.2 7.3 1.0 1.5 0.5 1.9 0.1 ORC2 ORC2L ENSG00000115942 "Origin recognition complex subunit 2" Q13416 2 200908973-200963680 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 63.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003693, HPA073881" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB003693: AB_425574, HPA073881: AB_2686640" "unprognostic (3.04e-1)" "unprognostic (1.76e-1)" "unprognostic (2.89e-1)" "unprognostic (8.12e-3)" "unprognostic (3.40e-2)" "unprognostic (1.52e-2)" "unprognostic (2.37e-3)" "unprognostic (3.28e-1)" "prognostic unfavorable (8.42e-4)" "unprognostic (6.18e-2)" "unprognostic (4.56e-2)" "unprognostic (4.63e-3)" "prognostic unfavorable (1.97e-4)" "unprognostic (9.67e-2)" "unprognostic (3.74e-1)" "unprognostic (1.42e-1)" "unprognostic (5.31e-3)" 11.7 10.6 8.3 15.9 14.0 9.0 14.0 19.0 14.6 12.6 16.1 11.8 15.1 15.7 18.4 12.9 12.3 10.3 10.7 14.6 9.8 9.2 10.8 9.5 9.5 13.5 8.6 10.4 14.6 14.3 13.7 18.0 14.4 12.9 11.8 12.3 10.3 18.1 22.0 16.1 14.6 16.9 8.9 9.0 14.1 12.1 33.2 6.8 20.3 14.7 12.7 14.2 10.9 11.7 8.1 6.9 5.1 3.6 4.6 8.9 2.2 11.3 8.1 9.0 9.0 3.7 6.3 15.4 11.7 7.3 10.7 10.6 16.6 9.1 7.0 8.5 6.8 12.1 9.2 19.6 13.1 16.2 15.7 18.5 16.4 14.3 20.3 7.3 12.9 11.8 6.0 7.8 10.9 13.4 8.4 12.2 11.9 26.1 8.7 9.3 10.7 17.9 12.2 22.0 10.8 19.2 12.8 9.2 10.4 11.2 9.1 14.5 10.9 10.1 9.0 6.4 18.5 6.5 6.4 9.3 9.4 9.8 8.0 11.6 6.3 14.9 11.6 7.4 12.6 8.8 0.3 3.6 5.1 5.0 1.4 6.3 8.1 6.8 4.7 3.0 7.2 8.9 6.0 1.8 4.6 2.4 6.9 4.6 2.2 8.3 14.0 19.0 14.6 9.8 9.2 8.6 10.4 12.9 6.8 8.9 14.4 7.5 8.0 16.9 14.2 14.9 12.7 14.7 20.5 8.7 23.6 18.1 6.6 8.1 29.1 11.7 9.8 0.0 10.9 15.4 8.0 7.9 10.4 9.0 7.8 6.4 4.1 13.5 6.8 6.2 11.2 5.7 10.1 6.4 13.8 8.7 8.4 7.0 7.8 7.0 14.7 19.4 7.1 63.3 19.6 13.6 9.0 12.9 13.4 6.1 ORC3 "IMAGE50150, LATHEO, ORC3L" ENSG00000135336 "Origin recognition complex subunit 3" Q9UBD5 6 87590067-87667453 "Predicted intracellular proteins, Predicted membrane proteins" "DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039553, HPA053748" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA039553: AB_2676566, HPA053748: AB_2682247" "unprognostic (9.38e-3)" "unprognostic (2.38e-1)" "unprognostic (3.74e-2)" "prognostic unfavorable (2.89e-5)" "unprognostic (8.63e-2)" "unprognostic (1.28e-1)" "unprognostic (1.39e-2)" "unprognostic (2.15e-1)" "unprognostic (1.16e-1)" "unprognostic (2.26e-3)" "unprognostic (1.21e-1)" "unprognostic (9.07e-2)" "prognostic unfavorable (7.23e-4)" "unprognostic (1.33e-1)" "unprognostic (2.92e-2)" "unprognostic (3.38e-3)" "unprognostic (1.09e-1)" 16.9 22.6 17.6 11.4 23.1 8.9 18.7 33.9 24.4 18.1 10.7 12.1 12.4 8.1 16.5 19.6 11.0 18.1 11.2 21.7 17.8 19.6 16.7 17.3 12.4 15.2 17.6 19.4 24.8 11.8 27.8 30.0 17.6 28.5 16.4 12.9 11.5 11.0 14.2 23.6 12.2 11.4 13.8 19.8 15.4 10.0 26.8 19.4 29.0 18.6 15.3 15.3 17.0 11.1 15.1 9.7 14.9 17.1 15.1 20.6 11.1 8.5 11.4 21.4 16.1 16.5 17.5 15.9 17.4 15.5 20.4 28.8 15.8 10.7 17.1 23.4 11.7 17.2 15.6 23.9 13.8 28.2 20.8 16.3 15.7 17.1 16.2 8.9 17.6 5.4 15.5 11.1 23.1 20.2 11.7 12.4 17.8 35.4 18.1 19.2 10.8 7.4 9.3 15.0 12.0 12.9 17.2 28.8 10.3 15.7 12.3 15.4 11.2 13.6 8.2 13.1 23.2 11.3 15.3 10.1 10.4 10.0 21.1 20.4 8.8 19.0 11.7 13.7 18.0 15.6 14.9 8.8 9.5 11.4 14.2 16.8 15.1 16.3 14.2 7.2 12.9 20.6 17.2 5.9 15.1 17.1 9.7 15.4 11.1 17.6 23.1 33.9 24.4 17.8 19.6 17.6 19.4 28.5 19.4 11.9 11.2 14.1 9.3 4.4 18.3 27.8 12.7 24.1 13.6 7.0 11.8 19.8 18.3 9.5 43.1 9.0 17.6 23.3 9.0 20.3 13.2 8.4 11.5 8.5 16.9 6.4 9.9 12.3 7.1 19.9 17.3 9.7 8.5 7.2 13.7 18.1 8.4 9.9 14.5 20.3 29.1 12.9 7.8 43.9 30.9 3.9 12.2 13.8 10.4 6.3 ORC4 "HsORC4, ORC4L, Orc4p" ENSG00000115947 "Origin recognition complex subunit 4" O43929 2 147930397-148021604 "Disease related genes, Predicted intracellular proteins" "DNA replication" DNA-binding "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015124, HPA064562" Approved Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "CAB015124: AB_2157883, HPA064562: AB_2685287" "unprognostic (5.04e-2)" "unprognostic (6.56e-2)" "unprognostic (4.51e-2)" "prognostic unfavorable (7.27e-4)" "unprognostic (8.28e-2)" "unprognostic (6.45e-2)" "prognostic unfavorable (4.98e-8)" "unprognostic (5.55e-2)" "unprognostic (8.00e-2)" "unprognostic (1.81e-2)" "unprognostic (4.92e-2)" "unprognostic (1.19e-1)" "prognostic favorable (4.10e-6)" "unprognostic (2.49e-1)" "unprognostic (1.34e-1)" "unprognostic (1.62e-1)" "unprognostic (1.95e-3)" 11.5 14.3 19.0 11.4 20.5 19.6 17.3 29.8 27.2 13.6 14.6 11.0 12.0 13.9 14.8 13.5 13.1 17.3 11.9 13.8 18.1 22.3 24.5 15.5 10.9 11.9 18.1 18.1 21.2 12.1 18.9 29.5 14.3 30.9 14.9 16.8 12.7 15.2 14.6 16.0 11.6 15.6 13.8 18.1 11.0 10.9 17.3 11.8 20.4 19.0 12.7 13.6 13.3 12.6 16.1 18.1 21.5 19.1 20.2 16.6 13.1 12.4 10.9 21.4 11.7 8.3 8.2 23.2 14.3 12.0 18.0 18.0 26.8 12.7 16.1 15.6 8.4 16.0 12.7 24.2 14.0 18.8 11.3 20.6 22.3 11.8 18.1 11.1 14.0 8.4 6.9 17.0 19.6 7.9 13.4 12.1 15.4 21.1 8.5 11.7 13.2 10.9 11.4 24.2 10.3 15.9 12.0 14.4 14.6 19.9 25.9 20.3 15.9 12.8 14.1 17.1 20.3 10.8 6.8 8.8 13.7 13.5 9.9 13.0 8.5 20.0 15.3 11.2 11.0 8.3 21.5 15.0 19.8 16.2 19.1 16.6 16.1 15.8 16.6 18.1 15.4 16.6 16.3 21.1 20.2 14.8 9.2 16.0 13.1 19.0 20.5 29.8 27.2 18.1 22.3 18.1 18.1 30.9 11.8 77.4 53.4 11.0 19.9 23.1 44.5 24.2 10.2 96.4 80.8 12.2 37.3 33.7 38.1 27.8 19.2 16.5 17.2 0.0 15.1 40.8 23.7 20.2 42.9 15.3 20.8 50.9 22.1 17.2 20.0 13.4 20.8 22.1 20.3 18.0 18.1 32.9 16.3 14.0 20.1 41.6 35.2 32.3 19.5 55.5 25.3 21.8 27.3 22.4 22.5 17.3 ORC5 "ORC5L, Orc5p, ORC5T, PPP1R117" ENSG00000164815 "Origin recognition complex subunit 5" O43913 7 104126341-104208047 "Predicted intracellular proteins" "DNA replication, Photosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019730 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA019730: AB_10696205" "unprognostic (1.82e-1)" "unprognostic (1.49e-1)" "unprognostic (6.72e-2)" "unprognostic (4.77e-2)" "unprognostic (7.42e-2)" "unprognostic (3.11e-2)" "unprognostic (2.53e-3)" "unprognostic (3.47e-2)" "unprognostic (9.26e-2)" "unprognostic (2.33e-1)" "unprognostic (1.77e-1)" "unprognostic (2.00e-2)" "unprognostic (3.83e-2)" "unprognostic (6.52e-2)" "unprognostic (9.71e-2)" "unprognostic (2.53e-2)" "unprognostic (7.73e-2)" 12.4 13.7 10.6 9.3 17.9 6.2 16.3 18.7 21.6 12.9 14.2 12.1 9.0 10.1 14.4 17.5 14.1 11.3 8.5 8.2 13.0 12.9 12.6 20.3 10.2 13.7 10.1 11.8 13.8 17.4 10.8 15.9 11.4 17.6 21.5 16.0 14.0 11.8 13.8 10.9 14.8 11.0 14.2 8.6 12.0 12.3 27.3 10.0 20.5 12.6 7.9 15.8 13.4 12.7 14.0 7.2 6.8 7.4 12.5 18.6 8.2 16.3 17.2 10.0 18.0 10.6 10.6 8.9 14.5 13.9 16.4 13.7 11.2 10.7 24.2 12.2 9.0 18.1 15.6 20.0 13.9 19.7 13.1 12.9 8.9 9.8 11.3 14.8 16.8 7.9 10.0 13.3 18.8 17.5 6.9 15.4 13.5 29.0 14.0 13.9 23.2 23.5 17.0 10.7 22.2 18.0 9.8 18.1 24.0 12.6 12.2 13.4 11.3 13.6 27.8 18.6 8.2 9.3 13.0 8.9 14.9 17.5 24.3 18.2 15.5 33.4 31.9 10.7 22.9 18.7 6.8 6.3 4.5 13.1 7.4 17.1 14.0 13.6 15.0 7.2 11.9 17.2 18.6 0.8 12.5 6.0 7.0 11.3 8.2 10.6 17.9 18.7 21.6 13.0 12.9 10.1 11.8 17.6 10.0 3.0 7.4 9.1 2.8 3.9 5.9 4.8 10.2 16.0 7.9 3.5 0.0 18.8 1.7 8.0 4.0 8.0 4.7 0.0 7.7 11.6 5.8 4.1 4.7 8.3 7.7 3.2 5.2 4.9 4.5 4.5 5.8 5.3 1.7 8.2 8.3 2.9 6.4 3.5 7.4 5.7 11.5 0.0 12.3 30.5 22.8 7.4 8.8 9.6 9.1 1.4 ORC6 ORC6L ENSG00000091651 "Origin recognition complex subunit 6" Q9Y5N6 16 46689643-46698394 "Disease related genes, Predicted intracellular proteins" "DNA replication" DNA-binding "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.2;lymphoid tissue: 12.8;testis: 23.1" "Cell type enhanced" "Detected in many" 10 "Spermatocytes: 84.9;Spermatogonia: 102.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016330, HPA072587" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" Yes No Nucleoplasm "Nucleoli fibrillar center" "CAB016330: AB_670295, HPA072587: AB_2686537" "unprognostic (3.47e-2)" "unprognostic (8.99e-3)" "unprognostic (2.92e-1)" "unprognostic (4.47e-2)" "unprognostic (2.27e-1)" "unprognostic (2.19e-2)" "unprognostic (3.15e-6)" "unprognostic (1.36e-2)" "prognostic unfavorable (3.53e-4)" "prognostic favorable (1.48e-4)" "unprognostic (1.50e-4)" "unprognostic (3.97e-2)" "unprognostic (3.90e-14)" "unprognostic (2.08e-1)" "unprognostic (4.24e-1)" "unprognostic (2.79e-1)" "unprognostic (5.98e-2)" 0.8 1.4 4.1 8.9 7.0 14.2 1.1 3.8 6.1 1.3 2.8 1.2 1.4 2.7 1.5 1.9 6.7 0.9 1.2 2.3 4.4 3.5 0.8 1.6 1.5 10.6 3.1 4.5 0.9 0.6 0.3 1.2 5.2 2.4 0.8 3.1 0.5 1.4 0.6 0.4 1.9 2.7 1.7 2.9 4.1 1.5 23.1 1.4 12.8 0.9 4.2 10.7 2.6 2.0 4.1 3.4 1.0 2.6 2.8 4.1 2.5 10.9 10.1 16.2 12.6 2.0 2.5 12.0 19.6 7.3 21.7 11.4 14.2 6.7 12.7 10.3 3.7 11.0 11.2 20.8 5.4 18.4 6.5 16.8 10.5 5.4 14.3 2.5 17.2 11.1 0.7 1.0 11.8 6.2 3.5 7.1 11.1 12.7 6.5 13.1 9.6 23.1 21.6 17.9 7.6 27.9 27.9 29.8 12.9 5.3 3.8 19.4 11.5 10.0 11.1 6.8 13.5 5.9 13.7 4.3 20.0 13.6 12.6 18.4 5.0 6.7 44.4 8.5 11.3 15.4 0.0 1.1 1.0 3.5 2.6 1.4 2.7 2.0 2.0 2.2 4.1 2.9 1.4 0.5 2.8 2.5 3.4 4.1 2.5 4.1 7.0 3.8 6.1 4.4 3.5 3.1 4.5 2.4 1.4 3.0 16.4 15.2 2.4 6.0 6.1 3.3 2.5 17.4 9.1 5.2 3.9 22.0 1.7 2.6 9.4 3.0 2.1 0.0 0.6 30.9 9.9 1.7 1.1 8.3 13.2 11.1 1.7 0.0 3.3 6.2 2.6 6.1 32.1 0.0 5.6 2.5 1.6 0.0 3.2 0.7 8.4 0.0 2.2 84.9 102.2 5.3 9.2 4.4 10.3 1.7 OSBP OSBP1 ENSG00000110048 "Oxysterol binding protein" P22059 11 59574398-59616144 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039227, HPA043625" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039227: AB_2676401, HPA043625: AB_2678587" "unprognostic (3.09e-2)" "unprognostic (3.76e-2)" "prognostic favorable (2.08e-5)" "unprognostic (7.80e-3)" "unprognostic (7.32e-2)" "unprognostic (2.79e-2)" "unprognostic (2.13e-1)" "unprognostic (1.49e-2)" "unprognostic (3.34e-1)" "unprognostic (7.42e-2)" "unprognostic (1.42e-3)" "unprognostic (1.22e-1)" "prognostic favorable (3.08e-7)" "unprognostic (1.25e-1)" "unprognostic (9.00e-2)" "unprognostic (1.93e-1)" "unprognostic (2.67e-1)" 15.6 36.6 12.3 10.6 16.3 13.8 16.5 14.7 18.0 16.1 18.8 13.7 35.4 17.3 15.9 19.9 15.9 13.8 19.5 14.7 10.3 11.6 26.3 54.8 12.9 9.7 12.4 12.7 16.6 30.2 31.4 14.7 29.4 17.9 16.1 17.3 12.6 27.7 26.2 32.5 20.9 22.3 15.1 9.5 12.5 19.1 11.3 12.1 18.8 19.6 12.5 13.8 16.7 13.7 4.6 7.9 3.5 3.1 4.0 6.1 2.1 17.7 14.9 11.1 14.9 26.2 24.6 12.2 14.5 18.9 17.5 15.8 16.8 18.1 18.0 19.5 16.7 21.5 18.7 20.4 19.3 19.8 17.3 9.4 12.1 11.6 11.3 28.1 15.4 24.0 18.8 24.1 16.4 43.4 18.3 18.7 16.9 20.7 16.8 15.5 8.2 14.5 11.4 12.6 26.1 14.7 14.1 17.8 12.4 20.8 20.7 13.1 9.3 17.2 21.6 19.8 16.0 30.2 9.9 20.2 15.0 10.5 22.4 9.7 23.5 19.0 18.3 16.9 11.2 12.0 3.5 3.1 2.8 5.9 2.9 5.5 4.6 6.1 4.6 3.2 3.4 5.6 4.7 3.0 4.0 2.5 7.9 2.6 2.1 12.3 16.3 14.7 18.0 10.3 11.6 12.4 12.7 17.9 12.1 23.8 7.0 11.2 14.5 35.1 21.6 29.9 33.1 20.1 17.0 26.2 21.6 11.7 6.6 12.1 7.6 17.2 30.7 0.0 16.0 10.9 16.4 26.0 27.6 56.3 13.4 25.4 28.8 10.4 12.9 10.6 14.7 12.1 13.5 3.6 35.0 16.7 18.6 22.9 18.7 17.9 19.4 6.5 13.7 21.8 13.2 41.4 25.7 10.2 25.1 19.0 OSBPL11 "FLJ13012, FLJ13164, ORP-11, ORP11" ENSG00000144909 "Oxysterol binding protein like 11" Q9BXB4 3 125528858-125595090 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 48.9" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039144 Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA039144: AB_10794086" "unprognostic (1.14e-1)" "unprognostic (1.31e-3)" "unprognostic (2.57e-3)" "unprognostic (9.73e-3)" "unprognostic (6.38e-2)" "unprognostic (6.56e-3)" "unprognostic (7.05e-2)" "unprognostic (1.43e-1)" "unprognostic (6.68e-2)" "unprognostic (1.42e-1)" "unprognostic (9.25e-2)" "unprognostic (9.84e-2)" "unprognostic (6.43e-2)" "unprognostic (2.32e-1)" "unprognostic (1.07e-1)" "unprognostic (3.58e-2)" "unprognostic (1.13e-1)" 8.1 5.1 12.6 8.1 16.9 4.7 13.2 5.7 9.7 5.4 7.2 14.1 4.9 5.1 6.1 6.1 6.8 5.0 5.2 5.3 11.0 7.7 6.8 22.4 10.9 11.1 11.2 8.3 4.5 3.8 8.5 5.1 9.0 8.7 4.6 6.6 4.6 5.1 9.7 48.9 6.3 6.0 7.0 10.3 11.4 5.2 7.8 10.9 8.3 5.9 6.0 9.4 6.3 5.3 3.5 11.8 12.8 9.5 1.9 2.2 3.2 13.1 7.1 13.6 7.7 15.5 8.3 17.8 9.9 8.0 12.6 14.5 13.7 4.7 21.7 12.4 8.2 10.4 9.9 15.1 8.7 16.9 5.8 6.5 9.9 8.6 9.1 8.7 7.4 13.6 6.7 10.7 10.5 9.2 5.1 9.1 10.5 10.2 9.9 11.4 7.8 14.7 3.6 18.7 9.7 6.4 13.0 7.9 25.3 10.5 8.2 3.0 8.1 12.2 7.0 10.5 9.8 7.3 3.9 9.4 10.1 9.1 14.6 7.7 6.3 6.6 26.6 7.1 2.6 9.7 10.8 9.3 2.4 1.8 9.5 1.5 3.5 1.0 1.8 11.8 2.7 1.2 1.4 12.8 1.9 7.8 4.5 2.2 3.2 12.6 16.9 5.7 8.4 11.0 7.7 11.2 8.3 8.7 10.9 8.9 11.8 18.6 7.4 8.9 18.9 7.9 5.1 9.4 12.5 8.7 11.8 10.0 5.0 8.2 0.8 9.2 12.6 0.0 6.1 9.0 7.4 5.3 3.5 31.6 22.8 7.9 4.1 11.6 56.9 2.5 6.1 35.7 11.8 13.6 5.2 11.2 8.5 11.9 6.7 8.0 32.0 6.5 8.1 9.1 20.4 13.8 19.3 8.4 6.2 9.6 OSBPL1A "ORP-1, ORP1, OSBPL1B" ENSG00000141447 "Oxysterol binding protein like 1A" Q9BXW6 18 24162044-24397880 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 73.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 18 "basophil: 33.7" "Lineage enriched" "Detected in many" 18 "granulocytes: 33.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040959, HPA043401" Supported Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA040959: AB_10964295, HPA043401: AB_10960208" "unprognostic (1.75e-2)" "unprognostic (3.35e-2)" "unprognostic (9.84e-3)" "unprognostic (4.92e-3)" "unprognostic (2.34e-1)" "unprognostic (3.06e-2)" "unprognostic (5.82e-2)" "unprognostic (2.06e-1)" "unprognostic (5.88e-2)" "unprognostic (2.62e-2)" "unprognostic (2.41e-1)" "unprognostic (8.53e-2)" "prognostic favorable (4.98e-13)" "prognostic unfavorable (1.86e-4)" "unprognostic (2.18e-2)" "unprognostic (5.42e-3)" "unprognostic (1.56e-1)" 32.3 14.3 33.3 5.9 28.9 7.0 23.8 6.2 43.1 27.7 13.8 33.9 6.2 10.2 24.4 9.0 15.5 15.2 10.6 24.7 37.6 22.6 21.7 6.6 11.9 5.0 40.6 27.7 14.3 8.3 21.0 8.8 4.2 29.9 12.0 11.5 16.6 23.3 13.9 73.2 8.7 9.8 20.4 49.0 4.8 9.7 6.9 29.0 1.0 14.6 9.9 4.1 12.0 29.7 0.2 1.8 33.7 1.8 0.1 0.4 0.6 15.3 4.6 11.0 20.5 25.8 21.1 10.3 5.7 16.7 5.2 4.3 2.9 16.1 0.0 6.8 10.2 8.3 15.7 4.3 10.0 4.8 0.0 8.1 4.8 3.3 0.0 12.9 12.1 2.5 27.3 14.5 3.9 16.3 22.9 6.5 4.3 0.0 0.1 6.4 6.5 2.7 3.6 9.0 7.9 15.3 0.0 8.8 1.3 1.4 11.3 7.2 7.0 13.4 15.7 18.3 10.8 5.7 8.7 1.4 19.5 4.1 6.2 5.5 0.1 2.1 0.4 9.4 3.5 11.1 33.7 1.8 0.4 0.1 0.9 0.0 0.0 0.4 0.2 1.7 0.2 0.2 0.2 0.7 0.1 0.3 1.8 0.3 0.6 33.3 28.9 6.2 43.1 37.6 22.6 40.6 27.7 29.9 29.0 14.9 16.3 3.2 36.9 17.9 60.0 66.8 28.1 24.1 23.9 19.2 21.6 9.0 54.7 10.3 58.6 58.9 23.8 0.0 6.7 7.0 27.8 29.4 17.3 10.4 24.0 23.8 4.6 33.7 16.4 59.6 39.7 21.9 55.6 1.8 32.2 86.9 8.0 14.8 51.6 55.2 92.0 32.3 45.3 6.7 10.6 8.9 5.4 4.3 8.6 23.1 OSBPL7 "MGC71150, ORP7" ENSG00000006025 "Oxysterol binding protein like 7" Q9BZF2 17 47807372-47821834 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "stomach 1: 37.9" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 25.9;Mucus-secreting cells: 23.6;Paneth cells: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036076, HPA053083, HPA073967" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA036076: AB_10601042, HPA053083: AB_2682038, HPA073967: " "unprognostic (3.88e-2)" "unprognostic (2.01e-1)" "unprognostic (2.25e-1)" "unprognostic (1.90e-1)" "unprognostic (1.13e-1)" "unprognostic (6.55e-3)" "unprognostic (2.05e-3)" "unprognostic (1.19e-1)" "unprognostic (3.95e-2)" "unprognostic (3.33e-1)" "unprognostic (1.97e-1)" "unprognostic (6.78e-2)" "prognostic unfavorable (8.30e-4)" "unprognostic (2.17e-1)" "unprognostic (1.36e-1)" "unprognostic (3.08e-1)" "prognostic favorable (1.19e-5)" 4.1 3.4 9.0 9.6 13.4 7.3 3.9 10.7 11.9 6.8 16.8 12.0 7.5 24.6 6.7 3.7 2.8 6.1 10.5 4.6 9.7 7.3 7.2 1.4 6.3 7.9 13.9 9.8 7.4 11.4 5.3 7.8 3.2 10.3 10.1 10.3 7.7 8.8 10.1 20.2 1.9 32.2 6.2 6.6 12.3 37.9 1.4 16.4 7.9 8.4 2.9 8.1 6.8 5.2 2.6 2.9 1.7 1.4 1.1 5.5 2.1 3.8 4.6 2.0 2.3 2.2 3.2 1.7 1.5 2.1 2.5 2.9 4.6 11.8 3.9 5.8 2.1 0.9 28.9 1.1 3.1 0.8 13.1 1.6 2.9 8.6 3.0 2.0 6.0 0.1 5.0 0.6 1.6 1.1 7.9 5.1 6.9 2.8 5.4 3.9 5.0 6.0 6.4 1.2 15.5 5.8 5.6 3.1 5.4 3.4 3.0 2.0 4.8 2.4 0.8 2.2 2.6 4.2 3.9 5.9 3.9 3.4 0.0 1.2 9.9 3.6 3.8 4.2 5.1 1.4 0.0 1.4 1.7 5.5 1.0 2.3 2.6 2.2 3.1 1.7 1.4 1.6 2.3 0.9 1.1 0.0 2.9 2.7 2.1 9.0 13.4 10.7 11.9 9.7 7.3 13.9 9.8 10.3 16.4 0.0 3.8 4.5 1.0 0.1 5.7 2.8 2.5 1.4 7.9 3.5 5.9 0.2 0.0 2.4 0.0 3.7 25.9 0.0 13.3 0.1 1.5 2.4 2.3 0.4 2.3 11.1 5.8 5.5 2.8 0.0 2.6 0.8 1.7 1.0 23.6 7.7 6.3 26.8 2.5 0.8 7.7 0.0 1.0 0.0 0.2 0.1 0.5 7.2 13.6 0.5 OSCAR ENSG00000170909 "Osteoclast associated, immunoglobulin-like receptor" Q8IYS5 19 54094668-54102692 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 20.6;bone marrow: 18.9;lung: 40.4;lymphoid tissue: 20.2" "Group enriched" "Detected in some" 5 "Hofbauer cells: 36.7;Kupffer cells: 33.7;Macrophages: 28.2;monocytes: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 34 "classical monocyte: 20.6;eosinophil: 11.7;intermediate monocyte: 12.8;myeloid DC: 9.4;neutrophil: 18.3;non-classical monocyte: 11.2" "Group enriched" "Detected in many" 75 "dendritic cells: 9.4;granulocytes: 18.3;monocytes: 20.6" "Cell line enhanced" "Detected in some" "EFO-21: 13.6;HHSteC: 9.3;hTERT-HME1: 4.9;NB-4: 5.4;U-937: 16.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA073996 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 72000000 "Nucleoplasm, Plasma membrane, Cytosol" "HPA073996: " "unprognostic (9.09e-2)" "unprognostic (6.79e-3)" "unprognostic (8.47e-3)" "unprognostic (2.14e-1)" "unprognostic (2.12e-2)" "unprognostic (9.04e-2)" "unprognostic (1.39e-1)" "unprognostic (3.86e-1)" "unprognostic (8.57e-2)" "unprognostic (1.15e-1)" "unprognostic (2.05e-2)" "unprognostic (3.01e-1)" "prognostic unfavorable (2.71e-5)" "unprognostic (1.84e-1)" "unprognostic (2.88e-2)" "unprognostic (9.69e-2)" "unprognostic (4.28e-2)" 4.5 1.0 1.4 3.8 2.8 18.9 1.4 0.4 1.5 1.3 0.9 3.5 0.0 0.4 0.7 1.3 1.2 2.2 2.3 1.1 3.8 1.9 1.0 1.7 40.4 4.7 3.5 0.4 1.2 0.7 0.3 0.5 2.2 4.0 0.8 0.7 1.0 1.3 0.8 0.7 1.9 1.0 2.8 5.6 20.2 1.3 0.6 2.4 1.7 1.0 0.0 1.2 1.7 3.1 0.0 9.4 18.3 20.6 0.0 0.2 7.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.1 0.4 0.0 13.6 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 9.3 0.7 0.0 0.0 0.2 0.6 4.9 0.8 0.0 0.1 0.0 0.4 0.1 0.1 0.0 5.4 0.3 0.2 1.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.9 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.6 0.5 16.8 0.0 0.0 20.6 11.7 0.1 12.8 0.0 0.0 0.1 0.2 9.4 0.0 0.0 0.0 18.3 0.0 11.2 0.4 0.1 7.0 1.4 2.8 0.4 1.4 3.8 1.9 3.5 0.4 4.0 2.4 3.0 5.1 0.0 0.5 0.7 0.0 0.3 2.5 6.7 3.4 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.8 0.2 1.1 0.0 36.7 0.0 0.0 0.0 33.7 0.0 0.0 28.2 0.0 39.7 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.6 0.1 0.2 0.0 0.0 0.3 OSCP1 "C1orf102, NOR1" ENSG00000116885 "Organic solute carrier partner 1" Q8WVF1 1 36415827-36450451 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 35.8;testis: 49.9" "Group enriched" "Detected in many" 5 "Ciliated cells: 144.6;Early spermatids: 336.5;Spermatocytes: 91.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028436, HPA052655" Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA028436: AB_10600885, HPA052655: " "unprognostic (3.46e-3)" "unprognostic (7.57e-2)" "unprognostic (4.67e-2)" "prognostic favorable (6.88e-4)" "unprognostic (1.28e-2)" "unprognostic (4.81e-2)" "unprognostic (3.38e-2)" "unprognostic (4.52e-2)" "unprognostic (5.52e-2)" "unprognostic (8.80e-2)" "unprognostic (2.21e-2)" "unprognostic (3.87e-2)" "prognostic favorable (2.18e-6)" "unprognostic (1.20e-1)" "unprognostic (2.04e-2)" "unprognostic (1.02e-2)" "unprognostic (4.20e-2)" 3.9 5.3 6.2 1.5 14.0 1.2 6.0 3.6 12.7 6.2 3.6 6.5 7.5 1.8 6.3 14.1 3.2 35.8 5.5 4.7 6.5 8.9 11.9 1.8 6.7 1.3 4.9 5.3 5.9 6.2 15.7 15.7 8.9 7.8 6.4 2.5 6.7 5.3 6.8 2.4 3.4 1.3 5.0 3.2 0.9 3.5 49.9 3.2 1.3 11.1 3.5 2.4 3.2 2.6 0.8 3.8 0.3 1.7 0.3 3.1 0.8 5.2 5.0 6.2 7.1 7.4 7.2 1.1 3.2 7.8 7.9 5.4 0.1 4.6 1.1 6.0 5.7 5.8 4.1 0.2 6.0 5.1 0.9 4.7 0.0 3.3 0.5 9.1 0.6 0.9 8.1 9.8 11.1 4.9 11.5 5.4 5.0 0.1 1.3 6.2 3.7 2.7 1.9 6.3 2.0 2.1 2.9 2.5 0.9 12.9 1.8 16.6 7.3 5.9 2.8 4.1 6.1 6.1 0.9 4.6 5.7 2.1 10.3 5.3 2.3 2.3 0.5 11.0 0.1 3.8 0.0 0.7 0.0 0.9 1.7 0.0 0.4 0.9 0.7 1.8 0.8 2.2 3.1 0.3 0.3 0.2 3.8 2.2 0.8 6.2 14.0 3.6 12.7 6.5 8.9 4.9 5.3 7.8 3.2 8.9 7.5 0.5 6.7 1.3 5.3 4.7 5.1 144.6 19.4 12.2 15.7 9.8 19.9 11.2 336.5 2.4 0.7 0.0 8.1 2.6 4.1 4.3 0.0 1.9 3.8 4.8 4.7 2.5 0.6 35.1 11.5 1.2 3.3 0.0 2.6 12.3 7.9 4.0 8.5 18.1 18.9 0.0 3.3 91.2 18.9 2.8 16.8 0.7 2.6 3.3 OSGEP "GCPL1, KAE1, OSGEP1, PRSMG1, TCS3" ENSG00000092094 "O-sialoglycoprotein endopeptidase" Q9NPF4 14 20446411-20455105 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Acyltransferase, Transferase" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039751 Uncertain Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA039751: AB_10794754" "prognostic favorable (1.48e-4)" "unprognostic (4.15e-3)" "unprognostic (1.29e-1)" "unprognostic (4.33e-3)" "unprognostic (1.54e-2)" "unprognostic (3.95e-2)" "unprognostic (5.54e-3)" "unprognostic (2.80e-3)" "unprognostic (2.98e-1)" "unprognostic (1.05e-1)" "unprognostic (3.35e-3)" "unprognostic (1.22e-1)" "prognostic unfavorable (4.64e-6)" "unprognostic (4.83e-2)" "unprognostic (1.86e-2)" "unprognostic (2.53e-2)" "unprognostic (9.91e-2)" 11.2 14.2 13.2 13.1 14.5 10.7 14.4 21.3 18.3 14.3 15.6 18.6 11.6 8.8 16.0 19.2 12.9 13.1 13.6 15.8 13.4 10.2 12.3 22.2 12.4 16.9 13.4 12.5 12.4 12.4 10.6 20.8 13.6 15.5 10.8 14.0 14.5 12.4 18.6 19.6 9.9 12.4 16.8 12.3 18.8 13.6 5.7 15.2 16.2 15.7 9.6 18.7 16.6 11.0 24.5 28.8 23.4 19.1 13.0 14.2 15.7 6.3 10.2 3.3 10.0 5.9 4.0 10.4 5.0 6.5 12.7 12.3 14.0 7.5 13.2 6.5 6.3 5.5 5.5 10.2 10.0 8.0 10.4 13.0 8.3 8.6 18.0 4.3 14.3 11.9 3.1 3.0 15.2 8.1 2.7 8.3 12.0 8.0 7.6 9.9 11.8 14.0 6.2 5.1 18.3 20.3 22.3 6.3 7.4 7.2 7.2 13.2 2.6 8.8 9.3 6.7 2.0 6.2 13.6 3.8 5.3 13.0 6.7 5.9 2.3 12.3 18.0 3.3 22.3 6.4 5.1 19.1 23.4 13.7 17.6 11.9 20.5 14.2 12.0 28.8 24.5 11.3 12.9 8.7 13.0 13.6 12.4 12.9 15.7 13.2 14.5 21.3 18.3 13.4 10.2 13.4 12.5 15.5 15.2 32.8 30.4 31.8 18.6 10.2 35.1 14.5 17.8 25.4 31.8 22.7 35.3 58.5 29.9 21.8 2.7 18.3 27.1 0.0 25.9 38.4 17.9 13.7 24.4 16.6 56.2 9.5 25.8 22.7 27.5 2.5 17.8 30.6 20.3 17.2 21.1 28.4 19.2 31.5 20.1 30.7 52.1 12.9 23.0 5.1 15.6 10.0 38.6 22.5 29.5 13.6 OSGIN1 "BDGI, OKL38" ENSG00000140961 "Oxidative stress induced growth inhibitor 1" Q9UJX0 16 83948282-83966332 "Predicted intracellular proteins" "Differentiation, Growth regulation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 63.5" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 47.5;Enterocytes: 69.2;Hepatocytes: 52.5;Late spermatids: 191.7" "Cancer enriched" "Detected in all" 5 "liver cancer: 65.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "non-classical monocyte: 12.3" "Group enriched" "Detected in many" 8 "granulocytes: 4.5;monocytes: 12.3" "Cell line enhanced" "Detected in many" "A549: 25.7;Hep G2: 38.6;T-47d: 28.7;WM-115: 24.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA019239 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA019239: AB_1854779" "unprognostic (8.36e-2)" "unprognostic (9.44e-2)" "unprognostic (4.28e-2)" "prognostic favorable (4.89e-5)" "unprognostic (3.31e-3)" "unprognostic (9.14e-3)" "unprognostic (2.51e-2)" "unprognostic (3.57e-2)" "unprognostic (1.06e-1)" "unprognostic (2.75e-1)" "unprognostic (7.63e-2)" "unprognostic (9.20e-2)" "unprognostic (2.80e-2)" "unprognostic (2.45e-2)" "unprognostic (2.48e-2)" "unprognostic (8.28e-3)" "unprognostic (1.89e-1)" 4.0 9.8 1.7 3.0 6.5 0.8 28.2 0.6 3.7 1.7 17.4 2.1 0.7 18.1 1.3 1.7 5.6 1.8 5.1 6.9 1.3 1.4 13.8 63.5 8.2 1.6 13.4 0.0 3.2 5.2 2.5 1.4 1.2 6.6 2.1 1.8 5.1 2.0 1.7 7.8 1.6 21.3 5.5 13.7 5.4 5.0 5.6 1.9 0.0 5.2 13.5 2.9 6.0 10.6 0.0 1.0 4.5 12.3 0.0 0.0 0.8 1.7 25.7 0.2 1.1 1.6 2.4 2.0 2.9 2.8 2.6 1.0 6.3 9.3 0.0 6.9 2.4 11.9 4.7 1.1 1.9 1.0 0.3 0.3 0.4 5.7 38.6 5.6 0.9 10.1 1.4 1.5 7.0 1.6 1.5 2.6 1.8 2.3 2.5 3.4 11.9 0.3 0.3 0.2 6.2 5.9 0.8 2.6 1.2 1.8 2.2 0.1 0.6 6.2 2.0 12.5 0.7 28.7 1.0 8.9 4.2 6.3 6.1 2.0 1.1 0.4 0.1 14.0 1.3 24.0 0.1 2.1 0.0 0.0 5.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 4.5 0.0 12.3 0.0 0.0 0.8 1.7 6.5 0.6 3.7 1.3 1.4 13.4 0.0 6.6 1.9 14.9 3.8 0.5 8.2 1.3 0.5 6.9 10.2 1.4 1.2 1.8 0.0 1.2 5.0 10.5 47.5 2.7 69.2 0.0 5.7 0.3 2.1 9.5 1.1 52.5 8.5 0.0 4.1 6.7 8.6 191.7 3.7 3.2 6.8 2.8 7.3 7.5 11.6 10.5 11.3 8.7 0.2 12.9 8.0 1.9 1.0 1.5 1.1 0.0 7.1 5.8 OSR2 FLJ90037 ENSG00000164920 "Odd-skipped related transciption factor 2" Q8N2R0 8 98944403-98952104 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 47.9" "Group enriched" "Detected in many" 7 "Leydig cells: 726.0;Peritubular cells: 712.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 17 "ASC diff: 113.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052425, HPA063486" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA052425: AB_2681826, HPA063486: AB_2685022" "unprognostic (1.72e-1)" "unprognostic (1.92e-3)" "unprognostic (1.03e-1)" "unprognostic (5.94e-2)" "unprognostic (1.57e-1)" "prognostic favorable (2.44e-5)" "unprognostic (1.70e-2)" "unprognostic (1.15e-2)" "unprognostic (1.89e-2)" "unprognostic (3.73e-3)" "unprognostic (3.01e-2)" "unprognostic (6.19e-2)" "unprognostic (1.57e-7)" "unprognostic (1.37e-2)" "unprognostic (2.39e-1)" "unprognostic (2.56e-4)" "unprognostic (8.54e-3)" 10.6 2.4 0.5 4.2 0.7 0.0 10.9 0.6 0.5 41.7 3.1 0.5 10.2 0.0 47.9 18.9 4.6 37.6 7.3 1.9 0.5 0.0 1.3 0.5 1.3 2.0 0.8 0.5 36.3 1.4 0.6 1.0 7.7 0.7 20.9 0.8 0.5 1.4 23.7 3.5 6.7 7.4 15.3 0.8 0.5 1.3 27.0 0.6 0.8 1.8 1.8 3.0 6.7 24.1 0.0 0.0 1.0 0.0 0.0 0.6 0.6 6.3 0.9 0.0 0.8 113.9 3.6 0.9 3.5 6.7 2.8 2.8 0.6 0.8 0.0 0.6 5.3 0.1 2.5 0.5 0.9 1.4 0.3 2.6 0.1 0.6 0.3 1.8 0.1 0.1 3.5 2.0 0.4 0.3 0.1 0.0 0.9 0.7 0.0 0.1 2.8 0.5 1.1 0.0 0.5 0.5 2.7 0.3 0.2 0.2 0.5 0.2 0.0 0.3 1.5 0.0 0.0 0.8 1.4 0.0 0.4 0.0 2.8 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.7 0.6 0.5 0.5 0.0 0.8 0.5 0.7 0.6 0.0 0.0 0.0 4.2 12.6 0.0 0.6 0.0 0.0 2.3 0.0 0.0 11.1 0.0 0.0 5.0 0.6 1.3 0.0 0.0 96.9 87.0 2.9 0.0 0.0 8.4 0.0 0.0 0.0 0.8 6.4 726.0 1.5 15.1 0.0 1.7 0.0 0.0 0.0 712.8 0.0 0.0 32.3 19.6 3.4 4.7 8.0 20.3 0.0 1.2 0.9 OSTM1 "GL, HSPC019" ENSG00000081087 "Osteopetrosis associated transmembrane protein 1" Q86WC4 6 108041409-108165854 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Osteopetrosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Melanocytes: 143.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010851 Uncertain Approved Nucleoplasm,Vesicles,Cytosol No No 130000 Cytosol "Nucleoplasm, Vesicles" "HPA010851: AB_1079533" "prognostic unfavorable (4.36e-4)" "unprognostic (4.03e-2)" "unprognostic (2.81e-1)" "unprognostic (1.11e-1)" "unprognostic (1.16e-1)" "unprognostic (1.72e-3)" "prognostic unfavorable (4.26e-4)" "unprognostic (9.40e-2)" "unprognostic (2.56e-1)" "unprognostic (2.25e-1)" "unprognostic (4.06e-2)" "unprognostic (2.65e-1)" "prognostic unfavorable (1.34e-6)" "prognostic unfavorable (1.20e-4)" "unprognostic (2.32e-2)" "unprognostic (1.40e-1)" "unprognostic (1.77e-1)" 26.3 21.9 9.0 18.1 13.5 5.5 16.7 13.7 17.2 14.4 17.8 12.8 9.9 8.4 21.8 10.3 14.1 15.0 13.5 23.2 10.4 16.5 22.0 15.9 17.0 17.2 11.0 10.5 15.6 9.7 11.8 26.0 24.7 20.0 15.4 12.4 29.7 10.8 19.0 18.0 10.4 12.9 24.7 13.1 21.7 14.3 11.1 10.7 13.6 12.4 8.1 13.9 21.0 19.4 10.8 12.4 20.9 28.1 14.5 16.4 16.9 2.1 6.4 7.6 11.1 23.0 7.5 10.9 16.0 16.1 11.7 19.5 3.8 3.6 5.0 13.2 11.1 31.6 4.1 7.5 5.4 18.1 11.5 5.9 10.6 4.1 4.7 17.8 11.6 24.7 10.9 13.6 14.4 11.5 10.8 5.9 5.7 8.3 18.5 18.9 3.0 2.5 2.6 3.0 2.6 4.9 4.1 11.1 2.7 8.4 5.8 0.8 4.5 12.9 3.3 28.5 10.6 3.7 16.9 7.2 10.3 3.8 22.7 22.6 7.1 12.1 4.4 30.4 7.9 22.6 16.8 13.9 15.2 15.0 19.9 16.0 10.8 12.8 16.4 12.4 6.2 12.0 15.0 20.9 14.5 28.1 8.9 15.4 16.9 9.0 13.5 13.7 17.2 10.4 16.5 11.0 10.5 20.0 10.7 8.9 21.3 25.4 14.7 41.4 29.2 18.5 12.7 5.3 6.8 12.2 9.8 18.7 1.7 10.8 3.4 18.0 10.3 0.0 19.8 29.3 16.9 16.3 24.2 12.4 46.3 27.0 4.1 28.8 46.6 2.7 13.3 33.0 143.4 10.8 4.2 24.0 15.6 12.9 26.9 21.0 15.7 25.8 33.9 19.8 19.5 27.1 51.1 27.7 2.9 14.0 OTP ENSG00000171540 "Orthopedia homeobox" Q5XKR4 5 77628712-77639688 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 16.2" "Group enriched" "Detected in some" 8 "Sertoli cells: 6.5;Spermatocytes: 2.6" "Cancer enriched" "Detected in single" 6 "glioma: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 3.3;SCLC-21H: 1.6;THP-1: 1.5" "Region enriched" "Detected in some" 7 "hypothalamus: 23.4" "Region enhanced" "Detected in some" "hypothalamus: 24.0" HPA059342 Enhanced Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies" NA NA Nucleoplasm "Nucleoli fibrillar center, Nuclear bodies" "HPA059342: AB_2732635" "unprognostic (1.00e-1)" "unprognostic (2.40e-2)" "unprognostic (6.25e-2)" "unprognostic (8.06e-3)" "unprognostic (1.16e-1)" "unprognostic (7.77e-2)" "unprognostic (7.77e-2)" "unprognostic (2.39e-2)" "unprognostic (9.66e-2)" "unprognostic (4.64e-2)" "unprognostic (7.76e-14)" "unprognostic (3.38e-2)" "unprognostic (1.84e-1)" "unprognostic (9.49e-3)" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 16.2 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.9 0.1 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 2.6 0.5 0.0 0.0 0.0 0.0 0.0 OTUB1 "FLJ20113, FLJ40710" ENSG00000167770 "OTU deubiquitinase, ubiquitin aldehyde binding 1" Q96FW1 11 63985853-64001811 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, DNA damage, DNA repair, Immunity, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039176, CAB072836" Approved Supported Approved Nucleoplasm,Cytosol NA NA 630000 "Nucleoplasm, Cytosol" "CAB072836: , HPA039176: AB_10674980" "unprognostic (2.50e-1)" "unprognostic (5.70e-3)" "unprognostic (3.93e-2)" "unprognostic (1.63e-1)" "unprognostic (2.78e-1)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.85e-3)" "unprognostic (1.34e-2)" "unprognostic (2.45e-1)" "unprognostic (1.27e-2)" "unprognostic (3.04e-1)" "unprognostic (1.34e-1)" "unprognostic (1.33e-3)" "unprognostic (6.76e-2)" "unprognostic (1.42e-1)" "unprognostic (4.84e-2)" "unprognostic (1.82e-1)" 19.8 24.7 41.9 24.1 61.6 32.6 20.8 41.8 101.9 24.3 25.0 31.9 22.3 24.7 21.9 23.6 37.8 34.5 21.6 31.6 46.9 37.8 27.2 27.6 23.0 31.9 33.1 45.4 23.4 23.0 26.0 21.6 30.7 60.4 23.8 24.1 24.2 30.4 27.7 26.7 36.9 26.0 23.1 26.7 25.7 23.9 22.1 21.2 27.8 29.9 24.5 32.8 27.1 22.9 46.0 60.8 56.1 71.3 44.8 64.5 78.2 30.7 55.7 30.7 27.2 20.8 23.0 23.7 18.6 27.6 41.4 30.6 37.4 29.5 16.4 35.3 29.8 36.0 38.6 39.7 46.3 25.7 19.0 30.7 27.4 33.5 47.3 29.2 27.1 30.0 24.4 30.1 31.6 20.2 21.5 39.0 15.3 19.1 18.6 27.7 63.4 29.6 35.9 36.1 26.1 26.5 24.3 12.0 28.1 43.0 45.1 23.3 33.6 21.0 32.3 33.9 22.0 50.1 24.0 28.1 22.1 21.5 29.5 24.4 22.0 13.8 23.6 28.6 17.7 21.1 55.1 56.3 54.3 53.1 71.3 41.4 46.0 49.1 48.6 60.8 41.9 38.4 42.6 56.1 44.8 60.9 42.1 64.5 78.2 41.9 61.6 41.8 101.9 46.9 37.8 33.1 45.4 60.4 21.2 17.9 66.5 50.3 60.6 42.8 41.6 27.7 35.7 62.9 52.4 43.6 37.3 125.6 63.0 73.0 63.0 39.3 99.3 23.3 74.8 89.9 46.6 44.0 46.3 28.0 78.9 28.6 84.2 34.4 55.6 67.0 31.7 66.2 49.0 114.6 62.4 40.9 72.8 56.1 24.1 69.5 48.4 25.8 45.3 45.7 63.7 45.9 162.9 67.3 48.9 63.9 OTUD1 "DUBA7, OTDC1" ENSG00000165312 "OTU deubiquitinase 1" Q5VV17 10 23439458-23442390 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 60.8;tongue: 61.1" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 124.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 25.3;HaCaT: 23.8;SiHa: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038503, HPA038504" Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA038503: AB_2676049, HPA038504: AB_10672712" "unprognostic (1.84e-1)" "unprognostic (2.80e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (4.59e-4)" "unprognostic (1.56e-1)" "unprognostic (1.29e-2)" "unprognostic (3.18e-3)" "unprognostic (2.41e-1)" "unprognostic (7.77e-2)" "unprognostic (4.10e-2)" "unprognostic (1.80e-2)" "unprognostic (1.32e-1)" "prognostic favorable (6.61e-7)" "unprognostic (1.62e-1)" "unprognostic (3.50e-2)" "unprognostic (3.66e-1)" "unprognostic (1.43e-2)" 11.6 9.2 5.9 8.5 6.9 39.3 14.7 9.7 9.5 13.8 8.8 9.3 6.9 4.9 9.8 10.0 8.2 9.0 9.9 25.9 6.0 5.9 14.7 7.3 26.6 11.0 6.2 6.7 10.9 6.5 12.8 7.8 11.5 5.4 8.0 5.8 9.8 6.4 6.2 60.8 17.5 7.9 7.3 6.5 13.1 16.9 9.9 5.8 8.1 14.9 61.1 12.3 12.7 10.5 3.5 1.0 5.1 4.0 0.2 3.5 0.5 3.0 1.5 1.6 0.7 6.4 3.2 2.1 1.2 2.7 3.0 2.7 0.6 25.3 1.4 2.7 1.6 1.0 23.8 1.7 3.0 2.0 10.7 4.6 0.0 3.7 0.9 5.6 0.2 2.1 3.3 13.2 0.9 4.2 2.6 1.0 1.5 0.3 10.1 1.6 1.5 0.9 0.9 1.2 1.7 0.8 1.5 7.3 1.4 3.9 2.6 0.7 1.7 15.4 2.7 7.0 4.4 1.1 2.2 1.8 1.7 2.4 4.6 0.5 5.0 9.2 0.7 2.6 1.0 0.7 5.1 1.6 2.6 0.8 1.7 1.0 1.9 1.5 0.8 1.0 3.5 1.2 1.7 3.6 0.2 4.0 0.6 3.5 0.5 5.9 6.9 9.7 9.5 6.0 5.9 6.2 6.7 5.4 5.8 62.5 14.4 35.3 7.1 28.4 17.9 124.4 10.2 8.1 4.5 5.2 2.0 2.2 10.0 5.5 7.1 15.7 28.0 0.0 6.1 2.7 16.0 9.2 5.7 7.2 41.9 50.9 5.8 16.5 44.2 4.7 6.1 61.4 32.1 1.8 19.7 27.9 10.6 14.4 12.4 18.8 24.4 6.5 18.9 6.7 2.8 26.7 6.6 10.1 12.6 5.9 OTUD3 "DUBA4, KIAA0459" ENSG00000169914 "OTU deubiquitinase 3" Q5T2D3 1 19882513-19912945 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028543, HPA028544" Approved Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA Cytosol "Nucleoplasm, Intermediate filaments" "HPA028543: AB_10599302, HPA028544: AB_10602277" "unprognostic (6.45e-3)" "unprognostic (9.26e-2)" "unprognostic (3.77e-1)" "unprognostic (1.95e-1)" "unprognostic (1.41e-1)" "unprognostic (3.16e-3)" "unprognostic (1.70e-3)" "unprognostic (3.15e-3)" "unprognostic (4.99e-2)" "unprognostic (1.09e-1)" "unprognostic (8.81e-2)" "unprognostic (4.68e-2)" "unprognostic (1.08e-1)" "unprognostic (9.83e-2)" "unprognostic (1.94e-1)" "unprognostic (7.28e-2)" "unprognostic (2.21e-2)" 6.5 11.0 15.0 6.9 19.2 11.4 10.0 19.3 23.2 10.6 8.9 6.6 6.4 10.2 14.2 13.0 6.1 8.2 7.2 5.2 12.6 7.3 7.1 4.8 8.5 7.0 9.9 12.5 11.2 7.2 9.3 20.2 5.4 9.0 9.8 8.3 6.9 6.2 9.2 9.2 13.0 9.6 11.9 8.1 7.7 7.3 28.4 9.7 6.0 6.9 2.9 6.3 7.0 7.6 1.7 0.6 0.8 0.4 0.6 2.2 0.3 5.1 1.9 8.7 10.4 3.8 3.3 8.6 5.5 3.2 2.8 2.8 9.1 4.9 8.1 4.5 12.1 2.0 5.0 8.1 3.2 5.5 5.3 10.8 7.8 10.4 6.3 2.1 5.7 7.2 2.7 3.2 4.4 5.7 6.0 3.7 8.3 5.5 3.5 4.8 2.8 4.3 5.7 4.1 4.1 5.1 10.1 22.3 3.0 4.7 5.6 7.7 5.5 3.9 3.2 4.2 8.9 4.8 4.2 4.5 6.8 8.7 7.5 4.7 4.0 3.4 5.0 4.8 7.6 3.1 0.8 0.4 0.1 1.5 0.3 1.4 1.7 1.7 1.4 0.3 1.3 2.2 1.8 0.7 0.6 0.1 0.6 0.9 0.3 15.0 19.2 19.3 23.2 12.6 7.3 9.9 12.5 9.0 9.7 14.9 6.9 3.0 5.2 12.6 13.5 3.6 0.0 10.7 1.2 8.7 15.7 2.3 0.0 4.5 9.9 4.5 3.8 0.0 4.0 4.7 4.2 8.8 1.1 2.1 1.6 25.4 11.5 9.2 1.6 11.5 5.2 3.3 5.0 2.8 6.7 10.2 3.9 5.9 5.6 3.4 16.0 6.5 3.5 19.1 21.2 7.8 2.1 4.4 5.9 3.0 OTUD5 "DKFZp761A052, DUBA" ENSG00000068308 "OTU deubiquitinase 5" Q96G74 X 48922028-48958386 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "U-266/70: 187.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017375 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA Cytosol "Nucleoplasm, Nucleoli fibrillar center" "HPA017375: AB_1854844" "unprognostic (9.73e-2)" "prognostic favorable (9.57e-4)" "unprognostic (2.67e-2)" "unprognostic (7.25e-2)" "unprognostic (1.08e-1)" "unprognostic (6.65e-2)" "unprognostic (2.33e-3)" "prognostic favorable (1.48e-4)" "unprognostic (1.11e-1)" "unprognostic (1.14e-1)" "prognostic favorable (8.20e-4)" "unprognostic (1.32e-1)" "unprognostic (3.60e-1)" "unprognostic (1.19e-1)" "unprognostic (1.10e-1)" "unprognostic (4.88e-2)" "unprognostic (5.05e-3)" 23.5 27.5 32.4 26.8 40.9 38.4 21.9 35.0 52.4 21.3 22.9 28.2 23.4 30.5 25.5 26.8 20.5 25.1 20.9 16.6 29.8 31.3 22.6 24.5 25.2 30.8 25.4 29.8 30.0 25.4 29.6 26.8 23.1 29.4 24.0 17.8 20.4 26.9 27.4 24.4 24.5 29.1 27.1 21.4 34.5 22.3 12.7 24.0 34.8 24.5 14.4 27.2 22.1 22.7 7.8 6.3 8.6 5.1 18.6 7.5 3.5 6.2 9.5 4.4 11.0 7.5 6.8 5.2 5.5 6.5 7.0 7.6 4.7 7.0 7.0 3.6 6.9 6.1 7.7 6.7 5.6 6.5 8.2 8.1 5.3 9.6 5.4 6.4 5.0 5.9 7.5 5.2 7.2 4.9 7.7 5.5 5.8 6.7 11.1 4.9 6.3 7.9 10.9 8.0 2.3 7.5 6.3 6.5 9.1 4.9 5.6 4.3 7.6 7.3 4.7 7.3 10.8 6.3 4.6 7.8 4.6 5.8 12.0 4.5 187.1 46.7 6.7 7.0 7.1 3.1 5.2 3.4 7.0 7.0 5.1 5.8 7.8 5.5 6.0 4.8 6.0 5.2 7.5 8.6 18.6 4.7 6.3 7.0 3.5 32.4 40.9 35.0 52.4 29.8 31.3 25.4 29.8 29.4 24.0 8.9 21.1 23.0 19.4 19.7 31.7 8.5 10.2 17.4 17.0 26.2 25.5 11.3 8.3 13.0 1.5 18.5 26.4 0.0 15.9 12.0 16.5 23.0 6.9 22.9 14.5 27.0 46.2 18.4 24.7 1.5 19.2 19.5 25.3 21.6 26.6 16.0 17.8 15.8 22.3 20.3 25.0 12.9 13.3 5.9 10.9 22.3 25.7 30.9 17.4 22.8 OTUD6B "CGI-77, DUBA5" ENSG00000155100 "OTU domain containing 6B" Q8N6M0 8 91070196-91087095 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024046, HPA024503, HPA024772" Approved Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus, Cytosol" "HPA024046: AB_10600925, HPA024503: AB_1854845, HPA024772: AB_1854846" "prognostic unfavorable (7.50e-4)" "unprognostic (1.28e-1)" "unprognostic (1.45e-1)" "unprognostic (4.78e-3)" "unprognostic (4.91e-2)" "unprognostic (1.49e-1)" "unprognostic (1.52e-2)" "unprognostic (1.16e-3)" "unprognostic (2.17e-1)" "unprognostic (5.51e-2)" "unprognostic (1.27e-2)" "unprognostic (8.61e-3)" "unprognostic (1.87e-2)" "unprognostic (1.96e-1)" "unprognostic (4.53e-1)" "unprognostic (8.78e-2)" "unprognostic (5.71e-2)" 11.4 11.3 14.6 14.1 18.2 8.9 13.2 13.8 19.6 12.3 11.3 9.9 10.3 9.2 12.1 9.0 13.2 9.1 8.6 14.0 14.9 13.7 11.0 10.5 10.0 13.8 18.5 15.5 12.5 9.9 11.2 14.4 14.9 16.2 11.6 11.3 6.0 9.5 14.8 35.3 11.2 9.1 12.4 19.9 11.3 8.8 11.9 17.4 13.9 11.8 11.0 11.9 11.9 14.0 7.2 12.9 8.8 7.8 7.8 6.8 2.9 16.3 9.4 8.5 6.3 3.8 2.9 8.8 13.0 4.9 12.1 7.9 8.1 10.3 17.3 6.3 6.8 4.9 5.6 17.5 10.6 18.8 13.9 10.7 23.6 9.8 6.1 8.2 12.0 12.5 4.8 5.1 9.7 23.1 7.2 9.8 13.7 23.6 10.9 10.3 8.9 20.1 7.9 4.5 12.5 18.7 9.1 8.1 15.5 9.4 11.8 2.0 7.6 1.2 28.8 12.5 11.5 14.7 5.8 10.0 7.2 10.9 11.0 12.3 10.9 20.7 25.5 10.6 15.1 13.8 8.8 6.5 4.3 5.9 7.8 6.8 7.2 4.8 5.7 8.1 6.8 6.7 5.9 0.9 7.8 5.8 12.9 3.6 2.9 14.6 18.2 13.8 19.6 14.9 13.7 18.5 15.5 16.2 17.4 8.9 9.9 12.4 5.2 20.6 13.1 14.0 10.2 9.4 13.6 1.8 31.4 9.3 8.3 4.7 0.4 7.5 3.1 0.0 4.3 8.3 5.1 4.0 18.4 9.2 7.0 11.1 10.4 9.2 7.5 0.9 8.9 9.4 3.3 8.2 4.2 13.4 5.3 4.2 3.9 6.2 16.7 0.0 7.2 1.9 6.6 15.8 5.6 7.9 5.6 4.7 OTX2 ENSG00000165588 "Orthodenticle homeobox 2" P32243 14 56799905-56810479 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "brain: 27.7;retina: 78.2" "Group enriched" "Detected in some" 16 "Bipolar cells: 181.3;Cone photoreceptor cells: 159.0;Rod photoreceptor cells: 203.6" "Cancer enriched" "Detected in single" 27 "testis cancer: 11.6" "Group enriched" "Detected in many" 5 "cerebellum: 20.4;pons and medulla: 27.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HAP1: 63.9;NTERA-2: 53.5" "Low region specificity" "Detected in many" "HPA000633, HPA001123" Uncertain Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA000633: AB_1079538, HPA001123: " "unprognostic (3.82e-1)" "unprognostic (2.56e-2)" "unprognostic (9.28e-2)" 0.2 0.2 0.0 0.2 0.3 0.2 0.2 20.4 0.3 0.2 0.2 3.7 0.0 0.2 0.2 1.0 0.2 0.2 0.2 0.2 1.8 2.7 0.2 0.2 0.2 0.5 4.7 0.0 0.5 0.2 0.2 2.8 0.2 27.7 0.3 0.2 78.2 0.2 1.3 0.2 0.5 0.2 0.2 0.2 0.4 0.2 3.1 2.3 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 20.4 0.3 1.8 2.7 4.7 0.0 27.7 2.3 0.0 0.0 0.0 0.0 0.0 181.3 0.2 0.0 0.0 0.0 0.0 159.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 203.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 OVCA2 ENSG00000262664 "OVCA2, serine hydrolase domain containing" Q8WZ82 17 2041936-2043430 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059002 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA059002: AB_2683875" 17.0 25.7 13.6 22.3 16.4 23.1 14.4 11.2 17.2 15.4 20.5 12.1 12.1 20.0 12.2 19.1 23.6 12.0 28.4 17.6 12.2 11.3 31.0 46.4 15.6 37.2 11.5 11.8 14.2 25.5 9.6 21.7 26.5 13.3 16.6 17.5 24.5 30.2 21.1 20.4 18.5 32.1 12.4 8.3 28.9 19.0 28.1 9.6 29.7 22.3 34.8 30.3 22.0 12.6 26.2 30.7 12.5 30.7 29.9 43.0 28.4 21.4 21.2 8.9 18.0 11.0 14.6 14.5 14.2 15.5 15.7 14.8 24.3 14.2 4.7 14.5 19.2 11.2 16.8 9.5 22.8 11.5 11.3 24.1 10.6 13.0 8.9 30.1 7.1 21.8 19.0 20.6 15.2 10.3 6.6 26.3 10.4 5.9 22.9 23.3 15.0 10.4 12.0 7.6 16.4 13.6 8.8 9.0 7.3 23.9 14.2 5.9 21.8 9.3 14.6 19.2 9.8 17.1 14.3 20.7 22.9 7.4 16.5 27.6 13.8 14.1 4.1 20.5 16.1 22.5 8.5 30.7 12.5 26.8 26.6 26.9 26.2 26.7 28.3 26.5 21.5 18.5 18.0 8.6 29.9 20.4 30.7 43.0 28.4 13.6 16.4 11.2 17.2 12.2 11.3 11.5 11.8 13.3 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OVOL1 HOVO1 ENSG00000172818 "Ovo like transcriptional repressor 1" O14753 11 65787022-65797219 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 42.6;tongue: 37.4" "Cell type enhanced" "Detected in many" 16 "Syncytiotrophoblasts: 291.8;Urothelial cells: 75.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "memory CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Cell line enhanced" "Detected in some" "A-431: 10.1;BEWO: 29.1;CACO-2: 7.3;HaCaT: 17.2;RT4: 16.9;SK-BR-3: 13.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA003984 Uncertain Approved Nucleoplasm Yes NA Nucleoplasm "HPA003984: AB_1854854" "unprognostic (4.26e-3)" "unprognostic (3.39e-1)" "unprognostic (3.96e-2)" "prognostic unfavorable (1.87e-4)" "unprognostic (1.37e-1)" "unprognostic (1.55e-1)" "unprognostic (3.37e-1)" "unprognostic (1.26e-2)" "unprognostic (1.95e-1)" "unprognostic (2.31e-2)" "unprognostic (2.01e-3)" "unprognostic (1.91e-1)" "prognostic favorable (1.00e-13)" "unprognostic (4.26e-2)" "unprognostic (3.51e-2)" "unprognostic (2.42e-1)" "unprognostic (9.04e-3)" 0.2 0.1 0.2 3.3 0.3 0.0 2.2 0.4 0.2 7.2 11.5 0.0 3.0 9.6 0.4 0.7 42.6 0.3 4.2 0.1 0.2 0.2 4.7 0.2 1.7 0.0 0.2 0.0 0.1 5.6 5.0 0.2 14.4 0.0 2.3 5.1 1.1 13.9 6.1 0.5 24.1 14.2 0.8 0.2 0.2 0.8 17.3 0.0 0.6 1.8 37.4 25.3 8.3 9.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 10.1 0.0 0.0 0.0 0.0 0.0 29.1 0.0 0.0 0.0 0.0 7.3 2.7 0.0 0.1 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 5.2 0.0 0.1 0.0 0.0 0.8 16.9 0.1 0.0 0.0 13.4 0.1 3.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 3.5 0.0 33.3 23.7 0.0 0.4 10.2 8.1 2.3 3.5 0.0 20.8 0.0 2.2 61.4 0.4 47.4 0.0 3.4 12.0 1.1 21.2 2.3 0.0 1.8 0.0 30.3 0.0 0.0 65.1 1.1 1.3 0.0 0.0 49.6 0.0 3.6 38.6 1.8 4.2 0.0 0.0 0.4 13.7 5.4 50.2 291.8 0.0 42.1 75.8 OVOL2 "bA504H3.3, CHED, CHED1, HOVO2, ZNF339" ENSG00000125850 "Ovo like zinc finger 2" Q9BRP0 20 17956979-18059188 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Corneal dystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 6.3;CACO-2: 4.9;CAPAN-2: 8.4;HaCaT: 6.3;OE19: 11.6;SCLC-21H: 9.8;SK-BR-3: 6.5" "Group enriched" "Detected in some" 4 "cerebral cortex: 10.5;hippocampal formation: 6.8" "Group enriched" "Detected in some" 4 "cerebral cortex: 7.6;hippocampal formation: 5.8" HPA038531 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038531: AB_10673012" "unprognostic (2.85e-2)" "unprognostic (5.13e-2)" "unprognostic (2.41e-2)" "unprognostic (7.35e-2)" "unprognostic (2.14e-1)" "unprognostic (5.14e-2)" "unprognostic (1.90e-1)" "unprognostic (5.23e-2)" "unprognostic (1.40e-1)" "unprognostic (2.61e-1)" "unprognostic (2.63e-2)" "unprognostic (1.62e-1)" "unprognostic (1.84e-4)" "unprognostic (4.77e-3)" "unprognostic (2.92e-1)" "unprognostic (2.57e-2)" "unprognostic (3.76e-2)" 0.0 0.0 0.0 3.4 0.0 0.0 3.7 0.0 0.6 3.0 9.8 0.0 18.2 5.0 1.0 3.3 7.6 1.6 8.9 0.0 0.0 0.0 1.8 0.0 4.1 0.0 0.0 0.0 0.6 8.7 1.0 1.8 2.5 0.0 7.0 2.6 0.0 10.5 14.2 0.1 7.6 8.7 0.5 0.0 0.0 14.7 1.5 0.0 0.3 18.1 5.0 4.4 2.6 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 4.9 8.4 0.0 1.2 0.0 0.4 6.3 1.5 1.6 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.3 0.0 3.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 11.6 0.1 0.0 0.0 2.4 0.1 3.1 9.8 0.0 0.0 6.5 0.1 0.1 3.3 1.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 6.0 6.7 0.0 9.2 7.3 0.0 0.6 10.2 1.4 7.9 1.8 0.0 1.6 0.0 6.7 14.4 0.0 12.7 0.0 9.7 2.5 0.1 8.2 0.0 0.0 0.1 1.6 3.5 0.0 0.0 3.2 0.3 0.0 0.0 0.0 13.4 0.5 11.5 10.2 0.4 1.2 0.0 0.0 0.1 3.9 0.2 8.5 0.1 0.0 9.7 9.7 OXNAD1 MGC15763 ENSG00000154814 "Oxidoreductase NAD binding domain containing 1" Q96HP4 3 16265160-16350299 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "T-cells: 39.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 33.0" "Lineage enriched" "Detected in all" 5 "T-cells: 33.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036830, HPA059160" Approved Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA036830: AB_2675338, HPA059160: AB_2683936" "unprognostic (4.49e-2)" "unprognostic (7.41e-3)" "unprognostic (2.71e-3)" "unprognostic (2.38e-3)" "unprognostic (4.65e-2)" "unprognostic (3.23e-2)" "unprognostic (1.46e-1)" "unprognostic (2.31e-2)" "unprognostic (1.23e-2)" "unprognostic (8.05e-2)" "unprognostic (1.46e-1)" "unprognostic (8.08e-2)" "prognostic favorable (1.00e-7)" "unprognostic (2.22e-2)" "unprognostic (1.03e-1)" "unprognostic (6.95e-3)" "prognostic favorable (7.63e-4)" 8.1 8.8 7.5 14.1 11.1 10.9 8.1 9.1 13.6 5.4 11.4 9.1 7.3 16.3 7.7 4.3 10.8 6.2 7.1 12.0 7.1 5.9 15.5 22.4 6.6 20.7 10.9 7.9 6.9 7.4 6.5 12.4 5.2 9.5 5.4 10.2 6.8 9.4 9.3 18.1 8.2 18.4 4.2 8.9 9.2 9.4 9.3 12.1 8.2 8.0 7.0 16.0 7.8 6.6 1.9 2.2 1.3 2.0 6.4 33.0 7.5 5.6 8.2 5.4 8.5 6.4 5.7 21.1 6.1 4.5 8.4 6.8 11.8 5.7 8.0 3.8 3.8 4.6 4.1 11.1 9.9 8.0 14.6 7.3 11.8 7.0 6.3 6.6 19.0 7.2 4.2 7.4 13.6 6.6 2.6 6.5 8.3 16.1 19.3 3.6 10.0 11.0 10.0 11.5 8.4 9.7 9.9 6.6 14.1 5.7 6.8 3.8 5.4 6.8 11.5 9.4 6.1 7.3 11.0 2.9 5.5 7.0 6.0 9.8 7.0 12.6 13.0 6.5 16.6 7.3 0.0 1.4 1.1 9.0 2.0 11.9 1.9 13.8 9.7 2.2 1.5 33.0 24.4 1.3 6.4 1.8 1.7 7.3 7.5 7.5 11.1 9.1 13.6 7.1 5.9 10.9 7.9 9.5 12.1 0.0 10.4 12.0 4.7 2.2 5.7 12.3 5.1 9.4 3.4 7.0 5.9 9.1 26.6 7.6 32.8 3.5 9.2 0.0 5.5 6.7 4.7 4.5 19.7 18.3 7.5 3.2 2.9 3.7 3.3 24.8 2.8 3.8 5.0 10.8 6.9 5.0 6.3 2.9 1.8 12.6 11.0 6.5 3.4 6.6 10.0 3.0 4.2 39.9 10.3 4.8 P3H2 "FLJ10718, LEPREL1, MLAT4" ENSG00000090530 "Prolyl 3-hydroxylase 2" Q8IVL5 3 189956728-190122437 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 74.5" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 44.7;Alveolar cells type 2: 62.9;Collecting duct cells: 41.8;Ito cells: 44.8;Muller glia cells: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 22 "plasmacytoid DC: 20.3" "Lineage enriched" "Detected in single" 104 "dendritic cells: 20.3" "Cell line enhanced" "Detected in many" "GAMG: 38.1;HaCaT: 34.0;RPTEC TERT1: 34.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA007890, HPA013355, HPA013611" Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles, Cytosol" "HPA007890: AB_1852796, HPA013355: AB_1852798, HPA013611: " "unprognostic (4.90e-2)" "unprognostic (1.57e-1)" "unprognostic (3.76e-1)" "unprognostic (4.32e-3)" "unprognostic (1.97e-2)" "unprognostic (7.75e-2)" "unprognostic (9.68e-2)" "unprognostic (2.17e-1)" "unprognostic (3.15e-1)" "unprognostic (1.19e-1)" "unprognostic (1.03e-3)" "unprognostic (1.60e-1)" "unprognostic (1.15e-2)" "unprognostic (1.80e-2)" "unprognostic (1.48e-1)" "unprognostic (1.10e-1)" "unprognostic (4.01e-2)" 2.4 22.6 2.9 4.0 3.9 0.2 3.1 0.7 2.2 14.3 11.8 6.2 11.5 1.2 15.0 13.5 8.9 4.6 8.4 3.8 2.8 2.1 74.5 3.5 22.5 3.6 8.1 1.0 11.2 3.9 1.4 6.1 11.0 5.6 19.9 5.3 10.3 2.7 14.3 0.6 8.6 3.6 16.3 7.6 33.7 12.0 2.8 5.3 2.0 1.7 6.3 2.7 5.7 9.8 0.0 20.3 0.1 0.1 0.0 0.0 0.1 14.0 5.6 11.0 0.0 0.2 0.4 13.3 15.0 5.9 2.4 4.0 4.5 5.5 0.0 8.5 2.6 38.1 34.0 0.0 20.1 5.1 0.1 1.9 0.0 3.8 0.0 11.4 0.0 0.1 5.4 6.8 4.8 1.7 23.3 0.4 0.0 0.0 0.1 3.8 0.3 0.0 0.1 3.4 9.4 1.1 0.0 2.2 0.8 34.7 23.7 0.8 0.1 20.4 1.1 8.9 16.9 0.0 0.2 7.5 14.6 5.5 0.1 2.7 1.0 0.0 0.1 3.3 0.0 18.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 20.3 0.0 0.1 2.9 3.9 0.7 2.2 2.8 2.1 8.1 1.0 5.6 5.3 44.7 62.9 1.9 7.4 0.0 2.2 1.0 5.1 0.0 5.7 41.8 3.9 30.9 5.0 3.8 14.3 4.5 0.0 0.0 0.7 11.7 2.0 13.7 1.1 0.6 9.1 9.5 0.0 44.8 4.6 11.4 4.4 4.7 0.0 1.0 0.2 49.8 18.0 0.0 0.0 24.5 0.8 0.0 2.7 0.5 0.4 0.0 32.3 0.0 0.0 2.8 PAAF1 "FLJ11848, Rpn14, WDR71" ENSG00000175575 "Proteasomal ATPase associated factor 1" Q9BRP4 11 73876699-73931124 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Cone photoreceptor cells: 106.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039952, HPA040020" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039952: AB_10793925, HPA040020: AB_2676802" "unprognostic (3.13e-1)" "unprognostic (1.50e-1)" "unprognostic (1.76e-1)" "unprognostic (1.18e-1)" "unprognostic (3.03e-1)" "unprognostic (2.05e-1)" "unprognostic (2.13e-2)" "unprognostic (4.51e-2)" "unprognostic (1.33e-1)" "unprognostic (4.58e-3)" "unprognostic (1.74e-1)" "unprognostic (4.48e-1)" "unprognostic (2.30e-2)" "unprognostic (1.24e-1)" "unprognostic (4.23e-1)" "unprognostic (2.73e-1)" "unprognostic (4.42e-1)" 9.5 12.8 32.4 6.9 30.6 5.2 12.3 18.0 23.2 11.7 8.7 34.4 7.6 7.8 11.5 17.2 10.0 13.9 8.0 9.9 30.5 27.4 16.0 13.8 7.9 7.6 37.4 19.6 17.8 19.8 16.8 10.1 7.7 25.4 14.5 11.5 12.9 9.9 14.5 11.9 12.8 7.8 12.1 38.9 7.1 6.8 18.8 27.0 8.2 13.0 2.1 11.1 7.9 6.3 22.6 19.3 22.1 15.1 16.5 22.6 15.1 5.6 13.1 11.9 9.3 13.0 13.4 6.8 9.7 11.3 15.6 11.1 25.6 4.5 17.1 15.2 9.9 14.5 13.0 14.5 11.7 23.2 12.7 9.0 17.4 12.9 21.0 15.6 16.2 6.7 13.7 18.4 17.0 20.9 12.6 11.7 13.8 21.0 14.7 14.4 11.0 14.3 16.9 5.5 30.0 10.3 13.3 31.9 27.9 11.5 9.8 12.7 14.9 11.5 7.7 30.0 11.7 23.1 9.2 8.4 11.0 7.0 15.5 9.4 18.2 20.4 34.8 7.7 10.6 11.5 22.1 15.1 17.4 16.0 9.5 17.5 22.6 17.5 16.2 19.3 18.8 22.6 19.4 1.3 16.5 3.4 14.0 19.6 15.1 32.4 30.6 18.0 22.3 30.5 27.4 37.4 19.6 25.4 27.0 3.0 12.2 13.7 9.7 4.1 48.0 18.3 12.7 10.7 9.1 15.7 106.0 29.8 11.6 14.3 27.2 7.1 7.7 23.3 12.1 3.2 10.4 7.7 18.5 11.9 16.3 44.5 3.5 11.1 7.3 17.7 15.5 10.4 13.5 16.2 8.0 35.5 8.4 7.0 17.0 42.1 46.1 6.5 13.7 49.6 25.8 7.0 15.3 11.5 10.3 6.5 PABPN1 "OPMD, PAB2, PABP2" ENSG00000100836 "Poly(A) binding protein nuclear 1" Q86U42 14 23321289-23326185 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000637 Supported Approved "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA000637: AB_1079553" "unprognostic (5.11e-3)" "unprognostic (2.65e-2)" "unprognostic (7.20e-2)" "unprognostic (2.95e-2)" "unprognostic (1.05e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (3.55e-4)" "unprognostic (1.88e-2)" "unprognostic (1.47e-1)" "unprognostic (1.95e-3)" "prognostic favorable (9.66e-4)" "unprognostic (5.88e-2)" "prognostic unfavorable (2.41e-7)" "unprognostic (1.52e-2)" "unprognostic (1.31e-2)" "unprognostic (1.07e-1)" "unprognostic (8.25e-3)" 41.1 46.0 67.4 39.8 73.7 57.1 34.0 79.5 80.2 36.1 42.2 39.4 51.2 55.1 55.3 67.7 38.3 43.2 43.4 35.3 64.4 44.7 46.6 47.1 33.2 46.4 62.4 45.8 48.6 35.2 44.8 54.0 40.6 60.3 46.2 52.8 39.4 42.3 45.2 46.6 53.7 55.9 50.2 47.4 46.0 41.4 54.1 69.3 53.5 51.0 29.6 54.6 33.3 46.5 11.4 15.6 13.1 9.8 12.0 9.0 2.8 25.7 28.9 64.0 50.6 30.1 33.8 41.7 26.8 26.5 36.7 35.2 34.6 48.6 46.2 14.4 33.8 41.2 41.0 71.4 37.0 51.1 39.5 27.2 35.7 41.4 89.5 33.7 55.4 49.1 39.3 37.2 27.3 32.2 55.8 40.1 40.1 33.4 36.3 35.0 49.1 58.1 67.8 70.1 32.3 33.1 58.2 24.8 27.9 41.5 53.6 44.3 34.6 34.4 32.0 27.2 45.5 24.2 40.2 33.8 25.7 32.8 25.1 34.0 43.4 30.0 54.9 15.2 45.5 29.8 13.1 9.8 8.9 7.3 7.0 5.9 8.7 7.3 6.3 7.6 11.4 9.0 8.5 11.9 12.0 7.7 15.6 7.9 2.8 67.4 73.7 79.5 80.2 64.4 44.7 62.4 45.8 60.3 69.3 32.8 49.6 74.5 72.7 140.2 113.5 11.8 99.3 25.4 35.2 120.4 137.4 57.9 11.6 47.7 43.5 69.2 70.8 23.3 49.1 55.5 69.1 73.0 23.1 97.3 54.7 73.1 155.0 58.3 81.4 34.5 75.1 76.0 50.6 58.7 95.5 69.4 49.3 88.5 56.3 31.1 80.6 71.1 69.2 26.5 29.2 157.2 52.5 43.6 98.9 93.2 PACRGL "C4orf28, MGC29898" ENSG00000163138 "Parkin coregulated like" Q8N7B6 4 20696282-20752907 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 166.5;Late spermatids: 63.0;Spermatocytes: 76.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054666 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA054666: AB_2682564" "unprognostic (1.32e-1)" "unprognostic (1.71e-1)" "unprognostic (6.90e-3)" "unprognostic (5.15e-2)" "unprognostic (1.15e-1)" "unprognostic (1.55e-2)" "unprognostic (1.09e-2)" "unprognostic (2.97e-1)" "unprognostic (4.55e-2)" "unprognostic (2.20e-2)" "unprognostic (5.08e-2)" "unprognostic (3.35e-2)" "unprognostic (1.25e-2)" "unprognostic (6.74e-3)" "unprognostic (3.63e-2)" "unprognostic (1.07e-2)" "prognostic favorable (4.85e-4)" 7.9 8.7 12.2 10.7 15.6 3.2 16.5 7.8 19.0 9.1 8.9 9.3 14.6 6.6 13.9 15.1 9.6 14.2 10.0 9.5 14.1 12.4 8.7 4.7 7.7 7.3 12.1 12.9 14.0 6.7 9.7 13.7 7.4 10.5 11.2 9.4 8.4 7.7 11.4 10.1 14.3 7.7 13.1 15.1 6.8 7.7 37.3 10.7 4.5 15.8 10.0 6.3 11.1 8.9 4.3 7.0 1.4 4.7 4.1 6.1 2.9 9.0 7.0 12.4 9.4 16.8 15.6 6.0 11.6 9.2 10.7 13.0 6.3 19.3 9.6 7.8 6.6 17.0 4.3 6.9 8.7 18.4 3.0 6.1 6.0 10.6 10.1 8.9 12.4 6.5 10.8 13.0 13.4 12.5 9.9 10.8 8.7 10.4 5.6 9.1 6.5 12.4 11.5 15.7 7.4 10.0 6.6 13.5 5.9 10.7 5.9 20.5 13.5 8.5 4.4 8.7 6.6 8.0 7.0 8.4 10.5 9.7 14.5 16.0 5.7 1.6 8.9 15.3 8.3 18.0 0.0 3.1 1.4 2.7 4.7 6.1 4.3 3.0 2.7 5.3 4.0 4.7 3.0 1.2 4.1 3.7 7.0 3.5 2.9 12.2 15.6 7.8 19.0 14.1 12.4 12.1 12.9 10.5 10.7 8.9 5.4 0.5 9.6 12.0 5.5 5.2 7.6 32.1 9.1 7.0 3.9 4.9 6.6 6.9 166.5 6.7 5.1 0.0 7.9 5.7 9.6 8.5 2.3 2.9 3.7 4.8 8.6 5.5 4.3 63.0 12.0 4.9 5.0 2.8 5.2 8.4 6.7 8.2 11.7 4.2 10.4 12.9 5.5 76.4 32.5 9.3 4.9 2.2 7.6 6.8 PACSIN1 SDPI ENSG00000124507 "Protein kinase C and casein kinase substrate in neurons 1" Q9BY11 6 34466061-34535231 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 81.7" "Group enriched" "Detected in some" 9 "Bipolar cells: 70.2;Cone photoreceptor cells: 76.6;Horizontal cells: 65.2;Rod photoreceptor cells: 88.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 15.0" "Lineage enriched" "Detected in many" 5 "dendritic cells: 15.0" "Cell line enhanced" "Detected in some" "MCF7: 9.9;RPMI-8226: 11.5;T-47d: 18.3;U-266/84: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009929, HPA028852, HPA055491" Enhanced Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB009929: AB_2268057, HPA028852: AB_10602812, HPA055491: AB_2682834" "unprognostic (3.33e-1)" "unprognostic (1.21e-1)" "unprognostic (6.33e-2)" "unprognostic (2.97e-1)" "unprognostic (1.72e-2)" "unprognostic (2.47e-3)" "unprognostic (2.14e-2)" "unprognostic (2.65e-1)" "unprognostic (1.74e-1)" "unprognostic (6.63e-2)" "unprognostic (3.95e-4)" "unprognostic (9.12e-2)" "unprognostic (3.02e-2)" "unprognostic (4.18e-2)" "unprognostic (9.90e-2)" "unprognostic (5.50e-2)" "unprognostic (9.33e-2)" 1.5 2.1 42.5 2.4 33.8 2.0 1.4 29.3 81.7 1.5 1.7 2.1 0.0 1.8 1.9 1.5 1.4 2.0 1.7 4.7 32.8 21.9 1.6 1.4 1.5 4.4 14.6 32.9 1.7 6.1 1.4 1.2 1.4 31.6 1.8 1.6 5.5 1.6 1.7 1.5 1.4 1.8 1.5 3.7 2.5 2.4 1.9 4.1 0.0 1.4 0.0 3.4 2.0 0.0 0.0 15.0 0.0 0.0 3.1 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 3.8 0.7 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.9 0.1 0.0 9.9 0.6 0.0 2.4 0.1 0.0 0.1 0.0 11.5 0.0 0.3 3.6 0.2 0.0 1.9 0.0 0.4 18.3 2.0 0.0 0.0 0.3 0.0 0.0 3.0 13.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.1 0.0 15.0 0.0 0.1 42.5 33.8 29.3 56.3 32.8 21.9 14.6 32.9 31.6 4.1 0.0 0.0 0.0 0.0 0.0 70.2 4.0 0.0 0.0 0.0 0.0 76.6 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 65.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.1 0.0 0.0 1.1 88.6 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.0 PADI1 "HPAD10, PAD1, PDI, PDI1" ENSG00000142623 "Peptidyl arginine deiminase 1" Q9ULC6 1 17205126-17246005 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 48.7;lymphoid tissue: 60.2" "Group enriched" "Detected in some" 12 "Cardiomyocytes: 12.6;Extravillous trophoblasts: 10.0;Urothelial cells: 3.8" "Cancer enhanced" "Detected in many" "pancreatic cancer: 13.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.5;EFO-21: 4.6;HaCaT: 2.9;LHCN-M2: 3.6;RPTEC TERT1: 4.9" "Region enhanced" "Detected in single" "olfactory region: 0.5" "Not detected" "Not detected" HPA062294 Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA062294: AB_2684741" "unprognostic (9.30e-2)" "unprognostic (2.44e-1)" "unprognostic (6.15e-2)" "unprognostic (1.40e-1)" "unprognostic (5.22e-2)" "unprognostic (7.27e-2)" "unprognostic (3.84e-1)" "unprognostic (3.37e-2)" "unprognostic (1.41e-1)" "unprognostic (7.75e-2)" "unprognostic (1.01e-3)" "unprognostic (3.64e-2)" "prognostic unfavorable (8.34e-11)" "unprognostic (2.00e-1)" "unprognostic (3.12e-1)" "unprognostic (1.07e-1)" "unprognostic (1.15e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.3 0.0 48.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.1 0.1 0.0 4.6 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.1 60.2 1.3 6.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.2 0.0 0.1 9.5 0.0 4.6 0.4 0.4 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 4.9 0.4 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 12.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.2 3.8 PADI3 PDI3 ENSG00000142619 "Peptidyl arginine deiminase 3" Q9ULW8 1 17249098-17284233 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 10.5;smooth muscle: 9.4;urinary bladder: 28.0" "Group enriched" "Detected in some" 5 "Collecting duct cells: 1.8;Urothelial cells: 6.4" "Cancer enhanced" "Detected in many" "urothelial cancer: 48.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 13.5;RT4: 16.2;T-47d: 12.2;U-87 MG: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA043739 Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA043739: AB_10959466" "unprognostic (4.47e-2)" "unprognostic (9.32e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (3.22e-4)" "unprognostic (1.05e-3)" "unprognostic (6.66e-2)" "unprognostic (3.10e-3)" "unprognostic (5.88e-2)" "unprognostic (2.06e-4)" "unprognostic (1.03e-1)" "unprognostic (3.47e-4)" "unprognostic (1.76e-1)" "prognostic unfavorable (1.55e-11)" "unprognostic (2.40e-2)" "unprognostic (4.73e-3)" "unprognostic (2.64e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 5.1 0.0 0.0 3.2 10.5 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.6 6.4 0.0 2.3 0.0 9.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 28.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 13.5 0.0 1.3 0.2 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 16.2 0.0 0.0 0.0 2.4 0.1 0.1 12.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 PAF1 "F23149_1, FLJ11123, PD2" ENSG00000006712 "PAF1 homolog, Paf1/RNA polymerase II complex component" Q8N7H5 19 39385852-39391195 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041875, HPA043637" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA041875: AB_2677720, HPA043637: AB_2678592" "unprognostic (5.33e-3)" "unprognostic (3.57e-1)" "unprognostic (1.70e-1)" "unprognostic (1.14e-1)" "unprognostic (1.92e-1)" "unprognostic (2.99e-1)" "prognostic unfavorable (8.68e-4)" "unprognostic (6.65e-2)" "unprognostic (4.21e-1)" "unprognostic (8.37e-2)" "prognostic favorable (8.66e-4)" "unprognostic (2.28e-1)" "unprognostic (2.35e-1)" "unprognostic (1.05e-1)" "unprognostic (2.32e-1)" "unprognostic (4.60e-1)" "unprognostic (2.73e-1)" 28.9 33.2 30.7 30.6 32.9 33.7 34.1 35.1 40.0 28.5 25.4 39.5 25.8 23.5 27.3 31.0 30.0 30.1 27.1 32.6 31.1 28.3 27.9 47.9 23.7 27.6 32.7 29.9 42.2 26.0 45.0 35.1 27.1 34.9 32.7 22.0 22.7 27.1 41.0 50.9 22.4 24.4 26.3 36.2 32.7 26.5 59.1 28.5 31.5 32.1 25.4 31.7 28.1 24.7 31.5 16.5 24.5 21.1 21.8 25.1 15.4 35.8 46.6 30.7 16.3 19.8 16.8 12.5 29.9 28.3 35.6 34.5 38.1 19.4 28.8 21.1 24.7 21.1 12.6 33.1 25.1 29.3 32.3 38.8 28.3 29.4 24.9 21.4 24.0 27.0 16.9 17.3 29.5 19.3 22.5 26.0 25.4 21.9 23.9 29.2 40.7 27.2 15.9 10.8 30.0 15.7 27.7 30.2 20.1 26.6 41.0 26.0 17.5 32.3 21.4 16.2 16.0 20.4 20.6 24.3 21.5 28.3 22.1 32.9 26.0 23.4 24.7 21.3 21.1 19.7 21.1 15.0 24.5 24.0 21.1 25.1 31.5 20.1 23.8 16.5 29.3 23.0 20.7 24.1 21.8 18.7 15.7 19.4 15.4 30.7 32.9 35.1 40.0 31.1 28.3 32.7 29.9 34.9 28.5 20.8 44.0 34.7 55.8 47.6 13.9 30.2 10.2 87.0 37.5 21.0 7.9 33.0 11.6 21.6 22.6 17.9 21.4 0.0 23.8 24.7 29.8 29.1 49.7 23.6 21.5 7.9 25.3 12.9 13.1 25.1 32.5 25.7 21.9 25.2 18.0 21.4 21.3 14.1 26.2 19.5 14.2 12.9 34.0 84.6 24.5 43.0 53.5 23.5 16.1 30.6 PAGE1 "CT16.3, GAGE-9, GAGEB1, PAGE-1" ENSG00000068985 "PAGE family member 1" O75459 X 49687450-49695993 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 126 "testis: 18.2" "Cell type enhanced" "Detected in some" 30 "Sertoli cells: 32.3;Spermatocytes: 65.7;Spermatogonia: 164.4" "Cancer enhanced" "Detected in many" "liver cancer: 10.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "A-431: 49.0;Karpas-707: 37.8;U-266/84: 58.3" HPA003473 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Mitochondria" "HPA003473: AB_1079558" "unprognostic (3.00e-1)" "unprognostic (1.99e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 37.8 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.1 0.7 58.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 5.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 32.3 0.0 65.7 164.4 0.0 0.0 0.0 0.0 0.0 PAGE3 "CT16.6, GAGED1, PAGE-3" ENSG00000204279 "PAGE family member 3" Q5JUK9 X 55258412-55264846 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 111 "testis: 11.1" "Group enriched" "Detected in some" 54 "Early spermatids: 91.5;Late spermatids: 208.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.0;PC-3: 1.9" "HPA045032, HPA062248" Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Nuclear speckles" Nucleoplasm "HPA045032: , HPA062248: AB_2684725" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 91.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 208.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.8 1.6 0.0 0.0 0.0 0.0 0.0 PAK2 "PAK65, PAKgamma" ENSG00000180370 "P21 (RAC1) activated kinase 2" Q13177 3 196739857-196832647 "Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Growth regulation, Host-virus interaction" "Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB007794 Approved Approved Nucleoplasm,Vesicles NA NA 590000 "Nucleoplasm, Vesicles" "CAB007794: AB_562363" "unprognostic (1.03e-2)" "unprognostic (6.34e-2)" "unprognostic (2.52e-1)" "unprognostic (2.50e-2)" "unprognostic (1.32e-1)" "unprognostic (1.80e-1)" "unprognostic (5.18e-3)" "unprognostic (1.85e-2)" "unprognostic (7.97e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (3.36e-4)" "prognostic unfavorable (9.58e-4)" "unprognostic (1.30e-3)" "unprognostic (4.57e-2)" "unprognostic (1.25e-2)" "unprognostic (1.70e-2)" "unprognostic (3.39e-1)" 28.7 18.9 22.4 27.6 23.5 21.4 56.5 17.4 20.7 19.5 23.0 27.8 17.4 19.0 22.6 19.2 23.4 17.9 20.7 29.0 22.6 22.0 19.5 34.3 35.7 50.2 26.8 13.5 19.9 16.6 30.5 13.0 27.6 22.8 17.7 23.0 12.9 19.6 21.2 34.2 16.3 25.2 23.0 32.1 34.6 18.4 15.9 24.8 44.9 16.9 19.1 31.9 24.1 32.7 6.6 13.7 25.9 12.6 6.6 10.8 7.0 36.0 12.9 18.1 13.3 12.9 17.1 27.0 18.3 15.1 19.9 18.1 30.6 18.5 23.1 52.3 18.4 20.3 18.5 19.2 17.4 30.8 10.4 9.3 34.2 14.9 24.0 26.2 33.2 32.9 13.6 14.3 17.8 37.9 21.1 19.6 25.7 16.4 28.8 19.3 38.0 31.6 17.2 10.8 19.4 19.5 28.9 10.3 20.9 17.4 25.3 10.6 12.1 24.5 17.3 13.8 14.6 60.5 24.1 20.2 16.5 9.2 17.3 26.9 19.6 34.6 56.9 13.7 33.3 15.7 16.5 10.3 24.5 6.3 12.6 8.5 6.4 7.3 7.1 13.7 6.6 5.4 6.3 25.9 6.6 10.8 5.1 10.8 7.0 22.4 23.5 17.4 20.7 22.6 22.0 26.8 13.5 22.8 24.8 74.5 44.7 76.2 49.3 86.5 39.1 56.5 63.7 88.3 47.8 78.5 49.1 41.1 28.2 62.3 49.4 78.8 52.5 0.0 51.3 82.8 47.0 116.6 143.4 125.4 90.3 52.4 43.1 63.3 144.6 51.0 56.4 118.7 32.1 120.0 42.8 58.0 77.2 48.4 42.8 60.3 40.6 38.8 52.3 24.2 41.4 75.4 29.2 71.3 38.3 112.3 PAK5 "KIAA1264, PAK7" ENSG00000101349 "P21 (RAC1) activated kinase 5" Q9P286 20 9537389-9839041 "Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 30.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "SCLC-21H: 10.2;SH-SY5Y: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020444 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA020444: AB_1854947" "unprognostic (5.14e-5)" "unprognostic (3.35e-1)" "unprognostic (1.05e-1)" "unprognostic (8.63e-2)" "unprognostic (3.21e-1)" "unprognostic (3.04e-1)" "unprognostic (2.25e-4)" "unprognostic (3.76e-1)" "unprognostic (2.56e-2)" "unprognostic (3.83e-1)" "unprognostic (3.35e-2)" "unprognostic (6.04e-2)" "unprognostic (4.58e-1)" 0.5 5.2 5.7 0.6 11.7 0.5 1.6 30.3 19.6 0.8 0.6 0.8 0.0 0.7 1.0 2.2 1.0 0.7 3.4 0.6 4.0 3.3 1.0 2.3 0.7 0.6 1.6 8.8 0.6 3.5 0.5 2.0 0.6 5.3 1.6 0.6 0.6 1.2 1.6 0.6 1.6 0.6 0.6 1.2 0.6 1.2 1.0 1.7 0.0 0.6 0.0 0.6 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 3.8 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.2 0.0 5.7 11.7 30.3 13.6 4.0 3.3 1.6 8.8 5.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PAK6 PAK5 ENSG00000137843 "P21 (RAC1) activated kinase 6" Q9NQU5 15 40238759-40277487 "Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 22.2" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 38.8;Suprabasal keratinocytes: 16.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 14.8;HaCaT: 23.0;hTCEpi: 14.1;SK-BR-3: 7.8" HPA031124 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cell Junctions" NA NA "Nucleoplasm, Nucleoli fibrillar center" "Cell Junctions" "HPA031124: AB_10601044" "unprognostic (1.85e-3)" "unprognostic (2.15e-1)" "unprognostic (3.33e-3)" "unprognostic (7.79e-3)" "unprognostic (7.08e-3)" "unprognostic (9.57e-2)" "unprognostic (2.71e-1)" "unprognostic (7.73e-2)" "unprognostic (1.34e-2)" "unprognostic (7.13e-3)" "unprognostic (4.04e-2)" "unprognostic (8.87e-3)" "unprognostic (1.72e-1)" "unprognostic (1.79e-1)" "unprognostic (7.37e-3)" "unprognostic (3.34e-2)" 0.3 5.3 14.7 0.8 18.4 0.8 2.3 11.3 20.1 3.0 1.3 1.6 2.5 1.4 1.0 1.1 15.8 4.3 1.4 7.9 11.6 5.2 3.4 0.4 2.6 1.0 3.0 10.9 0.6 7.4 12.9 6.4 8.1 2.1 3.6 1.2 0.3 3.4 7.5 3.5 22.2 1.4 0.8 1.2 1.0 3.6 12.8 2.2 0.0 7.4 8.5 5.1 3.0 5.1 1.4 0.7 2.9 0.7 2.0 5.5 1.2 2.7 0.0 0.2 0.1 0.0 0.0 4.4 0.0 0.1 0.6 0.4 14.8 2.0 0.1 2.4 0.0 0.9 23.0 3.3 4.9 0.2 0.1 0.7 0.0 1.9 0.1 0.0 0.1 0.3 0.0 14.1 0.2 3.3 0.2 0.0 3.9 1.1 0.2 0.0 3.2 0.0 0.3 0.4 2.7 2.0 0.2 0.1 1.8 1.1 6.0 5.4 1.3 1.9 7.8 0.2 1.3 0.9 7.2 0.0 0.2 0.4 0.0 0.1 0.0 0.2 0.0 0.5 0.4 0.1 2.1 0.7 2.9 5.5 0.3 2.1 1.4 0.5 4.2 0.7 0.5 0.3 1.2 1.3 2.0 0.2 0.5 0.1 1.2 14.7 18.4 11.3 20.1 11.6 5.2 3.0 10.9 2.1 2.2 0.0 3.4 0.0 6.8 8.8 3.9 0.0 7.6 4.0 4.5 5.2 0.0 38.8 11.6 4.0 5.9 0.0 0.0 0.0 3.7 1.2 0.6 4.0 0.0 0.0 3.5 0.0 4.7 0.0 0.3 4.5 1.7 0.3 1.7 0.0 0.8 1.4 2.7 0.0 1.8 0.0 0.0 0.0 0.1 1.6 1.5 16.7 7.6 1.3 1.9 6.8 PALB2 "FANCN, FLJ21816" ENSG00000083093 "Partner and localizer of BRCA2" Q86YC2 16 23603160-23641310 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Fanconi anemia, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 20.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB014895, HPA057000" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB014895: , HPA057000: AB_2683307" "unprognostic (1.11e-1)" "unprognostic (5.67e-3)" "prognostic favorable (2.83e-5)" "unprognostic (1.43e-2)" "unprognostic (6.22e-2)" "unprognostic (1.61e-2)" "unprognostic (2.00e-3)" "unprognostic (5.18e-2)" "unprognostic (2.46e-2)" "unprognostic (2.00e-2)" "prognostic unfavorable (2.35e-5)" "unprognostic (2.05e-2)" "unprognostic (1.04e-2)" "unprognostic (2.72e-1)" "unprognostic (1.25e-1)" "unprognostic (7.20e-2)" "unprognostic (3.21e-1)" 12.4 9.9 10.7 19.6 11.9 6.8 15.2 16.5 14.1 12.4 14.0 10.8 9.1 14.8 10.9 13.5 17.6 9.6 7.8 10.5 10.0 10.6 13.7 16.1 9.2 13.4 9.7 12.5 15.3 10.6 13.7 16.1 9.1 14.9 10.9 12.7 8.6 11.0 14.7 10.3 17.0 14.1 12.8 10.8 14.1 11.0 16.9 10.5 12.9 12.1 12.0 15.3 13.6 13.3 3.7 3.9 7.2 7.7 3.9 5.5 2.0 12.0 9.3 11.3 7.9 9.4 7.4 10.1 8.7 13.4 14.4 17.5 7.9 12.6 12.7 6.4 6.1 11.1 10.8 10.0 14.7 17.2 7.5 5.8 7.8 12.9 22.4 8.7 14.3 12.7 8.4 15.0 13.6 15.5 8.0 7.6 12.3 16.0 6.9 12.6 11.9 14.7 14.9 25.1 8.8 5.5 17.1 13.8 17.4 11.0 10.8 8.3 8.3 8.9 10.2 11.4 10.3 9.4 9.8 5.5 17.3 6.6 8.5 9.3 8.1 13.1 13.0 11.3 10.5 10.3 7.2 3.3 3.0 4.4 4.2 5.3 3.7 4.9 5.3 3.9 3.1 5.5 4.3 0.2 3.9 7.7 2.8 3.1 2.0 10.7 11.9 16.5 14.1 10.0 10.6 9.7 12.5 14.9 10.5 11.9 3.4 9.4 3.5 0.8 6.2 4.2 5.1 12.0 10.3 3.5 3.9 2.3 3.3 4.3 3.0 2.3 2.6 0.0 4.4 1.7 1.4 1.5 4.7 4.7 3.2 1.6 1.2 3.1 7.0 2.9 4.4 4.0 1.7 9.0 2.6 4.7 6.9 3.4 6.0 4.6 7.1 6.5 2.1 20.2 14.4 2.4 1.0 2.5 4.3 3.7 PALM KIAA0270 ENSG00000099864 Paralemmin O75781 19 708939-748329 "Predicted intracellular proteins" "Cell shape" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 47.6;brain: 56.5" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 44.7;Ito cells: 46.6;Leydig cells: 44.8;Muller glia cells: 69.4;Peritubular cells: 42.5;Proximal tubular cells: 43.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "non-classical monocyte: 4.7" "Lineage enriched" "Detected in single" 35 "monocytes: 4.7" "Cell line enhanced" "Detected in many" "AN3-CA: 16.5;EFO-21: 15.3;REH: 27.2;SH-SY5Y: 17.5;U-2197: 14.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041713, HPA049578" Approved Enhanced "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA041713: AB_10794305, HPA049578: AB_2680822" "unprognostic (9.08e-3)" "unprognostic (2.97e-2)" "unprognostic (2.11e-2)" "unprognostic (3.53e-3)" "unprognostic (1.61e-1)" "unprognostic (3.77e-2)" "unprognostic (1.42e-1)" "unprognostic (8.39e-2)" "unprognostic (7.62e-2)" "unprognostic (1.36e-2)" "prognostic favorable (9.81e-4)" "unprognostic (2.74e-2)" "prognostic favorable (5.44e-4)" "unprognostic (1.24e-2)" "unprognostic (1.13e-1)" "unprognostic (1.55e-2)" "unprognostic (6.00e-2)" 47.6 11.8 49.1 5.1 39.9 2.2 11.3 13.3 56.5 22.7 8.2 12.4 4.2 9.2 10.7 6.7 5.8 17.7 7.2 9.6 37.7 18.9 21.9 3.5 9.0 2.2 19.2 28.1 21.2 2.1 1.2 10.2 17.6 11.9 12.2 2.7 6.1 5.9 18.6 7.0 6.9 7.5 9.0 14.7 10.5 3.6 8.2 12.5 0.0 3.3 3.3 1.9 5.0 8.4 0.0 0.1 0.0 4.7 0.0 0.0 0.0 0.0 4.4 8.6 16.5 1.3 0.1 1.2 1.1 0.0 1.1 0.3 1.0 0.0 0.0 15.3 0.1 0.1 1.5 4.3 0.0 0.2 0.0 8.5 0.0 3.5 5.4 6.0 0.0 0.1 3.9 0.0 0.7 0.0 2.4 0.6 1.9 3.0 0.1 1.1 8.7 0.6 5.1 3.5 0.8 2.4 27.2 0.0 0.1 0.4 0.0 0.9 17.5 4.4 0.0 0.1 2.8 1.5 4.1 0.0 0.0 9.0 14.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 49.1 39.9 13.3 44.4 37.7 18.9 19.2 28.1 11.9 12.5 0.0 1.7 1.4 5.5 6.4 7.6 3.6 0.0 0.0 3.4 5.2 11.8 0.8 44.7 1.6 1.1 26.3 2.1 0.0 0.2 2.5 21.8 8.7 0.0 0.2 0.8 23.8 0.0 46.6 2.2 5.3 44.8 1.6 16.9 0.0 0.0 69.4 0.3 0.3 42.5 43.5 4.2 0.0 13.3 0.9 1.3 6.0 1.6 0.0 0.0 5.0 PALM2-AKAP2 ENSG00000157654 "PALM2-AKAP2 readthrough" 9 109780309-110172512 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 41.0;heart muscle: 26.8" "Group enriched" "Detected in some" 14 "Alveolar cells type 1: 125.0;granulocytes: 32.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 15.7;hTEC/SVTERT24-B: 15.1;RH-30: 29.7;U-251 MG: 13.2;WM-115: 17.3" "HPA058905, HPA074153, HPA076866" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nuclear bodies" "HPA058905: AB_2683851, HPA074153: AB_2686669, HPA076866: " "unprognostic (7.12e-2)" "unprognostic (1.64e-6)" "unprognostic (7.90e-2)" "unprognostic (3.67e-2)" "unprognostic (2.45e-1)" "unprognostic (3.19e-1)" "unprognostic (9.91e-2)" "unprognostic (1.37e-1)" "unprognostic (1.75e-1)" "unprognostic (8.37e-3)" "unprognostic (2.40e-2)" "unprognostic (2.77e-1)" "unprognostic (1.19e-1)" "unprognostic (2.05e-3)" "unprognostic (7.77e-2)" "unprognostic (1.98e-4)" "unprognostic (3.36e-5)" 41.0 2.8 1.6 3.3 1.6 0.1 19.6 0.7 4.7 4.8 2.3 1.5 2.1 1.1 15.2 4.7 2.1 2.5 5.0 26.8 1.8 2.4 2.4 24.8 9.7 1.2 1.9 0.5 5.9 1.1 1.6 1.1 9.2 3.0 3.2 0.6 1.1 2.0 3.6 4.5 1.8 1.0 7.8 1.4 0.5 1.1 1.4 0.9 0.0 3.8 2.5 0.3 5.2 8.9 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 3.3 0.0 15.7 5.6 1.3 5.5 5.4 1.6 3.7 0.0 0.1 0.0 0.5 5.7 6.5 2.0 0.0 1.3 4.6 0.2 1.6 0.0 5.1 0.1 0.1 0.0 0.0 7.1 0.1 15.1 2.4 4.8 0.1 0.0 0.0 0.0 5.8 0.0 0.0 0.0 4.4 0.0 1.4 0.0 29.7 0.0 4.1 0.0 1.8 0.0 2.1 0.2 7.5 4.6 0.6 0.0 0.1 3.4 8.6 0.3 13.2 0.0 0.2 0.0 4.3 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 1.6 1.6 0.7 3.0 1.8 2.4 1.9 0.5 3.0 0.9 125.0 5.8 0.0 0.0 0.0 0.0 1.1 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 32.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PALM3 ENSG00000187867 "Paralemmin 3" A6NDB9 19 14053365-14059159 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 26.5;testis: 19.7" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 53.6;Alveolar cells type 2: 36.3;Cholangiocytes: 17.8;Club cells: 18.2;Collecting duct cells: 36.6;Exocrine glandular cells: 24.3;Hepatocytes: 31.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 22.1;CACO-2: 23.7;HAP1: 19.8;NTERA-2: 14.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA052794, HPA056119" Enhanced Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Nucleoplasm, Nuclear bodies" "Plasma membrane" "HPA052794: AB_2681952, HPA056119: AB_2683042" "unprognostic (3.67e-2)" "unprognostic (9.08e-2)" "unprognostic (4.72e-2)" "prognostic unfavorable (7.87e-4)" "unprognostic (2.14e-2)" "unprognostic (1.47e-1)" "unprognostic (4.66e-2)" "unprognostic (7.62e-2)" "unprognostic (1.97e-1)" "unprognostic (3.91e-1)" "unprognostic (3.93e-2)" "unprognostic (3.88e-2)" "unprognostic (2.09e-2)" "unprognostic (1.06e-1)" "unprognostic (5.68e-2)" "unprognostic (1.10e-2)" "unprognostic (1.72e-3)" 0.2 0.2 4.3 0.9 1.9 0.0 2.1 3.7 3.6 2.9 0.5 3.2 0.2 2.7 0.4 11.1 0.2 1.5 1.6 0.2 4.2 2.8 12.9 26.5 2.4 0.2 1.7 4.3 0.4 11.7 1.8 0.2 0.7 10.1 1.8 0.2 1.1 6.9 8.0 0.2 0.2 0.8 0.9 2.7 0.2 13.0 19.7 4.9 0.2 6.8 0.2 1.0 3.9 1.9 0.9 0.2 0.0 0.3 0.0 1.8 0.0 1.6 1.5 3.7 22.1 0.3 0.1 4.5 0.4 0.1 1.3 0.6 23.7 0.5 0.0 0.2 0.4 7.0 0.1 19.8 0.0 0.3 0.0 1.3 0.1 0.5 2.6 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.6 0.1 0.0 4.6 0.0 0.0 3.7 0.2 0.1 14.2 1.8 1.3 0.0 0.0 0.0 0.0 1.9 2.7 3.6 0.1 0.0 0.0 4.0 1.4 0.0 0.2 0.0 4.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.5 0.1 0.9 0.8 0.3 0.0 0.1 0.9 1.8 1.8 0.0 0.0 0.1 0.2 0.5 0.0 4.3 1.9 3.7 3.6 4.2 2.8 1.7 4.3 10.1 4.9 53.6 36.3 0.0 0.6 0.0 0.8 0.3 17.8 2.7 18.2 36.6 0.0 0.2 1.7 6.7 0.0 0.0 0.9 0.0 24.3 2.0 1.0 1.4 1.1 31.8 0.1 0.0 1.2 1.3 1.3 0.0 0.9 0.1 1.7 1.8 1.9 0.4 3.8 0.6 2.5 6.8 0.5 0.0 0.0 0.0 6.8 0.0 1.8 0.0 0.6 0.2 PAM16 "Magmas, Tim16, TIMM16" ENSG00000217930 "Presequence translocase associated motor 16" Q9Y3D7 16 4331549-4355607 "Disease related genes, Predicted intracellular proteins" "Protein transport, Translocation, Transport" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 54.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 36.3" HPA062721 Approved Nucleoplasm,Microtubules,Mitochondria NA NA "Nucleoplasm, Mitochondria" Microtubules "HPA062721: AB_2684849" "unprognostic (2.69e-2)" "unprognostic (1.64e-1)" "unprognostic (4.06e-1)" "unprognostic (6.81e-2)" "unprognostic (6.98e-2)" "unprognostic (9.68e-2)" "unprognostic (1.83e-1)" "unprognostic (6.32e-2)" "unprognostic (1.99e-1)" "unprognostic (1.39e-1)" "unprognostic (4.79e-2)" "unprognostic (2.18e-2)" "prognostic unfavorable (5.73e-5)" "unprognostic (7.25e-2)" "unprognostic (2.22e-1)" "unprognostic (3.56e-1)" "prognostic favorable (1.33e-4)" 10.9 15.2 12.9 8.4 14.1 17.0 10.0 9.3 15.1 7.0 9.5 5.6 8.2 14.0 7.8 11.8 11.2 7.5 7.5 19.9 11.1 10.7 9.2 33.7 9.8 10.9 9.8 11.3 8.5 26.1 7.1 10.3 8.0 9.2 8.8 8.0 7.8 13.2 11.0 54.5 12.6 10.1 8.2 8.3 9.5 10.1 16.2 7.3 7.3 12.0 17.8 9.6 8.4 9.9 16.0 19.8 11.2 15.3 11.5 14.3 12.3 3.9 7.7 4.2 10.3 2.8 3.9 10.9 9.5 2.3 3.6 2.9 5.4 5.8 11.5 10.6 2.8 3.7 8.1 3.9 4.2 1.7 11.2 25.4 12.0 7.2 3.8 4.6 8.4 9.0 5.8 5.4 4.3 4.7 3.2 2.8 8.1 14.1 5.5 3.0 10.6 7.6 14.7 6.8 2.5 17.2 14.5 3.5 11.1 3.7 3.8 16.0 12.4 8.2 7.0 9.7 3.3 9.2 10.2 3.5 7.2 9.3 36.3 10.4 8.2 8.8 14.3 2.6 8.2 6.8 0.2 15.3 2.3 12.3 9.5 10.5 16.0 11.2 11.3 10.7 15.5 14.3 13.7 11.2 11.5 10.2 19.8 12.7 12.3 12.9 14.1 9.3 15.1 11.1 10.7 9.8 11.3 9.2 7.3 3.0 4.5 2.2 0.9 3.5 0.5 0.4 10.2 6.7 5.7 0.0 0.0 1.9 6.6 3.1 2.6 0.7 2.1 0.0 2.6 2.3 2.7 1.0 1.1 10.9 1.5 1.6 0.0 4.3 7.8 0.8 4.6 1.1 1.7 7.2 2.1 0.3 5.2 3.4 3.5 3.0 0.6 6.5 1.4 8.9 12.9 5.1 1.0 1.7 3.4 1.0 PAOX PAO ENSG00000148832 "Polyamine oxidase" Q6QHF9 10 133379234-133391694 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 36.7" "Group enriched" "Detected in many" 11 "Early spermatids: 115.5;Late spermatids: 346.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 4.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 6.4;K-562: 5.0;U-266/70: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047782 Uncertain Nucleoplasm,Centrosome NA NA Centrosome Nucleoplasm "HPA047782: " "unprognostic (3.67e-3)" "prognostic favorable (6.07e-5)" "unprognostic (2.49e-2)" "unprognostic (1.28e-3)" "unprognostic (1.96e-2)" "prognostic favorable (1.38e-5)" "unprognostic (7.39e-2)" "unprognostic (1.99e-3)" "unprognostic (2.20e-1)" "unprognostic (4.48e-2)" "unprognostic (1.11e-2)" "unprognostic (2.99e-1)" "prognostic favorable (9.49e-4)" "unprognostic (3.56e-2)" "unprognostic (2.86e-1)" "unprognostic (7.61e-2)" "unprognostic (8.29e-3)" 6.7 4.1 4.3 5.8 6.7 1.5 4.7 6.8 8.7 3.7 6.0 10.8 5.6 5.6 3.7 1.8 7.4 3.4 2.4 2.5 5.7 2.7 8.9 9.2 2.8 5.2 10.0 3.4 3.6 3.2 1.9 2.5 2.1 4.2 4.8 1.5 2.8 9.9 5.1 3.5 4.4 8.5 2.8 4.7 8.2 7.5 36.7 7.6 0.7 2.4 2.1 5.4 4.6 4.2 4.3 1.1 1.0 1.0 1.7 0.3 0.4 6.4 0.0 0.2 1.2 0.0 0.7 1.6 2.9 1.2 1.4 0.2 1.1 0.1 0.0 0.9 0.6 0.8 3.5 0.4 0.8 0.6 4.2 0.5 0.6 0.0 0.2 1.7 0.0 1.0 0.1 0.3 0.9 0.4 0.0 0.1 0.0 5.0 0.3 0.0 0.1 0.0 0.1 1.2 0.0 3.0 4.6 0.0 0.0 0.2 0.0 0.3 2.2 0.9 0.1 0.0 0.0 1.4 0.0 2.8 0.3 1.4 1.2 0.0 18.5 3.4 1.7 0.0 0.0 0.1 1.0 0.3 0.0 0.2 1.0 0.0 1.6 0.3 0.2 1.1 4.3 0.0 0.0 0.0 1.7 0.9 0.8 0.0 0.4 4.3 6.7 6.8 6.5 5.7 2.7 10.0 3.4 4.2 7.6 0.0 5.8 20.9 6.2 3.3 1.5 1.5 5.1 1.4 0.0 1.8 0.0 0.7 5.0 4.5 115.5 2.3 6.8 0.0 3.0 1.7 2.3 4.8 5.7 11.3 4.1 4.8 0.0 3.7 10.4 346.0 8.9 3.9 0.0 17.2 3.4 7.7 2.9 2.9 7.4 13.2 2.7 19.4 2.5 9.9 3.0 3.1 0.2 4.6 3.2 8.6 PAPD7 "LAK-1, POLK, POLS, TRF4, TRF4-1" ENSG00000112941 "Poly(A) RNA polymerase D7, non-canonical" Q5XG87 5 6713007-6757048 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045487, HPA046742" Enhanced Supported "Nucleoplasm,Nuclear membrane,Golgi apparatus" NA NA Nucleoplasm "Nuclear membrane, Golgi apparatus" "HPA045487: AB_2679346, HPA046742: AB_2679781" "unprognostic (1.45e-1)" "unprognostic (2.96e-1)" "unprognostic (2.08e-2)" "unprognostic (2.12e-3)" "unprognostic (7.57e-2)" "unprognostic (1.30e-2)" "unprognostic (4.22e-2)" "unprognostic (2.37e-1)" "unprognostic (2.62e-1)" "unprognostic (9.78e-2)" "unprognostic (3.10e-3)" "unprognostic (3.73e-2)" "prognostic unfavorable (7.99e-5)" "unprognostic (6.56e-2)" "unprognostic (2.08e-1)" "unprognostic (2.60e-2)" "prognostic favorable (8.55e-4)" 13.5 7.9 9.6 13.9 11.1 25.8 16.3 22.7 12.3 15.1 16.6 10.6 14.8 9.5 13.2 8.0 12.2 11.3 11.4 8.6 10.7 7.3 9.7 19.9 13.2 14.1 14.8 5.8 18.5 13.3 13.2 12.2 10.0 9.0 11.6 8.3 10.2 17.0 10.6 10.4 16.7 13.1 13.9 7.9 14.8 10.1 11.1 11.7 25.4 11.3 11.3 11.6 12.5 34.9 1.9 3.8 0.7 0.7 0.5 2.3 0.8 16.5 11.2 13.8 17.0 10.0 9.0 19.9 11.3 14.1 14.1 16.0 11.6 9.3 12.1 8.7 13.8 15.8 12.3 11.3 8.7 13.0 13.6 7.2 6.2 35.5 6.3 6.2 9.3 9.4 6.1 7.6 15.7 10.1 10.4 8.2 9.1 8.3 16.1 11.4 9.1 12.6 12.2 7.5 5.1 8.8 11.5 11.8 3.1 5.6 9.5 13.8 10.5 26.9 13.1 7.7 7.8 7.9 5.1 7.2 16.9 17.8 14.7 15.7 15.4 6.3 10.7 11.0 8.7 10.4 0.0 0.7 0.7 2.1 0.4 2.3 1.9 1.7 1.6 1.2 1.5 1.9 1.7 0.4 0.5 0.6 3.8 1.8 0.8 9.6 11.1 22.7 12.3 10.7 7.3 14.8 5.8 9.0 11.7 6.0 20.8 6.7 8.4 29.1 16.5 0.0 7.6 4.0 9.1 0.0 35.3 4.5 0.0 0.0 9.6 8.2 7.3 0.0 0.0 3.5 14.1 9.6 4.7 13.2 5.8 14.3 4.7 16.0 5.7 2.8 6.1 7.6 3.3 0.0 8.1 7.8 0.0 6.2 8.5 0.0 24.9 0.0 14.7 6.3 4.9 22.6 4.7 6.9 7.6 8.7 PAPLN MGC50452 ENSG00000100767 "Papilin, proteoglycan like sulfated glycoprotein" O95428 14 73237497-73274640 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Leydig cells: 31.9;Muller glia cells: 21.2;Peritubular cells: 41.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "neutrophil: 4.4;plasmacytoid DC: 8.8" "Group enriched" "Detected in many" 6 "dendritic cells: 8.8;granulocytes: 4.4" "Cell line enhanced" "Detected in many" "HHSteC: 13.1;HSkMC: 24.7;hTCEpi: 9.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA048682, HPA053453" Uncertain Approved Nucleoplasm "Secreted - unknown location" NA NA 46000000 Nucleoplasm "HPA048682: AB_2680492, HPA053453: AB_2682155" "unprognostic (1.97e-3)" "unprognostic (3.27e-2)" "unprognostic (1.88e-1)" "unprognostic (3.56e-3)" "unprognostic (7.42e-2)" "unprognostic (7.91e-3)" "unprognostic (2.01e-2)" "unprognostic (2.46e-3)" "unprognostic (9.13e-3)" "unprognostic (3.69e-2)" "unprognostic (1.41e-1)" "unprognostic (4.87e-2)" "unprognostic (1.89e-2)" "unprognostic (2.14e-2)" "unprognostic (3.05e-3)" "unprognostic (2.69e-2)" "unprognostic (5.58e-2)" 9.3 6.1 13.6 11.8 14.8 2.9 11.0 4.1 11.1 10.8 7.0 6.0 3.8 4.1 14.2 19.5 4.6 12.1 8.0 4.8 15.7 3.0 24.9 1.9 7.8 23.3 4.1 9.7 10.9 2.7 1.0 11.1 5.2 5.7 8.1 6.2 14.9 4.7 10.2 1.8 16.2 10.3 8.6 6.0 17.6 7.4 6.5 8.9 5.1 15.3 2.2 16.5 6.8 5.6 1.1 8.8 4.4 0.8 0.5 0.5 0.2 2.0 2.0 0.8 0.3 1.5 1.9 4.6 0.4 0.0 0.1 0.1 2.6 0.6 0.4 2.1 0.0 0.1 3.3 2.1 1.5 0.2 2.3 3.1 0.9 3.2 0.3 13.1 0.3 1.7 24.7 9.1 0.4 1.4 0.1 0.4 1.9 0.6 0.3 0.0 1.0 0.2 2.2 0.5 0.2 0.6 0.3 0.3 2.1 1.8 0.4 0.2 0.4 4.8 5.5 0.9 6.6 0.1 3.7 0.4 0.6 1.9 0.2 0.2 1.1 0.1 0.2 1.1 1.1 0.5 1.1 0.8 0.6 0.4 0.5 0.2 0.7 0.3 0.5 0.2 1.1 0.5 0.5 4.4 0.5 0.4 8.8 0.5 0.2 13.6 14.8 4.1 11.1 15.7 3.0 4.1 9.7 5.7 8.9 0.0 1.6 0.0 0.5 1.8 1.0 1.3 2.5 1.4 5.7 5.2 7.9 0.5 0.0 3.0 0.3 1.1 0.1 0.0 0.0 0.9 6.1 1.7 0.0 0.0 1.2 0.0 0.0 1.8 0.3 1.4 31.9 0.9 1.7 2.8 0.0 21.2 0.4 0.0 41.4 13.4 3.0 6.5 1.0 0.6 0.1 2.6 0.3 0.0 0.9 0.4 PAPOLA PAP ENSG00000090060 "Poly(A) polymerase alpha" P51003 14 96501433-96567111 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Syncytiotrophoblasts: 866.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001788 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA001788: AB_1079564" "unprognostic (3.18e-1)" "unprognostic (1.30e-1)" "unprognostic (9.69e-2)" "unprognostic (7.26e-2)" "unprognostic (9.10e-2)" "unprognostic (5.10e-3)" "prognostic unfavorable (2.41e-5)" "unprognostic (2.12e-2)" "unprognostic (2.82e-2)" "unprognostic (1.38e-3)" "unprognostic (3.13e-1)" "unprognostic (1.22e-3)" "unprognostic (3.37e-1)" "unprognostic (1.65e-1)" "unprognostic (1.77e-1)" "unprognostic (1.08e-2)" "unprognostic (4.05e-1)" 35.8 43.4 49.1 45.7 51.6 54.5 39.7 61.2 60.5 41.0 45.1 25.2 45.6 34.9 43.8 48.3 42.0 38.7 35.6 71.8 46.3 39.6 40.0 50.2 37.1 44.7 48.1 39.7 58.2 52.9 50.2 68.7 54.5 45.6 45.1 45.8 24.0 39.2 45.5 46.4 35.5 45.5 38.9 41.9 50.9 40.4 53.0 55.7 53.0 54.8 34.8 49.6 44.9 119.5 26.4 23.0 39.0 23.5 25.2 23.4 19.8 32.2 31.1 40.0 40.1 29.0 32.8 91.1 29.5 31.9 35.1 33.8 35.9 33.3 43.6 34.0 34.5 31.2 27.9 13.0 40.6 63.0 36.0 21.2 35.2 23.6 35.2 30.0 46.0 35.7 29.9 35.6 39.2 35.1 34.3 39.2 22.1 33.0 40.0 33.8 46.9 36.1 23.3 27.3 52.6 35.4 38.5 48.8 25.3 35.0 51.4 41.2 27.3 39.4 30.9 28.7 47.0 43.8 40.6 31.2 24.8 19.8 27.9 35.9 31.6 47.2 38.5 40.1 35.3 41.5 39.0 19.7 32.7 15.5 23.5 20.4 23.8 19.6 22.6 23.0 26.4 23.4 21.8 27.4 25.2 22.6 15.2 18.7 19.8 49.1 51.6 61.2 60.5 46.3 39.6 48.1 39.7 45.6 55.7 74.5 97.8 147.6 322.5 204.0 74.0 149.1 91.7 188.7 112.6 80.3 90.3 292.7 155.9 102.9 458.6 132.1 96.5 93.5 118.9 339.8 138.5 332.8 134.9 110.0 138.1 60.4 112.4 76.1 123.0 196.9 89.2 135.9 160.3 140.7 124.7 87.2 118.9 101.7 75.7 103.9 102.5 103.5 150.3 203.7 195.7 216.4 866.4 116.1 134.7 394.8 PAPOLB PAPT ENSG00000218823 "Poly(A) polymerase beta" Q9NRJ5 7 4857733-4861994 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 63 "testis: 33.0" "Group enriched" "Detected in some" 4 "Early spermatids: 67.3;Late spermatids: 69.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "THP-1: 1.7" "Not detected" "Not detected" HPA047285 Approved Nucleoplasm NA NA Nucleoplasm "HPA047285: " "unprognostic (7.58e-2)" "unprognostic (1.25e-1)" "unprognostic (1.68e-2)" "unprognostic (1.78e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 33.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.3 0.3 1.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.3 0.3 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.0 2.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.7 0.0 0.5 16.1 2.3 0.6 0.2 0.0 0.0 0.3 PAPOLG FLJ12972 ENSG00000115421 "Poly(A) polymerase gamma" Q9BWT3 2 60756230-60802085 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017795, HPA035349, HPA035350" Approved Enhanced Nucleoplasm No No Nucleoplasm "CAB017795: , HPA035349: AB_2674583, HPA035350: AB_2674584" "unprognostic (1.83e-1)" "unprognostic (1.06e-1)" "unprognostic (2.14e-1)" "unprognostic (3.39e-2)" "unprognostic (5.56e-2)" "unprognostic (3.54e-1)" "unprognostic (6.72e-4)" "unprognostic (2.49e-1)" "unprognostic (6.97e-3)" "unprognostic (6.83e-2)" "unprognostic (1.95e-1)" "unprognostic (1.88e-1)" "prognostic unfavorable (4.21e-4)" "unprognostic (2.67e-1)" "unprognostic (1.99e-2)" "unprognostic (3.06e-2)" "unprognostic (2.62e-2)" 12.3 9.5 11.6 11.6 11.9 5.8 9.9 19.4 15.3 10.2 8.2 9.8 7.8 6.8 12.1 6.2 10.1 9.0 10.2 8.5 15.1 10.1 8.6 6.9 9.4 14.8 10.9 11.3 17.1 9.9 13.3 18.9 11.8 12.5 9.6 9.2 7.7 11.1 8.7 13.1 11.7 9.7 9.9 21.0 15.0 9.1 14.2 11.0 23.1 27.5 6.6 14.3 10.9 11.1 6.1 3.7 13.2 6.9 9.4 9.7 4.1 5.2 4.9 9.2 7.4 11.8 8.9 8.8 5.8 5.7 5.0 5.3 8.3 4.5 7.5 6.1 4.4 6.6 8.9 13.0 5.5 9.4 13.0 6.9 9.6 4.7 5.8 7.1 10.0 6.6 6.7 6.5 6.0 12.7 7.6 8.0 7.8 9.4 7.2 5.6 4.2 11.5 6.9 14.5 7.7 4.5 9.4 16.3 6.8 5.4 5.0 5.4 7.5 9.3 5.8 5.2 10.7 3.8 6.1 7.5 6.4 7.7 4.8 5.4 7.1 4.2 18.3 5.2 11.4 4.6 13.2 4.1 8.7 6.7 4.3 8.3 5.9 7.2 6.0 3.7 6.1 7.9 7.3 10.6 9.4 6.9 3.3 9.7 4.1 11.6 11.9 19.4 15.3 15.1 10.1 10.9 11.3 12.5 11.0 11.9 9.8 4.5 13.0 11.1 5.7 6.3 5.1 8.1 10.3 8.7 23.6 5.3 3.3 3.9 4.3 9.2 4.3 0.0 3.7 3.5 8.2 12.6 12.7 4.0 6.5 4.8 2.4 10.4 11.6 3.3 6.9 12.4 11.8 7.2 5.1 5.1 3.6 5.8 8.1 2.4 10.1 25.8 8.2 23.3 14.7 13.9 7.3 15.8 3.2 12.0 PAPSS1 "ATPSK1, PAPSS" ENSG00000138801 "3'-phosphoadenosine 5'-phosphosulfate synthase 1" O43252 4 107590276-107720452 "Enzymes, Predicted intracellular proteins" "Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ciliated cells: 113.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "basophil: 50.3;eosinophil: 62.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 62.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049781 Approved Approved "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA049781: AB_2680879" "unprognostic (1.36e-2)" "unprognostic (5.03e-2)" "prognostic favorable (9.14e-4)" "prognostic favorable (8.58e-4)" "unprognostic (1.63e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (2.70e-5)" "unprognostic (1.58e-2)" "unprognostic (1.05e-1)" "unprognostic (8.92e-2)" "unprognostic (1.42e-1)" "unprognostic (5.76e-2)" "unprognostic (6.23e-3)" "unprognostic (1.29e-1)" "unprognostic (1.72e-1)" "unprognostic (1.61e-2)" "unprognostic (1.38e-1)" 13.5 7.4 24.3 14.4 28.5 11.1 25.2 16.4 32.2 26.6 10.0 45.0 9.4 7.9 25.1 22.8 18.3 24.9 13.3 7.7 31.3 23.9 16.7 5.1 22.0 14.7 29.7 21.9 15.6 24.6 15.6 15.5 8.5 38.2 21.7 12.7 9.5 32.2 14.0 3.3 24.5 8.5 17.0 59.9 9.6 30.4 8.1 25.5 14.7 10.3 11.0 24.6 16.5 13.7 8.5 9.2 62.2 10.2 4.6 6.8 5.8 10.5 9.7 16.4 20.4 20.2 25.5 13.1 13.5 25.4 13.2 17.8 14.8 15.3 16.5 8.6 24.7 10.2 13.3 15.5 26.7 17.1 38.8 11.7 19.3 21.0 33.0 11.1 29.2 33.4 21.1 13.8 15.2 12.5 32.2 29.3 21.1 4.2 32.2 37.0 16.2 23.5 9.0 17.5 11.4 10.8 19.8 25.9 4.7 19.9 14.7 18.6 26.9 14.0 21.1 16.5 21.8 12.5 4.5 17.3 16.6 17.1 11.1 11.3 25.9 17.2 15.4 20.1 22.4 26.0 50.3 8.9 62.2 3.0 9.6 3.5 8.5 4.0 3.4 9.2 4.1 2.5 2.9 9.4 4.6 10.2 1.8 6.8 5.8 24.3 28.5 16.4 32.2 31.3 23.9 29.7 21.9 38.2 25.5 89.3 19.8 21.5 31.5 28.4 13.4 6.5 30.6 113.8 69.4 54.1 9.8 17.1 14.9 29.3 5.2 17.4 7.0 0.0 40.0 37.0 49.8 27.9 41.5 8.1 53.6 28.6 22.5 20.3 50.0 3.7 16.7 46.3 57.3 35.1 18.0 37.3 29.6 7.0 24.1 21.2 13.7 25.8 22.7 16.5 14.3 35.8 7.4 11.8 15.1 20.1 PARG ENSG00000227345 "Poly(ADP-ribose) glycohydrolase" Q86W56 10 49818279-49970203 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021819, HPA053007" Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA021819: AB_1854974, HPA053007: AB_2682014" "unprognostic (5.77e-3)" "unprognostic (6.74e-2)" "unprognostic (3.06e-2)" "unprognostic (9.90e-2)" "unprognostic (1.22e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (5.57e-5)" "unprognostic (1.21e-1)" "unprognostic (3.97e-1)" "unprognostic (8.34e-2)" "unprognostic (1.47e-1)" "unprognostic (4.06e-2)" "unprognostic (5.20e-3)" "unprognostic (1.14e-1)" "unprognostic (1.77e-1)" "unprognostic (8.54e-2)" "unprognostic (1.13e-1)" 4.0 5.6 4.3 4.2 5.4 1.4 5.3 7.8 6.3 4.8 5.1 6.7 4.9 3.0 6.2 4.3 3.6 6.6 4.6 5.9 9.2 5.2 3.5 5.8 4.5 4.7 3.5 8.1 4.7 5.8 4.9 6.1 4.7 5.1 8.1 6.7 5.1 4.7 4.0 5.9 4.7 5.8 4.9 6.9 4.4 4.8 6.9 7.0 12.5 7.7 8.3 9.4 5.5 12.7 10.6 18.6 13.7 9.0 11.2 13.7 12.7 14.0 14.8 14.2 8.5 11.9 9.6 8.3 10.7 6.6 14.4 15.7 8.0 15.9 14.7 14.6 9.8 8.7 9.3 10.2 14.1 8.2 7.2 15.5 12.4 20.5 10.1 9.0 12.7 16.6 8.5 11.1 7.1 15.5 12.7 18.4 7.8 24.3 18.6 21.2 11.1 11.9 8.2 12.9 16.3 10.3 16.4 13.3 18.8 18.8 7.9 9.1 9.2 11.3 9.6 14.2 9.4 14.0 20.5 15.9 15.0 6.7 12.5 6.2 3.0 5.2 5.5 7.9 6.9 7.1 6.7 7.0 6.9 9.4 9.1 3.0 8.3 7.7 5.4 5.5 5.5 8.9 11.7 8.3 4.6 5.5 13.2 23.8 12.7 29.4 12.5 12.2 25.5 6.5 8.3 6.3 3.5 8.3 8.5 23.3 5.6 5.2 6.7 4.0 13.9 9.6 8.2 4.8 6.3 7.4 13.2 3.3 6.9 7.0 3.3 9.0 8.1 8.9 6.7 2.9 7.8 27.7 20.8 0.0 5.5 15.7 12.1 5.3 3.9 7.5 9.7 3.8 PARK7 "DJ-1, DJ1, GATD2" ENSG00000116288 "Parkinsonism associated deglycase" Q99497 1 7954291-7985505 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Autophagy, DNA damage, DNA repair, Fertilization, Inflammatory response, Stress response" "Chaperone, Hydrolase, Protease, RNA-binding" "Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004190, CAB005870" Supported Supported Nucleoplasm,Cytosol NA NA 69000000 "Nucleoplasm, Cytosol" "CAB005870: AB_444361, HPA004190: AB_1079566" "unprognostic (6.88e-3)" "unprognostic (7.50e-2)" "unprognostic (3.48e-2)" "unprognostic (1.16e-2)" "unprognostic (4.08e-2)" "unprognostic (5.68e-2)" "unprognostic (7.45e-2)" "unprognostic (9.63e-2)" "unprognostic (2.01e-1)" "unprognostic (1.66e-2)" "unprognostic (1.12e-1)" "unprognostic (2.02e-1)" "unprognostic (1.96e-3)" "unprognostic (8.17e-2)" "unprognostic (1.32e-1)" "unprognostic (1.30e-1)" "unprognostic (7.43e-2)" 44.6 67.9 69.3 38.1 64.9 33.7 45.4 57.2 62.7 34.0 36.4 33.4 43.2 27.3 35.8 56.6 40.9 39.0 41.6 71.7 56.9 57.2 60.5 77.1 28.6 46.1 61.6 57.2 45.9 60.4 66.6 48.4 44.6 41.2 44.7 39.5 38.6 46.5 39.4 128.7 19.8 27.5 48.1 52.5 37.5 37.2 38.2 32.2 38.8 71.6 43.3 46.5 41.3 43.4 49.5 141.8 38.8 61.0 52.8 87.2 90.6 68.3 61.6 61.4 70.6 66.1 63.6 30.1 63.7 59.8 62.8 50.7 56.2 75.0 84.8 72.1 68.4 44.1 49.2 66.2 85.2 81.6 75.5 71.6 91.2 92.1 83.3 57.1 87.0 56.2 59.9 36.4 63.9 76.9 49.2 65.7 44.7 88.5 63.2 87.0 64.1 60.5 110.6 50.1 84.9 63.7 46.6 82.5 116.3 98.4 35.2 71.9 60.4 63.7 98.5 99.5 53.8 54.9 64.8 62.3 57.9 46.2 53.4 69.8 61.4 98.5 120.8 76.4 133.2 82.0 22.7 61.0 38.8 52.6 55.4 49.7 49.5 52.7 62.2 73.9 38.6 45.6 52.4 21.0 52.8 44.1 141.8 87.2 90.6 69.3 64.9 57.2 62.7 56.9 57.2 61.6 57.2 41.2 32.2 122.1 136.9 226.3 328.5 185.6 175.5 422.7 221.7 227.5 176.3 235.5 74.6 504.6 721.2 419.3 26.4 207.3 136.6 46.7 416.0 502.3 279.0 413.5 199.9 332.4 385.8 176.4 228.6 156.5 174.9 43.1 331.6 265.8 340.8 806.1 224.5 530.4 359.6 213.9 356.1 742.4 177.0 271.7 346.0 212.8 299.8 125.7 392.7 243.9 261.6 388.0 PARM1 "Cipar1, DKFZP564O0823, WSC4" ENSG00000169116 "Prostate androgen-regulated mucin-like protein 1" Q6UWI2 4 74933095-75050115 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 143.3;Mucus-secreting cells: 90.2;Paneth cells: 120.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 14 "memory B-cell: 10.1;myeloid DC: 4.6;naive B-cell: 6.4" "Group enriched" "Detected in many" 15 "B-cells: 10.1;dendritic cells: 4.6" "Cell line enhanced" "Detected in many" "ASC diff: 24.5;Karpas-707: 23.9;U-266/70: 26.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038236 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles, Cytosol" "HPA038236: AB_10675789" "unprognostic (2.57e-2)" "unprognostic (5.20e-2)" "unprognostic (1.26e-3)" "unprognostic (8.61e-2)" "unprognostic (1.44e-1)" "unprognostic (8.49e-3)" "unprognostic (3.08e-1)" "unprognostic (2.42e-2)" "unprognostic (2.73e-1)" "unprognostic (9.74e-2)" "unprognostic (9.44e-2)" "unprognostic (3.51e-2)" "unprognostic (5.21e-2)" "unprognostic (1.96e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (2.23e-1)" 23.1 21.5 5.7 25.0 15.2 0.3 16.4 1.3 29.4 18.7 36.0 1.2 28.5 2.8 20.3 18.0 5.8 12.2 11.5 39.8 6.9 13.0 27.5 1.1 15.1 10.2 3.3 10.3 11.9 29.2 23.2 32.1 16.1 4.8 35.0 45.8 70.2 25.6 27.6 7.4 6.2 8.3 29.3 2.4 9.7 5.5 11.2 1.2 6.3 79.8 3.7 8.0 24.9 19.7 10.1 4.6 0.1 0.5 0.0 0.0 0.7 0.5 1.0 0.9 0.0 24.5 0.1 0.1 0.0 0.1 0.0 0.0 2.0 0.2 0.0 0.1 0.0 0.0 0.0 8.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 4.1 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.0 23.9 0.4 0.2 2.6 0.1 2.3 0.0 1.4 0.0 2.2 6.0 0.1 4.9 1.5 0.0 0.1 0.1 0.0 1.0 0.0 0.0 0.0 1.4 1.6 0.1 2.1 26.8 2.5 6.8 2.5 0.0 0.4 0.0 0.1 0.0 0.0 0.5 0.0 10.1 0.0 0.0 4.6 6.4 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.7 5.7 15.2 1.3 29.4 6.9 13.0 3.3 10.3 4.8 1.2 14.9 63.1 13.4 17.1 2.9 7.9 143.3 30.6 1.4 11.4 0.0 0.0 0.3 3.3 0.1 6.8 3.8 80.6 23.3 43.2 0.6 15.4 43.3 1.1 0.0 1.4 0.0 19.1 3.1 0.0 20.6 33.9 7.2 8.5 1.0 90.2 0.0 26.9 120.2 70.0 27.6 1.0 45.3 52.3 1.7 3.3 1.6 0.7 1.5 46.2 8.4 PARP1 "ADPRT, PARP, PPOL" ENSG00000143799 "Poly(ADP-ribose) polymerase 1" P09874 1 226360691-226408079 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "DNA-binding, Glycosyltransferase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cytotrophoblasts: 400.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000147, CAB003839, CAB003840, HPA045168, CAB075726, CAB075727" Supported Supported Enhanced Nucleoplasm,Nucleoli NA NA 39000 Nucleoplasm Nucleoli "CAB000147: AB_430876, CAB003839: AB_365493, CAB003840: AB_562187, CAB075726: AB_2665732, CAB075727: AB_2665733, HPA045168: AB_2679240" "unprognostic (2.02e-1)" "unprognostic (9.40e-2)" "unprognostic (7.44e-3)" "unprognostic (1.32e-1)" "unprognostic (4.29e-1)" "unprognostic (9.22e-2)" "prognostic unfavorable (3.40e-4)" "unprognostic (2.20e-1)" "unprognostic (3.62e-2)" "unprognostic (1.39e-1)" "unprognostic (2.13e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (1.35e-5)" "unprognostic (2.38e-2)" "unprognostic (1.82e-1)" "unprognostic (3.14e-2)" "unprognostic (2.64e-1)" 17.3 16.6 31.2 35.7 31.2 14.3 15.3 21.1 29.2 14.3 21.8 37.4 10.3 15.0 18.2 13.0 18.1 15.0 10.8 24.2 27.8 21.9 13.4 24.8 14.1 56.3 40.7 21.8 14.6 28.1 62.6 22.9 28.7 30.4 22.0 19.2 16.3 17.0 24.7 47.3 11.7 19.6 25.5 49.1 32.7 15.9 22.5 34.8 29.5 14.5 16.5 70.2 19.9 13.7 53.0 16.5 9.0 17.5 11.1 21.8 11.5 28.9 15.5 43.2 30.6 11.3 9.4 24.6 19.2 17.1 26.1 21.5 24.7 14.2 84.4 28.7 11.6 11.5 21.8 59.4 18.8 23.1 35.4 82.9 32.6 20.7 16.1 6.8 54.2 15.8 9.2 7.5 21.0 14.9 7.3 20.3 19.6 51.9 43.1 13.5 13.8 17.3 19.6 79.5 40.9 30.8 52.5 74.0 78.0 12.2 20.7 43.5 38.1 25.0 28.0 15.7 31.8 23.5 34.0 15.4 13.9 23.0 18.7 35.9 17.6 29.4 72.5 11.6 18.3 31.1 9.0 6.7 6.9 18.3 11.3 21.6 46.8 19.4 18.0 14.3 53.0 15.2 16.4 1.0 11.1 17.5 16.5 21.8 11.5 31.2 31.2 21.1 28.4 27.8 21.9 40.7 21.8 30.4 34.8 50.6 68.3 130.2 75.6 64.2 94.4 106.4 43.3 75.0 97.8 54.1 133.5 400.4 61.3 77.0 28.3 54.0 16.8 23.3 91.9 75.6 55.5 70.8 116.9 65.7 117.1 85.8 72.1 31.9 42.2 16.3 37.2 45.7 59.1 93.8 46.5 78.6 54.3 24.6 32.9 36.1 102.8 45.3 47.4 92.8 211.4 42.0 115.1 74.0 57.9 42.9 PARP11 C12orf6 ENSG00000111224 "Poly(ADP-ribose) polymerase family member 11" Q9NR21 12 3791047-3873448 "Enzymes, Predicted intracellular proteins" "Differentiation, mRNA transport, Protein transport, Spermatogenesis, Translocation, Transport" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 60.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026895 Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA026895: AB_1854980" "unprognostic (9.58e-2)" "unprognostic (1.77e-1)" "unprognostic (1.37e-1)" "unprognostic (1.80e-1)" "unprognostic (1.88e-1)" "unprognostic (4.12e-2)" "unprognostic (6.14e-2)" "unprognostic (1.49e-2)" "unprognostic (2.53e-1)" "unprognostic (2.61e-1)" "unprognostic (3.58e-2)" "unprognostic (2.32e-2)" "unprognostic (2.50e-1)" "unprognostic (2.11e-1)" "unprognostic (7.52e-2)" "unprognostic (3.81e-2)" "unprognostic (2.87e-2)" 7.1 14.5 11.2 8.6 9.2 3.7 8.3 11.0 9.1 6.4 5.4 5.6 4.8 4.9 10.2 7.5 5.0 6.3 5.6 5.1 6.1 5.7 5.7 5.7 6.3 12.8 5.0 5.7 13.1 6.6 10.0 10.4 4.1 7.6 12.0 5.7 7.2 6.6 6.0 4.1 3.9 6.5 7.2 6.1 9.2 4.2 12.8 5.6 16.9 12.3 2.7 12.1 8.3 5.8 10.7 10.2 18.3 10.2 8.2 12.5 7.1 2.3 1.9 12.8 2.0 4.1 6.5 3.6 2.8 4.8 5.0 5.0 7.3 1.8 7.0 1.8 6.2 6.3 2.0 4.2 4.2 8.1 14.1 4.2 10.0 0.0 5.4 4.6 6.7 3.8 5.2 3.3 3.9 11.1 0.0 3.7 13.7 2.6 5.7 7.0 3.3 3.5 2.6 4.7 2.4 0.3 7.1 8.7 1.6 2.3 5.3 0.8 2.9 2.8 2.4 3.6 14.6 0.4 6.1 7.2 4.3 4.3 6.6 3.8 2.7 5.9 9.8 4.1 3.7 1.1 18.3 10.2 10.2 9.2 8.5 12.5 10.7 10.2 6.7 10.2 10.1 11.7 9.4 10.2 8.2 6.4 8.9 4.3 7.1 11.2 9.2 11.0 9.1 6.1 5.7 5.0 5.7 7.6 5.6 8.9 7.4 11.8 4.3 1.6 11.1 3.2 2.5 6.7 2.3 1.8 2.0 3.0 0.0 3.1 60.8 4.5 2.1 0.0 2.6 1.5 4.6 8.0 14.9 3.4 6.2 3.2 3.5 8.0 9.1 25.5 9.8 6.9 1.7 3.6 3.7 6.2 2.9 4.2 8.1 3.3 6.9 6.5 5.1 7.5 8.7 1.6 2.2 10.2 4.3 3.4 PARP12 "FLJ22693, PARP-12, ZC3H1, ZC3HDC1" ENSG00000059378 "Poly(ADP-ribose) polymerase family member 12" Q9H0J9 7 140023744-140063721 "Enzymes, Plasma proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 12.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA003584, HPA063872" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA003584: AB_1079568, HPA063872: AB_2685139" "unprognostic (1.46e-3)" "unprognostic (2.93e-2)" "unprognostic (1.73e-1)" "unprognostic (2.71e-2)" "unprognostic (6.74e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (1.63e-4)" "unprognostic (2.30e-2)" "unprognostic (1.15e-2)" "unprognostic (4.86e-3)" "unprognostic (7.51e-3)" "unprognostic (2.68e-1)" "prognostic unfavorable (4.12e-7)" "unprognostic (3.31e-2)" "unprognostic (2.76e-1)" "unprognostic (1.75e-2)" "unprognostic (6.01e-2)" 3.1 1.8 1.0 3.7 0.9 6.1 2.5 0.1 0.7 2.1 2.2 4.2 2.8 4.2 2.1 2.5 3.1 1.7 1.0 1.0 3.1 3.0 5.2 3.8 1.0 3.2 2.7 2.5 3.3 3.4 2.8 3.9 4.3 1.4 0.9 8.6 4.4 1.5 1.3 6.0 2.3 5.7 3.2 2.7 1.9 3.1 1.0 1.3 3.4 2.0 2.3 3.3 2.4 3.7 2.3 0.0 0.4 1.1 0.5 3.9 0.6 0.5 4.7 8.0 2.7 3.5 1.7 2.8 1.1 4.8 3.8 1.5 4.4 1.3 4.7 4.7 1.4 1.4 1.8 2.1 0.4 1.4 1.6 2.6 2.0 4.3 3.3 5.0 2.7 4.1 2.3 0.0 2.9 4.5 12.1 0.2 1.8 7.0 2.0 0.0 0.0 2.1 2.3 1.4 0.0 2.4 1.1 3.5 0.6 0.6 0.9 9.6 1.5 2.2 0.5 3.5 0.1 0.1 0.4 0.9 6.0 0.8 0.7 2.0 2.2 2.9 1.7 1.1 0.3 1.9 2.9 1.3 1.0 0.6 1.9 3.4 2.3 1.9 0.7 3.3 2.4 6.0 11.7 6.0 6.5 5.8 3.0 4.2 10.2 5.3 5.7 10.4 2.0 4.5 1.7 10.9 0.6 11.7 32.5 0.0 22.8 16.4 5.3 10.8 19.6 9.6 21.5 0.0 23.1 6.2 10.2 0.4 6.6 13.9 6.8 12.6 13.2 2.6 27.2 25.9 6.7 5.6 2.2 0.0 5.9 28.7 11.9 8.7 1.7 8.7 8.0 9.2 PARP2 ADPRTL2 ENSG00000129484 "Poly(ADP-ribose) polymerase 2" Q9UGN5 14 20343582-20357905 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Glycosyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052003 Approved Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA052003: AB_2681689" "unprognostic (3.93e-1)" "unprognostic (7.92e-2)" "unprognostic (4.12e-1)" "unprognostic (1.24e-1)" "unprognostic (3.40e-2)" "unprognostic (7.30e-2)" "prognostic unfavorable (6.48e-4)" "unprognostic (1.97e-2)" "unprognostic (4.43e-2)" "unprognostic (9.35e-3)" "unprognostic (1.44e-2)" "unprognostic (1.42e-2)" "unprognostic (3.37e-3)" "unprognostic (2.83e-1)" "unprognostic (9.19e-2)" "unprognostic (1.91e-1)" "unprognostic (2.89e-2)" 11.5 16.6 23.6 8.9 28.5 20.9 15.2 36.7 31.3 12.0 11.7 16.8 9.3 11.2 18.8 16.8 10.7 14.7 8.9 14.0 19.2 17.8 14.0 15.0 12.0 11.8 16.6 30.8 20.2 11.8 11.6 14.6 11.3 22.1 11.3 12.9 10.8 10.5 12.9 25.9 15.1 10.8 14.6 13.9 11.4 11.6 20.4 17.4 6.0 11.7 13.9 15.2 9.3 10.4 6.7 5.6 1.8 5.0 6.9 12.3 4.9 20.3 14.9 23.0 17.2 7.6 7.3 16.7 22.7 12.4 28.9 35.8 14.1 19.5 15.1 10.3 7.1 25.8 19.2 30.6 10.4 34.2 12.1 14.9 13.8 18.1 23.5 6.8 28.6 7.9 5.0 8.9 18.0 19.9 8.0 14.8 18.5 14.6 20.7 19.8 12.6 14.6 12.3 12.6 23.2 23.3 18.3 31.3 9.8 11.5 10.6 16.0 11.0 25.3 14.1 6.6 15.3 13.0 9.7 10.1 17.6 26.7 12.1 18.4 19.4 24.7 20.1 7.3 12.7 19.5 1.8 5.0 0.5 9.5 4.5 12.3 6.7 8.9 8.3 5.4 4.6 9.6 9.3 0.1 6.9 2.5 5.6 5.2 4.9 23.6 28.5 36.7 31.3 19.2 17.8 16.6 30.8 22.1 17.4 23.8 6.2 10.4 9.3 5.8 26.8 12.3 5.1 36.1 21.6 7.0 11.8 19.1 6.6 10.5 7.3 10.0 3.4 23.3 7.7 17.9 8.4 3.7 8.1 9.6 10.2 28.6 4.6 6.2 4.9 7.3 10.6 6.4 8.5 4.6 4.2 21.9 8.0 5.5 15.9 5.6 21.7 6.5 9.5 17.7 33.3 4.3 12.5 4.4 5.2 4.6 PARP3 "ADPRT3, ADPRTL3, hPARP-3, IRT1, pADPRT-3" ENSG00000041880 "Poly(ADP-ribose) polymerase family member 3" Q9Y6F1 3 51942345-51948867 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Glycosyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020984, HPA067657" Supported Supported "Nucleoplasm,Nuclear bodies" Yes No "Nucleoplasm, Nuclear bodies" "HPA020984: , HPA067657: AB_2685881" "prognostic favorable (6.39e-5)" "unprognostic (1.25e-1)" "unprognostic (1.54e-2)" "unprognostic (2.85e-2)" "unprognostic (7.31e-2)" "unprognostic (1.56e-1)" "unprognostic (4.13e-1)" "unprognostic (3.53e-2)" "unprognostic (2.26e-1)" "unprognostic (2.01e-1)" "unprognostic (7.44e-3)" "unprognostic (4.30e-1)" "prognostic favorable (1.25e-8)" "unprognostic (5.63e-2)" "unprognostic (1.77e-1)" "unprognostic (1.40e-2)" "unprognostic (4.65e-3)" 15.2 29.2 11.2 14.6 17.1 2.8 13.6 5.7 18.8 7.5 17.3 10.6 14.3 26.9 10.3 14.1 10.8 12.1 16.2 12.4 11.6 12.3 17.3 22.3 13.3 9.7 12.0 14.2 8.2 3.9 34.2 9.8 6.2 12.2 12.1 10.7 13.2 14.0 18.1 14.6 6.1 26.3 18.9 8.7 12.8 15.8 4.5 10.2 2.9 17.0 9.6 10.3 15.1 8.9 9.0 2.9 1.7 4.1 6.6 4.9 2.3 5.9 3.3 0.9 9.0 8.7 16.5 2.5 9.8 15.8 12.1 13.6 1.9 15.8 8.1 2.6 16.1 7.0 0.9 2.5 8.8 5.9 19.9 0.6 4.1 6.7 6.3 9.4 2.5 5.7 13.0 5.5 7.7 5.2 18.6 6.0 5.1 1.7 7.7 9.3 1.5 2.2 6.3 1.2 2.0 9.5 3.5 1.5 7.0 7.4 6.5 1.0 3.4 9.9 2.8 5.2 0.7 3.4 2.8 13.6 24.4 5.1 3.6 5.9 11.8 14.3 3.5 15.7 7.4 7.6 0.0 2.6 1.7 3.6 4.1 3.4 9.0 4.2 2.8 2.9 4.3 4.9 4.9 0.1 6.6 2.0 1.2 4.3 2.3 11.2 17.1 5.7 18.8 11.6 12.3 12.0 14.2 12.2 10.2 6.0 10.6 10.1 10.0 2.4 1.7 5.9 12.7 9.4 7.9 0.0 0.0 0.4 6.6 8.8 5.9 3.0 15.8 0.0 5.7 0.3 4.5 3.4 4.6 8.5 3.4 0.0 2.9 1.8 2.2 8.4 4.4 2.9 6.8 6.4 11.0 4.0 7.9 3.5 1.4 16.1 2.1 6.5 6.2 3.2 1.8 1.3 0.5 5.3 11.2 6.4 PARP8 "FLJ21308, pART16" ENSG00000151883 "Poly(ADP-ribose) polymerase family member 8" Q8N3A8 5 50665899-50846522 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "T-cells: 90.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 42.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049183 Approved Approved "Nucleoplasm,Midbody ring,Cytosol" Yes No Nucleoplasm "Midbody ring, Cytosol" "HPA049183: AB_2680667" "unprognostic (1.22e-2)" "unprognostic (2.53e-1)" "unprognostic (1.77e-1)" "unprognostic (1.05e-1)" "unprognostic (2.12e-1)" "unprognostic (6.33e-2)" "unprognostic (8.86e-3)" "unprognostic (7.27e-2)" "unprognostic (1.86e-2)" "unprognostic (8.96e-2)" "unprognostic (2.85e-1)" "unprognostic (6.81e-2)" "unprognostic (9.63e-2)" "unprognostic (2.84e-2)" "unprognostic (4.42e-2)" "unprognostic (4.23e-2)" "prognostic favorable (1.12e-4)" 6.2 7.8 8.8 17.1 9.5 33.5 5.3 2.4 18.7 5.6 5.5 3.3 0.6 6.8 5.2 5.4 5.2 7.4 12.3 3.6 12.8 8.0 5.8 4.2 10.9 18.2 4.9 11.0 5.9 7.1 9.8 14.4 5.6 5.4 6.1 4.3 4.1 7.6 4.2 1.7 4.2 14.2 5.4 7.0 20.1 10.2 6.4 2.8 9.9 21.9 1.1 12.3 8.8 7.0 7.1 3.9 13.1 5.9 15.5 32.0 9.5 11.6 0.0 5.4 8.6 1.5 2.6 8.6 1.9 7.0 1.9 5.5 0.3 15.4 6.9 8.2 0.2 19.8 5.8 0.9 5.8 4.5 9.7 7.4 5.1 4.7 0.4 2.8 11.9 0.1 3.3 4.9 3.8 2.7 11.6 0.1 10.9 0.7 4.2 2.6 3.8 14.2 15.0 5.8 0.2 2.8 7.2 11.4 7.9 3.5 5.8 6.0 9.3 6.2 10.2 1.6 8.3 0.4 42.0 0.0 0.4 7.3 0.5 5.7 3.1 0.1 13.4 6.5 3.3 7.9 10.3 5.9 13.1 20.6 1.6 32.0 6.0 16.1 23.0 3.9 7.1 10.0 16.7 12.3 15.5 1.1 1.8 9.5 9.5 8.8 9.5 2.4 18.7 12.8 8.0 4.9 11.0 5.4 2.8 29.8 22.6 12.3 4.8 7.1 13.4 4.5 12.7 21.4 21.6 21.0 0.0 17.5 6.6 11.2 19.7 4.5 6.9 0.0 8.8 5.9 9.1 8.6 13.9 3.6 12.9 6.4 14.5 8.6 28.5 11.4 1.1 17.1 8.5 13.6 3.6 0.5 14.3 7.6 2.8 3.7 2.1 6.5 6.9 5.1 5.5 3.4 20.7 90.6 6.5 13.5 PARP9 "BAL, BAL1" ENSG00000138496 "Poly(ADP-ribose) polymerase family member 9" Q8IXQ6 3 122527924-122564577 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, DNA damage, DNA repair, Immunity, Innate immunity" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 35.1;BJ hTERT+ SV40 Large T+ RasG12V: 41.9;SK-MEL-30: 32.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066708 Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "HPA066708: AB_2685707" "unprognostic (3.06e-2)" "unprognostic (4.80e-2)" "unprognostic (1.55e-3)" "unprognostic (6.70e-3)" "unprognostic (1.11e-1)" "unprognostic (6.38e-2)" "unprognostic (4.73e-3)" "unprognostic (3.39e-3)" "unprognostic (1.31e-1)" "prognostic favorable (6.65e-4)" "unprognostic (1.00e-3)" "unprognostic (5.63e-3)" "unprognostic (1.56e-3)" "unprognostic (3.06e-2)" "unprognostic (3.70e-2)" "unprognostic (9.65e-3)" "unprognostic (1.56e-2)" 27.1 20.2 8.7 17.2 12.4 9.1 13.8 2.9 13.9 13.1 13.1 9.9 7.4 10.4 23.3 10.1 15.6 12.3 14.9 8.5 7.4 6.0 17.8 38.6 18.9 17.5 8.5 6.0 12.1 14.4 16.0 20.3 11.9 10.3 15.1 10.1 11.5 19.1 6.6 8.6 5.7 21.2 14.8 16.3 27.3 11.1 5.4 10.3 21.8 17.5 9.0 19.1 13.7 9.8 7.3 11.9 38.2 18.0 13.0 10.6 9.1 8.0 2.7 1.0 0.7 6.3 13.0 0.9 2.7 14.7 35.1 41.9 4.2 8.9 1.8 6.0 5.4 22.1 8.9 2.3 4.8 7.3 14.0 1.6 8.7 2.8 2.2 6.7 2.8 5.8 10.6 4.7 5.0 1.2 7.0 7.5 5.6 0.8 7.5 1.4 3.5 8.9 3.5 0.4 1.6 7.6 9.5 9.9 0.6 13.4 4.6 0.6 2.4 7.2 1.2 32.4 0.5 3.8 3.1 4.5 1.5 4.4 0.3 1.6 4.7 2.4 3.3 5.2 3.1 2.7 14.4 12.7 15.3 9.2 17.7 8.6 7.3 9.8 10.3 11.9 5.0 7.5 9.1 38.2 13.0 18.0 1.4 10.6 9.1 8.7 12.4 2.9 13.9 7.4 6.0 8.5 6.0 10.3 10.3 38.7 36.9 16.7 9.4 6.4 0.8 5.2 10.2 61.6 44.3 19.2 0.0 4.3 1.7 24.9 1.3 19.0 15.3 0.0 34.9 16.2 11.4 10.4 9.3 43.1 36.1 0.0 10.3 21.5 31.3 2.6 17.0 29.4 6.8 32.5 9.7 14.7 28.4 7.2 22.6 18.9 0.8 19.4 9.6 1.0 0.9 5.8 1.4 12.7 6.6 15.5 PARPBP "C12orf48, FLJ20641, PARI" ENSG00000185480 "PARP1 binding protein" Q9NWS1 12 102120185-102197520 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.6" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 23.3;Spermatocytes: 14.6;Spermatogonia: 13.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" HPA039677 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA039677: AB_10673426" "unprognostic (7.84e-3)" "unprognostic (1.34e-2)" "unprognostic (4.54e-3)" "unprognostic (3.03e-2)" "unprognostic (1.84e-1)" "unprognostic (3.03e-1)" "unprognostic (1.30e-5)" "unprognostic (2.52e-3)" "prognostic unfavorable (3.17e-4)" "unprognostic (2.38e-1)" "unprognostic (3.95e-3)" "unprognostic (2.83e-1)" "unprognostic (5.61e-8)" "unprognostic (3.50e-3)" "unprognostic (2.34e-1)" "unprognostic (9.16e-3)" "unprognostic (6.14e-2)" 1.8 1.5 1.7 6.3 1.9 11.0 2.4 2.0 2.8 1.8 4.0 1.0 1.4 3.3 2.4 1.9 6.7 0.9 1.4 2.4 1.6 4.8 3.1 1.0 1.8 5.4 1.8 2.2 1.8 1.1 0.3 1.0 4.1 4.4 2.9 5.5 0.4 2.2 1.1 1.2 2.6 3.7 2.2 1.7 5.6 2.4 14.5 0.4 26.6 1.4 5.9 6.7 3.3 2.7 3.0 1.9 6.2 1.5 1.2 4.5 1.9 7.4 15.9 13.4 7.6 2.2 2.0 9.4 11.5 6.3 18.4 16.4 8.2 5.6 13.8 6.6 4.1 9.3 8.1 21.8 6.5 19.5 14.1 13.0 17.5 9.5 7.4 0.6 18.5 5.3 1.8 1.4 12.8 7.8 4.6 12.0 10.5 16.2 8.5 11.8 5.8 16.4 17.0 17.8 9.8 14.7 11.1 21.9 8.9 5.7 11.6 9.1 8.7 7.6 9.3 6.6 14.7 15.1 6.6 4.6 9.4 9.2 11.7 14.0 6.6 13.1 12.3 6.5 18.8 12.3 6.2 1.2 2.4 1.6 1.5 0.4 3.0 2.5 2.2 1.9 1.5 1.4 1.6 0.0 1.2 1.2 1.7 4.5 1.9 1.7 1.9 2.0 2.8 1.6 4.8 1.8 2.2 4.4 0.4 0.0 0.0 5.2 1.6 3.3 1.7 0.4 0.0 1.4 2.3 1.8 0.0 6.2 5.0 1.0 1.5 1.9 0.9 23.3 1.1 11.1 3.6 0.5 5.7 0.0 5.5 3.2 1.7 2.5 4.5 1.6 1.1 3.2 0.0 2.8 1.6 0.2 0.8 0.0 0.4 1.1 0.7 0.0 0.5 14.6 13.9 1.4 3.0 3.2 5.0 1.0 PATZ1 "dJ400N23, MAZR, PATZ, RIAZ, ZBTB19, ZNF278, ZSG" ENSG00000100105 "POZ/BTB and AT hook containing zinc finger 1" Q9HBE1 22 31325804-31346232 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047893, HPA048315" Approved Supported Nucleoplasm No No Nucleoplasm "HPA047893: AB_2680201, HPA048315: AB_2680353" "unprognostic (3.25e-1)" "unprognostic (8.72e-2)" "unprognostic (1.77e-1)" "unprognostic (2.88e-3)" "prognostic favorable (1.06e-4)" "unprognostic (1.77e-1)" "unprognostic (8.34e-3)" "prognostic favorable (8.71e-5)" "unprognostic (1.14e-1)" "unprognostic (1.41e-2)" "unprognostic (1.99e-3)" "unprognostic (1.76e-1)" "prognostic favorable (8.54e-8)" "unprognostic (9.22e-2)" "unprognostic (2.15e-1)" "unprognostic (1.51e-1)" "prognostic favorable (7.79e-6)" 9.6 11.2 13.0 12.7 12.9 12.9 12.1 16.8 16.0 14.2 13.0 21.7 21.8 9.4 19.6 14.4 7.3 22.2 14.1 10.4 14.0 11.8 11.4 11.0 17.4 30.3 15.3 13.4 27.7 16.6 25.4 11.0 8.9 13.6 14.0 6.8 17.5 17.5 17.8 9.1 7.5 11.9 15.6 12.5 14.3 10.5 13.0 15.5 38.5 18.9 8.2 13.8 17.4 14.2 4.7 7.1 4.8 1.8 3.5 5.7 2.0 8.4 10.6 21.8 12.8 5.8 5.3 11.4 2.6 6.6 10.6 9.7 7.4 8.2 18.1 9.4 4.8 3.7 6.6 14.7 7.9 5.4 10.5 13.5 7.6 7.4 15.1 9.5 25.5 10.3 8.3 9.6 6.7 7.5 8.4 8.3 8.9 3.2 7.3 6.7 25.8 16.3 17.5 14.6 15.5 12.6 27.6 9.3 5.9 7.1 18.0 28.5 22.9 6.5 7.9 14.2 7.5 15.7 16.3 5.8 7.1 13.4 4.4 8.7 9.5 6.2 16.5 3.0 3.3 12.1 0.0 1.8 4.8 3.4 1.1 3.5 4.7 2.6 4.4 2.5 3.8 5.7 4.1 0.8 3.5 0.6 7.1 3.7 2.0 13.0 12.9 16.8 16.0 14.0 11.8 15.3 13.4 13.6 15.5 3.0 12.2 2.9 5.4 1.4 15.6 12.2 10.2 10.7 10.3 19.2 7.9 4.3 16.6 11.3 0.4 4.5 2.9 0.0 5.2 1.4 4.9 8.2 5.8 11.3 7.6 20.6 19.7 9.2 6.4 1.3 8.9 5.0 3.3 3.6 9.1 13.3 7.4 3.5 8.1 6.8 14.2 6.5 3.3 0.7 7.2 1.4 0.7 7.4 10.8 5.6 PAX2 ENSG00000075891 "Paired box 2" Q02962 10 100735603-100829941 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ductus deferens: 30.5;epididymis: 93.7;kidney: 43.1" "Group enriched" "Detected in some" 5 "Collecting duct cells: 137.9;Distal tubular cells: 41.4" "Group enriched" "Detected in some" 19 "endometrial cancer: 6.7;ovarian cancer: 7.0;renal cancer: 14.5" "Group enriched" "Detected in some" 6 "cerebellum: 1.0;pons and medulla: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "AN3-CA: 14.6;EFO-21: 20.2;RPTEC TERT1: 14.5" "Group enriched" "Detected in some" 9 "cerebellum: 1.5;pons and medulla: 3.5" "Region enhanced" "Detected in single" "pons and medulla: 8.1" "CAB013024, HPA047704, HPA070751" Enhanced Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "CAB013024: AB_2533990, HPA047704: AB_2636861, HPA070751: AB_2686305" "unprognostic (3.98e-2)" "unprognostic (9.55e-2)" "unprognostic (1.48e-2)" "prognostic unfavorable (4.56e-4)" "unprognostic (4.85e-2)" "unprognostic (5.54e-1)" "unprognostic (1.91e-1)" "unprognostic (2.05e-1)" "unprognostic (1.24e-2)" "unprognostic (6.59e-2)" "unprognostic (9.18e-2)" "unprognostic (3.30e-3)" "unprognostic (3.67e-1)" "unprognostic (1.97e-1)" "unprognostic (6.34e-2)" "unprognostic (8.26e-2)" 0.1 0.1 0.2 0.0 0.1 0.0 0.1 1.0 0.1 3.1 0.1 0.0 30.5 0.0 1.5 93.7 0.1 9.1 0.0 0.1 0.1 0.1 43.1 0.1 0.1 0.0 0.2 0.0 1.5 0.3 0.6 0.7 0.0 1.8 0.8 0.0 0.5 0.1 19.4 0.1 0.1 0.1 0.0 1.7 0.1 0.1 2.4 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 20.2 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 14.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.0 0.1 0.1 0.1 0.2 0.0 1.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 4.5 0.0 0.0 0.0 137.9 0.0 0.0 41.4 0.0 8.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.3 0.2 0.0 0.0 18.8 0.4 0.0 0.0 1.1 0.9 0.0 0.0 0.0 0.0 0.0 PAX3 "HUP2, WS1" ENSG00000135903 "Paired box 3" P23760 2 222199888-222298996 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Myogenesis, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Deafness, Disease mutation, Proto-oncogene, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 19.1;retina: 39.6" "Group enriched" "Detected in some" 8 "Early spermatids: 10.9;Late spermatids: 19.5;Melanocytes: 32.1" "Cancer enriched" "Detected in some" 24 "melanoma: 20.3" "Group enriched" "Detected in some" 6 "cerebellum: 19.1;pons and medulla: 7.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 7.6;BJ hTERT+ SV40 Large T+ RasG12V: 9.1;HBF TERT88: 6.7;RH-30: 13.1;SK-MEL-30: 23.1" "Group enriched" "Detected in some" 7 "cerebellum: 3.9;midbrain: 1.6;pons and medulla: 1.4" "Group enriched" "Detected in many" 5 "cerebellum: 10.0;midbrain: 11.7;pons and medulla: 3.5" "HPA063659, HPA069000" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063659: AB_2685080, HPA069000: AB_2686067" "unprognostic (2.57e-2)" "unprognostic (1.48e-2)" "unprognostic (1.27e-2)" "unprognostic (1.65e-1)" "unprognostic (2.61e-2)" "unprognostic (3.70e-1)" "unprognostic (6.18e-2)" "unprognostic (1.41e-1)" "unprognostic (2.26e-1)" "unprognostic (9.70e-2)" 0.8 0.1 0.0 0.1 0.8 0.1 2.9 19.1 0.2 0.3 0.1 0.1 0.3 0.1 0.2 0.1 0.1 0.1 0.1 0.3 0.0 0.2 0.1 0.1 0.1 0.2 2.2 0.0 0.1 0.2 0.1 0.0 0.1 7.8 0.4 0.1 39.6 7.9 0.2 8.6 7.9 0.1 0.1 4.2 0.1 0.2 2.9 0.8 0.0 0.1 3.9 0.5 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 5.2 5.1 7.6 9.1 0.0 0.5 0.0 0.0 3.5 0.1 0.0 0.0 0.0 6.7 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 5.4 0.1 0.0 0.0 0.0 13.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 23.1 5.9 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 2.9 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.8 19.1 0.1 0.0 0.2 2.2 0.0 7.8 0.8 0.0 0.0 0.0 0.0 2.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.9 0.0 32.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.3 0.4 0.0 0.0 0.0 0.0 PAX5 BSAP ENSG00000196092 "Paired box 5" Q02548 9 36833275-37034185 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 21.6;lymphoid tissue: 33.4" "Cell type enriched" "Detected in some" 27 "B-cells: 57.6" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "midbrain: 1.6" "Group enriched" "Detected in some" 209 "memory B-cell: 20.1;naive B-cell: 21.6" "Lineage enriched" "Detected in single" 216 "B-cells: 21.6" "Group enriched" "Detected in some" 8 "Daudi: 21.5;REH: 62.5;U-698: 28.2" "Region enriched" "Detected in single" 11 "midbrain: 4.7" "Group enriched" "Detected in some" 6 "hippocampal formation: 3.8;midbrain: 10.8;pons and medulla: 3.2" "CAB026269, CAB026869, HPA056394, HPA068498" Enhanced Supported Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "CAB026269: , CAB026869: , HPA056394: AB_2683116, HPA068498: AB_2685997" "unprognostic (4.69e-4)" "unprognostic (3.83e-1)" "unprognostic (9.13e-2)" "unprognostic (1.42e-1)" "unprognostic (2.65e-2)" "unprognostic (1.15e-1)" "unprognostic (2.09e-2)" "unprognostic (2.95e-2)" "unprognostic (2.48e-1)" "unprognostic (2.00e-2)" "unprognostic (1.03e-1)" "unprognostic (2.46e-2)" "unprognostic (1.11e-3)" "unprognostic (3.15e-1)" "unprognostic (8.96e-2)" "unprognostic (6.03e-2)" "unprognostic (1.01e-1)" 0.4 0.2 0.2 33.4 0.2 5.5 0.2 0.2 0.2 0.2 0.7 0.1 0.0 0.0 0.2 0.0 0.7 0.2 0.4 0.2 0.2 0.3 0.5 0.3 0.3 23.2 1.6 0.0 0.2 0.2 0.0 0.5 0.1 0.2 0.3 0.3 0.4 2.5 0.0 0.6 0.2 8.7 0.0 0.3 16.5 0.7 0.9 0.0 2.3 0.4 0.2 30.1 1.3 0.2 21.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.6 0.1 0.1 62.5 0.1 0.1 0.0 0.0 4.4 1.0 0.0 0.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.3 1.6 0.0 0.2 0.0 0.0 0.0 57.6 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 PAX6 "AN, AN2, D11S812E, WAGR" ENSG00000007372 "Paired box 6" P26367 11 31784779-31818062 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 78.3;retina: 29.4" "Group enriched" "Detected in some" 5 "Horizontal cells: 249.5;Muller glia cells: 410.0" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Region enriched" "Detected in all" 5 "cerebellum: 78.3" "Cell type enhanced" "Detected in some" "basophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 9.4;AN3-CA: 12.1;HEK 293: 11.3;hTERT-RPE1: 32.3;U-251 MG: 9.9" "Group enriched" "Detected in many" 5 "cerebellum: 61.0;olfactory region: 41.2" "Low region specificity" "Detected in all" "HPA030775, CAB034143" Enhanced Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB034143: AB_1127044, HPA030775: AB_10601243" "unprognostic (2.89e-1)" "unprognostic (2.98e-2)" "unprognostic (8.34e-2)" "unprognostic (3.85e-2)" "unprognostic (4.42e-2)" "unprognostic (7.82e-2)" "unprognostic (2.76e-1)" "unprognostic (1.91e-1)" "unprognostic (4.24e-3)" "unprognostic (1.68e-1)" "unprognostic (1.20e-2)" "unprognostic (3.91e-1)" "unprognostic (8.96e-2)" "unprognostic (1.32e-1)" "unprognostic (1.76e-1)" "unprognostic (1.57e-1)" "unprognostic (3.42e-3)" 0.8 2.0 12.6 0.8 10.4 1.1 1.0 78.3 23.5 0.8 1.1 9.3 0.0 3.5 0.8 1.8 0.8 0.8 0.8 0.8 16.0 3.7 0.9 0.9 0.7 0.9 3.9 9.1 0.8 15.8 0.8 4.6 0.8 10.8 0.8 1.4 29.4 0.8 0.9 1.9 1.6 2.0 0.8 16.1 0.8 19.4 2.8 9.8 0.0 0.8 0.0 1.0 1.1 0.3 0.2 0.2 1.6 0.4 0.4 0.5 0.1 0.0 0.1 9.4 12.1 2.9 4.0 3.6 0.0 0.0 0.1 0.0 0.7 2.2 0.0 3.8 1.2 5.5 0.2 1.0 0.0 0.2 0.0 11.3 5.3 8.8 5.0 0.0 0.2 0.0 0.0 0.4 0.0 0.2 32.3 0.0 3.3 4.2 0.0 0.1 0.0 2.2 0.3 0.2 0.0 6.1 0.0 4.4 0.0 0.5 0.3 0.4 0.0 0.2 0.0 0.0 0.0 2.7 0.0 0.0 3.2 0.2 0.0 9.9 0.0 0.1 0.0 5.0 0.0 0.0 1.6 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.0 0.2 0.2 0.2 0.3 1.0 0.4 0.4 0.2 0.1 0.1 12.6 10.4 78.3 12.2 16.0 3.7 3.9 9.1 10.8 9.8 0.0 0.0 0.0 0.0 0.5 15.4 4.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 249.5 71.5 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.1 410.0 4.1 0.6 0.0 0.0 27.5 0.0 0.3 3.7 2.9 0.0 0.0 0.0 0.0 0.0 PAX8 ENSG00000125618 "Paired box 8" Q06710 2 113215997-113278950 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "kidney: 69.3;thyroid gland: 120.5" "Group enriched" "Detected in many" 4 "Collecting duct cells: 233.8;Proximal tubular cells: 100.4" "Group enriched" "Detected in many" 12 "endometrial cancer: 60.6;ovarian cancer: 63.5;renal cancer: 33.2;thyroid cancer: 122.2" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 8 "EFO-21: 27.1;GAMG: 16.8;RPTEC TERT1: 63.8" "Region enriched" "Detected in some" 4 "pons and medulla: 5.8" "HPA030062, CAB055097, CAB061888, HPA064554" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB055097: AB_2236705, CAB061888: AB_10895719, HPA030062: AB_10603982, HPA064554: AB_2685283" "unprognostic (2.63e-3)" "unprognostic (3.80e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (1.75e-5)" "unprognostic (7.24e-2)" "unprognostic (5.16e-5)" "unprognostic (1.56e-2)" "unprognostic (3.29e-2)" "unprognostic (1.03e-1)" "unprognostic (2.16e-1)" "unprognostic (4.13e-2)" "unprognostic (4.00e-2)" "unprognostic (3.37e-2)" "unprognostic (3.27e-1)" "unprognostic (2.37e-1)" "unprognostic (8.93e-3)" "unprognostic (1.02e-1)" 0.9 1.4 1.1 0.5 0.4 0.0 0.6 0.2 0.8 3.8 0.4 0.2 11.7 0.1 2.2 15.2 0.6 9.6 0.8 0.6 0.5 0.5 69.3 0.4 0.5 0.7 0.4 0.3 3.8 0.6 0.1 0.7 0.8 1.5 1.1 0.1 0.5 0.5 10.0 0.3 0.5 0.6 0.4 0.8 0.3 0.4 1.9 0.2 0.4 120.5 0.0 0.2 0.8 1.9 4.4 2.8 1.5 3.4 1.9 2.5 1.1 2.9 0.2 0.1 0.0 0.1 0.0 1.0 0.8 2.7 0.2 0.4 1.8 0.5 0.5 27.1 0.2 16.8 0.0 0.5 0.8 0.2 1.2 0.0 0.4 0.2 1.0 0.3 0.0 0.0 0.7 0.1 0.2 0.6 3.3 0.0 0.0 0.4 2.0 0.8 0.6 0.3 1.2 0.1 0.7 1.8 0.0 0.2 0.6 63.8 4.7 0.5 0.0 3.4 0.0 1.8 0.0 0.0 1.1 0.9 4.6 0.1 0.8 2.3 0.4 1.4 0.1 4.0 0.6 0.0 1.5 3.4 0.0 0.6 1.8 1.5 4.4 1.5 1.1 2.8 1.9 2.5 1.5 0.5 1.9 1.3 1.1 0.8 1.1 1.1 0.4 0.2 0.8 0.5 0.5 0.4 0.3 1.5 0.2 3.0 1.3 0.8 1.7 0.6 0.6 0.8 2.5 0.0 4.5 233.8 0.0 2.1 39.7 9.6 1.5 0.5 5.8 0.0 2.6 2.0 1.9 1.0 0.0 0.0 4.5 0.0 4.6 1.3 1.3 3.1 4.6 2.6 0.0 2.8 2.3 3.3 17.3 7.0 0.4 100.4 0.7 6.5 0.1 4.2 5.8 0.6 0.7 1.0 3.7 1.7 PAX9 ENSG00000198807 "Paired box 9" P55771 14 36657568-36679715 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "esophagus: 58.6;lymphoid tissue: 33.2;parathyroid gland: 34.6;salivary gland: 86.1;tongue: 27.1" "Group enriched" "Detected in some" 19 "Basal glandular cells: 7.6;Ciliated cells: 29.4;Club cells: 14.8;Glandular cells: 15.1;Urothelial cells: 10.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "T-reg: 2.7" "Lineage enriched" "Detected in single" 19 "T-cells: 2.7" "Cell line enhanced" "Detected in many" "HaCaT: 8.1;HBEC3-KT: 8.1;HDLM-2: 30.7;PC-3: 13.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016239, HPA038462" Enhanced Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB016239: AB_2159984, HPA038462: AB_10672594" "unprognostic (3.09e-1)" "prognostic favorable (5.38e-4)" "unprognostic (1.56e-2)" "unprognostic (2.80e-2)" "unprognostic (1.40e-2)" "unprognostic (1.43e-2)" "unprognostic (5.93e-3)" "unprognostic (2.71e-3)" "unprognostic (2.96e-1)" "unprognostic (5.58e-2)" "unprognostic (2.41e-2)" "unprognostic (9.44e-2)" "unprognostic (2.31e-4)" "unprognostic (1.43e-1)" "unprognostic (1.20e-1)" "unprognostic (1.79e-1)" "unprognostic (1.17e-1)" 0.1 0.1 0.1 0.0 0.1 0.3 0.5 0.0 0.1 3.7 0.4 0.0 0.0 0.0 0.2 0.1 58.6 0.2 0.0 0.1 0.1 0.1 0.1 0.1 1.2 0.0 0.1 0.0 0.1 0.1 34.6 1.4 0.0 0.1 2.7 0.0 0.1 86.1 0.0 0.1 0.3 0.1 0.4 0.1 0.1 0.2 0.2 0.0 11.8 0.5 27.1 33.2 0.4 3.4 0.1 0.0 0.0 0.0 0.0 2.7 0.1 3.5 1.0 0.0 1.7 1.4 2.4 1.3 0.0 0.1 0.0 0.0 0.7 1.1 0.7 0.4 0.0 0.3 8.1 1.2 8.1 0.0 30.7 5.4 0.5 0.5 0.0 0.0 0.0 2.7 0.5 3.8 0.0 1.2 0.0 0.0 3.5 2.0 0.8 0.1 4.6 0.5 0.0 0.1 1.2 13.2 0.0 0.0 0.0 0.0 4.6 2.3 0.0 0.8 4.1 0.9 0.7 3.5 0.0 0.0 0.0 0.5 1.3 0.6 0.0 0.0 3.1 0.4 0.3 1.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.6 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 2.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 7.6 0.8 0.0 0.3 0.0 29.4 14.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.6 15.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.1 0.3 0.1 0.0 0.2 10.8 PAXBP1 "C21orf66, fSAP105, GCFC, GCFC1" ENSG00000159086 "PAX3 and PAX7 binding protein 1" Q9Y5B6 21 32733899-32771858 "Plasma proteins, Predicted intracellular proteins" "Myogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 78.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "NTERA-2: 35.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003757 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003757: AB_10600796" "unprognostic (8.21e-2)" "unprognostic (7.50e-2)" "unprognostic (1.04e-1)" "unprognostic (1.67e-1)" "unprognostic (6.53e-2)" "unprognostic (2.03e-3)" "unprognostic (2.38e-3)" "unprognostic (2.54e-2)" "unprognostic (6.89e-2)" "unprognostic (2.65e-1)" "unprognostic (2.01e-2)" "prognostic unfavorable (9.43e-4)" "prognostic unfavorable (1.50e-5)" "unprognostic (3.16e-1)" "unprognostic (3.78e-2)" "unprognostic (3.38e-1)" "unprognostic (1.09e-3)" 8.9 10.6 11.9 16.6 19.6 42.0 11.6 25.7 20.0 13.5 14.1 11.3 10.1 15.8 16.3 12.4 10.3 11.6 10.1 8.3 11.2 9.7 11.3 10.3 10.1 13.7 22.7 10.0 19.8 12.3 11.6 19.3 13.2 14.7 11.2 12.6 6.9 10.2 10.5 15.2 12.6 12.8 10.8 19.0 11.2 9.5 12.9 19.7 18.5 11.3 5.0 12.3 11.2 18.9 2.2 1.6 0.3 1.3 0.7 3.1 0.4 7.5 6.2 12.5 9.8 4.9 3.9 17.9 5.6 3.6 7.4 5.4 13.0 6.8 9.0 4.4 3.1 5.7 7.7 12.5 5.2 7.7 7.3 10.4 15.5 10.2 9.4 2.4 17.3 9.2 2.1 7.9 8.6 3.8 4.8 4.8 9.5 18.0 8.3 5.4 6.6 11.8 10.1 35.4 8.4 6.3 11.0 11.9 13.1 5.8 7.0 10.3 5.9 8.0 9.3 6.3 8.1 5.9 9.7 4.2 5.5 7.6 6.4 8.7 8.2 10.2 16.7 4.0 15.8 5.5 0.0 1.3 0.3 2.2 0.6 3.1 1.6 2.5 1.9 1.6 2.2 2.7 2.6 0.0 0.7 0.8 1.1 1.4 0.4 11.9 19.6 25.7 20.0 11.2 9.7 22.7 10.0 14.7 19.7 11.9 16.3 9.8 17.0 22.7 51.8 11.5 15.3 28.1 20.5 19.2 58.9 13.9 5.0 6.5 28.6 16.1 13.2 0.0 6.8 10.2 16.4 18.1 11.5 9.9 9.0 20.6 21.2 12.9 11.8 25.3 13.6 15.8 20.3 2.8 15.4 37.6 6.3 12.2 15.9 5.7 78.8 32.3 15.1 24.2 15.5 22.2 14.9 13.1 18.8 22.8 PAXIP1 "CAGF28, CAGF29, PAXIP1L, PTIP, TNRC2" ENSG00000157212 "PAX interacting protein 1" Q6ZW49 7 154943687-155003084 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 32.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006694, HPA016950" Enhanced Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA006694: AB_1855011, HPA016950: AB_2669489" "unprognostic (2.44e-2)" "unprognostic (1.28e-1)" "unprognostic (2.14e-2)" "unprognostic (2.66e-2)" "unprognostic (1.39e-1)" "unprognostic (1.63e-2)" "unprognostic (7.39e-3)" "unprognostic (2.65e-2)" "unprognostic (1.34e-3)" "unprognostic (1.19e-2)" "unprognostic (1.33e-1)" "unprognostic (2.36e-1)" "unprognostic (3.28e-2)" "unprognostic (4.99e-3)" "unprognostic (3.98e-1)" "unprognostic (2.44e-3)" "unprognostic (2.30e-1)" 6.0 5.4 5.7 6.2 5.0 9.7 6.3 32.3 5.7 7.8 5.5 5.8 4.5 5.2 6.5 6.7 7.1 5.7 5.0 4.7 6.0 3.4 5.7 6.9 4.7 9.4 5.7 1.4 7.1 8.4 7.2 8.7 7.9 5.6 7.7 5.7 6.9 6.6 5.4 7.1 7.4 6.9 9.3 4.2 6.4 5.9 10.4 6.2 31.2 6.4 4.7 6.9 6.1 5.9 2.2 3.3 1.4 3.1 2.9 6.5 2.5 9.9 8.2 10.9 18.4 4.8 4.0 9.7 4.4 4.7 6.1 7.2 9.0 7.9 13.1 5.6 5.3 12.7 7.9 13.9 7.0 7.6 13.1 10.9 9.9 5.9 7.7 3.4 13.5 13.3 3.8 5.3 6.1 2.5 3.5 5.8 13.3 13.6 8.8 6.1 13.9 28.7 11.3 17.6 9.8 5.6 16.4 11.1 14.2 6.3 8.4 8.7 5.6 11.8 8.8 5.5 10.3 6.7 11.6 2.9 5.1 0.9 7.3 10.6 9.0 5.2 18.0 12.6 16.0 13.8 0.7 2.3 1.4 2.5 2.6 3.8 1.3 4.0 2.9 2.6 2.2 6.5 1.7 1.0 2.9 3.1 3.3 3.2 2.5 5.7 5.0 32.3 5.7 6.0 3.4 5.7 1.4 5.6 6.2 6.0 7.5 6.5 4.7 5.7 18.0 6.1 7.6 4.0 9.1 8.7 9.8 7.4 5.0 3.5 1.5 5.0 4.7 0.0 2.9 6.4 6.0 6.1 2.3 8.9 3.9 3.2 2.4 3.1 4.0 2.7 8.1 3.6 3.3 3.6 8.7 9.3 4.0 2.9 8.9 3.1 12.8 0.0 2.5 15.2 19.9 6.0 5.1 3.9 9.9 3.5 PAXX "C9orf142, XLS" ENSG00000148362 "PAXX, non-homologous end joining factor" Q9BUH6 9 136992418-136993984 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cytotrophoblasts: 112.4;Distal tubular cells: 111.0;Extravillous trophoblasts: 180.6;Syncytiotrophoblasts: 74.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045268 Uncertain Supported Nucleoplasm NA NA 77000 Nucleoplasm "HPA045268: AB_10963079" "unprognostic (1.85e-1)" "prognostic favorable (2.06e-4)" "unprognostic (1.14e-3)" "unprognostic (9.88e-3)" "unprognostic (1.95e-1)" "unprognostic (2.15e-1)" "unprognostic (2.13e-3)" "unprognostic (3.22e-1)" "unprognostic (3.10e-1)" "unprognostic (1.00e-2)" "prognostic favorable (6.71e-4)" "unprognostic (3.54e-2)" "unprognostic (1.75e-2)" "unprognostic (9.64e-3)" "unprognostic (3.66e-1)" "unprognostic (9.31e-2)" "unprognostic (8.97e-3)" 14.0 10.2 20.7 17.2 18.4 28.0 15.6 14.7 25.4 11.9 17.8 16.4 10.3 22.0 10.6 12.9 14.1 11.8 14.3 12.4 19.4 16.9 14.2 18.2 12.9 24.2 20.7 12.5 10.1 25.9 9.4 17.1 17.1 16.0 16.0 4.9 9.9 24.8 15.7 15.8 19.5 18.1 7.1 25.3 27.8 28.0 6.4 14.7 34.5 16.4 11.5 15.0 11.5 10.3 8.3 56.3 4.1 12.6 19.1 36.2 13.5 10.2 11.5 1.8 7.0 3.3 3.0 27.5 7.9 4.8 5.3 2.9 5.0 7.5 9.3 13.9 2.0 2.0 16.4 0.6 5.9 0.4 23.7 16.4 7.2 5.9 4.2 5.0 10.3 16.1 2.2 5.6 1.8 2.3 0.9 4.8 17.0 10.7 2.7 1.1 22.6 10.8 16.8 11.1 11.9 35.3 14.1 3.8 26.2 3.5 5.3 8.8 11.0 6.8 16.9 9.0 0.3 20.2 8.7 6.3 2.5 7.8 12.0 9.3 5.1 4.5 6.2 4.5 11.8 9.4 4.1 10.8 4.1 36.2 12.6 31.1 8.3 20.2 31.2 11.0 7.8 11.2 25.6 3.7 19.1 6.4 56.3 15.1 13.5 20.7 18.4 14.7 25.4 19.4 16.9 20.7 12.5 16.0 14.7 14.9 25.1 0.0 0.0 0.0 0.0 0.0 0.0 21.4 13.6 38.4 0.0 112.4 111.0 40.3 0.0 0.0 0.0 0.0 37.7 180.6 0.0 0.0 11.6 0.0 69.5 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 61.3 0.0 0.0 33.7 0.0 0.0 58.6 0.0 0.0 0.0 0.0 0.0 0.0 74.1 0.0 0.0 0.0 PBDC1 "CXorf26, MGC874" ENSG00000102390 "Polysaccharide biosynthesis domain containing 1" Q9BVG4 X 76172936-76178204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003155 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA 88000 Nucleoplasm "Nucleoli, Cytosol" "HPA003155: AB_1078592" "unprognostic (6.95e-2)" "unprognostic (9.85e-2)" "unprognostic (1.02e-2)" "unprognostic (3.78e-2)" "unprognostic (2.09e-1)" "unprognostic (2.51e-2)" "unprognostic (2.47e-3)" "unprognostic (7.23e-2)" "unprognostic (1.78e-1)" "unprognostic (1.56e-3)" "unprognostic (8.82e-3)" "unprognostic (3.64e-1)" "unprognostic (1.39e-2)" "unprognostic (1.05e-1)" "unprognostic (4.98e-2)" "prognostic favorable (8.57e-4)" "unprognostic (1.62e-1)" 24.9 25.4 12.7 15.1 14.3 28.9 17.1 15.3 14.9 21.3 31.5 10.0 14.8 28.5 21.3 18.4 26.9 15.1 14.2 14.7 12.5 12.5 36.3 39.1 16.6 17.0 17.6 8.8 23.1 16.1 15.2 22.8 21.9 15.0 22.3 20.9 10.3 18.0 14.3 19.2 19.5 48.9 22.3 22.7 23.8 17.8 8.4 14.6 21.1 22.5 21.2 18.2 20.8 17.6 28.1 24.0 17.0 27.8 27.1 30.6 17.1 12.1 17.7 15.2 10.4 19.5 19.5 13.1 21.6 18.5 19.9 17.2 16.9 16.8 16.6 14.6 21.8 24.8 17.5 25.3 24.2 26.0 12.3 16.0 12.3 9.9 25.3 30.7 36.1 18.1 15.5 19.9 27.2 23.3 12.1 25.3 6.0 17.4 8.3 24.3 14.2 17.0 26.5 42.2 30.2 27.8 14.6 16.0 2.1 29.1 22.5 8.9 11.5 9.5 15.9 0.1 20.5 9.7 13.6 21.7 14.9 14.9 17.7 19.7 14.6 25.8 9.9 16.5 12.7 11.7 6.7 17.6 17.0 30.6 25.6 22.2 28.1 27.5 29.7 22.5 23.7 28.2 26.9 3.3 27.1 27.8 24.0 22.5 17.1 12.7 14.3 15.3 14.9 12.5 12.5 17.6 8.8 15.0 14.6 32.8 23.2 24.8 69.4 47.1 21.4 36.9 33.1 33.5 30.7 38.4 13.7 48.2 41.4 60.7 1.0 28.6 58.6 0.0 54.4 49.7 36.0 52.4 50.7 46.4 62.6 7.9 26.5 19.6 30.5 1.1 44.3 40.9 43.9 80.2 37.2 21.5 53.5 34.8 36.4 66.3 19.3 51.8 41.1 2.3 16.4 61.6 46.0 44.5 46.0 68.1 PBRM1 "BAF180, PB1" ENSG00000163939 "Polybromo 1" Q86U86 3 52545352-52685917 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015629, HPA059373" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA015629: AB_1855012, HPA059373: AB_2683994" "unprognostic (1.87e-1)" "unprognostic (1.73e-1)" "unprognostic (1.91e-2)" "unprognostic (2.00e-1)" "unprognostic (6.15e-2)" "unprognostic (1.34e-2)" "unprognostic (1.02e-2)" "unprognostic (9.54e-2)" "unprognostic (1.87e-2)" "unprognostic (1.43e-1)" "unprognostic (1.99e-2)" "unprognostic (4.32e-2)" "unprognostic (2.89e-3)" "unprognostic (3.06e-1)" "unprognostic (1.96e-1)" "unprognostic (1.53e-2)" "unprognostic (1.06e-1)" 24.3 14.8 13.8 20.6 15.9 17.2 24.4 19.1 13.8 18.9 18.5 14.0 22.9 12.2 25.9 13.9 19.9 18.9 13.7 15.9 11.1 10.0 11.7 14.5 14.9 16.5 16.5 8.2 25.1 15.4 14.4 30.6 28.0 14.7 16.1 15.3 12.7 17.5 16.2 21.8 17.2 14.3 21.1 15.6 19.1 14.8 13.1 13.7 51.0 22.0 10.5 17.1 22.4 23.0 6.6 10.7 11.1 8.7 4.6 7.4 1.9 12.5 8.1 29.0 14.2 14.3 14.6 20.3 17.3 11.9 20.0 17.6 9.1 8.5 30.4 2.4 20.3 16.6 8.6 25.1 13.1 24.4 32.5 13.5 28.8 15.3 7.0 20.5 24.0 21.9 13.6 15.2 22.4 14.5 15.8 19.3 24.1 16.4 16.7 20.1 4.2 39.5 7.2 17.6 8.5 13.3 20.7 18.2 15.5 8.3 24.5 19.7 21.8 20.8 5.0 16.5 18.4 9.4 13.9 22.2 18.8 14.3 16.2 21.1 12.1 19.0 28.9 11.6 19.5 18.7 10.1 5.0 11.1 4.8 3.2 4.9 3.6 4.8 5.3 4.8 6.6 7.4 4.7 2.7 4.6 8.7 10.7 4.5 1.9 13.8 15.9 19.1 13.8 11.1 10.0 16.5 8.2 14.7 13.7 38.7 54.1 19.5 31.0 35.9 42.0 48.4 28.1 53.5 38.7 22.7 45.2 31.3 16.6 31.4 28.7 40.3 25.3 23.3 40.4 28.9 31.5 35.3 27.8 37.0 45.9 28.6 33.8 35.0 63.3 14.7 31.7 46.6 45.5 50.5 30.6 28.5 42.9 28.1 54.8 13.9 43.3 25.8 45.3 41.9 32.8 45.0 42.6 34.1 34.5 33.3 PBX1 ENSG00000185630 "PBX homeobox 1" P40424 1 164555584-164899296 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Sexual differentiation, Steroidogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 2.9" "Lineage enriched" "Detected in single" 9 "granulocytes: 2.9" "Cell line enhanced" "Detected in many" "HEL: 30.9;NTERA-2: 30.3;SK-BR-3: 62.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003505, HPA003881, CAB018768" Supported Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "CAB018768: AB_675783, HPA003505: AB_1855019, HPA003881: AB_1855020" "unprognostic (2.26e-2)" "unprognostic (1.95e-1)" "unprognostic (9.09e-2)" "unprognostic (2.14e-2)" "unprognostic (5.21e-3)" "unprognostic (6.94e-3)" "unprognostic (5.95e-2)" "unprognostic (2.49e-1)" "unprognostic (1.65e-1)" "unprognostic (2.24e-3)" "unprognostic (2.30e-1)" "unprognostic (8.81e-2)" "unprognostic (1.34e-2)" "unprognostic (2.13e-1)" "unprognostic (5.07e-2)" "unprognostic (1.11e-1)" "unprognostic (1.25e-1)" 13.2 17.3 14.9 8.3 15.0 1.4 16.4 14.1 17.4 73.4 26.3 11.2 15.9 13.6 67.2 15.3 20.8 35.1 25.8 12.6 10.9 9.7 15.4 4.2 10.4 2.3 11.6 14.6 35.2 29.4 21.3 12.4 9.6 8.1 27.6 9.3 10.2 19.6 25.1 16.8 6.0 14.6 56.8 8.0 5.1 13.9 9.7 8.7 2.7 17.4 8.5 6.6 32.2 24.7 0.0 0.1 2.9 0.0 0.3 0.2 2.5 1.1 22.6 22.3 6.0 15.1 7.3 1.3 9.5 6.1 2.6 1.8 4.3 4.0 0.0 2.0 12.9 1.4 7.9 8.8 2.5 1.0 1.1 9.4 30.9 18.2 0.0 10.0 0.0 7.9 7.2 0.0 1.6 0.7 5.6 0.1 0.0 0.0 0.0 0.7 14.9 0.0 0.1 30.3 1.3 1.1 0.0 7.4 9.0 1.8 13.5 0.8 13.2 10.9 62.4 0.0 21.3 23.7 0.0 0.1 1.3 3.1 8.8 2.7 2.8 21.3 0.0 0.1 0.0 0.1 2.9 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.7 0.3 0.0 0.1 0.0 2.5 14.9 15.0 14.1 17.4 10.9 9.7 11.6 14.6 8.1 8.7 20.8 15.2 0.9 91.3 20.3 27.6 44.2 91.7 25.4 21.6 31.4 104.1 89.0 28.2 41.5 72.1 39.2 28.0 0.0 58.9 4.5 75.2 44.0 71.4 17.3 8.6 4.8 87.2 60.8 1.6 78.2 59.0 6.8 15.1 1.8 35.4 34.9 31.8 59.6 97.6 49.4 28.8 38.8 62.7 0.9 11.5 24.6 87.5 3.2 39.4 82.1 PBX2 "G17, HOX12, PBX2MHC" ENSG00000204304 "PBX homeobox 2" P40425 6 32184741-32190186 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.8" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061478 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA061478: AB_2684535" "unprognostic (9.73e-3)" "unprognostic (2.16e-2)" "unprognostic (1.40e-2)" "prognostic unfavorable (8.90e-5)" "unprognostic (4.98e-1)" "unprognostic (2.68e-2)" "unprognostic (9.87e-2)" "unprognostic (3.42e-2)" "unprognostic (1.81e-2)" "prognostic favorable (6.84e-4)" "unprognostic (3.84e-2)" "unprognostic (3.08e-1)" "unprognostic (3.79e-3)" "unprognostic (1.58e-1)" "unprognostic (3.06e-1)" "unprognostic (2.52e-2)" "unprognostic (2.27e-1)" 15.3 17.7 14.1 14.9 14.8 8.1 12.3 19.3 16.4 17.0 20.8 16.4 36.2 13.7 23.0 39.1 19.7 21.9 19.1 13.6 15.9 10.7 14.8 14.6 26.4 24.0 13.7 10.0 25.0 12.3 10.8 24.3 30.7 12.9 18.4 15.3 15.0 14.6 29.1 17.2 22.0 17.2 22.3 12.2 29.6 22.4 9.9 17.7 17.1 25.6 14.4 20.6 17.4 18.4 0.2 1.8 0.7 0.2 0.0 0.2 0.1 2.3 2.4 12.3 9.5 13.2 16.7 6.9 2.0 4.7 5.4 5.5 3.3 3.7 10.8 12.4 7.2 0.9 6.8 3.8 14.0 5.4 8.0 15.6 8.8 4.3 2.6 11.4 6.1 9.5 22.0 7.7 4.0 11.7 6.7 9.6 17.7 13.3 5.2 2.1 10.7 6.7 13.1 0.1 1.3 1.5 9.0 2.6 12.5 11.8 4.0 4.6 6.4 1.6 3.4 13.4 8.5 8.7 12.6 2.5 4.1 10.6 1.7 2.1 27.7 18.1 13.8 8.7 5.0 6.9 0.0 0.2 0.7 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.4 0.0 0.1 1.8 0.0 0.1 14.1 14.8 19.3 16.4 15.9 10.7 13.7 10.0 12.9 17.7 6.0 14.1 14.8 16.4 16.3 17.4 2.4 25.5 2.7 5.7 15.7 7.9 25.3 3.3 14.4 0.6 11.3 9.8 0.0 11.9 23.0 14.3 16.8 15.0 19.2 16.1 25.4 29.2 25.8 34.2 1.8 18.7 18.4 8.5 9.0 15.8 19.8 12.1 14.0 18.4 7.7 4.6 6.5 18.9 0.7 3.4 16.9 39.5 15.0 14.4 15.7 PBX3 ENSG00000167081 "PBX homeobox 3" P40426 9 125747345-125967377 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 86.7" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 52.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 16.1" "Lineage enriched" "Detected in all" 4 "dendritic cells: 16.1" "Cell line enhanced" "Detected in many" "THP-1: 36.5" "Region enhanced" "Detected in all" "olfactory region: 205.0" "Region enriched" "Detected in all" 4 "olfactory region: 287.4" HPA003881 Supported Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA003881: AB_1855020" "unprognostic (1.97e-2)" "unprognostic (3.78e-2)" "unprognostic (1.15e-1)" "unprognostic (1.93e-2)" "unprognostic (1.27e-1)" "unprognostic (2.35e-1)" "unprognostic (2.20e-1)" "unprognostic (3.38e-2)" "unprognostic (2.83e-1)" "unprognostic (2.88e-1)" "unprognostic (2.42e-3)" "unprognostic (7.02e-2)" "unprognostic (1.53e-1)" "unprognostic (2.74e-2)" "unprognostic (1.63e-1)" "unprognostic (8.03e-2)" "unprognostic (6.29e-2)" 8.0 25.0 4.4 16.2 11.6 3.0 10.4 6.6 3.4 16.6 18.9 3.7 6.5 3.1 10.7 10.9 9.1 5.9 22.8 16.1 2.9 6.3 3.4 7.6 9.4 6.1 9.5 3.4 35.0 12.9 86.7 6.8 3.1 13.0 18.8 6.1 7.1 10.5 12.3 3.6 8.2 6.0 21.2 17.6 5.5 10.0 5.1 6.2 6.8 14.7 5.5 3.8 13.3 12.0 1.8 16.1 2.9 1.8 3.8 2.1 1.0 4.7 4.6 20.8 19.2 5.8 9.5 3.7 12.4 7.1 8.7 6.2 5.9 9.4 4.7 1.5 9.9 8.9 3.6 11.7 5.0 17.2 5.0 8.3 4.0 3.5 2.3 7.4 4.4 7.3 4.8 5.7 6.8 4.4 19.2 9.7 3.2 0.2 4.5 17.9 2.5 4.1 2.1 15.3 5.7 3.1 7.7 31.0 0.6 6.6 2.8 11.2 19.4 8.6 1.6 3.8 8.2 7.1 36.5 11.7 17.6 4.8 10.3 23.2 3.2 5.0 4.9 8.4 6.2 9.0 2.9 1.8 2.3 0.9 1.6 1.2 1.4 1.2 1.0 2.1 1.8 2.1 1.0 1.7 3.8 1.3 16.1 1.8 1.0 4.4 11.6 6.6 3.4 2.9 6.3 9.5 3.4 13.0 6.2 8.9 14.7 3.2 9.5 20.1 6.8 52.9 2.5 9.4 13.6 12.2 35.3 0.3 6.6 9.5 11.1 10.8 0.9 0.0 2.2 0.8 11.1 16.7 16.1 9.6 14.6 39.7 11.1 11.1 29.5 8.8 18.4 15.9 6.8 9.0 6.2 8.0 2.8 15.9 10.6 1.5 38.9 0.0 12.0 12.2 7.9 23.1 0.3 7.2 2.3 7.6 PCBD1 "DCOH, PCBD, PCD" ENSG00000166228 "Pterin-4 alpha-carbinolamine dehydratase 1" P61457 10 70882280-70888784 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis, Transcription, Transcription regulation" "Activator, Lyase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 99.0" "Cell type enhanced" "Detected in all" 7 "Hepatocytes: 577.2;Proximal tubular cells: 733.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 67.0;Hep G2: 65.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037575, HPA061723" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 210000 Nucleoplasm Cytosol "HPA037575: AB_10671761, HPA061723: AB_2684594" "unprognostic (1.02e-1)" "unprognostic (5.05e-2)" "unprognostic (7.43e-2)" "unprognostic (3.69e-1)" "unprognostic (5.39e-2)" "unprognostic (4.80e-3)" "unprognostic (1.81e-1)" "unprognostic (1.47e-1)" "unprognostic (2.35e-1)" "unprognostic (2.40e-2)" "unprognostic (2.95e-1)" "unprognostic (5.63e-2)" "unprognostic (3.38e-2)" "unprognostic (9.26e-2)" "unprognostic (1.74e-1)" "unprognostic (5.76e-2)" "unprognostic (7.43e-3)" 18.3 25.5 18.1 9.6 15.6 4.3 19.7 13.2 14.8 13.9 18.4 7.8 24.3 12.6 13.9 21.4 26.5 25.6 22.9 32.5 10.8 23.7 38.7 99.0 14.0 7.8 16.7 12.3 18.5 73.0 15.8 15.5 11.7 16.4 26.9 20.3 16.3 16.2 20.7 23.1 5.8 17.2 18.1 14.5 10.2 19.2 7.0 8.7 4.3 36.8 16.2 12.3 22.4 31.8 11.8 20.9 3.5 19.4 8.0 16.9 7.5 20.2 48.2 2.9 29.9 10.9 10.2 3.9 6.6 10.9 10.2 8.2 67.0 36.0 4.1 19.1 7.2 7.9 13.5 18.2 10.5 7.0 10.9 32.8 3.6 7.7 65.8 11.5 3.6 13.5 10.0 11.5 10.1 4.8 15.5 27.4 2.6 7.1 0.3 7.1 33.9 0.4 12.1 4.0 54.9 45.1 1.9 4.0 13.3 42.9 21.0 12.6 21.4 5.4 37.3 14.2 8.4 10.8 7.0 11.3 1.7 14.3 2.5 16.0 0.1 0.8 0.1 9.3 11.8 2.6 0.0 10.7 3.5 8.8 19.4 6.9 11.8 11.6 12.6 20.9 4.1 3.8 7.9 0.6 8.0 13.3 15.3 16.9 7.5 18.1 15.6 13.2 14.8 10.8 23.7 16.7 12.3 16.4 8.7 38.7 59.6 41.0 140.4 44.3 32.7 140.4 142.7 72.3 73.9 177.9 5.9 105.7 384.7 161.2 1.3 33.8 116.6 23.3 147.5 63.7 71.1 169.6 31.1 577.2 160.3 33.4 169.3 32.5 54.4 5.8 62.5 71.4 74.2 90.2 228.3 70.5 157.8 147.3 89.8 733.2 28.5 84.1 57.7 4.9 7.9 40.0 64.9 33.8 199.7 158.3 PCBP2 "hnRNP-E2, HNRNPE2, HNRPE2" ENSG00000197111 "Poly(rC) binding protein 2" Q15366 12 53452102-53481162 "Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Viral RNA replication" "DNA-binding, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038356, HPA073145" Approved Supported Nucleoplasm,Cytosol NA NA 2000000 Nucleoplasm Cytosol "HPA038356: AB_10697248, HPA073145: " "unprognostic (1.44e-1)" "unprognostic (2.08e-1)" "unprognostic (9.89e-2)" "unprognostic (2.92e-3)" "unprognostic (4.34e-3)" "unprognostic (2.69e-2)" "prognostic unfavorable (1.82e-5)" "unprognostic (2.52e-1)" "unprognostic (2.05e-2)" "prognostic favorable (8.23e-4)" "unprognostic (3.53e-2)" "unprognostic (2.12e-1)" "unprognostic (2.04e-1)" "unprognostic (9.84e-2)" "unprognostic (3.35e-1)" "unprognostic (1.99e-1)" "unprognostic (8.20e-2)" 105.3 106.7 110.8 85.7 93.4 158.1 180.8 136.5 131.5 84.1 67.2 50.5 75.7 69.2 101.7 84.5 75.3 89.5 71.0 112.1 105.0 53.1 112.6 108.3 83.8 118.8 94.5 88.9 124.5 148.2 98.1 88.7 62.4 93.2 61.7 71.0 65.0 88.3 61.2 96.5 94.4 71.3 90.8 115.4 73.0 86.2 98.7 104.2 106.8 91.2 57.1 93.5 76.8 132.5 20.9 31.5 17.2 18.5 12.4 28.8 13.7 55.5 86.6 84.7 68.1 123.4 95.5 65.0 59.3 81.3 97.3 69.7 100.8 83.8 99.8 58.0 88.8 43.8 54.7 93.3 80.8 93.1 61.7 67.3 100.3 67.7 98.8 124.5 97.8 66.2 109.9 67.8 82.2 132.3 162.7 93.2 64.6 85.6 179.3 86.8 151.3 91.9 110.2 108.2 47.1 60.8 73.9 77.0 116.9 76.9 87.1 83.7 73.5 81.1 73.1 57.9 87.6 102.3 85.3 68.0 50.5 69.2 46.0 60.1 99.8 68.7 92.3 59.2 62.9 54.8 8.3 18.1 13.1 15.9 18.5 26.1 20.9 24.5 20.5 22.5 20.9 28.8 23.6 17.2 12.4 17.0 31.5 27.4 13.7 110.8 93.4 136.5 131.5 105.0 53.1 94.5 88.9 93.2 104.2 107.2 169.7 269.4 252.9 347.0 77.7 65.9 252.3 107.1 114.9 280.9 104.1 303.4 417.8 203.7 54.9 263.7 254.4 140.2 207.3 313.2 278.0 194.7 148.2 266.4 321.3 96.9 198.2 268.2 433.2 53.3 286.2 303.9 221.0 344.5 257.9 86.2 233.7 238.4 215.3 588.4 177.3 187.5 295.1 298.6 154.1 334.2 370.7 264.2 295.7 283.3 PCBP3 "FLJ44028, PCBP3-OT1, PCBP3OT" ENSG00000183570 "Poly(rC) binding protein 3" P57721 21 45643694-45942454 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.4" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 151.7;Cone photoreceptor cells: 47.1;Horizontal cells: 109.7;Late spermatids: 60.8;Rod photoreceptor cells: 75.1" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in all" 5 "cerebellum: 47.4;pons and medulla: 23.0" "Cell type enhanced" "Detected in many" "eosinophil: 5.9" "Group enriched" "Detected in many" 6 "B-cells: 2.9;granulocytes: 5.9;T-cells: 1.6" "Cell line enhanced" "Detected in some" "ASC TERT1: 14.9;HDLM-2: 27.2;HSkMC: 20.9;SH-SY5Y: 23.6;U-87 MG: 12.6;U-937: 15.1" "Region enriched" "Detected in all" 5 "olfactory region: 280.8" "Region enhanced" "Detected in all" "olfactory region: 184.8" "HPA030247, HPA073145" Approved Approved Nucleoplasm,Vesicles,Mitochondria NA NA "Nucleoplasm, Mitochondria" Vesicles "HPA030247: AB_10601244, HPA073145: " "unprognostic (3.88e-2)" "unprognostic (1.19e-1)" "unprognostic (2.01e-4)" "unprognostic (9.89e-4)" "unprognostic (2.74e-1)" "unprognostic (1.40e-1)" "unprognostic (4.10e-2)" "unprognostic (2.42e-1)" "unprognostic (3.87e-2)" "unprognostic (1.64e-3)" "unprognostic (1.12e-3)" "unprognostic (1.97e-2)" "unprognostic (1.96e-6)" "unprognostic (8.67e-2)" "unprognostic (2.32e-2)" "unprognostic (8.04e-2)" "unprognostic (1.97e-2)" 6.5 11.7 6.0 11.2 6.7 12.3 6.3 47.4 12.6 3.8 7.9 7.0 2.2 3.1 9.3 12.4 1.4 3.2 4.4 2.7 6.5 7.3 2.2 1.1 1.8 5.0 6.9 3.7 3.4 3.5 0.6 14.8 2.3 23.0 1.5 3.0 20.2 1.7 1.9 1.1 1.6 4.8 12.3 7.3 11.6 3.4 20.5 6.1 22.6 0.8 0.0 4.6 2.3 1.8 2.9 0.0 5.9 0.4 0.6 1.6 0.5 0.0 0.0 0.2 0.0 6.9 14.9 0.0 0.8 0.2 1.6 0.7 0.0 0.0 0.0 0.3 4.0 1.9 0.0 0.8 0.0 0.2 27.2 0.1 0.0 0.0 0.0 7.0 0.0 0.0 20.9 0.1 0.2 0.4 0.0 0.0 1.0 0.0 0.1 0.9 0.3 7.7 1.6 0.4 0.0 1.3 0.0 0.0 1.1 0.0 0.0 2.6 23.6 0.5 0.0 0.0 0.7 0.0 4.2 0.0 0.0 0.0 6.1 0.0 0.3 1.5 0.0 12.6 15.1 0.5 4.4 0.4 5.9 1.6 0.3 0.3 2.9 0.9 0.0 0.0 1.9 1.5 0.2 1.4 0.6 0.2 0.0 0.8 0.5 6.0 6.7 47.4 6.0 6.5 7.3 6.9 3.7 23.0 6.1 0.0 0.0 1.4 0.1 0.2 151.7 2.8 0.0 0.0 1.2 1.8 47.1 0.0 0.0 0.1 29.4 0.5 0.0 0.0 0.2 0.1 1.3 0.9 0.0 0.0 0.4 109.7 2.9 2.5 0.0 60.8 7.8 0.2 3.3 0.0 0.0 29.6 1.4 0.0 12.0 0.0 75.1 0.0 5.3 25.0 12.0 0.0 0.0 0.0 0.0 0.3 PCDH1 pc42 ENSG00000156453 "Protocadherin 1" Q08174 5 141853111-141879246 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 37.9;Exocrine glandular cells: 40.1;Pancreatic endocrine cells: 44.8;Urothelial cells: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.2;naive CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 6 "T-cells: 2.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 29.5;HaCaT: 36.8;HUVEC TERT2: 19.3;OE19: 26.1;RT4: 25.2;TIME: 25.1;WM-115: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047720, HPA050538" Enhanced Approved "Nucleoplasm,Nucleoli,Cell Junctions" NA NA 270000 "Nucleoplasm, Cell Junctions" Nucleoli "HPA047720: AB_2680130, HPA050538: AB_2681162" "unprognostic (4.67e-2)" "unprognostic (1.79e-1)" "unprognostic (5.30e-2)" "unprognostic (4.61e-3)" "unprognostic (5.03e-2)" "unprognostic (4.16e-2)" "prognostic unfavorable (4.96e-5)" "unprognostic (1.98e-2)" "unprognostic (4.87e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (3.61e-4)" "unprognostic (2.43e-1)" "prognostic favorable (7.55e-5)" "unprognostic (2.05e-1)" "unprognostic (4.16e-2)" "unprognostic (3.13e-2)" "unprognostic (1.91e-1)" 22.4 4.5 14.8 7.4 17.6 1.4 19.0 16.1 25.6 8.3 22.2 7.3 11.4 20.6 7.0 7.0 26.9 9.7 6.8 8.9 11.6 7.4 14.9 13.0 18.9 3.4 8.8 16.9 2.5 11.0 1.3 5.2 32.5 9.2 11.1 14.4 6.0 23.7 12.3 7.4 17.3 15.8 7.5 7.5 1.6 22.8 1.5 9.8 0.0 9.1 3.9 8.8 8.6 11.7 0.0 0.0 0.3 0.0 0.0 2.2 0.5 6.2 0.3 2.6 2.9 0.1 0.0 1.9 0.0 0.0 0.0 0.0 1.5 29.5 0.0 15.2 0.2 0.3 36.8 3.4 2.7 0.0 0.0 0.1 0.0 0.1 0.0 2.4 0.0 0.1 0.0 6.2 0.0 0.4 6.3 19.3 0.0 0.0 3.1 0.0 5.0 0.1 0.0 11.2 26.1 5.0 0.1 0.0 4.2 2.1 25.2 0.3 0.6 0.1 8.1 6.5 7.9 6.5 0.1 25.1 0.0 0.2 0.0 2.3 0.0 0.0 0.0 0.2 0.0 17.8 0.0 0.0 0.3 2.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.4 0.5 14.8 17.6 16.1 25.6 11.6 7.4 8.8 16.9 9.2 9.8 0.0 4.0 0.0 10.2 0.9 9.1 2.2 22.9 4.0 2.3 12.2 0.0 0.6 3.3 13.6 0.3 21.8 37.9 0.0 40.1 0.2 1.6 22.4 0.0 26.0 0.2 25.4 7.5 6.2 1.9 0.8 0.6 0.5 0.0 0.0 17.6 4.0 44.8 19.3 0.4 5.1 0.4 12.9 15.1 0.2 0.2 2.3 16.8 0.0 14.7 43.0 PCDH10 "KIAA1400, OL-PCDH" ENSG00000138650 "Protocadherin 10" Q9P2E7 4 133149315-133208606 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.0;placenta: 31.1;seminal vesicle: 23.6" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 16.2;Muller glia cells: 8.7;Smooth muscle cells: 4.7" "Cancer enhanced" "Detected in many" "glioma: 8.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 6.9;HUVEC TERT2: 16.1;MOLT-4: 13.4;TIME: 32.0;U-138 MG: 8.6;U-251 MG: 7.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011220, HPA073462" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" No NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA011220: AB_1855041, HPA073462: AB_2686605" "unprognostic (7.20e-2)" "unprognostic (8.74e-3)" "unprognostic (4.30e-2)" "unprognostic (8.12e-5)" "unprognostic (8.33e-2)" "unprognostic (3.20e-1)" "unprognostic (5.27e-3)" "unprognostic (4.51e-1)" "unprognostic (3.83e-2)" "unprognostic (1.15e-1)" "unprognostic (9.30e-3)" "unprognostic (8.72e-2)" "unprognostic (1.45e-1)" "unprognostic (8.68e-4)" "unprognostic (8.88e-2)" "unprognostic (6.31e-2)" "unprognostic (2.16e-4)" 1.9 7.6 17.9 1.5 35.5 1.2 1.3 1.7 48.0 3.3 1.5 23.2 4.5 1.3 3.1 1.9 1.6 2.6 1.9 1.8 17.5 12.6 3.7 1.3 2.0 1.2 13.2 16.3 4.1 1.4 1.2 1.7 31.1 13.6 14.7 1.5 1.3 1.8 23.6 1.2 1.3 1.7 2.0 6.8 1.2 1.3 2.9 19.2 0.9 1.5 0.0 1.2 3.6 3.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 5.2 0.0 0.1 0.0 0.0 5.0 2.7 0.4 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.0 2.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 6.9 16.1 0.0 0.2 0.0 2.4 0.0 13.4 0.0 0.0 0.0 0.1 0.3 0.2 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 32.0 8.6 0.0 0.0 7.3 0.0 0.0 0.0 0.6 0.0 4.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.9 35.5 1.7 27.7 17.5 12.6 13.2 16.3 13.6 19.2 0.0 1.1 0.0 0.2 0.1 16.2 2.0 0.0 0.0 1.2 0.0 0.0 0.7 1.7 0.0 3.3 1.0 0.0 0.0 0.0 0.7 1.6 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.4 0.0 2.3 0.0 4.7 1.8 0.7 0.3 2.4 0.0 0.0 0.4 PCDH9 ENSG00000184226 "Protocadherin 9" Q9HC56 13 66302834-67230445 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 16.5;brain: 47.0" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 324.5;Cardiomyocytes: 94.6;Horizontal cells: 187.5;Muller glia cells: 87.9" "Cancer enriched" "Detected in single" 8 "glioma: 2.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "naive B-cell: 16.5" "Lineage enriched" "Detected in many" 7 "B-cells: 16.5" "Cell line enhanced" "Detected in many" "AF22: 12.6;LHCN-M2: 20.8;TIME: 24.1;U-698: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015581 Approved Nucleoplasm,Centrosome NA NA 1300000 "Nucleoplasm, Centrosome" "HPA015581: AB_1855048" "unprognostic (1.77e-1)" "unprognostic (8.36e-2)" "unprognostic (9.12e-3)" "unprognostic (4.42e-5)" "unprognostic (7.54e-2)" "unprognostic (1.18e-1)" "unprognostic (3.04e-1)" "unprognostic (1.38e-1)" "unprognostic (2.35e-1)" "unprognostic (8.21e-2)" "unprognostic (3.33e-1)" "unprognostic (1.14e-1)" "unprognostic (8.47e-4)" "unprognostic (6.44e-3)" "unprognostic (1.13e-1)" "unprognostic (2.27e-1)" "unprognostic (4.35e-4)" 4.5 3.2 18.4 1.1 24.7 4.1 1.5 6.7 47.0 1.8 1.3 7.8 0.0 0.9 1.0 2.1 1.0 1.1 2.4 5.7 15.0 10.0 3.5 2.3 2.3 1.4 21.4 11.0 1.4 2.0 0.7 1.3 0.7 16.6 2.5 1.3 0.0 1.0 5.6 2.0 0.9 1.0 1.2 11.0 1.6 1.7 1.6 18.9 0.7 1.8 0.0 1.4 1.1 0.6 16.5 1.0 2.5 0.0 0.7 0.1 0.2 0.0 9.5 12.6 0.0 3.4 2.6 0.0 1.9 0.1 1.3 0.5 0.0 0.0 2.7 0.0 1.4 0.4 0.0 1.0 0.3 0.6 0.0 5.0 0.1 0.1 0.0 3.3 0.3 0.1 6.3 0.3 1.5 2.5 0.3 1.0 1.1 0.3 0.1 20.8 0.7 5.7 0.0 0.1 0.2 1.2 8.7 0.4 0.0 0.2 0.0 1.6 0.6 0.0 0.1 0.1 0.3 0.0 0.0 24.1 0.7 0.6 2.9 1.0 3.7 0.0 31.7 5.4 0.0 2.5 2.5 0.0 0.1 0.0 0.0 0.0 3.7 0.0 0.0 0.0 16.5 0.1 0.1 0.1 0.7 0.0 1.0 0.0 0.2 18.4 24.7 6.7 24.6 15.0 10.0 21.4 11.0 16.6 18.9 17.9 45.8 7.2 2.3 1.6 324.5 94.6 0.0 0.0 7.9 5.2 19.6 0.1 8.3 1.7 3.0 2.9 0.0 0.0 0.0 0.2 8.7 2.6 1.1 3.4 0.2 187.5 60.1 19.0 2.2 2.2 27.3 1.0 10.1 0.0 0.2 87.9 0.2 0.3 13.8 0.6 25.3 6.5 25.0 4.7 5.8 0.3 0.0 1.7 0.4 0.7 PCDHA4 "CNR1, CNRN1, CRNR1, PCDH-ALPHA4" ENSG00000204967 "Protocadherin alpha 4" Q9UN74 5 140806929-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.1" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 3.0;Ciliated cells: 5.3;granulocytes: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 9.1;AF22: 8.9;EFO-21: 7.7;T-47d: 7.7" "Low region specificity" "Detected in all" "HPA043180, HPA073478" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "HPA043180: AB_10806381, HPA073478: AB_2686608" "unprognostic (2.71e-3)" "unprognostic (1.16e-1)" "unprognostic (2.85e-1)" "unprognostic (5.32e-2)" "unprognostic (1.93e-1)" "unprognostic (3.14e-2)" "unprognostic (2.56e-1)" "unprognostic (7.90e-3)" "unprognostic (7.14e-3)" "unprognostic (7.00e-2)" "unprognostic (5.06e-3)" "unprognostic (6.94e-5)" "unprognostic (5.01e-3)" "unprognostic (6.21e-2)" "unprognostic (3.98e-1)" "unprognostic (6.29e-3)" "unprognostic (4.79e-2)" 0.9 0.8 5.1 0.9 6.5 3.2 1.7 12.1 8.7 2.1 1.1 1.6 0.4 0.9 2.3 2.0 0.6 1.6 5.1 1.2 4.5 3.2 2.0 0.6 1.7 1.5 1.9 2.1 1.1 4.1 1.0 1.4 0.7 3.9 1.8 1.1 0.4 1.1 1.3 1.1 2.0 0.9 1.1 3.0 1.1 1.0 1.4 2.4 0.0 1.3 0.1 0.7 1.3 0.8 1.5 1.3 2.0 0.7 0.8 1.1 0.0 0.2 9.1 8.9 0.4 0.1 0.3 0.3 0.2 0.1 0.1 0.1 0.2 1.8 0.3 7.7 0.2 0.4 0.3 0.0 0.1 0.2 0.2 0.2 0.4 0.6 0.3 0.1 0.3 0.5 0.4 2.4 0.2 0.4 0.6 0.5 0.4 0.2 1.2 0.3 0.2 0.2 0.3 2.5 1.9 1.3 0.2 0.2 0.3 0.3 0.4 0.4 3.8 0.1 2.0 0.8 1.6 7.7 0.3 0.9 2.0 1.3 0.7 0.2 0.5 0.2 0.2 0.3 0.4 0.8 1.8 0.7 0.7 1.1 0.4 0.8 0.8 0.8 0.7 0.3 1.5 0.8 1.1 2.0 0.8 0.7 1.3 0.6 0.0 5.1 6.5 12.1 6.6 4.5 3.2 1.9 2.1 3.9 2.4 3.0 1.3 0.0 0.5 0.0 0.9 0.8 0.0 5.3 1.2 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 3.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.0 0.0 0.7 0.0 0.3 0.5 0.2 0.0 0.0 0.0 0.0 0.3 PCDHAC1 ENSG00000248383 "Protocadherin alpha subfamily C, 1" Q9H158 5 140926369-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "parathyroid gland: 33.3" "Cell type enhanced" "Detected in some" 27 "Alveolar cells type 1: 6.0;Bipolar cells: 1.7;Ciliated cells: 1.4;Rod photoreceptor cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 8.7;EFO-21: 3.7;hTCEpi: 11.3;PC-3: 6.4;SCLC-21H: 5.0" "Low region specificity" "Detected in all" HPA052775 Approved Nucleoplasm,Nucleoli,Vesicles No No "Nucleoplasm, Nucleoli" Vesicles "HPA052775: AB_2681942" "unprognostic (2.52e-1)" "unprognostic (1.06e-1)" "unprognostic (3.32e-3)" "unprognostic (9.52e-3)" "unprognostic (1.36e-1)" "unprognostic (9.63e-2)" "unprognostic (4.27e-2)" "unprognostic (2.51e-2)" "unprognostic (1.17e-1)" "unprognostic (6.24e-2)" "unprognostic (2.09e-1)" "unprognostic (3.64e-3)" "unprognostic (1.04e-3)" "unprognostic (3.25e-3)" "unprognostic (1.35e-1)" "unprognostic (2.96e-1)" "unprognostic (3.29e-2)" 0.3 0.4 0.9 0.3 1.0 0.0 0.0 2.0 2.8 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.9 0.0 1.0 1.6 0.2 0.1 0.8 1.0 1.1 0.0 1.5 33.3 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.8 0.8 0.4 0.0 0.0 0.2 0.1 0.5 0.2 0.2 0.1 0.0 0.0 8.7 1.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.7 0.0 1.1 0.0 0.3 1.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 11.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 6.4 0.0 0.0 0.0 0.5 0.4 5.0 2.4 0.0 0.7 0.0 1.2 0.5 0.0 0.0 0.6 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.5 0.2 0.2 0.1 0.0 0.0 6.0 0.3 0.0 0.0 0.0 1.7 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 PCDHAC2 PCDH-ALPHA-C2 ENSG00000243232 "Protocadherin alpha subfamily C, 2" Q9Y5I4 5 140966235-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "brain: 14.1;parathyroid gland: 52.5" "Cell type enhanced" "Detected in some" 17 "Ciliated cells: 2.7;Ito cells: 2.5;Rod photoreceptor cells: 1.6" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "AN3-CA: 36.9" HPA076190 Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA076190: AB_2686785" "unprognostic (1.47e-1)" "unprognostic (3.58e-3)" "unprognostic (2.59e-1)" "unprognostic (5.31e-4)" "unprognostic (3.89e-1)" "unprognostic (1.82e-2)" "unprognostic (5.03e-2)" "unprognostic (1.79e-1)" "unprognostic (1.26e-1)" "unprognostic (2.13e-2)" "unprognostic (2.45e-1)" "unprognostic (1.41e-1)" "unprognostic (2.30e-1)" "unprognostic (4.46e-4)" "unprognostic (9.90e-2)" "unprognostic (1.34e-1)" "unprognostic (1.08e-3)" 1.1 1.7 5.7 1.0 9.2 0.5 0.7 13.6 14.1 1.5 0.9 2.3 0.0 0.7 1.2 0.6 0.6 0.8 3.2 1.2 4.5 5.2 0.9 1.3 2.5 2.2 2.9 6.4 0.7 0.9 52.5 3.1 2.2 3.8 0.9 0.9 2.7 1.1 0.7 0.6 0.6 0.7 1.4 2.0 2.1 1.0 2.4 1.7 0.0 1.6 0.0 1.1 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.7 36.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.2 0.0 1.5 0.0 0.7 4.0 0.0 0.0 0.1 0.0 8.4 0.0 0.5 0.0 0.0 0.1 5.5 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.4 0.0 1.3 0.0 0.0 0.0 1.3 0.0 1.6 6.6 0.0 0.0 0.1 0.8 1.4 0.2 0.0 0.7 0.7 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 9.2 13.6 14.1 4.5 5.2 2.9 6.4 3.8 1.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 PCDHB1 PCDH-BETA1 ENSG00000171815 "Protocadherin beta 1" Q9Y5F3 5 141051135-141059344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skeletal muscle: 4.9" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 2: 1.4;Basal glandular cells: 1.1;Cardiomyocytes: 2.2;Ciliated cells: 4.0;Club cells: 1.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA053921 Uncertain Uncertain "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA053921: AB_2682310" "unprognostic (5.54e-2)" "unprognostic (1.60e-2)" "unprognostic (9.01e-4)" "unprognostic (8.65e-2)" "unprognostic (8.00e-2)" "unprognostic (7.82e-2)" "unprognostic (2.63e-2)" "unprognostic (1.40e-1)" "unprognostic (8.17e-5)" "unprognostic (3.38e-2)" "unprognostic (9.40e-2)" "unprognostic (1.23e-1)" "unprognostic (5.77e-4)" 0.1 0.3 0.3 0.1 0.5 1.0 0.1 0.1 0.2 0.5 0.5 0.4 0.1 0.6 0.1 1.8 0.0 0.1 0.4 0.4 0.7 0.1 0.2 0.4 0.2 0.1 1.1 0.7 1.9 0.0 0.1 0.0 0.5 0.0 4.9 0.8 0.5 0.0 0.3 0.3 0.8 1.8 0.3 0.0 0.1 0.1 1.3 0.7 2.5 0.6 1.0 0.6 0.2 0.8 0.4 0.8 1.1 0.2 0.2 1.1 1.1 0.2 0.1 0.1 1.6 1.4 1.1 1.6 0.3 1.1 1.5 0.0 0.1 0.2 0.9 1.2 1.2 1.9 0.7 0.1 1.4 1.2 0.2 0.3 0.2 0.2 1.7 0.2 1.0 0.8 2.6 0.2 1.4 0.7 0.9 1.2 1.2 0.4 1.2 1.0 0.9 0.1 1.0 2.2 0.8 0.1 1.8 1.3 1.2 0.6 0.5 1.2 1.0 0.7 0.8 0.6 1.5 0.6 1.0 1.1 1.1 1.2 2.3 0.6 0.7 0.5 0.4 0.5 0.7 0.5 0.4 0.2 1.3 0.6 0.5 2.5 1.0 0.4 0.7 0.3 0.2 0.0 1.4 0.0 1.1 0.0 0.2 2.2 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.6 PCDHB2 PCDH-BETA2 ENSG00000112852 "Protocadherin beta 2" Q9Y5E7 5 141094578-141098703 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 9 "Melanocytes: 3.3;Spermatocytes: 7.1;Spermatogonia: 4.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 13.7;AN3-CA: 29.4;EFO-21: 16.7;U-138 MG: 12.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007548 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA007548: AB_2667859" "unprognostic (2.94e-3)" "unprognostic (5.77e-2)" "unprognostic (4.57e-4)" "unprognostic (1.31e-1)" "unprognostic (3.03e-3)" "unprognostic (7.01e-2)" "unprognostic (5.52e-2)" "unprognostic (2.24e-1)" "unprognostic (3.99e-1)" "unprognostic (2.19e-2)" "unprognostic (1.16e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (6.99e-4)" "unprognostic (2.13e-3)" "unprognostic (6.70e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (4.84e-4)" 7.3 3.0 3.4 1.6 8.6 0.8 5.5 5.7 13.3 3.9 4.4 7.0 0.0 2.1 6.7 2.1 4.0 2.8 4.4 4.3 4.1 1.9 2.9 0.8 6.2 1.0 3.2 5.1 4.3 2.7 0.9 5.3 2.4 4.8 5.9 2.8 4.0 3.8 1.7 1.9 4.3 2.6 4.3 8.4 1.6 1.9 12.1 5.0 0.0 2.8 1.2 0.9 4.4 2.6 0.2 0.2 0.8 0.1 0.5 0.4 0.3 0.2 1.9 13.7 29.4 3.8 1.8 6.3 0.5 2.1 0.0 0.0 0.3 0.1 0.5 16.7 0.9 3.3 0.0 0.6 0.1 0.0 0.2 0.4 0.0 0.0 3.8 0.0 0.0 1.4 0.9 0.0 0.0 0.2 0.6 0.3 1.6 0.4 0.4 4.0 0.1 3.7 0.0 6.0 0.2 3.9 0.0 10.1 0.1 1.5 0.0 7.5 2.1 0.0 1.8 4.3 8.0 8.3 2.4 1.5 12.9 3.9 6.0 1.9 0.2 0.0 0.1 2.8 0.1 7.7 0.5 0.1 0.0 0.4 0.1 0.0 0.1 0.4 0.1 0.0 0.2 0.1 0.2 0.8 0.5 0.1 0.2 0.0 0.3 3.4 8.6 5.7 11.0 4.1 1.9 3.2 5.1 4.8 5.0 0.0 0.3 0.0 0.9 0.7 2.9 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.5 1.4 1.3 0.0 0.0 0.3 0.0 1.6 0.9 0.0 0.0 0.1 1.6 1.2 0.0 0.0 0.4 1.1 0.0 3.3 0.0 0.2 2.6 0.3 0.0 1.4 0.4 1.2 0.0 0.8 7.1 4.7 0.4 0.0 0.0 0.0 0.4 PCDHB6 PCDH-BETA6 ENSG00000113211 "Protocadherin beta 6" Q9Y5E3 5 141150022-141153287 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 13.4" "Cell type enriched" "Detected in some" 7 "Spermatocytes: 9.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 16.9;SH-SY5Y: 7.2;T-47d: 5.4;U-2197: 7.6;WM-115: 10.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029566, HPA075308" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA029566: AB_10601385, HPA075308: " "unprognostic (3.25e-2)" "unprognostic (1.54e-2)" "unprognostic (1.81e-1)" "unprognostic (8.05e-2)" "unprognostic (7.65e-3)" "unprognostic (2.82e-1)" "unprognostic (1.73e-3)" "unprognostic (9.64e-3)" "unprognostic (8.62e-2)" "unprognostic (1.54e-3)" "unprognostic (2.28e-2)" "unprognostic (6.33e-2)" "prognostic unfavorable (5.52e-4)" "unprognostic (8.60e-4)" "unprognostic (2.31e-2)" "unprognostic (7.08e-3)" "unprognostic (6.52e-2)" 2.5 2.4 3.9 1.0 5.1 0.4 2.5 4.2 8.4 2.3 1.5 2.6 0.0 0.6 4.5 3.7 0.7 2.1 1.4 1.6 3.5 1.9 1.6 1.4 1.7 0.7 2.6 3.6 3.7 1.5 13.4 6.4 1.5 2.9 1.5 0.9 0.7 2.5 1.5 1.4 2.4 1.0 3.0 3.3 1.5 0.9 5.4 3.1 0.0 1.1 1.0 0.7 1.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 16.9 0.2 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 7.2 0.0 0.1 3.6 0.4 5.4 2.2 0.0 0.6 1.3 7.6 0.0 0.0 0.0 0.0 3.9 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 5.1 4.2 8.4 3.5 1.9 2.6 3.6 2.9 3.1 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.7 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.4 0.0 0.2 0.0 1.2 9.9 0.1 0.4 0.0 0.0 0.0 0.0 PCDHGA1 PCDH-GAMMA-A1 ENSG00000204956 "Protocadherin gamma subfamily A, 1" Q9Y5H4 5 141330571-141512981 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.7" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 3.0;Bipolar cells: 1.6;Cardiomyocytes: 1.7;Horizontal cells: 3.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 7.0;T-47d: 11.5;WM-115: 5.2" "Low region specificity" "Detected in many" "HPA008755, HPA010580, HPA036547" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA036547: AB_10669798" "unprognostic (9.50e-4)" "unprognostic (2.39e-2)" "unprognostic (9.88e-2)" "unprognostic (4.42e-3)" "unprognostic (3.39e-1)" "unprognostic (3.97e-2)" "unprognostic (2.42e-1)" "unprognostic (5.61e-3)" "unprognostic (1.70e-2)" "unprognostic (6.89e-2)" "unprognostic (2.86e-1)" "unprognostic (1.03e-1)" "unprognostic (1.07e-3)" "unprognostic (4.76e-2)" "unprognostic (1.38e-1)" "unprognostic (2.73e-2)" "unprognostic (1.45e-3)" 1.4 1.3 2.7 0.9 11.7 1.0 1.1 6.8 7.9 1.4 1.2 2.7 0.5 1.0 2.8 3.9 1.3 1.1 0.8 3.9 3.5 2.8 1.2 0.5 1.2 1.0 2.5 2.5 2.9 2.5 2.8 6.1 2.3 5.4 1.5 0.9 2.4 1.1 1.0 1.7 1.5 0.6 1.8 2.4 1.1 0.8 2.7 1.1 0.0 1.3 0.6 0.7 1.2 0.9 1.2 0.9 2.7 0.5 0.8 1.0 0.2 0.1 0.4 0.5 1.9 1.2 2.1 0.3 1.7 1.1 0.5 1.0 0.5 0.2 0.5 2.8 1.1 0.9 0.2 0.2 0.3 1.1 0.3 0.3 0.2 0.4 0.3 0.3 0.1 0.2 1.8 0.5 0.0 0.7 3.4 0.1 0.3 0.2 0.8 7.0 0.1 0.2 0.8 0.3 0.1 0.3 3.1 2.7 0.3 0.3 0.3 1.8 2.1 0.3 0.9 1.7 0.5 11.5 0.4 0.8 3.3 0.7 1.6 0.4 0.3 1.0 0.2 3.9 0.2 5.2 2.7 0.5 0.5 0.7 0.4 0.4 0.7 0.7 0.5 0.2 1.2 1.0 0.8 1.1 0.8 0.5 0.9 0.6 0.2 2.7 11.7 6.8 6.1 3.5 2.8 2.5 2.5 5.4 1.1 3.0 0.0 0.0 0.0 0.0 1.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PCDHGA10 PCDH-GAMMA-A10 ENSG00000253846 "Protocadherin gamma subfamily A, 10" Q9Y5H3 5 141412987-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 33.7" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 27.0;Cone photoreceptor cells: 15.7;Horizontal cells: 22.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 12.2;HSkMC: 13.8;T-47d: 16.3;U-2197: 9.6" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA077276" Approved Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077276: " "unprognostic (2.92e-1)" "unprognostic (2.17e-4)" "unprognostic (1.63e-1)" "unprognostic (3.33e-2)" "unprognostic (1.12e-1)" "unprognostic (3.05e-2)" "unprognostic (9.99e-2)" "unprognostic (1.06e-2)" "unprognostic (2.01e-1)" "unprognostic (2.02e-1)" "unprognostic (4.39e-2)" "unprognostic (2.03e-2)" "unprognostic (2.64e-3)" "unprognostic (2.32e-3)" "unprognostic (1.34e-1)" "unprognostic (2.06e-1)" "unprognostic (8.83e-3)" 5.2 4.2 7.9 1.6 11.4 1.2 2.7 2.4 33.7 3.6 2.9 9.8 1.2 2.4 3.0 2.4 4.3 3.6 3.7 2.3 9.1 4.4 2.0 6.5 3.5 1.7 5.1 7.2 3.6 1.9 1.4 2.4 7.4 5.3 3.6 2.6 4.9 4.1 4.6 2.0 4.7 2.9 3.1 6.7 2.5 4.7 2.0 6.5 0.0 4.9 1.5 3.3 2.5 3.5 0.9 1.1 1.5 0.7 0.8 1.0 0.2 0.0 0.0 12.2 6.2 5.4 2.3 5.8 2.1 0.1 3.0 4.8 0.3 0.7 0.7 8.1 3.0 0.2 0.3 2.9 1.9 2.4 0.8 0.0 0.0 0.3 0.0 2.2 1.2 0.2 13.8 0.3 2.0 0.8 0.3 1.1 0.3 0.0 0.1 7.4 0.0 0.1 0.3 1.2 0.0 0.1 0.1 1.0 0.0 2.1 0.1 1.6 0.6 0.3 0.0 0.3 3.0 16.3 1.5 2.7 5.6 0.3 9.6 0.1 0.2 0.9 0.1 2.9 0.0 0.3 1.5 0.3 0.3 1.0 0.4 1.0 0.6 0.4 0.6 0.1 0.9 0.4 0.9 0.9 0.8 0.7 1.1 0.3 0.2 7.9 11.4 2.4 8.5 9.1 4.4 5.1 7.2 5.3 6.5 0.0 1.3 0.0 1.8 0.1 27.0 2.3 2.5 0.0 2.3 1.8 15.7 1.7 0.0 0.9 0.0 2.1 0.4 0.0 1.2 1.1 1.2 3.2 1.1 1.1 0.8 22.3 1.2 3.1 0.0 0.0 3.1 0.3 1.7 0.0 1.1 8.7 2.1 0.0 2.1 0.0 5.2 6.5 1.1 0.3 0.7 0.4 0.3 0.0 0.8 0.9 PCDHGA11 PCDH-GAMMA-A11 ENSG00000253873 "Protocadherin gamma subfamily A, 11" Q9Y5H2 5 141421047-141512979 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.6" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 1.9;Horizontal cells: 1.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.9" "Lineage enhanced" "Detected in single" "dendritic cells: 1.9" "Cell line enhanced" "Detected in many" "ASC diff: 12.0;ASC TERT1: 13.0;GAMG: 22.7;hTERT-RPE1: 33.8;WM-115: 20.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.13e-2)" "unprognostic (1.78e-3)" "unprognostic (9.13e-2)" "unprognostic (1.15e-2)" "unprognostic (1.68e-2)" "unprognostic (2.62e-1)" "unprognostic (2.70e-2)" "unprognostic (1.16e-3)" "unprognostic (1.09e-1)" "unprognostic (1.95e-2)" "unprognostic (2.97e-1)" "unprognostic (2.22e-1)" "unprognostic (3.03e-2)" "unprognostic (3.74e-2)" "unprognostic (3.54e-1)" "unprognostic (4.34e-3)" "unprognostic (1.89e-1)" 3.4 2.5 7.4 2.8 9.4 0.5 2.1 4.1 8.5 2.4 2.5 8.5 0.0 1.2 2.6 1.7 3.1 2.1 2.1 3.4 11.6 1.9 1.9 1.2 2.3 1.8 4.5 5.2 3.8 2.3 1.3 1.9 8.3 5.0 2.5 1.5 3.3 2.8 3.4 2.8 6.6 1.2 3.3 4.9 1.6 1.8 2.2 7.1 0.1 3.4 0.6 1.7 1.7 2.2 0.0 1.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 1.1 12.0 13.0 0.4 2.6 5.0 2.0 3.2 0.0 0.1 0.3 4.3 2.6 22.7 1.7 0.0 0.3 3.2 0.0 1.1 0.0 0.0 0.0 2.0 0.2 0.0 9.3 0.1 3.5 0.0 33.8 3.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 5.0 0.2 1.5 3.6 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 20.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 7.4 9.4 4.1 8.5 11.6 1.9 4.5 5.2 5.0 7.1 0.0 0.6 0.0 0.1 0.0 1.9 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.2 0.2 0.5 0.0 0.0 0.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PCDHGA12 "CDH21, FIB3, KIAA0588, PCDH-GAMMA-A12" ENSG00000253159 "Protocadherin gamma subfamily A, 12" O60330 5 141430589-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.9" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 3.5;Cardiomyocytes: 1.8;Ito cells: 1.3" "Cancer enhanced" "Detected in many" "melanoma: 5.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 7.7;BJ hTERT+: 12.9;fHDF/TERT166: 19.1;HHSteC: 6.3;HSkMC: 14.3;TIME: 6.1" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.17e-3)" "unprognostic (2.71e-2)" "unprognostic (1.04e-2)" "unprognostic (2.67e-1)" "unprognostic (2.74e-1)" "unprognostic (5.06e-2)" "unprognostic (1.99e-1)" "unprognostic (9.01e-3)" "unprognostic (1.19e-1)" "unprognostic (4.65e-4)" "unprognostic (2.98e-1)" "unprognostic (3.02e-1)" "unprognostic (1.28e-4)" "unprognostic (8.30e-3)" "unprognostic (1.57e-1)" "unprognostic (2.42e-1)" "unprognostic (6.85e-3)" 5.1 12.7 14.8 2.8 18.9 0.7 2.4 4.7 13.8 4.9 1.8 8.6 0.6 1.4 5.4 2.3 3.5 2.7 11.3 6.5 15.7 5.6 3.1 2.8 6.5 1.6 4.7 7.3 6.2 3.6 2.0 2.7 6.5 8.4 3.5 1.7 3.4 1.7 4.9 1.9 5.1 1.5 5.3 8.4 3.7 2.2 1.6 12.4 0.4 3.0 0.6 1.7 4.5 3.6 3.7 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.6 1.2 0.1 7.7 12.9 0.0 0.0 0.0 0.0 0.4 0.0 19.1 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.3 0.0 0.0 14.3 0.0 3.8 0.0 0.0 4.5 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 6.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 14.8 18.9 4.7 10.4 15.7 5.6 4.7 7.3 8.4 12.4 0.0 0.0 0.0 0.2 0.0 3.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.3 0.1 0.0 0.4 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGA2 PCDH-GAMMA-A2 ENSG00000081853 "Protocadherin gamma subfamily A, 2" Q9Y5H1 5 141338760-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 2.7;Cardiomyocytes: 1.6;Leydig cells: 1.1;Peritubular cells: 2.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.8;BJ: 5.4;fHDF/TERT166: 6.3;HSkMC: 5.0;hTERT-RPE1: 5.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA038625" Approved Approved "Nucleoplasm,Nucleoli,Vesicles,Plasma membrane,Focal adhesion sites,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Nucleoli, Focal adhesion sites, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA038625: AB_2732480" "unprognostic (2.43e-3)" "unprognostic (2.10e-2)" "unprognostic (1.32e-2)" "unprognostic (4.54e-1)" "unprognostic (2.92e-1)" "unprognostic (1.14e-1)" "unprognostic (3.01e-1)" "unprognostic (2.82e-1)" "unprognostic (1.56e-1)" "unprognostic (1.18e-1)" "unprognostic (9.01e-2)" "unprognostic (4.32e-2)" "unprognostic (8.45e-3)" "unprognostic (9.68e-3)" "unprognostic (1.04e-2)" "unprognostic (1.18e-2)" "unprognostic (2.23e-4)" 5.1 4.3 6.7 2.1 8.0 0.6 4.2 5.2 12.6 6.6 2.6 4.6 1.0 0.9 6.5 5.7 2.4 5.5 5.5 11.1 6.5 4.6 3.3 2.4 4.6 1.1 6.0 2.3 15.3 8.4 9.2 10.6 2.2 7.8 5.3 1.4 13.8 3.3 5.8 2.6 2.9 1.4 5.2 5.6 1.9 2.1 10.4 3.5 0.0 4.3 1.2 1.1 3.2 5.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.3 3.9 9.8 0.1 5.4 2.1 0.5 0.9 0.1 0.1 0.1 0.7 6.3 0.8 0.2 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 5.0 0.2 0.1 0.3 5.8 2.0 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.1 1.4 0.3 0.2 0.8 0.0 0.3 0.7 0.0 3.6 0.1 0.5 0.7 0.0 3.3 0.9 0.5 0.3 0.1 0.0 0.4 0.0 2.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 8.0 5.2 7.2 6.5 4.6 6.0 2.3 7.8 3.5 0.0 0.0 0.0 0.1 0.0 2.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.5 0.3 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 PCDHGA3 PCDH-GAMMA-A3 ENSG00000254245 "Protocadherin gamma subfamily A, 3" Q9Y5H0 5 141343829-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 20 "Bipolar cells: 2.4;Cardiomyocytes: 1.1;Horizontal cells: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 11.2;BJ: 3.7;EFO-21: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (6.47e-2)" "unprognostic (4.79e-2)" "unprognostic (1.48e-2)" "unprognostic (1.64e-1)" "unprognostic (4.53e-2)" "unprognostic (1.03e-1)" "unprognostic (2.35e-1)" "unprognostic (1.85e-1)" "unprognostic (7.44e-2)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (3.17e-2)" "unprognostic (2.43e-1)" "unprognostic (2.32e-3)" "unprognostic (7.12e-3)" "unprognostic (3.31e-2)" "unprognostic (2.52e-4)" 4.0 4.5 11.7 1.4 10.5 0.7 2.5 6.9 13.7 4.7 1.3 7.9 0.0 0.7 4.5 3.5 1.5 2.9 3.5 12.2 8.5 5.8 2.5 2.5 2.6 1.0 6.6 7.7 8.6 3.6 1.8 6.3 5.7 8.7 3.0 1.3 4.6 2.9 3.2 1.5 1.9 1.1 3.6 6.0 1.5 1.2 5.2 3.8 0.0 3.3 1.3 1.0 1.7 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.1 0.2 1.5 0.0 3.7 0.3 0.0 0.1 0.0 0.0 0.1 9.2 0.8 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.4 0.1 0.5 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 10.5 6.9 13.7 8.5 5.8 6.6 7.7 8.7 3.8 0.0 0.0 0.0 0.1 0.0 2.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 PCDHGA4 PCDH-GAMMA-A4 ENSG00000262576 "Protocadherin gamma subfamily A, 4" Q9Y5G9 5 141355025-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "MAIT T-cell: 1.9" "Lineage enriched" "Detected in single" 7 "T-cells: 1.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.3;BJ: 5.7;HSkMC: 6.0;HUVEC TERT2: 5.7;U-87 MG: 8.2" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.27e-2)" "unprognostic (4.55e-3)" "unprognostic (2.00e-2)" "unprognostic (6.54e-4)" "unprognostic (1.87e-2)" "unprognostic (1.06e-2)" "unprognostic (1.02e-1)" "unprognostic (1.20e-2)" "unprognostic (5.62e-2)" "unprognostic (3.76e-1)" "unprognostic (6.31e-2)" "unprognostic (1.74e-1)" "unprognostic (2.94e-2)" "unprognostic (1.30e-2)" "unprognostic (2.30e-2)" "unprognostic (1.65e-1)" "unprognostic (2.31e-4)" 5.4 4.7 6.5 1.8 8.3 0.5 3.0 8.5 11.2 4.8 2.0 10.4 1.5 1.2 5.0 3.0 1.9 3.4 3.1 4.8 6.3 5.9 2.0 2.7 3.6 0.9 5.6 8.1 5.8 6.7 8.5 3.4 2.8 6.1 4.1 1.4 3.5 4.3 4.2 1.5 1.8 1.2 5.0 5.9 1.3 1.4 2.7 4.0 0.0 2.6 2.7 0.9 2.3 2.5 0.3 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 1.0 0.6 4.5 10.3 0.0 5.7 4.6 0.3 1.1 0.0 0.1 1.0 2.0 4.8 1.8 0.1 0.2 0.2 0.6 0.0 0.5 0.0 0.0 0.0 1.8 0.0 0.4 6.0 0.2 0.1 0.0 3.5 5.7 0.0 0.2 0.3 2.4 0.8 0.3 0.2 0.2 0.0 0.3 0.3 1.6 0.1 0.3 0.0 0.8 1.7 0.3 0.3 1.1 0.5 2.2 0.0 3.7 2.4 0.7 3.2 0.5 0.2 0.3 0.2 8.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.5 8.3 8.5 9.3 6.3 5.9 5.6 8.1 6.1 4.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PCDHGA5 "CDH-GAMMA-A5, ME3, PCDH-GAMMA-A5" ENSG00000253485 "Protocadherin gamma subfamily A, 5" Q9Y5G8 5 141364232-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 19.1" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 10.6;Horizontal cells: 9.5;Sertoli cells: 6.5" "Cancer enhanced" "Detected in single" "prostate cancer: 1.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "ASC diff: 18.9;ASC TERT1: 7.5" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.61e-2)" "unprognostic (1.04e-2)" "unprognostic (5.28e-2)" "unprognostic (4.83e-1)" "unprognostic (6.60e-3)" "unprognostic (5.71e-2)" "unprognostic (8.46e-2)" "unprognostic (6.53e-3)" "unprognostic (4.07e-1)" "unprognostic (9.40e-2)" "unprognostic (1.38e-1)" "unprognostic (1.05e-1)" "unprognostic (1.12e-1)" "unprognostic (5.90e-2)" "unprognostic (3.93e-2)" "unprognostic (1.55e-2)" "unprognostic (8.38e-4)" 4.0 2.7 6.1 1.8 9.1 0.9 3.9 19.1 9.6 9.0 2.7 7.7 4.1 1.0 7.6 3.2 3.3 4.7 4.5 4.9 6.9 4.0 1.5 1.2 3.3 1.3 3.2 3.8 6.6 1.7 3.3 3.7 2.7 4.6 5.6 1.6 4.1 2.5 4.0 1.5 3.0 1.5 4.3 6.3 1.4 1.7 1.7 3.7 0.0 1.8 0.9 1.0 2.5 4.2 0.9 0.8 1.6 0.6 1.9 0.7 0.2 0.0 0.5 0.3 0.1 18.9 7.5 0.0 0.8 0.2 0.1 0.4 0.0 0.0 0.9 0.4 0.3 1.0 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.2 0.1 0.2 0.1 0.1 1.8 0.2 0.0 0.0 0.4 0.6 0.0 0.1 0.6 0.8 0.3 0.5 0.7 0.1 0.0 0.3 0.9 0.7 0.1 0.0 0.0 0.2 0.3 0.1 0.3 0.3 0.3 1.6 0.0 1.0 0.7 0.2 1.0 0.7 0.1 1.0 0.1 0.3 0.2 0.8 1.5 0.6 0.6 0.7 0.3 0.3 0.6 0.6 0.4 0.1 0.9 0.7 0.7 1.6 1.9 0.2 0.8 0.4 0.2 6.1 9.1 19.1 9.6 6.9 4.0 3.2 3.8 4.6 3.7 0.0 0.6 0.0 0.6 0.1 10.6 1.6 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.4 0.3 1.1 0.0 0.1 9.5 0.0 1.8 0.3 0.0 3.4 0.0 0.0 0.0 0.0 3.3 0.2 0.0 1.8 0.0 1.1 6.5 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 PCDHGA6 PCDH-GAMMA-A6 ENSG00000253731 "Protocadherin gamma subfamily A, 6" Q9Y5G7 5 141373914-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.6" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 9.7;Cardiomyocytes: 4.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HSkMC: 5.8;SCLC-21H: 11.2;T-47d: 6.5;WM-115: 14.0" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (4.49e-2)" "unprognostic (8.91e-3)" "unprognostic (5.45e-2)" "unprognostic (1.43e-1)" "unprognostic (1.15e-1)" "unprognostic (1.49e-2)" "unprognostic (1.16e-1)" "unprognostic (1.18e-1)" "unprognostic (1.25e-1)" "unprognostic (2.07e-2)" "unprognostic (3.86e-3)" "unprognostic (2.02e-2)" "unprognostic (5.26e-2)" "unprognostic (7.44e-2)" "unprognostic (5.21e-2)" "unprognostic (1.11e-1)" "unprognostic (4.19e-3)" 4.1 3.8 6.1 2.3 8.4 0.8 2.9 19.6 10.8 7.9 3.4 8.3 2.9 1.0 6.9 4.7 2.6 4.3 3.6 3.7 5.0 4.3 2.8 1.7 3.3 1.4 2.9 4.7 9.7 2.5 2.5 4.5 6.9 3.3 4.0 1.6 5.8 4.1 5.3 2.1 4.7 1.5 6.1 2.8 2.8 1.7 2.2 2.9 0.2 3.8 1.2 1.5 4.6 3.6 1.3 0.7 2.8 0.6 0.5 0.8 0.2 0.1 0.4 3.2 0.5 1.6 5.4 0.1 2.3 0.8 1.2 1.2 0.0 0.2 2.2 3.1 3.7 1.2 0.5 0.1 0.5 0.8 0.0 0.3 0.0 0.3 0.3 0.9 0.1 0.1 5.8 0.4 0.3 0.1 1.1 1.8 0.1 0.3 1.3 0.4 0.5 0.7 1.8 0.3 0.1 0.1 1.5 0.4 0.0 0.4 0.1 11.2 0.9 0.1 0.3 0.7 0.7 6.5 0.1 5.5 0.9 0.4 0.9 0.8 0.4 1.8 0.4 0.9 0.8 14.0 1.8 0.6 0.3 0.8 0.3 0.3 0.8 0.6 0.2 0.1 1.3 0.3 0.5 2.8 0.5 0.3 0.7 0.5 0.2 6.1 8.4 19.6 10.8 5.0 4.3 2.9 4.7 3.3 2.9 0.0 2.1 0.5 0.5 0.0 9.7 4.5 2.5 1.4 1.2 0.0 0.0 0.0 0.0 0.3 0.4 1.0 0.0 0.0 1.3 0.1 0.3 0.4 0.0 0.5 0.1 1.6 0.0 1.8 0.0 0.0 1.1 0.3 0.0 0.0 0.0 1.9 0.5 0.0 2.1 0.0 1.0 0.0 0.5 0.1 0.2 0.0 0.2 0.0 0.0 0.1 PCDHGA7 PCDH-GAMMA-A7 ENSG00000253537 "Protocadherin gamma subfamily A, 7" Q9Y5G6 5 141382739-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.9" "Cell type enhanced" "Detected in some" 22 "Bipolar cells: 3.5;Cardiomyocytes: 1.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.9;BJ hTERT+: 17.3;hTERT-RPE1: 9.3;SH-SY5Y: 15.5;T-47d: 6.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.00e-2)" "unprognostic (4.73e-3)" "unprognostic (1.42e-1)" "unprognostic (7.49e-2)" "unprognostic (2.10e-1)" "unprognostic (6.85e-2)" "unprognostic (2.61e-1)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (5.78e-2)" "unprognostic (3.72e-2)" "unprognostic (1.66e-1)" "unprognostic (3.56e-1)" "unprognostic (4.21e-3)" "unprognostic (6.30e-2)" "unprognostic (4.99e-2)" "unprognostic (1.42e-3)" 1.7 2.0 3.1 1.3 9.0 0.6 2.1 5.3 14.9 3.5 3.0 7.1 2.1 1.0 4.2 4.1 2.2 3.3 1.9 3.0 5.1 3.3 3.2 1.9 2.2 1.0 5.1 6.6 4.7 2.5 4.6 3.4 4.8 5.4 3.7 1.5 5.8 2.6 3.3 1.6 3.8 1.2 3.0 6.3 1.3 1.4 2.1 5.1 0.0 6.6 1.5 1.0 2.4 2.5 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.4 1.9 0.0 5.8 9.9 0.0 2.6 17.3 3.5 5.2 0.0 0.0 0.4 4.3 0.5 0.1 0.1 0.0 0.1 2.9 0.0 0.3 0.0 0.4 0.1 1.0 0.0 0.0 4.3 0.1 0.0 0.6 9.3 1.4 0.0 0.0 0.1 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 15.5 0.0 0.1 0.1 3.3 6.8 0.0 5.2 0.1 0.1 2.5 0.0 0.1 1.5 0.0 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.1 9.0 5.3 7.7 5.1 3.3 5.1 6.6 5.4 5.1 0.0 0.0 0.0 0.4 0.0 3.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.6 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 PCDHGA8 "KIAA0327, PCDH-GAMMA-A8" ENSG00000253767 "Protocadherin gamma subfamily A, 8" Q9Y5G5 5 141390157-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ductus deferens: 7.1" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 10.4;Cardiomyocytes: 2.5;Horizontal cells: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 2.9;neutrophil: 2.8" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.9" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.28e-2)" "unprognostic (2.27e-2)" "unprognostic (4.86e-2)" "unprognostic (3.38e-2)" "unprognostic (2.80e-1)" "unprognostic (4.10e-2)" "unprognostic (7.68e-2)" "unprognostic (2.30e-2)" "unprognostic (1.83e-2)" "unprognostic (2.23e-1)" "unprognostic (1.24e-1)" "unprognostic (1.35e-2)" "unprognostic (1.49e-3)" "unprognostic (7.59e-2)" "unprognostic (3.92e-2)" "unprognostic (3.38e-1)" "unprognostic (1.99e-3)" 0.6 0.7 0.8 0.7 0.6 2.5 0.7 2.3 2.2 1.2 1.2 1.0 7.1 0.4 2.3 1.5 2.1 0.7 0.9 2.0 1.4 0.5 0.5 0.9 1.1 0.7 0.5 0.4 2.6 0.6 0.2 1.9 1.4 3.5 0.9 0.8 0.4 0.8 0.5 2.2 2.5 1.1 0.7 1.6 0.7 0.7 1.0 1.3 1.1 2.4 0.4 0.6 0.6 1.2 0.7 0.4 2.9 0.4 0.5 0.3 0.1 0.3 0.2 1.1 0.6 1.1 2.6 0.6 2.4 1.5 1.7 0.7 0.2 0.4 1.1 1.0 1.8 0.3 0.4 0.0 0.0 1.3 0.3 0.2 0.3 0.5 0.3 0.1 0.4 0.8 1.4 0.1 0.5 0.1 0.5 0.4 0.2 0.2 0.9 0.2 0.2 0.5 0.7 2.6 0.0 0.1 1.0 0.2 0.1 0.1 0.3 0.7 0.6 0.3 0.9 0.4 2.4 1.2 1.7 2.5 2.6 0.9 0.6 0.2 0.3 0.3 0.4 1.3 0.4 1.3 2.9 0.4 0.5 0.3 0.2 0.2 0.4 0.3 0.2 0.1 0.7 0.2 0.3 2.8 0.5 0.3 0.4 0.2 0.1 0.8 0.6 2.3 2.2 1.4 0.5 0.5 0.4 3.5 1.3 0.0 1.1 0.0 0.8 0.0 10.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.1 3.2 0.0 0.6 0.8 0.0 2.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 1.4 0.0 1.7 0.0 0.2 0.6 0.9 0.0 0.0 0.0 0.0 0.4 PCDHGA9 PCDH-GAMMA-A9 ENSG00000261934 "Protocadherin gamma subfamily A, 9" Q9Y5G4 5 141402932-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 3.7;Club cells: 1.2;Horizontal cells: 3.2;Muller glia cells: 1.3" "Cancer enhanced" "Detected in some" "glioma: 3.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 4.1;HSkMC: 4.6;hTERT-RPE1: 19.1;TIME: 5.0;U-87 MG: 5.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.98e-2)" "unprognostic (7.47e-3)" "unprognostic (9.86e-3)" "unprognostic (2.22e-1)" "unprognostic (4.68e-2)" "unprognostic (4.96e-2)" "unprognostic (1.61e-1)" "unprognostic (2.15e-1)" "unprognostic (2.39e-1)" "unprognostic (1.87e-3)" "unprognostic (2.26e-1)" "unprognostic (1.79e-1)" "unprognostic (4.48e-3)" "unprognostic (1.94e-2)" "unprognostic (8.83e-2)" "unprognostic (2.71e-1)" "unprognostic (1.83e-2)" 5.6 5.4 12.0 2.6 12.6 0.9 3.7 11.5 17.3 6.9 2.7 11.2 0.1 2.1 7.6 3.9 4.8 6.3 6.5 3.2 10.3 8.5 3.0 2.8 5.0 2.1 9.6 7.1 9.1 3.0 3.8 3.0 3.6 10.9 5.2 2.7 7.7 3.8 7.3 1.9 5.5 2.0 5.9 13.0 3.6 2.9 2.0 5.9 0.0 4.6 1.4 2.5 4.8 3.7 0.5 0.3 1.0 0.5 0.2 1.0 0.0 0.0 0.2 0.7 1.8 0.1 0.3 0.2 0.8 0.0 0.7 0.7 0.3 0.4 1.4 4.1 2.2 0.3 0.1 0.1 0.2 0.8 0.0 0.3 0.0 0.1 0.0 1.3 0.0 0.3 4.6 0.2 0.4 0.3 19.1 1.1 0.1 0.1 0.2 0.4 0.4 0.2 0.5 0.2 0.1 0.0 0.2 0.5 0.0 0.2 0.2 0.5 1.2 0.4 0.1 0.6 0.5 1.1 0.5 5.0 0.3 0.3 0.1 2.7 0.2 0.1 0.1 5.8 0.1 1.0 1.0 0.5 0.3 1.0 0.3 0.6 0.3 0.4 0.2 0.1 0.5 0.4 0.7 1.0 0.2 0.2 0.3 0.1 0.0 12.0 12.6 11.5 16.2 10.3 8.5 9.6 7.1 10.9 5.9 0.0 0.0 0.0 0.1 0.2 3.7 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 PCDHGB1 PCDH-GAMMA-B1 ENSG00000254221 "Protocadherin gamma subfamily B, 1" Q9Y5G3 5 141350102-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 32.2;pituitary gland: 13.7" "Group enriched" "Detected in some" 17 "Early spermatids: 5.4;Late spermatids: 5.9;Melanocytes: 1.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "naive CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Cell line enhanced" "Detected in many" "ASC diff: 14.7;ASC TERT1: 7.7;hTERT-RPE1: 8.0;T-47d: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA076182" Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Focal adhesion sites,Midbody" Yes No "Vesicles, Plasma membrane" "Nucleoplasm, Focal adhesion sites, Midbody" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076182: AB_2686783" "unprognostic (1.53e-2)" "unprognostic (1.94e-3)" "unprognostic (3.21e-1)" "unprognostic (4.38e-3)" "unprognostic (2.98e-1)" "unprognostic (8.36e-3)" "unprognostic (2.37e-1)" "unprognostic (9.57e-2)" "unprognostic (8.57e-2)" "unprognostic (1.06e-1)" "unprognostic (3.44e-2)" "unprognostic (4.78e-2)" "unprognostic (6.33e-2)" "unprognostic (3.15e-2)" "unprognostic (8.75e-2)" "unprognostic (1.93e-1)" "unprognostic (7.63e-3)" 2.3 2.7 8.2 1.4 7.5 1.0 2.1 4.3 32.2 2.5 1.4 9.4 0.1 1.2 3.7 2.0 1.7 1.9 2.1 2.2 7.6 5.7 2.1 1.3 2.4 1.2 5.5 5.0 4.1 2.8 1.4 13.7 1.6 7.0 2.5 1.4 2.6 1.7 3.1 1.1 1.4 1.3 3.0 6.9 1.4 1.2 1.5 5.6 0.0 2.5 0.0 1.2 1.4 1.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 2.0 1.8 0.0 14.7 7.7 0.1 1.4 3.6 0.5 0.8 0.2 0.5 0.5 4.7 0.5 3.5 0.6 0.4 0.2 0.5 0.0 0.9 0.0 0.2 1.3 0.2 0.0 0.1 1.2 0.0 0.0 0.0 8.0 0.1 0.0 0.2 0.2 3.3 1.8 0.4 0.3 0.2 0.0 0.0 0.0 2.7 0.1 0.0 0.0 1.1 0.8 0.0 0.9 0.1 1.5 9.6 0.0 1.1 0.2 1.6 1.2 0.0 0.0 2.6 0.3 2.9 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 8.2 7.5 4.3 9.6 7.6 5.7 5.5 5.0 7.0 5.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 1.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGB2 PCDH-GAMMA-B2 ENSG00000253910 "Protocadherin gamma subfamily B, 2" Q9Y5G2 5 141360042-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Cancer enriched" "Detected in many" 5 "glioma: 6.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 14.4;ASC TERT1: 10.5;LHCN-M2: 8.5;REH: 7.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA077526" Uncertain Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane, Cytosol" Nucleoplasm "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077526: AB_2732350" "unprognostic (7.14e-3)" "unprognostic (8.79e-3)" "unprognostic (3.21e-2)" "unprognostic (2.17e-1)" "prognostic unfavorable (8.67e-4)" "unprognostic (1.10e-2)" "unprognostic (2.19e-4)" "unprognostic (2.68e-1)" "unprognostic (2.64e-1)" "unprognostic (1.78e-1)" "unprognostic (1.05e-1)" "unprognostic (8.46e-3)" "unprognostic (4.59e-2)" "unprognostic (2.57e-1)" "unprognostic (3.06e-2)" "unprognostic (1.29e-1)" "unprognostic (3.36e-4)" 4.9 3.6 11.3 2.2 9.7 0.9 3.7 8.7 12.2 7.2 2.4 11.6 0.3 1.2 9.2 3.2 3.2 5.6 6.2 4.6 9.3 7.0 2.7 2.7 5.4 1.4 7.0 8.6 9.0 2.6 7.5 3.0 3.9 7.3 4.4 2.8 3.1 2.4 4.4 1.9 2.9 2.1 5.0 7.0 2.2 2.0 1.8 7.8 0.1 2.6 1.3 1.4 2.8 3.3 0.9 0.9 0.5 0.0 0.0 0.7 0.0 0.1 0.3 2.1 0.2 14.4 10.5 0.1 2.2 3.0 0.6 3.4 0.0 0.3 3.8 1.0 1.7 7.5 0.5 0.5 0.3 1.0 0.0 0.2 0.0 0.3 0.4 0.6 0.2 0.2 2.7 0.5 0.2 0.1 4.9 1.7 0.1 0.2 1.2 8.5 0.4 2.9 0.6 0.1 0.9 0.9 7.8 2.7 0.2 0.2 0.3 1.6 1.7 0.2 0.4 0.4 1.6 3.1 0.2 6.0 3.0 0.7 4.6 3.9 0.2 2.2 0.7 3.3 1.0 1.4 0.0 0.0 0.0 0.7 0.0 0.0 0.9 0.4 0.0 0.0 0.4 0.0 0.6 0.5 0.0 0.0 0.9 0.0 0.0 11.3 9.7 8.7 10.6 9.3 7.0 7.0 8.6 7.3 7.8 0.0 0.3 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGB3 PCDH-GAMMA-B3 ENSG00000262209 "Protocadherin gamma subfamily B, 3" Q9Y5G1 5 141370264-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 13.5;ASC TERT1: 10.9;TIME: 6.8" "HPA008755, HPA010580, HPA035822, HPA035823" Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA035822: , HPA035823: AB_2674802" "unprognostic (6.93e-3)" "unprognostic (9.10e-4)" "unprognostic (1.35e-1)" "unprognostic (7.05e-2)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" "unprognostic (7.83e-2)" "unprognostic (1.92e-1)" "unprognostic (6.08e-2)" "unprognostic (2.04e-1)" "unprognostic (3.51e-2)" "unprognostic (5.81e-2)" "unprognostic (3.11e-1)" "unprognostic (3.62e-2)" "unprognostic (3.89e-2)" "unprognostic (2.80e-3)" 4.1 1.7 3.3 1.6 6.5 0.5 3.1 3.5 5.6 3.0 3.0 7.2 0.7 0.7 4.9 3.7 3.3 3.3 2.9 4.6 3.3 2.3 2.9 2.0 2.5 3.7 1.9 3.8 5.2 4.2 4.6 5.4 2.3 2.6 2.6 2.2 3.1 6.6 2.6 1.9 3.3 1.4 4.3 2.9 2.4 2.3 1.5 2.8 0.3 3.4 3.2 3.5 2.7 4.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.5 0.3 13.5 10.9 0.2 1.4 2.5 0.9 1.1 0.0 0.0 2.2 0.4 4.3 0.8 0.6 0.0 0.3 0.7 0.0 0.3 0.0 0.3 0.1 0.6 0.1 0.0 2.7 0.6 0.2 0.1 0.2 1.2 0.0 0.3 1.0 0.3 0.4 0.7 1.1 0.1 0.0 0.1 1.9 0.7 0.0 0.2 0.1 3.0 0.6 0.0 0.1 0.3 0.4 0.8 0.0 6.8 0.6 0.1 0.7 0.7 0.3 2.1 0.2 0.6 0.6 1.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.3 6.5 3.5 5.6 3.3 2.3 1.9 3.8 2.6 2.8 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGB4 "CDH20, FIB2, PCDH-GAMMA-B4" ENSG00000253953 "Protocadherin gamma subfamily B, 4" Q9UN71 5 141387698-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 24 "Alveolar cells type 2: 1.1;Horizontal cells: 1.6" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 7 "NK-cell: 1.6" "Lineage enriched" "Detected in single" 7 "NK-cells: 1.6" "Cell line enhanced" "Detected in some" "BJ hTERT+: 28.6;SuSa: 10.9;TIME: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.33e-1)" "unprognostic (1.83e-3)" "unprognostic (2.91e-1)" "unprognostic (1.18e-1)" "unprognostic (1.23e-2)" "unprognostic (9.25e-3)" "unprognostic (2.20e-1)" "unprognostic (1.25e-2)" "unprognostic (1.99e-1)" "unprognostic (1.74e-1)" "unprognostic (1.29e-1)" "unprognostic (3.78e-2)" "unprognostic (2.31e-2)" "unprognostic (2.70e-2)" "unprognostic (2.62e-1)" "unprognostic (1.13e-1)" "unprognostic (3.27e-2)" 2.4 2.2 2.4 0.7 4.2 0.0 1.2 1.8 2.1 2.6 1.4 0.2 3.2 3.5 1.1 2.1 0.8 2.8 2.3 4.1 2.9 3.3 2.1 0.0 1.8 5.1 1.9 3.0 2.5 6.2 2.6 0.7 3.0 3.1 1.2 3.4 0.3 1.9 2.0 0.6 0.4 0.9 3.6 0.2 1.6 2.0 0.0 0.2 0.0 0.0 1.6 0.2 0.2 0.0 0.7 7.1 0.0 4.6 5.9 0.8 6.8 28.6 2.9 1.9 0.0 0.0 0.2 5.5 0.2 0.1 2.0 0.0 0.0 3.2 0.0 0.0 0.0 0.1 1.6 1.8 0.0 0.0 5.7 0.0 2.7 0.0 0.1 4.4 0.0 0.2 0.0 0.0 0.0 0.6 0.1 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 10.9 3.6 2.6 14.3 3.9 1.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGB5 PCDH-GAMMA-B5 ENSG00000276547 "Protocadherin gamma subfamily B, 5" Q9Y5G0 5 141397987-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 11.2" "Group enriched" "Detected in some" 4 "Bipolar cells: 1.7;Ciliated cells: 1.4" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 32.8;ASC TERT1: 24.8;BJ hTERT+ SV40 Large T+: 14.2;BJ hTERT+ SV40 Large T+ RasG12V: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (2.71e-3)" "unprognostic (1.95e-2)" "unprognostic (1.09e-1)" "unprognostic (4.14e-2)" "unprognostic (2.35e-1)" "unprognostic (1.20e-1)" "unprognostic (3.64e-2)" "unprognostic (2.34e-2)" "unprognostic (1.54e-1)" "unprognostic (1.23e-1)" "unprognostic (1.90e-1)" "unprognostic (2.29e-1)" "unprognostic (1.69e-4)" "unprognostic (9.63e-3)" "unprognostic (3.21e-1)" "unprognostic (1.12e-1)" "unprognostic (8.25e-4)" 2.1 1.9 0.8 0.3 3.2 0.0 3.6 2.0 4.3 1.4 0.4 2.5 1.9 0.0 2.1 2.5 1.1 2.1 0.8 1.9 0.0 1.6 3.1 6.8 2.6 0.9 1.5 4.9 2.8 11.2 2.1 9.5 1.5 2.2 0.2 3.7 3.2 3.2 1.4 2.6 0.0 1.9 3.0 0.5 0.7 1.0 2.2 0.8 3.5 0.0 0.7 1.9 1.4 0.5 0.2 0.0 0.3 0.0 1.9 0.1 0.0 1.2 0.1 0.0 32.8 24.8 0.6 8.7 0.0 14.2 16.0 1.4 4.7 4.9 11.4 9.6 0.0 6.6 0.0 3.6 8.0 0.0 1.4 0.0 0.0 0.0 3.4 0.0 3.1 8.7 0.7 0.8 4.6 6.1 4.3 0.0 0.1 0.0 0.4 3.7 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.8 2.6 0.0 0.0 0.0 0.0 0.0 1.0 9.2 0.0 4.4 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 1.9 0.0 0.0 0.5 0.3 0.0 0.2 0.2 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.7 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 PCDHGB6 PCDH-GAMMA-B6 ENSG00000253305 "Protocadherin gamma subfamily B, 6" Q9Y5F9 5 141408021-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 26.6" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 6.4;Cone photoreceptor cells: 5.9;Horizontal cells: 9.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 18.6;EFO-21: 6.3;HSkMC: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.11e-1)" "unprognostic (4.18e-2)" "unprognostic (2.63e-1)" "unprognostic (7.81e-2)" "unprognostic (1.04e-1)" "unprognostic (1.90e-1)" "unprognostic (1.18e-1)" "unprognostic (1.85e-2)" "unprognostic (3.51e-1)" "unprognostic (1.11e-1)" "unprognostic (4.77e-2)" "unprognostic (9.89e-2)" "unprognostic (1.43e-1)" "unprognostic (2.17e-2)" "unprognostic (3.27e-1)" "unprognostic (1.21e-2)" "unprognostic (7.71e-4)" 6.7 7.2 8.8 2.6 9.9 1.6 4.4 6.1 26.6 5.8 4.1 10.1 0.3 1.8 7.2 5.7 3.0 5.1 4.4 4.6 8.9 5.7 3.2 9.4 4.4 2.2 6.9 4.4 13.3 5.2 16.1 4.7 6.8 5.9 4.0 2.3 9.0 5.3 5.9 5.7 4.7 2.2 4.8 4.1 4.0 2.5 2.1 6.7 0.3 6.1 1.9 2.1 4.2 5.1 0.8 0.5 3.2 0.4 0.5 0.9 0.2 0.0 0.1 18.6 0.2 0.6 0.7 0.9 1.7 0.0 0.4 1.0 0.2 0.3 1.5 6.3 1.0 0.3 0.3 0.0 0.4 1.2 0.0 0.3 0.0 0.2 0.1 1.5 0.1 0.1 4.3 2.1 0.9 0.1 0.2 0.6 0.4 0.1 0.3 0.1 0.3 0.1 1.2 0.8 0.0 0.0 0.2 0.1 0.1 3.0 0.2 0.2 0.3 0.0 0.1 0.1 0.4 1.5 0.4 3.0 0.1 0.3 0.2 0.2 0.0 0.1 0.0 0.2 0.0 0.9 1.1 0.4 0.2 0.9 0.3 0.2 0.6 0.4 0.2 0.1 0.8 0.4 0.3 3.2 0.5 0.3 0.5 0.2 0.2 8.8 9.9 6.1 7.9 8.9 5.7 6.9 4.4 5.9 6.7 3.0 0.3 0.0 1.3 0.0 6.4 2.5 0.0 1.4 2.3 0.0 5.9 0.1 0.0 0.4 0.0 0.9 0.0 0.0 1.1 0.1 0.4 0.6 0.0 0.8 0.2 9.5 0.0 1.3 0.0 0.0 1.7 0.0 0.0 0.0 0.0 3.3 1.6 0.0 1.1 0.0 2.4 0.0 1.0 0.2 0.3 0.1 0.1 0.0 0.0 0.6 PCDHGB7 "ME6, PCDH-GAMMA-B7" ENSG00000254122 "Protocadherin gamma subfamily B, 7" Q9Y5F8 5 141417645-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 3.0;Bipolar cells: 7.4;Horizontal cells: 3.2" "Cancer enhanced" "Detected in many" "glioma: 7.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "AN3-CA: 38.8;HSkMC: 12.3;hTERT-RPE1: 32.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.22e-2)" "unprognostic (2.55e-2)" "unprognostic (7.39e-3)" "unprognostic (2.95e-1)" "unprognostic (1.49e-1)" "unprognostic (3.34e-1)" "unprognostic (1.98e-1)" "unprognostic (1.25e-1)" "unprognostic (8.40e-2)" "unprognostic (4.43e-2)" "unprognostic (2.61e-2)" "unprognostic (1.88e-2)" "unprognostic (3.05e-1)" "unprognostic (2.22e-2)" "unprognostic (1.44e-1)" "unprognostic (1.91e-1)" "unprognostic (5.68e-2)" 10.1 9.8 12.6 3.8 13.5 0.8 8.0 19.1 12.9 10.2 7.0 16.1 1.2 2.3 11.6 5.0 6.8 7.8 9.2 8.5 14.5 7.9 5.4 3.5 11.6 2.6 10.4 7.3 17.3 5.5 9.5 5.3 11.0 9.4 8.3 3.8 15.5 7.1 12.0 5.6 6.8 3.2 10.5 20.1 5.3 4.5 4.2 14.3 0.6 8.4 3.0 2.3 4.6 6.9 0.2 1.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.3 38.8 0.9 0.1 0.4 2.5 0.3 0.9 1.9 0.0 2.3 0.3 2.1 5.1 0.3 0.6 0.0 0.4 0.9 0.0 0.2 0.0 0.0 0.0 2.9 0.2 0.0 12.3 0.3 0.7 0.4 32.9 2.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.3 4.3 0.8 0.0 0.1 0.0 4.2 5.8 0.1 0.0 0.0 0.5 0.4 0.4 5.0 4.7 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 12.6 13.5 19.1 12.9 14.5 7.9 10.4 7.3 9.4 14.3 3.0 2.2 0.0 0.5 0.3 7.4 1.1 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.1 0.1 1.0 0.0 0.0 0.4 0.1 0.8 0.3 1.1 0.0 0.1 3.2 0.0 0.6 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.1 0.7 0.0 1.8 0.2 0.4 0.0 1.4 0.0 0.1 0.4 0.0 0.0 0.0 0.1 PCDHGC4 PCDH-GAMMA-C4 ENSG00000242419 "Protocadherin gamma subfamily C, 4" Q9Y5F7 5 141484997-141512979 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 23.6" "Cell type enhanced" "Detected in single" 32 "Horizontal cells: 3.2" "Cancer enriched" "Detected in single" 10 "glioma: 4.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "REH: 9.3;SCLC-21H: 7.9;SH-SY5Y: 15.2;SuSa: 11.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (6.05e-2)" "unprognostic (1.26e-3)" "unprognostic (4.78e-2)" "unprognostic (1.41e-1)" "unprognostic (3.44e-1)" "unprognostic (7.84e-2)" "unprognostic (9.48e-2)" "unprognostic (3.27e-1)" "unprognostic (4.55e-1)" "unprognostic (1.17e-1)" "unprognostic (8.72e-3)" "unprognostic (4.73e-3)" "unprognostic (2.20e-4)" "unprognostic (8.78e-2)" "unprognostic (3.06e-2)" "unprognostic (1.47e-1)" "unprognostic (2.75e-2)" 0.7 2.9 5.7 0.7 9.5 0.5 0.8 23.6 21.9 1.0 1.1 2.3 0.0 0.6 0.9 1.2 0.8 1.0 1.0 1.3 4.1 10.1 0.6 0.6 1.0 0.9 3.3 4.5 0.8 1.2 0.8 1.3 0.8 8.6 0.8 0.8 1.9 1.0 0.7 1.2 1.5 0.7 0.9 2.3 0.8 0.7 1.5 0.8 0.0 0.7 0.0 1.0 0.6 0.2 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.2 0.2 0.8 0.4 0.1 0.1 0.1 0.2 0.0 0.0 0.2 0.9 0.9 0.1 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.7 0.0 1.5 0.0 0.0 9.3 0.5 0.0 0.0 0.1 7.9 15.2 0.1 0.0 0.2 11.2 0.1 0.3 0.1 0.8 0.1 0.2 0.7 0.2 0.0 0.2 0.6 0.1 2.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 9.5 23.6 15.6 4.1 10.1 3.3 4.5 8.6 0.8 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGC5 PCDH-GAMMA-C5 ENSG00000240764 "Protocadherin gamma subfamily C, 5" Q9Y5F6 5 141489121-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 43.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "glioma: 3.1;head and neck cancer: 0.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 5.0;SuSa: 8.4;U-138 MG: 16.0;U-251 MG: 6.8;U-87 MG: 9.8" "Group enriched" "Detected in many" 5 "amygdala: 129.6;basal ganglia: 118.6;cerebral cortex: 130.2;hippocampal formation: 113.0;olfactory region: 85.4" "HPA008755, HPA010580, HPA076140" Supported Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076140: " "unprognostic (2.86e-3)" "unprognostic (7.63e-4)" "unprognostic (2.00e-1)" "unprognostic (3.52e-3)" "unprognostic (5.42e-2)" "unprognostic (1.14e-1)" "unprognostic (5.65e-2)" "unprognostic (2.38e-2)" "unprognostic (2.14e-1)" "unprognostic (3.16e-2)" "unprognostic (3.90e-1)" "unprognostic (1.66e-2)" "unprognostic (1.01e-9)" "unprognostic (6.87e-3)" "unprognostic (3.89e-2)" "unprognostic (3.13e-1)" "unprognostic (3.77e-3)" 1.0 1.1 7.4 1.1 34.5 0.9 1.1 3.0 43.7 1.1 1.0 2.8 0.0 0.9 1.4 1.3 1.0 1.2 1.2 2.8 11.8 2.8 0.9 0.9 1.1 0.9 2.2 10.0 1.1 1.0 1.0 1.1 1.0 2.3 1.3 1.0 0.0 0.9 1.6 1.6 1.5 0.9 2.0 0.8 1.0 1.0 1.3 1.1 0.0 1.0 0.0 1.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 1.7 0.2 0.8 0.6 0.5 0.6 0.0 0.0 0.5 1.6 2.4 0.1 0.1 0.0 0.4 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.5 0.0 5.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.9 0.8 0.3 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 8.4 0.1 0.2 0.1 16.0 0.2 0.2 6.8 0.0 0.0 0.0 9.8 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 34.5 3.0 39.2 11.8 2.8 2.2 10.0 2.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCED1A "bA12M19.1, C20orf81, FAM113A, FLJ22376" ENSG00000132635 "PC-esterase domain containing 1A" Q9H1Q7 20 2835314-2841190 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050816 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA050816: AB_2681246" "unprognostic (3.20e-1)" "unprognostic (3.25e-2)" "unprognostic (2.42e-3)" "unprognostic (1.90e-2)" "unprognostic (3.42e-1)" "unprognostic (6.91e-3)" "prognostic unfavorable (7.31e-4)" "unprognostic (1.00e-1)" "unprognostic (8.02e-2)" "unprognostic (2.99e-1)" "prognostic favorable (5.96e-5)" "unprognostic (1.03e-1)" "unprognostic (1.29e-2)" "unprognostic (4.10e-1)" "unprognostic (2.48e-1)" "unprognostic (7.30e-2)" "unprognostic (2.97e-3)" 18.0 17.3 25.5 21.9 29.1 13.1 14.4 18.7 29.0 17.6 13.4 27.6 18.8 17.1 23.8 20.3 12.6 22.4 23.0 9.7 24.2 17.1 23.1 21.0 16.4 23.5 30.0 20.8 28.4 16.1 38.2 27.0 16.4 25.1 25.4 9.1 21.6 23.7 18.3 6.9 12.7 18.2 15.2 14.5 33.1 20.0 9.4 28.7 14.2 36.0 4.8 16.7 15.8 17.6 9.4 8.2 3.1 7.4 14.2 12.0 6.8 12.5 16.6 16.9 9.3 17.7 24.5 12.2 12.1 13.9 13.0 14.2 11.6 23.2 3.7 8.4 8.2 21.7 20.7 4.0 11.3 6.1 18.2 12.4 14.5 18.4 16.0 14.3 2.8 4.9 32.5 24.1 15.9 21.2 18.7 9.3 18.9 11.4 17.4 9.5 8.7 2.0 18.3 18.6 9.6 9.9 10.0 5.6 7.6 14.6 10.6 15.7 24.2 12.0 15.9 20.8 11.2 20.4 9.8 8.9 12.8 8.8 13.1 5.8 28.7 14.2 1.0 3.1 10.3 15.0 2.9 7.4 3.1 11.0 6.6 10.6 8.6 6.4 9.3 8.2 9.4 12.0 10.6 0.6 14.2 6.1 7.1 4.5 6.8 25.5 29.1 18.7 29.0 24.2 17.1 30.0 20.8 25.1 28.7 14.9 20.3 6.4 10.6 3.5 10.9 4.0 5.1 6.7 10.3 8.7 9.8 4.4 11.6 3.2 0.4 8.3 6.8 0.0 1.8 2.2 8.9 7.3 0.0 11.3 6.1 11.1 8.1 11.6 8.6 2.8 8.3 8.0 1.7 2.8 6.7 9.3 4.1 7.0 2.1 8.4 11.9 6.5 7.6 11.5 7.6 3.1 2.9 11.7 5.4 5.2 PCF11 KIAA0824 ENSG00000165494 "PCF11 cleavage and polyadenylation factor subunit" O94913 11 83156988-83187451 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 54.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040779 Supported Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA040779: AB_2677133" "unprognostic (1.53e-1)" "unprognostic (7.24e-2)" "unprognostic (3.99e-2)" "unprognostic (1.18e-1)" "unprognostic (3.24e-3)" "prognostic favorable (1.34e-4)" "unprognostic (3.74e-2)" "unprognostic (4.89e-3)" "unprognostic (1.12e-3)" "unprognostic (9.53e-2)" "unprognostic (6.07e-2)" "unprognostic (5.63e-2)" "unprognostic (1.55e-1)" "unprognostic (3.91e-3)" "unprognostic (1.15e-1)" "unprognostic (1.07e-1)" "prognostic favorable (2.03e-5)" 17.6 15.2 21.8 33.5 23.3 32.1 21.1 29.7 21.3 22.1 19.7 13.6 30.8 14.0 25.6 36.8 21.9 23.4 20.8 14.0 21.7 10.0 15.7 14.5 24.0 25.8 26.6 15.4 28.9 16.1 22.4 32.5 18.9 19.2 25.6 17.9 13.8 22.5 28.5 27.0 32.5 21.2 21.4 20.6 27.2 17.7 20.1 27.4 29.4 23.4 22.5 25.1 24.8 29.3 11.4 6.8 17.5 7.2 13.0 10.5 5.3 11.2 8.1 13.1 11.2 15.8 15.5 10.6 10.8 8.0 10.5 8.0 13.7 11.3 25.4 8.2 7.8 9.9 11.4 19.1 7.4 10.1 18.0 6.5 14.8 10.5 9.6 8.9 17.4 16.6 10.9 14.5 7.9 11.6 14.1 10.5 17.1 17.2 12.4 9.7 12.0 16.3 19.4 13.7 19.3 9.1 15.6 16.6 15.2 9.1 16.8 11.0 12.2 13.2 10.6 10.6 12.7 10.5 12.1 10.8 14.9 7.7 11.0 7.1 11.2 18.7 54.0 6.5 11.6 11.5 12.0 7.2 14.2 10.5 6.9 9.1 11.4 7.4 7.6 6.7 10.4 8.6 8.5 17.5 13.0 5.1 6.8 5.1 5.3 21.8 23.3 29.7 21.3 21.7 10.0 26.6 15.4 19.2 27.4 38.7 59.9 50.4 59.3 47.7 46.6 38.1 30.6 25.4 48.9 43.6 31.4 24.8 21.6 18.2 150.1 49.7 50.2 23.3 15.9 22.0 35.6 61.5 34.8 18.3 32.9 52.4 30.6 53.4 42.5 25.5 55.8 46.3 27.0 28.9 46.6 43.9 16.5 42.1 42.5 12.6 55.5 38.8 61.3 43.2 16.6 54.7 33.0 57.3 41.7 58.5 PCGF1 "MGC10882, NSPC1, RNF68" ENSG00000115289 "Polycomb group ring finger 1" Q9BSM1 2 74505043-74508580 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011356, HPA069156" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA011356: AB_1855063, HPA069156: AB_2686095" "unprognostic (2.41e-1)" "unprognostic (5.97e-2)" "unprognostic (1.11e-3)" "unprognostic (2.71e-2)" "unprognostic (4.25e-2)" "unprognostic (2.73e-2)" "unprognostic (2.32e-2)" "unprognostic (4.18e-3)" "unprognostic (2.26e-1)" "unprognostic (2.14e-1)" "unprognostic (1.57e-1)" "unprognostic (1.26e-2)" "prognostic unfavorable (1.69e-4)" "unprognostic (1.00e-1)" "unprognostic (5.09e-2)" "unprognostic (1.21e-1)" "unprognostic (2.13e-1)" 3.8 3.1 2.5 2.5 6.1 4.8 4.5 5.6 7.4 4.2 4.6 4.1 2.5 4.0 5.2 2.5 3.0 4.4 2.5 2.9 2.5 2.3 3.4 3.3 3.5 4.0 2.5 6.2 5.4 4.1 4.4 4.2 3.1 5.4 3.1 3.4 2.5 3.6 2.5 2.5 4.3 3.2 3.0 5.7 3.1 3.4 5.1 2.5 2.5 5.1 2.5 4.1 2.6 3.4 7.5 8.5 2.9 7.7 4.1 8.1 3.9 4.0 2.9 2.4 3.5 2.2 3.5 4.3 4.5 4.9 4.2 2.5 7.5 2.0 6.0 2.1 4.3 7.5 2.2 4.3 5.8 2.9 5.2 8.4 2.5 3.5 5.5 3.8 7.8 4.2 6.4 4.2 2.5 12.9 5.9 2.4 6.4 7.2 4.3 2.6 6.1 5.7 8.1 3.9 5.8 2.8 4.4 6.1 2.9 5.3 5.4 3.2 10.7 3.7 4.5 6.4 3.1 1.7 7.3 3.1 4.8 4.3 7.8 4.1 3.5 3.1 5.0 4.2 3.9 5.4 1.7 7.7 2.9 5.4 5.5 6.0 7.2 7.0 6.8 8.5 7.5 5.7 5.6 2.7 4.1 6.1 4.8 8.1 3.9 2.5 6.1 5.6 7.4 2.5 2.3 2.5 6.2 5.4 2.5 3.0 2.6 4.2 8.8 11.1 5.1 2.8 12.7 1.4 3.4 3.5 3.9 9.9 26.6 9.7 14.5 5.8 10.3 0.0 9.0 14.2 11.1 8.8 10.3 5.4 12.1 4.8 1.2 6.2 8.7 2.3 7.2 11.0 6.8 13.6 11.7 6.0 10.0 17.3 4.6 13.2 8.7 6.5 8.3 13.5 7.4 16.6 15.3 8.5 8.1 6.4 PCGF2 "MEL-18, RNF110, ZNF144" ENSG00000277258 "Polycomb group ring finger 2" P35227 17 38733897-38749817 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047732, HPA063531" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA047732: AB_2680138, HPA063531: AB_2685031" "unprognostic (1.56e-1)" "unprognostic (1.46e-2)" "prognostic unfavorable (4.55e-4)" "unprognostic (2.45e-1)" "unprognostic (1.37e-1)" "unprognostic (1.31e-3)" "unprognostic (2.47e-2)" "unprognostic (7.78e-2)" "unprognostic (1.65e-1)" "unprognostic (1.09e-1)" "unprognostic (5.10e-3)" "unprognostic (8.18e-2)" "unprognostic (6.12e-2)" "unprognostic (7.66e-2)" "unprognostic (2.42e-1)" "unprognostic (1.00e-2)" "unprognostic (1.79e-1)" 5.7 7.2 6.6 2.9 6.7 0.0 12.2 11.6 7.7 9.0 3.6 1.1 8.7 2.6 8.9 9.5 4.4 8.8 7.8 7.0 6.9 10.7 1.8 7.9 2.2 2.4 4.4 11.4 4.7 10.1 12.0 8.3 3.9 6.7 3.8 11.4 7.8 7.6 3.3 4.1 4.2 5.9 2.9 5.3 5.2 2.7 3.7 0.0 7.7 3.9 1.6 6.3 18.6 0.8 0.3 0.3 0.4 0.0 0.5 0.1 8.1 19.2 14.2 25.5 7.9 6.4 5.9 6.5 10.1 10.4 9.6 11.8 9.3 0.6 7.2 8.2 10.6 13.2 7.2 6.2 7.4 5.0 10.4 3.9 9.9 28.6 8.5 0.6 4.9 6.2 5.5 7.7 7.6 13.6 13.4 4.7 7.2 10.8 7.0 21.7 0.8 0.1 11.5 4.2 7.7 6.5 8.1 1.6 8.5 11.9 8.4 16.0 6.3 4.6 13.5 14.3 18.0 0.9 14.3 13.2 14.3 12.7 11.4 6.5 1.9 2.0 10.3 1.0 12.2 0.0 0.4 0.0 0.5 0.0 0.5 0.8 0.3 0.0 0.3 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.1 3.0 13.6 2.0 9.8 12.6 56.6 1.6 17.8 1.4 5.7 19.2 9.8 11.6 44.7 21.9 5.9 29.3 17.1 0.0 12.0 21.3 20.7 13.2 1.1 1.0 4.0 33.4 12.7 46.1 3.8 3.2 34.2 4.0 13.5 5.4 12.8 17.7 16.9 7.0 27.6 39.6 14.2 0.0 14.2 4.1 14.0 14.8 18.5 0.0 12.4 7.8 PCGF3 "DONG1, FLJ36550, MGC40413, RNF3, RNF3A" ENSG00000185619 "Polycomb group ring finger 3" Q3KNV8 4 705748-770640 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061879 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA061879: AB_2684631" "unprognostic (1.24e-1)" "unprognostic (2.77e-1)" "unprognostic (2.62e-1)" "unprognostic (1.06e-2)" "unprognostic (1.66e-1)" "prognostic favorable (3.73e-4)" "unprognostic (2.76e-2)" "unprognostic (4.21e-2)" "unprognostic (9.52e-2)" "unprognostic (1.47e-2)" "prognostic favorable (1.44e-4)" "unprognostic (2.36e-2)" "unprognostic (6.84e-3)" "unprognostic (2.53e-1)" "unprognostic (2.20e-1)" "unprognostic (1.96e-1)" "prognostic favorable (5.25e-4)" 17.3 29.0 18.2 22.0 18.8 28.0 18.9 31.4 21.8 17.7 15.2 12.4 21.4 24.3 20.9 19.1 17.9 17.5 18.1 14.0 16.5 11.2 14.6 15.3 17.8 18.2 17.2 17.5 28.6 15.3 6.5 20.0 21.3 15.3 20.5 11.9 15.1 20.4 15.8 15.5 55.8 22.5 15.2 11.8 26.4 20.8 18.0 16.9 20.8 21.3 19.2 17.6 15.3 20.0 7.3 7.2 6.9 11.6 6.9 5.4 3.5 11.4 10.4 19.2 21.9 8.8 9.1 23.7 15.6 8.6 12.9 13.1 11.4 12.7 8.3 10.5 15.0 13.1 8.0 8.9 12.7 9.8 10.8 9.6 11.8 12.2 20.0 10.8 8.0 15.8 11.4 17.0 11.2 5.1 8.5 16.4 15.2 16.2 6.8 12.5 12.8 21.5 28.5 12.7 7.8 18.9 21.4 12.2 5.2 7.6 18.9 27.5 20.7 8.1 8.7 8.3 13.0 17.0 11.5 19.6 12.6 10.2 10.4 20.0 16.5 13.9 12.9 9.9 12.9 23.2 5.5 11.6 4.7 5.4 7.5 4.8 6.7 3.4 3.4 5.1 7.3 4.3 3.0 6.9 6.9 3.5 7.2 5.0 3.5 18.2 18.8 31.4 21.8 16.5 11.2 17.2 17.5 15.3 16.9 11.9 30.3 15.9 14.9 22.6 11.8 16.7 22.9 9.4 18.2 8.7 11.8 11.7 3.3 18.4 44.6 21.8 17.2 0.0 17.2 22.3 17.3 17.4 16.1 12.1 10.7 6.4 18.5 25.8 11.0 39.8 15.3 17.1 21.9 10.0 21.7 9.2 26.4 14.4 14.5 8.8 7.9 6.5 16.9 20.1 24.3 25.1 19.8 13.8 18.7 25.2 PCGF5 "MGC16202, RNF159" ENSG00000180628 "Polycomb group ring finger 5" Q86SE9 10 91163012-91284331 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Late spermatids: 252.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038349, HPA059071" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA038349: AB_10669523, HPA059071: " "unprognostic (1.34e-2)" "unprognostic (8.22e-2)" "unprognostic (1.25e-2)" "unprognostic (7.41e-2)" "unprognostic (1.15e-1)" "unprognostic (8.35e-2)" "unprognostic (6.53e-2)" "unprognostic (6.43e-2)" "unprognostic (3.89e-1)" "unprognostic (3.24e-2)" "unprognostic (3.75e-2)" "unprognostic (1.49e-1)" "prognostic favorable (4.98e-4)" "unprognostic (2.43e-1)" "unprognostic (2.00e-1)" "unprognostic (2.56e-2)" "prognostic favorable (6.90e-4)" 16.0 30.1 28.0 15.0 25.1 6.3 14.6 19.4 24.5 15.9 21.8 18.6 16.9 21.0 15.4 14.7 16.1 15.4 15.7 32.5 24.0 27.5 29.0 31.1 17.2 25.8 27.9 20.5 19.3 19.3 25.3 16.0 18.9 21.0 17.5 17.5 12.4 19.6 18.4 24.5 13.6 30.9 24.4 29.7 20.9 17.3 14.1 24.1 31.6 29.4 13.5 18.4 20.4 21.2 6.1 3.0 8.0 9.9 7.3 7.4 4.0 16.0 7.1 5.9 2.5 8.6 13.5 4.1 9.1 18.8 8.3 11.7 1.0 9.5 21.2 4.2 11.4 6.8 3.1 6.3 6.2 14.7 24.4 4.7 9.9 4.8 10.8 11.4 7.7 15.9 6.1 11.6 6.1 8.7 17.1 6.9 9.5 5.2 12.0 12.8 2.9 17.4 1.9 0.8 3.7 4.0 8.7 10.9 5.7 15.2 2.5 2.8 4.0 4.4 4.8 7.6 2.2 3.8 3.5 17.7 9.8 6.9 6.0 10.7 20.9 12.8 19.2 13.8 5.6 3.0 8.0 2.2 3.8 4.2 5.6 7.4 6.1 6.2 4.2 3.0 5.8 6.3 6.1 3.1 7.3 9.9 0.8 3.4 4.0 28.0 25.1 19.4 24.5 24.0 27.5 27.9 20.5 21.0 24.1 6.0 20.0 51.8 43.3 30.6 19.5 72.2 22.9 29.4 25.0 27.9 15.7 14.5 41.4 31.0 102.3 34.1 68.0 23.3 55.8 3.0 35.8 48.1 22.0 52.5 45.3 47.7 20.7 36.2 58.8 252.4 18.1 52.4 40.5 61.3 57.3 64.5 45.4 44.6 28.0 48.1 18.3 12.9 47.6 57.4 13.2 27.4 4.7 39.9 44.6 47.4 PCID2 FLJ11305 ENSG00000126226 "PCI domain containing 2" Q5JVF3 13 113177539-113208715 "Predicted intracellular proteins" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Spermatocytes: 129.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069107, HPA073074" Uncertain Approved Nucleoplasm,Nucleoli NA Yes Nucleoli Nucleoplasm "HPA069107: AB_2686088, HPA073074: AB_2686568" "unprognostic (2.53e-2)" "unprognostic (2.94e-2)" "unprognostic (4.02e-1)" "unprognostic (1.26e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (7.80e-5)" "unprognostic (1.73e-3)" "unprognostic (1.50e-1)" "unprognostic (1.89e-1)" "unprognostic (1.47e-1)" "unprognostic (3.02e-2)" "unprognostic (1.49e-2)" "prognostic unfavorable (4.24e-6)" "unprognostic (1.41e-2)" "unprognostic (5.41e-3)" "unprognostic (1.45e-1)" "unprognostic (6.28e-2)" 17.6 22.6 13.7 14.6 16.0 11.3 21.0 33.5 15.9 20.9 18.2 14.6 20.4 10.3 24.0 20.7 15.6 22.5 14.7 31.3 12.8 10.8 15.4 18.1 14.8 19.6 16.9 13.0 30.6 28.6 12.1 37.6 13.4 14.9 20.0 16.3 14.4 21.4 19.3 21.6 15.0 15.2 19.7 13.4 20.1 19.2 43.4 16.5 19.4 25.4 11.6 20.6 18.0 21.2 15.1 9.7 8.1 12.5 7.6 32.4 19.0 21.9 9.3 14.3 12.6 26.3 19.8 10.0 16.9 25.5 23.6 21.9 18.3 20.8 17.6 11.3 22.9 30.0 14.0 22.6 15.3 26.3 15.3 22.3 22.7 24.3 16.1 26.2 38.4 9.3 16.2 17.1 14.8 26.3 19.0 18.6 24.6 17.3 7.2 26.7 10.6 20.4 27.2 14.1 40.6 11.9 18.7 15.9 16.8 21.4 11.1 19.1 11.8 10.5 26.3 19.3 15.1 14.5 47.0 12.0 7.0 25.2 10.1 12.7 11.1 10.3 24.6 24.2 26.2 15.9 8.1 9.6 7.1 27.6 12.5 32.4 15.1 23.6 28.7 9.7 14.2 21.5 22.3 1.5 7.6 11.5 9.2 23.5 19.0 13.7 16.0 33.5 15.9 12.8 10.8 16.9 13.0 14.9 16.5 17.9 11.8 26.0 26.1 19.2 21.0 26.8 15.3 30.8 14.8 14.0 15.7 25.3 23.2 19.0 26.4 26.3 7.9 23.3 12.0 20.4 25.7 26.0 10.4 17.8 18.1 35.0 7.5 15.4 20.8 8.0 38.3 13.8 15.1 26.2 14.1 19.5 17.0 19.5 38.2 18.4 24.9 19.4 28.9 129.6 82.8 21.7 26.0 34.8 19.9 21.4 PCIF1 "bA465L10.1, C20orf67, PPP1R121" ENSG00000100982 "PDX1 C-terminal inhibiting factor 1" Q9H4Z3 20 45934628-45948023 "Plasma proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049517 Enhanced Supported "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes No Nucleoplasm "Microtubules, Cytokinetic bridge" "HPA049517: AB_2680801" "unprognostic (5.42e-3)" "unprognostic (7.76e-2)" "unprognostic (7.69e-2)" "prognostic unfavorable (8.86e-4)" "unprognostic (1.39e-2)" "unprognostic (4.20e-2)" "unprognostic (1.89e-2)" "unprognostic (2.11e-1)" "unprognostic (1.90e-1)" "unprognostic (1.72e-1)" "unprognostic (7.57e-2)" "unprognostic (1.29e-1)" "prognostic favorable (1.50e-6)" "unprognostic (1.01e-1)" "unprognostic (4.44e-2)" "unprognostic (9.14e-3)" "unprognostic (1.24e-1)" 18.5 15.7 12.7 18.4 17.8 26.2 19.2 33.7 27.9 26.0 19.4 26.7 15.9 14.7 29.8 17.0 19.4 28.8 16.9 23.7 12.9 12.4 16.3 13.2 18.9 23.9 17.7 13.6 37.5 23.5 21.5 18.9 18.7 14.4 20.0 10.8 23.9 20.6 20.8 27.1 24.2 17.1 19.6 16.1 22.8 16.3 17.6 16.2 36.0 24.8 15.3 22.2 18.7 20.4 31.8 28.1 42.4 26.4 38.3 32.7 31.9 11.4 15.9 12.4 15.3 8.7 10.7 13.8 4.7 14.1 14.2 13.8 27.1 15.5 12.4 15.7 12.4 16.4 13.0 8.8 16.1 6.1 7.6 6.3 15.9 12.8 18.1 16.5 14.2 16.1 14.7 16.9 8.7 14.0 12.7 11.8 20.7 11.1 17.4 10.1 24.1 28.0 26.7 4.4 13.9 14.0 17.5 11.5 15.2 11.5 12.1 17.0 17.1 17.6 16.6 8.9 6.9 17.5 16.7 10.1 17.5 14.0 15.4 9.2 20.2 11.6 11.4 22.0 13.2 10.1 37.2 26.4 42.4 32.7 25.7 25.6 30.2 28.3 29.5 28.1 31.8 29.8 25.9 42.3 38.3 24.8 22.6 29.1 31.9 12.7 17.8 33.7 27.9 12.9 12.4 17.7 13.6 14.4 16.2 3.0 13.9 23.9 22.3 7.7 9.2 19.8 15.3 14.7 5.7 10.4 2.0 16.0 13.3 16.7 7.6 13.9 10.8 0.0 33.3 18.9 12.0 21.3 13.9 9.7 15.1 12.7 25.5 9.2 13.9 6.4 10.6 17.3 16.9 24.4 15.0 10.3 21.8 14.0 12.0 18.2 9.5 0.0 13.9 12.6 10.4 9.4 23.2 27.3 11.9 32.3 PCMTD1 FLJ10883 ENSG00000168300 "Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1" Q96MG8 8 51817575-51899186 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025696, HPA061444" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA025696: AB_1855077, HPA061444: AB_2684519" "unprognostic (3.16e-2)" "unprognostic (1.24e-1)" "unprognostic (1.47e-1)" "unprognostic (2.79e-1)" "unprognostic (1.41e-1)" "unprognostic (6.73e-3)" "unprognostic (2.58e-2)" "unprognostic (2.53e-1)" "unprognostic (1.05e-1)" "unprognostic (1.66e-1)" "unprognostic (2.18e-2)" "unprognostic (8.38e-2)" "unprognostic (3.73e-1)" "unprognostic (2.48e-2)" "unprognostic (1.13e-1)" "unprognostic (3.11e-3)" "unprognostic (3.11e-3)" 22.0 24.1 13.1 18.2 17.1 9.0 41.1 24.3 21.7 22.8 24.4 11.7 33.2 14.8 29.0 24.5 21.6 21.5 22.1 26.1 13.5 12.6 21.5 16.7 29.2 21.0 18.4 11.4 33.3 53.8 57.9 34.2 19.2 15.6 22.8 14.8 15.0 39.8 38.8 45.7 18.0 18.7 38.5 18.9 24.3 19.6 10.4 16.9 27.8 33.6 23.6 15.5 28.4 28.6 16.5 15.4 32.4 12.1 22.3 15.2 10.6 6.5 4.2 14.5 2.6 21.4 20.1 8.3 8.7 15.5 3.7 5.9 1.9 15.1 6.3 12.2 11.6 6.2 16.2 2.5 10.2 6.5 8.0 4.9 7.2 7.5 4.4 28.3 2.6 7.4 19.9 19.5 4.6 12.7 22.7 17.5 9.4 5.5 20.7 5.8 2.7 15.1 6.6 5.6 9.7 1.9 4.7 2.8 8.1 15.1 13.0 9.6 8.1 6.1 8.0 8.7 12.1 7.9 4.0 14.3 3.3 4.4 5.0 3.1 12.6 9.4 2.2 9.9 6.3 4.0 19.6 9.6 22.9 10.2 12.1 12.4 16.2 13.0 12.1 9.7 16.5 15.2 13.4 32.4 22.3 12.1 15.4 13.8 10.6 13.1 17.1 24.3 21.7 13.5 12.6 18.4 11.4 15.6 16.9 107.2 59.0 50.0 62.9 48.0 67.0 80.0 43.3 58.9 44.3 80.3 9.8 30.3 54.7 23.7 3.8 68.6 25.0 46.7 35.1 30.0 62.0 88.3 49.9 30.5 22.5 55.6 44.9 57.1 47.5 4.7 96.4 57.4 67.4 34.3 40.3 112.9 43.4 28.1 112.8 59.7 23.9 38.8 59.7 9.3 14.7 51.8 57.3 41.5 27.0 64.6 PCMTD2 "C20orf36, FLJ10883" ENSG00000203880 "Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2" Q9NV79 20 64255695-64287821 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Rod photoreceptor cells: 170.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057849 Approved Approved Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA057849: AB_2683544" "unprognostic (2.41e-1)" "unprognostic (2.31e-2)" "unprognostic (2.62e-1)" "unprognostic (2.88e-2)" "unprognostic (2.23e-1)" "unprognostic (3.17e-2)" "unprognostic (1.59e-1)" "prognostic favorable (2.13e-4)" "unprognostic (1.07e-1)" "unprognostic (4.07e-2)" "unprognostic (1.90e-2)" "unprognostic (1.40e-2)" "prognostic favorable (3.82e-4)" "unprognostic (1.10e-1)" "unprognostic (3.46e-2)" "unprognostic (4.43e-2)" "unprognostic (7.05e-3)" 18.5 22.6 24.2 28.9 24.9 9.7 32.4 49.7 27.3 20.1 14.9 21.1 19.2 14.9 26.0 33.5 15.2 17.2 21.2 26.2 19.8 20.2 22.9 20.2 20.0 25.6 18.5 22.8 38.9 18.1 20.4 21.8 26.3 18.0 19.9 13.6 57.8 20.5 16.9 25.7 42.1 15.7 17.3 19.6 22.1 13.7 17.0 18.2 31.2 19.5 10.5 18.5 17.7 18.1 9.5 7.5 8.3 6.6 14.1 18.1 7.9 10.9 4.0 15.9 12.4 15.4 19.1 15.2 6.8 7.5 9.9 6.1 9.4 17.6 16.4 12.1 8.1 7.8 13.6 8.7 11.0 13.4 3.5 11.9 7.9 17.9 15.7 13.0 8.2 12.1 27.0 15.3 5.2 9.0 17.7 14.3 16.7 14.5 14.8 8.0 7.1 18.8 27.1 11.7 15.2 16.9 15.7 6.3 19.5 15.0 12.7 25.3 29.9 13.0 15.0 17.5 26.0 16.0 16.5 10.4 14.9 5.3 9.5 5.4 18.0 14.6 15.8 9.8 8.7 8.6 7.6 6.6 7.6 8.4 4.5 10.0 8.9 12.5 9.5 7.5 9.5 17.7 12.7 8.3 14.1 4.1 4.7 18.1 7.9 24.2 24.9 49.7 27.3 19.8 20.2 18.5 22.8 18.0 18.2 20.8 21.1 17.1 14.0 18.1 110.9 54.5 20.4 30.8 22.7 27.9 88.4 26.4 19.9 6.5 7.3 34.6 6.7 46.7 7.9 6.2 23.4 15.8 12.7 26.8 12.1 35.0 21.9 52.8 33.3 8.2 39.7 12.8 45.5 5.4 18.1 55.9 9.2 16.7 29.0 18.4 170.0 25.8 19.8 42.9 28.3 18.6 18.3 17.5 14.0 7.8 PCNA ENSG00000132646 "Proliferating cell nuclear antigen" P12004 20 5114953-5126626 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Host-virus interaction" DNA-binding "Cancer-related genes, Deafness, Disease mutation, Dwarfism, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 115.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB000148, HPA030521, HPA030522, HPA030523" Enhanced Enhanced Nucleoplasm No Yes Nucleoplasm "CAB000148: AB_628110, HPA030521: AB_10600218, HPA030522: AB_10602096, HPA030523: AB_10602199" "unprognostic (5.21e-2)" "prognostic favorable (1.86e-5)" "unprognostic (2.96e-2)" "unprognostic (2.43e-1)" "unprognostic (3.17e-1)" "unprognostic (5.60e-3)" "prognostic unfavorable (2.61e-4)" "unprognostic (1.47e-2)" "unprognostic (2.22e-1)" "unprognostic (3.89e-2)" "unprognostic (1.01e-2)" "unprognostic (9.78e-2)" "prognostic unfavorable (3.03e-6)" "unprognostic (2.12e-2)" "unprognostic (2.29e-1)" "unprognostic (7.11e-3)" "unprognostic (7.46e-2)" 13.9 21.4 11.1 31.8 15.8 87.2 13.7 17.2 14.6 13.7 23.1 15.6 13.7 18.9 15.7 13.7 36.0 12.7 17.5 13.6 11.6 9.8 21.7 14.9 17.8 41.6 18.8 10.8 14.4 14.3 14.0 13.9 24.0 14.3 10.8 26.1 18.7 17.7 15.6 11.0 16.5 20.5 12.8 16.1 24.5 15.7 40.5 17.4 115.8 18.1 40.7 38.7 17.3 17.2 16.9 16.0 8.7 11.6 19.6 24.4 16.9 74.2 58.5 59.3 25.5 14.1 13.2 41.6 48.9 28.8 46.1 65.6 45.6 59.4 75.5 15.9 17.4 40.4 55.8 35.0 58.9 42.3 22.4 38.7 53.0 22.5 106.2 6.0 72.5 23.8 9.6 14.0 39.2 9.3 9.7 26.3 50.4 47.2 63.8 44.9 26.8 138.7 80.3 44.4 58.0 32.4 76.6 52.2 60.9 20.8 43.4 51.0 34.6 34.3 53.0 33.6 22.8 37.4 37.0 17.5 33.3 38.3 46.8 55.8 32.4 92.5 127.9 15.0 69.1 42.6 2.4 11.6 8.7 19.2 10.9 23.8 16.9 24.4 19.3 16.0 13.6 22.4 20.1 3.8 19.6 11.4 14.7 23.3 16.9 11.1 15.8 17.2 14.6 11.6 9.8 18.8 10.8 14.3 17.4 41.7 27.0 42.4 43.7 60.1 36.0 11.2 17.8 34.8 43.3 55.8 25.5 92.8 51.4 37.7 137.5 25.2 25.5 46.7 34.8 161.2 34.6 21.0 20.9 24.7 83.0 30.2 19.1 35.6 27.3 83.6 33.4 41.7 35.4 67.7 35.2 57.6 24.8 21.0 37.8 36.6 74.2 51.8 33.9 133.4 89.3 43.4 55.5 43.6 63.4 25.0 PCNP ENSG00000081154 "PEST proteolytic signal containing nuclear protein" Q8WW12 3 101574095-101594437 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035011, HPA063861" Supported Enhanced "Nucleoplasm,Nuclear bodies" No No Nucleoplasm "Nuclear bodies" "HPA035011: AB_10601386, HPA063861: " "unprognostic (4.34e-2)" "unprognostic (9.65e-2)" "unprognostic (6.74e-2)" "unprognostic (2.08e-3)" "unprognostic (7.67e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (6.00e-5)" "unprognostic (1.91e-1)" "unprognostic (3.44e-3)" "unprognostic (1.21e-1)" "unprognostic (3.20e-2)" "unprognostic (4.99e-2)" "unprognostic (6.16e-2)" "unprognostic (2.20e-1)" "unprognostic (2.43e-1)" "unprognostic (8.32e-2)" "unprognostic (2.05e-1)" 27.9 30.4 40.0 25.8 48.5 30.7 34.0 48.6 40.2 33.8 32.2 25.0 25.0 24.1 34.1 34.4 30.5 28.3 25.5 35.6 35.1 36.9 32.0 29.7 29.0 32.2 41.1 35.7 45.9 25.2 34.6 32.9 30.7 39.8 36.9 28.6 26.8 25.4 32.8 37.2 24.1 22.8 48.6 32.3 24.3 24.8 17.8 38.0 25.1 38.7 22.4 34.6 40.1 44.3 19.8 15.8 31.0 22.1 23.6 22.9 25.6 39.0 21.5 30.6 24.4 28.8 41.5 34.4 27.0 36.0 27.6 31.3 25.7 21.5 41.5 20.0 28.8 27.4 21.2 41.0 34.3 58.1 30.0 23.3 44.6 26.7 30.7 21.5 40.9 21.7 24.4 33.7 23.3 31.2 39.3 38.1 18.4 41.6 24.4 33.9 16.5 35.1 34.6 49.6 31.9 34.6 20.6 28.8 31.5 36.5 23.1 41.2 32.5 25.1 24.7 36.0 36.3 22.6 31.1 24.4 25.4 35.3 13.2 28.5 18.5 28.6 50.9 25.4 43.7 31.3 31.0 15.1 24.7 15.6 17.7 20.3 19.8 20.5 18.9 15.8 16.0 21.1 19.4 13.7 23.6 22.1 12.5 22.9 25.6 40.0 48.5 48.6 40.2 35.1 36.9 41.1 35.7 39.8 38.0 56.6 85.6 123.1 198.8 206.6 88.0 104.4 40.8 76.3 75.1 61.1 37.3 103.3 225.5 110.5 19.7 119.3 36.9 93.5 83.2 165.8 133.0 159.9 99.4 48.4 81.1 92.2 78.6 69.3 77.9 9.6 121.1 124.6 237.8 140.7 62.5 68.0 98.5 63.1 126.6 113.9 66.7 129.4 228.9 90.0 72.4 208.4 197.3 140.2 67.4 167.6 PCNX1 "KIAA0805, KIAA0995, PCNX, PCNXL1, pecanex" ENSG00000100731 "Pecanex homolog 1" Q96RV3 14 70907405-71115382 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 27.5;Ciliated cells: 17.4;granulocytes: 14.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053532 Approved Nucleoplasm NA NA Nucleoplasm "HPA053532: AB_2682180" "unprognostic (1.96e-1)" "unprognostic (2.46e-1)" "unprognostic (2.01e-1)" "unprognostic (2.62e-1)" "unprognostic (2.21e-1)" "unprognostic (1.12e-1)" "unprognostic (1.12e-1)" "unprognostic (1.77e-1)" "unprognostic (7.41e-2)" "unprognostic (1.04e-2)" "unprognostic (4.16e-2)" "unprognostic (5.56e-2)" "prognostic favorable (4.05e-5)" "unprognostic (9.01e-3)" "unprognostic (2.90e-1)" "unprognostic (8.11e-2)" "unprognostic (7.37e-2)" 18.2 32.2 14.0 18.8 19.8 20.0 17.4 16.3 21.2 15.7 18.5 14.5 8.8 10.2 18.7 10.3 12.2 14.5 13.2 16.2 11.4 8.1 16.1 14.7 20.2 21.4 14.1 13.1 27.1 12.3 26.3 22.3 11.5 12.0 12.8 10.3 16.8 11.7 12.3 22.8 12.0 18.7 17.1 12.4 22.2 14.1 26.4 13.3 16.4 16.1 10.2 16.7 16.6 17.3 2.3 4.1 11.2 2.0 1.9 10.5 1.6 12.6 8.9 10.3 6.4 17.5 11.8 5.7 13.5 13.6 10.6 14.9 8.8 5.7 9.1 4.7 13.8 8.3 12.7 11.0 10.9 16.1 27.7 4.2 1.7 5.7 9.3 10.6 13.7 4.7 12.1 9.7 10.6 19.1 13.2 10.5 9.4 0.7 13.2 12.2 10.2 6.5 12.5 5.2 5.6 4.9 5.9 11.8 2.7 7.3 9.5 4.3 6.7 10.3 6.2 7.6 11.0 5.5 13.1 12.4 19.6 21.9 6.3 9.7 8.0 4.1 7.6 12.1 11.3 6.8 2.8 2.0 1.8 4.0 1.1 5.5 1.6 6.9 4.1 0.5 2.3 3.0 4.6 11.2 1.9 0.7 4.1 10.5 1.6 14.0 19.8 16.3 21.2 11.4 8.1 14.1 13.1 12.0 13.3 14.9 27.5 0.0 0.0 0.0 0.0 0.0 0.0 17.4 11.4 8.7 0.0 5.1 1.7 7.9 0.0 0.0 0.0 0.0 4.6 5.3 0.0 0.0 14.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 7.2 0.0 0.0 7.4 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 PCOLCE2 PCPE2 ENSG00000163710 "Procollagen C-endopeptidase enhancer 2" Q9UKZ9 3 142815922-142889203 "Predicted secreted proteins" Heparin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 55.6" "Cell type enhanced" "Detected in many" 15 "Cytotrophoblasts: 99.1;Extravillous trophoblasts: 55.3;Fibroblasts: 87.7;Syncytiotrophoblasts: 202.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 7 "neutrophil: 1.4" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.4" "Cell line enhanced" "Detected in many" "ASC diff: 25.9;RPMI-8226: 13.5;U-2197: 29.0;U-266/70: 28.7;U-266/84: 13.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA013203 Uncertain Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" NA NA "Nucleoplasm, Cytosol" "HPA013203: AB_1855084" "unprognostic (1.31e-1)" "unprognostic (3.75e-2)" "unprognostic (5.71e-6)" "unprognostic (8.36e-6)" "unprognostic (3.03e-2)" "unprognostic (1.06e-3)" "unprognostic (2.78e-2)" "unprognostic (9.39e-2)" "unprognostic (1.60e-2)" "unprognostic (1.67e-1)" "unprognostic (1.36e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (1.96e-5)" "unprognostic (1.85e-4)" "unprognostic (1.43e-1)" "unprognostic (1.74e-4)" "prognostic unfavorable (1.08e-4)" 35.2 1.2 1.0 2.0 0.5 5.5 29.0 0.3 0.7 12.4 3.6 0.5 9.1 0.0 3.9 6.0 16.8 2.1 3.8 55.6 1.4 1.2 7.3 7.9 6.9 1.6 0.6 0.7 2.5 0.6 0.1 13.8 20.1 0.4 14.2 2.1 2.5 2.7 3.9 6.3 2.7 1.5 41.6 0.8 1.2 2.0 1.9 0.3 0.0 3.5 6.2 0.9 28.2 30.6 0.0 0.0 1.4 0.2 0.0 0.0 0.3 0.5 4.3 1.4 0.0 25.9 7.2 0.0 0.3 0.1 1.2 1.5 0.2 0.5 0.0 1.2 1.9 6.4 0.0 5.1 0.0 1.4 0.0 8.5 0.9 2.8 0.0 0.0 0.5 0.0 2.9 0.0 2.6 0.7 5.9 0.0 0.7 0.2 0.0 0.5 0.7 1.5 0.4 2.1 0.1 9.0 0.0 3.2 13.5 1.3 0.0 2.7 1.7 6.7 0.0 2.5 1.9 0.0 1.8 0.0 2.3 5.2 29.0 2.1 28.7 13.2 0.0 6.4 0.7 2.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 1.0 0.5 0.3 0.7 1.4 1.2 0.6 0.7 0.4 0.3 0.0 2.7 0.0 0.5 6.5 13.2 33.1 0.0 0.0 1.2 12.2 23.6 99.1 0.0 0.0 0.5 2.7 0.0 0.0 0.0 55.3 87.7 0.6 1.1 12.1 13.7 6.4 0.0 0.6 0.6 0.6 0.6 2.6 3.3 0.0 0.0 13.7 0.5 0.0 0.0 0.0 11.1 0.0 6.3 8.7 49.4 6.5 202.1 0.0 0.0 0.1 PCP4 PEP-19 ENSG00000183036 "Purkinje cell protein 4" P48539 21 39867317-39929397 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 177.9;seminal vesicle: 234.5" "Cell type enhanced" "Detected in many" 23 "Bipolar cells: 431.9;Distal tubular cells: 547.2;Horizontal cells: 1320.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "basal ganglia: 177.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPMI-8226: 57.7;SK-BR-3: 9.7;T-47d: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005792 Enhanced Supported Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA005792: AB_1855086" "unprognostic (6.82e-2)" "prognostic favorable (9.76e-4)" "unprognostic (5.26e-2)" "unprognostic (1.56e-1)" "unprognostic (4.03e-2)" "unprognostic (2.94e-1)" "unprognostic (2.87e-2)" "unprognostic (1.07e-1)" "unprognostic (1.04e-1)" "unprognostic (3.95e-3)" "unprognostic (2.63e-1)" "prognostic favorable (1.85e-7)" "unprognostic (9.00e-2)" "unprognostic (2.99e-3)" "unprognostic (1.10e-1)" "unprognostic (1.07e-2)" 2.1 11.0 5.6 1.4 177.9 1.0 2.6 15.8 15.8 39.3 10.6 11.4 50.8 1.9 11.4 65.7 38.4 2.9 1.7 1.7 8.3 14.0 9.7 1.0 1.1 1.0 11.6 3.7 1.2 2.1 3.4 1.0 1.3 20.0 60.9 6.9 49.0 1.7 234.5 1.0 1.4 1.5 93.5 3.7 1.5 1.1 1.2 37.5 0.0 39.2 0.0 1.2 65.6 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.5 0.5 0.0 0.0 0.0 0.0 57.7 0.0 0.0 0.1 0.1 0.0 9.7 0.0 0.0 18.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 177.9 15.8 15.8 8.3 14.0 11.6 3.7 20.0 37.5 0.0 1.0 0.0 0.5 2.7 431.9 8.1 5.1 0.0 0.0 73.3 58.9 0.2 547.2 0.3 1.1 0.3 0.0 0.0 0.2 0.2 1.5 4.0 0.0 0.0 0.2 1320.5 1.2 0.0 0.0 0.0 8.9 1.9 20.3 0.0 0.0 53.7 1.2 0.0 0.4 219.7 168.9 0.0 3.1 0.5 3.8 5.3 2.4 0.0 0.2 0.9 PCP4L1 IQM1 ENSG00000248485 "Purkinje cell protein 4 like 1" A6NKN8 1 161258727-161285450 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.7;urinary bladder: 33.2" "Cell type enhanced" "Detected in many" 13 "Basal glandular cells: 23.9;Bipolar cells: 34.5;Sertoli cells: 19.4;Urothelial cells: 42.7" "Group enriched" "Detected in many" 6 "cervical cancer: 12.4;head and neck cancer: 5.1;lung cancer: 13.6;testis cancer: 18.9;urothelial cancer: 21.8" "Group enriched" "Detected in all" 5 "basal ganglia: 67.7;cerebral cortex: 17.9;pons and medulla: 30.8" "Cell type enhanced" "Detected in single" "T-reg: 3.1" "Lineage enhanced" "Detected in single" "T-cells: 3.1" "Group enriched" "Detected in some" 6 "RT4: 16.1;T-47d: 10.5" "Low region specificity" "Detected in all" HPA052833 Enhanced Supported Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA052833: AB_2681968" "unprognostic (1.81e-2)" "unprognostic (9.39e-2)" "unprognostic (5.25e-2)" "unprognostic (2.07e-1)" "unprognostic (3.03e-2)" "unprognostic (1.87e-2)" "unprognostic (2.51e-1)" "prognostic favorable (8.10e-5)" "unprognostic (2.39e-1)" "unprognostic (1.92e-1)" "unprognostic (4.93e-2)" "unprognostic (7.37e-2)" "unprognostic (3.63e-5)" "unprognostic (4.81e-2)" "unprognostic (1.25e-1)" "unprognostic (2.09e-1)" "unprognostic (6.15e-2)" 3.2 1.0 5.7 1.3 67.7 0.6 2.2 4.4 28.9 4.3 4.3 1.4 1.5 2.2 2.2 3.3 16.5 2.1 3.9 1.3 3.9 6.3 1.0 4.3 5.0 0.7 7.8 4.6 2.6 0.5 0.6 21.9 0.9 30.8 5.5 3.2 5.9 1.2 17.8 1.0 2.8 3.3 6.8 7.5 0.8 1.2 2.3 5.3 0.0 1.0 0.0 3.0 33.2 4.1 0.0 0.7 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.1 0.0 16.1 2.2 0.0 0.0 0.3 0.0 0.2 10.5 0.4 0.2 0.0 0.0 0.0 0.0 1.0 1.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 5.7 67.7 4.4 17.9 3.9 6.3 7.8 4.6 30.8 5.3 3.0 5.4 0.0 23.9 0.0 34.5 0.2 0.0 0.0 7.9 0.0 5.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.6 0.2 1.8 1.1 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.2 0.0 1.8 0.0 4.1 19.4 9.5 0.2 0.2 0.3 1.5 0.0 0.0 42.7 PCTP STARD2 ENSG00000141179 "Phosphatidylcholine transfer protein" Q9UKL6 17 55750979-55842830 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 56.4;liver: 53.2" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 61.2;Hepatocytes: 64.8;Syncytiotrophoblasts: 56.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 56.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 38.8" "Low region specificity" "Detected in all" HPA022979 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA022979: AB_2671018" "unprognostic (1.14e-1)" "unprognostic (5.20e-2)" "unprognostic (4.27e-2)" "unprognostic (7.35e-2)" "unprognostic (3.37e-2)" "prognostic unfavorable (3.43e-6)" "unprognostic (9.35e-3)" "unprognostic (2.69e-1)" "unprognostic (2.07e-1)" "unprognostic (8.65e-2)" "unprognostic (6.63e-3)" "unprognostic (1.16e-1)" "unprognostic (5.36e-3)" "unprognostic (1.26e-1)" "unprognostic (4.93e-1)" "unprognostic (6.89e-3)" "unprognostic (3.04e-1)" 8.2 5.6 4.9 8.2 8.2 5.1 8.4 3.1 5.3 6.2 11.9 3.0 29.8 9.3 5.2 15.8 6.6 4.9 10.1 12.1 5.1 4.7 17.0 53.2 11.6 7.8 6.2 4.9 5.2 7.5 4.2 5.3 19.4 5.5 7.5 12.7 5.3 7.1 32.1 10.8 4.1 9.8 8.3 5.0 10.0 12.5 8.0 3.9 3.0 5.7 5.8 5.2 8.1 9.9 2.0 12.1 56.4 15.3 6.2 2.7 6.5 8.7 8.1 6.1 2.2 8.2 8.0 15.7 3.4 4.6 5.5 5.4 9.1 11.4 2.4 26.8 5.4 5.1 4.9 3.5 5.8 5.0 38.8 8.2 21.7 2.4 16.9 7.3 8.2 17.2 6.6 7.7 3.2 6.0 6.8 10.6 7.4 15.6 8.8 6.0 7.6 6.5 6.7 6.6 0.0 7.2 3.3 8.8 2.0 5.8 6.5 3.0 6.9 1.7 3.8 14.5 14.0 10.1 14.3 7.7 6.3 4.5 7.0 4.5 24.9 7.8 1.5 5.8 13.6 10.8 15.1 15.3 56.4 2.5 12.6 1.5 2.0 1.6 2.5 12.1 1.4 0.9 2.2 15.9 6.2 13.2 0.9 2.7 6.5 4.9 8.2 3.1 5.3 5.1 4.7 6.2 4.9 5.5 3.9 3.0 7.2 5.1 2.5 0.9 3.8 15.3 17.8 2.7 0.0 8.7 2.0 42.8 10.0 11.2 13.2 7.3 11.8 0.0 12.0 61.2 6.7 1.4 15.0 64.8 19.2 1.6 12.6 9.2 22.6 15.4 15.3 12.6 11.8 10.8 16.2 3.5 8.3 7.0 24.4 30.7 2.2 12.9 10.3 9.8 8.1 1.3 56.2 8.5 14.3 1.7 PCYOX1L MGC3265 ENSG00000145882 "Prenylcysteine oxidase 1 like" Q8NBM8 5 149358007-149369653 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 11.1;Rod photoreceptor cells: 12.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 25.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037463, HPA038402" Approved Approved Nucleoplasm,Mitochondria "Secreted - unknown location" NA NA 930000 "Nucleoplasm, Mitochondria" "HPA037463: AB_10673632, HPA038402: AB_2675997" "unprognostic (1.34e-1)" "unprognostic (9.88e-3)" "unprognostic (2.04e-1)" "unprognostic (1.22e-1)" "unprognostic (7.83e-2)" "unprognostic (5.73e-2)" "unprognostic (4.18e-3)" "unprognostic (7.51e-3)" "unprognostic (2.30e-1)" "unprognostic (1.25e-1)" "unprognostic (3.05e-3)" "unprognostic (8.77e-2)" "unprognostic (4.90e-2)" "unprognostic (2.86e-1)" "unprognostic (2.49e-1)" "unprognostic (2.26e-3)" "unprognostic (3.28e-1)" 4.8 6.6 4.5 7.2 13.5 6.9 4.0 15.9 19.0 6.5 4.4 8.2 2.7 2.3 6.2 2.7 4.6 7.9 5.8 5.2 4.6 8.9 3.7 1.2 4.2 9.6 5.5 9.9 7.9 6.7 27.0 6.4 6.2 13.7 6.4 2.1 9.4 3.4 6.6 1.6 6.6 5.6 6.0 4.6 6.3 5.8 11.5 2.4 5.8 3.3 3.1 7.4 5.0 4.7 1.8 13.5 3.9 9.6 4.5 7.2 4.5 2.1 1.5 2.9 6.3 2.4 1.5 2.1 5.1 1.0 2.5 5.3 0.4 3.5 9.7 15.4 1.6 14.7 4.3 3.2 7.2 0.3 4.7 4.7 4.5 0.0 0.3 7.0 2.9 4.2 6.4 1.2 5.0 4.4 3.4 7.9 8.4 2.6 19.2 0.2 3.4 2.7 4.2 2.7 3.2 9.2 5.2 2.3 25.7 1.0 0.6 5.9 7.7 10.0 3.6 7.9 1.4 9.5 5.5 4.6 2.9 3.1 7.2 2.0 11.3 15.2 5.5 6.1 17.8 7.4 3.0 7.1 3.9 3.0 9.6 4.0 1.8 5.7 2.3 13.5 1.2 6.8 4.7 1.2 4.5 9.1 1.3 7.2 4.5 4.5 13.5 15.9 19.0 4.6 8.9 5.5 9.9 13.7 2.4 8.9 1.7 0.0 1.1 0.9 4.5 4.5 5.1 1.4 2.3 1.8 0.0 4.0 0.0 2.2 2.8 3.8 0.9 0.0 2.1 6.2 2.8 0.7 2.3 0.0 6.4 11.1 0.0 2.5 4.7 1.1 3.1 4.8 1.7 3.6 1.7 6.8 1.7 1.1 2.5 0.3 12.8 0.0 1.2 0.9 3.3 1.4 1.0 2.1 2.2 0.6 PCYT1A "CT, CTPCT, PCYT1" ENSG00000161217 "Phosphate cytidylyltransferase 1, choline, alpha" P49585 3 196214222-196287957 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Cone-rod dystrophy, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 73.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035428 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA035428: AB_10602045" "unprognostic (8.58e-3)" "unprognostic (2.63e-1)" "unprognostic (8.45e-2)" "unprognostic (8.61e-3)" "unprognostic (2.87e-1)" "unprognostic (1.85e-1)" "prognostic unfavorable (8.65e-5)" "unprognostic (8.52e-2)" "unprognostic (5.99e-2)" "unprognostic (1.65e-2)" "unprognostic (6.72e-3)" "unprognostic (1.74e-2)" "unprognostic (1.10e-1)" "unprognostic (2.11e-1)" "unprognostic (1.47e-2)" "unprognostic (7.16e-3)" "unprognostic (2.41e-2)" 24.8 22.2 15.3 19.9 18.7 25.8 18.0 14.2 17.8 13.6 25.3 23.0 21.1 41.1 18.2 18.7 25.2 15.0 19.8 36.0 14.8 13.8 20.2 17.8 18.7 15.6 16.6 14.1 15.6 13.9 16.0 12.1 14.2 20.5 13.3 16.5 14.4 17.1 19.2 45.8 32.8 37.2 19.5 18.3 23.4 18.1 19.4 18.6 13.2 14.8 28.0 19.0 17.6 16.7 7.8 8.7 20.5 9.8 7.9 13.5 4.6 28.7 11.6 8.1 11.9 16.7 18.6 12.3 22.0 15.7 18.9 16.7 28.3 10.5 7.4 73.8 25.2 19.9 22.5 12.9 16.9 16.2 13.4 9.0 21.2 12.2 12.0 15.0 10.2 18.2 15.7 13.0 18.3 13.1 12.2 20.2 6.9 11.8 16.5 18.8 24.3 6.4 5.4 7.0 18.1 17.3 10.6 10.4 11.9 11.6 16.2 8.0 5.9 14.9 25.7 14.3 11.8 37.7 12.8 30.2 15.1 8.4 20.5 29.7 15.3 29.1 13.6 23.1 14.3 18.9 7.5 8.7 9.2 9.6 9.2 8.0 7.8 7.2 10.2 8.7 5.7 4.6 6.8 20.5 7.9 9.8 5.6 13.5 4.6 15.3 18.7 14.2 17.8 14.8 13.8 16.6 14.1 20.5 18.6 14.9 18.8 17.9 8.2 12.9 14.3 58.5 17.8 33.5 15.9 14.0 23.6 10.4 11.6 21.4 63.4 19.5 43.0 0.0 19.9 14.2 13.7 9.7 19.7 31.7 32.6 7.9 21.2 25.2 28.9 52.1 18.4 30.0 18.6 33.3 20.4 11.8 20.8 14.8 26.5 19.4 12.4 25.8 13.7 30.0 10.6 18.7 15.6 22.7 20.5 11.0 PCYT2 ET ENSG00000185813 "Phosphate cytidylyltransferase 2, ethanolamine" Q99447 17 81900965-81911464 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 70.8" "Group enriched" "Detected in many" 11 "Early spermatids: 615.4;Late spermatids: 2143.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 61.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023033, HPA023034" Enhanced Approved Nucleoplasm,Cytosol NA NA 7000 Cytosol Nucleoplasm "HPA023033: AB_1855094, HPA023034: AB_1855095" "unprognostic (4.05e-3)" "unprognostic (4.39e-3)" "unprognostic (3.81e-1)" "unprognostic (9.72e-2)" "unprognostic (1.92e-1)" "unprognostic (9.86e-2)" "unprognostic (1.24e-2)" "unprognostic (1.06e-1)" "unprognostic (4.24e-1)" "unprognostic (8.97e-3)" "unprognostic (1.84e-1)" "unprognostic (2.34e-1)" "prognostic favorable (4.29e-6)" "unprognostic (1.19e-1)" "unprognostic (8.59e-2)" "unprognostic (1.63e-1)" "unprognostic (4.47e-2)" 13.6 5.5 13.3 5.7 12.7 5.3 10.4 12.2 17.0 6.5 16.2 13.4 6.4 30.7 5.8 8.6 7.6 12.2 8.0 17.7 14.0 11.8 21.7 46.5 7.2 6.3 13.4 16.0 7.8 11.5 8.2 4.6 6.0 15.9 10.1 8.5 5.8 10.8 6.6 13.5 4.5 26.5 5.0 14.3 4.1 11.5 70.8 11.0 5.6 6.7 6.8 5.8 7.5 4.4 7.3 6.6 2.1 3.5 4.7 8.4 4.0 11.8 6.8 5.5 15.5 27.6 14.5 8.1 8.5 18.4 12.0 14.3 26.7 12.4 4.1 4.7 8.9 22.3 9.8 8.3 15.9 7.0 1.2 6.8 9.0 9.4 61.2 29.5 9.0 7.6 11.9 9.2 10.8 8.4 4.3 11.1 12.7 16.7 8.6 8.9 10.0 10.7 11.1 4.4 41.7 7.3 7.1 5.9 14.7 14.4 22.5 7.0 6.4 6.4 35.5 8.3 11.3 9.8 21.4 7.4 8.9 5.8 6.6 7.0 5.6 2.3 4.0 9.2 12.1 8.7 2.1 3.5 1.2 7.1 3.4 4.6 6.0 8.4 7.2 6.6 7.3 7.0 7.2 1.0 4.7 3.0 6.5 5.0 4.0 13.3 12.7 12.2 17.0 14.0 11.8 13.4 16.0 15.9 11.0 0.0 15.9 13.0 6.8 4.7 11.8 14.9 56.0 10.7 4.5 24.4 0.0 67.4 101.2 15.9 615.4 7.1 65.6 23.3 16.0 30.7 6.8 9.0 9.2 125.6 20.2 15.9 13.4 20.3 10.0 2143.8 25.6 9.3 32.1 21.6 22.6 19.8 17.5 17.3 24.4 119.0 7.1 25.8 11.4 131.3 17.2 5.0 42.4 12.5 30.7 4.5 PDCD2 "RP8, ZMYND7" ENSG00000071994 "Programmed cell death 2" Q16342 6 170575295-170584692 "Predicted intracellular proteins" Apoptosis DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026713, HPA075534" Approved Approved "Nucleoplasm,Cytokinetic bridge" Yes No Nucleoplasm "Cytokinetic bridge" "HPA026713: AB_1855103, HPA075534: AB_2686754" "unprognostic (3.80e-3)" "unprognostic (1.90e-2)" "unprognostic (1.37e-2)" "unprognostic (4.61e-2)" "unprognostic (5.83e-2)" "unprognostic (8.91e-3)" "prognostic unfavorable (1.42e-6)" "unprognostic (9.91e-2)" "unprognostic (7.75e-2)" "unprognostic (1.25e-2)" "unprognostic (3.17e-2)" "unprognostic (3.85e-2)" "unprognostic (4.45e-3)" "unprognostic (9.16e-2)" "unprognostic (1.66e-1)" "unprognostic (2.00e-1)" "unprognostic (1.09e-1)" 22.8 24.2 18.1 25.4 16.7 20.0 73.3 14.2 20.2 19.6 25.6 12.0 26.6 21.6 23.1 28.5 29.8 23.3 28.3 32.0 17.0 15.6 28.5 33.4 27.5 52.9 16.5 12.8 24.3 53.4 19.9 16.4 21.2 15.4 21.6 26.8 18.0 27.0 32.0 30.8 19.1 26.1 20.7 20.8 30.3 26.3 17.2 10.5 44.3 31.9 28.5 32.9 25.2 22.3 13.8 15.3 9.6 12.3 16.4 17.5 10.6 13.4 9.9 15.0 35.2 21.7 23.9 16.6 16.1 18.5 19.1 21.4 17.7 11.9 24.5 13.1 17.7 25.6 19.4 32.2 26.7 28.1 20.0 35.2 34.7 12.8 32.0 26.4 43.0 23.4 21.7 26.3 24.2 39.3 20.1 26.5 34.1 68.8 16.0 23.3 29.4 29.8 31.1 21.6 43.7 15.2 21.3 11.6 31.7 28.8 8.0 27.7 28.9 18.3 30.0 18.8 17.1 15.2 44.1 20.0 9.4 20.3 22.4 28.4 21.6 25.1 26.6 17.6 42.1 24.0 3.7 11.0 9.6 13.4 10.6 15.7 13.3 15.3 14.1 15.3 13.8 15.2 14.1 4.7 16.4 12.3 14.2 17.5 10.6 18.1 16.7 14.2 20.2 17.0 15.6 16.5 12.8 15.4 10.5 11.9 11.7 52.0 64.7 44.0 33.6 21.0 35.7 14.7 10.3 27.9 11.8 52.7 66.3 54.2 13.5 31.8 31.0 23.3 64.2 59.4 32.4 48.8 16.1 24.6 43.9 15.9 45.3 38.6 37.4 12.9 45.5 39.8 33.7 35.1 39.8 22.3 51.7 35.1 38.2 65.4 32.9 19.4 39.1 28.4 93.3 40.3 39.0 65.7 63.8 68.2 PDCD4 H731 ENSG00000150593 "Programmed cell death 4" Q53EL6 10 110871795-110900006 "Predicted intracellular proteins" Apoptosis RNA-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 153.1" "Cell type enhanced" "Detected in many" 7 "Syncytiotrophoblasts: 657.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 59.4;U-266/70: 65.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001032, HPA027214, CAB037024" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "CAB037024: AB_1841089, HPA001032: AB_1079586, HPA027214: AB_1855107" "unprognostic (4.22e-3)" "unprognostic (1.23e-1)" "unprognostic (5.39e-2)" "unprognostic (1.00e-2)" "unprognostic (2.49e-1)" "unprognostic (1.78e-1)" "unprognostic (6.37e-2)" "unprognostic (3.79e-2)" "unprognostic (1.64e-2)" "unprognostic (1.64e-2)" "unprognostic (1.41e-1)" "unprognostic (9.40e-2)" "unprognostic (1.56e-2)" "unprognostic (1.62e-1)" "unprognostic (1.69e-1)" "unprognostic (2.07e-2)" "unprognostic (4.25e-1)" 14.9 9.1 9.4 20.6 9.8 11.8 28.1 15.6 8.1 20.0 46.7 9.1 64.0 18.0 19.1 18.1 40.6 12.3 11.9 8.1 8.4 8.1 6.5 30.6 9.9 13.8 7.8 6.4 27.8 153.1 61.2 30.3 51.4 8.5 18.7 26.1 16.2 81.7 61.7 5.8 37.3 47.1 13.2 8.6 24.0 27.6 10.1 9.5 22.6 55.4 18.8 27.8 15.1 22.7 18.5 12.6 50.9 9.0 26.9 33.1 11.2 5.2 5.1 8.3 8.7 12.4 23.0 4.9 6.1 18.0 3.0 5.2 3.2 13.0 50.2 17.2 8.4 2.3 24.2 5.0 15.5 6.5 43.4 10.0 25.3 29.8 5.3 5.6 12.6 27.6 18.3 49.8 3.1 16.9 13.6 5.6 8.0 6.7 23.8 7.4 13.3 4.6 14.5 2.1 3.7 9.0 2.0 14.8 26.6 4.9 7.3 3.6 15.2 11.7 6.3 21.3 9.2 59.4 23.9 14.3 4.7 3.5 3.4 2.3 65.3 31.6 28.9 4.4 17.6 4.9 50.9 6.1 15.9 18.5 8.3 33.1 18.5 17.1 20.2 7.3 14.3 14.9 18.1 12.0 26.9 9.0 12.6 9.2 11.2 9.4 9.8 15.6 8.1 8.4 8.1 7.8 6.4 8.5 9.5 17.9 50.8 79.3 72.6 118.1 53.9 14.6 22.9 45.5 69.4 24.4 29.5 205.4 29.9 41.5 11.1 69.1 177.9 0.0 89.4 54.3 62.3 50.5 127.3 20.3 49.3 20.6 32.3 79.2 72.9 9.0 134.3 49.5 276.7 41.5 157.6 33.5 61.9 230.3 209.3 20.9 191.1 38.8 44.8 44.6 64.0 144.5 657.3 161.3 172.4 52.3 PDCD5 "MGC9294, TFAR19" ENSG00000105185 "Programmed cell death 5" O14737 19 32581068-32587452 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018471 Enhanced Approved Nucleoplasm,Cytosol NA NA 31000 Cytosol Nucleoplasm "HPA018471: AB_1855108" "unprognostic (1.04e-1)" "unprognostic (2.08e-1)" "unprognostic (9.65e-2)" "prognostic unfavorable (2.60e-4)" "unprognostic (2.02e-1)" "unprognostic (8.64e-2)" "unprognostic (3.64e-3)" "unprognostic (2.43e-2)" "unprognostic (6.22e-2)" "unprognostic (8.49e-2)" "unprognostic (3.87e-2)" "unprognostic (1.93e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (6.00e-2)" "unprognostic (3.35e-2)" "unprognostic (1.10e-1)" "unprognostic (9.54e-2)" 34.1 40.6 42.1 32.3 35.9 18.9 28.9 28.7 33.0 21.2 31.7 16.4 27.0 31.4 22.9 24.8 33.8 21.4 23.1 63.7 33.0 34.2 37.0 52.0 20.6 25.9 32.9 31.9 25.8 47.6 14.7 38.8 29.5 31.0 23.2 27.6 14.7 27.3 24.5 107.4 23.9 27.1 32.1 26.4 26.8 28.0 52.4 23.5 15.2 25.4 42.7 26.6 30.6 31.8 34.6 29.1 11.2 44.8 24.2 49.8 26.9 69.3 86.3 20.8 22.4 35.2 54.4 26.9 51.2 33.0 41.6 35.9 69.9 26.7 37.8 74.8 25.0 38.4 18.6 28.8 39.1 31.9 68.1 46.3 57.1 37.9 41.7 41.9 72.7 23.0 34.5 37.2 28.2 46.4 20.3 27.7 30.0 51.9 41.5 35.0 44.4 32.5 37.8 22.8 54.1 29.3 32.0 32.0 45.7 31.9 18.1 43.9 25.0 48.6 47.4 35.3 15.2 20.7 42.6 42.7 37.4 41.8 40.3 82.5 40.3 57.1 65.7 44.5 66.7 33.0 6.9 23.1 11.2 26.7 34.9 33.9 34.6 42.9 33.0 28.5 25.5 30.4 29.3 3.2 24.2 44.8 29.1 49.8 26.9 42.1 35.9 28.7 33.0 33.0 34.2 32.9 31.9 31.0 23.5 68.5 54.2 33.4 145.9 108.0 36.9 288.5 96.8 120.5 73.9 71.5 25.5 162.5 160.8 234.0 357.7 120.8 81.3 0.0 214.8 167.1 134.8 123.3 46.1 120.1 128.8 47.7 68.5 80.4 43.1 361.1 132.0 84.8 118.1 147.9 102.5 60.5 238.5 74.8 115.6 146.4 36.6 71.1 140.0 373.0 377.8 104.8 119.6 62.3 133.4 113.1 PDCD6 "ALG-2, PEF1B" ENSG00000249915 "Programmed cell death 6" O75340 5 271621-353856 "Plasma proteins, Predicted intracellular proteins, Transporters" "Angiogenesis, Apoptosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047221 Supported Nucleoplasm,Cytosol No No 2100000 Cytosol Nucleoplasm "HPA047221: " "unprognostic (1.32e-1)" "unprognostic (5.01e-2)" "unprognostic (2.10e-2)" "unprognostic (4.41e-3)" "unprognostic (4.94e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (5.47e-5)" "unprognostic (1.56e-1)" "unprognostic (1.27e-2)" "unprognostic (4.37e-2)" "unprognostic (1.14e-1)" "unprognostic (2.46e-2)" "prognostic unfavorable (5.16e-6)" "unprognostic (7.97e-2)" "unprognostic (1.48e-1)" "unprognostic (2.67e-1)" "prognostic favorable (2.19e-4)" 28.3 48.5 44.6 36.3 42.1 21.0 44.6 42.1 52.0 37.1 47.3 33.7 35.7 41.4 31.5 59.7 58.0 38.9 46.5 23.5 44.4 39.7 35.5 37.1 39.8 48.1 39.2 38.6 36.9 46.2 28.8 36.2 35.4 39.3 32.9 51.0 26.8 40.3 40.4 19.2 31.1 44.3 31.4 38.4 36.6 32.0 31.7 35.1 31.0 42.3 31.9 41.2 31.3 37.7 69.8 67.2 79.9 62.3 70.6 69.9 89.4 27.3 38.5 16.9 25.2 30.7 27.8 34.7 21.3 28.4 27.4 25.8 27.1 34.7 21.5 53.2 28.7 35.6 20.8 25.5 53.6 22.3 72.7 31.6 19.1 99.1 35.0 37.6 27.6 24.5 24.8 33.1 22.2 40.0 28.5 25.7 15.2 24.0 17.0 24.5 42.8 22.4 48.3 17.9 33.5 54.4 18.4 15.7 30.7 64.8 35.3 16.3 22.0 54.2 58.1 39.7 18.3 40.4 38.5 19.8 18.2 14.7 15.7 18.2 22.6 28.0 25.5 26.6 36.2 24.1 40.8 62.3 79.9 49.6 58.7 61.7 69.8 62.2 55.8 67.2 60.9 69.9 56.2 69.0 70.6 56.1 53.8 66.7 89.4 44.6 42.1 42.1 52.0 44.4 39.7 39.2 38.6 39.3 35.1 59.6 50.2 74.3 103.0 72.9 44.2 43.4 84.1 89.7 69.4 97.7 35.3 208.9 213.9 147.4 51.9 103.4 116.6 23.3 113.2 262.6 88.0 103.4 81.8 70.0 126.3 60.4 76.5 63.8 70.9 40.4 108.7 80.4 118.1 180.3 159.6 116.3 131.1 136.8 109.6 163.7 39.4 84.1 82.4 81.7 129.8 80.8 298.3 82.9 170.4 145.4 PDCL "DKFZp564M1863, PhLP" ENSG00000136940 "Phosducin like" Q13371 9 122798389-122828631 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Sensory transduction, Vision" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021571, HPA021647, CAB026473" Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB026473: , HPA021571: AB_1855114, HPA021647: AB_1855115" "unprognostic (3.51e-2)" "unprognostic (4.11e-2)" "unprognostic (2.78e-1)" "unprognostic (1.17e-2)" "unprognostic (1.39e-2)" "unprognostic (1.39e-1)" "unprognostic (8.74e-3)" "unprognostic (1.77e-1)" "unprognostic (3.13e-2)" "unprognostic (1.49e-2)" "unprognostic (1.52e-1)" "unprognostic (1.50e-1)" "prognostic favorable (7.00e-4)" "unprognostic (9.84e-2)" "unprognostic (1.35e-1)" "unprognostic (3.35e-1)" "unprognostic (2.93e-1)" 20.7 14.8 17.5 14.1 21.0 23.8 23.0 20.5 21.9 19.6 15.1 23.7 11.4 13.2 21.5 12.8 18.4 15.9 14.9 14.6 18.4 17.3 13.7 10.1 19.7 17.5 20.2 17.1 15.5 13.0 17.5 13.7 20.6 22.2 17.1 15.9 13.9 21.7 14.7 8.1 15.4 14.7 17.2 22.8 18.4 15.5 12.1 18.8 19.1 17.3 13.3 17.6 15.8 16.4 12.6 14.7 20.6 16.3 16.2 25.3 10.8 9.6 13.3 23.1 8.5 21.0 14.2 12.8 13.5 14.3 12.5 12.9 8.8 12.8 16.1 11.1 16.2 13.8 18.9 14.2 13.3 14.0 15.7 7.2 16.6 17.8 14.7 10.8 14.0 32.9 12.1 9.7 12.3 6.2 11.8 25.7 10.3 16.6 9.5 14.1 14.8 14.9 12.6 16.9 16.6 10.5 15.7 21.9 11.9 15.2 0.0 18.5 16.5 18.3 10.4 8.1 15.8 15.7 9.7 28.0 11.7 13.9 17.0 13.0 7.3 14.6 17.2 10.0 11.3 11.1 20.6 11.9 19.6 13.9 10.4 15.0 11.4 16.7 12.8 12.3 12.6 17.5 15.2 9.8 16.2 16.3 14.7 25.3 10.8 17.5 21.0 20.5 21.9 18.4 17.3 20.2 17.1 22.2 18.8 8.9 8.6 12.8 13.9 21.5 41.4 3.6 10.2 18.7 4.5 19.2 21.6 24.0 8.3 18.4 4.7 30.5 7.9 0.0 15.8 22.8 25.4 15.3 56.5 6.6 22.4 38.1 12.1 26.4 23.7 2.1 21.3 16.0 18.6 41.5 17.7 34.4 14.0 15.9 15.9 11.8 34.6 19.4 22.7 12.0 17.2 20.3 26.7 20.8 12.1 14.0 PDCL3 VIAF1 ENSG00000115539 "Phosducin like 3" Q9H2J4 2 100562690-100576735 "Predicted intracellular proteins" "Angiogenesis, Apoptosis" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 154.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018469, HPA027094" Approved Enhanced Nucleoplasm,Cytosol No No Cytosol Nucleoplasm "HPA018469: AB_1855116, HPA027094: AB_10601387" "unprognostic (1.34e-1)" "unprognostic (8.30e-2)" "unprognostic (2.20e-1)" "unprognostic (3.32e-2)" "unprognostic (5.07e-3)" "unprognostic (1.13e-1)" "prognostic unfavorable (6.07e-5)" "unprognostic (1.44e-1)" "unprognostic (5.46e-2)" "unprognostic (1.66e-2)" "unprognostic (2.18e-2)" "unprognostic (2.26e-1)" "prognostic unfavorable (2.55e-5)" "unprognostic (7.94e-2)" "unprognostic (1.78e-1)" "unprognostic (8.22e-2)" "prognostic favorable (4.23e-4)" 12.9 15.9 14.7 16.4 16.2 12.0 18.0 10.7 16.5 12.7 18.8 14.3 15.3 10.5 20.1 23.5 22.5 14.9 13.1 17.6 14.6 15.8 20.9 12.2 13.5 14.0 24.4 15.9 15.4 10.4 10.8 11.4 17.1 17.4 19.6 17.9 10.2 12.0 15.4 35.7 22.0 12.1 49.6 18.3 14.5 13.3 14.0 14.5 13.4 13.0 18.8 19.6 29.9 16.8 26.5 33.4 22.2 43.6 25.6 31.4 23.3 12.8 18.0 19.0 16.4 6.1 8.6 21.1 16.0 9.9 29.0 18.1 22.6 8.0 20.7 24.4 18.7 39.1 10.8 23.4 15.4 23.0 33.3 20.2 21.9 9.7 26.4 16.2 23.1 23.4 9.5 28.3 25.6 16.4 7.6 17.8 16.6 18.1 14.1 21.5 21.9 23.1 35.5 24.8 13.8 26.5 22.6 20.3 14.5 17.7 29.8 17.8 15.7 12.6 17.2 17.6 16.0 13.5 16.0 13.9 18.2 19.4 14.1 22.0 8.5 15.8 21.8 11.3 27.0 14.3 18.6 19.3 22.2 19.4 34.9 22.1 26.5 29.7 21.5 33.4 20.8 31.0 23.8 2.1 25.6 43.6 18.4 31.4 23.3 14.7 16.2 10.7 16.5 14.6 15.8 24.4 15.9 17.4 14.5 17.9 28.0 24.3 30.3 58.3 10.6 33.9 20.4 22.7 33.0 14.0 5.9 56.6 51.4 45.5 25.5 21.8 14.2 0.0 33.9 42.2 26.3 23.8 88.1 14.7 52.5 11.1 19.0 15.4 12.4 11.4 13.6 57.2 33.7 154.1 22.6 13.5 29.8 17.5 31.5 63.2 11.2 51.8 50.5 5.2 45.8 50.3 43.8 40.8 28.7 30.1 PDE1A ENSG00000115252 "Phosphodiesterase 1A" P54750 2 182140036-182523192 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 66.0;kidney: 37.1" "Group enriched" "Detected in many" 6 "Distal tubular cells: 157.5;Early spermatids: 314.8;Late spermatids: 455.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 13.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "ASC diff: 22.8;HHSteC: 13.5;HSkMC: 28.9" "Group enriched" "Detected in many" 6 "amygdala: 118.0;basal ganglia: 76.2;cerebral cortex: 161.5;hippocampal formation: 155.8;hypothalamus: 47.8" "Low region specificity" "Detected in all" HPA022151 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA022151: AB_1855118" "unprognostic (3.63e-1)" "unprognostic (7.21e-2)" "unprognostic (1.32e-1)" "unprognostic (8.61e-2)" "unprognostic (1.58e-1)" "unprognostic (3.02e-1)" "unprognostic (3.84e-1)" "unprognostic (3.82e-1)" "unprognostic (1.02e-1)" "unprognostic (5.38e-2)" "unprognostic (2.78e-1)" "unprognostic (2.86e-1)" "unprognostic (5.55e-3)" "unprognostic (2.50e-3)" "unprognostic (5.96e-2)" "unprognostic (1.37e-1)" "unprognostic (1.40e-3)" 7.6 3.9 13.8 3.6 11.5 0.5 4.1 66.0 25.3 11.5 8.8 6.2 1.7 2.6 7.3 6.7 4.7 7.4 18.2 11.8 12.6 4.1 37.1 3.2 3.1 1.8 7.1 15.7 9.2 2.0 1.3 2.3 1.3 6.9 3.8 5.6 3.0 1.8 4.8 2.4 2.1 4.6 11.8 10.1 2.6 4.6 24.6 9.0 0.0 35.1 2.6 1.1 8.3 9.0 0.0 1.4 0.8 0.2 0.0 0.0 0.0 0.0 0.1 2.3 0.0 22.8 1.9 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 3.2 0.0 13.5 0.0 0.0 28.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.4 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 3.2 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 13.8 11.5 66.0 25.3 12.6 4.1 7.1 15.7 6.9 9.0 0.0 1.6 0.0 2.2 1.1 12.6 3.6 0.0 0.0 2.3 26.2 0.0 0.1 157.5 0.3 314.8 5.8 0.0 0.0 0.3 0.0 1.9 2.0 0.0 0.0 0.1 0.0 0.0 8.0 0.0 455.7 13.8 0.2 0.0 0.0 0.6 0.2 0.2 0.0 7.8 1.4 1.1 51.8 47.4 4.4 3.9 1.1 0.0 0.0 0.0 0.7 PDE1C Hcam3 ENSG00000154678 "Phosphodiesterase 1C" Q14123 7 31751179-32299329 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase" "Deafness, Disease mutation, FDA approved drug targets, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 33.6;heart muscle: 56.2" "Group enriched" "Detected in some" 7 "Bipolar cells: 55.0;Cardiomyocytes: 112.6;Cone photoreceptor cells: 49.1;Early spermatids: 40.4;Late spermatids: 38.3" "Cancer enhanced" "Detected in some" "glioma: 1.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 15.2;fHDF/TERT166: 49.0;hTERT-RPE1: 15.0;U-251 MG: 26.5;WM-115: 35.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052375 Approved Nucleoplasm NA NA Nucleoplasm "HPA052375: AB_2681802" "unprognostic (1.29e-2)" "unprognostic (2.20e-5)" "unprognostic (1.68e-2)" "unprognostic (1.20e-3)" "unprognostic (2.29e-1)" "unprognostic (5.65e-2)" "unprognostic (4.06e-3)" "unprognostic (2.75e-1)" "unprognostic (6.79e-3)" "unprognostic (6.49e-2)" "unprognostic (3.88e-5)" "unprognostic (7.03e-2)" "unprognostic (3.09e-3)" "unprognostic (5.76e-2)" "unprognostic (5.80e-2)" "unprognostic (1.49e-1)" "unprognostic (1.06e-3)" 2.9 2.7 10.6 3.2 27.7 0.9 5.1 2.4 17.1 1.2 2.7 30.1 0.0 2.3 3.1 6.8 7.4 8.4 2.4 56.2 14.8 7.5 4.0 1.0 5.0 1.4 31.1 12.0 4.9 2.7 1.3 1.3 4.0 16.3 2.9 2.7 7.9 2.6 4.2 1.4 0.9 2.8 10.4 17.1 1.4 3.8 4.2 33.6 0.0 3.9 0.2 1.0 7.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 5.2 0.0 0.2 0.1 0.0 15.2 6.2 7.2 5.9 0.0 0.0 0.0 0.0 49.0 0.0 0.4 0.0 0.0 9.3 0.0 0.0 0.4 0.4 0.0 0.0 0.0 10.9 0.6 0.0 1.5 0.1 15.0 2.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 7.4 0.0 2.3 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 8.1 3.0 0.1 26.5 0.0 0.0 0.0 0.7 0.1 35.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 27.7 2.4 17.1 14.8 7.5 31.1 12.0 16.3 33.6 0.0 0.0 0.0 0.8 0.0 55.0 112.6 0.0 4.0 1.2 1.8 49.1 0.0 0.0 5.6 40.4 2.9 0.0 0.0 0.4 0.0 0.0 0.2 8.1 0.0 0.1 3.2 0.0 0.0 0.0 38.3 0.3 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.4 0.0 4.4 0.0 2.1 1.1 0.7 0.0 0.0 0.0 0.0 0.0 PDE4A DPDE2 ENSG00000065989 "Phosphodiesterase 4A" P27815 19 10416773-10469631 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.5;testis: 31.8" "Cell type enhanced" "Detected in many" 13 "Late spermatids: 164.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 22.0;NB-4: 25.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017632, HPA043310, HPA076091" Uncertain Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB017632: AB_1127109, HPA043310: AB_2678419, HPA076091: AB_2686775" "unprognostic (1.29e-2)" "unprognostic (3.98e-2)" "unprognostic (8.91e-2)" "unprognostic (1.82e-1)" "unprognostic (7.00e-2)" "unprognostic (6.84e-2)" "unprognostic (1.54e-2)" "unprognostic (4.39e-2)" "unprognostic (7.91e-2)" "unprognostic (1.52e-2)" "unprognostic (6.90e-2)" "unprognostic (2.41e-1)" "unprognostic (2.27e-2)" "unprognostic (1.64e-2)" "unprognostic (2.57e-2)" "unprognostic (1.67e-1)" "unprognostic (2.15e-1)" 6.4 2.5 9.0 4.2 13.9 3.4 6.3 15.0 38.5 8.4 4.3 3.2 0.4 2.0 4.4 1.1 3.1 4.8 5.0 4.1 12.4 6.9 2.8 1.9 7.7 2.0 5.3 19.4 1.7 9.8 17.3 2.3 4.9 34.7 3.7 3.0 3.1 7.1 4.0 26.1 2.2 2.7 4.7 3.6 4.1 6.1 31.8 4.5 0.0 5.4 1.0 1.9 4.6 3.5 0.2 3.3 5.9 4.4 5.3 2.0 1.3 0.0 1.4 0.3 3.9 11.6 6.9 2.2 3.3 6.6 0.4 1.1 3.5 3.2 1.5 9.7 8.5 0.2 0.3 2.3 0.4 0.2 3.8 3.3 13.6 4.7 3.8 7.5 2.2 22.0 5.1 0.4 3.7 0.0 0.4 3.1 1.2 10.7 3.3 2.3 1.0 1.3 25.3 1.8 3.9 2.8 8.9 2.2 11.7 0.6 0.8 2.5 0.9 0.2 0.1 3.6 0.6 0.5 4.5 6.6 5.0 6.5 3.4 2.1 6.5 0.5 7.2 2.1 0.1 4.0 5.9 2.6 5.1 1.5 4.4 0.8 0.2 0.5 2.0 3.3 0.1 0.1 0.7 0.2 5.3 4.4 0.2 1.2 1.3 9.0 13.9 15.0 38.5 12.4 6.9 5.3 19.4 34.7 4.5 3.0 15.2 8.0 2.7 9.0 23.9 5.8 12.7 10.7 7.9 8.7 0.0 0.3 0.0 2.8 44.2 10.9 1.3 0.0 11.1 4.3 13.4 3.1 32.2 0.8 9.8 52.4 0.0 11.6 18.3 164.4 16.1 37.2 13.5 14.4 6.2 1.3 10.6 0.0 17.0 0.0 2.6 6.5 8.1 7.7 7.8 7.0 0.3 16.0 6.8 1.4 PDE7B ENSG00000171408 "Phosphodiesterase 7B" Q9NP56 6 135851696-136195574 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Collecting duct cells: 21.0;Endothelial cells: 18.2;Ito cells: 35.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 4.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 7.3;ASC TERT1: 8.6;EFO-21: 13.4;HeLa: 7.8;HSkMC: 18.7;HUVEC TERT2: 8.7;U-2197: 9.3" "Region enriched" "Detected in all" 5 "basal ganglia: 112.3" "Low region specificity" "Detected in all" HPA023967 Uncertain Approved Nucleoplasm No NA Nucleoplasm "HPA023967: AB_1855128" "unprognostic (3.18e-1)" "unprognostic (3.47e-1)" "unprognostic (2.34e-1)" "unprognostic (1.79e-3)" "unprognostic (3.34e-1)" "unprognostic (3.22e-4)" "unprognostic (1.37e-2)" "unprognostic (3.00e-1)" "unprognostic (2.80e-1)" "unprognostic (6.73e-3)" "unprognostic (1.11e-2)" "unprognostic (7.85e-2)" "prognostic favorable (1.59e-4)" "unprognostic (3.14e-3)" "unprognostic (2.68e-2)" "unprognostic (1.43e-1)" "unprognostic (3.34e-2)" 5.8 4.3 7.3 4.0 21.9 0.8 3.6 1.6 12.8 6.2 4.0 2.3 25.2 3.6 14.2 4.9 2.8 4.2 6.1 7.9 5.1 7.4 9.6 6.4 3.3 2.8 6.4 4.2 22.7 1.6 3.7 8.7 2.2 5.9 6.8 5.0 5.4 5.0 28.5 7.2 1.5 3.7 13.5 5.3 2.3 5.2 2.9 7.1 7.7 8.3 6.1 1.9 10.6 5.1 4.3 2.6 0.6 0.9 0.7 1.8 0.3 0.0 4.5 0.1 0.0 7.3 8.6 0.0 0.4 2.3 1.7 0.9 0.0 0.0 0.0 13.4 2.9 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 7.8 0.0 3.1 0.1 0.0 18.7 0.0 3.4 0.0 0.7 8.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 3.0 0.5 3.2 3.0 0.1 0.1 0.0 0.0 1.5 0.0 1.9 0.0 9.3 0.0 0.1 0.0 0.0 0.5 0.0 0.7 0.2 0.9 0.6 0.2 0.2 0.1 1.5 0.4 0.2 2.6 4.3 1.8 1.0 0.3 0.7 0.1 0.2 0.2 0.3 7.3 21.9 1.6 12.8 5.1 7.4 6.4 4.2 5.9 7.1 0.0 0.3 3.0 0.2 0.3 2.3 8.5 2.5 0.0 0.0 21.0 0.0 0.1 0.0 0.1 0.4 18.2 0.0 0.0 1.5 0.0 3.3 0.3 10.3 4.7 0.3 6.4 7.0 35.0 1.5 0.0 11.2 0.5 0.0 0.0 0.0 13.8 0.1 0.0 7.4 1.2 0.7 12.9 3.1 0.1 0.2 1.3 0.0 0.0 0.0 0.1 PDE8B ENSG00000113231 "Phosphodiesterase 8B" O95263 5 77210449-77429807 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "Cushing syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "thyroid gland: 67.7" "Group enriched" "Detected in many" 4 "Cardiomyocytes: 26.4;Cone photoreceptor cells: 51.1;Glandular cells: 41.8;Horizontal cells: 65.2;Muller glia cells: 77.6" "Cancer enriched" "Detected in many" 6 "thyroid cancer: 35.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "BJ hTERT+: 12.4;HeLa: 28.4;SK-BR-3: 7.6" "HPA036911, HPA036912" Supported Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA036911: AB_2675378, HPA036912: AB_10670377" "unprognostic (1.30e-1)" "unprognostic (7.95e-2)" "unprognostic (3.35e-2)" "unprognostic (7.61e-4)" "unprognostic (1.59e-2)" "unprognostic (1.41e-1)" "unprognostic (2.66e-2)" "unprognostic (4.48e-2)" "unprognostic (1.71e-1)" "unprognostic (3.26e-2)" "unprognostic (3.98e-2)" "unprognostic (2.44e-1)" "unprognostic (9.04e-3)" "unprognostic (3.40e-2)" "unprognostic (3.76e-2)" "unprognostic (1.98e-1)" "unprognostic (3.19e-2)" 6.8 2.5 9.9 0.7 14.2 0.4 3.8 1.1 16.3 6.3 1.2 2.3 0.3 1.2 11.3 3.2 1.1 10.1 2.1 7.9 8.2 9.2 3.1 1.2 2.2 0.7 5.4 8.3 1.9 4.2 0.3 3.8 13.1 8.6 10.5 0.8 2.0 5.3 7.1 0.4 0.7 1.3 10.3 2.3 0.4 1.5 1.5 5.7 0.3 67.7 0.3 0.7 0.8 1.4 0.2 0.8 1.4 2.3 0.4 0.4 0.1 0.3 3.4 1.4 0.4 1.2 0.0 0.5 1.1 12.4 0.2 0.1 1.4 0.2 0.5 0.2 0.1 0.3 0.9 0.1 0.0 0.2 0.2 1.1 0.7 28.4 0.3 0.0 0.5 0.6 0.5 0.0 0.0 0.0 0.6 0.0 0.6 0.2 0.3 0.0 0.2 0.6 0.7 0.8 0.3 0.1 0.8 1.4 0.7 0.0 0.3 3.8 1.1 1.7 7.6 0.8 1.1 1.6 1.1 0.6 0.4 0.2 0.2 0.6 0.9 0.5 0.6 1.6 0.7 0.4 0.0 0.3 1.4 0.3 2.2 0.1 0.2 0.2 0.3 0.8 0.2 0.4 0.0 0.3 0.4 2.3 0.5 0.1 0.1 9.9 14.2 1.1 16.3 8.2 9.2 5.4 8.3 8.6 5.7 3.0 3.2 0.0 1.6 0.3 11.8 26.4 0.0 0.0 2.3 1.8 51.1 0.0 0.0 1.8 3.6 0.7 0.0 0.0 0.0 0.0 2.3 41.8 1.1 0.0 0.3 65.2 4.7 4.3 0.6 3.0 5.5 0.0 1.7 0.0 0.6 77.6 0.2 0.0 0.0 0.8 4.6 6.5 8.2 0.6 2.1 1.0 0.0 0.0 0.5 2.4 PDE9A ENSG00000160191 "Phosphodiesterase 9A" O76083 21 42653636-42775509 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 15 "Enterocytes: 168.7;Paneth cells: 77.2" "Cancer enhanced" "Detected in all" "prostate cancer: 31.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 6.8" "Group enriched" "Detected in many" 4 "NK-cells: 1.7;T-cells: 6.8" "Cell line enhanced" "Detected in many" "AF22: 16.3;EFO-21: 16.5;MCF7: 12.2;NB-4: 18.2;NTERA-2: 22.5;SCLC-21H: 12.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011380, HPA011978" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA011380: AB_1855132, HPA011978: " "unprognostic (5.75e-2)" "unprognostic (9.92e-3)" "unprognostic (3.50e-1)" "unprognostic (1.08e-1)" "unprognostic (1.44e-1)" "unprognostic (1.40e-1)" "unprognostic (5.06e-2)" "unprognostic (3.99e-2)" "unprognostic (6.02e-2)" "unprognostic (1.60e-1)" "unprognostic (1.25e-2)" "unprognostic (5.01e-2)" "unprognostic (1.90e-2)" "unprognostic (4.01e-3)" "unprognostic (1.97e-1)" "unprognostic (6.55e-2)" "unprognostic (1.79e-1)" 6.1 6.6 9.9 6.8 15.2 0.8 9.4 13.7 9.0 3.7 37.1 11.9 14.0 3.0 5.7 18.8 6.1 10.3 7.7 3.5 6.2 7.7 13.2 2.5 4.7 4.6 10.0 4.9 4.1 4.0 4.7 6.0 9.6 6.9 33.2 15.8 9.7 8.8 15.9 2.3 3.8 26.1 22.3 8.0 15.9 8.4 1.5 8.9 4.9 5.2 2.1 4.1 12.6 4.0 0.5 0.9 1.0 0.1 1.7 6.8 0.5 0.0 1.5 16.3 2.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 1.8 9.8 0.0 16.5 0.0 1.1 0.0 1.4 5.3 0.0 0.0 5.6 0.0 0.0 3.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 12.2 0.8 18.2 22.5 8.0 0.0 0.0 0.0 0.6 11.2 4.5 12.5 7.4 2.8 0.0 0.2 4.0 0.1 10.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.1 0.0 0.0 0.0 0.8 0.1 0.0 0.0 2.1 0.6 0.2 0.5 6.8 1.7 1.0 1.7 0.1 0.9 2.2 0.5 9.9 15.2 13.7 6.7 6.2 7.7 10.0 4.9 6.9 8.9 3.0 5.3 0.0 8.5 0.9 21.0 1.4 5.1 1.4 0.0 17.4 0.0 0.0 24.9 6.2 0.3 6.7 168.7 0.0 2.1 0.1 3.1 27.6 1.1 0.8 5.6 33.4 12.6 3.7 0.6 1.7 10.9 1.0 27.0 1.8 19.3 9.4 5.1 77.2 5.6 7.6 2.7 12.9 5.9 0.4 0.7 0.5 0.3 2.1 22.2 13.1 PDF ENSG00000258429 "Peptide deformylase, mitochondrial" Q9HBH1 16 69328621-69330595 "Enzymes, Predicted intracellular proteins" "Protein biosynthesis" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 30.2" "Cell type enhanced" "Detected in single" 21 "Alveolar cells type 1: 3.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA063409 Approved Approved Nucleoplasm,Mitochondria "Intracellular and membrane" No No Mitochondria Nucleoplasm "HPA063409: AB_2685007" "unprognostic (4.28e-2)" "prognostic unfavorable (4.63e-4)" "unprognostic (1.37e-1)" "unprognostic (1.47e-1)" "unprognostic (2.85e-1)" "prognostic unfavorable (2.73e-4)" "unprognostic (2.98e-3)" "prognostic unfavorable (7.35e-4)" "unprognostic (5.84e-2)" "unprognostic (4.35e-1)" "unprognostic (1.02e-1)" "unprognostic (1.00e-1)" "prognostic favorable (6.11e-4)" "unprognostic (4.78e-2)" "unprognostic (1.05e-1)" "unprognostic (5.98e-2)" "unprognostic (1.22e-2)" 6.6 7.9 4.8 7.8 4.5 5.3 4.8 3.1 6.9 3.6 7.6 3.8 3.3 7.1 5.3 5.6 8.4 4.4 6.5 3.8 4.6 3.3 14.9 30.2 3.7 7.0 3.0 5.2 5.0 14.2 8.2 3.9 4.9 4.4 5.3 4.1 4.3 12.8 4.6 10.4 6.0 5.2 3.4 2.3 5.0 8.3 3.7 2.0 10.2 7.3 9.2 6.2 3.7 4.0 10.3 3.2 2.5 2.8 1.7 6.9 1.5 9.0 6.1 1.2 2.9 1.8 1.4 10.7 7.6 2.0 5.4 4.7 15.0 6.4 16.7 10.1 2.6 2.5 13.0 3.7 4.0 2.2 4.0 31.0 8.5 5.8 21.4 3.7 11.8 6.8 2.8 7.1 4.8 2.3 0.9 3.1 8.6 20.3 1.9 2.9 11.6 9.2 12.4 7.8 3.3 11.2 21.7 1.9 15.5 4.3 5.7 10.4 8.3 13.1 2.3 6.4 0.5 12.9 3.8 4.7 4.7 8.8 5.4 8.7 15.8 10.5 19.7 3.1 8.8 6.0 0.0 2.8 2.5 1.2 1.6 3.1 4.3 3.9 3.9 3.0 10.3 6.9 2.5 0.0 1.7 1.5 3.2 3.0 1.5 4.8 4.5 3.1 6.9 4.6 3.3 3.0 5.2 4.4 2.0 3.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 PDGFRA "CD140a, GAS9, PDGFR2" ENSG00000134853 "Platelet derived growth factor receptor alpha" P16234 4 54229097-54298247 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Chemotaxis, Host-virus interaction" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 81.5" "Group enriched" "Detected in many" 9 "Fibroblasts: 171.4;Leydig cells: 416.6;Peritubular cells: 384.4" "Cancer enhanced" "Detected in all" "glioma: 30.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 82.8;ASC TERT1: 38.8;BJ hTERT+: 48.0;fHDF/TERT166: 33.4;HHSteC: 28.0;HSkMC: 70.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004947, CAB018143" Supported Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Intracellular and membrane" NA NA 150000 "Nucleoplasm, Plasma membrane, Cell Junctions" "CAB018143: AB_2162351, HPA004947: AB_2732399" "unprognostic (1.67e-1)" "unprognostic (9.35e-2)" "unprognostic (4.59e-3)" "unprognostic (1.60e-1)" "unprognostic (8.92e-2)" "prognostic favorable (9.33e-4)" "unprognostic (1.24e-1)" "unprognostic (2.00e-2)" "unprognostic (1.46e-1)" "unprognostic (2.18e-2)" "unprognostic (2.18e-1)" "unprognostic (7.01e-2)" "prognostic unfavorable (9.79e-6)" "unprognostic (9.58e-3)" "unprognostic (9.87e-2)" "unprognostic (2.16e-2)" "unprognostic (1.72e-3)" 35.0 12.4 12.6 16.1 7.6 0.9 17.2 2.4 20.1 33.2 19.1 9.2 6.4 9.6 27.6 14.6 21.9 22.5 16.2 15.3 8.9 7.4 22.8 8.4 24.1 26.9 9.2 4.0 81.5 6.8 1.6 2.1 25.1 7.2 18.6 15.2 19.2 8.5 8.3 11.9 7.0 17.4 19.7 8.8 51.6 13.6 19.0 9.3 0.5 11.3 12.8 4.3 35.9 24.6 0.9 0.4 2.5 0.4 0.3 0.8 0.3 0.0 0.0 0.2 0.1 82.8 38.8 0.1 4.3 48.0 0.0 0.1 11.5 0.0 0.1 0.1 33.4 0.1 0.1 3.3 0.0 0.0 0.4 0.1 0.1 0.1 0.2 28.0 0.0 0.0 70.4 0.0 5.5 0.0 0.9 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 6.7 0.0 0.1 0.0 0.3 0.1 0.0 0.1 15.2 0.5 16.6 0.0 0.0 0.0 0.1 0.4 0.0 0.3 2.5 0.4 0.2 0.5 0.2 0.2 0.6 0.8 0.4 0.0 0.9 0.7 0.4 2.3 0.3 0.3 0.4 0.2 0.3 12.6 7.6 2.4 7.3 8.9 7.4 9.2 4.0 7.2 9.3 0.0 0.3 0.9 0.3 15.1 0.7 4.0 0.0 0.0 0.0 0.0 0.0 1.3 1.7 2.9 1.6 3.3 0.0 0.0 5.8 1.2 171.4 0.4 0.0 0.8 2.8 0.0 0.0 38.1 0.6 3.7 416.6 1.6 21.9 8.2 0.0 18.3 12.2 0.0 384.4 0.0 0.4 0.0 13.2 1.1 3.5 13.8 1.1 0.0 0.0 0.8 PDGFRL PRLTS ENSG00000104213 "Platelet derived growth factor receptor like" Q15198 8 17576433-17644071 "Disease related genes, Predicted secreted proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 14.3" "Cell type enhanced" "Detected in many" 11 "Fibroblasts: 36.0;Leydig cells: 69.0;Peritubular cells: 66.4" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.4;neutrophil: 1.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "AN3-CA: 49.5;BJ hTERT+: 40.1;HSkMC: 21.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052801 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Secreted - unknown location" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA052801: AB_2681956" "unprognostic (1.25e-1)" "unprognostic (1.73e-1)" "unprognostic (5.10e-2)" "unprognostic (1.59e-2)" "unprognostic (7.39e-3)" "unprognostic (1.31e-1)" "unprognostic (1.32e-1)" "unprognostic (6.54e-2)" "unprognostic (3.86e-1)" "unprognostic (7.46e-2)" "unprognostic (1.63e-1)" "unprognostic (6.72e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.58e-3)" "unprognostic (1.26e-1)" "unprognostic (4.47e-3)" "unprognostic (6.00e-3)" 7.7 0.4 0.5 0.1 0.9 0.0 14.3 0.6 0.5 8.0 1.3 0.0 3.6 2.0 0.3 5.8 2.6 1.2 0.3 0.4 0.4 0.3 0.7 0.0 0.4 11.6 1.6 2.3 2.0 1.5 0.9 0.0 1.4 1.1 3.3 1.8 0.6 6.3 0.5 0.2 1.0 0.9 8.3 0.0 0.9 2.0 0.0 0.9 1.4 1.4 0.0 0.0 0.1 0.0 4.5 0.2 49.5 1.5 0.6 3.2 0.9 40.1 1.8 8.0 0.2 0.0 0.0 0.2 0.6 6.0 0.0 2.7 0.2 1.0 0.0 3.0 0.0 1.4 1.0 3.8 0.0 0.0 21.9 0.0 2.2 0.0 0.0 3.3 0.4 0.0 0.6 0.2 3.2 0.0 0.1 2.4 0.2 0.7 0.0 0.0 0.1 0.2 2.9 0.1 0.3 0.3 0.3 0.8 3.0 0.1 0.0 0.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.4 11.7 0.4 2.2 0.0 0.0 3.4 0.0 0.0 14.1 0.0 2.5 19.2 2.7 0.1 0.0 6.4 17.2 36.0 1.7 0.0 0.0 2.7 0.0 1.2 2.5 0.0 3.1 69.0 0.3 10.1 2.8 1.0 1.3 4.9 0.0 66.4 0.0 0.4 0.0 6.1 0.5 1.0 8.7 8.1 0.0 0.2 0.3 PDHB PDHE1B ENSG00000168291 "Pyruvate dehydrogenase E1 beta subunit" P11177 3 58427630-58433857 "Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 245.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033794, HPA036744, HPA036745" Enhanced Supported Nucleoplasm,Mitochondria No No 6500000 Mitochondria Nucleoplasm "CAB033794: AB_2162946, HPA036744: AB_10670921, HPA036745: AB_2675285" "unprognostic (2.06e-2)" "unprognostic (1.79e-1)" "unprognostic (6.04e-3)" "unprognostic (1.22e-1)" "unprognostic (7.22e-2)" "unprognostic (1.42e-1)" "unprognostic (3.20e-2)" "unprognostic (6.13e-2)" "unprognostic (9.62e-2)" "unprognostic (5.94e-2)" "unprognostic (3.98e-1)" "unprognostic (2.35e-1)" "prognostic favorable (2.79e-8)" "unprognostic (2.67e-1)" "unprognostic (8.37e-2)" "unprognostic (1.06e-2)" "unprognostic (9.85e-2)" 21.8 34.3 22.5 19.5 28.4 8.6 17.1 15.1 26.2 18.0 21.6 18.4 19.2 16.2 17.2 18.2 22.8 15.0 16.5 64.2 24.1 20.8 38.7 41.8 13.9 18.2 23.7 23.3 11.0 17.2 26.0 20.0 21.6 26.4 19.5 23.9 16.1 17.6 22.1 92.2 14.3 17.3 24.5 22.8 23.2 21.4 21.8 17.5 20.9 16.1 33.8 20.6 17.9 14.4 37.0 50.1 33.6 39.8 43.4 38.6 38.3 19.0 26.7 27.7 20.8 28.2 34.7 33.3 24.1 30.2 35.7 36.8 48.2 18.5 40.8 13.6 30.5 33.1 11.1 33.7 22.1 27.3 23.6 24.8 36.4 50.5 36.3 28.6 29.5 20.5 30.3 20.5 28.7 16.9 41.9 30.7 34.1 18.7 18.4 38.7 18.2 27.9 31.0 38.2 20.2 30.4 13.3 21.6 39.3 56.3 26.2 19.3 21.2 22.3 32.2 24.0 41.8 47.6 31.7 22.5 19.1 25.5 20.0 27.2 25.8 36.6 28.7 29.3 35.1 18.0 16.4 35.4 33.6 31.5 39.8 33.2 37.0 31.2 30.0 50.1 33.3 35.1 31.4 7.0 43.4 35.9 33.7 38.6 38.3 22.5 28.4 15.1 26.2 24.1 20.8 23.7 23.3 26.4 17.5 56.6 28.0 47.4 32.8 24.7 30.0 245.7 48.4 69.6 48.9 33.2 23.6 144.4 195.6 84.1 43.2 62.9 34.8 23.3 63.6 85.4 31.9 17.8 38.1 61.1 74.4 54.0 55.7 43.6 38.0 10.4 55.8 41.0 54.0 89.2 44.3 51.8 51.0 41.3 48.1 105.9 44.7 64.7 61.8 85.0 80.3 26.1 131.5 46.0 47.8 28.8 PDHX "DLDBP, E3BP, OPDX, PDX1, proX" ENSG00000110435 "Pyruvate dehydrogenase complex component X" O00330 11 34915829-35020591 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 70.5" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 117.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038484, HPA038485" Enhanced Approved "Nucleoplasm,Plasma membrane,Mitochondria" NA NA "Nucleoplasm, Plasma membrane" Mitochondria "HPA038484: AB_10669645, HPA038485: AB_10669540" "unprognostic (1.60e-1)" "unprognostic (1.91e-1)" "unprognostic (1.42e-2)" "unprognostic (1.06e-1)" "unprognostic (2.03e-1)" "unprognostic (8.34e-3)" "unprognostic (3.56e-3)" "unprognostic (1.94e-1)" "unprognostic (2.14e-1)" "unprognostic (5.41e-2)" "unprognostic (2.60e-2)" "unprognostic (2.08e-1)" "prognostic favorable (1.83e-5)" "unprognostic (2.24e-1)" "unprognostic (8.28e-2)" "unprognostic (9.53e-2)" "unprognostic (2.82e-1)" 13.5 14.9 13.4 8.6 17.2 4.2 10.4 13.9 23.3 9.2 13.3 10.6 9.3 12.2 8.9 8.6 10.9 6.7 7.7 46.1 14.4 12.8 15.0 25.7 7.8 6.8 14.7 14.1 7.7 13.1 14.6 14.7 15.8 22.1 12.0 12.7 8.9 12.4 14.1 70.5 8.8 12.3 11.5 12.0 6.6 13.7 15.7 9.0 5.9 9.1 19.0 8.7 13.0 10.7 12.8 19.5 12.1 21.7 15.0 14.9 9.8 9.1 24.0 13.9 5.5 10.2 12.1 13.6 17.1 14.0 19.4 18.9 31.0 8.5 12.6 11.2 14.4 22.7 17.8 26.9 14.4 19.3 11.3 22.5 11.8 25.3 35.6 22.2 22.3 14.0 12.3 17.9 10.6 14.5 11.2 14.0 10.8 25.3 11.6 15.2 15.6 13.8 13.8 11.3 25.2 14.4 12.1 24.9 10.9 29.0 24.1 14.7 10.7 15.1 22.9 23.4 14.5 25.7 13.8 9.7 14.4 16.2 14.8 18.9 11.1 22.0 15.6 11.3 11.0 14.5 8.6 13.6 12.1 11.5 15.0 10.8 12.8 10.9 9.4 19.5 11.7 13.3 9.6 2.8 15.0 21.7 5.2 14.9 9.8 13.4 17.2 13.9 23.3 14.4 12.8 14.7 14.1 22.1 9.0 32.8 21.1 9.0 18.1 23.1 25.5 117.0 20.4 18.7 19.4 5.2 27.5 53.6 54.7 18.3 35.0 10.9 12.8 23.3 12.6 28.3 19.4 19.1 5.7 22.1 23.1 19.1 8.6 9.8 15.0 31.1 10.0 15.5 20.3 28.9 16.0 18.1 13.9 14.4 12.7 22.7 23.2 0.0 20.9 40.9 33.4 22.2 69.5 10.4 19.0 16.9 PDIA5 "FLJ30401, PDIR" ENSG00000065485 "Protein disulfide isomerase family A member 5" Q14554 3 123067062-123225227 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 66.0" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 119.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 12.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA030353, HPA030355" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" "Intracellular and membrane" NA NA 2900000 "Nucleoplasm, Golgi apparatus" "Nucleoli fibrillar center" "HPA030353: AB_10599734, HPA030355: AB_10602200" "unprognostic (8.81e-2)" "unprognostic (2.25e-2)" "unprognostic (8.93e-2)" "prognostic favorable (4.55e-4)" "unprognostic (4.34e-2)" "unprognostic (2.10e-2)" "unprognostic (7.38e-2)" "unprognostic (2.41e-1)" "unprognostic (3.21e-2)" "unprognostic (4.02e-2)" "unprognostic (1.55e-1)" "unprognostic (2.26e-3)" "prognostic unfavorable (8.09e-11)" "unprognostic (1.57e-1)" "unprognostic (1.92e-1)" "unprognostic (1.06e-2)" "unprognostic (4.06e-3)" 11.6 17.1 2.6 11.2 3.1 6.3 9.3 1.0 4.0 10.0 11.0 2.4 10.9 5.6 12.2 17.1 6.7 9.1 22.2 7.2 2.5 1.2 11.0 66.0 14.4 7.1 2.2 1.8 11.4 18.3 5.2 12.1 29.1 1.9 14.3 10.8 12.7 10.8 7.6 8.1 6.1 8.2 9.5 2.3 8.6 17.6 18.0 2.5 3.2 18.2 5.5 7.9 7.8 6.9 3.2 12.8 0.3 9.0 0.5 2.4 2.3 8.2 5.1 6.4 7.7 29.4 26.7 34.1 15.8 26.5 8.8 24.4 16.3 7.6 0.0 20.6 24.4 5.7 4.4 2.8 9.6 9.4 0.2 3.1 3.6 1.5 19.4 12.2 9.1 0.6 22.8 14.5 6.0 12.6 9.5 29.8 3.5 4.6 21.6 6.0 10.1 2.4 10.6 4.7 18.9 5.3 2.3 4.6 22.8 7.4 4.8 6.9 4.2 7.7 8.6 13.5 10.9 7.5 11.1 16.6 2.3 7.3 10.6 4.2 6.4 1.7 3.7 7.3 7.2 7.7 0.0 9.0 0.3 1.4 2.2 2.4 3.2 1.0 0.9 5.4 0.8 0.6 0.6 0.2 0.5 0.4 12.8 0.0 2.3 2.6 3.1 1.0 4.0 2.5 1.2 2.2 1.8 1.9 2.5 17.9 27.8 1.5 3.6 4.4 9.3 2.0 25.5 8.1 13.6 5.2 37.3 39.8 0.0 28.0 1.1 21.8 3.3 0.0 25.3 119.9 23.6 13.9 3.5 42.3 10.8 0.0 8.1 37.4 8.4 1.5 22.5 4.5 8.5 1.8 26.1 2.0 13.8 3.5 20.8 4.9 29.6 12.9 7.3 1.2 1.5 3.6 42.0 2.2 16.3 4.3 PDIK1L CLIK1L ENSG00000175087 "PDLIM1 interacting kinase 1 like" Q8N165 1 26111165-26125543 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 22.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064157 Supported Nucleoplasm NA NA Nucleoplasm "HPA064157: " "unprognostic (1.09e-1)" "unprognostic (1.81e-3)" "unprognostic (2.99e-3)" "unprognostic (2.52e-2)" "unprognostic (2.54e-1)" "unprognostic (1.34e-3)" "unprognostic (3.93e-2)" "unprognostic (1.72e-3)" "unprognostic (7.29e-3)" "unprognostic (1.08e-1)" "unprognostic (2.42e-2)" "unprognostic (3.59e-1)" "unprognostic (1.34e-2)" "unprognostic (4.24e-3)" "unprognostic (2.94e-1)" "unprognostic (4.47e-1)" "unprognostic (1.78e-2)" 7.0 6.0 8.6 6.2 12.3 19.9 11.5 17.8 15.9 8.6 8.9 7.1 7.6 9.5 7.8 6.4 11.4 7.5 5.8 4.8 8.5 10.6 8.5 11.3 6.7 8.0 9.3 9.9 10.2 15.3 10.7 9.9 5.6 11.5 6.8 10.6 6.1 10.2 8.9 7.7 9.4 9.7 6.5 8.3 8.3 10.2 7.8 9.3 19.1 22.2 6.7 8.8 8.8 8.0 6.7 9.3 11.0 6.1 5.6 10.4 5.2 5.5 2.1 5.9 7.4 2.3 3.1 1.9 1.4 2.0 3.8 2.5 1.4 8.0 11.7 4.3 2.1 3.0 4.1 7.8 2.9 3.6 4.2 5.2 10.4 3.3 1.5 3.4 10.9 6.3 1.6 4.2 3.4 6.7 2.6 3.4 11.4 12.3 11.7 1.3 3.1 15.8 4.9 2.7 6.8 3.2 8.4 5.4 14.0 2.5 4.4 9.4 8.0 5.6 7.1 7.2 1.6 4.1 3.7 3.1 4.1 3.6 5.2 4.6 17.5 17.2 8.9 4.3 13.6 3.9 11.0 5.0 4.2 6.7 4.6 6.2 6.7 9.4 7.4 9.3 5.6 10.0 8.0 0.5 5.6 6.1 3.5 10.4 5.2 8.6 12.3 17.8 15.9 8.5 10.6 9.3 9.9 11.5 9.3 8.9 3.4 4.5 1.8 2.9 17.8 1.6 10.2 9.4 7.9 1.8 0.0 3.2 0.0 2.7 0.9 3.5 3.9 0.0 3.5 0.4 2.6 3.1 6.9 9.7 3.4 22.3 12.6 3.1 6.5 0.0 2.3 4.2 3.3 0.0 9.1 10.1 3.0 0.0 2.8 6.0 9.8 0.0 1.4 8.1 4.3 6.5 1.4 4.9 10.0 2.4 PDK2 PDHK2 ENSG00000005882 "Pyruvate dehydrogenase kinase 2" Q15119 17 50094737-50112152 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 101.0" "Cell type enhanced" "Detected in many" 6 "Proximal tubular cells: 118.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008287 Supported Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA008287: AB_1079589" "unprognostic (2.74e-2)" "prognostic favorable (5.87e-4)" "unprognostic (1.16e-1)" "unprognostic (2.43e-3)" "unprognostic (1.22e-1)" "unprognostic (9.63e-3)" "unprognostic (9.80e-3)" "unprognostic (8.39e-3)" "unprognostic (3.19e-2)" "unprognostic (1.25e-1)" "unprognostic (1.17e-2)" "unprognostic (2.21e-1)" "prognostic favorable (9.59e-5)" "unprognostic (3.81e-1)" "unprognostic (2.54e-1)" "unprognostic (5.33e-1)" "unprognostic (1.55e-1)" 20.6 26.1 17.2 5.2 27.5 3.2 10.8 53.7 34.4 10.1 16.1 16.1 10.1 15.5 13.1 69.8 12.5 14.4 11.5 51.7 18.2 13.0 33.7 27.8 9.0 5.7 14.6 20.9 27.7 24.1 16.9 7.5 8.6 14.2 12.7 12.4 19.5 14.0 16.5 101.0 10.6 16.5 15.1 9.9 7.8 13.6 7.2 11.4 6.2 15.6 31.4 7.4 13.8 9.4 11.3 20.1 8.9 12.9 16.5 17.4 12.2 6.4 9.2 11.1 10.0 11.8 8.9 1.2 7.0 10.4 10.5 10.2 0.8 7.0 8.1 11.7 19.5 7.1 3.1 7.4 2.8 10.3 16.3 10.3 7.2 9.1 6.8 6.3 0.0 7.8 18.7 10.8 6.8 0.5 18.5 9.1 10.4 2.9 8.1 5.9 8.2 6.0 0.0 2.4 19.5 9.0 9.1 24.9 10.9 5.7 5.5 7.4 11.2 9.9 3.1 4.7 14.2 18.3 7.2 4.7 12.3 10.1 8.4 5.1 16.0 15.1 4.4 18.0 2.6 7.9 8.9 12.9 6.8 14.0 9.8 11.1 11.1 12.5 14.8 14.2 11.3 14.6 15.0 2.2 16.5 10.5 20.1 17.4 12.2 17.2 27.5 53.7 34.4 18.2 13.0 14.6 20.9 14.2 11.4 8.9 9.3 13.6 13.9 13.5 20.8 5.0 10.2 1.4 11.4 19.2 5.9 15.1 49.7 8.0 7.3 8.3 46.6 0.0 7.9 3.4 19.5 7.6 1.1 39.8 16.7 41.3 13.3 13.5 13.7 15.0 22.5 7.9 23.6 15.4 45.3 33.6 7.9 43.6 49.5 118.5 9.2 19.4 12.1 3.3 4.4 16.4 6.6 15.8 37.1 8.4 PDLIM5 "Enh, LIM" ENSG00000163110 "PDZ and LIM domain 5" Q96HC4 4 94451857-94668227 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 129.6;skeletal muscle: 173.0" "Cell type enriched" "Detected in all" 8 "Cardiomyocytes: 1784.7" "Cancer enriched" "Detected in all" 8 "prostate cancer: 132.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "basophil: 51.1" "Lineage enriched" "Detected in all" 4 "granulocytes: 51.1" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013511, HPA016740, HPA020026" Enhanced Supported "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA 2200000 "Nucleoplasm, Plasma membrane, Focal adhesion sites" "CAB013511: AB_2533388, HPA016740: AB_1855153, HPA020026: AB_1855154" "unprognostic (6.20e-2)" "unprognostic (1.94e-1)" "unprognostic (2.81e-2)" "unprognostic (1.08e-2)" "unprognostic (6.61e-2)" "unprognostic (2.24e-1)" "unprognostic (1.33e-1)" "unprognostic (2.46e-2)" "unprognostic (7.60e-2)" "unprognostic (2.65e-1)" "unprognostic (1.18e-2)" "unprognostic (1.47e-1)" "unprognostic (1.24e-1)" "unprognostic (2.11e-2)" "unprognostic (3.15e-2)" "unprognostic (1.91e-1)" "unprognostic (1.04e-1)" 11.6 4.8 6.2 4.2 6.1 8.7 9.8 3.4 5.8 12.7 11.0 3.7 7.1 5.6 37.5 12.9 14.0 10.2 11.0 129.6 5.3 5.2 12.9 13.9 5.6 5.3 5.4 4.5 10.3 8.1 3.4 6.8 18.9 10.2 15.3 5.4 12.6 15.3 12.5 173.0 5.6 15.8 22.1 4.9 7.0 5.6 5.5 3.7 1.0 5.3 52.9 9.5 17.7 7.1 3.2 5.6 51.1 12.2 2.7 3.9 3.8 8.2 24.4 9.5 3.7 21.0 14.4 3.7 20.1 16.7 11.5 9.3 22.5 18.3 3.3 20.6 20.1 5.9 8.5 12.9 18.8 19.3 5.8 5.4 12.0 15.9 8.5 30.3 3.9 10.8 19.3 16.6 27.6 21.5 51.4 25.9 3.4 5.1 3.6 24.5 8.1 4.0 1.3 3.2 18.1 10.2 1.9 7.0 2.9 12.9 26.4 4.7 6.3 11.0 25.1 5.6 8.0 2.9 1.2 32.4 30.1 4.8 13.0 12.2 2.5 3.2 3.3 16.4 2.8 7.0 51.1 6.8 5.9 3.8 11.8 3.1 3.2 3.7 3.9 5.6 2.5 2.5 3.2 6.8 2.7 12.2 1.9 3.4 3.8 6.2 6.1 3.4 3.9 5.3 5.2 5.4 4.5 10.2 3.7 41.7 23.4 12.7 232.1 172.6 4.3 1784.7 58.6 30.8 37.5 47.1 29.5 9.2 11.6 82.1 14.6 128.1 146.3 23.3 81.9 91.7 90.4 234.4 50.8 159.4 34.4 1.6 105.0 135.1 57.1 6.8 38.3 60.2 59.1 29.7 89.1 79.1 115.5 83.5 62.6 63.8 35.6 77.6 141.3 13.2 30.2 137.1 19.9 15.0 51.0 185.7 PDP1 "PDH, PDP, PPM2A, PPM2C" ENSG00000164951 "Pyruvate dehyrogenase phosphatase catalytic subunit 1" Q9P0J1 8 93857807-93926066 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 62.2" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 71.4;Early spermatids: 99.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basal ganglia: 38.9;cerebral cortex: 62.2;olfactory region: 32.5" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 39.5;hTERT-RPE1: 39.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018483, HPA019081, HPA021152" Uncertain Approved Nucleoplasm,Mitochondria,Cytosol Yes No "Nucleoplasm, Mitochondria, Cytosol" "HPA018483: AB_1855634, HPA019081: AB_1855633, HPA021152: AB_1855635" "prognostic unfavorable (8.61e-5)" "unprognostic (4.62e-1)" "unprognostic (8.79e-2)" "unprognostic (1.09e-1)" "unprognostic (9.46e-2)" "unprognostic (1.38e-1)" "unprognostic (1.59e-1)" "unprognostic (1.18e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (5.60e-4)" "unprognostic (1.71e-2)" "unprognostic (3.25e-1)" "prognostic favorable (8.42e-9)" "unprognostic (1.85e-1)" "unprognostic (1.84e-1)" "unprognostic (5.04e-2)" "unprognostic (1.67e-1)" 5.1 32.3 11.0 4.6 38.9 5.9 7.9 7.5 62.2 7.5 4.3 4.7 1.6 3.3 7.7 8.6 8.0 6.1 9.6 22.9 10.1 8.0 6.3 2.2 6.0 5.6 5.1 32.5 9.7 9.3 20.6 4.2 6.6 4.4 5.2 6.2 4.4 6.6 4.7 31.8 3.2 5.5 5.5 3.4 5.8 5.5 12.9 4.8 4.1 9.3 7.0 5.8 7.7 5.1 11.0 12.7 7.8 21.5 2.8 19.5 8.8 7.9 3.9 8.6 3.6 7.1 13.1 2.8 6.3 7.0 7.4 8.7 4.1 29.6 4.4 21.2 10.0 39.5 17.7 3.6 5.3 11.0 0.4 1.8 2.1 4.9 1.4 8.2 1.0 3.0 8.4 10.5 12.6 20.2 39.3 16.7 4.0 0.7 7.3 9.0 1.9 6.2 3.2 3.9 8.6 5.1 1.5 5.1 0.8 5.1 5.5 0.8 3.7 4.1 0.4 19.3 7.3 1.3 1.2 29.6 9.0 5.8 21.0 7.4 4.1 1.7 3.7 11.5 3.7 7.9 3.1 15.4 7.8 5.6 14.3 5.3 9.3 9.1 7.2 12.7 11.0 5.5 4.8 1.8 2.8 21.5 2.1 19.5 8.8 11.0 38.9 7.5 62.2 10.1 8.0 5.1 32.5 4.4 4.8 11.9 5.6 13.4 11.2 11.6 34.7 71.4 22.9 22.7 17.0 15.7 7.9 3.5 5.0 24.3 99.2 14.7 6.0 0.0 11.9 3.2 11.6 13.3 5.8 2.5 5.7 9.5 9.8 14.1 20.8 22.0 10.6 16.2 10.1 2.8 5.2 19.0 22.2 7.0 12.7 8.6 10.6 6.5 12.7 7.2 9.7 9.5 3.7 10.1 8.9 17.0 PDS5A "KIAA0648, PIG54, SCC-112" ENSG00000121892 "PDS5 cohesin associated factor A" Q29RF7 4 39822863-39977956 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036661, HPA036662" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA036661: AB_2675233, HPA036662: AB_10696783" "unprognostic (4.18e-2)" "unprognostic (1.42e-1)" "unprognostic (1.62e-3)" "unprognostic (6.21e-2)" "unprognostic (1.04e-1)" "unprognostic (1.09e-2)" "unprognostic (9.97e-3)" "unprognostic (2.97e-1)" "unprognostic (6.67e-3)" "unprognostic (3.19e-2)" "unprognostic (2.59e-2)" "unprognostic (5.74e-2)" "unprognostic (2.62e-1)" "unprognostic (1.94e-1)" "unprognostic (1.99e-1)" "unprognostic (2.51e-1)" "unprognostic (3.81e-2)" 24.9 18.7 15.8 34.7 17.3 22.6 44.9 25.9 19.2 20.5 23.8 12.7 22.9 17.5 20.7 19.8 28.3 17.2 17.4 18.3 17.0 16.6 21.1 29.6 26.8 35.1 16.5 13.1 26.3 23.7 34.0 18.7 30.3 15.5 19.9 22.0 12.2 23.2 21.4 22.3 21.6 21.9 18.7 19.3 26.9 18.1 12.1 15.4 61.3 26.0 18.6 29.9 21.3 41.7 5.2 4.6 3.7 3.4 6.3 6.7 2.2 19.6 14.7 18.9 19.9 18.3 18.4 15.1 15.9 15.2 18.9 18.9 14.2 22.3 38.4 17.6 18.8 30.1 10.8 32.2 18.6 27.3 12.8 12.2 26.3 18.5 14.9 18.3 32.1 22.6 12.1 21.1 20.0 29.7 16.8 24.0 23.0 31.1 16.4 19.3 13.8 40.0 28.2 10.7 18.6 9.9 37.4 33.7 14.0 18.1 20.0 26.2 15.5 22.0 15.2 14.1 14.8 15.4 28.5 22.5 21.4 22.3 15.5 26.9 13.9 24.2 41.3 15.3 33.0 16.8 3.7 2.5 3.7 5.2 3.4 6.7 4.5 5.1 5.7 3.8 5.2 6.2 4.7 1.0 6.3 2.2 4.6 4.2 2.2 15.8 17.3 25.9 19.2 17.0 16.6 16.5 13.1 15.5 15.4 80.4 55.3 32.7 32.4 50.4 33.3 34.7 12.7 17.4 53.4 21.0 56.9 26.4 6.6 19.2 7.4 38.6 26.7 0.0 22.5 31.3 29.0 40.9 27.8 51.6 26.8 12.7 29.3 43.0 40.7 5.0 30.5 41.3 43.9 22.6 36.1 14.1 31.8 24.6 31.1 22.3 25.8 32.3 25.8 28.7 44.7 59.6 32.4 34.1 34.7 50.3 PDS5B "APRIN, AS3, CG008, FLJ23236, KIAA0979" ENSG00000083642 "PDS5 cohesin associated factor B" Q9NTI5 13 32586427-32778019 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039513, HPA040015" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA039513: AB_10671999, HPA040015: AB_10671047" "unprognostic (3.52e-2)" "unprognostic (1.21e-1)" "unprognostic (4.25e-2)" "unprognostic (6.19e-2)" "unprognostic (2.00e-1)" "unprognostic (2.30e-1)" "unprognostic (8.98e-2)" "unprognostic (3.29e-1)" "unprognostic (4.17e-2)" "unprognostic (1.28e-2)" "unprognostic (3.96e-2)" "unprognostic (6.29e-2)" "unprognostic (5.47e-2)" "unprognostic (9.62e-3)" "unprognostic (2.60e-1)" "unprognostic (1.65e-1)" "unprognostic (3.91e-2)" 14.8 11.2 18.9 11.8 20.5 25.8 17.0 21.2 27.5 21.8 16.2 8.0 10.2 8.1 25.4 18.3 9.8 16.1 10.6 9.8 17.2 16.0 13.6 12.6 14.1 15.9 12.6 22.9 22.0 9.9 15.4 17.8 14.2 14.7 17.7 11.3 8.6 11.3 13.9 14.0 13.6 13.6 16.5 12.5 16.6 12.7 15.3 14.3 29.1 14.0 7.7 13.7 16.9 24.2 9.2 7.7 8.3 6.5 5.6 8.3 3.3 6.2 3.8 17.3 9.2 8.3 6.0 4.8 10.7 7.2 9.1 9.2 5.2 10.5 23.0 3.8 5.2 9.1 8.4 12.4 6.7 10.8 18.3 4.7 20.7 6.9 7.2 4.9 18.9 12.8 4.6 3.4 7.5 6.8 5.9 6.8 9.3 7.1 15.5 8.3 8.0 22.6 14.2 12.7 13.2 4.6 23.1 23.9 7.8 5.8 5.2 4.5 10.9 12.2 12.2 4.5 11.0 11.7 12.7 13.4 8.7 8.5 6.2 6.3 4.8 5.3 19.6 3.7 12.9 12.6 5.8 6.0 8.3 7.2 4.9 8.3 7.8 8.3 7.4 7.7 9.2 8.2 7.9 7.5 5.6 6.5 5.3 5.9 3.3 18.9 20.5 21.2 27.5 17.2 16.0 12.6 22.9 14.7 14.3 14.9 24.6 19.1 19.2 25.6 41.6 22.1 25.5 36.1 31.8 26.2 23.6 19.7 5.0 12.7 12.2 37.9 13.5 0.0 13.6 15.6 29.2 22.6 23.1 24.9 15.6 44.5 30.6 23.4 34.4 9.8 62.2 26.6 33.7 24.4 20.0 17.5 12.0 12.5 58.7 9.6 20.1 71.1 56.1 46.6 59.4 25.6 5.1 28.9 16.3 11.2 PDX1 "IDX-1, IPF1, MODY4, PDX-1, STF-1" ENSG00000139515 "Pancreatic and duodenal homeobox 1" P52945 13 27920020-27926231 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "gallbladder: 10.4;intestine: 33.0;pancreas: 24.2" "Group enriched" "Detected in some" 10 "Cholangiocytes: 5.1;Ductal cells: 7.6;Exocrine glandular cells: 8.8;Intestinal endocrine cells: 13.3;Pancreatic endocrine cells: 3.3" "Group enriched" "Detected in many" 11 "colorectal cancer: 8.4;liver cancer: 1.9;pancreatic cancer: 8.6;stomach cancer: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 6.2;HEK 293: 3.7;HeLa: 9.4;OE19: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025873, HPA059146" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB025873: , HPA059146: AB_2683927" "unprognostic (2.79e-2)" "unprognostic (2.22e-1)" "unprognostic (1.92e-1)" "unprognostic (2.65e-1)" "unprognostic (6.84e-2)" "unprognostic (3.89e-2)" "unprognostic (6.75e-3)" "unprognostic (7.10e-3)" "unprognostic (3.83e-2)" "unprognostic (1.65e-1)" "unprognostic (1.04e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 33.0 0.0 0.0 31.1 0.1 0.0 0.1 0.1 10.4 0.1 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.0 0.1 24.2 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 17.6 0.0 0.2 0.1 4.6 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.1 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 6.2 3.7 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 5.1 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 PDXK "C21orf124, C21orf97, FLJ21324, FLJ31940, MGC15873, PKH, PNK, PRED79" ENSG00000160209 "Pyridoxal kinase" O00764 21 43719094-43762307 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Charcot-Marie-Tooth disease, Disease mutation, FDA approved drug targets, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 68.9" "Group enriched" "Detected in all" 7 "Early spermatids: 1421.5;Late spermatids: 3146.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030196, HPA030197, HPA030198, CAB033918" Enhanced Enhanced Nucleoplasm NA NA 870000 Nucleoplasm "CAB033918: AB_2162502, HPA030196: AB_10599735, HPA030197: AB_10601792, HPA030198: AB_10603570" "unprognostic (1.01e-1)" "unprognostic (1.99e-1)" "unprognostic (5.88e-2)" "unprognostic (1.87e-1)" "unprognostic (8.29e-2)" "unprognostic (4.31e-3)" "unprognostic (3.64e-3)" "unprognostic (1.32e-1)" "unprognostic (8.66e-2)" "unprognostic (9.34e-2)" "unprognostic (2.10e-1)" "unprognostic (3.54e-1)" "unprognostic (3.70e-2)" "unprognostic (1.31e-3)" "unprognostic (1.10e-1)" "unprognostic (4.78e-2)" "unprognostic (1.51e-3)" 28.1 13.2 37.4 8.7 36.6 13.3 13.3 21.9 38.5 9.7 13.8 11.0 15.7 16.7 9.0 13.2 11.0 12.9 8.8 11.4 26.1 30.4 22.8 17.4 20.4 9.5 24.1 22.7 16.4 17.6 25.7 20.7 12.6 20.3 10.6 11.8 7.8 18.3 13.9 5.8 14.3 22.1 8.8 10.1 7.8 15.2 68.9 10.7 3.9 13.6 7.0 11.0 9.7 8.6 2.7 2.5 1.3 7.7 1.9 3.3 2.4 17.4 21.4 3.4 6.5 8.4 11.9 4.2 6.3 9.9 6.1 5.2 17.4 27.3 5.9 6.7 9.0 8.5 13.2 6.6 17.9 4.1 6.6 5.7 6.0 23.4 12.8 16.5 5.6 8.7 16.8 17.2 6.4 7.2 10.0 2.9 2.6 10.4 13.6 5.8 11.8 0.8 10.1 9.3 17.0 8.2 6.7 2.0 16.3 26.6 21.4 3.3 3.9 26.1 24.2 9.3 1.5 8.0 7.9 5.1 4.5 8.8 6.0 5.8 8.3 3.9 3.4 18.4 16.2 4.3 1.3 4.8 0.2 1.7 4.4 3.3 1.4 1.7 1.9 2.5 2.7 2.0 1.4 1.3 1.9 7.7 1.2 1.5 2.4 37.4 36.6 21.9 38.5 26.1 30.4 24.1 22.7 20.3 10.7 74.5 71.3 17.5 132.2 25.2 41.8 39.3 25.5 21.4 31.8 96.0 21.6 37.3 152.5 146.7 1421.5 25.3 96.0 46.7 174.9 62.9 26.6 143.6 32.2 46.0 193.8 49.3 28.9 18.4 44.0 3146.3 46.3 89.3 40.5 27.1 42.8 10.9 164.5 30.9 50.9 69.5 40.4 6.5 25.8 332.6 27.9 24.8 103.8 22.4 42.8 203.8 PDZD7 "bA108L7.8, DFNB57, FLJ23209, PDZK7" ENSG00000186862 "PDZ domain containing 7" Q9H5P4 10 101007683-101032295 "Disease related genes, Predicted intracellular proteins" "Deafness, Disease mutation, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.7;intestine: 25.3" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 13.1;Cone photoreceptor cells: 21.6;Rod photoreceptor cells: 7.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 6.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 12.1;THP-1: 17.7" "Low region specificity" "Detected in many" HPA074542 Supported Nucleoplasm NA NA Nucleoplasm "HPA074542: " "unprognostic (1.46e-1)" "unprognostic (2.85e-3)" "unprognostic (3.96e-2)" "unprognostic (2.10e-1)" "unprognostic (2.15e-2)" "unprognostic (2.83e-2)" "unprognostic (1.38e-2)" "unprognostic (5.31e-2)" "unprognostic (2.52e-2)" "unprognostic (2.95e-2)" "unprognostic (2.45e-1)" "unprognostic (1.87e-3)" "unprognostic (3.54e-3)" "unprognostic (3.89e-1)" "unprognostic (1.79e-1)" "unprognostic (3.51e-2)" "unprognostic (2.80e-1)" 2.4 2.3 7.0 1.7 10.7 2.4 0.9 15.9 11.6 0.8 3.4 2.4 0.0 17.4 2.5 1.9 1.0 1.1 3.0 1.2 6.3 7.8 2.2 0.7 1.9 1.6 12.5 8.3 1.4 1.7 3.8 6.2 1.8 17.7 1.5 0.7 1.1 2.1 1.2 1.4 3.8 25.3 2.0 9.1 2.6 1.9 2.1 4.8 0.0 2.2 0.0 0.6 1.3 1.0 1.3 0.7 6.9 2.1 2.3 1.5 0.6 7.4 1.1 0.6 0.9 1.0 0.2 2.5 1.3 0.7 0.0 0.4 1.7 1.9 3.7 3.6 0.3 1.0 2.3 0.2 0.7 0.0 1.0 2.5 0.2 3.6 2.4 0.6 0.6 3.3 0.4 0.3 0.2 0.2 4.3 0.3 3.4 0.6 0.9 0.1 1.9 0.5 1.4 0.6 1.5 2.7 1.7 1.0 0.5 1.8 0.8 12.1 5.6 0.8 0.4 1.2 1.2 2.5 17.7 0.5 1.2 2.6 1.5 1.1 1.6 0.1 0.3 6.6 1.3 0.7 2.9 2.1 1.5 1.0 1.3 1.0 1.1 0.9 1.3 0.4 1.3 1.5 0.8 6.9 2.3 0.8 0.7 0.6 0.6 7.0 10.7 15.9 11.6 6.3 7.8 12.5 8.3 17.7 4.8 0.0 0.0 0.0 0.6 0.5 13.1 1.4 5.1 0.0 0.0 1.8 21.6 0.1 1.7 0.7 1.4 0.3 0.3 0.0 0.3 4.7 0.7 0.5 0.0 0.0 1.8 1.6 0.0 0.6 1.2 1.0 0.3 0.8 0.0 0.0 0.0 0.8 0.9 0.0 1.1 1.3 7.6 0.0 0.8 2.8 2.3 0.4 1.6 0.0 0.0 0.1 PDZK1 "NHERF3, PDZD1" ENSG00000174827 "PDZ domain containing 1" Q5T2W1 1 145670852-145708148 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 49.2;kidney: 124.3" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 758.4" "Group enriched" "Detected in many" 12 "breast cancer: 8.9;liver cancer: 27.6;renal cancer: 44.3" "Region enriched" "Detected in single" 17 "cerebellum: 10.0" "Cell type enriched" "Detected in many" 4 "NK-cell: 7.6" "Lineage enriched" "Detected in many" 4 "NK-cells: 7.6" "Group enriched" "Detected in some" 4 "RPTEC TERT1: 43.1;T-47d: 112.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA005755, HPA006155, CAB008971" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "CAB008971: , HPA005755: AB_1855164, HPA006155: AB_1855163" "unprognostic (4.56e-3)" "unprognostic (3.07e-1)" "unprognostic (8.79e-2)" "unprognostic (4.41e-2)" "unprognostic (9.15e-2)" "unprognostic (2.09e-1)" "unprognostic (2.18e-1)" "unprognostic (3.42e-1)" "unprognostic (2.08e-1)" "unprognostic (3.27e-1)" "unprognostic (2.34e-2)" "unprognostic (9.87e-3)" "prognostic favorable (2.54e-7)" "unprognostic (9.90e-2)" "unprognostic (3.02e-1)" "unprognostic (1.00e-3)" "unprognostic (8.87e-2)" 0.1 0.6 0.2 0.2 0.3 0.0 5.8 10.0 0.2 0.3 16.5 0.2 0.8 13.2 0.3 6.7 0.1 0.1 10.6 0.1 0.2 0.2 124.3 25.7 0.4 0.1 0.3 0.2 0.2 4.2 0.0 0.1 0.9 0.5 0.1 1.3 1.2 0.1 0.1 0.1 0.7 49.2 0.1 0.4 0.2 0.4 0.3 0.1 0.2 0.1 0.1 0.1 0.1 0.1 1.0 1.1 0.5 0.2 7.6 1.8 0.5 1.3 0.2 0.1 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.1 18.9 0.1 0.1 0.2 1.1 0.0 0.6 0.0 0.1 0.1 1.8 0.3 0.1 0.4 7.8 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.1 1.1 0.1 0.2 0.2 0.2 0.5 0.0 1.3 0.2 43.1 0.0 0.1 1.2 0.3 0.3 0.0 1.2 112.0 0.1 0.1 0.2 0.2 0.1 0.1 1.6 0.1 0.1 0.1 0.1 0.0 0.5 0.2 0.1 1.5 0.2 0.6 1.0 0.4 1.8 0.2 1.0 0.4 0.7 0.4 7.6 0.1 1.1 0.1 0.5 0.2 0.3 10.0 0.2 0.2 0.2 0.3 0.2 0.5 0.1 0.0 0.0 0.9 0.0 0.1 0.4 0.4 61.1 0.0 0.0 54.1 0.0 0.0 117.7 1.7 8.9 0.0 18.0 0.0 1.6 0.1 0.2 0.1 0.0 45.6 0.2 0.0 6.3 1.8 1.2 5.2 0.0 0.0 0.0 0.0 0.5 0.0 1.8 2.9 0.0 758.4 0.3 0.0 0.3 0.2 0.2 0.0 0.1 0.0 1.0 0.0 PDZRN3 "KIAA1095, LNX3, SEMACAP3" ENSG00000121440 "PDZ domain containing ring finger 3" Q9UPQ7 3 73382433-73624940 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 61.9;Fibroblasts: 24.4;Peritubular cells: 26.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 52 "plasmacytoid DC: 5.2" "Lineage enriched" "Detected in single" 52 "dendritic cells: 5.2" "Cell line enhanced" "Detected in many" "AF22: 15.4;ASC diff: 28.1;ASC TERT1: 14.8;BJ hTERT+: 20.0;HSkMC: 20.5;U-87 MG: 14.8" "Group enriched" "Detected in many" 5 "amygdala: 12.4;basal ganglia: 7.4;cerebral cortex: 17.9;hippocampal formation: 14.5" "Low region specificity" "Detected in many" "HPA038822, HPA061420" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA038822: AB_10675952, HPA061420: AB_2684512" "unprognostic (3.22e-2)" "unprognostic (1.32e-1)" "unprognostic (1.00e-2)" "prognostic favorable (3.35e-5)" "unprognostic (1.09e-1)" "unprognostic (5.54e-2)" "unprognostic (8.47e-2)" "unprognostic (3.67e-1)" "unprognostic (1.60e-1)" "unprognostic (7.51e-2)" "prognostic favorable (4.93e-4)" "unprognostic (8.38e-2)" "prognostic favorable (3.65e-7)" "unprognostic (8.63e-3)" "unprognostic (1.63e-1)" "unprognostic (3.72e-2)" "unprognostic (2.86e-3)" 13.0 17.4 11.5 4.8 12.9 0.0 10.3 1.7 26.8 18.7 32.6 4.5 4.6 4.3 29.0 12.4 13.6 11.6 13.1 19.8 9.1 2.5 5.3 0.9 6.3 1.9 3.6 11.2 35.1 2.9 0.3 2.2 8.1 6.8 15.4 6.9 9.7 9.7 14.9 38.3 7.5 10.2 26.3 3.8 1.0 19.3 3.4 2.9 0.2 1.6 5.1 1.1 21.3 18.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 28.1 14.8 0.0 8.0 20.0 2.4 1.5 7.5 0.0 0.0 0.0 10.7 0.3 0.0 0.0 0.0 2.4 0.0 1.0 0.0 0.0 0.0 4.7 0.0 0.0 20.5 0.0 6.7 0.0 2.9 0.0 0.0 0.0 0.0 2.3 0.9 0.0 0.1 2.2 0.0 0.0 0.0 4.1 0.0 0.0 0.0 1.8 5.1 0.0 3.7 5.8 4.7 2.2 0.0 0.0 10.1 0.7 11.3 1.0 0.3 0.0 0.1 14.8 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 11.5 12.9 1.7 26.8 9.1 2.5 3.6 11.2 6.8 2.9 0.0 0.0 0.0 9.3 2.2 9.5 61.9 0.0 0.0 0.0 5.2 5.9 0.6 1.7 0.0 0.4 1.3 0.0 0.0 0.4 0.2 24.4 12.7 0.0 0.0 0.7 0.0 20.3 0.0 0.0 0.4 21.6 0.9 15.1 0.0 7.0 20.0 0.4 0.0 26.5 6.3 1.5 0.0 15.5 0.2 4.1 1.6 0.7 0.0 2.3 4.3 PEA15 "HMAT1, HUMMAT1H, MAT1, MAT1H, PEA-15, PED, PED-PEA15, PED/PEA15" ENSG00000162734 "Proliferation and apoptosis adaptor protein 15" Q15121 1 160205337-160215376 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 199.4" "Cell type enhanced" "Detected in many" 7 "monocytes: 420.2;Muller glia cells: 271.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 30.6" "Group enriched" "Detected in all" 6 "B-cells: 7.6;dendritic cells: 22.1;monocytes: 30.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028356, HPA070820" Enhanced Supported Nucleoplasm,Cytosol NA NA 240000 Cytosol Nucleoplasm "HPA028356: AB_10602814, HPA070820: AB_2732166" "unprognostic (1.29e-1)" "unprognostic (4.78e-2)" "unprognostic (1.05e-1)" "unprognostic (1.57e-1)" "unprognostic (2.53e-1)" "unprognostic (1.64e-2)" "unprognostic (1.99e-3)" "unprognostic (6.10e-2)" "unprognostic (4.57e-1)" "unprognostic (1.25e-1)" "unprognostic (6.31e-2)" "unprognostic (4.07e-2)" "prognostic unfavorable (6.53e-7)" "unprognostic (2.60e-2)" "unprognostic (1.39e-1)" "unprognostic (2.82e-3)" "unprognostic (1.24e-1)" 45.3 20.4 105.3 28.7 83.6 3.8 25.3 30.5 173.1 25.1 15.5 68.1 5.0 8.0 21.5 21.8 22.6 19.2 22.1 53.9 70.5 81.3 14.8 10.4 23.8 16.6 106.5 67.0 19.7 9.7 14.9 10.2 25.1 74.1 24.4 15.3 18.2 12.3 31.1 10.2 16.9 8.8 47.4 199.4 23.8 10.0 17.5 53.7 1.6 12.6 6.0 22.9 22.4 17.5 7.6 22.1 1.8 30.6 3.1 3.5 5.4 16.9 5.9 24.6 10.6 45.6 25.6 8.2 73.6 64.4 61.3 43.1 13.0 9.2 7.9 26.7 91.9 29.5 18.6 9.1 23.0 48.0 4.2 5.1 6.5 4.1 3.3 56.4 2.1 8.0 21.4 13.0 33.7 43.1 33.9 46.0 5.8 6.7 14.4 81.9 8.4 2.5 5.1 16.3 20.1 17.0 4.2 25.9 5.4 22.2 8.9 4.9 13.0 39.0 26.7 22.4 55.7 16.4 15.3 61.3 40.8 32.0 30.3 31.6 11.4 7.0 15.0 37.6 4.1 57.7 0.3 15.3 1.8 3.5 30.6 2.7 7.6 2.6 2.8 22.1 5.0 1.6 1.8 0.7 3.1 13.9 9.7 2.9 5.4 105.3 83.6 30.5 78.2 70.5 81.3 106.5 67.0 74.1 53.7 14.9 34.6 27.0 105.8 71.2 125.0 203.8 12.7 14.7 27.3 5.2 68.7 17.0 24.9 58.7 49.2 107.8 6.4 0.0 40.4 47.2 66.7 105.1 31.1 4.9 63.6 87.4 11.5 95.2 34.2 51.6 61.9 76.5 70.9 420.2 11.3 271.7 77.0 3.5 103.3 8.1 109.8 45.3 97.6 12.7 2.7 64.1 37.9 14.9 9.7 151.1 PEAR1 "FLJ00193, JEDI, MEGF12" ENSG00000187800 "Platelet endothelial aggregation receptor 1" Q5VY43 1 156893698-156916434 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Endothelial cells: 26.3;Erythroid cells: 23.3;Ito cells: 34.4;Leydig cells: 41.1;Peritubular cells: 33.6;Sertoli cells: 25.8;Smooth muscle cells: 14.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 9.1;HBEC3-KT: 13.8;HHSteC: 10.4;HUVEC TERT2: 24.4;TIME: 39.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035217 Approved Approved "Nucleoplasm,Cell Junctions,Centrosome" NA NA 35000000 "Nucleoplasm, Cell Junctions" Centrosome "HPA035217: AB_10669902" "unprognostic (1.02e-1)" "unprognostic (1.84e-5)" "unprognostic (4.77e-2)" "unprognostic (1.67e-1)" "unprognostic (1.34e-1)" "unprognostic (2.48e-1)" "unprognostic (5.62e-2)" "unprognostic (5.93e-2)" "unprognostic (1.04e-2)" "unprognostic (3.99e-1)" "unprognostic (2.17e-1)" "unprognostic (5.04e-1)" "prognostic unfavorable (4.31e-4)" "unprognostic (1.20e-2)" "unprognostic (3.37e-3)" "unprognostic (8.51e-2)" "unprognostic (2.64e-2)" 18.5 7.1 1.8 3.0 5.1 2.8 29.2 1.2 2.9 16.5 5.8 2.7 6.3 2.3 15.9 10.5 6.6 8.9 10.3 11.1 2.7 1.8 6.8 3.8 12.0 10.1 3.2 2.1 10.6 3.2 1.7 3.9 15.5 3.7 9.6 1.4 15.5 4.1 5.5 11.4 4.4 4.1 9.6 3.1 12.2 4.1 8.1 1.5 0.6 10.5 5.8 2.1 6.7 11.5 0.0 0.0 0.4 0.0 0.0 0.0 2.4 0.2 1.3 0.4 0.0 0.0 1.8 0.0 5.4 9.1 2.2 1.3 0.1 0.2 0.0 0.2 4.0 0.2 0.1 0.0 13.8 0.6 0.0 0.0 6.7 0.2 0.3 10.4 0.0 0.0 5.4 0.0 3.1 0.7 0.5 24.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 3.4 0.0 0.0 39.2 0.0 3.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.4 1.8 5.1 1.2 2.9 2.7 1.8 3.2 2.1 3.7 1.5 0.0 5.6 0.0 0.0 0.8 1.3 5.6 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.6 1.1 26.3 0.0 23.3 0.3 0.1 5.1 0.1 1.1 0.0 0.4 0.0 1.7 34.4 1.3 1.9 41.1 0.4 5.0 0.0 1.0 0.3 0.9 0.0 33.6 0.0 0.2 25.8 14.6 0.7 1.1 1.0 0.2 0.0 0.0 0.1 PEF1 PEF1A ENSG00000162517 "Penta-EF-hand domain containing 1" Q9UBV8 1 31629862-31644896 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061608 Approved Nucleoplasm,Vesicles,Cytosol NA NA 660000 "Nucleoplasm, Cytosol" Vesicles "HPA061608: AB_2684567" "unprognostic (2.92e-2)" "prognostic favorable (3.95e-4)" "unprognostic (1.59e-1)" "unprognostic (2.30e-2)" "unprognostic (1.11e-1)" "unprognostic (8.40e-2)" "prognostic unfavorable (2.88e-4)" "unprognostic (5.22e-3)" "unprognostic (1.04e-1)" "unprognostic (2.79e-2)" "unprognostic (1.60e-2)" "unprognostic (2.12e-1)" "unprognostic (1.35e-1)" "unprognostic (8.85e-3)" "unprognostic (2.38e-1)" "unprognostic (1.60e-1)" "unprognostic (2.89e-3)" 34.0 27.0 26.9 15.3 28.7 17.0 27.1 22.5 40.8 26.6 23.4 25.9 21.1 16.2 27.1 46.5 29.7 29.0 26.1 26.4 24.3 23.8 28.3 38.7 24.9 20.8 25.0 17.3 31.1 20.8 31.6 21.6 44.2 28.6 29.8 24.2 25.7 24.8 33.4 25.5 32.5 20.7 31.9 22.4 23.6 20.5 17.8 16.5 27.4 85.9 20.3 30.7 23.7 21.9 39.1 40.4 60.9 39.5 42.0 49.2 48.7 17.7 20.8 17.4 13.4 20.6 21.6 16.7 16.9 29.1 41.0 36.2 12.2 26.9 19.0 23.7 37.7 21.1 18.7 33.6 43.2 33.3 23.8 36.4 15.7 16.8 24.6 36.3 15.3 14.9 22.2 50.0 40.0 37.6 26.2 39.6 23.5 16.2 19.7 29.3 20.9 23.3 14.9 24.1 22.0 23.7 22.7 16.9 20.7 32.0 19.3 24.9 14.4 19.3 18.2 25.2 28.6 16.2 11.2 20.9 17.8 15.3 30.2 22.3 12.7 12.8 20.4 22.4 22.6 21.3 60.9 39.5 46.2 49.2 35.3 47.5 37.8 42.1 44.6 40.4 39.1 39.9 40.0 40.1 42.0 32.7 37.4 41.9 48.7 26.9 28.7 22.5 40.8 24.3 23.8 25.0 17.3 28.6 16.5 38.7 33.6 34.3 57.8 32.2 37.2 14.6 20.4 20.1 21.6 66.3 11.8 131.6 96.2 58.8 67.1 60.4 35.8 0.0 54.4 80.4 36.6 45.7 71.5 20.5 54.6 50.9 42.5 31.9 17.0 60.2 41.7 26.1 47.2 124.4 29.6 55.3 47.2 34.8 55.2 41.2 20.3 19.4 42.2 34.5 41.5 44.9 152.9 34.6 33.2 48.8 PEG10 "HB-1, KIAA1051, Mar2, Mart2, MEF3L, RGAG3, RTL2, SIRH1" ENSG00000242265 "Paternally expressed 10" Q86TG7 7 94656325-94669695 "Predicted intracellular proteins" "Apoptosis, Differentiation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 67.5;brain: 143.8;pituitary gland: 102.6;placenta: 171.4" "Group enriched" "Detected in many" 13 "Cytotrophoblasts: 1669.7;Syncytiotrophoblasts: 2388.4" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 143.8" "Cell type enhanced" "Detected in some" "memory B-cell: 2.1;naive B-cell: 2.6;NK-cell: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 95.0;HAP1: 123.3;Hep G2: 95.0;SCLC-21H: 60.4" "Region enhanced" "Detected in many" "hypothalamus: 130.3" "Low region specificity" "Detected in all" "HPA021324, HPA029915, HPA051038" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA021324: AB_1855181, HPA029915: AB_2673250, HPA051038: AB_2630372" "unprognostic (1.03e-1)" "unprognostic (2.98e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (8.15e-4)" "unprognostic (1.06e-1)" "unprognostic (5.70e-3)" "unprognostic (9.70e-3)" "unprognostic (2.61e-3)" "unprognostic (5.43e-2)" "unprognostic (1.68e-2)" "unprognostic (1.99e-2)" "unprognostic (3.23e-1)" "unprognostic (1.37e-2)" "unprognostic (1.66e-2)" "unprognostic (5.48e-2)" "unprognostic (6.01e-2)" "unprognostic (2.40e-2)" 2.3 67.5 32.0 2.1 143.8 1.4 10.6 25.6 16.8 4.2 2.1 7.4 0.0 1.5 3.3 1.9 2.0 5.1 2.4 1.8 21.0 47.0 4.0 2.0 7.3 2.9 13.1 21.3 27.0 5.4 2.3 102.6 171.4 27.4 2.2 1.9 1.8 4.3 2.2 1.9 1.4 1.6 2.6 14.4 1.8 2.1 19.8 11.1 1.5 5.4 0.0 2.3 1.8 1.0 2.6 0.0 0.0 0.0 2.7 0.7 0.2 2.6 13.4 95.0 40.1 2.0 3.6 5.5 7.3 4.3 5.2 7.1 22.3 4.4 0.2 0.2 8.4 10.8 0.8 123.3 5.2 7.3 0.3 13.0 0.0 15.3 95.0 1.5 15.1 0.0 8.0 1.7 13.0 9.0 4.6 3.1 0.0 0.0 29.8 10.2 0.6 0.0 0.0 43.5 2.2 8.5 5.7 30.4 7.9 23.9 9.9 60.4 3.4 0.0 2.0 7.2 24.9 12.9 0.0 0.0 4.2 0.2 0.5 5.5 8.0 5.3 11.8 9.4 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.0 2.1 0.0 0.7 0.0 2.6 0.0 0.1 0.0 2.7 0.0 0.0 0.1 0.2 32.0 143.8 25.6 14.4 21.0 47.0 13.1 21.3 27.4 11.1 142.9 64.2 2.4 7.4 0.7 70.4 25.2 7.6 16.0 126.3 15.7 7.9 1669.7 54.7 10.7 2.8 2.4 0.0 0.0 4.3 85.1 27.1 7.0 2.3 2.9 150.9 35.0 58.0 2.5 0.0 11.4 8.3 1.4 13.5 0.0 0.7 118.3 4.2 0.0 3.9 10.0 25.7 6.5 12.5 16.4 5.1 0.6 2388.4 0.5 0.1 0.6 PEG3 "KIAA0287, ZKSCAN22, ZNF904, ZSCAN24" ENSG00000198300 "Paternally expressed 3" Q9GZU2 19 56810083-56840728 "Predicted intracellular proteins, Transcription factors" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 51.0;ovary: 106.4;placenta: 49.8" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 267.6;Horizontal cells: 139.8;Peritubular cells: 103.3;Syncytiotrophoblasts: 399.0" "Cancer enhanced" "Detected in many" "testis cancer: 9.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 1.3;plasmacytoid DC: 1.1" "Lineage enhanced" "Detected in single" "dendritic cells: 1.3" "Group enriched" "Detected in some" 5 "BEWO: 32.2;Hep G2: 65.4;RH-30: 22.4" "Low region specificity" "Detected in all" HPA026070 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA026070: AB_10603328" "unprognostic (1.38e-2)" "unprognostic (1.90e-2)" "unprognostic (1.20e-1)" "unprognostic (7.12e-2)" "unprognostic (1.58e-1)" "unprognostic (4.84e-2)" "unprognostic (4.84e-2)" "unprognostic (4.44e-2)" "unprognostic (9.16e-2)" "unprognostic (1.21e-1)" "unprognostic (1.82e-3)" "unprognostic (9.92e-2)" "unprognostic (2.48e-5)" "unprognostic (6.92e-3)" "unprognostic (2.19e-1)" "prognostic unfavorable (1.56e-4)" "unprognostic (6.68e-3)" 2.0 29.8 10.1 1.0 51.0 0.5 4.5 9.8 22.4 4.1 2.4 5.9 0.0 0.7 9.1 2.6 1.7 5.8 1.2 2.3 9.7 9.6 1.8 2.1 1.7 0.7 3.5 16.0 106.4 1.9 7.3 24.6 49.8 21.3 1.8 1.2 0.4 2.3 2.5 1.7 1.8 1.7 4.1 4.8 1.6 2.0 12.3 7.3 0.0 2.7 0.0 2.7 2.6 2.0 0.0 1.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 32.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.4 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.1 0.0 22.4 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 10.1 51.0 9.8 22.4 9.7 9.6 3.5 16.0 21.3 7.3 0.0 5.8 0.0 1.7 4.2 19.4 12.3 2.5 4.0 3.4 1.8 7.9 267.6 1.7 0.7 24.4 2.6 0.0 0.0 0.0 33.5 7.8 1.7 0.0 2.9 29.8 139.8 0.0 4.9 0.6 15.2 54.4 1.0 13.5 0.0 0.0 18.1 0.5 0.0 103.3 0.8 11.8 12.9 7.3 26.9 17.4 2.3 399.0 0.0 0.0 0.7 PELI1 ENSG00000197329 "Pellino E3 ubiquitin protein ligase 1" Q96FA3 2 64092652-64144454 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 105.7" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 199.1;Suprabasal keratinocytes: 190.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 33.9" "Group enriched" "Detected in all" 4 "granulocytes: 33.9;monocytes: 9.2" "Cell line enhanced" "Detected in many" "CACO-2: 21.8;U-698: 54.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053182 Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments" NA NA "Nucleoplasm, Nucleoli, Intermediate filaments" "HPA053182: AB_2682072" "unprognostic (3.33e-2)" "unprognostic (3.43e-2)" "unprognostic (1.79e-2)" "prognostic unfavorable (5.33e-4)" "unprognostic (1.91e-2)" "unprognostic (3.12e-3)" "unprognostic (6.73e-3)" "unprognostic (8.01e-3)" "unprognostic (4.16e-2)" "unprognostic (3.52e-3)" "unprognostic (5.99e-3)" "unprognostic (3.33e-1)" "prognostic unfavorable (5.67e-6)" "unprognostic (6.72e-2)" "unprognostic (6.22e-2)" "unprognostic (8.88e-2)" "unprognostic (1.03e-1)" 15.7 5.1 10.0 15.1 20.5 105.7 22.3 15.1 8.9 9.9 14.5 11.0 3.3 9.9 14.5 7.1 26.4 8.0 14.9 11.6 11.3 6.8 6.7 8.6 20.1 16.8 15.6 5.2 4.8 6.2 11.0 14.8 13.7 10.8 7.6 11.8 6.0 12.3 8.5 4.5 17.5 17.3 8.4 15.0 17.8 10.2 7.8 12.8 19.9 6.3 10.2 19.3 14.1 14.8 3.9 2.3 33.9 9.2 1.3 5.0 2.5 1.3 1.0 14.0 9.3 1.6 1.2 3.2 1.8 2.0 1.6 2.6 21.8 1.5 17.9 4.4 0.6 0.6 2.1 4.2 3.9 3.3 4.4 3.3 1.6 0.7 3.5 4.9 1.7 3.2 1.6 3.1 2.4 8.4 1.7 9.2 6.9 1.0 4.5 1.4 0.1 3.8 2.5 9.1 4.1 0.6 4.8 4.8 10.2 6.7 4.0 6.4 9.0 1.3 2.1 4.8 4.5 1.1 1.2 6.5 1.5 2.2 1.5 2.6 10.4 1.0 54.2 0.8 1.6 4.1 5.1 6.5 6.3 0.4 6.1 0.7 3.9 2.2 0.9 2.3 2.4 2.7 1.1 33.9 1.3 9.2 0.2 5.0 2.5 10.0 20.5 15.1 8.8 11.3 6.8 15.6 5.2 10.8 12.8 26.8 45.1 22.4 65.1 199.1 0.9 5.1 10.2 30.8 55.7 5.2 0.0 1.4 1.7 4.5 8.5 42.7 37.0 0.0 23.1 6.5 25.9 43.3 14.0 6.8 19.1 3.2 24.6 36.2 52.6 7.8 1.4 57.1 106.3 13.6 22.2 4.5 18.2 28.1 1.8 7.7 1.8 0.0 48.4 6.1 7.8 190.1 3.3 11.5 27.3 104.0 PELI2 ENSG00000139946 "Pellino E3 ubiquitin protein ligase family member 2" Q9HAT8 14 56117814-56301526 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 21.4" "Cell type enhanced" "Detected in many" "neutrophil: 9.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 19.3;JURKAT: 24.9;MOLT-4: 21.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053182 Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments" NA NA "Nucleoplasm, Nucleoli, Intermediate filaments" "HPA053182: AB_2682072" "unprognostic (3.26e-1)" "unprognostic (2.25e-1)" "unprognostic (9.21e-2)" "unprognostic (8.94e-3)" "unprognostic (1.57e-1)" "unprognostic (1.68e-1)" "unprognostic (2.53e-2)" "unprognostic (3.36e-3)" "unprognostic (1.81e-1)" "unprognostic (2.68e-2)" "unprognostic (1.18e-1)" "unprognostic (2.14e-1)" "prognostic favorable (1.53e-6)" "unprognostic (3.64e-1)" "unprognostic (2.15e-1)" "unprognostic (5.43e-2)" "unprognostic (2.22e-1)" 12.3 3.3 5.2 5.6 4.6 16.5 8.7 21.4 6.5 7.5 9.4 5.4 9.7 11.1 9.3 7.1 4.7 5.9 11.5 3.4 4.6 4.5 9.7 3.1 7.3 4.8 5.2 3.9 16.0 38.9 1.7 5.5 3.3 4.4 8.2 4.2 9.2 7.6 12.4 3.8 6.5 12.6 17.7 5.8 6.6 14.1 10.0 4.2 38.2 4.9 3.4 2.6 13.3 14.9 0.9 2.0 9.0 3.0 0.5 0.8 1.1 0.0 1.8 5.1 0.0 2.8 4.2 0.1 0.7 2.4 0.5 0.0 0.1 0.4 0.1 2.4 1.4 0.0 0.5 3.9 0.0 0.2 1.2 1.4 4.4 7.9 0.0 2.4 0.6 19.3 2.7 0.2 0.0 0.0 2.8 0.9 24.9 3.2 0.0 0.5 0.0 21.6 0.2 8.3 0.0 0.7 10.6 0.3 0.9 2.1 8.7 10.2 0.0 0.4 0.0 5.7 3.3 0.0 3.5 0.3 1.5 2.6 0.4 2.5 0.4 0.0 0.5 2.7 3.0 1.5 1.4 3.0 3.5 0.5 1.6 0.8 0.2 0.6 0.3 2.0 0.9 0.4 0.3 9.0 0.5 1.2 0.5 0.0 1.1 5.2 4.6 21.4 4.4 4.6 4.5 5.2 3.9 4.4 4.2 0.0 7.7 2.7 11.0 12.7 30.0 1.9 7.6 14.7 10.3 12.2 27.5 0.0 3.3 4.4 2.3 10.9 8.4 0.0 12.2 0.1 5.6 7.0 5.7 0.8 1.1 20.6 6.9 11.1 16.5 4.1 15.8 11.1 16.9 2.8 7.4 10.0 8.6 3.7 17.0 8.8 18.5 12.9 22.1 1.4 27.2 15.9 0.1 3.5 3.0 9.7 PELI3 MGC35521 ENSG00000174516 "Pellino E3 ubiquitin protein ligase family member 3" Q8N2H9 11 66466327-66477337 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 20.6;Intestinal endocrine cells: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033750, HPA038875, HPA062281" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles NA NA "Nucleoplasm, Vesicles" Nucleoli "CAB033750: AB_2161361, HPA038875: AB_2676249, HPA062281: AB_2684735" "unprognostic (1.15e-1)" "unprognostic (1.58e-1)" "unprognostic (3.04e-1)" "unprognostic (1.43e-1)" "unprognostic (1.02e-2)" "unprognostic (1.89e-2)" "unprognostic (1.30e-2)" "unprognostic (1.94e-1)" "unprognostic (1.35e-1)" "unprognostic (1.19e-1)" "unprognostic (2.19e-3)" "unprognostic (7.91e-3)" "prognostic favorable (8.19e-4)" "unprognostic (1.59e-1)" "unprognostic (1.44e-1)" "unprognostic (1.91e-1)" "unprognostic (3.01e-2)" 6.7 9.5 14.5 3.8 17.0 1.8 7.4 19.6 33.1 7.4 8.3 6.7 6.4 4.8 10.3 9.1 10.6 8.2 10.1 7.7 17.4 13.5 4.6 3.2 7.1 4.3 13.0 12.5 15.3 9.9 21.5 8.3 3.8 15.8 11.5 2.9 6.4 10.4 22.3 10.8 11.2 4.7 11.3 6.2 5.0 5.8 6.2 7.8 0.3 8.5 2.7 3.4 9.0 11.8 3.3 3.3 1.3 6.8 1.2 3.1 1.4 15.5 6.6 5.4 4.2 8.6 3.4 4.3 5.0 6.5 4.8 4.1 9.6 3.5 3.9 5.0 5.4 8.6 8.4 3.5 6.3 2.0 7.6 3.1 1.0 5.4 2.8 5.4 0.8 7.6 3.2 7.1 4.9 1.7 7.0 1.0 5.2 1.8 6.1 2.0 9.5 3.2 2.4 3.4 8.2 6.8 10.8 3.9 4.1 2.6 5.0 6.5 3.6 2.5 7.2 17.0 2.4 8.4 4.2 2.7 4.2 6.5 18.3 4.1 5.6 3.2 2.1 8.9 2.5 3.5 1.3 2.5 0.4 2.5 1.8 2.0 2.8 2.1 3.1 3.3 3.3 2.2 1.8 0.1 1.2 6.8 1.0 2.4 1.4 14.5 17.0 19.6 33.1 17.4 13.5 13.0 12.5 15.8 7.8 6.0 1.3 0.0 3.4 1.4 12.1 6.2 2.5 0.0 0.0 0.0 9.8 1.9 1.7 2.7 3.7 2.5 0.0 0.0 2.1 1.7 3.1 2.0 0.0 2.4 2.9 20.6 25.4 1.8 0.6 5.6 6.9 3.2 0.0 2.8 0.5 5.5 1.9 0.8 9.2 2.2 8.5 6.5 4.8 1.9 3.2 0.3 0.2 0.0 0.6 1.6 PELP1 MNAR ENSG00000141456 "Proline, glutamate and leucine rich protein 1" Q8IZL8 17 4669774-4704337 "Predicted intracellular proteins" Transcription "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "monocytes: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053966, HPA056028, HPA060760" Supported Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA053966: AB_2682325, HPA056028: AB_2683013, HPA060760: AB_2684355" "unprognostic (8.81e-2)" "unprognostic (1.22e-2)" "unprognostic (2.81e-3)" "unprognostic (2.24e-1)" "unprognostic (1.39e-1)" "unprognostic (1.44e-1)" "prognostic unfavorable (6.44e-4)" "unprognostic (2.72e-1)" "unprognostic (2.76e-1)" "unprognostic (4.31e-2)" "prognostic favorable (4.07e-5)" "unprognostic (2.20e-2)" "unprognostic (4.05e-2)" "unprognostic (1.31e-2)" "unprognostic (3.31e-1)" "unprognostic (8.32e-2)" "unprognostic (5.15e-2)" 14.0 12.3 19.8 13.8 22.0 10.5 10.9 22.9 28.0 12.6 11.8 25.5 8.4 12.9 14.3 9.8 17.4 17.3 11.4 18.2 19.9 18.8 9.6 10.6 11.2 17.2 20.2 18.6 21.0 18.9 18.2 17.0 12.4 18.3 13.8 8.6 13.8 16.5 14.7 38.2 17.2 11.6 12.2 18.7 13.6 12.4 21.3 18.1 17.0 14.5 12.3 13.3 11.2 10.6 3.8 3.5 5.8 3.4 3.8 4.5 1.9 15.9 35.0 13.9 21.9 10.8 8.0 31.2 11.6 8.1 16.1 17.3 34.1 11.8 38.5 17.9 9.1 11.4 24.6 25.8 18.1 9.2 19.9 36.8 17.1 17.6 27.5 14.0 13.8 23.1 9.8 11.3 19.8 16.7 8.3 11.9 20.8 20.6 16.9 8.8 21.9 26.0 16.3 22.8 15.5 11.8 27.5 12.3 18.9 11.2 12.1 14.0 18.7 19.9 14.7 14.9 13.9 17.7 9.4 12.0 12.5 17.7 18.9 22.3 9.1 15.6 16.0 14.1 14.3 16.0 0.9 2.4 5.8 3.1 3.1 3.1 2.6 3.0 2.4 2.4 3.8 3.3 4.5 1.4 3.8 3.4 3.5 2.0 1.9 19.8 22.0 22.9 28.0 19.9 18.8 20.2 18.6 18.3 18.1 20.8 29.6 16.3 12.9 13.2 23.9 19.8 5.1 20.1 19.4 8.7 15.7 24.8 1.7 13.2 47.9 13.2 6.2 0.0 12.6 23.5 14.1 12.3 29.0 9.0 14.7 33.4 12.1 4.9 4.5 17.5 8.6 13.8 10.1 107.4 16.1 12.5 11.1 12.4 18.0 4.1 16.6 6.5 9.9 21.4 71.6 14.3 17.7 13.1 18.8 10.6 PEPD ENSG00000124299 "Peptidase D" P12955 19 33386950-33521794 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Collagen degradation" "Dipeptidase, Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 92.9;kidney: 106.0" "Cell type enriched" "Detected in many" 5 "Proximal tubular cells: 1020.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015599, HPA072045" Enhanced Approved Nucleoplasm NA NA 1000000000 Nucleoplasm "HPA015599: AB_1855192, HPA072045: AB_2732194" "unprognostic (1.39e-1)" "unprognostic (2.62e-2)" "unprognostic (2.27e-1)" "unprognostic (4.01e-2)" "unprognostic (2.98e-1)" "unprognostic (6.77e-2)" "unprognostic (2.82e-1)" "unprognostic (3.64e-2)" "unprognostic (3.96e-1)" "unprognostic (5.10e-2)" "unprognostic (1.11e-2)" "unprognostic (1.99e-1)" "prognostic favorable (6.50e-9)" "unprognostic (4.38e-2)" "unprognostic (1.99e-1)" "unprognostic (1.65e-1)" "unprognostic (1.29e-1)" 23.5 17.2 9.8 8.9 10.4 4.1 21.8 7.6 14.9 9.8 60.1 18.7 6.9 58.1 14.3 11.5 14.9 9.6 13.6 8.0 10.8 9.1 106.0 48.6 11.1 10.6 16.0 7.7 12.6 9.0 9.6 12.5 10.4 13.0 9.2 6.6 13.3 9.6 9.0 9.7 11.4 92.9 10.4 17.4 13.4 9.3 8.4 11.5 8.4 15.0 9.7 10.6 11.9 11.9 17.1 32.3 27.5 39.1 16.8 25.8 32.6 13.3 36.3 10.7 17.3 45.7 17.6 24.8 11.9 24.4 15.2 17.3 31.6 11.8 5.4 17.8 29.8 11.7 3.5 15.4 9.7 12.5 15.4 15.2 34.7 7.4 32.1 31.3 10.1 42.1 21.7 9.2 13.8 8.6 11.2 20.3 10.7 6.6 15.8 16.5 16.3 7.7 3.4 14.7 26.6 14.8 15.2 14.6 15.0 13.1 35.3 13.2 33.8 22.2 11.0 17.9 9.4 7.6 11.0 16.9 14.7 15.9 19.0 13.7 14.5 21.5 4.8 15.7 14.6 20.9 27.5 36.1 2.5 25.8 39.1 22.6 17.1 25.7 23.8 32.3 16.3 16.9 19.6 1.9 16.8 27.2 9.9 23.6 32.6 9.8 10.4 7.6 14.9 10.8 9.1 16.0 7.7 13.0 11.5 20.8 24.3 20.2 26.1 17.2 33.9 11.7 43.3 26.8 11.4 69.8 3.9 19.3 167.5 63.4 7.6 44.9 37.6 0.0 38.3 59.7 34.6 21.4 55.5 161.7 189.6 58.8 16.6 35.0 46.9 8.9 45.8 63.2 64.1 131.7 14.5 69.3 37.3 28.5 57.0 1020.8 23.8 38.8 38.8 11.4 48.3 17.8 25.4 31.0 16.7 18.0 PER1 "PER, RIGUI" ENSG00000179094 "Period circadian regulator 1" O15534 17 8140472-8156506 "Cancer-related genes, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 23.7;hTCEpi: 27.6;hTERT-HME1: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047947, HPA067064" Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA047947: AB_2680219, HPA067064: AB_2685774" "unprognostic (7.64e-2)" "prognostic favorable (3.89e-4)" "unprognostic (5.54e-2)" "unprognostic (1.20e-1)" "unprognostic (2.59e-1)" "unprognostic (9.44e-2)" "prognostic favorable (2.56e-4)" "unprognostic (5.28e-2)" "unprognostic (6.67e-2)" "unprognostic (6.21e-3)" "unprognostic (6.87e-2)" "unprognostic (4.68e-2)" "unprognostic (7.09e-3)" "prognostic unfavorable (1.94e-4)" "unprognostic (2.08e-1)" "unprognostic (1.37e-1)" "unprognostic (3.34e-2)" 39.4 33.4 13.2 21.6 15.0 27.3 31.3 19.5 23.9 27.8 24.6 20.9 27.8 6.9 19.5 17.2 31.6 25.2 36.9 24.0 13.3 6.3 14.2 18.6 25.8 10.8 15.6 11.3 50.1 61.8 19.3 29.8 12.7 20.1 23.1 8.1 36.6 23.3 43.5 70.3 47.9 16.9 29.3 17.5 16.7 23.6 13.8 17.1 4.6 28.5 33.1 12.1 30.2 25.0 1.6 4.9 3.3 3.6 0.5 2.1 1.2 1.0 3.9 4.5 6.5 14.8 10.9 2.5 1.5 2.8 2.0 2.4 3.9 2.5 7.3 1.2 2.2 2.2 3.1 4.5 23.7 1.4 2.3 5.6 3.8 8.5 1.1 20.4 1.5 5.8 16.3 27.6 3.4 27.0 2.6 4.3 5.6 4.7 10.1 3.6 3.5 4.4 3.0 3.8 1.2 2.6 6.1 2.5 3.8 4.7 0.8 1.9 4.8 3.3 3.8 3.1 1.9 2.8 1.1 7.3 2.3 4.3 0.8 1.3 6.0 2.2 2.5 3.1 1.9 1.6 0.0 3.6 1.7 1.9 2.5 2.1 1.0 1.7 1.2 4.9 1.6 1.6 1.1 3.3 0.5 1.2 0.7 1.1 1.2 13.2 15.0 19.5 23.9 13.3 6.3 15.6 11.3 20.1 17.1 50.6 66.2 20.2 37.2 47.3 37.1 20.0 33.1 30.8 42.1 26.2 92.3 5.0 5.0 4.0 27.7 50.9 21.9 23.3 3.5 3.3 40.1 42.6 67.1 35.2 17.4 19.1 48.1 36.2 45.9 38.0 38.0 57.8 45.5 7.2 12.9 31.6 7.5 14.4 31.8 3.3 48.6 32.3 42.8 5.2 7.8 52.2 11.3 20.8 9.3 9.3 PER2 KIAA0347 ENSG00000132326 "Period circadian regulator 2" O15055 2 238244038-238290102 "Disease related genes, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Suprabasal keratinocytes: 74.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053136, HPA060510" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA053136: , HPA060510: AB_2684298" "unprognostic (1.96e-2)" "unprognostic (4.41e-2)" "unprognostic (1.88e-2)" "unprognostic (9.28e-2)" "unprognostic (2.52e-1)" "prognostic favorable (2.29e-4)" "unprognostic (2.47e-2)" "unprognostic (2.17e-2)" "unprognostic (3.59e-3)" "unprognostic (3.59e-2)" "unprognostic (1.76e-2)" "unprognostic (2.13e-1)" "unprognostic (6.81e-2)" "unprognostic (1.37e-1)" "unprognostic (2.27e-1)" "unprognostic (2.58e-1)" "unprognostic (5.22e-2)" 12.7 3.8 5.1 11.4 10.3 7.8 16.1 16.0 13.4 16.4 8.8 9.2 12.8 5.5 15.4 9.7 15.2 11.8 15.6 6.7 5.8 4.7 4.9 13.7 7.9 4.8 4.7 6.8 14.6 15.7 5.5 11.1 8.4 8.0 12.9 7.1 11.6 23.0 20.7 11.9 20.0 9.1 13.5 4.5 4.9 14.8 19.0 5.3 6.0 9.9 21.3 13.7 11.1 11.3 4.5 4.8 4.1 5.6 3.1 4.5 0.8 1.4 10.1 2.2 3.7 0.1 1.1 7.3 1.0 3.6 1.3 1.3 1.5 5.1 8.8 1.0 2.3 1.4 7.5 2.1 3.0 1.9 2.5 1.5 7.7 5.2 6.9 1.8 11.6 8.2 1.4 7.4 1.6 5.4 1.3 0.7 3.6 3.7 5.6 1.1 6.5 5.7 12.8 3.1 6.5 2.0 13.9 4.9 2.9 1.3 2.9 8.6 1.0 2.5 5.5 1.6 0.7 5.2 7.3 1.8 3.2 3.8 2.5 3.5 6.3 1.4 10.7 6.0 5.1 3.9 4.1 3.7 0.9 2.9 5.6 4.5 4.4 4.5 3.4 3.7 4.5 4.4 4.5 2.9 3.1 5.1 4.8 3.1 0.8 5.1 10.3 16.0 13.4 5.8 4.7 4.7 6.8 8.0 5.3 14.9 26.7 4.2 49.4 65.7 21.5 5.2 20.4 41.5 52.4 26.2 2.0 7.0 6.6 6.4 4.2 9.3 14.6 0.0 9.0 5.4 17.7 14.6 9.2 32.6 3.4 11.1 23.6 8.6 8.9 2.5 10.3 9.3 23.6 1.0 21.2 13.2 7.0 24.3 17.3 3.3 8.0 6.5 25.8 24.7 15.9 74.5 10.9 7.2 24.4 18.4 PES1 "NOP7, PES" ENSG00000100029 "Pescadillo ribosomal biogenesis factor 1" O00541 22 30576625-30607083 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040210, HPA062439, HPA066670" Supported Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes Yes "Nucleoli, Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA040210: AB_2676885, HPA062439: AB_2684764, HPA066670: AB_2685700" "unprognostic (1.82e-1)" "unprognostic (5.88e-2)" "unprognostic (5.59e-3)" "unprognostic (4.83e-2)" "unprognostic (1.48e-1)" "unprognostic (3.23e-3)" "prognostic unfavorable (1.84e-9)" "unprognostic (3.29e-2)" "unprognostic (3.40e-1)" "unprognostic (1.73e-1)" "unprognostic (4.79e-2)" "unprognostic (2.46e-2)" "unprognostic (5.65e-2)" "unprognostic (1.27e-3)" "unprognostic (1.65e-1)" "unprognostic (4.56e-2)" "unprognostic (1.42e-1)" 24.4 28.1 26.0 26.1 30.1 28.2 29.6 19.0 31.8 19.7 21.9 27.2 18.1 20.4 28.0 21.3 31.2 28.0 22.7 18.1 26.3 18.5 24.2 34.9 19.8 30.0 27.2 26.6 30.5 49.0 31.3 17.0 20.2 23.6 24.2 19.2 18.6 22.2 22.1 34.1 32.3 19.8 22.9 24.3 26.4 25.2 34.5 27.2 21.2 25.3 23.1 24.9 21.8 22.6 14.4 17.8 3.9 19.4 12.4 16.2 16.3 34.3 39.2 14.5 30.8 16.7 16.4 22.3 22.9 18.8 39.1 30.5 45.4 14.8 46.6 20.5 26.0 30.2 24.0 44.5 40.8 28.8 19.9 42.8 22.6 22.5 39.1 41.7 54.5 23.8 23.1 25.7 40.6 40.9 18.7 25.1 16.7 37.2 19.0 23.6 43.3 26.4 55.3 28.1 33.8 28.8 33.8 25.3 45.6 21.4 23.8 25.1 26.0 22.6 25.8 30.3 12.1 18.1 28.0 19.8 45.9 34.8 23.3 38.2 24.2 20.7 47.6 32.2 25.1 29.3 3.9 15.8 3.9 13.3 19.4 16.2 14.4 12.4 12.7 17.8 13.8 14.2 12.7 0.6 12.4 13.9 15.4 9.5 16.3 26.0 30.1 19.0 31.8 26.3 18.5 27.2 26.6 23.6 27.2 3.0 17.6 13.7 18.1 20.0 6.4 3.4 25.5 26.8 19.4 24.4 7.9 30.6 21.6 36.3 38.4 21.1 24.6 0.0 38.0 33.3 14.9 13.1 17.4 20.7 33.9 3.2 22.5 28.8 29.7 10.4 18.4 20.8 20.3 31.5 19.9 13.1 33.1 14.0 19.1 39.6 8.1 19.4 18.4 23.5 19.3 19.9 23.8 15.0 24.7 12.2 PEX10 RNF69 ENSG00000157911 "Peroxisomal biogenesis factor 10" O60683 1 2403964-2413797 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Peroxisome biogenesis" "Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Late spermatids: 144.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049458, HPA049755" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA049458: AB_2680775, HPA049755: AB_2680867" "prognostic favorable (4.50e-6)" "unprognostic (1.96e-1)" "unprognostic (1.05e-1)" "unprognostic (8.15e-2)" "unprognostic (2.50e-1)" "unprognostic (2.16e-1)" "unprognostic (1.81e-2)" "unprognostic (2.91e-1)" "unprognostic (9.06e-2)" "unprognostic (1.17e-1)" "unprognostic (1.71e-1)" "unprognostic (1.95e-1)" "prognostic favorable (4.16e-6)" "unprognostic (4.78e-2)" "unprognostic (1.21e-1)" "unprognostic (1.19e-1)" "unprognostic (1.42e-1)" 14.6 18.7 20.5 6.2 19.9 5.6 16.3 7.6 24.6 9.8 9.2 23.1 6.6 10.1 7.6 13.6 10.6 11.4 8.3 12.9 17.8 15.5 12.0 12.1 8.3 7.6 19.2 13.5 13.0 19.4 12.5 12.2 10.2 16.0 15.4 7.0 11.4 17.4 12.3 22.1 10.8 9.0 6.6 21.3 8.9 10.1 17.3 12.6 6.0 10.5 11.8 9.0 8.1 6.8 7.4 11.5 2.2 10.7 4.5 6.4 4.8 12.2 10.2 8.0 8.9 5.8 6.7 7.4 6.5 7.5 10.8 7.8 16.3 18.5 6.4 17.2 8.5 7.1 9.5 7.3 12.0 5.0 10.3 14.1 4.8 10.5 32.4 11.2 8.6 2.6 6.6 6.3 7.9 10.9 6.8 9.1 7.7 5.9 8.0 9.5 16.0 8.0 4.1 6.8 6.7 20.5 6.6 8.2 13.3 11.6 4.2 12.5 9.6 7.7 11.6 21.1 4.9 10.1 3.4 8.8 9.9 4.4 15.1 8.6 11.7 4.8 5.8 11.4 6.7 7.8 1.9 6.9 2.2 5.2 10.7 6.0 7.4 4.5 6.4 11.5 6.9 5.2 3.9 1.6 4.5 8.7 9.8 2.5 4.8 20.5 19.9 7.6 24.6 17.8 15.5 19.2 13.5 16.0 12.6 3.0 4.1 5.4 10.8 7.8 15.7 0.7 10.2 8.1 4.5 14.0 0.0 22.0 29.9 19.3 42.4 9.2 9.3 0.0 26.3 21.1 10.8 12.5 0.0 8.2 20.4 12.7 12.7 4.9 10.5 144.2 9.8 10.3 21.9 26.2 9.1 39.6 17.3 3.5 12.7 20.2 9.7 0.0 8.5 24.9 16.2 5.4 23.0 4.4 14.9 9.1 PEX11B ENSG00000131779 "Peroxisomal biogenesis factor 11 beta" O96011 1 145911350-145918837 "Disease related genes, Predicted membrane proteins" "Peroxisome biogenesis" "Peroxisome biogenesis disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA017150, HPA050104" Supported Supported Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA017150: , HPA050104: AB_2681017" "unprognostic (4.59e-2)" "unprognostic (3.13e-2)" "unprognostic (1.80e-1)" "unprognostic (2.29e-1)" "unprognostic (3.62e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (2.67e-4)" "prognostic favorable (6.85e-4)" "unprognostic (1.19e-1)" "unprognostic (4.08e-2)" "unprognostic (2.10e-1)" "unprognostic (8.48e-2)" "unprognostic (6.96e-2)" "unprognostic (1.85e-1)" "unprognostic (1.84e-1)" "unprognostic (7.62e-3)" "unprognostic (4.28e-1)" 12.0 17.3 25.9 13.3 29.5 8.5 24.4 25.1 39.6 19.9 18.2 17.3 21.3 18.4 16.2 27.2 21.6 20.1 14.7 17.9 25.8 28.1 25.4 19.8 14.9 18.4 24.0 20.3 19.7 23.2 20.4 16.4 17.3 26.9 18.2 21.7 15.7 19.0 20.9 23.7 20.6 17.2 16.1 14.7 18.7 18.4 18.0 14.8 21.4 20.3 17.2 25.3 16.7 13.9 42.5 42.8 32.0 29.6 29.5 37.0 34.1 11.2 10.3 9.2 9.1 21.5 16.9 9.5 11.4 15.2 15.0 11.6 4.7 13.2 10.6 12.4 16.2 7.3 13.8 8.0 17.0 10.5 11.8 6.0 6.5 6.8 12.2 30.4 19.4 12.0 22.2 21.3 10.1 10.0 19.3 19.0 14.9 11.8 17.6 23.6 17.9 14.9 18.5 3.3 24.1 12.8 13.8 13.8 23.1 25.7 8.0 6.4 10.5 8.6 16.6 10.4 9.6 23.0 30.3 16.9 10.1 8.1 13.2 8.3 19.0 21.9 15.0 17.1 11.0 6.9 32.0 29.6 20.6 28.7 26.3 31.2 42.5 32.9 31.0 32.0 37.2 37.0 33.5 14.7 29.5 25.8 42.8 34.8 34.1 25.9 29.5 25.1 39.6 25.8 28.1 24.0 20.3 26.9 14.8 14.9 10.1 11.9 7.5 17.2 7.2 11.8 17.8 12.0 6.8 38.4 0.0 31.7 38.1 11.9 9.5 11.7 16.7 0.0 12.2 11.2 11.8 8.1 3.5 27.2 19.8 4.8 12.2 12.9 18.1 15.7 13.0 11.3 20.3 31.5 18.1 12.6 12.4 14.0 18.7 27.8 4.5 6.5 6.2 34.7 19.1 19.3 16.7 11.8 14.5 8.6 PEX3 ENSG00000034693 "Peroxisomal biogenesis factor 3" P56589 6 143450807-143490010 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Peroxisome biogenesis" "Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 65.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042830, HPA058006" Supported Approved Nucleoplasm,Peroxisomes NA NA "Nucleoplasm, Peroxisomes" "HPA042830: AB_10794918, HPA058006: AB_2683576" "unprognostic (3.52e-3)" "unprognostic (6.28e-2)" "unprognostic (1.81e-2)" "unprognostic (1.51e-2)" "unprognostic (1.21e-1)" "unprognostic (4.16e-1)" "unprognostic (8.45e-2)" "unprognostic (1.19e-1)" "unprognostic (1.09e-1)" "unprognostic (1.56e-2)" "unprognostic (2.50e-2)" "unprognostic (2.16e-1)" "prognostic favorable (3.80e-4)" "unprognostic (1.87e-1)" "unprognostic (7.30e-2)" "unprognostic (3.80e-2)" "unprognostic (2.12e-1)" 10.1 47.5 13.7 14.0 15.5 3.3 14.5 17.3 17.7 13.6 8.5 12.1 14.0 7.0 12.5 16.4 21.1 12.5 9.0 15.8 14.3 11.4 22.7 29.2 9.6 10.3 13.7 15.9 14.4 8.6 16.2 14.8 22.2 17.4 15.0 8.1 10.4 12.8 15.7 12.6 14.6 8.8 12.7 14.6 8.7 11.3 14.4 12.7 10.1 19.3 13.5 11.6 11.9 15.1 18.2 8.7 7.8 9.6 12.0 18.7 8.1 14.6 3.6 7.7 16.1 12.8 12.6 9.6 13.1 10.7 18.2 22.2 23.6 9.5 25.6 15.6 14.0 19.6 12.4 10.6 18.6 22.5 14.8 13.0 18.1 7.4 15.2 11.8 29.1 7.3 15.3 12.7 17.4 13.1 8.6 9.9 13.3 15.4 11.8 17.3 10.2 14.7 11.8 4.9 8.9 13.1 11.3 17.3 11.0 22.3 6.3 11.9 4.3 17.4 15.1 11.6 7.8 7.6 9.7 9.1 13.0 11.1 22.2 15.5 8.5 10.7 25.6 17.0 20.1 10.2 7.8 5.1 4.9 13.2 8.0 15.1 18.2 14.1 13.1 7.9 15.4 18.7 17.9 0.8 12.0 9.6 8.7 16.5 8.1 13.7 15.5 17.3 17.7 14.3 11.4 13.7 15.9 17.4 12.7 14.9 11.8 10.0 10.4 23.7 12.3 11.3 5.1 25.4 14.8 8.7 3.9 32.3 16.6 11.5 3.2 11.7 5.5 0.0 8.3 9.5 12.0 7.4 24.3 18.1 9.9 15.9 5.8 12.9 7.5 3.2 12.7 6.4 8.5 9.0 5.0 14.1 7.5 2.9 10.6 19.9 11.9 6.5 14.1 65.4 17.0 30.5 49.1 8.7 7.0 5.9 PEX6 "PAF-2, PXAAA1" ENSG00000124587 "Peroxisomal biogenesis factor 6" Q13608 6 42963870-42979220 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Peroxisome biogenesis" "Amelogenesis imperfecta, Deafness, Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 73.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 36.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025924, HPA074179" Supported Supported "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Nucleoplasm, Vesicles" "Nuclear bodies" "HPA025924: AB_1855230, HPA074179: " "unprognostic (7.32e-3)" "unprognostic (2.43e-1)" "unprognostic (1.38e-1)" "unprognostic (9.16e-2)" "unprognostic (9.18e-2)" "unprognostic (3.27e-1)" "unprognostic (8.88e-2)" "unprognostic (5.92e-2)" "unprognostic (3.36e-1)" "unprognostic (7.12e-2)" "unprognostic (7.24e-3)" "unprognostic (5.31e-2)" "unprognostic (3.79e-3)" "unprognostic (1.86e-1)" "unprognostic (1.13e-1)" "unprognostic (1.81e-1)" "unprognostic (1.55e-1)" 13.0 14.9 12.1 11.5 18.9 9.0 11.5 21.7 19.0 14.7 16.9 14.6 15.3 9.8 11.9 8.8 18.2 23.4 13.0 10.4 12.9 12.1 11.3 18.8 7.4 17.6 17.3 9.1 20.0 73.2 21.3 18.2 10.6 16.0 17.8 8.5 10.8 15.0 12.8 15.2 14.2 24.6 10.5 9.9 12.8 10.6 10.6 17.2 22.3 21.5 6.9 10.9 11.2 12.4 4.3 4.3 4.8 3.2 4.0 6.1 2.5 15.9 7.7 3.9 14.5 14.5 14.0 4.0 2.8 4.4 2.3 4.8 4.8 4.7 6.5 3.9 6.7 9.8 15.1 13.5 14.6 2.4 12.6 7.2 2.1 10.9 2.8 9.8 2.2 4.5 17.4 16.9 9.5 2.6 18.8 11.7 8.9 11.3 6.7 5.0 1.8 5.7 7.2 4.8 36.3 6.7 12.3 6.8 2.6 5.9 4.6 12.2 5.3 2.6 10.4 14.7 6.6 20.5 9.8 6.5 7.4 1.4 3.6 6.4 10.1 8.8 8.9 2.5 11.3 5.9 2.1 3.2 4.8 3.0 2.4 5.4 2.6 4.4 6.1 4.3 4.3 5.5 5.1 2.0 4.0 1.5 2.5 2.1 2.5 12.1 18.9 21.7 19.0 12.9 12.1 17.3 9.1 16.0 17.2 6.0 1.6 2.7 8.8 4.4 14.5 4.5 5.1 5.3 3.4 7.0 2.0 7.7 11.6 2.4 2.2 4.0 12.4 0.0 1.3 5.7 6.4 6.2 0.0 10.5 4.9 20.6 5.2 9.8 6.7 2.2 13.6 2.8 8.5 1.0 7.4 10.6 1.7 7.0 8.9 9.8 6.4 0.0 5.2 7.7 2.8 4.8 6.2 4.4 8.0 5.5 PEX7 "PTS2R, RD" ENSG00000112357 "Peroxisomal biogenesis factor 7" O00628 6 136822564-136913937 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Cataract, Deafness, Disease mutation, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa, Rhizomelic chondrodysplasia punctata" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 51.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049202 Uncertain Supported Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA049202: AB_2680674" "unprognostic (1.36e-2)" "unprognostic (2.07e-2)" "prognostic favorable (1.61e-4)" "unprognostic (4.01e-3)" "unprognostic (2.50e-2)" "unprognostic (6.38e-2)" "unprognostic (1.46e-1)" "unprognostic (1.71e-2)" "unprognostic (4.87e-2)" "unprognostic (1.23e-1)" "unprognostic (2.49e-1)" "unprognostic (6.88e-2)" "prognostic favorable (1.85e-10)" "unprognostic (3.57e-1)" "unprognostic (1.44e-1)" "unprognostic (2.52e-2)" "unprognostic (2.65e-1)" 5.5 17.8 8.1 7.0 8.9 4.0 13.5 7.0 10.7 8.7 8.5 7.9 14.0 6.1 5.5 18.9 9.1 8.9 17.0 14.5 7.2 6.7 16.3 10.0 9.2 4.7 8.9 9.5 6.1 43.6 15.5 10.2 6.7 6.9 11.7 9.2 13.6 15.4 18.9 11.7 12.0 6.6 7.5 9.6 4.7 14.5 19.4 5.4 5.9 11.5 7.5 6.8 6.9 7.0 4.6 5.4 4.3 5.3 2.9 6.9 1.8 4.7 4.6 4.6 6.5 6.0 8.9 2.5 6.6 8.3 7.1 7.5 5.7 5.6 1.7 12.6 7.1 8.6 6.1 3.3 12.3 8.8 4.9 8.0 6.4 4.6 0.8 14.4 8.0 3.7 8.5 13.1 5.1 10.2 8.1 5.3 11.7 11.9 5.1 9.7 11.3 3.5 9.9 4.7 12.6 7.9 4.7 4.7 5.0 15.4 6.4 8.8 12.6 6.1 8.8 8.5 5.4 5.7 10.1 4.0 4.7 2.2 7.3 5.1 7.2 4.7 0.0 3.7 7.3 5.6 0.2 3.0 4.3 2.6 2.5 2.0 4.6 3.4 4.2 5.3 2.9 6.9 4.1 0.5 2.9 5.3 5.4 6.4 1.8 8.1 8.9 7.0 10.7 7.2 6.7 8.9 9.5 6.9 5.4 3.0 6.5 1.5 10.9 10.8 8.2 14.1 5.1 8.1 7.9 10.4 7.9 16.2 51.4 13.6 8.7 5.3 10.7 0.0 19.9 17.5 7.5 13.8 13.9 5.7 10.8 0.0 9.9 6.2 5.4 7.3 8.3 7.2 13.5 15.4 17.9 14.0 15.4 14.0 9.2 27.9 8.5 6.5 9.4 34.9 17.6 15.8 14.3 4.3 17.8 15.3 PFDN6 "H2-KE2, HKE2, KE-2, PFD6" ENSG00000204220 "Prefoldin subunit 6" O15212 6 33289302-33298401 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043032, HPA048123" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 110000 "Nucleoplasm, Golgi apparatus" Cytosol "HPA043032: AB_2678278, HPA048123: AB_2680273" "unprognostic (1.04e-1)" "unprognostic (1.96e-2)" "unprognostic (7.66e-2)" "unprognostic (1.97e-1)" "unprognostic (2.00e-1)" "unprognostic (1.35e-2)" "unprognostic (8.29e-2)" "unprognostic (3.36e-1)" "unprognostic (1.55e-1)" "prognostic favorable (1.01e-4)" "unprognostic (6.93e-2)" "unprognostic (6.67e-2)" "prognostic unfavorable (8.97e-4)" "unprognostic (1.79e-1)" "unprognostic (4.13e-2)" "unprognostic (1.28e-1)" "unprognostic (4.68e-3)" 12.5 19.1 29.2 15.4 27.8 15.0 15.6 13.2 33.9 12.0 17.7 12.9 13.1 13.8 14.4 22.4 15.1 12.5 11.4 16.2 31.6 24.8 19.1 23.2 10.8 15.7 27.0 31.9 14.5 21.3 15.3 14.6 14.0 20.7 12.5 16.2 8.2 15.8 16.0 43.6 10.8 13.7 13.4 20.7 11.3 12.2 33.1 17.5 10.7 12.2 22.5 18.9 11.8 9.8 6.8 5.0 3.4 7.1 3.9 7.5 4.3 15.0 10.1 7.0 14.5 7.9 6.7 11.5 11.6 5.9 10.1 9.7 9.5 7.5 22.2 14.1 6.5 19.4 11.0 11.5 13.3 15.3 14.9 12.2 19.9 11.2 15.8 8.8 15.2 13.0 6.0 15.3 14.3 10.2 8.0 9.9 13.1 24.2 9.6 10.9 10.3 18.2 16.1 11.7 10.0 8.8 15.7 10.3 22.4 16.4 7.2 16.3 19.7 10.1 26.4 16.7 7.4 15.2 22.0 8.3 7.2 10.7 8.9 19.1 19.3 52.6 24.8 7.0 20.2 10.3 3.2 5.1 3.4 4.1 6.5 4.2 5.9 5.6 7.5 4.9 6.8 3.3 4.6 2.7 3.9 7.1 5.0 5.3 4.3 29.2 27.8 13.2 33.9 31.6 24.8 27.0 31.9 20.7 17.5 23.8 8.3 51.5 39.3 49.5 21.5 17.7 71.4 17.4 17.0 52.4 9.8 107.5 102.8 74.2 74.3 28.8 70.3 0.0 89.2 103.2 41.2 43.0 62.1 64.4 70.1 17.5 48.4 19.0 26.8 30.2 57.2 47.3 67.4 83.0 47.0 38.4 78.6 71.9 46.3 154.1 21.2 38.8 32.0 200.4 54.7 55.8 92.7 37.6 54.6 43.9 PFKFB2 ENSG00000123836 "6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2" O60825 1 207034366-207081024 "Enzymes, Predicted intracellular proteins" "Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 70.2;Late spermatids: 128.8;Rod photoreceptor cells: 111.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "eosinophil: 13.9;plasmacytoid DC: 16.7" "Group enriched" "Detected in many" 8 "dendritic cells: 16.7;granulocytes: 13.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA049975, HPA063575" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA049975: AB_2680977, HPA063575: AB_2685046" "unprognostic (1.30e-1)" "unprognostic (6.66e-2)" "unprognostic (1.48e-1)" "unprognostic (1.75e-2)" "unprognostic (2.27e-1)" "unprognostic (3.76e-2)" "unprognostic (9.96e-3)" "unprognostic (9.74e-2)" "unprognostic (7.27e-2)" "unprognostic (2.27e-2)" "unprognostic (6.01e-2)" "unprognostic (1.30e-1)" "prognostic favorable (3.23e-7)" "unprognostic (1.54e-2)" "unprognostic (1.27e-1)" "prognostic unfavorable (8.63e-4)" "unprognostic (1.86e-2)" 3.3 6.1 9.8 5.8 16.6 15.7 5.1 2.1 14.6 7.3 16.0 19.5 5.3 23.2 4.0 9.1 7.7 4.5 9.1 22.8 14.1 7.7 22.0 3.6 10.9 5.3 13.4 15.1 4.3 11.9 6.2 27.5 3.0 25.3 3.9 18.1 22.4 6.3 3.5 34.9 6.4 18.7 4.0 17.4 12.5 10.7 6.1 15.1 6.5 38.4 8.8 5.0 3.4 3.6 1.6 16.7 13.9 1.9 1.1 0.4 0.4 9.7 4.3 2.8 4.9 5.9 2.9 4.7 1.4 1.7 2.4 1.3 10.5 14.1 1.7 2.2 2.2 7.4 13.9 2.1 5.2 1.4 0.3 2.1 13.8 10.8 3.9 4.9 0.0 9.7 4.1 8.0 2.3 13.2 2.9 0.5 5.8 9.4 0.1 1.3 2.9 2.3 0.4 3.9 4.7 6.5 0.0 0.0 0.2 3.3 10.1 4.5 2.7 9.1 15.4 11.4 3.2 10.6 1.1 0.2 0.0 5.3 7.5 1.3 4.5 4.4 0.9 6.1 0.0 2.6 1.0 0.9 13.9 0.2 1.9 0.3 1.3 0.1 0.3 0.8 1.6 0.3 0.4 2.6 1.1 1.3 16.7 0.0 0.4 9.8 16.6 2.1 14.6 14.1 7.7 13.4 15.1 25.3 15.1 6.0 42.0 4.5 3.4 13.5 7.3 70.2 5.1 14.7 5.7 15.7 0.0 0.5 21.6 4.0 47.4 2.7 43.0 0.0 6.7 0.4 2.5 6.5 9.2 4.9 4.9 3.2 5.8 1.3 11.3 128.8 2.6 6.0 20.3 1.8 18.9 8.1 10.5 27.7 2.8 30.6 111.9 0.0 3.2 3.1 3.3 10.2 1.3 1.0 27.6 11.2 PFKFB3 ENSG00000170525 "6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3" Q16875 10 6144934-6254644 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 105.6;skeletal muscle: 135.7" "Cell type enhanced" "Detected in many" 8 "Collecting duct cells: 184.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 20.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 72.7;RPTEC TERT1: 45.9;T-47d: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008266, CAB020795, HPA043889" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "CAB020795: , HPA008266: AB_1855239, HPA043889: AB_2678717" "unprognostic (1.61e-1)" "unprognostic (5.08e-3)" "unprognostic (2.89e-2)" "unprognostic (6.18e-2)" "unprognostic (2.29e-1)" "unprognostic (1.79e-1)" "unprognostic (3.11e-3)" "unprognostic (1.88e-1)" "unprognostic (1.03e-1)" "unprognostic (1.04e-1)" "unprognostic (3.30e-2)" "unprognostic (7.34e-2)" "prognostic unfavorable (1.87e-7)" "unprognostic (1.89e-2)" "unprognostic (1.19e-1)" "unprognostic (1.13e-1)" "unprognostic (2.74e-1)" 105.6 9.0 16.4 25.7 17.9 77.0 43.4 8.5 29.4 6.6 8.8 29.1 10.6 7.4 9.4 6.3 13.0 14.4 22.4 5.7 16.6 13.2 22.1 11.2 15.1 12.1 19.2 12.9 8.0 8.1 4.0 10.2 7.5 20.7 5.4 3.8 19.3 9.1 20.0 135.7 11.8 6.9 6.5 36.0 12.4 6.7 4.6 16.8 3.3 2.9 4.7 10.3 10.3 10.1 1.5 3.6 20.5 7.1 0.8 4.7 2.9 5.2 72.7 5.8 4.7 21.9 2.7 3.0 7.7 5.5 5.8 9.0 3.4 19.3 9.0 5.1 3.3 4.5 17.0 6.2 12.3 6.7 10.7 4.3 5.3 3.7 1.2 1.8 5.1 8.1 1.9 4.1 9.9 2.4 14.8 11.1 6.3 3.9 3.4 4.6 8.6 3.6 4.8 5.6 7.5 5.1 8.2 2.8 3.5 45.9 2.7 5.5 2.2 5.6 6.2 11.0 10.4 47.8 6.1 14.0 6.1 5.6 0.7 9.3 7.0 2.4 8.1 16.7 6.0 9.2 2.2 5.6 5.5 1.8 7.1 4.7 1.5 3.4 2.3 3.6 1.4 2.5 2.4 20.5 0.8 4.1 2.2 3.2 2.9 16.4 17.9 8.5 16.9 16.6 13.2 19.2 12.9 20.7 16.8 71.5 75.9 13.7 14.3 91.1 7.8 17.3 15.3 13.4 42.1 184.9 49.1 0.2 0.0 42.7 5.1 29.2 7.4 0.0 22.5 4.6 29.8 4.3 41.7 11.6 19.4 6.4 8.2 9.2 79.2 6.1 2.6 37.7 43.9 23.4 5.2 0.4 46.2 5.8 6.7 2.4 1.6 0.0 21.1 0.7 1.6 55.8 0.8 21.3 5.4 9.9 PGAM1 "PGAM-B, PGAMA" ENSG00000171314 "Phosphoglycerate mutase 1" P18669 10 97426160-97433441 "Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Extravillous trophoblasts: 698.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042528, HPA060483" Approved Supported Nucleoplasm NA NA 200000000 Nucleoplasm "HPA042528: AB_2678039, HPA060483: AB_2684292" "prognostic unfavorable (2.04e-4)" "prognostic unfavorable (3.86e-4)" "unprognostic (3.64e-1)" "unprognostic (5.64e-2)" "unprognostic (1.16e-1)" "unprognostic (9.47e-3)" "unprognostic (7.60e-3)" "unprognostic (1.74e-3)" "unprognostic (3.22e-1)" "unprognostic (1.05e-1)" "unprognostic (4.37e-3)" "unprognostic (2.48e-2)" "unprognostic (1.48e-1)" "unprognostic (5.74e-2)" "unprognostic (4.94e-2)" "unprognostic (1.19e-1)" "unprognostic (2.61e-3)" 26.5 46.1 42.8 28.9 50.3 30.2 19.0 32.6 90.0 26.5 27.6 24.9 14.2 29.8 24.3 20.6 63.5 17.7 21.2 54.1 47.4 44.9 32.7 35.7 18.5 29.5 45.7 61.1 22.9 14.3 27.8 23.2 30.8 72.4 21.9 29.2 30.4 24.5 33.7 8.4 30.0 27.4 35.6 25.7 21.7 20.3 26.1 21.0 26.6 17.4 27.0 43.7 31.0 31.9 22.5 49.7 88.0 65.3 22.8 41.2 72.8 119.7 57.0 39.4 75.1 37.3 34.4 53.7 76.8 100.5 90.3 126.0 61.8 35.8 63.5 52.7 65.2 36.3 75.2 68.4 111.7 109.5 58.7 65.4 41.0 44.7 69.1 27.6 58.7 54.9 33.6 45.8 60.0 44.8 122.3 65.3 47.7 26.8 36.0 94.7 49.5 52.4 72.5 60.3 34.7 68.4 39.9 36.1 50.3 69.7 45.5 8.6 40.3 41.3 24.7 39.4 64.5 67.2 49.5 49.1 48.4 42.6 42.7 88.1 54.3 59.8 57.9 112.5 98.2 22.3 30.4 65.3 88.0 37.0 57.2 32.7 22.5 31.8 36.6 49.7 18.8 20.7 28.9 50.3 22.8 62.8 17.6 41.2 72.8 42.8 50.3 32.6 90.0 47.4 44.9 45.7 61.1 72.4 21.0 41.7 37.7 99.1 98.5 166.1 402.1 21.4 81.5 34.8 53.4 101.2 72.6 433.1 303.4 278.9 11.6 112.3 222.3 46.7 180.1 698.3 148.4 67.2 102.6 165.4 366.0 365.5 46.3 103.7 173.5 17.6 138.4 127.2 124.9 317.4 104.7 280.3 240.1 115.6 220.3 200.3 232.1 200.5 123.6 31.0 121.7 178.9 311.6 142.2 136.4 230.0 PGAM2 PGAM-M ENSG00000164708 "Phosphoglycerate mutase 2" P15259 7 44062727-44065587 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "heart muscle: 111.6;skeletal muscle: 379.1;tongue: 119.0" "Group enriched" "Detected in many" 13 "Early spermatids: 421.0;Late spermatids: 1332.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 1.2;neutrophil: 1.1;plasmacytoid DC: 1.3;T-reg: 1.7" "Group enriched" "Detected in many" 4 "dendritic cells: 1.3;granulocytes: 1.2;T-cells: 1.7" "Cell line enriched" "Detected in some" 9 "SCLC-21H: 39.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA043801, HPA050314, HPA060173" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA 60000000 Nucleoplasm "Nucleoli, Cytosol" "HPA043801: , HPA050314: AB_2732558, HPA060173: AB_2684215" 1.4 0.8 2.0 0.4 2.2 0.4 0.5 6.9 2.1 0.5 0.5 3.6 0.0 0.6 0.5 9.1 6.1 0.6 0.7 111.6 2.1 3.2 0.8 0.4 0.4 0.4 4.2 1.6 0.5 0.6 0.6 1.3 0.4 2.0 1.9 0.4 2.3 7.6 0.5 379.1 0.4 0.4 0.4 3.2 0.5 0.5 16.7 1.1 4.8 1.5 119.0 4.8 0.4 0.0 0.3 1.3 1.2 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.0 4.3 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.3 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 1.3 1.7 0.2 2.0 2.2 6.9 2.1 2.1 3.2 4.2 1.6 2.0 1.1 0.0 0.0 0.5 0.2 1.0 4.3 0.0 0.0 0.0 0.0 0.0 9.8 0.0 68.0 0.0 421.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 22.0 0.0 0.3 1332.7 7.2 0.4 1.7 0.0 0.0 3.8 0.2 0.2 5.6 1.9 4.2 25.8 3.1 30.5 5.6 0.5 0.0 0.0 0.2 0.4 PGAM4 "dJ1000K24.1, PGAM-B, PGAM1, PGAM3" ENSG00000226784 "Phosphoglycerate mutase family member 4" Q8N0Y7 X 77968874-77969638 "Enzymes, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 6 "Basal keratinocytes: 2.1;Melanocytes: 3.3;Suprabasal keratinocytes: 2.0" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 5.4" "HPA042528, HPA060483" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA042528: AB_2678039, HPA060483: AB_2684292" "unprognostic (3.10e-2)" "unprognostic (2.41e-2)" "unprognostic (5.25e-2)" "unprognostic (3.18e-2)" "unprognostic (4.37e-2)" "unprognostic (4.21e-2)" "unprognostic (7.71e-2)" "unprognostic (1.89e-2)" "unprognostic (1.78e-1)" "unprognostic (7.52e-3)" "unprognostic (3.19e-2)" "unprognostic (1.14e-1)" "unprognostic (4.20e-2)" "unprognostic (1.20e-1)" "unprognostic (4.15e-2)" "unprognostic (1.10e-1)" "unprognostic (2.76e-3)" 0.9 2.1 0.9 2.6 1.5 3.0 0.4 0.8 2.1 1.9 0.6 2.4 1.4 0.7 2.9 1.3 0.0 1.3 1.0 1.5 0.9 1.2 0.4 1.2 1.5 1.0 0.1 0.7 0.7 0.7 0.5 0.7 0.6 0.2 1.1 0.8 2.0 1.3 0.4 1.0 1.3 0.5 0.3 0.7 1.6 1.2 0.7 1.9 3.7 2.4 0.8 1.6 3.5 5.4 3.1 0.3 0.9 0.4 0.0 2.7 0.5 0.1 0.6 0.8 0.0 0.5 0.8 1.5 0.3 0.0 2.3 0.2 0.0 0.8 0.6 0.3 0.0 1.1 0.7 0.0 1.6 0.9 0.4 0.2 0.2 0.0 0.1 0.5 0.3 0.0 0.6 0.8 1.0 2.7 3.9 1.1 0.3 0.8 0.8 1.0 2.0 0.0 0.7 0.1 2.7 0.3 0.0 1.3 0.3 1.0 0.6 0.0 1.0 1.8 1.6 3.1 2.8 1.4 0.7 3.7 1.6 0.5 0.6 2.4 3.7 1.4 2.2 1.1 0.7 1.1 1.3 1.9 0.7 0.6 0.9 1.5 0.8 2.1 0.5 1.6 3.5 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.1 0.0 0.0 0.0 PGBD1 "dJ874C20.4, HUCEP-4, SCAND4" ENSG00000137338 "PiggyBac transposable element derived 1" Q96JS3 6 28281572-28302549 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.5;plasmacytoid DC: 4.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007267 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA007267: AB_1079601" "unprognostic (2.26e-1)" "unprognostic (2.43e-1)" "unprognostic (2.70e-1)" "unprognostic (1.96e-3)" "unprognostic (1.28e-2)" "unprognostic (8.81e-2)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.27e-1)" "prognostic unfavorable (1.71e-4)" "unprognostic (5.38e-3)" "prognostic favorable (6.79e-4)" "unprognostic (7.32e-3)" "prognostic unfavorable (4.97e-4)" "unprognostic (1.16e-2)" "unprognostic (1.61e-1)" "unprognostic (5.23e-2)" "unprognostic (2.68e-1)" 6.1 4.5 7.4 3.8 7.2 2.8 8.5 9.6 12.8 6.1 7.4 4.0 1.3 3.0 9.2 6.0 4.5 4.3 4.0 7.0 7.1 6.3 5.9 5.1 5.4 3.1 7.0 7.7 6.0 4.0 6.6 8.6 4.3 5.1 6.0 4.6 4.4 3.8 7.4 4.1 3.0 4.0 11.7 7.0 4.9 4.8 5.2 3.6 8.9 4.0 3.1 3.4 5.2 3.8 1.0 4.4 3.5 0.2 1.2 1.2 0.3 5.1 2.8 9.1 12.9 7.4 5.3 3.0 6.8 4.7 8.6 9.8 3.2 2.2 3.4 4.3 4.6 9.8 2.3 9.9 5.5 11.3 3.7 5.7 6.2 5.8 4.0 3.5 7.7 0.8 4.3 2.6 8.5 2.9 4.9 10.5 6.7 8.0 0.4 9.5 1.5 6.5 9.7 3.4 0.1 5.8 11.2 11.6 0.0 4.3 2.8 6.3 12.1 4.6 0.8 5.1 9.5 2.5 4.8 7.4 12.9 8.6 0.9 10.6 3.3 3.3 4.4 2.9 4.5 6.0 3.5 0.1 0.0 0.6 0.2 0.3 0.5 0.2 1.2 0.7 1.0 0.1 0.5 0.0 1.2 0.1 4.4 0.5 0.3 7.4 7.2 9.6 12.8 7.1 6.3 7.0 7.7 5.1 3.6 6.0 0.6 1.4 2.2 0.2 6.7 7.0 0.0 6.7 0.0 0.0 2.0 0.6 0.0 0.9 0.4 4.2 0.3 0.0 2.3 2.8 1.6 1.0 3.5 0.0 1.4 4.8 1.2 1.8 2.9 0.9 1.7 1.1 3.3 3.6 0.3 4.1 1.2 0.0 3.2 3.7 3.9 0.0 1.4 4.2 7.5 0.3 0.3 0.5 1.0 0.5 PGBD4 "FLJ32638, FLJ37497" ENSG00000182405 "PiggyBac transposable element derived 4" Q96DM1 15 34102073-34108684 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 18.6" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA040896, HPA059823" Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA040896: AB_10805831, HPA059823: AB_2684134" "unprognostic (9.54e-2)" "unprognostic (2.29e-1)" "unprognostic (1.45e-2)" "unprognostic (3.51e-2)" "unprognostic (7.43e-3)" "unprognostic (2.61e-2)" "unprognostic (1.10e-1)" "unprognostic (2.35e-2)" "unprognostic (6.47e-2)" "unprognostic (6.66e-2)" "unprognostic (1.32e-3)" "unprognostic (9.70e-2)" "unprognostic (6.68e-2)" "unprognostic (2.14e-2)" "unprognostic (8.54e-2)" "unprognostic (3.15e-2)" "unprognostic (7.73e-2)" 2.5 3.6 3.9 4.1 8.5 6.7 3.4 5.3 11.1 2.6 2.8 4.8 4.7 3.2 2.6 3.9 3.8 4.6 2.4 4.0 5.4 3.6 3.4 5.3 2.4 5.2 6.0 6.1 3.0 4.6 4.9 6.7 2.5 12.7 3.0 3.4 3.2 3.3 2.6 18.6 4.4 5.1 2.2 4.0 6.0 4.5 7.9 5.8 4.5 3.3 2.0 4.2 3.2 2.7 2.8 1.7 6.4 1.4 1.6 2.6 0.6 2.0 3.6 2.5 4.1 7.4 4.9 1.5 3.1 3.0 2.0 2.5 2.5 2.7 4.1 2.6 2.4 4.0 5.6 1.4 3.6 2.5 4.3 3.8 6.7 6.9 1.8 3.1 2.3 6.1 3.8 4.1 2.6 4.7 3.4 2.2 7.6 4.6 5.0 4.1 1.4 3.7 5.4 1.0 4.1 2.7 5.6 3.4 2.1 2.6 4.2 3.7 3.4 1.6 3.5 1.1 3.1 3.5 3.6 2.5 6.1 3.5 3.2 2.0 5.9 3.8 2.3 5.4 5.2 3.6 6.4 1.4 1.5 1.3 1.2 1.1 1.5 1.7 1.3 0.8 2.8 2.6 2.4 3.2 1.6 0.9 1.7 1.3 0.6 3.9 8.5 5.3 11.1 5.4 3.6 6.0 6.1 12.7 5.8 0.0 2.7 4.9 1.9 0.7 5.3 3.7 2.5 5.3 3.4 0.0 5.9 1.5 8.3 1.1 8.8 1.4 3.2 0.0 0.6 0.6 0.6 1.8 1.1 1.7 1.1 9.5 0.0 4.3 3.5 10.2 1.1 2.1 0.0 1.8 1.8 3.8 1.7 0.9 0.4 0.7 6.1 12.9 0.9 6.0 0.7 0.3 2.7 4.5 1.7 1.4 PGBD5 "DKFZp761A0620, FLJ11413" ENSG00000177614 "PiggyBac transposable element derived 5" Q8N414 1 230314482-230426371 "Disease related genes, Predicted intracellular proteins" Transposition "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.0;cervix, uterine: 21.9;pancreas: 21.6" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 23.0;Cone photoreceptor cells: 19.6;Horizontal cells: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Daudi: 18.0;GAMG: 9.2;NTERA-2: 18.3;RH-30: 10.0;SCLC-21H: 25.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065010 Supported Nucleoplasm NA NA Nucleoplasm "HPA065010: AB_2685402" "unprognostic (2.00e-2)" "unprognostic (4.25e-1)" "unprognostic (1.57e-1)" "unprognostic (1.61e-2)" "prognostic unfavorable (8.78e-5)" "unprognostic (1.44e-2)" "unprognostic (4.66e-2)" "unprognostic (4.91e-2)" "unprognostic (3.97e-1)" "unprognostic (1.15e-1)" "unprognostic (7.48e-3)" "unprognostic (2.57e-1)" "unprognostic (3.29e-2)" "unprognostic (6.69e-2)" "unprognostic (2.12e-1)" "unprognostic (3.13e-3)" "unprognostic (2.51e-1)" 0.8 10.8 16.0 0.8 14.1 0.6 0.7 17.9 27.0 21.9 1.5 6.0 0.1 1.0 5.8 0.5 1.8 5.6 2.2 13.3 20.0 8.0 1.5 2.8 1.8 0.9 7.1 8.9 0.9 21.6 0.9 4.0 2.6 8.0 1.4 1.3 1.0 3.2 1.2 2.8 0.9 1.0 3.0 5.0 2.6 1.6 5.8 4.6 0.5 6.0 0.6 5.1 1.6 1.5 0.8 0.6 1.5 0.6 0.6 0.6 0.2 0.0 0.0 4.6 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.0 4.0 0.0 18.0 1.7 0.1 9.2 3.4 1.4 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.1 0.9 0.1 3.6 18.3 0.0 0.1 0.0 10.0 2.8 2.1 0.0 25.3 4.7 0.6 0.0 0.2 0.4 0.2 6.1 0.0 0.0 1.5 0.0 1.4 7.7 5.8 0.0 0.0 1.5 0.3 1.5 0.6 1.2 0.6 0.6 0.5 0.4 0.5 0.4 0.4 0.8 0.6 0.6 1.2 0.6 0.6 0.6 0.4 0.2 16.0 14.1 17.9 23.8 20.0 8.0 7.1 8.9 8.0 4.6 0.0 3.4 0.0 0.6 0.1 23.0 5.5 0.0 1.4 0.0 0.0 19.6 0.0 0.0 6.1 0.6 0.1 0.0 0.0 5.1 0.1 0.4 1.3 10.4 4.0 8.7 20.6 8.7 0.0 3.7 0.4 0.0 0.6 1.7 0.0 0.0 2.4 4.9 0.0 0.0 0.6 9.3 0.0 0.7 0.7 1.5 0.0 0.2 0.0 0.0 0.9 PGC ENSG00000096088 Progastricsin P20142 6 41736711-41754109 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins, Transporters" Digestion "Aspartyl protease, Hydrolase, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "ductus deferens: 249.6;pancreas: 798.6;stomach 1: 963.7" "Cell type enhanced" "Detected in some" 28 "Alveolar cells type 2: 270.0;Cholangiocytes: 150.3;Pancreatic endocrine cells: 843.0" "Cancer enhanced" "Detected in many" "stomach cancer: 1050.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "intermediate monocyte: 1.9" "Lineage enriched" "Detected in single" 7 "monocytes: 1.9" "Group enriched" "Detected in some" 11 "Hep G2: 69.6;OE19: 42.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA031717, HPA031718" Enhanced Approved Nucleoplasm "Secreted to digestive system" NA NA Nucleoplasm "HPA031717: AB_10670130, HPA031718: AB_10610148" "unprognostic (9.18e-2)" "unprognostic (1.87e-1)" "unprognostic (9.83e-2)" "unprognostic (2.27e-1)" "unprognostic (7.18e-2)" "unprognostic (2.74e-1)" "unprognostic (1.47e-1)" "unprognostic (8.50e-2)" "unprognostic (1.86e-1)" "unprognostic (9.23e-2)" "unprognostic (1.09e-1)" "unprognostic (1.33e-2)" "unprognostic (2.92e-1)" "unprognostic (1.65e-1)" "unprognostic (8.74e-2)" 0.1 0.2 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.3 0.1 3.0 249.6 41.7 0.1 0.0 3.3 0.3 16.8 0.1 0.1 0.1 0.1 0.3 139.4 0.0 0.1 0.0 0.1 798.6 0.0 0.1 0.0 0.1 2.3 0.0 0.0 0.1 35.9 0.1 0.1 0.1 0.0 0.1 0.1 963.7 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 1.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.6 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 1.6 42.3 0.0 0.8 0.0 1.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 1.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 23.8 270.0 0.0 3.1 0.3 0.0 0.2 150.3 5.3 9.1 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 117.5 1.0 0.1 95.4 9.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.6 0.0 0.0 843.0 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 3.4 0.0 0.0 2.6 PGF "D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760" ENSG00000119630 "Placental growth factor" P49763 14 74941834-74955784 "Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 177.3" "Group enriched" "Detected in many" 16 "Extravillous trophoblasts: 1478.5;Syncytiotrophoblasts: 1775.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "BEWO: 93.4;HUVEC TERT2: 44.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA041624 Approved Nucleoplasm,Mitochondria,Cytosol "Secreted to blood" No No 20800 Nucleoplasm "Mitochondria, Cytosol" "HPA041624: AB_10794522" "unprognostic (1.67e-2)" "unprognostic (4.62e-2)" "unprognostic (9.25e-3)" "unprognostic (1.34e-3)" "unprognostic (8.67e-3)" "unprognostic (2.41e-1)" "prognostic unfavorable (1.40e-4)" "unprognostic (7.26e-2)" "unprognostic (1.48e-1)" "unprognostic (4.45e-1)" "unprognostic (1.45e-2)" "unprognostic (3.51e-3)" "prognostic unfavorable (1.33e-6)" "unprognostic (2.52e-3)" "unprognostic (1.20e-1)" "unprognostic (3.49e-2)" "unprognostic (1.14e-1)" 4.3 2.7 1.9 4.4 2.4 0.0 4.3 1.6 3.5 13.1 2.3 2.3 4.0 1.3 2.9 6.3 3.9 9.2 3.4 5.1 2.4 4.1 3.1 2.6 3.6 4.9 2.9 2.0 3.8 1.9 5.4 2.0 177.3 4.6 7.5 1.1 3.5 3.8 6.7 3.3 6.0 4.3 4.6 1.7 1.2 1.7 3.3 2.0 1.4 24.2 4.4 2.9 5.1 5.9 0.7 0.7 1.1 1.0 0.0 2.4 0.2 0.3 0.3 0.3 0.3 0.4 0.0 93.4 0.8 0.8 0.4 0.5 2.2 0.1 0.0 2.0 0.6 0.0 0.1 0.4 4.2 0.3 0.0 0.5 0.0 0.0 2.2 0.3 0.0 2.4 1.1 1.0 1.7 0.4 0.1 44.0 0.0 0.0 0.0 12.4 0.1 0.0 0.1 0.4 0.0 0.7 0.0 11.6 0.0 0.1 0.2 7.0 3.8 0.0 0.1 1.6 5.9 0.0 0.1 8.9 0.0 2.3 0.0 3.7 0.0 0.0 0.1 1.4 0.1 0.1 0.0 0.2 1.1 2.4 1.0 0.0 0.7 0.3 0.7 0.3 0.3 0.6 1.0 0.0 0.0 0.8 0.7 0.5 0.2 1.9 2.4 1.6 2.2 2.4 4.1 2.9 2.0 4.6 2.0 8.9 5.8 0.8 13.0 21.9 0.8 2.8 0.0 1.4 7.9 0.0 13.7 75.1 0.0 0.9 0.1 15.8 0.5 0.0 0.4 1478.5 42.9 3.3 5.8 0.0 33.1 0.0 6.8 7.4 0.3 0.6 12.0 4.5 20.3 0.0 1.1 1.9 0.6 0.2 18.4 0.4 7.5 103.5 62.6 0.2 3.4 17.1 1775.1 0.9 1.7 4.7 PGGT1B "BGGI, GGTI" ENSG00000164219 "Protein geranylgeranyltransferase type I subunit beta" P53609 5 115204012-115262872 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Prenyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Rod photoreceptor cells: 111.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030646 Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA "Nucleoplasm, Endoplasmic reticulum" Cytosol "HPA030646: AB_10602019" "unprognostic (2.73e-2)" "unprognostic (1.67e-1)" "unprognostic (3.92e-2)" "unprognostic (7.34e-2)" "unprognostic (5.57e-2)" "unprognostic (7.56e-3)" "unprognostic (1.34e-1)" "unprognostic (1.75e-1)" "unprognostic (3.25e-2)" "unprognostic (1.33e-1)" "unprognostic (2.17e-1)" "unprognostic (2.48e-1)" "unprognostic (4.38e-2)" "unprognostic (1.58e-1)" "unprognostic (3.75e-1)" "unprognostic (5.93e-3)" "unprognostic (1.15e-2)" 10.5 12.4 7.3 13.3 10.1 10.9 13.9 8.8 22.1 10.8 13.8 7.7 7.9 12.3 9.2 4.6 14.9 7.3 7.0 13.5 9.5 5.9 8.2 13.7 22.2 22.2 10.2 10.0 9.6 10.1 12.0 13.4 7.8 8.2 8.4 15.1 5.7 10.6 8.4 10.2 9.9 10.4 9.5 6.9 10.4 11.0 5.1 10.5 10.2 8.8 9.9 10.1 9.6 10.5 8.0 11.5 21.8 16.7 6.7 6.3 6.4 10.2 11.2 12.8 16.5 7.5 6.3 6.3 12.7 7.5 10.6 11.0 12.2 11.0 20.9 17.3 8.8 11.0 8.0 16.8 16.7 15.9 23.0 9.3 12.0 14.6 9.7 10.0 16.5 17.8 9.4 10.3 10.4 10.9 6.8 10.6 12.4 9.7 8.9 12.1 16.0 14.4 5.5 9.5 11.6 8.7 15.8 17.1 21.2 11.1 19.4 12.5 9.5 15.1 11.5 12.1 8.0 15.4 12.4 12.1 10.9 10.3 7.5 14.8 15.0 16.7 11.0 7.9 17.2 15.1 8.3 12.8 21.8 5.0 16.6 5.6 6.8 5.7 6.3 11.5 8.0 5.4 5.0 13.1 6.7 16.7 10.3 4.9 6.4 7.3 10.1 8.8 22.1 9.5 5.9 10.2 10.0 8.2 10.5 11.9 14.4 20.7 10.2 8.9 22.7 15.7 5.1 25.4 18.2 15.7 45.2 12.3 23.2 17.0 28.4 16.1 17.8 0.0 18.9 11.6 11.7 13.7 23.1 24.5 19.5 22.3 28.9 20.3 18.3 8.1 12.4 23.0 10.1 12.6 23.0 25.4 17.9 21.0 14.5 18.3 111.9 12.9 14.1 11.4 15.6 10.8 11.3 19.1 23.3 17.8 PGLS 6PGL ENSG00000130313 6-phosphogluconolactonase O95336 19 17511629-17521288 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 71.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040744, HPA042032" Approved Supported Nucleoplasm,Cytosol NA NA 10000000 Nucleoplasm Cytosol "HPA040744: AB_2677111, HPA042032: AB_2677809" "unprognostic (3.68e-2)" "unprognostic (8.98e-3)" "unprognostic (1.25e-1)" "unprognostic (9.64e-3)" "unprognostic (1.35e-1)" "unprognostic (1.04e-1)" "unprognostic (3.55e-3)" "unprognostic (2.95e-1)" "unprognostic (1.44e-1)" "unprognostic (7.55e-2)" "unprognostic (2.16e-1)" "unprognostic (1.30e-1)" "unprognostic (4.75e-3)" "unprognostic (2.39e-1)" "unprognostic (1.99e-1)" "unprognostic (5.05e-2)" "unprognostic (9.26e-3)" 27.3 31.5 15.6 23.6 13.9 29.3 33.7 9.0 20.1 23.8 29.5 16.0 17.9 21.9 16.6 18.7 38.0 25.9 27.8 18.5 13.9 11.6 25.9 42.7 27.5 60.0 14.3 11.8 32.0 42.1 19.1 16.4 26.5 10.9 23.5 13.5 16.8 31.5 20.7 10.9 27.2 30.8 13.3 16.8 31.4 20.8 15.8 12.2 46.6 26.7 19.2 27.6 18.5 21.6 17.6 46.4 45.8 44.5 17.4 14.9 22.4 18.9 17.1 10.7 7.3 16.5 27.4 20.6 13.0 21.2 13.1 16.9 8.1 28.7 21.0 14.6 20.3 9.3 13.1 6.0 20.3 3.9 10.4 23.5 9.9 7.9 14.5 28.3 10.4 11.0 32.1 28.2 7.8 23.5 13.5 17.6 8.2 11.1 5.1 16.1 20.8 22.9 29.5 14.4 19.7 71.7 15.5 6.9 13.3 17.7 15.3 13.7 16.5 8.3 9.2 18.3 6.1 13.3 19.0 16.4 13.6 3.8 27.1 7.3 9.2 6.4 8.9 19.4 26.9 13.3 15.2 40.8 45.8 14.9 44.5 12.1 16.4 13.2 13.2 46.4 17.6 12.5 12.6 39.6 17.4 41.5 34.4 14.0 22.4 15.6 13.9 9.0 20.1 13.9 11.6 14.3 11.8 10.9 12.2 26.8 37.6 86.9 79.0 57.4 21.4 7.6 91.7 29.4 39.8 45.4 15.7 102.5 94.5 158.8 26.8 57.1 173.6 23.3 181.6 135.6 85.0 78.7 25.3 85.9 223.6 25.4 127.8 76.1 277.9 55.5 84.0 130.9 70.9 196.6 120.1 61.4 172.0 171.9 65.0 148.8 22.8 51.8 55.6 36.4 23.4 84.1 88.0 79.9 140.5 131.2 PGLYRP1 "PGLYRP, PGRP, PGRP-S, PGRPS, TAG7, TNFSF3L" ENSG00000008438 "Peptidoglycan recognition protein 1" O75594 19 46019153-46023065 "Plasma proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 73.7;bone marrow: 130.1" "Cell type enhanced" "Detected in single" 35 "Alveolar cells type 2: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 190 "eosinophil: 63.0;neutrophil: 73.7" "Lineage enriched" "Detected in single" 205 "granulocytes: 73.7" "Cell line enhanced" "Detected in some" "A549: 7.3;HEK 293: 4.1;HeLa: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045702, HPA070227" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" NA NA 47000000 Vesicles "Nucleoplasm, Cytosol" "HPA045702: AB_10960204, HPA070227: " "unprognostic (2.87e-2)" "unprognostic (4.26e-1)" "unprognostic (1.32e-1)" "unprognostic (3.04e-1)" "unprognostic (1.58e-1)" "unprognostic (4.93e-3)" "unprognostic (2.20e-1)" "unprognostic (6.46e-2)" "unprognostic (7.77e-2)" "unprognostic (2.61e-2)" "unprognostic (8.51e-3)" "unprognostic (7.18e-2)" "unprognostic (2.04e-2)" "unprognostic (2.96e-1)" "unprognostic (1.03e-1)" "unprognostic (1.73e-1)" "unprognostic (4.37e-3)" 0.7 0.1 0.2 0.5 0.4 130.1 0.2 0.4 0.2 0.1 0.3 0.3 0.0 0.2 0.1 0.1 0.2 0.4 0.1 10.9 0.2 0.2 0.2 1.5 10.9 1.0 0.2 0.0 0.7 0.2 0.1 1.4 4.1 0.1 0.1 0.1 0.5 0.7 0.1 1.3 0.3 0.2 0.1 0.1 26.9 0.2 0.9 0.0 7.5 1.3 0.0 0.5 0.1 5.5 0.0 0.0 73.7 0.3 0.0 0.0 0.4 0.6 7.3 1.2 0.8 0.0 0.0 2.0 0.6 0.0 0.0 0.0 1.2 0.6 2.0 0.2 0.0 0.6 2.7 0.0 0.0 0.0 1.9 4.1 0.8 3.5 0.3 0.0 0.4 2.1 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.7 0.6 0.0 0.5 0.4 2.2 0.4 0.0 2.7 1.6 0.2 0.2 0.0 2.6 0.8 0.2 0.5 0.1 0.0 0.6 0.3 0.1 0.0 0.1 0.3 0.7 1.1 1.6 1.3 0.8 1.1 1.7 0.1 0.0 0.0 63.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.7 0.0 0.3 0.0 0.0 0.4 0.2 0.4 0.4 0.2 0.2 0.2 0.2 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PGM3 "AGM1, DKFZP434B187, PAGM" ENSG00000013375 "Phosphoglucomutase 3" O95394 6 83161150-83193936 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004998, HPA029759, HPA029760" Enhanced Approved Nucleoplasm,Cytosol NA NA 73000 "Nucleoplasm, Cytosol" "CAB004998: AB_425591, HPA029759: AB_10600305, HPA029760: AB_10601109" "prognostic unfavorable (8.78e-4)" "prognostic unfavorable (5.67e-4)" "unprognostic (1.45e-2)" "unprognostic (3.03e-2)" "unprognostic (1.51e-2)" "unprognostic (4.04e-2)" "unprognostic (1.09e-3)" "unprognostic (6.72e-3)" "unprognostic (3.11e-1)" "prognostic favorable (9.96e-4)" "unprognostic (4.00e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.39e-7)" "unprognostic (2.21e-1)" "unprognostic (7.98e-2)" "unprognostic (1.22e-1)" "unprognostic (4.22e-3)" 15.5 16.7 11.2 10.4 13.7 4.8 12.3 19.1 13.3 15.4 10.1 9.0 30.7 8.9 10.6 26.2 10.3 8.8 14.2 12.2 11.0 8.6 12.2 44.9 13.4 6.3 13.5 9.9 15.5 36.3 9.3 36.2 27.6 18.1 30.9 13.7 7.4 29.2 23.4 5.5 7.5 11.6 11.1 9.7 8.1 14.4 16.8 11.3 4.0 14.9 7.6 8.7 11.1 10.0 8.2 7.4 11.1 6.5 5.3 8.7 3.9 10.1 6.8 13.1 15.6 21.3 22.8 15.2 34.8 25.3 16.9 26.6 17.5 4.8 5.4 7.4 34.8 17.2 6.5 11.9 14.6 32.4 4.0 11.6 6.9 13.3 29.2 24.2 6.7 3.4 14.4 12.1 29.7 37.7 17.1 19.9 3.7 22.5 5.9 18.2 10.6 1.1 4.4 5.8 9.1 9.3 4.7 29.3 3.1 13.1 10.1 5.2 8.2 10.0 9.0 7.0 20.5 7.8 7.5 28.9 11.6 6.4 23.3 18.7 11.5 4.4 3.8 9.1 5.4 18.2 11.1 6.4 3.8 5.0 6.0 6.7 8.2 5.2 6.2 5.5 5.0 8.7 8.2 2.7 5.3 6.5 7.4 3.6 3.9 11.2 13.7 19.1 13.3 11.0 8.6 13.5 9.9 18.1 11.3 26.8 20.1 3.7 21.9 14.1 16.1 5.2 20.4 12.0 28.4 10.4 9.8 27.6 6.6 29.3 40.4 10.8 14.0 23.3 43.3 56.1 40.5 76.0 4.7 30.5 15.6 7.9 15.4 16.5 4.7 15.6 31.1 8.3 10.1 12.6 25.8 25.2 36.6 17.5 17.3 18.1 20.4 6.5 18.6 54.3 31.1 13.7 53.9 7.5 15.5 17.9 PHACTR3 "C20orf101, PPP1R123" ENSG00000087495 "Phosphatase and actin regulator 3" Q96KR7 20 59577509-59847711 "Predicted intracellular proteins" "Actin-binding, Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 56.1" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 11.9;Bipolar cells: 9.8;Cardiomyocytes: 7.3;Cholangiocytes: 10.2;Club cells: 6.8" "Group enriched" "Detected in some" 5 "glioma: 3.8;lung cancer: 1.6;pancreatic cancer: 2.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 2.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "THP-1: 53.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051834, HPA054847" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA051834: AB_2681629, HPA054847: " "unprognostic (7.14e-2)" "unprognostic (1.22e-1)" "unprognostic (3.72e-2)" "unprognostic (1.43e-7)" "unprognostic (1.99e-1)" "unprognostic (2.87e-2)" "unprognostic (5.83e-3)" "unprognostic (8.92e-2)" "unprognostic (5.02e-2)" "unprognostic (2.30e-2)" "unprognostic (7.71e-2)" "unprognostic (7.22e-2)" "unprognostic (1.74e-2)" "unprognostic (1.66e-1)" "unprognostic (5.43e-2)" "unprognostic (2.53e-3)" "unprognostic (1.32e-1)" 1.6 2.7 31.3 1.8 29.2 2.0 1.4 15.9 56.1 1.5 1.9 20.0 0.0 2.1 1.3 2.0 2.8 1.4 3.3 3.0 27.3 14.6 2.0 2.1 5.3 1.4 28.3 19.4 6.9 1.5 1.4 0.5 1.9 21.3 1.4 1.8 0.0 1.3 1.3 1.4 2.6 2.1 1.5 25.4 8.0 1.8 1.8 29.8 0.0 1.4 0.0 1.4 1.6 0.0 0.0 2.5 0.1 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.8 0.0 0.0 0.0 10.4 0.0 0.7 2.7 0.0 0.0 0.0 0.0 0.0 53.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 31.3 29.2 15.9 34.1 27.3 14.6 28.3 19.4 21.3 29.8 11.9 0.3 0.0 1.0 0.6 9.8 7.3 10.2 1.4 6.8 3.5 0.0 0.0 1.7 0.1 0.9 0.1 0.0 0.0 0.0 0.0 1.1 1.9 0.0 0.0 0.2 4.8 1.2 4.3 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.8 1.8 0.0 0.0 0.0 1.6 0.0 0.7 0.0 0.7 0.4 0.0 0.0 0.8 3.0 PHAX "FLJ13193, RNUXA" ENSG00000164902 "Phosphorylated adaptor for RNA export" Q9H814 5 126600268-126627252 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059630, HPA070326" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059630: AB_2684088, HPA070326: AB_2686253" "unprognostic (1.06e-3)" "unprognostic (4.77e-2)" "unprognostic (1.35e-2)" "unprognostic (2.64e-2)" "unprognostic (6.11e-2)" "unprognostic (1.22e-1)" "unprognostic (4.59e-3)" "unprognostic (9.20e-2)" "unprognostic (1.41e-1)" "unprognostic (1.43e-2)" "unprognostic (2.07e-1)" "unprognostic (2.29e-1)" "unprognostic (4.91e-3)" "unprognostic (7.21e-2)" "unprognostic (1.32e-1)" "unprognostic (2.13e-2)" "unprognostic (3.07e-2)" 3.9 4.9 7.9 3.2 7.6 1.5 4.2 8.9 8.2 3.7 3.2 2.1 4.9 3.9 4.8 4.2 3.6 5.0 7.2 6.5 3.8 4.0 3.1 5.2 6.9 6.6 3.5 4.6 3.0 3.5 4.5 3.0 3.5 3.2 5.7 5.7 2.3 4.3 6.6 3.2 2.9 2.5 4.6 5.3 3.8 3.0 10.4 8.2 8.8 7.2 13.1 11.2 6.6 9.6 9.7 8.6 16.9 12.6 12.5 12.3 13.8 10.2 11.3 10.7 13.7 9.8 9.7 12.6 17.5 13.9 7.9 12.2 18.9 16.6 15.8 13.3 8.1 11.4 5.5 7.5 6.6 9.0 12.3 10.6 11.2 10.1 10.6 9.6 5.5 6.5 11.4 17.3 8.3 9.3 8.4 11.0 6.5 8.1 7.6 12.2 8.0 10.5 11.4 11.5 13.1 12.2 10.9 14.1 8.8 14.3 9.4 15.0 19.2 10.8 10.6 20.8 8.9 8.4 11.0 13.7 11.2 13.8 8.8 6.3 8.1 9.6 7.2 10.9 10.4 9.5 9.9 6.2 9.5 10.8 11.2 5.3 13.1 7.2 8.2 8.0 6.6 23.8 31.5 43.5 29.2 25.3 57.1 47.0 15.3 76.3 38.7 33.2 37.3 44.7 63.0 45.9 31.1 34.6 15.3 0.0 29.2 41.6 31.9 25.6 45.1 25.4 26.2 71.5 26.4 21.5 16.8 8.7 38.9 26.7 20.3 55.1 22.5 88.5 34.5 22.8 38.9 39.8 65.9 45.3 24.7 51.1 80.1 22.6 43.0 27.7 23.4 25.1 PHC1 "EDR1, HPH1, RAE28" ENSG00000111752 "Polyhomeotic homolog 1" P78364 12 8913896-8941467 "Disease related genes, Predicted intracellular proteins" "Developmental protein, DNA-binding" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 37.6" "Cancer enriched" "Detected in many" 7 "testis cancer: 32.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 5 "BEWO: 31.7;NTERA-2: 114.0;SuSa: 41.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006973 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA006973: AB_1855278" "unprognostic (4.00e-2)" "unprognostic (1.79e-1)" "unprognostic (2.57e-1)" "unprognostic (1.73e-1)" "unprognostic (4.21e-3)" "unprognostic (7.46e-2)" "unprognostic (1.33e-1)" "unprognostic (1.59e-1)" "unprognostic (2.52e-1)" "unprognostic (1.47e-1)" "unprognostic (4.79e-3)" "unprognostic (1.69e-1)" "unprognostic (1.34e-2)" "unprognostic (7.55e-2)" "unprognostic (2.47e-1)" "unprognostic (9.27e-2)" "unprognostic (3.63e-2)" 7.9 10.0 23.5 12.1 27.7 4.4 9.6 37.1 20.7 15.0 11.9 10.6 19.9 4.9 23.3 11.1 12.6 18.4 12.2 11.0 18.4 10.2 11.0 3.0 10.8 11.1 9.8 20.6 23.5 10.2 26.2 34.5 10.3 13.9 14.2 7.1 18.3 15.5 16.3 8.0 4.0 8.2 17.1 9.1 9.9 9.2 26.5 12.3 7.8 18.9 5.5 10.5 11.5 13.5 2.4 2.9 1.5 5.9 2.1 3.8 1.9 1.4 2.7 10.5 9.6 3.0 3.3 31.7 1.4 3.0 2.6 3.4 1.4 2.3 3.7 1.2 2.4 3.8 1.1 2.8 3.4 3.2 12.3 1.6 4.9 2.6 1.6 3.5 2.4 8.4 4.1 2.1 4.2 4.1 7.9 3.0 4.2 0.9 1.3 2.7 1.6 3.5 4.2 114.0 0.5 0.7 5.1 6.7 0.1 2.6 5.5 1.9 6.9 2.2 5.2 3.7 41.2 0.7 2.5 1.8 4.4 7.5 3.0 2.0 2.6 1.6 5.3 2.1 1.3 3.1 1.5 0.5 0.0 2.1 2.5 1.3 2.4 3.5 3.8 0.3 2.4 3.1 2.5 0.1 2.1 5.9 2.9 1.9 1.9 23.5 27.7 37.1 20.7 18.4 10.2 9.8 20.6 13.9 12.3 14.9 20.3 1.7 4.9 2.2 21.8 0.4 10.2 20.1 20.5 8.7 25.5 4.9 1.7 4.7 19.5 9.0 0.5 0.0 4.5 9.0 6.9 5.1 18.5 1.7 3.8 15.9 10.9 7.4 2.5 14.4 13.3 3.4 6.8 1.8 2.2 16.3 4.7 2.3 11.3 4.7 37.6 0.0 6.6 13.5 23.0 2.0 4.2 6.9 1.1 4.1 PHC2 "EDR2, HPH2" ENSG00000134686 "Polyhomeotic homolog 2" Q8IXK0 1 33323623-33431052 "Predicted intracellular proteins" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 12 "neutrophil: 37.3" "Lineage enriched" "Detected in many" 13 "granulocytes: 37.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047403 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA047403: AB_10964220" "unprognostic (8.58e-3)" "unprognostic (2.10e-1)" "unprognostic (9.51e-2)" "unprognostic (3.69e-1)" "unprognostic (2.00e-1)" "unprognostic (2.77e-1)" "prognostic unfavorable (2.28e-6)" "unprognostic (1.04e-1)" "unprognostic (2.40e-1)" "unprognostic (7.91e-2)" "unprognostic (3.08e-1)" "unprognostic (1.85e-1)" "prognostic unfavorable (2.35e-4)" "unprognostic (2.16e-1)" "unprognostic (1.57e-1)" "unprognostic (3.65e-2)" "unprognostic (1.72e-1)" 58.8 32.6 16.9 32.5 30.5 27.9 38.7 22.8 25.6 28.4 31.0 32.4 20.0 16.6 31.5 19.4 27.9 27.9 32.1 49.8 19.3 16.7 46.5 52.6 46.3 45.5 36.6 13.5 32.4 32.9 18.4 24.0 29.5 28.0 25.4 18.5 37.9 23.7 31.1 90.9 21.8 20.0 39.4 28.1 47.9 30.7 25.9 31.9 24.3 43.6 12.3 17.8 45.3 25.6 0.6 1.5 37.3 2.9 0.7 1.1 0.8 11.2 7.4 32.3 12.3 34.0 39.1 9.6 11.2 24.5 15.6 17.2 4.6 25.3 10.1 9.5 17.6 12.7 6.0 6.4 19.2 15.2 4.8 5.8 6.7 3.6 11.6 52.5 8.2 6.5 63.7 11.9 28.1 22.3 29.9 20.6 9.8 5.9 7.7 40.7 4.6 17.8 8.4 7.3 19.2 21.6 20.3 13.4 5.6 28.6 8.5 19.7 18.1 8.7 8.8 44.2 14.2 4.4 10.6 20.4 15.6 7.9 13.3 21.0 5.4 3.7 7.6 37.3 8.7 42.9 3.1 2.6 1.2 0.8 2.5 0.7 0.6 0.9 0.7 1.3 0.5 1.1 0.6 37.3 0.7 2.9 1.5 0.6 0.8 16.9 30.5 22.8 25.6 19.3 16.7 36.6 13.5 28.0 31.9 14.9 11.5 7.5 25.5 12.6 66.5 26.6 7.6 9.4 11.4 33.2 64.8 9.4 14.9 29.6 50.7 26.3 10.9 0.0 37.8 7.7 14.4 19.3 5.8 45.0 19.5 58.8 36.1 56.4 64.7 50.1 27.0 29.7 20.3 3.6 21.9 52.1 60.6 14.4 28.0 23.7 74.9 12.9 21.3 10.7 7.0 9.5 9.6 8.7 15.7 26.5 PHC3 "EDR3, FLJ12729, FLJ12967, HPH3" ENSG00000173889 "Polyhomeotic homolog 3" Q8NDX5 3 170086732-170181749 "Predicted intracellular proteins" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Rod photoreceptor cells: 131.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039162, HPA062031" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA039162: AB_10671038, HPA062031: AB_2684666" "unprognostic (4.57e-2)" "unprognostic (1.03e-1)" "unprognostic (2.60e-1)" "unprognostic (4.85e-3)" "unprognostic (2.48e-1)" "unprognostic (1.18e-1)" "unprognostic (5.04e-2)" "unprognostic (1.19e-2)" "unprognostic (8.71e-2)" "unprognostic (2.28e-1)" "unprognostic (1.34e-3)" "unprognostic (3.26e-2)" "unprognostic (3.70e-1)" "unprognostic (1.54e-1)" "unprognostic (1.92e-1)" "unprognostic (9.58e-3)" "unprognostic (2.76e-2)" 17.9 11.7 12.0 13.1 19.2 50.9 17.4 28.2 16.7 14.9 16.1 18.8 13.8 12.8 19.1 10.1 14.6 14.4 15.0 14.2 14.8 7.6 12.0 11.2 18.7 19.2 15.4 11.7 19.0 13.5 23.3 26.3 11.5 14.7 15.4 13.3 19.1 18.4 16.0 17.3 15.9 17.0 20.4 16.5 15.0 16.0 14.6 17.7 16.4 19.2 8.6 17.1 20.9 15.4 15.7 19.7 18.6 8.7 8.9 14.5 5.3 16.9 16.0 3.5 5.8 9.9 10.2 6.5 7.2 8.1 7.5 9.4 10.6 8.5 8.1 17.8 10.1 10.0 8.5 7.6 6.9 13.5 18.6 7.1 13.7 14.4 4.8 5.9 17.0 7.5 7.3 4.1 11.2 15.9 5.4 5.6 6.3 3.3 22.6 6.9 15.6 7.8 3.6 3.6 5.4 6.0 5.8 15.0 11.6 3.8 19.1 3.8 2.3 24.0 15.1 5.0 2.3 17.4 13.2 11.1 10.4 6.3 8.6 12.4 21.8 17.6 23.8 6.6 6.5 6.3 6.6 5.5 18.6 12.7 8.7 10.7 13.1 12.3 11.1 5.9 15.7 12.7 11.2 7.5 8.9 5.4 19.7 14.5 5.3 12.0 19.2 28.2 16.7 14.8 7.6 15.4 11.7 14.7 17.7 20.8 26.4 22.3 15.2 12.6 33.3 19.6 20.4 21.4 19.4 26.2 56.9 12.6 0.0 6.9 4.8 19.6 11.4 23.3 6.4 8.0 18.8 19.0 12.7 13.4 9.8 50.9 7.5 17.8 14.8 2.7 27.3 20.3 18.6 11.8 13.9 21.0 9.1 19.0 26.2 8.2 131.7 6.5 19.8 19.1 19.0 13.9 15.3 30.6 12.9 14.3 PHF1 "MTF2L2, PCL1, TDRD19C" ENSG00000112511 "PHD finger protein 1" O43189 6 33410399-33416453 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 144.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 16.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031038 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA031038: AB_10671365" "unprognostic (1.96e-3)" "unprognostic (4.77e-2)" "prognostic unfavorable (9.64e-5)" "unprognostic (1.66e-1)" "unprognostic (4.71e-2)" "unprognostic (2.43e-3)" "unprognostic (2.31e-2)" "unprognostic (8.87e-3)" "unprognostic (1.41e-1)" "unprognostic (1.97e-1)" "unprognostic (2.42e-3)" "unprognostic (4.25e-2)" "unprognostic (1.21e-1)" "unprognostic (2.48e-2)" "unprognostic (1.29e-1)" "unprognostic (1.90e-1)" "prognostic favorable (1.72e-4)" 10.7 10.2 12.0 15.5 15.2 23.5 29.0 14.2 12.5 29.7 14.6 9.4 26.4 11.0 18.2 30.7 10.0 16.3 18.3 15.4 13.2 13.3 13.0 10.5 19.7 16.7 16.9 12.0 31.5 24.9 21.1 26.6 7.7 14.6 16.9 6.2 14.6 17.6 28.5 12.9 7.7 12.1 18.9 12.3 18.8 12.7 26.7 12.8 5.0 22.4 9.3 21.3 20.7 29.2 1.5 0.5 3.2 0.4 1.1 4.6 0.9 1.5 2.1 4.8 3.1 2.1 1.2 9.6 3.3 5.2 2.5 2.8 2.9 1.4 0.6 2.0 7.8 16.8 0.5 1.0 1.7 0.6 1.9 1.0 4.5 3.5 1.3 0.4 2.6 11.2 2.5 2.2 4.9 4.4 3.7 1.6 1.6 1.7 3.9 2.0 1.2 0.8 1.6 1.7 0.4 1.5 1.9 0.6 1.6 0.3 2.0 3.2 3.4 1.7 1.8 2.7 0.9 1.3 3.2 3.1 5.0 1.4 2.9 3.5 2.6 4.3 5.2 3.6 2.8 2.9 0.2 0.3 0.7 1.4 0.4 4.6 1.2 2.8 3.5 0.5 1.5 3.3 1.7 3.2 1.1 0.4 0.3 0.9 0.9 12.0 15.2 14.2 12.5 13.2 13.3 16.9 12.0 14.6 12.8 17.9 22.7 25.1 75.0 30.1 69.3 17.0 2.5 12.0 10.3 22.7 35.3 14.3 29.9 11.6 144.2 27.0 13.3 0.0 15.8 11.3 18.6 51.5 69.1 6.2 10.6 42.9 11.5 27.6 8.6 57.2 40.0 15.1 35.4 13.6 13.8 32.4 13.9 11.2 38.5 20.3 62.8 77.6 51.5 61.1 42.1 21.0 31.4 46.8 9.6 66.3 PHF10 "BAF45a, FLJ10975, XAP135" ENSG00000130024 "PHD finger protein 10" Q8WUB8 6 169703905-169725566 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055649 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA055649: AB_2682875" "unprognostic (1.74e-2)" "unprognostic (1.48e-1)" "unprognostic (1.40e-2)" "unprognostic (4.25e-2)" "unprognostic (4.45e-2)" "unprognostic (6.76e-3)" "prognostic unfavorable (3.42e-4)" "unprognostic (1.28e-1)" "unprognostic (1.11e-1)" "unprognostic (2.48e-1)" "prognostic favorable (1.12e-5)" "unprognostic (5.92e-2)" "prognostic unfavorable (1.56e-5)" "unprognostic (2.63e-1)" "unprognostic (6.82e-2)" "unprognostic (2.43e-1)" "unprognostic (2.76e-2)" 19.2 34.3 19.9 21.2 39.0 18.7 19.8 18.3 22.4 17.1 20.8 23.1 26.1 12.9 16.7 17.0 26.5 17.9 21.6 20.1 23.2 10.5 18.6 27.9 20.3 23.3 35.3 13.1 33.5 23.6 25.8 22.1 17.7 28.5 22.1 14.6 21.6 22.2 19.8 30.0 23.1 20.3 23.8 29.0 27.0 21.7 23.3 28.3 26.9 23.0 13.6 24.4 22.7 33.5 4.8 3.0 6.3 3.3 2.4 6.2 1.8 8.8 8.9 35.7 37.3 12.5 7.6 14.7 12.1 11.0 15.0 16.5 25.8 9.3 26.3 7.4 8.4 9.5 11.3 27.4 13.2 21.8 21.0 24.4 26.2 15.7 33.6 12.8 38.2 1.6 5.7 13.9 9.6 8.9 24.9 23.6 19.0 29.0 17.1 10.7 15.2 7.2 32.9 11.2 19.7 5.6 34.7 25.3 21.1 18.6 9.5 17.1 22.8 16.5 5.5 11.8 15.6 10.8 45.9 15.8 8.5 14.3 10.8 15.3 15.2 12.9 32.8 11.1 25.7 13.5 3.0 3.0 6.3 3.4 3.2 3.3 4.8 6.0 4.8 3.0 4.2 5.9 6.2 0.5 2.4 3.3 2.8 3.7 1.8 19.9 39.0 18.3 22.4 23.2 10.5 35.3 13.1 28.5 28.3 23.8 26.7 23.0 19.5 26.6 11.6 51.3 40.8 18.7 27.3 10.4 39.3 11.2 11.6 11.6 10.8 27.7 12.3 0.0 11.1 7.8 24.4 23.2 5.8 23.7 10.0 11.1 24.9 23.9 10.0 6.1 20.8 11.8 18.6 5.4 23.0 27.0 14.2 19.5 19.8 9.5 24.7 19.4 41.5 16.3 19.4 20.6 14.5 15.0 18.0 25.0 PHF11 "BCAP, IGER, NY-REN-34" ENSG00000136147 "PHD finger protein 11" Q9UIL8 13 49495610-49528987 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA016566, HPA016708" Uncertain Supported "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA016566: AB_2669387, HPA016708: AB_1855286" "unprognostic (1.65e-2)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" "prognostic favorable (7.98e-6)" "unprognostic (3.49e-3)" "unprognostic (6.29e-2)" "unprognostic (5.50e-2)" "unprognostic (6.91e-2)" "unprognostic (3.05e-2)" "unprognostic (1.64e-1)" "unprognostic (2.37e-1)" "unprognostic (8.48e-2)" "prognostic unfavorable (4.46e-7)" "unprognostic (9.81e-2)" "unprognostic (5.36e-3)" "unprognostic (1.05e-1)" "prognostic favorable (3.46e-4)" 25.2 32.3 16.8 37.8 23.7 23.3 27.6 6.1 18.8 18.9 20.6 18.0 13.7 17.8 22.0 21.5 19.4 17.2 22.9 19.5 15.2 17.9 22.4 17.1 20.7 38.0 23.3 12.5 19.2 23.1 10.1 13.6 20.8 18.0 21.4 16.2 12.7 27.1 20.5 11.3 19.2 23.1 32.1 22.9 31.3 20.0 9.7 22.2 37.1 25.7 17.8 28.1 25.8 20.3 21.4 20.7 26.2 27.0 14.4 39.3 21.7 5.4 2.2 0.8 0.0 11.4 21.9 7.0 13.2 15.2 19.1 20.3 0.0 13.2 13.3 3.7 14.9 12.7 3.8 4.9 4.6 11.4 26.9 4.1 6.5 4.5 5.8 14.2 4.7 10.3 13.1 7.3 7.7 4.3 7.8 12.2 11.0 1.3 5.9 14.3 4.4 15.0 11.2 2.6 3.6 1.5 14.6 0.0 4.0 17.3 10.1 0.4 0.1 3.5 7.5 0.2 1.1 4.4 10.9 10.8 4.7 1.8 6.6 3.7 4.2 2.1 8.2 9.6 6.8 7.0 13.9 22.3 15.2 23.7 27.0 27.4 21.4 30.3 27.9 20.7 19.3 25.0 27.4 26.2 14.4 24.4 18.0 39.3 21.7 16.8 23.7 6.1 18.8 15.2 17.9 23.3 12.5 18.0 22.2 14.9 26.6 29.9 32.1 20.0 4.6 15.9 17.8 75.0 39.8 34.9 0.0 21.7 29.9 37.6 24.6 32.1 14.7 0.0 36.8 38.1 24.5 26.5 22.1 21.2 37.5 11.1 4.1 28.8 37.5 36.9 29.7 37.9 11.8 57.7 13.3 15.1 36.6 8.6 29.7 21.9 4.2 45.3 27.0 9.1 2.8 17.7 17.6 41.7 11.2 29.2 PHF12 "KIAA1523, PF1" ENSG00000109118 "PHD finger protein 12" Q96QT6 17 28905250-28951771 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 25.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 25.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021410, HPA021452" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021410: AB_1855287, HPA021452: AB_2670708" "unprognostic (9.50e-2)" "unprognostic (2.67e-1)" "unprognostic (2.11e-2)" "unprognostic (1.21e-2)" "unprognostic (2.81e-1)" "unprognostic (1.46e-2)" "unprognostic (1.69e-2)" "unprognostic (3.10e-2)" "unprognostic (8.73e-2)" "unprognostic (5.38e-2)" "unprognostic (1.02e-3)" "unprognostic (6.71e-2)" "prognostic unfavorable (1.24e-5)" "unprognostic (2.16e-2)" "unprognostic (3.11e-1)" "unprognostic (3.24e-1)" "unprognostic (1.08e-3)" 14.0 12.0 16.7 16.5 17.9 38.4 15.6 30.7 18.4 17.1 17.4 18.5 25.4 13.2 21.0 16.4 11.4 18.1 16.1 11.3 13.0 10.5 14.2 14.8 17.2 17.7 18.6 15.2 20.7 20.3 18.6 18.7 12.2 14.0 23.4 12.9 18.9 16.6 24.5 15.6 16.5 18.0 16.2 10.2 25.2 15.4 17.5 18.2 22.1 18.9 7.3 18.0 19.2 16.6 4.5 4.9 25.6 2.7 3.5 4.3 1.5 10.2 16.4 22.5 13.5 13.7 9.8 10.6 10.1 14.9 15.5 14.9 10.9 9.6 11.4 12.6 11.6 12.7 10.6 14.4 8.5 15.1 18.9 15.6 12.0 18.2 8.6 12.4 12.9 15.0 10.8 9.3 14.2 13.1 14.6 11.1 14.9 10.2 11.9 9.7 10.5 24.6 17.5 13.1 22.0 7.3 24.2 18.5 11.3 10.3 12.6 15.3 13.2 15.1 24.1 12.1 12.3 13.1 18.3 6.7 12.9 11.9 12.4 12.0 14.8 13.1 13.4 9.9 10.1 13.2 9.6 2.7 3.9 3.9 2.2 3.9 2.7 3.1 4.3 1.5 4.5 3.0 3.3 25.6 3.5 2.4 4.9 1.7 1.5 16.7 17.9 30.7 18.4 13.0 10.5 18.6 15.2 14.0 18.2 14.9 7.5 13.3 7.2 13.6 20.8 5.9 7.6 4.0 13.6 3.5 13.7 6.2 1.7 7.6 7.2 14.3 7.8 0.0 9.1 6.3 8.7 17.0 13.9 9.6 8.0 23.8 10.3 16.0 11.3 4.1 15.8 11.6 11.8 17.2 15.4 12.3 8.3 7.0 15.6 3.8 21.0 25.8 11.8 14.4 11.1 14.3 5.0 17.5 9.8 11.9 PHF14 KIAA0783 ENSG00000106443 "PHD finger protein 14" O94880 7 10973336-11169630 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000538, HPA017376" Supported Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA000538: AB_1079604, HPA017376: AB_2732420" "unprognostic (1.16e-1)" "unprognostic (3.17e-1)" "unprognostic (3.73e-3)" "unprognostic (7.38e-3)" "unprognostic (8.05e-2)" "unprognostic (3.38e-1)" "unprognostic (4.66e-3)" "unprognostic (1.80e-1)" "unprognostic (5.32e-3)" "unprognostic (6.76e-2)" "unprognostic (2.94e-2)" "unprognostic (3.10e-1)" "unprognostic (4.84e-3)" "unprognostic (1.24e-1)" "unprognostic (2.30e-2)" "unprognostic (1.87e-2)" "unprognostic (2.33e-1)" 12.5 10.9 25.0 12.4 20.4 6.4 18.4 21.4 23.8 14.0 12.7 10.7 7.2 10.3 17.9 11.0 10.6 12.4 12.6 7.7 24.7 22.1 12.2 14.8 11.3 12.0 18.5 15.5 20.2 9.8 18.4 21.4 11.0 20.0 13.9 14.3 7.1 10.0 11.5 9.3 11.3 10.1 14.9 16.2 12.9 13.3 12.0 14.9 31.5 12.7 7.6 12.9 11.9 10.6 3.9 5.8 1.6 2.0 3.4 4.6 0.8 6.7 14.1 20.7 21.4 7.3 7.1 9.9 5.3 4.5 6.5 7.1 12.5 12.2 26.4 9.8 5.0 14.3 9.5 18.4 6.3 7.1 9.5 7.0 13.0 12.5 16.3 6.7 28.8 12.4 6.4 6.8 7.5 13.8 9.0 9.3 10.4 17.2 9.4 7.7 8.7 11.4 12.8 17.3 28.2 10.1 19.3 13.3 8.3 6.7 13.2 18.5 26.0 8.2 28.0 8.9 15.4 14.9 21.2 8.5 9.0 12.0 5.7 10.3 12.1 20.9 18.5 6.3 24.5 21.1 1.6 2.0 1.2 2.9 1.8 2.3 3.9 3.2 3.7 1.2 3.4 4.6 3.8 0.1 3.4 1.6 5.8 4.1 0.8 25.0 20.4 21.4 23.8 24.7 22.1 18.5 15.5 20.0 14.9 38.7 34.5 48.8 62.8 51.1 77.9 19.4 30.6 36.1 53.4 31.4 55.0 57.8 23.2 78.4 17.7 69.7 43.4 0.0 73.0 66.3 61.3 43.8 56.4 39.4 36.4 74.7 88.5 58.9 35.9 9.5 95.3 36.0 35.4 30.7 59.7 49.5 75.4 42.1 110.0 27.0 64.0 51.8 48.4 133.9 124.4 45.8 33.3 30.5 59.7 46.9 PHF2 "CENP-35, JHDM1E, KDM7C, KIAA0662" ENSG00000197724 "PHD finger protein 2" O75151 9 93576407-93679587 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 13 "Early spermatids: 142.5;Late spermatids: 473.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010831 Approved Supported "Nucleoplasm,Nucleoli rim" Yes No "Nucleoli rim" Nucleoplasm "HPA010831: AB_1855294" "unprognostic (9.42e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (9.34e-4)" "unprognostic (1.30e-1)" "unprognostic (2.79e-1)" "unprognostic (1.40e-1)" "unprognostic (2.44e-1)" "unprognostic (8.48e-2)" "unprognostic (1.07e-1)" "unprognostic (5.89e-2)" "unprognostic (7.63e-2)" "unprognostic (1.49e-1)" "prognostic favorable (1.12e-5)" "unprognostic (1.11e-1)" "unprognostic (2.20e-1)" "unprognostic (2.17e-1)" "unprognostic (4.19e-2)" 16.8 14.6 17.4 17.7 22.2 16.7 23.2 33.1 19.0 19.8 18.1 27.8 18.6 11.3 22.0 15.9 14.5 18.4 16.7 19.1 15.3 14.5 10.8 9.3 17.8 20.7 23.1 15.6 27.1 18.5 22.6 21.7 17.6 16.6 18.6 10.6 16.9 19.0 21.9 27.8 21.4 13.3 24.9 18.5 21.4 15.9 9.6 18.2 19.8 18.8 12.0 12.1 16.4 32.5 2.5 3.8 5.0 2.6 1.0 4.0 2.2 9.3 7.8 16.4 13.4 10.5 8.2 8.5 7.4 9.9 10.7 7.7 3.6 5.5 6.7 5.5 9.5 9.6 18.3 10.3 7.1 5.7 17.9 6.8 5.4 8.9 5.6 9.4 10.6 18.6 8.2 12.3 5.0 8.5 10.5 8.5 10.3 7.8 11.5 7.4 20.6 20.2 11.8 4.3 16.3 6.8 22.8 12.7 2.6 6.8 11.8 21.6 10.7 7.7 12.7 6.7 5.0 8.5 18.7 9.9 10.2 8.8 11.1 10.5 9.3 1.5 5.0 5.6 6.5 11.4 1.1 2.6 2.5 3.3 1.4 3.1 1.8 3.3 2.1 2.7 2.5 3.6 4.0 5.0 1.0 2.0 3.8 1.9 2.2 17.4 22.2 33.1 19.0 15.3 14.5 23.1 15.6 16.6 18.2 14.9 13.6 5.1 5.8 6.8 13.9 13.8 5.1 18.7 20.5 5.2 7.9 6.2 0.0 5.3 142.5 12.0 4.9 23.3 4.9 3.1 8.5 7.5 16.2 6.8 4.9 9.5 15.6 8.0 11.1 473.2 18.4 7.6 3.3 1.8 7.9 9.9 5.2 2.9 19.1 3.0 7.5 19.4 10.3 1.4 2.5 6.9 5.0 7.0 7.0 7.2 PHF20 "C20orf104, dJ1121G12.1, TDRD20A" ENSG00000025293 "PHD finger protein 20" Q9BVI0 20 35771974-35950381 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 349.5;Late spermatids: 510.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029619, HPA029620, HPA029621" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA029619: AB_10600090, HPA029620: AB_10601110, HPA029621: AB_10602201" "unprognostic (1.21e-3)" "unprognostic (7.30e-2)" "unprognostic (3.20e-2)" "unprognostic (2.35e-3)" "unprognostic (1.36e-1)" "unprognostic (1.95e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (2.76e-1)" "unprognostic (2.17e-1)" "unprognostic (2.64e-2)" "unprognostic (4.59e-2)" "unprognostic (1.09e-1)" "unprognostic (1.92e-2)" "unprognostic (1.17e-1)" "unprognostic (1.07e-1)" "unprognostic (7.23e-2)" "unprognostic (1.01e-2)" 19.1 11.6 14.0 16.8 19.0 14.1 17.2 25.1 19.2 15.9 15.9 16.1 8.1 8.1 19.1 11.6 16.5 14.2 14.8 15.2 14.1 13.8 11.2 11.1 16.5 17.3 14.9 13.0 18.9 9.4 17.9 20.0 15.6 15.0 14.7 11.7 14.7 15.3 15.7 46.6 12.9 12.3 17.2 18.9 20.8 12.7 17.4 15.2 19.4 14.2 14.5 20.8 18.7 21.8 12.0 8.2 23.6 11.9 13.0 12.4 6.5 9.7 7.8 13.7 20.3 10.0 11.5 12.8 11.2 10.7 11.3 9.9 22.8 7.4 16.4 10.2 14.9 13.9 6.1 12.6 15.6 13.8 7.4 5.4 30.5 15.0 8.4 10.0 14.6 11.9 9.0 22.0 11.9 18.4 13.4 12.3 11.7 12.5 10.6 12.9 5.8 14.7 8.5 6.8 6.5 9.8 10.8 20.3 9.7 9.0 6.8 12.5 10.2 20.0 23.2 10.2 13.0 18.3 10.9 17.2 25.1 5.7 13.0 11.4 9.8 11.6 12.0 18.5 10.7 12.8 11.9 8.6 23.6 10.6 9.0 11.3 12.0 10.5 11.9 8.2 9.8 12.0 12.4 20.5 13.0 11.9 7.7 5.5 6.5 14.0 19.0 25.1 19.0 14.1 13.8 14.9 13.0 15.0 15.2 35.7 39.9 77.0 65.2 30.9 75.5 47.0 30.6 57.6 40.9 36.6 92.3 85.9 31.5 25.8 349.5 40.9 11.8 0.0 17.4 39.0 36.8 47.3 136.5 15.3 46.9 108.1 34.5 39.3 53.1 510.4 33.1 60.9 37.1 31.5 24.9 44.2 20.8 25.7 50.2 19.5 75.2 19.4 39.6 55.4 46.4 24.7 18.7 82.0 29.0 53.3 PHF20L1 "CGI-72, FLJ13649, FLJ21615, MGC64923, TDRD20B" ENSG00000129292 "PHD finger protein 20 like 1" A8MW92 8 132775358-132848807 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025060, HPA028417" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA025060: AB_10599822, HPA028417: AB_10602278" "unprognostic (9.12e-3)" "unprognostic (2.29e-1)" "unprognostic (2.77e-1)" "unprognostic (2.10e-3)" "unprognostic (1.25e-1)" "unprognostic (1.51e-1)" "unprognostic (2.79e-2)" "unprognostic (7.53e-2)" "unprognostic (9.66e-2)" "unprognostic (1.24e-2)" "unprognostic (8.85e-2)" "unprognostic (1.19e-1)" "unprognostic (1.70e-2)" "unprognostic (1.58e-1)" "unprognostic (1.78e-1)" "unprognostic (2.24e-2)" "unprognostic (7.83e-2)" 14.5 19.9 15.3 15.7 26.6 27.1 17.6 22.2 22.0 15.7 14.2 12.6 11.7 11.6 17.6 13.0 16.0 12.4 13.6 22.5 15.9 10.5 13.6 16.4 12.9 13.5 11.8 14.8 16.9 12.7 22.4 18.6 15.1 12.9 13.1 12.9 10.0 14.9 14.6 27.0 9.5 12.9 14.5 12.9 15.4 12.8 15.9 13.7 38.9 28.5 9.2 14.7 14.7 16.9 2.4 4.0 14.7 4.3 3.0 3.4 1.6 10.1 10.2 16.7 9.6 13.1 15.7 6.0 14.9 11.7 10.3 10.1 5.7 7.0 11.6 13.1 14.9 8.9 6.0 11.3 7.9 12.8 19.5 8.0 12.5 12.1 4.0 13.8 9.9 8.9 11.7 9.9 10.7 16.0 10.0 11.3 18.6 15.3 18.3 15.3 10.1 32.3 4.4 7.4 11.6 13.6 15.8 11.2 10.0 8.4 8.8 41.5 12.1 9.5 6.8 12.0 7.3 13.3 11.3 14.7 16.7 13.4 10.9 14.2 10.9 14.2 14.9 14.8 17.6 14.8 3.7 4.3 7.5 2.5 2.5 2.5 2.2 2.3 2.9 4.0 2.4 3.4 2.7 14.7 3.0 3.8 3.3 2.6 1.6 15.3 26.6 22.2 22.0 15.9 10.5 11.8 14.8 12.9 13.7 23.8 45.9 43.8 43.6 29.9 53.6 77.9 17.8 29.4 46.6 34.9 41.2 23.1 19.9 33.0 47.6 43.8 33.8 23.3 27.3 24.9 37.5 35.9 58.9 30.1 32.0 50.9 42.0 35.6 44.0 39.6 37.2 48.6 21.9 31.5 24.8 47.4 32.7 24.1 40.3 22.0 52.6 45.3 42.3 61.6 42.6 31.7 37.6 42.1 22.2 54.3 PHF21A "BHC80, BM-006, KIAA1696" ENSG00000135365 "PHD finger protein 21A" Q96BD5 11 45929323-46121178 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 20.9" "Lineage enriched" "Detected in all" 4 "granulocytes: 20.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023253, HPA023580" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA023253: , HPA023580: AB_10962727" "unprognostic (5.30e-3)" "unprognostic (8.93e-2)" "prognostic unfavorable (6.15e-4)" "unprognostic (1.93e-2)" "unprognostic (1.05e-1)" "unprognostic (2.44e-2)" "prognostic unfavorable (1.66e-6)" "unprognostic (2.20e-2)" "unprognostic (3.10e-1)" "unprognostic (5.35e-2)" "unprognostic (1.25e-3)" "unprognostic (3.84e-1)" "prognostic unfavorable (2.59e-8)" "unprognostic (1.89e-1)" "unprognostic (1.97e-1)" "unprognostic (9.53e-2)" "unprognostic (1.21e-1)" 14.6 17.9 18.4 19.1 22.2 25.6 12.8 24.9 20.3 16.6 18.9 15.1 9.0 6.9 17.3 11.2 11.7 12.5 13.2 21.4 16.3 10.5 8.1 9.5 20.5 14.4 17.7 10.7 25.2 8.5 27.5 28.7 13.0 13.6 15.6 10.0 14.4 10.0 14.2 15.7 12.8 10.1 17.2 19.4 17.8 10.1 23.5 18.9 18.3 13.1 5.0 14.6 16.7 13.9 3.2 2.8 20.9 5.0 3.6 4.2 2.1 3.7 10.2 19.3 18.6 8.0 12.5 2.6 7.7 13.4 6.7 11.3 2.0 5.9 15.7 5.4 7.5 10.5 4.3 11.7 4.9 6.9 17.5 8.0 9.0 10.1 4.0 9.6 6.3 13.8 11.1 11.4 3.9 11.2 15.7 9.8 10.7 10.6 26.2 7.9 3.6 6.8 10.2 16.6 4.7 6.0 11.5 9.9 5.1 6.7 6.3 12.5 15.6 11.4 5.7 8.0 13.2 10.3 11.8 9.6 11.1 9.0 9.0 6.2 28.0 22.8 10.3 8.7 6.9 8.6 16.5 5.0 2.5 4.2 2.6 3.6 3.2 3.2 3.6 2.8 3.0 2.0 3.4 20.9 3.6 4.2 1.9 3.8 2.1 18.4 22.2 24.9 20.3 16.3 10.5 17.7 10.7 13.6 18.9 11.9 15.3 13.4 8.2 9.2 26.8 20.9 7.6 14.7 10.3 3.5 25.5 3.9 1.7 7.6 6.3 12.5 3.9 0.0 5.5 2.6 11.9 9.3 16.1 4.3 9.0 14.3 22.5 12.3 24.3 6.3 24.2 13.1 10.1 18.0 7.9 9.4 5.0 7.4 13.8 2.9 23.6 12.9 11.6 13.6 11.2 7.8 3.5 14.6 5.8 4.4 PHF21B "BHC80L, FLJ34161, PHF4" ENSG00000056487 "PHD finger protein 21B" Q96EK2 22 44881162-45009999 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.9" "Group enriched" "Detected in some" 5 "Bipolar cells: 12.5;Cone photoreceptor cells: 21.6;Early spermatids: 12.7;Horizontal cells: 27.0;Late spermatids: 30.5;Rod photoreceptor cells: 25.4" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.2;AN3-CA: 7.3;JURKAT: 6.4;NTERA-2: 5.2;SCLC-21H: 6.4;SH-SY5Y: 28.4;U-2 OS: 6.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA053834, HPA074665" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA053834: AB_2682276, HPA074665: " "unprognostic (1.04e-1)" "unprognostic (7.76e-2)" "unprognostic (2.00e-1)" "unprognostic (7.44e-2)" "unprognostic (1.37e-1)" "unprognostic (5.45e-2)" "unprognostic (1.68e-1)" "unprognostic (1.55e-1)" "unprognostic (3.83e-3)" "unprognostic (1.86e-3)" "unprognostic (2.02e-1)" "unprognostic (9.35e-2)" "unprognostic (2.27e-1)" "unprognostic (4.08e-2)" "unprognostic (1.22e-1)" 0.7 3.5 8.4 0.8 7.4 0.5 0.8 3.7 10.9 10.1 0.7 3.6 0.9 0.7 8.6 1.7 1.6 2.3 0.8 1.3 7.8 3.4 2.2 0.5 0.6 0.6 4.7 3.2 5.6 1.8 2.0 17.9 0.6 4.2 4.8 0.6 6.5 0.8 2.1 0.7 0.5 0.7 2.3 4.4 0.6 1.0 8.5 7.3 0.0 3.0 0.0 0.6 0.6 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 7.3 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 1.5 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.2 0.4 0.0 0.0 6.4 0.0 0.0 0.1 0.6 0.9 0.0 5.2 0.0 0.3 0.0 1.9 0.1 0.0 0.1 6.4 28.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.1 6.4 0.0 0.2 0.3 0.0 3.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 7.4 3.7 7.3 7.8 3.4 4.7 3.2 4.2 7.3 0.0 0.0 0.0 0.8 0.1 12.5 1.3 0.0 1.4 0.0 0.0 21.6 0.0 1.7 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 27.0 0.0 0.0 0.0 30.5 0.6 0.0 0.0 0.0 0.0 4.6 0.1 0.0 1.8 0.0 25.4 0.0 0.0 0.7 3.4 0.0 0.0 0.0 0.0 0.1 PHF23 "FLJ16355, MGC2941" ENSG00000040633 "PHD finger protein 23" Q9BUL5 17 7235028-7239722 "Disease related genes, Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052410 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA052410: AB_2681822" "unprognostic (1.76e-2)" "unprognostic (6.12e-2)" "unprognostic (4.72e-2)" "unprognostic (6.44e-3)" "unprognostic (1.50e-1)" "unprognostic (2.96e-2)" "unprognostic (2.41e-3)" "unprognostic (2.97e-1)" "unprognostic (1.17e-1)" "unprognostic (1.19e-1)" "unprognostic (2.67e-3)" "unprognostic (2.49e-1)" "unprognostic (1.12e-1)" "unprognostic (1.74e-1)" "unprognostic (4.40e-1)" "unprognostic (1.61e-1)" "unprognostic (3.48e-2)" 13.5 29.9 16.8 17.6 20.6 6.4 14.6 13.9 18.1 16.7 28.2 15.5 22.2 16.8 18.4 18.3 24.9 15.6 19.5 17.1 18.1 15.1 26.6 30.7 13.4 20.2 19.7 11.2 22.0 15.4 14.8 15.7 21.3 11.6 18.7 13.2 13.4 14.3 18.3 15.1 13.2 21.7 17.2 11.1 21.3 14.2 16.6 16.3 36.1 18.4 15.7 24.7 19.8 15.8 14.1 15.5 17.0 7.8 9.0 17.6 7.2 18.3 28.9 33.1 21.5 21.5 22.0 12.9 25.0 27.5 30.6 26.0 15.9 13.0 27.1 15.6 26.6 21.6 17.9 30.9 20.5 25.3 27.2 25.1 20.3 19.7 17.4 34.7 9.7 32.3 30.0 19.8 26.4 17.8 32.1 28.8 13.2 22.3 6.6 35.4 13.8 16.7 19.8 31.3 13.3 12.7 23.0 16.1 13.1 32.3 10.2 10.9 34.8 17.8 14.7 28.1 20.7 17.7 11.8 26.4 27.0 19.0 15.9 30.9 12.4 12.7 13.8 24.2 16.0 23.1 17.0 7.7 13.5 15.9 6.0 13.8 12.1 12.2 17.6 8.6 14.1 10.3 12.7 14.9 9.0 7.8 15.5 10.0 7.2 16.8 20.6 13.9 18.1 18.1 15.1 19.7 11.2 11.6 16.3 6.0 8.6 11.8 18.1 74.8 11.8 13.7 15.3 6.7 9.1 21.0 5.9 27.6 33.2 33.9 15.8 25.1 18.0 0.0 18.6 18.0 27.7 20.4 17.3 11.9 31.6 15.9 17.9 17.8 17.0 16.2 23.0 18.9 32.1 40.5 16.6 15.1 31.0 25.9 16.3 22.4 8.4 38.8 40.1 27.7 18.5 72.8 64.2 15.2 15.5 25.0 PHF3 ENSG00000118482 "PHD finger protein 3" Q92576 6 63635820-63779336 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024676, HPA025763" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA024676: AB_10599736, HPA025763: AB_10600987" "unprognostic (4.33e-1)" "unprognostic (2.16e-1)" "unprognostic (2.76e-2)" "unprognostic (2.00e-1)" "unprognostic (1.23e-2)" "unprognostic (2.89e-1)" "unprognostic (6.17e-2)" "unprognostic (1.44e-1)" "unprognostic (3.19e-2)" "unprognostic (1.76e-2)" "unprognostic (1.84e-2)" "unprognostic (2.43e-1)" "unprognostic (1.04e-2)" "unprognostic (2.30e-1)" "unprognostic (1.91e-1)" "unprognostic (2.65e-1)" "unprognostic (3.37e-1)" 23.7 19.6 17.1 22.9 20.0 33.0 23.5 44.4 19.4 32.6 23.5 9.4 21.9 14.9 22.7 23.4 18.8 16.9 15.9 16.2 19.1 13.3 19.5 26.7 21.0 21.5 20.0 18.5 34.1 17.4 30.3 43.5 23.0 18.7 25.6 17.5 8.5 19.1 21.5 24.5 19.4 19.2 18.1 26.8 21.9 17.1 16.8 24.9 36.3 26.0 12.9 16.9 30.5 26.6 10.3 7.5 16.2 11.5 5.5 12.2 4.5 19.4 9.4 16.3 9.5 16.5 17.5 16.0 12.8 18.4 9.6 13.0 13.0 9.1 23.8 11.1 11.4 14.0 8.6 15.6 13.5 16.2 18.9 12.7 28.5 12.1 20.6 14.7 24.3 11.6 12.6 12.1 13.7 19.7 17.2 11.2 12.8 31.0 22.5 9.8 11.5 10.3 13.0 9.2 12.7 5.8 18.2 14.6 11.3 11.6 11.6 17.5 13.0 15.4 6.9 11.4 18.6 11.9 22.5 15.7 14.9 17.7 11.3 15.2 19.0 19.8 22.8 6.8 19.5 11.4 14.4 6.8 7.3 9.0 8.9 8.9 8.4 8.5 7.0 6.0 10.3 12.2 8.9 16.2 5.5 11.5 7.5 5.9 4.5 17.1 20.0 44.4 19.4 19.1 13.3 20.0 18.5 18.7 24.9 145.9 104.5 56.7 61.6 48.8 64.2 90.4 33.1 103.1 129.7 43.6 45.2 38.2 13.3 36.1 24.3 50.4 43.4 23.3 32.7 26.7 39.3 56.1 97.4 41.4 24.8 47.7 41.3 30.7 43.8 20.2 75.1 40.6 21.9 35.1 41.1 50.4 28.8 39.5 53.4 29.6 63.6 58.2 33.0 87.4 63.1 37.5 26.1 46.8 42.8 35.3 PHF5A "bK223H9.2, INI, MGC1346, Rds3, SAP14b, SF3b14b, SF3B7" ENSG00000100410 "PHD finger protein 5A" Q7RTV0 22 41459717-41468725 "Predicted intracellular proteins, Transcription factors" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028885 Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA028885: AB_10602079" "unprognostic (4.38e-2)" "unprognostic (3.58e-1)" "unprognostic (2.12e-3)" "unprognostic (2.64e-2)" "unprognostic (1.07e-1)" "unprognostic (2.10e-2)" "prognostic unfavorable (3.02e-8)" "unprognostic (3.39e-3)" "unprognostic (3.97e-3)" "unprognostic (4.46e-2)" "unprognostic (6.95e-3)" "unprognostic (2.12e-1)" "unprognostic (5.25e-3)" "unprognostic (4.11e-2)" "unprognostic (1.75e-1)" "unprognostic (1.67e-1)" "unprognostic (6.91e-2)" 24.5 20.8 21.4 21.4 24.9 47.6 27.8 21.3 27.3 20.7 24.0 27.6 18.2 22.0 24.4 26.8 28.8 22.2 21.9 18.3 22.0 20.8 26.1 28.9 20.0 30.9 32.4 23.8 21.9 25.9 18.1 24.5 29.7 23.0 20.1 29.0 21.5 22.4 20.0 32.4 25.3 26.9 22.3 29.5 27.1 24.8 27.3 28.8 38.0 23.4 30.4 38.4 21.3 22.8 33.8 34.2 39.5 33.5 30.4 35.0 40.0 21.8 15.9 27.2 17.9 20.1 15.3 18.9 22.5 18.3 29.4 24.9 21.6 13.1 31.7 13.1 16.6 20.7 17.0 36.8 26.6 33.4 19.5 38.3 19.7 24.0 25.0 21.0 51.5 15.7 14.6 20.8 23.2 29.0 12.3 20.7 22.8 26.2 20.4 21.1 29.3 41.6 34.3 27.2 60.8 23.4 31.6 24.2 22.2 19.4 17.4 13.4 11.3 24.6 16.3 24.2 20.0 13.1 26.8 14.1 15.8 27.5 12.5 26.9 16.9 29.6 53.3 15.1 22.6 16.6 21.4 33.5 38.9 27.0 30.8 35.0 33.8 31.2 33.6 34.2 30.4 30.9 30.1 39.5 30.4 28.4 28.8 32.5 40.0 21.4 24.9 21.3 27.3 22.0 20.8 32.4 23.8 23.0 28.8 20.8 11.5 67.5 63.0 68.6 23.0 9.7 35.7 20.1 7.9 10.4 3.9 79.5 39.7 49.1 6.3 40.0 29.3 46.7 48.8 96.5 39.8 40.0 33.4 19.2 51.8 12.7 14.5 31.9 30.2 8.9 39.1 48.0 32.1 76.7 29.2 30.1 53.9 31.6 39.3 31.5 20.3 97.0 45.3 54.3 80.0 80.0 91.3 58.6 39.3 89.1 PHF6 "BFLS, BORJ, CENP-31, KIAA1823, MGC14797" ENSG00000156531 "PHD finger protein 6" Q8IWS0 X 134373253-134428791 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease mutation, Epilepsy, Hypotrichosis, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001023 Enhanced Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA001023: AB_1079606" "unprognostic (2.38e-3)" "unprognostic (8.21e-2)" "unprognostic (1.99e-1)" "unprognostic (3.04e-3)" "unprognostic (6.03e-3)" "unprognostic (5.20e-3)" "prognostic unfavorable (3.38e-4)" "unprognostic (1.81e-1)" "unprognostic (4.85e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (9.96e-4)" "unprognostic (1.09e-1)" "unprognostic (5.96e-2)" "unprognostic (4.84e-2)" "unprognostic (7.45e-2)" "unprognostic (1.28e-1)" "unprognostic (1.29e-2)" 7.4 19.3 10.2 14.1 12.2 6.5 9.7 18.2 13.5 8.7 8.0 11.6 20.3 7.8 9.0 30.1 11.5 7.3 6.1 7.2 11.0 11.1 9.9 7.5 8.4 20.4 12.5 9.3 30.7 10.4 24.1 18.1 8.2 13.3 8.6 9.5 5.4 11.3 16.8 6.2 7.4 10.2 8.1 17.1 17.8 8.1 8.3 14.4 30.2 11.8 6.0 25.0 8.9 9.8 18.4 11.0 5.3 7.4 9.6 9.9 5.0 11.5 9.6 42.3 17.3 7.9 10.1 8.0 11.6 9.3 12.5 15.5 5.7 12.0 18.6 26.7 7.0 12.2 10.4 29.5 13.1 21.1 15.1 13.7 18.0 16.5 6.6 8.4 17.9 10.0 6.7 10.0 13.6 17.0 12.6 17.4 18.2 13.2 9.2 15.3 7.6 28.9 8.9 12.9 15.8 13.0 28.5 15.4 14.1 13.3 14.0 14.7 17.2 8.9 8.2 12.2 13.1 7.7 9.9 13.2 11.7 8.4 14.6 17.8 4.7 10.9 25.1 7.6 21.4 14.5 5.3 6.1 3.7 7.9 6.0 8.5 18.4 8.2 7.1 8.8 12.8 9.9 8.2 2.5 9.6 7.4 11.0 8.3 5.0 10.2 12.2 18.2 13.5 11.0 11.1 12.5 9.3 13.3 14.4 20.8 17.3 24.1 12.5 11.6 21.9 13.7 7.6 16.0 13.6 15.7 17.7 9.9 19.9 12.5 2.6 14.3 7.9 0.0 11.8 6.8 11.3 10.2 23.2 12.7 13.2 17.5 10.9 19.6 12.6 2.1 19.2 15.3 6.8 19.0 13.4 25.6 12.4 15.0 14.5 16.5 18.2 25.8 9.2 4.6 17.9 10.0 3.9 22.0 16.6 11.0 PHF7 "HSPC226, NYD-SP6" ENSG00000010318 "PHD finger protein 7" Q9BWX1 3 52410657-52423641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 39 "testis: 260.7" "Group enriched" "Detected in many" 45 "Early spermatids: 2196.1;Late spermatids: 5962.4;Spermatocytes: 1575.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 14.1;U-266/70: 16.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA036283, HPA070305" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA036283: AB_10795026, HPA070305: AB_2686248" "prognostic favorable (7.38e-5)" "unprognostic (4.57e-2)" "unprognostic (6.97e-3)" "prognostic favorable (9.44e-5)" "unprognostic (3.63e-1)" "unprognostic (2.61e-3)" "unprognostic (7.44e-2)" "unprognostic (5.78e-2)" "unprognostic (2.98e-1)" "unprognostic (6.38e-3)" "unprognostic (1.55e-3)" "unprognostic (1.12e-1)" "prognostic favorable (1.05e-6)" "unprognostic (2.07e-2)" "unprognostic (1.82e-1)" "unprognostic (2.34e-2)" "unprognostic (6.79e-2)" 0.9 0.6 0.3 0.6 1.5 0.8 0.9 1.0 1.4 0.5 1.0 1.2 0.4 0.7 0.5 2.0 0.6 0.6 0.4 1.9 0.6 0.4 0.6 0.9 0.6 0.5 1.1 0.7 0.4 0.9 0.6 0.5 0.5 0.7 0.7 1.0 1.2 1.0 0.7 1.5 1.0 1.0 0.5 0.9 0.7 0.6 260.7 0.4 1.7 0.5 0.6 0.6 0.9 0.5 6.7 2.6 3.9 2.5 2.2 4.9 1.7 2.0 0.6 1.5 6.4 1.1 1.6 2.7 2.0 2.1 1.6 2.0 1.0 0.8 3.4 0.2 1.5 1.0 1.1 1.1 3.2 2.8 4.1 1.5 3.8 0.4 2.3 1.1 4.2 7.2 0.9 3.6 1.5 3.4 0.5 2.3 7.8 2.3 14.1 1.2 0.9 4.9 1.6 0.7 0.6 4.3 2.2 1.4 4.1 1.7 0.9 1.1 1.2 1.8 0.1 1.6 2.0 0.9 2.1 1.7 2.7 1.9 2.9 4.1 16.7 8.0 2.0 1.1 9.7 1.6 0.7 2.2 3.9 2.1 2.5 2.5 6.7 2.5 3.7 1.1 3.8 1.7 3.5 0.5 2.2 1.4 2.6 4.9 1.7 0.3 1.5 1.0 1.4 0.6 0.4 1.1 0.7 0.7 0.4 3.0 2.9 5.6 4.6 4.0 10.6 7.0 2.5 6.7 0.0 7.0 7.9 3.0 11.6 2.4 2196.1 2.9 8.4 0.0 2.5 1.7 2.9 1.7 6.9 4.0 3.7 12.7 11.1 1.8 4.3 5962.4 71.4 2.6 8.5 2.8 3.3 6.5 3.1 0.0 59.4 5.5 15.7 51.8 3.9 1575.4 63.9 2.6 0.5 4.4 11.8 2.2 PHF8 "JHDM1F, KDM7B, KIAA1111, ZNF422" ENSG00000172943 "PHD finger protein 8" Q9UPP1 X 53936676-54048958 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Activator, Chromatin regulator, Dioxygenase, Oxidoreductase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 48.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038779, HPA062015" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA038779: AB_10675950, HPA062015: AB_2684658" "unprognostic (6.35e-2)" "unprognostic (2.16e-2)" "unprognostic (1.70e-2)" "unprognostic (1.04e-1)" "unprognostic (8.76e-2)" "unprognostic (1.05e-1)" "unprognostic (1.40e-1)" "unprognostic (2.66e-3)" "unprognostic (1.97e-3)" "unprognostic (1.22e-1)" "unprognostic (5.64e-2)" "unprognostic (1.02e-1)" "unprognostic (5.17e-2)" "unprognostic (1.22e-1)" "unprognostic (9.94e-2)" "unprognostic (1.85e-2)" "prognostic favorable (3.74e-5)" 8.8 6.8 8.2 11.5 9.4 10.7 11.1 12.5 9.2 10.3 8.2 12.9 27.4 7.9 12.2 54.0 10.7 11.1 9.8 7.8 7.2 5.4 8.8 21.7 10.5 11.2 11.3 7.0 16.8 14.1 10.6 14.6 9.8 9.4 12.8 7.5 10.3 10.3 14.7 8.4 9.6 11.1 8.9 8.5 11.8 9.7 30.6 10.4 19.6 11.1 8.1 13.0 12.8 16.1 6.2 5.1 10.7 7.9 5.4 9.5 5.1 8.8 7.7 11.7 11.3 7.3 5.7 19.2 6.7 5.9 7.5 6.7 8.7 7.2 13.0 4.0 6.1 8.1 9.3 29.1 5.8 8.0 20.3 13.9 7.8 10.0 8.8 5.7 12.2 14.7 6.4 8.2 8.6 11.8 5.7 6.9 13.8 10.3 19.1 4.3 8.9 16.6 9.4 21.3 6.2 11.6 16.4 13.0 12.7 5.1 10.8 17.2 8.5 17.9 12.0 5.9 19.0 11.8 8.5 8.0 6.0 8.6 11.0 5.5 14.5 13.4 15.8 7.1 15.5 6.4 10.7 4.5 7.2 6.2 7.9 9.5 4.3 6.2 7.1 5.1 6.2 4.6 5.0 7.7 5.4 5.2 4.0 9.2 5.1 8.2 9.4 12.5 9.2 7.2 5.4 11.3 7.0 9.4 10.4 8.9 9.3 9.3 8.2 7.9 12.4 6.6 10.2 17.4 2.3 8.7 11.8 10.6 0.0 4.1 34.1 10.8 6.8 0.0 4.0 3.9 5.3 10.8 13.9 34.6 5.8 7.9 5.2 8.6 12.4 22.6 8.6 9.1 3.3 2.8 8.3 8.6 3.9 9.0 6.0 2.9 15.1 6.5 8.1 22.6 48.0 8.5 10.2 7.5 7.1 11.5 PHGDH "PDG, PGDH, SERA" ENSG00000092621 "Phosphoglycerate dehydrogenase" O43175 1 119648411-119744226 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Serine biosynthesis" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 16.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-MEL-30: 99.3" "Low region specificity" "Detected in all" "CAB003681, HPA021241, HPA024031, CAB068216" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" No No 9000000 "Plasma membrane, Cytosol" Nucleoplasm "CAB003681: AB_425928, CAB068216: AB_2665666, HPA021241: AB_1855299, HPA024031: AB_1855300" "unprognostic (2.30e-1)" "unprognostic (2.16e-1)" "unprognostic (1.80e-2)" "prognostic unfavorable (1.48e-4)" "prognostic favorable (1.62e-4)" "unprognostic (9.80e-2)" "unprognostic (1.56e-2)" "unprognostic (1.40e-1)" "unprognostic (5.24e-2)" "unprognostic (4.45e-3)" "unprognostic (8.80e-3)" "unprognostic (5.00e-2)" "unprognostic (2.37e-2)" "unprognostic (1.32e-1)" "unprognostic (1.74e-1)" "unprognostic (1.95e-1)" "unprognostic (1.78e-3)" 18.8 1.9 33.3 4.4 32.1 4.4 13.8 7.8 27.2 11.9 5.8 49.7 9.4 4.2 6.1 41.0 16.7 24.5 3.9 5.3 26.7 20.5 14.0 53.2 4.3 5.7 42.0 20.7 17.3 58.2 67.5 5.7 6.4 23.3 24.5 4.7 8.7 62.9 16.4 1.7 35.9 3.0 8.1 28.3 1.9 9.0 8.6 38.1 9.9 15.8 7.3 7.3 7.9 14.1 6.7 3.2 2.9 0.7 1.2 16.5 3.2 13.6 5.6 14.6 35.0 8.4 11.0 27.2 12.3 22.3 17.7 29.3 28.8 2.4 0.0 5.4 33.0 1.9 18.4 27.0 25.7 12.5 0.1 24.6 4.3 19.6 19.9 17.3 27.5 0.1 15.8 43.0 16.9 20.0 9.9 12.7 48.8 7.9 32.6 7.8 53.5 18.4 8.4 36.4 10.6 42.5 16.2 25.3 2.3 1.2 16.2 15.7 14.4 9.0 6.1 99.3 13.9 12.3 47.0 0.1 2.9 15.3 17.9 13.8 26.9 6.7 27.5 35.8 38.5 22.7 2.9 0.7 0.2 2.9 0.2 0.2 6.7 1.8 4.9 3.2 2.7 9.1 16.5 2.0 1.2 0.2 1.8 2.4 3.2 33.3 32.1 7.8 27.2 26.7 20.5 42.0 20.7 23.3 38.1 3.0 9.3 9.7 92.1 46.0 0.8 2.0 84.1 21.4 7.9 19.2 2.0 32.1 114.4 48.9 40.9 3.3 0.2 0.0 120.7 43.3 25.5 86.4 5.7 90.0 8.0 0.0 1.7 2.5 1.3 81.6 62.7 4.8 54.0 19.0 1.1 79.1 39.9 2.5 120.2 80.4 2.9 12.9 16.0 5.2 3.4 67.4 21.2 5.0 1.5 39.9 PHIP "BRWD2, DCAF14, FLJ20705, ndrp, WDR11" ENSG00000146247 "Pleckstrin homology domain interacting protein" Q8WWQ0 6 78935867-79078236 "Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019140, HPA019838" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA019140: AB_2670073, HPA019838: AB_2670287" "unprognostic (1.58e-1)" "unprognostic (1.60e-1)" "unprognostic (9.43e-2)" "unprognostic (8.47e-3)" "unprognostic (1.05e-1)" "unprognostic (2.01e-3)" "unprognostic (3.50e-3)" "unprognostic (5.03e-2)" "unprognostic (4.03e-2)" "unprognostic (6.40e-3)" "unprognostic (1.72e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (1.71e-5)" "unprognostic (2.76e-1)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (2.55e-2)" 14.7 9.6 13.3 14.9 16.9 40.2 19.4 30.1 14.6 19.1 13.9 11.8 15.0 9.4 18.1 14.1 11.6 16.1 12.3 12.2 11.0 9.7 10.4 7.9 15.4 16.8 15.8 11.0 19.8 15.5 20.6 28.4 14.2 12.8 14.7 12.8 11.0 15.6 18.3 16.6 14.1 13.8 17.1 13.7 14.9 12.9 10.2 17.9 27.8 13.4 8.8 14.4 17.1 22.6 8.3 6.2 17.3 6.1 5.1 7.3 2.2 9.0 7.4 17.8 17.2 6.8 9.9 10.3 9.8 7.8 8.4 10.8 9.1 5.7 15.1 7.8 6.1 7.1 8.4 13.2 6.2 14.3 21.7 9.6 16.9 13.9 6.7 3.1 18.8 10.8 6.0 5.6 10.1 10.2 7.1 8.8 9.6 16.9 14.7 8.1 6.1 7.2 13.5 11.1 4.7 8.1 12.7 22.7 6.5 9.0 12.4 17.4 11.1 13.1 10.0 6.1 11.8 7.8 25.2 10.4 9.8 7.0 4.7 16.1 10.0 9.8 8.6 4.1 12.2 14.6 10.2 5.0 8.4 5.6 3.3 6.0 6.8 6.6 6.1 3.3 8.3 7.3 5.8 17.3 5.1 6.1 6.2 5.4 2.2 13.3 16.9 30.1 14.6 11.0 9.7 15.8 11.0 12.8 17.9 65.5 95.2 80.9 77.1 56.1 179.4 47.2 53.5 178.0 106.9 52.4 143.3 72.7 1.7 63.5 24.5 73.6 39.6 0.0 40.8 78.5 66.7 73.6 111.0 16.3 44.0 171.6 69.9 57.1 82.9 10.5 93.7 72.3 47.2 116.4 56.3 84.3 48.2 48.9 82.4 15.3 178.7 51.8 78.3 100.9 50.8 49.3 85.4 74.6 53.5 73.7 PHKA2 "PHK, PYK" ENSG00000044446 "Phosphorylase kinase regulatory subunit alpha 2" P46019 X 18892300-18984598 "Disease related genes, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" Calmodulin-binding "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 44.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002912 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA002912: AB_10961321" "unprognostic (3.90e-2)" "unprognostic (2.06e-2)" "unprognostic (5.10e-2)" "unprognostic (1.43e-2)" "unprognostic (1.90e-2)" "unprognostic (1.12e-2)" "prognostic unfavorable (1.25e-5)" "unprognostic (2.07e-2)" "unprognostic (3.42e-1)" "unprognostic (1.82e-1)" "prognostic favorable (7.68e-4)" "unprognostic (7.51e-2)" "prognostic unfavorable (1.55e-5)" "unprognostic (2.05e-1)" "unprognostic (1.58e-2)" "unprognostic (7.16e-2)" "prognostic favorable (2.96e-5)" 9.5 8.6 4.0 9.8 8.3 10.8 7.9 10.9 5.9 8.7 7.7 7.8 4.5 10.1 8.5 5.4 5.8 8.3 10.9 8.6 4.2 3.7 6.2 29.4 5.4 14.1 7.1 3.6 14.5 13.1 8.8 16.9 11.6 6.9 8.3 5.2 9.5 7.4 12.4 6.0 6.9 10.1 4.9 6.6 8.5 6.9 12.4 5.4 29.6 9.2 3.4 9.1 7.2 10.4 3.0 3.2 9.9 5.6 4.2 3.4 2.6 8.4 7.9 4.6 7.7 6.3 5.9 13.0 3.7 3.1 5.4 6.0 8.3 5.5 9.8 2.8 4.7 8.6 7.8 8.3 9.5 5.9 4.9 8.7 11.8 12.3 10.0 4.5 11.0 15.2 9.8 6.4 6.6 9.6 9.0 5.6 10.4 3.9 6.1 3.7 8.6 11.5 18.4 5.7 3.8 8.7 9.2 9.6 10.9 3.5 3.7 4.0 6.2 11.3 11.5 5.0 16.2 14.4 6.4 9.9 7.4 4.3 7.9 5.7 6.0 5.0 7.5 4.2 6.0 4.0 5.1 4.6 9.9 3.2 5.6 3.4 2.5 2.6 2.3 3.2 3.0 3.2 3.0 8.2 4.2 3.6 1.7 3.2 2.6 4.0 8.3 10.9 5.9 4.2 3.7 7.1 3.6 6.9 5.4 8.9 14.6 6.2 5.3 5.8 9.7 19.0 15.3 1.4 4.5 8.7 9.8 14.3 0.0 5.1 4.3 5.8 7.7 23.3 4.4 14.6 5.1 5.9 1.1 44.0 6.8 4.8 4.1 19.0 17.6 4.7 6.9 6.4 5.0 1.0 6.5 23.5 6.5 9.5 7.4 3.9 12.4 0.0 3.4 5.4 7.2 4.1 8.8 4.6 11.9 3.3 PHLDA1 "DT1P1B11, PHRIP, TDAG51" ENSG00000139289 "Pleckstrin homology like domain family A member 1" Q8WV24 12 76025447-76033932 "Cancer-related genes, Predicted intracellular proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "salivary gland: 142.4" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 1037.1;Smooth muscle cells: 353.3;Urothelial cells: 680.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 2.4;MAIT T-cell: 3.9;memory CD4 T-cell: 2.5;memory CD8 T-cell: 2.5;non-classical monocyte: 2.5;T-reg: 4.1" "Group enriched" "Detected in many" 7 "monocytes: 2.5;T-cells: 4.1" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 65.6;RPTEC TERT1: 51.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016160, HPA019000, HPA063520" Enhanced Supported "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "CAB016160: AB_628117, HPA019000: AB_1855309, HPA063520: AB_2685028" "unprognostic (9.09e-2)" "unprognostic (2.27e-2)" "unprognostic (2.03e-1)" "unprognostic (4.51e-3)" "unprognostic (2.33e-1)" "unprognostic (2.60e-3)" "unprognostic (1.40e-1)" "unprognostic (4.18e-2)" "unprognostic (2.21e-1)" "unprognostic (1.16e-1)" "unprognostic (5.21e-3)" "unprognostic (5.03e-2)" "unprognostic (1.21e-1)" "unprognostic (3.34e-2)" "unprognostic (2.32e-1)" "unprognostic (1.29e-1)" "unprognostic (4.55e-3)" 13.2 15.9 9.4 8.4 12.1 9.0 13.5 6.4 15.7 11.5 4.5 11.1 4.8 3.4 7.1 3.1 33.3 5.1 20.0 9.6 8.2 7.9 13.8 33.2 14.2 3.0 8.4 5.6 10.8 8.8 2.6 6.0 7.1 10.0 4.8 5.5 24.9 142.4 6.5 3.3 6.3 7.0 7.6 9.7 14.6 10.8 2.3 10.1 2.5 18.0 13.2 19.9 17.0 17.8 0.3 0.1 0.4 2.5 0.3 4.1 0.6 12.7 15.3 12.0 6.6 5.6 11.7 0.8 10.8 29.2 4.9 6.8 8.4 15.6 0.0 3.2 4.5 16.3 6.5 0.3 18.1 10.6 1.9 0.2 0.3 0.7 14.3 8.2 0.3 3.3 3.6 13.3 20.4 40.6 65.6 11.8 0.0 1.0 0.3 25.1 1.6 0.0 1.6 4.4 7.7 23.6 0.0 3.1 0.3 51.5 28.9 0.8 2.3 1.8 0.1 35.1 15.6 7.7 0.1 10.9 16.8 1.6 19.5 10.6 0.1 0.0 0.0 28.4 0.1 20.9 0.3 0.1 0.2 2.4 0.2 3.9 0.3 2.5 2.5 0.0 0.2 0.5 0.6 0.4 0.3 2.5 0.1 4.1 0.6 9.4 12.1 6.4 7.7 8.2 7.9 8.4 5.6 10.0 10.1 11.9 17.2 2.7 1037.1 173.4 1.5 29.5 10.2 6.7 22.7 29.6 2.0 4.8 71.3 68.6 1.0 95.1 0.7 0.0 35.8 6.3 85.4 57.9 80.5 117.3 97.6 1.6 112.7 23.9 10.8 1.3 8.6 53.3 271.7 41.5 10.3 90.9 162.8 3.5 14.5 32.7 4.0 265.1 353.3 0.5 0.4 66.0 6.2 23.0 8.0 680.5 PHLDB1 "FLJ00141, KIAA0638, LL5a" ENSG00000019144 "Pleckstrin homology like domain family B member 1" Q86UU1 11 118606440-118658038 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 87.0" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 68.1;Late spermatids: 60.6;Leydig cells: 62.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 39.2;ASC TERT1: 39.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037959, HPA038448, HPA061506" Approved Approved "Nucleoplasm,Mitotic spindle" Yes No Nucleoplasm "Mitotic spindle" "HPA037959: AB_10673651, HPA038448: AB_10697390, HPA061506: AB_2684545" "unprognostic (7.81e-2)" "unprognostic (8.32e-3)" "unprognostic (1.13e-1)" "unprognostic (9.36e-3)" "unprognostic (8.28e-2)" "unprognostic (1.55e-1)" "unprognostic (4.37e-3)" "unprognostic (1.22e-1)" "unprognostic (3.21e-2)" "unprognostic (1.10e-1)" "unprognostic (1.44e-2)" "unprognostic (1.57e-1)" "prognostic unfavorable (6.36e-6)" "unprognostic (7.09e-2)" "unprognostic (2.42e-2)" "unprognostic (3.69e-2)" "unprognostic (1.44e-1)" 40.5 7.4 19.6 9.5 52.2 0.9 19.0 4.6 30.8 25.0 10.7 87.0 3.6 8.1 22.0 9.6 8.2 18.7 18.5 20.8 22.4 11.8 9.6 2.8 13.7 4.0 47.0 19.9 21.4 18.9 4.9 4.5 20.8 26.9 9.4 5.9 8.0 7.1 14.6 10.0 9.2 8.8 16.0 27.6 10.2 7.9 7.0 51.0 0.0 10.7 5.4 2.3 10.8 11.6 0.5 0.4 2.1 0.3 1.9 0.7 0.1 1.6 2.6 10.5 5.1 39.2 39.8 3.7 7.8 9.6 4.6 2.7 3.9 11.4 0.0 14.7 15.6 6.2 6.6 2.3 16.0 0.7 0.2 1.5 3.0 1.9 1.9 10.1 0.0 5.7 20.7 3.5 6.4 4.4 10.4 13.1 0.2 2.6 0.1 5.9 1.2 0.0 0.1 3.7 0.1 1.3 0.4 2.7 0.2 4.6 2.4 2.4 5.2 19.9 1.7 5.5 4.2 7.3 0.9 16.0 9.5 8.6 4.8 6.2 0.0 0.0 0.0 2.7 0.5 10.7 0.5 0.3 0.4 0.2 0.0 0.3 0.2 0.3 0.7 0.0 0.5 0.7 0.5 2.1 1.9 0.2 0.4 0.2 0.1 19.6 52.2 4.6 30.8 22.4 11.8 47.0 19.9 26.9 51.0 6.0 13.6 0.9 8.3 16.4 3.5 3.9 0.0 0.0 10.3 29.6 0.0 0.9 0.0 9.1 68.1 25.1 16.5 0.0 3.9 1.3 32.9 5.0 1.1 0.6 5.0 3.2 8.1 31.3 3.5 60.6 62.2 7.0 11.8 3.6 21.4 6.7 15.4 28.1 41.8 5.7 1.8 38.8 45.5 7.4 5.8 8.0 1.3 2.2 13.5 2.1 PHLPP2 "KIAA0931, PHLPPL, PPM3B" ENSG00000040199 "PH domain and leucine rich repeat protein phosphatase 2" Q6ZVD8 16 71637835-71724701 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 29.9" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 98.2;Enterocytes: 51.9;Rod photoreceptor cells: 60.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040761, HPA041837, HPA048598" Approved Supported "Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol" NA No Cytosol "Nucleoplasm, Cytokinetic bridge, Mitotic spindle" "HPA040761: , HPA041837: , HPA048598: AB_2680459" "unprognostic (5.67e-2)" "unprognostic (2.00e-1)" "unprognostic (2.29e-2)" "unprognostic (2.44e-2)" "unprognostic (1.76e-1)" "unprognostic (1.59e-1)" "unprognostic (1.17e-1)" "unprognostic (3.27e-1)" "unprognostic (1.22e-1)" "unprognostic (3.43e-1)" "unprognostic (1.97e-4)" "unprognostic (3.08e-2)" "unprognostic (8.85e-3)" "unprognostic (6.41e-2)" "unprognostic (4.92e-2)" "unprognostic (8.46e-3)" "unprognostic (8.27e-2)" 6.4 4.7 12.5 7.0 10.9 8.1 8.4 17.4 14.9 4.4 16.6 4.6 4.3 15.8 5.8 4.9 2.7 4.7 4.1 4.6 11.7 9.0 5.4 4.9 4.8 5.0 6.2 14.9 7.2 4.9 10.2 7.3 4.3 12.6 4.7 17.8 13.2 2.9 5.7 5.3 3.0 29.9 7.0 7.6 3.9 4.2 10.8 4.7 1.0 9.9 1.1 4.9 4.7 9.8 2.4 2.2 1.2 0.7 3.5 1.5 0.4 4.9 6.5 7.1 7.9 5.7 6.9 4.1 7.4 6.7 10.7 8.8 5.9 1.6 9.8 2.9 12.2 7.7 10.5 10.2 3.8 13.9 3.4 5.5 2.7 5.6 3.9 4.5 2.3 4.3 5.1 2.2 15.2 5.0 4.5 4.0 3.4 2.4 2.7 7.4 10.4 3.2 1.8 5.5 1.5 1.7 5.1 6.2 3.2 5.1 3.8 6.2 3.3 15.9 4.4 2.6 5.7 5.4 1.4 5.5 10.8 7.8 4.5 6.1 6.1 4.3 10.1 6.7 1.9 2.4 0.8 0.5 0.2 1.0 0.7 0.9 2.4 0.8 1.5 0.6 1.6 1.1 0.9 1.2 3.5 0.7 2.2 1.3 0.4 12.5 10.9 17.4 14.9 11.7 9.0 6.2 14.9 12.6 4.7 8.9 2.1 5.2 4.7 8.2 18.7 2.3 0.0 2.7 4.5 3.5 98.2 3.8 0.0 2.4 9.7 3.7 51.9 0.0 2.0 0.3 7.2 5.0 10.3 3.9 1.3 22.3 5.8 3.1 5.4 3.6 4.9 2.2 13.5 2.8 6.7 6.3 2.8 31.6 4.9 4.3 60.3 6.5 5.6 29.1 18.3 8.0 1.1 3.5 7.2 2.1 PHOSPHO2 MGC22679 ENSG00000144362 "Phosphatase, orphan 2" Q8TCD6 2 169694454-169701708 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 91.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034726, HPA034727" Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA034726: AB_10602191, HPA034727: AB_2674302" "unprognostic (1.98e-1)" "unprognostic (1.22e-1)" "unprognostic (7.56e-2)" "unprognostic (1.39e-3)" "unprognostic (1.30e-2)" "unprognostic (2.26e-1)" "prognostic unfavorable (3.82e-6)" "unprognostic (4.31e-2)" "unprognostic (2.11e-2)" "unprognostic (5.19e-2)" "unprognostic (1.40e-1)" "unprognostic (2.31e-1)" "prognostic favorable (9.53e-4)" "unprognostic (4.10e-1)" "unprognostic (2.60e-1)" "unprognostic (6.12e-2)" "unprognostic (7.53e-2)" 8.7 4.0 9.0 5.7 9.7 3.3 14.2 14.2 7.8 8.4 8.2 5.8 6.3 8.2 8.6 5.9 4.6 8.1 6.2 5.7 6.7 5.5 7.5 5.0 4.3 3.6 6.0 9.1 8.2 8.9 10.9 21.3 3.9 7.8 17.4 7.8 6.4 10.5 7.8 6.4 5.2 7.9 6.2 9.7 3.4 6.3 25.4 8.0 5.5 13.0 3.9 3.9 9.1 5.7 8.8 4.6 1.5 1.0 10.5 5.7 1.8 5.7 1.6 4.1 5.6 7.9 2.5 16.3 2.5 1.7 3.9 4.4 5.6 4.4 5.6 5.6 1.9 8.1 4.5 5.5 3.0 3.2 8.3 6.4 5.6 4.9 9.6 5.2 4.5 5.1 4.6 5.8 4.5 6.0 3.3 3.5 8.0 9.2 5.8 2.4 5.3 3.1 5.9 5.6 3.7 2.1 3.2 2.5 4.3 6.2 17.3 17.5 6.0 5.4 2.8 6.0 5.2 7.5 2.8 2.0 4.3 4.1 4.0 2.7 5.6 5.2 5.0 5.1 2.8 4.5 0.0 0.9 1.1 3.9 1.0 5.5 6.8 4.3 3.7 1.0 8.8 5.7 5.6 1.5 10.5 0.9 4.6 4.4 1.8 9.0 9.7 14.2 7.8 6.7 5.5 6.0 9.1 7.8 8.0 3.0 2.2 2.7 9.2 2.3 8.7 2.8 2.5 13.4 1.2 3.5 5.9 8.6 8.3 5.9 91.4 4.5 5.9 0.0 9.9 8.8 3.0 7.0 0.0 2.8 2.5 6.4 14.5 2.5 0.0 23.3 4.4 1.9 3.3 1.0 8.2 5.2 6.7 8.4 4.6 9.8 10.2 0.0 5.1 27.9 11.7 3.8 4.6 4.3 8.1 4.3 PHOX2A "ARIX, CFEOM2, FEOM2, PMX2A" ENSG00000165462 "Paired like homeobox 2a" O14813 11 72239077-72245664 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 24.6;brain: 12.1;lymphoid tissue: 9.7" "Cell type enriched" "Detected in single" 9 "Spermatogonia: 3.6" "Cancer enriched" "Detected in some" 9 "ovarian cancer: 9.3" "Region enriched" "Detected in single" 96 "pons and medulla: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 228 "SH-SY5Y: 115.5" "Region enriched" "Detected in single" 9 "pons and medulla: 0.8" "Not detected" "Not detected" "HPA053810, HPA065621, HPA078004" Enhanced Supported Nucleoplasm No NA Nucleoplasm "HPA053810: , HPA065621: AB_2685522, HPA078004: AB_2732367" "unprognostic (5.84e-2)" "unprognostic (8.51e-2)" "unprognostic (5.07e-2)" "unprognostic (2.19e-1)" "unprognostic (2.13e-1)" "unprognostic (9.92e-4)" "unprognostic (3.03e-2)" 0.4 24.6 0.0 9.7 0.0 0.0 0.0 0.0 0.1 0.2 3.3 0.5 0.0 0.4 0.1 0.0 1.4 0.1 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.8 0.0 12.1 0.9 0.7 1.7 0.7 3.7 0.0 0.0 3.2 0.3 2.1 0.1 1.6 5.2 0.0 0.0 0.0 0.0 0.0 2.6 0.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 115.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 PHOX2B "NBPhox, Phox2b, PMX2B" ENSG00000109132 "Paired like homeobox 2b" Q99453 4 41744082-41748970 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 14.5;brain: 24.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 99 "pons and medulla: 24.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 91 "SH-SY5Y: 53.6" "Region enriched" "Detected in single" 17 "pons and medulla: 5.9" "Region enriched" "Detected in single" 27 "pons and medulla: 2.0" "HPA074325, HPA074941" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA074325: AB_2686678, HPA074941: AB_2732272" "unprognostic (1.01e-1)" "unprognostic (2.47e-1)" "unprognostic (5.27e-2)" 0.0 14.5 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.2 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 24.8 0.2 1.4 0.8 0.0 0.0 0.0 0.0 3.2 0.5 0.4 0.0 0.9 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 53.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 24.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PHPT1 "bA216L13.10, CGI-202, DKFZp564M173, HSPC141, PHP14" ENSG00000054148 "Phosphohistidine phosphatase 1" Q9NRX4 9 136848724-136851027 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013584, HPA020952" Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA 430000 Cytosol "Nucleoplasm, Nuclear bodies, Plasma membrane" "CAB013584: , HPA020952: AB_1855331" "unprognostic (7.34e-2)" "unprognostic (9.21e-2)" "unprognostic (7.90e-2)" "unprognostic (1.57e-2)" "unprognostic (3.76e-2)" "unprognostic (2.30e-1)" "unprognostic (4.64e-2)" "unprognostic (1.69e-2)" "unprognostic (3.23e-2)" "unprognostic (1.82e-1)" "unprognostic (1.26e-3)" "unprognostic (5.85e-2)" "unprognostic (9.66e-3)" "unprognostic (1.11e-2)" "unprognostic (2.01e-1)" "unprognostic (3.95e-2)" "unprognostic (8.49e-2)" 15.8 26.4 31.5 12.1 28.0 11.7 15.3 14.7 27.2 19.2 15.7 18.5 13.7 14.7 11.2 21.7 13.7 21.1 14.2 59.1 22.7 19.3 18.4 12.6 12.1 12.7 27.0 21.0 13.7 46.5 15.6 21.2 14.7 20.8 20.2 11.6 14.1 30.5 22.6 86.0 9.2 16.3 16.9 24.3 10.3 13.4 13.8 18.6 7.5 20.7 19.8 10.4 12.0 9.8 24.9 48.8 3.3 35.4 20.0 24.3 32.1 7.1 52.0 29.7 18.9 19.2 34.9 43.7 16.6 21.2 20.3 18.1 18.9 16.3 15.2 20.2 20.5 24.3 18.9 6.4 37.5 6.4 13.6 13.2 4.8 34.2 41.5 23.9 9.5 19.5 43.5 30.9 11.6 14.0 18.4 26.6 11.9 11.5 14.1 31.4 40.6 13.8 20.0 23.5 47.6 22.4 11.5 13.0 25.1 32.1 11.9 14.6 13.8 17.9 21.0 8.6 14.8 15.9 26.4 21.6 42.5 13.2 11.7 15.3 9.4 9.1 9.3 24.0 6.9 25.4 2.9 35.4 3.3 24.3 34.2 20.9 24.9 21.1 21.9 37.5 16.5 15.0 21.3 1.7 20.0 24.0 48.8 22.9 32.1 31.5 28.0 14.7 27.2 22.7 19.3 27.0 21.0 20.8 18.6 89.3 132.7 80.4 156.2 133.5 37.9 336.8 191.1 136.5 125.1 205.9 21.6 300.5 633.3 164.3 214.6 110.1 411.5 70.0 220.3 372.9 227.8 244.3 120.2 179.9 249.5 63.5 254.7 94.5 103.8 640.4 189.8 148.3 317.2 367.9 241.4 126.9 202.0 354.2 210.0 509.4 53.8 84.1 248.0 93.6 149.9 141.4 220.8 93.5 262.8 160.3 PHTF2 DKFZp434D166 ENSG00000006576 "Putative homeodomain transcription factor 2" Q8N3S3 7 77798792-77957503 "Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 67.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "non-classical monocyte: 18.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012312 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA012312: AB_2668649" "unprognostic (1.96e-1)" "unprognostic (2.60e-3)" "unprognostic (4.04e-1)" "unprognostic (1.44e-1)" "unprognostic (5.70e-2)" "unprognostic (1.99e-3)" "unprognostic (5.36e-3)" "unprognostic (2.81e-2)" "unprognostic (1.63e-2)" "unprognostic (1.41e-2)" "unprognostic (3.86e-2)" "unprognostic (2.82e-1)" "prognostic unfavorable (3.09e-7)" "unprognostic (8.28e-3)" "unprognostic (2.28e-1)" "prognostic unfavorable (2.78e-4)" "unprognostic (5.53e-2)" 7.5 4.5 5.6 15.1 8.6 7.7 5.9 8.7 10.3 7.0 5.9 8.9 5.3 3.2 7.3 4.6 6.4 5.7 7.8 9.1 7.0 5.2 5.4 4.7 6.8 13.7 7.0 6.3 7.4 4.7 27.7 8.2 11.4 9.3 5.9 5.1 4.7 5.7 6.9 67.0 5.5 7.8 8.5 8.2 12.1 4.7 9.1 5.8 9.2 5.7 18.2 15.5 7.9 6.3 6.7 2.1 9.2 18.2 3.8 6.2 2.0 15.2 7.0 9.6 19.5 8.4 9.3 8.0 27.0 24.7 16.2 18.4 11.9 12.4 13.7 2.2 20.9 17.6 12.7 13.7 7.0 23.1 9.2 10.9 5.6 7.7 3.5 9.2 7.4 15.5 5.5 6.7 9.4 14.2 10.4 5.7 7.7 9.1 24.4 17.2 9.6 6.0 4.8 8.7 4.3 8.3 6.1 19.5 11.2 4.4 20.6 9.3 13.0 15.1 17.2 9.8 14.8 18.2 5.8 5.7 27.9 15.0 15.6 15.8 11.5 13.4 17.1 8.8 12.0 24.0 9.2 2.1 3.4 1.5 9.2 3.0 6.7 4.7 1.4 2.1 4.2 1.4 1.5 1.2 3.8 18.2 1.0 6.2 2.0 5.6 8.6 8.7 10.3 7.0 5.2 7.0 6.3 9.3 5.8 6.0 17.5 23.8 17.3 14.2 7.8 21.5 15.3 9.4 9.1 7.0 11.8 11.2 0.0 4.0 10.8 9.0 5.3 0.0 5.8 7.0 14.7 6.5 37.1 4.3 10.4 3.2 5.2 23.4 33.1 4.4 11.2 29.4 10.1 1.8 6.0 4.0 6.0 5.8 12.7 1.8 9.3 12.9 12.8 22.9 32.2 15.6 12.4 35.5 4.5 20.4 PHYHIP "DYRK1AP3, KIAA0273, PAHX-AP" ENSG00000168490 "Phytanoyl-CoA 2-hydroxylase interacting protein" Q92561 8 22219704-22232341 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 89.4;skin 1: 37.9" "Cell type enhanced" "Detected in many" 11 "Basal keratinocytes: 16.8;Smooth muscle cells: 7.8;Suprabasal keratinocytes: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPMI-8226: 12.9;SH-SY5Y: 5.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "amygdala: 111.3;basal ganglia: 281.7;cerebellum: 369.4;cerebral cortex: 248.5;hippocampal formation: 314.4" "HPA068030, HPA069318" Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA068030: AB_2685944, HPA069318: AB_2686117" "unprognostic (1.19e-2)" "unprognostic (2.33e-2)" "unprognostic (3.06e-2)" "unprognostic (9.22e-3)" "unprognostic (2.07e-3)" "unprognostic (2.35e-1)" "unprognostic (1.59e-1)" "unprognostic (2.80e-1)" "unprognostic (3.01e-2)" "unprognostic (7.44e-3)" "unprognostic (2.36e-1)" "unprognostic (4.05e-2)" "unprognostic (4.44e-5)" "unprognostic (8.62e-4)" "unprognostic (1.36e-1)" "unprognostic (1.35e-2)" "unprognostic (4.09e-3)" 5.4 18.6 25.0 2.3 71.8 1.3 3.5 58.9 89.4 3.2 2.1 3.0 0.0 2.2 6.0 3.4 7.1 9.8 6.2 2.9 31.2 12.3 2.2 1.4 1.8 1.4 7.3 40.3 2.3 2.2 1.3 5.5 3.0 21.1 3.6 1.7 0.0 1.4 5.9 1.7 37.9 2.4 7.2 3.5 3.6 1.6 5.8 10.4 0.0 2.0 0.0 1.4 7.8 2.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.3 0.5 0.0 0.3 0.8 1.1 0.3 1.3 0.4 0.4 0.1 2.0 0.0 2.2 0.6 1.4 3.8 0.0 0.7 0.1 0.0 0.2 0.0 4.0 1.5 1.7 0.0 0.0 0.9 0.0 0.8 0.0 3.6 2.5 0.1 0.2 1.3 0.0 0.0 0.0 0.0 0.9 0.7 0.3 0.0 0.2 12.9 0.0 0.0 4.3 5.0 2.9 0.0 3.4 0.3 0.0 0.3 1.1 0.0 2.1 1.6 0.7 1.0 0.2 0.0 2.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 71.8 58.9 82.9 31.2 12.3 7.3 40.3 21.1 10.4 0.0 0.0 0.0 5.1 16.8 0.7 1.2 0.0 0.0 2.3 3.5 0.0 0.1 0.0 0.2 0.6 1.3 0.5 0.0 1.8 0.2 2.3 0.5 0.0 0.9 0.2 0.0 0.0 1.3 0.0 1.3 2.8 0.0 1.7 0.0 0.3 0.4 0.4 0.0 3.5 2.2 0.9 0.0 7.8 0.2 0.0 9.5 1.8 0.0 0.0 3.9 PI4KA "PI4K-ALPHA, pi4K230, PIK4CA" ENSG00000241973 "Phosphatidylinositol 4-kinase alpha" P42356 22 20707691-20859417 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 48.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 52.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009092, HPA075515" Approved Approved "Nucleoplasm,Plasma membrane" NA NA 18000 Nucleoplasm "Plasma membrane" "CAB009092: AB_2164033, HPA075515: AB_2686753" "unprognostic (8.06e-2)" "unprognostic (1.53e-1)" "unprognostic (1.20e-2)" "unprognostic (4.45e-2)" "unprognostic (1.21e-1)" "unprognostic (5.01e-3)" "unprognostic (3.19e-2)" "prognostic favorable (5.24e-4)" "unprognostic (2.08e-1)" "unprognostic (4.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.29e-1)" "prognostic favorable (7.22e-5)" "unprognostic (1.37e-1)" "unprognostic (1.33e-1)" "unprognostic (2.35e-1)" "unprognostic (1.50e-1)" 7.7 9.2 28.8 10.5 34.2 12.5 6.5 14.1 48.0 9.7 8.8 10.1 4.9 9.1 9.7 6.1 8.3 8.4 8.0 8.5 30.4 19.2 9.0 12.6 9.0 11.2 19.0 25.9 10.2 8.6 25.6 12.5 10.4 19.3 9.8 8.9 10.8 6.8 10.6 7.1 6.6 10.0 13.2 6.8 10.2 9.9 13.1 8.2 17.9 9.9 2.9 10.2 8.4 4.8 5.0 12.5 7.6 5.5 9.1 7.7 2.9 9.9 8.4 7.4 11.1 21.2 12.8 10.6 9.0 13.7 13.3 13.1 6.5 4.2 18.7 5.4 18.1 13.1 8.8 14.0 8.7 8.2 15.9 21.5 19.2 11.3 7.4 10.6 19.0 15.4 11.4 5.5 11.3 6.3 8.7 10.8 5.7 52.4 15.9 10.3 13.7 16.6 6.5 5.8 17.8 8.7 16.7 16.2 3.4 7.4 15.9 18.2 13.3 11.8 13.8 9.4 10.8 11.6 8.7 10.9 24.3 12.6 8.9 7.6 12.2 12.4 14.9 16.0 13.7 10.1 3.1 5.5 7.3 5.1 5.4 4.9 4.6 5.6 6.1 3.6 5.0 5.7 7.7 7.6 9.1 4.6 12.5 5.8 2.9 28.8 34.2 14.1 48.0 30.4 19.2 19.0 25.9 19.3 8.2 11.9 25.4 14.0 5.7 9.0 32.8 25.7 25.5 6.7 9.1 7.0 45.2 15.6 1.7 8.5 30.2 12.8 18.2 0.0 5.5 16.0 10.8 10.3 11.5 15.5 17.4 35.0 18.4 14.7 15.5 19.2 18.4 16.5 10.1 6.4 16.8 22.8 7.1 10.5 22.6 9.1 23.8 25.8 10.5 32.1 28.9 8.5 16.7 13.3 12.7 7.0 PIANP "C12orf53, DKFZp547D2210, PANP" ENSG00000139200 "PILR alpha associated neural protein" Q8IYJ0 12 6693792-6700800 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 55.7" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 13.9;Horizontal cells: 17.5;Peritubular cells: 13.1" "Cancer enhanced" "Detected in many" "glioma: 14.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.4" "Lineage enriched" "Detected in single" 7 "T-cells: 2.4" "Cell line enhanced" "Detected in many" "BJ hTERT+: 7.9;HAP1: 7.8;hTERT-RPE1: 13.1;NTERA-2: 16.5;SH-SY5Y: 15.6;U-2 OS: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010631 Enhanced Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA010631: AB_10603680" "unprognostic (1.82e-1)" "unprognostic (9.21e-3)" "unprognostic (1.62e-2)" "unprognostic (7.65e-2)" "unprognostic (1.34e-1)" "unprognostic (3.03e-2)" "unprognostic (6.58e-2)" "unprognostic (1.07e-1)" "unprognostic (1.70e-1)" "unprognostic (6.41e-3)" "unprognostic (1.92e-2)" "unprognostic (3.89e-1)" "unprognostic (3.30e-3)" "unprognostic (3.26e-3)" "unprognostic (1.16e-1)" "unprognostic (2.30e-1)" "unprognostic (2.34e-2)" 1.5 8.3 28.0 2.2 55.7 1.2 1.5 27.4 52.8 7.2 2.7 2.6 0.5 1.9 11.6 4.1 1.8 2.2 3.3 1.5 19.5 26.2 1.5 1.1 1.5 2.4 11.0 20.9 1.8 1.7 1.2 4.0 1.5 9.0 3.4 2.0 1.7 2.2 8.7 1.3 1.7 2.2 8.1 4.6 1.6 2.1 4.4 8.3 0.0 1.4 0.0 1.7 1.8 2.5 0.3 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.4 5.9 1.1 0.2 0.3 0.2 1.5 7.9 4.1 3.7 0.1 0.2 0.1 0.0 2.8 0.6 0.2 7.8 0.2 2.0 0.2 1.0 0.3 0.2 0.0 0.2 0.3 0.2 1.0 0.0 1.6 0.0 13.1 0.0 2.4 0.0 0.2 0.3 0.2 0.2 0.2 16.5 0.0 0.0 1.1 0.0 0.1 0.1 0.1 2.1 15.6 0.0 0.1 0.0 1.1 0.0 0.0 0.0 4.3 8.7 4.4 1.1 0.2 0.0 0.3 5.8 0.2 0.0 0.0 0.0 0.0 0.1 0.1 2.4 0.0 0.7 0.2 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 28.0 55.7 27.4 27.8 19.5 26.2 11.0 20.9 9.0 8.3 0.0 0.0 0.0 0.0 0.2 13.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 17.5 0.0 0.0 0.0 0.6 2.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 13.1 0.0 3.0 0.0 1.4 0.1 4.5 0.1 0.1 0.0 0.0 0.0 PIAS2 "ARIP3, miz, PIASX-ALPHA, PIASX-BETA, ZMIZ4" ENSG00000078043 "Protein inhibitor of activated STAT 2" O75928 18 46803224-46920160 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 61.6" "Cell type enhanced" "Detected in all" 11 "Early spermatids: 405.0;Late spermatids: 431.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068792 Enhanced Supported Nucleoplasm Yes No Nucleoplasm "HPA068792: AB_2686037" "unprognostic (9.59e-3)" "unprognostic (2.14e-1)" "unprognostic (1.63e-1)" "unprognostic (2.75e-2)" "unprognostic (1.25e-1)" "unprognostic (6.39e-2)" "unprognostic (1.05e-3)" "unprognostic (3.67e-2)" "unprognostic (1.05e-1)" "unprognostic (3.71e-3)" "unprognostic (1.77e-3)" "unprognostic (1.02e-1)" "unprognostic (1.23e-1)" "unprognostic (1.58e-1)" "unprognostic (6.92e-2)" "prognostic unfavorable (1.27e-4)" "unprognostic (1.71e-1)" 5.6 6.7 9.8 4.7 12.7 7.0 6.1 16.7 13.5 4.7 5.6 8.1 8.0 3.7 6.0 8.8 4.7 5.3 5.5 7.5 8.4 8.1 7.4 6.6 4.9 6.5 7.9 8.5 5.8 5.0 19.3 10.4 4.8 12.1 7.7 8.1 8.2 5.9 7.9 15.6 8.5 4.8 5.7 7.6 6.5 5.3 61.6 9.1 7.5 9.2 4.1 5.8 5.3 4.6 6.8 5.1 2.9 4.4 4.8 6.7 2.1 11.9 4.9 5.6 7.9 5.6 7.1 2.6 6.3 5.1 5.5 5.1 5.8 4.5 12.1 3.5 4.7 5.6 4.1 11.1 6.7 7.9 5.9 4.2 7.4 4.7 6.7 5.5 12.3 5.4 7.3 4.1 4.8 5.2 9.0 4.9 10.6 5.5 3.2 10.8 6.4 7.2 7.3 6.1 2.2 3.2 13.2 12.0 0.1 5.1 9.2 10.7 8.3 5.7 3.7 4.1 6.6 5.5 5.6 6.2 11.9 5.1 4.1 4.7 9.4 4.6 15.4 8.8 13.4 11.6 1.5 4.4 2.8 5.4 3.4 3.8 4.1 4.8 6.1 5.0 6.8 6.7 5.7 2.9 4.8 3.0 5.1 4.2 2.1 9.8 12.7 16.7 13.5 8.4 8.1 7.9 8.5 12.1 9.1 17.9 18.7 15.8 17.1 18.3 46.7 26.5 12.7 10.7 6.8 24.4 84.4 1.9 16.6 11.8 405.0 21.0 11.6 23.3 7.7 1.9 16.5 28.6 13.9 17.9 22.7 30.2 27.3 35.6 40.4 431.0 31.1 16.5 11.8 31.5 14.1 27.0 7.6 17.5 32.9 18.9 39.4 6.5 16.4 130.6 70.9 13.4 1.1 15.0 21.8 15.3 PIAS3 "FLJ14651, ZMIZ5" ENSG00000131788 "Protein inhibitor of activated STAT 3" Q9Y6X2 1 145848522-145859836 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 40.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006389, HPA067383" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA006389: AB_2667576, HPA067383: AB_2685828" "unprognostic (1.23e-1)" "unprognostic (2.21e-1)" "unprognostic (1.11e-1)" "unprognostic (1.26e-1)" "unprognostic (1.79e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (6.12e-4)" "unprognostic (2.30e-2)" "unprognostic (5.92e-2)" "unprognostic (2.50e-1)" "unprognostic (2.77e-3)" "unprognostic (5.06e-1)" "prognostic unfavorable (1.21e-7)" "unprognostic (5.14e-2)" "unprognostic (4.98e-2)" "unprognostic (5.66e-2)" "unprognostic (2.11e-2)" 15.2 9.8 10.7 12.8 12.7 4.5 17.4 19.1 16.3 29.1 16.2 17.9 16.5 7.5 25.5 15.0 26.4 36.7 20.2 14.1 11.5 9.7 13.9 6.4 13.6 8.2 11.6 11.9 21.2 11.7 14.7 13.8 10.5 11.9 20.3 8.4 28.8 20.9 26.8 17.4 28.6 10.3 23.1 10.7 10.2 15.9 10.0 12.1 7.3 11.4 19.2 22.7 22.6 24.2 6.1 8.6 10.7 11.9 15.1 12.6 6.8 12.8 8.9 9.2 8.1 14.2 26.9 5.6 12.1 16.7 13.8 15.4 7.2 8.5 6.6 13.1 20.7 5.8 13.3 4.7 19.2 11.7 7.2 7.0 3.0 6.1 3.8 14.2 5.4 15.1 21.9 12.5 12.7 7.3 17.9 19.9 6.0 4.8 9.2 28.6 21.4 5.8 2.8 14.3 36.4 14.5 9.1 6.3 4.3 10.9 7.7 3.1 14.7 11.6 6.5 5.9 11.0 30.0 8.3 30.6 18.5 13.8 12.2 7.7 12.7 5.7 4.3 18.0 4.1 9.1 8.5 9.5 10.7 11.7 8.8 12.5 6.1 7.7 12.6 7.0 4.3 7.1 6.7 2.2 15.1 11.9 8.6 8.2 6.8 10.7 12.7 19.1 16.3 11.5 9.7 11.6 11.9 11.9 12.1 20.8 11.5 3.7 7.5 9.5 8.8 0.8 5.1 40.2 21.6 15.7 11.8 3.3 1.7 7.0 2.0 8.7 1.6 0.0 6.7 5.8 11.0 7.0 10.4 3.8 4.5 9.5 4.1 9.8 6.2 2.9 13.3 5.9 5.0 15.4 5.1 3.9 8.8 2.0 12.4 1.2 11.2 25.8 13.3 3.0 10.0 14.3 3.3 4.4 2.5 8.9 PIAS4 "FLJ12419, Piasg, PIASY, ZMIZ6" ENSG00000105229 "Protein inhibitor of activated STAT 4" Q8N2W9 19 4007646-4039386 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway, Wnt signaling pathway" "DNA-binding, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 73.5;Late spermatids: 189.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010598, HPA076008" Enhanced Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA010598: AB_1079616, HPA076008: " "unprognostic (1.23e-1)" "unprognostic (8.94e-3)" "unprognostic (3.50e-2)" "prognostic favorable (1.18e-5)" "unprognostic (2.45e-1)" "unprognostic (4.77e-3)" "unprognostic (4.01e-3)" "unprognostic (9.79e-2)" "unprognostic (6.89e-2)" "unprognostic (6.22e-2)" "prognostic favorable (7.04e-4)" "unprognostic (1.33e-2)" "unprognostic (5.98e-2)" "unprognostic (4.52e-3)" "unprognostic (5.76e-2)" "unprognostic (1.25e-1)" "unprognostic (4.67e-3)" 11.0 9.2 12.4 11.1 16.8 8.6 7.6 22.5 15.7 8.8 11.9 16.7 8.1 13.0 9.5 9.2 9.1 8.4 9.7 6.9 9.7 7.1 7.3 12.4 7.8 10.2 18.2 9.3 11.2 16.0 7.1 9.3 12.9 12.6 9.9 5.4 6.5 14.7 8.7 15.2 12.2 11.2 8.0 12.3 12.0 13.9 38.1 15.9 11.0 6.6 6.3 8.3 8.8 9.8 17.9 11.8 20.2 19.1 16.3 17.3 11.3 10.6 7.7 7.2 6.8 3.5 3.2 11.5 6.5 3.6 6.9 6.3 12.0 5.0 8.1 5.9 3.5 7.5 11.2 7.4 5.2 3.0 13.0 11.6 5.8 5.5 9.2 7.3 8.4 10.3 3.7 5.7 6.2 3.8 3.8 8.1 8.5 10.8 11.2 3.3 10.9 15.3 9.9 15.9 5.2 7.1 13.7 7.3 10.6 4.5 6.0 13.2 14.7 9.3 9.1 7.1 5.6 8.4 7.8 5.9 6.9 9.9 14.3 10.1 21.1 15.7 10.3 5.7 10.4 8.4 10.5 14.9 20.2 17.3 16.0 12.2 17.9 12.6 15.9 11.8 15.9 11.1 12.5 16.6 16.3 19.1 11.8 13.4 11.3 12.4 16.8 22.5 15.7 9.7 7.1 18.2 9.3 12.6 15.9 3.0 12.9 7.5 7.0 16.4 17.6 3.0 5.1 13.4 7.9 8.7 11.8 19.8 6.6 16.0 73.5 9.8 12.3 0.0 15.5 13.7 7.1 11.8 6.9 9.3 12.6 25.4 21.2 10.4 9.8 189.7 13.0 8.3 6.8 11.8 14.3 10.4 13.0 5.8 17.3 10.2 21.3 6.5 7.2 35.8 35.3 13.6 30.4 7.5 10.8 7.4 PIF1 "C15orf20, FLJ22692" ENSG00000140451 "PIF1 5'-to-3' DNA helicase" Q9H611 15 64815632-64825668 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 14.3" "Group enriched" "Detected in many" 5 "Early spermatids: 22.3;Erythroid cells: 70.0" "Cancer enhanced" "Detected in many" "testis cancer: 10.2" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Lineage enriched" "Detected in single" 5 "T-cells: 3.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" CAB018701 Supported Supported Nucleoplasm NA Yes Nucleoplasm "CAB018701: AB_2164654" "unprognostic (1.99e-1)" "unprognostic (6.11e-2)" "unprognostic (1.34e-1)" "unprognostic (3.12e-2)" "unprognostic (1.62e-1)" "unprognostic (8.33e-3)" "unprognostic (8.66e-4)" "unprognostic (1.47e-1)" "prognostic unfavorable (5.22e-4)" "unprognostic (6.68e-2)" "unprognostic (2.38e-2)" "unprognostic (3.27e-2)" "unprognostic (0.00e+0)" "unprognostic (2.96e-3)" "unprognostic (1.78e-1)" "unprognostic (9.61e-2)" "unprognostic (5.95e-2)" 1.8 1.1 0.6 12.9 0.6 6.0 0.6 0.6 1.2 1.2 5.2 0.6 0.6 3.3 2.0 1.3 4.6 0.8 1.4 0.9 0.6 1.8 0.7 0.6 1.9 7.5 0.9 0.6 0.6 0.6 0.0 0.6 1.4 1.0 2.5 1.8 0.9 0.8 1.2 0.6 1.6 3.7 2.1 0.6 7.0 2.7 3.3 0.6 14.3 0.6 5.1 6.0 1.8 1.9 0.7 0.3 0.0 0.0 0.0 3.2 0.4 5.2 6.1 15.0 6.0 2.7 3.2 5.5 5.1 2.8 5.2 4.0 9.6 8.8 6.3 2.1 2.5 4.8 14.5 15.3 4.3 1.9 10.0 5.6 7.3 17.1 6.9 1.4 2.9 6.0 1.8 0.0 2.3 1.9 1.3 5.3 9.5 4.8 12.7 4.9 4.6 3.1 12.2 12.2 6.6 4.2 6.5 5.0 8.9 2.9 2.9 6.2 4.0 3.9 4.4 2.3 6.9 4.9 3.2 3.6 3.1 16.4 5.0 9.4 10.2 9.4 6.0 3.0 12.9 4.4 0.0 0.0 0.0 1.5 0.0 0.5 0.7 0.1 1.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.3 3.2 0.4 0.6 0.6 0.6 1.2 0.6 1.8 0.9 0.6 1.0 0.6 0.0 1.4 0.8 0.6 1.6 0.4 1.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 22.3 1.5 0.3 70.0 0.0 5.6 2.6 0.9 0.0 0.0 4.8 0.0 0.0 7.4 2.2 1.3 1.4 3.1 0.0 0.0 0.8 0.6 0.2 0.0 2.1 0.0 0.8 6.5 2.7 0.1 1.9 0.9 0.9 8.9 0.9 1.1 PIGL ENSG00000108474 "Phosphatidylinositol glycan anchor biosynthesis class L" Q9Y2B2 17 16217191-16351797 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "GPI-anchor biosynthesis" Hydrolase "Deafness, Disease mutation, Ichthyosis, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA012739 Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" No No "Nucleoplasm, Cytosol" "HPA012739: AB_1855367" "unprognostic (3.07e-2)" "unprognostic (2.65e-1)" "unprognostic (2.15e-1)" "unprognostic (1.30e-2)" "unprognostic (7.70e-2)" "unprognostic (6.14e-2)" "unprognostic (9.39e-5)" "unprognostic (1.11e-2)" "unprognostic (1.15e-2)" "unprognostic (1.63e-2)" "unprognostic (6.37e-3)" "prognostic unfavorable (2.57e-4)" "prognostic unfavorable (1.47e-4)" "unprognostic (3.19e-2)" "unprognostic (2.13e-1)" "unprognostic (3.38e-1)" "unprognostic (2.75e-3)" 17.3 12.6 11.1 14.3 18.8 8.6 18.0 14.6 15.6 12.9 13.0 17.6 12.8 17.1 19.8 20.2 12.6 13.1 12.7 8.8 8.5 7.5 11.2 18.5 12.5 12.0 14.5 10.7 16.5 16.5 11.9 18.1 10.3 13.6 14.0 14.4 15.5 14.8 16.3 13.4 20.0 15.8 10.1 9.7 12.3 14.8 11.1 13.6 13.7 15.7 11.1 20.4 10.9 12.3 5.2 7.4 5.5 3.7 5.4 9.3 3.3 7.9 11.4 7.7 6.3 11.0 10.4 3.2 4.4 5.3 7.5 13.3 11.6 10.2 3.9 9.1 4.3 4.5 11.6 9.5 5.6 10.7 8.3 24.8 7.7 7.9 13.8 11.8 3.3 5.0 8.8 14.7 13.0 14.8 7.6 8.5 13.1 9.1 5.0 5.9 7.9 6.0 7.7 3.0 15.9 5.9 5.9 6.5 11.2 8.4 4.3 4.1 5.8 4.6 3.3 9.0 20.8 3.5 3.0 5.5 6.8 4.2 4.4 12.5 3.5 0.1 6.3 8.4 8.2 4.2 0.0 3.7 5.5 6.5 3.2 5.6 5.2 8.5 5.0 2.7 4.4 9.3 7.5 0.0 5.4 2.4 7.4 6.7 3.3 11.1 18.8 14.6 15.6 8.5 7.5 14.5 10.7 13.6 13.6 8.9 16.0 3.7 8.0 3.9 11.3 1.7 7.6 10.7 12.5 12.2 9.8 13.3 5.0 5.6 2.1 5.8 6.8 0.0 6.4 6.1 6.0 6.8 4.7 9.4 4.5 6.4 7.5 3.1 2.7 1.9 7.2 5.1 3.3 1.8 10.0 6.7 7.4 7.0 10.6 4.4 12.3 0.0 6.6 13.7 8.3 5.3 8.0 8.7 10.8 8.8 PIGO "DKFZp434M222, FLJ00135" ENSG00000165282 "Phosphatidylinositol glycan anchor biosynthesis class O" Q8TEQ8 9 35088688-35096601 "Disease related genes, Predicted membrane proteins" "GPI-anchor biosynthesis" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014905 Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA014905: AB_1855369" "unprognostic (1.41e-2)" "unprognostic (1.06e-1)" "unprognostic (4.03e-1)" "unprognostic (3.54e-1)" "unprognostic (1.09e-1)" "unprognostic (2.09e-1)" "unprognostic (6.98e-3)" "unprognostic (4.14e-2)" "unprognostic (5.08e-2)" "unprognostic (2.25e-1)" "unprognostic (3.63e-1)" "unprognostic (1.54e-1)" "prognostic favorable (3.05e-10)" "unprognostic (1.89e-2)" "unprognostic (1.30e-2)" "unprognostic (5.23e-3)" "unprognostic (3.81e-2)" 9.4 16.6 7.2 8.7 11.7 5.4 11.6 12.6 15.6 10.8 11.5 17.8 15.6 14.1 14.0 13.6 12.6 15.8 13.4 9.5 7.4 6.4 16.1 15.2 10.6 13.8 9.0 10.1 15.9 17.5 47.3 13.4 27.6 11.5 13.1 13.2 18.0 17.5 17.4 7.6 10.0 12.9 10.7 11.0 14.2 13.9 16.5 9.7 11.3 20.0 8.3 13.4 13.6 9.9 7.4 13.7 8.0 8.8 7.1 10.0 4.1 15.9 27.4 7.8 11.2 7.0 7.9 14.0 6.8 11.9 16.5 13.5 10.1 16.3 9.0 12.4 8.1 23.0 11.7 13.1 21.3 10.0 9.9 8.4 5.4 17.9 7.6 13.7 7.3 9.4 9.6 23.6 14.6 24.1 13.1 8.5 13.5 5.9 12.9 13.5 8.8 8.5 8.3 5.0 10.0 11.3 8.9 6.3 9.8 18.1 11.1 6.6 8.9 9.4 23.4 5.3 9.0 17.5 4.8 5.1 12.1 10.7 6.5 12.4 7.9 11.6 3.8 13.1 5.4 15.0 7.0 6.7 8.0 9.2 8.8 9.3 5.0 5.1 10.0 13.7 7.4 6.5 7.6 2.4 7.1 5.9 9.5 7.6 4.1 7.2 11.7 12.6 15.6 7.4 6.4 9.0 10.1 11.5 9.7 3.0 11.5 5.2 4.4 2.3 9.1 2.4 20.4 13.4 7.9 15.7 2.0 17.4 0.0 11.1 0.7 3.1 10.6 0.0 12.1 13.5 3.1 3.6 6.9 11.1 10.0 11.1 2.9 4.9 6.3 1.0 4.0 3.9 3.3 8.2 7.8 14.9 8.2 7.0 2.8 5.6 10.9 6.5 2.5 17.4 7.0 1.8 18.9 7.2 8.5 3.1 PIGQ "GPI1, hGPI1" ENSG00000007541 "Phosphatidylinositol glycan anchor biosynthesis class Q" Q9BRB3 16 566995-584136 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039105, HPA039828, HPA061414" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA039105: AB_10796221, HPA039828: AB_10795158, HPA061414: AB_2684508" "unprognostic (1.23e-2)" "unprognostic (6.12e-3)" "unprognostic (2.81e-1)" "unprognostic (2.65e-2)" "unprognostic (1.09e-2)" "unprognostic (2.42e-1)" "unprognostic (9.58e-2)" "unprognostic (8.05e-2)" "unprognostic (2.12e-1)" "unprognostic (2.02e-1)" "unprognostic (3.02e-2)" "unprognostic (8.98e-2)" "prognostic favorable (2.53e-6)" "unprognostic (2.73e-1)" "unprognostic (2.60e-1)" "unprognostic (2.55e-1)" "unprognostic (2.80e-2)" 13.9 15.7 12.8 8.7 13.9 48.4 8.4 12.8 20.6 8.4 9.7 11.4 16.7 15.4 10.9 23.3 7.2 10.0 13.6 7.4 10.5 11.1 18.9 12.5 13.0 6.2 9.1 13.2 10.4 29.3 18.1 15.3 8.4 9.4 11.2 4.1 15.4 15.5 17.6 12.4 12.8 8.1 5.5 7.2 10.3 13.6 15.3 8.2 11.8 18.4 4.2 7.9 9.8 6.7 5.6 10.5 5.9 6.0 5.5 5.3 3.9 8.6 13.0 4.6 6.5 3.0 1.8 8.7 9.0 3.5 3.9 4.3 9.1 8.0 4.5 11.8 2.0 3.5 13.8 2.1 4.0 0.8 13.1 19.0 6.9 14.1 6.4 5.8 6.0 6.5 3.3 6.0 6.5 1.3 2.6 3.6 8.5 15.5 2.6 1.3 11.2 11.1 6.9 6.3 1.8 13.4 21.6 3.9 10.5 3.5 3.5 8.4 13.2 10.3 4.7 6.6 1.5 10.7 4.2 8.7 6.6 8.4 7.5 6.3 10.0 2.9 3.6 2.2 3.3 6.5 1.2 4.8 3.0 5.3 5.6 4.6 4.4 4.6 5.1 4.9 5.6 5.1 3.1 5.9 5.5 6.0 10.5 4.2 3.9 12.8 13.9 12.8 20.6 10.5 11.1 9.1 13.2 9.4 8.2 14.9 20.7 3.0 6.7 4.2 12.5 7.3 0.0 17.4 9.1 38.4 3.9 8.9 3.3 16.0 23.2 7.0 20.0 46.7 15.1 7.4 9.1 8.5 8.1 14.3 8.2 9.5 19.4 5.5 7.3 44.6 6.9 7.4 15.1 5.4 11.8 17.5 12.5 9.9 6.7 11.5 12.9 0.0 9.5 27.2 12.6 4.3 4.9 6.9 11.0 3.5 PIGU "bA346K17.2, CDC91L1, GAB1" ENSG00000101464 "Phosphatidylinositol glycan anchor biosynthesis class U" Q9H490 20 34560542-34698790 "Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041706, HPA046766" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041706: AB_2677627, HPA046766: AB_2679794" "unprognostic (1.87e-2)" "unprognostic (1.26e-2)" "unprognostic (1.88e-2)" "unprognostic (1.48e-1)" "unprognostic (1.83e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (1.49e-7)" "unprognostic (1.64e-1)" "unprognostic (8.42e-3)" "unprognostic (7.94e-3)" "unprognostic (2.69e-1)" "unprognostic (9.86e-2)" "unprognostic (8.82e-3)" "unprognostic (3.75e-1)" "unprognostic (1.55e-1)" "unprognostic (5.27e-2)" "unprognostic (4.21e-3)" 16.8 17.6 18.9 12.9 23.6 10.0 15.2 15.7 26.5 14.7 21.5 43.0 10.8 13.3 21.8 22.8 20.0 28.2 12.7 17.4 21.4 20.2 18.4 16.3 11.3 11.6 21.5 11.9 23.9 16.2 34.4 21.7 17.3 26.9 14.1 24.9 20.1 17.9 15.9 16.4 14.0 14.2 19.6 30.5 11.1 11.5 22.1 18.1 16.5 14.7 15.9 19.5 14.2 15.0 10.0 10.8 9.4 6.3 12.1 15.0 6.7 11.7 15.0 19.1 14.0 12.6 15.2 19.2 12.1 14.5 20.6 18.2 27.7 25.1 15.2 19.8 11.9 26.4 22.0 17.4 22.9 21.0 6.2 9.4 34.2 9.9 31.1 11.7 20.8 8.2 13.4 14.8 11.8 13.5 9.5 14.8 15.0 17.1 13.5 17.4 13.2 17.6 21.2 9.6 26.8 22.7 12.8 24.0 24.3 18.2 11.0 12.3 11.6 22.7 41.2 14.8 11.2 22.7 14.7 8.7 33.9 12.1 18.3 12.1 9.1 12.7 10.1 20.7 21.8 14.6 9.4 4.4 1.9 13.4 6.3 12.2 9.2 12.4 15.0 10.8 10.0 12.7 12.5 0.9 12.1 5.3 10.6 11.2 6.7 18.9 23.6 15.7 26.5 21.4 20.2 21.5 11.9 26.9 18.1 8.9 3.7 1.5 11.9 3.9 8.5 5.2 12.7 26.8 9.1 10.4 15.7 33.8 1.7 16.1 13.6 5.0 10.3 0.0 15.2 23.8 8.0 10.0 8.1 6.7 13.7 1.6 9.8 8.6 5.6 11.0 5.2 3.5 1.7 6.4 13.8 8.1 9.8 21.0 7.4 8.4 9.5 19.4 12.0 31.9 12.2 5.1 17.7 7.0 22.1 7.6 PIGX FLJ20522 ENSG00000163964 "Phosphatidylinositol glycan anchor biosynthesis class X" Q8TBF5 3 196639775-196736007 "Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 15.5;eosinophil: 34.5;neutrophil: 8.6" "Lineage enriched" "Detected in all" 8 "granulocytes: 34.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029409, HPA073301" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA029409: AB_10610280, HPA073301: " "unprognostic (8.83e-2)" "prognostic favorable (2.12e-4)" "unprognostic (2.14e-1)" "unprognostic (2.42e-3)" "unprognostic (9.25e-2)" "unprognostic (2.00e-1)" "prognostic unfavorable (7.45e-5)" "unprognostic (1.91e-1)" "unprognostic (3.97e-2)" "unprognostic (1.11e-2)" "unprognostic (3.18e-2)" "unprognostic (4.02e-1)" "unprognostic (1.30e-1)" "unprognostic (1.15e-1)" "unprognostic (1.53e-1)" "unprognostic (1.46e-1)" "unprognostic (2.01e-1)" 19.1 13.7 25.1 12.7 25.5 9.3 19.2 16.9 25.8 13.1 15.5 13.1 7.8 12.3 15.2 18.5 16.6 12.6 12.7 13.9 23.2 25.4 18.1 12.5 15.6 27.0 24.8 13.4 10.9 16.0 28.1 18.2 17.7 14.5 18.6 17.1 16.3 12.9 18.5 18.6 12.3 11.8 17.1 21.7 18.4 10.6 9.0 14.2 24.6 15.5 10.6 14.7 13.6 10.7 1.7 3.2 34.5 4.4 3.6 2.1 1.5 22.3 10.2 13.4 9.4 14.2 10.8 7.6 10.1 12.2 12.4 12.9 9.8 14.6 11.0 33.9 10.1 15.4 12.3 11.4 9.6 15.4 10.0 10.6 9.1 7.1 6.6 13.1 10.2 17.0 8.1 15.0 10.0 9.5 9.9 6.7 18.0 6.2 22.1 11.3 20.3 26.3 13.3 6.0 17.8 11.6 14.3 15.8 15.9 12.8 7.5 13.0 14.4 17.0 11.7 13.9 10.5 40.5 9.5 3.5 11.9 5.2 13.0 15.5 27.9 32.1 20.8 10.8 12.6 12.3 15.5 3.0 34.5 1.5 4.4 1.3 1.7 1.4 2.1 3.2 1.7 1.6 1.4 8.6 3.6 4.4 1.4 1.7 1.5 25.1 25.5 16.9 25.8 23.2 25.4 24.8 13.4 14.5 14.2 17.9 21.8 19.9 24.6 15.1 31.0 10.7 20.4 9.4 11.4 27.9 45.2 17.1 29.9 6.9 19.9 15.7 18.7 0.0 4.9 17.4 22.4 27.9 11.5 14.4 17.0 31.8 15.1 17.8 18.3 17.2 25.9 19.4 20.3 10.8 17.7 33.8 5.4 14.4 32.9 29.9 34.6 25.8 19.4 21.4 33.5 13.9 9.7 17.8 26.3 16.3 PIH1D2 ENSG00000150773 "PIH1 domain containing 2" Q8WWB5 11 112064010-112074274 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 41.9" "Group enriched" "Detected in many" 10 "Ciliated cells: 123.1;Early spermatids: 307.7;Late spermatids: 93.6;Spermatocytes: 103.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 12.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039496 Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039496: AB_10959385" "unprognostic (8.74e-2)" "unprognostic (6.64e-3)" "unprognostic (1.29e-1)" "unprognostic (3.01e-3)" "unprognostic (4.72e-2)" "unprognostic (1.35e-2)" "unprognostic (3.74e-2)" "unprognostic (1.17e-1)" "unprognostic (2.43e-3)" "unprognostic (5.82e-2)" "unprognostic (9.05e-3)" "unprognostic (1.03e-1)" "unprognostic (2.81e-3)" "unprognostic (1.59e-1)" "unprognostic (6.08e-2)" "unprognostic (3.38e-2)" "unprognostic (1.12e-1)" 0.7 1.0 1.5 0.3 3.3 0.2 1.6 0.9 2.0 1.6 0.8 3.2 2.3 0.4 1.5 8.1 1.0 14.4 1.2 0.9 2.6 2.0 4.9 0.5 2.8 0.3 1.1 1.8 2.5 1.2 4.4 10.5 0.5 9.7 1.4 0.7 2.7 1.1 1.5 0.9 0.9 0.5 0.9 0.8 0.4 0.8 41.9 1.2 0.1 5.8 0.6 0.3 0.9 0.8 1.2 1.0 0.7 1.2 0.3 0.3 0.2 2.9 1.5 4.6 2.0 2.3 2.6 3.2 1.1 3.8 3.8 3.7 5.7 9.4 1.3 4.0 2.2 4.5 3.7 1.0 2.4 3.7 1.4 3.8 2.1 2.5 2.5 2.1 2.2 1.4 1.6 2.8 7.0 4.0 3.4 2.0 2.7 2.7 0.8 2.3 1.1 0.9 2.8 1.3 1.6 2.5 1.8 3.0 3.2 9.8 1.5 5.9 1.5 3.7 1.4 1.9 1.9 12.6 0.6 1.1 2.1 2.4 1.3 1.0 1.1 0.4 1.6 3.1 0.3 1.7 0.0 0.3 0.7 0.0 1.2 0.3 1.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.2 1.5 3.3 0.9 2.0 2.6 2.0 1.1 1.8 9.7 1.2 6.0 0.3 0.0 1.6 0.6 2.0 2.0 7.6 123.1 10.3 3.5 2.0 0.8 13.3 3.1 307.7 0.9 0.2 0.0 2.0 0.6 0.9 0.7 1.1 0.0 0.6 1.6 2.9 0.6 0.3 93.6 2.6 0.8 3.3 1.0 0.3 3.4 1.5 0.0 1.4 6.8 15.4 0.0 1.0 103.7 7.7 0.9 0.2 0.0 0.4 0.8 PIK3AP1 "BCAP, FLJ35564" ENSG00000155629 "Phosphoinositide-3-kinase adaptor protein 1" Q6ZUJ8 10 96593312-96720514 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 38.9;liver: 38.4;lymphoid tissue: 32.0;salivary gland: 29.7" "Cell type enhanced" "Detected in many" 11 "Hepatocytes: 66.5;Kupffer cells: 114.3;Macrophages: 53.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "intermediate monocyte: 15.5;memory B-cell: 17.5;naive B-cell: 16.2;non-classical monocyte: 38.9" "Group enriched" "Detected in all" 6 "B-cells: 17.5;monocytes: 38.9" "Cell line enhanced" "Detected in some" "Daudi: 24.7;NB-4: 17.8;REH: 52.8;THP-1: 26.9;U-698: 33.7;U-937: 27.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB026136, HPA038452" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" No No Cytosol "Nucleoplasm, Plasma membrane" "CAB026136: , HPA038452: AB_2676019" "unprognostic (2.83e-2)" "unprognostic (4.61e-3)" "unprognostic (7.32e-2)" "unprognostic (1.70e-1)" "unprognostic (1.79e-1)" "unprognostic (1.49e-1)" "unprognostic (4.60e-2)" "unprognostic (1.10e-1)" "unprognostic (2.33e-1)" "unprognostic (1.31e-1)" "unprognostic (1.96e-1)" "unprognostic (2.10e-1)" "unprognostic (5.11e-2)" "unprognostic (1.28e-1)" "unprognostic (4.69e-2)" "unprognostic (5.45e-1)" "unprognostic (1.13e-1)" 5.8 2.2 2.9 16.8 7.1 14.7 4.8 1.0 3.0 1.4 2.2 3.2 0.0 1.9 1.3 2.3 1.3 2.0 8.5 3.3 3.1 2.4 6.2 38.4 6.0 19.5 5.3 0.5 3.3 16.1 0.3 3.0 10.9 5.1 1.8 2.7 1.6 29.7 0.8 1.1 1.5 6.6 2.4 7.3 32.0 1.9 1.7 4.3 2.0 2.4 0.6 19.2 4.1 2.2 17.5 4.4 4.7 38.9 4.5 4.8 4.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.8 0.4 24.7 2.5 0.0 0.4 0.0 5.2 0.0 0.2 13.7 0.9 3.7 0.0 0.4 0.0 10.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.1 0.3 17.8 0.2 7.0 0.3 52.8 1.2 5.8 0.0 0.0 1.1 0.6 0.0 0.0 0.3 0.1 0.0 26.9 0.0 0.0 0.8 0.0 0.2 0.2 0.0 33.7 0.0 27.7 0.0 1.7 5.4 3.3 4.8 15.5 1.7 17.5 0.1 1.5 4.4 16.2 0.0 1.2 4.7 4.5 38.9 3.9 0.1 4.2 2.9 7.1 1.0 3.0 3.1 2.4 5.3 0.5 5.1 4.3 3.0 3.8 29.6 0.0 1.3 0.2 2.2 28.1 1.4 3.4 1.8 2.0 0.4 1.7 26.1 3.3 1.4 2.6 0.0 25.2 0.7 1.0 0.5 13.9 66.5 41.2 0.0 1.7 8.0 114.3 0.4 1.1 53.7 5.0 2.8 2.5 0.2 22.8 18.4 2.1 12.8 3.3 0.0 1.7 0.2 0.2 1.0 1.9 27.7 2.9 0.1 PIK3C2A PI3K-C2alpha ENSG00000011405 "Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha" O00443 11 17077730-17207983 "Enzymes, Predicted intracellular proteins" "Endocytosis, Exocytosis" "Kinase, Transferase" "Cataract, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037641, HPA037642" Uncertain Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA037641: AB_10671878, HPA037642: AB_10697081" "unprognostic (2.35e-1)" "unprognostic (2.16e-2)" "unprognostic (3.71e-2)" "unprognostic (1.06e-1)" "unprognostic (1.63e-1)" "unprognostic (6.63e-2)" "unprognostic (2.47e-2)" "unprognostic (1.39e-1)" "unprognostic (2.29e-2)" "unprognostic (1.86e-2)" "unprognostic (4.74e-2)" "unprognostic (1.84e-1)" "prognostic favorable (1.66e-4)" "unprognostic (3.20e-2)" "unprognostic (1.51e-1)" "unprognostic (1.18e-1)" "unprognostic (1.37e-1)" 22.3 16.8 17.6 17.2 26.3 9.2 20.0 22.6 17.2 22.1 17.2 13.9 22.2 15.6 20.3 19.2 16.8 18.2 20.2 16.3 14.5 11.6 25.7 16.3 22.2 11.3 17.6 16.1 17.6 14.2 62.9 23.0 23.5 28.5 18.7 14.3 15.2 15.6 27.5 15.4 13.1 17.9 19.5 31.8 17.5 18.3 19.4 18.0 11.4 32.2 9.3 11.5 23.1 20.5 4.4 5.2 6.0 7.2 4.2 4.8 1.6 23.1 10.6 17.8 11.1 12.9 13.2 16.0 14.7 15.9 10.8 15.1 25.8 2.6 6.8 7.3 12.6 17.7 15.4 14.2 11.2 19.2 5.8 12.3 4.2 12.9 10.1 14.1 5.2 6.7 10.2 7.9 10.6 20.9 10.1 25.6 4.3 9.9 6.6 8.3 7.1 2.8 3.3 10.1 13.0 8.2 2.9 18.5 4.7 13.4 20.6 10.5 9.3 22.3 9.6 10.3 15.6 5.7 5.3 31.9 8.7 12.6 22.5 8.9 2.7 5.9 5.6 10.4 4.9 10.0 4.1 4.1 2.9 4.6 2.5 3.0 3.6 3.7 3.6 5.2 4.4 4.8 2.8 6.0 4.2 7.2 3.7 2.3 1.6 17.6 26.3 22.6 17.2 14.5 11.6 17.6 16.1 28.5 18.0 71.5 56.0 17.6 19.9 31.4 47.8 22.4 22.9 29.4 39.8 34.9 66.8 25.6 16.6 15.8 21.3 80.2 17.1 0.0 21.6 14.0 19.7 34.1 30.2 28.6 16.4 33.4 27.5 108.1 38.5 12.0 23.9 23.8 18.6 11.8 20.1 82.7 22.6 11.5 29.4 17.0 41.1 38.8 29.8 36.4 15.5 29.6 120.0 19.2 17.2 27.3 PIK3C2B "C2-PI3K, PI3K-C2beta" ENSG00000133056 "Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta" O00750 1 204422628-204494724 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "granulocytes: 32.3;Ito cells: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 7.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 32.3;RT4: 33.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030515, HPA050360" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030515: AB_10670043, HPA050360: AB_2681104" "unprognostic (5.77e-2)" "unprognostic (1.36e-1)" "unprognostic (1.36e-1)" "unprognostic (2.18e-2)" "unprognostic (3.45e-1)" "unprognostic (2.19e-3)" "prognostic unfavorable (5.42e-4)" "unprognostic (3.35e-3)" "unprognostic (3.57e-3)" "unprognostic (2.72e-2)" "unprognostic (8.54e-2)" "unprognostic (1.10e-1)" "unprognostic (2.54e-1)" "unprognostic (5.36e-2)" "unprognostic (1.26e-1)" "unprognostic (1.75e-1)" "prognostic favorable (1.16e-4)" 12.9 4.5 11.0 16.0 19.3 5.3 11.0 9.1 17.5 7.4 17.0 36.0 9.6 15.5 10.5 5.8 14.6 7.7 14.7 10.7 14.4 9.1 7.6 5.8 18.0 23.9 24.2 11.2 3.9 6.1 4.7 4.3 20.4 14.5 7.3 14.5 6.3 8.0 14.1 20.0 22.6 15.7 11.2 16.2 14.2 20.7 2.4 23.0 31.8 9.8 8.1 23.1 13.1 11.8 7.4 0.3 0.5 0.2 1.6 2.0 0.4 3.2 6.6 5.9 5.4 3.5 0.3 32.3 0.4 1.3 1.3 0.9 3.9 8.7 5.6 1.2 0.7 1.1 8.2 3.5 2.3 0.5 3.4 0.9 0.1 13.1 1.4 0.2 1.9 4.3 0.4 2.5 0.3 0.2 0.5 8.6 5.7 2.0 3.8 0.1 7.3 6.7 5.6 5.4 12.9 4.2 7.3 1.5 1.0 1.6 33.8 6.5 3.6 11.7 16.4 3.8 2.2 7.3 1.0 0.3 0.2 2.1 0.6 0.1 4.1 1.1 7.3 0.2 3.0 0.8 0.1 0.2 0.0 1.2 0.0 1.0 2.9 1.3 0.8 0.3 7.4 0.7 0.6 0.5 1.6 0.0 0.1 2.0 0.4 11.0 19.3 9.1 17.5 14.4 9.1 24.2 11.2 14.5 23.0 0.0 12.6 11.1 1.9 3.4 16.6 6.4 0.0 2.7 4.5 3.5 0.0 3.8 0.0 1.1 0.6 20.0 14.8 0.0 3.0 3.4 4.1 2.2 32.3 3.9 3.3 14.3 9.2 27.0 2.2 0.0 1.1 2.3 3.3 2.8 23.7 2.5 3.3 10.5 7.1 1.9 1.0 0.0 3.1 0.0 1.5 6.9 1.8 2.5 13.2 6.3 PIK3CB PIK3C1 ENSG00000051382 "Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta" P42338 3 138652699-138834938 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Autophagy, Cell adhesion, Endocytosis" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 42.0;HMC-1: 66.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB031938, HPA042288, HPA064207" Approved Supported Nucleoplasm,Nucleoli,Vesicles,Midbody Yes No Nucleoplasm "Nucleoli, Vesicles, Midbody" "CAB031938: AB_2165408, HPA042288: , HPA064207: AB_2685212" "unprognostic (4.89e-2)" "unprognostic (1.42e-2)" "unprognostic (5.97e-2)" "unprognostic (7.85e-2)" "unprognostic (4.89e-2)" "unprognostic (6.01e-2)" "prognostic unfavorable (6.42e-4)" "unprognostic (3.98e-2)" "unprognostic (1.35e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (3.99e-5)" "unprognostic (2.15e-1)" "unprognostic (6.18e-3)" "unprognostic (9.33e-2)" "unprognostic (7.82e-2)" "unprognostic (2.79e-1)" "unprognostic (4.59e-2)" 12.5 9.9 10.6 9.7 20.6 17.4 11.5 29.9 25.0 12.4 14.6 11.9 11.7 13.7 9.6 6.9 15.2 10.9 8.7 12.7 12.2 14.2 22.6 9.3 9.5 9.1 11.9 15.2 8.8 20.3 20.2 10.9 18.1 24.1 13.4 15.7 12.2 14.9 15.9 33.4 19.6 16.4 8.3 12.5 9.9 11.0 6.4 10.7 14.4 37.4 7.1 11.9 13.4 11.0 4.6 9.1 11.3 7.8 1.3 6.5 2.6 23.0 10.0 4.3 3.6 3.9 5.3 29.3 5.4 5.2 5.5 5.9 10.7 8.8 9.3 14.8 5.3 10.6 9.9 5.6 8.6 9.9 11.8 6.3 42.0 6.8 6.4 4.0 10.2 66.6 4.5 6.6 3.8 7.8 9.8 8.3 4.5 16.0 6.9 6.9 10.6 5.9 7.2 6.2 17.0 9.4 4.3 4.5 6.6 8.5 12.8 3.7 2.7 15.0 6.5 19.3 13.2 16.3 24.4 8.7 3.5 4.5 7.7 7.6 11.7 7.6 8.5 8.6 9.9 4.9 7.0 7.8 11.3 4.0 4.5 2.7 4.6 5.2 3.0 9.1 4.1 6.5 4.4 10.0 1.3 4.3 1.4 2.2 2.6 10.6 20.6 29.9 25.0 12.2 14.2 11.9 15.2 24.1 10.7 8.9 14.7 4.7 12.9 16.9 15.4 30.2 12.7 14.7 21.6 17.4 23.6 29.1 5.0 9.4 0.9 8.5 21.3 0.0 16.5 46.3 6.5 23.0 13.9 15.8 13.4 20.6 15.6 11.6 28.8 1.1 3.4 19.7 6.8 14.4 14.9 8.2 15.2 21.8 6.3 18.9 17.9 6.5 6.1 10.7 14.9 20.5 40.0 6.1 12.7 15.3 PIK3R3 p55 ENSG00000117461 "Phosphoinositide-3-kinase regulatory subunit 3" Q92569 1 46040140-46133036 "Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 44.0;Cone photoreceptor cells: 43.2;Endothelial cells: 43.8;Rod photoreceptor cells: 44.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 8.6" "Group enriched" "Detected in many" 8 "granulocytes: 8.6;monocytes: 3.1;T-cells: 3.5" "Cell line enhanced" "Detected in many" "RT4: 33.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005751, HPA071988" Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA005751: AB_1855350, HPA071988: AB_2686479" "unprognostic (1.98e-1)" "unprognostic (3.75e-3)" "unprognostic (8.04e-2)" "prognostic favorable (1.93e-4)" "unprognostic (6.32e-2)" "prognostic favorable (3.62e-4)" "unprognostic (4.88e-2)" "unprognostic (3.33e-3)" "unprognostic (4.16e-2)" "unprognostic (4.63e-2)" "unprognostic (1.05e-2)" "unprognostic (1.45e-1)" "unprognostic (9.99e-3)" "unprognostic (2.87e-2)" "unprognostic (9.74e-2)" "unprognostic (6.71e-2)" "unprognostic (8.22e-3)" 33.7 10.9 7.4 7.0 8.2 0.8 24.7 36.4 11.0 16.9 6.3 3.5 9.1 3.3 15.8 11.0 8.4 7.6 10.9 28.7 6.8 8.5 10.4 4.1 20.0 6.0 8.7 3.1 4.6 4.0 18.7 10.2 13.4 10.4 9.0 5.3 13.6 9.4 8.0 14.8 4.6 6.0 12.3 7.1 10.9 7.4 24.0 4.5 5.9 12.7 6.2 5.3 12.3 8.7 0.5 0.6 8.6 3.1 0.1 3.5 0.9 4.7 1.6 21.6 10.9 2.1 0.9 6.9 2.8 2.0 3.7 4.6 0.9 1.4 6.2 8.6 1.1 4.5 2.8 7.5 2.6 2.4 4.8 6.7 3.9 19.4 0.7 0.7 3.5 5.4 2.7 1.5 3.9 1.4 3.6 7.7 14.5 1.4 4.5 5.2 7.2 14.1 2.2 7.6 1.3 4.3 18.2 5.7 7.4 9.3 33.6 15.6 11.3 9.1 24.1 2.6 13.5 6.7 3.2 14.3 4.0 3.7 0.6 2.7 6.4 6.6 3.8 3.1 4.7 2.0 0.0 0.3 8.6 3.3 0.5 3.0 0.5 0.8 2.9 0.0 0.0 0.3 1.9 0.1 0.1 3.1 0.6 3.5 0.9 7.4 8.2 36.4 8.9 6.8 8.5 8.7 3.1 10.4 4.5 0.0 9.6 0.0 3.0 2.3 44.0 17.3 0.0 17.4 5.7 17.4 43.2 4.0 0.0 0.4 8.7 43.8 5.1 0.0 1.0 1.0 4.5 7.4 9.2 0.0 1.4 3.2 7.5 0.0 0.0 12.1 1.1 1.8 5.0 1.0 1.5 30.4 1.3 1.1 7.4 3.4 44.4 0.0 12.5 29.2 28.5 1.6 1.1 1.5 1.7 3.3 PIK3R6 "C17orf38, FLJ34500, HsT41028, p87PIKAP" ENSG00000276231 "Phosphoinositide-3-kinase regulatory subunit 6" Q5UE93 17 8802723-8867677 "Predicted intracellular proteins" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 32.1;lymphoid tissue: 12.2" "Cell type enhanced" "Detected in some" 26 "Early spermatids: 8.7;granulocytes: 45.2;Late spermatids: 13.8" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "eosinophil: 32.1" "Lineage enriched" "Detected in many" 7 "granulocytes: 32.1" "Cell line enriched" "Detected in some" 8 "HMC-1: 58.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023077 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" "Plasma membrane, Cytosol" "HPA023077: AB_1854909" "unprognostic (4.29e-2)" "unprognostic (8.56e-3)" "unprognostic (9.39e-2)" "unprognostic (5.96e-3)" "unprognostic (2.46e-1)" "unprognostic (5.25e-3)" "unprognostic (4.50e-3)" "unprognostic (2.29e-2)" "unprognostic (3.12e-2)" "unprognostic (3.14e-1)" "unprognostic (2.20e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (1.50e-6)" "unprognostic (3.45e-1)" "unprognostic (3.91e-2)" "unprognostic (2.68e-1)" "unprognostic (8.98e-2)" 2.2 0.0 2.1 12.2 5.4 5.3 1.0 0.0 3.7 1.5 1.9 2.5 1.4 3.5 2.6 2.3 1.2 0.4 6.6 2.6 3.1 0.0 0.6 3.4 4.4 2.5 0.0 0.3 0.8 0.3 0.0 1.4 3.2 2.4 1.5 1.4 0.9 0.7 1.0 1.8 5.2 2.2 3.1 6.3 2.3 1.1 2.7 6.9 0.0 0.8 6.4 3.0 3.3 1.3 4.9 32.1 4.3 0.5 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 7.5 0.0 0.0 0.0 0.0 58.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 7.7 3.4 32.1 0.2 4.3 0.2 1.3 0.0 0.1 4.9 0.1 0.0 0.1 0.5 0.5 3.3 0.0 0.0 1.4 0.0 2.2 0.0 0.0 0.5 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.1 0.2 0.0 45.2 0.0 6.3 0.0 0.0 0.0 2.6 13.8 0.0 3.2 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 1.5 0.0 0.0 PIMREG "CATS, FAM64A, FLJ10156, FLJ10491, RCS1" ENSG00000129195 "PICALM interacting mitotic regulator" Q9BSJ6 17 6444415-6451469 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 27.3" "Cell type enriched" "Detected in some" 4 "Hofbauer cells: 5.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 50.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA043783, HPA049934" Uncertain Enhanced Nucleoplasm Yes Yes Nucleoplasm "HPA043783: AB_2678669, HPA049934: AB_2680959" "unprognostic (5.32e-3)" "unprognostic (1.14e-2)" "unprognostic (2.33e-1)" "unprognostic (4.37e-3)" "unprognostic (1.46e-1)" "unprognostic (1.24e-2)" "unprognostic (6.55e-3)" "unprognostic (1.23e-3)" "unprognostic (1.80e-1)" "unprognostic (5.88e-2)" "unprognostic (1.47e-3)" "unprognostic (1.50e-2)" "unprognostic (0.00e+0)" "unprognostic (8.65e-2)" "unprognostic (1.04e-1)" "unprognostic (1.01e-1)" "unprognostic (1.11e-1)" 1.9 4.5 1.2 1.6 1.1 3.1 2.2 1.0 0.8 1.3 4.7 0.6 0.4 4.3 1.6 1.7 6.0 0.3 2.5 1.6 0.5 0.5 0.8 0.9 2.1 1.7 0.6 0.4 1.6 0.4 0.0 1.0 0.9 1.2 0.8 6.2 0.4 1.3 0.4 0.4 3.7 4.5 2.7 1.0 9.5 1.8 1.0 0.4 27.3 0.4 3.9 3.6 2.3 2.0 0.4 0.0 0.8 0.4 3.3 1.5 1.2 12.6 17.1 50.8 22.8 0.4 1.5 3.9 14.9 9.2 24.5 16.6 10.1 5.5 0.0 6.0 12.1 12.1 9.3 25.6 6.6 13.2 19.5 10.2 0.0 10.2 12.2 0.0 0.5 15.5 0.8 0.4 10.1 3.9 2.3 7.7 11.3 3.0 7.2 15.3 9.1 2.7 0.1 22.2 10.2 11.2 22.7 20.4 8.9 4.0 1.9 11.6 16.3 12.9 13.4 12.6 6.4 6.2 1.2 3.6 19.2 15.6 11.3 24.3 2.6 9.2 0.0 7.5 6.2 29.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.3 0.0 0.4 0.2 0.7 0.8 3.3 0.4 0.0 1.3 1.2 1.2 1.1 1.0 0.7 0.5 0.5 0.6 0.4 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PIN1 dod ENSG00000127445 "Peptidylprolyl cis/trans isomerase, NIMA-interacting 1" Q13526 19 9835257-9849682 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cell cycle" "Isomerase, Rotamase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 88.2" "Cell type enhanced" "Detected in all" 7 "Late spermatids: 571.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB004528, CAB009326, HPA068650, HPA070887" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 30000 Nucleoplasm Cytosol "CAB004528: AB_628132, CAB009326: AB_2237080, HPA068650: AB_2686014, HPA070887: " "unprognostic (2.54e-1)" "unprognostic (6.14e-3)" "unprognostic (6.50e-2)" "unprognostic (4.36e-2)" "unprognostic (1.71e-2)" "unprognostic (6.50e-3)" "unprognostic (1.90e-1)" "unprognostic (2.86e-2)" "unprognostic (2.67e-1)" "unprognostic (7.23e-3)" "prognostic favorable (3.25e-4)" "unprognostic (9.43e-2)" "prognostic favorable (7.80e-5)" "unprognostic (2.20e-2)" "unprognostic (2.56e-1)" "unprognostic (3.13e-2)" "unprognostic (1.21e-2)" 24.5 36.3 40.0 18.7 38.8 25.6 9.3 27.4 66.0 9.2 15.8 18.1 8.5 22.9 14.0 8.3 11.3 16.4 10.1 25.9 38.0 35.2 17.4 14.5 13.2 14.8 38.7 37.2 13.9 21.1 9.5 13.6 13.3 57.3 23.2 6.5 14.1 21.3 15.7 50.2 10.2 21.7 11.1 19.6 15.4 19.6 24.8 15.0 19.7 9.9 8.1 9.3 11.1 9.7 36.4 72.8 88.2 44.9 40.7 53.8 46.2 26.2 24.1 18.0 16.7 6.3 5.6 10.6 19.7 8.5 14.7 14.2 22.3 8.4 16.3 31.4 7.3 15.3 13.5 12.4 11.9 4.7 34.7 52.6 42.4 29.6 19.2 10.3 19.7 24.9 7.7 8.0 9.5 4.5 11.0 11.9 29.3 19.1 24.8 8.8 18.4 29.9 77.2 17.2 11.0 37.1 27.4 18.7 27.3 10.5 12.9 22.7 26.7 19.0 9.5 22.0 7.7 12.2 23.7 20.1 20.4 16.3 31.5 31.5 32.1 30.1 21.9 21.7 25.3 25.0 52.2 43.4 88.2 42.0 44.9 39.2 35.6 41.5 42.1 39.7 36.4 33.1 37.2 26.8 40.7 41.7 72.8 53.8 46.2 40.0 38.8 27.4 66.0 38.0 35.2 38.7 37.2 57.3 15.0 26.8 21.5 49.1 53.7 42.8 68.5 65.3 43.3 56.2 14.8 59.3 11.8 107.3 139.3 95.7 197.0 54.9 69.5 46.7 95.4 80.4 81.4 55.2 63.4 41.4 123.0 57.2 95.8 47.3 50.0 571.0 83.4 67.4 118.1 174.1 57.9 60.8 85.6 73.7 122.0 109.4 50.6 64.7 97.1 136.8 72.0 57.6 46.0 94.4 62.6 47.8 PIN4 "EPVH, PAR14, PAR17" ENSG00000102309 "Peptidylprolyl cis/trans isomerase, NIMA-interacting 4" Q9Y237 X 72181353-72302926 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA-binding, Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 68.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054483, HPA064504" Approved Supported "Nucleoplasm,Nucleoli,Mitotic chromosome" Yes No "Nucleoplasm, Nucleoli" "Mitotic chromosome" "HPA054483: AB_2682503, HPA064504: AB_2685274" "unprognostic (2.47e-1)" "unprognostic (6.97e-3)" "unprognostic (1.65e-1)" "unprognostic (3.77e-2)" "unprognostic (8.42e-2)" "unprognostic (1.30e-2)" "unprognostic (1.14e-2)" "prognostic favorable (6.37e-4)" "unprognostic (1.56e-1)" "unprognostic (2.13e-2)" "unprognostic (2.49e-1)" "unprognostic (9.54e-2)" "unprognostic (2.09e-3)" "unprognostic (1.92e-1)" "prognostic favorable (2.58e-4)" "unprognostic (3.34e-3)" "prognostic favorable (2.66e-4)" 14.4 11.3 15.0 8.0 14.7 6.1 18.8 10.7 16.2 9.7 9.7 8.4 6.7 9.5 11.6 19.3 8.9 8.7 30.7 11.2 15.2 12.2 15.6 23.2 7.9 7.9 12.9 11.0 12.7 8.1 8.0 9.2 9.8 10.0 10.4 11.1 6.6 30.7 37.1 68.7 7.3 9.6 9.2 12.4 16.7 9.3 4.7 6.9 9.7 12.9 40.1 9.1 7.8 9.2 28.9 26.8 23.4 23.6 22.4 33.4 22.7 15.4 18.1 19.0 12.9 13.0 10.9 10.1 10.6 12.2 13.0 13.4 9.1 11.5 4.6 31.0 10.9 17.6 11.0 16.8 18.6 16.1 11.7 37.8 7.9 21.6 23.9 7.2 12.5 6.7 7.3 10.3 14.2 4.9 14.7 13.2 14.2 13.3 20.6 9.7 18.7 10.9 21.1 13.5 17.6 16.4 10.9 15.1 13.7 16.5 10.8 12.2 21.7 12.4 5.8 10.9 14.6 9.0 11.5 13.2 5.9 9.1 16.2 7.7 7.1 7.6 7.7 17.0 12.6 6.4 21.9 23.3 23.4 26.8 23.6 26.4 28.9 28.3 25.5 22.8 26.4 29.3 29.4 9.7 22.4 21.8 26.8 33.4 22.7 15.0 14.7 10.7 16.2 15.2 12.2 12.9 11.0 10.0 6.9 62.5 35.0 52.8 54.1 38.4 26.9 74.7 81.5 84.3 51.2 113.4 7.9 137.4 154.2 102.6 10.6 70.5 117.6 23.3 102.2 92.0 70.9 50.1 55.5 238.7 95.4 27.0 88.9 80.4 73.2 6.2 69.0 61.7 57.3 68.5 76.9 55.6 124.5 101.7 76.4 218.0 33.7 84.1 78.3 14.4 39.1 40.9 100.9 62.3 82.1 54.0 PINX1 "FLJ20565, Gno1, LPTL, LPTS, MGC8850, PinX1, Pxr1" ENSG00000254093 "PIN2/TERF1 interacting telomerase inhibitor 1" Q96BK5 8 10764963-10839884 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 40.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023139, HPA023146" Uncertain Supported Nucleoplasm,Nucleoli,Mitochondria NA NA Nucleoli "Nucleoplasm, Mitochondria" "HPA023139: AB_1855384, HPA023146: " "unprognostic (4.01e-1)" "prognostic favorable (2.45e-5)" "unprognostic (7.80e-3)" "unprognostic (3.35e-2)" "unprognostic (4.10e-1)" "unprognostic (4.61e-2)" "unprognostic (1.83e-2)" "unprognostic (3.40e-2)" "unprognostic (9.73e-3)" "unprognostic (2.49e-1)" "unprognostic (1.40e-1)" "unprognostic (4.37e-1)" "unprognostic (2.59e-1)" "unprognostic (1.13e-1)" "unprognostic (1.45e-1)" "unprognostic (1.45e-1)" "unprognostic (2.08e-2)" 14.3 14.4 9.9 16.0 13.9 14.8 13.8 14.5 16.5 12.6 14.2 12.6 7.1 11.5 15.7 8.9 19.3 10.7 9.3 11.7 10.6 10.1 13.1 19.4 11.2 19.2 13.2 10.9 16.1 17.2 7.6 10.7 13.3 17.6 11.4 12.0 15.6 14.9 8.5 21.2 19.0 11.3 15.9 11.1 14.8 11.7 24.0 9.7 18.7 12.4 17.8 19.6 11.5 14.3 9.8 8.8 4.4 8.4 8.9 16.0 8.4 6.4 8.7 9.4 8.9 8.0 6.5 10.8 9.9 4.5 10.9 7.4 9.1 5.7 17.4 3.5 5.3 13.4 13.1 23.8 18.3 14.1 7.0 7.1 7.3 6.1 9.8 9.0 7.8 4.6 5.4 11.7 8.6 16.1 3.9 15.1 11.9 23.1 10.8 10.7 7.7 25.5 9.8 21.6 28.3 9.7 20.9 11.5 15.9 8.1 8.0 7.8 8.1 6.6 7.9 21.7 12.0 8.4 9.7 9.1 6.6 14.3 8.4 12.7 4.9 12.7 31.7 6.8 14.8 14.9 1.5 6.8 4.4 12.5 8.4 16.0 9.7 10.9 13.1 8.8 9.8 15.0 11.6 0.4 8.9 7.3 6.8 12.3 8.4 9.9 13.9 14.5 16.5 10.6 10.1 13.2 10.9 17.6 9.7 3.0 4.1 9.9 14.8 23.7 5.2 3.3 7.6 10.7 9.1 3.5 11.8 14.9 10.0 0.0 29.6 11.4 4.0 0.0 0.0 9.6 8.0 5.2 13.9 6.6 14.3 3.2 8.1 11.6 4.0 22.3 8.6 9.6 6.8 0.0 3.9 6.2 0.0 4.8 6.0 8.2 21.5 0.0 6.2 24.9 25.1 25.0 40.3 11.7 7.7 8.0 PIP4K2B "PIP5K2B, PIP5KIIB, PIP5KIIbeta" ENSG00000276293 "Phosphatidylinositol-5-phosphate 4-kinase type 2 beta" P78356 17 38765689-38800126 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 23.6" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 41.3" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062220 Supported Nucleoplasm NA NA Nucleoplasm "HPA062220: AB_2684715" "unprognostic (7.77e-2)" "unprognostic (8.37e-2)" "unprognostic (3.74e-2)" "unprognostic (1.13e-1)" "unprognostic (2.67e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (4.54e-4)" "unprognostic (2.64e-1)" "unprognostic (2.33e-1)" "unprognostic (1.50e-2)" "unprognostic (6.10e-3)" "unprognostic (3.79e-1)" "unprognostic (4.82e-3)" "unprognostic (3.38e-2)" "unprognostic (3.22e-1)" "prognostic favorable (1.36e-4)" "unprognostic (2.48e-1)" 5.1 6.5 12.4 3.3 12.9 1.1 5.0 8.8 17.4 6.8 2.7 7.0 4.2 2.2 7.2 5.9 3.5 7.4 3.6 7.1 9.6 4.1 2.2 5.0 4.2 5.4 13.3 13.3 3.0 5.1 2.7 5.4 7.5 5.1 3.2 4.1 3.8 6.5 23.6 5.8 2.3 7.3 4.7 5.1 2.5 2.8 6.5 2.0 4.7 2.2 4.5 3.7 5.9 3.3 3.1 2.4 2.4 3.4 5.0 3.7 5.7 12.7 21.2 22.0 18.5 14.7 4.3 10.8 12.0 13.6 11.2 8.6 5.7 14.8 6.8 18.4 11.9 12.4 14.0 8.9 13.1 10.2 9.0 12.8 8.2 12.6 8.4 14.6 7.9 12.9 10.9 10.6 7.9 19.2 11.3 15.4 11.2 7.0 14.6 4.3 13.4 10.7 11.8 6.4 5.9 14.6 20.9 8.1 10.0 7.2 11.8 17.1 10.9 4.4 11.0 23.1 14.0 13.8 11.9 11.5 7.6 9.9 9.3 9.2 11.5 6.7 13.7 11.6 10.4 1.6 2.4 0.8 4.8 2.2 5.0 3.1 4.1 4.6 3.1 3.3 4.7 4.2 2.4 3.4 1.8 3.0 3.9 3.7 17.9 10.7 3.7 3.7 5.5 33.8 18.9 7.6 4.0 9.1 5.2 9.8 6.3 1.7 4.7 8.7 14.6 3.9 0.0 4.2 4.1 8.5 4.5 1.1 9.8 7.5 41.3 11.1 20.3 8.3 13.7 14.1 5.7 1.7 1.8 6.9 12.9 5.4 3.5 15.6 6.7 13.4 6.5 7.2 4.6 8.1 3.9 2.1 7.2 7.3 1.8 PIP4K2C "FLJ22055, PIP5K2C" ENSG00000166908 "Phosphatidylinositol-5-phosphate 4-kinase type 2 gamma" Q8TBX8 12 57591174-57603418 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 112.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 49.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028658 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA028658: AB_10601245" "unprognostic (7.84e-3)" "unprognostic (1.51e-1)" "unprognostic (2.42e-1)" "unprognostic (2.77e-2)" "unprognostic (2.49e-2)" "unprognostic (3.37e-2)" "prognostic unfavorable (7.98e-4)" "unprognostic (3.17e-2)" "unprognostic (6.00e-2)" "unprognostic (5.51e-2)" "unprognostic (1.75e-1)" "unprognostic (1.88e-1)" "prognostic favorable (2.06e-6)" "unprognostic (1.87e-1)" "unprognostic (2.16e-1)" "unprognostic (3.27e-1)" "unprognostic (3.42e-1)" 9.3 13.3 13.9 9.2 25.9 16.7 15.0 18.9 45.5 12.5 17.5 14.6 15.8 11.6 14.2 62.0 20.0 20.0 12.1 10.8 15.4 10.9 26.9 14.4 14.4 9.2 14.3 21.2 12.3 14.9 29.6 13.7 11.1 18.8 16.7 19.4 17.4 18.6 14.6 9.4 18.4 13.3 11.9 12.7 10.7 27.6 25.6 12.1 5.9 17.9 8.5 13.1 14.6 14.1 6.8 5.4 29.7 8.4 9.4 16.1 6.5 19.1 13.5 5.5 6.6 0.0 0.0 17.8 8.0 15.0 14.5 13.5 17.2 27.7 4.1 17.6 9.3 17.9 17.5 9.0 15.7 11.7 6.2 10.1 7.5 6.5 12.1 12.8 6.9 13.5 5.0 26.7 5.5 10.3 17.8 7.3 4.6 9.6 12.6 7.5 18.9 6.2 6.0 10.5 11.7 11.8 0.1 49.9 6.2 15.2 32.8 9.3 11.5 17.2 11.5 10.9 19.4 31.6 6.4 1.6 7.3 10.1 10.7 8.4 9.7 11.3 9.3 14.4 5.9 12.1 29.7 5.2 15.3 16.1 6.2 10.7 5.9 9.9 12.0 5.4 6.8 9.6 11.5 10.2 9.4 8.4 2.3 12.1 6.5 13.9 25.9 18.9 45.5 15.4 10.9 14.3 21.2 18.8 12.1 8.9 7.5 3.0 5.7 11.0 13.1 112.2 15.3 13.4 9.1 33.2 17.7 9.3 18.3 16.2 23.8 3.5 18.0 0.0 17.1 13.6 4.9 9.9 3.5 11.6 7.9 7.9 21.4 9.8 2.9 35.3 6.4 4.1 11.8 8.2 16.1 6.5 28.1 13.6 4.9 10.1 8.3 19.4 6.4 11.9 7.1 11.2 14.5 8.7 8.6 7.1 PIP5K1A ENSG00000143398 "Phosphatidylinositol-4-phosphate 5-kinase type 1 alpha" Q99755 1 151197949-151249536 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 92.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029366 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA029366: AB_10602116" "unprognostic (1.05e-1)" "unprognostic (2.36e-2)" "unprognostic (8.64e-2)" "unprognostic (7.94e-3)" "unprognostic (1.17e-1)" "unprognostic (3.28e-2)" "unprognostic (1.26e-2)" "unprognostic (3.01e-1)" "unprognostic (8.79e-2)" "unprognostic (1.15e-1)" "unprognostic (1.37e-1)" "unprognostic (1.04e-1)" "prognostic unfavorable (4.16e-7)" "unprognostic (1.44e-1)" "unprognostic (8.14e-2)" "unprognostic (2.93e-1)" "unprognostic (1.59e-1)" 18.1 19.5 15.7 15.4 21.0 9.6 20.2 22.6 27.6 19.8 18.0 20.3 14.7 16.4 24.8 22.6 20.7 19.4 20.7 18.9 17.3 13.4 17.8 18.3 21.7 17.1 12.7 17.5 20.4 16.6 21.8 25.3 44.6 14.6 17.3 15.6 29.5 17.8 15.2 26.1 20.4 20.4 27.2 16.1 20.1 16.8 42.1 14.0 19.3 20.1 13.9 22.3 16.2 17.7 9.1 8.7 11.7 6.2 4.7 5.9 6.3 17.7 13.8 21.4 24.7 14.1 15.0 21.1 23.5 33.0 43.9 39.4 25.1 17.2 16.2 25.0 25.0 19.8 15.1 27.7 16.1 38.5 24.3 19.8 12.8 18.3 12.0 26.7 22.9 16.2 19.9 15.0 27.3 34.6 19.4 17.8 25.8 12.5 13.8 22.0 24.9 22.8 11.4 31.7 13.6 21.5 22.1 18.7 12.0 22.5 10.3 14.4 19.0 31.7 24.4 20.6 37.4 25.6 21.7 17.1 17.5 24.4 16.1 28.2 19.3 32.1 36.5 17.0 6.7 20.8 0.1 5.5 7.3 5.3 6.2 4.1 9.1 5.0 5.9 8.4 4.6 5.4 4.2 11.7 4.7 4.8 8.7 3.9 6.3 15.7 21.0 22.6 27.6 17.3 13.4 12.7 17.5 14.6 14.0 29.8 13.5 19.0 21.3 58.7 33.2 17.3 12.7 12.0 11.4 29.6 92.3 21.0 8.3 11.8 2.8 13.2 15.9 0.0 7.5 24.0 19.1 15.9 11.5 11.6 11.1 25.4 5.8 17.8 10.1 3.6 12.4 11.5 11.8 10.0 8.4 13.8 13.3 8.4 10.3 7.9 43.5 12.9 19.6 46.5 22.4 43.7 53.1 8.7 9.5 32.5 PIP5K1B "MSS4, STM7" ENSG00000107242 "Phosphatidylinositol-4-phosphate 5-kinase type 1 beta" O14986 9 68705414-69009176 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Muller glia cells: 103.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "eosinophil: 22.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 22.1" "Cell line enhanced" "Detected in some" "AF22: 23.8;HEL: 8.9;Hep G2: 7.3;OE19: 39.1;U-266/70: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009687 Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA009687: AB_1855391" "unprognostic (2.02e-3)" "unprognostic (1.84e-2)" "unprognostic (3.77e-2)" "unprognostic (2.72e-1)" "unprognostic (1.56e-1)" "unprognostic (1.62e-1)" "unprognostic (5.85e-3)" "unprognostic (1.80e-2)" "unprognostic (1.38e-2)" "unprognostic (1.17e-1)" "unprognostic (2.98e-2)" "unprognostic (2.92e-2)" "prognostic favorable (1.03e-9)" "unprognostic (2.10e-2)" "unprognostic (1.71e-1)" "unprognostic (1.19e-1)" "unprognostic (3.34e-1)" 4.0 9.5 9.4 8.4 6.5 10.2 4.2 33.4 14.6 5.6 26.9 4.1 10.8 26.1 6.1 2.0 1.2 5.0 7.6 24.6 8.1 11.7 6.1 0.8 12.6 2.1 10.4 6.4 1.4 6.7 21.3 8.5 16.8 32.8 3.3 23.1 28.7 11.6 13.6 3.0 2.4 39.7 2.6 3.7 3.1 19.9 17.6 1.5 0.0 1.6 1.9 3.3 3.5 2.9 3.9 0.9 22.1 0.3 0.0 1.0 0.2 0.0 0.0 23.8 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 2.5 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 8.9 0.2 7.3 0.0 0.5 2.2 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.4 5.1 0.1 0.6 0.0 0.1 1.2 39.1 0.7 0.7 0.0 0.1 0.1 1.8 0.4 0.0 0.0 0.0 0.3 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 9.2 1.7 1.1 0.0 1.6 0.0 3.1 0.3 22.1 0.0 0.0 0.0 3.3 0.2 0.0 0.1 3.9 0.5 0.0 1.2 0.0 0.1 0.9 1.0 0.2 9.4 6.5 33.4 14.6 8.1 11.7 10.4 6.4 32.8 1.5 32.8 27.2 5.2 3.0 0.6 4.6 51.2 5.1 4.0 2.3 5.2 2.0 16.1 23.2 1.3 54.3 3.0 49.9 46.7 12.3 0.7 1.0 2.3 5.7 0.0 3.2 0.0 35.5 1.8 1.3 32.7 2.3 2.2 5.0 0.0 26.7 103.2 5.6 33.1 1.4 0.7 3.1 25.8 46.7 1.2 1.7 0.3 7.3 1.3 23.7 4.3 PIP5K1C "KIAA0589, LCCS3, PIP5Kgamma" ENSG00000186111 "Phosphatidylinositol-4-phosphate 5-kinase type 1 gamma" O60331 19 3630183-3700479 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell adhesion, Chemotaxis, Endocytosis, Exocytosis, Phagocytosis" "Kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 38.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017168 Approved Approved Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA017168: AB_1855395" "unprognostic (1.20e-1)" "prognostic favorable (1.79e-4)" "unprognostic (1.36e-3)" "prognostic favorable (7.28e-5)" "unprognostic (7.03e-2)" "unprognostic (4.02e-3)" "unprognostic (5.80e-3)" "unprognostic (8.50e-2)" "unprognostic (1.31e-1)" "unprognostic (2.57e-3)" "prognostic favorable (2.32e-4)" "unprognostic (1.51e-1)" "prognostic favorable (3.00e-4)" "unprognostic (2.25e-1)" "unprognostic (1.84e-1)" "unprognostic (2.30e-1)" "unprognostic (2.70e-1)" 16.1 10.2 20.5 12.8 25.8 4.5 8.0 58.6 46.3 10.7 23.5 8.5 14.8 10.9 19.8 10.0 12.3 12.8 12.7 13.8 22.8 10.7 7.5 3.8 11.5 7.5 11.3 17.1 11.5 17.2 10.0 9.2 13.7 19.0 16.7 6.4 16.9 20.0 33.4 13.5 10.2 11.5 19.2 6.3 15.8 13.6 23.9 8.7 5.3 9.3 3.9 6.0 17.3 19.0 2.5 3.2 3.6 3.0 1.7 2.8 2.0 9.2 8.8 6.9 8.9 13.5 11.0 10.4 17.9 11.3 7.7 6.2 7.8 2.6 3.9 6.9 19.1 8.5 8.2 3.2 5.8 3.2 13.8 5.8 4.4 7.3 6.3 11.3 4.5 13.8 12.2 5.5 6.3 2.4 5.5 13.0 5.9 6.7 7.2 7.2 7.7 5.4 3.3 7.2 3.4 12.2 10.2 5.3 5.3 5.7 8.0 7.0 6.0 9.2 5.0 5.4 9.0 4.0 6.8 28.6 10.8 6.2 38.1 8.3 8.3 6.6 1.7 14.5 9.5 7.7 3.6 2.8 0.0 2.8 2.6 1.2 2.5 2.1 2.0 3.2 1.3 1.0 1.6 2.2 1.7 3.0 2.2 1.4 2.0 20.5 25.8 58.6 46.3 22.8 10.7 11.3 17.1 19.0 8.7 6.0 5.3 5.4 2.8 4.7 40.8 5.5 7.6 2.7 0.0 15.7 35.3 6.2 1.7 6.9 8.4 12.0 7.0 0.0 6.2 6.0 8.5 4.9 1.1 3.6 13.3 28.6 8.1 16.0 11.0 17.7 13.8 10.8 5.0 13.6 9.2 10.5 9.9 7.0 22.6 5.7 26.6 12.9 10.7 19.0 10.4 5.9 13.7 6.4 5.7 3.8 PITPNC1 "RDGB-BETA, RDGBB, RDGBB1" ENSG00000154217 "Phosphatidylinositol transfer protein, cytoplasmic 1" Q9UKF7 17 67377281-67697261 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 69.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026563, HPA031250" Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA026563: AB_1855409, HPA031250: AB_2673808" "unprognostic (1.33e-1)" "unprognostic (1.43e-1)" "unprognostic (1.94e-1)" "unprognostic (1.14e-3)" "unprognostic (4.17e-2)" "prognostic favorable (4.85e-5)" "unprognostic (6.57e-2)" "unprognostic (6.32e-3)" "unprognostic (1.23e-3)" "unprognostic (1.19e-1)" "unprognostic (5.70e-2)" "unprognostic (2.31e-2)" "unprognostic (1.34e-2)" "unprognostic (9.83e-2)" "unprognostic (7.88e-2)" "unprognostic (2.65e-3)" "unprognostic (1.16e-2)" 20.8 10.0 22.9 18.0 31.0 11.3 16.6 18.9 33.5 12.0 7.5 18.7 7.0 4.6 10.7 11.7 11.0 22.4 12.5 11.7 23.4 19.1 17.3 14.3 13.5 24.3 21.4 17.0 16.7 23.3 5.4 12.3 19.0 22.7 11.2 9.1 31.2 18.3 13.1 5.1 5.2 8.1 11.7 14.8 13.9 11.8 5.1 17.8 14.5 10.4 6.0 27.0 12.0 16.8 1.6 1.6 16.1 5.5 7.2 16.4 5.0 5.9 2.3 5.9 11.6 5.2 7.1 6.9 6.7 5.3 1.3 1.0 0.0 8.8 7.3 2.2 6.2 2.2 2.5 10.5 10.1 1.4 13.4 6.1 0.8 9.8 4.8 1.4 1.4 13.8 5.5 4.4 0.8 5.4 0.7 5.1 9.9 0.6 26.6 5.1 12.8 17.0 6.2 10.1 2.8 12.1 21.6 1.3 6.5 12.6 7.2 7.3 19.3 2.6 5.1 6.0 6.6 3.8 7.3 5.1 3.2 1.3 4.0 3.2 17.3 8.6 5.6 20.2 6.0 2.5 1.1 2.5 16.1 16.4 4.0 9.6 1.0 10.7 15.5 1.6 1.6 12.3 13.0 3.1 7.2 5.5 0.4 4.0 5.0 22.9 31.0 18.9 25.3 23.4 19.1 21.4 17.0 22.7 17.8 8.9 0.6 10.0 40.5 4.7 18.6 5.3 20.4 2.7 2.3 0.0 2.0 7.0 18.3 38.5 0.3 48.5 1.3 0.0 43.0 8.8 5.8 29.8 4.7 7.9 12.4 69.9 5.8 17.2 15.8 1.0 4.6 11.0 10.1 19.0 1.3 25.9 36.1 3.5 13.8 12.6 22.1 25.8 21.1 0.5 3.8 3.8 2.9 45.7 2.8 41.1 PITX2 "ARP1, Brx1, IGDS, IHG2, IRID2, Otlx2, RGS, RIEG, RIEG1, RS" ENSG00000164093 "Paired like homeodomain 2" Q99697 4 110617423-110642123 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Disease mutation, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 30.4;retina: 53.5;skeletal muscle: 28.8" "Cell type enhanced" "Detected in some" 9 "Cardiomyocytes: 12.7;Cytotrophoblasts: 5.5;Enterocytes: 6.5;Extravillous trophoblasts: 5.4;Hofbauer cells: 6.6;Spermatogonia: 5.6;Syncytiotrophoblasts: 8.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 16 "hypothalamus: 2.1;midbrain: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 18.1;HEK 293: 8.0;LHCN-M2: 18.6;RH-30: 15.7" "Region enhanced" "Detected in single" "hypothalamus: 9.8" "Region enhanced" "Detected in single" "hypothalamus: 5.1" "HPA050074, HPA062728" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA050074: AB_2681005, HPA062728: AB_2684851" "unprognostic (1.08e-1)" "unprognostic (1.23e-2)" "unprognostic (9.29e-2)" "unprognostic (9.24e-2)" "unprognostic (1.68e-1)" "unprognostic (1.14e-2)" "unprognostic (9.61e-4)" "unprognostic (3.22e-2)" "unprognostic (1.74e-1)" "unprognostic (2.24e-1)" "unprognostic (1.16e-1)" "unprognostic (2.77e-1)" "unprognostic (1.11e-15)" "unprognostic (6.97e-3)" "unprognostic (1.43e-1)" "unprognostic (5.98e-2)" "unprognostic (9.91e-2)" 0.6 0.1 0.0 18.6 0.0 0.1 0.3 0.0 0.1 1.1 3.0 0.0 0.3 0.1 0.1 1.3 2.7 0.2 1.1 3.5 0.0 2.1 0.3 0.1 0.1 0.1 1.1 0.0 0.1 0.5 0.1 12.5 30.4 0.0 8.3 0.3 53.5 9.3 0.2 28.8 0.9 3.4 15.9 0.0 0.1 0.5 0.3 0.0 0.0 0.1 16.8 0.4 19.4 5.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.0 1.9 0.0 0.7 1.9 1.6 3.0 0.6 0.3 2.0 1.5 18.1 0.0 0.0 3.9 3.7 2.4 0.3 0.1 0.0 1.1 0.0 8.0 0.0 1.4 0.0 6.7 0.0 3.8 2.1 0.1 0.3 0.0 0.6 0.0 2.0 0.5 0.0 18.6 0.5 2.0 0.0 0.3 0.0 0.3 0.0 15.7 0.0 0.3 2.5 0.0 0.0 1.4 2.5 0.2 0.3 0.1 0.0 0.0 2.5 5.9 0.0 2.9 0.0 0.1 0.8 1.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 12.7 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 6.5 0.0 0.3 5.4 4.5 0.2 0.0 0.0 6.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.9 0.0 1.3 0.0 0.0 1.7 1.2 5.6 0.1 8.8 0.0 1.2 0.0 PIWIL4 "FLJ36156, HIWI2, Miwi2" ENSG00000134627 "Piwi like RNA-mediated gene silencing 4" Q7Z3Z4 11 94543840-94621421 "Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.8;testis: 30.9" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 10.2;Mucus-secreting cells: 7.8;Paneth cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.4" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "NB-4: 44.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036587, HPA036588, HPA057508" Enhanced Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA036587: AB_2732473, HPA036588: AB_10673502, HPA057508: AB_2683452" "unprognostic (1.43e-1)" "unprognostic (9.46e-2)" "unprognostic (2.59e-3)" "unprognostic (2.22e-3)" "unprognostic (3.16e-2)" "unprognostic (1.07e-3)" "unprognostic (1.96e-2)" "unprognostic (5.18e-2)" "unprognostic (1.41e-1)" "unprognostic (1.70e-1)" "unprognostic (6.17e-2)" "unprognostic (2.68e-1)" "unprognostic (1.21e-4)" "unprognostic (6.89e-2)" "unprognostic (1.68e-1)" "unprognostic (2.50e-1)" "unprognostic (2.80e-2)" 1.9 0.6 1.9 1.9 3.1 17.8 2.7 4.1 1.7 2.2 3.8 1.7 1.7 4.5 2.5 1.7 1.7 2.0 3.6 1.7 1.9 1.7 1.7 1.7 1.7 2.5 1.7 1.7 2.2 8.2 0.2 1.7 2.3 1.7 1.7 5.0 1.7 7.6 2.0 1.7 0.8 4.3 1.7 2.5 2.3 3.6 30.9 1.7 1.7 1.7 1.7 1.8 1.7 1.7 0.0 0.8 0.5 2.4 0.3 1.3 1.0 0.1 0.0 0.2 0.0 3.3 2.2 0.2 0.2 0.1 0.1 0.4 0.3 0.3 0.0 0.2 1.3 0.1 0.0 0.4 0.0 0.1 1.2 0.1 0.1 0.3 0.0 1.3 3.1 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.5 0.2 0.1 44.9 0.0 4.4 0.3 0.1 0.0 0.0 1.0 0.0 0.2 0.1 0.2 0.4 0.2 0.1 0.0 9.9 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 2.4 0.5 1.0 1.0 0.0 0.0 0.1 0.6 0.8 0.0 1.3 0.4 0.0 0.3 1.0 0.0 0.4 1.0 1.9 3.1 4.1 1.7 1.9 1.7 1.7 1.7 1.7 1.7 0.0 0.3 0.0 0.2 1.1 0.6 1.4 10.2 2.7 2.3 0.0 0.0 3.3 1.7 3.6 2.8 0.5 2.9 0.0 1.8 0.3 0.9 0.4 0.0 0.0 1.5 0.0 0.0 1.3 3.1 1.0 0.3 1.5 0.0 1.0 7.8 0.3 2.7 6.5 1.1 0.6 2.8 0.0 0.8 0.7 1.5 0.1 0.8 0.0 4.7 0.0 PJA1 "FLJ11830, RNF70" ENSG00000181191 "Praja ring finger ubiquitin ligase 1" Q8NG27 X 69160851-69165793 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 98.7" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 77.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HAP1: 38.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000595 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA000595: AB_1079826" "unprognostic (3.40e-2)" "unprognostic (2.28e-1)" "unprognostic (4.03e-2)" "unprognostic (2.58e-3)" "unprognostic (5.44e-2)" "unprognostic (1.30e-2)" "unprognostic (1.26e-3)" "unprognostic (4.61e-2)" "unprognostic (3.82e-3)" "unprognostic (1.84e-2)" "unprognostic (6.10e-2)" "unprognostic (1.60e-1)" "prognostic favorable (7.44e-5)" "unprognostic (1.49e-1)" "unprognostic (2.35e-1)" "unprognostic (2.01e-1)" "unprognostic (2.10e-1)" 12.6 9.9 21.6 5.5 35.7 2.6 7.9 13.4 23.7 12.2 5.8 8.9 19.3 4.7 9.2 98.7 5.7 10.2 7.1 7.5 18.4 23.4 7.5 4.4 7.4 5.9 14.9 16.7 16.2 6.0 27.1 12.5 10.7 11.7 9.9 5.3 7.2 6.4 20.3 4.7 7.1 4.4 9.8 12.0 5.9 6.5 13.7 9.5 3.0 13.8 2.9 7.4 7.8 7.9 11.2 4.3 2.7 4.5 14.8 17.8 9.0 10.4 8.0 25.1 17.6 8.8 9.3 7.6 7.0 8.4 6.6 8.9 6.5 9.9 1.6 10.9 11.1 15.6 9.1 38.6 13.7 8.3 7.8 13.7 3.1 6.6 4.3 11.0 1.8 6.0 9.7 9.1 11.3 6.7 6.4 7.4 5.3 2.9 1.1 6.7 5.6 0.8 3.6 17.1 8.9 13.2 7.5 11.2 2.5 10.6 8.8 18.7 12.1 11.2 1.9 8.5 20.9 3.1 2.6 6.7 5.7 9.2 16.9 3.2 0.0 0.1 3.8 6.2 5.1 7.6 2.7 3.3 1.0 15.5 4.5 17.8 8.7 13.7 14.2 3.6 11.2 14.4 16.6 1.1 14.8 2.9 4.3 8.3 9.0 21.6 35.7 13.4 23.7 18.4 23.4 14.9 16.7 11.7 9.5 14.9 4.5 5.1 14.7 36.5 16.4 6.3 5.1 2.7 11.4 3.5 7.9 30.0 13.3 20.5 77.4 5.1 0.7 0.0 10.2 12.8 18.9 7.8 4.6 1.7 6.7 4.8 5.2 5.5 3.8 22.6 25.0 4.1 5.0 1.8 2.8 28.6 13.9 1.4 18.4 4.4 5.9 6.5 17.0 0.9 1.0 25.7 17.4 7.9 2.3 17.6 PKIG ENSG00000168734 "CAMP-dependent protein kinase inhibitor gamma" Q9Y2B9 20 44531785-44624247 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 177.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "memory B-cell: 58.2;naive B-cell: 62.1" "Lineage enriched" "Detected in many" 10 "B-cells: 62.1" "Cell line enhanced" "Detected in many" "BJ hTERT+: 104.3;HSkMC: 42.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042703, HPA063690" Uncertain Supported Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA042703: AB_10797018, HPA063690: AB_2685091" "unprognostic (3.15e-2)" "unprognostic (5.65e-2)" "unprognostic (8.07e-2)" "unprognostic (1.44e-3)" "unprognostic (3.16e-1)" "unprognostic (9.49e-2)" "unprognostic (3.96e-2)" "unprognostic (6.46e-3)" "unprognostic (1.16e-1)" "unprognostic (1.38e-1)" "prognostic favorable (4.90e-5)" "unprognostic (6.26e-2)" "unprognostic (9.08e-2)" "unprognostic (1.19e-2)" "unprognostic (1.35e-2)" "unprognostic (4.22e-1)" "unprognostic (3.96e-2)" 21.1 25.1 39.2 22.7 31.9 7.5 18.4 12.9 37.7 28.0 44.0 13.5 15.4 12.5 31.8 19.3 31.7 31.4 29.3 107.1 23.0 17.2 22.9 14.4 39.0 17.9 16.7 25.9 17.2 13.3 13.8 19.5 32.6 14.3 30.2 13.3 26.2 18.8 32.5 25.6 8.0 17.9 52.8 11.9 13.2 24.1 41.5 11.4 3.2 25.8 18.6 18.2 42.2 20.3 62.1 6.2 0.4 0.3 0.7 1.6 3.1 5.3 5.4 8.8 5.8 13.4 27.4 1.3 12.8 104.3 14.5 11.0 12.4 2.4 20.5 10.5 11.2 12.1 2.0 1.7 2.8 4.7 10.4 3.2 3.2 0.8 8.8 12.4 0.4 0.2 42.3 5.7 7.0 1.6 7.3 32.3 5.7 2.5 0.5 1.3 6.7 3.2 5.2 4.7 0.0 7.8 0.5 0.2 0.5 8.0 1.1 3.6 11.8 3.3 1.5 8.6 4.0 4.1 2.6 20.9 19.9 8.9 8.8 6.1 2.8 7.7 14.4 9.9 0.3 8.5 0.4 0.3 0.1 0.2 0.2 0.2 58.2 0.3 0.3 1.5 62.1 1.0 1.6 0.4 0.7 0.2 6.2 0.1 3.1 39.2 31.9 12.9 37.7 23.0 17.2 16.7 25.9 14.3 11.4 8.9 6.7 86.2 15.6 22.3 17.8 177.7 22.9 76.3 13.6 43.6 19.6 11.6 107.8 61.0 80.2 91.6 30.7 0.0 27.2 12.5 63.7 12.6 46.2 28.4 7.2 9.5 42.4 39.3 3.1 23.1 67.6 9.1 47.2 11.8 13.1 46.7 31.9 44.8 57.7 115.7 24.6 116.4 170.2 111.2 27.2 26.2 30.7 5.2 21.3 9.2 PKMYT1 "MYT1, PPP1R126" ENSG00000127564 "Protein kinase, membrane associated tyrosine/threonine 1" Q99640 16 2968024-2980539 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 19.5;lymphoid tissue: 42.8;testis: 61.4" "Group enriched" "Detected in many" 6 "Extravillous trophoblasts: 39.8;Spermatocytes: 108.0;Spermatogonia: 40.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 5 "T-reg: 4.4" "Lineage enriched" "Detected in single" 5 "T-cells: 4.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA068860 Supported "Nucleoplasm,Nucleoli,Golgi apparatus" NA Yes "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA068860: AB_2686050" "unprognostic (7.82e-2)" "unprognostic (8.70e-2)" "unprognostic (5.93e-2)" "unprognostic (2.04e-2)" "unprognostic (4.54e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (8.33e-4)" "prognostic unfavorable (3.37e-4)" "unprognostic (4.52e-2)" "unprognostic (2.15e-1)" "unprognostic (1.61e-2)" "unprognostic (7.95e-3)" "unprognostic (0.00e+0)" "unprognostic (1.09e-3)" "unprognostic (9.13e-2)" "unprognostic (1.96e-1)" "unprognostic (5.91e-2)" 0.9 0.7 0.7 9.4 0.6 19.5 1.3 2.6 0.8 1.3 2.9 0.3 0.5 1.9 0.8 1.5 7.2 0.2 1.5 1.4 0.7 0.7 0.8 1.0 1.3 6.2 0.8 0.2 0.3 1.3 0.0 0.7 4.3 0.4 0.6 0.8 0.3 1.3 0.2 1.6 3.4 3.2 0.6 1.0 4.4 2.7 61.4 0.2 42.8 0.3 9.2 12.7 0.7 2.0 0.8 0.4 0.3 0.5 0.4 4.4 1.0 24.9 17.5 6.8 9.8 0.1 0.3 18.6 19.4 4.6 12.3 11.8 13.6 14.8 15.6 8.7 2.1 7.3 32.1 4.8 6.2 2.2 20.0 15.7 7.9 15.8 11.9 0.0 8.8 22.5 0.2 0.5 7.3 2.0 1.5 2.5 17.3 22.7 27.7 4.0 37.4 24.6 24.5 11.2 11.7 9.3 26.9 15.3 30.2 2.3 5.5 13.0 13.8 9.4 24.5 7.3 3.9 14.0 17.6 2.3 16.6 21.0 24.2 20.3 21.0 15.6 26.8 6.3 11.8 19.2 0.0 0.4 0.3 0.3 0.3 0.0 0.8 0.5 0.5 0.4 0.0 0.0 0.0 0.1 0.4 0.5 0.1 4.4 1.0 0.7 0.6 2.6 0.8 0.7 0.7 0.8 0.2 0.4 0.2 0.0 1.4 0.0 0.8 2.3 0.1 0.4 2.5 0.0 2.3 1.8 5.9 3.0 0.0 1.1 11.2 0.3 0.2 0.0 0.5 39.8 0.4 0.5 0.0 0.2 10.2 0.0 1.7 0.0 1.3 7.5 0.3 1.3 0.0 1.0 1.2 0.3 0.3 0.0 0.4 0.0 6.7 0.0 0.0 108.0 40.5 0.5 6.2 0.7 3.5 0.4 PKN2 "Pak-2, PRK2, PRKCL2, STK7" ENSG00000065243 "Protein kinase N2" Q16513 1 88684222-88836255 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 35.7" "Lineage enriched" "Detected in all" 8 "granulocytes: 35.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034861, HPA057913" Approved Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol" Yes No "Nucleoplasm, Intermediate filaments" "Nuclear bodies, Plasma membrane, Centrosome, Cytosol" "HPA034861: AB_2674363, HPA057913: AB_2732617" "unprognostic (7.52e-2)" "unprognostic (1.46e-1)" "prognostic favorable (5.67e-4)" "unprognostic (5.95e-2)" "unprognostic (3.39e-2)" "unprognostic (2.51e-2)" "unprognostic (4.64e-3)" "unprognostic (1.38e-1)" "unprognostic (4.43e-2)" "unprognostic (1.27e-2)" "unprognostic (2.90e-3)" "unprognostic (1.23e-1)" "unprognostic (1.51e-2)" "unprognostic (5.98e-2)" "unprognostic (2.38e-1)" "unprognostic (1.01e-2)" "unprognostic (1.99e-1)" 21.9 20.7 12.2 21.2 13.7 33.5 27.6 25.6 16.6 28.6 39.3 12.6 15.1 22.9 20.0 20.2 28.2 17.1 13.3 16.2 10.3 8.9 15.9 15.9 26.0 16.4 13.7 8.7 27.2 18.9 24.6 29.7 20.8 13.3 19.6 23.6 14.1 19.5 25.1 15.9 17.5 49.0 17.5 12.5 18.0 15.9 12.4 16.2 29.1 20.3 14.4 13.1 21.9 22.0 4.0 3.7 35.7 4.5 1.4 3.0 1.0 23.7 9.3 18.5 11.1 12.4 14.1 12.0 14.1 13.0 15.8 16.5 9.9 17.1 9.4 16.8 13.4 19.5 18.8 18.0 10.7 21.7 3.3 13.1 6.9 19.4 8.4 10.9 6.8 2.1 11.6 11.1 12.4 15.0 12.6 18.0 7.5 11.5 6.9 17.0 4.8 7.8 5.9 9.3 9.0 10.9 7.5 28.2 3.8 14.0 46.8 9.0 5.9 21.1 12.2 18.1 14.6 9.1 6.2 16.8 13.5 12.1 17.2 14.7 3.8 3.2 6.4 5.6 6.7 5.0 4.9 4.5 6.8 2.6 2.5 2.3 3.3 2.3 2.4 2.1 4.0 3.0 2.6 35.7 1.4 3.2 3.7 1.8 1.0 12.2 13.7 25.6 16.6 10.3 8.9 13.7 8.7 13.3 16.2 38.7 52.6 24.5 42.6 42.9 83.6 41.1 40.8 45.5 39.8 66.3 84.4 37.5 10.0 51.4 2.1 51.2 79.8 70.0 52.5 29.4 35.1 52.3 15.1 32.6 20.4 62.0 42.5 51.0 34.3 2.9 50.3 29.0 30.4 41.5 55.9 64.3 62.0 87.7 45.3 22.4 151.6 38.8 29.8 35.8 18.8 45.8 31.2 21.0 50.9 118.4 PKNOX1 PREP1 ENSG00000160199 "PBX/knotted 1 homeobox 1" P55347 21 42974510-43033931 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 104.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004285, HPA057215, HPA065017" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB004285: AB_2164128, HPA057215: AB_2683372, HPA065017: AB_2685405" "unprognostic (1.68e-2)" "unprognostic (2.64e-1)" "unprognostic (1.59e-1)" "unprognostic (8.39e-2)" "unprognostic (1.90e-2)" "unprognostic (4.81e-2)" "prognostic unfavorable (4.54e-8)" "unprognostic (2.03e-1)" "unprognostic (8.03e-2)" "unprognostic (3.67e-2)" "prognostic favorable (6.71e-4)" "unprognostic (9.45e-2)" "unprognostic (3.94e-2)" "unprognostic (1.85e-1)" "unprognostic (1.21e-2)" "unprognostic (6.16e-2)" "unprognostic (4.31e-3)" 6.8 6.4 7.9 8.7 9.2 3.9 7.3 24.2 9.1 12.3 8.3 9.9 9.0 5.0 14.3 9.8 7.4 10.0 8.4 6.1 7.2 7.9 6.7 6.6 6.9 8.1 10.7 5.4 14.4 15.7 6.9 13.3 11.9 8.6 8.7 6.9 5.4 7.1 12.4 11.7 9.2 6.1 15.2 7.6 7.5 6.6 42.9 10.1 12.2 16.4 5.8 7.6 9.3 18.2 4.9 3.3 10.1 4.9 4.0 7.6 4.1 8.7 3.1 4.1 3.9 7.7 11.7 5.1 11.3 7.8 6.9 5.9 5.3 6.8 12.3 9.4 9.8 5.4 4.7 9.3 7.1 9.0 8.4 7.6 7.3 5.9 5.0 8.0 6.5 5.8 8.9 11.8 8.5 6.9 7.2 6.5 4.3 5.7 9.2 15.5 5.2 6.1 7.3 6.3 12.5 6.8 9.8 18.5 6.7 13.5 7.1 13.1 7.9 8.0 5.8 7.7 4.9 4.9 8.3 7.7 10.8 5.4 5.9 7.2 5.4 6.0 6.4 13.5 11.7 5.6 0.4 3.7 2.7 7.2 4.9 7.6 4.9 5.2 5.9 3.3 4.1 6.4 5.6 10.1 4.0 3.3 3.0 5.3 4.1 7.9 9.2 24.2 9.1 7.2 7.9 10.7 5.4 8.6 10.1 6.0 14.9 6.0 71.8 15.5 22.3 5.6 12.7 20.1 20.5 15.7 3.9 12.4 8.3 14.2 104.0 11.7 9.1 23.3 10.9 24.3 19.4 19.9 5.8 6.8 10.9 12.7 14.3 9.2 8.3 26.8 17.3 17.5 13.5 18.0 9.6 9.7 13.8 5.8 27.6 5.9 11.2 32.3 22.6 61.7 24.3 12.0 24.3 15.8 9.3 44.5 PKNOX2 ENSG00000165495 "PBX/knotted 1 homeobox 2" Q96KN3 11 125164687-125433389 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 14 "Early spermatids: 28.7;Melanocytes: 8.5;Peritubular cells: 16.6" "Cancer enhanced" "Detected in many" "melanoma: 8.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 27.2;AN3-CA: 6.8;hTEC/SVTERT24-B: 5.4;LHCN-M2: 8.0;SK-MEL-30: 5.4;WM-115: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028867, CAB034342, HPA055368, HPA066962" Supported Enhanced "Nucleoplasm,Cytokinetic bridge" NA NA Nucleoplasm "Cytokinetic bridge" "CAB034342: AB_2164138, HPA028867: AB_2672802, HPA055368: AB_2682796, HPA066962: AB_2685757" "unprognostic (2.91e-2)" "unprognostic (1.62e-1)" "unprognostic (2.10e-2)" "unprognostic (7.26e-2)" "unprognostic (9.46e-2)" "unprognostic (3.97e-2)" "unprognostic (2.41e-1)" "unprognostic (2.12e-2)" "unprognostic (1.56e-1)" "unprognostic (2.44e-2)" "unprognostic (7.66e-2)" "unprognostic (3.70e-1)" "unprognostic (4.10e-6)" "unprognostic (1.76e-3)" "unprognostic (7.11e-2)" "unprognostic (1.71e-2)" "unprognostic (6.48e-3)" 5.8 4.1 10.0 3.3 12.4 0.7 1.7 16.3 25.7 5.1 2.8 3.6 0.2 2.0 5.6 4.7 2.7 9.8 3.4 7.9 7.3 6.9 2.9 1.1 9.6 2.4 5.2 12.3 23.6 6.3 0.9 7.3 12.8 6.9 10.2 2.8 24.3 2.5 8.7 19.5 4.0 2.4 4.6 4.6 3.4 2.5 7.2 3.1 0.0 18.3 8.4 2.2 3.3 3.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 27.2 6.8 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.9 0.0 0.0 1.4 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.2 0.0 0.0 2.7 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 4.4 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 12.4 16.3 25.7 7.3 6.9 5.2 12.3 6.9 3.1 0.0 0.0 0.0 0.0 0.8 0.9 4.3 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.7 28.7 0.5 0.0 0.0 0.2 0.0 1.4 1.8 0.0 0.0 0.2 7.9 0.0 1.3 0.0 7.4 4.6 0.0 8.5 0.0 0.0 3.3 0.2 0.0 16.6 0.0 0.2 6.5 3.1 0.7 0.1 0.4 0.1 0.0 0.0 0.0 PKP1 B6P ENSG00000081277 "Plakophilin 1" Q13835 1 201283452-201332993 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Developmental protein" "Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 80.1;skin 1: 137.6;tongue: 129.6" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 124.1;Suprabasal keratinocytes: 357.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 295.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 45.1;HBEC3-KT: 27.6;hTCEpi: 98.2;hTERT-HME1: 26.1;PC-3: 37.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027221, CAB033130" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 2700000 "Nucleoplasm, Plasma membrane" "CAB033130: AB_2164139, HPA027221: AB_10599737" "unprognostic (3.55e-3)" "unprognostic (7.63e-2)" "unprognostic (1.99e-1)" "unprognostic (2.13e-1)" "unprognostic (1.03e-1)" "unprognostic (7.17e-2)" "unprognostic (2.40e-2)" "unprognostic (3.48e-2)" "unprognostic (1.49e-1)" "unprognostic (5.02e-2)" "unprognostic (2.20e-3)" "unprognostic (2.67e-1)" "unprognostic (9.17e-3)" "unprognostic (2.52e-2)" "unprognostic (1.61e-1)" "unprognostic (1.45e-1)" "unprognostic (6.59e-3)" 10.1 0.1 0.0 0.1 0.0 0.1 7.0 0.0 0.4 19.7 0.5 0.0 2.5 0.1 1.5 1.9 80.1 0.3 0.1 0.1 0.0 0.0 0.1 0.1 1.4 0.1 0.0 0.2 0.1 0.1 0.1 0.0 1.6 0.0 6.8 0.1 4.9 10.1 3.9 2.1 137.6 0.2 0.1 0.0 0.1 0.1 0.1 0.0 9.2 0.1 129.6 37.2 1.2 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 45.1 0.0 27.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 98.2 1.1 26.1 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 37.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 46.2 124.1 6.7 1.3 0.0 0.0 4.5 0.0 2.0 0.0 0.0 0.9 0.0 1.6 0.0 0.0 1.0 0.0 7.1 21.9 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 1.2 3.2 9.4 0.0 0.0 0.0 37.2 0.0 3.9 0.0 0.0 357.5 0.1 0.0 0.0 44.2 PKP2 ENSG00000057294 "Plakophilin 2" Q99959 12 32790745-32896840 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "heart muscle: 134.7" "Cell type enhanced" "Detected in many" 16 "Cardiomyocytes: 399.9;Extravillous trophoblasts: 148.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 10.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 56.3;OE19: 20.4;SuSa: 45.7" "Region enriched" "Detected in many" 4 "hippocampal formation: 22.1" "Low region specificity" "Detected in all" "HPA014314, CAB037336, HPA056908" Enhanced Enhanced "Nucleoplasm,Cell Junctions" NA NA "Cell Junctions" Nucleoplasm "CAB037336: , HPA014314: AB_1855451, HPA056908: AB_2683272" "unprognostic (1.89e-1)" "unprognostic (1.70e-2)" "prognostic favorable (8.55e-4)" "unprognostic (2.55e-1)" "unprognostic (1.13e-1)" "unprognostic (3.88e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (6.79e-4)" "unprognostic (2.90e-1)" "unprognostic (1.83e-2)" "unprognostic (5.94e-3)" "unprognostic (2.22e-1)" "unprognostic (4.94e-2)" "unprognostic (1.21e-2)" "unprognostic (1.35e-1)" "unprognostic (2.41e-2)" "unprognostic (3.76e-2)" 3.1 0.7 1.4 7.9 5.2 1.1 3.3 2.2 1.8 6.1 14.2 1.4 6.9 6.5 1.2 2.0 3.3 21.6 4.4 134.7 3.9 0.9 3.6 13.6 1.1 3.4 0.7 2.0 9.5 5.4 9.6 14.7 24.1 3.8 3.5 13.3 12.6 24.6 5.0 3.4 1.9 13.3 1.3 1.3 2.4 4.8 3.4 0.4 2.7 0.6 2.3 4.3 2.0 2.1 0.6 3.9 10.4 2.1 1.5 1.0 0.6 15.7 3.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 56.3 14.2 0.0 9.7 0.0 2.1 14.0 1.9 12.4 0.0 0.0 4.5 0.1 0.6 14.7 8.8 0.8 0.2 0.0 11.7 0.0 13.6 6.3 0.5 0.0 2.8 4.4 1.3 4.1 0.0 0.1 8.6 20.4 2.7 0.0 6.8 4.7 4.1 7.5 1.7 1.5 0.6 3.3 0.0 45.7 7.1 0.2 0.1 0.0 6.3 0.0 3.8 3.7 0.0 0.1 0.0 0.0 0.7 5.1 1.4 10.4 0.4 1.6 1.0 0.2 0.6 0.4 3.9 0.6 0.9 0.5 1.2 1.5 2.1 0.8 0.6 0.6 1.4 5.2 2.2 1.8 3.9 0.9 0.7 2.0 3.8 0.4 0.0 0.0 2.4 42.2 6.3 1.0 399.9 15.3 12.0 19.4 1.8 3.9 39.7 3.3 12.2 3.0 3.5 74.7 0.0 8.6 148.3 17.6 16.8 4.6 39.3 7.7 1.6 26.0 3.7 13.1 1.3 10.9 7.4 10.1 0.0 60.1 13.0 16.5 52.6 2.1 8.4 1.1 0.0 1.4 5.4 7.2 2.9 34.7 0.7 87.1 25.7 PKP3 ENSG00000184363 "Plakophilin 3" Q9Y446 11 392614-404908 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 69.0;skin 1: 48.4;tongue: 59.0" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 206.5;Extravillous trophoblasts: 144.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.6;NK-cell: 2.3" "Group enriched" "Detected in many" 5 "NK-cells: 2.3;T-cells: 1.6" "Cell line enhanced" "Detected in many" "A-431: 37.6;CAPAN-2: 26.4;HaCaT: 50.7;hTCEpi: 33.2;MCF7: 23.7;SK-BR-3: 38.5" "Region enriched" "Detected in single" 37 "cerebellum: 10.0" "Low region specificity" "Detected in many" "CAB012993, HPA062937" Enhanced Enhanced "Nucleoplasm,Cell Junctions" NA NA "Cell Junctions" Nucleoplasm "CAB012993: AB_2533221, HPA062937: AB_2684908" "unprognostic (4.74e-2)" "unprognostic (5.28e-2)" "unprognostic (4.45e-2)" "unprognostic (2.25e-2)" "unprognostic (1.58e-2)" "unprognostic (1.57e-1)" "unprognostic (8.88e-3)" "prognostic unfavorable (2.89e-5)" "unprognostic (1.25e-1)" "unprognostic (6.73e-3)" "prognostic unfavorable (3.93e-4)" "unprognostic (3.55e-2)" "prognostic unfavorable (1.08e-4)" "unprognostic (2.16e-2)" "unprognostic (3.41e-1)" "unprognostic (2.60e-1)" "unprognostic (3.15e-2)" 0.6 0.0 0.2 3.7 0.3 0.0 3.3 0.2 0.3 14.5 14.6 0.3 5.0 11.2 1.9 6.2 69.0 2.6 8.9 0.5 0.3 0.1 0.6 0.2 4.3 0.2 0.2 0.2 1.1 10.2 3.9 3.8 23.2 0.2 4.5 3.6 0.2 12.5 2.5 0.6 48.4 25.4 1.0 0.2 0.3 10.4 0.5 0.2 2.2 5.8 59.0 29.9 2.8 21.5 0.3 0.0 0.0 0.0 2.3 1.6 0.1 37.6 7.3 0.0 0.1 0.0 0.0 15.8 0.3 0.2 0.8 0.4 15.0 26.4 0.0 1.5 0.3 1.7 50.7 0.0 19.2 0.1 0.0 9.5 0.0 4.3 10.4 0.1 0.0 0.0 0.1 33.2 0.1 8.1 0.1 0.1 0.0 11.2 0.2 0.1 23.7 0.1 0.0 0.0 19.0 12.7 0.2 0.0 0.1 0.4 7.6 10.8 0.1 10.9 38.5 0.0 0.5 13.9 0.1 1.3 0.2 1.4 0.7 0.2 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.8 0.0 0.3 0.0 0.7 0.0 2.3 0.0 0.0 0.0 0.1 0.2 0.3 0.2 0.3 0.3 0.1 0.2 0.2 0.2 0.2 14.9 15.4 0.0 43.7 64.1 0.0 1.1 7.6 9.4 12.5 12.2 0.0 112.3 0.0 83.2 0.0 0.4 206.5 0.0 54.5 144.7 3.5 34.6 13.8 0.0 11.6 0.0 20.8 0.0 0.0 0.0 0.9 1.8 1.7 3.6 76.4 0.5 96.8 93.0 0.0 0.7 0.1 0.0 1.6 0.0 0.4 77.5 91.8 0.0 83.6 52.6 PLA1A ps-PLA1 ENSG00000144837 "Phospholipase A1 member A" Q53H76 3 119597842-119629811 "Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "ductus deferens: 47.8;epididymis: 63.1;seminal vesicle: 123.8" "Cell type enhanced" "Detected in many" 9 "Collecting duct cells: 14.0;Hepatocytes: 21.7;Peritubular cells: 13.4" "Group enriched" "Detected in many" 5 "liver cancer: 14.8;melanoma: 55.4;prostate cancer: 24.2;renal cancer: 21.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "T-reg: 1.9" "Lineage enriched" "Detected in single" 5 "T-cells: 1.9" "Cell line enriched" "Detected in some" 18 "SK-MEL-30: 23.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059740 Approved "Nucleoplasm,Nuclear speckles,Cytoplasmic bodies" "Secreted in other tissues" NA NA "Nuclear speckles, Cytoplasmic bodies" Nucleoplasm "HPA059740: AB_2684118" "unprognostic (1.35e-1)" "prognostic favorable (2.81e-7)" "unprognostic (2.24e-2)" "unprognostic (3.46e-2)" "unprognostic (3.18e-2)" "unprognostic (1.94e-2)" "unprognostic (1.11e-2)" "unprognostic (2.43e-1)" "unprognostic (3.87e-1)" "unprognostic (1.43e-2)" "unprognostic (1.25e-1)" "unprognostic (9.09e-2)" "unprognostic (1.55e-3)" "unprognostic (9.53e-3)" "unprognostic (3.94e-2)" "unprognostic (1.67e-1)" "unprognostic (2.67e-1)" 2.5 0.4 3.8 1.5 4.7 0.2 1.8 1.4 2.5 2.5 1.3 1.7 47.8 0.6 3.2 63.1 0.8 2.7 1.3 5.0 3.6 4.3 9.3 17.2 13.7 6.1 6.0 1.0 0.5 1.8 11.4 1.0 4.4 7.0 6.0 1.2 10.7 1.5 123.8 10.3 0.3 1.9 4.2 7.4 0.5 2.2 2.0 2.5 0.4 5.0 0.4 3.7 2.1 1.3 0.0 0.0 0.0 0.4 0.0 1.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.7 0.3 0.5 0.1 0.0 0.2 0.0 0.0 23.9 0.0 0.0 0.0 1.3 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.9 0.0 3.8 4.7 1.4 2.5 3.6 4.3 6.0 1.0 7.0 2.5 0.0 1.7 0.0 0.3 0.6 0.0 1.2 2.5 2.7 1.2 14.0 0.0 0.1 1.7 2.7 5.2 8.7 0.0 0.0 1.9 0.0 0.6 0.3 1.1 21.7 1.6 0.0 1.7 4.9 0.3 2.2 0.3 5.3 1.7 7.2 0.0 0.0 2.2 0.0 13.4 4.9 0.0 0.0 0.3 0.0 0.2 0.5 1.6 0.0 0.0 0.3 PLA2G15 "GXVPLA2, LLPL, LYPLA3" ENSG00000103066 "Phospholipase A2 group XV" Q8NCC3 16 68245304-68261062 "Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid degradation, Lipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Hofbauer cells: 96.5;Syncytiotrophoblasts: 42.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041702, HPA041727" Enhanced Supported Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 20000000 "Nucleoplasm, Vesicles" "HPA041702: AB_10794486, HPA041727: AB_10793931" "unprognostic (3.47e-2)" "unprognostic (9.99e-2)" "unprognostic (1.54e-3)" "unprognostic (6.84e-3)" "unprognostic (1.38e-2)" "unprognostic (1.65e-2)" "unprognostic (4.12e-3)" "unprognostic (3.16e-1)" "unprognostic (2.12e-2)" "unprognostic (1.84e-2)" "unprognostic (2.56e-1)" "unprognostic (9.29e-2)" "unprognostic (2.45e-3)" "unprognostic (2.98e-2)" "unprognostic (5.40e-3)" "unprognostic (6.28e-2)" "unprognostic (3.47e-2)" 23.8 9.1 9.6 6.6 9.4 5.6 19.7 16.4 16.1 5.4 6.2 10.0 4.7 5.0 7.7 11.2 5.7 7.2 8.5 31.3 7.9 8.6 24.1 11.8 15.9 23.1 7.5 9.2 7.4 6.4 11.3 9.2 24.4 7.7 6.2 5.7 8.5 7.6 5.8 39.9 10.0 5.3 8.2 6.8 16.2 6.2 9.3 6.2 11.3 10.4 6.8 4.9 9.1 5.0 3.7 8.8 9.4 18.2 1.3 4.5 7.7 4.6 5.0 4.0 12.6 19.0 13.9 9.2 11.6 15.5 17.6 14.8 11.6 8.7 8.5 14.6 16.5 13.7 7.3 4.2 5.0 8.1 2.4 6.4 2.4 4.9 9.2 10.2 2.3 12.6 9.5 5.7 17.6 2.8 22.4 10.7 4.2 3.5 4.5 11.3 10.1 3.2 7.0 2.5 4.4 5.7 4.7 5.7 26.3 8.8 4.3 1.3 2.6 15.5 4.7 9.5 3.5 12.1 11.4 8.7 15.4 7.5 19.8 7.2 17.0 14.4 10.3 14.0 6.6 5.9 9.4 14.4 9.3 3.1 16.8 3.2 3.3 3.4 4.5 8.8 3.7 4.5 3.7 0.6 1.3 18.2 7.8 3.2 7.7 9.6 9.4 16.4 16.1 7.9 8.6 7.5 9.2 7.7 6.2 6.0 3.5 0.0 2.1 4.2 12.2 19.7 2.5 1.4 4.5 8.7 7.9 17.6 5.0 8.5 1.7 6.3 4.0 0.0 6.2 7.0 6.9 2.5 15.0 10.9 96.5 36.5 0.0 11.1 32.7 4.5 2.0 16.4 11.8 6.4 6.1 4.3 5.7 4.5 1.4 18.1 5.5 0.0 4.1 3.9 2.2 3.0 42.4 4.3 3.3 1.7 PLA2G4F PLA2G4F/Z ENSG00000168907 "Phospholipase A2 group IVF" Q68DD2 15 42139034-42156636 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 30.4;skin 1: 48.1" "Cell type enriched" "Detected in many" 5 "Alveolar cells type 2: 54.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "OE19: 14.1;RT4: 10.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA042713, HPA056752" Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA042713: AB_10793982, HPA056752: AB_2683226" "unprognostic (1.99e-1)" "unprognostic (6.21e-3)" "unprognostic (1.59e-1)" "prognostic unfavorable (2.00e-4)" "unprognostic (1.06e-2)" "unprognostic (2.32e-3)" "unprognostic (1.48e-2)" "unprognostic (5.85e-2)" "unprognostic (2.25e-1)" "unprognostic (4.79e-2)" "unprognostic (6.65e-2)" "unprognostic (1.21e-2)" "unprognostic (9.32e-2)" "unprognostic (1.11e-1)" "unprognostic (4.55e-2)" "unprognostic (1.63e-1)" 0.1 0.1 0.0 2.5 0.3 0.3 1.8 0.0 0.1 4.5 11.0 0.0 4.7 4.2 0.4 9.7 10.4 0.2 3.1 1.0 0.0 0.0 10.8 0.2 30.4 0.1 0.0 0.0 0.1 0.1 0.7 4.1 0.3 0.0 3.3 2.5 0.0 5.3 2.8 8.6 48.1 12.3 1.1 0.1 0.2 1.6 0.1 0.0 6.2 1.6 14.9 3.4 2.2 6.3 0.6 0.3 0.2 0.1 0.0 0.3 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.4 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.0 0.0 0.1 0.0 14.1 0.1 0.0 0.0 0.1 0.0 10.6 0.6 0.1 0.0 1.1 0.0 0.1 1.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 54.9 0.0 3.3 4.8 0.0 3.2 0.0 0.0 0.0 5.2 0.0 1.5 3.3 0.2 0.0 0.0 12.0 0.0 1.2 0.7 0.2 2.7 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 4.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 1.0 0.0 4.3 1.6 PLAA "DOA1, FLJ11281, FLJ12699, PLA2P, PLAP" ENSG00000137055 "Phospholipase A2 activating protein" Q9Y263 9 26904083-26947463 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Neurogenesis "Developmental protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005035, HPA020994, HPA020996" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 5300 "Plasma membrane, Cytosol" Nucleoplasm "CAB005035: AB_562036, HPA020994: AB_1855444, HPA020996: AB_1855445" "unprognostic (5.48e-2)" "unprognostic (1.39e-1)" "unprognostic (4.00e-3)" "unprognostic (5.00e-1)" "unprognostic (1.61e-1)" "unprognostic (4.06e-2)" "unprognostic (4.50e-3)" "unprognostic (2.48e-1)" "unprognostic (5.54e-2)" "prognostic favorable (7.87e-4)" "unprognostic (3.24e-2)" "unprognostic (1.44e-1)" "unprognostic (9.29e-3)" "unprognostic (1.86e-2)" "unprognostic (6.68e-2)" "unprognostic (1.39e-2)" "unprognostic (5.10e-1)" 13.6 20.1 9.4 12.4 13.1 29.6 11.9 12.9 18.0 13.4 12.3 11.1 13.5 10.5 15.6 12.8 16.2 10.8 13.6 26.2 10.1 10.2 15.0 19.6 14.4 16.4 9.6 10.9 12.3 12.9 15.0 10.0 17.4 13.4 12.1 13.1 9.5 13.4 11.6 52.6 13.5 12.3 16.1 10.0 16.1 12.0 15.7 7.9 27.0 13.0 18.2 14.6 14.9 12.7 13.2 12.2 19.2 17.9 13.5 16.5 8.6 27.8 16.5 20.9 21.1 14.2 18.1 15.8 26.2 15.0 20.1 19.7 5.8 13.4 25.2 21.9 20.0 14.0 11.2 20.7 20.7 22.2 33.1 8.7 15.6 27.2 11.1 14.5 12.5 21.4 16.1 12.5 24.5 17.9 15.2 20.0 18.9 9.5 25.6 21.6 11.6 24.2 12.2 30.3 14.4 14.4 17.3 13.1 14.9 15.6 16.7 13.4 23.0 14.0 16.6 8.2 21.4 11.5 9.7 24.2 0.0 24.9 13.0 21.2 8.4 18.3 26.2 14.2 17.9 10.4 19.2 11.9 18.7 11.2 16.8 12.5 13.2 11.6 11.3 12.2 11.5 10.7 12.2 11.2 13.5 17.9 6.3 16.5 8.6 9.4 13.1 12.9 18.0 10.1 10.2 9.6 10.9 13.4 7.9 14.9 9.1 11.2 9.4 9.7 8.3 21.0 2.5 12.0 13.6 8.7 0.0 21.0 8.3 14.9 21.7 15.3 9.5 0.0 14.0 21.7 10.4 9.6 40.3 9.0 18.5 4.8 9.2 12.9 13.3 3.6 8.1 9.9 1.7 10.8 7.3 8.5 12.8 8.7 7.8 7.9 6.1 19.4 17.8 24.7 22.0 8.3 41.2 13.8 11.4 10.2 PLAC8L1 ENSG00000173261 "PLAC8 like 1" A1L4L8 5 146084386-146104369 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 20.4" "Group enriched" "Detected in some" 78 "Early spermatids: 401.3;Late spermatids: 218.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 9.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA074266 Approved Nucleoplasm NA NA Nucleoplasm "HPA074266: AB_2686676" "unprognostic (6.38e-3)" "unprognostic (1.90e-2)" "unprognostic (1.32e-1)" "unprognostic (4.24e-1)" "unprognostic (1.62e-2)" "unprognostic (7.48e-2)" "unprognostic (4.13e-2)" "unprognostic (3.79e-1)" "unprognostic (6.45e-2)" "unprognostic (5.05e-2)" "unprognostic (1.80e-3)" "unprognostic (1.23e-1)" "unprognostic (1.21e-6)" "unprognostic (9.72e-2)" "unprognostic (1.79e-1)" "unprognostic (1.89e-1)" "unprognostic (4.18e-2)" 0.4 0.1 0.9 0.4 1.0 0.1 1.0 1.6 0.8 0.4 0.4 0.4 0.4 0.0 0.5 0.5 0.4 0.6 0.4 0.4 1.0 1.0 0.4 0.5 0.4 0.4 1.1 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.4 0.9 3.1 0.6 0.5 1.9 0.4 0.1 20.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.2 1.3 0.0 0.0 0.0 0.5 0.0 0.9 2.7 2.6 9.8 0.7 1.1 0.6 1.0 0.4 4.2 2.7 0.4 1.2 1.5 2.2 1.1 0.9 0.7 4.0 0.0 3.5 3.2 5.6 2.2 0.9 1.1 0.5 0.9 1.8 0.0 6.3 3.2 2.5 0.5 1.5 3.3 0.2 2.0 1.1 0.0 0.9 2.9 0.5 0.3 3.8 0.9 0.5 0.0 0.3 0.0 2.4 1.2 1.1 0.4 2.3 0.8 0.2 0.9 1.1 0.0 3.7 1.1 1.9 1.2 3.2 1.3 0.8 1.6 2.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.9 1.0 1.6 0.8 1.0 1.0 1.1 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 401.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.6 0.0 0.6 0.0 218.3 4.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.4 0.0 0.2 3.2 1.5 0.0 0.1 0.0 0.1 0.0 PLAG1 ZNF912 ENSG00000181690 "PLAG1 zinc finger" Q6DJT9 8 56160904-56211324 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 24.0;Horizontal cells: 30.2;Rod photoreceptor cells: 28.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 13.1;ASC TERT1: 17.5;HSkMC: 12.3;hTERT-HME1: 12.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA072290 Supported "Nucleoplasm,Nuclear speckles,Centrosome,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" "Centrosome, Cytosol" "HPA072290: AB_2686508" "unprognostic (1.89e-2)" "unprognostic (1.93e-2)" "unprognostic (1.22e-3)" "unprognostic (1.63e-4)" "unprognostic (6.81e-2)" "unprognostic (1.07e-1)" "unprognostic (5.63e-3)" "unprognostic (8.56e-2)" "unprognostic (1.18e-1)" "unprognostic (7.99e-2)" "unprognostic (3.42e-2)" "unprognostic (1.97e-1)" "unprognostic (1.32e-3)" "unprognostic (2.83e-2)" "unprognostic (3.94e-1)" "unprognostic (1.21e-2)" "unprognostic (6.14e-2)" 1.9 3.6 2.4 3.5 2.9 2.1 2.5 11.0 2.7 7.6 3.8 4.1 9.0 3.4 3.4 9.8 2.0 7.5 2.1 6.8 1.9 1.8 3.7 1.2 4.6 6.7 4.8 2.1 11.6 2.2 2.1 17.8 8.0 4.6 5.1 1.6 7.9 7.5 9.2 1.4 3.4 5.5 2.5 6.3 6.2 3.0 5.2 4.5 11.7 3.5 1.5 5.2 4.8 7.0 3.5 0.2 1.1 0.5 0.7 4.6 1.0 1.5 0.0 9.6 0.1 13.1 17.5 3.0 4.3 5.5 2.0 0.9 0.6 5.0 0.2 4.2 2.3 0.5 0.3 2.7 5.7 2.1 0.1 5.9 6.1 0.5 1.4 2.8 2.0 1.9 12.3 3.2 1.1 12.8 5.6 3.8 4.3 2.6 0.1 4.2 0.0 0.5 3.6 2.8 0.4 1.4 4.7 0.7 3.7 2.6 0.5 0.1 0.0 0.1 0.0 0.3 6.8 0.1 1.9 5.7 3.0 3.8 4.8 1.0 1.5 1.1 2.3 3.4 0.7 0.8 1.1 0.1 1.1 0.3 0.1 0.2 3.5 1.0 0.6 0.1 2.0 4.6 4.3 1.0 0.7 0.5 0.2 0.2 1.0 2.4 2.9 11.0 2.7 1.9 1.8 4.8 2.1 4.6 4.5 6.0 2.7 6.2 2.3 0.9 24.0 9.4 2.5 1.4 2.3 5.2 23.6 6.8 0.0 0.6 4.6 3.3 2.1 0.0 1.2 3.6 3.7 2.8 1.1 0.5 4.5 30.2 5.2 19.6 1.3 4.5 14.1 1.9 15.1 0.0 3.0 18.4 1.2 0.9 9.6 0.5 28.0 0.0 0.7 4.3 6.8 0.6 5.9 1.0 1.6 5.3 PLAGL2 ZNF900 ENSG00000126003 "PLAG1 like zinc finger 2" Q9UPG8 20 32192503-32207791 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 46.8;Late spermatids: 113.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "intermediate monocyte: 11.7;non-classical monocyte: 20.7" "Lineage enriched" "Detected in many" 14 "monocytes: 20.7" "Cell line enhanced" "Detected in all" "CACO-2: 34.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005900 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005900: AB_1079629" "unprognostic (9.40e-2)" "unprognostic (1.67e-1)" "unprognostic (6.95e-3)" "unprognostic (1.09e-3)" "unprognostic (1.09e-1)" "unprognostic (1.36e-1)" "unprognostic (4.11e-3)" "unprognostic (8.63e-2)" "unprognostic (8.97e-2)" "unprognostic (2.99e-1)" "unprognostic (1.29e-2)" "unprognostic (2.26e-1)" "unprognostic (3.08e-1)" "unprognostic (5.84e-2)" "unprognostic (2.28e-1)" "unprognostic (7.90e-2)" "unprognostic (1.09e-1)" 5.9 5.1 6.1 9.0 7.8 30.2 5.8 10.5 7.7 6.9 10.6 6.8 5.6 11.5 9.6 6.6 17.9 10.9 5.8 5.6 6.2 4.0 7.0 6.1 9.3 9.0 5.8 4.9 11.7 11.6 8.5 12.9 5.4 7.2 7.6 9.2 9.8 10.2 6.7 10.1 10.4 24.8 8.3 4.2 10.4 10.1 33.2 7.4 16.4 7.9 13.7 12.9 6.8 11.4 0.9 1.4 1.4 20.7 0.3 1.0 1.2 7.9 4.6 12.2 4.4 4.6 3.5 7.7 3.1 5.0 6.9 6.3 34.2 4.0 8.2 4.4 3.2 9.7 7.9 15.2 7.3 9.2 4.9 6.8 33.2 3.7 16.4 5.6 14.5 7.4 4.3 6.5 5.5 3.9 3.2 4.9 8.8 11.6 7.5 3.6 4.5 15.9 10.0 5.7 6.1 5.3 10.3 15.8 5.2 2.9 6.1 5.6 6.1 7.8 4.2 6.9 7.4 6.3 17.8 3.7 8.4 9.0 6.0 6.4 20.5 11.3 10.6 4.9 30.7 5.1 1.4 2.1 0.5 0.5 11.7 1.0 0.9 0.6 1.0 1.4 0.6 0.8 0.4 0.6 0.3 20.7 0.3 0.5 1.2 6.1 7.8 10.5 7.7 6.2 4.0 5.8 4.9 7.2 7.4 11.9 19.7 6.6 11.4 6.6 6.9 2.9 2.5 4.0 14.8 1.8 29.5 2.9 3.3 3.2 46.8 3.8 13.1 0.0 4.5 2.6 4.0 10.4 2.3 2.4 5.0 3.2 10.3 4.9 5.1 113.2 2.3 6.6 0.0 1.0 10.4 6.6 5.6 8.6 6.7 2.6 20.2 6.5 2.5 9.4 9.2 10.2 3.4 4.4 13.9 20.2 PLCB3 ENSG00000149782 "Phospholipase C beta 3" Q01970 11 64251523-64269150 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "intestine: 77.5" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 54.0;Mucus-secreting cells: 41.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009257, HPA039279, HPA043907" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA 94000 "Nucleoplasm, Golgi apparatus" "CAB009257: AB_654079, HPA039279: AB_2676425, HPA043907: AB_2678726" "unprognostic (1.30e-1)" "unprognostic (1.21e-2)" "unprognostic (2.86e-1)" "unprognostic (2.35e-1)" "unprognostic (9.35e-2)" "unprognostic (6.23e-3)" "prognostic unfavorable (1.39e-4)" "unprognostic (2.44e-2)" "unprognostic (6.61e-2)" "unprognostic (1.26e-1)" "unprognostic (8.07e-3)" "unprognostic (1.00e-2)" "prognostic unfavorable (4.31e-5)" "unprognostic (5.04e-3)" "unprognostic (1.52e-1)" "unprognostic (1.20e-1)" "unprognostic (3.88e-2)" 5.8 9.7 6.1 7.0 5.4 3.7 10.9 6.3 5.8 8.6 40.6 3.1 8.8 59.3 9.1 5.9 16.8 7.7 11.8 4.8 5.4 2.6 5.5 3.2 9.1 4.8 3.5 2.2 11.0 4.0 7.6 2.9 11.1 4.8 6.4 7.0 5.0 6.5 6.3 3.8 10.7 77.5 7.0 4.5 7.2 8.0 4.6 5.4 4.2 5.0 8.2 9.3 6.3 8.8 0.3 4.4 0.9 1.4 0.3 0.8 0.4 17.8 10.0 9.9 14.7 10.4 8.0 9.9 14.2 10.8 12.2 7.4 8.8 13.6 1.2 8.6 17.8 10.5 30.8 11.1 13.3 4.2 8.5 6.1 13.9 20.6 6.6 7.2 3.3 9.2 6.7 8.9 13.2 9.8 13.4 17.7 5.4 6.8 1.5 15.4 21.5 4.2 7.0 16.0 22.7 11.0 9.3 22.3 5.2 7.5 18.9 2.6 10.9 21.0 26.5 10.1 6.4 13.9 6.5 30.7 11.3 13.5 25.8 9.1 1.9 0.9 1.4 18.7 8.0 10.4 0.0 1.4 0.2 0.7 1.4 0.8 0.1 0.8 0.7 1.3 0.3 0.4 0.4 0.9 0.3 1.4 4.4 0.2 0.4 6.1 5.4 6.3 5.8 5.4 2.6 3.5 2.2 4.8 5.4 3.0 9.3 0.0 5.1 11.6 1.0 2.6 10.2 0.0 3.4 15.7 0.0 7.8 1.7 6.2 0.9 7.3 54.0 0.0 6.7 14.6 9.3 5.1 5.7 2.6 9.0 3.2 2.4 19.6 12.7 1.1 9.2 11.0 8.5 29.7 41.8 4.3 12.8 23.0 11.7 3.3 0.7 25.8 7.2 2.6 8.7 10.3 12.2 1.3 31.0 7.2 PLCB4 ENSG00000101333 "Phospholipase C beta 4" Q15147 20 9068763-9481242 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.9;retina: 40.2;salivary gland: 39.8" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 79.8;Cardiomyocytes: 57.6;Ciliated cells: 56.2;Horizontal cells: 155.7" "Cancer enhanced" "Detected in many" "colorectal cancer: 23.5" "Group enriched" "Detected in all" 4 "cerebellum: 44.9;pons and medulla: 11.9" "Cell type enriched" "Detected in single" 20 "plasmacytoid DC: 6.6" "Lineage enriched" "Detected in single" 20 "dendritic cells: 6.6" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 38.2;hTERT-HME1: 18.7;LHCN-M2: 30.8;OE19: 17.8;RPTEC TERT1: 39.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007951 Approved Approved Nucleoplasm,Microtubules NA NA Microtubules Nucleoplasm "HPA007951: AB_2667944" "unprognostic (3.88e-2)" "unprognostic (3.62e-1)" "unprognostic (1.19e-2)" "prognostic favorable (2.11e-4)" "unprognostic (1.44e-2)" "unprognostic (9.72e-3)" "unprognostic (3.32e-3)" "unprognostic (2.57e-2)" "unprognostic (7.75e-2)" "unprognostic (4.23e-2)" "unprognostic (5.21e-3)" "unprognostic (1.35e-1)" "unprognostic (4.64e-3)" "unprognostic (7.12e-2)" "unprognostic (1.37e-1)" "unprognostic (2.22e-1)" "unprognostic (4.45e-2)" 5.5 5.0 2.1 4.5 4.6 0.2 5.6 44.9 5.2 6.0 13.1 2.7 2.4 1.6 12.3 16.2 6.9 10.9 6.2 12.4 2.3 6.6 2.3 0.9 4.4 1.0 4.0 3.3 2.9 1.3 0.5 15.1 4.4 11.9 6.9 12.6 40.2 39.8 7.1 2.5 4.3 3.1 12.3 3.1 1.1 9.7 2.1 2.4 4.3 21.9 4.4 2.0 7.1 8.8 0.0 6.6 0.0 0.0 0.3 0.0 0.0 0.0 6.1 3.1 0.0 0.0 0.1 0.0 13.4 3.8 4.0 2.5 1.2 0.9 0.0 0.2 38.2 14.5 0.0 0.9 2.9 6.0 0.0 1.8 1.6 2.2 0.0 0.6 0.0 0.0 0.9 1.2 5.2 18.7 7.3 0.0 0.0 1.5 0.1 30.8 2.0 0.0 0.0 3.3 17.8 3.9 0.0 0.0 0.2 39.4 2.8 10.2 7.1 0.0 9.2 5.6 4.3 7.8 0.0 0.1 4.3 0.3 0.4 5.2 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 6.6 0.0 0.0 2.1 4.6 44.9 5.2 2.3 6.6 4.0 3.3 11.9 2.4 6.0 0.3 0.0 3.6 2.2 79.8 57.6 0.0 56.2 11.4 5.2 0.0 0.0 0.0 0.5 1.0 35.4 2.3 0.0 0.2 0.0 4.8 10.1 0.0 0.0 0.1 155.7 40.4 1.3 0.0 0.4 1.4 0.3 6.8 1.0 35.3 1.9 5.0 7.0 19.4 0.6 5.4 12.9 23.6 1.4 1.3 0.9 0.1 0.0 34.0 1.8 PLCG2 ENSG00000197943 "Phospholipase C gamma 2" P16885 16 81739097-81962693 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 55.8" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 211.5;Muller glia cells: 142.4;Rod photoreceptor cells: 205.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 40.5;HMC-1: 19.4;REH: 16.5;U-698: 90.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB004280, HPA020099, HPA020100" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA 21000 "Vesicles, Cytosol" Nucleoplasm "CAB004280: AB_628120, HPA020099: AB_1855324, HPA020100: AB_1855325" "unprognostic (2.86e-2)" "unprognostic (1.34e-1)" "unprognostic (1.09e-3)" "unprognostic (1.10e-1)" "unprognostic (1.58e-1)" "prognostic favorable (6.71e-4)" "unprognostic (6.23e-2)" "unprognostic (5.01e-2)" "unprognostic (2.22e-1)" "unprognostic (4.58e-2)" "unprognostic (4.66e-2)" "unprognostic (1.71e-2)" "prognostic favorable (4.88e-4)" "unprognostic (1.52e-2)" "unprognostic (1.21e-1)" "unprognostic (2.89e-1)" "unprognostic (3.40e-3)" 8.4 3.8 3.3 55.8 4.9 14.1 10.7 1.0 2.4 5.6 10.3 5.3 3.1 8.7 11.2 12.2 6.0 4.7 10.1 4.4 3.3 2.8 20.6 8.8 10.7 35.5 5.2 1.8 2.0 3.6 1.0 1.8 4.1 4.5 4.3 3.6 4.6 8.8 2.8 2.0 4.1 17.6 4.6 8.6 33.6 4.2 2.3 4.2 6.3 5.3 2.6 44.6 7.5 7.7 18.8 3.9 26.8 12.2 14.0 1.1 2.3 0.3 0.7 0.1 0.6 0.0 0.0 0.9 0.0 0.1 0.5 0.2 0.2 1.8 40.5 6.9 0.0 1.7 0.9 0.9 0.1 0.3 0.3 0.4 4.8 0.0 0.0 0.3 4.8 19.4 0.0 0.4 0.3 0.2 0.0 0.9 1.8 0.5 3.4 0.1 1.2 0.5 12.1 0.7 0.5 0.2 16.5 0.0 5.2 0.1 0.8 0.3 0.1 1.1 0.3 0.3 0.9 0.7 15.0 0.2 0.0 0.7 0.1 0.1 8.1 13.2 90.0 0.0 6.7 0.3 2.8 4.4 26.8 0.7 5.7 0.3 18.8 0.2 1.1 3.9 17.3 0.3 0.8 24.8 14.0 12.2 2.6 0.1 2.3 3.3 4.9 1.0 2.4 3.3 2.8 5.2 1.8 4.5 4.2 11.9 81.1 49.9 1.4 2.6 211.5 5.2 40.8 10.7 21.6 15.7 98.2 11.2 11.6 2.3 17.0 11.7 1.0 70.0 0.0 1.8 5.8 2.7 38.3 37.2 23.7 95.3 20.6 36.2 45.8 26.9 10.3 15.6 8.5 7.2 0.4 142.4 0.1 5.8 4.6 4.5 205.4 6.5 2.3 4.4 2.9 1.9 9.3 26.2 1.2 4.8 PLCXD2 FLJ31579 ENSG00000240891 "Phosphatidylinositol specific phospholipase C X domain containing 2" Q0VAA5 3 111674676-111846447 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 16.0" "Cell type enhanced" "Detected in many" 10 "Collecting duct cells: 57.6;Distal tubular cells: 135.9;Hepatocytes: 132.8;Proximal tubular cells: 94.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 7.2" "Group enriched" "Detected in many" 5 "dendritic cells: 7.2;NK-cells: 2.1;T-cells: 3.6" "Cell line enhanced" "Detected in many" "HBF TERT88: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055947 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA055947: AB_2682981" "unprognostic (2.68e-1)" "unprognostic (6.43e-2)" "unprognostic (7.26e-2)" "unprognostic (2.42e-1)" "unprognostic (3.09e-2)" "unprognostic (2.76e-2)" "unprognostic (1.36e-1)" "unprognostic (4.64e-1)" "unprognostic (3.47e-1)" "unprognostic (1.99e-2)" "unprognostic (3.38e-2)" "unprognostic (2.04e-1)" "prognostic favorable (1.23e-7)" "unprognostic (7.47e-2)" "unprognostic (1.29e-1)" "unprognostic (1.30e-1)" "prognostic favorable (2.99e-4)" 1.5 1.0 1.9 3.4 5.8 9.6 1.2 5.8 10.9 1.6 2.8 0.4 0.0 6.1 1.0 0.6 1.8 1.2 1.9 1.5 3.6 2.5 2.5 4.1 2.0 5.9 2.9 6.8 1.1 2.3 0.4 4.1 16.0 10.3 1.5 3.6 4.1 2.0 0.7 1.2 1.5 5.9 0.9 2.9 3.5 2.1 4.2 1.1 3.1 3.2 0.5 4.8 1.9 1.6 0.9 7.2 0.6 0.0 2.1 3.6 0.6 3.0 2.7 2.6 1.2 0.1 0.1 0.8 5.3 2.5 5.0 4.4 1.9 1.5 2.2 2.7 0.2 1.6 7.5 1.1 5.1 9.7 0.6 1.3 0.5 5.0 1.7 0.4 0.7 2.6 0.0 1.0 1.6 3.0 4.7 2.8 2.9 0.1 5.4 0.6 0.3 1.5 0.5 0.9 2.0 6.8 1.4 3.8 2.0 2.4 3.1 0.6 4.6 1.1 0.7 1.1 3.1 0.4 0.2 2.6 1.1 6.8 0.5 1.0 6.5 0.9 0.4 0.5 0.4 0.3 0.6 0.0 0.0 3.6 0.0 3.5 0.5 1.9 3.5 0.3 0.9 0.9 2.0 0.2 2.1 0.0 7.2 1.7 0.6 1.9 5.8 5.8 10.9 3.6 2.5 2.9 6.8 10.3 1.1 17.9 2.1 0.5 6.9 0.1 0.7 1.9 28.1 0.0 1.2 57.6 3.9 0.0 135.9 36.1 11.5 0.0 1.3 0.0 43.6 0.0 0.1 3.8 0.0 132.8 0.0 6.4 24.1 0.0 1.6 8.9 0.3 0.0 0.0 0.0 4.9 0.0 45.8 0.0 0.4 94.0 3.7 0.0 0.0 0.5 0.4 0.1 0.0 2.2 1.1 12.2 PLD3 HU-K4 ENSG00000105223 "Phospholipase D family member 3" Q8IV08 19 40348456-40380439 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response" "Exonuclease, Hydrolase, Nuclease" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Hofbauer cells: 638.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "basophil: 149.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 149.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012800, CAB020812" Approved Approved "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA 490000 "Endoplasmic reticulum, Cytosol" Nucleoplasm "CAB020812: , HPA012800: AB_1855330" "unprognostic (1.11e-1)" "unprognostic (1.06e-1)" "unprognostic (1.64e-3)" "unprognostic (2.56e-3)" "unprognostic (2.06e-3)" "unprognostic (2.68e-1)" "unprognostic (4.52e-2)" "unprognostic (3.89e-2)" "unprognostic (1.09e-1)" "unprognostic (4.60e-2)" "prognostic favorable (6.44e-4)" "unprognostic (4.34e-2)" "prognostic favorable (2.21e-4)" "unprognostic (3.49e-2)" "unprognostic (2.10e-1)" "unprognostic (1.38e-2)" "unprognostic (6.42e-2)" 45.7 57.5 44.6 23.1 79.0 12.8 21.9 35.5 126.1 31.2 23.5 25.4 17.1 22.6 26.3 35.0 18.3 30.0 30.8 33.0 46.4 73.4 22.1 25.6 49.7 25.2 44.7 53.9 44.8 42.5 32.9 122.1 38.9 62.2 29.6 16.1 31.6 35.3 37.2 27.4 24.2 23.5 25.6 28.6 48.9 23.0 17.0 19.3 11.9 20.6 11.2 12.9 27.3 20.7 3.6 23.0 149.2 24.6 9.7 7.8 16.8 14.1 43.7 28.3 44.5 78.9 37.6 21.6 35.1 35.8 25.5 29.2 8.3 16.0 6.1 36.9 30.5 8.3 6.6 6.8 13.8 11.2 22.9 24.9 6.6 15.0 10.4 53.9 2.7 75.9 71.5 28.9 19.4 13.4 42.8 21.4 10.1 23.3 24.9 18.3 18.5 4.8 13.1 18.5 23.2 9.0 6.1 21.6 25.2 13.1 10.6 20.3 33.8 16.8 10.4 18.8 30.9 14.3 47.6 37.6 21.5 10.3 18.2 7.8 26.0 27.7 6.3 34.6 11.0 13.3 149.2 24.6 35.3 7.8 12.8 6.4 3.6 6.2 6.9 23.0 3.1 6.5 6.5 2.5 9.7 5.7 3.3 6.1 16.8 44.6 79.0 35.5 126.1 46.4 73.4 44.7 53.9 62.2 19.3 29.8 62.9 34.4 70.6 31.5 98.5 18.5 25.5 12.0 28.4 54.1 31.4 137.8 18.3 50.7 5.8 46.8 52.7 0.0 51.3 94.8 142.4 49.1 59.9 35.8 638.2 114.4 69.9 90.9 219.8 8.6 140.4 84.2 87.7 44.1 36.8 99.5 49.7 41.2 135.1 30.0 39.3 19.4 53.1 13.9 57.5 29.2 163.8 35.4 34.5 52.0 PLEKHA1 TAPP1 ENSG00000107679 "Pleckstrin homology domain containing A1" Q9HB21 10 122374696-122442602 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 261.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 6 "B-cells: 6.9;NK-cells: 11.6;T-cells: 16.5" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 64.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002043, HPA064795" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA002043: AB_1079632, HPA064795: AB_2685354" "unprognostic (1.79e-2)" "unprognostic (3.18e-2)" "unprognostic (2.70e-1)" "unprognostic (5.44e-3)" "unprognostic (7.41e-2)" "unprognostic (1.69e-1)" "unprognostic (5.50e-2)" "unprognostic (4.07e-2)" "unprognostic (3.88e-1)" "unprognostic (2.69e-1)" "unprognostic (7.98e-2)" "unprognostic (7.63e-2)" "unprognostic (1.11e-1)" "unprognostic (1.46e-1)" "unprognostic (7.42e-2)" "unprognostic (4.31e-2)" "unprognostic (5.23e-2)" 11.7 7.4 18.2 8.7 30.2 2.6 13.6 15.8 37.9 13.6 14.9 25.4 11.4 17.1 17.9 14.5 26.7 8.8 16.3 19.4 19.8 16.6 27.1 25.4 24.4 9.0 15.6 24.4 13.9 18.1 18.8 22.9 30.6 20.7 12.7 13.9 9.5 16.0 13.6 22.5 43.9 17.2 16.0 19.6 8.7 14.0 25.5 15.0 3.4 18.7 13.9 11.7 16.1 16.1 6.9 1.8 1.3 1.6 11.6 16.5 6.2 7.8 7.3 7.4 5.1 10.8 12.3 8.9 8.8 15.4 5.3 5.8 6.1 10.0 4.9 4.3 7.9 5.4 17.4 7.0 26.9 4.9 3.5 6.8 0.0 7.2 7.2 7.1 0.9 2.3 6.7 22.3 4.4 18.8 8.8 17.9 10.4 7.3 0.0 4.9 3.0 4.4 0.7 5.7 12.1 4.9 1.2 10.6 0.9 64.9 8.8 10.1 4.9 11.4 8.5 8.9 10.9 4.7 0.1 17.0 4.5 3.7 4.9 4.4 0.0 0.0 1.6 7.0 0.0 2.8 0.1 1.5 1.3 16.5 1.4 10.8 2.9 10.0 13.2 1.8 6.9 15.9 13.5 0.5 11.6 1.6 0.9 6.6 6.2 18.2 30.2 15.8 37.9 19.8 16.6 15.6 24.4 20.7 15.0 134.0 37.7 19.5 46.6 64.7 41.5 49.8 43.3 33.5 60.3 54.1 70.7 47.5 34.9 55.8 165.5 60.9 41.2 0.0 73.6 39.9 30.4 51.3 4.7 42.4 29.9 25.4 21.5 27.6 18.2 261.8 40.9 15.7 23.6 28.9 21.1 25.4 58.5 28.1 33.9 98.4 50.3 25.8 30.1 90.5 82.0 74.2 33.2 33.3 24.5 60.8 PLEKHA2 TAPP2 ENSG00000169499 "Pleckstrin homology domain containing A2" 8 38901235-38973909 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 69.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 53.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004706 Approved Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies, Cytosol" "HPA004706: AB_1079633" "unprognostic (2.78e-1)" "unprognostic (8.80e-3)" "unprognostic (4.15e-3)" "unprognostic (3.03e-1)" "unprognostic (8.61e-2)" "unprognostic (9.07e-3)" "unprognostic (6.16e-3)" "unprognostic (1.45e-1)" "unprognostic (1.76e-1)" "unprognostic (1.08e-1)" "unprognostic (1.39e-2)" "unprognostic (6.59e-2)" "prognostic unfavorable (1.95e-6)" "unprognostic (2.39e-2)" "unprognostic (1.00e-1)" "unprognostic (4.55e-2)" "unprognostic (9.60e-3)" 7.7 9.7 8.8 19.1 6.6 14.2 6.4 3.4 6.9 8.6 8.2 4.8 11.8 3.7 9.0 11.5 6.7 6.9 8.9 17.7 7.0 4.7 7.3 4.0 9.7 29.9 6.6 6.9 10.5 4.5 15.3 6.9 6.9 4.8 9.0 5.0 16.7 5.9 10.3 5.4 5.4 8.8 9.9 8.0 16.3 6.4 5.0 5.7 5.2 7.8 3.2 26.2 12.8 8.6 14.2 5.3 7.5 2.0 3.8 2.7 0.9 9.5 2.2 1.4 3.4 3.6 7.2 1.5 11.6 9.2 8.9 7.6 1.2 6.6 53.5 13.9 10.7 8.0 6.0 3.7 7.4 13.5 13.5 0.3 27.3 19.0 1.3 13.2 8.7 11.2 16.4 5.1 4.6 8.3 21.0 1.5 8.9 2.7 15.5 8.3 1.2 17.8 4.1 1.3 7.7 3.4 4.6 7.4 11.3 10.9 8.3 0.1 2.1 13.6 2.5 9.3 2.2 5.7 4.3 2.1 6.5 5.1 1.1 9.2 4.9 4.5 24.9 10.3 9.5 1.4 5.2 1.5 7.5 2.0 2.0 2.1 8.9 2.3 2.3 1.8 14.2 1.5 2.7 3.4 3.8 2.0 5.3 1.9 0.9 8.8 6.6 3.4 6.9 7.0 4.7 6.6 6.9 4.8 5.7 3.0 22.7 61.4 10.3 7.8 1.4 36.3 12.7 16.0 7.9 38.4 0.0 6.5 1.7 7.0 0.6 10.3 9.7 0.0 4.7 13.6 10.8 9.2 35.8 10.2 42.5 55.6 12.6 26.4 69.1 0.9 21.0 38.7 15.1 13.6 10.4 15.1 16.5 3.5 23.7 11.5 1.4 12.9 14.1 0.5 6.1 5.8 3.8 36.2 12.1 26.6 PLEKHA5 "FLJ10667, KIAA1686, PEPP2" ENSG00000052126 "Pleckstrin homology domain containing A5" Q9HAU0 12 19129752-19376400 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "monocytes: 290.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 14.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 27.2;NTERA-2: 27.8;SuSa: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035923, HPA035924, HPA041455" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA035923: AB_10673491, HPA035924: AB_10672994, HPA041455: AB_2677490" "unprognostic (3.16e-1)" "unprognostic (8.35e-3)" "unprognostic (1.30e-1)" "unprognostic (4.85e-3)" "unprognostic (6.14e-2)" "unprognostic (2.04e-1)" "unprognostic (1.32e-1)" "unprognostic (2.35e-2)" "unprognostic (3.62e-1)" "unprognostic (2.55e-1)" "prognostic unfavorable (5.41e-5)" "unprognostic (3.71e-1)" "prognostic unfavorable (7.42e-5)" "unprognostic (1.27e-1)" "unprognostic (2.43e-1)" "unprognostic (4.03e-2)" "unprognostic (1.07e-2)" 7.7 52.3 13.8 7.8 22.0 2.9 11.9 13.0 22.4 23.5 9.8 7.2 19.4 10.0 23.1 25.7 16.0 16.0 16.7 25.2 11.2 11.5 32.2 12.1 9.9 2.4 10.7 16.3 26.1 11.3 27.2 14.4 10.2 15.0 17.6 10.8 22.2 11.4 22.7 2.0 13.2 10.0 23.1 23.7 2.8 13.7 14.8 13.0 6.1 11.5 5.9 4.3 18.1 18.1 0.4 2.7 14.8 0.4 1.7 6.4 0.4 10.7 5.3 19.4 0.2 6.6 8.9 6.9 4.6 10.0 2.8 4.4 7.9 9.7 0.2 1.5 5.1 5.7 4.6 13.0 8.5 5.9 27.2 4.6 6.4 11.8 3.8 6.2 0.2 0.9 5.2 9.0 8.0 15.3 15.4 3.0 5.5 2.7 0.4 2.9 3.3 4.1 0.8 27.8 8.7 2.8 0.1 9.0 0.1 19.6 12.7 1.8 4.0 4.4 2.6 16.4 27.5 3.2 1.5 4.5 1.8 7.7 0.4 0.2 0.3 0.2 0.2 4.2 0.1 3.5 14.8 0.4 0.3 2.7 0.3 6.4 0.2 2.5 2.3 1.8 0.4 0.4 1.9 1.0 1.7 0.2 2.7 2.1 0.4 13.8 22.0 13.0 22.4 11.2 11.5 10.7 16.3 15.0 13.0 23.8 23.3 2.7 42.8 18.2 89.3 123.9 50.9 72.3 50.0 43.6 129.6 22.7 29.9 26.9 20.2 15.5 24.5 0.0 28.7 34.1 41.5 27.0 3.5 36.2 5.8 119.2 31.2 16.5 8.6 11.8 37.4 12.0 111.3 290.4 12.7 99.2 39.4 30.6 26.5 85.1 145.1 32.3 27.2 41.2 47.8 22.5 22.1 10.7 33.8 41.1 PLEKHA7 DKFZp686M22243 ENSG00000166689 "Pleckstrin homology domain containing A7" Q6IQ23 11 16777317-17014443 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 23.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "eosinophil: 6.8;MAIT T-cell: 4.5" "Group enriched" "Detected in many" 6 "granulocytes: 6.8;T-cells: 4.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 43.4;HaCaT: 28.7;OE19: 23.8;RT4: 39.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038610, HPA066103" Approved Enhanced "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cell Junctions" Cytosol "HPA038610: AB_10671746, HPA066103: AB_2732738" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "unprognostic (3.81e-2)" "unprognostic (4.30e-2)" "unprognostic (2.51e-2)" "unprognostic (6.95e-3)" "unprognostic (2.81e-2)" "unprognostic (1.85e-2)" "unprognostic (2.65e-1)" "unprognostic (1.73e-1)" "unprognostic (2.65e-3)" "unprognostic (3.13e-2)" "prognostic favorable (1.89e-15)" "unprognostic (9.74e-2)" "unprognostic (1.17e-2)" "unprognostic (4.81e-1)" "unprognostic (2.65e-2)" 6.8 1.2 5.3 6.6 8.0 0.1 10.7 2.9 4.9 7.7 18.1 10.9 10.0 17.7 4.7 6.0 30.6 6.0 15.1 13.6 7.5 4.2 18.1 9.0 6.4 1.2 7.2 4.6 8.1 18.9 19.1 3.2 18.7 14.5 6.0 11.5 18.2 15.0 16.3 2.7 8.9 32.0 2.7 8.1 1.7 15.2 7.4 7.9 1.4 7.2 1.9 5.5 10.7 12.4 0.5 0.9 6.8 0.3 0.2 4.5 0.3 5.1 4.6 4.9 2.2 0.2 0.0 8.1 0.0 0.1 1.7 3.2 7.9 43.4 0.0 2.0 0.6 0.2 28.7 6.5 0.0 1.2 1.5 6.3 13.3 3.7 5.4 0.1 0.0 0.1 0.2 2.5 0.0 0.1 4.0 0.0 5.6 0.5 0.1 0.7 3.3 3.0 0.1 2.7 23.8 4.5 4.1 0.0 1.0 4.2 39.3 3.1 0.3 5.9 16.9 0.2 9.3 4.3 1.5 1.1 0.0 1.6 1.2 1.0 2.9 0.9 5.8 0.0 0.2 0.0 0.2 0.3 6.8 0.6 0.1 4.5 0.5 0.8 0.6 0.3 0.2 0.2 0.4 0.6 0.2 0.1 0.9 0.1 0.3 5.3 8.0 2.9 4.9 7.5 4.2 7.2 4.6 14.5 7.9 3.0 13.4 0.0 1.2 0.6 1.2 8.7 5.1 6.7 12.5 10.4 23.6 5.4 3.3 4.7 11.7 2.3 8.4 0.0 5.3 0.8 0.6 0.8 2.3 2.4 1.7 0.0 0.0 0.6 1.0 4.5 0.6 2.4 0.0 1.0 4.6 3.9 7.6 3.5 0.4 8.1 10.6 0.0 0.3 0.2 0.5 0.4 5.0 0.5 2.6 4.6 PLEKHA8 "FAPP2, MGC3358" ENSG00000106086 "Pleckstrin homology domain containing A8" Q96JA3 7 30027404-30130483 "Predicted intracellular proteins" "Lipid transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072314 Supported "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA072314: AB_2686511" "unprognostic (5.49e-3)" "unprognostic (8.62e-3)" "unprognostic (2.39e-1)" "unprognostic (5.14e-2)" "unprognostic (1.22e-1)" "unprognostic (2.71e-1)" "unprognostic (1.70e-4)" "unprognostic (5.96e-2)" "unprognostic (2.86e-1)" "unprognostic (3.21e-2)" "unprognostic (1.41e-1)" "unprognostic (2.31e-2)" "unprognostic (2.96e-2)" "unprognostic (1.48e-1)" "unprognostic (1.82e-1)" "unprognostic (2.19e-2)" "unprognostic (3.07e-2)" 7.3 5.6 9.7 7.2 11.6 3.2 7.5 16.3 13.0 8.5 7.8 8.3 4.8 8.3 8.6 10.0 9.2 5.4 7.7 6.0 8.2 7.5 14.0 6.1 7.1 8.7 9.9 5.8 9.3 9.0 10.5 8.8 21.0 9.9 7.6 8.4 9.1 8.5 9.0 4.8 7.9 9.0 8.7 7.8 5.2 6.9 8.1 9.6 6.9 6.6 1.7 10.2 8.7 8.6 1.2 0.5 2.8 0.9 1.0 1.7 0.3 6.5 4.5 20.6 21.8 5.9 4.7 14.3 4.7 3.8 3.8 5.0 8.5 2.8 15.3 6.5 4.8 9.9 4.8 10.7 5.7 5.4 2.9 7.2 8.8 7.6 7.8 5.1 3.8 3.1 2.3 4.4 5.2 7.4 4.7 8.2 7.5 8.0 5.6 5.4 4.3 7.7 2.7 13.7 3.2 5.1 0.0 5.8 10.3 4.3 5.2 2.7 15.7 5.3 17.2 6.8 19.4 6.0 4.0 6.9 3.4 14.4 3.5 5.5 11.5 20.0 8.9 6.6 2.5 8.0 2.8 0.6 2.5 1.7 0.6 0.9 1.2 1.0 1.1 0.5 0.8 1.2 1.6 0.1 1.0 0.9 0.1 1.0 0.3 9.7 11.6 16.3 13.0 8.2 7.5 9.9 5.8 9.9 9.6 3.0 1.6 4.2 5.3 10.0 14.2 4.1 2.5 0.0 1.2 12.2 23.6 16.1 3.3 9.5 1.5 4.9 6.2 0.0 6.2 15.8 6.2 8.6 4.6 4.0 5.9 9.5 2.4 3.7 2.2 1.1 3.1 4.2 10.1 5.4 4.4 5.8 9.4 23.0 4.6 8.7 19.1 6.5 5.6 8.1 12.2 11.0 16.9 3.3 3.4 8.4 PLEKHG1 "ARHGEF41, KIAA1209" ENSG00000120278 "Pleckstrin homology and RhoGEF domain containing G1" Q9ULL1 6 150599883-150843665 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 39.7" "Cell type enhanced" "Detected in many" 9 "Endothelial cells: 43.2;Ito cells: 39.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 28 "memory B-cell: 14.7;naive B-cell: 15.9" "Lineage enriched" "Detected in single" 29 "B-cells: 15.9" "Cell line enhanced" "Detected in many" "AF22: 12.5;HAP1: 18.4;Karpas-707: 16.4;U-698: 11.4" "Region enriched" "Detected in many" 5 "thalamus: 56.1" "Low region specificity" "Detected in all" "HPA027128, HPA027319, HPA028270" Approved Enhanced Nucleoplasm Yes No Nucleoplasm "HPA027128: AB_2672124, HPA027319: AB_10600306, HPA028270: AB_10611388" "unprognostic (2.93e-1)" "unprognostic (3.44e-1)" "unprognostic (3.04e-3)" "unprognostic (2.34e-1)" "unprognostic (1.05e-1)" "unprognostic (2.80e-3)" "unprognostic (1.85e-1)" "unprognostic (4.82e-2)" "unprognostic (2.10e-1)" "unprognostic (1.60e-1)" "unprognostic (3.47e-2)" "unprognostic (1.50e-1)" "unprognostic (4.62e-3)" "unprognostic (3.63e-1)" "unprognostic (4.30e-2)" "unprognostic (3.83e-1)" "unprognostic (2.15e-2)" 27.5 2.2 7.3 10.6 7.3 2.3 10.0 2.4 7.1 8.3 5.8 10.1 4.8 4.8 7.8 14.1 9.6 8.9 8.1 5.9 7.7 6.7 4.5 5.1 12.1 13.5 10.5 3.0 4.7 2.8 8.2 5.1 13.9 11.1 4.1 6.2 3.4 3.5 5.4 6.4 8.9 6.0 5.7 19.6 28.9 4.5 7.3 7.7 39.7 6.0 5.8 13.3 7.4 8.5 15.9 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.1 12.5 0.1 0.0 0.0 8.9 0.0 0.0 0.0 0.0 6.9 3.0 4.9 4.8 0.0 1.2 1.8 18.4 1.6 0.0 7.7 2.0 0.3 0.9 0.0 0.0 0.0 1.4 0.8 4.7 0.0 0.1 0.0 7.7 4.1 0.0 16.4 0.0 0.2 1.5 0.0 0.9 4.8 0.5 0.8 0.0 0.0 3.6 8.2 0.4 0.1 0.0 2.2 1.5 1.4 0.0 0.0 7.7 0.0 1.7 0.0 3.3 0.0 0.0 11.4 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.5 14.7 0.3 0.4 0.0 15.9 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.4 7.3 7.3 2.4 7.1 7.7 6.7 10.5 3.0 11.1 7.7 0.0 3.8 8.1 0.6 3.8 0.2 1.6 2.5 5.3 3.4 7.0 0.0 4.2 3.3 2.3 2.7 43.2 4.3 0.0 1.0 1.3 9.9 0.7 0.0 3.0 0.5 0.0 5.2 39.9 6.1 1.3 0.3 0.8 5.0 8.2 9.0 8.3 6.3 10.5 0.4 2.8 0.5 0.0 2.3 1.0 0.9 3.1 2.4 3.2 4.2 2.4 PLEKHG2 "ARHGEF42, CLG, FLJ00018" ENSG00000090924 "Pleckstrin homology and RhoGEF domain containing G2" Q9H7P9 19 39412585-39428415 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease mutation, Leukodystrophy, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 30.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 36.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017973, HPA048054" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA017973: AB_2669719, HPA048054: AB_2680241" "unprognostic (3.55e-1)" "unprognostic (6.73e-2)" "prognostic unfavorable (3.53e-4)" "unprognostic (3.97e-2)" "unprognostic (1.54e-1)" "unprognostic (1.41e-3)" "unprognostic (1.24e-2)" "unprognostic (4.48e-2)" "unprognostic (1.39e-1)" "unprognostic (8.09e-2)" "unprognostic (2.10e-1)" "unprognostic (4.99e-1)" "prognostic unfavorable (3.79e-8)" "unprognostic (8.01e-2)" "unprognostic (3.90e-2)" "unprognostic (7.52e-2)" "unprognostic (1.63e-1)" 15.7 6.1 2.9 30.8 4.4 14.8 14.2 2.8 4.0 18.7 12.4 3.9 5.6 5.9 20.3 10.1 9.7 12.6 17.6 13.5 3.5 2.6 10.7 5.1 21.4 20.2 4.5 2.2 17.5 4.4 5.8 7.6 17.4 7.4 12.3 3.9 13.6 6.8 15.0 7.1 4.4 9.6 14.1 6.9 24.8 8.8 8.7 3.6 49.3 11.1 9.5 24.6 13.0 10.1 3.9 4.2 2.8 1.8 1.4 4.4 2.7 3.5 17.6 32.2 17.4 3.1 4.1 4.6 9.5 7.5 6.6 5.7 11.3 6.4 6.3 7.0 12.3 5.5 1.2 4.8 8.4 3.5 20.7 4.4 8.1 9.2 5.1 5.3 0.9 10.2 9.3 1.4 7.9 3.8 11.5 8.4 18.2 5.4 7.4 10.5 7.1 10.1 3.2 7.6 3.3 1.7 36.4 3.9 1.9 5.6 6.6 0.8 10.4 2.1 0.8 3.1 11.7 9.5 9.3 10.7 17.3 13.6 6.4 6.0 5.5 1.7 9.1 9.6 3.7 9.5 2.8 1.4 0.4 4.4 0.8 2.6 3.9 2.1 2.5 1.0 3.6 2.8 3.5 2.6 1.4 1.8 4.2 3.9 2.7 2.9 4.4 2.8 4.0 3.5 2.6 4.5 2.2 7.4 3.6 6.0 30.1 7.5 3.2 3.5 0.6 5.6 5.1 2.7 9.1 0.0 0.0 0.7 0.0 5.3 9.7 8.1 2.6 0.0 4.3 2.3 6.4 2.6 2.3 0.8 8.9 0.0 1.2 10.4 12.9 11.7 6.6 11.4 5.0 7.2 2.6 1.2 3.0 2.3 7.8 0.2 2.6 6.5 8.0 2.6 2.2 2.5 0.9 6.7 3.0 1.3 PLEKHG3 "ARHGEF43, KIAA0599" ENSG00000126822 "Pleckstrin homology and RhoGEF domain containing G3" A1L390 14 64704102-64750247 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 45.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "granulocytes: 16.7;NK-cells: 6.4;T-cells: 12.2" "Cell line enhanced" "Detected in many" "A-431: 29.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063455, HPA065323, HPA073702, HPA074734" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytokinetic bridge,Centrosome,Cytosol" Yes No "Plasma membrane, Cytosol" "Nucleoplasm, Cytokinetic bridge, Centrosome" "HPA063455: AB_2685015, HPA065323: AB_2685467, HPA073702: AB_2732238, HPA074734: AB_2732265" "unprognostic (8.71e-2)" "unprognostic (1.69e-1)" "unprognostic (4.38e-2)" "unprognostic (4.04e-2)" "unprognostic (2.18e-1)" "unprognostic (7.22e-2)" "unprognostic (7.21e-2)" "unprognostic (5.53e-3)" "unprognostic (1.49e-1)" "unprognostic (3.34e-3)" "unprognostic (3.63e-1)" "unprognostic (3.54e-2)" "prognostic favorable (7.39e-8)" "unprognostic (2.29e-1)" "unprognostic (2.67e-1)" "unprognostic (4.24e-2)" "unprognostic (2.67e-3)" 12.8 2.9 17.2 7.8 36.9 11.4 19.8 7.3 29.4 15.2 15.9 67.3 9.3 10.2 31.6 9.9 26.4 19.8 17.5 12.5 24.2 12.8 19.5 16.5 8.4 4.0 40.7 21.6 16.8 22.7 17.9 3.7 22.3 19.5 12.3 12.1 13.6 19.6 31.6 5.9 19.6 10.0 20.7 24.5 16.0 11.5 5.1 40.9 1.2 14.5 6.4 5.3 16.6 17.1 0.0 0.7 16.7 1.9 6.4 12.2 2.9 29.0 13.5 11.3 17.1 1.2 0.0 19.7 3.3 3.9 5.2 4.2 14.2 12.9 0.0 5.9 3.1 1.8 28.1 7.6 25.9 1.8 0.0 6.6 12.9 16.7 3.4 1.5 0.4 6.2 1.5 15.0 1.1 9.4 8.7 3.4 0.1 0.0 0.1 1.7 13.7 0.0 11.8 3.8 7.7 14.5 0.1 5.6 2.0 14.3 21.3 3.9 6.9 6.7 10.1 9.7 10.9 11.0 2.9 6.5 2.3 23.4 0.1 4.5 0.0 0.0 0.0 0.2 1.3 4.0 4.5 1.9 11.7 12.2 1.1 8.6 0.0 3.7 5.2 0.7 0.0 0.4 2.7 16.7 6.4 0.7 0.0 1.1 2.9 17.2 36.9 7.3 29.4 24.2 12.8 40.7 21.6 19.5 40.9 3.0 3.8 0.8 15.7 17.2 3.6 6.9 17.8 2.7 3.4 45.4 0.0 6.9 10.0 25.0 0.7 3.0 14.7 0.0 17.7 8.6 8.4 13.8 1.1 9.6 4.4 0.0 33.4 1.8 6.0 0.9 6.9 3.3 5.0 0.0 22.8 11.7 28.1 20.1 24.1 7.0 0.8 25.8 16.5 0.0 1.1 18.7 2.2 5.7 15.0 33.4 PLEKHG4B KIAA1909 ENSG00000153404 "Pleckstrin homology and RhoGEF domain containing G4B" Q96PX9 5 92151-189972 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 25.4;Club cells: 19.4;Collecting duct cells: 10.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "pons and medulla: 8.5" "Cell type enriched" "Detected in single" 21 "plasmacytoid DC: 5.4" "Lineage enriched" "Detected in single" 21 "dendritic cells: 5.4" "Cell line enhanced" "Detected in some" "AN3-CA: 10.4;HAP1: 9.3;NTERA-2: 9.6;REH: 21.7;SCLC-21H: 9.7;SH-SY5Y: 8.7;SK-BR-3: 9.2;SuSa: 9.5;T-47d: 13.0" "HPA036274, HPA058157" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA036274: AB_10669668, HPA058157: AB_2683625" "unprognostic (3.60e-2)" "unprognostic (8.52e-2)" "unprognostic (5.44e-3)" "unprognostic (1.48e-1)" "unprognostic (2.20e-2)" "unprognostic (3.91e-1)" "unprognostic (3.59e-1)" "prognostic favorable (3.47e-4)" "unprognostic (5.96e-2)" "unprognostic (7.08e-2)" "unprognostic (2.56e-2)" "unprognostic (1.58e-1)" "unprognostic (9.98e-7)" "unprognostic (1.43e-2)" "unprognostic (7.00e-2)" "unprognostic (1.63e-3)" "unprognostic (1.08e-3)" 0.1 0.2 1.7 0.3 0.5 1.4 3.9 1.5 0.6 4.4 1.0 3.1 0.0 0.6 3.6 1.0 0.6 3.1 0.0 0.1 1.3 0.9 1.4 0.1 1.3 1.5 0.8 0.0 3.3 2.5 0.2 8.2 7.9 8.5 5.4 0.1 5.1 4.5 1.2 0.4 0.9 0.9 0.7 0.4 0.2 2.1 4.8 1.1 5.2 8.2 0.6 1.6 0.3 0.8 0.0 5.4 0.2 0.0 0.1 0.2 0.0 0.0 0.9 6.9 10.4 0.0 0.0 0.1 0.7 0.2 0.7 1.5 1.2 0.1 0.1 2.3 0.9 0.6 0.4 9.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.0 2.8 0.0 0.0 0.0 0.2 0.1 0.0 9.6 0.0 0.1 21.7 4.9 5.6 0.8 0.0 9.7 8.7 5.3 9.2 0.0 9.5 13.0 0.0 0.0 0.2 2.6 0.0 0.2 0.1 0.0 0.4 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 5.4 0.0 0.0 1.7 0.5 1.5 0.6 1.3 0.9 0.8 0.0 8.5 1.1 0.0 4.3 0.0 2.9 0.3 0.4 1.6 0.0 25.4 19.4 10.4 0.0 4.2 0.0 0.4 0.2 0.0 0.0 0.0 0.2 3.8 0.6 2.5 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.2 5.7 0.3 1.5 0.0 0.0 0.7 PLEKHG5 "GEF720, KIAA0720, Syx, Tech" ENSG00000171680 "Pleckstrin homology and RhoGEF domain containing G5" O94827 1 6466092-6520061 "Disease related genes, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 59.8;skin 1: 60.0" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 12.9;Suprabasal keratinocytes: 12.7" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 59.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "TIME: 17.5" "Group enriched" "Detected in many" 4 "amygdala: 18.7;basal ganglia: 13.2;cerebral cortex: 26.7;hippocampal formation: 40.2" "Low region specificity" "Detected in all" HPA049570 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA049570: AB_2680818" "unprognostic (5.59e-2)" "unprognostic (1.33e-1)" "unprognostic (2.47e-1)" "unprognostic (2.81e-1)" "unprognostic (1.50e-3)" "unprognostic (5.10e-2)" "unprognostic (1.02e-1)" "unprognostic (5.46e-2)" "unprognostic (4.40e-2)" "unprognostic (1.02e-2)" "unprognostic (4.85e-1)" "unprognostic (2.70e-2)" "unprognostic (1.28e-3)" "unprognostic (4.85e-1)" "unprognostic (1.20e-1)" "unprognostic (3.13e-1)" "unprognostic (4.85e-2)" 10.6 9.7 8.7 2.9 6.3 0.7 4.1 59.8 11.6 3.9 3.0 1.2 2.5 3.3 3.8 4.5 7.1 3.9 6.5 5.4 7.7 2.9 2.3 0.8 3.6 2.7 1.8 6.7 2.6 3.1 4.0 15.2 7.6 4.4 3.4 2.8 4.9 4.2 5.3 3.4 60.0 4.3 2.7 1.8 16.9 2.6 2.6 1.4 0.0 2.4 6.5 4.8 2.3 4.4 0.5 0.6 2.1 0.5 0.3 1.0 0.4 4.0 1.1 8.1 4.7 0.8 2.8 1.4 5.5 3.1 1.7 1.0 2.3 8.0 0.1 12.6 1.8 3.1 13.7 0.9 12.0 0.9 7.9 1.6 0.0 5.6 1.4 1.2 0.0 0.7 2.9 6.4 5.9 6.9 10.5 12.3 0.9 0.0 1.0 0.4 3.4 0.1 15.6 2.5 1.2 12.2 0.1 1.0 1.1 4.3 1.3 5.2 14.9 0.6 4.1 0.3 4.1 5.4 0.1 17.5 4.2 3.0 0.0 3.3 0.1 0.0 0.9 4.6 0.0 0.3 1.8 0.5 0.3 0.4 0.4 1.0 0.2 0.8 0.7 0.1 0.5 0.5 0.6 2.1 0.3 0.2 0.6 0.2 0.4 8.7 6.3 59.8 11.6 7.7 2.9 1.8 6.7 4.4 1.4 0.0 1.0 0.0 2.1 6.5 0.6 3.2 2.5 1.4 2.3 3.5 2.0 2.2 0.0 1.1 8.6 4.5 3.3 0.0 1.2 3.3 1.8 1.4 0.0 0.0 4.0 1.6 3.4 5.5 1.2 2.6 1.7 0.0 0.0 0.0 5.2 9.2 3.3 5.8 8.1 0.6 1.5 12.9 1.0 1.9 3.2 12.7 1.6 0.0 2.7 5.5 PLEKHH2 "KIAA2028, PLEKHH1L" ENSG00000152527 "Pleckstrin homology, MyTH4 and FERM domain containing H2" Q8IVE3 2 43637273-43767987 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 35.7;Collecting duct cells: 62.8;Peritubular cells: 47.4;Sertoli cells: 45.3" "Cancer enhanced" "Detected in many" "renal cancer: 6.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.3;RPTEC TERT1: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077225 Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA077225: AB_2686828" "unprognostic (1.11e-1)" "unprognostic (1.05e-1)" "unprognostic (3.49e-2)" "unprognostic (1.59e-1)" "unprognostic (2.16e-1)" "unprognostic (4.27e-3)" "unprognostic (1.77e-1)" "unprognostic (2.32e-2)" "unprognostic (2.94e-2)" "unprognostic (6.99e-2)" "unprognostic (2.81e-1)" "unprognostic (2.53e-2)" "unprognostic (1.92e-3)" "unprognostic (3.03e-2)" "unprognostic (1.29e-1)" "unprognostic (8.57e-3)" "unprognostic (1.82e-2)" 10.1 2.7 3.7 9.2 6.5 0.3 7.5 5.4 5.6 27.2 8.5 2.9 3.6 4.1 30.0 9.5 5.2 9.8 8.1 3.7 4.2 2.7 8.7 1.8 21.7 3.0 3.4 3.3 19.4 2.5 9.6 1.8 4.2 8.3 7.9 5.0 7.4 3.8 7.8 5.4 6.9 5.7 13.1 9.7 4.7 4.1 4.2 4.0 0.0 4.7 4.7 4.3 11.1 8.6 0.8 0.6 1.4 0.4 0.7 1.0 0.0 0.6 5.2 2.1 0.1 4.3 10.3 0.4 0.7 2.7 1.1 2.8 0.0 1.8 1.3 0.3 0.9 4.5 3.5 0.6 0.8 2.0 0.1 1.5 0.1 0.7 0.2 0.7 0.0 0.7 3.0 0.8 2.6 0.1 1.5 2.3 2.1 4.9 0.2 0.9 1.4 1.0 0.2 1.2 0.8 5.2 0.0 6.2 0.1 8.5 0.3 1.7 0.8 0.5 0.0 5.2 1.6 0.7 0.2 0.2 6.1 1.8 0.3 1.8 1.2 0.3 0.0 2.5 0.0 0.6 0.8 0.4 0.4 0.4 0.2 0.4 0.3 0.7 0.5 0.2 0.8 1.0 0.6 1.4 0.7 0.3 0.6 0.5 0.0 3.7 6.5 5.4 5.6 4.2 2.7 3.4 3.3 8.3 4.0 35.7 8.3 0.5 14.5 7.7 0.7 1.2 10.2 8.1 15.9 62.8 5.9 0.3 5.0 4.0 1.3 2.9 0.0 0.0 1.2 0.3 31.9 6.8 1.1 0.0 0.7 0.0 0.0 3.7 0.3 2.5 33.1 1.1 11.8 0.0 0.0 7.2 4.4 0.0 47.4 2.2 4.1 45.3 15.1 4.3 6.1 7.3 0.5 1.3 0.0 7.2 PLEKHO2 "DKFZp761K2312, PLEKHQ1, PP1628, pp9099" ENSG00000241839 "Pleckstrin homology domain containing O2" Q8TD55 15 64841883-64868007 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 57.9" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 56.4;Ito cells: 42.4;Kupffer cells: 40.1;Muller glia cells: 62.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 10.4;granulocytes: 30.2;monocytes: 26.6" "Cell line enhanced" "Detected in many" "ASC diff: 31.3" HPA040055 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 450000 "Plasma membrane, Cytosol" Nucleoplasm "HPA040055: AB_10793954" "unprognostic (4.32e-2)" "unprognostic (7.32e-3)" "unprognostic (8.60e-2)" "unprognostic (9.10e-2)" "unprognostic (1.11e-1)" "unprognostic (2.90e-2)" "unprognostic (3.05e-2)" "unprognostic (2.80e-1)" "unprognostic (7.70e-2)" "unprognostic (2.05e-2)" "unprognostic (8.67e-2)" "unprognostic (1.02e-1)" "unprognostic (3.08e-3)" "unprognostic (1.12e-1)" "unprognostic (4.20e-2)" "unprognostic (1.78e-1)" "unprognostic (5.85e-3)" 22.1 17.4 12.9 19.9 16.6 29.4 12.4 6.2 9.9 10.3 12.2 11.5 5.2 6.8 11.9 13.3 10.7 13.0 17.4 9.3 13.3 8.0 8.1 8.2 22.4 19.6 10.1 8.7 10.4 5.7 5.1 6.4 22.6 17.2 10.5 5.6 17.0 6.1 10.2 5.9 6.0 9.4 16.9 14.5 57.9 10.2 7.0 11.3 5.1 18.6 6.6 13.8 17.1 14.1 4.0 10.4 30.2 26.6 2.7 5.4 10.3 2.7 1.8 3.5 3.4 31.3 18.0 8.3 8.1 12.2 8.7 8.9 2.2 1.7 7.4 4.3 16.5 8.8 1.0 4.0 3.3 5.1 11.4 1.2 7.4 0.8 2.5 24.1 8.3 11.1 13.0 2.9 10.8 3.5 7.5 12.0 1.5 2.2 26.5 11.5 0.8 1.7 9.0 6.7 1.4 1.7 6.4 8.5 5.3 1.4 1.9 0.3 3.0 3.4 1.2 11.1 6.0 1.2 11.3 15.5 6.7 6.2 6.3 3.3 9.9 15.5 2.5 7.2 10.8 3.9 7.0 14.3 9.2 5.4 20.4 5.0 4.0 3.1 5.0 10.4 2.6 1.3 2.7 30.2 2.7 26.6 1.2 4.1 10.3 12.9 16.6 6.2 9.9 13.3 8.0 10.1 8.7 17.2 11.3 0.0 9.3 8.6 2.1 4.9 0.7 2.6 2.5 1.4 2.3 8.7 0.0 3.3 3.3 2.2 3.2 18.3 0.0 0.0 1.3 4.0 9.3 2.4 18.4 0.8 56.4 0.0 0.0 42.4 40.1 1.8 17.0 30.6 13.5 6.4 0.1 62.2 2.1 0.0 24.1 2.1 3.2 12.9 8.0 0.9 1.9 3.9 5.0 11.5 0.2 3.1 PLK2 SNK ENSG00000145632 "Polo like kinase 2" Q9NYY3 5 58453982-58460260 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 180.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 10.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 147.8;T-47d: 51.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB009624, HPA069329" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "CAB009624: AB_2167745, HPA069329: " "unprognostic (4.82e-2)" "unprognostic (1.08e-2)" "unprognostic (2.38e-1)" "unprognostic (6.51e-2)" "prognostic unfavorable (7.75e-4)" "unprognostic (1.22e-1)" "unprognostic (2.55e-2)" "unprognostic (1.03e-2)" "unprognostic (2.44e-2)" "unprognostic (1.06e-2)" "unprognostic (1.01e-1)" "unprognostic (3.11e-1)" "prognostic unfavorable (2.08e-4)" "unprognostic (6.56e-2)" "unprognostic (1.43e-1)" "unprognostic (3.46e-1)" "unprognostic (1.95e-3)" 11.4 3.7 19.6 4.0 40.2 4.4 23.4 1.3 39.4 20.6 5.7 3.7 5.0 5.1 19.2 7.1 17.7 9.5 18.2 28.1 18.8 5.1 6.9 17.6 17.7 3.8 4.2 20.6 11.8 12.6 3.8 3.3 25.9 8.7 8.7 8.7 12.6 22.1 6.2 8.7 20.9 6.1 15.4 2.7 54.7 4.7 19.8 7.4 1.0 8.9 16.6 7.5 14.2 15.5 1.2 2.9 3.0 1.6 10.4 1.2 0.6 16.4 14.9 5.2 0.4 2.7 4.5 2.0 3.5 5.9 11.7 6.8 1.1 14.6 0.0 23.2 12.6 28.5 20.7 0.2 8.1 10.7 0.0 0.4 0.0 6.7 1.2 14.8 0.0 0.4 2.6 11.3 4.5 12.7 147.8 23.5 0.0 0.0 0.5 23.1 6.0 0.0 0.0 0.9 1.6 2.4 0.8 14.3 0.0 30.8 3.3 0.3 0.7 10.8 2.1 9.5 9.7 51.9 0.2 30.0 3.2 8.7 1.4 28.1 0.0 0.0 0.0 2.5 0.0 14.4 3.0 0.7 2.3 0.1 1.6 0.0 1.2 0.7 0.0 2.9 0.9 1.2 0.6 1.9 10.4 0.6 2.0 0.5 0.6 19.6 40.2 1.3 39.4 18.8 5.1 4.2 20.6 8.7 7.4 17.9 18.6 2.7 128.0 125.8 2.8 105.2 22.9 18.7 68.2 17.4 3.9 55.6 8.3 96.4 5.7 109.7 37.3 0.0 69.2 180.6 32.4 45.1 9.2 6.0 13.5 0.0 80.9 51.5 8.9 2.3 11.8 11.2 23.6 5.4 25.3 3.5 71.6 40.7 10.3 2.5 2.7 0.0 79.3 72.4 10.4 90.5 108.6 6.4 24.3 54.0 PLOD1 "LH1, LLH, PLOD" ENSG00000083444 "Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1" Q02809 1 11934205-11975538 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease mutation, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 215.9;Sertoli cells: 103.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049137, HPA055799" Uncertain Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 2700000 Vesicles Nucleoplasm "HPA049137: AB_2680649, HPA055799: AB_2682924" "unprognostic (1.00e-1)" "unprognostic (2.69e-3)" "unprognostic (9.21e-3)" "unprognostic (5.43e-2)" "unprognostic (7.53e-3)" "unprognostic (1.12e-2)" "prognostic unfavorable (2.79e-4)" "unprognostic (1.13e-3)" "unprognostic (1.23e-1)" "unprognostic (1.79e-1)" "unprognostic (4.15e-3)" "unprognostic (2.32e-1)" "prognostic unfavorable (1.91e-12)" "unprognostic (2.79e-1)" "unprognostic (7.12e-2)" "unprognostic (5.92e-2)" "prognostic unfavorable (2.43e-4)" 29.0 19.5 14.9 16.8 24.0 7.1 32.1 12.1 17.6 35.8 21.7 17.0 17.7 19.1 34.2 21.1 16.5 24.7 21.3 31.2 17.6 14.8 27.5 51.3 22.2 19.7 24.5 9.9 31.8 30.3 18.2 16.3 41.5 20.8 21.1 12.0 25.1 39.3 22.0 18.3 13.3 20.8 39.0 13.2 21.1 18.6 10.0 22.4 1.7 34.8 11.1 8.2 19.5 69.7 1.6 16.3 17.7 19.4 2.6 9.1 9.3 16.9 14.5 8.0 37.4 54.7 30.6 6.4 50.4 67.0 26.6 45.3 16.5 11.1 9.8 53.4 55.7 19.8 14.3 11.6 17.6 18.3 10.2 12.4 5.3 23.3 20.9 33.9 3.3 25.8 37.1 9.3 32.1 12.9 90.3 47.1 2.2 14.8 4.8 27.7 11.0 0.8 8.9 3.5 17.3 21.6 3.9 16.3 21.3 15.3 3.8 3.0 12.7 22.0 15.1 25.4 13.1 7.6 8.5 46.5 30.4 22.8 38.0 24.7 11.3 18.3 5.8 67.4 11.6 49.6 0.0 19.4 0.9 9.1 17.2 1.6 1.0 1.6 4.4 16.3 1.6 0.6 3.4 17.7 2.6 15.0 2.4 1.0 9.3 14.9 24.0 12.1 17.6 17.6 14.8 24.5 9.9 20.8 22.4 0.0 9.3 3.7 7.6 6.3 4.2 16.2 10.2 4.0 5.7 10.4 2.0 34.8 3.3 30.5 1.1 20.4 18.7 0.0 8.4 215.9 28.4 9.2 0.0 29.9 41.8 6.4 8.1 46.6 21.6 1.7 41.1 15.6 10.1 18.0 9.8 10.1 24.0 12.9 23.0 13.7 2.7 103.5 26.2 0.5 3.6 4.4 28.1 4.4 11.0 3.8 PLPP4 "DPPL2, PPAPDC1, PPAPDC1A" ENSG00000203805 "Phospholipid phosphatase 4" Q5VZY2 10 120456954-120589855 "Enzymes, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.5;kidney: 12.6" "Cell type enhanced" "Detected in some" 11 "Cholangiocytes: 12.7;Distal tubular cells: 6.6;Early spermatids: 7.1;Late spermatids: 7.9;Leydig cells: 17.8;Peritubular cells: 7.4;Proximal tubular cells: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "eosinophil: 2.2" "Lineage enriched" "Detected in single" 22 "granulocytes: 2.2" "Group enriched" "Detected in some" 4 "hTERT-RPE1: 62.8;U-251 MG: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045188 Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA045188: AB_2679246" "unprognostic (8.19e-2)" "unprognostic (2.94e-2)" "unprognostic (8.86e-2)" "unprognostic (1.90e-3)" "unprognostic (3.45e-1)" "unprognostic (2.92e-2)" "unprognostic (2.69e-1)" "unprognostic (2.26e-3)" "unprognostic (1.55e-1)" "unprognostic (8.62e-3)" "unprognostic (2.70e-3)" "unprognostic (1.89e-1)" "unprognostic (2.40e-3)" "unprognostic (3.49e-2)" "unprognostic (3.75e-2)" "unprognostic (1.11e-1)" "unprognostic (1.21e-3)" 0.6 1.7 11.4 1.2 13.6 4.9 3.1 11.6 18.2 3.4 1.2 12.1 1.0 0.7 1.7 2.7 0.9 1.2 11.3 0.7 15.9 17.4 12.6 2.8 0.5 0.6 15.5 6.0 0.6 0.6 0.4 0.5 0.6 26.5 3.0 0.8 0.0 2.0 6.1 0.4 1.7 0.8 1.5 19.1 0.5 1.2 11.1 12.5 0.0 1.5 0.0 0.5 0.8 0.7 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.8 1.7 1.0 0.0 1.0 0.0 0.0 8.0 6.3 0.1 0.7 0.1 0.9 1.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.8 0.0 62.8 6.5 0.0 0.7 1.6 0.7 0.0 0.0 0.0 0.7 0.0 2.0 0.0 0.0 0.0 3.3 0.0 0.6 0.1 0.5 0.0 0.5 3.5 1.4 0.0 9.0 7.2 4.0 0.3 34.8 0.0 0.0 0.0 6.6 0.0 1.9 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 13.6 11.6 10.0 15.9 17.4 15.5 6.0 26.5 12.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 12.7 0.0 0.0 3.5 0.0 0.0 6.6 0.0 7.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 1.9 0.0 0.0 2.5 0.0 7.9 17.8 0.0 0.0 0.0 0.0 0.0 1.5 0.0 7.4 7.6 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.3 PLPP6 "FLJ46512, FLJ90191, PDP1, PPAPDC2" ENSG00000205808 "Phospholipid phosphatase 6" Q8IY26 9 4662315-4665258 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 74.5;Late spermatids: 33.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "HDLM-2: 47.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018096 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA018096: AB_1855609" "unprognostic (2.55e-2)" "unprognostic (8.29e-2)" "unprognostic (1.03e-1)" "unprognostic (4.36e-3)" "unprognostic (1.17e-1)" "unprognostic (4.38e-2)" "unprognostic (6.95e-3)" "unprognostic (1.33e-1)" "unprognostic (5.26e-2)" "unprognostic (9.06e-2)" "unprognostic (2.20e-2)" "unprognostic (1.45e-1)" "prognostic favorable (3.99e-4)" "unprognostic (2.56e-1)" "unprognostic (2.28e-2)" "unprognostic (2.87e-2)" "unprognostic (5.88e-2)" 4.0 8.3 4.4 7.2 6.8 1.1 7.3 11.9 9.7 5.7 9.4 6.2 4.2 10.2 4.9 13.2 9.2 4.1 9.7 3.0 4.9 4.8 6.3 20.0 4.7 8.3 8.6 6.3 4.2 19.2 8.7 5.5 13.1 9.4 16.9 10.0 4.7 10.4 8.5 2.2 8.6 15.4 3.3 4.9 7.1 10.7 8.4 3.4 16.2 7.2 6.9 9.6 7.4 5.5 4.3 5.1 8.5 5.1 4.7 13.0 5.1 3.9 4.1 4.4 5.4 3.6 4.0 4.4 2.7 3.5 2.2 2.5 1.0 2.6 3.8 1.1 2.6 5.5 4.9 3.1 3.8 2.3 47.7 2.9 7.6 3.9 5.4 3.2 2.7 5.7 4.4 3.1 1.7 3.8 2.9 3.3 4.3 1.3 4.0 2.8 4.2 2.5 7.2 4.0 4.0 1.4 2.5 0.0 2.9 3.8 4.5 11.1 5.6 3.2 2.9 1.6 5.7 4.1 6.1 3.8 2.0 1.7 2.6 1.7 0.8 3.0 1.0 3.1 1.9 1.8 8.5 5.1 4.1 4.2 4.4 4.6 3.5 7.4 6.3 5.1 4.3 13.0 9.2 2.1 4.7 4.9 3.9 10.0 5.1 4.4 6.8 11.9 9.7 4.9 4.8 8.6 6.3 9.4 3.4 6.0 2.4 3.4 2.0 0.0 6.8 0.0 5.1 0.0 2.3 1.8 2.0 14.4 1.7 10.9 74.5 1.4 8.5 0.0 12.1 2.1 0.0 7.1 0.0 13.2 5.4 3.2 10.5 4.3 5.3 33.5 2.6 2.2 0.0 1.8 8.4 3.8 8.7 7.4 4.6 2.6 4.3 0.0 0.0 0.6 1.0 0.0 8.7 1.5 6.4 2.6 PLPP7 "C9orf67, FLJ14662, MGC12921, NET39, PPAPDC3" ENSG00000160539 "Phospholipid phosphatase 7 (inactive)" Q8NBV4 9 131289459-131359022 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 29.0;skeletal muscle: 107.3" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 16.8;Horizontal cells: 7.9;Leydig cells: 4.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 11.0;ASC diff: 11.6;ASC TERT1: 8.8;SCLC-21H: 11.3;SH-SY5Y: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070252 Uncertain Approved Nucleoplasm,Vesicles No No Vesicles Nucleoplasm "HPA070252: AB_2686242" "unprognostic (2.19e-1)" "unprognostic (3.07e-1)" "unprognostic (3.07e-2)" "unprognostic (2.71e-1)" "unprognostic (8.78e-2)" "unprognostic (7.03e-2)" "unprognostic (1.23e-3)" "unprognostic (1.02e-1)" "unprognostic (1.43e-1)" "unprognostic (1.65e-1)" "unprognostic (3.96e-3)" "unprognostic (1.47e-1)" "unprognostic (1.71e-3)" "unprognostic (3.69e-2)" "unprognostic (1.10e-2)" "unprognostic (7.85e-2)" "unprognostic (9.72e-3)" 3.6 3.7 3.3 1.7 4.6 1.2 2.8 7.7 8.2 2.3 3.2 4.6 0.0 1.5 2.5 3.1 2.5 2.0 2.3 29.0 3.6 3.9 1.9 1.1 1.5 1.3 3.7 4.2 3.9 1.8 1.1 1.7 1.4 3.7 2.6 1.3 2.0 1.6 2.6 107.3 1.3 1.6 2.9 3.2 1.7 1.4 2.2 3.2 0.0 1.2 22.6 1.2 2.1 1.6 1.3 4.6 0.0 5.2 2.3 0.5 1.9 0.0 0.0 2.2 11.0 11.6 8.8 2.3 1.7 1.2 0.3 0.0 0.0 0.0 0.0 0.3 4.4 2.5 0.0 0.2 0.0 0.1 0.0 1.9 0.0 0.1 3.5 2.9 0.0 0.0 3.0 0.0 3.2 0.0 0.0 0.0 0.0 0.2 0.0 5.2 0.1 0.0 0.1 2.6 0.0 0.0 0.0 0.0 0.0 2.5 0.0 11.3 8.7 0.0 0.1 0.0 0.3 0.3 2.7 0.1 0.1 0.8 0.5 0.0 0.0 0.4 0.0 1.9 0.0 1.7 0.0 5.2 0.0 0.0 3.3 0.0 1.0 0.0 0.0 4.6 1.3 0.4 0.5 0.0 2.3 2.8 2.0 0.0 1.9 3.3 4.6 7.7 8.2 3.6 3.9 3.7 4.2 3.7 3.2 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 1.8 2.0 0.0 1.7 0.0 0.9 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.5 7.9 0.0 1.8 0.8 1.3 4.6 0.4 0.0 0.0 0.0 2.3 0.4 0.0 3.5 1.9 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLPPR1 "FLJ20300, LPPR1, MGC26189, PRG-3" ENSG00000148123 "Phospholipid phosphatase related 1" Q8TBJ4 9 101028709-101325135 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 38.5;kidney: 24.4" "Group enriched" "Detected in some" 4 "Distal tubular cells: 31.5;Proximal tubular cells: 27.8" "Group enriched" "Detected in some" 5 "glioma: 11.1;liver cancer: 5.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Hep G2: 5.8;SCLC-21H: 10.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA014760, HPA014968, HPA014979" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA014760: AB_2669084, HPA014968: AB_1855702, HPA014979: AB_2669130" "unprognostic (1.08e-2)" "unprognostic (2.79e-1)" "unprognostic (2.98e-2)" "unprognostic (2.54e-1)" "unprognostic (1.14e-1)" "unprognostic (7.33e-2)" "unprognostic (3.41e-1)" "prognostic favorable (1.37e-4)" "unprognostic (2.09e-1)" "unprognostic (1.14e-1)" "unprognostic (9.86e-4)" "unprognostic (1.44e-1)" "unprognostic (1.65e-6)" "unprognostic (3.68e-2)" "unprognostic (1.46e-1)" "unprognostic (2.85e-1)" "unprognostic (4.83e-2)" 0.8 0.9 12.6 0.7 38.5 0.7 1.4 1.7 24.4 1.0 0.9 7.6 0.0 0.8 0.8 5.2 0.8 1.0 0.9 0.8 12.7 7.0 24.4 5.0 2.8 0.7 7.5 5.5 0.7 1.1 0.7 0.1 0.8 5.3 1.0 1.0 0.1 1.1 0.8 0.8 0.8 0.8 0.8 10.2 0.7 0.9 1.5 9.3 0.0 0.7 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.9 10.5 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 38.5 1.7 6.4 12.7 7.0 7.5 5.5 5.3 9.3 0.0 4.6 0.0 0.0 0.0 2.2 0.0 2.5 0.0 1.2 0.0 0.0 0.0 31.5 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 4.4 0.1 0.0 1.2 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.0 27.8 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PLPPR2 "LPPR2, PRG-4" ENSG00000105520 "Phospholipid phosphatase related 2" Q96GM1 19 11355386-11365698 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 32.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 32.3" "Cell line enhanced" "Detected in many" "U-2197: 37.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048973 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA048973: AB_2680580" "unprognostic (1.29e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (6.45e-4)" "unprognostic (2.90e-1)" "unprognostic (1.43e-1)" "unprognostic (1.70e-2)" "unprognostic (7.10e-2)" "unprognostic (1.37e-1)" "unprognostic (9.60e-2)" "unprognostic (1.72e-1)" "prognostic favorable (6.82e-4)" "unprognostic (2.23e-1)" "prognostic unfavorable (7.46e-11)" "unprognostic (1.99e-2)" "unprognostic (1.46e-1)" "unprognostic (4.37e-2)" "unprognostic (1.17e-1)" 12.0 17.1 32.5 10.5 39.9 14.1 6.6 17.7 51.2 14.0 11.1 10.8 5.1 6.0 12.7 8.4 8.4 9.7 13.7 10.4 37.0 22.3 5.5 18.0 10.0 5.4 11.8 17.9 15.2 12.4 11.7 22.7 11.5 12.3 18.5 5.1 11.8 13.1 15.1 23.1 16.2 5.7 16.8 10.5 10.6 9.3 7.6 9.4 0.5 7.7 4.4 3.3 9.8 8.1 0.0 2.9 32.3 7.2 0.0 0.3 2.3 8.8 5.5 3.0 12.6 12.8 12.3 0.8 15.8 14.7 9.8 10.1 1.0 1.6 1.7 9.4 20.1 2.0 1.6 1.7 4.7 5.3 4.6 3.2 0.5 3.8 1.0 6.7 0.5 18.0 11.0 8.6 8.4 1.6 14.2 6.6 2.8 8.5 14.1 8.2 13.1 0.2 2.4 3.3 3.0 30.7 0.2 0.4 4.8 4.6 4.2 3.3 10.9 6.6 5.7 3.3 1.0 8.2 11.3 7.6 22.2 4.7 37.5 8.3 8.8 5.4 0.6 21.6 8.1 8.7 0.8 7.2 3.7 0.3 6.7 0.0 0.0 0.1 0.0 2.9 0.0 0.1 0.0 32.3 0.0 4.4 0.1 0.3 2.3 32.5 39.9 17.7 51.2 37.0 22.3 11.8 17.9 12.3 9.4 6.0 8.8 0.5 5.5 0.0 5.1 0.0 7.6 2.7 2.3 3.5 11.8 0.5 1.7 6.2 11.0 6.9 0.0 0.0 7.6 2.1 2.1 16.2 2.3 6.7 4.0 7.9 16.4 8.0 9.7 8.2 13.3 3.9 0.0 0.0 2.5 15.3 7.5 0.0 15.6 1.3 6.3 6.5 0.0 1.8 4.9 0.0 2.4 0.0 0.8 4.1 PLPPR3 "FLJ11535, LPPR3, PRG-2, PRG2" ENSG00000129951 "Phospholipid phosphatase related 3" Q6T4P5 19 812488-821977 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "bone marrow: 18.2;brain: 30.0;fallopian tube: 12.6" "Cell type enhanced" "Detected in single" 21 "Horizontal cells: 1.6" "Cancer enhanced" "Detected in many" "testis cancer: 4.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 8 "eosinophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.6" "Group enriched" "Detected in some" 6 "NB-4: 24.1;THP-1: 51.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052293, HPA057034" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA052293: AB_2681787, HPA057034: AB_2683316" "unprognostic (7.65e-2)" "unprognostic (1.39e-2)" "unprognostic (1.33e-2)" "unprognostic (3.66e-3)" "unprognostic (1.00e-1)" "unprognostic (1.59e-2)" "unprognostic (2.62e-2)" "unprognostic (1.47e-1)" "unprognostic (4.32e-1)" "unprognostic (4.51e-4)" "unprognostic (8.06e-3)" "unprognostic (1.07e-1)" "unprognostic (1.72e-12)" "unprognostic (1.21e-2)" "unprognostic (6.82e-2)" "unprognostic (8.50e-2)" "unprognostic (2.91e-1)" 0.7 0.7 20.5 1.2 30.0 18.2 2.1 0.1 21.3 0.9 0.7 0.7 0.0 0.7 1.3 0.7 0.7 12.6 1.1 0.7 14.4 13.1 0.7 0.7 2.6 0.9 3.9 14.9 1.0 0.7 0.7 0.1 0.8 4.7 0.9 0.7 0.1 0.7 0.8 0.9 0.8 1.0 0.7 1.1 0.9 0.9 3.0 3.1 0.0 0.7 0.0 0.7 0.8 0.0 0.1 0.0 1.6 0.0 0.0 0.1 0.0 0.1 0.6 5.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.3 0.0 0.0 3.5 0.0 0.0 0.1 0.9 0.0 0.0 0.0 2.1 0.0 0.6 0.0 0.2 1.7 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.1 0.0 0.4 0.0 24.1 3.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 6.4 0.1 0.0 0.0 2.7 2.2 51.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 3.9 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.5 30.0 0.1 21.3 14.4 13.1 3.9 14.9 4.7 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 PLSCR1 MMTRA1B ENSG00000188313 "Phospholipid scramblase 1" O15162 3 146515180-146544864 "Predicted intracellular proteins, Transporters" "Antiviral defense" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 55.1;BJ hTERT+ SV40 Large T+ RasG12V: 73.3;HHSteC: 50.5;SK-MEL-30: 91.2" "HPA068923, CAB070421" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" NA Yes "Nucleoplasm, Golgi apparatus, Plasma membrane" "CAB070421: AB_11153452, HPA068923: AB_2686059" "unprognostic (7.88e-2)" "unprognostic (1.10e-1)" "unprognostic (5.34e-2)" "prognostic unfavorable (1.35e-4)" "unprognostic (1.12e-1)" "unprognostic (3.35e-1)" "unprognostic (5.22e-2)" "unprognostic (7.73e-3)" "unprognostic (9.19e-3)" "unprognostic (6.93e-3)" "unprognostic (3.07e-3)" "unprognostic (1.10e-1)" "unprognostic (1.09e-3)" "unprognostic (5.26e-2)" "unprognostic (1.64e-2)" "unprognostic (1.76e-1)" "unprognostic (1.63e-1)" 60.9 14.9 11.9 39.7 21.4 27.0 31.1 5.7 19.0 20.9 29.6 7.2 22.1 18.4 19.6 25.7 25.4 19.5 30.8 22.7 16.1 12.7 32.0 36.5 33.8 38.6 17.6 4.9 40.0 26.1 10.3 18.4 25.7 22.1 25.0 28.0 12.6 32.3 34.2 16.4 9.9 24.6 19.4 29.8 46.0 20.5 15.4 14.8 16.4 27.5 14.9 19.5 27.5 48.0 6.5 27.5 26.2 41.2 14.3 8.1 17.6 17.2 6.9 4.4 2.0 6.6 11.2 6.8 5.4 14.8 55.1 73.3 5.5 14.4 1.3 12.9 3.4 43.1 14.2 3.5 5.1 9.3 5.3 3.5 11.1 2.2 4.1 50.5 6.3 5.8 17.8 8.7 6.1 31.1 8.8 8.0 3.2 7.1 17.2 11.2 6.7 4.9 2.4 4.2 11.7 6.2 4.4 4.9 0.4 15.5 4.7 2.7 0.0 6.9 3.4 91.2 6.3 3.4 7.7 4.8 4.4 3.8 9.9 9.0 13.2 2.4 0.0 4.5 4.6 3.8 8.2 41.2 11.0 5.6 40.4 8.1 6.5 3.7 5.0 27.5 4.9 2.6 3.8 26.2 14.3 22.7 7.3 2.1 17.6 11.9 21.4 5.7 19.0 16.1 12.7 17.6 4.9 22.1 14.8 32.8 47.9 22.6 70.0 32.7 0.4 4.0 86.6 81.7 60.3 90.7 0.0 46.8 63.0 225.1 1.5 110.1 67.7 0.0 192.6 100.1 54.5 74.2 26.7 25.9 121.5 0.0 31.9 91.4 84.8 2.2 106.4 157.8 45.5 24.4 60.9 52.6 150.7 102.1 43.2 33.8 1.3 38.8 58.7 0.3 2.2 25.0 37.2 21.3 51.4 160.1 PLSCR2 ENSG00000163746 "Phospholipid scramblase 2" Q9NRY7 3 146391421-146495991 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 8.1;testis: 16.8" "Group enriched" "Detected in some" 25 "Early spermatids: 161.5;Late spermatids: 194.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.9;EFO-21: 2.3;GAMG: 3.7;Karpas-707: 2.5;U-266/70: 2.1" HPA051352 Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA Nucleoplasm "Endoplasmic reticulum, Vesicles" "HPA051352: " "unprognostic (1.11e-1)" "unprognostic (9.83e-2)" "unprognostic (8.94e-3)" "unprognostic (7.53e-3)" "unprognostic (3.81e-2)" "unprognostic (1.51e-2)" "unprognostic (3.67e-2)" "unprognostic (1.84e-2)" "unprognostic (4.11e-1)" "unprognostic (5.52e-3)" "unprognostic (1.73e-1)" "unprognostic (3.16e-1)" "unprognostic (1.88e-4)" "unprognostic (4.06e-1)" "unprognostic (9.71e-2)" "unprognostic (3.02e-1)" "unprognostic (1.23e-2)" 0.3 0.3 0.3 1.7 0.3 1.3 0.4 1.0 0.4 0.4 1.5 0.0 1.3 0.2 0.3 8.1 0.6 0.9 1.4 0.3 1.1 0.3 1.4 0.3 1.0 1.8 0.3 0.4 1.0 1.2 0.3 3.2 0.5 1.6 0.4 0.5 0.6 1.4 3.0 0.3 0.3 0.4 0.2 0.8 0.3 0.5 16.8 0.0 0.1 2.5 0.7 0.1 0.3 2.2 0.6 0.5 1.7 1.1 1.3 1.6 0.6 0.0 0.3 0.0 0.0 0.0 1.4 0.2 0.0 0.4 0.6 0.8 0.2 1.9 0.0 2.3 0.0 3.7 0.2 0.3 0.0 0.4 0.1 0.4 0.6 0.8 0.2 0.8 0.0 0.7 0.5 0.5 0.2 0.9 0.6 0.0 0.2 0.3 2.5 0.1 0.0 0.0 0.0 0.5 0.0 1.5 0.2 0.0 0.0 1.5 0.0 0.6 0.0 0.1 0.0 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.2 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.6 0.6 1.3 0.6 0.9 1.4 0.5 0.3 1.4 1.6 1.7 1.3 0.0 0.4 0.0 0.6 0.3 0.3 1.0 0.4 1.1 0.3 0.3 0.4 1.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 2.5 1.4 0.0 7.0 0.0 0.1 1.7 0.8 161.5 0.0 0.0 0.0 0.5 0.1 0.3 0.3 0.0 0.0 0.1 0.0 1.7 0.6 0.0 194.1 1.7 0.3 0.0 0.0 0.0 1.0 0.7 0.0 1.4 1.1 0.3 0.0 0.1 4.8 2.3 0.1 0.0 0.0 0.6 0.1 PLSCR4 ENSG00000114698 "Phospholipid scramblase 4" Q9NRQ2 3 146192339-146251179 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Endothelial cells: 48.7;Fibroblasts: 48.9;Ito cells: 88.4;Muller glia cells: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "NK-cell: 1.3" "Lineage enriched" "Detected in single" 5 "NK-cells: 1.3" "Cell line enhanced" "Detected in many" "ASC diff: 24.5;ASC TERT1: 19.3;hTERT-RPE1: 24.1;HUVEC TERT2: 19.8;TIME: 40.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002276 Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA002276: AB_1855479" "unprognostic (3.73e-3)" "unprognostic (4.03e-2)" "unprognostic (9.83e-2)" "prognostic unfavorable (3.90e-4)" "unprognostic (2.62e-1)" "unprognostic (6.77e-3)" "unprognostic (1.19e-1)" "unprognostic (4.36e-2)" "unprognostic (7.33e-2)" "unprognostic (2.49e-1)" "unprognostic (2.50e-1)" "unprognostic (4.17e-2)" "prognostic unfavorable (4.13e-4)" "unprognostic (1.79e-2)" "unprognostic (1.35e-1)" "unprognostic (8.13e-3)" "unprognostic (2.97e-3)" 40.5 29.6 19.4 5.9 20.4 1.7 53.3 19.1 23.4 25.1 17.7 14.8 10.8 4.6 21.9 13.9 15.8 28.0 29.4 20.3 23.1 13.8 16.9 43.4 24.2 16.7 13.7 14.6 25.2 13.0 3.8 11.7 35.9 21.8 17.9 16.9 15.9 14.8 18.2 8.7 11.1 9.3 25.0 28.7 18.4 11.0 16.8 16.6 0.9 25.1 8.9 4.5 23.3 28.7 0.0 0.2 0.0 0.2 1.3 0.0 0.5 0.0 3.6 0.6 0.0 24.5 19.3 0.1 4.3 5.9 1.9 4.3 0.4 4.8 0.0 4.8 8.1 1.9 0.5 0.9 0.4 1.1 0.0 0.0 1.9 2.9 0.4 11.2 0.0 0.5 11.7 0.6 4.0 1.2 24.1 19.8 0.0 0.0 0.3 2.9 0.1 0.0 0.0 0.8 1.9 1.2 0.0 0.3 0.0 0.0 0.0 0.2 0.0 7.4 0.0 1.4 1.0 0.3 0.2 40.8 4.1 1.0 9.1 0.8 0.1 0.0 0.0 1.0 0.0 3.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.5 19.4 20.4 19.1 23.4 23.1 13.8 13.7 14.6 21.8 16.6 3.0 10.1 0.0 4.4 9.6 0.3 3.2 17.8 6.7 10.3 3.5 0.0 0.7 0.0 5.0 0.9 48.7 9.1 23.3 10.2 0.2 48.9 3.1 1.1 39.0 0.7 0.0 9.9 88.4 8.6 1.3 39.7 2.5 3.3 0.0 13.5 48.4 5.7 8.6 30.4 16.5 1.3 0.0 25.0 0.7 0.4 7.5 0.7 1.0 6.6 2.2 PLXNA1 "NOV, PLXN1" ENSG00000114554 "Plexin A1" Q9UIW2 3 126988594-127037392 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 44.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007499, CAB012483" Uncertain Supported Nucleoplasm,Cytosol NA NA 2600000 Nucleoplasm Cytosol "CAB012483: , HPA007499: AB_1079637" "unprognostic (1.87e-1)" "unprognostic (1.11e-1)" "unprognostic (4.38e-2)" "unprognostic (1.19e-2)" "unprognostic (1.66e-2)" "unprognostic (4.17e-2)" "prognostic unfavorable (4.13e-6)" "unprognostic (1.79e-2)" "unprognostic (9.06e-2)" "prognostic unfavorable (1.35e-4)" "unprognostic (3.77e-2)" "unprognostic (7.45e-2)" "prognostic unfavorable (5.64e-5)" "unprognostic (4.50e-3)" "unprognostic (7.62e-3)" "unprognostic (1.37e-3)" "unprognostic (1.73e-1)" 4.6 2.1 4.4 3.8 2.5 0.0 3.1 5.2 9.3 3.6 2.5 2.5 2.5 1.6 3.8 5.2 3.7 3.3 2.7 10.2 6.2 5.3 2.5 5.3 6.3 3.1 2.9 5.0 5.0 4.9 18.7 2.5 4.9 3.9 3.7 0.7 2.5 7.9 4.1 5.6 8.8 2.5 2.9 2.5 5.6 2.3 5.2 2.5 2.5 3.2 2.5 2.5 3.5 12.6 0.6 0.0 0.0 0.9 0.0 1.1 0.5 18.0 8.6 9.5 7.5 12.6 14.1 15.2 10.8 9.2 6.2 6.2 28.5 8.5 2.0 16.3 11.6 8.4 28.0 4.9 21.2 2.6 2.9 7.7 0.2 5.0 7.3 8.3 2.1 1.5 14.1 14.9 11.5 9.0 6.3 3.1 6.1 10.4 3.8 6.6 10.6 4.2 4.0 9.2 5.7 7.7 5.6 24.4 5.6 5.4 36.5 8.5 9.3 7.8 7.5 10.3 6.5 12.0 13.7 11.4 10.0 12.9 18.2 11.3 2.3 1.5 3.9 14.3 4.1 10.5 0.0 0.0 0.0 0.7 0.1 1.1 0.5 0.6 0.3 0.0 0.6 0.3 0.4 0.0 0.0 0.9 0.0 0.8 0.5 4.4 2.5 5.2 9.3 6.2 5.3 2.9 5.0 3.9 2.5 44.7 2.6 1.5 4.5 14.1 3.8 10.9 2.5 5.3 18.2 12.2 3.9 16.8 0.0 7.4 1.2 4.3 5.1 0.0 6.0 2.1 11.4 4.7 0.0 1.0 11.3 19.1 9.2 2.5 5.6 0.8 7.2 2.8 8.5 1.8 4.5 2.4 12.9 2.9 6.0 1.1 2.9 6.5 9.5 6.3 9.2 14.1 6.1 0.0 3.9 5.0 PLXNA3 "6.3, Plxn3, PLXN4, SEX, XAP-6" ENSG00000130827 "Plexin A3" P51805 X 154458281-154477779 "Plasma proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058989 Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA 58000 "Vesicles, Plasma membrane" Nucleoplasm "HPA058989: AB_2683872" "unprognostic (2.79e-2)" "unprognostic (3.03e-1)" "unprognostic (1.04e-3)" "unprognostic (8.04e-3)" "unprognostic (1.63e-1)" "unprognostic (9.05e-3)" "unprognostic (1.06e-2)" "unprognostic (2.25e-1)" "unprognostic (2.42e-1)" "unprognostic (6.26e-2)" "unprognostic (1.05e-1)" "unprognostic (4.10e-2)" "unprognostic (1.38e-3)" "unprognostic (2.30e-1)" "unprognostic (3.00e-1)" "unprognostic (4.33e-2)" "unprognostic (5.73e-2)" 6.9 7.6 9.8 6.6 9.3 3.5 13.3 25.9 7.4 8.1 6.2 13.8 7.3 7.2 8.6 9.2 5.3 8.3 7.9 6.6 10.5 8.0 5.1 2.5 7.2 7.1 8.7 3.6 16.4 9.9 5.1 35.2 7.4 8.2 9.2 4.8 6.1 13.8 7.5 2.9 19.5 7.2 8.2 8.4 7.0 10.0 5.8 9.8 4.6 9.3 1.8 7.2 6.3 16.4 1.8 0.5 2.7 0.5 2.1 1.0 0.3 8.2 1.6 4.9 12.4 5.2 6.6 6.6 11.8 2.5 2.8 3.8 6.2 3.5 1.5 6.4 12.7 6.6 7.3 4.9 5.7 1.0 0.7 3.7 1.5 19.3 3.4 4.1 0.8 6.9 8.9 4.2 4.1 0.3 9.7 3.1 2.4 3.8 1.3 4.3 10.2 1.4 6.3 1.6 2.6 3.7 5.3 0.4 0.5 3.7 5.5 10.3 5.3 4.4 7.9 2.0 3.6 4.8 1.8 7.8 6.1 5.6 0.6 5.0 0.9 0.1 2.2 11.4 1.1 1.6 2.7 0.5 0.8 0.8 0.4 0.6 1.8 1.0 0.8 0.1 1.2 0.6 0.8 1.4 2.1 0.3 0.5 0.7 0.3 9.8 9.3 25.9 7.4 10.5 8.0 8.7 3.6 8.2 9.8 11.9 11.4 0.9 8.3 7.7 18.3 4.5 2.5 10.7 5.7 10.4 11.8 2.9 0.0 11.1 0.0 3.7 8.0 0.0 5.0 4.9 9.1 8.5 8.1 0.9 7.4 4.8 6.9 3.7 4.3 0.4 10.6 6.4 13.5 7.2 11.4 5.2 13.0 10.5 8.1 0.7 8.9 12.9 6.2 0.2 2.2 6.5 7.8 6.4 7.1 6.5 PM20D2 "ACY1L2, bA63L7.3" ENSG00000146281 "Peptidase M20 domain containing 2" Q8IYS1 6 89146050-89165565 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 34.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030325, HPA030326, HPA030327" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA030325: , HPA030326: AB_2673429, HPA030327: AB_10603129" "unprognostic (3.60e-2)" "unprognostic (1.40e-1)" "unprognostic (6.36e-2)" "unprognostic (3.18e-3)" "unprognostic (3.22e-2)" "unprognostic (2.73e-1)" "unprognostic (1.13e-3)" "unprognostic (8.60e-2)" "unprognostic (1.04e-1)" "unprognostic (5.86e-2)" "unprognostic (2.27e-2)" "unprognostic (1.04e-1)" "unprognostic (9.99e-2)" "unprognostic (6.84e-2)" "unprognostic (1.28e-1)" "unprognostic (1.32e-1)" "unprognostic (1.31e-1)" 6.8 5.0 4.8 11.4 6.9 6.5 7.6 11.2 4.9 11.9 13.4 4.4 9.3 7.0 11.3 7.1 14.2 11.0 9.1 16.9 5.1 5.5 9.6 9.7 6.2 8.3 3.7 3.1 21.0 11.3 12.5 23.8 6.9 8.6 23.5 8.5 17.6 8.6 8.7 38.5 10.2 8.0 27.7 4.8 5.2 7.6 4.0 2.9 16.6 23.0 10.6 12.1 19.5 8.5 4.1 2.4 3.0 1.0 4.8 4.0 1.5 11.9 5.3 4.8 7.4 1.6 1.0 0.3 6.0 6.0 9.0 11.6 6.2 5.9 34.9 7.4 1.3 7.7 4.6 9.8 4.8 20.6 10.8 12.5 7.0 3.2 5.8 1.8 20.2 5.7 1.6 3.6 3.4 7.3 7.4 2.1 10.5 2.7 18.7 2.8 1.8 12.7 16.0 1.9 10.4 5.3 21.2 23.8 25.3 10.1 2.3 13.5 9.4 3.6 5.8 5.9 6.5 0.0 17.9 3.5 0.2 5.5 1.9 12.6 10.0 14.6 7.4 2.5 17.5 0.8 1.9 1.0 2.9 2.2 0.6 3.5 4.1 2.7 3.7 1.6 3.1 4.0 3.5 3.0 4.8 0.6 2.4 0.5 1.5 4.8 6.9 11.2 3.9 5.1 5.5 3.7 3.1 8.6 2.9 8.9 9.3 11.5 19.6 26.9 19.1 18.2 28.1 10.7 14.8 15.7 29.5 2.0 5.0 11.3 4.3 10.5 4.9 0.0 9.0 1.9 14.7 40.0 5.8 7.3 3.0 7.9 10.4 7.4 8.2 7.0 22.7 3.2 16.9 19.8 16.1 10.3 16.0 3.5 18.0 13.2 21.1 6.5 17.6 4.5 6.1 27.7 1.0 10.0 24.9 14.4 PMF1 ENSG00000160783 "Polyamine modulated factor 1" Q6P1K2 1 156212993-156240042 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA034583, HPA071854" Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA034583: AB_2674234, HPA071854: AB_2686459" "unprognostic (1.17e-2)" "unprognostic (3.76e-3)" "unprognostic (2.58e-2)" "unprognostic (5.67e-2)" "unprognostic (3.86e-2)" "unprognostic (2.22e-2)" "unprognostic (6.44e-2)" "unprognostic (1.32e-1)" "unprognostic (3.13e-1)" "unprognostic (1.26e-2)" "unprognostic (1.41e-2)" "unprognostic (9.29e-2)" "unprognostic (5.22e-2)" "unprognostic (2.51e-2)" "unprognostic (1.33e-1)" "unprognostic (1.76e-1)" "unprognostic (1.62e-2)" 20.6 21.7 18.2 19.8 20.4 40.8 23.3 24.3 23.7 27.4 20.3 26.1 25.2 20.1 25.2 27.5 26.4 20.4 24.4 37.9 16.4 15.5 38.0 32.4 21.3 30.5 23.9 17.4 25.1 28.0 23.6 22.8 35.5 17.1 25.5 18.0 27.6 26.8 20.5 65.7 28.9 20.1 20.9 21.3 29.9 22.8 13.4 22.4 23.6 30.5 48.3 29.5 21.6 22.7 22.8 41.1 26.2 36.5 19.9 31.1 29.0 21.2 26.3 28.4 21.4 5.4 11.2 22.1 11.1 15.7 30.1 25.0 32.2 30.7 19.6 24.2 14.1 10.4 14.3 28.5 18.5 15.5 14.0 33.8 14.5 20.1 28.7 11.2 20.4 20.2 10.1 18.7 13.5 14.3 11.6 22.6 14.4 21.6 22.8 14.5 43.4 21.3 26.4 49.3 31.5 23.4 23.5 15.1 38.8 31.4 16.1 26.0 32.7 18.4 21.2 14.4 21.7 34.5 25.1 13.0 13.0 16.7 14.4 21.7 17.1 17.6 38.5 10.4 19.8 18.0 7.9 36.5 16.4 20.2 25.2 18.1 22.8 19.9 18.8 30.0 21.6 19.4 19.5 26.2 19.9 22.1 41.1 31.1 29.0 18.2 20.4 24.3 23.7 16.4 15.5 23.9 17.4 17.1 22.4 17.9 21.4 70.7 66.4 44.3 11.4 9.7 48.4 6.7 22.7 71.5 11.8 119.8 149.2 81.5 4.4 45.6 19.1 23.3 85.9 94.2 46.0 45.9 43.9 44.8 68.8 7.9 47.1 37.4 37.6 4.2 36.2 38.4 81.0 60.5 42.8 53.7 66.2 42.9 26.5 90.8 23.8 25.8 42.9 14.7 35.1 44.5 131.6 52.3 46.9 60.9 PMF1-BGLAP ENSG00000260238 "PMF1-BGLAP readthrough" 1 156212982-156243332 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 13 "Ciliated cells: 2.7;Distal tubular cells: 3.3;Proximal tubular cells: 2.2;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA034583, HPA071854" Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA034583: AB_2674234, HPA071854: AB_2686459" "unprognostic (8.15e-2)" "unprognostic (1.80e-1)" "unprognostic (8.56e-4)" "unprognostic (1.65e-2)" "unprognostic (4.01e-2)" "unprognostic (1.99e-1)" "prognostic unfavorable (1.50e-4)" "unprognostic (4.66e-2)" "unprognostic (1.28e-1)" "unprognostic (8.52e-3)" "unprognostic (1.85e-4)" "unprognostic (2.39e-1)" "prognostic unfavorable (3.22e-4)" "unprognostic (1.12e-1)" "unprognostic (2.37e-1)" "unprognostic (5.31e-3)" "unprognostic (2.36e-1)" 9.8 15.7 16.2 10.3 16.2 12.1 7.8 18.1 14.6 14.6 13.0 13.9 13.4 8.6 13.1 16.3 11.7 15.0 12.9 24.6 14.1 14.2 20.6 17.4 11.0 16.4 12.6 9.0 15.6 15.0 10.4 16.2 19.2 8.8 15.7 7.0 14.8 21.5 13.2 31.8 10.7 10.5 10.9 11.2 14.0 9.5 7.4 11.8 12.5 16.4 26.4 15.8 9.8 11.1 9.8 7.1 10.2 8.9 5.1 10.7 8.1 7.0 7.3 9.7 6.6 2.6 6.8 4.2 6.4 4.2 6.3 5.2 5.4 6.5 6.2 10.8 5.7 2.6 4.9 9.0 8.2 3.2 10.6 15.2 4.3 7.1 10.0 12.4 4.2 7.7 8.3 7.7 5.7 5.0 7.9 5.9 5.7 4.2 10.0 4.4 8.6 3.7 9.0 19.9 4.8 13.4 7.1 3.8 9.1 4.9 3.4 6.7 8.6 4.2 1.7 11.0 8.8 9.9 17.0 6.5 3.1 3.1 3.9 5.7 6.1 7.3 9.4 4.5 5.6 6.2 3.6 8.9 4.4 4.9 5.8 4.8 4.8 7.7 7.1 6.6 9.8 10.7 6.0 10.2 5.1 6.1 7.1 8.4 8.1 16.2 16.2 18.1 12.8 14.1 14.2 12.6 9.0 8.8 11.8 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.0 2.7 1.2 0.0 0.0 0.4 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.2 0.0 0.6 0.3 0.0 0.0 0.6 1.2 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 2.2 0.0 6.5 0.0 0.2 0.5 0.0 0.8 0.0 0.5 0.3 PMM2 "CDG1, CDG1a, CDGS, PMI, PMI1" ENSG00000140650 "Phosphomannomutase 2" O15305 16 8788823-8849331 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Isomerase "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Club cells: 46.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "basophil: 52.2" "Lineage enriched" "Detected in all" 10 "granulocytes: 52.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040852, HPA063649" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040852: AB_10794069, HPA063649: AB_2685074" "unprognostic (8.62e-3)" "unprognostic (8.00e-3)" "prognostic favorable (1.04e-4)" "unprognostic (3.58e-2)" "unprognostic (1.79e-1)" "unprognostic (1.98e-2)" "unprognostic (6.09e-2)" "unprognostic (1.01e-1)" "unprognostic (1.47e-1)" "unprognostic (2.09e-1)" "unprognostic (5.14e-3)" "unprognostic (2.62e-1)" "prognostic unfavorable (8.97e-6)" "unprognostic (1.22e-1)" "unprognostic (2.50e-2)" "unprognostic (6.89e-2)" "unprognostic (5.02e-2)" 14.8 13.1 6.8 15.4 9.0 4.3 13.6 8.2 8.2 11.4 19.4 7.0 11.6 18.9 9.7 13.1 22.7 10.0 13.9 10.7 4.7 2.9 14.6 43.3 11.8 11.2 6.6 4.3 7.8 40.4 7.8 28.3 19.9 6.6 12.0 20.4 8.8 21.2 13.5 12.5 13.2 19.6 9.5 5.7 12.0 15.2 9.7 7.8 7.6 10.0 12.0 22.0 10.5 12.2 2.9 3.5 52.2 4.9 1.6 3.6 3.0 10.8 24.3 5.4 14.1 9.6 15.2 12.0 17.0 20.6 17.1 18.5 18.2 13.5 17.4 7.2 29.7 9.0 15.1 11.0 20.8 17.5 12.9 12.9 5.7 14.7 31.0 18.3 15.2 13.8 22.7 14.8 18.2 16.8 7.9 17.4 10.8 7.8 17.0 11.3 28.5 15.6 14.0 22.9 25.4 15.8 19.8 12.0 34.6 19.0 19.3 10.3 19.3 14.0 30.9 10.2 9.0 20.1 13.4 20.1 12.3 13.9 33.2 16.6 21.0 17.6 21.9 10.3 19.2 16.3 52.2 4.9 0.9 2.5 3.7 3.6 2.9 2.2 3.2 3.5 2.4 2.5 2.4 7.8 1.6 2.3 3.2 1.6 3.0 6.8 9.0 8.2 8.2 4.7 2.9 6.6 4.3 6.6 7.8 14.9 17.9 9.8 6.8 3.4 4.8 2.4 5.1 26.8 46.6 0.0 13.7 7.4 8.3 10.9 0.2 4.5 10.2 23.3 24.6 9.5 5.4 9.5 22.0 11.3 5.1 1.6 7.5 3.7 6.0 0.6 5.8 6.3 1.7 8.2 11.5 2.3 17.8 10.2 2.1 10.0 8.9 0.0 5.2 1.6 3.1 3.6 8.9 5.1 9.2 11.3 PMS1 "MLH2, PMSL1" ENSG00000064933 "PMS1 homolog 1, mismatch repair system component" P54277 2 189784085-189877629 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Hereditary nonpolyposis colorectal cancer, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 11 "Early spermatids: 386.0;Late spermatids: 438.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031013 Supported "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA031013: AB_2673696" "unprognostic (1.03e-1)" "unprognostic (1.58e-2)" "unprognostic (9.31e-2)" "unprognostic (2.14e-1)" "unprognostic (3.16e-3)" "unprognostic (1.49e-2)" "prognostic unfavorable (2.38e-6)" "unprognostic (5.31e-2)" "unprognostic (1.60e-2)" "unprognostic (7.29e-3)" "unprognostic (3.55e-1)" "unprognostic (2.30e-1)" "prognostic unfavorable (1.86e-6)" "unprognostic (1.29e-1)" "unprognostic (3.77e-2)" "unprognostic (1.92e-2)" "prognostic favorable (3.73e-4)" 9.8 8.2 9.6 9.8 12.4 9.9 10.1 14.6 13.2 10.6 7.5 6.9 17.3 6.6 11.8 14.5 7.3 11.4 7.5 7.1 9.7 8.0 6.3 8.6 7.1 11.1 10.1 9.9 12.2 9.8 7.6 18.2 7.6 14.2 8.9 8.2 6.7 8.4 15.0 8.4 9.9 8.5 9.6 10.7 11.1 11.5 38.8 10.9 9.6 9.6 7.3 9.2 8.2 8.4 14.0 8.1 2.9 5.5 9.0 13.2 3.7 7.9 7.1 18.3 14.4 10.1 15.2 16.2 15.2 7.5 12.9 15.7 11.8 10.8 23.6 8.6 6.3 9.2 11.7 17.8 11.2 18.4 17.6 10.4 23.5 13.0 17.6 14.0 13.6 10.6 9.7 11.4 12.0 24.5 11.1 13.3 16.5 19.6 12.9 15.8 5.4 16.0 19.0 18.1 8.4 16.5 18.6 12.5 22.6 12.4 11.6 17.1 12.0 11.2 7.1 10.8 22.8 8.1 11.2 10.4 14.0 9.7 8.8 13.3 10.2 12.6 20.4 8.2 12.0 8.9 2.2 5.5 2.9 12.0 3.3 11.2 11.7 8.8 13.2 5.0 14.0 8.9 11.4 2.8 9.0 4.1 8.1 8.2 3.7 9.6 12.4 14.6 13.2 9.7 8.0 10.1 9.9 14.2 10.9 14.9 11.8 8.2 7.4 6.2 26.5 15.2 7.6 38.8 19.4 5.2 7.9 13.7 0.0 6.1 386.0 12.2 2.9 0.0 7.0 9.4 9.8 6.4 12.7 8.3 8.1 9.5 11.5 9.8 17.0 438.4 20.1 9.2 6.8 5.4 5.9 12.8 5.5 4.8 18.4 4.5 26.1 12.9 6.9 16.6 22.0 6.0 4.3 10.2 10.8 3.9 PMS2 "H_DJ0042M02.9, HNPCC4, MLH4, PMSL2" ENSG00000122512 "PMS1 homolog 2, mismatch repair system component" P54278 7 5973239-6009125 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010235, HPA066490, HPA070310" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB010235: AB_2167281, HPA066490: AB_2685677, HPA070310: AB_2686250" "unprognostic (5.13e-2)" "unprognostic (6.55e-3)" "unprognostic (1.54e-1)" "unprognostic (1.43e-3)" "unprognostic (5.14e-2)" "unprognostic (1.29e-1)" "unprognostic (7.36e-2)" "unprognostic (1.02e-1)" "unprognostic (7.43e-2)" "unprognostic (2.35e-1)" "unprognostic (1.86e-1)" "unprognostic (7.38e-2)" "prognostic favorable (1.23e-5)" "unprognostic (5.31e-2)" "unprognostic (2.01e-2)" "unprognostic (3.67e-2)" "unprognostic (2.81e-2)" 6.3 7.4 8.7 6.0 19.8 3.6 8.1 15.5 21.2 6.2 6.0 11.5 6.9 6.4 6.4 6.3 7.5 7.5 5.0 5.3 9.0 10.3 14.2 5.8 5.5 9.1 8.4 9.5 7.5 7.1 16.6 7.1 5.9 16.2 7.0 6.2 8.0 7.1 7.8 5.7 14.8 6.8 7.1 7.5 6.9 6.1 4.8 5.8 7.5 12.4 5.7 10.7 7.7 6.5 6.2 5.8 7.2 7.9 4.0 9.3 6.3 9.7 10.6 8.5 21.2 6.7 9.9 7.3 5.2 4.0 5.1 4.1 9.2 7.0 18.3 6.2 7.5 11.5 13.4 12.7 3.4 5.5 7.2 5.2 8.0 8.6 6.6 11.4 9.8 5.5 10.4 9.7 4.0 15.2 7.3 9.4 8.7 14.9 8.9 8.4 9.0 2.9 7.0 8.6 4.4 6.5 10.0 10.3 9.3 10.7 7.3 7.8 16.8 10.2 14.9 11.2 13.2 18.5 6.9 8.0 6.5 14.5 9.5 9.4 12.0 20.0 18.5 4.5 9.7 14.8 7.2 5.4 3.1 8.4 7.9 9.3 6.2 6.6 7.2 5.8 5.6 8.8 6.2 2.4 4.0 3.2 5.3 6.4 6.3 8.7 19.8 15.5 21.2 9.0 10.3 8.4 9.5 16.2 5.8 11.9 5.1 17.2 8.2 4.4 12.6 2.8 5.1 6.7 7.9 10.4 21.6 7.8 29.9 4.7 6.9 7.4 2.0 0.0 2.9 5.4 5.5 8.4 4.7 9.6 4.5 28.6 5.2 7.4 7.3 5.6 11.8 4.9 6.8 5.4 2.3 5.2 3.5 2.9 9.6 32.0 14.2 25.8 6.6 24.2 10.2 7.0 10.6 8.5 2.6 10.2 PNKP PNK ENSG00000039650 "Polynucleotide kinase 3'-phosphatase" Q96T60 19 49859882-49878351 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Disease mutation, Epilepsy, Mental retardation, Neurodegeneration, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006782 Supported Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA006782: AB_1855496" "prognostic favorable (9.18e-4)" "unprognostic (1.87e-1)" "unprognostic (4.31e-2)" "unprognostic (4.23e-1)" "unprognostic (1.00e-1)" "unprognostic (4.40e-2)" "unprognostic (1.08e-2)" "unprognostic (1.24e-1)" "unprognostic (3.36e-1)" "unprognostic (1.58e-1)" "unprognostic (3.71e-2)" "unprognostic (1.70e-1)" "unprognostic (4.55e-2)" "unprognostic (3.00e-2)" "unprognostic (2.82e-1)" "unprognostic (7.24e-2)" "unprognostic (3.68e-3)" 13.1 32.4 11.2 22.0 11.8 24.3 15.0 18.0 13.8 14.0 17.4 17.0 26.4 15.6 16.7 25.3 13.6 18.1 18.2 16.8 12.3 9.5 20.1 16.8 15.9 21.0 13.9 14.2 17.1 22.5 19.7 26.8 17.1 12.9 18.7 15.0 19.6 20.3 22.4 12.8 15.3 15.7 13.2 10.1 30.7 17.9 17.2 13.9 22.3 23.0 17.0 20.6 14.6 12.4 7.9 7.5 19.3 12.7 2.7 7.7 3.8 13.0 8.8 8.9 14.0 8.5 6.6 14.5 21.1 10.8 9.8 8.6 7.0 17.2 8.5 6.7 6.4 5.7 10.7 3.2 11.9 5.8 10.9 13.5 14.4 16.6 6.1 6.4 13.6 19.3 6.2 6.3 8.9 5.8 8.7 12.8 10.7 7.0 17.1 12.7 8.3 13.7 10.8 8.3 13.5 18.0 11.7 8.2 17.1 10.0 27.9 10.6 17.1 9.2 27.8 4.7 8.1 4.8 8.4 18.1 19.1 11.7 4.6 17.4 18.9 7.6 6.9 17.3 6.1 15.2 1.4 8.8 12.2 7.7 8.5 6.4 6.5 6.6 5.8 7.5 7.9 4.9 4.4 19.3 2.7 12.7 4.3 6.8 3.8 11.2 11.8 18.0 13.8 12.3 9.5 13.9 14.2 12.9 13.9 14.9 23.4 40.2 28.5 11.8 40.7 8.9 15.3 24.1 9.1 19.2 76.6 37.9 19.9 36.3 12.0 20.2 24.9 0.0 34.6 29.2 14.8 28.4 27.8 18.7 34.1 31.8 29.3 31.9 22.4 20.0 55.0 24.9 13.5 42.3 23.1 20.6 38.1 20.1 42.1 26.9 76.0 19.4 14.4 18.2 29.6 11.4 41.2 42.4 27.4 25.2 PNMA1 MA1 ENSG00000176903 "PNMA family member 1" Q8ND90 14 73711783-73714372 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 97.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003817, HPA015007" Enhanced Supported "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA Cytosol "Nucleoplasm, Focal adhesion sites" "HPA003817: AB_1079646, HPA015007: AB_1855502" "unprognostic (2.82e-2)" "unprognostic (3.26e-1)" "unprognostic (9.50e-2)" "unprognostic (1.10e-1)" "unprognostic (2.96e-1)" "prognostic unfavorable (7.49e-5)" "prognostic unfavorable (3.00e-5)" "unprognostic (2.90e-1)" "unprognostic (5.35e-2)" "unprognostic (3.63e-1)" "unprognostic (5.58e-2)" "unprognostic (4.58e-2)" "unprognostic (1.67e-3)" "unprognostic (2.04e-3)" "unprognostic (4.17e-2)" "unprognostic (2.23e-3)" "prognostic unfavorable (4.51e-5)" 19.6 18.0 39.1 11.1 42.4 4.7 17.4 30.4 68.2 16.0 19.3 11.2 15.8 8.2 20.5 32.4 13.9 20.9 14.3 13.1 29.6 33.5 16.4 3.1 8.4 12.5 25.8 39.4 31.8 5.7 6.7 20.9 12.3 27.0 29.0 10.1 8.9 4.6 53.4 5.8 4.5 9.1 29.5 19.8 10.1 10.9 38.1 17.3 6.0 11.0 2.5 7.3 14.8 21.2 3.3 3.6 4.0 4.6 4.8 12.8 6.4 15.0 13.7 23.7 17.6 17.9 19.0 9.8 16.0 9.0 14.7 10.8 12.9 9.4 0.3 11.2 19.4 14.0 10.1 18.2 9.5 15.2 14.3 11.2 8.6 11.5 9.6 19.2 4.7 13.7 16.7 11.5 17.5 11.1 29.0 22.1 9.3 7.4 9.6 19.9 37.0 9.4 11.6 7.1 7.8 48.5 14.9 14.8 0.3 19.3 0.4 28.2 21.6 28.2 6.5 12.6 15.0 31.6 8.1 21.3 29.7 23.9 18.0 12.9 8.5 13.1 4.5 29.3 6.8 9.8 2.6 1.7 4.0 8.4 3.3 5.6 2.9 10.8 8.5 3.6 3.3 10.6 9.7 1.6 4.8 4.6 0.6 12.8 6.4 39.1 42.4 30.4 59.9 29.6 33.5 25.8 39.4 27.0 17.3 6.0 4.0 2.4 6.5 3.4 46.6 16.9 0.0 17.4 3.4 14.0 11.8 6.4 13.3 8.4 68.4 12.6 3.1 0.0 5.9 9.3 17.3 7.4 16.1 0.9 13.5 55.6 18.0 22.1 5.4 42.0 30.2 13.2 18.6 19.8 3.7 60.0 19.1 0.0 79.5 17.9 44.9 71.1 44.2 97.4 36.5 3.3 5.0 13.8 1.7 3.1 PNMA8A "FLJ10781, KIAA1183L, PNMAL1" ENSG00000182013 "PNMA family member 8A" Q86V59 19 46466491-46471563 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 61.0" "Group enriched" "Detected in some" 4 "Ciliated cells: 20.1;Collecting duct cells: 10.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 17.9;K-562: 18.9;LHCN-M2: 19.6;SH-SY5Y: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012956, HPA077702" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA012956: AB_1844328, HPA077702: " "unprognostic (1.98e-2)" "unprognostic (2.52e-1)" "unprognostic (1.42e-1)" "unprognostic (1.93e-1)" "unprognostic (2.21e-1)" "unprognostic (1.42e-1)" "unprognostic (1.12e-1)" "unprognostic (2.98e-2)" "unprognostic (9.35e-3)" "unprognostic (1.01e-1)" "unprognostic (6.90e-3)" "unprognostic (1.76e-3)" "unprognostic (9.56e-2)" "unprognostic (1.78e-2)" "unprognostic (2.85e-2)" "unprognostic (1.82e-1)" "unprognostic (6.48e-3)" 1.2 17.4 18.6 1.2 26.4 1.1 3.9 24.8 61.0 2.9 1.6 5.1 1.2 1.2 9.7 12.7 1.5 16.7 4.3 10.7 16.6 29.9 7.2 0.9 1.8 0.8 14.1 25.7 13.5 5.0 3.8 14.5 2.4 19.5 7.1 1.1 5.4 4.4 8.1 1.2 1.5 1.3 5.9 8.9 0.9 1.4 16.1 4.4 4.3 11.7 0.0 1.0 1.9 0.7 1.1 1.1 3.0 0.5 0.8 2.6 0.3 0.0 7.4 10.8 10.7 3.2 7.2 2.0 0.7 0.1 1.3 0.7 0.1 0.8 0.0 10.1 0.5 3.8 0.1 17.9 2.9 0.9 0.0 6.7 0.0 0.2 0.2 5.3 0.1 0.1 1.8 3.6 4.5 0.0 1.0 1.0 6.4 18.9 0.1 19.6 0.0 0.1 0.1 9.1 0.0 0.0 0.0 11.9 0.0 4.5 0.0 8.8 17.4 0.0 0.2 0.0 10.4 0.1 0.2 0.6 0.0 0.1 0.1 3.6 0.0 0.0 0.1 0.1 0.0 1.2 3.0 0.5 0.3 0.3 0.3 0.2 1.1 0.3 0.9 0.1 0.7 0.4 2.6 1.3 0.8 0.1 1.1 0.2 0.3 18.6 26.4 24.8 37.2 16.6 29.9 14.1 25.7 19.5 4.4 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 20.1 3.4 10.4 0.0 0.7 3.3 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PNO1 "KHRBP1, RRP20" ENSG00000115946 "Partner of NOB1 homolog" Q9NRX1 2 68157844-68176238 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056928 Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA056928: " "unprognostic (1.81e-3)" "unprognostic (4.83e-1)" "unprognostic (5.93e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (5.88e-2)" "unprognostic (1.66e-3)" "prognostic unfavorable (3.04e-8)" "unprognostic (5.82e-2)" "unprognostic (2.59e-2)" "unprognostic (1.16e-1)" "unprognostic (9.13e-3)" "unprognostic (3.33e-2)" "unprognostic (1.46e-2)" "unprognostic (1.42e-1)" "unprognostic (2.58e-1)" "unprognostic (3.74e-2)" "unprognostic (7.66e-2)" 18.5 19.2 13.0 17.2 19.0 21.8 15.4 10.0 12.8 10.8 13.1 9.1 10.2 9.9 15.3 15.4 14.9 13.8 13.2 24.5 19.1 9.6 16.6 27.4 12.9 15.0 15.0 11.9 20.0 27.0 13.2 15.7 16.3 13.1 14.4 12.2 8.9 12.7 15.0 48.8 12.4 9.5 15.1 11.7 13.6 13.2 11.4 13.9 9.7 16.6 15.1 15.2 15.8 21.4 14.7 12.6 2.0 13.2 10.6 15.5 14.4 15.1 16.6 7.7 12.6 9.5 7.9 19.3 14.4 9.4 16.3 11.6 31.7 9.0 20.7 12.1 9.5 22.6 13.0 24.7 17.0 25.6 14.4 17.3 20.1 7.9 23.2 14.8 16.0 9.3 10.2 12.6 16.4 18.8 4.7 11.9 13.4 27.7 11.3 14.5 11.1 15.6 15.2 21.6 27.5 18.1 13.3 18.9 22.0 12.4 12.8 13.8 10.2 10.7 13.4 23.1 12.9 9.4 9.0 8.9 18.7 20.2 16.6 39.9 9.1 13.0 32.0 15.4 24.1 25.5 0.4 9.4 1.9 10.1 13.2 15.5 14.7 11.4 11.5 12.6 11.1 13.3 12.2 2.0 10.6 9.4 9.0 11.7 14.4 13.0 19.0 10.0 12.8 19.1 9.6 15.0 11.9 13.1 13.9 14.9 10.4 31.0 31.3 73.8 22.7 10.4 12.7 33.5 46.6 7.0 11.8 34.1 16.6 26.1 20.1 20.3 4.2 0.0 25.8 33.6 22.6 19.3 30.1 14.3 23.5 17.5 16.6 13.5 10.6 4.2 11.5 23.3 11.8 20.8 9.7 13.7 24.7 7.0 15.6 27.9 40.1 6.5 48.7 23.9 42.8 49.1 39.8 20.4 13.6 22.3 PNPLA2 "ATGL, desnutrin, FP17548, iPLA2zeta, TTS-2.2" ENSG00000177666 "Patatin like phospholipase domain containing 2" Q96AD5 11 818902-825573 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "adipose tissue: 158.1;breast: 155.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 65.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055173, HPA062602, HPA075175" Approved Enhanced "Nucleoplasm,Lipid droplets" NA NA "Lipid droplets" Nucleoplasm "HPA055173: AB_2682725, HPA062602: AB_2684804, HPA075175: " "unprognostic (2.11e-2)" "unprognostic (3.37e-2)" "unprognostic (5.87e-3)" "unprognostic (2.51e-2)" "unprognostic (8.97e-3)" "unprognostic (1.68e-2)" "unprognostic (6.39e-2)" "unprognostic (3.28e-2)" "unprognostic (3.00e-1)" "unprognostic (5.61e-2)" "unprognostic (7.93e-2)" "unprognostic (2.09e-2)" "unprognostic (1.10e-1)" "unprognostic (1.68e-1)" "unprognostic (5.46e-1)" "unprognostic (4.09e-1)" "unprognostic (2.07e-2)" 158.1 7.2 1.6 9.4 1.8 11.2 155.2 2.7 2.3 4.1 35.9 1.5 3.8 5.6 4.5 7.8 8.6 4.3 7.2 12.6 1.7 1.1 15.6 7.4 11.3 4.5 1.6 1.6 4.9 11.8 2.5 4.2 11.6 1.8 5.2 1.5 1.9 8.1 8.1 25.0 6.1 23.1 3.0 2.1 4.9 8.2 4.0 1.5 1.5 11.3 4.8 5.1 13.0 18.6 4.2 6.5 18.7 8.5 3.6 5.3 3.6 10.5 8.3 1.7 4.5 65.2 5.8 11.2 11.3 9.1 7.1 6.3 7.1 10.7 6.3 6.7 8.5 4.4 9.5 2.6 4.7 2.2 8.1 23.1 8.7 3.7 11.3 21.4 6.0 11.0 11.4 6.1 4.7 5.5 7.3 5.8 4.7 7.4 6.4 6.3 6.2 8.0 13.1 5.0 10.8 17.9 7.7 3.8 14.1 7.0 2.4 6.4 8.5 21.0 17.9 6.5 1.1 7.7 6.9 10.4 6.4 5.0 4.1 5.1 24.7 15.2 5.3 16.1 8.5 4.4 9.3 8.5 18.7 3.6 5.5 3.5 4.2 4.6 5.2 5.7 3.6 5.3 4.3 7.7 3.6 6.0 6.5 3.9 3.6 1.6 1.8 2.7 1.9 1.7 1.1 1.6 1.6 1.8 1.5 6.0 16.9 27.0 63.2 39.3 8.8 42.3 63.7 5.3 13.6 48.8 7.9 56.2 28.2 55.9 14.2 38.0 114.0 23.3 57.3 27.0 25.2 72.1 11.5 41.9 27.6 11.1 49.4 84.1 28.5 4.2 44.8 24.9 40.5 27.9 80.0 34.7 98.9 112.2 36.7 37.9 7.5 64.7 32.2 42.2 28.2 36.0 141.7 36.2 41.4 167.2 PNPLA8 "IPLA2-2, IPLA2G, iPLA2gamma" ENSG00000135241 "Patatin like phospholipase domain containing 8" Q9NP80 7 108470422-108569666 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020083 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA020083: AB_1851849" "unprognostic (4.48e-2)" "unprognostic (3.37e-1)" "unprognostic (5.73e-2)" "unprognostic (2.75e-1)" "unprognostic (4.61e-1)" "unprognostic (2.73e-2)" "unprognostic (3.48e-2)" "unprognostic (3.32e-1)" "unprognostic (2.80e-2)" "unprognostic (1.03e-1)" "unprognostic (2.48e-1)" "unprognostic (2.49e-1)" "prognostic favorable (1.86e-6)" "unprognostic (3.16e-2)" "unprognostic (3.64e-1)" "unprognostic (4.28e-3)" "unprognostic (1.24e-1)" 21.5 35.7 29.3 12.4 28.9 51.5 15.0 15.6 27.2 15.4 13.4 9.5 9.3 8.6 13.4 13.7 18.3 9.7 15.9 17.9 23.0 22.1 23.1 24.6 16.7 12.0 20.7 17.5 15.6 10.1 20.7 33.4 25.2 23.2 14.4 11.4 6.0 11.4 13.9 29.8 11.4 10.8 15.3 20.3 19.5 11.1 10.8 21.1 16.1 22.6 13.0 15.3 22.5 12.8 20.0 19.3 16.7 26.8 14.6 12.5 13.7 14.1 6.4 11.3 10.1 25.2 17.4 16.7 13.5 23.8 11.1 18.6 6.1 8.1 7.9 17.1 13.2 22.4 5.4 19.1 8.6 16.9 11.8 5.3 5.4 10.5 4.5 18.4 3.7 11.2 15.7 16.3 14.9 13.8 12.2 15.0 8.9 6.3 22.7 13.8 9.3 8.7 8.9 5.0 8.9 9.1 3.2 11.9 16.7 13.3 18.0 9.4 13.2 12.9 14.0 16.2 14.9 5.9 6.4 12.1 18.3 8.2 27.2 7.4 19.3 19.5 11.7 17.4 5.7 11.8 14.1 19.7 16.7 10.5 21.8 12.5 20.0 10.3 10.3 19.3 18.7 11.2 10.7 16.5 14.6 26.8 7.6 12.5 13.7 29.3 28.9 15.6 27.2 23.0 22.1 20.7 17.5 23.2 21.1 38.7 43.0 28.7 103.5 82.5 61.7 43.5 10.2 81.7 58.0 22.7 17.7 46.4 79.6 26.9 49.7 39.4 25.7 0.0 33.2 30.6 50.6 71.1 70.4 40.3 28.4 30.2 54.7 19.6 49.4 40.1 29.7 48.1 52.3 17.2 16.2 37.9 25.2 14.1 37.1 33.7 29.7 19.4 38.2 17.7 27.4 118.6 108.9 23.5 13.6 109.8 PNPO PDXPO ENSG00000108439 "Pyridoxamine 5'-phosphate oxidase" Q9NVS9 17 47941506-47949308 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Pyridoxine biosynthesis" Oxidoreductase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 64.7" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 53.0;Hepatocytes: 47.2;Proximal tubular cells: 75.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023204, HPA027776" Enhanced Approved Nucleoplasm,Cytosol NA NA 150000 "Nucleoplasm, Cytosol" "HPA023204: AB_1855506, HPA027776: AB_10601246" "unprognostic (1.88e-2)" "unprognostic (1.17e-1)" "unprognostic (1.17e-1)" "unprognostic (1.07e-1)" "unprognostic (9.25e-2)" "unprognostic (2.39e-2)" "unprognostic (1.23e-2)" "unprognostic (1.41e-1)" "unprognostic (2.62e-1)" "unprognostic (1.97e-2)" "unprognostic (6.65e-2)" "unprognostic (8.34e-2)" "unprognostic (2.02e-3)" "unprognostic (7.47e-3)" "unprognostic (8.75e-2)" "unprognostic (3.34e-2)" "unprognostic (2.74e-1)" 6.0 13.1 9.9 5.1 13.0 2.9 8.6 8.3 16.5 6.2 7.0 8.6 6.9 8.5 4.2 9.6 8.1 8.4 10.1 10.2 8.7 12.0 26.0 64.7 5.3 7.7 11.2 9.9 8.0 13.7 17.3 7.4 5.8 11.1 6.9 7.4 8.4 8.3 7.1 14.7 5.5 9.6 5.2 7.1 6.8 6.7 6.4 6.0 5.2 14.4 8.2 6.1 5.4 5.2 6.8 12.2 2.4 16.4 7.7 8.2 8.7 17.6 14.6 1.1 2.7 7.5 5.8 0.0 6.0 3.9 6.7 5.8 23.9 13.0 16.8 28.6 5.9 2.7 10.6 9.1 16.3 9.7 20.4 7.8 11.8 6.8 24.8 8.0 10.5 8.2 7.6 12.7 12.4 15.5 6.2 8.7 12.6 11.1 5.8 7.8 13.1 10.6 3.4 2.1 17.5 18.1 9.0 5.1 12.2 18.6 9.1 5.9 4.9 5.5 8.9 5.0 4.3 15.7 3.8 9.1 10.8 6.4 10.8 12.4 13.9 15.3 8.9 8.8 9.1 5.5 2.1 11.0 2.4 6.8 16.4 8.0 6.8 6.2 7.4 12.2 5.7 8.2 7.9 1.1 7.7 10.4 8.9 6.4 8.7 9.9 13.0 8.3 16.5 8.7 12.0 11.2 9.9 11.1 6.0 11.9 15.2 1.5 5.9 1.3 0.7 1.7 22.9 5.3 7.9 12.2 3.9 7.5 53.0 15.3 0.4 3.6 11.0 0.0 13.5 2.0 3.1 7.8 12.7 47.2 15.2 3.2 3.5 4.9 7.0 0.4 9.2 8.5 1.7 8.2 9.9 6.7 13.1 10.5 5.6 75.4 1.7 0.0 1.7 0.7 1.3 1.9 5.3 1.0 13.6 4.8 PNRC1 "B4-2, PROL2, PRR2" ENSG00000146278 "Proline rich nuclear receptor coactivator 1" Q12796 6 89080751-89085160 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Suprabasal keratinocytes: 1093.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 54.1;hTCEpi: 57.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029839, HPA066513" Approved Approved Nucleoplasm,Nucleoli NA Yes "Nucleoplasm, Nucleoli" "HPA029839: AB_10601247, HPA066513: AB_2685684" "unprognostic (9.02e-3)" "unprognostic (7.65e-2)" "unprognostic (3.01e-2)" "unprognostic (2.31e-2)" "unprognostic (6.10e-2)" "unprognostic (1.52e-1)" "unprognostic (2.28e-1)" "unprognostic (1.78e-1)" "unprognostic (5.20e-2)" "unprognostic (5.28e-3)" "unprognostic (1.96e-2)" "unprognostic (6.29e-2)" "prognostic unfavorable (6.88e-6)" "unprognostic (8.63e-3)" "unprognostic (2.05e-1)" "unprognostic (1.03e-1)" "unprognostic (5.09e-2)" 70.5 58.1 21.3 46.1 28.3 105.4 48.1 30.8 31.8 55.9 51.5 30.3 27.0 23.6 60.3 30.9 45.4 73.6 45.0 48.5 20.8 17.9 32.9 97.9 59.5 87.1 23.1 22.3 83.4 41.3 31.3 29.5 38.8 20.4 56.6 26.0 46.5 35.5 40.8 154.1 49.0 32.4 63.6 31.1 46.9 38.2 35.5 20.8 91.2 38.4 30.8 45.4 113.2 41.0 9.6 7.3 37.5 7.1 6.9 10.4 3.8 2.9 2.8 6.1 10.3 24.8 41.8 4.2 3.8 26.8 7.2 16.9 2.4 8.2 6.4 18.7 4.6 29.6 10.1 3.2 5.8 11.0 8.0 10.0 1.1 16.5 7.7 54.1 5.9 14.8 30.0 57.5 4.8 22.2 27.2 11.8 7.6 0.9 19.7 7.9 2.9 1.5 31.3 1.7 3.3 6.1 7.0 7.4 5.1 16.9 5.2 3.9 11.0 9.9 13.6 10.0 19.0 6.7 29.9 11.2 5.7 3.4 4.0 1.4 31.0 15.1 2.1 11.5 5.1 3.5 10.3 6.6 36.7 7.5 7.1 7.8 8.3 8.9 7.8 4.2 9.6 10.4 10.4 37.5 6.9 6.3 7.3 7.1 3.8 21.3 28.3 30.8 31.8 20.8 17.9 23.1 22.3 20.4 20.8 131.0 125.0 333.4 716.3 860.7 129.0 174.7 124.9 45.5 52.4 85.5 47.1 189.8 198.9 158.1 59.9 195.6 165.4 23.3 206.9 57.7 278.7 681.2 165.7 181.5 204.0 68.3 237.9 148.0 328.8 20.9 446.1 557.5 416.7 926.1 131.7 222.1 145.2 115.8 354.7 216.2 99.3 413.9 840.5 47.0 44.3 1093.4 229.5 380.5 99.7 411.4 PNRC2 ENSG00000189266 "Proline rich nuclear receptor coactivator 2" Q9NPJ4 1 23959109-23963462 "Predicted intracellular proteins" "Nonsense-mediated mRNA decay, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027820, HPA045837" Uncertain Supported "Nucleoplasm,Golgi apparatus" No No Nucleoplasm "Golgi apparatus" "HPA027820: AB_10602147, HPA045837: AB_2679467" "prognostic favorable (6.02e-4)" "unprognostic (5.99e-2)" "unprognostic (3.15e-3)" "unprognostic (2.10e-2)" "unprognostic (3.58e-1)" "unprognostic (4.45e-3)" "prognostic unfavorable (7.97e-5)" "unprognostic (4.05e-2)" "prognostic unfavorable (1.41e-4)" "unprognostic (1.22e-1)" "unprognostic (1.53e-1)" "unprognostic (1.92e-3)" "unprognostic (1.81e-2)" "unprognostic (1.49e-1)" "unprognostic (2.18e-1)" "unprognostic (4.44e-2)" "prognostic favorable (4.05e-4)" 35.6 32.8 21.1 39.3 21.4 39.0 36.8 22.3 21.0 38.6 40.6 17.1 25.9 32.0 37.5 24.4 28.7 24.9 32.7 41.9 20.9 19.4 33.3 21.3 37.2 40.6 21.8 20.2 39.7 25.2 29.2 28.5 36.2 18.6 37.1 30.8 23.8 26.2 30.1 32.8 18.7 38.4 37.9 26.1 34.4 29.3 16.9 18.7 44.6 56.0 23.0 34.4 49.1 35.6 46.8 38.9 69.5 40.5 36.6 48.9 52.8 23.9 9.5 41.9 28.9 28.9 26.6 16.0 26.7 23.8 31.1 25.0 27.7 30.4 65.5 26.2 16.9 11.7 21.4 28.0 23.2 34.6 46.5 18.1 62.2 29.2 29.1 24.7 60.2 28.5 20.0 29.4 25.4 23.8 20.4 29.9 34.0 52.6 36.9 18.2 19.6 37.2 23.0 56.6 22.8 17.8 42.3 27.2 27.8 31.2 25.8 25.1 21.9 23.1 19.9 27.1 32.0 21.6 38.0 23.9 20.1 19.5 19.7 16.9 31.2 35.8 44.7 13.7 58.4 20.6 69.5 40.0 44.0 39.6 40.5 41.3 46.8 43.3 42.6 38.9 46.7 48.9 41.2 26.7 36.6 37.1 27.9 44.6 52.8 21.1 21.4 22.3 21.0 20.9 19.4 21.8 20.2 18.6 18.7 172.7 84.5 75.1 213.3 11.7 31.2 75.8 33.1 101.7 112.6 59.3 17.7 106.7 202.2 72.5 5.4 75.4 113.0 116.8 112.0 88.3 60.2 176.8 73.0 27.6 59.3 19.1 96.3 74.3 66.3 11.0 73.1 84.5 1.7 63.1 76.5 50.4 90.7 85.4 76.4 88.9 24.5 45.3 47.6 22.4 23.0 11.0 118.5 109.3 95.0 217.3 POC5 "C5orf37, FLJ35779, hPOC5, MGC120442, MGC120443, MGC120444" ENSG00000152359 "POC5 centriolar protein" Q8NA72 5 75674124-75717481 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 63.9;Late spermatids: 39.9;Rod photoreceptor cells: 37.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037509, HPA037510, HPA061521" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA037509: AB_2797227, HPA037510: AB_10672349, HPA061521: AB_2797263" "unprognostic (1.33e-1)" "unprognostic (4.35e-2)" "unprognostic (1.97e-1)" "unprognostic (8.62e-2)" "unprognostic (1.26e-1)" "unprognostic (2.08e-2)" "prognostic unfavorable (1.60e-7)" "unprognostic (1.99e-1)" "unprognostic (6.38e-2)" "unprognostic (2.97e-1)" "unprognostic (4.62e-2)" "unprognostic (6.81e-2)" "prognostic unfavorable (6.74e-5)" "unprognostic (1.02e-1)" "unprognostic (1.22e-1)" "unprognostic (1.28e-1)" "prognostic favorable (1.09e-4)" 8.3 8.9 9.3 9.2 17.0 12.4 13.5 12.7 11.5 9.8 7.1 10.1 6.4 6.2 10.9 12.0 6.1 12.8 6.2 5.4 8.6 8.3 9.8 6.6 8.2 14.1 13.8 8.7 16.2 7.8 8.6 6.5 10.5 16.2 9.8 9.1 10.2 6.7 7.7 5.6 8.9 8.6 10.4 13.6 15.1 7.6 25.5 11.1 27.2 8.3 5.3 14.6 8.5 8.4 15.6 15.2 20.4 9.9 14.9 18.5 7.6 9.0 7.1 11.9 11.9 5.2 4.2 8.8 8.6 5.1 15.2 11.5 10.4 8.2 12.0 16.8 4.5 20.5 8.4 10.6 8.4 11.4 12.5 6.9 7.8 5.3 5.6 7.0 9.0 15.6 4.7 8.3 11.4 19.4 5.1 6.0 12.4 7.5 22.1 7.0 10.5 14.7 11.4 5.1 2.0 6.2 9.2 9.9 14.3 6.9 4.4 9.5 10.5 8.0 4.4 9.1 6.2 8.4 10.2 2.6 5.1 11.4 8.9 17.2 13.9 28.7 17.5 7.7 11.8 12.2 7.1 9.3 20.4 13.7 9.9 12.0 13.4 14.0 14.8 13.6 15.6 14.7 14.0 8.8 14.9 7.6 15.2 18.5 7.6 9.3 17.0 12.7 11.5 8.6 8.3 13.8 8.7 16.2 11.1 6.0 12.0 8.0 2.7 2.4 12.5 3.6 5.1 21.4 5.7 7.0 11.8 5.9 8.3 6.5 63.9 5.3 2.3 23.3 6.0 6.6 3.7 1.9 2.3 1.8 5.3 9.5 4.7 6.2 3.7 39.9 5.8 5.0 3.3 1.0 4.5 4.6 4.8 2.9 6.7 4.2 37.8 6.5 3.1 29.3 15.1 2.5 3.4 7.5 4.5 1.3 POF1B "FLJ22792, POF" ENSG00000124429 "POF1B, actin binding protein" Q8WVV4 X 85277396-85379743 "Disease related genes, Predicted intracellular proteins" Actin-binding "Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 55.8;skin 1: 55.6" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 90.6;Mucus-secreting cells: 54.0;Paneth cells: 51.8;Undifferentiated cells: 38.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 44.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 6.0;naive B-cell: 3.2" "Lineage enriched" "Detected in single" 7 "B-cells: 6.0" "Group enriched" "Detected in some" 5 "OE19: 59.5;RT4: 26.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA002033, HPA050027" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA 430000 "Golgi apparatus" Nucleoplasm "HPA002033: AB_1079650, HPA050027: " "unprognostic (2.23e-1)" "unprognostic (1.05e-1)" "unprognostic (2.54e-3)" "prognostic unfavorable (3.08e-4)" "unprognostic (1.97e-1)" "unprognostic (3.39e-2)" "prognostic unfavorable (2.03e-4)" "unprognostic (1.86e-1)" "unprognostic (1.72e-1)" "unprognostic (1.30e-1)" "unprognostic (1.17e-2)" "unprognostic (2.50e-1)" "unprognostic (4.42e-2)" "unprognostic (1.07e-2)" "unprognostic (1.81e-1)" "unprognostic (5.57e-4)" "unprognostic (1.01e-2)" 0.5 0.4 0.3 9.9 0.3 0.0 3.7 0.4 0.4 7.0 41.8 0.0 0.5 10.9 0.8 1.6 21.4 1.6 10.0 6.3 0.3 0.3 2.5 0.5 1.4 0.4 0.3 0.2 1.0 2.9 0.0 2.5 3.4 0.1 3.9 16.9 0.1 5.6 0.9 0.4 55.6 55.8 0.7 0.4 5.5 7.6 0.4 0.0 0.3 0.7 20.3 9.2 4.9 6.9 6.0 0.0 0.0 0.0 0.0 0.8 0.1 1.2 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 7.8 3.9 1.1 0.0 0.0 7.9 1.7 0.1 0.0 0.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.2 1.3 0.0 3.0 0.0 0.0 0.0 59.5 0.0 0.0 0.3 0.0 0.0 26.5 0.0 0.0 0.0 2.0 0.0 0.6 0.8 0.3 0.0 0.0 0.0 0.0 0.1 0.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.4 0.0 0.0 3.2 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.3 0.3 0.4 0.4 0.3 0.3 0.3 0.2 0.1 0.0 0.0 0.3 0.9 4.2 8.0 0.0 13.2 10.2 8.1 11.4 5.2 0.0 2.1 0.0 10.5 0.0 2.2 90.6 0.0 13.4 0.7 0.2 3.2 0.0 0.0 0.2 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 1.0 54.0 0.0 17.7 51.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 25.0 4.5 0.0 38.3 17.2 POGK "BASS2, KIAA15131, KRBOX2, LST003" ENSG00000143157 "Pogo transposable element derived with KRAB domain" Q9P215 1 166839447-166856344 "Predicted intracellular proteins" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007838, HPA031630, HPA075919" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA007838: AB_1079651, HPA031630: AB_10601490, HPA075919: " "unprognostic (3.48e-2)" "unprognostic (2.03e-2)" "unprognostic (4.31e-2)" "unprognostic (3.18e-3)" "unprognostic (4.20e-2)" "unprognostic (2.59e-1)" "prognostic unfavorable (5.93e-4)" "unprognostic (4.85e-1)" "unprognostic (6.09e-2)" "unprognostic (1.02e-2)" "unprognostic (2.19e-2)" "unprognostic (3.44e-2)" "unprognostic (1.33e-1)" "unprognostic (3.22e-1)" "unprognostic (9.74e-2)" "unprognostic (2.70e-1)" "unprognostic (2.11e-2)" 12.1 10.3 24.3 15.1 27.3 10.4 24.2 18.4 23.6 17.6 13.1 27.6 8.4 10.2 17.6 12.6 16.1 13.5 12.4 11.1 24.4 18.4 15.7 12.0 20.9 13.5 27.7 17.7 19.9 14.8 30.0 10.0 15.1 21.1 12.0 15.4 12.2 12.9 15.2 6.6 20.2 12.1 16.8 30.5 14.5 14.9 6.8 25.6 9.2 13.0 5.2 17.7 16.9 24.2 9.4 10.0 6.3 10.8 9.9 7.3 5.6 15.8 13.5 14.8 18.2 15.7 13.1 8.4 11.0 11.3 14.2 10.8 10.2 13.6 17.9 16.6 11.4 12.1 15.9 18.4 14.7 13.0 21.7 12.6 7.0 12.3 7.2 13.4 25.1 19.8 9.9 23.2 15.9 22.9 12.6 12.6 16.8 24.1 12.1 13.5 7.6 15.5 6.3 24.2 18.6 15.6 17.8 8.1 15.8 14.8 38.9 19.4 23.4 15.7 21.8 20.3 23.0 20.7 23.4 11.6 15.1 15.0 11.8 19.9 17.2 22.1 23.4 8.4 12.6 14.2 2.8 7.7 6.3 6.7 9.9 7.3 9.4 6.5 7.1 10.0 5.8 6.1 6.3 1.1 9.9 10.8 5.0 5.6 5.6 24.3 27.3 18.4 23.6 24.4 18.4 27.7 17.7 21.1 25.6 50.6 15.0 10.2 22.1 19.5 30.6 7.9 15.3 12.0 23.9 12.2 9.8 9.2 1.7 15.3 2.2 16.8 7.4 0.0 13.9 10.1 12.1 19.9 23.1 12.1 14.0 46.1 8.6 12.3 18.1 0.7 10.0 16.1 8.5 10.0 12.1 14.5 12.4 14.0 17.0 7.4 27.0 12.9 13.4 0.9 2.1 21.0 7.6 7.5 15.2 25.1 POGZ "KIAA0461, ZNF280E, ZNF635m" ENSG00000143442 "Pogo transposable element derived with ZNF domain" Q7Z3K3 1 151402724-151459465 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cell cycle, Cell division" DNA-binding "Autism spectrum disorder, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006800, HPA008781" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006800: AB_1855516, HPA008781: AB_1855517" "unprognostic (2.87e-1)" "unprognostic (7.16e-2)" "unprognostic (7.47e-2)" "prognostic unfavorable (8.67e-4)" "unprognostic (2.87e-2)" "unprognostic (1.11e-2)" "unprognostic (2.30e-2)" "unprognostic (1.41e-1)" "unprognostic (7.99e-3)" "unprognostic (2.99e-1)" "unprognostic (1.00e-2)" "unprognostic (9.69e-2)" "prognostic unfavorable (3.92e-5)" "unprognostic (2.32e-1)" "unprognostic (2.92e-2)" "unprognostic (3.29e-1)" "prognostic favorable (4.40e-4)" 11.6 15.2 18.3 15.6 20.1 23.5 18.2 40.6 24.8 16.1 17.8 22.2 21.9 10.0 24.2 39.0 11.0 23.9 17.7 12.4 15.4 13.5 16.9 14.4 13.9 12.7 18.7 20.7 37.4 13.2 33.0 26.8 10.4 17.3 17.8 14.5 17.1 15.4 17.6 15.4 24.1 13.0 19.3 20.3 16.7 13.1 21.2 21.8 20.3 21.6 7.4 13.9 15.0 17.6 5.2 4.0 7.8 2.6 2.9 5.6 1.8 9.8 12.9 32.4 18.3 14.5 14.1 11.1 8.7 8.0 10.0 10.4 14.4 10.3 20.8 15.1 10.9 7.9 8.7 18.7 9.3 13.1 17.6 10.4 12.7 17.6 8.3 10.7 17.5 13.0 12.5 7.6 11.0 13.3 18.7 15.8 15.7 11.9 20.1 9.7 25.3 19.3 11.4 22.9 10.2 7.8 18.9 15.6 10.6 10.7 16.2 17.7 18.1 14.7 12.5 14.4 27.6 16.3 23.0 13.2 12.1 14.5 10.0 12.5 14.6 12.5 40.3 8.7 9.3 10.2 7.8 2.5 5.5 4.2 2.1 3.6 5.0 4.2 5.6 2.2 5.2 4.3 4.2 4.8 2.9 2.6 4.0 2.9 1.8 18.3 20.1 40.6 24.8 15.4 13.5 18.7 20.7 17.3 21.8 56.6 41.2 14.7 23.8 40.2 81.8 15.1 35.7 18.7 28.4 61.1 78.5 13.4 3.3 19.4 12.1 41.3 27.5 0.0 12.8 9.3 31.4 29.8 26.6 38.4 18.3 74.7 55.9 49.7 22.8 6.9 49.8 26.0 49.0 19.8 30.0 52.4 20.1 26.4 69.3 9.8 57.4 64.7 32.5 27.9 57.7 29.7 9.6 25.9 33.7 23.5 POLA1 "NSX, p180, POLA" ENSG00000101868 "DNA polymerase alpha 1, catalytic subunit" P09884 X 24693919-24996986 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "DNA replication, Host-virus interaction" "DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Disease mutation, Dwarfism, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002947, CAB012274" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB012274: , HPA002947: AB_1079652" "unprognostic (6.92e-2)" "unprognostic (4.43e-3)" "unprognostic (3.27e-3)" "unprognostic (1.53e-2)" "unprognostic (2.53e-1)" "unprognostic (1.49e-1)" "prognostic unfavorable (4.80e-5)" "unprognostic (1.87e-1)" "unprognostic (9.25e-3)" "unprognostic (2.48e-2)" "unprognostic (8.41e-2)" "unprognostic (7.42e-2)" "unprognostic (2.09e-1)" "unprognostic (1.44e-1)" "unprognostic (3.66e-2)" "unprognostic (3.48e-2)" "unprognostic (3.08e-1)" 10.5 5.5 8.0 15.0 10.2 14.3 10.9 12.0 9.6 10.1 9.7 11.8 5.8 5.7 11.2 7.7 10.2 8.9 5.5 9.3 7.8 6.6 6.1 4.9 7.2 12.7 10.3 4.5 12.9 7.3 8.5 8.5 10.7 8.7 7.3 11.0 7.5 7.9 9.3 22.4 9.3 7.5 9.7 13.1 9.0 7.9 5.7 10.0 30.1 7.0 8.5 14.7 9.9 10.6 4.6 2.5 1.2 4.6 2.7 3.8 1.7 14.3 10.7 14.1 11.4 2.6 3.2 3.1 10.7 5.8 11.5 13.2 8.8 7.5 18.3 3.6 4.5 10.3 11.8 26.8 8.6 15.6 9.5 11.4 13.6 20.9 6.6 1.1 17.8 7.3 2.0 1.8 14.3 4.1 2.9 5.9 9.5 12.5 9.3 8.0 9.9 19.3 5.9 13.7 9.6 9.0 17.3 37.0 13.8 4.2 9.4 12.8 7.9 12.6 6.0 5.7 16.3 11.8 5.9 4.6 10.2 7.0 19.4 10.2 5.6 8.1 14.7 5.9 8.5 11.3 0.0 2.0 1.2 3.0 4.6 2.9 4.6 3.4 3.8 2.5 3.2 2.4 2.4 0.6 2.7 1.3 1.6 3.6 1.7 8.0 10.2 12.0 9.6 7.8 6.6 10.3 4.5 8.7 10.0 8.9 6.2 2.2 3.8 2.5 2.9 9.3 0.0 9.4 11.4 1.8 2.0 4.3 3.3 2.8 0.3 3.6 1.5 46.7 2.6 4.3 2.4 2.0 9.2 2.8 3.9 1.6 4.1 3.7 4.3 0.4 5.8 2.4 0.0 1.8 3.7 4.5 1.3 0.0 3.2 1.2 7.2 6.5 3.8 3.4 4.2 1.9 1.9 2.9 4.3 2.2 POLA2 FLJ21662 ENSG00000014138 "DNA polymerase alpha 2, accessory subunit" Q14181 11 65261762-65305589 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037570 Supported Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA037570: AB_10672280" "unprognostic (2.28e-1)" "prognostic favorable (4.61e-4)" "unprognostic (1.67e-2)" "unprognostic (7.44e-2)" "unprognostic (5.20e-2)" "unprognostic (3.18e-2)" "prognostic unfavorable (2.11e-6)" "unprognostic (1.14e-1)" "unprognostic (2.87e-2)" "unprognostic (1.15e-2)" "unprognostic (4.05e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (4.09e-8)" "unprognostic (1.60e-3)" "unprognostic (8.26e-2)" "unprognostic (8.16e-2)" "unprognostic (6.25e-3)" 7.5 6.6 4.9 11.9 8.8 9.8 7.5 14.1 8.8 12.0 9.6 9.8 6.4 6.7 10.1 5.5 10.4 9.3 5.9 6.1 5.2 4.5 7.9 7.0 7.5 14.7 10.3 5.5 10.3 7.9 8.0 4.8 9.3 6.5 7.1 9.6 6.7 8.9 7.5 6.5 8.0 9.2 10.7 10.2 13.6 8.8 15.0 8.4 35.7 7.9 10.3 19.7 8.6 7.3 6.0 13.3 8.0 10.1 4.9 7.3 7.7 14.4 13.3 22.0 10.2 3.3 3.9 7.5 9.9 15.8 32.0 23.7 5.3 12.7 17.4 11.4 8.6 15.5 9.1 17.9 14.8 27.4 9.4 6.7 13.1 20.2 6.0 1.9 12.1 10.8 2.7 2.1 27.7 5.8 5.8 11.9 8.9 12.6 11.8 21.6 20.0 26.0 5.4 16.4 10.7 8.5 14.1 12.8 16.8 9.6 10.0 14.4 8.6 9.5 10.4 3.3 14.4 13.0 6.2 4.3 11.8 9.5 15.6 7.2 5.5 6.6 17.9 8.5 7.7 15.8 8.0 10.1 3.9 6.5 9.5 7.3 6.0 6.9 7.1 13.3 5.6 5.6 5.1 5.0 4.9 7.6 10.4 7.1 7.7 4.9 8.8 14.1 8.8 5.2 4.5 10.3 5.5 6.5 8.4 0.0 4.3 0.8 3.8 1.4 2.5 2.7 5.1 2.7 3.4 5.2 2.0 8.3 3.3 5.7 2.1 3.5 1.0 0.0 3.0 14.9 4.4 2.2 0.0 1.6 8.4 3.2 2.9 3.7 2.1 2.9 6.9 4.3 0.0 10.8 2.2 2.3 3.6 2.6 7.1 1.4 4.9 6.5 3.6 12.0 14.5 1.3 6.1 5.1 5.3 3.2 POLD1 "CDC2, POLD" ENSG00000062822 "DNA polymerase delta 1, catalytic subunit" P28340 19 50384204-50418016 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA excision, DNA repair, DNA replication" "DNA-binding, DNA-directed DNA polymerase, Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, Transferase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Paneth cells: 38.7;Spermatogonia: 26.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004375, HPA046524" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB004375: AB_675487, HPA046524: AB_2679684" "unprognostic (2.45e-1)" "unprognostic (7.02e-3)" "unprognostic (1.59e-1)" "unprognostic (4.35e-2)" "unprognostic (2.55e-1)" "unprognostic (1.85e-2)" "prognostic unfavorable (2.87e-6)" "unprognostic (4.12e-2)" "unprognostic (1.16e-2)" "unprognostic (2.83e-1)" "unprognostic (5.08e-1)" "unprognostic (3.92e-3)" "unprognostic (4.01e-3)" "unprognostic (1.28e-2)" "unprognostic (1.61e-1)" "unprognostic (2.89e-1)" "unprognostic (3.70e-2)" 7.9 5.7 5.4 18.3 9.9 31.6 6.6 9.4 5.4 8.2 10.0 6.1 5.9 6.8 9.5 7.2 11.3 6.9 5.2 5.5 4.4 3.2 7.6 9.3 10.9 15.7 7.0 3.6 8.2 8.4 5.2 5.1 10.9 6.7 6.3 5.2 4.9 8.1 5.4 7.2 13.1 9.9 6.2 7.7 14.1 6.5 13.2 6.5 27.4 12.1 8.1 14.2 5.9 7.8 9.3 10.5 2.1 8.5 5.4 7.3 5.6 18.2 25.2 13.8 7.9 1.8 1.5 14.2 11.4 5.0 14.1 17.9 13.7 14.5 26.2 6.4 3.4 6.3 15.0 16.3 12.4 4.8 22.1 43.8 22.8 24.4 18.0 1.6 21.7 20.1 2.9 3.8 12.7 3.8 3.0 7.2 22.0 24.5 20.4 5.8 12.3 33.5 33.9 16.3 11.8 18.3 33.3 23.2 23.0 4.5 17.5 14.4 13.0 11.3 13.9 2.6 5.2 7.6 20.6 5.6 7.1 23.2 7.7 20.0 19.2 31.6 28.0 7.8 24.5 7.0 1.6 6.2 2.1 7.3 7.8 6.2 7.8 6.5 5.9 5.7 9.3 6.5 5.9 1.1 5.4 8.5 10.5 4.5 5.6 5.4 9.9 9.4 5.4 4.4 3.2 7.0 3.6 6.7 6.5 3.0 3.8 3.7 1.7 5.7 3.3 2.8 2.5 2.7 3.4 3.5 5.9 12.2 0.0 4.4 1.7 2.6 4.6 0.0 3.4 11.7 4.1 1.3 0.0 2.1 13.6 0.0 6.9 1.8 6.3 1.1 2.8 5.0 5.0 3.6 5.3 1.2 3.9 38.7 4.9 2.2 4.1 0.0 2.1 10.9 26.7 4.5 6.4 4.3 10.0 0.6 POLD2 ENSG00000106628 "DNA polymerase delta 2, accessory subunit" P49005 7 44114681-44124358 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA excision, DNA repair, DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 217.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026745 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA026745: AB_1855520" "unprognostic (9.09e-2)" "unprognostic (1.41e-1)" "unprognostic (9.89e-2)" "unprognostic (1.84e-3)" "unprognostic (1.55e-1)" "unprognostic (2.10e-3)" "unprognostic (1.50e-3)" "unprognostic (4.94e-3)" "unprognostic (8.17e-2)" "unprognostic (1.01e-3)" "unprognostic (4.53e-2)" "unprognostic (1.12e-1)" "unprognostic (3.72e-2)" "unprognostic (2.14e-1)" "unprognostic (5.18e-2)" "unprognostic (1.03e-1)" "unprognostic (4.44e-3)" 17.2 19.1 17.5 14.3 16.7 16.3 33.9 14.3 25.9 15.8 15.4 17.1 12.6 13.9 16.1 9.7 27.5 34.5 14.5 35.9 16.3 13.8 15.9 43.6 15.3 16.2 15.2 14.7 24.4 49.0 18.9 17.9 12.9 15.0 15.9 12.9 17.4 19.9 14.3 42.6 19.3 11.5 15.7 13.7 11.9 16.0 14.4 14.8 27.7 20.3 25.1 15.8 13.4 16.7 28.1 37.0 3.2 13.7 13.3 29.3 21.3 26.5 35.1 19.6 41.0 17.4 18.7 19.4 16.4 16.5 22.5 16.9 29.6 25.6 61.5 21.0 23.5 45.1 36.8 32.0 44.7 14.7 17.4 37.6 13.5 37.7 25.0 19.9 41.3 16.6 17.0 27.4 34.8 33.9 23.7 18.8 41.6 49.5 29.6 24.8 43.3 50.3 78.1 30.8 38.3 34.5 33.9 26.3 87.2 19.5 17.2 38.9 30.4 20.4 73.7 14.0 13.2 42.6 53.3 14.7 29.9 37.7 36.6 51.2 46.5 68.7 58.9 26.8 41.9 42.2 0.5 13.7 3.2 17.9 12.4 26.8 28.1 21.6 18.2 23.2 27.3 29.3 21.4 1.1 13.3 11.8 37.0 17.0 21.3 17.5 16.7 14.3 25.9 16.3 13.8 15.2 14.7 15.0 14.8 6.0 35.1 22.3 62.4 43.8 38.9 57.0 38.2 60.2 37.5 27.9 29.5 61.7 87.9 57.0 88.9 29.0 11.8 0.0 52.0 69.9 44.0 51.0 25.5 84.6 40.8 50.9 40.3 20.3 12.3 217.8 38.6 15.8 47.2 10.0 53.1 37.9 39.5 14.0 50.2 78.7 48.2 19.4 68.0 59.4 64.6 52.9 29.6 23.3 71.7 63.1 POLD3 "KIAA0039, P66, P68, PPP1R128" ENSG00000077514 "DNA polymerase delta 3, accessory subunit" Q15054 11 74493851-74669117 "Predicted intracellular proteins" "DNA damage, DNA excision, DNA repair, DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058846 Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "HPA058846: AB_2683833" "unprognostic (3.68e-1)" "unprognostic (3.22e-2)" "unprognostic (2.05e-3)" "unprognostic (3.28e-1)" "unprognostic (1.74e-1)" "unprognostic (3.49e-1)" "prognostic unfavorable (9.17e-4)" "unprognostic (1.08e-1)" "prognostic unfavorable (5.48e-4)" "unprognostic (3.99e-3)" "unprognostic (1.54e-3)" "unprognostic (9.21e-3)" "prognostic unfavorable (7.90e-6)" "unprognostic (7.92e-3)" "unprognostic (2.65e-1)" "unprognostic (9.11e-2)" "unprognostic (1.23e-1)" 12.6 8.2 11.3 12.8 17.5 8.3 12.7 10.3 16.4 13.8 15.6 12.5 10.3 14.5 18.1 11.7 14.1 15.6 14.1 9.6 10.2 7.8 40.3 10.0 12.7 14.0 12.1 13.1 15.9 17.5 9.3 16.0 12.4 12.3 13.2 17.2 9.9 13.0 11.8 10.4 10.8 17.1 18.2 9.1 13.9 14.5 19.8 13.9 15.2 14.2 8.0 13.5 15.9 13.7 8.1 14.7 16.5 19.0 8.7 11.0 9.6 12.0 11.0 17.0 11.6 5.3 9.1 12.1 16.4 9.2 17.2 14.6 14.4 15.7 17.2 12.2 7.8 10.0 15.8 14.1 10.7 21.7 12.9 9.0 11.0 17.1 4.8 3.8 20.9 10.0 4.0 6.8 20.0 10.8 5.4 6.6 15.3 9.9 13.9 9.8 9.5 23.5 9.4 10.2 36.0 11.3 22.6 42.9 14.3 7.8 11.7 11.4 7.7 19.5 9.8 19.0 10.8 11.5 13.4 6.3 17.0 12.3 19.1 12.9 9.8 20.5 38.6 9.7 13.3 12.8 6.0 19.0 12.5 8.2 15.1 8.1 8.1 10.4 7.2 14.7 6.7 10.4 8.5 16.5 8.7 14.8 4.3 11.0 9.6 11.3 17.5 10.3 16.4 10.2 7.8 12.1 13.1 12.3 13.9 11.9 18.3 8.2 6.3 5.3 11.8 5.6 7.6 53.5 23.9 8.7 7.9 13.0 5.0 14.6 22.4 11.1 10.3 23.3 28.4 23.6 8.2 7.5 18.5 3.4 13.9 22.3 5.2 6.2 8.5 19.4 11.5 15.5 3.3 22.6 9.2 14.6 17.7 8.5 8.1 23.8 17.1 6.5 4.7 34.3 31.1 4.6 10.9 8.2 16.6 10.5 POLE POLE1 ENSG00000177084 "DNA polymerase epsilon, catalytic subunit" Q07864 12 132623753-132687365 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, DNA-directed DNA polymerase, Hydrolase, Nucleotidyltransferase, Transferase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Sertoli cells: 25.8;Spermatocytes: 25.4" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 34.8" "Cell type enhanced" "Detected in some" "NK-cell: 4.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA058210, HPA067385" Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA058210: AB_2683639, HPA067385: AB_2685830" "unprognostic (1.60e-1)" "unprognostic (1.77e-3)" "unprognostic (2.00e-1)" "unprognostic (9.17e-2)" "unprognostic (1.68e-1)" "unprognostic (2.01e-2)" "unprognostic (3.96e-3)" "unprognostic (2.23e-1)" "prognostic unfavorable (1.44e-4)" "unprognostic (7.12e-2)" "unprognostic (2.21e-1)" "unprognostic (1.67e-1)" "prognostic unfavorable (3.19e-8)" "unprognostic (8.60e-2)" "unprognostic (3.18e-1)" "unprognostic (1.28e-1)" "unprognostic (9.95e-2)" 6.1 3.4 6.7 10.2 4.4 29.3 6.2 34.8 14.4 7.0 6.6 2.0 7.6 7.3 6.1 4.4 7.5 6.2 6.5 4.7 5.6 1.6 3.8 8.6 5.4 8.2 3.3 4.3 8.7 6.8 3.6 3.1 6.5 5.1 6.8 7.7 4.3 8.7 7.4 8.9 17.9 8.5 6.8 3.7 16.7 7.8 25.6 4.4 29.8 5.1 6.0 10.3 6.7 8.7 0.5 1.7 0.8 0.8 4.8 0.7 0.5 11.2 15.0 22.3 10.6 4.7 3.7 19.9 11.5 5.2 13.8 10.1 18.2 6.7 12.9 4.9 6.2 5.3 15.7 15.5 7.8 8.4 6.0 19.6 20.4 19.4 8.9 0.9 15.9 11.7 2.8 3.1 14.4 4.7 3.8 4.8 16.6 22.8 7.3 6.8 18.2 26.1 29.2 17.3 5.3 9.0 21.7 12.6 5.8 4.4 18.4 18.6 10.7 13.4 11.0 2.5 11.2 16.2 9.9 4.4 12.6 12.9 9.5 11.6 9.7 6.5 20.3 6.9 22.0 8.9 0.0 0.3 0.8 0.5 0.1 0.7 0.5 0.3 0.4 0.7 0.3 0.5 0.3 0.1 4.8 0.8 1.7 0.6 0.5 6.7 4.4 34.8 14.4 5.6 1.6 3.3 4.3 5.1 4.4 0.0 7.9 4.5 3.5 5.0 8.1 5.6 0.0 2.7 0.0 1.8 0.0 6.2 0.0 2.1 6.5 3.0 4.7 0.0 2.7 9.0 4.7 3.7 2.3 8.9 10.4 0.0 6.9 12.9 7.9 7.0 6.4 3.2 5.0 1.0 6.7 3.7 2.4 5.8 3.2 0.8 5.0 25.8 3.3 25.4 7.9 6.8 3.3 5.7 9.8 2.5 POLE2 DPE2 ENSG00000100479 "DNA polymerase epsilon 2, accessory subunit" P56282 14 49643555-49688422 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "DNA replication" DNA-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.6;lymphoid tissue: 17.6" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 23.3;Spermatogonia: 22.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027555 Uncertain Supported "Nucleoplasm,Nuclear bodies,Vesicles" No No "Nucleoplasm, Nuclear bodies" Vesicles "HPA027555: AB_10610282" "unprognostic (1.42e-1)" "unprognostic (6.57e-3)" "unprognostic (3.53e-2)" "unprognostic (7.44e-2)" "unprognostic (2.04e-2)" "unprognostic (4.99e-3)" "unprognostic (7.60e-3)" "unprognostic (2.32e-3)" "unprognostic (1.10e-3)" "unprognostic (2.69e-2)" "unprognostic (1.88e-2)" "unprognostic (1.37e-3)" "unprognostic (5.13e-11)" "unprognostic (9.97e-2)" "unprognostic (1.66e-1)" "unprognostic (1.27e-1)" "unprognostic (1.50e-3)" 3.3 2.2 1.5 11.6 2.8 17.6 3.4 1.7 1.6 4.4 4.2 1.1 1.5 2.6 2.8 3.5 9.0 2.4 2.3 1.6 1.0 1.2 2.5 5.1 2.2 5.3 1.1 0.3 2.7 5.0 1.4 2.5 4.1 1.4 2.1 5.2 2.6 2.6 0.7 1.1 3.7 7.7 2.9 2.7 5.4 3.0 5.3 2.4 17.6 1.6 10.3 8.4 2.1 4.2 1.2 0.9 0.7 0.0 3.2 2.7 0.5 17.3 8.9 16.9 7.8 0.8 5.0 8.6 9.9 5.0 15.8 18.3 8.9 13.6 10.8 5.6 5.5 8.5 10.7 16.9 6.1 18.7 12.6 9.3 16.1 9.8 11.0 0.4 19.2 7.0 1.4 0.4 8.6 1.4 2.0 9.1 14.5 14.1 6.9 15.8 15.2 19.5 12.5 9.9 14.2 20.8 16.6 15.5 9.8 5.7 9.8 12.2 7.0 10.0 5.9 3.1 8.5 11.8 6.8 3.2 2.5 18.8 10.5 7.8 5.1 10.3 25.0 4.8 14.2 10.2 0.0 0.0 0.7 0.9 0.0 0.7 1.2 0.9 1.7 0.6 1.2 0.1 0.8 0.0 3.2 0.0 0.9 2.7 0.5 1.5 2.8 1.7 1.6 1.0 1.2 1.1 0.3 1.4 2.4 3.0 0.3 0.8 1.6 4.2 0.8 0.8 0.0 1.4 1.2 0.0 0.0 5.3 0.0 1.2 0.9 0.8 0.8 23.3 1.3 8.5 2.6 1.2 0.0 3.2 4.7 0.0 1.2 6.7 3.7 0.2 1.4 1.2 1.7 1.0 2.0 2.1 0.6 0.0 2.8 0.8 3.3 0.0 1.9 3.0 22.2 3.1 2.9 0.9 2.9 0.8 POLE3 "CHARAC17, CHRAC17, p17, Ybl1" ENSG00000148229 "DNA polymerase epsilon 3, accessory subunit" Q9NRF9 9 113407235-113410672 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" DNA-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047945 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA047945: AB_2680218" "unprognostic (9.55e-2)" "unprognostic (3.39e-3)" "unprognostic (1.56e-1)" "unprognostic (1.67e-1)" "unprognostic (6.52e-2)" "unprognostic (1.86e-2)" "prognostic unfavorable (8.35e-4)" "unprognostic (1.04e-2)" "unprognostic (1.60e-2)" "unprognostic (1.10e-1)" "unprognostic (4.59e-3)" "unprognostic (2.31e-3)" "unprognostic (1.75e-2)" "unprognostic (1.56e-2)" "unprognostic (1.04e-1)" "unprognostic (1.28e-1)" "unprognostic (1.18e-1)" 16.9 23.9 18.2 22.0 18.5 56.3 19.3 36.0 25.0 17.0 17.6 15.8 12.5 15.1 18.2 16.5 27.8 17.6 17.0 17.9 16.1 14.8 14.3 29.5 15.8 29.0 15.1 18.5 15.4 20.8 13.1 8.4 21.2 20.0 15.9 20.3 12.4 17.9 16.3 48.3 24.7 17.3 16.9 16.9 26.8 17.2 29.9 15.9 35.0 16.3 27.3 32.4 18.8 16.7 34.9 33.5 34.3 34.4 28.0 44.0 47.7 15.9 19.9 14.0 21.0 8.0 7.2 12.3 21.3 10.9 24.2 19.1 18.4 14.5 58.1 13.3 12.4 14.7 27.4 27.3 23.4 22.4 11.0 16.5 30.1 20.7 18.8 8.6 62.4 18.2 8.1 16.2 21.0 27.0 8.8 16.7 29.6 41.9 32.5 16.7 40.6 42.8 33.6 18.1 34.3 36.1 43.9 58.5 32.6 10.5 15.3 30.5 17.6 31.0 19.6 16.7 8.9 29.3 28.1 13.7 17.9 24.3 22.7 36.4 17.0 55.5 78.3 16.4 36.9 21.4 25.4 34.0 34.3 35.5 34.4 44.0 34.9 34.0 33.7 33.2 33.5 36.9 34.3 7.2 28.0 26.6 33.5 39.0 47.7 18.2 18.5 36.0 25.0 16.1 14.8 15.1 18.5 20.0 15.9 35.7 27.5 46.8 23.7 83.3 13.9 39.7 22.9 46.8 44.3 29.6 5.9 49.3 36.5 26.8 4.0 34.3 14.2 0.0 39.2 47.2 34.7 19.7 54.5 37.2 44.5 12.7 23.6 23.4 27.8 11.5 33.1 54.6 38.8 53.3 31.4 30.3 28.9 10.5 40.0 22.0 17.1 12.9 47.2 27.9 98.5 82.9 29.2 63.4 39.3 18.2 POLE4 p12 ENSG00000115350 "DNA polymerase epsilon 4, accessory subunit" Q9NR33 2 74958492-74970128 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" DNA-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 35.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054979, HPA071815" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA054979: AB_2682661, HPA071815: AB_2686453" "unprognostic (2.56e-2)" "unprognostic (4.27e-2)" "unprognostic (1.17e-1)" "unprognostic (4.19e-2)" "unprognostic (4.85e-2)" "unprognostic (1.59e-2)" "prognostic unfavorable (6.49e-4)" "unprognostic (3.09e-1)" "unprognostic (1.99e-1)" "unprognostic (2.95e-1)" "unprognostic (1.39e-2)" "unprognostic (4.44e-2)" "unprognostic (8.64e-3)" "unprognostic (6.61e-2)" "unprognostic (3.73e-1)" "unprognostic (3.47e-2)" "unprognostic (1.95e-1)" 19.2 14.5 23.6 15.2 17.3 27.1 21.4 4.4 15.5 18.4 13.4 8.6 7.0 9.0 10.4 9.0 10.0 9.7 13.1 18.1 15.9 10.6 11.6 18.8 10.7 17.0 13.9 12.6 12.8 12.5 2.8 3.9 9.6 12.2 12.0 8.8 13.9 16.2 11.2 28.1 8.1 12.4 14.1 11.7 12.2 12.5 11.0 10.0 5.5 13.1 15.1 10.4 13.9 31.9 14.7 14.7 8.0 22.2 4.4 9.9 12.3 11.8 11.3 1.0 1.0 3.9 8.6 0.0 8.0 10.0 12.9 11.0 15.0 5.3 11.6 6.8 9.1 3.2 5.4 5.4 6.7 15.1 5.3 14.5 9.0 6.5 14.8 14.0 12.7 14.2 8.7 13.1 5.4 11.9 4.0 5.6 1.6 11.0 6.8 9.8 11.5 3.7 35.8 7.9 6.9 21.2 4.5 9.7 9.3 10.7 0.3 3.6 5.4 11.0 4.6 6.4 0.6 3.4 4.1 6.2 2.9 3.3 2.0 7.7 2.4 1.6 4.3 10.5 19.1 14.2 2.3 22.2 8.0 6.3 13.2 7.0 14.7 8.9 7.8 12.9 13.7 9.9 6.9 1.6 4.4 12.4 14.7 8.5 12.3 23.6 17.3 4.4 15.5 15.9 10.6 13.9 12.6 12.2 10.0 23.8 36.0 84.1 81.2 75.1 21.9 40.6 58.6 34.8 21.6 69.8 41.2 124.8 126.0 43.1 10.2 56.2 119.0 23.3 70.2 125.8 83.2 82.4 61.1 123.4 106.6 17.5 11.7 68.7 111.2 19.3 62.2 91.0 92.8 30.7 80.6 78.1 62.4 147.3 51.2 125.5 104.8 77.6 87.3 41.3 86.7 85.4 78.6 69.3 78.6 82.9 POLH "RAD30A, XP-V" ENSG00000170734 "DNA polymerase eta" Q9Y253 6 43576150-43615660 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, DNA synthesis" "DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase" "Disease mutation, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 23.3;Spermatocytes: 17.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 41.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006721, HPA026762" Approved Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA006721: AB_1847785, HPA026762: AB_10601248" "unprognostic (1.79e-1)" "unprognostic (7.29e-2)" "unprognostic (2.25e-1)" "unprognostic (7.28e-2)" "unprognostic (3.61e-1)" "unprognostic (5.11e-3)" "unprognostic (9.68e-2)" "unprognostic (1.40e-1)" "unprognostic (3.18e-1)" "unprognostic (7.75e-2)" "unprognostic (4.11e-3)" "unprognostic (2.24e-1)" "unprognostic (9.50e-2)" "unprognostic (6.73e-2)" "unprognostic (8.77e-2)" "unprognostic (7.91e-2)" "unprognostic (6.02e-2)" 7.4 9.4 7.5 9.7 10.4 4.6 7.2 10.5 10.5 8.5 8.4 12.7 8.0 5.7 9.6 7.1 11.4 7.8 6.2 6.7 5.3 4.4 7.2 7.5 9.8 16.3 8.9 8.1 7.4 13.0 7.1 9.7 5.1 7.9 6.9 10.1 8.9 8.6 5.6 9.5 11.7 7.9 11.8 6.9 9.2 7.6 24.7 6.8 22.1 9.9 6.2 18.3 8.6 8.4 8.6 4.3 4.5 2.6 6.8 7.2 3.2 20.5 4.7 6.4 9.3 9.1 15.1 15.2 22.0 6.9 12.9 14.8 5.4 3.6 22.8 5.5 8.9 3.7 5.2 6.4 13.8 16.1 11.5 4.9 6.7 13.3 15.6 6.8 11.4 9.0 10.1 17.0 10.5 5.7 5.2 12.1 7.0 10.5 13.7 16.2 6.8 10.3 3.0 1.9 15.7 3.6 11.3 6.6 5.7 4.9 15.4 7.2 2.5 7.0 5.8 3.5 7.4 8.3 5.1 16.4 11.9 11.6 5.6 11.1 12.9 8.9 41.2 5.7 6.7 12.9 4.5 2.6 4.1 7.2 2.5 6.4 7.8 6.0 5.2 2.1 8.6 5.0 5.2 2.0 6.8 1.9 4.3 7.0 3.2 7.5 10.4 10.5 10.5 5.3 4.4 8.9 8.1 7.9 6.8 11.9 5.1 4.9 2.6 4.1 6.3 2.4 2.5 5.3 7.9 3.5 9.8 1.7 5.0 2.0 7.6 2.1 2.6 23.3 0.7 2.4 2.6 2.1 0.0 2.1 1.5 0.0 5.2 0.6 1.5 6.0 3.1 1.7 1.7 2.8 2.2 2.3 1.6 2.9 2.8 1.4 8.5 0.0 3.1 17.9 5.9 2.6 1.6 2.9 3.1 2.5 POLK "DINB1, DINP, POLQ" ENSG00000122008 "DNA polymerase kappa" Q9UBT6 5 75511756-75601144 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, DNA synthesis" "DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 167.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012035, HPA057303, HPA068117, HPA069375" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA012035: AB_2668606, HPA057303: AB_2683406, HPA068117: AB_2685957, HPA069375: AB_2686131" "unprognostic (9.66e-2)" "unprognostic (5.29e-2)" "unprognostic (5.37e-2)" "unprognostic (2.70e-1)" "unprognostic (1.86e-1)" "unprognostic (1.66e-1)" "unprognostic (1.73e-2)" "unprognostic (7.76e-2)" "unprognostic (1.65e-2)" "unprognostic (6.29e-3)" "unprognostic (2.42e-1)" "unprognostic (5.93e-2)" "unprognostic (1.80e-2)" "unprognostic (9.96e-3)" "unprognostic (1.58e-1)" "unprognostic (9.64e-2)" "unprognostic (2.02e-1)" 14.7 12.7 10.1 8.6 12.9 6.3 13.4 17.0 13.4 18.1 10.7 8.8 13.6 6.3 21.3 12.1 11.7 10.5 9.5 11.4 14.1 10.5 12.6 12.3 12.2 9.2 14.1 12.9 15.5 11.1 18.5 23.9 15.2 17.2 13.9 8.1 6.5 10.2 10.5 15.2 10.3 9.2 15.4 16.9 13.1 9.0 9.8 12.4 12.1 18.8 9.3 8.9 12.7 10.2 7.0 7.5 6.0 13.3 4.6 4.5 2.5 6.4 6.6 4.1 5.3 5.5 10.9 3.5 12.3 8.8 9.6 10.0 4.2 5.2 6.6 10.2 8.1 6.3 2.5 3.8 4.2 11.6 7.3 4.5 6.0 5.8 2.0 10.4 3.9 5.0 5.1 5.3 7.7 5.3 7.7 8.0 4.4 5.3 3.9 9.1 0.5 7.5 3.1 1.5 0.7 3.9 3.2 10.6 4.6 5.8 2.2 4.2 4.6 9.3 2.5 3.3 2.9 3.6 3.7 10.1 7.1 3.6 3.3 7.0 4.6 4.1 6.0 4.7 6.1 12.1 5.7 7.1 3.4 3.3 7.9 2.9 7.0 3.7 4.0 6.1 5.4 4.5 3.0 6.0 4.6 13.3 7.5 4.1 2.5 10.1 12.9 17.0 13.4 14.1 10.5 14.1 12.9 17.2 12.4 29.8 39.4 38.7 18.4 13.1 33.6 17.1 30.6 18.7 29.6 27.9 19.6 14.0 19.9 16.1 167.0 32.1 9.2 23.3 13.7 11.0 21.7 14.6 49.8 20.9 18.7 62.0 14.3 49.7 37.8 38.8 34.8 32.2 21.9 27.9 12.4 23.5 16.5 11.5 36.0 17.0 40.7 6.5 16.5 43.4 16.6 11.3 5.6 18.5 10.6 10.5 POLL ENSG00000166169 "DNA polymerase lambda" Q9UGP5 10 101578882-101588270 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, DNA synthesis" "DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 45.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076828 Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA076828: " "unprognostic (3.71e-3)" "unprognostic (6.93e-3)" "unprognostic (1.73e-2)" "unprognostic (2.47e-2)" "unprognostic (9.52e-2)" "unprognostic (1.80e-2)" "unprognostic (2.11e-2)" "unprognostic (1.24e-1)" "unprognostic (8.11e-2)" "unprognostic (1.71e-2)" "unprognostic (1.12e-2)" "unprognostic (7.19e-2)" "unprognostic (4.74e-2)" "unprognostic (1.06e-2)" "unprognostic (1.94e-1)" "unprognostic (3.86e-1)" "unprognostic (1.64e-3)" 11.0 15.1 14.4 16.0 17.1 9.2 13.4 11.2 22.1 13.7 12.6 16.4 15.6 14.3 15.1 22.1 15.4 18.1 17.7 12.3 11.1 10.4 16.4 16.5 11.8 13.0 9.6 13.0 20.9 30.7 21.7 23.7 11.7 12.7 17.2 15.0 19.5 17.8 14.7 26.1 12.8 11.9 12.7 9.4 15.6 16.7 53.2 11.2 4.6 18.3 10.2 14.2 14.8 11.6 8.5 10.7 1.1 8.5 8.4 11.9 7.1 11.7 10.7 8.5 11.8 8.6 16.0 11.9 7.8 13.5 11.9 12.6 7.8 14.2 2.9 12.3 7.0 6.7 14.8 9.3 11.5 9.7 10.3 12.7 9.2 10.1 8.9 15.9 9.5 8.4 14.6 15.7 13.2 27.4 33.6 12.8 5.7 10.2 10.2 7.5 9.3 0.0 10.4 4.5 6.5 6.4 0.0 7.5 4.8 10.0 7.1 5.9 8.7 4.8 8.1 13.3 13.0 24.5 5.6 6.8 4.3 8.7 4.9 8.5 14.7 7.4 4.4 9.3 8.3 3.2 0.5 8.5 1.1 6.7 5.9 10.6 8.5 7.4 6.8 10.7 7.1 11.9 7.9 0.9 8.4 5.7 0.2 8.9 7.1 14.4 17.1 11.2 22.1 11.1 10.4 9.6 13.0 12.7 11.2 6.0 11.7 10.2 7.5 3.3 15.9 6.7 12.7 4.0 5.7 7.0 45.2 14.0 5.0 8.6 16.4 5.6 10.5 0.0 18.3 7.2 6.9 5.2 13.9 8.1 10.0 20.6 12.6 4.9 12.3 39.9 13.0 8.8 10.1 15.4 12.0 9.9 11.4 7.0 10.6 8.4 22.0 12.9 5.7 23.8 9.1 1.8 9.6 9.6 12.8 5.2 POLM Tdt-N ENSG00000122678 "DNA polymerase mu" Q9NP87 7 44072247-44082540 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 31.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 31.6" "Cell line enhanced" "Detected in many" "HBEC3-KT: 38.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058900, HPA066007" Approved Nucleoplasm NA NA Nucleoplasm "HPA058900: AB_2683848, HPA066007: AB_2685595" "unprognostic (2.44e-2)" "unprognostic (8.18e-2)" "unprognostic (2.21e-3)" "unprognostic (3.93e-2)" "unprognostic (5.40e-2)" "unprognostic (1.83e-1)" "unprognostic (2.75e-1)" "unprognostic (1.22e-1)" "unprognostic (5.12e-2)" "unprognostic (3.91e-1)" "unprognostic (9.36e-2)" "unprognostic (8.26e-2)" "unprognostic (2.46e-3)" "unprognostic (6.31e-2)" "unprognostic (1.47e-1)" "unprognostic (2.87e-1)" "unprognostic (3.87e-3)" 10.7 8.7 7.0 18.0 7.1 7.6 12.2 11.9 8.8 13.8 11.2 11.1 11.7 12.2 10.1 12.0 11.7 11.8 11.8 10.8 6.8 4.4 13.0 12.5 10.1 20.9 9.9 7.0 13.8 12.3 10.0 9.0 8.1 8.2 11.8 7.1 12.4 13.5 14.3 11.2 12.0 12.6 8.9 9.0 18.7 12.0 6.8 8.1 30.1 15.4 8.3 17.6 12.4 10.7 5.9 4.8 31.6 2.1 3.5 4.2 1.3 1.1 1.5 1.5 3.5 2.2 2.6 5.0 3.5 4.0 2.7 1.6 1.9 2.6 11.3 3.6 3.0 3.4 3.4 1.6 38.3 1.6 3.9 3.6 1.3 1.6 0.7 3.1 3.5 5.1 4.0 3.7 2.3 2.8 5.6 4.9 11.3 1.6 5.5 2.3 2.6 7.1 3.1 3.3 3.4 8.2 5.7 0.9 4.4 3.0 1.8 1.6 3.0 1.7 7.3 3.7 2.7 4.6 6.0 3.4 1.9 2.8 1.9 5.1 9.0 4.5 8.8 3.5 3.2 4.6 8.6 1.8 5.1 3.3 2.1 3.3 4.0 2.9 3.0 1.6 5.9 4.2 3.4 31.6 3.5 1.6 4.8 2.7 1.3 7.0 7.1 11.9 8.8 6.8 4.4 9.9 7.0 8.2 8.1 3.0 8.5 24.9 9.9 3.9 18.3 5.5 15.3 4.0 9.1 12.2 27.5 10.7 1.7 6.4 0.4 6.4 12.3 0.0 8.2 8.5 5.0 11.9 24.2 8.9 9.0 17.5 5.2 12.9 10.8 0.4 13.0 9.1 10.1 10.0 7.3 7.2 6.9 15.6 9.6 3.8 38.8 0.0 13.0 10.8 11.5 4.4 8.1 14.4 10.1 10.7 POLN ENSG00000130997 "DNA polymerase nu" Q7Z5Q5 4 2071918-2242121 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Late spermatids: 9.2;Spermatocytes: 17.6;Spermatogonia: 10.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 2.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 5.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035939, HPA035940" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035939: AB_2674875, HPA035940: AB_2674876" "unprognostic (8.52e-3)" "unprognostic (1.55e-1)" "unprognostic (4.87e-2)" "unprognostic (1.32e-1)" "unprognostic (2.53e-1)" "unprognostic (1.45e-2)" "unprognostic (3.46e-1)" "unprognostic (2.70e-1)" "unprognostic (5.83e-2)" "unprognostic (2.23e-1)" "unprognostic (2.02e-3)" "unprognostic (1.25e-1)" "unprognostic (1.49e-3)" "unprognostic (9.14e-2)" "unprognostic (2.67e-1)" "unprognostic (2.66e-1)" "unprognostic (1.82e-2)" 13.6 3.9 6.1 2.5 5.7 1.8 5.2 11.1 5.5 2.8 2.9 3.5 2.9 2.7 4.0 5.8 2.6 3.6 3.3 2.8 4.4 2.9 3.6 3.4 3.0 2.7 4.3 4.0 2.8 3.1 2.4 7.6 2.3 3.8 4.6 1.8 1.7 4.7 3.5 2.7 2.7 2.4 3.3 5.6 3.5 2.9 12.3 5.2 8.5 2.4 0.9 2.6 2.5 2.6 0.2 0.1 2.4 0.0 0.0 0.9 0.1 0.3 2.7 0.5 2.0 5.7 2.2 0.0 2.0 1.0 1.1 1.6 0.1 0.2 1.2 0.6 1.7 1.0 0.4 2.2 0.8 1.6 0.3 2.9 0.1 2.0 0.0 0.7 0.2 2.6 3.1 0.8 1.7 1.4 2.6 0.6 0.5 0.2 2.3 3.1 0.3 0.2 0.2 0.2 0.1 0.6 0.0 3.8 0.9 0.8 0.5 2.5 0.0 0.2 0.0 0.2 1.0 0.1 0.7 0.3 0.1 1.9 1.1 0.6 0.6 0.7 0.0 0.6 1.9 1.1 0.0 0.0 2.4 0.2 0.0 0.9 0.2 0.2 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.4 0.1 6.1 5.7 11.1 5.5 4.4 2.9 4.3 4.0 3.8 5.2 0.0 0.0 0.0 1.0 0.8 3.2 1.6 2.5 1.4 2.3 0.0 0.0 0.2 3.3 0.4 6.8 0.8 0.0 0.0 0.9 0.2 1.7 1.1 0.0 0.6 0.5 3.2 4.6 4.9 1.0 9.2 4.0 1.4 0.0 0.0 0.0 2.6 0.4 0.0 3.5 0.5 3.6 0.0 1.3 17.6 10.0 1.4 0.0 0.7 0.2 1.3 POLQ POLH ENSG00000051341 "DNA polymerase theta" O75417 3 121431427-121546641 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 9.5;lymphoid tissue: 21.4" "Cell type enhanced" "Detected in some" 10 "Club cells: 3.4;Extravillous trophoblasts: 2.8;Spermatocytes: 7.0;Spermatogonia: 3.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 1.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 5.2" HPA053359 Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA Yes Nucleoplasm "Golgi apparatus, Cytosol" "HPA053359: " "unprognostic (1.59e-1)" "unprognostic (4.18e-2)" "unprognostic (2.66e-2)" "prognostic unfavorable (5.46e-5)" "unprognostic (2.70e-1)" "unprognostic (6.23e-3)" "unprognostic (3.09e-5)" "unprognostic (8.55e-3)" "unprognostic (1.09e-4)" "unprognostic (2.86e-1)" "unprognostic (5.59e-5)" "unprognostic (2.06e-3)" "unprognostic (0.00e+0)" "prognostic favorable (1.04e-4)" "unprognostic (1.76e-1)" "unprognostic (6.01e-2)" "unprognostic (5.76e-2)" 0.5 0.8 0.2 8.2 0.7 9.5 0.6 0.6 0.4 0.9 3.5 0.2 0.8 2.0 0.9 0.6 6.0 0.3 0.4 0.8 0.3 0.2 0.4 0.6 0.9 4.7 0.3 0.0 0.4 0.4 0.0 0.2 2.8 0.3 0.4 3.7 0.1 1.1 0.8 1.2 2.4 3.9 0.5 0.4 2.6 1.1 5.8 0.6 21.4 0.3 5.6 7.5 0.6 1.7 0.5 1.1 1.6 0.4 0.0 0.4 0.0 13.5 9.2 7.9 5.6 0.7 0.9 7.2 6.4 2.5 7.6 10.2 7.3 5.0 16.1 2.9 3.5 9.2 10.7 9.3 4.1 12.9 4.7 5.1 10.3 5.7 4.5 0.0 11.1 9.5 0.1 0.3 6.9 4.3 1.3 3.7 6.0 6.8 12.3 7.9 5.2 10.0 6.5 7.5 4.1 4.5 8.5 9.5 5.7 2.4 7.8 4.3 3.9 7.4 4.0 2.6 7.2 3.7 11.1 2.9 6.7 8.8 2.6 8.3 6.2 5.0 16.7 3.2 8.3 4.9 1.6 0.2 0.0 0.3 0.2 0.0 0.3 0.4 0.3 0.4 0.5 0.0 0.2 0.0 0.0 0.4 1.1 0.1 0.0 0.2 0.7 0.6 0.4 0.3 0.2 0.3 0.0 0.3 0.6 0.0 0.3 0.0 0.4 0.8 0.3 1.4 0.0 1.4 3.4 0.0 0.0 0.9 0.0 0.1 0.3 0.0 0.4 0.0 0.0 2.8 0.7 0.3 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.2 0.3 1.5 0.0 1.0 0.4 0.5 0.3 0.3 0.0 0.1 0.1 0.0 0.5 7.0 3.3 0.1 0.2 0.9 0.9 0.9 POLR1A "DKFZP586M0122, FLJ21915, RPA1, RPO1-4" ENSG00000068654 "RNA polymerase I subunit A" O95602 2 86020216-86106155 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Nucleotidyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010145, HPA031513, HPA049700" Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments" No No "Nucleoli fibrillar center" "Nucleoplasm, Intermediate filaments" "CAB010145: AB_675814, HPA031513: AB_2673916, HPA049700: AB_2680856" "unprognostic (1.22e-1)" "unprognostic (1.82e-2)" "unprognostic (1.55e-1)" "unprognostic (2.46e-2)" "unprognostic (1.32e-1)" "unprognostic (1.93e-1)" "prognostic unfavorable (3.70e-9)" "unprognostic (1.06e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (3.37e-4)" "unprognostic (4.31e-2)" "unprognostic (4.56e-2)" "unprognostic (3.27e-1)" "unprognostic (2.20e-3)" "unprognostic (1.94e-1)" "prognostic unfavorable (8.41e-4)" "unprognostic (7.20e-2)" 14.3 12.9 10.1 12.4 16.5 9.7 10.3 12.2 20.3 11.1 11.0 17.4 8.3 9.4 19.5 7.4 13.5 12.3 11.7 12.7 9.0 9.2 11.5 15.1 9.4 9.6 9.0 9.4 12.6 14.3 18.2 15.9 11.4 13.8 10.7 11.8 13.9 11.2 12.5 22.5 12.3 8.6 16.0 8.0 11.2 10.4 14.9 10.9 14.0 10.3 11.4 14.2 10.9 9.6 2.6 2.6 1.8 2.5 2.0 3.8 1.2 9.4 21.6 9.6 18.5 9.5 7.6 14.0 8.7 5.8 12.6 7.8 27.0 7.5 21.7 9.3 8.9 12.2 11.0 24.7 12.9 11.2 9.0 12.8 18.7 9.2 18.1 6.7 17.7 10.1 5.8 8.1 18.6 14.5 4.8 9.7 10.1 24.7 5.5 8.6 8.4 13.1 7.5 17.5 12.7 14.3 15.8 21.1 10.2 5.6 15.5 15.0 7.8 9.6 12.8 6.9 6.9 7.5 6.2 15.4 15.3 12.1 13.0 17.5 7.8 7.5 19.0 7.9 15.3 13.4 1.8 1.5 0.2 3.0 2.5 3.8 2.0 1.5 2.5 1.8 2.6 1.4 1.8 0.7 2.0 1.9 2.6 0.7 1.2 10.1 16.5 12.2 20.3 9.0 9.2 9.0 9.4 13.8 10.9 3.0 7.8 6.1 2.9 3.8 11.5 7.8 15.3 6.7 3.4 8.7 15.7 5.7 3.3 5.9 2.4 5.7 4.2 0.0 4.0 4.4 3.8 4.3 5.8 7.2 10.2 11.1 9.2 4.9 2.8 1.5 5.8 3.1 5.0 1.8 6.1 2.9 5.0 0.0 4.9 3.0 10.1 0.0 4.7 4.2 7.5 2.4 3.2 4.4 9.0 3.7 POLR1C "RPA39, RPA40, RPA5, RPAC1" ENSG00000171453 "RNA polymerase I subunit C" O15160 6 43509702-43562419 "Disease related genes, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 80.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031010 Supported Nucleoplasm NA NA Nucleoplasm "HPA031010: AB_10603131" "unprognostic (2.84e-1)" "unprognostic (1.67e-1)" "unprognostic (3.15e-1)" "unprognostic (6.57e-2)" "unprognostic (7.01e-2)" "unprognostic (3.59e-1)" "unprognostic (6.69e-3)" "unprognostic (1.09e-3)" "unprognostic (2.00e-3)" "unprognostic (1.90e-2)" "unprognostic (2.05e-1)" "unprognostic (7.32e-2)" "prognostic unfavorable (4.17e-4)" "unprognostic (1.20e-2)" "unprognostic (4.69e-2)" "unprognostic (3.01e-1)" "unprognostic (6.41e-2)" 16.2 20.8 11.8 15.6 18.6 7.4 22.1 11.8 19.2 19.1 19.1 16.4 14.1 14.0 22.5 18.0 24.0 23.3 14.5 12.7 11.7 13.3 26.9 26.6 12.4 13.5 12.4 10.3 22.9 30.7 14.2 20.5 18.5 13.4 19.3 17.4 19.1 24.1 15.4 17.5 21.9 12.8 16.2 9.9 21.3 16.1 20.9 11.4 17.4 35.2 18.3 27.9 16.3 16.8 23.0 18.6 2.1 13.4 17.5 26.2 14.7 19.8 16.6 7.3 19.7 11.2 12.2 11.5 12.1 9.0 13.7 11.7 21.9 6.7 22.5 13.3 11.8 11.7 12.1 17.5 15.5 16.0 11.9 18.3 15.3 16.7 30.3 14.1 23.4 10.8 10.8 15.0 18.7 23.7 8.1 10.7 9.5 35.3 6.6 11.9 28.0 12.2 17.0 13.4 80.8 14.4 8.4 11.4 15.1 16.4 27.8 13.5 9.0 10.6 9.2 16.0 5.6 10.0 20.7 12.7 9.8 13.2 10.5 19.1 9.6 21.2 37.6 6.6 16.1 10.8 2.1 13.4 1.9 16.0 10.3 21.7 21.6 19.0 15.8 18.6 23.0 26.2 23.5 1.3 17.5 8.3 16.9 13.6 14.7 11.8 18.6 11.8 19.2 11.7 13.3 12.4 10.3 13.4 11.4 11.9 15.3 11.0 39.5 55.0 7.2 4.5 17.8 44.2 26.1 5.2 5.9 25.7 13.3 23.9 7.2 21.5 4.9 0.0 21.0 14.4 16.4 14.9 13.9 11.1 11.7 4.8 12.5 15.4 7.0 5.6 10.6 9.4 20.3 6.4 11.2 8.1 16.9 14.0 11.0 20.8 14.5 6.5 25.3 27.7 39.0 35.8 11.3 14.1 15.2 34.1 POLR1D "MGC9850, RPA16, RPA9, RPAC2, RPO1-3" ENSG00000186184 "RNA polymerase I subunit D" "P0DPB5, P0DPB6" 13 27620742-27744237 "Disease related genes, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 641.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039337 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA039337: AB_10672961" "unprognostic (1.33e-3)" "unprognostic (5.96e-2)" "unprognostic (4.35e-2)" "unprognostic (8.50e-3)" "unprognostic (1.98e-2)" "unprognostic (3.71e-3)" "unprognostic (5.33e-3)" "unprognostic (2.04e-1)" "unprognostic (4.18e-2)" "unprognostic (4.39e-2)" "unprognostic (2.80e-1)" "unprognostic (5.18e-3)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (2.56e-2)" "unprognostic (8.28e-2)" "unprognostic (6.45e-2)" 30.5 43.8 17.0 35.4 22.1 46.5 36.5 41.2 23.7 34.6 40.8 15.9 34.4 30.9 26.0 29.9 58.9 21.4 32.3 28.5 16.7 14.4 27.3 29.9 32.6 36.5 14.8 20.6 43.6 115.9 16.7 24.3 24.7 15.6 37.4 32.7 20.9 46.2 39.5 38.1 44.8 36.4 41.2 17.4 31.9 41.7 23.7 13.0 50.9 32.3 40.7 40.7 56.8 54.0 29.2 42.7 21.4 39.3 27.9 56.6 26.2 20.0 18.9 21.8 22.3 25.1 45.1 29.3 19.9 34.4 26.4 26.2 30.5 40.9 65.1 15.1 22.4 43.8 31.0 40.1 63.6 31.4 20.1 23.8 46.2 20.6 51.1 37.9 42.0 36.4 40.5 67.3 21.4 40.1 29.7 36.4 37.5 25.2 11.6 25.6 20.8 41.2 51.2 52.5 62.8 20.1 28.4 37.5 29.2 41.6 31.2 37.2 29.2 13.3 26.9 71.8 28.7 16.4 39.2 25.2 11.7 18.3 20.0 21.7 19.1 21.5 36.8 10.2 30.4 22.7 21.4 38.4 17.3 24.9 39.3 32.8 28.4 40.2 31.4 42.7 29.2 43.6 34.2 13.7 27.9 34.2 31.2 56.6 26.2 17.0 22.1 41.2 23.7 16.7 14.4 14.8 20.6 15.6 13.0 83.4 87.9 125.7 260.0 299.0 36.8 61.7 99.3 46.8 102.4 27.9 15.7 139.0 63.0 120.2 371.4 103.0 105.8 70.0 267.5 226.2 97.1 149.2 93.5 69.2 148.4 42.9 119.5 90.9 175.3 641.0 107.9 125.4 75.9 153.3 182.4 43.5 227.4 97.9 74.3 100.6 35.5 77.6 116.0 153.7 85.9 277.2 122.0 126.4 173.3 290.2 POLR1E "FLJ13390, FLJ13970, PAF53, PRAF1" ENSG00000137054 "RNA polymerase I subunit E" Q9GZS1 9 37485935-37503697 "Predicted intracellular proteins, Predicted membrane proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022527, HPA052400" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA022527: AB_1854924, HPA052400: AB_2681815" "prognostic favorable (2.27e-4)" "unprognostic (2.09e-1)" "unprognostic (9.90e-3)" "unprognostic (1.10e-2)" "unprognostic (7.16e-3)" "unprognostic (2.07e-1)" "unprognostic (1.09e-2)" "unprognostic (7.14e-2)" "unprognostic (1.04e-1)" "unprognostic (2.48e-1)" "unprognostic (2.80e-1)" "unprognostic (2.48e-1)" "unprognostic (1.07e-1)" "unprognostic (4.96e-2)" "unprognostic (5.23e-1)" "unprognostic (1.58e-1)" "unprognostic (4.24e-2)" 15.4 12.2 10.5 20.2 11.6 9.3 19.7 10.7 9.0 19.0 13.9 10.0 14.9 7.0 20.5 14.7 15.1 17.3 13.7 14.9 9.1 9.2 7.6 23.9 10.1 15.5 9.0 9.2 36.9 25.9 10.3 9.6 8.7 9.5 17.3 9.3 9.5 19.5 18.4 17.2 13.1 9.0 22.4 10.2 10.8 13.0 11.2 11.5 16.0 15.3 13.3 17.1 21.9 16.8 8.1 3.9 1.4 4.3 9.0 16.9 5.5 19.7 18.6 10.3 16.3 19.3 24.9 6.7 17.6 6.8 18.3 16.2 15.9 6.6 28.8 8.5 20.2 12.4 8.3 25.1 20.9 23.1 27.8 11.8 13.8 23.6 11.3 14.5 26.4 9.8 26.4 7.4 35.7 30.9 11.5 9.2 16.1 36.0 12.7 16.0 9.5 18.2 9.0 18.3 13.6 15.3 16.2 9.5 13.8 9.5 7.4 14.7 12.1 11.7 9.4 15.1 8.9 9.2 17.6 6.3 21.7 33.1 18.5 35.0 7.0 9.8 30.3 7.5 16.8 18.0 0.0 2.5 1.4 10.6 4.3 16.9 7.4 10.2 10.8 3.9 8.1 12.8 11.1 0.8 9.0 3.4 2.7 5.4 5.5 10.5 11.6 10.7 9.0 9.1 9.2 9.0 9.2 9.5 11.5 0.0 6.7 8.5 20.9 25.1 6.4 7.6 15.3 5.3 9.1 0.0 3.9 12.9 6.6 12.3 4.4 7.5 2.7 0.0 18.2 17.4 12.1 6.6 8.1 15.8 6.6 3.2 1.7 3.7 8.6 8.6 13.8 7.3 5.0 8.2 7.3 6.7 14.5 0.0 14.2 4.1 5.7 0.0 17.9 11.5 16.1 15.6 7.0 12.9 12.1 11.6 POLR2A "POLR2, POLRA, RPB1" ENSG00000181222 "RNA polymerase II subunit A" P24928 17 7484366-7514616 "Enzymes, Predicted intracellular proteins" "Host-virus interaction, Transcription" "DNA-binding, Nucleotidyltransferase, RNA-directed RNA polymerase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 4.9" "Cell line enhanced" "Detected in some" "HEK 293: 3.0;HL-60: 2.7;HMC-1: 4.0" "CAB012226, CAB016388, CAB022311" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB012226: AB_304749, CAB016388: AB_677353, CAB022311: " "unprognostic (2.03e-1)" "unprognostic (1.32e-1)" "unprognostic (1.58e-1)" "unprognostic (2.40e-1)" "unprognostic (1.71e-1)" "unprognostic (5.43e-2)" "unprognostic (8.77e-3)" "unprognostic (1.48e-1)" "unprognostic (5.19e-3)" "unprognostic (1.81e-1)" "unprognostic (1.52e-1)" "unprognostic (3.70e-2)" "unprognostic (1.01e-3)" "unprognostic (1.25e-1)" "unprognostic (2.30e-2)" "unprognostic (1.49e-1)" "unprognostic (4.70e-2)" 5.0 5.9 4.5 5.7 7.4 26.4 8.5 5.8 7.8 7.2 4.3 4.8 4.5 4.3 5.5 5.4 7.0 4.6 4.2 4.5 6.0 3.5 4.6 4.4 6.4 11.5 4.7 4.2 5.2 5.8 5.4 4.8 4.2 5.4 4.3 4.9 6.3 5.5 8.1 6.6 6.6 6.0 4.5 6.1 6.2 5.3 13.2 2.9 15.0 5.6 4.1 5.0 5.3 4.6 0.7 0.7 4.9 1.0 0.0 1.2 0.0 0.3 0.0 0.3 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.4 0.4 0.1 0.6 0.2 0.0 0.2 0.0 0.2 0.4 3.0 0.7 1.2 0.2 0.0 2.7 4.0 0.4 0.0 0.3 0.0 0.4 0.2 0.7 0.3 0.0 0.5 0.0 0.1 0.8 0.5 0.0 0.9 1.2 0.0 0.0 0.0 1.4 0.3 0.9 1.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.3 0.5 0.8 0.4 0.2 0.4 0.0 0.6 0.3 3.0 0.5 0.6 1.2 0.4 0.3 0.3 0.5 0.4 0.1 0.7 0.6 0.5 4.9 0.0 1.0 0.7 0.5 0.0 4.5 7.4 5.8 7.8 6.0 3.5 4.7 4.2 5.4 2.9 20.8 47.7 32.5 35.2 38.0 86.4 20.7 38.2 29.4 23.9 22.7 104.1 31.3 3.3 23.3 19.9 38.6 39.3 0.0 26.5 23.6 28.9 29.0 41.5 22.9 39.8 52.4 73.6 38.6 32.1 7.2 34.2 31.4 35.4 35.1 39.1 29.5 28.0 30.0 39.3 10.6 80.9 6.5 33.7 53.7 121.1 36.0 45.0 39.2 30.5 29.3 POLR2B RPB2 ENSG00000047315 "RNA polymerase II subunit B" P30876 4 56977722-57031168 "Enzymes, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037506 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA037506: AB_10672597" "unprognostic (9.88e-3)" "unprognostic (4.38e-2)" "unprognostic (1.83e-3)" "unprognostic (7.51e-2)" "unprognostic (2.30e-2)" "unprognostic (4.21e-3)" "unprognostic (1.24e-3)" "unprognostic (3.51e-1)" "unprognostic (6.39e-2)" "unprognostic (1.22e-1)" "unprognostic (1.23e-1)" "unprognostic (1.95e-1)" "prognostic favorable (7.17e-4)" "unprognostic (1.91e-1)" "unprognostic (1.51e-1)" "unprognostic (3.43e-1)" "unprognostic (7.35e-2)" 24.5 34.3 31.1 34.6 31.0 21.4 24.8 43.8 33.3 25.9 26.0 18.8 24.9 22.5 35.1 21.4 27.4 28.3 21.2 32.9 29.3 21.7 26.2 21.4 21.2 32.4 28.0 30.2 26.4 28.1 40.7 37.3 25.4 28.3 24.8 26.5 18.4 30.5 28.2 61.8 24.4 27.3 27.6 26.4 27.1 28.8 26.6 26.8 33.4 27.0 34.7 35.1 31.5 22.4 19.8 15.2 27.8 13.9 18.0 23.8 12.7 25.3 21.1 38.2 32.3 31.6 28.5 20.5 33.7 34.3 33.8 31.7 26.9 25.5 39.5 32.0 31.2 24.3 18.0 45.9 25.6 48.4 18.7 20.6 29.7 23.6 23.4 36.6 51.0 34.3 30.7 25.8 38.6 23.5 28.1 40.2 31.8 44.0 33.7 38.9 18.5 48.0 19.7 31.4 32.8 24.8 35.1 25.2 21.7 23.1 28.9 31.9 35.7 21.0 39.9 29.0 32.0 21.4 28.4 29.3 24.6 33.1 25.7 44.2 27.2 25.9 57.5 28.1 27.5 30.4 27.8 12.2 16.8 20.7 12.4 22.0 19.8 20.3 21.4 15.2 14.4 19.9 23.8 11.3 18.0 13.9 12.9 20.9 12.7 31.1 31.0 43.8 33.3 29.3 21.7 28.0 30.2 28.3 26.8 26.8 41.7 44.7 39.5 36.7 45.8 30.9 38.2 57.6 45.5 34.9 41.2 41.3 16.6 52.1 4.5 31.4 29.1 0.0 47.4 25.1 30.5 50.4 55.6 27.2 25.9 42.9 28.7 35.6 42.2 5.4 53.2 38.7 42.2 44.1 31.2 30.4 47.4 30.2 35.7 26.9 48.2 71.1 26.2 79.4 64.2 34.9 34.3 61.0 31.7 71.1 POLR2C RPB3 ENSG00000102978 "RNA polymerase II subunit C" P19387 16 57462387-57472010 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040919, HPA041826" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040919: AB_10795483, HPA041826: AB_10793935" "unprognostic (2.10e-2)" "unprognostic (4.42e-2)" "unprognostic (7.52e-3)" "unprognostic (1.82e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (1.48e-4)" "unprognostic (2.90e-1)" "unprognostic (9.54e-2)" "unprognostic (1.95e-1)" "unprognostic (2.48e-2)" "unprognostic (2.60e-2)" "unprognostic (6.63e-2)" "prognostic favorable (3.03e-6)" "unprognostic (2.29e-1)" "unprognostic (2.31e-2)" "unprognostic (1.20e-1)" "unprognostic (5.43e-3)" 26.2 30.1 24.2 18.4 26.9 23.9 25.8 34.1 37.6 27.2 22.9 28.8 23.1 21.5 26.0 45.0 26.2 30.3 29.9 32.6 24.5 25.9 38.3 44.8 29.9 30.2 25.0 30.1 37.2 39.4 33.7 35.0 29.2 25.5 29.2 26.0 29.6 30.4 31.4 47.5 23.7 27.9 26.1 24.1 22.4 25.2 26.4 21.9 30.5 35.8 27.3 27.1 27.5 22.2 21.8 16.2 41.7 19.8 26.2 28.6 21.9 17.7 29.4 24.6 22.3 22.3 20.1 21.9 23.5 25.6 37.7 24.9 37.6 22.6 20.1 27.6 25.8 22.9 18.7 32.5 24.7 42.0 9.2 24.2 15.4 17.6 42.8 25.3 27.9 29.7 18.0 20.4 28.7 26.6 20.6 22.7 27.5 26.7 11.4 24.6 24.5 30.9 29.6 36.9 21.4 44.8 45.1 29.2 35.6 30.5 17.6 31.3 36.5 38.0 21.3 24.6 24.2 16.2 25.8 17.5 23.8 24.3 18.1 26.7 26.3 22.5 40.9 24.0 24.1 31.4 24.8 17.3 29.0 20.7 16.4 22.6 21.8 23.6 19.1 16.2 20.9 28.6 26.8 41.7 26.2 19.8 13.2 22.5 21.9 24.2 26.9 34.1 37.6 24.5 25.9 25.0 30.1 25.5 21.9 23.8 34.7 45.5 39.7 27.5 84.3 9.7 33.1 28.1 14.8 26.2 53.0 65.7 77.9 47.3 3.0 36.0 36.6 0.0 57.8 72.3 37.6 40.0 61.0 18.5 36.7 49.3 36.7 22.1 18.6 6.6 47.8 21.9 38.8 64.9 27.6 87.9 46.7 36.8 48.8 96.7 87.2 45.3 39.2 40.2 65.5 26.2 77.7 42.4 33.6 35.9 POLR2D RBP4 ENSG00000144231 "RNA polymerase II subunit D" O15514 2 127843551-127858157 "Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 46.4" "Cell type enhanced" "Detected in all" 8 "Late spermatids: 142.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034694, HPA046092" Approved Supported "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA034694: AB_2674284, HPA046092: AB_10963049" "unprognostic (3.57e-2)" "unprognostic (3.76e-2)" "unprognostic (2.59e-1)" "unprognostic (2.54e-2)" "unprognostic (2.77e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (8.91e-4)" "unprognostic (2.51e-1)" "unprognostic (7.95e-3)" "unprognostic (2.64e-3)" "unprognostic (1.97e-1)" "unprognostic (2.51e-1)" "prognostic unfavorable (2.79e-4)" "unprognostic (3.66e-2)" "unprognostic (6.57e-2)" "unprognostic (1.17e-1)" "unprognostic (2.38e-1)" 8.2 9.4 8.1 8.9 9.1 17.9 7.9 9.3 12.6 6.9 7.7 12.3 6.9 6.3 7.5 6.2 9.8 7.7 7.6 7.3 7.8 6.3 6.3 13.5 7.2 11.8 9.9 7.5 10.3 17.4 7.4 9.4 10.2 8.7 7.2 9.9 7.3 7.6 6.5 21.9 8.9 7.8 9.8 8.8 11.1 7.8 46.4 9.9 16.7 6.3 9.1 16.8 8.0 7.2 16.7 20.6 11.4 22.1 16.7 21.0 14.3 18.4 12.1 22.5 15.7 8.4 9.2 18.1 17.7 8.4 21.4 19.2 27.3 15.3 28.7 15.3 11.9 12.2 9.8 32.3 15.3 33.2 16.8 17.6 28.4 12.1 25.0 9.8 30.4 15.8 6.5 11.5 28.5 16.4 5.9 13.9 21.1 39.5 25.8 12.2 14.7 30.2 13.8 31.5 19.4 14.0 29.1 23.8 25.9 7.1 12.7 14.0 18.7 11.9 14.8 14.9 17.6 16.6 21.1 14.0 18.6 26.2 10.5 20.4 30.5 49.4 51.7 16.2 15.2 18.2 5.7 15.8 11.4 19.4 21.5 18.1 16.7 15.6 16.9 20.6 15.1 21.0 17.8 5.0 16.7 22.1 13.5 13.9 14.3 8.1 9.1 9.3 12.6 7.8 6.3 9.9 7.5 8.7 9.9 3.0 9.4 14.9 17.2 9.6 14.8 9.0 10.2 8.1 12.5 12.2 7.9 26.9 10.0 17.6 54.9 9.5 7.0 23.3 15.2 23.1 10.3 13.9 18.4 14.9 19.4 31.8 8.1 9.2 9.1 142.9 16.4 11.5 8.5 25.2 10.6 11.8 13.4 10.5 17.3 8.7 12.9 12.9 14.1 61.1 55.3 8.8 22.3 13.8 13.4 14.0 POLR2E "hRPB25, hsRPB5, RPABC1, RPB5, XAP4" ENSG00000099817 "RNA polymerase II subunit E" P19388 19 1086579-1095380 "Predicted intracellular proteins, RNA polymerase related proteins" "Host-virus interaction, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "monocytes: 562.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063030, HPA068992" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA063030: AB_2684926, HPA068992: AB_2686065" "unprognostic (2.52e-1)" "unprognostic (3.73e-2)" "unprognostic (2.49e-1)" "unprognostic (1.51e-2)" "unprognostic (2.14e-1)" "unprognostic (6.42e-2)" "unprognostic (2.59e-3)" "unprognostic (1.60e-1)" "unprognostic (2.08e-1)" "unprognostic (2.05e-1)" "unprognostic (2.03e-3)" "unprognostic (3.03e-2)" "prognostic favorable (3.21e-6)" "unprognostic (3.22e-1)" "unprognostic (1.47e-1)" "unprognostic (1.72e-3)" "unprognostic (4.77e-2)" 41.4 26.2 29.6 22.8 27.9 19.8 27.6 19.0 36.9 20.1 26.5 18.6 18.4 20.1 21.4 22.6 34.1 26.3 25.8 27.6 29.6 26.3 34.0 57.9 25.1 25.1 30.1 22.6 22.0 21.0 39.7 13.0 26.4 33.4 24.3 29.5 20.3 17.9 18.9 33.2 23.7 26.9 25.7 22.1 23.1 21.5 29.3 15.5 31.9 30.6 21.1 36.7 22.1 20.6 12.8 28.2 17.9 30.4 16.7 17.5 20.9 14.3 13.3 18.7 14.9 25.7 16.0 8.7 10.7 14.8 17.6 10.4 15.6 5.3 12.1 4.8 31.5 2.7 11.7 35.0 11.7 33.0 12.5 10.6 15.8 16.5 14.3 10.2 23.1 11.9 11.7 7.7 12.3 23.4 18.4 16.2 6.4 17.7 13.8 19.8 11.9 12.7 7.2 15.0 10.4 10.2 13.6 18.5 11.5 18.1 16.7 9.5 10.8 17.8 12.4 7.4 17.5 13.1 10.8 22.0 8.9 9.9 16.2 12.3 21.3 28.4 21.0 14.7 15.0 10.2 12.1 30.4 17.9 16.4 20.5 17.5 11.7 15.5 17.2 28.2 12.8 12.4 12.7 16.1 16.7 22.2 19.6 14.7 20.9 29.6 27.9 19.0 36.9 29.6 26.3 30.1 22.6 33.4 15.5 29.8 62.4 90.1 75.3 92.6 50.5 67.4 50.9 58.9 45.5 52.4 39.3 221.3 147.6 142.7 13.0 69.6 118.5 23.3 122.2 211.1 104.5 73.3 70.3 80.1 223.7 52.4 67.8 65.7 94.1 29.8 64.2 133.4 94.5 562.7 71.8 57.9 139.5 77.7 58.4 154.9 42.3 25.8 93.9 81.4 85.2 95.9 196.2 79.8 97.1 90.4 POLR2F "HRBP14.4, RPB6" ENSG00000100142 "RNA polymerase II subunit F" P61218 22 37952607-38041915 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in single" "melanoma: 1.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000827, CAB009882" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "CAB009882: AB_2299942, HPA000827: AB_1079834" "unprognostic (8.27e-2)" "unprognostic (7.50e-2)" "unprognostic (1.51e-3)" "unprognostic (1.43e-2)" "unprognostic (1.12e-1)" "unprognostic (1.35e-1)" "unprognostic (2.09e-1)" "unprognostic (2.73e-3)" "unprognostic (2.85e-1)" "unprognostic (5.87e-2)" "unprognostic (4.06e-1)" "unprognostic (1.40e-3)" "unprognostic (1.11e-4)" "unprognostic (9.08e-2)" "unprognostic (1.01e-1)" "unprognostic (2.90e-1)" "unprognostic (7.86e-2)" 31.7 31.4 37.5 23.4 43.8 23.0 28.2 32.6 54.5 25.2 27.8 57.3 20.4 26.3 24.2 18.7 24.6 23.2 20.3 37.8 33.5 31.2 25.1 58.5 17.9 19.8 44.8 44.1 30.2 26.1 43.5 28.8 21.2 38.4 21.4 21.0 21.0 38.0 29.6 67.9 19.0 25.7 20.8 39.6 16.8 26.9 21.9 48.3 13.1 28.5 23.4 18.0 19.0 26.8 36.1 49.5 52.4 36.7 40.1 38.5 29.3 34.3 40.7 28.8 30.7 34.6 20.3 25.7 32.3 18.9 33.1 31.2 47.2 12.2 26.6 23.3 27.9 33.2 24.8 39.6 31.2 16.4 32.5 66.9 24.8 41.9 64.0 30.2 48.3 15.9 26.9 23.7 44.7 17.3 17.2 28.3 29.7 47.3 22.5 24.0 48.9 37.5 58.3 41.4 40.0 31.0 37.4 26.4 31.0 18.2 21.4 43.3 16.2 29.7 21.3 46.5 17.5 14.9 33.5 25.9 29.2 41.5 36.1 36.4 25.3 39.2 55.5 29.7 24.6 32.8 34.5 36.7 52.4 34.3 33.3 32.1 36.1 30.0 33.2 33.4 28.9 27.3 27.2 46.2 40.1 28.1 49.5 38.5 29.3 37.5 43.8 32.6 42.7 33.5 31.2 44.8 44.1 38.4 48.3 35.7 81.8 93.0 98.8 181.6 23.8 0.2 117.2 73.6 56.9 115.1 23.6 207.5 164.2 148.0 67.2 91.8 136.4 46.7 138.2 263.3 141.6 91.0 88.8 237.4 154.9 27.0 112.4 95.2 90.9 30.1 147.9 85.4 214.2 119.0 111.6 70.5 150.4 114.3 142.1 213.7 31.1 155.2 124.9 159.7 214.2 196.1 177.2 87.1 119.2 105.4 POLR2G "hRPB19, hsRPB7, RPB7" ENSG00000168002 "RNA polymerase II subunit G" P62487 11 62761544-62766710 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053000 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA053000: AB_2682010" "unprognostic (7.58e-3)" "unprognostic (2.75e-1)" "unprognostic (2.37e-2)" "prognostic favorable (8.23e-4)" "unprognostic (1.39e-1)" "unprognostic (2.16e-2)" "prognostic unfavorable (6.02e-5)" "unprognostic (8.50e-2)" "unprognostic (6.01e-2)" "unprognostic (6.26e-3)" "unprognostic (9.41e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (1.11e-4)" "unprognostic (1.53e-1)" "unprognostic (1.64e-1)" "unprognostic (2.46e-1)" "unprognostic (2.21e-1)" 27.9 34.6 39.4 28.7 37.7 29.4 37.2 18.6 33.5 28.0 25.4 39.9 25.0 17.3 27.0 44.0 27.4 32.3 25.2 25.0 35.0 27.7 30.6 32.1 29.8 47.5 41.4 27.6 28.1 29.0 29.6 20.4 29.0 30.7 28.3 32.9 31.4 22.3 27.2 18.9 27.5 19.5 32.6 45.4 30.7 22.6 18.7 33.6 47.7 28.2 26.3 49.2 25.4 23.2 48.9 61.3 51.5 54.1 46.4 47.4 64.6 25.3 45.3 48.9 30.6 25.6 24.9 12.1 18.0 22.9 43.5 34.6 27.4 29.6 36.9 42.0 27.4 19.2 24.9 22.2 34.0 38.8 70.3 27.9 24.3 36.1 32.1 36.0 32.3 22.3 24.3 34.5 20.2 41.2 23.3 33.9 34.7 30.4 24.4 30.8 79.7 46.8 42.5 30.3 27.3 46.4 38.5 44.8 48.4 32.1 21.7 20.5 34.7 30.8 23.5 45.0 19.4 67.6 27.9 13.4 21.9 23.6 42.5 20.9 19.2 35.5 40.2 22.3 20.7 28.9 46.9 49.0 51.5 45.2 51.7 43.5 48.5 39.0 43.9 57.6 48.9 37.1 45.7 21.6 46.4 54.1 61.3 47.4 64.6 39.4 37.7 18.6 33.5 35.0 27.7 41.4 27.6 30.7 33.6 35.7 53.8 83.6 47.8 40.0 39.2 42.0 71.4 26.8 27.3 73.3 7.9 194.5 119.3 105.3 6.0 64.2 28.4 0.0 97.0 114.7 79.8 30.5 88.8 64.4 164.9 36.5 56.2 66.3 73.0 11.5 65.6 81.3 84.4 189.4 51.6 114.6 76.4 55.7 58.4 119.9 42.6 77.6 50.4 42.6 40.8 52.8 116.3 115.1 66.7 30.2 POLR2H RPB8 ENSG00000163882 "RNA polymerase II subunit H" P52434 3 184361718-184368596 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037745, HPA055813" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA037745: AB_10672914, HPA055813: AB_2797254" "unprognostic (3.21e-1)" "unprognostic (4.96e-3)" "unprognostic (3.61e-3)" "unprognostic (7.15e-2)" "unprognostic (1.17e-2)" "unprognostic (6.72e-2)" "prognostic unfavorable (2.01e-4)" "unprognostic (8.82e-3)" "unprognostic (2.84e-1)" "unprognostic (4.02e-3)" "unprognostic (4.24e-2)" "unprognostic (1.27e-3)" "prognostic unfavorable (1.65e-10)" "unprognostic (1.34e-1)" "unprognostic (4.01e-1)" "unprognostic (1.71e-1)" "unprognostic (2.93e-3)" 18.1 32.6 19.6 19.2 17.5 14.8 24.5 24.2 24.6 28.8 29.9 13.8 19.8 32.0 19.9 23.5 26.7 23.1 26.7 16.3 17.8 16.3 34.1 41.0 17.8 21.7 16.4 17.0 21.8 46.4 15.8 20.7 27.2 17.0 19.2 33.6 19.7 26.0 17.0 19.9 20.7 38.8 20.0 13.2 21.5 25.6 20.6 12.5 28.1 29.7 23.1 26.3 18.5 16.2 17.4 18.2 7.7 15.3 14.6 26.6 11.5 49.5 17.4 18.8 27.8 21.0 14.9 23.4 18.7 19.7 25.7 33.1 44.5 23.8 28.1 47.0 14.6 39.1 20.1 33.6 33.6 22.9 27.4 44.4 26.9 20.5 27.8 19.0 28.3 15.7 19.2 19.2 16.7 30.3 23.1 26.5 28.2 20.7 18.6 20.3 58.8 27.9 37.9 20.4 62.1 36.4 16.4 17.3 38.0 30.5 22.5 28.5 20.3 15.8 49.1 27.2 19.0 61.4 22.8 13.8 12.2 19.4 16.3 49.8 37.5 38.8 52.5 19.4 30.3 16.3 3.4 9.6 7.7 15.2 15.3 18.4 17.4 18.0 16.2 18.0 16.4 26.6 19.7 0.7 14.6 9.6 18.2 18.7 11.5 19.6 17.5 24.2 24.6 17.8 16.3 16.4 17.0 17.0 12.5 35.7 40.3 38.7 63.2 100.7 21.3 13.7 53.5 36.1 31.8 41.8 15.7 88.4 119.3 59.7 14.9 50.9 83.1 0.0 78.5 122.8 54.6 65.8 31.1 57.8 53.4 23.8 53.5 32.5 21.4 9.6 42.6 31.5 49.0 30.7 62.9 23.6 80.3 69.9 26.2 102.6 23.4 38.8 60.4 72.4 110.1 64.7 102.3 28.8 72.3 83.9 POLR2I "hRPB14.5, RPB9" ENSG00000105258 "RNA polymerase II subunit I" P36954 19 36113710-36115346 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 10 "Early spermatids: 926.9;Late spermatids: 1719.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035632, HPA045156" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035632: AB_2674711, HPA045156: AB_10964748" "unprognostic (1.95e-2)" "unprognostic (7.88e-3)" "unprognostic (3.54e-1)" "unprognostic (7.41e-3)" "unprognostic (2.05e-1)" "unprognostic (3.01e-1)" "unprognostic (1.24e-2)" "unprognostic (4.12e-2)" "unprognostic (7.39e-2)" "unprognostic (4.69e-3)" "unprognostic (2.86e-2)" "unprognostic (8.16e-2)" "unprognostic (1.83e-1)" "unprognostic (3.36e-2)" "unprognostic (3.84e-3)" "unprognostic (1.08e-1)" "unprognostic (1.16e-1)" 9.6 10.7 27.4 6.1 26.7 10.7 14.3 17.5 29.3 15.1 12.4 24.5 9.8 12.4 9.2 10.7 11.5 18.2 10.4 21.6 25.8 23.7 10.7 19.8 8.6 10.1 29.0 17.1 14.0 25.9 9.7 14.0 8.3 16.2 10.9 6.6 7.4 18.4 18.5 30.3 14.8 7.1 9.4 37.8 10.3 11.4 26.8 16.6 9.7 11.4 15.9 9.3 8.3 7.9 13.5 22.0 6.9 10.2 9.2 13.7 10.3 7.4 23.6 4.0 4.1 2.9 2.4 8.9 6.7 3.6 9.5 5.4 14.6 5.4 15.9 13.9 2.4 3.5 4.9 6.6 9.7 2.0 14.5 24.7 18.2 6.9 11.1 6.8 15.3 7.8 3.6 5.4 5.4 5.6 2.8 4.2 8.9 11.4 7.1 3.0 21.2 8.0 16.4 9.2 22.7 20.4 14.6 5.9 10.4 7.6 4.5 25.8 14.7 7.8 14.0 4.0 3.0 6.7 5.1 4.1 6.4 11.0 4.2 9.0 6.7 13.0 11.2 8.7 9.9 6.8 6.9 10.2 5.9 9.0 7.2 11.8 13.5 11.2 12.3 13.2 13.3 13.7 12.7 0.6 9.2 8.7 22.0 10.7 10.3 27.4 26.7 17.5 29.1 25.8 23.7 29.0 17.1 16.2 16.6 77.4 63.0 61.4 82.8 70.2 62.0 215.0 145.2 326.6 109.2 155.3 23.6 129.0 298.4 131.5 926.9 106.7 149.5 140.2 208.3 142.1 97.5 103.1 80.8 234.2 108.6 31.8 101.9 92.7 71.3 1719.1 128.9 73.2 160.3 125.4 134.4 86.3 165.9 201.5 144.9 353.5 48.4 109.9 114.1 313.9 161.1 95.2 86.8 65.0 140.6 77.0 POLR2J "hRPB14, POLR2J1, RPB11, RPB11A, RPB11m" ENSG00000005075 "RNA polymerase II subunit J" P52435 7 102473118-102478907 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046970 Approved Nucleoplasm NA NA Nucleoplasm "HPA046970: AB_2679882" "unprognostic (1.11e-1)" "unprognostic (1.24e-2)" "unprognostic (1.46e-2)" "unprognostic (1.62e-1)" "unprognostic (1.90e-2)" "unprognostic (4.80e-2)" "unprognostic (6.47e-2)" "unprognostic (4.26e-2)" "unprognostic (3.46e-1)" "unprognostic (1.53e-3)" "unprognostic (4.46e-2)" "unprognostic (7.32e-2)" "unprognostic (7.13e-2)" "unprognostic (2.45e-1)" "unprognostic (4.23e-2)" "unprognostic (1.37e-1)" "unprognostic (2.19e-2)" 19.0 28.1 30.9 16.5 28.9 37.0 52.2 17.9 27.6 20.0 20.6 15.1 22.7 22.2 16.3 27.9 20.0 19.6 27.9 65.7 26.1 25.1 21.0 40.9 21.2 31.9 28.5 17.8 21.7 50.2 16.0 23.4 15.6 22.3 18.4 16.7 19.4 28.2 23.9 75.9 19.1 24.3 28.1 35.9 18.6 20.7 18.1 23.1 20.8 24.9 38.8 18.6 19.9 18.3 42.8 42.3 63.4 40.1 25.5 44.8 38.1 31.5 32.3 22.2 29.2 21.1 16.3 16.3 17.5 18.8 25.8 22.0 29.3 24.7 14.6 33.9 24.4 37.2 17.0 20.5 21.6 15.9 27.2 36.6 14.6 23.2 28.3 25.8 28.2 21.9 21.2 27.1 23.1 13.0 16.9 23.0 31.4 34.1 43.7 21.1 97.3 46.3 50.4 20.5 31.5 41.7 22.1 21.8 43.0 20.6 21.0 18.9 31.5 21.1 40.4 24.9 23.6 18.1 34.6 18.5 29.2 37.2 45.7 34.2 27.0 39.2 37.8 26.0 35.2 33.9 48.3 40.1 63.4 32.1 39.1 30.4 42.8 34.5 35.6 31.3 37.6 29.8 30.0 58.5 25.5 35.5 42.3 44.8 38.1 30.9 28.9 17.9 27.6 26.1 25.1 28.5 17.8 22.3 23.1 32.8 37.7 101.2 100.0 84.3 36.9 165.4 71.4 69.6 36.4 118.7 11.8 175.6 232.1 122.3 40.3 90.9 189.8 140.2 173.5 165.1 101.3 117.4 42.7 165.1 176.1 33.4 98.9 85.3 97.5 33.8 117.6 117.2 135.0 153.3 115.9 97.7 155.7 164.9 104.0 180.9 34.8 51.8 107.2 95.4 243.8 101.5 152.3 76.2 104.4 130.5 POLR2J2 RPB11b1 ENSG00000228049 "RNA polymerase II subunit J2" Q9GZM3 7 102665368-102671629 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 32.6" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 23.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 18.1;RT4: 13.0;U-2 OS: 12.8" HPA046970 Approved Nucleoplasm NA NA Nucleoplasm "HPA046970: AB_2679882" 3.8 3.9 12.0 9.5 10.0 5.4 6.6 10.6 32.6 7.2 4.6 6.5 3.4 7.9 6.9 6.5 4.8 4.6 7.4 4.3 12.5 5.5 5.8 6.1 6.1 7.8 10.1 7.7 9.0 3.7 3.2 6.1 5.7 7.8 4.6 5.2 4.5 11.2 3.4 11.9 9.9 10.3 9.8 9.3 7.5 6.6 3.5 6.2 4.2 5.8 1.3 11.0 4.7 5.1 7.9 6.0 11.3 4.0 2.9 6.5 1.3 2.5 2.2 1.5 1.9 3.4 4.8 3.0 2.8 0.6 1.7 1.8 1.6 5.1 2.6 0.5 1.9 1.0 2.4 1.1 0.7 4.3 1.8 3.0 1.4 3.1 1.0 1.5 6.1 2.8 0.9 0.5 1.3 2.4 0.8 0.6 1.6 2.6 6.6 1.3 1.0 18.1 1.8 1.1 0.9 0.6 2.3 0.4 2.4 1.0 13.0 1.4 1.7 2.4 1.3 1.1 2.4 0.8 1.0 1.0 3.9 12.8 0.6 2.1 2.9 2.1 2.3 1.6 2.7 1.3 11.3 4.0 2.9 5.9 2.3 3.9 5.5 6.0 4.2 1.9 7.9 6.5 5.0 3.2 2.9 3.6 6.0 3.5 1.3 12.0 10.0 10.6 32.6 12.5 5.5 10.1 7.7 7.8 6.2 6.0 1.6 10.0 3.2 1.4 6.1 0.0 2.5 4.0 1.2 8.7 9.8 6.1 5.0 2.9 0.0 3.1 2.9 23.3 0.7 3.5 2.4 2.0 1.1 1.7 3.2 4.8 3.5 5.5 3.2 0.0 8.3 3.8 0.0 8.2 1.9 1.3 1.5 0.0 3.2 2.9 4.1 0.0 2.2 8.6 10.7 1.1 6.5 4.3 2.3 2.7 POLR2J3 ENSG00000168255 "RNA polymerase II subunit J3" 7 102537918-102572653 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 12.3" "Group enriched" "Detected in some" 635 "Cytotrophoblasts: 71.6;Extravillous trophoblasts: 52.6;Hofbauer cells: 37.9;Syncytiotrophoblasts: 92.0" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 21.5" "HPA011403, HPA046970" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA011403: AB_2668503, HPA046970: AB_2679882" "unprognostic (3.55e-2)" "unprognostic (2.04e-4)" "unprognostic (4.55e-3)" "unprognostic (5.85e-2)" "unprognostic (1.71e-1)" "unprognostic (9.26e-2)" "unprognostic (2.63e-2)" "unprognostic (1.44e-2)" "unprognostic (7.12e-3)" "unprognostic (1.23e-1)" "unprognostic (2.41e-2)" "unprognostic (1.00e-1)" "unprognostic (5.90e-4)" "unprognostic (3.04e-1)" "unprognostic (7.43e-2)" "unprognostic (1.07e-1)" "unprognostic (1.04e-2)" 2.8 3.0 0.9 1.7 1.4 2.3 1.9 4.0 4.7 3.1 2.4 3.6 4.5 0.1 2.3 4.9 0.3 1.3 1.1 1.1 2.2 2.8 2.2 1.0 1.5 4.5 1.7 2.9 2.3 1.7 2.5 2.1 4.1 0.2 1.0 5.0 3.5 1.8 1.6 3.9 2.2 0.8 4.0 3.5 4.1 2.2 4.9 5.9 12.3 5.6 4.4 4.4 3.4 8.5 4.1 1.7 0.1 0.2 0.7 0.7 5.1 1.5 3.3 3.8 3.2 2.4 1.2 0.3 0.0 4.8 4.1 2.7 2.1 3.6 21.5 4.7 2.4 3.2 1.0 0.9 3.0 2.2 0.3 1.8 1.7 1.7 6.5 5.2 2.1 2.7 1.5 0.5 6.9 7.5 0.4 0.0 3.0 5.2 0.3 2.9 2.0 0.8 1.1 1.7 0.3 9.4 0.9 5.0 2.1 0.0 1.4 4.2 3.1 8.3 0.0 1.3 0.2 0.6 3.6 5.2 2.4 3.4 9.0 5.6 7.8 3.3 2.0 1.7 4.7 3.1 4.4 5.9 4.9 3.8 3.6 12.3 4.4 3.5 4.3 4.2 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.6 0.0 0.0 0.0 0.0 37.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.0 0.0 0.0 0.0 POLR2J3 ENSG00000285437 "RNA polymerase II subunit J3" 7 102562133-102572583 "Predicted intracellular proteins, RNA polymerase related proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 29.2;skeletal muscle: 14.6" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 246.4;Cone photoreceptor cells: 333.8;Rod photoreceptor cells: 291.4" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA046970 Approved Nucleoplasm NA NA Nucleoplasm "HPA046970: AB_2679882" 0.5 2.3 1.9 5.5 1.3 5.7 0.0 3.9 2.0 2.7 3.7 1.7 0.0 0.5 0.0 2.9 2.7 0.5 1.9 1.3 0.3 0.0 0.5 0.5 2.0 0.0 0.6 14.6 2.0 1.6 0.0 2.1 1.6 1.2 0.5 1.1 0.5 22.4 26.8 29.2 25.2 16.5 23.5 14.4 14.4 1.8 20.7 18.4 1.1 4.3 7.8 20.3 0.7 4.4 1.3 6.8 11.5 6.7 10.1 3.5 10.7 8.9 2.7 4.8 13.4 0.9 3.1 15.4 26.1 20.2 2.9 25.7 15.2 4.7 6.0 2.4 1.8 12.0 5.9 12.3 13.3 39.1 1.9 7.3 36.5 11.4 6.2 18.4 0.5 17.1 18.6 19.3 5.8 18.4 9.9 14.8 16.1 16.2 14.2 24.5 6.2 14.8 6.5 27.6 12.5 24.2 16.3 17.6 25.9 40.6 15.4 18.1 16.6 26.8 19.9 29.2 17.7 18.0 16.1 22.4 23.5 20.0 17.9 20.2 20.4 19.5 21.1 16.5 25.2 26.8 21.8 14.4 6.0 1.6 68.9 89.5 10.9 246.4 14.3 89.2 9.4 5.7 7.0 333.8 0.0 1.7 0.3 6.1 20.5 47.8 23.3 0.3 0.0 14.6 61.1 13.8 37.1 0.0 168.5 56.1 102.5 57.8 5.0 84.0 10.8 23.6 1.8 38.2 55.9 0.9 59.6 48.4 2.2 291.4 25.8 24.7 93.1 107.3 12.9 0.0 90.0 43.8 82.1 POLR2L "hRPB7.6, hsRPB10b, RBP10, RPABC5, RPB10beta, RPB7.6" ENSG00000177700 "RNA polymerase II subunit L" P62875 11 837356-842545 "Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 87.6;PC-3: 112.2" "Low region specificity" "Detected in all" HPA073614 Supported Nucleoplasm NA NA Nucleoplasm "HPA073614: " "unprognostic (2.65e-2)" "unprognostic (6.56e-3)" "unprognostic (1.40e-1)" "unprognostic (5.71e-2)" "unprognostic (3.49e-2)" "unprognostic (3.46e-2)" "prognostic unfavorable (2.37e-4)" "unprognostic (6.17e-3)" "unprognostic (1.34e-1)" "unprognostic (7.51e-3)" "unprognostic (2.37e-2)" "unprognostic (6.77e-2)" "prognostic favorable (5.56e-4)" "unprognostic (3.60e-2)" "unprognostic (1.32e-1)" "unprognostic (4.03e-3)" "unprognostic (1.73e-1)" 42.9 27.7 22.4 18.4 18.3 16.9 63.3 10.1 18.8 16.6 28.3 9.9 29.7 18.7 14.1 23.8 37.5 15.0 28.5 86.7 19.2 17.3 32.9 43.3 26.3 21.2 18.8 10.7 16.6 88.3 14.8 21.1 21.0 12.5 19.3 11.5 23.0 41.6 35.4 44.8 17.3 18.9 21.5 13.5 19.2 17.1 18.3 9.3 18.7 37.9 41.8 15.7 17.6 21.0 28.6 52.3 43.0 44.1 41.7 38.6 42.2 16.0 87.6 8.3 10.3 23.9 17.4 7.5 20.7 14.5 20.5 13.7 25.6 15.0 10.1 5.7 25.7 17.4 10.8 12.3 24.8 6.5 9.3 60.4 9.6 26.1 32.3 14.2 9.2 7.8 28.6 11.2 11.6 5.8 12.5 16.2 10.7 10.2 11.2 24.1 40.5 9.3 9.7 13.0 18.7 112.2 9.1 6.7 15.4 24.7 12.4 16.8 5.3 20.6 21.2 15.9 4.7 12.7 5.5 18.0 13.9 11.0 7.6 12.8 6.8 7.8 9.8 21.0 9.1 12.2 26.4 44.1 43.0 36.1 38.4 38.6 28.6 34.4 35.7 41.7 26.0 29.5 35.6 11.5 41.7 25.9 52.3 33.0 42.2 22.4 18.3 10.1 18.8 19.2 17.3 18.8 10.7 12.5 9.3 381.2 358.3 236.7 203.3 543.4 62.5 432.3 639.5 250.3 323.0 499.0 23.6 587.7 1090.9 434.7 67.7 336.6 720.6 350.4 588.2 345.4 532.7 243.7 259.8 1459.1 606.2 47.7 482.2 661.1 436.0 177.8 283.0 301.5 624.2 530.2 452.3 186.9 631.2 462.9 239.7 1293.9 56.1 155.2 446.5 174.7 248.7 608.9 376.0 284.4 422.8 251.0 POLR2M "GCOM1, Gdown, Gdown1, GRINL1A" ENSG00000255529 "RNA polymerase II subunit M" "P0CAP2, Q6EEV4" 15 57706629-57782762 "Predicted intracellular proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068141 Approved Nucleoplasm NA NA Nucleoplasm "HPA068141: AB_2685962" "unprognostic (3.07e-1)" "unprognostic (1.08e-1)" "unprognostic (2.63e-1)" "unprognostic (3.73e-1)" "unprognostic (1.11e-2)" "unprognostic (1.38e-1)" "unprognostic (9.80e-2)" "unprognostic (7.30e-2)" "unprognostic (4.30e-2)" "unprognostic (9.25e-2)" "unprognostic (2.81e-1)" "unprognostic (3.56e-2)" "unprognostic (6.61e-2)" "unprognostic (1.39e-1)" "unprognostic (3.25e-2)" "unprognostic (2.43e-1)" "unprognostic (1.07e-1)" 17.0 16.3 22.9 8.5 26.5 25.2 33.5 15.3 25.1 18.1 11.5 21.0 14.0 9.6 28.0 15.5 12.1 16.1 13.1 22.2 22.7 21.9 15.8 12.0 14.7 19.5 29.9 15.8 27.0 14.8 23.6 12.3 14.4 19.7 21.1 11.5 19.2 12.6 20.5 25.3 11.8 9.6 21.5 25.0 13.2 10.2 10.8 24.0 11.7 19.0 7.1 12.5 18.9 15.1 15.2 14.3 16.2 13.9 22.4 19.5 13.5 9.4 15.9 11.2 28.1 19.6 20.5 10.6 15.7 24.8 16.5 15.7 11.7 7.2 15.2 15.8 10.7 13.7 15.8 12.5 11.8 22.1 15.8 8.5 18.4 12.5 7.4 21.6 17.0 17.6 18.3 19.2 9.3 27.0 18.6 12.7 16.4 18.6 13.3 13.9 6.0 15.4 10.8 18.2 13.0 8.1 15.3 24.8 11.5 12.4 9.5 8.3 14.5 12.0 12.2 18.4 15.3 14.0 24.2 11.6 24.9 20.9 37.3 18.4 15.3 15.7 20.1 15.0 25.5 17.4 16.2 13.9 15.4 15.8 13.5 19.4 15.2 17.2 16.1 14.3 14.7 19.5 17.2 1.6 22.4 11.1 9.9 18.9 13.5 22.9 26.5 15.3 25.1 22.7 21.9 29.9 15.8 19.7 24.0 20.8 7.8 22.9 18.9 14.9 13.6 24.3 10.2 13.4 14.8 24.4 3.9 10.8 21.6 11.0 32.2 19.0 10.3 0.0 13.2 15.2 21.1 25.2 11.6 11.6 15.8 11.1 22.4 17.8 17.8 9.0 20.4 15.3 23.6 13.6 17.7 17.1 17.6 14.0 26.5 13.3 6.5 19.4 28.8 17.9 21.4 12.5 10.1 27.4 19.2 14.5 POLR3A "hRPC155, RPC1, RPC155" ENSG00000148606 "RNA polymerase III subunit A" O14802 10 77969251-78029545 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Nucleotidyltransferase, Transferase" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 60.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 40.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037926 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA037926: AB_10672400" "unprognostic (6.83e-2)" "unprognostic (3.41e-2)" "unprognostic (4.54e-2)" "unprognostic (2.76e-2)" "unprognostic (6.41e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (3.64e-6)" "unprognostic (3.25e-1)" "unprognostic (1.07e-1)" "unprognostic (1.73e-1)" "unprognostic (6.64e-2)" "unprognostic (2.09e-2)" "unprognostic (1.51e-2)" "unprognostic (1.34e-1)" "unprognostic (3.19e-1)" "unprognostic (1.30e-1)" "unprognostic (4.11e-2)" 7.1 10.2 10.3 8.3 21.7 5.9 10.6 22.2 29.7 9.2 8.1 12.8 7.4 8.6 9.4 13.3 8.6 8.5 7.4 7.4 9.4 9.6 9.3 9.3 6.8 8.7 8.1 11.0 11.5 10.7 13.8 17.3 10.1 20.4 10.2 10.7 10.4 8.6 8.2 17.6 11.2 7.8 9.7 6.6 8.9 8.2 11.7 9.8 12.6 9.6 4.4 13.4 7.9 8.0 7.5 5.4 8.0 6.4 6.5 8.8 3.6 7.4 8.9 9.5 15.7 6.3 8.0 6.3 8.6 11.2 11.1 11.0 11.7 5.4 9.3 5.3 7.4 6.3 8.8 16.4 9.4 13.6 6.8 12.0 7.5 7.1 14.4 5.9 12.8 6.3 6.8 6.8 19.7 18.3 10.7 9.7 7.6 13.8 5.8 10.7 5.6 9.6 8.1 10.3 6.1 40.8 9.2 6.0 6.0 5.6 4.9 8.7 11.0 8.2 15.4 8.8 8.9 11.4 6.7 10.6 7.2 7.0 7.7 17.0 9.0 9.5 11.3 12.8 13.5 3.5 8.0 5.2 2.9 7.8 6.4 7.6 5.6 6.0 7.2 4.8 7.5 5.7 6.6 3.3 6.5 5.4 5.4 8.8 3.6 10.3 21.7 22.2 29.7 9.4 9.6 8.1 11.0 20.4 9.8 0.0 7.8 6.1 4.6 8.9 27.0 10.4 7.6 14.7 12.5 0.0 60.9 6.7 1.7 5.4 1.2 7.3 6.3 0.0 5.3 5.6 5.7 3.5 5.8 9.2 4.8 14.3 6.9 6.2 5.7 0.0 12.0 4.5 1.7 3.6 9.8 15.5 7.1 7.0 7.8 3.8 32.8 6.5 6.6 10.9 17.0 8.0 3.4 4.9 8.6 3.2 POLR3C "RPC3, RPC62" ENSG00000186141 "RNA polymerase III subunit C" Q9BUI4 1 145824088-145842505 "Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 15 "Early spermatids: 260.3;Late spermatids: 416.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027508, HPA027516" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA027508: AB_10600091, HPA027516: AB_10600894" "unprognostic (1.43e-2)" "unprognostic (1.70e-2)" "unprognostic (2.97e-2)" "prognostic unfavorable (1.56e-4)" "unprognostic (6.87e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (5.48e-4)" "unprognostic (2.51e-1)" "prognostic unfavorable (1.50e-4)" "unprognostic (1.13e-1)" "unprognostic (1.41e-2)" "unprognostic (4.46e-1)" "prognostic unfavorable (1.85e-5)" "unprognostic (2.34e-1)" "unprognostic (4.95e-2)" "unprognostic (1.07e-2)" "unprognostic (1.38e-1)" 21.1 11.9 13.5 21.2 13.4 16.9 21.7 28.3 16.4 18.0 14.2 12.2 11.1 9.4 19.2 16.2 15.1 16.9 14.6 12.7 12.1 9.9 15.7 15.3 13.3 25.4 14.7 15.8 21.9 23.1 16.7 10.9 13.9 12.6 15.7 15.9 11.9 16.9 13.0 18.3 20.3 14.9 17.5 11.0 20.5 14.9 29.3 15.0 26.5 15.9 11.4 21.3 17.5 15.8 21.1 23.6 29.5 23.9 20.6 20.7 15.9 16.1 13.4 11.2 9.2 14.7 18.0 11.9 15.3 18.8 21.8 20.9 19.3 8.7 27.9 15.5 20.9 11.9 16.0 18.1 16.3 22.7 11.4 14.2 14.9 15.7 11.5 26.6 30.6 19.3 17.1 12.0 24.4 43.5 12.5 13.5 13.4 18.7 16.5 23.0 22.4 15.8 13.9 16.0 16.9 18.0 14.9 14.0 18.3 14.2 11.6 10.4 15.7 13.7 20.2 20.7 18.5 15.5 28.6 14.1 19.2 15.3 10.4 21.3 25.8 25.0 32.4 7.0 15.9 14.8 29.5 20.9 21.1 15.9 23.9 20.7 20.1 17.6 16.4 22.0 21.1 18.0 16.4 1.7 20.6 17.3 23.6 14.9 15.9 13.5 13.4 28.3 16.4 12.1 9.9 14.7 15.8 12.6 15.0 6.0 9.6 9.0 6.7 4.4 3.1 15.7 5.1 8.1 10.3 3.5 3.9 9.9 10.0 9.4 260.3 6.8 4.7 23.3 18.5 10.2 9.0 4.8 8.1 4.5 12.4 1.6 4.1 7.4 9.7 416.7 9.5 9.1 1.7 11.8 6.5 3.6 14.3 7.0 13.8 10.2 3.7 19.4 11.3 18.9 17.0 3.8 8.0 8.7 7.3 8.1 POLR3D "BN51T, RPC4, TSBN51" ENSG00000168495 "RNA polymerase III subunit D" P05423 8 22245104-22254600 "Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061331, HPA067875, HPA068461, HPA069089" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA061331: AB_2684480, HPA067875: AB_2685912, HPA068461: AB_2685993, HPA069089: AB_2686081" "unprognostic (2.33e-1)" "unprognostic (2.27e-1)" "unprognostic (9.38e-3)" "unprognostic (9.33e-3)" "unprognostic (1.24e-1)" "unprognostic (8.02e-2)" "prognostic unfavorable (1.21e-4)" "unprognostic (2.02e-1)" "unprognostic (2.19e-2)" "unprognostic (3.27e-1)" "unprognostic (8.03e-2)" "unprognostic (2.20e-1)" "prognostic unfavorable (9.15e-6)" "unprognostic (1.15e-1)" "unprognostic (3.13e-1)" "unprognostic (6.93e-2)" "prognostic unfavorable (2.12e-4)" 14.7 12.9 10.3 14.0 13.6 9.8 18.4 8.8 15.7 13.9 11.9 13.9 8.2 9.3 14.3 9.3 16.5 11.9 13.9 16.6 10.0 8.3 11.7 11.2 12.7 13.4 16.5 13.7 18.1 20.8 10.5 16.3 20.2 13.2 14.5 11.9 9.7 14.5 11.2 34.4 11.9 9.6 17.5 13.5 13.2 12.2 29.4 12.0 8.0 12.6 10.8 13.1 14.7 15.9 9.1 13.6 1.6 5.7 11.2 10.7 5.3 6.7 20.2 11.0 12.4 10.8 15.8 11.9 18.2 11.3 15.6 13.4 14.3 5.7 22.2 15.5 11.5 16.6 11.8 25.2 8.4 12.6 7.3 9.5 19.4 10.2 19.4 17.2 6.0 15.3 13.1 17.1 19.7 23.0 16.8 13.1 16.4 25.6 14.6 12.7 10.1 22.1 12.8 27.8 15.0 11.5 17.4 14.7 17.0 7.4 6.0 12.7 23.4 7.3 8.4 25.3 14.8 6.5 8.5 14.3 15.3 14.3 18.9 17.9 16.8 15.5 13.7 10.2 11.2 20.1 0.1 5.6 1.6 8.5 5.6 10.4 8.3 9.1 10.3 7.4 9.1 10.7 9.4 0.2 11.2 5.7 13.6 5.9 5.3 10.3 13.6 8.8 15.7 10.0 8.3 16.5 13.7 13.2 12.0 8.9 6.2 12.3 29.1 17.3 11.2 10.2 2.5 12.0 11.4 10.4 15.7 13.5 10.0 17.8 33.8 11.9 5.9 0.0 10.2 25.8 15.8 23.9 18.4 4.9 12.5 3.2 20.6 12.9 8.4 31.7 14.7 7.7 8.5 14.4 13.3 4.3 19.8 5.8 12.0 10.6 11.4 19.4 15.5 36.2 50.0 16.8 22.5 12.9 11.2 32.9 POLR3E "FLJ10509, RPC5, SIN" ENSG00000058600 "RNA polymerase III subunit E" Q9NVU0 16 22297375-22335103 "Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041419, HPA041477" Approved Enhanced Nucleoplasm Yes No Nucleoplasm "HPA041419: AB_2677468, HPA041477: AB_10796345" "unprognostic (3.09e-2)" "unprognostic (8.59e-2)" "unprognostic (8.23e-2)" "unprognostic (1.04e-1)" "unprognostic (1.51e-1)" "unprognostic (7.28e-2)" "unprognostic (2.42e-2)" "unprognostic (7.73e-2)" "unprognostic (2.96e-2)" "unprognostic (1.34e-1)" "unprognostic (2.03e-1)" "prognostic unfavorable (1.74e-4)" "unprognostic (8.14e-2)" "unprognostic (1.91e-1)" "unprognostic (8.96e-2)" "unprognostic (8.19e-3)" "unprognostic (3.41e-2)" 10.8 15.8 8.9 10.4 11.1 9.8 15.5 11.7 12.9 11.7 10.7 12.0 13.0 9.7 12.4 9.3 13.1 11.1 8.5 13.9 10.9 7.0 9.5 14.0 9.5 12.7 11.1 9.8 11.0 21.2 15.7 15.8 8.9 10.7 12.7 6.6 11.8 15.0 15.2 50.7 12.7 8.9 9.2 10.0 9.5 12.4 9.6 10.7 10.4 12.3 9.1 14.0 11.4 10.4 5.9 5.7 1.9 3.8 5.3 7.2 4.8 6.6 9.3 2.7 6.7 5.3 4.0 9.2 5.4 2.8 3.6 2.5 11.7 4.7 13.8 7.1 3.8 2.5 6.4 13.3 7.5 2.9 9.1 19.0 7.0 10.1 22.3 6.5 10.9 7.8 3.9 8.3 7.7 9.4 1.7 9.1 5.8 19.9 5.6 4.1 10.8 10.9 4.5 13.7 7.4 7.9 14.3 6.0 17.7 3.7 4.0 9.9 7.4 5.1 9.5 5.2 2.3 5.5 6.3 5.7 3.6 4.1 3.1 5.9 7.6 13.5 12.7 4.1 8.4 6.7 0.0 3.3 1.9 6.5 3.8 7.2 5.9 7.2 6.8 5.7 5.1 7.0 5.8 0.3 5.3 3.1 3.3 7.2 4.8 8.9 11.1 11.7 12.9 10.9 7.0 11.1 9.8 10.7 10.7 3.0 14.3 16.6 20.1 28.8 22.8 16.2 7.6 16.0 11.4 17.4 29.5 19.3 5.0 10.9 31.0 13.1 10.9 0.0 11.0 16.4 14.4 22.7 27.6 11.1 11.5 19.1 14.5 5.5 12.3 13.9 11.5 9.4 13.5 7.2 16.4 10.6 13.0 11.5 8.5 9.1 38.3 12.9 16.5 18.4 16.2 34.6 23.7 19.2 15.0 23.8 POLR3F "RPC39, RPC6" ENSG00000132664 "RNA polymerase III subunit F" Q9H1D9 20 18467127-18484643 "Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049441, HPA050173, HPA072298" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA049441: AB_2680768, HPA050173: AB_2681042, HPA072298: AB_2686510" "unprognostic (4.59e-2)" "unprognostic (1.83e-1)" "unprognostic (3.44e-1)" "unprognostic (1.69e-2)" "unprognostic (1.55e-1)" "unprognostic (7.39e-2)" "prognostic unfavorable (8.87e-9)" "unprognostic (1.80e-1)" "unprognostic (1.50e-1)" "unprognostic (2.20e-1)" "prognostic favorable (6.48e-4)" "unprognostic (3.04e-1)" "unprognostic (4.01e-1)" "unprognostic (3.28e-1)" "unprognostic (1.79e-1)" "unprognostic (2.88e-3)" "unprognostic (4.98e-3)" 8.6 7.8 8.1 6.0 11.9 4.4 8.0 24.6 15.3 9.9 7.5 8.7 8.5 5.6 11.6 6.5 11.0 9.6 6.7 14.2 8.7 10.1 11.2 7.3 5.9 8.8 7.8 12.9 12.5 7.3 4.5 9.8 8.0 13.9 9.2 6.4 6.7 7.5 7.4 12.0 6.2 5.0 9.0 8.5 6.3 6.7 10.0 7.7 6.3 16.3 7.2 9.1 10.7 6.5 3.1 3.2 1.9 4.5 3.3 6.4 4.1 6.5 6.7 7.0 8.8 5.7 6.9 12.6 9.7 6.8 12.5 9.6 8.4 6.7 5.1 4.1 9.4 8.3 9.0 9.2 8.0 8.2 5.0 7.7 3.7 2.6 3.6 8.1 11.0 6.3 4.4 5.2 18.7 8.6 6.0 5.6 4.5 9.4 4.5 8.6 7.1 9.2 4.7 9.9 6.7 15.3 6.5 15.3 5.6 5.6 2.8 14.6 9.6 7.5 12.6 15.7 4.9 5.8 7.4 5.4 12.9 6.3 9.6 13.6 2.3 15.3 4.0 5.4 5.1 9.3 0.1 2.1 1.9 4.3 4.5 6.4 2.8 3.9 1.2 2.2 3.1 4.1 2.1 0.8 3.3 1.9 3.2 3.4 4.1 8.1 11.9 24.6 15.3 8.7 10.1 7.8 12.9 13.9 7.7 8.9 3.7 5.4 3.0 7.9 17.3 7.3 2.5 12.0 4.5 1.8 9.8 8.6 8.3 7.0 15.9 6.5 2.9 0.0 5.9 10.3 6.7 3.5 5.7 4.5 6.7 11.1 6.4 6.7 7.0 4.1 5.8 6.9 5.0 11.8 3.1 12.5 6.4 0.0 9.6 9.8 17.4 12.9 5.5 17.7 22.0 9.9 6.1 8.5 3.9 2.7 POLR3G "RPC32, RPC7" ENSG00000113356 "RNA polymerase III subunit G" O15318 5 90471748-90514553 "Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 20.2" "Cell type enhanced" "Detected in many" 10 "Spermatogonia: 27.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 37.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010109, HPA052658, HPA074330" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "CAB010109: AB_2165718, HPA052658: AB_2681904, HPA074330: " "unprognostic (4.31e-1)" "unprognostic (5.35e-2)" "unprognostic (2.62e-2)" "unprognostic (3.55e-3)" "unprognostic (1.18e-1)" "unprognostic (3.42e-2)" "unprognostic (4.19e-6)" "unprognostic (2.17e-3)" "unprognostic (1.91e-1)" "unprognostic (1.93e-2)" "unprognostic (3.52e-2)" "unprognostic (9.71e-2)" "unprognostic (1.21e-14)" "unprognostic (3.86e-2)" "unprognostic (3.19e-2)" "unprognostic (1.53e-2)" "unprognostic (8.17e-5)" 2.7 1.6 7.1 3.6 10.2 4.4 3.8 7.2 7.2 3.7 2.6 6.7 1.4 2.8 2.7 8.4 7.3 2.7 2.4 2.7 7.7 7.7 1.7 4.0 2.9 8.1 10.3 6.1 4.1 4.1 11.1 3.9 3.1 20.2 2.9 3.1 2.6 4.2 1.5 4.4 7.4 2.3 4.2 16.0 3.3 2.1 8.0 8.1 1.0 5.9 8.5 3.2 4.4 4.7 3.9 2.1 6.8 2.8 5.4 3.2 0.8 10.7 6.2 7.4 1.9 2.3 4.1 3.4 5.4 1.7 8.6 7.0 3.6 8.0 29.4 1.8 2.2 8.5 4.5 9.2 8.6 30.8 13.5 8.2 10.8 2.9 5.5 3.9 7.5 2.7 2.7 4.0 14.3 10.9 1.7 10.6 11.7 15.3 2.7 3.1 5.2 7.9 4.7 34.9 1.5 27.7 7.0 3.2 16.6 2.5 1.0 9.4 2.5 2.2 4.1 14.9 3.4 2.2 2.1 12.7 4.7 9.0 6.6 20.3 6.8 17.4 21.7 10.4 10.0 37.3 6.8 0.6 0.3 3.2 0.8 1.6 3.9 1.1 2.0 0.9 2.4 2.4 2.6 1.6 5.4 2.8 2.1 0.5 0.8 7.1 10.2 7.2 7.2 7.7 7.7 10.3 6.1 20.2 8.1 6.0 2.1 0.8 1.2 3.2 2.7 3.4 0.0 2.7 0.0 1.8 7.9 0.7 3.3 2.6 3.0 1.4 0.5 0.0 3.9 5.2 1.5 3.0 6.9 2.4 1.5 3.2 6.4 3.7 0.3 1.0 0.3 0.6 1.7 0.0 1.3 0.6 2.9 2.0 1.1 1.3 0.8 0.0 1.4 7.7 27.4 7.4 0.7 0.0 1.6 0.6 POLR3H "KIAA1665, RPC8" ENSG00000100413 "RNA polymerase III subunit H" Q9Y535 22 41525804-41544606 "Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 113.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046787 Approved Supported Nucleoplasm,Vesicles,Centrosome NA NA Nucleoplasm "Vesicles, Centrosome" "HPA046787: AB_2679806" "unprognostic (1.55e-1)" "unprognostic (6.74e-2)" "unprognostic (1.06e-1)" "unprognostic (3.87e-3)" "unprognostic (9.57e-2)" "unprognostic (1.26e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.05e-2)" "unprognostic (1.33e-2)" "unprognostic (5.43e-2)" "prognostic favorable (5.41e-4)" "unprognostic (6.40e-2)" "unprognostic (1.54e-1)" "unprognostic (2.94e-2)" "unprognostic (1.49e-1)" "unprognostic (4.00e-2)" "unprognostic (1.70e-1)" 16.8 14.0 30.0 9.1 28.8 5.5 13.5 21.0 27.4 12.1 7.5 15.8 12.6 6.1 10.5 11.7 17.0 19.0 10.3 14.8 24.0 20.5 10.0 18.9 14.7 10.9 22.2 17.6 22.4 13.7 13.1 11.5 7.9 17.2 11.0 6.8 12.1 12.2 14.2 7.7 14.6 6.2 14.4 14.2 7.2 7.9 14.2 16.5 7.0 15.4 8.2 9.3 8.1 9.1 11.6 11.2 0.6 13.8 3.9 10.2 7.5 16.3 11.0 10.2 14.9 11.2 10.2 6.8 13.7 12.8 23.4 18.9 22.2 5.4 13.9 10.8 23.0 13.2 7.5 18.6 22.4 14.7 12.7 23.0 8.3 17.5 10.6 11.6 34.4 14.2 12.7 14.6 30.8 8.3 8.9 11.4 13.9 17.4 8.9 13.0 15.5 8.8 9.4 7.2 21.7 14.3 13.5 8.0 14.5 10.9 9.6 9.8 5.9 17.9 18.2 8.7 6.6 7.2 9.8 10.2 14.0 15.2 24.3 18.1 6.8 12.6 21.0 24.4 12.3 13.3 0.0 10.0 0.1 7.3 13.8 10.2 11.6 7.1 8.6 11.2 10.1 10.0 8.1 0.6 3.9 12.7 10.8 4.4 7.5 30.0 28.8 21.0 26.9 24.0 20.5 22.2 17.6 17.2 16.5 0.0 23.5 18.2 9.8 15.8 16.9 5.1 12.7 9.4 21.6 15.7 15.7 29.8 39.7 26.3 30.8 8.2 2.9 23.3 25.7 23.4 15.5 13.0 11.5 29.7 27.4 20.6 13.7 9.2 6.9 113.5 15.5 10.0 23.6 22.6 4.1 18.5 23.5 7.0 19.1 28.8 20.6 0.0 10.5 44.7 55.2 22.3 15.0 10.2 8.5 11.3 POLR3K RPC11 ENSG00000161980 "RNA polymerase III subunit K" Q9Y2Y1 16 46407-53628 "Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA005891 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005891: AB_1079653" "unprognostic (3.00e-1)" "unprognostic (1.50e-3)" "unprognostic (1.53e-1)" "unprognostic (7.16e-3)" "unprognostic (1.47e-1)" "unprognostic (1.40e-1)" "unprognostic (8.03e-3)" "unprognostic (9.06e-2)" "unprognostic (7.40e-2)" "unprognostic (5.72e-2)" "unprognostic (9.96e-2)" "unprognostic (1.84e-1)" "unprognostic (7.36e-3)" "unprognostic (2.68e-2)" "unprognostic (3.63e-2)" "unprognostic (3.53e-2)" "unprognostic (9.63e-2)" 7.3 12.4 15.4 16.6 17.6 11.3 8.3 14.3 18.8 8.0 9.1 9.0 11.9 9.8 8.3 9.3 9.8 9.3 7.4 12.0 13.7 15.4 9.1 10.3 7.6 19.6 11.9 15.5 9.1 11.0 12.1 7.5 8.0 9.0 10.0 9.2 5.9 11.1 12.7 21.8 5.7 9.3 8.2 9.8 14.0 9.1 5.7 7.9 13.7 11.5 12.4 18.6 9.9 8.6 39.6 25.3 32.2 18.9 13.5 30.0 18.2 10.8 18.7 11.9 12.3 4.9 3.0 9.5 15.5 4.9 13.8 9.1 24.1 11.7 28.2 11.8 5.4 5.5 10.8 27.7 7.1 9.9 16.9 25.5 20.7 14.0 17.1 3.7 18.6 20.4 3.0 6.3 15.3 7.8 3.2 6.7 12.6 29.5 9.0 8.9 26.9 22.3 12.3 19.5 13.7 17.9 27.1 13.8 29.4 7.8 7.8 17.5 10.3 10.6 19.9 9.1 5.2 11.7 16.8 6.4 8.9 10.9 11.9 18.7 5.8 13.9 55.5 3.8 13.7 13.3 9.0 13.6 32.2 15.8 18.9 16.2 39.6 20.3 18.2 12.4 35.1 18.4 17.2 9.8 13.5 17.3 25.3 30.0 18.2 15.4 17.6 14.3 18.8 13.7 15.4 11.9 15.5 9.0 7.9 3.0 9.9 34.1 17.9 29.7 15.1 25.5 25.5 12.0 7.9 17.4 3.9 34.6 41.4 28.4 0.6 20.3 13.2 0.0 30.5 38.6 19.5 23.0 21.9 26.0 38.9 9.5 17.2 19.0 13.1 0.4 19.5 22.5 21.9 56.9 19.5 12.9 29.0 14.0 15.6 36.1 8.4 12.9 17.5 4.7 15.1 38.6 10.8 27.7 24.8 19.5 POM121 "DKFZP586G1822, DKFZP586P2220, KIAA0618, POM121A" ENSG00000196313 "POM121 transmembrane nucleoporin" Q96HA1 7 72879365-72951440 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cone photoreceptor cells: 92.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB003710, HPA043809, HPA049817" Approved Enhanced "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "CAB003710: , HPA043809: AB_2678680, HPA049817: AB_2680896" "unprognostic (2.33e-1)" "unprognostic (3.05e-2)" "unprognostic (9.71e-2)" "unprognostic (5.86e-3)" "unprognostic (1.70e-1)" "unprognostic (2.06e-1)" "unprognostic (1.40e-1)" "unprognostic (6.38e-2)" "unprognostic (7.07e-3)" "unprognostic (3.08e-2)" "unprognostic (3.84e-2)" "unprognostic (1.71e-1)" "unprognostic (1.85e-1)" "unprognostic (3.66e-2)" "unprognostic (2.39e-1)" "unprognostic (7.43e-3)" "unprognostic (2.40e-1)" 19.4 15.2 14.5 16.0 17.7 35.0 14.4 25.9 22.0 13.1 16.6 16.0 14.2 19.5 17.9 14.8 15.8 15.8 14.9 11.8 11.7 10.0 14.0 16.6 13.3 18.7 10.8 12.7 18.6 23.3 14.9 20.6 15.4 13.4 18.6 11.4 20.2 17.4 11.7 18.4 17.0 19.1 12.1 12.7 19.0 16.3 17.3 13.5 24.5 19.5 15.2 22.3 15.8 14.5 3.7 4.3 3.7 3.6 4.5 5.2 2.6 17.1 12.6 15.7 35.3 8.5 7.0 13.1 12.3 10.5 12.3 10.7 22.2 10.9 23.7 4.0 10.6 13.7 13.2 15.6 11.9 13.8 20.5 31.1 17.7 12.6 14.7 8.7 36.6 22.6 9.2 8.5 16.3 15.0 8.0 9.1 13.8 48.4 17.8 12.0 13.2 21.8 23.3 16.5 9.6 15.3 20.0 12.3 20.0 6.2 15.1 22.5 19.8 10.8 20.8 11.0 11.0 17.3 19.3 12.8 22.1 13.6 17.4 24.6 21.4 19.8 34.4 12.9 23.5 21.8 0.1 2.3 3.7 5.2 1.4 3.0 3.0 3.3 3.8 2.6 3.7 3.0 4.3 2.6 4.5 3.6 4.3 1.7 2.6 14.5 17.7 25.9 22.0 11.7 10.0 10.8 12.7 13.4 13.5 35.7 28.2 12.7 8.8 22.3 31.1 4.4 25.5 17.4 20.5 17.4 92.3 14.5 5.0 10.8 6.8 14.2 16.9 23.3 14.7 10.9 16.5 15.7 16.1 20.3 13.8 38.1 17.2 17.8 15.8 4.2 13.8 18.3 18.6 7.2 19.6 18.3 17.2 10.5 16.6 5.4 23.8 12.9 15.9 14.2 11.8 27.0 16.2 18.1 19.0 18.4 POM121C ENSG00000272391 "POM121 transmembrane nucleoporin C" 7 75416787-75486271 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 64.8" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA043809, HPA049817" Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA043809: AB_2678680, HPA049817: AB_2680896" "unprognostic (9.11e-2)" "unprognostic (1.27e-1)" "unprognostic (2.85e-1)" "unprognostic (1.44e-1)" "unprognostic (3.51e-2)" "unprognostic (1.09e-1)" "unprognostic (1.18e-1)" "unprognostic (4.27e-2)" "unprognostic (4.97e-2)" "unprognostic (1.08e-1)" "unprognostic (5.84e-3)" "unprognostic (2.03e-1)" "unprognostic (5.06e-2)" "unprognostic (2.40e-1)" "unprognostic (2.35e-1)" "unprognostic (1.44e-2)" "unprognostic (4.00e-2)" 5.5 5.5 6.5 9.9 8.4 11.0 4.5 11.2 7.4 5.9 5.1 5.8 6.5 4.5 7.0 7.5 6.6 5.9 6.0 5.3 6.8 6.9 6.3 5.0 10.3 4.3 4.4 8.4 7.5 7.7 10.1 6.6 5.4 5.4 5.2 9.3 6.5 5.3 5.7 5.5 6.2 6.2 4.6 6.7 5.3 4.6 6.3 13.1 7.0 7.3 12.0 6.6 5.0 3.5 3.4 3.9 1.6 2.7 3.8 1.7 15.8 13.3 18.4 35.2 6.9 7.8 12.1 11.6 10.7 9.5 9.2 15.9 10.3 28.1 4.8 12.6 14.9 14.4 15.6 14.3 15.7 18.9 21.6 13.9 15.3 10.6 9.2 36.8 19.8 6.6 9.1 14.4 10.8 14.0 9.6 11.7 38.9 15.8 15.3 16.0 22.4 18.7 14.6 12.3 15.1 20.2 12.3 14.4 5.2 21.7 20.6 27.0 13.4 21.4 9.4 17.4 18.6 13.1 10.6 23.1 12.5 16.8 23.9 16.9 19.8 34.8 15.0 18.9 21.2 0.6 1.2 1.3 3.8 1.6 3.3 2.6 2.9 1.1 0.9 3.5 1.5 1.9 3.9 2.7 1.0 3.4 0.5 1.7 32.8 22.1 15.2 8.3 16.0 29.4 10.1 30.6 21.4 28.4 12.2 64.8 11.5 5.0 11.7 1.5 15.8 11.4 0.0 14.9 8.4 12.0 18.1 7.0 12.3 10.2 23.8 27.5 12.9 17.3 2.9 16.7 15.5 6.8 7.2 13.8 20.6 15.0 3.5 14.5 8.6 28.6 12.9 12.1 14.0 12.3 16.2 14.2 20.1 16.9 19.0 POMK "FLJ23356, SgK196" ENSG00000185900 "Protein-O-mannose kinase" Q9H5K3 8 43093506-43123434 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Kinase, Transferase" "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 1.4;Club cells: 2.3;Melanocytes: 1.7;monocytes: 1.8;Spermatogonia: 1.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013321 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA013321: AB_2668809" "unprognostic (1.66e-2)" "unprognostic (1.12e-2)" "unprognostic (1.27e-1)" "unprognostic (4.37e-2)" "unprognostic (1.29e-1)" "unprognostic (4.62e-2)" "unprognostic (5.56e-2)" "unprognostic (2.42e-1)" "unprognostic (2.50e-1)" "unprognostic (8.10e-2)" "unprognostic (1.23e-3)" "unprognostic (1.03e-1)" "unprognostic (2.32e-1)" "unprognostic (7.09e-2)" "unprognostic (1.06e-1)" "unprognostic (3.71e-3)" "unprognostic (2.10e-2)" 4.7 5.5 9.8 5.6 14.3 12.5 5.1 12.3 18.6 6.9 4.8 8.3 2.2 4.5 6.9 4.4 7.1 6.2 4.8 3.8 7.7 7.0 3.4 4.5 5.5 6.0 4.8 11.1 5.8 9.3 6.3 7.4 6.1 10.5 5.6 5.9 6.1 6.8 4.0 6.2 7.1 5.6 6.4 6.7 7.6 6.8 7.1 7.2 7.5 7.4 3.2 7.4 4.6 5.0 2.6 2.6 6.7 2.9 1.0 3.3 1.3 3.5 7.6 5.8 15.2 2.8 3.5 5.5 2.1 3.2 5.5 4.1 5.5 9.2 5.0 4.7 3.8 2.3 5.9 8.3 6.4 5.4 1.9 1.4 14.0 5.6 2.5 2.0 4.7 7.9 3.8 2.7 7.4 5.3 1.7 5.4 7.1 3.3 14.9 3.7 1.6 10.0 2.0 11.9 2.1 1.0 6.8 6.8 2.9 1.5 9.9 5.6 4.2 9.1 3.2 3.0 4.4 9.8 3.3 7.5 8.4 8.5 8.7 4.2 4.9 8.6 9.4 3.6 3.2 10.0 0.8 2.9 1.9 2.3 2.4 3.3 1.8 1.3 1.3 2.6 2.6 1.8 2.3 6.7 1.0 1.5 2.5 1.1 1.3 9.8 14.3 12.3 18.6 7.7 7.0 4.8 11.1 10.5 7.2 0.0 0.3 0.0 0.1 0.3 1.4 0.3 0.0 0.0 2.3 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.7 0.3 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.7 1.8 0.0 0.5 0.3 0.0 0.0 0.0 0.8 0.0 0.1 0.4 1.4 0.1 0.5 0.0 0.2 0.1 POMT2 LGMD2N ENSG00000009830 "Protein O-mannosyltransferase 2" Q9UKY4 14 77274956-77320884 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003663 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA003663: AB_1079655" "unprognostic (2.15e-1)" "unprognostic (1.07e-2)" "unprognostic (7.92e-2)" "unprognostic (3.37e-2)" "unprognostic (1.48e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.40e-4)" "unprognostic (7.10e-3)" "unprognostic (1.17e-1)" "unprognostic (1.68e-1)" "unprognostic (6.89e-3)" "unprognostic (1.94e-3)" "unprognostic (8.50e-3)" "unprognostic (1.37e-1)" "unprognostic (2.44e-1)" "unprognostic (6.75e-3)" "unprognostic (3.46e-2)" 6.7 10.8 10.4 6.8 11.4 3.8 7.7 12.5 13.3 6.8 6.3 18.0 9.8 4.6 6.9 17.1 5.7 8.7 6.9 7.7 9.3 7.7 8.1 8.3 6.2 3.0 11.7 6.2 7.6 10.6 14.7 16.1 11.4 9.7 7.3 5.8 8.2 10.1 12.3 17.0 4.3 4.6 7.8 8.4 5.2 5.6 30.9 14.4 2.5 11.5 4.9 3.8 5.7 5.0 1.4 1.9 0.8 1.9 0.0 1.7 0.4 10.4 13.4 13.0 14.7 9.3 7.5 10.4 9.2 7.6 13.8 11.8 6.6 9.4 3.1 7.5 8.6 19.1 11.7 6.1 9.2 9.6 4.6 8.3 1.9 6.6 5.4 11.4 2.1 6.3 7.6 9.8 12.9 12.6 9.6 8.0 3.1 4.9 7.3 9.0 20.6 3.6 10.1 3.7 14.5 11.3 3.5 12.7 2.8 14.3 7.7 11.0 10.8 6.0 10.2 7.7 8.9 10.5 4.4 6.6 10.4 16.4 12.0 8.0 4.8 9.4 1.4 5.3 3.2 9.1 0.0 0.4 0.0 1.7 1.9 0.4 1.4 0.0 0.3 0.9 0.2 0.1 0.0 0.8 0.0 0.8 1.9 0.0 0.4 10.4 11.4 12.5 13.3 9.3 7.7 11.7 6.2 9.7 14.4 6.0 3.2 2.2 2.3 2.7 6.5 4.0 5.1 0.0 0.0 1.8 15.7 5.0 0.0 6.6 8.0 2.8 3.9 0.0 6.4 8.6 6.0 3.5 2.3 4.4 4.8 7.9 17.2 3.1 2.4 12.1 1.7 2.2 1.7 3.6 3.0 8.2 5.8 1.9 3.9 3.0 15.0 0.0 3.9 9.8 8.5 1.6 4.8 0.0 2.6 1.4 POMZP3 "POM-ZP3, POM121" ENSG00000146707 "POM121 and ZP3 fusion" Q6PJE2 7 76609986-76627261 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 38.3;Late spermatids: 28.3" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA049817 Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA049817: AB_2680896" "unprognostic (2.23e-1)" "prognostic favorable (4.34e-4)" "unprognostic (1.06e-1)" "unprognostic (2.17e-1)" "unprognostic (9.79e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (3.78e-4)" "unprognostic (4.31e-1)" "unprognostic (7.49e-2)" "prognostic favorable (9.31e-4)" "unprognostic (4.94e-1)" "unprognostic (3.40e-1)" "unprognostic (1.45e-2)" "unprognostic (1.90e-1)" "unprognostic (1.85e-1)" "unprognostic (1.20e-1)" "unprognostic (3.99e-2)" 4.0 3.0 4.7 3.4 5.6 6.6 4.5 6.0 5.3 4.7 4.6 2.4 5.8 5.2 3.8 2.8 2.1 3.8 4.7 3.5 4.4 2.2 3.6 3.1 3.5 5.8 4.7 2.0 3.1 1.7 4.5 3.7 4.3 5.1 14.2 5.3 3.0 7.0 4.0 2.5 3.9 9.5 3.9 3.6 4.0 3.9 4.2 3.5 5.7 3.3 3.0 4.8 1.1 1.9 8.1 13.0 16.7 8.6 3.4 1.9 2.9 4.5 2.1 2.7 4.7 3.6 1.2 0.8 2.6 4.6 1.1 3.0 1.3 2.0 4.9 4.6 5.4 4.4 2.7 2.0 2.4 3.6 2.9 5.4 7.2 2.5 1.0 1.3 2.1 2.9 9.4 9.2 2.5 4.2 10.0 5.7 3.0 4.0 1.8 9.5 2.0 1.5 3.0 6.8 12.3 2.5 11.8 4.2 14.4 4.5 3.1 5.0 6.6 0.9 16.4 6.7 2.4 2.1 8.7 1.3 9.7 9.2 1.4 3.3 5.7 2.4 1.5 3.5 2.5 3.9 4.0 3.3 4.2 4.8 2.7 3.8 3.0 1.6 3.5 3.4 1.1 3.0 2.6 3.0 6.4 6.3 4.1 6.0 2.5 4.0 0.0 5.2 11.8 5.7 0.0 1.1 38.3 3.0 4.5 0.0 1.9 3.1 6.0 4.2 5.7 1.7 2.6 3.2 12.5 1.8 4.1 28.3 5.8 3.0 10.1 0.0 2.7 4.6 1.6 4.0 7.4 3.5 5.2 12.9 3.2 22.1 4.1 6.0 8.7 2.2 5.6 8.4 POP5 ENSG00000167272 "POP5 homolog, ribonuclease P/MRP subunit" Q969H6 12 120578764-120581398 "Enzymes, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047598, HPA069204" Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA047598: AB_2680096, HPA069204: " "unprognostic (1.50e-2)" "prognostic favorable (2.68e-5)" "unprognostic (1.55e-1)" "unprognostic (3.61e-3)" "unprognostic (3.81e-1)" "unprognostic (1.50e-1)" "unprognostic (4.80e-3)" "unprognostic (1.28e-1)" "unprognostic (7.34e-2)" "unprognostic (5.75e-2)" "unprognostic (4.13e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (4.85e-4)" "unprognostic (3.07e-1)" "unprognostic (6.21e-2)" "unprognostic (2.68e-1)" "unprognostic (5.68e-2)" 16.3 33.8 16.2 25.6 14.4 14.1 23.9 8.7 16.7 18.6 17.5 13.6 24.2 11.8 14.5 27.1 15.9 14.6 19.5 25.8 18.1 13.9 24.1 24.1 18.3 19.7 16.9 15.9 11.7 18.9 25.0 17.5 8.2 14.2 15.6 18.0 15.1 20.9 22.6 13.3 12.7 15.1 19.5 14.4 20.3 15.2 9.0 12.1 24.2 19.8 18.9 19.6 13.7 19.2 32.0 33.5 3.6 19.7 18.2 28.2 22.8 20.1 34.6 12.3 15.0 23.4 12.6 19.6 17.0 11.0 20.8 16.0 29.8 9.3 11.9 25.9 13.6 10.9 21.4 20.6 32.4 18.7 28.1 31.2 14.5 22.6 33.7 16.5 20.4 15.2 15.9 18.7 24.0 11.0 11.7 17.3 28.4 17.7 7.7 20.6 44.4 16.6 18.4 14.7 29.3 29.9 19.5 15.1 32.5 29.1 20.8 9.6 10.6 28.8 8.5 21.9 14.6 39.4 19.7 12.5 10.9 16.3 17.3 18.5 19.9 33.5 21.0 21.2 24.9 17.3 3.6 16.2 3.5 24.7 19.7 22.6 32.0 22.6 23.0 19.0 22.4 28.2 26.8 1.1 18.2 16.7 33.5 21.4 22.8 16.2 14.4 8.7 16.7 18.1 13.9 16.9 15.9 14.2 12.1 11.9 25.1 40.9 40.5 17.4 19.6 53.8 40.8 25.4 37.5 73.3 13.7 49.9 131.0 34.2 1.3 26.7 23.2 23.3 38.8 36.9 22.4 23.7 54.2 46.1 46.0 17.5 21.2 23.9 18.3 2.7 33.4 31.2 47.2 27.1 27.7 54.1 31.5 24.6 35.3 99.7 28.3 19.4 28.8 19.1 33.4 21.7 14.8 37.4 37.5 25.7 POR "CYPOR, FLJ26468" ENSG00000127948 "Cytochrome p450 oxidoreductase" P16435 7 75899200-75986855 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Congenital adrenal hyperplasia, Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 78.4" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 443.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 74.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004372, HPA010136" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "CAB004372: AB_627391, HPA010136: AB_1079657" "unprognostic (1.89e-1)" "unprognostic (1.53e-1)" "unprognostic (2.81e-3)" "unprognostic (8.67e-2)" "prognostic unfavorable (8.54e-4)" "unprognostic (1.65e-1)" "unprognostic (1.17e-2)" "unprognostic (4.32e-2)" "unprognostic (1.69e-2)" "unprognostic (1.46e-1)" "unprognostic (1.22e-1)" "unprognostic (2.58e-1)" "unprognostic (1.11e-1)" "unprognostic (9.31e-2)" "unprognostic (1.71e-1)" "unprognostic (3.94e-2)" "unprognostic (9.89e-2)" 12.8 48.2 7.4 7.5 10.8 3.6 15.0 5.3 16.4 11.0 20.8 9.6 32.1 24.9 9.0 8.2 13.4 12.8 9.9 8.4 7.1 7.2 12.0 78.4 13.7 9.9 5.2 10.1 14.4 12.8 12.1 18.5 18.6 7.1 9.3 5.3 10.8 7.8 58.7 13.1 10.0 24.3 7.0 5.2 11.7 9.8 22.4 5.0 8.2 33.3 9.9 8.6 9.8 10.2 5.7 20.6 26.7 18.4 11.2 9.9 13.9 12.8 28.2 12.9 24.0 48.9 18.6 21.6 5.4 17.7 10.2 14.3 21.1 57.3 12.3 5.0 11.7 34.8 6.3 16.9 8.5 4.4 10.5 12.5 5.7 8.3 39.0 34.0 5.7 10.2 38.1 10.7 13.4 9.8 8.2 9.4 6.1 17.0 5.3 9.1 18.9 6.1 10.2 16.1 20.2 16.0 8.8 8.5 13.2 11.5 15.6 13.5 12.9 14.5 74.1 19.5 7.6 21.2 9.6 8.5 9.6 10.6 14.4 10.6 5.2 8.0 8.4 13.6 8.7 12.3 26.7 18.4 25.3 9.9 17.7 8.3 5.4 8.4 9.2 20.6 5.7 8.4 7.1 24.3 11.2 13.0 5.8 8.7 13.9 7.4 10.8 5.3 16.4 7.1 7.2 5.2 10.1 7.1 5.0 35.7 31.2 12.6 24.7 15.1 30.1 9.3 56.0 78.9 37.5 69.8 11.8 88.1 1.7 55.5 13.2 25.3 144.8 0.0 25.7 71.6 24.8 20.8 24.3 443.8 58.9 14.3 19.0 27.6 38.6 6.1 70.2 40.5 11.8 16.2 29.0 33.2 24.3 119.3 105.7 27.5 21.8 64.7 30.9 14.7 32.6 12.8 161.6 20.0 36.8 40.7 POSTN "OSF-2, periostin, PN" ENSG00000133110 Periostin Q15063 13 37562583-37598844 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Basal keratinocytes: 262.6" "Cancer enhanced" "Detected in all" "breast cancer: 231.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "hTEC/SVTERT24-B: 75.1;SuSa: 71.0;U-138 MG: 96.0;U-2197: 65.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA012306 Enhanced Approved "Nucleoplasm,Golgi apparatus" "Secreted to extracellular matrix" NA NA 740000000 "Golgi apparatus" Nucleoplasm "HPA012306: AB_1854827" "unprognostic (7.73e-2)" "unprognostic (1.44e-3)" "unprognostic (2.19e-2)" "unprognostic (2.57e-2)" "unprognostic (4.73e-2)" "unprognostic (2.22e-2)" "unprognostic (4.19e-3)" "prognostic unfavorable (2.93e-4)" "unprognostic (3.05e-3)" "unprognostic (7.10e-2)" "unprognostic (1.32e-2)" "unprognostic (5.93e-2)" "prognostic unfavorable (1.83e-7)" "prognostic unfavorable (4.86e-4)" "unprognostic (1.15e-1)" "unprognostic (1.20e-1)" "unprognostic (8.32e-3)" 60.9 2.0 5.3 12.7 4.0 0.0 26.9 0.5 2.7 17.6 14.1 0.6 11.7 0.6 29.0 20.0 16.5 20.3 14.5 34.1 6.2 0.5 47.5 3.0 28.4 19.5 0.5 1.1 21.0 3.1 8.2 1.7 17.3 2.5 12.4 19.7 0.8 10.8 10.2 14.2 46.1 9.6 14.5 1.7 0.7 37.3 21.5 0.1 3.1 8.0 5.5 1.7 23.5 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.2 13.3 8.0 0.0 3.4 0.0 0.8 0.1 0.0 0.2 0.0 0.0 2.7 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 14.2 0.0 75.1 0.3 2.4 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.0 0.1 0.0 0.0 96.0 0.0 65.3 0.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 4.0 0.5 2.7 6.2 0.5 0.5 1.1 2.5 0.1 6.0 18.3 0.0 1.4 262.6 0.0 19.4 0.0 9.4 33.0 0.0 0.0 1.5 0.0 0.0 0.4 27.7 0.0 0.0 0.0 0.2 42.9 0.3 3.5 0.0 3.2 0.0 0.0 16.5 0.0 0.2 6.1 0.2 28.7 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 62.4 1.1 0.2 42.3 2.9 0.0 0.0 0.0 POT1 "DKFZp586D211, hPot1" ENSG00000128513 "Protection of telomeres 1" Q9NUX5 7 124822386-124929983 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 27.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA068538 Supported Nucleoplasm NA NA Nucleoplasm "HPA068538: AB_2686001" "unprognostic (1.39e-3)" "unprognostic (1.34e-1)" "unprognostic (2.04e-1)" "unprognostic (5.71e-2)" "unprognostic (1.69e-1)" "unprognostic (1.49e-1)" "unprognostic (1.38e-3)" "unprognostic (7.88e-2)" "unprognostic (2.26e-2)" "unprognostic (1.51e-1)" "unprognostic (2.48e-2)" "unprognostic (9.89e-2)" "unprognostic (1.42e-1)" "unprognostic (2.92e-1)" "unprognostic (1.75e-2)" "unprognostic (4.77e-3)" "unprognostic (7.42e-2)" 12.0 13.2 11.1 8.3 14.3 6.2 15.8 13.0 16.6 13.4 10.1 16.0 12.0 7.8 17.0 13.4 10.1 12.6 11.3 11.2 15.5 11.3 16.6 14.7 9.9 14.0 15.0 12.4 15.7 9.4 15.5 29.6 11.1 16.4 12.0 9.7 12.2 8.7 10.1 9.5 8.0 8.8 13.1 16.4 13.6 9.5 15.8 14.8 17.9 21.5 9.3 12.9 13.6 9.8 4.8 3.6 2.7 3.3 5.2 7.4 2.7 12.9 5.5 8.2 6.3 5.5 10.3 5.8 7.3 8.6 8.3 12.6 4.5 13.1 11.7 5.9 5.5 11.6 5.1 9.0 7.4 13.2 15.1 13.1 11.4 5.5 4.8 12.4 11.0 6.8 7.3 8.9 7.7 12.1 9.6 10.5 4.8 20.2 28.1 9.3 2.5 14.6 11.6 9.3 8.4 9.1 8.7 8.6 16.7 7.2 7.2 8.8 11.7 7.4 9.9 10.3 13.2 4.4 10.6 3.4 10.0 4.4 12.1 9.6 15.6 15.9 16.6 10.1 12.6 12.4 0.9 3.1 2.7 4.3 3.3 6.3 4.8 4.5 5.0 3.1 3.4 7.4 5.5 0.7 5.2 3.0 3.6 4.4 2.7 11.1 14.3 13.0 16.6 15.5 11.3 15.0 12.4 16.4 14.8 6.0 5.5 4.2 5.9 4.0 7.0 8.2 7.6 2.7 2.3 12.2 9.8 5.8 16.6 4.2 13.5 4.3 0.8 0.0 3.9 6.8 6.0 3.8 3.5 10.4 5.6 7.9 8.6 6.2 10.0 6.8 8.1 6.1 15.1 4.6 3.2 12.6 3.0 0.0 4.2 8.6 9.3 0.0 8.2 27.5 12.0 2.3 3.8 6.2 4.0 1.8 POU1F1 "GHF-1, PIT1, POU1F1a" ENSG00000064835 "POU class 1 homeobox 1" P28069 3 87259404-87276587 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 49 "pituitary gland: 138.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.8;SiHa: 1.1;U-87 MG: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA041646, HPA050624" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041646: AB_10794672, HPA050624: AB_2681192" "unprognostic (1.88e-1)" "unprognostic (2.06e-1)" "unprognostic (4.27e-1)" "unprognostic (1.44e-1)" "unprognostic (3.60e-1)" "unprognostic (2.93e-1)" "unprognostic (1.87e-2)" "unprognostic (7.63e-3)" "unprognostic (3.21e-1)" "unprognostic (1.50e-1)" "unprognostic (4.69e-3)" "unprognostic (1.55e-1)" "unprognostic (1.52e-2)" "unprognostic (1.87e-2)" "unprognostic (1.22e-1)" "unprognostic (1.05e-4)" 0.3 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.2 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 138.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 2.8 0.3 0.1 0.0 0.0 0.4 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.4 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 1.1 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.7 0.2 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 POU2F1 "OCT1, OTF1" ENSG00000143190 "POU class 2 homeobox 1" P14859 1 167220829-167427345 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 36.4" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 96.2;Rod photoreceptor cells: 106.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002608, HPA058559, HPA064323" Supported Supported "Nucleoplasm,Endoplasmic reticulum,Vesicles" No No "Nucleoplasm, Vesicles" "Endoplasmic reticulum" "CAB002608: , HPA058559: AB_2683756, HPA064323: AB_2685245" "unprognostic (1.74e-1)" "unprognostic (9.33e-2)" "unprognostic (1.28e-2)" "unprognostic (1.40e-3)" "unprognostic (5.78e-3)" "unprognostic (4.26e-2)" "unprognostic (5.67e-6)" "unprognostic (4.47e-2)" "unprognostic (5.14e-1)" "unprognostic (7.94e-3)" "unprognostic (1.95e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (2.98e-5)" "unprognostic (1.89e-1)" "unprognostic (4.02e-1)" "unprognostic (3.42e-1)" "unprognostic (1.17e-2)" 6.9 5.7 15.5 7.3 11.9 12.6 7.2 36.4 13.8 7.7 6.6 9.5 5.2 4.1 7.5 8.4 5.3 6.5 4.3 5.1 14.5 6.7 7.0 5.8 6.6 8.2 7.7 10.8 8.1 6.1 15.5 8.3 9.6 7.1 6.7 6.8 12.0 5.5 6.5 10.5 8.8 6.6 5.5 6.3 9.3 6.1 10.1 10.9 7.4 6.9 4.9 9.7 7.6 6.2 7.5 5.9 8.6 5.9 1.4 4.4 2.2 6.4 5.2 13.5 4.1 1.6 1.6 5.5 0.8 1.4 1.6 1.6 7.5 3.7 7.3 3.5 1.3 1.5 5.0 8.2 2.5 2.4 2.9 3.1 5.1 3.6 6.1 1.0 5.6 3.4 1.1 1.4 1.8 3.3 2.0 2.1 5.1 5.4 4.2 2.1 3.4 5.1 3.6 15.7 3.5 2.1 7.5 4.9 3.2 2.8 3.6 8.2 6.2 5.0 3.7 3.3 7.1 4.1 6.9 3.4 3.1 4.9 1.9 3.1 4.0 1.8 16.9 1.4 3.4 3.9 8.6 2.3 2.8 4.4 2.7 3.3 7.5 2.3 2.0 2.5 6.8 3.2 2.4 3.3 1.4 5.9 5.9 2.1 2.2 15.5 11.9 36.4 13.8 14.5 6.7 7.7 10.8 7.1 10.9 11.9 12.1 21.9 10.4 11.8 54.9 13.2 12.7 6.7 10.3 19.2 96.2 15.4 5.0 8.8 23.3 16.6 8.5 0.0 10.1 15.3 13.4 14.9 19.6 11.6 11.2 44.5 23.2 11.1 35.6 28.6 23.9 14.6 6.8 23.4 14.3 47.2 12.6 7.0 19.4 6.9 106.3 25.8 11.9 18.5 40.0 9.7 43.3 13.8 13.0 9.7 POU2F2 "OCT2, OTF2" ENSG00000028277 "POU class 2 homeobox 2" P09086 19 42086110-42196585 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 33.1;brain: 12.0;intestine: 10.8;lymphoid tissue: 43.1" "Cell type enhanced" "Detected in many" 13 "B-cells: 158.6;Bipolar cells: 50.4;Kupffer cells: 98.2;Macrophages: 80.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 33.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 18.5;Daudi: 39.0;hTEC/SVTERT24-B: 15.3;U-266/70: 27.1;U-266/84: 26.2;U-698: 30.9;U-87 MG: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002513, HPA049056, HPA062096, HPA064404, HPA073998" Enhanced Enhanced Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB002513: AB_442118, HPA049056: AB_2732550, HPA062096: AB_2684681, HPA064404: AB_2685259, HPA073998: " "unprognostic (2.07e-2)" "unprognostic (1.14e-1)" "unprognostic (1.16e-2)" "unprognostic (8.89e-2)" "unprognostic (6.77e-2)" "unprognostic (1.44e-2)" "unprognostic (1.62e-2)" "unprognostic (3.34e-1)" "unprognostic (8.39e-2)" "unprognostic (2.09e-1)" "unprognostic (1.52e-1)" "unprognostic (8.56e-2)" "prognostic unfavorable (7.57e-11)" "unprognostic (2.31e-1)" "unprognostic (1.76e-1)" "unprognostic (2.61e-2)" "unprognostic (1.54e-1)" 1.9 2.0 5.6 43.1 7.4 4.8 1.2 12.0 5.7 0.9 3.2 2.5 0.0 2.1 0.9 1.7 1.4 1.5 2.3 4.8 5.7 5.9 1.6 1.4 3.1 31.4 6.8 1.5 0.7 1.6 0.4 2.1 2.5 6.6 2.5 2.1 1.4 2.1 2.3 0.7 1.2 10.8 1.9 6.5 22.7 3.1 6.0 6.2 1.9 1.3 0.6 30.0 4.3 1.0 13.9 8.0 1.7 33.1 0.6 2.7 4.5 0.3 0.5 0.6 0.0 0.0 1.0 0.2 2.8 18.5 1.8 3.6 0.1 0.5 39.0 1.0 1.0 0.3 0.3 0.2 3.0 8.3 0.1 0.1 0.9 0.1 0.0 0.2 0.3 0.8 0.8 0.6 15.3 1.0 0.1 1.1 0.8 0.4 9.0 0.4 0.3 0.1 2.0 0.1 0.0 0.2 0.4 0.0 0.1 0.0 0.2 0.6 0.3 0.1 0.2 0.3 0.2 0.0 4.9 1.5 7.9 0.8 0.0 0.3 27.1 26.2 30.9 15.0 1.0 1.0 1.0 10.7 0.1 1.2 19.3 1.1 11.0 1.8 1.6 8.0 13.9 0.9 1.3 1.7 0.6 33.1 1.3 2.7 4.5 5.6 7.4 12.0 5.7 5.7 5.9 6.8 1.5 6.6 6.2 0.0 9.5 158.6 6.7 6.9 50.4 2.2 5.1 1.4 3.4 0.0 5.9 0.7 0.0 0.9 12.2 1.4 2.7 0.0 2.5 0.8 2.0 2.9 5.8 0.8 41.8 1.6 9.1 4.9 98.2 7.7 0.9 80.0 8.5 1.8 1.1 1.7 2.5 0.0 0.4 0.5 6.9 0.0 2.4 31.0 7.0 7.8 3.1 17.5 0.7 4.7 POU2F3 "Epoc-1, OCT11, PLA-1, Skn-1a" ENSG00000137709 "POU class 2 homeobox 3" Q9UKI9 11 120236640-120319944 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "ductus deferens: 36.5;seminal vesicle: 13.2;skin 1: 38.2" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 18.5;Pancreatic endocrine cells: 12.7;Suprabasal keratinocytes: 33.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.2;EFO-21: 2.7;SK-BR-3: 5.3;T-47d: 9.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019652, HPA073468" Enhanced Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Plasma membrane,Cytosol" NA NA Nucleoplasm "Nucleoli, Nuclear bodies, Plasma membrane, Cytosol" "HPA019652: AB_1855585, HPA073468: " "unprognostic (1.75e-1)" "unprognostic (2.12e-2)" "unprognostic (6.37e-2)" "unprognostic (2.41e-4)" "unprognostic (2.60e-1)" "unprognostic (4.46e-3)" "unprognostic (8.56e-3)" "unprognostic (9.34e-2)" "unprognostic (3.45e-2)" "unprognostic (1.12e-1)" "unprognostic (1.40e-3)" "unprognostic (2.08e-1)" "unprognostic (1.27e-2)" "unprognostic (9.69e-3)" "unprognostic (1.70e-1)" "prognostic favorable (8.14e-4)" "unprognostic (1.45e-1)" 0.2 0.2 0.1 0.2 0.1 0.0 1.6 0.1 0.1 1.2 0.9 0.0 36.5 0.7 0.4 1.2 2.5 0.3 0.4 0.2 0.1 0.1 0.3 0.2 1.6 0.4 0.1 0.0 0.2 0.3 6.4 1.3 4.4 0.1 1.1 0.1 0.0 1.1 13.2 0.1 38.2 1.0 0.2 0.1 0.2 0.4 0.6 0.0 0.4 4.5 4.8 2.2 0.7 2.6 1.0 0.7 2.1 0.5 0.9 0.6 0.2 2.5 0.0 0.0 0.2 0.0 0.0 0.8 0.3 0.6 0.0 0.0 0.1 7.2 0.3 2.7 0.0 0.1 1.3 0.0 0.4 0.0 0.3 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.7 0.4 0.2 0.0 0.1 0.0 1.4 0.0 0.1 0.1 0.2 0.3 0.1 0.6 0.0 0.0 0.1 0.0 1.9 0.5 0.1 0.1 5.3 0.0 0.9 9.7 0.4 0.8 0.0 0.2 0.4 0.1 0.1 0.1 0.0 1.1 0.2 0.1 1.4 0.4 0.5 0.5 0.3 0.5 0.5 0.6 0.4 0.1 1.0 0.6 0.6 2.1 0.9 0.5 0.7 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 5.1 0.0 9.0 18.5 0.0 0.8 0.0 1.4 2.3 10.4 0.0 1.2 0.0 3.6 1.7 0.0 0.3 0.0 1.2 0.2 0.2 5.0 0.0 0.4 0.1 0.0 2.9 0.0 0.0 3.8 0.0 0.0 5.0 0.0 0.0 0.2 12.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 33.0 6.6 0.0 0.5 10.1 POU3F1 "OCT6, OTF6, SCIP" ENSG00000185668 "POU class 3 homeobox 1" Q03052 1 38044611-38046794 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 10.5;skin 1: 31.0" "Cell type enhanced" "Detected in some" 15 "Basal keratinocytes: 24.3;Cone photoreceptor cells: 21.6;Muller glia cells: 14.6;Rod photoreceptor cells: 19.3;Suprabasal keratinocytes: 48.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 11.1;HDLM-2: 19.2;NTERA-2: 5.3;SCLC-21H: 3.8;SK-MEL-30: 15.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 7.0;cerebral cortex: 3.5;hippocampal formation: 9.7" "HPA055980, HPA073824" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA055980: AB_2682995, HPA073824: AB_2686635" "unprognostic (9.99e-2)" "unprognostic (1.63e-1)" "unprognostic (1.69e-1)" "unprognostic (1.43e-2)" "unprognostic (7.46e-3)" "unprognostic (1.96e-2)" "unprognostic (1.33e-2)" "unprognostic (2.56e-1)" "unprognostic (1.11e-1)" "unprognostic (3.07e-2)" "unprognostic (4.40e-2)" "unprognostic (1.40e-1)" "unprognostic (4.61e-4)" "unprognostic (2.79e-2)" "unprognostic (1.97e-1)" "unprognostic (3.61e-2)" "unprognostic (2.67e-3)" 0.8 2.1 4.0 0.9 10.5 0.7 0.8 1.2 6.8 0.6 0.7 1.1 0.0 0.6 0.7 0.8 3.4 0.7 0.7 0.7 7.7 0.9 0.7 0.6 0.6 1.7 3.9 2.9 0.7 0.8 0.6 0.0 0.6 1.4 3.6 0.6 1.6 0.6 0.7 1.3 31.0 0.7 2.5 0.6 0.7 0.7 1.5 2.6 0.0 0.7 1.3 1.7 1.5 0.4 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 11.1 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 19.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.1 0.0 0.0 0.1 0.0 0.7 3.8 0.0 0.0 0.0 15.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.0 10.5 1.2 6.8 7.7 0.9 3.9 2.9 1.4 2.6 0.0 0.0 0.0 1.7 24.3 7.4 4.3 0.0 0.0 0.0 0.0 21.6 0.1 0.0 0.0 0.2 0.7 0.4 0.0 0.0 0.1 0.9 0.8 0.0 0.0 0.2 1.6 1.7 0.0 0.0 0.0 0.3 0.0 6.8 0.0 0.6 14.6 0.0 0.0 0.0 0.0 19.3 0.0 2.0 0.2 1.7 48.8 0.1 0.0 0.4 2.1 POU3F2 "BRN2, OCT7, OTF7, POUF3" ENSG00000184486 "POU class 3 homeobox 2" P20265 6 98834592-98839470 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "brain: 28.0" "Cell type enriched" "Detected in some" 8 "Muller glia cells: 12.3" "Cancer enriched" "Detected in some" 11 "glioma: 16.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 52.2;SK-MEL-30: 7.1;U-251 MG: 15.9;WM-115: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047081, HPA056261" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA047081: , HPA056261: AB_2683081" "unprognostic (5.94e-4)" "unprognostic (7.80e-2)" "unprognostic (3.07e-3)" "unprognostic (1.83e-1)" "unprognostic (3.57e-1)" "unprognostic (1.38e-1)" "unprognostic (1.17e-3)" "unprognostic (1.84e-1)" "unprognostic (1.16e-1)" "unprognostic (1.60e-1)" "unprognostic (1.63e-3)" "unprognostic (4.77e-1)" "unprognostic (9.38e-11)" "unprognostic (4.77e-2)" "unprognostic (2.84e-2)" "unprognostic (8.47e-3)" "unprognostic (4.04e-1)" 0.9 1.0 9.0 0.9 10.8 0.9 0.9 3.4 28.0 0.9 0.9 10.3 0.0 0.9 0.9 0.9 0.9 0.9 0.9 0.9 9.8 7.1 0.9 0.9 0.9 0.9 10.7 6.8 0.9 0.9 0.9 0.0 0.9 9.7 0.9 0.9 0.0 0.9 0.9 0.9 1.0 0.9 0.9 8.4 0.9 0.9 1.2 9.0 0.0 0.9 0.0 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 52.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.9 0.0 0.0 0.0 0.4 0.0 0.2 0.0 2.2 1.7 0.4 0.0 0.0 0.0 2.9 1.5 0.0 0.0 7.1 0.0 0.4 0.0 0.0 0.3 0.0 0.1 15.9 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 9.0 10.8 3.4 12.5 9.8 7.1 10.7 6.8 9.7 9.0 0.0 0.0 0.0 0.2 0.1 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.4 0.1 0.0 0.0 0.0 0.2 POU3F3 "BRN1, OTF8" ENSG00000198914 "POU class 3 homeobox 3" P20264 2 104855511-104858574 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "brain: 18.9;epididymis: 27.2;kidney: 23.7;seminal vesicle: 12.1" "Group enriched" "Detected in some" 5 "Collecting duct cells: 55.8;Distal tubular cells: 23.2" "Group enriched" "Detected in some" 6 "glioma: 21.5;renal cancer: 24.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AF22: 27.6;AN3-CA: 26.4;HEK 293: 10.2;RPTEC TERT1: 31.4;SH-SY5Y: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052792, HPA056039, HPA067151" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA052792: AB_2681951, HPA056039: AB_2683018, HPA067151: AB_2685790" "unprognostic (3.05e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (4.26e-5)" "unprognostic (9.66e-2)" "unprognostic (1.97e-1)" "unprognostic (4.69e-1)" "unprognostic (1.16e-1)" "unprognostic (7.28e-2)" "unprognostic (1.15e-3)" "unprognostic (7.15e-2)" 0.2 0.2 9.0 0.1 8.6 0.0 0.1 4.3 18.9 0.0 0.3 0.0 0.0 27.2 0.0 0.0 0.0 0.0 9.9 6.0 23.7 0.0 0.0 0.1 8.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.1 0.0 0.5 0.0 0.0 10.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.4 0.4 0.9 0.2 0.3 0.2 0.0 0.0 0.0 27.6 26.4 0.2 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 3.2 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 2.9 0.6 0.0 31.4 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.8 1.0 0.0 0.0 0.0 55.8 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.0 0.0 0.0 0.2 0.0 0.0 0.0 7.7 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 POU3F4 "BRN4, DFN3, DFNX2, OTF9" ENSG00000196767 "POU class 3 homeobox 4" P49335 X 83508261-83512127 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "brain: 39.0" "Cell type enriched" "Detected in some" 6 "Collecting duct cells: 10.4" "Cancer enriched" "Detected in single" 21 "glioma: 5.6" "Region enriched" "Detected in all" 6 "basal ganglia: 39.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 145 "AF22: 15.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA062295 Supported Nucleoplasm NA NA Nucleoplasm "HPA062295: AB_2732681" "unprognostic (5.73e-2)" "unprognostic (2.00e-1)" 0.5 0.5 3.3 0.5 39.0 0.6 0.5 5.0 15.2 0.5 0.7 2.4 0.0 0.5 0.5 0.5 0.5 0.5 1.3 0.5 2.8 1.6 2.5 0.5 0.5 0.5 2.4 3.7 1.1 0.5 0.5 0.1 0.5 2.4 0.5 0.6 0.0 0.5 0.5 0.5 0.5 0.5 0.6 1.7 0.5 0.5 0.5 6.6 0.0 0.5 0.0 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 39.0 5.0 4.2 2.8 1.6 2.4 3.7 2.4 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POU4F3 "BRN3C, DFNA15, DFNA42, DFNA52" ENSG00000091010 "POU class 4 homeobox 3" Q15319 5 146338839-146341722 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.8" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.6" "Region enhanced" "Detected in single" "cerebellum: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 2.0;SCLC-21H: 1.9;U-2 OS: 1.9" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 0.5" HPA038215 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA038215: AB_10697245" "unprognostic (8.41e-3)" "unprognostic (9.46e-2)" "unprognostic (1.84e-1)" "unprognostic (6.26e-4)" "unprognostic (1.86e-1)" "unprognostic (1.12e-1)" "unprognostic (1.03e-1)" "unprognostic (9.54e-2)" "unprognostic (1.61e-1)" "unprognostic (2.09e-3)" "unprognostic (1.20e-3)" "unprognostic (1.24e-3)" "unprognostic (1.38e-1)" "unprognostic (1.87e-1)" "unprognostic (8.84e-2)" "unprognostic (7.82e-2)" 0.6 0.1 0.4 0.4 0.6 1.0 0.4 2.8 0.9 0.3 0.2 0.2 0.2 0.1 0.6 0.7 0.2 0.4 0.3 0.2 0.7 0.4 0.3 0.2 0.3 0.2 0.7 0.2 0.6 0.2 0.0 0.2 1.8 0.2 0.2 0.2 0.2 1.1 0.4 0.2 0.8 0.2 0.8 2.4 0.6 0.2 0.4 0.2 1.5 0.5 0.2 0.2 0.6 0.2 0.7 0.4 0.0 0.0 0.0 0.4 0.0 0.2 1.0 0.2 0.4 0.2 0.3 0.0 0.0 0.0 0.2 0.4 0.9 0.2 0.3 0.2 0.3 0.1 0.5 0.3 0.0 0.9 0.4 0.5 0.0 0.1 0.0 0.1 0.1 0.8 0.4 1.6 0.4 0.1 0.0 0.3 0.2 0.2 0.5 0.1 0.1 0.4 2.0 0.1 0.0 0.3 0.8 0.0 0.1 0.4 0.5 1.9 1.6 0.6 0.5 0.1 0.3 0.4 0.1 0.0 0.0 1.9 0.0 0.6 0.6 0.9 0.7 0.0 0.6 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 2.8 0.2 0.7 0.4 0.7 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POU5F1 "MGC22487, OCT3, Oct4, OTF3" ENSG00000204531 "POU class 5 homeobox 1" Q01860 6 31164337-31180731 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 15.3;Collecting duct cells: 8.7;Enterocytes: 8.4;Pancreatic endocrine cells: 8.5" "Cancer enriched" "Detected in many" 34 "testis cancer: 355.9" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 12 "HAP1: 49.8;NTERA-2: 132.5;SuSa: 87.3" "CAB025600, CAB026380, HPA058267, CAB079773" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB025600: , CAB026380: , CAB079773: AB_2687916, HPA058267: AB_2683659" "unprognostic (3.25e-2)" "unprognostic (3.12e-1)" "unprognostic (2.87e-1)" "unprognostic (1.06e-2)" "unprognostic (3.02e-2)" "unprognostic (2.11e-2)" "unprognostic (2.62e-2)" "unprognostic (2.27e-1)" "unprognostic (2.59e-1)" "unprognostic (9.27e-2)" "unprognostic (2.27e-2)" "unprognostic (4.79e-2)" "unprognostic (1.19e-3)" "unprognostic (1.38e-1)" "unprognostic (1.35e-1)" "unprognostic (3.86e-2)" "prognostic favorable (2.04e-5)" 1.2 0.0 1.2 1.2 1.2 1.2 1.2 1.2 1.2 2.3 2.3 1.2 1.2 4.9 3.1 5.7 1.2 5.2 4.3 1.2 1.2 0.0 11.1 5.0 2.0 1.2 1.2 1.2 1.2 8.8 0.0 1.2 1.2 1.2 4.7 1.0 1.2 1.2 3.0 1.2 1.8 5.9 1.2 1.2 1.2 6.3 2.2 1.2 1.2 1.2 1.2 1.2 11.2 1.2 3.0 1.8 1.8 1.0 1.1 0.9 0.3 0.5 0.2 7.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.6 49.8 0.6 0.0 0.0 0.2 0.0 0.4 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 132.5 0.2 0.0 0.1 0.1 0.1 1.0 1.0 0.0 0.0 0.2 0.0 0.0 87.3 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.1 0.0 1.4 1.0 0.5 0.8 0.7 0.5 1.0 0.4 0.4 0.2 3.0 0.9 0.6 1.8 1.1 0.5 1.8 0.3 0.3 1.2 1.2 1.2 1.2 1.2 0.0 1.2 1.2 1.2 1.2 0.0 1.4 0.5 2.4 4.6 0.7 0.4 15.3 1.4 1.2 8.7 2.0 0.0 0.0 4.8 0.0 0.7 8.4 0.0 5.8 0.1 0.5 3.6 0.0 1.5 0.1 0.0 1.2 0.6 0.0 0.0 0.0 0.8 1.7 1.0 3.1 0.0 8.5 3.7 0.7 2.1 0.9 0.0 1.2 0.0 0.4 3.3 0.1 0.0 2.9 3.8 POU5F1B "OTF3C, OTF3P1, POU5F1P1" ENSG00000212993 "POU class 5 homeobox 1B" Q06416 8 127322183-127420066 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 8 "Cone photoreceptor cells: 3.9;Enterocytes: 2.6;Paneth cells: 2.9" "Cancer enhanced" "Detected in some" "colorectal cancer: 1.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 2.5;EFO-21: 3.4;hTERT-HME1: 8.5;NTERA-2: 4.2" HPA058267 Supported Nucleoplasm NA NA Nucleoplasm "HPA058267: AB_2683659" "unprognostic (1.74e-2)" "unprognostic (2.27e-2)" "unprognostic (2.58e-2)" "unprognostic (8.22e-3)" "unprognostic (1.65e-1)" "unprognostic (5.85e-2)" "unprognostic (9.31e-4)" "unprognostic (2.21e-3)" "unprognostic (1.13e-1)" "unprognostic (3.25e-1)" "unprognostic (6.56e-2)" "unprognostic (5.11e-2)" "unprognostic (5.60e-10)" "unprognostic (1.21e-1)" "unprognostic (7.05e-3)" "unprognostic (1.37e-1)" "unprognostic (7.33e-3)" 1.0 0.2 0.2 0.2 0.2 0.6 2.0 0.0 0.4 1.0 0.9 0.0 2.6 1.7 0.9 1.5 0.5 0.3 0.4 0.3 2.8 0.7 0.6 0.7 0.1 0.5 1.2 2.5 0.9 0.6 2.5 1.4 5.1 0.9 0.0 1.6 0.5 0.2 0.0 1.1 0.7 0.4 1.7 0.4 0.8 1.2 0.5 0.1 3.0 0.2 0.0 1.4 0.1 0.5 0.1 0.1 1.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 2.5 1.2 0.0 3.4 0.0 0.0 0.5 0.4 0.2 0.1 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.1 0.8 0.4 0.0 8.5 0.3 0.1 0.5 0.0 0.2 0.0 0.3 0.1 0.1 4.2 0.5 0.1 0.0 0.0 0.0 0.3 0.3 1.3 0.1 0.0 0.5 0.2 1.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 3.0 0.1 0.3 1.0 0.1 1.4 0.1 0.3 0.4 0.0 0.5 0.7 0.9 2.6 0.0 0.2 0.1 1.4 0.1 0.0 0.3 0.0 0.2 0.2 0.0 0.5 0.0 0.0 0.0 0.0 3.9 0.0 1.7 1.3 0.2 0.7 2.6 0.0 1.5 0.0 0.2 0.2 0.0 0.0 0.0 1.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.6 2.9 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 1.5 0.3 POU5F2 "FLJ25680, SPRM-1" ENSG00000248483 "POU domain class 5, transcription factor 2" Q8N7G0 5 93733220-93741637 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 26.8" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 15.9;Rod photoreceptor cells: 15.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "U-2 OS: 8.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA077615 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA077615: " "unprognostic (1.07e-1)" "unprognostic (2.78e-2)" "unprognostic (2.53e-1)" "unprognostic (1.17e-1)" "unprognostic (3.03e-1)" "unprognostic (9.17e-3)" "unprognostic (3.72e-2)" "unprognostic (5.87e-3)" "unprognostic (4.58e-1)" "unprognostic (1.49e-1)" "unprognostic (3.53e-2)" "unprognostic (3.84e-1)" "unprognostic (6.16e-9)" "unprognostic (1.87e-1)" "unprognostic (2.01e-1)" "unprognostic (2.21e-1)" "unprognostic (1.44e-3)" 0.2 0.2 0.2 0.2 0.2 1.2 0.8 0.2 0.9 0.2 0.2 0.2 0.2 0.6 0.2 0.6 0.2 0.1 0.4 0.2 0.2 0.2 0.2 0.2 0.4 0.4 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.3 0.1 0.2 0.2 0.2 0.2 1.4 0.6 0.2 0.2 0.3 0.5 26.8 0.2 0.2 0.5 0.2 0.2 0.2 0.2 2.0 0.5 2.7 0.6 1.1 1.3 0.3 0.4 0.6 1.1 0.5 0.2 0.4 0.5 0.2 0.0 0.3 0.1 0.3 0.5 0.9 0.4 0.2 0.7 0.6 0.9 0.3 0.5 0.6 0.7 0.8 0.7 0.7 0.2 0.8 0.8 0.5 0.7 0.5 0.4 0.5 0.2 0.8 0.6 1.1 0.4 0.4 0.7 1.0 0.7 0.3 0.3 0.5 1.2 0.9 0.2 0.3 1.0 0.9 0.6 0.7 0.2 0.5 0.5 0.7 0.7 0.6 8.5 0.7 0.7 0.8 0.5 0.8 0.5 0.9 0.4 1.4 0.6 0.3 1.0 0.4 1.0 0.8 0.7 0.6 0.1 2.0 0.7 1.1 2.7 1.1 0.4 0.5 1.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 3.0 2.1 3.0 2.1 1.9 10.5 0.4 2.5 1.4 0.0 1.8 5.9 0.7 0.0 1.5 1.7 1.4 1.4 0.0 0.8 0.9 1.4 2.0 8.1 0.8 1.0 15.9 2.9 2.5 1.3 4.5 4.4 2.9 1.7 2.8 0.5 5.4 1.7 0.0 1.4 0.1 15.8 0.0 0.9 6.9 2.3 2.4 0.5 5.4 1.0 2.0 PP2D1 "C3orf48, FLJ25449" ENSG00000183977 "Protein phosphatase 2C like domain containing 1" A8MPX8 3 19979961-20012330 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "testis: 28.8" "Group enriched" "Detected in some" 83 "Early spermatids: 319.7;Late spermatids: 185.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-266/84: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036870, HPA066083" Enhanced Uncertain "Nucleoplasm,Intermediate filaments" NA NA Nucleoplasm "Intermediate filaments" "HPA036870: AB_10671246, HPA066083: AB_2685611" "unprognostic (1.14e-1)" "unprognostic (1.14e-1)" "unprognostic (1.29e-2)" "unprognostic (2.04e-1)" "unprognostic (3.76e-1)" "unprognostic (6.27e-4)" "unprognostic (3.29e-2)" "unprognostic (1.50e-1)" "unprognostic (2.49e-1)" "unprognostic (3.40e-1)" "unprognostic (4.35e-2)" "unprognostic (6.00e-2)" "unprognostic (3.50e-1)" "unprognostic (8.77e-2)" "unprognostic (1.87e-1)" "unprognostic (4.93e-3)" "unprognostic (1.04e-1)" 0.2 0.1 0.1 0.2 0.1 3.0 0.1 0.7 0.4 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.3 0.3 0.2 0.1 0.1 0.3 0.2 28.8 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.7 0.5 1.2 0.6 0.0 0.9 0.0 0.3 0.6 0.7 0.9 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.5 0.8 1.5 0.1 0.0 0.3 0.6 0.0 0.0 0.0 0.2 0.6 0.6 0.9 0.2 0.0 1.5 0.5 0.0 0.0 0.0 0.0 0.8 0.0 1.0 0.5 0.7 0.0 0.2 1.0 0.8 1.0 0.4 0.3 0.9 0.9 1.6 0.0 0.3 0.4 1.9 0.1 2.3 1.4 1.1 0.7 0.8 0.3 0.0 0.3 0.3 0.5 0.6 4.1 1.6 1.8 0.8 0.3 0.0 0.5 0.9 0.8 0.6 0.3 0.2 0.5 0.4 0.1 0.7 0.9 0.8 1.2 0.0 0.4 0.5 0.0 0.0 0.1 0.1 0.7 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 319.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 185.6 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.9 0.0 0.0 3.1 1.3 0.0 0.0 0.0 0.0 0.0 PPARA "hPPAR, NR1C1, PPAR" ENSG00000186951 "Peroxisome proliferator activated receptor alpha" Q07869 22 46150521-46243756 "FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 93.5;Hepatocytes: 134.7;Rod photoreceptor cells: 152.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 12.1;plasmacytoid DC: 3.8" "Group enriched" "Detected in many" 5 "dendritic cells: 3.8;granulocytes: 12.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058901, HPA067049, CAB075701" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB075701: , HPA058901: AB_2683849, HPA067049: AB_2685770" "unprognostic (1.96e-1)" "unprognostic (2.19e-1)" "unprognostic (1.02e-1)" "unprognostic (4.76e-2)" "unprognostic (3.94e-3)" "unprognostic (4.30e-2)" "unprognostic (1.24e-1)" "unprognostic (4.94e-2)" "unprognostic (2.95e-1)" "unprognostic (5.52e-3)" "unprognostic (4.50e-2)" "unprognostic (1.01e-1)" "prognostic favorable (4.39e-9)" "unprognostic (4.84e-2)" "unprognostic (2.76e-1)" "unprognostic (1.23e-1)" "unprognostic (3.18e-2)" 5.7 6.6 5.8 6.0 6.2 4.2 6.9 2.6 4.5 3.8 11.8 5.9 9.9 13.9 4.8 6.6 6.3 3.9 9.1 19.6 5.1 4.1 17.8 30.9 3.8 3.4 6.1 4.9 9.1 13.4 6.6 3.5 3.1 7.8 6.2 7.1 13.5 8.1 8.2 17.1 5.8 19.7 5.0 4.7 3.5 5.7 2.7 7.1 1.3 5.4 10.4 4.8 7.3 12.3 1.5 3.8 12.1 1.4 0.9 1.5 0.3 6.9 1.7 2.2 7.7 12.4 8.0 4.9 6.1 12.1 6.6 6.8 3.4 3.4 2.5 3.1 14.1 6.0 3.1 6.5 8.0 5.9 7.2 8.3 7.7 4.4 7.1 7.7 5.3 13.3 6.3 6.4 4.8 11.1 5.6 1.4 5.7 2.8 5.8 6.1 1.8 6.0 1.9 0.3 5.8 1.7 7.1 8.0 3.2 4.5 4.1 2.2 6.6 2.3 2.2 7.7 3.2 2.5 4.1 2.3 6.8 7.4 6.2 2.6 5.9 3.4 1.0 10.7 6.0 2.1 1.7 1.0 12.1 1.4 1.4 1.2 1.0 0.7 0.7 0.7 1.5 0.8 0.6 0.8 0.9 0.8 3.8 1.5 0.3 5.8 6.2 2.6 4.5 5.1 4.1 6.1 4.9 7.8 7.1 3.0 9.9 5.2 13.1 20.7 14.7 84.0 25.5 2.7 7.9 7.0 58.9 6.8 8.3 7.2 0.4 16.1 66.1 93.5 14.3 5.4 13.0 13.9 4.7 134.7 7.4 4.8 19.1 20.9 22.5 0.4 18.1 9.6 3.3 11.8 34.6 15.2 11.6 24.6 28.3 36.9 152.6 6.5 14.4 0.7 1.7 29.9 2.5 7.5 31.6 17.9 PPARG "NR1C3, PPARG1, PPARG2, PPARgamma" ENSG00000132170 "Peroxisome proliferator activated receptor gamma" P37231 3 12287368-12434356 "Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes, Diabetes mellitus, Disease mutation, FDA approved drug targets, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 97.6;breast: 102.1" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 90.9;Extravillous trophoblasts: 187.1;Urothelial cells: 210.8" "Cancer enhanced" "Detected in all" "urothelial cancer: 33.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 1.8;intermediate monocyte: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 47.9;ASC TERT1: 27.3;BEWO: 56.5;CAPAN-2: 25.2;HSkMC: 28.1;RT4: 34.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB004282, HPA051239, HPA063663" Approved Enhanced Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB004282: AB_628115, HPA051239: AB_2681400, HPA063663: AB_2685081" "unprognostic (7.35e-3)" "unprognostic (3.27e-2)" "unprognostic (4.05e-2)" "unprognostic (8.37e-2)" "unprognostic (2.41e-2)" "unprognostic (5.27e-3)" "prognostic unfavorable (3.41e-5)" "unprognostic (9.13e-2)" "unprognostic (2.32e-2)" "unprognostic (1.38e-1)" "unprognostic (1.02e-2)" "unprognostic (2.77e-1)" "prognostic favorable (1.59e-8)" "unprognostic (1.51e-2)" "unprognostic (1.46e-1)" "unprognostic (9.68e-3)" "prognostic favorable (5.52e-5)" 97.6 1.6 1.9 17.1 1.2 0.7 102.1 1.5 1.3 3.1 24.9 0.8 2.1 7.5 3.5 2.2 2.8 2.4 8.7 12.5 1.4 0.9 6.7 5.9 24.8 11.4 1.1 0.9 6.7 1.2 2.8 0.3 26.8 0.9 10.4 13.9 1.1 5.8 1.5 5.0 2.7 9.6 7.4 1.2 7.0 11.9 3.5 0.6 0.9 6.2 4.3 2.1 30.2 14.1 0.0 0.4 0.0 2.3 0.0 0.7 0.3 9.7 8.7 0.0 0.0 47.9 27.3 56.5 0.9 10.5 1.3 0.5 1.8 25.2 0.0 0.0 0.9 17.1 4.0 3.5 0.1 0.2 23.5 4.9 0.0 1.9 2.3 12.8 0.0 0.0 28.1 2.3 2.4 9.1 5.0 0.1 0.2 0.0 0.0 2.0 2.5 0.0 0.1 0.1 22.7 25.2 0.0 0.0 0.0 7.2 34.5 0.0 0.2 4.1 1.5 0.5 1.7 0.0 7.8 7.9 1.8 2.6 1.0 0.0 0.0 0.0 0.0 0.8 0.1 0.2 0.0 1.8 0.0 0.0 2.3 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.3 1.9 1.2 1.5 1.3 1.4 0.9 1.1 0.9 0.9 0.6 3.0 7.4 0.0 33.7 0.9 0.5 5.2 2.5 2.7 3.4 5.2 0.0 90.9 1.7 0.1 2.6 17.7 47.1 0.0 0.6 187.1 4.3 35.2 9.2 3.8 46.3 0.0 8.1 19.6 14.5 0.8 3.7 8.6 3.3 2.8 20.5 0.5 10.2 42.1 0.0 11.3 0.0 12.9 5.7 7.9 21.8 1.0 74.4 1.3 16.6 210.8 PPARGC1A "PGC-1alpha, PGC1, PGC1A, PPARGC1" ENSG00000109819 "PPARG coactivator 1 alpha" Q9UBK2 4 23755041-23904089 "Cancer-related genes, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Activator, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 49.5;liver: 49.7;skeletal muscle: 55.6" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 81.8;Cholangiocytes: 66.2;Early spermatids: 52.7;Hepatocytes: 48.9;Late spermatids: 51.4" "Cancer enhanced" "Detected in many" "renal cancer: 7.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "A-431: 43.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063136 Supported Nucleoplasm NA NA Nucleoplasm "HPA063136: AB_2684948" "unprognostic (1.08e-1)" "unprognostic (7.47e-2)" "unprognostic (6.85e-3)" "unprognostic (2.28e-6)" "unprognostic (5.00e-2)" "unprognostic (1.15e-1)" "prognostic favorable (3.35e-6)" "unprognostic (3.04e-1)" "unprognostic (1.79e-1)" "unprognostic (1.69e-1)" "unprognostic (6.77e-2)" "unprognostic (4.58e-2)" "prognostic favorable (1.49e-14)" "unprognostic (3.62e-2)" "unprognostic (2.31e-1)" "prognostic unfavorable (5.80e-4)" "unprognostic (3.07e-3)" 5.7 2.4 3.1 2.4 4.2 0.3 1.3 4.7 5.5 2.6 9.4 4.2 1.8 5.7 0.9 4.8 3.0 1.2 2.2 24.6 3.3 3.1 49.5 49.7 2.5 0.4 3.1 1.8 1.3 2.8 14.6 7.6 0.3 7.8 2.6 6.6 14.0 30.4 3.0 55.6 5.5 14.2 1.6 3.2 0.8 3.1 3.4 3.4 0.3 17.4 18.2 1.5 1.7 1.0 0.0 0.0 0.2 0.6 0.0 0.0 0.3 43.9 0.0 0.8 0.0 1.3 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 2.1 5.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 3.5 0.0 0.0 0.3 0.0 6.3 0.0 2.1 0.1 1.4 0.0 1.8 2.2 0.2 0.7 0.0 0.4 0.4 0.0 0.8 3.9 0.0 0.0 0.8 0.7 0.1 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.1 4.2 4.7 5.5 3.3 3.1 3.1 1.8 7.8 3.4 17.9 1.6 1.7 5.5 0.8 3.8 81.8 66.2 8.1 6.8 34.9 37.3 0.0 44.7 6.6 52.7 0.3 26.8 0.0 0.0 0.0 0.2 1.4 1.1 48.9 0.0 0.0 25.6 1.8 2.4 51.4 0.9 0.0 6.8 0.0 13.0 5.8 0.9 7.0 2.1 22.6 0.7 0.0 5.1 0.7 0.2 1.0 0.0 1.0 10.8 0.4 PPARGC1B "PERC, PGC1B" ENSG00000155846 "PPARG coactivator 1 beta" Q86YN6 5 149730298-149855022 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Bipolar cells: 105.6;Cone photoreceptor cells: 127.6;Rod photoreceptor cells: 72.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 6.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050543 Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA050543: AB_2681165" "unprognostic (2.86e-1)" "unprognostic (1.07e-2)" "unprognostic (5.09e-3)" "unprognostic (1.13e-3)" "unprognostic (2.63e-1)" "unprognostic (2.00e-3)" "unprognostic (4.51e-3)" "unprognostic (6.55e-2)" "unprognostic (9.14e-3)" "unprognostic (2.65e-2)" "unprognostic (1.83e-1)" "unprognostic (1.21e-1)" "unprognostic (9.01e-6)" "unprognostic (8.45e-2)" "unprognostic (5.09e-2)" "unprognostic (1.51e-1)" "unprognostic (2.77e-3)" 4.5 2.4 3.9 9.5 7.1 4.3 3.5 16.3 8.7 3.9 15.6 1.6 16.3 13.1 5.4 2.6 9.0 5.5 6.2 10.0 3.3 4.1 2.3 3.7 7.4 3.0 3.3 4.8 3.2 3.4 17.7 2.0 3.2 7.2 6.4 11.6 7.6 4.0 19.7 10.3 6.6 16.6 18.6 2.7 4.2 7.9 2.0 1.3 2.2 1.7 8.4 5.8 11.5 5.6 1.9 2.4 2.2 6.2 0.8 0.7 0.5 0.5 1.9 0.8 4.6 1.8 0.6 7.4 0.3 0.0 0.5 0.7 8.3 1.9 9.0 1.3 0.0 2.1 5.6 6.8 3.4 0.6 0.5 5.9 8.4 3.2 1.7 0.5 11.5 3.4 0.9 4.6 1.8 3.1 0.3 1.0 4.0 5.7 3.0 0.4 2.2 4.2 5.4 3.0 2.5 4.9 8.0 5.0 5.0 1.4 11.0 2.5 0.6 1.3 9.8 1.5 1.4 2.6 3.8 1.3 1.1 1.7 3.7 1.8 3.7 2.7 5.3 2.3 7.3 0.9 1.0 2.0 0.7 0.4 3.8 0.7 1.9 0.4 0.3 2.4 0.9 0.6 0.6 2.2 0.8 6.2 0.3 0.3 0.5 3.9 7.1 16.3 8.7 3.3 4.1 3.3 4.8 7.2 1.3 0.0 0.6 1.5 3.2 4.5 105.6 18.8 2.5 0.0 1.2 1.8 127.6 1.5 1.7 0.2 0.2 3.5 17.2 0.0 0.7 1.2 1.8 1.7 1.1 3.4 6.9 7.9 5.2 5.5 9.5 0.0 1.4 8.3 3.3 1.0 8.5 3.6 0.5 3.5 0.4 1.9 72.0 6.5 6.1 0.2 3.2 9.4 4.1 0.0 19.0 3.4 PPDPF "C20orf149, dJ697K14.9, exdpf" ENSG00000125534 "Pancreatic progenitor cell differentiation and proliferation factor" Q9H3Y8 20 63520724-63522206 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Distal tubular cells: 2540.0;Paneth cells: 2816.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 18.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040929 Approved Nucleoplasm,Nucleoli,Microtubules Yes No "Nucleoplasm, Microtubules" Nucleoli "HPA040929: AB_10794155" "unprognostic (3.75e-2)" "unprognostic (5.39e-2)" "unprognostic (4.37e-2)" "unprognostic (9.03e-2)" "unprognostic (1.07e-1)" "unprognostic (2.38e-2)" "unprognostic (2.03e-2)" "unprognostic (2.42e-1)" "unprognostic (3.43e-2)" "unprognostic (1.91e-1)" "unprognostic (2.00e-1)" "unprognostic (4.20e-1)" "prognostic favorable (3.91e-4)" "unprognostic (1.04e-1)" "unprognostic (1.03e-1)" "unprognostic (4.20e-1)" "unprognostic (2.09e-2)" 63.9 19.9 42.2 46.0 43.0 36.5 38.8 22.3 55.1 54.3 78.6 61.5 43.5 41.3 39.9 46.0 112.6 44.7 67.3 53.2 32.9 31.0 72.1 28.4 56.5 42.8 44.5 34.9 45.6 69.5 15.4 35.0 22.2 48.7 75.3 32.2 58.8 143.7 54.1 116.1 86.2 48.5 61.8 72.0 40.0 120.2 49.0 21.6 28.7 48.0 73.3 87.9 68.6 65.2 5.8 3.4 18.9 4.5 2.4 5.2 3.4 44.6 13.9 9.5 19.2 10.8 18.2 30.7 27.5 8.9 36.0 14.2 25.4 26.9 9.6 37.1 18.3 13.7 47.3 4.8 31.4 5.8 17.1 9.5 3.9 13.0 4.8 29.7 0.0 20.6 17.9 63.4 9.1 12.7 11.9 14.1 12.2 16.1 22.7 13.1 60.8 45.7 0.4 10.3 35.8 80.8 20.9 21.5 19.4 25.7 18.4 32.6 24.9 27.3 44.1 18.9 6.6 63.0 26.2 23.2 30.4 34.6 40.2 22.7 18.1 14.2 6.5 21.5 11.3 19.8 1.9 2.4 18.9 5.2 3.1 4.3 4.6 4.6 4.8 2.9 5.8 4.1 4.5 1.1 2.4 4.5 3.4 5.0 3.4 42.2 43.0 22.3 55.1 32.9 31.0 44.5 34.9 48.7 21.6 291.8 201.0 276.1 613.6 510.4 42.1 61.0 749.1 294.5 174.0 910.7 11.8 432.7 2540.0 793.9 185.5 235.8 2093.0 327.1 669.9 547.6 555.3 988.2 330.2 190.7 548.2 47.7 765.2 266.4 322.1 856.1 344.3 360.7 1130.3 1110.9 1414.5 95.8 744.2 2816.1 271.2 1340.7 49.4 194.1 670.9 133.9 288.9 814.8 346.3 385.8 996.5 1073.4 PPHLN1 ENSG00000134283 "Periphilin 1" Q8NEY8 12 42238447-42459715 "Predicted intracellular proteins" "Keratinization, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 85.8" "Low region specificity" "Detected in all" "HPA038902, HPA038903" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA038902: AB_10674844, HPA038903: AB_2676263" "unprognostic (4.06e-2)" "unprognostic (1.66e-1)" "unprognostic (6.51e-2)" "unprognostic (2.61e-2)" "unprognostic (1.80e-1)" "unprognostic (7.92e-2)" "prognostic unfavorable (1.28e-7)" "unprognostic (2.85e-2)" "unprognostic (7.56e-2)" "unprognostic (1.07e-2)" "unprognostic (1.58e-1)" "unprognostic (4.42e-3)" "prognostic unfavorable (5.06e-5)" "unprognostic (3.16e-1)" "unprognostic (3.08e-1)" "unprognostic (3.22e-3)" "unprognostic (2.04e-2)" 25.6 32.4 29.0 37.2 34.2 37.6 27.8 43.0 32.2 24.3 23.7 18.9 27.7 19.2 35.3 27.7 27.0 25.3 24.5 29.0 25.6 28.7 25.2 25.2 23.0 44.3 23.8 35.0 30.6 21.3 20.7 39.9 24.2 26.3 22.6 27.1 21.6 31.1 24.9 32.0 26.1 26.9 28.3 24.6 30.5 23.1 48.4 24.9 51.4 23.1 28.6 47.2 28.1 25.3 25.0 24.1 23.1 14.5 23.7 33.2 12.2 14.7 13.8 16.4 13.6 14.8 16.5 14.5 17.4 19.8 18.3 15.2 22.2 18.7 25.2 22.1 18.5 8.6 13.8 16.8 18.2 22.6 21.6 17.5 39.4 14.2 20.1 15.6 46.4 22.8 19.6 18.7 14.5 14.0 20.9 22.8 22.2 19.2 19.5 20.0 11.3 26.0 28.0 14.2 40.5 13.7 22.2 18.7 23.1 28.5 13.1 11.6 17.1 15.3 12.4 14.9 16.3 18.9 23.3 15.7 10.7 19.1 10.3 14.9 22.5 31.3 40.6 18.1 85.8 7.0 21.0 12.8 23.1 19.3 14.5 23.2 25.0 24.7 25.9 24.1 21.1 22.7 22.6 8.3 23.7 13.4 22.9 33.2 12.2 29.0 34.2 43.0 32.2 25.6 28.7 23.8 35.0 26.3 24.9 38.7 47.5 78.2 56.2 67.3 59.8 29.5 45.9 54.9 54.6 40.1 27.5 73.8 31.5 53.2 175.7 43.2 30.4 23.3 59.6 62.8 45.5 38.3 54.4 29.8 46.7 35.0 32.3 38.1 37.1 48.4 54.1 61.7 60.8 100.0 34.6 43.3 55.2 38.6 49.1 39.8 57.0 51.8 37.6 123.1 54.7 51.7 37.0 76.2 39.2 43.7 PPIB "CYPB, OI9" ENSG00000166794 "Peptidylprolyl isomerase B" P23284 15 64155812-64163205 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Isomerase, Rotamase" "Disease mutation, Dwarfism, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011487, HPA012720" Enhanced Supported "Nucleoplasm,Endoplasmic reticulum" "Secreted to blood" No No 120000000 "Endoplasmic reticulum" Nucleoplasm "CAB011487: AB_443295, HPA012720: AB_1847399" "unprognostic (3.00e-3)" "unprognostic (5.65e-3)" "unprognostic (2.81e-1)" "prognostic favorable (1.56e-5)" "unprognostic (1.65e-1)" "unprognostic (1.07e-3)" "unprognostic (3.69e-2)" "unprognostic (1.27e-2)" "unprognostic (7.19e-2)" "unprognostic (8.80e-3)" "unprognostic (2.87e-1)" "unprognostic (2.79e-2)" "prognostic unfavorable (2.02e-11)" "unprognostic (7.05e-2)" "unprognostic (3.77e-2)" "unprognostic (1.82e-1)" "unprognostic (3.90e-2)" 56.9 64.3 23.9 49.3 26.9 54.9 48.1 15.1 32.1 75.3 44.1 35.4 102.8 42.0 64.2 106.9 48.0 54.8 58.1 44.5 23.8 27.3 89.5 285.9 57.2 63.8 29.7 19.6 67.5 193.7 26.7 71.8 120.2 27.5 51.0 47.7 36.2 123.3 95.4 19.5 33.1 57.5 54.3 30.7 78.0 47.7 27.2 29.5 53.7 154.3 45.7 69.1 49.2 51.7 63.5 191.6 41.0 51.1 44.9 71.6 87.1 39.7 50.0 45.2 102.6 158.3 91.9 39.8 94.9 124.7 75.2 89.4 71.9 73.8 38.0 77.2 147.0 76.4 64.9 82.5 63.8 38.8 24.1 31.1 53.6 55.2 94.1 166.0 53.4 48.5 84.6 68.8 43.8 106.9 93.2 90.8 18.2 37.3 132.4 56.9 63.5 16.3 82.0 39.4 110.7 32.2 31.2 48.0 193.7 78.0 62.0 25.6 40.3 43.5 74.8 69.1 69.6 44.7 163.5 55.8 75.2 62.3 42.0 64.0 71.9 69.6 39.9 70.2 86.1 75.0 41.0 51.1 33.9 71.6 39.2 71.5 63.5 50.5 58.1 67.4 38.0 33.0 44.2 25.5 44.9 25.2 191.6 40.1 87.1 23.9 26.9 15.1 32.1 23.8 27.3 29.7 19.6 27.5 29.5 116.1 168.3 153.4 361.8 142.3 26.7 0.7 280.2 128.5 194.5 258.2 29.5 546.5 76.3 534.3 16.2 209.5 301.3 70.0 495.6 1107.3 581.4 486.2 176.7 431.7 566.9 42.9 284.9 371.4 213.7 20.8 422.5 284.2 266.6 285.9 313.7 126.6 471.5 326.7 369.5 231.9 33.9 226.4 234.9 37.1 72.8 126.6 935.7 261.7 353.5 357.9 PPID CYP-40 ENSG00000171497 "Peptidylprolyl isomerase D" Q08752 4 158709134-158723396 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Protein transport, Transport" "Chaperone, Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019520, HPA019692" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA Cytosol "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA019520: AB_1847400, HPA019692: AB_1847401" "unprognostic (4.26e-2)" "unprognostic (2.03e-2)" "unprognostic (8.91e-3)" "unprognostic (8.17e-3)" "unprognostic (1.50e-1)" "unprognostic (2.04e-3)" "unprognostic (4.72e-2)" "unprognostic (1.62e-2)" "unprognostic (4.72e-2)" "unprognostic (5.92e-2)" "unprognostic (4.54e-2)" "unprognostic (1.46e-2)" "unprognostic (2.66e-3)" "unprognostic (8.78e-2)" "unprognostic (1.74e-1)" "unprognostic (1.64e-1)" "unprognostic (1.09e-1)" 16.8 25.8 20.1 15.5 21.4 14.9 22.3 26.7 26.8 12.6 16.8 14.4 18.2 33.4 14.6 13.6 16.5 15.4 13.0 28.8 19.4 22.1 21.5 45.3 11.0 17.4 22.6 18.9 14.6 17.5 11.3 30.3 14.5 26.0 16.1 14.2 9.1 15.4 13.7 53.3 24.0 29.2 13.1 22.7 16.5 15.5 16.9 23.4 22.7 21.7 16.0 16.8 15.4 55.0 15.6 17.2 33.4 22.2 23.9 24.4 17.1 15.5 14.5 14.6 20.0 21.7 16.3 22.1 15.4 8.4 14.2 10.8 18.8 10.7 16.5 6.9 14.3 22.3 12.0 44.2 17.7 17.3 54.5 15.4 29.5 13.1 25.8 16.8 18.4 22.2 10.3 14.4 12.1 18.2 18.4 15.4 28.2 36.7 29.4 15.8 14.9 26.4 16.7 20.1 25.5 19.4 12.0 7.2 14.1 15.6 7.8 24.7 16.6 11.5 24.0 21.9 22.1 11.0 17.7 14.9 14.2 16.0 15.6 20.3 16.9 35.0 21.0 18.1 20.0 14.2 33.4 15.3 33.2 21.2 22.2 24.4 14.6 20.7 19.6 16.7 15.6 21.5 22.0 20.9 23.9 22.0 17.2 22.4 17.1 20.1 21.4 26.7 26.8 19.4 22.1 22.6 18.9 26.0 23.4 6.0 12.0 18.8 25.3 9.0 24.6 50.0 28.1 76.3 33.0 26.2 21.6 33.4 31.5 34.8 23.6 25.6 19.0 0.0 20.1 39.2 21.3 25.8 31.2 16.1 36.7 71.5 18.8 18.4 11.0 15.7 19.0 21.8 13.5 63.1 22.9 21.7 26.7 21.6 21.2 24.9 25.3 6.5 30.2 78.8 76.3 10.3 39.8 27.4 24.2 17.2 PPIL2 "CYC4, Cyp-60, UBOX7" ENSG00000100023 "Peptidylprolyl isomerase like 2" Q13356 22 21666009-21700015 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 67.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "K-562: 71.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035344, HPA055637" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035344: AB_10672863, HPA055637: AB_2682869" "unprognostic (1.97e-3)" "unprognostic (3.61e-2)" "unprognostic (2.70e-2)" "unprognostic (4.31e-2)" "unprognostic (2.27e-1)" "unprognostic (2.90e-3)" "unprognostic (5.16e-3)" "unprognostic (3.77e-2)" "unprognostic (9.46e-2)" "unprognostic (1.54e-1)" "unprognostic (2.33e-2)" "unprognostic (1.89e-2)" "unprognostic (2.45e-3)" "unprognostic (5.46e-2)" "unprognostic (5.39e-2)" "unprognostic (5.39e-2)" "unprognostic (1.54e-3)" 15.0 21.5 19.4 20.9 24.6 16.6 13.5 24.1 30.9 17.7 17.4 25.3 19.1 18.6 21.8 17.0 22.3 15.7 16.5 20.0 17.2 17.1 21.2 20.3 14.6 23.7 15.6 20.9 16.6 31.4 23.6 30.2 31.4 19.0 19.5 17.6 23.6 22.0 16.5 25.5 17.5 19.1 15.2 15.0 21.3 19.5 18.4 17.6 32.8 27.0 13.6 33.5 17.4 16.2 8.7 11.7 4.8 17.3 12.8 13.2 9.1 6.6 6.9 8.1 8.5 8.3 7.1 7.3 8.7 6.2 10.7 9.2 7.0 4.4 11.5 5.3 9.7 5.4 9.8 10.8 7.5 6.4 7.1 11.1 10.7 6.9 8.3 6.0 16.9 10.1 7.7 6.8 7.6 5.8 6.5 9.2 7.3 71.2 8.3 7.6 10.4 7.6 4.6 7.8 12.4 4.3 9.8 12.0 2.3 5.4 6.7 12.7 6.9 7.9 12.7 2.9 5.0 9.1 5.7 11.1 6.7 11.0 7.9 5.5 9.6 7.0 8.7 7.6 6.4 8.1 1.0 8.6 4.7 9.5 13.9 11.4 7.0 11.1 12.0 11.7 8.7 9.8 8.9 4.8 12.8 17.3 11.1 13.2 9.1 19.4 24.6 24.1 30.9 17.2 17.1 15.6 20.9 19.0 17.6 8.9 25.6 20.6 7.3 2.9 22.7 4.0 30.6 6.7 17.0 14.0 31.4 13.2 11.6 10.6 57.9 5.4 16.9 0.0 14.6 12.4 5.7 12.9 16.2 16.6 13.2 17.5 10.9 11.1 24.4 67.5 11.2 14.4 1.7 10.0 20.5 12.3 15.0 17.3 12.7 7.0 29.8 0.0 4.4 18.6 16.3 5.0 18.5 15.9 18.4 10.3 PPIL3 CyPJ ENSG00000240344 "Peptidylprolyl isomerase like 3" Q9H2H8 2 200870907-200889303 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040765, HPA062187" Approved Approved Nucleoplasm,Nucleoli NA NA 35000 Nucleoplasm Nucleoli "HPA040765: AB_2677125, HPA062187: AB_2684706" "unprognostic (8.96e-3)" "unprognostic (6.07e-2)" "unprognostic (5.34e-2)" "unprognostic (8.16e-2)" "unprognostic (2.69e-2)" "unprognostic (9.61e-2)" "unprognostic (8.31e-2)" "unprognostic (8.05e-2)" "unprognostic (1.40e-2)" "prognostic favorable (1.19e-4)" "unprognostic (5.23e-2)" "unprognostic (6.60e-2)" "prognostic unfavorable (5.16e-4)" "unprognostic (1.14e-1)" "unprognostic (5.96e-2)" "unprognostic (2.21e-2)" "unprognostic (4.87e-2)" 12.4 17.9 18.1 15.5 19.2 24.2 21.1 20.1 20.2 19.4 16.4 18.4 21.1 12.7 17.2 24.3 25.4 19.1 15.9 17.6 17.5 21.8 15.9 19.4 15.9 23.7 20.0 11.8 31.4 16.7 11.9 17.4 15.5 23.0 19.5 16.6 16.3 13.8 15.8 13.4 14.7 15.7 16.8 23.2 20.2 15.7 18.2 13.0 26.3 23.7 19.4 25.5 28.6 13.6 23.4 21.7 18.7 14.1 20.6 20.6 10.7 8.0 7.1 22.1 9.6 17.3 37.2 7.2 12.8 13.9 14.8 15.0 5.2 15.2 7.7 13.6 13.8 17.4 10.6 7.7 15.6 13.3 16.3 18.5 32.5 19.9 35.1 8.9 31.1 16.5 13.5 15.3 12.1 19.1 25.0 9.8 15.3 25.7 18.9 18.8 12.8 23.9 24.8 13.5 8.1 11.5 9.1 12.4 12.1 19.4 12.4 9.2 8.5 12.9 12.3 20.6 27.1 10.2 14.2 13.4 21.3 12.1 12.6 10.5 20.7 19.6 36.3 16.3 13.9 13.5 18.7 12.7 12.7 12.7 10.8 18.5 23.4 15.6 13.7 21.7 18.9 19.1 20.6 3.0 20.6 14.1 17.9 20.1 10.7 18.1 19.2 20.1 20.2 17.5 21.8 20.0 11.8 23.0 13.0 0.0 11.5 24.3 38.6 28.2 12.5 17.8 17.8 21.4 11.4 15.7 9.8 45.1 48.0 20.2 14.8 15.7 12.9 0.0 14.0 44.2 34.2 17.7 25.4 15.7 41.6 3.2 9.1 16.0 41.1 2.7 33.9 45.8 27.0 23.4 25.0 17.1 18.9 24.6 26.5 45.3 10.5 19.4 29.4 36.5 22.3 40.5 25.7 32.6 29.2 23.7 PPIL4 ENSG00000131013 "Peptidylprolyl isomerase like 4" Q8WUA2 6 149504733-149546038 "Enzymes, Predicted intracellular proteins" "Isomerase, RNA-binding, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031599, HPA031600" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA031599: AB_2673950, HPA031600: AB_10600928" "unprognostic (6.12e-2)" "unprognostic (4.90e-2)" "unprognostic (3.85e-2)" "unprognostic (8.42e-2)" "unprognostic (7.53e-2)" "unprognostic (6.36e-3)" "unprognostic (2.91e-3)" "unprognostic (2.22e-1)" "unprognostic (4.22e-2)" "unprognostic (1.09e-1)" "unprognostic (2.38e-1)" "unprognostic (4.62e-2)" "unprognostic (3.88e-2)" "unprognostic (2.11e-1)" "unprognostic (1.59e-1)" "unprognostic (8.50e-2)" "unprognostic (7.94e-2)" 20.0 20.1 20.6 15.0 35.5 30.6 21.2 35.1 27.8 24.0 15.3 19.7 10.1 14.1 21.1 27.2 15.7 18.0 19.8 18.3 21.3 15.6 18.8 23.0 17.9 15.7 20.9 18.0 32.9 16.0 20.8 36.6 22.6 23.9 20.5 16.8 15.7 18.2 16.7 14.8 15.4 16.0 20.0 22.7 17.6 16.0 15.9 19.4 27.0 26.8 8.2 16.8 22.0 19.2 21.4 16.6 24.9 17.8 28.7 24.6 14.8 11.1 6.0 21.0 17.3 12.5 16.4 19.6 22.0 21.0 24.1 25.7 12.6 11.4 11.8 15.2 16.9 14.4 10.1 16.0 8.4 38.3 17.1 15.1 13.0 13.2 21.6 19.7 23.6 11.1 12.8 14.4 24.6 20.6 13.5 13.1 8.6 28.3 7.1 18.7 11.9 13.4 20.3 16.6 11.2 9.5 18.2 19.4 5.9 18.3 8.5 12.4 9.5 26.2 11.5 15.0 15.2 13.5 17.2 15.3 16.0 12.5 28.3 20.9 9.4 4.8 18.5 13.5 19.0 23.0 24.9 16.1 18.1 14.7 17.8 20.4 21.4 19.5 16.9 16.6 16.6 24.6 18.7 13.4 28.7 16.1 16.2 20.7 14.8 20.6 35.5 35.1 27.8 21.3 15.6 20.9 18.0 23.9 19.4 62.5 64.3 22.6 54.3 43.4 44.2 33.3 17.8 80.3 61.4 43.6 7.9 43.1 36.5 34.7 17.2 37.3 15.2 0.0 23.1 37.9 55.5 27.1 73.0 18.7 31.8 27.0 22.3 30.7 21.3 9.6 57.2 29.9 38.8 47.7 19.7 40.0 26.4 22.9 52.6 27.5 35.5 51.8 68.4 58.2 53.4 39.5 54.6 41.5 20.0 32.7 PPIL6 "bA425D10.6, dJ919F19.1, MGC41939, RSPH12" ENSG00000185250 "Peptidylprolyl isomerase like 6" Q8IXY8 6 109390215-109441171 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 36.5" "Group enriched" "Detected in many" 4 "Ciliated cells: 187.4;Early spermatids: 262.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 6.5;ASC diff: 10.4;ASC TERT1: 12.9;hTERT-RPE1: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA036717, HPA058165" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA036717: AB_10671969, HPA058165: " "unprognostic (1.24e-1)" "unprognostic (2.40e-1)" "unprognostic (5.68e-2)" "unprognostic (2.68e-2)" "unprognostic (3.12e-1)" "unprognostic (3.61e-2)" "unprognostic (1.26e-1)" "unprognostic (5.53e-2)" "unprognostic (3.14e-1)" "unprognostic (8.03e-2)" "unprognostic (1.42e-3)" "unprognostic (2.51e-2)" "unprognostic (4.71e-2)" "unprognostic (1.95e-1)" "unprognostic (3.29e-2)" "unprognostic (5.86e-2)" "unprognostic (2.32e-1)" 1.5 1.4 5.5 1.1 8.6 0.7 3.6 5.0 4.8 4.6 1.7 7.2 7.4 1.9 3.8 12.7 2.0 36.5 1.7 2.6 6.0 5.4 4.9 1.2 8.9 1.1 3.4 3.2 6.3 4.3 6.6 7.6 1.6 18.3 1.8 1.6 2.6 2.8 5.0 3.9 1.7 1.1 5.4 3.2 1.3 2.3 20.4 5.3 0.0 17.2 1.4 1.1 2.9 2.0 5.1 1.7 2.0 1.3 1.7 1.3 1.1 1.8 1.0 1.2 6.5 10.4 12.9 1.1 0.0 2.3 0.5 0.2 0.1 1.8 0.0 0.5 0.6 0.9 1.2 1.0 0.0 0.3 0.5 0.9 0.5 0.1 0.0 5.2 0.6 0.3 2.7 6.2 0.2 3.9 9.3 0.8 1.4 0.9 0.3 0.4 0.6 0.1 0.6 0.2 4.2 1.3 0.8 0.0 0.6 5.0 0.1 1.5 2.5 0.2 0.3 4.3 0.3 0.5 1.0 0.4 0.1 0.2 1.1 0.2 0.3 0.1 0.1 2.1 0.1 0.4 2.0 1.2 1.2 0.9 1.3 0.9 5.1 1.2 1.1 1.7 3.2 1.1 1.0 1.6 1.7 1.1 1.7 1.3 1.1 5.5 8.6 5.0 4.8 6.0 5.4 3.4 3.2 18.3 5.3 6.0 5.8 0.0 3.5 1.9 2.1 3.3 5.1 187.4 22.7 3.5 2.0 0.5 21.6 1.6 262.5 1.5 0.7 0.0 1.0 0.7 1.7 2.9 0.0 0.0 0.3 1.6 2.9 0.6 0.0 40.8 4.9 0.5 3.3 1.0 1.8 4.9 0.7 0.0 4.9 8.0 11.5 0.0 1.2 52.6 22.0 2.6 0.6 0.5 1.7 1.1 PPL ENSG00000118898 Periplakin O60437 16 4882507-4960741 "Plasma proteins, Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 126.9;lymphoid tissue: 60.9;tongue: 57.8" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 68.5;Collecting duct cells: 54.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 4 "neutrophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 27.2;HaCaT: 57.0;MCF7: 20.8;SiHa: 30.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA042550, HPA059859" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 310000 "Plasma membrane" "Nucleoplasm, Cytosol" "HPA042550: AB_2678048, HPA059859: AB_2684145" "unprognostic (2.12e-2)" "unprognostic (1.78e-1)" "unprognostic (1.16e-1)" "unprognostic (3.90e-2)" "unprognostic (2.84e-2)" "unprognostic (1.40e-1)" "unprognostic (3.70e-3)" "unprognostic (5.58e-2)" "unprognostic (2.41e-1)" "prognostic unfavorable (2.76e-4)" "unprognostic (2.41e-2)" "unprognostic (1.31e-1)" "unprognostic (4.13e-3)" "unprognostic (2.43e-2)" "unprognostic (2.25e-1)" "unprognostic (1.19e-1)" "unprognostic (7.86e-2)" 10.8 0.7 2.2 1.4 0.7 0.2 6.8 0.6 3.0 23.5 2.9 0.2 4.1 1.7 2.6 5.1 126.9 2.9 5.8 1.8 1.8 0.2 3.0 3.3 4.7 0.2 0.0 0.9 1.7 2.8 1.6 2.8 2.9 0.5 4.6 1.0 0.7 24.3 3.3 3.2 30.7 2.0 5.0 0.0 0.2 2.1 1.5 0.0 0.5 7.2 57.8 60.9 5.0 39.9 0.1 0.0 1.6 0.0 0.0 0.0 0.0 6.9 2.5 0.0 0.0 18.7 27.2 9.0 0.0 0.4 0.0 0.1 11.6 17.8 0.1 4.1 0.3 1.0 57.0 0.3 6.8 0.0 0.0 0.4 0.0 13.8 2.0 1.2 0.0 0.0 1.3 6.3 0.0 2.2 1.4 0.0 0.0 0.0 0.0 0.0 20.8 0.0 0.0 1.8 9.2 5.4 0.0 0.0 8.7 13.6 11.1 9.4 0.1 30.5 10.2 0.1 2.8 5.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.0 3.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 2.2 0.7 0.6 3.0 1.8 0.2 0.0 0.9 0.5 0.0 68.5 23.2 0.5 33.9 31.1 7.7 3.5 30.6 12.0 30.7 54.1 5.9 1.6 1.7 15.3 0.6 6.4 4.5 0.0 4.0 1.2 11.0 30.6 0.0 10.9 0.6 1.6 37.8 4.3 0.8 0.2 51.2 1.8 16.9 1.8 3.9 5.3 16.8 5.8 3.9 0.8 11.2 0.0 5.6 3.9 2.9 44.8 1.1 0.7 5.0 47.5 PPM1D "PP2C-DELTA, Wip1" ENSG00000170836 "Protein phosphatase, Mg2+/Mn2+ dependent 1D" O15297 17 60600183-60666280 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Hydrolase, Protein phosphatase" "Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 51.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 26.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022277, HPA061848" Approved Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA022277: AB_1858839, HPA061848: " "unprognostic (1.48e-1)" "unprognostic (1.36e-2)" "prognostic favorable (3.52e-4)" "unprognostic (1.76e-1)" "unprognostic (1.02e-1)" "unprognostic (5.12e-2)" "prognostic unfavorable (4.27e-4)" "unprognostic (5.50e-2)" "unprognostic (1.70e-2)" "unprognostic (6.07e-2)" "unprognostic (2.52e-3)" "unprognostic (3.46e-2)" "unprognostic (1.95e-3)" "unprognostic (7.33e-2)" "unprognostic (1.58e-1)" "unprognostic (1.71e-2)" "unprognostic (1.98e-1)" 12.2 7.0 6.1 5.7 9.2 13.6 11.9 30.8 6.6 11.1 10.0 10.6 7.8 7.6 12.0 8.3 8.6 11.1 8.3 5.8 7.7 4.4 7.4 7.4 9.2 7.9 10.3 4.6 17.3 12.3 8.1 8.9 18.5 8.8 9.3 9.4 8.2 8.1 6.8 9.7 8.1 8.1 8.2 7.3 9.2 7.3 16.2 12.5 15.5 8.7 6.9 7.0 7.8 11.3 7.3 13.1 20.5 13.2 6.8 8.3 6.8 2.7 5.5 6.2 5.3 4.2 2.6 8.0 4.3 2.9 2.8 4.0 5.6 1.6 7.9 3.6 3.0 1.1 3.0 4.0 1.8 3.8 1.4 8.8 5.7 5.4 6.5 3.5 2.3 4.4 2.3 2.9 4.2 2.5 2.3 6.4 3.4 4.1 3.3 3.0 26.9 6.2 3.4 2.7 2.6 4.3 7.6 7.9 4.7 2.5 3.4 8.5 6.2 5.7 1.9 1.3 6.9 2.3 3.1 4.7 3.7 10.1 2.8 2.3 5.4 5.7 6.0 1.5 2.3 2.8 8.2 13.2 14.1 6.7 10.2 5.9 7.3 5.6 6.1 13.1 5.9 6.1 6.2 20.5 6.8 6.1 5.8 8.3 6.8 6.1 9.2 30.8 6.6 7.7 4.4 10.3 4.6 8.8 12.5 29.8 7.7 13.7 4.0 18.7 12.0 5.6 5.1 2.7 4.5 5.2 3.9 13.6 3.3 6.0 51.4 15.8 10.1 0.0 6.0 5.1 11.2 6.9 1.1 2.8 7.5 3.2 13.8 20.3 23.0 8.1 12.7 9.8 3.3 6.4 9.0 6.4 5.1 8.6 7.1 4.2 10.1 0.0 12.0 24.5 13.9 15.7 32.3 7.5 10.5 5.5 PPM1E "CaMKP-N, KIAA1072, POPX1, PP2CH" ENSG00000175175 "Protein phosphatase, Mg2+/Mn2+ dependent 1E" Q8WY54 17 58755869-58985176 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 10.7;brain: 36.5;testis: 13.1" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 16.0;Cone photoreceptor cells: 29.5;Early spermatids: 22.1;Horizontal cells: 73.1" "Cancer enhanced" "Detected in some" "prostate cancer: 3.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "basophil: 2.5" "Lineage enriched" "Detected in single" 25 "granulocytes: 2.5" "Cell line enhanced" "Detected in many" "AF22: 10.2;HAP1: 16.5;MOLT-4: 7.8;SCLC-21H: 7.6;SH-SY5Y: 15.8;THP-1: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018462, HPA019263" Approved Approved Nucleoplasm,Nucleoli Yes No Nucleoli Nucleoplasm "HPA018462: AB_1855623, HPA019263: AB_1855624" "unprognostic (2.50e-2)" "unprognostic (5.75e-2)" "unprognostic (8.12e-2)" "unprognostic (2.99e-2)" "unprognostic (5.30e-1)" "unprognostic (8.19e-2)" "unprognostic (3.96e-1)" "unprognostic (1.52e-1)" "unprognostic (3.22e-2)" "unprognostic (5.24e-2)" "unprognostic (8.80e-5)" "unprognostic (4.97e-2)" "unprognostic (1.23e-7)" "unprognostic (1.05e-4)" "unprognostic (1.64e-2)" "unprognostic (1.27e-1)" "unprognostic (9.12e-2)" 0.7 10.7 15.0 0.8 7.5 0.7 0.7 11.9 23.3 1.0 0.7 3.6 0.0 0.8 1.1 2.2 0.7 3.3 0.8 2.3 36.5 5.4 1.9 2.4 1.0 0.9 3.2 9.2 1.0 1.7 0.8 3.4 0.6 10.5 3.2 0.7 3.5 0.8 0.7 0.6 0.7 1.0 1.3 2.7 0.8 1.4 13.1 2.0 0.0 0.8 0.0 1.0 0.6 0.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.5 0.0 0.0 0.8 0.0 0.0 0.8 1.2 0.0 0.0 6.5 0.1 0.1 2.3 0.0 16.5 0.0 0.4 0.1 4.9 0.0 0.1 0.0 1.2 0.5 2.1 0.3 1.3 0.1 0.0 0.5 0.0 4.1 1.6 0.0 0.0 2.9 7.8 0.0 2.9 0.0 0.8 0.0 1.3 0.0 0.0 0.0 7.6 15.8 0.2 0.0 1.0 0.1 0.0 7.0 0.0 0.0 1.9 0.0 2.4 0.0 0.1 4.4 0.3 0.0 2.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 7.5 11.9 14.0 36.5 5.4 3.2 9.2 10.5 2.0 0.0 0.0 0.0 0.0 0.0 16.0 1.6 0.0 0.0 3.4 0.0 29.5 0.0 0.0 0.0 22.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.8 0.1 73.1 2.9 0.0 0.3 14.6 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.4 0.0 11.7 0.0 0.0 9.3 2.5 0.0 0.0 0.0 0.0 0.0 PPM1F "CAMKP, CaMKPase, FEM-2, KIAA0015, POPX2" ENSG00000100034 "Protein phosphatase, Mg2+/Mn2+ dependent 1F" P49593 22 21919420-21952837 "Enzymes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ito cells: 61.4;Kupffer cells: 32.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 17.7" "Group enriched" "Detected in many" 7 "dendritic cells: 5.5;granulocytes: 17.7;monocytes: 13.9" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 36.5;K-562: 55.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030989, HPA030990" Approved Approved "Nucleoplasm,Plasma membrane" NA NA 780000 Nucleoplasm "Plasma membrane" "HPA030989: AB_10669549, HPA030990: AB_10601249" "unprognostic (6.26e-2)" "unprognostic (2.50e-1)" "unprognostic (1.82e-1)" "unprognostic (2.11e-1)" "unprognostic (2.51e-1)" "unprognostic (4.77e-3)" "unprognostic (4.88e-3)" "unprognostic (1.94e-1)" "unprognostic (1.70e-1)" "unprognostic (1.65e-2)" "unprognostic (1.45e-2)" "unprognostic (4.81e-2)" "prognostic unfavorable (6.03e-5)" "unprognostic (6.44e-2)" "unprognostic (3.02e-2)" "unprognostic (3.30e-1)" "unprognostic (4.11e-2)" 25.0 15.6 14.0 21.8 14.3 24.3 18.4 16.9 16.3 18.1 13.2 7.6 12.5 9.6 17.6 9.7 23.6 12.3 13.1 17.0 13.9 14.9 13.2 8.5 21.6 15.1 11.6 10.1 14.4 10.7 8.3 7.7 28.1 14.5 15.6 4.9 11.2 11.2 16.5 15.8 15.5 11.1 15.4 15.5 31.4 10.5 6.7 10.9 6.2 10.9 15.1 10.2 15.8 37.6 0.7 5.5 17.7 13.9 1.7 1.4 2.8 9.2 9.9 6.4 6.2 3.5 6.3 8.1 10.6 6.3 9.4 6.5 4.5 3.7 5.6 13.3 7.4 4.0 11.2 2.8 6.6 3.3 8.0 9.0 21.7 4.6 4.3 5.9 8.0 5.9 5.9 2.0 9.1 4.3 6.7 36.5 5.6 55.2 2.4 12.0 8.6 4.7 6.2 2.7 2.9 10.9 7.1 16.5 1.6 3.2 3.9 2.6 10.0 10.0 3.3 8.6 2.6 4.1 5.6 30.7 11.3 11.5 10.3 10.1 4.7 3.7 6.2 11.4 15.3 21.6 0.0 7.7 3.3 1.0 12.9 0.7 0.7 0.7 0.6 5.5 0.6 0.7 0.8 17.7 1.7 13.9 1.4 1.4 2.8 14.0 14.3 16.9 16.3 13.9 14.9 11.6 10.1 14.5 10.9 6.0 5.9 5.1 4.4 7.2 7.0 13.1 15.3 4.0 3.4 1.8 2.0 13.3 3.3 4.9 1.1 31.9 2.0 0.0 4.3 7.2 7.7 3.9 3.5 5.5 17.5 7.9 5.8 61.4 32.9 1.1 6.6 18.0 6.8 8.2 3.9 3.8 5.6 0.0 6.3 3.4 6.5 6.5 5.7 7.4 10.5 5.0 2.5 5.7 3.8 5.4 PPM1G "PP2CG, PP2Cgamma" ENSG00000115241 "Protein phosphatase, Mg2+/Mn2+ dependent 1G" O15355 2 27381194-27409687 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 93.3" "Cell type enhanced" "Detected in all" 17 "Early spermatids: 1236.5;Late spermatids: 2467.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035530, HPA035531" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035530: AB_10670021, HPA035531: AB_10610283" "unprognostic (7.50e-2)" "unprognostic (8.89e-2)" "unprognostic (1.53e-1)" "unprognostic (1.02e-1)" "unprognostic (2.27e-1)" "unprognostic (4.15e-2)" "prognostic unfavorable (3.14e-7)" "unprognostic (9.36e-3)" "unprognostic (7.73e-2)" "prognostic favorable (6.08e-5)" "unprognostic (3.74e-2)" "unprognostic (1.23e-1)" "unprognostic (7.46e-3)" "unprognostic (1.06e-2)" "unprognostic (5.33e-2)" "unprognostic (1.78e-1)" "unprognostic (7.83e-2)" 12.7 17.0 9.9 19.9 9.2 19.4 30.2 10.9 19.3 17.9 14.6 9.1 16.9 12.1 26.8 12.5 19.4 19.2 17.7 13.6 8.8 7.6 12.6 18.6 14.7 20.2 9.4 8.0 13.4 18.6 13.8 13.2 11.4 8.7 10.2 16.4 9.1 16.4 18.7 24.1 10.9 12.2 14.9 6.7 14.7 14.1 93.3 8.4 25.8 14.1 19.1 22.5 25.2 17.3 20.2 40.3 24.5 29.1 22.7 38.3 19.0 50.9 42.1 30.9 23.7 19.7 16.1 28.5 31.8 20.9 38.2 30.7 64.8 27.0 60.2 23.4 22.5 32.5 27.9 51.9 35.7 34.4 25.1 42.2 58.6 30.7 68.4 17.8 57.8 24.8 17.4 20.7 38.9 31.4 18.2 36.5 29.9 49.0 18.7 28.9 45.6 42.9 62.8 44.9 35.4 30.4 44.4 64.8 31.6 25.8 35.6 41.6 47.1 28.5 31.6 22.8 25.6 17.5 19.0 29.3 28.6 34.6 25.0 48.2 40.8 45.7 95.2 22.4 47.4 21.4 22.1 17.8 24.5 26.9 22.3 26.5 20.2 28.7 27.9 28.5 18.0 21.7 22.4 9.1 22.7 29.1 40.3 38.3 19.0 9.9 9.2 10.9 19.3 8.8 7.6 9.4 8.0 8.7 8.4 59.6 43.5 61.1 65.0 72.0 42.0 33.6 50.9 61.6 66.0 66.3 27.5 71.4 28.2 97.8 1236.5 66.3 54.6 23.3 120.2 139.9 42.7 66.0 58.8 37.8 76.1 46.1 77.4 35.6 49.4 2467.5 65.0 65.1 23.6 147.9 59.6 64.9 122.3 42.1 66.8 48.3 34.6 45.3 45.8 594.3 323.3 70.4 44.4 79.7 83.2 121.2 PPM1H "ARHCL1, FLJ13253, KIAA1157, NERPP-2C" ENSG00000111110 "Protein phosphatase, Mg2+/Mn2+ dependent 1H" Q9ULR3 12 62643982-62935037 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.1;parathyroid gland: 36.6" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 5.3" "Group enriched" "Detected in many" 11 "dendritic cells: 2.3;granulocytes: 5.3;monocytes: 1.7" "Cell line enhanced" "Detected in many" "CACO-2: 35.9;HMC-1: 29.0;SK-BR-3: 16.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020694, HPA044244, HPA058777" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB020694: , HPA044244: AB_2678871, HPA058777: AB_2683816" "unprognostic (3.41e-2)" "unprognostic (1.94e-1)" "unprognostic (9.51e-2)" "unprognostic (8.61e-3)" "unprognostic (1.44e-1)" "unprognostic (1.23e-1)" "unprognostic (1.86e-2)" "unprognostic (5.85e-2)" "unprognostic (3.17e-1)" "unprognostic (1.78e-2)" "unprognostic (5.53e-3)" "unprognostic (2.19e-1)" "prognostic favorable (2.72e-5)" "unprognostic (3.90e-2)" "unprognostic (1.73e-1)" "unprognostic (8.04e-3)" "unprognostic (1.14e-1)" 2.6 2.1 10.6 1.6 12.4 3.1 5.7 37.1 16.3 8.5 2.8 14.0 12.4 3.6 6.9 7.7 1.1 7.5 9.1 2.2 13.0 12.2 11.7 3.9 3.2 1.5 14.3 9.0 9.4 4.9 36.6 13.3 7.1 8.5 15.0 3.6 7.7 10.2 11.6 1.5 1.2 2.1 2.2 8.9 1.3 6.2 1.4 15.0 0.5 3.8 0.1 2.1 3.4 1.2 0.0 2.3 5.3 1.7 0.2 0.0 0.3 0.5 5.6 1.0 0.0 0.2 0.0 12.2 1.3 1.3 0.8 0.2 35.9 2.6 0.0 1.2 0.6 0.8 0.7 3.9 0.1 0.5 0.1 1.9 6.7 1.0 8.1 0.0 2.0 29.0 0.0 0.1 0.0 0.3 0.8 0.1 1.2 1.7 0.0 0.6 4.1 0.6 0.9 7.3 1.8 2.7 0.9 2.5 10.0 8.3 12.7 3.2 0.0 2.2 16.4 5.3 4.1 8.9 1.2 0.1 0.2 0.7 0.1 0.4 1.5 9.2 1.8 0.1 0.0 0.5 5.3 1.7 3.0 0.0 1.4 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 1.2 0.2 1.4 0.0 0.0 0.3 10.6 12.4 37.1 16.3 13.0 12.2 14.3 9.0 8.5 15.0 6.0 6.6 0.0 0.1 0.1 7.9 1.4 15.3 5.3 1.2 15.7 25.5 18.6 3.3 4.1 8.8 1.4 0.1 0.0 5.5 1.3 1.1 4.6 13.9 4.9 5.4 11.1 8.6 12.3 3.0 8.0 0.9 0.7 3.3 1.8 2.2 6.0 4.6 2.5 1.4 5.7 10.6 0.0 0.0 0.0 0.1 0.1 5.7 0.0 2.4 0.4 PPM1L PP2CE ENSG00000163590 "Protein phosphatase, Mg2+/Mn2+ dependent 1L" Q5SGD2 3 160755602-161078907 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 59.9;Cardiomyocytes: 33.6;Cone photoreceptor cells: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 7.6" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 5 "HDLM-2: 35.6;U-266/70: 35.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019891, HPA019953" Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA019891: AB_1855631, HPA019953: AB_2170360" "prognostic unfavorable (4.90e-4)" "unprognostic (7.29e-3)" "unprognostic (2.01e-1)" "unprognostic (2.59e-2)" "unprognostic (8.03e-2)" "unprognostic (1.03e-1)" "unprognostic (1.91e-1)" "unprognostic (1.63e-2)" "unprognostic (2.49e-2)" "unprognostic (1.92e-1)" "unprognostic (4.51e-2)" "unprognostic (7.51e-2)" "unprognostic (2.69e-3)" "unprognostic (1.81e-1)" "unprognostic (2.39e-1)" "unprognostic (9.13e-3)" "unprognostic (2.07e-1)" 7.7 8.5 7.4 3.5 11.5 3.3 6.3 15.8 23.2 11.3 7.0 5.5 1.1 3.0 6.2 3.7 8.7 6.1 12.6 9.9 6.3 7.8 8.4 6.0 4.6 1.9 8.0 10.1 3.7 5.4 33.6 26.3 11.5 13.8 9.6 5.9 5.6 18.9 3.7 25.7 7.6 3.6 16.4 4.6 3.4 8.4 2.8 3.7 5.6 14.4 9.6 3.5 16.6 10.8 0.7 1.3 4.9 7.6 1.1 2.6 2.0 1.2 0.8 4.1 2.1 2.4 0.0 2.5 0.2 0.1 0.4 0.1 0.2 0.2 0.2 0.4 0.1 0.9 3.7 3.4 0.2 0.1 35.6 3.6 3.5 3.3 0.4 0.1 2.1 4.1 0.4 1.6 0.1 0.2 0.3 0.2 1.7 0.1 5.6 0.0 1.9 0.8 0.2 2.3 6.5 0.8 4.2 0.7 0.8 0.1 3.8 4.9 4.2 2.0 2.4 0.1 1.4 2.7 2.1 0.2 0.4 0.4 0.3 1.3 35.6 0.1 2.0 0.6 1.8 0.8 0.7 2.3 4.9 2.6 5.5 0.2 0.2 0.6 1.7 1.3 0.7 1.0 1.8 0.2 1.1 7.6 0.8 0.0 2.0 7.4 11.5 15.8 17.9 6.3 7.8 8.0 10.1 13.8 3.7 6.0 2.4 0.0 5.2 7.7 59.9 33.6 10.2 13.4 5.7 1.8 33.4 2.4 0.0 1.5 1.1 2.4 3.8 0.0 3.7 1.6 7.0 6.0 0.0 14.9 5.9 6.4 13.3 0.6 12.4 0.4 4.6 7.2 3.3 2.8 7.6 9.3 1.7 7.0 4.9 3.3 10.1 0.0 11.2 1.5 3.1 7.5 2.2 2.9 4.9 18.0 PPME1 PME-1 ENSG00000214517 "Protein phosphatase methylesterase 1" Q9Y570 11 74171099-74254703 "Enzymes, Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 69.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 92.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004541, HPA043900, HPA064396" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA 16000 Nucleoplasm "Nuclear bodies" "CAB004541: AB_628161, HPA043900: AB_2678722, HPA064396: AB_2685254" "unprognostic (2.99e-2)" "unprognostic (1.27e-2)" "unprognostic (2.28e-1)" "unprognostic (1.98e-1)" "unprognostic (9.26e-2)" "unprognostic (5.77e-3)" "prognostic unfavorable (4.45e-6)" "unprognostic (2.31e-2)" "unprognostic (7.92e-2)" "unprognostic (9.76e-2)" "unprognostic (1.57e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (2.76e-4)" "unprognostic (1.84e-1)" "unprognostic (1.54e-1)" "unprognostic (4.14e-3)" "unprognostic (1.33e-3)" 9.4 16.1 13.3 6.2 27.6 8.4 9.3 27.4 38.5 11.4 9.2 13.5 9.4 7.1 13.1 16.5 13.5 15.2 8.9 12.8 14.6 18.3 12.3 6.5 8.2 5.5 13.6 18.6 12.4 10.4 69.0 13.6 15.5 22.4 15.1 9.8 9.6 11.9 15.9 21.0 16.2 7.4 13.4 12.7 5.0 8.3 22.9 9.3 8.6 14.9 7.9 8.5 11.4 10.2 7.5 11.3 10.9 9.6 12.2 14.0 8.4 10.1 13.3 9.1 9.6 9.6 7.9 9.0 15.0 9.9 28.4 22.5 29.3 6.8 5.4 10.5 11.1 15.8 17.0 13.5 10.2 26.7 7.6 5.2 8.1 14.5 12.5 19.0 5.9 7.2 7.6 8.4 15.0 6.6 11.1 8.2 7.8 18.8 4.6 49.5 6.7 6.9 6.3 7.2 12.5 10.6 8.2 92.7 8.2 10.7 7.1 12.4 10.7 17.9 8.2 21.0 9.9 15.0 6.1 5.0 11.4 13.6 10.9 11.4 8.7 11.0 9.6 8.4 5.3 9.2 1.3 8.6 10.9 10.8 9.6 13.3 6.9 13.8 12.7 10.8 7.5 14.0 11.2 5.0 12.2 8.5 11.3 9.7 8.4 13.3 27.6 27.4 38.5 14.6 18.3 13.6 18.6 22.4 9.3 26.8 10.9 9.0 17.3 18.0 29.2 15.3 7.6 36.1 30.7 33.2 35.3 10.9 14.9 14.1 36.8 11.4 10.9 70.0 11.8 27.4 13.1 16.6 8.1 7.4 11.8 31.8 24.6 8.0 5.7 10.9 12.7 13.2 3.3 13.6 11.9 15.0 12.8 10.8 23.7 10.1 18.2 6.5 17.0 60.5 41.0 21.8 12.9 10.4 10.7 15.4 PPP1CA "PP-1A, PP1A, PP1alpha, PPP1A" ENSG00000172531 "Protein phosphatase 1 catalytic subunit alpha" P62136 11 67398183-67421183 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism, Host-virus interaction" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 177.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004545, HPA046833" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 8100000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB004545: AB_628177, HPA046833: AB_2679829" "unprognostic (1.03e-1)" "unprognostic (5.82e-3)" "unprognostic (1.10e-1)" "unprognostic (2.67e-1)" "unprognostic (2.09e-1)" "unprognostic (1.51e-2)" "unprognostic (3.15e-3)" "unprognostic (3.93e-2)" "unprognostic (2.07e-1)" "unprognostic (3.89e-2)" "unprognostic (5.05e-3)" "unprognostic (8.00e-2)" "unprognostic (1.66e-1)" "unprognostic (9.96e-2)" "unprognostic (7.69e-2)" "prognostic favorable (1.17e-4)" "unprognostic (7.60e-2)" 28.4 35.4 24.2 42.0 32.3 42.1 25.1 19.6 33.4 23.9 39.6 22.1 29.9 33.9 19.6 25.8 59.7 22.8 28.6 33.0 21.8 17.1 43.7 55.0 27.6 49.3 19.9 19.9 20.1 53.3 23.1 21.6 44.0 19.3 27.2 33.2 23.2 49.7 31.1 39.0 34.4 47.3 20.5 21.3 53.7 35.1 15.7 19.4 77.7 38.5 40.5 63.9 25.5 25.7 78.8 76.6 126.2 118.0 68.2 113.9 177.2 45.3 52.4 31.1 45.8 15.5 19.0 31.7 22.5 26.4 45.4 34.5 74.9 54.8 39.1 38.4 34.1 33.8 39.8 35.9 46.8 27.9 41.1 24.4 37.5 24.7 39.2 33.9 47.6 48.5 21.4 31.0 38.6 22.8 21.6 45.5 38.3 34.8 32.4 36.7 103.5 60.3 93.6 51.6 86.5 41.5 42.9 43.0 33.8 44.6 37.6 24.3 40.4 26.1 46.9 69.4 24.3 56.1 33.0 32.4 35.1 35.9 41.3 29.1 32.5 30.1 44.4 42.0 32.7 36.9 81.4 80.1 126.2 88.6 100.5 69.3 78.8 79.8 90.5 76.6 77.0 49.1 69.2 93.3 68.2 118.0 54.4 113.9 177.2 24.2 32.3 19.6 33.4 21.8 17.1 19.9 19.9 19.3 19.4 71.5 93.0 166.0 108.0 88.8 35.0 7.9 117.2 41.5 46.6 82.0 9.8 320.7 180.8 238.7 1.8 77.3 292.4 23.3 272.4 398.0 69.2 127.9 107.3 102.4 338.5 41.3 93.0 87.2 194.1 5.3 45.5 157.2 129.9 390.5 160.1 42.9 250.4 210.5 26.9 236.5 23.6 97.0 60.9 13.0 106.5 106.3 357.3 222.6 164.6 168.4 PPP1CB "PP-1B, PP1B, PP1beta" ENSG00000213639 "Protein phosphatase 1 catalytic subunit beta" P62140 2 28751640-28802940 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism" "Hydrolase, Protein phosphatase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022558, HPA065425, CAB069426" Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 7700000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB022558: , CAB069426: , HPA065425: AB_2685489" "unprognostic (2.90e-1)" "unprognostic (5.03e-2)" "unprognostic (5.49e-2)" "unprognostic (2.00e-1)" "unprognostic (7.08e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (6.52e-6)" "unprognostic (3.47e-2)" "unprognostic (2.44e-1)" "unprognostic (3.15e-2)" "unprognostic (1.54e-3)" "unprognostic (3.95e-1)" "unprognostic (1.68e-1)" "unprognostic (3.66e-1)" "unprognostic (1.89e-1)" "unprognostic (4.56e-1)" "unprognostic (2.26e-2)" 28.5 22.6 30.0 20.5 37.6 29.5 32.4 19.1 29.8 51.1 39.3 21.1 30.7 24.4 58.0 31.8 86.0 37.0 33.3 67.1 27.8 27.9 32.0 20.0 35.3 22.3 27.4 24.4 39.7 21.9 48.9 28.7 42.3 22.0 46.4 27.7 25.2 36.5 38.6 99.6 25.1 30.0 100.8 27.5 25.2 31.4 25.5 21.4 28.1 27.5 32.9 25.3 82.1 50.5 15.6 25.4 41.5 42.7 23.5 28.3 17.9 37.1 23.4 81.7 25.2 28.0 26.1 47.6 20.0 22.8 19.5 19.3 20.7 22.0 29.7 25.1 20.6 21.6 23.0 23.2 26.7 23.2 47.1 12.0 22.5 28.8 22.4 61.0 25.4 10.6 20.0 38.0 21.0 44.0 20.5 23.5 15.8 20.4 29.5 25.5 18.6 26.9 22.0 26.8 28.6 18.6 26.4 72.4 22.6 63.3 44.9 22.4 27.7 31.0 34.6 27.1 24.4 16.7 14.2 28.1 26.1 28.7 18.6 24.0 21.1 33.1 60.9 27.7 27.4 19.3 22.5 24.8 32.1 16.8 37.8 21.3 15.6 25.5 19.6 25.4 13.4 22.7 25.5 41.5 23.5 42.7 19.6 28.3 17.9 30.0 37.6 19.1 29.8 27.8 27.9 27.4 24.4 22.0 21.4 86.4 80.7 105.5 134.5 437.2 53.8 298.4 104.4 129.8 72.8 294.8 25.5 104.9 207.2 242.7 375.6 106.2 128.9 163.5 183.3 167.5 182.4 291.0 146.3 81.8 104.3 154.1 271.6 108.6 144.9 304.1 182.1 233.4 318.9 92.8 133.9 100.9 238.2 181.4 283.9 113.6 53.2 620.9 265.8 57.5 61.8 400.4 328.6 110.8 99.3 394.6 PPP1R10 "CAT53, FB19, p99, PNUTS" ENSG00000204569 "Protein phosphatase 1 regulatory subunit 10" Q96QC0 6 30600400-30618612 "Predicted intracellular proteins" "DNA-binding, Protein phosphatase inhibitor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025501, HPA047248, HPA056756" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "CAB025501: , HPA047248: AB_2679996, HPA056756: AB_2683227" "unprognostic (1.68e-1)" "prognostic favorable (4.84e-4)" "unprognostic (1.21e-1)" "unprognostic (9.31e-3)" "unprognostic (6.31e-2)" "unprognostic (9.57e-3)" "unprognostic (2.02e-1)" "unprognostic (1.36e-1)" "unprognostic (1.62e-2)" "unprognostic (1.25e-1)" "prognostic favorable (9.74e-5)" "unprognostic (2.72e-1)" "unprognostic (8.02e-3)" "unprognostic (5.90e-2)" "unprognostic (1.76e-1)" "unprognostic (2.89e-1)" "unprognostic (3.74e-2)" 11.5 19.1 10.8 19.6 12.6 5.2 17.4 18.8 16.2 20.4 13.0 24.2 17.0 12.6 14.7 13.0 14.7 15.2 16.4 9.7 15.9 10.3 14.0 20.4 14.6 14.1 14.5 12.4 16.0 21.6 28.8 17.9 10.1 10.4 14.9 15.5 19.6 12.8 21.0 14.1 12.8 13.0 15.4 14.1 17.4 15.6 21.6 11.8 33.5 16.6 12.5 17.0 14.7 13.2 4.8 6.1 6.2 5.4 1.8 5.7 3.5 5.4 6.8 8.7 7.1 7.9 5.4 4.6 5.4 7.0 7.9 6.6 7.3 3.4 5.3 4.0 4.6 7.1 8.5 10.2 10.1 6.0 5.8 5.5 6.6 5.9 3.5 8.1 5.8 6.5 6.4 5.9 6.9 14.4 6.2 7.1 10.5 6.1 6.7 6.9 6.8 7.3 4.9 4.4 4.7 4.8 7.7 9.0 10.3 7.9 6.8 12.1 5.3 7.1 6.8 6.1 7.1 6.8 7.1 4.4 6.1 5.3 6.7 4.4 12.4 6.7 5.8 5.7 6.7 5.3 6.2 5.1 5.6 5.3 4.5 5.7 4.8 3.7 4.3 5.6 4.0 3.5 3.9 6.2 1.8 5.4 6.1 3.9 3.5 10.8 12.6 18.8 16.2 15.9 10.3 14.5 12.4 10.4 11.8 29.8 32.3 50.6 46.1 62.0 63.4 50.4 25.5 45.5 28.4 26.2 123.7 37.8 29.9 22.0 27.0 59.5 73.1 0.0 20.0 22.1 35.9 41.1 42.8 30.7 28.6 33.4 68.5 38.6 27.8 7.7 42.8 51.6 35.4 33.3 69.9 54.1 26.0 52.6 28.3 33.7 94.6 32.3 49.7 44.2 23.8 68.1 74.0 50.1 58.1 29.5 PPP1R13B "ASPP1, KIAA0771, p53BP2-like, p85" ENSG00000088808 "Protein phosphatase 1 regulatory subunit 13B" Q96KQ4 14 103733752-103847590 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 48.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "MCF7: 16.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006394, CAB015454" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB015454: AB_2252775, HPA006394: AB_1079668" "unprognostic (1.20e-1)" "unprognostic (8.61e-2)" "unprognostic (6.65e-2)" "unprognostic (1.45e-1)" "unprognostic (2.12e-1)" "unprognostic (1.37e-1)" "unprognostic (1.25e-2)" "prognostic favorable (1.41e-4)" "unprognostic (3.22e-3)" "unprognostic (5.13e-2)" "unprognostic (5.39e-2)" "unprognostic (1.62e-3)" "prognostic favorable (3.28e-11)" "unprognostic (1.68e-1)" "unprognostic (1.69e-1)" "unprognostic (1.97e-2)" "unprognostic (2.23e-1)" 7.1 5.5 12.1 5.0 13.2 1.0 7.7 23.3 16.6 8.6 9.0 7.8 6.4 8.7 9.1 4.5 13.5 12.3 5.8 24.5 10.0 6.5 8.3 5.9 11.9 3.3 5.3 9.8 13.3 13.2 12.2 15.6 7.1 10.5 13.3 7.3 13.9 11.6 8.2 7.6 12.9 11.2 6.7 5.2 13.0 11.9 21.2 6.3 1.1 28.4 4.3 7.9 10.1 7.3 0.7 0.0 0.0 0.0 0.2 2.0 0.3 4.0 3.4 0.4 4.7 0.8 0.3 1.7 2.5 1.9 3.5 1.6 2.6 3.6 1.0 9.8 2.1 4.0 8.4 4.9 3.7 2.9 2.1 3.4 0.0 1.2 4.4 3.2 0.4 3.8 0.9 4.3 0.3 4.0 1.3 6.8 2.4 0.5 1.7 2.2 16.3 0.0 0.3 0.8 9.7 4.3 10.2 2.8 2.3 7.2 10.1 5.5 14.8 7.9 6.2 1.9 2.2 15.5 0.6 5.7 2.5 3.3 2.0 2.4 3.7 4.5 6.8 1.6 2.5 1.2 0.0 0.0 0.0 1.4 0.0 2.0 0.7 1.3 0.0 0.0 0.5 0.2 0.5 0.0 0.2 0.0 0.0 0.9 0.3 12.1 13.2 23.3 16.6 10.0 6.5 5.3 9.8 10.5 6.3 17.9 36.1 4.2 14.2 11.9 13.6 40.4 20.4 6.7 14.8 7.0 11.8 2.3 3.3 6.3 46.9 17.7 20.6 0.0 5.6 0.9 6.1 16.9 0.0 8.6 2.2 14.3 15.0 9.8 0.6 48.7 4.0 2.0 3.3 0.0 14.5 4.5 6.1 19.5 19.1 5.4 12.5 6.5 5.3 14.6 12.3 11.3 1.8 4.3 14.4 13.2 PPP1R14A "CPI-17, PPP1INL" ENSG00000167641 "Protein phosphatase 1 regulatory inhibitor subunit 14A" Q96A00 19 38251237-38256591 "Plasma proteins, Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 16 "Leydig cells: 315.8;Peritubular cells: 616.7;Sertoli cells: 963.6;Smooth muscle cells: 478.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "memory B-cell: 46.4;naive B-cell: 42.7;plasmacytoid DC: 39.3" "Group enriched" "Detected in many" 29 "B-cells: 46.4;dendritic cells: 39.3" "Group enriched" "Detected in some" 4 "A549: 40.6;EFO-21: 35.0;K-562: 16.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB005044, CAB009803, HPA042097, HPA054534" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "CAB005044: AB_562091, CAB009803: AB_2168720, HPA042097: AB_2677846, HPA054534: AB_2682518" "unprognostic (5.40e-2)" "unprognostic (4.00e-3)" "unprognostic (4.02e-2)" "unprognostic (2.53e-1)" "unprognostic (1.74e-1)" "unprognostic (8.92e-3)" "unprognostic (2.18e-3)" "unprognostic (1.30e-1)" "unprognostic (2.28e-2)" "unprognostic (1.96e-1)" "unprognostic (1.27e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (1.25e-5)" "prognostic unfavorable (7.12e-4)" "unprognostic (4.13e-1)" "unprognostic (5.81e-2)" "unprognostic (2.22e-2)" 45.4 34.9 22.5 15.1 28.7 2.6 20.1 4.4 37.9 21.1 56.1 60.9 16.6 13.9 39.6 10.8 32.6 20.1 31.7 13.0 34.4 19.0 8.9 4.0 21.1 2.8 43.6 19.2 22.7 17.1 1.7 1.6 24.2 28.4 29.7 10.0 4.4 10.4 70.3 13.9 3.5 16.5 79.9 76.0 31.1 22.9 18.7 38.2 0.0 3.3 3.4 2.1 51.6 15.6 46.4 39.3 1.1 0.1 1.4 0.1 3.7 0.0 40.6 0.1 0.0 0.2 0.0 1.7 3.8 0.0 0.0 0.0 3.2 0.0 0.0 35.0 0.2 0.0 0.1 3.5 0.0 0.0 0.5 0.0 7.2 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 16.9 0.1 0.0 0.3 0.0 0.1 1.3 0.0 0.0 0.0 1.0 0.1 0.0 0.0 1.1 0.1 0.0 0.0 0.0 2.7 0.0 0.2 0.1 0.0 0.3 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 1.1 0.1 0.2 0.0 0.1 0.0 46.4 0.0 0.0 6.8 42.7 0.1 0.0 0.3 1.4 0.0 39.3 0.0 3.7 22.5 28.7 4.4 29.7 34.4 19.0 43.6 19.2 28.4 38.2 0.0 1.4 18.2 2.3 8.5 0.3 8.4 0.0 0.0 1.2 0.0 0.0 37.8 0.0 0.4 11.0 30.1 2.0 0.0 9.7 3.1 66.4 2.1 3.5 1.6 8.4 0.0 1.7 207.5 6.3 20.1 315.8 19.1 8.5 111.0 0.1 0.5 2.8 1.1 616.7 0.3 0.9 963.6 478.5 9.1 53.5 6.9 22.1 1.9 0.1 0.7 PPP1R18 "KIAA1949, phostensin" ENSG00000146112 "Protein phosphatase 1 regulatory subunit 18" Q6NYC8 6 30676389-30687895 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 54.5" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 175.4;monocytes: 233.6;T-cells: 186.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "eosinophil: 54.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 54.5" "Cell line enhanced" "Detected in many" "HMC-1: 35.0;U-937: 36.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044745, HPA051000" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA044745: AB_2679070, HPA051000: AB_2681304" "unprognostic (3.25e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (4.71e-4)" "unprognostic (1.01e-1)" "unprognostic (2.11e-2)" "unprognostic (1.59e-2)" "unprognostic (2.90e-2)" "unprognostic (3.37e-2)" "unprognostic (2.44e-1)" "unprognostic (1.18e-1)" "unprognostic (3.61e-2)" "unprognostic (2.40e-1)" "prognostic unfavorable (1.11e-16)" "unprognostic (1.73e-1)" "unprognostic (4.42e-2)" "unprognostic (9.33e-2)" "unprognostic (4.76e-2)" 17.2 7.1 5.6 24.7 7.9 34.0 16.1 1.7 4.7 12.6 15.9 6.2 4.6 5.3 17.5 7.3 11.5 10.9 13.9 10.1 6.5 3.4 6.1 8.3 20.2 44.9 7.2 1.8 14.9 4.0 2.3 2.9 13.3 6.0 11.2 3.7 7.3 7.9 6.1 6.6 9.5 11.3 13.9 9.8 37.4 9.1 4.9 6.2 48.2 7.8 7.8 23.6 18.2 18.0 4.2 3.4 54.5 4.1 10.2 11.9 5.2 10.0 1.6 6.0 7.2 4.3 11.6 0.2 6.0 7.0 5.3 3.6 1.2 2.0 9.8 5.5 10.5 12.0 6.7 3.0 6.6 2.8 8.2 0.6 23.6 2.9 1.2 3.4 6.1 35.0 7.1 7.7 13.1 11.8 6.3 4.3 16.6 4.3 4.9 6.2 1.1 8.7 12.1 0.0 0.3 0.4 27.8 5.3 8.0 3.1 0.6 0.4 2.0 5.6 2.2 11.1 0.3 1.6 8.4 14.2 21.0 5.3 0.0 14.9 1.8 9.6 12.1 6.0 36.4 24.5 8.1 2.8 54.5 11.7 4.1 8.5 3.1 5.7 11.9 1.8 4.2 4.7 9.0 13.2 10.2 3.0 3.4 9.4 5.2 5.6 7.9 1.7 4.7 6.5 3.4 7.2 1.8 6.0 6.2 3.0 20.7 66.3 25.5 96.9 1.3 2.8 10.2 6.7 4.5 8.7 0.0 2.5 0.0 20.1 23.9 64.4 0.4 0.0 7.1 17.8 32.0 15.2 51.9 7.8 175.4 3.2 1.7 30.7 131.5 14.6 25.6 119.9 37.1 233.6 0.5 0.9 18.0 0.0 21.9 1.3 2.9 25.8 79.5 0.5 1.4 52.1 3.3 186.8 0.4 22.5 PPP1R1C Inhibitor-1-like ENSG00000150722 "Protein phosphatase 1 regulatory inhibitor subunit 1C" Q8WVI7 2 181954241-182131398 "Predicted intracellular proteins" "Cell cycle, Cell division" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 7.5;heart muscle: 27.8" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 106.6;Late spermatids: 139.1;Spermatocytes: 41.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.0;HAP1: 1.2;JURKAT: 1.1;MOLT-4: 2.1;SiHa: 1.3;SuSa: 1.2;U-266/70: 1.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA055043 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA Nucleoplasm "Nucleoli, Golgi apparatus" "HPA055043: AB_2797251" "unprognostic (1.70e-1)" "unprognostic (3.15e-1)" "unprognostic (4.54e-3)" "unprognostic (1.08e-2)" "unprognostic (1.36e-1)" "unprognostic (1.01e-1)" "unprognostic (2.44e-2)" "unprognostic (3.77e-2)" "unprognostic (6.57e-2)" "unprognostic (6.59e-3)" "unprognostic (1.13e-1)" "unprognostic (7.98e-2)" "unprognostic (3.70e-2)" "unprognostic (1.00e-3)" "unprognostic (7.68e-2)" "unprognostic (3.07e-2)" "unprognostic (9.75e-3)" 0.2 0.1 0.7 0.1 3.5 0.1 0.2 3.5 1.8 0.1 0.2 3.0 0.0 0.2 0.2 0.1 0.3 0.2 0.5 27.8 1.5 1.1 0.2 1.2 0.3 0.2 0.8 0.6 0.1 0.6 0.1 0.4 0.2 7.5 1.4 0.2 0.5 0.5 0.2 4.3 0.2 0.7 0.1 2.5 0.2 0.4 0.6 1.3 0.0 0.2 3.3 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.4 2.1 0.0 0.5 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 1.3 0.2 0.3 1.2 0.2 0.0 0.0 0.0 0.6 0.0 0.0 1.9 0.0 0.2 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.5 3.5 1.8 1.5 1.1 0.8 0.6 7.5 1.3 11.9 5.4 0.0 0.5 0.2 0.8 34.2 10.2 1.4 11.4 3.5 0.0 2.7 1.7 2.3 106.6 0.0 0.0 0.0 9.8 5.6 0.7 0.1 0.0 17.9 0.5 0.0 5.8 0.0 0.3 139.1 5.5 0.0 3.3 6.4 0.3 6.0 14.6 0.0 0.7 0.5 1.9 0.0 0.5 41.8 2.0 0.3 2.1 0.0 0.7 0.9 PPP1R2 "IPP2, PPP1R2A" ENSG00000184203 "Protein phosphatase 1 regulatory inhibitor subunit 2" P41236 3 195514425-195543386 "Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 363.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 67.5" "HPA043729, HPA059420" Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043729: AB_2678639, HPA059420: AB_2684009" "unprognostic (1.85e-2)" "unprognostic (3.71e-3)" "unprognostic (6.26e-2)" "unprognostic (3.58e-1)" "unprognostic (5.66e-2)" "unprognostic (1.44e-1)" "unprognostic (4.17e-2)" "unprognostic (3.92e-1)" "unprognostic (4.20e-2)" "unprognostic (2.00e-1)" "unprognostic (6.73e-2)" "unprognostic (8.32e-2)" "unprognostic (4.99e-2)" "unprognostic (2.28e-1)" "unprognostic (3.74e-1)" "unprognostic (2.71e-1)" "unprognostic (2.13e-1)" 16.4 12.7 19.9 17.7 26.0 45.2 18.3 16.2 22.9 16.1 21.2 11.4 17.4 19.5 18.9 20.7 25.6 15.3 15.8 23.3 18.6 21.7 16.7 13.0 21.7 30.4 16.5 15.4 17.1 12.0 9.5 17.6 16.1 21.2 17.0 16.0 13.7 15.0 19.0 57.1 14.1 22.6 17.7 15.4 24.2 13.9 21.8 7.0 38.1 19.1 25.2 23.5 26.5 15.5 26.0 26.6 63.2 16.9 22.8 50.2 30.1 11.6 2.5 4.3 4.9 7.3 7.8 7.9 7.3 10.6 7.8 6.7 39.5 5.3 4.6 29.2 8.9 8.4 5.2 4.5 7.4 9.6 9.1 8.5 5.3 4.2 13.2 11.3 5.5 5.5 9.5 5.7 5.8 11.8 6.2 6.7 4.9 4.0 9.9 6.8 8.1 9.8 6.2 4.5 14.0 11.8 4.6 7.5 13.7 9.3 8.9 10.2 5.6 8.8 9.7 13.1 8.3 15.3 5.6 7.4 5.0 5.8 8.2 9.9 67.5 29.3 22.1 7.0 10.1 9.7 26.3 16.7 63.2 19.6 16.9 26.9 26.0 41.2 27.0 17.6 23.6 50.2 34.0 39.4 22.8 16.4 26.6 41.7 30.1 19.9 26.0 16.2 22.9 18.6 21.7 16.5 15.4 21.2 7.0 20.8 39.2 125.0 121.2 83.7 47.5 46.2 25.5 66.9 38.7 21.0 55.0 57.7 106.1 61.4 363.0 65.1 53.1 46.7 57.9 34.5 51.3 104.3 109.6 24.6 55.6 49.3 55.0 39.3 59.0 190.1 47.8 82.0 92.8 141.5 44.1 50.2 58.5 55.2 59.8 82.6 79.3 25.8 64.1 239.4 84.1 67.9 86.3 140.6 44.9 143.1 PPP1R21 "CCDC128, FLJ16566, KLRAQ1" ENSG00000162869 "Protein phosphatase 1 regulatory subunit 21" Q6ZMI0 2 48440598-48515391 "Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036791, HPA036792" Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA036791: AB_10671713, HPA036792: AB_2675317" "unprognostic (1.25e-1)" "unprognostic (2.13e-1)" "unprognostic (2.51e-1)" "prognostic unfavorable (6.83e-4)" "unprognostic (1.57e-2)" "unprognostic (1.01e-1)" "unprognostic (2.78e-3)" "unprognostic (1.44e-2)" "unprognostic (7.46e-2)" "unprognostic (3.00e-1)" "prognostic favorable (8.05e-4)" "unprognostic (1.13e-1)" "prognostic favorable (4.59e-6)" "unprognostic (9.23e-2)" "unprognostic (1.93e-1)" "prognostic favorable (9.87e-4)" "unprognostic (6.60e-2)" 9.0 10.4 16.4 8.9 18.7 8.1 7.9 16.2 21.6 8.3 8.8 15.0 7.9 7.0 15.8 18.8 11.2 13.5 9.8 8.9 13.2 12.2 25.6 10.4 10.0 10.9 17.7 13.6 12.7 7.3 35.5 11.9 11.3 14.4 10.8 9.8 8.4 6.8 10.2 6.4 9.5 9.0 11.9 12.0 11.0 9.4 8.4 15.9 10.4 19.5 2.4 10.8 12.7 8.8 7.7 5.6 14.1 6.0 3.8 7.9 2.3 13.8 6.7 5.8 7.1 14.5 10.8 15.2 8.2 9.3 5.0 6.1 3.7 8.7 9.4 13.6 11.5 9.8 7.7 4.8 7.4 10.6 12.0 4.1 10.1 5.7 8.9 10.1 4.5 8.1 13.5 6.8 9.1 11.2 12.8 12.7 4.8 4.0 15.8 13.7 7.6 8.6 7.3 14.6 9.9 7.1 7.2 15.5 10.2 10.6 9.2 7.7 4.8 15.2 4.0 14.7 15.9 7.2 7.3 11.3 5.4 6.7 4.8 6.5 11.8 3.3 8.6 8.6 10.1 7.1 14.1 5.4 8.5 4.4 6.0 3.5 5.9 5.2 5.1 5.6 7.7 7.9 6.4 13.0 3.8 5.1 3.5 5.0 2.3 16.4 18.7 16.2 21.6 13.2 12.2 17.7 13.6 14.4 15.9 20.8 13.9 9.9 27.6 9.3 8.6 9.2 7.6 26.8 9.1 24.4 2.0 18.6 5.0 9.1 1.9 11.3 9.5 0.0 7.4 13.6 10.8 14.2 11.5 12.3 28.7 27.0 18.0 12.9 18.0 4.0 11.2 16.4 11.8 19.0 9.6 20.1 9.9 8.6 19.4 45.5 6.2 12.9 17.6 9.1 12.1 12.3 22.7 10.9 8.0 22.7 PPP1R26 KIAA0649 ENSG00000196422 "Protein phosphatase 1 regulatory subunit 26" Q5T8A7 9 135479079-135488893 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 17.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 3.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 25.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044686, HPA063817" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA044686: AB_10795987, HPA063817: " "unprognostic (1.79e-1)" "unprognostic (8.80e-3)" "prognostic unfavorable (3.98e-4)" "prognostic favorable (9.91e-4)" "unprognostic (2.67e-1)" "unprognostic (1.21e-1)" "unprognostic (1.09e-1)" "unprognostic (8.79e-2)" "unprognostic (1.50e-1)" "unprognostic (2.38e-1)" "prognostic favorable (6.93e-4)" "unprognostic (9.23e-2)" "prognostic favorable (6.20e-13)" "unprognostic (4.46e-3)" "unprognostic (8.31e-2)" "unprognostic (3.94e-1)" "unprognostic (2.07e-3)" 5.2 6.2 13.8 3.0 10.1 1.0 8.4 3.0 18.2 6.0 6.4 6.9 12.4 7.9 5.0 6.4 5.1 9.0 8.1 11.3 13.2 10.2 8.1 6.6 8.9 2.1 8.3 9.6 7.5 12.5 22.9 11.9 5.4 9.1 7.4 4.4 8.9 13.3 10.8 6.9 4.0 8.0 8.1 5.7 4.7 11.4 6.1 7.3 1.1 8.2 2.8 4.5 7.4 3.7 0.6 1.7 3.0 1.3 2.6 0.6 0.4 6.7 10.2 5.5 5.6 2.3 2.0 0.0 3.7 5.1 5.1 3.4 9.9 11.8 0.0 7.1 3.6 13.0 25.3 5.0 4.8 1.7 0.3 5.6 0.1 15.4 7.3 5.5 3.3 12.6 1.4 9.0 2.5 6.3 5.6 3.2 0.0 6.7 0.0 2.9 15.4 0.1 1.0 8.0 13.9 14.1 0.0 9.6 11.2 4.9 9.1 8.4 12.4 6.6 9.3 6.9 4.5 7.1 3.0 3.8 1.9 8.6 9.1 4.2 5.2 12.3 0.2 4.0 0.6 4.8 0.0 1.3 3.0 0.4 0.4 0.0 0.6 0.2 0.0 1.7 0.4 0.0 0.0 0.3 2.6 0.6 0.3 0.6 0.4 13.8 10.1 3.0 18.2 13.2 10.2 8.3 9.6 9.1 7.3 3.0 4.8 0.0 2.0 1.9 10.1 7.3 17.8 2.7 2.3 7.0 7.9 0.4 5.0 5.2 0.2 2.3 5.2 0.0 2.9 0.7 2.3 4.1 2.3 4.9 4.8 1.6 6.3 4.3 2.4 0.0 1.1 1.1 3.3 0.0 9.7 7.2 6.1 7.0 1.8 3.9 7.7 0.0 1.7 0.3 3.6 1.5 0.2 0.0 6.5 2.3 PPP1R2B "MGC87149, PPP1R2P3" ENSG00000231989 "PPP1R2 family member B" 5 156850538-156852528 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 33 "testis: 36.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 13 "U-266/84: 5.3" "HPA043729, HPA059420" Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043729: AB_2678639, HPA059420: AB_2684009" "unprognostic (1.96e-1)" "unprognostic (2.42e-1)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" "unprognostic (9.36e-2)" "unprognostic (1.46e-2)" "unprognostic (1.89e-1)" "unprognostic (4.47e-2)" "unprognostic (1.39e-2)" "unprognostic (3.26e-2)" "unprognostic (1.77e-1)" "unprognostic (1.33e-1)" "unprognostic (8.51e-2)" "unprognostic (1.41e-1)" "unprognostic (1.06e-2)" "unprognostic (1.07e-2)" "unprognostic (5.19e-2)" 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.2 0.2 0.3 0.3 0.0 0.4 0.3 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.5 0.0 36.0 0.0 0.4 0.4 0.0 0.2 0.1 0.0 0.5 0.4 0.9 0.5 0.5 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 5.3 0.0 0.1 0.0 0.1 0.5 0.1 0.9 0.2 0.5 0.5 0.5 0.6 0.5 0.4 0.2 1.1 0.5 0.6 0.5 0.2 0.1 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PPP1R35 "C7orf47, MGC22793" ENSG00000160813 "Protein phosphatase 1 regulatory subunit 35" Q8TAP8 7 100435282-100436565 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 129.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021604, HPA051607" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA021604: AB_2670774, HPA051607: AB_2681548" "unprognostic (2.17e-3)" "unprognostic (2.17e-1)" "unprognostic (7.40e-3)" "unprognostic (1.12e-1)" "unprognostic (1.25e-1)" "unprognostic (1.15e-1)" "unprognostic (3.53e-2)" "unprognostic (1.33e-1)" "unprognostic (6.99e-2)" "unprognostic (1.20e-1)" "unprognostic (6.77e-2)" "unprognostic (5.17e-2)" "unprognostic (1.85e-3)" "unprognostic (1.40e-1)" "unprognostic (9.51e-2)" "unprognostic (1.86e-1)" "prognostic favorable (4.97e-4)" 5.3 12.0 4.4 12.5 5.6 8.8 5.9 9.7 8.7 9.9 9.6 3.6 7.2 12.8 7.1 6.1 7.4 6.3 7.2 5.4 4.2 4.1 7.4 11.1 5.6 14.4 3.9 7.1 10.6 12.4 7.4 7.9 7.9 4.8 7.7 2.8 7.4 10.6 6.8 7.0 7.7 11.2 6.8 3.6 20.8 8.8 32.2 2.6 20.3 8.6 4.5 10.7 7.6 6.1 4.6 6.8 12.1 2.0 2.7 6.8 2.5 16.0 6.9 4.9 8.6 1.6 1.6 6.3 4.4 4.8 3.7 4.3 2.6 16.5 5.2 7.9 2.6 18.8 5.2 2.5 4.3 0.7 11.4 6.4 5.2 4.9 6.2 6.8 4.5 6.9 3.1 7.7 3.3 5.0 6.0 7.6 18.4 7.4 10.7 4.7 15.3 13.3 21.9 9.6 7.4 9.3 3.6 1.8 15.7 4.8 4.4 4.6 11.5 4.0 28.0 12.7 3.0 8.4 12.9 5.9 5.5 6.5 6.3 11.2 12.4 6.9 6.9 6.1 7.9 11.0 12.1 2.0 4.5 5.2 0.8 5.6 3.5 5.3 6.0 1.7 4.6 3.1 3.0 9.3 2.7 0.5 6.8 6.8 2.5 4.4 5.6 9.7 8.7 4.2 4.1 3.9 7.1 4.8 2.6 14.9 8.1 24.8 32.5 18.7 33.7 1.6 20.4 10.7 2.3 45.4 7.9 56.3 44.7 6.8 7.0 20.0 21.1 0.0 8.7 34.2 11.4 31.9 8.1 13.9 14.4 46.1 17.9 8.0 6.5 4.7 16.7 17.8 16.9 13.6 25.2 25.5 9.8 26.8 8.9 33.9 36.2 12.9 13.3 129.2 24.3 29.2 28.4 28.7 24.7 37.5 PPP1R3F Hb2E ENSG00000049769 "Protein phosphatase 1 regulatory subunit 3F" Q6ZSY5 X 49269843-49301461 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 35.3;Horizontal cells: 46.1;Rod photoreceptor cells: 15.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "T-reg: 15.3" "Lineage enriched" "Detected in single" 16 "T-cells: 15.3" "Cell line enhanced" "Detected in many" "GAMG: 18.0;HDLM-2: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000244, HPA000918" Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA000244: AB_2665949, HPA000918: AB_2268692" "unprognostic (6.69e-2)" "unprognostic (2.87e-2)" "unprognostic (4.98e-4)" "unprognostic (1.83e-2)" "unprognostic (6.48e-2)" "unprognostic (4.93e-2)" "unprognostic (1.26e-1)" "unprognostic (5.17e-2)" "unprognostic (1.91e-2)" "unprognostic (2.89e-1)" "prognostic favorable (1.85e-6)" "unprognostic (5.99e-2)" "unprognostic (1.50e-1)" "unprognostic (1.43e-1)" "unprognostic (2.76e-1)" "unprognostic (7.96e-2)" "unprognostic (1.55e-1)" 3.0 7.6 15.9 3.7 13.8 2.7 2.3 17.2 21.2 4.3 3.5 7.6 4.5 2.4 4.7 15.9 5.4 6.7 3.6 16.1 16.0 13.1 3.3 2.8 3.4 4.6 12.3 5.4 7.5 2.6 4.4 8.6 2.4 9.1 4.6 1.7 5.3 5.3 6.1 24.0 3.1 3.1 4.1 11.3 5.1 2.9 4.5 7.3 3.5 5.5 1.9 3.0 3.5 4.8 0.4 0.3 0.0 0.9 0.4 15.3 0.5 2.4 5.0 4.4 4.9 6.1 4.4 2.1 2.9 4.5 1.9 3.1 3.5 2.9 2.9 0.6 2.1 18.0 3.9 1.7 1.2 1.0 15.8 5.5 0.3 2.9 0.3 4.0 0.4 1.8 3.0 3.6 2.0 1.6 4.5 0.5 4.0 0.7 1.2 2.3 8.7 1.1 3.9 13.6 0.6 9.5 6.4 3.8 0.9 1.9 1.1 5.2 4.5 1.5 0.5 7.4 9.8 4.5 2.5 2.3 5.5 1.1 4.8 2.1 3.6 4.5 1.9 1.8 6.2 6.9 0.0 0.2 0.0 0.2 0.4 1.0 0.4 3.0 1.0 0.2 0.1 2.4 1.1 0.0 0.4 0.9 0.3 15.3 0.5 15.9 13.8 17.2 19.3 16.0 13.1 12.3 5.4 9.1 7.3 0.0 0.3 0.5 2.5 1.6 35.3 13.7 0.0 2.7 0.0 3.5 7.9 0.8 6.6 0.4 0.1 1.9 0.0 0.0 0.2 0.1 3.0 1.6 0.0 0.8 0.6 46.1 2.9 1.8 0.0 0.4 4.4 0.9 0.0 0.0 0.0 9.7 0.4 0.0 2.8 4.9 15.4 0.0 3.9 0.5 5.6 1.1 1.0 1.5 0.0 2.2 PPP1R8 "ard-1, ARD1, NIPP-1, NIPP1, PRO2047" ENSG00000117751 "Protein phosphatase 1 regulatory subunit 8" Q12972 1 27830778-27851676 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein phosphatase inhibitor, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027406, HPA027417, HPA027452" Enhanced Enhanced "Nucleoplasm,Nuclear speckles" NA NA "Nuclear speckles" Nucleoplasm "HPA027406: AB_1854488, HPA027417: AB_1854489, HPA027452: AB_1854490" "unprognostic (5.61e-2)" "unprognostic (2.55e-1)" "unprognostic (4.42e-3)" "unprognostic (3.76e-2)" "unprognostic (2.00e-2)" "unprognostic (9.09e-3)" "prognostic unfavorable (2.19e-5)" "unprognostic (4.82e-2)" "unprognostic (2.14e-3)" "unprognostic (2.20e-1)" "unprognostic (3.16e-2)" "unprognostic (9.16e-2)" "unprognostic (6.26e-2)" "unprognostic (8.08e-2)" "unprognostic (2.91e-2)" "unprognostic (4.86e-2)" "unprognostic (2.58e-2)" 18.0 14.5 28.6 15.5 37.0 23.2 19.4 23.1 29.7 18.9 16.0 18.2 12.0 13.3 24.0 15.6 19.6 19.4 14.6 16.2 23.4 17.7 13.9 14.8 17.6 28.6 24.6 25.7 24.6 18.5 14.2 18.9 17.4 24.4 15.3 18.0 11.7 15.1 19.5 17.8 17.8 15.1 21.8 24.6 16.9 14.3 21.4 25.6 20.7 17.9 9.4 24.6 18.6 16.0 11.9 9.7 17.0 11.4 14.0 16.5 14.9 21.1 15.0 32.7 21.2 20.6 21.6 18.8 22.8 24.0 39.1 31.7 16.8 24.4 30.3 16.1 25.9 15.2 19.1 38.4 21.3 28.4 25.4 23.4 39.5 20.4 24.7 20.8 36.3 28.1 18.8 23.3 35.4 31.7 17.6 23.1 26.0 33.4 20.7 23.2 13.8 39.6 21.4 40.4 18.7 17.5 32.5 27.1 28.8 21.0 19.5 22.9 20.9 28.0 21.9 27.0 17.5 19.2 22.9 19.0 19.3 17.6 30.2 21.1 19.2 29.3 38.3 18.8 47.4 24.6 17.0 10.0 9.1 14.0 10.0 16.5 11.6 11.6 15.8 9.7 11.9 12.8 12.1 5.9 14.0 11.4 7.3 11.4 14.9 28.6 37.0 23.1 29.7 23.4 17.7 24.6 25.7 24.4 25.6 14.9 7.7 28.1 17.4 15.3 22.6 11.5 7.6 18.7 20.5 5.2 2.0 41.6 26.6 24.8 26.4 14.6 12.6 0.0 22.4 34.1 19.0 13.0 25.4 15.8 23.1 7.9 11.1 20.3 14.3 18.7 22.2 16.9 10.1 40.5 14.5 19.8 24.7 16.1 15.9 19.9 13.9 25.8 16.4 27.9 40.2 12.3 36.7 24.5 15.3 17.4 PPP2CB PP2Abeta ENSG00000104695 "Protein phosphatase 2 catalytic subunit beta" P62714 8 30774457-30814314 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Peritubular cells: 248.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018600, HPA043236" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB018600: AB_675841, HPA043236: AB_2678379" "unprognostic (9.77e-2)" "unprognostic (1.30e-1)" "unprognostic (2.51e-2)" "unprognostic (3.82e-1)" "unprognostic (6.70e-2)" "unprognostic (7.79e-2)" "unprognostic (1.13e-2)" "unprognostic (3.51e-1)" "unprognostic (2.28e-1)" "unprognostic (2.86e-2)" "unprognostic (4.50e-2)" "unprognostic (1.89e-2)" "prognostic favorable (5.82e-7)" "unprognostic (9.24e-2)" "unprognostic (2.04e-1)" "unprognostic (1.39e-1)" "unprognostic (2.65e-3)" 26.7 21.0 61.3 11.9 54.9 2.6 28.7 32.0 46.2 28.8 24.1 30.7 19.4 21.7 34.5 37.5 29.7 28.2 23.1 27.2 57.3 43.7 41.0 35.7 27.7 8.4 52.6 39.8 48.0 22.9 33.7 14.8 27.4 47.7 23.7 24.5 12.5 19.5 29.1 27.4 18.0 31.2 39.0 49.7 15.0 18.9 18.8 48.2 6.3 44.5 14.0 14.0 17.7 34.3 5.8 7.9 5.1 6.5 7.3 4.8 1.7 22.1 19.4 33.9 12.9 33.9 30.9 18.9 29.7 27.8 30.8 32.3 20.3 16.3 10.8 29.2 39.5 29.5 13.4 20.2 34.1 41.6 6.7 10.6 14.4 13.2 20.4 38.9 6.4 8.2 27.2 39.0 26.0 29.2 31.3 36.9 18.1 22.3 11.5 51.9 10.9 17.5 8.2 24.7 33.5 11.2 12.3 13.6 8.0 41.2 18.0 32.6 13.5 13.7 14.6 28.6 39.5 8.0 11.0 38.7 26.6 20.0 8.7 24.5 5.9 7.7 12.8 22.8 6.0 34.0 4.8 5.0 3.3 4.2 6.5 4.8 5.8 3.8 4.2 3.5 2.7 3.8 4.6 5.1 7.3 3.0 7.9 2.8 1.7 61.3 54.9 32.0 46.2 57.3 43.7 52.6 39.8 47.7 48.2 65.5 53.8 13.8 81.2 92.5 34.5 71.2 40.8 34.8 50.0 82.0 29.5 36.8 39.7 34.2 13.3 49.6 112.3 0.0 42.0 43.1 62.0 108.1 17.3 81.5 48.8 44.5 31.0 101.3 52.3 13.4 67.9 30.8 38.8 16.2 51.0 105.4 64.5 41.8 248.2 63.4 21.1 45.3 59.7 30.2 35.8 83.6 59.0 14.0 32.4 132.7 PPP2R3B "PPP2R3L, PPP2R3LY, PR48, PR70" ENSG00000167393 "Protein phosphatase 2 regulatory subunit B''beta" Q9Y5P8 X 333963-386955 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 43.5" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 62.0;Cone photoreceptor cells: 25.5;Spermatogonia: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 2.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 15.5;U-698: 24.3" "Low region specificity" "Detected in all" HPA026606 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA026606: " "unprognostic (1.25e-1)" "unprognostic (4.35e-3)" "unprognostic (5.10e-2)" "unprognostic (1.16e-1)" "unprognostic (6.03e-2)" "unprognostic (2.46e-3)" "unprognostic (1.56e-2)" "unprognostic (2.73e-2)" "unprognostic (1.75e-1)" "unprognostic (1.79e-2)" "prognostic favorable (2.92e-5)" "unprognostic (4.65e-2)" "unprognostic (2.29e-8)" "unprognostic (1.15e-1)" "unprognostic (4.97e-2)" "unprognostic (3.17e-1)" "prognostic favorable (1.90e-5)" 1.8 1.3 8.8 1.1 11.7 3.8 4.8 9.1 8.7 7.6 1.2 0.0 0.0 1.4 6.6 0.7 2.4 2.3 1.4 17.7 12.2 2.9 4.1 1.1 1.5 1.7 15.4 6.2 6.9 2.9 1.5 11.0 8.9 13.0 2.4 0.7 0.0 1.6 1.2 43.5 3.9 1.3 1.6 8.3 1.8 1.8 4.1 15.0 0.0 1.0 0.0 0.9 2.9 2.6 0.1 0.6 2.3 0.1 0.0 1.3 0.1 0.5 5.3 0.7 2.2 0.1 0.2 7.1 5.9 1.5 5.3 6.3 5.3 0.0 0.0 3.2 4.5 0.6 0.0 0.2 0.0 1.4 3.7 4.3 1.2 1.8 0.2 0.0 1.9 2.2 0.1 0.1 0.0 3.2 0.2 0.1 3.2 1.0 0.3 1.2 2.6 9.0 7.8 2.3 0.1 15.5 4.1 3.4 0.3 1.4 1.5 0.0 9.2 0.0 0.9 4.2 4.2 0.0 2.3 0.3 3.1 2.9 0.0 2.0 0.0 0.0 24.3 0.1 2.7 3.9 0.0 0.0 2.3 0.1 0.1 1.3 0.1 0.1 0.0 0.6 0.1 0.3 0.3 0.1 0.0 0.1 0.5 0.0 0.1 8.8 11.7 9.1 8.7 12.2 2.9 15.4 6.2 13.0 15.0 0.0 1.7 0.9 7.8 6.1 11.5 62.0 2.5 2.7 1.2 0.0 25.5 5.6 0.0 2.8 0.5 3.5 1.4 0.0 3.5 5.6 3.0 2.2 0.0 1.0 3.2 6.4 4.6 4.3 2.1 1.5 3.7 5.3 5.0 3.6 3.8 11.2 2.6 0.0 2.8 1.3 19.8 0.0 3.8 12.9 25.5 6.6 3.3 1.9 3.1 3.9 PPP2R3C "C14orf10, FLJ20644, G4-1, G5PR" ENSG00000092020 "Protein phosphatase 2 regulatory subunit B''gamma" Q969Q6 14 35085467-35122517 "Predicted intracellular proteins" "Cone-rod dystrophy, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 10 "Early spermatids: 382.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040835, HPA058834" Approved Supported "Nucleoplasm,Golgi apparatus,Cytosol" No No Nucleoplasm "Golgi apparatus, Cytosol" "HPA040835: AB_10794152, HPA058834: AB_2683831" "unprognostic (1.41e-1)" "unprognostic (1.52e-1)" "unprognostic (1.15e-1)" "unprognostic (7.32e-3)" "unprognostic (5.33e-2)" "unprognostic (9.73e-2)" "unprognostic (1.10e-3)" "unprognostic (3.05e-1)" "unprognostic (7.85e-2)" "unprognostic (9.48e-3)" "unprognostic (1.17e-2)" "unprognostic (1.91e-1)" "unprognostic (2.18e-1)" "unprognostic (3.04e-2)" "unprognostic (3.15e-3)" "unprognostic (8.55e-2)" "unprognostic (8.29e-2)" 14.5 12.5 19.1 15.5 23.8 26.4 12.2 17.9 22.1 12.9 13.8 11.4 9.5 14.1 10.9 11.0 8.9 10.0 12.5 14.8 17.9 11.4 10.1 10.5 12.1 18.9 28.4 17.2 12.6 9.5 11.3 30.8 12.7 20.6 11.8 14.7 6.8 10.2 9.7 20.0 6.5 15.3 14.5 22.8 21.5 13.1 46.8 24.1 18.9 8.7 7.5 16.4 14.7 10.4 12.2 12.7 32.1 19.2 13.9 14.7 11.4 15.6 8.6 14.9 13.3 9.8 19.8 11.2 12.6 10.7 14.9 18.3 6.8 11.3 16.8 5.0 12.0 6.1 6.7 6.7 4.8 22.2 18.4 7.8 9.4 4.6 24.9 14.4 17.4 18.5 15.2 4.5 11.2 6.9 8.0 20.2 9.9 9.9 17.1 21.4 11.3 18.3 16.3 13.5 9.2 10.0 18.2 11.5 13.8 5.2 9.1 16.1 14.0 15.5 11.2 20.3 7.1 7.4 20.8 17.1 16.3 7.0 13.7 14.4 15.3 20.1 34.2 8.3 16.7 18.5 20.0 15.0 32.1 10.7 19.2 11.7 12.2 10.8 13.8 12.7 11.0 9.6 11.7 28.1 13.9 16.4 8.1 14.7 11.4 19.1 23.8 17.9 22.1 17.9 11.4 28.4 17.2 20.6 24.1 14.9 24.8 50.1 18.1 10.2 15.8 23.0 25.5 22.7 12.5 19.2 3.9 16.4 28.2 26.6 382.3 29.2 28.5 23.3 31.4 21.7 23.5 24.4 33.4 19.2 53.2 7.9 30.0 26.4 42.9 134.4 26.2 49.9 27.0 72.1 21.2 18.8 38.8 20.3 28.7 31.1 19.1 32.3 31.1 103.4 61.7 11.8 29.1 39.5 20.2 26.5 PPP2R5C "B56G, B56gamma, PR61G" ENSG00000078304 "Protein phosphatase 2 regulatory subunit B'gamma" Q13362 14 101761798-101927989 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "T-cells: 251.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027553 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA027553: AB_10602081" "unprognostic (3.28e-1)" "unprognostic (1.66e-1)" "unprognostic (2.19e-1)" "unprognostic (3.24e-2)" "unprognostic (1.36e-1)" "unprognostic (1.10e-1)" "unprognostic (2.78e-1)" "unprognostic (1.23e-1)" "unprognostic (1.99e-1)" "unprognostic (1.31e-3)" "unprognostic (2.08e-1)" "unprognostic (1.12e-1)" "unprognostic (2.33e-3)" "unprognostic (1.17e-1)" "unprognostic (3.09e-1)" "unprognostic (4.49e-1)" "unprognostic (1.72e-1)" 25.5 29.4 52.6 37.7 45.3 48.1 27.4 25.7 38.9 27.8 31.1 25.6 30.1 22.4 24.0 29.2 32.7 22.3 25.4 48.4 49.3 35.6 25.5 38.1 34.5 53.8 44.7 32.4 28.4 25.6 27.6 35.3 19.5 27.5 23.1 33.3 26.6 28.9 27.8 30.5 28.9 31.7 27.7 45.5 36.8 25.4 27.6 29.5 51.4 29.6 28.3 52.1 33.2 21.9 20.1 24.9 35.3 25.3 16.8 60.5 20.9 21.0 14.5 24.6 23.7 22.3 31.5 23.8 19.9 26.4 25.0 24.0 14.5 36.8 57.7 19.3 25.8 17.6 22.2 22.4 21.1 32.6 25.9 10.6 16.7 17.2 14.1 16.5 25.6 35.9 20.7 27.4 17.2 16.0 22.3 22.4 31.5 34.7 24.4 23.8 32.1 25.7 28.3 14.3 42.5 24.2 21.8 27.7 14.2 24.0 24.0 19.3 36.1 27.0 17.9 33.7 18.0 32.8 19.7 22.1 15.8 15.1 60.7 19.7 34.1 51.0 96.2 23.7 19.0 17.5 20.1 19.8 18.2 60.5 24.3 38.9 20.1 39.7 47.5 16.9 17.8 28.6 44.1 35.3 16.8 25.3 24.9 39.7 20.9 52.6 45.3 25.7 38.9 49.3 35.6 44.7 32.4 27.5 29.5 77.4 85.3 74.9 37.2 52.1 31.6 113.5 48.4 68.3 52.4 34.9 55.0 41.1 39.7 33.2 55.5 45.2 45.9 46.7 40.7 39.2 41.8 41.7 66.0 70.6 61.7 25.4 45.5 59.5 108.0 50.8 48.6 71.4 81.0 136.1 71.3 33.5 39.8 66.8 42.8 53.6 38.0 38.8 46.4 23.7 25.4 61.5 43.8 251.6 58.7 59.3 PPP2R5D "B56D, B56delta" ENSG00000112640 "Protein phosphatase 2 regulatory subunit B'delta" Q14738 6 42984499-43012342 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029045, HPA029046" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA029045: AB_10598912, HPA029046: AB_10600988" "unprognostic (2.25e-1)" "unprognostic (7.14e-2)" "unprognostic (4.73e-2)" "unprognostic (6.89e-2)" "unprognostic (1.74e-2)" "unprognostic (1.70e-1)" "prognostic unfavorable (3.89e-4)" "unprognostic (4.08e-2)" "unprognostic (1.24e-1)" "unprognostic (9.44e-2)" "unprognostic (2.59e-1)" "unprognostic (2.71e-1)" "unprognostic (1.21e-1)" "unprognostic (9.96e-2)" "unprognostic (2.70e-1)" "unprognostic (7.95e-2)" "unprognostic (6.05e-2)" 17.9 14.4 19.7 17.0 31.5 15.1 14.2 28.3 41.0 20.2 24.5 13.7 15.9 31.1 20.7 11.4 18.1 19.0 14.3 22.0 17.7 18.4 15.7 15.8 15.0 16.2 16.6 25.1 20.7 16.5 17.4 11.2 16.6 26.3 18.4 18.6 16.5 13.7 19.2 41.0 17.9 36.4 20.8 11.2 14.4 14.9 27.1 13.1 35.5 13.4 11.1 14.7 19.1 18.5 9.2 12.5 17.9 11.3 11.8 19.7 15.3 24.4 12.9 19.8 25.8 12.3 16.9 11.1 13.6 9.7 27.2 24.1 20.9 6.7 18.3 13.2 16.5 18.8 13.9 26.6 15.6 24.4 15.6 23.1 21.9 16.0 19.6 8.5 15.1 16.1 9.3 10.3 21.7 9.9 15.5 20.7 23.1 22.9 14.2 15.7 10.4 38.8 13.8 8.8 55.4 12.3 27.2 24.5 12.0 8.3 11.6 25.1 16.5 18.4 12.3 14.7 17.1 17.2 14.1 19.6 19.6 18.2 20.5 21.6 14.7 18.5 37.6 7.7 14.1 16.9 14.8 11.3 17.9 16.8 9.8 17.6 9.2 15.3 19.0 11.6 9.0 11.8 14.1 6.9 11.8 7.4 12.5 19.7 15.3 19.7 31.5 28.3 41.0 17.7 18.4 16.6 25.1 26.3 13.1 8.9 7.0 5.2 2.5 7.4 11.6 4.0 5.1 4.0 7.9 7.0 9.8 6.2 5.0 5.8 4.2 6.2 21.7 0.0 6.8 8.7 8.5 2.9 8.1 10.9 8.0 3.2 8.6 8.0 5.9 5.3 8.9 4.2 10.1 6.4 7.6 7.3 7.9 8.4 13.8 3.8 7.5 6.5 8.0 7.5 9.4 8.3 3.8 7.4 9.5 1.7 PPP3CA "CALN, CALNA, CNA1, PPP2B" ENSG00000138814 "Protein phosphatase 3 catalytic subunit alpha" Q08209 4 101023409-101348278 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase, Protein phosphatase" "Craniosynostosis, Disease mutation, Dwarfism, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 71.8" "Low cell type specificity" "Detected in many" "Cancer enriched" "Detected in all" 7 "prostate cancer: 98.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012778, CAB018581" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 35000 Nucleoplasm Cytosol "CAB018581: AB_2168324, HPA012778: AB_1855660" "unprognostic (6.66e-2)" "unprognostic (1.96e-1)" "unprognostic (3.40e-1)" "unprognostic (1.36e-1)" "unprognostic (1.56e-1)" "unprognostic (7.81e-2)" "unprognostic (1.77e-2)" "unprognostic (1.08e-1)" "unprognostic (7.87e-2)" "unprognostic (3.49e-3)" "prognostic unfavorable (3.82e-4)" "unprognostic (3.38e-2)" "unprognostic (2.51e-2)" "unprognostic (5.12e-2)" "unprognostic (1.98e-1)" "unprognostic (1.84e-2)" "unprognostic (5.74e-2)" 12.2 9.2 22.7 7.4 71.8 7.7 10.6 42.1 52.4 9.4 9.5 4.8 9.8 5.8 6.2 6.9 7.4 7.2 6.8 4.3 36.0 13.5 5.8 8.4 10.0 6.7 10.1 22.1 9.6 4.7 7.0 4.2 6.6 11.9 34.6 8.4 2.6 10.4 21.1 23.7 11.4 6.4 7.9 7.5 6.9 11.0 5.3 13.0 3.8 6.8 6.8 8.9 8.4 6.8 27.7 18.3 44.3 14.9 22.3 15.5 6.6 19.4 13.8 3.8 7.5 21.6 16.4 7.4 21.5 19.8 8.7 9.2 8.0 24.4 9.3 9.0 19.4 10.8 9.8 13.9 28.6 14.8 22.7 6.4 14.7 19.8 10.2 15.9 23.6 7.5 17.0 15.0 19.0 21.8 16.6 16.3 6.0 5.7 25.6 13.9 23.4 4.9 17.7 6.4 22.5 9.0 9.0 35.0 10.7 8.4 15.4 30.4 11.5 17.7 15.2 10.3 5.5 13.6 13.5 19.0 20.6 23.5 18.8 14.2 12.0 12.2 16.4 11.4 13.4 5.5 24.6 11.8 24.8 13.6 11.4 15.5 27.7 12.9 13.1 9.9 23.4 6.2 12.3 44.3 22.3 14.9 18.3 8.6 6.6 22.7 71.8 42.1 51.5 36.0 13.5 10.1 22.1 11.9 13.0 71.5 48.8 59.1 33.3 149.9 74.7 24.1 33.1 32.1 20.5 29.6 37.3 28.9 28.2 18.2 1.8 105.6 33.9 0.0 27.3 76.5 53.9 157.6 33.6 37.0 32.1 17.5 122.2 43.6 52.2 4.7 60.1 49.5 87.7 44.1 39.6 19.3 41.1 107.8 57.3 31.7 81.9 12.9 39.4 7.2 22.1 150.4 23.0 55.4 39.9 32.0 PPP4C "PP4, PPX" ENSG00000149923 "Protein phosphatase 4 catalytic subunit" P60510 16 30075978-30085377 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043837 Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA043837: AB_2678695" "unprognostic (1.20e-1)" "unprognostic (1.33e-2)" "unprognostic (2.68e-1)" "unprognostic (4.74e-2)" "unprognostic (2.16e-1)" "unprognostic (5.79e-3)" "unprognostic (3.28e-3)" "unprognostic (2.60e-3)" "unprognostic (3.82e-1)" "unprognostic (1.29e-1)" "unprognostic (2.52e-1)" "unprognostic (3.17e-2)" "unprognostic (1.98e-2)" "unprognostic (3.78e-2)" "unprognostic (9.36e-2)" "unprognostic (9.96e-2)" "unprognostic (1.88e-1)" 24.7 26.6 13.5 26.1 14.1 26.7 18.6 16.0 15.9 19.2 28.4 14.5 20.5 22.5 19.2 28.4 39.1 17.7 31.9 28.5 12.6 12.1 28.9 52.3 27.4 25.3 12.5 12.8 22.5 26.3 23.9 16.2 51.6 11.9 18.3 17.4 18.8 22.0 14.9 26.0 26.1 38.8 15.9 11.9 36.2 22.6 39.0 9.5 59.7 27.1 26.5 37.9 22.2 21.1 19.5 30.3 57.3 28.2 12.4 23.6 12.0 30.8 34.6 23.1 32.2 21.9 18.5 36.0 27.5 30.7 36.2 40.2 30.4 40.3 24.0 35.4 32.4 23.6 25.2 28.6 34.1 21.4 30.1 51.2 16.3 21.5 67.2 33.3 22.9 30.9 26.8 30.2 33.0 21.0 21.7 42.0 31.3 31.8 22.0 27.6 88.9 39.9 41.8 44.0 24.5 18.4 44.7 24.0 41.8 34.2 31.8 22.5 33.3 13.5 40.8 23.5 20.2 37.6 39.0 26.7 21.2 22.3 17.1 21.1 37.8 41.5 28.1 30.2 29.6 25.6 21.4 26.9 57.3 18.3 28.2 13.1 17.0 19.2 20.6 30.3 19.5 17.2 15.2 56.9 12.4 24.5 23.5 23.6 12.0 13.5 14.1 16.0 15.9 12.6 12.1 12.5 12.8 11.9 9.5 47.6 33.1 81.7 96.8 130.7 20.0 9.3 89.2 54.9 23.9 73.3 27.5 268.8 134.3 208.0 127.6 84.2 174.4 0.0 169.7 278.1 71.4 111.6 69.1 85.6 210.3 33.4 120.5 58.9 91.3 98.3 58.1 124.3 75.9 252.5 114.3 41.8 254.7 168.4 49.1 156.3 25.7 71.1 65.1 231.9 141.6 150.8 352.1 111.4 129.3 192.9 PPP4R1 PP4R1 ENSG00000154845 "Protein phosphatase 4 regulatory subunit 1" Q8TF05 18 9546791-9615240 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 23.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 23.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040905, HPA041089" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA040905: AB_10794869, HPA041089: AB_10805836" "unprognostic (1.76e-1)" "unprognostic (5.33e-2)" "unprognostic (1.40e-2)" "unprognostic (5.14e-2)" "unprognostic (3.74e-1)" "unprognostic (3.63e-1)" "unprognostic (1.14e-3)" "unprognostic (9.36e-2)" "unprognostic (1.16e-2)" "unprognostic (4.00e-3)" "unprognostic (3.13e-3)" "unprognostic (4.15e-1)" "unprognostic (7.06e-3)" "unprognostic (1.45e-1)" "unprognostic (2.76e-1)" "unprognostic (2.05e-2)" "unprognostic (1.12e-1)" 18.0 11.1 9.6 10.7 11.4 16.5 25.1 11.6 12.4 17.7 22.0 13.0 15.5 13.7 16.1 14.5 46.2 13.1 14.3 12.2 9.9 8.9 13.5 12.9 26.7 14.8 9.9 7.8 12.1 20.5 15.9 9.3 28.1 10.3 13.1 12.2 10.1 15.8 13.8 12.8 16.3 25.5 18.1 11.1 15.3 14.4 24.2 11.9 9.4 12.1 28.2 25.3 16.8 21.6 2.5 4.6 23.9 3.9 2.5 3.5 2.0 23.5 16.6 40.3 11.0 8.0 12.2 20.5 23.0 15.5 22.8 22.1 15.1 13.7 11.4 16.9 22.5 19.4 10.1 18.6 34.1 30.9 13.3 7.5 10.8 12.3 10.8 12.5 27.6 16.4 10.8 22.1 19.7 18.7 17.1 26.0 7.7 15.7 10.4 24.6 11.9 19.2 10.6 16.1 32.9 10.5 24.0 24.3 7.1 19.2 33.2 11.8 14.0 27.3 12.3 8.9 27.0 6.7 10.6 27.8 40.3 25.0 20.7 28.2 9.3 12.9 20.8 15.1 11.5 18.2 7.2 3.9 6.7 2.7 3.1 3.5 2.5 2.9 2.7 4.6 1.4 1.0 2.3 23.9 2.5 3.0 1.9 3.0 2.0 9.6 11.4 11.6 12.4 9.9 8.9 9.9 7.8 10.3 11.9 92.3 66.2 7.2 26.1 35.8 18.3 18.2 5.1 53.5 71.7 21.0 9.8 21.9 5.0 21.0 75.8 28.5 19.5 0.0 30.2 13.6 16.7 18.7 3.5 11.5 14.4 31.8 16.7 28.8 16.5 46.4 16.1 14.5 13.5 9.0 14.6 11.2 35.6 10.5 11.0 7.9 20.2 12.9 14.0 13.7 10.7 37.1 19.2 9.5 13.1 57.2 PPP4R2 ENSG00000163605 "Protein phosphatase 4 regulatory subunit 2" Q9NY27 3 72996785-73069199 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034695, HPA039837, HPA073758" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA034695: AB_10671231, HPA039837: AB_2676707, HPA073758: AB_2686632" "unprognostic (4.60e-2)" "unprognostic (2.75e-1)" "unprognostic (3.98e-3)" "unprognostic (5.62e-2)" "unprognostic (8.86e-2)" "unprognostic (4.64e-2)" "unprognostic (2.38e-1)" "unprognostic (1.95e-1)" "unprognostic (1.11e-1)" "unprognostic (2.13e-3)" "unprognostic (1.87e-2)" "unprognostic (2.86e-3)" "unprognostic (1.67e-2)" "unprognostic (4.63e-2)" "unprognostic (1.71e-1)" "unprognostic (1.23e-1)" "unprognostic (3.35e-1)" 16.7 19.6 18.3 17.2 25.9 57.7 17.7 18.0 23.4 19.7 17.5 15.7 10.7 16.1 18.0 13.2 15.9 18.7 15.6 24.5 18.6 14.2 15.8 34.0 17.6 15.8 30.8 14.8 24.0 15.1 21.0 20.2 28.5 20.5 14.3 16.2 13.4 16.1 12.0 27.2 12.1 18.1 15.9 20.8 17.1 14.0 17.0 25.8 28.4 17.1 9.8 16.5 14.4 18.8 7.1 14.3 17.7 4.7 8.5 13.6 3.2 12.6 14.8 31.7 19.3 17.0 15.0 19.2 25.3 17.9 23.1 24.2 21.6 15.2 23.7 14.8 15.2 22.0 9.0 24.6 14.1 30.0 36.1 9.2 26.9 16.7 25.5 18.6 39.0 28.1 16.1 21.0 27.8 22.8 16.1 16.4 24.5 23.7 27.4 19.0 18.3 32.4 17.4 29.1 18.8 12.3 30.5 17.9 22.0 19.4 33.8 7.6 18.9 29.5 19.5 23.4 24.1 17.8 22.2 17.9 20.8 25.0 23.8 21.5 17.1 35.0 46.9 14.6 30.2 23.2 5.4 4.7 10.7 10.6 2.6 11.7 5.5 10.9 10.9 4.0 7.1 9.6 8.7 17.7 8.5 4.1 14.3 13.6 3.2 18.3 25.9 18.0 23.4 18.6 14.2 30.8 14.8 20.5 25.8 53.6 23.0 41.6 103.2 104.1 49.6 47.9 48.4 57.6 52.4 26.2 13.7 62.2 16.6 53.0 36.6 47.4 48.4 46.7 46.6 59.6 54.0 103.0 29.0 63.5 37.8 47.7 51.6 33.2 36.2 6.8 49.5 45.3 54.0 37.9 52.8 50.0 57.3 56.9 45.6 38.3 34.0 38.8 45.8 101.1 66.9 95.4 115.7 31.6 45.2 114.6 PPP4R3A "FLFL1, FLJ20707, KIAA2010, MSTP033, PP4R3, SMEK1, smk-1, smk1" ENSG00000100796 "Protein phosphatase 4 regulatory subunit 3A" Q6IN85 14 91457611-91510554 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002568, HPA063917" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA Nucleoplasm "Nuclear speckles, Cytosol" "HPA002568: AB_1079207, HPA063917: AB_2685153" "unprognostic (5.51e-2)" "unprognostic (2.93e-2)" "unprognostic (3.26e-1)" "unprognostic (1.40e-1)" "unprognostic (4.40e-2)" "unprognostic (9.95e-3)" "unprognostic (4.10e-2)" "unprognostic (5.71e-3)" "unprognostic (1.05e-1)" "unprognostic (8.34e-3)" "unprognostic (1.33e-1)" "unprognostic (3.85e-2)" "unprognostic (3.07e-1)" "unprognostic (1.13e-1)" "unprognostic (2.57e-1)" "unprognostic (1.57e-1)" "unprognostic (4.53e-2)" 19.0 14.2 22.1 25.7 19.7 48.5 20.1 33.2 22.6 20.6 22.7 15.0 22.0 19.8 22.0 17.7 22.7 21.0 23.4 15.7 19.4 14.2 20.7 27.8 21.4 29.0 20.8 16.8 23.4 21.7 25.6 24.0 25.1 16.3 21.6 20.9 14.7 20.5 29.1 34.8 25.4 27.1 19.9 18.0 29.1 21.2 25.3 18.3 44.6 19.6 20.3 27.5 19.9 25.6 9.0 7.4 8.5 4.7 12.1 10.0 3.6 14.8 17.8 22.4 15.7 12.3 12.2 30.6 12.8 12.5 14.5 14.4 15.4 19.5 33.4 16.4 11.3 9.9 16.1 21.8 16.5 22.8 27.2 8.9 17.2 12.5 12.6 13.9 33.6 18.8 8.5 25.6 11.3 17.1 12.2 14.7 18.0 15.5 24.8 16.1 23.9 25.2 16.3 16.4 24.0 12.6 29.3 24.2 14.3 14.6 24.1 26.2 14.4 19.0 46.4 16.1 20.1 24.3 19.4 14.5 12.9 11.6 13.3 16.2 19.1 28.6 38.5 15.5 15.8 20.1 8.5 3.1 3.6 7.2 3.5 10.0 7.1 7.3 6.5 2.9 9.0 9.0 7.3 3.4 12.1 4.7 7.4 9.3 3.6 22.1 19.7 33.2 22.6 19.4 14.2 20.8 16.8 16.3 18.3 29.8 38.7 24.8 38.8 0.0 25.4 0.0 28.1 30.8 55.7 43.6 19.6 27.8 24.9 17.8 7.1 24.8 26.2 0.0 21.5 23.8 19.2 43.0 18.6 43.3 22.6 30.2 12.9 29.4 42.3 4.7 34.8 35.8 0.0 19.0 36.6 23.0 22.0 35.1 40.0 19.2 27.4 25.8 0.0 69.4 52.6 0.0 37.1 40.5 33.2 68.0 PPP4R3B "FLFL2, FLJ31474, KIAA1387, PSY2, SMEK2" ENSG00000275052 "Protein phosphatase 4 regulatory subunit 3B" Q5MIZ7 2 55547292-55618880 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001233, CAB017185" Approved Supported "Nucleoplasm,Nuclear speckles,Centrosome" NA NA "Nucleoplasm, Nuclear speckles" Centrosome "CAB017185: , HPA001233: AB_1080033" "unprognostic (9.60e-2)" "unprognostic (2.47e-2)" "unprognostic (5.77e-2)" "unprognostic (1.87e-2)" "unprognostic (6.34e-2)" "unprognostic (3.56e-1)" "unprognostic (2.66e-2)" "unprognostic (3.27e-2)" "unprognostic (8.27e-3)" "unprognostic (7.62e-2)" "unprognostic (1.07e-2)" "unprognostic (3.69e-1)" "prognostic unfavorable (6.03e-4)" "unprognostic (9.73e-2)" "unprognostic (1.45e-1)" "unprognostic (6.28e-2)" "unprognostic (2.77e-1)" 11.9 10.4 12.1 10.6 13.1 8.1 10.9 17.5 13.1 11.2 11.4 8.6 7.4 11.5 8.8 7.8 12.0 12.5 9.1 5.3 12.8 12.7 18.1 8.3 13.0 13.3 7.9 10.8 13.6 10.7 11.7 11.1 11.4 9.5 10.6 7.8 9.6 9.1 6.0 11.0 14.4 10.3 11.1 10.8 11.0 8.0 12.3 18.7 12.6 6.2 14.3 11.3 10.0 17.6 16.9 23.9 19.6 20.0 25.3 21.6 19.8 15.5 17.2 14.5 18.4 19.4 23.6 16.1 17.6 13.9 12.0 18.3 19.3 27.1 32.7 15.9 22.1 17.3 19.5 13.2 20.9 38.9 8.1 27.0 14.6 24.4 29.8 30.7 22.4 15.0 32.0 17.0 29.3 17.9 21.8 15.0 25.5 27.4 18.3 23.3 19.7 20.2 16.9 26.1 12.3 18.5 26.0 20.4 19.1 20.9 21.3 13.0 17.5 24.2 26.0 12.0 15.3 24.9 17.1 21.3 27.4 10.4 22.1 28.4 21.3 10.4 20.0 29.3 22.7 21.2 15.6 23.9 20.4 19.6 23.0 17.6 21.5 21.2 16.9 16.9 25.3 22.0 18.1 20.0 19.3 9.2 21.5 21.6 41.7 35.8 11.1 36.9 0.0 44.1 0.0 17.8 115.1 53.4 15.7 31.4 25.9 33.2 27.6 4.8 23.3 28.5 0.0 35.4 23.5 13.4 47.5 27.9 46.9 23.3 50.9 17.5 23.9 37.1 5.9 25.9 31.9 0.0 36.9 39.3 48.7 31.4 28.1 33.9 42.6 36.0 6.5 0.0 36.3 23.1 0.0 39.9 35.5 36.7 53.1 PPP6R3 "C11orf23, DKFZp781E17107, DKFZp781E2374, DKFZp781O2362, FLJ11058, FLJ43065, KIAA1558, MGC125711, MGC125712, PP6R3, SAP190, SAPL, SAPLa, SAPS3" ENSG00000110075 "Protein phosphatase 6 regulatory subunit 3" Q5H9R7 11 68460731-68615334 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017183, HPA038467, HPA038468" Supported Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "CAB017183: , HPA038467: AB_2676029, HPA038468: AB_2676030" "unprognostic (9.46e-3)" "unprognostic (1.45e-1)" "unprognostic (4.62e-2)" "unprognostic (1.60e-2)" "unprognostic (1.12e-1)" "unprognostic (6.19e-2)" "unprognostic (1.97e-2)" "unprognostic (1.11e-1)" "unprognostic (1.71e-2)" "unprognostic (3.33e-2)" "unprognostic (1.02e-1)" "unprognostic (2.38e-2)" "unprognostic (2.20e-3)" "unprognostic (3.29e-1)" "prognostic unfavorable (8.23e-4)" "unprognostic (1.54e-2)" "unprognostic (6.43e-2)" 33.0 29.8 16.7 25.7 24.1 36.5 26.8 35.7 25.8 33.2 29.6 27.9 24.9 21.5 43.8 24.3 29.9 26.6 24.6 27.5 17.3 16.5 28.8 28.2 27.9 26.8 25.0 18.5 36.4 23.8 49.0 48.1 40.0 23.7 28.3 27.5 28.2 28.2 29.2 46.4 25.8 31.5 35.5 24.3 31.1 27.7 28.2 24.0 45.5 39.2 34.8 31.8 34.3 26.9 14.8 15.0 16.9 16.7 11.7 17.7 7.1 24.4 29.0 30.1 21.0 16.1 16.4 23.3 21.5 20.9 25.0 23.0 50.3 24.9 28.2 21.2 20.0 26.4 23.2 33.0 24.3 33.2 27.3 13.9 32.6 29.5 16.9 15.4 30.9 29.2 16.2 16.4 25.7 27.9 14.1 22.8 22.7 27.5 21.1 17.8 32.8 31.0 23.9 15.0 48.5 17.2 29.2 41.0 27.4 16.7 35.6 17.0 20.3 30.5 24.2 44.3 26.2 35.9 16.6 22.6 24.7 23.4 26.2 18.2 16.7 23.2 37.1 17.9 13.7 26.2 14.6 11.5 14.4 14.7 15.2 14.0 14.1 15.6 14.4 7.4 14.8 17.7 16.1 16.9 11.7 16.7 15.0 15.0 7.1 16.7 24.1 35.7 25.8 17.3 16.5 25.0 18.5 23.7 24.0 41.7 36.5 27.5 21.7 29.5 48.6 33.5 28.1 24.1 38.7 26.2 53.0 16.9 13.3 13.4 59.6 29.4 28.0 23.3 14.3 14.1 23.1 34.0 26.6 21.2 15.0 25.4 29.2 29.4 18.4 17.8 28.7 25.2 20.3 10.8 26.5 31.9 19.2 28.3 29.7 13.5 49.0 19.4 28.1 27.7 29.7 31.0 27.5 26.6 23.4 35.3 PPRC1 "KIAA0595, MGC74642, PRC" ENSG00000148840 "Peroxisome proliferator-activated receptor gamma, coactivator-related 1" Q5VV67 10 102132994-102150331 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Basal keratinocytes: 39.4;Suprabasal keratinocytes: 38.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038511, HPA057571" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA038511: AB_10672521, HPA057571: AB_2683472" "unprognostic (2.27e-1)" "unprognostic (7.66e-2)" "unprognostic (2.35e-2)" "unprognostic (4.77e-2)" "unprognostic (1.63e-1)" "unprognostic (4.96e-2)" "unprognostic (4.29e-3)" "unprognostic (6.31e-2)" "unprognostic (3.95e-2)" "unprognostic (1.26e-1)" "unprognostic (2.33e-1)" "unprognostic (2.86e-1)" "prognostic unfavorable (6.71e-7)" "unprognostic (8.65e-2)" "unprognostic (4.22e-1)" "unprognostic (1.12e-1)" "unprognostic (4.93e-2)" 18.9 12.0 10.0 20.2 12.3 18.1 14.2 13.1 12.2 13.4 15.6 9.5 9.7 9.1 17.4 10.1 18.4 16.2 14.2 14.4 9.3 6.1 10.3 18.0 18.9 14.2 15.0 7.8 25.4 35.6 13.5 13.1 15.3 10.4 14.2 9.8 10.0 12.6 9.7 32.8 19.6 11.3 17.0 9.7 14.7 14.8 11.5 11.4 13.2 12.2 15.9 19.3 14.2 15.4 4.0 4.6 0.3 2.4 7.6 4.6 2.2 13.3 20.0 12.3 24.6 11.0 11.3 15.8 12.0 16.2 17.3 14.4 22.4 15.4 29.2 10.1 18.0 10.9 25.2 25.0 23.8 15.3 11.9 19.5 27.7 14.3 21.5 14.8 21.8 12.1 15.0 21.4 20.2 38.5 11.5 10.7 12.0 20.6 17.3 13.6 22.9 17.4 30.5 21.1 12.7 11.9 24.4 17.5 12.4 14.8 13.3 8.5 12.4 10.2 11.4 14.3 12.4 18.4 11.5 11.7 13.8 17.5 14.0 26.9 14.5 10.2 26.3 15.6 27.4 6.9 0.0 2.1 0.3 3.6 2.4 4.6 3.1 2.8 4.4 4.6 4.0 3.3 4.1 0.1 7.6 2.3 1.9 1.7 2.2 10.0 12.3 13.1 12.2 9.3 6.1 15.0 7.8 10.4 11.4 26.8 10.4 12.2 29.1 39.4 4.5 7.4 5.1 2.7 12.5 5.2 3.9 6.7 1.7 7.4 0.7 10.5 3.3 0.0 8.3 10.5 11.3 19.5 10.4 7.3 7.7 1.6 8.1 8.6 3.5 1.8 5.8 8.5 8.5 2.8 9.1 2.0 10.6 5.8 6.0 2.2 3.4 6.5 17.6 6.4 11.8 38.0 4.2 5.3 8.1 30.1 PQLC1 FLJ22378 ENSG00000122490 "PQ loop repeat containing 1" Q8N2U9 18 79902420-79951664 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 150.7;Late spermatids: 119.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051666 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA051666: AB_2681567" "unprognostic (6.03e-2)" "unprognostic (1.51e-1)" "unprognostic (2.36e-1)" "unprognostic (6.45e-2)" "unprognostic (3.94e-2)" "unprognostic (2.07e-2)" "unprognostic (1.39e-1)" "unprognostic (2.47e-1)" "unprognostic (2.50e-1)" "unprognostic (4.58e-2)" "unprognostic (1.02e-2)" "unprognostic (4.34e-1)" "unprognostic (1.40e-3)" "unprognostic (2.00e-1)" "unprognostic (1.20e-1)" "unprognostic (1.79e-1)" "unprognostic (1.70e-2)" 31.3 12.5 17.4 12.4 16.6 28.3 23.0 12.5 27.0 9.4 16.9 12.3 9.6 8.9 13.4 12.0 20.0 10.8 13.2 13.8 21.3 12.6 16.5 56.7 14.3 14.2 13.0 13.8 9.9 23.8 8.0 8.5 9.5 14.2 10.8 7.1 19.9 21.4 10.1 29.6 19.2 10.0 12.4 7.5 14.0 10.1 22.9 9.7 8.7 25.8 14.4 13.6 11.7 15.8 1.7 7.2 3.8 3.8 2.0 2.5 1.9 16.5 5.7 5.8 11.3 13.1 8.5 8.0 10.9 7.5 8.8 8.3 7.5 9.0 6.9 4.3 9.8 5.1 17.0 8.0 11.6 2.3 21.5 11.7 8.8 8.0 20.2 15.7 20.9 22.3 9.4 11.6 8.0 3.1 4.5 7.5 7.7 3.3 5.7 4.5 12.6 10.3 22.5 1.9 2.2 15.5 18.5 6.1 11.6 5.9 11.9 17.3 7.8 8.2 10.5 12.0 1.6 6.2 23.0 9.4 13.4 13.8 7.1 8.2 3.0 4.6 9.0 10.3 25.5 5.9 0.7 3.8 3.8 1.7 3.8 1.0 1.7 1.7 0.8 4.0 1.5 2.1 2.5 2.5 2.0 3.1 7.2 1.5 1.9 17.4 16.6 12.5 27.0 21.3 12.6 13.0 13.8 14.2 9.7 23.8 16.5 28.9 22.8 35.4 28.8 10.5 15.3 4.0 6.8 5.2 70.7 11.6 1.7 8.6 85.6 20.5 37.1 0.0 12.8 11.6 14.5 23.0 19.5 150.7 31.2 87.4 15.5 18.4 32.9 119.4 18.4 20.5 18.6 7.2 29.7 21.7 13.1 35.1 22.3 16.5 33.4 6.5 19.8 8.6 10.2 44.2 17.4 8.6 26.2 38.7 PQLC2L C3orf55 ENSG00000174899 "PQ loop repeat containing 2 like" A1A4F0 3 157543246-157677749 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 29.8;breast: 36.0" "Cell type enhanced" "Detected in some" 20 "Collecting duct cells: 21.0;Ductal cells: 5.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 33.9;ASC TERT1: 18.8;EFO-21: 12.8;HSkMC: 12.1;hTERT-RPE1: 13.4;LHCN-M2: 17.0" HPA054395 Uncertain Approved "Nucleoplasm,Nuclear bodies" No NA "Nucleoplasm, Nuclear bodies" "HPA054395: AB_2682473" "unprognostic (1.25e-1)" "unprognostic (1.19e-1)" "unprognostic (6.80e-2)" "unprognostic (1.41e-2)" "unprognostic (3.80e-3)" "unprognostic (1.65e-3)" "unprognostic (1.83e-5)" "unprognostic (2.29e-2)" "unprognostic (2.67e-1)" "unprognostic (3.56e-2)" "unprognostic (3.34e-2)" "unprognostic (4.59e-3)" "unprognostic (7.47e-7)" "unprognostic (1.17e-3)" "unprognostic (2.75e-1)" "unprognostic (4.81e-2)" "unprognostic (7.56e-3)" 29.8 1.6 0.2 1.8 1.3 0.1 36.0 0.0 0.8 5.3 4.1 0.0 0.0 0.1 1.3 2.0 3.1 1.8 4.3 5.6 0.3 1.2 4.5 0.1 8.4 1.6 0.5 0.1 0.4 1.4 0.1 5.9 2.6 1.3 3.9 1.4 4.6 4.5 1.0 4.8 2.2 1.6 3.4 0.3 0.1 3.8 2.7 0.0 0.0 11.8 3.0 0.5 4.2 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.7 0.0 0.0 33.9 18.8 0.0 1.7 3.5 0.7 1.0 0.0 2.4 0.0 12.8 5.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.5 0.0 0.0 2.7 0.0 0.0 12.1 0.6 5.2 0.3 13.4 5.3 0.0 0.3 0.0 17.0 0.1 0.0 0.0 0.1 0.6 3.0 0.0 0.0 0.0 0.1 2.1 0.0 0.1 0.1 1.1 0.0 0.0 4.8 0.0 4.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 1.3 0.0 0.8 0.3 1.2 0.5 0.1 1.3 0.0 0.0 0.3 0.0 0.6 0.0 0.3 0.3 2.5 1.4 1.2 21.0 0.0 0.0 0.0 5.8 4.2 0.0 0.0 0.0 1.8 0.6 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 4.2 0.3 0.0 0.0 0.0 0.0 0.2 3.5 0.0 0.7 0.8 1.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.6 PRAC1 "C17orf92, PRAC" ENSG00000159182 "PRAC1 small nuclear protein" Q96KF2 17 48721719-48722522 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "intestine: 62.1;prostate: 40.3" "Group enriched" "Detected in some" 5 "Intestinal endocrine cells: 873.8;Mucus-secreting cells: 545.9;Undifferentiated cells: 434.0" "Cancer enriched" "Detected in many" 5 "prostate cancer: 291.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 33 "PC-3: 92.5" HPA047871 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA047871: AB_2680195" "unprognostic (7.59e-2)" "unprognostic (2.43e-2)" "unprognostic (2.04e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.6 2.0 30.8 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 40.3 62.1 0.1 0.1 0.1 0.1 0.0 0.1 1.5 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 9.9 5.1 0.8 0.0 2.2 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 92.5 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.2 0.5 0.0 0.2 0.5 0.0 0.4 0.0 0.8 0.1 0.1 2.2 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 97.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 67.9 0.0 0.0 0.0 0.1 118.0 0.0 0.0 0.0 0.0 873.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 545.9 0.0 0.0 121.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 434.0 46.7 PRAME "CT130, MAPE" ENSG00000185686 "Preferentially expressed antigen in melanoma" P78395 22 22547701-22559361 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Differentiation, Growth regulation, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 54.3" "Cell type enriched" "Detected in some" 8 "Spermatogonia: 241.6" "Group enriched" "Detected in many" 5 "endometrial cancer: 73.4;melanoma: 139.6;ovarian cancer: 29.4;testis cancer: 51.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "K-562: 143.2" "Not detected" "Not detected" "HPA045153, HPA068562" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA045153: AB_10797259, HPA068562: " "unprognostic (9.36e-3)" "unprognostic (9.74e-2)" "unprognostic (1.02e-1)" "unprognostic (3.87e-2)" "unprognostic (5.20e-2)" "prognostic unfavorable (3.41e-4)" "unprognostic (3.43e-2)" "unprognostic (4.00e-2)" "unprognostic (1.33e-1)" "unprognostic (6.52e-3)" "unprognostic (9.68e-3)" "unprognostic (2.06e-1)" "prognostic unfavorable (7.48e-9)" "unprognostic (1.95e-1)" "unprognostic (2.21e-1)" "unprognostic (8.87e-2)" "unprognostic (1.26e-1)" 0.1 1.7 0.1 0.3 0.3 0.0 0.1 0.3 0.1 0.2 0.3 0.1 0.5 0.0 2.8 10.9 0.1 0.2 0.1 0.3 0.2 0.0 0.7 0.1 0.1 0.1 0.1 0.1 2.2 0.1 0.0 0.1 0.4 0.4 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.8 0.2 0.0 54.3 0.1 0.3 0.1 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 9.4 0.0 19.8 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 14.2 0.0 0.0 0.0 0.6 0.0 0.0 8.6 2.1 5.0 3.7 0.1 0.0 0.4 27.3 0.0 0.0 0.0 0.0 0.0 0.0 2.2 143.2 2.3 0.0 1.2 0.0 0.0 0.0 4.2 0.6 0.8 0.0 0.0 0.0 0.0 0.1 29.4 0.0 0.0 0.0 0.0 4.3 3.5 0.7 0.0 25.8 0.0 0.0 0.4 2.0 0.1 0.0 0.1 3.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.1 0.2 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 9.5 0.0 0.0 0.0 30.6 5.2 0.0 0.0 5.4 0.0 0.2 0.1 0.0 3.2 0.8 0.3 6.5 0.0 29.8 241.6 0.0 0.0 0.0 0.0 0.0 PRAMEF12 ENSG00000116726 "PRAME family member 12" O95522 1 12774841-12777906 "Plasma proteins, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.8" "HPA045286, HPA051704" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045286: AB_10794782, HPA051704: AB_2681581" "unprognostic (6.60e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRC1 ASE1 ENSG00000198901 "Protein regulator of cytokinesis 1" O43663 15 90966038-90995629 "Predicted intracellular proteins" "Cell cycle, Cell division" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 43.3;lymphoid tissue: 44.5;testis: 44.3" "Group enriched" "Detected in many" 4 "Erythroid cells: 70.0;Extravillous trophoblasts: 59.0;Spermatocytes: 129.3;Spermatogonia: 60.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "basophil: 18.9;T-reg: 5.8" "Group enriched" "Detected in many" 6 "granulocytes: 18.9;T-cells: 5.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA034521, HPA048816" Enhanced Supported "Nucleoplasm,Plasma membrane,Microtubules,Cytokinetic bridge,Midbody" Yes Yes "Plasma membrane, Microtubules, Cytokinetic bridge, Midbody" Nucleoplasm "HPA034521: AB_10670169, HPA048816: " "unprognostic (1.14e-1)" "unprognostic (3.98e-2)" "unprognostic (9.21e-2)" "unprognostic (1.75e-3)" "unprognostic (2.39e-1)" "unprognostic (3.43e-2)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.24e-3)" "unprognostic (3.86e-3)" "unprognostic (1.65e-2)" "prognostic unfavorable (2.76e-5)" "unprognostic (2.49e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.09e-2)" "unprognostic (1.79e-1)" "unprognostic (7.90e-2)" "unprognostic (3.92e-2)" 3.2 2.8 3.5 13.0 3.8 43.3 3.6 12.5 5.8 3.4 9.3 1.6 0.2 6.1 3.5 4.7 15.0 2.6 2.8 3.5 5.1 4.9 2.3 1.9 5.8 9.2 3.4 4.7 3.6 3.8 1.6 1.5 10.4 5.2 2.4 9.9 2.7 3.9 1.0 2.5 9.9 6.6 5.4 3.5 5.8 5.0 44.3 0.8 44.5 1.8 15.3 16.5 3.5 4.9 0.9 2.0 18.9 0.4 2.0 5.8 0.7 32.9 40.2 33.7 22.8 3.5 6.0 18.1 47.4 28.0 52.5 40.3 26.8 32.1 12.5 18.9 30.2 32.5 44.9 38.3 20.3 49.8 23.2 42.5 26.0 52.6 24.6 0.9 12.8 22.5 1.5 2.6 29.8 30.6 11.7 29.4 20.3 21.6 26.9 48.8 28.6 13.1 19.5 13.2 43.1 17.3 13.8 42.0 16.8 23.4 25.0 30.7 24.3 45.1 25.1 16.3 24.3 30.1 25.3 17.6 34.7 30.7 28.6 68.2 8.7 23.1 15.5 15.2 31.8 53.0 18.9 0.4 2.0 0.5 0.0 0.3 0.9 1.0 1.0 1.8 0.4 0.9 0.4 0.2 2.0 0.2 2.0 5.8 0.7 3.5 3.8 12.5 5.8 5.1 4.9 3.4 4.7 5.2 0.8 0.0 1.9 12.3 5.2 14.7 6.8 2.4 0.0 4.0 10.3 3.5 0.0 9.5 0.0 2.9 17.7 3.2 2.0 70.0 2.5 59.0 7.4 5.1 9.2 1.6 17.6 3.2 5.2 9.8 8.6 12.3 3.4 7.0 3.3 9.0 4.5 4.5 1.7 2.6 1.8 0.0 3.5 6.5 10.3 129.3 60.0 12.4 12.2 6.9 7.4 5.4 PRDM1 "BLIMP1, PRDI-BF1" ENSG00000057657 "PR/SET domain 1" O75626 6 106086320-106109939 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Adaptive immunity, Immunity, Innate immunity, Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 49.9" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 49.1;T-cells: 100.2;Urothelial cells: 77.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "eosinophil: 5.6;gdT-cell: 12.6;MAIT T-cell: 19.3;memory CD4 T-cell: 12.0;memory CD8 T-cell: 11.6;naive CD8 T-cell: 6.8;neutrophil: 6.8;T-reg: 15.4" "Group enriched" "Detected in many" 5 "granulocytes: 6.8;T-cells: 19.3" "Cell line enhanced" "Detected in some" "Karpas-707: 68.5;RPMI-8226: 12.8;U-266/70: 25.7;U-266/84: 16.6" "Region enriched" "Detected in single" 6 "olfactory region: 4.4" "Low region specificity" "Detected in all" "HPA030033, HPA075427" Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA030033: AB_10601050, HPA075427: " "unprognostic (9.60e-2)" "unprognostic (3.28e-2)" "unprognostic (1.71e-1)" "unprognostic (1.98e-2)" "unprognostic (4.03e-1)" "unprognostic (3.77e-2)" "unprognostic (1.04e-1)" "unprognostic (1.49e-1)" "unprognostic (2.42e-1)" "unprognostic (1.81e-1)" "unprognostic (3.50e-2)" "unprognostic (7.56e-2)" "prognostic unfavorable (9.81e-5)" "unprognostic (1.52e-1)" "unprognostic (3.51e-1)" "unprognostic (2.45e-3)" "unprognostic (7.90e-2)" 11.6 1.5 1.6 26.3 3.2 10.4 7.0 5.3 1.6 14.0 16.5 1.9 1.4 5.4 11.6 2.2 33.4 3.8 8.1 2.3 1.9 2.0 3.1 2.4 18.8 33.3 2.1 0.5 4.2 1.8 1.2 2.1 9.0 4.9 3.6 11.0 4.3 10.6 3.0 2.0 8.9 18.2 3.4 7.4 24.2 8.6 3.0 1.5 3.1 7.7 35.7 49.9 12.8 18.0 1.5 0.2 6.8 0.6 2.5 19.3 1.3 0.4 0.1 0.3 0.0 0.5 0.7 0.0 2.3 7.2 0.7 1.3 0.4 2.8 0.6 0.1 4.6 0.1 0.1 0.0 1.1 0.8 6.4 0.0 0.1 1.4 0.0 1.1 0.2 0.5 0.7 3.6 1.0 3.0 0.2 0.9 0.3 0.4 68.5 0.1 0.0 0.0 0.1 0.2 0.4 0.0 0.1 0.0 12.8 0.6 0.1 0.0 0.0 0.3 0.3 0.0 0.5 0.3 0.7 0.4 1.1 0.6 0.6 2.1 25.7 16.6 1.5 1.6 0.4 0.6 1.2 0.4 5.6 12.6 0.6 19.3 1.5 12.0 11.6 0.2 0.5 1.1 6.8 6.8 2.5 0.1 0.2 15.4 1.3 1.6 3.2 5.3 1.6 1.9 2.0 2.1 0.5 4.9 1.5 0.0 9.0 19.7 8.0 17.3 0.8 1.4 0.0 2.7 7.9 3.5 49.1 0.4 0.0 0.3 0.8 20.4 7.3 23.3 0.2 0.5 5.1 3.1 3.5 1.5 19.3 0.0 1.7 8.0 24.7 0.0 0.0 38.5 35.4 47.7 3.1 0.5 4.8 4.3 1.1 0.1 0.4 0.0 16.4 0.3 1.3 36.3 0.6 100.2 2.5 77.0 PRDM10 "KIAA1231, MGC131802, PFM7" ENSG00000170325 "PR/SET domain 10" Q9NQV6 11 129899706-130002835 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 33.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026997, HPA061749" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" NA NA Nucleoplasm "Nucleoli fibrillar center, Vesicles" "HPA026997: AB_1855681, HPA061749: " "unprognostic (4.40e-2)" "unprognostic (2.17e-1)" "unprognostic (5.32e-3)" "unprognostic (2.03e-1)" "unprognostic (1.50e-1)" "unprognostic (1.52e-3)" "unprognostic (2.19e-2)" "unprognostic (2.48e-1)" "unprognostic (1.87e-3)" "unprognostic (3.33e-2)" "unprognostic (4.45e-2)" "unprognostic (3.57e-2)" "unprognostic (1.87e-1)" "unprognostic (5.69e-2)" "unprognostic (4.88e-1)" "unprognostic (6.23e-2)" "unprognostic (1.51e-1)" 5.8 5.4 7.6 7.2 8.9 14.2 8.5 20.3 10.4 7.4 7.8 6.4 5.8 6.6 8.2 6.8 8.4 5.4 5.5 4.6 7.7 6.2 5.0 7.3 6.3 6.9 6.6 6.5 7.3 6.2 9.7 11.2 8.3 6.4 7.1 8.0 5.5 6.7 5.4 12.9 12.1 7.0 6.1 6.3 6.7 7.8 5.6 6.3 14.4 6.5 4.7 9.9 6.2 7.0 8.8 3.3 9.4 3.8 7.1 5.0 1.8 3.0 4.1 5.1 3.4 2.3 2.8 3.4 2.5 3.3 2.1 2.8 4.2 3.3 12.2 3.1 2.9 2.9 4.1 4.3 2.1 3.5 4.7 4.2 8.0 5.0 3.2 1.5 7.2 33.3 2.0 4.8 3.2 2.1 3.3 3.8 3.3 4.4 4.7 3.1 3.6 4.8 3.6 3.9 4.1 3.0 4.5 3.2 1.8 3.1 5.6 5.6 2.9 3.7 4.3 1.2 3.0 3.0 3.0 3.7 5.0 2.3 2.5 3.3 1.2 2.0 16.9 2.2 3.9 4.5 3.9 3.4 8.5 4.5 3.4 4.1 8.8 3.5 3.5 3.3 6.0 5.0 2.4 9.4 7.1 3.8 3.2 4.1 1.8 7.6 8.9 20.3 10.4 7.7 6.2 6.6 6.5 6.4 6.3 3.0 2.4 0.0 1.9 5.5 3.2 2.4 2.5 1.4 1.2 0.0 0.0 1.2 0.0 1.0 2.9 0.6 3.5 0.0 1.0 1.1 2.0 3.2 1.1 1.5 1.3 1.6 1.7 1.3 2.8 2.9 2.3 1.8 0.0 1.0 2.8 0.8 0.8 2.6 1.8 0.7 2.2 0.0 1.4 0.3 0.6 4.4 0.5 1.8 2.3 2.7 PRDM12 ENSG00000130711 "PR/SET domain 12" Q9H4Q4 9 130664594-130682981 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 20 "RH-30: 19.4" "Region enriched" "Detected in single" 7 "basal ganglia: 11.2" "Group enriched" "Detected in some" 33 "basal ganglia: 6.1;hypothalamus: 2.0" HPA043143 Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA043143: AB_10806379" "unprognostic (3.25e-2)" "unprognostic (2.32e-1)" "unprognostic (3.40e-1)" "unprognostic (1.81e-4)" "unprognostic (7.90e-2)" "unprognostic (4.75e-3)" "unprognostic (2.48e-3)" "unprognostic (4.18e-2)" "unprognostic (4.61e-1)" "unprognostic (2.70e-1)" "unprognostic (6.43e-2)" "unprognostic (7.58e-2)" "unprognostic (4.03e-3)" "unprognostic (3.01e-2)" "unprognostic (4.79e-2)" "unprognostic (6.30e-4)" "unprognostic (1.40e-1)" 0.1 0.7 1.0 0.3 1.5 0.0 0.1 1.1 2.2 0.0 0.1 0.3 0.0 0.9 0.0 0.0 0.0 0.0 1.0 3.7 0.0 0.2 0.0 0.0 0.5 0.0 0.8 0.1 0.2 0.0 0.0 0.3 0.5 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.1 0.6 0.3 0.1 0.0 0.4 0.0 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.3 0.1 0.0 0.2 0.3 0.2 0.1 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.9 0.0 0.8 0.0 0.1 0.1 0.0 19.4 0.5 0.0 0.0 0.9 0.3 0.4 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 PRDM14 ENSG00000147596 "PR/SET domain 14" Q9GZV8 8 70051651-70071693 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 5.4" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 658 "testis cancer: 34.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 57 "NTERA-2: 33.7;SuSa: 9.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019094, HPA057070" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA019094: AB_1855686, HPA057070: AB_2683327" "unprognostic (5.86e-2)" "unprognostic (9.32e-2)" "unprognostic (6.14e-3)" "unprognostic (1.37e-2)" "unprognostic (8.62e-2)" 0.2 0.2 0.2 0.2 0.2 1.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.8 0.4 1.1 0.2 0.3 0.2 1.1 0.2 0.2 0.5 0.2 0.5 0.2 0.2 0.2 0.5 0.2 0.3 0.3 0.2 0.2 0.2 0.1 1.7 0.3 0.2 0.4 1.2 0.2 0.2 0.2 0.6 0.3 5.4 0.2 0.2 0.3 0.2 0.2 0.2 0.2 1.6 1.0 1.4 1.6 1.0 2.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 9.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.5 0.6 1.0 0.4 0.8 1.4 1.1 0.7 0.3 1.6 2.5 1.9 1.4 1.0 1.6 1.0 0.4 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 PRDM15 "C21orf83, ZNF298" ENSG00000141956 "PR/SET domain 15" P57071 21 41798225-41879482 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 15.1;Club cells: 12.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 17.9;U-266/70: 16.5;U-698: 32.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024268, HPA029255, HPA029256" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA024268: AB_1855688, HPA029255: AB_2672970, HPA029256: AB_2672971" "unprognostic (8.73e-2)" "unprognostic (1.32e-2)" "unprognostic (2.43e-2)" "unprognostic (6.93e-2)" "unprognostic (2.44e-1)" "unprognostic (1.85e-4)" "unprognostic (4.22e-4)" "unprognostic (6.50e-2)" "unprognostic (4.88e-2)" "unprognostic (1.91e-2)" "unprognostic (5.52e-2)" "unprognostic (1.77e-1)" "unprognostic (1.30e-8)" "unprognostic (1.34e-1)" "unprognostic (2.70e-1)" "unprognostic (9.72e-2)" "unprognostic (4.86e-3)" 4.8 4.7 9.0 8.1 7.0 4.6 5.5 10.4 7.5 4.8 5.4 7.3 8.4 7.9 5.4 4.5 6.7 5.9 4.9 4.4 4.3 3.4 3.9 5.1 4.7 17.0 8.0 4.8 6.7 5.9 5.6 6.4 3.3 6.0 6.3 5.0 4.3 7.6 7.3 9.3 8.3 7.7 5.1 6.6 9.4 5.4 6.2 7.8 10.8 6.1 6.9 16.8 4.8 7.7 3.0 1.5 1.2 2.5 0.1 1.3 1.3 1.3 3.0 2.6 3.3 0.7 1.3 2.7 1.2 0.9 1.3 1.0 2.0 1.7 17.9 1.2 1.4 1.2 2.9 2.3 1.5 1.3 1.7 2.3 3.2 6.8 2.1 0.7 2.8 2.1 0.7 1.8 1.5 1.3 1.4 1.8 2.2 3.0 1.1 1.6 3.7 2.7 2.0 2.8 1.8 1.9 4.6 1.7 2.1 1.4 2.4 4.2 2.6 5.4 2.2 1.0 1.0 2.2 1.6 2.3 2.0 0.7 1.4 2.1 16.5 1.9 32.6 1.6 3.4 2.8 0.0 1.4 1.2 1.3 2.5 0.1 3.0 0.2 1.1 1.5 1.0 0.8 1.2 0.0 0.1 0.6 0.7 0.8 1.3 9.0 7.0 10.4 7.5 4.3 3.4 8.0 4.8 6.0 7.8 3.0 15.1 4.5 1.9 2.6 2.9 3.8 2.5 5.3 12.5 1.8 5.9 1.2 0.0 1.2 1.4 2.0 1.3 0.0 2.2 0.7 2.2 1.8 3.5 1.8 1.7 3.2 0.0 0.6 2.2 2.5 1.1 2.1 1.7 0.0 1.4 1.0 1.3 0.0 0.4 0.6 2.4 0.0 1.4 2.1 3.0 3.0 0.6 2.2 2.0 1.1 PRDM16 "KIAA1675, KMT8F, MEL1, MGC166915, PFM13" ENSG00000142611 "PR/SET domain 16" Q9HAZ2 1 3069168-3438621 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Methyltransferase, Repressor, Transferase" "Cancer-related genes, Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 32.8;Cholangiocytes: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 13 "NK-cell: 5.4" "Lineage enriched" "Detected in single" 13 "NK-cells: 5.4" "Cell line enhanced" "Detected in some" "AN3-CA: 2.5;HEK 293: 2.9;HHSteC: 3.4;hTERT-RPE1: 11.5;MCF7: 2.6;OE19: 5.7" "Region enriched" "Detected in many" 5 "basal ganglia: 16.1" "Low region specificity" "Detected in many" "HPA050343, HPA060467" Supported Nucleoplasm NA NA Nucleoplasm "HPA050343: AB_2681099, HPA060467: AB_2684287" "unprognostic (2.44e-1)" "unprognostic (1.44e-1)" "unprognostic (5.31e-4)" "unprognostic (1.27e-1)" "unprognostic (1.14e-1)" "unprognostic (3.95e-2)" "unprognostic (9.15e-3)" "unprognostic (5.68e-4)" "unprognostic (2.58e-1)" "unprognostic (2.07e-2)" "unprognostic (5.21e-2)" "unprognostic (1.71e-1)" "unprognostic (7.80e-6)" "unprognostic (2.14e-1)" "unprognostic (1.73e-1)" "prognostic unfavorable (4.70e-5)" "unprognostic (4.06e-2)" 2.7 0.7 5.3 1.4 5.6 0.5 1.6 0.5 4.7 2.1 6.2 3.3 12.8 14.1 1.5 4.5 1.1 2.0 11.7 5.1 5.2 1.9 7.0 0.6 4.2 1.4 2.9 3.1 3.6 12.7 1.2 1.1 0.6 3.3 1.1 0.9 16.1 1.3 15.0 1.2 0.9 8.0 1.5 2.5 4.2 14.8 1.4 4.8 0.0 10.7 0.0 0.9 1.1 1.5 0.3 0.1 0.0 0.0 5.4 0.4 0.0 0.0 0.0 0.9 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.4 0.5 0.0 0.4 0.0 0.4 0.0 2.2 0.0 0.0 0.2 2.9 0.0 0.0 0.5 3.4 0.0 1.2 0.0 0.0 0.0 0.0 11.5 0.0 0.2 0.0 0.0 0.0 2.6 0.2 0.0 0.3 5.7 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.4 0.0 5.4 0.0 0.0 0.0 0.0 5.3 5.6 0.5 4.7 5.2 1.9 2.9 3.1 3.3 4.8 32.8 8.0 0.0 0.2 0.6 0.0 4.8 17.8 2.7 9.1 7.0 0.0 0.0 5.0 7.6 0.0 0.7 0.0 0.0 4.3 2.9 0.0 0.3 0.0 0.0 0.0 1.6 5.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 1.3 5.3 0.0 1.8 0.2 0.0 0.0 5.3 0.2 1.1 0.0 0.0 0.0 1.2 0.1 PRDM2 "HUMHOXY1, KMT8, KMT8A, MTB-ZF, RIZ, RIZ1, RIZ2" ENSG00000116731 "PR/SET domain 2" Q13029 1 13700198-13825079 "Enzymes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005809 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA005809: AB_1079673" "unprognostic (2.22e-1)" "unprognostic (3.28e-1)" "unprognostic (5.34e-2)" "unprognostic (1.28e-2)" "unprognostic (6.70e-2)" "unprognostic (2.72e-3)" "unprognostic (1.94e-2)" "unprognostic (1.12e-2)" "unprognostic (3.20e-2)" "unprognostic (2.53e-2)" "unprognostic (2.30e-1)" "unprognostic (1.35e-1)" "unprognostic (9.63e-3)" "unprognostic (3.81e-1)" "unprognostic (2.45e-1)" "unprognostic (1.85e-1)" "unprognostic (5.85e-3)" 15.2 14.5 26.0 17.2 28.1 64.1 17.2 32.3 44.9 16.2 18.1 19.8 12.6 12.4 18.8 16.4 19.6 14.4 16.4 14.3 19.8 14.5 10.8 9.3 15.6 23.4 18.9 27.8 30.7 12.8 16.0 26.7 15.7 18.0 17.7 13.6 10.3 15.8 18.9 45.2 21.6 16.8 16.8 21.6 16.9 14.2 17.1 17.8 14.4 23.3 11.7 22.7 19.8 19.3 16.0 5.4 9.7 5.1 5.7 5.7 2.5 6.9 4.0 14.4 5.5 11.4 8.8 6.9 9.0 5.5 6.2 7.0 6.2 7.9 21.2 8.0 8.7 5.2 8.6 10.7 5.3 6.9 13.1 7.6 14.2 4.6 2.9 6.3 4.7 12.3 9.3 9.4 6.5 5.5 5.9 6.1 8.4 12.6 24.6 7.7 3.5 7.6 7.5 4.3 5.5 5.3 10.6 7.8 6.3 3.5 7.8 12.5 8.1 7.2 4.6 9.9 9.0 6.5 7.7 10.8 7.9 8.7 7.2 4.9 36.1 24.4 30.4 7.1 11.1 10.2 3.9 4.8 6.8 5.7 3.1 3.8 16.0 4.5 5.2 2.9 12.5 5.2 4.5 9.7 5.7 5.1 5.4 4.1 2.5 26.0 28.1 32.3 44.9 19.8 14.5 18.9 27.8 18.0 17.8 35.7 37.8 66.5 49.3 55.2 46.9 34.7 25.5 53.5 40.9 22.7 43.2 19.3 14.9 15.3 8.6 29.3 23.6 46.7 11.9 11.9 42.7 46.2 39.3 16.4 14.7 66.7 36.4 25.2 38.9 11.6 40.9 37.0 28.7 28.9 18.8 23.0 13.7 14.4 42.5 6.6 36.8 25.8 27.0 41.2 51.7 45.7 15.3 50.4 15.2 52.5 PRDM4 PFM1 ENSG00000110851 "PR/SET domain 4" Q9UKN5 12 107732866-107761272 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024322, HPA067437" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA024322: AB_1855691, HPA067437: AB_2685839" "unprognostic (4.64e-2)" "unprognostic (3.16e-3)" "unprognostic (1.73e-3)" "unprognostic (2.35e-1)" "unprognostic (1.94e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.86e-4)" "unprognostic (1.11e-3)" "prognostic unfavorable (7.66e-4)" "unprognostic (9.64e-2)" "unprognostic (9.06e-3)" "unprognostic (5.31e-2)" "prognostic favorable (3.15e-7)" "unprognostic (9.24e-2)" "unprognostic (1.09e-1)" "unprognostic (1.59e-1)" "unprognostic (2.62e-3)" 13.5 9.6 14.6 10.4 18.0 13.5 12.3 21.2 20.6 12.1 15.2 12.7 13.3 12.1 15.4 13.1 16.3 11.4 10.6 9.1 11.5 11.3 19.5 6.8 11.9 10.5 13.3 15.4 14.6 11.4 53.6 9.5 12.8 15.8 11.3 15.5 12.4 12.9 12.1 12.9 13.1 14.8 13.1 9.3 12.1 11.6 10.3 14.6 10.4 13.2 7.4 13.5 12.8 28.1 5.1 4.5 2.6 7.5 2.1 4.2 1.4 11.4 12.7 13.9 14.4 15.1 15.6 10.7 15.6 20.4 15.9 12.1 8.9 5.0 14.8 6.6 16.5 14.8 8.2 14.5 11.4 17.3 10.8 14.8 11.7 9.3 9.4 19.5 16.6 12.1 19.0 22.1 17.9 30.9 17.4 20.6 13.9 14.1 18.0 18.9 12.0 9.3 14.8 7.3 7.4 17.4 7.6 13.9 14.5 16.4 17.6 17.3 16.2 11.8 8.4 14.1 9.9 10.2 8.5 20.8 12.2 8.9 16.2 13.0 12.7 12.5 10.5 8.9 7.9 9.0 2.2 1.7 2.6 4.0 5.8 2.8 5.1 2.1 3.6 4.5 4.5 3.5 4.2 0.7 2.1 7.5 2.4 4.0 1.4 14.6 18.0 21.2 20.6 11.5 11.3 13.3 15.4 15.8 14.6 8.9 5.4 9.9 7.4 12.9 12.4 5.6 2.5 8.1 6.8 12.2 13.7 5.6 8.3 13.0 18.9 9.2 10.8 0.0 9.9 6.4 9.7 9.1 3.5 3.9 10.0 31.8 12.1 9.2 11.0 19.5 5.8 8.7 8.5 14.4 9.3 7.2 13.0 5.8 4.6 7.1 10.1 6.5 10.3 5.9 10.3 14.8 4.0 10.2 10.9 9.1 PRDM5 PFM2 ENSG00000138738 "PR/SET domain 5" Q9NQX1 4 120684919-120922870 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 57.4;Late spermatids: 22.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 25 "eosinophil: 9.1;neutrophil: 6.7" "Lineage enriched" "Detected in single" 29 "granulocytes: 9.1" "Cell line enhanced" "Detected in many" "U-266/84: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051406 Enhanced Supported "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" Nucleoli "HPA051406: AB_2681472" "unprognostic (7.74e-2)" "unprognostic (8.45e-3)" "unprognostic (3.15e-3)" "unprognostic (1.09e-1)" "unprognostic (7.20e-2)" "unprognostic (9.30e-2)" "unprognostic (3.28e-2)" "unprognostic (4.52e-2)" "unprognostic (5.09e-2)" "unprognostic (8.71e-2)" "unprognostic (6.29e-2)" "unprognostic (4.13e-1)" "unprognostic (3.00e-2)" "unprognostic (4.91e-4)" "unprognostic (2.34e-1)" "unprognostic (1.29e-1)" "unprognostic (5.56e-3)" 5.0 5.9 3.5 3.6 3.9 4.6 5.4 1.9 5.4 9.3 5.2 2.7 6.3 1.9 8.6 7.0 3.3 7.7 6.1 5.0 3.2 3.1 3.1 0.8 7.4 2.7 3.4 4.2 15.2 10.3 19.3 12.5 5.0 6.1 7.7 4.4 9.4 3.3 6.8 2.2 2.7 3.2 9.5 6.2 3.3 4.1 5.0 3.3 0.5 8.4 5.1 2.3 5.8 14.1 0.0 0.0 9.1 0.0 0.0 0.3 0.0 1.8 2.9 6.6 0.1 4.0 8.3 7.8 3.9 8.6 4.0 3.5 3.7 1.1 0.4 1.1 5.2 3.8 0.0 0.0 0.8 5.3 0.0 1.1 2.4 2.6 0.2 4.3 8.1 0.1 5.8 2.6 2.8 3.6 3.7 2.9 1.0 0.0 12.1 4.9 0.3 1.2 0.0 4.9 0.6 2.2 0.0 7.7 5.0 1.4 0.0 1.2 5.3 0.0 0.1 0.8 3.6 5.5 3.4 1.1 0.2 2.4 4.1 3.8 11.2 15.6 0.0 3.0 0.0 3.0 0.1 0.0 9.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 6.7 0.0 0.0 0.0 0.0 0.0 3.5 3.9 1.9 5.4 3.2 3.1 3.4 4.2 6.1 3.3 11.9 3.5 0.5 2.5 1.4 9.5 7.3 0.0 2.7 5.7 1.8 7.9 0.8 1.7 1.8 57.4 4.9 0.0 0.0 2.1 2.1 4.4 2.0 2.3 0.0 0.7 0.0 3.5 3.7 0.3 22.0 8.1 0.8 1.7 0.0 2.7 8.2 1.9 0.0 8.9 0.0 8.0 6.5 3.6 5.0 3.3 1.5 0.5 0.0 2.4 0.6 PRDM6 "KMT8C, PRISM" ENSG00000061455 "PR/SET domain 6" Q9NQX0 5 123089121-123194266 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 19.7;smooth muscle: 29.7;urinary bladder: 18.4;vagina: 18.7" "Cell type enhanced" "Detected in some" 8 "Early spermatids: 2.9;Fibroblasts: 6.0;Late spermatids: 4.1;Melanocytes: 3.3" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 6 "pons and medulla: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.0;HEK 293: 9.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA030324 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA030324: AB_10670032" "unprognostic (2.33e-1)" "unprognostic (1.39e-1)" "unprognostic (2.18e-1)" "unprognostic (2.32e-3)" "unprognostic (3.12e-1)" "unprognostic (5.44e-2)" "unprognostic (2.22e-1)" "unprognostic (1.54e-2)" "unprognostic (4.66e-2)" "unprognostic (7.66e-3)" "unprognostic (1.23e-1)" "unprognostic (1.92e-2)" "unprognostic (1.02e-7)" "unprognostic (9.30e-4)" "unprognostic (1.10e-1)" "unprognostic (3.43e-4)" "unprognostic (1.27e-1)" 1.3 0.3 0.3 0.6 0.3 0.0 1.4 0.4 0.5 1.6 6.7 0.4 0.3 0.4 1.8 0.6 1.2 0.6 19.7 0.9 0.4 0.3 0.6 0.3 10.6 0.0 0.5 0.4 3.8 0.5 0.3 0.5 8.1 3.6 14.1 1.9 0.0 0.3 0.8 0.2 0.4 1.0 29.7 0.8 0.1 1.1 0.5 0.0 0.0 1.4 0.2 0.6 18.4 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.6 0.9 7.0 0.1 0.0 0.0 0.1 0.1 0.3 0.1 0.2 0.5 0.2 0.0 1.4 0.0 0.0 0.3 9.8 2.1 0.9 0.0 2.0 0.0 0.3 0.1 0.1 0.2 0.1 0.3 0.0 0.1 0.0 0.2 0.0 1.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.2 1.1 0.4 0.1 1.5 0.0 0.0 0.5 0.6 0.0 0.1 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 0.5 0.4 0.3 0.5 0.4 3.6 0.0 0.0 0.0 0.0 0.1 1.6 0.8 1.1 0.0 0.0 0.0 0.0 2.0 0.3 0.0 0.1 2.9 0.5 0.0 0.0 0.2 0.2 6.0 0.1 0.0 0.5 0.7 0.0 0.0 0.0 0.3 4.1 2.0 0.7 3.3 0.0 0.0 0.2 0.1 0.0 1.1 0.3 0.8 0.0 1.4 1.9 1.9 1.1 0.3 0.0 0.0 0.0 PRELID1 "CGI-106, PRELI, PX19" ENSG00000169230 "PRELI domain containing 1" Q9Y255 5 177303774-177306959 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005701 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA005701: AB_1079721" "unprognostic (1.27e-1)" "unprognostic (8.99e-2)" "unprognostic (3.18e-2)" "unprognostic (2.09e-3)" "unprognostic (2.19e-1)" "unprognostic (8.07e-2)" "prognostic unfavorable (5.46e-5)" "unprognostic (7.63e-3)" "unprognostic (1.49e-1)" "unprognostic (8.90e-3)" "unprognostic (1.71e-1)" "unprognostic (6.97e-2)" "prognostic unfavorable (2.89e-7)" "unprognostic (3.59e-2)" "unprognostic (1.15e-1)" "unprognostic (1.89e-1)" "unprognostic (2.21e-1)" 18.9 25.0 21.9 33.9 20.3 30.3 21.6 12.0 31.1 16.9 44.6 14.8 15.4 43.5 18.3 15.5 35.6 17.4 20.6 16.8 19.3 18.6 46.1 62.3 18.9 43.0 20.2 14.7 20.3 91.6 12.3 17.7 29.4 21.0 19.8 35.0 18.9 40.1 16.4 11.9 26.2 70.6 19.0 14.8 43.5 24.6 12.9 13.5 25.2 29.3 27.2 33.7 18.0 18.9 27.1 77.4 111.7 94.2 30.4 26.4 49.2 32.3 30.4 18.5 49.4 16.6 18.0 61.7 23.1 16.2 33.8 32.7 68.1 37.1 27.5 27.3 21.7 36.8 18.4 33.0 61.8 23.1 117.7 45.7 23.8 31.5 45.3 17.5 37.3 33.4 16.2 22.3 26.6 22.8 14.0 41.8 19.8 26.1 39.9 32.8 84.0 23.9 54.6 37.7 37.8 50.4 7.7 37.4 49.4 22.0 27.1 29.6 37.2 21.6 43.1 40.1 24.1 27.8 46.0 23.0 31.0 27.1 25.4 55.3 22.4 38.2 40.0 26.7 50.4 32.1 31.5 75.7 111.7 26.4 94.2 25.8 27.1 21.9 26.2 77.4 21.1 19.3 21.1 55.2 30.4 90.3 28.3 23.3 49.2 21.9 20.3 12.0 31.1 19.3 18.6 20.2 14.7 21.0 13.5 20.8 22.6 181.8 227.7 309.4 61.7 0.3 145.2 13.4 28.4 99.5 21.6 650.2 257.0 407.3 4.8 123.4 610.0 116.8 488.9 446.5 187.8 329.7 110.3 191.7 318.8 57.2 151.0 114.8 245.1 15.2 105.6 182.1 243.0 153.3 210.5 81.8 553.8 343.7 102.6 293.8 49.9 45.3 167.5 80.1 183.7 367.9 738.9 173.0 351.5 462.0 PRELID2 "FLJ38376, MGC21644" ENSG00000186314 "PRELI domain containing 2" Q8N945 5 145471799-145835369 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 31.2" "Cell type enriched" "Detected in many" 4 "Cone photoreceptor cells: 377.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 15.8;myeloid DC: 5.2" "Group enriched" "Detected in all" 5 "dendritic cells: 5.2;granulocytes: 15.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA042486 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA042486: AB_10797498" "unprognostic (9.45e-3)" "unprognostic (1.95e-1)" "unprognostic (7.58e-3)" "unprognostic (2.71e-5)" "unprognostic (1.96e-3)" "unprognostic (6.53e-4)" "unprognostic (6.62e-5)" "unprognostic (2.27e-1)" "unprognostic (4.21e-1)" "unprognostic (1.04e-1)" "prognostic unfavorable (3.78e-4)" "unprognostic (3.83e-1)" "prognostic unfavorable (9.65e-6)" "unprognostic (2.65e-1)" "unprognostic (1.29e-1)" "unprognostic (7.83e-4)" "unprognostic (6.42e-3)" 6.6 2.4 1.6 5.3 2.0 3.9 4.4 0.7 2.9 4.9 16.4 2.3 2.8 10.6 5.2 2.9 2.4 3.0 14.5 6.4 1.4 1.4 2.6 2.7 2.4 2.7 2.3 1.1 5.2 15.9 1.3 2.8 0.9 2.0 4.2 16.2 9.2 4.3 2.7 1.3 3.0 31.2 6.2 2.5 2.1 7.8 2.5 1.5 0.8 4.1 2.4 1.9 4.3 11.6 1.8 5.2 15.8 1.9 1.8 2.0 0.9 10.8 3.6 3.4 5.4 0.8 1.9 0.0 3.6 6.3 6.8 9.6 11.6 17.9 0.0 6.2 4.3 15.6 3.3 2.6 8.2 10.1 3.1 4.2 12.5 4.0 6.0 2.1 1.6 13.3 1.1 3.5 7.8 6.9 9.5 7.6 0.0 6.8 5.0 3.3 1.8 0.0 1.9 1.7 12.6 2.4 0.0 0.0 1.7 3.2 1.7 1.5 3.0 4.6 0.6 7.2 1.6 5.5 2.4 7.0 5.9 3.2 10.4 8.1 0.2 0.0 0.0 10.6 0.0 2.4 15.8 1.3 0.4 0.8 1.9 0.4 1.7 1.6 1.2 5.2 1.8 0.2 1.2 0.5 1.8 1.3 0.6 2.0 0.9 1.6 2.0 0.7 2.9 1.4 1.4 2.3 1.1 2.0 1.5 0.0 2.4 1.9 11.1 3.7 19.4 7.7 5.1 2.7 6.8 0.0 377.0 0.1 0.0 11.6 3.4 5.8 91.5 0.0 11.4 2.4 5.3 2.7 17.3 2.1 2.4 4.8 9.2 3.1 2.1 1.0 3.1 4.3 0.0 3.6 27.5 7.5 15.0 48.0 4.2 2.4 47.8 0.0 4.7 0.9 1.0 2.9 0.2 3.2 32.3 8.0 PRELID3B "C20orf45, dJ543J19.5, SLMO2" ENSG00000101166 "PRELI domain containing 3B" Q9Y3B1 20 59033145-59042909 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 91.2" "Cell type enhanced" "Detected in many" 5 "Urothelial cells: 165.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047721 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047721: AB_2680131" "unprognostic (1.62e-1)" "unprognostic (1.02e-1)" "unprognostic (3.82e-2)" "prognostic unfavorable (5.04e-4)" "unprognostic (1.37e-1)" "unprognostic (3.54e-3)" "prognostic unfavorable (6.96e-5)" "unprognostic (5.72e-2)" "unprognostic (1.76e-1)" "unprognostic (3.24e-2)" "unprognostic (1.71e-2)" "unprognostic (2.47e-2)" "unprognostic (1.20e-3)" "unprognostic (5.84e-2)" "unprognostic (2.64e-1)" "unprognostic (2.61e-2)" "unprognostic (8.96e-2)" 18.6 17.0 14.1 17.0 13.9 13.7 20.4 10.3 14.1 10.0 45.2 8.7 11.2 41.3 9.6 9.6 26.7 8.8 10.3 13.3 12.9 13.4 20.5 30.1 13.5 19.1 15.4 10.0 11.1 24.2 12.7 34.3 28.8 12.3 10.5 30.0 6.1 15.3 12.6 17.2 14.0 91.2 11.6 16.7 19.9 19.3 11.5 12.1 21.4 18.9 25.5 21.2 13.9 14.4 25.8 17.5 26.6 21.0 27.1 27.6 20.2 25.9 12.8 12.5 16.3 9.3 13.2 17.6 19.2 17.1 36.1 19.3 35.7 22.0 41.3 34.0 14.7 27.9 28.4 25.4 30.6 38.0 24.4 15.9 28.6 21.8 7.6 19.8 37.3 26.6 11.7 40.4 20.7 48.3 11.9 11.7 34.3 11.2 18.1 15.4 33.3 42.0 16.6 6.2 42.2 35.6 21.9 28.4 23.4 17.9 22.2 22.6 21.7 30.8 52.4 44.3 9.6 26.5 29.2 13.7 13.1 12.7 23.9 10.1 12.3 17.5 33.4 14.3 18.4 14.6 26.6 13.6 13.5 21.4 17.9 25.9 25.8 26.1 24.0 17.5 18.6 23.6 24.8 11.7 27.1 21.0 14.7 27.6 20.2 14.1 13.9 10.3 14.1 12.9 13.4 15.4 10.0 12.3 12.1 20.8 31.8 13.4 46.7 0.0 8.1 0.0 25.5 41.5 28.4 21.0 5.9 58.5 58.0 57.9 52.0 18.0 96.3 0.0 49.8 92.9 28.8 59.3 15.1 23.2 49.1 11.1 26.9 12.3 34.8 17.4 13.8 30.9 0.0 55.9 65.9 14.3 59.9 56.1 14.9 41.1 6.5 25.8 0.0 62.2 36.7 0.0 103.8 36.2 68.2 165.6 PRICKLE1 "EPM1B, FLJ31937, RILP" ENSG00000139174 "Prickle planar cell polarity protein 1" Q96MT3 12 42456757-42590355 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 71.4;Peritubular cells: 23.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 8.1;naive B-cell: 13.3" "Lineage enriched" "Detected in many" 5 "B-cells: 13.3" "Cell line enriched" "Detected in many" 18 "HBEC3-KT: 152.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001379, HPA050037" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA001379: AB_1855703, HPA050037: " "unprognostic (2.44e-1)" "unprognostic (2.50e-1)" "unprognostic (1.81e-2)" "unprognostic (2.48e-1)" "prognostic unfavorable (3.93e-4)" "unprognostic (1.22e-1)" "unprognostic (2.34e-4)" "unprognostic (3.53e-1)" "unprognostic (1.69e-2)" "unprognostic (5.89e-2)" "unprognostic (5.29e-2)" "unprognostic (7.77e-2)" "unprognostic (1.21e-3)" "unprognostic (2.29e-4)" "unprognostic (1.12e-1)" "unprognostic (8.95e-3)" "unprognostic (5.33e-4)" 9.1 4.1 8.8 6.1 12.6 2.1 17.2 6.6 27.0 16.6 6.1 2.0 5.2 3.4 15.7 8.4 3.2 10.1 17.5 16.4 7.5 5.8 6.4 2.3 11.7 5.4 4.5 10.5 16.3 2.9 2.3 3.9 6.5 5.5 7.1 3.1 11.2 12.6 7.4 4.5 7.2 3.9 16.0 4.4 16.7 3.8 7.2 1.5 0.1 9.9 3.7 4.4 8.6 12.4 13.3 1.7 2.6 1.8 0.6 0.8 0.8 1.1 0.6 2.6 0.0 1.9 2.1 0.1 1.6 0.7 0.4 0.8 0.0 2.4 0.0 4.8 0.2 0.0 0.4 1.8 152.5 0.5 0.0 0.9 2.5 0.1 0.0 0.2 0.0 0.0 3.0 1.1 1.9 0.2 0.2 6.0 0.0 0.2 0.4 0.4 0.0 0.0 0.0 8.5 0.0 2.7 0.0 0.1 0.0 3.2 0.1 0.6 0.4 0.0 0.1 0.1 2.2 0.0 5.2 0.4 0.1 2.1 2.1 2.1 0.1 0.0 0.9 0.0 1.6 0.1 1.8 1.8 0.4 0.3 1.0 0.8 8.1 0.3 0.3 1.0 13.3 0.5 0.3 2.6 0.6 0.6 1.7 0.2 0.8 8.8 12.6 6.6 27.0 7.5 5.8 4.5 10.5 5.5 1.5 14.9 5.1 3.7 4.6 2.4 11.8 4.9 20.4 0.0 3.4 1.8 2.0 0.4 0.0 3.7 71.4 5.2 0.0 0.0 2.2 0.2 9.7 0.5 1.1 0.0 0.6 7.9 0.0 14.1 1.2 16.6 9.2 0.0 6.8 0.0 0.0 2.3 2.8 0.0 23.3 2.5 4.0 0.0 3.0 3.0 4.7 1.3 0.6 0.0 0.0 0.6 PRIM1 ENSG00000198056 "DNA primase subunit 1" P49642 12 56731596-56752373 "Predicted intracellular proteins" "DNA replication, Transcription" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 70.0;Spermatocytes: 38.6;Spermatogonia: 82.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040010 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA Yes "Nucleoplasm, Golgi apparatus, Vesicles" "HPA040010: AB_10805599" "unprognostic (3.04e-3)" "unprognostic (1.67e-2)" "unprognostic (2.12e-2)" "unprognostic (1.51e-2)" "unprognostic (4.63e-2)" "unprognostic (3.61e-2)" "prognostic unfavorable (2.40e-8)" "unprognostic (4.68e-2)" "unprognostic (2.73e-3)" "unprognostic (1.82e-3)" "unprognostic (1.56e-1)" "unprognostic (1.82e-1)" "unprognostic (1.98e-3)" "unprognostic (3.94e-1)" "unprognostic (2.16e-1)" "unprognostic (5.35e-2)" "unprognostic (6.53e-2)" 5.7 5.2 6.7 9.8 9.3 26.0 10.1 16.0 10.6 6.0 8.2 6.7 5.5 4.5 6.2 4.9 9.6 6.2 3.1 4.0 7.6 4.6 4.5 8.2 5.4 11.1 9.2 4.6 9.7 10.7 7.9 12.3 5.0 7.9 5.2 11.1 5.3 7.0 4.3 6.3 7.9 8.3 6.1 11.8 10.2 6.3 17.0 10.8 28.3 5.1 6.8 13.2 5.6 6.9 8.6 6.3 3.5 6.2 5.3 12.7 4.6 12.2 10.6 14.7 9.0 1.7 2.6 17.3 10.4 8.5 18.5 17.3 11.4 15.8 24.1 8.7 4.8 7.4 12.4 17.7 11.3 20.4 12.0 11.0 31.8 6.8 10.9 0.5 38.9 13.5 1.1 2.1 16.4 7.1 2.8 6.6 28.1 29.9 38.1 10.7 9.1 22.2 14.8 16.3 8.8 13.3 25.0 25.8 20.8 4.4 9.3 15.0 13.3 12.4 6.0 5.6 11.2 19.4 14.9 3.0 9.6 22.8 10.0 13.1 13.9 27.7 13.6 6.0 16.5 12.7 1.4 1.4 3.5 7.8 3.4 9.0 8.6 10.5 7.5 3.4 8.2 12.7 10.0 0.0 5.3 6.2 6.3 9.1 4.6 6.7 9.3 16.0 10.6 7.6 4.6 9.2 4.6 7.9 10.8 6.0 5.0 11.5 11.9 3.4 4.2 2.4 2.5 8.1 6.8 7.0 5.9 7.0 0.0 4.4 5.0 5.8 1.3 70.0 6.4 22.0 3.3 2.7 3.5 4.3 10.3 19.1 1.2 3.7 7.3 2.5 6.6 7.2 3.3 9.0 2.9 5.6 3.4 0.0 4.6 1.6 11.8 12.9 3.9 38.6 82.6 3.4 3.8 10.5 8.5 2.0 PRIM2 PRIM2A ENSG00000146143 "DNA primase subunit 2" P49643 6 57314805-57646849 "Plasma proteins, Predicted intracellular proteins" "DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 21.7;prostate: 22.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046566 Supported Nucleoplasm NA NA Nucleoplasm "HPA046566: AB_2679701" "unprognostic (1.24e-1)" "unprognostic (1.55e-2)" "unprognostic (2.66e-2)" "prognostic unfavorable (6.98e-4)" "unprognostic (3.08e-1)" "unprognostic (6.24e-2)" "prognostic unfavorable (3.44e-5)" "unprognostic (2.31e-1)" "unprognostic (1.00e-2)" "prognostic favorable (3.00e-5)" "prognostic unfavorable (5.25e-4)" "unprognostic (3.89e-1)" "prognostic unfavorable (7.34e-6)" "unprognostic (2.04e-2)" "unprognostic (2.07e-1)" "unprognostic (1.67e-1)" "unprognostic (1.08e-1)" 5.4 1.6 1.7 9.0 2.3 7.8 4.1 6.5 3.3 5.3 3.9 2.5 2.4 3.0 9.7 3.7 5.6 3.7 2.7 3.1 2.8 3.5 2.7 2.7 7.1 3.6 1.5 4.3 2.2 2.4 5.4 5.9 1.7 22.6 5.0 3.5 7.3 3.4 1.1 3.4 3.7 5.8 3.6 6.7 2.4 5.3 3.1 21.7 4.6 4.5 8.7 4.7 2.7 5.0 7.3 2.5 5.4 5.6 7.9 2.7 15.4 6.3 12.6 14.6 7.2 12.8 10.5 19.1 18.7 21.3 28.6 10.0 7.4 14.1 10.6 23.8 14.5 10.5 11.3 10.9 26.4 15.4 9.2 16.7 8.6 16.7 2.9 16.1 10.6 4.8 4.1 23.5 8.2 5.2 9.6 15.2 15.8 37.6 17.7 9.7 16.9 12.8 8.0 13.2 6.3 12.9 17.5 11.3 7.7 8.0 9.3 7.1 12.4 5.9 7.7 14.6 12.6 13.9 6.6 21.7 21.4 39.7 16.1 5.1 9.8 16.4 9.9 17.0 11.6 0.3 2.4 2.5 5.5 5.1 6.2 5.0 5.0 7.5 4.1 4.9 3.6 7.9 1.0 5.6 5.4 7.3 5.9 2.7 0.0 2.4 5.1 5.5 3.5 5.0 0.9 2.5 2.7 3.4 3.5 11.8 13.3 3.3 3.7 7.2 2.9 3.5 23.3 4.5 19.3 5.2 5.5 11.5 3.8 7.9 6.4 1.2 4.9 4.8 2.8 6.1 5.1 0.0 5.4 6.1 4.9 3.9 5.3 6.3 1.4 4.5 19.4 5.2 10.6 12.1 2.6 4.8 12.8 7.5 5.0 PRIMPOL "CCDC111, FLJ33167" ENSG00000164306 "Primase and DNA directed polymerase" Q96LW4 4 184649613-184694963 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription" "DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Mucus-secreting cells: 61.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 18.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054372 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA054372: AB_2682466" "unprognostic (1.68e-1)" "unprognostic (1.27e-3)" "unprognostic (1.67e-1)" "unprognostic (1.18e-1)" "unprognostic (2.67e-2)" "unprognostic (4.75e-2)" "unprognostic (2.02e-2)" "unprognostic (3.34e-2)" "unprognostic (3.32e-3)" "unprognostic (5.86e-2)" "unprognostic (2.52e-2)" "unprognostic (5.02e-1)" "unprognostic (3.04e-1)" "unprognostic (3.04e-2)" "unprognostic (3.81e-1)" "unprognostic (1.49e-1)" "unprognostic (1.05e-1)" 12.3 12.6 8.3 17.0 11.5 9.1 13.5 14.6 11.0 17.7 14.3 15.4 18.1 6.9 25.4 13.1 12.0 15.1 14.6 12.0 8.0 8.3 8.6 9.9 11.3 10.8 8.4 11.5 18.7 9.0 9.8 14.0 10.8 10.2 14.8 13.2 12.0 11.0 17.9 10.3 10.0 11.2 14.8 14.7 11.9 11.0 8.0 10.2 15.0 12.1 6.4 10.8 16.3 15.9 3.3 2.5 18.6 4.1 3.6 4.9 2.6 9.4 3.8 9.6 11.0 12.8 16.7 6.5 9.2 15.2 16.2 14.3 3.0 9.2 5.4 3.5 7.1 9.3 5.6 7.8 9.8 17.2 10.9 4.0 5.7 5.5 3.6 8.3 4.9 8.5 10.5 8.1 14.8 9.8 9.5 8.5 14.7 11.3 18.7 11.5 3.1 9.4 4.2 3.2 4.3 3.4 8.6 7.0 6.1 8.1 5.7 7.3 9.1 5.7 1.6 10.4 8.0 4.9 8.6 4.5 5.4 7.3 4.4 6.2 9.5 6.8 2.7 8.0 6.3 13.5 7.8 2.0 18.6 3.5 1.9 4.9 3.1 3.2 3.4 2.5 3.3 2.7 2.7 1.0 3.6 4.1 2.2 3.7 2.6 8.3 11.5 14.6 11.0 8.0 8.3 8.4 11.5 10.2 10.2 6.0 7.5 3.7 10.1 8.5 5.8 2.0 10.2 17.4 9.1 5.2 0.0 11.3 5.0 6.4 4.0 4.2 6.1 0.0 4.5 8.4 8.3 4.1 15.0 5.4 8.3 7.9 6.4 8.0 11.8 4.1 11.5 6.1 8.5 6.4 61.4 10.1 3.6 7.0 8.5 4.7 8.2 12.9 7.0 18.0 9.4 8.5 4.1 8.6 8.1 3.3 PRKAB1 ENSG00000111725 "Protein kinase AMP-activated non-catalytic subunit beta 1" Q9Y478 12 119667753-119681630 "FDA approved drug targets, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004247, CAB005058" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB005058: AB_562038, HPA004247: AB_1078149" "unprognostic (1.20e-1)" "unprognostic (3.08e-2)" "unprognostic (7.42e-2)" "prognostic favorable (8.66e-4)" "unprognostic (2.33e-1)" "unprognostic (2.89e-2)" "unprognostic (8.97e-3)" "unprognostic (1.46e-2)" "unprognostic (6.26e-2)" "unprognostic (3.63e-2)" "unprognostic (2.85e-1)" "unprognostic (1.23e-1)" "prognostic favorable (5.40e-9)" "unprognostic (5.60e-2)" "unprognostic (2.28e-1)" "unprognostic (1.92e-1)" "unprognostic (1.32e-2)" 16.3 17.2 8.1 16.6 11.9 23.4 13.8 12.5 20.7 16.8 22.8 14.6 6.7 20.4 13.6 13.2 17.9 11.6 19.3 9.2 8.3 7.2 40.1 12.3 21.4 20.6 8.9 9.8 14.2 21.7 11.7 10.8 19.1 11.1 9.7 22.7 20.6 15.3 10.7 12.0 10.6 23.9 12.5 10.5 20.7 25.0 33.4 8.3 20.0 17.5 9.4 16.6 16.3 10.6 26.4 17.4 38.8 19.9 22.1 20.9 18.3 4.7 12.8 10.2 9.6 8.7 7.6 13.4 7.7 10.0 12.6 9.6 13.4 10.9 15.9 10.2 10.5 5.6 6.7 10.2 15.9 11.6 10.2 9.4 24.9 5.6 19.4 15.7 11.5 31.7 11.4 13.5 11.4 15.4 14.2 9.3 23.7 38.0 6.2 9.7 13.1 26.0 12.9 14.3 7.0 14.3 15.1 8.8 9.2 14.3 15.2 8.1 13.8 10.2 3.9 10.5 13.1 12.6 15.1 11.0 7.7 8.2 5.9 7.7 20.0 17.6 11.8 7.6 7.8 11.0 24.8 16.4 38.8 17.2 18.4 20.9 26.4 18.3 18.3 17.4 21.7 19.9 18.6 19.1 22.1 19.9 15.4 19.7 18.3 8.1 11.9 12.5 20.7 8.3 7.2 8.9 9.8 11.1 8.3 44.7 42.5 11.8 5.5 3.0 12.0 4.1 10.2 10.7 17.0 21.0 3.9 15.7 39.7 7.1 1.0 13.5 16.9 0.0 27.0 8.5 8.2 5.6 11.5 5.0 10.3 20.6 18.9 4.3 5.6 1.8 5.2 9.0 3.3 12.6 16.7 11.9 10.0 14.1 6.0 29.4 17.3 6.5 6.0 25.0 9.4 3.8 12.6 10.2 21.5 7.6 PRKAB2 ENSG00000131791 "Protein kinase AMP-activated non-catalytic subunit beta 2" O43741 1 147155106-147172550 "Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 52.1" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 57.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044342 Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044342: AB_10966508" "prognostic unfavorable (4.55e-4)" "unprognostic (2.03e-2)" "unprognostic (1.84e-1)" "unprognostic (4.03e-2)" "unprognostic (9.59e-3)" "prognostic unfavorable (7.32e-4)" "unprognostic (6.30e-2)" "unprognostic (1.23e-1)" "unprognostic (3.06e-2)" "unprognostic (6.78e-2)" "unprognostic (4.65e-2)" "unprognostic (1.98e-1)" "unprognostic (5.34e-2)" "unprognostic (1.31e-1)" "unprognostic (3.57e-1)" "prognostic unfavorable (6.78e-7)" "unprognostic (4.78e-2)" 7.7 7.6 5.6 4.6 7.1 4.7 7.6 13.3 10.9 9.3 24.6 8.9 8.9 19.1 13.0 8.1 10.0 7.4 6.5 15.2 5.6 5.2 6.2 32.6 6.3 3.8 5.9 9.3 8.1 21.0 18.4 6.2 7.5 7.8 10.9 6.9 6.3 5.7 12.6 52.1 9.4 19.1 20.5 8.4 5.7 11.1 6.9 5.5 2.6 5.8 19.9 4.7 19.0 10.3 1.2 1.7 2.9 1.6 5.1 2.5 0.8 3.9 2.2 5.9 4.5 14.0 12.1 21.3 7.5 4.1 5.0 5.5 8.8 7.9 7.2 3.8 5.9 2.9 10.6 6.8 8.4 4.9 2.8 4.7 3.2 7.0 14.2 9.6 3.7 1.4 9.5 16.9 5.2 24.7 7.5 4.9 5.6 4.4 2.9 4.3 4.0 2.7 2.1 12.3 6.8 9.8 4.3 7.9 3.5 3.6 3.2 3.8 7.1 5.6 6.4 26.7 22.0 6.0 4.6 5.6 5.7 12.6 5.2 12.1 4.7 5.1 3.7 5.9 3.3 7.4 2.9 1.2 1.9 1.5 1.2 2.5 1.2 1.6 0.9 1.7 1.1 1.7 1.1 0.3 5.1 1.6 0.8 0.7 0.8 5.6 7.1 13.3 10.9 5.6 5.2 5.9 9.3 7.8 5.5 3.0 1.3 5.0 9.8 14.7 13.2 57.1 25.5 4.0 2.3 17.4 13.7 15.9 1.7 5.0 0.4 6.7 25.7 0.0 6.0 30.8 10.6 4.3 1.1 35.0 5.1 11.1 10.9 6.7 7.3 1.1 8.9 4.1 15.1 9.0 10.7 6.6 7.4 10.1 15.2 4.7 18.6 19.4 21.1 12.4 9.4 12.3 17.2 7.5 8.8 3.9 PRKAG1 ENSG00000181929 "Protein kinase AMP-activated non-catalytic subunit gamma 1" P54619 12 49002274-49019197 "Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 80.1" "Low region specificity" "Detected in all" HPA077805 Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA077805: AB_2686855" "unprognostic (3.24e-2)" "unprognostic (1.94e-1)" "unprognostic (1.41e-1)" "unprognostic (1.63e-2)" "unprognostic (3.44e-1)" "unprognostic (2.03e-2)" "prognostic unfavorable (2.84e-7)" "unprognostic (1.45e-1)" "unprognostic (4.68e-2)" "unprognostic (1.93e-2)" "unprognostic (5.35e-2)" "unprognostic (8.49e-2)" "prognostic favorable (1.83e-4)" "unprognostic (3.40e-1)" "unprognostic (2.57e-1)" "unprognostic (1.97e-2)" "unprognostic (5.57e-2)" 23.8 30.3 18.5 13.6 18.6 22.6 25.5 14.2 27.0 19.2 18.8 19.6 18.0 13.3 16.0 23.9 26.8 14.1 14.2 39.4 15.2 18.2 27.1 30.8 13.9 14.9 19.7 18.4 18.9 19.6 19.2 22.2 18.9 22.1 19.1 17.0 20.3 18.4 21.0 58.4 21.7 19.8 20.4 15.9 18.7 17.4 19.2 10.7 22.5 22.5 24.9 23.0 23.2 15.7 29.2 41.0 44.0 35.9 40.1 36.9 37.9 18.1 11.3 12.9 20.2 33.0 33.9 7.3 20.0 26.3 20.4 13.1 11.1 16.2 11.7 18.0 23.0 12.1 15.9 9.3 25.8 19.8 13.4 15.4 15.9 17.5 8.9 27.4 21.0 12.5 26.6 20.3 14.8 31.2 27.1 19.6 17.3 12.1 16.8 27.4 11.7 8.7 8.0 7.9 80.1 23.8 4.9 11.4 14.8 27.4 15.3 10.7 13.7 14.2 26.1 30.3 9.4 31.9 11.8 18.2 9.6 13.0 21.9 15.1 27.7 27.0 7.8 23.3 15.1 8.7 41.1 35.9 33.6 31.5 34.2 30.3 29.2 28.4 29.4 41.0 26.4 25.9 26.8 44.0 40.1 33.0 27.6 36.9 37.9 18.5 18.6 14.2 27.0 15.2 18.2 19.7 18.4 22.1 10.7 8.9 24.3 32.2 25.2 17.7 28.4 45.2 15.3 16.0 11.4 34.9 35.3 58.2 64.6 42.7 7.4 19.4 28.4 0.0 40.9 47.6 27.3 19.9 20.8 18.7 46.3 14.3 20.2 30.7 29.3 10.2 33.9 31.8 35.4 65.9 24.8 35.9 39.1 11.5 25.5 49.6 28.2 19.4 26.9 45.8 41.6 22.7 56.1 26.6 29.9 18.7 PRKAG2 "AAKG, AAKG2, CMH6, H91620p, WPWS" ENSG00000106617 "Protein kinase AMP-activated non-catalytic subunit gamma 2" Q9UGJ0 7 151556111-151877125 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Cardiomyopathy, Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 77.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 58.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004246, CAB018641" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB018641: AB_2170355, HPA004246: AB_1078151" "unprognostic (4.11e-2)" "unprognostic (2.82e-1)" "unprognostic (1.46e-2)" "unprognostic (9.29e-2)" "unprognostic (1.76e-1)" "unprognostic (4.33e-3)" "unprognostic (7.13e-2)" "unprognostic (8.09e-2)" "unprognostic (1.77e-1)" "unprognostic (1.18e-1)" "unprognostic (2.46e-2)" "unprognostic (1.42e-1)" "unprognostic (1.35e-1)" "unprognostic (1.67e-1)" "unprognostic (3.80e-1)" "unprognostic (3.61e-2)" "unprognostic (4.52e-1)" 12.8 5.5 15.3 8.7 28.8 6.3 9.7 31.1 19.2 8.8 11.5 7.5 9.4 16.7 10.4 10.9 10.8 8.6 12.0 77.2 15.1 13.5 15.4 18.5 8.6 7.7 12.3 14.3 6.8 6.2 6.7 5.1 20.0 18.3 17.5 13.5 7.8 11.9 14.8 21.5 6.9 17.8 32.8 8.5 12.8 13.8 9.7 9.5 2.3 12.6 5.2 7.1 22.4 12.4 7.9 7.8 18.4 6.0 3.1 6.1 3.5 15.5 4.5 3.0 3.6 13.9 11.8 5.4 7.1 6.4 7.7 7.6 2.9 19.9 0.0 11.8 9.5 58.6 5.0 1.9 8.3 12.5 3.7 2.1 4.1 0.5 0.3 20.7 3.1 4.0 5.7 17.8 7.7 8.2 12.8 13.2 4.7 1.4 1.9 23.3 5.8 1.6 2.2 3.1 6.8 13.2 1.5 2.2 3.2 14.7 3.7 13.7 2.1 4.2 7.8 3.1 8.3 2.5 4.1 17.6 1.8 1.5 0.9 4.5 1.4 1.6 0.0 21.9 9.6 17.3 18.4 6.0 10.5 5.1 5.4 3.7 7.9 4.5 4.5 4.3 3.8 4.2 6.1 13.6 3.1 5.4 7.8 2.4 3.5 15.3 28.8 31.1 19.2 15.1 13.5 12.3 14.3 18.3 9.5 6.0 17.5 17.5 32.5 9.4 15.4 84.3 7.6 14.7 13.6 43.6 7.9 2.9 54.7 13.4 39.3 19.4 29.8 0.0 19.9 19.0 16.6 41.6 21.9 55.7 17.5 3.2 12.6 19.6 50.9 26.6 6.9 39.9 15.1 42.3 27.6 18.6 19.6 17.5 7.4 14.7 4.4 12.9 29.1 3.5 19.8 9.5 42.3 26.1 25.4 38.3 PRKCB "PKCB, PRKCB1, PRKCB2" ENSG00000166501 "Protein kinase C beta" P05771 16 23835946-24220611 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Adaptive immunity, Apoptosis, Immunity, Transcription, Transcription regulation" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 57.2;lymphoid tissue: 31.2" "Cell type enhanced" "Detected in many" 11 "B-cells: 149.8;Bipolar cells: 172.0;Horizontal cells: 74.7;Kupffer cells: 192.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 41.7;HMC-1: 41.8;K-562: 59.4;THP-1: 18.8;U-937: 16.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003843, HPA048321, HPA054203" Approved Supported Nucleoplasm,Cytosol NA NA 3400000 Nucleoplasm Cytosol "CAB003843: AB_562197, HPA048321: AB_2680357, HPA054203: AB_2682416" "unprognostic (1.53e-3)" "unprognostic (4.53e-4)" "unprognostic (2.52e-3)" "unprognostic (3.07e-2)" "unprognostic (1.72e-1)" "unprognostic (7.13e-3)" "unprognostic (2.06e-1)" "unprognostic (1.67e-3)" "unprognostic (3.19e-2)" "unprognostic (1.79e-1)" "unprognostic (7.38e-2)" "unprognostic (1.06e-1)" "unprognostic (3.17e-3)" "unprognostic (2.08e-1)" "unprognostic (2.12e-2)" "unprognostic (3.28e-1)" "unprognostic (4.95e-2)" 4.0 1.9 13.9 20.8 55.6 20.4 1.8 14.1 57.2 4.1 4.7 4.4 0.6 4.9 3.5 1.2 3.2 2.6 3.9 1.5 23.4 7.8 1.8 3.7 5.4 31.0 11.0 20.4 1.2 1.4 0.9 1.4 2.5 8.3 6.2 4.4 3.5 1.9 8.4 1.2 4.6 9.1 5.8 7.3 31.2 3.8 6.4 6.4 24.1 3.9 0.0 27.7 7.6 1.7 23.6 18.5 21.8 14.6 20.1 19.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.8 41.7 2.0 0.0 0.0 6.0 41.8 0.0 0.2 0.0 0.0 0.0 0.0 7.2 59.4 0.1 0.0 0.0 13.1 13.2 0.4 0.0 0.0 12.5 0.1 2.4 0.1 3.6 7.3 0.0 0.0 0.0 0.6 0.2 0.0 18.8 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.0 16.8 0.0 17.5 7.6 14.4 14.5 10.7 6.7 23.6 9.5 17.2 6.2 22.1 7.8 19.0 21.8 20.1 14.6 18.5 6.7 7.5 13.9 55.6 14.1 57.2 23.4 7.8 11.0 20.4 8.3 6.4 3.0 8.2 149.8 3.5 5.4 172.0 1.7 5.1 2.7 1.2 1.8 2.0 0.1 0.0 0.0 16.3 1.4 1.7 0.0 0.2 0.2 1.3 0.7 69.4 1.6 41.0 74.7 0.0 16.5 192.8 10.0 0.0 22.7 3.3 6.4 0.7 9.9 0.0 9.5 0.4 0.1 7.3 0.0 2.2 3.6 3.7 12.5 0.7 57.5 1.2 4.3 PRKD2 "DKFZP586E0820, HSPC187, PKD2" ENSG00000105287 "Protein kinase D2" Q9BZL6 19 46674275-46717127 "Enzymes, Predicted intracellular proteins" "Adaptive immunity, Angiogenesis, Cell adhesion, Immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-266/84: 58.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA021490, HPA056727" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA021490: AB_1855708, HPA056727: AB_2683217" "unprognostic (3.01e-2)" "unprognostic (1.22e-2)" "unprognostic (1.23e-3)" "unprognostic (7.06e-2)" "unprognostic (8.91e-2)" "unprognostic (1.99e-2)" "unprognostic (8.79e-3)" "unprognostic (2.61e-1)" "unprognostic (6.22e-2)" "unprognostic (4.21e-3)" "unprognostic (8.89e-2)" "unprognostic (2.74e-1)" "unprognostic (3.45e-3)" "unprognostic (1.04e-2)" "unprognostic (7.19e-2)" "unprognostic (4.34e-2)" "prognostic favorable (9.15e-4)" 17.1 7.6 7.0 25.8 6.5 18.1 18.0 2.5 6.8 16.8 13.7 5.8 18.7 13.7 14.8 16.5 23.4 15.6 17.4 7.4 6.3 3.1 13.2 9.1 21.3 24.8 7.5 2.7 17.0 12.5 10.3 17.2 20.1 6.6 14.8 7.7 11.9 15.6 21.5 7.5 26.8 19.8 11.7 6.8 34.8 15.2 6.6 7.2 41.5 18.7 10.5 33.0 17.4 37.5 6.6 0.4 7.3 1.0 2.9 6.1 1.9 8.8 13.7 5.4 6.6 4.5 3.6 7.0 4.6 7.3 9.6 10.6 7.6 8.6 10.3 8.1 6.1 5.2 13.2 4.8 12.3 3.0 8.7 7.1 10.8 4.2 3.9 6.0 7.9 16.1 4.4 6.0 5.5 4.7 7.2 16.9 9.7 6.9 14.9 3.9 9.3 15.1 25.6 4.6 12.8 7.0 9.9 2.6 16.7 5.9 13.2 3.5 11.0 8.6 7.2 1.8 5.9 5.7 3.1 8.0 4.1 8.2 3.4 3.7 14.6 58.2 5.1 4.3 6.5 4.3 0.9 1.0 3.4 5.6 0.9 4.9 6.1 5.7 6.1 0.4 6.6 5.1 4.9 7.3 2.9 0.7 0.0 4.0 1.9 7.0 6.5 2.5 6.8 6.3 3.1 7.5 2.7 6.6 7.2 8.9 13.5 45.5 26.8 19.6 5.8 11.5 17.8 4.0 10.3 8.7 0.0 11.1 6.6 16.0 0.9 29.2 30.9 23.3 24.3 11.4 10.0 21.5 13.9 7.3 7.7 1.6 20.7 36.2 12.7 2.4 10.9 7.2 11.8 5.4 17.7 6.1 22.1 24.6 6.3 7.1 4.5 12.9 5.9 2.8 15.8 23.3 24.8 23.0 11.2 24.6 PRKD3 "EPK2, PRKCN" ENSG00000115825 "Protein kinase D3" O94806 2 37250502-37324808 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 110.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029529 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA029529: AB_10602082" "unprognostic (1.39e-1)" "unprognostic (7.34e-2)" "prognostic favorable (4.84e-4)" "unprognostic (1.23e-2)" "unprognostic (5.61e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (3.47e-4)" "unprognostic (1.10e-1)" "unprognostic (1.16e-1)" "unprognostic (2.52e-2)" "unprognostic (2.93e-1)" "unprognostic (1.81e-1)" "unprognostic (7.62e-3)" "unprognostic (2.49e-2)" "unprognostic (1.18e-1)" "unprognostic (1.36e-1)" "unprognostic (1.35e-1)" 16.1 22.1 9.5 20.7 10.7 5.3 35.1 4.8 9.2 17.2 18.0 7.2 7.2 6.0 19.2 16.0 9.8 11.3 10.0 11.6 12.7 6.1 9.9 8.4 20.4 22.3 11.4 3.7 15.0 7.6 12.9 20.7 11.1 10.3 14.4 8.3 27.8 11.1 13.3 19.1 11.5 12.1 16.5 15.4 22.0 10.5 16.8 10.8 16.2 11.8 9.3 21.2 12.4 17.7 16.4 8.2 5.7 8.3 6.3 11.5 3.4 12.8 5.4 14.5 11.9 11.1 18.6 10.6 8.3 15.5 9.4 9.6 8.7 4.5 18.8 7.0 12.4 14.1 5.1 9.8 10.2 12.7 24.3 14.4 12.4 8.4 5.8 4.5 8.8 7.6 8.8 5.2 14.9 9.8 8.7 16.7 6.3 10.4 23.2 10.9 2.1 3.8 6.9 15.3 0.1 5.3 13.0 22.9 16.1 6.2 14.4 10.9 28.3 8.0 4.6 48.8 7.8 4.9 8.1 16.1 27.0 14.0 10.7 9.3 26.5 49.1 22.0 9.4 3.7 16.2 5.7 8.3 5.5 10.5 6.6 9.1 12.4 8.8 8.4 7.8 16.4 10.4 11.5 1.5 6.3 3.3 8.2 4.1 3.4 9.5 10.7 4.8 9.2 12.7 6.1 11.4 3.7 10.3 10.8 38.7 16.2 38.3 20.7 33.7 29.6 7.1 15.3 5.3 13.6 17.4 64.8 9.1 3.3 10.9 42.2 44.7 5.4 0.0 9.0 28.2 34.8 27.0 77.1 11.3 11.1 41.3 18.1 38.1 28.4 78.9 31.1 24.5 47.2 12.6 6.1 16.0 12.3 3.5 29.0 7.1 110.0 25.8 26.9 56.0 44.5 20.8 8.1 27.4 11.0 32.3 PRKDC "DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, p350, XRCC7" ENSG00000253729 "Protein kinase, DNA-activated, catalytic polypeptide" P78527 8 47773108-47960183 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, Ribosome biogenesis" "DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005167, HPA035174" Supported Enhanced Nucleoplasm NA NA 1100000 Nucleoplasm "CAB005167: AB_2172845, HPA035174: AB_2674504" "unprognostic (3.14e-2)" "unprognostic (3.02e-3)" "unprognostic (1.56e-2)" "prognostic unfavorable (1.03e-4)" "unprognostic (8.95e-2)" "unprognostic (1.34e-1)" "unprognostic (7.70e-3)" "unprognostic (5.74e-2)" "unprognostic (1.12e-2)" "unprognostic (1.60e-2)" "unprognostic (7.76e-3)" "unprognostic (7.77e-2)" "unprognostic (2.84e-2)" "unprognostic (2.32e-1)" "unprognostic (2.20e-1)" "unprognostic (6.76e-3)" "unprognostic (2.15e-2)" 21.3 20.5 16.0 22.3 22.0 27.4 30.2 16.5 23.1 19.6 20.6 17.3 18.1 12.0 26.2 14.5 27.4 24.4 13.0 21.1 20.8 15.2 16.7 18.4 17.0 33.6 16.6 18.2 24.6 23.8 33.4 29.4 20.5 17.3 17.9 20.3 17.8 17.9 17.8 34.0 23.9 18.4 27.0 20.3 24.4 19.1 20.5 15.9 44.4 20.8 15.9 27.9 21.3 19.1 17.0 13.9 7.1 11.5 11.5 11.3 2.3 32.9 28.2 27.5 26.1 17.1 18.2 11.6 14.0 13.8 19.8 19.5 18.4 10.9 31.5 12.2 17.2 14.7 18.8 36.3 19.2 31.0 6.9 22.5 61.8 25.4 22.5 7.4 23.5 12.9 13.1 6.3 31.1 32.7 7.6 20.3 21.9 41.1 13.3 21.8 15.5 33.1 19.4 30.2 23.1 8.6 16.2 21.6 11.1 9.9 28.4 13.8 17.5 43.3 14.1 13.6 17.7 20.2 16.2 23.5 25.9 22.0 20.4 28.1 11.6 14.8 45.3 14.6 26.7 20.9 6.7 8.1 3.5 8.7 6.3 10.9 12.6 10.8 8.8 5.9 17.0 11.3 10.3 7.1 11.5 11.5 13.9 7.4 2.3 16.0 22.0 16.5 23.1 20.8 15.2 16.6 18.2 17.3 15.9 35.7 26.0 39.5 30.4 34.1 100.6 65.8 25.5 52.2 39.8 40.1 117.8 48.3 14.9 34.6 26.1 40.5 10.5 0.0 30.9 53.5 37.0 37.2 43.9 39.8 32.1 98.5 24.8 33.7 41.6 10.8 52.6 32.7 18.6 29.7 26.8 69.1 30.3 14.0 65.4 18.7 102.0 51.8 28.8 106.0 117.5 35.5 27.6 38.3 45.0 27.8 PRKRA "DYT16, HSD14, PACT, RAX" ENSG00000180228 "Protein activator of interferon induced protein kinase EIF2AK2" O75569 2 178431414-178451512 "Disease related genes, Predicted intracellular proteins" "Host-virus interaction, RNA-mediated gene silencing" RNA-binding "Disease mutation, Dystonia, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 249.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004648, HPA034996, HPA034997" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB004648: AB_425767, HPA034996: AB_2674402, HPA034997: AB_2674403" "unprognostic (2.53e-1)" "unprognostic (9.18e-2)" "unprognostic (5.38e-2)" "unprognostic (4.02e-3)" "unprognostic (1.22e-1)" "unprognostic (1.04e-1)" "prognostic unfavorable (8.33e-5)" "unprognostic (9.66e-2)" "unprognostic (7.10e-3)" "unprognostic (2.32e-3)" "unprognostic (4.79e-2)" "unprognostic (1.29e-1)" "unprognostic (2.16e-3)" "unprognostic (8.99e-2)" "prognostic favorable (5.45e-4)" "unprognostic (1.38e-1)" "unprognostic (6.78e-2)" 15.7 14.5 18.3 11.3 20.3 13.0 31.2 17.1 30.9 15.7 18.7 16.9 10.8 11.0 18.0 19.4 16.6 13.9 13.1 22.2 17.4 17.5 18.0 14.5 13.7 12.1 18.3 17.2 14.9 19.8 17.4 21.5 8.7 18.8 17.4 14.8 13.2 13.8 18.1 55.3 18.2 10.9 33.1 20.2 9.4 15.2 23.5 15.7 13.8 16.7 14.8 14.1 18.5 17.7 19.4 29.2 13.5 13.9 13.5 20.1 16.4 11.0 8.5 25.1 12.3 23.2 26.6 19.8 17.1 16.7 21.6 23.6 23.6 15.9 22.7 19.4 19.6 16.2 10.4 19.6 13.5 24.1 20.2 12.8 14.0 10.2 22.5 27.0 11.0 7.7 15.3 31.1 20.3 22.7 22.7 20.5 18.6 12.8 19.4 29.2 11.6 21.4 28.1 22.8 18.4 17.2 18.9 42.1 22.9 24.3 12.6 15.7 19.7 11.1 10.9 22.2 20.7 15.2 14.3 11.8 18.1 20.5 16.4 14.2 26.8 16.7 27.6 21.0 16.8 10.6 3.1 13.9 13.5 11.0 13.5 15.9 19.4 17.2 13.4 19.9 15.3 19.5 15.9 3.7 13.5 13.2 29.2 20.1 16.4 18.3 20.3 17.1 30.9 17.4 17.5 18.3 17.2 18.8 15.7 14.9 30.2 31.4 76.5 56.0 47.4 39.5 17.8 16.0 18.2 24.4 41.2 34.1 106.1 43.4 109.2 28.7 17.6 0.0 36.9 43.7 38.9 66.8 27.7 15.8 28.1 9.5 46.0 22.1 18.4 249.4 36.5 30.4 65.8 41.5 33.8 31.0 32.9 21.0 35.0 60.8 77.6 45.3 75.2 62.1 50.4 68.5 36.3 27.3 35.9 56.5 PRKX PKX1 ENSG00000183943 "Protein kinase, X-linked" P51817 X 3604370-3713608 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Angiogenesis, Differentiation" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "granulocytes: 85.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 38.8" "Low region specificity" "Detected in all" HPA015324 Supported Supported Nucleoplasm No No Nucleoplasm "HPA015324: AB_1855715" "unprognostic (1.07e-1)" "unprognostic (1.23e-2)" "unprognostic (1.57e-1)" "unprognostic (3.63e-1)" "unprognostic (2.45e-1)" "unprognostic (3.33e-2)" "unprognostic (1.47e-1)" "unprognostic (1.33e-2)" "unprognostic (4.14e-1)" "unprognostic (1.68e-1)" "unprognostic (2.68e-1)" "unprognostic (2.92e-1)" "unprognostic (1.07e-3)" "unprognostic (2.15e-2)" "unprognostic (9.91e-2)" "unprognostic (2.52e-1)" "unprognostic (1.70e-2)" 4.3 1.3 12.3 7.5 15.8 5.4 11.2 4.4 12.3 6.9 5.2 5.4 11.5 4.1 7.3 8.4 13.6 16.5 3.9 4.0 14.0 7.4 14.2 2.0 8.4 9.5 27.9 5.6 4.8 4.1 3.2 2.3 6.6 22.7 3.7 5.2 3.1 6.5 5.3 1.6 9.9 6.0 3.0 17.6 10.0 3.1 6.1 22.7 6.1 28.8 3.2 8.0 3.7 11.2 2.5 2.8 12.2 4.1 3.3 3.8 1.7 4.5 4.2 11.6 8.6 2.2 3.0 10.6 2.7 1.0 1.3 1.8 6.2 3.1 0.4 2.7 2.1 2.8 3.1 10.7 8.1 2.3 5.0 7.5 5.0 3.2 0.1 2.3 6.4 38.8 2.0 8.7 1.4 5.3 3.7 13.1 6.3 5.8 6.5 4.4 3.9 7.3 5.7 7.7 3.5 4.8 13.7 11.1 8.5 10.7 3.8 7.8 5.0 2.8 1.8 2.7 19.0 1.4 5.1 7.1 1.2 2.0 1.9 1.8 0.1 0.3 5.8 0.7 5.8 3.0 12.2 3.1 1.8 3.5 3.3 3.8 2.5 3.7 3.3 2.3 2.4 3.1 3.3 0.8 3.3 4.1 2.8 2.5 1.7 12.3 15.8 4.4 12.3 14.0 7.4 27.9 5.6 22.7 22.7 3.0 13.1 6.5 16.9 19.1 0.6 1.4 25.5 17.4 9.1 5.2 0.0 17.4 11.6 10.4 7.2 17.0 7.7 0.0 2.7 3.8 9.7 9.1 85.2 1.7 15.1 1.6 4.6 11.1 19.0 34.3 18.4 20.8 5.0 6.4 11.4 2.1 4.7 10.5 20.5 5.1 0.7 32.3 22.0 1.6 21.7 23.5 6.5 25.5 22.2 16.5 PRM1 CT94.1 ENSG00000175646 "Protamine 1" P04553 16 11280836-11281350 "Predicted intracellular proteins" "Differentiation, DNA condensation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 125 "testis: 747.3" "Group enriched" "Detected in some" 154 "Early spermatids: 123959.8;Late spermatids: 465852.4" "Cancer enriched" "Detected in single" 161 "testis cancer: 11.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.1;Hep G2: 1.1;NB-4: 6.0;U-2197: 4.5;U-698: 2.0" "HPA055150, HPA059371" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA055150: AB_2682718, HPA059371: " "unprognostic (2.10e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 747.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 123959.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 465852.4 1718.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1588.2 0.0 0.0 1138.3 0.0 1916.0 855.6 0.0 0.0 0.0 0.0 0.0 PRMT1 "ANM1, HCP1, HRMT1L2" ENSG00000126457 "Protein arginine methyltransferase 1" Q99873 19 49675786-49689029 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022550, HPA069769, HPA072136" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB022550: , HPA069769: AB_2686193, HPA072136: AB_2686490" "unprognostic (1.88e-2)" "unprognostic (1.28e-2)" "unprognostic (3.00e-2)" "unprognostic (3.84e-1)" "unprognostic (4.13e-2)" "unprognostic (3.33e-2)" "prognostic unfavorable (8.04e-5)" "unprognostic (3.43e-2)" "unprognostic (1.82e-1)" "unprognostic (1.77e-1)" "unprognostic (3.59e-2)" "unprognostic (1.05e-1)" "unprognostic (7.19e-3)" "unprognostic (2.21e-1)" "unprognostic (3.66e-2)" "unprognostic (4.73e-2)" "unprognostic (1.10e-2)" 21.3 31.5 27.4 28.1 29.7 21.8 22.0 29.4 35.9 31.8 25.5 26.9 27.8 21.4 36.0 22.5 28.9 45.4 24.5 56.4 25.2 28.6 23.4 20.8 22.0 34.9 32.0 23.8 43.4 35.0 20.0 31.7 27.9 25.6 33.3 18.4 34.1 20.9 31.5 83.8 21.9 19.8 38.3 20.9 33.3 20.3 24.9 28.0 25.0 32.9 31.3 32.0 29.8 23.8 51.9 41.2 9.2 23.6 38.7 35.5 31.8 38.2 87.7 60.8 73.3 16.5 18.8 32.0 24.6 43.0 71.2 61.3 65.3 30.6 63.0 18.4 28.8 28.0 28.3 51.2 52.0 31.2 48.9 87.9 45.9 24.1 70.8 40.5 55.2 33.0 26.2 25.9 39.8 57.3 24.0 42.1 51.1 48.3 44.8 27.6 57.9 71.3 68.4 64.1 48.1 57.1 50.7 49.1 57.5 40.1 80.8 67.8 52.8 28.4 29.5 15.1 20.5 22.3 32.6 26.1 41.9 40.8 19.2 58.6 43.1 64.9 62.2 25.7 40.0 43.9 5.8 20.2 9.2 28.6 23.6 35.5 51.9 26.6 30.5 34.2 41.9 29.9 29.1 3.9 38.7 17.1 41.2 24.2 31.8 27.4 29.7 29.4 35.9 25.2 28.6 32.0 23.8 25.6 28.0 3.0 15.9 80.4 187.9 183.9 238.6 13.0 28.1 1.4 7.9 41.8 100.1 170.7 107.8 159.3 3.5 104.4 27.5 0.0 117.3 137.0 110.0 82.0 55.2 18.3 92.0 122.3 110.5 96.3 30.9 13.2 96.4 65.7 106.3 237.2 61.8 106.4 105.3 52.0 83.8 63.8 130.7 90.5 132.8 70.0 132.2 138.9 196.7 52.4 83.7 157.1 PRMT2 "HRMT1L1, MGC111373" ENSG00000160310 "Protein arginine methyltransferase 2" P55345 21 46635167-46665124 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018976, HPA029591" Uncertain Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA018976: AB_1855719, HPA029591: AB_10601250" "unprognostic (1.82e-1)" "unprognostic (2.96e-1)" "unprognostic (8.61e-3)" "unprognostic (1.74e-1)" "unprognostic (1.08e-1)" "unprognostic (1.58e-2)" "unprognostic (1.29e-3)" "unprognostic (1.34e-1)" "unprognostic (2.23e-1)" "unprognostic (6.78e-2)" "unprognostic (4.34e-3)" "unprognostic (1.72e-1)" "unprognostic (4.62e-3)" "unprognostic (8.76e-3)" "unprognostic (2.86e-2)" "unprognostic (1.91e-3)" "unprognostic (2.23e-1)" 19.9 14.7 37.1 21.8 43.6 18.7 28.4 21.4 37.2 25.5 25.2 35.4 12.0 14.7 24.5 15.9 30.7 27.1 23.4 29.4 37.4 53.1 19.9 8.5 21.7 28.7 44.8 32.2 48.5 15.1 19.9 20.1 26.2 44.9 22.0 17.1 20.6 21.0 28.0 9.5 28.1 20.0 28.5 69.6 25.6 17.4 10.1 40.3 13.8 20.1 7.4 28.3 23.1 26.0 18.9 27.6 64.2 26.1 50.8 60.2 41.6 22.7 19.5 39.5 14.7 28.9 28.2 9.7 21.5 24.2 24.4 22.4 27.4 18.6 13.4 27.4 38.3 33.3 6.7 18.4 27.1 14.2 33.4 17.7 34.7 16.5 20.4 14.0 10.3 16.5 17.4 27.0 29.6 21.2 27.4 35.3 19.2 22.0 25.2 37.3 25.5 14.8 19.4 21.7 14.5 23.1 19.1 10.0 8.8 19.0 19.5 28.6 17.8 22.7 10.4 41.1 6.1 14.0 10.7 31.8 23.9 16.4 12.7 14.1 6.7 6.1 8.5 21.9 28.1 34.5 44.2 19.6 64.2 60.2 26.0 43.6 18.9 40.5 51.0 27.6 16.7 49.9 56.9 26.3 50.8 26.1 23.8 29.0 41.6 37.1 43.6 21.4 37.2 37.4 53.1 44.8 32.2 44.9 40.3 86.4 33.4 59.7 59.7 41.0 46.0 58.2 71.4 75.0 52.4 71.5 27.5 55.8 76.3 68.8 2.4 76.8 42.4 23.3 45.8 37.4 57.5 64.0 111.2 26.7 91.9 35.0 34.3 129.5 113.7 5.6 51.5 104.6 82.7 214.6 26.3 44.1 63.8 35.4 58.4 73.2 53.9 64.7 66.1 20.2 31.9 39.4 57.9 132.0 32.2 56.9 PRMT5 "HRMT1L5, SKB1, SKB1Hs" ENSG00000100462 "Protein arginine methyltransferase 5" O14744 14 22920511-22929585 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005525, CAB012459, HPA064708" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB012459: , HPA005525: AB_1079679, HPA064708: AB_2685330" "unprognostic (8.34e-2)" "unprognostic (5.14e-3)" "unprognostic (1.19e-2)" "unprognostic (2.19e-1)" "unprognostic (4.56e-3)" "prognostic unfavorable (1.82e-4)" "prognostic unfavorable (4.77e-5)" "unprognostic (3.64e-2)" "unprognostic (6.80e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (2.61e-4)" "unprognostic (4.69e-2)" "unprognostic (1.99e-3)" "unprognostic (1.21e-1)" "unprognostic (7.04e-2)" "unprognostic (6.28e-2)" "prognostic unfavorable (1.04e-4)" 17.0 21.6 18.3 17.8 22.8 12.0 21.2 18.4 24.9 20.3 25.0 18.1 24.9 16.1 24.9 19.6 33.1 28.0 16.6 22.3 15.3 13.2 25.7 22.2 15.8 15.6 17.2 15.2 30.2 30.9 30.8 17.4 24.3 15.9 21.1 22.6 16.9 19.0 21.7 42.0 21.7 14.5 22.2 13.4 17.9 19.5 22.1 17.3 22.7 30.9 19.6 22.1 20.8 22.0 17.6 23.8 4.3 17.6 9.8 15.6 15.5 40.7 39.4 28.5 28.2 13.6 15.5 31.1 28.1 20.9 43.6 37.0 36.0 37.9 39.8 23.0 20.7 25.9 32.6 56.4 47.2 50.5 25.5 27.2 24.7 26.6 55.3 26.1 51.8 21.6 15.2 25.2 33.7 61.6 17.8 20.6 31.8 35.0 21.8 22.5 36.8 37.1 23.2 25.5 35.5 49.8 43.8 34.5 28.9 21.2 28.0 30.7 20.1 30.7 32.9 14.3 25.5 22.2 19.6 19.3 18.5 26.4 26.3 35.8 29.9 63.7 52.9 11.7 25.2 28.9 1.7 16.8 0.2 8.2 17.6 13.4 17.6 11.3 13.5 23.8 15.5 15.6 12.5 4.3 9.8 13.2 14.1 9.4 15.5 18.3 22.8 18.4 24.9 15.3 13.2 17.2 15.2 15.9 17.3 17.9 10.8 4.5 23.8 23.6 9.5 0.8 28.1 26.8 11.4 7.0 7.9 33.6 19.9 25.6 1.9 11.2 6.3 0.0 23.3 26.7 18.6 11.3 6.9 15.5 17.4 15.9 5.8 11.1 4.9 2.7 15.3 10.4 25.3 11.8 15.7 19.1 60.5 8.6 19.8 18.4 7.5 6.5 27.8 34.9 54.7 24.3 27.9 10.1 19.0 16.8 PRMT6 "FLJ10559, HRMT1L6" ENSG00000198890 "Protein arginine methyltransferase 6" Q96LA8 1 107056679-107059294 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 5 "MCF7: 83.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059424 Approved Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA059424: AB_2684012" "unprognostic (5.17e-3)" "unprognostic (1.48e-1)" "unprognostic (1.47e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (2.68e-1)" "unprognostic (2.55e-1)" "unprognostic (1.36e-3)" "unprognostic (2.13e-2)" "unprognostic (9.72e-2)" "unprognostic (2.53e-2)" "unprognostic (1.42e-1)" "unprognostic (2.63e-1)" "unprognostic (3.15e-2)" "unprognostic (1.03e-1)" "unprognostic (8.34e-2)" "unprognostic (1.01e-1)" "unprognostic (1.73e-3)" 6.6 16.1 14.4 10.5 13.4 4.6 10.8 12.6 13.9 8.9 10.3 11.5 10.4 8.1 9.7 11.3 10.9 12.2 9.8 5.0 11.8 16.2 16.7 16.3 5.9 11.5 12.2 14.1 12.3 16.8 15.0 13.8 9.6 13.2 11.8 9.7 12.6 8.3 11.4 2.1 7.6 9.3 8.0 13.6 11.5 9.5 9.4 10.6 18.2 9.5 3.4 11.1 10.1 7.3 9.7 14.7 1.8 10.1 14.6 10.9 7.6 3.6 0.0 7.3 3.2 4.8 5.4 2.0 4.9 3.7 4.8 4.9 4.7 2.5 9.0 6.8 4.5 2.6 5.2 6.6 7.2 3.8 0.0 7.1 5.4 10.2 6.7 4.8 11.2 3.4 5.0 4.0 4.3 4.4 3.2 4.1 5.2 7.2 1.4 4.3 83.6 6.5 3.9 3.1 2.9 6.9 8.3 15.9 3.4 11.5 7.4 13.6 16.6 6.7 9.7 3.2 4.6 6.7 8.4 4.7 3.5 7.3 7.4 7.3 1.5 1.0 1.5 5.3 5.3 2.8 1.8 8.9 1.6 7.5 10.1 8.4 6.9 7.6 6.8 11.9 9.7 10.9 10.9 0.5 14.6 9.2 14.7 7.8 7.6 14.4 13.4 12.6 13.9 11.8 16.2 12.2 14.1 13.2 10.6 0.0 4.1 8.2 6.2 3.9 12.5 2.2 0.0 8.1 2.3 14.0 0.0 16.1 23.2 9.0 0.9 4.2 3.5 0.0 6.5 11.9 3.9 3.6 1.1 0.0 8.5 14.3 16.8 4.9 7.0 2.3 8.1 3.6 1.7 1.8 8.7 6.9 4.9 7.0 8.5 15.2 4.3 12.9 8.4 8.4 8.8 5.4 5.9 5.4 9.5 5.8 PRMT7 "FLJ10640, KIAA1933" ENSG00000132600 "Protein arginine methyltransferase 7" Q9NVM4 16 68310974-68358563 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 51.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044241 Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center" No No Nucleoplasm "Nucleoli fibrillar center" "HPA044241: AB_2678869" "unprognostic (9.33e-2)" "unprognostic (5.33e-2)" "unprognostic (1.52e-1)" "prognostic favorable (2.31e-5)" "unprognostic (2.92e-2)" "unprognostic (1.95e-1)" "unprognostic (4.12e-2)" "unprognostic (1.22e-1)" "unprognostic (3.74e-1)" "unprognostic (1.19e-1)" "unprognostic (4.74e-3)" "unprognostic (3.09e-2)" "unprognostic (7.72e-2)" "unprognostic (1.75e-1)" "unprognostic (9.23e-2)" "unprognostic (3.57e-1)" "unprognostic (1.31e-1)" 14.8 14.4 15.6 12.7 22.0 11.1 12.9 29.4 20.5 11.4 11.7 20.2 13.9 7.0 18.9 11.9 12.7 18.1 9.3 23.1 14.4 13.1 9.5 12.2 9.7 17.0 11.2 18.7 21.9 14.8 12.0 14.0 11.4 13.3 12.8 7.6 20.8 17.3 16.2 34.0 16.9 9.9 18.5 11.6 12.4 9.9 17.0 13.1 24.4 11.1 12.0 14.9 13.3 10.4 10.8 26.2 9.9 8.5 18.6 18.1 11.5 10.2 16.7 8.0 20.0 7.6 7.2 26.7 10.3 5.6 13.1 10.9 42.3 10.3 21.9 17.4 8.7 4.8 13.4 11.3 10.4 7.3 7.8 16.9 6.5 18.8 19.1 5.5 11.9 10.2 8.0 4.5 10.8 10.2 8.1 7.8 11.4 15.4 1.2 7.1 17.2 14.7 18.5 13.1 10.3 11.4 19.8 11.7 14.8 6.1 9.4 10.9 8.5 34.5 8.7 7.0 6.8 14.5 11.9 9.3 9.3 8.3 11.1 9.2 6.7 12.4 22.5 11.8 12.8 9.6 9.9 7.0 5.9 15.8 8.5 18.1 10.1 10.6 13.9 10.2 10.8 16.1 14.1 0.8 18.6 7.7 26.2 11.7 11.5 15.6 22.0 29.4 20.5 14.4 13.1 11.2 18.7 13.3 13.1 17.9 11.7 10.4 7.4 6.2 20.5 11.8 15.3 14.7 9.1 8.7 51.1 21.8 5.0 11.0 3.4 6.8 24.9 0.0 14.4 6.5 8.0 6.2 6.9 7.5 10.2 28.6 12.7 6.7 5.9 3.2 10.9 8.3 8.5 4.6 27.0 9.4 15.1 26.9 12.4 6.8 16.4 12.9 5.7 6.3 20.0 5.3 9.7 15.2 23.3 9.3 PRMT9 "FLJ46629, PRMT10" ENSG00000164169 "Protein arginine methyltransferase 9" Q6P2P2 4 147637785-147684230 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 106.0;Rod photoreceptor cells: 79.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036844, HPA042537" Uncertain Approved Nucleoplasm,Microtubules,Cytosol NA NA Microtubules "Nucleoplasm, Cytosol" "HPA036844: AB_10672341, HPA042537: AB_2678043" "unprognostic (2.17e-1)" "unprognostic (1.46e-2)" "unprognostic (4.65e-3)" "unprognostic (2.35e-1)" "unprognostic (8.46e-3)" "unprognostic (1.10e-1)" "unprognostic (1.35e-1)" "unprognostic (1.55e-2)" "unprognostic (4.14e-2)" "unprognostic (7.29e-2)" "unprognostic (2.11e-2)" "unprognostic (2.33e-1)" "prognostic favorable (3.58e-7)" "unprognostic (1.72e-1)" "unprognostic (4.52e-2)" "unprognostic (1.54e-2)" "unprognostic (1.30e-2)" 6.0 17.2 6.0 5.2 8.6 12.4 6.9 8.0 8.9 5.6 4.5 4.2 7.9 2.5 8.6 7.6 5.0 7.5 8.4 6.5 5.6 5.0 7.5 5.8 7.6 5.3 5.8 5.3 22.6 7.2 16.3 10.0 5.0 7.1 6.0 4.5 9.8 5.8 11.3 6.7 5.6 4.3 6.1 4.6 4.5 5.9 11.2 3.9 11.6 15.8 2.8 5.4 5.5 5.2 9.6 6.0 10.8 6.1 5.1 10.4 2.7 3.5 2.3 5.7 4.3 4.4 7.6 5.0 3.9 6.3 6.0 6.4 1.8 4.0 12.3 1.8 3.4 3.1 2.5 6.7 3.4 8.3 4.4 3.9 6.8 4.5 3.0 3.3 9.8 3.8 5.2 3.5 3.7 3.3 4.9 5.0 6.2 6.7 7.2 5.1 2.0 8.3 3.9 2.9 3.4 4.3 5.6 4.8 4.5 4.9 2.8 3.5 5.4 6.3 5.0 3.2 3.9 2.1 2.2 4.2 3.9 3.1 4.3 4.3 8.2 6.5 8.1 4.3 6.1 2.8 7.4 6.0 10.8 6.7 6.1 6.5 9.5 8.1 8.2 4.0 9.6 10.4 9.0 4.2 5.1 4.4 6.0 6.8 2.7 6.0 8.6 8.0 8.9 5.6 5.0 5.8 5.3 7.1 3.9 0.0 7.7 61.1 2.9 0.0 54.5 5.5 7.6 2.7 1.2 33.2 106.0 12.1 5.0 5.9 58.8 4.3 5.9 0.0 5.8 8.6 8.5 4.1 34.5 5.7 15.3 47.7 16.7 12.3 31.0 9.5 16.7 14.9 0.0 9.0 4.8 26.9 5.9 3.6 15.9 3.3 79.2 12.9 4.6 29.1 14.0 0.0 12.7 30.5 4.7 1.4 PROB1 C5orf65 ENSG00000228672 "Proline rich basic protein 1" E7EW31 5 139390592-139395713 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 37.7" "Cell type enhanced" "Detected in some" 26 "Cardiomyocytes: 25.4;Ito cells: 4.3;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.1;T-reg: 1.1" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "HDLM-2: 48.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA053354, HPA060103" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA053354: , HPA060103: AB_2684205" "unprognostic (4.14e-2)" "prognostic favorable (9.26e-4)" "unprognostic (2.60e-1)" "unprognostic (1.72e-1)" "unprognostic (3.53e-2)" "unprognostic (9.27e-3)" "unprognostic (4.72e-2)" "unprognostic (1.40e-1)" "unprognostic (8.28e-3)" "unprognostic (3.21e-2)" "unprognostic (4.84e-4)" "unprognostic (7.10e-2)" "unprognostic (1.75e-2)" "unprognostic (9.05e-2)" "unprognostic (3.62e-2)" "unprognostic (5.89e-2)" "unprognostic (8.24e-2)" 0.6 1.6 0.7 0.3 0.8 0.0 0.3 0.0 0.3 0.3 0.3 0.6 0.5 0.1 0.3 0.7 0.1 6.6 0.7 0.6 0.7 0.0 0.0 0.4 0.5 0.0 0.0 1.8 0.8 0.2 1.3 0.0 0.7 0.6 37.7 0.0 0.8 0.1 0.2 0.3 0.6 0.0 0.1 0.1 0.3 0.1 0.5 1.1 0.0 0.1 0.0 1.1 0.0 0.6 0.4 0.1 0.1 0.0 0.2 0.2 0.5 0.1 0.5 0.5 2.0 1.3 3.0 0.5 1.6 0.0 0.3 0.2 0.0 0.1 48.1 0.6 0.7 1.2 0.2 1.3 0.0 1.6 0.4 0.4 1.2 0.3 0.4 0.1 2.0 0.2 3.0 1.7 0.5 2.5 1.2 0.6 0.3 1.2 7.7 0.2 5.8 0.1 0.0 0.6 0.3 2.8 3.0 0.1 0.7 1.1 1.6 0.2 0.1 0.1 0.1 0.2 0.4 0.8 4.3 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.1 1.1 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 25.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 2.2 0.0 0.0 0.0 0.2 0.5 0.4 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.3 0.2 0.0 1.1 1.4 0.0 6.5 1.7 0.1 0.3 0.0 2.2 0.0 0.2 0.3 PRODH "HSPOX2, PIG6, PRODH1, PRODH2, TP53I6" ENSG00000100033 "Proline dehydrogenase 1" O43272 22 18912777-18936553 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Proline metabolism" Oxidoreductase "Disease mutation, Schizophrenia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 48.9" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 24.6;Melanocytes: 20.3;Suprabasal keratinocytes: 13.2" "Cancer enhanced" "Detected in many" "testis cancer: 11.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 10 "OE19: 39.9;RPTEC TERT1: 19.8" HPA020361 Approved Approved Nucleoplasm,Vesicles,Mitochondria NA NA Mitochondria "Nucleoplasm, Vesicles" "HPA020361: AB_10963116" "unprognostic (2.46e-2)" "prognostic favorable (1.54e-4)" "unprognostic (1.40e-1)" "unprognostic (3.70e-2)" "unprognostic (3.80e-2)" "unprognostic (1.20e-1)" "unprognostic (1.78e-2)" "unprognostic (1.07e-2)" "unprognostic (2.49e-2)" "unprognostic (6.56e-2)" "unprognostic (3.12e-2)" "unprognostic (1.61e-2)" "unprognostic (7.44e-2)" "unprognostic (1.07e-1)" "unprognostic (1.21e-1)" "unprognostic (5.34e-2)" "unprognostic (3.94e-2)" 3.8 2.3 20.8 2.8 19.3 2.0 3.3 9.8 21.3 2.0 3.5 16.2 0.1 13.8 2.3 2.2 8.8 2.4 2.2 4.6 22.2 10.8 9.9 6.6 8.6 2.3 14.9 21.8 2.4 2.2 1.9 1.5 2.4 13.5 2.6 2.6 7.4 2.1 2.4 15.5 13.0 48.9 1.9 12.6 2.2 2.1 3.5 9.8 0.1 4.3 4.1 3.7 2.1 2.3 0.4 0.4 0.0 0.0 1.0 0.3 0.0 0.0 0.4 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 1.4 2.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 2.4 39.9 0.0 0.0 0.0 0.2 19.8 0.4 0.0 0.1 0.4 0.6 0.1 2.9 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 20.8 19.3 9.8 21.3 22.2 10.8 14.9 21.8 13.5 9.8 14.9 24.6 0.0 0.2 4.5 0.0 1.6 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.9 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.0 0.5 0.0 2.9 0.0 0.0 0.0 0.0 0.7 0.0 0.3 13.2 0.0 0.0 0.4 0.1 PRODH2 HSPOX1 ENSG00000250799 "Proline dehydrogenase 2" Q9UF12 19 35799988-35813299 "Enzymes, Predicted intracellular proteins" "Proline metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 29 "kidney: 51.2;liver: 49.3" "Group enriched" "Detected in some" 8 "Hepatocytes: 140.6;Proximal tubular cells: 216.9" "Group enriched" "Detected in some" 50 "liver cancer: 28.1;renal cancer: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "Hep G2: 26.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA051287 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051287: AB_2681420" "unprognostic (2.58e-1)" "unprognostic (3.41e-3)" "unprognostic (2.75e-2)" "unprognostic (7.03e-2)" "unprognostic (1.73e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 1.7 0.1 0.0 0.3 0.1 0.1 0.0 51.2 49.3 0.1 0.1 0.1 0.1 0.1 1.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 3.4 0.0 0.1 0.3 0.3 0.0 0.0 0.0 12.2 0.0 0.0 23.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 140.6 0.1 0.0 0.0 1.3 4.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 216.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 PROM2 ENSG00000155066 "Prominin 2" Q8N271 2 95274453-95291308 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 45.9;Collecting duct cells: 31.4;Urothelial cells: 37.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 23.8;CAPAN-2: 42.0;HaCaT: 22.6;hTCEpi: 24.6;MCF7: 18.6;RT4: 25.6;SK-BR-3: 36.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB046005, HPA063728" Enhanced Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Nucleoplasm, Plasma membrane" "Cell Junctions" "CAB046005: AB_2284371, HPA063728: AB_2685104" "prognostic unfavorable (2.16e-4)" "unprognostic (1.60e-1)" "unprognostic (1.41e-1)" "unprognostic (1.86e-2)" "unprognostic (1.76e-1)" "unprognostic (7.30e-2)" "unprognostic (2.23e-1)" "unprognostic (1.70e-2)" "unprognostic (1.37e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.26e-1)" "prognostic unfavorable (1.55e-6)" "unprognostic (1.46e-2)" "unprognostic (4.59e-1)" "unprognostic (5.24e-2)" "unprognostic (2.50e-2)" 0.3 0.2 0.5 2.9 0.6 0.0 9.3 1.1 0.5 11.4 5.2 0.3 22.2 4.4 1.4 22.5 42.6 2.2 37.2 0.5 0.6 0.5 18.8 0.4 1.3 0.3 0.6 0.3 1.5 8.6 8.1 1.5 12.5 0.3 11.6 4.2 0.3 35.6 20.0 1.3 26.7 2.6 2.7 0.7 0.4 11.5 1.8 0.3 1.7 5.7 21.6 22.2 20.0 14.8 0.0 0.2 0.6 0.0 0.0 0.3 0.0 23.8 0.0 0.0 0.2 0.1 0.0 12.1 0.0 0.0 0.1 0.1 0.2 42.0 0.0 0.0 0.0 0.0 22.6 0.0 13.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 24.6 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 18.6 0.1 0.1 0.0 1.1 0.1 0.0 0.0 0.0 0.0 25.6 0.2 0.0 0.0 36.7 0.0 0.3 11.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.2 0.2 0.0 0.5 0.6 1.1 0.5 0.6 0.5 0.6 0.3 0.3 0.3 3.0 3.4 0.0 20.8 6.0 0.2 1.4 45.9 6.7 11.4 31.4 3.9 15.3 10.0 12.0 0.4 0.0 2.6 0.0 9.6 2.3 0.8 11.1 0.0 0.0 2.0 0.0 3.5 0.0 0.0 1.1 0.3 0.0 6.8 1.0 10.5 0.0 12.7 7.0 0.7 0.0 0.9 0.0 1.0 0.7 0.0 11.2 9.4 0.0 12.4 37.6 PROSER1 "bA50D16.2, C13orf23, FLJ12661" ENSG00000120685 "Proline and serine rich 1" Q86XN7 13 39009866-39038076 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034225, HPA055687" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB034225: AB_1564157, HPA055687: AB_2682886" "unprognostic (6.75e-3)" "unprognostic (9.56e-3)" "unprognostic (1.33e-1)" "unprognostic (3.81e-2)" "unprognostic (7.06e-2)" "unprognostic (2.92e-2)" "unprognostic (3.73e-3)" "unprognostic (5.98e-2)" "unprognostic (1.10e-1)" "unprognostic (1.39e-1)" "unprognostic (3.60e-1)" "unprognostic (1.07e-1)" "unprognostic (2.93e-1)" "unprognostic (9.31e-3)" "unprognostic (2.33e-1)" "unprognostic (1.87e-1)" "unprognostic (1.95e-1)" 10.8 9.9 10.6 12.8 13.3 26.8 11.3 22.6 14.3 8.5 13.7 17.4 9.6 12.9 11.9 11.8 14.5 9.2 8.0 8.8 10.7 6.9 12.6 11.3 15.0 15.2 14.8 9.0 10.0 19.0 7.0 19.5 35.4 12.2 13.4 17.3 11.0 17.9 8.3 11.8 18.5 15.0 9.9 16.3 16.6 12.8 19.0 15.0 26.1 14.3 8.2 17.3 10.8 11.2 4.1 4.8 6.0 4.4 7.5 6.4 4.2 7.2 5.6 17.7 12.2 6.1 4.9 28.2 6.9 6.1 6.9 7.5 17.9 11.4 17.0 5.6 6.7 9.4 12.6 19.0 12.4 11.4 25.7 15.6 25.0 6.1 12.3 13.9 26.0 15.5 6.5 15.0 11.0 25.2 4.3 11.3 19.6 12.3 10.3 7.4 12.7 15.8 13.9 26.4 14.4 6.1 16.7 18.8 10.7 7.0 11.4 10.0 11.5 4.8 12.7 10.2 14.4 13.6 15.1 10.3 4.0 6.5 7.9 8.7 9.7 9.9 18.5 6.5 14.5 7.9 6.0 3.4 0.6 5.7 3.2 6.4 4.1 5.5 6.1 4.1 3.1 4.9 5.3 0.9 7.5 4.4 4.8 3.0 4.2 10.6 13.3 22.6 14.3 10.7 6.9 14.8 9.0 12.2 15.0 3.0 15.4 11.2 4.5 6.3 10.5 5.2 2.5 4.0 4.5 0.0 7.9 16.6 1.7 6.4 15.1 7.7 6.3 0.0 11.6 15.4 5.4 9.9 11.5 5.6 9.0 15.9 10.9 6.7 18.3 5.0 6.1 6.5 5.0 4.6 16.0 4.0 13.2 14.4 4.6 2.8 9.3 0.0 3.8 13.4 12.4 6.4 22.4 9.2 13.6 7.4 PROX1 ENSG00000117707 "Prospero homeobox 1" Q92786 1 213983181-214041502 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 72.4" "Cell type enhanced" "Detected in many" 17 "Bipolar cells: 195.1;Hepatocytes: 270.2;Horizontal cells: 494.2" "Cancer enhanced" "Detected in many" "liver cancer: 15.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 20 "memory B-cell: 2.0" "Lineage enriched" "Detected in single" 20 "B-cells: 2.0" "Cell line enhanced" "Detected in some" "Hep G2: 16.0;RH-30: 8.5;SH-SY5Y: 41.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000842, HPA001030, HPA027298" Enhanced Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA000842: AB_2666112, HPA001030: AB_2666177, HPA027298: " "unprognostic (3.07e-1)" "unprognostic (5.98e-2)" "unprognostic (1.06e-3)" "unprognostic (3.42e-1)" "unprognostic (7.71e-2)" "unprognostic (1.39e-1)" "unprognostic (1.45e-2)" "unprognostic (6.59e-2)" "unprognostic (1.85e-2)" "unprognostic (2.31e-1)" "unprognostic (3.29e-3)" "unprognostic (6.64e-2)" "unprognostic (4.56e-6)" "unprognostic (7.24e-2)" "unprognostic (1.72e-1)" "unprognostic (6.71e-4)" "unprognostic (1.05e-1)" 2.3 9.6 3.7 2.1 8.1 1.0 2.9 14.0 5.8 1.8 3.0 13.1 0.3 2.7 1.9 2.0 1.5 3.0 2.6 13.1 6.2 4.1 5.4 72.4 2.0 13.5 8.4 4.3 7.3 13.9 1.0 11.4 1.3 5.5 1.4 3.2 2.4 1.1 1.3 4.1 1.5 3.1 1.7 9.6 14.9 2.8 5.9 9.2 0.0 7.5 0.6 1.5 1.6 2.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.2 0.1 1.2 0.0 0.0 0.0 0.5 0.3 0.0 16.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 1.8 1.2 2.8 0.0 0.2 0.0 0.2 0.0 0.8 1.0 0.7 0.0 8.5 1.2 0.1 0.2 1.2 41.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.3 0.1 0.5 0.0 0.0 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 8.1 14.0 5.8 6.2 4.1 8.4 4.3 5.5 9.2 0.0 2.9 0.0 1.0 5.3 195.1 97.2 84.1 1.4 2.3 8.7 2.0 0.0 13.3 17.3 37.5 17.8 2.6 0.0 2.4 0.1 6.7 2.3 0.0 270.2 0.7 494.2 64.2 4.9 4.5 5.9 1.1 1.1 10.1 0.0 15.2 38.7 5.2 79.3 1.1 0.3 8.6 0.0 2.7 0.2 0.1 4.0 0.0 0.0 8.0 0.6 PRPF3 "hPrp3, Prp3, RP18, SNRNP90" ENSG00000117360 "Pre-mRNA processing factor 3" O43395 1 150321476-150353195 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027226, HPA067116" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA027226: AB_1855770, HPA067116: AB_2685783" "unprognostic (2.75e-1)" "unprognostic (3.00e-1)" "unprognostic (2.20e-1)" "unprognostic (2.77e-1)" "unprognostic (1.78e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (6.59e-5)" "unprognostic (7.89e-2)" "unprognostic (7.13e-3)" "unprognostic (1.04e-2)" "unprognostic (1.42e-1)" "unprognostic (1.04e-2)" "prognostic unfavorable (3.19e-5)" "unprognostic (6.77e-3)" "unprognostic (1.65e-1)" "unprognostic (1.24e-1)" "unprognostic (7.78e-3)" 21.9 18.6 22.1 28.6 24.0 38.4 23.3 37.8 27.5 21.2 20.0 25.6 27.8 16.7 35.7 27.9 18.6 21.5 17.4 17.3 18.9 12.3 17.6 19.7 20.9 26.2 19.6 19.5 32.7 17.4 22.5 41.9 23.5 17.0 22.0 20.3 27.7 18.9 23.2 19.2 21.6 20.1 22.5 23.6 26.8 16.2 18.9 24.0 27.6 27.7 18.1 27.3 20.7 20.9 13.2 9.3 12.4 19.1 9.9 15.6 7.7 16.0 17.4 17.7 11.3 11.9 13.0 24.1 16.8 11.8 26.1 18.1 13.3 15.1 21.3 11.3 13.7 24.4 19.0 32.0 11.8 23.5 10.6 14.8 18.4 25.3 12.6 11.9 22.6 11.9 9.4 16.4 22.2 19.2 12.4 15.8 14.4 21.8 12.9 18.5 23.9 18.5 19.7 25.4 41.4 15.8 27.0 14.4 14.0 10.7 9.7 15.3 13.5 14.1 16.6 12.7 25.0 19.7 54.5 12.5 16.4 12.7 13.8 27.6 12.4 22.2 23.9 10.9 20.5 17.0 6.9 8.6 12.4 15.6 11.4 15.0 13.2 11.3 10.1 9.3 10.2 11.7 12.1 5.2 9.9 19.1 7.5 8.5 7.7 22.1 24.0 37.8 27.5 18.9 12.3 19.6 19.5 17.0 24.0 32.8 22.6 8.6 11.5 10.4 29.6 10.9 5.1 22.7 21.6 10.4 17.7 13.9 11.6 12.9 7.7 17.9 12.4 0.0 10.1 13.5 9.9 9.7 22.0 8.9 10.6 30.2 2.4 12.9 9.1 3.2 18.7 11.2 10.1 11.8 13.3 29.6 11.0 8.6 17.3 4.4 42.9 12.9 14.1 41.1 14.0 8.8 16.7 14.9 10.1 8.8 PRPF31 "hPrp31, NY-BR-99, PRP31, RP11, SNRNP61" ENSG00000105618 "Pre-mRNA processing factor 31" Q8WWY3 19 54115410-54131719 "Disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041939, HPA061873" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA041939: AB_10793938, HPA061873: AB_2684630" "unprognostic (1.32e-1)" "unprognostic (1.73e-2)" "unprognostic (1.26e-2)" "unprognostic (7.98e-2)" "unprognostic (1.28e-1)" "unprognostic (3.28e-2)" "prognostic unfavorable (7.33e-4)" "unprognostic (9.55e-2)" "unprognostic (2.16e-1)" "unprognostic (1.66e-1)" "unprognostic (5.26e-3)" "unprognostic (1.81e-2)" "unprognostic (2.06e-1)" "unprognostic (2.16e-1)" "unprognostic (5.94e-2)" "unprognostic (2.53e-1)" "unprognostic (7.04e-2)" 22.8 24.5 23.8 26.3 25.8 24.2 22.1 29.0 33.2 22.2 24.4 24.1 29.5 24.0 33.1 23.3 25.1 26.9 25.9 23.3 23.3 20.3 22.5 27.2 21.0 30.1 24.8 31.6 27.3 21.1 34.2 22.2 24.1 22.0 23.4 18.6 22.9 39.9 27.1 50.0 24.7 21.8 25.9 23.3 26.2 22.9 26.0 22.7 25.8 25.8 25.4 25.4 24.5 26.8 16.2 18.6 10.1 18.2 17.9 21.2 15.9 18.9 31.1 12.8 18.7 8.5 8.2 11.7 16.3 11.8 16.6 15.5 15.6 13.5 20.9 12.2 10.7 8.0 9.5 17.6 16.7 12.7 18.6 50.4 17.0 23.8 18.3 9.2 31.9 13.8 10.6 8.0 13.5 11.5 9.8 17.0 14.8 21.0 9.6 10.6 14.8 21.2 8.9 11.5 15.8 34.7 18.9 18.9 16.0 11.1 24.8 14.5 16.4 22.8 17.2 8.7 6.7 11.0 13.2 19.2 21.5 17.2 10.4 24.5 12.8 22.3 23.5 16.5 17.5 13.2 7.4 15.2 10.1 18.0 18.2 18.9 16.2 17.3 18.9 18.6 16.0 15.3 15.3 3.3 17.9 15.8 15.7 21.2 15.9 23.8 25.8 29.0 33.2 23.3 20.3 24.8 31.6 22.0 22.7 32.8 26.1 31.5 36.9 37.9 29.7 29.9 33.1 34.8 31.8 24.4 13.7 82.0 51.4 55.7 4.0 43.0 25.4 23.3 54.9 75.7 41.4 31.7 31.1 24.6 59.1 28.6 33.5 23.4 18.4 5.9 35.4 37.7 38.8 88.4 33.7 49.2 51.2 30.2 46.0 44.9 29.3 38.8 49.1 65.0 61.3 36.8 63.7 44.1 40.9 22.4 PRPF38A "FLJ14936, Prp38" ENSG00000134748 "Pre-mRNA processing factor 38A" Q8NAV1 1 52404564-52420839 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053099, HPA058407" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA053099: AB_2682044, HPA058407: AB_2683709" "unprognostic (1.29e-1)" "unprognostic (6.12e-2)" "prognostic favorable (7.16e-4)" "unprognostic (1.34e-2)" "unprognostic (8.40e-2)" "unprognostic (2.15e-3)" "prognostic unfavorable (3.83e-5)" "unprognostic (3.83e-2)" "unprognostic (7.84e-3)" "unprognostic (7.06e-2)" "unprognostic (1.62e-1)" "unprognostic (9.69e-2)" "prognostic unfavorable (7.41e-5)" "unprognostic (6.54e-3)" "unprognostic (3.35e-1)" "unprognostic (1.89e-1)" "unprognostic (2.82e-1)" 13.5 13.2 21.5 16.9 19.2 25.4 20.6 30.5 18.5 17.3 17.2 20.7 12.9 12.9 22.1 16.0 15.0 18.0 11.3 11.5 19.1 16.8 15.4 12.1 15.1 22.1 20.3 14.0 28.1 12.6 19.2 19.9 15.9 16.6 17.6 19.1 17.2 13.4 15.1 10.0 17.4 16.2 14.5 19.3 17.8 12.9 18.8 22.1 36.4 19.3 13.7 22.1 14.1 20.1 9.1 9.7 12.5 8.8 13.3 15.3 6.6 8.3 4.1 14.7 7.0 5.9 5.8 8.8 5.7 3.9 9.5 9.2 7.5 4.2 17.3 6.0 3.9 7.4 6.2 20.9 6.2 12.4 9.4 16.0 23.2 15.4 7.7 7.2 25.8 8.6 4.4 5.6 10.4 10.1 7.2 8.0 12.6 21.3 4.5 5.6 4.7 19.9 15.5 18.1 8.9 9.7 19.6 22.3 14.5 8.4 5.0 9.8 12.0 11.6 9.6 11.2 10.4 6.7 21.0 6.2 5.4 8.1 8.0 11.2 8.7 12.4 17.5 8.0 22.6 6.8 12.5 7.5 10.5 9.8 8.8 13.3 9.1 11.0 11.8 9.7 8.5 15.3 11.6 6.0 13.3 8.6 5.4 10.7 6.6 21.5 19.2 30.5 18.5 19.1 16.8 20.3 14.0 16.6 22.1 38.7 27.2 33.7 76.8 47.2 31.2 23.5 15.3 17.4 30.7 15.7 88.4 53.1 29.9 28.6 65.9 47.2 52.0 23.3 25.7 65.9 30.1 36.9 57.8 15.5 35.1 23.8 34.3 22.7 35.1 11.0 23.9 30.8 28.7 23.4 38.6 45.7 21.8 45.6 31.5 26.9 42.6 51.8 41.1 111.6 55.6 48.9 86.5 62.3 47.3 64.1 PRPF39 "FLJ11128, FLJ20666" ENSG00000185246 "Pre-mRNA processing factor 39" Q86UA1 14 45084099-45116282 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001176 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA001176: AB_2171026" "unprognostic (1.79e-1)" "unprognostic (2.75e-1)" "unprognostic (1.03e-1)" "unprognostic (2.19e-1)" "unprognostic (1.91e-2)" "unprognostic (6.75e-3)" "prognostic unfavorable (3.84e-5)" "unprognostic (9.51e-3)" "prognostic unfavorable (6.51e-4)" "prognostic favorable (8.48e-4)" "unprognostic (4.34e-3)" "prognostic unfavorable (4.04e-4)" "unprognostic (5.02e-3)" "unprognostic (1.83e-1)" "unprognostic (9.04e-2)" "unprognostic (8.93e-2)" "prognostic favorable (2.99e-4)" 11.9 8.6 15.3 13.3 19.1 12.8 12.4 34.0 21.4 10.5 11.9 11.2 12.6 9.1 14.3 11.6 8.3 13.4 6.4 8.7 12.5 11.5 13.1 10.6 9.1 11.2 14.5 14.4 15.2 9.4 12.9 22.3 9.7 11.4 13.9 8.1 7.0 9.5 13.5 14.2 9.5 11.0 12.2 14.2 10.6 10.1 10.2 15.6 9.5 10.8 6.7 10.4 9.8 13.8 8.7 7.6 7.7 7.4 6.5 11.0 4.9 11.8 9.0 14.8 7.7 9.8 6.7 9.7 11.8 6.6 10.6 10.8 6.2 9.9 9.3 8.4 7.0 7.5 8.7 15.6 10.0 16.2 12.5 8.9 12.6 10.5 9.3 8.0 16.8 6.1 4.4 7.1 6.5 8.2 6.5 8.3 9.8 13.6 11.6 13.4 12.6 16.0 12.2 10.0 11.3 9.4 15.9 14.5 10.5 8.7 12.0 12.4 3.8 9.0 11.3 12.9 9.2 7.0 11.3 10.5 7.0 10.4 7.7 12.7 9.4 16.4 19.2 5.0 11.7 7.4 7.7 4.3 6.6 8.3 7.0 10.8 8.7 7.6 8.2 7.6 8.2 10.0 11.0 3.0 6.5 7.4 3.2 8.7 4.9 15.3 19.1 34.0 21.4 12.5 11.5 14.5 14.4 11.4 15.6 23.8 22.7 8.3 14.7 24.3 18.8 13.7 10.2 6.7 17.0 7.0 13.7 10.3 8.3 7.2 1.2 12.1 8.0 0.0 8.2 9.1 12.7 12.1 15.1 6.6 6.6 15.9 9.2 10.4 5.1 3.3 13.8 10.2 13.5 7.2 8.6 9.4 7.0 5.8 13.8 4.4 22.7 6.5 11.3 10.6 11.8 22.1 10.1 10.2 7.9 8.9 PRPF40B HYPC ENSG00000110844 "Pre-mRNA processing factor 40 homolog B" Q6NWY9 12 49568218-49644666 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 50.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038426, HPA038599" Enhanced Approved "Nucleoplasm,Nuclear bodies,Aggresome,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Aggresome, Cytosol" "HPA038426: AB_10674684, HPA038599: AB_10674689" "unprognostic (1.03e-1)" "unprognostic (2.32e-2)" "unprognostic (2.44e-3)" "unprognostic (2.36e-2)" "unprognostic (1.83e-1)" "unprognostic (2.47e-1)" "unprognostic (7.50e-6)" "unprognostic (1.02e-1)" "unprognostic (1.56e-1)" "unprognostic (1.45e-1)" "unprognostic (5.06e-3)" "unprognostic (3.31e-1)" "unprognostic (3.29e-3)" "unprognostic (3.23e-2)" "unprognostic (2.05e-1)" "unprognostic (3.01e-1)" "unprognostic (2.80e-2)" 6.2 12.3 16.6 5.8 12.6 1.5 9.7 15.6 20.3 12.8 8.8 11.7 13.2 5.5 14.7 13.8 8.5 15.2 8.3 16.3 12.6 10.6 12.9 5.5 6.6 4.1 13.3 14.5 22.0 10.3 30.3 17.5 11.8 12.0 11.0 4.9 10.4 14.2 17.9 22.3 13.1 4.7 10.4 9.6 7.3 8.9 25.1 12.9 2.3 19.4 5.5 5.2 9.9 9.1 1.8 1.5 0.0 0.4 3.1 3.5 0.8 5.2 7.6 7.7 7.5 6.4 4.1 7.2 4.3 6.0 4.6 2.3 8.8 11.7 4.2 9.2 5.6 6.5 3.1 4.6 14.8 2.4 3.1 1.8 4.4 2.8 3.1 8.1 1.4 5.9 5.9 12.6 4.6 16.7 9.9 3.6 8.7 2.1 2.3 5.4 4.9 1.0 3.0 3.2 5.9 2.9 3.7 1.2 3.3 9.7 4.8 8.2 9.9 3.4 9.6 5.2 7.4 18.3 4.0 1.5 2.8 11.5 3.7 1.8 5.4 3.0 1.6 8.5 1.1 2.6 0.0 0.4 0.0 2.4 0.3 3.5 1.1 2.3 1.1 0.6 1.8 2.7 2.9 0.0 3.1 0.2 1.5 1.0 0.8 16.6 12.6 15.6 20.3 12.6 10.6 13.3 14.5 12.0 12.9 11.9 16.9 0.5 8.0 3.2 18.1 1.0 5.1 29.4 22.7 17.4 9.8 17.6 6.6 11.1 22.9 3.5 0.7 0.0 9.6 6.1 6.7 4.7 2.3 2.6 4.6 11.1 7.5 8.0 1.0 17.7 10.9 1.4 3.3 8.2 2.7 9.4 7.1 0.0 11.3 4.4 17.6 12.9 7.2 50.8 17.7 5.3 22.1 2.5 4.5 3.9 PRPF8 "hPrp8, Prp8, PRPC8, RP13, SNRNP220" ENSG00000174231 "Pre-mRNA processing factor 8" Q6P2Q9 17 1650629-1684882 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Cancer-related genes, Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cone photoreceptor cells: 237.6;Rod photoreceptor cells: 234.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009941, CAB015457" Supported Enhanced Nucleoplasm NA NA 240000 Nucleoplasm "CAB009941: AB_2171185, CAB015457: AB_831685" "unprognostic (1.23e-1)" "unprognostic (1.49e-1)" "unprognostic (2.76e-2)" "unprognostic (3.13e-2)" "unprognostic (1.56e-1)" "unprognostic (4.94e-2)" "unprognostic (6.58e-2)" "unprognostic (1.56e-1)" "unprognostic (4.19e-2)" "unprognostic (1.77e-1)" "unprognostic (2.69e-2)" "unprognostic (1.04e-1)" "unprognostic (2.45e-3)" "unprognostic (2.00e-1)" "unprognostic (2.66e-1)" "unprognostic (1.16e-1)" "unprognostic (1.23e-1)" 30.0 37.4 23.1 25.7 40.3 39.0 26.2 43.1 57.2 31.2 28.0 36.5 29.5 19.4 35.6 28.4 29.4 35.4 28.1 34.0 22.2 24.3 23.3 35.5 27.9 30.7 21.3 23.9 47.7 25.9 66.5 45.4 31.1 32.5 30.7 27.2 45.1 30.5 33.1 46.3 30.7 27.5 36.3 17.9 34.1 26.4 45.9 19.6 63.4 30.9 22.2 41.2 32.2 27.9 14.5 20.1 10.0 12.3 10.1 17.1 5.4 18.7 41.0 24.7 20.0 21.4 16.8 19.9 14.1 18.0 27.6 22.4 38.0 9.3 27.6 15.0 25.3 21.4 26.2 60.2 24.2 31.9 17.4 38.7 21.9 35.6 32.5 12.5 25.9 24.4 15.9 15.5 35.6 24.9 14.3 24.2 19.6 21.6 22.0 19.8 20.5 18.7 32.4 17.0 16.2 15.2 36.7 14.1 13.2 10.6 20.9 12.7 19.1 28.4 10.3 13.9 21.6 15.2 17.4 22.3 16.9 14.5 25.7 32.1 8.0 8.3 19.5 14.0 18.8 20.8 10.0 6.5 6.7 15.7 8.9 17.1 13.3 14.7 15.7 9.7 14.5 13.0 16.4 7.1 10.1 12.3 20.1 14.8 5.4 23.1 40.3 43.1 57.2 22.2 24.3 21.3 23.9 32.5 19.6 56.6 70.5 44.4 25.5 26.8 124.9 33.1 56.0 34.8 56.9 45.4 237.6 37.8 6.6 32.2 9.5 43.6 40.3 23.3 35.2 22.6 31.1 25.8 50.8 34.2 34.2 68.3 35.1 36.8 40.3 8.9 67.9 32.5 18.6 38.7 37.2 56.5 35.5 37.6 49.1 15.8 234.7 71.1 36.0 74.1 83.3 24.3 33.1 38.7 42.3 27.4 PRPSAP2 PAP41 ENSG00000141127 "Phosphoribosyl pyrophosphate synthetase associated protein 2" O60256 17 18840085-18931287 "Predicted intracellular proteins" "Nucleotide biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SuSa: 82.5" "Low region specificity" "Detected in all" HPA021881 Approved Approved Nucleoplasm,Cytosol NA NA 28000 "Nucleoplasm, Cytosol" "HPA021881: AB_1855782" "unprognostic (1.34e-1)" "unprognostic (7.25e-2)" "unprognostic (6.78e-2)" "unprognostic (1.18e-1)" "unprognostic (2.01e-2)" "unprognostic (1.90e-1)" "unprognostic (3.25e-2)" "unprognostic (9.82e-2)" "unprognostic (1.36e-2)" "unprognostic (1.80e-1)" "prognostic favorable (3.71e-4)" "unprognostic (4.57e-2)" "unprognostic (8.98e-3)" "unprognostic (1.41e-1)" "unprognostic (1.80e-1)" "unprognostic (1.69e-1)" "unprognostic (9.08e-2)" 9.5 15.5 18.9 22.7 20.0 16.0 12.7 42.9 23.0 13.6 16.1 27.2 13.7 19.0 16.3 14.6 15.9 16.6 16.6 13.9 20.5 22.0 22.9 16.2 13.7 35.9 23.6 19.4 20.9 16.2 18.5 24.9 10.4 20.2 13.1 19.1 16.2 13.4 13.6 9.8 15.3 16.4 13.5 35.0 14.8 17.0 22.7 22.6 28.1 20.5 10.3 41.1 12.7 13.5 26.0 18.9 17.0 14.7 21.4 29.9 16.7 11.2 12.4 18.0 12.9 7.9 5.0 18.5 8.5 6.6 11.1 10.4 15.5 5.3 28.7 8.7 7.3 11.2 13.7 21.1 10.6 12.2 12.9 16.9 9.0 10.4 12.9 10.9 5.7 8.1 5.7 7.1 14.0 10.8 11.3 10.4 16.2 13.2 4.8 9.9 12.4 12.0 6.7 12.8 22.2 8.2 17.0 29.7 12.7 6.9 7.1 10.6 13.8 12.9 5.1 13.0 82.5 14.2 8.3 6.8 4.6 9.1 15.5 10.4 7.8 9.1 11.9 9.4 8.4 9.4 12.7 13.8 17.0 16.7 14.1 18.5 26.0 21.2 17.1 18.9 24.3 29.9 22.3 5.8 21.4 14.7 13.1 21.1 16.7 18.9 20.0 42.9 20.1 20.5 22.0 23.6 19.4 20.2 22.6 14.9 24.8 27.4 16.5 14.1 35.2 8.6 28.1 30.8 13.6 10.4 27.5 11.2 23.2 20.4 42.2 12.0 14.5 0.0 19.3 30.7 13.4 14.7 45.1 16.3 20.6 15.9 25.4 18.4 14.5 33.2 13.0 15.5 11.8 23.4 21.1 23.3 18.4 11.5 12.7 22.8 31.0 19.4 12.4 47.7 58.0 18.2 11.7 17.5 20.0 13.4 PRR13 "DKFZP564J157, FLJ23818" ENSG00000205352 "Proline rich 13" Q9NZ81 12 53441605-53446645 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 190.5" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 1157.2;Enterocytes: 1047.2;Proximal tubular cells: 808.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA039396, HPA046219" Uncertain Supported Nucleoplasm NA Yes Nucleoplasm "HPA039396: AB_2676484, HPA046219: AB_10963936" "unprognostic (1.09e-1)" "prognostic favorable (9.08e-4)" "unprognostic (1.15e-1)" "unprognostic (3.26e-1)" "unprognostic (8.97e-3)" "unprognostic (4.88e-3)" "unprognostic (1.86e-3)" "unprognostic (7.23e-2)" "unprognostic (1.23e-1)" "unprognostic (3.49e-1)" "unprognostic (1.41e-2)" "unprognostic (5.41e-2)" "unprognostic (6.81e-3)" "unprognostic (1.81e-1)" "unprognostic (1.08e-1)" "unprognostic (2.34e-1)" "prognostic favorable (7.55e-4)" 31.9 48.0 29.7 38.3 36.4 64.0 29.3 19.5 38.3 23.8 81.1 27.0 26.6 117.5 24.2 34.4 31.2 35.0 40.1 31.1 30.9 30.1 88.2 51.4 35.5 49.3 34.3 39.2 30.2 29.3 16.1 26.5 32.5 31.3 30.0 70.6 27.1 26.1 44.9 33.3 22.9 110.7 24.5 32.5 53.6 51.9 15.7 28.7 41.6 34.3 21.6 45.6 35.8 25.3 79.6 60.1 190.5 86.5 50.8 72.9 117.1 25.3 51.2 12.7 14.1 21.8 27.9 27.8 21.2 31.0 27.3 26.7 92.6 59.7 39.9 72.5 30.7 33.6 22.9 25.8 33.5 33.5 38.5 19.2 58.1 28.2 43.4 53.8 86.6 80.1 36.9 34.0 51.0 35.1 29.5 29.1 24.1 49.9 40.1 42.8 68.7 48.5 85.1 20.9 32.4 34.7 43.0 10.8 42.4 60.7 44.0 11.4 8.4 31.5 45.1 38.0 27.4 63.6 67.2 29.9 18.5 18.2 33.0 20.8 29.8 36.2 58.5 24.8 52.5 34.8 63.6 75.8 142.7 50.7 84.6 49.4 79.6 56.9 53.8 60.1 70.8 53.5 57.5 190.5 50.8 86.5 49.7 72.9 117.1 29.7 36.4 19.5 38.3 30.9 30.1 34.3 39.2 31.3 28.7 77.4 108.7 131.7 128.0 42.2 6.7 20.7 178.3 136.5 72.8 177.9 27.5 204.3 1157.2 205.4 8.6 70.6 1047.2 0.0 224.1 275.8 70.2 205.1 179.3 136.2 316.3 17.5 163.2 59.5 331.1 4.2 53.8 241.9 102.9 348.1 279.4 63.8 250.2 733.0 43.2 808.7 20.6 77.6 60.4 33.7 20.1 48.9 243.4 192.8 262.9 167.7 PRR14 MGC3121 ENSG00000156858 "Proline rich 14" Q9BWN1 16 30650717-30656440 "Predicted intracellular proteins" Myogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052022, HPA060265, HPA075914" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA052022: AB_2681698, HPA060265: AB_2684236, HPA075914: " "unprognostic (1.57e-1)" "prognostic favorable (8.19e-5)" "unprognostic (3.74e-3)" "unprognostic (1.42e-2)" "unprognostic (5.18e-2)" "unprognostic (5.44e-2)" "unprognostic (5.28e-3)" "unprognostic (1.42e-2)" "unprognostic (5.75e-2)" "unprognostic (1.82e-2)" "unprognostic (1.61e-2)" "unprognostic (5.69e-2)" "unprognostic (1.83e-2)" "unprognostic (3.81e-2)" "unprognostic (4.54e-1)" "unprognostic (9.10e-2)" "unprognostic (2.31e-3)" 17.7 13.8 15.1 18.2 14.1 24.4 16.1 27.4 17.2 19.5 18.8 19.2 16.4 19.3 21.7 11.1 18.1 17.2 16.7 10.1 14.5 9.1 16.5 15.1 15.8 18.9 16.4 7.8 18.2 19.6 18.6 15.3 13.9 10.6 17.8 9.8 14.8 22.1 22.6 13.6 24.5 18.4 15.6 13.6 23.4 23.2 9.3 13.7 31.2 17.7 10.0 19.3 16.4 19.6 8.8 5.8 18.1 8.2 6.1 8.4 4.5 8.7 10.9 9.2 7.1 8.1 5.6 6.2 9.3 5.3 9.2 8.3 5.0 7.3 15.1 8.0 5.6 4.6 8.9 7.1 10.3 2.7 21.4 20.8 8.7 11.2 9.9 11.5 7.2 20.9 5.3 11.0 6.0 5.5 9.8 11.3 4.0 11.3 9.9 4.8 21.8 16.3 12.5 2.9 5.1 5.8 12.3 4.2 20.7 5.3 3.7 7.0 16.5 3.6 12.7 8.2 1.9 15.5 4.1 8.2 7.9 8.8 7.3 9.3 23.2 14.7 9.0 5.3 15.8 6.9 8.6 4.9 17.8 8.4 4.8 6.4 6.3 6.9 8.4 4.6 8.8 6.4 6.5 18.1 6.1 8.2 5.8 8.2 4.5 15.1 14.1 27.4 17.2 14.5 9.1 16.4 7.8 10.6 13.7 8.9 7.2 15.2 22.4 20.3 13.4 5.0 25.5 6.7 5.7 12.2 13.7 12.9 13.3 19.0 5.3 18.6 21.3 0.0 19.2 12.8 16.3 19.2 11.5 9.0 16.1 1.6 12.1 19.6 12.7 1.8 17.8 17.0 8.5 37.9 14.8 12.0 18.0 14.0 19.8 11.8 12.8 19.4 20.8 17.0 22.6 20.1 11.8 24.9 16.6 14.9 PRR14L "C22orf30, MGC50372" ENSG00000183530 "Proline rich 14 like" Q5THK1 22 31676256-31750140 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062645 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA062645: AB_2684817" "unprognostic (2.87e-1)" "unprognostic (1.34e-1)" "unprognostic (3.36e-2)" "unprognostic (2.79e-1)" "unprognostic (2.42e-2)" "unprognostic (2.13e-1)" "unprognostic (1.37e-2)" "unprognostic (4.10e-2)" "unprognostic (8.86e-3)" "unprognostic (1.80e-1)" "unprognostic (2.10e-1)" "unprognostic (4.90e-2)" "prognostic favorable (3.00e-4)" "unprognostic (1.73e-1)" "unprognostic (1.95e-1)" "unprognostic (7.48e-2)" "unprognostic (4.14e-3)" 10.9 10.6 9.8 13.9 12.0 15.1 10.8 18.2 14.0 9.7 11.9 9.9 8.9 8.1 10.0 8.4 14.4 10.4 8.3 9.0 10.1 7.2 8.6 9.8 10.3 12.0 9.4 9.3 13.9 9.7 18.7 21.5 13.5 11.2 8.7 13.6 7.6 11.6 11.9 8.0 13.0 16.4 9.8 10.6 12.8 11.1 11.0 11.8 20.3 10.3 5.8 13.3 11.1 12.1 4.2 4.4 10.0 12.2 3.2 3.8 1.9 9.5 9.3 10.2 10.0 9.4 8.8 10.6 5.2 6.3 8.3 7.8 8.5 3.5 10.9 5.1 10.3 6.2 9.5 19.9 7.9 8.7 14.5 8.4 6.6 7.8 6.7 8.0 20.3 14.3 7.8 8.0 11.5 10.0 7.2 11.5 8.7 9.9 7.3 8.6 9.1 7.1 6.5 11.7 13.8 3.6 10.8 16.3 6.3 6.9 11.0 14.1 8.3 12.3 7.4 6.9 12.6 6.6 8.2 10.9 5.1 10.3 6.7 7.2 11.4 13.4 8.4 7.9 10.0 7.8 9.2 5.3 6.1 3.8 6.4 3.3 3.9 2.3 3.1 3.9 4.2 3.5 3.5 10.0 3.2 12.2 4.4 3.0 1.9 9.8 12.0 18.2 14.0 10.1 7.2 9.4 9.3 11.2 11.8 20.8 16.9 13.0 8.1 6.6 11.4 17.3 15.3 21.4 35.2 10.4 19.6 14.7 8.3 16.4 4.8 9.5 22.2 0.0 14.8 12.9 10.6 11.8 25.5 17.0 12.5 14.3 9.8 12.9 18.1 4.0 13.8 15.1 1.7 15.4 18.6 13.8 18.9 14.0 7.8 9.2 11.0 12.9 7.2 11.6 14.0 8.4 18.5 10.2 16.9 15.9 PRR16 DSC54 ENSG00000184838 "Proline rich 16" Q569H4 5 120464278-120687332 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 13.7;Early spermatids: 13.9;Fibroblasts: 10.5;Horizontal cells: 14.3;Smooth muscle cells: 8.3" "Cancer enriched" "Detected in many" 5 "prostate cancer: 13.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 24.5;BJ hTERT+: 25.5;fHDF/TERT166: 30.7;HSkMC: 19.7;hTERT-RPE1: 32.1;LHCN-M2: 29.7;U-138 MG: 36.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049254 Approved Approved Nucleoplasm,Midbody,Cytosol Yes No Nucleoplasm "Midbody, Cytosol" "HPA049254: AB_2680693" "unprognostic (1.71e-1)" "unprognostic (3.87e-2)" "unprognostic (3.45e-1)" "unprognostic (1.20e-1)" "unprognostic (6.61e-2)" "unprognostic (7.07e-2)" "unprognostic (1.53e-1)" "unprognostic (2.42e-2)" "unprognostic (8.33e-2)" "unprognostic (4.40e-2)" "unprognostic (2.76e-2)" "unprognostic (2.06e-1)" "unprognostic (2.54e-8)" "unprognostic (3.05e-2)" "unprognostic (9.13e-2)" "unprognostic (2.65e-1)" "unprognostic (2.38e-3)" 11.6 4.4 4.7 7.0 4.9 0.9 11.3 21.1 7.6 20.3 5.2 2.2 1.8 2.9 15.7 4.6 4.1 5.8 8.2 16.9 4.7 3.8 3.6 1.5 10.0 3.1 2.3 4.9 6.9 2.4 1.8 2.5 12.8 9.6 10.9 6.7 1.4 3.2 3.9 30.4 4.4 4.9 11.6 3.0 4.3 4.3 3.2 1.6 0.0 4.9 14.2 1.8 8.7 23.2 0.5 1.4 0.7 3.2 0.2 0.2 1.0 1.0 0.0 2.5 0.0 7.0 24.5 0.0 11.1 25.5 15.9 12.2 0.0 0.0 0.0 0.0 30.7 2.8 0.0 2.4 0.2 16.8 0.0 0.6 0.0 0.3 0.0 6.7 0.0 0.0 19.7 2.7 4.7 15.0 32.1 0.5 0.0 0.0 0.0 29.7 0.0 0.0 0.0 0.2 0.0 0.4 0.0 1.9 0.0 1.3 0.0 0.0 4.9 0.0 0.0 0.3 2.0 0.0 0.0 0.1 36.7 4.2 1.1 5.7 0.1 0.0 0.0 2.1 0.0 1.2 0.5 3.2 0.2 0.1 1.8 0.1 0.2 0.1 0.0 1.4 0.5 0.1 0.2 0.7 0.2 1.1 0.5 0.1 1.0 4.7 4.9 21.1 7.6 4.7 3.8 2.3 4.9 9.6 1.6 0.0 0.0 0.0 6.4 1.1 2.0 2.5 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.1 13.9 0.1 0.0 0.0 0.0 0.0 10.5 6.0 0.0 0.0 0.5 14.3 0.0 0.6 1.2 7.4 2.6 1.2 1.7 0.0 0.0 1.8 0.2 0.0 0.0 0.0 0.5 0.0 8.3 0.6 1.5 0.5 0.5 0.0 0.0 0.5 PRR19 MGC70924 ENSG00000188368 "Proline rich 19" A6NJB7 19 42302098-42310821 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 25.8" "Group enriched" "Detected in some" 8 "Early spermatids: 22.2;Late spermatids: 45.8;Spermatocytes: 32.9;Spermatogonia: 25.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA070350 Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Mitotic chromosome,Mitochondria" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" "Nucleoplasm, Nuclear bodies, Mitochondria" "HPA070350: AB_2686259" "unprognostic (2.05e-1)" "unprognostic (8.03e-3)" "unprognostic (4.02e-2)" "unprognostic (7.55e-3)" "unprognostic (7.33e-2)" "unprognostic (1.08e-2)" "unprognostic (2.44e-5)" "unprognostic (3.57e-1)" "unprognostic (1.92e-2)" "unprognostic (8.10e-3)" "unprognostic (3.85e-2)" "unprognostic (2.77e-1)" "unprognostic (2.87e-3)" "unprognostic (4.21e-1)" "unprognostic (7.26e-2)" "unprognostic (1.78e-1)" "unprognostic (4.36e-2)" 0.5 1.0 2.2 1.3 5.8 3.5 0.8 2.6 2.9 1.0 0.5 0.7 0.6 0.7 0.8 0.8 1.0 0.9 1.1 0.3 1.8 1.6 0.7 0.9 0.6 0.9 0.9 0.8 0.9 0.5 1.0 0.8 1.2 1.7 0.9 0.5 0.6 1.0 0.8 0.6 1.3 0.8 0.7 1.6 0.7 0.6 25.8 1.0 1.3 0.8 0.3 0.9 0.8 0.5 3.1 2.3 2.8 2.2 2.6 2.9 1.3 3.9 6.1 3.3 4.5 0.2 0.3 3.5 2.3 1.8 5.4 5.1 2.5 3.8 0.7 7.0 1.9 4.0 1.3 1.6 1.7 1.2 2.6 1.5 4.2 3.6 1.5 1.2 1.1 2.6 1.8 2.4 3.5 0.7 1.1 0.9 4.4 2.2 2.0 2.4 9.3 3.9 2.0 3.5 3.7 0.0 1.6 0.6 0.4 1.8 3.4 7.6 3.0 3.2 2.3 0.9 1.1 3.0 1.5 1.2 3.6 5.3 0.9 3.1 0.4 1.4 1.2 3.8 2.9 3.6 2.8 2.2 0.6 2.4 1.8 0.8 3.1 1.7 2.3 2.3 2.2 2.3 1.3 2.4 2.6 0.7 1.5 2.9 1.3 2.2 5.8 2.6 2.9 1.8 1.6 0.9 0.8 1.7 1.0 0.0 0.3 0.0 0.7 0.6 0.4 0.4 0.0 4.0 0.0 0.0 0.0 0.7 1.7 0.9 22.2 0.5 0.4 0.0 1.0 0.6 0.4 0.4 0.0 0.2 0.7 1.6 0.0 0.0 0.0 45.8 1.1 0.0 0.0 0.0 0.0 0.0 0.6 0.3 1.1 0.5 0.1 0.0 0.6 32.9 25.6 0.6 0.5 0.0 0.5 0.4 PRR22 MGC24975 ENSG00000212123 "Proline rich 22" Q8IZ63 19 5782960-5784765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "testis: 82.5" "Group enriched" "Detected in many" 13 "Early spermatids: 151.0;Late spermatids: 60.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 16.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA044157 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA044157: AB_10960694" "unprognostic (8.09e-2)" "unprognostic (1.53e-3)" "unprognostic (5.19e-3)" "unprognostic (7.53e-2)" "unprognostic (1.25e-1)" "unprognostic (1.80e-1)" "unprognostic (3.20e-2)" "unprognostic (2.89e-2)" "unprognostic (1.20e-1)" "unprognostic (3.77e-2)" "unprognostic (3.42e-3)" "unprognostic (9.37e-3)" "unprognostic (4.18e-2)" "unprognostic (9.93e-4)" "unprognostic (1.07e-1)" "unprognostic (5.07e-1)" "unprognostic (2.79e-3)" 1.1 1.0 1.1 1.7 1.5 2.0 1.1 1.1 1.7 1.1 1.3 1.2 1.1 3.1 1.1 1.1 1.6 2.5 1.1 1.1 1.1 0.7 2.4 4.4 1.1 1.5 1.1 1.1 1.1 2.7 1.0 1.2 1.1 1.1 2.7 0.3 1.1 3.2 1.1 1.1 5.4 3.3 1.1 1.1 2.7 2.4 82.5 1.1 1.1 2.3 1.1 1.1 1.1 1.1 0.2 0.0 0.0 0.2 0.0 0.9 0.1 1.8 3.2 1.4 6.6 0.0 0.2 6.6 1.3 0.6 1.0 1.6 3.2 1.8 2.9 3.7 0.2 0.7 2.4 1.0 1.3 0.2 4.5 10.3 1.4 1.4 1.1 0.6 3.1 16.1 0.8 1.1 1.4 0.4 0.1 0.2 3.6 7.2 0.0 0.8 6.9 3.6 3.8 8.3 0.3 3.3 3.5 1.2 4.6 0.3 2.1 1.8 3.3 0.3 2.4 3.7 0.3 2.8 2.5 1.0 2.5 6.8 8.7 1.6 9.4 7.3 5.6 0.2 6.2 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.9 0.4 0.0 0.0 0.2 0.0 0.0 0.1 1.1 1.5 1.1 1.1 1.1 0.7 1.1 1.1 1.1 1.1 3.0 0.3 0.8 0.4 0.2 5.3 0.3 2.5 0.0 2.3 3.5 0.0 1.9 0.0 0.7 151.0 0.4 2.6 0.0 0.6 0.7 0.8 1.1 0.0 2.1 0.9 4.8 2.4 0.6 1.0 60.2 2.0 0.0 0.0 0.0 2.6 2.2 0.7 1.5 0.4 1.0 5.3 6.5 0.0 8.3 6.6 1.0 1.5 0.0 2.7 0.5 PRR23A ENSG00000206260 "Proline rich 23A" A6NEV1 3 139005468-139006268 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 8 "testis: 6.1" "Cell type enriched" "Detected in single" 6 "Spermatocytes: 1.1" "Cancer enriched" "Detected in single" 17 "testis cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 2.8" HPA047473 Uncertain Approved "Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" NA NA "Nucleoplasm, Microtubules" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA047473: AB_2680062" "unprognostic (1.48e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 PRR23B FLJ46116 ENSG00000184814 "Proline rich 23B" Q6ZRT6 3 139019031-139020926 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 36 "testis: 4.7" "Group enriched" "Detected in some" 13 "Spermatocytes: 6.6;Spermatogonia: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047473 Uncertain Uncertain "Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" NA NA "Nucleoplasm, Microtubules" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA047473: AB_2680062" "unprognostic (7.57e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 4.1 0.0 0.0 0.0 0.0 0.1 PRR23C FLJ46210 ENSG00000233701 "Proline rich 23C" Q6ZRP0 3 139042102-139044892 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "blood: 3.4;testis: 4.3" "Cell type enhanced" "Detected in some" 16 "Early spermatids: 3.0;Late spermatids: 1.5;Spermatocytes: 1.4;Spermatogonia: 2.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in single" "HeLa: 1.2" HPA047473 Uncertain Approved "Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" NA NA "Nucleoplasm, Microtubules" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA047473: AB_2680062" "unprognostic (1.00e-1)" 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.1 4.3 0.0 0.0 0.0 0.0 1.0 0.4 3.4 0.4 0.8 0.4 0.2 0.1 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.3 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.3 0.9 1.2 0.0 0.3 0.6 0.3 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.3 0.0 0.3 0.2 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.2 0.3 0.2 0.0 0.1 0.2 0.0 0.1 0.1 0.3 0.1 0.0 0.1 0.1 3.4 0.4 0.6 0.2 0.2 0.2 0.3 0.3 0.1 0.0 1.0 0.3 0.4 2.2 0.8 0.1 0.4 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.5 0.1 0.0 0.0 0.0 0.0 PRR3 "CAT56, Em:AB014077.1, Em:AB023052.2" ENSG00000204576 "Proline rich 3" P79522 6 30556886-30563723 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 10.0;HAP1: 12.6;JURKAT: 8.8;U-266/84: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064061 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA064061: AB_2685185" "unprognostic (3.76e-2)" "unprognostic (6.72e-3)" "unprognostic (8.90e-2)" "unprognostic (2.10e-3)" "unprognostic (1.92e-3)" "unprognostic (1.39e-1)" "unprognostic (1.65e-3)" "unprognostic (1.25e-2)" "unprognostic (3.73e-2)" "prognostic favorable (6.49e-6)" "prognostic favorable (5.61e-5)" "unprognostic (4.71e-2)" "prognostic unfavorable (7.84e-7)" "unprognostic (2.80e-1)" "unprognostic (2.82e-1)" "unprognostic (3.66e-1)" "unprognostic (1.21e-3)" 7.6 5.6 9.7 5.5 7.4 4.0 3.5 15.0 13.8 5.4 4.5 5.6 3.1 2.5 7.3 15.3 3.6 6.2 4.0 3.2 10.1 12.1 4.3 3.8 4.9 6.1 5.9 7.6 13.5 5.4 10.6 8.8 3.4 8.0 4.4 5.3 6.9 2.6 6.9 3.1 6.5 3.4 3.8 4.6 5.0 5.9 8.6 5.7 11.1 4.9 1.7 5.6 6.4 4.0 2.0 2.3 1.5 1.2 1.3 1.9 0.4 0.6 1.6 5.3 10.0 2.6 0.9 0.0 0.0 0.0 0.0 0.0 4.6 0.5 4.6 3.9 0.9 3.5 0.6 12.6 1.0 0.0 2.7 4.5 6.7 0.0 0.0 0.0 0.0 0.0 0.8 0.1 3.1 0.0 0.0 0.0 8.8 7.3 0.0 1.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.3 0.2 0.0 6.8 2.3 0.6 0.0 0.0 0.0 3.1 0.7 4.0 0.0 0.0 0.0 7.6 8.5 4.4 0.0 2.6 2.9 1.5 1.2 0.3 0.5 0.3 1.0 1.0 1.6 1.2 1.0 2.0 0.9 1.9 1.0 1.3 0.6 2.3 0.0 0.4 9.7 7.4 15.0 13.8 10.1 12.1 5.9 7.6 8.0 5.7 8.9 22.1 16.0 6.3 5.0 9.0 2.4 7.6 14.7 13.6 3.5 13.7 12.1 6.6 4.0 0.6 5.0 7.9 0.0 8.1 6.2 9.1 4.6 11.5 3.9 7.0 6.4 7.5 9.2 6.2 1.8 9.5 7.7 10.1 10.0 7.6 8.0 4.9 5.3 9.6 8.2 18.5 6.5 7.2 8.1 5.9 5.0 8.2 10.2 6.5 3.4 PRR36 ENSG00000183248 "Proline rich 36" Q9H6K5 19 7868719-7874379 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 20.5;pituitary gland: 6.5" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 12.4;Cone photoreceptor cells: 11.8;Horizontal cells: 9.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 22.3;SCLC-21H: 6.5;SH-SY5Y: 14.6;T-47d: 7.3" "Low region specificity" "Detected in all" HPA062741 Uncertain Approved "Nucleoplasm,Nuclear speckles,Golgi apparatus" Yes No "Golgi apparatus" "Nucleoplasm, Nuclear speckles" "HPA062741: AB_2684860" "unprognostic (3.15e-2)" "unprognostic (1.02e-1)" "unprognostic (6.23e-2)" "unprognostic (5.61e-2)" "unprognostic (1.72e-1)" "unprognostic (1.20e-2)" "unprognostic (9.62e-2)" "unprognostic (3.46e-3)" "unprognostic (1.18e-1)" "unprognostic (1.15e-3)" "unprognostic (1.75e-2)" "unprognostic (2.99e-1)" "unprognostic (5.69e-3)" "unprognostic (7.89e-2)" "prognostic favorable (7.74e-4)" "unprognostic (3.56e-1)" "unprognostic (8.52e-3)" 0.4 2.0 11.8 0.5 11.4 0.3 1.5 12.0 20.5 0.7 0.4 0.8 0.0 0.8 1.2 0.8 0.3 1.1 0.5 0.3 8.0 1.1 0.4 1.3 0.4 0.0 10.6 0.9 3.2 1.6 6.5 0.3 5.5 2.5 0.4 0.5 3.0 1.0 0.3 0.8 0.4 0.4 0.7 0.4 1.4 0.7 1.2 0.0 1.0 0.0 0.3 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.1 0.7 5.3 4.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.1 2.3 0.0 1.5 0.0 0.5 0.1 4.1 0.0 0.0 0.0 5.2 0.0 0.2 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 2.6 0.1 0.1 0.0 2.3 0.2 0.2 2.0 0.3 0.4 22.3 0.0 0.2 3.0 4.3 6.5 14.6 0.0 0.2 0.0 0.4 7.3 0.0 0.0 0.0 2.7 0.1 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 12.4 0.8 2.5 0.0 0.0 5.2 11.8 0.2 5.0 2.7 5.2 0.0 0.0 0.0 0.8 0.2 0.0 1.8 0.0 0.2 0.1 9.5 3.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 4.2 0.7 0.0 0.0 1.0 4.3 0.0 0.3 0.2 0.7 0.0 0.2 0.0 0.4 1.0 PRR7 MGC10772 ENSG00000131188 "Proline rich 7, synaptic" Q8TB68 5 177446445-177456286 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5" "Cell type enhanced" "Detected in many" 6 "Intestinal endocrine cells: 41.2;Suprabasal keratinocytes: 58.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 17.4;SK-MEL-30: 16.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046636 Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA046636: AB_2679730" "unprognostic (3.69e-1)" "unprognostic (9.07e-2)" "unprognostic (1.16e-1)" "unprognostic (3.48e-2)" "unprognostic (4.08e-2)" "unprognostic (7.94e-3)" "prognostic unfavorable (1.50e-4)" "unprognostic (1.55e-1)" "unprognostic (1.01e-1)" "unprognostic (4.75e-2)" "unprognostic (5.86e-2)" "unprognostic (2.76e-2)" "prognostic unfavorable (1.98e-4)" "unprognostic (8.84e-3)" "unprognostic (2.22e-1)" "unprognostic (3.76e-2)" "unprognostic (1.69e-1)" 1.9 2.4 12.5 3.2 22.0 15.1 1.7 4.1 28.5 1.1 2.9 9.8 0.0 2.9 1.7 1.3 1.9 3.2 1.9 1.1 14.1 7.6 1.5 2.2 2.0 3.6 4.8 8.4 1.2 4.0 2.6 6.2 1.3 6.2 2.0 1.4 4.7 5.2 1.5 1.7 8.8 2.6 1.2 4.4 4.9 4.6 3.2 4.6 1.2 1.2 0.8 2.3 1.5 0.9 3.2 3.0 10.8 0.6 2.0 7.3 1.5 7.2 2.8 0.8 5.7 0.0 0.4 2.5 3.4 0.6 1.0 1.3 0.6 3.9 7.0 9.0 0.5 2.9 6.1 0.4 3.1 0.4 6.1 9.0 2.1 2.7 2.1 0.6 4.2 5.1 0.6 1.3 0.4 0.2 0.9 0.4 2.7 1.1 5.0 0.9 9.7 3.5 10.7 1.4 1.1 17.4 9.9 2.6 7.0 1.2 0.6 14.1 10.1 1.3 3.4 16.1 0.0 3.0 0.6 2.6 5.7 9.7 5.1 8.2 2.7 1.5 3.4 5.6 6.8 4.1 2.4 0.1 10.8 3.0 0.5 7.3 2.1 3.4 5.1 0.1 3.2 3.2 4.1 4.8 2.0 0.6 3.0 2.5 1.5 12.5 22.0 4.1 28.5 14.1 7.6 4.8 8.4 6.2 4.6 3.0 0.0 13.7 25.0 38.5 12.6 1.2 10.2 0.0 1.2 7.0 0.0 0.9 8.3 10.1 10.8 4.5 7.1 0.0 9.4 0.7 3.9 23.6 27.5 2.8 1.4 6.4 41.2 1.8 2.2 9.7 0.9 2.9 27.0 1.0 9.4 15.2 9.0 7.8 2.1 9.8 13.1 0.0 9.8 3.3 11.7 58.5 1.1 25.5 9.1 15.4 PRR9 ENSG00000203783 "Proline rich 9" Q5T870 1 153217584-153219317 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "skin 1: 33.1;tongue: 13.0" "Group enriched" "Detected in some" 16 "Early spermatids: 3.6;Late spermatids: 8.1;Syncytiotrophoblasts: 7.4" "Group enriched" "Detected in many" 6 "cervical cancer: 4.2;endometrial cancer: 4.1;head and neck cancer: 11.8;melanoma: 3.4;urothelial cancer: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "SuSa: 20.7" "Not detected" "Not detected" HPA027714 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA Cytosol "Nucleoplasm, Vesicles" "HPA027714: AB_10602194" "unprognostic (1.45e-1)" "unprognostic (1.46e-1)" "unprognostic (4.17e-1)" "unprognostic (3.48e-1)" "unprognostic (7.02e-2)" "unprognostic (8.27e-2)" "unprognostic (1.89e-1)" "unprognostic (1.23e-2)" 1.0 0.0 0.0 0.0 0.0 1.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.1 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.6 0.3 13.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 20.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 PRRC2A "BAT2, D6S51E, G2" ENSG00000204469 "Proline rich coiled-coil 2A" P48634 6 31620720-31637771 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 26.4;HEK 293: 48.2;U-266/70: 24.8;U-266/84: 26.3;U-698: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026383, HPA046791, HPA066501" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "CAB026383: , HPA046791: AB_2679809, HPA066501: AB_2732747" "unprognostic (2.07e-1)" "unprognostic (6.84e-2)" "unprognostic (3.82e-1)" "unprognostic (2.25e-3)" "unprognostic (5.04e-2)" "unprognostic (4.63e-1)" "unprognostic (2.42e-3)" "unprognostic (2.09e-1)" "unprognostic (3.07e-1)" "unprognostic (1.14e-1)" "unprognostic (8.29e-3)" "unprognostic (2.38e-1)" "unprognostic (2.75e-1)" "unprognostic (1.01e-1)" "unprognostic (1.57e-1)" "unprognostic (5.40e-2)" "unprognostic (3.10e-1)" 10.9 18.4 20.7 28.9 22.1 5.0 12.2 25.2 29.1 15.0 24.6 18.4 11.9 4.8 19.7 51.5 47.2 32.3 13.8 24.2 18.4 13.2 16.0 10.2 41.7 14.9 14.3 20.4 29.3 12.2 4.8 18.5 8.6 15.9 30.9 7.1 15.0 12.3 15.9 35.1 28.8 23.0 12.8 11.5 43.5 34.6 46.3 16.7 27.1 16.8 10.4 14.4 16.0 13.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.1 0.0 0.0 11.9 11.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 7.5 13.4 0.0 0.0 0.0 26.4 0.0 0.0 48.2 0.1 0.1 0.0 0.0 0.1 0.0 5.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.7 0.0 0.0 24.8 26.3 25.1 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.7 22.1 25.2 29.1 18.4 13.2 14.3 20.4 15.9 16.7 0.0 5.6 32.9 25.1 29.2 36.4 5.9 22.9 4.0 3.4 38.4 56.9 23.5 5.0 21.7 40.5 23.2 27.9 0.0 22.0 18.4 28.7 31.4 10.4 23.6 28.8 35.0 37.4 33.2 22.9 13.8 45.5 23.5 18.6 25.2 37.1 21.4 27.4 37.9 42.1 12.2 34.7 19.4 30.3 66.6 44.4 24.8 15.3 26.2 41.7 23.6 PRRG1 PRGP1 ENSG00000130962 "Proline rich and Gla domain 1" O14668 X 37349275-37457295 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.4" "Cell type enhanced" "Detected in many" 5 "Collecting duct cells: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 39.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078129 Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA078129: AB_2686878" "unprognostic (8.82e-2)" "prognostic unfavorable (4.65e-4)" "unprognostic (8.34e-2)" "unprognostic (2.08e-3)" "unprognostic (1.92e-1)" "unprognostic (5.11e-3)" "unprognostic (2.24e-2)" "unprognostic (7.23e-3)" "unprognostic (1.01e-2)" "unprognostic (1.74e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (8.21e-2)" "prognostic favorable (2.05e-7)" "unprognostic (1.43e-2)" "unprognostic (1.81e-1)" "unprognostic (1.08e-2)" "unprognostic (1.48e-1)" 11.6 5.5 12.0 3.1 22.0 0.7 5.8 2.6 18.7 6.7 5.7 35.9 4.6 4.1 6.2 2.5 5.9 4.0 12.4 8.5 17.9 10.7 14.9 10.7 6.3 2.5 31.0 9.9 6.2 2.6 1.2 2.3 10.6 21.3 5.1 6.0 3.0 3.9 11.6 19.3 3.1 4.3 7.5 43.4 4.0 3.4 2.4 23.7 0.0 11.6 2.9 1.6 5.9 4.5 0.6 0.2 2.6 1.7 0.2 0.4 0.1 15.0 3.4 2.8 2.8 9.4 7.6 1.2 6.4 8.6 2.3 4.0 8.2 9.7 0.0 11.1 5.0 4.3 4.9 7.6 4.8 4.0 0.0 2.4 2.7 3.6 2.8 11.5 0.0 3.5 11.8 4.0 4.5 3.8 4.6 11.9 0.0 1.2 0.0 8.0 1.1 0.0 0.0 3.3 2.4 7.2 0.0 6.2 0.0 39.4 0.7 0.0 0.0 4.7 7.5 2.8 7.7 0.0 1.6 8.5 3.6 2.2 7.0 1.9 0.0 0.0 0.0 3.6 0.0 3.3 2.6 1.7 0.1 0.2 0.5 0.2 0.6 0.1 0.3 0.1 0.4 0.2 0.4 0.8 0.2 0.2 0.2 0.2 0.1 12.0 22.0 2.6 13.9 17.9 10.7 31.0 9.9 21.3 23.7 6.0 3.4 0.0 4.2 10.1 1.8 7.6 12.7 0.0 0.0 31.4 0.0 5.5 6.6 5.9 0.6 16.5 5.6 0.0 2.7 11.7 8.7 5.9 1.1 15.3 3.8 17.5 2.9 14.7 5.1 0.0 4.4 1.4 3.3 1.0 4.8 1.9 12.9 8.0 2.5 7.3 0.2 6.5 5.6 0.9 3.6 5.5 8.7 0.0 4.1 7.4 PRRG2 PRGP2 ENSG00000126460 "Proline rich and Gla domain 2" O14669 19 49580646-49591015 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 38.8;Paneth cells: 31.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 11.7;OE19: 13.8;RT4: 9.0;SK-BR-3: 10.5;T-47d: 11.4;U-266/84: 13.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010702 Approved Approved Nucleoplasm,Nucleoli,Cytosol No NA "Nucleoplasm, Nucleoli" Cytosol "HPA010702: AB_1079693" "unprognostic (2.25e-2)" "unprognostic (1.04e-1)" "unprognostic (3.46e-2)" "unprognostic (1.04e-2)" "unprognostic (1.04e-1)" "unprognostic (7.55e-2)" "unprognostic (5.60e-1)" "unprognostic (1.55e-1)" "unprognostic (1.14e-1)" "unprognostic (1.77e-1)" "unprognostic (1.51e-1)" "unprognostic (1.67e-1)" "prognostic favorable (3.82e-9)" "unprognostic (4.89e-2)" "unprognostic (1.46e-1)" "unprognostic (6.58e-3)" "unprognostic (3.68e-2)" 0.9 0.4 0.5 1.1 0.6 0.0 4.8 1.1 1.3 4.0 14.3 0.4 17.5 8.3 1.9 9.6 13.7 3.3 9.8 0.7 0.5 0.4 15.0 12.1 5.2 0.4 0.7 0.4 1.9 13.4 13.8 16.1 8.6 0.7 5.4 5.3 0.7 24.9 14.6 1.2 10.1 23.2 1.4 0.5 1.0 7.1 1.7 0.4 2.1 21.9 9.8 7.8 4.2 4.2 1.2 4.2 2.1 0.9 0.0 1.4 0.4 8.4 0.3 0.2 0.7 1.0 0.0 3.6 0.2 0.0 0.3 0.3 1.7 11.7 0.5 1.3 0.1 0.2 6.8 0.2 6.6 0.3 0.8 0.9 0.4 0.5 0.6 0.7 0.3 0.9 0.7 5.8 0.2 0.2 0.6 2.6 0.7 0.2 0.6 0.0 1.8 0.1 0.7 0.5 13.8 1.1 0.2 0.3 6.6 5.2 9.0 1.9 0.2 1.0 10.5 0.1 0.9 11.4 0.1 0.4 0.7 0.5 0.3 0.1 4.1 13.7 0.4 0.1 0.2 0.3 0.0 0.9 0.4 1.4 0.1 0.7 1.2 0.6 0.6 0.1 0.7 0.8 0.7 2.1 0.0 0.7 4.2 0.6 0.4 0.5 0.6 1.1 1.3 0.5 0.4 0.7 0.4 0.7 0.4 6.0 12.0 1.3 12.1 3.7 1.9 0.8 10.2 4.0 9.1 12.2 2.0 11.6 3.3 27.3 0.7 6.2 38.8 0.0 29.0 5.4 0.8 11.8 2.3 4.9 2.1 4.8 15.5 0.6 3.2 0.0 0.3 2.3 1.7 12.6 13.9 0.8 24.3 31.6 0.0 12.1 3.7 0.0 1.8 0.5 1.5 4.1 10.6 0.8 14.2 12.8 PRRT3 FLJ33674 ENSG00000163704 "Proline rich transmembrane protein 3" Q5FWE3 3 9945542-9952394 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 26.0;fallopian tube: 10.8;parathyroid gland: 24.7;pituitary gland: 6.9" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 23.6;Rod photoreceptor cells: 22.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 12.7;MCF7: 16.1;SK-BR-3: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035127, HPA035128, HPA069859" Enhanced Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA 18000 "Plasma membrane" Nucleoplasm "HPA035127: AB_10602822, HPA035128: AB_2674482, HPA069859: " "unprognostic (1.55e-1)" "unprognostic (8.41e-2)" "unprognostic (3.42e-1)" "unprognostic (2.38e-3)" "unprognostic (1.27e-1)" "unprognostic (3.41e-2)" "unprognostic (1.15e-4)" "unprognostic (2.27e-3)" "unprognostic (1.37e-2)" "unprognostic (2.76e-2)" "unprognostic (2.20e-3)" "unprognostic (3.60e-1)" "unprognostic (1.01e-4)" "unprognostic (2.25e-1)" "unprognostic (1.39e-1)" "unprognostic (4.64e-2)" "unprognostic (2.09e-1)" 1.4 2.9 8.4 1.8 11.9 2.1 2.0 13.4 26.0 2.4 1.4 4.2 0.0 1.0 2.0 2.2 1.7 10.8 1.9 1.6 5.9 3.2 1.5 0.9 1.4 1.8 2.7 8.3 2.9 2.9 24.7 6.9 0.8 11.4 4.0 0.8 1.8 2.0 2.9 1.5 2.5 1.2 1.7 2.3 1.5 1.5 3.9 3.2 1.2 3.4 0.0 2.0 2.1 1.8 1.8 1.5 0.9 0.6 1.7 3.8 1.0 0.2 0.7 2.6 3.4 12.7 1.7 0.8 1.2 2.4 1.5 3.3 0.2 2.4 1.3 0.3 3.0 1.5 0.2 0.9 3.2 0.6 6.8 1.4 0.5 1.3 0.0 1.3 0.3 1.2 3.2 0.2 1.2 0.5 7.1 0.6 4.3 0.7 3.4 1.8 16.1 3.0 0.2 6.2 0.1 1.5 1.8 0.3 1.3 0.7 0.2 4.9 3.2 1.2 24.2 0.4 1.0 6.5 0.3 0.6 0.3 3.5 0.6 0.9 4.4 4.5 0.4 8.0 0.2 0.9 0.9 0.6 0.5 3.3 0.3 3.7 1.6 3.4 3.3 0.2 1.8 3.8 3.5 0.8 1.7 0.4 1.5 0.6 1.0 8.4 11.9 13.4 26.0 5.9 3.2 2.7 8.3 11.4 3.2 0.0 1.3 3.0 3.6 2.4 23.6 2.5 7.6 8.1 1.2 10.4 13.7 0.6 3.3 2.6 3.1 2.8 4.2 0.0 4.4 0.4 4.8 3.6 1.1 2.4 3.1 14.3 10.9 1.8 1.3 2.7 5.2 2.1 1.7 17.2 4.7 9.8 3.2 0.0 2.5 6.2 22.5 0.0 4.7 9.7 5.7 1.9 0.3 4.6 3.6 2.0 PRRT4 ENSG00000224940 "Proline rich transmembrane protein 4" C9JH25 7 128350325-128361685 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 49.0" "Cell type enriched" "Detected in some" 8 "Horizontal cells: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 72.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA046373, HPA052681" Uncertain Approved "Nucleoplasm,Peroxisomes,Plasma membrane" "Intracellular and membrane" NA NA Nucleoplasm "Peroxisomes, Plasma membrane" "HPA046373: AB_2679642, HPA052681: AB_2681912" "unprognostic (1.72e-1)" "unprognostic (4.55e-2)" "unprognostic (5.36e-3)" "unprognostic (1.20e-4)" "unprognostic (2.60e-1)" "unprognostic (7.81e-2)" "unprognostic (1.88e-1)" "unprognostic (1.56e-1)" "unprognostic (5.62e-3)" "unprognostic (1.61e-1)" "unprognostic (2.48e-4)" "unprognostic (9.11e-2)" "unprognostic (3.73e-4)" "unprognostic (5.28e-3)" "unprognostic (9.09e-2)" "unprognostic (1.22e-2)" "unprognostic (1.27e-2)" 12.1 1.9 2.0 5.9 11.3 49.0 6.8 6.5 3.1 1.6 2.7 0.6 0.0 0.6 0.7 0.5 1.9 1.0 1.1 2.4 1.7 6.2 0.5 0.7 0.8 0.6 1.6 2.4 1.0 0.6 0.8 0.0 0.6 2.9 0.8 0.7 3.4 1.9 1.3 4.2 1.5 0.8 1.0 2.8 1.3 1.6 0.7 1.5 0.7 0.7 1.7 1.0 2.0 3.2 0.0 0.4 0.4 0.4 0.0 1.5 0.4 0.0 0.0 0.1 0.1 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.3 0.7 14.1 0.3 0.0 0.0 3.9 0.2 0.3 0.0 0.0 0.1 72.0 0.1 0.0 0.1 0.5 0.0 1.9 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.2 0.5 0.0 0.0 1.5 0.7 0.4 0.0 0.0 0.4 0.0 0.4 2.0 11.3 6.5 3.1 1.7 6.2 1.6 2.4 2.9 1.5 0.0 0.0 0.0 0.0 0.6 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 9.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.4 0.3 0.2 0.0 0.0 0.0 PRRX1 "PHOX1, PMX1" ENSG00000116132 "Paired related homeobox 1" P54821 1 170662728-170739419 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Early spermatids: 327.5;Late spermatids: 303.2;Leydig cells: 237.3;Peritubular cells: 98.3;Smooth muscle cells: 139.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 73.9;ASC TERT1: 59.0;BJ: 20.9;BJ hTERT+: 41.3;HSkMC: 30.1;U-138 MG: 29.0;U-2197: 27.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051084, HPA063566" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA051084: AB_2681338, HPA063566: AB_2732702" "unprognostic (2.03e-1)" "unprognostic (2.00e-1)" "unprognostic (1.09e-1)" "unprognostic (7.00e-2)" "unprognostic (1.24e-1)" "unprognostic (4.97e-2)" "unprognostic (2.52e-2)" "unprognostic (1.88e-2)" "unprognostic (2.94e-3)" "unprognostic (1.13e-1)" "unprognostic (1.98e-2)" "unprognostic (3.29e-1)" "prognostic unfavorable (6.60e-10)" "unprognostic (4.23e-3)" "unprognostic (4.48e-2)" "unprognostic (2.68e-3)" "unprognostic (1.69e-3)" 44.8 4.4 5.2 7.2 6.3 0.0 21.0 4.0 9.2 58.5 4.1 6.7 10.6 0.4 31.4 19.4 10.8 17.9 14.5 19.5 6.8 4.5 1.8 0.7 10.4 13.0 6.1 5.3 27.6 1.9 3.4 3.1 2.7 7.7 17.3 2.5 17.4 18.4 34.1 58.6 11.9 2.2 23.0 6.6 1.0 2.3 17.6 6.8 5.0 21.7 28.7 14.9 19.4 31.2 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 73.9 59.0 0.0 20.9 41.3 2.9 2.9 0.0 0.0 0.0 0.0 17.2 0.0 0.0 3.6 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 30.1 0.0 14.4 0.0 5.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 29.0 0.5 27.6 3.2 0.0 0.0 0.0 15.2 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 5.2 6.3 4.0 3.9 6.8 4.5 6.1 5.3 7.7 6.8 0.0 0.3 0.0 0.4 14.4 0.0 29.7 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.9 327.5 6.4 0.0 0.0 0.2 0.2 42.1 1.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 303.2 237.3 3.9 13.5 0.0 0.0 0.3 0.9 0.0 98.3 0.0 0.1 51.8 139.5 6.0 1.4 10.3 0.1 0.0 0.0 1.3 PRRX2 "PMX2, PRX2" ENSG00000167157 "Paired related homeobox 2" Q99811 9 129665641-129722674 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 24.4;Early spermatids: 53.9;Fibroblasts: 25.4;Smooth muscle cells: 37.7;Suprabasal keratinocytes: 26.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 8.1;BJ: 17.1;BJ hTERT+: 12.2;fHDF/TERT166: 24.6;U-2197: 20.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA006607, HPA026808" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA006607: AB_2667623, HPA026808: AB_10603228" "unprognostic (4.02e-2)" "unprognostic (5.17e-2)" "unprognostic (7.65e-3)" "unprognostic (4.47e-3)" "unprognostic (2.77e-1)" "unprognostic (1.92e-1)" "unprognostic (2.16e-2)" "unprognostic (1.03e-2)" "unprognostic (8.58e-3)" "unprognostic (9.27e-2)" "unprognostic (1.22e-1)" "unprognostic (1.22e-1)" "unprognostic (1.94e-10)" "unprognostic (6.66e-2)" "unprognostic (4.48e-1)" "unprognostic (2.65e-2)" "unprognostic (9.47e-3)" 8.4 2.1 0.4 2.5 0.4 0.2 7.3 0.2 0.6 15.6 2.4 0.5 3.5 0.7 4.6 5.4 5.3 2.1 2.3 8.6 0.4 0.2 0.6 0.4 2.8 1.8 0.3 0.1 3.2 2.2 0.3 2.8 2.6 1.7 15.1 0.7 12.8 4.6 5.2 6.6 15.8 1.1 10.2 1.2 0.4 1.6 6.7 0.0 0.6 7.9 9.3 6.5 10.8 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 2.1 8.1 0.0 17.1 12.2 2.2 2.5 0.0 0.0 0.0 6.2 24.6 0.9 0.2 0.5 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.7 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 2.6 1.2 3.8 0.0 0.0 0.0 0.5 0.0 0.0 1.6 0.8 0.0 0.0 0.9 1.6 0.3 0.0 0.0 5.1 20.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.2 0.6 0.4 0.2 0.3 0.1 1.7 0.0 0.0 0.0 0.0 1.2 24.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.1 53.9 0.1 0.0 0.0 0.0 0.3 25.4 2.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 7.7 2.6 0.0 8.5 0.0 0.0 0.0 0.6 0.0 3.2 0.0 0.0 0.0 37.7 3.2 6.8 26.0 0.3 0.0 0.0 5.0 PRSS12 "BSSP-3, MRT1" ENSG00000164099 "Serine protease 12" P56730 4 118280038-118353003 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 27.5;testis: 31.3" "Group enriched" "Detected in many" 4 "Ciliated cells: 84.3;Club cells: 46.6;Cytotrophoblasts: 36.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 20.8;SH-SY5Y: 66.0;THP-1: 29.5" "Group enriched" "Detected in many" 5 "amygdala: 11.6;basal ganglia: 8.7;cerebral cortex: 26.5;hippocampal formation: 15.3;olfactory region: 11.0" "Low region specificity" "Detected in all" HPA035054 Uncertain Approved "Nucleoplasm,Actin filaments" "Secreted - unknown location" NA NA "Actin filaments" Nucleoplasm "HPA035054: AB_10603990" "unprognostic (4.30e-2)" "unprognostic (1.04e-2)" "unprognostic (2.55e-1)" "unprognostic (4.41e-2)" "prognostic favorable (2.66e-4)" "prognostic favorable (1.03e-4)" "unprognostic (4.21e-1)" "unprognostic (3.48e-2)" "unprognostic (7.83e-2)" "unprognostic (6.38e-2)" "unprognostic (1.09e-1)" "unprognostic (1.27e-1)" "unprognostic (2.41e-2)" "unprognostic (1.29e-1)" "unprognostic (1.85e-1)" "unprognostic (9.55e-2)" "unprognostic (1.09e-1)" 0.9 0.5 2.1 4.1 1.4 0.0 1.9 0.5 2.8 16.5 6.0 2.0 1.3 2.2 3.0 2.7 3.6 9.8 27.5 0.3 2.2 0.9 1.1 0.8 8.0 0.0 0.7 2.4 1.9 9.8 0.0 0.9 20.4 4.1 2.0 5.8 20.0 3.1 3.2 0.3 5.9 8.6 1.0 0.5 0.3 8.1 31.3 0.2 0.3 0.6 7.7 7.7 3.1 16.2 0.3 0.4 0.0 0.1 0.0 0.7 0.0 1.5 0.0 0.5 0.0 0.0 4.2 0.0 13.7 12.5 2.9 4.9 0.0 5.6 0.0 0.0 20.8 1.5 0.2 9.3 2.8 3.9 0.0 2.1 0.0 1.1 0.0 0.4 0.0 0.0 1.3 5.3 1.0 3.0 9.6 0.0 0.1 0.0 0.0 2.4 0.0 0.1 2.8 0.6 10.7 0.9 0.0 11.8 0.0 0.0 2.0 1.5 66.0 0.0 0.0 0.8 9.9 0.0 29.5 0.0 5.9 0.8 3.7 2.7 0.3 0.0 0.0 0.3 0.9 3.4 0.0 0.1 0.0 0.0 0.1 0.7 0.3 0.0 0.0 0.4 0.3 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 2.1 1.4 0.5 2.8 2.2 0.9 0.7 2.4 4.1 0.2 6.0 2.9 0.0 0.8 7.4 0.4 1.2 12.7 84.3 46.6 1.8 0.0 36.7 0.0 0.4 7.1 0.7 9.7 0.0 8.8 2.7 5.6 0.3 6.9 0.0 3.2 0.0 5.1 0.0 0.0 11.8 0.0 1.1 5.0 0.0 2.2 0.0 6.5 8.0 0.0 0.3 0.2 0.0 2.1 8.0 13.8 3.8 10.0 0.0 4.2 4.2 PRSS22 "BSSP-4, hBSSP-4, SP001LA" ENSG00000005001 "Serine protease 22" Q9GZN4 16 2852727-2858170 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.4;lymphoid tissue: 40.1;tongue: 36.5" "Cell type enhanced" "Detected in many" 18 "Basal glandular cells: 187.4;Pancreatic endocrine cells: 242.0;Urothelial cells: 517.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 16 "cerebellum: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.6;MCF7: 12.7;RT4: 5.9;SK-BR-3: 13.4" "Region enhanced" "Detected in single" "cerebral cortex: 2.6" "Low region specificity" "Detected in all" HPA049161 Approved Approved Nucleoplasm "Secreted in other tissues" NA NA Nucleoplasm "HPA049161: AB_2680660" "unprognostic (1.45e-1)" "unprognostic (9.80e-2)" "unprognostic (3.50e-2)" "unprognostic (4.48e-1)" "unprognostic (2.29e-4)" "unprognostic (2.58e-1)" "unprognostic (4.42e-2)" "unprognostic (1.52e-2)" "unprognostic (5.06e-1)" "unprognostic (7.52e-2)" "unprognostic (3.74e-3)" "unprognostic (4.12e-1)" "unprognostic (2.32e-4)" "unprognostic (1.04e-2)" "unprognostic (1.58e-1)" "unprognostic (1.62e-1)" "unprognostic (2.75e-1)" 0.4 0.7 0.0 0.4 0.0 0.6 1.3 1.5 0.4 9.9 1.0 0.0 8.6 1.5 3.0 0.6 40.4 3.0 6.8 0.4 0.0 0.0 2.4 0.7 3.0 0.4 0.0 0.0 0.4 7.5 0.4 1.1 4.3 0.0 5.1 0.6 0.0 13.4 10.6 2.3 1.3 0.4 0.7 0.0 0.4 3.5 0.4 0.0 0.0 1.5 36.5 40.1 5.2 9.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.7 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 13.4 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 3.4 0.0 187.4 20.6 0.0 0.2 33.1 8.1 23.9 15.7 0.0 30.9 1.7 101.8 0.0 0.0 4.2 0.0 86.5 19.4 0.8 63.4 0.0 0.0 2.0 0.0 3.5 0.0 0.0 0.0 0.0 0.9 6.8 1.8 5.3 0.0 242.0 10.5 0.0 0.0 0.0 0.0 1.0 0.0 0.1 24.1 8.8 0.0 5.2 517.3 PRTFDC1 HHGP ENSG00000099256 "Phosphoribosyl transferase domain containing 1" Q9NRG1 10 24848607-24952604 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.0" "Cell type enhanced" "Detected in many" 7 "Muller glia cells: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "NK-cell: 7.9" "Lineage enriched" "Detected in many" 7 "NK-cells: 7.9" "Cell line enhanced" "Detected in many" "CACO-2: 30.1;CAPAN-2: 38.0;HEL: 22.1" HPA021458 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA021458: AB_1855793" "unprognostic (2.61e-1)" "unprognostic (3.47e-1)" "unprognostic (3.69e-1)" "prognostic unfavorable (2.66e-4)" "unprognostic (9.49e-3)" "unprognostic (2.03e-1)" "unprognostic (1.26e-2)" "unprognostic (1.64e-1)" "unprognostic (2.36e-1)" "unprognostic (3.09e-2)" "unprognostic (1.19e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (9.27e-5)" "unprognostic (2.25e-2)" "unprognostic (2.50e-1)" "unprognostic (7.66e-3)" "unprognostic (1.94e-2)" 4.1 18.3 18.1 3.3 18.2 0.6 6.1 6.1 24.0 8.1 7.7 29.0 2.4 13.9 12.9 6.1 4.5 5.9 11.8 8.6 16.8 13.0 4.0 2.2 3.4 2.8 18.1 12.6 17.1 3.6 10.2 11.0 2.3 16.2 6.5 9.2 6.0 7.2 6.9 0.9 1.4 13.2 8.0 22.5 2.3 13.8 1.7 20.7 2.3 3.7 1.1 2.4 6.0 4.6 0.0 0.3 0.1 0.0 7.9 1.1 1.7 7.6 16.5 12.3 5.0 2.0 10.3 0.0 8.1 6.1 5.8 8.0 30.1 38.0 0.0 1.3 9.4 0.4 4.3 14.0 0.0 9.1 0.0 0.6 22.1 3.0 0.0 6.1 0.0 0.0 3.0 0.1 3.1 0.0 5.5 9.1 0.9 7.2 4.2 2.7 0.2 3.4 0.0 8.5 1.3 0.3 3.8 0.0 0.0 5.2 0.2 8.8 0.4 7.7 0.0 0.0 0.3 0.4 1.7 4.9 2.6 6.5 9.4 4.8 0.4 0.0 0.0 6.9 0.0 0.3 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.4 0.5 0.3 0.0 0.1 0.3 0.1 7.9 0.0 0.2 0.0 1.7 18.1 18.2 6.1 15.8 16.8 13.0 18.1 12.6 16.2 20.7 0.0 0.3 0.0 3.7 2.4 10.4 6.9 5.1 1.4 4.5 3.5 2.0 0.5 5.0 4.6 1.0 1.6 4.1 0.0 0.5 4.3 14.2 0.7 0.0 0.0 5.4 6.4 5.2 9.2 1.6 0.8 11.2 0.3 3.3 1.8 4.2 32.0 2.4 2.6 9.2 0.0 15.3 0.0 9.5 2.3 4.1 2.5 0.7 0.0 14.3 0.9 PRY "PRY1, PTPN13LY" ENSG00000169789 "PTPN13-like, Y-linked" O14603 Y 22490397-22514637 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 1.9;epididymis: 2.3;testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "memory CD4 T-cell: 1.9" "Lineage enriched" "Detected in single" 20 "T-cells: 1.9" "Cell line enhanced" "Detected in some" "A549: 3.1;HDLM-2: 2.3;SK-MEL-30: 1.5" "HPA046366, HPA059887" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA046366: AB_2679639, HPA059887: " 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRY2 PTPN13LY2 ENSG00000169807 "PTPN13-like, Y-linked 2" O14603 Y 22071756-22096007 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 1.4;testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.4;naive CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Cell line enhanced" "Detected in single" "SK-MEL-30: 3.6" "HPA046366, HPA059887" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA046366: AB_2679639, HPA059887: " 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PSD "EFA6, EFA6A, KIAA2011, PSD1, TYL" ENSG00000059915 "Pleckstrin and Sec7 domain containing" A5PKW4 10 102402617-102421539 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 66.8" "Group enriched" "Detected in many" 4 "Bipolar cells: 51.6;Cone photoreceptor cells: 90.3;Rod photoreceptor cells: 65.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HSkMC: 10.3;MOLT-4: 5.5;SCLC-21H: 9.7;SH-SY5Y: 8.5;U-2 OS: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059237 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA059237: AB_2683954" "unprognostic (2.43e-1)" "unprognostic (1.74e-1)" "unprognostic (5.62e-3)" "unprognostic (1.53e-1)" "unprognostic (3.16e-2)" "unprognostic (2.90e-2)" "unprognostic (7.73e-3)" "unprognostic (1.75e-1)" "unprognostic (9.59e-2)" "unprognostic (7.59e-2)" "unprognostic (2.24e-3)" "unprognostic (4.71e-2)" "unprognostic (1.52e-1)" "unprognostic (2.61e-2)" "unprognostic (8.50e-2)" "unprognostic (2.24e-2)" "unprognostic (5.50e-2)" 1.2 9.8 48.7 4.3 59.4 1.6 1.5 8.0 66.8 6.7 21.5 1.7 0.0 6.7 23.9 2.4 3.2 11.1 9.4 1.9 48.7 12.2 1.5 1.4 1.7 1.8 7.6 26.7 5.6 4.7 2.5 13.6 1.8 4.2 6.2 4.4 3.7 1.5 2.2 1.2 2.1 5.8 20.7 1.8 1.5 4.8 4.6 7.0 0.0 1.2 0.0 1.5 11.7 3.0 0.8 0.0 1.1 0.2 0.9 1.3 0.0 0.3 0.1 3.9 3.5 1.4 0.8 0.3 0.3 0.0 0.1 0.0 2.7 0.4 0.3 2.5 0.1 0.3 0.2 0.2 0.0 0.0 0.3 0.2 0.1 0.1 0.1 2.2 0.0 0.1 10.3 0.3 0.6 0.1 1.7 0.0 1.4 0.6 0.9 0.0 2.1 5.5 0.3 0.5 0.3 0.0 1.5 0.0 0.1 0.0 0.2 9.7 8.5 0.1 0.1 0.2 0.3 0.6 0.5 0.0 2.9 4.7 0.2 0.0 2.5 0.3 0.1 0.3 0.2 0.1 0.0 0.2 0.3 0.0 0.0 0.2 0.2 0.2 0.3 0.0 0.8 0.3 1.3 1.1 0.9 0.0 0.0 0.0 0.0 48.7 59.4 8.0 41.2 48.7 12.2 7.6 26.7 4.2 7.0 3.0 0.3 0.0 0.2 0.6 51.6 1.2 5.1 0.0 2.3 0.0 90.3 0.2 1.7 0.1 4.1 0.3 0.8 0.0 1.7 0.1 1.7 0.3 0.0 0.5 0.6 12.7 17.2 0.0 0.0 2.0 3.4 0.0 0.0 0.0 0.6 8.6 0.7 0.6 3.9 0.7 65.1 0.0 0.3 3.7 3.4 0.1 0.6 0.0 0.8 0.1 PSD3 "DKFZp761K1423, EFA6D, EFA6R, HCA67, KIAA0942" ENSG00000156011 "Pleckstrin and Sec7 domain containing 3" Q9NYI0 8 18527301-19084730 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 51.6" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 598.4;Late spermatids: 164.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 26.2;hTERT-RPE1: 22.8;LHCN-M2: 22.0;U-87 MG: 23.6" "Low region specificity" "Detected in all" HPA002455 Enhanced Approved Nucleoplasm,Vesicles,Cytosol Yes No "Nucleoplasm, Vesicles" Cytosol "HPA002455: AB_2666597" "unprognostic (3.87e-2)" "unprognostic (2.52e-2)" "prognostic favorable (7.55e-4)" "prognostic unfavorable (5.76e-5)" "unprognostic (2.56e-1)" "unprognostic (2.66e-2)" "unprognostic (1.04e-2)" "unprognostic (8.84e-2)" "unprognostic (7.27e-2)" "unprognostic (3.39e-1)" "unprognostic (2.50e-3)" "unprognostic (2.13e-1)" "unprognostic (7.18e-3)" "unprognostic (3.71e-2)" "unprognostic (8.77e-2)" "unprognostic (3.83e-2)" "unprognostic (1.45e-1)" 2.3 15.5 18.3 2.7 40.5 1.3 5.2 51.6 50.7 11.3 5.7 13.4 2.5 4.2 7.8 3.6 4.8 2.6 6.5 21.8 23.2 9.3 2.1 15.6 4.1 2.2 10.0 27.6 16.0 8.3 9.5 9.6 5.6 10.7 3.7 6.5 5.4 3.2 5.5 1.3 3.9 4.3 5.2 7.4 8.4 8.0 12.7 11.4 0.0 5.4 1.4 3.1 6.1 3.3 3.1 0.6 2.3 1.3 1.9 2.0 0.7 4.9 2.6 11.7 0.0 4.2 26.2 0.6 2.6 4.1 2.4 5.0 1.5 2.0 2.9 1.7 10.7 10.6 0.4 3.4 4.7 4.6 0.0 3.0 0.2 2.0 0.2 7.7 0.0 0.1 6.8 2.9 13.3 2.3 22.8 3.1 0.7 0.3 2.3 22.0 1.7 0.0 0.5 2.3 4.3 6.8 2.3 10.2 1.3 6.1 6.4 5.0 5.6 1.1 0.5 1.8 2.6 0.0 1.1 12.9 7.5 5.2 17.6 2.3 0.2 0.3 6.7 23.6 1.2 2.5 2.3 1.3 1.3 1.0 0.8 1.3 1.6 1.0 0.6 0.5 3.1 0.5 0.6 1.5 1.9 1.1 0.6 2.0 0.7 18.3 40.5 51.6 50.7 23.2 9.3 10.0 27.6 10.7 11.4 3.0 2.4 0.5 11.9 19.5 56.4 111.0 5.1 32.1 13.6 8.7 111.9 2.6 1.7 13.2 598.4 4.9 21.3 0.0 7.4 1.2 30.9 8.6 0.0 36.1 11.0 17.5 5.8 6.2 9.7 164.8 30.8 10.6 1.7 103.6 15.1 80.8 19.5 14.4 50.5 0.2 50.2 12.9 11.5 10.0 15.8 8.7 0.9 0.0 13.0 24.0 PSEN1 "AD3, FAD, PS1, S182" ENSG00000080815 "Presenilin 1" P49768 14 73136418-73223691 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Cell adhesion, Notch signaling pathway" "Hydrolase, Protease" "Alzheimer disease, Amyloidosis, Cancer-related genes, Cardiomyopathy, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006844, HPA030760, HPA067496" Approved Supported "Nucleoplasm,Golgi apparatus,Cell Junctions" Yes No "Golgi apparatus" "Nucleoplasm, Cell Junctions" "CAB006844: , HPA030760: AB_10696211, HPA067496: AB_2685853" "unprognostic (1.67e-1)" "unprognostic (4.79e-2)" "unprognostic (7.39e-2)" "unprognostic (8.68e-3)" "unprognostic (3.84e-1)" "unprognostic (5.48e-3)" "prognostic unfavorable (1.99e-5)" "unprognostic (1.65e-1)" "unprognostic (8.99e-2)" "unprognostic (8.45e-2)" "unprognostic (1.76e-3)" "unprognostic (2.74e-1)" "prognostic favorable (1.52e-8)" "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (7.12e-3)" "unprognostic (1.85e-1)" 16.3 15.3 21.0 13.4 34.9 19.2 15.7 15.5 24.7 16.5 26.2 66.1 9.5 26.6 14.2 15.4 19.0 12.6 17.1 9.9 28.6 18.2 19.7 16.9 16.9 10.8 42.1 20.7 13.5 15.0 21.8 9.2 22.7 31.8 13.6 25.6 15.0 16.8 13.4 13.0 24.7 27.9 14.6 61.9 14.6 16.3 16.8 39.7 15.4 19.7 8.7 15.9 17.2 13.5 9.0 24.4 38.1 34.0 11.7 10.5 17.1 14.4 22.2 20.8 8.3 29.1 20.8 18.9 21.3 24.5 21.9 27.6 27.6 36.2 9.4 14.1 20.2 17.9 38.5 17.5 16.1 23.9 21.5 10.8 10.8 15.1 13.4 26.9 10.8 21.1 21.3 29.4 18.1 22.4 20.0 17.5 10.6 12.0 19.2 20.4 28.7 8.2 14.1 9.0 25.7 16.5 10.5 17.7 12.0 30.4 30.7 11.6 15.5 23.2 21.8 18.9 19.7 27.0 24.3 18.5 22.3 18.4 18.1 10.0 12.6 18.4 9.6 18.7 13.2 13.5 29.2 27.1 27.1 7.2 30.8 7.0 7.2 7.0 5.9 24.4 9.0 6.6 6.4 38.1 11.7 34.0 12.8 10.5 17.1 21.0 34.9 15.5 24.7 28.6 18.2 42.1 20.7 31.8 39.7 26.8 35.7 14.6 21.9 25.3 16.5 10.1 20.4 22.7 26.1 22.7 37.3 22.8 5.0 24.3 8.6 20.3 63.6 0.0 23.2 24.7 22.1 24.7 17.4 18.6 27.3 12.7 15.5 13.5 47.8 10.0 15.3 43.2 15.1 33.3 34.1 13.6 29.5 51.8 14.5 13.3 27.4 25.8 18.4 21.6 13.7 28.9 41.8 20.3 36.6 44.4 PSEN2 "AD3L, AD4, PS2, STM2" ENSG00000143801 "Presenilin 2" P49810 1 226870184-226896105 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Notch signaling pathway" "Hydrolase, Protease" "Alzheimer disease, Amyloidosis, Cardiomyopathy, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013634, HPA038005" Supported Nucleoplasm NA NA Nucleoplasm "CAB013634: , HPA038005: " "unprognostic (3.40e-2)" "unprognostic (4.73e-3)" "unprognostic (2.94e-1)" "unprognostic (3.86e-2)" "unprognostic (6.54e-2)" "unprognostic (1.64e-3)" "unprognostic (4.72e-2)" "unprognostic (1.31e-1)" "unprognostic (9.98e-2)" "unprognostic (2.73e-2)" "unprognostic (8.25e-3)" "unprognostic (8.53e-3)" "unprognostic (8.45e-2)" "unprognostic (1.17e-1)" "unprognostic (8.36e-2)" "unprognostic (1.68e-1)" "unprognostic (1.06e-1)" 8.9 13.2 9.5 5.9 7.9 1.2 8.1 16.6 10.7 9.2 9.2 5.9 7.3 9.4 16.4 9.0 9.4 8.7 12.0 9.7 6.5 10.8 7.8 7.7 9.0 11.6 8.1 9.3 13.1 31.6 14.0 15.2 7.6 14.8 12.8 6.9 15.9 9.6 13.4 22.1 6.8 12.2 17.0 4.9 10.6 7.1 21.8 5.3 1.4 6.0 7.2 7.0 9.0 7.2 5.1 7.7 19.4 18.7 12.3 3.4 3.1 9.0 13.6 4.0 12.6 5.5 1.8 6.7 7.7 15.1 9.6 7.4 10.6 11.7 0.1 10.4 9.8 6.6 4.6 7.1 7.3 3.9 9.7 13.1 6.1 9.6 6.9 9.3 4.8 10.1 5.4 8.2 11.5 6.3 6.8 4.4 0.0 10.5 4.1 5.6 7.6 0.1 5.5 12.4 11.3 11.2 0.1 14.8 14.5 8.5 7.7 7.1 11.8 6.2 17.1 30.5 11.8 14.7 6.1 4.8 6.8 5.8 6.2 9.6 16.6 24.4 0.4 12.2 1.5 9.0 19.4 5.7 12.1 3.2 6.5 3.4 5.1 1.1 2.9 7.7 2.6 0.6 1.7 1.2 12.3 18.7 0.6 1.4 3.1 9.5 7.9 16.6 10.7 6.5 10.8 8.1 9.3 14.8 5.3 14.9 13.3 3.0 4.2 1.4 6.0 7.5 12.7 2.7 3.4 5.2 0.0 12.2 1.7 11.0 1.9 7.7 6.7 0.0 15.7 4.3 7.6 4.8 13.9 6.8 16.3 15.9 5.8 23.4 5.3 0.9 6.6 8.3 32.1 30.7 4.3 20.0 11.9 5.8 12.4 6.0 5.4 6.5 4.7 0.7 4.5 1.6 38.3 2.5 4.1 3.9 PSIP1 "DFS70, LEDGF, p52, p75, PSIP2" ENSG00000164985 "PC4 and SFRS1 interacting protein 1" O75475 9 15464066-15511019 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Spermatocytes: 273.8;Spermatogonia: 282.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 132.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013718, HPA019697" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB013718: , HPA019697: AB_1852779" "unprognostic (8.54e-2)" "unprognostic (3.70e-2)" "unprognostic (1.31e-1)" "unprognostic (3.29e-2)" "unprognostic (1.22e-1)" "unprognostic (2.23e-1)" "unprognostic (2.89e-3)" "unprognostic (5.10e-2)" "unprognostic (5.93e-2)" "unprognostic (2.53e-2)" "unprognostic (6.49e-3)" "unprognostic (5.49e-2)" "unprognostic (6.98e-2)" "unprognostic (2.04e-1)" "unprognostic (2.99e-1)" "unprognostic (7.14e-2)" "unprognostic (1.39e-1)" 15.1 20.3 42.7 20.8 48.8 24.9 12.2 65.3 49.4 22.6 16.1 19.0 11.5 10.8 27.9 18.2 12.9 20.0 14.9 16.0 38.7 42.7 16.1 10.5 15.6 35.4 34.1 30.2 43.6 8.1 18.8 24.9 18.7 32.4 18.3 15.3 12.3 9.0 21.1 16.3 12.3 14.2 21.3 37.7 24.6 12.5 37.2 29.3 70.4 18.1 6.5 31.9 17.0 16.1 11.4 2.6 8.5 4.3 8.0 16.4 1.9 17.9 11.9 40.7 29.8 8.8 10.7 9.1 21.7 15.5 19.5 23.3 5.0 9.3 38.3 5.0 11.4 10.9 5.0 25.3 11.7 28.3 25.1 15.3 132.4 31.3 9.3 10.7 15.4 14.7 8.9 3.4 16.3 12.0 19.5 17.0 18.1 21.8 21.3 12.6 6.5 31.9 38.4 63.1 0.4 18.6 29.8 22.2 7.7 10.9 6.3 25.9 28.5 19.4 8.6 10.1 26.5 8.6 20.8 12.0 14.2 14.4 10.6 20.5 9.1 12.8 34.5 11.4 15.6 8.1 8.5 2.1 4.2 5.5 1.6 6.7 8.4 11.0 7.6 2.4 11.4 16.4 10.1 7.2 8.0 4.3 2.6 9.8 1.9 42.7 48.8 65.3 46.6 38.7 42.7 34.1 30.2 32.4 29.3 50.6 32.2 51.9 42.9 28.3 223.7 37.1 20.4 58.9 36.4 45.4 62.8 99.5 53.0 8.4 62.0 69.9 10.7 46.7 7.5 66.4 50.7 20.2 15.0 16.3 26.7 130.3 36.5 55.3 27.7 44.5 116.5 31.1 38.8 43.3 27.2 149.7 3.6 23.2 126.2 41.8 252.4 122.9 61.2 273.8 282.5 18.4 34.6 73.4 41.7 15.4 PSKH2 ENSG00000147613 "Protein serine kinase H2" Q96QS6 8 86048373-86088621 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "kidney: 1.9;placenta: 1.2;testis: 2.0" "Cell type enhanced" "Detected in single" 35 "Rod photoreceptor cells: 1.3" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "HEL: 14.3" "HPA015095, HPA056839" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA015095: AB_1855815, HPA056839: " "unprognostic (1.77e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PSMA1 "HC2, MGC14542, MGC14575, MGC14751, MGC1667, MGC21459, MGC22853, MGC23915, NU, PROS30" ENSG00000129084 "Proteasome subunit alpha 1" P25786 11 14504874-14643635 "Enzymes, Predicted intracellular proteins" Immunity "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB033765, HPA037646, HPA043891" Supported Enhanced Nucleoplasm NA NA 27000000 Nucleoplasm "CAB033765: AB_2253026, HPA037646: AB_10670386, HPA043891: AB_2678718" "unprognostic (1.72e-2)" "unprognostic (4.97e-2)" "unprognostic (7.33e-2)" "unprognostic (4.74e-2)" "unprognostic (7.52e-2)" "unprognostic (6.66e-3)" "prognostic unfavorable (3.79e-5)" "unprognostic (3.28e-3)" "unprognostic (7.44e-2)" "unprognostic (3.43e-3)" "unprognostic (8.27e-3)" "unprognostic (8.77e-2)" "prognostic unfavorable (4.03e-11)" "unprognostic (1.93e-1)" "unprognostic (1.69e-1)" "unprognostic (4.66e-2)" "unprognostic (1.23e-2)" 46.6 46.3 33.7 36.0 40.2 45.7 39.0 28.3 42.7 33.4 35.5 23.1 37.4 37.3 42.1 43.1 43.7 33.0 32.2 55.4 31.7 34.1 47.8 61.0 38.8 42.3 32.0 32.4 34.0 35.6 28.2 39.4 55.2 36.9 35.6 42.4 32.9 34.9 37.1 86.6 35.3 42.7 39.0 26.7 45.8 37.3 31.6 25.9 53.0 45.5 62.8 42.2 41.5 31.7 24.2 55.4 20.9 42.3 30.5 35.7 45.2 67.4 47.7 40.0 47.9 39.9 40.2 33.4 39.9 52.5 60.9 50.1 41.3 85.2 59.0 44.2 42.1 55.8 50.9 45.6 49.5 57.7 57.3 67.7 36.8 31.7 48.7 52.4 61.0 48.1 38.9 29.5 33.0 69.2 44.5 59.5 47.6 69.0 49.8 54.1 44.7 55.5 45.9 33.4 57.6 71.2 37.6 59.3 36.7 52.9 47.9 33.0 20.8 42.5 47.7 35.6 43.1 28.4 37.3 47.0 39.9 37.5 69.8 48.7 21.8 58.3 52.8 59.0 48.6 50.9 20.9 42.3 11.0 24.3 31.1 32.3 24.2 28.3 27.2 55.4 20.6 25.7 25.0 9.4 30.5 29.4 31.3 35.7 45.2 33.7 40.2 28.3 42.7 31.7 34.1 32.0 32.4 36.9 25.9 77.4 91.8 78.9 188.2 127.0 44.8 0.0 73.9 65.6 95.5 83.7 17.7 398.7 217.2 193.4 40.4 121.2 89.1 70.0 203.0 301.8 137.7 149.4 72.1 111.7 261.1 54.0 38.6 87.8 164.2 23.5 107.9 156.0 136.7 273.3 81.1 94.3 195.2 111.4 119.9 182.7 40.0 84.1 135.9 126.7 65.4 132.7 524.5 142.0 111.1 217.3 PSMA4 "HC9, HsT17706" ENSG00000041357 "Proteasome subunit alpha 4" P25789 15 78540405-78552419 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004973, HPA055466, HPA060613" Supported Supported Nucleoplasm,Vesicles,Cytosol No No 12000000 "Nucleoplasm, Cytosol" Vesicles "CAB004973: AB_425627, HPA055466: AB_2682824, HPA060613: AB_2684332" "unprognostic (1.80e-1)" "unprognostic (7.08e-3)" "unprognostic (1.31e-1)" "unprognostic (1.62e-1)" "unprognostic (4.71e-2)" "unprognostic (5.35e-2)" "unprognostic (6.26e-3)" "unprognostic (1.09e-1)" "unprognostic (3.28e-2)" "unprognostic (2.08e-3)" "unprognostic (2.75e-3)" "unprognostic (1.26e-1)" "prognostic unfavorable (6.74e-10)" "unprognostic (1.68e-1)" "unprognostic (1.56e-1)" "unprognostic (3.78e-3)" "unprognostic (6.32e-3)" 41.2 38.8 24.9 36.7 25.8 33.4 33.0 25.3 37.5 32.4 38.0 17.9 23.7 39.4 35.3 32.5 49.9 27.1 24.4 37.7 29.8 27.6 55.7 76.3 37.4 45.1 25.5 26.9 31.2 24.4 20.2 25.9 55.4 33.8 35.3 41.3 19.1 26.0 25.0 60.3 26.3 49.1 36.6 28.1 45.5 31.5 36.5 21.4 61.6 42.6 75.0 44.8 41.3 28.3 29.4 61.9 31.4 75.6 37.7 40.0 61.4 40.8 59.2 51.2 45.1 32.4 30.6 40.2 38.4 30.9 47.4 50.8 61.4 59.6 89.1 56.8 35.3 53.1 55.9 103.3 41.6 45.8 36.5 72.0 74.8 44.3 49.5 52.5 76.0 46.2 24.7 26.1 39.8 39.7 29.2 51.0 49.1 80.2 35.0 38.6 58.7 51.2 71.4 48.2 47.5 34.8 44.6 67.8 29.8 47.9 71.5 45.2 33.0 61.6 45.0 46.8 66.1 41.6 62.6 40.6 35.4 47.2 38.9 65.3 32.0 75.4 84.0 33.2 114.3 39.0 18.8 47.4 31.4 27.8 75.6 28.5 29.4 29.2 29.0 61.9 22.9 23.3 28.3 21.7 37.7 69.7 35.3 40.0 61.4 24.9 25.8 25.3 37.5 29.8 27.6 25.5 26.9 33.8 21.4 119.1 93.9 158.5 221.9 205.7 52.1 151.9 114.7 164.6 121.7 115.1 9.8 396.5 263.6 267.2 515.0 152.3 149.0 93.5 255.0 368.3 172.3 213.0 169.8 170.4 287.4 68.3 140.2 108.6 138.2 238.7 139.8 214.9 126.5 342.7 139.0 49.5 230.5 135.3 138.6 288.5 32.6 148.8 177.5 257.9 168.3 185.9 373.9 156.9 171.4 236.4 PSMA6 "IOTA, MGC22756, MGC2333, MGC23846, p27K, PROS27" ENSG00000100902 "Proteasome subunit alpha 6" P60900 14 35278633-35317493 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 12 "Late spermatids: 395.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003049 Approved Supported Nucleoplasm NA NA 19000000 Nucleoplasm "HPA003049: AB_1079703" "unprognostic (9.68e-3)" "unprognostic (5.91e-2)" "unprognostic (1.90e-2)" "unprognostic (8.07e-2)" "unprognostic (3.42e-2)" "unprognostic (4.11e-3)" "unprognostic (7.48e-2)" "unprognostic (1.25e-1)" "unprognostic (1.16e-1)" "prognostic favorable (3.27e-4)" "unprognostic (1.29e-3)" "unprognostic (2.63e-1)" "unprognostic (1.52e-2)" "unprognostic (2.05e-1)" "unprognostic (5.45e-2)" "unprognostic (3.49e-1)" "unprognostic (5.08e-2)" 33.8 42.7 26.7 31.4 38.8 37.1 38.7 24.2 35.0 28.0 35.8 19.4 24.5 32.2 31.0 30.2 37.9 24.7 20.3 54.2 30.5 27.6 47.3 49.0 37.3 36.4 30.1 36.8 31.1 36.7 14.2 35.8 61.2 31.8 22.5 38.6 18.1 27.3 25.5 94.6 31.8 39.5 27.3 25.2 35.7 28.9 67.5 26.5 86.2 26.0 37.2 38.1 28.8 24.5 37.9 68.5 41.4 65.1 49.9 54.8 104.8 59.7 44.2 33.1 33.6 27.3 29.2 66.2 31.3 38.3 47.4 43.1 41.1 43.3 40.0 60.3 30.4 28.5 42.8 38.6 35.7 56.8 40.2 21.1 31.4 32.2 122.9 31.0 65.3 29.4 22.2 29.7 33.1 42.2 23.6 40.0 68.7 33.5 28.0 38.2 63.3 99.9 55.8 31.6 49.2 50.4 148.9 33.6 32.0 40.5 76.8 35.2 29.8 34.9 51.5 32.9 29.2 61.6 43.3 33.3 30.5 30.2 31.0 34.6 29.9 65.4 73.1 24.8 41.4 34.4 32.8 65.1 41.4 46.3 59.4 46.2 37.9 44.8 47.1 66.8 29.9 35.9 43.0 23.5 49.9 56.6 68.5 54.8 104.8 26.7 38.8 24.2 35.0 30.5 27.6 30.1 36.8 31.8 26.5 41.7 28.9 14.5 10.6 29.7 14.3 1.2 15.3 83.0 59.1 14.0 23.6 27.2 18.3 26.4 121.5 28.7 25.7 23.3 31.8 22.0 14.4 12.4 53.1 20.3 20.7 23.8 17.2 30.7 36.5 395.6 21.0 54.6 23.6 27.1 17.6 8.7 26.5 21.0 16.3 18.9 17.8 12.9 22.1 22.9 17.9 29.0 34.6 29.4 22.2 15.3 PSMB1 "HC5, PMSB1" ENSG00000008018 "Proteasome subunit beta 1" P20618 6 170535117-170553341 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029635, HPA029637, CAB033911" Enhanced Supported Nucleoplasm NA NA 14000000 Nucleoplasm "CAB033911: AB_2268890, HPA029635: AB_10599738, HPA029637: AB_10601793" "unprognostic (2.78e-2)" "unprognostic (3.10e-2)" "unprognostic (6.73e-2)" "unprognostic (1.34e-1)" "unprognostic (1.20e-1)" "unprognostic (5.41e-3)" "unprognostic (2.36e-2)" "unprognostic (3.32e-2)" "unprognostic (8.39e-2)" "unprognostic (4.28e-2)" "unprognostic (3.07e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (3.76e-6)" "unprognostic (3.63e-1)" "unprognostic (7.50e-2)" "unprognostic (1.45e-3)" "unprognostic (9.62e-2)" 60.8 59.3 38.5 40.4 53.7 53.2 55.0 31.4 46.4 40.5 48.6 37.9 49.9 45.1 56.8 90.6 51.7 49.8 43.1 71.9 40.9 40.1 56.4 93.2 46.9 66.7 40.8 41.1 43.7 67.3 35.4 48.4 80.6 48.4 40.6 52.7 43.8 43.6 50.0 109.3 56.1 46.0 59.7 44.9 51.4 46.9 47.1 38.1 47.1 47.9 75.2 60.4 50.1 42.0 71.0 98.1 51.9 81.9 71.6 79.3 104.1 43.1 40.6 57.9 74.7 51.8 40.7 61.7 41.3 60.8 69.0 70.5 88.7 37.3 63.2 54.0 55.3 63.5 43.7 64.1 65.7 72.0 64.2 72.2 54.0 41.2 111.2 60.8 63.2 48.1 46.4 40.4 66.5 43.2 47.5 58.8 40.0 106.5 54.3 62.8 116.2 47.3 88.3 52.8 78.8 55.9 45.9 45.9 80.1 71.5 26.0 57.9 47.3 39.7 61.8 31.6 53.9 42.2 91.6 44.7 28.1 45.1 68.3 76.3 46.5 61.4 78.4 65.6 71.7 60.2 40.1 81.9 51.9 53.2 75.8 62.1 71.0 62.2 57.7 98.1 53.4 59.2 57.2 47.5 71.6 67.6 55.8 79.3 104.1 38.5 53.7 31.4 46.4 40.9 40.1 40.8 41.1 48.4 38.1 104.2 145.5 160.9 308.1 192.9 104.7 211.7 249.7 199.4 117.2 134.3 39.3 748.5 339.8 368.1 245.5 214.1 220.2 116.8 565.6 684.7 208.1 230.0 184.8 268.0 350.5 112.8 158.7 149.8 159.1 57.7 237.3 212.8 219.4 422.0 169.6 196.7 419.2 227.4 221.7 419.5 99.6 187.5 291.5 198.6 166.3 188.6 1001.7 194.1 216.2 303.9 PSMB2 HC7-I ENSG00000126067 "Proteasome subunit beta 2" P49721 1 35599544-35641844 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026322, HPA026324" Approved Enhanced Nucleoplasm NA NA 15000000 Nucleoplasm "HPA026322: AB_1855821, HPA026324: AB_1855822" "unprognostic (3.54e-2)" "unprognostic (8.53e-2)" "unprognostic (1.63e-3)" "unprognostic (6.93e-2)" "unprognostic (6.41e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (3.49e-7)" "unprognostic (2.81e-2)" "unprognostic (5.23e-2)" "unprognostic (3.34e-3)" "unprognostic (7.87e-2)" "unprognostic (4.45e-1)" "prognostic unfavorable (2.80e-6)" "unprognostic (1.65e-1)" "unprognostic (2.83e-1)" "unprognostic (3.77e-2)" "unprognostic (2.93e-2)" 26.5 30.5 29.4 28.0 35.1 37.2 25.3 20.1 50.9 23.2 26.1 35.9 15.4 27.5 27.8 25.0 30.4 26.5 20.7 23.8 30.6 33.4 27.9 63.8 24.6 30.4 30.6 24.8 22.7 24.6 22.0 21.8 37.5 32.6 23.1 27.8 22.8 23.0 24.9 54.7 28.2 27.0 28.7 32.5 29.3 22.8 23.5 21.5 42.8 22.7 29.1 34.0 23.9 22.4 24.6 30.2 19.4 35.3 25.1 28.1 25.4 40.9 25.7 28.1 19.1 14.9 17.9 35.5 19.4 22.9 40.1 32.7 30.4 49.3 40.9 45.7 22.9 24.5 25.5 36.1 32.2 33.8 33.3 33.5 37.1 28.1 29.7 26.9 38.9 21.9 19.5 20.4 47.9 23.2 16.4 31.5 33.9 44.2 23.4 25.8 18.8 50.6 29.1 37.5 18.2 27.4 31.4 28.6 28.8 27.8 22.2 24.9 18.3 22.3 21.1 30.1 33.5 15.5 17.7 21.6 20.1 23.7 18.9 45.9 20.2 32.4 41.5 29.7 41.0 34.8 17.4 27.0 19.4 23.1 33.0 23.4 24.6 23.1 24.2 29.7 19.3 16.7 20.9 9.7 25.1 35.3 30.2 28.1 25.4 29.4 35.1 20.1 50.9 30.6 33.4 30.6 24.8 32.6 21.5 59.6 61.8 70.7 120.5 98.8 48.7 51.8 71.4 68.3 47.8 62.8 15.7 342.2 122.7 240.6 77.0 88.7 69.5 23.3 197.3 290.1 75.1 97.6 33.6 136.0 195.7 55.6 94.4 84.7 99.4 12.8 93.2 93.1 72.6 231.8 76.2 58.8 222.8 74.6 85.9 183.0 36.4 90.5 72.1 168.5 124.8 97.5 369.7 82.8 96.1 159.8 PSMB4 "HN3, PROS26" ENSG00000159377 "Proteasome subunit beta 4" P28070 1 151399534-151401944 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006700, HPA073499" Approved Supported Nucleoplasm,Mitochondria NA NA 15000000 Nucleoplasm Mitochondria "HPA006700: AB_1079704, HPA073499: " "unprognostic (1.11e-1)" "unprognostic (1.44e-1)" "unprognostic (2.69e-1)" "unprognostic (2.52e-1)" "unprognostic (1.63e-1)" "unprognostic (5.74e-2)" "prognostic unfavorable (7.45e-4)" "unprognostic (2.27e-1)" "unprognostic (1.69e-1)" "unprognostic (4.37e-3)" "unprognostic (3.73e-1)" "unprognostic (3.77e-1)" "prognostic unfavorable (2.90e-10)" "unprognostic (5.33e-2)" "unprognostic (2.46e-2)" "unprognostic (3.82e-2)" "unprognostic (5.85e-2)" 45.7 64.5 47.4 40.4 49.5 40.2 56.3 39.6 84.0 44.4 44.3 28.5 58.8 41.2 53.5 65.3 55.7 51.2 37.8 66.6 47.0 50.7 57.3 71.9 43.6 81.1 49.2 61.0 52.4 87.0 40.0 45.4 50.9 48.4 42.6 47.5 37.8 46.7 56.1 68.7 45.7 39.7 66.4 55.1 46.6 43.4 31.8 36.3 51.1 46.8 63.3 62.2 58.6 37.7 68.5 106.5 58.6 81.4 72.5 89.0 78.3 52.1 54.7 46.6 55.8 52.8 50.4 64.1 30.8 67.2 89.9 63.1 73.2 70.5 47.5 93.4 51.5 47.8 52.4 47.3 57.9 51.3 66.2 47.8 32.8 41.0 54.7 57.1 45.7 45.2 55.0 55.4 84.4 34.7 45.8 62.7 51.3 53.0 93.0 63.3 139.7 54.8 53.9 119.2 77.4 71.0 52.6 34.1 83.8 73.4 42.7 51.8 61.5 35.8 78.3 103.0 60.3 70.7 72.5 39.7 39.5 42.1 41.9 67.6 92.7 106.1 91.6 58.3 40.7 83.0 54.6 81.4 49.5 63.9 75.2 75.9 68.5 74.9 72.5 96.4 60.8 65.8 68.0 58.6 72.5 56.9 106.5 89.0 78.3 47.4 49.5 39.6 84.0 47.0 50.7 49.2 61.0 48.4 36.3 142.9 125.8 60.3 65.1 68.1 51.9 108.2 81.5 179.3 134.2 68.0 15.7 176.7 87.9 106.1 12.6 85.2 80.0 46.7 168.6 123.7 82.9 62.0 103.4 133.7 108.0 46.1 63.8 90.9 107.2 13.4 96.7 88.1 91.1 226.4 73.7 84.2 122.6 66.6 99.0 122.6 44.8 64.7 80.2 38.6 45.3 66.4 223.6 74.3 80.9 77.2 PSMB5 "MB1, X" ENSG00000100804 "Proteasome subunit beta 5" P28074 14 23016543-23035230 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049518, HPA061796" Approved Supported Nucleoplasm,Centrosome NA NA 8200000 "Nucleoplasm, Centrosome" "HPA049518: AB_2680802, HPA061796: AB_2684612" "unprognostic (3.03e-1)" "unprognostic (1.99e-2)" "unprognostic (8.35e-2)" "unprognostic (6.13e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (2.85e-4)" "prognostic unfavorable (2.90e-5)" "unprognostic (2.55e-2)" "unprognostic (9.95e-2)" "prognostic favorable (1.08e-4)" "unprognostic (2.06e-1)" "unprognostic (1.19e-1)" "unprognostic (5.30e-2)" "unprognostic (1.75e-1)" "unprognostic (1.95e-1)" "unprognostic (4.95e-2)" "prognostic unfavorable (4.73e-4)" 28.1 38.8 33.6 19.3 35.5 9.6 29.0 19.4 42.9 24.7 28.3 26.8 25.4 21.0 24.2 49.2 31.6 31.6 22.0 37.7 32.9 33.3 35.3 45.4 20.6 18.3 37.5 35.4 22.2 36.6 35.4 26.6 32.5 33.9 27.2 32.2 21.1 28.4 28.7 101.2 22.3 17.2 34.9 32.5 16.7 25.1 27.6 27.3 15.7 29.0 47.3 22.7 20.6 25.2 32.3 53.4 24.6 39.9 19.4 46.8 39.5 22.5 48.1 34.4 32.6 46.4 40.1 34.0 32.2 38.4 56.9 48.4 40.5 36.0 28.0 30.1 43.8 39.5 30.8 54.9 40.2 55.0 17.2 37.9 17.8 35.1 142.5 36.6 21.6 21.4 44.7 37.7 42.2 35.2 37.8 58.8 24.7 26.7 16.0 46.5 66.5 12.3 29.6 38.2 43.6 78.0 16.6 26.0 18.7 44.2 32.7 43.9 34.2 22.7 46.1 31.0 47.0 22.2 28.1 31.6 27.9 28.4 25.8 31.6 13.8 27.3 21.0 21.8 17.4 34.5 24.6 39.9 17.3 29.3 39.0 34.2 32.3 35.1 28.1 42.6 30.1 46.8 35.6 15.5 19.4 27.9 53.4 28.7 39.5 33.6 35.5 19.4 42.9 32.9 33.3 37.5 35.4 33.9 27.3 71.5 50.9 58.0 134.8 124.6 57.4 134.8 129.9 149.9 80.8 90.7 27.5 350.9 233.8 261.5 57.3 106.7 63.2 0.0 201.1 383.6 136.2 130.9 30.1 134.4 190.5 66.7 148.5 90.9 54.9 77.1 109.9 70.7 109.6 199.2 94.1 137.0 244.2 80.7 114.9 331.7 53.8 97.0 134.4 207.4 76.8 137.3 359.7 49.8 123.0 163.4 PSMB6 "DELTA, Y" ENSG00000142507 "Proteasome subunit beta 6" P28072 17 4796144-4798503 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023312, HPA063656" Supported Supported Nucleoplasm,Cytosol NA NA 2800000 Nucleoplasm Cytosol "HPA023312: AB_1855828, HPA063656: AB_2685078" "unprognostic (2.71e-1)" "unprognostic (1.86e-2)" "unprognostic (2.75e-1)" "unprognostic (3.32e-3)" "unprognostic (8.80e-2)" "unprognostic (1.44e-1)" "unprognostic (2.73e-1)" "unprognostic (2.22e-2)" "unprognostic (2.37e-1)" "unprognostic (2.64e-2)" "unprognostic (1.98e-2)" "unprognostic (7.47e-2)" "prognostic unfavorable (5.93e-4)" "unprognostic (1.81e-1)" "unprognostic (2.34e-1)" "unprognostic (5.27e-2)" "unprognostic (5.66e-2)" 28.6 35.0 33.7 23.2 36.4 31.7 34.0 24.2 41.5 29.6 31.7 26.7 26.8 22.6 33.4 47.1 41.9 30.3 24.2 72.0 30.4 30.5 41.4 67.1 25.7 35.3 33.4 34.0 25.3 41.8 40.8 26.6 49.6 35.9 26.4 36.1 23.5 30.6 36.6 97.4 33.6 23.2 40.5 29.7 29.0 31.2 27.0 28.0 35.8 34.6 53.8 39.6 27.9 26.0 93.9 96.3 51.1 95.3 60.4 81.2 107.9 46.8 82.1 44.3 37.8 37.8 34.0 51.1 24.9 52.1 76.0 59.7 61.0 38.3 36.5 49.4 59.5 43.8 47.6 67.3 69.6 74.2 47.4 71.0 21.6 54.0 70.8 43.6 22.3 34.5 32.0 53.5 66.4 63.2 42.9 73.8 58.3 33.0 55.5 58.2 55.8 39.4 37.3 37.5 60.6 57.0 44.2 31.5 48.3 57.1 31.6 25.9 31.8 35.7 27.9 25.6 48.4 34.0 25.1 35.2 37.5 28.4 50.4 60.1 23.2 30.9 22.2 53.7 40.8 45.1 51.1 95.3 50.5 57.1 87.5 57.8 93.9 62.3 62.6 96.3 79.8 53.7 56.1 32.9 60.4 78.0 89.7 81.2 107.9 33.7 36.4 24.2 41.5 30.4 30.5 33.4 34.0 35.9 28.0 125.0 90.0 86.3 149.5 203.5 62.3 388.1 150.3 148.5 136.5 127.4 15.7 501.8 303.4 283.2 179.9 152.8 127.2 46.7 303.5 339.8 176.1 166.1 102.7 181.7 306.8 30.2 142.4 94.5 116.6 27.7 101.5 205.7 224.4 422.0 103.5 128.7 291.3 143.8 115.6 455.7 57.6 109.9 242.8 120.2 84.7 242.3 555.7 109.0 129.8 191.2 PSMB7 ENSG00000136930 "Proteasome subunit beta 7" Q99436 9 124353466-124415444 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052408, HPA054902" Supported Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" No No 2700000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA052408: AB_2681820, HPA054902: AB_2682635" "unprognostic (7.75e-2)" "unprognostic (1.83e-2)" "unprognostic (1.27e-1)" "unprognostic (3.64e-3)" "unprognostic (2.83e-1)" "unprognostic (1.25e-1)" "unprognostic (2.02e-2)" "unprognostic (2.24e-3)" "unprognostic (9.03e-2)" "unprognostic (3.60e-1)" "unprognostic (2.99e-1)" "unprognostic (1.78e-1)" "unprognostic (1.26e-2)" "unprognostic (1.67e-1)" "unprognostic (3.45e-1)" "unprognostic (1.93e-3)" "unprognostic (3.98e-2)" 36.9 56.9 51.0 32.8 55.1 53.4 41.9 33.7 52.7 26.6 33.3 34.0 27.9 32.5 33.6 52.1 41.9 32.6 29.2 59.6 44.5 41.3 53.7 87.1 27.0 33.6 43.6 46.9 32.7 67.1 38.5 24.1 53.2 47.3 28.8 37.1 31.1 48.2 26.9 76.7 48.7 32.2 31.4 39.9 28.6 33.1 50.3 36.5 48.2 32.7 67.7 39.5 32.3 30.8 53.4 67.9 45.2 62.7 53.6 66.2 69.0 52.6 64.4 44.1 53.3 31.2 37.2 63.6 51.3 70.8 74.4 51.4 84.6 51.6 60.1 41.5 48.0 73.5 75.4 54.9 54.3 68.4 57.8 47.4 37.7 102.4 70.2 70.5 74.7 37.6 44.5 48.0 77.5 77.7 57.5 62.4 54.6 76.8 42.8 57.4 91.7 53.5 50.2 65.2 80.2 92.2 47.4 65.8 70.2 52.6 34.5 52.1 42.3 48.8 62.5 76.0 45.2 72.1 32.9 49.4 48.2 38.9 61.4 76.8 46.5 130.1 60.7 80.6 46.1 67.6 40.4 61.7 45.2 41.8 62.7 45.0 53.4 48.1 46.1 67.9 47.5 46.3 44.9 27.3 53.6 58.4 57.8 66.2 69.0 51.0 55.1 33.7 52.7 44.5 41.3 43.6 46.9 47.3 36.5 71.5 73.0 111.6 140.8 172.4 37.7 121.6 112.1 101.7 62.6 66.3 21.6 382.0 280.2 281.6 279.3 121.5 147.6 46.7 340.4 299.5 140.7 127.9 102.7 222.4 205.6 31.8 135.5 87.8 123.1 322.3 128.9 128.4 189.0 172.3 121.7 86.0 308.8 129.0 117.8 341.8 43.4 84.1 126.0 246.2 184.2 191.3 408.7 106.6 146.6 177.4 PSMC1 "p56, S4" ENSG00000100764 "Proteasome 26S subunit, ATPase 1" P62191 14 90256495-90275429 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 178.0" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 478.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000872, HPA016885" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 46000 "Nucleoplasm, Cytosol" "HPA000872: AB_1079705, HPA016885: " "unprognostic (4.10e-1)" "unprognostic (9.70e-2)" "unprognostic (8.17e-2)" "unprognostic (1.29e-1)" "unprognostic (2.55e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (1.23e-2)" "unprognostic (1.00e-2)" "unprognostic (1.58e-1)" "unprognostic (1.03e-3)" "unprognostic (1.12e-2)" "unprognostic (1.10e-2)" "unprognostic (1.14e-2)" "unprognostic (1.28e-1)" "unprognostic (1.03e-1)" "unprognostic (2.85e-1)" "unprognostic (1.11e-2)" 23.7 21.6 28.2 16.7 26.6 26.9 24.6 17.1 39.1 18.4 21.0 11.8 14.3 12.7 23.7 27.9 23.4 18.0 13.7 34.5 37.8 19.1 22.8 29.7 17.9 16.2 19.8 29.3 16.1 20.4 21.8 15.9 25.3 37.2 19.0 23.0 12.1 18.9 22.8 178.0 22.9 17.2 23.2 31.3 19.3 20.0 42.1 15.6 14.4 18.0 29.2 25.4 23.3 17.2 21.4 37.7 57.0 38.1 28.7 36.4 37.8 32.4 30.9 35.5 37.0 31.2 28.7 37.4 31.5 44.2 69.7 52.6 28.5 36.7 27.7 48.2 38.1 32.0 33.8 43.4 36.8 81.7 33.1 19.0 21.7 20.7 24.4 27.0 32.9 29.1 25.7 29.2 45.3 33.4 29.2 41.9 30.9 30.6 16.7 47.8 61.7 24.4 42.9 31.3 42.0 38.3 29.4 46.0 22.6 39.2 33.9 37.4 25.0 25.7 67.0 26.3 30.8 42.1 29.1 31.7 26.9 24.0 28.8 45.5 29.0 45.7 41.1 38.9 30.0 40.9 30.9 37.6 57.0 26.6 34.1 26.2 21.4 27.5 27.2 37.7 20.7 25.3 24.8 41.7 28.7 38.1 26.4 36.4 37.8 28.2 26.6 17.1 39.1 37.8 19.1 19.8 29.3 37.2 15.6 95.3 66.7 41.0 73.5 57.8 47.2 33.6 99.3 137.9 116.0 52.4 49.1 265.6 101.2 136.5 478.8 81.7 77.7 46.7 171.7 144.5 72.1 66.8 95.8 167.6 133.3 74.7 54.8 77.3 91.6 350.7 70.8 81.8 64.1 188.4 56.4 79.4 161.0 64.3 77.1 126.3 54.1 84.1 75.2 77.1 45.5 43.8 392.6 74.6 66.8 81.4 PSMC3 "TBP-1, TBP1" ENSG00000165916 "Proteasome 26S subunit, ATPase 3" P17980 11 47418769-47426473 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 134.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006065 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 180000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA006065: AB_1079706" "unprognostic (2.01e-2)" "unprognostic (5.08e-3)" "unprognostic (9.43e-2)" "unprognostic (8.12e-3)" "unprognostic (6.32e-2)" "unprognostic (5.71e-2)" "unprognostic (8.99e-3)" "unprognostic (1.63e-1)" "unprognostic (9.95e-2)" "unprognostic (1.27e-2)" "unprognostic (3.88e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (4.24e-4)" "unprognostic (1.49e-1)" "unprognostic (2.25e-1)" "unprognostic (2.55e-2)" "unprognostic (1.84e-1)" 27.9 25.9 37.3 24.1 49.3 31.8 26.2 25.6 39.7 25.1 28.2 24.9 21.1 20.3 27.2 26.0 29.4 25.0 21.8 45.7 32.8 28.0 30.7 60.2 21.5 22.8 36.1 27.3 21.0 25.2 31.0 16.8 39.8 28.2 22.6 24.0 21.3 32.1 29.8 134.7 34.8 20.9 30.8 24.3 25.7 24.9 24.0 22.9 33.5 27.1 38.3 28.8 25.5 25.3 39.2 45.1 32.6 54.7 45.0 51.1 61.3 39.2 44.7 43.0 31.6 20.7 22.3 41.9 32.8 48.8 82.5 58.6 39.8 23.0 31.9 20.4 41.2 36.3 39.5 37.6 42.9 37.3 47.4 48.7 30.6 54.7 38.4 26.8 35.6 32.8 24.8 23.2 33.4 37.8 18.3 46.3 33.2 43.3 30.1 50.2 87.5 44.9 45.4 42.1 49.9 54.0 47.6 84.6 27.9 38.4 29.6 31.5 27.2 26.8 37.8 20.6 19.0 46.8 37.2 32.6 47.3 59.9 66.9 83.9 32.7 37.7 36.9 48.9 35.8 59.1 24.4 43.5 32.6 47.9 53.1 43.7 39.2 40.4 43.8 45.1 32.8 35.6 36.2 9.8 45.0 54.7 45.1 51.1 61.3 37.3 49.3 25.6 39.7 32.8 28.0 36.1 27.3 28.2 22.9 53.6 40.7 50.7 95.5 76.6 41.9 207.9 76.5 49.5 45.5 64.6 15.7 229.8 129.3 164.4 108.0 86.3 137.8 116.8 176.4 216.8 106.9 72.7 72.8 141.0 139.1 35.0 61.9 63.8 58.5 158.2 82.0 66.5 94.5 170.5 67.3 81.7 174.0 108.7 94.0 148.2 36.4 116.4 134.6 87.3 61.8 67.5 295.1 69.6 93.3 88.7 PSMC3IP "GT198, Hop2, HUMGT198A, TBPIP" ENSG00000131470 "PSMC3 interacting protein" Q9P2W1 17 42572315-42577831 "Disease related genes, Predicted intracellular proteins" "DNA recombination, Meiosis" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 29.8" "Cell type enhanced" "Detected in many" 14 "Spermatocytes: 109.9;Spermatogonia: 37.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 6.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044439 Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "HPA044439: AB_10964210" "unprognostic (2.98e-1)" "unprognostic (3.66e-1)" "unprognostic (1.33e-1)" "unprognostic (2.87e-1)" "unprognostic (6.59e-2)" "unprognostic (2.39e-2)" "unprognostic (1.28e-7)" "unprognostic (6.22e-2)" "unprognostic (6.14e-2)" "unprognostic (2.47e-1)" "unprognostic (7.26e-2)" "unprognostic (1.21e-2)" "prognostic unfavorable (9.41e-4)" "unprognostic (6.03e-2)" "unprognostic (3.68e-1)" "unprognostic (1.39e-2)" "unprognostic (1.82e-1)" 4.0 2.0 6.6 4.2 12.1 9.2 5.2 5.0 7.7 3.4 4.3 7.0 4.1 1.7 5.2 5.5 3.9 8.6 2.4 2.1 7.4 6.3 2.8 1.2 3.1 4.7 9.7 4.1 4.8 2.7 8.5 2.1 5.4 8.7 5.5 4.3 2.4 2.5 5.7 1.9 4.1 1.9 6.9 12.7 2.3 2.8 29.8 9.9 3.1 2.5 1.5 7.1 4.2 3.3 2.4 6.2 2.2 0.5 0.2 1.9 0.3 6.4 9.7 16.2 11.8 3.8 5.4 3.6 25.2 8.0 22.1 27.4 9.6 4.2 6.9 5.6 7.4 8.8 9.8 12.5 9.6 25.5 9.5 10.5 4.1 21.8 11.4 0.5 14.6 4.7 1.8 2.2 34.9 11.7 3.0 6.4 9.1 14.0 12.6 19.2 7.5 9.8 9.1 9.9 7.2 9.2 10.4 16.5 6.2 5.0 5.3 21.6 13.7 10.1 3.7 10.2 8.4 9.0 6.4 3.0 24.0 13.7 17.9 41.6 9.9 16.8 9.9 11.2 6.9 25.9 0.0 0.2 1.8 1.9 0.3 1.9 2.4 0.9 1.7 0.2 0.8 0.3 0.9 2.2 0.2 0.5 6.2 1.2 0.3 6.6 12.1 5.0 7.7 7.4 6.3 9.7 4.1 8.7 9.9 3.0 3.0 3.0 2.5 4.7 5.8 0.8 2.5 22.7 3.4 3.5 9.8 7.6 0.0 3.4 9.2 3.2 0.0 23.3 2.8 16.4 4.3 1.3 1.1 0.9 6.3 0.0 0.0 2.5 3.8 9.4 4.9 2.4 5.0 9.0 0.7 4.6 1.6 0.0 8.1 1.9 13.3 19.4 9.2 109.9 37.9 3.6 4.3 1.9 2.6 0.7 PSMC4 "MGC13687, MGC23214, MGC8570, MIP224, S6, TBP-7, TBP7" ENSG00000013275 "Proteasome 26S subunit, ATPase 4" P43686 19 39971005-39981441 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Syncytiotrophoblasts: 334.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002044, HPA005471" Approved Supported Nucleoplasm,Cytosol NA NA 66000 "Nucleoplasm, Cytosol" "HPA002044: AB_1079707, HPA005471: AB_1855838" "unprognostic (1.66e-1)" "unprognostic (9.08e-2)" "unprognostic (1.69e-1)" "unprognostic (1.83e-2)" "unprognostic (7.46e-2)" "unprognostic (2.27e-2)" "unprognostic (1.29e-3)" "unprognostic (1.53e-2)" "unprognostic (4.45e-1)" "unprognostic (4.42e-2)" "unprognostic (9.90e-2)" "unprognostic (8.45e-2)" "unprognostic (1.10e-1)" "unprognostic (2.34e-1)" "unprognostic (2.02e-1)" "unprognostic (2.81e-1)" "unprognostic (2.32e-1)" 24.0 31.3 23.4 26.1 26.9 15.0 20.3 23.9 37.1 22.8 25.0 26.1 24.9 26.4 29.8 34.0 29.9 25.1 22.2 35.9 24.1 25.4 40.4 65.6 20.1 21.3 25.6 27.4 22.7 19.6 33.1 22.1 29.7 32.3 22.5 24.6 21.8 21.1 28.1 57.3 25.8 24.8 27.1 26.0 25.2 24.1 29.7 25.5 27.9 30.2 28.0 28.5 28.9 20.1 18.1 34.4 16.0 43.1 19.8 28.1 25.8 22.6 73.8 15.0 19.6 12.9 10.7 17.2 13.5 16.5 30.0 23.3 42.6 16.5 11.3 26.3 15.9 17.9 12.3 20.1 18.2 22.8 20.0 21.0 16.7 13.9 34.7 18.9 17.3 20.1 11.3 14.8 24.4 16.7 8.9 19.6 14.4 21.4 17.3 18.3 34.3 20.6 10.0 27.0 28.1 22.5 18.0 18.0 16.3 20.0 34.2 19.4 25.0 15.2 24.3 12.1 14.4 16.8 15.3 12.9 19.7 19.6 17.9 32.7 20.9 36.3 17.5 24.9 18.5 21.6 14.8 20.5 16.0 23.6 32.2 20.0 18.1 21.1 23.9 34.4 16.9 17.1 17.6 11.1 19.8 43.1 17.1 28.1 25.8 23.4 26.9 23.9 37.1 24.1 25.4 25.6 27.4 32.3 25.5 29.8 16.6 42.4 70.2 56.8 48.5 34.4 48.4 48.2 30.7 41.8 13.7 160.1 77.9 114.4 141.3 51.7 104.4 46.7 97.0 94.8 52.8 56.5 40.4 40.6 138.7 39.7 56.7 28.3 37.6 88.3 50.9 55.7 42.2 126.2 23.8 57.9 103.2 84.2 65.7 117.8 40.5 90.5 51.4 54.2 45.4 50.8 334.1 60.9 43.9 72.7 PSMC6 p42 ENSG00000100519 "Proteasome 26S subunit, ATPase 6" P62333 14 52707172-52728587 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042823 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" No No 190000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042823: AB_2678188" "unprognostic (2.38e-2)" "unprognostic (2.72e-2)" "unprognostic (9.18e-2)" "unprognostic (1.29e-1)" "unprognostic (1.19e-2)" "unprognostic (4.26e-3)" "unprognostic (3.14e-3)" "unprognostic (6.30e-2)" "unprognostic (1.06e-1)" "unprognostic (2.79e-2)" "unprognostic (3.50e-2)" "unprognostic (1.00e-2)" "unprognostic (1.52e-2)" "unprognostic (5.00e-2)" "unprognostic (2.68e-1)" "unprognostic (4.13e-2)" "unprognostic (4.67e-1)" 30.4 31.1 29.1 23.0 36.8 19.9 30.7 30.1 40.9 26.4 26.4 19.7 29.8 25.6 27.8 27.0 38.0 26.1 19.3 39.7 30.6 28.3 36.1 45.7 21.6 25.7 29.9 35.0 27.8 25.2 26.5 34.7 37.1 44.0 25.5 28.8 14.7 23.4 25.3 73.3 23.0 26.4 29.5 30.1 28.2 24.9 15.5 31.1 30.0 28.6 44.9 32.9 31.6 24.5 37.6 43.1 37.0 40.9 29.8 48.5 40.6 47.1 30.6 36.8 27.3 25.8 27.0 39.8 37.2 35.8 60.4 45.5 38.3 38.8 41.1 46.6 32.2 30.5 36.0 46.8 32.6 63.6 39.4 20.4 30.1 25.2 40.8 31.2 42.6 29.3 20.0 32.6 30.5 30.9 33.0 37.9 20.7 44.7 17.8 44.0 43.2 33.2 29.6 29.7 44.7 42.1 28.4 64.7 18.3 39.8 48.1 26.5 19.7 33.1 20.7 31.7 34.6 42.6 31.2 29.0 33.7 47.3 26.1 38.1 12.6 32.1 46.0 21.8 29.3 30.5 35.8 36.5 37.0 32.1 40.9 37.1 37.6 39.6 34.9 43.1 34.2 38.2 37.3 30.6 29.8 39.9 22.4 48.5 40.6 29.1 36.8 30.1 40.9 30.6 28.3 29.9 35.0 44.0 31.1 65.5 57.0 70.1 126.5 76.5 60.1 71.1 58.6 97.7 95.5 54.1 64.8 139.1 114.4 111.7 19.5 70.0 62.6 46.7 92.7 114.5 84.1 71.0 64.8 74.2 82.7 58.8 67.5 44.2 77.8 18.3 62.2 71.9 75.9 72.1 50.7 62.8 96.7 45.6 61.5 108.8 98.3 71.1 100.0 39.9 74.1 63.0 198.6 69.5 59.8 107.7 PSMD1 "P112, Rpn2, S1" ENSG00000173692 "Proteasome 26S subunit, non-ATPase 1" Q99460 2 231056864-231172827 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021092, HPA036736, HPA036737" Enhanced Approved "Nucleoplasm,Actin filaments" NA NA 49000 Nucleoplasm "Actin filaments" "CAB021092: AB_10123242, HPA036736: AB_2675278, HPA036737: AB_2675279" "unprognostic (9.32e-3)" "unprognostic (2.08e-2)" "unprognostic (1.07e-1)" "unprognostic (3.81e-2)" "unprognostic (2.71e-1)" "unprognostic (1.78e-2)" "prognostic unfavorable (8.63e-12)" "prognostic unfavorable (2.34e-4)" "unprognostic (2.57e-1)" "unprognostic (1.72e-2)" "unprognostic (3.09e-3)" "unprognostic (2.49e-1)" "unprognostic (8.91e-3)" "unprognostic (1.10e-2)" "unprognostic (6.26e-2)" "unprognostic (4.16e-2)" "unprognostic (1.70e-3)" 21.9 25.5 21.5 19.0 27.8 14.4 18.4 22.3 29.0 17.3 20.6 16.2 15.3 21.7 24.3 17.6 25.3 16.1 13.0 34.9 31.8 22.1 20.9 27.8 16.8 16.3 20.3 27.2 16.4 10.9 73.9 24.6 28.5 34.0 18.7 23.7 15.0 16.7 21.1 75.5 20.2 17.9 27.2 17.5 18.7 17.4 16.8 17.8 20.6 17.3 23.7 22.3 17.8 16.4 14.3 21.2 23.5 26.7 25.6 21.6 15.4 29.1 31.8 35.9 28.0 37.4 27.0 34.7 38.8 40.5 39.4 40.1 38.6 29.1 22.9 36.7 43.3 41.4 28.1 49.8 36.2 53.8 34.7 26.7 42.4 26.1 44.2 19.3 37.2 36.8 23.2 18.0 42.3 22.5 22.4 46.3 21.0 58.5 17.3 46.6 28.4 29.0 21.4 46.2 29.0 25.5 24.7 55.1 21.9 29.0 30.3 24.0 21.5 31.1 28.1 19.0 38.9 22.3 22.0 43.2 31.4 33.1 37.8 36.8 15.1 22.2 40.8 48.4 28.8 35.8 23.5 19.2 14.6 19.2 25.9 19.0 14.3 18.3 16.9 21.2 12.0 14.9 16.8 10.8 25.6 26.7 12.1 21.6 15.4 21.5 27.8 22.3 27.6 31.8 22.1 20.3 27.2 34.0 17.8 47.6 43.2 20.8 30.2 29.5 45.8 114.2 38.2 77.6 44.3 31.4 39.3 104.8 14.9 66.5 4.9 46.6 49.9 0.0 88.3 83.2 46.2 31.9 100.6 73.7 64.0 85.8 37.8 29.4 37.8 8.1 32.2 38.0 16.9 67.7 24.4 50.0 76.2 24.9 43.2 30.0 51.3 71.1 32.5 124.1 96.9 29.0 140.1 29.8 34.0 35.9 PSMD11 "MGC3844, p44.5, Rpn6, S9" ENSG00000108671 "Proteasome 26S subunit, non-ATPase 11" O00231 17 32444261-32483318 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042275, HPA067433" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA 78000 "Nucleoplasm, Golgi apparatus" "HPA042275: AB_10794793, HPA067433: AB_2685838" "unprognostic (1.16e-1)" "unprognostic (2.71e-1)" "unprognostic (6.94e-2)" "unprognostic (2.86e-2)" "unprognostic (2.01e-1)" "unprognostic (1.20e-2)" "prognostic unfavorable (6.33e-6)" "unprognostic (2.64e-2)" "unprognostic (3.97e-1)" "unprognostic (8.10e-2)" "unprognostic (5.88e-2)" "unprognostic (9.17e-3)" "prognostic unfavorable (5.73e-6)" "unprognostic (9.39e-3)" "unprognostic (6.65e-2)" "unprognostic (2.90e-1)" "unprognostic (2.17e-2)" 26.0 22.4 20.7 19.9 22.3 19.9 17.4 22.2 27.1 16.3 19.2 23.8 14.9 19.2 24.2 17.2 28.5 17.6 16.5 24.7 18.3 18.7 21.7 38.2 19.1 19.5 24.4 16.9 19.1 25.8 30.1 19.1 27.5 28.1 18.6 23.7 17.3 19.2 16.7 69.0 25.3 18.8 25.4 19.1 20.0 18.3 22.8 19.8 27.7 19.5 26.9 26.8 18.9 18.9 24.4 30.8 22.8 28.0 30.1 33.1 26.8 35.7 39.7 29.0 31.2 19.7 14.7 31.0 20.4 26.5 45.4 36.9 40.0 32.8 28.1 32.6 22.1 43.7 41.7 33.0 28.4 44.7 14.2 22.5 22.7 20.1 30.9 19.2 26.9 24.4 13.1 15.0 39.4 27.4 14.5 31.8 25.2 43.0 33.0 26.6 22.2 40.2 15.9 39.8 19.3 20.0 25.0 37.6 38.0 22.3 26.9 25.7 17.4 25.9 18.8 20.6 31.4 45.5 12.9 21.8 25.4 29.6 31.3 47.1 18.4 28.7 37.2 36.8 21.1 42.6 22.8 27.4 16.7 28.3 27.1 31.0 24.4 27.7 28.4 30.8 23.7 24.9 26.0 12.6 30.1 28.0 25.1 33.1 26.8 20.7 22.3 22.2 27.1 18.3 18.7 24.4 16.9 28.1 19.8 44.7 26.9 44.2 79.8 112.8 41.5 63.9 50.9 28.1 51.2 24.4 29.5 156.7 68.0 89.4 179.8 49.7 62.9 46.7 93.2 121.7 52.5 82.6 45.0 95.7 80.8 35.0 46.7 49.7 44.8 37.3 45.5 50.2 25.3 80.2 45.1 59.3 94.8 45.6 45.6 82.8 40.8 51.8 72.9 151.9 108.8 102.8 258.4 51.7 51.7 105.7 PSMD12 "p55, Rpn5" ENSG00000197170 "Proteasome 26S subunit, non-ATPase 12" O00232 17 67337916-67366627 "Disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023119 Approved Approved Nucleoplasm,Microtubules,Cytosol NA NA 44000 Microtubules "Nucleoplasm, Cytosol" "HPA023119: AB_1855845" "unprognostic (6.06e-2)" "unprognostic (3.16e-2)" "prognostic favorable (4.39e-4)" "unprognostic (1.35e-2)" "unprognostic (2.28e-1)" "unprognostic (1.97e-3)" "prognostic unfavorable (1.21e-4)" "unprognostic (1.28e-2)" "unprognostic (3.72e-2)" "prognostic favorable (6.32e-4)" "unprognostic (2.63e-1)" "unprognostic (7.32e-3)" "prognostic unfavorable (4.73e-6)" "unprognostic (1.52e-2)" "unprognostic (1.82e-1)" "unprognostic (1.08e-1)" "unprognostic (1.36e-1)" 16.4 18.0 16.0 12.3 16.0 11.8 14.1 19.5 26.7 11.7 11.8 8.8 11.5 9.4 12.5 13.3 16.4 9.9 11.4 14.9 17.0 19.7 17.1 31.4 10.8 11.3 23.6 15.3 12.6 17.6 15.7 12.9 13.7 32.5 12.8 13.8 8.1 12.5 11.0 42.3 11.6 10.8 15.7 13.4 12.0 12.4 15.5 11.3 12.7 12.2 18.9 16.7 17.2 19.6 8.8 10.8 12.1 18.1 11.4 14.0 8.9 28.4 17.4 13.8 15.1 10.6 12.9 18.9 20.3 13.0 22.6 20.1 18.0 12.7 16.4 13.1 16.5 17.8 16.9 23.9 20.8 34.0 7.9 17.8 19.1 14.5 18.5 13.8 19.8 11.8 14.2 13.9 21.4 16.9 10.1 22.2 12.7 25.4 9.8 21.2 19.5 18.1 19.2 16.6 13.7 23.1 9.3 35.5 14.7 16.8 23.8 13.2 19.1 15.0 29.4 19.6 17.0 21.0 16.8 22.8 24.1 16.2 18.0 36.6 10.0 15.3 13.9 28.4 21.0 13.8 12.1 10.6 8.8 9.9 17.4 14.0 8.6 13.0 11.1 10.8 8.8 11.7 12.3 7.6 11.4 18.1 7.0 12.1 8.9 16.0 16.0 19.5 26.7 17.0 19.7 23.6 15.3 32.5 11.3 44.7 50.4 33.7 90.9 99.7 41.1 95.7 28.1 60.2 102.4 43.6 23.6 81.6 59.7 68.1 139.8 67.3 22.6 23.3 68.5 68.6 54.6 70.8 48.6 75.5 49.5 87.4 31.6 41.1 43.5 155.9 42.8 55.9 45.5 62.3 25.6 57.8 66.4 21.0 41.4 62.2 40.5 25.8 111.2 105.1 101.1 82.8 102.9 48.5 28.3 110.7 PSMD14 "pad1, POH1, Rpn11" ENSG00000115233 "Proteasome 26S subunit, non-ATPase 14" O00487 2 161308038-161411717 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002114, HPA003828" Approved Supported Nucleoplasm NA NA 9400 Nucleoplasm "HPA002114: AB_1855850, HPA003828: AB_2667057" "unprognostic (3.50e-3)" "unprognostic (1.48e-1)" "unprognostic (9.61e-2)" "unprognostic (6.63e-2)" "unprognostic (2.57e-1)" "unprognostic (7.61e-3)" "prognostic unfavorable (2.66e-8)" "unprognostic (3.11e-2)" "unprognostic (4.04e-2)" "unprognostic (3.90e-3)" "unprognostic (9.84e-3)" "unprognostic (3.02e-1)" "prognostic unfavorable (3.10e-6)" "unprognostic (2.86e-2)" "unprognostic (4.70e-2)" "unprognostic (3.54e-1)" "unprognostic (1.66e-1)" 18.2 26.3 24.8 19.9 25.0 16.8 19.8 21.0 36.9 14.7 17.9 13.5 11.0 15.0 15.6 16.3 23.7 14.4 12.2 22.3 24.8 26.1 23.5 33.7 16.2 24.9 26.2 16.1 11.8 15.0 18.6 24.3 21.5 27.9 16.8 21.9 13.0 15.1 16.7 60.8 16.7 14.3 20.6 26.0 20.2 13.6 19.0 15.3 22.1 18.2 21.6 25.6 15.2 13.1 22.9 27.2 13.1 24.6 23.6 29.6 24.7 35.5 30.9 34.8 30.5 25.4 21.7 42.6 37.4 36.0 53.6 43.7 45.4 30.3 42.2 57.1 27.2 31.8 27.4 37.9 39.6 53.6 43.9 28.5 42.1 25.0 50.9 31.2 40.8 25.1 16.5 30.0 60.5 56.6 20.8 39.8 25.3 45.6 30.4 44.5 33.9 30.1 30.8 48.3 26.2 46.9 26.0 33.8 41.2 47.2 30.5 30.3 22.3 25.4 28.7 34.6 30.2 19.5 26.2 31.4 36.0 33.8 24.4 40.8 18.2 49.2 39.6 38.6 27.2 39.4 13.1 17.9 8.8 25.3 24.6 26.5 22.9 27.4 27.0 27.2 19.1 22.2 26.5 1.9 23.6 19.1 26.7 29.6 24.7 24.8 25.0 21.0 36.9 24.8 26.1 26.2 16.1 27.9 15.3 47.6 33.9 44.7 39.4 44.0 40.0 76.7 63.7 42.8 47.8 22.7 17.7 140.9 76.3 104.7 52.8 33.7 43.3 116.8 102.6 127.3 45.3 47.7 48.7 107.7 92.8 44.5 50.4 38.6 35.5 24.8 25.6 45.0 45.5 84.8 42.0 72.5 114.5 46.3 32.2 81.6 54.2 32.3 39.1 93.8 67.0 48.9 184.2 43.6 58.4 43.1 PSMD3 "P58, Rpn3, S3, TSTA2" ENSG00000108344 "Proteasome 26S subunit, non-ATPase 3" O43242 17 39980797-39997960 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Syncytiotrophoblasts: 227.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 141.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017038, HPA048972" Approved Enhanced Nucleoplasm,Cytosol No No 380000 Nucleoplasm Cytosol "CAB017038: , HPA048972: AB_2680579" "unprognostic (3.44e-2)" "unprognostic (3.10e-1)" "unprognostic (2.22e-2)" "unprognostic (5.21e-2)" "unprognostic (7.87e-2)" "unprognostic (8.36e-3)" "unprognostic (5.75e-3)" "unprognostic (7.46e-2)" "unprognostic (6.19e-2)" "unprognostic (1.61e-1)" "unprognostic (6.89e-2)" "unprognostic (4.42e-2)" "prognostic unfavorable (4.47e-7)" "unprognostic (1.54e-1)" "unprognostic (1.32e-1)" "unprognostic (2.85e-2)" "unprognostic (7.45e-2)" 25.1 27.7 20.0 25.0 26.1 22.0 21.3 30.0 40.3 22.5 28.1 22.4 16.8 23.2 26.8 21.2 27.7 22.7 23.7 36.1 20.6 21.4 23.8 54.4 20.8 22.3 19.2 23.7 24.0 23.6 28.1 20.8 33.8 24.5 23.2 25.4 21.4 22.5 21.9 93.2 33.2 23.5 24.7 17.6 26.9 21.1 19.9 17.5 35.7 24.3 39.2 26.3 20.7 21.2 15.6 24.3 14.4 17.0 13.1 17.7 12.0 32.7 40.9 22.5 32.3 18.4 11.9 26.8 24.2 25.2 43.7 34.0 33.8 28.3 39.5 61.0 25.9 29.3 51.5 39.9 31.6 29.6 39.7 44.5 22.8 21.0 33.4 16.7 30.7 25.6 15.8 27.0 46.2 20.3 14.7 24.6 27.7 46.5 24.7 20.2 23.9 47.5 21.1 31.2 21.3 24.3 35.0 31.3 37.0 21.8 22.2 29.7 22.5 23.1 141.9 19.9 28.6 31.9 26.6 21.9 18.9 33.5 27.9 43.2 26.9 34.1 44.0 29.0 23.2 30.5 6.6 16.8 14.4 15.1 17.0 15.1 14.4 14.6 17.7 24.3 15.6 13.7 16.5 5.5 13.1 14.3 16.7 12.6 12.0 20.0 26.1 30.0 40.3 20.6 21.4 19.2 23.7 24.5 17.5 41.7 37.3 61.7 49.4 41.4 70.1 17.3 15.3 16.0 29.6 15.7 19.6 147.2 39.7 91.3 204.0 32.3 72.1 23.3 91.5 109.0 44.2 48.0 24.3 44.4 86.1 57.2 25.3 27.0 23.7 35.1 58.1 39.1 62.4 73.1 44.9 81.4 81.7 58.8 50.9 43.1 47.4 25.8 47.6 47.1 57.9 39.0 227.2 36.2 61.2 47.1 PSMD4 "AF, AF-1, Rpn10, S5A" ENSG00000159352 "Proteasome 26S subunit, non-ATPase 4" P55036 1 151254703-151267479 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038807, HPA039252, CAB047300" Enhanced Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB047300: , HPA038807: AB_2676217, HPA039252: AB_10673418" "unprognostic (3.83e-2)" "unprognostic (7.89e-2)" "unprognostic (6.86e-3)" "unprognostic (1.70e-1)" "unprognostic (2.63e-1)" "unprognostic (2.89e-2)" "unprognostic (1.79e-3)" "unprognostic (2.16e-1)" "unprognostic (2.81e-1)" "unprognostic (2.61e-2)" "unprognostic (7.57e-2)" "unprognostic (2.11e-1)" "prognostic unfavorable (6.66e-10)" "unprognostic (9.80e-2)" "unprognostic (6.60e-2)" "unprognostic (2.03e-2)" "unprognostic (3.91e-1)" 27.5 28.0 44.3 24.4 46.4 25.5 29.9 25.7 50.4 21.9 28.6 28.3 16.5 22.7 25.1 41.5 26.7 31.4 21.8 38.7 37.5 36.8 25.3 44.7 20.2 28.2 47.5 44.8 26.7 27.7 27.4 19.3 30.0 43.2 23.0 28.1 24.3 25.6 31.2 86.7 28.0 20.5 39.3 29.6 26.3 25.8 35.9 29.1 23.1 23.7 25.7 36.2 28.0 19.8 62.7 65.1 111.6 76.0 54.2 74.2 88.2 42.3 51.0 37.7 30.8 41.1 30.5 41.1 28.7 35.3 45.9 36.7 66.7 48.5 34.4 70.6 40.5 31.8 44.4 48.4 43.4 39.3 56.1 42.2 33.6 43.5 68.7 45.4 39.4 39.2 33.0 36.1 52.4 48.5 34.5 40.0 38.7 52.2 43.8 38.4 124.8 36.2 48.0 71.6 65.6 51.6 30.8 36.7 62.1 45.0 36.3 29.6 50.5 31.9 46.9 38.0 58.2 49.0 78.0 35.1 22.9 36.0 28.1 49.0 52.5 65.1 73.4 38.0 37.2 41.7 59.6 71.5 111.6 43.0 76.0 48.4 62.7 50.5 47.3 65.1 61.1 46.4 46.0 95.8 54.2 75.5 39.2 74.2 88.2 44.3 46.4 25.7 50.4 37.5 36.8 47.5 44.8 43.2 29.1 53.6 55.8 113.9 90.7 78.8 48.8 216.6 79.0 80.3 42.1 57.6 25.5 289.4 142.6 149.2 182.3 103.4 106.2 93.5 163.0 189.2 97.9 84.2 80.9 96.2 163.2 31.8 80.8 69.3 92.1 179.3 97.5 96.7 99.5 354.3 71.9 58.4 143.7 95.1 92.6 161.4 44.8 116.4 130.8 169.8 77.8 75.7 346.7 94.7 97.0 85.8 PSMD5 "KIAA0072, S5B" ENSG00000095261 "Proteasome 26S subunit, non-ATPase 5" Q16401 9 120815496-120842984 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003216 Uncertain Approved Nucleoplasm,Cytosol No No 12000000 Cytosol Nucleoplasm "HPA003216: AB_1079709" "unprognostic (7.72e-2)" "unprognostic (5.20e-2)" "unprognostic (2.75e-2)" "unprognostic (2.63e-2)" "unprognostic (1.39e-1)" "unprognostic (1.25e-2)" "unprognostic (1.44e-3)" "unprognostic (8.02e-2)" "unprognostic (5.11e-2)" "unprognostic (3.45e-1)" "unprognostic (3.45e-2)" "unprognostic (2.04e-3)" "unprognostic (4.39e-1)" "unprognostic (3.11e-2)" "unprognostic (1.45e-1)" "unprognostic (4.23e-2)" "unprognostic (1.87e-1)" 14.1 20.1 10.2 12.2 16.2 14.7 32.5 20.7 21.8 14.6 12.9 10.2 12.3 10.3 14.8 14.1 17.3 13.8 10.6 12.7 11.7 12.3 11.5 21.0 34.8 23.6 9.8 14.1 16.7 32.2 13.3 11.7 10.5 14.5 16.1 12.5 8.8 15.1 15.7 10.0 16.7 11.2 24.5 9.9 12.3 14.4 11.3 8.1 13.0 12.6 9.2 15.5 14.9 13.5 17.5 14.4 15.2 17.9 14.2 25.2 14.2 13.1 17.1 8.3 15.4 18.6 18.5 9.8 19.5 15.3 18.5 16.9 15.2 8.7 13.4 8.9 19.8 14.6 19.7 0.0 19.2 21.6 12.2 1.9 11.2 23.8 8.4 14.0 3.9 4.2 15.5 12.5 17.9 19.2 9.2 10.7 14.7 41.0 9.0 17.2 16.3 11.9 8.1 12.3 32.1 12.2 11.0 18.1 10.6 17.0 11.6 11.4 7.3 23.6 20.1 9.3 6.5 24.0 9.5 16.5 0.0 10.0 7.7 17.2 5.4 5.4 14.7 11.4 12.9 16.3 15.2 14.9 12.3 17.1 16.5 18.6 17.5 19.9 20.5 14.4 13.2 19.4 15.1 8.1 14.2 17.9 10.5 25.2 14.2 10.2 16.2 20.7 21.8 11.7 12.3 9.8 14.1 14.5 8.1 8.9 14.2 12.8 9.5 11.0 14.0 7.5 12.7 6.7 21.6 8.7 11.8 10.1 10.0 10.8 5.2 10.9 9.5 0.0 11.6 9.5 13.9 12.5 13.9 22.2 10.6 4.8 7.5 16.0 13.9 3.2 12.0 10.6 13.5 7.2 14.3 9.5 13.9 10.8 15.2 12.9 10.4 6.5 15.1 21.1 20.0 11.8 9.2 17.5 9.3 8.4 PSMD7 "MOV34, P40, Rpn8, S12" ENSG00000103035 "Proteasome 26S subunit, non-ATPase 7" P51665 16 74296775-74306288 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Syncytiotrophoblasts: 498.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019379, HPA049824, HPA056069" Enhanced Enhanced Nucleoplasm NA NA 340000 Nucleoplasm "CAB019379: , HPA049824: AB_2680899, HPA056069: AB_2683025" "unprognostic (4.75e-3)" "unprognostic (1.30e-1)" "unprognostic (2.84e-2)" "unprognostic (6.95e-2)" "unprognostic (7.62e-2)" "prognostic unfavorable (6.64e-5)" "prognostic unfavorable (7.71e-6)" "unprognostic (1.97e-2)" "unprognostic (6.51e-2)" "unprognostic (1.91e-2)" "unprognostic (9.34e-3)" "unprognostic (1.34e-2)" "unprognostic (2.52e-2)" "unprognostic (5.06e-3)" "unprognostic (7.04e-2)" "unprognostic (2.12e-1)" "unprognostic (1.86e-2)" 26.5 30.3 23.6 20.8 32.8 45.7 21.7 21.7 34.4 17.7 26.6 22.4 17.0 19.8 24.3 26.1 31.5 16.9 17.6 59.0 22.0 21.7 25.0 47.8 20.3 23.5 24.9 22.9 17.1 18.8 23.2 17.4 44.1 36.1 30.3 28.3 16.7 22.8 27.1 88.8 30.6 22.3 26.4 25.1 27.1 21.8 20.3 22.4 30.7 18.2 34.4 28.4 34.6 22.3 50.3 71.0 64.7 60.8 44.6 56.5 58.1 27.2 45.4 33.7 17.2 24.4 25.3 42.6 38.4 32.4 47.3 43.9 60.1 38.0 37.4 42.7 31.1 20.9 35.4 26.9 34.8 42.3 22.1 29.6 28.9 35.3 45.8 32.2 46.7 49.3 23.2 35.1 42.6 42.8 21.1 41.4 23.7 42.7 16.6 30.1 67.6 26.8 44.2 36.6 27.9 22.8 38.8 21.8 49.7 25.0 41.2 21.5 24.3 37.3 14.0 22.0 26.9 29.7 32.2 37.5 28.4 23.8 30.9 28.7 35.6 45.7 109.0 38.7 34.2 29.3 45.6 58.4 64.7 49.8 60.8 48.5 50.3 49.7 52.0 71.0 36.1 48.7 49.9 34.8 44.6 60.2 59.6 56.5 58.1 23.6 32.8 21.7 34.4 22.0 21.7 24.9 22.9 36.1 22.4 62.5 54.4 81.1 136.0 92.7 50.9 45.6 63.7 85.6 83.0 43.6 7.9 286.0 68.0 118.6 92.9 69.2 93.5 70.0 165.2 180.6 80.2 157.1 101.6 127.1 167.8 54.0 82.1 71.8 72.2 15.2 52.3 110.5 94.5 141.5 71.9 64.7 136.6 87.7 61.5 80.1 48.3 90.5 77.3 113.4 94.9 113.0 498.5 82.8 82.9 180.5 PSME2 PA28beta ENSG00000100911 "Proteasome activator subunit 2" Q9UL46 14 24143362-24147570 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 120.2" "Cell type enhanced" "Detected in many" 6 "monocytes: 1118.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA062661 Approved Nucleoplasm NA NA 8000000 Nucleoplasm "HPA062661: AB_2684825" "prognostic favorable (1.27e-4)" "unprognostic (7.55e-3)" "unprognostic (2.84e-1)" "unprognostic (8.72e-2)" "unprognostic (2.69e-1)" "unprognostic (1.50e-1)" "unprognostic (3.71e-1)" "unprognostic (1.02e-1)" "unprognostic (2.30e-2)" "unprognostic (2.90e-3)" "unprognostic (2.07e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (3.47e-5)" "unprognostic (3.09e-2)" "unprognostic (3.00e-1)" "unprognostic (6.43e-3)" "unprognostic (3.07e-3)" 15.4 43.4 14.9 33.9 17.1 16.4 17.1 14.2 14.3 17.5 42.7 9.9 33.5 63.3 17.6 30.2 24.4 17.6 31.3 15.8 13.1 14.7 36.3 64.6 27.5 38.7 13.9 11.0 20.7 26.4 14.6 30.1 25.9 15.3 22.2 35.5 14.3 28.2 36.8 13.6 15.1 102.2 18.6 12.3 61.5 21.4 12.5 13.8 32.7 27.5 27.9 35.9 20.0 18.5 38.8 48.9 20.0 112.2 49.9 45.1 120.2 18.7 19.5 12.6 28.5 9.4 13.7 18.7 11.1 25.9 35.3 44.2 15.1 43.7 25.6 6.5 12.4 36.0 16.9 7.6 19.5 21.2 40.5 6.5 14.9 10.9 60.3 30.4 21.0 22.5 13.6 6.0 24.4 9.9 14.3 17.3 17.1 7.3 32.3 13.5 41.6 41.0 31.0 4.3 31.1 26.5 38.7 19.3 27.9 23.9 44.0 7.7 10.2 20.3 34.6 14.4 7.0 17.7 25.1 13.2 17.6 16.2 8.1 20.2 30.1 39.2 28.4 12.9 23.0 21.9 8.3 60.5 20.0 43.6 112.2 45.1 38.8 43.6 42.8 48.9 29.4 32.8 39.9 19.4 49.9 71.7 35.8 41.7 120.2 14.9 17.1 14.2 14.3 13.1 14.7 13.9 11.0 15.3 13.8 47.6 112.2 196.6 142.5 137.6 37.8 61.3 160.5 129.8 102.4 111.7 21.6 275.9 253.7 303.1 9.6 150.1 574.8 0.0 494.7 240.1 145.1 162.7 140.6 195.6 314.2 27.0 94.0 60.2 127.5 9.7 68.4 275.5 129.9 1118.1 171.6 43.0 283.1 252.6 73.2 281.2 17.2 45.3 111.2 53.1 17.4 122.2 190.9 197.9 289.3 191.8 PSME3 "Ki, PA28-gamma, PA28G, REG-GAMMA" ENSG00000131467 "Proteasome activator subunit 3" P61289 17 42824385-42843758 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 225.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008388, HPA012510" Supported Enhanced Nucleoplasm NA NA 260000 Nucleoplasm "CAB008388: AB_592552, HPA012510: AB_1855752" "unprognostic (4.22e-2)" "unprognostic (2.38e-2)" "unprognostic (1.63e-3)" "unprognostic (2.65e-1)" "unprognostic (1.36e-1)" "unprognostic (8.30e-3)" "prognostic unfavorable (5.41e-5)" "unprognostic (6.02e-3)" "unprognostic (2.30e-1)" "unprognostic (1.26e-2)" "unprognostic (1.89e-2)" "unprognostic (2.41e-1)" "unprognostic (5.17e-2)" "unprognostic (4.09e-2)" "unprognostic (1.17e-1)" "unprognostic (5.41e-3)" "unprognostic (1.02e-1)" 29.8 32.4 31.7 27.8 37.6 28.2 25.9 22.7 52.7 25.3 28.6 25.3 16.7 26.3 28.4 18.8 44.9 24.8 22.1 32.1 24.8 25.9 47.9 48.5 24.8 32.5 28.7 28.3 27.1 31.0 38.1 21.3 31.3 34.9 23.9 32.0 26.8 29.2 27.5 49.7 32.3 30.1 28.9 21.0 32.8 30.5 32.7 20.4 34.5 29.7 20.4 39.5 31.1 24.8 26.2 38.0 50.4 43.3 32.4 32.3 38.4 39.0 64.8 29.8 31.7 27.3 27.9 40.6 44.9 34.2 62.0 43.8 54.0 29.7 60.0 35.2 38.7 33.8 35.3 48.2 47.4 72.9 30.7 48.3 32.0 33.8 38.6 30.9 70.3 37.1 27.3 32.6 46.8 46.9 17.6 37.9 32.5 62.6 21.4 41.9 22.7 66.0 24.5 44.1 56.4 35.4 43.5 54.3 47.8 32.8 55.4 37.4 38.3 27.4 23.0 34.7 46.2 53.2 30.3 36.5 48.7 34.1 40.2 65.2 33.5 51.6 75.8 34.3 40.6 49.6 22.9 38.2 35.0 30.1 43.3 32.3 26.2 24.8 28.9 38.0 24.1 23.1 26.1 50.4 32.4 35.2 21.3 28.9 38.4 31.7 37.6 22.7 52.7 24.8 25.9 28.7 28.3 34.9 20.4 17.9 22.9 26.1 27.0 26.9 12.0 31.9 25.5 17.4 18.2 27.9 13.7 38.0 23.2 57.0 225.1 19.7 27.4 0.0 45.8 61.2 19.5 29.4 21.9 24.5 43.4 12.7 23.7 17.2 29.8 99.0 14.4 20.8 15.1 42.3 22.2 16.0 52.4 20.9 18.7 37.0 18.5 19.4 21.9 30.2 45.8 41.3 63.7 17.0 27.9 49.5 PSME4 "KIAA0077, PA200" ENSG00000068878 "Proteasome activator subunit 4" Q14997 2 53864067-53970840 "Predicted intracellular proteins" "Differentiation, DNA damage, DNA repair, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 49.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060922 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA060922: AB_2684386" "unprognostic (2.77e-2)" "unprognostic (1.57e-1)" "unprognostic (5.00e-2)" "prognostic unfavorable (8.99e-4)" "unprognostic (7.26e-2)" "unprognostic (2.27e-1)" "prognostic unfavorable (4.84e-4)" "unprognostic (4.76e-2)" "unprognostic (6.67e-2)" "unprognostic (5.65e-2)" "unprognostic (3.72e-3)" "unprognostic (1.38e-1)" "unprognostic (1.80e-3)" "unprognostic (1.73e-1)" "unprognostic (1.40e-1)" "unprognostic (1.60e-1)" "unprognostic (2.89e-1)" 11.3 8.4 5.2 10.1 7.8 9.9 8.5 4.2 8.3 12.2 8.0 9.1 7.0 3.9 11.2 5.9 8.8 7.5 10.6 30.9 6.2 3.4 4.9 12.2 11.3 7.9 8.7 5.1 6.6 7.0 7.4 8.4 6.1 6.7 6.8 6.2 6.1 14.2 8.6 49.8 7.1 6.8 11.6 4.1 6.4 9.5 23.8 9.4 8.6 9.0 11.7 8.6 11.5 10.1 4.3 2.0 2.4 1.3 2.3 3.3 0.8 15.6 11.0 17.2 4.9 5.8 12.4 10.5 16.5 15.7 18.2 14.9 17.2 6.5 22.6 14.9 17.9 8.8 10.8 19.5 14.5 31.8 15.8 9.9 33.8 11.2 23.0 7.5 17.7 10.0 9.3 8.9 20.7 16.8 7.6 18.7 6.1 27.3 14.7 16.3 6.5 10.7 7.3 15.6 8.2 9.3 12.8 23.9 14.8 9.9 16.5 12.1 13.8 10.6 14.8 8.9 11.3 11.1 7.5 21.6 16.0 12.9 11.6 15.2 9.1 9.0 14.1 12.5 15.2 9.7 2.2 0.8 2.4 3.3 1.3 1.8 3.2 2.2 2.0 1.2 4.3 2.4 3.0 2.2 2.3 1.1 2.0 1.6 0.8 5.2 7.8 4.2 8.3 6.2 3.4 8.7 5.1 6.7 9.4 14.9 34.9 28.3 54.9 67.3 19.7 59.7 22.9 26.8 46.6 21.0 43.2 13.9 3.3 18.5 73.6 25.2 13.7 23.3 31.7 10.5 30.0 89.0 27.7 30.6 17.2 23.8 38.9 19.6 21.4 71.5 19.5 25.3 27.0 19.0 15.2 14.6 36.2 11.6 9.9 8.4 28.4 12.9 26.9 21.4 18.5 57.7 24.8 27.7 11.9 88.5 PSMG1 "c21-LRP, DSCR2, LRPC21, PAC1" ENSG00000183527 "Proteasome assembly chaperone 1" O95456 21 39174769-39183851 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 67.3" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 408.1;Spermatocytes: 226.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057193, HPA070225" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" No No "Nucleoplasm, Golgi apparatus, Cytosol" "HPA057193: AB_2683363, HPA070225: AB_2686236" "unprognostic (1.52e-2)" "unprognostic (1.24e-1)" "unprognostic (1.27e-1)" "unprognostic (2.34e-1)" "unprognostic (2.10e-1)" "unprognostic (9.38e-2)" "unprognostic (5.06e-3)" "unprognostic (2.02e-1)" "unprognostic (1.66e-2)" "unprognostic (5.09e-2)" "unprognostic (1.09e-1)" "unprognostic (7.99e-2)" "prognostic unfavorable (3.58e-5)" "unprognostic (2.84e-1)" "unprognostic (8.98e-2)" "unprognostic (1.32e-2)" "unprognostic (4.17e-3)" 7.0 11.0 8.2 8.7 8.0 15.1 6.9 7.7 13.1 7.0 10.2 4.7 5.2 9.2 8.2 9.2 12.5 6.9 9.4 7.6 7.5 8.9 11.7 21.4 6.1 8.1 6.9 10.2 7.9 21.5 5.1 10.0 7.5 8.5 5.7 10.0 7.3 8.0 5.2 13.0 7.0 8.4 8.3 7.1 7.0 7.1 67.3 4.6 7.8 10.6 10.4 7.6 6.7 7.4 11.4 11.5 7.3 7.9 6.7 14.9 7.9 27.1 8.9 6.5 8.9 3.2 3.7 17.3 15.0 6.6 11.8 7.6 16.3 7.1 29.4 8.0 4.2 10.5 7.8 10.2 8.0 7.7 12.6 16.1 55.6 13.8 21.1 5.8 26.4 11.1 5.1 6.0 12.5 12.6 2.6 6.2 12.8 40.9 16.9 7.0 14.4 16.2 14.3 22.4 10.4 13.9 26.5 8.1 29.9 4.9 8.1 20.7 6.1 18.9 10.7 14.9 1.2 10.1 13.3 7.0 13.6 4.7 18.2 21.2 13.0 20.5 25.5 11.5 44.7 10.4 7.3 6.4 3.5 10.6 7.8 12.2 11.4 14.9 12.2 11.5 9.0 11.9 10.4 0.5 6.7 7.9 10.5 12.6 7.9 8.2 8.0 7.7 13.1 7.5 8.9 6.9 10.2 8.5 4.6 6.0 18.3 19.9 34.3 120.8 14.8 21.8 22.9 12.0 29.6 19.2 3.9 93.4 56.3 35.1 408.1 22.4 14.4 0.0 43.3 92.9 37.1 22.6 34.7 28.1 51.9 7.9 28.7 19.6 18.1 33.7 29.4 26.6 43.9 26.2 40.2 9.4 31.9 21.0 31.1 76.3 16.1 25.8 31.9 226.4 91.0 85.4 45.5 20.3 50.8 26.7 PSMG2 "CLAST3, HCCA3, HsT1707, MDS003, MGC15092, PAC2, TNFSF5IP1" ENSG00000128789 "Proteasome assembly chaperone 2" Q969U7 18 12658043-12725740 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 378.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 93.0" "Low region specificity" "Detected in all" "HPA041517, HPA046741" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA041517: AB_2677530, HPA046741: AB_2679780" "unprognostic (2.28e-2)" "unprognostic (9.44e-3)" "unprognostic (9.68e-2)" "unprognostic (1.15e-1)" "unprognostic (4.40e-1)" "unprognostic (1.43e-1)" "unprognostic (4.66e-2)" "unprognostic (1.63e-1)" "unprognostic (1.06e-1)" "prognostic favorable (3.09e-4)" "unprognostic (5.91e-2)" "unprognostic (2.27e-1)" "unprognostic (1.73e-1)" "unprognostic (9.04e-2)" "unprognostic (1.23e-1)" "unprognostic (4.82e-2)" "unprognostic (6.75e-3)" 37.3 31.0 24.1 25.2 25.2 42.0 37.4 26.2 27.4 30.5 30.3 24.7 20.6 25.6 34.8 39.6 43.4 27.8 39.2 28.5 23.5 23.4 38.7 46.8 30.9 41.8 24.0 18.9 35.7 44.8 9.9 26.4 35.4 23.0 32.5 35.2 24.8 31.9 28.5 29.0 32.2 34.6 38.1 27.0 35.1 31.0 71.6 20.6 49.0 40.3 37.1 41.3 38.1 29.9 28.8 31.2 33.0 40.9 27.6 41.5 33.2 18.0 11.6 13.5 17.5 25.3 37.0 18.0 17.3 28.4 32.6 36.9 19.7 20.3 20.9 14.2 21.0 23.4 11.5 21.9 23.8 28.5 10.8 10.4 11.4 10.5 23.9 24.2 38.7 17.8 29.6 18.9 19.2 26.3 18.8 22.8 16.2 17.0 26.8 25.3 18.0 24.4 53.6 10.6 93.0 13.7 16.7 20.4 29.9 29.3 25.4 16.6 12.7 17.0 20.1 16.3 14.1 17.5 32.5 14.6 36.3 46.6 30.5 20.2 22.4 31.0 24.6 21.3 20.1 14.5 29.0 35.8 33.0 27.5 36.3 32.7 28.8 36.1 31.6 31.2 26.1 33.1 31.0 12.0 27.6 40.9 25.8 41.5 33.2 24.1 25.2 26.2 27.4 23.5 23.4 24.0 18.9 23.0 20.6 47.6 38.4 56.2 83.4 80.8 24.2 29.0 58.6 49.5 38.7 78.5 21.6 169.1 131.0 97.4 378.7 70.5 65.0 0.0 96.8 115.7 101.3 74.8 60.0 52.1 131.4 23.8 65.8 80.4 130.8 85.9 124.3 107.7 69.2 107.4 75.8 51.3 90.0 80.1 91.2 141.7 16.9 84.1 96.6 169.3 251.7 78.7 155.8 80.3 91.4 103.6 PSMG4 "C6orf86, PAC4" ENSG00000180822 "Proteasome assembly chaperone 4" Q5JS54 6 3231403-3303373 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067652, HPA074376, HPA075846" Approved Approved Nucleoplasm,Mitochondria No No "Nucleoplasm, Mitochondria" "HPA067652: AB_2685880, HPA074376: , HPA075846: " "unprognostic (3.13e-3)" "unprognostic (6.00e-2)" "unprognostic (3.60e-1)" "unprognostic (4.11e-2)" "unprognostic (4.11e-1)" "unprognostic (2.20e-1)" "unprognostic (6.52e-3)" "unprognostic (1.57e-2)" "unprognostic (6.96e-2)" "unprognostic (6.74e-3)" "unprognostic (7.40e-3)" "unprognostic (3.02e-2)" "prognostic unfavorable (7.45e-4)" "unprognostic (1.59e-1)" "unprognostic (8.18e-2)" "unprognostic (2.54e-1)" "unprognostic (3.48e-2)" 13.9 12.7 12.6 13.0 26.1 14.3 16.0 18.5 14.4 15.8 15.1 11.8 11.3 17.3 16.7 23.1 16.9 13.4 18.7 12.9 11.4 14.0 13.1 18.1 11.0 15.2 10.7 12.2 13.8 30.9 8.9 16.2 9.6 10.7 15.5 8.9 13.6 21.0 18.8 36.6 17.9 16.8 18.1 10.6 11.9 17.4 13.3 9.8 13.5 17.2 16.5 14.6 13.1 11.3 25.6 18.5 12.2 20.1 16.2 24.4 13.2 21.5 10.6 6.4 15.7 5.8 8.6 11.0 9.8 7.3 9.4 15.3 8.9 7.5 7.2 26.7 5.8 7.6 10.1 5.3 6.5 6.1 12.2 22.8 5.8 10.9 23.0 6.9 16.7 6.2 7.3 7.3 6.8 10.2 5.4 11.7 14.5 22.5 5.6 5.0 20.6 9.5 31.0 7.8 11.1 20.9 12.8 3.5 40.1 7.4 8.6 27.4 8.0 4.3 6.2 20.9 6.3 7.9 7.5 11.1 8.0 7.6 8.9 9.4 18.2 25.7 13.3 5.6 12.1 10.8 6.2 20.1 12.2 14.8 18.4 17.0 25.3 24.4 17.8 15.5 25.6 24.4 20.9 4.8 16.2 18.1 18.5 20.5 13.2 12.6 26.1 18.5 14.4 11.4 14.0 10.7 12.2 10.7 9.8 20.8 13.9 20.9 23.8 24.7 28.8 18.6 35.7 16.0 19.4 41.8 7.9 32.9 71.3 34.8 24.9 32.9 22.0 0.0 76.0 30.2 26.7 25.6 21.9 55.5 30.7 23.8 21.9 29.4 18.9 9.7 34.2 21.2 28.7 31.5 27.1 15.1 47.9 24.6 21.5 42.5 26.2 45.3 30.9 29.8 76.7 33.4 10.1 20.6 32.0 22.6 PSORS1C1 "C6orf16, SEEK1" ENSG00000204540 "Psoriasis susceptibility 1 candidate 1" Q9UIG5 6 31114750-31140092 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 7 "testis: 52.2" "Group enriched" "Detected in many" 5 "Early spermatids: 289.3;Late spermatids: 996.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.0;hTCEpi: 5.5;JURKAT: 2.4;U-2 OS: 1.7" HPA045049 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045049: " "unprognostic (1.15e-1)" "unprognostic (4.25e-2)" "unprognostic (2.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.72e-1)" "unprognostic (9.23e-2)" "unprognostic (4.77e-3)" "unprognostic (8.48e-2)" "unprognostic (3.05e-3)" "unprognostic (1.66e-2)" "unprognostic (4.17e-2)" "unprognostic (9.56e-2)" "unprognostic (5.72e-3)" "unprognostic (4.80e-2)" "unprognostic (1.59e-1)" "unprognostic (6.33e-2)" "unprognostic (1.30e-1)" 0.9 0.7 1.1 0.7 2.8 0.7 0.8 0.5 1.5 3.4 6.9 2.2 2.6 0.7 7.7 6.4 2.1 1.1 7.5 0.7 0.7 0.6 1.0 0.7 3.7 0.7 4.4 0.0 1.9 1.5 0.7 0.4 1.7 3.0 1.7 1.1 0.2 0.9 1.8 0.7 2.0 6.0 6.5 3.4 0.7 1.1 52.2 0.9 0.0 1.8 1.1 0.7 3.6 3.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.0 0.6 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.0 5.5 0.6 1.0 0.0 0.0 2.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.4 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.8 0.5 1.5 0.7 0.6 4.4 0.0 3.0 0.9 17.9 2.7 0.0 3.6 7.8 0.0 2.0 17.8 0.0 3.4 8.7 0.0 0.1 0.0 13.8 289.3 3.6 20.7 0.0 1.9 0.4 8.0 2.6 0.0 0.0 0.3 0.0 2.9 3.7 0.0 996.1 8.6 0.0 3.3 1.0 4.6 0.5 9.4 8.0 6.3 0.7 0.0 6.5 1.4 117.0 17.9 9.3 0.1 0.0 4.7 2.3 PSPC1 "FLJ10955, PSP1" ENSG00000121390 "Paraspeckle component 1" Q8WXF1 13 19674752-19783019 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 143.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038904 Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center" No No Nucleoplasm "Nucleoli fibrillar center" "HPA038904: AB_10673291" "unprognostic (2.13e-3)" "unprognostic (3.48e-1)" "unprognostic (1.52e-2)" "unprognostic (1.25e-1)" "unprognostic (4.14e-3)" "unprognostic (2.14e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (1.13e-3)" "unprognostic (9.57e-2)" "unprognostic (1.09e-1)" "unprognostic (1.69e-3)" "unprognostic (3.04e-3)" "unprognostic (2.92e-1)" "unprognostic (3.69e-2)" "unprognostic (8.61e-2)" "prognostic favorable (1.46e-4)" "unprognostic (7.72e-2)" 10.6 14.6 17.8 14.1 18.7 45.0 16.8 24.6 24.7 13.9 15.0 15.3 11.7 12.6 16.0 23.3 15.6 17.1 12.8 11.4 18.9 19.8 13.1 9.2 10.2 19.0 14.6 18.4 16.3 11.2 8.4 23.6 25.7 15.9 11.9 16.4 17.6 11.4 9.4 20.3 14.7 13.1 15.0 12.2 13.8 12.3 23.9 13.6 27.5 12.9 10.7 21.2 12.3 10.9 18.2 17.8 14.8 18.7 9.6 18.2 12.1 18.4 7.7 18.1 9.0 7.5 8.0 23.5 9.9 13.1 18.8 17.1 25.4 10.7 24.7 10.7 10.5 9.8 9.4 20.9 12.0 19.7 10.6 10.2 28.2 5.5 30.9 14.7 20.3 18.1 12.2 2.5 11.4 12.8 7.4 16.0 24.5 15.3 10.1 16.4 20.0 23.7 19.8 25.3 10.2 10.2 16.3 18.1 12.8 19.3 28.0 16.7 8.6 13.5 22.9 8.6 18.1 13.3 21.4 9.4 11.4 10.9 10.8 9.4 8.8 5.2 42.6 5.2 12.2 13.5 10.6 18.1 11.0 10.2 18.7 11.1 18.2 13.7 9.4 16.6 18.0 13.8 10.4 14.8 9.6 13.5 17.8 18.2 12.1 17.8 18.7 24.6 24.7 18.9 19.8 14.6 18.4 15.9 13.6 17.9 25.6 35.9 21.3 29.7 39.8 24.2 20.4 24.1 15.9 15.7 55.0 59.0 18.3 25.3 13.9 22.2 14.0 0.0 29.7 85.2 25.3 15.0 9.2 9.4 23.6 28.6 24.2 25.2 29.3 17.3 29.1 21.8 18.6 46.9 18.6 25.3 21.5 20.1 25.1 19.5 66.0 32.3 30.3 143.2 73.9 29.7 67.3 30.5 23.2 22.7 PSRC1 DDA3 ENSG00000134222 "Proline and serine rich coiled-coil 1" Q6PGN9 1 109279556-109283186 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.2" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 23.6;Extravillous trophoblasts: 28.6;Peritubular cells: 42.1;Rod photoreceptor cells: 70.6" "Cancer enhanced" "Detected in all" "glioma: 50.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 12.3" "Group enriched" "Detected in many" 10 "dendritic cells: 5.4;granulocytes: 7.3;monocytes: 12.3" "Low cell line specificity" "Detected in all" "Group enriched" "Detected in some" 6 "amygdala: 3.5;cerebral cortex: 7.5;hippocampal formation: 6.3" "Low region specificity" "Detected in all" HPA056561 Approved Nucleoplasm,Cytosol NA Yes Cytosol Nucleoplasm "HPA056561: AB_2683175" "unprognostic (1.14e-1)" "unprognostic (1.65e-1)" "unprognostic (1.42e-3)" "unprognostic (6.78e-3)" "unprognostic (2.17e-1)" "unprognostic (4.76e-2)" "prognostic unfavorable (1.36e-9)" "unprognostic (3.51e-2)" "unprognostic (6.21e-2)" "unprognostic (4.88e-3)" "unprognostic (1.76e-2)" "unprognostic (1.92e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (9.43e-2)" "unprognostic (2.08e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" 1.7 2.4 17.1 4.3 21.6 8.3 3.0 3.8 27.3 2.0 4.0 31.2 0.3 5.1 3.0 3.4 6.3 3.2 3.7 2.0 25.9 11.2 1.7 2.6 2.2 4.0 29.8 12.9 3.6 1.4 0.8 1.7 4.8 16.8 4.0 3.3 4.5 2.9 5.9 1.0 6.1 5.3 4.7 30.6 2.3 2.4 8.6 20.7 5.5 2.0 0.4 5.0 2.6 2.3 0.0 5.4 7.3 12.3 0.2 0.7 3.2 18.8 9.8 40.0 19.3 1.6 3.2 11.0 15.0 12.2 20.5 19.7 15.0 7.9 9.6 5.5 7.4 9.6 13.6 21.5 12.3 17.2 3.7 10.4 6.0 13.1 12.2 1.8 6.4 6.9 3.6 1.1 8.1 5.8 7.7 10.0 11.5 13.6 4.4 16.4 17.1 9.7 4.3 16.5 8.7 11.2 15.1 38.5 3.2 6.9 5.0 16.8 9.7 8.4 12.9 15.4 15.2 7.8 6.1 5.1 12.7 21.0 8.9 24.6 3.4 2.2 3.3 10.2 15.3 35.3 0.0 12.3 1.8 0.7 4.8 0.5 0.0 0.7 0.2 5.4 0.0 0.4 0.4 7.3 0.2 2.6 0.0 0.7 3.2 17.1 21.6 3.8 16.4 25.9 11.2 29.8 12.9 16.8 20.7 0.0 3.8 0.0 2.3 1.8 6.5 0.9 2.5 1.4 0.0 1.8 23.6 3.4 0.0 0.9 0.5 0.4 0.5 0.0 0.7 28.6 2.3 0.6 1.1 0.9 9.2 3.2 0.0 1.3 4.0 1.9 5.5 1.6 1.7 0.0 3.2 7.7 0.4 0.0 42.1 2.3 70.6 0.0 2.3 2.7 1.2 1.0 2.4 0.0 2.0 0.7 PSTPIP2 ENSG00000152229 "Proline-serine-threonine phosphatase interacting protein 2" Q9H939 18 45983536-46072272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 38.1;bone marrow: 36.9;lymphoid tissue: 46.7" "Cell type enhanced" "Detected in many" 5 "granulocytes: 41.7;Kupffer cells: 40.3;Macrophages: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 38.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 37.7;HMC-1: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040923, HPA040944" Enhanced Approved "Nucleoplasm,Plasma membrane,Mitochondria" No No 7100000 "Plasma membrane, Mitochondria" Nucleoplasm "HPA040923: AB_10794429, HPA040944: AB_10795485" "unprognostic (1.61e-1)" "unprognostic (9.08e-2)" "unprognostic (1.21e-1)" "unprognostic (1.53e-2)" "unprognostic (2.57e-2)" "unprognostic (1.60e-1)" "unprognostic (1.17e-2)" "unprognostic (4.80e-3)" "unprognostic (1.87e-1)" "unprognostic (1.33e-1)" "unprognostic (5.83e-2)" "unprognostic (3.06e-1)" "prognostic unfavorable (2.39e-7)" "unprognostic (5.21e-2)" "unprognostic (3.55e-1)" "unprognostic (1.61e-1)" "unprognostic (1.93e-1)" 4.6 3.3 1.8 6.1 3.1 36.9 4.9 0.6 2.1 3.4 3.4 0.9 2.7 2.0 2.7 2.8 4.4 2.9 4.4 4.0 4.5 1.2 3.3 8.6 7.4 11.5 3.4 0.4 3.1 3.9 2.2 3.9 11.6 3.5 5.8 3.0 3.5 4.5 8.8 16.6 5.9 3.1 4.1 4.6 46.7 4.3 1.9 3.2 3.0 1.8 6.5 5.6 4.6 3.0 0.0 8.9 38.1 12.4 0.9 3.9 6.3 1.0 0.0 1.4 0.0 0.3 2.6 7.9 5.6 2.8 2.0 1.7 4.3 1.5 0.0 0.3 1.8 0.0 13.7 7.7 10.6 2.5 0.0 1.2 37.7 1.9 0.0 2.3 2.2 41.9 1.9 13.2 1.9 6.3 1.8 4.0 0.0 9.0 0.0 8.8 1.3 0.3 0.0 0.9 0.0 0.0 0.0 2.9 1.8 4.2 13.8 0.1 0.8 0.9 3.9 0.1 11.4 12.4 4.4 2.9 0.2 3.2 0.3 0.0 0.0 0.1 0.0 0.5 0.0 0.1 20.7 9.0 38.1 3.9 12.4 1.3 0.0 2.3 2.8 8.9 0.0 2.8 3.3 4.9 0.9 11.9 0.3 1.4 6.3 1.8 3.1 0.6 2.1 4.5 1.2 3.4 0.4 3.5 3.2 11.9 15.2 6.9 15.7 12.2 0.6 2.8 2.5 2.7 13.6 0.0 0.0 21.1 3.3 8.8 1.9 2.2 0.4 0.0 3.3 2.5 3.8 21.9 41.7 16.3 12.6 0.0 1.2 10.4 40.3 5.0 2.6 35.6 6.8 6.4 2.6 9.5 20.5 0.0 2.1 2.9 0.2 6.5 6.2 0.5 1.1 8.9 7.3 12.5 2.2 17.0 PTAFR ENSG00000169403 "Platelet activating factor receptor" P25105 1 28147166-28193936 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 98.3" "Group enriched" "Detected in many" 7 "granulocytes: 73.9;Hofbauer cells: 62.8;Kupffer cells: 70.6;Macrophages: 55.7;Pancreatic endocrine cells: 55.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "classical monocyte: 28.2;eosinophil: 98.3;neutrophil: 85.7" "Group enriched" "Detected in many" 5 "granulocytes: 98.3;monocytes: 28.2" "Group enriched" "Detected in some" 4 "HBEC3-KT: 14.7;HMC-1: 53.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027543 Approved Uncertain "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Nucleoplasm, Vesicles" "Plasma membrane" "HPA027543: AB_10610287" "unprognostic (2.22e-2)" "unprognostic (2.59e-2)" "unprognostic (6.73e-2)" "unprognostic (1.24e-1)" "unprognostic (2.75e-1)" "unprognostic (3.74e-2)" "unprognostic (1.07e-1)" "unprognostic (1.72e-1)" "unprognostic (3.35e-1)" "unprognostic (1.23e-1)" "unprognostic (2.39e-1)" "unprognostic (1.60e-1)" "unprognostic (2.79e-2)" "unprognostic (3.52e-1)" "unprognostic (2.59e-2)" "unprognostic (5.48e-2)" "unprognostic (1.38e-2)" 5.6 2.3 2.4 16.2 1.9 20.3 2.4 0.6 2.0 6.9 3.4 1.6 3.5 1.8 2.8 1.4 16.8 2.8 7.5 3.5 2.1 2.3 6.4 1.8 9.2 6.1 4.1 1.0 1.5 2.7 0.9 0.7 3.5 1.8 2.6 3.4 0.6 3.4 2.6 1.1 2.8 5.0 3.8 5.1 15.4 2.3 2.2 1.1 2.3 1.4 22.2 21.7 5.9 3.6 1.5 13.2 98.3 28.2 0.0 0.1 10.1 7.7 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.1 2.2 0.5 0.0 0.0 0.1 5.3 0.2 14.7 0.3 0.1 0.2 2.9 0.0 0.3 0.0 0.7 53.6 0.0 2.4 0.2 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.5 0.0 7.2 0.2 0.2 0.1 0.1 0.0 0.0 3.6 0.8 0.1 0.0 0.0 7.3 0.0 0.2 0.1 2.0 0.0 0.1 0.3 0.0 0.0 0.5 0.4 2.1 0.0 0.9 0.2 5.9 28.2 98.3 0.0 8.9 0.1 1.5 0.0 0.0 13.2 0.7 0.0 0.0 85.7 0.0 3.5 0.1 0.1 10.1 2.4 1.9 0.6 2.0 2.1 2.3 4.1 1.0 1.8 1.1 6.0 7.9 4.3 1.5 5.8 1.2 2.0 2.5 6.7 2.3 1.8 2.0 0.5 0.0 8.8 0.0 5.9 0.2 0.0 4.6 0.4 2.2 0.4 73.9 0.8 62.8 0.0 0.0 1.8 70.6 0.0 0.6 55.7 0.0 4.6 0.0 0.2 55.1 0.0 0.0 0.0 0.8 0.0 0.9 2.1 0.5 2.5 1.3 1.0 0.0 8.6 PTBP1 "HNRNP-I, HNRPI, pPTB, PTB, PTB-1, PTB2, PTB3, PTB4" ENSG00000011304 "Polypyrimidine tract binding protein 1" P26599 19 797075-812327 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013507 Supported Supported Nucleoplasm NA NA 3100000 Nucleoplasm "CAB013507: AB_2533082" "unprognostic (2.82e-1)" "unprognostic (2.75e-1)" "unprognostic (1.22e-2)" "unprognostic (1.24e-1)" "unprognostic (6.01e-2)" "unprognostic (6.22e-2)" "prognostic unfavorable (2.71e-4)" "unprognostic (4.06e-3)" "unprognostic (2.08e-2)" "unprognostic (1.92e-2)" "unprognostic (5.47e-2)" "unprognostic (4.62e-3)" "unprognostic (2.41e-2)" "unprognostic (7.91e-3)" "unprognostic (4.28e-2)" "unprognostic (8.31e-2)" "unprognostic (3.72e-2)" 38.7 31.3 13.2 37.5 16.9 43.5 38.4 13.5 16.2 36.4 35.9 19.1 32.5 34.9 42.9 32.7 49.7 31.8 39.0 24.0 13.9 9.5 45.3 68.8 37.7 56.2 20.2 9.6 47.5 47.5 37.5 31.8 65.0 15.9 35.3 24.7 35.5 51.9 31.0 15.9 43.6 41.0 26.2 13.8 49.2 31.2 34.1 18.2 94.9 49.4 43.7 62.7 31.5 36.2 19.2 26.3 14.6 27.7 22.8 24.7 23.4 78.2 68.9 40.2 34.3 13.7 17.4 60.7 47.9 24.2 39.9 31.8 66.7 37.9 66.1 30.9 32.8 14.9 46.7 55.2 45.6 37.9 69.0 61.0 54.2 65.4 67.0 25.8 72.9 58.0 17.3 31.9 49.6 27.6 14.2 37.9 30.1 82.8 34.5 64.4 68.9 87.5 35.6 69.6 30.2 37.0 99.1 30.2 39.2 24.7 76.6 45.0 51.4 59.8 33.3 27.3 27.9 35.3 42.8 57.5 43.5 45.5 47.8 83.4 38.1 69.5 89.0 24.9 53.2 52.3 8.2 21.6 14.6 24.0 27.7 24.7 18.6 19.5 22.2 26.3 19.2 19.6 19.2 9.5 22.8 24.6 15.0 21.1 23.4 13.2 16.9 13.5 16.2 13.9 9.5 20.2 9.6 15.9 18.2 38.7 73.7 72.2 83.2 68.2 18.2 29.1 81.5 36.1 37.5 45.4 33.4 94.3 29.9 71.2 12.0 74.4 107.3 23.3 75.4 150.8 59.6 69.1 91.0 71.0 69.1 31.8 97.0 74.3 54.3 15.3 73.9 56.8 37.1 42.3 112.0 29.8 77.8 95.3 61.9 37.2 21.6 58.2 60.8 38.7 59.9 71.6 111.6 50.7 106.6 94.3 PTBP2 "brPTB, nPTB, PTB, PTBLP" ENSG00000117569 "Polypyrimidine tract binding protein 2" Q9UKA9 1 96721665-96823738 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Muller glia cells: 48.7;Spermatocytes: 71.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 39.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047420 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047420: AB_10962353" "unprognostic (2.14e-2)" "unprognostic (3.01e-2)" "unprognostic (1.27e-1)" "prognostic unfavorable (7.80e-4)" "unprognostic (1.70e-2)" "unprognostic (1.25e-2)" "unprognostic (2.41e-5)" "unprognostic (2.26e-3)" "unprognostic (1.50e-2)" "unprognostic (6.83e-3)" "unprognostic (1.70e-2)" "unprognostic (3.31e-2)" "unprognostic (5.48e-3)" "unprognostic (3.01e-2)" "unprognostic (1.75e-1)" "unprognostic (5.24e-2)" "unprognostic (1.27e-2)" 12.5 10.5 17.1 9.9 21.2 34.4 15.3 22.0 25.8 16.7 26.6 20.0 11.3 7.6 23.6 11.2 12.8 11.9 10.7 7.8 18.8 18.4 12.0 8.1 7.3 9.8 17.9 18.9 14.6 7.3 6.1 22.0 8.1 21.7 16.3 13.0 9.0 7.4 17.3 15.4 8.3 11.0 28.1 18.6 10.3 11.6 35.4 19.9 16.6 14.7 6.8 8.4 21.1 12.8 3.6 1.6 1.4 1.8 4.1 4.2 0.7 3.5 1.9 16.7 8.8 4.0 4.9 9.4 3.2 3.5 5.5 5.1 2.4 3.5 12.2 3.7 2.1 12.1 2.3 10.0 2.6 8.0 2.0 3.0 6.7 5.6 3.1 2.3 3.4 3.5 2.7 1.6 6.9 2.9 4.4 2.7 5.9 4.9 3.3 7.2 1.2 11.0 11.1 10.2 1.4 4.4 6.5 39.6 1.8 5.6 2.0 9.6 9.9 4.1 2.7 4.7 8.7 2.6 7.0 2.6 3.8 7.5 3.1 4.1 2.7 2.0 14.2 1.8 5.5 1.6 0.9 1.4 0.9 2.7 1.7 2.0 3.5 3.5 2.5 0.8 3.6 4.2 2.9 1.4 4.1 1.8 1.6 3.2 0.7 17.1 21.2 22.0 24.7 18.8 18.4 17.9 18.9 21.7 19.9 8.9 11.5 10.8 8.8 12.4 26.4 10.8 5.1 8.1 5.7 19.2 13.7 4.6 11.6 5.9 3.7 14.6 4.0 0.0 4.4 3.6 9.3 8.6 7.0 8.2 2.9 28.6 23.5 8.0 11.3 5.3 8.3 7.7 13.5 6.4 6.2 48.7 4.2 3.5 7.4 6.2 21.7 6.5 27.8 71.4 31.7 6.1 1.7 8.7 4.7 4.8 PTBP3 "DKFZp781I1117, ROD1" ENSG00000119314 "Polypyrimidine tract binding protein 3" O95758 9 112217716-112333667 "Predicted intracellular proteins" "Differentiation, Erythrocyte maturation, mRNA processing, mRNA splicing" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048374 Approved Nucleoplasm NA NA Nucleoplasm "HPA048374: AB_2680376" "unprognostic (6.12e-2)" "unprognostic (3.05e-1)" "unprognostic (2.77e-2)" "unprognostic (1.33e-1)" "unprognostic (2.44e-1)" "unprognostic (2.12e-1)" "unprognostic (4.38e-3)" "prognostic unfavorable (2.10e-4)" "unprognostic (1.39e-2)" "unprognostic (6.23e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (1.17e-1)" "prognostic favorable (2.51e-4)" "unprognostic (1.72e-2)" "unprognostic (4.99e-2)" "unprognostic (3.04e-2)" "unprognostic (5.10e-2)" 22.4 9.4 7.2 24.5 9.2 22.9 26.3 9.5 6.8 17.2 21.7 5.6 18.9 17.7 14.3 18.9 38.4 10.0 17.2 11.6 6.1 8.7 26.8 12.7 25.1 37.2 6.2 4.5 13.0 17.9 9.0 17.8 25.8 6.6 13.8 22.1 9.0 20.2 22.6 8.0 25.0 32.4 12.8 11.4 23.9 20.9 22.6 6.6 41.7 12.6 30.7 38.4 22.1 21.5 7.0 11.8 23.9 9.5 4.3 8.7 4.5 20.0 21.3 8.1 7.0 7.2 7.9 41.5 8.2 6.7 10.1 10.5 24.2 30.1 23.0 9.2 10.6 8.0 28.5 11.2 23.4 13.5 25.6 3.9 23.3 8.8 17.0 9.1 30.5 28.4 8.9 15.9 13.5 18.7 6.4 17.1 17.9 31.1 21.6 11.5 18.7 30.1 8.3 12.8 31.0 7.3 19.6 27.7 11.6 14.9 26.6 10.2 6.5 16.3 21.4 7.9 18.2 25.3 13.8 13.2 8.9 12.2 12.8 10.1 11.1 27.4 20.9 7.7 15.6 8.7 14.2 6.3 11.8 8.4 7.7 8.7 5.5 6.3 6.8 7.2 7.0 5.0 6.0 23.9 4.3 9.5 11.8 6.5 4.5 7.2 9.2 9.5 6.8 6.1 8.7 6.2 4.5 6.6 6.6 26.8 59.3 29.8 34.2 71.2 7.7 6.7 63.7 69.6 70.5 108.2 17.7 29.6 24.9 37.2 53.1 41.4 73.5 46.7 61.6 89.7 27.7 65.8 62.5 27.0 49.5 7.9 86.8 43.6 100.8 105.3 20.1 76.6 27.0 63.1 73.2 3.5 88.0 63.3 17.7 25.4 15.7 19.4 25.9 17.2 19.8 90.8 29.3 57.3 69.2 200.8 PTDSS1 "KIAA0024, PSS1, PSSA" ENSG00000156471 "Phosphatidylserine synthase 1" P48651 8 96261715-96336995 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016852 Uncertain Approved "Nucleoplasm,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" Nucleoplasm "HPA016852: AB_1855878" "unprognostic (1.44e-1)" "unprognostic (1.71e-1)" "unprognostic (1.08e-1)" "unprognostic (7.89e-3)" "unprognostic (7.48e-2)" "unprognostic (5.68e-3)" "prognostic unfavorable (1.08e-5)" "prognostic unfavorable (9.83e-4)" "unprognostic (2.79e-1)" "unprognostic (1.71e-2)" "unprognostic (2.36e-2)" "unprognostic (1.19e-1)" "unprognostic (2.29e-3)" "unprognostic (4.78e-2)" "unprognostic (1.79e-1)" "unprognostic (4.08e-2)" "unprognostic (3.55e-2)" 8.2 7.9 8.0 8.1 14.7 10.2 10.4 10.2 15.0 9.7 8.3 5.1 22.5 10.6 8.4 7.8 9.6 7.0 7.9 20.1 8.6 9.9 9.5 12.8 7.8 21.8 7.1 8.0 9.6 12.1 23.2 4.9 10.8 9.6 5.7 7.4 5.2 8.8 29.8 10.1 10.4 8.3 9.0 6.0 11.8 8.1 5.1 3.6 20.7 11.0 7.7 11.8 9.3 6.8 3.6 6.1 9.4 3.7 5.0 4.6 7.8 10.4 8.1 1.4 3.9 2.9 6.1 2.4 7.6 10.5 7.3 5.1 3.0 3.0 17.2 7.0 7.1 1.5 4.3 9.9 7.6 11.4 8.8 7.1 16.9 15.7 1.6 3.0 12.4 5.9 5.1 7.3 10.2 7.2 1.8 4.7 5.3 8.4 8.9 6.6 3.0 9.6 1.9 2.2 3.4 7.6 7.7 7.3 13.0 4.1 8.9 6.1 2.5 2.8 2.5 1.1 1.7 5.9 4.2 8.3 6.6 4.1 4.6 8.7 1.8 9.3 8.4 4.1 13.1 5.4 9.4 3.7 2.1 2.8 2.5 4.0 2.6 4.6 3.4 6.1 3.6 4.0 2.9 1.3 5.0 2.4 1.8 2.6 7.8 8.0 14.7 10.2 15.0 8.6 9.9 7.1 8.0 9.6 3.6 17.9 10.8 40.8 14.5 28.0 8.9 88.9 22.9 2.7 14.8 10.4 9.8 67.1 1.7 16.6 53.9 21.0 13.3 23.3 38.8 47.5 19.7 14.5 32.3 28.4 42.1 4.8 5.2 19.0 42.5 34.9 21.6 30.4 18.6 17.2 15.0 4.8 21.4 5.8 24.4 15.9 4.3 0.0 17.6 10.3 16.6 29.4 67.6 35.2 29.4 13.6 PTEN "BZS, MHAM, MMAC1, PTEN1, TEP1" ENSG00000171862 "Phosphatase and tensin homolog" P60484 10 87863113-87971930 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Lipid metabolism, Neurogenesis" "Hydrolase, Protein phosphatase" "Autism spectrum disorder, Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 29.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004076, HPA031335" Approved Supported Nucleoplasm,Cytosol "Secreted - unknown location" NA NA Nucleoplasm Cytosol "CAB004076: AB_390810, HPA031335: AB_2797221" "unprognostic (8.72e-2)" "unprognostic (2.45e-1)" "unprognostic (5.43e-1)" "unprognostic (1.50e-2)" "unprognostic (3.71e-2)" "unprognostic (1.30e-1)" "unprognostic (2.18e-1)" "unprognostic (2.08e-1)" "unprognostic (2.07e-1)" "unprognostic (6.87e-2)" "unprognostic (9.77e-2)" "unprognostic (2.71e-1)" "prognostic unfavorable (7.35e-4)" "unprognostic (1.57e-1)" "unprognostic (2.73e-1)" "unprognostic (6.54e-3)" "unprognostic (2.41e-1)" 42.4 24.1 17.7 20.9 17.7 13.5 32.8 39.9 19.7 43.1 26.7 9.9 19.0 15.1 29.8 22.8 26.8 30.3 21.0 19.1 16.0 17.4 19.6 32.4 27.2 30.4 15.7 19.5 29.1 21.3 16.4 23.6 36.4 14.2 35.3 17.7 21.6 16.8 20.8 16.8 20.4 25.4 26.0 11.7 40.9 17.8 18.7 12.5 49.7 25.2 13.3 18.6 29.6 30.9 4.3 5.1 29.6 11.0 4.3 4.7 2.0 10.2 4.8 5.5 5.0 12.8 8.8 5.0 5.5 12.2 6.5 9.1 4.9 12.6 12.1 3.7 9.0 3.8 6.2 7.4 6.3 10.3 6.0 2.1 4.0 12.5 6.0 13.7 13.5 6.9 6.0 17.6 8.2 10.6 27.6 9.1 7.7 3.0 32.9 5.9 7.8 7.6 24.6 2.0 8.9 0.0 11.8 2.9 8.9 10.1 5.8 2.0 9.0 7.3 3.5 9.2 4.6 9.7 19.6 7.9 21.4 5.0 8.3 4.4 10.8 14.0 13.8 6.6 12.8 1.2 8.3 7.9 12.2 3.6 11.0 3.9 4.3 4.0 3.5 5.1 3.7 4.7 4.5 29.6 4.3 7.2 4.2 3.5 2.0 17.7 17.7 39.9 19.7 16.0 17.4 15.7 19.5 14.2 12.5 32.8 55.3 40.2 50.0 49.8 113.3 39.2 40.8 25.4 28.4 27.9 37.3 22.6 28.2 23.2 57.0 44.4 33.9 0.0 25.8 44.5 52.3 36.9 25.3 58.6 31.3 42.9 30.0 47.9 167.4 70.7 52.6 69.1 59.1 27.9 44.1 54.1 30.2 24.6 51.2 30.8 55.8 90.5 118.8 24.9 24.0 52.6 47.9 35.7 39.2 51.2 PTER ENSG00000165983 "Phosphotriesterase related" Q96BW5 10 16436943-16513745 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Proximal tubular cells: 86.8" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 4 "amygdala: 21.6;cerebellum: 8.9;cerebral cortex: 30.8;hippocampal formation: 22.7;hypothalamus: 8.9" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA038044, HPA038045" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038044: AB_2675803, HPA038045: AB_10672616" "unprognostic (5.57e-2)" "unprognostic (1.04e-1)" "unprognostic (2.76e-2)" "unprognostic (3.14e-2)" "unprognostic (9.72e-3)" "unprognostic (2.45e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.17e-1)" "unprognostic (4.51e-2)" "unprognostic (2.86e-1)" "unprognostic (2.05e-3)" "unprognostic (1.86e-1)" "prognostic favorable (6.52e-6)" "unprognostic (2.24e-1)" "unprognostic (1.79e-1)" "unprognostic (1.54e-2)" "unprognostic (5.36e-3)" 11.1 5.4 21.6 10.6 2.9 1.3 8.7 8.9 30.8 6.2 12.1 1.6 14.5 9.2 5.8 8.1 6.9 3.4 3.8 7.8 22.7 8.9 31.3 21.9 9.2 12.6 4.2 1.3 5.3 17.9 11.1 3.4 11.2 3.1 11.3 5.4 6.8 10.6 12.9 6.2 4.0 21.9 5.7 2.6 11.8 9.2 2.9 1.5 17.2 12.0 3.9 9.6 7.7 10.9 15.3 11.7 6.9 16.7 7.6 19.5 9.4 16.1 9.7 0.1 2.9 4.1 8.1 9.7 4.8 0.5 1.8 2.7 8.9 15.3 17.0 4.0 3.2 1.0 7.4 5.5 3.2 2.7 16.6 7.2 15.8 4.6 3.6 4.9 5.1 4.8 5.9 10.4 5.5 0.9 0.0 0.8 15.4 10.8 6.0 2.8 5.4 11.9 5.1 3.9 11.1 2.4 8.9 1.3 8.9 25.5 5.1 12.3 0.8 8.5 2.4 14.0 3.5 5.7 16.2 2.1 0.1 4.3 3.9 0.1 4.5 5.6 18.0 2.0 9.4 6.0 3.5 11.7 6.9 12.7 16.7 13.5 15.3 14.6 12.6 11.7 8.8 11.0 10.9 2.2 7.6 14.5 9.9 19.5 9.4 21.6 2.9 8.9 30.8 22.7 8.9 4.2 1.3 3.1 1.5 26.8 19.9 5.7 12.7 9.7 0.8 22.7 15.3 17.4 28.4 27.9 0.0 17.1 44.7 19.3 0.2 7.1 13.2 0.0 29.9 14.6 7.8 8.8 23.1 21.2 13.0 0.0 11.1 10.4 11.6 0.0 0.9 17.5 8.5 9.0 12.4 13.5 21.4 28.8 0.0 86.8 8.0 6.5 10.3 0.9 6.8 10.8 10.1 12.5 16.8 19.7 PTF1A "bHLHa29, PTF1-p48" ENSG00000168267 "Pancreas specific transcription factor, 1a" Q7RTS3 10 23192327-23194252 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 154 "pancreas: 129.8" "Cell type enhanced" "Detected in some" 19 "Early spermatids: 1.3;Exocrine glandular cells: 4.2;Pancreatic endocrine cells: 1.3;Spermatocytes: 3.3" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "U-2 OS: 7.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" CAB022612 Approved Nucleoplasm NA NA Nucleoplasm "CAB022612: " "unprognostic (2.02e-1)" "unprognostic (1.85e-1)" "unprognostic (4.49e-1)" "unprognostic (1.80e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 129.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.7 0.0 0.0 0.0 0.0 0.0 PTGES3 "cPGES, p23, TEBP" ENSG00000110958 "Prostaglandin E synthase 3" Q15185 12 56663341-56688408 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Chaperone, Isomerase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 358.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034319, HPA038672, HPA038673" Enhanced Approved Nucleoplasm,Cytosol NA NA 580000 Cytosol Nucleoplasm "CAB034319: AB_2175206, HPA038672: AB_10697395, HPA038673: AB_10670786" "prognostic unfavorable (2.15e-5)" "unprognostic (2.60e-1)" "unprognostic (8.67e-3)" "unprognostic (7.07e-2)" "unprognostic (2.24e-1)" "unprognostic (2.96e-3)" "prognostic unfavorable (4.44e-6)" "unprognostic (4.33e-3)" "unprognostic (3.64e-2)" "prognostic favorable (4.36e-4)" "unprognostic (2.73e-2)" "unprognostic (2.31e-2)" "unprognostic (3.05e-3)" "unprognostic (1.01e-1)" "unprognostic (2.17e-1)" "unprognostic (2.28e-1)" "unprognostic (2.07e-1)" 44.7 41.4 56.0 41.2 55.7 39.6 175.0 44.2 51.7 49.0 51.9 38.1 49.5 46.4 57.7 52.0 52.6 69.8 36.0 46.0 54.6 57.2 52.1 67.1 46.4 62.0 67.0 41.4 82.3 55.1 43.2 49.2 50.3 57.0 60.7 55.3 24.0 36.6 49.4 64.2 37.0 46.7 64.7 72.5 42.7 36.6 39.7 65.1 53.5 72.5 36.7 55.1 72.7 358.9 40.6 36.9 27.3 74.8 29.2 42.5 60.5 81.4 71.0 57.7 34.3 42.5 38.6 87.9 53.4 40.8 68.8 51.4 60.1 85.9 90.3 81.1 45.5 46.3 52.5 108.0 69.7 87.2 66.3 71.9 70.5 44.9 69.5 31.1 83.7 51.2 27.9 51.0 51.9 63.1 65.5 70.7 58.1 113.0 86.5 67.1 50.8 83.1 79.6 98.5 71.9 83.0 72.7 54.4 121.2 60.5 63.8 74.8 43.7 54.5 78.6 46.2 79.6 90.5 70.3 42.3 41.3 48.1 49.5 73.7 36.5 100.4 72.6 45.0 69.1 74.3 27.3 37.5 23.2 32.0 59.0 42.0 40.6 42.5 38.1 36.9 28.5 42.3 36.4 14.8 29.2 74.8 31.3 42.5 60.5 56.0 55.7 44.2 51.7 54.6 57.2 67.0 41.4 57.0 65.1 166.7 121.6 178.4 623.1 343.3 128.5 151.7 150.3 313.2 146.7 179.7 72.6 370.5 316.7 252.0 38.5 189.7 176.9 116.8 186.9 545.4 268.2 456.4 232.8 165.2 311.0 106.5 250.8 168.1 180.7 81.6 221.2 245.7 268.2 312.0 185.6 201.5 190.6 194.6 200.5 268.7 99.7 142.3 307.9 546.1 341.1 330.1 473.4 233.5 241.8 443.4 PTHLH "HHM, PLP, PTHR, PTHRP" ENSG00000087494 "Parathyroid hormone like hormone" P12272 12 27958084-27972705 "Cancer-related genes, Disease related genes, Predicted secreted proteins" Hormone "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 45.6" "Cell type enhanced" "Detected in some" 15 "Exocrine glandular cells: 7.9;Melanocytes: 21.9;Sertoli cells: 6.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 64.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "T-reg: 3.0" "Lineage enriched" "Detected in single" 30 "T-cells: 3.0" "Group enriched" "Detected in some" 4 "HaCaT: 64.7;HBEC3-KT: 80.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035982 Approved Approved Supported "Nucleoplasm,Golgi apparatus,Cytosol" "Secreted in other tissues" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA035982: AB_10794631" "unprognostic (1.67e-1)" "unprognostic (5.26e-3)" "unprognostic (1.31e-1)" "unprognostic (4.41e-2)" "unprognostic (2.11e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (3.37e-4)" "unprognostic (1.60e-2)" "unprognostic (1.18e-1)" "unprognostic (5.16e-2)" "unprognostic (4.09e-3)" "unprognostic (3.84e-1)" "prognostic unfavorable (1.82e-9)" "unprognostic (2.01e-2)" "unprognostic (1.34e-1)" "unprognostic (5.23e-3)" "unprognostic (7.87e-3)" 2.9 1.0 6.5 3.5 5.3 0.0 20.2 1.4 8.7 11.0 2.3 1.4 2.1 2.4 11.2 2.0 17.0 1.2 45.6 4.0 4.3 3.5 0.4 0.2 1.3 1.1 1.4 4.3 2.6 1.7 0.7 2.3 3.6 3.1 5.5 1.8 2.4 5.3 2.6 0.7 1.5 1.6 13.4 0.8 3.6 1.9 1.3 1.0 0.1 1.4 15.8 3.4 8.0 12.3 0.0 0.0 0.0 0.0 0.0 3.0 0.1 0.3 2.2 0.0 0.0 0.6 0.6 0.0 0.0 0.2 0.1 0.2 0.0 1.7 0.0 0.1 0.5 2.1 64.7 0.2 80.0 0.0 1.6 0.3 0.1 0.4 0.0 0.2 0.0 0.1 0.0 4.4 2.0 7.9 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.7 0.0 0.3 0.1 7.7 0.0 0.0 0.0 3.6 0.0 0.4 2.7 0.1 0.0 1.2 0.3 2.0 1.1 17.0 1.0 0.0 2.6 1.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.1 6.5 5.3 1.4 6.2 4.3 3.5 1.4 4.3 3.1 1.0 0.0 0.0 0.0 1.1 4.0 0.1 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.0 4.2 1.3 0.0 0.0 7.9 0.0 4.4 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.8 0.9 0.2 21.9 1.0 0.0 2.2 5.5 0.0 0.0 0.0 0.3 6.5 2.8 0.4 0.1 1.3 0.0 0.0 0.0 0.1 PTK6 BRK ENSG00000101213 "Protein tyrosine kinase 6" Q13882 20 63528001-63537370 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 44.0;intestine: 24.2;skin 1: 24.2" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 2: 34.1;Enterocytes: 90.1;Mucus-secreting cells: 39.1;Paneth cells: 65.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 10.6;CAPAN-2: 20.4;HaCaT: 16.6;hTCEpi: 22.5;OE19: 27.4;RT4: 13.0;T-47d: 12.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB032952, HPA036070, HPA036071" Approved Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Plasma membrane, Cytosol" "CAB032952: AB_634461, HPA036070: AB_10602292, HPA036071: AB_10669982" "unprognostic (2.32e-2)" "unprognostic (1.36e-1)" "unprognostic (1.05e-1)" "unprognostic (2.42e-2)" "unprognostic (1.41e-1)" "unprognostic (1.35e-1)" "unprognostic (1.04e-1)" "unprognostic (2.29e-1)" "unprognostic (3.03e-1)" "unprognostic (3.72e-2)" "prognostic unfavorable (1.96e-4)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.26e-9)" "unprognostic (4.19e-2)" "unprognostic (1.74e-1)" "unprognostic (1.73e-1)" "unprognostic (4.24e-2)" 0.7 0.0 0.4 5.3 0.4 0.0 1.7 0.4 0.4 7.6 18.1 0.5 0.8 13.6 0.6 0.5 44.0 0.0 11.7 0.4 0.4 0.0 0.8 1.7 1.1 0.4 0.4 0.4 0.4 1.4 0.0 0.4 0.6 0.4 2.2 7.4 0.4 7.6 0.4 0.4 24.2 24.2 0.9 0.4 0.4 12.5 0.4 0.4 0.4 0.4 18.9 17.2 6.5 15.0 1.3 4.5 1.2 2.4 0.3 1.9 0.9 10.6 1.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 20.4 0.0 3.6 0.0 0.0 16.6 0.0 0.0 0.0 2.6 0.2 0.0 4.3 0.0 0.0 0.0 3.4 0.0 22.5 0.0 0.1 0.1 0.0 0.0 0.1 1.2 0.1 5.9 0.0 0.1 0.1 27.4 7.7 0.0 0.6 0.2 0.0 13.0 0.1 1.1 1.2 4.0 0.0 0.0 12.5 0.8 0.1 0.1 0.2 0.4 0.1 0.2 0.0 0.0 0.2 0.2 0.5 1.2 2.4 0.4 0.5 1.7 1.9 1.2 0.4 0.1 4.5 1.3 0.4 0.6 1.2 0.3 1.3 0.3 0.5 0.9 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 11.9 34.1 0.0 2.8 5.3 2.0 0.4 12.7 9.4 17.0 0.0 2.0 0.2 0.0 1.4 0.0 0.3 90.1 0.0 1.4 0.1 0.4 1.3 9.2 1.5 0.7 0.0 5.2 0.6 4.1 0.0 0.3 2.8 0.0 0.0 39.1 2.4 10.3 65.1 0.0 0.1 3.9 0.0 0.4 0.2 0.2 13.6 0.1 0.0 18.8 13.8 PTMA TMSA ENSG00000187514 "Prothymosin alpha" P06454 2 231706895-231713541 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047183 Approved Enhanced Nucleoplasm,Cytosol No Yes 610000 Nucleoplasm Cytosol "HPA047183: AB_2679972" "unprognostic (1.49e-3)" "prognostic favorable (6.56e-4)" "unprognostic (3.73e-1)" "unprognostic (1.91e-1)" "unprognostic (2.05e-1)" "unprognostic (2.52e-2)" "prognostic unfavorable (3.61e-4)" "unprognostic (5.99e-2)" "unprognostic (1.56e-2)" "unprognostic (3.72e-3)" "unprognostic (2.35e-3)" "unprognostic (9.24e-2)" "prognostic unfavorable (1.99e-7)" "unprognostic (5.54e-2)" "unprognostic (6.07e-2)" "unprognostic (3.81e-3)" "unprognostic (8.64e-3)" 72.8 37.7 60.0 78.4 65.2 161.4 76.1 38.2 64.2 75.0 80.9 53.9 33.9 56.3 84.8 59.9 83.7 66.7 47.2 38.7 66.3 48.3 67.3 73.5 63.5 104.0 68.7 59.6 80.5 79.5 31.3 97.9 59.1 54.2 50.0 82.7 42.2 55.5 53.4 60.6 92.5 62.8 58.4 86.6 90.1 69.2 113.9 67.2 127.5 73.4 50.4 118.6 70.0 69.9 189.1 134.7 114.4 126.9 117.0 167.3 255.0 99.6 59.9 85.5 76.2 26.0 34.7 87.8 68.1 57.2 59.5 62.5 58.0 116.9 157.9 78.1 53.1 41.2 52.8 120.2 83.9 75.7 125.1 94.5 203.5 49.5 93.6 32.3 230.8 87.1 50.3 31.5 52.7 43.6 56.8 97.0 129.0 118.2 67.2 51.9 142.5 324.2 314.8 128.7 99.1 50.0 223.4 60.9 107.3 72.8 89.1 174.5 107.4 78.2 78.3 59.4 70.5 59.0 183.6 72.0 50.2 89.1 61.3 73.1 81.5 40.1 316.2 34.3 141.6 80.4 114.4 113.6 75.3 99.1 114.0 143.5 189.1 143.8 120.6 126.3 160.4 160.6 134.8 23.1 117.0 126.9 134.7 167.3 255.0 60.0 65.2 38.2 64.2 66.3 48.3 68.7 59.6 54.2 67.2 902.2 1420.8 3111.4 3331.5 6879.8 692.5 258.3 1666.3 1917.9 1803.9 2156.5 276.9 2179.3 3208.0 2815.5 89.5 3767.9 1421.2 1752.0 3609.4 4317.6 3273.0 2682.0 2759.5 1209.1 2876.6 767.5 1629.9 1539.5 3031.9 138.7 1209.6 4164.5 3499.0 2458.1 2866.2 2213.1 3219.9 1988.5 1320.3 2161.4 753.7 1895.0 6501.7 798.6 2809.8 6944.4 2286.6 2724.1 3072.9 3503.3 PTMS ParaT ENSG00000159335 Parathymosin P20962 12 6765516-6770952 "Predicted intracellular proteins" Immunity "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 12.9;eosinophil: 3.3;plasmacytoid DC: 4.2" "Group enriched" "Detected in many" 6 "dendritic cells: 4.2;granulocytes: 12.9" "Cell line enhanced" "Detected in many" "HDLM-2: 84.1" HPA038186 Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim" No No 31000 "Nucleoli, Nucleoli rim" Nucleoplasm "HPA038186: AB_10673042" "unprognostic (3.11e-2)" "unprognostic (1.31e-3)" "unprognostic (1.76e-1)" "unprognostic (3.57e-2)" "unprognostic (1.09e-1)" "unprognostic (2.83e-1)" "unprognostic (1.13e-1)" "unprognostic (2.47e-1)" "unprognostic (4.16e-1)" "unprognostic (1.01e-1)" "unprognostic (8.69e-3)" "unprognostic (2.52e-1)" "prognostic unfavorable (6.18e-5)" "unprognostic (1.02e-1)" "unprognostic (3.21e-1)" "unprognostic (2.35e-3)" "unprognostic (1.55e-2)" 47.0 24.7 45.4 23.5 54.9 7.5 79.3 54.0 40.3 46.0 58.1 7.9 32.4 17.8 71.3 24.9 43.7 36.5 30.8 21.8 31.7 20.0 43.4 155.3 50.7 19.4 11.1 28.6 72.9 18.3 45.8 21.0 26.3 17.9 58.7 19.1 26.6 22.7 58.1 22.6 29.9 24.4 62.5 17.7 20.8 28.3 16.1 15.3 9.5 28.3 29.8 13.0 44.4 81.6 0.1 4.2 12.9 0.3 0.2 1.3 0.3 6.1 27.1 46.7 43.7 25.2 21.2 16.9 26.7 30.0 24.4 21.0 17.2 25.2 2.3 20.1 48.6 20.5 12.9 27.1 24.9 9.7 84.1 36.8 3.0 16.0 5.9 28.6 0.7 7.2 20.1 10.1 17.5 36.2 37.4 27.3 1.2 21.3 6.2 22.2 15.4 1.1 4.9 44.5 13.1 29.4 0.5 12.2 5.1 19.2 1.2 14.3 46.5 29.3 11.0 22.9 34.4 10.0 3.1 37.0 33.6 46.8 4.6 24.4 5.4 2.6 3.2 26.1 2.0 24.5 12.9 0.3 3.3 1.3 0.1 0.6 0.1 0.1 1.2 0.3 0.0 0.0 0.2 1.0 0.2 0.0 4.2 0.5 0.3 45.4 54.9 54.0 40.3 31.7 20.0 11.1 28.6 17.9 15.3 0.0 19.7 44.0 264.1 257.1 332.2 6.9 79.0 10.7 12.5 146.5 188.5 124.4 198.9 34.5 5.5 262.5 134.0 116.8 29.5 354.7 255.9 393.3 54.0 544.5 395.5 109.7 492.9 234.5 56.9 9.0 453.3 138.5 215.9 116.4 209.5 249.7 32.6 106.6 650.6 469.2 250.9 588.6 361.9 5.8 34.1 217.8 136.5 54.3 187.5 139.3 PTOV1 ENSG00000104960 "Prostate tumor overexpressed 1" Q86YD1 19 49850735-49860744 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 255.0;Late spermatids: 494.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051812, HPA075125" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA051812: , HPA075125: AB_2732280" "unprognostic (2.70e-1)" "unprognostic (1.36e-2)" "prognostic unfavorable (6.64e-4)" "unprognostic (4.68e-2)" "unprognostic (1.37e-1)" "unprognostic (6.31e-2)" "unprognostic (1.94e-2)" "unprognostic (1.40e-1)" "unprognostic (2.70e-1)" "unprognostic (9.08e-2)" "prognostic favorable (9.20e-4)" "unprognostic (4.65e-2)" "unprognostic (3.22e-2)" "unprognostic (2.47e-1)" "unprognostic (1.26e-2)" "unprognostic (5.27e-2)" "unprognostic (6.70e-2)" 24.1 49.1 31.6 23.7 33.6 26.8 27.3 37.8 47.1 23.7 20.9 32.5 28.4 25.0 29.9 28.1 16.3 24.9 24.6 23.5 31.1 34.1 24.9 29.3 19.1 22.5 32.2 30.3 34.3 39.3 26.9 40.1 24.5 28.5 32.6 7.3 19.5 44.6 27.4 70.2 23.6 28.8 14.3 29.0 28.9 27.3 27.4 27.9 24.8 33.0 18.6 11.4 18.9 30.4 7.9 9.9 9.5 3.5 6.0 5.1 1.5 11.8 24.7 25.1 26.9 3.5 5.8 15.4 14.7 13.1 13.8 14.5 13.4 20.7 12.9 14.1 7.3 9.4 13.3 9.3 11.4 3.3 33.6 62.0 8.3 19.2 20.8 9.1 6.8 17.1 11.0 7.4 5.8 2.4 9.3 11.4 18.4 19.4 15.7 6.3 14.7 30.7 31.1 16.1 8.6 22.6 37.4 10.2 18.0 11.9 21.0 32.6 35.6 12.6 14.8 6.2 6.6 14.4 7.6 16.4 16.5 27.3 9.8 11.9 16.6 9.9 16.9 17.0 9.7 20.8 7.9 3.5 5.0 3.6 3.0 4.7 7.9 4.0 3.1 2.4 7.8 5.1 4.7 9.5 6.0 1.7 9.9 1.6 1.5 31.6 33.6 37.8 47.1 31.1 34.1 32.2 30.3 28.5 27.9 35.7 25.5 28.4 70.8 32.4 46.5 25.7 61.1 32.1 27.3 41.8 17.7 90.7 76.3 25.5 255.0 32.2 66.7 23.3 22.8 72.7 56.7 80.2 15.0 50.8 43.9 33.4 95.7 33.7 24.0 494.5 59.5 28.7 42.2 10.8 58.5 74.1 33.9 46.3 75.7 105.6 42.1 58.2 48.4 33.9 59.8 31.7 128.5 22.4 50.2 60.4 PTPA "PPP2R4, PR53" ENSG00000119383 "Protein phosphatase 2 phosphatase activator" Q15257 9 129110950-129148946 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 50.6;Cytotrophoblasts: 42.8;Distal tubular cells: 46.4;Ductal cells: 58.5;Exocrine glandular cells: 54.1;Hofbauer cells: 45.3;Pancreatic endocrine cells: 49.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005695, CAB022068, CAB035999" Approved Enhanced Nucleoplasm,Cytosol NA NA 4800000 Nucleoplasm Cytosol "CAB022068: , CAB035999: , HPA005695: AB_1855658" "unprognostic (4.97e-2)" "unprognostic (1.70e-2)" "unprognostic (1.13e-2)" "prognostic favorable (6.50e-5)" "unprognostic (1.56e-2)" "unprognostic (1.15e-1)" "unprognostic (6.65e-2)" "unprognostic (6.44e-3)" "unprognostic (2.22e-1)" "unprognostic (1.15e-2)" "unprognostic (3.20e-2)" "unprognostic (1.37e-1)" "unprognostic (1.01e-2)" "unprognostic (1.92e-2)" "unprognostic (1.18e-1)" "unprognostic (1.48e-1)" "unprognostic (1.69e-1)" 16.5 35.1 41.6 19.8 41.2 18.1 23.9 32.0 74.2 27.5 27.4 27.2 30.1 18.3 26.7 26.0 31.8 30.1 28.7 42.1 38.0 32.4 32.6 41.0 22.1 19.8 30.8 35.5 23.2 22.4 55.0 22.5 21.4 37.0 33.4 21.7 20.8 36.0 41.5 110.7 27.2 18.8 35.3 21.9 24.4 23.8 62.4 17.6 23.7 27.2 37.0 21.3 22.1 23.9 12.6 19.2 7.8 15.5 17.7 18.4 14.9 24.3 43.2 26.6 49.3 18.0 22.1 26.6 25.5 28.9 35.0 24.5 23.1 30.1 25.4 19.3 43.2 39.8 39.7 27.8 31.4 30.2 45.0 15.2 15.7 45.7 21.9 53.6 27.0 34.1 26.5 31.0 25.6 24.4 53.1 35.6 26.6 23.2 28.2 29.4 63.2 24.6 16.7 41.9 66.2 43.0 24.6 24.6 46.6 36.7 30.6 28.9 20.4 51.6 53.3 31.9 26.4 56.5 11.8 26.1 29.1 26.3 30.0 35.9 25.8 65.9 22.9 35.8 17.7 40.1 5.8 15.5 7.8 18.4 15.5 17.6 9.6 14.0 16.4 19.2 12.6 13.1 13.1 5.4 17.7 14.4 13.8 14.0 14.9 41.6 41.2 32.0 74.2 38.0 32.4 30.8 35.5 37.0 17.6 3.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 50.6 0.0 42.8 46.4 58.5 0.0 0.0 0.0 0.0 54.1 37.3 0.0 0.0 8.1 0.0 45.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 37.9 0.0 0.0 49.9 0.0 0.0 32.9 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 PTPDC1 "FLJ37312, PTP9Q22" ENSG00000158079 "Protein tyrosine phosphatase domain containing 1" A2A3K4 9 94030794-94109856 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 32.3" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.0" "Group enriched" "Detected in many" 5 "B-cells: 1.1;T-cells: 2.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016747, HPA026832" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA016747: AB_1855908, HPA026832: AB_10602917" "unprognostic (3.99e-2)" "unprognostic (2.54e-1)" "unprognostic (1.74e-1)" "unprognostic (4.91e-2)" "unprognostic (1.94e-1)" "unprognostic (3.64e-2)" "unprognostic (1.90e-3)" "unprognostic (4.71e-1)" "unprognostic (2.43e-1)" "unprognostic (2.56e-1)" "unprognostic (3.49e-2)" "unprognostic (3.55e-2)" "unprognostic (2.48e-2)" "unprognostic (2.45e-2)" "unprognostic (2.17e-1)" "unprognostic (1.28e-1)" "unprognostic (2.61e-2)" 7.0 12.0 7.6 4.4 32.3 1.5 6.4 4.7 16.4 4.7 4.9 25.3 1.4 3.1 6.2 4.9 4.4 4.4 4.7 10.0 12.1 6.9 5.1 2.4 6.8 3.7 13.9 8.9 6.3 12.2 6.8 8.9 3.7 19.9 5.6 5.9 4.1 4.3 4.4 7.0 6.2 3.6 8.3 20.5 3.0 7.1 15.0 13.0 1.6 5.1 1.3 3.9 4.9 3.6 1.1 0.3 0.0 0.2 0.0 2.0 0.1 6.1 2.7 4.9 6.3 6.1 8.5 6.5 4.5 3.2 4.6 3.9 2.6 5.2 5.2 3.1 3.4 10.6 4.9 5.0 2.9 4.5 7.0 1.4 1.2 7.2 2.8 8.0 1.4 4.0 8.4 10.5 7.0 9.8 2.8 4.9 8.6 3.0 0.0 8.6 3.3 5.2 2.2 3.4 5.0 5.1 5.6 9.7 0.0 2.6 1.5 4.3 5.5 6.2 5.8 9.7 6.8 3.1 2.5 6.9 6.2 3.8 9.5 5.4 7.6 8.4 0.7 4.6 2.5 8.6 0.0 0.2 0.0 0.1 0.0 0.1 0.4 1.1 0.0 0.3 1.1 2.0 0.7 0.0 0.0 0.2 0.2 0.0 0.1 7.6 32.3 4.7 16.4 12.1 6.9 13.9 8.9 19.9 13.0 0.0 7.7 1.9 2.6 4.2 10.5 8.4 2.5 1.4 1.2 5.2 9.8 0.3 3.3 2.9 8.0 5.7 0.9 0.0 2.5 1.6 5.0 1.9 5.7 0.8 2.7 4.8 3.4 6.2 0.3 3.8 3.4 2.7 3.3 0.0 2.4 2.3 5.0 1.1 13.4 1.0 9.8 19.4 4.8 12.0 15.9 3.8 0.2 2.5 2.3 1.7 PTPN11 "BPTP3, NS1, PTP2C, SH-PTP2, SHP-2, SHP2" ENSG00000179295 "Protein tyrosine phosphatase, non-receptor type 11" Q06124 12 112418351-112509913 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Hydrolase, Protein phosphatase" "Cancer-related genes, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 136.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005377 Approved Supported "Nucleoplasm,Nucleoli rim,Actin filaments,Cytosol" NA NA 160000 "Nucleoli rim" "Nucleoplasm, Actin filaments, Cytosol" "CAB005377: AB_632401" "unprognostic (2.18e-3)" "unprognostic (1.73e-3)" "unprognostic (5.62e-2)" "unprognostic (1.19e-1)" "unprognostic (1.63e-2)" "unprognostic (2.27e-1)" "unprognostic (6.05e-2)" "unprognostic (4.25e-2)" "unprognostic (3.55e-2)" "unprognostic (1.88e-1)" "unprognostic (2.22e-2)" "unprognostic (8.85e-2)" "unprognostic (3.75e-3)" "unprognostic (1.66e-1)" "unprognostic (2.46e-1)" "unprognostic (3.62e-2)" "unprognostic (1.80e-2)" 25.4 16.8 38.6 14.4 39.0 17.7 30.8 17.5 39.5 18.3 14.7 26.9 9.9 11.9 19.1 13.3 17.6 11.1 13.1 30.1 38.0 32.2 18.0 23.1 15.1 14.5 45.3 22.5 13.1 14.0 29.3 12.9 16.6 26.2 16.2 13.9 9.4 12.0 20.0 34.0 14.1 11.1 28.0 45.7 10.9 12.8 7.6 32.1 10.9 21.2 8.2 13.7 17.4 15.4 17.3 17.1 22.0 11.8 11.3 15.4 6.3 35.4 33.8 24.7 23.4 36.0 35.2 29.2 43.1 47.0 34.0 25.6 33.7 13.7 37.5 22.5 39.8 21.5 21.2 31.7 38.2 56.5 28.4 26.1 54.5 31.5 18.4 35.9 43.7 34.8 28.4 38.5 36.5 51.9 32.8 28.0 29.0 41.4 13.2 32.8 25.6 30.7 21.3 29.9 34.7 22.2 31.6 36.4 21.5 31.3 39.9 17.2 21.1 41.5 31.8 26.5 26.1 36.6 30.3 34.1 40.0 35.9 23.7 37.6 25.6 42.2 37.5 33.3 30.7 37.3 22.0 11.0 15.0 14.8 9.5 14.1 15.5 13.4 12.1 12.6 17.3 15.4 11.8 10.3 11.3 11.8 17.1 9.8 6.3 38.6 39.0 17.5 39.5 38.0 32.2 45.3 22.5 26.2 32.1 56.6 53.2 13.4 22.8 22.8 27.6 136.3 30.6 20.1 50.0 34.9 15.7 20.0 28.2 34.0 65.9 35.8 17.2 0.0 36.7 21.0 25.9 57.9 26.7 93.6 22.8 12.7 12.6 27.0 32.4 19.0 47.8 23.7 13.5 16.2 19.6 59.0 45.4 20.4 75.0 29.8 21.4 32.3 31.9 7.7 5.3 24.0 29.4 19.8 18.7 65.6 PTPN13 "PTP-BAS, PTP-BL, PTP1E, PTPL1" ENSG00000163629 "Protein tyrosine phosphatase, non-receptor type 13" Q12923 4 86594315-86815171 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 152.9;Basal keratinocytes: 97.1;Rod photoreceptor cells: 171.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "intermediate monocyte: 3.0;MAIT T-cell: 2.3;memory CD4 T-cell: 2.2;non-classical monocyte: 4.9" "Group enriched" "Detected in many" 7 "monocytes: 4.9;T-cells: 2.3" "Cell line enhanced" "Detected in many" "AF22: 45.2;RT4: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002213, HPA063119" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Cytosol" "CAB002213: AB_564089, HPA063119: " "unprognostic (5.36e-2)" "unprognostic (4.46e-1)" "unprognostic (1.11e-1)" "unprognostic (2.54e-3)" "unprognostic (4.02e-1)" "unprognostic (9.03e-3)" "unprognostic (4.43e-2)" "unprognostic (4.38e-2)" "unprognostic (2.46e-1)" "unprognostic (7.05e-2)" "unprognostic (3.69e-2)" "unprognostic (1.46e-1)" "unprognostic (1.28e-3)" "unprognostic (3.95e-3)" "unprognostic (2.26e-1)" "unprognostic (2.66e-1)" "unprognostic (2.85e-2)" 10.3 5.9 10.8 2.7 16.9 0.7 9.9 5.7 11.6 15.9 4.1 13.0 7.6 1.2 10.8 21.2 18.7 11.4 6.5 5.3 10.4 5.7 22.1 1.6 18.0 4.3 16.9 7.9 24.1 4.3 26.6 38.3 3.0 14.2 12.0 2.4 39.0 5.9 9.4 1.0 43.0 2.3 8.7 10.3 3.5 3.6 12.2 17.6 1.9 16.9 12.4 11.8 15.7 17.6 0.0 0.5 0.1 4.9 0.1 2.3 0.1 5.1 2.6 45.2 4.4 19.1 16.7 0.0 9.5 19.4 3.6 4.6 0.0 2.6 0.0 2.1 10.5 1.3 17.0 7.8 14.3 7.0 0.1 5.8 4.3 5.6 0.0 2.3 7.5 0.0 10.7 4.6 2.6 8.7 7.6 0.0 0.0 0.0 7.4 0.0 2.3 0.6 2.7 10.3 0.0 1.9 1.5 0.0 0.0 13.8 21.5 2.6 3.8 2.8 6.3 5.2 7.6 3.7 0.2 0.0 3.5 2.7 0.0 1.2 7.7 0.0 0.0 3.7 0.0 1.5 0.0 0.2 0.0 0.2 3.0 2.3 0.0 2.2 0.3 0.5 0.0 0.0 0.0 0.1 0.1 4.9 0.0 0.1 0.1 10.8 16.9 5.7 11.6 10.4 5.7 16.9 7.9 14.2 17.6 44.7 152.9 0.0 21.0 97.1 9.8 1.7 10.2 32.1 75.1 45.4 86.4 0.2 3.3 4.3 20.2 2.2 0.0 0.0 3.0 0.1 20.2 12.1 4.7 0.0 0.2 1.6 4.6 1.8 2.2 14.8 42.3 5.7 18.6 0.0 0.5 14.1 4.3 3.5 30.8 9.2 171.6 12.9 12.5 24.4 21.6 86.9 0.2 4.4 0.2 45.5 PTPN14 PEZ ENSG00000152104 "Protein tyrosine phosphatase, non-receptor type 14" Q15678 1 214348696-214552449 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 68.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB011469, HPA053864, CAB069441" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "CAB011469: AB_299202, CAB069441: , HPA053864: AB_2682281" "unprognostic (1.54e-1)" "unprognostic (8.19e-2)" "unprognostic (5.42e-5)" "unprognostic (1.42e-1)" "unprognostic (2.91e-1)" "unprognostic (5.97e-2)" "unprognostic (1.26e-1)" "unprognostic (1.58e-1)" "unprognostic (2.84e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.29e-4)" "unprognostic (7.43e-2)" "unprognostic (8.34e-3)" "prognostic unfavorable (5.16e-4)" "unprognostic (1.16e-1)" "unprognostic (2.21e-1)" "unprognostic (4.81e-3)" 13.6 10.0 3.0 6.5 2.4 0.2 15.0 0.8 3.7 13.6 8.5 2.6 11.0 1.0 15.4 8.0 8.6 9.2 9.7 7.0 3.5 1.9 11.2 2.0 12.2 6.6 2.4 1.3 11.8 5.0 6.3 4.0 13.2 4.9 10.6 2.9 7.2 9.2 23.4 21.6 18.8 3.5 9.4 4.3 5.3 5.7 8.3 2.4 1.4 8.1 6.9 3.7 12.4 17.7 1.0 0.5 1.9 0.4 1.0 0.6 0.1 8.8 3.9 3.2 4.7 5.6 9.6 9.5 10.1 9.4 7.7 6.5 7.9 4.6 0.0 11.2 23.4 4.4 7.9 4.4 11.2 13.2 0.1 3.3 0.8 11.3 1.5 10.2 0.1 0.4 7.1 11.8 13.4 21.6 12.7 14.9 0.3 0.0 0.1 18.6 0.9 0.1 0.1 7.0 1.6 4.3 0.1 16.2 0.0 13.9 4.5 0.0 0.7 12.5 8.2 5.1 11.9 8.1 0.3 26.5 18.1 7.1 6.4 14.2 0.5 0.0 0.0 9.7 0.1 15.0 1.3 0.4 0.3 0.5 0.3 0.6 0.5 0.5 0.4 0.1 1.0 0.5 0.6 1.9 1.0 0.4 0.5 0.6 0.1 3.0 2.4 0.8 3.7 3.5 1.9 2.4 1.3 4.9 2.4 68.5 15.9 0.5 27.7 50.3 0.4 17.5 2.5 21.4 44.3 27.9 0.0 30.2 6.6 12.0 8.1 42.7 0.4 0.0 9.4 11.6 27.8 19.5 1.1 0.8 4.0 0.0 3.4 36.8 1.2 4.0 24.2 2.5 10.1 0.0 5.0 3.3 20.7 0.0 27.6 12.5 1.3 19.4 20.6 0.7 7.2 31.6 20.3 1.8 2.9 24.0 PTPN2 "PTPT, TC-PTP, TCELLPTP, TCPTP" ENSG00000175354 "Protein tyrosine phosphatase, non-receptor type 2" P17706 18 12785478-12929643 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015004, HPA046176" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA015004: AB_2669131, HPA046176: AB_2679569" "unprognostic (5.83e-3)" "unprognostic (8.50e-2)" "unprognostic (5.85e-2)" "unprognostic (7.21e-3)" "unprognostic (8.94e-3)" "unprognostic (2.31e-1)" "unprognostic (1.12e-1)" "unprognostic (1.68e-1)" "unprognostic (2.37e-3)" "prognostic favorable (1.37e-4)" "unprognostic (1.06e-2)" "unprognostic (1.75e-2)" "prognostic unfavorable (1.20e-8)" "unprognostic (3.19e-1)" "unprognostic (6.84e-3)" "unprognostic (2.17e-1)" "unprognostic (4.61e-3)" 16.7 12.5 12.6 27.0 14.3 33.7 19.9 32.6 19.2 14.7 15.0 7.8 17.8 12.9 12.2 14.9 17.0 13.7 15.7 12.8 13.1 6.8 13.6 20.5 21.6 30.3 15.3 10.3 22.1 28.2 10.4 27.2 13.3 13.8 14.4 17.1 7.9 26.3 16.0 13.1 16.0 15.3 11.8 24.7 24.2 13.1 9.4 15.9 61.3 14.7 11.7 28.9 16.5 15.8 29.1 32.8 19.9 28.0 31.7 29.2 19.6 12.0 7.4 8.6 2.8 9.9 17.8 8.4 8.1 18.0 17.4 15.6 16.0 17.5 19.0 13.7 8.3 19.5 7.3 14.0 22.2 22.9 7.3 8.4 13.4 6.4 16.6 13.6 31.5 12.8 14.9 21.1 15.8 31.4 10.7 8.8 20.8 13.0 25.9 13.9 13.8 31.4 26.0 10.3 49.8 8.6 10.6 13.6 21.5 14.6 19.4 15.5 8.0 16.4 9.7 14.0 9.6 8.1 18.1 6.7 22.1 21.3 16.4 17.4 8.3 8.3 27.5 10.4 17.3 9.2 11.5 28.0 19.9 21.0 24.6 28.2 29.1 24.8 23.1 32.8 20.3 18.3 20.0 10.2 31.7 22.8 28.0 29.2 19.6 12.6 14.3 32.6 19.2 13.1 6.8 15.3 10.3 13.8 15.9 32.8 62.4 68.6 84.1 53.1 42.4 13.2 38.2 33.5 60.3 14.0 98.2 46.3 11.6 47.9 16.6 28.1 29.6 23.3 59.5 44.8 31.3 89.2 55.4 27.0 47.0 14.3 31.0 16.5 81.8 19.2 27.0 82.9 21.9 111.8 30.9 14.8 39.1 38.6 24.1 17.3 84.6 19.4 21.1 15.4 50.3 43.8 67.9 68.2 36.2 140.6 PTPN21 "PTPD1, PTPRL10" ENSG00000070778 "Protein tyrosine phosphatase, non-receptor type 21" Q16825 14 88465778-88554733 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 53.6;Syncytiotrophoblasts: 85.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RH-30: 23.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB011468, HPA073999" Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Centriolar satellite,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Golgi apparatus, Centriolar satellite" "CAB011468: AB_442979, HPA073999: AB_2732247" "unprognostic (2.18e-1)" "unprognostic (4.21e-2)" "unprognostic (7.60e-2)" "unprognostic (3.09e-2)" "unprognostic (4.60e-2)" "unprognostic (5.71e-2)" "unprognostic (6.55e-2)" "unprognostic (5.19e-3)" "unprognostic (6.62e-2)" "unprognostic (1.02e-2)" "unprognostic (8.71e-3)" "unprognostic (3.04e-3)" "prognostic favorable (3.16e-9)" "unprognostic (6.52e-2)" "unprognostic (2.69e-1)" "unprognostic (2.56e-1)" "unprognostic (7.67e-2)" 10.5 4.7 5.3 8.6 7.3 0.0 13.2 4.4 5.8 10.7 8.7 10.7 7.4 4.9 10.6 10.7 8.9 8.3 12.7 17.4 7.4 4.2 8.1 6.0 15.3 1.6 6.6 4.2 15.8 7.8 10.6 3.9 15.6 6.4 11.9 6.5 12.6 6.5 10.5 8.8 24.2 10.5 15.7 7.3 3.7 7.4 15.2 6.5 0.8 16.0 8.4 3.1 12.0 26.1 0.8 0.0 0.0 0.1 0.0 0.1 0.0 3.6 2.9 7.7 3.0 8.2 7.2 8.0 9.8 7.5 5.8 8.1 5.2 6.6 0.0 2.4 12.4 5.2 3.4 1.1 3.4 8.5 0.2 1.7 0.0 3.2 2.1 9.2 0.0 0.1 4.7 6.8 4.8 5.8 7.5 4.7 0.0 1.1 0.1 14.8 3.0 0.0 0.1 2.2 3.9 5.6 0.0 23.1 0.0 5.0 2.6 0.5 9.0 5.6 14.1 3.2 6.8 6.9 1.5 9.2 10.8 8.5 4.4 6.7 0.3 1.2 0.0 4.0 0.1 4.3 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.3 7.3 4.4 5.8 7.4 4.2 6.6 4.2 6.4 6.5 53.6 5.9 0.0 4.0 9.3 7.3 31.1 5.1 9.4 7.9 7.0 33.4 7.6 0.0 4.4 12.7 4.5 9.3 0.0 7.2 4.4 9.3 7.8 2.3 9.0 1.6 1.6 4.6 7.4 1.2 3.5 15.8 0.7 0.0 0.0 14.6 4.9 8.2 5.8 25.5 3.3 9.0 0.0 8.5 12.1 6.1 10.5 85.2 0.0 4.6 4.7 PTPN22 "Lyp, Lyp1, Lyp2, PTPN8" ENSG00000134242 "Protein tyrosine phosphatase, non-receptor type 22" Q9Y2R2 1 113813811-113871759 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Autophagy, Immunity" "Hydrolase, Protein phosphatase" "Diabetes mellitus, Disease mutation, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 23.6;lymphoid tissue: 46.0" "Cell type enhanced" "Detected in many" 15 "B-cells: 29.6;granulocytes: 26.6;Kupffer cells: 19.2;Macrophages: 20.5;T-cells: 65.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 33.5;HL-60: 13.3;U-266/70: 14.4;U-698: 18.0;U-937: 13.6" "Region enriched" "Detected in single" 10 "cerebellum: 5.9" "Not detected" "Not detected" "HPA004912, CAB012209, HPA013350" Approved Uncertain "Nucleoplasm,Vesicles,Plasma membrane" NA NA Nucleoplasm "Vesicles, Plasma membrane" "CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570" "unprognostic (2.25e-2)" "unprognostic (5.31e-3)" "unprognostic (3.48e-1)" "unprognostic (3.33e-4)" "unprognostic (9.14e-2)" "unprognostic (2.47e-3)" "unprognostic (9.60e-2)" "unprognostic (8.14e-2)" "unprognostic (3.71e-1)" "unprognostic (1.82e-1)" "unprognostic (1.62e-1)" "unprognostic (3.02e-1)" "unprognostic (2.75e-6)" "unprognostic (3.19e-1)" "unprognostic (1.10e-1)" "unprognostic (1.61e-1)" "unprognostic (3.22e-2)" 4.2 1.4 0.5 17.1 0.8 23.6 1.9 1.0 0.5 2.4 3.3 0.3 1.0 4.1 2.0 2.2 2.0 1.7 3.2 2.5 0.6 0.7 3.4 1.8 9.0 14.9 0.7 0.4 1.5 2.4 0.0 0.9 0.9 1.0 1.7 2.8 1.3 2.7 3.0 0.6 1.0 9.9 0.9 2.1 19.0 3.1 1.1 0.4 46.0 1.5 2.4 12.8 4.8 1.7 7.2 6.2 17.2 3.5 7.5 14.9 4.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.2 0.0 0.3 0.0 0.2 33.5 0.0 0.1 0.0 0.0 0.0 0.0 0.2 3.1 0.0 4.7 0.0 0.0 0.1 13.3 10.5 3.0 0.0 1.4 0.1 2.7 5.2 8.4 0.0 7.7 5.1 0.1 9.4 7.5 0.0 0.0 0.0 0.5 3.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.8 2.4 8.0 0.1 0.1 0.2 14.4 3.0 18.0 5.5 13.6 0.0 10.2 3.5 17.2 12.8 0.9 14.9 7.2 6.5 10.1 6.2 4.7 3.9 9.4 1.7 7.5 0.4 3.7 10.0 4.6 0.5 0.8 1.0 0.5 0.6 0.7 0.7 0.4 1.0 0.4 0.0 9.2 29.6 0.2 2.3 0.4 0.5 0.0 4.0 0.0 1.8 2.0 0.0 0.0 0.0 0.3 0.0 2.3 0.0 0.5 0.2 0.9 0.2 26.6 0.6 7.1 0.0 0.0 0.6 19.2 0.6 0.0 20.5 3.3 1.8 1.0 0.0 0.6 0.0 0.0 0.0 0.4 12.9 0.9 0.3 0.2 2.4 0.1 65.4 1.7 0.2 PTPN23 "DKFZP564F0923, HD-PTP, KIAA1471" ENSG00000076201 "Protein tyrosine phosphatase, non-receptor type 23" Q9H3S7 3 47381011-47413441 "Enzymes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016845 Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles" Yes No "Nucleoplasm, Nuclear bodies" Vesicles "HPA016845: AB_1855926" "unprognostic (1.17e-3)" "unprognostic (8.68e-2)" "unprognostic (2.56e-1)" "unprognostic (1.26e-1)" "unprognostic (1.63e-1)" "unprognostic (6.24e-2)" "unprognostic (1.07e-3)" "unprognostic (2.07e-2)" "unprognostic (9.55e-2)" "unprognostic (7.12e-2)" "unprognostic (5.67e-2)" "unprognostic (4.34e-2)" "prognostic favorable (1.82e-4)" "unprognostic (3.05e-2)" "unprognostic (4.40e-1)" "unprognostic (9.53e-2)" "unprognostic (4.68e-2)" 15.9 18.5 23.1 17.4 22.3 19.2 21.6 22.8 25.0 18.1 12.5 21.4 14.6 20.7 20.0 15.1 17.2 17.2 12.8 13.2 17.9 11.7 16.4 13.0 16.8 17.8 24.6 23.7 23.4 19.4 53.4 29.9 17.1 20.5 16.9 10.4 15.2 20.8 19.0 25.7 25.9 16.0 16.0 20.3 19.2 17.9 17.8 22.7 9.7 24.8 9.7 11.1 17.7 18.1 1.4 1.1 3.7 1.2 0.9 1.5 0.8 13.0 18.6 10.4 13.4 13.6 10.5 10.0 11.9 11.9 11.2 9.5 15.7 12.9 9.3 11.0 13.5 19.9 11.7 8.9 12.9 5.4 8.6 9.6 12.8 13.6 14.6 15.0 7.5 17.4 13.9 13.3 14.5 14.9 7.9 13.7 7.9 9.5 12.8 11.9 18.3 7.1 6.3 11.1 9.1 13.1 4.4 5.0 11.2 8.4 25.3 5.5 13.0 10.5 22.4 8.7 6.6 12.8 7.2 13.7 17.1 14.5 23.7 16.8 18.4 12.0 5.4 18.6 7.1 12.1 3.7 1.2 0.0 0.8 0.5 0.6 1.4 0.6 1.3 0.4 0.7 0.6 0.8 1.4 0.9 0.5 1.1 1.5 0.8 23.1 22.3 22.8 25.0 17.9 11.7 24.6 23.7 20.5 22.7 8.9 6.5 1.5 4.4 7.1 11.3 6.2 10.2 10.7 7.9 5.2 13.7 8.5 1.7 9.1 1.4 11.1 14.2 0.0 7.6 6.5 6.1 7.9 2.3 9.6 11.6 15.9 7.0 12.3 11.1 2.1 17.8 7.8 11.8 9.0 15.6 9.2 11.8 8.6 12.7 8.2 13.8 6.5 6.2 7.4 10.9 9.5 7.8 4.3 11.5 6.3 PTPN4 PTPMEG ENSG00000088179 "Protein tyrosine phosphatase, non-receptor type 4" P29074 2 119759631-119983818 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Bipolar cells: 53.9;Cone photoreceptor cells: 98.2;Horizontal cells: 152.6;Rod photoreceptor cells: 80.5;T-cells: 90.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 16 "NK-cells: 12.2;T-cells: 19.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019351 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA019351: AB_1855928" "unprognostic (1.45e-1)" "unprognostic (1.22e-1)" "unprognostic (1.07e-1)" "unprognostic (7.63e-2)" "unprognostic (9.00e-2)" "unprognostic (9.57e-2)" "unprognostic (2.34e-1)" "prognostic favorable (5.16e-4)" "unprognostic (3.31e-2)" "unprognostic (3.34e-3)" "unprognostic (3.13e-1)" "unprognostic (1.10e-1)" "unprognostic (3.34e-2)" "unprognostic (1.74e-1)" "unprognostic (1.87e-1)" "unprognostic (4.08e-2)" "unprognostic (1.81e-1)" 6.8 6.9 10.0 5.9 12.2 7.3 7.2 37.4 16.9 9.6 5.5 7.2 5.2 8.1 7.2 6.6 6.9 8.9 6.3 8.9 10.2 8.4 12.0 6.6 8.0 7.9 7.3 13.1 8.9 6.3 11.6 16.3 4.1 8.3 6.2 4.0 7.1 7.9 6.6 11.2 5.8 5.5 4.7 7.3 9.2 8.9 7.7 6.5 18.9 22.5 6.8 6.5 5.3 5.8 0.5 0.3 0.9 0.4 12.2 19.3 4.7 7.4 4.4 5.8 7.7 5.2 5.4 9.9 3.4 9.6 1.9 5.3 6.6 11.6 5.4 8.2 3.8 5.8 6.6 4.5 5.3 5.2 12.6 3.8 3.7 4.2 6.2 3.5 3.8 2.8 4.9 10.0 9.0 4.1 6.6 8.5 5.5 6.4 5.5 5.1 5.7 5.2 4.4 7.6 4.2 7.2 3.6 10.0 7.6 7.0 10.2 7.6 9.4 4.7 6.0 3.9 5.1 2.9 2.4 10.6 0.3 6.7 2.3 4.1 9.5 13.2 6.8 5.1 0.2 3.2 0.2 0.2 0.9 19.3 0.3 15.6 0.5 9.6 15.1 0.3 0.5 3.2 11.0 0.7 12.2 0.4 0.3 5.6 4.7 10.0 12.2 37.4 16.9 10.2 8.4 7.3 13.1 8.3 6.5 3.0 10.5 14.0 12.8 7.2 53.9 13.9 10.2 6.7 6.8 15.7 98.2 8.5 6.6 6.1 3.8 12.8 8.1 0.0 6.3 9.0 7.6 8.7 11.5 9.0 3.6 152.6 8.7 13.5 5.6 7.1 16.1 5.3 8.5 7.2 7.8 23.6 5.5 10.1 13.4 10.4 80.5 0.0 5.0 21.2 20.6 5.8 3.1 90.0 10.6 7.8 PTPN6 "HCP, HCPH, PTP-1C, SHP-1, SHP1" ENSG00000111679 "Protein tyrosine phosphatase, non-receptor type 6" P29350 12 6946468-6961316 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 107.1;lymphoid tissue: 69.0" "Group enriched" "Detected in many" 5 "B-cells: 106.2;Early spermatids: 45.6;granulocytes: 130.8;Hofbauer cells: 168.2;Kupffer cells: 145.1;Macrophages: 118.2;T-cells: 105.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 28.7;HL-60: 25.5;HMC-1: 112.6;THP-1: 43.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001466, CAB004572, CAB072845" Enhanced Supported Nucleoplasm,Nucleoli NA NA 7400000 Nucleoplasm Nucleoli "CAB004572: AB_628251, CAB072845: , HPA001466: AB_1855930" "unprognostic (4.28e-3)" "prognostic favorable (1.87e-4)" "prognostic unfavorable (5.42e-4)" "prognostic favorable (6.65e-4)" "unprognostic (6.54e-2)" "unprognostic (7.92e-2)" "unprognostic (2.36e-1)" "unprognostic (1.44e-2)" "unprognostic (6.93e-3)" "unprognostic (3.57e-1)" "unprognostic (1.41e-2)" "unprognostic (2.61e-1)" "unprognostic (1.60e-3)" "unprognostic (1.98e-3)" "unprognostic (2.60e-2)" "unprognostic (5.91e-2)" "prognostic favorable (2.64e-8)" 6.6 8.8 2.4 42.9 4.4 27.7 4.6 1.2 2.7 2.8 7.0 5.1 4.7 7.5 3.7 8.8 7.0 5.0 9.8 2.9 3.1 2.3 7.0 6.8 25.4 58.1 5.2 1.8 2.3 6.7 2.7 5.6 7.7 3.9 5.6 5.2 3.6 10.6 7.0 1.3 6.1 21.0 2.6 4.9 69.0 6.6 1.5 3.3 31.4 6.3 4.1 50.7 8.5 4.2 63.9 38.0 107.1 103.2 22.2 28.2 63.2 2.9 5.6 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 3.0 6.6 2.0 1.5 0.0 0.0 3.4 0.0 3.9 0.0 1.2 1.2 28.7 0.6 2.4 0.0 25.5 112.6 0.0 2.8 0.0 1.2 0.0 0.0 10.3 0.0 0.2 0.0 6.1 9.2 14.9 1.5 6.8 0.9 8.4 0.0 14.5 3.1 5.5 0.5 0.0 0.9 4.6 0.0 4.1 1.4 43.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 11.2 0.1 54.4 35.9 107.1 28.2 71.3 18.2 62.3 13.7 21.0 38.0 63.9 15.8 19.9 66.7 22.2 103.2 10.0 14.4 63.2 2.4 4.4 1.2 2.7 3.1 2.3 5.2 1.8 3.9 3.3 6.0 18.1 106.2 8.1 8.0 0.0 1.6 12.7 12.0 11.4 5.2 0.0 21.7 13.3 12.3 45.6 4.1 15.8 23.3 13.5 15.5 3.5 4.1 130.8 10.2 168.2 0.0 23.7 9.8 145.1 8.7 0.9 118.2 13.5 6.4 12.0 0.4 11.8 17.3 0.0 10.5 0.6 6.5 2.3 0.3 1.1 7.5 15.4 105.5 15.6 5.6 PTPRA "HLPR, HPTPA, LRP, PTPA, PTPRL2, RPTPA" ENSG00000132670 "Protein tyrosine phosphatase, receptor type A" P18433 20 2864184-3039076 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029412, CAB034366, HPA069480" Approved Approved Nucleoplasm,Vesicles NA NA 21000 Vesicles Nucleoplasm "CAB034366: AB_2269058, HPA029412: AB_10602293, HPA069480: AB_2686141" "unprognostic (1.39e-1)" "unprognostic (2.05e-1)" "unprognostic (4.58e-2)" "unprognostic (2.39e-3)" "unprognostic (1.15e-1)" "unprognostic (1.62e-1)" "unprognostic (5.43e-3)" "unprognostic (5.34e-2)" "unprognostic (1.55e-1)" "unprognostic (3.24e-1)" "unprognostic (7.33e-2)" "unprognostic (1.16e-1)" "prognostic favorable (3.29e-6)" "unprognostic (1.25e-1)" "unprognostic (4.02e-1)" "unprognostic (1.60e-2)" "unprognostic (4.19e-1)" 21.9 18.5 55.6 14.3 48.6 16.4 23.3 44.5 56.0 29.7 19.7 37.5 9.4 14.7 26.3 18.7 22.7 26.5 21.3 14.0 45.9 41.1 22.1 13.5 21.6 16.9 38.0 46.7 28.6 14.9 41.5 23.4 29.0 52.5 23.5 20.0 18.5 16.7 21.8 8.2 21.0 15.3 25.7 52.6 17.9 16.3 27.4 30.4 20.6 32.4 8.5 20.4 22.9 19.2 7.7 5.7 7.9 6.7 6.2 11.0 3.7 21.0 12.9 37.2 11.4 41.2 75.1 7.9 15.8 31.0 19.6 24.1 15.3 29.2 13.8 12.5 21.2 19.8 22.6 15.0 22.6 22.2 21.3 9.6 19.6 5.4 19.4 14.7 19.7 9.3 33.5 23.5 16.2 17.1 24.2 27.1 19.9 19.7 17.7 19.4 8.6 22.7 22.3 14.3 18.9 10.3 17.4 18.0 17.2 16.7 16.3 20.6 19.7 15.3 26.1 23.5 16.9 16.3 16.9 19.4 17.6 8.7 19.5 13.9 13.0 18.0 18.2 8.1 18.7 16.4 7.9 4.8 7.5 11.0 4.8 9.0 7.7 7.4 7.9 3.7 5.1 7.4 9.0 6.0 6.2 6.7 5.7 8.1 3.7 55.6 48.6 44.5 56.0 45.9 41.1 38.0 46.7 52.5 30.4 20.8 16.3 29.4 29.9 14.1 87.6 6.5 45.9 17.4 27.3 43.6 29.5 25.3 23.2 13.3 11.8 26.9 31.5 23.3 13.4 35.4 36.1 29.8 23.0 28.0 33.5 66.7 42.6 43.6 35.2 12.5 55.8 21.8 35.4 10.8 27.0 77.3 13.8 25.8 46.0 19.2 55.1 38.8 26.4 51.2 75.4 15.1 27.3 39.5 26.2 27.6 PTPRC "CD45, GP180, LCA, T200" ENSG00000081237 "Protein tyrosine phosphatase, receptor type C" 1 198638457-198757476 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 116.9;lymphoid tissue: 172.5" "Cell type enhanced" "Detected in many" 12 "B-cells: 266.4;granulocytes: 232.9;Kupffer cells: 338.8;Macrophages: 290.3;T-cells: 539.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 47.1;HEL: 26.6;HL-60: 24.0;JURKAT: 61.5;MOLT-4: 35.5;THP-1: 19.7;U-266/70: 22.0;U-266/84: 20.0;U-698: 28.2;U-937: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB000052, HPA000440, CAB002800, CAB056154, CAB068221" Enhanced Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Nucleoplasm, Vesicles" "CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: AB_2665572, CAB068221: AB_2665571, HPA000440: AB_611377" "unprognostic (1.51e-2)" "unprognostic (1.24e-2)" "unprognostic (5.10e-3)" "unprognostic (2.33e-3)" "unprognostic (1.30e-1)" "unprognostic (2.40e-3)" "unprognostic (1.62e-1)" "unprognostic (3.17e-2)" "unprognostic (1.25e-1)" "unprognostic (3.18e-2)" "unprognostic (8.08e-2)" "unprognostic (3.95e-1)" "prognostic unfavorable (2.42e-4)" "unprognostic (2.31e-1)" "unprognostic (3.43e-2)" "unprognostic (6.41e-2)" "unprognostic (7.06e-2)" 9.8 2.9 3.4 48.0 6.2 36.1 4.3 1.3 3.5 3.1 5.6 2.8 0.5 4.9 2.9 3.9 4.8 5.6 8.8 4.9 3.9 4.5 4.4 5.2 27.5 93.2 7.9 1.3 2.9 2.1 0.3 2.5 4.5 5.3 4.2 5.8 3.3 10.7 1.0 1.7 2.5 22.2 4.5 13.2 89.3 6.5 2.3 5.3 172.5 4.6 3.9 53.2 13.1 3.7 28.5 42.8 94.7 103.8 53.7 76.1 116.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 47.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 26.6 0.0 0.0 0.0 24.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 61.5 0.5 0.7 0.0 0.0 35.5 14.5 0.1 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.1 0.1 0.0 0.0 19.7 0.3 0.0 0.2 0.1 0.1 22.0 20.0 28.2 0.0 21.5 0.1 20.8 52.0 56.3 76.1 99.7 64.5 28.5 52.9 72.7 42.8 26.8 60.2 60.3 94.7 53.7 103.8 6.4 54.6 116.9 3.4 6.2 1.3 3.5 3.9 4.5 7.9 1.3 5.3 5.3 41.7 86.9 266.4 0.7 14.1 0.0 4.1 7.6 21.4 26.1 1.8 0.0 0.4 0.0 0.0 2.0 11.9 0.1 23.3 0.0 0.5 8.9 0.9 232.9 3.0 90.3 0.0 1.2 14.1 338.8 1.5 1.1 290.3 20.3 120.0 0.2 0.0 0.1 0.0 0.0 1.7 0.2 6.5 4.3 0.2 0.2 13.2 0.7 539.1 0.5 0.9 PTPRD "HPTP, PTPD" ENSG00000153707 "Protein tyrosine phosphatase, receptor type D" P23468 9 8314246-10612723 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.1;parathyroid gland: 37.5" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 110.1;Intestinal endocrine cells: 34.0;Muller glia cells: 44.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 23.5;HAP1: 5.1;HSkMC: 8.0;NTERA-2: 5.7;RH-30: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054829 Uncertain Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 2500000 Vesicles Nucleoplasm "HPA054829: AB_2682618" "unprognostic (4.74e-1)" "unprognostic (4.79e-2)" "unprognostic (1.44e-2)" "unprognostic (7.86e-2)" "unprognostic (2.34e-1)" "unprognostic (9.90e-2)" "unprognostic (1.85e-1)" "unprognostic (1.66e-1)" "unprognostic (1.91e-2)" "unprognostic (2.13e-2)" "unprognostic (7.52e-3)" "unprognostic (2.62e-1)" "prognostic favorable (7.45e-6)" "unprognostic (3.56e-4)" "unprognostic (7.59e-2)" "unprognostic (4.84e-2)" "unprognostic (3.08e-3)" 2.6 1.7 19.7 1.5 19.2 1.1 1.1 27.9 32.1 5.6 5.4 21.7 0.2 4.0 3.6 1.8 1.5 3.6 2.6 3.0 18.0 13.5 11.4 4.2 3.4 0.9 17.9 22.3 12.7 1.7 37.5 4.4 9.4 15.1 3.3 5.3 1.9 1.1 2.0 1.0 1.2 4.6 2.8 29.7 1.4 1.7 2.5 18.5 0.0 3.2 0.0 1.0 2.7 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 23.5 0.0 0.3 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 2.6 4.8 0.6 0.0 0.0 0.0 0.2 8.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.7 0.0 5.7 0.0 1.5 2.9 8.7 0.0 2.1 0.0 4.0 0.3 0.0 0.0 0.0 3.9 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 19.7 19.2 27.9 32.1 18.0 13.5 17.9 22.3 15.1 18.5 0.0 2.7 0.0 0.2 0.5 110.1 4.6 25.5 0.0 2.3 5.2 15.7 0.3 0.0 2.5 13.0 0.4 10.1 0.0 0.0 0.1 7.6 1.7 0.0 12.8 1.0 4.8 34.0 1.3 0.6 3.7 14.7 0.0 0.0 0.0 14.3 44.7 0.3 3.5 0.0 22.3 7.4 0.0 3.7 1.1 1.1 0.6 0.2 0.0 5.2 0.0 PTRHD1 "C2orf79, LOC391356" ENSG00000184924 "Peptidyl-tRNA hydrolase domain containing 1" Q6GMV3 2 24789734-24793382 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019951 Approved Approved Nucleoplasm NA NA 55000 Nucleoplasm "HPA019951: AB_1853109" "unprognostic (1.28e-2)" "unprognostic (5.79e-2)" "unprognostic (6.34e-2)" "unprognostic (1.34e-2)" "unprognostic (2.61e-2)" "unprognostic (3.99e-1)" "unprognostic (8.84e-3)" "unprognostic (1.26e-1)" "unprognostic (3.69e-1)" "unprognostic (8.31e-3)" "unprognostic (1.58e-1)" "unprognostic (2.12e-1)" "prognostic unfavorable (2.31e-4)" "unprognostic (2.93e-1)" "unprognostic (1.55e-1)" "unprognostic (1.51e-1)" "unprognostic (5.76e-2)" 8.2 20.0 19.4 10.8 16.2 20.4 13.3 4.6 13.0 6.7 13.6 8.5 7.8 16.1 5.6 11.9 12.7 8.2 10.2 15.8 15.6 14.4 11.3 16.0 9.2 17.6 16.9 8.8 8.5 28.1 2.7 8.4 12.2 10.4 11.0 9.4 7.6 25.9 7.5 30.1 10.3 15.0 5.6 15.5 10.4 11.7 25.2 6.9 17.5 15.6 19.9 12.9 8.3 8.4 29.1 44.1 8.2 27.9 14.5 23.7 26.1 8.2 19.7 6.4 2.8 3.6 8.1 11.0 6.0 5.7 7.9 5.1 19.4 7.8 6.9 2.5 6.4 4.9 5.5 5.3 5.6 2.6 9.3 35.5 12.4 9.5 21.1 7.5 10.1 11.7 7.7 4.6 3.7 4.1 6.3 7.3 6.3 12.4 5.5 5.8 17.9 8.3 18.9 13.4 5.0 11.9 6.8 19.5 11.4 9.2 15.4 10.0 15.4 6.6 8.9 7.7 3.1 8.6 7.8 12.0 6.7 10.5 3.2 5.0 4.3 13.3 7.4 6.3 6.4 4.5 8.2 27.9 5.9 16.6 19.0 8.5 29.1 16.4 14.5 42.9 22.1 15.3 17.8 3.2 14.5 13.7 44.1 23.7 26.1 19.4 16.2 4.6 13.0 15.6 14.4 16.9 8.8 10.4 6.9 47.6 55.7 79.8 66.2 106.5 9.2 71.1 66.2 88.3 51.2 62.8 5.9 158.8 97.8 80.3 89.5 45.2 101.8 0.0 123.7 124.1 73.0 66.7 40.4 82.2 114.7 1.6 84.6 51.0 98.7 121.2 43.7 98.5 64.1 162.3 129.2 35.2 108.6 131.0 37.4 119.9 11.8 71.1 48.3 75.3 38.1 124.0 140.3 64.8 148.8 111.1 PTTG1IP "C21orf1, C21orf3, PBF" ENSG00000183255 "PTTG1 interacting protein" P53801 21 44849585-44873903 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034146, HPA061827" Uncertain Supported Nucleoplasm NA NA 380000 Nucleoplasm "CAB034146: AB_1568894, HPA061827: AB_2684620" "unprognostic (1.78e-2)" "prognostic unfavorable (8.61e-4)" "unprognostic (5.24e-3)" "unprognostic (3.18e-2)" "unprognostic (1.68e-2)" "unprognostic (2.03e-2)" "unprognostic (3.59e-2)" "unprognostic (1.22e-2)" "unprognostic (1.98e-2)" "unprognostic (3.77e-2)" "prognostic unfavorable (2.28e-4)" "unprognostic (9.30e-2)" "unprognostic (3.17e-2)" "prognostic unfavorable (5.40e-4)" "unprognostic (1.38e-2)" "unprognostic (8.88e-2)" "unprognostic (1.90e-1)" 47.1 52.1 46.7 33.6 48.7 29.6 53.3 20.9 38.7 50.1 47.2 57.0 29.3 43.6 53.2 47.6 36.2 40.4 50.9 59.9 51.8 31.0 75.6 71.9 58.2 38.8 59.6 30.2 49.6 39.8 23.4 27.3 111.6 43.0 40.5 41.4 50.0 46.0 57.7 30.8 32.1 72.8 51.8 45.8 38.8 58.9 35.2 52.6 19.8 62.4 25.1 25.3 48.2 60.0 5.3 40.5 58.1 35.6 12.5 16.8 37.2 31.0 17.5 20.8 19.7 40.8 23.8 16.9 28.5 40.6 23.1 22.3 37.7 42.7 4.2 108.8 44.3 55.5 14.4 9.5 18.2 22.3 7.3 10.5 33.1 11.0 33.0 39.8 12.6 11.3 36.6 30.0 25.1 17.5 46.3 49.6 11.6 16.6 11.2 71.3 13.4 9.1 12.9 22.0 45.1 22.1 9.1 21.3 20.5 99.6 10.9 15.7 24.3 31.6 34.8 61.6 26.4 26.9 21.2 68.0 29.3 17.1 22.7 43.6 10.7 10.0 5.4 19.7 28.4 26.2 58.1 35.6 20.8 10.3 28.9 16.8 5.3 13.4 10.8 40.5 5.0 13.0 8.9 49.4 12.5 30.4 18.4 16.8 37.2 46.7 48.7 20.9 35.7 51.8 31.0 59.6 30.2 43.0 52.6 366.3 135.9 29.8 68.7 45.1 14.1 137.7 73.9 242.2 240.0 137.9 5.9 181.6 41.4 311.5 36.3 156.9 223.5 0.0 105.1 61.5 84.2 101.0 76.5 97.8 96.5 11.1 76.1 106.2 71.4 76.2 66.7 89.8 82.7 81.2 82.0 66.8 225.0 140.3 93.0 67.3 14.0 64.7 78.7 66.8 49.6 37.5 306.6 30.5 75.0 159.3 PUF60 "FIR, RoBPI, SIAHBP1" ENSG00000179950 "Poly(U) binding splicing factor 60" Q9UHX1 8 143816344-143829859 "Disease related genes, Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "DNA-binding, Repressor, Ribonucleoprotein, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 73.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045733, HPA052096, HPA059714" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA045733: AB_10960503, HPA052096: AB_2681722, HPA059714: AB_2684110" "unprognostic (3.49e-2)" "unprognostic (8.78e-2)" "unprognostic (2.66e-1)" "unprognostic (4.05e-2)" "unprognostic (1.81e-2)" "unprognostic (3.47e-2)" "unprognostic (1.51e-2)" "unprognostic (4.34e-3)" "unprognostic (2.64e-2)" "unprognostic (1.07e-2)" "unprognostic (1.75e-1)" "unprognostic (5.45e-2)" "unprognostic (2.36e-2)" "unprognostic (2.64e-2)" "unprognostic (7.00e-2)" "unprognostic (2.28e-2)" "unprognostic (3.42e-2)" 35.4 21.1 28.5 19.1 29.5 51.1 20.8 22.8 40.0 19.5 28.4 37.3 16.7 41.2 25.6 21.3 23.8 30.8 23.8 26.7 29.8 25.5 21.7 34.4 18.0 28.7 29.9 30.9 23.9 24.4 13.3 21.6 33.0 24.3 22.8 11.2 22.8 39.1 31.4 47.5 36.6 23.8 21.0 29.4 26.2 28.5 28.9 27.9 28.7 23.2 24.2 21.9 20.2 21.3 40.9 42.9 28.3 44.6 41.4 50.9 53.3 21.2 49.5 7.5 7.2 4.0 3.6 12.4 17.1 6.3 16.5 16.7 21.6 24.1 18.6 16.3 13.4 12.8 18.8 20.3 21.2 0.9 20.4 32.7 23.9 26.2 22.8 14.7 7.8 16.8 10.1 13.3 21.7 6.7 4.8 15.9 20.8 19.3 8.3 4.9 73.0 35.7 5.3 18.6 13.7 44.1 19.4 10.3 19.6 4.6 21.1 14.5 17.2 21.8 9.3 17.5 2.0 26.4 3.6 18.1 17.0 41.3 20.1 22.1 15.5 21.8 24.5 17.1 11.6 16.4 24.1 37.9 28.3 45.6 43.3 50.9 38.6 38.3 45.2 42.9 40.9 35.8 41.7 21.1 41.4 44.6 26.2 44.9 53.3 28.5 29.5 22.8 40.0 29.8 25.5 29.9 30.9 24.3 27.9 35.7 45.6 62.1 84.0 95.7 56.5 52.6 38.2 66.9 47.8 27.9 27.5 127.5 77.9 88.5 14.8 59.5 85.2 0.0 78.5 109.1 67.7 50.1 55.3 71.2 88.1 41.3 64.2 39.3 46.1 34.6 59.2 57.1 86.0 133.5 53.5 174.2 79.1 97.9 55.5 90.1 46.1 64.7 74.1 92.1 123.9 93.6 145.0 64.0 69.8 74.0 PUM1 "KIAA0099, PUMH1" ENSG00000134644 "Pumilio RNA binding family member 1" Q14671 1 30931506-31065991 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Translation regulation" RNA-binding "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027424, HPA027449" Approved Enhanced Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA027424: AB_10602918, HPA027449: AB_2672281" "unprognostic (1.26e-1)" "unprognostic (1.21e-1)" "unprognostic (1.44e-3)" "unprognostic (1.10e-1)" "unprognostic (1.31e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (3.73e-4)" "unprognostic (1.02e-1)" "unprognostic (2.11e-2)" "unprognostic (2.44e-2)" "unprognostic (3.19e-3)" "unprognostic (4.42e-2)" "prognostic favorable (7.62e-8)" "unprognostic (1.57e-1)" "unprognostic (5.41e-2)" "unprognostic (1.19e-1)" "unprognostic (2.74e-1)" 25.1 26.3 30.1 17.1 35.0 36.3 27.0 38.1 35.9 24.0 20.8 28.1 16.5 17.6 27.6 24.5 22.6 29.1 18.3 22.0 24.2 29.7 23.6 20.3 20.4 18.8 22.8 25.5 33.9 21.8 38.1 31.7 31.4 33.1 22.8 24.0 25.8 25.4 23.9 40.7 29.7 22.8 25.9 20.1 19.1 20.6 15.9 22.1 27.9 28.3 15.6 27.1 23.4 24.1 18.9 25.2 27.6 24.8 28.5 27.1 22.0 16.4 22.1 36.0 22.8 28.4 24.6 24.7 19.8 24.2 20.6 23.5 23.2 28.6 19.5 20.9 26.7 12.9 24.3 29.5 21.8 26.7 16.1 25.7 21.0 25.9 27.5 19.9 25.6 20.2 26.2 27.7 27.3 29.0 27.3 28.1 18.6 28.9 18.4 23.5 13.8 25.0 18.5 36.8 20.6 15.5 26.0 24.6 20.7 30.1 25.1 29.8 22.7 27.3 21.2 23.4 41.7 21.4 19.5 29.2 17.2 15.6 22.8 19.6 14.8 13.6 21.5 15.4 19.0 21.7 27.6 24.8 18.5 25.7 23.8 26.3 18.9 23.2 25.0 25.2 18.8 26.6 26.9 14.8 28.5 24.6 14.6 27.1 22.0 30.1 35.0 38.1 35.9 24.2 29.7 22.8 25.5 33.1 22.1 68.5 50.4 39.5 44.5 80.1 52.6 70.4 76.5 18.7 44.3 34.9 74.6 42.5 19.9 36.8 23.3 48.8 36.7 70.0 31.4 36.3 46.0 63.4 17.4 50.5 29.7 31.8 100.5 44.2 71.5 13.3 66.7 39.7 16.9 15.4 66.5 44.7 48.2 31.6 75.7 38.8 56.7 32.3 42.2 36.3 19.1 81.9 65.2 34.6 58.4 78.2 PURB PURBETA ENSG00000146676 "Purine rich element binding protein B" Q96QR8 7 44876293-44885361 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048766 Supported Nucleoplasm NA NA 13000 Nucleoplasm "HPA048766: " "unprognostic (1.16e-1)" "unprognostic (1.46e-1)" "unprognostic (3.21e-2)" "unprognostic (9.49e-2)" "unprognostic (4.96e-2)" "unprognostic (2.18e-1)" "unprognostic (8.44e-3)" "unprognostic (1.53e-1)" "unprognostic (1.72e-1)" "unprognostic (1.88e-3)" "unprognostic (2.01e-1)" "unprognostic (4.12e-1)" "unprognostic (5.66e-2)" "unprognostic (4.29e-2)" "unprognostic (7.96e-2)" "unprognostic (1.41e-1)" "unprognostic (3.22e-2)" 12.1 9.6 19.1 12.0 20.3 13.5 14.2 30.8 22.0 13.7 14.2 11.1 6.6 8.7 13.1 9.4 13.9 11.6 11.6 9.1 18.5 9.2 11.3 10.0 12.4 11.1 15.6 13.4 12.5 10.1 17.4 10.4 15.4 12.9 12.8 9.0 11.0 11.3 11.6 14.3 16.7 10.7 18.5 12.4 10.8 10.8 7.8 15.0 12.3 13.9 7.8 11.9 11.7 11.8 1.5 1.6 3.3 1.2 1.5 2.0 0.6 8.9 5.0 9.0 16.9 8.4 13.5 6.0 12.4 9.8 9.3 9.1 7.5 7.0 13.4 10.9 14.3 22.1 16.6 8.4 11.0 18.5 10.8 6.9 6.7 12.4 4.2 8.4 10.5 10.7 11.0 14.1 17.8 13.1 10.0 9.8 11.1 11.7 12.6 19.5 12.4 8.7 13.2 14.1 6.0 8.8 7.2 27.4 8.7 7.7 15.4 9.0 12.7 12.3 25.8 7.6 11.4 17.2 12.1 16.5 16.4 18.0 10.6 20.7 22.2 19.3 4.3 12.2 12.3 21.7 1.6 1.2 1.7 1.9 1.1 2.0 0.9 1.6 1.5 0.6 1.5 1.5 1.7 3.3 1.5 0.9 1.6 1.2 0.6 19.1 20.3 30.8 22.0 18.5 9.2 15.6 13.4 12.9 15.0 35.7 36.3 18.8 30.6 62.0 57.4 16.5 20.4 30.8 31.8 17.4 31.4 16.0 8.3 16.9 16.5 32.7 14.2 0.0 19.4 11.1 24.9 35.8 35.8 11.6 15.0 50.9 19.5 36.8 19.7 14.0 19.2 30.9 16.9 10.0 18.0 38.9 23.0 7.0 18.7 9.2 51.0 45.3 32.7 16.8 12.2 75.3 15.8 20.0 21.5 37.3 PURG "PURG-A, PURG-B" ENSG00000172733 "Purine rich element binding protein G" Q9UJV8 8 30995802-31033715 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.7" "Group enriched" "Detected in some" 7 "Bipolar cells: 11.8;Early spermatids: 11.1;Horizontal cells: 19.1;Late spermatids: 16.8;Muller glia cells: 11.3" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.7;JURKAT: 6.1;NTERA-2: 6.8;SH-SY5Y: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047746 Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" Nucleoli "HPA047746: AB_2680145" "unprognostic (3.37e-1)" "unprognostic (2.15e-1)" "unprognostic (6.69e-2)" "unprognostic (7.33e-3)" "unprognostic (3.65e-2)" "unprognostic (1.78e-1)" "unprognostic (3.51e-3)" "unprognostic (1.10e-2)" "unprognostic (1.49e-1)" "unprognostic (1.62e-1)" "unprognostic (4.79e-2)" "unprognostic (8.72e-2)" "unprognostic (1.46e-3)" "unprognostic (1.03e-1)" "unprognostic (1.27e-1)" "unprognostic (1.83e-2)" "unprognostic (5.30e-2)" 1.3 1.9 11.0 1.2 10.3 0.6 0.9 14.7 13.5 2.4 1.0 2.4 0.5 1.0 5.6 2.6 1.5 1.6 3.0 1.6 9.4 6.2 1.7 0.7 1.4 1.3 4.9 7.3 1.6 0.7 0.6 3.9 1.5 6.2 1.9 1.1 1.7 1.6 2.6 1.0 0.9 1.0 5.0 4.5 2.5 1.3 8.1 6.4 0.0 0.8 0.0 1.0 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.2 0.1 0.0 0.0 0.2 0.4 0.7 1.8 0.0 0.0 0.2 0.0 0.0 3.0 0.0 2.9 0.0 1.0 0.0 4.4 1.6 0.0 0.2 0.0 0.0 0.2 1.3 0.0 1.3 0.0 1.0 4.3 6.1 0.4 0.5 0.2 0.0 0.9 0.0 6.8 0.0 0.3 2.2 1.2 0.0 0.0 0.0 1.2 8.2 0.0 0.0 0.0 3.3 0.0 0.0 2.6 2.9 3.7 0.0 0.4 0.3 0.0 0.2 2.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 10.3 14.7 8.9 9.4 6.2 4.9 7.3 6.2 6.4 0.0 0.0 0.0 0.0 0.0 11.8 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 11.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 16.8 0.6 0.0 0.0 0.0 0.0 11.3 0.0 0.0 1.4 0.0 1.8 0.0 0.3 1.7 1.1 0.0 0.0 0.0 0.0 0.0 PUS1 ENSG00000177192 "Pseudouridylate synthase 1" Q9Y606 12 131929200-131945896 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" Isomerase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051636, HPA057593" Approved Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA051636: AB_2681560, HPA057593: AB_2683479" "unprognostic (2.72e-1)" "unprognostic (9.13e-2)" "unprognostic (1.81e-1)" "unprognostic (2.69e-2)" "unprognostic (8.12e-3)" "unprognostic (8.07e-2)" "unprognostic (4.57e-3)" "unprognostic (7.34e-2)" "unprognostic (1.01e-1)" "unprognostic (3.34e-1)" "unprognostic (2.06e-1)" "unprognostic (5.30e-2)" "prognostic unfavorable (3.49e-8)" "unprognostic (1.80e-3)" "unprognostic (8.06e-2)" "unprognostic (8.59e-2)" "unprognostic (1.56e-2)" 12.7 15.8 18.8 19.5 23.3 26.2 11.2 8.8 16.9 8.7 11.9 9.4 11.0 12.4 13.6 18.7 16.5 12.9 25.1 8.6 15.6 8.3 10.7 22.8 11.0 21.4 11.7 15.8 10.1 19.8 7.2 9.5 8.3 11.7 11.7 10.5 7.6 11.4 15.7 13.5 15.4 13.9 9.7 6.2 17.4 13.6 11.9 16.4 11.6 10.3 11.6 15.8 10.8 12.8 5.9 4.6 1.9 2.0 9.1 4.0 1.3 15.4 20.2 4.8 8.5 4.6 7.9 29.5 11.9 5.0 9.1 5.9 22.3 10.1 18.4 13.8 6.5 7.1 19.6 15.8 11.3 5.9 8.1 31.9 18.5 9.8 19.4 12.5 31.7 17.1 8.0 9.2 10.4 8.9 4.4 8.9 12.9 22.9 5.7 5.2 26.8 20.8 28.5 25.3 12.6 30.8 19.9 6.8 19.1 7.4 21.5 13.4 7.5 10.0 13.7 11.0 4.9 15.0 34.3 7.7 7.3 15.6 15.4 17.2 15.6 11.7 21.9 7.5 25.4 10.0 1.2 2.0 0.4 3.2 1.4 2.2 5.9 2.7 3.3 1.6 5.5 4.0 2.1 1.9 9.1 1.3 4.6 2.4 1.3 18.8 23.3 8.8 16.9 15.6 8.3 11.7 15.8 11.7 16.4 0.0 6.7 10.0 16.1 26.3 5.2 4.5 12.7 4.0 3.4 5.2 21.6 12.0 5.0 9.3 0.6 9.0 4.5 0.0 8.2 14.4 9.6 13.4 16.1 11.3 13.6 0.0 13.8 8.0 7.3 2.0 7.2 8.9 6.8 8.2 17.2 4.6 12.7 7.0 8.9 10.4 9.6 6.5 11.8 16.5 22.1 19.8 7.2 7.5 15.5 13.7 PUS10 "CCDC139, FLJ32312" ENSG00000162927 "Pseudouridylate synthase 10" Q3MIT2 2 60940222-61018259 "Enzymes, Predicted intracellular proteins" "tRNA processing" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044736, HPA049582" Approved Approved "Nucleoplasm,Nuclear bodies,Mitochondria" No No "Nucleoplasm, Nuclear bodies, Mitochondria" "HPA044736: AB_2679066, HPA049582: AB_2680824" "unprognostic (1.90e-3)" "unprognostic (1.35e-1)" "unprognostic (3.49e-2)" "unprognostic (2.44e-4)" "unprognostic (1.77e-1)" "unprognostic (1.86e-2)" "unprognostic (1.25e-1)" "unprognostic (1.72e-2)" "unprognostic (2.90e-2)" "unprognostic (8.21e-2)" "unprognostic (3.68e-2)" "unprognostic (1.45e-1)" "unprognostic (1.16e-4)" "unprognostic (1.07e-1)" "unprognostic (6.60e-2)" "unprognostic (9.45e-2)" "unprognostic (1.15e-3)" 7.0 8.7 7.4 5.0 7.3 3.9 7.3 6.8 7.9 4.8 10.0 5.1 3.0 9.2 7.7 9.1 5.0 5.4 6.4 4.6 6.5 6.9 8.5 17.6 6.3 6.5 8.5 4.6 6.8 7.2 6.3 10.3 4.2 5.9 6.6 6.0 6.7 6.2 3.9 6.7 4.3 19.8 3.6 7.1 5.9 4.2 7.8 8.0 9.1 10.4 4.1 8.3 4.4 4.4 5.2 4.9 9.8 6.9 4.8 4.3 1.8 2.7 1.6 4.5 7.7 4.0 4.4 5.2 5.7 5.3 5.6 5.3 4.3 3.9 8.7 5.9 3.2 5.2 3.0 5.1 4.6 6.8 8.8 2.5 7.9 2.1 13.4 7.1 8.7 5.0 5.2 5.4 3.9 9.5 6.9 7.0 8.7 8.1 6.1 3.8 2.5 6.9 7.0 4.1 2.1 3.0 6.8 6.0 4.4 3.2 5.3 2.6 3.6 4.5 8.0 9.1 3.2 3.1 5.6 5.3 5.4 4.2 3.5 4.1 7.4 3.2 18.6 4.6 5.2 6.0 9.8 1.9 2.0 3.9 2.2 4.3 5.2 2.5 2.6 1.6 3.2 3.0 3.4 4.1 4.8 6.9 4.9 1.5 1.8 7.4 7.3 6.8 7.9 6.5 6.9 8.5 4.6 5.9 8.0 0.0 11.0 1.9 2.2 2.2 6.8 4.2 0.0 10.7 3.4 3.5 0.0 5.2 6.6 2.6 1.5 3.9 16.5 0.0 4.4 3.8 2.8 2.9 0.0 11.6 5.3 1.6 1.2 6.2 5.1 1.1 2.8 3.2 1.7 10.8 2.0 6.5 4.3 2.9 1.4 5.1 6.3 6.5 2.1 7.1 10.9 1.9 10.4 5.7 3.3 4.3 PUS3 FKSG32 ENSG00000110060 "Pseudouridylate synthase 3" Q9BZE2 11 125893485-125903221 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" Isomerase "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038040, HPA063802" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038040: AB_10697092, HPA063802: AB_2685126" "unprognostic (5.89e-2)" "unprognostic (7.24e-2)" "unprognostic (1.29e-1)" "unprognostic (4.37e-3)" "unprognostic (4.59e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (7.67e-2)" "unprognostic (1.77e-1)" "unprognostic (8.92e-3)" "unprognostic (4.47e-3)" "unprognostic (3.37e-2)" "unprognostic (1.06e-1)" "unprognostic (2.08e-3)" "unprognostic (9.95e-2)" "unprognostic (1.32e-1)" "unprognostic (1.13e-1)" "unprognostic (2.44e-1)" 8.6 8.8 5.9 7.4 7.7 2.3 8.7 9.0 8.4 7.4 9.2 3.6 4.6 9.9 8.4 8.6 8.1 6.4 5.9 7.6 8.0 6.4 9.6 36.6 6.1 11.0 8.7 7.2 7.7 17.9 8.2 21.1 7.6 7.7 10.4 7.4 5.4 10.6 5.1 15.2 8.2 11.5 13.9 9.7 8.9 9.3 5.3 7.3 9.6 12.4 10.6 9.2 11.1 7.3 13.0 8.8 9.9 12.3 13.0 16.5 7.1 3.5 4.3 13.2 14.7 13.5 17.2 6.3 11.7 9.8 6.7 7.5 13.9 13.3 17.9 19.4 5.2 9.8 12.2 21.3 10.9 6.8 15.2 10.3 18.4 5.4 10.0 14.3 11.5 5.4 13.6 13.1 8.0 17.1 9.9 12.3 13.5 18.7 9.3 7.2 2.1 12.8 12.3 11.4 26.3 8.4 2.5 12.0 10.1 11.0 5.6 15.3 13.6 8.0 11.2 6.4 9.9 24.0 7.5 8.3 14.2 5.8 6.7 9.6 7.0 10.5 18.8 3.8 18.6 9.7 9.9 9.7 7.8 13.0 9.4 15.2 13.0 12.8 12.5 8.8 12.2 16.5 15.6 3.7 13.0 12.3 7.8 12.9 7.1 5.9 7.7 9.0 8.4 8.0 6.4 8.7 7.2 7.7 7.3 8.9 8.6 9.0 9.4 11.4 9.1 5.2 15.3 8.1 14.8 5.2 27.5 7.4 5.0 12.3 5.9 7.7 4.2 23.3 23.5 10.6 5.6 7.1 12.7 28.8 7.2 4.8 4.6 7.4 3.2 4.3 7.2 5.4 1.7 3.6 3.9 8.9 13.5 3.5 7.4 14.6 10.4 6.5 11.0 4.6 6.9 10.3 11.7 7.5 6.0 9.3 PUS7 FLJ20485 ENSG00000091127 "Pseudouridylate synthase 7 (putative)" Q96PZ0 7 105439661-105522267 "Predicted intracellular proteins" "tRNA processing" Isomerase "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024116 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA024116: AB_1848754" "unprognostic (3.07e-1)" "unprognostic (1.52e-3)" "unprognostic (9.03e-2)" "unprognostic (4.94e-2)" "unprognostic (8.91e-2)" "unprognostic (7.95e-2)" "prognostic unfavorable (4.89e-6)" "unprognostic (2.86e-2)" "prognostic unfavorable (7.58e-5)" "unprognostic (1.87e-1)" "unprognostic (5.64e-3)" "unprognostic (4.14e-2)" "prognostic unfavorable (1.03e-8)" "unprognostic (2.76e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (6.28e-4)" "unprognostic (4.90e-2)" 12.7 6.9 7.7 13.0 12.5 5.8 14.1 12.2 12.9 10.2 9.6 8.5 4.6 7.0 11.4 5.6 14.7 9.8 6.0 9.4 8.3 7.0 7.5 11.8 8.8 8.3 12.3 8.0 10.0 11.9 17.0 8.1 9.8 11.4 8.6 11.6 5.3 9.3 11.0 19.5 13.3 6.3 13.2 9.0 5.4 8.0 8.5 13.8 4.3 14.6 13.5 10.0 8.0 11.0 5.9 3.3 0.4 5.0 2.7 5.4 2.0 15.4 10.4 9.2 14.2 6.6 7.8 10.0 7.7 6.7 13.8 11.8 13.7 5.9 9.0 12.9 7.9 11.7 12.0 17.4 9.2 21.4 6.4 13.3 13.7 8.8 12.4 8.2 21.1 4.9 7.7 10.1 11.6 14.7 4.8 13.7 8.0 30.7 7.3 8.7 20.5 23.2 16.5 22.3 18.3 12.2 14.5 14.9 38.5 14.2 11.7 15.0 14.8 15.3 24.9 9.5 11.1 9.0 4.3 8.4 19.3 13.3 24.2 16.1 5.7 10.9 25.7 6.5 17.7 16.0 0.0 2.1 0.4 2.6 5.0 5.4 5.9 3.5 2.8 3.3 3.6 2.9 3.8 0.2 2.7 4.2 0.1 2.2 2.0 7.7 12.5 12.2 12.9 8.3 7.0 12.3 8.0 11.4 13.8 6.0 7.0 1.5 6.8 11.8 4.1 3.1 0.0 5.3 7.9 1.8 2.0 4.0 1.7 6.5 0.9 6.0 0.9 0.0 6.2 7.8 5.1 7.2 11.5 3.9 3.7 0.0 6.9 3.7 1.3 1.2 3.7 3.5 0.0 5.4 3.4 1.5 6.0 2.9 1.8 4.4 2.9 0.0 10.8 1.4 10.9 8.5 2.9 0.7 6.0 6.4 PVALB D22S749 ENSG00000100362 Parvalbumin P20472 22 36800684-36819479 "Predicted intracellular proteins" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 125.0;parathyroid gland: 137.5" "Group enriched" "Detected in some" 10 "Distal tubular cells: 543.8;Horizontal cells: 1442.9" "Group enriched" "Detected in many" 10 "breast cancer: 14.2;renal cancer: 59.5;urothelial cancer: 12.3" "Region enhanced" "Detected in all" "cerebellum: 125.0" "Cell type enriched" "Detected in single" 6 "neutrophil: 3.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.4" "Cell line enriched" "Detected in single" 198 "RPMI-8226: 134.1" "Region enriched" "Detected in many" 5 "cerebellum: 2377.5" "Low region specificity" "Detected in all" "CAB002515, HPA048536" Enhanced Approved "Nucleoplasm,Nucleoli,Cell Junctions" No NA Nucleoplasm "Nucleoli, Cell Junctions" "CAB002515: AB_563948, HPA048536: AB_2680433" "unprognostic (4.41e-2)" "unprognostic (1.60e-1)" "unprognostic (9.75e-2)" "unprognostic (1.79e-3)" "unprognostic (7.80e-2)" "unprognostic (2.49e-2)" "unprognostic (2.52e-2)" "unprognostic (6.53e-2)" "unprognostic (2.37e-1)" "unprognostic (2.24e-1)" "unprognostic (1.61e-1)" "unprognostic (2.13e-1)" "unprognostic (5.21e-2)" "unprognostic (6.92e-2)" "unprognostic (1.91e-1)" "unprognostic (1.65e-2)" "unprognostic (8.99e-3)" 0.9 0.8 1.2 0.9 3.9 0.8 4.3 125.0 47.2 0.8 0.8 6.6 0.0 0.8 1.1 0.9 0.8 0.8 0.9 0.8 4.5 9.4 16.7 1.8 1.2 1.2 28.6 2.5 0.8 0.8 137.5 0.2 1.2 22.9 0.9 0.9 27.3 1.2 1.0 5.0 0.8 0.8 0.9 12.6 1.2 0.9 1.1 1.2 0.0 0.9 0.0 1.4 1.2 1.0 0.0 0.5 3.4 0.4 0.0 0.3 12.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 134.1 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 3.4 0.0 0.0 0.5 0.3 12.2 1.2 3.9 125.0 47.2 4.5 9.4 28.6 2.5 22.9 1.2 0.0 0.0 0.0 0.0 0.0 39.1 0.2 0.0 0.0 0.0 36.6 9.8 0.2 543.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 10.5 0.0 40.7 1442.9 0.0 40.5 3.7 0.0 0.6 0.9 0.0 0.0 0.0 41.2 0.0 0.0 0.0 0.8 104.1 0.0 0.0 0.0 0.6 0.0 0.3 1.0 0.0 0.0 PVR "CD155, HVED, Necl-5, NECL5, PVS, Tage4" ENSG00000073008 "Poliovirus receptor" P15151 19 44643798-44663583 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 65.6" "Cell type enhanced" "Detected in many" 5 "Pancreatic endocrine cells: 48.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 6.4;intermediate monocyte: 6.6;myeloid DC: 5.6;non-classical monocyte: 8.1" "Group enriched" "Detected in many" 5 "dendritic cells: 5.6;monocytes: 8.1" "Cell line enhanced" "Detected in many" "TIME: 53.4" "HPA012568, HPA064739" Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" "Secreted - unknown location" NA NA 940000000 "Nucleoplasm, Vesicles, Plasma membrane" "HPA012568: AB_1846248, HPA064739: " "unprognostic (2.90e-3)" "prognostic unfavorable (1.29e-4)" "unprognostic (3.36e-1)" "unprognostic (2.34e-1)" "unprognostic (7.89e-2)" "unprognostic (2.45e-3)" "unprognostic (3.06e-2)" "prognostic unfavorable (9.30e-4)" "unprognostic (9.05e-3)" "unprognostic (1.69e-1)" "unprognostic (2.09e-3)" "unprognostic (2.64e-3)" "unprognostic (1.69e-1)" "unprognostic (4.97e-1)" "unprognostic (1.27e-1)" "unprognostic (1.04e-3)" "prognostic unfavorable (2.75e-4)" 10.0 13.9 7.4 7.5 8.1 4.7 9.2 11.0 11.0 6.5 10.6 6.5 4.1 13.7 11.3 5.7 6.6 8.8 9.2 23.5 5.8 10.0 10.6 65.6 14.8 2.4 6.0 6.5 10.4 15.9 9.9 20.7 15.5 9.7 10.4 7.7 6.6 8.5 6.9 19.8 5.5 13.0 11.1 7.0 4.8 12.3 6.0 7.2 2.3 8.5 10.8 3.7 8.3 6.7 0.0 5.6 1.2 8.1 0.6 0.4 2.2 21.8 15.3 1.5 6.1 1.9 2.3 2.6 36.9 10.3 12.1 13.9 8.9 9.3 0.0 21.2 10.7 21.2 14.4 5.2 14.0 8.1 2.6 10.1 3.9 9.6 6.0 12.9 1.5 8.4 2.9 6.9 10.7 21.0 12.1 13.1 2.3 1.8 0.0 5.6 1.9 1.3 1.3 3.4 7.4 11.3 0.0 7.0 2.0 26.0 6.7 6.6 7.7 23.4 14.7 5.2 1.7 8.3 3.7 53.4 14.7 18.1 10.8 28.8 0.0 2.1 0.0 11.7 7.5 8.3 0.0 6.4 0.0 0.2 6.6 0.0 0.0 0.0 0.4 5.6 0.0 0.2 0.1 1.2 0.6 8.1 0.5 0.0 2.2 7.4 8.1 11.0 11.0 5.8 10.0 6.0 6.5 9.7 7.2 14.9 28.0 4.5 12.8 3.2 6.9 11.2 20.4 2.7 18.2 1.8 2.0 2.4 3.3 43.0 8.5 13.5 11.9 0.0 30.3 30.1 5.4 11.3 1.1 36.5 7.4 1.6 12.6 7.4 9.2 10.2 5.2 7.8 1.7 25.2 9.7 1.3 48.8 14.4 14.9 2.8 3.3 0.0 17.8 3.4 1.5 4.8 0.8 0.0 10.6 6.5 PWWP2A KIAA1935 ENSG00000170234 "PWWP domain containing 2A" Q96N64 5 160061801-160119423 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 52.7" "Cell type enhanced" "Detected in all" 5 "Bipolar cells: 94.1;Horizontal cells: 89.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046733, HPA058233" Supported "Nucleoplasm,Focal adhesion sites" NA NA Nucleoplasm "Focal adhesion sites" "HPA046733: AB_2679777, HPA058233: AB_2683647" "unprognostic (1.03e-1)" "unprognostic (2.67e-1)" "unprognostic (5.13e-2)" "unprognostic (1.85e-1)" "unprognostic (1.18e-2)" "unprognostic (7.86e-3)" "unprognostic (1.40e-3)" "unprognostic (6.24e-2)" "unprognostic (2.42e-2)" "unprognostic (7.08e-2)" "unprognostic (7.25e-2)" "unprognostic (8.24e-3)" "prognostic unfavorable (3.70e-4)" "unprognostic (2.23e-1)" "unprognostic (3.88e-2)" "unprognostic (1.08e-1)" "prognostic favorable (3.51e-4)" 8.4 9.3 9.5 12.7 22.3 11.9 9.1 52.7 16.0 14.4 13.6 19.9 5.3 9.6 10.8 7.2 8.7 9.5 8.1 7.4 15.9 8.8 10.3 8.6 9.8 12.0 25.2 8.9 10.5 10.5 10.6 15.1 11.2 17.0 11.9 14.7 10.3 8.8 8.4 7.0 14.7 10.6 9.3 13.8 12.5 11.8 6.3 21.3 18.6 9.8 5.8 11.4 10.7 10.1 6.0 2.9 6.0 4.4 1.1 4.9 0.9 10.7 5.2 13.5 11.5 15.1 11.8 19.1 8.6 7.0 7.7 7.9 16.8 21.0 17.4 13.2 6.6 12.6 7.8 11.7 13.5 12.7 18.0 13.0 12.5 9.6 8.6 11.5 12.5 9.5 8.4 6.7 15.5 11.8 17.3 12.3 9.9 9.5 11.3 13.0 9.0 10.7 12.2 15.9 9.2 6.7 16.9 12.0 11.1 9.4 7.7 15.9 11.1 14.5 14.7 15.6 11.5 11.3 13.9 16.4 13.5 9.3 10.0 16.7 13.0 11.6 15.5 8.8 12.7 13.2 6.0 4.4 2.4 2.8 2.0 2.2 6.0 3.0 3.3 2.9 3.7 4.9 2.7 5.0 1.1 2.6 2.7 2.5 0.9 9.5 22.3 52.7 16.0 15.9 8.8 25.2 8.9 17.0 21.3 8.9 14.8 18.5 12.5 28.3 94.1 10.6 10.2 14.7 17.0 19.2 68.7 11.2 14.9 11.6 1.5 15.3 18.4 23.3 9.6 10.5 16.2 15.6 23.1 7.6 7.8 89.0 31.6 12.9 11.0 2.1 51.8 14.6 10.1 12.6 19.4 22.7 13.1 14.4 36.0 5.8 50.6 25.8 22.6 9.7 17.2 22.6 7.8 17.3 20.4 11.2 PWWP2B "bA432J24.1, FLJ46823, PWWP2" ENSG00000171813 "PWWP domain containing 2B" Q6NUJ5 10 132397168-132417863 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 53.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 29.8;MCF7: 22.5;SK-BR-3: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038056, HPA038502, HPA078118" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA038056: AB_10697093, HPA038502: AB_2676048, HPA078118: " "unprognostic (2.28e-1)" "unprognostic (5.47e-2)" "unprognostic (1.11e-2)" "unprognostic (1.30e-2)" "unprognostic (5.51e-1)" "unprognostic (1.05e-1)" "unprognostic (1.67e-2)" "unprognostic (8.82e-2)" "unprognostic (2.66e-1)" "unprognostic (2.40e-1)" "unprognostic (1.33e-1)" "unprognostic (2.00e-1)" "prognostic favorable (5.75e-4)" "unprognostic (4.77e-2)" "unprognostic (1.46e-1)" "unprognostic (3.15e-1)" "unprognostic (1.19e-2)" 7.3 14.1 5.1 4.2 14.7 3.0 6.6 1.8 13.4 5.1 10.0 2.0 9.0 6.4 4.3 3.3 8.9 5.1 8.4 3.8 6.4 4.3 4.1 2.3 5.5 3.7 4.1 6.9 4.7 23.4 8.9 6.3 12.6 4.3 5.5 3.3 5.1 14.0 5.9 19.5 6.2 5.7 5.4 1.1 14.9 14.7 6.5 7.1 2.1 5.7 4.8 6.9 5.8 4.5 4.9 2.1 3.7 7.2 7.2 2.0 1.0 10.9 6.7 0.8 4.3 0.6 0.5 29.8 1.3 1.3 0.8 0.7 2.9 6.5 0.0 4.6 0.8 1.7 11.8 1.2 1.6 0.1 8.1 3.3 1.3 5.9 2.8 3.2 3.6 4.9 0.4 4.2 0.4 1.2 0.7 0.6 1.5 2.1 0.9 0.5 22.5 0.1 13.6 1.3 4.3 4.9 2.6 0.0 2.5 0.3 8.3 5.5 6.8 0.8 17.4 3.4 0.9 5.3 8.9 2.2 0.4 2.4 2.1 0.9 0.2 0.1 2.3 2.7 3.3 0.8 0.0 2.4 3.7 2.0 5.0 1.6 1.5 1.1 1.3 2.1 4.9 0.9 0.8 0.4 7.2 7.2 1.3 0.0 1.0 5.1 14.7 1.8 13.4 6.4 4.3 4.1 6.9 4.3 7.1 20.8 11.2 11.2 12.6 15.7 5.9 4.9 12.7 22.7 5.7 8.7 7.9 27.4 11.6 13.6 28.6 8.5 17.3 0.0 18.8 44.1 7.2 13.6 2.3 1.1 11.5 14.3 24.3 12.3 10.5 53.6 3.4 7.7 13.5 3.6 29.5 1.9 10.0 23.0 2.1 1.3 11.8 0.0 2.4 0.9 0.9 17.8 44.3 2.5 18.4 25.5 PXDNL "FLJ25471, PMR1" ENSG00000147485 "Peroxidasin like" A1KZ92 8 51319578-51809445 "Enzymes, Predicted intracellular proteins" "Hydrogen peroxide" "Endonuclease, Hydrolase, Nuclease, Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "heart muscle: 59.1" "Group enriched" "Detected in some" 9 "Cardiomyocytes: 29.9;Early spermatids: 34.8;Muller glia cells: 18.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "memory B-cell: 1.5" "Lineage enriched" "Detected in single" 4 "B-cells: 1.5" "Group enriched" "Detected in some" 7 "AF22: 11.1;Daudi: 8.3;SH-SY5Y: 8.9" HPA007919 Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Nucleoplasm, Cytosol" "HPA007919: AB_1855966" "prognostic unfavorable (3.27e-5)" "unprognostic (4.59e-4)" "unprognostic (5.57e-3)" "unprognostic (2.83e-3)" "unprognostic (2.71e-1)" "unprognostic (5.14e-2)" "unprognostic (1.18e-1)" "unprognostic (7.18e-3)" "unprognostic (1.85e-1)" "unprognostic (1.15e-1)" "unprognostic (7.07e-2)" "unprognostic (1.07e-1)" "unprognostic (2.60e-4)" "unprognostic (2.28e-2)" "unprognostic (3.35e-2)" "unprognostic (2.42e-2)" "unprognostic (2.97e-4)" 1.1 0.1 0.3 0.1 0.2 0.0 0.2 0.1 0.9 0.1 0.1 0.0 0.2 0.0 0.3 7.9 0.4 0.1 0.7 59.1 0.2 0.3 1.0 0.1 0.2 0.3 0.3 0.3 0.1 0.1 0.0 0.1 0.0 0.3 0.1 0.0 1.8 1.1 0.3 0.9 0.2 0.2 0.1 0.2 0.3 0.1 5.2 0.0 0.1 0.2 2.5 0.3 0.2 0.1 1.5 0.3 0.3 0.0 0.0 0.1 0.0 0.7 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 8.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.5 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.3 0.1 0.0 0.3 0.2 0.1 0.9 0.2 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.7 29.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 34.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.4 0.6 0.1 0.0 0.0 0.0 0.0 PYCARD "ASC, CARD5, TMS-1" ENSG00000103490 "PYD and CARD domain containing" Q9ULZ3 16 31201485-31203450 "Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 130.8" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 312.0;Hofbauer cells: 375.8;Kupffer cells: 516.6;Macrophages: 364.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 37.8;classical monocyte: 90.4;eosinophil: 71.4;intermediate monocyte: 87.5;myeloid DC: 66.8;neutrophil: 130.8;non-classical monocyte: 85.0;plasmacytoid DC: 61.0" "Group enriched" "Detected in all" 6 "dendritic cells: 66.8;granulocytes: 130.8;monocytes: 90.4" "Cell line enhanced" "Detected in many" "MCF7: 34.5;NB-4: 54.4;THP-1: 40.1;U-937: 24.9" "CAB006853, CAB015948, HPA049074, HPA054496" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol NA NA 1100000 Nucleoplasm "Nucleoli, Cytosol" "CAB006853: , CAB015948: , HPA049074: AB_2680621, HPA054496: AB_2682506" "unprognostic (1.00e-3)" "unprognostic (2.62e-2)" "unprognostic (2.40e-1)" "unprognostic (4.67e-3)" "unprognostic (3.34e-1)" "unprognostic (1.87e-1)" "unprognostic (5.29e-2)" "unprognostic (2.88e-2)" "unprognostic (3.12e-1)" "unprognostic (2.33e-1)" "unprognostic (6.52e-3)" "unprognostic (3.88e-2)" "prognostic unfavorable (6.09e-7)" "unprognostic (4.45e-3)" "unprognostic (2.51e-1)" "unprognostic (3.61e-2)" "unprognostic (6.97e-2)" 11.6 4.4 3.6 16.7 4.6 22.4 8.6 3.6 3.3 8.2 26.8 6.8 4.1 38.7 5.4 7.9 20.7 6.8 8.5 6.6 2.4 2.6 5.6 6.8 15.0 32.8 6.4 1.8 6.6 6.1 1.3 3.2 6.6 4.0 9.7 4.4 4.7 9.6 5.6 3.5 31.2 29.9 3.5 6.4 34.1 13.3 3.7 3.3 20.6 5.5 22.3 26.3 7.9 11.8 17.1 66.8 130.8 90.4 16.0 16.0 53.1 5.7 13.5 0.1 0.0 1.3 3.0 0.1 2.8 4.0 1.8 1.2 0.0 7.2 2.4 0.0 2.7 0.0 16.0 0.7 10.7 0.0 17.3 0.0 2.2 1.6 4.4 4.6 20.1 16.0 4.0 5.6 0.8 0.1 0.0 3.9 0.0 9.9 3.7 0.5 34.5 0.0 54.4 3.7 2.3 0.0 17.5 0.0 7.6 0.1 5.6 0.1 0.0 2.4 0.0 2.7 0.0 3.3 40.1 2.6 0.1 0.2 2.4 0.0 0.1 0.0 0.0 1.4 24.9 0.0 37.8 90.4 71.4 15.1 87.5 9.5 17.1 12.7 15.5 66.8 15.2 8.9 12.3 130.8 16.0 85.0 61.0 16.0 53.1 3.6 4.6 3.6 3.3 2.4 2.6 6.4 1.8 4.0 3.3 20.8 28.2 73.7 67.5 65.8 0.1 2.8 28.1 36.1 29.6 24.4 0.0 46.3 5.0 83.5 0.3 38.6 312.0 23.3 50.3 8.9 26.7 26.8 108.5 3.0 375.8 0.0 56.6 41.7 516.6 1.5 43.7 364.0 92.8 16.2 110.6 0.0 56.2 271.9 21.2 1.4 0.6 25.8 23.3 0.3 1.1 143.2 14.9 75.0 247.3 42.2 PYGO1 ENSG00000171016 "Pygopus family PHD finger 1" Q9Y3Y4 15 55538890-55588947 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 26.6" "Cell type enhanced" "Detected in many" 5 "Peritubular cells: 11.3;Spermatocytes: 10.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-698: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042248 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042248: AB_10794272" "unprognostic (5.55e-2)" "unprognostic (9.82e-2)" "unprognostic (2.61e-2)" "unprognostic (4.54e-2)" "unprognostic (7.20e-2)" "unprognostic (1.61e-1)" "unprognostic (1.31e-1)" "unprognostic (8.23e-2)" "unprognostic (1.41e-1)" "unprognostic (1.06e-1)" "unprognostic (2.68e-1)" "unprognostic (2.29e-1)" "unprognostic (6.72e-6)" "unprognostic (3.36e-4)" "unprognostic (4.84e-2)" "unprognostic (2.30e-2)" "unprognostic (1.80e-2)" 3.0 3.8 3.8 1.6 8.2 0.6 3.1 10.1 5.1 10.8 5.1 2.8 8.2 0.9 9.8 5.8 3.3 4.2 3.9 2.6 5.2 4.3 1.8 0.6 3.2 1.0 4.2 2.8 14.2 2.3 26.6 6.9 3.2 5.0 7.9 1.9 5.5 1.9 9.4 18.7 1.5 1.8 7.9 5.2 0.8 2.8 6.0 3.2 0.0 10.1 5.7 1.0 7.6 9.2 0.6 0.2 0.9 0.2 0.3 0.4 0.0 2.8 5.1 8.9 4.7 3.4 7.7 3.7 6.1 6.7 4.8 5.6 3.4 0.0 0.0 1.8 3.9 6.8 0.0 9.1 0.0 6.2 0.0 3.1 1.3 1.4 0.3 4.9 4.9 0.0 4.1 4.7 4.3 0.7 4.9 2.5 0.7 0.1 0.0 7.6 0.1 0.2 0.0 2.4 0.6 2.6 0.0 11.4 0.0 1.5 2.0 4.9 5.8 5.5 0.0 4.2 1.3 1.7 1.5 0.0 12.1 5.5 0.2 7.1 0.1 0.1 25.9 3.8 0.0 2.8 0.4 0.2 0.2 0.4 0.2 0.2 0.2 0.3 0.0 0.0 0.6 0.3 0.4 0.9 0.3 0.1 0.2 0.1 0.0 3.8 8.2 10.1 2.8 5.2 4.3 4.2 2.8 5.0 3.2 8.9 4.6 0.0 4.1 1.4 4.9 3.9 0.0 2.7 3.4 8.7 0.0 0.9 0.0 0.3 1.7 0.7 0.0 0.0 0.0 0.1 6.6 4.8 0.0 0.0 0.4 0.0 0.0 0.6 0.6 1.9 9.2 0.8 6.8 0.0 0.0 6.3 0.8 0.0 11.3 0.0 3.1 0.0 4.1 10.7 2.1 0.6 0.2 0.0 0.0 0.5 PYGO2 ENSG00000163348 "Pygopus family PHD finger 2" Q9BRQ0 1 154957026-154963853 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023689, HPA074813" Supported Supported "Nucleoplasm,Plasma membrane" No No Nucleoplasm "Plasma membrane" "HPA023689: AB_1855974, HPA074813: " "unprognostic (1.49e-2)" "unprognostic (1.33e-1)" "unprognostic (6.96e-3)" "unprognostic (2.58e-2)" "unprognostic (5.85e-2)" "unprognostic (4.32e-3)" "prognostic unfavorable (3.88e-6)" "unprognostic (2.45e-1)" "unprognostic (2.07e-1)" "unprognostic (2.00e-2)" "unprognostic (1.51e-1)" "unprognostic (3.74e-1)" "unprognostic (7.40e-3)" "unprognostic (1.63e-2)" "unprognostic (2.81e-2)" "unprognostic (2.17e-1)" "prognostic favorable (1.76e-4)" 14.0 28.4 22.2 22.8 23.7 6.6 26.1 28.5 26.8 20.8 20.5 23.4 22.1 21.3 18.7 27.9 21.4 24.1 21.6 15.0 18.7 22.9 19.1 17.4 17.2 26.7 22.2 19.4 32.5 17.5 37.7 31.0 18.4 21.3 24.5 17.9 21.3 25.3 32.6 16.4 25.0 22.5 18.3 22.1 26.4 19.1 15.7 22.1 30.9 35.5 12.9 30.1 20.3 21.8 8.9 4.3 10.5 8.2 6.3 12.8 5.7 12.9 9.2 19.6 17.3 19.8 9.7 18.0 8.1 11.0 12.9 11.1 12.3 16.3 16.3 12.9 9.4 14.0 17.7 17.0 11.3 8.5 16.1 12.1 13.0 15.0 10.9 9.2 11.9 11.6 8.0 16.4 11.6 9.8 14.7 7.9 25.0 17.0 27.8 12.1 19.8 16.4 13.9 20.9 26.1 16.6 18.6 12.5 25.7 13.1 12.3 23.6 35.1 12.8 23.4 16.1 19.9 28.7 21.5 6.6 11.5 17.4 12.4 11.7 27.6 24.4 17.4 9.6 15.2 15.2 2.4 3.9 10.5 9.0 6.8 11.6 7.5 11.5 11.9 4.3 8.9 12.8 9.6 4.0 6.3 8.2 4.2 6.0 5.7 22.2 23.7 28.5 26.8 18.7 22.9 22.2 19.4 21.3 22.1 8.9 8.2 8.4 3.2 4.8 10.2 4.2 5.1 1.4 6.8 12.2 2.0 12.8 16.6 5.0 2.7 6.8 7.0 0.0 5.1 10.1 5.3 4.2 0.0 7.8 5.5 20.6 5.2 6.7 6.9 1.8 8.3 3.9 5.0 4.6 9.7 9.8 8.0 8.6 8.5 7.6 6.1 6.5 6.6 4.1 10.9 4.5 9.7 11.7 9.5 2.8 PYHIN1 "IFIX, MGC23885" ENSG00000163564 "Pyrin and HIN domain family member 1" Q6K0P9 1 158930796-158977054 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.4;lymphoid tissue: 23.3" "Cell type enriched" "Detected in some" 11 "T-cells: 126.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "gdT-cell: 33.4;MAIT T-cell: 19.1;memory CD4 T-cell: 14.2;memory CD8 T-cell: 25.2;naive CD8 T-cell: 16.0;NK-cell: 11.4;T-reg: 21.0" "Group enriched" "Detected in many" 5 "NK-cells: 11.4;T-cells: 33.4" "Cell line enriched" "Detected in some" 6 "U-698: 33.1" "HPA051224, HPA055373" Enhanced Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA051224: AB_2681394, HPA055373: " "unprognostic (1.64e-3)" "unprognostic (1.75e-3)" "unprognostic (2.93e-3)" "unprognostic (2.64e-3)" "unprognostic (3.99e-2)" "unprognostic (3.57e-3)" "unprognostic (2.44e-3)" "unprognostic (2.10e-2)" "unprognostic (1.52e-1)" "unprognostic (1.47e-3)" "unprognostic (3.94e-2)" "unprognostic (2.23e-1)" "unprognostic (1.70e-6)" "unprognostic (1.83e-1)" "unprognostic (2.31e-1)" "unprognostic (2.76e-2)" "unprognostic (4.45e-3)" 4.0 0.6 0.5 20.1 0.5 3.9 2.1 0.4 0.4 2.0 2.7 0.2 0.3 1.2 2.2 1.4 1.7 1.6 3.2 1.2 0.6 0.5 1.8 2.6 11.7 18.8 0.7 0.0 1.6 0.8 0.0 0.8 1.7 0.4 2.6 1.8 1.2 3.4 1.2 0.7 0.9 7.8 0.4 1.3 20.7 2.0 1.0 0.0 6.6 2.5 1.9 23.3 5.7 1.6 4.9 0.1 1.2 0.1 11.4 33.4 6.0 0.0 0.0 0.0 0.0 0.5 0.3 0.4 0.0 0.1 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.6 0.0 33.1 0.0 5.1 0.0 0.4 0.1 0.1 33.4 0.1 19.1 4.9 14.2 25.2 0.1 2.4 4.8 16.0 1.2 11.4 0.1 0.1 21.0 6.0 0.5 0.5 0.4 0.4 0.6 0.5 0.7 0.0 0.4 0.0 11.9 3.2 9.5 0.7 0.3 0.2 0.3 0.0 9.4 3.4 3.5 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 1.1 0.4 2.3 1.3 2.1 0.0 0.0 3.1 4.3 0.0 0.0 1.4 1.7 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.6 0.0 0.2 0.0 0.1 0.5 0.1 126.8 0.0 0.3 PYM1 "PYM, WIBG" ENSG00000170473 "PYM homolog 1, exon junction complex associated factor" Q9BRP8 12 55901413-55932618 "Predicted intracellular proteins" "Nonsense-mediated mRNA decay, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 146.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012803, HPA039717, HPA046200" Supported Supported "Nucleoplasm,Nucleoli,Cell Junctions,Cytosol" No No "Nucleoplasm, Nucleoli, Cytosol" "Cell Junctions" "CAB012803: AB_2269494, HPA039717: AB_2676644, HPA046200: AB_10965556" "unprognostic (3.03e-2)" "unprognostic (1.00e-1)" "unprognostic (5.65e-2)" "unprognostic (8.82e-2)" "unprognostic (1.97e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (3.05e-4)" "unprognostic (3.29e-1)" "unprognostic (2.17e-3)" "unprognostic (2.44e-2)" "unprognostic (3.94e-2)" "unprognostic (1.29e-1)" "unprognostic (1.32e-2)" "unprognostic (1.59e-2)" "unprognostic (2.22e-1)" "unprognostic (1.29e-1)" "prognostic favorable (1.34e-4)" 17.5 21.4 16.2 21.2 14.8 13.2 20.3 16.3 17.1 15.2 21.2 14.2 27.1 21.8 16.1 30.8 46.7 16.3 21.5 13.6 14.0 14.7 19.4 31.3 14.4 28.6 14.7 14.0 13.3 24.8 15.3 19.8 21.5 12.8 20.7 21.5 18.3 22.9 24.5 18.2 27.2 29.9 16.3 13.2 25.5 15.8 21.1 14.1 26.3 22.5 31.2 39.1 16.5 19.9 29.5 35.9 21.6 27.2 14.4 53.6 24.1 17.5 14.1 20.6 11.4 12.5 16.3 33.8 13.0 15.7 12.3 10.4 20.5 21.0 22.1 19.8 12.5 5.7 13.9 15.8 27.8 9.9 17.0 11.8 18.0 12.0 25.2 15.3 20.8 16.5 14.7 17.9 13.8 20.8 15.6 13.0 9.9 15.3 24.6 14.4 26.5 13.3 37.2 35.9 20.1 7.3 12.0 8.2 25.3 25.2 25.0 13.9 16.0 16.6 22.3 11.6 20.0 27.1 44.1 10.1 7.4 10.5 11.5 9.4 13.0 19.7 34.1 12.7 14.5 11.6 3.9 24.5 21.6 18.7 27.2 22.9 29.5 34.0 26.1 35.9 25.2 22.6 22.6 5.8 14.4 18.5 19.6 53.6 24.1 16.2 14.8 16.3 17.1 14.0 14.7 14.7 14.0 12.8 14.1 17.9 15.9 15.9 26.4 0.0 13.6 0.0 28.1 30.8 26.1 22.7 7.9 72.4 66.3 34.7 9.6 12.4 38.3 23.3 44.0 61.6 11.5 34.5 17.4 32.7 48.8 6.4 7.0 19.0 44.8 7.4 21.6 40.2 0.0 146.1 41.7 34.7 43.4 37.0 22.3 44.1 10.6 12.9 0.0 18.1 24.3 0.0 51.8 37.4 37.7 28.0 PYURF PreY ENSG00000145337 "PIGY upstream reading frame" Q96I23 4 88520985-88523813 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036455 Uncertain Approved Nucleoplasm NA Yes Nucleoplasm "HPA036455: AB_10673388" "unprognostic (8.25e-2)" "unprognostic (9.14e-2)" "unprognostic (6.61e-2)" "unprognostic (2.03e-1)" "unprognostic (5.03e-2)" "unprognostic (7.23e-2)" "unprognostic (1.10e-2)" "unprognostic (8.84e-3)" "unprognostic (3.64e-1)" "unprognostic (1.48e-2)" "unprognostic (1.20e-2)" "unprognostic (2.35e-2)" "unprognostic (9.04e-3)" "unprognostic (1.59e-1)" "unprognostic (1.16e-1)" "unprognostic (1.01e-1)" "unprognostic (4.78e-3)" 40.4 48.3 47.3 29.2 43.9 44.2 63.2 28.2 43.4 40.6 38.4 31.2 35.2 35.8 47.4 56.4 40.9 41.0 36.4 62.5 45.4 45.1 48.7 59.1 33.5 43.1 47.6 35.3 44.9 61.8 40.7 42.6 39.0 43.2 42.7 37.7 31.6 48.6 42.9 54.0 37.1 37.5 44.7 51.4 36.9 33.8 28.5 38.4 28.3 47.7 40.5 33.0 41.7 51.4 45.3 50.8 35.0 43.3 47.3 54.1 74.3 29.4 9.9 19.9 23.6 40.3 41.5 13.5 21.8 30.7 27.4 23.2 7.7 23.5 0.1 24.6 30.8 18.6 12.7 18.0 27.4 34.6 36.0 31.3 32.7 13.2 29.3 30.6 54.0 21.1 28.6 41.5 17.6 36.1 26.0 44.7 10.2 36.7 33.2 39.5 22.3 32.8 33.1 16.7 34.5 19.1 33.5 18.6 34.3 22.5 16.7 24.1 23.6 27.6 25.3 57.4 20.6 11.7 27.2 30.4 29.2 26.9 28.4 20.0 23.6 19.1 3.6 25.6 27.5 32.0 30.9 43.3 35.0 45.0 42.0 50.2 45.3 52.0 48.5 50.8 35.5 54.1 51.6 8.6 47.3 41.0 31.9 51.8 74.3 47.3 43.9 28.2 43.4 45.4 45.1 47.6 35.3 43.2 38.4 47.6 58.8 74.6 136.8 204.7 28.0 4.5 68.8 84.3 85.3 82.0 9.8 205.8 243.7 96.5 35.0 121.7 71.5 23.3 113.5 97.9 127.4 138.8 102.8 109.9 125.1 25.4 110.1 92.7 113.8 79.3 116.5 112.4 330.7 100.0 88.2 79.4 90.7 113.1 112.8 171.4 25.3 58.2 140.4 100.3 65.3 252.6 137.1 99.2 113.0 120.5 QKI QK3 ENSG00000112531 "QKI, KH domain containing RNA binding" Q96PU8 6 163414000-163578596 "Cancer-related genes, Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, mRNA transport, Translation regulation, Transport" "Developmental protein, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 100.3" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 308.9" "Cancer enriched" "Detected in all" 6 "glioma: 42.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "AF22: 64.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019123, CAB022602" Enhanced Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB022602: , HPA019123: AB_1855980" "unprognostic (2.42e-1)" "unprognostic (5.81e-2)" "unprognostic (1.31e-1)" "unprognostic (1.06e-2)" "unprognostic (8.57e-2)" "unprognostic (1.65e-1)" "prognostic unfavorable (1.27e-4)" "unprognostic (1.34e-1)" "unprognostic (7.06e-2)" "unprognostic (1.76e-3)" "unprognostic (1.08e-1)" "unprognostic (5.15e-2)" "prognostic unfavorable (2.31e-5)" "prognostic unfavorable (3.69e-4)" "unprognostic (1.16e-1)" "unprognostic (3.86e-1)" "unprognostic (4.09e-2)" 32.4 12.4 37.5 16.2 63.5 27.1 14.6 15.1 100.3 14.9 12.2 83.9 3.7 4.0 14.7 4.9 16.0 12.3 15.7 64.0 43.7 18.1 11.1 18.4 24.9 11.4 72.5 31.9 18.4 7.6 7.8 4.7 23.4 46.5 7.9 8.4 7.1 10.2 11.1 59.9 12.4 7.1 21.1 68.8 16.9 8.9 20.5 74.3 5.0 10.4 10.8 11.4 15.8 17.7 1.7 7.3 10.8 8.4 7.4 3.8 1.3 4.3 18.2 64.8 21.5 19.6 21.9 15.1 11.8 27.9 19.3 23.4 12.3 4.0 5.2 9.9 29.5 13.2 6.5 34.3 12.2 31.4 10.5 11.1 20.6 10.1 13.8 24.0 11.0 6.3 25.6 5.0 20.7 32.9 18.9 26.6 7.8 30.2 12.4 12.4 8.2 7.3 2.3 8.3 4.3 9.2 11.3 40.4 10.5 10.6 13.7 1.3 7.5 12.6 6.8 5.2 27.5 2.6 18.0 27.0 13.4 11.3 14.4 21.6 7.9 9.6 6.4 11.5 9.7 31.4 3.4 8.4 3.8 2.3 5.4 3.8 1.4 1.6 2.0 4.3 1.7 1.5 2.5 10.8 7.4 5.5 7.3 1.1 1.3 37.5 63.5 15.1 41.4 43.7 18.1 72.5 31.9 46.5 74.3 140.0 54.6 32.8 29.3 136.6 56.8 308.9 40.8 21.4 36.4 19.2 55.0 41.8 18.3 21.6 45.5 100.3 0.0 46.7 10.3 40.7 66.9 33.8 60.0 61.0 75.9 30.2 0.0 146.1 189.4 77.1 80.3 114.7 108.0 31.5 0.0 113.1 17.4 0.0 92.6 25.9 30.1 45.3 91.7 34.4 14.6 118.9 46.1 25.8 0.0 35.3 QRICH1 FLJ20259 ENSG00000198218 "Glutamine rich 1" Q2TAL8 3 49029707-49094363 "Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037677, HPA037678" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA037677: AB_10671883, HPA037678: AB_2675603" "unprognostic (2.38e-2)" "unprognostic (2.05e-1)" "unprognostic (8.29e-2)" "unprognostic (1.67e-1)" "unprognostic (2.41e-1)" "unprognostic (3.14e-2)" "unprognostic (2.77e-3)" "unprognostic (6.94e-2)" "unprognostic (2.82e-2)" "prognostic favorable (7.46e-4)" "unprognostic (1.12e-1)" "unprognostic (1.40e-2)" "unprognostic (2.17e-3)" "unprognostic (5.06e-2)" "unprognostic (3.84e-1)" "unprognostic (1.76e-1)" "unprognostic (1.06e-1)" 28.9 27.6 20.4 23.6 26.8 43.1 27.8 38.9 35.0 26.2 23.3 27.0 21.2 21.0 30.7 22.0 28.4 26.7 23.7 21.5 20.9 16.7 20.3 22.1 26.0 30.3 17.8 22.1 30.5 23.3 30.7 27.3 32.1 23.6 22.6 21.4 28.4 26.4 26.0 32.3 34.1 30.0 24.6 15.9 35.2 25.8 53.9 21.8 40.3 25.9 20.2 37.1 28.1 23.6 15.5 16.0 15.9 26.0 15.8 20.1 11.1 18.6 17.9 35.6 16.4 23.4 22.5 22.2 21.1 27.7 35.4 32.3 19.5 23.7 29.9 13.6 27.5 28.6 14.9 32.6 29.5 30.8 25.6 19.6 29.3 24.8 16.1 21.1 25.5 33.8 25.5 22.5 35.4 22.7 21.6 27.4 27.6 19.8 27.4 24.0 13.8 37.1 17.5 29.1 19.6 22.5 18.6 18.6 24.7 22.1 29.1 13.6 27.4 24.0 22.4 17.4 29.4 20.0 28.9 23.8 23.2 26.4 20.5 30.1 24.7 28.7 36.2 21.2 24.6 26.5 14.0 13.2 15.9 16.8 16.5 19.9 15.4 16.2 18.6 16.0 15.5 17.5 20.1 9.9 15.8 26.0 11.4 16.6 11.1 20.4 26.8 38.9 35.0 20.9 16.7 17.8 22.1 23.6 21.8 8.9 13.9 26.2 11.9 19.7 13.5 17.6 17.8 12.0 17.0 19.2 21.6 22.0 1.7 13.7 8.6 15.8 13.1 0.0 11.9 22.9 14.2 14.3 16.1 18.7 17.0 11.1 24.9 18.4 24.3 7.9 20.8 21.5 11.8 17.2 21.2 10.6 16.0 7.0 29.0 9.7 17.1 6.5 17.0 40.7 25.1 19.7 30.8 18.4 16.9 13.5 QRICH2 DKFZP434P0316 ENSG00000129646 "Glutamine rich 2" Q9H0J4 17 76274049-76307998 "Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 27.4" "Cell type enhanced" "Detected in some" 21 "Cholangiocytes: 7.6;Early spermatids: 25.8;Late spermatids: 5.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" HPA052219 Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles" NA NA "Nucleoplasm, Nuclear membrane, Vesicles" "HPA052219: AB_2681766" "unprognostic (3.11e-2)" "unprognostic (2.44e-3)" "unprognostic (9.11e-3)" "unprognostic (4.42e-3)" "unprognostic (1.35e-1)" "unprognostic (1.32e-2)" "unprognostic (2.09e-1)" "unprognostic (1.89e-1)" "unprognostic (1.83e-1)" "unprognostic (2.61e-1)" "unprognostic (8.82e-4)" "unprognostic (3.64e-1)" "unprognostic (1.39e-1)" "unprognostic (6.97e-2)" "unprognostic (7.15e-2)" "unprognostic (1.05e-1)" "unprognostic (1.71e-3)" 0.9 0.8 1.2 0.9 2.2 1.9 0.9 5.7 2.0 0.9 0.9 0.9 0.9 0.3 0.9 1.0 1.0 1.2 0.9 0.9 1.4 2.0 0.9 1.1 1.1 0.9 1.4 0.9 0.9 1.3 0.6 0.9 1.4 0.9 0.9 0.8 0.9 5.6 0.9 1.4 1.7 0.9 0.9 1.2 0.9 0.3 27.4 0.9 0.9 3.0 0.9 0.9 0.9 0.9 0.9 0.0 0.0 0.1 0.3 0.4 0.3 1.2 2.5 4.8 5.4 2.6 2.4 2.2 2.2 0.5 1.7 0.5 1.3 0.5 6.5 0.9 1.4 1.3 0.5 6.3 1.1 2.1 1.8 3.8 0.6 1.7 5.8 1.4 0.9 3.0 2.1 1.0 1.9 0.1 3.3 2.1 2.0 3.5 1.3 0.6 3.8 3.4 0.8 1.9 1.6 5.2 7.6 3.9 0.2 0.9 2.3 4.4 4.4 1.1 0.6 2.6 4.9 2.0 2.7 2.1 1.4 5.1 6.8 2.6 1.8 1.7 0.6 1.5 3.8 1.6 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.1 0.0 0.0 0.9 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.3 1.2 2.2 5.7 2.0 1.4 2.0 1.4 0.9 0.9 0.9 0.0 0.0 0.0 0.3 0.1 0.5 1.6 7.6 0.0 0.0 1.8 0.0 0.6 0.0 0.7 25.8 0.6 0.3 0.0 0.0 0.9 0.2 0.3 0.0 0.8 0.2 1.6 0.0 0.0 0.3 5.8 0.9 0.0 1.7 1.0 0.5 1.5 0.5 0.0 0.7 0.4 1.8 0.0 0.6 2.1 1.1 0.3 0.3 0.0 0.4 0.3 QSER1 FLJ21924 ENSG00000060749 "Glutamine and serine rich 1" Q2KHR3 11 32893178-32993316 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005682 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005682: AB_1855985" "unprognostic (2.94e-1)" "unprognostic (6.55e-2)" "unprognostic (1.36e-1)" "unprognostic (2.76e-1)" "unprognostic (6.78e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (7.94e-5)" "unprognostic (1.14e-1)" "unprognostic (4.75e-2)" "unprognostic (6.71e-2)" "prognostic unfavorable (5.27e-5)" "unprognostic (6.77e-2)" "prognostic unfavorable (6.87e-4)" "unprognostic (1.80e-2)" "unprognostic (7.20e-2)" "unprognostic (8.12e-2)" "unprognostic (7.96e-2)" 10.8 8.3 13.6 9.1 11.3 8.3 22.0 21.3 14.9 13.1 8.7 9.8 9.5 5.4 13.8 13.1 15.9 11.2 8.9 10.0 12.5 7.1 9.3 9.5 9.1 8.2 13.1 10.9 21.4 15.6 16.5 11.4 9.0 11.5 11.5 9.2 10.9 16.7 9.7 9.8 20.1 7.9 10.4 11.5 10.1 9.3 14.2 12.8 14.2 14.2 14.0 10.1 11.8 24.8 2.0 2.2 0.3 2.4 1.7 1.1 0.4 11.4 14.2 16.6 15.3 6.5 12.6 8.0 10.0 9.0 7.3 9.0 12.3 5.4 12.0 6.5 12.1 12.2 14.9 15.2 9.0 15.6 5.1 9.8 11.2 13.7 10.2 4.9 13.5 6.1 6.1 9.6 9.3 15.1 8.9 10.0 7.0 17.1 5.4 11.4 10.2 6.5 5.4 17.6 7.1 8.7 10.8 32.8 5.0 7.5 12.6 8.7 12.4 18.9 10.1 6.3 12.8 10.4 7.1 9.8 17.8 17.9 31.9 21.4 3.7 5.0 12.6 11.5 6.4 11.4 0.0 1.2 0.3 1.1 2.4 0.5 2.0 0.7 1.0 1.1 0.9 0.6 0.7 0.0 1.7 0.6 2.2 0.2 0.4 13.6 11.3 21.3 14.9 12.5 7.1 13.1 10.9 11.5 12.8 17.9 12.0 7.3 8.6 24.7 16.5 26.8 12.7 13.4 19.4 7.0 13.7 10.6 3.3 8.1 11.1 13.5 4.2 0.0 10.3 10.6 16.9 9.2 3.5 9.0 12.2 9.5 0.0 13.5 16.4 7.6 22.7 13.3 15.1 1.8 11.0 11.8 10.0 11.6 19.8 6.9 14.1 6.5 12.0 19.7 19.1 24.1 3.5 4.3 10.4 11.1 QSOX2 "DKFZp762A2013, QSCN6L1, SOXN" ENSG00000165661 "Quiescin sulfhydryl oxidase 2" Q6ZRP7 9 136206333-136245841 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 26.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 3.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012716, HPA017280" Uncertain Enhanced "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA 5700000 "Golgi apparatus" Nucleoplasm "HPA012716: AB_2173315, HPA017280: AB_2669565" "unprognostic (7.29e-2)" "unprognostic (7.35e-3)" "unprognostic (6.23e-2)" "unprognostic (5.28e-2)" "unprognostic (1.49e-1)" "unprognostic (4.46e-3)" "unprognostic (1.10e-3)" "unprognostic (4.48e-2)" "unprognostic (1.20e-1)" "unprognostic (4.06e-3)" "unprognostic (5.96e-2)" "unprognostic (2.56e-2)" "prognostic unfavorable (9.64e-6)" "unprognostic (1.23e-2)" "unprognostic (1.22e-1)" "unprognostic (1.75e-2)" "unprognostic (1.10e-2)" 7.2 8.0 8.4 15.9 14.1 16.0 7.3 30.3 10.6 5.8 5.8 9.4 8.9 6.0 8.1 13.2 5.6 8.1 5.5 7.0 7.6 7.1 7.0 9.2 6.5 19.1 11.0 6.7 9.4 21.7 12.1 29.2 5.8 9.6 6.1 6.7 7.9 6.5 4.9 5.1 12.4 10.3 8.1 7.1 14.6 7.6 11.7 10.1 8.3 12.1 6.0 16.7 5.4 6.4 3.4 0.8 1.6 0.3 0.4 0.8 0.2 7.0 17.1 14.2 18.8 8.0 9.8 17.9 8.9 10.0 17.5 16.1 12.7 15.3 10.8 14.8 12.0 32.2 22.8 16.8 12.9 14.2 15.9 8.4 5.8 28.3 14.0 11.4 17.2 8.9 7.8 13.2 17.3 21.1 7.7 12.8 11.4 14.0 29.3 9.2 11.9 6.3 11.5 16.8 21.2 10.9 11.8 18.5 17.7 6.0 6.3 15.2 11.5 14.1 11.2 7.5 9.7 8.0 10.1 7.3 21.3 15.4 17.4 20.3 10.4 13.8 23.8 14.2 9.1 19.8 1.6 0.3 0.7 0.5 0.0 0.8 1.9 0.6 0.2 0.1 3.4 0.2 0.4 0.1 0.4 0.0 0.8 0.3 0.2 8.4 14.1 30.3 10.6 7.6 7.1 11.0 6.7 9.6 10.1 8.9 6.4 6.9 2.5 5.0 16.1 3.1 0.0 8.1 5.7 5.2 17.7 1.2 1.7 3.3 4.9 7.0 1.1 0.0 3.4 2.5 4.7 4.8 1.1 3.4 2.0 4.8 15.6 2.5 4.8 4.7 5.5 2.7 0.0 1.0 4.9 2.8 3.5 0.0 6.7 1.9 8.2 6.5 5.7 16.8 26.4 10.0 0.8 3.1 3.4 3.3 QTRT2 "FLJ12960, QTRTD1" ENSG00000151576 "Queuine tRNA-ribosyltransferase accessory subunit 2" Q9H974 3 114005833-114088422 "Predicted intracellular proteins" "tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 16.9;Club cells: 19.4;granulocytes: 14.0;monocytes: 14.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036827, HPA036828" Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA Nucleoplasm "Intermediate filaments" "HPA036827: AB_2675336, HPA036828: AB_10696788" "unprognostic (2.22e-1)" "unprognostic (1.11e-1)" "unprognostic (6.71e-3)" "unprognostic (1.01e-3)" "unprognostic (8.57e-2)" "unprognostic (4.41e-1)" "unprognostic (5.82e-3)" "unprognostic (3.58e-1)" "unprognostic (1.35e-1)" "unprognostic (6.94e-2)" "unprognostic (6.48e-3)" "prognostic unfavorable (6.95e-4)" "unprognostic (1.44e-1)" "unprognostic (8.74e-2)" "unprognostic (2.65e-2)" "unprognostic (1.98e-1)" "unprognostic (1.18e-3)" 17.1 13.9 8.7 12.4 10.4 13.3 14.1 6.4 10.3 11.0 11.2 14.9 7.9 10.4 16.1 9.2 13.7 13.1 13.6 7.5 6.7 6.7 15.8 15.7 12.2 14.9 11.0 7.6 12.6 15.3 10.7 16.9 11.6 9.4 11.2 12.5 17.7 11.8 9.8 7.5 12.4 12.9 10.8 11.3 19.9 10.7 14.1 10.0 17.3 13.2 10.9 21.6 11.6 10.9 13.9 15.8 5.3 12.9 6.4 6.6 5.0 13.4 14.0 11.7 12.9 5.2 6.4 11.1 7.1 4.5 12.1 11.2 13.3 9.8 25.1 10.4 6.5 14.5 13.5 22.7 10.7 16.0 4.7 10.2 11.3 8.4 9.4 7.4 20.4 10.6 5.0 9.7 11.0 15.7 4.9 12.5 11.7 11.8 9.0 6.8 10.7 17.1 8.0 22.4 19.2 15.4 15.5 8.2 13.5 9.5 9.3 16.0 7.6 10.3 10.2 13.0 10.2 11.3 10.4 8.2 10.6 11.6 4.1 13.7 6.4 9.2 35.1 9.3 15.2 21.3 0.3 12.4 2.9 5.6 12.9 5.3 13.9 4.8 5.5 15.8 9.5 6.6 5.3 5.3 6.4 9.1 6.6 5.9 5.0 8.7 10.4 6.4 10.3 6.7 6.7 11.0 7.6 9.4 10.0 17.9 16.9 0.0 0.0 0.0 0.0 0.0 0.0 8.1 19.4 3.5 0.0 9.4 1.7 13.8 0.0 0.0 0.0 0.0 10.8 8.6 0.0 0.0 14.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 14.4 0.0 0.0 12.5 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 R3HCC1 DKFZp564N123 ENSG00000104679 "R3H domain and coiled-coil containing 1" Q9Y3T6 8 23270120-23296279 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 93.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023073, HPA023153" Uncertain Approved Nucleoplasm,Cytosol Yes No Cytosol Nucleoplasm "HPA023073: AB_1855987, HPA023153: AB_2237834" "unprognostic (5.80e-2)" "unprognostic (4.70e-3)" "prognostic favorable (4.08e-4)" "unprognostic (7.46e-3)" "unprognostic (1.97e-1)" "unprognostic (7.26e-2)" "unprognostic (8.49e-3)" "unprognostic (1.02e-2)" "unprognostic (7.73e-2)" "unprognostic (2.92e-1)" "prognostic favorable (8.66e-4)" "unprognostic (7.65e-2)" "prognostic favorable (6.80e-5)" "unprognostic (1.22e-2)" "unprognostic (1.17e-1)" "unprognostic (4.18e-1)" "unprognostic (3.43e-1)" 14.8 14.2 21.4 14.8 20.9 18.4 24.6 16.5 36.3 13.9 18.4 26.0 14.8 14.5 16.4 18.2 12.5 17.9 16.4 23.8 21.5 16.9 13.2 16.6 18.8 15.9 30.1 16.3 22.1 50.3 16.0 14.7 10.4 20.7 14.8 12.0 15.3 24.8 20.7 36.6 16.3 14.4 18.3 33.7 13.0 16.9 17.4 21.4 15.8 13.6 14.7 13.9 12.9 12.6 28.5 29.7 41.6 27.1 29.7 36.5 25.7 21.2 26.7 21.5 20.8 9.2 12.5 14.6 14.0 13.6 24.1 17.6 18.5 10.0 21.5 15.0 17.3 16.5 16.0 22.6 26.2 16.3 13.7 22.2 20.0 18.4 15.5 21.8 13.6 15.0 14.8 20.8 20.6 9.7 17.8 18.4 24.4 23.1 18.2 14.1 17.4 30.7 22.8 17.1 23.0 19.5 21.0 26.2 12.8 11.5 23.4 27.5 23.7 16.0 19.1 22.9 15.4 17.4 16.4 15.6 22.2 18.5 18.4 28.6 13.4 11.9 22.1 17.2 19.1 27.4 17.8 27.1 41.6 36.5 22.6 31.5 28.5 29.6 30.4 29.7 21.0 23.2 26.6 16.6 29.7 24.2 27.7 30.5 25.7 21.4 20.9 16.5 36.3 21.5 16.9 30.1 16.3 20.7 21.4 23.8 14.3 5.2 14.0 13.3 22.4 21.3 17.8 24.1 10.3 5.2 25.5 16.1 48.0 25.7 28.8 17.9 24.9 0.0 43.9 18.7 27.2 9.6 22.0 17.3 25.7 17.5 18.4 12.9 13.7 72.6 16.4 14.0 20.3 15.4 21.3 35.2 32.4 19.2 20.5 24.7 93.2 12.9 29.3 43.5 32.0 14.2 6.4 20.0 22.8 9.9 R3HCC1L "C10orf28, GIDRP86, PSORT" ENSG00000166024 "R3H domain and coiled-coil containing 1 like" Q7Z5L2 10 98134624-98244897 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 40.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037367 Enhanced Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA037367: AB_10696930" "unprognostic (3.00e-1)" "unprognostic (2.55e-2)" "unprognostic (1.72e-2)" "unprognostic (2.39e-1)" "unprognostic (7.67e-2)" "unprognostic (7.04e-2)" "unprognostic (1.15e-3)" "unprognostic (1.33e-1)" "unprognostic (1.73e-1)" "unprognostic (1.40e-1)" "unprognostic (6.00e-2)" "unprognostic (1.55e-1)" "unprognostic (1.74e-3)" "unprognostic (7.39e-2)" "unprognostic (3.12e-1)" "unprognostic (1.49e-1)" "unprognostic (1.43e-2)" 14.5 8.2 9.5 14.9 12.9 19.1 13.0 16.4 11.4 11.1 12.9 8.9 10.3 8.0 11.4 13.0 12.0 8.0 7.7 8.1 10.2 6.2 9.6 10.8 10.9 13.8 11.9 5.4 9.3 10.1 15.6 20.7 14.4 11.8 13.7 13.1 12.9 12.0 9.5 10.0 14.1 15.0 10.1 16.7 13.2 9.4 25.2 12.5 17.1 11.0 6.9 15.7 11.5 16.0 10.2 6.0 18.6 12.9 10.2 13.9 5.5 10.6 7.0 10.7 9.4 9.2 9.8 8.9 12.1 16.9 11.9 13.2 9.5 7.7 15.1 6.5 7.2 6.7 12.2 10.7 7.3 13.5 11.3 7.3 8.9 5.5 10.6 11.3 12.1 10.9 8.9 8.4 10.4 15.5 10.5 7.6 9.5 7.7 9.4 9.2 10.2 9.5 12.6 7.7 5.1 9.2 9.8 12.2 6.1 8.6 6.3 3.7 7.9 6.2 4.6 23.6 14.3 8.3 7.7 8.4 8.0 8.5 8.9 9.0 9.6 10.1 25.8 11.4 12.7 5.8 10.7 6.9 18.6 9.9 9.4 8.8 10.2 10.2 10.0 5.3 9.5 9.0 8.8 8.5 10.2 12.9 6.0 13.9 5.5 9.5 12.9 16.4 11.4 10.2 6.2 11.9 5.4 11.8 12.5 14.9 13.7 6.5 4.8 3.0 6.2 7.7 10.2 17.4 7.9 7.0 5.9 7.9 5.0 6.5 18.2 6.2 10.2 0.0 6.0 8.3 4.5 5.3 16.2 3.9 6.2 4.8 5.8 3.1 9.8 9.4 4.9 9.1 11.8 10.0 10.6 6.2 7.5 5.8 5.3 2.9 13.3 0.0 5.1 40.0 22.6 3.3 10.9 7.5 7.6 7.1 R3HDM1 "KIAA0029, R3HDM" ENSG00000048991 "R3H domain containing 1" Q15032 2 135531455-135725270 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 57.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030936 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA030936: AB_10670835" "unprognostic (1.93e-1)" "unprognostic (4.32e-2)" "unprognostic (8.16e-3)" "unprognostic (1.10e-3)" "unprognostic (1.35e-1)" "unprognostic (1.65e-1)" "unprognostic (2.00e-3)" "prognostic unfavorable (8.02e-4)" "unprognostic (3.51e-2)" "unprognostic (9.52e-2)" "unprognostic (5.51e-2)" "unprognostic (5.76e-2)" "prognostic unfavorable (5.83e-7)" "unprognostic (1.16e-2)" "unprognostic (7.23e-2)" "unprognostic (4.32e-3)" "unprognostic (2.47e-1)" 6.5 6.4 23.2 8.3 27.8 13.4 5.3 22.2 57.6 6.7 7.5 4.5 2.4 4.5 6.9 6.6 6.2 5.5 6.3 5.3 17.9 15.5 6.0 6.2 5.0 11.0 11.5 32.7 5.3 8.4 20.1 13.2 4.2 7.7 5.4 10.3 4.3 4.3 6.1 13.5 5.3 5.6 8.6 7.9 6.6 5.4 14.3 7.6 14.2 8.7 3.6 13.2 8.4 4.3 6.5 12.7 3.5 8.4 9.6 9.6 5.0 20.2 12.5 17.7 20.4 9.5 13.0 10.4 12.7 13.4 12.9 14.1 22.3 14.1 32.2 10.2 18.1 9.4 9.2 23.0 23.7 22.6 20.2 11.6 26.0 15.9 22.2 11.4 22.1 16.8 12.2 10.6 22.6 29.1 11.7 20.6 35.2 26.8 27.7 14.7 20.9 38.3 15.2 13.6 15.2 14.7 22.8 12.2 19.3 12.8 17.9 18.1 14.1 20.5 8.4 9.2 16.1 11.3 11.9 15.0 11.9 11.9 15.0 16.0 22.2 30.4 30.3 13.5 18.2 15.2 3.5 7.8 3.0 6.1 8.4 5.8 6.5 6.6 9.1 11.2 4.4 6.4 7.2 1.0 9.6 7.1 12.7 9.6 5.0 23.2 27.8 22.2 57.6 17.9 15.5 11.5 32.7 7.7 7.6 6.0 1.9 14.1 5.9 7.0 44.7 14.0 12.7 4.0 18.2 7.0 19.6 6.4 16.6 7.5 37.1 12.0 3.8 23.3 6.5 8.3 7.5 7.5 17.4 10.2 10.6 25.4 22.0 13.5 20.0 33.7 12.7 14.2 6.8 10.8 9.7 8.7 7.2 3.5 10.6 9.0 38.8 0.0 8.6 22.3 25.1 8.4 2.6 13.8 10.3 5.2 R3HDM2 KIAA1002 ENSG00000179912 "R3H domain containing 2" Q9Y2K5 12 57253762-57431005 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038327, HPA038328" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA038327: AB_10674681, HPA038328: AB_2675962" "unprognostic (9.46e-2)" "unprognostic (1.40e-1)" "unprognostic (2.93e-2)" "unprognostic (3.48e-1)" "unprognostic (7.41e-2)" "unprognostic (2.20e-1)" "unprognostic (8.17e-2)" "unprognostic (1.90e-1)" "unprognostic (2.46e-1)" "unprognostic (2.25e-1)" "unprognostic (1.09e-2)" "unprognostic (8.89e-2)" "unprognostic (1.67e-2)" "unprognostic (1.42e-1)" "unprognostic (1.92e-1)" "unprognostic (2.15e-1)" "unprognostic (7.49e-2)" 15.9 16.6 33.7 15.7 26.3 18.0 15.6 44.0 35.0 16.2 14.6 21.6 16.5 19.2 20.5 13.2 17.6 20.8 17.2 28.2 26.4 18.8 15.1 18.6 20.6 17.9 21.4 28.1 28.7 16.9 20.4 33.1 15.0 19.5 25.1 14.6 17.8 13.6 14.7 32.0 18.7 17.0 15.5 25.5 19.4 16.9 17.0 20.7 15.1 17.7 10.0 15.0 17.7 14.5 6.6 3.3 8.7 8.3 5.2 5.3 1.3 10.0 14.1 11.7 14.5 19.2 27.2 8.1 10.5 12.9 7.5 6.9 4.6 12.2 11.1 13.2 14.8 8.6 13.1 6.9 13.3 8.7 15.4 9.0 13.7 5.5 5.8 14.3 9.0 17.5 18.4 21.0 12.9 27.3 32.6 10.4 19.9 9.4 14.7 12.6 13.1 12.6 6.7 3.0 6.1 10.3 7.7 9.7 7.2 6.6 10.9 11.9 12.9 10.0 13.4 10.8 7.0 11.7 16.7 12.1 7.8 6.0 17.7 10.8 8.8 4.3 4.5 16.4 9.5 13.9 5.3 4.3 3.2 2.8 3.6 3.6 6.6 5.0 2.6 2.1 3.5 5.3 3.2 8.7 5.2 8.3 3.3 2.0 1.3 33.7 26.3 44.0 35.0 26.4 18.8 21.4 28.1 19.5 20.7 29.8 32.5 21.7 22.9 38.6 106.3 25.4 30.6 24.1 12.5 36.6 74.6 18.0 43.1 12.7 13.7 17.5 28.5 23.3 9.6 16.3 27.9 25.6 24.4 64.2 17.0 103.3 23.7 28.8 59.2 25.8 55.3 28.4 25.3 8.2 28.8 35.9 11.0 34.5 45.3 34.8 68.5 32.3 28.9 44.9 50.2 44.9 20.4 34.1 28.8 22.4 R3HDM4 "C19orf22, MGC16353" ENSG00000198858 "R3H domain containing 4" Q96D70 19 896503-913245 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 93.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 93.1" "Lineage enriched" "Detected in all" 12 "granulocytes: 93.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043025, HPA048638" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043025: AB_2678275, HPA048638: AB_2680472" "unprognostic (9.22e-2)" "unprognostic (2.32e-2)" "unprognostic (1.28e-2)" "prognostic favorable (7.33e-6)" "unprognostic (4.30e-2)" "unprognostic (2.02e-2)" "unprognostic (3.94e-3)" "unprognostic (1.06e-1)" "unprognostic (3.67e-1)" "unprognostic (1.17e-1)" "unprognostic (2.02e-1)" "unprognostic (4.28e-1)" "unprognostic (1.46e-3)" "unprognostic (7.44e-2)" "unprognostic (4.52e-1)" "unprognostic (2.08e-1)" "unprognostic (6.74e-2)" 15.4 11.7 23.3 33.2 19.5 57.7 15.4 12.7 26.6 15.9 16.5 16.3 10.0 17.1 15.3 13.2 33.0 15.7 20.1 12.5 20.2 11.9 18.8 24.1 22.7 43.3 14.8 11.9 19.2 34.9 10.0 16.2 18.5 12.8 17.7 12.6 15.5 24.2 14.5 21.6 22.4 18.0 13.4 10.3 41.1 24.1 8.1 12.5 31.9 14.6 19.6 43.0 20.6 19.0 6.4 2.2 93.1 2.0 1.2 7.7 3.8 17.8 10.5 11.2 15.2 7.1 12.7 18.5 12.2 9.7 12.3 10.9 11.1 15.4 13.0 10.1 13.7 2.6 16.4 6.5 14.4 5.6 19.8 13.7 17.8 9.2 19.4 21.5 9.7 31.6 16.8 27.9 7.9 16.8 11.3 14.1 15.5 32.9 26.5 11.4 32.0 13.9 18.7 14.5 21.8 17.3 13.7 5.4 24.6 20.3 18.8 19.8 19.2 10.7 23.7 19.9 9.0 20.9 23.6 14.2 22.5 12.5 26.1 12.0 29.5 15.4 18.9 14.3 14.1 19.5 14.6 2.0 16.2 2.5 1.5 3.9 6.4 5.0 3.4 2.2 3.8 4.8 3.3 93.1 1.2 2.0 0.9 7.7 3.8 23.3 19.5 12.7 26.6 20.2 11.9 14.8 11.9 12.8 12.5 17.9 28.7 41.0 33.3 31.1 15.9 6.0 20.4 12.0 13.6 17.4 7.9 34.5 6.6 39.6 0.9 18.0 18.6 23.3 47.7 40.0 23.1 40.7 23.1 10.5 23.7 27.0 31.4 12.9 21.9 1.7 10.3 25.3 23.6 54.1 28.0 6.0 48.9 26.9 11.0 13.6 10.4 25.8 23.1 0.7 3.9 27.7 57.7 29.8 20.7 65.5 RAB11FIP2 "KIAA0941, nRip11, Rab11-FIP2" ENSG00000107560 "RAB11 family interacting protein 2" Q7L804 10 118004916-118046603 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037726 Approved Supported Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA037726: AB_10672390" "unprognostic (1.97e-1)" "unprognostic (1.68e-2)" "unprognostic (3.61e-1)" "unprognostic (4.45e-2)" "unprognostic (1.30e-1)" "unprognostic (5.58e-2)" "unprognostic (2.17e-2)" "unprognostic (3.34e-2)" "unprognostic (1.83e-2)" "unprognostic (2.15e-1)" "unprognostic (2.06e-1)" "unprognostic (1.47e-1)" "prognostic favorable (9.69e-5)" "unprognostic (1.17e-1)" "unprognostic (1.56e-1)" "unprognostic (1.90e-1)" "unprognostic (2.17e-1)" 8.8 7.1 11.8 6.4 21.6 12.0 7.2 13.3 19.9 11.4 9.7 7.9 19.0 3.8 23.0 29.8 6.8 12.9 8.6 7.2 10.5 7.1 12.8 5.6 7.7 8.5 8.0 12.9 10.7 7.0 8.6 6.6 8.3 11.5 12.7 5.3 6.9 6.2 27.2 6.5 6.3 6.7 20.0 7.5 7.7 15.5 8.6 8.8 10.0 11.8 3.8 5.6 10.5 13.7 2.3 2.6 1.9 1.2 0.9 2.3 0.4 5.2 6.8 5.7 7.2 9.5 12.2 6.1 10.6 12.3 6.5 6.8 5.5 5.7 10.9 8.5 10.7 4.8 3.7 7.9 4.6 10.1 2.8 8.3 3.9 7.0 3.8 13.8 7.2 4.3 11.9 8.9 9.2 20.3 8.7 4.0 7.1 2.8 9.4 8.4 1.9 5.4 5.4 4.8 2.4 4.8 4.8 20.2 3.6 9.7 4.2 1.3 10.6 7.4 3.0 12.9 7.2 2.3 6.8 5.8 8.8 7.1 10.3 10.4 6.8 5.7 7.1 9.0 12.4 5.4 1.5 1.2 1.4 1.5 0.8 1.4 2.2 1.2 1.5 0.6 2.3 2.3 1.3 1.9 0.9 0.7 2.6 0.6 0.4 11.8 21.6 13.3 19.9 10.5 7.1 8.0 12.9 11.5 8.8 53.6 29.8 9.1 7.7 9.2 29.2 23.6 22.9 6.7 6.8 40.1 27.5 9.0 6.6 10.6 13.5 12.8 4.1 0.0 16.2 7.0 22.4 9.2 3.5 7.7 9.7 36.5 13.9 11.6 25.1 5.0 31.1 14.4 21.9 10.0 6.4 24.9 16.4 5.9 26.9 15.6 29.1 25.8 19.8 10.9 20.9 8.3 4.3 8.6 5.8 5.4 RAB11FIP3 "eferin, KIAA0665, Rab11-FIP3" ENSG00000090565 "RAB11 family interacting protein 3" O75154 16 425619-523011 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 70.5" "Cell type enriched" "Detected in many" 14 "Proximal tubular cells: 333.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028088, HPA028631, HPA030086" Enhanced Enhanced "Nucleoplasm,Vesicles,Cytokinetic bridge,Centriolar satellite,Mitochondria" Yes No "Vesicles, Centriolar satellite" "Nucleoplasm, Cytokinetic bridge, Mitochondria" "HPA028088: AB_10601672, HPA028631: AB_10601853, HPA030086: AB_10669596" "unprognostic (6.65e-2)" "unprognostic (1.84e-2)" "unprognostic (1.51e-1)" "prognostic favorable (1.22e-4)" "unprognostic (2.87e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (9.87e-5)" "unprognostic (6.71e-2)" "unprognostic (4.74e-1)" "unprognostic (9.66e-2)" "prognostic favorable (3.16e-5)" "unprognostic (1.12e-1)" "prognostic favorable (7.99e-4)" "unprognostic (1.39e-1)" "unprognostic (1.77e-1)" "unprognostic (1.58e-1)" "unprognostic (1.44e-1)" 10.2 13.4 19.3 7.5 16.9 8.7 7.3 29.7 27.4 11.5 10.6 12.2 9.0 13.4 11.9 11.0 8.2 9.5 11.3 14.0 18.7 12.1 70.5 12.2 10.5 8.1 12.0 18.0 13.4 22.2 22.4 14.6 10.0 10.6 11.5 5.4 9.9 13.2 12.6 23.5 12.2 14.6 10.8 8.9 10.2 7.6 13.5 11.9 5.7 8.6 7.4 5.3 9.7 16.6 1.1 0.8 0.1 0.1 0.1 1.5 0.6 4.4 10.2 9.8 8.6 14.5 9.5 8.5 8.5 8.0 7.8 5.6 7.5 2.1 12.3 10.0 12.4 6.9 4.6 6.1 9.0 2.7 9.1 8.7 5.5 9.5 21.7 15.5 5.5 6.9 9.1 6.2 8.0 7.0 9.1 11.9 8.5 2.8 4.9 9.8 13.7 8.9 10.9 8.2 3.2 4.2 18.5 7.8 3.2 7.8 2.7 10.2 9.5 8.7 10.7 5.4 3.5 5.9 10.2 19.2 11.4 7.6 10.6 5.6 6.8 5.3 14.5 4.3 3.9 8.4 0.0 0.1 0.0 1.5 0.0 1.3 0.8 0.9 0.7 0.5 1.1 0.6 0.3 0.1 0.1 0.0 0.8 0.0 0.6 19.3 16.9 29.7 27.4 18.7 12.1 12.0 18.0 10.6 11.9 3.0 1.7 3.4 0.4 3.3 8.2 11.7 7.6 4.0 6.8 5.2 5.9 0.8 23.2 1.4 1.0 2.5 6.4 0.0 1.0 0.1 2.3 1.1 1.1 14.1 0.7 20.6 2.9 19.6 5.1 1.6 0.6 1.2 0.0 0.0 2.7 6.1 1.6 1.7 1.8 333.9 7.1 6.5 2.1 2.7 3.0 1.9 0.7 2.6 4.1 0.3 RAB3A ENSG00000105649 "RAB3A, member RAS oncogene family" P20336 19 18196784-18204074 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 114.7" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 94.1;Distal tubular cells: 33.2;Horizontal cells: 87.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 13.8;SCLC-21H: 25.3;SH-SY5Y: 12.1;U-2197: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003160, CAB009949, CAB078998" Enhanced Supported Approved Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "CAB009949: AB_632292, CAB078998: , HPA003160: AB_1079731" "unprognostic (1.82e-1)" "unprognostic (2.22e-1)" "unprognostic (6.80e-3)" "prognostic unfavorable (3.17e-4)" "unprognostic (1.21e-1)" "unprognostic (1.88e-1)" "unprognostic (1.36e-1)" "unprognostic (1.40e-3)" "unprognostic (1.85e-1)" "unprognostic (1.64e-1)" "unprognostic (4.46e-3)" "unprognostic (1.13e-1)" "prognostic favorable (6.14e-7)" "unprognostic (1.23e-1)" "unprognostic (1.88e-1)" "unprognostic (1.85e-2)" "unprognostic (6.14e-2)" 2.3 13.0 32.3 2.6 50.5 2.0 2.0 39.1 114.7 2.8 3.1 6.3 0.0 3.6 2.7 2.6 2.4 3.2 2.8 17.0 40.8 32.7 4.1 2.2 2.5 2.4 31.5 35.6 8.0 2.3 5.0 7.5 2.4 38.2 3.8 2.8 5.8 4.2 4.4 7.5 2.5 3.0 2.9 7.0 2.5 2.5 2.2 4.8 0.0 2.9 0.1 2.1 2.9 0.7 4.6 6.0 5.1 3.0 0.7 4.2 2.6 0.9 1.0 2.4 3.2 3.8 1.0 1.4 2.1 1.2 1.4 1.9 0.9 0.6 3.4 2.3 1.7 1.3 2.7 11.0 1.3 0.7 0.7 3.5 1.3 4.0 3.8 1.0 2.3 4.2 3.2 1.3 0.8 0.4 2.8 0.4 4.2 0.7 1.2 1.3 3.2 5.1 0.6 1.9 2.8 13.8 3.6 0.2 2.8 1.5 0.5 25.3 12.1 1.0 4.4 2.4 1.0 0.9 0.4 0.4 1.3 0.9 17.5 1.2 2.1 4.6 0.8 3.3 1.7 1.1 0.0 3.0 3.8 3.0 2.2 4.0 4.6 3.2 3.0 6.0 2.2 4.1 4.2 5.1 0.7 2.7 5.5 1.8 2.6 32.3 50.5 39.1 95.0 40.8 32.7 31.5 35.6 38.2 4.8 0.0 0.0 0.9 2.1 2.9 94.1 1.1 2.5 0.0 0.0 15.7 7.9 1.4 33.2 2.1 2.4 1.4 1.4 0.0 0.8 3.6 3.9 1.4 0.0 1.5 4.3 87.4 9.2 3.1 1.6 0.0 4.0 4.3 10.1 2.8 2.3 11.3 0.8 2.0 5.3 6.3 28.8 0.0 8.6 0.3 2.8 4.3 1.5 2.2 3.7 1.4 RAB3GAP1 "KIAA0066, RAB3GAP, RAB3GAP130, WARBM1" ENSG00000115839 "RAB3 GTPase activating protein catalytic subunit 1" Q15042 2 135052265-135176394 "Disease related genes, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034494, HPA034495" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034494: AB_2674188, HPA034495: AB_10670158" "unprognostic (1.02e-2)" "unprognostic (2.43e-2)" "unprognostic (5.73e-2)" "prognostic unfavorable (2.96e-4)" "unprognostic (2.18e-1)" "unprognostic (9.57e-2)" "unprognostic (2.96e-2)" "unprognostic (7.00e-2)" "unprognostic (3.18e-1)" "unprognostic (1.13e-2)" "unprognostic (3.15e-2)" "unprognostic (2.05e-1)" "unprognostic (8.40e-3)" "unprognostic (2.41e-2)" "unprognostic (3.75e-1)" "unprognostic (4.11e-1)" "unprognostic (2.15e-1)" 24.1 18.4 22.1 20.8 32.9 27.3 21.8 27.1 37.2 25.1 24.0 21.2 20.0 15.7 42.2 27.0 26.1 20.1 18.3 28.4 21.4 29.1 20.1 16.9 18.6 19.7 24.5 28.1 31.3 29.4 31.7 50.0 33.0 34.5 26.0 24.0 23.2 37.3 25.4 37.4 25.1 19.4 26.4 26.0 17.5 22.7 19.6 21.3 28.8 26.2 20.9 24.6 25.2 24.8 9.1 5.4 9.3 7.1 3.6 10.7 2.4 19.6 8.0 14.2 11.6 27.9 23.8 13.1 30.3 25.0 24.1 23.9 17.7 16.2 29.3 18.8 30.9 9.2 16.7 14.9 27.9 29.5 13.9 15.1 14.5 10.2 15.4 19.5 17.9 15.9 20.7 37.0 22.1 40.2 21.8 17.4 13.4 18.8 17.1 21.9 11.6 9.1 7.0 10.8 11.9 13.5 15.8 18.2 12.2 14.2 17.6 11.4 9.0 20.5 12.3 14.3 12.9 10.8 13.1 20.9 24.5 18.7 10.5 12.6 12.2 6.8 22.1 16.0 10.9 13.6 9.3 5.0 7.6 2.0 6.7 1.8 7.0 5.0 2.8 5.4 9.1 10.7 5.3 2.0 3.6 7.1 2.9 6.5 2.4 22.1 32.9 27.1 37.2 21.4 29.1 24.5 28.1 34.5 21.3 23.8 26.1 28.6 33.7 26.9 27.2 50.9 43.3 33.5 35.2 29.6 47.1 19.8 10.0 18.0 25.6 25.5 29.6 23.3 23.1 14.0 23.7 41.6 45.1 21.5 19.7 28.6 33.3 27.0 20.9 19.3 28.4 29.1 21.9 17.2 33.0 18.1 30.5 20.1 33.6 17.0 32.0 45.3 27.8 34.5 21.1 26.0 32.7 11.4 20.3 42.6 RAB5A RAB5 ENSG00000144566 "RAB5A, member RAS oncogene family" P20339 3 19947079-19985175 "Predicted intracellular proteins, RAS pathway related proteins" "Endocytosis, Phagocytosis, Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004567, HPA049354" Approved Supported Nucleoplasm,Vesicles NA NA 920000 "Nucleoplasm, Vesicles" "CAB004567: AB_628191, HPA049354: AB_2680725" "unprognostic (2.49e-3)" "unprognostic (1.95e-1)" "unprognostic (2.58e-2)" "unprognostic (4.72e-1)" "unprognostic (3.85e-1)" "unprognostic (5.58e-2)" "unprognostic (1.40e-2)" "unprognostic (6.75e-2)" "unprognostic (7.12e-2)" "unprognostic (5.97e-2)" "unprognostic (1.83e-3)" "unprognostic (4.68e-2)" "unprognostic (2.10e-2)" "unprognostic (1.93e-1)" "unprognostic (1.33e-1)" "unprognostic (2.45e-1)" "unprognostic (8.36e-2)" 25.8 21.2 42.5 19.3 34.7 26.5 25.5 25.2 36.6 24.8 21.9 26.0 18.1 21.6 17.5 33.4 32.4 16.3 24.7 28.3 38.4 38.0 25.5 31.3 22.5 16.3 43.5 33.8 16.2 21.9 39.2 23.8 36.1 35.1 24.0 23.4 16.2 25.4 23.3 35.8 27.2 21.6 21.2 49.1 17.0 23.6 15.7 30.3 22.7 31.4 22.2 20.8 23.7 23.7 5.0 11.2 22.7 14.8 12.5 7.0 6.8 11.6 10.7 15.7 10.8 27.6 24.6 16.0 20.6 24.2 19.7 22.8 12.6 18.6 8.6 12.5 22.6 11.5 7.4 11.7 15.3 23.1 14.8 9.7 12.5 10.4 12.2 34.6 17.4 15.8 22.5 29.1 23.0 33.9 24.8 24.8 11.5 14.3 13.9 23.5 18.0 13.5 12.5 19.7 16.2 17.3 10.1 11.1 12.5 40.2 15.5 4.9 16.3 14.7 18.5 23.7 24.5 14.4 14.2 24.6 14.4 12.5 18.2 17.4 17.2 28.2 11.4 22.9 16.0 23.3 15.1 11.4 18.7 5.3 12.1 7.0 5.0 6.3 6.4 11.2 3.5 5.9 5.4 22.7 12.5 14.8 7.4 6.6 6.8 42.5 34.7 25.2 36.6 38.4 38.0 43.5 33.8 35.1 30.3 56.6 39.7 36.6 109.3 151.1 33.1 53.1 22.9 46.8 40.9 40.1 29.5 67.4 87.9 48.7 14.5 60.9 53.0 23.3 40.0 57.3 76.1 98.0 84.2 36.4 48.3 14.3 59.4 39.3 42.9 12.4 33.9 55.8 79.2 41.5 43.4 64.7 48.5 38.6 33.2 49.4 31.1 51.8 76.2 19.5 25.5 164.4 137.4 44.9 37.0 131.9 RAB8A "MEL, RAB8" ENSG00000167461 "RAB8A, member RAS oncogene family" P61006 19 16111629-16134234 "Predicted intracellular proteins" "Autophagy, Cilium biogenesis/degradation, Protein transport, Transport" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041945 Supported "Nucleoplasm,Plasma membrane" No No 16000000 "Nucleoplasm, Plasma membrane" "HPA041945: " "unprognostic (1.10e-1)" "unprognostic (3.95e-3)" "unprognostic (1.98e-2)" "unprognostic (2.59e-1)" "unprognostic (1.63e-1)" "unprognostic (1.66e-1)" "unprognostic (1.19e-1)" "unprognostic (2.11e-1)" "unprognostic (2.57e-1)" "unprognostic (1.14e-2)" "unprognostic (2.52e-3)" "unprognostic (1.29e-2)" "prognostic unfavorable (6.56e-5)" "unprognostic (6.60e-2)" "unprognostic (7.25e-2)" "prognostic favorable (1.71e-4)" "unprognostic (9.99e-2)" 23.4 22.8 15.6 24.5 14.1 32.5 15.9 16.6 13.6 18.2 23.1 18.5 15.0 37.6 17.2 11.8 22.9 18.0 17.1 10.6 13.6 11.2 24.8 57.8 19.3 24.9 14.2 8.4 23.3 24.7 8.8 15.5 30.9 13.6 16.3 20.1 16.5 27.4 14.7 5.2 22.3 56.2 14.1 16.7 43.4 20.1 15.9 14.7 33.4 18.5 12.7 36.1 19.7 17.9 34.3 45.4 55.2 81.1 39.0 31.8 75.5 29.0 19.6 16.2 13.6 13.2 11.7 25.4 17.7 15.3 23.6 24.8 22.4 33.6 20.1 20.2 17.3 20.6 19.3 21.7 21.8 15.0 41.2 12.7 42.1 18.3 23.0 15.1 36.5 42.0 12.1 11.3 22.2 9.7 12.7 19.3 20.7 19.5 30.7 18.7 33.5 30.4 32.0 20.3 34.9 31.6 34.6 17.8 35.6 17.4 22.3 15.0 14.8 17.9 21.2 11.2 10.9 17.2 13.6 19.1 19.8 12.9 38.6 30.1 16.7 34.3 30.3 19.1 36.5 21.4 36.0 50.6 55.2 31.8 69.8 28.4 34.3 28.4 28.6 45.4 31.8 22.5 26.5 53.8 39.0 81.1 32.5 26.6 75.5 15.6 14.1 16.6 13.6 13.6 11.2 14.2 8.4 13.6 14.7 23.8 26.1 58.8 41.8 42.4 14.1 2.8 17.8 45.5 23.9 29.6 13.7 78.7 69.6 59.2 24.1 29.5 105.7 0.0 45.1 81.2 38.0 31.1 46.3 44.5 79.7 6.4 29.1 23.9 36.3 12.6 25.6 79.9 32.1 147.9 48.7 29.6 58.4 77.2 23.3 44.7 12.2 32.3 24.7 24.4 19.0 45.9 66.6 64.7 40.4 32.5 RAB8B ENSG00000166128 "RAB8B, member RAS oncogene family" Q92930 15 63189469-63267782 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 177.9;Late spermatids: 271.9;monocytes: 180.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "WM-115: 44.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074534 Supported Nucleoplasm,Vesicles NA NA 5200000 Vesicles Nucleoplasm "HPA074534: AB_2686700" "unprognostic (7.67e-2)" "unprognostic (3.33e-2)" "unprognostic (2.75e-1)" "unprognostic (1.32e-1)" "unprognostic (5.20e-2)" "unprognostic (4.01e-2)" "unprognostic (1.46e-2)" "unprognostic (5.94e-2)" "unprognostic (3.19e-1)" "unprognostic (2.75e-2)" "unprognostic (1.71e-2)" "unprognostic (4.17e-1)" "prognostic unfavorable (2.44e-4)" "unprognostic (1.97e-2)" "unprognostic (3.14e-2)" "unprognostic (4.19e-2)" "unprognostic (7.47e-2)" 21.8 12.1 15.2 20.9 12.9 50.8 22.6 10.1 12.2 15.8 17.7 11.8 7.6 13.6 14.2 8.6 10.9 12.7 18.4 17.5 19.2 14.4 13.7 11.4 27.7 30.8 15.3 12.9 25.2 5.7 6.6 11.7 22.0 16.9 14.3 9.0 9.8 9.3 11.3 7.5 8.2 21.1 14.3 19.5 33.7 9.8 11.8 11.5 38.8 16.4 4.7 27.8 24.4 23.7 10.7 10.4 30.8 14.5 13.1 19.2 14.3 4.8 4.1 15.7 6.5 30.0 24.8 4.7 4.8 11.0 8.7 17.1 4.4 3.9 13.2 4.4 10.3 10.5 2.4 13.5 6.5 14.7 19.8 2.6 16.6 3.7 2.8 28.0 6.2 10.5 14.9 3.4 16.4 9.6 11.3 22.0 13.8 6.5 12.8 15.9 3.2 10.1 3.4 9.8 4.5 4.0 8.7 21.0 1.9 6.9 22.9 1.3 3.3 7.3 0.9 13.4 10.5 3.5 6.3 24.8 16.3 10.5 8.6 6.4 8.3 8.2 12.5 10.4 17.7 44.1 27.1 14.5 11.9 15.8 13.1 14.4 10.7 12.8 15.0 10.4 10.6 10.0 12.2 30.8 13.1 11.6 1.3 19.2 14.3 15.2 12.9 10.1 12.0 19.2 14.4 15.3 12.9 16.9 11.5 17.9 20.2 18.8 6.9 27.6 1.9 3.1 12.7 8.1 7.9 7.0 11.8 10.5 10.0 19.1 177.9 29.2 2.4 0.0 11.5 84.9 38.5 11.2 38.1 5.5 47.2 19.1 10.3 34.4 65.8 271.9 29.4 57.9 33.7 180.3 4.1 12.8 27.6 0.0 35.7 18.6 12.1 19.4 19.5 43.7 15.9 19.6 31.2 66.1 3.0 20.9 RAB9A RAB9 ENSG00000123595 "RAB9A, member RAS oncogene family" P51151 X 13689125-13710506 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "monocytes: 563.5;Syncytiotrophoblasts: 309.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003094, CAB016411" Supported Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB016411: AB_630176, HPA003094: AB_1079736" "unprognostic (3.40e-2)" "unprognostic (1.36e-2)" "unprognostic (3.56e-3)" "unprognostic (3.08e-2)" "unprognostic (1.62e-1)" "unprognostic (2.56e-2)" "unprognostic (1.79e-2)" "unprognostic (1.45e-1)" "unprognostic (8.77e-2)" "unprognostic (8.23e-2)" "unprognostic (1.27e-2)" "unprognostic (4.88e-2)" "prognostic favorable (3.35e-5)" "unprognostic (3.93e-2)" "unprognostic (3.19e-1)" "unprognostic (1.46e-1)" "unprognostic (2.68e-2)" 17.1 36.0 17.7 20.3 17.1 30.6 48.4 16.2 24.1 14.8 17.6 20.2 19.7 9.3 18.8 14.3 19.7 11.9 14.5 23.1 16.9 14.3 19.6 15.6 17.3 21.0 24.7 13.8 18.9 23.6 19.1 11.3 17.8 18.1 13.5 16.2 8.0 22.8 17.6 12.0 21.2 12.3 15.3 25.5 15.1 14.2 6.4 23.4 9.8 16.8 13.2 19.3 16.1 19.7 13.1 19.1 17.7 25.7 19.8 27.3 13.9 12.5 6.7 8.6 20.4 29.0 23.2 7.7 7.0 24.7 10.8 15.7 7.2 14.0 11.4 17.4 11.0 25.8 12.9 12.8 14.9 10.6 25.1 19.9 3.6 14.8 8.2 17.4 6.3 9.8 24.9 26.4 13.5 14.6 17.4 9.9 6.4 6.9 16.8 11.5 8.6 5.9 10.3 9.3 8.7 12.7 8.2 9.1 33.9 29.5 11.6 7.1 5.0 14.9 21.2 24.2 22.5 11.7 6.7 7.7 8.2 4.3 29.0 4.2 13.4 23.2 4.5 8.2 5.5 8.0 17.7 25.7 11.1 27.3 16.6 21.1 13.1 15.0 22.4 17.6 10.0 11.3 19.4 15.3 19.8 14.5 19.1 11.7 13.9 17.7 17.1 16.2 24.1 16.9 14.3 24.7 13.8 18.1 23.4 44.7 26.4 18.5 59.6 57.6 9.0 13.8 43.3 33.5 26.1 31.4 0.0 70.1 68.0 112.1 0.4 21.5 28.9 0.0 55.4 48.9 36.8 75.0 44.9 17.8 51.1 14.3 23.5 13.5 35.6 1.1 34.8 34.0 54.0 563.5 26.2 40.0 73.2 70.2 37.8 51.9 8.8 12.9 28.8 5.9 19.0 72.9 309.7 49.6 23.6 72.2 RABGGTA PTAR3 ENSG00000100949 "Rab geranylgeranyltransferase alpha subunit" Q92696 14 24265538-24271739 "Enzymes, Predicted intracellular proteins" "Prenyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043488 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA043488: AB_10794887" "unprognostic (2.00e-1)" "unprognostic (8.37e-2)" "unprognostic (2.61e-3)" "unprognostic (1.13e-1)" "unprognostic (8.34e-2)" "unprognostic (1.39e-1)" "unprognostic (2.78e-1)" "unprognostic (5.78e-2)" "unprognostic (3.89e-2)" "unprognostic (7.11e-2)" "unprognostic (3.12e-2)" "unprognostic (1.12e-1)" "prognostic favorable (5.44e-4)" "unprognostic (1.77e-1)" "unprognostic (1.84e-1)" "prognostic favorable (1.51e-4)" "unprognostic (2.01e-1)" 6.9 9.9 8.6 7.1 9.4 8.7 7.5 9.4 16.2 8.2 9.8 8.4 13.6 7.2 6.4 11.6 37.2 12.3 8.1 10.9 6.9 8.0 12.5 15.0 10.6 10.7 7.7 8.5 8.0 16.4 15.7 10.2 14.1 10.6 8.0 8.0 7.2 12.8 9.2 11.1 13.3 12.1 6.9 6.1 11.5 9.4 11.3 7.0 7.3 9.4 20.3 18.2 8.4 11.4 6.5 12.7 6.7 16.8 6.9 6.3 6.3 3.5 6.0 2.3 3.2 3.8 7.0 12.8 5.4 5.2 8.8 7.6 6.1 5.3 5.5 4.0 6.6 3.5 7.1 2.9 12.5 3.5 7.0 7.3 3.2 5.1 21.0 7.2 6.7 12.2 7.4 14.3 4.3 5.8 5.0 7.3 6.1 2.8 4.3 6.8 15.6 3.6 5.0 1.4 5.2 8.8 3.1 2.2 3.8 8.0 6.9 6.3 3.7 4.1 8.4 4.4 3.6 4.2 4.8 5.3 4.1 3.1 1.9 2.9 5.8 4.4 3.5 2.9 4.3 6.4 3.1 10.0 6.7 5.9 16.8 5.1 6.5 5.7 5.1 12.7 4.2 5.0 4.4 2.6 6.9 12.4 4.0 6.3 6.3 8.6 9.4 9.4 16.2 6.9 8.0 7.7 8.5 10.6 7.0 8.9 12.3 17.9 17.1 15.8 6.9 10.1 25.5 12.0 9.1 5.2 5.9 32.5 13.3 22.0 2.6 7.4 21.7 0.0 23.8 25.8 10.7 12.8 35.7 5.9 24.6 11.1 12.6 7.4 15.6 5.6 8.3 17.3 15.1 18.0 13.1 8.2 28.8 21.0 6.7 18.0 4.1 6.5 12.8 3.0 24.9 10.8 47.9 18.7 15.8 17.4 RABL3 MGC23920 ENSG00000144840 "RAB, member of RAS oncogene family like 3" Q5HYI8 3 120686681-120742993 "Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Cone photoreceptor cells: 110.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035150, HPA035151" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA035150: AB_2674493, HPA035151: AB_10601154" "unprognostic (1.69e-2)" "unprognostic (5.10e-2)" "unprognostic (8.32e-2)" "unprognostic (3.96e-2)" "unprognostic (1.88e-1)" "unprognostic (7.22e-2)" "unprognostic (1.37e-1)" "unprognostic (1.27e-1)" "unprognostic (7.19e-2)" "unprognostic (2.94e-1)" "unprognostic (2.11e-3)" "unprognostic (2.78e-1)" "prognostic favorable (2.79e-5)" "unprognostic (2.33e-1)" "unprognostic (6.15e-2)" "unprognostic (8.44e-3)" "unprognostic (3.65e-1)" 21.5 26.7 16.5 9.3 19.5 8.8 14.8 15.7 19.9 12.2 14.1 16.6 13.6 10.6 11.8 12.2 16.6 11.0 9.9 11.9 14.6 16.6 19.7 20.5 10.3 10.3 19.2 16.2 18.7 13.9 23.3 14.7 13.4 20.9 14.4 15.1 12.8 11.2 14.9 19.6 10.3 13.0 11.6 22.5 11.3 11.4 8.2 14.0 11.2 22.9 12.6 11.8 13.8 11.9 7.8 11.4 5.7 11.8 13.1 10.9 5.6 16.6 12.9 11.6 3.7 12.6 17.1 9.7 15.0 11.3 8.7 8.1 8.8 6.9 13.5 7.8 13.2 13.7 6.8 11.7 8.2 16.5 11.3 5.5 13.7 9.2 11.3 8.1 24.0 8.7 8.9 15.8 7.4 8.9 11.6 13.0 8.8 11.1 9.1 11.4 14.4 18.4 6.3 7.1 18.9 7.7 8.6 14.2 7.5 11.4 7.5 5.5 7.4 7.1 6.4 8.3 4.7 11.8 15.7 17.7 6.7 6.0 4.9 15.7 6.7 6.3 11.4 19.0 23.8 8.2 5.6 5.8 4.2 10.9 11.8 9.0 7.8 9.7 10.3 10.7 6.8 9.3 10.8 5.7 13.1 6.6 11.4 10.3 5.6 16.5 19.5 15.7 19.9 14.6 16.6 19.2 16.2 20.9 14.0 8.9 9.4 9.3 14.5 5.7 16.9 11.6 20.4 17.4 14.8 8.7 110.0 11.8 6.6 14.2 16.2 11.9 9.8 0.0 13.9 15.5 8.2 11.6 8.1 14.7 12.8 7.9 5.2 4.3 8.3 6.9 5.5 9.5 10.1 10.8 12.2 15.7 13.4 13.6 5.6 20.3 18.0 0.0 5.9 9.7 7.5 9.7 18.4 6.9 10.2 13.1 RAC1 "p21-Rac1, Rac-1, TC-25" ENSG00000136238 "Rac family small GTPase 1" P63000 7 6374523-6403977 "Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB035994, HPA047820" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA 44000000 "Nucleoplasm, Cytosol" Nucleoli "CAB035994: , HPA047820: AB_2680167" "unprognostic (8.66e-3)" "unprognostic (2.47e-1)" "unprognostic (4.00e-1)" "unprognostic (2.40e-2)" "unprognostic (1.88e-3)" "unprognostic (4.06e-2)" "prognostic unfavorable (1.74e-5)" "prognostic unfavorable (4.59e-4)" "unprognostic (1.59e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (4.57e-5)" "unprognostic (3.63e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.95e-1)" "unprognostic (2.11e-2)" "unprognostic (4.13e-2)" "unprognostic (8.72e-3)" 45.2 35.0 71.0 28.4 64.0 24.4 46.5 42.1 93.0 48.7 58.9 75.5 22.5 51.6 48.7 49.5 93.4 47.2 40.0 48.4 73.8 59.8 47.8 42.9 45.6 38.3 76.7 60.9 45.1 29.2 51.0 25.2 55.8 54.9 40.5 64.0 37.2 43.3 48.9 57.4 58.6 49.8 57.3 88.2 35.0 49.7 28.1 47.1 41.3 40.9 42.8 50.7 52.2 54.0 11.0 32.0 49.1 31.9 7.3 11.8 10.7 75.1 34.1 35.3 38.3 41.9 53.5 21.1 42.4 52.1 56.6 57.7 33.5 71.1 21.2 27.5 59.1 58.6 53.6 37.6 51.4 72.5 9.9 31.2 21.3 27.6 24.1 50.4 19.2 17.4 35.6 46.0 40.7 45.7 43.1 49.8 21.0 38.0 16.8 60.9 54.8 10.5 45.2 63.2 38.3 40.9 18.7 35.9 31.1 72.7 47.7 26.8 45.1 29.9 109.6 34.0 42.1 61.8 57.8 52.2 37.2 56.0 45.5 48.9 12.8 14.0 20.0 34.3 36.7 70.4 7.6 31.9 16.4 7.2 22.2 4.5 11.0 8.1 9.2 32.0 11.0 9.8 6.5 49.1 7.3 22.1 18.2 11.8 10.7 71.0 64.0 42.1 93.0 73.8 59.8 76.7 60.9 54.9 47.1 137.0 112.5 192.8 745.4 829.8 84.3 183.1 481.6 92.3 104.6 338.5 23.6 691.3 454.3 121.1 58.5 522.9 706.2 303.7 149.3 914.8 466.9 1152.5 132.3 288.4 738.1 138.2 323.2 535.2 736.9 43.7 441.0 745.3 435.3 408.4 531.5 280.9 231.2 471.0 444.5 611.5 54.4 472.1 495.6 210.1 328.6 1004.1 707.0 194.1 436.1 1582.5 RACGAP1 MgcRacGAP ENSG00000161800 "Rac GTPase activating protein 1" Q9H0H5 12 49976923-50033136 "Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Ion transport, Spermatogenesis, Transport" "Developmental protein, GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 40.9" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 46.7;Extravillous trophoblasts: 40.9;Spermatocytes: 65.3;Spermatogonia: 40.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025859, HPA039427, HPA043912" Enhanced Enhanced Nucleoplasm Yes Yes Nucleoplasm "CAB025859: , HPA039427: AB_2676503, HPA043912: AB_2678728" "prognostic unfavorable (1.51e-4)" "unprognostic (1.91e-1)" "unprognostic (3.74e-3)" "unprognostic (1.53e-2)" "unprognostic (1.58e-1)" "unprognostic (4.82e-2)" "prognostic unfavorable (1.86e-6)" "unprognostic (1.15e-3)" "unprognostic (3.07e-3)" "unprognostic (5.31e-2)" "prognostic unfavorable (4.12e-6)" "unprognostic (5.56e-2)" "prognostic unfavorable (3.98e-8)" "unprognostic (3.13e-2)" "unprognostic (4.94e-1)" "unprognostic (6.16e-2)" "unprognostic (2.15e-1)" 3.7 2.6 4.9 10.0 11.3 21.0 4.2 6.3 7.8 4.2 10.1 4.7 1.5 6.5 3.3 1.9 17.7 2.7 4.0 2.7 4.8 4.5 5.9 2.8 5.6 13.7 7.8 5.0 2.5 2.0 3.3 1.4 8.4 5.4 2.4 11.9 2.0 4.7 2.1 3.8 8.7 7.5 7.6 5.9 5.9 6.8 29.4 6.6 40.9 2.4 8.7 17.8 6.0 6.5 6.3 2.2 16.5 3.5 8.8 14.8 4.8 44.6 40.8 32.5 20.8 6.0 7.2 27.8 47.4 22.8 49.7 34.0 40.7 34.2 24.8 21.2 25.1 24.3 30.3 32.4 22.0 53.0 47.5 20.4 31.9 40.4 13.3 2.2 33.6 26.4 3.9 4.1 33.7 26.9 14.6 16.8 22.7 23.0 38.1 46.4 31.3 27.7 16.8 23.2 25.3 27.0 26.4 39.8 18.2 13.2 22.3 27.4 23.7 38.7 24.6 13.1 17.3 47.8 15.2 15.3 32.9 29.7 21.0 34.1 20.2 49.9 29.4 16.6 23.0 19.2 16.5 2.6 3.9 5.7 3.5 4.9 6.3 6.9 7.8 2.2 3.9 4.2 5.5 0.5 8.8 1.9 1.5 14.8 4.8 4.9 11.3 6.3 7.8 4.8 4.5 7.8 5.0 5.4 6.6 6.0 5.4 8.5 2.4 11.4 1.6 1.2 2.5 2.7 3.4 5.2 3.9 6.2 16.6 1.5 9.3 1.7 1.5 46.7 1.8 40.9 4.1 2.1 2.3 1.8 11.4 1.6 0.0 6.2 11.7 11.4 1.4 8.0 1.7 3.6 2.6 1.7 1.6 0.0 3.5 1.9 0.7 12.9 2.8 65.3 40.1 11.3 7.2 4.4 4.1 1.1 RACK1 "Gnb2-rs1, GNB2L1, H12.3" ENSG00000204628 "Receptor for activated C kinase 1" P63244 5 181236909-181248096 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Apoptosis, Biological rhythms, Cell cycle, Gastrulation, Growth regulation, Host-virus interaction, Translation regulation" "Developmental protein, Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 2715.9;Exocrine glandular cells: 2901.4;Extravillous trophoblasts: 3765.3;Pancreatic endocrine cells: 2156.8;Syncytiotrophoblasts: 2681.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004288, HPA021676" Uncertain Supported Nucleoplasm,Cytosol NA NA 130000 "Nucleoplasm, Cytosol" "CAB004288: AB_2247471, HPA021676: AB_1849868" "unprognostic (4.02e-2)" "unprognostic (2.94e-1)" "unprognostic (2.58e-1)" "unprognostic (2.03e-2)" "unprognostic (1.07e-2)" "unprognostic (7.43e-2)" "prognostic unfavorable (2.98e-6)" "unprognostic (4.19e-1)" "unprognostic (3.04e-1)" "unprognostic (2.00e-1)" "unprognostic (2.07e-1)" "unprognostic (3.81e-1)" "unprognostic (1.05e-3)" "unprognostic (3.67e-1)" "unprognostic (1.78e-1)" "unprognostic (3.50e-1)" "unprognostic (2.62e-1)" 100.5 72.1 32.2 92.0 32.8 74.9 185.3 45.0 34.3 102.3 85.7 36.2 66.0 43.0 86.0 82.9 128.1 98.3 81.8 102.5 29.8 29.2 80.6 113.7 95.7 223.3 38.2 27.6 189.2 330.4 48.8 68.3 72.3 31.8 102.6 61.2 57.8 119.7 66.9 133.8 115.5 72.1 92.8 37.6 107.8 70.5 52.9 32.4 197.4 115.4 117.0 141.8 99.7 113.5 92.9 69.4 19.2 50.8 47.1 81.4 138.7 67.0 57.2 87.0 108.8 133.7 245.8 87.9 60.5 165.0 142.1 143.6 122.8 59.5 136.9 79.3 105.0 94.1 46.4 99.3 336.3 105.2 136.1 107.1 46.7 63.3 61.2 167.3 107.4 47.4 235.1 181.3 106.8 148.8 152.4 144.4 142.6 61.8 100.6 109.0 104.1 106.1 69.1 60.6 79.0 51.9 82.9 53.9 114.2 150.1 64.3 72.4 85.3 30.9 103.3 152.3 58.0 70.5 93.7 76.1 49.3 45.0 43.4 91.4 75.5 108.6 85.3 47.3 83.9 50.2 19.2 50.8 16.3 45.9 43.6 69.5 91.9 70.3 53.8 69.4 92.9 81.4 65.2 7.8 47.1 37.1 53.3 68.6 138.7 32.2 32.8 45.0 34.3 29.8 29.2 38.2 27.6 31.8 32.4 536.0 821.6 0.0 0.0 0.0 0.0 0.0 0.0 465.7 831.4 472.8 0.0 2715.9 1482.2 1555.6 0.0 0.0 0.0 0.0 2901.4 3765.3 0.0 0.0 618.5 0.0 1726.4 0.0 0.0 0.0 0.0 0.0 0.0 340.2 0.0 2040.6 0.0 0.0 2156.8 0.0 0.0 2023.5 0.0 0.0 0.0 0.0 0.0 0.0 2681.1 0.0 0.0 0.0 RAD1 "HRAD1, REC1" ENSG00000113456 "RAD1 checkpoint DNA exonuclease" O60671 5 34905264-34918989 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006692 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA006692: AB_2667645" "prognostic unfavorable (6.30e-4)" "unprognostic (1.85e-2)" "unprognostic (9.40e-2)" "unprognostic (1.98e-3)" "unprognostic (2.00e-1)" "unprognostic (2.38e-2)" "prognostic unfavorable (1.06e-5)" "unprognostic (1.22e-2)" "unprognostic (2.25e-3)" "unprognostic (1.61e-3)" "unprognostic (2.57e-1)" "unprognostic (2.57e-1)" "unprognostic (2.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.72e-1)" "unprognostic (2.11e-1)" "unprognostic (3.12e-3)" 3.1 6.5 3.4 3.2 4.9 4.8 4.4 5.2 4.7 5.4 3.2 2.9 4.6 3.8 3.7 3.5 3.3 6.6 3.5 4.4 3.7 3.5 5.6 6.1 2.9 4.0 3.3 3.0 3.4 6.0 5.3 3.1 4.3 3.7 7.4 4.5 3.6 3.3 2.6 3.1 3.7 5.8 5.2 4.7 3.8 4.7 9.4 7.6 7.2 3.1 4.8 9.3 2.6 5.8 6.8 7.3 14.0 5.1 6.0 10.4 9.2 9.0 9.7 8.0 6.4 8.0 15.2 3.3 8.2 11.7 5.4 8.0 5.6 10.9 6.8 6.8 8.1 20.7 4.4 8.8 11.1 7.5 5.3 4.8 10.6 7.1 3.6 4.7 6.6 14.4 9.1 8.2 7.3 11.3 7.9 9.5 3.8 10.3 10.4 15.2 5.3 4.7 6.2 7.5 7.9 19.0 13.0 8.5 5.3 8.0 9.3 4.2 12.7 9.7 6.5 9.6 5.0 9.1 13.4 6.6 16.8 8.8 7.2 3.0 6.8 5.9 3.1 7.7 8.7 6.5 8.0 2.9 9.4 9.3 8.0 2.3 4.8 2.9 7.6 5.3 2.6 20.8 39.2 16.0 18.1 26.0 22.1 20.7 15.3 9.4 13.6 19.2 25.5 69.8 16.6 14.1 15.1 14.1 9.5 23.3 19.5 44.4 23.7 18.0 20.8 12.1 20.7 22.3 12.6 9.2 13.2 11.8 23.3 15.3 16.9 10.0 11.0 18.9 14.2 10.5 20.5 13.2 33.2 12.9 19.1 59.4 59.0 25.0 67.4 26.3 11.2 19.7 RAD17 "CCYC, RAD17Sp, Rad24" ENSG00000152942 "RAD17 checkpoint clamp loader component" O75943 5 69369293-69414801 "Predicted intracellular proteins" "Cell cycle, DNA damage" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 97.3;Spermatocytes: 125.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004551, HPA005448" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004551: AB_628195, HPA005448: AB_1079738" "unprognostic (1.25e-1)" "unprognostic (1.46e-1)" "unprognostic (3.28e-3)" "unprognostic (2.21e-1)" "unprognostic (2.30e-1)" "unprognostic (6.04e-2)" "unprognostic (7.75e-3)" "unprognostic (6.09e-2)" "unprognostic (1.66e-2)" "unprognostic (2.42e-2)" "unprognostic (1.59e-2)" "unprognostic (5.74e-2)" "prognostic favorable (5.79e-6)" "unprognostic (1.02e-1)" "unprognostic (1.92e-1)" "unprognostic (3.09e-1)" "unprognostic (2.24e-2)" 11.8 12.6 10.6 15.3 15.3 9.3 16.5 13.9 14.2 11.0 10.9 12.3 13.7 7.0 12.9 12.2 10.0 9.9 7.8 11.5 11.1 12.8 18.6 16.1 13.2 24.6 11.6 10.7 11.7 18.3 15.1 32.0 12.9 14.7 12.2 13.3 10.0 12.8 18.8 15.7 9.6 11.9 10.5 13.4 14.5 11.6 37.7 11.6 17.0 15.1 10.0 17.0 10.5 13.6 10.5 4.4 4.9 3.6 7.6 7.5 3.1 7.6 3.4 10.7 12.6 0.0 0.1 13.1 7.6 9.6 10.4 14.8 8.1 8.4 33.8 8.3 4.4 20.9 3.6 10.6 4.4 16.2 0.0 5.8 8.2 8.3 8.1 12.9 0.2 10.8 7.6 7.4 7.7 7.6 0.0 9.0 8.9 7.9 10.3 13.1 0.0 15.0 5.6 6.6 3.2 4.3 13.1 9.8 7.5 12.5 7.0 11.2 7.9 7.0 2.2 0.3 11.9 10.4 10.1 2.7 0.0 9.5 4.8 4.9 13.3 20.5 11.5 10.7 16.1 6.9 1.4 3.0 4.9 6.0 3.6 5.7 10.5 5.4 6.4 4.4 7.2 7.5 6.3 1.2 7.6 1.7 2.2 7.2 3.1 10.6 15.3 13.9 14.2 11.1 12.8 11.6 10.7 14.7 11.6 29.8 13.2 13.4 4.7 4.8 17.0 29.6 15.3 44.2 27.3 5.2 19.6 15.1 21.6 10.9 97.3 7.1 8.1 0.0 11.2 14.1 10.3 7.8 29.0 9.7 8.9 6.4 14.6 13.5 10.7 61.1 13.3 11.4 5.0 10.8 9.8 18.3 10.4 7.0 10.3 17.0 44.8 6.5 8.0 125.0 69.7 5.1 11.8 11.4 11.1 4.3 RAD18 RNF73 ENSG00000070950 "RAD18, E3 ubiquitin protein ligase" Q9NS91 3 8775402-8963773 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006716, HPA006724, HPA008752" Supported Approved Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA006716: AB_2667650, HPA006724: AB_2667655, HPA008752: AB_2668129" "unprognostic (1.26e-1)" "unprognostic (1.07e-1)" "unprognostic (4.45e-2)" "unprognostic (1.25e-3)" "unprognostic (2.73e-2)" "unprognostic (6.15e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (2.01e-1)" "unprognostic (9.76e-2)" "unprognostic (1.17e-1)" "unprognostic (2.02e-2)" "prognostic unfavorable (3.73e-4)" "prognostic unfavorable (3.65e-5)" "unprognostic (1.97e-2)" "unprognostic (1.51e-1)" "unprognostic (7.92e-2)" "unprognostic (1.89e-2)" 6.2 5.7 7.4 5.6 12.7 7.9 9.5 16.4 11.4 5.5 6.6 3.9 5.4 17.7 6.5 3.7 7.6 4.9 5.6 4.4 4.7 3.3 4.3 5.7 5.9 7.6 8.4 6.9 7.1 4.2 3.4 6.9 6.9 5.7 7.4 9.0 3.5 7.5 3.5 3.7 8.5 10.5 6.0 7.8 8.5 5.1 9.5 9.8 16.6 6.7 4.7 7.5 6.1 6.8 3.7 6.3 8.7 3.0 4.3 5.5 1.5 9.9 9.4 7.9 4.7 2.0 4.2 9.7 15.8 5.4 15.2 10.5 8.6 6.4 12.3 3.0 8.9 8.9 3.5 8.3 8.2 15.6 7.6 10.5 10.4 9.5 5.1 1.2 13.7 9.0 1.6 3.0 15.0 10.2 4.1 4.9 10.5 11.1 12.2 13.3 11.5 13.9 9.8 11.0 7.9 17.4 11.1 8.8 9.7 4.4 7.7 3.3 7.5 7.0 6.8 5.1 6.5 7.0 6.1 4.0 12.7 6.9 10.7 13.5 6.2 9.4 26.7 9.3 15.3 9.3 7.4 2.7 8.7 3.0 3.0 5.5 3.7 4.0 5.2 3.4 3.7 4.3 3.2 1.2 4.3 1.8 6.3 5.0 1.5 7.4 12.7 16.4 11.4 4.7 3.3 8.4 6.9 5.7 9.8 14.9 9.8 8.2 5.8 9.8 5.1 2.0 5.1 4.0 9.1 3.5 2.0 6.6 1.7 6.5 3.3 4.2 3.8 0.0 7.1 10.7 4.3 7.0 12.8 2.9 5.9 3.2 1.7 4.9 3.7 2.1 3.7 4.6 3.3 7.2 5.0 2.8 7.9 5.8 2.5 2.4 2.2 6.5 4.7 15.5 13.6 10.3 5.6 4.6 5.2 2.7 RAD21 "hHR21, KIAA0078, SCC1" ENSG00000164754 "RAD21 cohesin complex component" O60216 8 116845935-116874866 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Chromosome partition, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation" "Activator, Developmental protein, Repressor" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020044, CAB022065" Supported Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB022065: , HPA020044: AB_1856035" "unprognostic (7.85e-2)" "unprognostic (4.92e-1)" "unprognostic (3.05e-1)" "unprognostic (5.43e-3)" "unprognostic (9.56e-2)" "unprognostic (3.50e-1)" "prognostic unfavorable (1.71e-4)" "unprognostic (1.86e-3)" "unprognostic (8.99e-2)" "unprognostic (8.80e-2)" "unprognostic (5.58e-3)" "unprognostic (3.56e-2)" "unprognostic (4.40e-2)" "unprognostic (2.00e-1)" "unprognostic (1.82e-1)" "unprognostic (1.39e-1)" "unprognostic (1.95e-1)" 31.6 40.9 48.2 30.5 52.2 78.5 37.7 58.8 55.3 24.2 36.3 37.5 21.5 24.8 30.5 25.3 32.1 23.1 22.0 37.8 45.6 44.1 30.5 27.9 29.6 49.2 54.3 35.4 33.5 18.2 29.1 30.0 38.9 45.5 26.5 37.3 19.0 25.3 31.0 37.8 24.0 26.0 33.4 49.7 31.2 31.5 37.6 56.2 58.3 41.9 20.9 50.4 37.1 36.0 8.7 5.4 17.9 7.1 8.0 25.4 6.2 41.6 20.5 40.2 22.5 20.2 17.5 18.0 29.0 27.5 32.2 29.8 16.8 39.3 61.6 16.0 20.6 17.2 23.3 34.2 18.7 37.8 81.7 21.9 62.8 25.2 21.3 12.7 20.1 37.0 14.9 15.4 18.8 22.8 21.3 25.1 89.9 25.2 86.3 27.7 25.1 92.1 11.9 23.6 53.8 25.9 33.8 29.2 30.9 19.2 24.5 50.8 26.2 30.4 82.1 19.6 22.0 34.4 24.9 18.4 22.8 33.4 23.8 30.3 45.7 52.5 55.5 19.5 29.0 27.2 17.2 4.5 15.5 11.0 5.3 11.2 8.7 12.9 13.0 5.4 8.3 13.5 13.0 17.9 8.0 7.1 4.5 25.4 6.2 48.2 52.2 58.8 55.3 45.6 44.1 54.3 35.4 45.5 56.2 238.2 123.7 70.9 67.0 84.9 73.4 149.3 48.4 87.0 138.8 52.4 29.5 106.6 36.5 47.5 247.8 88.8 56.4 70.0 38.8 119.7 73.7 80.6 143.9 61.8 58.9 63.5 81.0 64.4 91.5 303.2 107.9 82.3 65.8 97.4 62.9 99.6 49.1 57.5 100.0 50.1 60.7 71.1 54.7 31.6 81.6 87.8 95.1 93.8 69.2 65.3 RAD23A "HHR23A, MGC111083" ENSG00000179262 "RAD23 homolog A, nucleotide excision repair protein" P54725 19 12945855-12953642 "Cancer-related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "skeletal muscle: 225.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026418, HPA053901, HPA057003, HPA065599" Approved Enhanced Nucleoplasm,Cytosol NA NA 3100000 Nucleoplasm Cytosol "HPA026418: AB_2732430, HPA053901: AB_2682300, HPA057003: AB_2683309, HPA065599: AB_2685516" "unprognostic (2.09e-1)" "unprognostic (1.58e-3)" "unprognostic (1.23e-3)" "unprognostic (7.90e-3)" "unprognostic (1.45e-1)" "unprognostic (1.48e-1)" "unprognostic (3.78e-3)" "unprognostic (3.57e-3)" "unprognostic (3.13e-1)" "unprognostic (3.12e-3)" "unprognostic (1.09e-1)" "unprognostic (4.08e-2)" "unprognostic (2.09e-3)" "unprognostic (2.32e-3)" "unprognostic (9.99e-2)" "unprognostic (8.56e-2)" "unprognostic (6.59e-3)" 19.6 15.2 19.1 13.4 17.7 19.9 16.0 15.1 25.3 12.9 18.0 14.6 10.7 13.6 15.3 14.3 19.9 17.7 13.6 34.3 16.6 16.0 13.2 24.5 14.2 14.1 15.4 15.6 17.1 21.1 14.0 12.3 17.3 15.5 15.1 10.7 12.6 18.6 15.8 225.3 19.8 11.9 16.5 15.4 15.7 14.9 19.1 12.5 14.6 17.2 37.7 13.8 20.7 17.0 29.5 30.0 22.7 35.6 26.5 32.1 22.5 31.6 11.7 13.6 14.0 22.6 26.0 22.8 15.5 31.2 36.9 33.6 13.1 22.9 27.0 35.8 23.3 24.9 24.6 18.6 32.2 14.0 38.1 23.6 10.9 15.2 12.6 44.1 23.5 32.0 26.5 48.4 26.6 51.0 22.0 25.3 42.9 27.9 24.9 33.2 31.0 29.2 29.1 18.6 28.7 29.1 15.5 14.1 43.9 28.7 12.7 25.2 19.8 17.2 31.3 34.3 10.4 24.4 40.8 19.8 53.1 14.2 63.0 47.3 36.0 30.2 19.7 43.7 44.5 43.6 10.4 27.9 22.7 29.7 35.6 32.1 29.2 25.3 25.1 23.4 29.5 24.6 27.8 3.9 26.5 34.9 30.0 27.0 22.5 19.1 17.7 15.1 25.3 16.6 16.0 15.4 15.6 15.5 12.5 80.4 45.1 117.4 151.7 107.0 47.8 58.9 99.3 85.6 69.4 52.4 19.6 181.0 140.9 124.8 141.7 106.7 99.7 397.1 165.8 204.0 114.4 158.2 108.6 79.1 154.6 49.3 83.8 66.9 72.2 22.4 109.6 119.4 135.0 233.6 105.8 52.4 156.1 119.3 107.1 115.4 44.7 109.9 155.2 223.5 168.2 128.1 204.7 114.9 143.0 156.7 RAD23B "HHR23B, HR23B, P58" ENSG00000119318 "RAD23 homolog B, nucleotide excision repair protein" P54727 9 107283137-107332194 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 9 "Late spermatids: 940.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029718, HPA029720, CAB033868" Enhanced Supported Nucleoplasm,Cytosol No No 8200000 "Nucleoplasm, Cytosol" "CAB033868: AB_1128418, HPA029718: AB_10600116, HPA029720: AB_10601008" "unprognostic (3.95e-3)" "unprognostic (1.01e-2)" "unprognostic (2.28e-2)" "unprognostic (8.14e-2)" "unprognostic (4.71e-2)" "prognostic unfavorable (2.58e-4)" "unprognostic (2.94e-1)" "prognostic unfavorable (6.71e-4)" "unprognostic (1.34e-1)" "unprognostic (3.72e-1)" "unprognostic (3.31e-2)" "unprognostic (1.20e-1)" "unprognostic (2.94e-3)" "unprognostic (2.69e-2)" "unprognostic (2.43e-1)" "unprognostic (7.49e-3)" "unprognostic (1.04e-1)" 41.0 30.1 21.9 23.5 24.5 37.0 28.9 33.3 28.1 28.9 31.4 18.4 28.2 21.8 27.0 38.0 45.3 22.6 24.1 45.5 22.2 23.0 29.7 82.0 27.7 20.7 20.8 23.3 31.6 45.9 21.0 24.8 66.1 25.6 31.1 25.9 17.3 28.7 25.8 98.2 38.2 29.1 29.4 22.6 29.8 23.0 38.5 18.6 32.8 30.4 34.0 27.1 42.1 32.6 5.2 2.5 7.1 2.7 5.0 4.9 1.2 32.4 29.0 41.0 26.3 28.2 44.8 46.3 50.5 41.6 44.9 30.9 47.9 35.6 45.6 20.5 55.1 40.8 45.7 56.5 44.9 45.5 31.0 18.5 23.7 30.5 36.6 37.6 42.4 20.4 37.5 42.0 43.0 64.9 35.8 31.2 20.3 38.2 34.4 40.5 53.1 41.3 21.6 43.6 58.0 33.8 30.9 53.8 21.6 38.6 30.8 37.5 25.4 34.9 49.4 31.0 64.7 50.4 17.4 28.6 33.6 33.0 41.4 37.7 23.6 43.2 24.7 35.8 25.3 35.2 1.7 2.7 2.3 4.4 2.7 4.9 4.0 2.6 3.7 2.2 5.2 4.4 3.5 7.1 5.0 1.7 2.5 4.6 1.2 21.9 24.5 33.3 27.4 22.2 23.0 20.8 23.3 25.6 18.6 41.7 36.8 34.3 97.8 173.7 41.1 108.8 76.5 32.1 30.7 33.2 25.5 238.3 43.1 77.6 384.7 63.9 55.5 23.3 67.0 220.2 83.7 122.4 35.7 191.4 88.0 47.7 96.9 48.5 67.6 940.0 69.9 68.6 70.9 80.2 75.4 36.1 76.0 42.1 82.0 75.7 41.1 77.6 91.4 34.9 59.0 210.7 244.1 43.6 64.4 130.5 RAD50 "hRad50, RAD50-2" ENSG00000113522 "RAD50 double strand break repair protein" Q92878 5 132556019-132646344 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, Host-virus interaction, Meiosis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB022103, CAB024979, HPA052291" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB022103: , CAB024979: , HPA052291: AB_2681786" "unprognostic (3.46e-3)" "prognostic unfavorable (3.77e-4)" "unprognostic (7.50e-3)" "unprognostic (4.22e-3)" "unprognostic (6.71e-2)" "unprognostic (5.98e-2)" "unprognostic (2.76e-2)" "unprognostic (1.06e-1)" "unprognostic (6.84e-2)" "unprognostic (2.55e-1)" "unprognostic (5.40e-3)" "unprognostic (1.62e-1)" "prognostic favorable (1.95e-4)" "unprognostic (1.86e-1)" "unprognostic (1.36e-1)" "unprognostic (2.49e-2)" "unprognostic (2.40e-1)" 11.3 8.4 10.2 8.7 11.2 10.4 11.7 8.2 11.9 8.4 11.2 4.1 8.6 6.7 13.0 20.6 15.0 8.2 7.6 11.9 8.3 5.0 11.0 12.4 11.2 6.0 9.1 9.7 11.8 10.8 14.9 16.2 11.2 10.7 9.7 8.4 3.6 11.4 11.4 13.5 19.8 11.7 8.0 7.6 10.1 8.8 12.8 9.9 11.4 13.9 7.2 6.5 9.6 12.8 6.9 3.6 6.7 4.9 9.8 8.0 3.1 5.3 14.9 1.4 8.5 10.1 9.9 4.5 3.6 6.6 3.9 6.7 14.1 10.1 13.9 2.2 6.2 9.7 7.7 6.8 8.4 5.9 4.7 9.1 5.3 9.3 8.8 8.5 6.9 5.5 7.9 16.7 7.4 17.3 4.2 2.9 4.8 8.4 2.5 6.2 5.3 5.1 9.6 6.8 7.0 6.3 3.5 1.9 5.1 6.4 9.8 7.4 10.0 8.0 3.3 1.2 4.0 7.3 4.7 3.6 2.6 3.9 8.2 5.3 4.1 4.8 15.8 6.4 8.8 3.9 6.7 4.6 0.5 5.9 4.3 8.0 6.9 7.5 5.8 3.6 6.1 6.5 6.6 0.2 9.8 4.9 3.2 3.5 3.1 10.2 11.2 8.2 11.8 8.3 5.0 9.1 9.7 10.7 9.9 35.7 21.9 41.2 33.0 23.1 53.5 114.6 48.4 50.9 33.0 7.0 84.4 59.3 1.7 4.9 12.4 22.2 32.6 23.3 5.3 46.8 38.4 21.5 30.0 33.4 33.1 35.0 35.6 22.7 24.7 8.5 56.1 12.7 15.1 1.0 39.7 45.9 3.7 28.1 50.2 3.4 62.5 32.3 27.4 96.8 76.8 23.3 27.7 21.9 45.4 23.3 RAD51AP1 PIR51 ENSG00000111247 "RAD51 associated protein 1" Q96B01 12 4538798-4560048 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 29.8" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 33.7;Erythroid cells: 46.7;Extravillous trophoblasts: 30.1;Hofbauer cells: 34.3;Late spermatids: 50.0;Spermatocytes: 35.8;Spermatogonia: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 9.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051499 Approved Nucleoplasm Yes Yes Nucleoplasm "HPA051499: AB_2681508" "unprognostic (1.03e-1)" "unprognostic (5.44e-3)" "unprognostic (1.84e-1)" "prognostic unfavorable (9.42e-4)" "unprognostic (6.30e-2)" "unprognostic (5.25e-3)" "prognostic unfavorable (3.53e-4)" "unprognostic (2.15e-2)" "unprognostic (2.26e-2)" "unprognostic (6.29e-3)" "prognostic unfavorable (1.22e-5)" "unprognostic (1.00e-1)" "prognostic unfavorable (4.44e-15)" "unprognostic (2.68e-2)" "unprognostic (2.22e-1)" "unprognostic (6.88e-2)" "unprognostic (3.75e-2)" 3.0 2.0 1.7 9.2 3.6 15.4 2.7 4.5 2.6 1.8 5.4 1.4 3.8 5.4 1.5 3.2 7.6 1.1 2.2 1.9 1.5 1.2 1.7 1.7 2.6 8.8 2.1 1.7 1.5 1.2 0.5 1.2 4.2 1.8 1.7 7.1 1.5 2.8 1.0 1.2 3.2 6.2 1.9 2.9 5.8 2.9 9.2 2.5 29.8 1.4 4.7 8.2 2.1 3.1 4.5 9.7 0.9 3.1 1.9 1.5 0.9 13.0 4.6 16.5 8.2 1.0 2.1 19.3 17.2 7.6 19.2 25.4 12.5 12.7 17.1 2.5 3.7 9.0 8.3 11.4 5.1 29.5 13.4 9.7 21.5 8.0 8.6 0.2 19.5 10.9 0.4 0.5 11.5 11.2 2.7 7.7 11.8 13.4 19.7 12.1 4.7 15.9 7.1 40.1 12.7 5.2 16.0 19.8 6.7 5.8 6.5 5.5 6.1 12.8 10.0 4.1 17.4 4.0 11.4 3.4 13.1 13.4 14.1 18.3 3.0 3.4 32.7 4.9 14.1 10.5 0.0 0.8 0.9 0.2 3.1 0.8 4.2 0.6 1.5 0.6 4.5 0.2 0.4 0.0 1.9 2.7 9.7 1.4 0.9 1.7 3.6 4.5 2.6 1.5 1.2 2.1 1.7 1.8 2.5 0.0 0.3 7.5 1.7 4.6 3.0 1.2 2.5 0.0 5.7 0.0 3.9 6.8 0.0 2.0 33.7 0.7 1.3 46.7 2.3 30.1 2.9 1.1 1.1 1.0 34.3 0.0 2.4 1.8 4.7 50.0 1.1 6.6 0.0 10.8 2.8 2.6 1.1 0.0 1.4 1.2 4.9 0.0 1.9 35.8 29.9 2.3 3.9 3.8 7.7 0.9 RAD51B "hREC2, R51H2, RAD51L1, REC2" ENSG00000182185 "RAD51 paralog B" O15315 14 67819779-68730218 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016191, HPA051869" Enhanced Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "CAB016191: AB_2238209, HPA051869: AB_2681644" "unprognostic (9.10e-3)" "unprognostic (5.45e-2)" "unprognostic (4.92e-1)" "unprognostic (6.65e-2)" "unprognostic (2.38e-2)" "unprognostic (4.85e-2)" "unprognostic (6.42e-3)" "unprognostic (2.54e-2)" "unprognostic (1.06e-1)" "unprognostic (3.08e-1)" "unprognostic (6.80e-3)" "unprognostic (1.47e-1)" "unprognostic (6.25e-2)" "unprognostic (1.77e-1)" "unprognostic (2.49e-2)" "unprognostic (6.79e-2)" "unprognostic (8.13e-3)" 5.1 4.9 4.2 4.6 10.1 9.2 8.2 2.0 5.6 8.2 4.3 11.6 11.2 1.7 10.8 13.8 7.0 6.0 6.4 3.4 5.6 3.2 4.3 3.2 5.0 6.6 9.2 4.0 10.0 5.7 8.0 10.0 8.0 7.5 7.0 4.0 9.4 18.7 3.8 2.4 7.1 5.8 6.7 7.3 6.9 3.7 3.4 7.3 12.6 4.9 4.6 12.1 7.7 8.3 13.6 6.6 14.0 5.9 7.8 10.1 4.8 12.2 4.9 5.4 3.3 5.1 8.7 3.4 6.2 4.8 6.9 8.9 3.4 16.7 15.2 4.1 3.8 8.0 11.1 3.4 10.0 9.5 6.7 3.5 7.2 4.4 2.7 2.7 6.1 7.3 4.4 7.7 7.9 8.4 3.2 6.2 11.3 5.8 7.1 5.6 9.6 11.8 2.1 3.2 11.9 4.9 13.4 6.5 5.5 5.4 3.5 3.7 2.4 5.0 1.8 10.8 6.7 8.4 5.5 1.6 8.5 8.2 6.6 5.1 3.4 3.5 12.0 4.7 10.7 4.8 14.0 5.9 5.4 8.6 4.7 7.1 13.6 8.2 9.2 6.5 11.5 10.1 9.7 0.7 7.8 4.5 6.6 9.1 4.8 4.2 10.1 2.0 5.6 5.6 3.2 9.2 4.0 7.5 7.3 0.0 0.6 3.9 4.8 6.0 1.3 1.5 0.0 1.4 2.3 1.8 7.9 4.8 3.3 1.8 1.5 3.6 1.4 0.0 1.2 5.5 2.5 3.4 4.6 0.6 5.7 1.6 4.6 0.6 4.3 1.3 3.4 3.6 8.5 10.0 2.7 5.1 1.1 0.0 4.2 1.6 5.9 0.0 2.0 3.8 3.2 6.0 3.3 2.5 1.3 3.1 RAD51C "FANCO, RAD51L2" ENSG00000108384 "RAD51 paralog C" O43502 17 58692573-58735611 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Spermatocytes: 113.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 79.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045198 Supported "Nucleoplasm,Vesicles,Cell Junctions,Mitochondria,Cytosol" NA NA "Nucleoplasm, Mitochondria, Cytosol" "Vesicles, Cell Junctions" "HPA045198: AB_2679250" "unprognostic (5.39e-3)" "unprognostic (2.39e-2)" "unprognostic (1.23e-2)" "unprognostic (6.20e-2)" "unprognostic (1.83e-1)" "unprognostic (4.59e-2)" "prognostic unfavorable (8.68e-5)" "unprognostic (3.65e-2)" "unprognostic (2.91e-2)" "unprognostic (1.03e-2)" "prognostic favorable (5.33e-4)" "unprognostic (2.55e-1)" "unprognostic (2.62e-2)" "unprognostic (7.62e-2)" "unprognostic (2.41e-1)" "unprognostic (9.52e-2)" "unprognostic (2.42e-2)" 11.1 22.7 22.1 10.1 20.8 19.4 15.4 20.8 31.0 12.3 13.7 16.0 11.1 7.3 14.3 23.1 13.2 11.8 10.9 24.9 20.2 17.4 13.7 13.9 8.9 19.6 17.2 21.4 13.4 11.2 20.0 18.3 15.1 28.9 18.3 15.0 13.2 10.6 12.7 15.5 10.3 9.6 14.4 14.0 14.4 13.2 18.9 12.7 23.8 12.6 11.7 18.6 12.6 11.8 14.4 13.0 18.8 11.3 11.2 21.7 9.2 15.7 18.3 11.3 12.4 6.2 5.3 25.8 8.6 4.0 11.6 14.8 7.8 10.2 9.3 12.8 5.9 15.3 6.0 15.1 12.2 21.6 22.6 31.3 13.1 20.6 29.4 6.1 16.8 11.7 3.2 11.0 12.9 10.5 6.2 12.9 15.6 20.3 12.8 9.9 79.0 23.8 23.4 3.0 10.5 17.0 15.3 17.9 17.5 7.0 9.9 14.0 13.0 6.9 3.4 13.0 3.0 10.2 17.8 4.1 9.8 26.0 8.8 10.5 12.0 44.5 27.2 9.9 16.6 11.2 18.8 7.5 9.8 13.7 11.3 13.3 14.1 15.0 14.9 13.0 14.4 16.4 15.4 4.6 11.2 9.8 11.7 21.7 9.2 22.1 20.8 20.8 31.0 20.2 17.4 17.2 21.4 28.9 12.7 17.9 11.5 15.2 17.6 10.5 14.6 54.1 10.2 10.7 13.6 15.7 5.9 46.3 49.7 22.6 78.9 14.9 4.2 70.0 16.3 78.6 13.4 14.4 23.0 12.5 29.2 15.9 6.4 14.1 13.4 51.1 16.1 22.9 23.6 22.6 13.1 21.7 12.0 10.5 14.5 19.5 23.0 32.3 22.1 113.9 80.6 9.4 30.3 21.3 12.5 8.4 RAD54L "hHR54, hRAD54, RAD54A" ENSG00000085999 "RAD54 like" Q92698 1 46247688-46278473 "Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 41.9;testis: 56.6" "Cell type enhanced" "Detected in some" 11 "Extravillous trophoblasts: 7.8;granulocytes: 4.6;Spermatocytes: 8.0;Spermatogonia: 4.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 4.1" "Lineage enriched" "Detected in single" 4 "T-cells: 4.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA028954, HPA051537" Approved Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA028954: AB_2672840, HPA051537: AB_2681525" "unprognostic (2.12e-2)" "prognostic favorable (6.67e-4)" "unprognostic (5.12e-2)" "unprognostic (5.36e-3)" "unprognostic (3.24e-1)" "unprognostic (1.08e-2)" "unprognostic (9.75e-6)" "unprognostic (3.91e-2)" "unprognostic (2.17e-3)" "unprognostic (2.95e-2)" "unprognostic (1.77e-4)" "unprognostic (5.58e-2)" "unprognostic (1.11e-16)" "unprognostic (6.76e-3)" "unprognostic (1.66e-1)" "unprognostic (2.67e-1)" "unprognostic (1.74e-1)" 1.9 0.6 1.5 12.9 4.7 9.4 1.3 3.0 1.9 1.1 4.8 0.7 0.5 2.8 1.2 2.1 5.2 0.3 1.2 1.5 1.8 1.5 1.4 0.5 1.5 6.0 1.9 0.7 0.8 1.4 0.6 0.5 4.2 0.9 1.1 5.8 0.6 1.4 1.0 1.4 3.0 3.6 1.8 3.2 4.1 1.7 56.6 0.6 41.9 1.7 3.8 9.6 1.0 1.7 0.5 0.3 0.0 0.1 0.9 4.1 0.7 9.0 6.8 20.5 12.5 1.5 1.0 19.1 10.7 4.7 18.1 18.6 14.5 6.0 17.8 8.2 4.5 16.5 9.4 18.9 6.0 16.0 9.7 19.1 21.8 18.2 14.4 0.0 21.8 12.8 0.6 0.5 18.0 5.3 3.0 5.6 20.7 15.6 18.2 9.9 8.6 27.1 24.2 18.3 8.0 11.2 21.7 11.4 7.8 4.4 7.8 9.8 7.0 7.8 10.8 2.6 17.4 3.8 15.9 2.4 19.5 11.6 10.0 18.0 7.7 4.4 19.2 5.2 14.5 7.8 0.0 0.1 0.0 1.2 0.1 0.2 0.5 0.2 0.3 0.3 0.2 0.0 0.1 0.0 0.9 0.1 0.0 4.1 0.7 1.5 4.7 3.0 1.9 1.8 1.5 1.9 0.7 0.9 0.6 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 1.8 0.1 0.2 0.0 0.0 7.8 0.4 0.3 4.6 0.0 2.2 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 8.0 4.2 0.3 1.4 0.0 1.2 0.4 RAD54L2 "ARIP4, KIAA0809, SRISNF2L" ENSG00000164080 "RAD54 like 2" Q9Y4B4 3 51541144-51668667 "Enzymes, Predicted intracellular proteins" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035004, HPA039992, HPA077351" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA035004: AB_10671930, HPA039992: AB_2676789, HPA077351: " "unprognostic (1.46e-2)" "unprognostic (3.67e-2)" "unprognostic (2.61e-1)" "unprognostic (5.01e-2)" "unprognostic (1.15e-1)" "unprognostic (4.38e-2)" "unprognostic (1.63e-1)" "unprognostic (1.45e-2)" "unprognostic (9.24e-2)" "unprognostic (2.76e-1)" "unprognostic (1.59e-1)" "unprognostic (1.51e-1)" "prognostic favorable (1.71e-5)" "unprognostic (3.72e-2)" "unprognostic (3.19e-1)" "unprognostic (3.30e-2)" "unprognostic (6.63e-2)" 4.4 4.1 3.3 3.5 4.3 5.2 4.1 7.8 4.3 3.6 4.4 2.2 5.3 4.6 3.6 3.9 2.5 3.1 3.4 3.5 3.4 8.8 4.2 3.8 3.4 5.6 5.0 5.3 3.9 4.9 3.8 3.5 3.7 4.2 7.3 4.6 4.1 4.3 4.1 4.7 4.4 4.7 4.2 5.2 3.8 3.5 6.9 5.2 6.5 7.1 6.3 8.3 4.0 5.6 4.4 11.4 11.2 6.4 4.6 6.0 4.8 6.8 6.6 6.3 7.8 3.3 14.8 1.4 8.4 6.9 4.4 17.9 6.0 8.2 7.8 4.0 12.7 9.5 5.1 5.8 14.1 7.6 5.2 4.8 10.1 9.8 4.2 7.3 12.9 8.3 8.1 5.2 4.3 12.6 6.4 9.0 2.8 4.8 5.8 8.8 2.0 3.3 7.3 4.7 8.9 7.6 7.3 4.9 7.2 4.7 8.5 9.5 7.0 8.0 7.1 9.3 8.7 8.8 15.0 7.5 8.0 8.8 6.5 4.8 4.7 8.1 6.0 8.3 4.3 7.1 6.6 5.2 6.9 4.7 5.4 2.2 6.3 7.1 5.2 6.3 4.0 8.9 11.8 9.0 6.6 8.1 33.3 9.7 10.2 10.7 7.9 8.7 29.5 13.5 1.7 8.3 6.1 11.1 4.2 0.0 9.0 7.3 8.0 8.9 17.4 20.7 7.7 44.5 15.6 11.1 11.4 1.9 14.1 6.8 13.5 4.6 6.8 10.4 10.2 6.2 15.9 3.4 31.5 12.9 9.2 37.2 39.4 7.9 24.8 9.6 7.0 9.8 RAD9A RAD9 ENSG00000172613 "RAD9 checkpoint clamp component A" Q99638 11 67317871-67398410 "Enzymes, Predicted intracellular proteins" "DNA damage" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006725, HPA048155" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA006725: AB_1856041, HPA048155: AB_2680290" "unprognostic (7.64e-2)" "prognostic favorable (6.95e-4)" "unprognostic (8.83e-3)" "unprognostic (1.13e-1)" "unprognostic (2.68e-1)" "unprognostic (2.12e-3)" "unprognostic (9.64e-3)" "unprognostic (1.05e-2)" "unprognostic (1.23e-1)" "unprognostic (1.97e-1)" "unprognostic (9.19e-2)" "unprognostic (2.50e-2)" "prognostic unfavorable (2.82e-5)" "unprognostic (6.16e-2)" "unprognostic (3.72e-3)" "unprognostic (2.19e-1)" "prognostic favorable (7.52e-6)" 5.4 5.2 7.0 10.6 8.4 10.8 6.1 7.7 6.3 6.7 11.8 8.5 5.1 14.2 7.1 4.1 8.2 12.1 6.3 6.1 3.8 3.5 6.9 9.4 9.5 9.0 7.8 2.5 6.8 20.1 3.7 7.2 10.2 5.5 8.6 3.3 4.9 12.8 8.1 7.8 12.8 17.5 5.5 4.1 10.7 11.3 7.2 6.0 18.2 11.7 7.2 16.8 6.2 7.1 6.7 5.1 8.9 3.9 4.7 9.0 3.2 6.7 11.0 5.8 8.3 1.7 0.8 7.8 4.3 2.9 5.0 4.3 13.1 12.9 8.1 8.1 0.9 7.9 11.4 3.4 3.3 0.7 7.7 9.5 10.9 5.9 6.5 2.4 7.1 14.4 2.1 3.3 4.3 1.8 3.1 3.3 15.3 8.8 9.0 1.0 20.9 13.8 13.8 8.8 9.4 8.3 11.5 7.9 9.2 1.3 5.4 6.7 7.2 6.0 16.4 13.6 1.3 11.6 6.8 2.5 7.2 9.4 14.6 5.1 9.6 8.9 7.0 4.8 7.0 5.9 8.0 3.2 8.9 9.0 3.6 6.4 6.7 7.2 7.3 2.1 5.3 4.9 5.7 4.7 4.7 3.9 5.1 3.9 3.2 7.0 8.4 7.7 6.3 3.8 3.5 7.8 2.5 5.5 6.0 20.8 17.9 32.3 16.6 15.1 18.1 0.8 12.7 29.4 23.9 19.2 66.8 21.0 11.6 10.1 18.0 13.7 57.3 0.0 11.5 18.5 14.7 20.0 19.7 5.9 13.4 20.6 13.7 8.6 7.1 9.4 9.8 22.6 18.6 4.6 18.9 14.0 9.0 24.6 11.7 6.9 31.2 12.9 9.7 27.6 15.0 15.2 34.0 41.5 24.0 11.9 RADIL "FLJ10324, KIAA1849, RASIP2" ENSG00000157927 "Rap associating with DIL domain" Q96JH8 7 4797055-4883719 "Predicted intracellular proteins" "Cell adhesion" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.9;testis: 18.5" "Cell type enhanced" "Detected in many" 10 "Horizontal cells: 12.7;Spermatocytes: 18.2;Spermatogonia: 9.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 7.7;HEK 293: 6.0;NTERA-2: 6.8;SCLC-21H: 9.5;SH-SY5Y: 20.6;U-2197: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051776 Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA051776: AB_2681605" "unprognostic (6.77e-2)" "unprognostic (1.07e-1)" "unprognostic (5.61e-2)" "unprognostic (1.80e-2)" "unprognostic (1.80e-2)" "unprognostic (1.21e-1)" "unprognostic (9.74e-4)" "unprognostic (4.63e-2)" "unprognostic (3.48e-1)" "unprognostic (2.83e-2)" "unprognostic (7.89e-4)" "unprognostic (5.32e-2)" "unprognostic (1.49e-4)" "unprognostic (5.10e-3)" "unprognostic (2.46e-1)" "unprognostic (3.33e-3)" "unprognostic (4.28e-3)" 7.5 2.4 4.3 0.8 4.6 0.5 3.7 29.9 9.9 5.9 3.3 3.3 0.7 0.8 6.1 1.4 1.7 6.4 2.1 7.8 4.1 4.0 1.1 0.7 7.5 0.6 3.4 4.4 1.6 2.5 1.5 3.3 7.2 7.5 2.1 1.1 2.7 1.1 4.3 4.5 1.2 1.8 3.1 4.3 1.0 1.4 18.5 4.0 0.0 2.8 0.6 0.7 2.2 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 3.8 7.7 0.2 1.9 0.0 0.9 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.8 1.1 0.0 3.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 1.7 4.1 0.0 0.4 2.1 0.0 0.0 6.8 0.0 1.3 5.0 0.2 0.0 0.0 0.0 9.5 20.6 0.1 0.0 0.0 1.6 3.0 0.6 0.0 0.0 0.0 5.5 1.5 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 4.6 29.9 9.9 4.1 4.0 3.4 4.4 7.5 4.0 3.0 1.0 0.0 0.0 0.7 0.5 1.7 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.0 5.6 1.3 0.0 0.0 1.6 0.0 2.4 0.4 0.0 0.0 0.1 12.7 0.0 0.0 0.0 4.1 3.1 0.0 6.8 0.0 0.1 3.3 0.3 0.0 3.5 0.0 0.5 6.5 3.6 18.2 9.7 0.5 0.1 0.0 0.0 0.0 RAE1 Mnrp41 ENSG00000101146 "Ribonucleic acid export 1" P78406 20 57351010-57379211 "Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 64.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048795 Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA048795: AB_2680523" "unprognostic (1.20e-1)" "unprognostic (5.98e-2)" "unprognostic (4.55e-2)" "prognostic unfavorable (2.44e-4)" "unprognostic (3.23e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (2.12e-7)" "unprognostic (1.88e-1)" "unprognostic (8.26e-2)" "unprognostic (1.22e-1)" "unprognostic (5.50e-3)" "unprognostic (3.88e-2)" "unprognostic (7.48e-2)" "unprognostic (3.55e-1)" "unprognostic (9.49e-2)" "unprognostic (2.89e-1)" "unprognostic (2.01e-1)" 9.2 10.0 9.4 11.1 15.2 28.6 12.0 18.1 18.3 9.5 9.7 11.5 9.3 8.0 13.0 13.9 14.0 12.2 7.9 8.1 9.8 11.0 9.2 10.7 7.1 12.5 8.1 12.6 12.1 9.1 12.3 13.7 13.5 10.4 9.2 11.4 9.4 8.9 11.0 9.6 14.8 8.8 11.3 7.3 12.1 8.6 64.8 8.3 19.4 11.7 11.5 17.3 10.0 11.5 17.0 16.6 39.1 21.5 11.8 20.2 17.8 12.8 15.9 15.8 9.0 9.6 8.8 14.4 10.4 14.7 51.4 19.9 50.4 10.3 20.6 14.6 15.0 19.6 17.1 29.7 25.6 42.4 6.2 13.4 14.1 14.2 22.3 18.0 16.9 12.7 12.9 23.1 22.1 24.8 8.6 15.5 14.1 24.7 10.0 16.1 34.7 25.2 14.8 10.0 24.5 28.0 14.1 15.4 13.7 12.0 13.5 17.3 14.3 17.7 40.4 18.2 12.9 22.0 14.8 9.0 21.9 19.7 12.9 17.3 10.9 23.3 23.5 15.3 10.5 10.9 9.1 21.5 39.1 15.6 18.1 18.9 17.0 15.2 15.5 16.6 16.3 20.2 18.4 19.4 11.8 17.9 12.6 12.9 17.8 9.4 15.2 18.1 18.3 9.8 11.0 8.1 12.6 10.4 8.3 17.9 14.7 22.4 14.7 15.2 14.6 8.5 12.7 21.4 12.5 17.4 13.7 44.8 23.2 28.2 84.3 14.2 7.9 23.3 12.5 32.5 15.6 10.5 36.9 11.3 33.3 3.2 6.3 10.4 63.2 48.9 20.1 28.8 10.1 27.1 13.0 17.6 17.6 20.4 21.2 16.6 15.0 19.4 15.0 94.3 78.1 18.3 58.9 21.5 18.0 14.9 RAG1 "MGC43321, RNF74" ENSG00000166349 "Recombination activating 1" P15918 11 36510709-36593156 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA recombination, Ubl conjugation pathway" "Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Multifunctional enzyme, Nuclease, Transferase" "Disease mutation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 62 "lymphoid tissue: 462.4" "Cell type enhanced" "Detected in some" 12 "Distal tubular cells: 3.3;Ito cells: 9.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "MOLT-4: 67.2;REH: 64.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA043939 Supported Nucleoplasm NA NA Nucleoplasm "HPA043939: AB_2732512" "unprognostic (7.35e-2)" "unprognostic (1.57e-3)" "unprognostic (8.75e-2)" "unprognostic (3.44e-1)" "unprognostic (2.14e-1)" "unprognostic (1.46e-2)" "unprognostic (2.30e-1)" "unprognostic (1.70e-2)" "unprognostic (1.43e-1)" "unprognostic (1.54e-2)" "unprognostic (5.98e-3)" "unprognostic (1.28e-1)" "unprognostic (1.16e-9)" "unprognostic (2.16e-2)" "unprognostic (1.04e-1)" "unprognostic (2.53e-4)" "unprognostic (1.53e-1)" 0.7 2.3 0.5 0.5 0.5 7.4 0.7 0.5 0.5 0.5 0.6 0.5 0.5 1.2 0.5 1.3 0.5 0.6 0.5 0.6 0.5 0.2 2.4 1.2 0.8 0.5 0.5 0.5 0.6 1.1 1.9 0.5 0.8 0.5 0.5 0.4 0.5 1.5 0.5 0.5 0.2 1.5 0.5 0.5 4.4 0.8 0.9 0.5 462.4 4.5 0.5 0.8 0.7 0.5 0.2 0.3 0.0 0.0 0.2 1.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 13.4 0.0 0.0 0.1 0.0 67.2 0.0 0.5 0.0 0.0 64.2 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.8 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.5 0.5 0.5 0.5 0.5 0.2 0.5 0.5 0.5 0.5 0.0 0.0 0.0 1.0 0.1 1.2 0.8 0.0 0.0 0.0 1.8 0.0 0.2 3.3 0.4 1.7 1.5 1.4 0.0 0.4 0.1 0.2 0.3 0.0 1.7 0.3 0.0 0.0 9.2 1.6 1.3 0.0 0.0 0.0 1.8 0.6 0.1 0.7 0.0 0.0 2.1 0.8 0.0 0.4 1.2 0.7 0.4 0.3 0.0 0.4 0.5 RAG2 ENSG00000175097 "Recombination activating 2" P55895 11 36575574-36598279 "Disease related genes, Predicted intracellular proteins" "DNA recombination" "Chromatin regulator" "Disease mutation, SCID" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 165.8" "Cell type enriched" "Detected in single" 6 "Early spermatids: 1.4" "Cancer enriched" "Detected in single" 21 "thyroid cancer: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 14.0;MOLT-4: 15.6;REH: 62.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA065704 Approved Nucleoplasm NA NA Nucleoplasm "HPA065704: AB_2732737" "unprognostic (4.30e-2)" "unprognostic (9.09e-2)" "unprognostic (1.21e-1)" "unprognostic (1.77e-1)" "unprognostic (4.58e-2)" "unprognostic (2.17e-1)" "unprognostic (8.11e-2)" "unprognostic (1.68e-3)" 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.1 0.1 0.2 0.0 0.0 0.3 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 165.8 24.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 62.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 RAI1 "DKFZP434A139, KIAA1820, MGC12824, SMCR, SMS" ENSG00000108557 "Retinoic acid induced 1" Q7Z5J4 17 17681473-17811453 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023898, HPA054906" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA023898: AB_10971089, HPA054906: AB_2682637" "unprognostic (7.57e-2)" "unprognostic (3.83e-2)" "unprognostic (1.37e-1)" "unprognostic (1.37e-1)" "unprognostic (1.94e-2)" "unprognostic (3.85e-2)" "unprognostic (3.02e-3)" "unprognostic (1.30e-1)" "unprognostic (4.65e-2)" "prognostic unfavorable (8.47e-4)" "unprognostic (2.61e-2)" "unprognostic (5.29e-2)" "unprognostic (4.20e-2)" "unprognostic (6.97e-2)" "unprognostic (1.35e-1)" "unprognostic (1.50e-2)" "unprognostic (8.28e-2)" 8.0 13.8 13.8 12.6 17.6 8.1 10.1 21.5 22.9 18.1 12.2 14.2 13.3 11.3 17.8 11.8 12.1 20.3 16.8 13.6 11.3 11.9 10.3 5.8 11.2 9.7 11.1 11.3 17.3 17.2 22.4 19.6 8.4 11.3 17.7 5.4 23.3 24.0 18.2 8.2 19.1 9.5 16.7 6.6 18.5 16.6 8.8 15.7 10.4 15.6 7.7 11.2 19.6 30.0 1.0 3.0 0.7 1.2 2.8 1.0 0.7 15.7 21.4 13.6 11.2 1.8 3.8 2.3 5.4 5.9 4.6 4.5 11.1 6.7 5.1 7.5 7.0 3.9 18.6 4.7 10.8 1.9 5.0 10.6 9.3 12.9 5.6 6.1 3.7 5.9 4.3 5.3 4.1 6.2 5.4 5.6 6.5 3.9 4.1 2.3 14.1 7.8 3.6 0.9 8.2 6.3 18.4 10.6 7.2 3.8 18.9 9.5 16.9 8.6 7.6 17.6 16.4 10.2 4.7 10.7 7.3 9.4 11.6 7.6 3.7 0.8 3.2 7.1 4.6 19.8 0.0 1.0 0.7 0.8 0.8 0.5 0.1 0.4 0.6 0.5 1.0 0.3 1.0 0.1 2.8 1.2 3.0 0.0 0.7 13.8 17.6 21.5 22.9 11.3 11.9 11.1 11.3 11.3 15.7 11.9 28.1 1.9 9.0 10.8 24.9 3.6 10.2 1.4 11.4 14.0 21.6 0.1 0.0 13.7 2.5 7.8 2.4 0.0 8.0 0.5 8.8 11.5 13.9 5.6 2.1 22.3 10.9 14.1 2.2 3.1 6.4 6.3 8.5 2.8 6.9 5.8 9.6 0.0 5.6 1.8 12.0 6.5 6.4 1.4 12.4 7.8 0.3 2.9 6.3 11.1 RAI14 "DKFZp564G013, KIAA1334, NORPEG, RAI13" ENSG00000039560 "Retinoic acid induced 14" Q9P0K7 5 34656237-34832627 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 64.4" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 166.4;Early spermatids: 198.0;Late spermatids: 250.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 59.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA036949, HPA036950" Supported Supported "Nucleoplasm,Actin filaments,Cytosol" NA NA Nucleoplasm "Actin filaments, Cytosol" "HPA036949: AB_10670568, HPA036950: AB_10669721" "unprognostic (7.63e-2)" "unprognostic (9.86e-2)" "unprognostic (4.87e-2)" "unprognostic (1.40e-1)" "unprognostic (3.38e-2)" "unprognostic (4.75e-2)" "unprognostic (5.49e-2)" "unprognostic (6.18e-2)" "unprognostic (6.28e-2)" "unprognostic (2.62e-1)" "unprognostic (8.18e-2)" "unprognostic (4.58e-2)" "prognostic unfavorable (9.75e-4)" "prognostic unfavorable (2.05e-4)" "unprognostic (1.33e-1)" "unprognostic (4.81e-2)" "unprognostic (4.34e-2)" 5.6 4.5 3.9 8.3 5.9 0.5 5.1 4.4 3.2 23.3 9.1 5.5 14.1 2.5 29.2 8.2 8.8 6.8 8.8 3.6 4.4 3.5 7.7 11.2 10.4 5.1 6.9 1.5 9.5 4.8 6.4 2.7 64.4 5.6 10.4 4.0 8.2 8.4 10.8 2.0 7.6 3.6 34.7 17.0 21.2 6.0 26.6 5.7 2.1 6.7 2.7 3.8 22.5 14.9 0.8 0.6 2.5 0.8 2.5 3.3 0.3 2.7 10.8 12.5 8.3 6.7 23.5 16.0 32.7 26.4 18.9 19.0 8.2 3.5 0.6 13.1 16.0 20.7 1.8 14.2 24.1 41.1 0.0 6.8 4.5 10.2 5.0 20.8 0.1 0.4 21.9 7.6 33.9 27.1 31.2 59.9 1.0 6.3 0.2 24.6 2.2 0.4 0.1 9.7 1.6 10.5 3.9 19.1 0.1 22.0 15.6 3.3 1.8 19.3 2.9 8.8 19.1 3.3 0.5 38.5 30.8 16.5 7.5 14.2 0.7 0.0 0.0 26.0 0.0 11.9 2.5 0.8 0.3 3.3 0.3 0.4 0.5 1.0 0.2 0.2 0.8 0.3 0.6 1.6 2.5 0.1 0.6 0.1 0.3 3.9 5.9 4.4 3.2 4.4 3.5 6.9 1.5 5.6 5.7 98.3 166.4 1.7 20.2 10.6 1.9 3.3 5.1 24.1 95.5 33.2 64.8 23.9 6.6 30.0 198.0 51.8 3.2 0.0 24.7 59.3 26.2 11.8 3.5 21.9 6.5 14.3 1.7 16.5 2.4 250.8 66.7 4.2 5.0 1.8 0.8 18.5 39.1 1.9 29.7 18.0 4.7 0.0 17.3 8.1 12.4 13.8 130.6 2.5 2.3 63.1 RALGDS "RalGEF, RGDS, RGF" ENSG00000160271 "Ral guanine nucleotide dissociation stimulator" Q12967 9 133097720-133149334 "Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Suprabasal keratinocytes: 88.7;Urothelial cells: 86.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 16.7;MAIT T-cell: 6.6;memory CD4 T-cell: 7.6;memory CD8 T-cell: 12.0;naive CD8 T-cell: 6.5;NK-cell: 5.7;T-reg: 13.1" "Group enriched" "Detected in many" 9 "NK-cells: 5.7;T-cells: 16.7" "Cell line enhanced" "Detected in all" "HDLM-2: 53.1;SH-SY5Y: 33.7" "HPA025961, CAB032582" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "CAB032582: AB_2238105, HPA025961: AB_2671795" "unprognostic (1.01e-1)" "prognostic favorable (4.19e-4)" "unprognostic (1.35e-2)" "unprognostic (7.92e-3)" "unprognostic (8.20e-2)" "unprognostic (7.95e-2)" "unprognostic (5.09e-2)" "unprognostic (2.20e-1)" "unprognostic (8.91e-2)" "unprognostic (2.88e-1)" "unprognostic (2.69e-3)" "unprognostic (5.03e-2)" "unprognostic (9.54e-3)" "unprognostic (5.51e-2)" "unprognostic (1.18e-1)" "unprognostic (1.52e-1)" "unprognostic (1.08e-1)" 18.9 19.8 28.2 14.5 43.2 26.3 16.8 33.1 38.1 14.8 11.1 43.6 12.8 13.0 10.3 10.4 28.7 18.8 23.9 18.7 30.4 23.0 6.3 5.7 19.9 18.8 45.6 19.2 26.6 17.4 11.5 31.8 8.2 38.0 11.8 8.0 8.0 21.6 16.7 13.1 24.8 15.3 10.6 44.3 13.4 13.3 3.8 48.0 5.5 12.2 14.5 13.6 17.1 12.7 1.1 0.5 1.3 0.4 5.7 16.7 3.5 2.6 3.8 8.1 10.0 3.1 4.5 6.8 3.1 4.7 3.2 2.1 3.3 5.7 3.9 2.9 5.3 4.9 12.4 8.2 5.7 1.1 53.1 5.8 3.4 7.6 4.7 4.0 5.3 6.2 5.3 8.1 1.7 3.6 8.8 6.6 7.8 6.6 24.8 2.9 8.5 7.6 5.1 5.5 11.7 10.0 7.8 1.9 6.6 3.9 4.5 25.6 33.7 3.7 5.5 4.9 3.3 5.7 5.6 3.5 3.6 3.8 2.7 2.1 1.1 3.0 4.7 3.2 6.1 4.0 1.3 0.4 0.5 16.7 0.2 6.6 1.1 7.6 12.0 0.5 0.3 1.7 6.5 0.2 5.7 0.1 0.5 13.1 3.5 28.2 43.2 33.1 38.1 30.4 23.0 45.6 19.2 38.0 48.0 29.8 13.7 6.9 42.4 49.2 12.3 5.9 12.7 12.0 17.0 8.7 11.8 3.6 3.3 9.9 0.4 26.3 24.7 0.0 5.8 3.4 9.1 38.3 15.1 3.0 11.6 58.8 35.5 37.4 8.3 1.5 12.4 18.0 21.9 1.8 13.4 20.5 10.0 13.5 8.5 2.2 8.5 0.0 11.2 2.3 3.8 88.7 4.9 23.0 15.8 86.8 RALGPS2 "FLJ10244, FLJ25604, KIAA0351" ENSG00000116191 "Ral GEF with PH domain and SH3 binding motif 2" Q86X27 1 178725147-178921841 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Alzheimer disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 37.7" "Cell type enhanced" "Detected in all" 10 "Cone photoreceptor cells: 194.4;Rod photoreceptor cells: 376.7;Spermatocytes: 162.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 11 "memory B-cell: 17.8;naive B-cell: 14.6" "Lineage enriched" "Detected in many" 12 "B-cells: 17.8" "Cell line enhanced" "Detected in many" "U-266/84: 62.7;U-698: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027143, HPA028328" Enhanced Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA027143: AB_10602071, HPA028328: AB_10601889" "unprognostic (8.13e-2)" "unprognostic (1.46e-2)" "unprognostic (4.06e-3)" "unprognostic (2.71e-1)" "unprognostic (1.23e-1)" "unprognostic (1.50e-1)" "unprognostic (5.72e-2)" "unprognostic (6.63e-3)" "unprognostic (4.07e-2)" "unprognostic (1.33e-1)" "unprognostic (2.82e-2)" "unprognostic (7.77e-2)" "unprognostic (1.55e-1)" "unprognostic (3.45e-1)" "unprognostic (6.35e-2)" "unprognostic (4.37e-2)" "unprognostic (8.97e-2)" 5.5 6.4 5.0 27.9 10.5 6.2 5.4 8.9 5.1 8.0 9.9 1.2 7.2 5.8 8.2 7.3 14.0 8.7 4.7 4.7 6.0 3.2 6.1 16.4 3.7 25.3 2.2 4.1 11.5 5.0 6.2 8.4 4.6 3.8 5.3 6.4 9.9 9.2 7.4 2.1 10.0 19.7 6.1 3.2 26.1 6.8 37.7 2.1 16.0 4.3 4.7 29.4 7.5 8.4 17.8 0.5 1.4 0.1 0.3 0.5 0.8 10.3 3.4 10.5 0.1 11.8 17.3 4.1 9.1 20.1 7.4 6.7 4.1 10.2 22.0 3.0 26.7 3.7 8.6 4.6 2.3 9.7 0.0 2.7 0.0 2.2 3.8 2.0 2.8 0.1 7.6 2.0 9.5 6.7 5.1 6.4 4.1 5.3 0.8 4.8 1.6 4.3 0.9 7.2 4.0 3.6 6.1 10.8 0.2 2.5 6.6 1.6 4.7 5.9 6.6 12.8 7.5 7.9 1.4 4.7 3.4 3.3 12.3 4.3 25.1 62.7 51.4 1.9 1.5 3.8 0.5 0.1 1.4 0.2 0.0 0.2 17.8 0.1 0.1 0.2 14.6 0.5 0.1 0.8 0.3 0.0 0.5 0.0 0.8 5.0 10.5 8.9 5.1 6.0 3.2 2.2 4.1 3.8 2.1 11.9 8.6 135.8 14.0 13.2 83.6 11.7 5.1 26.8 7.9 14.0 194.4 6.4 18.3 12.8 103.8 2.7 23.8 23.3 10.3 8.6 12.0 23.1 8.1 51.8 5.0 12.7 34.4 3.1 7.5 137.4 46.3 3.6 8.5 1.8 18.2 23.8 20.4 24.6 43.9 6.6 376.7 19.4 8.1 162.4 24.7 29.7 2.7 4.8 13.0 54.0 RALY "HNRPCL2, P542" ENSG00000125970 "RALY heterogeneous nuclear ribonucleoprotein" Q9UKM9 20 33993646-34108308 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040971, HPA043614" Enhanced Enhanced Nucleoplasm,Vesicles NA NA 12000 Nucleoplasm Vesicles "HPA040971: AB_2677230, HPA043614: AB_2678581" "unprognostic (2.06e-1)" "unprognostic (9.54e-3)" "unprognostic (3.72e-2)" "unprognostic (2.28e-1)" "unprognostic (4.68e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (3.60e-4)" "unprognostic (3.06e-1)" "unprognostic (1.27e-1)" "unprognostic (3.66e-1)" "unprognostic (4.20e-2)" "unprognostic (8.59e-2)" "unprognostic (3.29e-2)" "unprognostic (2.88e-2)" "unprognostic (8.61e-3)" "unprognostic (1.64e-2)" "unprognostic (8.80e-2)" 37.7 23.4 26.3 39.9 30.7 65.2 55.4 22.4 33.9 35.0 43.7 37.6 35.1 41.9 36.4 31.0 41.6 35.2 38.9 51.9 27.3 24.4 39.3 30.3 40.9 53.9 33.0 23.4 38.3 38.5 21.9 20.7 41.9 26.5 34.9 34.9 32.0 38.7 32.7 62.0 39.8 48.8 41.7 40.9 40.4 36.0 56.8 28.9 76.0 76.7 43.6 42.6 33.5 49.7 30.8 40.9 61.6 54.1 54.1 48.4 40.4 37.0 25.6 41.5 31.6 18.6 19.8 33.6 25.9 21.6 34.8 30.1 68.9 33.6 29.2 38.2 21.6 44.6 41.7 19.5 40.5 19.8 19.1 20.2 69.1 15.1 68.8 25.8 35.6 35.3 21.0 24.7 25.8 26.5 26.4 33.8 37.7 28.6 50.1 22.2 35.8 88.6 57.5 21.4 44.5 49.5 52.5 56.7 39.7 21.2 23.5 39.6 44.3 43.3 41.5 58.9 21.5 42.3 38.0 26.5 72.1 43.7 35.0 32.4 50.1 42.0 52.0 36.2 27.0 33.0 32.9 32.4 61.6 44.3 39.9 33.1 30.8 40.1 48.4 40.9 30.7 35.6 33.6 52.9 54.1 54.1 33.8 42.0 40.4 26.3 30.7 22.4 33.9 27.3 24.4 33.0 23.4 26.5 28.9 50.6 54.9 87.2 97.9 70.3 18.7 53.7 58.6 25.4 27.3 52.4 17.7 128.1 107.8 136.9 27.6 80.9 214.0 70.0 140.3 190.7 86.4 99.8 59.9 32.8 138.7 7.9 89.2 68.2 94.3 35.9 60.7 107.6 109.6 188.4 118.3 48.1 145.4 157.8 58.4 84.7 21.3 109.9 97.1 67.3 96.5 70.6 143.4 124.9 145.1 145.7 RALYL HNRPCL3 ENSG00000184672 "RALY RNA binding protein like" Q86SE5 8 84182787-84921844 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 25.6;brain: 54.9;kidney: 23.5" "Cell type enhanced" "Detected in some" 24 "Bipolar cells: 38.5;Distal tubular cells: 150.9;Horizontal cells: 31.8;Muller glia cells: 33.3" "Cancer enhanced" "Detected in single" "glioma: 1.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "OE19: 26.8" "Low region specificity" "Detected in all" "HPA055868, HPA059112" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA055868: AB_2682950, HPA059112: AB_2683908" "unprognostic (1.13e-5)" "unprognostic (1.62e-1)" "unprognostic (7.48e-2)" "unprognostic (1.36e-1)" "unprognostic (5.04e-2)" "unprognostic (1.25e-2)" "unprognostic (1.74e-1)" "unprognostic (4.82e-5)" "unprognostic (2.74e-2)" "unprognostic (2.52e-1)" 1.1 25.6 14.0 1.1 23.0 1.2 1.1 54.9 38.2 0.9 1.3 1.1 0.0 1.4 1.1 1.8 0.9 1.7 7.1 3.7 14.9 22.6 23.5 1.3 1.1 1.0 14.7 20.0 1.0 3.7 1.0 7.6 2.4 9.8 1.2 1.5 0.4 1.1 3.4 1.1 1.2 1.8 1.1 4.6 3.8 1.6 1.4 3.5 0.0 1.1 0.0 1.0 1.0 0.2 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 26.8 0.1 0.0 0.3 0.0 0.0 0.0 0.6 0.1 0.1 0.2 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 14.0 23.0 54.9 23.0 14.9 22.6 14.7 20.0 9.8 3.5 0.0 0.0 0.0 0.0 0.0 38.5 4.4 22.9 0.0 0.0 7.0 2.0 0.0 150.9 0.7 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 31.8 1.7 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 33.3 0.1 0.0 0.0 14.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RAMP1 ENSG00000132329 "Receptor activity modifying protein 1" O60894 2 237858893-237912114 "FDA approved drug targets, Predicted membrane proteins" Transport Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 91.6;pancreas: 94.7" "Cell type enhanced" "Detected in many" 18 "Exocrine glandular cells: 240.1;monocytes: 755.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 16 "NK-cell: 30.0" "Lineage enriched" "Detected in many" 16 "NK-cells: 30.0" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.1;HDLM-2: 37.9;PC-3: 44.2;SH-SY5Y: 55.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057814 Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA057814: AB_2683536" "unprognostic (1.13e-2)" "unprognostic (5.96e-2)" "unprognostic (3.03e-3)" "unprognostic (3.69e-1)" "unprognostic (4.29e-1)" "unprognostic (1.75e-1)" "prognostic favorable (7.61e-4)" "unprognostic (2.54e-1)" "unprognostic (3.49e-1)" "unprognostic (5.45e-3)" "unprognostic (2.32e-1)" "unprognostic (1.43e-1)" "unprognostic (2.46e-3)" "prognostic unfavorable (1.68e-4)" "unprognostic (1.74e-1)" "unprognostic (3.98e-2)" "unprognostic (2.08e-3)" 3.5 13.8 22.4 9.4 23.9 1.2 1.6 7.8 22.5 34.1 38.8 9.9 8.9 24.9 91.6 21.7 8.9 29.1 19.0 61.7 19.6 15.4 3.1 13.4 3.1 3.3 18.0 12.7 8.4 94.7 1.0 1.6 4.5 14.6 25.5 3.5 1.5 1.5 25.1 62.4 2.4 14.4 51.8 19.5 2.4 14.2 4.3 17.1 0.0 1.1 5.4 2.0 18.3 14.0 0.1 0.4 0.2 0.0 30.0 1.8 1.4 7.9 0.0 0.1 0.0 3.4 5.3 0.3 0.5 0.9 0.5 0.4 0.0 13.1 0.0 0.1 0.2 0.0 0.0 2.0 0.0 0.0 37.9 1.0 0.0 0.0 0.2 10.7 0.0 0.0 4.1 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.7 0.0 0.3 0.1 0.0 44.2 0.0 0.4 0.2 0.0 0.0 0.4 55.7 0.8 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.3 0.0 0.4 0.0 0.2 0.1 0.2 30.0 0.0 0.0 0.0 1.4 22.4 23.9 7.8 15.3 19.6 15.4 18.0 12.7 14.6 17.1 0.0 1.0 0.5 11.4 10.3 2.1 136.4 91.7 14.7 9.1 10.4 0.0 2.1 0.0 55.5 0.2 4.2 4.9 0.0 240.1 7.5 28.8 73.7 1.1 137.8 18.7 1.6 110.7 51.5 4.0 0.4 7.8 6.3 60.8 755.6 26.2 3.3 79.4 4.0 10.6 0.0 2.3 6.5 86.3 0.0 4.9 5.1 1.9 3.2 6.6 3.8 RAN "ARA24, Gsp1, TC4" ENSG00000132341 "RAN, member RAS oncogene family" P62826 12 130871879-130877678 "Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Host-virus interaction, Mitosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA063353 Enhanced Nucleoplasm No No 2100000 Nucleoplasm "HPA063353: " "unprognostic (2.22e-2)" "unprognostic (5.16e-2)" "unprognostic (2.30e-2)" "unprognostic (3.34e-2)" "unprognostic (1.75e-1)" "unprognostic (3.39e-3)" "prognostic unfavorable (9.99e-8)" "unprognostic (2.81e-3)" "unprognostic (1.28e-1)" "unprognostic (5.41e-3)" "unprognostic (2.76e-2)" "prognostic unfavorable (7.86e-5)" "prognostic unfavorable (1.46e-7)" "unprognostic (6.55e-2)" "unprognostic (2.79e-1)" "unprognostic (4.62e-1)" "unprognostic (3.16e-2)" 52.3 68.3 46.9 75.7 62.7 80.6 53.4 42.1 62.6 38.1 61.9 32.5 41.4 41.7 47.9 59.9 96.4 44.0 36.1 55.2 53.9 59.7 52.6 65.9 50.1 90.3 48.9 61.0 46.9 51.3 31.8 43.8 57.0 50.8 37.0 65.6 28.6 43.7 40.2 84.2 45.5 45.1 59.6 42.1 60.1 47.8 87.2 31.0 84.8 51.7 89.6 108.3 44.7 49.5 94.1 69.3 34.3 62.3 60.5 96.5 110.2 97.8 134.7 116.7 67.5 53.7 66.3 90.1 129.3 67.8 126.1 87.2 144.7 104.3 161.8 87.4 92.9 79.3 63.5 169.6 134.3 137.0 54.2 133.5 95.0 102.8 146.3 65.7 164.3 81.9 62.1 84.0 108.7 158.0 84.2 121.8 116.3 140.0 48.2 123.7 120.3 160.2 198.5 136.9 101.7 215.5 125.3 100.2 90.7 117.6 171.0 107.1 65.5 74.8 67.6 90.7 100.9 133.2 119.1 84.2 72.9 111.4 73.9 120.3 67.4 109.7 227.3 74.9 101.7 101.2 29.6 51.5 34.3 69.6 62.3 84.7 94.1 95.5 79.9 69.3 78.5 87.0 82.5 10.7 60.5 58.0 65.7 96.5 110.2 46.9 62.7 42.1 62.6 53.9 59.7 48.9 61.0 50.8 31.0 169.7 129.5 266.6 518.3 564.3 160.2 103.4 160.5 183.4 197.9 160.5 35.3 577.4 328.3 654.2 67.6 212.9 137.7 233.6 391.9 1042.2 424.8 302.9 190.4 172.1 550.1 131.9 193.7 150.4 155.0 125.0 197.6 285.4 315.5 519.4 219.7 197.5 494.0 152.6 217.1 304.7 106.2 161.7 425.8 567.1 580.4 478.1 512.7 322.1 399.9 542.5 RANBP2 "ADANE, ANE1, NUP358" ENSG00000153201 "RAN binding protein 2" P49792 2 108719481-108785811 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway" "RNA-binding, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA018437, HPA023960, CAB034063, HPA049497, HPA051675, HPA067564" Supported Supported "Nucleoplasm,Nuclear membrane,Vesicles" NA NA "Nuclear membrane" "Nucleoplasm, Vesicles" "CAB034063: AB_2176784, HPA018437: AB_2620151, HPA023960: AB_2671385, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (2.51e-1)" "unprognostic (3.99e-2)" "unprognostic (1.22e-1)" "unprognostic (4.37e-2)" "unprognostic (1.28e-2)" "unprognostic (9.30e-2)" "unprognostic (5.47e-2)" "unprognostic (2.91e-1)" "unprognostic (4.02e-2)" "unprognostic (2.54e-1)" "unprognostic (4.23e-1)" "unprognostic (5.23e-2)" "unprognostic (1.62e-2)" "unprognostic (8.74e-2)" "unprognostic (3.08e-1)" "unprognostic (3.40e-2)" "unprognostic (2.53e-1)" 20.5 24.3 14.4 17.0 18.6 35.5 24.4 23.1 22.2 19.8 17.1 12.8 25.5 13.3 19.9 21.5 17.0 19.1 14.8 20.2 12.9 12.5 18.9 19.5 17.7 19.2 15.1 17.0 32.4 24.1 48.5 37.5 18.8 16.5 21.8 15.8 14.3 20.0 31.6 37.5 17.3 17.4 23.2 17.8 16.3 20.9 20.6 15.9 26.6 28.7 18.0 17.5 20.5 19.7 5.6 5.1 8.3 6.3 4.2 8.7 2.3 18.4 11.3 16.3 14.7 19.0 17.0 15.8 16.6 13.2 13.8 12.1 28.1 8.9 29.1 12.9 17.3 17.0 15.6 27.8 17.3 20.1 17.7 13.5 30.3 14.0 19.8 11.1 35.3 10.2 14.3 13.2 21.5 16.8 13.6 21.0 12.7 32.4 16.1 18.2 10.2 15.6 14.4 20.5 9.3 13.6 14.8 25.0 14.0 12.2 23.1 23.7 10.9 14.7 12.7 16.1 10.2 8.1 16.3 25.0 14.4 19.1 10.1 18.5 13.4 19.8 26.4 11.2 16.0 11.1 8.3 5.3 5.1 7.6 3.4 8.7 5.5 6.3 6.9 4.2 5.6 6.2 6.7 8.3 4.2 6.3 5.1 5.1 2.3 14.4 18.6 23.1 22.2 12.9 12.5 15.1 17.0 16.5 15.9 71.5 71.1 34.9 25.8 49.5 43.3 85.9 33.1 57.6 70.5 55.8 68.7 22.7 1.7 31.3 59.8 43.8 25.7 0.0 44.1 15.0 32.3 38.2 83.1 49.9 41.1 30.2 102.2 27.0 44.0 22.0 35.6 64.2 45.5 49.5 50.9 18.7 36.5 25.9 52.6 15.4 37.7 45.3 62.9 74.1 59.2 59.2 34.0 44.5 31.5 31.5 RANBP3 ENSG00000031823 "RAN binding protein 3" Q9H6Z4 19 5916139-5978142 "Cancer-related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043375, HPA043389" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA043375: AB_10959889, HPA043389: AB_10963696" "unprognostic (1.81e-1)" "unprognostic (1.18e-3)" "unprognostic (3.61e-1)" "prognostic favorable (1.22e-5)" "unprognostic (4.24e-2)" "unprognostic (1.42e-3)" "unprognostic (5.44e-2)" "unprognostic (3.90e-2)" "unprognostic (3.58e-1)" "unprognostic (1.08e-1)" "prognostic favorable (4.14e-4)" "unprognostic (2.27e-1)" "unprognostic (3.80e-2)" "unprognostic (2.91e-1)" "unprognostic (5.15e-2)" "prognostic favorable (8.14e-4)" "unprognostic (1.06e-2)" 19.5 30.2 24.8 25.2 31.5 20.9 18.6 38.2 40.9 21.2 29.8 31.6 18.3 24.7 28.2 16.5 23.4 23.9 20.3 30.8 25.0 26.5 19.3 24.6 21.9 26.7 24.3 21.2 29.2 33.1 22.4 26.1 22.3 28.8 25.6 14.2 30.1 27.9 28.0 33.9 21.2 25.1 27.9 25.0 24.9 24.9 36.7 28.0 33.5 21.9 14.7 27.7 28.0 20.9 20.7 21.3 25.0 21.4 14.9 28.7 20.1 30.2 21.3 18.1 20.2 13.7 13.9 12.9 19.4 18.3 22.7 24.7 26.9 10.7 28.6 21.8 15.0 14.3 18.9 16.1 18.9 14.0 29.2 26.3 15.3 16.7 31.9 14.9 22.4 22.6 13.6 13.1 14.2 16.2 10.6 16.5 15.7 27.7 27.1 12.8 12.7 37.2 10.9 33.2 13.2 27.0 27.6 17.4 26.0 14.7 23.5 20.0 22.5 17.2 18.2 17.1 11.1 13.9 17.0 17.1 19.2 14.1 33.5 28.4 28.1 28.3 24.6 24.3 28.2 23.6 13.2 20.8 25.0 22.7 21.4 23.3 17.0 22.0 22.7 21.3 20.7 19.6 25.1 24.0 14.9 20.6 20.2 28.7 20.1 24.8 31.5 38.2 40.9 25.0 26.5 24.3 21.2 28.8 28.0 23.8 18.7 17.9 17.1 10.9 15.9 13.3 17.8 20.1 13.6 7.0 23.6 23.8 36.5 25.9 39.7 15.2 15.8 23.3 18.2 26.3 16.4 14.7 17.3 9.5 21.6 22.3 12.7 6.7 14.3 57.9 15.5 17.0 20.3 44.1 14.6 18.9 18.6 10.5 23.3 14.7 16.8 19.4 13.7 51.1 37.9 10.3 29.6 21.7 13.3 20.9 RANBP3L FLJ25422 ENSG00000164188 "RAN binding protein 3 like" Q86VV4 5 36248434-36302114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.3;kidney: 33.8" "Cell type enhanced" "Detected in some" 23 "Collecting duct cells: 8.7;Distal tubular cells: 39.7;Muller glia cells: 12.8;Sertoli cells: 12.9" "Cancer enhanced" "Detected in some" "prostate cancer: 4.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "ASC diff: 16.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037471, HPA037472, HPA061526" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA037471: AB_10671756, HPA037472: AB_2675489, HPA061526: AB_2684552" "unprognostic (1.19e-1)" "unprognostic (1.02e-1)" "unprognostic (1.27e-1)" "unprognostic (1.41e-3)" "unprognostic (5.52e-3)" "unprognostic (2.85e-1)" "unprognostic (2.35e-3)" "unprognostic (1.08e-2)" "unprognostic (9.56e-2)" "unprognostic (2.66e-1)" "unprognostic (2.81e-1)" "unprognostic (1.28e-1)" "unprognostic (3.76e-4)" "unprognostic (1.68e-2)" "unprognostic (9.13e-2)" "unprognostic (8.87e-3)" "unprognostic (5.71e-2)" 4.6 2.8 25.7 1.0 27.5 0.8 10.7 8.5 24.5 2.4 1.1 5.6 0.6 1.0 1.4 3.1 1.4 2.3 3.0 2.5 30.3 5.6 33.8 12.2 3.2 1.1 8.2 16.5 3.4 1.2 1.1 5.3 7.0 12.2 18.6 1.3 1.0 1.5 4.7 0.9 0.9 1.0 6.6 21.4 1.0 2.7 6.4 18.4 0.0 3.6 0.0 1.5 8.2 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 16.9 0.6 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.1 0.1 0.0 3.5 0.0 0.1 0.0 2.7 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.7 27.5 8.5 21.2 30.3 5.6 8.2 16.5 12.2 18.4 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 8.7 0.0 0.0 39.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 1.2 0.0 1.3 1.4 0.0 0.0 0.6 0.0 0.0 2.0 0.0 1.7 0.0 0.0 12.8 0.0 0.0 2.1 0.1 0.5 12.9 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 RANBP9 RanBPM ENSG00000010017 "RAN binding protein 9" Q96S59 6 13621498-13711564 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 73.9;Late spermatids: 76.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033767, HPA050007, HPA076784" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB033767: AB_2176959, HPA050007: AB_2680990, HPA076784: " "unprognostic (3.59e-2)" "unprognostic (6.57e-2)" "unprognostic (4.37e-2)" "unprognostic (2.67e-1)" "unprognostic (1.78e-1)" "prognostic favorable (9.97e-4)" "unprognostic (1.30e-1)" "unprognostic (4.61e-2)" "unprognostic (5.87e-3)" "prognostic favorable (2.47e-4)" "unprognostic (1.61e-1)" "unprognostic (6.74e-2)" "unprognostic (3.51e-1)" "unprognostic (7.19e-3)" "unprognostic (1.52e-1)" "unprognostic (3.49e-1)" "unprognostic (3.09e-1)" 12.4 12.7 15.1 14.0 13.6 30.1 24.8 13.1 24.0 14.5 14.4 9.8 9.8 8.3 13.2 14.3 40.8 9.7 15.5 12.2 15.0 16.0 11.8 16.0 17.9 10.5 18.0 14.3 12.4 11.9 14.7 10.6 15.7 13.7 13.9 11.4 8.3 14.4 11.4 31.8 16.9 9.1 14.7 12.4 9.5 11.0 60.1 12.6 20.9 10.7 20.0 18.0 14.4 21.0 2.0 2.3 3.8 2.0 2.7 8.1 1.2 16.4 7.2 17.5 17.6 23.7 22.1 18.5 20.2 22.8 21.2 22.4 11.0 9.7 14.6 33.0 23.5 16.3 9.0 13.4 11.7 29.3 24.4 12.5 14.7 14.3 20.3 32.9 22.8 11.0 22.2 15.2 25.0 20.8 17.2 17.1 25.8 31.0 11.7 23.5 16.5 26.1 19.1 7.7 15.8 10.2 20.9 13.7 20.7 16.8 19.0 22.0 15.5 16.3 30.2 29.9 34.8 16.1 19.5 16.9 19.3 13.7 15.8 20.7 28.2 34.3 19.8 8.9 14.6 35.7 0.8 1.3 3.8 1.9 1.8 3.8 2.0 4.0 2.0 1.4 1.7 3.8 2.6 1.8 2.7 2.0 2.3 8.1 1.2 15.1 13.6 13.1 24.0 15.0 16.0 18.0 14.3 13.7 12.6 17.9 26.2 5.2 7.4 22.0 22.2 34.0 10.2 14.7 19.4 17.4 13.7 13.9 1.7 7.7 73.9 29.8 11.6 0.0 9.3 7.6 18.5 14.9 9.3 15.6 15.1 6.4 12.7 19.0 23.5 76.0 14.7 15.7 16.9 11.8 16.6 18.6 13.3 3.5 23.3 9.1 16.1 6.5 13.7 65.4 35.1 22.8 23.8 15.3 9.9 10.2 RANGRF "HSPC165, HSPC236, MOG1, RANGNRF" ENSG00000108961 "RAN guanine nucleotide release factor" Q9HD47 17 8288497-8290092 "Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 361.7;Late spermatids: 822.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057280, HPA057888" Approved Supported Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA057280: AB_2683393, HPA057888: AB_2683549" "unprognostic (2.87e-2)" "unprognostic (2.93e-2)" "unprognostic (7.41e-2)" "prognostic favorable (1.65e-4)" "unprognostic (1.47e-2)" "unprognostic (2.51e-1)" "unprognostic (1.90e-3)" "unprognostic (2.26e-2)" "unprognostic (2.45e-1)" "unprognostic (2.01e-2)" "prognostic favorable (4.39e-4)" "unprognostic (1.43e-1)" "unprognostic (6.34e-2)" "unprognostic (3.11e-1)" "unprognostic (1.01e-1)" "unprognostic (2.14e-1)" "unprognostic (1.13e-2)" 14.5 14.7 24.7 11.7 29.1 11.8 26.5 10.9 19.2 31.5 15.4 7.9 13.5 10.5 20.0 22.5 10.6 21.5 10.9 23.4 15.1 17.8 17.0 11.5 18.9 26.9 16.2 19.2 21.0 6.3 16.2 17.1 14.6 18.8 15.9 10.8 17.2 6.0 19.4 11.4 9.8 11.9 18.8 12.2 15.4 16.7 70.1 15.9 16.8 11.6 9.1 20.3 14.1 10.5 26.8 22.3 25.3 16.3 21.8 40.2 18.2 16.0 18.9 13.9 14.2 10.2 12.9 11.7 9.4 18.6 26.1 24.4 10.1 6.4 30.7 10.2 11.3 10.4 18.2 25.6 12.7 18.7 21.4 32.4 15.3 14.9 13.9 23.1 9.6 22.4 12.6 23.2 22.2 21.3 12.5 20.6 29.8 6.7 8.7 15.9 0.4 29.4 31.5 9.7 9.7 7.3 26.0 10.8 18.3 14.1 7.1 5.4 15.1 7.6 11.3 20.0 9.1 0.9 9.3 11.4 5.7 10.0 11.0 19.0 14.8 11.7 37.0 12.1 19.1 8.3 4.9 16.2 25.3 24.2 16.3 22.6 24.2 29.3 27.4 17.3 26.8 26.2 22.4 2.1 21.8 12.5 22.3 40.2 18.2 24.7 29.1 10.9 19.2 15.1 17.8 16.2 19.2 18.8 15.9 8.9 25.0 41.4 21.7 16.1 23.2 4.0 0.0 14.7 14.8 24.4 11.8 83.8 58.0 22.9 361.7 25.3 11.9 23.3 16.5 38.1 26.0 20.4 26.6 13.6 42.0 19.1 19.0 19.6 11.9 822.0 26.2 23.5 16.9 36.1 15.2 23.5 17.8 24.5 29.7 43.5 28.7 19.4 20.8 112.7 18.1 17.1 94.4 41.5 22.9 11.9 RAPGEF5 "GFR, KIAA0277, MR-GEF" ENSG00000136237 "Rap guanine nucleotide exchange factor 5" Q92565 7 22118238-22357144 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 67.0;parathyroid gland: 258.2" "Cell type enhanced" "Detected in many" 8 "Ito cells: 81.0;Late spermatids: 45.4;Sertoli cells: 84.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 11.8;HUVEC TERT2: 25.2;SCLC-21H: 19.5;TIME: 14.3;U-698: 21.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057821, HPA076772" Uncertain Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" NA NA Nucleoplasm "Nuclear bodies" "HPA057821: AB_2683538, HPA076772: AB_2686814" "unprognostic (1.00e-1)" "unprognostic (1.57e-1)" "unprognostic (3.17e-2)" "prognostic unfavorable (9.44e-4)" "unprognostic (5.22e-2)" "prognostic favorable (3.52e-5)" "unprognostic (1.16e-1)" "unprognostic (2.10e-2)" "unprognostic (1.64e-1)" "unprognostic (2.10e-1)" "unprognostic (1.97e-1)" "unprognostic (1.31e-1)" "unprognostic (3.76e-2)" "unprognostic (6.36e-3)" "unprognostic (6.57e-2)" "unprognostic (2.55e-1)" "unprognostic (8.26e-3)" 10.8 5.8 12.6 3.6 22.6 1.8 6.2 5.2 25.1 4.5 4.6 47.6 0.6 3.9 4.4 3.1 6.1 4.2 7.0 6.7 21.3 10.1 7.3 8.5 14.1 5.7 41.8 13.3 3.7 7.9 258.2 3.3 23.2 31.5 2.8 5.2 0.9 3.4 3.4 2.7 4.4 4.1 5.6 67.0 17.1 3.7 3.5 29.5 3.9 5.4 1.8 4.9 3.9 4.9 0.7 0.0 0.0 0.0 0.0 0.2 0.4 1.5 0.0 2.6 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 3.0 0.8 11.8 0.6 0.1 0.4 7.4 1.5 1.1 0.0 0.0 2.3 0.1 0.0 2.9 0.0 0.0 0.0 0.3 1.3 0.7 0.4 0.4 25.2 3.3 2.6 0.1 0.0 0.6 1.6 0.0 2.0 2.9 2.3 2.9 0.0 4.0 2.4 1.0 19.5 5.2 0.3 3.4 0.0 0.4 1.7 0.0 14.3 0.0 0.6 0.2 0.6 6.6 1.3 21.2 0.3 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 12.6 22.6 5.2 25.1 21.3 10.1 41.8 13.3 31.5 29.5 8.9 13.9 2.2 4.3 9.7 14.8 7.3 10.2 0.0 5.7 0.0 0.0 0.1 1.7 4.3 41.5 38.5 14.3 0.0 5.9 0.1 2.1 2.2 8.1 5.8 0.2 22.3 6.9 81.0 5.1 45.4 1.7 1.5 6.8 0.0 16.0 0.5 6.0 17.5 4.6 0.2 1.1 84.1 10.3 0.9 1.1 9.8 0.2 2.1 8.8 3.7 RAPGEFL1 Link-GEFII ENSG00000108352 "Rap guanine nucleotide exchange factor like 1" Q9UHV5 17 40177010-40195656 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 37.7;skin 1: 87.1" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 40.4;Enterocytes: 66.1;Paneth cells: 46.5;Suprabasal keratinocytes: 84.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 2.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HaCaT: 39.0;hTCEpi: 19.5;T-47d: 34.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022895 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes No "Nucleoplasm, Microtubules" "Cytokinetic bridge" "HPA022895: AB_1856071" "prognostic favorable (8.43e-4)" "prognostic favorable (3.28e-4)" "unprognostic (1.61e-1)" "unprognostic (1.13e-2)" "unprognostic (4.64e-3)" "unprognostic (3.48e-2)" "unprognostic (5.92e-2)" "unprognostic (1.80e-1)" "unprognostic (3.64e-2)" "unprognostic (2.67e-1)" "unprognostic (7.46e-3)" "unprognostic (8.84e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.23e-2)" "unprognostic (1.50e-1)" "unprognostic (1.15e-1)" "unprognostic (2.03e-2)" 1.5 1.3 15.9 2.7 17.2 1.8 4.1 8.2 22.7 8.9 19.5 1.8 0.9 18.8 1.6 4.3 37.7 2.9 5.9 1.1 11.2 6.2 0.6 1.7 1.6 1.1 2.8 20.2 0.8 1.6 0.8 2.7 1.2 5.5 3.4 17.7 1.3 5.7 3.2 4.6 87.1 15.5 2.0 1.9 1.4 12.6 2.4 2.9 0.2 0.9 13.3 10.7 6.5 19.4 0.1 0.9 2.9 0.4 0.0 0.6 0.0 2.1 1.1 5.8 4.3 0.6 1.4 2.8 0.8 0.6 1.1 1.3 2.4 3.1 1.7 0.8 1.1 1.0 39.0 1.1 1.3 1.6 3.1 2.9 1.0 1.3 2.4 0.7 2.1 3.6 1.6 19.5 1.2 0.5 1.7 1.7 5.8 0.7 1.2 0.8 6.0 1.9 2.5 1.8 10.7 1.1 3.6 0.7 1.0 0.7 11.4 11.2 2.3 1.3 13.2 0.5 5.1 34.1 1.6 3.3 1.4 2.9 1.5 1.3 1.9 1.8 1.4 3.3 1.3 1.7 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.4 0.4 0.9 0.0 0.1 0.2 2.9 0.0 0.4 0.2 0.0 0.0 15.9 17.2 8.2 22.7 11.2 6.2 2.8 20.2 5.5 2.9 0.0 0.6 0.8 9.6 40.4 2.1 1.6 20.4 0.0 1.2 1.8 5.9 0.1 0.0 0.5 2.4 1.6 66.1 0.0 0.7 0.2 1.0 5.0 5.7 3.8 0.5 1.6 4.7 4.9 0.8 1.4 3.1 1.6 5.0 1.8 32.6 2.8 1.2 46.5 3.5 0.0 4.6 0.0 1.4 11.5 10.4 84.8 0.6 0.0 32.3 31.9 RARA "NR1B1, RAR" ENSG00000131759 "Retinoic acid receptor alpha" P10276 17 40309192-40357643 "Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 26.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 63.9;SK-BR-3: 40.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058282, HPA071548" Supported "Nucleoplasm,Nucleoli,Actin filaments,Cytosol" NA NA Nucleoplasm "Nucleoli, Actin filaments, Cytosol" "HPA058282: AB_2683666, HPA071548: " "unprognostic (8.05e-3)" "unprognostic (1.89e-1)" "unprognostic (9.48e-3)" "prognostic favorable (2.60e-4)" "unprognostic (8.67e-3)" "unprognostic (4.87e-3)" "unprognostic (2.77e-1)" "unprognostic (5.73e-2)" "unprognostic (1.45e-1)" "unprognostic (3.54e-2)" "unprognostic (1.19e-1)" "unprognostic (1.79e-1)" "unprognostic (2.29e-3)" "unprognostic (1.59e-2)" "unprognostic (5.60e-2)" "unprognostic (1.60e-1)" "unprognostic (1.09e-2)" 27.6 13.5 5.0 18.6 7.6 32.3 23.7 11.5 15.2 30.2 29.6 5.0 16.8 18.0 23.8 23.9 17.3 23.3 30.2 24.3 5.9 6.1 14.6 24.0 32.0 23.4 4.6 7.8 50.0 9.3 7.4 18.1 16.6 6.5 22.9 8.5 26.8 12.1 32.7 43.1 14.3 31.6 18.6 3.7 31.1 14.3 21.8 2.9 9.7 16.3 15.4 20.2 31.5 20.3 1.0 6.1 26.6 9.3 2.5 2.6 1.9 5.1 12.1 3.6 6.1 7.1 10.9 3.6 4.2 6.4 6.2 4.0 8.3 4.4 2.7 6.6 9.5 5.7 15.0 4.1 10.0 3.6 20.5 6.1 7.8 6.1 8.1 11.4 2.8 24.7 15.3 2.9 6.6 8.4 23.7 9.2 2.4 4.9 6.0 7.0 63.9 1.8 9.5 3.1 4.7 3.8 3.6 21.3 10.3 3.6 4.1 1.5 12.4 9.0 40.6 12.4 3.6 38.2 11.2 10.7 7.8 13.3 13.6 4.6 14.4 4.8 2.3 13.1 5.5 23.0 8.7 4.2 15.7 1.6 6.9 2.6 1.0 1.7 1.7 6.1 0.9 0.8 1.3 26.6 2.5 9.3 1.8 1.4 1.9 5.0 7.6 11.5 15.2 5.9 6.1 4.6 7.8 6.5 2.9 3.0 9.5 5.6 22.6 17.3 24.2 3.2 10.2 4.0 2.3 7.0 5.9 1.9 11.6 14.3 58.0 20.4 52.7 0.0 16.9 5.1 23.8 11.2 34.6 22.8 11.3 3.2 9.2 22.7 35.4 50.8 38.6 37.4 27.0 0.0 14.2 9.3 16.8 24.6 21.5 11.8 8.2 32.3 33.0 2.9 6.9 16.6 4.3 11.5 13.2 19.2 RARB "HAP, NR1B2, RRB2" ENSG00000077092 "Retinoic acid receptor beta" P10826 3 25174332-25597932 "Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets, Microphthalmia, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 39.1" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 17.9;Cone photoreceptor cells: 23.6;Ito cells: 20.3;Muller glia cells: 27.5" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 22.6" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 7.0;HEK 293: 7.9;hTERT-RPE1: 41.7;WM-115: 18.1" "Region enriched" "Detected in many" 9 "basal ganglia: 97.9" "Low region specificity" "Detected in all" "CAB002617, HPA004174" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB002617: , HPA004174: AB_1079744" "unprognostic (2.04e-2)" "unprognostic (3.53e-2)" "unprognostic (1.93e-1)" "unprognostic (1.09e-1)" "unprognostic (1.56e-1)" "unprognostic (6.72e-2)" "unprognostic (1.30e-2)" "unprognostic (2.70e-2)" "unprognostic (2.43e-1)" "unprognostic (4.71e-2)" "unprognostic (1.62e-1)" "unprognostic (2.86e-1)" "prognostic favorable (3.43e-5)" "unprognostic (9.24e-3)" "unprognostic (2.28e-1)" "unprognostic (9.99e-2)" "unprognostic (6.56e-3)" 3.9 7.1 2.4 2.3 22.6 0.0 6.8 1.5 9.1 13.4 6.0 2.2 6.8 1.7 14.4 7.5 8.1 6.2 5.3 13.6 2.6 2.2 17.5 6.2 5.6 5.6 2.0 3.7 12.2 1.5 12.8 18.9 13.9 3.2 13.0 2.3 39.1 13.7 11.8 2.5 1.4 2.4 14.7 4.6 7.7 4.8 1.7 4.8 0.0 10.0 2.9 4.6 12.1 10.2 1.0 0.4 0.1 0.6 0.1 0.8 0.0 0.0 0.9 0.6 3.1 7.0 1.8 0.0 0.8 0.4 0.0 0.3 0.1 0.0 0.0 0.1 1.2 0.1 0.2 0.0 0.1 0.0 0.0 7.9 0.0 0.0 0.5 0.1 0.1 0.0 3.7 0.0 0.0 0.0 41.7 6.6 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 4.2 0.0 0.1 0.0 4.9 0.0 0.0 0.0 0.5 0.0 1.1 3.4 0.1 0.0 0.0 2.8 0.1 18.1 0.0 0.6 0.0 0.8 0.1 0.3 0.3 0.5 0.5 0.4 1.0 0.6 0.8 0.1 0.1 0.1 0.4 0.0 0.0 2.4 22.6 1.5 9.1 2.6 2.2 2.0 3.7 3.2 4.8 0.0 0.3 0.0 17.9 0.1 4.2 9.3 7.6 6.7 12.5 10.4 23.6 0.1 0.0 1.4 1.3 3.8 0.0 0.0 0.8 0.1 3.1 5.5 0.0 2.0 0.3 4.8 0.0 20.3 4.1 0.4 0.0 0.0 0.0 0.0 0.0 27.5 1.1 0.0 0.0 0.5 6.1 0.0 9.2 0.2 1.1 0.1 0.2 0.0 0.0 7.1 RARG "NR1B3, RARC" ENSG00000172819 "Retinoic acid receptor gamma" P13631 12 53210567-53232980 "Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 49.4;skin 1: 52.1" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 30.3;Suprabasal keratinocytes: 48.8;Urothelial cells: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 17.0" "Group enriched" "Detected in all" 4 "dendritic cells: 5.6;T-cells: 17.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 33.3;MCF7: 35.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053883 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA053883: AB_2682292" "unprognostic (7.29e-2)" "unprognostic (1.95e-2)" "unprognostic (6.11e-2)" "prognostic unfavorable (3.68e-6)" "unprognostic (2.53e-1)" "unprognostic (5.43e-2)" "unprognostic (2.28e-1)" "unprognostic (1.08e-2)" "unprognostic (3.54e-3)" "unprognostic (7.21e-3)" "unprognostic (3.78e-3)" "unprognostic (4.44e-2)" "prognostic unfavorable (3.08e-6)" "unprognostic (5.41e-3)" "unprognostic (1.98e-2)" "unprognostic (5.94e-3)" "unprognostic (7.41e-2)" 4.8 5.0 2.7 7.0 3.6 1.3 10.8 6.3 3.8 26.8 6.3 1.8 7.3 1.0 14.6 6.0 49.4 10.6 8.6 6.9 3.0 1.4 3.7 1.9 7.4 6.7 2.4 2.3 12.6 2.7 4.2 2.8 4.4 1.6 11.3 3.4 10.3 9.5 10.6 2.6 52.1 3.0 9.7 1.5 4.7 6.0 3.9 1.7 2.3 7.3 30.6 26.8 10.9 19.8 1.8 5.6 1.5 2.5 1.7 17.0 2.9 7.2 8.0 1.8 16.9 18.9 16.2 0.5 7.6 16.6 10.0 7.9 2.7 33.3 0.1 4.2 30.6 5.4 24.5 6.1 14.6 2.5 1.9 3.1 1.0 6.1 2.3 8.0 0.0 3.0 12.0 21.5 9.5 2.1 25.3 4.2 1.5 0.2 3.2 3.9 35.1 0.4 0.3 5.4 9.8 14.2 2.3 0.6 5.8 3.0 12.0 1.5 7.6 15.5 16.8 10.2 2.4 14.5 0.4 4.5 12.0 5.7 7.9 0.4 1.5 0.8 0.5 14.8 1.2 17.0 1.5 2.5 0.7 6.6 0.8 17.0 1.8 5.7 4.8 5.6 0.6 4.8 4.1 0.0 1.7 0.0 0.4 1.5 2.9 2.7 3.6 6.3 3.8 3.0 1.4 2.4 2.3 1.6 1.7 3.0 6.5 0.0 19.4 30.3 0.7 2.8 5.1 0.0 2.3 3.5 2.0 7.2 0.0 8.7 0.0 6.9 0.4 0.0 4.5 0.7 19.6 11.9 1.1 0.0 2.3 0.0 1.7 20.9 5.2 0.2 4.9 2.8 8.5 1.8 1.6 2.9 9.8 3.5 4.9 0.6 4.9 6.5 12.2 0.4 4.1 48.8 1.5 5.7 5.2 33.4 RARS DALRD1 ENSG00000113643 "Arginyl-tRNA synthetase" P54136 5 168486445-168519299 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003979, HPA004130" Approved Enhanced Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA003979: AB_1856083, HPA004130: AB_1856084" "unprognostic (1.06e-2)" "unprognostic (1.92e-2)" "unprognostic (2.74e-3)" "unprognostic (2.82e-2)" "unprognostic (2.50e-1)" "prognostic unfavorable (7.59e-5)" "prognostic unfavorable (1.10e-8)" "unprognostic (3.26e-3)" "unprognostic (5.16e-1)" "unprognostic (4.22e-2)" "unprognostic (2.92e-2)" "unprognostic (4.27e-2)" "unprognostic (5.43e-2)" "unprognostic (6.43e-2)" "unprognostic (2.35e-1)" "unprognostic (2.39e-1)" "unprognostic (1.33e-2)" 21.8 26.3 16.0 18.3 15.3 6.2 22.6 17.1 18.4 21.2 29.4 9.1 20.4 33.3 22.9 21.4 34.7 19.5 14.4 21.7 19.8 12.3 29.8 33.5 18.7 18.6 13.9 15.2 21.3 33.0 19.9 34.5 30.3 15.8 18.9 27.4 15.5 34.0 15.4 27.8 27.9 48.7 21.5 14.5 22.1 24.4 17.2 11.8 20.5 21.5 32.3 23.7 22.4 22.6 11.1 21.8 5.2 17.7 16.8 16.3 11.7 27.2 32.4 24.0 26.6 33.2 38.1 41.3 40.2 34.6 41.9 49.0 55.0 29.8 29.0 33.0 38.2 43.1 26.5 31.4 54.1 54.7 30.1 21.6 19.5 29.5 34.5 28.8 46.0 20.8 29.2 28.9 45.6 21.9 25.8 33.5 15.9 29.1 14.7 44.8 25.2 19.1 18.3 39.4 24.0 22.1 8.4 35.0 27.6 37.3 31.1 22.9 28.2 30.7 35.5 41.5 30.5 32.3 19.3 33.2 30.4 27.9 23.4 46.8 14.7 26.9 29.8 33.1 32.9 28.8 3.4 14.4 5.2 12.5 17.7 14.3 11.1 12.6 13.3 21.8 6.6 15.6 16.3 4.0 16.8 16.4 10.3 12.8 11.7 16.0 15.3 17.1 18.4 19.8 12.3 13.9 15.2 15.8 11.8 53.6 32.3 25.1 37.6 26.3 25.0 43.6 35.7 46.8 39.8 24.4 25.5 88.8 14.9 80.1 16.6 27.5 40.6 23.3 83.1 79.2 34.8 24.5 26.6 31.4 51.1 12.7 12.6 33.2 24.6 11.6 23.0 35.0 27.0 72.1 36.7 22.7 61.2 38.7 23.0 36.0 22.7 19.4 28.9 27.7 42.2 31.1 70.5 20.1 44.8 35.2 RASAL3 FLJ21438 ENSG00000105122 "RAS protein activator like 3" Q86YV0 19 15451624-15464571 "Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 29.9" "Group enriched" "Detected in many" 5 "B-cells: 38.9;granulocytes: 39.2;T-cells: 62.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 14.4;HEL: 11.9;HMC-1: 23.1;Karpas-707: 25.7;NB-4: 13.1;RPMI-8226: 10.9;TIME: 17.1;U-937: 16.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043417 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA043417: AB_2678473" "unprognostic (2.72e-2)" "prognostic favorable (8.75e-4)" "unprognostic (3.27e-2)" "prognostic favorable (3.58e-5)" "unprognostic (2.31e-1)" "prognostic favorable (3.07e-4)" "unprognostic (1.82e-2)" "unprognostic (6.21e-3)" "unprognostic (7.40e-3)" "unprognostic (1.02e-1)" "unprognostic (3.49e-2)" "unprognostic (3.32e-1)" "prognostic unfavorable (1.16e-6)" "unprognostic (2.98e-1)" "unprognostic (1.90e-2)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" 2.8 2.1 3.1 19.2 3.8 16.7 1.7 0.5 1.9 1.4 3.4 4.6 0.7 3.6 1.7 1.1 3.0 1.9 4.5 1.1 4.1 1.8 3.3 2.8 8.0 23.5 4.5 1.3 0.9 1.3 0.3 1.4 0.8 3.7 2.3 1.9 1.5 7.5 1.1 0.7 1.2 14.5 0.9 5.1 29.9 4.0 0.6 4.6 27.3 3.1 1.6 28.9 4.5 2.0 2.9 3.2 8.8 9.3 8.9 16.4 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 11.9 0.0 0.0 0.2 9.5 23.1 0.0 0.0 0.0 0.0 0.0 0.1 3.9 0.0 25.7 0.0 0.1 5.0 13.1 0.0 0.0 0.0 1.4 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 17.1 0.0 0.0 0.0 0.0 0.2 4.6 7.0 0.0 16.1 0.0 4.3 1.7 8.8 14.9 3.4 8.9 2.2 9.5 16.4 2.6 2.9 8.0 9.6 2.5 8.9 9.3 3.2 6.4 3.5 3.1 3.8 0.5 1.9 4.1 1.8 4.5 1.3 3.7 4.6 3.0 9.3 38.9 0.0 0.2 0.0 2.2 0.0 8.1 2.3 0.0 0.0 0.1 0.0 0.1 0.4 2.9 0.0 0.0 0.5 0.2 0.9 0.1 39.2 3.9 9.8 0.0 0.0 4.3 9.2 0.6 0.0 7.4 0.0 2.8 0.0 0.1 0.3 0.0 1.1 0.8 0.0 0.0 0.5 0.4 0.3 0.5 0.3 62.3 0.0 0.1 RASD1 "AGS1, DEXRAS1" ENSG00000108551 "Ras related dexamethasone induced 1" Q9Y272 17 17494437-17496395 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Mucus-secreting cells: 239.8;Muller glia cells: 245.0;Peritubular cells: 441.6;Sertoli cells: 556.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 47 "plasmacytoid DC: 48.0" "Lineage enriched" "Detected in many" 47 "dendritic cells: 48.0" "Cell line enhanced" "Detected in some" "ASC diff: 34.4;HSkMC: 8.4;REH: 32.9" "Group enriched" "Detected in many" 5 "basal ganglia: 77.3;hippocampal formation: 60.2;thalamus: 58.1" "Low region specificity" "Detected in all" HPA047896 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA047896: AB_10960535" "unprognostic (1.59e-1)" "unprognostic (1.32e-1)" "unprognostic (3.28e-2)" "unprognostic (3.31e-2)" "unprognostic (6.40e-2)" "unprognostic (8.13e-2)" "unprognostic (8.65e-2)" "unprognostic (7.60e-2)" "unprognostic (5.50e-2)" "unprognostic (2.11e-1)" "unprognostic (3.17e-3)" "unprognostic (2.92e-1)" "unprognostic (7.40e-2)" "unprognostic (1.11e-2)" "unprognostic (1.38e-1)" "unprognostic (1.30e-1)" "unprognostic (1.38e-2)" 79.6 24.3 14.0 6.2 23.2 8.3 30.4 11.6 32.0 49.1 7.1 8.5 18.6 5.9 19.9 17.1 10.9 11.6 11.8 20.1 14.7 15.5 30.2 85.9 5.6 3.7 10.0 22.5 33.5 17.5 7.2 81.3 2.6 22.2 17.8 6.9 6.6 49.4 51.8 37.2 9.1 6.1 4.3 19.6 12.2 6.1 13.8 8.9 9.1 37.7 9.2 2.5 6.2 5.5 0.0 48.0 0.0 1.0 0.0 0.1 0.3 0.0 0.1 0.1 0.0 34.4 1.9 0.1 0.4 0.6 0.0 0.1 1.4 0.0 0.0 3.9 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.1 3.8 0.2 0.0 0.1 8.4 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.1 3.4 6.2 0.6 0.7 0.6 2.1 32.9 0.0 0.0 0.7 0.0 6.2 0.2 0.5 0.4 7.2 1.0 0.0 0.0 1.9 0.0 0.3 0.2 0.1 7.0 0.2 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 48.0 0.0 0.3 14.0 23.2 11.6 32.0 14.7 15.5 10.0 22.5 22.2 8.9 26.8 30.8 3.7 47.7 15.2 21.5 61.3 12.7 8.1 40.9 141.3 3.9 2.5 11.6 55.0 2.1 17.5 18.7 0.0 1.1 2.2 69.9 113.7 8.1 13.2 3.4 6.4 213.7 10.4 3.7 4.2 101.5 8.8 28.7 3.6 239.8 245.0 13.9 15.8 441.6 3.8 20.0 556.2 153.3 1.6 1.6 11.5 5.6 6.9 22.1 20.7 RASGEF1B "FLJ31695, GPIG4" ENSG00000138670 "RasGEF domain family member 1B" Q0VAM2 4 81426393-82044244 "Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "granulocytes: 104.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "intermediate monocyte: 7.7;memory B-cell: 6.4;naive B-cell: 8.8;non-classical monocyte: 12.4;plasmacytoid DC: 18.0" "Group enriched" "Detected in many" 5 "B-cells: 8.8;dendritic cells: 18.0;monocytes: 12.4" "Cell line enhanced" "Detected in some" "CACO-2: 12.0;Daudi: 15.4;Karpas-707: 10.4;NTERA-2: 7.1;OE19: 8.5;SCLC-21H: 6.9;SuSa: 7.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044574 Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA044574: AB_10794292" "unprognostic (3.24e-1)" "prognostic favorable (6.40e-4)" "unprognostic (1.32e-1)" "unprognostic (1.53e-1)" "unprognostic (1.19e-1)" "prognostic favorable (1.49e-5)" "unprognostic (4.42e-2)" "unprognostic (6.31e-2)" "unprognostic (4.43e-1)" "unprognostic (4.85e-2)" "unprognostic (1.13e-2)" "unprognostic (3.88e-2)" "prognostic favorable (4.21e-6)" "unprognostic (4.19e-3)" "unprognostic (1.44e-2)" "unprognostic (3.19e-2)" "unprognostic (6.04e-2)" 11.7 5.3 12.2 8.4 18.9 22.2 14.3 3.5 8.4 7.6 8.0 10.0 2.6 10.8 3.0 9.9 10.9 6.6 10.1 4.9 6.2 8.2 9.4 32.8 19.1 9.2 13.0 3.5 3.3 2.5 1.7 12.6 10.3 38.3 3.8 6.0 6.1 9.7 4.2 3.5 20.3 10.7 5.0 8.7 13.2 12.2 1.9 19.3 8.0 3.9 4.7 8.5 4.8 5.6 8.8 18.0 0.8 12.4 2.5 2.0 0.7 0.0 0.0 0.1 0.0 0.2 0.0 1.1 0.1 0.0 0.0 0.0 12.0 0.3 15.4 0.0 0.0 0.1 0.3 1.0 0.1 0.0 0.1 2.2 1.2 1.0 0.5 0.5 0.3 0.7 0.2 0.5 0.0 0.5 0.1 0.0 2.6 0.2 10.4 0.0 0.5 5.0 0.5 7.1 8.5 3.2 1.5 0.1 5.8 0.5 0.2 6.9 0.1 0.0 2.1 0.0 7.3 1.0 0.0 0.0 0.0 0.5 0.4 0.1 0.1 0.0 4.7 1.1 0.2 0.1 0.4 2.1 0.2 1.4 7.7 1.5 6.4 1.1 1.1 1.7 8.8 2.0 1.9 0.8 2.5 12.4 18.0 0.3 0.7 12.2 18.9 3.5 8.4 6.2 8.2 13.0 3.5 38.3 19.3 26.8 22.3 27.4 6.7 52.3 9.9 8.1 15.3 44.2 12.5 14.0 35.3 26.8 11.6 2.8 0.4 8.7 10.4 0.0 3.5 2.1 12.4 11.0 104.0 39.5 37.5 3.2 25.7 51.5 43.3 1.1 0.9 59.7 59.1 1.0 6.8 0.8 2.4 5.1 1.8 7.7 4.4 0.0 15.9 0.7 0.2 49.4 9.4 7.5 6.5 6.5 RASGRP3 "CalDAG-GEFIII, GRP3, KIAA0846" ENSG00000152689 "RAS guanyl releasing protein 3" Q8IV61 2 33436324-33564750 "Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.4;skeletal muscle: 28.7" "Cell type enhanced" "Detected in many" 5 "Endothelial cells: 50.6;Ito cells: 52.2;Urothelial cells: 57.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 15 "basophil: 11.4;memory B-cell: 10.4;naive B-cell: 13.4" "Group enriched" "Detected in many" 16 "B-cells: 13.4;granulocytes: 11.4" "Group enriched" "Detected in some" 6 "Daudi: 29.9;HEL: 31.6;U-266/70: 49.5;U-266/84: 18.9;U-698: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058937 Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA058937: AB_2683858" "unprognostic (2.64e-1)" "unprognostic (9.50e-2)" "unprognostic (1.45e-1)" "unprognostic (5.76e-3)" "unprognostic (1.05e-1)" "unprognostic (1.09e-2)" "unprognostic (3.90e-1)" "unprognostic (7.57e-2)" "unprognostic (2.39e-2)" "unprognostic (4.35e-2)" "unprognostic (2.43e-1)" "unprognostic (1.48e-1)" "unprognostic (9.96e-3)" "unprognostic (1.83e-2)" "unprognostic (2.93e-2)" "unprognostic (2.87e-1)" "unprognostic (5.82e-2)" 7.8 2.6 9.4 13.6 13.3 3.2 4.9 2.0 9.6 3.1 3.5 35.0 0.0 5.7 2.6 1.3 2.0 2.1 5.0 24.3 13.4 8.8 5.1 4.1 5.8 19.8 25.2 5.5 1.6 3.7 9.3 3.1 8.2 19.9 2.1 5.3 6.7 5.4 1.7 28.7 2.3 4.5 3.7 42.4 10.1 5.4 1.3 26.3 1.9 6.7 5.0 25.0 5.4 2.1 13.4 0.2 11.4 0.1 0.2 0.7 0.9 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.2 1.5 4.5 0.8 0.2 29.9 0.1 0.2 0.3 0.0 0.0 0.0 0.4 3.1 0.3 31.6 0.2 0.0 0.4 0.1 4.3 0.0 0.0 0.0 0.0 0.6 1.8 0.3 0.1 1.6 0.6 0.0 0.2 2.3 0.1 0.2 0.0 0.0 1.4 0.0 0.3 1.9 0.2 0.0 0.0 0.1 1.4 0.0 0.0 0.2 0.5 0.1 0.1 0.1 0.2 49.5 18.9 13.2 0.0 0.1 0.1 11.4 0.0 0.0 0.3 0.0 0.4 10.4 0.5 0.5 0.2 13.4 0.7 0.2 0.0 0.2 0.1 0.0 0.7 0.9 9.4 13.3 2.0 9.6 13.4 8.8 25.2 5.5 19.9 26.3 0.0 8.0 43.4 28.1 4.7 1.2 45.2 0.0 4.0 5.7 5.2 0.0 0.4 10.0 14.6 1.0 50.6 0.0 0.0 47.5 1.1 3.9 22.2 18.4 4.4 38.6 0.0 0.0 52.2 7.2 0.6 0.9 10.2 38.8 22.6 0.0 0.3 44.4 0.0 1.8 9.8 1.1 0.0 3.8 0.9 2.3 3.1 0.5 4.4 0.0 57.1 RASGRP4 ENSG00000171777 "RAS guanyl releasing protein 4" Q8TDF6 19 38409051-38426305 "Predicted intracellular proteins, RAS pathway related proteins" Differentiation "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 22.4;bone marrow: 23.3;lymphoid tissue: 23.1" "Group enriched" "Detected in some" 8 "Cardiomyocytes: 10.9;granulocytes: 26.5;Hofbauer cells: 12.0;Kupffer cells: 34.4;Macrophages: 11.0" "Cancer enhanced" "Detected in many" "testis cancer: 3.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 22.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HEL: 19.4;HMC-1: 19.4;U-937: 5.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA041929 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA041929: AB_10961405" "unprognostic (1.22e-1)" "unprognostic (1.31e-1)" "unprognostic (1.58e-1)" "unprognostic (1.17e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-2)" "unprognostic (1.39e-2)" "unprognostic (2.10e-1)" "unprognostic (2.00e-1)" "unprognostic (5.23e-4)" "unprognostic (6.54e-2)" "unprognostic (1.27e-1)" "unprognostic (2.30e-3)" "unprognostic (2.19e-2)" "unprognostic (1.05e-1)" "unprognostic (4.56e-1)" "unprognostic (2.66e-2)" 4.5 1.8 2.4 8.0 3.3 23.3 5.4 0.7 1.8 1.8 1.7 2.8 0.1 1.4 1.6 2.9 1.6 2.6 3.4 6.2 2.0 1.3 1.5 1.8 11.8 23.1 3.4 0.2 1.1 1.6 0.5 0.9 3.0 1.8 1.7 1.2 1.7 1.6 0.8 1.5 1.4 2.4 2.7 4.2 19.2 1.9 0.8 2.4 0.5 1.0 0.2 1.0 2.6 3.1 0.1 5.2 22.4 9.5 0.0 0.7 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 19.4 0.0 0.0 0.0 0.1 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 6.0 7.1 10.6 0.0 8.5 0.0 0.0 0.2 0.0 5.2 0.1 0.0 0.0 22.4 0.0 9.5 0.4 0.7 2.1 2.4 3.3 0.7 1.8 2.0 1.3 3.4 0.2 1.8 2.4 0.0 1.1 0.0 0.0 0.7 0.0 10.9 0.0 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.2 0.0 26.5 0.0 12.0 0.0 0.0 1.8 34.4 0.0 0.0 11.0 1.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.1 RASSF2 "CENP-34, KIAA0168" ENSG00000101265 "Ras association domain family member 2" P50749 20 4780023-4823645 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 106.1" "Cell type enhanced" "Detected in many" 9 "Kupffer cells: 93.0;monocytes: 117.2;Peritubular cells: 140.7;Rod photoreceptor cells: 154.5" "Cancer enhanced" "Detected in all" "glioma: 48.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 19.6;BEWO: 20.6;Daudi: 21.0;HL-60: 24.6;NB-4: 31.8;U-937: 39.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051200 Uncertain Supported "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Plasma membrane, Cytosol" "HPA051200: AB_2681386" "unprognostic (6.51e-2)" "unprognostic (3.67e-3)" "unprognostic (5.31e-2)" "unprognostic (1.47e-2)" "unprognostic (3.15e-1)" "unprognostic (1.46e-3)" "unprognostic (2.80e-1)" "unprognostic (7.01e-2)" "unprognostic (1.38e-2)" "unprognostic (2.41e-2)" "unprognostic (4.93e-2)" "unprognostic (3.90e-1)" "prognostic unfavorable (7.82e-4)" "unprognostic (3.51e-2)" "unprognostic (1.35e-1)" "unprognostic (3.49e-1)" "unprognostic (6.46e-2)" 8.3 5.1 26.5 21.5 26.9 38.6 3.6 10.2 45.8 14.9 4.1 59.5 0.1 2.7 13.0 11.6 5.2 9.8 7.8 2.4 33.2 22.4 2.0 3.0 10.1 26.2 54.7 8.7 3.5 1.7 0.7 2.6 4.5 39.7 3.9 5.0 19.8 2.0 4.8 1.2 2.2 5.7 18.6 106.1 14.9 3.3 9.9 27.3 4.7 2.5 0.6 34.2 10.7 2.7 7.9 14.1 42.1 17.9 2.4 4.7 10.6 0.0 4.9 12.1 19.6 0.1 0.0 20.6 1.2 3.4 0.2 0.0 1.1 0.0 21.0 1.9 1.0 0.4 0.0 1.7 0.0 0.3 7.5 0.7 13.7 0.0 0.2 0.0 24.6 14.0 0.0 0.0 0.4 0.0 0.4 8.0 2.4 0.0 8.3 0.0 0.0 3.6 31.8 2.7 0.0 0.4 5.6 1.3 8.0 0.0 9.7 0.1 0.9 0.0 0.3 0.6 2.7 0.0 15.7 0.2 0.5 2.6 0.2 1.5 0.1 1.9 12.9 0.1 39.2 0.1 21.1 17.9 29.5 2.4 15.4 4.7 7.9 3.9 3.3 14.1 5.3 2.6 2.1 42.1 2.4 16.8 9.4 3.4 10.6 26.5 26.9 10.2 19.3 33.2 22.4 54.7 8.7 39.7 27.3 0.0 14.9 27.7 0.0 4.1 37.9 1.6 2.5 0.0 3.4 0.0 25.5 2.4 1.7 1.0 5.0 12.7 0.0 0.0 0.8 4.8 8.2 0.8 51.0 0.8 24.8 6.4 0.0 16.0 93.0 15.3 30.8 38.0 8.5 117.2 0.0 12.7 0.4 0.0 140.7 0.2 154.5 0.0 3.3 0.7 0.6 2.3 1.1 10.2 0.0 0.9 RASSF4 "AD037, MGC44914" ENSG00000107551 "Ras association domain family member 4" Q9H2L5 10 44959407-44995891 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Hofbauer cells: 128.5;monocytes: 389.5;Muller glia cells: 247.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 28.3;intermediate monocyte: 21.7;myeloid DC: 28.5;non-classical monocyte: 11.5" "Group enriched" "Detected in many" 9 "dendritic cells: 28.5;monocytes: 28.3" "Cell line enhanced" "Detected in many" "Karpas-707: 21.5;RH-30: 54.6;RPMI-8226: 17.8;U-937: 27.9;WM-115: 18.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038834, HPA077069" Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol" NA NA "Nucleoplasm, Nucleoli" "Cell Junctions, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA038834: AB_10795576, HPA077069: " "unprognostic (1.83e-1)" "unprognostic (8.21e-3)" "unprognostic (1.21e-2)" "unprognostic (1.04e-1)" "unprognostic (1.25e-1)" "unprognostic (5.14e-2)" "unprognostic (3.15e-2)" "unprognostic (2.18e-2)" "unprognostic (8.81e-2)" "unprognostic (4.83e-2)" "unprognostic (8.75e-3)" "unprognostic (4.20e-1)" "unprognostic (4.11e-3)" "unprognostic (4.02e-2)" "unprognostic (2.22e-2)" "unprognostic (1.42e-1)" "unprognostic (6.20e-2)" 23.4 5.9 16.7 17.0 25.5 6.0 8.4 12.5 36.5 3.6 8.2 26.7 12.1 11.2 2.6 14.9 4.3 3.3 9.0 29.1 16.6 15.1 37.2 10.5 9.7 14.1 34.5 9.7 3.0 11.5 2.2 8.4 10.4 19.4 4.5 5.3 8.4 14.0 9.9 7.6 2.9 10.8 7.0 21.8 12.6 4.3 5.7 31.5 1.2 23.0 2.9 7.4 8.3 3.9 0.0 28.5 0.9 28.3 2.2 3.0 13.8 0.4 0.1 2.0 3.9 6.1 0.3 1.4 0.2 0.3 0.6 1.2 1.6 0.2 0.0 0.7 0.2 1.3 0.0 0.8 0.9 0.9 12.2 0.0 0.0 0.0 12.7 6.5 0.8 0.0 4.5 0.0 0.6 0.0 3.7 0.9 0.5 0.0 21.5 0.9 0.0 0.9 13.9 0.4 0.0 0.4 2.6 54.6 17.8 0.1 0.3 0.3 0.3 0.0 0.1 0.6 3.7 0.3 10.6 0.2 0.1 1.2 1.0 2.1 0.2 0.2 0.0 6.4 27.9 18.1 0.0 28.3 0.0 3.0 21.7 0.0 0.0 0.2 1.3 28.5 0.0 0.2 1.0 0.9 2.2 11.5 0.7 0.1 13.8 16.7 25.5 12.5 18.2 16.6 15.1 34.5 9.7 19.4 31.5 17.9 15.0 4.7 1.2 3.3 17.2 38.7 38.2 6.7 10.3 15.7 3.9 0.9 14.9 40.8 1.2 4.7 11.8 0.0 3.4 1.1 7.0 1.3 1.1 15.5 128.5 35.0 11.1 8.0 63.6 3.2 9.8 81.9 8.5 389.5 8.7 247.8 4.1 14.0 2.1 98.2 13.3 25.8 17.6 0.3 0.9 1.5 2.2 6.4 16.6 0.5 RASSF6 ENSG00000169435 "Ras association domain family member 6" Q6ZTQ3 4 73571550-73620631 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 77.9" "Cell type enhanced" "Detected in many" 7 "Exocrine glandular cells: 70.5;Intestinal endocrine cells: 115.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 8 "memory B-cell: 6.4" "Lineage enriched" "Detected in single" 13 "B-cells: 6.4" "Cell line enhanced" "Detected in some" "Daudi: 32.3;hTERT-HME1: 9.7;RPTEC TERT1: 10.4;RT4: 30.0;U-266/70: 8.9;U-698: 26.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA037712 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA037712: AB_2675625" "unprognostic (9.08e-3)" "unprognostic (1.23e-1)" "unprognostic (4.82e-2)" "unprognostic (3.09e-3)" "unprognostic (1.02e-1)" "unprognostic (1.55e-1)" "unprognostic (8.47e-2)" "unprognostic (2.05e-1)" "unprognostic (1.01e-1)" "unprognostic (3.11e-2)" "unprognostic (6.76e-2)" "unprognostic (3.89e-2)" "unprognostic (5.86e-2)" "unprognostic (2.95e-1)" "unprognostic (8.97e-3)" "unprognostic (5.03e-2)" 0.5 0.3 0.3 12.9 0.3 0.0 4.8 0.3 0.3 1.8 12.1 0.4 3.7 5.8 0.4 3.7 3.7 1.3 7.7 0.3 0.3 0.5 13.4 1.2 4.2 3.0 0.3 0.1 1.8 11.3 0.0 2.2 11.2 1.1 6.4 7.8 0.4 5.1 6.3 0.4 3.1 23.2 2.1 0.5 0.6 21.5 0.9 0.1 77.9 3.3 2.0 8.2 11.0 2.5 6.4 0.0 0.4 0.0 0.0 0.4 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 5.2 32.3 0.5 0.0 0.1 1.6 0.0 2.6 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 2.5 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.7 0.1 0.0 0.0 0.2 10.4 30.0 1.2 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.9 0.0 26.4 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 6.4 0.4 0.0 0.0 0.7 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.3 0.3 0.3 0.5 0.3 0.1 1.1 0.1 11.9 3.2 3.2 34.4 8.8 0.0 1.1 25.5 37.5 40.9 7.0 0.0 42.9 14.9 16.0 0.2 0.1 49.3 0.0 70.5 17.2 0.7 17.9 1.1 3.9 3.9 0.0 115.4 0.0 0.8 0.0 0.0 0.7 1.7 1.0 48.1 14.3 57.4 59.6 0.0 32.3 0.4 0.0 1.0 0.0 0.0 1.3 39.5 0.0 16.8 36.0 RAVER1 KIAA1978 ENSG00000161847 "Ribonucleoprotein, PTB binding 1" Q8IY67 19 10316212-10333640 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 11.7;Intestinal endocrine cells: 15.6;monocytes: 10.8;Undifferentiated cells: 14.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 67.4" "Low region specificity" "Detected in all" "HPA043575, HPA049457" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA043575: AB_2678562, HPA049457: AB_2680774" "unprognostic (2.04e-1)" "unprognostic (3.15e-2)" "unprognostic (1.54e-1)" "unprognostic (2.34e-2)" "unprognostic (2.36e-1)" "unprognostic (1.80e-2)" "unprognostic (1.59e-1)" "unprognostic (4.22e-2)" "unprognostic (2.01e-2)" "unprognostic (7.20e-2)" "unprognostic (2.64e-2)" "unprognostic (3.22e-2)" "unprognostic (3.40e-2)" "unprognostic (1.14e-2)" "unprognostic (1.53e-1)" "unprognostic (8.98e-2)" "unprognostic (2.97e-1)" 11.8 11.3 7.0 24.3 8.5 25.5 14.1 11.1 10.1 14.1 15.1 10.3 11.2 27.3 19.8 9.4 12.6 17.5 15.0 8.3 8.1 5.6 11.0 7.4 14.0 18.7 9.2 7.2 17.8 16.6 6.5 15.4 10.6 9.0 13.0 5.8 10.2 17.9 13.5 8.3 9.7 27.8 9.1 8.8 19.4 14.7 15.0 8.2 46.9 12.3 8.9 16.4 15.8 16.1 4.3 3.7 2.9 5.7 3.6 8.6 2.8 16.3 10.5 3.8 5.9 1.5 2.0 8.6 8.7 3.9 6.8 6.1 11.5 4.7 17.4 12.2 2.8 5.5 8.5 4.3 5.7 1.3 14.6 25.7 26.8 7.1 12.8 3.5 16.7 17.4 2.3 2.0 4.6 1.7 2.2 4.4 13.3 21.1 15.4 2.0 15.3 22.4 67.4 15.2 3.4 20.3 20.7 5.6 15.2 1.9 6.5 11.2 13.0 9.4 6.1 5.0 1.4 8.7 8.1 6.1 17.8 9.1 15.6 14.5 34.1 28.1 14.7 11.7 11.7 11.5 0.5 2.1 2.9 6.2 2.6 3.4 2.7 5.1 8.6 3.7 4.3 3.7 3.0 2.1 3.6 5.7 1.7 1.9 2.8 7.0 8.5 11.1 9.2 8.1 5.6 9.2 7.2 9.0 8.2 0.0 1.4 0.5 0.3 0.7 0.7 0.3 0.0 1.4 0.0 0.0 0.0 1.7 0.0 3.4 0.3 0.2 11.7 0.0 3.7 1.7 0.8 0.2 4.6 0.4 1.1 0.0 15.6 0.6 0.0 0.0 0.0 0.0 0.0 10.8 6.9 0.5 4.4 7.0 0.7 0.3 0.9 0.0 0.4 0.5 0.2 0.1 1.3 2.5 14.2 0.1 RAVER2 "FLJ10770, KIAA1579" ENSG00000162437 "Ribonucleoprotein, PTB binding 2" Q9HCJ3 1 64745095-64833232 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 31.0;Mucus-secreting cells: 30.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "basophil: 7.8" "Lineage enriched" "Detected in single" 9 "granulocytes: 7.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045785 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA045785: AB_10964058" "unprognostic (8.02e-2)" "unprognostic (5.23e-2)" "unprognostic (4.23e-3)" "unprognostic (2.73e-1)" "unprognostic (2.32e-1)" "unprognostic (2.89e-2)" "unprognostic (2.22e-3)" "unprognostic (1.23e-2)" "unprognostic (3.14e-1)" "unprognostic (1.47e-1)" "unprognostic (6.56e-2)" "unprognostic (1.09e-1)" "prognostic favorable (5.14e-6)" "unprognostic (1.74e-1)" "unprognostic (3.50e-2)" "unprognostic (1.41e-1)" "unprognostic (5.09e-2)" 5.2 9.6 13.2 9.2 14.0 7.8 9.0 17.4 9.3 11.5 21.8 7.2 13.9 22.3 9.1 5.9 10.8 7.5 15.2 17.1 13.4 8.1 7.5 1.7 7.9 1.9 8.6 6.1 8.2 7.3 15.2 27.7 6.9 9.1 12.0 25.7 12.6 15.3 15.1 18.5 6.5 41.4 9.1 9.5 4.6 11.8 2.6 7.4 7.0 7.2 10.7 6.8 8.4 8.4 0.2 0.9 7.8 0.1 0.2 0.4 0.0 10.3 3.2 9.9 10.7 1.8 1.5 2.7 2.3 4.2 4.8 5.4 8.5 4.6 0.0 5.4 2.4 10.8 7.9 10.0 6.9 5.8 0.0 11.1 12.6 8.6 7.6 3.4 16.9 0.1 4.5 6.4 0.3 4.9 11.1 7.8 10.6 2.7 10.5 0.4 3.8 5.6 3.5 12.2 8.2 8.6 19.3 15.5 4.2 5.1 7.8 7.4 16.7 10.4 0.0 10.1 9.7 8.1 2.7 2.9 4.4 7.2 4.4 8.1 8.0 9.0 4.4 2.7 0.0 4.1 7.8 0.1 0.1 0.2 0.0 0.4 0.2 0.2 0.1 0.9 0.1 0.1 0.1 0.0 0.2 0.0 0.4 0.1 0.0 13.2 14.0 17.4 9.3 13.4 8.1 8.6 6.1 9.1 7.4 6.0 9.1 0.0 5.5 7.1 5.8 21.8 10.2 5.3 11.4 1.8 13.7 0.1 0.0 2.5 6.3 6.9 31.0 0.0 4.5 0.3 5.3 5.9 1.1 0.0 0.5 0.0 17.3 4.3 4.0 10.7 6.1 0.7 3.3 0.0 30.2 24.7 3.0 14.4 7.8 1.6 3.5 0.0 8.1 1.2 0.9 5.1 0.2 1.5 25.1 6.3 RB1 "OSRC, PPP1R130, RB" ENSG00000139687 "RB transcriptional corepressor 1" P06400 13 48303726-48599436 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "monocytes: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 58.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000095, CAB016687, HPA050082" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB000095: , CAB016687: AB_1622010, HPA050082: AB_2681008" "unprognostic (4.24e-3)" "unprognostic (1.00e-1)" "unprognostic (3.62e-2)" "unprognostic (4.67e-2)" "unprognostic (2.04e-2)" "unprognostic (3.86e-1)" "unprognostic (4.69e-2)" "unprognostic (7.08e-2)" "unprognostic (1.59e-1)" "prognostic unfavorable (6.92e-4)" "unprognostic (4.06e-2)" "unprognostic (9.40e-2)" "unprognostic (4.67e-2)" "unprognostic (1.79e-1)" "unprognostic (9.99e-2)" "unprognostic (2.31e-1)" "unprognostic (1.70e-1)" 19.6 21.5 14.9 23.2 18.4 14.7 28.1 25.6 19.4 18.0 13.2 11.5 19.0 12.3 16.8 19.5 27.9 12.7 15.3 19.5 15.4 15.3 18.1 12.1 25.4 30.1 17.0 11.8 15.2 11.6 12.8 17.2 21.5 16.0 15.5 15.3 11.6 20.0 17.4 27.9 20.3 14.3 16.8 23.6 29.4 13.7 14.4 15.3 39.1 19.9 15.8 25.3 17.4 23.6 20.5 10.3 13.2 12.2 3.6 4.6 4.0 9.1 4.9 13.5 14.5 6.7 7.8 6.1 18.0 15.0 19.0 16.2 4.2 16.2 11.8 4.2 12.0 10.5 12.7 17.5 14.5 29.0 16.5 6.7 21.7 10.2 7.2 7.1 18.6 20.6 4.3 8.9 12.3 15.8 15.9 13.1 29.2 7.2 9.7 21.7 4.3 58.2 9.4 6.6 20.8 5.4 25.0 13.5 13.5 19.7 8.9 0.6 13.8 17.8 8.9 14.7 12.5 9.7 24.3 10.1 11.8 7.7 14.3 16.2 4.3 1.2 0.1 6.2 11.7 15.9 11.0 9.7 5.0 4.6 12.2 3.7 17.4 3.8 4.6 9.3 20.5 3.2 3.8 13.2 3.6 12.1 10.3 4.5 4.0 14.9 18.4 25.6 19.4 15.4 15.3 17.0 11.8 16.0 15.3 3.0 18.7 56.5 18.3 25.2 14.4 15.9 17.8 20.1 14.8 29.6 27.5 5.9 13.3 15.8 20.6 33.6 15.9 0.0 10.4 8.0 15.4 21.4 11.5 14.7 64.6 17.5 16.8 38.6 83.9 10.6 24.2 88.8 25.3 107.4 18.5 21.8 13.3 9.9 26.9 21.1 18.5 19.4 20.6 27.9 14.3 33.4 3.7 20.8 15.0 14.4 RBAK ZNF769 ENSG00000146587 "RB associated KRAB zinc finger" Q9NYW8 7 5045821-5069488 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071231 Supported Nucleoplasm NA NA Nucleoplasm "HPA071231: AB_2686370" "unprognostic (2.82e-2)" "unprognostic (1.98e-2)" "unprognostic (7.40e-2)" "unprognostic (1.85e-2)" "unprognostic (5.04e-1)" "unprognostic (4.32e-1)" "unprognostic (2.62e-1)" "unprognostic (2.32e-1)" "unprognostic (4.67e-2)" "unprognostic (5.91e-2)" "unprognostic (6.84e-2)" "unprognostic (5.10e-2)" "unprognostic (1.28e-1)" "unprognostic (2.50e-1)" "unprognostic (3.66e-2)" "unprognostic (6.12e-3)" "unprognostic (5.75e-2)" 7.6 7.3 7.1 15.0 11.6 5.8 10.7 19.0 10.6 9.2 8.3 5.9 12.0 7.9 9.6 9.7 14.4 8.4 7.5 7.7 9.4 8.3 8.8 12.0 7.7 16.5 8.8 11.6 9.7 11.0 17.5 11.6 8.1 8.7 9.1 9.1 6.2 11.0 14.2 7.9 10.7 9.8 8.9 7.9 10.6 8.8 6.0 11.0 20.0 10.3 15.1 11.7 11.1 10.0 1.7 1.9 1.7 1.8 2.0 3.0 0.6 7.7 6.1 8.5 15.7 6.2 5.8 7.0 4.9 3.9 4.9 5.8 7.4 5.0 9.4 4.2 5.7 9.3 9.8 9.4 7.7 7.6 2.0 6.7 6.7 7.8 6.2 6.6 11.6 8.2 5.7 9.3 4.8 11.0 7.2 4.8 5.5 14.1 3.4 6.1 13.9 2.8 10.5 13.4 2.7 6.3 4.6 13.8 6.9 5.8 10.2 8.7 14.4 7.0 11.7 10.3 11.4 7.1 13.7 4.0 5.9 9.4 6.7 8.1 10.5 8.3 8.4 5.9 8.5 7.6 0.0 0.9 1.7 2.4 1.8 3.0 1.7 1.8 1.7 1.5 1.3 2.2 1.8 0.1 2.0 0.4 1.9 1.2 0.6 7.1 11.6 19.0 10.6 9.4 8.3 8.8 11.6 8.7 11.0 0.0 5.1 5.4 3.1 3.8 7.7 11.5 5.1 4.0 6.8 0.0 9.8 2.2 1.7 5.3 0.8 4.3 4.9 23.3 5.1 1.8 4.2 4.6 5.7 4.0 3.1 20.6 4.7 9.2 7.9 1.0 7.5 2.5 3.3 1.8 5.2 5.0 5.2 3.6 8.1 3.7 7.4 0.0 5.2 4.1 3.3 6.0 1.6 6.9 5.6 3.5 RBBP4 "lin-53, NURF55, RbAp48" ENSG00000162521 "RB binding protein 4, chromatin remodeling factor" Q09028 1 32651142-32686211 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006264, HPA060710, HPA060724" Supported Enhanced Nucleoplasm NA NA 27000 Nucleoplasm "CAB006264: AB_425651, HPA060710: AB_2684347, HPA060724: AB_2684350" "unprognostic (1.18e-3)" "unprognostic (1.79e-3)" "unprognostic (2.96e-3)" "unprognostic (1.82e-2)" "prognostic favorable (9.23e-4)" "unprognostic (1.62e-2)" "prognostic unfavorable (1.89e-6)" "unprognostic (1.24e-2)" "prognostic unfavorable (6.45e-4)" "unprognostic (1.57e-2)" "unprognostic (1.30e-1)" "unprognostic (2.69e-1)" "unprognostic (1.36e-3)" "unprognostic (3.05e-2)" "unprognostic (1.51e-1)" "unprognostic (2.29e-1)" "unprognostic (1.88e-2)" 23.8 33.6 28.2 34.3 27.8 23.4 29.1 30.5 35.1 32.2 24.1 32.0 42.3 20.5 36.0 29.2 26.0 35.4 21.3 24.0 27.9 24.8 25.2 25.4 23.0 43.9 30.6 29.0 37.6 31.3 27.0 32.9 26.2 26.9 24.2 35.5 31.2 30.1 43.1 31.8 24.9 26.8 32.6 26.9 27.6 28.8 53.4 31.4 73.3 35.8 20.5 65.2 32.5 26.6 33.7 45.4 26.7 39.4 33.1 32.4 48.4 15.6 13.7 39.2 28.6 12.1 11.5 15.9 11.9 10.4 24.4 23.8 19.6 32.2 47.5 13.2 14.1 14.1 10.1 42.9 12.4 26.3 18.5 20.6 44.3 27.7 25.7 17.5 41.8 19.2 12.6 15.8 18.4 12.0 19.0 18.0 32.9 31.1 34.1 20.8 10.9 53.5 13.1 43.6 15.5 16.0 52.0 41.3 41.2 17.1 33.5 37.5 22.3 28.2 10.1 19.3 40.4 17.3 19.3 14.9 14.8 15.1 18.7 16.0 27.0 28.3 53.3 17.7 33.8 22.7 26.4 38.8 26.7 31.1 39.4 32.4 33.7 29.7 31.4 45.4 26.6 26.7 28.8 10.2 33.1 35.3 38.3 30.3 48.4 28.2 27.8 30.5 35.1 27.9 24.8 30.6 29.0 26.9 31.4 38.7 41.4 104.6 60.7 63.4 104.9 19.4 79.0 50.9 46.6 69.8 135.5 102.1 71.3 72.0 18.9 58.2 40.2 23.3 50.7 69.8 69.6 53.3 47.4 69.1 71.5 100.1 93.2 70.6 73.4 13.7 73.6 63.2 47.2 72.1 69.7 74.5 62.2 28.8 83.1 53.7 104.1 97.0 47.5 120.2 77.3 67.8 71.5 85.3 75.6 47.1 RBBP5 "RBQ3, SWD1" ENSG00000117222 "RB binding protein 5, histone lysine methyltransferase complex subunit" Q15291 1 205086142-205122015 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049042, HPA058085" Uncertain Supported Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA049042: AB_2680610, HPA058085: AB_2683600" "unprognostic (8.72e-2)" "unprognostic (6.35e-2)" "unprognostic (2.14e-2)" "unprognostic (1.36e-2)" "unprognostic (1.60e-1)" "unprognostic (1.17e-1)" "unprognostic (4.61e-3)" "unprognostic (1.24e-1)" "unprognostic (3.07e-2)" "unprognostic (2.88e-1)" "unprognostic (2.75e-1)" "unprognostic (4.98e-2)" "unprognostic (6.90e-2)" "unprognostic (3.78e-3)" "unprognostic (4.95e-2)" "unprognostic (1.28e-1)" "unprognostic (4.88e-2)" 12.9 17.0 13.7 10.9 23.1 13.5 13.0 20.9 23.3 13.7 11.2 16.4 6.7 11.3 16.4 12.8 11.9 12.6 9.9 10.4 13.2 12.9 20.6 17.3 10.5 16.5 13.5 12.5 16.2 16.8 15.9 21.5 10.3 15.0 11.8 13.2 12.7 14.6 12.0 18.8 14.9 12.7 11.6 10.5 14.0 10.7 9.5 13.7 22.5 17.4 8.9 19.8 11.7 16.7 8.6 6.1 19.1 7.7 7.7 9.6 3.3 10.7 11.4 11.0 13.0 15.4 8.9 12.0 10.2 8.8 13.1 13.1 12.0 13.0 16.8 7.9 7.5 10.7 12.4 18.3 6.8 15.6 14.2 9.8 14.0 11.6 9.7 10.0 17.5 11.5 7.1 8.9 12.2 10.4 8.8 10.5 12.1 27.0 17.2 10.9 9.9 16.8 7.5 17.9 9.4 19.0 15.1 23.5 20.9 9.1 7.9 17.3 14.0 14.4 15.3 13.0 13.8 16.5 9.9 7.9 10.9 11.7 15.9 13.4 8.5 11.7 20.6 9.7 11.0 16.7 19.1 5.2 7.5 8.6 6.3 9.2 8.6 8.1 8.8 5.4 7.1 8.0 9.6 11.9 7.7 7.7 6.1 8.1 3.3 13.7 23.1 20.9 23.3 13.2 12.9 13.5 12.5 15.0 13.7 17.9 13.5 16.3 9.4 23.9 13.8 6.5 7.6 14.7 17.0 21.0 27.5 8.0 8.3 10.8 6.4 13.8 14.0 0.0 10.0 8.2 9.8 10.8 12.8 20.2 9.7 15.9 11.6 17.8 14.1 1.7 11.8 15.2 18.6 10.0 12.4 15.8 11.6 10.5 15.2 23.1 18.8 19.4 9.8 8.8 18.1 29.5 9.0 21.7 13.3 12.2 RBBP7 RbAp46 ENSG00000102054 "RB binding protein 7, chromatin remodeling factor" Q16576 X 16839283-16870414 "Predicted intracellular proteins" "DNA replication, Transcription, Transcription regulation" "Chaperone, Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 376.6;Syncytiotrophoblasts: 445.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037084, HPA060710, HPA060724" Supported Enhanced Nucleoplasm NA NA 25000 Nucleoplasm "CAB037084: AB_477448, HPA060710: AB_2684347, HPA060724: AB_2684350" "unprognostic (5.18e-1)" "unprognostic (3.29e-2)" "unprognostic (6.68e-3)" "unprognostic (1.09e-2)" "unprognostic (8.85e-2)" "unprognostic (2.39e-1)" "prognostic unfavorable (5.55e-4)" "unprognostic (3.64e-1)" "unprognostic (1.87e-2)" "unprognostic (3.00e-2)" "unprognostic (7.82e-2)" "unprognostic (1.10e-1)" "unprognostic (6.07e-2)" "unprognostic (1.58e-1)" "unprognostic (1.20e-1)" "prognostic favorable (2.43e-4)" "unprognostic (5.65e-2)" 16.0 81.2 16.6 21.1 26.7 20.3 15.5 13.3 16.2 34.6 22.8 15.3 103.2 13.1 32.3 77.3 20.9 24.5 19.7 36.2 15.1 13.1 17.3 18.5 14.3 19.7 13.7 15.5 41.6 19.0 47.8 16.0 28.7 12.2 26.2 18.1 16.5 19.0 87.6 78.2 16.4 17.9 25.9 15.9 16.0 23.5 31.6 13.6 30.8 18.1 18.2 24.5 24.3 18.5 36.6 29.4 23.7 41.2 32.8 37.7 27.3 54.1 40.3 30.7 40.4 19.3 22.8 19.5 27.0 27.1 39.8 45.1 23.6 35.9 59.9 41.5 26.1 45.8 28.7 54.7 40.1 52.8 33.9 75.1 25.3 49.0 28.0 16.4 38.2 30.7 17.7 14.8 45.8 33.6 25.6 39.8 25.3 25.3 32.0 31.4 36.4 42.7 35.4 34.5 26.2 37.5 37.5 56.5 70.7 28.9 36.5 28.6 21.2 50.9 24.5 23.9 45.1 81.3 23.2 18.3 19.2 19.7 50.6 29.9 22.4 32.0 78.7 24.7 25.8 23.3 16.6 18.3 23.7 36.4 31.3 34.8 36.6 30.4 37.7 25.4 31.0 32.2 35.9 7.4 32.8 41.2 29.4 27.9 27.3 16.6 26.7 13.3 16.2 15.1 13.1 13.7 15.5 12.2 13.6 47.6 54.2 48.2 88.5 66.4 28.9 94.0 30.6 84.3 85.3 52.4 27.5 376.6 66.3 71.3 10.8 45.8 40.0 0.0 65.2 134.7 86.4 63.3 56.6 33.9 93.5 23.8 58.3 39.9 27.6 22.8 105.3 44.7 79.2 75.7 53.5 73.6 61.9 31.6 176.0 51.2 38.7 135.8 87.2 52.9 107.5 53.3 445.1 67.8 67.4 67.3 RBBP8 "COM1, CtIP, RIM, SCKL2" ENSG00000101773 "RB binding protein 8, endonuclease" Q99708 18 22798261-23026488 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis" "DNA-binding, Endonuclease, Hydrolase, Nuclease" "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 82.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 21.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA039890, HPA052946" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA039890: AB_10794756, HPA052946: AB_2681996" "unprognostic (1.55e-3)" "unprognostic (4.10e-3)" "unprognostic (7.89e-2)" "unprognostic (1.01e-1)" "unprognostic (2.44e-1)" "unprognostic (7.28e-2)" "unprognostic (3.60e-3)" "unprognostic (1.87e-1)" "prognostic unfavorable (7.21e-4)" "unprognostic (2.29e-2)" "unprognostic (1.58e-3)" "unprognostic (1.04e-2)" "prognostic favorable (1.71e-5)" "unprognostic (3.91e-3)" "unprognostic (2.42e-2)" "unprognostic (1.01e-2)" "unprognostic (4.48e-1)" 9.0 6.2 6.0 10.8 6.4 9.4 19.4 4.2 5.9 16.4 13.4 4.1 22.5 5.4 13.1 18.6 17.1 17.6 8.7 8.3 4.9 6.8 49.6 12.3 17.0 7.8 6.6 3.6 12.2 14.3 17.4 29.2 11.5 11.5 13.4 8.0 5.3 14.8 29.1 3.8 17.4 14.0 10.3 4.5 9.8 7.8 16.7 3.8 24.2 14.7 10.8 10.0 10.4 13.0 4.3 5.1 7.8 21.0 5.0 2.8 2.2 9.6 7.4 11.0 12.7 5.7 6.1 8.6 13.3 9.4 12.4 17.5 13.6 10.9 28.1 6.2 8.3 11.9 20.3 12.4 27.0 24.4 20.0 10.0 12.3 10.1 12.9 7.0 44.1 13.5 4.3 26.2 18.7 32.6 7.3 5.0 19.8 7.2 21.1 12.6 14.3 32.6 14.8 10.4 17.7 12.6 16.9 20.2 17.3 35.8 10.4 25.9 12.3 22.2 6.8 11.4 6.6 39.3 11.6 3.6 33.3 15.3 16.0 23.1 28.6 30.7 30.9 15.2 21.4 17.8 7.8 4.0 2.3 0.8 14.8 0.3 4.3 1.1 1.4 5.1 3.3 0.6 1.0 1.5 5.0 21.0 5.1 2.8 2.2 6.0 6.4 4.2 5.9 4.9 6.8 6.6 3.6 11.5 3.8 32.8 33.1 14.7 39.9 24.4 4.5 8.5 20.4 34.8 53.4 27.9 3.9 9.7 36.5 26.8 13.1 13.4 13.5 0.0 28.8 8.0 9.5 23.1 66.7 17.3 10.0 1.6 7.5 6.7 6.0 10.6 6.1 14.7 21.9 3.6 8.1 1.3 35.0 10.2 4.9 19.4 7.3 0.0 12.8 82.6 71.3 17.2 12.7 7.1 12.1 45.5 RBBP9 Bog ENSG00000089050 "RB binding protein 9, serine hydrolase" O75884 20 18486540-18497243 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015830, HPA049005" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA015830: AB_1845410, HPA049005: AB_2680597" "unprognostic (1.17e-2)" "unprognostic (2.51e-2)" "unprognostic (2.37e-2)" "unprognostic (1.32e-1)" "unprognostic (4.27e-2)" "unprognostic (1.26e-3)" "unprognostic (2.14e-1)" "unprognostic (7.63e-2)" "unprognostic (1.52e-1)" "unprognostic (4.71e-2)" "unprognostic (2.28e-1)" "unprognostic (1.03e-1)" "unprognostic (2.14e-2)" "unprognostic (3.93e-3)" "unprognostic (1.08e-1)" "unprognostic (2.21e-1)" "unprognostic (6.21e-2)" 8.6 18.4 10.7 7.1 11.6 3.6 11.0 11.4 11.2 16.1 7.4 15.4 9.1 7.7 10.7 8.0 9.3 7.0 11.9 9.0 9.0 9.6 19.8 39.3 9.6 8.6 11.5 7.4 9.5 7.2 15.3 14.4 6.6 12.8 10.1 8.8 12.8 13.2 10.8 4.4 14.1 10.2 9.2 13.0 10.1 8.1 5.1 9.4 9.0 27.5 9.9 9.8 8.9 7.8 3.6 3.3 10.8 3.8 2.8 4.6 3.1 7.4 8.8 8.2 11.5 5.9 9.8 8.4 8.6 8.4 11.2 11.6 6.3 6.8 9.4 3.5 6.0 7.8 8.5 6.5 14.2 13.5 2.8 7.9 4.9 2.9 19.3 3.7 7.1 3.0 5.0 5.7 9.2 5.5 5.6 14.0 7.9 3.1 7.4 9.7 4.2 7.4 5.0 5.4 10.4 16.7 7.3 24.4 5.9 10.1 8.2 7.1 12.0 11.6 14.0 5.9 5.8 11.2 2.0 8.0 18.9 6.2 11.8 7.6 8.4 20.8 6.5 7.4 3.4 6.0 10.8 3.0 0.9 3.2 3.8 4.6 3.6 3.8 2.2 3.3 3.1 3.4 2.7 0.5 2.8 2.8 0.6 4.5 3.1 10.7 11.6 11.4 11.2 9.0 9.6 11.5 7.4 12.8 9.4 20.8 16.5 0.0 2.9 6.5 4.3 7.0 0.0 12.0 9.1 10.4 0.0 2.9 13.3 5.3 2.4 5.3 5.8 0.0 2.4 3.4 4.3 2.7 0.0 16.3 4.7 3.2 5.2 4.9 5.1 0.5 4.9 4.4 5.0 6.4 4.2 8.8 3.8 0.0 6.7 18.4 5.9 0.0 4.1 0.3 4.3 5.4 2.1 3.9 5.8 3.3 RBFOX1 "A2BP1, FOX-1, HRNBP1" ENSG00000078328 "RNA binding fox-1 homolog 1" Q9NWB1 16 5239802-7713338 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 57.2;heart muscle: 17.6;skeletal muscle: 67.6" "Cell type enriched" "Detected in some" 11 "Cardiomyocytes: 81.4" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 15 "RH-30: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040809, HPA066746, HPA075862" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol" No No Nucleoplasm "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA040809: AB_10796228, HPA066746: , HPA075862: " "unprognostic (3.75e-3)" "unprognostic (2.11e-1)" "unprognostic (1.59e-1)" "unprognostic (1.76e-2)" "unprognostic (5.19e-3)" "unprognostic (8.82e-5)" "unprognostic (5.02e-1)" "unprognostic (3.08e-1)" "unprognostic (1.47e-1)" "unprognostic (1.43e-2)" "unprognostic (3.24e-2)" "unprognostic (2.23e-1)" "unprognostic (5.00e-2)" "unprognostic (2.28e-1)" 1.2 2.4 19.9 1.5 33.0 1.6 1.3 31.5 57.2 1.4 1.9 1.9 0.0 1.3 1.3 5.0 2.0 2.2 1.3 17.6 16.4 6.7 1.5 1.3 1.2 1.2 3.7 21.7 1.4 1.3 1.2 0.5 1.3 13.5 2.6 1.7 0.0 1.7 4.9 67.6 1.5 1.4 1.2 3.5 1.2 1.4 1.7 5.6 0.0 1.3 9.7 1.2 1.5 0.3 1.7 0.7 3.1 0.7 1.2 1.4 0.0 0.1 0.2 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.6 0.0 0.0 0.0 1.4 0.0 0.0 0.0 25.1 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.0 0.1 0.2 0.2 0.0 2.4 0.6 2.0 1.1 0.3 0.7 1.0 0.9 0.8 0.3 1.7 1.4 1.0 3.1 1.2 0.7 0.7 1.0 0.0 19.9 33.0 31.5 34.3 16.4 6.7 3.7 21.7 13.5 5.6 0.0 0.3 0.0 0.0 0.0 2.3 81.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 1.1 0.0 1.7 1.0 0.4 7.1 0.0 0.0 0.0 0.2 2.8 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.8 0.0 RBFOX2 "FOX-2, HNRBP2, HRNBP2, RBM9" ENSG00000100320 "RNA binding fox-1 homolog 2" O43251 22 35738736-36028425 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.1" "Lineage enriched" "Detected in single" 4 "T-cells: 3.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006240, HPA075862" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA006240: AB_1079750, HPA075862: " "unprognostic (3.17e-1)" "unprognostic (4.80e-2)" "unprognostic (9.30e-2)" "unprognostic (3.21e-3)" "unprognostic (3.42e-1)" "unprognostic (2.74e-2)" "unprognostic (2.28e-1)" "unprognostic (2.14e-1)" "unprognostic (1.42e-2)" "unprognostic (1.63e-2)" "unprognostic (1.08e-1)" "unprognostic (1.43e-1)" "unprognostic (1.02e-1)" "unprognostic (5.78e-3)" "unprognostic (2.13e-2)" "unprognostic (1.53e-2)" "unprognostic (6.08e-2)" 14.0 11.6 25.7 7.6 30.5 0.4 12.7 58.4 37.2 26.4 23.2 7.4 11.2 7.9 38.5 13.8 22.9 20.4 16.7 20.8 19.6 15.9 10.2 10.6 12.7 3.7 12.0 26.3 43.3 9.3 20.5 20.6 21.3 22.8 18.3 13.6 9.7 10.3 20.5 40.7 12.6 10.6 32.6 9.7 5.4 13.3 10.4 10.1 1.8 18.7 5.7 5.3 18.1 15.9 0.0 0.7 0.0 0.0 0.1 3.1 0.1 15.1 9.9 32.3 18.9 20.3 34.2 13.3 28.4 38.1 21.2 23.3 18.9 6.5 9.7 13.7 32.2 12.4 14.7 11.7 13.0 27.1 7.7 13.5 5.4 8.8 7.0 6.1 1.5 4.1 24.8 16.8 20.2 23.0 19.3 25.7 2.4 4.1 1.2 23.2 5.9 1.5 0.8 12.6 5.7 13.7 2.3 28.7 2.2 14.6 17.0 10.0 37.9 32.4 5.1 10.0 17.1 6.0 1.8 31.7 30.3 17.9 17.9 13.1 1.1 3.1 12.0 14.2 2.2 17.1 0.0 0.0 0.0 1.0 0.0 3.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.7 0.0 0.1 25.7 30.5 58.4 37.2 19.6 15.9 12.0 26.3 22.8 10.1 62.5 32.6 0.5 41.3 33.0 3.3 54.1 25.5 14.7 33.0 26.2 0.0 50.4 29.9 47.1 14.6 43.8 18.4 0.0 27.9 74.6 68.9 41.7 2.3 20.9 8.6 111.2 54.8 32.5 1.3 5.4 73.6 3.3 15.1 4.6 22.3 15.4 54.8 2.9 87.7 14.0 5.9 51.8 71.0 35.7 22.7 29.5 24.3 2.5 23.4 50.4 RBFOX3 "FOX-3, HRNBP3, NeuN" ENSG00000167281 "RNA binding fox-1 homolog 3" A6NFN3 17 79089345-79516148 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.4;seminal vesicle: 21.5" "Cell type enhanced" "Detected in many" 12 "Glandular cells: 12.8;Peritubular cells: 9.9;Spermatogonia: 21.3" "Cancer enhanced" "Detected in some" "prostate cancer: 1.1" "Region enhanced" "Detected in all" "cerebellum: 60.4" "Cell type enhanced" "Detected in single" "gdT-cell: 1.4" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "A549: 13.2;NTERA-2: 11.9;SCLC-21H: 19.2;U-2 OS: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030790, HPA075862, CAB078782" Enhanced Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB078782: , HPA030790: AB_10602305, HPA075862: " "unprognostic (2.84e-1)" "unprognostic (1.88e-1)" "unprognostic (4.10e-2)" "unprognostic (9.23e-3)" "unprognostic (8.85e-2)" "unprognostic (2.34e-1)" "unprognostic (1.69e-1)" "unprognostic (1.09e-1)" "unprognostic (7.72e-2)" "unprognostic (1.50e-1)" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (3.22e-15)" "unprognostic (8.92e-3)" "unprognostic (1.92e-1)" "unprognostic (1.61e-1)" "unprognostic (1.88e-1)" 0.5 1.0 10.2 0.6 23.5 0.6 0.2 60.4 33.2 0.5 15.2 0.3 0.2 1.5 9.3 3.0 8.3 1.0 0.3 0.3 8.6 3.3 0.4 0.2 0.3 0.4 1.8 3.5 0.3 0.5 0.2 0.9 0.3 5.5 13.2 2.2 0.2 0.2 21.5 0.3 0.3 1.3 8.1 2.3 0.4 0.5 7.2 5.6 0.2 0.3 0.2 0.2 15.2 1.0 0.7 0.2 0.0 0.7 0.0 1.4 0.2 0.0 13.2 0.2 0.2 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 11.9 0.0 0.2 0.2 0.5 0.0 0.0 0.0 19.2 0.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 9.0 0.5 0.0 0.8 0.0 0.3 0.4 0.3 0.0 0.0 0.7 0.0 1.4 0.3 0.0 0.7 0.1 0.4 0.2 0.7 0.4 0.9 0.0 0.0 0.0 0.1 0.0 0.2 10.2 23.5 60.4 19.5 8.6 3.3 1.8 3.5 5.5 5.6 0.0 0.0 0.0 4.7 1.8 2.5 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.8 0.4 0.0 0.0 0.0 0.1 1.0 12.8 0.0 0.0 0.1 4.8 0.0 0.0 0.8 7.1 0.3 0.7 5.0 0.0 0.0 1.0 0.0 0.0 9.9 0.0 3.3 0.0 2.3 0.7 21.3 1.3 0.1 2.1 0.0 2.0 RBKS "DKFZp686G13268, RBSK" ENSG00000171174 Ribokinase Q9H477 2 27781364-27891098 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 57.6;Proximal tubular cells: 88.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 10.5;RPTEC TERT1: 22.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019725, HPA028285" Enhanced Approved Nucleoplasm,Cytosol No No Cytosol Nucleoplasm "HPA019725: AB_1856105, HPA028285: AB_10601480" "unprognostic (1.25e-1)" "unprognostic (2.16e-1)" "unprognostic (2.51e-2)" "unprognostic (5.54e-3)" "unprognostic (4.15e-3)" "unprognostic (2.44e-1)" "unprognostic (1.43e-2)" "unprognostic (4.77e-2)" "unprognostic (2.45e-1)" "unprognostic (5.35e-2)" "unprognostic (1.46e-1)" "unprognostic (3.98e-1)" "unprognostic (1.20e-1)" "unprognostic (1.19e-1)" "unprognostic (1.72e-1)" "unprognostic (1.74e-1)" "unprognostic (9.27e-2)" 14.4 22.2 2.5 2.4 5.2 4.1 2.2 2.1 4.1 2.6 3.0 1.7 4.9 12.4 4.7 4.7 3.1 7.4 10.7 3.5 3.7 4.3 15.1 22.6 10.4 0.8 3.0 2.4 24.2 2.4 3.5 10.3 6.2 12.3 6.9 2.4 2.2 1.4 16.8 7.6 1.0 11.8 3.8 4.7 1.7 1.6 4.8 1.4 0.3 4.5 2.8 1.1 4.8 12.0 5.8 5.1 5.6 3.8 4.9 6.5 3.4 3.1 2.1 0.3 0.4 0.4 0.7 2.1 0.8 0.6 0.4 0.6 4.8 1.5 1.1 10.5 1.7 1.5 1.3 0.2 1.0 0.8 0.4 0.2 0.1 0.5 4.1 1.6 0.9 0.2 1.0 1.7 2.7 3.7 0.7 0.6 1.9 0.1 1.3 2.0 4.1 0.7 2.3 0.0 2.1 1.7 0.9 0.2 0.7 22.1 0.2 0.9 1.2 2.9 4.0 1.7 1.1 1.8 4.6 0.2 0.7 0.5 1.9 1.2 6.7 7.9 2.1 1.9 3.1 0.1 5.6 3.8 1.9 3.0 1.6 6.1 5.8 4.0 6.5 5.1 4.6 4.2 3.6 5.6 4.9 0.8 0.8 5.8 3.4 2.5 5.2 2.1 4.1 3.7 4.3 3.0 2.4 12.3 1.4 6.0 5.3 1.9 2.8 1.8 10.3 6.4 2.5 57.6 7.9 17.4 3.9 3.3 39.7 9.3 26.8 4.1 18.8 0.0 11.1 1.1 1.9 1.1 2.3 25.3 5.5 7.9 3.5 1.8 1.8 21.9 1.4 7.2 1.7 2.8 3.2 12.1 7.7 7.0 2.5 88.0 18.7 0.0 2.1 15.4 14.5 1.4 1.3 5.0 6.4 1.7 RBL1 "cp107, p107, PRB1" ENSG00000080839 "RB transcriptional corepressor like 1" P28749 20 36996349-37095995 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 2: 14.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA054962, HPA056525" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA054962: AB_2682652, HPA056525: AB_2683165" "unprognostic (1.97e-1)" "unprognostic (2.47e-2)" "unprognostic (1.30e-2)" "unprognostic (3.70e-3)" "unprognostic (2.13e-1)" "unprognostic (1.51e-1)" "unprognostic (6.25e-5)" "unprognostic (6.91e-2)" "unprognostic (7.19e-3)" "unprognostic (1.20e-1)" "unprognostic (4.49e-3)" "unprognostic (3.23e-2)" "prognostic unfavorable (2.52e-6)" "unprognostic (3.15e-2)" "unprognostic (2.75e-1)" "unprognostic (1.47e-2)" "unprognostic (1.26e-1)" 5.0 4.3 4.9 12.3 7.1 20.4 4.8 16.6 7.8 5.1 5.6 5.5 5.9 4.0 8.1 3.0 7.7 4.4 3.6 4.0 4.0 3.6 3.3 3.0 4.5 11.1 6.5 2.2 7.8 6.0 5.9 5.9 8.3 5.7 4.4 6.1 5.3 4.8 2.7 10.2 5.3 5.9 5.9 7.1 6.9 4.6 8.2 5.5 19.6 5.3 6.1 11.4 4.7 7.1 5.0 5.1 2.2 1.9 3.6 7.4 1.6 12.2 7.9 10.0 6.7 2.5 3.4 6.4 14.3 6.4 12.4 12.9 8.4 6.9 13.7 4.1 5.9 7.3 12.1 8.9 9.2 20.7 4.7 4.8 13.5 9.5 7.1 1.5 17.3 9.4 1.6 1.3 16.3 5.8 2.1 6.9 9.1 9.8 13.3 7.0 5.2 16.1 5.7 2.9 6.2 7.8 10.5 29.8 10.4 2.8 6.1 2.4 6.0 15.6 9.0 4.1 3.3 5.8 12.5 4.5 21.9 8.4 20.0 12.4 4.4 7.8 13.9 15.7 12.2 10.8 1.4 1.2 2.2 5.0 1.4 4.2 5.0 5.6 4.5 2.2 3.9 6.0 4.8 0.6 3.6 1.9 5.1 7.4 1.6 4.9 7.1 16.6 7.8 4.0 3.6 6.5 2.2 5.7 5.5 6.0 14.1 9.2 1.4 2.2 5.2 2.4 0.0 1.4 10.3 0.0 2.0 4.7 0.0 1.3 1.3 2.1 0.8 0.0 1.0 4.2 2.5 0.6 8.1 1.0 4.0 3.2 1.2 1.8 2.8 0.2 2.0 3.2 1.7 4.6 1.1 4.0 1.1 2.8 2.8 0.6 12.8 6.5 1.2 8.7 6.6 1.1 3.2 5.4 2.3 0.7 RBL2 "p130, Rb2" ENSG00000103479 "RB transcriptional corepressor like 2" Q08999 16 53433977-53491649 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 410.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016547, HPA019703" Supported Supported "Nucleoplasm,Nucleoli rim,Mitotic chromosome,Cytosol" Yes No "Nucleoplasm, Nucleoli rim, Mitotic chromosome" Cytosol "CAB016547: AB_785011, HPA019703: AB_1856106" "unprognostic (1.51e-1)" "unprognostic (4.38e-2)" "unprognostic (4.00e-2)" "unprognostic (1.26e-1)" "unprognostic (6.88e-2)" "unprognostic (6.43e-2)" "unprognostic (5.03e-2)" "unprognostic (2.46e-2)" "unprognostic (1.04e-1)" "unprognostic (2.11e-1)" "unprognostic (4.70e-1)" "unprognostic (8.12e-2)" "prognostic favorable (3.57e-5)" "unprognostic (9.57e-3)" "unprognostic (1.02e-1)" "unprognostic (8.70e-2)" "unprognostic (7.51e-2)" 27.8 20.6 15.7 22.2 20.0 11.1 25.5 24.1 18.7 26.3 23.7 24.7 25.6 15.4 30.0 20.2 21.5 25.1 19.5 19.9 15.5 11.7 23.8 34.2 24.0 31.6 25.8 13.7 29.3 30.7 55.3 22.6 12.4 15.8 28.2 18.9 20.2 26.2 30.5 28.3 20.8 24.6 26.1 17.9 27.2 24.9 28.6 22.8 54.4 31.0 10.3 31.6 36.5 26.8 9.1 8.0 20.2 9.8 26.2 35.1 24.5 12.6 8.6 11.6 10.7 30.3 29.3 5.4 9.3 13.3 11.7 4.0 5.6 16.0 18.6 14.2 15.8 11.0 16.0 8.7 14.5 18.6 6.6 12.0 8.3 8.8 10.4 13.1 11.6 26.2 18.6 17.8 7.9 11.4 23.5 18.0 20.6 6.8 11.7 13.0 3.7 23.0 15.6 4.7 14.4 7.9 16.8 21.1 21.3 11.4 13.0 9.4 7.9 21.2 9.3 9.1 10.1 12.1 15.2 14.9 14.5 7.7 11.9 6.9 17.9 10.6 21.8 18.0 14.5 9.9 16.4 8.2 20.2 21.2 5.9 23.7 8.7 23.8 24.3 8.0 9.1 35.1 29.6 15.7 26.2 9.8 4.9 17.5 24.5 15.7 20.0 24.1 18.7 15.5 11.7 25.8 13.7 15.8 22.8 38.7 83.1 23.6 26.7 20.5 27.2 10.1 40.8 42.8 43.3 26.2 19.6 4.5 14.9 10.6 410.5 23.6 18.8 0.0 8.9 12.0 22.6 37.9 53.2 40.8 10.1 33.4 19.0 33.2 46.3 128.8 38.9 26.4 10.1 23.4 31.9 37.2 10.2 10.5 40.3 21.4 22.5 38.8 24.7 118.2 42.4 24.1 3.4 79.1 23.7 30.9 RBM11 ENSG00000185272 "RNA binding motif protein 11" P57052 21 14216130-14228372 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 20.6;epididymis: 55.3" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 13.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 4.1" "Lineage enriched" "Detected in single" 11 "T-cells: 4.1" "Cell line enhanced" "Detected in some" "HEL: 3.6;NTERA-2: 2.8;REH: 2.8;SK-BR-3: 3.1;SuSa: 3.4;U-266/70: 2.8;WM-115: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045885 Supported Nucleoplasm NA NA Nucleoplasm "HPA045885: AB_10963937" "unprognostic (1.95e-2)" "unprognostic (1.35e-1)" "unprognostic (3.57e-1)" "unprognostic (5.44e-4)" "unprognostic (2.18e-1)" "unprognostic (7.97e-2)" "unprognostic (3.89e-1)" "unprognostic (1.38e-1)" "unprognostic (1.41e-1)" "unprognostic (3.23e-2)" "unprognostic (9.92e-4)" "unprognostic (5.74e-2)" "unprognostic (1.16e-4)" "unprognostic (3.45e-2)" "unprognostic (4.81e-2)" "unprognostic (2.69e-1)" "unprognostic (9.24e-3)" 1.2 1.8 5.0 1.4 5.8 1.5 1.5 2.3 7.3 1.0 1.2 1.9 0.6 1.3 1.8 55.3 1.6 2.1 1.2 1.3 5.9 6.1 1.4 1.0 1.2 1.3 6.1 4.3 3.5 1.4 2.2 5.4 1.1 9.7 1.6 1.1 2.8 1.5 2.2 1.0 1.1 1.0 1.4 20.6 1.5 1.3 2.5 6.1 0.0 2.4 0.0 1.2 1.1 0.9 0.3 0.0 0.0 0.1 0.0 4.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.3 1.1 0.0 0.4 0.0 1.4 0.0 0.4 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 1.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 1.5 1.1 0.0 2.8 0.0 0.0 2.8 0.0 0.0 0.7 1.1 0.3 0.0 0.4 3.1 0.0 3.4 0.6 0.6 0.0 0.0 1.0 0.0 0.0 2.8 0.0 0.4 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.6 0.0 0.0 0.3 4.1 1.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 5.8 2.3 7.3 5.9 6.1 6.1 4.3 9.7 6.1 3.0 2.4 0.0 5.9 1.5 6.8 0.0 0.0 1.4 1.2 1.8 0.0 2.0 13.3 2.3 6.7 0.1 0.0 0.0 1.1 0.7 0.7 5.9 2.3 0.0 0.7 4.8 7.5 0.0 0.0 3.6 0.6 0.0 0.0 1.0 0.7 8.1 1.0 0.0 0.7 0.6 4.3 0.0 3.3 3.9 6.9 1.0 1.0 0.0 0.2 4.3 RBM12 "HRIHFB2091, KIAA0765, SWAN" ENSG00000244462 "RNA binding motif protein 12" Q9NTZ6 20 35648925-35664956 "Disease related genes, Predicted intracellular proteins" RNA-binding "Disease mutation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043258, HPA043621" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA043258: AB_2678395, HPA043621: AB_2678584" "unprognostic (8.94e-2)" "unprognostic (2.39e-1)" "unprognostic (1.04e-3)" "unprognostic (7.57e-2)" "unprognostic (1.04e-1)" "unprognostic (4.19e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (7.96e-2)" "unprognostic (8.56e-2)" "unprognostic (1.28e-1)" "unprognostic (7.47e-2)" "unprognostic (3.34e-2)" "unprognostic (3.67e-1)" "unprognostic (3.29e-1)" "unprognostic (4.44e-1)" "unprognostic (3.92e-1)" "unprognostic (6.87e-2)" 23.3 26.1 18.6 26.6 20.6 22.5 23.1 28.1 19.9 26.7 20.8 19.3 21.2 17.5 31.1 21.3 27.9 29.4 22.4 21.1 17.8 12.5 19.5 18.7 23.8 32.2 17.7 20.0 39.5 18.9 24.4 25.7 31.4 15.6 22.7 21.6 22.1 25.6 18.6 24.4 22.1 25.7 25.2 15.4 28.5 21.7 20.6 18.6 52.8 29.3 21.9 37.6 28.0 22.8 15.1 14.9 9.9 13.8 11.5 17.3 11.7 25.1 16.9 36.4 22.2 8.9 17.7 22.4 14.0 16.6 19.7 19.5 23.4 17.8 45.5 15.7 28.1 20.6 17.9 43.0 35.9 25.3 21.5 15.5 38.1 16.8 15.6 15.4 41.3 20.5 25.2 18.6 22.6 15.1 12.7 21.9 24.8 36.2 22.1 17.2 18.5 49.0 11.7 26.4 16.4 17.5 30.0 44.8 22.2 14.3 41.6 19.3 25.0 25.0 19.7 18.8 31.3 25.4 15.3 30.8 16.7 24.7 16.3 20.7 24.0 26.0 48.2 14.6 16.2 21.6 6.0 11.9 9.9 14.8 13.8 17.3 15.1 13.1 17.0 14.9 14.4 14.0 12.1 9.2 11.5 11.1 9.6 12.0 11.7 18.6 20.6 28.1 19.9 17.8 12.5 17.7 20.0 15.6 18.6 23.8 20.8 19.8 17.7 26.3 14.7 19.0 22.9 24.1 18.2 3.5 25.5 18.2 1.7 13.5 3.2 15.7 13.7 0.0 15.3 15.3 17.9 15.2 25.5 11.9 15.6 7.9 23.6 22.1 23.9 3.6 13.6 19.9 15.1 14.4 21.7 11.6 16.5 14.0 15.6 10.2 13.9 6.5 18.6 15.7 14.9 25.7 14.6 20.3 18.5 23.8 RBM12B ENSG00000183808 "RNA binding motif protein 12B" Q8IXT5 8 93729356-93741017 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 41.2;Horizontal cells: 42.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024398, HPA053050" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA024398: AB_1856109, HPA053050: AB_2682026" "unprognostic (4.57e-2)" "unprognostic (7.72e-2)" "unprognostic (3.39e-1)" "unprognostic (3.57e-2)" "unprognostic (1.78e-1)" "unprognostic (2.66e-2)" "unprognostic (2.40e-3)" "unprognostic (3.05e-1)" "unprognostic (3.92e-2)" "unprognostic (3.66e-2)" "unprognostic (1.13e-1)" "unprognostic (2.54e-2)" "unprognostic (1.84e-3)" "unprognostic (9.15e-2)" "unprognostic (4.82e-1)" "unprognostic (4.34e-2)" "unprognostic (2.62e-2)" 10.0 10.6 14.1 15.5 14.5 9.3 13.2 22.9 15.1 18.1 10.8 16.2 11.0 10.1 24.3 11.4 11.4 13.6 9.5 14.8 12.3 7.3 10.7 10.0 12.3 20.6 13.3 12.3 28.0 11.4 15.3 21.1 14.8 11.7 15.2 10.8 13.4 15.3 10.2 12.6 9.4 13.1 16.6 14.5 14.3 11.8 18.9 14.2 22.0 18.1 7.4 18.2 13.2 16.6 3.4 3.9 13.4 3.2 3.7 6.1 2.7 12.5 9.5 24.4 17.3 6.0 11.6 11.9 10.6 7.9 12.1 12.8 7.1 17.2 22.1 16.9 5.9 12.9 12.9 21.1 5.6 13.7 15.6 10.9 28.7 22.2 6.1 7.1 10.6 14.6 7.5 7.3 7.9 7.9 8.1 8.1 13.2 23.5 18.6 10.7 7.3 19.7 8.4 0.1 9.5 10.2 14.6 17.3 7.3 6.2 10.8 16.1 12.7 11.4 3.6 8.9 17.5 13.8 8.2 15.8 11.4 17.2 8.2 10.8 21.8 16.0 18.8 8.1 15.2 19.0 13.4 3.0 5.8 3.5 2.9 5.0 2.2 4.4 3.4 3.1 3.4 6.1 5.0 4.5 3.7 3.2 3.9 4.9 2.7 14.1 14.5 22.9 15.1 12.3 7.3 13.3 12.3 11.7 14.2 6.0 7.2 8.6 7.2 3.5 28.2 11.2 12.7 12.0 4.5 12.2 41.2 6.5 3.3 5.2 0.8 10.3 4.1 0.0 4.0 3.9 7.2 7.5 0.0 6.4 3.9 42.9 15.1 12.3 11.5 0.9 11.5 6.7 5.0 10.0 8.2 19.2 6.1 6.6 9.6 4.1 29.5 19.4 7.2 18.6 8.9 3.8 3.3 10.2 7.3 4.1 RBM14-RBM4 ENSG00000248643 "RBM14-RBM4 readthrough" 11 66616626-66646469 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 5 "Ciliated cells: 6.7;Club cells: 9.1;Cone photoreceptor cells: 3.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 12.3;SK-MEL-30: 7.0" HPA047849 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA047849: AB_2680180" "unprognostic (2.41e-1)" "unprognostic (1.11e-1)" "unprognostic (2.98e-2)" "unprognostic (1.10e-2)" "unprognostic (2.52e-2)" "unprognostic (2.01e-2)" "unprognostic (1.37e-1)" "unprognostic (7.25e-2)" "unprognostic (1.77e-4)" "unprognostic (3.92e-2)" "unprognostic (2.52e-1)" "unprognostic (3.77e-4)" "unprognostic (5.74e-7)" "unprognostic (1.43e-1)" "unprognostic (2.53e-2)" "unprognostic (1.30e-1)" "unprognostic (3.10e-2)" 7.3 5.9 5.7 7.4 7.7 13.9 5.0 12.3 8.2 5.4 7.5 6.9 7.5 2.8 8.1 11.4 6.4 4.9 7.1 12.2 5.9 5.4 6.2 14.7 6.3 6.4 8.5 4.9 6.0 7.9 2.8 9.1 5.9 5.5 7.6 4.8 7.5 5.8 5.8 9.3 4.0 6.3 7.3 5.3 7.5 7.7 11.9 6.5 13.2 7.2 4.9 9.2 6.7 5.7 8.6 10.8 7.5 6.4 4.3 5.4 4.4 2.1 1.5 0.8 1.8 1.6 0.2 1.1 1.1 0.5 2.1 0.4 3.5 0.6 0.7 1.2 0.2 1.7 3.7 1.4 0.4 0.5 0.0 0.7 3.3 1.3 2.4 0.6 1.8 1.7 0.0 0.3 0.9 0.2 0.5 0.0 0.6 4.7 1.5 1.1 3.8 2.6 12.3 1.2 2.2 4.7 1.8 5.2 0.6 0.4 2.3 2.6 0.9 0.6 1.7 7.0 0.4 0.8 1.3 0.0 2.7 2.6 1.7 1.5 0.2 0.7 1.6 0.9 1.2 0.8 6.4 6.4 7.5 5.4 5.6 3.8 8.6 3.6 4.1 6.7 8.0 1.3 3.1 3.5 4.3 5.3 10.8 2.3 4.4 5.7 7.7 12.3 8.2 5.9 5.4 8.5 4.9 5.5 6.5 0.0 0.6 0.0 0.5 0.0 0.9 0.0 0.0 6.7 9.1 0.0 3.9 0.4 0.0 0.4 1.4 0.4 0.0 0.0 0.2 0.3 0.2 0.6 0.0 0.5 0.2 0.0 0.0 0.0 0.3 0.9 0.0 0.1 0.0 0.0 0.3 0.2 0.4 0.0 0.0 0.1 0.7 0.0 0.0 0.7 0.9 0.1 0.9 0.0 0.2 0.7 RBM15 "OTT, OTT1" ENSG00000162775 "RNA binding motif protein 15" Q96T37 1 110338506-110346681 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" RNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 48.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015201, HPA019824, HPA049642" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB015201: , HPA019824: AB_1856113, HPA049642: AB_2680839" "unprognostic (1.70e-1)" "unprognostic (1.63e-1)" "unprognostic (9.39e-2)" "unprognostic (7.57e-3)" "unprognostic (2.43e-1)" "unprognostic (2.11e-2)" "prognostic unfavorable (7.61e-4)" "unprognostic (1.13e-1)" "unprognostic (1.84e-2)" "unprognostic (4.91e-2)" "unprognostic (9.67e-2)" "unprognostic (2.76e-2)" "prognostic unfavorable (1.37e-4)" "prognostic favorable (7.97e-4)" "unprognostic (2.88e-1)" "unprognostic (2.46e-2)" "unprognostic (2.12e-1)" 8.5 7.6 6.3 12.2 7.6 48.7 7.9 18.6 8.3 6.6 8.8 7.6 8.3 7.3 8.5 7.2 8.0 7.3 6.6 8.8 5.2 4.3 6.3 11.0 10.5 13.7 8.3 6.0 8.6 7.5 7.1 8.1 7.1 5.9 5.7 5.7 8.1 7.4 6.4 17.2 7.2 11.3 5.5 5.0 12.5 8.3 14.0 7.9 21.8 7.0 5.3 13.4 6.5 8.6 10.5 4.8 9.8 6.9 5.0 9.9 5.5 7.1 7.8 7.0 7.2 4.5 4.7 11.1 3.8 5.0 6.0 7.9 9.5 6.5 13.5 6.1 4.3 4.9 10.1 11.0 9.5 8.9 14.0 10.1 10.9 11.8 6.9 6.2 11.8 11.6 4.3 6.6 8.3 7.8 3.1 6.3 10.3 15.4 23.7 6.0 7.3 10.6 9.3 15.0 6.3 4.4 12.6 10.6 9.2 4.9 7.2 8.5 4.3 8.3 10.5 8.0 7.9 7.2 14.3 4.4 5.7 10.4 6.2 6.9 18.3 9.2 29.3 8.6 12.0 7.1 8.2 6.9 9.4 7.0 6.0 9.9 10.5 7.7 6.0 4.8 10.0 6.8 8.2 9.8 5.0 6.4 4.7 7.5 5.5 6.3 7.6 18.6 8.3 5.2 4.3 8.3 6.0 5.9 7.9 6.0 3.0 15.3 8.2 29.5 5.4 10.8 7.6 9.4 2.3 3.5 13.7 7.6 0.0 3.4 6.2 9.8 7.5 0.0 3.1 6.2 8.9 8.6 28.8 13.5 5.6 0.0 9.2 10.4 5.7 4.1 3.7 5.5 8.5 1.8 8.4 5.6 4.2 2.9 4.9 3.3 7.1 0.0 13.3 24.4 14.5 29.5 3.9 12.5 7.6 6.7 RBM15B "HUMAGCGB, OTT3" ENSG00000259956 "RNA binding motif protein 15B" Q8NDT2 3 51391268-51397908 "Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036645, HPA058136" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA036645: AB_10671965, HPA058136: AB_2683618" "unprognostic (2.65e-3)" "unprognostic (1.31e-1)" "unprognostic (1.01e-2)" "unprognostic (1.39e-1)" "unprognostic (5.29e-1)" "unprognostic (5.28e-2)" "unprognostic (3.13e-3)" "unprognostic (1.70e-1)" "unprognostic (5.25e-2)" "unprognostic (3.11e-1)" "unprognostic (3.39e-1)" "unprognostic (3.01e-2)" "prognostic favorable (1.84e-5)" "unprognostic (1.35e-1)" "unprognostic (1.69e-1)" "unprognostic (1.89e-1)" "unprognostic (3.84e-1)" 8.6 3.8 4.9 5.6 6.3 5.2 7.1 4.4 9.0 8.0 7.5 6.1 6.3 5.9 7.4 6.5 8.4 7.2 10.1 5.6 5.2 4.8 9.4 6.7 11.6 4.9 4.1 9.3 9.8 9.2 3.3 7.3 4.1 8.3 7.1 5.1 7.2 7.0 4.9 9.9 9.3 7.4 2.2 7.8 6.4 9.1 4.1 23.0 8.2 5.4 7.3 6.8 9.3 4.5 4.9 1.5 5.7 3.4 5.0 3.1 10.9 9.8 22.9 23.8 20.7 16.2 14.0 10.2 19.1 16.4 13.6 12.1 8.0 15.9 8.5 18.4 18.1 10.2 13.1 18.4 7.9 12.7 10.2 13.7 15.3 10.3 12.1 17.8 7.8 17.6 22.9 15.0 17.9 17.9 16.9 26.2 10.2 10.8 14.0 11.7 31.0 11.3 18.2 10.1 15.4 11.1 10.1 13.5 14.6 26.6 14.9 21.4 13.2 17.6 11.7 15.9 13.9 21.2 15.2 16.8 14.7 14.1 19.2 16.0 14.4 17.7 13.7 14.4 17.8 0.0 4.1 1.5 4.0 5.7 4.4 2.4 5.0 4.2 4.5 4.5 5.0 3.1 0.8 3.4 5.3 4.9 2.3 3.1 3.0 4.8 10.7 31.2 22.6 18.0 15.1 5.1 8.1 7.9 14.0 9.8 13.5 10.0 18.2 18.6 17.5 15.0 23.3 19.7 17.7 12.1 26.3 4.7 18.3 15.9 14.3 12.1 12.3 26.2 8.6 14.7 10.5 6.8 4.6 19.4 12.3 25.8 8.6 14.2 14.3 12.9 25.8 18.7 11.4 6.4 24.6 16.5 11.7 20.8 29.3 RBM17 "MGC14439, SPF45" ENSG00000134453 "RNA binding motif protein 17" Q96I25 10 6088987-6117457 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037477, HPA037478" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA037477: AB_10671372, HPA037478: AB_2675494" "unprognostic (8.55e-2)" "unprognostic (2.41e-1)" "unprognostic (3.11e-3)" "unprognostic (6.23e-2)" "unprognostic (1.05e-2)" "unprognostic (3.33e-2)" "prognostic unfavorable (4.57e-8)" "unprognostic (3.78e-2)" "unprognostic (6.39e-2)" "unprognostic (3.47e-3)" "unprognostic (1.44e-1)" "unprognostic (8.32e-2)" "prognostic unfavorable (4.31e-5)" "unprognostic (1.82e-1)" "unprognostic (5.53e-2)" "unprognostic (1.26e-2)" "unprognostic (3.01e-2)" 36.5 28.0 36.2 40.7 43.1 67.9 52.5 37.2 35.8 31.4 31.9 38.2 25.2 36.4 40.0 29.9 31.3 32.7 30.5 28.9 35.5 24.6 28.5 25.8 44.9 46.0 37.0 29.2 34.1 37.1 30.2 23.4 42.6 35.1 25.2 38.5 24.7 30.2 28.7 50.5 25.9 40.3 37.4 39.2 47.6 30.2 35.7 41.0 49.3 38.2 20.5 46.8 29.9 53.3 47.9 33.6 41.4 34.0 31.4 41.2 22.8 41.3 24.4 31.7 27.4 17.2 15.8 38.9 27.8 12.4 28.4 30.9 39.8 33.4 49.3 19.8 20.2 10.8 41.2 28.0 30.0 30.9 48.6 27.8 42.5 24.4 33.8 21.4 23.0 20.9 16.1 22.8 29.2 16.1 15.2 34.5 36.2 44.7 25.0 18.2 47.5 41.0 14.4 19.8 48.4 17.0 44.5 17.5 25.6 20.7 26.0 13.2 17.5 26.5 24.5 20.6 28.1 32.3 23.6 20.9 17.4 34.6 37.2 29.3 24.8 28.3 83.1 16.1 30.1 11.1 28.2 34.0 41.4 33.4 33.4 34.1 43.7 33.0 33.0 29.4 47.9 33.7 31.5 17.5 31.4 24.6 33.6 41.2 22.8 36.2 43.1 37.2 35.8 35.5 24.6 37.0 29.2 35.1 41.0 83.4 50.1 84.5 77.4 114.8 68.7 69.4 53.5 33.5 73.9 62.8 47.1 106.5 76.3 75.8 45.6 96.7 64.3 23.3 62.1 156.6 84.9 66.1 92.6 61.0 86.0 87.4 69.9 72.4 62.5 13.9 61.2 71.7 49.0 197.4 77.6 73.3 72.9 86.2 57.0 58.5 61.1 71.1 88.6 166.4 204.4 95.0 81.1 76.2 87.4 89.1 RBM18 MGC2734 ENSG00000119446 "RNA binding motif protein 18" Q96H35 9 122237624-122264839 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057281, HPA077955" Uncertain Enhanced "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes No Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA057281: AB_2683394, HPA077955: " "unprognostic (1.75e-2)" "unprognostic (7.23e-2)" "unprognostic (2.70e-1)" "unprognostic (1.44e-1)" "unprognostic (5.81e-3)" "unprognostic (2.52e-3)" "unprognostic (1.08e-1)" "unprognostic (9.39e-3)" "unprognostic (7.27e-3)" "unprognostic (2.79e-2)" "unprognostic (1.45e-1)" "unprognostic (8.51e-2)" "prognostic favorable (8.00e-7)" "unprognostic (2.88e-1)" "unprognostic (1.60e-1)" "unprognostic (1.24e-1)" "unprognostic (1.44e-1)" 12.8 14.8 16.5 9.1 16.5 15.1 24.6 18.1 20.3 14.4 13.4 10.5 13.7 10.4 13.6 16.2 11.8 11.6 11.7 27.2 16.7 18.6 17.3 12.2 10.7 10.9 17.8 13.2 15.1 13.7 16.0 18.2 16.2 16.3 17.2 12.6 8.2 12.6 13.9 29.4 10.1 10.8 13.2 16.0 12.4 12.3 7.6 15.0 11.9 15.3 13.5 11.1 13.0 14.4 8.7 9.5 16.0 13.0 7.7 10.0 8.2 5.8 6.1 8.4 9.2 12.4 15.4 7.3 13.3 10.9 9.1 8.5 7.0 5.8 10.2 5.8 8.6 10.1 13.7 13.1 13.8 11.5 10.4 5.9 7.6 10.2 5.9 14.0 15.1 10.5 13.1 15.7 9.6 19.6 9.2 13.1 8.3 10.4 8.0 13.6 6.3 7.8 9.3 6.5 19.8 10.2 7.0 17.4 13.8 12.7 6.6 17.6 9.3 10.0 14.1 15.0 6.9 8.2 8.6 7.2 8.6 4.9 13.7 13.0 11.7 21.5 8.5 14.1 9.4 10.2 6.8 9.2 16.0 10.0 10.5 9.6 8.7 8.9 9.7 9.5 6.0 9.3 9.7 9.7 7.7 13.0 6.9 9.1 8.2 16.5 16.5 18.1 20.3 16.7 18.6 17.8 13.2 16.3 15.0 29.8 10.9 16.7 9.8 19.3 11.8 46.6 7.6 17.4 13.6 24.4 2.0 28.1 23.2 20.9 61.1 24.8 12.3 0.0 14.0 35.6 16.0 18.9 17.3 13.7 24.5 3.2 18.9 13.5 21.4 54.6 12.4 16.2 18.6 10.0 16.7 15.8 18.5 13.9 15.9 18.9 11.6 19.4 23.1 10.1 19.4 22.6 47.6 17.3 13.6 14.1 RBM20 ENSG00000203867 "RNA binding motif protein 20" Q5T481 10 110644397-110839469 "Disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 45.9;skeletal muscle: 20.9" "Cell type enriched" "Detected in some" 8 "Cardiomyocytes: 137.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 5.7;HEL: 4.8;K-562: 4.6;RH-30: 15.7;SH-SY5Y: 14.6;SuSa: 5.0;T-47d: 8.8" "Region enhanced" "Detected in some" "olfactory region: 4.6" "Not detected" "Not detected" "HPA035806, HPA070358" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" Yes No "Nucleoplasm, Nucleoli, Golgi apparatus" "HPA035806: AB_10672097, HPA070358: " "unprognostic (2.43e-1)" "unprognostic (8.24e-3)" "unprognostic (5.81e-2)" "unprognostic (1.27e-2)" "unprognostic (1.03e-1)" "unprognostic (2.03e-2)" "unprognostic (2.75e-2)" "unprognostic (5.47e-3)" "unprognostic (1.33e-1)" "unprognostic (2.78e-2)" "unprognostic (4.14e-3)" "unprognostic (1.44e-1)" "unprognostic (2.39e-3)" "unprognostic (3.34e-1)" "unprognostic (3.35e-2)" "unprognostic (1.20e-1)" "unprognostic (6.46e-2)" 1.7 0.1 0.4 0.6 1.9 0.1 2.2 0.5 1.5 0.9 2.6 1.3 0.0 0.2 2.5 7.5 3.6 1.9 2.3 45.9 0.6 0.2 1.1 0.1 0.5 0.1 0.3 1.3 2.4 13.7 0.9 1.2 1.4 1.4 1.0 0.5 4.3 6.3 0.7 20.9 0.7 1.0 2.1 0.6 0.1 0.6 0.9 1.4 0.0 0.7 3.4 0.5 1.8 3.2 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 1.5 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.1 0.1 0.0 0.0 2.3 5.7 4.8 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.2 0.0 0.0 0.0 0.4 0.0 1.4 0.0 15.7 0.0 0.0 0.0 0.1 14.6 0.1 0.0 0.6 5.0 8.8 0.0 0.0 0.3 0.5 0.0 0.0 0.4 0.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 1.9 0.5 1.5 0.6 0.2 0.3 1.3 1.4 1.4 0.0 0.0 0.0 0.2 0.1 1.3 137.1 0.0 17.4 0.0 0.0 2.0 1.0 1.7 0.0 0.7 0.6 0.4 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.4 4.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 12.7 1.4 2.3 6.5 1.9 0.0 0.5 0.0 2.6 0.0 0.0 0.1 RBM22 "Cwc2, FLJ10290, fSAP47, ZC3H16" ENSG00000086589 "RNA binding motif protein 22" Q9NW64 5 150690794-150701107 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001634 Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA001634: AB_1079746" "unprognostic (1.94e-1)" "unprognostic (1.17e-3)" "unprognostic (6.86e-3)" "unprognostic (1.00e-2)" "unprognostic (1.49e-1)" "unprognostic (3.04e-2)" "prognostic unfavorable (5.50e-6)" "unprognostic (7.08e-2)" "unprognostic (2.51e-1)" "unprognostic (4.58e-2)" "unprognostic (8.71e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (3.58e-5)" "unprognostic (7.29e-2)" "unprognostic (2.37e-1)" "unprognostic (7.82e-2)" "unprognostic (9.87e-3)" 26.2 17.5 20.3 16.3 26.3 50.1 21.2 29.4 29.5 20.6 20.1 37.4 16.7 17.4 28.0 18.5 18.8 23.8 20.5 18.5 19.7 19.1 20.0 18.8 20.5 23.5 25.7 16.9 29.2 19.6 21.5 18.0 37.8 23.5 20.9 21.5 19.1 18.3 19.2 30.4 21.5 19.1 19.7 28.0 23.0 17.8 13.5 24.6 38.6 23.8 16.3 27.6 20.3 19.2 25.8 24.9 36.3 28.8 28.4 26.7 20.8 14.9 16.3 25.1 29.2 17.0 16.0 35.5 15.3 17.6 31.0 35.1 26.4 22.2 22.2 24.5 15.0 29.4 15.8 32.5 28.2 32.4 24.6 25.7 17.6 16.2 11.1 16.4 31.1 20.8 13.3 22.5 25.7 16.9 13.6 21.8 18.3 18.6 22.4 19.3 17.4 28.7 20.7 15.0 18.4 17.2 29.4 20.7 19.7 15.3 15.4 23.6 17.9 17.2 28.6 28.2 15.7 29.7 27.9 14.4 25.0 19.8 10.9 27.9 20.8 23.4 32.0 19.7 28.4 18.7 17.6 20.8 33.5 24.4 24.9 26.7 25.8 22.6 22.7 24.9 25.3 24.6 22.9 36.3 28.4 28.8 13.3 24.2 20.8 20.3 26.3 29.4 29.5 19.7 19.1 25.7 16.9 23.5 24.6 26.8 26.2 37.5 47.4 23.1 34.3 26.9 28.1 28.1 39.8 15.7 23.6 46.8 21.6 29.7 5.0 41.2 27.1 0.0 29.8 38.5 28.7 21.3 62.3 15.1 38.1 28.6 24.9 27.0 25.1 2.6 40.0 33.7 21.9 45.9 27.2 34.4 23.2 35.1 42.8 16.5 16.9 32.3 29.3 21.3 28.8 19.1 60.8 45.7 30.2 34.3 RBM23 "CAPERbeta, FLJ10482, RNPC4" ENSG00000100461 "RNA binding motif protein 23" Q86U06 14 22893206-22919184 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004144 Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA "Intermediate filaments" Nucleoplasm "HPA004144: AB_1079747" "unprognostic (5.93e-2)" "unprognostic (1.47e-1)" "unprognostic (1.48e-1)" "unprognostic (7.11e-2)" "unprognostic (1.11e-1)" "unprognostic (1.41e-2)" "unprognostic (2.14e-2)" "unprognostic (1.06e-1)" "unprognostic (4.27e-2)" "unprognostic (4.70e-2)" "unprognostic (3.73e-3)" "unprognostic (2.29e-1)" "prognostic favorable (8.06e-9)" "unprognostic (4.41e-2)" "unprognostic (3.06e-1)" "unprognostic (5.05e-2)" "unprognostic (1.81e-1)" 18.7 26.9 22.0 22.1 29.3 28.1 24.8 33.7 35.7 28.6 22.5 26.9 25.9 18.3 35.0 24.7 25.9 36.9 24.2 20.3 19.9 24.2 27.8 27.0 25.2 25.0 19.7 23.7 40.8 23.2 56.6 37.5 43.9 23.9 27.2 25.7 35.4 25.3 25.8 18.0 22.3 24.8 28.2 22.6 32.7 25.3 23.5 26.7 44.0 42.4 19.7 31.2 24.8 34.9 14.0 17.8 49.9 17.2 20.5 14.3 9.8 20.1 31.9 32.6 17.0 17.9 15.4 13.6 22.1 30.4 43.1 33.9 14.4 24.8 33.8 17.5 20.5 20.7 28.7 36.5 18.6 35.2 26.5 30.1 15.9 24.9 1.1 28.2 30.5 26.2 19.7 25.8 24.8 16.5 24.1 24.0 17.0 20.0 22.0 21.1 25.7 33.3 13.7 14.5 30.8 30.0 28.8 27.0 20.5 16.8 28.6 22.5 25.2 33.2 25.8 14.0 22.4 19.0 18.1 22.2 7.5 12.8 17.9 20.4 20.9 26.7 31.9 12.5 17.6 26.7 11.3 17.2 17.6 14.3 13.3 9.8 10.8 10.2 12.3 17.8 14.0 12.5 10.9 49.9 20.5 16.4 9.3 10.4 9.8 22.0 29.3 33.7 35.7 19.9 24.2 19.7 23.7 23.9 26.7 41.7 38.7 72.9 41.5 16.4 60.7 21.2 58.6 76.3 47.8 31.4 110.0 43.5 38.1 32.4 6.9 35.1 49.3 46.7 29.6 40.1 28.0 24.3 68.2 30.6 27.8 47.7 62.8 44.8 37.7 8.2 32.8 36.7 15.1 54.1 33.4 44.2 29.7 35.3 26.5 21.4 123.6 32.3 32.8 39.7 58.7 18.3 84.8 83.0 31.8 22.7 RBM24 "dJ259A10.1, FLJ30829, RNPC6" ENSG00000112183 "RNA binding motif protein 24" Q9BX46 6 17281346-17293875 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 41.0;skeletal muscle: 153.8;tongue: 37.3" "Cell type enriched" "Detected in some" 8 "Cardiomyocytes: 165.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.4" "Lineage enriched" "Detected in single" 25 "T-cells: 2.4" "Cell line enhanced" "Detected in many" "LHCN-M2: 29.0;RH-30: 29.8;T-47d: 13.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA066927, HPA067231" Enhanced Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA066927: AB_2685750, HPA067231: AB_2685808" "unprognostic (9.05e-3)" "unprognostic (2.57e-1)" "unprognostic (2.24e-1)" "unprognostic (1.67e-3)" "unprognostic (1.53e-1)" "unprognostic (4.54e-4)" "unprognostic (3.34e-2)" "unprognostic (1.33e-2)" "unprognostic (2.97e-3)" "unprognostic (3.38e-2)" "unprognostic (2.98e-2)" "unprognostic (1.43e-1)" "unprognostic (1.45e-1)" "unprognostic (1.16e-2)" "unprognostic (3.06e-2)" "unprognostic (1.08e-2)" "unprognostic (2.33e-4)" 3.4 0.2 1.4 0.9 2.2 0.1 1.1 0.3 1.9 7.0 2.7 0.1 3.0 0.5 9.7 7.3 3.4 7.8 1.7 41.0 1.5 1.7 0.3 0.4 0.4 0.2 0.5 1.1 2.1 0.2 0.1 1.8 0.2 0.3 3.6 2.4 1.6 2.5 2.2 153.8 0.4 1.2 9.3 0.5 0.4 0.8 1.3 0.1 0.1 1.4 37.3 1.9 5.1 2.9 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.7 4.5 6.0 0.0 0.0 0.0 0.0 9.1 3.3 6.2 6.6 0.0 0.5 0.0 2.9 6.5 9.8 0.0 5.6 0.2 11.3 0.0 0.2 0.0 0.5 3.1 0.2 0.0 0.5 3.3 0.0 1.2 0.2 8.0 0.7 0.0 0.0 0.0 29.0 1.3 0.0 0.0 2.0 0.0 0.7 0.0 29.8 0.0 0.0 0.0 3.9 0.4 0.0 0.0 0.1 4.9 13.9 0.2 0.0 2.1 5.0 0.0 7.8 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.2 0.3 1.9 1.5 1.7 0.5 1.1 0.3 0.1 0.0 0.0 0.0 0.2 1.0 1.6 165.8 0.0 20.1 2.3 0.0 0.0 0.1 0.0 0.0 0.5 0.5 0.0 0.0 0.0 9.2 0.8 0.2 1.1 0.0 0.2 1.6 4.6 0.0 0.0 1.0 0.0 0.0 1.7 0.0 3.9 0.6 0.2 0.0 0.7 0.1 0.0 6.5 16.2 0.3 7.7 0.9 0.7 0.0 1.5 0.1 RBM3 IS1-RNPL ENSG00000102317 "RNA binding motif protein 3" P98179 X 48574449-48579066 "Predicted intracellular proteins" "Stress response" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Exocrine glandular cells: 1250.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003624, CAB062559" Enhanced Enhanced Nucleoplasm NA NA 24000 Nucleoplasm "CAB062559: AB_2665621, HPA003624: AB_10602123" "unprognostic (1.07e-2)" "unprognostic (1.14e-3)" "prognostic favorable (3.07e-7)" "unprognostic (1.65e-3)" "unprognostic (2.87e-1)" "unprognostic (4.05e-2)" "unprognostic (1.42e-2)" "unprognostic (1.91e-1)" "unprognostic (9.37e-2)" "unprognostic (1.63e-2)" "unprognostic (2.65e-2)" "unprognostic (2.02e-2)" "unprognostic (6.18e-2)" "unprognostic (1.10e-1)" "unprognostic (5.05e-2)" "unprognostic (3.92e-2)" "unprognostic (1.59e-1)" 71.2 25.5 12.6 43.0 13.9 59.0 52.2 16.4 22.5 44.7 32.7 20.9 16.4 23.9 38.5 58.2 46.4 32.9 36.4 44.8 12.2 12.3 53.5 32.9 36.8 115.8 15.0 15.2 38.6 43.2 15.2 19.1 62.2 30.5 21.0 36.0 43.4 39.7 25.0 59.1 56.2 37.8 33.0 23.6 48.4 27.2 27.2 7.4 73.6 24.0 76.8 67.6 46.4 30.1 32.9 56.5 6.4 44.2 29.9 31.8 45.7 20.2 28.4 30.9 32.3 7.7 40.7 19.3 26.4 46.1 66.0 46.1 28.5 53.7 41.8 8.4 53.4 12.9 17.7 26.9 36.0 52.9 38.8 35.7 21.0 46.5 25.4 28.2 57.6 42.9 31.4 25.7 22.2 21.5 8.5 58.5 22.3 11.7 32.5 45.6 34.2 47.8 31.5 17.0 5.4 40.0 46.2 31.6 31.7 28.4 33.7 12.3 30.5 26.4 34.7 28.8 15.5 45.9 57.3 78.8 21.6 35.0 74.7 43.9 16.1 17.6 47.0 32.4 34.6 43.9 5.8 38.4 6.2 27.0 44.2 31.8 32.9 27.6 26.7 56.5 20.5 28.2 27.4 6.4 29.9 37.5 39.1 28.6 45.7 12.6 13.9 16.4 22.5 12.2 12.3 15.0 15.2 30.5 7.4 154.9 140.4 318.0 135.2 461.5 60.5 71.4 114.7 91.0 153.6 50.6 45.2 435.3 149.2 258.9 4.9 222.6 136.8 70.0 1250.6 594.7 406.0 86.3 255.6 72.3 381.7 39.7 237.4 173.7 454.7 10.5 227.6 401.8 496.0 551.0 243.6 125.2 635.6 224.5 138.6 113.6 76.3 129.4 465.6 25.6 174.8 443.8 409.2 335.1 293.7 176.9 RBM33 "DKFZp434D1319, DKFZp686F102, MGC20460, PRR8" ENSG00000184863 "RNA binding motif protein 33" Q96EV2 7 155644451-155781485 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Horizontal cells: 125.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019232, HPA021497, HPA021768" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA019232: AB_1856121, HPA021497: AB_2176261, HPA021768: AB_1856123" "unprognostic (1.35e-2)" "unprognostic (1.99e-1)" "unprognostic (1.11e-1)" "unprognostic (3.04e-2)" "unprognostic (2.06e-1)" "prognostic favorable (9.63e-5)" "unprognostic (3.48e-2)" "unprognostic (2.07e-2)" "unprognostic (6.85e-2)" "unprognostic (3.89e-2)" "unprognostic (8.90e-2)" "unprognostic (7.13e-2)" "prognostic unfavorable (1.05e-4)" "unprognostic (1.98e-1)" "unprognostic (2.42e-1)" "unprognostic (4.46e-2)" "prognostic favorable (4.29e-4)" 16.8 14.1 18.6 24.5 20.9 65.0 16.2 46.1 27.6 14.8 15.1 24.1 13.4 17.2 16.3 21.9 16.4 11.9 14.1 13.2 16.3 12.5 15.6 21.0 19.8 21.1 22.8 14.9 19.3 20.5 14.3 29.1 13.2 16.4 15.7 16.2 13.8 15.9 13.6 33.0 26.9 20.8 14.0 25.5 21.4 17.1 16.0 20.8 28.5 17.3 10.2 19.7 13.8 18.7 5.7 5.7 23.9 6.8 5.0 5.6 2.5 16.8 19.8 12.4 11.5 6.6 8.8 12.6 10.6 7.5 6.5 9.6 18.0 16.1 18.6 14.4 7.8 17.9 12.1 11.3 8.9 8.8 17.6 16.3 17.7 20.7 11.7 7.4 24.9 17.9 8.5 10.6 10.5 15.0 9.7 11.5 20.9 22.5 15.4 9.3 16.2 25.6 21.6 13.4 11.3 13.0 20.7 13.9 15.3 9.5 18.1 12.8 13.1 17.8 12.0 10.0 9.8 9.0 13.2 13.5 11.2 6.7 20.1 14.1 27.3 20.6 27.7 18.4 16.6 14.3 16.3 6.8 13.7 4.5 6.3 3.6 5.7 4.5 5.4 5.6 5.3 4.1 5.2 23.9 5.0 4.9 5.7 5.6 2.5 18.6 20.9 46.1 27.6 16.3 12.5 22.8 14.9 16.4 20.8 29.8 28.4 44.1 18.2 17.4 54.2 25.2 12.7 17.4 12.5 3.5 78.5 15.9 6.6 16.4 18.4 20.7 29.0 23.3 15.5 14.0 14.9 26.2 37.1 25.1 14.0 125.5 25.2 16.0 26.6 29.8 24.2 26.3 11.8 30.7 25.7 29.4 19.7 26.2 16.6 13.8 96.9 12.9 19.6 29.3 22.4 20.6 21.9 32.0 21.8 22.2 RBM34 KIAA0117 ENSG00000188739 "RNA binding motif protein 34" P42696 1 235131183-235161457 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028606 Approved Supported "Nucleoplasm,Nucleoli,Mitotic chromosome" Yes No Nucleoli "Nucleoplasm, Mitotic chromosome" "HPA028606: AB_10601494" "unprognostic (4.53e-2)" "unprognostic (3.64e-2)" "unprognostic (7.30e-2)" "unprognostic (3.68e-2)" "unprognostic (1.28e-1)" "unprognostic (2.32e-2)" "unprognostic (6.57e-4)" "unprognostic (2.98e-2)" "unprognostic (5.65e-3)" "unprognostic (2.02e-2)" "unprognostic (1.38e-1)" "unprognostic (1.13e-1)" "unprognostic (1.69e-8)" "unprognostic (8.50e-2)" "unprognostic (1.85e-1)" "unprognostic (8.73e-2)" "unprognostic (7.09e-4)" 15.8 10.5 17.2 16.4 18.1 30.6 14.8 15.5 22.3 11.0 13.5 10.6 7.0 16.7 10.9 15.2 15.4 9.9 11.3 15.2 13.4 11.6 19.4 14.2 11.5 20.0 16.9 9.9 13.9 13.5 6.6 24.9 14.7 20.9 13.5 12.6 7.6 18.3 11.2 22.2 17.9 17.6 10.9 17.9 14.6 13.1 28.8 17.3 17.5 14.7 10.9 17.1 14.1 16.0 34.2 27.2 38.0 19.2 25.3 35.5 22.7 12.0 9.1 9.5 12.1 7.2 13.0 23.6 12.8 8.9 11.5 11.1 12.3 13.8 20.8 13.9 7.7 9.2 18.1 11.3 11.7 11.1 18.8 18.4 15.6 6.5 8.5 14.4 24.6 15.3 11.4 13.5 10.7 7.4 10.6 9.2 20.8 22.1 10.7 14.5 6.9 21.4 21.2 27.6 16.6 6.5 20.1 10.5 24.0 11.9 9.2 11.8 21.5 17.7 11.3 28.9 6.9 24.6 26.8 9.6 11.7 10.2 16.1 25.6 13.0 21.0 22.0 13.7 16.5 18.2 38.0 16.9 20.4 23.7 19.2 28.2 34.2 27.3 30.4 17.2 26.3 26.0 29.9 8.2 25.3 19.1 27.2 35.5 22.7 17.2 18.1 15.5 22.3 13.4 11.6 16.9 9.9 20.9 17.3 17.9 10.9 5.1 5.4 2.9 3.3 2.6 5.1 16.0 11.4 3.5 9.8 5.2 5.0 5.6 5.6 3.5 3.6 0.0 5.4 3.7 3.5 4.5 22.0 3.0 2.9 0.0 7.5 5.5 6.8 4.4 3.7 4.3 3.3 9.0 2.6 4.1 7.1 2.9 5.3 7.9 4.9 0.0 5.2 6.1 5.3 3.3 5.1 11.4 3.7 5.7 RBM38 "dJ800J21.2, HSRNASEB, RNPC1, seb4B, SEB4D" ENSG00000132819 "RNA binding motif protein 38" Q9H0Z9 20 57391407-57409333 "Predicted intracellular proteins" "Cell cycle, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 64.3;skeletal muscle: 107.9" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 70.0;Intestinal endocrine cells: 60.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 39.4;U-698: 41.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" CAB017036 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB017036: " "unprognostic (1.03e-1)" "prognostic favorable (3.64e-7)" "unprognostic (3.71e-2)" "unprognostic (7.73e-3)" "unprognostic (4.16e-2)" "unprognostic (4.85e-2)" "unprognostic (1.53e-2)" "unprognostic (4.37e-3)" "unprognostic (3.04e-1)" "unprognostic (9.04e-3)" "unprognostic (3.90e-2)" "unprognostic (2.29e-1)" "prognostic unfavorable (1.05e-5)" "unprognostic (2.13e-2)" "unprognostic (2.29e-1)" "prognostic favorable (1.63e-4)" "unprognostic (1.83e-1)" 4.4 3.5 4.5 22.8 4.9 64.3 4.3 10.0 5.2 9.2 28.1 6.4 7.1 5.9 13.0 6.7 16.3 10.4 6.5 24.4 4.2 3.9 5.3 6.7 9.8 23.3 4.7 2.3 17.2 5.9 1.9 4.4 9.9 5.0 12.2 3.4 10.9 11.6 8.3 107.9 2.7 12.9 27.4 3.4 22.0 8.1 16.7 4.1 26.8 4.1 18.9 28.0 25.1 11.4 6.4 2.2 3.5 2.9 5.5 7.6 3.4 5.5 5.7 2.9 7.3 0.0 0.4 16.3 1.8 0.4 3.9 1.0 23.4 5.9 39.4 15.6 0.5 3.9 5.1 2.4 2.3 0.6 7.9 9.7 33.4 2.2 14.8 1.8 16.1 15.7 0.5 1.1 1.6 0.3 0.6 2.6 15.1 27.2 7.2 0.4 24.0 11.6 16.6 10.5 3.1 7.2 22.6 7.1 32.0 2.9 2.6 11.9 7.6 4.4 14.6 7.3 2.7 8.1 22.6 4.7 1.3 12.5 1.7 7.6 17.3 22.9 41.5 0.3 11.5 1.2 0.0 1.0 3.5 5.4 2.9 3.5 5.6 4.5 3.7 1.8 6.4 5.7 5.0 1.3 5.5 2.7 2.2 7.6 3.4 4.5 4.9 10.0 5.2 4.2 3.9 4.7 2.3 5.0 4.1 3.0 6.9 45.5 27.2 8.0 0.9 37.4 7.6 12.0 5.7 1.8 0.0 1.3 8.3 5.5 4.0 9.3 25.7 70.0 4.3 4.4 6.0 14.9 8.1 4.5 8.5 0.0 60.3 6.2 7.0 2.7 4.0 11.1 1.7 1.0 49.7 11.8 6.1 28.8 5.6 13.3 1.3 6.5 4.4 1.2 15.1 7.3 1.9 48.7 40.0 16.2 RBM39 "CAPER, CAPERalpha, CC1.3, fSAP59, HCC1, RNPC2" ENSG00000131051 "RNA binding motif protein 39" Q14498 20 35701347-35742312 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001591 Supported Supported "Nucleoplasm,Nuclear speckles,Microtubules,Centriolar satellite" NA NA "Nucleoplasm, Nuclear speckles" "Microtubules, Centriolar satellite" "HPA001591: AB_1079749" "unprognostic (1.37e-2)" "unprognostic (4.97e-1)" "unprognostic (2.72e-2)" "unprognostic (9.09e-2)" "unprognostic (3.47e-1)" "unprognostic (4.99e-2)" "unprognostic (3.55e-3)" "unprognostic (4.56e-2)" "unprognostic (7.83e-2)" "unprognostic (2.65e-1)" "unprognostic (2.04e-2)" "unprognostic (7.65e-3)" "prognostic unfavorable (2.78e-5)" "unprognostic (1.88e-1)" "unprognostic (2.86e-1)" "unprognostic (2.64e-1)" "unprognostic (2.28e-3)" 41.4 44.1 37.5 41.5 41.4 120.8 38.5 57.5 41.8 43.4 35.0 30.7 46.3 29.5 51.9 34.3 42.8 35.3 40.7 40.2 35.8 29.9 39.2 32.4 40.4 41.8 41.1 31.4 52.3 35.6 40.9 71.5 45.2 37.4 39.2 27.0 28.9 37.1 46.0 44.1 32.1 30.6 40.2 43.0 38.4 33.5 22.9 46.4 52.4 40.7 28.2 40.5 39.9 46.1 27.6 32.5 88.9 25.1 24.2 22.5 16.8 28.9 26.9 27.9 24.7 22.1 25.1 30.6 38.9 19.5 25.4 23.9 38.8 26.8 39.9 30.3 15.0 23.7 27.4 41.5 24.6 29.3 26.8 29.7 53.2 27.2 44.9 25.0 48.9 33.3 10.2 42.7 21.3 24.1 25.2 23.6 19.8 54.8 35.7 21.7 25.1 56.9 35.3 33.8 30.4 32.3 34.8 44.5 30.1 23.0 20.9 27.2 23.7 30.4 38.7 33.9 45.7 26.1 34.5 27.2 33.1 28.3 30.6 34.9 23.0 46.6 58.7 22.7 39.4 24.2 41.2 25.1 38.2 22.5 22.1 22.1 25.3 19.8 20.7 22.4 27.6 18.9 18.0 88.9 24.2 19.4 32.5 22.1 16.8 37.5 41.4 57.5 41.8 35.8 29.9 41.1 31.4 37.4 46.4 217.4 272.9 286.2 469.4 547.4 245.5 170.5 147.7 277.1 246.9 190.1 298.4 332.4 160.8 177.8 36.1 270.2 247.4 93.5 161.5 312.9 353.4 410.0 503.4 165.1 177.4 208.2 283.3 159.0 179.4 26.2 243.1 231.7 256.4 248.9 177.6 221.0 173.7 189.4 201.5 125.5 372.3 161.7 294.1 267.2 236.8 513.0 469.7 366.7 196.0 480.8 RBM4 "LARK, RBM4A, ZCCHC21, ZCRB3A" ENSG00000173933 "RNA binding motif protein 4" Q9BWF3 11 66638617-66666682 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, RNA-mediated gene silencing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042174, HPA047849" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042174: AB_2677885, HPA047849: AB_2680180" "unprognostic (8.43e-2)" "unprognostic (1.55e-1)" "unprognostic (2.17e-1)" "unprognostic (1.53e-2)" "unprognostic (9.46e-3)" "unprognostic (1.13e-1)" "unprognostic (5.41e-3)" "unprognostic (6.42e-2)" "unprognostic (4.34e-3)" "unprognostic (1.57e-1)" "unprognostic (1.22e-1)" "unprognostic (4.42e-2)" "unprognostic (2.53e-1)" "unprognostic (2.13e-1)" "unprognostic (2.27e-1)" "unprognostic (4.76e-2)" "unprognostic (3.07e-3)" 41.6 50.3 37.1 34.4 37.2 57.5 38.3 55.5 43.9 40.6 39.1 35.5 43.4 33.9 42.2 48.3 44.5 37.4 33.6 33.0 32.1 31.0 40.9 37.2 34.3 44.7 30.1 32.7 51.1 63.9 44.9 41.5 42.5 31.1 42.7 33.2 41.3 54.6 33.2 40.8 37.4 36.2 36.7 26.9 48.5 42.1 47.3 32.2 68.2 59.5 37.9 48.7 36.5 37.2 51.4 45.0 61.7 51.9 57.5 72.7 54.3 26.9 35.7 54.3 30.6 20.0 21.7 33.0 28.5 23.1 30.1 21.6 59.5 35.2 34.9 39.4 28.5 27.1 30.1 57.9 33.9 32.3 34.6 30.2 47.5 36.6 35.5 39.6 32.4 20.7 31.8 29.5 34.6 49.1 30.7 39.8 34.4 37.3 25.8 31.3 55.8 53.3 33.4 68.2 52.8 39.4 50.0 50.9 38.6 39.8 43.7 45.8 32.9 50.2 36.9 79.8 38.3 70.0 32.7 40.4 31.4 27.7 19.4 23.0 32.5 33.9 56.4 25.1 25.6 44.9 61.7 45.7 48.6 56.8 46.8 51.0 48.0 59.0 61.8 45.0 51.4 63.8 63.5 53.6 57.5 51.9 40.6 72.7 54.3 37.1 37.2 55.5 43.9 32.1 31.0 30.1 32.7 31.1 32.2 26.8 35.6 27.0 53.2 15.9 54.4 4.1 12.7 41.5 33.0 19.2 88.4 31.8 13.3 19.9 32.7 23.2 24.5 23.3 20.1 24.9 21.1 36.2 35.8 8.5 12.6 58.8 33.4 19.0 14.3 5.2 25.3 23.5 18.6 25.2 13.9 15.1 17.3 18.2 19.1 8.1 77.2 19.4 25.8 24.7 32.8 19.4 36.6 42.7 18.0 55.6 RBM42 MGC10433 ENSG00000126254 "RNA binding motif protein 42" Q9BTD8 19 35629030-35637686 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 321.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043671 Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043671: AB_10794890" "unprognostic (4.77e-3)" "unprognostic (3.37e-2)" "unprognostic (6.33e-2)" "unprognostic (7.03e-2)" "unprognostic (3.05e-1)" "unprognostic (7.36e-2)" "unprognostic (4.19e-2)" "unprognostic (3.34e-1)" "unprognostic (1.53e-1)" "unprognostic (8.81e-2)" "unprognostic (4.95e-3)" "unprognostic (3.26e-2)" "unprognostic (5.78e-3)" "unprognostic (3.37e-2)" "unprognostic (1.66e-2)" "unprognostic (1.40e-1)" "unprognostic (7.33e-2)" 26.0 22.0 16.6 20.3 16.0 29.2 23.6 12.1 23.4 20.4 27.3 22.6 18.8 24.2 25.5 21.8 25.5 18.3 23.6 24.9 13.7 12.0 22.2 33.3 19.3 19.2 15.7 17.6 27.6 17.7 20.7 15.0 41.3 16.0 19.5 9.9 15.9 25.1 24.6 44.6 31.5 24.7 18.6 18.1 25.4 22.0 23.7 16.0 41.1 25.8 21.9 21.3 21.2 22.4 43.6 49.1 61.3 48.9 38.9 45.6 33.9 32.4 51.2 11.4 15.5 10.4 8.3 31.2 22.4 12.4 26.4 20.8 30.2 21.2 18.1 41.0 14.2 14.3 13.4 13.1 15.7 7.7 46.8 23.5 25.0 17.1 24.6 27.1 22.0 24.1 11.7 12.6 19.4 10.7 8.4 14.4 19.1 25.9 14.9 11.9 37.0 27.9 29.1 13.1 29.5 21.1 30.5 15.6 18.0 12.5 15.1 15.0 21.8 25.4 21.0 17.0 6.6 16.7 34.7 22.0 18.9 25.8 24.9 38.9 36.5 38.4 27.9 18.2 21.0 26.3 46.1 42.1 61.3 45.6 48.9 39.3 41.0 37.9 45.5 49.1 43.6 34.2 37.7 38.6 38.9 45.4 45.4 41.9 33.9 16.6 16.0 12.1 23.4 13.7 12.0 15.7 17.6 16.0 16.0 35.7 21.1 26.7 41.9 46.0 19.2 12.0 50.9 26.8 28.4 50.6 11.8 174.8 63.0 68.5 26.2 42.7 70.6 0.0 78.3 85.4 48.9 29.9 50.7 27.6 78.2 9.5 50.1 48.5 29.8 12.0 53.8 45.9 50.6 83.8 42.6 43.4 64.2 45.6 59.4 63.4 13.9 51.8 59.0 62.6 56.9 38.0 321.4 45.9 48.9 38.9 RBM43 "C2orf38, FLJ45645" ENSG00000184898 "RNA binding motif protein 43" Q6ZSC3 2 151247940-151261879 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ciliated cells: 32.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 18.2;HSkMC: 16.4" "Low region specificity" "Detected in all" HPA038204 Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA038204: AB_10669520" "unprognostic (3.50e-2)" "unprognostic (5.45e-2)" "unprognostic (2.41e-1)" "unprognostic (1.52e-1)" "unprognostic (1.15e-1)" "unprognostic (2.17e-1)" "unprognostic (2.48e-1)" "unprognostic (1.12e-1)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" "unprognostic (9.72e-3)" "unprognostic (2.57e-2)" "unprognostic (3.43e-3)" "unprognostic (1.22e-2)" "unprognostic (3.07e-2)" "unprognostic (1.12e-2)" "unprognostic (9.94e-2)" 10.7 14.8 5.2 7.6 6.4 6.0 7.9 1.6 4.9 14.4 8.1 5.4 7.4 3.1 14.6 14.6 8.4 13.6 7.2 4.4 6.0 4.8 7.8 7.0 14.3 13.6 4.5 5.3 17.6 6.8 8.7 7.8 6.0 4.3 14.4 4.7 14.3 6.2 8.9 4.5 6.2 6.3 11.5 5.6 8.4 5.9 6.5 4.1 11.0 13.4 3.6 6.9 20.5 6.6 3.2 1.1 5.9 4.6 5.3 4.9 1.2 2.9 1.9 3.1 4.1 8.3 18.2 2.0 3.4 7.8 4.3 6.3 0.1 4.9 2.3 1.3 6.1 2.3 1.5 0.9 3.9 2.2 3.4 2.1 5.5 0.7 0.2 8.1 6.7 1.9 16.4 4.4 3.4 2.6 6.5 9.1 2.5 2.2 2.6 5.8 2.9 3.8 3.2 1.1 0.0 3.6 2.6 3.5 1.3 7.3 2.5 1.1 3.6 3.3 2.4 6.4 0.5 3.5 4.4 5.1 3.2 2.9 2.8 1.4 0.9 0.6 0.0 8.5 2.7 1.9 1.9 1.7 5.9 2.8 2.1 4.6 2.8 3.9 3.5 1.1 3.2 4.9 3.4 2.0 5.3 4.6 0.5 1.9 1.2 5.2 6.4 1.6 4.9 6.0 4.8 4.5 5.3 4.3 4.1 3.0 6.2 4.7 2.3 3.0 7.5 2.1 15.3 32.1 6.8 17.4 0.0 5.6 23.2 4.9 2.3 9.0 2.9 0.0 5.1 3.3 8.7 3.3 3.5 8.6 4.7 6.4 5.8 15.4 11.3 1.1 25.9 4.8 3.3 8.2 6.9 21.7 3.8 5.3 27.3 8.8 0.9 0.0 5.7 0.7 3.2 2.8 1.1 5.9 4.3 2.0 RBM45 "DRB1, FLJ44612" ENSG00000155636 "RNA binding motif protein 45" Q8IUH3 2 178112424-178139011 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020448 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA020448: AB_1856133" "unprognostic (3.11e-2)" "unprognostic (1.91e-1)" "unprognostic (6.56e-2)" "unprognostic (2.79e-1)" "unprognostic (1.34e-1)" "unprognostic (2.62e-1)" "prognostic unfavorable (5.74e-9)" "unprognostic (1.66e-1)" "unprognostic (4.25e-2)" "unprognostic (2.71e-2)" "unprognostic (2.42e-1)" "unprognostic (5.79e-2)" "prognostic unfavorable (5.34e-9)" "unprognostic (3.26e-1)" "unprognostic (2.68e-1)" "unprognostic (1.05e-1)" "unprognostic (2.94e-1)" 9.5 13.7 15.7 12.4 18.1 7.3 17.3 15.3 15.4 12.2 16.2 10.4 19.7 11.8 13.9 19.3 12.3 14.7 10.3 10.5 14.8 13.1 13.4 15.6 11.0 14.4 15.2 16.2 12.2 16.1 16.2 24.0 6.9 14.6 12.1 19.1 11.1 17.0 14.1 11.2 16.1 13.2 12.0 11.9 16.5 12.4 13.4 16.3 21.6 14.0 7.0 18.7 11.1 10.2 10.8 8.1 4.4 9.5 11.8 11.5 5.6 8.8 9.5 15.2 6.2 13.7 15.4 9.1 11.8 13.7 12.2 13.6 10.0 7.4 14.9 8.2 14.0 12.0 8.0 12.5 16.0 15.6 11.7 10.6 11.6 6.9 14.5 13.9 13.9 11.1 12.2 13.6 12.9 10.8 11.9 13.2 7.8 10.5 12.4 16.2 14.1 14.0 9.4 10.8 12.9 12.0 10.9 10.9 14.8 18.1 20.6 9.4 10.0 8.8 8.7 11.2 18.1 12.4 13.0 11.2 9.2 8.5 10.5 11.6 11.6 13.0 18.5 8.9 11.0 12.4 4.4 5.6 1.8 6.9 8.5 8.4 10.8 7.5 7.5 7.5 8.4 6.7 8.2 1.2 11.8 9.5 8.1 11.5 5.6 15.7 18.1 15.3 15.4 14.8 13.1 15.2 16.2 14.6 16.3 3.0 3.4 1.5 2.6 2.3 5.5 3.6 7.6 6.7 3.4 1.8 9.8 5.2 6.6 6.2 2.6 6.7 4.5 0.0 5.8 8.4 4.7 1.9 8.1 3.4 7.3 9.5 5.8 4.3 9.4 3.1 4.0 5.0 1.7 7.2 5.4 8.0 4.7 4.3 5.3 5.9 7.6 6.5 5.2 8.4 5.1 3.0 1.5 2.9 5.0 2.5 RBM46 "CT68, MGC27016" ENSG00000151962 "RNA binding motif protein 46" Q8TBY0 4 154781213-154828813 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 73 "testis: 34.5" "Group enriched" "Detected in some" 13 "Spermatocytes: 74.4;Spermatogonia: 75.5" "Cancer enriched" "Detected in single" 15 "testis cancer: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NTERA-2: 2.7;SuSa: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA079488 Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA079488: " "unprognostic (4.79e-1)" "unprognostic (1.14e-2)" "unprognostic (3.23e-1)" "unprognostic (1.59e-2)" "unprognostic (3.33e-3)" "unprognostic (1.13e-1)" "unprognostic (8.11e-2)" "unprognostic (2.24e-2)" "unprognostic (2.99e-7)" "unprognostic (4.86e-2)" "unprognostic (7.31e-2)" "unprognostic (4.27e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 34.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 5.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 74.4 75.5 0.0 0.0 0.0 0.0 0.0 RBM47 "FLJ20273, NET18" ENSG00000163694 "RNA binding motif protein 47" A0AV96 4 40423267-40630875 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 42.4" "Group enriched" "Detected in many" 11 "dendritic cells: 11.3;granulocytes: 42.4;monocytes: 14.2" "Cell line enhanced" "Detected in many" "A549: 16.8;BEWO: 50.3;CAPAN-2: 22.1;SK-BR-3: 16.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA006347 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA006347: AB_2181208" "unprognostic (2.28e-2)" "unprognostic (2.46e-1)" "unprognostic (5.49e-3)" "unprognostic (2.38e-2)" "unprognostic (7.72e-2)" "unprognostic (1.52e-2)" "unprognostic (7.35e-3)" "unprognostic (1.39e-1)" "unprognostic (1.22e-1)" "unprognostic (9.42e-2)" "unprognostic (3.04e-2)" "unprognostic (1.47e-1)" "prognostic favorable (3.33e-16)" "unprognostic (1.62e-2)" "unprognostic (9.81e-2)" "unprognostic (1.72e-1)" "unprognostic (5.77e-2)" 8.2 33.6 1.9 8.2 2.4 2.6 10.9 0.8 1.2 5.4 22.9 3.3 28.7 24.1 2.6 15.4 27.3 5.3 12.7 4.0 2.4 1.1 37.0 16.1 14.5 11.3 3.0 0.3 4.6 19.2 8.0 2.9 27.2 6.6 13.2 17.3 9.2 60.8 36.0 0.9 6.0 42.8 2.2 4.1 15.0 22.2 7.1 2.2 1.6 31.5 13.7 20.6 7.8 9.7 2.0 11.3 42.4 14.2 0.1 0.1 4.8 11.6 16.8 0.0 0.5 0.0 0.0 50.3 0.3 0.3 0.1 0.1 9.8 22.1 0.0 8.8 0.3 0.9 4.6 0.3 3.3 0.1 0.0 2.8 0.0 1.2 2.7 0.2 0.1 0.1 0.2 2.0 0.0 0.0 0.3 0.0 0.0 0.6 2.5 0.0 6.6 0.0 0.3 5.1 16.3 0.9 0.0 0.0 13.0 15.5 14.8 0.5 0.1 6.6 16.8 0.1 3.8 7.4 3.1 0.0 0.1 0.6 0.1 0.3 8.9 13.2 1.4 1.5 1.4 0.0 0.1 14.2 0.1 0.0 10.9 0.1 2.0 0.0 0.0 11.3 1.2 0.1 0.0 42.4 0.1 8.1 4.6 0.0 4.8 1.9 2.4 0.8 1.2 2.4 1.1 3.0 0.3 6.6 2.2 74.5 109.6 29.8 66.4 52.3 0.0 2.0 63.7 107.1 92.1 106.4 0.0 84.5 54.7 73.9 0.9 3.4 253.2 0.0 99.6 71.8 8.3 174.3 6.9 117.3 81.1 1.6 116.9 35.0 113.3 1.5 2.3 85.9 35.4 57.7 177.9 0.4 94.8 165.8 1.1 114.0 0.0 0.0 3.1 1.9 11.4 65.9 219.6 0.0 144.7 244.6 RBM48 "C7orf64, DKFZp564O0523, HSPC304" ENSG00000127993 "RNA binding motif protein 48" Q5RL73 7 92528773-92538005 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021777, HPA025306" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021777: AB_1845763, HPA025306: AB_1845764" "unprognostic (2.79e-2)" "unprognostic (2.15e-1)" "unprognostic (2.12e-1)" "unprognostic (1.30e-2)" "unprognostic (2.81e-2)" "unprognostic (5.04e-2)" "prognostic unfavorable (3.17e-4)" "unprognostic (2.86e-2)" "unprognostic (2.37e-2)" "unprognostic (3.22e-1)" "unprognostic (1.59e-3)" "unprognostic (3.38e-2)" "unprognostic (1.72e-1)" "unprognostic (6.51e-2)" "unprognostic (7.79e-2)" "unprognostic (2.43e-2)" "unprognostic (8.04e-2)" 11.1 13.0 23.9 10.8 36.0 24.6 14.1 28.3 34.2 11.7 9.0 18.4 7.1 10.3 12.0 12.4 9.9 10.9 8.9 12.1 22.8 15.2 12.4 10.5 9.9 17.1 42.4 15.1 17.0 10.6 11.1 18.3 10.6 20.7 11.5 11.0 9.0 13.0 8.9 16.5 10.8 10.7 9.7 28.0 14.5 9.8 12.5 36.9 13.6 14.5 6.6 13.9 10.2 10.1 20.1 10.6 37.5 12.1 18.1 25.8 14.0 7.5 5.6 9.7 15.2 11.9 12.4 7.6 9.1 9.4 12.1 11.5 6.5 10.4 10.8 16.5 7.7 15.2 7.8 9.9 7.3 13.5 12.2 12.2 8.5 12.2 7.4 10.1 14.9 10.2 9.5 14.4 11.9 12.7 13.9 12.1 14.1 16.8 19.2 11.2 8.9 19.2 15.2 8.6 10.8 9.4 8.9 8.5 14.6 9.6 7.3 11.5 16.2 9.1 17.6 12.7 13.3 5.5 14.7 6.2 17.1 9.3 13.5 13.0 11.4 15.1 18.5 8.1 13.1 15.6 37.5 10.1 21.0 18.5 12.1 20.2 20.1 20.3 18.9 9.7 18.5 25.8 22.1 13.4 18.1 9.9 10.6 18.3 14.0 23.9 36.0 28.3 34.2 22.8 15.2 42.4 15.1 20.7 36.9 11.9 6.9 15.6 11.1 7.6 12.2 14.6 5.1 9.4 11.4 3.5 0.0 8.8 6.6 6.9 6.1 9.3 5.8 23.3 5.2 4.8 8.7 8.9 29.0 3.8 5.4 11.1 0.0 4.9 6.5 5.7 5.5 8.9 5.0 8.2 3.8 12.5 4.1 6.6 6.0 7.4 12.5 12.9 8.3 21.2 15.6 9.9 12.8 14.1 5.2 10.3 RBM4B "MGC10871, RBM30, RBM4L, ZCCHC15, ZCCHC21B, ZCRB3B" ENSG00000173914 "RNA binding motif protein 4B" Q9BQ04 11 66664998-66677921 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042174, HPA047849" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042174: AB_2677885, HPA047849: AB_2680180" "unprognostic (1.65e-2)" "unprognostic (1.83e-1)" "unprognostic (3.32e-2)" "unprognostic (1.98e-3)" "unprognostic (3.57e-1)" "unprognostic (1.87e-2)" "prognostic unfavorable (2.94e-4)" "unprognostic (1.28e-1)" "unprognostic (1.09e-2)" "unprognostic (6.22e-2)" "prognostic favorable (2.10e-4)" "unprognostic (1.05e-2)" "prognostic unfavorable (1.02e-4)" "unprognostic (1.10e-2)" "unprognostic (1.40e-1)" "unprognostic (4.29e-2)" "unprognostic (1.71e-2)" 7.1 12.3 17.6 9.6 17.3 4.0 10.2 35.9 19.3 13.4 10.0 22.8 13.5 9.3 19.0 20.2 10.1 18.3 9.8 9.2 17.5 17.4 9.9 9.8 8.8 13.8 15.4 16.2 29.8 11.8 15.7 25.6 12.2 17.3 14.6 11.5 14.5 14.1 15.0 13.9 17.4 10.3 14.0 16.4 11.8 9.8 17.0 18.7 8.5 12.3 7.6 15.5 11.3 11.5 21.8 11.4 26.8 15.1 13.2 12.5 8.4 13.1 13.2 29.1 24.2 14.3 14.7 9.8 12.7 12.7 14.2 14.6 18.5 13.9 14.7 18.2 16.0 13.9 17.2 19.1 17.5 15.1 14.2 13.0 16.0 16.6 19.7 10.5 16.2 15.8 15.3 12.0 14.5 12.4 16.3 13.7 12.0 12.1 14.8 19.1 21.2 10.0 12.5 17.3 29.7 17.8 20.6 23.2 15.1 12.9 13.3 17.9 16.4 15.1 7.8 28.3 19.5 20.8 15.4 12.6 15.7 16.2 15.3 11.3 7.3 12.3 15.1 14.5 11.5 13.8 12.7 9.6 26.8 10.8 14.1 10.4 21.8 10.1 10.4 11.4 18.6 12.5 9.2 6.1 13.2 15.1 9.4 7.4 8.4 17.6 17.3 35.9 19.3 17.5 17.4 15.4 16.2 17.3 18.7 11.9 5.1 15.9 14.0 7.1 35.5 4.5 7.6 21.4 10.3 17.4 31.4 32.2 10.0 12.0 21.2 7.0 8.5 0.0 5.0 14.2 17.8 7.3 9.2 7.4 11.1 23.8 18.4 6.7 8.7 36.0 17.0 8.2 15.1 9.0 8.6 21.8 5.3 7.4 12.7 11.2 56.8 6.5 11.3 42.1 40.0 6.1 18.5 13.4 10.3 4.3 RBM5 "H37, LUCA15" ENSG00000003756 "RNA binding motif protein 5" P52756 3 50088908-50119021 "Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017335, HPA018011" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA017335: AB_1856134, HPA018011: AB_1856135" "unprognostic (4.11e-3)" "unprognostic (1.19e-1)" "unprognostic (6.12e-2)" "unprognostic (4.00e-2)" "unprognostic (2.07e-1)" "unprognostic (2.61e-3)" "prognostic unfavorable (9.77e-4)" "prognostic favorable (6.46e-4)" "unprognostic (1.16e-2)" "unprognostic (2.85e-1)" "prognostic favorable (7.58e-4)" "unprognostic (5.58e-2)" "unprognostic (1.49e-2)" "unprognostic (1.93e-1)" "unprognostic (1.58e-1)" "unprognostic (2.41e-1)" "unprognostic (3.89e-3)" 33.8 25.9 34.1 43.7 37.8 37.7 37.0 51.2 38.9 38.5 33.1 47.7 41.3 25.1 53.2 45.9 28.9 40.5 27.6 28.5 31.1 25.0 30.4 26.9 30.3 41.2 38.1 38.4 63.5 36.3 37.7 58.6 40.3 30.3 41.5 33.5 40.4 35.7 37.9 45.9 54.5 34.7 37.9 41.1 47.0 30.9 36.4 39.5 41.4 42.0 28.5 45.5 31.8 36.6 14.3 12.2 29.6 14.4 14.0 20.1 10.3 9.7 12.1 43.8 19.0 18.3 26.7 10.3 29.8 18.0 22.2 15.7 12.1 11.3 23.0 10.3 19.4 21.9 8.6 29.6 14.4 23.9 21.4 10.8 28.9 41.2 10.8 22.7 26.4 23.4 23.7 16.4 24.1 23.8 38.3 23.5 23.7 19.7 15.5 20.8 8.7 26.8 17.9 15.7 16.7 13.8 14.6 19.2 11.8 16.1 49.1 6.3 14.6 24.5 10.7 14.8 31.2 9.9 25.4 26.6 14.8 15.5 20.4 17.2 21.5 31.4 24.4 11.0 16.2 17.0 29.6 14.0 18.5 17.5 14.4 16.6 13.7 15.8 18.1 12.2 14.3 20.1 15.8 26.1 14.0 14.0 9.3 18.4 10.3 34.1 37.8 51.2 38.9 31.1 25.0 38.1 38.4 30.3 39.5 65.5 105.1 31.8 36.7 28.4 88.7 39.5 17.8 100.4 86.4 36.6 172.8 40.3 10.0 22.5 120.2 50.7 39.5 0.0 18.1 21.2 40.9 41.1 64.9 37.6 27.8 89.0 70.6 55.3 39.9 150.2 59.5 45.4 42.2 37.9 45.1 49.6 24.7 36.8 54.5 7.6 131.6 32.3 43.2 48.9 34.1 29.6 68.3 55.8 33.6 34.9 RBM7 ENSG00000076053 "RNA binding motif protein 7" Q9Y580 11 114400030-114414203 "Predicted intracellular proteins" Meiosis RNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 146.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA013993, HPA048003" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA013993: AB_1856137, HPA048003: AB_2680231" "unprognostic (2.90e-3)" "unprognostic (8.21e-3)" "prognostic favorable (6.14e-4)" "unprognostic (1.03e-2)" "unprognostic (1.43e-1)" "unprognostic (2.58e-2)" "unprognostic (1.93e-2)" "unprognostic (2.89e-1)" "unprognostic (9.38e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.17e-4)" "unprognostic (1.05e-1)" "unprognostic (3.62e-2)" "unprognostic (5.49e-2)" "unprognostic (4.74e-2)" "unprognostic (1.84e-1)" "unprognostic (8.30e-2)" 21.6 13.0 11.4 12.9 14.9 39.9 20.2 15.1 13.0 19.9 17.2 11.9 8.4 11.0 20.2 13.9 19.2 18.2 15.4 13.9 12.1 7.3 14.7 28.6 18.2 18.7 15.5 8.7 26.3 14.9 14.4 17.7 23.8 11.9 20.9 16.8 8.4 18.1 12.1 17.2 13.9 17.7 18.7 15.8 20.0 16.6 16.7 16.1 22.0 21.5 12.5 15.8 24.3 20.5 13.4 15.4 36.2 16.5 17.5 18.6 12.7 12.8 8.6 11.3 10.7 14.8 20.1 12.4 21.1 28.6 24.8 28.7 18.7 29.1 15.5 29.5 19.6 22.8 11.7 13.7 15.4 32.6 14.3 7.5 18.5 9.8 15.4 25.1 12.1 12.9 19.9 20.6 20.7 29.2 22.3 22.0 12.9 18.0 2.9 19.1 3.7 14.1 12.4 14.1 12.1 14.3 11.1 20.6 14.8 20.7 14.3 9.2 8.8 18.3 8.6 9.6 22.4 8.4 8.3 19.7 7.5 17.7 9.5 22.1 7.6 7.8 13.7 5.3 21.5 12.7 36.2 16.2 18.2 13.0 16.5 18.6 13.4 14.0 12.3 15.4 11.9 17.5 15.0 15.6 17.5 16.0 14.8 14.9 12.7 11.4 14.9 15.1 13.0 12.1 7.3 15.5 8.7 11.9 16.1 14.9 18.8 43.6 71.5 59.9 11.2 12.8 10.2 24.1 19.4 27.9 11.8 43.4 56.3 42.2 146.5 38.3 29.0 0.0 30.7 67.9 54.3 61.6 39.3 23.2 27.3 7.9 45.5 34.4 25.7 16.1 29.1 22.4 40.5 31.5 26.8 21.6 37.8 33.2 15.9 28.4 11.6 0.0 60.8 29.2 15.2 60.0 77.2 40.5 34.3 73.7 RBMS2 SCR3 ENSG00000076067 "RNA binding motif single stranded interacting protein 2" Q15434 12 56521929-56596196 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ito cells: 47.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 32.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039225, HPA058784" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA039225: AB_10963056, HPA058784: AB_2683819" "unprognostic (1.35e-1)" "unprognostic (5.31e-2)" "unprognostic (2.61e-1)" "unprognostic (5.29e-2)" "unprognostic (9.09e-2)" "unprognostic (3.19e-3)" "unprognostic (4.78e-2)" "unprognostic (1.89e-2)" "unprognostic (7.01e-2)" "unprognostic (2.80e-1)" "unprognostic (2.86e-2)" "unprognostic (2.15e-1)" "prognostic favorable (3.22e-4)" "unprognostic (2.67e-2)" "unprognostic (4.73e-2)" "unprognostic (4.06e-3)" "unprognostic (2.63e-2)" 24.5 7.2 5.7 5.8 10.0 3.6 31.3 8.5 8.7 12.2 9.9 6.0 6.1 4.7 17.5 11.9 9.3 10.4 10.4 19.3 8.6 5.1 12.4 4.4 53.1 8.0 7.5 5.2 12.6 7.5 11.5 12.1 24.8 11.4 9.6 9.6 14.3 10.3 9.8 9.3 7.5 7.5 12.9 19.2 13.2 8.0 4.8 7.4 2.7 16.5 8.1 5.3 11.7 19.2 1.1 4.9 3.0 8.3 2.1 2.3 1.5 11.7 9.8 4.2 6.1 10.4 10.0 4.3 14.9 15.4 11.5 10.1 7.7 20.9 0.2 17.8 15.1 4.5 8.5 3.9 23.7 12.9 3.9 3.1 1.4 7.6 2.3 6.7 1.7 2.8 8.9 6.0 11.9 14.1 13.4 21.1 2.5 0.7 2.9 19.4 1.5 1.6 1.9 2.5 0.0 3.6 0.9 4.7 0.2 14.2 2.8 0.4 3.2 17.3 6.3 2.1 9.9 6.7 3.1 32.2 7.2 15.3 3.9 3.5 2.6 1.1 0.8 2.6 0.4 10.0 1.0 8.3 2.6 1.6 2.6 1.7 0.6 0.7 2.3 4.9 1.1 1.8 1.2 3.0 2.1 0.6 1.3 0.9 1.5 5.7 10.0 8.5 8.7 8.6 5.1 7.5 5.2 11.4 7.4 38.7 15.6 0.0 8.0 3.3 4.1 6.7 15.3 6.7 17.0 12.2 9.8 17.8 1.7 19.9 9.7 41.2 4.1 0.0 14.6 31.2 7.2 11.1 8.1 1.0 9.3 7.9 5.2 47.9 21.6 17.0 16.1 7.3 0.0 2.8 6.9 6.1 28.5 11.2 23.3 9.1 1.6 25.8 8.3 0.7 1.1 1.8 19.8 0.9 6.6 11.5 RBMX "hnRNP-G, HNRNPG, RNMX" ENSG00000147274 "RNA binding motif protein, X-linked" P38159 X 136848004-136880764 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription" "Activator, Repressor, Ribonucleoprotein, RNA-binding" "Cancer-related genes, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057707 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA057707: AB_2683508" "unprognostic (1.53e-1)" "unprognostic (1.52e-3)" "unprognostic (2.12e-3)" "unprognostic (1.14e-2)" "unprognostic (2.62e-2)" "unprognostic (8.13e-2)" "prognostic unfavorable (5.16e-6)" "unprognostic (5.59e-2)" "unprognostic (1.05e-2)" "unprognostic (1.68e-2)" "unprognostic (4.87e-2)" "unprognostic (2.32e-2)" "unprognostic (2.94e-2)" "unprognostic (1.57e-1)" "unprognostic (7.65e-2)" "unprognostic (6.27e-2)" "unprognostic (4.64e-3)" 31.0 25.0 30.6 57.1 41.1 48.0 40.6 28.7 33.0 44.2 28.3 32.5 32.7 24.6 45.9 31.7 26.7 38.9 22.1 31.4 26.5 18.0 25.6 20.9 34.4 64.6 34.0 29.3 81.9 39.1 30.1 30.1 25.3 30.5 28.4 33.4 27.5 29.9 29.4 50.0 27.6 27.3 43.0 44.2 27.4 30.1 23.6 29.2 70.1 31.5 34.4 44.8 36.1 33.4 47.1 41.9 25.0 44.9 39.4 60.7 62.9 40.4 44.2 81.1 36.0 20.3 34.4 47.3 40.4 44.0 56.0 59.5 47.2 40.7 73.7 41.8 28.8 35.2 27.1 86.0 42.2 64.9 31.8 40.5 56.4 43.6 50.3 17.8 61.4 51.9 28.2 20.5 43.5 61.1 43.1 45.1 69.9 50.6 37.8 45.5 51.5 89.7 41.5 51.5 43.3 37.1 74.6 54.3 45.5 41.5 48.5 47.4 51.3 32.2 29.2 37.4 50.1 33.5 41.5 28.6 31.8 34.5 21.9 51.4 27.1 36.2 78.0 22.6 44.9 43.3 25.0 37.5 20.8 36.4 44.9 50.3 47.1 47.4 43.1 41.9 45.0 60.7 49.6 6.0 39.4 39.2 25.4 46.8 62.9 30.6 41.1 28.7 33.0 26.5 18.0 34.0 29.3 30.5 29.2 104.2 138.2 258.8 161.8 135.0 109.2 87.6 155.4 174.0 208.1 83.7 90.3 148.4 131.0 128.6 6.7 123.5 81.3 233.6 127.9 222.2 130.2 86.5 255.9 103.0 103.4 87.4 194.8 214.2 240.2 4.3 159.0 111.5 91.1 117.2 164.5 89.1 96.1 94.7 125.2 73.8 131.7 90.5 161.3 27.3 77.1 107.0 93.3 214.2 203.4 130.2 RBMXL1 KAT3 ENSG00000213516 "RNA binding motif protein, X-linked like 1" Q96E39 1 88979456-88992960 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA057707 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA057707: AB_2683508" "prognostic favorable (7.60e-4)" "unprognostic (2.22e-1)" "unprognostic (2.87e-2)" "unprognostic (1.75e-1)" "unprognostic (1.00e-1)" "unprognostic (5.84e-2)" "unprognostic (1.17e-3)" "unprognostic (2.89e-1)" "unprognostic (2.09e-1)" "unprognostic (1.03e-2)" "prognostic unfavorable (7.26e-4)" "unprognostic (2.55e-1)" "unprognostic (1.74e-2)" "unprognostic (2.75e-1)" "unprognostic (2.35e-1)" "unprognostic (1.17e-1)" "unprognostic (1.04e-1)" 13.3 9.8 18.5 11.7 15.3 23.8 13.4 12.0 18.0 18.2 12.2 15.3 9.7 9.8 18.5 16.2 20.9 16.7 11.5 14.0 17.1 15.2 17.4 18.3 13.0 13.5 17.1 17.0 22.8 14.5 25.0 14.1 16.7 17.9 16.3 9.5 14.8 11.8 14.3 8.9 12.1 12.2 16.9 17.4 14.4 13.9 14.2 13.0 11.7 16.2 10.1 14.0 19.3 12.4 8.8 8.6 12.3 10.1 6.3 10.8 8.4 10.7 3.2 9.2 12.0 10.9 11.1 17.6 4.6 10.7 9.4 11.1 5.3 7.3 9.1 9.2 5.5 21.9 6.3 17.4 11.5 10.5 8.3 7.7 10.8 11.2 7.0 6.3 8.5 5.9 6.4 6.7 8.4 7.5 4.1 6.0 6.5 15.0 6.0 5.6 4.0 9.0 4.4 16.9 7.0 7.3 8.3 22.6 4.5 6.2 12.5 6.7 10.3 5.0 11.3 11.6 12.9 8.2 8.9 4.4 6.1 12.5 7.1 7.8 9.5 8.9 9.4 4.3 5.2 5.6 2.5 6.6 5.9 6.9 8.9 9.3 6.7 9.7 7.3 8.6 8.8 10.8 6.6 12.3 6.3 10.1 4.4 7.6 8.4 18.5 15.3 12.0 18.0 17.1 15.2 17.1 17.0 17.9 13.0 32.8 34.6 13.7 48.3 27.2 18.9 17.1 20.4 24.1 29.6 12.2 13.7 25.6 3.3 7.6 1.2 18.0 9.7 0.0 7.6 24.9 16.5 19.0 33.5 28.7 10.2 23.8 27.6 14.1 21.3 1.5 15.8 13.8 20.3 19.0 9.4 26.1 8.1 5.8 14.2 4.3 16.8 6.5 23.1 10.1 15.4 21.2 28.5 20.8 10.5 30.8 RBP1 "CRABP-I, CRBP, CRBP1, CRBPI, RBPC" ENSG00000114115 "Retinol binding protein 1" P09455 3 139517434-139539829 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 161.0;pancreas: 107.4;retina: 85.3" "Group enriched" "Detected in many" 7 "Ductal cells: 920.8;Exocrine glandular cells: 932.2;Ito cells: 319.8;Pancreatic endocrine cells: 450.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 136.6" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 4 "basal ganglia: 56.8" "HPA007338, CAB018603, CAB019276" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB018603: AB_2060572, CAB019276: , HPA007338: AB_2667814" "unprognostic (9.62e-3)" "unprognostic (7.67e-2)" "unprognostic (9.53e-3)" "unprognostic (5.17e-1)" "unprognostic (7.48e-3)" "unprognostic (2.27e-2)" "unprognostic (6.29e-2)" "unprognostic (1.16e-1)" "unprognostic (7.12e-2)" "unprognostic (3.91e-3)" "unprognostic (2.74e-2)" "unprognostic (8.86e-2)" "unprognostic (1.11e-3)" "unprognostic (2.60e-2)" "unprognostic (1.71e-1)" "unprognostic (4.50e-2)" "unprognostic (1.28e-3)" 1.9 43.1 6.5 3.3 11.3 0.1 7.5 5.1 7.8 7.8 3.2 11.5 8.4 4.5 26.8 11.3 3.3 58.4 42.7 7.5 7.7 8.1 3.7 20.1 4.9 6.5 10.4 4.9 161.0 107.4 4.3 26.2 20.6 31.5 9.8 2.1 85.3 4.7 6.4 1.8 2.9 4.8 17.5 8.7 4.7 2.8 12.9 4.3 0.9 3.3 2.6 2.0 7.7 7.2 0.5 0.5 2.1 0.9 0.7 0.4 0.2 1.2 0.3 1.1 26.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.2 0.0 8.7 0.0 0.4 0.0 6.1 0.1 0.0 0.0 0.7 0.0 0.4 11.2 25.8 0.0 0.0 0.4 0.0 0.0 0.0 26.4 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 5.2 0.0 0.0 0.0 3.2 136.6 5.6 0.0 0.0 2.3 0.5 0.1 0.0 0.0 20.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 1.2 0.9 0.8 0.4 0.8 0.1 0.4 0.2 0.1 0.0 0.5 0.3 0.2 2.1 0.7 0.5 0.5 0.1 0.2 6.5 11.3 5.1 7.8 7.7 8.1 10.4 4.9 31.5 4.3 29.8 5.1 10.5 43.6 15.7 12.3 15.5 63.7 5.3 12.5 22.7 2.0 2.6 11.6 920.8 3.9 54.2 0.0 0.0 932.2 6.9 95.1 21.2 0.0 6.6 16.2 3.2 41.3 319.8 11.5 8.3 25.0 2.8 8.5 23.4 0.5 79.7 450.0 0.0 4.2 2.7 7.0 25.8 22.5 2.3 4.1 30.6 3.2 2.5 0.8 27.7 RBPJ "CBF1, IGKJRB, IGKJRB1, KBF2, RBP-J, RBPJK, RBPSUH, SUH" ENSG00000168214 "Recombination signal binding protein for immunoglobulin kappa J region" Q06330 4 26163455-26435131 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Notch signaling pathway, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000251, HPA060647" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA000251: , HPA060647: AB_2684337" "unprognostic (2.68e-1)" "unprognostic (2.71e-3)" "unprognostic (2.61e-1)" "prognostic favorable (2.98e-4)" "unprognostic (3.78e-2)" "unprognostic (1.37e-1)" "unprognostic (3.64e-3)" "unprognostic (1.66e-1)" "unprognostic (1.22e-1)" "unprognostic (3.01e-1)" "unprognostic (5.80e-2)" "unprognostic (2.19e-1)" "unprognostic (1.31e-3)" "unprognostic (1.46e-1)" "unprognostic (1.34e-1)" "unprognostic (2.04e-2)" "unprognostic (1.15e-3)" 37.7 16.2 23.9 25.7 37.0 35.9 26.3 28.0 34.1 27.5 30.4 37.2 19.4 16.3 37.0 20.9 24.0 22.7 21.7 18.5 27.3 22.4 18.3 13.3 29.6 19.9 33.4 23.5 30.6 21.8 25.3 21.2 44.3 28.3 24.8 23.1 14.1 20.4 20.1 21.5 26.1 21.6 32.3 36.5 22.1 21.0 24.3 38.9 21.9 21.3 15.8 20.6 35.7 36.1 11.8 43.7 70.6 29.8 23.1 21.0 18.0 19.1 6.0 18.4 11.5 27.9 37.9 13.6 16.5 13.9 15.4 18.3 5.0 10.8 16.0 11.2 10.8 12.1 3.5 16.4 8.6 30.3 9.2 8.9 12.6 8.2 8.7 13.4 23.3 11.2 17.9 8.1 30.4 11.1 20.8 8.1 10.6 12.9 6.3 28.4 6.5 15.7 22.9 48.7 5.8 8.7 14.9 35.1 7.4 8.2 7.3 26.7 11.1 7.4 6.3 7.2 17.9 6.5 16.2 9.8 15.6 8.3 25.0 15.6 12.2 14.0 17.3 36.6 26.0 13.6 6.4 29.8 35.8 10.5 24.1 13.5 11.8 16.4 11.4 43.7 11.2 14.2 12.1 70.6 23.1 21.7 10.0 21.0 18.0 23.9 37.0 28.0 34.1 27.3 22.4 33.4 23.5 28.3 38.9 44.7 63.4 40.1 72.5 135.8 91.7 36.3 58.6 66.9 85.3 43.6 121.7 84.8 63.0 58.7 33.2 75.2 26.5 23.3 57.8 61.5 101.0 92.3 55.4 49.9 286.2 81.0 75.2 51.0 181.5 46.8 125.4 205.8 75.9 86.6 45.2 97.1 64.6 38.6 79.2 44.7 103.8 84.1 99.8 114.2 139.3 95.5 70.1 63.8 45.2 45.7 RBPMS HERMES ENSG00000157110 "RNA binding protein, mRNA processing factor" Q93062 8 30384479-30572261 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 3.9" "Lineage enriched" "Detected in single" 5 "dendritic cells: 3.9" "Cell line enhanced" "Detected in many" "ASC diff: 71.1;RPTEC TERT1: 49.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA056999 Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA056999: AB_2683306" "unprognostic (1.65e-1)" "unprognostic (7.81e-2)" "unprognostic (1.53e-1)" "unprognostic (2.23e-3)" "unprognostic (8.66e-2)" "unprognostic (1.54e-1)" "unprognostic (2.42e-2)" "unprognostic (3.47e-3)" "unprognostic (4.63e-2)" "unprognostic (2.32e-1)" "unprognostic (4.67e-2)" "unprognostic (2.88e-2)" "unprognostic (1.76e-2)" "unprognostic (4.76e-2)" "unprognostic (2.52e-1)" "unprognostic (4.91e-2)" "unprognostic (2.16e-3)" 71.3 20.4 2.3 28.4 6.9 0.2 112.8 1.4 2.9 81.7 66.1 4.4 46.3 6.9 90.8 31.8 66.2 35.7 50.4 53.8 2.8 2.7 69.1 34.5 36.7 19.3 5.4 3.4 65.5 15.0 12.2 10.4 29.2 9.3 77.3 13.7 41.2 22.9 59.8 14.5 11.8 22.3 181.8 10.3 28.9 38.1 27.4 2.9 4.8 54.1 8.5 10.9 155.4 88.9 0.5 3.9 0.3 0.2 0.7 0.3 0.0 0.1 11.0 12.5 0.0 71.1 21.3 31.3 15.7 21.5 19.4 16.1 16.1 6.6 0.1 8.4 20.1 17.8 6.2 14.3 11.4 23.4 0.0 3.0 0.3 5.2 16.5 30.6 0.1 2.5 24.7 2.9 18.6 2.4 21.8 11.1 0.5 0.1 0.0 9.4 6.7 0.0 0.2 32.1 12.8 7.2 0.7 3.4 0.9 49.1 18.6 0.2 2.5 1.6 11.8 7.8 43.3 2.4 0.0 10.2 9.6 0.9 16.5 2.6 0.0 0.0 0.0 15.8 0.0 4.2 0.0 0.1 0.0 0.2 0.2 0.3 0.3 0.1 0.0 0.0 0.5 0.2 0.2 0.3 0.7 0.0 3.9 0.1 0.0 2.3 6.9 1.4 2.9 2.8 2.7 5.4 3.4 9.3 2.9 50.6 90.6 2.2 53.3 8.2 6.3 93.4 68.8 17.4 43.3 134.3 2.0 85.5 96.2 84.7 73.8 58.9 0.5 0.0 81.9 170.5 37.3 65.0 9.3 48.4 31.6 0.0 1.7 44.8 2.7 22.7 158.5 7.2 13.5 3.6 0.0 0.8 62.0 0.0 169.4 182.3 5.0 109.9 122.1 30.7 15.5 6.9 34.4 4.9 0.0 117.1 RBX1 "BA554C12.1, RNF75, ROC1" ENSG00000100387 "Ring-box 1" P62877 22 40951347-40973309 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003038 Supported Nucleoplasm NA NA Nucleoplasm "HPA003038: AB_1079827" "unprognostic (2.34e-1)" "unprognostic (1.54e-2)" "unprognostic (1.31e-1)" "unprognostic (1.60e-3)" "unprognostic (2.30e-1)" "unprognostic (2.92e-2)" "unprognostic (1.82e-3)" "unprognostic (1.74e-1)" "unprognostic (6.61e-2)" "prognostic favorable (6.63e-4)" "unprognostic (5.01e-3)" "unprognostic (2.19e-1)" "unprognostic (4.99e-3)" "unprognostic (2.22e-2)" "unprognostic (1.34e-1)" "unprognostic (4.57e-2)" "unprognostic (3.05e-2)" 24.1 27.9 41.6 22.2 35.3 37.6 32.9 28.0 35.7 23.0 22.7 27.4 15.8 18.4 19.4 43.7 27.6 21.2 16.6 39.2 38.3 37.4 34.2 28.3 23.6 28.1 40.4 22.3 18.5 15.6 12.3 19.5 54.1 32.4 20.3 23.9 22.1 21.3 20.8 46.5 21.8 23.0 23.2 45.2 26.4 21.4 16.4 24.8 31.7 31.1 37.4 34.4 19.5 19.4 33.4 60.7 32.2 41.5 23.9 38.5 62.6 31.4 18.0 34.0 16.9 24.2 29.0 19.2 25.4 23.3 38.3 33.9 29.1 15.2 27.6 17.2 24.9 15.4 18.0 32.3 29.0 40.5 32.1 51.5 17.1 26.4 35.5 20.8 41.7 22.2 24.0 23.5 27.7 20.1 21.9 32.4 16.9 20.2 28.1 33.7 38.6 25.0 48.1 18.7 62.3 19.0 32.9 23.6 34.7 43.7 20.4 16.1 10.4 22.3 22.4 22.7 19.9 19.3 28.7 21.5 23.3 24.1 19.5 24.1 23.9 21.9 40.9 29.3 21.3 25.9 32.2 37.2 29.9 24.7 37.0 23.1 33.4 30.9 26.0 37.6 29.4 27.0 29.2 12.6 23.9 41.5 60.7 38.5 62.6 41.6 35.3 28.0 35.7 38.3 37.4 40.4 22.3 32.4 24.8 214.4 129.3 179.4 176.3 267.3 89.0 482.7 183.4 214.2 152.4 212.9 23.6 426.2 431.0 299.7 34.9 245.1 200.1 537.3 290.2 543.9 259.5 193.3 126.0 227.4 379.6 84.2 155.8 166.3 230.6 64.7 172.0 279.5 323.9 596.9 175.3 142.8 316.2 192.9 166.6 432.2 119.9 116.4 233.8 222.2 235.9 324.0 565.2 152.3 178.9 211.6 RCAN2 "DSCR1L1, ZAKI-4" ENSG00000172348 "Regulator of calcineurin 2" Q14206 6 46220736-46491972 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 98.8" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 229.0;Muller glia cells: 167.3;Sertoli cells: 97.0;Smooth muscle cells: 159.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 34 "gdT-cell: 3.9;memory CD4 T-cell: 2.6;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.7" "Lineage enriched" "Detected in single" 43 "T-cells: 4.8" "Group enriched" "Detected in some" 6 "fHDF/TERT166: 25.3;HDLM-2: 50.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053880 Uncertain Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA053880: AB_2682290" "unprognostic (2.82e-1)" "unprognostic (7.76e-2)" "unprognostic (4.13e-2)" "unprognostic (1.14e-1)" "unprognostic (5.55e-3)" "unprognostic (4.52e-2)" "unprognostic (1.29e-3)" "unprognostic (1.86e-3)" "unprognostic (2.26e-1)" "unprognostic (4.33e-1)" "prognostic favorable (2.48e-4)" "unprognostic (1.37e-1)" "prognostic favorable (1.12e-6)" "unprognostic (3.83e-2)" "unprognostic (1.98e-1)" "unprognostic (1.02e-1)" "unprognostic (2.11e-2)" 13.7 7.2 13.2 4.3 33.4 0.8 5.9 19.5 51.8 10.9 10.6 13.4 2.3 5.5 7.3 27.6 13.9 7.8 18.0 98.8 14.7 24.2 17.5 4.0 8.3 2.6 38.3 27.1 13.5 6.2 47.7 6.7 1.1 60.3 13.8 12.2 27.9 5.5 14.9 29.3 5.9 7.7 14.2 17.0 4.1 14.0 3.5 11.0 0.0 10.8 14.4 4.1 15.9 8.8 0.0 0.0 0.1 0.1 0.0 4.8 0.8 0.0 0.0 0.6 0.0 0.3 0.1 0.0 0.4 6.1 0.4 0.0 0.0 0.0 0.0 0.3 25.3 0.0 0.0 0.0 0.0 0.1 50.9 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.0 0.0 0.0 0.0 1.1 0.1 0.2 0.1 5.6 0.0 0.1 0.1 2.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.7 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.9 0.0 0.0 0.0 2.6 4.8 0.0 0.0 0.0 3.7 0.1 0.0 0.1 0.0 0.0 0.8 13.2 33.4 19.5 51.8 14.7 24.2 38.3 27.1 60.3 11.0 6.0 4.3 0.8 3.8 5.6 19.4 229.0 2.5 0.0 0.0 3.5 3.9 0.0 59.7 5.8 22.0 10.8 0.0 0.0 2.1 0.0 5.6 1.7 0.0 0.2 0.1 28.6 24.1 0.0 0.3 11.0 27.0 1.8 30.4 0.0 0.3 167.3 4.3 0.0 47.4 1.4 8.0 97.0 159.7 0.7 0.9 6.5 0.0 0.0 0.1 1.1 RCBTB1 "CLLD7, CLLL7, FLJ10716" ENSG00000136144 "RCC1 and BTB domain containing protein 1" Q8NDN9 13 49531946-49585583 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Chromatin regulator" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 41.7;Cone photoreceptor cells: 60.9;Rod photoreceptor cells: 37.8;Sertoli cells: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056783 Approved Nucleoplasm NA NA Nucleoplasm "HPA056783: AB_2683234" "unprognostic (1.02e-1)" "unprognostic (2.11e-1)" "unprognostic (1.49e-1)" "unprognostic (5.70e-2)" "unprognostic (2.34e-2)" "unprognostic (2.40e-1)" "unprognostic (7.52e-2)" "prognostic favorable (5.51e-5)" "unprognostic (1.61e-1)" "prognostic unfavorable (1.21e-5)" "unprognostic (1.17e-3)" "unprognostic (1.52e-1)" "prognostic favorable (1.75e-4)" "unprognostic (1.29e-1)" "unprognostic (1.42e-1)" "unprognostic (1.82e-1)" "unprognostic (5.49e-2)" 7.4 17.6 16.9 6.5 19.7 8.8 10.3 9.4 16.9 7.0 5.0 27.5 21.3 4.5 12.2 15.1 4.1 9.6 7.0 11.1 18.3 16.5 13.7 6.2 9.3 9.4 26.5 11.2 5.8 8.2 30.9 15.3 9.2 15.8 8.4 6.3 15.1 6.0 14.6 5.0 5.8 5.6 10.8 22.7 9.9 7.4 6.4 22.3 10.9 32.0 4.1 7.7 8.5 6.5 4.6 7.4 15.3 8.1 2.5 8.7 3.2 3.0 7.1 15.8 14.2 21.1 18.4 9.2 11.8 11.8 8.9 9.2 6.0 7.8 10.5 2.6 9.7 7.8 4.4 11.7 18.1 15.5 15.3 9.0 12.5 5.7 15.3 25.3 10.0 10.0 16.3 11.2 7.4 11.9 11.8 15.5 20.8 5.5 4.6 17.9 2.8 14.4 5.8 16.4 10.4 4.4 18.8 11.9 6.6 11.2 8.5 8.3 11.0 6.0 4.6 11.7 13.9 6.2 7.3 10.8 6.7 5.4 14.0 5.7 4.7 5.7 17.1 6.0 10.0 9.4 15.3 5.8 6.1 2.9 7.2 3.4 4.6 4.8 2.3 7.4 3.2 3.0 2.8 2.9 2.5 8.1 1.0 8.7 3.2 16.9 19.7 9.4 14.3 18.3 16.5 26.5 11.2 15.8 22.3 41.7 9.6 6.5 2.3 3.3 8.3 14.8 12.7 16.0 14.8 1.8 60.9 2.5 6.6 6.4 0.3 7.4 0.7 0.0 4.3 2.5 3.5 4.2 2.3 7.3 7.5 9.5 15.5 5.5 12.0 0.4 3.1 8.4 8.5 7.2 2.5 5.8 4.9 0.0 5.3 7.9 37.8 38.8 7.1 1.7 3.6 2.0 0.9 4.9 1.9 1.8 RCBTB2 CHC1L ENSG00000136161 "RCC1 and BTB domain containing protein 2" O95199 13 48488959-48533256 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 9 "MOLT-4: 78.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040242 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA040242: AB_10795362" "unprognostic (2.86e-1)" "unprognostic (5.93e-2)" "unprognostic (8.47e-2)" "unprognostic (9.47e-3)" "unprognostic (1.60e-1)" "unprognostic (1.86e-3)" "unprognostic (1.29e-1)" "unprognostic (5.40e-3)" "unprognostic (8.28e-3)" "unprognostic (1.20e-1)" "unprognostic (4.85e-2)" "unprognostic (3.60e-1)" "prognostic favorable (2.45e-4)" "unprognostic (1.06e-2)" "unprognostic (8.31e-2)" "unprognostic (4.75e-2)" "unprognostic (1.98e-1)" 15.8 10.6 9.1 10.3 8.9 3.8 9.7 7.3 12.1 14.2 7.3 19.0 15.2 4.3 22.3 11.1 11.9 11.7 10.5 11.6 9.0 8.6 14.8 8.0 8.8 8.5 15.8 6.2 18.0 6.1 4.7 25.8 14.9 11.4 14.6 7.0 20.0 27.4 18.5 6.1 4.6 6.1 11.9 16.3 14.9 8.0 5.8 12.8 4.4 23.9 6.9 10.6 10.3 11.3 0.5 13.1 25.9 19.0 6.7 7.3 9.1 0.4 0.3 6.5 0.4 5.1 4.5 0.0 1.9 2.4 1.1 0.8 0.2 0.4 1.3 1.4 3.0 0.7 0.8 0.9 0.7 1.3 1.6 1.2 3.4 0.9 0.3 1.9 1.5 2.1 4.6 1.9 1.5 0.7 2.7 3.5 8.7 0.2 2.0 4.1 0.1 78.3 4.4 3.5 0.1 1.0 6.6 0.6 5.6 2.2 1.0 1.4 1.2 1.5 0.3 2.3 2.8 0.1 3.9 3.0 1.3 0.6 0.3 0.7 0.1 0.1 1.5 0.7 3.5 2.5 2.2 19.0 2.1 7.1 13.7 4.3 0.5 6.0 7.3 13.1 0.5 3.6 5.4 25.9 6.7 12.0 0.2 7.1 9.1 9.1 8.9 7.3 9.7 9.0 8.6 15.8 6.2 11.4 12.8 3.0 3.5 7.8 10.6 5.5 1.2 11.8 5.1 2.7 9.1 5.2 2.0 1.2 6.6 0.7 5.6 17.6 0.7 0.0 0.7 1.1 8.7 5.6 8.1 4.7 22.1 1.6 7.9 25.8 30.3 5.9 8.6 30.1 8.5 16.2 2.0 31.9 1.1 0.9 13.4 9.6 3.7 12.9 7.6 10.1 3.2 5.0 0.8 20.8 2.0 6.8 RCC1 CHC1 ENSG00000180198 "Regulator of chromosome condensation 1" P18754 1 28505943-28539300 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "DNA-binding, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 12 "Early spermatids: 181.3;Late spermatids: 634.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015413, HPA027573, HPA027574" Enhanced Supported "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "CAB015413: AB_831160, HPA027573: AB_10599303, HPA027574: AB_10601236" "unprognostic (6.23e-2)" "unprognostic (1.60e-1)" "unprognostic (1.53e-2)" "unprognostic (1.01e-1)" "unprognostic (1.25e-1)" "unprognostic (1.69e-2)" "prognostic unfavorable (1.91e-5)" "unprognostic (3.93e-2)" "unprognostic (2.03e-3)" "unprognostic (1.53e-1)" "unprognostic (5.79e-3)" "unprognostic (8.50e-2)" "prognostic unfavorable (2.43e-11)" "unprognostic (1.04e-2)" "unprognostic (2.78e-1)" "unprognostic (3.02e-1)" "unprognostic (6.23e-2)" 12.3 11.2 7.5 21.1 10.9 32.0 13.9 5.8 10.4 11.6 17.9 5.0 8.0 17.5 12.1 10.1 30.1 12.6 8.6 6.9 8.0 4.6 9.5 23.0 15.3 22.7 14.8 4.0 16.3 21.0 4.7 12.4 17.0 9.8 10.2 19.0 6.0 20.6 7.8 13.6 11.7 14.7 12.7 17.7 23.0 11.8 46.7 10.2 34.2 47.9 28.4 34.2 16.4 16.7 8.4 16.0 4.6 8.7 6.2 11.5 6.9 48.3 21.0 18.2 21.5 13.0 16.9 20.4 19.0 11.6 30.9 24.2 20.8 38.9 62.1 11.7 18.2 12.8 29.1 59.4 30.2 24.3 25.1 35.4 54.8 25.6 27.4 9.8 59.7 32.9 21.3 20.1 29.7 24.5 18.6 21.0 37.5 40.8 19.2 12.5 26.2 47.6 21.7 39.2 22.3 20.5 47.2 32.2 30.3 11.5 22.7 29.3 14.9 20.6 32.7 15.8 10.3 13.8 18.7 16.1 15.9 31.5 19.5 36.8 11.7 16.5 47.5 15.5 88.4 17.1 4.6 8.7 3.2 6.2 8.7 11.5 8.4 9.2 9.6 16.0 7.7 8.3 9.1 1.9 6.2 6.2 9.1 8.4 6.9 7.5 10.9 5.8 10.4 8.0 4.6 14.8 4.0 9.8 10.2 0.0 9.3 16.4 8.8 32.5 0.8 4.0 7.6 9.4 9.1 7.0 2.0 18.6 3.3 28.4 181.3 8.7 7.4 23.3 20.5 31.6 11.8 10.1 1.1 5.3 18.6 12.7 5.2 4.3 10.5 634.1 15.8 9.7 13.5 16.2 15.5 0.2 34.0 3.5 9.9 3.5 0.3 6.5 13.3 11.4 18.1 29.5 20.5 12.9 23.4 16.3 RCC1L WBSCR16 ENSG00000274523 "RCC1 like" Q96I51 7 75027122-75074228 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor, RNA-binding, rRNA-binding" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 33.4" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 50.0;Distal tubular cells: 41.4;Extravillous trophoblasts: 33.6;monocytes: 29.7;Syncytiotrophoblasts: 45.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052184, HPA060643" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA052184: AB_2681752, HPA060643: AB_2684335" "unprognostic (9.73e-2)" "unprognostic (9.42e-2)" "unprognostic (1.69e-1)" "unprognostic (5.87e-2)" "prognostic unfavorable (4.88e-4)" "unprognostic (8.91e-2)" "unprognostic (3.34e-3)" "unprognostic (7.36e-2)" "unprognostic (1.94e-1)" "unprognostic (7.40e-2)" "unprognostic (1.28e-3)" "unprognostic (6.35e-2)" "unprognostic (1.13e-3)" "unprognostic (2.14e-1)" "unprognostic (1.35e-1)" "unprognostic (1.05e-1)" "unprognostic (2.43e-1)" 7.4 8.5 4.4 7.0 5.1 4.2 3.3 4.3 5.6 5.8 6.4 7.0 7.2 6.4 5.0 4.8 7.4 4.8 7.7 11.5 3.7 7.9 12.0 3.9 5.5 5.6 4.0 7.1 9.1 4.9 3.3 6.5 3.8 7.2 3.2 7.3 7.8 6.4 33.4 4.3 6.0 9.5 2.3 6.8 4.8 5.4 5.7 3.6 8.7 8.4 6.8 5.8 7.7 6.8 5.5 4.8 4.9 6.7 9.2 2.6 15.3 23.5 12.4 21.1 8.9 7.3 17.2 15.0 10.8 12.9 10.6 23.7 18.9 16.3 6.9 12.1 16.9 18.2 10.5 10.0 5.4 17.9 16.7 12.0 15.7 22.1 12.6 19.2 19.5 9.0 8.3 11.2 9.1 8.7 11.4 3.5 38.4 10.6 9.9 32.6 0.9 29.1 29.0 18.6 18.5 9.3 10.1 34.0 11.2 14.0 13.5 20.2 20.1 42.6 18.3 9.1 30.0 20.1 12.8 17.1 14.3 15.2 19.5 11.9 9.4 25.6 13.1 20.4 22.5 4.8 3.8 2.2 7.3 4.9 5.7 5.7 7.8 6.4 5.3 6.8 7.5 9.2 1.4 6.7 3.5 5.5 5.9 2.6 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 5.3 4.5 21.0 0.0 50.0 41.4 21.1 0.0 0.0 0.0 0.0 17.7 33.6 0.0 0.0 4.7 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 29.7 0.0 0.0 16.6 0.0 0.0 24.8 0.0 0.0 0.0 0.0 0.0 0.0 45.5 0.0 0.0 0.0 RCHY1 "ARNIP, CHIMP, DKFZp586C1620, PIRH2, PRO1996, RNF199, ZCHY, ZNF363" ENSG00000163743 "Ring finger and CHY zinc finger domain containing 1" Q96PM5 4 75479037-75514764 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030338, HPA030339" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA Cytosol "Nucleoplasm, Vesicles" "HPA030338: , HPA030339: AB_10603232" "unprognostic (1.53e-1)" "unprognostic (1.57e-1)" "prognostic favorable (9.09e-4)" "unprognostic (1.90e-1)" "unprognostic (3.45e-3)" "unprognostic (1.19e-2)" "unprognostic (7.87e-3)" "unprognostic (5.82e-2)" "unprognostic (1.96e-1)" "unprognostic (1.98e-1)" "unprognostic (7.45e-3)" "unprognostic (4.60e-2)" "prognostic favorable (3.62e-5)" "unprognostic (1.69e-1)" "unprognostic (2.07e-1)" "unprognostic (1.83e-1)" "prognostic favorable (7.89e-5)" 8.8 12.1 15.7 9.9 20.1 15.6 17.8 20.7 16.8 10.2 12.7 9.8 8.7 9.0 11.0 7.5 8.4 12.9 7.2 17.6 14.1 16.2 17.1 12.5 10.4 12.2 15.9 15.7 16.2 10.6 14.9 13.0 10.5 17.1 12.0 14.2 7.7 12.3 11.3 29.7 5.9 9.2 12.4 16.7 12.2 10.3 13.4 15.4 14.9 20.3 8.0 12.7 9.7 12.1 4.4 7.4 18.9 8.8 4.6 7.4 4.3 6.1 3.2 9.5 8.9 10.0 8.8 5.4 4.1 9.7 8.6 10.2 8.7 7.6 10.2 7.9 5.9 8.5 3.7 24.1 7.3 13.1 8.3 7.9 13.2 6.0 11.1 8.6 17.8 7.3 8.1 9.2 9.9 9.3 10.4 17.3 13.3 12.2 10.4 20.0 9.9 16.3 7.2 15.8 16.8 5.6 8.8 22.4 8.7 13.4 10.5 14.7 8.1 6.8 16.0 17.7 10.9 9.0 8.1 6.8 5.7 5.6 5.0 6.9 11.1 7.9 14.5 6.9 12.7 8.9 18.9 8.8 8.5 4.3 5.2 7.4 4.4 5.3 5.0 7.4 2.2 3.9 5.5 3.7 4.6 4.7 3.8 5.2 4.3 15.7 20.1 20.7 16.8 14.1 16.2 15.9 15.7 17.1 15.4 17.9 6.4 18.7 28.1 36.1 36.0 49.4 12.7 6.7 7.9 22.7 19.6 28.8 58.0 26.3 26.2 18.6 15.4 0.0 19.8 19.5 23.5 31.2 4.7 21.3 16.6 22.3 13.3 23.9 33.0 39.2 20.8 22.4 27.0 14.4 23.7 22.1 21.3 24.6 23.7 44.0 19.0 32.3 22.7 60.0 42.9 27.0 28.3 34.8 27.1 23.7 RCL1 "RNAC, RPCL1" ENSG00000120158 "RNA terminal phosphate cyclase like 1" Q9Y2P8 9 4792869-4885917 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "liver: 108.1;pancreas: 37.5" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 135.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in all" 4 "HDLM-2: 35.1;HEL: 90.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071308 Approved Nucleoplasm NA NA Nucleoplasm "HPA071308: AB_2686384" "prognostic favorable (5.48e-4)" "unprognostic (7.60e-3)" "unprognostic (7.55e-2)" "unprognostic (4.19e-2)" "unprognostic (1.07e-2)" "unprognostic (3.29e-1)" "prognostic favorable (8.02e-4)" "unprognostic (3.55e-1)" "unprognostic (1.47e-1)" "unprognostic (2.81e-2)" "unprognostic (1.19e-1)" "unprognostic (2.59e-2)" "prognostic favorable (2.40e-7)" "unprognostic (1.01e-1)" "unprognostic (1.06e-1)" "unprognostic (2.27e-1)" "unprognostic (3.66e-2)" 15.9 6.8 4.2 6.7 5.9 17.2 12.9 5.5 6.3 5.6 3.8 6.2 6.3 2.4 5.5 5.4 5.5 5.6 3.8 3.7 4.1 3.6 5.7 108.1 6.9 9.1 5.8 4.2 9.0 37.5 3.8 5.1 6.8 5.6 3.6 4.2 4.5 4.8 9.1 10.9 10.5 4.1 5.2 7.1 5.0 5.2 6.8 5.6 5.7 4.5 8.1 7.2 5.3 6.8 10.4 6.8 12.9 2.3 10.8 9.1 3.5 5.6 6.7 2.6 4.1 3.9 2.6 6.8 2.6 2.9 5.0 4.2 3.4 3.3 10.9 1.9 2.4 5.6 3.6 11.9 8.0 5.8 35.1 6.1 90.1 8.1 6.7 5.6 8.1 7.3 5.8 4.6 4.8 7.4 2.7 4.9 8.0 9.2 7.1 3.0 7.3 6.6 14.0 8.9 6.8 2.7 8.2 3.4 5.7 6.1 6.4 7.4 6.1 3.4 5.0 3.9 5.3 4.7 9.6 3.4 3.0 3.3 4.1 8.2 2.9 8.2 11.7 5.4 5.0 1.9 12.9 1.5 3.8 5.6 2.3 6.8 8.0 6.6 7.6 4.0 10.4 8.9 9.1 0.6 10.8 1.2 6.8 5.5 3.5 4.2 5.9 5.5 6.3 4.1 3.6 5.8 4.2 5.6 5.6 6.0 5.0 10.0 14.8 22.7 4.8 10.1 5.1 16.0 6.8 3.5 0.0 33.2 21.6 11.0 59.1 7.7 2.2 0.0 9.9 10.9 10.3 6.4 13.9 135.7 15.5 4.8 2.9 16.0 8.8 39.4 21.3 5.8 3.3 15.4 6.4 7.8 9.2 2.9 35.3 12.1 6.5 12.9 14.6 17.7 19.5 18.4 29.6 10.1 7.2 12.6 RCOR1 "COREST, KIAA0071, RCOR" ENSG00000089902 "REST corepressor 1" Q9UKL0 14 102592661-102730576 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Suprabasal keratinocytes: 102.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001956, HPA049327, HPA054241" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "CAB001956: , HPA049327: AB_2680715, HPA054241: AB_2682426" "unprognostic (1.98e-1)" "unprognostic (6.00e-2)" "unprognostic (1.17e-1)" "unprognostic (4.01e-3)" "unprognostic (1.25e-1)" "unprognostic (2.18e-1)" "unprognostic (9.96e-3)" "unprognostic (1.72e-2)" "unprognostic (1.87e-2)" "unprognostic (4.98e-2)" "unprognostic (1.46e-2)" "unprognostic (6.05e-3)" "unprognostic (7.23e-2)" "unprognostic (1.39e-1)" "unprognostic (2.02e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (3.72e-4)" 8.0 5.9 4.2 15.2 4.5 25.2 6.2 8.8 4.4 9.8 14.6 3.8 9.7 7.0 9.7 9.7 16.4 5.8 10.4 6.0 4.4 4.4 5.3 6.0 15.1 8.1 4.1 2.6 7.3 5.3 8.9 6.0 12.5 3.6 7.1 6.7 6.3 8.5 7.6 11.2 9.5 16.1 6.5 4.5 8.6 7.9 18.4 3.8 21.2 5.4 10.4 12.9 8.7 10.3 0.8 2.8 7.0 3.1 1.3 1.1 0.9 10.5 9.9 8.9 9.8 7.2 10.0 18.9 10.9 7.8 10.3 9.8 9.0 12.9 11.9 9.0 9.5 5.2 16.7 13.4 7.8 15.5 5.0 4.9 22.1 9.0 8.8 9.8 21.9 20.0 7.0 12.3 9.0 14.0 11.1 11.2 11.3 17.5 9.1 10.3 17.2 13.6 14.8 4.4 11.7 17.1 35.1 9.0 5.3 12.5 13.1 11.6 7.2 24.5 11.3 7.0 11.7 15.5 17.4 12.1 7.2 5.4 22.7 7.1 6.7 8.1 12.8 8.6 16.1 7.5 4.9 2.7 3.7 0.4 2.9 0.6 0.7 0.7 1.1 2.8 0.8 0.6 0.7 7.0 1.3 3.1 1.1 1.0 0.9 4.2 4.5 8.8 4.4 4.4 4.4 4.1 2.6 3.6 3.8 44.7 30.7 22.9 21.2 51.2 7.5 15.9 5.1 12.0 23.9 3.5 2.0 24.5 5.0 5.7 4.2 11.8 21.2 0.0 6.4 16.3 18.3 23.4 24.2 10.9 13.2 9.5 20.2 12.3 35.2 4.0 22.5 28.9 23.6 1.8 16.0 10.0 12.7 13.3 19.8 6.9 5.1 0.0 20.6 22.4 18.5 102.9 36.0 13.8 18.0 56.9 RCOR2 ENSG00000167771 "REST corepressor 2" Q8IZ40 11 63911221-63916844 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.6" "Cell type enriched" "Detected in some" 4 "Bipolar cells: 15.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 18.1;NTERA-2: 23.4;SCLC-21H: 36.7;SH-SY5Y: 24.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021638 Uncertain Approved Nucleoplasm,Vesicles,Midbody Yes NA Nucleoplasm "Vesicles, Midbody" "HPA021638: AB_10960885" "unprognostic (1.96e-2)" "unprognostic (1.15e-1)" "unprognostic (4.10e-2)" "unprognostic (1.98e-3)" "unprognostic (3.10e-2)" "unprognostic (5.86e-2)" "unprognostic (2.33e-4)" "unprognostic (8.64e-2)" "unprognostic (1.46e-1)" "unprognostic (4.80e-2)" "unprognostic (1.67e-1)" "unprognostic (1.72e-3)" "unprognostic (2.62e-1)" "unprognostic (1.75e-1)" "unprognostic (3.51e-1)" "unprognostic (9.93e-2)" "unprognostic (6.06e-3)" 0.8 1.4 3.3 0.7 8.0 0.3 0.7 9.3 16.6 3.0 1.4 3.4 0.0 2.0 3.5 2.6 1.2 3.7 1.6 5.9 4.0 2.6 0.7 0.4 1.0 0.3 2.4 3.8 5.2 1.4 3.2 5.0 1.8 1.8 1.7 1.7 3.3 2.3 1.7 3.1 0.6 1.6 2.5 2.2 0.5 1.2 7.0 2.5 4.1 0.6 0.6 0.3 2.5 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 18.1 1.2 0.3 1.5 5.4 0.1 0.3 0.2 0.6 0.7 0.1 0.1 0.2 0.4 0.3 0.2 7.9 0.0 0.2 0.2 1.0 0.2 0.1 5.8 3.0 0.0 0.1 1.8 0.0 0.3 0.0 0.0 0.1 2.4 0.9 0.0 0.0 1.6 1.6 6.4 23.4 2.3 0.0 5.8 1.0 0.5 0.0 0.0 36.7 24.4 0.1 1.6 0.9 4.6 1.3 2.2 0.1 0.0 1.2 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 8.0 9.3 11.0 4.0 2.6 2.4 3.8 1.8 2.5 0.0 0.0 0.0 0.0 0.0 15.7 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.2 3.7 0.5 0.0 0.0 0.0 0.2 3.2 1.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.1 0.9 0.3 0.0 0.4 0.0 2.1 0.0 0.2 0.7 2.6 0.3 0.7 0.0 1.1 0.0 RCOR3 FLJ10876 ENSG00000117625 "REST corepressor 3" Q9P2K3 1 211258377-211316385 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007413, HPA007621, HPA071997" Enhanced Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA007413: AB_1079796, HPA007621: , HPA071997: AB_2732193" "unprognostic (2.39e-2)" "unprognostic (1.23e-1)" "unprognostic (9.35e-2)" "unprognostic (3.07e-2)" "prognostic favorable (1.35e-5)" "unprognostic (4.02e-3)" "unprognostic (2.28e-2)" "prognostic favorable (5.75e-5)" "unprognostic (2.04e-1)" "unprognostic (1.27e-1)" "unprognostic (5.12e-2)" "unprognostic (9.86e-2)" "unprognostic (1.03e-2)" "unprognostic (3.62e-2)" "unprognostic (1.82e-1)" "unprognostic (3.95e-1)" "unprognostic (3.56e-3)" 15.1 15.0 17.2 14.9 19.6 25.8 18.9 33.7 21.7 17.3 16.2 17.3 26.8 11.8 19.1 21.9 13.5 16.0 17.1 20.8 16.3 14.4 15.7 13.5 15.8 15.3 18.8 20.8 27.5 18.2 21.4 23.8 14.1 18.6 23.7 13.4 17.3 18.0 35.5 55.3 17.7 16.5 23.6 18.1 17.5 14.4 31.4 21.3 20.6 30.0 16.4 13.4 17.9 16.3 10.0 9.5 27.3 8.5 11.8 10.7 5.4 9.9 7.8 15.9 8.9 13.8 12.9 17.7 11.3 11.3 12.8 13.3 7.6 13.0 14.6 7.9 14.5 9.0 15.0 12.7 11.2 10.0 14.9 7.5 13.3 14.0 10.1 15.5 20.1 12.9 14.3 10.6 13.9 17.2 14.1 7.9 14.5 13.8 18.3 18.5 6.6 10.3 11.6 17.4 6.8 9.6 11.3 30.8 16.7 10.6 17.2 10.2 22.2 29.0 15.1 21.1 15.7 18.9 14.4 10.8 11.4 13.0 14.7 12.7 16.2 10.6 18.3 9.5 12.0 10.0 15.3 8.1 27.3 6.0 7.5 7.9 10.0 6.5 6.2 8.5 8.0 10.7 7.6 13.7 11.8 8.5 9.5 7.6 5.4 17.2 19.6 33.7 21.7 16.3 14.4 18.8 20.8 18.6 21.3 35.7 41.5 10.2 9.5 12.9 43.2 61.3 28.1 25.4 29.6 14.0 33.4 21.6 18.3 8.4 51.5 15.5 17.7 0.0 13.4 12.4 17.2 13.2 18.5 18.7 17.5 22.3 32.8 20.9 20.2 93.2 20.8 21.1 21.9 17.2 17.5 25.7 9.1 16.7 25.5 19.9 49.5 0.0 20.2 56.9 31.5 14.8 21.3 17.5 16.9 7.6 RDH14 "PAN2, SDR7C4" ENSG00000240857 "Retinol dehydrogenase 14" Q9HBH5 2 18554723-18560680 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056686, HPA078577" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA056686: AB_2683209, HPA078577: " "unprognostic (5.79e-2)" "unprognostic (3.96e-2)" "unprognostic (1.64e-1)" "unprognostic (7.03e-2)" "unprognostic (1.99e-2)" "unprognostic (8.71e-3)" "unprognostic (1.11e-2)" "unprognostic (1.48e-1)" "unprognostic (2.12e-1)" "unprognostic (8.83e-3)" "unprognostic (6.41e-2)" "unprognostic (1.92e-1)" "unprognostic (1.82e-1)" "unprognostic (8.98e-2)" "unprognostic (1.58e-2)" "unprognostic (4.32e-2)" "unprognostic (3.69e-2)" 13.8 16.2 10.7 8.7 14.3 5.1 14.0 14.2 15.4 11.3 14.1 11.0 9.6 12.7 16.2 14.3 16.0 12.7 11.0 29.0 12.2 10.4 23.0 22.1 12.5 14.6 11.7 9.0 11.7 21.0 23.5 13.5 14.2 13.2 20.7 12.0 10.6 13.8 13.1 27.8 9.9 16.3 22.9 10.3 15.4 15.9 11.1 8.8 17.4 18.1 13.6 10.7 18.1 17.9 9.9 7.6 7.2 2.0 3.7 7.6 1.6 18.6 5.9 5.0 4.1 15.1 16.1 16.8 11.4 11.7 10.3 10.3 4.6 9.7 18.4 6.8 6.8 13.4 10.2 7.2 13.3 12.1 10.2 19.8 7.2 6.5 13.8 12.9 8.7 9.8 12.2 13.6 10.0 15.7 14.5 9.5 7.5 12.8 6.3 16.9 6.0 7.5 15.4 13.5 14.3 16.9 11.0 13.6 7.9 20.2 12.2 7.7 13.4 6.2 13.7 16.2 10.9 6.8 5.0 9.5 14.7 9.1 11.6 13.5 17.9 14.7 13.7 10.5 6.0 11.5 1.7 1.8 7.2 4.4 2.0 7.6 7.4 5.1 6.3 2.3 9.9 7.3 6.0 0.8 3.7 1.9 7.6 5.8 1.6 10.7 14.3 14.2 15.4 12.2 10.4 11.7 9.0 13.2 8.8 14.9 10.9 21.4 26.0 21.8 22.4 43.0 22.9 2.7 6.8 15.7 5.9 40.0 26.6 32.8 16.1 17.9 14.0 0.0 30.8 42.8 33.7 31.0 12.7 26.8 21.0 14.3 12.7 17.2 15.1 9.4 61.9 14.8 21.9 22.6 27.1 25.0 23.9 32.3 42.1 30.5 18.0 32.3 30.7 71.9 28.2 16.3 38.2 17.5 29.8 23.7 RDH8 "PRRDH, SDR28C2" ENSG00000080511 "Retinol dehydrogenase 8 (all-trans)" 19 10013249-10022279 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "retina: 29.4" "Cell type enhanced" "Detected in some" 28 "Bipolar cells: 33.9;Cone photoreceptor cells: 51.1;Early spermatids: 58.4;Rod photoreceptor cells: 203.6" "Group enriched" "Detected in some" 8 "melanoma: 2.2;stomach cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.9;SK-MEL-30: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA064473 Approved "Nucleoplasm,Midbody ring,Cytosol" NA NA Nucleoplasm "Midbody ring, Cytosol" "HPA064473: " "unprognostic (4.12e-1)" "unprognostic (2.22e-2)" "unprognostic (1.08e-1)" "unprognostic (9.98e-3)" "unprognostic (4.58e-3)" "unprognostic (2.66e-1)" "unprognostic (1.45e-1)" "unprognostic (1.02e-1)" "unprognostic (3.86e-1)" "unprognostic (2.63e-1)" 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 2.9 0.8 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.9 0.3 0.0 0.0 0.0 0.0 51.1 0.0 0.0 0.0 58.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.4 0.0 203.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 RDX DFNB24 ENSG00000137710 Radixin P35241 11 109864295-110296722 "Disease related genes, Predicted intracellular proteins" "Actin capping, Actin-binding" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 81.0" "Cell type enhanced" "Detected in all" 4 "Alveolar cells type 1: 449.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000263, HPA000763, CAB037312" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA 77000000 "Plasma membrane" Nucleoplasm "CAB037312: AB_261933, HPA000263: AB_1856043, HPA000763: AB_1856042" "unprognostic (2.23e-3)" "unprognostic (2.56e-2)" "unprognostic (3.85e-1)" "unprognostic (2.74e-2)" "unprognostic (6.93e-2)" "unprognostic (9.82e-2)" "unprognostic (2.01e-2)" "unprognostic (1.44e-2)" "unprognostic (3.91e-2)" "unprognostic (6.91e-2)" "unprognostic (1.32e-3)" "unprognostic (6.47e-2)" "unprognostic (4.14e-3)" "unprognostic (5.43e-2)" "unprognostic (4.40e-1)" "unprognostic (1.24e-1)" "unprognostic (1.08e-3)" 15.9 81.0 17.9 7.0 29.2 4.2 22.3 9.3 20.2 14.7 10.1 19.5 11.1 2.9 12.7 9.1 11.9 8.8 11.6 16.9 20.8 17.0 21.7 28.6 20.4 8.7 27.5 15.2 23.7 22.0 16.0 16.1 16.4 31.6 11.3 4.9 7.4 9.0 11.9 35.5 5.5 5.3 14.9 50.4 10.6 8.3 13.9 30.6 3.5 19.7 11.8 5.9 13.4 11.9 9.4 9.6 17.1 11.4 13.1 15.8 5.6 17.1 9.1 36.3 14.4 21.4 23.8 20.7 21.8 12.4 14.4 15.9 25.5 30.1 0.0 33.5 27.0 22.6 15.8 20.1 20.9 21.6 10.3 11.1 12.7 30.4 18.9 20.0 4.7 8.8 24.3 11.9 17.9 32.2 23.9 39.1 2.8 18.1 7.7 33.3 30.3 2.7 3.8 11.5 1.0 14.9 7.9 25.5 7.5 18.3 8.6 9.9 10.7 38.4 17.4 13.7 28.5 22.3 7.6 24.1 24.0 17.9 11.5 16.9 2.5 4.1 16.6 9.1 2.8 55.1 17.1 11.4 16.5 9.4 9.4 12.5 9.4 8.4 6.9 9.6 6.1 5.7 4.6 1.3 13.1 7.1 7.8 15.8 5.6 17.9 29.2 9.3 19.0 20.8 17.0 27.5 15.2 31.6 30.6 449.6 96.4 30.6 43.1 49.8 78.4 144.4 71.4 41.5 64.8 71.5 41.2 104.4 92.9 108.4 11.2 193.3 6.7 70.0 374.9 158.2 87.8 55.0 65.8 217.4 75.7 95.3 21.4 279.3 93.7 28.8 254.9 61.2 69.2 186.7 9.3 84.0 127.6 20.1 250.7 141.1 88.4 122.9 79.0 72.1 242.5 35.4 190.1 31.6 16.8 27.6 REC8 "kleisin-alpha, REC8L1, Rec8p" ENSG00000100918 "REC8 meiotic recombination protein" O95072 14 24171853-24180257 "Plasma proteins, Predicted intracellular proteins" "Chromosome partition, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 30.4" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 48.2;Early spermatids: 113.3;Late spermatids: 57.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AF22: 6.7;HHSteC: 5.7;MOLT-4: 6.9;SH-SY5Y: 30.2;SuSa: 17.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031727, HPA031729" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA031727: AB_10602920, HPA031729: AB_10669915" "prognostic favorable (2.19e-4)" "unprognostic (2.57e-2)" "unprognostic (2.15e-2)" "unprognostic (1.77e-2)" "unprognostic (2.00e-1)" "unprognostic (5.10e-3)" "unprognostic (1.00e-1)" "unprognostic (1.21e-2)" "unprognostic (3.16e-1)" "unprognostic (1.31e-1)" "prognostic favorable (5.57e-4)" "unprognostic (1.16e-1)" "prognostic unfavorable (1.41e-7)" "unprognostic (8.98e-2)" "unprognostic (2.12e-1)" "unprognostic (1.88e-2)" "unprognostic (6.40e-3)" 2.8 4.6 3.1 2.9 4.6 8.2 1.5 20.3 6.1 3.0 2.7 5.2 9.9 2.0 3.3 3.0 1.5 17.4 30.4 1.6 3.8 3.8 6.3 1.7 3.6 4.0 3.8 5.4 2.2 1.7 0.9 21.4 1.0 10.8 3.2 0.9 8.0 2.1 10.3 1.3 1.4 2.2 3.7 5.1 4.2 8.5 13.3 3.4 22.3 2.0 0.0 4.4 1.7 1.7 2.1 6.2 10.7 6.3 3.3 6.9 1.3 0.0 0.1 6.7 0.0 0.2 0.3 0.3 0.3 0.3 0.6 0.5 0.0 0.7 0.1 0.0 0.0 0.4 0.3 0.2 0.0 0.4 0.6 0.1 0.2 0.3 0.0 5.7 0.1 0.9 3.1 0.3 0.2 0.0 2.6 1.2 0.2 0.0 0.9 0.0 0.1 6.9 1.1 2.1 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.1 30.2 0.0 0.0 0.2 17.5 0.1 0.2 0.2 0.0 0.1 0.2 0.0 1.1 0.3 0.1 0.0 0.1 0.1 2.6 0.1 10.7 6.1 1.2 6.9 2.1 2.2 3.3 3.8 1.6 1.0 3.1 0.1 3.3 6.3 6.2 3.5 1.3 3.1 4.6 20.3 6.1 3.8 3.8 3.8 5.4 10.8 3.4 11.9 13.3 7.0 4.4 1.6 15.5 1.7 22.9 48.2 13.6 26.2 0.0 1.1 5.0 2.2 113.3 4.1 3.5 0.0 2.4 2.8 2.4 1.0 3.5 2.5 2.0 6.4 4.6 4.3 5.9 57.2 4.4 5.6 1.7 1.0 2.3 23.8 3.6 0.0 2.8 23.3 1.6 0.0 1.4 1.9 37.5 1.8 0.3 8.7 1.7 1.8 RECQL "RecQ1, RecQL1" ENSG00000004700 "RecQ like helicase" P46063 12 21468911-21501669 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009743, HPA030960, HPA064259" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB009743: AB_655306, HPA030960: AB_10794912, HPA064259: AB_2685230" "unprognostic (9.70e-3)" "unprognostic (2.55e-2)" "unprognostic (1.86e-2)" "unprognostic (6.25e-3)" "unprognostic (2.47e-1)" "unprognostic (1.39e-1)" "unprognostic (8.97e-3)" "unprognostic (1.89e-3)" "unprognostic (8.74e-2)" "prognostic unfavorable (3.15e-4)" "unprognostic (3.77e-3)" "unprognostic (3.78e-2)" "unprognostic (2.85e-1)" "unprognostic (1.27e-1)" "unprognostic (1.09e-1)" "unprognostic (2.99e-1)" "unprognostic (3.69e-2)" 32.7 15.8 10.0 22.0 12.7 10.8 18.2 10.9 11.2 18.0 16.3 9.4 11.0 7.5 19.8 14.4 18.7 14.6 14.1 17.9 11.2 7.2 19.6 18.0 19.5 25.7 15.3 7.6 16.0 11.9 8.0 14.8 17.1 12.0 14.0 12.7 6.7 13.1 12.4 15.0 12.4 15.5 20.5 19.5 34.0 12.9 10.8 13.0 27.4 17.4 14.3 25.0 22.6 13.0 19.3 15.2 11.3 20.7 23.1 28.0 13.8 17.2 17.5 13.3 9.8 26.9 33.8 15.4 33.3 28.2 21.5 25.2 19.1 14.4 20.7 12.9 22.7 27.3 12.6 14.2 16.6 30.7 34.6 9.4 25.3 19.4 8.1 10.4 17.5 19.1 18.8 8.6 30.5 22.4 19.8 24.1 14.6 8.8 10.1 28.3 8.4 19.1 20.4 22.1 5.3 11.9 15.8 53.9 16.0 8.3 11.9 3.6 10.6 24.9 6.7 17.5 48.0 17.0 11.2 32.5 30.3 19.7 26.5 30.9 4.1 12.2 45.4 25.6 10.3 22.2 9.3 11.8 11.3 21.9 20.7 21.3 19.3 20.5 21.0 15.2 16.0 13.6 18.8 5.5 23.1 18.8 11.6 28.0 13.8 10.0 12.7 10.9 11.2 11.2 7.2 15.3 7.6 12.0 13.0 20.8 19.7 38.7 12.7 20.9 10.9 7.3 12.7 30.8 25.0 14.0 13.7 9.7 8.3 16.8 0.5 36.0 3.2 0.0 21.6 23.8 30.7 7.0 50.8 11.9 25.0 14.3 9.4 28.3 30.7 2.0 20.4 35.9 28.7 49.5 6.0 17.7 24.4 5.5 35.3 9.5 10.9 12.9 25.8 6.0 8.1 37.5 3.0 41.7 6.9 8.2 RECQL4 RecQ4 ENSG00000160957 "RecQ like helicase 4" 8 144511288-144517845 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 21.0;lymphoid tissue: 18.9" "Cell type enhanced" "Detected in many" 13 "Extravillous trophoblasts: 7.1;Spermatocytes: 12.6;Spermatogonia: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 14 "B-cells: 1.9;monocytes: 1.0;T-cells: 1.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB017800, HPA025821" Supported Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB017800: , HPA025821: AB_1856168" "unprognostic (5.92e-2)" "unprognostic (1.86e-1)" "unprognostic (2.05e-1)" "unprognostic (1.18e-1)" "unprognostic (9.17e-2)" "unprognostic (3.17e-2)" "prognostic unfavorable (1.91e-4)" "unprognostic (1.12e-2)" "unprognostic (4.12e-2)" "unprognostic (7.53e-2)" "unprognostic (2.65e-2)" "unprognostic (4.26e-2)" "unprognostic (1.12e-3)" "unprognostic (8.82e-3)" "unprognostic (1.74e-1)" "unprognostic (2.24e-1)" "unprognostic (1.34e-1)" 2.0 1.6 2.6 12.3 5.6 21.0 2.8 11.5 3.7 1.8 4.3 1.5 1.6 5.6 2.5 4.9 9.4 1.5 1.9 1.9 2.3 1.7 1.6 1.9 1.6 5.9 1.5 2.2 1.9 3.5 0.3 2.4 2.7 2.2 7.7 1.5 1.4 5.4 0.9 2.1 9.4 4.8 1.1 1.7 4.7 3.0 18.1 1.8 18.9 2.5 5.3 8.0 1.6 1.8 1.9 0.1 0.0 1.0 0.0 1.6 0.2 10.4 18.7 8.7 18.4 0.5 0.9 15.3 10.6 1.9 7.9 6.6 18.4 15.5 7.1 7.1 1.7 4.6 12.7 5.8 4.5 2.2 12.5 22.0 25.7 32.0 13.7 0.1 6.5 21.5 1.1 0.6 8.8 1.8 1.1 2.2 14.6 25.5 9.3 2.7 32.4 23.7 17.7 6.1 8.7 22.4 24.9 6.9 11.9 2.1 11.3 17.3 10.4 14.4 12.1 3.7 2.5 14.7 14.4 2.9 12.8 38.7 15.3 19.5 5.2 5.4 12.1 7.3 20.2 12.8 0.0 0.1 0.0 1.1 1.0 0.0 1.9 0.5 1.1 0.1 0.0 0.9 1.6 0.0 0.0 0.0 0.1 0.0 0.2 2.6 5.6 11.5 3.7 2.3 1.7 1.5 2.2 2.2 1.8 0.0 0.0 2.2 0.4 1.3 2.5 1.6 2.5 0.0 0.0 0.0 3.9 1.2 0.0 0.4 3.1 0.0 0.4 0.0 0.4 7.1 0.8 0.5 0.0 0.6 3.0 0.0 0.0 0.0 0.3 6.2 1.1 0.6 0.0 0.0 1.4 0.2 0.3 0.0 1.4 0.3 1.6 0.0 0.4 12.6 21.1 0.9 1.3 0.0 3.1 0.4 RECQL5 "FLJ90603, RecQ5" ENSG00000108469 "RecQ like helicase 5" O94762 17 75626845-75667189 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, DNA replication" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029971 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029971: AB_10611389" "unprognostic (2.19e-1)" "unprognostic (6.16e-3)" "unprognostic (2.26e-2)" "prognostic unfavorable (1.73e-6)" "unprognostic (8.39e-2)" "unprognostic (2.34e-2)" "unprognostic (3.57e-3)" "unprognostic (5.83e-2)" "unprognostic (3.15e-1)" "unprognostic (5.84e-2)" "prognostic favorable (4.34e-4)" "unprognostic (4.07e-2)" "unprognostic (7.01e-2)" "unprognostic (6.37e-2)" "unprognostic (1.42e-1)" "unprognostic (4.78e-1)" "unprognostic (1.81e-2)" 7.4 12.9 12.6 11.7 16.0 10.0 9.8 11.4 17.7 9.4 10.6 24.4 17.4 22.9 10.5 13.2 20.4 11.8 12.4 6.7 12.9 8.6 14.9 15.8 8.4 16.8 14.5 11.0 14.3 10.8 17.6 21.9 32.3 14.3 12.2 9.8 13.2 15.6 14.0 6.8 21.1 23.2 9.6 13.2 16.6 23.8 21.0 17.0 12.1 21.4 6.2 16.0 12.1 12.8 5.2 16.4 6.0 3.9 3.8 4.2 3.2 11.2 20.9 8.5 12.0 11.8 7.9 19.6 8.3 7.0 10.9 9.7 9.2 12.0 13.4 9.1 7.3 14.5 10.8 8.8 10.0 10.4 7.2 16.4 24.4 25.3 13.2 11.9 7.9 12.2 11.2 12.3 10.8 13.1 12.5 14.2 14.9 12.3 11.9 8.0 10.0 16.1 10.7 5.5 10.8 16.2 13.1 19.8 13.5 9.2 13.4 10.2 9.9 9.1 16.4 11.2 12.2 29.5 6.3 7.2 14.1 16.2 7.7 8.6 17.0 9.7 12.9 11.6 7.9 10.1 6.0 3.1 4.4 4.2 3.9 2.7 3.6 2.7 3.1 3.8 5.2 4.1 2.9 2.1 3.8 1.9 16.4 2.2 3.2 12.6 16.0 11.4 17.7 12.9 8.6 14.5 11.0 14.3 17.0 0.0 9.9 5.4 2.9 0.9 7.9 6.1 5.1 14.7 2.3 26.2 17.7 6.8 5.0 4.6 3.7 3.6 11.1 0.0 2.9 4.2 3.1 2.9 1.1 6.0 4.4 9.5 4.6 8.0 5.9 1.5 3.7 3.9 3.3 1.8 8.5 7.4 5.3 8.2 2.5 3.7 12.8 0.0 1.0 10.9 10.5 1.8 9.7 4.4 6.3 8.9 RELB REL-B ENSG00000104856 "RELB proto-oncogene, NF-kB subunit" Q01201 19 45001430-45038198 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 90.3;Glandular cells: 104.0;monocytes: 170.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 14.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 25.4;HDLM-2: 32.4;U-698: 27.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB007753, HPA040506" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB007753: AB_562340, HPA040506: AB_2677011" "prognostic favorable (1.55e-4)" "unprognostic (1.20e-1)" "unprognostic (7.13e-2)" "unprognostic (5.52e-2)" "unprognostic (1.12e-2)" "unprognostic (3.41e-2)" "unprognostic (1.71e-2)" "unprognostic (4.30e-2)" "unprognostic (5.81e-3)" "unprognostic (1.02e-3)" "unprognostic (6.01e-2)" "unprognostic (6.48e-2)" "prognostic unfavorable (2.99e-6)" "unprognostic (2.68e-2)" "unprognostic (4.69e-2)" "unprognostic (2.09e-1)" "unprognostic (2.20e-2)" 8.0 6.8 2.2 27.6 3.6 27.8 6.8 1.2 3.1 4.9 12.2 2.1 1.6 8.8 8.5 4.7 6.4 5.2 10.9 11.9 1.8 1.6 10.1 7.4 12.8 18.2 3.6 0.9 7.8 12.3 1.9 2.1 4.7 2.8 9.9 3.4 3.6 7.3 4.8 8.1 8.3 13.0 8.4 3.9 17.2 8.3 3.7 1.7 17.7 5.6 7.2 24.8 8.8 6.1 8.2 3.9 14.5 5.0 2.1 2.2 1.7 8.9 5.3 0.5 2.4 1.2 4.0 1.9 1.6 11.6 2.5 4.1 1.8 9.9 25.4 4.7 2.6 8.9 4.1 0.2 3.7 2.2 32.4 0.8 0.9 0.3 1.0 10.4 1.9 15.1 6.5 1.5 5.2 6.1 2.3 1.6 0.7 0.2 16.5 0.9 2.1 0.4 6.0 0.8 2.5 1.0 1.9 1.3 3.0 4.2 13.9 0.0 0.8 1.7 4.8 4.6 0.6 1.7 4.9 5.2 6.1 3.0 2.2 5.9 21.0 12.4 27.3 6.7 0.7 3.4 0.0 5.0 2.1 1.4 3.2 2.1 8.2 2.2 2.0 3.6 7.9 1.8 0.9 14.5 2.1 2.6 3.9 1.1 1.7 2.2 3.6 1.2 3.1 1.8 1.6 3.6 0.9 2.8 1.7 6.0 14.3 26.4 90.3 33.7 0.0 1.7 12.7 1.4 11.4 3.5 0.0 3.5 8.3 30.3 5.1 11.3 45.5 0.0 27.0 5.8 13.4 104.0 51.7 3.4 17.6 3.2 21.9 6.7 13.3 2.4 4.4 25.4 23.6 170.5 12.4 0.6 29.3 80.7 2.5 14.3 0.2 6.5 41.2 0.5 1.2 27.9 8.2 7.5 8.1 75.4 RELT "FLJ14993, TNFRSF19L" ENSG00000054967 "RELT, TNF receptor" Q969Z4 11 73376264-73397474 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis Receptor "Amelogenesis imperfecta, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 92.2" "Cell type enhanced" "Detected in many" 5 "Macrophages: 37.2;monocytes: 30.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062824, HPA071518" Supported Nucleoplasm NA NA Nucleoplasm "HPA062824: AB_2684875, HPA071518: AB_2686408" "unprognostic (3.49e-1)" "unprognostic (2.43e-1)" "unprognostic (2.25e-1)" "unprognostic (1.67e-2)" "unprognostic (1.80e-3)" "unprognostic (9.92e-3)" "unprognostic (1.67e-3)" "unprognostic (1.17e-1)" "unprognostic (1.21e-1)" "unprognostic (2.87e-1)" "unprognostic (8.42e-2)" "unprognostic (4.13e-2)" "prognostic unfavorable (4.07e-11)" "unprognostic (1.64e-1)" "unprognostic (3.07e-3)" "unprognostic (2.01e-2)" "unprognostic (1.69e-1)" 3.5 2.2 3.5 11.7 8.8 92.2 2.8 3.5 5.7 1.4 2.1 7.4 0.0 2.7 1.9 2.5 3.2 1.6 4.1 5.3 4.0 5.2 2.0 2.0 8.4 18.2 8.3 3.9 1.5 1.6 1.8 3.1 4.1 13.9 1.7 2.0 2.3 4.6 1.3 22.1 2.5 5.6 2.8 14.3 18.1 2.5 3.0 4.6 4.8 1.8 3.9 9.0 3.3 2.1 4.7 6.8 12.1 19.2 0.3 1.1 3.1 5.7 5.8 4.5 4.5 0.5 0.7 5.1 6.4 4.0 7.4 4.5 5.5 2.5 10.6 21.0 4.1 5.9 8.5 2.8 3.1 2.7 6.4 5.4 10.0 7.2 2.0 1.3 9.9 17.6 0.7 1.3 7.8 2.0 1.7 2.6 5.3 7.5 14.1 2.0 5.4 7.1 10.3 4.1 4.5 7.2 14.1 7.9 9.2 1.5 2.5 6.0 5.7 5.4 4.9 6.6 1.1 2.7 8.6 3.6 9.3 6.6 15.4 11.3 4.9 3.9 11.6 5.7 9.8 9.8 0.4 7.0 12.1 0.5 14.3 1.1 4.7 0.6 1.0 6.8 3.7 0.8 0.4 11.6 0.3 19.2 6.8 0.2 3.1 3.5 8.8 3.5 5.7 4.0 5.2 8.3 3.9 13.9 4.6 6.0 2.1 15.9 11.9 23.6 1.9 2.2 0.0 1.4 3.4 0.0 11.8 1.4 0.0 3.5 0.7 2.3 2.1 0.0 0.7 9.4 6.6 7.8 25.3 0.0 20.4 28.6 3.4 0.6 23.5 1.0 0.0 37.2 5.0 30.7 0.6 10.0 4.1 0.6 0.0 0.4 2.0 6.5 7.8 2.7 7.5 15.9 17.6 7.5 1.3 14.8 REPIN1 "AP4, H_DJ0584D14.12, RIP60, Zfp464, ZNF464" ENSG00000214022 "Replication initiator 1" Q9BWE0 7 150368189-150374044 "Predicted intracellular proteins" "DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "monocytes: 126.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 66.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036022 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA036022: AB_10610417" "unprognostic (2.73e-1)" "unprognostic (2.21e-2)" "unprognostic (1.54e-1)" "unprognostic (7.50e-3)" "unprognostic (5.42e-2)" "unprognostic (7.00e-3)" "unprognostic (1.52e-2)" "unprognostic (6.88e-3)" "unprognostic (6.68e-2)" "unprognostic (6.59e-2)" "prognostic favorable (1.12e-4)" "unprognostic (3.40e-2)" "prognostic favorable (5.56e-4)" "prognostic favorable (1.61e-4)" "unprognostic (1.79e-1)" "unprognostic (2.02e-3)" "prognostic favorable (6.41e-4)" 17.0 30.1 16.2 24.9 23.1 25.7 16.9 24.2 21.7 12.0 27.5 21.5 23.2 29.2 15.4 23.6 14.9 17.5 23.6 22.1 15.6 17.1 18.6 36.1 12.3 22.4 21.9 14.3 16.6 34.0 21.5 28.5 10.4 15.6 19.0 20.3 21.9 26.9 23.2 78.4 14.4 27.1 11.4 13.3 23.1 20.6 7.0 18.9 45.4 20.1 20.0 20.3 18.1 15.9 3.6 11.2 3.5 2.1 2.3 3.5 1.2 16.1 19.8 18.8 23.0 4.6 3.3 11.5 8.0 9.9 7.9 6.9 15.3 10.5 18.0 20.4 5.7 13.7 12.1 10.2 3.1 4.0 19.6 15.4 10.5 10.7 19.2 15.3 18.5 17.2 4.3 9.7 4.3 1.0 7.5 11.1 11.0 25.2 11.3 6.5 21.0 25.6 21.1 19.7 10.9 19.7 14.1 21.8 66.9 8.3 28.8 27.7 35.4 12.1 30.5 20.5 8.1 14.9 14.9 11.7 6.1 5.0 6.7 16.1 33.0 12.2 16.4 10.7 16.5 15.0 0.1 2.1 3.5 1.2 1.0 1.9 3.6 2.7 2.3 3.0 3.5 3.5 1.7 2.0 2.3 0.5 11.2 1.1 1.2 16.2 23.1 24.2 21.7 15.6 17.1 21.9 14.3 15.6 18.9 32.8 18.1 23.0 16.6 8.4 59.5 40.5 35.7 16.0 12.5 14.0 39.3 23.1 53.0 32.6 5.8 19.7 43.4 0.0 43.4 10.2 13.5 26.1 24.3 55.7 27.7 76.3 65.4 19.6 14.6 6.3 20.4 14.8 15.1 126.2 53.2 77.2 34.2 24.6 18.7 26.1 52.6 6.5 17.0 8.9 3.2 15.6 21.4 18.5 98.3 16.9 RERG MGC15754 ENSG00000134533 "RAS like estrogen regulated growth inhibitor" Q96A58 12 15107783-15348675 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 73.6" "Cell type enhanced" "Detected in many" 10 "Sertoli cells: 90.5;Smooth muscle cells: 84.3" "Cancer enhanced" "Detected in all" "breast cancer: 19.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 4 "myeloid DC: 1.5" "Lineage enriched" "Detected in single" 4 "dendritic cells: 1.5" "Cell line enhanced" "Detected in some" "AN3-CA: 8.2;BEWO: 18.8;T-47d: 36.0;U-2 OS: 12.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041387 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nucleoli fibrillar center" "HPA041387: AB_10796669" "unprognostic (5.33e-2)" "unprognostic (1.05e-1)" "unprognostic (7.72e-2)" "prognostic unfavorable (7.56e-4)" "unprognostic (8.72e-2)" "unprognostic (9.42e-3)" "unprognostic (2.47e-1)" "unprognostic (2.38e-2)" "unprognostic (1.85e-3)" "unprognostic (2.76e-2)" "unprognostic (5.07e-2)" "unprognostic (2.69e-1)" "unprognostic (7.16e-3)" "unprognostic (2.61e-3)" "unprognostic (3.30e-2)" "unprognostic (3.50e-1)" "unprognostic (2.58e-2)" 12.6 21.9 3.5 8.2 23.9 0.2 22.8 0.8 9.3 31.9 14.5 0.8 24.6 2.0 73.6 43.2 7.3 29.0 6.7 6.0 4.2 4.8 19.5 1.3 7.8 2.0 4.3 4.1 23.6 5.1 0.9 0.9 15.4 17.6 12.6 4.6 2.9 6.0 38.9 3.5 4.2 7.4 40.3 2.3 15.2 9.8 11.7 3.5 0.0 2.6 2.8 1.8 15.7 10.6 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.1 8.2 3.4 0.2 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.3 0.0 3.3 0.0 2.6 0.0 1.1 0.4 0.5 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.7 0.3 0.1 0.1 0.9 0.0 0.5 0.0 0.0 0.1 3.2 0.1 0.0 1.2 1.3 1.4 0.0 0.6 36.0 0.0 0.0 0.5 12.1 0.2 0.1 0.1 2.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 23.9 0.8 9.3 4.2 4.8 4.3 4.1 17.6 3.5 0.0 2.1 0.0 7.7 3.4 1.0 0.7 5.1 0.0 5.7 7.0 0.0 10.8 13.3 6.3 15.0 2.2 0.0 0.0 9.0 11.7 23.8 2.4 0.0 0.0 1.8 3.2 1.7 1.8 0.0 13.1 20.4 2.3 6.8 0.0 0.0 6.0 1.6 0.0 30.1 20.9 0.6 90.5 84.3 7.9 14.5 4.8 11.7 0.0 0.0 4.2 RERGL FLJ22655 ENSG00000111404 "RERG like" Q9H628 12 18080869-18320107 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 32 "Sertoli cells: 161.7;Smooth muscle cells: 159.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 719 "REH: 72.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA041740 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA041740: AB_10795694" "unprognostic (3.53e-2)" "unprognostic (7.03e-4)" "unprognostic (6.29e-2)" "unprognostic (1.56e-1)" "unprognostic (1.09e-2)" "unprognostic (4.39e-2)" "unprognostic (1.10e-2)" "unprognostic (3.14e-2)" "unprognostic (5.51e-2)" "unprognostic (7.26e-2)" "unprognostic (8.47e-2)" "unprognostic (1.25e-1)" "unprognostic (6.76e-3)" "unprognostic (1.96e-1)" "unprognostic (2.39e-2)" "unprognostic (1.66e-2)" 22.4 4.0 5.4 3.2 8.3 0.0 13.0 1.8 8.9 33.4 10.3 4.3 3.5 2.1 16.5 29.2 8.7 19.6 17.3 4.7 7.5 6.1 12.8 0.9 3.1 0.9 9.4 6.0 11.3 1.0 0.8 0.7 0.3 9.0 12.6 12.3 1.6 2.1 14.1 7.7 5.6 6.3 11.8 6.2 1.1 3.9 11.7 4.2 0.4 7.0 8.0 1.1 8.5 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 8.3 1.8 8.9 7.5 6.1 9.4 6.0 9.0 4.2 0.0 0.0 0.0 0.1 3.9 0.0 3.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.3 1.9 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.0 0.0 0.0 0.0 0.1 0.0 1.4 0.4 0.0 161.7 159.4 0.1 0.7 2.0 0.1 0.0 0.0 0.3 REST "NRSF, XBR" ENSG00000084093 "RE1 silencing transcription factor" Q13127 4 56907876-56966678 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006079, CAB068222" Supported Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB068222: AB_2665651, HPA006079: AB_1079801" "unprognostic (7.49e-3)" "unprognostic (3.36e-2)" "unprognostic (2.50e-2)" "unprognostic (2.03e-2)" "unprognostic (1.86e-1)" "unprognostic (1.39e-1)" "unprognostic (7.47e-3)" "unprognostic (2.30e-1)" "unprognostic (4.65e-2)" "unprognostic (1.70e-2)" "unprognostic (4.32e-3)" "unprognostic (1.73e-1)" "prognostic favorable (9.50e-5)" "unprognostic (1.49e-1)" "unprognostic (1.59e-1)" "unprognostic (1.24e-1)" "unprognostic (4.79e-2)" 14.4 11.4 6.0 15.6 8.9 21.5 39.7 2.1 6.3 13.7 11.0 5.6 13.0 6.5 14.2 13.7 14.5 11.2 13.8 22.1 6.1 4.5 13.9 12.0 18.2 35.6 8.2 3.0 13.9 15.9 22.4 4.5 14.4 11.8 17.3 7.6 7.2 14.0 27.6 13.8 11.6 12.0 16.3 15.2 18.7 10.4 15.3 8.2 43.4 13.4 8.3 14.0 15.6 19.5 16.7 10.7 9.0 8.4 16.7 15.3 4.2 7.1 9.0 12.6 12.4 9.5 11.9 15.9 10.6 9.5 11.3 10.3 9.0 11.0 16.9 17.0 11.5 7.5 6.5 9.2 11.2 17.9 8.9 5.5 15.4 7.2 7.9 11.5 19.5 9.3 11.8 10.0 10.9 11.2 14.2 14.0 12.6 9.9 18.2 13.1 11.3 22.4 13.3 10.6 8.0 5.9 19.9 10.8 5.3 12.8 12.8 0.2 5.7 12.8 12.5 9.5 18.1 13.3 12.7 19.7 14.5 12.9 8.1 9.5 7.3 5.4 10.3 9.3 11.1 7.4 9.0 3.6 7.7 10.6 5.3 8.9 12.0 10.5 10.4 8.1 16.7 15.3 9.3 3.7 16.7 8.4 10.7 10.3 4.2 6.0 8.9 2.1 6.3 6.1 4.5 8.2 3.0 11.8 8.2 65.5 53.4 33.5 45.2 50.7 0.7 41.7 45.9 45.5 45.5 27.9 76.6 44.5 19.9 50.7 6.8 41.7 19.2 23.3 33.6 47.5 36.3 41.5 50.7 27.6 29.0 0.0 3.5 39.9 29.8 7.6 36.5 34.3 20.3 92.8 21.2 48.8 37.7 26.8 34.6 18.5 36.6 32.3 40.1 56.1 40.7 40.0 55.5 57.1 21.8 42.5 RETREG3 "DKFZp686B1036, FAM134C, FLJ33806" ENSG00000141699 "Reticulophagy regulator family member 3" Q86VR2 17 42579513-42610623 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 23.8;Alveolar cells type 2: 28.0;Collecting duct cells: 29.6;Exocrine glandular cells: 21.8;Pancreatic endocrine cells: 25.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016492 Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Nuclear membrane" Cytosol "HPA016492: AB_1853027" "unprognostic (6.79e-2)" "unprognostic (1.29e-2)" "unprognostic (2.78e-1)" "prognostic favorable (1.61e-4)" "unprognostic (5.57e-3)" "unprognostic (1.74e-1)" "unprognostic (1.53e-2)" "unprognostic (2.21e-1)" "unprognostic (2.61e-1)" "unprognostic (2.58e-2)" "unprognostic (1.00e-2)" "unprognostic (2.51e-1)" "prognostic unfavorable (6.82e-4)" "unprognostic (1.24e-1)" "unprognostic (5.68e-1)" "unprognostic (9.64e-3)" "unprognostic (5.43e-2)" 23.2 17.4 11.9 15.8 15.6 5.8 16.3 23.1 21.9 17.0 18.8 13.2 15.5 13.1 25.4 20.9 21.6 15.0 20.8 10.0 11.2 12.3 16.0 28.7 16.2 19.0 11.3 9.8 17.4 43.2 19.6 16.5 29.4 13.7 19.4 16.1 32.5 24.6 14.1 18.5 31.1 17.5 15.7 7.8 24.0 17.1 27.2 8.5 29.9 17.8 16.7 26.3 14.8 17.1 14.1 7.8 22.6 11.4 13.7 27.8 16.6 6.6 20.6 9.0 14.7 23.3 13.0 13.0 9.5 12.9 11.3 13.3 9.7 14.3 14.6 13.4 15.4 11.6 26.0 11.6 14.2 11.0 15.6 11.1 5.9 12.6 17.2 16.0 10.1 15.3 19.8 19.6 12.4 12.6 12.6 12.1 10.8 12.1 14.5 8.9 11.5 14.8 14.8 5.7 12.5 5.1 8.1 14.1 14.9 12.9 21.4 16.3 11.2 10.2 8.3 14.4 17.4 23.7 7.9 15.3 12.3 7.6 12.1 9.0 25.1 29.8 13.0 11.2 6.5 9.3 22.6 8.0 17.7 24.2 10.0 21.2 13.0 20.0 23.0 7.8 14.1 19.8 22.2 7.2 13.7 11.4 7.7 27.8 16.6 11.9 15.6 23.1 21.9 11.2 12.3 11.3 9.8 13.7 8.5 23.8 28.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 11.4 29.6 0.0 17.6 6.6 15.5 0.0 0.0 0.0 0.0 21.8 13.6 0.0 0.0 7.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 12.6 0.0 0.0 25.9 0.0 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 REV3L "POLZ, REV3" ENSG00000009413 "REV3 like, DNA directed polymerase zeta catalytic subunit" O60673 6 111299028-111483715 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 40.2;ASC TERT1: 30.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064853, HPA069382" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA064853: AB_2685369, HPA069382: AB_2686134" "unprognostic (5.54e-2)" "unprognostic (2.06e-1)" "unprognostic (5.09e-2)" "unprognostic (1.71e-1)" "unprognostic (1.59e-1)" "unprognostic (8.59e-3)" "unprognostic (4.42e-2)" "unprognostic (1.56e-2)" "unprognostic (8.09e-2)" "unprognostic (1.17e-1)" "unprognostic (6.87e-3)" "unprognostic (1.27e-1)" "unprognostic (4.34e-2)" "unprognostic (2.80e-1)" "unprognostic (1.67e-1)" "unprognostic (1.67e-1)" "unprognostic (1.03e-3)" 21.0 7.1 7.8 8.8 7.3 7.3 15.1 26.0 7.6 31.7 11.0 5.8 14.1 5.4 34.5 18.5 7.6 12.2 7.4 7.1 6.5 6.1 6.5 6.4 10.8 6.3 5.4 5.8 11.3 8.1 7.8 15.1 10.2 6.8 11.4 7.4 8.3 6.9 16.3 17.1 8.2 7.0 18.0 6.9 7.1 8.6 10.3 6.7 10.2 9.2 7.2 5.5 18.3 16.2 5.1 2.8 6.0 2.9 1.7 4.6 1.0 4.7 3.0 5.8 8.8 40.2 30.6 6.4 6.7 11.1 3.7 6.1 5.3 2.9 10.4 4.9 9.7 5.8 4.9 8.5 3.7 6.3 6.1 4.7 6.9 7.6 7.1 5.6 7.2 4.2 19.5 3.4 6.8 10.7 6.4 6.8 5.4 8.8 6.6 7.1 4.4 8.5 1.5 2.0 2.4 5.0 5.5 6.4 3.4 2.8 5.9 7.7 6.1 8.4 3.1 7.2 4.7 3.8 7.8 7.8 5.6 5.2 26.0 7.6 7.0 8.1 9.3 5.4 5.6 7.3 1.9 1.7 3.3 3.3 1.3 4.6 2.8 2.5 3.0 1.7 5.1 1.6 2.8 6.0 1.7 2.9 2.8 1.9 1.0 7.8 7.3 26.0 7.2 6.5 6.1 5.4 5.8 6.8 6.7 44.7 73.8 34.3 19.1 27.1 106.3 31.0 12.7 56.2 45.5 19.2 53.0 18.3 3.3 13.5 30.3 42.0 13.4 0.0 9.9 10.9 62.7 15.8 45.1 12.5 10.9 33.4 57.4 19.0 18.3 11.9 46.6 44.7 20.3 15.4 14.8 74.6 10.1 13.5 36.7 9.2 58.5 38.8 60.6 40.2 68.7 23.5 27.6 22.4 17.7 6.7 REXO1 "EloA-BP1, KIAA1138, TCEB3BP1" ENSG00000079313 "RNA exonuclease 1 homolog" Q8N1G1 19 1815246-1848463 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Early spermatids: 159.9;Horizontal cells: 44.5;Late spermatids: 156.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042155, HPA042552" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA042155: AB_10806233, HPA042552: AB_10794280" "unprognostic (1.36e-1)" "unprognostic (3.86e-3)" "unprognostic (7.52e-2)" "unprognostic (3.70e-3)" "unprognostic (4.21e-2)" "unprognostic (2.38e-3)" "unprognostic (7.15e-2)" "unprognostic (5.10e-2)" "unprognostic (1.88e-1)" "unprognostic (2.39e-2)" "unprognostic (6.12e-3)" "unprognostic (3.75e-2)" "unprognostic (2.87e-2)" "unprognostic (1.10e-2)" "unprognostic (1.58e-1)" "unprognostic (1.96e-1)" "unprognostic (2.42e-2)" 10.9 17.6 15.6 11.9 19.5 19.3 11.5 13.0 25.4 6.2 9.3 10.3 3.4 12.1 9.5 5.5 8.3 7.7 7.8 7.7 14.0 5.9 8.3 10.3 9.0 14.2 8.6 10.3 9.7 16.1 5.1 6.6 13.7 8.9 7.8 5.6 7.6 11.1 7.1 13.8 14.2 11.7 9.4 5.7 20.0 10.4 31.7 11.6 9.6 7.8 6.2 9.7 7.8 9.0 1.4 1.2 2.0 0.8 0.7 1.4 1.0 11.9 7.7 7.1 11.0 2.8 3.7 14.4 8.7 4.7 6.4 5.7 10.0 6.7 10.3 5.9 6.0 4.1 10.6 5.3 9.7 2.8 16.3 8.3 10.8 8.4 5.8 6.5 9.5 17.8 6.5 5.6 8.4 5.6 3.6 5.8 14.8 16.2 17.9 3.3 7.5 15.7 10.7 16.0 4.8 7.6 14.1 5.9 9.7 4.2 6.8 10.5 11.5 5.4 9.2 11.2 5.0 8.0 14.1 10.0 10.1 8.8 16.8 14.5 29.2 14.0 8.9 8.1 11.5 13.0 1.3 0.8 0.5 1.0 0.7 0.8 0.6 0.8 0.6 0.6 1.4 1.1 1.4 2.0 0.7 0.8 1.2 0.3 1.0 15.6 19.5 13.0 25.4 14.0 5.9 8.6 10.3 8.9 11.6 0.0 5.1 3.4 6.8 14.2 17.4 1.2 5.1 0.0 6.8 17.4 7.9 17.4 1.7 7.1 159.9 11.1 17.3 0.0 7.4 9.6 9.1 7.7 5.7 13.0 9.4 44.5 17.6 12.3 9.8 156.1 6.9 6.6 6.8 6.4 15.3 7.2 11.6 15.9 7.1 7.1 17.6 0.0 6.6 14.6 16.9 14.6 17.2 8.7 14.4 9.0 REXO4 "hPMC2, XPMC2H" ENSG00000148300 "REX4 homolog, 3'-5' exonuclease" Q9GZR2 9 133406059-133418096 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047006 Uncertain Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA047006: AB_2679900" "unprognostic (2.69e-2)" "unprognostic (3.76e-1)" "unprognostic (8.13e-2)" "unprognostic (1.30e-1)" "unprognostic (6.77e-2)" "unprognostic (6.52e-2)" "prognostic unfavorable (4.76e-6)" "unprognostic (2.15e-3)" "unprognostic (2.17e-1)" "unprognostic (1.43e-1)" "unprognostic (1.14e-3)" "unprognostic (1.55e-2)" "prognostic favorable (2.65e-4)" "unprognostic (2.25e-2)" "unprognostic (2.86e-2)" "unprognostic (9.20e-2)" "unprognostic (1.20e-1)" 9.9 13.7 16.9 15.1 18.4 10.9 14.5 21.6 18.3 12.7 11.9 11.9 13.2 13.8 14.5 10.7 15.5 13.5 11.2 14.6 13.8 11.8 12.0 19.3 9.7 18.3 18.0 13.2 22.2 21.4 13.3 14.6 14.1 15.4 13.7 10.1 8.8 14.9 13.1 36.4 15.1 13.5 11.9 16.1 16.9 13.0 18.7 18.4 15.0 15.2 9.1 16.3 12.5 21.3 5.5 3.6 3.3 2.5 7.2 5.2 1.8 5.7 13.5 6.3 9.3 6.6 6.9 11.3 10.0 5.7 10.6 7.0 16.0 7.5 18.9 6.8 5.4 8.6 15.8 13.2 10.5 6.1 12.2 12.3 10.2 14.3 12.5 8.3 23.3 10.0 6.4 8.9 11.1 15.3 8.1 7.7 10.2 22.4 8.3 6.7 16.6 16.3 14.0 12.8 20.9 19.4 11.6 10.4 18.7 6.7 5.5 18.2 9.9 10.6 12.4 11.4 6.6 15.2 9.4 6.7 19.4 10.1 9.2 12.1 5.5 6.7 12.9 7.2 13.5 11.5 0.7 2.5 3.3 3.9 2.5 4.3 4.7 4.0 4.0 2.0 5.5 5.1 5.2 0.1 7.2 2.0 3.6 3.4 1.8 16.9 18.4 21.6 18.3 13.8 11.8 18.0 13.2 15.4 18.4 20.8 16.7 29.8 15.4 22.1 25.1 8.3 20.4 10.7 5.7 24.4 21.6 30.4 16.6 26.8 36.5 13.7 23.1 0.0 24.7 31.4 12.1 12.4 17.3 25.5 18.7 15.9 12.7 14.1 16.4 56.5 26.7 12.6 6.8 50.5 19.2 14.2 26.4 17.5 22.6 14.7 29.5 19.4 11.7 39.0 65.9 24.1 26.3 27.7 26.9 11.2 RFC1 "A1, MHCBFB, PO-GA, RFC140" ENSG00000035928 "Replication factor C subunit 1" P35251 4 39287456-39366375 "Plasma proteins, Predicted intracellular proteins" "DNA replication, Transcription, Transcription regulation" "Activator, DNA-binding" Neuropathy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009520, HPA046116, HPA069306" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB009520: AB_2178317, HPA046116: AB_2679544, HPA069306: AB_2686115" "unprognostic (8.23e-2)" "unprognostic (2.30e-1)" "prognostic favorable (4.43e-5)" "unprognostic (4.15e-2)" "unprognostic (4.08e-2)" "unprognostic (3.38e-2)" "unprognostic (7.48e-2)" "unprognostic (3.30e-1)" "unprognostic (4.70e-2)" "unprognostic (2.47e-1)" "unprognostic (4.17e-2)" "unprognostic (4.14e-2)" "unprognostic (1.62e-3)" "unprognostic (4.48e-2)" "unprognostic (1.31e-1)" "unprognostic (5.41e-2)" "unprognostic (1.47e-2)" 18.7 24.0 20.2 22.5 24.9 26.8 21.2 19.9 22.7 23.8 17.8 17.1 20.3 12.5 20.7 19.0 19.4 15.8 11.9 15.4 17.9 14.6 23.4 24.9 17.2 26.3 29.0 22.7 26.2 34.1 41.3 30.7 17.6 23.5 20.1 14.5 10.5 17.4 18.9 13.5 17.8 16.0 21.0 32.7 21.6 17.1 12.4 28.9 33.6 22.3 14.6 27.3 25.3 17.4 15.3 13.0 6.4 8.1 10.8 13.5 4.7 15.8 7.2 20.5 16.7 9.9 12.6 10.5 18.4 16.8 18.9 22.5 13.9 16.2 39.2 12.5 12.3 20.3 7.7 18.8 16.0 30.5 7.0 12.8 17.5 13.8 12.7 12.0 24.5 11.7 9.6 12.9 19.1 21.4 15.1 14.6 19.6 17.3 8.3 14.3 6.4 35.9 15.8 12.5 9.9 9.2 28.6 37.4 12.3 8.2 11.1 14.4 14.0 10.8 4.3 13.9 13.4 11.3 13.8 11.1 15.6 19.3 14.4 23.3 11.9 16.1 37.3 12.8 25.7 15.5 6.4 8.1 3.2 13.2 6.2 9.6 12.4 11.4 11.2 6.2 15.3 13.5 11.9 3.7 10.8 7.4 13.0 9.9 4.7 20.2 24.9 19.9 22.7 17.9 14.6 29.0 22.7 23.5 28.9 59.6 101.9 40.2 33.4 18.3 67.9 62.9 30.6 45.5 48.9 54.1 56.9 32.4 61.3 47.2 30.3 54.6 23.3 23.3 57.3 45.5 31.2 43.3 24.4 70.3 26.9 81.0 28.8 55.9 42.4 22.0 75.9 33.8 15.1 37.9 46.9 81.0 46.5 31.6 86.3 63.9 74.7 58.2 24.5 40.8 69.2 18.6 26.9 55.4 43.2 40.9 RFC2 "A1, RFC40" ENSG00000049541 "Replication factor C subunit 2" P35250 7 74231499-74254458 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA replication" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029493 Approved Supported "Nucleoplasm,Golgi apparatus" NA Yes Nucleoplasm "Golgi apparatus" "HPA029493: AB_10603991" "unprognostic (1.25e-1)" "prognostic favorable (9.91e-4)" "unprognostic (1.44e-1)" "unprognostic (7.66e-3)" "unprognostic (1.17e-2)" "unprognostic (1.93e-1)" "prognostic unfavorable (6.35e-4)" "unprognostic (2.08e-2)" "unprognostic (5.74e-2)" "unprognostic (2.35e-2)" "unprognostic (5.57e-2)" "unprognostic (2.79e-2)" "prognostic unfavorable (2.09e-7)" "unprognostic (2.22e-1)" "unprognostic (6.65e-2)" "unprognostic (3.61e-2)" "unprognostic (2.59e-1)" 11.0 9.5 16.1 15.8 15.4 23.0 15.3 13.9 16.6 10.1 12.8 10.0 5.0 8.6 10.0 9.4 17.9 10.1 9.0 9.1 12.1 9.1 10.1 23.0 10.6 20.4 12.3 14.0 11.7 15.1 10.9 8.6 17.5 15.1 11.0 15.0 8.9 12.2 8.1 16.5 18.8 10.0 12.7 14.8 14.2 12.2 13.5 14.0 22.1 10.4 14.7 28.5 9.9 11.6 22.4 18.7 27.5 24.2 24.8 13.6 15.8 22.9 17.9 20.9 20.7 4.3 5.1 9.6 13.5 14.9 27.5 33.2 19.8 21.4 21.7 3.8 9.5 26.1 15.8 17.0 22.6 28.6 15.5 29.5 13.2 24.9 14.7 3.4 19.8 8.2 5.1 5.1 25.9 17.9 6.0 14.7 20.9 27.4 13.4 21.1 27.1 19.7 38.6 23.8 36.5 15.1 29.5 23.2 27.1 14.7 18.6 17.0 21.6 16.0 30.3 11.0 26.9 21.9 18.3 5.7 27.3 18.1 21.0 30.1 8.2 10.6 37.7 13.8 30.7 28.3 19.5 22.0 15.6 11.4 24.2 11.7 19.0 9.9 10.4 18.7 22.4 12.6 9.5 27.5 24.8 22.4 10.0 13.6 15.8 16.1 15.4 13.9 16.6 12.1 9.1 12.3 14.0 15.1 14.0 11.9 12.0 15.3 19.1 21.2 14.1 5.0 10.2 9.4 15.9 5.2 2.0 51.5 5.0 14.8 2.2 11.7 9.9 0.0 16.7 50.3 12.7 9.4 22.0 13.1 32.8 3.2 4.6 11.6 12.7 1.8 8.1 24.0 20.3 34.3 7.8 12.8 12.3 5.8 10.3 7.8 8.7 6.5 15.1 23.6 52.6 14.9 38.6 23.6 15.6 12.4 RFC3 "MGC5276, RFC38" ENSG00000133119 "Replication factor C subunit 3" P40938 13 33818049-33966558 "Predicted intracellular proteins" "DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 32.4;Spermatogonia: 43.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 70.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030149 Approved Supported Nucleoplasm,Vesicles No No "Nucleoplasm, Vesicles" "HPA030149: AB_10602921" "unprognostic (3.86e-2)" "unprognostic (5.27e-2)" "unprognostic (1.12e-1)" "unprognostic (1.16e-2)" "unprognostic (5.76e-2)" "unprognostic (3.07e-3)" "unprognostic (3.32e-2)" "unprognostic (4.93e-2)" "unprognostic (9.02e-3)" "unprognostic (4.49e-1)" "unprognostic (6.46e-2)" "unprognostic (4.05e-2)" "unprognostic (5.24e-3)" "unprognostic (4.05e-2)" "unprognostic (1.79e-1)" "unprognostic (5.08e-2)" "unprognostic (2.86e-1)" 8.0 17.7 5.7 19.1 7.2 14.4 10.9 19.9 10.2 7.9 7.5 5.6 5.9 6.9 11.6 8.9 10.3 7.0 6.5 6.2 5.2 5.5 5.4 6.2 6.6 19.1 4.7 5.6 9.6 7.6 3.7 5.9 14.2 8.6 5.7 10.3 7.0 7.8 4.6 6.1 7.5 7.0 6.6 5.6 11.8 6.3 17.8 3.7 34.7 6.1 9.7 19.2 5.2 7.0 8.2 7.9 8.5 7.5 3.3 8.3 4.1 11.6 11.7 22.3 18.0 1.7 2.7 12.1 16.2 7.5 21.9 19.0 15.3 18.1 43.8 6.9 6.3 13.4 18.0 28.2 11.5 29.6 16.8 16.8 25.3 13.6 16.6 1.9 30.6 12.2 2.6 1.5 18.8 13.0 3.6 7.2 15.9 17.6 11.1 13.1 13.6 25.8 14.6 26.2 25.1 10.2 9.7 26.0 10.0 6.5 10.5 11.6 20.4 12.2 16.5 8.5 12.7 13.3 17.0 3.8 11.5 12.9 14.6 17.2 6.2 8.5 70.2 8.3 18.1 22.0 1.6 5.7 8.5 4.5 7.5 4.9 8.2 5.5 4.7 7.9 7.8 7.4 6.3 1.3 3.3 6.5 3.3 8.3 4.1 5.7 7.2 19.9 10.2 5.2 5.5 4.7 5.6 8.6 3.7 8.9 3.8 9.7 6.5 10.9 14.0 7.4 2.5 4.0 10.3 3.5 7.9 18.1 3.3 4.6 7.0 5.8 0.4 0.0 7.7 32.4 6.6 2.9 1.1 5.4 10.2 7.9 5.8 8.6 7.3 5.0 5.8 5.0 8.5 6.4 4.3 5.7 3.9 0.0 4.2 3.5 11.3 6.5 3.8 25.0 43.9 6.0 13.7 4.6 4.5 1.4 RFC4 "A1, RFC37" ENSG00000163918 "Replication factor C subunit 4" P35249 3 186789880-186807058 "Plasma proteins, Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 48.3;Spermatocytes: 67.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004557, HPA049123, HPA058507" Enhanced Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB004557: AB_2178593, HPA049123: AB_2680642, HPA058507: AB_2683736" "unprognostic (2.45e-1)" "prognostic favorable (7.41e-5)" "unprognostic (2.84e-1)" "unprognostic (1.81e-3)" "unprognostic (1.03e-1)" "unprognostic (6.69e-3)" "prognostic unfavorable (6.75e-7)" "unprognostic (5.29e-3)" "unprognostic (1.15e-2)" "unprognostic (2.34e-3)" "prognostic unfavorable (7.38e-4)" "unprognostic (5.92e-2)" "prognostic unfavorable (2.22e-16)" "unprognostic (1.80e-2)" "unprognostic (4.98e-1)" "unprognostic (6.15e-2)" "unprognostic (2.16e-1)" 7.1 6.9 11.5 14.1 16.0 26.8 10.5 28.0 13.9 8.8 11.6 5.3 5.8 8.2 11.8 7.3 13.0 10.2 7.6 8.0 8.6 6.2 8.2 9.3 6.6 22.1 14.5 9.8 12.7 11.9 6.5 9.0 11.0 12.5 7.3 16.1 5.9 8.1 5.8 8.1 8.7 11.8 13.6 8.4 15.6 9.8 20.3 12.8 28.6 6.4 11.0 25.2 8.3 8.5 11.2 7.7 7.4 10.3 7.0 16.5 6.2 34.8 12.0 28.5 18.2 4.1 4.5 22.5 16.9 10.7 27.0 29.9 17.9 16.7 25.2 39.3 8.1 25.9 18.4 25.1 16.5 33.3 38.0 22.1 25.9 18.4 18.2 3.2 27.3 17.4 3.8 6.0 18.5 14.5 6.0 9.0 39.5 20.1 35.9 18.4 16.6 34.3 25.6 25.2 31.2 16.4 27.2 24.5 34.6 9.7 13.0 27.9 13.9 21.1 23.3 19.1 22.4 39.6 26.2 4.1 16.4 20.7 27.4 50.4 20.1 44.4 83.9 14.4 30.1 21.5 0.0 2.2 7.4 9.8 3.3 9.4 10.6 9.7 10.1 3.9 11.2 9.8 8.9 0.4 7.0 10.3 7.7 16.5 6.2 11.5 16.0 28.0 13.9 8.6 6.2 14.5 9.8 12.5 12.8 0.0 2.1 20.1 13.1 5.4 17.0 6.9 10.2 9.4 7.9 10.4 0.0 26.7 5.0 9.4 18.6 4.5 2.0 23.3 14.4 48.3 5.1 4.1 8.1 2.9 20.0 7.9 1.2 6.7 2.1 7.9 9.8 5.2 1.7 15.4 4.2 12.4 7.9 3.5 7.4 6.7 14.0 6.5 10.3 67.9 38.7 2.6 9.4 8.6 11.5 3.1 RFC5 RFC36 ENSG00000111445 "Replication factor C subunit 5" P40937 12 118013588-118033130 "Plasma proteins, Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041037 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041037: AB_10805834" "unprognostic (9.63e-2)" "prognostic favorable (8.05e-5)" "unprognostic (5.12e-3)" "unprognostic (2.25e-2)" "unprognostic (1.06e-2)" "unprognostic (2.16e-2)" "unprognostic (1.40e-3)" "unprognostic (1.10e-1)" "unprognostic (2.35e-3)" "unprognostic (1.42e-1)" "unprognostic (1.05e-1)" "unprognostic (2.81e-2)" "prognostic unfavorable (2.30e-4)" "unprognostic (1.44e-1)" "unprognostic (2.15e-1)" "unprognostic (2.70e-1)" "unprognostic (5.06e-1)" 9.4 9.3 9.8 15.1 10.7 30.3 11.7 14.4 12.5 11.4 11.0 10.2 12.6 10.2 12.9 10.8 14.3 12.2 8.4 6.7 15.2 6.5 9.3 13.9 8.4 16.0 7.0 10.1 18.7 12.3 7.3 11.4 9.1 11.0 8.7 14.5 8.5 9.9 12.6 7.3 11.2 11.5 9.0 9.3 11.1 9.8 16.4 9.3 33.4 12.0 11.2 17.0 12.6 10.8 12.9 8.8 14.2 10.4 9.1 14.1 7.9 19.5 21.4 21.0 11.7 5.2 6.1 23.0 14.8 10.1 28.7 21.5 22.0 8.5 23.1 10.5 7.6 17.6 18.8 28.9 14.5 27.1 16.2 24.1 18.1 16.8 14.4 3.1 28.3 13.8 3.2 4.8 21.6 6.9 12.3 11.9 28.5 24.1 8.4 13.4 21.4 35.6 21.4 15.9 11.8 19.7 26.7 25.8 22.0 12.4 17.8 28.2 12.3 25.5 7.1 9.1 12.8 26.3 10.9 5.5 15.4 17.3 21.0 27.8 14.3 18.5 28.3 14.8 20.4 26.1 14.2 6.2 3.9 11.2 10.4 10.0 12.9 13.7 9.8 8.8 11.1 10.7 9.3 6.1 9.1 5.8 7.6 14.1 7.9 9.8 10.7 14.4 12.5 15.2 6.5 7.0 10.1 11.0 9.3 0.0 3.5 0.0 7.8 7.4 3.7 2.6 2.5 17.4 4.5 8.7 2.0 12.7 8.3 7.5 1.3 4.1 2.5 46.7 5.6 22.1 4.3 2.5 5.7 5.8 8.0 1.6 4.1 4.3 2.6 1.7 3.7 4.1 0.0 2.8 5.6 7.8 3.4 3.5 7.8 4.6 6.3 0.0 5.2 12.6 9.3 4.6 7.4 6.9 10.8 1.8 RFESD ENSG00000175449 "Rieske Fe-S domain containing" Q8TAC1 5 95646754-95684773 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 28.3" "Cell type enriched" "Detected in many" 4 "Erythroid cells: 163.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 3.7;NK-cells: 5.0;T-cells: 12.7" "Cell line enhanced" "Detected in many" "HEL: 21.2;K-562: 39.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB016546 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB016546: AB_630417" "unprognostic (1.15e-1)" "unprognostic (5.40e-2)" "unprognostic (1.06e-1)" "unprognostic (1.37e-2)" "unprognostic (6.07e-3)" "unprognostic (2.72e-1)" "unprognostic (1.33e-3)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (9.91e-2)" "unprognostic (8.24e-3)" "unprognostic (4.89e-2)" "unprognostic (5.83e-3)" "unprognostic (6.78e-2)" "unprognostic (9.03e-2)" "unprognostic (9.35e-2)" "unprognostic (1.09e-1)" 2.4 3.8 2.8 2.8 5.5 28.3 8.6 4.9 5.1 3.5 2.6 3.1 3.3 1.8 3.1 6.2 3.4 2.8 1.9 5.4 3.8 3.1 3.4 4.4 3.7 3.8 4.5 4.1 4.2 10.7 6.9 9.7 2.9 5.5 4.5 2.2 2.8 8.1 4.9 6.8 9.7 2.3 2.1 8.6 3.7 3.4 16.0 3.9 8.6 4.5 1.4 4.1 3.3 2.9 3.7 1.6 0.3 0.9 5.0 12.7 2.8 1.8 2.9 0.5 1.8 1.9 3.4 0.0 1.0 1.5 1.6 1.7 2.3 2.0 3.0 2.1 0.8 3.9 2.7 2.0 1.5 1.8 4.4 1.7 21.2 2.9 0.8 2.3 1.9 2.2 1.5 2.9 2.1 1.9 1.5 1.6 8.9 39.4 2.3 2.6 1.2 6.2 8.4 2.3 0.8 2.7 3.0 0.3 1.3 0.6 1.1 2.8 2.0 2.8 1.3 0.0 0.2 1.4 1.0 0.8 2.1 1.6 1.5 1.7 2.1 5.0 2.3 1.8 2.3 1.1 0.0 0.7 0.3 3.5 0.9 9.4 3.7 8.5 6.0 1.5 2.9 12.7 7.2 0.0 5.0 0.8 1.6 4.9 2.8 2.8 5.5 4.9 5.1 3.8 3.1 4.5 4.1 5.5 3.9 11.9 3.5 4.5 3.7 2.9 2.2 8.3 0.0 6.7 5.7 1.8 0.0 2.9 1.7 2.0 11.8 1.1 0.1 163.5 1.5 10.4 1.9 1.5 3.5 1.6 3.3 1.6 0.0 2.5 1.0 6.3 1.7 0.8 0.0 3.6 1.0 2.7 2.1 0.0 1.1 2.1 1.2 6.5 1.1 39.4 10.8 5.9 1.7 2.2 1.3 2.5 RFLNA "Cfm2, FAM101A, FLJ44614, RefilinA" ENSG00000178882 "Refilin A" Q6ZTI6 12 123973241-124316024 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "stomach 1: 118.3" "Cell type enriched" "Detected in some" 24 "Pancreatic endocrine cells: 66.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "hTEC/SVTERT24-B: 9.0;HUVEC TERT2: 12.8;LHCN-M2: 22.4;OE19: 23.3;RH-30: 7.3" "Low region specificity" "Detected in all" "HPA058911, HPA078021" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA058911: AB_2683853, HPA078021: AB_2732368" "unprognostic (1.71e-1)" "unprognostic (6.85e-2)" "unprognostic (1.63e-2)" "unprognostic (1.36e-1)" "unprognostic (3.15e-2)" "unprognostic (8.78e-4)" "unprognostic (2.01e-1)" "prognostic unfavorable (3.16e-5)" "unprognostic (8.87e-2)" "unprognostic (1.59e-1)" "unprognostic (1.71e-3)" "unprognostic (1.15e-3)" "unprognostic (1.77e-8)" "unprognostic (2.48e-1)" "unprognostic (1.36e-1)" "unprognostic (6.27e-2)" "unprognostic (1.37e-2)" 5.5 3.0 6.4 5.2 8.6 2.6 8.2 10.8 6.6 11.7 20.9 9.7 7.0 19.5 4.8 4.8 3.0 5.5 3.7 5.1 6.3 6.3 5.4 5.3 3.2 2.8 9.8 5.2 5.2 7.6 2.7 9.4 3.4 9.0 6.3 15.4 6.3 8.7 5.4 8.5 4.2 20.7 3.4 8.3 2.8 118.3 2.7 8.3 1.9 9.6 2.3 2.8 3.3 4.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 2.3 0.0 0.0 0.3 0.3 1.1 0.8 0.0 0.1 3.1 0.1 0.0 1.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.5 0.0 9.0 0.0 0.5 12.8 1.3 0.0 0.0 22.4 0.0 0.0 0.0 1.9 23.3 0.0 0.0 7.3 0.1 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 6.4 8.6 10.8 6.6 6.3 6.3 9.8 5.2 9.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.7 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RFNG ENSG00000169733 "RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase" Q9Y644 17 82047902-82051831 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011564, HPA031673" Uncertain Approved Nucleoplasm No No 450000 Nucleoplasm "HPA011564: AB_1079803, HPA031673: AB_2673989" "unprognostic (4.17e-3)" "unprognostic (7.60e-3)" "unprognostic (2.87e-3)" "unprognostic (2.49e-1)" "unprognostic (2.05e-1)" "unprognostic (2.65e-2)" "unprognostic (1.62e-1)" "unprognostic (9.86e-2)" "unprognostic (1.02e-1)" "unprognostic (1.53e-1)" "prognostic favorable (4.81e-4)" "unprognostic (1.20e-1)" "unprognostic (6.96e-3)" "unprognostic (1.77e-1)" "unprognostic (2.16e-1)" "unprognostic (6.93e-2)" "unprognostic (4.14e-2)" 19.5 13.0 13.8 9.3 13.3 11.7 43.8 14.3 13.8 11.4 11.8 9.0 22.7 14.9 13.5 20.9 13.4 16.3 17.0 12.2 11.6 8.7 12.5 34.5 16.7 10.1 11.2 8.0 19.7 26.6 4.1 10.7 8.2 9.9 11.8 4.8 10.6 27.3 20.4 32.6 13.3 12.7 12.9 8.5 8.9 13.2 12.8 10.6 5.7 12.6 10.5 7.6 12.4 12.8 3.4 3.4 4.3 5.0 0.4 6.3 1.5 9.5 9.5 2.8 9.6 7.2 6.3 12.3 8.9 5.2 4.3 3.4 5.8 6.8 2.2 6.4 14.1 8.8 5.3 1.9 7.7 0.9 2.9 10.0 3.2 2.3 23.6 35.5 1.2 7.1 11.5 5.2 7.3 12.5 8.4 8.0 7.5 4.0 8.4 3.4 11.7 7.1 3.3 2.8 6.4 10.0 5.0 3.4 5.0 4.8 5.8 5.0 12.4 3.4 5.8 26.3 3.2 16.1 6.8 3.0 6.8 9.2 6.4 4.8 11.3 2.1 2.3 8.5 2.0 5.8 2.3 5.0 4.3 4.1 1.4 1.5 2.5 2.8 4.3 3.4 3.4 2.8 1.9 2.0 0.4 1.5 2.7 6.3 1.5 13.8 13.3 14.3 13.8 11.6 8.7 11.2 8.0 9.9 10.6 6.0 11.3 5.2 11.2 8.7 28.3 10.0 7.6 4.0 3.4 22.7 23.6 4.8 6.6 7.0 2.9 9.2 17.1 0.0 12.8 2.8 17.9 13.2 1.1 42.9 8.3 11.1 10.9 17.8 9.7 8.5 20.1 6.1 10.1 2.8 13.3 30.4 11.9 17.3 18.7 28.9 24.4 0.0 7.0 17.9 3.1 8.9 3.1 7.5 11.1 7.0 RFWD3 "FANCW, FLJ10520, RNF201" ENSG00000168411 "Ring finger and WD repeat domain 3" Q6PCD5 16 74621394-74666881 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 46.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048258, HPA075649" Approved Enhanced Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA048258: AB_2680332, HPA075649: AB_2686761" "unprognostic (4.79e-2)" "unprognostic (6.45e-3)" "unprognostic (6.35e-2)" "unprognostic (6.61e-2)" "unprognostic (2.73e-1)" "unprognostic (1.97e-1)" "unprognostic (1.11e-3)" "unprognostic (5.04e-2)" "unprognostic (3.64e-2)" "unprognostic (1.01e-1)" "unprognostic (4.03e-3)" "unprognostic (2.53e-3)" "unprognostic (1.73e-3)" "unprognostic (2.84e-1)" "unprognostic (4.31e-1)" "unprognostic (5.74e-2)" "unprognostic (3.29e-1)" 7.3 5.2 4.2 12.2 6.1 33.9 7.8 7.8 5.6 7.4 6.7 8.4 8.4 5.5 9.7 10.0 12.8 6.3 5.5 5.4 3.9 3.7 6.5 5.6 6.5 12.0 6.1 4.8 7.7 9.6 8.5 7.5 11.5 5.3 6.5 8.1 7.2 8.0 8.4 4.5 11.6 7.8 5.6 4.8 9.7 6.2 35.1 7.2 40.5 7.0 7.5 18.0 7.2 8.6 9.3 7.1 13.8 10.9 9.1 11.7 6.5 14.1 18.2 13.8 10.0 2.9 4.0 15.5 12.8 9.9 20.5 17.9 23.7 14.9 19.8 10.5 10.0 10.3 17.1 22.4 13.3 25.2 6.2 13.4 17.5 14.8 13.3 2.5 17.6 18.3 2.8 4.2 25.8 16.0 5.3 8.7 16.9 26.4 8.9 15.4 22.6 25.6 16.1 27.1 8.3 8.8 39.9 9.3 17.4 7.3 15.1 10.2 10.9 20.6 7.3 9.1 13.0 13.4 15.0 8.4 15.0 14.4 8.4 16.1 12.1 22.4 59.4 10.7 13.6 18.2 13.8 6.8 9.9 9.3 6.3 10.2 7.8 7.7 8.6 7.1 9.3 11.7 8.1 7.7 9.1 10.9 5.5 10.9 6.5 4.2 6.1 7.8 5.6 3.9 3.7 6.1 4.8 5.3 7.2 0.0 5.1 11.2 5.0 9.6 5.8 2.4 2.5 2.7 5.7 1.8 9.8 9.1 10.0 5.6 4.2 5.2 4.2 23.3 6.6 6.6 4.8 9.2 4.6 6.4 7.6 3.2 9.1 10.4 13.7 5.4 3.4 6.1 15.1 3.6 8.3 3.5 8.2 0.0 3.9 3.4 6.8 6.5 5.6 46.5 30.6 8.2 6.3 7.5 7.3 12.0 RFX1 EF-C ENSG00000132005 "Regulatory factor X1" P22670 19 13961538-14007039 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 122.1;Late spermatids: 79.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 10.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048722, HPA052966" Approved Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA048722: AB_2680500, HPA052966: " "unprognostic (6.40e-2)" "unprognostic (1.26e-1)" "unprognostic (1.55e-3)" "unprognostic (2.63e-1)" "unprognostic (5.45e-2)" "prognostic favorable (2.42e-4)" "unprognostic (2.62e-1)" "unprognostic (1.71e-1)" "unprognostic (2.88e-1)" "unprognostic (1.61e-2)" "prognostic favorable (4.92e-4)" "unprognostic (1.35e-1)" "unprognostic (4.41e-2)" "unprognostic (1.83e-2)" "unprognostic (2.96e-1)" "unprognostic (1.50e-1)" "unprognostic (1.56e-2)" 7.4 7.4 13.1 8.7 13.1 9.8 7.0 36.2 19.3 10.3 6.0 6.2 10.2 10.6 8.0 4.6 8.0 8.5 6.3 7.0 11.7 5.9 7.9 8.6 7.0 7.2 8.6 9.5 10.2 12.5 11.9 18.9 8.0 9.5 8.5 3.1 9.8 12.7 12.4 11.0 7.0 9.2 4.4 6.8 12.0 11.2 21.0 10.8 11.6 10.9 3.4 9.3 6.8 13.6 3.9 3.5 10.8 3.5 3.4 2.0 1.1 6.2 6.3 3.4 4.1 2.1 2.6 10.3 3.5 2.3 4.0 3.5 6.5 6.3 3.5 7.0 1.8 3.5 8.2 2.5 2.5 1.4 3.5 14.1 4.0 7.1 5.8 3.9 4.1 8.6 1.9 2.7 3.6 2.1 3.6 3.2 3.1 10.2 4.0 2.1 9.5 7.4 8.9 7.7 3.4 9.7 6.5 3.5 5.0 4.0 3.4 14.2 7.5 6.0 5.3 4.8 1.9 5.6 4.3 3.7 7.1 5.8 7.7 5.9 9.4 4.2 2.4 5.6 4.0 6.2 0.7 3.5 1.6 1.4 1.1 1.3 2.9 1.6 1.5 1.7 3.9 1.7 2.0 10.8 3.4 2.0 3.5 1.0 1.1 13.1 13.1 36.2 19.3 11.7 5.9 8.6 9.5 9.5 10.8 14.9 9.9 15.9 8.0 4.9 27.9 7.7 5.1 1.4 12.5 21.0 33.4 8.2 8.3 8.7 122.1 9.8 14.9 0.0 8.4 10.4 9.6 6.2 11.5 14.4 9.2 22.3 16.0 13.5 17.5 79.7 23.9 8.5 1.7 3.6 14.5 13.8 9.3 12.5 26.2 6.7 47.6 12.9 6.1 31.2 17.5 6.6 15.9 15.3 12.7 5.6 RFX2 FLJ14226 ENSG00000087903 "Regulatory factor X2" P48378 19 5993164-6199572 "Predicted intracellular proteins, Transcription factors" "Cilium biogenesis/degradation, Differentiation, Spermatogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 51.5" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 120.5;Early spermatids: 120.3;Late spermatids: 146.0;Spermatocytes: 95.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 9 "neutrophil: 18.3" "Lineage enriched" "Detected in many" 9 "granulocytes: 18.3" "Cell line enhanced" "Detected in many" "HMC-1: 16.3;SCLC-21H: 20.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA048969 Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus, Cytosol" "HPA048969: AB_2680577" "unprognostic (1.31e-1)" "prognostic favorable (2.80e-4)" "unprognostic (6.72e-2)" "prognostic favorable (2.67e-4)" "unprognostic (1.37e-1)" "unprognostic (4.15e-2)" "unprognostic (1.22e-2)" "unprognostic (1.12e-3)" "unprognostic (1.86e-2)" "unprognostic (3.84e-2)" "prognostic favorable (7.36e-4)" "unprognostic (3.73e-1)" "unprognostic (1.26e-1)" "unprognostic (1.93e-1)" "unprognostic (2.70e-2)" "unprognostic (2.50e-2)" "unprognostic (1.07e-1)" 6.7 2.0 8.4 5.3 9.4 8.6 6.4 8.3 7.0 6.9 11.3 7.2 0.7 4.1 15.7 7.0 9.0 22.0 6.4 5.4 9.5 3.6 1.9 2.5 10.0 2.1 4.4 4.0 7.2 5.3 2.9 12.9 2.2 9.9 4.1 2.6 3.1 2.4 3.3 2.5 6.6 5.7 14.8 9.0 2.1 5.9 51.5 7.5 4.1 3.0 12.1 3.1 8.7 5.3 0.3 1.6 18.3 2.0 0.5 0.5 0.6 4.0 3.3 5.3 10.3 2.8 1.6 3.1 2.6 3.6 2.2 3.5 1.4 5.1 4.6 2.8 3.4 4.8 6.4 1.3 5.2 3.0 1.1 0.8 7.2 3.3 1.4 3.2 3.1 16.3 1.9 4.5 4.9 2.6 2.7 3.3 6.4 4.6 0.2 2.2 2.0 6.2 4.3 1.4 5.6 2.0 1.7 3.2 0.5 2.8 7.9 20.1 2.5 2.5 2.0 1.4 0.6 3.4 3.5 4.8 0.9 4.6 3.6 2.6 6.7 2.2 2.6 2.8 11.6 1.9 0.0 2.0 0.8 0.1 0.4 0.0 0.3 0.4 0.3 1.6 0.1 0.4 0.5 18.3 0.5 1.1 0.0 0.0 0.6 8.4 9.4 8.3 7.0 9.5 3.6 4.4 4.0 9.9 7.5 23.8 40.1 2.2 23.8 23.5 3.3 7.2 15.3 120.5 40.9 3.5 2.0 5.2 3.3 3.9 120.3 9.9 3.0 0.0 1.5 5.4 9.7 5.5 44.0 2.0 7.0 0.0 13.2 6.7 8.7 146.0 7.5 13.6 6.8 5.4 4.4 5.5 2.3 1.5 3.9 1.5 3.6 25.8 14.6 95.0 13.0 19.3 4.7 4.9 5.2 17.3 RFX3 ENSG00000080298 "Regulatory factor X3" P48380 9 3218297-3526004 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.1;testis: 36.5" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 140.5;Early spermatids: 159.1;Intestinal endocrine cells: 135.5;Late spermatids: 86.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 22.4;HDLM-2: 13.2;SCLC-21H: 12.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035689 Enhanced Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA035689: AB_10671224" "prognostic favorable (1.47e-4)" "unprognostic (8.78e-2)" "unprognostic (1.18e-1)" "unprognostic (5.52e-2)" "unprognostic (2.27e-2)" "unprognostic (1.50e-1)" "unprognostic (8.26e-3)" "unprognostic (3.06e-2)" "unprognostic (1.68e-1)" "unprognostic (6.49e-2)" "unprognostic (7.58e-3)" "unprognostic (1.31e-2)" "unprognostic (1.64e-1)" "unprognostic (1.20e-1)" "unprognostic (2.31e-1)" "unprognostic (2.52e-1)" "unprognostic (8.89e-3)" 5.2 4.6 17.9 7.6 14.9 11.4 6.7 35.1 19.5 6.9 4.7 6.9 5.0 5.0 6.8 6.3 3.8 22.0 5.2 4.0 12.8 7.5 5.0 4.1 7.2 6.7 6.0 11.9 7.0 5.4 9.0 21.7 5.8 9.9 6.1 5.6 4.2 4.7 4.6 5.7 4.4 5.0 4.0 12.5 5.7 6.6 36.5 11.0 12.7 5.7 2.9 7.5 4.5 7.8 8.3 4.6 8.9 4.8 5.3 9.3 3.2 2.0 2.7 22.4 5.4 0.9 1.0 2.2 0.8 2.4 1.9 1.4 0.8 2.6 3.2 0.9 1.1 1.6 1.1 5.5 2.3 3.4 13.2 1.5 6.0 3.0 1.8 1.1 1.2 0.8 1.4 1.1 2.3 3.8 3.8 3.3 4.2 1.1 3.3 2.0 1.6 3.8 4.4 5.9 1.7 1.2 4.0 1.5 0.8 3.1 1.6 12.0 5.3 1.3 0.6 2.0 4.6 1.1 3.2 2.0 1.4 3.3 0.7 1.3 1.1 0.5 6.4 1.6 1.4 1.5 3.5 3.2 6.2 8.8 4.8 5.4 6.3 8.1 7.2 3.1 8.3 5.7 7.0 8.9 5.3 1.4 4.6 9.3 3.2 17.9 14.9 35.1 19.5 12.8 7.5 6.0 11.9 9.9 11.0 6.0 7.7 6.2 7.4 4.4 22.0 4.9 0.0 140.5 34.2 3.5 23.6 1.6 0.0 3.1 159.1 13.5 2.5 0.0 2.2 2.1 4.3 9.6 5.8 0.9 2.7 36.5 135.5 11.6 6.9 86.4 6.6 6.2 1.7 1.0 9.2 13.8 3.2 5.8 7.1 1.7 25.2 0.0 10.3 10.2 2.5 5.5 1.1 6.7 5.5 3.3 RFX4 ENSG00000111783 "Regulatory factor X4" Q33E94 12 106582907-106762803 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 43.9;testis: 70.5" "Cell type enhanced" "Detected in some" 31 "Early spermatids: 34.1;Late spermatids: 23.0;Spermatocytes: 99.6" "Cancer enriched" "Detected in single" 54 "glioma: 15.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.2;NK-cell: 1.0" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 14 "AF22: 33.3" "Low region specificity" "Detected in all" HPA050527 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA050527: AB_2681158" "unprognostic (3.67e-1)" "unprognostic (4.86e-2)" "unprognostic (1.76e-3)" "unprognostic (1.60e-2)" "unprognostic (1.09e-1)" "unprognostic (6.97e-2)" "unprognostic (7.97e-2)" "unprognostic (3.04e-1)" "unprognostic (6.80e-2)" "unprognostic (2.72e-3)" "unprognostic (1.66e-3)" "unprognostic (1.15e-2)" "unprognostic (1.30e-2)" "unprognostic (5.46e-2)" 1.3 1.2 13.8 1.2 14.5 1.2 1.2 7.6 20.6 1.2 1.2 21.0 0.0 1.2 1.2 1.3 1.2 1.3 1.3 1.3 15.7 9.9 1.3 1.2 1.3 1.3 12.0 8.6 1.2 1.4 1.2 8.0 1.2 20.6 1.4 1.2 0.0 1.2 1.3 1.2 1.2 1.3 1.2 43.9 1.2 1.3 70.5 13.7 0.0 1.4 0.0 1.2 1.2 0.1 0.5 0.0 0.0 0.0 1.0 1.2 0.0 0.0 0.2 33.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 13.8 14.5 7.6 13.6 15.7 9.9 12.0 8.6 20.6 13.7 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 34.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 23.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 99.6 3.1 0.0 0.0 0.0 0.0 0.0 RFX7 "FLJ12994, RFXDC2" ENSG00000181827 "Regulatory factor X7" Q2KHR2 15 56087280-56243266 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 28.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035462 Supported Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA035462: AB_10602152" "unprognostic (2.36e-1)" "unprognostic (2.09e-2)" "unprognostic (1.53e-1)" "unprognostic (1.32e-1)" "unprognostic (4.72e-2)" "unprognostic (2.73e-2)" "unprognostic (9.58e-2)" "unprognostic (1.50e-1)" "unprognostic (4.10e-2)" "unprognostic (2.78e-2)" "unprognostic (2.60e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.12e-5)" "unprognostic (2.24e-1)" "unprognostic (5.09e-1)" "unprognostic (1.50e-1)" "unprognostic (1.84e-1)" 6.6 6.6 4.2 4.1 7.1 6.7 5.0 28.2 11.7 4.4 3.5 8.6 3.0 4.3 4.4 4.9 5.1 4.1 3.1 4.2 4.7 3.6 4.4 4.2 4.1 7.1 4.5 8.3 4.7 6.3 7.1 10.6 4.1 8.1 3.9 3.9 2.7 5.3 7.1 13.7 9.8 4.6 4.1 6.4 6.0 4.1 6.0 6.8 15.4 4.2 3.7 7.2 4.9 4.8 1.3 1.5 4.6 0.8 1.4 2.6 0.5 3.9 6.1 14.6 11.1 6.3 7.2 3.8 2.9 4.1 3.9 6.2 4.3 2.9 11.1 4.8 4.3 3.3 10.1 8.8 5.6 5.3 5.9 3.5 13.1 8.3 9.3 6.5 10.6 2.3 5.9 13.3 3.5 8.8 6.9 7.0 11.3 6.1 5.8 6.6 4.6 8.9 4.3 6.9 3.2 2.3 9.9 9.4 10.1 5.7 10.1 8.1 10.2 3.7 4.3 5.2 11.1 3.3 8.6 5.8 10.7 5.4 2.7 6.3 5.5 5.2 12.6 3.8 11.4 4.7 4.6 0.5 0.9 1.2 0.8 1.6 1.2 1.8 1.9 0.9 1.3 1.0 1.3 0.0 1.4 0.4 1.5 2.6 0.5 4.2 7.1 28.2 11.7 4.7 3.6 4.5 8.3 8.1 6.8 6.0 11.2 5.4 4.2 11.8 15.8 5.3 2.5 6.7 4.5 7.0 9.8 3.5 3.3 3.0 16.3 6.2 3.0 23.3 4.0 1.2 5.4 5.4 11.6 7.6 4.7 15.9 4.6 8.0 11.3 9.1 6.1 5.6 5.0 1.8 5.6 4.1 3.0 6.5 9.9 3.7 7.4 0.0 3.6 6.6 5.8 15.4 1.4 6.4 6.2 5.1 RFX8 FLJ42986 ENSG00000196460 "RFX family member 8, lacking RFX DNA binding domain" Q6ZV50 2 101397361-101474703 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 10.0;breast: 7.5;lymphoid tissue: 7.8" "Group enriched" "Detected in some" 5 "Early spermatids: 14.4;Late spermatids: 6.0;Spermatocytes: 4.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 12 "basophil: 2.0" "Lineage enriched" "Detected in single" 12 "granulocytes: 2.0" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.0;hTEC/SVTERT24-B: 15.7;LHCN-M2: 7.5;U-87 MG: 10.4;U-937: 4.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA059745 Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA059745: AB_2684120" "unprognostic (1.02e-1)" "unprognostic (1.88e-2)" "unprognostic (1.24e-1)" "unprognostic (5.55e-2)" "unprognostic (2.56e-3)" "unprognostic (8.14e-2)" "unprognostic (3.63e-2)" "unprognostic (6.04e-2)" "unprognostic (4.93e-2)" "unprognostic (9.55e-2)" "unprognostic (1.51e-2)" "unprognostic (4.76e-2)" "unprognostic (4.73e-5)" "unprognostic (4.96e-2)" "unprognostic (1.74e-1)" "unprognostic (3.14e-1)" "unprognostic (1.09e-2)" 2.1 0.6 0.4 0.8 0.7 10.0 7.5 0.2 2.3 0.9 0.5 0.8 1.3 0.4 0.7 1.7 0.7 0.2 1.0 0.8 0.4 0.9 0.6 0.7 0.7 0.9 0.7 1.6 0.7 0.6 1.0 2.2 0.9 1.6 0.5 0.1 0.8 0.9 0.1 0.5 1.4 0.3 0.8 0.8 0.4 0.4 2.6 0.0 7.8 1.5 0.0 0.3 0.6 2.1 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 5.0 0.0 2.0 1.4 1.4 1.4 0.0 3.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 2.1 0.0 15.7 0.1 0.0 0.0 0.5 0.0 0.0 7.5 0.0 0.6 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.2 0.0 0.0 1.9 2.8 0.0 0.0 0.0 10.4 4.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.2 2.3 0.4 0.9 0.7 1.6 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.8 6.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 1.5 4.7 0.7 0.0 1.1 0.0 0.0 0.1 RFXANK "ANKRA1, BLS, F14150_1, MGC138628, RFX-B" ENSG00000064490 "Regulatory factor X associated ankyrin containing protein" O14593 19 19192229-19201869 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049157, HPA053330" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA049157: AB_2680658, HPA053330: AB_2682114" "unprognostic (3.16e-2)" "unprognostic (6.39e-3)" "unprognostic (1.47e-2)" "unprognostic (1.22e-1)" "unprognostic (5.23e-2)" "unprognostic (4.46e-2)" "unprognostic (1.25e-3)" "unprognostic (3.40e-2)" "unprognostic (3.89e-1)" "unprognostic (1.57e-1)" "unprognostic (2.71e-1)" "unprognostic (1.97e-1)" "unprognostic (1.31e-2)" "unprognostic (3.62e-2)" "unprognostic (3.52e-1)" "unprognostic (2.73e-2)" "unprognostic (2.04e-3)" 16.2 11.0 15.8 19.5 17.8 28.4 15.6 7.6 15.3 19.5 20.1 14.9 17.4 16.9 16.6 20.3 21.8 25.3 12.8 17.7 14.3 12.7 19.0 11.3 14.3 22.5 16.0 10.1 18.8 17.9 12.2 14.0 21.9 13.6 17.7 9.0 16.1 27.0 22.4 32.0 18.7 15.3 11.9 13.0 26.5 16.7 8.5 9.3 49.6 36.6 21.8 23.4 15.1 13.8 25.1 31.7 28.4 18.2 18.3 23.3 15.7 18.6 11.7 8.3 16.6 2.9 8.2 20.9 9.3 9.8 16.0 15.9 9.7 39.1 18.4 23.9 9.6 6.8 13.9 7.1 18.4 7.1 12.6 11.1 14.6 11.9 14.1 30.5 20.8 31.1 15.6 10.9 14.0 10.3 9.8 15.9 18.3 29.1 21.0 8.7 37.4 27.1 27.7 10.0 19.7 26.6 23.0 8.5 32.0 13.2 13.1 6.9 14.4 9.7 12.4 22.8 5.8 17.9 42.6 15.5 8.8 9.3 20.7 14.9 24.3 26.3 27.3 12.7 26.0 16.7 20.5 17.7 28.4 15.1 18.2 12.6 23.6 16.9 16.3 20.0 25.1 17.1 16.5 7.6 18.3 13.3 31.7 23.3 15.7 15.8 17.8 7.6 15.3 14.3 12.7 16.0 10.1 13.6 9.3 29.8 34.6 34.2 28.5 19.6 7.8 3.3 25.5 41.5 14.8 29.6 2.0 50.0 64.6 40.6 4.0 26.3 43.3 23.3 49.9 50.7 21.3 23.9 32.2 13.6 54.2 14.3 35.7 31.3 48.3 7.6 28.1 33.6 20.3 68.5 37.0 24.1 47.4 36.8 18.0 53.8 10.1 38.8 25.9 5.2 17.2 21.5 38.1 28.0 39.4 21.3 RGCC "bA157L14.2, C13orf15, RGC-32, RGC32" ENSG00000102760 "Regulator of cell cycle" Q9H4X1 13 41457559-41470882 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 109.9;lung: 120.1" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 621.5;Erythroid cells: 303.7;Glandular cells: 288.4;Hofbauer cells: 320.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 46.2" "Lineage enriched" "Detected in many" 26 "T-cells: 46.2" "Cell line enhanced" "Detected in some" "ASC TERT1: 15.4;BJ hTERT+: 80.7;Daudi: 26.2;U-698: 27.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035638, HPA063701" Enhanced Supported Nucleoplasm,Nucleoli "Intracellular and membrane" No No 390000 Nucleoplasm Nucleoli "HPA035638: AB_10670152, HPA063701: AB_2685096" "unprognostic (1.39e-3)" "unprognostic (4.61e-2)" "prognostic unfavorable (5.60e-4)" "unprognostic (2.28e-1)" "unprognostic (4.27e-2)" "unprognostic (2.85e-1)" "unprognostic (1.49e-3)" "unprognostic (1.49e-2)" "unprognostic (3.99e-2)" "unprognostic (1.57e-3)" "unprognostic (1.19e-1)" "unprognostic (1.17e-1)" "unprognostic (2.81e-2)" "unprognostic (3.04e-3)" "unprognostic (1.48e-1)" "unprognostic (2.30e-1)" "unprognostic (1.42e-3)" 58.6 6.7 26.7 8.8 33.1 109.9 27.7 21.6 22.7 12.8 5.6 36.1 4.2 5.7 8.7 3.1 5.4 7.6 14.3 15.1 32.1 16.8 11.0 8.3 120.1 10.8 41.7 15.2 1.8 13.4 8.7 7.1 70.6 21.1 10.7 3.6 16.1 33.2 6.8 12.7 10.8 4.9 11.3 22.2 7.3 8.0 7.1 34.8 15.2 26.9 5.8 6.9 9.5 8.7 1.7 1.7 0.2 0.2 0.1 46.2 2.8 0.2 0.1 9.0 0.0 1.7 15.4 0.3 0.2 80.7 0.0 0.3 11.2 0.1 26.2 0.2 1.0 0.0 0.2 0.3 0.5 0.1 2.7 1.3 0.0 1.9 0.8 0.9 0.9 0.3 1.2 1.7 0.3 11.2 0.1 9.2 6.1 2.0 0.0 0.2 0.0 5.8 0.5 0.1 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.8 0.2 5.0 6.2 0.0 1.0 0.5 0.1 0.0 0.0 27.6 0.0 0.6 0.2 0.0 0.2 0.0 1.6 0.1 1.6 1.2 13.8 4.4 1.7 1.7 46.2 10.5 0.2 0.1 0.0 0.5 23.1 2.8 26.7 33.1 21.6 21.7 32.1 16.8 41.7 15.2 21.1 34.8 229.3 54.7 23.2 621.5 76.8 0.8 12.0 0.0 38.8 47.8 3.5 2.0 3.9 29.9 0.6 7.3 237.2 0.3 303.7 0.0 5.3 88.9 288.4 49.5 0.8 320.9 0.0 81.3 31.9 23.8 7.0 7.5 180.3 183.9 0.0 7.4 1.4 0.3 3.4 2.1 0.5 1.4 122.9 80.2 14.1 4.1 57.0 9.3 44.5 6.6 105.6 RGL1 RGL ENSG00000143344 "Ral guanine nucleotide dissociation stimulator like 1" Q9NZL6 1 183636085-183928531 "Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ito cells: 46.1;Kupffer cells: 85.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 5.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 18.6;HSkMC: 29.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019788 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus, Vesicles" "HPA019788: AB_1856215" "unprognostic (3.08e-1)" "unprognostic (5.25e-3)" "unprognostic (8.73e-2)" "unprognostic (1.24e-2)" "unprognostic (2.34e-1)" "unprognostic (4.79e-3)" "prognostic unfavorable (1.49e-5)" "prognostic favorable (4.32e-4)" "unprognostic (1.12e-1)" "unprognostic (6.34e-2)" "unprognostic (5.77e-3)" "unprognostic (4.59e-2)" "unprognostic (2.63e-3)" "unprognostic (4.87e-2)" "unprognostic (2.70e-2)" "unprognostic (1.13e-1)" "unprognostic (2.88e-2)" 22.1 15.7 22.1 16.9 24.8 1.5 19.7 14.2 23.2 18.1 9.9 25.5 8.8 7.9 17.4 11.5 9.9 14.4 20.3 15.0 21.5 15.0 25.7 14.3 18.4 17.4 18.2 16.3 18.7 6.3 10.5 9.7 14.2 19.1 12.5 11.9 21.0 7.8 11.1 3.0 8.4 9.4 19.8 19.6 37.5 7.6 13.0 20.4 1.7 9.1 2.9 8.9 18.1 12.6 0.0 2.4 0.2 5.2 0.0 1.1 1.2 0.1 0.7 13.7 2.1 18.6 8.6 13.9 6.3 10.6 2.9 3.6 6.1 0.4 0.1 5.9 4.4 2.2 0.3 0.9 1.6 2.8 0.2 1.0 0.1 1.4 6.2 5.0 0.2 0.7 29.2 0.3 7.3 1.7 13.7 10.6 1.4 0.0 10.1 6.0 0.0 1.4 0.1 4.9 0.4 0.4 11.8 0.9 12.0 0.8 3.8 1.7 4.1 1.9 2.1 1.0 4.6 0.1 0.1 7.7 4.1 1.6 12.8 3.4 1.0 0.2 0.0 4.3 0.1 11.3 0.0 2.1 0.0 0.2 5.2 0.4 0.0 0.8 0.0 2.4 0.0 1.1 0.6 0.2 0.0 1.8 0.0 0.6 1.2 22.1 24.8 14.2 21.9 21.5 15.0 18.2 16.3 19.1 20.4 8.9 10.5 2.2 2.1 7.2 2.4 7.5 5.1 16.0 11.4 5.2 0.0 3.9 5.0 2.6 10.2 13.6 2.1 0.0 0.8 1.7 10.8 3.3 3.5 2.1 33.6 7.9 0.0 46.1 85.8 11.8 12.0 15.6 5.0 1.0 0.8 26.6 0.8 0.0 19.4 23.7 1.9 25.8 4.7 1.6 2.7 4.1 4.3 0.5 0.4 1.4 RGL2 "HKE1.5, KE1.5, RAB2L" ENSG00000237441 "Ral guanine nucleotide dissociation stimulator like 2" O15211 6 33291654-33299324 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.2" "Lineage enriched" "Detected in single" 4 "granulocytes: 4.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047039, HPA053444" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA047039: AB_2732538, HPA053444: AB_2682153" "unprognostic (4.12e-2)" "unprognostic (2.29e-1)" "unprognostic (1.07e-2)" "unprognostic (6.31e-2)" "unprognostic (1.18e-2)" "unprognostic (2.74e-3)" "unprognostic (2.64e-1)" "unprognostic (1.04e-2)" "unprognostic (3.30e-2)" "unprognostic (2.35e-1)" "prognostic favorable (6.16e-4)" "unprognostic (1.27e-1)" "unprognostic (5.00e-2)" "unprognostic (4.84e-2)" "unprognostic (3.04e-1)" "unprognostic (1.14e-1)" "unprognostic (1.62e-2)" 12.1 9.2 6.7 10.0 8.4 4.5 6.8 9.4 8.4 8.6 7.0 7.1 15.3 6.7 8.9 9.5 6.5 8.3 9.9 9.1 7.2 3.2 7.5 4.2 9.9 7.2 7.5 4.8 10.7 6.6 4.9 17.1 7.7 8.6 7.5 4.2 7.5 6.8 13.3 19.9 4.6 6.6 6.3 4.9 19.0 7.1 6.4 6.6 4.6 12.8 4.5 6.8 7.5 10.7 0.5 0.7 4.2 0.9 0.7 0.4 0.8 3.6 1.0 4.1 2.1 0.6 0.4 2.0 1.7 1.0 0.5 0.7 0.5 0.9 1.2 6.1 0.3 2.0 0.8 0.8 0.5 0.3 3.0 2.1 2.5 1.0 0.9 0.5 1.8 3.9 0.8 0.5 1.6 0.3 2.6 1.1 1.5 3.1 0.9 0.3 0.7 1.2 2.6 0.1 0.5 1.8 1.2 2.3 1.3 0.8 0.7 3.5 3.4 1.2 2.2 5.2 1.1 1.8 2.1 3.2 2.0 2.9 1.3 4.6 5.1 2.9 3.2 0.6 1.3 3.5 1.6 0.8 2.0 0.4 0.9 0.4 0.5 0.3 0.4 0.7 0.5 0.2 0.3 4.2 0.7 0.2 0.0 0.3 0.8 6.7 8.4 9.4 8.4 7.2 3.2 7.5 4.8 8.6 6.6 14.9 40.4 15.9 31.8 25.2 27.7 22.9 12.7 21.4 30.7 21.0 21.6 22.8 11.6 19.0 3.9 54.2 6.1 0.0 12.7 34.3 17.5 39.0 10.5 10.4 26.5 30.2 27.4 61.4 25.6 10.3 15.5 20.5 16.9 10.8 10.4 20.9 17.4 22.9 13.8 9.7 29.6 25.8 21.7 27.8 16.2 21.2 85.5 20.8 8.3 35.6 RGL3 FLJ32585 ENSG00000205517 "Ral guanine nucleotide dissociation stimulator like 3" Q3MIN7 19 11384341-11419342 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 65.1;thyroid gland: 38.2" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 48.8;Muller glia cells: 28.8;Sertoli cells: 38.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "neutrophil: 1.4" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.4" "Cell line enhanced" "Detected in many" "BEWO: 14.8;CACO-2: 8.4;RT4: 17.4;SK-BR-3: 7.7;T-47d: 12.8" "Region enriched" "Detected in single" 6 "cerebellum: 10.1" "HPA042763, HPA043615, HPA064578" Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042763: AB_10968569, HPA043615: AB_10959470, HPA064578: " "prognostic favorable (7.35e-4)" "unprognostic (3.12e-2)" "unprognostic (2.92e-1)" "unprognostic (5.69e-2)" "unprognostic (2.08e-1)" "unprognostic (6.60e-2)" "unprognostic (3.82e-2)" "unprognostic (5.31e-2)" "unprognostic (1.24e-2)" "unprognostic (1.48e-2)" "unprognostic (3.19e-3)" "unprognostic (5.99e-2)" "prognostic favorable (6.61e-4)" "unprognostic (4.17e-2)" "unprognostic (3.37e-1)" "unprognostic (3.21e-2)" "unprognostic (7.12e-3)" 4.3 6.2 5.3 1.2 7.9 0.7 4.3 1.9 6.8 7.6 1.9 3.4 23.3 1.8 4.9 14.5 1.1 5.3 6.5 5.2 8.2 1.3 20.7 6.0 7.5 1.2 6.7 3.0 1.6 12.1 65.1 9.1 5.8 7.9 4.1 1.8 7.3 3.5 23.9 5.0 1.1 1.2 1.4 9.5 5.1 6.8 1.1 7.3 0.0 38.2 0.4 0.9 4.5 4.5 0.3 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.9 0.1 14.8 0.9 1.1 0.5 1.6 8.4 6.0 0.0 5.4 1.0 2.1 3.7 0.0 0.0 0.0 0.0 0.0 0.1 3.1 2.6 2.3 0.0 0.0 0.0 0.1 0.1 0.0 3.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.3 1.1 0.0 0.6 1.6 5.1 17.4 0.8 4.4 0.2 7.7 2.6 3.1 12.8 0.0 0.0 2.7 0.0 2.0 0.7 0.0 0.4 0.7 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 5.3 7.9 1.9 6.8 8.2 1.3 6.7 3.0 7.9 7.3 17.9 15.2 0.0 2.0 0.1 0.1 2.5 5.1 2.7 22.7 48.8 0.0 12.2 10.0 8.3 0.0 3.9 0.0 0.0 3.6 9.6 4.6 1.0 1.1 4.3 2.6 0.0 9.9 25.8 4.3 0.0 3.4 0.6 5.0 0.0 7.1 28.8 5.8 5.3 0.4 3.0 0.4 38.8 12.4 0.5 1.2 0.0 10.1 0.0 2.7 1.4 RGMA "RGM, RGMa" ENSG00000182175 "Repulsive guidance molecule BMP co-receptor a" Q96B86 15 93035273-93089204 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 59.0;skeletal muscle: 85.5" "Group enriched" "Detected in many" 5 "Leydig cells: 110.1;Peritubular cells: 110.0;Spermatogonia: 37.2" "Cancer enriched" "Detected in many" 6 "glioma: 26.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 31.0;BEWO: 9.1;MOLT-4: 9.2;NTERA-2: 13.9;REH: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012343, HPA039880, HPA044222" Approved Approved Nucleoplasm,Cytosol "Secreted - unknown location" NA NA 1400000 Nucleoplasm Cytosol "CAB012343: AB_777667, HPA039880: AB_2676723, HPA044222: AB_2678861" "unprognostic (3.21e-2)" "unprognostic (1.59e-1)" "unprognostic (8.85e-2)" "unprognostic (3.96e-3)" "unprognostic (5.73e-2)" "unprognostic (4.72e-3)" "unprognostic (2.53e-2)" "prognostic favorable (2.78e-4)" "unprognostic (2.19e-2)" "unprognostic (1.12e-1)" "unprognostic (2.11e-1)" "unprognostic (6.25e-2)" "unprognostic (3.59e-4)" "unprognostic (8.11e-2)" "unprognostic (2.92e-2)" "unprognostic (1.73e-1)" "unprognostic (7.98e-5)" 12.2 3.3 17.4 17.6 24.7 1.8 9.3 11.0 59.0 21.0 22.2 22.2 0.9 9.1 21.8 9.4 23.1 12.1 9.5 7.7 19.3 16.2 2.3 1.6 2.8 3.1 23.0 12.8 16.6 9.1 1.9 2.1 2.5 30.9 5.5 6.5 2.3 16.2 7.0 85.5 4.9 12.3 46.9 36.8 2.2 26.6 15.8 23.1 0.2 2.9 12.2 5.6 4.1 8.8 1.3 0.7 1.7 1.0 0.7 0.5 0.2 1.2 0.2 31.0 0.5 6.5 3.6 9.1 0.2 0.0 0.0 0.0 0.3 0.4 0.1 0.1 0.2 0.0 2.0 5.2 0.1 0.0 0.0 6.2 0.0 0.1 0.0 0.0 0.1 0.1 3.8 0.1 0.0 0.0 0.2 0.0 0.6 0.0 0.1 0.0 0.6 9.2 0.1 13.9 0.0 0.0 8.0 7.1 0.0 0.0 0.3 3.3 1.8 0.3 0.1 0.0 1.7 2.5 1.6 0.1 0.0 6.7 0.3 0.0 0.1 0.0 0.1 0.1 0.1 0.8 1.4 0.7 0.6 0.4 1.0 0.3 0.6 0.5 0.5 0.1 1.3 0.4 0.5 1.7 0.7 0.4 0.7 0.3 0.2 17.4 24.7 11.0 21.3 19.3 16.2 23.0 12.8 30.9 23.1 0.0 1.0 0.0 15.6 4.8 0.2 3.2 0.0 1.4 2.3 0.0 2.0 3.8 0.0 4.7 0.8 1.1 0.0 0.0 0.6 1.0 7.4 13.3 0.0 0.0 1.8 0.0 0.0 3.1 3.7 2.6 110.1 1.1 3.3 0.0 0.0 4.1 0.6 0.0 110.0 0.0 1.1 12.9 12.3 0.7 37.2 2.5 2.1 0.7 0.0 12.0 RGMB "DRAGON, FLJ90406" ENSG00000174136 "Repulsive guidance molecule BMP co-receptor b" Q6NW40 5 98768650-98798643 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 51.6;Mucus-secreting cells: 39.5;Undifferentiated cells: 50.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 8.3" "Group enriched" "Detected in many" 12 "B-cells: 4.1;T-cells: 8.3" "Cell line enhanced" "Detected in many" "BJ: 68.4;fHDF/TERT166: 37.5;HBF TERT88: 48.5;LHCN-M2: 35.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016993 Approved Nucleoplasm NA NA 150000 Nucleoplasm "HPA016993: AB_1856216" "unprognostic (1.50e-2)" "unprognostic (3.77e-2)" "unprognostic (9.03e-2)" "unprognostic (8.92e-2)" "unprognostic (2.88e-1)" "unprognostic (5.27e-2)" "unprognostic (7.44e-2)" "unprognostic (1.60e-2)" "unprognostic (8.24e-2)" "unprognostic (2.19e-1)" "unprognostic (3.60e-3)" "unprognostic (9.00e-2)" "unprognostic (3.88e-2)" "unprognostic (3.90e-2)" "unprognostic (6.40e-2)" "unprognostic (4.20e-2)" "unprognostic (3.78e-3)" 8.3 7.2 14.0 9.9 11.7 0.8 14.4 18.0 23.9 8.8 19.7 5.6 9.9 19.0 8.4 5.7 17.7 10.1 8.9 8.8 9.8 14.4 3.9 6.6 10.8 4.1 7.2 13.3 20.1 15.4 9.0 12.3 5.1 11.5 19.2 28.5 6.8 18.4 15.6 23.1 28.1 22.9 10.6 11.6 6.2 34.5 13.3 5.6 1.0 13.5 7.2 7.7 9.7 15.7 4.1 0.1 0.5 0.2 0.3 8.3 1.6 1.8 1.3 19.1 1.7 5.7 9.9 2.6 68.4 30.5 30.5 21.6 0.9 0.8 1.0 2.9 37.5 2.3 1.8 2.2 5.9 48.5 3.4 2.8 0.0 1.6 1.1 2.8 0.1 0.0 8.1 2.0 19.9 6.1 8.2 5.5 3.2 0.0 0.8 35.6 1.7 0.0 0.0 1.5 0.7 4.4 2.8 11.7 1.8 1.1 1.8 8.3 4.2 0.9 2.1 3.2 0.9 1.7 0.0 13.5 19.4 4.0 12.4 31.0 1.8 2.2 1.4 7.3 0.0 4.2 0.0 0.0 0.2 0.3 0.2 1.4 3.1 3.9 1.3 0.1 4.1 8.3 3.9 0.5 0.3 0.0 0.0 5.3 1.6 14.0 11.7 18.0 21.5 9.8 14.4 7.2 13.3 11.5 5.6 14.9 2.6 4.2 12.8 27.5 4.9 13.0 5.1 2.7 1.2 8.7 15.7 3.8 1.7 4.6 51.6 7.4 7.8 0.0 4.5 4.7 13.2 10.6 0.0 7.5 1.7 0.0 20.9 8.6 1.3 12.3 8.3 2.1 11.8 1.0 39.5 1.3 6.6 10.5 6.7 1.2 3.6 0.0 18.6 4.9 12.6 21.3 1.5 0.0 50.0 15.9 RGS10 ENSG00000148908 "Regulator of G protein signaling 10" O43665 10 119499828-119542708 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 77.9;lymphoid tissue: 96.9" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 256.9;granulocytes: 281.0;Hofbauer cells: 444.1;Macrophages: 293.8;monocytes: 273.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 94.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004559, HPA021305, HPA058485" Enhanced Supported Supported "Nucleoplasm,Plasma membrane" NA NA 1400000 "Nucleoplasm, Plasma membrane" "CAB004559: AB_628216, HPA021305: AB_1856225, HPA058485: AB_2683732" "unprognostic (1.64e-2)" "prognostic favorable (6.81e-4)" "unprognostic (7.98e-2)" "prognostic favorable (6.32e-4)" "unprognostic (5.21e-2)" "unprognostic (6.19e-2)" "unprognostic (4.32e-3)" "unprognostic (6.35e-2)" "unprognostic (9.90e-3)" "unprognostic (1.10e-1)" "unprognostic (1.42e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (4.20e-10)" "unprognostic (2.50e-1)" "unprognostic (9.20e-2)" "unprognostic (7.70e-2)" "unprognostic (7.92e-3)" 9.6 7.7 11.9 28.2 12.1 23.6 15.4 2.8 12.4 25.8 44.0 17.0 5.3 12.5 15.3 13.1 21.9 10.8 18.8 11.7 12.0 10.5 8.3 3.9 13.5 47.6 17.4 6.7 10.3 3.9 0.8 6.6 16.9 10.5 17.8 18.9 6.4 18.1 8.2 13.2 9.3 23.1 19.1 28.5 18.7 12.8 3.7 11.1 96.9 14.7 11.1 34.3 17.9 20.0 6.9 40.2 20.5 26.3 7.6 77.9 63.0 30.1 5.6 0.4 53.0 7.6 49.0 5.0 14.1 21.4 8.5 13.7 1.7 7.2 12.9 7.5 10.9 8.3 6.7 7.9 8.5 22.6 6.3 9.1 34.6 1.6 4.1 12.3 7.0 94.1 19.0 11.4 16.5 15.4 29.1 16.1 12.7 8.8 10.5 9.8 13.7 40.9 24.5 2.4 3.7 15.3 8.0 0.0 4.8 4.3 7.1 2.1 1.7 2.7 34.7 49.6 6.8 6.6 12.5 21.3 4.9 4.2 7.0 12.0 0.5 8.1 4.7 1.5 30.7 2.1 20.5 21.5 0.2 15.0 26.3 15.7 6.9 32.5 25.8 40.2 3.6 77.9 58.5 9.9 7.6 21.6 23.9 35.0 63.0 11.9 12.1 2.8 12.4 12.0 10.5 17.4 6.7 10.5 11.1 0.0 19.1 64.8 23.8 32.6 0.0 1.2 0.0 2.7 11.4 1.8 0.0 10.7 51.4 0.7 1.8 5.3 4.2 256.9 5.6 30.7 57.9 75.3 281.0 0.4 444.1 0.0 18.0 14.7 196.4 3.9 46.3 293.8 89.4 273.3 63.2 1.4 8.0 5.8 8.9 3.8 0.8 12.9 31.9 0.2 1.7 24.6 8.5 117.2 14.2 34.9 RGS12 ENSG00000159788 "Regulator of G protein signaling 12" O14924 4 3293028-3439913 "Plasma proteins, Predicted intracellular proteins" Transcription "GTPase activation, Repressor, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 37.2" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 118.6;Suprabasal keratinocytes: 96.1;Urothelial cells: 169.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054646, HPA067421" Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA054646: AB_2682555, HPA067421: AB_2685836" "unprognostic (2.08e-1)" "unprognostic (1.71e-3)" "unprognostic (7.50e-2)" "unprognostic (4.18e-2)" "unprognostic (1.65e-1)" "prognostic favorable (7.03e-4)" "unprognostic (3.43e-2)" "unprognostic (1.93e-1)" "unprognostic (1.76e-1)" "unprognostic (9.02e-2)" "unprognostic (1.70e-2)" "unprognostic (2.13e-1)" "prognostic favorable (8.43e-4)" "unprognostic (2.54e-1)" "unprognostic (2.60e-1)" "unprognostic (5.92e-2)" "unprognostic (1.11e-2)" 4.7 4.4 20.7 4.1 22.0 2.3 4.4 10.2 37.2 5.4 2.9 10.2 1.5 5.3 6.4 5.6 13.5 7.5 4.4 4.7 13.4 5.6 4.4 6.7 6.5 3.4 12.3 16.3 8.9 3.1 3.1 6.1 4.1 9.4 6.8 2.2 3.1 6.5 5.7 6.8 20.6 4.6 3.0 18.9 4.1 3.2 5.5 9.9 4.3 3.8 3.4 3.6 5.5 7.9 1.0 1.5 1.6 3.9 0.4 1.3 0.7 4.0 5.1 10.3 7.4 3.5 2.7 4.3 4.3 3.5 4.5 3.3 4.1 2.4 1.0 2.7 3.8 6.6 3.9 2.0 13.9 1.5 0.1 1.6 0.4 2.9 10.0 3.1 0.3 5.7 2.3 9.5 2.3 3.2 4.1 9.9 3.6 4.7 0.2 4.1 3.4 0.7 10.8 4.9 2.3 4.9 10.2 4.0 3.3 2.3 12.0 11.7 12.0 2.7 1.9 9.1 2.6 4.7 6.9 7.4 8.8 5.8 1.8 4.6 5.1 4.0 2.3 5.1 6.0 6.2 1.0 1.2 0.3 0.9 3.9 0.3 0.2 0.8 0.5 1.5 1.0 1.3 0.5 1.6 0.4 3.7 0.8 0.6 0.7 20.7 22.0 10.2 37.2 13.4 5.6 12.3 16.3 9.4 9.9 6.0 8.3 0.5 118.6 75.0 19.0 7.5 15.3 29.4 20.5 5.2 27.5 5.3 3.3 9.0 3.8 21.1 5.1 0.0 9.2 1.0 10.0 34.2 13.9 22.7 19.8 9.5 14.3 25.8 6.1 4.2 13.8 19.0 16.9 5.4 9.9 38.9 11.1 0.0 7.4 18.1 18.7 0.0 8.8 20.2 14.9 96.1 5.6 4.5 8.0 169.4 RGS14 ENSG00000169220 "Regulator of G protein signaling 14" O43566 5 177357837-177372601 "Predicted intracellular proteins" "Cell cycle, Cell division" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 43.9;brain: 76.1" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 61.1;Proximal tubular cells: 68.0;Suprabasal keratinocytes: 100.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 4 "basal ganglia: 76.1" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 40.7;HMC-1: 36.4;NB-4: 16.0;RPMI-8226: 21.0" "Group enriched" "Detected in many" 11 "amygdala: 68.3;basal ganglia: 58.1;cerebral cortex: 46.1;hippocampal formation: 102.5" "Low region specificity" "Detected in all" "HPA046847, HPA061819" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Intermediate filaments" No No Nucleoplasm "Vesicles, Plasma membrane, Intermediate filaments" "HPA046847: AB_2679836, HPA061819: " "unprognostic (6.05e-3)" "unprognostic (1.65e-2)" "unprognostic (8.57e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (6.97e-4)" "unprognostic (7.27e-2)" "prognostic unfavorable (1.84e-6)" "unprognostic (1.95e-2)" "unprognostic (4.34e-2)" "unprognostic (2.04e-3)" "unprognostic (2.71e-1)" "unprognostic (1.28e-1)" "unprognostic (9.95e-2)" "unprognostic (3.17e-2)" "unprognostic (1.66e-1)" "unprognostic (1.17e-2)" "unprognostic (2.78e-2)" 1.9 1.5 7.7 12.5 76.1 17.5 1.3 0.4 8.8 1.7 2.6 1.9 0.6 5.1 1.3 1.4 3.2 6.6 3.4 0.7 17.1 1.9 2.1 6.9 4.3 15.5 2.5 3.6 0.8 1.5 0.1 0.9 1.0 0.8 1.2 0.5 0.7 5.2 1.8 1.6 3.5 5.7 1.2 0.7 12.8 3.7 0.7 4.4 24.2 4.3 1.7 12.9 4.9 1.6 9.2 12.2 43.9 12.3 6.5 20.7 12.4 1.9 0.4 0.7 0.4 0.0 0.0 1.2 0.0 0.0 0.1 0.2 1.2 3.8 4.8 2.7 0.0 0.4 3.9 0.0 1.2 0.0 40.7 0.1 7.5 0.1 1.5 0.2 5.8 36.4 0.6 0.3 0.2 0.2 0.0 0.2 5.5 1.3 9.8 0.0 0.1 7.8 16.0 0.6 1.9 1.0 3.6 0.0 21.0 0.4 0.1 0.1 0.7 0.0 0.1 3.0 0.0 1.3 9.2 0.3 0.0 0.7 0.0 3.5 5.2 2.5 2.1 0.6 11.0 0.9 18.6 12.3 43.9 20.5 11.4 20.7 9.2 19.1 18.7 12.2 8.0 16.0 14.3 43.0 6.5 11.6 5.4 18.2 12.4 7.7 76.1 0.4 8.8 17.1 1.9 2.5 3.6 0.8 4.4 6.0 4.1 20.7 25.0 61.1 0.4 1.6 40.8 14.7 4.5 10.4 2.0 3.2 26.6 10.5 0.5 6.0 7.5 0.0 14.4 8.2 5.3 12.3 24.3 55.7 21.0 0.0 4.6 7.4 13.7 0.8 2.6 16.9 20.3 0.0 5.3 8.0 12.8 14.4 2.1 68.0 1.9 0.0 5.1 0.0 15.1 100.6 2.7 40.0 3.3 13.7 RGS6 ENSG00000182732 "Regulator of G protein signaling 6" P49758 14 71932439-72566529 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.8" "Group enriched" "Detected in some" 9 "Early spermatids: 155.9;Late spermatids: 221.8" "Group enriched" "Detected in some" 7 "glioma: 3.1;thyroid cancer: 1.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.6;T-reg: 1.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "HEL: 8.3;Karpas-707: 30.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003067 Uncertain Approved Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA003067: AB_1079807" "unprognostic (7.18e-2)" "unprognostic (7.78e-2)" "unprognostic (1.00e-1)" "unprognostic (6.85e-2)" "unprognostic (5.61e-2)" "unprognostic (3.80e-2)" "unprognostic (1.24e-4)" "unprognostic (7.83e-2)" "unprognostic (2.03e-1)" "unprognostic (8.17e-2)" "unprognostic (1.30e-1)" "unprognostic (2.06e-2)" "unprognostic (8.64e-2)" "unprognostic (5.11e-2)" "unprognostic (8.06e-3)" "unprognostic (2.10e-1)" "unprognostic (3.68e-2)" 6.9 0.8 8.6 1.1 11.1 2.0 4.9 4.0 18.0 7.9 1.8 2.8 0.3 0.8 2.7 4.2 1.0 3.6 1.9 15.7 3.7 7.5 3.3 0.6 1.7 0.5 15.4 9.3 2.3 0.6 10.9 2.6 4.6 20.8 0.7 1.8 1.3 1.3 2.5 1.7 1.4 1.4 2.2 5.2 1.5 0.8 13.9 2.4 0.0 8.5 0.3 1.0 1.1 1.3 0.5 0.4 1.6 0.2 0.6 1.2 4.1 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 8.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 30.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.6 0.6 0.0 0.4 1.2 4.1 8.6 11.1 4.0 18.0 3.7 7.5 15.4 9.3 20.8 2.4 0.0 0.0 0.0 0.0 0.2 1.4 19.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 155.9 0.7 0.0 0.0 0.2 0.1 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 221.8 1.7 0.0 0.0 8.2 0.0 0.0 0.0 0.0 7.1 0.1 0.4 12.9 20.2 1.2 1.0 0.1 0.7 0.0 0.0 0.4 RGS9 "MGC111763, MGC26458, PERRS, RGS9L" ENSG00000108370 "Regulator of G protein signaling 9" O75916 17 65100812-65227703 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Sensory transduction, Vision" "Signal transduction inhibitor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.3" "Group enriched" "Detected in many" 7 "Cone photoreceptor cells: 306.3;Rod photoreceptor cells: 472.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 6 "basal ganglia: 47.3" "Group enriched" "Detected in many" 6 "gdT-cell: 11.0;MAIT T-cell: 2.8;memory CD8 T-cell: 7.4;naive CD8 T-cell: 3.6;NK-cell: 3.7" "Group enriched" "Detected in many" 74 "NK-cells: 3.7;T-cells: 11.0" "Group enriched" "Detected in some" 4 "HDLM-2: 23.2;HEL: 9.5" "Region enriched" "Detected in many" 9 "basal ganglia: 222.4" "Region enriched" "Detected in all" 9 "basal ganglia: 79.8" "HPA013550, HPA014137" Enhanced Supported Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA013550: , HPA014137: AB_2668943" "unprognostic (4.43e-3)" "unprognostic (7.49e-3)" "unprognostic (5.12e-2)" "unprognostic (3.09e-5)" "unprognostic (1.07e-1)" "unprognostic (1.14e-1)" "unprognostic (3.17e-1)" "unprognostic (1.93e-1)" "unprognostic (1.20e-1)" "unprognostic (4.88e-2)" "prognostic favorable (1.35e-4)" "unprognostic (1.07e-1)" "unprognostic (5.07e-2)" "unprognostic (4.94e-2)" "unprognostic (3.69e-1)" "unprognostic (1.51e-1)" "unprognostic (1.49e-1)" 1.1 1.9 3.3 4.4 47.3 1.0 2.3 4.1 8.9 3.4 5.2 7.2 2.7 3.3 4.2 7.2 4.1 9.5 3.9 1.3 5.4 7.4 2.0 5.0 5.9 5.3 3.5 3.7 6.7 3.7 7.3 7.9 3.0 4.5 8.6 3.4 24.1 3.2 9.2 1.6 1.5 3.6 4.0 3.4 4.3 3.7 1.7 6.6 0.4 4.2 0.5 7.5 5.1 2.4 0.0 0.0 0.0 0.0 3.7 11.0 1.4 0.2 0.0 1.1 0.1 0.1 0.2 0.0 0.0 2.1 0.0 0.2 0.1 0.0 0.7 1.6 0.0 0.0 0.1 0.0 0.1 0.2 23.2 0.5 9.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 3.7 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.2 3.6 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 11.0 0.0 2.8 0.0 1.0 7.4 0.0 0.0 0.0 3.6 0.0 3.7 0.0 0.0 0.0 1.4 3.3 47.3 4.1 4.5 5.4 7.4 3.5 3.7 4.5 6.6 3.0 1.0 0.0 0.9 0.3 21.5 0.4 0.0 1.4 2.3 1.8 306.3 0.0 3.3 6.8 0.6 0.3 0.0 0.0 2.8 0.1 2.3 0.2 0.0 0.0 0.1 49.3 57.3 1.8 0.0 1.7 0.9 3.2 1.7 33.3 2.2 27.8 3.9 0.0 4.6 8.1 472.2 0.0 0.9 0.0 0.4 0.1 0.1 9.2 0.4 0.1 RHBDL1 "RHBDL, RRP" ENSG00000103269 "Rhomboid like 1" O75783 16 675666-678268 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.3" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 12.0;Cone photoreceptor cells: 11.8;Horizontal cells: 14.3;Rod photoreceptor cells: 35.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 3.4" "Group enriched" "Detected in many" 20 "B-cells: 2.2;NK-cells: 1.3;T-cells: 3.4" "Cell line enhanced" "Detected in many" "HeLa: 9.3;MCF7: 9.8;U-266/70: 11.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030359, HPA030360, HPA046593" Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA030359: AB_2673445, HPA030360: AB_2673446, HPA046593: AB_2679711" "prognostic favorable (8.12e-4)" "unprognostic (1.70e-1)" "unprognostic (7.38e-2)" "unprognostic (4.45e-1)" "unprognostic (2.07e-1)" "unprognostic (1.58e-2)" "unprognostic (3.27e-2)" "unprognostic (1.94e-1)" "unprognostic (2.78e-1)" "unprognostic (6.60e-3)" "unprognostic (2.74e-2)" "unprognostic (3.97e-2)" "unprognostic (5.63e-3)" "unprognostic (5.89e-2)" "unprognostic (1.27e-1)" "unprognostic (8.30e-3)" "unprognostic (1.49e-2)" 1.7 6.3 10.0 1.1 8.3 2.3 0.7 21.3 14.5 1.3 2.2 1.3 2.2 5.8 1.3 1.7 1.1 1.0 1.2 2.4 8.4 9.9 3.9 1.2 0.8 1.1 5.5 7.2 0.9 6.2 2.2 4.4 1.1 4.6 1.5 1.1 1.5 6.1 2.6 0.8 3.1 5.9 0.7 2.2 0.6 4.5 2.2 1.9 0.7 0.6 0.6 0.5 0.8 0.5 2.2 0.1 0.0 0.0 1.3 3.4 0.7 1.8 2.3 1.3 2.0 1.0 2.7 6.9 0.8 1.3 0.4 0.1 4.8 1.3 0.7 1.6 0.5 0.2 1.2 0.1 0.4 0.0 1.7 8.7 1.0 9.3 1.9 1.0 1.7 1.3 1.8 3.3 0.3 0.0 1.0 0.1 3.1 1.3 1.3 0.1 9.8 0.4 4.7 1.3 2.5 0.7 8.3 1.2 1.8 0.1 1.6 1.7 2.3 1.0 0.5 2.2 0.9 3.6 4.9 0.5 2.8 2.6 0.9 0.6 11.9 1.6 2.3 1.0 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.4 0.3 0.0 0.5 0.5 0.2 0.0 1.3 0.0 0.1 1.2 0.7 10.0 8.3 21.3 14.5 8.4 9.9 5.5 7.2 4.6 1.9 0.0 0.0 0.0 4.2 1.9 12.0 0.8 0.0 8.1 1.2 0.0 11.8 0.2 0.0 0.7 2.0 0.0 3.9 0.0 0.5 0.2 0.9 1.4 0.0 0.8 0.3 14.3 2.4 0.6 1.2 1.1 1.4 0.0 0.0 0.0 4.5 2.0 1.0 3.6 2.5 7.4 35.2 0.0 0.5 0.7 2.1 1.6 0.2 0.0 4.7 1.6 RHBG SLC42A2 ENSG00000132677 "Rh family B glycoprotein (gene/pseudogene)" Q9H310 1 156369212-156385219 "Predicted membrane proteins, Transporters" "Ammonia transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 23.2;kidney: 16.9;ovary: 5.9" "Cell type enhanced" "Detected in some" 15 "Collecting duct cells: 21.0;Distal tubular cells: 16.6;Early spermatids: 10.7;Late spermatids: 8.6" "Group enriched" "Detected in some" 5 "liver cancer: 14.2;renal cancer: 5.1;urothelial cancer: 4.1" "Region enriched" "Detected in some" 15 "cerebellum: 23.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 65 "CACO-2: 4.8;Hep G2: 5.7;RT4: 10.0" "Low region specificity" "Detected in all" "HPA042726, HPA048489" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA042726: AB_2678131, HPA048489: AB_2680417" "unprognostic (1.20e-1)" "unprognostic (2.05e-1)" "unprognostic (4.55e-3)" "unprognostic (5.04e-2)" "unprognostic (2.95e-2)" "unprognostic (3.76e-3)" "unprognostic (2.00e-1)" "unprognostic (1.19e-1)" "unprognostic (1.49e-1)" "unprognostic (2.45e-1)" "unprognostic (3.72e-1)" "unprognostic (3.63e-2)" "unprognostic (4.91e-2)" "unprognostic (1.51e-1)" "unprognostic (1.96e-1)" "unprognostic (1.91e-3)" "prognostic favorable (8.06e-4)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 23.2 0.1 0.3 0.3 0.0 1.0 0.0 0.1 0.0 2.2 0.0 0.0 0.1 0.1 0.1 16.9 3.3 0.1 0.0 0.1 0.1 5.9 0.2 0.0 0.1 0.0 1.5 0.1 0.0 0.0 0.1 0.4 0.1 1.0 0.3 0.0 0.1 0.1 0.1 1.2 0.0 0.0 0.1 1.1 1.2 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 23.2 0.1 0.1 0.1 0.1 0.1 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 21.0 0.0 0.0 16.6 0.3 10.7 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.0 4.3 0.1 0.0 0.0 0.0 0.0 8.6 0.3 0.0 0.0 1.0 0.0 1.1 0.1 0.0 0.4 0.9 0.0 0.0 0.0 2.2 0.4 0.4 0.0 0.0 0.0 0.0 RHCE "CD240CE, RH" ENSG00000188672 "Rh blood group CcEe antigens" P18577 1 25362249-25430192 "Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 40.5" "Cell type enriched" "Detected in some" 33 "Erythroid cells: 210.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.4" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.4" "Cell line enriched" "Detected in some" 5 "HEL: 44.7" "HPA060951, HPA077385" Supported Uncertain "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA060951: , HPA077385: " "unprognostic (1.37e-1)" "unprognostic (3.53e-1)" "unprognostic (2.38e-1)" "unprognostic (6.75e-2)" "unprognostic (1.41e-2)" "unprognostic (4.91e-2)" "unprognostic (7.01e-2)" "unprognostic (3.12e-2)" "unprognostic (3.81e-2)" "unprognostic (1.35e-1)" "unprognostic (6.08e-2)" "unprognostic (4.61e-2)" "unprognostic (5.77e-5)" "unprognostic (1.38e-1)" "unprognostic (3.94e-2)" "unprognostic (7.15e-3)" "unprognostic (1.63e-1)" 0.6 0.8 2.0 0.6 5.1 40.5 0.9 3.3 4.7 0.8 0.7 3.5 1.0 0.7 0.7 5.2 1.4 1.6 0.8 2.1 2.6 1.5 0.8 2.2 0.7 1.0 2.1 2.5 0.9 9.6 0.5 4.0 1.6 5.9 1.6 0.8 2.2 8.4 0.8 1.9 1.1 0.6 0.5 2.9 2.1 0.8 2.6 1.4 1.2 1.1 1.2 0.8 0.5 0.6 0.1 0.2 2.4 0.2 0.1 0.3 0.9 0.1 0.0 0.1 0.2 0.4 0.3 0.0 0.1 0.1 0.2 0.0 0.0 0.7 0.3 0.5 0.5 0.0 0.1 0.0 0.1 0.1 0.2 0.0 44.7 0.0 0.0 0.6 0.0 0.3 1.0 0.7 0.3 0.2 0.0 0.0 0.3 8.7 0.2 0.2 0.4 0.0 0.3 0.9 0.3 0.2 0.1 0.1 1.2 0.0 0.0 0.3 0.4 0.1 0.1 0.5 0.4 0.2 0.0 0.0 0.1 0.0 0.4 0.0 2.6 0.6 0.5 1.5 0.4 0.2 2.4 0.2 0.6 0.3 0.0 0.3 0.1 0.0 0.1 0.2 0.0 0.2 0.0 1.0 0.1 0.0 0.1 0.3 0.9 2.0 5.1 3.3 4.7 2.6 1.5 2.1 2.5 5.9 1.4 0.0 0.0 0.0 0.5 0.5 3.3 0.4 2.5 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.8 0.0 0.0 210.2 0.2 0.4 0.2 0.4 4.6 0.4 0.2 6.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.1 0.4 0.0 0.7 0.0 2.5 6.5 0.0 2.8 5.1 1.3 0.7 0.0 0.1 0.7 RHD "CD240D, DIIIc, RH, Rh30a, Rh4, RhII, RhPI" ENSG00000187010 "Rh blood group D antigen" Q02161 1 25272393-25330445 "Blood group antigen proteins, CD markers, Predicted membrane proteins, Transporters" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 10.0;bone marrow: 16.5;salivary gland: 7.1" "Cell type enriched" "Detected in some" 20 "Erythroid cells: 23.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 10.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 10.0" "Group enriched" "Detected in some" 6 "HEL: 28.2;K-562: 8.7" "HPA060951, HPA077385" Supported Uncertain "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA060951: , HPA077385: " "unprognostic (4.75e-3)" "unprognostic (7.70e-2)" "unprognostic (1.34e-1)" "unprognostic (1.38e-1)" "unprognostic (1.09e-2)" "unprognostic (4.84e-2)" "unprognostic (1.11e-2)" "unprognostic (5.25e-2)" "unprognostic (1.11e-2)" "unprognostic (1.91e-1)" "unprognostic (1.27e-2)" "unprognostic (1.89e-1)" "unprognostic (4.96e-3)" "unprognostic (1.93e-1)" "unprognostic (8.09e-2)" "unprognostic (5.53e-2)" "unprognostic (4.92e-3)" 0.3 0.3 0.3 0.5 0.5 16.5 0.3 1.5 1.4 0.6 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.3 0.4 0.9 0.3 0.2 0.3 0.3 2.5 0.8 0.3 0.3 0.9 0.3 0.1 0.4 0.3 1.1 0.5 0.0 0.3 7.1 0.3 4.1 2.5 0.4 0.3 0.4 1.8 0.3 0.5 0.3 0.3 0.4 2.3 0.3 0.3 0.3 2.0 0.6 10.0 1.4 1.4 1.4 1.2 0.1 0.0 0.2 0.2 0.1 0.0 0.4 0.1 0.1 0.1 0.0 0.1 0.3 0.4 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.1 28.2 0.7 0.2 0.0 0.3 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 8.7 0.7 0.0 0.1 0.2 0.2 3.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.5 0.3 0.1 0.2 0.1 0.1 0.2 0.5 0.4 0.5 0.2 0.4 0.1 0.3 0.1 0.1 0.5 0.2 0.1 4.9 1.4 2.8 1.0 0.6 1.1 1.3 1.3 0.8 0.2 2.0 1.4 1.3 10.0 1.4 0.8 0.6 0.9 1.2 0.3 0.5 1.5 1.4 0.3 0.2 0.3 0.3 1.1 0.3 0.0 0.3 0.0 0.1 0.1 0.2 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 23.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 RHEBL1 "FLJ25797, MGC34869, RHEB2" ENSG00000167550 "RHEB like 1" Q8TAI7 12 49064685-49070025 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 10.6;brain: 9.5" "Cell type enhanced" "Detected in many" 15 "Ciliated cells: 9.4;Erythroid cells: 23.3;monocytes: 7.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 3.1;granulocytes: 10.6;T-cells: 10.1" "Cell line enhanced" "Detected in many" "HDLM-2: 16.7;U-266/84: 33.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA053111, HPA061001" Uncertain Uncertain Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA053111: AB_2682047, HPA061001: AB_2684409" "unprognostic (2.94e-1)" "unprognostic (1.11e-3)" "unprognostic (2.36e-2)" "unprognostic (9.81e-3)" "unprognostic (8.76e-2)" "unprognostic (2.03e-2)" "unprognostic (3.03e-5)" "unprognostic (9.13e-2)" "unprognostic (9.02e-3)" "unprognostic (2.13e-1)" "unprognostic (3.98e-1)" "unprognostic (1.24e-1)" "unprognostic (1.13e-10)" "unprognostic (4.67e-2)" "unprognostic (1.11e-1)" "unprognostic (7.66e-2)" "unprognostic (2.07e-1)" 1.6 0.6 3.6 2.7 2.0 4.0 2.3 4.0 9.5 0.8 1.1 0.4 1.3 1.1 3.3 2.5 0.9 5.5 1.0 1.4 2.2 2.7 0.9 0.7 2.6 6.8 2.0 5.1 1.0 0.6 0.2 0.7 1.4 1.9 0.5 1.8 0.4 1.0 1.3 0.6 5.6 1.8 1.0 1.2 5.2 1.2 3.0 0.9 2.5 0.8 0.0 3.9 1.0 4.1 3.1 0.9 10.6 1.6 1.3 10.1 1.2 0.9 2.0 1.2 2.9 0.7 0.1 1.2 0.9 2.7 5.1 5.8 1.8 1.6 2.8 0.9 0.2 2.9 0.8 0.8 1.1 2.3 16.7 0.1 2.7 1.4 0.9 0.6 1.1 5.8 0.3 0.4 2.6 0.8 0.3 2.0 5.0 3.5 8.1 1.9 0.8 1.2 6.8 1.8 3.5 2.9 2.6 1.8 4.4 0.4 0.1 0.6 1.7 0.7 0.7 4.5 1.8 0.3 1.8 1.0 1.6 2.6 3.1 0.9 9.8 33.3 1.7 1.3 4.1 0.6 10.6 0.3 0.7 7.3 1.6 10.1 1.9 3.1 3.9 0.7 3.1 1.0 3.8 0.6 1.3 1.4 0.9 6.1 1.2 3.6 2.0 4.0 9.5 2.2 2.7 2.0 5.1 1.9 0.9 0.0 0.0 4.3 0.2 1.1 1.5 0.8 2.5 9.4 2.3 0.0 0.0 0.1 0.0 0.4 0.4 1.4 0.0 23.3 0.2 0.4 0.8 0.3 0.0 0.0 1.5 3.2 0.0 1.3 0.0 0.4 0.0 1.8 0.0 7.2 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.0 1.0 0.9 5.0 1.8 0.1 5.1 0.2 0.0 RHOBTB1 KIAA0740 ENSG00000072422 "Rho related BTB domain containing 1" O94844 10 60869438-61001440 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 50.9;skeletal muscle: 63.5" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 127.6;Horizontal cells: 316.2;Syncytiotrophoblasts: 252.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 1.6;NK-cell: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 34.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA040205, HPA040226" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040205: AB_2676883, HPA040226: AB_10795377" "unprognostic (1.25e-1)" "unprognostic (2.72e-2)" "unprognostic (6.69e-3)" "unprognostic (2.63e-2)" "unprognostic (1.08e-1)" "unprognostic (1.34e-1)" "unprognostic (3.22e-3)" "unprognostic (1.64e-1)" "unprognostic (2.25e-1)" "unprognostic (4.31e-1)" "unprognostic (1.39e-1)" "unprognostic (5.53e-2)" "unprognostic (8.54e-3)" "unprognostic (1.38e-1)" "unprognostic (1.79e-1)" "unprognostic (7.16e-2)" "unprognostic (2.57e-2)" 7.6 9.8 2.7 2.0 5.8 0.5 4.5 0.8 5.0 8.8 4.7 7.2 16.5 3.4 10.2 4.9 1.9 6.8 6.3 6.6 3.7 2.5 20.5 3.4 5.4 1.4 6.7 2.3 6.9 6.0 7.4 2.2 50.9 4.6 4.9 2.6 13.3 1.4 20.3 63.5 1.9 3.5 7.7 3.8 7.4 11.7 8.5 5.7 0.6 2.3 5.2 0.9 5.0 5.2 0.5 1.6 0.7 0.6 1.3 0.0 1.3 0.1 6.2 9.5 0.0 4.5 4.0 0.0 2.7 2.5 2.3 3.5 0.3 0.1 0.0 11.7 14.5 1.1 0.1 2.8 0.8 2.7 0.0 2.5 0.5 4.5 34.5 4.9 0.7 0.2 5.7 1.6 1.4 1.4 8.8 10.8 2.0 5.1 0.0 10.1 0.2 2.6 0.0 4.1 0.1 4.1 2.3 13.3 3.2 7.5 0.3 2.6 10.2 3.3 3.6 3.6 6.2 0.7 1.2 9.6 4.4 11.7 0.1 3.0 0.0 0.0 0.0 2.2 2.0 2.4 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.5 0.0 0.0 0.7 1.3 0.6 0.0 0.0 1.3 2.7 5.8 0.8 5.0 3.7 2.5 6.7 2.3 4.6 5.7 14.9 8.3 0.0 0.8 1.5 2.7 24.9 2.5 12.0 3.4 1.8 127.6 49.5 1.7 3.2 49.1 7.1 0.6 0.0 13.6 3.6 9.0 1.0 0.0 1.8 10.1 316.2 7.9 16.5 12.3 26.5 7.5 3.2 1.7 0.0 6.7 20.9 14.1 3.4 4.6 30.1 26.0 6.5 4.1 1.6 1.0 1.3 252.8 0.0 2.3 0.2 RHOF "ARHF, FLJ20247, RIF" ENSG00000139725 "Ras homolog family member F, filopodia associated" Q9HBH0 12 121777754-121803403 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Enterocytes: 150.8;monocytes: 394.1;Pancreatic endocrine cells: 113.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 37.5;HDLM-2: 52.6;PC-3: 36.9;RPTEC TERT1: 29.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045912, HPA076019" Enhanced Supported Approved "Nucleoplasm,Golgi apparatus" NA NA 58000 "Nucleoplasm, Golgi apparatus" "HPA045912: , HPA076019: AB_2732299" "unprognostic (1.26e-1)" "unprognostic (8.73e-2)" "unprognostic (2.05e-1)" "unprognostic (3.40e-2)" "unprognostic (1.90e-1)" "unprognostic (4.26e-5)" "unprognostic (1.38e-3)" "unprognostic (2.37e-4)" "unprognostic (1.34e-1)" "unprognostic (5.51e-2)" "unprognostic (1.10e-4)" "unprognostic (1.10e-1)" "unprognostic (5.01e-3)" "unprognostic (1.30e-1)" "unprognostic (2.02e-2)" "unprognostic (7.51e-4)" "unprognostic (1.14e-1)" 5.0 13.8 13.3 19.2 15.6 29.3 5.8 53.2 19.3 16.5 17.8 8.9 15.9 24.7 12.7 17.5 13.7 10.9 10.3 13.5 13.8 9.8 16.4 6.9 18.7 28.6 20.2 8.7 8.8 7.5 9.1 14.7 4.7 14.2 8.3 14.1 12.4 9.6 12.1 8.5 7.3 26.5 9.9 11.2 28.4 20.9 9.0 18.9 27.2 18.3 6.2 24.4 14.2 10.2 17.4 24.2 13.4 21.0 18.5 32.9 13.6 16.4 19.1 3.6 4.2 1.2 1.9 1.6 1.7 1.5 0.7 1.3 7.7 37.5 1.6 12.7 1.7 0.4 2.3 6.3 9.8 0.6 52.6 2.1 8.8 12.9 7.2 2.9 9.8 7.3 2.5 2.1 1.6 0.8 6.4 5.0 12.4 1.5 2.7 0.4 10.5 13.7 14.8 3.0 3.8 36.9 7.2 0.2 2.9 29.8 1.4 2.9 2.4 9.9 1.3 0.7 1.6 5.6 4.3 6.1 1.2 11.4 3.6 0.4 3.8 1.9 5.0 1.5 11.2 0.7 6.2 3.5 13.4 32.9 11.1 31.0 17.4 26.0 28.1 10.9 14.8 20.1 24.5 7.7 18.5 21.0 24.2 27.3 13.6 13.3 15.6 53.2 19.3 13.8 9.8 20.2 8.7 14.2 18.9 35.7 12.5 61.8 1.6 7.7 7.4 1.2 20.4 13.4 12.5 22.7 0.0 1.7 34.9 38.6 18.0 2.0 150.8 0.0 50.1 3.3 7.8 3.4 19.7 4.0 13.6 0.0 6.4 12.3 10.0 46.1 3.7 30.7 20.3 394.1 21.3 4.0 113.8 31.6 2.1 12.4 9.1 6.5 2.2 20.9 2.6 11.5 4.6 105.8 7.6 6.4 RHOJ "ARHJ, FLJ14445, RASL7B, TCL" ENSG00000126785 "Ras homolog family member J" Q9H4E5 14 63204114-63293219 "Predicted intracellular proteins" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 18 "Endothelial cells: 65.7;Ito cells: 34.4;Peritubular cells: 15.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 15.6;HUVEC TERT2: 90.5;TIME: 24.0;WM-115: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003050 Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA003050: AB_1079812" "unprognostic (7.24e-2)" "unprognostic (1.72e-1)" "unprognostic (4.37e-2)" "unprognostic (2.42e-1)" "unprognostic (6.71e-2)" "unprognostic (1.77e-2)" "unprognostic (2.89e-1)" "unprognostic (2.33e-2)" "unprognostic (2.19e-1)" "unprognostic (3.04e-3)" "unprognostic (1.42e-2)" "unprognostic (7.07e-2)" "prognostic unfavorable (1.31e-4)" "unprognostic (3.50e-3)" "unprognostic (4.84e-2)" "unprognostic (1.86e-2)" "unprognostic (1.06e-3)" 17.0 2.9 11.4 6.4 12.0 0.2 14.3 7.3 15.8 15.1 12.0 3.4 7.9 5.8 22.8 14.7 12.4 15.6 20.0 13.0 11.3 4.6 7.3 4.0 18.6 7.0 8.0 9.8 11.9 3.6 3.3 6.5 7.3 6.8 15.9 8.8 14.8 7.2 11.8 5.8 6.0 8.4 25.3 5.4 9.4 9.4 4.7 8.5 0.0 13.1 13.9 3.9 16.9 9.2 1.2 0.9 2.6 0.8 1.4 0.6 0.1 0.0 0.0 15.6 0.0 0.0 0.0 0.0 2.5 10.5 0.9 1.5 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 8.9 90.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.2 0.0 0.0 24.0 0.0 0.2 0.2 1.4 0.0 0.0 0.0 0.0 0.0 26.0 1.0 0.8 0.6 0.5 0.4 0.3 0.7 0.4 0.4 0.2 1.2 0.6 0.6 2.6 1.4 0.2 0.9 0.2 0.1 11.4 12.0 7.3 15.8 11.3 4.6 8.0 9.8 6.8 8.5 0.0 2.2 0.0 0.2 5.3 0.0 2.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.4 0.4 65.7 0.0 0.0 0.7 0.0 11.6 0.5 0.0 0.0 0.1 0.0 0.0 34.4 1.0 0.5 10.9 1.7 3.3 0.0 0.0 9.1 0.1 0.0 15.2 0.0 0.2 6.5 8.0 0.1 0.4 4.3 0.1 0.0 0.0 0.5 RHOXF1 "OTEX, PEPP1" ENSG00000101883 "Rhox homeobox family member 1" Q8NHV9 X 120109053-120115937 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 8.1;brain: 9.2;testis: 27.8" "Cell type enriched" "Detected in some" 39 "Spermatogonia: 154.2" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 9.2" "Cell type enriched" "Detected in some" 6 "T-reg: 8.1" "Lineage enriched" "Detected in single" 30 "T-cells: 8.1" "Cell line enhanced" "Detected in some" "HDLM-2: 3.2;HEK 293: 3.9;NB-4: 2.8" "HPA052560, HPA056506" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA052560: , HPA056506: AB_2683157" "unprognostic (5.03e-3)" "unprognostic (1.22e-2)" "unprognostic (5.22e-2)" "unprognostic (2.31e-2)" "unprognostic (8.65e-2)" "unprognostic (1.07e-3)" "unprognostic (2.46e-1)" "unprognostic (3.15e-1)" "unprognostic (3.89e-1)" "unprognostic (2.15e-1)" "unprognostic (7.50e-4)" "unprognostic (1.97e-1)" "unprognostic (5.85e-4)" "unprognostic (3.00e-1)" "unprognostic (7.96e-2)" "unprognostic (2.26e-1)" "unprognostic (1.73e-3)" 2.8 0.5 0.9 0.5 1.1 0.3 0.9 9.2 1.7 0.5 0.7 0.5 0.5 0.2 0.5 0.5 0.5 1.5 0.5 0.5 0.8 2.4 0.8 0.5 0.5 0.6 0.8 0.5 2.2 0.5 0.8 0.9 1.1 0.5 0.5 0.1 0.5 0.8 0.6 0.5 2.4 0.5 0.5 0.5 0.5 0.2 27.8 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.1 0.2 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.7 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 3.2 3.9 0.4 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.3 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.2 8.1 0.0 0.9 1.1 9.2 1.7 0.8 2.4 0.8 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.3 0.6 0.1 0.0 2.7 0.0 0.0 3.9 0.1 1.7 0.1 1.0 0.1 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.6 0.0 0.0 0.0 0.1 0.8 0.0 0.0 1.4 0.0 1.3 0.0 0.0 2.9 154.2 0.3 0.0 0.0 0.1 0.0 RHOXF2 "CT107, PEPP-2, PEPP2, THG1" ENSG00000131721 "Rhox homeobox family member 2" Q9BQY4 X 120158561-120165630 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 23.0" "Group enriched" "Detected in some" 60 "Spermatocytes: 5.2;Spermatogonia: 6.8" "Cancer enhanced" "Detected in single" "testis cancer: 0.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 10.1;K-562: 62.2;NB-4: 46.0;THP-1: 17.3;U-266/84: 27.6" "HPA003314, CAB020794" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB020794: , HPA003314: AB_1855193" "unprognostic (1.60e-1)" "unprognostic (5.04e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 1.0 0.5 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.2 0.0 0.0 0.0 0.0 46.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.2 0.0 0.0 0.0 0.0 0.0 27.6 0.0 0.0 0.0 0.0 1.0 0.3 0.4 0.4 0.4 0.4 0.2 0.3 0.2 0.2 0.3 0.3 0.4 0.7 1.1 0.5 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 6.8 0.0 0.0 0.0 0.0 0.0 RHOXF2B ENSG00000203989 "Rhox homeobox family member 2B" P0C7M4 X 120070672-120077705 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 2.6;testis: 9.4" "Cell type enriched" "Detected in single" 20 "Spermatogonia: 2.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 348 "HL-60: 47.1;K-562: 47.2;NB-4: 76.4" HPA003314 Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA003314: AB_1855193" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.2 0.0 9.4 0.0 0.0 0.0 0.0 1.0 1.6 2.6 1.3 1.7 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.2 0.0 0.0 0.0 0.0 76.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.7 0.8 0.5 0.9 1.0 0.7 0.5 0.7 0.7 1.0 0.7 0.7 1.4 1.7 1.3 1.6 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 RHPN1 "KIAA1929, ODF5, RHPN" ENSG00000158106 "Rhophilin Rho GTPase binding protein 1" Q8TCX5 8 143368887-143384220 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 22.7;Collecting duct cells: 36.6;Cone photoreceptor cells: 29.5;Rod photoreceptor cells: 23.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 6 "T-cells: 1.0" "Cell line enhanced" "Detected in many" "MCF7: 17.0;MOLT-4: 15.3;RPMI-8226: 11.3;T-47d: 27.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA024288, HPA024671" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA024288: AB_1856274, HPA024671: AB_1856275" "unprognostic (2.04e-1)" "unprognostic (3.71e-1)" "unprognostic (1.54e-2)" "unprognostic (2.20e-1)" "unprognostic (5.82e-2)" "unprognostic (6.38e-2)" "unprognostic (2.07e-3)" "unprognostic (3.12e-1)" "unprognostic (3.57e-1)" "unprognostic (1.02e-1)" "unprognostic (8.27e-3)" "unprognostic (1.23e-1)" "unprognostic (1.16e-2)" "unprognostic (1.24e-3)" "unprognostic (9.92e-2)" "unprognostic (1.43e-1)" "unprognostic (1.77e-2)" 3.3 3.2 17.9 3.6 11.9 5.9 4.0 2.5 14.3 5.7 2.6 10.8 6.2 1.2 1.1 6.2 1.9 8.0 3.7 1.3 19.4 9.7 9.7 0.9 4.0 4.0 9.0 9.4 0.8 7.8 10.3 14.8 1.4 10.9 3.2 1.3 2.0 6.6 7.2 0.8 5.3 1.9 1.7 8.3 5.6 5.2 2.7 14.1 15.4 14.9 0.5 2.5 2.4 1.2 0.0 0.1 0.0 0.0 0.0 1.0 0.0 1.7 3.0 0.7 2.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.4 1.2 0.1 6.1 0.0 0.1 0.7 0.0 0.0 0.0 0.3 2.7 0.0 1.9 0.1 0.2 0.1 1.9 0.0 0.5 0.0 0.0 0.5 0.6 7.2 0.6 3.7 0.0 17.0 15.3 1.5 1.1 3.5 8.3 4.2 0.0 11.3 2.8 2.8 4.5 1.7 0.9 5.1 1.0 0.0 27.7 0.0 0.0 0.0 3.2 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.3 0.3 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 11.9 2.5 12.7 19.4 9.7 9.0 9.4 10.9 14.1 6.0 6.9 0.8 2.4 2.3 2.5 0.8 5.1 22.7 4.5 36.6 29.5 1.3 10.0 8.7 4.3 3.6 0.0 0.0 2.4 0.2 1.1 3.3 0.0 0.8 2.8 6.4 21.8 2.5 2.2 7.2 0.3 1.1 6.8 1.8 2.3 11.4 3.3 0.0 1.4 12.9 23.5 0.0 0.7 6.0 7.3 1.3 1.6 3.2 3.0 2.6 RIF1 "FLJ10599, FLJ12870" ENSG00000080345 "Replication timing regulatory factor 1" Q5UIP0 2 151409883-151508013 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036887, HPA036888" Supported Uncertain "Nucleoplasm,Nuclear bodies,Plasma membrane" No No "Nucleoplasm, Nuclear bodies, Plasma membrane" "HPA036887: AB_2675361, HPA036888: AB_2675362" "unprognostic (1.09e-1)" "unprognostic (2.20e-1)" "unprognostic (2.71e-1)" "unprognostic (4.71e-3)" "unprognostic (5.87e-2)" "unprognostic (1.79e-2)" "unprognostic (3.73e-2)" "unprognostic (1.86e-1)" "unprognostic (2.51e-2)" "unprognostic (2.84e-2)" "unprognostic (1.80e-3)" "unprognostic (4.07e-2)" "unprognostic (1.63e-2)" "unprognostic (1.65e-1)" "unprognostic (2.22e-1)" "unprognostic (1.57e-2)" "unprognostic (8.41e-2)" 13.7 9.0 12.1 11.7 18.2 31.1 16.6 23.6 17.1 12.7 10.9 12.4 8.7 7.2 15.5 7.3 10.2 11.5 9.8 8.5 11.7 8.5 9.8 11.2 10.9 13.0 15.7 11.6 19.4 12.1 16.3 17.3 13.4 13.6 10.8 10.6 9.6 12.0 9.3 18.3 13.9 10.4 13.5 11.6 10.2 10.1 17.8 15.9 18.4 15.5 9.4 12.9 11.6 11.9 6.2 2.6 7.9 4.7 10.7 7.8 2.3 9.9 8.5 13.3 10.1 5.5 7.0 12.8 12.1 9.0 11.0 13.2 13.9 8.2 19.1 11.0 8.5 9.1 10.4 20.4 8.6 18.7 13.4 9.7 30.4 10.4 9.9 5.8 30.5 10.2 5.3 5.6 19.7 15.0 6.1 10.6 11.8 24.5 16.2 11.2 6.7 18.0 10.6 21.3 5.3 11.6 18.5 21.1 12.5 5.7 12.4 12.1 9.3 15.8 7.3 8.2 9.8 6.4 11.1 13.2 16.7 11.7 10.1 12.8 8.0 13.9 27.9 7.6 12.3 11.0 7.9 3.6 4.3 6.8 2.5 7.8 6.2 5.8 4.9 2.6 5.2 7.7 5.9 4.2 10.7 4.7 2.4 4.0 2.3 12.1 18.2 23.6 17.1 11.7 8.5 15.7 11.6 13.6 15.9 89.3 38.8 22.7 37.6 43.8 43.2 30.5 30.6 22.7 51.2 14.0 29.5 33.1 1.7 31.1 9.9 38.7 14.2 0.0 18.7 32.2 38.4 39.1 32.4 17.1 19.6 44.5 24.0 27.6 27.0 9.9 40.6 34.9 28.7 29.7 28.7 37.8 25.0 23.5 32.2 9.5 42.4 84.1 40.1 87.8 126.0 36.4 34.2 27.4 28.4 37.2 RIIAD1 "C1orf230, FLJ36032, NCRNA00166" ENSG00000178796 "Regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1" A6NNX1 1 151710433-151729805 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 43.4;pituitary gland: 29.2" "Cell type enhanced" "Detected in many" 15 "Ciliated cells: 113.8;Early spermatids: 62.9;Intestinal endocrine cells: 44.4;Late spermatids: 46.5" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "CACO-2: 6.6;SCLC-21H: 3.6;SH-SY5Y: 7.1;SK-BR-3: 11.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045703 Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA045703: AB_10965795" "unprognostic (8.28e-3)" "unprognostic (3.42e-1)" "unprognostic (8.21e-2)" "prognostic favorable (5.46e-4)" "unprognostic (1.06e-2)" "unprognostic (3.09e-1)" "unprognostic (8.99e-2)" "unprognostic (3.20e-3)" "unprognostic (3.95e-1)" "unprognostic (1.41e-2)" "unprognostic (3.65e-3)" "unprognostic (8.50e-2)" "unprognostic (1.57e-3)" "unprognostic (2.79e-2)" "unprognostic (3.06e-2)" "unprognostic (2.48e-4)" 0.5 2.7 4.0 0.5 9.3 0.5 1.1 0.5 5.6 1.6 1.1 0.8 1.2 0.6 2.1 6.1 0.7 43.4 0.9 0.5 4.6 5.1 0.6 0.5 3.1 0.5 2.5 5.2 2.6 1.2 1.1 29.2 0.5 3.6 1.0 1.3 1.2 0.5 1.9 0.5 0.6 0.8 1.1 0.5 0.5 2.0 14.7 2.1 0.0 0.5 0.0 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.6 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.6 7.1 0.0 11.2 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 9.3 0.5 5.6 4.6 5.1 2.5 5.2 3.6 2.1 17.9 1.0 0.0 0.0 0.0 6.7 14.0 0.0 113.8 15.9 5.2 15.7 0.0 3.3 3.1 62.9 0.0 0.0 0.0 0.7 0.0 0.4 0.1 0.0 0.0 0.1 0.0 44.4 0.0 0.0 46.5 0.6 0.3 3.3 0.0 2.0 0.8 0.2 0.0 1.4 2.2 2.7 0.0 1.0 14.9 7.8 0.0 0.0 0.0 0.8 0.0 RILPL1 FLJ39378 ENSG00000188026 "Rab interacting lysosomal protein like 1" Q5EBL4 12 123470054-123533718 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "brain: 21.1;heart muscle: 43.8;skeletal muscle: 66.2" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 35.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041314 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA041314: AB_10795587" "unprognostic (2.21e-1)" "unprognostic (1.26e-1)" "unprognostic (3.71e-2)" "unprognostic (5.36e-2)" "unprognostic (3.12e-2)" "unprognostic (2.99e-3)" "unprognostic (1.94e-2)" "unprognostic (1.61e-1)" "unprognostic (2.65e-1)" "unprognostic (1.75e-1)" "unprognostic (2.30e-2)" "unprognostic (8.30e-2)" "unprognostic (4.25e-2)" "unprognostic (2.98e-1)" "unprognostic (2.32e-1)" "unprognostic (6.07e-3)" "unprognostic (2.81e-1)" 6.1 5.7 9.9 3.5 12.3 3.0 3.7 5.2 11.3 4.8 4.7 12.6 4.4 2.1 6.6 5.0 4.8 5.0 4.3 43.8 9.6 7.5 3.8 3.0 5.5 2.3 21.1 5.8 7.2 3.2 5.7 3.6 7.1 11.1 6.2 2.2 4.9 8.0 7.8 66.2 6.2 2.7 9.8 14.4 3.8 3.0 2.9 15.1 0.3 8.2 9.7 1.9 4.7 5.3 1.6 1.2 4.6 1.2 1.2 2.0 0.7 5.9 8.4 7.6 5.9 8.6 8.1 8.0 10.8 6.1 5.9 5.3 5.2 1.4 0.3 5.4 10.5 4.3 6.5 5.6 5.2 2.4 6.1 10.3 0.8 5.4 7.6 15.1 0.3 2.3 9.2 10.3 6.6 9.6 14.8 6.0 1.1 4.7 0.4 5.9 9.9 0.6 1.9 5.6 1.7 8.9 1.0 4.2 0.3 4.2 6.3 1.2 7.1 5.8 5.1 12.9 4.4 6.7 0.2 11.8 7.8 3.9 11.2 6.8 1.3 0.6 0.2 8.0 0.1 4.8 1.4 1.0 0.7 0.9 0.5 0.8 0.9 1.0 0.8 0.3 1.6 2.0 1.6 4.6 1.2 1.2 1.2 0.9 0.7 9.9 12.3 5.2 9.9 9.6 7.5 21.1 5.8 11.1 15.1 35.7 13.2 0.0 4.3 4.0 13.4 9.2 5.1 5.3 11.4 10.4 5.9 7.9 1.7 1.8 1.3 4.6 0.0 0.0 1.8 5.2 5.6 3.2 1.1 1.3 4.4 22.3 0.0 10.4 1.3 0.9 14.4 1.0 5.0 1.0 1.0 20.0 2.1 0.0 7.8 1.8 6.2 6.5 6.1 0.9 2.3 3.3 7.8 1.3 0.5 2.6 RIMBP2 "KIAA0318, MGC15831, PPP1R133, RBP2, RIM-BP2" ENSG00000060709 "RIMS binding protein 2" O15034 12 130396137-130716281 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.7;parathyroid gland: 49.1;pituitary gland: 42.7" "Cell type enhanced" "Detected in some" 23 "Bipolar cells: 19.7;Cone photoreceptor cells: 29.5;Intestinal endocrine cells: 72.5;Rod photoreceptor cells: 13.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "naive B-cell: 2.7" "Lineage enriched" "Detected in single" 28 "B-cells: 2.7" "Group enriched" "Detected in some" 6 "SCLC-21H: 17.6;SH-SY5Y: 34.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041494, HPA044114" Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA041494: , HPA044114: AB_2678815" "unprognostic (4.15e-4)" "unprognostic (9.77e-3)" "unprognostic (1.20e-1)" "unprognostic (6.45e-2)" "unprognostic (1.91e-3)" "unprognostic (3.63e-1)" "unprognostic (1.32e-2)" "unprognostic (1.76e-1)" "unprognostic (1.47e-1)" "unprognostic (6.82e-3)" "prognostic favorable (4.16e-4)" "unprognostic (2.86e-1)" "unprognostic (6.41e-3)" "unprognostic (5.27e-2)" "unprognostic (2.07e-1)" "unprognostic (1.03e-1)" "unprognostic (4.73e-2)" 0.9 11.9 14.1 1.1 13.0 0.6 0.6 1.1 24.7 6.1 1.5 1.6 0.0 2.5 2.5 2.4 0.8 6.6 1.1 0.4 15.3 11.0 2.8 0.6 0.7 0.5 5.6 12.9 2.1 2.3 49.1 42.7 0.4 4.9 1.3 1.8 4.1 0.6 1.4 0.5 2.4 2.3 2.3 5.6 1.1 5.2 2.3 1.6 0.0 0.9 0.0 0.5 0.8 0.7 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 3.3 0.0 0.0 0.0 0.2 4.2 0.0 0.0 17.6 34.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 13.0 1.1 24.7 15.3 11.0 5.6 12.9 4.9 1.6 0.0 0.0 0.0 0.0 1.8 19.7 0.8 0.0 1.4 0.0 0.0 29.5 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 9.5 72.5 0.0 0.0 1.7 0.9 0.0 0.0 0.0 1.2 3.1 0.1 0.0 0.7 0.0 13.7 0.0 0.0 1.1 1.2 0.5 0.0 0.0 0.6 0.0 RIMKLB "FAM80B, KIAA1238, NAAGS, NAAGS-I" ENSG00000166532 "Ribosomal modification protein rimK like family member B" Q9ULI2 12 8681600-8783095 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 171.4;Late spermatids: 230.6;Syncytiotrophoblasts: 114.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SuSa: 31.2;U-698: 52.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059552 Approved "Nucleoplasm,Centriolar satellite" NA NA "Nucleoplasm, Centriolar satellite" "HPA059552: " "unprognostic (5.29e-3)" "unprognostic (2.26e-2)" "unprognostic (1.89e-5)" "unprognostic (2.40e-2)" "unprognostic (2.30e-1)" "unprognostic (3.35e-2)" "unprognostic (6.56e-2)" "unprognostic (8.52e-2)" "unprognostic (8.67e-3)" "unprognostic (1.76e-1)" "unprognostic (3.25e-1)" "unprognostic (2.15e-1)" "unprognostic (2.01e-1)" "unprognostic (2.16e-2)" "unprognostic (3.02e-1)" "unprognostic (3.74e-1)" "unprognostic (3.99e-1)" 22.5 10.7 15.9 10.7 19.2 15.8 20.1 23.3 21.2 18.1 17.6 16.4 11.2 5.1 35.9 18.2 10.4 25.4 12.5 10.7 17.6 12.8 9.2 3.2 13.9 7.6 10.2 19.0 22.7 7.3 36.2 10.1 21.2 19.9 11.7 6.5 18.0 9.0 13.5 9.5 8.8 8.7 25.5 14.0 11.5 7.7 27.8 12.1 13.6 15.6 4.8 6.4 11.8 18.4 4.0 1.3 5.3 2.9 2.8 3.9 2.5 1.2 7.1 16.5 17.5 2.2 2.0 23.5 6.9 3.3 5.8 4.0 0.6 7.5 10.3 6.5 4.5 6.5 2.6 8.3 9.2 6.5 0.1 5.1 4.8 20.1 0.0 2.6 1.4 4.9 4.3 4.1 5.5 9.6 4.0 7.5 8.7 6.6 0.0 3.6 4.3 9.5 0.6 19.4 0.0 0.4 14.9 22.5 0.0 8.9 3.6 0.5 10.8 7.6 9.8 6.7 31.2 2.1 4.7 14.1 6.1 20.4 3.2 2.2 0.1 0.0 52.5 5.3 0.9 4.2 5.3 2.9 1.2 2.4 1.1 3.0 2.2 2.4 3.5 1.2 4.0 3.9 1.5 0.7 2.8 1.4 1.3 0.1 2.5 15.9 19.2 23.3 19.5 17.6 12.8 10.2 19.0 19.9 12.1 26.8 40.5 5.0 21.6 13.5 20.8 13.7 10.2 41.5 35.2 12.2 0.0 49.9 13.3 12.1 171.4 30.3 2.0 23.3 2.6 14.1 23.7 15.5 11.5 0.0 16.2 12.7 8.6 20.3 7.5 230.6 21.6 7.7 32.1 1.0 2.5 35.5 5.6 2.9 29.0 7.9 3.1 12.9 22.8 49.1 26.8 11.7 114.2 5.1 1.0 15.0 RIMS3 "NIM3, RIM3" ENSG00000117016 "Regulating synaptic membrane exocytosis 3" Q9UJD0 1 40620679-40665657 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 47.7" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 10.7;Late spermatids: 23.5;Muller glia cells: 12.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "MAIT T-cell: 1.8;plasmacytoid DC: 4.6" "Group enriched" "Detected in many" 9 "dendritic cells: 4.6;T-cells: 1.8" "Cell line enhanced" "Detected in many" "Daudi: 37.3;JURKAT: 13.2;SH-SY5Y: 17.7;U-87 MG: 16.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055285 Approved Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" Nucleoplasm "HPA055285: AB_2682771" "unprognostic (3.51e-3)" "unprognostic (7.18e-3)" "unprognostic (4.44e-3)" "unprognostic (1.44e-4)" "unprognostic (3.70e-1)" "unprognostic (2.88e-2)" "unprognostic (1.44e-5)" "unprognostic (2.41e-1)" "unprognostic (1.53e-1)" "unprognostic (2.87e-1)" "unprognostic (2.54e-1)" "unprognostic (7.93e-2)" "unprognostic (1.09e-1)" "unprognostic (2.19e-1)" "unprognostic (3.25e-2)" "unprognostic (3.11e-2)" "unprognostic (2.19e-2)" 1.3 7.2 13.6 2.2 19.2 3.7 3.1 21.5 47.7 1.4 3.4 3.4 0.0 1.1 3.0 2.2 2.9 2.1 1.3 1.5 7.8 17.4 1.4 0.7 3.1 2.0 7.4 22.3 2.5 1.1 4.0 0.5 3.8 4.9 3.2 3.8 2.0 2.0 4.1 0.6 2.7 1.7 4.8 3.4 1.7 2.5 3.1 4.4 0.7 2.8 0.0 2.8 1.7 1.0 0.1 4.6 0.1 0.3 0.1 1.8 0.1 1.9 0.7 2.9 3.1 0.1 0.0 0.4 0.0 0.0 0.5 0.6 0.3 0.6 37.3 0.0 0.0 1.4 0.3 1.9 0.3 0.3 6.4 0.9 2.1 0.2 1.0 0.1 0.3 1.7 0.0 1.5 0.1 0.1 0.1 0.1 13.2 1.8 1.4 0.0 3.4 5.5 0.2 1.8 0.3 0.2 2.5 2.6 6.9 0.5 0.5 10.0 17.7 0.4 1.8 1.2 4.0 0.4 10.4 0.0 0.3 3.0 0.0 0.5 0.3 2.7 8.2 16.3 0.6 0.3 0.1 0.0 0.0 0.1 0.0 1.8 0.0 0.5 0.2 0.2 0.1 0.0 0.2 0.0 0.1 0.3 4.6 0.4 0.1 13.6 19.2 21.5 47.7 7.8 17.4 7.4 22.3 4.9 4.4 6.0 0.0 0.0 0.2 0.5 6.3 1.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.7 10.7 0.1 1.7 0.0 1.3 0.1 0.3 0.4 1.1 0.0 2.4 4.8 0.0 0.0 2.1 23.5 0.0 1.1 0.0 1.0 1.9 12.8 2.3 0.8 0.7 0.3 0.6 0.0 2.2 3.3 1.1 0.1 0.2 0.0 0.6 0.1 RIMS4 "C20orf190, dJ781B1.3" ENSG00000101098 "Regulating synaptic membrane exocytosis 4" Q9H426 20 44751808-44810338 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.8;testis: 14.6" "Cell type enhanced" "Detected in some" 19 "Horizontal cells: 36.5;Peritubular cells: 12.4;Sertoli cells: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 13.1;MCF7: 8.8;SCLC-21H: 27.1;SH-SY5Y: 13.9;SiHa: 9.4;U-2 OS: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060928 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA060928: AB_2684387" "unprognostic (1.54e-1)" "unprognostic (1.98e-1)" "unprognostic (1.64e-1)" "unprognostic (9.46e-2)" "unprognostic (2.97e-1)" "unprognostic (1.90e-2)" "unprognostic (4.63e-3)" "unprognostic (4.86e-2)" "unprognostic (1.48e-1)" "unprognostic (4.21e-3)" "unprognostic (1.70e-1)" "unprognostic (8.60e-3)" "unprognostic (3.37e-2)" "unprognostic (1.28e-1)" "unprognostic (7.66e-3)" "unprognostic (2.94e-2)" 1.0 2.1 13.8 0.8 23.3 0.4 1.2 9.6 23.8 11.8 1.2 0.2 0.0 0.6 3.2 2.2 1.3 11.9 1.4 0.6 14.1 7.5 0.6 0.5 1.7 0.6 4.9 8.8 9.5 0.6 0.5 6.0 0.6 4.1 3.2 1.2 1.0 2.0 1.8 1.8 0.5 0.7 4.3 1.3 0.5 2.3 14.6 2.6 0.0 7.5 0.9 1.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.1 0.0 1.3 0.0 13.1 0.1 0.0 0.0 5.5 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 8.8 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 27.1 13.9 9.4 0.0 0.1 0.4 4.1 0.4 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 23.3 9.6 19.0 14.1 7.5 4.9 8.8 4.1 2.6 0.0 0.0 0.0 0.0 0.2 2.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 36.5 1.7 0.0 0.0 2.4 6.6 0.0 0.0 0.0 0.7 0.8 0.1 0.0 12.4 0.0 0.7 25.8 0.0 0.7 4.1 0.1 0.0 0.0 0.0 0.0 RIN1 ENSG00000174791 "Ras and Rab interactor 1" Q13671 11 66330242-66336840 "Predicted intracellular proteins, RAS pathway related proteins" Endocytosis "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 31.5" "Cell type enhanced" "Detected in many" 4 "Suprabasal keratinocytes: 13.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 9.7;non-classical monocyte: 19.1" "Lineage enriched" "Detected in many" 6 "monocytes: 19.1" "Cell line enhanced" "Detected in many" "hTCEpi: 26.7;PC-3: 20.1;U-2197: 29.3" "Group enriched" "Detected in many" 6 "amygdala: 37.2;basal ganglia: 37.4;cerebral cortex: 29.2;hippocampal formation: 35.3;olfactory region: 16.6" "Group enriched" "Detected in many" 6 "amygdala: 9.1;basal ganglia: 17.1;cerebral cortex: 8.2;hippocampal formation: 12.4;olfactory region: 9.1" HPA035491 Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "HPA035491: AB_10601608" "unprognostic (1.25e-2)" "unprognostic (1.04e-1)" "unprognostic (4.69e-2)" "prognostic favorable (2.21e-4)" "unprognostic (1.11e-2)" "unprognostic (2.57e-1)" "unprognostic (6.82e-3)" "unprognostic (3.84e-2)" "unprognostic (1.11e-2)" "unprognostic (2.52e-3)" "unprognostic (8.32e-2)" "unprognostic (2.99e-1)" "prognostic unfavorable (9.34e-7)" "unprognostic (2.42e-2)" "unprognostic (1.14e-1)" "unprognostic (7.82e-3)" "unprognostic (2.46e-1)" 4.9 5.1 11.1 7.1 22.7 3.9 3.4 13.0 13.5 5.9 5.2 1.5 2.4 8.0 4.2 2.3 15.8 5.8 8.7 3.3 9.7 2.3 2.3 2.7 3.8 5.4 1.4 5.8 4.8 6.6 1.5 5.0 4.5 2.2 4.7 3.6 2.5 4.8 3.5 10.3 31.5 5.8 2.8 0.8 4.6 11.1 2.8 2.5 0.0 1.5 8.7 8.6 3.4 7.0 0.1 3.3 0.0 19.1 0.0 1.5 2.0 1.6 4.5 1.3 2.8 1.6 8.8 1.0 10.1 9.2 7.8 3.8 2.8 5.1 0.3 5.1 7.3 3.2 10.7 0.0 13.6 1.0 0.5 0.0 0.4 4.3 2.4 3.0 0.1 4.7 8.5 26.7 7.9 4.7 9.7 1.6 0.3 0.2 0.1 3.4 0.3 0.1 11.5 0.6 2.1 20.1 0.1 3.9 0.0 2.3 1.7 10.0 2.7 2.6 1.3 13.8 0.4 0.9 0.8 4.4 12.5 7.4 29.3 2.5 0.2 0.5 0.0 17.4 2.7 5.0 0.0 4.3 0.0 0.2 9.7 1.5 0.1 1.0 0.3 3.3 0.0 1.1 0.5 0.0 0.0 19.1 0.0 0.1 2.0 11.1 22.7 13.0 13.5 9.7 2.3 1.4 5.8 2.2 2.5 0.0 0.3 0.0 7.8 11.8 3.3 0.8 2.5 1.4 1.2 0.0 0.0 0.6 0.0 2.4 0.3 2.9 8.6 0.0 6.1 4.3 5.1 1.9 4.6 0.0 4.3 0.0 2.9 4.9 9.5 1.0 4.0 4.2 1.7 1.0 5.2 0.5 6.7 7.0 1.8 0.0 0.9 0.0 1.4 1.6 0.9 13.2 0.2 1.3 6.6 6.3 RING1 RNF1 ENSG00000204227 "Ring finger protein 1" Q06587 6 33208495-33212722 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008701 Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA008701: AB_1079814" "unprognostic (2.12e-3)" "unprognostic (7.98e-2)" "unprognostic (3.77e-2)" "unprognostic (1.37e-1)" "unprognostic (3.91e-2)" "unprognostic (3.21e-1)" "unprognostic (1.53e-1)" "unprognostic (4.75e-2)" "unprognostic (7.76e-2)" "unprognostic (1.26e-2)" "unprognostic (3.70e-2)" "unprognostic (1.62e-2)" "unprognostic (2.22e-1)" "unprognostic (1.04e-1)" "unprognostic (1.55e-1)" "unprognostic (2.13e-1)" "unprognostic (9.88e-2)" 26.7 22.6 17.8 15.9 21.3 12.0 14.6 27.6 24.2 22.2 17.6 22.0 21.0 18.2 31.9 17.3 14.5 18.8 21.4 14.4 17.3 18.2 19.3 21.6 16.8 14.5 24.0 15.4 25.0 18.3 24.0 34.0 14.9 17.0 21.8 7.6 20.0 19.0 20.5 18.0 21.7 19.5 22.9 18.5 23.2 24.1 16.9 20.8 25.5 29.3 13.1 14.3 13.9 17.1 1.2 2.2 0.8 1.5 0.2 2.2 0.2 4.2 3.6 4.2 4.1 4.3 1.4 9.8 11.2 6.8 4.6 4.7 3.8 3.2 7.0 4.7 4.5 5.8 7.7 3.6 3.4 3.2 8.6 2.9 8.4 5.9 7.2 9.7 4.8 6.9 0.0 3.4 4.1 7.6 3.6 1.7 3.8 12.1 5.4 4.8 0.0 0.3 3.7 1.9 3.1 4.6 4.5 7.0 7.7 5.0 3.7 8.4 5.2 4.0 4.3 11.6 1.1 5.0 8.4 2.3 5.1 3.8 0.0 9.2 6.1 6.2 6.7 3.8 4.4 3.1 0.0 1.5 0.8 2.2 0.4 0.4 1.1 0.7 1.0 0.7 1.2 1.7 0.9 0.3 0.2 0.5 2.2 0.4 0.2 17.8 21.3 27.6 24.2 17.3 18.2 24.0 15.4 17.0 20.8 0.0 22.7 20.1 35.5 24.5 30.5 21.4 17.8 17.4 14.8 21.0 15.7 36.0 13.3 28.6 21.1 23.2 23.3 0.0 30.3 27.6 28.0 27.3 19.6 30.5 26.3 23.8 29.4 30.7 29.6 13.2 37.2 20.0 16.9 20.8 19.8 38.3 26.5 21.0 28.0 26.9 18.0 25.8 22.7 32.9 18.8 26.7 52.7 25.4 21.0 24.7 RINL FLJ45909 ENSG00000187994 "Ras and Rab interactor like" Q6ZS11 19 38867834-38878279 "Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "T-cells: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 17.3;Karpas-707: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA042083, HPA042103" Uncertain Approved Nucleoplasm,Vesicles No No "Nucleoplasm, Vesicles" "HPA042083: AB_10793977, HPA042103: AB_10797380" "unprognostic (1.30e-1)" "prognostic favorable (6.49e-5)" "unprognostic (7.38e-2)" "unprognostic (1.75e-2)" "unprognostic (6.05e-2)" "prognostic favorable (1.64e-4)" "unprognostic (2.61e-2)" "unprognostic (3.64e-2)" "unprognostic (4.87e-2)" "unprognostic (5.95e-2)" "unprognostic (1.85e-1)" "unprognostic (7.90e-2)" "unprognostic (3.18e-1)" "unprognostic (1.75e-1)" "unprognostic (1.89e-1)" "unprognostic (3.17e-2)" "unprognostic (6.40e-3)" 5.5 3.7 6.3 10.2 10.3 5.4 10.4 6.5 5.8 2.6 3.9 4.2 6.2 3.4 1.8 2.4 5.3 4.6 6.1 3.9 5.1 6.4 5.0 6.0 7.0 20.4 5.5 3.8 1.7 17.4 4.9 5.7 3.3 5.5 2.6 3.5 5.9 7.9 4.5 3.0 3.2 6.3 2.6 4.5 13.0 6.1 1.4 3.5 7.6 6.4 3.1 15.7 4.3 2.9 16.6 12.3 3.1 2.1 4.1 8.7 2.9 0.0 1.4 0.4 0.2 0.6 0.3 2.6 0.3 0.2 0.3 0.4 2.3 7.0 7.9 3.7 0.4 0.1 0.2 1.3 3.0 0.4 1.7 0.8 9.8 2.0 5.0 1.7 5.5 17.3 1.6 0.6 0.9 0.6 0.3 3.5 6.1 2.0 20.3 0.0 1.2 1.7 3.9 0.6 4.1 0.3 1.1 0.1 5.9 1.9 0.2 2.6 1.1 3.2 5.2 2.8 0.4 0.6 6.7 2.2 0.1 1.5 0.4 0.0 8.7 7.2 6.2 0.6 3.1 0.4 3.1 0.9 1.5 8.7 2.1 5.5 12.4 5.8 6.3 1.6 16.6 4.6 5.4 2.8 4.1 2.0 12.3 6.1 2.9 6.3 10.3 6.5 5.8 5.1 6.4 5.5 3.8 5.5 3.5 3.0 7.7 15.2 4.6 2.9 3.2 3.0 12.7 1.4 1.2 3.5 7.9 11.3 6.6 5.6 0.4 6.8 0.0 0.0 6.2 5.5 3.8 2.2 15.0 5.4 7.9 0.0 6.9 8.6 5.9 0.4 2.8 5.0 10.1 10.8 0.3 4.8 4.8 1.7 2.5 8.1 10.5 0.0 1.9 2.9 1.8 3.3 3.4 24.5 1.0 3.0 RIOX2 "FLJ14393, JMJD10, mdig, MINA, MINA53, NO52" ENSG00000170854 "Ribosomal oxygenase 2" Q8IUF8 3 97941818-97972457 "Predicted intracellular proteins" "Ribosome biogenesis, Transcription, Transcription regulation" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 25.4;Cytotrophoblasts: 30.5;Distal tubular cells: 41.4;Extravillous trophoblasts: 36.7;Syncytiotrophoblasts: 26.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007603, HPA008080, CAB013458" Supported Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "CAB013458: AB_2533432, HPA007603: AB_1853957, HPA008080: AB_1853960" "prognostic unfavorable (4.41e-4)" "unprognostic (8.64e-2)" "unprognostic (1.59e-3)" "unprognostic (2.11e-2)" "unprognostic (1.26e-1)" "unprognostic (2.53e-3)" "unprognostic (1.64e-3)" "unprognostic (8.68e-2)" "unprognostic (9.68e-2)" "unprognostic (5.34e-2)" "unprognostic (1.56e-3)" "unprognostic (6.95e-2)" "unprognostic (1.35e-2)" "unprognostic (1.23e-1)" "unprognostic (1.49e-1)" "unprognostic (3.44e-3)" "unprognostic (1.76e-1)" 13.9 9.6 12.7 13.6 16.7 2.2 14.1 8.1 11.1 9.8 11.0 12.2 14.5 8.1 10.7 11.3 20.4 11.3 12.1 8.2 10.9 12.6 13.1 14.2 9.1 13.1 13.9 11.9 14.2 22.5 13.8 15.0 27.1 14.1 11.2 13.9 10.2 20.3 11.3 27.1 14.9 8.3 11.2 14.7 12.1 10.5 6.6 11.2 6.3 48.4 12.8 15.6 14.7 12.5 13.1 21.8 1.6 11.1 8.2 13.6 9.1 20.3 12.3 4.4 9.5 10.3 15.9 11.6 10.0 7.6 11.8 9.7 8.3 10.8 27.3 11.5 11.3 16.0 11.9 13.9 14.2 18.5 51.7 6.4 8.6 5.4 9.9 16.8 17.6 4.1 12.1 19.2 9.0 22.1 5.8 11.9 12.3 11.9 12.2 11.9 6.0 13.9 5.7 9.5 22.4 16.4 0.0 14.8 27.3 11.9 12.0 23.5 8.5 10.7 14.8 16.6 5.1 13.1 7.3 9.6 11.8 13.0 6.4 20.6 18.0 9.3 27.5 13.9 17.6 12.7 1.6 10.9 0.6 8.7 9.4 13.3 13.1 13.6 10.6 13.4 10.3 13.2 10.8 0.7 8.2 11.1 21.8 12.0 9.1 12.7 16.7 8.1 11.1 10.9 12.6 13.9 11.9 14.1 11.2 8.9 10.2 0.0 0.0 0.0 0.0 0.0 0.0 25.4 19.4 7.0 0.0 30.5 41.4 14.2 0.0 0.0 0.0 0.0 11.5 36.7 0.0 0.0 2.3 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 12.6 0.0 0.0 10.2 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 0.0 RIPOR3 "C20orf175, C20orf176, dJ530I15.2, dJ530I15.3, FAM65C" ENSG00000042062 "RIPOR family member 3" Q96MK2 20 50586108-50691528 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 3.0;Collecting duct cells: 3.5;monocytes: 3.6;Proximal tubular cells: 2.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 19.9;ASC TERT1: 9.3;HEL: 29.1;HSkMC: 18.3;K-562: 16.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA051823, HPA054759" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA051823: AB_2681626, HPA054759: AB_2682596" "unprognostic (7.23e-2)" "unprognostic (4.17e-2)" "unprognostic (1.23e-2)" "unprognostic (1.41e-1)" "unprognostic (1.38e-2)" "prognostic favorable (1.66e-5)" "unprognostic (4.96e-4)" "unprognostic (1.32e-1)" "unprognostic (2.66e-2)" "unprognostic (2.18e-1)" "unprognostic (2.88e-2)" "unprognostic (1.13e-1)" "unprognostic (1.10e-3)" "unprognostic (1.98e-1)" "unprognostic (9.21e-3)" "unprognostic (1.67e-2)" "unprognostic (4.58e-2)" 18.9 11.8 4.6 4.2 8.1 22.8 8.1 3.0 5.3 18.6 6.4 2.9 2.4 3.3 14.1 5.7 5.8 13.5 4.3 5.7 4.3 1.1 15.1 7.7 2.9 9.1 5.1 0.9 5.1 2.1 1.5 5.5 2.7 5.2 5.4 2.2 6.3 4.3 1.1 11.7 3.0 5.8 5.8 3.8 4.2 3.2 6.4 6.3 2.7 4.2 2.5 2.6 6.6 24.6 1.1 0.7 1.9 0.3 0.1 1.1 1.0 0.0 0.0 0.5 0.0 19.9 9.3 0.0 0.0 6.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 29.1 0.0 0.1 2.3 0.0 0.0 18.3 0.0 0.5 0.0 0.0 0.0 0.0 16.9 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 1.7 0.0 0.0 2.8 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.1 1.4 0.1 1.9 1.1 0.3 0.0 1.1 0.8 0.4 0.1 0.8 0.8 0.4 1.1 0.1 0.2 0.7 0.3 1.0 4.6 8.1 3.0 5.3 4.3 1.1 5.1 0.9 5.2 6.3 3.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 3.5 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 RITA1 "C12orf52, FLJ14827, RITA" ENSG00000139405 "RBPJ interacting and tubulin associated 1" Q96K30 12 113185526-113192368 "Predicted intracellular proteins" "Neurogenesis, Notch signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039094, HPA039095, HPA061531" Supported Supported Nucleoplasm No No Nucleoplasm "HPA039094: AB_10671037, HPA039095: AB_2676345, HPA061531: AB_2684554" "unprognostic (7.10e-2)" "unprognostic (4.26e-2)" "unprognostic (2.78e-2)" "unprognostic (3.55e-2)" "unprognostic (2.56e-2)" "unprognostic (6.98e-2)" "prognostic unfavorable (9.79e-4)" "unprognostic (3.47e-2)" "unprognostic (2.92e-2)" "unprognostic (1.77e-1)" "unprognostic (1.30e-2)" "unprognostic (2.02e-1)" "unprognostic (1.98e-1)" "unprognostic (2.59e-3)" "unprognostic (1.44e-1)" "unprognostic (2.93e-1)" "unprognostic (2.01e-1)" 6.7 20.7 14.4 7.9 17.6 7.4 7.7 16.6 29.7 8.4 10.7 7.8 3.4 14.7 7.2 8.2 11.3 16.4 8.3 12.3 13.4 12.9 14.1 24.1 7.5 11.5 11.8 15.0 10.5 9.6 7.3 10.6 5.9 13.2 9.2 7.1 10.5 14.8 10.5 31.4 9.3 15.3 5.6 5.7 8.7 8.0 6.6 7.3 13.0 12.3 12.0 11.1 7.6 6.4 7.8 14.2 24.6 8.9 12.8 10.2 8.0 12.4 16.2 4.2 11.1 5.6 4.3 7.7 8.2 16.8 12.0 9.6 19.1 6.1 23.9 12.8 6.8 10.4 9.6 9.5 10.5 7.1 14.4 13.8 8.1 8.0 12.1 9.3 10.8 6.8 6.7 9.6 11.8 6.7 16.7 9.8 11.8 15.6 4.4 7.1 17.8 12.0 29.3 14.1 10.6 20.5 10.8 4.5 20.1 9.7 17.8 14.1 8.2 10.4 21.7 17.5 5.4 18.2 16.5 6.4 7.7 10.9 8.8 11.5 15.5 12.9 25.7 11.5 9.0 10.7 24.6 8.9 5.7 10.1 4.2 10.2 7.3 9.0 9.1 10.2 7.8 9.0 9.7 0.2 12.8 4.9 14.2 9.5 8.0 14.4 17.6 16.6 29.7 13.4 12.9 11.8 15.0 13.2 7.3 0.0 9.9 15.9 6.3 5.7 8.2 5.6 15.3 13.4 5.7 14.0 3.9 15.5 41.4 14.9 8.7 8.2 21.2 0.0 14.3 13.7 6.6 7.5 0.0 27.7 12.4 14.3 10.9 6.2 7.8 21.2 9.2 2.5 5.0 3.6 14.5 9.5 12.9 12.5 7.8 38.6 5.2 6.5 7.2 3.8 6.7 5.6 8.5 11.4 10.5 6.7 RLBP1 CRALBP ENSG00000140522 "Retinaldehyde binding protein 1" P12271 15 89209869-89221751 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Transport, Vision" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "retina: 164.1" "Cell type enriched" "Detected in some" 43 "Muller glia cells: 2424.2" "Group enriched" "Detected in some" 30 "glioma: 3.7;melanoma: 7.4" "Group enriched" "Detected in many" 4 "amygdala: 6.9;basal ganglia: 10.6;cerebral cortex: 7.0;hippocampal formation: 3.7" "Group enriched" "Detected in some" 7 "basophil: 3.3;neutrophil: 1.9" "Lineage enriched" "Detected in single" 9 "granulocytes: 3.3" "Cell line enriched" "Detected in single" 48 "SK-MEL-30: 21.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042051, HPA044083" Enhanced Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA Cytosol "Nucleoplasm, Centrosome" "HPA042051: AB_2732495, HPA044083: AB_2678802" "unprognostic (3.19e-2)" "unprognostic (2.66e-1)" "unprognostic (1.86e-1)" "unprognostic (1.25e-1)" "unprognostic (8.68e-2)" "unprognostic (1.76e-1)" "unprognostic (8.24e-3)" "unprognostic (5.21e-2)" "unprognostic (3.17e-1)" "unprognostic (2.63e-2)" "unprognostic (1.76e-1)" "unprognostic (2.78e-1)" "unprognostic (1.13e-1)" "unprognostic (8.42e-2)" 0.2 0.7 6.9 0.6 10.6 0.6 0.2 0.6 11.5 0.2 0.8 0.3 0.1 0.9 0.2 1.0 0.3 0.2 0.3 0.2 3.7 1.3 0.2 0.2 0.3 0.3 1.6 0.6 0.2 0.2 0.2 1.7 0.3 0.4 0.2 0.8 164.1 0.2 0.2 0.5 0.3 0.6 0.5 0.5 0.3 0.2 1.1 0.1 0.1 0.2 0.1 0.2 0.2 0.1 0.0 0.0 3.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 6.9 10.6 0.6 7.0 3.7 1.3 1.6 0.6 0.4 0.1 0.0 0.0 0.0 0.0 0.0 17.2 0.3 0.0 0.0 0.0 0.0 37.3 3.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 2424.2 0.0 0.0 0.0 0.0 56.9 0.0 0.0 0.1 0.0 0.0 16.7 0.0 0.0 0.0 RLF "Zn-15L, ZNF292L" ENSG00000117000 "Rearranged L-myc fusion" Q13129 1 40161373-40240921 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054653, HPA057300" Uncertain Approved Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA054653: AB_2682557, HPA057300: AB_2683404" "unprognostic (1.71e-1)" "unprognostic (2.24e-2)" "unprognostic (6.46e-2)" "unprognostic (1.88e-2)" "unprognostic (6.78e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (1.75e-4)" "unprognostic (5.84e-2)" "unprognostic (3.43e-2)" "unprognostic (2.18e-2)" "unprognostic (2.60e-2)" "unprognostic (9.38e-2)" "prognostic unfavorable (7.68e-6)" "unprognostic (1.86e-1)" "unprognostic (2.59e-1)" "unprognostic (1.12e-1)" "unprognostic (4.69e-2)" 14.8 8.1 12.6 11.3 12.6 44.5 13.9 20.8 17.1 12.4 11.1 11.6 7.1 8.6 14.1 8.6 12.4 9.9 11.2 12.3 11.0 8.3 8.7 12.7 12.8 11.8 12.8 11.8 14.6 9.4 12.5 15.1 11.9 15.4 13.2 9.2 10.2 9.4 9.9 13.4 17.7 9.9 14.3 14.1 10.1 9.3 15.9 11.8 14.9 10.0 8.4 13.5 18.1 14.8 4.1 3.5 10.1 4.1 4.1 4.9 2.4 12.4 4.8 9.5 9.9 8.5 6.9 11.3 4.7 7.0 8.1 10.8 9.7 6.6 12.4 6.2 6.0 6.1 11.8 11.9 8.2 14.8 5.8 8.1 10.2 5.9 5.9 6.7 8.4 6.2 6.8 8.7 8.6 9.8 9.7 5.5 6.9 15.5 7.7 7.4 3.9 7.1 5.1 12.6 4.6 5.6 5.6 15.6 7.2 5.2 12.6 6.8 9.5 8.7 11.7 8.3 15.4 5.5 30.8 4.7 9.6 10.2 7.8 8.7 7.0 6.6 11.7 8.3 7.9 5.9 10.1 2.8 5.5 3.7 3.9 4.9 4.1 3.7 3.8 3.5 4.1 4.8 4.0 6.3 4.1 4.1 1.6 3.3 2.4 12.6 12.6 20.8 17.1 11.0 8.3 12.8 11.8 15.4 11.8 29.8 10.8 22.4 42.2 58.3 17.2 13.4 5.1 30.8 30.7 3.5 15.7 6.9 5.0 10.9 32.9 23.3 8.4 0.0 5.9 8.0 34.2 25.7 26.5 8.3 8.5 25.4 19.4 16.0 13.9 4.9 8.3 16.8 16.9 10.0 7.8 17.0 9.3 14.0 7.4 5.7 15.8 12.9 27.8 26.5 20.0 53.3 14.4 14.1 6.7 27.2 RLIM "MGC15161, NY-REN-43, RNF12" ENSG00000131263 "Ring finger protein, LIM domain interacting" Q9NVW2 X 74585217-74614617 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018895 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA018895: AB_1856323" "unprognostic (1.17e-2)" "unprognostic (1.08e-1)" "unprognostic (1.72e-1)" "unprognostic (1.31e-3)" "unprognostic (1.25e-1)" "unprognostic (1.03e-1)" "unprognostic (8.98e-3)" "unprognostic (1.36e-1)" "unprognostic (1.03e-1)" "unprognostic (2.06e-1)" "unprognostic (1.12e-1)" "unprognostic (4.91e-2)" "unprognostic (2.25e-1)" "unprognostic (3.82e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (6.04e-4)" "unprognostic (1.20e-1)" 11.8 14.3 17.5 10.6 25.6 37.4 12.4 12.6 20.5 12.2 7.4 8.3 5.6 6.4 10.6 8.0 10.2 9.5 10.7 10.5 17.1 16.6 11.6 9.7 13.8 9.2 12.4 13.7 12.4 9.7 19.5 18.5 10.5 28.6 11.9 7.6 5.2 8.9 8.7 11.2 10.2 7.1 10.1 13.9 9.8 8.4 6.9 12.4 9.7 13.0 6.2 10.1 10.5 9.3 3.5 4.8 16.3 7.4 5.2 4.6 3.0 13.7 14.0 13.6 11.3 13.7 14.5 13.4 13.2 15.4 11.9 14.7 10.9 14.4 7.4 15.5 16.6 16.1 11.9 27.3 15.9 18.2 6.7 14.4 13.0 24.7 6.6 12.2 19.5 23.2 14.0 10.0 16.9 29.1 10.2 13.8 12.4 11.2 13.5 15.6 10.5 14.5 11.1 20.9 8.5 13.5 13.9 28.8 12.5 11.0 16.5 10.0 11.7 24.9 12.1 15.4 13.0 6.8 15.4 18.3 14.4 14.0 14.7 11.5 7.2 13.8 11.9 15.7 19.9 14.0 16.3 5.9 5.6 3.2 7.4 3.3 3.0 4.1 4.0 4.8 3.5 4.5 4.1 11.4 5.2 5.4 2.6 4.6 3.0 17.5 25.6 12.6 20.5 17.1 16.6 12.4 13.7 28.6 12.4 14.9 17.1 2.9 24.0 31.8 12.3 26.3 15.3 24.1 20.5 24.4 13.7 14.1 10.0 12.7 5.5 27.4 7.8 0.0 9.2 17.5 26.4 21.1 36.9 11.9 16.0 20.6 22.2 20.3 20.2 3.3 9.2 23.6 16.9 3.6 9.8 13.7 11.6 8.6 17.7 9.6 13.8 6.5 17.6 7.2 17.2 33.9 22.0 17.0 10.2 31.0 RMC1 "C18orf8, HsT2591, MIC1, WDR98" ENSG00000141452 "Regulator of MON1-CCZ1" Q96DM3 18 23503470-23531807 "Cancer-related genes, Predicted intracellular proteins" Autophagy "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 13.6;monocytes: 15.4;Proximal tubular cells: 14.5;Syncytiotrophoblasts: 16.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043589 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA043589: AB_2678568" "unprognostic (6.45e-2)" "unprognostic (6.43e-3)" "unprognostic (2.38e-2)" "unprognostic (1.78e-1)" "unprognostic (5.51e-3)" "unprognostic (8.16e-2)" "prognostic unfavorable (3.94e-4)" "unprognostic (4.26e-2)" "unprognostic (3.77e-1)" "unprognostic (1.73e-2)" "unprognostic (2.37e-1)" "unprognostic (1.27e-1)" "unprognostic (3.03e-1)" "unprognostic (3.76e-1)" "unprognostic (1.25e-1)" "unprognostic (3.04e-2)" "unprognostic (4.13e-2)" 16.6 14.3 11.6 13.9 13.2 30.1 25.2 15.8 20.5 13.2 17.1 13.1 11.8 20.3 16.4 12.4 15.0 14.4 13.3 12.7 16.6 10.7 20.9 23.8 19.5 24.1 15.4 12.0 14.1 17.3 14.6 23.5 17.5 13.4 13.2 14.1 16.2 16.3 14.2 17.2 16.3 23.1 13.6 14.0 21.9 18.9 26.2 11.6 19.7 13.3 11.0 22.9 16.3 14.8 20.0 27.1 24.1 25.4 19.7 18.0 10.2 8.4 8.7 6.5 11.3 14.9 10.7 8.7 13.3 14.2 17.9 21.4 7.9 5.2 12.7 11.2 11.4 26.0 16.7 16.9 7.5 15.9 13.1 9.6 6.4 6.2 7.9 19.5 16.8 22.9 9.6 11.8 22.1 12.7 10.3 10.5 11.1 10.0 13.7 11.9 10.9 14.0 7.7 3.5 12.1 13.4 11.3 9.8 12.5 9.4 8.2 8.8 11.9 17.2 8.7 10.9 9.4 6.7 10.5 10.1 15.3 4.1 6.1 11.4 21.9 16.5 14.6 15.8 11.5 11.5 24.1 9.9 21.5 15.5 18.4 16.0 19.9 13.8 14.9 12.1 20.0 9.4 11.4 9.6 19.7 25.4 27.1 18.0 10.2 11.6 13.2 15.8 20.5 16.6 10.7 15.4 12.0 13.4 11.6 8.9 13.6 0.0 0.0 0.0 0.0 0.0 0.0 2.7 6.8 7.0 0.0 8.9 5.0 10.1 0.0 0.0 0.0 0.0 10.7 6.5 0.0 0.0 3.5 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 15.4 0.0 0.0 10.2 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 RMI1 "BLAP75, C9orf76, FLJ12888" ENSG00000178966 "RecQ mediated genome instability 1" Q9H9A7 9 83980711-84004074 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 35.7" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 51.0;Late spermatids: 50.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021661 Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA021661: " "unprognostic (9.59e-2)" "unprognostic (7.96e-2)" "unprognostic (6.72e-3)" "unprognostic (3.03e-2)" "unprognostic (1.47e-1)" "unprognostic (2.90e-2)" "prognostic unfavorable (8.71e-4)" "unprognostic (2.65e-1)" "unprognostic (3.39e-3)" "unprognostic (1.32e-1)" "unprognostic (5.55e-2)" "unprognostic (2.26e-1)" "unprognostic (1.53e-1)" "unprognostic (3.68e-3)" "unprognostic (3.42e-1)" "unprognostic (2.42e-1)" "unprognostic (9.24e-2)" 9.3 9.9 6.2 16.6 7.5 3.9 5.1 13.1 6.1 5.7 7.6 2.9 5.9 7.6 4.1 6.3 7.7 7.5 3.5 3.8 5.3 8.5 5.5 6.3 7.0 13.2 7.4 3.5 5.4 10.0 9.1 7.5 11.0 9.6 6.6 9.1 3.9 7.7 6.3 6.4 5.4 10.5 4.0 8.1 21.0 7.1 11.7 4.8 35.7 7.3 6.3 11.4 5.6 4.5 4.3 9.8 14.4 8.1 5.1 3.9 3.7 14.0 9.6 20.3 7.0 3.1 4.9 19.1 14.0 8.0 12.9 11.8 4.6 9.5 29.7 5.1 6.9 12.9 20.4 13.5 6.7 15.0 17.0 3.4 12.5 7.8 5.8 4.5 23.0 12.9 4.3 4.4 10.2 7.6 4.0 6.1 17.0 9.3 15.3 13.4 9.9 28.6 8.0 17.4 17.2 9.2 26.5 19.9 11.0 5.9 6.0 17.4 10.7 13.1 10.0 5.4 9.3 10.7 10.2 4.3 13.3 8.7 13.1 11.1 6.6 13.9 11.3 8.5 10.0 14.4 14.4 6.1 11.2 2.8 7.3 3.3 4.3 3.3 2.9 9.8 4.0 3.2 3.7 10.6 5.1 8.1 2.8 3.9 3.7 6.2 7.5 13.1 6.1 5.3 8.5 7.4 3.5 9.6 4.8 8.9 6.1 6.4 2.9 2.4 2.3 7.3 0.0 12.0 12.5 1.8 3.9 5.4 5.0 4.7 51.0 3.8 6.3 23.3 2.6 12.5 2.3 4.8 4.6 11.5 6.8 9.5 6.4 7.4 10.5 50.5 2.0 5.4 11.8 1.8 9.6 8.5 2.4 5.5 2.1 4.1 3.7 0.0 1.0 32.3 22.7 4.3 3.5 2.2 7.6 2.2 RMND5A "FLJ13910, GID2, GID2A, p44CTLH, RMD5" ENSG00000153561 "Required for meiotic nuclear division 5 homolog A" Q9H871 2 86720173-86778041 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046795, HPA060843" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA046795: AB_10963573, HPA060843: AB_2684378" "unprognostic (4.54e-2)" "unprognostic (9.23e-2)" "unprognostic (3.45e-2)" "prognostic unfavorable (3.03e-4)" "unprognostic (2.32e-2)" "unprognostic (4.40e-2)" "unprognostic (1.52e-1)" "unprognostic (1.37e-1)" "unprognostic (3.00e-2)" "unprognostic (1.49e-2)" "unprognostic (1.04e-2)" "unprognostic (2.36e-1)" "unprognostic (1.29e-2)" "unprognostic (8.34e-3)" "unprognostic (1.41e-1)" "unprognostic (1.47e-1)" "unprognostic (1.56e-1)" 9.8 7.0 11.1 6.5 11.7 15.6 10.1 47.3 19.2 9.0 11.8 8.4 6.8 9.7 11.3 8.4 19.7 8.1 8.9 23.1 12.5 8.5 11.2 25.6 6.9 12.6 9.3 10.0 9.0 9.9 15.8 7.6 9.6 7.0 8.4 13.1 10.3 12.0 7.1 34.2 13.4 9.0 12.0 11.2 8.0 7.2 5.5 5.5 24.1 7.9 10.6 8.1 9.2 12.0 4.6 6.4 20.7 8.7 6.0 8.8 5.1 8.1 4.4 7.8 4.6 10.4 4.6 16.1 3.2 2.7 4.3 4.9 16.1 8.8 28.5 10.0 2.9 5.0 9.8 19.7 6.8 6.7 8.2 15.1 25.1 9.7 14.5 10.5 18.2 8.3 7.0 13.6 4.5 15.8 4.9 7.4 21.2 15.8 16.4 3.4 5.3 16.7 15.6 13.2 9.8 5.7 20.1 24.1 17.9 8.9 9.8 14.5 11.2 7.3 14.8 11.8 11.5 7.4 15.8 7.1 3.0 5.8 5.4 5.0 7.4 7.7 19.6 2.5 22.1 3.4 20.7 8.7 5.4 6.0 6.8 7.1 3.2 4.6 6.7 6.4 4.6 6.4 8.8 19.0 6.0 7.9 5.1 3.1 5.1 11.1 11.7 47.3 19.2 12.5 8.5 9.3 10.0 7.0 5.5 11.9 12.8 15.0 18.5 37.3 19.8 71.8 17.8 18.7 6.8 10.4 5.9 17.5 19.9 11.7 8.4 19.2 33.8 70.0 12.3 16.0 17.9 26.5 8.1 55.5 13.7 22.3 37.9 19.0 33.6 4.7 17.8 17.1 30.4 8.2 48.6 14.1 19.1 31.7 16.3 23.8 15.2 6.5 18.6 16.6 26.7 47.9 20.6 18.5 24.4 21.7 RMND5B "FLJ22318, GID2, GID2B" ENSG00000145916 "Required for meiotic nuclear division 5 homolog B" Q96G75 5 178130996-178150565 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 11 "Early spermatids: 149.7;Late spermatids: 317.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 56.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047778 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047778: AB_2680153" "unprognostic (2.08e-1)" "unprognostic (6.83e-2)" "unprognostic (2.58e-1)" "unprognostic (1.35e-2)" "unprognostic (4.38e-2)" "unprognostic (9.81e-3)" "unprognostic (2.64e-3)" "unprognostic (1.18e-1)" "unprognostic (1.32e-1)" "unprognostic (2.48e-1)" "prognostic favorable (7.66e-4)" "unprognostic (1.60e-1)" "prognostic favorable (7.22e-8)" "unprognostic (1.77e-2)" "unprognostic (1.41e-1)" "unprognostic (6.43e-2)" "unprognostic (5.78e-2)" 12.2 12.6 11.6 7.3 13.7 7.7 9.7 10.4 18.8 11.4 11.8 16.2 9.1 9.0 16.2 11.8 36.7 12.8 12.5 17.2 11.4 9.0 11.3 13.1 11.5 11.1 14.5 16.7 11.8 16.9 12.8 15.7 11.3 13.0 12.2 8.2 16.1 15.8 11.9 23.4 18.0 11.7 18.7 9.1 10.5 12.0 42.0 9.2 11.2 14.3 13.0 18.2 11.5 14.0 13.2 8.5 22.4 13.8 2.2 12.8 7.2 6.4 10.9 7.5 18.1 9.7 1.0 22.4 5.4 6.1 7.9 9.5 12.8 9.6 14.1 10.8 4.0 9.1 9.0 7.4 11.3 3.1 39.5 9.9 14.4 13.0 6.7 10.3 6.9 5.4 2.0 9.1 5.5 9.4 4.9 8.2 4.9 12.0 10.0 2.6 56.9 5.0 4.2 9.6 8.6 6.8 6.2 5.4 9.7 7.3 10.5 7.7 10.8 7.2 24.8 12.6 6.4 17.3 10.0 5.6 4.8 7.1 4.4 6.7 14.5 13.4 11.6 6.0 7.0 6.5 9.2 9.7 22.4 4.2 11.2 1.8 11.1 8.5 4.8 5.7 13.2 12.8 7.6 6.8 2.2 13.8 8.5 12.5 7.2 11.6 13.7 10.4 18.8 11.4 9.0 14.5 16.7 13.0 9.2 11.9 5.8 15.6 17.3 8.5 46.1 20.9 20.4 4.0 5.7 29.6 49.1 27.9 19.9 17.7 149.7 10.6 18.7 46.7 16.6 24.1 15.3 18.0 4.7 11.9 18.8 46.1 8.6 14.7 10.7 317.0 26.7 11.0 6.8 24.4 13.7 29.1 16.2 13.6 23.7 16.5 53.1 12.9 14.2 79.2 34.1 11.7 37.2 10.0 16.2 17.6 RNASE1 "RAC1, RNS1" ENSG00000129538 "Ribonuclease A family member 1, pancreatic" P07998 14 20801228-20803278 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Endonuclease, Hydrolase, Lyase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "pancreas: 809.6" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 863.6;Alveolar cells type 2: 748.9;Hofbauer cells: 1257.5;Ito cells: 532.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 8.0;myeloid DC: 16.1" "Group enriched" "Detected in many" 9 "dendritic cells: 16.1;monocytes: 8.0" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 74.4;OE19: 16.9;RT4: 29.1;TIME: 38.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001140 Enhanced Approved Nucleoplasm,Vesicles "Secreted to digestive system" NA NA 1500000000 Vesicles Nucleoplasm "HPA001140: AB_1079816" "unprognostic (2.32e-2)" "unprognostic (3.16e-2)" "unprognostic (9.51e-3)" "unprognostic (7.77e-2)" "unprognostic (6.93e-2)" "unprognostic (1.28e-1)" "unprognostic (3.42e-3)" "unprognostic (6.59e-3)" "unprognostic (4.69e-2)" "unprognostic (7.92e-2)" "unprognostic (6.32e-2)" "unprognostic (3.56e-2)" "unprognostic (5.14e-3)" "unprognostic (1.11e-2)" "unprognostic (1.47e-1)" "unprognostic (2.43e-2)" "unprognostic (1.67e-1)" 79.2 48.4 28.7 12.0 38.5 1.6 59.7 4.0 32.2 21.3 33.7 57.8 63.6 16.8 13.6 49.1 19.3 24.3 37.5 70.3 41.2 21.6 33.8 8.6 94.3 23.5 39.0 16.0 19.2 809.6 6.7 4.1 79.0 25.1 23.0 39.8 106.4 15.9 35.6 31.7 10.8 20.6 26.6 52.3 34.5 87.9 86.5 27.1 7.8 11.2 14.3 7.2 29.0 10.9 0.0 16.1 1.3 8.0 0.0 0.0 2.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.5 0.1 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 74.4 0.0 7.2 0.1 0.0 0.0 0.0 0.5 0.3 16.9 0.0 0.0 0.0 0.3 0.0 29.1 0.3 0.3 0.0 0.2 0.0 0.5 0.0 0.0 38.7 0.0 0.7 0.5 0.0 0.1 0.0 0.0 1.0 0.0 1.0 1.3 8.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.0 2.0 28.7 38.5 4.0 32.2 41.2 21.6 39.0 16.0 25.1 27.1 863.6 748.9 16.1 0.9 31.6 0.0 58.9 40.8 58.9 295.7 15.7 0.0 12.0 0.0 8.2 17.6 308.3 107.7 0.0 270.1 10.2 30.9 1.4 23.3 4.9 1257.5 1.6 46.9 532.2 311.7 43.1 29.7 100.6 38.8 4.6 398.3 0.8 308.4 78.7 10.3 0.3 1.8 97.0 15.6 7.0 5.3 24.6 21.6 7.5 165.1 1.7 RNASEH1 ENSG00000171865 "Ribonuclease H1" O60930 2 3544793-3558616 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Disease mutation, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA034817, HPA043037" Uncertain Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA034817: , HPA043037: AB_2678280" "unprognostic (1.64e-1)" "unprognostic (1.38e-1)" "unprognostic (8.81e-3)" "unprognostic (4.32e-3)" "unprognostic (1.79e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (7.83e-6)" "unprognostic (9.43e-2)" "unprognostic (8.46e-3)" "unprognostic (6.38e-2)" "unprognostic (2.29e-3)" "unprognostic (2.67e-1)" "unprognostic (4.06e-2)" "unprognostic (2.34e-2)" "unprognostic (2.11e-1)" "unprognostic (3.06e-2)" "unprognostic (2.23e-3)" 16.6 12.8 10.1 14.5 15.4 14.7 16.1 11.0 13.1 9.7 12.1 11.4 10.8 11.8 13.3 14.0 14.1 10.0 11.0 18.5 13.1 10.3 10.9 17.0 11.2 18.3 12.9 11.4 10.1 15.1 10.5 10.8 11.5 12.3 11.2 12.6 9.5 11.2 16.0 35.3 11.3 11.3 17.7 11.9 12.4 11.8 13.8 12.5 10.9 10.1 10.3 14.5 12.8 11.8 16.6 15.9 7.4 12.8 17.2 14.6 10.8 8.8 20.6 7.1 12.1 7.5 7.8 15.9 14.5 12.6 12.4 10.0 15.7 10.7 17.0 15.7 13.0 17.8 9.7 11.9 11.8 9.9 12.7 7.8 14.7 12.2 26.3 14.2 19.1 13.9 6.9 9.9 13.4 15.8 5.4 10.9 27.2 20.0 17.0 12.7 17.5 11.3 10.7 13.8 17.7 15.4 13.8 11.7 17.8 7.5 15.6 12.0 15.7 12.3 8.6 12.1 6.9 7.3 7.3 11.2 16.4 11.2 13.0 20.1 25.2 34.1 28.4 15.3 14.4 21.4 2.8 11.5 7.4 14.5 12.8 14.6 16.6 12.7 13.6 14.2 13.8 12.9 12.5 3.2 17.2 11.1 15.9 11.2 10.8 10.1 15.4 11.0 13.1 13.1 10.3 12.9 11.4 12.3 12.5 20.8 5.8 33.5 22.9 6.6 24.6 21.5 10.2 13.4 6.8 3.5 19.6 27.2 31.5 32.0 2.8 17.3 13.6 0.0 42.6 35.7 17.7 24.8 27.6 15.3 27.4 33.4 14.5 14.1 16.4 2.3 12.7 15.4 10.1 37.9 11.2 16.4 36.8 7.0 24.8 20.1 17.0 19.4 19.0 18.4 29.0 10.7 30.6 16.0 14.7 29.8 RNASEH2A "AGS4, RNASEHI, RNHIA, RNHL" ENSG00000104889 "Ribonuclease H2 subunit A" O75792 19 12806556-12815201 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Aicardi-Goutieres syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 44.8" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 97.8;Spermatocytes: 51.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042692 Enhanced Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA042692: AB_10793981" "unprognostic (6.74e-2)" "prognostic favorable (1.18e-4)" "prognostic favorable (6.18e-4)" "unprognostic (2.24e-1)" "unprognostic (2.62e-1)" "unprognostic (5.13e-2)" "prognostic unfavorable (8.72e-5)" "unprognostic (8.48e-2)" "unprognostic (9.33e-2)" "prognostic favorable (1.22e-4)" "unprognostic (3.80e-3)" "unprognostic (8.71e-2)" "prognostic unfavorable (6.29e-6)" "unprognostic (3.40e-3)" "unprognostic (4.35e-2)" "unprognostic (5.35e-2)" "unprognostic (8.60e-2)" 6.5 5.5 6.4 11.4 10.6 21.9 6.6 11.0 7.5 6.8 6.6 9.2 1.6 8.6 6.8 4.4 14.1 6.0 5.7 5.1 6.7 4.8 8.7 5.9 5.5 9.2 10.6 5.8 7.3 7.0 6.2 4.1 11.8 6.1 5.3 5.7 5.5 8.8 4.3 7.1 13.4 7.1 4.4 7.8 12.0 7.4 14.1 8.4 44.8 8.6 13.4 17.4 6.0 8.0 11.3 7.8 7.1 6.8 12.9 8.6 5.0 14.9 11.3 6.8 6.8 1.0 1.9 8.4 7.0 2.9 10.5 12.1 8.9 5.7 16.0 10.5 1.6 5.9 8.9 5.6 6.9 5.8 8.7 15.1 7.7 12.0 6.8 0.8 7.0 7.1 1.0 1.7 8.8 3.2 2.0 4.0 13.1 10.6 4.8 5.0 25.7 12.9 7.0 6.8 5.6 19.7 13.9 9.9 11.5 2.6 5.9 14.2 8.3 7.5 2.8 3.2 3.1 7.4 4.4 3.8 12.5 6.3 17.7 11.5 11.6 12.8 12.7 7.4 11.3 10.0 7.1 6.8 6.4 8.6 6.6 7.0 9.8 7.0 6.1 4.2 11.3 6.6 6.5 6.8 12.9 5.9 7.8 5.5 5.0 6.4 10.6 11.0 7.5 6.7 4.8 10.6 5.8 6.1 8.4 0.0 1.6 10.4 15.3 12.5 15.9 2.4 10.2 4.0 1.2 0.0 3.9 40.3 0.0 3.9 12.7 4.9 4.6 0.0 5.4 97.8 9.3 6.6 3.5 3.4 41.5 7.9 8.1 10.4 10.3 15.1 7.8 11.9 11.8 6.4 7.7 10.1 1.9 7.0 4.6 0.8 11.2 6.5 11.3 51.9 45.0 11.5 19.0 12.5 19.0 7.3 RNASEH2B "AGS2, DLEU8, FLJ11712" ENSG00000136104 "Ribonuclease H2 subunit B" Q5TBB1 13 50909678-51024120 "Disease related genes, Predicted intracellular proteins" "Aicardi-Goutieres syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 120.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 68.3;REH: 57.1;THP-1: 51.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040084, HPA041469" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA040084: AB_10697714, HPA041469: AB_2677496" "unprognostic (4.33e-2)" "unprognostic (1.71e-1)" "unprognostic (2.80e-2)" "unprognostic (3.20e-1)" "unprognostic (2.59e-1)" "unprognostic (1.16e-1)" "unprognostic (8.33e-2)" "unprognostic (2.79e-2)" "unprognostic (2.50e-2)" "unprognostic (9.63e-3)" "unprognostic (1.13e-1)" "unprognostic (5.10e-2)" "prognostic unfavorable (2.54e-8)" "unprognostic (1.05e-1)" "unprognostic (3.13e-1)" "unprognostic (1.39e-2)" "unprognostic (3.34e-1)" 11.9 10.5 11.3 20.2 14.1 28.3 10.9 11.3 10.9 14.0 15.2 9.4 12.9 8.9 20.0 12.6 11.6 15.8 11.6 14.7 10.0 8.8 9.1 7.9 14.3 25.7 11.8 9.9 14.0 18.0 6.3 12.0 10.6 8.5 15.4 12.4 9.6 12.7 12.9 15.8 8.5 13.9 15.5 10.0 18.5 11.5 16.4 11.3 120.1 15.8 11.0 20.4 15.1 12.2 34.2 31.3 5.5 13.9 12.0 34.5 16.9 7.9 6.6 3.6 7.2 4.8 9.5 8.6 5.7 6.6 8.3 7.0 8.6 12.4 22.8 3.7 5.9 8.0 7.7 11.3 5.3 10.0 8.3 9.2 20.4 4.6 5.0 6.5 37.3 13.5 3.8 6.7 7.3 6.5 7.6 7.3 48.0 11.3 10.9 11.3 3.8 68.3 50.7 11.6 17.3 5.2 57.1 10.6 15.3 6.3 4.7 8.0 11.7 6.9 2.5 7.3 4.8 3.9 51.0 5.2 7.5 6.2 8.8 12.7 14.6 9.6 27.0 1.9 27.9 8.7 0.9 12.6 5.5 11.1 13.9 12.7 34.2 22.1 18.2 18.2 29.0 19.9 18.5 2.1 12.0 11.9 31.3 34.5 16.9 11.3 14.1 11.3 10.9 10.0 8.8 11.8 9.9 8.5 11.3 35.7 22.1 62.1 24.8 16.7 12.9 43.5 20.4 53.5 28.4 15.7 5.9 29.9 24.9 37.0 45.2 13.9 8.1 23.3 44.0 45.2 22.6 20.1 50.8 13.1 86.8 1.6 11.6 16.5 44.7 31.5 25.6 35.6 15.1 89.2 18.7 8.1 26.5 3.5 28.0 22.5 4.7 12.9 24.2 70.7 39.5 18.3 15.0 48.4 36.3 22.0 RNASEH2C "AGS3, AYP1" ENSG00000172922 "Ribonuclease H2 subunit C" Q8TDP1 11 65714005-65720947 "Disease related genes, Predicted intracellular proteins" "Aicardi-Goutieres syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065375 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA065375: AB_2685481" "unprognostic (1.61e-1)" "unprognostic (6.84e-2)" "unprognostic (2.06e-1)" "unprognostic (1.37e-1)" "unprognostic (1.43e-1)" "unprognostic (2.26e-2)" "unprognostic (7.88e-3)" "unprognostic (1.13e-1)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "prognostic favorable (3.68e-5)" "unprognostic (1.48e-1)" "prognostic unfavorable (6.35e-4)" "unprognostic (3.72e-2)" "unprognostic (1.84e-1)" "unprognostic (1.67e-2)" "unprognostic (9.99e-2)" 10.3 18.0 16.6 16.6 17.9 29.9 16.2 33.3 21.2 13.4 18.9 13.5 19.8 15.6 19.1 12.6 8.8 15.7 16.0 25.8 14.8 11.4 14.5 10.0 10.6 22.6 20.1 9.6 24.7 17.0 19.7 22.2 10.0 14.5 20.2 7.9 14.6 13.0 22.4 10.9 20.4 14.3 11.5 11.0 25.0 13.6 7.3 19.1 20.0 14.2 12.0 14.4 14.6 17.1 12.6 20.1 3.6 13.5 9.4 10.3 9.4 5.1 6.2 8.5 6.0 7.3 3.4 3.6 3.4 2.4 9.9 7.9 6.5 8.2 10.6 4.0 3.7 12.8 8.4 6.4 5.0 6.5 8.9 18.1 9.4 18.6 3.4 0.7 1.5 10.4 3.7 1.7 8.5 2.6 5.4 4.0 10.9 4.7 13.1 3.7 8.6 17.7 11.9 5.4 2.7 9.0 16.2 4.9 16.6 2.6 3.5 10.9 8.7 1.8 6.8 3.3 2.5 9.9 5.1 3.6 10.0 8.1 7.3 4.7 13.0 4.0 2.3 13.9 8.2 8.5 2.7 13.5 3.6 10.3 9.2 10.2 11.7 6.8 7.6 8.5 12.6 8.6 6.8 2.8 9.4 6.9 20.1 6.7 9.4 16.6 17.9 33.3 16.3 14.8 11.4 20.1 9.6 14.5 19.1 23.8 32.8 96.1 92.8 28.0 25.3 54.6 91.7 34.8 23.9 64.6 7.9 68.7 89.5 55.7 29.6 77.7 75.9 140.2 40.5 92.5 63.1 75.9 64.6 90.4 112.4 22.3 123.3 101.3 90.4 104.8 125.7 55.3 60.8 65.9 45.1 30.6 48.8 66.2 94.0 205.6 23.2 109.9 87.2 53.0 71.1 32.2 173.9 62.3 50.2 83.3 RNASEK-C17orf49 ENSG00000161939 "RNASEK-C17orf49 readthrough" 17 7012635-7017520 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.3" "Group enriched" "Detected in many" 8 "Alveolar cells type 1: 59.6;Alveolar cells type 2: 63.9;Ciliated cells: 103.1;Club cells: 56.9;granulocytes: 55.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 5.3;THP-1: 6.3;U-87 MG: 6.9" "HPA022961, HPA024457" Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA022961: AB_1845592, HPA024457: AB_1845593" "unprognostic (4.08e-2)" "unprognostic (3.30e-1)" "unprognostic (1.58e-1)" "unprognostic (9.37e-5)" "unprognostic (4.19e-1)" "unprognostic (1.71e-1)" "unprognostic (7.91e-2)" "unprognostic (3.01e-2)" "unprognostic (2.52e-1)" "unprognostic (2.87e-1)" "unprognostic (3.77e-3)" "unprognostic (8.26e-3)" "unprognostic (8.58e-3)" "unprognostic (3.00e-1)" "unprognostic (2.30e-1)" "unprognostic (1.19e-1)" "unprognostic (1.78e-1)" 4.8 4.8 2.8 3.5 3.5 5.3 2.9 3.6 4.0 2.0 2.8 0.4 1.5 1.4 4.9 3.3 2.3 2.7 3.2 6.3 2.5 3.3 6.6 14.5 16.7 20.3 2.9 2.4 2.4 7.9 1.4 4.7 2.5 1.8 1.8 1.4 0.4 1.6 5.0 4.2 1.9 6.3 2.3 1.7 9.1 1.6 6.4 0.7 4.1 2.0 4.6 3.4 2.3 1.6 1.9 4.0 7.5 4.3 0.9 1.7 2.8 1.2 3.6 0.5 0.5 0.0 0.0 1.1 2.3 1.9 2.8 2.2 2.3 1.1 1.9 0.2 0.0 0.3 0.6 0.7 5.3 0.8 0.0 4.4 0.0 2.9 1.0 2.8 0.0 0.6 0.0 0.0 1.6 0.0 0.4 0.7 0.2 0.6 0.0 0.0 1.2 1.9 2.3 2.3 0.5 1.2 1.4 0.0 0.0 0.8 0.7 0.5 1.8 0.0 0.0 0.2 0.3 0.6 6.3 0.0 0.0 0.2 3.5 1.0 0.0 0.8 0.2 6.9 0.5 0.0 3.6 4.3 3.4 1.2 3.0 1.7 1.9 1.5 0.8 3.8 1.8 1.4 1.2 7.5 0.9 3.1 4.0 0.9 2.8 2.8 3.5 3.6 4.0 2.5 3.3 2.9 2.4 1.8 0.7 59.6 63.9 0.0 0.0 0.3 0.0 0.0 0.0 103.1 56.9 0.0 0.0 0.2 3.3 6.7 0.0 0.1 2.9 0.0 7.0 0.1 0.2 0.1 55.8 0.0 0.6 0.0 5.2 0.6 1.2 0.0 0.3 1.0 0.0 8.2 4.7 0.0 6.7 6.8 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.7 0.0 2.7 0.1 RNF10 "KIAA0262, RIE2" ENSG00000022840 "Ring finger protein 10" Q8N5U6 12 120533480-120577594 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052643 Approved Approved Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA052643: AB_2681897" "unprognostic (1.54e-1)" "unprognostic (3.04e-1)" "unprognostic (5.40e-2)" "unprognostic (2.83e-3)" "unprognostic (1.09e-2)" "unprognostic (3.58e-2)" "prognostic unfavorable (5.30e-5)" "unprognostic (5.02e-2)" "unprognostic (3.06e-1)" "unprognostic (1.68e-1)" "unprognostic (1.93e-1)" "unprognostic (2.31e-1)" "unprognostic (3.43e-2)" "unprognostic (2.41e-1)" "unprognostic (2.18e-1)" "unprognostic (4.10e-2)" "unprognostic (2.40e-1)" 26.2 37.7 32.6 23.0 34.5 64.3 64.2 33.4 44.0 27.7 30.5 25.3 30.1 23.8 24.1 41.4 40.2 22.5 32.2 79.6 32.4 27.0 36.0 37.9 43.8 44.8 27.2 27.0 25.2 34.0 36.0 27.0 26.5 21.9 25.2 27.7 23.8 26.6 33.8 118.9 26.6 29.5 32.1 26.9 29.0 28.1 46.0 23.5 23.9 25.7 45.0 27.0 28.4 51.7 11.3 17.7 49.7 15.2 13.1 17.2 14.0 29.9 39.7 19.5 31.0 38.3 30.4 23.1 28.2 32.2 23.5 25.1 32.7 13.9 35.6 25.9 46.6 18.4 20.7 35.7 38.3 33.6 34.9 20.0 36.3 22.2 33.6 51.5 32.5 25.7 30.9 44.4 33.0 45.4 40.9 47.5 26.9 36.1 24.7 35.2 34.5 21.4 35.8 29.6 28.0 39.6 19.2 25.1 50.8 46.5 61.7 19.2 20.9 39.3 25.4 21.6 28.3 40.9 18.9 37.7 17.1 19.2 27.3 18.2 21.4 38.2 25.2 28.4 22.2 18.3 41.0 15.2 49.7 14.3 13.2 15.5 11.3 14.1 16.3 17.7 10.0 12.8 12.8 35.1 13.1 14.8 9.1 17.2 14.0 32.6 34.5 33.4 44.0 32.4 27.0 27.2 27.0 21.9 23.5 23.8 27.5 42.7 46.5 55.1 36.2 82.7 25.5 8.1 20.5 45.4 21.6 51.8 139.3 44.1 48.0 40.9 63.6 23.3 51.0 58.9 41.3 56.3 36.8 39.4 32.6 52.4 47.3 42.4 43.0 33.1 52.6 32.9 54.0 43.3 45.8 30.4 52.5 56.8 51.6 53.3 50.7 51.8 51.4 131.6 55.8 57.5 93.5 44.8 40.1 68.6 RNF111 "ARK, Arkadia, DKFZP761D081, FLJ38008" ENSG00000157450 "Ring finger protein 111" Q6ZNA4 15 58865175-59097419 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038576, HPA038577" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038576: AB_10964492, HPA038577: AB_10960052" "unprognostic (7.30e-2)" "unprognostic (2.60e-2)" "unprognostic (2.39e-1)" "unprognostic (3.37e-1)" "unprognostic (7.94e-2)" "unprognostic (2.09e-1)" "unprognostic (2.19e-1)" "unprognostic (3.21e-1)" "unprognostic (5.10e-2)" "unprognostic (6.12e-3)" "unprognostic (3.10e-2)" "unprognostic (1.42e-1)" "unprognostic (2.05e-3)" "unprognostic (2.05e-1)" "unprognostic (6.61e-2)" "unprognostic (1.20e-1)" "unprognostic (9.74e-2)" 12.8 11.2 15.3 15.6 19.3 21.2 12.7 24.1 21.9 15.1 9.8 18.8 10.9 11.4 16.4 9.8 16.2 12.6 13.0 11.0 13.0 13.0 12.9 14.8 13.3 13.9 15.7 15.5 16.8 14.8 20.8 19.2 16.7 17.8 12.7 10.3 12.9 14.9 12.5 15.0 14.1 10.9 11.7 14.2 14.3 12.0 15.7 16.9 14.9 16.4 6.5 17.8 15.8 14.8 7.9 5.2 26.7 9.9 3.3 6.1 2.0 9.6 22.5 14.3 12.3 12.5 14.1 12.3 12.7 14.9 12.7 16.4 9.9 6.5 11.9 14.4 17.7 10.9 19.0 3.9 9.5 15.9 12.3 8.0 14.7 9.2 7.6 13.6 8.6 16.6 11.0 10.3 13.7 15.2 11.6 14.1 11.1 13.6 12.0 15.6 4.7 11.3 5.5 11.8 3.0 8.8 11.4 20.5 9.7 9.7 17.3 11.8 17.2 11.4 11.3 11.0 17.5 8.9 10.6 16.2 20.4 17.0 10.6 12.1 8.7 11.8 14.2 12.4 13.9 15.3 6.4 9.9 9.3 4.8 7.0 4.8 7.4 4.9 4.3 5.2 7.9 5.5 4.2 26.7 3.3 7.6 4.9 6.1 2.0 15.3 19.3 24.1 21.9 13.0 13.0 15.7 15.5 17.8 16.9 3.0 11.8 14.0 10.9 17.9 11.2 16.9 7.6 14.7 9.1 12.2 7.9 7.3 3.3 10.3 18.4 13.4 9.2 0.0 6.0 8.1 9.5 12.3 15.1 9.8 11.7 9.5 15.5 19.0 17.7 7.0 7.2 16.6 11.8 16.2 9.4 9.5 10.9 11.4 13.8 8.4 12.3 25.8 9.2 11.9 7.8 17.3 26.8 11.7 7.9 20.4 RNF113A "Cwc24, RNF113, ZNF183" ENSG00000125352 "Ring finger protein 113A" O15541 X 119870475-119871827 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, mRNA processing, mRNA splicing, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA000160, HPA076658" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA000160: AB_1079821, HPA076658: AB_2732319" "unprognostic (2.85e-1)" "unprognostic (4.38e-3)" "unprognostic (5.55e-3)" "unprognostic (2.38e-2)" "unprognostic (1.02e-1)" "unprognostic (1.28e-2)" "unprognostic (3.65e-3)" "unprognostic (2.02e-3)" "unprognostic (6.29e-2)" "unprognostic (2.57e-1)" "unprognostic (6.49e-3)" "unprognostic (1.83e-1)" "prognostic unfavorable (7.93e-4)" "unprognostic (7.99e-2)" "unprognostic (3.19e-1)" "unprognostic (3.91e-2)" "prognostic favorable (6.23e-4)" 11.3 10.7 12.3 14.3 14.9 35.2 12.6 18.6 15.5 11.8 14.6 8.7 14.8 15.0 14.9 12.3 12.7 12.8 11.8 14.2 12.2 14.4 10.9 20.6 12.3 25.1 12.8 11.4 16.4 20.5 7.6 11.4 11.9 11.3 10.5 11.8 11.1 17.6 13.7 12.7 17.6 17.8 9.4 12.9 26.2 13.3 4.0 12.9 25.6 14.2 8.3 21.7 14.0 21.7 33.2 24.4 39.8 25.3 22.9 35.6 26.4 8.1 12.3 5.9 9.2 11.9 8.6 11.5 7.5 13.9 10.0 12.0 10.4 7.2 14.6 14.5 7.5 13.5 10.4 13.6 10.5 7.4 10.6 9.4 8.3 13.6 12.2 16.4 16.8 14.4 10.6 11.6 9.9 14.8 11.3 9.5 9.9 6.2 20.1 9.6 24.8 11.6 20.6 8.1 15.2 17.7 10.6 12.2 22.5 10.2 10.6 7.7 6.8 11.6 17.8 16.4 7.4 4.4 16.0 6.7 9.9 3.3 13.5 14.8 22.7 17.3 13.8 9.1 22.5 6.3 29.1 23.0 39.8 30.4 22.4 30.9 31.5 32.8 32.4 24.4 33.2 34.8 30.9 10.3 22.9 25.3 20.1 35.6 26.4 12.3 14.9 18.6 15.5 12.2 14.4 12.8 11.4 11.3 12.9 8.9 17.9 28.8 13.9 21.6 10.1 7.3 12.7 13.4 14.8 14.0 13.7 15.5 8.3 14.7 0.3 15.7 12.3 0.0 14.5 27.8 14.4 9.7 24.4 12.1 21.6 12.7 4.1 14.7 16.8 0.4 11.2 20.8 25.3 8.2 13.3 12.9 15.4 14.4 9.2 17.3 12.0 6.5 20.3 2.2 5.4 21.3 22.1 50.8 13.9 13.1 RNF121 FLJ11099 ENSG00000137522 "Ring finger protein 121" Q9H920 11 71928701-71997597 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046041 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA046041: AB_10965850" "unprognostic (1.36e-2)" "unprognostic (8.84e-2)" "unprognostic (9.72e-2)" "unprognostic (1.16e-1)" "unprognostic (2.64e-1)" "unprognostic (1.38e-2)" "unprognostic (1.41e-2)" "unprognostic (3.73e-2)" "unprognostic (1.22e-1)" "unprognostic (6.54e-2)" "unprognostic (1.85e-2)" "unprognostic (1.90e-1)" "prognostic favorable (2.72e-6)" "unprognostic (1.54e-1)" "unprognostic (1.81e-1)" "unprognostic (2.57e-2)" "unprognostic (1.70e-1)" 9.8 14.1 18.5 14.0 14.9 6.5 14.1 18.5 16.6 12.6 13.0 12.4 22.4 18.5 17.9 26.3 10.6 14.3 10.8 13.1 11.7 11.7 20.2 16.9 9.4 8.9 12.4 13.4 15.0 15.6 24.1 19.4 18.9 12.1 13.5 13.1 15.7 18.0 19.5 19.2 11.8 18.7 14.1 10.1 10.1 12.8 16.3 13.6 8.9 15.6 8.1 15.3 11.9 10.4 5.9 6.9 8.8 5.5 5.6 7.0 5.1 4.9 10.8 11.1 8.2 10.8 8.5 7.8 9.2 9.9 14.6 15.4 21.0 11.0 4.6 8.1 10.3 14.2 11.7 12.2 11.1 15.8 6.6 7.1 7.7 10.5 10.3 8.0 6.7 6.6 8.0 9.9 15.8 9.5 15.8 26.0 7.3 11.6 4.9 12.8 11.2 4.5 7.7 7.7 22.5 11.0 5.8 23.5 4.3 16.5 9.7 7.9 8.5 11.9 10.2 16.7 12.3 11.8 4.9 16.1 10.4 9.8 6.9 7.7 6.0 5.4 5.2 9.0 4.4 9.1 8.8 4.1 4.0 5.6 5.5 7.0 5.9 4.7 4.5 3.9 2.2 5.3 5.9 2.1 5.6 3.9 6.9 3.9 5.1 18.5 14.9 18.5 16.6 11.7 11.7 12.4 13.4 12.1 13.6 6.0 14.0 12.6 8.9 7.8 15.3 7.9 12.7 6.7 4.5 19.2 19.6 28.1 6.6 23.5 3.1 4.9 16.2 23.3 28.0 22.0 10.8 9.4 6.9 12.1 12.5 9.5 9.2 8.0 5.7 2.0 12.0 10.2 10.1 17.2 10.4 17.5 24.0 9.9 11.7 16.5 17.5 19.4 9.0 21.6 17.7 5.1 26.0 12.8 8.3 8.2 RNF126 FLJ20552 ENSG00000070423 "Ring finger protein 126" Q9BV68 19 647526-663277 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043050 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043050: AB_10794768" "unprognostic (2.24e-1)" "unprognostic (1.64e-1)" "unprognostic (1.97e-1)" "unprognostic (2.48e-3)" "unprognostic (1.90e-1)" "unprognostic (2.32e-1)" "unprognostic (1.09e-3)" "unprognostic (3.57e-2)" "unprognostic (1.28e-1)" "unprognostic (1.70e-1)" "unprognostic (1.88e-2)" "unprognostic (2.68e-2)" "unprognostic (9.96e-3)" "unprognostic (7.04e-3)" "unprognostic (3.39e-2)" "unprognostic (2.05e-1)" "unprognostic (4.67e-2)" 14.2 14.2 13.4 17.0 13.7 18.7 14.5 12.2 24.7 9.8 16.0 14.8 7.4 24.3 10.4 9.2 19.8 9.5 13.1 14.2 13.1 10.2 11.6 27.9 10.4 19.9 11.4 11.6 12.1 22.4 5.9 10.0 14.1 12.3 10.0 6.3 10.1 13.2 9.3 50.3 21.9 20.3 9.9 10.0 18.6 21.0 33.6 9.3 16.1 8.6 19.5 18.6 13.1 11.2 15.9 13.6 7.5 13.8 17.1 17.3 9.2 25.9 8.6 7.3 10.3 1.7 2.4 12.5 13.6 5.2 7.9 7.5 17.4 9.1 21.5 8.9 5.7 3.1 17.4 4.4 10.2 2.2 14.2 31.8 10.9 9.0 14.4 6.6 21.6 16.1 4.1 8.1 6.5 5.1 3.2 7.2 17.7 21.9 21.7 4.1 20.9 22.1 10.1 19.5 5.5 17.0 16.1 6.3 33.8 6.0 14.5 17.4 13.6 10.3 13.6 13.9 2.6 8.7 17.0 9.4 14.4 10.4 21.1 23.3 38.3 19.0 25.2 18.3 12.7 14.8 0.6 9.8 7.5 17.3 11.5 14.2 15.9 15.7 16.7 12.4 15.6 12.2 11.4 2.2 17.1 13.8 13.6 16.8 9.2 13.4 13.7 12.2 24.7 13.1 10.2 11.4 11.6 12.3 9.3 11.9 6.1 54.8 41.2 122.5 31.3 24.2 15.3 12.0 10.3 8.7 15.7 58.6 46.4 55.4 113.7 26.1 51.9 0.0 66.1 118.3 35.3 49.3 14.9 20.2 38.3 30.2 20.8 20.3 27.6 18.2 19.8 38.3 40.5 56.9 34.2 27.0 95.1 54.9 18.4 25.6 22.0 58.2 45.0 118.2 66.8 126.6 73.7 55.3 49.7 76.9 RNF13 RZF ENSG00000082996 "Ring finger protein 13" O43567 3 149812708-149962139 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 72.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064784 Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA064784: AB_2685350" "unprognostic (1.27e-1)" "unprognostic (2.32e-2)" "unprognostic (1.03e-1)" "unprognostic (1.93e-2)" "unprognostic (1.80e-1)" "unprognostic (9.64e-2)" "unprognostic (8.49e-2)" "unprognostic (4.36e-3)" "unprognostic (1.72e-1)" "unprognostic (1.25e-1)" "unprognostic (6.94e-3)" "unprognostic (1.13e-1)" "prognostic favorable (2.00e-8)" "unprognostic (2.95e-1)" "unprognostic (4.11e-2)" "unprognostic (2.17e-1)" "unprognostic (1.79e-1)" 24.0 21.3 30.6 19.0 39.4 9.8 28.5 19.9 30.4 19.0 17.7 39.9 16.2 14.3 16.8 33.7 16.8 15.9 20.4 16.4 40.5 29.7 35.8 39.2 31.7 19.6 60.9 26.8 18.1 19.6 23.5 14.9 32.4 40.7 25.5 20.3 19.5 36.1 20.9 18.0 18.4 16.3 20.4 102.2 25.5 17.0 12.5 51.2 13.3 32.1 18.8 15.9 21.4 16.5 8.8 15.7 72.4 31.5 7.8 8.5 14.6 19.7 12.3 8.3 9.5 32.8 20.1 13.9 10.9 28.2 10.6 15.8 10.8 28.4 8.2 16.0 13.4 19.5 18.8 11.1 14.0 14.9 10.0 8.1 9.9 5.7 10.5 21.8 10.6 14.1 21.2 26.6 8.9 24.2 12.8 11.7 7.9 3.1 16.7 9.4 11.1 7.6 7.0 5.5 19.1 9.6 5.5 8.9 34.8 20.5 9.2 4.4 12.7 9.0 13.6 35.2 6.8 25.9 11.2 12.2 14.4 5.8 15.2 7.0 28.4 18.7 16.9 12.1 9.9 7.7 12.9 20.3 16.6 6.8 25.2 8.5 8.8 7.6 7.6 15.7 8.3 7.3 7.5 72.4 7.8 31.5 11.2 8.3 14.6 30.6 39.4 19.9 29.2 40.5 29.7 60.9 26.8 40.7 51.2 101.3 59.5 39.3 61.2 65.4 43.7 25.6 38.2 34.8 61.4 45.4 27.5 86.4 36.5 54.3 2.2 62.6 27.6 0.0 62.0 65.2 68.3 63.5 58.9 46.6 172.6 20.6 19.4 77.3 168.9 4.7 70.5 155.4 97.8 42.3 26.4 85.9 48.5 29.6 82.7 59.8 32.2 90.5 50.9 19.7 29.6 63.2 43.8 51.0 24.3 45.5 RNF14 "ARA54, HFB30, TRIAD2" ENSG00000013561 "Ring finger protein 14" Q9UBS8 5 141958328-141990291 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Early spermatids: 162.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008716, HPA064746" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA008716: AB_1856337, HPA064746: " "unprognostic (7.45e-3)" "unprognostic (1.38e-1)" "unprognostic (8.56e-2)" "unprognostic (1.20e-1)" "unprognostic (3.47e-2)" "unprognostic (7.24e-3)" "unprognostic (2.35e-1)" "unprognostic (4.05e-2)" "unprognostic (5.22e-2)" "unprognostic (7.42e-2)" "unprognostic (7.92e-2)" "unprognostic (1.46e-1)" "prognostic favorable (1.71e-4)" "unprognostic (6.89e-3)" "unprognostic (2.82e-1)" "prognostic unfavorable (2.21e-4)" "unprognostic (1.06e-2)" 21.2 29.5 23.7 11.2 33.9 7.8 22.0 22.5 40.2 18.4 18.7 26.2 16.0 15.3 21.0 21.5 15.6 14.3 15.4 32.9 23.6 24.7 31.3 31.3 13.8 13.3 28.9 17.3 15.9 17.1 26.3 28.8 23.6 47.7 21.6 19.8 20.9 18.1 20.1 27.7 11.9 20.9 20.5 26.3 13.8 15.7 33.7 15.0 16.2 26.3 13.3 14.9 16.7 14.0 12.3 17.1 32.6 18.8 16.8 17.0 12.2 12.7 21.4 15.0 29.5 27.1 28.4 10.1 26.3 14.7 18.5 20.5 17.7 14.9 22.6 30.8 26.9 27.9 7.0 19.1 25.8 16.6 17.0 16.5 14.4 11.2 8.0 29.8 15.7 12.9 21.3 22.8 24.6 30.9 16.1 22.9 15.8 17.4 31.6 37.8 15.2 15.2 5.0 6.3 15.6 24.4 10.1 16.7 24.5 25.4 22.2 16.6 13.5 23.0 42.2 44.6 17.6 29.3 12.3 23.6 24.6 7.9 11.6 24.9 19.9 23.2 20.7 21.1 19.3 30.3 32.6 13.4 13.0 17.0 15.8 16.5 12.3 15.0 16.9 16.2 10.6 11.5 16.7 3.3 16.8 18.8 17.1 16.7 12.2 23.7 33.9 22.5 40.2 23.6 24.7 28.9 17.3 47.7 15.0 8.9 22.9 9.0 14.0 9.5 20.9 36.8 7.6 13.4 13.6 21.0 15.7 24.8 58.0 23.0 162.7 16.9 20.2 23.3 21.8 21.4 16.2 17.2 21.9 29.6 21.4 22.3 14.5 17.8 25.5 22.0 17.8 19.3 30.4 10.8 14.1 20.6 22.7 11.5 31.5 34.8 14.6 38.8 25.8 42.6 27.1 9.3 50.6 17.5 13.3 12.7 RNF141 "ZFP26, ZNF230" ENSG00000110315 "Ring finger protein 141" Q8WVD5 11 10511678-10541230 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 903.9;Late spermatids: 383.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CAPAN-2: 63.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018133 Approved Approved Nucleoplasm,Microtubules NA NA Microtubules Nucleoplasm "HPA018133: AB_1859142" "unprognostic (7.41e-2)" "unprognostic (1.16e-1)" "unprognostic (7.88e-3)" "unprognostic (8.42e-2)" "unprognostic (2.12e-1)" "unprognostic (3.09e-2)" "unprognostic (1.08e-3)" "unprognostic (1.48e-1)" "unprognostic (1.44e-1)" "unprognostic (5.50e-2)" "prognostic unfavorable (1.14e-4)" "unprognostic (4.57e-2)" "prognostic favorable (2.60e-4)" "unprognostic (6.11e-2)" "unprognostic (1.30e-1)" "unprognostic (1.71e-2)" "unprognostic (1.61e-2)" 14.0 17.6 27.9 14.8 39.0 10.0 15.8 10.2 28.8 10.9 10.0 44.4 6.0 12.5 8.2 11.8 33.7 9.7 8.4 12.8 30.1 23.6 14.2 12.4 12.3 9.4 44.7 18.7 6.5 8.2 19.4 9.5 8.5 33.7 13.6 9.9 7.3 20.6 8.8 23.9 24.2 17.5 7.8 56.2 15.1 12.3 42.2 39.3 7.7 13.3 12.8 15.4 10.6 12.9 19.1 8.2 43.5 29.2 2.4 4.2 8.6 17.7 9.3 12.9 7.8 19.7 19.2 9.5 12.1 9.5 4.6 5.6 13.9 63.6 7.3 11.2 9.3 8.3 12.8 5.5 13.9 7.1 8.0 7.4 5.0 5.9 7.2 7.6 7.9 6.0 12.6 16.2 2.5 15.3 17.0 12.4 9.4 13.5 6.9 11.5 7.4 7.8 2.9 6.5 11.4 5.2 10.0 5.8 8.0 7.4 19.2 4.0 8.5 11.7 13.7 7.5 11.3 8.8 4.2 13.1 11.6 7.2 9.5 3.7 3.1 5.9 8.2 14.2 11.2 13.9 8.5 15.0 25.2 2.5 29.2 4.2 19.1 2.9 2.4 8.2 18.4 3.3 2.2 43.5 2.4 27.0 7.6 3.4 8.6 27.9 39.0 10.2 28.4 30.1 23.6 44.7 18.7 33.7 39.3 17.9 42.2 20.1 35.2 36.2 18.2 41.6 17.8 22.7 11.4 19.2 11.8 11.7 34.9 17.4 903.9 18.9 19.7 0.0 21.5 12.7 11.6 45.2 12.7 24.5 34.2 35.0 20.2 22.1 101.8 383.0 18.1 24.1 18.6 27.9 29.7 19.0 35.2 5.8 18.4 25.6 11.0 6.5 13.7 68.5 25.8 35.0 15.0 10.4 22.5 62.0 RNF145 FLJ31951 ENSG00000145860 "Ring finger protein 145" Q96MT1 5 159157409-159210053 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036562 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA036562: AB_10696657" "unprognostic (1.57e-1)" "unprognostic (9.02e-3)" "unprognostic (4.11e-2)" "unprognostic (3.88e-2)" "unprognostic (3.24e-2)" "unprognostic (2.93e-2)" "prognostic unfavorable (1.64e-6)" "unprognostic (1.35e-1)" "unprognostic (1.02e-2)" "unprognostic (1.54e-1)" "unprognostic (3.53e-1)" "unprognostic (1.67e-1)" "unprognostic (8.92e-3)" "unprognostic (1.49e-1)" "unprognostic (1.00e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-1)" 13.3 20.1 23.9 15.6 23.0 7.1 24.1 30.2 27.3 11.3 11.7 5.7 5.3 4.7 12.6 13.6 26.7 11.4 20.8 16.8 22.0 8.4 8.2 6.1 30.7 36.3 17.5 9.7 14.1 6.0 26.9 29.0 21.9 18.5 11.8 12.6 10.2 17.8 14.8 5.5 14.9 11.0 13.8 12.4 12.7 11.2 7.9 18.0 12.4 14.3 8.0 19.6 19.3 15.7 8.9 2.7 14.4 2.6 2.1 6.2 1.3 20.3 20.1 31.0 37.2 32.8 14.6 6.0 16.3 28.5 15.1 24.6 6.9 16.9 7.0 29.4 14.3 28.8 26.7 24.4 21.5 26.7 28.8 8.7 14.7 22.9 5.7 14.1 9.7 14.1 9.0 38.9 14.1 20.7 21.2 14.8 17.1 14.6 27.1 14.2 0.5 11.0 3.0 13.4 6.4 10.3 14.7 13.5 14.0 20.2 7.0 11.3 20.9 16.5 17.7 26.8 22.1 12.4 8.9 15.8 17.0 15.6 13.6 28.9 6.0 8.3 6.5 19.8 12.1 36.3 2.8 2.6 14.4 3.2 2.5 3.7 8.9 4.7 3.8 1.9 4.4 6.2 4.3 9.7 2.1 2.2 2.7 5.7 1.3 23.9 23.0 30.2 27.3 22.0 8.4 17.5 9.7 18.5 18.0 104.2 213.5 76.8 93.4 109.1 103.7 10.0 79.0 48.2 106.9 34.9 55.0 2.7 16.6 63.7 22.1 50.7 48.5 46.7 99.7 20.5 58.0 100.6 68.1 16.3 39.0 108.1 52.0 127.7 90.9 29.9 42.8 54.8 62.4 223.6 41.8 63.1 90.1 51.8 48.8 8.4 48.6 45.3 49.5 14.9 33.0 86.9 9.2 73.0 57.2 150.2 RNF146 "dactylidin, dJ351K20.1, DKFZp434O1427" ENSG00000118518 "Ring finger protein 146" Q9NTX7 6 127266610-127288567 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway, Wnt signaling pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027158, HPA027209" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" Nucleoplasm "HPA027158: AB_10600772, HPA027209: AB_10602312" "unprognostic (8.22e-2)" "unprognostic (1.20e-2)" "unprognostic (1.21e-1)" "unprognostic (1.32e-1)" "unprognostic (1.38e-2)" "unprognostic (1.17e-2)" "unprognostic (1.37e-1)" "unprognostic (5.47e-3)" "unprognostic (1.87e-1)" "unprognostic (6.74e-2)" "prognostic favorable (5.26e-5)" "unprognostic (2.65e-2)" "prognostic favorable (7.32e-4)" "unprognostic (4.04e-2)" "unprognostic (1.29e-1)" "unprognostic (6.13e-2)" "unprognostic (2.15e-2)" 27.3 20.9 28.5 16.6 29.1 5.1 23.9 63.7 34.5 22.7 18.6 29.2 10.5 11.8 32.0 35.2 14.2 17.9 21.3 25.2 26.3 21.7 20.9 16.8 21.0 17.3 30.0 27.7 28.5 12.6 26.5 27.4 27.8 31.3 18.6 17.6 17.5 16.7 20.3 55.9 16.0 15.2 26.1 28.7 24.6 15.5 16.3 27.7 9.2 26.7 15.5 17.6 19.2 18.7 11.7 14.2 22.8 22.8 11.5 10.3 9.1 5.5 7.0 26.7 23.5 24.8 24.9 9.7 18.9 30.3 10.1 14.6 9.1 8.4 10.0 13.4 15.4 15.9 7.1 7.9 8.9 14.8 11.5 6.9 12.7 8.4 12.7 24.6 7.5 9.1 21.7 18.7 11.4 22.8 23.4 17.7 10.0 13.7 9.9 22.3 10.6 7.4 13.6 9.7 3.4 7.3 9.4 6.9 5.0 14.4 6.1 16.0 16.2 7.4 10.5 11.6 16.5 7.1 26.1 20.8 17.9 5.9 18.5 13.3 14.3 8.8 6.6 13.7 13.2 16.8 16.8 18.9 16.1 9.3 20.0 9.7 11.1 8.0 10.3 14.2 11.7 7.3 10.2 22.8 11.5 22.8 7.1 8.6 9.1 28.5 29.1 63.7 34.5 26.3 21.7 30.0 27.7 31.3 27.7 32.8 24.8 20.8 11.4 15.8 34.0 33.0 38.2 20.1 7.9 8.7 3.9 25.1 34.9 24.3 40.1 34.9 12.8 0.0 14.1 22.7 38.1 21.4 21.9 25.2 22.8 28.6 19.7 28.3 67.8 33.7 64.5 25.0 43.9 24.4 11.5 36.1 15.1 13.9 62.6 42.1 18.1 32.3 33.5 44.7 12.2 17.6 32.2 28.7 10.9 14.1 RNF165 "ARKL2, RNF111L2" ENSG00000141622 "Ring finger protein 165" Q6ZSG1 18 46326809-46463140 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6" "Group enriched" "Detected in many" 8 "Bipolar cells: 36.3;Cone photoreceptor cells: 94.2;Horizontal cells: 76.3;Rod photoreceptor cells: 51.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "MAIT T-cell: 1.1;NK-cell: 3.9;plasmacytoid DC: 1.5" "Group enriched" "Detected in many" 4 "dendritic cells: 1.5;NK-cells: 3.9;T-cells: 1.1" "Cell line enhanced" "Detected in some" "AF22: 12.7;HaCaT: 7.0;HeLa: 6.9;RPMI-8226: 6.7;SCLC-21H: 13.2;SH-SY5Y: 15.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041615, HPA047798" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA041615: AB_2677582, HPA047798: AB_2680158" "unprognostic (6.46e-3)" "unprognostic (7.25e-2)" "unprognostic (4.55e-2)" "unprognostic (1.24e-5)" "unprognostic (3.43e-1)" "unprognostic (4.57e-2)" "unprognostic (5.18e-2)" "unprognostic (1.69e-1)" "unprognostic (1.04e-3)" "unprognostic (1.95e-1)" "unprognostic (1.23e-1)" "unprognostic (2.07e-1)" "unprognostic (1.87e-5)" "unprognostic (3.53e-3)" "unprognostic (1.90e-1)" "unprognostic (1.29e-1)" "unprognostic (1.64e-1)" 1.9 1.7 9.9 1.0 9.5 0.9 2.1 28.6 13.8 1.0 0.8 1.7 1.7 0.4 1.0 8.4 2.7 3.0 1.0 2.5 6.1 4.4 2.3 8.3 1.0 0.9 2.2 7.2 0.5 1.0 13.1 4.8 0.8 2.0 3.6 0.6 2.7 1.4 3.9 3.6 3.5 1.0 0.7 1.7 5.3 0.7 1.3 1.0 1.7 8.8 1.2 1.3 1.2 1.0 0.0 1.5 0.5 0.0 3.9 1.1 0.0 1.5 0.1 12.7 0.1 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 7.0 0.5 1.0 0.0 0.0 1.0 0.1 6.9 0.0 0.0 2.9 0.0 0.0 0.8 0.0 0.0 0.3 0.0 2.2 0.0 0.2 0.0 0.0 2.3 1.0 1.7 0.3 1.2 2.4 0.5 6.7 0.8 2.1 13.2 15.0 2.3 0.0 0.0 0.9 0.3 0.6 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 4.1 0.4 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 3.9 0.0 1.5 0.0 0.0 9.9 9.5 28.6 13.8 6.1 4.4 2.2 7.2 2.0 1.0 3.0 1.7 0.0 8.3 2.4 36.3 7.9 0.0 0.0 3.4 0.0 94.2 0.1 3.3 0.0 2.7 1.9 0.0 0.0 0.0 0.2 1.5 1.7 0.0 5.7 0.1 76.3 0.0 0.6 0.8 3.1 2.3 0.0 1.7 0.0 0.0 3.7 0.1 0.0 3.9 0.0 51.7 0.0 0.8 0.5 0.5 1.8 0.2 2.9 0.0 1.6 RNF166 "MGC14381, MGC2647" ENSG00000158717 "Ring finger protein 166" Q96A37 16 88696495-88706421 "Predicted intracellular proteins" "Autophagy, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 63.9" "Cell type enhanced" "Detected in many" 7 "Kupffer cells: 37.7;Macrophages: 37.5;T-cells: 66.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 44.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042970 Approved "Nucleoplasm,Plasma membrane,Cytosol" No No Nucleoplasm "Plasma membrane, Cytosol" "HPA042970: AB_10796682" "unprognostic (3.01e-2)" "unprognostic (6.98e-3)" "unprognostic (3.96e-2)" "unprognostic (5.36e-3)" "unprognostic (1.23e-1)" "unprognostic (2.71e-2)" "unprognostic (6.52e-2)" "unprognostic (5.86e-2)" "unprognostic (4.88e-2)" "unprognostic (2.38e-2)" "prognostic favorable (1.04e-4)" "unprognostic (3.22e-2)" "prognostic unfavorable (9.45e-6)" "unprognostic (1.54e-1)" "unprognostic (3.91e-2)" "unprognostic (1.28e-1)" "unprognostic (2.69e-2)" 9.2 8.1 9.2 22.8 8.9 63.9 10.5 13.7 15.3 6.7 7.2 11.2 3.7 12.0 8.1 8.3 6.4 9.1 12.3 10.0 8.6 7.3 9.6 9.7 20.8 30.5 8.9 6.5 9.7 11.4 5.3 8.5 7.5 8.4 8.9 4.9 11.0 12.1 6.0 14.8 8.2 16.0 8.3 11.1 47.2 10.9 9.2 9.1 21.6 8.8 7.8 23.8 9.7 6.7 2.0 11.8 28.7 12.5 5.5 17.1 9.7 4.2 6.8 5.3 8.4 2.6 2.2 10.1 4.3 2.8 5.1 2.3 4.6 2.7 5.1 5.6 2.5 2.9 4.7 3.1 2.8 2.0 2.6 9.2 6.9 5.0 7.7 6.9 6.8 8.8 2.6 2.7 4.0 3.3 2.8 5.3 8.7 11.5 3.8 2.1 8.3 15.9 44.6 8.7 1.8 9.1 14.9 3.3 13.2 2.3 1.9 4.9 5.5 9.8 2.0 5.3 2.7 5.8 23.3 7.3 3.8 5.7 5.7 5.1 8.6 5.0 12.4 3.4 25.9 5.3 3.0 12.5 28.7 17.1 9.1 14.8 2.0 10.4 14.8 11.8 1.9 8.7 12.5 20.4 5.5 10.5 7.3 10.5 9.7 9.2 8.9 13.7 15.3 8.6 7.3 8.9 6.5 8.4 9.1 8.9 5.1 15.7 4.7 4.2 10.1 2.4 7.6 1.4 3.4 7.0 5.9 7.4 8.3 5.2 1.1 8.0 2.0 0.0 8.0 7.5 8.2 3.6 20.7 4.0 34.7 7.9 4.7 10.4 37.7 1.8 8.6 37.5 10.1 11.8 2.7 8.9 4.6 0.0 7.4 5.6 8.6 6.5 7.1 9.4 8.6 5.1 3.1 66.8 4.1 1.3 RNF168 FLJ35794 ENSG00000163961 "Ring finger protein 168" Q8IYW5 3 196468783-196503768 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 199.9;Late spermatids: 360.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046109 Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA046109: AB_2679540" "unprognostic (6.15e-3)" "prognostic favorable (8.21e-4)" "unprognostic (3.11e-1)" "unprognostic (1.11e-2)" "unprognostic (4.22e-1)" "unprognostic (5.04e-2)" "prognostic unfavorable (2.29e-4)" "unprognostic (6.81e-3)" "unprognostic (5.30e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (8.31e-4)" "unprognostic (4.83e-3)" "unprognostic (2.80e-3)" "unprognostic (5.98e-2)" "unprognostic (1.45e-1)" "unprognostic (1.95e-2)" "unprognostic (6.65e-2)" 20.8 9.3 8.9 10.7 11.1 31.6 18.7 21.1 13.0 13.6 11.2 10.7 12.3 11.1 13.9 8.5 14.3 10.1 10.9 12.0 10.2 10.2 7.5 18.8 14.3 12.0 13.8 11.0 14.6 9.2 12.0 8.1 9.9 15.3 10.1 10.8 9.1 11.0 13.6 20.8 20.1 10.1 12.9 10.5 11.7 10.7 18.4 13.4 17.6 9.6 13.9 15.2 14.7 17.1 6.2 5.8 21.8 10.0 7.7 11.6 5.7 12.5 5.0 9.0 11.8 8.4 6.1 12.9 7.7 4.9 5.2 8.2 9.8 6.2 13.3 17.8 6.4 7.3 12.8 12.6 9.2 8.0 6.3 6.2 25.2 12.7 12.1 4.4 7.7 6.3 6.1 3.5 8.1 7.2 3.7 7.5 11.0 7.5 14.0 5.2 21.2 25.5 4.6 10.7 6.8 6.5 11.5 10.5 10.8 4.4 17.4 7.5 7.6 8.7 10.7 6.6 7.0 16.2 6.9 7.4 9.0 7.1 9.5 10.1 12.0 11.2 20.2 8.8 9.4 7.1 21.8 6.6 7.5 11.6 7.1 10.4 5.7 9.8 8.3 5.8 6.2 8.7 9.1 7.3 7.7 10.0 5.5 6.2 5.7 8.9 11.1 21.1 13.0 10.2 10.2 13.8 11.0 15.3 13.4 14.9 29.1 17.1 44.2 89.0 35.1 19.7 12.7 18.7 19.4 14.0 56.9 11.4 14.9 11.9 199.9 29.2 13.6 0.0 7.9 20.7 33.6 23.5 49.6 25.8 15.9 14.3 13.8 17.2 29.0 360.7 18.7 39.0 25.3 37.9 16.0 13.4 8.6 14.4 19.4 8.4 39.6 12.9 35.0 11.1 67.5 110.7 8.9 46.0 18.6 50.5 RNF169 KIAA1991 ENSG00000166439 "Ring finger protein 169" Q8NCN4 11 74748868-74842413 "Enzymes, Predicted intracellular proteins" "DNA damage, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038505, HPA046138, HPA047952" Uncertain Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" "Nucleoli, Nucleoli rim, Cytosol" "HPA038505: , HPA046138: AB_2679553, HPA047952: " "unprognostic (1.71e-1)" "unprognostic (4.18e-2)" "unprognostic (4.34e-2)" "unprognostic (3.72e-2)" "unprognostic (3.86e-2)" "unprognostic (3.25e-2)" "unprognostic (1.74e-1)" "unprognostic (1.35e-1)" "unprognostic (2.68e-1)" "unprognostic (6.47e-2)" "prognostic unfavorable (8.04e-4)" "unprognostic (2.76e-1)" "unprognostic (1.46e-1)" "unprognostic (3.23e-1)" "unprognostic (2.34e-1)" "unprognostic (9.55e-3)" "unprognostic (1.21e-1)" 12.3 7.0 12.0 11.6 14.0 23.1 12.0 22.6 15.6 13.1 11.2 12.2 6.3 7.4 14.2 8.2 20.6 10.7 10.8 9.2 12.6 5.9 8.9 9.3 16.9 11.3 15.4 9.1 14.6 10.7 17.5 10.4 8.6 13.9 10.5 10.0 8.4 12.4 8.8 15.0 14.1 10.3 14.2 10.1 12.6 10.3 7.2 14.9 12.6 11.5 7.4 12.5 13.1 15.8 0.6 0.8 5.0 1.9 1.2 1.6 0.6 8.3 6.4 7.8 7.6 5.0 6.8 3.1 6.5 6.2 7.3 6.4 10.7 6.3 14.9 6.7 7.8 5.0 8.1 10.4 7.8 9.6 7.4 6.7 10.3 11.8 4.2 5.8 5.4 8.6 6.2 6.2 8.3 19.0 8.2 11.8 10.2 9.1 12.0 7.3 7.0 9.3 9.8 3.0 10.6 4.2 8.7 18.5 8.1 4.7 8.7 3.5 6.3 8.8 6.7 14.2 6.5 8.4 7.0 7.8 12.2 10.3 7.6 5.8 8.7 4.5 17.7 2.4 6.0 7.0 2.8 1.9 1.5 1.6 1.1 1.2 0.3 1.5 0.9 0.8 0.6 1.1 0.9 5.0 1.2 1.0 0.8 1.2 0.6 12.0 14.0 22.6 15.6 12.6 5.9 15.4 9.1 13.9 14.9 8.9 10.7 13.0 26.3 17.6 51.9 2.8 2.5 5.3 7.9 3.5 49.1 5.0 5.0 8.8 2.2 11.7 6.7 0.0 9.5 5.0 9.3 37.6 6.9 11.0 7.6 35.0 11.5 8.6 10.7 2.2 6.9 9.2 10.1 1.8 7.8 33.2 9.1 5.8 9.9 9.1 32.5 25.8 15.1 10.4 10.9 16.3 6.8 16.6 9.7 39.6 RNF181 HSPC238 ENSG00000168894 "Ring finger protein 181" Q9P0P0 2 85595725-85597613 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046112, HPA062121" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA046112: AB_2679542, HPA062121: AB_2684687" "unprognostic (3.79e-1)" "unprognostic (8.31e-2)" "unprognostic (5.08e-2)" "unprognostic (2.05e-1)" "unprognostic (3.24e-1)" "unprognostic (1.67e-2)" "unprognostic (3.12e-1)" "unprognostic (2.22e-2)" "unprognostic (3.22e-2)" "unprognostic (5.85e-2)" "unprognostic (1.11e-1)" "unprognostic (4.96e-2)" "prognostic unfavorable (1.06e-6)" "unprognostic (3.24e-1)" "unprognostic (2.04e-1)" "prognostic favorable (4.59e-5)" "unprognostic (1.49e-2)" 32.9 41.5 42.2 26.4 36.2 32.8 40.4 19.0 38.7 34.4 40.5 33.0 36.0 34.5 28.1 44.5 40.2 33.3 34.8 52.4 34.5 32.9 57.8 85.1 36.0 33.1 41.2 29.3 31.6 85.1 21.8 20.2 50.7 36.0 34.2 35.4 32.1 42.1 45.7 47.0 30.4 46.5 33.2 42.2 37.2 35.7 36.3 31.3 31.0 43.7 39.2 42.6 43.8 29.4 53.2 80.2 78.6 94.7 39.3 54.4 83.3 32.7 33.2 25.9 28.1 26.4 32.8 41.8 27.7 54.6 59.1 56.3 50.6 34.8 31.2 54.5 41.1 56.1 30.7 22.3 44.3 63.6 35.6 27.5 23.7 17.2 60.8 46.5 26.2 32.5 34.2 59.0 39.4 65.9 45.5 49.1 29.4 27.8 32.5 79.8 52.5 24.7 61.1 18.0 43.3 50.2 26.5 54.4 44.4 55.2 30.5 15.5 20.4 23.4 34.1 45.5 32.5 33.8 34.9 42.4 29.0 20.7 58.0 39.5 45.4 37.8 39.1 45.4 39.7 25.5 40.4 94.7 71.6 40.7 69.3 37.7 53.2 42.6 39.1 71.0 44.3 36.7 36.8 78.6 39.3 51.8 80.2 54.4 83.3 42.2 36.2 19.0 38.7 34.5 32.9 41.2 29.3 36.0 31.3 137.0 86.2 115.3 81.4 103.8 25.0 99.1 145.2 88.3 91.0 143.1 2.0 196.4 353.1 216.8 308.0 104.6 151.4 70.0 252.2 207.3 131.6 104.1 100.4 194.3 230.7 17.5 67.4 87.8 155.3 193.3 81.7 162.9 161.9 198.4 101.4 48.2 256.8 175.4 73.6 513.2 19.4 58.2 121.5 89.5 30.4 103.6 185.0 97.2 90.7 92.8 RNF182 MGC33993 ENSG00000180537 "Ring finger protein 182" Q8N6D2 6 13924446-13980302 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 12.9;brain: 17.6" "Group enriched" "Detected in some" 4 "Bipolar cells: 16.5;Horizontal cells: 14.3;Muller glia cells: 15.3;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 37.0;RPTEC TERT1: 29.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012309 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus" Vesicles "HPA012309: AB_1856349" "unprognostic (1.29e-1)" "unprognostic (1.06e-2)" "unprognostic (2.74e-1)" "prognostic unfavorable (4.66e-5)" "unprognostic (6.16e-2)" "unprognostic (2.08e-1)" "unprognostic (9.01e-2)" "unprognostic (6.12e-2)" "unprognostic (1.71e-2)" "unprognostic (4.21e-1)" "unprognostic (6.04e-2)" "unprognostic (1.42e-1)" "unprognostic (1.05e-1)" "unprognostic (9.33e-5)" "unprognostic (6.66e-3)" "unprognostic (1.33e-3)" "unprognostic (1.26e-1)" 1.2 0.7 7.6 0.6 6.2 12.9 1.2 16.6 17.6 1.2 0.7 7.5 2.0 0.8 1.6 2.5 1.0 2.7 0.9 1.0 11.0 7.3 2.6 0.5 5.7 0.8 6.8 8.5 1.1 3.6 0.5 2.0 2.9 14.3 0.9 0.6 2.2 1.9 4.7 0.9 0.8 1.1 1.0 5.1 0.5 0.6 7.0 2.9 0.0 3.0 0.0 0.4 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.8 5.3 0.0 1.8 2.3 0.3 2.7 3.7 7.5 7.3 0.1 0.0 0.0 0.0 2.9 8.2 0.0 6.2 0.0 13.8 0.0 2.0 0.1 37.0 0.0 0.0 0.0 0.0 1.2 0.0 11.6 0.1 8.7 0.1 1.5 0.2 0.0 5.2 0.0 0.0 0.9 3.0 0.0 10.3 1.5 1.3 0.4 29.7 0.0 6.4 6.1 0.2 0.0 10.4 2.0 0.0 1.0 2.8 9.2 2.0 0.1 6.1 0.0 0.0 0.0 6.2 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 6.2 16.6 12.1 11.0 7.3 6.8 8.5 14.3 2.9 0.0 0.0 0.0 0.0 0.2 16.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 14.3 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 15.3 0.1 0.0 0.0 0.5 1.2 6.5 0.8 3.0 1.9 0.0 0.2 0.0 0.0 0.0 RNF187 "RACO-1, RACO1" ENSG00000168159 "Ring finger protein 187" Q5TA31 1 228487061-228495766 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 8.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 42.3;U-266/70: 76.8" "Low region specificity" "Detected in all" HPA030098 Approved Supported Nucleoplasm,Cytosol Yes No "Nucleoplasm, Cytosol" "HPA030098: AB_10602923" "unprognostic (4.84e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (2.83e-4)" "unprognostic (4.90e-3)" "unprognostic (1.13e-1)" "unprognostic (2.93e-2)" "unprognostic (3.46e-2)" "unprognostic (2.53e-1)" "unprognostic (1.36e-1)" "unprognostic (5.66e-3)" "unprognostic (1.37e-1)" "unprognostic (1.55e-1)" "unprognostic (2.92e-3)" "unprognostic (1.59e-1)" "unprognostic (9.76e-2)" "unprognostic (1.76e-1)" "unprognostic (2.32e-2)" 15.7 30.3 25.6 12.5 28.1 12.3 10.3 33.2 54.7 11.4 10.7 15.5 12.5 14.7 12.9 12.2 18.0 14.2 14.5 17.7 25.2 24.9 16.2 20.4 11.5 9.8 20.2 29.3 20.2 19.4 22.3 16.4 8.8 22.7 15.0 6.6 12.3 30.3 12.6 55.5 15.5 13.2 8.6 16.3 19.0 14.2 9.5 11.4 11.1 27.9 19.4 11.2 10.0 13.1 2.0 1.7 8.7 2.1 1.0 2.3 0.6 9.4 7.1 5.0 10.5 5.5 3.6 9.7 7.9 4.9 5.0 3.8 3.6 6.6 21.6 16.6 9.0 4.1 7.6 6.3 6.7 1.9 9.8 8.1 6.5 5.3 4.7 15.0 7.4 12.8 6.3 12.1 3.8 5.2 6.1 4.4 16.5 10.4 42.3 3.6 5.3 11.8 6.6 11.2 6.7 7.3 10.1 4.6 20.3 3.6 6.0 11.1 11.2 8.1 16.8 21.4 1.7 11.8 17.8 10.1 6.2 6.4 6.7 7.5 76.8 23.0 11.8 16.7 7.8 10.4 0.0 1.1 8.7 1.3 2.1 1.5 1.2 1.5 2.3 1.4 2.0 1.4 1.2 0.3 1.0 1.4 1.7 1.3 0.6 25.6 28.1 33.2 47.3 25.2 24.9 20.2 29.3 22.7 11.4 23.8 13.3 36.1 41.5 32.2 84.0 56.1 38.2 8.1 18.2 38.4 17.7 14.3 96.2 13.8 0.5 22.6 33.3 0.0 20.8 20.1 31.6 30.3 44.9 56.2 24.8 52.4 38.4 29.4 29.7 2.5 22.7 23.8 37.1 6.4 26.7 103.2 20.8 20.4 24.4 99.3 37.8 19.4 38.1 4.4 22.0 48.3 14.8 41.5 27.6 24.7 RNF2 "BAP-1, BAP1, DING, HIPI3, RING1B, RING2" ENSG00000121481 "Ring finger protein 2" Q99496 1 185045364-185102608 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 78.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026803 Uncertain Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA026803: AB_10602086" "unprognostic (1.23e-1)" "unprognostic (3.71e-2)" "unprognostic (1.70e-1)" "unprognostic (1.35e-3)" "unprognostic (1.70e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.08e-5)" "unprognostic (5.85e-2)" "unprognostic (3.56e-3)" "unprognostic (1.62e-2)" "unprognostic (2.01e-2)" "unprognostic (5.51e-2)" "prognostic unfavorable (1.94e-7)" "unprognostic (2.08e-1)" "unprognostic (5.51e-2)" "unprognostic (9.89e-3)" "unprognostic (2.52e-1)" 17.8 15.0 14.3 13.9 12.4 15.3 29.7 15.6 23.6 16.6 12.0 7.8 20.7 10.4 16.2 12.6 15.2 11.5 13.1 12.0 16.0 13.1 13.7 11.1 16.7 20.7 9.4 10.4 19.9 15.0 12.3 26.5 28.4 11.4 13.2 13.5 10.1 17.3 20.6 13.1 12.5 9.8 14.8 11.2 16.2 12.2 27.8 9.4 17.2 15.1 11.5 16.1 17.6 16.9 14.7 19.9 20.6 22.1 17.4 19.4 12.0 13.8 7.6 28.2 11.2 8.0 13.7 26.8 9.8 12.4 15.5 12.5 12.1 23.1 4.1 12.3 12.0 10.5 4.9 19.3 14.2 18.9 12.1 10.1 22.3 4.7 10.6 11.8 22.8 12.6 12.9 8.7 12.7 16.3 12.6 15.6 14.4 17.6 9.9 11.2 8.6 19.7 6.7 37.8 11.7 4.2 22.6 17.5 3.9 11.7 9.8 8.3 14.3 6.8 4.1 19.9 32.0 8.7 12.2 11.0 11.2 14.5 10.6 12.4 16.4 10.6 15.4 7.0 10.8 12.5 19.3 17.0 20.6 13.5 21.1 19.4 14.6 12.5 12.6 19.9 14.7 12.8 12.6 7.9 17.4 22.1 10.0 13.2 12.0 14.3 12.4 15.6 23.6 16.0 13.1 9.4 10.4 11.4 9.4 3.0 5.4 10.8 18.7 20.6 9.2 5.9 7.6 5.3 3.4 8.7 3.9 22.5 19.9 10.5 4.8 17.9 4.0 0.0 11.1 42.7 21.1 12.7 12.7 7.3 17.9 6.4 28.4 21.5 20.3 5.2 8.9 21.4 20.3 28.9 10.4 8.5 10.4 11.5 11.0 10.6 5.9 0.0 12.1 29.9 78.0 17.8 23.8 15.0 11.5 33.6 RNF20 "BRE1, BRE1A, FLJ11189, FLJ20382, hBRE1, KAIA2779" ENSG00000155827 "Ring finger protein 20" Q5VTR2 9 101533851-101563344 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012478, HPA051773" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB012478: , HPA051773: AB_2681604" "unprognostic (7.02e-2)" "unprognostic (2.21e-1)" "unprognostic (9.04e-2)" "unprognostic (2.03e-1)" "unprognostic (3.12e-2)" "unprognostic (1.68e-1)" "unprognostic (1.41e-2)" "unprognostic (2.90e-1)" "unprognostic (2.01e-1)" "unprognostic (5.47e-2)" "unprognostic (7.27e-3)" "unprognostic (1.60e-1)" "prognostic favorable (1.64e-6)" "unprognostic (2.72e-1)" "unprognostic (1.76e-1)" "unprognostic (2.32e-1)" "unprognostic (9.54e-3)" 16.4 17.1 24.6 17.0 24.9 12.1 17.7 24.4 26.3 18.6 16.4 27.7 15.9 10.1 18.3 18.7 20.4 19.1 13.2 24.1 22.3 22.1 20.5 14.4 14.9 15.5 25.2 20.7 21.1 19.5 31.5 23.1 15.1 30.0 21.6 16.1 16.8 16.2 17.7 32.0 16.3 12.5 23.6 28.8 17.0 13.9 28.2 25.8 21.2 22.0 15.3 18.6 21.1 19.0 13.0 12.5 21.0 23.5 13.8 18.6 10.4 9.7 24.8 14.3 15.7 17.7 14.0 12.2 17.0 13.7 17.1 15.0 15.0 10.4 21.6 9.2 13.1 14.3 24.8 16.6 14.5 17.6 22.5 7.7 11.5 22.7 15.0 13.0 19.8 13.9 13.7 15.6 15.1 19.6 12.9 10.0 8.0 10.9 12.8 18.5 12.7 15.4 5.3 31.6 22.0 12.6 14.9 49.6 10.7 7.0 9.4 15.3 19.3 24.1 12.9 14.0 15.0 11.6 9.4 14.1 15.9 16.0 11.3 14.3 13.9 42.7 11.8 14.0 7.5 19.2 21.0 12.7 19.1 18.6 17.5 14.0 13.0 15.4 13.9 12.5 11.2 16.2 14.9 13.9 13.8 23.5 7.9 11.9 10.4 24.6 24.9 24.4 26.3 22.3 22.1 25.2 20.7 30.0 25.8 23.8 24.5 7.5 8.1 5.7 29.1 42.4 10.2 33.5 26.1 21.0 5.9 13.6 5.0 14.3 26.2 11.3 12.2 0.0 12.1 9.6 11.5 7.2 20.9 16.8 14.4 41.3 23.6 7.4 23.8 15.2 16.7 20.0 10.1 27.9 10.7 27.6 10.2 15.3 22.3 9.1 23.0 32.3 14.4 24.7 15.8 5.1 6.4 16.0 12.0 5.4 RNF208 DKFZP761H1710 ENSG00000212864 "Ring finger protein 208" Q9H0X6 9 137220247-137221581 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.4" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 21.6;Horizontal cells: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Hep G2: 12.4;MCF7: 29.7;REH: 23.9;RPMI-8226: 13.2;T-47d: 10.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021256, HPA021429" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021256: AB_1844331, HPA021429: AB_2180654" "unprognostic (2.97e-1)" "unprognostic (7.37e-2)" "unprognostic (1.46e-2)" "unprognostic (6.33e-3)" "unprognostic (9.99e-2)" "unprognostic (2.10e-3)" "unprognostic (3.52e-3)" "unprognostic (1.50e-1)" "unprognostic (9.51e-2)" "unprognostic (2.95e-2)" "unprognostic (8.42e-3)" "unprognostic (1.60e-1)" "prognostic favorable (1.12e-8)" "unprognostic (3.41e-1)" "unprognostic (1.69e-1)" "unprognostic (7.66e-2)" "unprognostic (3.40e-2)" 3.7 7.1 17.3 1.2 13.3 0.7 4.3 10.1 27.4 1.9 1.7 1.5 1.2 2.0 1.7 2.7 4.6 3.4 1.2 6.2 18.1 10.8 3.7 8.1 1.8 3.4 9.4 4.6 1.5 8.8 5.7 3.0 1.2 3.5 4.0 0.6 1.8 11.4 5.5 13.2 6.6 2.4 1.2 3.3 1.8 3.4 3.1 2.1 1.2 2.1 3.2 1.2 2.1 1.3 0.6 0.0 0.8 0.7 0.0 1.2 0.8 0.8 1.5 1.1 1.8 0.7 0.1 3.2 0.4 0.6 0.7 0.7 4.5 2.8 0.4 2.3 0.5 0.1 2.3 2.5 0.1 0.1 1.1 0.9 3.1 5.2 12.4 2.4 0.6 1.1 0.5 0.8 0.7 0.3 2.8 0.7 4.6 4.4 0.2 0.3 29.7 1.6 1.4 1.3 2.9 3.3 23.9 0.2 13.2 0.8 0.1 3.0 10.6 0.3 0.9 0.6 0.6 10.7 2.3 0.3 0.5 0.7 1.1 0.0 0.4 0.4 0.1 1.4 0.2 0.6 0.0 0.4 0.2 0.0 0.5 1.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.8 0.0 0.7 0.0 0.0 0.8 17.3 13.3 10.1 27.4 18.1 10.8 9.4 4.6 3.5 2.1 6.0 2.1 1.5 1.1 0.3 8.2 8.2 5.1 4.0 0.0 7.0 11.8 0.2 21.6 3.9 0.5 1.4 4.0 0.0 1.9 0.2 0.9 1.6 0.0 6.8 1.1 15.9 7.5 1.3 0.3 0.5 1.1 0.0 1.7 1.8 3.9 5.5 3.5 4.2 3.2 8.8 3.2 0.0 0.9 1.7 2.2 1.6 0.2 0.8 3.3 0.7 RNF216 "TRIAD3, UBCE7IP1, ZIN" ENSG00000011275 "Ring finger protein 216" Q9NWF9 7 5620047-5781739 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Ubl conjugation pathway" Transferase "Disease mutation, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 118.7;Late spermatids: 171.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018955, HPA021123" Supported Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA018955: AB_1858500, HPA021123: AB_1858501" "unprognostic (3.31e-2)" "unprognostic (4.24e-2)" "unprognostic (1.28e-2)" "unprognostic (1.58e-2)" "unprognostic (1.81e-2)" "unprognostic (1.56e-1)" "prognostic unfavorable (2.26e-4)" "unprognostic (2.35e-1)" "unprognostic (2.40e-1)" "unprognostic (1.40e-2)" "prognostic favorable (6.24e-5)" "unprognostic (2.88e-2)" "unprognostic (9.01e-2)" "unprognostic (3.49e-1)" "unprognostic (1.73e-2)" "unprognostic (1.06e-2)" "unprognostic (3.69e-3)" 16.9 14.9 22.0 18.8 24.8 22.2 18.4 33.5 27.8 17.8 26.9 22.0 13.4 11.5 26.9 13.3 18.7 19.6 14.2 29.1 20.5 17.4 12.7 11.8 14.9 23.8 23.8 14.8 25.6 21.3 23.2 24.9 14.6 20.4 17.7 11.8 18.9 16.2 21.5 22.5 15.1 20.1 25.0 18.7 23.3 18.3 34.3 26.3 18.5 19.8 9.6 24.1 17.7 30.7 8.8 6.7 24.5 8.4 10.0 9.7 6.5 14.3 15.4 12.7 21.6 15.2 13.1 8.7 15.3 16.1 15.9 14.8 11.1 8.2 12.5 7.9 17.1 27.6 10.3 13.1 10.8 13.0 7.8 11.4 9.7 9.3 11.2 18.1 15.8 16.6 13.5 13.8 12.2 14.9 13.2 12.6 12.2 19.3 8.8 17.6 22.0 5.9 25.2 17.4 8.1 12.9 15.1 17.9 7.0 9.5 12.1 9.7 15.4 9.7 24.3 8.7 14.9 9.6 16.2 13.6 16.1 29.1 16.4 13.8 7.2 5.3 10.2 12.1 14.7 25.6 1.3 7.7 24.5 9.0 8.4 9.0 7.3 7.9 6.7 6.7 8.8 9.7 9.1 13.1 10.0 7.7 5.4 7.0 6.5 22.0 24.8 33.5 27.8 20.5 17.4 23.8 14.8 20.4 26.3 6.0 19.2 11.0 16.6 14.7 36.2 25.7 5.1 13.4 14.8 12.2 49.1 11.9 21.6 15.1 118.7 24.8 10.2 0.0 12.0 11.1 20.5 16.4 18.5 13.4 19.2 27.0 5.8 23.9 19.0 171.4 34.5 23.8 11.8 33.3 12.5 35.8 13.1 3.5 28.3 10.6 49.0 25.8 22.7 96.9 99.0 14.2 12.7 23.0 10.8 13.1 RNF219 "C13orf7, FLJ13449" ENSG00000152193 "Ring finger protein 219" Q5W0B1 13 78614291-78659179 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 51.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034785, HPA034786" Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA034785: AB_10601496, HPA034786: AB_2674331" "unprognostic (2.99e-1)" "unprognostic (1.11e-1)" "unprognostic (1.79e-1)" "unprognostic (2.60e-1)" "unprognostic (7.88e-2)" "unprognostic (1.34e-2)" "unprognostic (2.83e-3)" "unprognostic (1.50e-1)" "unprognostic (1.67e-2)" "unprognostic (1.45e-1)" "unprognostic (3.84e-2)" "unprognostic (4.26e-3)" "prognostic unfavorable (4.99e-6)" "unprognostic (6.87e-2)" "unprognostic (2.01e-1)" "unprognostic (6.91e-2)" "unprognostic (2.53e-2)" 17.6 7.7 10.7 8.9 15.5 3.4 10.6 24.2 16.3 11.9 8.0 4.7 7.3 7.4 11.3 7.8 8.7 9.1 7.1 10.6 10.7 10.3 7.6 6.7 8.0 13.9 11.9 12.1 12.3 6.6 5.0 11.5 12.2 12.7 10.2 8.5 4.0 7.1 10.1 8.7 8.5 8.7 12.7 13.4 13.6 6.8 21.7 13.4 21.8 9.5 8.5 16.7 12.8 9.2 10.5 7.0 8.2 10.6 12.3 13.3 7.8 11.2 4.4 19.4 11.3 6.8 6.6 8.8 9.4 7.1 9.3 11.7 8.7 8.4 19.0 4.6 5.9 6.1 11.2 15.2 7.4 16.4 11.8 11.1 29.0 5.7 7.7 5.7 28.0 9.1 6.3 8.3 7.7 8.4 5.3 7.6 9.7 7.5 2.6 12.1 3.1 17.0 9.5 0.0 12.0 4.9 19.9 15.9 7.3 6.3 6.0 14.1 7.9 6.5 8.3 7.0 11.5 4.2 22.6 6.2 8.1 7.4 5.3 7.8 2.7 3.1 18.3 13.0 17.1 8.7 4.8 6.0 8.2 9.5 9.7 11.3 10.5 10.7 11.6 7.0 10.1 13.3 11.9 2.0 12.3 10.6 5.9 10.4 7.8 10.7 15.5 24.2 16.3 10.7 10.3 11.9 12.1 12.7 13.4 14.9 3.0 8.0 7.0 7.4 10.5 18.7 10.2 12.0 10.3 8.7 5.9 13.2 5.0 9.1 22.1 14.3 2.7 0.0 3.9 10.1 8.0 5.7 9.3 5.7 8.1 9.5 4.7 12.3 10.6 11.0 13.6 12.8 11.8 7.2 4.7 9.6 7.1 2.9 9.9 7.6 8.0 0.0 5.2 23.9 51.1 10.0 4.2 9.5 7.1 5.8 RNF220 "C1orf164, FLJ10597" ENSG00000187147 "Ring finger protein 220" Q5VTB9 1 44405194-44651724 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 57.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 37.2" "Low region specificity" "Detected in all" "HPA027577, HPA027578" Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA027577: AB_2672339, HPA027578: AB_10601482" "unprognostic (3.12e-2)" "unprognostic (1.24e-1)" "unprognostic (3.49e-2)" "unprognostic (2.56e-1)" "unprognostic (2.94e-2)" "unprognostic (6.96e-3)" "prognostic unfavorable (2.35e-6)" "unprognostic (1.55e-1)" "unprognostic (8.47e-2)" "unprognostic (2.13e-1)" "unprognostic (2.14e-3)" "unprognostic (2.96e-2)" "prognostic unfavorable (5.12e-4)" "unprognostic (1.51e-2)" "unprognostic (1.98e-1)" "unprognostic (1.37e-3)" "unprognostic (6.46e-2)" 9.8 7.4 20.9 9.6 38.5 12.7 6.7 12.6 40.1 5.4 9.2 40.7 2.7 10.7 8.0 8.8 6.0 9.3 4.5 9.2 33.4 20.9 7.4 5.1 7.4 7.6 49.8 19.8 9.5 8.1 7.0 5.7 8.7 25.8 7.7 5.9 4.2 9.3 7.1 28.4 8.7 8.8 8.0 57.4 7.9 7.6 7.0 49.6 5.0 7.3 4.6 8.0 7.9 5.6 3.6 6.6 2.8 2.3 1.9 4.3 1.4 6.1 2.9 12.6 4.2 4.9 4.5 9.4 7.2 6.7 5.6 8.3 5.0 6.1 11.9 6.4 5.8 8.0 4.0 14.0 5.9 7.6 14.7 12.5 16.3 9.1 8.4 7.9 11.5 8.4 4.9 13.6 6.2 10.0 4.6 3.2 6.3 12.0 5.9 3.5 4.2 11.3 8.7 13.7 6.7 6.6 9.6 7.4 8.5 3.6 3.8 5.7 7.0 6.1 4.3 8.7 4.6 3.2 20.4 4.9 6.0 6.4 5.6 13.3 13.5 12.9 8.5 4.9 37.2 3.5 2.4 2.3 2.8 3.2 1.8 2.4 2.4 1.0 4.3 3.4 3.6 1.9 1.7 1.5 1.9 1.3 6.6 3.2 1.4 20.9 38.5 12.6 30.8 33.4 20.9 49.8 19.8 25.8 49.6 8.9 12.0 15.9 12.3 13.5 23.6 19.4 25.5 4.0 9.1 22.7 23.6 15.6 14.9 16.5 7.9 16.1 22.2 46.7 24.8 20.6 12.8 18.6 10.4 25.9 22.1 22.3 17.3 15.4 25.1 11.8 17.8 12.8 11.8 15.4 22.6 13.2 19.6 20.1 13.1 27.9 17.0 6.5 9.9 27.4 27.9 15.3 8.5 20.0 25.2 12.7 RNF25 "AO7, FLJ13906" ENSG00000163481 "Ring finger protein 25" Q96BH1 2 218663864-218672411 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036420, HPA036421" Uncertain Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA Cytosol "Nucleoplasm, Actin filaments" "HPA036420: AB_2675114, HPA036421: AB_10669604" "unprognostic (3.22e-2)" "unprognostic (7.85e-3)" "unprognostic (1.34e-2)" "unprognostic (2.29e-2)" "unprognostic (1.33e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (6.58e-4)" "unprognostic (3.58e-2)" "unprognostic (2.67e-2)" "unprognostic (3.46e-1)" "unprognostic (2.04e-3)" "unprognostic (8.82e-2)" "unprognostic (1.26e-3)" "unprognostic (2.50e-1)" "unprognostic (1.37e-1)" "unprognostic (2.44e-1)" "unprognostic (6.69e-2)" 13.4 12.7 13.9 11.1 16.1 6.2 13.7 13.4 27.6 17.3 13.3 17.1 9.8 4.3 16.6 16.2 12.2 16.8 11.8 17.2 13.1 16.5 13.7 15.6 11.9 12.1 12.1 11.6 17.8 13.0 19.3 14.8 17.7 15.4 14.7 9.0 15.3 13.6 17.9 16.9 15.7 10.3 16.0 10.0 12.9 11.8 18.4 9.1 15.3 16.8 12.7 16.8 14.0 11.8 13.3 8.2 23.3 11.2 14.8 15.0 13.9 5.9 7.6 6.9 8.0 10.6 6.5 7.5 6.8 17.1 23.4 21.8 12.7 4.0 4.0 5.4 14.3 12.9 5.4 8.0 13.3 10.2 4.3 10.9 5.4 5.6 12.0 13.0 4.8 5.9 14.3 12.4 21.2 14.3 6.5 12.7 15.4 9.1 6.2 15.0 17.0 5.4 5.9 11.0 4.9 8.7 7.6 4.4 5.8 14.3 6.4 7.0 7.9 5.2 5.9 10.1 5.0 7.0 8.8 7.3 13.3 6.3 5.2 9.6 5.4 4.2 6.7 11.2 6.0 8.0 23.3 10.6 14.9 13.9 10.3 12.6 11.9 13.7 13.6 8.2 13.3 15.0 11.7 8.9 14.8 11.2 7.4 11.5 13.9 13.9 16.1 13.4 27.6 13.1 16.5 12.1 11.6 15.4 9.1 0.0 0.3 4.7 4.6 5.6 7.4 3.1 5.1 5.3 2.3 1.8 7.9 11.1 13.3 10.5 10.3 5.9 6.4 0.0 11.4 8.1 7.2 3.0 6.9 6.4 11.3 4.8 1.2 9.2 5.9 3.4 6.6 4.6 8.5 10.0 4.9 7.0 10.2 8.6 12.0 11.5 4.5 25.8 6.1 14.4 11.9 5.9 8.4 10.1 4.8 3.9 RNF26 MGC2642 ENSG00000173456 "Ring finger protein 26" Q9BY78 11 119334527-119337313 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027620 Uncertain Approved Nucleoplasm,Vesicles,Cytosol NA Yes Nucleoplasm "Vesicles, Cytosol" "HPA027620: AB_1856356" "unprognostic (9.23e-3)" "unprognostic (3.54e-2)" "unprognostic (1.36e-1)" "unprognostic (8.68e-3)" "unprognostic (3.40e-1)" "unprognostic (1.07e-2)" "prognostic unfavorable (3.19e-4)" "unprognostic (2.14e-2)" "unprognostic (3.26e-1)" "unprognostic (1.69e-1)" "unprognostic (7.24e-3)" "unprognostic (6.22e-2)" "prognostic favorable (3.45e-6)" "unprognostic (9.61e-2)" "unprognostic (3.50e-2)" "unprognostic (4.41e-2)" "prognostic unfavorable (7.73e-4)" 19.0 21.5 13.6 15.4 21.6 25.6 16.9 18.4 38.9 19.8 22.0 17.6 14.5 20.3 31.2 15.6 26.0 24.4 19.8 15.1 17.1 13.8 22.3 28.7 17.3 17.5 15.0 16.6 25.6 18.5 31.4 14.3 27.5 27.2 19.2 18.2 20.2 20.0 28.5 17.6 19.8 21.4 27.0 14.3 19.8 24.3 27.6 13.0 26.7 20.6 14.0 21.1 25.8 18.1 13.8 14.2 7.1 15.5 9.8 16.7 16.2 15.7 17.5 16.4 19.3 16.2 12.8 17.4 17.2 18.6 20.1 15.9 29.5 33.2 14.0 23.8 20.4 30.5 28.8 23.2 25.9 12.6 16.6 12.8 36.8 8.2 24.3 12.4 15.4 15.3 13.3 13.3 25.0 22.6 13.2 15.2 21.7 17.8 22.0 13.8 34.5 14.1 16.0 16.4 18.3 22.4 14.7 16.8 11.1 12.3 11.5 11.7 11.3 13.9 17.6 4.6 16.5 39.9 12.9 10.0 24.3 16.2 12.7 15.6 5.3 8.6 0.1 8.1 26.1 18.9 7.1 15.5 3.9 16.7 14.5 11.0 9.0 12.7 14.5 14.2 13.8 14.5 12.4 1.1 9.8 14.1 8.1 6.6 16.2 13.6 21.6 18.4 38.9 17.1 13.8 15.0 16.6 27.2 13.0 3.0 6.5 9.0 12.0 6.2 9.1 0.5 28.1 2.7 7.9 10.4 2.0 31.3 5.0 17.7 3.4 7.5 10.0 0.0 15.0 54.3 13.5 11.2 7.0 19.8 18.0 4.8 13.2 8.6 9.9 4.9 13.0 8.8 1.7 12.6 10.2 9.7 11.8 10.2 16.6 10.3 7.6 6.5 10.3 12.2 8.3 7.4 20.4 9.6 14.5 8.6 RNF34 "FLJ21786, RIF, RIFF" ENSG00000170633 "Ring finger protein 34" Q969K3 12 121400041-121430623 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074151 Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA074151: AB_2686668" "unprognostic (3.54e-1)" "unprognostic (4.83e-2)" "unprognostic (1.90e-1)" "unprognostic (6.10e-2)" "unprognostic (9.92e-2)" "unprognostic (2.55e-2)" "prognostic unfavorable (6.72e-8)" "unprognostic (3.39e-1)" "unprognostic (9.99e-2)" "unprognostic (1.60e-2)" "unprognostic (5.87e-3)" "unprognostic (2.80e-2)" "prognostic unfavorable (4.63e-4)" "unprognostic (1.09e-1)" "unprognostic (3.55e-1)" "unprognostic (5.55e-3)" "prognostic favorable (3.02e-4)" 11.9 10.6 18.2 19.6 23.4 10.4 12.3 25.2 26.9 11.2 17.3 21.5 10.0 17.0 15.0 12.7 14.4 11.7 15.5 16.0 17.6 17.7 10.8 11.1 11.6 27.2 19.3 19.4 14.0 12.2 11.1 17.1 10.2 19.3 10.2 14.2 12.7 12.4 12.9 45.7 13.8 16.0 15.0 21.3 19.4 16.3 20.8 17.2 21.7 12.7 9.1 22.5 16.4 11.5 31.8 16.9 36.5 20.3 29.9 42.8 25.8 18.5 22.5 14.7 15.4 11.7 10.8 18.5 19.8 17.8 19.8 15.2 27.9 7.1 26.8 15.3 21.3 10.5 13.4 22.2 12.4 17.7 38.9 13.0 30.9 15.6 25.6 14.0 26.7 21.8 9.5 16.9 17.2 15.0 11.4 20.7 16.1 23.3 12.5 19.4 14.7 23.4 39.1 18.9 11.0 20.5 22.4 19.4 15.7 13.7 22.3 21.8 14.2 24.9 9.3 15.1 14.2 16.1 20.3 16.6 17.1 12.4 14.8 15.6 22.4 36.9 29.1 12.2 18.8 17.1 26.9 17.9 36.5 32.4 19.9 33.0 31.8 37.8 34.1 16.9 25.5 32.8 32.6 27.4 29.9 20.3 14.3 42.8 25.8 18.2 23.4 25.2 26.9 17.6 17.7 19.3 19.4 19.3 17.2 14.9 15.2 25.2 16.8 15.5 12.1 18.7 20.4 17.4 12.5 8.7 3.9 20.4 31.5 27.7 10.1 13.5 18.6 23.3 23.8 32.6 15.4 11.7 17.3 9.0 18.1 12.7 39.2 14.1 14.2 7.0 15.8 11.3 16.9 39.7 16.1 17.1 23.7 16.9 17.0 15.3 18.7 19.4 14.6 73.2 30.9 14.1 20.3 41.5 19.5 21.9 RNF38 ENSG00000137075 "Ring finger protein 38" Q9H0F5 9 36336396-36487548 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 20 "Early spermatids: 442.1;Late spermatids: 1049.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015853 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA015853: AB_1856365" "unprognostic (2.26e-1)" "unprognostic (2.49e-1)" "unprognostic (1.53e-1)" "unprognostic (8.16e-2)" "unprognostic (6.49e-2)" "unprognostic (3.65e-3)" "unprognostic (3.30e-3)" "unprognostic (1.64e-2)" "unprognostic (1.58e-1)" "unprognostic (9.69e-2)" "unprognostic (2.29e-1)" "unprognostic (4.15e-2)" "prognostic favorable (2.90e-6)" "unprognostic (3.88e-2)" "unprognostic (5.94e-2)" "unprognostic (1.46e-1)" "unprognostic (5.39e-2)" 11.9 8.0 13.1 7.7 14.5 20.3 11.1 18.8 17.0 13.6 14.1 12.2 8.1 6.4 16.3 12.9 10.1 11.7 9.6 9.5 10.0 11.1 12.3 6.8 11.7 14.5 9.2 12.3 24.4 12.8 12.2 5.7 21.2 14.0 15.3 10.1 14.4 10.3 12.8 9.6 8.9 10.2 16.9 8.5 11.4 8.7 46.3 10.0 13.1 14.4 4.3 11.1 16.5 13.5 6.2 4.1 12.2 4.3 8.4 8.7 4.2 9.0 5.2 20.0 11.8 9.2 8.5 19.6 5.7 7.1 7.0 9.2 8.7 5.0 13.7 6.0 10.9 9.2 3.6 12.7 6.6 10.8 12.1 5.4 16.5 7.3 8.5 7.1 12.1 15.1 8.7 7.2 8.8 8.6 11.6 17.7 13.6 3.4 13.2 11.3 3.1 12.4 6.4 13.3 6.0 3.7 11.4 9.0 7.5 11.9 10.5 8.3 9.0 6.4 6.5 6.4 24.4 6.2 12.4 17.4 6.7 10.2 3.9 6.7 8.7 18.1 9.7 6.1 10.2 8.5 12.2 4.3 7.2 7.2 4.1 6.0 5.8 6.5 7.6 4.1 6.2 7.0 7.0 8.0 8.4 4.1 3.3 8.7 4.2 13.1 14.5 18.8 17.0 10.0 11.1 9.2 12.3 14.0 10.0 11.9 13.2 7.3 9.1 15.3 13.4 14.1 12.7 2.7 11.4 7.0 17.7 11.6 8.3 9.5 442.1 22.6 12.5 0.0 10.2 9.9 11.0 16.6 5.8 15.7 9.9 25.4 16.1 22.7 20.0 1049.3 30.5 14.5 18.6 6.4 14.6 14.1 11.6 2.9 37.4 13.4 22.6 12.9 15.8 31.6 18.9 13.0 12.5 17.3 10.5 14.0 RNF4 "RES4-26, SLX5, SNURF" ENSG00000063978 "Ring finger protein 4" P78317 4 2462220-2625320 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022047, HPA049356" Approved Supported "Nucleoplasm,Nuclear bodies,Microtubule ends" NA NA "Nucleoplasm, Nuclear bodies" "Microtubule ends" "HPA022047: , HPA049356: AB_2680726" "unprognostic (8.38e-3)" "unprognostic (1.69e-1)" "unprognostic (1.29e-2)" "unprognostic (1.33e-1)" "unprognostic (1.45e-1)" "unprognostic (9.31e-3)" "unprognostic (9.03e-3)" "prognostic unfavorable (6.38e-4)" "unprognostic (1.34e-1)" "unprognostic (6.79e-2)" "unprognostic (2.58e-1)" "unprognostic (5.64e-2)" "unprognostic (1.93e-2)" "unprognostic (6.40e-2)" "unprognostic (4.70e-2)" "unprognostic (8.67e-2)" "unprognostic (1.54e-1)" 28.6 29.1 25.4 32.2 39.4 36.4 28.6 35.9 50.3 28.2 25.1 34.8 28.4 27.0 32.2 28.0 30.3 27.8 27.1 24.6 22.7 22.8 32.3 25.6 27.4 41.9 23.5 23.4 32.1 31.0 31.2 30.0 29.4 36.7 28.5 26.7 29.2 36.1 28.5 26.0 28.5 29.3 31.8 23.1 41.9 28.9 36.8 23.7 50.4 29.3 19.1 51.5 27.7 26.3 36.9 35.3 41.8 39.9 39.7 43.7 45.8 20.1 19.1 20.0 13.9 17.5 18.2 22.4 24.6 27.7 26.2 23.8 21.6 19.0 25.5 14.7 24.8 34.7 13.2 21.2 19.3 25.0 12.0 12.8 30.9 19.7 20.7 26.2 21.7 27.1 21.1 23.4 24.3 20.3 18.4 24.2 21.7 16.3 35.3 26.7 13.8 34.7 30.3 30.8 16.9 24.0 25.4 19.1 13.2 17.8 25.7 18.6 17.6 17.3 13.4 17.2 22.5 21.3 16.4 20.1 22.9 11.2 21.5 37.7 45.7 60.8 28.3 22.3 23.7 23.7 14.6 29.6 41.8 43.7 39.3 43.7 36.9 37.5 43.0 35.3 27.2 36.2 36.3 32.9 39.7 39.9 23.6 39.9 45.8 25.4 39.4 35.9 50.3 22.7 22.8 23.5 23.4 36.7 23.7 20.8 20.3 25.1 14.7 24.5 12.4 15.7 17.8 13.4 21.6 21.0 15.7 18.0 18.3 19.5 11.0 20.2 14.8 0.0 20.4 27.8 17.2 19.5 13.9 17.8 17.4 12.7 11.6 15.4 34.2 17.3 15.8 20.0 6.8 27.9 14.2 9.2 25.2 14.0 19.4 17.7 16.5 25.8 21.7 26.7 47.3 28.1 18.2 33.1 15.6 29.1 RNF40 "BRE1B, KIAA0661, RBP95, STARING" ENSG00000103549 "Ring finger protein 40" O75150 16 30761745-30776307 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 74.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041330, HPA054227" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA041330: AB_10793872, HPA054227: AB_2682422" "unprognostic (1.61e-1)" "unprognostic (1.74e-2)" "unprognostic (3.06e-1)" "unprognostic (4.87e-2)" "unprognostic (1.21e-1)" "unprognostic (4.01e-1)" "unprognostic (5.97e-3)" "unprognostic (1.56e-1)" "unprognostic (1.50e-1)" "unprognostic (1.89e-1)" "unprognostic (2.16e-2)" "unprognostic (1.91e-2)" "prognostic favorable (8.11e-8)" "unprognostic (9.96e-2)" "unprognostic (1.36e-1)" "unprognostic (6.55e-3)" "unprognostic (6.60e-3)" 21.0 25.2 26.4 21.3 26.5 40.8 20.9 36.8 28.2 25.8 21.0 22.0 18.0 20.1 28.4 17.0 25.6 24.4 21.3 22.8 22.2 17.1 20.0 21.2 20.2 21.9 20.9 18.9 30.5 24.4 44.0 21.6 25.3 19.6 21.4 15.1 20.0 27.3 21.1 20.0 25.5 20.3 18.3 18.6 20.0 19.6 43.1 22.8 23.5 26.8 15.4 20.6 22.5 21.4 7.6 12.0 15.0 14.9 9.9 13.3 12.9 20.3 31.9 19.4 18.4 14.8 15.5 21.2 20.8 16.1 24.1 18.8 25.8 19.0 16.2 30.6 17.8 16.5 22.1 35.3 18.5 18.9 23.2 41.4 15.9 35.0 26.7 19.8 27.4 18.6 14.4 15.5 30.2 17.1 16.1 20.2 14.4 34.8 15.5 14.6 34.0 26.1 25.8 20.2 16.3 19.3 51.9 21.4 31.2 10.6 18.1 32.4 23.8 16.3 20.9 15.1 10.7 32.0 31.2 21.8 27.1 13.8 19.1 23.7 23.2 28.5 32.2 22.5 24.4 27.6 6.2 11.5 14.7 12.9 13.4 13.3 7.6 7.2 9.9 12.0 6.5 5.4 8.3 15.0 9.9 14.9 6.2 6.2 12.9 26.4 26.5 36.8 28.2 22.2 17.1 20.9 18.9 19.6 22.8 11.9 26.4 10.4 10.9 12.4 14.5 2.0 30.6 9.4 11.4 21.0 3.9 13.3 74.6 12.9 18.8 10.9 22.6 0.0 11.6 13.8 11.8 14.0 4.6 18.7 18.7 4.8 13.4 9.8 24.6 16.8 16.7 13.0 16.9 9.0 20.9 16.6 13.6 14.0 16.6 19.9 13.3 12.9 11.2 19.7 9.4 17.2 19.0 13.6 23.6 10.0 RNF41 "NRDP1, SBBI03" ENSG00000181852 "Ring finger protein 41" Q9H4P4 12 56202175-56221933 "Enzymes, Predicted intracellular proteins" "Apoptosis, Autophagy, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016812 Approved Approved "Nucleoplasm,Nuclear bodies,Midbody ring" NA NA "Nucleoplasm, Nuclear bodies" "Midbody ring" "HPA016812: AB_1856370" "unprognostic (1.14e-2)" "unprognostic (6.30e-2)" "unprognostic (4.04e-2)" "unprognostic (6.86e-2)" "unprognostic (9.59e-2)" "unprognostic (8.22e-2)" "prognostic unfavorable (6.49e-4)" "unprognostic (6.93e-2)" "unprognostic (4.18e-2)" "unprognostic (1.67e-1)" "unprognostic (5.80e-2)" "unprognostic (5.90e-2)" "prognostic favorable (2.52e-5)" "unprognostic (1.64e-1)" "unprognostic (1.65e-1)" "unprognostic (1.45e-1)" "unprognostic (1.43e-1)" 22.2 17.6 18.6 11.8 30.2 12.0 14.3 30.9 47.1 16.2 15.0 16.9 12.3 8.5 16.4 9.7 16.5 17.7 18.0 22.6 17.3 22.4 14.1 10.5 16.5 14.8 15.3 18.2 17.0 16.0 17.9 16.7 14.6 25.3 25.2 13.6 14.6 10.5 15.6 21.2 10.1 10.8 20.3 11.8 13.5 12.2 10.1 12.1 11.3 20.5 10.1 17.0 16.2 11.5 24.6 13.1 41.1 11.5 13.4 12.5 12.3 7.5 11.6 12.6 20.0 26.5 19.3 9.4 25.3 25.1 22.8 18.6 14.2 9.9 14.6 13.5 21.4 7.6 8.7 17.0 12.2 16.6 15.3 9.3 19.6 8.3 8.1 55.6 21.4 21.4 24.6 28.7 19.0 33.6 30.1 22.1 12.4 13.9 15.0 12.6 12.2 12.2 9.6 15.2 7.6 13.6 13.3 9.1 8.8 12.1 11.1 23.1 14.0 22.1 12.7 20.0 13.2 17.8 25.2 13.3 11.5 12.3 14.8 9.8 10.8 12.4 13.3 13.7 12.9 13.7 21.0 11.5 41.1 12.5 11.4 11.2 22.7 10.6 10.9 13.1 24.6 11.0 11.2 15.8 13.4 11.2 10.2 12.1 12.3 18.6 30.2 30.9 47.1 17.3 22.4 15.3 18.2 25.3 12.1 41.7 26.4 27.0 18.8 10.6 26.2 20.1 25.5 24.1 25.0 15.7 21.6 13.2 14.9 14.3 78.7 16.4 9.3 23.3 18.6 14.4 14.9 30.9 24.4 14.9 17.6 27.0 19.5 22.1 29.2 38.0 21.3 21.9 6.8 21.6 13.2 23.9 17.8 16.1 24.4 15.8 16.9 25.8 21.4 9.9 12.2 14.4 14.1 15.0 13.6 16.9 RNF44 KIAA1100 ENSG00000146083 "Ring finger protein 44" Q7L0R7 5 176526697-176538025 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 100.6;Late spermatids: 305.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 37.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038981 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA038981: AB_10674846" "unprognostic (1.85e-1)" "unprognostic (3.07e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (2.57e-7)" "unprognostic (1.50e-1)" "unprognostic (2.56e-2)" "prognostic unfavorable (8.45e-4)" "unprognostic (1.61e-1)" "unprognostic (4.54e-2)" "unprognostic (5.36e-2)" "unprognostic (5.78e-2)" "unprognostic (1.61e-2)" "unprognostic (1.16e-1)" "unprognostic (1.56e-3)" "unprognostic (1.62e-1)" "unprognostic (5.12e-3)" "unprognostic (1.15e-2)" 10.8 12.7 16.5 27.1 17.7 38.5 12.4 27.1 21.6 10.3 14.8 14.3 7.3 20.5 12.6 10.0 17.0 12.1 12.4 10.0 15.7 10.9 15.2 9.3 14.1 34.9 14.6 13.7 17.8 16.0 10.3 11.0 20.6 13.4 12.8 13.5 11.1 15.9 10.8 10.2 20.5 22.2 8.6 14.5 38.1 16.4 14.5 16.1 43.3 17.3 7.5 24.1 14.1 13.3 4.1 1.9 9.4 3.1 3.3 5.5 2.6 3.7 8.6 13.8 12.8 2.7 2.3 37.0 2.2 1.9 1.4 1.9 13.0 8.3 7.2 13.6 1.2 6.7 10.2 6.1 13.1 1.7 27.7 10.8 7.6 7.3 12.0 3.5 8.8 10.6 4.4 10.6 1.6 5.0 4.8 4.0 14.0 8.5 10.8 2.0 13.0 20.5 19.9 18.2 4.9 10.6 8.4 3.6 10.3 5.0 8.8 17.0 20.7 3.3 9.1 12.5 9.5 10.0 17.8 6.6 3.7 5.6 3.0 4.0 13.8 10.3 9.8 1.8 18.3 4.8 0.0 2.7 4.7 5.5 3.1 4.1 3.5 4.2 4.6 1.8 4.1 4.2 5.0 9.4 3.3 2.5 1.9 5.0 2.6 16.5 17.7 27.1 21.6 15.7 10.9 14.6 13.7 13.4 16.1 11.9 29.4 27.6 8.3 35.7 14.8 11.0 17.8 8.1 15.9 12.2 9.8 8.2 6.6 10.2 100.6 18.0 25.7 0.0 13.9 10.1 10.4 14.5 15.1 8.7 13.1 27.0 39.1 15.4 41.2 305.8 18.4 19.0 5.0 7.2 38.5 8.8 18.6 20.1 11.7 8.4 7.7 6.5 7.2 3.4 10.0 43.3 10.1 35.5 34.0 12.3 RNF7 "CKBBP1, ROC2, SAG" ENSG00000114125 "Ring finger protein 7" Q9UBF6 3 141738204-141747560 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 615.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036995 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036995: AB_10673627" "unprognostic (5.68e-2)" "unprognostic (4.94e-3)" "unprognostic (1.83e-1)" "unprognostic (3.24e-1)" "unprognostic (9.11e-2)" "unprognostic (3.45e-1)" "prognostic unfavorable (2.21e-4)" "unprognostic (4.53e-2)" "unprognostic (1.24e-2)" "unprognostic (3.98e-3)" "unprognostic (5.17e-3)" "unprognostic (8.58e-3)" "prognostic unfavorable (1.54e-9)" "unprognostic (4.60e-1)" "unprognostic (2.20e-1)" "unprognostic (3.69e-2)" "unprognostic (2.36e-2)" 26.0 44.0 31.4 21.7 37.0 30.7 38.3 19.4 28.6 26.1 37.0 17.5 36.3 38.6 30.4 42.0 37.1 22.9 41.8 47.6 27.4 27.6 33.2 35.3 27.2 32.1 26.7 21.6 30.5 57.6 16.2 33.9 40.6 20.5 37.3 34.5 29.2 36.2 28.9 69.9 35.7 42.7 36.2 23.9 23.7 26.8 44.4 18.7 27.0 35.1 50.6 27.4 37.5 35.2 32.7 44.9 36.3 52.2 22.5 41.7 42.9 46.6 18.9 28.2 22.7 26.9 37.2 18.6 26.2 24.8 22.5 23.9 22.0 23.3 15.7 61.5 29.0 55.4 22.9 17.4 24.6 28.6 15.0 32.6 15.5 17.9 31.8 35.9 24.3 15.2 34.7 27.8 17.9 30.7 30.2 31.8 27.0 16.3 22.0 33.3 35.9 15.3 27.4 29.9 47.4 31.5 16.8 18.0 33.9 48.0 20.6 15.6 19.5 30.0 31.1 43.6 38.3 29.1 32.0 24.1 22.6 21.6 39.9 22.0 21.0 17.5 32.3 35.2 27.0 25.5 36.3 52.2 33.7 33.0 44.5 33.1 32.7 35.6 35.0 44.9 29.3 34.7 35.9 18.5 22.5 46.6 41.4 41.7 42.9 31.4 37.0 19.4 28.6 27.4 27.6 26.7 21.6 20.5 18.7 56.6 51.0 67.8 126.0 117.7 34.2 80.9 84.1 76.3 55.7 96.0 25.5 151.5 215.5 196.2 256.9 96.6 240.4 0.0 216.5 209.1 117.2 147.3 71.5 105.8 191.8 27.0 120.6 99.4 110.4 615.6 109.0 126.7 136.7 155.1 160.5 58.0 201.5 213.1 114.5 270.8 43.1 84.1 120.7 194.2 117.2 126.5 108.6 109.0 157.3 138.1 RNF8 KIAA0646 ENSG00000112130 "Ring finger protein 8" O76064 6 37353972-37394738 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Host-virus interaction, Mitosis, Ubl conjugation pathway" "Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 40.7" "Low region specificity" "Detected in all" "HPA050731, HPA064925" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA050731: AB_2681222, HPA064925: AB_2685385" "unprognostic (1.80e-2)" "unprognostic (2.23e-1)" "unprognostic (1.39e-2)" "unprognostic (8.20e-2)" "unprognostic (5.17e-2)" "unprognostic (3.99e-2)" "prognostic unfavorable (3.33e-5)" "unprognostic (2.36e-2)" "prognostic unfavorable (1.91e-4)" "unprognostic (2.26e-3)" "unprognostic (3.38e-1)" "prognostic unfavorable (4.99e-5)" "unprognostic (7.95e-3)" "unprognostic (1.78e-1)" "unprognostic (3.41e-2)" "unprognostic (3.66e-3)" "unprognostic (1.09e-1)" 8.0 11.7 13.1 8.2 17.8 8.9 11.5 25.7 18.7 9.2 9.5 10.6 6.8 6.9 13.5 5.7 18.3 12.0 8.8 17.6 13.4 14.8 11.8 7.5 10.8 8.3 12.0 16.0 13.2 6.5 11.9 16.4 10.2 13.7 8.6 8.2 8.0 10.2 11.9 15.2 9.9 8.4 10.7 9.6 7.7 7.6 19.8 13.8 6.6 8.0 9.4 13.3 12.9 15.2 8.8 8.3 2.6 8.1 7.6 10.8 5.5 6.6 4.0 9.7 11.5 7.8 11.3 2.8 6.9 8.6 13.2 14.5 6.0 3.7 8.3 4.2 6.7 11.4 6.3 13.5 8.8 13.8 8.7 13.1 14.2 7.0 8.9 4.5 7.6 10.5 5.6 8.5 7.8 9.1 8.1 12.6 9.8 9.6 2.9 7.5 4.4 9.1 9.4 6.7 3.4 5.3 7.2 8.9 5.7 6.7 4.7 19.1 6.4 5.2 5.9 9.5 6.6 5.3 7.4 5.7 8.7 7.7 8.2 10.2 8.6 11.3 40.7 4.2 10.8 10.0 1.0 4.6 2.6 10.8 6.0 10.0 8.8 8.1 10.2 8.3 6.0 7.1 9.4 0.6 7.6 8.1 3.6 9.3 5.5 13.1 17.8 25.7 18.7 13.4 14.8 12.0 16.0 13.7 13.8 17.9 23.4 13.0 21.7 16.3 26.0 28.3 10.2 28.1 15.9 24.4 37.3 20.9 13.3 20.8 35.2 15.8 8.6 0.0 16.6 21.6 23.9 20.0 27.7 14.7 15.4 47.7 21.4 22.1 14.2 20.2 24.7 13.8 10.1 20.8 16.1 21.5 23.6 15.6 29.0 16.8 29.6 12.9 16.4 43.0 33.1 19.3 4.9 15.8 16.2 17.0 RNFT2 "FLJ14627, TMEM118" ENSG00000135119 "Ring finger protein, transmembrane 2" Q96EX2 12 116738178-116853631 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.0" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 15.3;Cone photoreceptor cells: 15.7;Early spermatids: 40.0;Late spermatids: 40.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064161 Enhanced Approved Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA064161: AB_2685202" "unprognostic (1.56e-1)" "unprognostic (1.79e-2)" "unprognostic (1.54e-1)" "unprognostic (3.59e-1)" "unprognostic (3.98e-1)" "unprognostic (3.10e-2)" "unprognostic (8.14e-5)" "unprognostic (8.62e-2)" "unprognostic (6.28e-3)" "unprognostic (2.58e-1)" "unprognostic (9.25e-3)" "unprognostic (2.75e-1)" "unprognostic (7.61e-3)" "unprognostic (2.86e-2)" "unprognostic (1.35e-1)" "unprognostic (8.36e-3)" "unprognostic (4.01e-4)" 1.7 3.2 8.8 2.6 15.1 3.5 1.4 13.6 21.0 1.5 1.6 6.6 0.0 2.0 1.5 4.3 1.5 1.5 1.6 1.4 9.9 12.1 2.0 1.0 1.5 4.1 9.7 9.8 1.7 1.4 2.6 7.5 2.9 19.0 1.2 1.7 3.6 2.6 1.2 2.1 2.7 1.8 1.4 6.2 2.9 1.9 7.0 3.4 2.5 2.1 0.0 4.4 1.2 0.4 4.3 2.2 4.0 1.1 2.8 3.1 0.9 1.5 9.2 4.8 15.6 0.2 0.0 8.0 0.6 0.7 1.9 1.7 3.6 1.8 8.1 2.3 0.1 2.4 1.9 10.2 0.7 1.9 7.6 5.1 1.5 7.4 4.9 2.1 0.6 4.7 0.2 0.2 3.2 1.0 1.6 0.3 5.7 6.2 2.9 0.2 7.8 7.8 1.9 4.8 2.0 1.8 5.1 2.7 4.1 3.7 1.9 7.4 6.7 2.3 1.2 2.2 3.3 7.3 1.8 0.5 1.3 5.3 3.1 3.1 3.7 12.2 8.4 5.9 0.8 1.0 4.0 1.1 1.3 2.0 0.7 0.6 4.3 1.8 1.4 0.6 3.3 2.9 3.1 3.4 2.8 0.8 2.2 1.1 0.9 8.8 15.1 13.6 20.9 9.9 12.1 9.7 9.8 19.0 3.4 0.0 0.3 0.0 0.2 0.0 15.3 0.8 2.5 1.4 0.0 7.0 15.7 2.7 0.0 0.8 40.0 2.1 0.4 0.0 0.2 2.3 0.6 0.3 0.0 0.0 1.8 9.5 4.1 0.0 2.2 40.6 0.6 1.0 1.7 1.0 0.4 6.9 0.7 0.0 1.4 0.8 8.9 0.0 0.4 2.6 3.6 0.0 1.4 0.0 0.6 0.1 RNGTT "hCAP, HCE, HCE1" ENSG00000111880 "RNA guanylyltransferase and 5'-phosphatase" O60942 6 88610272-88963721 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA capping, mRNA processing" "Hydrolase, Multifunctional enzyme, Nucleotidyltransferase, Protein phosphatase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 43.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003750 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA003750: AB_1856383" "unprognostic (5.19e-3)" "unprognostic (1.00e-1)" "unprognostic (2.82e-2)" "unprognostic (3.45e-3)" "unprognostic (4.82e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.37e-4)" "unprognostic (4.48e-3)" "unprognostic (1.28e-1)" "unprognostic (4.05e-3)" "unprognostic (3.76e-2)" "unprognostic (1.55e-1)" "unprognostic (2.23e-3)" "unprognostic (9.83e-2)" "unprognostic (6.55e-2)" "unprognostic (1.67e-1)" "unprognostic (8.08e-3)" 9.1 12.1 10.2 19.6 12.2 14.2 9.9 18.5 13.1 10.0 8.1 8.7 7.0 7.4 11.1 7.2 12.5 8.7 7.2 9.6 10.5 16.0 9.4 11.8 9.4 26.3 9.8 6.4 10.4 6.6 12.1 23.1 11.6 11.1 9.8 9.8 9.4 8.4 11.6 10.5 9.0 10.7 10.7 10.7 14.3 7.5 15.0 10.4 28.0 10.0 7.8 28.2 10.9 13.8 18.6 4.4 5.7 4.6 8.0 8.4 4.3 5.7 8.8 13.7 17.5 8.1 8.5 8.2 13.2 8.6 10.7 13.6 10.0 4.4 14.9 10.8 9.4 14.2 7.2 16.0 10.6 19.7 20.2 12.5 19.3 7.9 8.0 6.6 20.7 11.0 5.4 9.3 11.1 10.8 9.2 9.4 8.2 19.1 12.0 15.8 7.6 9.1 14.8 8.2 9.5 7.7 18.0 21.2 8.4 9.6 8.9 8.1 11.6 10.9 6.6 7.2 13.6 7.1 20.8 7.5 8.7 8.0 9.8 17.7 10.9 19.0 8.4 12.8 15.5 15.8 3.5 3.0 5.7 6.4 4.6 6.4 18.6 7.2 7.9 4.4 16.8 8.2 8.4 2.5 8.0 3.9 3.1 6.7 4.3 10.2 12.2 18.5 13.1 10.5 16.0 9.8 6.4 11.1 10.4 0.0 18.1 34.7 7.8 7.3 19.8 9.2 2.5 13.4 18.2 12.2 37.3 8.7 0.0 5.7 4.9 4.7 5.9 0.0 4.3 8.0 7.1 6.8 8.1 8.6 6.7 14.3 8.7 6.2 7.5 3.6 5.5 9.8 3.3 6.4 5.7 8.7 5.6 3.5 7.4 5.8 43.3 6.5 7.5 19.9 21.7 7.5 9.8 13.8 6.3 5.8 RNH1 "RAI, RNH" ENSG00000023191 "Ribonuclease/angiogenin inhibitor 1" P13489 11 494512-507300 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039223, HPA040781" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 27000000 "Nucleoplasm, Cytosol" "HPA039223: AB_10795581, HPA040781: AB_10796227" "unprognostic (1.87e-1)" "unprognostic (2.44e-1)" "unprognostic (1.38e-1)" "unprognostic (1.59e-3)" "unprognostic (2.48e-3)" "unprognostic (6.09e-2)" "unprognostic (4.82e-3)" "unprognostic (1.35e-1)" "unprognostic (1.96e-1)" "unprognostic (2.20e-1)" "unprognostic (1.55e-1)" "unprognostic (2.44e-1)" "prognostic favorable (2.14e-5)" "unprognostic (3.35e-1)" "unprognostic (1.66e-1)" "unprognostic (4.78e-2)" "unprognostic (4.35e-2)" 39.8 35.7 18.5 27.6 25.7 40.8 57.9 14.7 33.1 34.9 27.8 43.0 25.9 27.3 36.6 34.2 51.4 30.5 32.8 49.5 20.4 16.5 32.6 46.2 36.1 36.6 37.1 25.3 36.2 32.4 25.7 21.1 35.1 24.3 30.7 8.7 25.6 37.5 33.2 41.6 60.7 26.0 37.7 31.7 29.8 25.3 37.9 29.6 17.1 41.4 41.9 25.8 35.5 38.6 12.9 47.8 10.3 53.3 9.8 12.1 35.3 21.3 30.3 3.3 11.3 18.5 26.3 12.5 20.0 13.9 18.3 15.9 17.0 26.1 11.8 15.5 38.1 11.7 20.0 5.8 20.1 2.9 15.0 27.6 7.9 8.4 15.6 62.3 10.4 25.6 22.4 29.8 10.6 13.2 8.1 12.4 7.6 10.3 20.1 10.4 21.3 8.1 19.8 5.5 12.2 30.9 10.3 7.3 15.1 11.2 7.8 9.7 6.6 12.0 17.5 19.9 2.1 12.5 33.0 22.2 31.3 9.2 11.3 13.4 12.8 13.6 8.7 34.2 23.8 20.5 5.7 44.4 10.3 10.4 53.3 12.1 12.9 11.2 10.4 47.8 9.5 10.5 9.3 3.2 9.8 48.7 13.9 10.7 35.3 18.5 25.7 14.7 33.1 20.4 16.5 37.1 25.3 24.3 29.6 104.2 68.6 78.2 202.3 179.6 102.0 71.4 86.6 58.9 50.0 75.0 104.1 190.2 190.6 176.0 77.4 124.7 114.8 23.3 144.3 181.6 179.4 129.6 138.4 60.6 342.3 158.9 55.0 87.8 170.9 28.6 195.9 258.9 183.9 413.0 69.3 139.4 142.6 119.3 169.0 169.2 137.1 174.6 167.4 144.3 173.7 227.2 255.5 84.8 86.0 194.1 RNMT RG7MT1 ENSG00000101654 "RNA guanine-7 methyltransferase" O43148 18 13726660-13764558 "Enzymes, Predicted intracellular proteins" "mRNA capping, mRNA processing" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039409 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA039409: AB_10795289" "unprognostic (3.02e-1)" "unprognostic (1.07e-2)" "unprognostic (3.48e-1)" "unprognostic (1.71e-3)" "unprognostic (3.57e-1)" "unprognostic (3.04e-1)" "unprognostic (6.17e-3)" "unprognostic (1.43e-1)" "unprognostic (3.76e-2)" "unprognostic (1.42e-3)" "unprognostic (9.45e-2)" "unprognostic (9.15e-2)" "unprognostic (1.00e-1)" "unprognostic (1.25e-1)" "unprognostic (1.56e-1)" "unprognostic (2.77e-2)" "unprognostic (1.78e-1)" 18.9 10.1 13.3 12.7 20.4 40.1 16.6 19.7 27.3 14.0 11.5 10.3 12.1 9.1 15.4 13.1 12.6 12.2 9.9 21.2 14.9 18.2 12.9 12.0 12.4 14.6 14.5 21.8 19.6 13.3 16.6 21.2 16.1 28.5 14.7 11.6 10.8 12.8 12.2 29.1 14.3 11.3 15.1 16.1 12.3 11.4 17.1 12.6 12.2 19.2 15.8 15.8 26.5 11.4 20.1 20.8 21.6 13.1 9.4 15.7 4.1 11.5 6.8 13.3 10.0 9.9 12.6 9.3 9.5 11.8 9.9 13.5 8.1 5.6 12.9 11.7 9.7 15.4 4.7 15.7 13.6 16.7 7.1 8.4 9.7 7.0 7.6 10.9 25.3 8.3 9.6 14.8 10.4 29.4 13.0 7.6 14.8 14.5 13.0 11.2 7.2 16.1 9.1 10.1 23.4 5.3 10.5 14.1 17.5 9.1 9.1 10.3 15.5 10.7 7.9 18.2 14.2 6.8 10.6 7.8 19.9 28.0 16.1 10.1 26.2 28.5 26.8 14.6 9.7 9.9 21.6 13.1 8.5 12.5 10.3 10.1 16.2 11.9 10.3 8.1 20.1 15.7 12.2 7.1 9.4 11.4 20.8 12.8 4.1 13.3 20.4 19.7 27.3 14.9 18.2 14.5 21.8 28.5 12.6 68.5 25.1 34.8 48.8 62.5 108.1 45.4 17.8 33.5 27.3 43.6 115.8 54.2 58.0 42.6 22.7 38.6 37.3 0.0 41.9 49.2 49.0 53.0 34.6 31.8 35.7 100.1 71.9 33.2 58.5 8.0 67.3 52.8 47.2 39.7 36.5 38.3 46.4 37.6 57.3 53.0 142.0 38.8 52.5 78.5 106.7 59.7 105.7 61.8 39.2 36.6 RNPC3 "FLJ20008, KIAA1839, RBM40, SNRNP65" ENSG00000185946 "RNA binding region (RNP1, RRM) containing 3" Q96LT9 1 103525691-103555239 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 95.4;Cone photoreceptor cells: 125.7;Rod photoreceptor cells: 145.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052434 Supported Nucleoplasm NA NA Nucleoplasm "HPA052434: AB_2681832" "unprognostic (1.87e-2)" "unprognostic (9.61e-2)" "unprognostic (1.04e-1)" "unprognostic (4.31e-3)" "unprognostic (2.92e-2)" "unprognostic (1.34e-5)" "unprognostic (9.00e-2)" "prognostic favorable (1.53e-4)" "unprognostic (1.94e-2)" "unprognostic (7.61e-2)" "prognostic favorable (7.82e-4)" "prognostic unfavorable (7.70e-4)" "unprognostic (3.65e-2)" "unprognostic (1.59e-2)" "unprognostic (2.28e-1)" "unprognostic (3.19e-1)" "prognostic favorable (5.25e-4)" 19.8 18.5 42.1 16.7 52.4 15.3 20.7 53.4 41.2 22.3 17.8 19.1 22.2 16.4 24.2 40.7 11.9 25.8 15.4 20.1 33.5 12.7 19.4 10.9 17.0 22.4 25.6 28.6 27.2 29.6 25.1 42.5 9.0 24.4 17.5 16.3 17.2 26.9 18.2 28.9 26.6 19.3 13.8 24.5 20.3 16.1 11.0 33.0 15.5 37.9 14.0 18.3 18.7 18.4 33.6 26.3 61.3 23.1 9.3 19.2 3.2 7.0 5.7 12.3 6.1 7.6 13.5 8.2 9.8 6.5 7.9 11.8 6.1 12.0 13.4 15.7 4.8 4.7 14.3 7.5 7.7 9.3 8.7 14.2 14.0 29.9 6.1 5.4 18.5 12.1 12.4 11.8 6.7 4.7 11.6 7.2 11.7 8.7 15.6 9.0 3.9 10.5 9.4 8.0 6.8 8.7 14.6 11.4 10.5 10.4 7.6 13.1 6.4 6.6 9.2 9.8 7.1 6.2 8.6 9.6 8.6 8.5 4.6 6.3 11.7 3.9 11.8 15.1 14.4 4.3 42.7 23.1 15.3 13.5 10.7 9.8 24.6 16.1 12.2 6.7 33.6 19.2 17.5 61.3 9.3 12.1 26.3 10.7 3.2 42.1 52.4 53.4 41.2 33.5 12.7 25.6 28.6 24.4 33.0 26.8 37.9 11.5 17.0 6.6 95.4 16.9 12.7 62.9 43.3 26.2 125.7 6.4 13.3 8.2 22.1 16.6 19.7 0.0 9.0 3.6 9.1 9.5 19.7 8.6 6.7 58.8 16.3 14.1 21.9 3.6 23.0 16.8 15.1 15.4 16.3 53.0 9.0 12.5 20.1 4.3 145.9 25.8 11.2 18.2 8.1 7.9 9.2 17.5 12.1 11.7 RNPEPL1 ENSG00000142327 "Arginyl aminopeptidase like 1" Q9HAU8 2 240565804-240581372 "Enzymes, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 92.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036772, HPA036773" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA036772: AB_10670848, HPA036773: " "unprognostic (3.92e-2)" "unprognostic (7.28e-2)" "unprognostic (1.20e-2)" "unprognostic (2.39e-1)" "unprognostic (5.24e-3)" "prognostic favorable (7.43e-4)" "prognostic unfavorable (5.06e-4)" "unprognostic (3.72e-3)" "unprognostic (9.10e-2)" "unprognostic (1.66e-3)" "unprognostic (3.10e-1)" "unprognostic (1.71e-1)" "unprognostic (1.98e-2)" "unprognostic (5.33e-2)" "unprognostic (1.57e-1)" "unprognostic (5.31e-2)" "unprognostic (9.86e-2)" 17.2 13.7 10.1 13.7 8.8 17.2 48.4 7.2 10.5 11.0 21.0 9.5 11.8 18.6 8.0 8.9 22.1 8.0 22.3 28.3 9.2 6.0 18.2 26.7 32.2 54.1 12.9 8.2 7.1 40.0 7.7 4.3 10.1 8.1 14.9 9.1 7.0 21.5 13.5 26.5 22.5 31.0 11.4 9.7 25.7 20.0 5.9 7.6 23.1 8.8 16.7 12.1 14.4 18.8 7.0 7.6 22.4 9.1 7.6 12.4 5.4 6.9 11.7 2.6 6.9 9.6 10.0 8.9 4.5 11.2 5.0 6.3 3.2 20.6 2.0 2.3 11.3 7.1 7.6 2.9 8.4 0.5 12.2 4.0 4.6 3.8 18.9 24.1 3.0 8.4 11.8 13.6 2.6 5.2 8.1 17.3 8.0 3.4 13.6 3.4 9.8 3.7 11.3 3.4 13.6 4.7 7.9 3.9 16.9 20.5 9.6 2.4 5.2 3.0 10.4 20.3 3.1 7.3 13.8 11.8 5.5 5.7 7.6 5.1 12.9 1.9 2.3 11.3 8.4 8.2 5.8 9.1 22.4 12.4 7.8 10.6 7.0 9.6 11.1 6.4 6.8 5.4 8.1 16.0 7.6 7.6 7.6 11.1 5.4 10.1 8.8 7.2 10.5 9.2 6.0 12.9 8.2 8.1 7.6 20.8 28.4 28.0 12.0 6.9 6.3 30.7 15.3 2.7 10.3 12.2 0.0 6.1 14.9 22.4 2.6 17.8 92.4 0.0 42.5 5.7 9.9 19.0 33.5 37.6 38.2 3.2 25.3 28.3 58.8 3.7 8.1 30.5 21.9 22.6 46.2 12.2 47.4 37.7 12.7 26.5 6.2 12.9 16.5 0.9 8.3 8.2 4.2 40.6 33.1 19.2 RNPS1 ENSG00000205937 "RNA binding protein with serine rich domain 1" Q15287 16 2253116-2268412 "Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, Nonsense-mediated mRNA decay" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044014 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA044014: AB_10966286" "unprognostic (3.50e-2)" "unprognostic (2.74e-3)" "unprognostic (3.46e-1)" "unprognostic (1.49e-3)" "unprognostic (2.92e-1)" "unprognostic (1.47e-1)" "unprognostic (1.18e-3)" "unprognostic (1.96e-1)" "unprognostic (2.76e-1)" "unprognostic (1.15e-1)" "unprognostic (2.30e-1)" "unprognostic (2.93e-2)" "unprognostic (1.04e-1)" "unprognostic (7.13e-3)" "unprognostic (2.38e-1)" "unprognostic (4.64e-2)" "unprognostic (2.27e-1)" 15.5 17.7 25.2 17.4 22.9 42.6 17.1 36.0 34.1 16.4 19.2 19.2 11.5 16.2 20.7 17.0 22.1 21.4 18.3 20.0 23.1 26.7 15.5 18.5 14.8 23.7 20.7 27.4 22.2 17.1 18.3 20.9 26.8 21.7 18.6 14.4 16.7 15.7 20.0 50.9 23.0 15.6 17.8 16.2 19.5 16.6 73.5 13.7 19.5 17.6 29.9 22.8 17.2 15.9 52.4 40.0 30.2 44.3 43.9 48.7 62.1 18.3 28.3 28.2 32.0 16.2 15.4 34.7 20.0 17.2 34.5 30.0 55.0 26.7 37.1 22.9 19.0 19.2 28.5 38.2 27.4 23.1 29.1 50.0 24.5 23.4 35.8 27.6 26.4 29.3 18.5 31.4 27.5 37.5 14.4 26.2 25.2 48.2 38.4 27.0 46.7 64.7 61.7 63.9 22.8 22.8 82.0 28.9 58.8 22.3 12.9 66.6 38.4 25.4 30.6 29.2 14.2 31.0 33.3 16.9 29.8 28.3 26.3 30.9 35.0 47.7 92.6 12.7 29.2 34.9 10.0 37.1 30.2 46.7 42.9 46.1 48.1 45.5 47.6 40.0 52.4 43.5 45.9 11.4 43.9 44.3 33.9 48.7 62.1 25.2 22.9 36.0 34.1 23.1 26.7 20.7 27.4 21.7 13.7 41.7 60.8 131.7 157.1 183.5 110.7 32.3 50.9 40.2 63.7 48.8 131.6 149.8 59.7 107.8 13.7 82.0 69.1 46.7 81.2 199.4 93.8 114.0 102.6 30.8 92.9 92.2 117.0 57.1 53.6 19.1 87.2 74.7 92.8 124.4 85.6 85.3 94.1 70.2 64.7 48.4 116.7 84.1 124.8 116.4 243.4 185.7 135.5 138.5 109.0 172.1 ROBO2 KIAA1568 ENSG00000185008 "Roundabout guidance receptor 2" Q9HCK4 3 75906695-77649964 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Differentiation, Neurogenesis" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.1" "Group enriched" "Detected in many" 4 "Bipolar cells: 34.7;Horizontal cells: 49.3" "Cancer enhanced" "Detected in many" "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BJ hTERT+: 15.2;HEL: 41.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013371 Approved Approved "Nucleoplasm,Centriolar satellite" NA NA 660000 "Nucleoplasm, Centriolar satellite" "HPA013371: AB_1856391" "unprognostic (1.14e-3)" "unprognostic (1.93e-1)" "unprognostic (1.46e-2)" "unprognostic (7.25e-3)" "unprognostic (1.82e-2)" "unprognostic (5.93e-3)" "unprognostic (3.87e-1)" "unprognostic (2.83e-3)" "unprognostic (4.07e-2)" "unprognostic (4.23e-1)" "unprognostic (2.90e-2)" "unprognostic (1.76e-1)" "unprognostic (3.08e-4)" "unprognostic (2.06e-1)" "unprognostic (1.07e-1)" "unprognostic (1.99e-2)" "unprognostic (9.65e-3)" 1.1 3.3 6.4 0.8 13.8 0.3 1.1 19.0 26.1 3.6 1.3 2.2 0.0 0.9 2.9 0.8 6.2 0.4 3.1 1.0 6.3 6.5 2.5 1.8 12.3 1.8 9.6 5.5 9.4 2.2 6.8 2.1 6.4 9.9 1.9 0.8 4.8 2.1 7.8 0.4 3.0 1.2 1.9 7.8 3.6 1.1 4.5 3.6 3.6 0.4 4.2 3.0 2.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 4.0 4.3 0.0 0.1 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 5.0 41.7 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.6 4.7 0.0 0.0 0.5 2.7 6.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 13.8 19.0 11.3 6.3 6.5 9.6 5.5 9.9 3.6 0.0 0.3 0.0 1.5 1.5 34.7 1.9 2.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.1 7.6 0.0 0.0 0.0 0.1 49.3 0.0 4.3 0.0 1.7 2.8 0.0 0.0 0.0 1.4 0.9 0.3 0.0 5.6 0.0 4.4 0.0 0.8 0.2 0.7 1.0 0.1 0.0 0.0 0.1 RORB "NR1F2, ROR-BETA, RZRB" ENSG00000198963 "RAR related orphan receptor B" Q92753 9 74497365-74693177 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Sensory transduction, Transcription, Transcription regulation, Vision" "Activator, Developmental protein, DNA-binding, Receptor" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.5;cervix, uterine: 20.8" "Group enriched" "Detected in many" 5 "Horizontal cells: 1322.1;Muller glia cells: 409.4" "Group enriched" "Detected in some" 5 "glioma: 2.1;prostate cancer: 2.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.8" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "HHSteC: 18.3;HSkMC: 10.1;JURKAT: 18.1;MOLT-4: 5.1;SH-SY5Y: 10.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA008393 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA008393: AB_1079830" "unprognostic (6.89e-3)" "unprognostic (4.06e-3)" "unprognostic (1.38e-1)" "unprognostic (3.97e-1)" "unprognostic (1.34e-1)" "unprognostic (1.05e-3)" "unprognostic (1.28e-1)" "unprognostic (1.18e-2)" "unprognostic (1.07e-1)" "unprognostic (3.07e-1)" "unprognostic (3.52e-1)" "unprognostic (5.46e-2)" "unprognostic (8.81e-8)" "unprognostic (5.97e-3)" "unprognostic (2.17e-2)" "unprognostic (2.26e-2)" "unprognostic (4.00e-2)" 3.1 7.9 8.3 1.2 11.1 1.0 1.4 1.8 35.5 20.8 1.3 2.1 2.2 1.1 8.9 0.9 1.7 1.5 4.5 3.9 5.6 7.0 2.0 1.0 2.0 0.9 4.1 18.7 1.4 1.1 1.1 4.0 10.6 6.1 10.5 1.6 18.7 1.2 11.7 0.9 1.3 1.1 1.7 6.7 1.0 1.6 2.0 3.7 2.2 1.5 0.0 1.5 2.3 2.2 0.2 0.2 1.8 0.2 0.6 0.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 18.3 0.0 0.5 10.1 0.0 0.0 0.0 0.0 0.0 18.1 0.0 2.8 0.0 0.1 5.1 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.9 0.0 0.0 0.0 0.4 2.5 0.0 1.3 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.6 1.8 0.6 0.1 0.2 0.0 0.0 8.3 11.1 1.8 35.5 5.6 7.0 4.1 18.7 6.1 3.7 0.0 3.7 0.0 0.6 1.4 160.1 11.7 0.0 1.4 0.0 0.0 113.9 0.0 0.0 0.0 5.3 0.6 0.0 0.0 0.0 0.4 5.4 2.3 1.1 0.0 0.6 1322.1 0.0 1.3 0.0 0.5 0.0 1.3 1.7 0.0 0.0 409.4 0.1 0.0 0.0 5.7 181.1 0.0 3.1 0.5 0.1 0.4 0.1 0.8 0.0 0.8 RP2 "NM23-H10, NME10, TBCCD2" ENSG00000102218 "RP2, ARL3 GTPase activating protein" O75695 X 46836940-46882358 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Kupffer cells: 61.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000234, HPA000909" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA 77000 "Nucleoplasm, Plasma membrane" "Nuclear bodies" "HPA000234: AB_1079831, HPA000909: AB_2666140" "unprognostic (2.26e-1)" "unprognostic (6.01e-3)" "unprognostic (2.79e-2)" "unprognostic (2.98e-1)" "unprognostic (1.69e-1)" "unprognostic (3.40e-1)" "prognostic unfavorable (7.97e-4)" "unprognostic (2.58e-2)" "unprognostic (9.76e-3)" "unprognostic (3.10e-2)" "unprognostic (3.79e-3)" "unprognostic (9.75e-2)" "unprognostic (6.15e-3)" "unprognostic (2.96e-2)" "unprognostic (9.66e-2)" "unprognostic (1.61e-1)" "unprognostic (4.28e-3)" 17.2 10.6 5.0 10.7 6.6 31.4 8.2 5.6 4.3 6.3 10.1 5.5 3.5 7.4 8.4 7.1 17.2 5.8 9.3 5.9 5.7 4.8 10.2 17.1 14.0 18.1 8.1 2.8 6.9 4.7 5.6 4.1 28.0 8.5 6.9 7.7 4.9 8.3 6.1 2.9 5.0 18.6 6.3 10.6 24.3 6.4 5.7 6.7 12.1 5.9 8.7 11.7 7.0 8.7 5.0 10.7 23.0 15.9 3.4 3.3 5.3 11.3 5.4 11.0 6.0 8.7 10.8 26.2 14.6 11.5 12.9 13.1 23.4 9.8 13.5 5.9 15.4 11.0 7.5 10.6 10.6 17.6 5.9 6.1 7.2 6.9 5.6 10.0 15.0 25.3 8.4 7.0 10.2 5.5 7.3 16.3 6.1 3.2 7.1 14.5 1.0 9.3 13.8 6.8 7.7 10.5 11.9 15.1 7.2 8.3 11.6 4.1 5.5 12.9 8.1 6.6 20.6 9.0 14.2 14.4 10.0 7.5 15.8 5.1 2.7 3.5 8.0 5.2 10.8 10.4 23.0 10.6 16.6 3.2 14.4 2.6 5.0 2.6 2.7 10.7 4.6 3.3 3.0 20.9 3.4 15.9 3.8 2.8 5.3 5.0 6.6 5.6 4.3 5.7 4.8 8.1 2.8 8.5 6.7 8.9 6.1 9.3 2.7 14.1 1.7 1.2 10.2 13.4 3.4 8.7 2.0 20.8 0.0 4.1 1.0 6.7 17.1 0.0 4.6 5.1 11.3 5.8 11.5 18.8 21.5 0.0 3.5 11.6 61.8 1.9 5.2 29.1 20.3 10.8 8.8 3.2 9.2 11.6 5.3 3.1 4.8 6.5 6.0 6.0 4.6 13.0 31.9 6.5 8.0 11.8 RP9 PAP-1 ENSG00000164610 "RP9, pre-mRNA splicing factor" Q8TA86 7 33094797-33109401 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031523, HPA050778" Uncertain Enhanced Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA031523: AB_10603235, HPA050778: AB_2681233" "unprognostic (1.12e-1)" "unprognostic (1.80e-1)" "unprognostic (1.07e-2)" "unprognostic (1.82e-1)" "unprognostic (6.65e-2)" "unprognostic (1.84e-1)" "prognostic unfavorable (2.58e-4)" "unprognostic (6.71e-2)" "unprognostic (6.22e-2)" "unprognostic (7.53e-2)" "unprognostic (7.03e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (2.65e-5)" "unprognostic (4.19e-2)" "unprognostic (2.63e-2)" "unprognostic (2.70e-1)" "unprognostic (1.61e-1)" 10.1 13.8 11.7 9.4 16.0 20.7 14.9 17.1 16.0 10.9 12.2 13.0 7.0 10.3 14.6 18.8 8.1 10.0 10.7 19.2 11.1 10.1 11.4 11.5 9.7 19.4 17.4 8.6 14.2 16.9 10.4 14.2 11.7 11.0 14.0 11.8 12.8 15.0 14.4 34.7 10.7 12.5 15.7 11.8 17.2 10.5 15.2 12.6 13.6 15.6 9.0 18.2 13.4 16.0 34.1 11.7 8.1 5.0 5.9 8.4 3.3 9.9 14.3 15.1 17.2 9.6 9.0 7.2 12.7 10.9 14.7 11.8 12.7 7.3 12.6 8.4 10.5 18.1 10.0 18.3 10.9 19.0 5.7 11.4 9.2 11.3 11.8 16.9 12.3 6.5 9.0 10.3 16.7 33.1 12.0 12.0 13.5 16.5 11.6 14.7 20.6 13.2 33.8 12.7 13.3 10.3 13.3 13.1 8.4 10.6 9.6 14.6 20.0 8.9 20.0 21.7 18.7 10.5 17.1 9.6 14.6 20.5 12.9 20.6 18.9 17.1 25.1 10.3 17.6 28.2 6.4 5.0 8.1 6.6 3.6 6.1 22.0 7.0 7.4 5.3 34.1 8.4 7.8 0.9 5.9 4.6 11.7 5.9 3.3 11.7 16.0 17.1 16.0 11.1 10.1 17.4 8.6 11.0 12.6 11.9 8.5 17.4 13.8 18.7 16.3 32.5 12.7 10.7 11.4 14.0 13.7 16.9 18.3 14.1 3.5 21.7 10.5 0.0 13.7 16.3 19.4 11.5 3.5 15.1 16.0 7.9 9.8 14.7 7.6 2.7 16.7 9.9 21.9 9.0 16.4 15.8 13.4 5.8 15.2 13.5 12.9 25.8 20.2 33.0 48.0 15.7 8.7 11.8 18.0 10.7 RPA1 "HSSB, REPA1, RF-A, RP-A, RPA70" ENSG00000132383 "Replication protein A1" P27694 17 1829702-1900082 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004563, HPA006914, HPA046497" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004563: AB_628224, HPA006914: AB_1856410, HPA046497: AB_2679675" "unprognostic (1.84e-1)" "unprognostic (1.47e-2)" "unprognostic (7.38e-2)" "unprognostic (1.01e-1)" "unprognostic (7.53e-2)" "unprognostic (6.58e-3)" "prognostic unfavorable (9.00e-9)" "unprognostic (9.59e-2)" "unprognostic (2.20e-1)" "unprognostic (2.69e-1)" "unprognostic (6.03e-3)" "unprognostic (1.75e-2)" "unprognostic (3.37e-2)" "unprognostic (2.19e-1)" "unprognostic (6.57e-2)" "unprognostic (2.62e-1)" "unprognostic (4.52e-2)" 19.8 18.9 17.5 22.2 18.6 15.7 19.6 21.0 19.2 20.1 21.2 17.0 26.7 15.9 23.7 20.1 23.8 23.2 20.6 27.6 15.0 15.6 13.3 15.2 19.2 27.6 19.6 19.8 28.8 17.8 18.8 15.7 15.2 15.0 20.2 16.5 20.9 22.9 23.3 46.1 23.6 18.6 21.7 15.0 18.7 17.0 13.9 17.5 36.7 21.1 24.4 33.1 23.6 19.1 24.6 14.5 23.9 19.7 34.2 27.1 25.2 27.7 28.6 26.0 23.9 13.1 13.3 29.1 22.9 14.3 30.5 31.9 40.4 12.9 39.2 21.6 14.5 11.9 25.9 32.2 19.6 34.4 25.6 37.9 23.7 35.4 16.8 8.7 17.4 21.1 10.8 12.9 30.0 13.2 10.8 22.0 25.3 22.4 22.6 21.3 16.0 37.5 11.2 19.9 19.7 16.7 52.2 13.9 21.3 13.5 19.3 11.2 17.5 32.5 11.5 20.2 19.6 23.4 13.7 17.0 20.7 18.1 24.0 34.6 6.3 16.4 22.6 14.8 27.5 25.8 16.7 11.3 23.9 25.9 16.2 26.3 24.6 27.1 25.7 13.8 15.4 26.8 24.3 5.5 34.2 19.7 14.5 25.0 25.2 17.5 18.6 21.0 19.2 15.0 15.6 19.6 19.8 15.0 17.5 8.9 14.3 22.9 13.7 26.3 17.6 18.2 28.1 18.7 11.4 38.4 3.9 55.5 5.0 16.5 15.8 20.1 15.1 46.7 17.4 61.3 22.4 11.7 33.4 20.3 39.8 35.0 15.0 26.4 37.7 27.5 30.0 18.4 27.0 41.5 20.4 34.7 13.6 3.5 32.5 8.5 17.6 0.0 22.7 13.1 21.4 25.5 36.4 25.5 18.1 8.5 RPA2 ENSG00000117748 "Replication protein A2" P15927 1 27891524-27914746 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, DNA replication" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Spermatogonia: 183.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016538, HPA026306, HPA026309" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB016538: AB_670974, HPA026306: AB_10598913, HPA026309: AB_10601572" "unprognostic (2.59e-1)" "prognostic favorable (4.33e-4)" "unprognostic (8.98e-2)" "unprognostic (6.89e-2)" "unprognostic (1.04e-1)" "prognostic favorable (8.12e-4)" "unprognostic (4.29e-3)" "unprognostic (2.03e-2)" "unprognostic (8.62e-3)" "unprognostic (1.68e-1)" "unprognostic (1.58e-2)" "unprognostic (2.31e-1)" "unprognostic (3.59e-2)" "unprognostic (9.13e-2)" "unprognostic (2.30e-1)" "unprognostic (2.18e-3)" "unprognostic (2.82e-2)" 18.6 17.1 33.6 24.3 38.8 20.5 26.6 23.6 30.5 20.0 15.4 17.2 17.6 9.9 19.5 26.3 18.7 28.8 19.2 22.5 31.4 22.1 19.5 18.4 19.3 37.1 22.0 26.7 32.6 15.3 16.4 27.0 17.2 25.4 17.2 19.0 18.0 16.2 19.8 45.0 22.6 16.8 18.6 22.1 28.4 15.3 34.6 27.7 25.4 30.7 17.2 37.9 20.3 17.1 46.2 31.5 48.4 18.1 49.3 55.9 65.9 13.2 12.6 21.2 16.0 14.4 13.4 12.9 24.6 16.7 31.5 27.4 17.9 16.4 33.7 15.8 9.7 11.3 12.3 30.0 13.9 30.8 25.0 27.8 39.2 17.1 15.4 7.3 52.0 27.6 5.7 7.8 30.4 15.7 9.8 13.6 30.6 40.9 29.4 18.2 13.4 37.0 22.7 41.6 26.0 27.1 24.7 31.5 15.7 11.3 14.4 18.1 17.6 27.2 11.0 21.5 17.6 11.3 15.4 8.7 7.8 16.9 42.1 16.1 23.9 53.2 29.3 19.3 46.1 14.0 42.8 18.1 48.4 51.6 14.0 55.9 46.2 48.8 47.3 20.4 39.0 55.8 53.9 18.1 49.3 18.1 31.5 42.5 65.9 33.6 38.8 23.6 30.5 31.4 22.1 22.0 26.7 25.4 27.7 20.8 14.9 53.6 28.2 18.7 26.4 26.0 28.1 30.8 25.0 21.0 2.0 71.3 29.9 26.8 35.0 27.8 9.3 23.3 18.1 52.7 29.0 16.7 60.0 13.5 44.9 7.9 13.3 26.4 35.6 17.1 38.3 36.5 35.4 118.2 13.1 96.8 21.4 7.0 43.5 17.7 30.1 32.3 27.8 118.9 183.5 19.6 46.6 91.4 17.8 15.7 RPA4 HSU24186 ENSG00000204086 "Replication protein A4" Q13156 X 96883908-96885467 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 5.2" "Cell type enhanced" "Detected in many" 6 "Sertoli cells: 6.5;Spermatocytes: 7.6;Syncytiotrophoblasts: 8.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 3.0;HL-60: 3.0" HPA066010 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA066010: AB_2685596" "unprognostic (6.23e-2)" "unprognostic (2.55e-2)" "unprognostic (1.17e-1)" "unprognostic (6.66e-6)" "unprognostic (1.33e-1)" "unprognostic (6.33e-2)" "unprognostic (9.75e-4)" "unprognostic (3.15e-1)" "unprognostic (7.61e-3)" "unprognostic (2.59e-3)" "unprognostic (1.55e-1)" "unprognostic (2.62e-1)" "unprognostic (2.47e-12)" "unprognostic (8.95e-3)" "unprognostic (6.05e-3)" "unprognostic (8.17e-2)" "unprognostic (4.59e-2)" 0.9 0.1 0.0 0.3 0.1 1.0 0.4 0.0 0.1 0.5 0.2 0.4 0.1 0.2 0.3 0.0 0.3 0.6 0.0 0.0 0.1 1.1 0.8 0.2 0.0 0.6 0.1 0.0 0.0 0.8 0.4 0.6 0.4 0.2 0.4 0.3 0.1 0.2 0.1 0.1 0.2 5.2 0.2 0.2 0.4 0.8 1.3 1.4 2.5 2.3 0.0 2.1 0.1 0.0 0.7 0.1 1.1 0.0 0.3 0.0 0.8 0.0 0.4 0.8 1.3 0.3 1.6 0.3 0.6 2.5 0.0 2.4 0.1 0.7 0.0 1.0 0.0 3.0 0.1 0.1 3.0 0.8 0.2 0.1 2.0 0.9 0.0 0.1 1.2 0.0 2.4 2.1 0.4 1.0 1.6 1.1 0.0 1.1 0.0 0.9 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.5 0.4 0.0 0.0 0.7 1.4 0.6 0.6 0.5 0.1 0.0 1.0 0.5 1.8 1.0 0.0 2.3 2.5 1.8 0.9 2.1 1.0 0.4 0.4 0.6 1.3 0.3 0.5 1.4 0.0 1.8 1.4 1.3 0.1 0.0 3.5 0.0 0.1 0.7 0.4 0.0 0.0 0.0 1.2 0.0 0.0 2.9 0.0 0.7 0.8 1.6 1.3 0.0 0.5 0.9 0.9 0.4 0.0 1.9 1.7 0.0 3.5 0.0 2.4 0.4 1.4 0.4 0.0 0.0 2.2 0.2 0.9 3.5 1.4 0.0 1.2 6.5 0.2 7.6 2.5 1.1 8.2 0.0 2.0 0.1 RPAIN "hRIP, MGC4189, RIP" ENSG00000129197 "RPA interacting protein" Q86UA6 17 5419641-5432876 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023924, HPA031526" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA023924: AB_10601890, HPA031526: AB_10601555" "unprognostic (1.68e-1)" "unprognostic (9.31e-3)" "unprognostic (2.32e-1)" "unprognostic (7.88e-2)" "unprognostic (5.41e-2)" "unprognostic (3.58e-2)" "unprognostic (5.29e-2)" "unprognostic (1.87e-3)" "unprognostic (3.98e-2)" "unprognostic (4.25e-3)" "prognostic favorable (5.20e-4)" "prognostic unfavorable (4.41e-5)" "unprognostic (6.03e-2)" "unprognostic (1.75e-1)" "unprognostic (9.78e-2)" "unprognostic (6.67e-2)" "unprognostic (1.00e-3)" 12.4 19.5 24.4 12.1 26.4 14.9 22.1 18.3 24.0 14.6 13.4 12.1 18.4 12.1 13.8 21.6 11.9 17.0 12.2 25.4 20.2 21.0 17.1 19.3 11.5 12.8 18.0 24.9 17.4 15.8 10.9 25.5 12.0 19.7 14.5 14.6 12.9 11.9 14.0 41.6 12.3 9.5 13.5 17.5 10.5 14.6 11.4 18.9 16.2 12.1 15.8 15.0 12.2 10.5 25.3 19.3 22.3 13.4 12.1 24.7 13.0 8.6 19.4 20.3 16.6 15.4 11.7 8.8 8.7 16.6 19.3 17.3 11.4 3.1 10.4 12.3 5.6 13.6 9.2 26.2 8.3 16.7 10.7 19.0 8.1 9.5 14.4 19.9 10.4 18.7 10.0 17.0 11.7 23.8 23.1 17.0 34.3 8.6 6.7 10.5 7.4 23.9 19.0 10.4 10.6 9.9 11.5 14.6 9.2 14.2 10.1 13.5 24.0 7.9 6.2 22.5 15.6 9.0 14.5 8.3 6.0 8.2 4.9 16.8 6.6 10.9 10.4 8.9 10.7 9.1 11.2 13.4 22.3 12.5 12.0 15.8 25.3 17.0 16.2 12.8 21.4 20.4 18.2 2.4 12.1 10.5 19.3 24.7 13.0 24.4 26.4 18.3 24.0 20.2 21.0 18.0 24.9 19.7 18.9 65.5 50.7 59.6 66.4 56.1 44.3 29.4 56.0 84.3 62.6 38.4 49.1 68.2 87.9 61.5 70.6 39.1 37.3 70.0 50.2 37.9 52.2 69.0 59.1 35.8 48.9 44.5 105.7 37.4 42.9 8.5 65.6 45.6 45.5 56.9 46.6 59.2 64.8 60.0 67.5 60.9 56.8 71.1 54.6 90.7 27.9 65.5 49.9 57.9 50.1 82.7 RPAP1 "DKFZP727M111, FLJ12732, KIAA1403, MGC858" ENSG00000103932 "RNA polymerase II associated protein 1" Q9BWH6 15 41517176-41544269 "Predicted intracellular proteins, Predicted membrane proteins" Transcription "DNA-binding, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041739 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041739: AB_2677647" "unprognostic (8.83e-3)" "unprognostic (2.78e-3)" "unprognostic (1.63e-1)" "unprognostic (4.45e-2)" "unprognostic (1.97e-1)" "unprognostic (8.61e-2)" "unprognostic (1.78e-3)" "unprognostic (1.84e-1)" "unprognostic (3.25e-2)" "unprognostic (4.72e-2)" "unprognostic (1.23e-2)" "unprognostic (7.02e-2)" "unprognostic (3.73e-2)" "unprognostic (3.26e-1)" "unprognostic (2.46e-1)" "prognostic unfavorable (9.32e-4)" "unprognostic (4.30e-3)" 10.1 10.2 12.8 8.5 12.4 4.7 8.1 7.8 15.6 7.8 10.2 12.6 7.9 8.5 10.7 6.0 12.3 10.4 6.9 9.5 10.9 6.1 6.7 10.8 7.3 9.8 12.3 10.1 12.4 9.4 12.9 9.4 8.7 11.9 9.4 7.1 9.5 9.8 9.2 27.0 10.3 8.0 10.1 8.0 9.1 9.4 12.6 11.8 11.2 8.3 7.9 10.7 11.2 8.4 5.9 4.5 0.0 5.9 4.9 7.2 3.3 7.2 8.7 11.9 12.5 10.0 7.3 10.1 7.2 6.2 9.3 9.1 23.5 6.6 5.7 11.9 8.0 15.0 17.2 21.4 10.5 8.0 10.0 10.4 10.7 12.1 10.3 6.3 8.8 6.8 7.4 13.3 11.0 7.7 6.3 10.4 13.0 25.0 6.5 8.6 4.6 9.5 5.4 21.0 11.2 8.1 17.2 10.3 6.1 4.1 17.1 10.9 14.6 9.2 9.6 4.9 10.8 15.9 11.0 9.4 14.7 9.6 14.6 11.5 11.0 30.1 6.4 10.4 9.6 13.8 0.0 2.6 0.0 7.2 3.5 6.6 4.8 4.3 4.5 4.5 5.9 6.1 5.3 0.0 4.9 5.9 2.9 4.4 3.3 12.8 12.4 7.8 15.6 10.9 6.1 12.3 10.1 11.9 11.8 3.0 4.8 9.1 3.8 2.5 9.4 8.1 2.5 5.3 4.5 5.2 11.8 5.6 1.7 4.8 1.1 4.6 3.5 0.0 4.7 5.3 4.1 4.9 2.3 8.1 4.2 15.9 2.4 3.7 4.0 1.3 3.4 3.3 1.7 6.4 5.6 4.8 4.8 0.0 8.9 2.4 7.0 0.0 3.8 11.2 9.8 3.6 2.3 6.9 6.6 2.7 RPE ENSG00000197713 Ribulose-5-phosphate-3-epimerase Q96AT9 2 210002565-210022259 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA036498, HPA036499" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA036498: AB_2675157, HPA036499: AB_10670109" "unprognostic (5.07e-2)" "unprognostic (8.15e-2)" "unprognostic (3.06e-1)" "unprognostic (2.34e-3)" "unprognostic (2.00e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (1.42e-6)" "unprognostic (1.59e-3)" "unprognostic (1.69e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (7.00e-6)" "unprognostic (2.33e-2)" "unprognostic (2.55e-2)" "unprognostic (1.10e-1)" "unprognostic (1.95e-1)" "unprognostic (2.89e-1)" "unprognostic (5.84e-2)" 19.4 26.9 20.6 16.7 28.0 14.6 22.6 26.4 27.7 18.7 19.7 23.3 20.7 17.4 27.8 21.5 24.0 17.6 17.3 17.2 21.1 21.0 26.7 23.3 19.4 21.6 21.7 21.7 22.9 14.1 14.8 41.9 24.4 18.6 20.5 26.6 18.9 18.3 27.9 12.3 17.2 16.0 27.1 25.8 15.6 19.8 11.9 19.7 23.5 25.2 14.5 23.2 24.1 20.2 8.6 28.9 8.0 20.5 30.5 10.7 11.3 20.6 26.8 17.4 17.5 28.3 27.4 29.9 27.2 21.8 25.9 34.8 38.5 31.7 13.9 17.9 21.0 35.1 20.3 25.6 29.0 39.6 16.7 18.1 25.8 39.3 35.9 38.6 27.3 19.9 19.2 28.9 29.7 38.7 23.6 33.7 13.9 25.9 19.4 21.2 32.9 14.8 23.8 25.5 41.7 19.6 18.7 20.8 19.9 29.9 30.9 20.9 12.0 23.0 22.5 18.2 32.8 19.4 31.4 27.6 34.8 23.2 16.9 25.1 11.7 14.8 29.9 25.2 27.0 22.5 6.9 17.3 8.0 10.2 20.5 8.9 8.6 8.0 9.6 28.9 8.4 10.7 9.6 1.7 30.5 13.7 10.6 10.7 11.3 20.6 28.0 26.4 27.7 21.1 21.0 21.7 21.7 18.6 19.7 6.0 6.9 14.7 13.5 14.7 12.5 5.3 7.6 13.4 19.4 17.4 19.6 32.4 26.6 20.5 8.8 11.9 12.3 23.3 15.1 36.8 15.5 12.1 5.8 15.5 33.1 9.5 9.8 17.2 17.6 9.3 10.3 20.4 13.5 16.2 14.2 8.2 17.4 14.0 13.8 37.0 12.9 6.5 14.1 16.4 16.1 17.8 21.4 11.4 18.9 12.0 RPEL1 ENSG00000235376 "Ribulose-5-phosphate-3-epimerase like 1" Q2QD12 10 103245887-103248016 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.4;brain: 1.2;pituitary gland: 1.2" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 2.9;Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 2.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 1.1;NB-4: 1.1" "HPA036498, HPA036499" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA036498: AB_2675157, HPA036499: AB_10670109" "unprognostic (7.52e-2)" "unprognostic (1.69e-1)" "unprognostic (4.78e-2)" "unprognostic (1.54e-1)" "unprognostic (1.45e-1)" "unprognostic (1.83e-1)" "unprognostic (6.01e-2)" "unprognostic (1.15e-1)" "unprognostic (8.91e-2)" "unprognostic (6.59e-2)" "unprognostic (4.34e-1)" "unprognostic (1.14e-1)" "unprognostic (5.69e-2)" "unprognostic (1.62e-1)" "unprognostic (6.72e-2)" "unprognostic (5.06e-2)" 0.0 0.1 0.1 1.0 0.3 0.1 0.1 1.2 0.2 0.0 0.0 0.3 0.4 0.4 0.1 0.0 0.0 0.1 0.1 0.3 0.3 0.0 0.0 0.4 0.1 0.0 0.8 0.0 1.2 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.2 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.4 1.0 0.3 0.7 1.4 0.6 0.2 0.5 0.5 0.1 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.2 0.4 0.7 0.1 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.6 0.0 0.3 1.1 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.2 1.1 0.7 0.2 0.0 0.0 0.1 0.3 0.5 0.2 0.3 0.1 0.3 0.4 0.2 0.1 0.1 0.4 0.0 0.1 0.9 0.1 0.2 0.3 0.1 0.3 0.7 0.4 0.1 0.3 0.7 0.2 0.5 0.7 0.5 0.4 0.4 0.3 1.0 0.4 0.5 0.6 0.0 1.4 0.4 0.3 0.4 0.2 0.0 0.0 0.0 0.1 0.1 2.9 1.5 0.0 0.0 1.2 0.0 7.9 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.0 0.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.6 0.0 0.2 0.0 0.0 0.0 2.6 0.0 0.9 0.0 0.2 0.3 0.3 0.0 0.7 0.0 RPF2 "bA397G5.4, BXDC1, FLJ21087" ENSG00000197498 "Ribosome production factor 2 homolog" Q9H7B2 6 110982015-111028263 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-2197: 83.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035475 Supported Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "HPA035475: AB_10669861" "unprognostic (2.85e-3)" "unprognostic (2.19e-2)" "unprognostic (6.00e-2)" "unprognostic (2.90e-3)" "unprognostic (4.45e-1)" "prognostic unfavorable (2.04e-4)" "prognostic unfavorable (2.25e-4)" "unprognostic (1.14e-1)" "unprognostic (1.12e-1)" "unprognostic (1.99e-1)" "unprognostic (8.43e-2)" "unprognostic (9.16e-2)" "prognostic unfavorable (2.07e-6)" "unprognostic (2.39e-2)" "unprognostic (2.35e-1)" "unprognostic (1.28e-1)" "unprognostic (1.86e-1)" 21.1 17.1 13.9 14.1 19.2 15.4 20.7 16.7 17.3 14.5 13.8 9.0 10.3 10.3 15.4 12.1 19.2 15.8 14.4 19.6 16.5 11.0 18.8 30.7 12.2 15.3 16.8 11.3 20.9 25.9 13.7 21.6 15.5 19.3 15.5 14.1 9.5 14.0 11.5 46.3 16.7 10.6 19.8 17.4 16.3 14.2 18.1 18.7 10.0 20.4 29.3 15.8 22.1 15.1 10.3 9.3 0.8 7.7 11.1 12.4 6.1 8.0 3.9 4.4 17.4 7.7 12.1 11.6 11.6 6.9 10.3 10.3 15.7 5.9 19.0 11.1 5.8 15.3 9.2 14.6 11.0 23.4 8.0 13.4 12.4 4.9 9.1 9.3 18.8 6.0 7.3 8.8 14.3 29.3 6.9 8.2 8.8 33.0 10.5 12.9 7.8 13.9 19.8 12.8 13.1 7.1 13.3 8.4 13.5 9.9 8.1 7.5 9.7 5.1 6.8 19.1 6.6 6.2 16.1 5.3 8.5 7.5 83.2 31.0 4.5 7.0 23.7 11.3 23.8 17.1 0.3 6.9 0.8 5.9 7.7 12.4 10.3 8.4 7.7 8.1 7.8 11.1 10.5 0.2 11.1 4.9 9.3 7.3 6.1 13.9 19.2 16.7 17.3 16.5 11.0 16.8 11.3 19.3 18.7 17.9 26.9 21.2 94.7 69.6 12.6 61.4 45.9 61.6 63.7 17.4 0.0 40.8 58.0 40.9 72.5 33.0 12.0 0.0 41.1 44.2 40.8 42.1 44.0 66.6 48.0 17.5 10.9 22.7 27.3 20.4 31.9 26.8 35.4 18.0 26.8 18.6 37.2 21.0 25.5 70.4 8.2 12.9 35.4 37.2 27.3 58.0 28.9 17.9 32.7 65.4 RPIA ENSG00000153574 "Ribose 5-phosphate isomerase A" P49247 2 88691644-88750935 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Isomerase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Cytotrophoblasts: 210.0;Syncytiotrophoblasts: 188.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042620, HPA057954" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA 4100000 "Nucleoplasm, Vesicles, Plasma membrane" "HPA042620: AB_10793980, HPA057954: AB_2683563" "unprognostic (3.35e-2)" "unprognostic (1.35e-2)" "unprognostic (6.96e-2)" "unprognostic (9.24e-2)" "unprognostic (4.31e-1)" "unprognostic (8.24e-2)" "prognostic unfavorable (1.46e-5)" "unprognostic (2.73e-3)" "unprognostic (1.82e-3)" "unprognostic (8.70e-2)" "unprognostic (8.82e-2)" "unprognostic (2.79e-1)" "prognostic unfavorable (8.53e-6)" "unprognostic (3.47e-2)" "unprognostic (2.53e-1)" "unprognostic (1.01e-2)" "unprognostic (8.79e-3)" 12.9 8.8 6.6 15.6 7.0 43.0 12.1 11.1 6.4 8.1 12.7 6.1 11.0 12.4 11.1 7.3 18.3 8.5 14.0 10.9 5.0 4.9 6.8 6.2 9.0 16.2 7.2 3.8 11.7 26.5 3.6 11.4 26.1 6.5 8.8 13.4 6.0 12.6 8.5 17.6 9.2 12.7 7.7 5.1 15.4 10.4 8.9 7.6 30.7 9.6 10.5 19.3 8.1 11.8 18.5 14.1 21.4 12.5 13.3 22.4 11.6 8.5 5.0 10.2 8.1 7.2 7.4 22.4 4.8 4.5 7.9 5.4 17.8 11.4 43.7 10.4 5.5 10.9 5.2 12.7 4.0 12.5 20.7 16.5 17.5 3.2 17.6 7.3 32.0 12.9 6.8 3.4 7.0 11.0 3.9 11.1 23.4 18.7 7.6 7.4 13.4 35.1 28.1 9.2 28.4 8.3 18.4 12.1 10.7 6.5 13.8 7.3 8.3 5.7 7.4 11.0 5.8 4.0 13.2 6.3 4.7 12.4 15.4 13.6 5.9 4.8 43.8 4.8 29.1 6.7 5.5 9.7 21.4 11.1 9.8 14.2 18.5 15.5 16.4 14.1 15.4 22.4 18.4 2.3 13.3 12.5 6.8 12.6 11.6 6.6 7.0 11.1 6.4 5.0 4.9 7.2 3.8 6.5 7.6 11.9 10.4 45.3 15.3 33.2 8.7 11.4 15.3 2.7 3.4 19.2 2.0 210.0 8.3 13.5 6.8 26.6 15.2 70.0 30.1 69.7 29.7 21.6 21.8 5.9 38.8 12.7 18.4 17.8 15.5 2.6 18.4 22.5 38.8 25.2 24.7 4.3 21.4 28.1 17.7 12.9 5.1 19.4 18.0 25.3 32.5 35.8 188.7 37.3 56.2 35.5 RPL22 "EAP, L22" ENSG00000116251 "Ribosomal protein L22" P35268 1 6181269-6209389 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Heparin-binding, Ribonucleoprotein, Ribosomal protein, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068294 Approved Nucleoplasm,Nucleoli NA NA 320000 Nucleoli Nucleoplasm "HPA068294: AB_2732781" "unprognostic (3.16e-3)" "unprognostic (1.28e-1)" "unprognostic (3.13e-1)" "unprognostic (3.62e-2)" "unprognostic (2.27e-2)" "unprognostic (1.09e-1)" "unprognostic (1.29e-3)" "unprognostic (4.40e-2)" "unprognostic (7.06e-2)" "unprognostic (3.26e-1)" "unprognostic (1.48e-1)" "unprognostic (4.24e-2)" "unprognostic (1.46e-3)" "unprognostic (3.83e-1)" "unprognostic (3.88e-2)" "unprognostic (2.46e-1)" "unprognostic (1.98e-1)" 75.5 71.5 54.3 79.7 42.8 124.7 75.0 46.7 39.5 95.8 73.9 39.2 53.9 66.5 133.6 63.9 103.9 59.1 61.8 50.8 47.4 38.6 58.8 90.2 55.3 142.6 50.6 39.7 163.1 154.8 30.4 57.0 49.8 37.4 90.8 46.4 57.0 140.3 66.8 114.0 79.7 62.6 106.6 58.3 79.1 62.0 38.2 35.0 95.3 91.0 112.8 81.1 101.5 91.9 75.6 62.3 11.0 38.9 42.2 98.8 73.9 89.4 25.5 54.4 55.5 38.3 60.3 43.0 78.2 31.5 28.8 24.6 50.6 77.8 138.9 64.4 28.9 19.9 51.8 40.8 40.6 38.0 68.0 66.5 135.0 58.1 62.8 38.0 178.6 54.2 53.1 33.7 25.6 53.1 59.6 35.9 39.0 111.2 84.2 33.0 39.5 78.0 145.7 33.8 59.9 56.7 75.3 112.8 107.6 42.1 31.1 75.2 69.0 63.6 184.4 143.1 49.3 59.3 141.6 87.7 41.1 45.3 54.2 73.4 67.7 92.9 210.2 27.2 184.7 25.4 11.0 38.9 8.8 38.0 34.3 66.9 75.6 71.1 52.3 59.8 72.4 98.8 78.1 2.9 42.2 27.8 62.3 54.0 73.9 54.3 42.8 46.7 39.5 47.4 38.6 50.6 39.7 37.4 35.0 413.9 647.4 2117.2 1742.6 1617.7 195.0 241.8 1080.3 472.4 833.7 554.8 123.7 1561.4 1614.8 1042.5 368.7 1236.7 707.2 537.3 1569.0 2352.9 1052.3 1320.4 878.8 1234.2 1317.3 133.5 877.3 1218.4 1697.8 247.8 1877.2 1676.9 1020.7 1556.4 1647.3 322.2 1580.5 1090.7 1160.1 1724.2 283.7 763.2 1114.2 317.0 420.5 1692.2 1548.7 1448.0 2302.5 1714.3 RPL22L1 ENSG00000163584 "Ribosomal protein L22 like 1" Q6P5R6 3 170864875-170870483 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 101.9" "Low region specificity" "Detected in all" "HPA048060, HPA056207, HPA068294" Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA048060: AB_2732544, HPA056207: AB_2683065, HPA068294: AB_2732781" "unprognostic (1.99e-1)" "unprognostic (3.45e-1)" "unprognostic (2.59e-1)" "unprognostic (1.45e-2)" "unprognostic (1.94e-1)" "unprognostic (2.31e-3)" "unprognostic (1.01e-2)" "unprognostic (9.50e-2)" "unprognostic (1.97e-1)" "prognostic favorable (8.60e-5)" "unprognostic (1.17e-3)" "unprognostic (4.52e-2)" "prognostic unfavorable (5.13e-12)" "unprognostic (5.12e-2)" "unprognostic (3.55e-1)" "unprognostic (1.23e-1)" "unprognostic (6.96e-2)" 17.2 14.6 8.9 28.1 9.5 36.0 21.5 6.0 9.3 14.3 15.7 5.3 6.6 8.4 12.2 12.3 33.6 15.3 11.8 11.3 7.4 8.5 11.4 64.3 18.8 31.4 10.1 5.7 18.6 71.6 1.9 12.1 10.5 10.7 14.7 15.7 6.4 15.7 14.0 17.7 19.4 13.7 12.2 11.5 37.5 17.4 9.7 8.9 17.9 15.2 32.5 27.8 18.9 15.9 24.1 24.2 1.9 7.6 13.1 13.8 3.5 15.8 17.9 5.8 67.6 17.3 101.9 17.8 16.1 37.2 13.1 8.5 7.6 3.7 49.0 3.7 15.0 41.1 4.1 14.4 41.1 7.3 2.9 2.6 4.4 2.2 17.1 70.0 9.0 6.5 74.0 84.0 4.1 44.6 20.5 44.5 27.2 3.1 3.1 71.8 20.1 65.7 5.1 90.9 6.1 3.2 88.2 2.1 7.5 32.5 35.3 0.9 4.9 1.6 8.1 7.0 3.3 11.3 8.0 20.6 2.5 19.3 5.0 22.4 5.0 3.5 7.8 45.9 5.5 52.1 1.0 4.8 1.9 6.8 5.7 13.8 24.1 10.0 9.0 5.1 17.9 6.7 7.4 1.0 13.1 7.6 24.2 6.3 3.5 8.9 9.5 6.0 8.1 7.4 8.5 10.1 5.7 10.7 8.9 8.9 36.6 274.9 201.6 175.5 13.0 14.5 53.5 57.6 92.1 19.2 3.9 84.0 56.3 132.5 30.8 89.5 76.2 23.3 199.7 252.2 105.2 161.6 105.0 90.9 170.2 7.9 138.8 87.8 140.5 29.1 129.2 89.6 74.2 57.7 130.6 34.1 350.4 115.2 83.8 69.0 18.4 45.3 94.8 47.6 26.2 216.6 82.3 126.9 150.6 274.6 RPL27 L27 ENSG00000131469 "Ribosomal protein L27" P61353 17 42998273-43002959 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Cancer-related genes, Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002649 Approved Enhanced Nucleoplasm,Nucleoli NA NA 30000 Nucleoli Nucleoplasm "HPA002649: AB_1079840" "unprognostic (8.53e-3)" "unprognostic (7.15e-2)" "unprognostic (3.97e-2)" "unprognostic (2.81e-2)" "unprognostic (4.99e-2)" "unprognostic (4.31e-2)" "unprognostic (1.91e-3)" "unprognostic (7.32e-2)" "unprognostic (9.17e-2)" "unprognostic (1.19e-1)" "unprognostic (5.12e-2)" "unprognostic (3.86e-1)" "prognostic unfavorable (7.80e-8)" "unprognostic (1.10e-1)" "unprognostic (2.70e-1)" "unprognostic (2.70e-1)" "unprognostic (1.14e-1)" 78.4 66.9 61.7 82.2 45.7 150.0 148.7 63.1 82.7 75.1 76.8 27.2 65.4 48.8 74.8 80.1 91.9 64.9 80.8 120.6 46.2 38.5 76.2 121.7 109.5 222.2 49.2 49.0 123.7 185.0 17.2 44.1 81.0 48.3 65.3 55.0 43.8 119.1 78.5 127.5 113.8 61.9 82.4 43.6 84.4 69.7 40.3 28.8 72.6 70.5 153.8 78.5 86.1 80.9 178.5 152.7 44.2 99.0 111.4 184.7 216.0 114.1 144.8 88.7 128.4 157.1 233.0 143.3 133.0 109.3 143.0 102.6 205.0 89.9 216.5 113.2 104.6 77.6 100.2 101.6 169.8 137.6 100.2 241.7 85.0 121.4 216.7 193.9 244.1 89.5 219.6 145.5 96.5 123.8 146.7 118.5 114.9 158.0 134.0 132.0 111.6 203.2 206.9 134.3 132.4 92.7 142.6 249.8 244.5 120.8 154.3 99.8 110.2 52.2 103.0 211.8 125.8 173.2 258.0 133.7 106.6 105.6 130.2 195.6 117.1 188.5 211.9 95.8 151.7 108.6 44.2 99.0 29.5 106.6 87.9 150.2 178.5 159.0 124.5 118.6 168.3 184.7 159.1 20.4 111.4 67.3 152.7 112.5 216.0 61.7 45.7 63.1 82.7 46.2 38.5 49.2 49.0 48.3 28.8 681.9 960.2 2744.7 1731.4 2247.5 123.8 670.7 1245.8 627.7 1104.4 492.0 84.4 1811.7 1268.3 1382.3 339.9 1526.1 906.3 700.8 2626.7 2977.9 1476.5 1638.9 947.9 1517.2 1848.2 62.0 876.6 1298.9 2145.4 659.2 2254.1 2398.0 1353.0 2460.8 1687.2 280.7 2397.9 1157.3 1202.8 1660.9 156.7 853.7 1593.4 457.6 394.4 2946.9 1827.2 1797.0 2037.9 2132.8 RPP14 P14 ENSG00000163684 "Ribonuclease P/MRP subunit p14" O95059 3 58306247-58324695 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 53.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036194 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA036194: AB_10672082" "unprognostic (6.05e-2)" "unprognostic (2.02e-2)" "unprognostic (1.50e-3)" "unprognostic (1.36e-1)" "unprognostic (4.08e-3)" "unprognostic (2.51e-1)" "unprognostic (1.30e-1)" "unprognostic (2.05e-2)" "unprognostic (1.46e-1)" "unprognostic (1.09e-1)" "unprognostic (2.95e-3)" "unprognostic (3.76e-2)" "prognostic favorable (3.07e-10)" "unprognostic (5.19e-3)" "unprognostic (2.36e-1)" "prognostic unfavorable (2.96e-4)" "unprognostic (5.78e-2)" 7.1 8.5 8.3 5.7 12.9 5.3 7.1 15.8 10.7 6.6 8.6 5.9 6.6 10.2 8.2 7.8 8.5 7.4 6.2 11.8 7.2 6.8 11.2 15.0 5.6 7.6 6.5 9.9 8.4 11.9 10.8 9.4 6.0 7.2 7.4 8.2 9.0 8.5 7.0 53.5 7.4 9.1 11.7 5.5 7.7 7.7 9.1 5.9 6.3 8.1 18.5 8.5 7.2 7.0 4.6 6.6 4.7 9.8 9.8 6.4 3.5 10.1 8.1 9.4 7.5 7.9 8.5 10.4 8.6 9.3 12.4 14.0 12.3 6.7 12.2 2.0 11.5 10.8 6.2 14.1 12.8 12.1 8.5 7.4 11.6 9.7 6.7 7.7 19.9 9.7 9.3 12.4 14.7 14.1 6.2 9.7 15.0 9.9 8.7 12.0 5.5 13.5 7.0 12.3 8.4 15.4 5.5 7.4 11.8 9.0 14.6 5.9 10.5 8.1 9.7 11.6 6.8 9.3 9.6 8.8 9.4 10.5 9.9 16.3 13.0 22.3 17.6 10.7 14.0 6.6 3.0 5.7 4.7 4.2 4.9 5.6 4.1 5.5 5.8 6.6 4.6 6.4 6.2 2.6 9.8 9.8 6.2 3.0 3.5 8.3 12.9 15.8 10.7 7.2 6.8 6.5 9.9 7.2 5.9 8.9 11.0 7.0 7.1 27.7 24.7 26.6 5.1 8.1 5.7 3.5 23.6 7.2 10.0 5.3 0.7 7.2 11.7 0.0 5.3 5.2 8.4 6.9 3.5 17.9 5.4 17.5 9.2 12.3 11.4 0.9 11.5 9.5 21.9 8.2 12.5 12.9 6.2 3.5 9.2 10.1 28.1 0.0 20.5 8.6 13.5 37.6 8.6 7.0 13.4 6.2 RPP25 FLJ20374 ENSG00000178718 "Ribonuclease P and MRP subunit p25" Q9BUL9 15 74954416-74957464 "Enzymes, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 79.4;Hofbauer cells: 60.4;Rod photoreceptor cells: 56.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 16.7" "Group enriched" "Detected in many" 4 "dendritic cells: 16.7;monocytes: 6.4" "Cell line enhanced" "Detected in many" "HHSteC: 18.6;SCLC-21H: 17.1;SK-MEL-30: 25.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046900 Approved Supported "Nucleoplasm,Centriolar satellite" NA NA Nucleoplasm "Centriolar satellite" "HPA046900: AB_10962049" "unprognostic (9.36e-2)" "unprognostic (7.17e-3)" "unprognostic (5.54e-2)" "unprognostic (2.27e-1)" "prognostic unfavorable (2.24e-5)" "unprognostic (7.18e-2)" "unprognostic (5.73e-3)" "unprognostic (5.50e-3)" "unprognostic (7.78e-2)" "unprognostic (1.44e-1)" "unprognostic (3.58e-2)" "unprognostic (1.70e-1)" "unprognostic (4.71e-3)" "unprognostic (5.50e-3)" "unprognostic (5.58e-2)" "unprognostic (1.10e-1)" "unprognostic (2.53e-1)" 3.9 7.3 3.0 1.9 4.6 0.0 2.2 3.2 14.0 3.4 6.7 3.7 1.2 6.0 1.7 1.3 3.3 1.8 3.7 2.5 2.5 6.8 2.6 1.9 5.1 2.7 8.0 5.1 12.0 4.9 9.0 2.8 6.1 10.6 2.1 4.1 3.2 2.4 1.3 1.9 2.1 4.6 2.0 7.9 6.2 5.6 1.9 1.8 3.1 4.9 2.6 2.5 4.1 2.4 2.3 16.7 0.3 6.4 0.3 2.7 1.4 8.9 6.8 1.7 0.0 0.6 0.4 2.9 1.7 2.0 0.5 0.4 9.2 8.2 0.0 7.9 1.7 0.5 2.7 5.3 0.3 0.1 3.3 0.2 0.0 7.9 0.2 18.6 0.0 5.3 2.4 0.2 3.4 0.0 0.3 7.9 2.3 6.0 0.0 1.7 3.4 1.4 2.4 8.2 15.7 2.7 0.0 0.0 6.0 1.6 0.1 17.1 12.8 12.8 11.3 25.6 0.9 2.2 7.1 1.8 0.0 0.7 1.6 0.0 0.1 0.0 0.0 0.9 13.9 10.0 0.0 3.3 0.0 1.5 6.4 0.9 2.3 1.1 1.3 3.3 1.9 2.7 2.1 0.3 0.3 4.8 16.7 0.4 1.4 3.0 4.6 3.2 14.0 2.5 6.8 8.0 5.1 10.6 1.8 3.0 0.6 4.5 6.4 9.7 79.4 1.5 10.2 0.0 1.2 8.7 3.9 1.7 11.6 11.4 0.3 5.8 17.2 0.0 16.7 3.9 18.6 13.1 0.0 1.0 60.4 20.6 9.8 36.8 12.1 0.9 36.5 7.9 13.5 22.6 9.4 7.8 15.6 15.8 28.3 12.8 56.0 12.9 10.3 0.5 7.0 10.0 1.9 2.5 18.4 8.7 RPP25L "bA296L22.5, C9orf23, MGC29635" ENSG00000164967 "Ribonuclease P/MRP subunit p25 like" Q8N5L8 9 34610486-34612104 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 56.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052187, HPA059698" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA052187: AB_2681755, HPA059698: AB_2684106" "unprognostic (1.56e-1)" "unprognostic (1.43e-2)" "unprognostic (7.44e-2)" "unprognostic (1.38e-1)" "unprognostic (1.98e-1)" "unprognostic (1.78e-1)" "unprognostic (4.78e-2)" "unprognostic (2.56e-1)" "unprognostic (1.66e-1)" "unprognostic (2.53e-2)" "unprognostic (3.39e-2)" "unprognostic (2.44e-1)" "prognostic favorable (3.01e-9)" "unprognostic (4.63e-3)" "unprognostic (6.20e-2)" "unprognostic (3.40e-1)" "prognostic favorable (8.21e-4)" 7.4 10.1 11.1 7.9 13.8 4.9 9.3 8.6 14.0 8.2 18.0 7.2 14.0 15.4 9.9 11.4 13.3 11.8 10.9 19.9 9.8 8.8 11.1 19.9 9.3 10.1 10.1 9.1 11.7 20.4 6.3 7.6 11.0 7.5 14.4 8.2 6.4 15.7 9.5 56.0 9.7 18.4 9.3 7.1 11.4 8.6 10.9 6.1 14.4 14.8 21.9 11.3 11.0 10.4 40.7 30.1 41.5 35.4 32.5 41.7 24.8 18.8 24.6 10.0 9.8 10.3 9.5 10.0 8.1 8.5 13.5 15.5 10.8 12.8 14.6 12.7 4.9 6.3 12.7 15.1 20.4 4.8 29.5 20.3 8.7 18.3 15.8 22.0 8.9 13.3 16.9 19.7 11.2 26.2 11.7 14.1 20.4 13.9 15.7 10.3 20.2 18.6 33.7 9.2 19.3 22.4 16.5 10.6 14.6 14.5 9.9 6.7 3.9 14.9 16.8 9.5 5.2 15.3 15.8 6.4 4.2 12.4 10.2 6.7 7.6 13.3 16.6 12.9 18.7 20.3 41.5 35.4 33.3 25.6 28.8 31.6 34.9 30.2 26.9 30.1 40.7 35.5 33.5 32.9 32.5 33.6 24.5 41.7 24.8 11.1 13.8 8.6 14.0 9.8 8.8 10.1 9.1 7.5 6.1 0.0 13.7 24.8 44.7 9.8 7.9 31.3 28.1 13.4 13.6 19.2 2.0 52.4 84.6 22.9 2.2 12.0 59.6 46.7 17.3 31.1 14.9 29.7 10.3 68.6 28.4 0.0 32.3 26.4 34.1 4.5 20.8 12.1 11.8 25.2 40.0 19.0 18.3 51.8 14.5 51.9 9.3 6.5 17.4 49.2 25.4 12.9 35.0 22.7 46.6 41.5 RPP30 TSG15 ENSG00000148688 "Ribonuclease P/MRP subunit p30" P78346 10 90871716-90908553 "Enzymes, Plasma proteins, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037578 Approved Approved "Nucleoplasm,Nucleoli,Microtubule ends,Cytosol" NA NA "Nucleoplasm, Nucleoli" "Microtubule ends, Cytosol" "HPA037578: AB_10696939" "unprognostic (1.55e-1)" "unprognostic (1.77e-3)" "unprognostic (2.35e-1)" "unprognostic (4.08e-1)" "unprognostic (5.64e-2)" "unprognostic (3.05e-2)" "unprognostic (3.80e-3)" "unprognostic (1.27e-1)" "unprognostic (2.73e-1)" "unprognostic (1.03e-1)" "unprognostic (2.27e-2)" "unprognostic (2.65e-1)" "prognostic unfavorable (1.01e-6)" "unprognostic (1.98e-1)" "unprognostic (9.84e-3)" "unprognostic (3.43e-2)" "unprognostic (2.10e-2)" 24.2 19.0 20.9 16.8 20.3 27.2 22.3 26.0 24.0 18.9 19.0 16.2 16.3 11.5 25.2 18.6 23.8 19.2 16.0 26.6 19.8 16.8 20.6 18.4 17.1 23.2 18.5 20.4 23.9 17.7 37.7 23.6 23.6 19.3 18.8 19.3 18.7 19.2 16.5 35.9 23.5 16.4 20.6 19.2 21.3 19.2 32.0 21.6 31.2 18.1 24.0 26.3 21.7 18.9 19.4 22.2 16.2 19.5 14.2 20.3 16.2 28.6 19.1 20.0 24.1 13.0 14.1 7.1 20.5 18.5 34.4 36.1 32.2 23.1 16.9 15.7 13.0 22.4 20.1 26.6 18.2 35.5 27.1 18.3 11.4 12.2 25.4 12.4 23.0 14.4 11.5 11.9 25.9 29.4 14.5 19.4 15.6 22.6 15.5 22.7 17.7 26.6 31.3 12.4 16.3 21.7 14.9 17.1 17.8 12.9 13.6 10.9 10.9 12.0 8.7 24.1 19.2 23.5 14.6 11.0 17.2 17.2 9.7 42.3 10.5 26.8 36.3 21.5 12.5 13.1 4.3 19.5 16.2 17.1 18.7 18.6 19.4 19.6 18.7 22.2 16.7 17.0 18.5 2.2 14.2 15.3 20.7 20.3 16.2 20.9 20.3 26.0 24.0 19.8 16.8 18.5 20.4 19.3 21.6 29.8 20.0 24.7 27.9 30.6 18.6 39.9 22.9 17.4 20.5 14.0 17.7 50.9 26.6 34.6 73.2 18.4 8.7 0.0 30.3 55.9 20.4 16.0 23.1 12.4 49.9 15.9 19.0 20.3 22.6 37.3 26.7 27.6 21.9 32.5 17.8 20.3 27.7 14.0 27.6 27.1 20.1 38.8 28.1 53.2 47.3 29.6 28.3 27.3 17.5 21.8 RPP40 "bA428J1.3, RNASEP1" ENSG00000124787 "Ribonuclease P/MRP subunit p40" O75818 6 4994732-5004063 "Enzymes, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035685, HPA035686" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA035685: AB_2674734, HPA035686: AB_10670153" "unprognostic (2.93e-2)" "unprognostic (3.22e-2)" "unprognostic (1.94e-1)" "prognostic unfavorable (6.10e-6)" "unprognostic (8.00e-2)" "unprognostic (4.78e-2)" "prognostic unfavorable (5.41e-4)" "unprognostic (1.20e-1)" "unprognostic (1.72e-2)" "unprognostic (6.44e-2)" "unprognostic (8.17e-2)" "unprognostic (9.57e-2)" "prognostic unfavorable (7.54e-8)" "unprognostic (1.54e-1)" "unprognostic (5.10e-1)" "unprognostic (4.08e-2)" "unprognostic (2.19e-1)" 6.9 16.8 10.8 7.2 10.7 6.7 11.1 3.5 11.9 6.0 5.5 4.2 6.3 4.6 6.1 6.6 11.9 5.5 4.7 5.5 10.0 8.8 5.6 10.8 3.9 10.1 9.9 5.8 6.2 7.8 5.2 8.6 5.6 9.1 5.3 5.3 1.5 4.0 6.7 7.7 9.8 3.6 7.5 5.3 6.8 4.3 10.5 8.0 6.1 5.6 13.0 8.3 9.1 6.9 7.8 12.3 0.0 11.1 7.9 8.4 5.0 6.4 10.8 3.4 9.7 6.4 8.1 10.9 6.4 3.2 12.3 9.8 14.7 5.0 14.0 28.3 6.6 16.9 6.9 7.0 9.9 11.2 5.3 14.2 8.8 7.0 19.9 7.5 11.3 5.0 6.3 8.5 12.2 12.2 2.7 12.0 12.9 13.9 2.8 8.9 18.4 5.7 19.5 5.7 7.7 17.6 12.2 6.5 25.6 6.2 7.0 12.3 3.6 6.0 5.8 6.4 9.5 10.5 9.4 5.7 16.2 10.9 10.9 14.5 5.0 21.1 11.0 3.0 19.0 8.3 0.0 6.9 0.0 3.4 11.1 5.0 7.8 5.9 4.1 12.3 6.5 8.1 7.2 0.0 7.9 3.5 5.9 8.4 5.0 10.8 10.7 3.5 11.9 10.0 8.8 9.9 5.8 9.1 8.0 0.0 0.6 4.5 7.0 11.0 0.2 3.6 0.0 5.3 4.5 1.8 0.0 11.1 10.0 8.1 5.5 7.0 0.4 0.0 8.1 10.7 6.0 3.1 0.0 5.8 9.9 0.0 2.9 6.7 2.1 2.1 5.2 3.4 8.5 1.8 3.1 1.3 3.9 2.3 4.6 11.7 0.2 0.0 7.2 11.4 26.8 12.9 8.0 1.9 6.8 7.0 RPRD1A "FLJ10656, HsT3101, P15RS" ENSG00000141425 "Regulation of nuclear pre-mRNA domain containing 1A" Q96P16 18 35984387-36067576 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 88.6" "Group enriched" "Detected in many" 5 "Early spermatids: 215.3;Late spermatids: 274.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040602 Supported Supported "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA040602: AB_10673137" "unprognostic (2.06e-1)" "unprognostic (9.14e-2)" "unprognostic (1.41e-3)" "unprognostic (2.22e-1)" "unprognostic (9.92e-3)" "unprognostic (2.69e-1)" "unprognostic (2.93e-3)" "unprognostic (1.68e-1)" "unprognostic (2.80e-2)" "unprognostic (3.94e-3)" "unprognostic (1.13e-1)" "unprognostic (1.89e-1)" "unprognostic (5.50e-3)" "unprognostic (7.95e-2)" "unprognostic (6.78e-3)" "unprognostic (1.49e-1)" "unprognostic (4.30e-1)" 16.8 27.0 32.1 12.0 32.0 7.8 19.0 28.5 36.9 16.9 18.1 22.8 26.3 14.4 20.0 88.6 18.4 19.7 14.4 21.3 30.2 27.6 20.8 16.5 14.5 13.8 27.5 31.3 19.3 17.6 20.2 24.0 13.7 30.2 23.3 16.1 13.2 20.2 23.4 36.1 15.3 13.5 21.2 27.8 16.0 14.9 20.3 23.5 10.2 24.4 11.1 14.3 20.6 20.1 8.6 10.7 5.0 8.4 9.3 7.6 4.3 12.1 13.4 22.9 24.3 12.6 14.8 14.3 22.0 21.6 12.8 18.1 3.6 13.5 17.0 23.2 15.9 6.8 20.3 25.3 22.1 18.2 15.1 14.5 18.1 20.2 14.3 22.2 30.0 9.8 11.3 29.6 12.1 34.7 16.1 18.2 20.4 16.2 18.7 16.3 15.1 16.0 12.8 18.4 6.3 9.7 13.4 7.3 27.2 19.5 26.2 40.0 33.7 18.3 10.2 18.7 19.5 14.0 21.7 22.1 13.4 8.4 7.1 17.8 21.2 29.2 17.7 13.6 25.0 13.4 0.9 6.3 3.0 4.4 8.4 6.5 7.5 5.8 5.0 10.7 8.6 7.6 5.8 5.0 9.3 5.5 7.4 3.1 4.3 32.1 32.0 28.5 36.9 30.2 27.6 27.5 31.3 30.2 23.5 29.8 16.5 47.2 28.5 30.6 50.7 32.9 15.3 13.4 13.6 33.2 29.5 13.9 23.2 18.7 215.3 21.0 12.2 0.0 17.2 14.7 15.0 35.2 12.7 22.1 8.8 35.0 27.6 19.6 16.8 274.1 20.4 15.7 28.7 5.4 18.5 29.4 17.3 23.7 21.5 21.4 49.7 12.9 26.9 34.1 37.7 33.4 12.2 20.1 19.5 29.4 RPRD1B "C20orf77, CREPT, dJ1057B20.2, DKFZp434P0735, FLJ44520, K-H, Kub5-Hera, NET60" ENSG00000101413 "Regulation of nuclear pre-mRNA domain containing 1B" Q9NQG5 20 38033546-38127780 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 113.9" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 67.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066290, HPA070590, HPA072645" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA066290: AB_2685650, HPA070590: , HPA072645: " "unprognostic (3.14e-2)" "unprognostic (3.30e-1)" "unprognostic (5.38e-2)" "unprognostic (1.18e-3)" "unprognostic (3.08e-1)" "unprognostic (3.77e-2)" "unprognostic (2.68e-2)" "unprognostic (4.84e-2)" "unprognostic (1.03e-1)" "unprognostic (3.20e-2)" "unprognostic (1.14e-1)" "unprognostic (5.25e-2)" "unprognostic (1.72e-1)" "unprognostic (1.70e-2)" "unprognostic (5.77e-2)" "unprognostic (1.36e-2)" "unprognostic (3.47e-1)" 8.8 9.4 7.5 14.5 8.3 20.9 9.6 9.8 10.0 9.0 10.2 12.5 11.4 7.3 12.9 10.7 10.7 11.5 10.4 16.4 7.6 6.5 10.2 113.9 8.9 13.4 7.9 7.6 10.5 16.2 13.7 8.6 9.4 8.3 10.7 8.6 11.0 9.1 15.5 24.3 9.6 10.2 9.6 7.5 10.7 9.1 10.2 7.2 11.4 10.4 8.4 19.3 12.7 9.0 5.5 8.3 7.3 10.7 5.6 8.9 6.3 15.7 7.1 13.6 6.9 8.9 12.3 14.0 11.4 9.2 12.8 11.5 36.5 14.9 13.2 16.7 7.6 12.5 19.0 12.1 18.5 15.3 6.2 6.9 22.3 9.4 18.2 10.7 16.9 7.6 9.6 18.4 13.2 15.4 8.8 8.0 13.5 19.4 10.6 9.7 11.1 25.0 12.1 7.8 16.5 15.1 16.1 27.8 13.3 6.9 13.2 14.9 10.2 19.8 29.6 13.8 8.7 15.8 15.4 9.3 25.9 15.2 9.7 12.5 13.3 12.5 24.3 15.4 9.9 8.5 0.7 8.3 7.3 7.0 9.4 8.9 5.5 6.8 6.3 8.3 5.1 8.7 7.8 6.7 5.6 10.7 4.4 4.0 6.3 7.5 8.3 9.8 10.0 7.6 6.5 7.9 7.6 8.3 7.2 14.9 21.6 13.0 10.6 14.1 16.1 40.8 20.4 20.1 10.3 17.4 17.7 12.4 13.3 6.5 6.3 13.4 11.7 0.0 7.4 10.0 12.1 16.6 12.7 67.0 10.7 17.5 22.5 28.3 18.8 7.9 9.8 10.9 10.1 3.6 20.1 11.4 7.9 10.5 12.4 14.1 16.2 6.5 8.2 12.6 12.0 16.3 13.0 12.8 13.4 13.6 RPRD2 "FLJ32145, HSPC099, KIAA0460" ENSG00000163125 "Regulation of nuclear pre-mRNA domain containing 2" Q5VT52 1 150363091-150476566 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061693 Approved Approved Nucleoplasm,Vesicles NA NA 91000 "Nucleoplasm, Vesicles" "HPA061693: AB_2684587" "unprognostic (1.68e-1)" "unprognostic (1.52e-1)" "unprognostic (2.00e-1)" "unprognostic (7.25e-2)" "unprognostic (5.67e-3)" "unprognostic (3.79e-2)" "unprognostic (1.75e-2)" "unprognostic (9.03e-2)" "unprognostic (1.50e-1)" "unprognostic (3.93e-2)" "unprognostic (2.52e-1)" "unprognostic (1.27e-1)" "unprognostic (1.10e-3)" "unprognostic (1.11e-1)" "unprognostic (1.71e-1)" "unprognostic (7.92e-2)" "unprognostic (1.38e-1)" 14.0 16.9 16.8 12.0 21.6 13.2 14.0 40.1 22.1 20.2 17.9 21.4 16.6 11.5 21.0 16.4 17.0 24.2 12.2 14.1 16.3 14.1 18.3 12.5 14.0 13.8 16.3 14.1 34.2 17.9 27.5 29.4 10.7 15.2 18.3 16.3 19.8 14.5 19.2 28.5 15.6 13.9 20.1 13.8 16.7 14.2 16.2 17.4 25.6 25.4 10.4 17.3 21.6 17.1 8.0 4.2 6.0 8.6 5.1 9.1 2.5 15.8 12.1 16.1 16.2 16.7 14.2 15.2 11.5 13.7 12.7 12.5 10.4 19.5 25.1 13.2 14.0 7.1 17.6 22.5 17.1 13.9 11.5 9.5 14.4 14.3 12.5 12.0 21.5 17.8 15.0 13.0 17.7 23.4 14.1 15.6 15.4 14.0 27.4 12.8 22.8 18.9 7.0 20.1 20.0 13.7 17.4 11.9 25.3 18.6 14.6 17.1 17.3 23.5 20.0 15.2 15.0 15.8 19.2 14.3 11.8 12.2 9.8 16.2 16.8 18.4 19.0 11.7 16.2 11.5 6.0 3.6 4.4 8.1 2.4 7.4 7.6 7.6 6.4 3.5 8.0 8.9 8.8 2.0 5.1 8.6 4.2 9.1 2.5 16.8 21.6 40.1 22.1 16.3 14.1 16.3 14.1 15.2 17.4 17.9 20.4 25.7 8.7 13.7 32.3 23.0 17.8 20.1 27.3 31.4 15.7 11.8 6.6 11.0 7.2 20.1 14.2 0.0 11.2 7.3 13.6 13.3 17.3 22.2 12.7 11.1 24.8 25.8 16.8 3.2 35.1 10.1 10.1 10.8 22.5 25.1 12.3 14.0 37.4 22.1 27.5 32.3 12.7 21.8 23.4 12.8 8.4 23.6 23.4 9.9 RPS19 "DBA, S19" ENSG00000105372 "Ribosomal protein S19" P39019 19 41859918-41872926 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 546.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063217 Supported Nucleoplasm NA NA 52000 Nucleoplasm "HPA063217: AB_2732699" "unprognostic (8.02e-3)" "unprognostic (9.04e-2)" "unprognostic (5.93e-2)" "unprognostic (1.14e-1)" "unprognostic (7.32e-3)" "unprognostic (1.32e-1)" "unprognostic (2.69e-2)" "unprognostic (9.14e-2)" "unprognostic (1.06e-1)" "unprognostic (6.68e-2)" "unprognostic (5.78e-2)" "unprognostic (9.96e-2)" "prognostic unfavorable (2.32e-8)" "unprognostic (1.16e-1)" "unprognostic (7.55e-2)" "unprognostic (1.58e-1)" "unprognostic (1.72e-2)" 63.2 51.5 41.6 67.3 38.6 116.3 98.2 20.5 36.2 62.3 86.8 29.7 48.4 64.8 89.9 47.7 134.3 75.2 66.9 43.2 31.9 26.5 52.0 110.8 53.6 104.9 48.4 38.1 139.4 121.2 11.7 38.5 69.8 38.4 88.3 53.3 28.9 117.8 41.3 64.7 110.0 62.7 44.9 35.7 110.4 61.4 79.0 36.3 103.3 81.6 95.2 94.4 70.0 138.8 420.3 255.5 23.6 255.6 250.5 376.5 546.5 138.8 201.1 128.9 114.0 168.1 222.6 143.0 108.3 129.4 139.3 124.7 155.6 95.5 205.5 123.1 97.0 67.2 74.0 110.8 184.6 64.9 84.4 204.3 101.3 62.7 159.3 289.1 168.3 105.1 315.1 377.6 83.6 163.2 228.5 139.0 197.4 112.1 143.9 113.3 160.0 154.8 118.8 148.9 395.4 83.6 172.6 103.4 98.8 127.4 150.0 91.9 113.2 59.7 203.9 150.6 203.0 115.1 275.2 107.6 89.8 142.1 59.8 170.2 162.0 169.4 191.3 98.2 145.9 101.9 23.6 116.2 12.4 221.3 206.9 333.3 403.7 329.8 286.1 186.0 420.3 376.5 337.2 17.0 250.5 255.6 255.5 248.1 546.5 41.6 38.6 20.5 36.2 31.9 26.5 48.4 38.1 38.4 36.3 1527.6 2084.4 8605.5 7900.9 11848.7 270.9 645.2 2677.7 1311.6 2599.0 1357.4 119.8 5889.1 2238.2 3795.7 354.1 3914.2 2329.1 1845.5 7458.5 8187.3 3822.9 5482.6 1732.0 2563.4 4139.5 128.7 2143.3 3174.7 4844.3 1450.2 3737.8 5327.2 4322.3 6508.7 4064.5 386.9 6711.2 3300.0 1779.1 2720.9 355.9 1558.7 4061.9 516.1 1479.2 14818.6 5464.6 5600.3 7205.6 6831.8 RPS19BP1 "FLJ21770, MGC52010" ENSG00000187051 "Ribosomal protein S19 binding protein 1" Q86WX3 22 39529093-39532855 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042874 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA Yes "Nucleoli, Cytosol" Nucleoplasm "HPA042874: AB_10793988" "unprognostic (2.44e-1)" "unprognostic (1.67e-1)" "unprognostic (7.79e-2)" "unprognostic (5.07e-3)" "unprognostic (1.65e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (3.71e-4)" "unprognostic (1.65e-1)" "unprognostic (5.68e-2)" "unprognostic (8.31e-2)" "unprognostic (7.00e-2)" "unprognostic (6.73e-2)" "unprognostic (1.04e-1)" "unprognostic (6.11e-2)" "unprognostic (1.65e-1)" "unprognostic (2.34e-1)" "unprognostic (4.32e-2)" 32.8 38.8 38.9 29.5 30.6 36.9 47.5 24.2 34.7 26.4 28.0 19.2 40.6 31.4 18.8 25.2 24.1 18.0 25.0 30.5 38.9 28.4 30.8 40.7 22.5 29.4 40.3 27.0 23.4 45.0 15.4 18.8 21.9 31.9 31.6 14.4 19.2 65.2 35.4 55.0 19.8 30.9 28.5 31.1 27.1 32.6 28.8 24.6 16.3 40.8 28.0 23.7 24.3 54.5 64.2 73.5 67.3 57.7 42.8 60.3 50.5 20.9 25.9 12.5 17.6 14.1 9.2 26.3 24.1 19.6 21.1 16.8 28.7 13.9 26.2 25.2 14.2 17.2 17.0 19.6 24.7 7.3 37.7 62.7 25.2 22.0 25.3 20.6 36.8 32.9 13.8 18.7 18.1 22.2 11.4 14.3 19.9 28.1 19.0 13.3 23.2 17.6 36.7 21.7 46.7 49.7 28.1 16.3 39.4 22.1 20.8 27.9 15.6 19.5 31.1 43.3 8.0 22.4 29.8 16.9 17.6 40.2 19.6 31.4 33.1 30.4 40.7 23.9 25.6 41.1 42.1 57.7 67.3 53.4 52.1 49.2 62.0 54.4 55.2 46.3 64.2 53.2 54.1 63.4 42.8 42.0 73.5 60.3 50.5 38.9 30.6 24.2 34.7 38.9 28.4 40.3 27.0 31.9 24.6 41.7 44.3 107.2 91.0 121.8 95.6 68.3 109.5 34.8 36.4 92.5 49.1 134.1 184.1 166.7 17.8 129.5 196.8 46.7 167.0 202.1 94.9 166.3 69.2 175.1 185.7 33.4 136.9 111.1 105.7 22.2 126.8 125.3 102.9 172.3 137.0 80.8 187.2 164.9 118.5 232.2 81.9 77.6 104.0 59.0 146.0 129.4 110.1 136.4 130.8 112.7 RPS6KA1 "HU-1, p90Rsk, RSK, RSK1" ENSG00000117676 "Ribosomal protein S6 kinase A1" Q15418 1 26529761-26575030 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 45.2" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 85.8;monocytes: 68.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 29.9;U-937: 32.2" "Region enriched" "Detected in all" 5 "cerebellum: 60.4" "Low region specificity" "Detected in all" "CAB003852, HPA007981" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB003852: AB_289590, HPA007981: AB_1079850" "unprognostic (1.04e-3)" "unprognostic (1.23e-1)" "unprognostic (1.61e-3)" "prognostic favorable (7.20e-7)" "unprognostic (7.35e-2)" "unprognostic (3.69e-1)" "unprognostic (6.93e-3)" "unprognostic (1.12e-2)" "unprognostic (1.09e-1)" "unprognostic (7.51e-3)" "unprognostic (2.37e-2)" "unprognostic (9.64e-2)" "prognostic favorable (1.84e-4)" "prognostic favorable (4.58e-4)" "unprognostic (4.77e-2)" "unprognostic (7.61e-2)" "prognostic favorable (8.33e-4)" 11.0 8.2 6.3 24.2 9.7 15.8 5.0 14.4 6.3 4.9 23.2 11.1 4.4 24.5 2.1 3.6 8.9 6.0 8.0 3.4 5.3 5.1 13.6 5.4 26.1 32.7 10.3 3.5 2.1 10.1 10.0 7.4 3.3 8.6 8.6 15.8 3.6 19.0 5.5 1.1 9.0 45.2 2.8 7.9 27.0 9.7 2.7 9.0 15.9 13.9 4.9 17.3 6.2 4.5 5.0 22.0 40.1 18.0 7.9 8.3 17.1 9.9 3.5 2.8 3.7 0.1 0.0 3.8 0.8 1.6 4.2 4.1 4.0 8.2 18.5 4.6 0.5 5.1 11.7 6.4 22.9 3.0 15.3 4.1 20.3 8.6 7.1 1.3 23.9 29.9 0.7 8.4 3.9 7.0 1.9 1.8 7.4 3.4 6.7 0.2 5.5 0.8 23.6 7.3 19.3 11.1 12.8 3.6 8.1 12.1 2.7 4.1 1.6 7.0 6.6 3.2 3.1 4.2 20.6 1.2 0.2 5.4 0.7 3.3 4.2 4.9 10.1 2.5 32.2 4.1 9.6 18.0 40.1 8.3 16.4 6.9 4.9 6.1 7.3 22.0 5.0 3.9 5.5 34.5 7.9 17.3 8.6 6.0 17.1 6.3 9.7 14.4 6.3 5.3 5.1 10.3 3.5 8.6 9.0 14.9 23.5 13.7 7.4 16.6 1.3 1.2 10.2 10.7 5.7 8.7 3.9 1.2 6.6 15.5 1.8 4.2 85.8 0.0 16.3 14.5 1.9 13.9 32.2 3.8 43.9 0.0 15.6 12.3 57.1 0.5 0.0 36.8 1.7 68.5 34.3 0.4 21.8 41.9 0.0 13.6 1.7 6.5 2.1 1.1 2.7 10.2 3.4 41.5 32.9 6.8 RPS6KA2 "HU-2, RSK, RSK3" ENSG00000071242 "Ribosomal protein S6 kinase A2" Q15349 6 166409364-166906451 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Horizontal cells: 271.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "eosinophil: 17.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 17.5" "Cell line enhanced" "Detected in many" "ASC diff: 48.4;ASC TERT1: 35.5;HHSteC: 35.9;HSkMC: 31.9;hTERT-HME1: 38.6;hTERT-RPE1: 70.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026243, HPA045061, HPA054237, CAB069428" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB026243: , CAB069428: AB_1622639, HPA045061: AB_2679203, HPA054237: AB_2682425" "unprognostic (8.71e-2)" "unprognostic (3.14e-3)" "unprognostic (7.29e-2)" "unprognostic (1.72e-1)" "unprognostic (3.80e-1)" "unprognostic (2.45e-1)" "unprognostic (6.44e-3)" "unprognostic (8.63e-2)" "unprognostic (1.40e-1)" "prognostic unfavorable (8.63e-5)" "unprognostic (8.68e-2)" "unprognostic (4.11e-2)" "prognostic favorable (2.86e-5)" "unprognostic (3.12e-3)" "unprognostic (1.51e-1)" "unprognostic (1.56e-2)" "unprognostic (2.01e-1)" 15.4 6.5 26.8 5.3 35.5 6.9 12.7 12.1 21.5 13.5 7.1 20.3 11.5 4.3 18.3 5.2 14.0 11.9 12.5 40.9 25.0 18.3 9.9 3.3 24.6 10.6 22.4 18.4 20.9 30.2 32.6 18.0 12.1 22.7 10.6 7.4 11.1 9.0 10.5 14.4 7.5 7.2 15.8 37.2 16.5 10.4 5.1 25.7 0.8 24.8 3.5 4.9 15.5 10.2 0.4 3.9 17.5 1.6 3.3 0.6 0.2 1.9 0.0 3.9 5.7 48.4 35.5 0.0 4.1 8.1 2.3 3.2 0.0 1.2 0.2 1.3 14.6 1.8 1.7 2.0 9.0 2.1 0.8 0.5 0.0 8.5 0.1 35.9 0.1 1.6 31.9 6.5 12.5 38.6 70.4 12.6 4.1 0.0 0.0 9.5 0.4 0.1 0.4 1.0 1.9 2.3 0.6 2.0 5.7 2.4 2.1 2.1 15.2 1.4 3.9 5.3 1.0 0.1 3.0 4.6 8.3 0.8 22.8 1.2 1.1 1.7 0.5 5.5 0.2 7.8 0.1 0.5 17.5 0.5 0.7 0.2 0.3 0.5 0.2 0.7 0.4 0.6 0.3 0.4 3.3 1.6 3.9 0.4 0.2 26.8 35.5 12.1 21.5 25.0 18.3 22.4 18.4 22.7 25.7 20.8 34.5 0.0 4.1 4.1 34.9 54.9 22.9 2.7 13.6 34.9 7.9 0.1 10.0 12.8 12.0 47.2 0.5 0.0 20.9 0.2 8.0 9.4 2.3 11.6 7.2 271.7 5.2 38.6 5.0 48.4 4.9 4.7 18.6 3.6 5.5 8.3 22.7 1.4 4.2 4.4 15.4 12.9 6.9 3.2 1.1 3.0 0.2 1.3 1.2 5.8 RPS6KA3 "CLS, HU-3, MRX19, RSK, RSK2" ENSG00000177189 "Ribosomal protein S6 kinase A3" P51812 X 20149911-20267519 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 69.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003221, CAB003853, CAB013520" Approved Supported Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "CAB003853: AB_562343, CAB013520: AB_2533378, HPA003221: AB_1853553" "unprognostic (1.87e-2)" "unprognostic (1.03e-1)" "unprognostic (1.80e-2)" "unprognostic (4.26e-2)" "unprognostic (3.53e-1)" "unprognostic (1.11e-1)" "unprognostic (1.15e-2)" "unprognostic (1.61e-3)" "unprognostic (1.02e-1)" "unprognostic (1.57e-1)" "unprognostic (5.04e-1)" "unprognostic (1.07e-1)" "unprognostic (1.04e-1)" "unprognostic (4.49e-3)" "unprognostic (3.91e-1)" "unprognostic (1.09e-1)" "unprognostic (2.22e-1)" 19.7 12.5 9.9 23.0 12.5 8.2 16.5 15.2 12.1 11.4 23.2 4.4 22.1 13.7 12.4 10.1 13.6 12.7 15.7 21.3 9.7 8.8 14.1 25.8 21.6 34.0 9.9 10.0 12.7 14.0 36.6 9.8 11.0 10.2 14.5 18.8 7.7 14.3 11.3 45.2 11.7 23.7 16.1 11.7 25.8 11.8 4.8 9.7 29.4 13.5 15.0 18.2 20.3 19.0 4.2 8.6 12.5 6.9 8.3 11.3 2.7 12.9 22.7 8.6 4.4 8.4 14.8 2.6 11.2 17.1 8.4 11.6 25.7 16.7 8.5 3.9 11.8 12.3 9.2 9.8 9.5 15.7 7.1 7.8 10.0 14.3 69.0 8.6 19.5 10.4 9.4 7.6 13.2 16.7 7.4 30.4 9.0 6.6 24.4 8.8 6.1 12.6 6.0 6.2 16.9 13.7 6.7 18.2 9.8 7.3 10.9 4.0 3.9 15.1 4.6 16.4 11.2 0.0 5.8 16.9 9.2 6.4 29.1 6.3 19.5 11.9 9.5 17.4 9.7 21.7 12.5 4.7 9.5 6.3 6.9 11.3 2.9 7.3 6.9 7.0 4.2 5.0 6.0 7.5 8.3 6.9 8.6 3.5 2.7 9.9 12.5 15.2 12.1 9.7 8.8 9.9 10.0 10.2 9.7 41.7 68.2 18.2 31.8 48.3 33.6 19.4 38.2 21.4 51.2 15.7 21.6 3.3 3.3 23.3 0.1 48.1 43.4 0.0 26.0 5.7 28.8 47.0 42.8 61.1 20.6 12.7 24.0 29.4 46.1 1.1 12.0 60.4 35.4 20.8 53.4 26.6 30.0 46.0 19.8 23.7 8.7 19.4 35.0 3.3 7.7 48.6 3.0 56.7 46.1 54.2 RPS6KA4 "MSK2, RSK-B" ENSG00000162302 "Ribosomal protein S6 kinase A4" O75676 11 64359148-64372215 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Inflammatory response, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 60.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 12.6" "Lineage enriched" "Detected in many" 4 "dendritic cells: 12.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008649, HPA023225" Approved Supported Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "CAB008649: AB_1619460, HPA023225: AB_1854144" "unprognostic (2.30e-1)" "unprognostic (7.05e-2)" "unprognostic (2.03e-1)" "unprognostic (4.07e-2)" "unprognostic (2.40e-1)" "unprognostic (7.47e-2)" "prognostic unfavorable (8.17e-4)" "prognostic unfavorable (9.27e-4)" "unprognostic (2.45e-1)" "unprognostic (9.03e-2)" "unprognostic (1.41e-2)" "unprognostic (3.06e-3)" "unprognostic (1.98e-2)" "unprognostic (3.93e-3)" "unprognostic (5.25e-2)" "unprognostic (1.09e-1)" "unprognostic (2.85e-1)" 14.9 9.1 13.3 15.7 17.1 13.2 7.6 37.6 22.7 7.7 12.4 13.1 5.8 14.0 11.0 6.9 18.5 8.1 10.5 7.8 10.9 10.1 8.7 9.6 10.9 15.0 16.7 9.9 6.5 9.2 5.7 4.7 16.6 9.8 8.3 8.4 10.0 10.9 8.9 16.3 17.3 15.4 9.8 11.5 22.2 18.3 3.3 13.5 7.6 6.7 16.7 16.4 9.7 8.8 0.5 12.6 1.4 3.0 0.3 1.0 2.1 28.1 15.8 2.3 5.7 5.1 4.8 32.6 15.0 7.9 11.8 5.8 15.6 14.8 2.9 17.5 8.6 15.0 26.1 2.7 12.2 5.8 8.9 5.3 6.6 13.5 7.9 5.1 6.7 12.4 4.7 11.5 10.0 8.2 4.2 7.1 5.4 2.7 4.1 5.9 25.8 6.0 10.5 2.5 10.9 33.3 11.8 9.4 9.4 8.1 13.0 3.4 2.7 15.5 9.5 13.0 3.4 11.1 8.3 14.1 16.1 20.2 29.0 13.3 4.9 3.8 2.9 10.6 7.7 8.1 1.1 3.0 1.4 0.9 2.4 1.0 0.5 0.7 0.7 2.7 0.4 0.4 0.4 0.2 0.3 1.4 12.6 0.6 2.1 13.3 17.1 37.6 22.7 10.9 10.1 16.7 9.9 9.8 13.5 3.0 4.0 5.7 4.6 10.8 6.3 11.8 5.1 0.0 1.2 3.5 3.9 60.8 5.0 13.7 0.2 7.4 17.0 0.0 21.8 31.5 9.1 7.1 19.5 6.4 26.9 7.9 8.1 11.6 29.2 0.7 10.3 15.3 8.5 12.6 11.6 3.1 40.7 10.7 6.3 7.3 2.0 0.0 9.2 0.7 7.2 9.4 39.0 8.7 13.9 8.5 RPS6KA5 "MSK1, RLPK" ENSG00000100784 "Ribosomal protein S6 kinase A5" O75582 14 90847862-91060636 "Enzymes, Predicted intracellular proteins" "Inflammatory response, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "granulocytes: 86.9;Syncytiotrophoblasts: 93.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 30.1;SK-BR-3: 15.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001274, HPA001780, CAB025458" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB025458: , HPA001274: AB_1079417, HPA001780: AB_2666432" "unprognostic (3.05e-2)" "unprognostic (2.19e-3)" "unprognostic (4.27e-4)" "unprognostic (1.98e-3)" "unprognostic (4.79e-2)" "unprognostic (4.20e-4)" "unprognostic (3.70e-2)" "unprognostic (5.80e-4)" "unprognostic (6.70e-2)" "unprognostic (8.39e-2)" "unprognostic (1.84e-1)" "unprognostic (1.97e-1)" "unprognostic (1.38e-4)" "unprognostic (5.73e-3)" "unprognostic (1.07e-1)" "unprognostic (2.42e-1)" "unprognostic (1.75e-1)" 4.9 2.4 8.3 13.0 21.6 5.8 16.3 32.9 12.2 7.0 11.0 12.0 4.2 9.3 11.8 2.6 11.9 8.9 6.7 6.1 9.0 7.9 4.5 4.1 6.1 7.3 12.8 9.7 10.2 4.9 12.0 6.9 14.9 11.0 8.0 11.7 2.8 8.7 9.9 14.3 6.6 9.8 19.4 17.1 7.4 9.8 5.2 13.7 4.8 8.6 7.8 7.7 11.6 7.3 5.8 2.5 20.0 3.2 8.4 7.1 2.2 1.2 1.7 2.0 1.3 0.0 0.4 8.7 0.7 1.1 2.3 3.4 0.9 2.3 5.9 2.5 2.2 1.6 3.8 1.7 1.7 4.8 0.9 3.1 5.9 1.7 0.2 0.0 5.8 30.1 0.5 3.6 1.4 1.1 0.5 2.5 4.1 0.6 6.7 2.3 2.5 1.8 2.9 0.6 3.7 2.7 3.2 9.6 3.0 2.5 2.2 10.1 3.2 2.5 15.1 8.5 1.8 2.9 1.9 0.5 0.7 1.3 0.6 2.9 2.9 2.8 5.1 1.4 4.3 9.5 10.5 2.7 7.8 3.6 2.1 5.9 4.4 4.8 3.5 2.5 5.8 5.6 3.0 20.0 8.4 3.2 1.0 7.1 2.2 8.3 21.6 32.9 12.2 9.0 7.9 12.8 9.7 11.0 13.7 17.9 27.4 40.7 37.9 35.8 29.4 14.1 12.7 37.5 29.6 7.0 15.7 31.0 0.0 8.9 5.5 19.6 27.6 0.0 4.6 4.7 13.2 25.2 86.9 6.8 6.4 25.4 15.6 14.1 16.1 2.1 13.0 16.9 18.6 2.8 17.9 12.9 3.0 11.5 11.0 2.8 29.2 12.9 27.6 13.1 23.7 40.5 93.5 39.5 18.8 42.3 RPS6KA6 RSK4 ENSG00000072133 "Ribosomal protein S6 kinase A6" Q9UK32 X 84058346-84187907 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 20.7" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 19.9;Collecting duct cells: 17.4;Cone photoreceptor cells: 23.6;Intestinal endocrine cells: 24.0;Rod photoreceptor cells: 18.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 11.0;PC-3: 11.9;RH-30: 14.6;SH-SY5Y: 11.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002852, HPA003904" Uncertain Supported Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoplasm, Mitochondria" Nucleoli "HPA002852: AB_1079854, HPA003904: AB_1079853" "unprognostic (1.17e-1)" "unprognostic (1.02e-2)" "unprognostic (3.44e-1)" "unprognostic (4.93e-4)" "unprognostic (1.71e-1)" "unprognostic (3.04e-3)" "unprognostic (2.09e-2)" "unprognostic (2.50e-1)" "unprognostic (2.86e-1)" "unprognostic (4.88e-2)" "unprognostic (3.38e-3)" "unprognostic (2.88e-1)" "unprognostic (2.12e-9)" "unprognostic (4.44e-3)" "unprognostic (1.30e-2)" "unprognostic (2.34e-2)" "unprognostic (8.49e-3)" 0.7 2.9 5.9 1.0 12.2 0.0 2.3 4.7 5.1 3.1 4.5 1.1 20.7 1.7 2.7 4.0 1.5 4.0 1.9 1.2 5.1 2.9 9.2 0.9 0.8 0.2 1.5 3.3 4.9 3.4 13.5 9.1 0.5 4.4 4.3 3.7 1.5 3.0 15.0 1.4 2.3 2.0 1.7 1.0 0.6 2.4 2.6 2.7 0.8 14.5 0.9 0.6 3.3 2.3 1.2 0.8 2.4 0.5 0.7 2.8 0.1 0.0 3.7 3.6 0.0 3.4 3.4 0.0 7.7 4.1 3.4 2.9 2.8 3.0 0.0 0.0 4.1 0.0 0.1 9.1 6.1 8.1 0.0 4.6 0.0 0.1 0.0 3.1 0.0 0.0 1.9 0.0 0.0 3.8 3.8 0.8 0.0 0.0 0.2 2.7 0.0 1.3 0.1 11.0 0.0 11.9 0.0 14.6 0.0 0.6 8.5 0.0 11.7 0.0 4.2 0.0 5.2 2.0 0.0 0.0 0.1 4.4 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.0 2.4 0.4 0.5 0.5 0.3 0.4 1.2 0.4 0.7 0.8 0.6 0.4 0.4 1.1 0.7 0.5 0.4 2.8 0.1 5.9 12.2 4.7 5.1 5.1 2.9 1.5 3.3 4.4 2.7 8.9 2.4 2.0 4.4 0.2 19.9 2.0 12.7 6.7 3.4 17.4 23.6 2.1 1.7 0.4 0.4 0.6 3.4 0.0 1.1 0.6 0.3 7.4 0.0 1.5 0.2 1.6 24.0 1.3 0.0 0.0 4.0 0.0 0.0 0.0 5.0 2.8 1.3 2.9 5.6 3.3 18.2 0.0 0.6 3.7 6.3 0.4 1.9 0.0 5.3 4.2 RPS6KB1 "p70(S6K)-alpha, PS6K, S6K1, STK14A" ENSG00000108443 "Ribosomal protein S6 kinase B1" P23443 17 59893046-59950564 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Translation regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "MCF7: 76.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003838, CAB018346, HPA039442" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB003838: AB_562325, CAB018346: AB_632156, HPA039442: AB_2676510" "unprognostic (2.25e-1)" "unprognostic (4.52e-2)" "unprognostic (1.91e-3)" "unprognostic (1.35e-2)" "unprognostic (9.81e-2)" "unprognostic (1.13e-1)" "unprognostic (3.72e-3)" "unprognostic (1.70e-1)" "unprognostic (5.86e-2)" "unprognostic (1.66e-1)" "unprognostic (3.67e-1)" "unprognostic (1.76e-2)" "prognostic unfavorable (5.09e-7)" "unprognostic (3.45e-1)" "unprognostic (2.09e-1)" "unprognostic (3.98e-2)" "unprognostic (1.52e-3)" 18.4 18.3 16.6 23.2 19.5 20.5 18.4 25.7 24.2 18.1 18.2 13.1 18.4 13.1 19.6 16.5 25.4 14.5 14.9 14.2 15.7 12.6 13.5 20.0 14.8 17.3 20.3 17.5 21.6 22.3 24.5 18.9 20.3 17.6 16.7 15.0 10.1 17.3 21.5 50.3 15.8 14.1 19.3 19.8 17.6 17.5 10.7 20.0 17.8 16.8 18.4 22.0 18.5 20.8 8.9 12.8 25.9 11.1 9.4 13.5 8.3 10.9 10.6 9.1 8.6 6.3 9.2 6.9 10.1 9.4 8.9 10.0 8.7 5.5 13.2 12.6 8.4 10.7 5.7 12.0 9.1 14.4 7.3 13.4 9.0 6.9 9.9 9.3 13.9 9.1 9.4 7.0 10.3 7.6 7.4 11.6 8.5 11.9 8.5 6.6 76.1 16.5 5.9 6.1 9.6 8.2 9.8 15.4 12.3 7.4 8.1 6.6 8.0 8.5 5.0 5.4 11.0 9.8 7.7 10.0 8.7 14.5 7.0 13.4 15.4 13.0 14.9 6.6 8.6 6.9 25.9 10.1 9.0 11.4 10.2 13.5 8.9 10.5 13.0 12.8 8.6 12.3 12.9 10.0 9.4 11.1 8.0 9.5 8.3 16.6 19.5 25.7 24.2 15.7 12.6 20.3 17.5 17.6 20.0 20.8 32.2 20.1 17.7 29.3 16.3 13.7 17.8 25.4 38.7 3.5 17.7 20.8 3.3 10.9 2.6 18.8 10.1 0.0 14.1 15.1 21.8 21.4 22.0 12.4 10.6 17.5 12.7 11.1 14.8 2.1 14.7 18.0 10.1 16.2 16.1 11.9 13.7 10.5 17.0 7.2 18.5 25.8 22.8 11.1 13.1 28.0 25.5 20.3 13.4 24.3 RPS6KL1 MGC11287 ENSG00000198208 "Ribosomal protein S6 kinase like 1" Q9Y6S9 14 74903954-74923396 "Enzymes, Predicted intracellular proteins" "Kinase, Ribonucleoprotein, Ribosomal protein, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.1" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 67.9;Cone photoreceptor cells: 78.5;Horizontal cells: 38.1;Rod photoreceptor cells: 72.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 2.0;naive CD4 T-cell: 1.9;naive CD8 T-cell: 2.0;plasmacytoid DC: 5.4" "Group enriched" "Detected in many" 26 "B-cells: 2.0;dendritic cells: 5.4;T-cells: 2.0" "Cell line enhanced" "Detected in many" "HMC-1: 13.0;SCLC-21H: 24.9;SK-BR-3: 14.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027451, HPA027794" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA027451: AB_10599304, HPA027794: AB_10602098" "unprognostic (2.71e-2)" "unprognostic (9.33e-3)" "unprognostic (3.36e-1)" "unprognostic (1.13e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-2)" "unprognostic (1.44e-2)" "unprognostic (7.49e-4)" "unprognostic (2.06e-1)" "unprognostic (1.54e-1)" "unprognostic (4.09e-3)" "unprognostic (2.91e-1)" "unprognostic (1.11e-1)" "unprognostic (1.33e-2)" "unprognostic (1.14e-1)" "unprognostic (7.03e-2)" "unprognostic (7.52e-2)" 4.2 7.5 14.7 2.3 13.6 4.2 5.7 18.2 29.1 2.1 4.8 9.0 2.2 3.8 5.1 8.8 5.3 2.5 3.7 10.2 14.3 13.7 2.3 2.1 2.5 2.5 11.1 15.3 1.5 6.7 4.0 10.6 1.4 8.4 2.8 5.6 5.9 3.2 5.4 12.7 1.2 2.8 6.9 8.8 1.7 2.0 11.4 6.8 0.0 3.8 1.2 2.5 1.9 0.8 2.0 5.4 0.1 0.0 0.0 2.0 0.1 2.3 0.3 1.0 3.8 0.1 0.0 4.5 0.4 0.2 1.8 0.5 5.6 1.6 0.0 3.5 0.7 0.5 0.3 1.8 0.3 2.4 0.0 0.8 1.9 0.8 4.2 4.7 2.2 13.0 0.3 3.2 2.0 0.0 0.0 5.9 0.0 2.7 0.7 0.1 7.6 0.0 0.8 0.8 0.7 3.7 1.8 0.0 7.2 1.8 0.0 24.9 3.0 0.3 14.4 2.4 2.0 1.4 1.5 4.0 0.1 0.2 3.1 0.0 10.1 5.3 5.3 1.4 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.2 2.0 0.4 0.1 0.0 0.4 1.9 2.0 0.1 0.0 0.0 5.4 0.0 0.1 14.7 13.6 18.2 18.2 14.3 13.7 11.1 15.3 8.4 6.8 0.0 0.0 0.0 1.8 0.7 67.9 5.1 0.0 5.3 0.0 3.5 78.5 1.4 1.7 1.2 6.5 2.6 2.0 0.0 5.3 1.1 1.0 1.6 0.0 2.1 3.0 38.1 6.4 1.3 0.0 5.6 2.0 1.2 3.3 0.0 1.5 4.0 3.1 1.5 2.5 0.8 72.2 6.5 2.7 22.3 15.8 1.1 1.1 1.3 2.5 1.3 RPUSD1 "C16orf40, MGC19600, RLUCL" ENSG00000007376 "RNA pseudouridylate synthase domain containing 1" Q9UJJ7 16 784974-788397 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041144, HPA041938" Approved Approved "Nucleoplasm,Golgi apparatus,Cell Junctions,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cell Junctions, Cytosol" "HPA041144: AB_10794265, HPA041938: AB_10795601" "unprognostic (1.51e-2)" "unprognostic (1.26e-3)" "unprognostic (2.03e-1)" "unprognostic (4.01e-1)" "unprognostic (2.99e-1)" "unprognostic (9.05e-3)" "unprognostic (1.07e-3)" "unprognostic (3.45e-2)" "unprognostic (1.08e-1)" "unprognostic (3.31e-1)" "unprognostic (2.04e-1)" "unprognostic (1.23e-1)" "unprognostic (6.25e-2)" "unprognostic (8.07e-3)" "unprognostic (5.44e-2)" "unprognostic (2.95e-1)" "unprognostic (1.41e-1)" 9.5 9.7 12.0 16.5 14.8 20.9 10.4 15.3 23.8 7.4 11.2 9.4 6.2 17.6 10.5 14.0 13.9 8.6 11.2 8.1 12.7 10.4 10.7 13.4 8.2 18.2 9.5 11.3 10.0 15.3 9.9 8.9 8.2 11.2 11.3 5.1 10.9 19.8 10.5 11.1 16.8 12.8 8.3 7.0 17.4 15.1 6.2 9.2 15.5 8.5 15.1 15.6 10.8 10.7 17.3 23.1 17.7 19.9 18.0 20.4 15.8 10.6 12.6 3.1 14.0 2.7 3.2 14.4 8.9 5.1 11.7 8.5 29.3 10.1 14.9 9.7 4.2 8.2 18.3 7.1 9.0 2.1 13.5 29.0 7.3 19.3 10.5 4.4 13.5 12.4 4.8 8.7 10.1 2.7 3.4 8.0 8.8 17.1 6.7 4.0 33.8 16.8 14.1 15.8 4.9 21.8 30.0 8.3 30.6 4.2 6.6 16.3 11.7 10.2 16.8 9.8 1.9 8.6 16.9 9.0 11.7 15.2 12.2 12.8 10.8 10.8 17.1 5.6 10.6 9.5 17.5 19.9 17.7 18.3 18.0 18.1 14.9 15.5 20.4 23.1 17.3 16.2 16.3 12.7 18.0 17.4 21.2 18.7 15.8 12.0 14.8 15.3 23.8 12.7 10.4 9.5 11.3 11.2 9.2 3.0 3.5 18.7 3.5 14.2 38.1 3.3 2.5 2.7 0.0 8.7 2.0 17.7 6.6 13.7 0.4 6.8 18.6 0.0 23.3 22.4 8.9 4.4 0.0 4.0 17.2 1.6 12.7 10.4 1.6 1.4 6.4 7.9 13.5 23.4 11.0 7.8 22.5 14.0 6.0 8.1 3.3 12.9 5.6 4.2 12.0 14.6 12.2 10.2 16.7 4.7 RPUSD2 "C15orf19, C18B11, FLJ31409" ENSG00000166133 "RNA pseudouridylate synthase domain containing 2" Q8IZ73 15 40569300-40574943 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042079, HPA042194" Approved Approved Nucleoplasm,Microtubules NA NA "Nucleoplasm, Microtubules" "HPA042079: AB_10794643, HPA042194: AB_10794416" "unprognostic (3.24e-1)" "unprognostic (1.72e-1)" "unprognostic (1.32e-1)" "unprognostic (2.30e-2)" "unprognostic (2.72e-2)" "unprognostic (2.84e-2)" "unprognostic (1.31e-1)" "unprognostic (6.60e-2)" "unprognostic (8.32e-2)" "unprognostic (4.41e-2)" "unprognostic (1.26e-2)" "unprognostic (1.16e-1)" "prognostic favorable (7.63e-7)" "unprognostic (7.27e-2)" "unprognostic (8.28e-2)" "unprognostic (3.12e-2)" "unprognostic (2.75e-2)" 6.6 9.8 7.8 7.7 15.3 14.2 9.3 7.7 14.6 7.7 9.3 7.7 8.1 8.3 10.9 9.9 9.9 8.5 6.4 11.4 7.6 7.4 7.0 12.2 6.5 10.6 6.8 8.8 11.0 9.8 6.9 7.5 7.5 8.4 8.5 7.3 7.7 13.3 8.9 19.8 10.6 8.8 6.5 5.0 11.0 7.9 7.9 6.6 13.7 10.4 10.5 10.5 8.2 6.3 20.1 8.9 2.9 8.9 17.8 16.0 8.1 7.7 8.8 7.5 12.4 6.5 4.9 14.2 7.0 8.3 12.1 9.6 10.8 4.9 7.5 10.1 8.0 11.0 21.1 17.3 12.2 6.9 8.6 11.8 13.2 12.2 12.7 9.7 10.9 9.5 6.9 11.5 7.9 10.9 5.6 7.4 12.3 16.1 8.9 5.9 9.5 13.0 13.8 9.6 11.3 9.6 16.7 8.3 11.4 7.7 6.8 8.6 9.9 9.4 10.7 5.6 6.5 10.2 15.0 4.6 8.3 9.7 10.6 7.9 9.2 18.3 20.0 7.2 17.2 6.4 0.0 3.5 2.9 13.5 4.1 12.4 15.6 13.3 14.3 6.8 20.1 16.0 13.3 0.4 17.8 8.9 8.9 13.6 8.1 7.8 15.3 7.7 14.6 7.6 7.4 6.8 8.8 8.4 6.6 6.0 1.6 5.9 11.3 9.4 12.1 7.0 5.1 10.7 3.4 7.0 15.7 13.5 21.6 7.6 1.6 4.6 3.2 0.0 9.4 7.0 7.1 7.4 4.6 7.8 6.1 17.5 12.7 3.7 1.2 1.5 6.6 3.5 3.3 3.6 5.3 14.0 5.4 3.5 9.6 9.9 14.7 12.9 7.6 5.5 17.0 9.4 4.7 8.4 8.3 7.9 RPUSD3 MGC29784 ENSG00000156990 "RNA pseudouridylate synthase domain containing 3" Q6P087 3 9837849-9844602 "Predicted intracellular proteins" "mRNA processing" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 105.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 77.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037551, HPA037552" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA037551: AB_2675538, HPA037552: AB_10672600" "unprognostic (1.57e-1)" "unprognostic (8.88e-2)" "unprognostic (5.43e-2)" "unprognostic (1.04e-2)" "unprognostic (2.05e-2)" "unprognostic (2.35e-1)" "prognostic unfavorable (1.73e-5)" "unprognostic (1.31e-1)" "unprognostic (2.36e-1)" "unprognostic (3.00e-2)" "unprognostic (2.56e-2)" "unprognostic (1.48e-1)" "unprognostic (5.17e-3)" "unprognostic (2.02e-1)" "unprognostic (2.16e-1)" "unprognostic (2.94e-2)" "unprognostic (8.83e-2)" 10.8 18.9 19.5 11.8 25.9 17.0 13.2 21.1 26.5 11.1 14.9 12.9 9.8 16.0 14.0 14.4 19.3 13.9 14.0 20.7 17.2 17.0 16.9 19.5 11.8 14.3 14.4 16.5 14.7 17.5 24.1 17.0 15.2 17.4 13.3 15.6 14.6 12.5 17.5 43.3 18.6 11.9 15.6 10.6 13.2 13.6 36.3 16.4 16.5 15.3 13.9 18.7 15.0 12.2 23.7 22.2 12.4 24.7 37.0 29.7 19.0 9.0 13.5 10.3 6.6 17.4 12.9 77.2 7.8 11.2 13.0 13.8 11.8 9.3 15.6 9.8 8.6 19.2 7.7 22.9 14.0 10.4 12.0 24.0 20.8 12.1 12.6 13.6 12.7 13.2 15.8 19.5 15.1 17.6 10.7 17.1 21.1 15.3 10.9 12.8 21.3 17.3 23.3 11.2 13.2 20.3 12.3 8.5 26.1 14.3 6.8 8.0 6.7 9.8 12.6 21.5 15.5 21.5 13.8 10.1 5.2 9.4 9.1 11.4 16.2 19.3 20.5 11.0 24.2 12.0 12.4 24.7 11.9 22.6 17.6 22.9 23.7 21.2 21.1 22.2 20.0 24.2 21.5 6.0 37.0 12.0 21.3 29.7 19.0 19.5 25.9 21.1 26.5 17.2 17.0 14.4 16.5 17.4 16.4 17.9 8.1 21.6 19.2 7.1 24.2 21.4 12.7 13.4 14.8 14.0 19.6 38.5 39.7 26.0 63.8 13.4 18.8 0.0 27.6 39.4 12.4 15.6 20.7 24.1 33.7 11.1 12.7 23.4 14.3 42.6 19.8 16.7 15.1 26.2 14.4 16.9 22.0 14.4 20.1 35.2 21.2 6.5 18.6 105.6 21.0 11.2 14.4 25.9 26.2 10.1 RPUSD4 FLJ14494 ENSG00000165526 "RNA pseudouridylate synthase domain containing 4" Q96CM3 11 126202094-126211692 "Predicted intracellular proteins" "tRNA processing" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 72.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039689 Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA039689: AB_10673537" "unprognostic (2.02e-2)" "unprognostic (3.65e-1)" "prognostic favorable (6.14e-4)" "unprognostic (3.16e-3)" "unprognostic (2.90e-2)" "unprognostic (3.75e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (1.32e-1)" "unprognostic (7.64e-3)" "unprognostic (1.07e-1)" "unprognostic (3.03e-2)" "unprognostic (1.20e-2)" "unprognostic (1.56e-1)" "unprognostic (7.11e-2)" "unprognostic (5.44e-2)" "unprognostic (7.33e-2)" "unprognostic (5.47e-2)" 7.5 6.8 5.1 7.7 7.8 6.0 7.8 8.2 9.6 6.3 6.0 4.8 7.6 6.4 7.0 6.8 7.8 7.2 5.2 13.2 5.1 4.9 6.3 10.2 5.0 7.7 6.5 8.1 10.1 16.1 5.7 5.1 4.5 7.2 6.9 6.9 5.2 9.5 8.2 72.0 8.9 5.9 8.3 4.8 7.6 9.3 7.0 7.1 6.2 7.7 18.2 9.3 6.2 12.0 9.8 11.0 1.0 8.5 8.4 15.2 8.7 6.6 6.7 8.0 9.6 12.6 16.5 5.7 7.5 10.5 8.2 7.3 20.5 13.2 15.7 7.4 6.7 11.4 11.7 18.3 11.5 8.7 13.1 10.1 36.6 7.1 19.2 8.3 19.2 8.4 15.1 17.4 8.9 11.2 12.3 16.4 12.9 22.8 11.6 9.6 6.5 12.0 22.2 8.8 22.7 11.8 14.1 12.2 14.5 12.5 9.7 13.9 9.5 9.6 14.3 7.0 8.7 21.4 10.2 9.9 9.2 6.4 6.9 8.8 4.9 5.2 13.5 4.2 21.9 9.4 1.0 8.5 0.8 10.8 7.7 14.0 9.8 13.3 10.3 11.0 9.5 15.2 12.2 0.7 8.4 8.3 4.7 12.2 8.7 5.1 7.8 8.2 9.6 5.1 4.9 6.5 8.1 7.2 7.1 3.0 6.7 16.7 17.9 24.5 8.9 30.7 12.7 8.1 5.7 7.0 7.9 11.7 8.3 10.7 1.1 11.3 9.7 0.0 16.9 13.7 10.1 10.5 5.7 11.1 11.8 11.1 14.9 8.6 10.2 1.4 8.9 8.5 10.1 21.6 9.3 4.5 13.0 7.0 8.1 11.8 7.6 6.5 10.8 7.7 15.4 21.0 11.1 15.9 15.7 13.3 RRAD "RAD, REM3" ENSG00000166592 "RRAD, Ras related glycolysis inhibitor and calcium channel regulator" P55042 16 66921679-66925644 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 246.0" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 183.7;Cardiomyocytes: 231.4;Sertoli cells: 109.9;Smooth muscle cells: 182.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HDLM-2: 62.2;U-87 MG: 18.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA041755 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA041755: AB_2677655" "unprognostic (1.40e-2)" "unprognostic (2.78e-2)" "unprognostic (9.77e-2)" "unprognostic (3.84e-2)" "unprognostic (1.36e-2)" "unprognostic (1.11e-1)" "unprognostic (3.74e-2)" "unprognostic (2.37e-1)" "unprognostic (1.66e-1)" "unprognostic (2.46e-2)" "unprognostic (2.12e-2)" "unprognostic (1.08e-1)" "unprognostic (2.06e-3)" "unprognostic (3.46e-2)" "unprognostic (3.33e-2)" "unprognostic (2.04e-2)" "unprognostic (4.80e-3)" 7.3 2.1 0.4 2.4 2.7 1.3 5.0 1.2 1.7 4.7 2.0 3.2 1.8 1.2 3.3 8.5 20.4 6.3 4.1 61.2 0.7 0.6 5.6 0.8 6.3 1.3 1.5 0.8 4.7 0.7 1.0 2.0 10.7 4.6 4.2 0.4 3.9 4.3 1.4 246.0 2.2 1.2 5.7 1.7 0.8 1.7 2.3 1.2 0.3 3.9 14.7 4.3 4.5 5.7 0.0 0.0 0.0 0.1 0.0 0.8 0.1 0.0 2.8 0.0 0.0 0.0 0.3 0.1 1.6 0.1 0.2 1.4 0.7 1.9 0.0 1.6 0.1 0.5 0.1 0.0 0.1 0.2 62.2 0.1 0.0 0.0 0.7 2.8 0.0 0.2 0.8 0.3 5.0 0.0 1.2 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.1 0.0 0.3 0.0 0.1 0.2 1.5 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.1 2.0 0.0 0.1 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 2.7 1.2 1.0 0.7 0.6 1.5 0.8 4.6 1.2 65.5 183.7 3.5 1.9 8.4 12.5 231.4 0.0 83.0 19.4 64.6 9.8 1.0 19.9 33.7 1.5 14.0 4.9 0.0 2.7 2.7 26.9 9.8 33.5 0.0 1.3 1.6 10.2 1.3 1.5 0.4 0.6 14.2 21.9 1.0 2.7 1.5 34.5 1.7 4.9 5.8 3.0 109.9 182.3 1.7 1.9 8.8 4.7 2.2 3.0 2.6 RRAGC "FLJ13311, GTR2" ENSG00000116954 "Ras related GTP binding C" Q9HB90 1 38838198-38859823 "Disease related genes, Predicted intracellular proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Syncytiotrophoblasts: 187.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018247, HPA055489" Supported Supported Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA018247: AB_1856475, HPA055489: AB_2682832" "unprognostic (2.04e-2)" "unprognostic (1.58e-1)" "unprognostic (2.63e-2)" "unprognostic (1.41e-2)" "unprognostic (3.40e-1)" "unprognostic (1.42e-1)" "prognostic unfavorable (9.97e-9)" "unprognostic (2.14e-1)" "unprognostic (3.61e-2)" "unprognostic (4.98e-2)" "unprognostic (2.23e-2)" "unprognostic (1.71e-1)" "unprognostic (5.13e-2)" "unprognostic (6.38e-2)" "unprognostic (2.69e-1)" "unprognostic (2.77e-1)" "unprognostic (3.82e-2)" 27.8 14.0 18.6 11.9 24.1 20.1 36.5 15.9 22.3 13.4 19.4 13.3 11.0 14.1 14.9 11.1 20.7 11.8 13.6 19.0 16.7 13.8 18.8 13.9 15.0 14.2 18.9 14.1 17.6 12.9 13.9 8.9 27.6 21.4 12.6 13.3 11.9 12.7 13.8 15.5 24.6 13.0 17.0 15.6 12.8 12.9 12.7 15.9 11.2 12.9 8.2 16.0 16.0 14.9 4.9 11.3 7.7 3.3 2.0 4.0 2.0 12.1 5.5 7.3 7.9 39.0 26.5 11.3 11.3 23.3 15.5 16.4 4.2 8.1 7.6 6.5 17.6 24.9 7.3 13.6 7.5 12.8 12.3 9.6 7.3 6.8 4.8 47.9 8.5 8.3 23.5 19.0 16.5 21.5 12.3 16.1 8.3 7.4 15.4 22.3 3.3 6.1 4.8 9.3 5.3 9.5 5.9 12.9 5.1 10.9 14.2 3.8 5.7 9.0 6.8 23.6 17.2 6.2 6.5 14.2 18.9 7.8 20.6 9.6 12.1 19.4 9.0 17.6 9.6 9.7 0.5 3.3 6.7 2.5 3.0 4.0 4.6 3.7 3.0 3.1 4.9 3.3 3.1 7.7 2.0 2.3 11.3 3.3 2.0 18.6 24.1 15.9 22.3 16.7 13.8 18.9 14.1 21.4 15.9 29.8 28.3 36.0 36.3 99.5 18.7 21.2 22.9 10.7 11.4 12.2 11.8 70.5 10.0 46.2 51.6 21.1 19.1 23.3 41.7 49.6 38.6 38.8 16.1 10.2 61.8 36.5 13.8 38.1 28.2 37.2 28.4 37.6 50.6 80.2 9.7 40.2 38.6 14.4 35.0 23.7 21.1 19.4 41.2 23.3 25.2 122.8 187.4 20.3 13.0 38.8 RRAGD "bA11D8.2.1, DKFZP761H171" ENSG00000025039 "Ras related GTP binding D" Q9NQL2 6 89364636-89412270 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 60.0" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 118.0;Distal tubular cells: 99.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 6.3" "Group enriched" "Detected in many" 7 "granulocytes: 6.3;monocytes: 3.9" "Cell line enhanced" "Detected in many" "Karpas-707: 28.2;SCLC-21H: 14.8;U-266/70: 35.7;U-266/84: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068664 Approved Approved Nucleoplasm,Vesicles,Centrosome NA NA Nucleoplasm "Vesicles, Centrosome" "HPA068664: AB_2686016" "unprognostic (3.06e-1)" "unprognostic (1.10e-1)" "unprognostic (1.53e-3)" "unprognostic (1.09e-1)" "unprognostic (2.03e-1)" "unprognostic (2.09e-1)" "prognostic unfavorable (7.80e-4)" "unprognostic (3.75e-2)" "unprognostic (1.66e-2)" "unprognostic (4.33e-2)" "unprognostic (1.11e-2)" "unprognostic (1.00e-1)" "prognostic favorable (8.47e-8)" "unprognostic (8.41e-3)" "unprognostic (1.23e-1)" "unprognostic (9.46e-2)" "unprognostic (4.40e-2)" 8.1 8.4 9.2 2.6 12.8 8.9 8.8 22.4 16.3 8.7 3.3 7.9 3.1 2.2 2.1 6.6 12.8 11.9 3.7 29.9 8.6 7.4 21.8 5.0 6.4 2.8 8.5 7.9 2.2 6.4 16.0 11.5 3.4 10.7 5.9 2.4 12.8 38.7 4.2 60.0 5.5 2.1 7.5 12.6 4.4 2.3 6.1 9.2 4.1 23.3 13.9 5.2 9.2 9.3 0.1 0.7 6.3 3.9 0.1 0.6 0.3 0.0 0.7 1.9 1.4 0.2 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.7 0.0 10.0 0.0 10.7 0.0 0.0 0.0 5.3 2.4 0.0 0.0 0.8 7.1 8.5 0.2 0.6 0.0 0.0 0.0 0.0 7.4 0.2 28.2 0.0 0.7 3.4 3.5 1.6 0.0 0.7 7.1 10.3 0.1 2.6 0.2 14.8 0.8 0.2 1.0 12.0 0.6 0.3 5.6 0.0 0.8 1.2 5.1 1.3 35.7 16.5 0.0 2.7 5.4 0.8 3.9 1.2 2.6 0.0 1.1 0.1 0.1 0.4 0.0 0.7 0.0 0.3 0.6 6.3 0.1 3.9 0.6 0.0 0.3 9.2 12.8 22.4 9.1 8.6 7.4 8.5 7.9 10.7 9.2 8.9 11.8 7.5 12.1 14.3 18.0 118.0 15.3 13.4 5.7 14.0 29.5 0.4 99.5 14.2 15.2 3.6 0.0 0.0 14.9 1.2 6.0 29.7 4.6 8.6 46.1 44.5 1.2 3.1 19.9 10.4 2.8 8.5 37.1 5.4 0.3 18.0 12.3 0.0 3.9 15.6 14.2 0.0 6.6 8.4 25.7 19.7 0.6 1.5 0.0 25.7 RRAS2 TC21 ENSG00000133818 "RAS related 2" P62070 11 14277926-14364506 "Disease related genes, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 12.3" "Group enriched" "Detected in many" 5 "B-cells: 12.3;NK-cells: 3.5;T-cells: 6.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB010420, HPA050942" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB010420: AB_2253855, HPA050942: AB_2681285" "unprognostic (6.13e-2)" "unprognostic (1.85e-1)" "unprognostic (1.92e-1)" "unprognostic (1.47e-1)" "unprognostic (1.99e-1)" "prognostic unfavorable (7.80e-4)" "prognostic unfavorable (3.31e-4)" "unprognostic (4.15e-2)" "unprognostic (1.59e-1)" "unprognostic (1.97e-2)" "prognostic unfavorable (2.44e-4)" "unprognostic (4.50e-2)" "unprognostic (4.15e-1)" "unprognostic (9.02e-2)" "unprognostic (1.05e-1)" "unprognostic (6.80e-2)" "unprognostic (1.63e-1)" 22.3 11.8 8.3 27.5 7.8 2.3 22.6 9.5 7.0 14.1 16.9 6.4 7.8 11.9 16.2 9.8 13.5 11.1 12.9 29.8 8.7 8.1 25.6 33.0 18.1 15.2 6.5 7.6 16.6 18.5 13.5 7.4 50.8 8.4 16.7 11.0 14.5 15.1 12.9 31.4 9.2 37.7 31.4 7.6 17.6 13.7 21.0 5.2 11.3 26.2 14.4 20.8 27.3 15.0 12.3 0.4 1.5 0.0 3.5 6.2 0.9 15.3 6.7 6.4 5.6 22.9 22.4 9.5 54.3 28.4 46.9 59.6 13.5 19.2 17.7 9.1 36.4 15.2 17.7 10.8 19.4 47.3 15.7 10.5 1.1 4.0 10.7 24.5 0.0 0.1 23.7 36.8 18.7 60.1 19.3 23.3 4.3 7.7 0.0 40.7 7.4 3.7 0.9 18.2 3.1 6.3 3.7 21.2 0.3 24.0 8.5 1.7 3.3 13.1 8.4 7.4 22.6 5.4 1.1 53.1 25.4 14.1 48.7 14.7 0.0 0.0 8.3 10.2 0.0 5.1 1.5 0.0 0.0 6.2 0.0 2.6 12.3 1.1 3.2 0.0 6.9 0.6 2.5 0.4 3.5 0.0 0.4 0.0 0.9 8.3 7.8 9.5 7.0 8.7 8.1 6.5 7.6 8.4 5.2 17.9 17.6 46.8 50.4 61.6 5.2 23.2 43.3 10.7 18.2 17.4 0.0 32.7 19.9 40.3 48.4 18.0 39.6 0.0 16.1 49.9 26.8 69.2 9.2 27.6 6.9 12.7 18.3 12.9 1.6 34.5 15.3 2.5 25.3 2.8 16.6 18.6 42.0 25.9 10.6 70.4 10.3 19.4 21.2 34.6 41.4 43.5 24.3 26.6 19.6 64.4 RRM2B p53R2 ENSG00000048392 "Ribonucleotide reductase regulatory TP53 inducible subunit M2B" Q7LG56 8 102204502-102239118 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair, DNA replication" Oxidoreductase "Disease mutation, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006854, HPA028812" Approved Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB006854: , HPA028812: AB_10602246" "unprognostic (7.76e-3)" "unprognostic (4.14e-2)" "unprognostic (9.41e-3)" "unprognostic (3.41e-1)" "unprognostic (1.13e-2)" "unprognostic (1.28e-1)" "unprognostic (5.51e-2)" "unprognostic (1.35e-2)" "unprognostic (1.66e-1)" "unprognostic (9.40e-2)" "unprognostic (1.74e-2)" "unprognostic (1.03e-1)" "unprognostic (1.70e-2)" "unprognostic (4.32e-1)" "unprognostic (1.47e-1)" "unprognostic (2.52e-1)" "unprognostic (7.17e-2)" 11.8 18.6 11.7 11.5 11.4 4.3 9.3 8.5 13.5 9.5 10.1 9.8 9.5 10.2 8.2 10.8 8.0 9.7 8.2 11.3 17.5 12.8 17.5 15.1 15.8 12.6 14.9 10.6 9.7 9.5 34.7 24.8 11.6 23.1 11.2 11.1 7.7 9.7 10.9 34.6 7.4 7.6 8.2 26.1 10.6 7.1 6.6 9.4 6.3 37.1 8.1 13.1 10.7 7.0 7.4 6.2 18.3 8.4 3.0 3.3 2.8 5.6 10.0 11.9 7.0 16.8 16.2 9.4 13.0 15.8 7.0 8.2 3.5 4.5 35.8 12.3 14.3 7.1 2.1 5.7 13.2 9.9 5.8 6.2 9.0 4.2 7.5 13.6 2.7 19.2 20.5 24.9 7.7 11.8 16.7 19.6 6.2 6.6 5.5 22.4 5.5 4.7 5.2 6.6 6.1 7.4 3.0 4.8 7.2 16.3 6.4 3.0 5.9 6.8 3.6 7.7 31.0 9.7 6.2 14.9 10.9 21.1 7.5 3.5 5.8 5.3 32.6 16.0 4.2 11.5 10.0 5.1 5.3 2.2 4.5 3.3 5.6 2.0 2.8 6.2 7.4 2.3 2.5 18.3 3.0 8.4 1.8 1.4 2.8 11.7 11.4 8.5 13.5 17.5 12.8 14.9 10.6 23.1 9.4 53.6 24.0 7.2 8.1 17.2 13.1 17.9 20.4 38.8 25.0 38.4 13.7 11.2 21.6 6.2 1.6 16.4 6.4 0.0 7.0 4.9 10.4 10.8 10.5 20.3 11.1 9.5 28.3 18.4 21.8 1.1 13.3 17.8 16.9 7.2 10.3 23.6 5.5 7.0 13.8 18.1 14.7 6.5 10.8 8.2 10.0 16.2 4.0 12.8 11.7 5.4 RRP15 "CGI-115, KIAA0507" ENSG00000067533 "Ribosomal RNA processing 15 homolog" Q9Y3B9 1 218285287-218337983 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024639 Approved Approved "Nucleoplasm,Nucleoli rim,Mitotic chromosome,Mitochondria" Yes No "Nucleoli rim, Mitotic chromosome" "Nucleoplasm, Mitochondria" "HPA024639: AB_1844368" "unprognostic (2.68e-2)" "unprognostic (4.94e-2)" "unprognostic (2.04e-1)" "unprognostic (1.22e-1)" "unprognostic (5.19e-2)" "unprognostic (1.33e-2)" "prognostic unfavorable (4.26e-5)" "unprognostic (7.87e-2)" "unprognostic (1.07e-1)" "unprognostic (2.18e-1)" "unprognostic (3.65e-3)" "unprognostic (2.54e-1)" "unprognostic (2.76e-3)" "unprognostic (1.52e-1)" "unprognostic (5.77e-1)" "unprognostic (1.11e-2)" "unprognostic (3.23e-2)" 10.3 7.2 8.9 8.0 9.9 8.5 11.6 11.6 10.4 8.4 8.0 5.5 5.4 5.3 10.1 7.1 8.7 8.9 5.0 11.4 8.6 6.3 9.3 10.7 7.5 8.3 8.0 5.0 9.8 8.4 12.1 10.0 8.7 8.6 7.8 7.2 5.8 7.9 6.4 33.5 8.5 6.8 11.8 9.4 10.3 7.6 6.3 9.0 6.5 8.9 10.5 8.3 8.5 9.4 5.1 3.3 0.6 2.4 3.1 5.7 1.6 8.1 6.1 6.8 4.9 5.0 7.0 5.9 8.3 6.3 8.8 6.4 11.9 7.5 11.8 11.5 6.4 5.9 7.4 11.6 11.0 14.7 4.7 8.7 9.1 5.8 6.6 10.3 14.1 5.0 4.8 6.8 11.4 15.3 3.9 5.6 5.5 18.6 3.9 9.8 7.5 9.3 6.9 13.6 6.5 12.8 6.6 4.2 11.6 7.0 7.6 8.0 11.5 7.1 13.3 12.2 8.5 9.5 10.2 7.9 7.1 6.6 12.5 15.4 4.7 7.2 12.2 8.1 6.9 11.2 0.6 1.6 0.2 3.5 2.4 4.8 4.7 4.2 2.9 2.4 5.1 5.7 5.5 0.5 3.1 2.1 3.3 2.5 1.6 8.9 9.9 11.6 10.4 8.6 6.3 8.0 5.0 8.6 9.0 29.8 25.5 31.5 28.8 58.0 29.7 58.0 17.8 13.4 30.7 34.9 9.8 32.1 23.2 30.7 5.9 26.0 2.9 0.0 44.6 48.1 26.3 14.3 30.1 37.6 29.3 25.4 11.6 19.0 13.3 2.7 34.8 25.8 20.3 17.2 18.6 20.3 31.8 2.9 23.3 23.5 21.8 25.8 28.8 46.4 75.7 41.7 15.1 22.4 25.7 22.8 RRP1B "KIAA0179, Nnp1, PPP1R136, RRP1" ENSG00000160208 "Ribosomal RNA processing 1B" Q14684 21 43659548-43696079 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 123.7;Early spermatids: 195.5;Late spermatids: 173.7;Rod photoreceptor cells: 138.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA017893, HPA020324" Supported Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA017893: AB_1852274, HPA020324: AB_1852276" "unprognostic (1.03e-1)" "unprognostic (1.37e-2)" "unprognostic (4.03e-1)" "unprognostic (1.32e-3)" "unprognostic (1.24e-1)" "unprognostic (1.92e-2)" "unprognostic (2.03e-2)" "unprognostic (7.19e-2)" "unprognostic (1.98e-2)" "unprognostic (5.55e-3)" "unprognostic (1.08e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.95e-9)" "unprognostic (1.45e-1)" "unprognostic (1.10e-1)" "unprognostic (1.05e-2)" "unprognostic (4.24e-2)" 12.7 10.3 10.7 20.0 13.7 7.6 14.5 13.9 12.5 13.1 11.1 11.5 9.4 9.5 16.1 9.2 15.7 14.0 12.2 8.4 9.5 8.6 7.5 17.7 10.4 22.8 13.1 7.5 20.0 20.6 11.8 11.4 8.4 10.3 11.3 10.9 15.0 13.9 12.8 21.6 14.1 11.1 12.9 9.9 16.9 11.8 32.5 12.6 25.6 9.6 12.6 20.5 13.5 14.1 6.0 3.2 2.1 2.7 5.8 9.8 5.3 16.9 10.0 10.7 16.1 7.0 7.5 8.8 8.9 6.4 9.9 8.2 22.7 7.4 33.2 5.9 7.0 11.5 7.6 26.4 15.4 11.8 11.1 21.0 19.6 11.6 14.2 9.7 30.5 7.8 7.7 9.9 11.9 13.8 6.1 11.0 14.4 30.6 9.8 8.7 8.8 24.2 9.3 36.5 11.0 11.2 32.0 10.8 23.2 7.2 8.1 21.3 11.4 16.8 12.4 12.4 4.1 8.1 9.6 9.8 3.1 9.7 8.1 16.2 13.3 16.9 39.7 9.7 33.0 10.0 2.1 2.6 0.7 7.2 2.7 8.5 6.0 9.1 8.6 3.2 5.3 8.6 9.8 0.1 5.8 2.3 2.6 7.0 5.3 10.7 13.7 13.9 12.5 9.5 8.6 13.1 7.5 10.3 12.6 29.8 16.0 22.1 12.1 20.3 28.9 10.4 12.7 21.4 28.4 5.2 123.7 6.5 1.7 12.9 195.5 15.9 4.7 0.0 13.7 13.6 13.6 12.0 33.7 16.6 16.5 23.8 5.2 11.1 11.9 173.7 20.8 11.6 8.5 11.8 8.5 14.7 16.6 0.0 25.1 9.5 138.2 0.0 16.0 24.0 34.2 27.7 3.7 27.3 13.8 12.2 RRP36 "C6orf153, dJ20C7.4" ENSG00000124541 "Ribosomal RNA processing 36" Q96EU6 6 43021645-43034156 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029904, HPA029905" Uncertain Enhanced Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "HPA029904: AB_10611817, HPA029905: AB_2673244" "unprognostic (1.76e-1)" "unprognostic (4.47e-1)" "unprognostic (3.78e-2)" "unprognostic (1.46e-2)" "unprognostic (3.25e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (5.95e-4)" "unprognostic (2.61e-1)" "unprognostic (6.83e-2)" "unprognostic (1.32e-3)" "unprognostic (1.39e-1)" "unprognostic (3.38e-1)" "prognostic unfavorable (2.48e-5)" "unprognostic (3.53e-1)" "unprognostic (1.63e-1)" "unprognostic (1.09e-1)" "unprognostic (2.09e-2)" 25.0 29.7 21.0 24.9 27.2 23.3 57.7 18.0 42.1 21.3 22.4 16.0 24.9 19.4 23.8 24.7 31.9 20.6 20.1 31.3 22.7 21.4 25.2 32.7 24.1 46.5 21.1 28.0 17.3 37.4 37.0 28.8 23.4 27.3 24.6 23.8 19.5 23.5 36.4 61.9 28.4 21.4 28.3 28.5 29.4 25.7 23.9 15.8 25.0 22.6 30.9 31.8 23.7 28.2 6.5 9.7 4.0 4.6 3.1 7.7 1.2 39.4 22.3 22.2 32.4 24.0 22.5 18.7 31.3 28.4 40.2 39.5 40.5 17.3 18.3 25.6 32.6 29.5 21.2 37.1 38.0 44.5 23.1 37.8 29.4 24.8 43.2 27.9 24.4 22.9 22.7 23.3 48.0 20.6 14.4 32.6 16.6 35.5 20.0 37.2 41.6 29.3 26.7 24.6 70.7 23.2 27.7 21.9 21.1 24.6 37.4 28.5 25.0 23.1 21.2 35.8 21.8 29.2 30.1 26.2 37.2 28.3 24.4 49.1 18.8 28.2 48.9 16.2 30.9 34.5 3.9 3.6 3.1 5.9 4.6 4.7 6.5 4.2 7.0 3.7 2.6 3.9 7.7 4.0 3.1 3.6 9.7 2.1 1.2 21.0 27.2 18.0 42.1 22.7 21.4 21.1 28.0 27.3 15.8 0.0 14.1 20.6 9.5 11.8 15.3 13.7 28.1 8.1 12.5 19.2 15.7 25.9 11.6 31.6 8.6 11.3 10.5 0.0 38.9 36.9 13.2 13.1 5.8 34.3 25.3 17.5 13.4 22.1 14.3 18.5 10.9 13.4 13.5 28.9 11.3 25.1 32.5 7.0 17.7 16.1 17.2 6.5 12.0 7.6 10.2 16.3 28.1 10.0 12.8 12.1 RRP7A "CGI-96, Rrp7" ENSG00000189306 "Ribosomal RNA processing 7 homolog A" Q9Y3A4 22 42509968-42519802 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001586, HPA046768" Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions" NA NA "Nucleoplasm, Nucleoli" "Cell Junctions" "HPA001586: AB_1078506, HPA046768: AB_2679796" "unprognostic (8.46e-2)" "unprognostic (3.30e-3)" "unprognostic (5.96e-2)" "unprognostic (3.21e-3)" "unprognostic (9.71e-3)" "unprognostic (2.92e-1)" "prognostic unfavorable (1.21e-5)" "unprognostic (6.73e-2)" "unprognostic (3.00e-1)" "unprognostic (2.28e-1)" "unprognostic (2.41e-1)" "unprognostic (3.22e-2)" "unprognostic (9.53e-3)" "unprognostic (8.02e-2)" "unprognostic (2.12e-1)" "unprognostic (4.66e-2)" "unprognostic (1.71e-2)" 10.4 12.9 19.9 15.4 26.6 16.5 13.5 18.5 20.9 12.8 12.2 15.1 9.4 10.2 12.0 47.3 15.1 18.9 12.0 11.1 17.5 14.8 14.0 18.1 11.3 21.5 14.8 9.3 21.2 12.0 16.6 10.3 17.7 17.4 17.8 10.8 12.6 15.2 14.6 13.5 14.9 13.3 11.9 11.7 15.6 12.0 11.2 18.6 17.4 11.6 8.7 16.4 10.7 11.0 26.2 30.5 17.4 27.5 15.2 18.4 20.3 13.0 18.4 10.1 11.9 6.5 4.3 20.5 11.1 6.7 14.4 12.2 23.4 7.5 21.8 5.7 7.9 8.0 14.5 11.6 15.5 6.2 5.5 23.7 11.8 12.8 12.6 6.2 28.3 10.2 5.5 7.8 19.5 9.9 5.2 8.7 11.7 16.6 6.3 8.5 26.5 27.2 11.6 8.4 10.4 13.4 47.4 10.4 9.6 7.5 16.0 5.5 3.9 8.2 23.6 10.8 5.4 9.6 12.8 6.5 11.0 14.2 8.4 11.3 9.7 7.2 25.6 9.2 10.9 15.8 10.0 23.5 17.4 18.4 26.4 17.7 20.5 16.1 16.8 18.1 26.2 17.7 16.5 4.7 15.2 27.5 30.5 13.5 20.3 19.9 26.6 18.5 20.9 17.5 14.8 14.8 9.3 17.4 18.6 20.8 35.8 52.9 72.3 38.9 26.5 14.2 25.5 34.8 33.0 21.0 15.7 80.7 14.9 65.2 48.5 37.9 36.0 23.3 23.4 117.3 32.9 62.0 46.2 29.2 83.7 25.4 25.3 31.3 37.8 94.1 20.4 49.8 32.1 146.1 29.9 22.2 58.6 42.1 17.3 34.2 28.7 6.5 26.9 30.9 22.8 33.1 100.7 41.5 40.0 87.7 RRP8 "KIAA0409, NML" ENSG00000132275 "Ribosomal RNA processing 8" O43159 11 6595075-6603620 "Predicted intracellular proteins" "rRNA processing, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038487, HPA057562" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli, Cytosol" "HPA038487: AB_10672518, HPA057562: AB_2683468" "unprognostic (9.01e-2)" "unprognostic (5.84e-2)" "unprognostic (2.53e-1)" "unprognostic (1.10e-2)" "unprognostic (1.92e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (3.10e-7)" "unprognostic (4.64e-2)" "unprognostic (2.48e-1)" "unprognostic (2.79e-1)" "unprognostic (1.41e-1)" "unprognostic (6.23e-2)" "unprognostic (3.81e-3)" "unprognostic (2.71e-1)" "unprognostic (1.24e-1)" "unprognostic (1.81e-1)" "unprognostic (1.87e-2)" 13.8 11.9 13.9 15.8 14.8 32.1 17.9 18.1 15.3 15.9 24.9 16.1 10.5 14.0 15.5 21.3 13.8 11.9 15.4 16.2 16.0 10.3 13.3 24.7 14.3 16.0 18.4 13.6 12.4 12.7 12.0 12.3 12.8 14.2 19.8 14.4 11.8 10.9 19.7 18.6 15.5 12.8 19.5 11.0 17.7 15.1 12.3 18.6 11.8 14.2 9.7 16.6 20.2 13.9 13.3 14.4 20.3 12.0 14.4 13.8 10.2 10.1 10.2 4.1 5.2 8.5 7.4 5.8 5.2 6.6 12.2 11.5 10.4 12.0 14.3 5.2 5.0 9.0 10.3 11.6 9.3 13.0 6.8 16.6 6.7 12.2 11.8 9.8 12.2 9.4 6.3 12.1 5.8 10.6 8.1 12.5 6.7 13.3 8.4 9.6 12.6 11.8 18.2 10.0 17.9 9.2 10.6 3.3 3.2 11.4 8.2 6.3 7.4 7.5 15.4 8.6 7.0 8.4 10.7 6.4 11.6 5.3 11.2 10.1 9.4 8.4 13.6 9.8 12.3 7.4 20.3 11.0 10.7 13.7 11.8 13.2 10.9 13.5 12.6 14.4 13.3 13.3 13.8 4.4 14.4 12.0 11.0 12.6 10.2 13.9 14.8 18.1 15.3 16.0 10.3 18.4 13.6 14.2 18.6 20.8 12.9 13.7 14.7 20.6 17.1 18.3 7.6 10.7 15.9 8.7 13.7 19.6 10.0 15.6 5.3 16.6 10.9 23.3 13.9 17.0 14.6 9.7 17.3 19.1 16.3 3.2 6.9 9.8 8.4 10.4 12.0 12.0 8.5 19.8 12.8 13.3 18.6 13.3 9.2 16.5 27.4 0.0 20.9 21.2 17.2 23.7 16.7 14.9 15.9 12.2 RRP9 "RNU3IP2, U3-55K" ENSG00000114767 "Ribosomal RNA processing 9, U3 small nucleolar RNA binding protein" O43818 3 51933430-51941941 "Predicted intracellular proteins" "rRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 59.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038798 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA038798: AB_10672653" "unprognostic (5.57e-2)" "unprognostic (9.47e-2)" "unprognostic (2.29e-1)" "unprognostic (1.33e-2)" "unprognostic (4.18e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (2.90e-5)" "unprognostic (1.24e-1)" "unprognostic (2.00e-1)" "unprognostic (1.63e-1)" "unprognostic (2.82e-2)" "unprognostic (8.25e-3)" "unprognostic (2.60e-3)" "unprognostic (1.17e-1)" "unprognostic (1.71e-1)" "unprognostic (4.15e-2)" "unprognostic (5.92e-2)" 18.6 19.4 17.5 17.3 22.9 14.1 15.9 11.0 16.3 15.0 12.7 9.3 11.2 14.4 16.4 8.9 16.5 16.7 15.9 12.7 13.6 9.1 12.0 18.6 13.4 18.7 14.2 18.6 17.4 34.7 12.6 10.6 12.1 12.8 13.8 10.5 8.7 13.2 13.1 30.9 15.7 11.0 14.1 9.5 15.6 12.1 15.3 14.0 11.1 12.7 17.7 13.6 13.9 21.6 12.8 13.1 1.5 9.3 12.9 13.7 7.0 10.6 15.3 7.3 17.5 10.8 6.1 18.7 11.8 6.5 20.1 12.8 26.0 12.2 31.0 5.0 8.3 27.3 9.9 25.4 18.2 8.1 14.1 11.0 21.0 9.1 23.1 21.8 22.8 17.6 12.5 13.5 25.1 23.9 4.9 7.7 11.1 19.8 7.9 8.8 17.0 19.2 22.8 28.9 16.5 39.4 11.9 8.4 23.8 9.7 15.9 9.1 10.7 10.7 12.0 11.4 6.6 6.2 14.9 7.3 14.1 18.8 34.8 48.5 13.6 21.9 29.0 12.5 28.6 22.1 1.5 6.6 0.4 12.8 9.3 13.7 12.8 11.0 11.2 12.4 10.5 8.7 10.4 0.5 12.9 4.5 13.1 8.9 7.0 17.5 22.9 11.0 16.3 13.6 9.1 14.2 18.6 12.8 14.0 0.0 10.9 20.3 16.9 59.3 13.0 3.1 10.2 9.4 9.1 5.2 3.9 23.6 13.3 18.6 5.8 7.5 4.2 0.0 11.8 33.0 17.5 9.1 15.0 7.2 20.5 15.9 8.1 4.9 2.1 3.6 8.1 6.9 20.3 14.4 7.2 10.0 15.4 8.6 8.5 14.9 7.8 6.5 18.9 7.6 26.6 44.2 14.0 10.9 15.3 13.2 RSBN1 "FLJ11220, ROSBIN" ENSG00000081019 "Round spermatid basic protein 1" Q5VWQ0 1 113761832-113812476 "Predicted intracellular proteins" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042124, HPA049484" Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles" NA NA Nucleoplasm "Nuclear bodies, Vesicles" "HPA042124: AB_10794644, HPA049484: AB_2680787" "unprognostic (3.26e-2)" "unprognostic (1.32e-1)" "unprognostic (1.15e-3)" "unprognostic (2.13e-1)" "unprognostic (3.66e-2)" "unprognostic (2.30e-2)" "unprognostic (5.06e-2)" "unprognostic (6.60e-2)" "unprognostic (1.06e-1)" "unprognostic (1.97e-2)" "unprognostic (1.56e-1)" "unprognostic (3.96e-1)" "unprognostic (1.51e-2)" "unprognostic (4.67e-2)" "unprognostic (1.43e-1)" "unprognostic (1.24e-1)" "unprognostic (1.15e-3)" 10.4 8.4 8.6 9.4 14.6 35.8 10.3 23.9 12.0 17.0 14.4 6.9 8.1 7.7 13.4 8.6 9.7 10.9 8.4 8.1 8.9 9.1 10.4 7.9 11.5 11.8 8.1 7.3 18.3 13.3 17.6 15.1 8.2 8.4 11.5 10.9 9.6 10.1 10.7 17.1 10.7 10.9 11.5 7.2 12.8 8.8 12.4 10.0 22.6 11.8 5.7 12.7 16.6 10.7 20.7 16.4 25.7 9.2 14.3 20.8 7.3 11.9 3.4 11.8 7.0 7.0 8.1 5.7 4.2 9.2 8.7 9.1 4.0 3.6 10.5 6.8 5.2 4.0 5.3 8.3 5.2 14.2 10.1 6.0 7.9 3.7 4.6 5.3 14.8 8.5 6.1 5.7 7.4 7.1 7.4 6.8 11.8 11.9 6.6 6.3 12.2 11.8 8.8 9.9 3.8 5.9 21.6 11.5 5.4 5.2 5.2 11.9 9.5 8.1 8.0 7.2 6.2 3.9 10.0 8.1 7.8 8.5 11.6 6.9 8.8 6.6 13.3 8.1 9.1 13.0 25.7 9.2 14.6 18.6 6.9 18.8 18.3 20.1 17.1 7.6 20.7 20.8 16.9 17.9 14.3 7.5 16.4 17.4 7.3 8.6 14.6 23.9 12.0 8.9 9.1 8.1 7.3 8.4 10.0 32.8 16.1 30.8 35.7 66.3 83.2 16.9 15.3 29.4 29.6 24.4 62.8 21.1 16.6 17.4 15.1 40.5 36.7 23.3 22.6 20.3 33.4 36.6 34.7 17.0 17.1 92.2 47.3 27.0 20.5 4.0 46.6 26.3 38.8 34.3 43.1 59.4 19.0 44.2 46.7 12.8 100.8 38.8 50.9 94.3 33.0 57.0 26.3 58.9 38.5 36.5 RSC1A1 RS1 ENSG00000215695 "Regulator of solute carriers 1" Q92681 1 15659869-15661722 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027813, HPA028676" Approved Supported "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA027813: AB_10600308, HPA028676: AB_10600895" 3.0 0.9 0.3 1.7 0.4 2.8 2.6 0.1 0.6 2.2 0.6 0.0 1.2 0.0 3.5 1.2 1.1 2.9 0.3 0.5 4.0 7.7 2.7 2.0 0.4 4.6 0.2 2.1 1.3 2.3 3.9 1.3 0.1 0.8 0.6 2.1 0.6 3.0 0.8 0.1 0.6 4.7 1.7 3.2 1.1 2.2 1.1 2.8 0.5 3.5 1.7 2.3 1.5 3.3 3.9 4.8 3.2 6.0 4.2 6.4 2.8 4.7 7.9 7.4 6.4 5.5 7.4 2.8 6.3 3.9 2.3 12.5 4.0 9.7 4.9 3.1 6.9 7.7 6.8 1.3 10.1 3.5 3.3 0.0 13.6 7.5 1.8 4.9 5.0 19.0 7.0 5.7 3.3 5.3 0.0 5.2 1.9 2.2 4.5 6.8 3.1 1.8 6.2 3.9 1.6 5.3 2.4 4.6 4.3 3.4 0.9 4.8 4.0 7.4 3.6 2.1 2.1 4.0 12.9 1.6 2.7 2.8 0.0 1.2 0.5 0.4 3.5 1.4 1.1 0.5 2.3 2.8 0.2 0.6 0.5 0.0 1.7 0.1 0.7 2.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RSF1 "HBXAP, p325, RSF-1, XAP8" ENSG00000048649 "Remodeling and spacing factor 1" Q96T23 11 77659996-77821017 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022626, HPA046129, HPA057547, HPA064567" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "CAB022626: , HPA046129: AB_2679550, HPA057547: AB_2683462, HPA064567: AB_2685289" "unprognostic (2.67e-1)" "unprognostic (2.02e-1)" "unprognostic (2.39e-1)" "unprognostic (4.35e-3)" "unprognostic (5.00e-3)" "unprognostic (5.57e-2)" "unprognostic (1.23e-2)" "unprognostic (2.46e-1)" "unprognostic (7.33e-3)" "unprognostic (2.35e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (6.19e-2)" "prognostic favorable (5.94e-4)" "unprognostic (1.71e-1)" "unprognostic (2.22e-1)" "unprognostic (2.21e-1)" "unprognostic (1.15e-1)" 15.9 20.1 20.4 19.5 23.5 21.1 14.4 32.3 20.0 19.0 14.2 11.0 15.2 8.7 19.3 14.6 13.4 14.1 15.7 13.1 18.7 17.2 14.0 10.9 15.6 13.2 16.2 15.3 26.0 15.6 25.3 27.3 16.9 18.7 16.3 12.0 8.1 13.4 21.3 15.7 13.5 12.7 16.7 15.8 16.2 12.5 21.1 21.8 22.4 21.1 8.4 12.3 21.3 25.8 21.7 18.5 27.7 15.7 13.6 17.1 4.0 10.5 7.1 24.8 13.2 8.4 10.7 9.3 12.5 12.3 10.3 12.7 18.7 14.8 18.0 13.4 8.7 15.9 11.1 14.5 9.3 19.3 12.8 6.5 16.9 10.1 5.0 8.1 16.0 12.1 8.9 7.1 14.0 22.6 12.0 12.9 6.0 27.5 17.1 11.8 7.2 11.2 9.0 14.4 12.7 9.8 18.8 43.1 11.7 5.4 13.8 15.0 15.2 19.2 7.6 7.5 13.5 13.6 8.0 16.1 18.2 15.8 28.4 8.9 10.3 13.2 41.5 4.8 10.9 13.6 21.3 10.7 17.8 17.1 9.9 11.7 18.2 10.3 10.7 8.1 21.7 14.3 14.2 27.7 13.6 15.7 18.5 9.6 4.0 20.4 23.5 32.3 20.0 18.7 17.2 16.2 15.3 18.7 21.8 110.2 97.4 50.0 60.3 80.4 120.3 86.5 48.4 78.9 81.9 69.8 70.7 51.8 39.7 63.9 69.5 87.9 40.1 70.0 48.5 44.1 80.8 77.0 91.4 37.7 39.8 138.2 82.1 72.4 47.5 29.1 117.3 58.4 54.0 85.6 57.6 115.2 62.7 57.7 111.0 31.1 94.9 103.5 72.1 96.0 109.4 73.4 56.4 77.8 54.2 72.5 RSG1 "C1orf89, MGC10731" ENSG00000132881 "REM2 and RAB like small GTPase 1" Q9BU20 1 16231700-16237162 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 5 "Alveolar cells type 2: 3.5;granulocytes: 4.6;Spermatocytes: 3.7;Spermatogonia: 3.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028453 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA028453: AB_10601692" "unprognostic (7.52e-2)" "unprognostic (3.22e-1)" "unprognostic (3.61e-2)" "unprognostic (1.34e-2)" "unprognostic (1.05e-2)" "unprognostic (1.25e-2)" "unprognostic (6.12e-3)" "unprognostic (1.11e-1)" "unprognostic (2.55e-1)" "unprognostic (1.14e-1)" "unprognostic (8.31e-2)" "unprognostic (4.79e-2)" "prognostic favorable (1.36e-10)" "unprognostic (1.45e-2)" "unprognostic (2.36e-1)" "unprognostic (1.56e-1)" "unprognostic (2.16e-2)" 3.2 7.5 14.2 3.7 17.1 5.8 3.3 3.7 9.8 6.0 3.7 3.9 12.6 4.2 5.6 3.2 8.9 11.8 3.8 7.9 10.4 12.0 5.3 3.6 3.2 4.5 9.3 10.5 10.1 8.3 7.9 8.0 4.1 10.4 5.4 3.3 5.7 8.0 7.5 2.1 7.4 3.6 6.1 7.9 5.9 6.6 6.7 7.5 1.7 11.6 0.3 4.0 5.9 3.0 3.2 2.2 4.0 3.5 2.9 6.2 1.4 4.0 11.0 3.4 11.1 2.3 4.2 3.1 4.5 2.9 3.7 1.6 4.0 6.2 8.7 9.2 2.5 7.3 3.3 6.1 5.9 0.4 13.1 5.1 4.3 9.6 0.8 5.7 2.9 7.9 2.2 5.1 4.3 3.9 3.7 3.5 6.7 15.6 3.4 3.0 5.0 3.1 2.1 0.8 4.3 4.3 7.8 0.4 7.0 3.3 2.5 8.2 5.5 1.8 2.8 4.1 2.6 8.4 2.7 3.5 1.1 1.8 2.2 1.5 9.4 3.5 5.0 3.0 6.3 6.2 0.0 1.2 4.0 5.0 3.5 6.2 3.0 3.1 1.4 2.2 3.2 3.0 2.4 1.1 2.9 2.2 0.7 3.2 1.4 14.2 17.1 3.7 9.8 10.4 12.0 9.3 10.5 10.4 7.5 0.0 3.5 0.5 1.5 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 1.7 0.0 0.0 0.8 0.7 2.0 0.0 0.0 2.0 0.7 1.0 4.6 0.8 2.1 0.0 1.2 0.6 1.3 0.9 1.1 0.0 1.7 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.7 3.7 0.3 0.9 0.0 1.2 0.5 RSL24D1 "C15orf15, HRP-L30-iso, L30, RPL24, RPL24L" ENSG00000137876 "Ribosomal L24 domain containing 1" Q9UHA3 15 55180806-55197067 "Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062724, HPA063392" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA062724: AB_2684850, HPA063392: AB_2685002" "unprognostic (3.40e-2)" "unprognostic (3.00e-1)" "unprognostic (3.83e-1)" "unprognostic (7.28e-2)" "unprognostic (3.80e-2)" "unprognostic (1.07e-3)" "unprognostic (6.71e-3)" "unprognostic (1.15e-1)" "unprognostic (6.56e-3)" "unprognostic (1.34e-1)" "unprognostic (6.19e-3)" "unprognostic (7.22e-2)" "unprognostic (1.13e-1)" "unprognostic (4.44e-1)" "unprognostic (4.54e-2)" "unprognostic (4.95e-1)" "unprognostic (2.41e-1)" 27.7 24.3 26.7 23.4 28.8 76.1 47.8 35.7 29.9 40.6 32.2 10.0 25.6 18.1 34.5 26.6 34.2 26.4 21.4 25.3 25.1 25.3 24.3 26.7 27.0 35.8 25.4 25.8 54.7 37.8 15.0 23.2 22.4 24.1 44.3 20.5 11.2 25.8 21.3 47.2 19.3 21.1 50.4 27.5 28.6 28.8 24.2 20.6 39.5 43.1 36.9 27.4 61.9 49.6 29.1 27.0 11.4 24.1 22.7 45.1 47.7 16.1 16.4 18.1 23.7 14.2 26.8 14.7 17.1 19.2 14.4 18.4 15.7 9.9 50.4 15.5 12.3 14.1 19.8 23.8 19.8 19.4 24.5 14.8 25.8 13.2 19.5 32.8 48.5 16.9 22.7 42.0 14.4 41.9 23.3 17.8 37.9 48.6 36.6 16.7 16.5 26.5 42.8 22.3 33.1 14.8 21.2 22.7 75.9 21.6 15.0 25.7 30.8 7.9 22.3 55.4 15.0 21.4 71.8 12.4 11.9 13.9 13.8 24.4 35.3 53.9 50.1 18.5 48.1 19.9 11.4 23.8 11.4 19.6 23.4 31.1 29.1 29.5 24.3 27.0 22.5 45.1 34.0 6.0 22.7 24.1 21.1 32.4 47.7 26.7 28.8 35.7 29.9 25.1 25.3 25.4 25.8 24.1 20.6 92.3 65.6 256.3 349.8 515.7 83.5 63.5 89.2 77.6 80.8 80.3 21.6 138.6 242.1 170.0 67.8 119.6 46.1 70.0 234.1 222.4 198.3 186.8 150.0 57.1 128.0 14.3 134.4 79.8 196.0 28.6 188.4 183.5 269.9 194.8 102.0 68.6 201.1 134.0 140.4 191.4 51.1 155.2 258.6 71.0 148.8 456.4 145.9 187.5 118.2 292.9 RSPH4A "CILD11, dJ412I7.1, FLJ37974, RSHL3, RSPH6B" ENSG00000111834 "Radial spoke head 4 homolog A" Q5TD94 6 116616479-116632985 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.8;fallopian tube: 35.9;pituitary gland: 16.7" "Cell type enriched" "Detected in many" 10 "Ciliated cells: 365.4" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.6" "Group enriched" "Detected in many" 4 "basal ganglia: 9.4;pons and medulla: 19.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RPMI-8226: 7.6;U-266/84: 5.5" "Low region specificity" "Detected in many" "HPA031196, HPA031197, HPA031198" Enhanced Approved Nucleoplasm No NA Nucleoplasm "HPA031196: AB_10601612, HPA031197: AB_10671097, HPA031198: AB_10670025" "unprognostic (9.83e-4)" "unprognostic (1.26e-1)" "unprognostic (6.94e-2)" "unprognostic (9.69e-3)" "unprognostic (9.37e-2)" "unprognostic (1.13e-3)" "unprognostic (4.52e-1)" "unprognostic (1.07e-1)" "unprognostic (1.06e-1)" "unprognostic (5.08e-2)" "unprognostic (9.56e-5)" "unprognostic (2.87e-1)" "unprognostic (2.69e-4)" "unprognostic (1.96e-2)" "unprognostic (2.51e-1)" "unprognostic (3.55e-2)" "unprognostic (5.21e-2)" 0.5 0.7 1.8 0.5 9.4 0.9 0.7 1.2 0.9 2.2 0.4 10.2 0.4 0.5 1.9 13.3 0.4 35.9 0.8 0.5 3.0 3.3 0.7 0.4 11.1 0.5 0.5 1.1 13.7 0.6 2.8 16.7 0.3 19.8 0.6 0.4 0.2 0.4 0.5 1.0 0.6 0.4 0.6 0.7 1.0 0.8 6.6 1.8 0.0 1.0 0.0 0.5 0.4 0.1 0.8 0.1 1.3 0.2 0.2 1.0 0.0 0.1 0.2 1.4 3.2 0.1 0.1 0.3 0.4 0.8 0.6 0.8 0.7 1.1 1.0 0.3 0.1 1.2 0.2 0.3 0.6 0.6 0.8 1.1 0.4 0.5 1.2 0.0 0.8 1.1 0.4 0.2 1.0 0.2 0.1 0.0 0.9 0.2 0.1 0.6 0.2 0.7 0.1 0.6 0.1 0.1 0.8 1.6 7.6 3.2 0.4 2.8 1.2 0.2 0.2 0.5 0.3 0.5 0.6 0.5 0.4 0.7 0.5 0.5 0.5 5.5 0.4 0.1 0.4 0.5 1.3 0.2 0.8 1.0 0.1 0.1 0.4 0.3 0.0 0.0 0.8 0.2 0.5 0.0 0.2 0.1 0.1 0.0 0.0 1.8 9.4 1.2 0.7 3.0 3.3 0.5 1.1 19.8 1.8 3.0 4.3 0.0 0.0 0.0 3.0 0.4 0.0 365.4 35.2 0.0 2.0 0.0 1.7 0.4 18.2 0.1 0.0 0.0 0.3 0.1 0.0 0.1 2.3 0.0 0.1 1.6 0.0 2.5 0.0 8.7 0.3 0.0 1.7 0.0 0.0 1.7 0.2 0.0 0.0 0.0 3.2 0.0 0.4 4.4 1.5 0.1 0.2 0.0 0.0 0.0 RSRP1 "C1orf63, DJ465N24.2.1" ENSG00000117616 "Arginine and serine rich protein 1" Q9BUV0 1 25242237-25338213 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 353.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 27.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058992, HPA067651" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA058992: AB_2683873, HPA067651: AB_2685879" "unprognostic (1.03e-1)" "unprognostic (4.52e-2)" "unprognostic (2.18e-1)" "unprognostic (7.24e-2)" "unprognostic (3.65e-2)" "unprognostic (3.81e-2)" "unprognostic (5.77e-3)" "unprognostic (3.67e-2)" "unprognostic (2.22e-2)" "unprognostic (1.21e-1)" "unprognostic (1.02e-2)" "unprognostic (7.51e-3)" "unprognostic (1.73e-3)" "unprognostic (4.84e-2)" "unprognostic (1.87e-1)" "unprognostic (7.87e-2)" "prognostic favorable (2.91e-5)" 11.3 55.9 13.2 23.7 20.6 21.3 9.4 18.3 16.7 48.3 13.4 17.8 44.2 10.4 19.2 26.0 15.6 14.7 30.3 16.5 16.8 13.6 19.4 17.5 16.3 11.0 31.0 15.6 20.2 22.8 6.7 25.0 17.0 18.6 21.4 6.4 12.7 36.7 36.6 9.9 16.9 12.6 12.0 25.9 15.0 17.3 14.0 21.5 23.1 17.5 10.5 20.9 12.2 21.1 7.7 18.6 39.2 18.0 10.0 10.5 7.7 3.4 9.7 1.5 1.3 8.4 2.2 3.3 3.4 1.3 4.8 5.1 7.5 4.0 2.8 12.3 0.9 1.5 5.6 7.5 0.8 1.3 6.9 5.1 11.2 10.8 9.0 2.4 4.9 5.7 0.8 4.6 1.9 0.2 2.8 2.9 3.7 8.7 27.6 1.3 4.1 1.3 9.4 5.4 7.0 5.6 4.1 3.8 4.1 3.3 0.2 4.7 1.3 2.5 1.7 2.0 0.8 2.0 5.0 4.0 3.0 2.4 2.8 2.1 15.1 13.5 3.1 2.3 12.4 2.2 36.5 18.0 25.5 7.9 11.4 8.2 7.4 8.2 6.4 18.6 7.7 7.9 5.2 39.2 10.0 14.9 11.8 10.5 7.7 13.2 20.6 18.3 16.7 16.8 13.6 31.0 15.6 18.6 21.5 56.6 75.6 125.0 203.5 0.0 95.1 40.3 40.8 108.4 69.4 89.0 133.5 64.6 18.3 33.2 24.1 69.8 353.7 23.3 18.8 45.9 62.1 147.7 216.6 15.7 55.8 79.4 125.4 61.4 67.3 10.1 129.8 97.5 0.0 83.0 125.1 79.6 32.5 277.0 84.8 7.9 146.7 122.9 31.5 64.2 96.5 0.0 101.4 148.1 107.4 174.4 RTCA "RPC, RTC1, RTCD1" ENSG00000137996 "RNA 3'-terminal phosphate cyclase" O00442 1 100266207-100292769 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027982, HPA027990, HPA028151, HPA028331" Uncertain Enhanced Nucleoplasm NA NA 8700 Nucleoplasm "HPA027982: AB_10601769, HPA027990: AB_2672452, HPA028151: AB_10602099, HPA028331: " "unprognostic (4.79e-2)" "unprognostic (1.17e-2)" "unprognostic (3.97e-2)" "unprognostic (3.82e-2)" "unprognostic (6.76e-2)" "unprognostic (4.12e-2)" "prognostic unfavorable (2.76e-5)" "unprognostic (9.55e-3)" "unprognostic (3.64e-2)" "unprognostic (1.12e-2)" "unprognostic (2.46e-1)" "unprognostic (8.09e-3)" "unprognostic (3.74e-3)" "unprognostic (2.10e-2)" "unprognostic (1.44e-1)" "unprognostic (3.59e-1)" "unprognostic (2.94e-2)" 20.9 25.0 19.4 17.8 24.9 25.5 20.0 22.6 31.7 14.7 22.9 20.3 19.9 31.7 14.2 26.0 27.0 13.4 19.9 25.5 20.0 21.0 31.7 23.0 16.1 21.8 21.5 20.7 13.3 27.7 21.1 17.2 21.2 33.1 20.9 22.2 14.1 18.5 17.4 35.4 14.6 37.8 15.4 20.5 24.2 21.8 12.2 12.4 25.0 18.3 20.2 20.8 18.7 17.5 9.6 8.0 8.2 19.6 11.0 20.1 7.7 22.0 11.4 11.3 15.2 14.3 23.3 30.9 26.2 12.8 17.1 14.8 18.6 11.1 22.6 19.9 16.6 21.1 11.2 13.8 12.4 20.7 22.6 11.5 14.9 13.0 23.4 22.1 27.1 23.6 18.9 19.6 22.3 29.9 17.0 21.2 16.5 25.6 34.5 25.8 7.3 13.9 21.1 17.3 15.7 22.1 10.0 20.2 9.9 21.0 18.1 9.1 11.4 16.9 24.5 35.8 18.5 5.3 34.8 18.4 16.2 11.3 25.2 31.4 20.0 20.1 18.1 34.0 23.6 9.6 8.2 9.1 7.5 10.8 11.3 13.8 9.6 10.0 12.8 8.0 7.1 9.3 10.5 4.4 11.0 19.6 7.6 20.1 7.7 19.4 24.9 22.6 31.7 20.0 21.0 21.5 20.7 33.1 12.4 6.0 14.4 26.1 13.0 12.0 22.2 49.6 7.6 13.4 10.3 17.4 11.8 48.9 21.6 37.0 11.5 17.5 35.4 0.0 30.2 65.3 13.9 14.2 12.7 15.3 69.5 20.6 18.5 22.7 41.9 6.4 17.8 28.9 15.1 50.5 26.6 20.6 46.7 37.1 12.0 49.6 26.8 6.5 12.3 27.2 14.7 12.8 38.8 32.0 29.7 15.7 RTCB "C22orf28, FAAP, HSPC117" ENSG00000100220 "RNA 2',3'-cyclic phosphate and 5'-OH ligase" Q9Y3I0 22 32387582-32412255 "Enzymes, Predicted intracellular proteins" "tRNA processing" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000535, HPA001103" Supported Supported Nucleoplasm,Vesicles,Cytosol NA NA 43000 Nucleoplasm "Vesicles, Cytosol" "HPA000535: AB_2666021, HPA001103: AB_1078351" "unprognostic (1.84e-1)" "unprognostic (6.48e-2)" "unprognostic (1.07e-2)" "unprognostic (2.71e-3)" "unprognostic (7.21e-3)" "unprognostic (1.43e-2)" "unprognostic (1.75e-3)" "unprognostic (1.49e-1)" "unprognostic (3.01e-1)" "unprognostic (1.52e-1)" "unprognostic (2.40e-2)" "unprognostic (5.07e-2)" "prognostic favorable (4.25e-5)" "unprognostic (6.91e-2)" "unprognostic (5.35e-2)" "unprognostic (2.05e-1)" "unprognostic (1.55e-1)" 26.4 30.1 20.1 20.4 29.7 15.1 29.2 22.9 34.5 25.7 35.6 35.2 32.7 51.6 29.7 25.8 30.8 26.9 22.9 26.4 19.6 24.6 42.4 55.1 23.1 22.7 29.1 26.2 29.0 29.4 38.4 29.9 33.7 36.7 27.0 42.3 27.1 29.9 28.6 40.9 46.6 61.7 31.8 24.4 29.3 29.7 30.8 25.5 32.0 32.7 30.1 46.6 26.5 24.2 44.6 51.5 29.0 47.7 37.0 40.5 44.0 32.2 29.0 36.4 27.3 31.9 23.8 29.0 28.3 34.1 45.3 43.1 37.6 13.2 8.0 19.0 33.0 27.9 22.0 41.6 41.1 58.7 40.4 41.8 22.8 24.6 34.1 22.0 53.3 20.9 23.4 27.3 44.8 43.6 25.0 40.7 22.6 27.0 22.8 33.0 26.9 22.6 18.5 20.8 37.5 26.6 35.2 39.3 41.2 31.1 28.1 37.6 20.8 30.7 19.9 35.9 40.0 21.8 20.7 30.6 25.0 36.9 21.7 27.1 15.9 12.7 28.9 25.9 24.2 32.6 29.0 43.5 27.4 31.7 47.7 35.5 44.6 33.3 33.0 51.5 43.6 39.9 34.6 4.3 37.0 35.5 28.9 40.5 44.0 20.1 29.7 22.9 34.5 19.6 24.6 29.1 26.2 36.7 25.5 29.8 30.2 40.2 48.9 53.8 50.9 32.3 48.4 37.5 22.7 33.2 19.6 98.9 56.3 89.0 3.8 37.9 93.2 0.0 84.1 74.7 40.4 51.2 42.6 54.7 75.2 49.3 44.9 35.0 41.7 7.0 32.5 40.0 28.7 107.4 50.3 61.1 82.4 59.7 44.9 108.7 48.0 25.8 37.2 57.2 58.8 66.5 81.8 30.9 51.3 61.4 RTF1 KIAA0252 ENSG00000137815 "RTF1 homolog, Paf1/RNA polymerase II complex component" Q92541 15 41408408-41483563 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006714 Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA006714: AB_1079855" "unprognostic (1.10e-1)" "unprognostic (5.03e-2)" "unprognostic (1.40e-1)" "unprognostic (1.86e-2)" "unprognostic (1.21e-2)" "unprognostic (1.88e-1)" "unprognostic (8.87e-2)" "unprognostic (5.36e-2)" "unprognostic (4.21e-1)" "unprognostic (2.39e-1)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.19e-1)" "unprognostic (1.69e-2)" "unprognostic (8.22e-2)" "unprognostic (3.13e-2)" "unprognostic (1.80e-1)" "unprognostic (9.50e-2)" 20.4 27.8 27.6 21.6 33.8 34.3 20.4 40.5 34.5 23.7 22.5 14.3 17.6 16.9 25.7 18.4 22.4 18.5 18.4 24.8 26.5 21.4 17.6 19.6 17.2 23.0 17.0 35.1 27.7 15.2 37.0 20.3 36.9 27.2 22.0 20.6 15.4 19.5 23.2 55.2 24.8 20.7 24.7 14.9 23.5 19.0 25.4 13.5 25.3 26.7 15.6 21.6 27.8 20.2 8.0 7.4 11.6 4.3 8.6 5.7 1.4 15.3 10.1 33.4 27.1 19.0 22.6 15.8 20.6 23.2 28.3 23.7 19.7 9.8 14.6 16.7 21.5 12.6 27.4 19.3 17.1 24.3 22.2 18.0 30.7 22.9 14.7 13.3 27.3 18.0 16.2 17.4 15.1 15.3 21.1 22.7 26.8 23.3 17.0 23.1 11.7 26.1 16.9 18.0 19.2 13.9 28.4 26.1 13.9 18.4 33.1 17.2 22.8 18.5 23.7 9.3 19.0 19.4 26.5 18.6 27.8 17.7 27.6 22.5 19.7 30.3 24.3 20.0 26.1 16.9 5.9 4.3 8.4 4.8 2.8 4.4 8.0 4.7 4.1 3.0 6.5 5.7 4.7 11.6 8.6 3.3 7.4 5.4 1.4 27.6 33.8 40.5 34.5 26.5 21.4 17.0 35.1 27.2 13.5 119.1 70.9 118.3 89.5 128.8 209.3 81.2 112.1 69.6 75.1 116.9 88.4 138.6 139.3 89.0 242.0 101.3 97.3 116.8 95.9 97.3 120.4 91.4 89.0 170.3 83.7 139.8 84.2 119.7 72.1 267.8 134.3 89.8 102.9 103.6 107.1 106.0 103.7 94.8 150.3 100.0 188.1 84.1 92.0 109.4 66.6 142.4 183.4 97.8 106.5 90.9 RTF2 "C20orf43, CDAO5, HSPC164, RTFDC1" ENSG00000022277 "Replication termination factor 2" Q9BY42 20 56468585-56519449 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 133.3;Distal tubular cells: 132.6;monocytes: 160.5;Syncytiotrophoblasts: 153.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053986 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA053986: AB_2682333" "unprognostic (1.65e-1)" "unprognostic (1.94e-3)" "unprognostic (2.01e-1)" "prognostic unfavorable (6.35e-4)" "unprognostic (3.54e-2)" "unprognostic (3.97e-2)" "prognostic unfavorable (1.31e-4)" "unprognostic (8.90e-2)" "unprognostic (4.02e-3)" "unprognostic (1.16e-1)" "unprognostic (8.98e-2)" "unprognostic (3.66e-2)" "unprognostic (1.55e-2)" "unprognostic (1.55e-1)" "unprognostic (1.96e-1)" "unprognostic (4.58e-1)" "unprognostic (8.48e-3)" 33.4 34.2 43.5 29.1 43.9 52.6 28.9 27.4 48.7 28.8 29.4 53.0 20.1 28.0 31.4 24.1 30.5 31.6 23.2 38.7 40.6 35.6 31.8 30.3 24.2 29.7 49.6 35.7 35.2 27.5 26.0 29.3 30.5 46.6 28.5 26.0 26.0 25.8 31.7 74.6 27.9 29.8 34.1 59.7 30.2 25.3 29.1 45.2 31.4 29.1 28.9 34.4 29.0 23.9 20.0 35.1 91.6 31.8 29.4 23.0 33.2 28.9 20.8 21.1 20.6 26.4 23.6 19.6 45.2 34.2 65.3 37.5 42.4 28.1 24.8 53.7 36.6 32.1 32.5 21.1 34.8 45.2 11.6 16.4 31.0 22.8 32.8 30.3 44.1 42.9 20.9 36.2 29.1 25.3 27.8 28.0 26.6 24.0 26.0 32.0 55.3 36.9 37.6 15.6 41.1 39.7 25.4 57.5 32.7 27.2 19.1 21.8 23.7 47.5 80.6 42.5 16.3 37.3 42.1 30.0 55.9 36.2 30.4 36.5 21.7 24.9 35.3 44.0 30.1 30.4 39.2 31.8 84.1 20.9 29.6 17.6 18.6 18.0 20.3 35.1 20.0 20.5 18.8 91.6 29.4 28.8 29.9 23.0 33.2 43.5 43.9 27.4 48.7 40.6 35.6 49.6 35.7 46.6 45.2 47.6 50.4 0.0 0.0 0.0 0.0 0.0 0.0 62.9 62.6 62.8 0.0 133.3 132.6 81.8 0.0 0.0 0.0 0.0 83.7 92.1 0.0 0.0 83.7 0.0 98.1 0.0 0.0 0.0 0.0 0.0 0.0 45.0 0.0 160.5 0.0 0.0 80.1 0.0 0.0 106.9 0.0 0.0 0.0 0.0 0.0 0.0 153.0 0.0 0.0 0.0 RTKN B5 ENSG00000114993 Rhotekin Q9BST9 2 74425836-74442422 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 9.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 33.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030259 Approved Approved Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA030259: AB_10601484" "unprognostic (4.09e-1)" "unprognostic (1.28e-1)" "unprognostic (1.20e-2)" "unprognostic (2.47e-1)" "unprognostic (3.51e-2)" "unprognostic (1.47e-3)" "unprognostic (5.32e-2)" "unprognostic (1.95e-2)" "unprognostic (2.57e-2)" "unprognostic (9.43e-3)" "unprognostic (4.99e-2)" "unprognostic (2.48e-2)" "unprognostic (2.96e-2)" "unprognostic (7.15e-2)" "unprognostic (1.85e-1)" "unprognostic (5.81e-2)" "unprognostic (1.23e-3)" 3.2 4.9 17.1 3.9 24.2 0.4 7.1 3.9 23.6 5.6 8.7 29.7 7.3 21.2 5.1 4.0 8.0 9.0 9.7 7.2 22.2 13.7 27.0 39.0 6.3 1.9 34.8 7.7 3.6 16.3 12.8 5.3 7.9 17.2 6.5 8.8 6.0 17.3 7.0 7.5 21.1 16.4 4.4 36.3 2.2 6.0 1.4 29.4 1.9 7.4 5.3 4.3 3.1 5.6 1.7 9.7 0.0 0.0 3.1 0.4 0.6 16.8 5.2 6.7 19.8 4.1 4.8 29.0 2.6 3.3 3.8 2.8 26.2 9.4 0.1 7.5 2.5 4.7 23.2 2.5 16.9 1.8 3.3 10.9 4.0 0.9 33.0 2.5 0.0 0.0 2.9 13.5 3.3 10.8 7.0 1.9 0.2 2.0 0.1 5.6 12.0 0.6 3.3 7.3 24.5 10.5 3.7 21.0 2.5 18.6 0.1 6.8 6.5 7.2 28.1 14.9 6.5 15.7 1.5 0.2 7.2 5.0 3.2 3.5 1.7 1.1 0.6 6.9 0.0 6.7 0.0 0.0 0.0 0.4 0.0 0.3 1.1 0.2 0.3 0.9 1.7 0.0 0.1 0.0 3.1 0.0 9.7 0.0 0.6 17.1 24.2 3.9 14.9 22.2 13.7 34.8 7.7 17.2 29.4 8.9 10.2 1.7 19.9 17.7 0.0 2.5 17.8 2.7 17.0 10.4 2.0 38.3 18.3 38.6 0.8 7.0 35.9 0.0 17.8 4.0 10.3 22.4 1.1 34.6 8.2 0.0 29.6 3.1 2.6 0.4 11.8 0.0 27.0 1.0 15.4 5.8 24.3 31.6 8.1 43.3 0.4 6.5 3.4 1.1 3.4 18.9 27.9 2.9 21.8 14.5 RTKN2 "bA531F24.1, Em:AC024597.2, FLJ39352, PLEKHK1" ENSG00000182010 "Rhotekin 2" Q8IZC4 10 62183035-62268707 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "lung: 67.6" "Cell type enriched" "Detected in many" 4 "Alveolar cells type 1: 1628.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in some" 7 "T-reg: 15.4" "Lineage enriched" "Detected in single" 47 "T-cells: 15.4" "Cell line enhanced" "Detected in many" "A-431: 25.5;HaCaT: 20.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037946, HPA038446" Enhanced Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA037946: AB_10795398, HPA038446: AB_10796218" "unprognostic (2.33e-1)" "unprognostic (2.59e-1)" "unprognostic (2.52e-2)" "unprognostic (1.52e-2)" "unprognostic (1.26e-1)" "unprognostic (8.92e-3)" "unprognostic (6.66e-5)" "unprognostic (7.81e-3)" "unprognostic (2.33e-2)" "unprognostic (3.24e-1)" "unprognostic (3.72e-2)" "unprognostic (9.48e-4)" "unprognostic (3.70e-11)" "unprognostic (3.95e-2)" "unprognostic (9.34e-3)" "unprognostic (4.68e-3)" "unprognostic (1.55e-1)" 0.3 0.1 0.7 1.8 0.8 0.5 0.7 0.1 1.6 1.5 1.1 0.0 0.1 0.7 0.6 0.1 7.1 0.2 0.4 0.2 0.5 0.2 0.5 0.2 67.6 2.3 0.2 0.5 0.3 0.2 0.2 0.8 0.7 0.1 0.7 1.2 0.1 1.6 0.1 0.1 0.7 1.1 0.3 0.2 0.8 0.7 5.3 0.1 6.9 0.8 1.3 4.1 0.7 3.0 0.3 0.2 0.3 0.1 0.2 15.4 0.2 25.5 1.4 13.7 6.3 0.0 0.1 3.3 3.7 4.3 4.2 6.7 10.6 5.1 0.1 1.6 1.4 4.3 20.5 7.6 0.6 4.4 3.6 5.2 4.2 3.1 4.4 0.0 5.7 3.3 0.2 0.3 5.2 0.5 2.3 0.6 6.8 0.2 0.2 5.6 3.2 11.0 7.3 5.8 3.8 5.2 9.5 14.6 0.0 2.7 11.1 7.5 8.6 2.4 8.6 3.5 4.2 7.8 3.1 0.0 1.9 12.5 0.1 9.3 0.1 0.0 9.8 2.5 0.0 3.0 0.1 0.1 0.1 1.3 0.0 0.1 0.1 2.1 0.4 0.0 0.3 0.8 0.3 0.3 0.2 0.1 0.2 15.4 0.2 0.7 0.8 0.1 1.6 0.5 0.2 0.2 0.5 0.1 0.1 1628.8 44.5 0.9 8.3 4.1 0.6 0.4 0.0 4.0 15.9 0.0 0.0 3.0 0.0 1.4 376.8 0.1 0.4 0.0 1.4 4.9 2.5 7.0 3.5 0.0 2.1 0.0 1.7 1.8 0.6 65.6 2.0 2.2 1.7 0.0 5.9 0.4 9.1 0.0 1.8 1.4 0.5 0.0 1.9 21.3 23.6 1.6 1.7 12.7 3.3 87.2 RTL3 "FLJ38865, Mar3, Mart3, SIRH9, ZCCHC5, ZHC5" ENSG00000179300 "Retrotransposon Gag like 3" Q8N8U3 X 78656069-78659328 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "endometrium 1: 2.5;intestine: 2.6;smooth muscle: 2.7;stomach 1: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 2.6;fHDF/TERT166: 4.0;GAMG: 3.2;HBF TERT88: 5.4;hTEC/SVTERT24-B: 3.9;RH-30: 4.7;U-251 MG: 3.4" "HPA051991, HPA053174, HPA075136" Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA Nucleoplasm "Golgi apparatus, Plasma membrane" "HPA051991: AB_2681683, HPA053174: AB_2682069, HPA075136: AB_2686737" "unprognostic (3.43e-1)" "unprognostic (1.06e-1)" "unprognostic (1.29e-1)" "unprognostic (6.74e-2)" "unprognostic (5.11e-2)" "unprognostic (8.64e-2)" "unprognostic (1.23e-1)" "unprognostic (1.69e-2)" "unprognostic (2.85e-1)" "unprognostic (4.00e-6)" "unprognostic (1.53e-2)" "unprognostic (3.64e-1)" "unprognostic (2.49e-1)" 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 2.6 0.2 2.5 0.2 0.5 0.4 0.5 2.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.5 0.7 0.0 0.1 0.3 1.1 2.7 0.0 0.0 3.2 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.9 2.4 2.6 0.0 0.0 0.0 0.1 4.0 3.2 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.9 0.0 0.6 0.0 0.6 0.0 0.1 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.8 0.0 0.1 1.4 0.2 3.4 0.2 0.0 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RTL4 "FLJ46608, Mar4, Mart4, SIRH11, ZCCHC16" ENSG00000187823 "Retrotransposon Gag like 4" Q6ZR62 X 112454500-112457112 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "kidney: 3.5;liver: 4.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "testis cancer: 1.4;thyroid cancer: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.8;SuSa: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003272 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA003272: AB_2257414" "unprognostic (9.86e-2)" "unprognostic (2.04e-4)" "unprognostic (6.35e-2)" "unprognostic (5.33e-3)" 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 3.5 4.7 0.0 0.0 0.7 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RTL5 "KIAA2001, Mar5, Mart5, RGAG4, SIRH8" ENSG00000242732 "Retrotransposon Gag like 5" Q5HYW3 X 72127110-72131901 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 9 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.2;Ciliated cells: 4.0;Club cells: 3.4;Distal tubular cells: 1.7;granulocytes: 2.3;Hofbauer cells: 3.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.6;AN3-CA: 6.3;SCLC-21H: 7.6;SH-SY5Y: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003652 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA003652: AB_1079805" "unprognostic (7.97e-2)" "unprognostic (1.31e-2)" "unprognostic (5.29e-3)" "unprognostic (2.98e-2)" "unprognostic (3.93e-2)" "unprognostic (3.64e-1)" "unprognostic (4.20e-1)" "prognostic favorable (7.30e-4)" "unprognostic (1.62e-1)" "unprognostic (2.82e-1)" "prognostic favorable (3.41e-4)" "unprognostic (4.23e-1)" "unprognostic (4.18e-3)" "unprognostic (3.19e-2)" "unprognostic (5.58e-2)" "unprognostic (1.35e-1)" "unprognostic (1.79e-2)" 5.4 7.2 7.0 2.7 12.5 1.9 7.7 22.7 14.2 4.9 4.5 3.5 6.2 2.8 9.6 10.1 2.6 4.9 6.0 4.0 10.3 8.9 4.4 4.2 5.5 2.4 5.2 11.2 10.5 1.1 7.4 16.3 5.2 6.3 5.7 3.0 3.0 3.7 6.9 2.3 2.1 3.2 6.7 9.5 2.7 5.4 12.4 4.8 0.0 11.7 0.8 2.0 5.5 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 5.6 6.3 1.5 1.8 0.3 2.1 0.8 0.3 0.9 0.4 0.0 0.0 0.9 0.4 1.0 0.0 1.1 0.1 1.1 0.0 0.8 0.2 0.1 0.0 0.1 0.0 0.7 3.4 0.1 0.9 0.0 1.8 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.6 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 7.6 10.6 0.4 0.0 0.0 2.4 0.2 0.0 0.7 0.8 0.7 1.4 0.0 0.1 0.0 0.0 1.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 7.0 12.5 22.7 14.2 10.3 8.9 5.2 11.2 6.3 4.8 3.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 4.0 3.4 0.0 0.0 0.1 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 RTN4RL1 "DKFZp547J144, NgR3, NGRH2" ENSG00000185924 "Reticulon 4 receptor like 1" Q86UN2 17 1934677-2025345 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.3" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 17.9;Cone photoreceptor cells: 35.3;Horizontal cells: 31.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 10.8;HaCaT: 10.8;hTCEpi: 10.3;T-47d: 13.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044428 Uncertain Approved "Nucleoplasm,Plasma membrane,Actin filaments,Midbody" "Intracellular and membrane" NA NA "Actin filaments" "Nucleoplasm, Plasma membrane, Midbody" "HPA044428: AB_10963229" "unprognostic (5.23e-1)" "unprognostic (3.52e-2)" "unprognostic (2.06e-1)" "unprognostic (2.12e-1)" "unprognostic (2.93e-2)" "unprognostic (7.25e-2)" "unprognostic (2.61e-3)" "unprognostic (1.17e-1)" "unprognostic (8.97e-3)" "unprognostic (6.21e-2)" "unprognostic (2.55e-3)" "unprognostic (6.32e-3)" "prognostic unfavorable (7.69e-4)" "unprognostic (3.86e-2)" "unprognostic (1.05e-1)" "unprognostic (7.01e-2)" "unprognostic (3.15e-2)" 8.3 5.0 6.8 1.2 8.0 0.6 7.0 4.6 19.3 3.4 1.3 0.6 7.2 0.8 1.9 1.0 1.4 3.6 2.9 2.7 9.6 2.7 2.6 3.2 3.9 0.8 1.3 7.9 1.6 3.8 2.0 6.5 1.3 0.7 6.1 0.8 8.4 9.8 5.3 3.9 11.3 1.2 1.2 1.0 2.7 1.2 1.3 0.1 0.0 1.5 0.8 0.9 1.4 3.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 1.4 1.6 1.8 2.5 2.1 0.3 0.0 0.1 1.1 0.3 0.0 0.0 0.0 0.0 0.1 10.8 0.2 10.8 4.7 0.1 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 10.3 0.0 3.7 0.0 0.0 2.6 0.1 0.0 0.1 0.5 0.0 0.0 0.3 0.0 0.3 0.8 0.3 1.2 0.0 0.0 2.3 0.1 0.3 0.8 1.8 0.3 13.5 0.1 0.0 0.0 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 8.0 4.6 19.3 9.6 2.7 1.3 7.9 0.7 0.1 0.0 2.1 0.0 0.2 2.4 17.9 2.6 0.0 2.7 2.3 3.5 35.3 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.1 1.1 0.0 2.1 1.4 31.8 0.0 6.7 0.0 0.9 0.0 0.0 3.3 0.0 0.0 1.5 0.1 0.0 0.0 0.0 10.0 0.0 0.5 0.0 0.1 2.5 0.0 0.0 0.0 0.2 RTP4 "IFRG28, Z3CXXC4" ENSG00000136514 "Receptor transporter protein 4" Q96DX8 3 187368332-187372076 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 27.5;Urothelial cells: 41.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 8.9;GAMG: 11.9;HDLM-2: 9.8;Karpas-707: 8.1;REH: 7.9;SK-MEL-30: 15.2" "HPA064887, HPA071189" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA064887: AB_2685383, HPA071189: AB_2686357" "unprognostic (1.45e-2)" "unprognostic (2.46e-2)" "unprognostic (1.30e-1)" "unprognostic (1.44e-2)" "unprognostic (6.35e-2)" "unprognostic (3.24e-1)" "unprognostic (2.32e-1)" "unprognostic (3.78e-1)" "unprognostic (1.18e-1)" "unprognostic (6.87e-2)" "prognostic unfavorable (6.83e-4)" "unprognostic (1.34e-1)" "unprognostic (5.49e-2)" "unprognostic (3.44e-2)" "unprognostic (2.95e-2)" "prognostic favorable (4.35e-4)" "prognostic favorable (1.45e-4)" 7.7 4.6 3.2 6.9 3.6 0.7 5.9 1.0 3.1 8.1 13.3 6.0 3.8 9.2 6.7 7.1 6.2 11.3 7.6 2.9 3.1 3.0 8.6 8.8 8.0 12.0 3.8 3.0 6.4 9.7 0.3 3.0 5.9 3.3 10.1 6.1 7.7 10.8 5.6 0.9 2.2 23.2 5.2 5.4 13.5 8.0 1.9 1.5 16.8 10.5 4.3 8.6 10.5 4.7 5.1 6.0 4.7 10.5 12.4 16.2 5.6 2.4 0.0 0.0 0.0 1.2 4.2 0.1 0.0 1.0 1.7 1.5 0.0 8.9 1.1 0.0 1.0 11.9 3.0 0.0 0.1 0.0 9.8 0.0 0.0 0.0 0.1 1.6 0.0 2.2 1.0 0.0 0.3 0.0 0.3 0.3 0.2 0.0 8.1 0.0 0.0 5.7 0.0 0.0 0.0 0.0 7.9 0.0 6.4 2.1 6.4 0.0 0.0 0.0 0.2 15.2 0.1 0.0 3.9 0.1 0.1 0.2 0.0 0.1 6.5 2.1 0.0 0.0 2.2 4.9 4.7 6.9 4.7 10.4 8.5 10.2 5.1 8.3 9.4 6.0 4.8 6.4 7.4 2.1 12.4 10.5 0.1 16.2 5.6 3.2 3.6 1.0 3.1 3.1 3.0 3.8 3.0 3.3 1.5 6.0 5.0 2.7 24.0 1.4 0.0 0.4 12.7 17.4 7.9 5.2 0.0 0.0 13.3 27.5 0.0 7.3 8.0 0.0 8.6 0.1 2.3 9.7 1.1 2.9 5.4 0.0 8.7 9.8 5.9 0.0 2.0 4.0 1.7 3.6 11.3 4.1 12.4 10.5 4.6 2.2 0.0 0.0 1.1 0.0 0.0 1.1 0.2 7.2 7.2 41.4 RTRAF "C14orf166, CGI-99, CLE, CLE7, hCLE1, LCRP369, RLLM1" ENSG00000087302 "RNA transcription, translation and transport factor" Q9Y224 14 51989475-52010691 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 281.4;Distal tubular cells: 261.9;Exocrine glandular cells: 252.9;Extravillous trophoblasts: 296.5;monocytes: 269.7;Proximal tubular cells: 245.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039824 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA039824: AB_10793922" "unprognostic (2.99e-2)" "unprognostic (2.90e-1)" "unprognostic (7.89e-2)" "unprognostic (2.28e-2)" "unprognostic (1.53e-1)" "unprognostic (6.08e-2)" "unprognostic (1.66e-3)" "unprognostic (1.46e-1)" "unprognostic (2.23e-2)" "unprognostic (6.50e-2)" "unprognostic (2.80e-1)" "unprognostic (2.07e-1)" "unprognostic (2.31e-2)" "unprognostic (3.34e-1)" "unprognostic (5.03e-2)" "unprognostic (5.74e-2)" "unprognostic (1.99e-1)" 41.8 46.1 28.7 43.9 38.7 51.9 78.8 21.0 52.1 28.8 40.2 18.8 44.3 26.9 36.3 45.8 38.7 29.7 41.3 110.7 31.2 25.8 34.5 37.8 44.8 80.0 30.8 31.5 45.4 72.2 25.1 33.7 29.9 39.2 32.1 40.6 21.4 39.5 49.6 95.6 36.5 30.6 58.9 39.1 30.6 46.9 94.7 26.3 54.7 38.6 55.1 44.5 38.6 47.6 37.5 40.3 19.2 35.9 32.0 47.9 37.7 44.4 30.2 52.1 50.4 35.0 46.7 49.9 35.6 39.4 39.5 44.7 32.4 39.4 60.9 38.2 29.5 31.1 35.7 48.5 32.5 51.6 32.8 27.2 23.6 63.0 43.0 56.2 50.2 27.3 35.2 33.8 29.7 49.1 46.1 44.5 57.6 24.3 29.2 38.1 49.5 63.5 63.6 40.5 51.9 51.3 58.0 49.6 28.7 37.9 52.0 36.9 37.6 45.0 81.4 55.6 68.8 54.5 39.9 31.0 43.3 47.6 36.3 44.4 11.0 15.4 61.9 21.3 39.7 49.0 14.3 32.0 19.2 26.9 34.8 33.5 37.5 37.7 32.2 40.3 31.3 35.2 35.1 6.7 32.0 35.9 36.9 47.9 37.7 28.7 38.7 21.0 52.1 31.2 25.8 30.8 31.5 39.2 26.3 41.7 56.3 0.0 0.0 0.0 0.0 0.0 0.0 91.0 71.7 69.8 0.0 281.4 261.9 188.5 0.0 0.0 0.0 0.0 252.9 296.5 0.0 0.0 57.0 0.0 212.6 0.0 0.0 0.0 0.0 0.0 0.0 33.4 0.0 269.7 0.0 0.0 209.0 0.0 0.0 245.9 0.0 0.0 0.0 0.0 0.0 0.0 218.8 0.0 0.0 0.0 RUFY2 "FLJ10063, KIAA1537, RABIP4R, ZFYVE13" ENSG00000204130 "RUN and FYVE domain containing 2" Q8WXA3 10 68341107-68407294 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 63.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039792 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA039792: AB_10673363" "unprognostic (1.23e-1)" "unprognostic (3.37e-1)" "unprognostic (1.91e-1)" "unprognostic (2.19e-1)" "unprognostic (2.48e-3)" "unprognostic (2.22e-2)" "unprognostic (4.36e-3)" "unprognostic (1.96e-1)" "unprognostic (2.13e-2)" "unprognostic (2.08e-2)" "unprognostic (1.92e-1)" "unprognostic (1.28e-2)" "unprognostic (2.00e-3)" "unprognostic (3.23e-1)" "unprognostic (3.82e-1)" "unprognostic (7.74e-2)" "unprognostic (3.40e-2)" 8.1 7.0 15.5 5.4 16.3 2.6 10.1 34.3 28.7 9.6 6.6 14.8 6.4 4.9 12.1 7.7 8.1 8.9 7.6 6.5 16.9 16.2 8.3 3.2 7.8 5.2 19.1 11.6 15.0 6.9 11.3 11.9 8.3 16.5 10.0 7.9 5.2 6.2 8.3 6.3 6.9 5.7 10.4 32.8 6.4 7.3 5.8 16.3 5.7 9.7 4.8 5.9 8.6 6.4 2.1 1.0 2.3 1.7 6.5 3.0 0.7 9.9 3.6 5.8 7.4 7.9 12.7 3.6 8.6 10.8 9.5 9.7 5.3 9.0 2.9 6.3 13.5 4.4 6.9 2.6 9.2 9.6 1.4 5.9 1.8 2.8 2.6 8.6 2.3 1.2 10.3 9.9 10.9 11.0 13.5 9.8 2.5 3.8 4.8 9.4 4.0 2.3 3.1 2.6 2.9 10.1 3.1 5.2 1.7 8.6 5.7 7.1 6.9 6.0 7.7 4.9 8.0 11.5 3.0 11.4 11.3 8.4 6.4 11.6 5.1 2.6 1.6 10.3 2.6 4.4 1.5 1.0 2.3 1.7 1.4 1.7 1.7 2.2 2.3 0.6 2.1 2.5 3.0 1.2 6.5 1.7 1.0 0.6 0.7 15.5 16.3 34.3 17.7 16.9 16.2 19.1 11.6 16.5 16.3 29.8 10.8 8.3 14.6 6.0 31.0 10.0 0.0 25.4 27.3 24.4 56.9 7.4 1.7 13.7 6.1 20.2 6.2 0.0 11.2 5.0 13.0 12.8 7.0 5.5 5.7 30.2 9.8 20.3 7.8 4.1 22.5 10.9 11.8 10.8 10.9 21.7 13.4 3.5 16.6 8.1 63.6 12.9 14.2 8.4 26.5 7.0 8.0 8.7 6.9 9.5 RUNX1 "AML1, AMLCR1, CBFA2, PEBP2A2" ENSG00000159216 "Runt related transcription factor 1" Q01196 21 34787801-36004667 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 54.3;lymphoid tissue: 58.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 61.2;HMC-1: 36.9;JURKAT: 56.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA004176, HPA037912" Enhanced Enhanced Nucleoplasm,Vesicles No No Nucleoplasm Vesicles "HPA004176: AB_1078412, HPA037912: AB_2675733" "unprognostic (4.06e-3)" "unprognostic (2.35e-2)" "unprognostic (1.42e-2)" "unprognostic (1.52e-1)" "unprognostic (5.15e-3)" "unprognostic (2.62e-1)" "unprognostic (5.87e-2)" "unprognostic (1.15e-1)" "unprognostic (1.13e-1)" "unprognostic (1.12e-3)" "unprognostic (2.33e-2)" "unprognostic (3.47e-2)" "prognostic unfavorable (3.44e-15)" "unprognostic (1.48e-1)" "unprognostic (1.50e-1)" "unprognostic (6.17e-2)" "unprognostic (5.47e-2)" 11.5 3.2 5.2 14.8 7.3 29.8 54.3 1.0 4.3 12.5 4.7 3.8 4.0 3.8 2.9 7.4 6.5 4.6 12.4 7.6 6.1 2.0 4.2 6.7 17.9 13.9 8.5 1.1 6.5 5.8 1.6 5.5 6.4 6.0 9.9 5.1 3.5 29.8 8.8 14.4 8.3 5.1 6.8 12.3 10.6 12.7 2.9 6.6 58.6 4.6 5.7 14.2 11.0 9.1 3.2 3.4 17.0 3.9 1.3 4.8 2.0 12.2 0.9 0.0 0.0 3.2 4.1 8.1 6.9 7.1 3.9 2.9 0.6 9.4 6.1 0.4 6.1 6.5 11.1 0.7 8.3 5.6 9.3 0.9 61.2 2.4 2.8 5.9 7.0 36.9 8.0 5.0 11.8 11.7 5.4 2.2 56.6 4.1 3.5 8.2 2.6 28.5 11.2 0.5 6.7 3.6 28.9 21.4 3.7 5.2 4.9 0.3 0.0 7.2 1.8 2.5 1.8 3.7 16.6 9.1 6.4 8.3 9.5 10.4 11.8 4.8 5.7 8.0 15.5 9.3 17.0 3.2 6.3 3.4 1.4 3.3 3.2 3.1 3.2 0.9 3.1 4.8 3.8 3.5 1.3 3.9 3.4 4.0 2.0 5.2 7.3 1.0 4.3 6.1 2.0 8.5 1.1 6.0 6.6 50.6 30.7 14.5 44.6 37.0 2.1 2.2 38.2 56.2 39.8 19.2 0.0 0.8 1.7 35.7 16.8 5.8 12.0 0.0 24.4 19.6 25.7 45.4 16.3 4.3 57.2 0.0 5.8 4.9 79.5 21.7 4.4 63.0 27.0 31.5 10.8 0.5 63.1 12.7 4.2 1.2 0.6 0.0 31.5 23.0 24.9 17.7 2.1 37.4 14.4 53.7 RUNX1T1 "AML1T1, CBFA2T1, CDR, ETO, MTG8, ZMYND2" ENSG00000079102 "RUNX1 translocation partner 1" Q06455 8 91954967-92103286 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 57.8" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 122.4;Ito cells: 87.8;Leydig cells: 89.2;Peritubular cells: 93.0;Sertoli cells: 64.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 4 "cerebellum: 57.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 13.2;fHDF/TERT166: 11.2;HEL: 24.1;HSkMC: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049852, HPA070951" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA049852: AB_2680914, HPA070951: AB_2686326" "unprognostic (2.37e-1)" "unprognostic (1.90e-1)" "unprognostic (1.90e-1)" "unprognostic (2.35e-1)" "unprognostic (1.62e-1)" "unprognostic (3.37e-4)" "unprognostic (2.29e-4)" "unprognostic (5.56e-3)" "unprognostic (1.24e-2)" "unprognostic (1.62e-2)" "unprognostic (2.11e-2)" "unprognostic (2.37e-1)" "unprognostic (5.70e-4)" "unprognostic (8.98e-3)" "unprognostic (6.78e-2)" "unprognostic (1.51e-1)" "unprognostic (7.80e-3)" 9.6 4.6 7.7 4.5 11.5 0.4 6.9 57.8 13.0 14.0 7.8 1.1 2.0 2.0 11.8 5.9 4.1 7.7 7.8 12.3 5.8 4.0 2.5 1.3 6.0 2.0 3.6 9.6 7.7 1.8 1.7 8.6 8.7 4.2 4.2 4.0 5.3 4.7 4.1 5.5 3.6 3.6 10.3 3.0 2.9 4.2 5.6 3.7 0.0 5.2 3.3 1.8 5.7 5.9 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.3 3.5 5.1 0.0 5.2 7.9 3.5 5.4 0.0 0.0 13.2 0.0 11.2 0.0 0.0 2.8 0.3 2.3 0.0 2.2 24.1 0.0 0.0 1.4 0.0 0.0 9.7 0.0 5.8 0.3 0.0 7.4 0.0 0.1 0.0 0.9 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 4.2 0.0 0.0 0.0 5.7 0.0 0.0 0.8 0.3 0.0 0.6 0.0 2.6 0.0 4.2 0.5 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 7.7 11.5 57.8 13.0 5.8 4.0 3.6 9.6 4.2 3.7 0.0 0.6 0.0 0.1 5.6 122.4 43.1 0.0 0.0 1.2 0.0 15.7 1.1 1.7 0.0 2.0 49.6 0.0 0.0 0.2 0.2 62.1 0.3 1.1 0.5 1.7 33.4 45.7 87.8 4.9 4.0 89.2 0.8 10.1 0.0 0.0 3.9 0.3 0.0 93.0 0.0 7.1 64.7 41.5 3.0 13.0 4.3 0.9 0.0 0.0 0.0 RUNX2 "AML3, CBFA1, CCD, CCD1, PEBP2A1, PEBP2aA1" ENSG00000124813 "Runt related transcription factor 2" Q13950 6 45328157-45664349 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 67.7;monocytes: 20.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 16.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 18.6;Karpas-707: 29.1;RH-30: 24.3;U-698: 25.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB008374, HPA022040, CAB062561, CAB068226, HPA070715" Enhanced Enhanced Nucleoplasm No No Nucleoplasm "CAB008374: AB_590789, CAB062561: AB_2665599, CAB068226: AB_2665598, HPA022040: AB_1846086, HPA070715: " "unprognostic (1.49e-1)" "unprognostic (8.90e-3)" "unprognostic (3.99e-2)" "unprognostic (2.22e-1)" "unprognostic (1.71e-2)" "unprognostic (1.65e-1)" "unprognostic (1.29e-1)" "unprognostic (1.14e-1)" "unprognostic (3.06e-1)" "unprognostic (1.23e-1)" "unprognostic (3.70e-2)" "unprognostic (3.18e-1)" "prognostic unfavorable (3.97e-9)" "prognostic unfavorable (2.24e-4)" "unprognostic (5.52e-2)" "unprognostic (5.35e-2)" "prognostic unfavorable (6.66e-5)" 3.7 2.1 4.9 13.7 7.0 15.5 5.7 1.0 7.2 13.5 6.0 5.6 7.4 4.1 3.5 2.3 3.4 2.4 6.8 1.8 7.4 3.5 3.9 1.8 5.3 8.6 6.3 3.4 5.0 1.9 1.3 3.8 3.3 7.2 9.5 7.8 5.4 19.8 14.9 2.2 4.9 10.8 3.4 10.5 6.6 6.0 2.1 7.3 6.5 4.2 4.5 11.7 7.3 8.9 0.1 11.4 5.3 0.6 16.0 10.2 0.7 1.6 0.5 0.3 0.0 1.5 4.0 0.0 1.5 3.6 5.1 7.2 0.0 0.9 0.0 1.8 2.1 2.3 2.0 0.0 1.4 9.4 6.1 0.7 0.0 1.1 0.0 8.0 6.3 0.0 10.8 1.1 4.5 5.1 18.6 0.0 2.5 0.0 29.1 9.1 0.4 0.2 11.0 0.3 1.4 0.2 0.0 24.3 0.0 5.0 3.2 0.0 0.0 1.1 0.0 1.8 4.5 1.7 0.5 0.2 5.2 4.2 8.0 5.5 9.2 0.0 25.4 5.9 2.4 2.3 5.3 0.6 3.2 1.2 0.1 10.2 0.1 2.8 3.2 1.8 0.1 0.5 1.5 4.8 16.0 0.1 11.4 2.3 0.7 4.9 7.0 1.0 7.2 7.4 3.5 6.3 3.4 7.2 7.3 0.0 2.4 3.7 14.8 2.5 0.0 1.7 0.0 4.0 4.5 3.5 0.0 0.0 0.0 0.6 67.7 0.3 0.0 0.0 0.2 0.0 2.7 15.7 2.3 0.5 3.8 0.0 0.0 1.8 4.5 13.2 1.1 7.9 6.8 20.8 0.7 0.0 0.4 0.0 2.1 2.2 0.0 6.5 2.5 0.9 0.4 1.4 0.1 17.3 0.0 18.2 RUNX3 "AML2, CBFA3, PEBP2A3" ENSG00000020633 "Runt related transcription factor 3" Q13761 1 24899511-24965121 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 31.5;lymphoid tissue: 47.6" "Cell type enhanced" "Detected in many" 17 "B-cells: 38.9;granulocytes: 46.0;Macrophages: 35.5;Melanocytes: 43.9;monocytes: 68.5;T-cells: 144.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 39.5;Karpas-707: 53.2;SK-MEL-30: 29.5;U-266/70: 18.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004195, CAB025416, HPA059006" Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "CAB025416: , HPA004195: , HPA059006: AB_2683877" "unprognostic (7.75e-3)" "unprognostic (6.51e-3)" "prognostic unfavorable (8.71e-4)" "unprognostic (1.42e-1)" "unprognostic (7.60e-2)" "unprognostic (1.81e-2)" "unprognostic (6.51e-2)" "unprognostic (6.95e-2)" "unprognostic (3.39e-1)" "unprognostic (1.28e-2)" "unprognostic (1.01e-1)" "unprognostic (4.71e-1)" "prognostic unfavorable (5.59e-5)" "unprognostic (1.10e-1)" "unprognostic (4.42e-2)" "unprognostic (3.08e-1)" "unprognostic (1.62e-1)" 3.0 1.1 0.9 25.4 1.1 31.5 3.4 0.5 1.0 11.9 8.0 1.2 0.3 2.5 1.7 1.4 3.5 1.7 6.2 1.3 0.9 1.1 2.2 2.3 11.7 28.8 2.8 0.7 1.3 1.0 0.0 1.0 1.3 1.8 2.3 2.3 2.8 6.5 2.2 2.2 9.5 13.7 1.3 1.8 30.6 2.7 2.1 0.8 14.2 1.8 3.1 47.6 8.9 2.2 4.5 1.0 4.3 4.6 18.1 15.1 3.1 0.1 3.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 6.3 6.2 5.4 0.0 0.1 3.7 0.0 0.2 39.5 0.6 0.1 0.6 0.0 0.0 1.4 13.7 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.0 53.2 0.0 0.0 0.4 12.2 0.2 0.0 1.0 0.0 0.0 7.4 0.0 0.1 1.2 0.0 2.4 0.0 29.5 1.0 0.0 8.5 0.0 0.0 0.6 0.0 0.1 18.4 12.8 6.0 0.0 13.8 1.5 0.4 0.7 4.3 15.1 3.0 8.1 4.5 5.7 13.2 0.9 3.8 2.8 10.3 0.9 18.1 4.6 1.0 5.7 3.1 0.9 1.1 0.5 1.0 0.9 1.1 2.8 0.7 1.8 0.8 0.0 5.1 38.9 0.7 6.8 0.0 2.2 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.2 0.1 1.2 0.7 46.0 0.8 4.9 0.0 0.0 1.8 17.0 0.8 0.0 35.5 43.9 68.5 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 4.7 0.2 2.7 5.1 0.2 144.9 0.0 0.4 RUVBL1 "ECP54, INO80H, NMP238, Pontin52, RVB1, TIH1, TIP49, TIP49a" ENSG00000175792 "RuvB like AAA ATPase 1" Q9Y265 3 128064778-128153914 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Growth regulation, Mitosis, Transcription, Transcription regulation" "Activator, Chromatin regulator, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 208.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019947, HPA019948" Enhanced Supported Nucleoplasm,Cytosol NA NA 47000 "Nucleoplasm, Cytosol" "HPA019947: AB_1856516, HPA019948: AB_1856514" "unprognostic (7.40e-2)" "unprognostic (2.17e-1)" "unprognostic (1.28e-1)" "unprognostic (4.73e-2)" "unprognostic (3.55e-1)" "unprognostic (2.66e-2)" "prognostic unfavorable (1.21e-8)" "unprognostic (2.43e-2)" "unprognostic (3.31e-2)" "unprognostic (1.39e-1)" "unprognostic (2.25e-2)" "unprognostic (7.39e-2)" "unprognostic (2.98e-2)" "unprognostic (1.73e-1)" "unprognostic (1.51e-1)" "unprognostic (1.61e-1)" "unprognostic (9.27e-2)" 17.6 15.1 10.7 15.8 14.2 11.9 13.9 7.9 14.0 12.5 11.6 12.9 14.3 8.4 19.2 11.4 19.2 37.3 11.3 18.6 11.4 13.6 20.9 13.7 12.9 18.7 10.0 9.8 15.4 13.6 26.5 14.2 19.9 13.0 12.0 14.1 11.5 10.2 12.0 12.9 11.8 10.2 16.1 8.8 21.9 10.9 44.7 10.3 33.4 15.2 18.1 23.9 12.6 15.0 10.6 8.7 1.5 7.9 10.9 20.2 7.2 26.9 24.5 15.1 24.5 11.8 11.5 19.7 13.2 11.4 25.5 17.6 25.6 16.1 38.3 13.2 12.6 19.7 21.5 40.1 28.1 29.8 15.6 19.7 31.8 14.2 17.1 12.2 29.7 10.2 11.7 14.8 21.4 27.6 9.7 17.1 14.6 26.0 9.0 14.5 38.4 31.8 22.5 37.9 30.5 21.0 26.2 18.3 26.6 15.3 10.2 25.3 22.7 14.6 12.1 20.2 14.6 22.0 22.0 11.0 11.6 14.2 17.4 20.0 9.2 14.6 37.6 14.3 18.3 14.5 0.8 4.8 1.5 11.3 7.9 14.6 10.6 13.6 14.0 7.7 10.2 11.5 12.8 0.2 10.9 7.4 8.7 20.2 7.2 10.7 14.2 7.9 14.0 11.4 13.6 10.0 9.8 13.0 10.3 20.8 11.7 25.1 16.5 17.7 16.3 18.7 22.9 208.8 31.8 21.0 2.0 45.7 39.7 29.2 14.5 21.2 2.9 0.0 26.3 53.6 20.6 11.7 25.4 13.2 26.2 22.3 16.3 11.1 5.6 19.6 14.1 10.5 10.1 12.6 12.4 26.0 22.8 14.0 17.3 41.5 16.2 12.9 13.3 96.8 64.3 14.8 20.1 24.9 23.0 11.9 RUVBL2 "ECP51, INO80J, Reptin52, RVB2, TIH2, TIP48, TIP49b" ENSG00000183207 "RuvB like AAA ATPase 2" Q9Y230 19 48993448-49015995 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation" "Activator, Chromatin regulator, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 59.0" "Group enriched" "Detected in all" 4 "Ciliated cells: 184.7;Early spermatids: 493.7;Late spermatids: 663.3;Spermatocytes: 292.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012432, HPA042880, HPA067966" Enhanced Supported Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "CAB012432: , HPA042880: AB_2678210, HPA067966: AB_2685933" "unprognostic (1.71e-1)" "unprognostic (9.06e-3)" "unprognostic (3.51e-1)" "unprognostic (3.93e-2)" "unprognostic (1.19e-1)" "unprognostic (2.47e-2)" "prognostic unfavorable (9.28e-4)" "unprognostic (7.06e-3)" "unprognostic (6.25e-2)" "unprognostic (3.28e-1)" "unprognostic (8.13e-2)" "unprognostic (7.58e-2)" "unprognostic (2.81e-2)" "unprognostic (2.21e-2)" "unprognostic (7.61e-3)" "unprognostic (1.61e-1)" "unprognostic (2.58e-1)" 6.9 5.3 6.7 7.5 7.1 13.4 4.8 8.2 10.4 4.8 9.9 7.6 6.3 11.2 8.3 5.5 16.1 5.5 7.2 9.1 6.9 6.0 7.6 10.3 5.5 8.2 7.7 8.1 6.5 8.7 1.6 6.4 5.5 6.7 6.0 3.2 6.5 10.0 6.6 27.8 7.7 10.0 3.7 7.1 6.9 10.7 59.0 5.8 14.6 8.8 9.4 8.1 6.4 12.9 12.6 16.4 5.6 14.3 11.0 12.5 15.2 28.9 29.8 3.5 20.0 1.5 2.7 9.4 15.7 6.8 18.0 11.8 15.4 12.6 27.2 12.1 3.1 5.1 15.4 2.2 10.3 2.1 16.5 12.2 17.7 9.0 7.8 5.0 34.8 12.4 3.1 2.1 4.0 2.1 3.3 6.6 23.0 30.7 11.6 1.6 5.9 30.7 4.1 10.8 6.0 4.4 25.5 16.1 17.5 3.2 11.2 14.3 20.6 15.8 13.2 5.6 1.1 11.6 13.4 9.7 11.4 16.8 7.5 38.7 23.5 26.8 28.1 8.4 17.1 16.3 5.6 14.3 4.2 11.1 11.1 11.2 10.9 11.1 9.1 16.4 12.6 12.2 8.0 1.0 11.0 10.8 12.5 12.5 15.2 6.7 7.1 8.2 10.4 6.9 6.0 7.7 8.1 6.7 5.8 11.9 20.2 23.7 40.9 24.6 15.0 38.6 28.1 184.7 36.4 31.4 31.4 91.2 39.7 59.0 493.7 24.1 23.6 23.3 61.9 63.4 32.5 34.0 12.7 31.1 44.6 17.5 16.8 27.6 18.3 663.3 33.4 26.7 25.3 43.3 33.6 23.6 48.7 31.6 40.3 61.6 24.1 19.4 37.1 292.2 46.3 24.1 96.9 25.3 49.4 33.5 RXRA NR2B1 ENSG00000186350 "Retinoid X receptor alpha" P19793 9 134317098-134440585 "Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 186.8;Kupffer cells: 115.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 14.9;non-classical monocyte: 12.3" "Group enriched" "Detected in many" 8 "granulocytes: 14.9;monocytes: 12.3" "Cell line enhanced" "Detected in many" "BEWO: 24.3;HaCaT: 27.4;RT4: 24.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004565, CAB005352" Supported Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "CAB004565: AB_2184877, CAB005352: AB_2184874" "unprognostic (2.68e-1)" "unprognostic (7.94e-2)" "unprognostic (3.67e-2)" "unprognostic (7.22e-2)" "unprognostic (2.07e-2)" "unprognostic (6.69e-2)" "unprognostic (1.52e-1)" "unprognostic (2.15e-1)" "unprognostic (3.45e-2)" "unprognostic (1.65e-3)" "prognostic favorable (7.02e-4)" "unprognostic (7.72e-2)" "prognostic unfavorable (5.58e-4)" "unprognostic (1.25e-2)" "unprognostic (2.58e-1)" "unprognostic (1.49e-2)" "unprognostic (2.59e-1)" 18.5 10.1 9.9 10.4 6.7 19.6 36.8 4.6 9.8 11.0 9.3 4.9 8.1 14.0 10.1 6.1 24.2 9.3 12.9 14.2 9.0 3.7 11.7 49.3 12.8 10.4 6.0 7.0 11.7 20.6 8.0 10.7 9.6 9.4 9.7 2.0 9.5 9.3 9.7 45.8 19.0 15.2 10.6 9.5 11.5 8.8 5.9 8.1 1.5 13.6 18.3 5.9 16.0 23.7 0.1 1.7 14.9 12.3 1.3 1.1 1.8 5.6 15.8 2.0 5.0 3.6 3.3 24.3 3.0 3.5 4.4 2.5 8.8 8.8 0.0 8.3 4.4 3.8 27.4 0.7 10.7 0.2 8.0 2.0 0.0 19.3 13.3 4.6 6.6 2.4 5.4 4.6 5.5 2.6 0.6 3.7 0.9 10.9 0.5 1.0 15.1 0.5 1.4 3.8 4.1 5.5 2.9 7.5 10.9 0.2 24.4 4.5 2.0 9.6 9.2 2.4 0.1 12.8 9.0 4.8 5.4 6.5 5.7 2.7 0.7 0.0 0.1 4.1 6.7 3.5 1.1 5.2 2.8 1.1 9.3 0.0 0.1 0.7 0.7 1.7 0.0 0.2 0.9 14.9 1.3 12.3 0.1 0.9 1.8 9.9 6.7 4.6 9.8 9.0 3.7 6.0 7.0 9.4 8.1 29.8 22.2 2.2 14.1 30.7 3.8 30.8 79.0 8.1 21.6 8.7 23.6 24.3 1.7 11.9 4.5 17.5 46.7 23.3 12.2 27.0 17.3 15.8 1.1 186.8 29.1 31.8 9.2 72.4 115.8 14.1 30.0 27.5 11.8 5.4 24.8 42.2 14.1 34.5 19.8 16.2 21.2 19.4 17.9 0.7 12.3 40.9 20.0 13.1 23.9 26.0 RXRB "H-2RIIBP, NR2B2, RCoR-1" ENSG00000204231 "Retinoid X receptor beta" P28702 6 33193588-33200688 "Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CACO-2: 6.9;GAMG: 9.4;RH-30: 8.6;RT4: 8.1;T-47d: 8.4;U-698: 8.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002003, HPA063653" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB002003: , HPA063653: AB_2685076" "unprognostic (3.51e-1)" "unprognostic (8.46e-2)" "unprognostic (1.94e-1)" "unprognostic (2.22e-2)" "unprognostic (2.00e-2)" "unprognostic (4.71e-3)" "unprognostic (4.18e-2)" "unprognostic (2.21e-2)" "unprognostic (1.86e-1)" "unprognostic (2.03e-1)" "unprognostic (1.67e-3)" "unprognostic (8.13e-3)" "unprognostic (9.53e-3)" "unprognostic (8.30e-2)" "unprognostic (1.55e-1)" "unprognostic (6.38e-2)" "unprognostic (8.53e-3)" 24.9 18.9 13.0 14.0 16.1 9.8 16.0 24.7 23.2 22.8 17.1 17.7 17.3 19.0 17.4 56.6 13.7 18.5 17.1 27.7 13.5 12.3 14.1 17.4 16.5 9.8 16.4 15.6 19.1 16.2 3.6 17.5 19.2 15.5 20.1 8.4 16.0 16.2 22.0 19.7 25.5 14.1 28.4 10.4 19.8 13.9 10.4 18.2 18.5 22.0 10.9 24.5 14.0 14.5 1.9 1.4 5.2 1.2 1.9 2.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 6.9 0.0 5.2 4.0 0.0 9.4 3.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 5.2 0.0 0.0 0.2 3.1 0.0 0.0 0.0 8.6 0.0 5.2 8.1 0.0 4.6 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 3.7 0.0 0.0 6.7 5.8 8.4 0.0 0.0 0.0 5.2 0.8 2.9 2.5 0.9 1.8 1.9 2.5 2.4 1.3 0.8 2.4 1.5 1.9 1.9 1.2 1.4 2.5 0.7 13.0 16.1 24.7 23.2 13.5 12.3 16.4 15.6 15.5 18.2 38.7 14.1 14.7 14.6 15.3 25.5 16.1 5.1 9.4 15.9 5.2 19.6 19.4 21.6 16.6 2.2 14.7 19.6 0.0 14.1 13.3 14.6 14.4 10.3 14.9 14.0 17.5 21.1 9.8 14.2 3.2 15.0 8.5 15.1 22.6 20.2 15.7 12.5 17.3 15.2 10.7 19.7 25.8 17.6 14.7 13.6 16.4 24.0 17.9 20.7 11.7 RXRG NR2B3 ENSG00000143171 "Retinoid X receptor gamma" P48443 1 165400917-165445355 "Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 14.9;pituitary gland: 29.8;retina: 13.5;skeletal muscle: 44.8" "Cell type enhanced" "Detected in some" 15 "Cone photoreceptor cells: 23.6;Melanocytes: 27.0;Muller glia cells: 9.1;Sertoli cells: 12.9" "Group enriched" "Detected in many" 13 "melanoma: 25.7;thyroid cancer: 34.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "SK-MEL-30: 29.0" "Region enriched" "Detected in many" 5 "basal ganglia: 89.8" "Low region specificity" "Detected in all" "CAB002615, HPA012933" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB002615: , HPA012933: AB_2732406" "unprognostic (2.29e-1)" "unprognostic (1.08e-2)" "unprognostic (1.51e-1)" "unprognostic (1.66e-1)" "unprognostic (4.29e-2)" "unprognostic (6.19e-2)" "unprognostic (1.35e-1)" "unprognostic (1.05e-2)" "unprognostic (9.13e-2)" "unprognostic (6.86e-2)" "unprognostic (2.95e-2)" "unprognostic (5.41e-3)" "unprognostic (2.52e-2)" "unprognostic (6.12e-3)" "unprognostic (1.18e-1)" "prognostic favorable (9.40e-5)" "unprognostic (5.03e-2)" 1.9 3.9 5.4 1.0 14.9 0.6 1.0 0.3 5.9 4.0 2.5 5.3 0.6 1.3 1.8 1.3 1.7 3.6 1.2 5.8 7.5 8.9 0.7 0.8 3.4 0.8 4.1 4.3 1.7 2.7 0.8 29.8 1.3 14.1 1.1 2.7 13.5 1.9 2.1 44.8 2.9 2.0 1.8 8.9 1.0 1.1 1.5 5.4 0.0 1.1 2.5 0.6 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 29.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 14.9 0.3 5.9 7.5 8.9 4.1 4.3 14.1 5.4 0.0 0.0 0.0 0.0 0.6 0.3 2.0 0.0 0.0 0.0 0.0 23.6 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.9 4.6 0.0 27.0 0.0 0.0 9.1 0.1 0.0 2.1 0.0 4.0 12.9 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 RXYLT1 "HP10481, TMEM5" ENSG00000118600 "Ribitol xylosyltransferase 1" Q9Y2B1 12 63779803-63809558 "Disease related genes, Predicted intracellular proteins" Transferase "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 25.4;Distal tubular cells: 31.5;Exocrine glandular cells: 26.6;Extravillous trophoblasts: 28.9;Syncytiotrophoblasts: 31.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064014 Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA064014: AB_2685176" "unprognostic (1.19e-1)" "unprognostic (3.28e-1)" "unprognostic (2.15e-2)" "unprognostic (3.58e-1)" "unprognostic (1.33e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (5.24e-5)" "unprognostic (1.47e-2)" "unprognostic (2.09e-3)" "unprognostic (3.17e-1)" "unprognostic (7.03e-2)" "unprognostic (1.39e-1)" "unprognostic (9.33e-2)" "unprognostic (5.27e-2)" "unprognostic (2.29e-2)" "unprognostic (1.14e-1)" "unprognostic (5.96e-2)" 9.7 19.6 10.3 9.8 11.3 5.7 14.7 8.2 13.6 10.3 9.3 10.6 11.3 7.8 9.2 20.8 9.6 10.9 9.6 21.1 9.8 11.4 15.2 20.1 11.9 14.8 10.7 8.0 17.4 33.4 20.2 19.0 10.5 9.5 12.1 10.1 12.4 17.0 14.5 14.7 11.1 8.2 12.2 13.1 10.6 8.1 16.1 9.0 9.1 17.2 10.7 9.7 11.8 8.1 6.6 7.2 1.8 3.6 4.7 7.0 2.2 7.7 14.3 10.1 8.5 8.8 11.9 11.7 8.7 12.6 13.0 8.6 5.2 7.4 16.6 15.1 9.1 10.5 7.1 12.2 11.1 15.5 17.3 12.4 9.0 4.0 8.2 13.4 13.7 7.9 10.6 11.1 12.6 16.4 12.1 7.2 12.5 10.1 14.2 19.6 12.4 7.4 5.7 6.1 7.1 18.2 7.5 11.7 8.9 12.4 10.2 25.0 4.3 9.1 6.9 17.2 6.6 14.7 6.9 8.3 11.6 12.0 7.2 11.9 9.4 13.5 11.6 7.9 8.3 15.3 1.2 3.1 1.8 4.0 2.9 6.9 6.6 4.4 4.8 3.0 4.2 5.9 4.8 0.6 4.7 3.6 7.2 7.0 2.2 10.3 11.3 8.2 13.6 9.8 11.4 10.7 8.0 9.5 9.0 8.9 5.9 0.0 0.0 0.0 0.0 0.0 0.0 25.4 19.4 15.7 0.0 21.6 31.5 19.6 0.0 0.0 0.0 0.0 26.6 28.9 0.0 0.0 7.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 14.4 0.0 0.0 17.5 0.0 0.0 23.9 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.0 0.0 RYBP "AAP1, DEDAF, YEAF1" ENSG00000163602 "RING1 and YY1 binding protein" Q8N488 3 72371825-72446621 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053357 Approved Supported Nucleoplasm NA No Nucleoplasm "HPA053357: AB_2682124" "unprognostic (6.80e-2)" "unprognostic (2.81e-1)" "unprognostic (6.40e-2)" "unprognostic (1.58e-1)" "unprognostic (7.60e-2)" "unprognostic (1.60e-3)" "unprognostic (1.44e-1)" "unprognostic (1.65e-1)" "unprognostic (1.14e-2)" "unprognostic (2.40e-2)" "unprognostic (3.84e-1)" "unprognostic (4.12e-2)" "prognostic favorable (2.50e-5)" "unprognostic (1.89e-1)" "unprognostic (4.24e-1)" "unprognostic (3.09e-2)" "unprognostic (4.22e-1)" 7.7 6.3 9.5 10.5 12.1 8.2 8.6 6.1 13.3 9.7 7.6 23.1 7.7 5.8 13.3 6.8 7.0 7.1 8.2 5.8 10.9 8.6 7.4 10.2 11.3 6.3 20.4 4.2 10.4 6.3 6.4 11.5 15.8 15.8 10.9 7.6 9.0 5.8 8.0 3.4 6.7 9.4 8.8 12.6 9.0 6.0 9.3 26.1 3.8 6.0 5.2 7.1 7.9 6.8 1.6 4.2 8.5 3.0 1.9 1.8 0.8 5.7 3.5 7.4 6.2 8.4 11.9 5.5 5.8 8.6 7.4 8.7 5.3 6.6 4.6 5.0 6.5 10.7 2.5 7.7 5.9 9.6 33.3 4.0 17.9 4.2 5.4 9.0 4.4 6.0 13.2 12.2 9.6 16.3 12.7 4.3 5.9 5.8 15.2 7.8 7.4 5.5 5.2 18.7 10.3 4.9 5.8 5.6 3.5 7.2 8.3 6.5 17.5 10.6 10.0 10.4 14.2 4.5 6.4 4.6 11.2 9.3 7.5 4.9 15.4 13.6 5.2 4.4 9.7 12.1 3.3 1.4 4.7 1.4 2.8 1.4 1.3 1.6 1.2 1.5 1.6 1.8 1.3 8.5 1.9 3.0 4.2 1.8 0.8 9.5 12.1 6.1 13.3 10.9 8.6 20.4 4.2 15.8 26.1 53.6 25.9 40.2 53.6 95.2 67.6 35.5 35.7 32.1 30.7 40.1 15.7 21.9 28.2 17.6 17.9 54.0 40.7 23.3 20.9 26.6 75.6 56.6 67.0 28.7 14.8 36.5 77.9 52.8 44.8 10.5 23.9 39.3 33.7 13.6 41.9 21.1 24.4 32.3 41.1 15.0 40.9 32.3 33.0 37.0 33.1 84.8 156.3 27.7 25.8 52.2 RYR2 "ARVC2, ARVD2, VTSIP" ENSG00000198626 "Ryanodine receptor 2" Q92736 1 237042205-237833988 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor" "Cardiomyopathy, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "heart muscle: 106.6" "Cell type enriched" "Detected in many" 30 "Cardiomyocytes: 1960.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 7.8;HEK 293: 10.7;K-562: 3.3;NB-4: 2.7;NTERA-2: 4.0;U-937: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020028 Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA020028: AB_1856528" "unprognostic (5.23e-3)" "unprognostic (2.15e-2)" "unprognostic (5.02e-4)" "unprognostic (6.26e-2)" "unprognostic (8.74e-2)" "unprognostic (2.99e-3)" "unprognostic (5.28e-2)" "unprognostic (1.45e-3)" "unprognostic (2.69e-2)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (4.04e-2)" "unprognostic (0.00e+0)" "unprognostic (2.36e-2)" "unprognostic (1.42e-1)" "unprognostic (3.13e-2)" "unprognostic (1.06e-2)" 1.1 0.9 6.2 0.9 18.7 0.5 1.1 14.8 10.5 1.3 1.2 0.0 1.2 0.7 1.1 0.7 1.8 1.0 1.8 106.6 5.7 1.1 0.9 0.9 1.4 0.6 1.0 7.3 2.2 4.2 0.5 2.0 1.1 1.6 2.0 0.8 0.2 0.9 1.4 0.9 1.0 1.0 4.6 1.0 1.0 1.2 1.1 3.0 0.0 2.7 0.0 0.6 1.2 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.3 0.0 0.0 0.3 0.6 0.0 0.0 7.8 10.7 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.0 0.0 2.7 4.0 0.1 0.4 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 4.9 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.2 18.7 14.8 10.5 5.7 1.1 1.0 7.3 1.6 3.0 0.0 0.3 0.0 0.0 0.3 65.2 1960.0 0.0 1.4 2.3 1.8 9.8 0.0 0.0 0.0 15.8 1.5 0.0 0.0 2.5 0.0 2.1 0.0 0.0 0.0 0.1 1.6 3.4 1.3 0.0 10.2 1.1 0.0 8.5 0.0 0.0 1.5 0.3 0.0 0.0 0.0 4.7 0.0 18.6 3.2 0.9 0.0 0.0 0.0 0.0 0.0 S100A1 "S100-alpha, S100A" ENSG00000160678 "S100 calcium binding protein A1" P23297 1 153627926-153632039 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 465.5;skeletal muscle: 423.5" "Cell type enhanced" "Detected in many" 22 "Collecting duct cells: 146.5;Distal tubular cells: 137.6;Hofbauer cells: 149.3;Melanocytes: 323.9;Proximal tubular cells: 712.0" "Group enriched" "Detected in all" 5 "melanoma: 210.5;ovarian cancer: 110.1;thyroid cancer: 123.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Hep G2: 43.7;SK-MEL-30: 149.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002599, HPA006462" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 240000 Cytosol "Nucleoplasm, Golgi apparatus" "CAB002599: AB_2315307, HPA006462: AB_1079857" "unprognostic (6.13e-2)" "unprognostic (7.60e-2)" "unprognostic (5.96e-5)" "prognostic unfavorable (1.12e-4)" "unprognostic (1.19e-1)" "unprognostic (3.24e-2)" "unprognostic (2.36e-1)" "unprognostic (2.34e-3)" "unprognostic (6.83e-3)" "unprognostic (5.22e-1)" "unprognostic (5.04e-3)" "unprognostic (9.62e-2)" "prognostic unfavorable (3.08e-4)" "unprognostic (1.68e-1)" "unprognostic (4.56e-2)" "unprognostic (2.70e-3)" "unprognostic (9.74e-4)" 27.7 3.2 70.0 2.8 67.3 2.2 14.3 4.1 42.5 2.0 2.4 47.3 0.0 3.5 2.6 8.5 14.1 8.8 2.6 465.5 44.9 42.9 20.0 2.6 2.4 2.5 85.0 30.7 2.2 4.5 2.0 4.3 4.5 31.4 6.3 2.1 4.3 99.3 3.7 423.5 4.0 2.9 2.1 87.7 2.4 3.3 2.8 31.8 0.0 29.0 57.6 4.7 2.9 0.1 0.6 0.6 2.1 1.0 0.3 0.5 0.5 0.7 0.3 0.5 4.6 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.9 0.4 0.5 19.6 0.0 0.2 1.1 0.0 0.0 0.0 0.5 0.4 1.0 0.6 43.7 0.0 0.3 0.3 0.1 0.0 0.0 0.0 1.0 0.0 0.1 3.5 0.5 0.0 1.2 0.1 0.5 0.2 0.5 0.4 3.1 0.4 1.1 0.8 1.7 0.7 0.2 0.3 1.4 149.9 1.4 4.5 2.3 0.4 0.4 0.3 0.3 0.4 0.7 0.7 0.7 0.3 0.8 0.2 2.1 0.3 0.0 0.1 0.3 0.1 0.0 0.2 0.5 0.0 0.6 0.3 0.0 0.0 0.3 1.0 0.6 0.0 0.5 70.0 67.3 4.1 42.5 44.9 42.9 85.0 30.7 31.4 31.8 0.0 0.0 0.0 1.1 8.7 0.6 57.3 5.1 0.0 0.0 146.5 2.0 0.9 137.6 0.7 0.5 2.1 0.9 0.0 3.4 0.8 2.3 1.2 0.0 3.2 149.3 0.0 1.7 13.5 0.6 1.5 6.1 1.3 323.9 0.0 2.2 60.1 1.1 0.0 8.5 712.0 2.2 0.0 2.1 0.9 0.7 1.9 2.9 0.0 1.5 0.6 S100A13 ENSG00000189171 "S100 calcium binding protein A13" Q99584 1 153618787-153631360 "Predicted intracellular proteins, Predicted secreted proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Leydig cells: 714.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 19.4" "Group enriched" "Detected in many" 5 "dendritic cells: 8.4;NK-cells: 19.4" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 94.7;SuSa: 111.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019592, CAB025494" Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" "Secreted in other tissues" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Nucleoli" "CAB025494: , HPA019592: AB_10601499" "unprognostic (1.50e-2)" "unprognostic (9.09e-2)" "unprognostic (2.08e-2)" "unprognostic (1.45e-1)" "unprognostic (7.77e-2)" "unprognostic (9.72e-3)" "unprognostic (1.75e-3)" "unprognostic (9.93e-2)" "unprognostic (6.48e-2)" "unprognostic (1.67e-1)" "unprognostic (1.21e-2)" "unprognostic (4.83e-3)" "prognostic unfavorable (1.97e-4)" "unprognostic (3.43e-2)" "unprognostic (8.10e-2)" "unprognostic (1.82e-3)" "unprognostic (1.72e-2)" 38.2 20.9 49.6 13.8 48.3 1.2 61.8 11.5 28.2 39.1 32.3 25.0 13.9 9.4 23.5 25.0 19.9 34.5 32.0 56.3 30.3 32.0 28.0 20.2 23.3 12.7 54.2 32.7 29.9 13.9 45.9 9.7 21.6 37.7 23.0 19.3 21.1 19.8 21.7 73.8 14.1 13.7 27.2 38.9 13.7 11.9 10.3 28.5 2.4 79.0 28.2 14.6 21.1 16.0 2.6 8.4 3.0 1.5 19.4 0.9 0.8 21.1 17.7 20.5 13.0 18.1 53.1 7.4 29.4 46.6 17.8 20.5 17.2 23.6 0.5 55.9 49.8 2.6 20.2 8.5 18.2 15.8 0.0 7.9 1.3 22.2 14.6 12.0 0.6 4.6 42.7 6.9 15.9 17.2 52.5 40.2 0.1 6.8 0.0 55.3 74.9 0.0 0.3 16.5 18.2 53.5 3.3 21.2 0.1 94.7 16.2 6.3 0.2 62.8 32.4 63.5 111.1 26.4 0.7 56.9 12.3 6.9 16.4 35.3 0.2 0.5 0.9 22.0 0.3 7.2 3.0 1.5 0.1 0.3 0.7 0.6 2.6 0.3 0.2 5.0 1.6 0.5 0.3 0.2 19.4 0.9 8.4 0.9 0.8 49.6 48.3 11.5 28.2 30.3 32.0 54.2 32.7 37.7 28.5 26.8 88.4 17.1 154.8 98.1 2.0 108.1 175.8 60.2 93.3 441.4 0.0 118.0 210.5 277.9 6.5 300.3 126.3 46.7 281.2 170.7 294.9 188.4 23.1 34.1 128.8 0.0 119.8 371.4 32.4 21.5 714.6 43.9 226.0 20.8 107.7 97.5 336.0 115.8 295.2 330.9 5.7 0.0 84.3 7.5 18.3 66.1 62.5 8.6 64.8 157.7 S100A2 "CAN19, S100L" ENSG00000196754 "S100 calcium binding protein A2" P29034 1 153561108-153567890 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 224.8;tongue: 246.5" "Cell type enhanced" "Detected in many" 20 "Basal glandular cells: 2667.8;Basal keratinocytes: 10183.7;Suprabasal keratinocytes: 3170.0;Urothelial cells: 4604.3" "Cancer enhanced" "Detected in all" "head and neck cancer: 1229.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 11.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 11.9" "Group enriched" "Detected in some" 5 "HBEC3-KT: 671.5;RT4: 262.5" "Not detected" "Not detected" "CAB002600, CAB047340, HPA062451" Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" NA NA 130000 "Nucleoplasm, Cytosol" "Nucleoli, Plasma membrane" "CAB002600: , CAB047340: , HPA062451: AB_2684767" "unprognostic (8.47e-3)" "unprognostic (5.54e-2)" "unprognostic (1.57e-2)" "unprognostic (1.42e-3)" "unprognostic (1.98e-1)" "unprognostic (3.20e-1)" "unprognostic (4.21e-4)" "unprognostic (9.00e-2)" "unprognostic (1.64e-1)" "unprognostic (1.23e-2)" "prognostic unfavorable (2.04e-4)" "unprognostic (3.52e-2)" "unprognostic (8.91e-2)" "unprognostic (1.35e-1)" "unprognostic (2.70e-1)" "unprognostic (1.39e-1)" "unprognostic (2.68e-1)" 0.4 0.0 0.4 0.5 0.4 0.0 2.1 0.4 0.5 16.9 0.4 0.4 0.9 0.0 1.8 1.9 224.8 0.5 0.4 0.4 0.4 0.0 16.6 0.4 1.6 0.4 0.4 0.4 0.4 0.4 0.0 0.5 0.6 0.6 3.3 0.0 0.4 23.3 2.1 0.7 27.5 0.4 1.5 0.5 0.4 0.0 0.5 0.4 0.7 1.0 246.5 48.4 36.2 43.8 0.5 2.6 11.9 0.6 0.0 2.9 0.7 25.4 0.2 0.0 0.0 0.3 0.1 0.0 0.3 0.3 0.2 0.2 0.0 0.8 0.0 13.5 0.5 0.5 63.2 0.0 671.5 0.3 0.1 0.1 0.1 1.7 0.1 0.1 0.0 0.0 0.2 89.4 0.7 102.0 0.7 0.4 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.6 4.9 0.0 16.0 0.0 15.9 262.5 0.5 0.0 1.1 0.1 0.2 0.2 0.1 0.1 0.1 0.4 22.2 2.9 8.6 0.0 0.0 0.1 0.8 0.0 0.7 11.9 0.5 0.0 2.9 0.0 1.8 0.5 2.0 1.6 0.4 0.0 0.6 0.5 5.0 0.0 0.6 2.6 1.8 0.7 0.4 0.4 0.4 0.5 0.4 0.0 0.4 0.4 0.6 0.4 8.9 15.9 2.2 2667.8 10183.7 0.0 2.0 2.5 307.9 1714.1 207.6 0.0 0.1 1039.5 26.2 3.0 3.6 1.3 0.0 24.2 0.9 117.2 609.3 16.2 0.0 1.8 0.0 1.7 0.6 1.5 3.8 0.6 38.5 720.4 9.0 1.7 1.0 390.7 2.9 0.7 9.8 0.0 0.0 213.2 0.2 2.3 3170.0 0.2 1.3 1.5 4604.3 S100A5 S100D ENSG00000196420 "S100 calcium binding protein A5" P33763 1 153537147-153541765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 7.6;thyroid gland: 9.1" "Group enriched" "Detected in some" 5 "Collecting duct cells: 3.5;Distal tubular cells: 3.3;Extravillous trophoblasts: 7.2" "Group enriched" "Detected in many" 5 "ovarian cancer: 3.7;thyroid cancer: 11.7;urothelial cancer: 2.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "OE19: 24.3;PC-3: 7.1;RPTEC TERT1: 8.6;RT4: 14.2;SCLC-21H: 12.7" "Region enriched" "Detected in single" 85 "olfactory region: 1210.8" "Region enriched" "Detected in single" 30 "olfactory region: 16.8" HPA064184 Approved Nucleoplasm Yes NA Nucleoplasm "HPA064184: AB_2685206" "unprognostic (6.09e-2)" "unprognostic (2.92e-2)" "unprognostic (8.92e-2)" "unprognostic (1.63e-5)" "unprognostic (2.43e-3)" "unprognostic (2.45e-2)" "unprognostic (1.52e-3)" "unprognostic (4.11e-2)" "unprognostic (2.69e-1)" "unprognostic (7.39e-3)" "unprognostic (3.08e-2)" "unprognostic (2.20e-2)" "unprognostic (1.07e-2)" "unprognostic (9.53e-2)" "unprognostic (5.70e-2)" "unprognostic (4.68e-3)" 0.5 0.1 0.8 2.4 0.2 0.9 0.4 0.2 0.9 0.6 0.3 0.2 0.2 2.3 1.0 0.2 1.3 0.7 1.6 0.2 0.4 0.1 2.3 0.2 3.0 4.6 0.2 0.2 0.2 0.2 0.0 0.4 1.1 0.2 1.5 0.0 0.2 3.8 0.2 0.2 6.0 0.5 0.2 0.2 1.1 1.9 0.2 0.2 1.6 9.1 0.2 2.6 1.8 0.6 0.9 4.6 2.3 1.2 0.0 7.6 1.2 1.5 4.1 0.0 0.0 0.4 0.3 0.3 0.7 0.9 0.5 1.0 0.4 3.0 0.0 2.7 1.5 0.3 1.2 0.1 0.7 0.6 0.3 0.0 1.9 1.5 0.1 0.3 0.0 2.5 0.0 0.8 2.0 0.6 0.3 0.4 0.0 0.5 0.1 2.2 0.1 0.3 0.9 0.1 24.3 7.1 0.0 1.3 0.7 8.6 14.2 12.7 0.0 0.1 6.5 0.6 1.2 0.0 0.4 0.3 0.1 0.9 1.9 1.2 0.0 0.6 0.0 0.4 0.5 0.2 0.0 1.2 2.3 2.0 0.2 7.6 0.9 4.2 2.2 2.8 0.5 2.4 1.1 1.9 0.0 0.6 4.6 6.1 1.2 0.8 0.2 0.2 0.9 0.4 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.2 7.2 0.7 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.8 0.0 0.3 0.3 0.0 1.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.2 0.0 0.0 0.4 S100A9 "60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14" ENSG00000163220 "S100 calcium binding protein A9" P06702 1 153357854-153361027 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity" "Antimicrobial, Antioxidant" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 638.3;bone marrow: 820.1;esophagus: 642.6;tongue: 477.6" "Cell type enriched" "Detected in many" 7 "Kupffer cells: 11072.0" "Cancer enhanced" "Detected in all" "cervical cancer: 5468.0;head and neck cancer: 6692.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "classical monocyte: 381.5;neutrophil: 638.3" "Group enriched" "Detected in many" 6 "granulocytes: 638.3;monocytes: 381.5" "Cell line enriched" "Detected in some" 6 "SK-BR-3: 233.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA004193, CAB009441" Enhanced Supported "Nucleoplasm,Cell Junctions,Cytosol" "Secreted to blood" NA NA 10600000 1400000000 "Nucleoplasm, Cell Junctions, Cytosol" "CAB009441: AB_2184420, HPA004193: AB_1856537" "unprognostic (1.72e-1)" "unprognostic (3.33e-2)" "unprognostic (2.40e-1)" "unprognostic (3.94e-3)" "unprognostic (1.36e-2)" "unprognostic (5.45e-3)" "prognostic unfavorable (1.13e-6)" "unprognostic (1.10e-2)" "unprognostic (4.31e-1)" "unprognostic (3.06e-1)" "unprognostic (1.35e-2)" "unprognostic (5.59e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (1.48e-1)" "unprognostic (7.52e-2)" "unprognostic (5.39e-2)" "unprognostic (1.75e-2)" 19.5 2.1 1.3 41.9 4.2 820.1 4.1 0.9 2.1 143.6 4.4 0.7 0.4 0.7 4.9 4.0 642.6 9.9 4.4 51.2 2.5 0.4 2.8 4.8 29.2 169.0 5.3 0.6 3.4 4.4 0.1 0.9 10.4 5.2 2.2 0.7 2.0 109.6 0.5 3.4 7.5 1.4 13.1 2.1 103.2 3.5 2.9 1.4 3.8 6.7 477.6 228.0 24.3 237.0 0.5 87.5 638.3 381.5 0.3 1.0 323.2 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.8 36.6 0.0 0.0 2.2 0.0 15.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 12.7 0.0 0.8 0.0 0.0 0.0 0.7 0.3 0.0 2.9 0.0 0.3 0.0 0.2 0.0 0.0 0.5 7.7 0.0 9.5 0.1 0.0 0.3 233.1 0.1 0.1 3.6 29.6 0.6 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 6.7 0.0 5.3 381.5 46.4 0.5 31.6 1.0 0.4 0.4 0.3 87.5 0.5 0.3 0.3 638.3 0.3 15.0 2.9 0.5 323.2 1.3 4.2 0.9 2.1 2.5 0.4 5.3 0.6 5.2 1.4 214.4 574.2 57.1 52.5 17.7 0.0 2.5 66.2 112.4 185.4 34.9 0.0 111.0 5.0 49.4 1.3 7.0 0.5 23.3 32.9 44.2 7.1 19.6 151.1 16.4 1627.6 0.0 0.0 71.2 11072.0 2.2 5.5 1162.8 0.0 4.6 2.1 0.0 10.3 0.8 0.0 16.3 0.2 0.0 2.5 0.3 1.3 29.1 1033.7 24.9 1.9 291.7 S100B S100beta ENSG00000160307 "S100 calcium binding protein B" P04271 21 46598962-46605208 "Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 342.0" "Cell type enhanced" "Detected in some" 16 "Kupffer cells: 25.7;Macrophages: 53.7;Melanocytes: 94.5;monocytes: 55.9" "Group enriched" "Detected in all" 58 "glioma: 463.5;melanoma: 495.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 78.0" "Lineage enriched" "Detected in many" 7 "T-cells: 78.0" "Group enriched" "Detected in some" 7 "SK-MEL-30: 82.9;WM-115: 163.0" "Low region specificity" "Detected in all" "CAB000073, HPA015768, CAB078196" Enhanced Supported Supported Nucleoplasm,Vesicles,Cytosol NA NA 120000 "Nucleoplasm, Cytosol" Vesicles "CAB000073: AB_10013383, CAB078196: AB_2665776, HPA015768: AB_1856538" "unprognostic (5.67e-3)" "unprognostic (6.39e-3)" "unprognostic (2.08e-3)" "unprognostic (2.08e-2)" "unprognostic (4.54e-3)" "unprognostic (1.10e-2)" "unprognostic (1.01e-1)" "unprognostic (6.68e-3)" "unprognostic (2.03e-1)" "unprognostic (1.37e-1)" "unprognostic (8.57e-3)" "unprognostic (6.70e-2)" "unprognostic (4.41e-7)" "unprognostic (3.55e-2)" "unprognostic (7.56e-2)" "unprognostic (1.07e-1)" "unprognostic (1.74e-1)" 67.7 14.0 60.9 5.6 51.0 2.0 13.2 39.4 151.2 5.2 9.1 101.0 3.0 4.7 1.5 7.6 8.6 2.1 8.3 6.6 74.6 65.4 1.5 1.6 2.9 9.8 152.0 36.5 2.4 3.0 1.1 3.1 1.4 90.3 3.0 8.3 7.4 10.1 15.3 1.3 5.7 7.5 4.3 342.0 5.7 4.3 1.5 46.4 0.0 1.3 1.8 10.8 8.2 1.6 0.1 3.4 0.7 1.9 11.0 78.0 10.6 0.1 0.0 18.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 82.9 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.2 1.0 163.0 0.0 0.1 0.0 78.0 1.8 22.4 0.0 0.2 14.5 3.4 0.1 0.6 33.3 0.7 11.0 1.9 0.8 0.0 10.6 60.9 51.0 39.4 37.6 74.6 65.4 152.0 36.5 90.3 46.4 3.0 7.4 0.9 0.2 14.9 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.2 7.6 0.0 0.0 4.9 25.7 0.4 5.2 53.7 94.5 55.9 0.0 9.7 0.1 0.0 0.0 0.0 4.0 0.0 2.1 0.0 0.1 11.0 0.1 0.5 0.0 0.1 S100P ENSG00000163993 "S100 calcium binding protein P" P25815 4 6693069-6697170 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 89.9;bone marrow: 42.8;stomach 1: 70.0;urinary bladder: 47.6" "Group enriched" "Detected in many" 5 "Syncytiotrophoblasts: 2319.4;Urothelial cells: 3591.7" "Cancer enhanced" "Detected in many" "urothelial cancer: 564.7" "Group enriched" "Detected in some" 41 "basophil: 47.8;eosinophil: 24.8;neutrophil: 89.9" "Lineage enriched" "Detected in many" 68 "granulocytes: 89.9" "Cell line enhanced" "Detected in some" "BEWO: 28.5;Hep G2: 30.0;hTCEpi: 33.4;OE19: 130.4;RT4: 61.3;SK-BR-3: 34.3" "HPA019502, HPA075251" Enhanced Supported Nucleoplasm NA NA 1200000 Nucleoplasm "HPA019502: AB_1856530, HPA075251: " "unprognostic (1.46e-1)" "unprognostic (1.50e-1)" "unprognostic (7.52e-2)" "unprognostic (1.44e-1)" "unprognostic (2.22e-1)" "unprognostic (7.34e-2)" "unprognostic (1.60e-3)" "unprognostic (3.92e-2)" "unprognostic (7.19e-2)" "unprognostic (9.24e-2)" "prognostic unfavorable (2.00e-4)" "unprognostic (3.87e-2)" "unprognostic (1.96e-2)" "unprognostic (1.72e-1)" "unprognostic (9.24e-2)" "unprognostic (3.65e-1)" "unprognostic (1.12e-2)" 0.1 0.0 0.0 1.1 0.0 42.8 0.0 0.0 0.0 0.3 5.2 0.1 0.0 0.0 23.3 0.3 1.0 0.0 0.0 0.0 0.0 1.9 2.4 0.0 0.0 0.0 0.0 0.0 0.0 16.4 4.8 5.4 1.1 0.0 0.0 3.9 0.5 0.1 0.0 4.4 70.0 0.0 0.0 2.5 47.6 5.1 0.0 0.0 89.9 1.3 0.0 0.0 0.4 3.8 2.4 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.0 0.0 0.1 0.5 0.0 1.4 0.0 0.0 4.7 0.0 0.0 0.0 1.8 0.0 0.0 2.7 30.0 0.0 1.7 0.1 0.0 33.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.4 0.0 3.5 0.0 130.4 4.3 0.0 0.0 0.0 0.0 61.3 0.0 0.0 5.6 34.3 0.0 1.2 0.9 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 47.8 1.3 24.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 89.9 0.0 0.1 0.0 0.0 0.4 8.9 66.8 2.9 152.0 1.0 0.0 0.8 43.3 224.9 151.2 1.8 0.0 512.0 0.0 0.2 11.8 0.5 133.5 0.0 27.6 604.2 12.6 292.8 30.1 1.1 61.5 0.0 16.0 1.8 14.1 5.6 0.0 3.6 8.5 2.8 160.2 0.0 481.5 254.0 0.0 0.1 0.0 0.0 2.1 0.0 0.2 5.5 2319.4 2.2 48.0 3591.7 SAAL1 FLJ41463 ENSG00000166788 "Serum amyloid A like 1" Q96ER3 11 18069935-18106091 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039003, HPA039004" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA039003: AB_2676303, HPA039004: AB_10673602" "unprognostic (1.13e-1)" "unprognostic (3.00e-1)" "unprognostic (4.35e-1)" "unprognostic (2.37e-2)" "unprognostic (1.88e-1)" "unprognostic (5.76e-2)" "unprognostic (4.10e-3)" "unprognostic (1.53e-2)" "unprognostic (4.75e-2)" "unprognostic (7.26e-2)" "unprognostic (3.36e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (5.78e-5)" "unprognostic (2.86e-1)" "unprognostic (1.39e-1)" "unprognostic (3.72e-1)" "unprognostic (1.87e-1)" 10.1 10.1 12.5 23.6 11.4 22.5 14.0 17.3 12.5 10.7 13.0 12.9 9.2 11.0 13.2 11.6 11.8 9.9 10.2 10.2 10.0 8.8 10.1 11.3 7.6 18.2 11.7 8.2 12.7 14.4 5.8 16.8 9.6 10.3 9.6 16.9 10.8 10.1 8.7 9.5 9.7 11.2 13.5 9.4 15.1 11.5 17.8 12.9 22.1 8.7 11.5 20.5 11.6 10.5 14.5 17.8 7.4 12.0 8.1 16.2 8.5 10.9 17.2 12.5 17.0 8.5 9.5 10.4 12.4 8.5 19.1 22.7 23.9 4.2 29.9 6.6 6.9 26.6 14.5 23.8 20.1 26.9 13.2 24.8 13.7 10.7 15.1 6.9 23.0 12.2 6.6 9.5 12.2 18.4 7.2 16.1 26.2 20.2 10.1 15.6 15.1 26.6 22.0 16.2 17.1 17.2 26.7 22.0 10.4 10.8 13.1 15.5 14.7 11.2 12.0 14.7 16.6 7.6 10.6 6.5 21.9 15.2 12.4 17.7 4.9 14.9 33.1 9.1 18.5 19.9 7.4 10.5 3.3 11.8 12.0 11.6 14.5 14.0 10.8 17.8 10.2 11.5 11.9 0.5 8.1 11.5 9.0 16.2 8.5 12.5 11.4 17.3 12.5 10.0 8.8 11.7 8.2 10.3 12.9 0.0 9.6 16.1 7.5 4.0 8.6 7.3 2.5 5.3 2.3 1.8 2.0 18.5 5.0 8.2 11.0 7.2 5.5 23.3 8.9 17.5 6.1 3.8 13.9 4.0 14.0 0.0 26.9 6.7 9.1 1.9 7.5 7.9 5.0 10.8 10.7 5.6 6.7 3.5 7.4 5.7 7.2 6.5 11.3 35.1 28.9 4.6 8.7 12.9 14.6 4.7 SACM1L "KIAA0851, SAC1" ENSG00000211456 "SAC1 like phosphatidylinositide phosphatase" Q9NTJ5 3 45689056-45745424 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039573, HPA069869" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA 8400000 "Nucleoplasm, Golgi apparatus" "HPA039573: AB_10674983, HPA069869: AB_2686216" "unprognostic (2.07e-1)" "unprognostic (4.08e-1)" "unprognostic (1.36e-3)" "unprognostic (1.14e-1)" "unprognostic (2.31e-2)" "unprognostic (4.34e-2)" "unprognostic (2.82e-1)" "unprognostic (1.03e-2)" "unprognostic (8.54e-2)" "unprognostic (1.94e-2)" "unprognostic (1.22e-2)" "unprognostic (6.29e-3)" "prognostic favorable (5.47e-7)" "unprognostic (3.50e-1)" "unprognostic (1.62e-1)" "unprognostic (2.50e-1)" "unprognostic (1.33e-2)" 18.4 24.9 22.0 18.9 23.3 14.9 18.2 23.3 26.3 19.0 19.4 16.4 21.2 18.9 22.6 19.3 17.0 18.1 16.6 15.6 21.8 22.8 31.9 22.7 23.2 19.9 20.5 24.9 15.7 18.3 25.1 31.9 21.2 28.7 21.1 20.1 17.7 20.0 18.2 12.7 14.7 20.4 17.0 22.2 20.9 20.5 11.0 19.6 26.8 35.8 8.5 19.7 20.9 20.9 5.8 13.7 13.4 8.7 30.1 14.9 13.4 11.0 8.3 15.5 8.6 26.4 18.1 11.9 17.0 18.1 16.0 13.8 11.0 9.0 18.1 9.8 16.3 20.3 8.7 19.1 11.5 20.6 11.4 11.6 18.6 13.6 10.6 14.2 27.9 22.8 11.9 18.2 16.2 12.5 13.1 10.9 17.6 20.4 18.7 26.2 5.4 23.7 15.3 16.6 12.2 17.0 6.2 8.1 17.0 17.5 16.2 6.1 14.7 11.7 15.5 17.9 16.4 11.6 27.0 12.3 14.6 8.1 14.7 17.5 10.7 26.1 12.9 17.0 43.1 14.5 4.3 8.7 13.4 13.6 7.0 14.9 5.8 9.8 13.6 13.7 5.3 10.1 13.1 7.1 30.1 6.0 5.7 8.2 13.4 22.0 23.3 23.3 26.3 21.8 22.8 20.5 24.9 28.7 19.6 26.8 31.2 19.3 7.8 17.4 22.6 14.0 17.8 10.7 13.6 7.0 29.5 17.8 16.6 9.1 1.3 13.5 15.8 0.0 8.7 9.5 15.3 14.3 16.2 13.1 21.0 31.8 11.5 14.7 19.1 2.4 15.5 17.3 16.9 18.0 8.8 14.1 10.7 17.3 21.5 16.5 21.4 6.5 12.0 10.1 10.9 15.2 15.3 41.7 10.3 8.9 SAE1 "AOS1, FLJ3091, Sua1" ENSG00000142230 "SUMO1 activating enzyme subunit 1" Q9UBE0 19 47113274-47210636 "Predicted intracellular proteins" "Ubl conjugation pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041906, HPA043552" Supported Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041906: AB_2677735, HPA043552: AB_2678548" "unprognostic (9.69e-3)" "unprognostic (1.96e-2)" "unprognostic (1.08e-1)" "unprognostic (1.68e-1)" "unprognostic (1.37e-1)" "unprognostic (2.49e-1)" "prognostic unfavorable (5.49e-8)" "unprognostic (9.86e-2)" "unprognostic (1.62e-2)" "unprognostic (1.58e-1)" "unprognostic (1.93e-3)" "unprognostic (1.58e-1)" "prognostic unfavorable (8.15e-5)" "unprognostic (1.80e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (2.76e-4)" "unprognostic (1.27e-1)" 20.1 17.8 26.7 22.8 30.5 24.0 18.6 21.9 45.9 23.6 50.1 17.6 21.6 14.0 30.2 13.1 27.5 21.3 17.1 22.5 21.2 23.9 14.6 16.0 19.2 30.6 20.4 34.6 19.0 14.4 28.0 13.9 26.8 24.3 20.2 27.3 20.9 15.7 28.6 24.1 19.0 20.1 38.5 15.9 25.8 30.5 60.2 16.2 32.7 37.5 17.2 37.5 33.0 25.8 19.1 22.3 22.8 19.0 35.2 41.3 29.4 36.2 39.8 62.5 29.8 21.5 25.3 21.2 44.9 39.2 50.7 62.0 34.2 24.2 43.7 17.7 36.0 26.9 17.3 64.0 28.3 55.2 36.6 46.5 42.5 26.9 39.0 23.7 47.0 26.5 18.8 14.6 27.7 29.9 20.0 48.5 31.5 50.5 22.1 47.8 29.1 30.8 129.8 31.2 39.3 21.3 48.5 41.9 17.9 22.7 43.0 24.7 27.2 46.0 31.7 27.1 35.8 25.9 28.7 25.2 26.7 30.7 17.5 48.2 27.6 80.2 62.1 18.8 39.1 39.0 22.8 19.0 10.4 23.0 16.9 24.8 19.1 29.0 23.2 22.3 15.7 41.3 31.3 7.9 35.2 11.3 15.0 33.5 29.4 26.7 30.5 21.9 45.9 21.2 23.9 20.4 34.6 24.3 16.2 8.9 16.0 34.0 28.7 22.8 17.8 18.6 7.6 4.0 10.3 12.2 5.9 57.7 10.0 35.8 11.1 31.4 10.5 23.3 30.4 80.2 33.8 28.6 15.0 17.4 48.9 19.1 18.5 20.3 19.0 12.8 14.4 20.0 43.9 71.3 22.5 18.0 30.8 14.4 17.7 11.5 15.0 51.8 35.6 95.2 109.0 21.5 48.1 33.2 28.3 25.8 SAFB "HET, SAFB1" ENSG00000160633 "Scaffold attachment factor B" Q15424 19 5623035-5668478 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001969, HPA016832, HPA020076" Supported Enhanced Nucleoplasm,Midbody NA NA Nucleoplasm Midbody "CAB001969: , HPA016832: AB_1850622, HPA020076: AB_1850624" "unprognostic (2.41e-2)" "unprognostic (8.18e-3)" "unprognostic (6.66e-2)" "unprognostic (3.81e-3)" "unprognostic (6.50e-2)" "unprognostic (7.82e-2)" "unprognostic (1.62e-3)" "unprognostic (9.31e-2)" "unprognostic (5.76e-2)" "unprognostic (4.85e-2)" "prognostic favorable (9.75e-5)" "unprognostic (3.25e-2)" "unprognostic (3.53e-3)" "unprognostic (3.14e-2)" "unprognostic (2.67e-2)" "unprognostic (4.07e-1)" "prognostic favorable (1.70e-4)" 28.7 27.6 26.4 34.8 32.5 50.7 26.2 50.8 36.0 28.9 29.7 34.3 18.6 31.0 32.1 17.3 26.6 25.8 22.6 26.9 28.2 25.8 23.8 29.0 27.1 38.0 31.5 26.2 35.0 29.2 31.2 35.0 35.5 28.1 27.5 20.5 21.4 31.1 28.8 53.6 35.5 31.0 27.8 31.4 39.1 28.4 30.3 32.1 61.4 26.3 19.5 31.3 30.7 45.6 32.8 31.6 48.4 42.3 31.2 37.5 30.5 27.5 24.4 29.8 19.1 13.2 11.9 34.1 20.7 13.5 17.7 15.0 36.6 15.9 44.8 16.5 10.3 14.9 26.0 28.6 17.0 18.7 30.2 28.0 32.9 22.5 34.2 12.5 40.4 29.1 10.6 15.8 15.8 16.9 12.7 14.0 19.7 45.6 23.0 13.5 24.5 42.5 32.0 39.6 19.0 24.4 42.8 32.6 31.0 13.8 23.2 27.4 23.6 23.3 18.8 21.2 17.9 17.4 21.9 21.5 18.1 22.3 22.1 31.8 37.4 31.9 41.0 17.4 33.6 23.9 35.0 28.4 48.4 36.2 28.4 36.7 32.8 36.0 35.2 31.6 32.2 37.5 36.0 30.6 31.2 42.3 26.6 34.5 30.5 26.4 32.5 50.8 36.0 28.2 25.8 31.5 26.2 28.1 32.1 29.8 16.0 30.4 40.5 58.3 38.8 35.0 10.2 85.6 50.0 15.7 33.4 43.6 21.6 36.0 5.2 35.2 30.0 0.0 30.2 47.2 40.1 31.6 48.6 24.5 32.8 47.7 28.6 23.4 21.9 4.5 33.1 39.9 28.7 50.5 36.7 29.9 28.1 28.8 24.4 22.4 44.2 19.4 47.0 78.8 82.8 57.1 52.3 44.7 34.5 34.2 SAFB2 KIAA0138 ENSG00000130254 "Scaffold attachment factor B2" Q14151 19 5586999-5624046 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050894 Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles" NA NA Nucleoplasm "Nuclear bodies, Vesicles" "HPA050894: AB_2681266" "unprognostic (7.46e-2)" "unprognostic (3.09e-1)" "unprognostic (7.69e-3)" "prognostic favorable (7.10e-4)" "unprognostic (7.95e-2)" "unprognostic (6.76e-3)" "unprognostic (4.19e-3)" "unprognostic (5.93e-2)" "unprognostic (2.11e-1)" "unprognostic (5.14e-2)" "prognostic favorable (2.53e-4)" "unprognostic (2.23e-2)" "unprognostic (2.82e-3)" "unprognostic (1.17e-2)" "unprognostic (1.55e-1)" "unprognostic (4.11e-2)" "prognostic favorable (2.12e-4)" 25.7 29.6 31.0 29.6 33.7 35.4 17.4 50.8 46.2 27.4 21.6 28.4 23.1 25.8 30.2 27.4 15.7 26.8 19.4 21.0 30.3 24.6 32.2 20.0 18.2 26.8 30.5 26.5 42.8 24.2 31.0 38.4 17.3 28.6 28.4 20.9 21.3 23.6 34.8 38.1 18.9 25.7 24.8 43.4 29.4 20.1 23.4 34.3 23.5 26.9 11.1 25.2 24.1 32.7 11.4 9.3 24.3 9.5 6.4 13.3 5.6 17.8 23.3 17.0 12.5 16.7 10.8 19.8 17.0 9.3 10.7 10.1 29.7 13.0 34.2 15.6 8.5 8.7 16.5 20.7 10.6 17.7 23.7 22.1 26.0 23.7 23.0 9.7 21.7 24.5 10.7 11.3 15.6 12.1 10.6 10.4 12.4 24.9 17.3 12.6 20.0 25.9 20.7 29.0 14.0 24.7 32.9 14.7 19.0 12.0 30.6 16.0 14.9 22.6 10.4 13.7 11.4 15.4 13.4 16.4 13.2 13.8 16.5 23.2 23.0 20.5 24.8 13.6 18.9 21.6 24.3 9.5 15.8 11.9 8.2 13.3 10.3 10.5 9.2 8.3 11.4 11.7 9.1 18.3 6.4 8.5 9.3 9.5 5.6 31.0 33.7 50.8 46.2 30.3 24.6 30.5 26.5 28.6 34.3 38.7 42.6 34.8 47.8 41.4 64.3 26.8 12.7 65.6 37.5 31.4 70.7 37.5 19.9 41.3 5.9 42.1 42.8 23.3 38.9 37.8 33.4 47.8 39.5 21.3 27.2 41.3 41.2 22.7 23.2 5.1 67.0 39.7 25.3 49.5 33.1 83.1 36.3 42.1 61.9 50.7 79.7 45.3 49.5 61.2 74.7 36.6 27.0 50.7 37.9 44.8 SAGE1 "CT14, SAGE" ENSG00000181433 "Sarcoma antigen 1" Q9NXZ1 X 135889205-135913061 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 13 "testis: 10.9" "Cell type enriched" "Detected in single" 26 "Spermatogonia: 8.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 15.1;K-562: 10.9;Karpas-707: 18.8;U-2 OS: 5.3;U-266/70: 6.6;U-266/84: 16.4" "HPA003033, HPA003208" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA003033: AB_1079865, HPA003208: AB_1079863" "unprognostic (1.11e-1)" "unprognostic (5.26e-2)" "unprognostic (1.15e-1)" "unprognostic (1.02e-2)" "unprognostic (2.37e-1)" "unprognostic (7.12e-4)" "unprognostic (1.45e-2)" "unprognostic (1.10e-1)" 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 6.6 16.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 SALL1 "Hsal1, TBS, ZNF794" ENSG00000103449 "Spalt like transcription factor 1" Q9NSC2 16 51135975-51151367 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" Deafness "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.9;kidney: 26.8;liver: 32.0" "Group enriched" "Detected in some" 14 "Cholangiocytes: 7.6;Collecting duct cells: 8.7;Cone photoreceptor cells: 23.6;Distal tubular cells: 10.0;Hepatocytes: 27.2;Proximal tubular cells: 16.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 15.2;BJ hTERT+: 12.9;NTERA-2: 24.6;RPTEC TERT1: 20.9;U-87 MG: 24.1" "Region enriched" "Detected in many" 5 "olfactory region: 64.6" "Low region specificity" "Detected in many" "HPA049829, HPA074673" Enhanced Approved "Nucleoplasm,Nucleoli,Nuclear speckles,Cytosol" NA NA Nucleoplasm "Nucleoli, Nuclear speckles, Cytosol" "HPA049829: AB_2680902, HPA074673: " "unprognostic (9.91e-2)" "unprognostic (9.42e-2)" "unprognostic (1.82e-6)" "prognostic favorable (1.28e-4)" "unprognostic (2.55e-1)" "unprognostic (1.17e-1)" "unprognostic (1.96e-2)" "unprognostic (4.41e-3)" "unprognostic (1.71e-2)" "unprognostic (2.88e-1)" "unprognostic (1.48e-1)" "unprognostic (3.96e-1)" "prognostic favorable (1.91e-7)" "unprognostic (1.86e-1)" "unprognostic (2.14e-1)" "unprognostic (3.03e-2)" "unprognostic (1.76e-1)" 0.8 0.7 12.2 1.2 14.5 0.7 0.9 1.7 18.9 16.1 3.1 31.9 0.0 1.6 17.8 1.5 0.8 10.4 1.1 1.2 13.6 5.5 26.8 32.0 0.6 0.6 21.8 9.1 5.2 1.6 0.9 4.3 4.3 17.6 1.3 3.2 0.0 0.9 2.3 0.6 0.7 1.4 9.4 19.7 0.7 3.0 2.2 19.4 0.0 23.7 0.0 0.6 2.2 4.8 1.0 1.9 2.3 3.1 0.1 1.1 1.1 0.0 0.8 15.2 0.1 0.4 0.3 0.0 5.0 12.9 0.3 0.7 0.0 0.0 0.0 5.8 7.1 4.5 0.0 9.4 0.0 0.4 0.0 5.7 0.0 0.0 9.1 0.3 0.0 4.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.6 0.0 0.0 1.8 0.9 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 24.1 0.0 5.0 0.6 3.1 2.3 0.7 2.0 0.7 1.0 1.0 0.9 1.9 0.8 0.6 0.6 1.8 0.1 1.5 1.9 1.1 1.1 12.2 14.5 1.7 10.3 13.6 5.5 21.8 9.1 17.6 19.4 0.0 0.0 0.0 0.0 0.2 0.0 1.1 7.6 0.0 0.0 8.7 23.6 0.0 10.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 27.2 0.1 0.0 0.0 0.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 16.7 0.2 0.0 0.2 0.2 0.4 0.1 0.0 0.0 0.0 0.1 SALL2 "Hsal2, KIAA0360, ZNF795" ENSG00000165821 "Spalt like transcription factor 2" Q9Y467 14 21521081-21537216 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.9;parathyroid gland: 36.0" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 14.3;Cone photoreceptor cells: 7.9;Horizontal cells: 12.7;Muller glia cells: 11.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 3.8" "Group enriched" "Detected in many" 5 "dendritic cells: 1.7;T-cells: 3.8" "Cell line enhanced" "Detected in many" "AF22: 46.7;NTERA-2: 35.3;SCLC-21H: 15.9;SuSa: 15.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004162 Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA004162: AB_2667155" "unprognostic (5.73e-2)" "unprognostic (7.88e-2)" "unprognostic (3.21e-2)" "prognostic unfavorable (3.97e-4)" "unprognostic (1.24e-1)" "unprognostic (1.03e-1)" "unprognostic (5.53e-2)" "unprognostic (4.58e-3)" "unprognostic (1.03e-1)" "unprognostic (1.15e-1)" "prognostic favorable (1.23e-4)" "unprognostic (7.98e-2)" "unprognostic (2.09e-1)" "unprognostic (5.28e-3)" "unprognostic (2.03e-1)" "unprognostic (3.75e-2)" "unprognostic (1.86e-1)" 2.6 4.7 11.5 1.6 12.7 0.5 5.3 30.9 21.9 7.5 4.5 10.4 2.9 2.3 10.5 6.0 3.5 11.6 4.0 3.7 11.7 8.9 4.2 1.7 4.8 1.9 7.4 9.3 19.5 3.7 36.0 10.9 1.5 13.5 5.8 2.4 4.3 3.3 10.0 2.1 2.2 3.1 10.5 9.5 2.1 3.2 1.9 11.4 3.7 12.0 0.1 1.9 4.6 4.8 0.3 1.7 0.0 0.0 0.5 3.8 0.6 0.0 0.8 46.7 11.6 0.8 0.7 0.0 1.1 1.5 3.7 3.1 0.8 0.7 0.0 1.0 1.3 1.4 0.1 11.4 1.2 4.3 0.7 6.4 0.0 0.4 1.0 1.4 0.0 0.0 3.1 0.3 1.5 0.0 8.1 0.9 5.0 7.6 0.0 2.9 0.8 7.2 0.0 35.3 0.0 0.2 6.8 1.1 0.0 3.4 4.9 15.9 8.9 0.0 0.2 0.1 15.3 4.6 0.1 0.0 0.5 5.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.8 0.0 1.0 0.1 1.5 1.2 0.2 0.3 1.8 3.8 0.0 0.5 0.0 1.7 1.6 0.6 11.5 12.7 30.9 14.3 11.7 8.9 7.4 9.3 13.5 11.4 3.0 2.2 0.0 0.4 0.6 14.3 0.8 2.5 0.0 2.3 5.2 7.9 0.1 1.7 1.6 0.2 0.2 0.0 0.0 0.0 0.1 2.0 0.3 0.0 0.0 0.1 12.7 0.0 1.8 0.0 0.0 4.6 0.0 0.0 0.0 0.0 11.0 0.5 0.0 5.6 1.0 2.8 0.0 1.4 0.0 0.2 0.5 0.1 0.0 0.0 0.1 SALL4 "dJ1112F19.1, ZNF797" ENSG00000101115 "Spalt like transcription factor 4" Q9UJQ4 20 51782331-51802520 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease mutation, Oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "parathyroid gland: 8.8;testis: 11.7;thyroid gland: 8.6" "Cell type enriched" "Detected in some" 7 "Horizontal cells: 25.4" "Cancer enriched" "Detected in many" 11 "testis cancer: 22.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "NK-cell: 6.3" "Lineage enriched" "Detected in single" 9 "NK-cells: 6.3" "Cell line enhanced" "Detected in some" "AF22: 13.1;AN3-CA: 9.1;BEWO: 17.5;NTERA-2: 31.5;SiHa: 8.0;SuSa: 22.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015291, HPA015791" Enhanced Enhanced Nucleoplasm Yes No Nucleoplasm "HPA015291: AB_1856548, HPA015791: AB_1856547" "unprognostic (1.30e-1)" "unprognostic (2.35e-2)" "unprognostic (1.11e-1)" "unprognostic (1.09e-3)" "unprognostic (3.55e-2)" "unprognostic (7.43e-2)" "unprognostic (3.63e-2)" "unprognostic (1.47e-1)" "unprognostic (1.20e-1)" "unprognostic (9.23e-2)" "unprognostic (2.50e-2)" "unprognostic (2.39e-2)" "unprognostic (2.42e-8)" "unprognostic (5.90e-3)" "unprognostic (1.82e-1)" "unprognostic (5.00e-5)" "unprognostic (7.41e-2)" 0.3 0.4 0.3 0.3 0.9 1.2 0.3 0.8 0.9 0.4 0.7 0.3 2.2 0.1 0.3 0.8 0.3 0.2 0.3 0.3 0.3 0.1 0.5 1.9 0.3 0.3 0.3 0.3 0.3 4.6 8.8 0.6 0.3 0.9 3.1 0.2 4.5 2.2 0.4 0.3 0.3 0.7 0.3 0.3 0.8 0.3 11.7 0.3 0.3 8.6 0.3 0.3 0.9 0.3 0.1 0.1 0.6 0.1 6.3 0.2 0.0 0.0 0.8 13.1 9.1 0.0 0.0 17.5 0.0 0.1 0.0 0.1 4.5 0.1 0.0 0.1 0.1 0.1 2.2 0.1 0.0 0.1 0.2 0.0 0.0 3.0 0.2 0.1 0.0 1.0 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 31.5 0.1 0.2 1.2 0.0 0.0 0.0 0.2 3.0 1.6 8.0 0.0 0.7 22.0 0.0 0.5 0.0 0.5 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.6 6.3 0.1 0.1 0.0 0.0 0.3 0.9 0.8 0.9 0.3 0.1 0.3 0.3 0.9 0.3 0.0 1.3 0.0 0.7 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.2 0.0 0.4 1.1 0.0 0.0 0.2 25.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.5 1.7 0.0 0.0 0.0 0.0 1.0 SAMD10 C20orf136 ENSG00000130590 "Sterile alpha motif domain containing 10" Q9BYL1 20 63974113-63980008 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.7" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 8.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.9;T-cells: 6.2" "Cell line enhanced" "Detected in many" "HMC-1: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040973 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA040973: AB_10794258" "unprognostic (5.89e-3)" "unprognostic (1.16e-3)" "unprognostic (6.27e-2)" "unprognostic (3.19e-1)" "unprognostic (2.28e-1)" "unprognostic (2.84e-3)" "prognostic unfavorable (4.60e-4)" "unprognostic (2.69e-2)" "unprognostic (1.92e-1)" "unprognostic (7.33e-3)" "unprognostic (3.96e-2)" "unprognostic (1.08e-1)" "unprognostic (5.83e-2)" "unprognostic (4.97e-3)" "unprognostic (4.20e-1)" "unprognostic (1.28e-1)" "unprognostic (6.94e-3)" 2.4 2.8 6.4 6.1 14.5 3.4 5.4 25.7 10.4 2.3 4.4 1.6 9.2 7.3 1.4 3.0 10.3 4.7 8.8 3.2 5.5 5.0 6.5 4.4 3.6 10.1 3.5 3.5 0.5 5.6 5.3 3.3 3.3 3.2 4.8 3.7 2.7 9.7 6.5 1.7 9.3 6.8 1.5 1.9 5.7 10.2 3.2 2.4 5.7 3.1 2.7 12.3 5.4 4.2 2.9 1.0 0.6 0.4 1.0 6.2 1.6 5.9 0.0 2.0 0.2 0.5 0.6 0.1 1.9 1.6 3.9 1.8 5.7 11.6 0.4 4.0 0.9 0.2 8.1 1.9 2.4 2.0 12.1 4.0 2.0 5.9 8.6 0.8 10.0 16.2 0.5 4.4 2.1 0.3 2.9 1.8 4.3 4.8 4.9 0.7 4.5 4.5 9.3 3.2 8.5 9.2 6.3 0.1 10.5 6.4 10.5 2.2 4.7 1.3 11.3 2.4 0.8 7.6 5.0 1.7 1.2 2.8 0.0 0.3 1.0 0.7 3.3 3.8 8.1 1.1 0.0 0.2 0.6 4.9 0.2 2.7 2.9 3.3 2.9 0.6 1.3 5.6 6.2 0.0 1.0 0.4 1.0 2.5 1.6 6.4 14.5 25.7 10.4 5.5 5.0 3.5 3.5 3.2 2.4 3.0 0.0 2.2 2.2 0.9 6.1 2.0 0.0 2.7 1.2 8.7 2.0 2.3 1.7 3.4 0.0 1.0 2.6 0.0 3.0 0.4 0.3 2.6 0.0 0.6 1.1 0.0 4.7 2.5 1.5 0.0 0.0 0.7 1.7 2.8 4.2 2.7 5.2 1.9 0.0 3.1 2.6 0.0 0.8 0.5 1.3 1.6 2.3 4.4 2.2 3.4 SAMD11 MGC45873 ENSG00000187634 "Sterile alpha motif domain containing 11" Q96NU1 1 923928-944581 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 7 "Rod photoreceptor cells: 235.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "NK-cell: 4.7" "Lineage enriched" "Detected in single" 10 "NK-cells: 4.7" "Group enriched" "Detected in many" 4 "HEK 293: 38.7;HeLa: 42.9;SCLC-21H: 28.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA030110 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA030110: " "unprognostic (9.96e-2)" "unprognostic (1.75e-1)" "unprognostic (4.11e-2)" "unprognostic (1.11e-2)" "unprognostic (1.20e-2)" "unprognostic (2.42e-1)" "unprognostic (9.28e-2)" "unprognostic (6.90e-2)" "unprognostic (3.11e-2)" "unprognostic (1.45e-1)" "unprognostic (1.62e-2)" "unprognostic (1.56e-1)" "prognostic unfavorable (3.35e-5)" "unprognostic (3.01e-2)" "unprognostic (1.05e-2)" "unprognostic (3.26e-2)" "unprognostic (1.18e-1)" 2.1 10.0 2.4 5.0 3.0 1.0 1.6 1.6 4.7 4.4 3.0 7.2 2.5 5.1 9.5 7.4 4.2 13.6 4.5 8.5 5.7 4.0 10.0 2.9 2.4 2.1 6.9 2.0 5.9 1.8 0.6 21.9 0.6 5.9 12.4 1.4 16.9 2.4 22.1 1.4 0.3 5.6 6.0 8.8 11.7 5.5 2.7 5.1 0.3 4.6 0.6 0.5 7.2 22.8 0.3 0.0 0.0 0.2 4.7 0.4 0.0 0.1 2.7 0.0 2.5 0.1 0.0 0.9 4.2 0.2 0.2 0.1 0.1 0.8 0.0 8.1 8.7 2.2 5.5 2.7 0.0 0.0 0.3 38.7 0.0 42.9 0.1 0.7 0.0 0.3 1.6 0.0 0.0 0.0 4.3 0.0 0.1 1.4 0.0 0.0 2.9 0.0 0.0 1.6 0.1 0.3 0.2 0.6 2.2 0.4 0.0 28.0 8.6 8.8 4.2 0.0 2.6 4.9 0.2 0.5 1.4 6.4 0.1 0.9 0.5 0.0 0.1 1.8 0.6 0.0 0.0 0.1 0.0 0.3 0.2 0.4 0.3 0.2 0.2 0.0 0.1 0.1 0.4 0.0 4.7 0.1 0.0 0.0 0.0 2.4 3.0 1.6 4.7 5.7 4.0 6.9 2.0 5.9 5.1 0.0 2.6 0.0 0.1 0.3 16.4 0.8 0.0 0.0 3.4 3.5 27.5 0.2 0.0 0.5 2.2 0.8 0.0 0.0 0.3 0.6 2.3 2.5 0.0 0.0 0.2 33.4 25.4 6.7 0.3 7.9 0.9 0.0 0.0 0.0 0.0 15.0 2.6 0.2 3.9 0.2 235.2 0.0 1.4 0.9 16.6 0.5 0.1 0.0 0.0 0.3 SAMD14 FLJ36890 ENSG00000167100 "Sterile alpha motif domain containing 14" Q8IZD0 17 50110040-50129882 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 45.8" "Group enriched" "Detected in many" 4 "Bipolar cells: 42.7;Horizontal cells: 11.1;Intestinal endocrine cells: 12.2" "Cancer enhanced" "Detected in some" "glioma: 3.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 2.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.3" "Cell line enhanced" "Detected in some" "HDLM-2: 10.9;HEL: 6.9;HMC-1: 23.2;SH-SY5Y: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051916 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA051916: AB_2681662" "unprognostic (2.33e-2)" "unprognostic (6.05e-2)" "unprognostic (2.85e-1)" "unprognostic (2.10e-1)" "unprognostic (3.24e-1)" "unprognostic (2.31e-1)" "unprognostic (8.84e-3)" "unprognostic (6.77e-2)" "unprognostic (1.32e-2)" "unprognostic (1.74e-1)" "unprognostic (2.61e-2)" "unprognostic (3.06e-2)" "unprognostic (1.23e-3)" "unprognostic (1.93e-2)" "unprognostic (4.00e-2)" "unprognostic (9.01e-2)" "unprognostic (7.48e-4)" 2.8 3.8 18.3 3.9 19.5 2.0 1.0 45.8 18.5 2.4 2.2 3.1 1.1 2.0 3.2 4.3 1.6 1.3 2.2 1.5 15.4 10.3 2.9 1.7 5.4 2.2 7.9 16.1 1.7 1.5 2.9 2.1 3.9 10.9 3.9 1.8 4.3 1.3 4.0 6.1 1.6 2.6 2.8 6.8 3.0 3.2 4.6 6.9 0.0 1.3 0.0 3.2 2.2 0.9 0.0 0.0 2.3 0.0 0.3 0.0 0.4 0.0 0.1 4.0 0.0 1.1 0.2 0.0 2.5 0.9 0.0 0.0 0.5 0.0 0.1 3.7 1.0 0.0 0.1 0.2 0.0 0.1 10.9 0.1 6.9 0.2 0.0 0.6 0.0 23.2 0.3 0.0 0.0 0.0 0.4 0.6 0.0 0.2 0.3 0.0 0.0 0.1 0.6 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.7 10.9 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.4 1.4 0.3 0.0 0.2 0.0 0.0 2.0 0.0 0.8 2.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 18.3 19.5 45.8 18.5 15.4 10.3 7.9 16.1 10.9 6.9 0.0 0.3 0.0 0.1 0.3 42.7 1.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.2 2.1 2.9 0.0 0.0 0.3 0.1 1.4 0.1 2.3 0.0 0.1 11.1 12.2 4.9 0.3 1.9 1.4 0.8 0.0 2.8 0.0 1.4 0.3 0.0 3.2 0.8 3.1 0.0 2.2 1.4 1.1 0.1 0.3 0.0 0.0 0.0 SAMD15 "C14orf174, FAM15A, FLJ35963" ENSG00000100583 "Sterile alpha motif domain containing 15" Q9P1V8 14 77376689-77391497 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 29.1;testis: 22.1" "Group enriched" "Detected in many" 7 "Ciliated cells: 65.6;Cone photoreceptor cells: 58.9;Early spermatids: 61.5;Late spermatids: 75.0;Rod photoreceptor cells: 75.7;Spermatocytes: 45.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "MCF7: 10.8" "Low region specificity" "Detected in many" "HPA030673, HPA030677" Enhanced Approved "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA "Nucleoplasm, Nuclear membrane, Nucleoli" "HPA030673: AB_10600655, HPA030677: AB_10599938" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (3.76e-2)" "unprognostic (1.15e-1)" "unprognostic (1.02e-2)" "unprognostic (1.38e-2)" "unprognostic (3.70e-3)" "unprognostic (5.20e-2)" "unprognostic (5.76e-2)" "unprognostic (1.11e-1)" "unprognostic (3.83e-3)" "unprognostic (6.19e-2)" "unprognostic (2.53e-3)" "unprognostic (6.87e-3)" "unprognostic (9.90e-2)" "unprognostic (3.73e-3)" "unprognostic (1.76e-2)" 0.8 1.3 5.3 0.5 6.7 0.9 1.5 0.8 3.3 1.2 0.7 2.2 3.1 0.6 1.5 7.5 0.7 6.2 1.5 0.6 3.7 2.9 6.0 0.6 1.8 1.9 1.4 3.1 3.2 2.7 5.2 29.1 0.5 7.9 1.3 0.5 4.4 0.8 1.1 0.5 0.8 0.6 0.6 1.5 0.7 0.7 22.1 2.3 0.1 6.9 0.0 1.8 1.9 0.7 0.6 0.2 2.3 0.5 0.6 0.4 0.1 3.6 4.9 1.9 4.1 0.5 2.1 1.8 1.5 1.3 4.0 3.6 3.5 3.3 4.0 1.6 1.5 3.5 3.5 1.4 2.0 5.5 0.3 0.7 0.6 1.4 0.9 0.2 0.7 4.3 2.0 1.3 3.4 0.4 1.7 2.7 2.0 0.4 1.2 1.6 10.8 0.9 0.4 0.8 0.9 1.6 1.7 1.9 0.2 6.9 2.0 4.3 2.7 5.1 0.8 0.7 0.8 6.4 1.2 1.0 3.7 2.2 3.9 1.9 0.7 3.3 2.6 4.7 0.2 1.9 0.7 0.5 1.2 0.2 0.1 0.1 0.2 0.2 0.1 0.2 0.6 0.3 0.4 2.3 0.6 0.5 0.1 0.4 0.1 5.3 6.7 0.8 3.3 3.7 2.9 1.4 3.1 7.9 2.3 0.0 0.0 0.0 0.4 0.2 9.7 0.8 2.5 65.6 2.3 0.0 58.9 0.2 1.7 2.4 61.5 0.3 0.0 0.0 0.6 0.2 0.6 0.5 0.0 0.0 0.1 3.2 3.5 0.0 0.0 75.0 1.4 0.0 0.0 0.0 0.0 4.8 1.0 0.0 0.0 3.4 75.7 0.0 0.3 45.6 6.0 0.0 0.2 0.0 0.0 0.1 SAMHD1 "AGS5, HDDC1, Mg11, MOP-5, SBBI88" ENSG00000101347 "SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1" Q9Y3Z3 20 36889773-36951901 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, DNA damage, DNA repair, DNA replication, Host-virus interaction, Immunity, Innate immunity" "Allosteric enzyme, Hydrolase" "Aicardi-Goutieres syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Hofbauer cells: 131.6;Kupffer cells: 243.3;Macrophages: 175.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 46.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 58.1;BJ hTERT+ SV40 Large T+: 24.6;BJ hTERT+ SV40 Large T+ RasG12V: 26.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047072 Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA 100000 Nucleoplasm "Plasma membrane" "HPA047072: AB_2679921" "unprognostic (1.09e-1)" "unprognostic (7.30e-3)" "unprognostic (1.65e-2)" "unprognostic (3.85e-2)" "unprognostic (1.28e-1)" "unprognostic (1.91e-2)" "unprognostic (2.15e-1)" "unprognostic (4.07e-2)" "unprognostic (2.03e-1)" "unprognostic (3.63e-1)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "prognostic unfavorable (5.12e-4)" "unprognostic (1.44e-1)" "unprognostic (9.06e-2)" "unprognostic (3.18e-2)" "unprognostic (2.72e-2)" 54.3 18.6 8.7 31.8 13.0 9.9 35.9 4.9 9.7 14.5 21.2 9.0 8.7 15.8 13.5 20.2 24.1 33.4 15.3 25.4 8.7 6.0 12.5 12.4 25.7 48.3 14.5 4.9 22.1 18.1 4.9 22.4 13.7 10.2 14.0 13.2 11.6 14.7 9.7 9.2 11.4 20.6 21.3 13.7 40.7 19.2 15.1 15.0 9.7 14.9 10.7 18.5 23.2 50.2 0.4 46.7 2.8 23.4 6.0 10.9 19.1 3.9 1.5 0.7 1.5 58.1 11.0 0.7 2.3 4.2 24.6 26.4 4.9 1.3 8.3 3.3 1.6 15.0 3.0 6.1 2.9 5.2 2.4 2.0 0.4 2.1 2.6 5.1 4.7 1.5 13.5 0.1 8.6 0.2 1.4 3.2 0.0 1.5 2.0 0.5 1.2 0.0 1.8 0.7 2.4 3.2 0.2 4.0 3.2 0.9 0.6 3.0 0.4 3.0 1.1 2.9 0.2 1.4 7.6 0.8 1.9 2.1 2.0 3.4 1.2 3.0 3.5 1.6 0.4 0.6 0.2 19.4 0.6 6.1 23.4 5.6 0.4 6.9 6.4 46.7 0.4 8.5 6.3 2.8 6.0 20.4 11.0 10.9 19.1 8.7 13.0 4.9 9.7 8.7 6.0 14.5 4.9 10.2 15.0 26.8 30.5 23.8 1.9 5.7 5.3 16.9 25.5 83.0 53.4 1.8 3.9 2.5 0.0 9.3 2.3 36.5 1.1 0.0 8.6 2.8 23.4 2.7 11.6 17.4 131.6 6.4 5.8 47.9 243.3 2.3 76.2 175.7 5.0 16.2 4.3 30.6 11.1 20.1 90.5 1.2 2.6 58.2 29.8 5.1 5.4 5.1 2.4 54.9 4.5 4.7 SAMSN1 "HACS1, NASH1, SASH2, SH3D6B, SLy2" ENSG00000155307 "SAM domain, SH3 domain and nuclear localization signals 1" Q9NSI8 21 14485228-14658821 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 53.6;bone marrow: 72.1;lymphoid tissue: 43.6" "Group enriched" "Detected in many" 6 "granulocytes: 1107.2;monocytes: 1399.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 53.6;eosinophil: 49.9" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "HEL: 60.9;K-562: 72.4;Karpas-707: 31.6" "Region enriched" "Detected in some" 7 "olfactory region: 25.4" "Low region specificity" "Detected in all" "HPA010645, HPA017055, HPA046639" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA010645: AB_1856559, HPA017055: AB_1856560, HPA046639: AB_2679732" "unprognostic (7.62e-3)" "unprognostic (1.46e-2)" "unprognostic (1.03e-2)" "unprognostic (3.11e-2)" "unprognostic (2.44e-1)" "unprognostic (3.91e-2)" "unprognostic (1.41e-1)" "unprognostic (1.01e-1)" "unprognostic (2.17e-1)" "unprognostic (6.13e-2)" "unprognostic (2.10e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (4.52e-6)" "unprognostic (9.14e-2)" "unprognostic (3.05e-2)" "unprognostic (2.17e-1)" "unprognostic (1.68e-2)" 14.4 3.9 5.8 33.0 10.4 72.1 4.2 1.1 5.1 2.9 4.7 4.9 0.0 3.1 3.4 4.6 4.1 6.8 10.1 5.1 4.4 3.4 5.9 7.2 27.9 28.3 11.1 1.4 3.3 2.3 1.0 2.7 6.7 6.7 4.1 7.0 3.4 3.4 1.2 1.6 1.9 13.6 4.7 17.5 43.6 5.0 2.4 7.1 12.6 2.6 2.8 16.7 11.8 4.5 6.5 5.6 53.6 17.3 3.7 12.9 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.1 0.0 60.9 0.0 0.0 0.0 7.1 2.9 0.0 0.0 0.0 9.0 2.4 0.8 1.1 72.4 31.6 0.0 0.0 3.4 8.7 0.0 0.0 0.0 5.9 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 7.9 0.0 0.0 0.0 0.0 13.6 0.1 0.0 0.3 4.6 0.0 53.6 8.8 49.9 5.3 11.6 3.6 6.5 10.3 7.8 5.6 2.6 6.6 4.6 11.0 3.7 17.3 0.2 12.9 6.8 5.8 10.4 1.1 5.1 4.4 3.4 11.1 1.4 6.7 7.1 20.8 87.5 39.7 0.8 13.9 54.7 1.2 2.5 14.7 20.5 34.9 0.0 0.4 0.0 0.4 0.0 7.1 0.0 23.3 5.4 0.5 6.2 0.4 1107.2 0.9 57.4 0.0 0.0 3.1 159.2 0.0 0.6 220.5 20.3 1399.5 0.1 1.5 0.6 0.0 0.0 0.4 4.2 0.0 3.3 0.0 0.0 11.5 0.5 120.4 0.0 0.7 SAP18 "2HOR0202, MGC27131, SAP18p" ENSG00000150459 "Sin3A associated protein 18" O00422 13 21140514-21149084 "Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011352, CAB012273" Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "CAB012273: , HPA011352: AB_1856563" "unprognostic (5.08e-2)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (1.19e-3)" "unprognostic (2.84e-1)" "unprognostic (5.21e-2)" "unprognostic (3.02e-1)" "unprognostic (3.18e-1)" "unprognostic (8.15e-2)" "unprognostic (3.48e-1)" "unprognostic (1.01e-1)" "unprognostic (4.14e-2)" "unprognostic (2.33e-2)" "unprognostic (7.75e-3)" "unprognostic (4.70e-2)" "unprognostic (3.70e-3)" "unprognostic (2.78e-2)" 35.3 67.0 55.2 45.3 57.4 81.0 38.0 35.2 49.1 30.0 44.8 43.9 37.6 53.1 37.5 40.3 59.5 32.4 33.0 66.3 68.4 61.3 63.2 47.5 34.8 41.7 64.9 50.2 37.3 52.3 16.2 38.8 43.1 54.9 34.4 23.8 26.4 50.1 34.5 121.6 31.4 48.6 48.1 73.5 31.6 41.6 79.2 49.3 34.0 34.9 51.0 24.4 37.3 48.6 90.1 107.4 97.9 96.4 70.0 94.1 143.8 29.7 16.8 27.3 29.4 29.6 24.9 42.3 38.1 28.4 35.4 26.2 30.3 57.8 30.9 47.1 31.5 38.5 31.3 33.5 23.9 40.0 47.1 17.0 44.0 22.2 50.2 33.7 59.7 35.7 25.0 27.3 27.0 32.4 27.4 26.5 37.6 20.8 17.7 31.9 38.1 67.4 98.2 34.2 83.3 18.5 42.8 43.1 30.7 49.6 26.8 31.8 27.8 24.5 36.5 47.1 31.8 35.2 87.7 32.2 21.8 24.3 39.4 44.3 27.5 38.1 85.1 21.2 35.6 39.9 69.6 82.9 97.9 70.0 89.0 70.6 90.1 86.2 82.4 81.2 77.6 84.2 83.2 83.4 70.0 96.4 107.4 94.1 143.8 55.2 57.4 35.2 49.1 68.4 61.3 64.9 50.2 54.9 49.3 125.0 120.4 256.8 291.2 407.4 98.9 565.8 201.2 230.2 162.7 221.6 39.3 478.6 643.2 319.3 984.2 273.5 352.1 93.5 320.2 439.3 341.9 285.9 252.8 227.3 346.1 112.8 225.1 143.1 173.7 111.6 316.9 273.6 386.3 458.1 262.9 223.0 331.8 354.2 285.3 790.7 102.1 200.5 388.3 329.4 303.0 369.1 759.6 214.2 268.2 375.5 SAP30 ENSG00000164105 "Sin3A associated protein 30" O75446 4 173369969-173377532 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 63.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Karpas-707: 60.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022627, HPA059012" Enhanced Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "CAB022627: , HPA059012: AB_2683880" "unprognostic (1.53e-1)" "unprognostic (3.67e-2)" "unprognostic (3.26e-1)" "unprognostic (1.39e-1)" "unprognostic (5.83e-2)" "unprognostic (8.71e-2)" "prognostic unfavorable (1.24e-6)" "unprognostic (4.95e-2)" "unprognostic (7.23e-2)" "unprognostic (3.93e-2)" "unprognostic (4.48e-1)" "unprognostic (1.93e-2)" "prognostic unfavorable (1.54e-7)" "unprognostic (3.97e-1)" "unprognostic (5.70e-2)" "unprognostic (1.30e-1)" "unprognostic (2.21e-1)" 16.9 19.8 15.6 19.2 18.3 29.6 13.7 19.4 21.6 13.5 21.9 22.5 11.1 14.3 13.6 15.2 13.0 15.4 13.4 20.1 18.0 14.7 7.6 10.3 13.5 10.5 23.4 13.9 17.3 10.5 6.6 9.2 10.7 15.8 16.3 11.2 15.3 11.8 15.7 10.0 8.0 13.8 19.0 24.2 15.7 28.6 26.8 23.3 10.7 12.1 7.2 9.7 24.9 17.6 0.7 2.9 1.9 4.1 0.0 1.9 0.8 15.5 5.3 15.4 14.9 9.9 6.2 3.4 7.3 6.3 8.2 10.3 2.2 6.3 14.1 3.4 8.5 10.4 3.9 12.4 6.2 6.4 15.8 11.8 18.8 12.8 6.3 9.4 10.8 12.0 10.2 3.0 7.0 7.1 11.7 9.7 10.3 9.7 60.2 10.6 6.6 15.2 12.1 6.8 7.0 10.3 12.4 5.5 10.0 5.0 2.5 12.6 26.6 10.4 10.5 4.7 4.1 4.4 6.4 9.4 5.9 8.0 13.8 16.9 34.0 12.1 13.4 19.2 26.4 16.8 1.3 4.1 0.0 1.9 2.4 0.7 0.4 1.0 1.2 2.9 0.7 0.2 0.6 1.9 0.0 1.3 0.1 1.4 0.8 15.6 18.3 19.4 21.6 18.0 14.7 23.4 13.9 15.8 23.3 0.0 2.9 4.5 6.1 45.9 23.7 25.0 2.5 4.0 3.4 7.0 21.6 2.3 0.0 2.4 12.6 13.1 3.6 23.3 3.1 8.4 19.9 7.4 6.9 7.9 8.2 23.8 18.9 10.4 63.3 2.3 9.5 10.8 32.1 2.8 7.4 48.7 2.5 3.5 6.0 4.5 43.5 51.8 19.5 53.9 9.8 46.3 1.0 5.0 9.7 2.6 SAP30BP "HCNGP, HTRG, HTRP" ENSG00000161526 "SAP30 binding protein" Q9UHR5 17 75667116-75708062 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042382, HPA052943" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA042382: AB_10793881, HPA052943: AB_2681995" "unprognostic (6.92e-2)" "unprognostic (8.56e-3)" "unprognostic (1.20e-1)" "unprognostic (5.34e-3)" "unprognostic (2.95e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (4.71e-5)" "unprognostic (1.53e-2)" "unprognostic (2.15e-1)" "unprognostic (8.32e-3)" "unprognostic (1.03e-2)" "unprognostic (3.31e-3)" "prognostic unfavorable (1.98e-4)" "unprognostic (1.31e-1)" "unprognostic (1.88e-1)" "unprognostic (6.06e-2)" "unprognostic (6.58e-2)" 19.2 18.4 28.7 21.7 27.6 28.6 22.1 25.2 31.2 25.3 22.6 39.0 15.4 17.2 25.7 26.5 22.0 22.8 22.0 22.3 29.5 24.9 19.3 23.1 19.6 24.3 29.6 23.9 23.9 21.0 29.2 21.1 25.4 24.7 22.3 22.4 22.6 31.8 26.6 31.2 19.3 19.2 24.5 31.7 24.3 20.1 21.6 25.0 26.1 20.4 15.6 31.0 25.4 21.0 21.3 29.9 21.6 21.4 22.6 25.8 20.1 13.0 15.7 13.2 12.3 13.1 13.8 14.6 13.9 15.4 26.1 27.3 14.4 11.0 14.2 7.5 13.3 24.1 10.2 15.7 15.6 26.9 5.0 17.9 11.1 11.4 15.4 12.9 11.7 9.8 12.9 14.3 20.0 21.3 14.8 36.0 15.1 13.2 11.3 20.6 13.7 19.0 9.8 10.9 19.1 18.6 12.4 19.7 10.7 22.1 11.2 8.9 15.2 12.8 12.7 14.5 21.0 20.4 10.0 13.4 22.8 14.0 10.0 18.4 8.2 3.2 16.8 15.4 8.7 18.2 13.6 21.4 21.2 23.7 17.5 25.8 20.9 21.9 24.2 18.1 21.3 21.7 22.5 21.6 22.6 20.0 29.9 23.0 20.1 28.7 27.6 25.2 31.2 29.5 24.9 29.6 23.9 24.7 25.0 50.6 60.8 45.5 99.7 44.0 18.7 43.6 22.9 76.3 79.6 21.0 11.8 51.1 58.0 63.1 43.1 62.4 47.7 23.3 63.6 54.6 56.3 38.2 74.1 31.8 50.3 9.5 34.4 45.4 38.7 69.2 41.1 51.7 54.0 68.5 33.6 59.7 77.0 45.6 32.5 35.4 14.4 64.7 61.4 29.6 29.0 39.6 80.3 65.0 24.9 96.7 SAP30L "FLJ11526, NS4ATP2" ENSG00000164576 "SAP30 like" Q9HAJ7 5 154445957-154461054 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048665, HPA078308" Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA048665: AB_2680486, HPA078308: " "unprognostic (3.79e-3)" "unprognostic (1.44e-2)" "unprognostic (1.25e-1)" "unprognostic (7.70e-2)" "unprognostic (1.07e-1)" "prognostic favorable (9.09e-4)" "unprognostic (1.33e-1)" "unprognostic (1.61e-1)" "unprognostic (1.32e-1)" "unprognostic (4.33e-2)" "prognostic favorable (2.06e-5)" "unprognostic (3.36e-1)" "prognostic favorable (1.71e-4)" "unprognostic (1.62e-2)" "unprognostic (3.34e-2)" "unprognostic (1.45e-2)" "prognostic favorable (2.69e-4)" 12.1 11.5 14.8 9.5 14.2 2.0 16.9 14.0 16.4 18.1 18.4 15.4 10.2 13.5 18.0 12.4 10.0 17.7 16.4 13.5 14.2 11.1 17.4 12.4 12.1 8.1 14.9 8.7 27.0 8.7 21.5 6.8 10.0 12.7 16.2 11.7 12.7 12.9 17.3 16.6 14.6 18.8 15.7 14.9 10.9 11.1 16.2 12.2 13.0 15.2 8.2 10.5 13.8 34.5 1.9 1.4 1.0 3.6 4.5 2.3 1.1 6.7 5.6 10.3 6.8 22.6 18.1 5.1 7.0 15.3 8.1 8.8 3.7 3.8 7.3 5.6 10.6 9.5 5.4 7.7 5.7 9.1 3.6 7.6 5.9 5.4 2.6 6.8 7.7 4.4 6.5 10.5 3.6 8.9 12.5 6.5 6.9 2.4 4.6 6.7 3.4 7.2 5.0 2.5 6.1 3.8 7.0 10.3 3.6 4.6 3.3 6.3 8.2 5.5 12.1 13.3 10.1 4.3 9.6 9.2 5.7 4.2 7.5 4.9 4.4 6.3 3.8 8.3 6.1 3.3 0.0 1.2 1.0 1.7 1.3 2.3 0.9 2.1 2.1 1.1 1.9 2.1 1.5 0.8 4.5 3.6 1.4 1.9 1.1 14.8 14.2 14.0 16.4 14.2 11.1 14.9 8.7 12.7 12.2 17.9 5.8 3.0 6.8 15.3 4.5 15.7 20.4 9.4 6.8 3.5 5.9 6.4 3.3 4.3 17.1 14.8 23.9 0.0 7.1 10.2 15.1 13.1 1.1 13.1 7.3 9.5 6.9 12.3 11.3 15.9 19.0 7.5 10.1 4.6 12.2 17.0 8.3 12.2 17.0 8.2 5.7 0.0 11.3 15.7 17.6 15.8 5.3 6.7 11.1 11.2 SAPCD2 "C9orf140, p42.3" ENSG00000186193 "Suppressor APC domain containing 2" Q86UD0 9 137062124-137070588 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.4" "Cell type enhanced" "Detected in some" 7 "Basal keratinocytes: 3.8;Mucus-secreting cells: 6.4;Paneth cells: 4.9;Undifferentiated cells: 4.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 1.7" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044154 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA Yes Cytosol "Nucleoplasm, Nucleoli" "HPA044154: AB_10959464" "unprognostic (3.68e-2)" "unprognostic (9.85e-2)" "unprognostic (1.13e-1)" "unprognostic (1.11e-1)" "unprognostic (2.80e-2)" "unprognostic (1.27e-1)" "unprognostic (5.42e-8)" "prognostic unfavorable (5.88e-4)" "unprognostic (8.33e-2)" "unprognostic (7.47e-2)" "unprognostic (1.22e-2)" "unprognostic (1.45e-1)" "unprognostic (9.83e-7)" "unprognostic (4.37e-3)" "unprognostic (4.62e-1)" "unprognostic (3.82e-2)" "unprognostic (1.35e-2)" 1.0 0.4 11.5 10.5 7.0 3.3 2.6 1.4 14.4 2.5 6.2 10.1 0.0 7.6 1.0 0.4 7.8 0.8 5.4 0.4 9.6 7.5 1.2 0.4 2.7 4.7 8.0 3.8 0.3 0.8 0.3 0.4 1.8 5.4 5.4 3.5 0.0 7.3 0.4 0.4 5.4 7.7 1.0 7.0 2.7 4.6 1.5 2.7 9.2 0.6 3.5 10.0 1.0 1.9 0.5 0.8 0.5 1.7 0.0 0.4 0.4 16.0 8.7 3.4 10.2 0.1 0.2 18.5 2.6 1.8 2.8 1.3 16.4 7.4 16.8 8.6 1.3 2.6 22.8 10.8 3.0 0.6 11.5 12.4 7.3 9.6 18.3 0.0 8.3 12.7 0.0 0.5 1.0 1.8 0.7 4.6 8.6 10.1 7.6 0.8 37.7 2.4 22.4 6.4 37.2 19.8 25.6 13.1 18.6 3.5 4.6 17.9 10.6 10.2 28.6 3.9 0.8 23.1 15.8 2.9 2.6 8.8 7.7 13.0 2.6 7.6 8.1 6.0 9.9 8.1 0.2 1.7 0.0 0.0 0.5 0.4 0.5 0.3 0.0 0.8 0.2 0.1 0.0 0.5 0.0 0.8 0.2 0.3 0.4 11.5 7.0 1.4 6.1 9.6 7.5 8.0 3.8 5.4 2.7 0.0 0.0 0.0 0.6 3.8 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.7 1.7 0.3 0.0 0.0 0.4 0.0 0.0 2.7 0.6 2.1 0.0 0.0 2.5 0.0 0.0 0.6 3.0 0.0 0.0 1.8 0.0 0.0 6.4 0.6 0.3 4.9 0.0 0.0 0.5 0.0 0.3 0.0 1.2 2.4 0.5 1.0 4.5 0.5 SARS2 "FLJ20450, mtSerRS, SARS, SARSM, SerRSmt, SERS, SYS" ENSG00000104835 "Seryl-tRNA synthetase 2, mitochondrial" Q9NP81 19 38915266-38930896 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 34.4;Late spermatids: 42.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA052730, HPA056957" Approved Uncertain Nucleoplasm,Vesicles,Mitochondria NA NA "Nucleoplasm, Mitochondria" Vesicles "HPA052730: AB_2681929, HPA056957: AB_2683286" "unprognostic (3.20e-3)" "unprognostic (1.17e-1)" "unprognostic (1.38e-1)" "unprognostic (3.53e-3)" "unprognostic (1.08e-1)" "unprognostic (1.88e-3)" "unprognostic (4.38e-3)" "unprognostic (1.22e-1)" "unprognostic (2.57e-2)" "unprognostic (8.62e-3)" "unprognostic (8.36e-2)" "unprognostic (1.67e-1)" "unprognostic (5.62e-3)" "unprognostic (2.50e-2)" "unprognostic (1.82e-1)" "unprognostic (9.24e-2)" "unprognostic (2.69e-2)" 5.8 16.5 9.9 7.2 12.8 11.1 7.4 10.7 20.4 8.0 9.2 11.3 11.4 12.3 9.0 9.4 12.9 11.5 8.2 12.3 8.3 8.6 13.4 20.6 6.3 11.0 10.9 7.8 9.5 14.4 11.2 11.4 10.7 15.0 11.0 8.5 11.8 13.6 9.9 15.5 15.6 9.9 8.1 7.2 11.3 11.1 8.8 11.5 11.4 13.8 9.5 12.6 11.0 8.3 6.3 12.7 0.4 7.2 6.5 8.0 4.3 5.7 17.4 7.0 4.1 2.9 6.0 9.6 4.0 5.5 9.5 7.5 14.2 7.1 6.5 5.8 5.7 3.8 5.4 7.3 11.4 2.4 5.5 9.4 12.9 7.5 12.2 6.9 11.0 12.9 9.1 6.2 6.2 4.3 4.7 6.7 10.5 11.1 6.4 4.8 12.2 8.3 10.0 7.1 9.0 3.5 12.0 6.3 7.1 10.1 13.9 12.0 7.6 5.4 14.5 3.6 2.7 7.4 7.4 4.3 5.9 6.8 4.6 3.9 4.7 2.7 5.1 3.8 7.7 4.9 0.0 4.1 0.4 8.0 7.2 6.4 6.3 5.9 8.0 12.7 5.7 4.3 4.9 0.3 6.5 6.4 5.0 6.6 4.3 9.9 12.8 10.7 20.4 8.3 8.6 10.9 7.8 15.0 11.5 6.0 6.4 9.5 3.4 3.8 7.2 8.1 10.2 4.0 4.5 5.2 7.9 34.4 13.3 13.2 10.2 3.2 5.1 0.0 11.2 19.0 5.1 2.3 5.7 8.1 11.2 4.8 10.9 6.2 6.2 42.6 4.4 3.5 3.3 6.4 7.1 2.9 7.8 3.5 4.6 5.6 13.4 0.0 2.1 1.5 7.2 3.6 24.4 6.9 16.6 2.6 SART3 "KIAA0156, p110, RP11-13G14, TIP110" ENSG00000075856 "Squamous cell carcinoma antigen recognized by T cells 3" Q15020 12 108522580-108561400 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028840, HPA044322" Approved Supported Nucleoplasm No No Nucleoplasm "HPA028840: , HPA044322: AB_2678895" "unprognostic (1.72e-1)" "unprognostic (1.16e-1)" "unprognostic (7.59e-2)" "unprognostic (1.72e-1)" "unprognostic (2.00e-1)" "unprognostic (1.21e-2)" "prognostic unfavorable (6.32e-6)" "unprognostic (2.74e-1)" "prognostic unfavorable (8.74e-4)" "unprognostic (1.38e-1)" "unprognostic (7.88e-2)" "unprognostic (1.05e-1)" "unprognostic (1.23e-1)" "unprognostic (1.23e-3)" "unprognostic (7.91e-2)" "unprognostic (1.61e-1)" "unprognostic (6.36e-2)" 18.0 19.0 29.3 30.0 27.6 25.9 19.6 35.7 27.9 22.8 19.1 19.1 19.4 14.7 24.7 19.5 23.7 22.5 19.1 16.2 21.5 19.3 16.1 19.8 18.6 28.7 16.3 26.1 30.2 17.2 28.9 25.8 20.2 19.6 21.6 21.0 19.0 18.6 28.7 43.9 23.3 19.6 20.2 15.7 25.9 18.7 20.5 20.1 36.2 25.5 15.5 30.5 20.9 20.5 11.7 13.0 14.3 10.4 11.4 15.0 9.2 12.6 23.9 21.1 21.9 12.5 10.0 16.9 12.3 16.8 23.4 18.2 21.1 8.8 21.5 7.3 12.3 14.7 12.1 34.4 16.8 21.7 22.9 18.5 29.5 16.0 20.7 19.3 28.1 15.9 14.0 15.2 16.4 24.3 18.6 14.5 20.0 31.5 13.3 14.0 16.7 24.9 24.3 32.3 13.9 25.3 24.3 17.8 19.2 12.3 24.0 21.9 15.2 17.2 6.8 11.1 20.1 18.4 21.0 9.4 13.9 8.8 10.6 11.0 16.9 23.3 29.5 14.2 17.1 18.1 14.3 9.3 10.4 13.5 7.8 15.0 11.7 9.1 12.0 13.0 11.3 14.0 11.2 3.1 11.4 10.4 8.8 13.6 9.2 29.3 27.6 35.7 27.9 21.5 19.3 16.3 26.1 19.6 20.1 17.9 20.3 16.0 15.2 13.1 39.9 15.5 10.2 32.1 29.6 17.4 33.4 18.6 6.6 12.2 30.3 18.5 8.5 0.0 11.0 11.2 14.1 13.5 16.3 11.3 11.5 33.4 12.0 12.9 15.2 25.8 9.5 14.4 15.1 17.2 9.1 25.3 11.4 5.8 16.6 6.2 39.8 32.3 12.6 21.4 29.6 15.7 19.8 17.5 10.9 13.6 SASH1 "dJ323M4.1, KIAA0790, SH3D6A" ENSG00000111961 "SAM and SH3 domain containing 1" O94885 6 148272304-148552050 "Predicted intracellular proteins" "Disease mutation, Hypotrichosis, Palmoplantar keratoderma, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Endothelial cells: 97.4;Muller glia cells: 93.7;Sertoli cells: 77.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "classical monocyte: 2.9;intermediate monocyte: 5.5;non-classical monocyte: 2.6" "Lineage enriched" "Detected in single" 32 "monocytes: 5.5" "Cell line enhanced" "Detected in many" "ASC diff: 60.2;ASC TERT1: 22.8;HUVEC TERT2: 21.8;WM-115: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029947, HPA029949" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029947: AB_10598915, HPA029949: AB_10602280" "unprognostic (9.71e-2)" "unprognostic (4.74e-2)" "unprognostic (5.32e-2)" "prognostic unfavorable (2.42e-4)" "unprognostic (3.55e-2)" "unprognostic (4.79e-3)" "unprognostic (6.69e-2)" "unprognostic (4.76e-2)" "unprognostic (2.06e-1)" "unprognostic (8.65e-3)" "unprognostic (9.94e-2)" "unprognostic (2.96e-1)" "unprognostic (2.13e-3)" "unprognostic (5.45e-2)" "unprognostic (3.53e-1)" "unprognostic (8.04e-3)" "unprognostic (1.54e-1)" 41.4 5.4 19.6 5.3 21.7 0.7 25.7 9.9 28.1 16.8 9.2 22.2 4.4 5.6 11.2 9.3 35.6 10.0 15.6 13.2 21.9 14.2 13.5 7.7 16.7 4.7 26.3 11.4 5.3 7.7 15.0 3.5 23.5 22.8 9.8 8.3 9.2 12.2 8.1 10.6 17.5 6.7 13.2 28.6 10.3 6.0 4.8 22.3 0.2 30.9 10.4 8.2 13.2 17.9 0.0 0.0 0.1 5.5 0.0 0.1 0.6 1.3 0.8 6.9 2.3 60.2 22.8 1.1 7.9 19.1 6.0 9.2 1.7 1.6 0.0 4.2 21.1 3.0 1.6 2.1 1.9 5.0 0.0 1.5 0.0 3.9 1.6 1.8 0.0 0.4 10.6 1.9 9.0 2.4 2.4 21.8 0.0 0.1 0.0 5.6 1.5 0.0 0.0 2.0 0.7 1.1 0.0 5.0 0.0 4.4 4.3 0.2 0.0 2.4 8.9 6.2 1.8 0.7 3.9 18.9 5.9 1.2 18.6 1.7 0.0 0.0 0.0 9.4 0.0 27.8 0.1 2.9 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.0 0.6 19.6 21.7 9.9 17.9 21.9 14.2 26.3 11.4 22.8 22.3 14.9 20.8 0.8 6.3 36.5 12.5 18.3 7.6 14.7 21.6 43.6 5.9 16.4 6.6 2.2 0.5 97.4 2.5 0.0 2.1 55.4 26.8 6.2 2.3 6.6 8.1 3.2 4.6 63.8 31.8 1.1 17.0 12.1 40.5 0.0 4.5 93.7 1.2 2.9 26.5 12.2 3.9 77.6 64.3 0.3 4.5 28.9 27.3 0.0 6.4 5.7 SASH3 "753P9, CXorf9, HACS2, SH3D6C, SLY" ENSG00000122122 "SAM and SH3 domain containing 3" O75995 X 129779979-129795201 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 61.8;bone marrow: 33.2;lymphoid tissue: 85.3" "Cell type enhanced" "Detected in some" 12 "B-cells: 45.6;Hofbauer cells: 45.7;Kupffer cells: 59.2;T-cells: 75.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 43.6;JURKAT: 31.2;MOLT-4: 31.1;NB-4: 23.7;REH: 23.3;U-698: 39.8;U-937: 30.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001085 Enhanced Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nuclear bodies" "HPA001085: AB_2184289" "unprognostic (1.88e-2)" "unprognostic (5.82e-3)" "unprognostic (1.49e-3)" "prognostic favorable (3.15e-4)" "unprognostic (1.12e-1)" "unprognostic (1.19e-3)" "unprognostic (1.67e-1)" "unprognostic (3.23e-3)" "unprognostic (7.92e-3)" "unprognostic (3.45e-1)" "unprognostic (8.75e-2)" "unprognostic (2.16e-1)" "prognostic unfavorable (6.51e-5)" "unprognostic (3.30e-1)" "unprognostic (3.56e-2)" "unprognostic (3.17e-2)" "unprognostic (1.53e-1)" 7.8 3.4 2.8 34.6 5.2 33.2 2.7 0.7 2.2 2.0 3.3 4.0 0.2 3.9 1.9 2.1 2.9 3.4 3.6 2.0 3.3 2.4 3.3 3.0 10.6 38.2 5.2 1.1 1.3 1.8 0.2 1.8 2.5 4.2 2.7 3.5 1.6 7.8 0.8 0.9 1.1 18.8 2.4 6.2 55.7 4.2 0.8 4.0 85.3 2.5 2.0 38.6 7.0 2.0 22.0 27.6 53.7 44.2 33.4 46.9 61.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.2 0.0 3.7 0.0 0.0 31.1 23.7 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.1 0.0 0.1 0.0 0.0 0.0 8.8 39.8 0.0 30.9 0.0 7.9 29.4 53.7 46.9 44.1 38.7 19.1 26.7 43.1 27.6 22.0 19.3 30.0 29.1 33.4 44.2 12.7 32.3 61.8 2.8 5.2 0.7 2.2 3.3 2.4 5.2 1.1 4.2 4.0 0.0 5.1 45.6 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 23.3 0.0 0.5 0.4 0.0 21.9 0.9 45.7 0.0 0.0 3.7 59.2 0.0 0.3 20.3 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.5 75.2 0.0 0.0 SATB1 ENSG00000182568 "SATB homeobox 1" Q01826 3 18345387-18445588 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "lymphoid tissue: 331.6" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 82.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 37.9" "Group enriched" "Detected in many" 6 "NK-cells: 18.6;T-cells: 37.9" "Cell line enhanced" "Detected in many" "HDLM-2: 91.1;JURKAT: 44.0;REH: 25.4;THP-1: 38.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051769, CAB056144, HPA070534" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "CAB056144: AB_10584780, HPA051769: AB_2681600, HPA070534: " "unprognostic (2.16e-1)" "unprognostic (3.99e-1)" "unprognostic (7.13e-2)" "unprognostic (3.58e-1)" "unprognostic (9.15e-2)" "unprognostic (4.22e-3)" "unprognostic (2.16e-1)" "unprognostic (1.62e-3)" "unprognostic (2.90e-2)" "unprognostic (6.14e-2)" "prognostic favorable (8.97e-4)" "unprognostic (1.66e-1)" "prognostic favorable (1.96e-7)" "unprognostic (1.92e-2)" "unprognostic (2.18e-1)" "unprognostic (2.79e-2)" "unprognostic (1.47e-3)" 6.7 5.3 11.8 11.7 11.0 16.4 5.9 10.1 22.7 5.6 15.1 3.6 16.1 6.8 5.9 11.1 5.3 8.0 7.7 10.9 10.8 8.1 5.4 7.2 7.6 25.9 10.0 15.6 6.2 14.8 22.4 12.9 1.8 6.6 10.1 8.2 5.9 17.9 26.2 35.7 9.2 11.3 12.1 8.1 11.5 10.4 2.9 4.5 331.6 11.3 4.6 11.8 18.7 11.0 4.7 1.2 4.7 0.6 18.6 37.9 7.9 0.4 0.0 2.6 0.0 3.6 3.6 0.2 0.7 2.5 0.6 2.0 0.1 4.7 0.9 0.0 0.8 0.2 0.0 9.5 1.1 1.2 91.1 5.8 0.0 0.2 0.0 0.5 5.3 0.8 1.5 0.8 0.0 0.1 7.4 0.6 44.0 0.1 5.0 0.4 0.0 21.2 6.8 3.8 0.3 0.3 25.4 1.3 0.9 1.0 3.1 1.2 7.2 0.0 0.8 0.0 2.2 20.4 38.9 0.3 2.6 1.7 1.2 0.7 0.2 0.0 2.0 2.1 20.5 1.1 4.7 0.5 1.3 14.3 0.6 25.8 0.5 9.7 7.4 1.0 4.7 37.9 22.6 1.2 18.6 0.3 1.2 1.7 7.9 11.8 11.0 10.1 22.7 10.8 8.1 10.0 15.6 6.6 4.5 23.8 26.4 13.7 11.8 12.7 10.1 57.9 22.9 46.8 14.8 29.6 82.5 0.4 1.7 10.0 4.8 11.7 11.0 23.3 10.8 0.1 8.7 29.4 22.0 18.8 9.1 0.0 31.2 31.3 44.9 3.5 7.8 19.2 10.1 1.0 32.6 14.2 11.1 28.1 7.8 7.3 62.2 6.5 9.5 0.7 2.5 19.3 0.2 62.3 25.2 14.4 SATB2 "FLJ21474, KIAA1034" ENSG00000119042 "SATB homeobox 2" Q9UPW6 2 199269500-199471266 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, DNA-binding, Repressor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 26.1;intestine: 33.2;lymphoid tissue: 11.0" "Group enriched" "Detected in many" 7 "Enterocytes: 72.1;Intestinal endocrine cells: 95.8;Mucus-secreting cells: 76.0;Paneth cells: 48.9;Undifferentiated cells: 85.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 10.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 19.8;K-562: 21.6;THP-1: 29.5" "Group enriched" "Detected in some" 9 "amygdala: 7.9;cerebral cortex: 29.7;hippocampal formation: 19.7" "Group enriched" "Detected in many" 10 "cerebral cortex: 52.6;hippocampal formation: 45.2" "HPA001042, CAB023669, HPA029543, CAB062562, CAB067751, CAB068229, CAB068230, CAB068231" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB023669: AB_1129287, CAB062562: AB_2665615, CAB067751: AB_2665629, CAB068229: AB_2665628, CAB068230: AB_2665630, CAB068231: AB_2665631, HPA001042: AB_10601711, HPA029543: AB_10959737" "unprognostic (1.77e-2)" "unprognostic (1.90e-1)" "unprognostic (8.53e-3)" "unprognostic (4.77e-2)" "unprognostic (1.07e-1)" "unprognostic (9.39e-3)" "unprognostic (1.80e-1)" "unprognostic (5.54e-3)" "unprognostic (8.26e-2)" "unprognostic (3.75e-1)" "unprognostic (2.04e-2)" "unprognostic (1.13e-1)" "prognostic favorable (5.37e-8)" "unprognostic (1.14e-1)" "unprognostic (2.84e-1)" "unprognostic (7.95e-6)" "unprognostic (1.08e-3)" 2.4 5.0 4.5 11.0 10.0 0.5 2.0 0.5 26.1 2.3 27.9 0.4 0.4 1.4 1.7 1.1 0.9 1.1 1.4 0.7 5.6 1.6 3.6 2.8 0.8 0.6 2.3 15.5 1.9 3.4 3.1 1.1 0.8 4.6 1.9 33.2 0.1 1.5 2.6 2.1 1.7 5.0 2.9 4.9 0.7 1.0 2.4 0.0 0.0 1.6 2.4 1.0 1.6 3.1 0.2 0.0 0.0 0.7 0.0 0.5 0.1 1.2 0.8 8.9 4.1 4.3 5.2 0.6 3.0 4.5 2.2 2.9 0.2 2.9 0.4 0.1 6.6 3.5 0.2 7.0 1.8 3.6 4.5 6.1 19.8 1.7 2.4 0.9 9.0 8.8 2.5 3.3 4.4 2.9 5.8 0.2 3.0 21.6 0.0 6.5 0.4 0.4 11.2 1.6 1.0 1.4 0.8 3.0 0.1 3.4 0.3 1.9 0.0 1.5 0.0 4.6 1.6 1.8 29.5 3.0 16.3 3.0 5.1 8.1 1.3 4.2 13.0 11.2 7.2 12.8 0.0 0.1 0.0 0.2 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 4.5 10.0 0.5 26.1 5.6 1.6 2.3 15.5 4.6 0.0 0.0 0.6 0.0 2.4 1.5 1.8 1.4 0.0 0.0 0.0 0.0 3.9 0.1 1.7 0.1 0.8 0.6 72.1 0.0 2.3 0.3 0.3 3.9 0.0 4.0 0.7 0.0 95.8 1.3 2.8 0.9 2.3 1.6 5.0 0.0 76.0 0.8 1.2 48.9 1.1 4.4 0.5 0.0 11.4 4.6 4.2 2.6 0.1 0.0 85.8 1.7 SATL1 ENSG00000184788 "Spermidine/spermine N1-acetyl transferase like 1" Q86VE3 X 85092287-85243961 "Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 2.7;brain: 5.4;pituitary gland: 7.2;testis: 4.8" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 11.7;Ciliated cells: 17.4;Club cells: 12.5;Late spermatids: 10.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.3;HAP1: 3.5;HEL: 1.2;RH-30: 1.5;SH-SY5Y: 1.4;SuSa: 1.0" HPA060369 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA060369: AB_2684265" "unprognostic (1.77e-1)" "unprognostic (2.06e-1)" "unprognostic (4.69e-3)" "unprognostic (7.88e-2)" 0.3 2.7 2.9 0.4 2.6 0.4 0.4 5.4 4.6 0.4 0.4 0.2 0.0 0.3 0.4 0.3 0.3 0.4 0.3 0.5 2.2 2.0 1.1 0.4 0.3 0.3 1.1 2.7 0.4 0.3 0.3 7.2 0.4 2.2 0.5 0.4 0.0 0.4 0.3 0.7 0.6 0.3 0.3 1.4 0.4 0.3 4.8 0.4 0.0 0.4 0.2 0.3 0.4 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 3.5 0.0 0.0 0.0 0.6 1.2 0.1 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 1.5 0.0 0.0 0.1 0.5 1.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 2.6 5.4 4.6 2.2 2.0 1.1 2.7 2.2 0.4 11.9 11.7 0.0 0.0 0.0 0.0 0.0 0.0 17.4 12.5 0.0 0.0 0.0 3.3 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SAXO2 "DKFZp666G057, FAM154B" ENSG00000188659 "Stabilizer of axonemal microtubules 2" Q658L1 15 82262810-82284930 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 46.8" "Cell type enhanced" "Detected in many" 28 "Ciliated cells: 370.7;Early spermatids: 61.6;Late spermatids: 100.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 6.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 12.3;K-562: 11.2;SCLC-21H: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040487, HPA040833" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA040487: AB_10796457, HPA040833: AB_10796561" "unprognostic (3.03e-2)" "unprognostic (3.59e-1)" "unprognostic (1.91e-2)" "unprognostic (1.19e-2)" "unprognostic (1.98e-1)" "unprognostic (2.28e-1)" "unprognostic (4.13e-1)" "unprognostic (4.69e-2)" "unprognostic (6.26e-2)" "unprognostic (3.11e-2)" "unprognostic (1.04e-3)" "unprognostic (1.97e-1)" "unprognostic (2.91e-1)" "unprognostic (2.90e-2)" "unprognostic (4.71e-2)" "unprognostic (6.20e-2)" "unprognostic (3.87e-2)" 0.9 1.3 4.1 1.3 5.4 0.7 2.8 4.4 5.3 2.7 1.2 3.5 5.0 0.9 2.1 14.8 0.7 46.8 1.9 1.4 5.5 2.8 2.3 1.1 9.1 1.1 3.1 2.8 9.2 2.6 4.7 11.5 0.7 5.6 2.4 1.8 1.6 2.3 3.0 1.2 1.9 1.6 0.9 2.3 1.3 2.3 18.0 3.7 1.0 3.1 0.1 1.6 1.0 1.2 6.7 1.3 5.3 0.2 3.2 2.7 0.5 1.6 2.2 1.3 4.9 1.1 2.2 0.6 0.5 0.4 0.9 1.8 0.2 2.7 1.6 1.2 0.0 2.6 12.3 2.1 1.8 2.1 1.1 8.0 0.6 3.8 0.0 0.1 0.4 0.5 1.5 2.6 1.7 1.4 2.8 1.9 3.4 11.2 0.9 1.2 1.1 0.6 0.0 3.2 0.6 0.9 1.5 0.6 1.0 0.9 1.1 9.4 1.5 1.3 0.0 1.7 0.8 4.7 0.5 0.2 2.4 1.4 5.0 0.9 2.6 2.8 1.0 2.3 0.6 1.6 0.0 0.1 5.3 1.1 0.0 1.4 2.5 0.4 2.7 0.1 6.7 1.8 0.8 0.1 3.2 0.2 1.3 0.1 0.5 4.1 5.4 4.4 5.3 5.5 2.8 3.1 2.8 5.6 3.7 0.0 2.4 0.0 1.7 0.0 2.6 1.1 2.5 370.7 44.3 3.5 3.9 0.4 1.7 0.4 61.6 0.5 0.0 0.0 0.4 0.4 0.2 1.8 1.1 0.0 0.1 0.0 2.4 0.0 0.0 100.5 2.3 0.0 0.0 0.0 2.1 3.3 0.3 0.0 2.1 3.5 4.9 6.5 0.1 40.5 7.2 0.0 0.2 0.0 0.6 1.2 SBDS "CGI-97, FLJ10917, SDS, SWDS" ENSG00000126524 "SBDS, ribosome maturation factor" Q9Y3A5 7 66987677-66995601 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Late spermatids: 1381.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028891 Approved Supported Nucleoplasm,Cytosol NA NA 55000 "Nucleoplasm, Cytosol" "HPA028891: AB_10601500" "prognostic unfavorable (1.49e-4)" "unprognostic (1.87e-2)" "unprognostic (5.73e-2)" "unprognostic (1.71e-3)" "unprognostic (8.06e-3)" "prognostic unfavorable (3.65e-4)" "unprognostic (1.07e-1)" "unprognostic (2.22e-2)" "unprognostic (1.44e-1)" "unprognostic (6.99e-2)" "unprognostic (7.84e-3)" "unprognostic (4.59e-1)" "unprognostic (1.04e-2)" "unprognostic (9.38e-3)" "unprognostic (1.83e-1)" "unprognostic (2.30e-1)" "unprognostic (5.06e-3)" 40.9 34.5 37.7 18.7 44.0 41.7 44.5 23.6 43.2 30.7 37.5 35.3 20.2 39.1 35.6 27.3 40.8 27.7 34.0 70.0 39.2 40.9 36.9 38.4 32.1 16.7 50.6 36.6 31.9 27.5 50.4 26.9 38.6 44.6 35.1 35.7 20.1 23.5 40.5 130.7 26.1 34.4 52.0 63.2 16.7 32.8 15.9 48.2 7.2 33.9 38.7 15.6 54.0 38.0 21.6 15.5 20.8 12.6 16.6 39.1 19.4 31.4 13.3 11.8 10.7 43.2 32.3 13.2 53.5 44.1 41.0 31.5 27.4 16.2 11.7 40.6 48.9 27.1 15.3 19.9 31.8 44.1 11.1 26.3 5.7 24.9 16.4 38.5 14.6 8.0 29.1 42.8 31.1 54.2 21.2 25.2 7.7 42.2 12.8 63.6 18.8 7.7 21.2 13.1 43.4 31.7 5.9 25.5 24.4 43.2 14.1 18.2 12.5 26.8 46.4 35.5 27.3 34.6 12.4 33.5 55.4 18.9 28.0 39.0 7.9 9.3 26.7 19.0 24.0 30.6 20.8 11.1 20.2 23.4 12.6 29.6 21.6 30.6 27.2 11.3 18.7 39.1 31.5 4.7 16.6 11.2 15.5 25.9 19.4 37.7 44.0 23.6 43.2 39.2 40.9 50.6 36.6 44.6 48.2 282.9 101.3 66.6 339.3 412.4 74.2 273.7 79.0 58.9 128.5 87.2 11.8 116.1 222.2 161.5 544.8 139.6 267.8 46.7 145.1 193.1 210.9 212.5 144.6 97.2 95.0 55.6 97.9 127.7 39.0 1381.2 117.6 84.1 243.0 99.2 183.0 124.0 212.7 199.9 158.4 222.6 46.7 161.7 333.7 75.3 45.3 375.9 333.3 96.2 134.2 299.8 SBF2 "CMT4B2, DENND7B, KIAA1766, MTMR13" ENSG00000133812 "SET binding factor 2" Q86WG5 11 9778667-10294207 "Disease related genes, Predicted intracellular proteins" Autophagy "Guanine-nucleotide releasing factor" "Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 49.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050933 Uncertain Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA Nucleoplasm "Intermediate filaments, Cytosol" "HPA050933: AB_2681280" "unprognostic (2.26e-1)" "unprognostic (1.45e-2)" "unprognostic (1.91e-2)" "unprognostic (1.00e-1)" "unprognostic (2.28e-1)" "unprognostic (5.36e-2)" "unprognostic (5.55e-2)" "unprognostic (6.44e-3)" "unprognostic (2.84e-2)" "unprognostic (1.87e-1)" "unprognostic (3.62e-3)" "unprognostic (2.43e-1)" "prognostic favorable (3.66e-5)" "unprognostic (3.72e-2)" "unprognostic (8.77e-2)" "unprognostic (3.43e-1)" "unprognostic (4.11e-2)" 26.2 12.7 19.8 8.9 22.5 6.1 17.9 26.7 17.4 23.6 15.6 18.4 13.2 9.8 19.1 14.2 16.9 15.3 14.9 13.7 16.3 12.3 20.8 13.8 13.8 8.7 14.6 12.0 26.8 8.0 33.9 23.2 20.5 13.7 16.8 15.3 15.6 14.7 17.7 8.8 13.2 11.1 22.0 16.1 12.4 13.3 15.3 19.1 7.8 24.0 9.1 9.2 20.2 25.5 0.6 1.0 3.9 3.9 0.9 0.6 0.5 6.7 6.1 9.6 6.8 12.9 17.2 49.3 5.3 9.6 6.3 8.9 4.0 8.3 2.6 2.8 9.3 9.2 4.5 5.7 4.3 11.0 2.7 4.1 1.0 4.4 5.4 5.2 2.4 3.6 8.7 5.8 3.3 12.3 9.6 10.2 5.6 2.2 2.5 7.4 2.0 3.5 0.7 4.1 6.1 6.1 3.3 6.7 3.4 5.6 6.1 3.2 7.1 7.3 10.2 4.5 5.2 3.0 1.7 11.1 11.3 5.6 11.2 4.3 0.9 1.9 3.7 8.4 1.2 7.9 0.0 1.9 0.1 0.2 1.8 0.6 0.3 0.2 0.4 1.0 0.6 0.3 0.1 3.9 0.9 3.9 0.4 0.2 0.5 19.8 22.5 26.7 17.4 16.3 12.3 14.6 12.0 13.7 19.1 41.7 103.3 8.8 32.8 22.7 31.5 23.8 15.3 38.8 31.8 15.7 70.7 11.6 3.3 11.0 12.7 38.3 13.8 0.0 7.5 10.5 31.5 47.0 19.8 14.7 16.3 35.0 42.1 51.0 51.2 6.2 47.2 31.9 28.7 15.4 17.1 13.0 10.9 21.8 25.5 9.8 76.6 25.8 28.8 16.8 16.8 26.8 11.6 34.6 17.2 43.4 SBNO1 "FLJ10701, FLJ10833, MOP3, Sno" ENSG00000139697 "Strawberry notch homolog 1" A3KN83 12 123289109-123364843 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 57.1" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 294.5;Spermatogonia: 190.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042388 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA042388: AB_10795704" "unprognostic (1.61e-2)" "unprognostic (9.61e-2)" "unprognostic (5.12e-2)" "unprognostic (2.54e-3)" "unprognostic (3.50e-1)" "unprognostic (3.59e-2)" "unprognostic (1.21e-2)" "unprognostic (1.48e-1)" "unprognostic (5.33e-2)" "unprognostic (2.22e-1)" "unprognostic (2.22e-1)" "unprognostic (1.22e-1)" "unprognostic (6.61e-3)" "unprognostic (2.06e-1)" "unprognostic (3.74e-1)" "unprognostic (2.44e-1)" "unprognostic (1.49e-2)" 7.6 7.6 12.9 9.8 12.2 21.4 9.0 24.3 15.9 9.4 8.6 6.4 6.9 7.4 10.9 6.4 10.7 9.3 6.4 7.5 11.3 9.2 9.5 11.0 7.4 12.7 12.1 10.9 10.4 9.5 13.7 15.6 11.8 12.2 10.2 9.5 5.3 7.2 9.1 11.2 8.6 10.1 10.0 9.7 9.4 8.7 57.1 12.3 19.5 14.6 4.8 12.0 8.6 10.4 11.6 8.1 13.8 13.5 7.9 14.7 6.7 11.3 22.1 8.9 16.5 12.7 9.9 18.5 10.4 10.4 9.3 7.8 15.6 7.4 24.5 12.5 11.9 10.4 13.5 18.8 11.6 15.4 18.0 7.1 23.8 13.8 12.6 6.5 29.0 20.7 7.8 9.2 13.0 12.8 10.1 9.1 13.6 29.2 8.0 16.0 11.5 16.0 11.7 13.5 9.8 11.5 17.2 13.0 12.6 7.2 29.6 15.1 6.4 18.1 12.8 9.6 10.9 22.2 10.1 12.0 12.6 16.0 14.9 9.2 8.1 17.2 31.3 7.2 17.3 14.2 8.3 8.2 10.9 12.6 9.6 14.7 11.6 12.2 12.5 8.1 9.7 12.0 12.9 13.8 7.9 13.5 7.6 9.4 6.7 12.9 12.2 24.3 15.9 11.3 9.2 12.1 10.9 12.2 12.3 26.8 18.8 38.5 40.3 56.2 86.0 31.1 22.9 37.5 33.0 34.9 74.6 55.8 19.9 28.9 42.5 25.9 21.1 0.0 23.7 43.8 36.7 29.8 28.8 23.6 23.9 60.4 38.6 28.3 35.1 26.7 23.6 31.9 32.1 54.1 22.7 48.9 30.2 17.5 57.0 23.2 55.9 25.8 44.2 294.5 190.1 53.6 88.7 42.7 36.6 41.3 SC5D SC5DL ENSG00000109929 Sterol-C5-desaturase O75845 11 121292453-121308694 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 143.5" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 117.3;Ito cells: 163.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066283, HPA070248" Enhanced Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol" No No "Nucleoplasm, Endoplasmic reticulum" "Plasma membrane, Cytosol" "HPA066283: AB_2685648, HPA070248: AB_2686240" "unprognostic (4.78e-2)" "unprognostic (7.29e-2)" "unprognostic (2.26e-2)" "unprognostic (2.36e-1)" "unprognostic (3.98e-2)" "prognostic unfavorable (3.30e-4)" "unprognostic (2.79e-2)" "unprognostic (7.96e-2)" "prognostic unfavorable (3.98e-4)" "unprognostic (4.03e-2)" "unprognostic (3.18e-2)" "unprognostic (1.01e-1)" "prognostic favorable (1.07e-7)" "unprognostic (4.29e-2)" "unprognostic (2.51e-1)" "unprognostic (2.29e-1)" "unprognostic (1.98e-1)" 10.9 15.3 16.9 5.5 18.4 2.7 23.3 10.4 26.9 9.4 9.4 17.8 24.5 17.4 6.8 30.1 19.5 7.2 7.4 9.4 18.7 19.6 19.7 143.5 10.1 5.5 20.8 17.8 7.8 8.9 17.5 14.7 6.3 40.8 40.3 8.6 8.2 9.5 24.0 3.9 7.7 13.4 7.6 43.4 4.1 8.8 9.7 16.0 3.7 10.4 8.2 8.1 14.0 14.6 6.0 9.8 7.5 6.3 6.8 10.0 3.8 6.8 3.4 51.8 11.0 20.1 17.5 7.3 7.7 14.5 5.2 9.2 21.6 25.5 6.5 24.4 8.4 41.5 25.7 16.1 19.5 5.1 3.2 22.0 9.6 22.6 17.2 16.4 6.0 3.3 14.3 16.0 16.4 16.9 4.4 7.8 6.4 6.2 9.4 24.0 7.1 2.4 7.9 16.1 19.8 11.0 3.4 13.0 5.5 36.5 30.8 13.7 7.7 17.7 4.0 10.1 36.2 16.2 10.4 14.9 5.0 8.1 8.8 3.6 1.8 2.9 8.7 1.9 13.4 8.6 7.5 4.8 1.2 5.0 6.3 8.5 6.0 6.8 6.0 8.5 6.0 10.0 9.5 0.4 6.8 4.5 9.8 6.9 3.8 16.9 18.4 10.4 26.9 18.7 19.6 20.8 17.8 40.8 16.0 17.9 26.4 26.2 53.7 8.7 21.9 17.8 15.3 14.7 18.2 19.2 29.5 13.8 5.0 17.3 2.2 8.4 23.5 0.0 25.4 14.2 17.3 59.7 17.3 117.3 17.9 22.3 13.8 163.9 25.6 1.0 17.8 15.1 18.6 22.6 12.7 40.5 14.5 11.4 15.9 14.6 29.6 12.9 16.7 6.0 13.0 13.6 15.6 21.7 11.9 45.5 SCAF1 "FLJ00034, SR-A1" ENSG00000126461 "SR-related CTD associated factor 1" Q9H7N4 19 49642125-49658642 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 73.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046828, HPA054593" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA046828: AB_10961907, HPA054593: AB_2682536" "unprognostic (1.16e-1)" "unprognostic (3.08e-1)" "prognostic unfavorable (9.59e-4)" "unprognostic (3.38e-2)" "unprognostic (1.79e-1)" "unprognostic (2.10e-1)" "unprognostic (4.43e-3)" "unprognostic (4.11e-3)" "unprognostic (1.01e-1)" "unprognostic (8.30e-3)" "unprognostic (1.29e-2)" "unprognostic (3.52e-3)" "unprognostic (4.78e-2)" "unprognostic (3.03e-1)" "unprognostic (2.15e-1)" "unprognostic (1.63e-1)" "unprognostic (3.18e-2)" 21.6 15.6 22.2 17.0 30.5 14.4 12.9 24.9 48.3 14.1 15.0 27.0 7.4 18.2 18.9 7.4 27.2 24.0 17.2 21.3 21.4 18.9 12.4 13.9 13.9 17.7 17.5 21.6 24.1 21.1 13.7 17.5 18.4 26.1 15.0 8.6 14.1 20.8 11.8 28.4 18.5 17.0 14.6 14.8 20.2 17.0 15.9 15.7 19.7 18.4 8.4 13.1 16.9 13.6 5.1 5.1 7.8 2.9 1.9 4.2 3.2 26.5 46.7 12.8 21.1 6.1 5.8 15.6 20.1 6.6 9.4 8.0 25.3 16.6 15.5 13.8 7.4 14.3 20.5 9.2 12.3 2.8 23.9 26.2 17.4 23.1 12.6 10.5 16.5 17.3 9.7 7.8 11.3 8.0 9.2 7.6 6.4 22.4 16.0 7.4 17.1 16.5 8.8 16.3 12.1 28.0 20.5 17.8 16.0 6.2 38.5 19.1 20.9 20.7 21.9 7.4 8.2 15.2 9.2 20.8 34.4 19.9 12.2 29.4 22.7 33.7 14.8 20.7 10.5 19.4 4.0 2.9 2.7 4.2 2.5 2.7 5.1 2.4 2.8 2.3 4.7 2.2 2.4 7.8 1.9 2.2 5.1 0.5 3.2 22.2 30.5 24.9 48.3 21.4 18.9 17.5 21.6 26.1 15.7 6.0 0.0 14.5 7.4 10.8 11.9 2.4 12.7 0.0 0.0 21.0 3.9 12.5 6.6 11.8 26.1 4.5 25.6 0.0 11.2 11.6 9.9 10.2 5.7 14.4 12.3 9.5 13.8 17.8 9.2 73.7 20.4 6.3 10.1 10.8 18.1 9.9 13.8 17.6 22.3 11.2 6.9 12.9 8.2 13.7 19.2 10.5 18.4 8.9 17.2 10.2 SCAF11 "CASP11, SFRS2IP, SIP1, SRRP129, SRSF2IP" ENSG00000139218 "SR-related CTD associated factor 11" Q99590 12 45919131-45992120 "Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038862, HPA045456, HPA046345" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA038862: AB_10672830, HPA045456: AB_2679331, HPA046345: AB_2679630" "unprognostic (2.83e-2)" "unprognostic (4.10e-2)" "unprognostic (2.01e-1)" "unprognostic (5.88e-2)" "unprognostic (1.19e-1)" "unprognostic (5.19e-3)" "unprognostic (6.67e-3)" "unprognostic (9.00e-2)" "unprognostic (1.37e-2)" "unprognostic (1.30e-2)" "unprognostic (4.10e-2)" "unprognostic (2.15e-2)" "unprognostic (6.30e-3)" "unprognostic (1.68e-1)" "unprognostic (2.76e-1)" "unprognostic (4.30e-2)" "unprognostic (4.13e-2)" 34.4 17.0 17.5 34.1 19.5 46.1 25.8 19.1 17.9 29.0 24.5 12.4 29.0 17.0 25.1 25.9 25.8 21.0 21.1 33.6 15.8 16.6 27.9 32.2 27.8 29.9 19.2 12.5 31.7 21.3 32.7 26.8 23.0 20.6 26.5 21.4 15.3 24.3 31.0 35.4 24.1 30.7 25.5 21.7 38.1 17.4 22.7 20.6 42.3 27.8 21.9 28.6 29.1 33.9 18.4 19.2 32.8 13.6 12.9 15.3 7.9 15.1 13.8 17.1 14.2 11.8 16.2 15.9 17.9 14.6 15.5 11.3 49.4 16.7 31.8 20.2 19.0 9.2 15.0 17.5 14.4 17.7 17.4 11.8 29.6 18.3 12.9 9.3 31.0 20.0 13.4 15.5 13.3 20.2 17.9 15.9 13.9 22.6 17.5 19.5 14.3 23.2 17.3 13.3 0.2 18.8 18.9 23.0 16.0 14.7 19.4 9.9 10.1 19.8 17.0 9.6 14.2 15.8 33.6 19.7 16.0 13.2 12.0 9.5 12.7 9.4 52.0 13.5 66.8 6.1 20.9 13.0 17.3 14.7 12.5 13.3 17.7 13.9 14.1 9.8 18.4 15.3 13.7 32.8 12.9 13.6 19.2 12.4 7.9 17.5 19.5 19.1 17.9 15.8 16.6 19.2 12.5 20.6 20.6 163.8 142.7 110.7 106.1 114.1 130.0 160.2 84.1 199.4 167.2 75.0 119.8 73.3 46.4 103.3 42.7 114.7 93.2 23.3 93.9 58.9 105.3 100.7 213.0 117.3 96.4 101.7 99.3 118.4 141.0 26.6 112.8 152.3 64.1 130.8 108.9 103.7 84.4 88.0 97.6 67.1 187.2 122.9 106.1 130.4 56.4 105.3 51.0 110.7 86.0 129.0 SCAF4 "DKFZp434E098, KIAA1172, SFRS15, SRA4" ENSG00000156304 "SR-related CTD associated factor 4" O95104 21 31671033-31732075 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018319, HPA018668, HPA021504, HPA028807" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA018319: AB_1856784, HPA018668: AB_1856783, HPA021504: AB_1856785, HPA028807: AB_10602927" "unprognostic (9.18e-2)" "unprognostic (1.17e-1)" "unprognostic (9.29e-2)" "unprognostic (1.79e-1)" "unprognostic (1.88e-1)" "unprognostic (1.85e-2)" "unprognostic (3.99e-3)" "unprognostic (4.31e-1)" "unprognostic (2.19e-1)" "unprognostic (2.66e-2)" "unprognostic (3.28e-1)" "unprognostic (6.11e-2)" "unprognostic (1.85e-3)" "unprognostic (2.87e-1)" "unprognostic (7.65e-3)" "unprognostic (1.10e-1)" "unprognostic (2.16e-3)" 18.8 14.9 15.1 32.7 16.3 19.0 18.4 24.0 21.4 19.9 23.2 20.3 12.9 19.4 21.6 17.6 22.3 16.8 22.3 15.4 13.2 11.5 14.0 22.5 19.0 27.1 15.3 11.9 23.9 18.5 23.7 18.1 20.3 14.3 17.6 16.8 17.1 18.4 19.3 23.3 24.2 21.9 16.1 13.3 23.7 17.9 25.6 14.6 44.2 16.5 12.8 26.4 18.9 20.4 14.1 12.0 12.7 13.2 9.6 12.8 8.4 14.0 9.4 18.9 13.7 10.2 7.9 12.9 10.5 11.1 11.1 10.4 17.9 10.2 28.9 6.4 10.2 12.2 8.8 20.5 10.2 12.3 12.9 12.2 23.0 7.3 14.9 11.8 24.5 9.7 8.7 11.6 14.9 12.8 7.1 9.7 11.6 30.4 15.1 9.2 18.9 26.0 17.9 24.3 13.8 8.1 25.8 21.1 9.5 7.7 11.1 13.0 14.1 16.1 12.5 9.1 10.9 9.6 16.5 11.2 11.6 11.2 11.1 10.6 9.8 9.0 33.4 8.3 19.8 10.8 8.2 9.4 12.7 12.8 13.2 12.8 14.1 7.5 12.1 12.0 14.0 8.8 9.5 5.0 9.6 11.4 8.4 6.6 8.4 15.1 16.3 24.0 21.4 13.2 11.5 15.3 11.9 14.3 14.6 6.0 9.7 35.8 31.3 41.4 22.2 7.9 15.3 20.1 12.5 10.4 23.6 14.1 3.3 14.7 7.8 15.8 31.5 23.3 12.1 13.5 20.6 25.6 11.5 19.8 13.5 20.6 19.0 18.4 19.1 2.0 20.4 14.9 32.1 16.2 16.7 15.3 14.7 18.4 13.4 5.0 22.8 12.9 17.5 20.9 22.2 35.9 15.8 20.0 19.6 28.7 SCAF8 "KIAA1116, RBM16" ENSG00000213079 "SR-related CTD associated factor 8" Q9UPN6 6 154733325-154834244 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035601, HPA035602" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035601: AB_2674698, HPA035602: AB_10673220" "unprognostic (4.60e-3)" "unprognostic (3.67e-2)" "unprognostic (7.90e-3)" "unprognostic (2.50e-2)" "unprognostic (6.18e-2)" "unprognostic (1.13e-1)" "unprognostic (1.01e-2)" "unprognostic (3.41e-2)" "unprognostic (2.05e-1)" "prognostic unfavorable (6.61e-4)" "unprognostic (3.65e-1)" "unprognostic (2.08e-1)" "unprognostic (9.08e-2)" "unprognostic (2.66e-1)" "unprognostic (1.52e-1)" "unprognostic (2.42e-1)" "unprognostic (1.11e-1)" 27.9 19.1 17.4 32.0 19.1 36.1 27.5 28.1 22.2 30.0 23.4 18.2 20.8 14.2 28.3 21.6 18.5 25.1 21.9 19.3 16.9 13.4 19.8 17.6 19.6 23.5 16.2 15.1 32.6 20.0 33.6 24.1 23.8 14.8 24.4 20.7 17.9 21.9 30.1 28.5 26.9 21.2 23.8 14.3 21.7 19.9 25.4 20.2 42.6 24.7 20.1 22.8 26.1 32.9 5.4 3.3 3.8 6.7 6.1 7.5 2.6 8.5 8.4 24.9 15.0 16.8 17.3 15.3 14.1 19.9 18.7 19.0 13.1 8.7 26.9 11.5 16.2 16.6 11.7 21.9 18.6 25.1 11.7 11.0 24.1 9.1 16.0 19.5 22.2 16.2 18.6 19.8 16.3 25.6 14.5 15.8 11.9 27.9 16.4 17.1 15.6 23.7 15.1 17.3 13.2 6.3 22.8 13.6 14.5 15.8 15.8 15.4 18.0 14.7 19.4 10.7 18.7 12.7 25.9 14.4 10.7 13.0 13.8 14.2 15.4 11.3 29.8 13.3 13.9 16.5 1.2 2.8 3.5 6.0 3.9 5.8 4.8 6.2 5.9 3.3 5.4 6.3 5.6 3.8 6.1 6.7 3.2 7.5 2.6 17.4 19.1 28.1 22.2 16.9 13.4 16.2 15.1 14.8 20.2 23.8 18.6 14.1 10.3 11.2 17.7 31.1 7.6 13.4 9.1 12.2 23.6 9.2 1.7 9.3 2.7 13.5 12.2 0.0 10.2 7.4 13.5 10.4 33.5 10.4 11.2 12.7 12.5 19.6 25.1 4.2 15.3 11.4 10.1 6.4 13.9 14.8 11.9 8.6 11.7 5.3 18.6 25.8 8.2 21.4 22.4 9.4 8.9 10.0 13.6 12.8 SCAI "C9orf126, FLJ36664, NET40" ENSG00000173611 "Suppressor of cancer cell invasion" Q8N9R8 9 124942608-125143506 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Repressor, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 34.4" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 65.5;Cone photoreceptor cells: 188.5;Rod photoreceptor cells: 114.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020632 Approved Supported "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA020632: AB_1845804" "unprognostic (1.93e-1)" "unprognostic (1.88e-2)" "unprognostic (1.42e-1)" "unprognostic (2.93e-2)" "unprognostic (6.90e-2)" "unprognostic (3.34e-3)" "unprognostic (7.75e-2)" "unprognostic (4.54e-3)" "unprognostic (5.69e-2)" "unprognostic (2.78e-1)" "unprognostic (4.72e-3)" "unprognostic (1.47e-1)" "unprognostic (1.87e-2)" "unprognostic (3.57e-2)" "unprognostic (6.40e-2)" "unprognostic (1.96e-1)" "unprognostic (1.26e-3)" 4.5 6.5 9.5 6.4 14.3 6.8 5.4 9.5 19.1 5.0 4.5 3.5 3.1 3.3 5.9 4.6 4.1 6.1 3.7 3.7 7.1 7.9 4.4 3.8 8.5 7.2 4.6 12.0 7.6 4.6 5.7 4.6 2.7 4.8 5.5 5.0 12.4 3.7 3.3 4.2 6.6 4.0 4.0 4.0 5.0 4.4 5.2 5.1 34.4 5.3 2.1 6.2 4.2 4.5 2.9 3.1 1.5 1.7 2.5 2.6 1.3 3.7 2.9 3.9 3.7 2.2 5.3 6.5 2.3 4.9 2.5 3.6 3.7 3.6 6.7 1.8 2.3 3.0 6.3 5.0 2.6 5.2 4.7 1.8 4.4 5.3 3.2 3.0 4.7 3.4 2.0 2.3 3.9 2.6 4.3 3.6 12.2 6.2 7.9 3.8 4.0 14.9 3.2 3.8 7.2 3.2 9.4 6.2 5.8 1.7 5.1 4.0 2.5 5.5 3.1 2.9 4.4 7.6 2.1 3.7 2.3 4.3 3.8 4.0 4.4 8.3 6.4 2.8 3.8 3.4 0.8 1.2 0.2 1.1 1.7 1.2 2.0 1.9 1.3 0.8 2.9 2.6 1.8 1.5 2.5 0.6 3.1 2.6 1.3 9.5 14.3 9.5 17.0 7.1 7.9 4.6 12.0 4.8 5.1 65.5 23.3 13.0 7.7 2.5 39.5 3.9 17.8 9.4 12.5 17.4 188.5 5.6 1.7 3.0 9.2 6.8 5.0 0.0 1.8 4.3 5.4 6.4 4.7 7.6 3.5 15.9 12.6 13.5 5.6 4.1 8.9 3.2 3.3 1.8 7.1 32.7 2.2 6.6 5.6 1.9 114.6 0.0 3.8 27.2 20.4 3.8 2.2 8.7 8.6 3.7 SCAMP1 SCAMP37 ENSG00000085365 "Secretory carrier membrane protein 1" O15126 5 78360583-78479071 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044753, CAB079009" Supported Approved "Nucleoplasm,Vesicles,Cell Junctions" NA NA "Nucleoplasm, Vesicles, Cell Junctions" "CAB079009: , HPA044753: " "unprognostic (8.25e-2)" "unprognostic (3.65e-2)" "unprognostic (1.40e-3)" "unprognostic (5.34e-3)" "unprognostic (2.60e-1)" "unprognostic (2.57e-3)" "unprognostic (5.51e-2)" "unprognostic (3.43e-2)" "unprognostic (1.31e-1)" "unprognostic (8.23e-3)" "unprognostic (2.35e-2)" "unprognostic (2.56e-1)" "prognostic favorable (1.92e-4)" "unprognostic (8.44e-3)" "unprognostic (7.56e-2)" "unprognostic (3.12e-2)" "unprognostic (4.99e-2)" 7.5 8.3 9.2 4.0 19.3 2.4 10.0 12.8 19.5 8.4 6.4 5.4 9.9 5.3 8.7 9.3 8.6 10.7 6.4 8.0 15.8 10.4 6.2 5.9 3.9 6.5 15.8 8.8 8.8 17.5 14.6 7.6 14.6 12.2 7.3 7.6 10.6 11.0 4.7 5.8 5.3 9.1 9.0 3.9 9.6 4.5 7.1 4.1 14.2 3.8 3.7 8.8 6.3 7.9 14.9 15.3 15.8 10.0 9.9 7.4 12.5 9.9 9.9 30.6 13.7 17.7 15.6 11.6 16.9 9.6 21.9 3.7 23.5 18.5 13.1 16.9 27.5 10.2 14.0 21.8 17.2 6.5 13.3 8.5 7.9 7.6 8.8 5.4 6.6 11.6 20.2 10.9 17.3 24.2 14.6 10.4 3.2 13.3 18.2 14.7 9.3 11.5 8.0 5.4 10.2 11.4 16.3 21.1 17.5 14.9 28.1 17.1 10.7 15.2 10.9 10.5 21.1 9.8 14.9 10.6 7.9 11.7 9.7 9.3 11.2 11.5 20.7 20.3 8.8 15.3 11.4 12.8 8.2 12.6 9.9 7.9 9.4 9.8 14.9 6.6 7.8 6.8 7.0 10.0 15.8 4.6 9.1 7.4 23.8 19.0 6.7 28.6 34.8 72.3 33.0 20.4 71.0 26.1 38.4 66.8 10.4 11.6 22.7 31.3 27.8 11.7 23.3 26.3 21.3 31.0 36.1 11.5 13.9 16.8 30.2 34.0 22.1 30.5 12.1 18.7 22.7 28.7 6.4 33.6 43.2 26.4 11.5 26.9 20.5 63.0 12.9 25.0 17.0 20.4 39.5 8.8 13.8 17.0 25.0 SCAPER "Zfp291, ZNF291" ENSG00000140386 "S-phase cyclin A associated protein in the ER" Q9BY12 15 76347904-76905444 "Predicted intracellular proteins" "Disease mutation, Mental retardation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Cone photoreceptor cells: 237.6;Rod photoreceptor cells: 661.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046253, HPA048077" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA No "Nucleoplasm, Nuclear speckles" Cytosol "HPA046253: AB_2679600, HPA048077: " "unprognostic (3.67e-1)" "unprognostic (8.60e-2)" "unprognostic (6.08e-2)" "unprognostic (8.37e-2)" "unprognostic (1.48e-1)" "unprognostic (1.63e-1)" "unprognostic (1.37e-1)" "unprognostic (2.76e-2)" "unprognostic (4.94e-2)" "unprognostic (3.74e-2)" "unprognostic (5.40e-2)" "unprognostic (1.02e-1)" "prognostic favorable (2.69e-9)" "unprognostic (2.14e-1)" "unprognostic (3.79e-1)" "unprognostic (1.86e-1)" "unprognostic (2.89e-3)" 9.0 10.9 17.0 9.3 15.6 8.8 9.4 26.0 20.7 10.3 8.3 10.7 9.8 8.9 10.0 10.8 12.1 9.0 7.5 17.8 15.9 17.2 12.6 9.9 8.4 7.1 17.3 13.2 16.8 10.9 24.1 36.3 24.6 15.6 9.9 6.3 7.7 9.7 9.5 17.9 9.8 8.3 10.4 20.6 7.5 7.9 25.7 14.7 12.6 16.3 8.7 7.7 9.4 9.5 13.2 6.6 20.4 4.6 12.0 14.3 2.8 5.0 4.7 6.6 3.8 3.3 6.2 5.5 7.0 4.9 3.2 4.6 5.0 4.1 5.1 6.1 2.3 8.6 5.5 15.5 2.9 4.8 11.9 7.6 2.7 5.7 2.4 4.3 7.2 6.4 5.1 5.2 3.8 6.2 7.0 4.3 10.5 3.8 14.6 5.5 2.1 7.0 2.2 2.0 4.7 2.8 6.4 10.5 1.8 2.9 5.2 15.7 7.6 9.2 3.2 7.5 8.4 4.8 6.0 5.2 7.4 6.9 3.5 6.0 8.9 18.6 7.6 4.3 9.1 4.9 20.4 4.6 11.5 8.6 2.5 9.8 11.0 8.7 7.6 2.5 13.2 14.3 9.1 7.7 12.0 2.9 6.6 6.6 2.8 17.0 15.6 26.0 17.1 15.9 17.2 17.3 13.2 15.6 14.7 92.3 52.8 16.4 22.9 18.3 84.2 167.4 15.3 16.0 40.9 12.2 237.6 23.7 1.7 11.6 45.9 22.0 20.2 0.0 5.1 9.4 13.4 12.1 20.9 7.9 11.7 73.1 15.5 19.0 11.0 17.8 19.0 10.3 10.1 3.6 7.7 46.4 5.9 11.6 18.0 5.7 661.5 19.4 11.7 121.4 69.5 16.4 43.5 21.2 12.4 19.7 SCARF2 "HUMZD58C02, SREC-II, SREC2" ENSG00000244486 "Scavenger receptor class F member 2" Q96GP6 22 20424815-20437826 "Disease related genes, Predicted membrane proteins" "Cell adhesion" Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 28.8;Fibroblasts: 17.0;Leydig cells: 12.4;Peritubular cells: 16.6;Sertoli cells: 12.9;Smooth muscle cells: 14.4" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ: 14.2;SH-SY5Y: 15.8;SK-MEL-30: 15.7;U-138 MG: 21.8;U-2 OS: 22.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA035079 Approved Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 360000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA035079: AB_10670287" "unprognostic (2.12e-1)" "unprognostic (2.16e-2)" "unprognostic (2.06e-2)" "unprognostic (1.06e-3)" "unprognostic (2.29e-1)" "unprognostic (2.92e-1)" "unprognostic (7.68e-2)" "unprognostic (7.87e-2)" "unprognostic (8.27e-2)" "unprognostic (2.18e-2)" "unprognostic (1.68e-1)" "unprognostic (2.94e-1)" "prognostic unfavorable (2.78e-5)" "unprognostic (4.38e-3)" "unprognostic (3.18e-2)" "unprognostic (3.00e-3)" "prognostic unfavorable (4.28e-4)" 6.5 2.4 0.0 4.1 0.3 0.1 9.2 0.0 1.2 10.6 3.2 0.4 2.9 1.4 8.1 6.6 1.8 2.6 11.3 3.4 0.6 3.2 1.1 5.9 5.1 0.8 0.4 12.6 1.6 0.0 0.6 5.6 0.9 5.5 0.0 9.2 1.1 6.8 1.8 2.2 1.9 9.9 0.5 5.3 1.4 2.5 0.0 0.0 5.4 3.3 1.4 7.1 10.9 0.1 0.1 0.9 0.0 0.0 1.8 0.0 0.4 0.2 3.2 5.5 1.9 2.7 1.3 14.2 5.9 3.4 1.8 0.0 0.0 0.2 8.3 6.8 0.2 0.1 1.8 0.0 0.4 0.4 11.9 1.1 0.2 2.5 11.8 0.0 0.6 4.6 0.0 1.7 0.8 1.6 1.7 0.0 0.1 0.1 1.2 0.6 0.0 0.2 4.3 0.0 1.8 0.3 9.0 0.0 0.0 0.0 1.4 15.8 0.1 0.0 15.7 0.6 0.5 0.0 2.1 21.8 22.9 0.5 3.2 0.6 0.2 0.2 0.1 0.3 10.8 0.0 0.0 0.9 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 1.7 2.5 3.0 28.8 0.0 0.0 0.0 0.0 2.0 0.3 0.0 0.0 0.2 3.3 0.0 0.0 0.0 1.2 17.0 2.2 0.0 0.0 0.5 0.0 0.0 2.5 0.6 0.0 12.4 0.6 3.3 0.0 0.0 0.5 0.0 0.0 16.6 0.0 0.4 12.9 14.4 0.5 0.2 2.4 0.3 0.0 0.0 0.5 SCEL "FLJ21667, MGC22531" ENSG00000136155 Sciellin O95171 13 77535674-77645263 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 145.6;skin 1: 70.8;tongue: 62.2" "Cell type enriched" "Detected in many" 13 "Alveolar cells type 1: 631.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 12.4;HaCaT: 23.3;HBEC3-KT: 11.1;OE19: 31.1;RPTEC TERT1: 45.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA039737, HPA040154" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" No No "Plasma membrane" "Nucleoplasm, Cytosol" "HPA039737: AB_10805485, HPA040154: AB_10795359" "unprognostic (1.18e-1)" "unprognostic (1.17e-1)" "unprognostic (2.00e-1)" "prognostic unfavorable (4.07e-4)" "unprognostic (5.91e-2)" "unprognostic (4.54e-2)" "unprognostic (6.62e-2)" "unprognostic (3.51e-1)" "unprognostic (8.08e-3)" "prognostic unfavorable (1.24e-4)" "unprognostic (4.57e-2)" "prognostic favorable (6.87e-4)" "unprognostic (1.81e-1)" "unprognostic (2.82e-1)" "unprognostic (1.75e-3)" "prognostic unfavorable (1.73e-5)" 0.4 0.0 0.1 0.2 0.4 0.0 4.9 0.1 0.2 15.2 0.2 0.2 0.1 0.0 0.8 0.2 145.6 0.0 0.3 0.1 0.1 0.0 0.4 0.1 27.8 0.1 0.1 0.1 0.2 0.1 0.0 0.1 3.7 0.2 0.1 0.4 0.1 11.8 0.1 0.3 70.8 0.2 0.1 0.2 0.1 0.0 0.5 0.1 0.4 0.5 62.2 35.1 0.4 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.7 0.0 0.0 23.3 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.1 6.3 0.0 0.0 0.0 45.3 0.0 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 631.3 30.6 0.0 0.0 9.5 0.0 0.2 0.0 6.7 42.1 0.0 0.0 0.3 0.0 4.1 5.8 0.0 0.0 0.0 0.2 0.0 0.3 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.6 1.7 0.0 4.3 1.5 26.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.7 48.8 0.1 0.0 0.0 2.6 SCFD1 "C14orf163, KIAA0917, RA410, SLY1, STXBP1L2" ENSG00000092108 "Sec1 family domain containing 1" Q8WVM8 14 30622112-30735812 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003579 Approved Approved Nucleoplasm,Cytosol NA NA 59000 Nucleoplasm Cytosol "HPA003579: AB_1079872" "unprognostic (2.33e-1)" "unprognostic (1.04e-1)" "unprognostic (1.07e-1)" "unprognostic (2.50e-1)" "unprognostic (1.81e-1)" "unprognostic (1.08e-2)" "unprognostic (1.24e-2)" "unprognostic (1.21e-1)" "unprognostic (3.21e-2)" "unprognostic (3.07e-2)" "unprognostic (8.35e-2)" "unprognostic (2.65e-1)" "unprognostic (7.52e-3)" "unprognostic (1.05e-1)" "unprognostic (3.08e-1)" "unprognostic (3.05e-1)" "unprognostic (6.32e-2)" 22.4 22.7 20.6 17.6 29.7 15.5 21.7 21.9 28.1 27.7 20.0 12.6 19.3 17.1 20.5 23.3 25.9 19.0 13.4 20.9 19.2 17.8 24.5 33.9 18.8 16.6 16.5 19.4 21.8 33.8 28.5 68.5 29.4 26.0 20.3 21.9 14.5 34.5 22.3 24.7 15.7 22.0 19.6 15.6 20.4 18.8 18.8 17.1 24.4 31.0 18.0 19.0 17.2 22.3 14.3 16.3 18.8 17.2 19.4 15.9 9.2 24.4 10.6 13.6 9.0 22.4 25.3 19.8 18.3 25.5 27.0 32.1 17.2 18.5 13.5 8.8 28.9 12.0 14.2 16.7 19.3 31.5 18.9 9.2 9.3 14.9 58.0 28.1 17.4 12.1 18.8 14.8 16.6 28.3 19.2 18.3 8.5 15.3 25.8 26.6 28.8 10.7 10.1 13.0 24.3 18.7 9.4 14.9 16.3 21.8 21.2 14.2 11.9 17.7 17.7 18.1 14.4 25.9 13.0 14.7 18.7 14.4 15.6 15.2 17.8 16.6 18.5 8.8 13.5 19.4 18.8 13.4 15.6 9.6 14.4 12.4 14.3 11.1 12.0 16.3 12.3 10.5 10.7 4.3 19.4 17.2 13.3 15.9 9.2 20.6 29.7 21.9 28.1 19.2 17.8 16.5 19.4 26.0 17.1 47.6 25.3 39.5 46.3 22.1 34.1 32.1 20.4 52.2 36.4 24.4 41.2 55.2 54.7 40.9 20.1 30.2 26.5 23.3 44.2 52.3 39.9 39.2 51.0 18.5 40.8 28.6 45.3 22.1 24.6 13.2 35.6 40.1 35.4 67.7 33.2 29.7 37.5 25.9 37.8 30.5 39.0 12.9 31.2 66.2 51.7 21.3 69.5 39.9 24.8 40.0 SCFD2 "FLJ39514, STXBP1L1" ENSG00000184178 "Sec1 family domain containing 2" Q8WU76 4 52872982-53366075 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036526, HPA036527" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA036526: AB_10673499, HPA036527: AB_2675175" "unprognostic (1.50e-2)" "unprognostic (7.99e-2)" "unprognostic (2.99e-2)" "unprognostic (3.31e-1)" "unprognostic (4.22e-2)" "unprognostic (6.16e-2)" "unprognostic (1.27e-2)" "unprognostic (7.08e-2)" "unprognostic (4.02e-2)" "unprognostic (4.29e-2)" "unprognostic (1.12e-1)" "unprognostic (2.78e-1)" "prognostic favorable (3.81e-6)" "unprognostic (9.39e-3)" "unprognostic (1.10e-1)" "unprognostic (4.86e-3)" "unprognostic (2.51e-2)" 13.7 19.4 11.0 15.8 15.1 12.5 13.7 7.8 17.6 12.9 11.7 16.2 6.5 10.5 14.2 9.0 16.7 9.9 10.0 11.9 11.5 13.2 13.6 17.2 10.4 12.7 15.7 9.3 13.2 18.3 11.4 15.3 11.2 16.4 8.7 11.8 10.5 13.0 10.4 13.8 13.5 10.7 14.2 13.2 12.7 10.6 5.1 12.4 16.2 10.1 10.2 19.3 10.4 12.1 6.5 15.9 1.4 9.7 13.9 9.5 9.1 6.6 6.2 3.6 8.3 11.9 12.1 4.4 15.5 11.7 5.4 4.6 4.4 8.6 12.7 12.0 29.5 5.7 4.2 11.5 13.5 10.4 3.9 6.7 7.1 6.6 5.3 5.6 8.4 13.1 8.3 8.2 10.4 4.1 5.2 9.1 3.4 12.0 7.4 9.2 7.7 12.4 5.4 2.1 19.1 7.8 7.7 3.3 13.4 6.0 4.5 10.3 5.8 3.5 13.1 6.9 4.3 5.1 4.1 8.4 11.8 7.5 13.3 11.3 8.7 4.7 15.0 8.0 10.5 33.5 0.0 5.6 1.4 7.8 9.7 7.8 6.5 6.4 8.8 15.9 5.7 9.5 8.6 1.2 13.9 9.3 10.3 5.5 9.1 11.0 15.1 7.8 16.9 11.5 13.2 15.7 9.3 16.4 12.4 0.0 1.9 7.5 4.6 3.3 3.3 2.8 15.3 5.3 0.0 3.5 5.9 6.7 1.7 3.5 1.8 3.0 2.2 0.0 4.5 6.2 5.1 2.5 12.7 5.3 4.7 4.8 1.2 3.1 2.7 1.7 6.1 3.9 5.0 0.0 3.0 3.8 2.2 2.9 5.3 5.4 3.2 0.0 3.1 4.3 3.2 4.6 3.5 4.4 4.0 1.8 SCHIP1 SCHIP-1 ENSG00000151967 "Schwannomin interacting protein 1" P0DPB3 3 159839861-159897360 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 55.0;heart muscle: 65.9;skeletal muscle: 54.5" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 11.3;Horizontal cells: 14.3" "Cancer enriched" "Detected in single" 7 "glioma: 2.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 9.7" "Group enriched" "Detected in many" 58 "dendritic cells: 9.7;granulocytes: 3.1" "Cell line enhanced" "Detected in some" "AF22: 9.5;AN3-CA: 17.3;HUVEC TERT2: 20.5;NTERA-2: 10.5;SH-SY5Y: 59.6" "HPA003243, HPA069824" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cell Junctions, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA003243: AB_1079877, HPA069824: AB_2732142" "unprognostic (1.07e-1)" "unprognostic (3.27e-2)" "unprognostic (1.37e-2)" "unprognostic (2.36e-5)" "prognostic favorable (2.80e-4)" "unprognostic (6.25e-2)" "unprognostic (4.56e-3)" "unprognostic (1.11e-1)" "unprognostic (7.81e-2)" "unprognostic (1.38e-1)" "unprognostic (6.45e-3)" "unprognostic (4.67e-2)" "unprognostic (2.12e-1)" "unprognostic (4.66e-4)" "unprognostic (2.30e-1)" "unprognostic (4.52e-2)" "unprognostic (4.96e-1)" 6.1 3.9 30.1 1.5 22.0 2.0 1.9 23.9 55.0 3.7 3.6 21.1 0.0 2.2 4.7 2.0 4.2 3.4 3.0 65.9 29.6 17.9 3.5 1.9 3.1 1.7 22.8 24.1 1.8 1.6 1.4 6.0 10.3 15.6 6.2 2.3 0.7 2.9 2.6 54.5 1.4 1.9 5.9 28.9 5.1 2.0 2.7 24.3 0.0 2.0 7.6 1.6 1.9 0.6 0.0 9.7 3.1 0.0 0.1 0.0 0.1 0.0 0.0 9.5 17.3 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.4 0.1 4.0 0.1 20.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 10.5 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.0 59.6 0.0 0.0 0.0 2.6 0.0 1.0 3.7 0.2 0.5 0.1 0.8 0.7 0.0 0.0 0.2 0.7 0.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.0 9.7 0.0 0.1 30.1 22.0 23.9 28.9 29.6 17.9 22.8 24.1 15.6 24.3 6.0 1.7 0.0 4.6 0.3 4.2 11.3 0.0 4.0 3.4 3.5 2.0 1.0 0.0 0.2 0.0 4.6 0.0 0.0 0.2 0.4 0.6 0.5 0.0 0.5 0.2 14.3 0.0 1.8 0.0 0.0 0.0 0.0 3.3 0.0 0.0 4.9 0.9 0.0 0.0 0.7 0.5 0.0 1.8 0.0 0.4 0.5 0.7 0.0 0.0 1.4 SCMH1 Scml3 ENSG00000010803 "Scm polycomb group protein homolog 1" Q96GD3 1 41027200-41242154 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 50.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048898, HPA053292" Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No Nucleoplasm "Nuclear bodies, Cytosol" "HPA048898: , HPA053292: AB_2797246" "unprognostic (6.02e-2)" "unprognostic (1.34e-2)" "unprognostic (1.60e-1)" "unprognostic (1.31e-2)" "unprognostic (2.08e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (3.82e-4)" "unprognostic (1.98e-2)" "unprognostic (8.77e-2)" "unprognostic (8.93e-3)" "unprognostic (2.77e-2)" "unprognostic (1.40e-1)" "unprognostic (7.38e-2)" "unprognostic (9.47e-2)" "unprognostic (1.63e-1)" "unprognostic (8.08e-2)" "prognostic favorable (5.80e-4)" 12.5 13.1 14.7 18.2 15.3 11.2 21.3 15.9 13.9 15.8 27.9 6.7 23.4 9.0 21.4 16.7 11.1 16.5 17.2 27.2 12.6 8.8 14.8 9.5 11.4 10.5 7.6 12.5 24.8 30.2 26.5 23.0 7.8 10.7 22.7 12.6 16.8 19.2 23.8 28.4 8.4 12.7 36.9 7.4 8.7 18.5 26.6 6.7 11.3 14.3 11.1 8.3 22.7 25.7 4.3 7.6 2.2 2.2 2.9 4.2 1.7 9.0 6.1 14.5 13.3 6.7 12.7 0.0 7.3 12.8 12.3 12.8 5.8 11.7 16.6 5.6 13.2 10.3 2.3 11.2 9.8 10.6 11.4 8.5 7.7 8.2 14.4 29.0 16.5 12.8 13.8 10.0 8.1 19.8 14.9 12.3 20.7 7.2 12.9 12.0 4.9 16.5 14.3 13.3 7.7 6.5 18.3 15.2 9.8 9.8 11.4 10.2 11.0 12.7 10.2 10.5 10.3 9.0 42.5 9.0 12.9 10.1 7.9 13.3 13.2 7.4 18.1 8.1 14.8 11.7 1.3 1.2 2.2 3.3 2.2 4.2 4.3 3.9 3.1 3.7 2.1 2.9 2.4 0.0 2.9 0.5 7.6 2.7 1.7 14.7 15.3 15.9 13.9 12.6 8.8 7.6 12.5 10.7 6.7 8.9 6.7 8.0 23.8 6.0 13.8 13.5 10.2 4.0 7.9 12.2 15.7 6.7 1.7 8.8 7.2 6.8 7.8 0.0 18.3 2.6 8.0 20.7 4.7 4.7 5.2 7.9 8.1 6.7 4.8 9.4 15.3 3.1 8.5 2.8 6.2 6.0 11.3 3.5 17.0 11.5 13.5 19.4 8.0 50.0 28.6 3.1 4.0 4.8 11.7 11.9 SCML1 ENSG00000047634 "Scm polycomb group protein like 1" Q9UN30 X 17737449-17754988 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 214.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 17.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-2197: 39.9" "HPA035270, HPA035271, HPA061397" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA035270: AB_10672860, HPA035271: AB_10602795, HPA061397: AB_2684503" "unprognostic (6.36e-2)" "unprognostic (5.86e-3)" "unprognostic (3.83e-1)" "unprognostic (3.18e-1)" "unprognostic (1.73e-1)" "unprognostic (5.18e-1)" "unprognostic (2.12e-3)" "unprognostic (9.49e-2)" "unprognostic (8.40e-2)" "unprognostic (2.04e-1)" "unprognostic (3.75e-2)" "unprognostic (7.56e-2)" "unprognostic (1.44e-3)" "unprognostic (2.84e-1)" "unprognostic (1.18e-1)" "unprognostic (1.41e-1)" "unprognostic (1.07e-3)" 12.6 12.1 5.9 6.7 6.2 3.1 9.6 5.5 7.7 9.6 10.7 6.7 13.5 8.8 10.4 8.3 6.8 7.2 6.2 7.2 6.4 4.6 7.8 30.4 11.9 8.2 5.1 4.1 19.6 7.4 4.1 8.8 10.9 9.5 8.5 8.3 12.7 7.1 15.0 19.5 6.2 8.5 11.1 8.0 7.9 6.0 35.4 4.3 6.3 5.2 7.3 6.1 11.5 7.6 3.5 2.2 0.8 3.2 8.0 17.1 2.1 10.2 2.8 8.8 3.0 8.4 11.1 1.0 10.0 9.7 11.1 14.2 5.8 4.7 0.0 4.4 6.9 7.2 5.9 11.5 7.1 16.5 0.0 22.7 0.8 8.0 11.3 11.3 0.0 5.5 7.4 6.5 14.6 10.9 2.4 0.1 4.0 1.6 0.0 10.1 3.2 0.0 0.0 1.4 7.6 11.1 0.0 4.6 4.6 4.4 2.5 1.8 2.3 4.6 0.0 3.8 5.3 1.6 0.2 5.2 10.7 4.4 39.9 6.5 6.2 5.6 0.0 8.7 0.9 3.0 0.0 1.1 0.7 0.2 2.9 0.2 1.3 2.9 0.3 2.2 3.5 17.1 8.0 0.8 8.0 3.2 0.5 0.4 2.1 5.9 6.2 5.5 7.7 6.4 4.6 5.1 4.1 9.5 4.3 17.9 22.6 10.3 31.8 84.3 54.6 21.8 5.1 8.1 17.0 15.7 64.8 4.1 8.3 4.9 20.6 22.7 19.6 0.0 7.6 1.9 35.3 28.9 10.4 52.5 16.1 36.5 10.9 14.1 12.9 14.8 55.0 17.0 27.0 3.6 17.7 32.4 4.8 21.6 32.2 4.4 85.4 51.8 45.3 214.3 49.6 99.6 4.7 5.7 32.0 23.7 SCML4 dJ47M23.1 ENSG00000146285 "Scm polycomb group protein like 4" Q8N228 6 107704104-107824317 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.3;lymphoid tissue: 24.6" "Group enriched" "Detected in many" 21 "Early spermatids: 71.9;Late spermatids: 104.1;T-cells: 35.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 5 "gdT-cell: 19.5;MAIT T-cell: 18.0;memory CD4 T-cell: 27.3;memory CD8 T-cell: 24.3;naive CD4 T-cell: 26.9;naive CD8 T-cell: 23.9;NK-cell: 17.6" "Group enriched" "Detected in many" 5 "NK-cells: 17.6;T-cells: 27.3" "Cell line enriched" "Detected in some" 5 "HDLM-2: 37.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA063326, HPA065958" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA063326: AB_2684986, HPA065958: AB_2685587" "unprognostic (4.00e-5)" "unprognostic (2.10e-3)" "unprognostic (4.71e-2)" "unprognostic (4.24e-3)" "unprognostic (1.38e-3)" "unprognostic (4.75e-4)" "unprognostic (3.84e-3)" "unprognostic (6.65e-3)" "unprognostic (4.26e-1)" "unprognostic (1.53e-2)" "unprognostic (2.13e-4)" "unprognostic (3.68e-1)" "unprognostic (3.77e-4)" "unprognostic (8.65e-2)" "unprognostic (3.68e-2)" "unprognostic (2.52e-3)" "unprognostic (5.09e-3)" 1.3 0.6 0.5 13.9 0.6 2.7 1.4 0.3 0.5 1.2 5.4 0.3 0.3 10.1 0.9 4.9 1.3 1.2 2.4 0.6 1.7 0.9 1.7 2.7 3.2 24.6 0.4 0.0 0.7 1.4 0.0 3.9 0.3 0.5 1.2 2.1 1.6 5.7 0.0 0.3 0.9 12.4 0.4 0.9 11.5 2.4 10.4 0.2 23.9 1.5 1.3 24.5 2.3 1.3 4.5 0.3 3.6 0.1 17.6 27.3 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.4 0.0 2.1 19.5 0.0 18.0 4.5 27.3 24.3 0.0 3.5 26.9 23.9 3.6 17.6 0.1 0.3 2.6 9.4 0.5 0.6 0.3 0.5 1.7 0.9 0.4 0.0 0.5 0.2 0.0 0.0 0.9 0.0 1.3 0.0 0.8 0.0 1.4 0.0 0.0 0.0 1.0 0.0 0.6 71.9 0.3 1.0 0.0 0.0 0.0 0.6 0.0 1.1 1.7 0.2 1.6 0.0 1.3 0.0 104.1 0.9 0.8 3.3 1.0 1.6 0.0 0.1 0.3 0.7 0.0 0.0 0.0 1.0 1.1 0.5 0.1 0.1 35.9 2.9 0.0 SCN1A "FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI" ENSG00000144285 "Sodium voltage-gated channel alpha subunit 1" P35498 2 165984641-166149214 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Autism, Autism spectrum disorder, Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 33.9" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 26.9;Bipolar cells: 33.9" "Cancer enriched" "Detected in single" 8 "glioma: 1.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC TERT1: 11.6;Hep G2: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078664 Supported "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "Nuclear bodies" "HPA078664: AB_2686888" "unprognostic (9.25e-2)" "unprognostic (3.97e-2)" "unprognostic (6.88e-2)" "unprognostic (7.44e-2)" "unprognostic (1.50e-1)" "unprognostic (2.74e-1)" "unprognostic (4.70e-2)" "unprognostic (2.88e-1)" "unprognostic (1.67e-1)" "unprognostic (9.59e-2)" "unprognostic (1.23e-1)" "unprognostic (5.03e-9)" "unprognostic (6.92e-2)" "unprognostic (3.69e-2)" "unprognostic (5.06e-3)" "unprognostic (6.93e-1)" 1.1 1.3 5.2 1.1 13.6 1.0 1.1 10.3 26.6 1.1 1.1 2.3 0.0 1.0 1.1 1.1 1.0 6.8 1.0 1.1 6.9 8.3 1.1 1.1 5.6 1.0 5.7 9.7 1.0 1.0 1.1 2.9 1.2 33.9 1.1 1.1 0.3 1.0 1.0 1.2 1.1 1.1 1.1 3.6 1.1 1.1 1.4 4.2 0.0 1.1 0.0 1.0 1.1 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 11.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 6.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 5.2 13.6 10.3 26.6 6.9 8.3 5.7 9.7 33.9 4.2 6.0 26.9 0.0 0.0 0.0 33.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 SCN4A "HYKPP, HYPP, Nav1.4, SkM1" ENSG00000007314 "Sodium voltage-gated channel alpha subunit 4" P35499 17 63938554-63972918 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skeletal muscle: 53.7" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 3.4;Ito cells: 3.1;Late spermatids: 2.9" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.2" "Cell type enhanced" "Detected in single" "naive B-cell: 1.9" "Lineage enhanced" "Detected in single" "B-cells: 1.9" "Group enriched" "Detected in some" 11 "REH: 10.1;RH-30: 31.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA053992 Approved "Nucleoplasm,Centriolar satellite" NA NA Nucleoplasm "Centriolar satellite" "HPA053992: AB_2797249" "unprognostic (2.47e-1)" "unprognostic (1.74e-1)" "unprognostic (1.57e-2)" "unprognostic (1.78e-3)" "unprognostic (2.80e-2)" "unprognostic (1.63e-2)" "unprognostic (3.87e-4)" "unprognostic (3.84e-3)" "unprognostic (1.61e-1)" "unprognostic (1.36e-1)" "unprognostic (1.59e-3)" "unprognostic (3.15e-2)" "unprognostic (2.70e-2)" "unprognostic (4.38e-3)" "unprognostic (3.46e-1)" "unprognostic (4.15e-1)" "unprognostic (6.45e-2)" 5.9 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.0 0.5 0.0 53.7 0.0 0.0 0.0 0.0 0.1 0.0 0.4 1.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 10.1 31.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.1 0.0 0.0 0.0 0.0 SCN5A "CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1" ENSG00000183873 "Sodium voltage-gated channel alpha subunit 5" Q14524 3 38548057-38649673 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease mutation, FDA approved drug targets, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "heart muscle: 67.3" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 66.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "LHCN-M2: 22.0;RH-30: 18.3" "Group enriched" "Detected in some" 5 "amygdala: 3.2;basal ganglia: 10.5;hypothalamus: 7.0" "Low region specificity" "Detected in many" HPA063346 Supported "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA063346: " "unprognostic (9.29e-4)" "unprognostic (4.05e-2)" "unprognostic (9.95e-2)" "unprognostic (1.74e-1)" "unprognostic (9.21e-2)" "unprognostic (1.24e-2)" "unprognostic (1.15e-1)" "unprognostic (1.48e-1)" "unprognostic (7.36e-2)" "unprognostic (8.48e-2)" "unprognostic (7.12e-3)" "unprognostic (5.28e-2)" "unprognostic (1.16e-4)" "unprognostic (4.85e-3)" "unprognostic (1.09e-1)" "unprognostic (5.35e-2)" "unprognostic (4.95e-3)" 0.3 0.2 1.3 0.2 0.3 0.4 0.6 0.1 2.3 2.0 0.4 0.0 0.4 0.3 0.9 0.8 0.2 0.4 0.3 67.3 0.5 0.7 0.1 0.1 0.2 0.1 0.1 0.3 0.6 0.2 0.1 0.8 0.3 0.0 1.3 0.2 1.2 0.3 1.6 5.5 0.2 0.3 0.4 0.1 0.2 0.2 0.5 0.0 0.0 0.3 0.1 0.1 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.8 0.4 0.0 0.1 0.3 2.7 0.0 0.0 0.0 0.9 0.9 2.7 0.0 0.4 0.0 1.2 0.7 0.0 0.1 0.1 0.0 0.1 0.5 0.0 0.5 0.0 1.7 3.6 0.4 0.0 0.0 22.0 1.1 0.0 0.0 2.0 0.0 0.0 0.0 18.3 0.0 0.0 2.4 0.3 2.4 0.0 0.0 0.0 0.7 0.0 0.0 4.4 0.0 4.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.1 2.3 0.5 0.7 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.2 3.1 66.1 0.0 0.0 0.0 0.0 13.7 0.1 0.0 0.1 1.0 0.4 0.0 0.0 0.0 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.7 0.0 0.4 0.3 0.9 0.0 0.0 0.0 0.0 1.0 SCNM1 MGC3180 ENSG00000163156 "Sodium channel modifier 1" Q9BWG6 1 151156664-151170297 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "THP-1: 77.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052439, HPA054324" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA052439: AB_2681834, HPA054324: AB_2682451" "unprognostic (1.20e-1)" "unprognostic (4.42e-2)" "unprognostic (6.13e-2)" "unprognostic (7.79e-2)" "unprognostic (8.96e-3)" "unprognostic (1.77e-1)" "unprognostic (4.25e-3)" "unprognostic (1.25e-2)" "unprognostic (1.77e-1)" "prognostic favorable (1.23e-4)" "unprognostic (1.38e-1)" "unprognostic (3.23e-1)" "prognostic unfavorable (2.17e-13)" "unprognostic (8.74e-2)" "unprognostic (1.13e-1)" "unprognostic (8.48e-2)" "unprognostic (9.71e-2)" 20.5 15.5 22.2 21.1 21.1 32.9 16.2 17.0 20.0 15.3 16.8 21.0 8.0 16.3 18.4 15.0 19.4 16.5 15.5 16.5 19.8 17.1 19.5 19.8 16.1 34.0 22.9 14.9 16.8 13.5 10.3 12.1 23.6 20.2 17.3 14.7 20.3 16.2 15.2 47.9 21.7 20.5 18.0 22.3 41.8 14.6 14.4 19.4 40.9 16.1 20.1 27.2 21.6 15.6 28.2 61.4 50.9 45.3 28.8 30.1 37.8 13.1 9.2 10.3 12.1 14.5 10.9 17.4 10.4 12.1 25.4 19.9 20.1 12.9 21.0 17.0 11.2 6.6 17.8 12.0 9.6 12.4 13.2 13.3 18.1 13.2 12.8 21.0 24.0 17.8 11.4 18.7 17.8 16.0 11.9 15.3 14.7 14.4 16.1 12.4 32.4 17.0 37.3 26.2 20.5 14.4 23.3 12.4 26.0 13.6 8.8 12.8 20.6 11.8 19.2 23.3 13.4 17.8 77.1 11.2 12.2 11.4 12.6 22.1 20.9 28.4 32.8 12.7 25.5 15.6 50.9 45.3 45.6 20.4 33.7 19.3 28.2 24.8 23.0 60.2 24.7 22.9 19.9 45.7 28.8 21.0 61.4 30.1 37.8 22.2 21.1 17.0 20.0 19.8 17.1 22.9 14.9 20.2 19.4 3.0 17.5 25.9 17.5 23.7 17.9 26.6 12.7 24.1 21.6 27.9 17.7 31.2 46.4 32.0 24.9 23.7 24.2 46.7 27.7 28.6 28.9 12.3 39.3 11.0 62.2 7.9 13.8 18.4 58.4 19.2 28.7 54.1 20.3 52.3 15.5 22.0 32.8 28.1 20.1 28.3 14.5 32.3 33.0 22.8 13.5 15.9 23.0 46.7 16.8 19.6 SCNN1G "ENaCgamma, SCNEG" ENSG00000166828 "Sodium channel epithelial 1 gamma subunit" P51170 16 23182715-23216883 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Sodium transport, Taste, Transport" "Ion channel, Sodium channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 42.9;salivary gland: 26.8" "Cell type enhanced" "Detected in some" 29 "Alveolar cells type 1: 17.9;Club cells: 21.6;Collecting duct cells: 85.5" "Cancer enhanced" "Detected in many" "urothelial cancer: 15.6" "Region enriched" "Detected in some" 6 "cerebellum: 9.7" "Cell type enhanced" "Detected in single" "neutrophil: 1.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.8" "Group enriched" "Detected in some" 7 "hTCEpi: 31.4;RT4: 14.2" "Region enriched" "Detected in single" 13 "cerebellum: 2.8" "Low region specificity" "Detected in all" HPA071194 Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA071194: AB_2686359" "unprognostic (2.90e-1)" "unprognostic (5.21e-3)" "unprognostic (5.79e-2)" "unprognostic (4.31e-2)" "unprognostic (1.92e-3)" "unprognostic (1.71e-3)" "unprognostic (1.97e-1)" "unprognostic (4.85e-2)" "unprognostic (7.84e-3)" "unprognostic (1.90e-1)" "unprognostic (2.57e-2)" "prognostic unfavorable (3.20e-7)" "unprognostic (2.80e-2)" "unprognostic (1.34e-1)" "unprognostic (2.63e-1)" "unprognostic (4.17e-3)" 1.1 0.3 0.6 0.2 0.0 0.4 2.5 9.7 0.4 14.0 5.5 0.0 4.8 0.2 3.2 1.7 10.3 0.5 0.2 0.2 1.5 0.0 42.9 0.2 15.6 0.2 0.0 0.3 0.2 3.8 0.2 6.5 0.7 0.7 10.2 1.1 0.0 26.8 12.8 2.2 6.6 0.2 0.3 0.3 0.2 6.9 0.3 0.0 1.5 25.5 3.3 3.9 1.7 11.3 0.3 0.3 1.8 0.2 0.2 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 14.2 1.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.3 0.2 0.1 0.1 0.1 0.1 0.0 0.3 0.2 0.1 1.8 0.2 0.1 0.3 0.1 0.0 0.6 0.0 9.7 0.4 1.5 0.0 0.0 0.3 0.7 0.0 17.9 3.4 0.0 4.0 0.3 0.0 0.8 0.0 2.7 21.6 85.5 0.0 0.1 0.0 1.3 0.0 0.0 0.3 0.0 1.5 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 1.4 SCOC "HRIHFB2072, SCOCO, UNC-69" ENSG00000153130 "Short coiled-coil protein" Q9UIL1 4 140257286-140385726 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 356.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061198, HPA070321" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA061198: AB_2684449, HPA070321: AB_2686252" "unprognostic (2.27e-2)" "unprognostic (2.26e-2)" "unprognostic (3.18e-2)" "unprognostic (1.10e-2)" "unprognostic (7.34e-3)" "unprognostic (1.37e-3)" "unprognostic (8.99e-3)" "unprognostic (1.13e-1)" "unprognostic (6.14e-2)" "unprognostic (1.23e-2)" "unprognostic (2.30e-1)" "unprognostic (4.03e-1)" "prognostic favorable (4.82e-12)" "unprognostic (2.98e-2)" "unprognostic (1.32e-1)" "unprognostic (7.51e-2)" "unprognostic (1.28e-2)" 16.2 26.6 49.3 9.7 45.0 4.5 27.7 36.3 57.1 17.7 16.1 25.0 15.0 16.5 18.8 32.2 20.4 17.3 15.3 38.3 47.1 66.9 38.6 27.9 13.7 9.7 59.7 32.5 16.6 19.0 29.6 30.5 18.5 74.5 24.2 19.2 15.0 17.9 20.1 13.5 11.0 16.0 19.9 61.8 9.9 19.6 11.1 25.0 6.0 26.0 13.0 11.8 14.8 11.8 18.8 14.3 18.5 12.4 19.2 27.9 19.2 14.8 10.1 27.9 14.5 25.0 34.7 20.0 24.4 23.8 19.7 22.2 6.7 22.2 6.1 21.8 25.0 18.2 6.4 16.9 34.7 30.1 21.0 12.1 9.6 5.2 15.9 22.1 19.3 12.2 23.1 47.0 17.5 19.8 38.3 26.3 18.0 14.8 18.2 34.4 9.8 23.9 11.7 8.7 13.1 17.5 14.7 11.7 9.0 57.9 13.7 19.6 20.5 16.5 24.9 26.8 25.9 18.1 11.9 20.0 30.2 17.6 24.8 23.7 27.9 47.7 16.3 35.1 8.8 29.5 18.5 9.0 11.7 15.7 12.4 20.1 18.8 19.0 15.5 11.2 15.2 27.9 21.4 5.2 19.2 12.0 14.3 16.6 19.2 49.3 45.0 36.3 57.1 47.1 66.9 59.7 32.5 74.5 25.0 44.7 38.0 35.7 59.8 54.3 131.0 122.4 43.3 54.9 37.5 120.4 21.6 120.6 271.9 89.4 356.8 55.2 50.3 0.0 99.5 67.4 61.2 77.2 35.8 56.1 42.7 162.1 36.2 44.2 22.2 56.1 55.5 40.5 131.6 45.9 40.9 160.2 87.9 28.8 62.2 179.9 63.0 45.3 62.8 39.4 51.3 49.4 74.4 27.3 40.9 46.3 SCP2 ENSG00000116171 "Sterol carrier protein 2" P22307 1 52927229-53051703 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid transport, Transport" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 168.3" "Cell type enhanced" "Detected in all" 6 "Hepatocytes: 1150.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027101, HPA027135, HPA027317" Supported Supported Nucleoplasm,Peroxisomes NA NA 370000 Peroxisomes Nucleoplasm "HPA027101: AB_1856634, HPA027135: AB_1856633, HPA027317: AB_10610422" "unprognostic (7.51e-2)" "unprognostic (5.23e-2)" "prognostic favorable (7.05e-5)" "unprognostic (9.68e-2)" "unprognostic (1.53e-2)" "unprognostic (5.53e-2)" "unprognostic (1.87e-3)" "unprognostic (1.22e-2)" "unprognostic (1.62e-2)" "unprognostic (1.59e-1)" "unprognostic (4.53e-2)" "unprognostic (6.16e-2)" "prognostic favorable (7.85e-8)" "unprognostic (1.49e-2)" "unprognostic (1.09e-1)" "unprognostic (8.64e-2)" "unprognostic (1.13e-2)" 29.1 26.2 21.8 19.9 21.2 14.0 30.3 12.0 19.7 24.4 51.9 15.9 28.1 49.2 19.0 28.8 32.2 18.1 32.1 29.3 20.0 20.0 54.2 168.3 21.8 14.0 25.6 17.8 22.8 24.6 16.7 24.1 17.1 21.9 25.5 40.5 18.9 21.8 23.3 22.0 18.8 80.1 20.6 27.1 20.9 33.9 16.7 19.4 23.0 28.2 28.6 17.6 22.3 20.5 36.4 57.1 67.8 50.7 40.8 49.2 61.2 25.6 14.1 19.0 34.8 62.4 53.4 20.6 30.6 45.9 20.1 29.2 12.6 27.8 24.4 33.1 44.8 23.5 18.0 13.0 28.6 30.8 35.5 18.9 26.2 20.3 25.9 41.6 37.7 44.2 43.3 39.0 23.8 11.9 44.1 56.9 28.9 23.3 12.7 40.6 14.8 42.0 32.8 20.8 65.1 27.7 22.0 33.5 33.3 55.8 43.6 15.7 19.0 26.7 54.2 25.6 44.1 27.7 43.2 44.0 27.4 14.2 47.7 24.4 21.3 27.0 28.5 35.5 37.5 25.3 55.4 48.7 67.8 49.2 50.7 39.9 36.4 39.2 48.6 57.1 29.8 33.2 47.1 7.5 40.8 46.8 37.1 47.1 61.2 21.8 21.2 12.0 19.7 20.0 20.0 25.6 17.8 21.9 19.4 125.0 163.3 99.5 107.7 133.6 35.0 136.8 201.2 147.2 103.5 176.2 29.5 158.8 401.3 140.3 42.8 125.8 592.0 70.0 143.6 134.4 129.4 170.2 138.2 1150.9 181.7 39.7 225.9 115.4 211.6 39.0 170.6 166.5 182.2 152.3 388.8 98.9 131.8 498.1 161.5 617.2 27.0 77.6 119.7 10.6 19.8 149.3 112.0 172.0 297.8 155.6 SCRIB "KIAA0147, SCRB1, Vartul" ENSG00000180900 "Scribbled planar cell polarity protein" Q14160 8 143790920-143815379 "Disease related genes, Predicted intracellular proteins" "Differentiation, Host-virus interaction, Inhibition of host innate immune response by virus, Inhibition of host interferon signaling pathway by virus, Inhibition of host STAT1 by virus, Inhibition of host STAT2 by virus, Viral immunoevasion" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015463, CAB022081, HPA023557, HPA064312" Supported Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions,Rods & Rings" NA NA "Plasma membrane, Cell Junctions" "Nucleoplasm, Rods & Rings" "CAB015463: AB_2238926, CAB022081: , HPA023557: AB_2671238, HPA064312: AB_2685242" "unprognostic (1.24e-1)" "unprognostic (1.94e-2)" "unprognostic (7.78e-2)" "unprognostic (8.95e-2)" "unprognostic (3.77e-1)" "unprognostic (3.96e-2)" "unprognostic (1.14e-3)" "unprognostic (1.86e-2)" "unprognostic (2.46e-1)" "unprognostic (2.56e-1)" "unprognostic (8.22e-2)" "unprognostic (1.87e-1)" "unprognostic (2.16e-3)" "unprognostic (3.46e-3)" "unprognostic (1.99e-1)" "unprognostic (1.10e-1)" "unprognostic (1.83e-1)" 13.0 6.1 15.1 10.8 12.2 9.4 15.9 10.1 13.9 15.1 18.4 17.5 9.8 14.8 9.4 5.9 36.6 11.6 11.9 8.0 12.2 7.7 10.2 13.6 11.5 12.9 13.5 12.8 10.9 17.2 11.2 9.6 9.5 11.8 10.9 7.6 7.5 22.9 11.2 36.8 33.3 16.3 11.2 9.7 11.2 17.0 10.1 16.4 14.0 9.1 11.9 9.6 11.6 17.8 0.6 0.5 0.2 0.4 0.2 1.5 0.6 18.6 15.1 6.9 8.8 2.5 3.3 11.7 10.5 3.0 4.9 4.1 6.6 12.2 7.4 12.8 3.1 2.8 19.5 3.7 14.1 0.9 8.2 20.8 10.3 13.0 11.6 5.7 4.3 5.8 2.8 13.7 4.7 4.1 2.2 5.3 8.1 13.0 2.6 3.7 37.2 11.1 9.2 5.2 11.6 19.2 13.4 6.4 8.2 2.5 18.8 15.1 11.1 11.9 13.1 11.1 2.2 16.5 10.3 10.2 5.4 22.4 9.5 14.7 9.3 9.1 7.5 5.5 4.3 8.4 0.1 0.1 0.1 0.6 0.4 1.5 0.6 0.4 1.2 0.5 0.4 0.4 0.4 0.2 0.2 0.1 0.2 0.4 0.6 15.1 12.2 10.1 13.9 12.2 7.7 13.5 12.8 11.8 16.4 0.0 6.9 6.9 4.2 7.6 11.1 10.8 15.3 1.4 1.2 14.0 13.7 8.9 3.3 7.5 1.2 6.0 18.4 23.3 8.1 5.3 5.1 8.0 0.0 7.5 5.5 4.8 13.3 4.3 6.3 0.4 8.3 4.6 8.5 4.6 19.5 11.9 9.9 20.1 9.2 4.3 14.0 12.9 4.2 7.9 9.2 9.4 4.2 5.1 19.5 5.9 SCRN2 ENSG00000141295 "Secernin 2" Q96FV2 17 47837692-47841333 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Proximal tubular cells: 296.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022934, HPA023434" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA 350000 Nucleoplasm "Golgi apparatus" "HPA022934: AB_1856638, HPA023434: AB_1856639" "unprognostic (2.35e-2)" "unprognostic (1.42e-2)" "unprognostic (2.86e-1)" "unprognostic (6.14e-2)" "unprognostic (2.46e-2)" "unprognostic (1.73e-1)" "prognostic favorable (3.86e-4)" "unprognostic (4.63e-2)" "unprognostic (3.25e-2)" "unprognostic (5.77e-2)" "unprognostic (1.28e-3)" "unprognostic (8.72e-2)" "unprognostic (3.43e-2)" "unprognostic (5.28e-3)" "unprognostic (1.64e-1)" "unprognostic (1.20e-1)" "prognostic favorable (5.83e-4)" 43.4 10.3 8.3 14.2 14.1 6.7 20.8 17.7 13.1 10.6 17.3 11.2 23.6 25.1 11.4 18.1 8.9 15.4 13.3 17.9 8.6 8.9 29.3 17.4 8.3 8.7 8.1 9.6 11.8 25.3 11.4 14.5 7.8 10.5 13.6 6.1 14.8 20.1 19.2 20.0 10.9 20.1 9.7 7.3 15.0 9.8 4.0 10.9 8.5 18.1 9.0 11.0 10.7 10.0 16.9 19.2 25.9 13.4 16.5 22.1 10.8 12.0 19.2 5.3 5.1 15.7 12.2 16.3 6.1 12.5 9.4 9.6 14.4 14.4 6.7 12.3 3.2 5.0 6.6 1.7 10.7 3.2 15.9 13.2 6.8 14.1 12.4 5.6 3.2 5.4 11.7 8.1 5.7 4.5 14.0 10.5 16.2 2.3 7.6 12.8 10.9 10.7 5.6 2.7 5.2 7.6 14.3 4.0 26.9 7.4 5.5 4.1 17.2 3.4 7.3 8.0 3.8 16.6 6.4 4.8 8.6 9.2 2.4 2.8 31.5 4.1 3.1 23.3 5.7 1.9 12.3 12.8 25.9 16.9 13.4 16.3 16.9 14.0 16.4 16.3 15.6 22.1 12.2 3.2 16.5 6.5 19.2 13.9 10.8 8.3 14.1 17.7 13.1 8.6 8.9 8.1 9.6 10.5 10.9 35.7 25.1 11.2 25.9 14.0 11.3 19.8 12.7 26.8 14.8 15.7 9.8 38.7 63.0 22.9 2.8 20.3 52.0 0.0 53.1 8.3 23.5 18.8 16.1 25.3 19.4 19.1 21.5 23.9 8.1 2.1 30.8 12.7 40.5 11.8 30.3 26.6 27.6 34.5 15.6 296.5 15.6 6.5 17.0 5.2 14.9 10.0 28.3 26.1 34.7 16.9 SCRT2 ZNF898B ENSG00000215397 "Scratch family transcriptional repressor 2" Q9NQ03 20 661596-676179 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 17.9;retina: 6.1" "Cell type enriched" "Detected in some" 51 "Horizontal cells: 57.2" "Cancer enriched" "Detected in single" 5 "glioma: 1.0" "Group enriched" "Detected in many" 4 "cerebellum: 8.8;cerebral cortex: 17.9" "Cell type enriched" "Detected in single" 25 "neutrophil: 2.4" "Lineage enriched" "Detected in single" 25 "granulocytes: 2.4" "Group enriched" "Detected in some" 5 "Karpas-707: 4.0;NTERA-2: 3.7;RPMI-8226: 8.1;SCLC-21H: 3.9;SH-SY5Y: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA067697 Approved Nucleoplasm NA NA Nucleoplasm "HPA067697: AB_2685890" "unprognostic (9.71e-2)" "unprognostic (2.03e-1)" "unprognostic (6.97e-2)" "unprognostic (9.70e-2)" "unprognostic (1.70e-1)" 0.3 0.3 0.7 0.3 0.7 0.3 0.3 8.8 17.9 0.3 0.3 0.6 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.7 0.6 0.3 0.3 0.3 0.3 1.9 0.0 0.3 1.3 0.3 0.0 0.4 3.2 0.3 0.3 6.1 0.3 0.3 0.3 0.3 0.3 0.3 1.1 0.6 0.3 0.7 0.0 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 8.1 0.0 0.0 3.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.7 0.7 8.8 17.9 0.7 0.6 1.9 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 57.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SDAD1 FLJ10498 ENSG00000198301 "SDA1 domain containing 1" Q9NVU7 4 75940950-75990962 "Predicted intracellular proteins" "Protein transport, Ribosome biogenesis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035949 Uncertain Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA035949: AB_10673225" "unprognostic (8.82e-3)" "unprognostic (3.39e-3)" "unprognostic (7.62e-3)" "unprognostic (1.10e-1)" "unprognostic (2.17e-1)" "unprognostic (7.74e-2)" "prognostic unfavorable (1.32e-4)" "unprognostic (5.15e-2)" "unprognostic (1.44e-1)" "unprognostic (1.59e-1)" "unprognostic (2.08e-2)" "unprognostic (3.98e-2)" "prognostic favorable (2.13e-4)" "unprognostic (1.57e-1)" "unprognostic (1.41e-1)" "unprognostic (2.24e-2)" "unprognostic (4.62e-1)" 17.0 17.9 19.6 16.5 30.2 7.3 21.5 17.6 26.7 19.9 17.9 9.6 14.0 14.0 26.2 23.2 19.5 18.9 10.6 16.4 18.2 15.4 21.9 23.9 14.6 22.8 16.4 19.1 22.7 26.9 20.4 30.6 17.5 22.6 18.5 18.6 9.4 18.3 20.8 32.3 19.6 16.1 24.9 16.2 23.5 18.1 24.1 19.9 21.5 25.8 17.1 22.9 21.3 17.5 13.2 10.3 5.6 16.8 15.4 17.8 10.5 14.6 5.9 14.6 19.5 17.4 15.7 15.3 20.8 18.1 17.4 15.2 18.2 21.0 23.0 15.7 19.0 16.7 15.1 22.2 20.1 21.9 20.2 11.7 19.6 13.1 15.0 16.4 33.3 22.4 13.7 22.8 18.4 20.3 10.8 15.2 15.7 35.1 19.0 17.8 16.2 33.7 11.8 23.7 23.7 9.0 20.5 27.5 19.3 16.6 16.4 22.1 18.4 14.2 29.0 23.5 16.6 13.3 19.6 14.3 18.8 19.0 22.4 17.3 17.5 18.2 31.4 21.1 15.1 23.2 5.6 9.9 2.7 14.2 12.7 17.7 12.1 17.4 16.1 10.3 13.2 17.8 14.9 1.6 15.4 16.8 9.0 14.7 10.5 19.6 30.2 17.6 26.7 18.2 15.4 16.4 19.1 22.6 19.9 17.9 26.7 35.6 21.5 24.5 19.7 10.6 15.3 33.5 50.0 21.0 5.9 26.9 29.9 34.3 86.0 21.1 13.9 0.0 21.5 26.1 23.2 22.2 48.5 20.5 32.6 12.7 21.9 16.0 23.5 81.4 23.6 29.5 23.6 39.7 22.8 22.4 28.9 22.9 31.1 37.2 19.7 19.4 24.5 58.5 94.3 29.0 20.9 32.0 26.0 19.7 SDC3 "N-syndecan, SYND3" ENSG00000162512 "Syndecan 3" O75056 1 30869467-30908761 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 16 "Collecting duct cells: 45.4;Kupffer cells: 157.7;Late spermatids: 63.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 52.5;WM-115: 73.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017087, CAB025786, HPA048085" Approved Approved Nucleoplasm,Mitochondria Yes No Mitochondria Nucleoplasm "CAB025786: , HPA017087: AB_1857706, HPA048085: AB_2680256" "unprognostic (1.42e-3)" "unprognostic (5.52e-2)" "unprognostic (1.20e-1)" "unprognostic (4.55e-2)" "unprognostic (1.79e-2)" "unprognostic (1.87e-1)" "unprognostic (1.79e-3)" "unprognostic (2.83e-1)" "prognostic favorable (2.36e-4)" "unprognostic (9.77e-2)" "unprognostic (5.14e-2)" "unprognostic (1.65e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (6.45e-2)" "unprognostic (2.74e-1)" "unprognostic (9.80e-3)" "unprognostic (1.46e-1)" 17.9 48.8 35.4 11.6 44.7 1.9 9.2 10.4 53.1 20.4 20.8 21.7 10.9 6.9 25.6 7.1 9.8 13.7 15.9 11.1 26.8 32.2 4.7 11.5 12.0 15.4 36.1 16.4 6.2 4.4 6.1 5.4 9.7 34.1 14.8 8.1 8.2 8.6 29.2 17.7 5.7 9.1 33.1 28.3 45.3 9.3 2.4 15.5 2.6 5.5 1.7 4.2 14.4 6.0 1.2 1.0 3.2 2.5 2.1 1.2 0.9 2.7 2.0 16.3 7.6 12.6 3.0 3.2 6.8 9.7 3.2 2.0 0.3 2.5 0.2 17.3 19.0 4.6 3.7 1.7 1.5 2.1 1.4 1.4 0.0 0.8 0.4 12.1 0.0 1.8 7.3 7.5 0.2 3.2 17.9 4.0 0.7 1.3 0.2 6.2 2.9 0.1 0.1 8.3 1.9 2.4 0.1 15.6 0.6 4.0 2.9 6.4 4.1 8.6 1.2 52.5 10.9 1.2 1.2 4.4 4.0 6.9 0.5 1.5 0.0 0.1 0.2 0.4 0.0 73.1 3.2 1.3 1.0 0.8 2.5 1.2 0.8 0.8 0.9 0.9 1.2 1.0 1.0 2.5 2.1 1.8 1.0 0.9 0.9 35.4 44.7 10.4 29.5 26.8 32.2 36.1 16.4 34.1 15.5 0.0 2.1 0.8 2.8 2.3 8.1 3.2 15.3 0.0 2.3 45.4 0.0 2.1 0.0 9.0 17.7 8.7 0.0 0.0 2.6 2.8 10.0 6.9 0.0 0.2 13.2 0.0 2.9 28.8 157.7 63.3 2.0 2.2 18.6 5.4 0.9 1.5 6.1 0.6 7.4 0.3 25.6 0.0 5.6 0.7 0.4 1.9 3.0 0.0 1.2 3.7 SDCBP "MDA-9, SYCL" ENSG00000137575 "Syndecan binding protein" O00560 8 58552924-58582860 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Melanocytes: 843.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 166.5" "Group enriched" "Detected in all" 5 "granulocytes: 166.5;monocytes: 44.8" "Cell line enhanced" "Detected in many" "HHSteC: 100.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012245, HPA023840" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" "Intracellular and membrane" NA NA 1500000 "Nucleoplasm, Cytosol" "Nuclear membrane" "CAB012245: , HPA023840: AB_1857712" "unprognostic (2.39e-2)" "unprognostic (3.34e-2)" "unprognostic (1.84e-2)" "unprognostic (4.45e-2)" "unprognostic (9.15e-2)" "unprognostic (2.60e-3)" "unprognostic (7.14e-2)" "unprognostic (1.04e-3)" "unprognostic (1.11e-1)" "unprognostic (5.68e-2)" "unprognostic (3.05e-2)" "unprognostic (3.01e-1)" "unprognostic (1.53e-2)" "unprognostic (3.14e-1)" "unprognostic (8.02e-2)" "unprognostic (2.82e-2)" "unprognostic (2.92e-1)" 106.2 32.0 28.5 37.6 45.2 51.5 67.4 20.9 29.0 42.7 28.4 18.8 22.2 19.7 38.4 28.2 37.8 28.0 47.9 36.9 32.1 25.8 41.4 41.7 73.1 49.7 33.4 16.9 35.5 20.1 36.4 16.4 68.5 47.6 35.5 33.6 53.0 41.5 20.7 22.5 24.7 34.3 37.9 39.0 70.1 31.0 25.4 22.2 34.3 44.4 23.4 21.4 50.0 44.2 5.9 21.7 166.5 44.8 3.4 9.8 29.7 14.5 22.6 24.1 12.5 90.5 78.0 10.6 15.0 53.8 21.9 28.8 9.0 30.7 0.0 24.2 20.1 40.3 6.1 13.0 17.3 27.1 2.6 11.1 22.0 20.1 7.2 100.5 5.6 35.8 53.2 23.4 22.0 66.1 34.2 52.4 15.3 10.8 12.9 49.6 3.8 12.3 6.6 15.1 57.5 6.5 6.0 7.3 2.8 34.8 15.3 10.6 19.1 16.0 6.9 73.8 27.9 6.3 15.3 45.0 21.1 9.1 24.9 9.6 3.9 5.2 8.8 53.8 0.0 18.9 52.9 44.8 43.7 5.7 30.0 7.1 5.9 7.6 6.0 21.7 5.4 9.8 7.4 166.5 3.4 26.4 6.0 8.5 29.7 28.5 45.2 20.9 29.0 32.1 25.8 33.4 16.9 47.6 22.2 196.5 114.3 99.6 291.9 300.9 9.9 48.4 58.6 61.6 77.3 195.4 15.7 224.5 190.6 334.0 5.9 318.0 108.1 46.7 256.7 631.9 182.6 258.8 390.0 80.9 683.1 14.3 107.7 330.8 517.6 7.7 216.6 535.9 843.5 212.0 105.0 74.6 227.0 96.2 150.3 153.5 9.7 97.0 282.9 12.5 6.5 151.4 403.9 126.8 84.4 372.9 SDCBP2 "SITAC18, ST-2" ENSG00000125775 "Syndecan binding protein 2" Q9H190 20 1309909-1329239 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 104.7" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 454.6;Pancreatic endocrine cells: 472.7;Paneth cells: 448.9;Urothelial cells: 654.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 11.2;OE19: 33.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA005804, HPA064490" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA005804: , HPA064490: AB_2732713" "unprognostic (1.96e-2)" "unprognostic (5.44e-2)" "unprognostic (2.37e-1)" "unprognostic (5.85e-2)" "unprognostic (2.54e-1)" "unprognostic (2.27e-2)" "unprognostic (2.57e-2)" "prognostic unfavorable (2.42e-4)" "unprognostic (1.01e-1)" "unprognostic (3.78e-3)" "prognostic unfavorable (3.07e-4)" "unprognostic (3.17e-1)" "unprognostic (1.07e-2)" "unprognostic (1.30e-1)" "unprognostic (1.69e-1)" "unprognostic (1.20e-1)" "prognostic favorable (3.37e-4)" 1.7 0.4 5.2 10.6 6.7 0.2 1.5 1.5 4.9 6.6 59.4 1.2 0.9 46.1 1.5 9.1 32.4 0.9 35.1 1.3 3.5 3.6 2.5 3.8 3.7 0.9 2.8 1.0 1.2 4.4 0.2 1.4 1.9 1.4 3.7 19.0 1.0 6.4 1.9 1.1 13.4 104.7 2.5 1.1 1.1 34.0 1.5 1.6 1.0 4.0 12.5 24.3 17.0 9.8 1.2 2.6 4.4 2.0 2.1 5.3 1.8 6.3 0.3 0.9 0.3 3.7 3.3 0.6 1.9 3.9 1.8 1.7 1.3 11.2 0.7 1.3 0.7 1.2 5.0 0.3 9.3 0.9 0.2 0.6 0.5 0.4 0.9 3.7 0.6 0.7 1.1 6.6 1.4 1.4 3.8 6.1 1.2 0.9 0.5 0.7 1.5 1.0 1.8 0.9 33.8 0.4 1.0 0.4 1.2 0.7 8.7 1.5 1.2 1.0 5.7 2.1 0.4 0.3 0.5 4.1 0.9 0.4 1.8 0.7 1.7 1.6 0.6 0.4 2.5 0.5 0.4 2.0 4.4 2.4 0.7 1.8 0.6 3.2 2.5 2.6 1.2 2.7 4.7 2.2 2.1 1.3 1.7 5.3 1.8 5.2 6.7 1.5 4.9 3.5 3.6 2.8 1.0 1.4 1.6 14.9 6.2 5.0 56.0 49.5 0.7 0.7 81.5 4.0 6.8 15.7 0.0 1.3 23.2 94.6 12.4 13.0 454.6 0.0 187.2 0.8 4.4 102.5 9.2 4.9 0.9 1.6 34.4 4.9 1.6 1.1 1.4 2.2 8.5 3.6 127.5 1.0 472.7 448.9 0.0 1.3 1.0 0.0 4.2 1.7 6.6 83.6 1.4 2.5 60.5 654.3 SDHAF4 "C6orf57, Sdh8" ENSG00000154079 "Succinate dehydrogenase complex assembly factor 4" Q5VUM1 6 70566917-70589569 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031824 Supported Approved Nucleoplasm,Mitochondria "Intracellular and membrane" No No Mitochondria Nucleoplasm "HPA031824: AB_10602113" "unprognostic (8.72e-2)" "unprognostic (1.64e-1)" "unprognostic (4.95e-2)" "unprognostic (9.96e-2)" "unprognostic (4.58e-1)" "unprognostic (2.02e-1)" "unprognostic (2.17e-1)" "unprognostic (1.81e-1)" "unprognostic (1.15e-1)" "unprognostic (1.42e-3)" "unprognostic (3.18e-2)" "unprognostic (3.17e-1)" "prognostic favorable (1.95e-5)" "unprognostic (2.45e-2)" "unprognostic (9.37e-2)" "unprognostic (3.05e-1)" "unprognostic (9.94e-2)" 13.4 14.5 18.1 6.5 20.1 6.1 14.3 15.7 25.7 8.3 9.5 7.9 10.3 7.9 9.0 14.6 9.8 16.0 8.5 17.6 18.0 21.2 14.9 10.7 8.4 10.6 14.7 17.4 9.7 14.2 10.5 18.3 10.2 15.5 10.6 10.6 11.1 9.7 8.9 30.5 9.7 7.9 8.8 13.0 6.9 8.8 7.3 9.7 7.4 11.5 10.2 7.8 8.1 6.9 10.5 13.4 9.1 10.5 9.6 9.3 6.2 10.0 3.3 14.3 8.8 7.3 10.9 2.8 5.4 4.2 2.6 4.0 2.9 8.5 6.9 10.4 2.8 6.4 1.8 4.9 4.8 3.9 14.4 3.3 4.8 1.4 2.9 12.4 4.7 3.8 7.8 15.4 2.0 11.8 9.2 6.5 11.6 3.2 10.7 8.6 6.9 4.2 11.7 6.8 5.1 3.3 4.7 9.7 8.0 11.4 3.3 13.2 9.6 3.2 1.6 6.8 6.4 7.3 12.2 4.8 2.7 2.1 2.2 5.8 5.0 3.4 2.2 3.0 11.2 6.4 6.0 10.5 9.1 7.7 9.2 8.0 8.7 8.5 9.0 11.3 10.5 9.3 8.5 7.1 9.6 9.5 13.4 9.1 6.2 18.1 20.1 15.7 25.7 18.0 21.2 14.7 17.4 15.5 9.7 11.9 15.2 2.2 7.2 0.0 7.5 17.6 7.6 25.4 10.3 7.0 7.9 8.8 19.9 8.0 4.0 5.2 3.3 0.0 10.1 7.4 5.1 7.1 4.7 11.3 9.1 17.5 3.5 3.7 4.1 2.2 11.5 8.5 0.0 12.6 6.6 9.9 9.8 3.5 6.3 11.8 5.8 12.9 3.1 10.7 5.3 0.0 4.2 4.4 6.4 6.9 SDHB "SDH, SDH1" ENSG00000117118 "Succinate dehydrogenase complex iron sulfur subunit B" P21912 1 17018722-17054170 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Electron transport, Transport, Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 395.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002868, CAB009822, CAB068233, CAB068234, CAB068235" Enhanced Supported "Nucleoplasm,Plasma membrane,Mitochondria" "Intracellular and membrane" NA NA Mitochondria "Nucleoplasm, Plasma membrane" "CAB009822: AB_2183458, CAB068233: AB_2665638, CAB068234: AB_2665639, CAB068235: AB_2665640, HPA002868: AB_1079889" "unprognostic (1.06e-1)" "unprognostic (2.86e-2)" "unprognostic (2.19e-2)" "unprognostic (2.93e-2)" "unprognostic (1.88e-1)" "unprognostic (2.79e-3)" "unprognostic (1.58e-1)" "unprognostic (3.02e-1)" "unprognostic (1.19e-1)" "unprognostic (8.45e-2)" "unprognostic (5.51e-2)" "unprognostic (3.93e-2)" "prognostic favorable (2.93e-7)" "unprognostic (1.46e-1)" "unprognostic (2.75e-1)" "unprognostic (7.82e-2)" "unprognostic (3.82e-2)" 17.8 25.6 19.8 16.6 21.7 17.0 26.4 18.0 29.1 13.9 30.8 12.3 15.1 34.0 14.2 15.7 19.8 13.6 15.1 86.9 18.2 16.4 51.0 75.1 16.8 24.6 20.1 18.9 10.5 30.7 20.0 11.3 15.6 16.7 13.0 31.5 11.7 15.9 19.5 96.2 13.2 31.4 21.3 16.5 17.2 21.7 18.7 15.7 14.2 15.5 52.2 18.0 15.4 17.1 22.2 45.9 48.5 48.7 18.9 26.7 25.0 26.0 25.8 14.7 18.8 28.7 28.5 16.8 22.8 29.3 52.3 47.2 36.3 31.3 35.7 28.5 30.7 33.8 30.7 58.7 45.4 59.0 20.9 48.1 32.1 26.9 27.8 35.1 50.2 23.9 29.3 30.0 45.2 76.6 27.8 36.9 31.4 26.8 41.4 36.3 21.5 33.3 28.7 12.2 41.9 51.9 24.0 28.4 44.2 48.1 14.8 27.8 15.2 30.9 38.7 64.9 16.3 22.7 28.4 18.3 20.1 22.7 36.9 30.0 17.3 21.3 36.5 30.8 76.6 22.2 16.6 38.4 37.4 18.3 48.7 18.3 22.2 21.2 19.5 45.9 18.3 19.3 19.5 48.5 18.9 42.2 21.5 26.7 25.0 19.8 21.7 18.0 29.1 18.2 16.4 20.1 18.9 16.7 15.7 59.6 39.6 77.3 79.1 46.2 28.1 395.8 109.5 78.9 40.9 45.4 13.7 93.2 300.1 104.4 146.0 54.0 212.4 116.8 130.5 121.6 58.6 70.1 65.7 198.8 162.9 35.0 46.7 41.7 81.2 13.8 53.5 90.6 60.8 125.4 89.5 52.1 97.2 192.9 63.6 355.3 35.5 38.8 60.4 85.9 68.4 47.7 101.8 52.3 135.8 97.0 SDK2 "FLJ10832, KIAA1514" ENSG00000069188 "Sidekick cell adhesion molecule 2" Q58EX2 17 73334384-73644089 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 13.6" "Cell type enhanced" "Detected in many" 7 "Extravillous trophoblasts: 14.2;Horizontal cells: 19.1;Intestinal endocrine cells: 14.3;Late spermatids: 15.3;Spermatocytes: 12.4;Syncytiotrophoblasts: 14.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 2.7;plasmacytoid DC: 2.3" "Group enriched" "Detected in many" 5 "B-cells: 2.7;dendritic cells: 2.3" "Cell line enhanced" "Detected in some" "AF22: 14.7;BEWO: 12.1;RPMI-8226: 4.8;SuSa: 8.1;U-2 OS: 5.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014725 Approved Nucleoplasm NA NA 2000000 Nucleoplasm "HPA014725: AB_2183303" "unprognostic (7.22e-4)" "unprognostic (5.57e-2)" "unprognostic (1.70e-1)" "unprognostic (7.00e-3)" "unprognostic (1.62e-2)" "unprognostic (3.18e-1)" "unprognostic (3.16e-1)" "unprognostic (1.15e-1)" "unprognostic (1.98e-1)" "unprognostic (1.49e-1)" "unprognostic (8.80e-4)" "unprognostic (7.69e-2)" "unprognostic (3.89e-2)" "unprognostic (1.44e-2)" "unprognostic (1.38e-1)" "unprognostic (1.37e-2)" "unprognostic (6.64e-2)" 0.4 0.6 2.1 5.3 1.2 0.7 2.6 0.5 2.7 8.9 0.5 0.6 0.0 0.0 3.1 5.1 0.9 3.5 1.4 3.5 1.7 4.1 1.1 0.5 4.2 4.8 1.6 0.0 0.8 0.4 0.0 1.9 3.7 1.9 2.6 0.3 2.2 2.0 1.4 0.4 0.5 0.5 0.3 3.0 3.6 0.6 13.6 0.0 0.1 1.8 1.1 2.9 0.7 7.2 2.7 2.3 0.0 0.0 0.2 0.5 0.0 0.0 2.1 14.7 4.2 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 3.1 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 1.9 0.0 0.0 0.5 0.0 4.8 0.0 0.0 3.3 0.1 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 5.1 0.0 0.0 4.4 1.8 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 2.7 0.5 0.4 0.0 0.2 0.0 2.3 0.0 0.0 2.1 1.2 0.5 2.5 1.7 4.1 1.6 0.0 1.9 0.0 0.0 2.4 4.5 3.7 0.8 3.5 2.0 0.0 0.0 2.3 0.0 0.0 3.8 0.0 0.2 10.9 0.3 0.0 0.0 0.2 14.2 1.9 2.3 1.1 0.0 0.6 19.1 14.3 0.0 0.0 15.3 0.6 0.0 1.7 1.8 0.2 7.8 0.0 0.0 0.0 0.0 0.6 0.0 0.9 12.4 3.5 0.1 14.9 0.0 0.0 0.3 SDR39U1 "C14orf124, HCDI" ENSG00000100445 "Short chain dehydrogenase/reductase family 39U member 1" Q9NRG7 14 24439766-24442905 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044294, HPA075356" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA044294: AB_10961400, HPA075356: " "unprognostic (2.99e-2)" "unprognostic (1.21e-1)" "unprognostic (4.13e-2)" "unprognostic (2.42e-2)" "unprognostic (2.36e-1)" "unprognostic (6.28e-2)" "unprognostic (2.06e-2)" "unprognostic (1.67e-3)" "unprognostic (4.24e-1)" "unprognostic (2.87e-3)" "prognostic favorable (2.34e-4)" "unprognostic (9.13e-2)" "unprognostic (1.13e-3)" "unprognostic (7.47e-2)" "unprognostic (2.48e-1)" "unprognostic (1.63e-1)" "unprognostic (5.32e-2)" 19.5 29.3 21.6 12.4 24.1 21.4 15.6 47.7 26.9 13.9 13.5 23.0 17.1 14.8 16.3 16.5 12.0 19.6 10.4 37.1 21.7 18.5 22.2 18.6 11.8 17.0 32.5 19.6 19.2 22.3 17.2 27.9 12.9 22.0 17.2 8.7 19.5 31.1 21.9 64.2 16.2 14.9 13.9 18.8 22.4 16.5 15.2 29.8 13.3 18.0 17.0 12.2 13.9 14.7 25.8 30.6 17.2 19.5 27.5 24.5 15.6 10.6 17.7 12.6 14.8 17.6 13.5 12.9 6.3 7.9 13.1 15.2 13.7 13.3 14.4 15.6 6.4 10.1 18.7 11.2 14.1 5.7 19.6 19.7 12.6 13.2 34.9 8.6 11.5 12.7 15.0 17.1 9.4 13.6 13.5 13.9 32.6 11.3 12.3 12.8 18.6 18.9 18.6 12.1 15.0 16.5 24.3 6.5 10.1 23.0 13.4 22.0 19.1 15.5 27.7 13.6 7.9 19.1 17.0 7.4 4.1 13.8 11.9 7.8 21.2 13.3 17.3 10.8 14.7 10.9 17.2 19.5 11.5 21.9 11.6 21.0 25.8 16.6 17.1 21.9 25.2 23.7 24.5 6.0 27.5 9.5 30.6 19.3 15.6 21.6 24.1 47.7 26.9 21.7 18.5 32.5 19.6 22.0 29.8 26.8 20.8 26.1 35.9 23.6 34.7 0.2 35.7 17.4 26.1 38.4 11.8 43.4 102.8 23.4 11.6 31.5 17.8 46.7 17.5 20.7 25.9 23.5 34.7 34.4 25.8 27.0 26.5 16.5 18.1 19.8 30.5 19.8 40.5 15.4 21.6 56.9 16.4 11.5 29.7 56.4 36.7 0.0 31.9 63.7 13.0 23.8 46.9 27.7 21.3 26.3 SEC13 "D3S1231E, npp-20, SEC13L1, SEC13R" ENSG00000157020 "SEC13 homolog, nuclear pore and COPII coat complex component" P55735 3 10293131-10321178 "Predicted intracellular proteins, Transporters" "ER-Golgi transport, mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035292, HPA057943" Approved Supported Nucleoplasm,Vesicles NA NA 15000 "Nucleoplasm, Vesicles" "HPA035292: AB_10959451, HPA057943: AB_2683560" "unprognostic (3.33e-3)" "unprognostic (6.16e-2)" "unprognostic (2.28e-2)" "unprognostic (4.95e-2)" "unprognostic (4.22e-1)" "unprognostic (2.64e-2)" "prognostic unfavorable (1.73e-4)" "unprognostic (2.43e-1)" "unprognostic (2.67e-1)" "unprognostic (1.69e-1)" "unprognostic (4.58e-1)" "unprognostic (1.17e-1)" "unprognostic (1.40e-1)" "unprognostic (4.60e-1)" "unprognostic (2.43e-1)" "unprognostic (2.03e-1)" "unprognostic (8.33e-2)" 25.2 30.7 19.0 24.2 24.7 20.6 25.5 16.2 24.9 37.9 47.0 22.6 38.1 47.7 29.6 30.8 30.1 24.7 41.6 30.6 19.5 20.7 33.2 58.3 27.0 19.9 24.7 17.5 24.7 66.8 22.3 48.1 44.1 20.2 23.2 27.9 22.3 63.5 33.4 42.6 25.5 57.1 32.0 21.9 25.9 27.2 26.4 20.5 29.0 38.2 32.8 28.6 25.8 24.2 26.9 60.8 29.1 44.6 23.2 27.7 41.2 21.2 32.3 26.0 10.0 42.3 47.0 86.4 43.6 53.3 51.0 58.9 26.7 17.5 19.5 20.0 69.0 28.7 8.7 33.4 38.8 26.2 16.9 34.7 23.8 26.2 64.4 58.1 27.1 21.1 41.6 31.4 53.3 33.2 37.6 60.4 26.2 25.4 28.9 39.3 43.9 26.4 29.8 29.5 27.7 39.2 25.7 18.6 34.6 31.0 16.0 14.6 18.2 19.1 17.8 17.0 22.8 22.9 26.4 45.1 21.0 24.0 31.3 37.3 24.0 33.3 45.1 39.7 38.1 34.6 28.0 44.6 28.1 24.5 38.4 27.2 26.9 24.6 23.7 60.8 22.2 20.3 21.2 29.1 23.2 29.5 54.2 27.7 41.2 19.0 24.7 16.2 24.9 19.5 20.7 24.7 17.5 20.2 20.5 44.7 52.3 27.4 45.1 34.9 14.7 37.0 17.8 72.3 47.8 26.2 9.8 98.1 56.3 69.8 20.2 33.5 63.9 0.0 95.6 135.9 66.7 49.4 41.6 54.2 93.9 11.1 39.7 36.8 34.0 6.8 49.5 49.1 25.3 67.7 75.6 30.7 74.0 53.4 49.5 72.3 20.1 12.9 43.2 42.4 36.5 35.1 141.0 40.1 67.8 50.4 SEC14L1 "PRELID4A, SEC14L" ENSG00000129657 "SEC14 like lipid binding 1" Q92503 17 77086716-77217101 "Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 11 "Ito cells: 287.8;Late spermatids: 570.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "neutrophil: 71.8" "Lineage enriched" "Detected in all" 11 "granulocytes: 71.8" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 92.7;TIME: 57.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021463, HPA028703" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021463: AB_2670712, HPA028703: AB_10602300" "unprognostic (1.19e-1)" "unprognostic (8.61e-2)" "unprognostic (1.51e-2)" "unprognostic (4.64e-3)" "unprognostic (1.26e-1)" "unprognostic (1.24e-1)" "unprognostic (1.03e-1)" "unprognostic (1.61e-1)" "unprognostic (7.37e-2)" "unprognostic (1.21e-1)" "unprognostic (7.40e-3)" "unprognostic (1.39e-1)" "unprognostic (1.32e-1)" "unprognostic (1.37e-1)" "unprognostic (1.33e-3)" "unprognostic (3.09e-1)" "unprognostic (4.30e-2)" 40.8 34.0 25.4 25.3 39.1 33.4 40.6 42.3 33.2 27.7 11.1 21.9 12.2 13.3 15.8 18.9 18.8 15.9 21.2 18.2 27.0 19.5 25.1 15.8 38.4 25.8 31.6 20.6 12.6 18.3 17.3 18.6 49.3 22.5 10.8 10.5 24.2 21.4 12.9 51.0 11.9 12.2 16.2 25.8 33.9 18.4 35.4 24.4 10.0 24.0 14.4 26.0 15.7 14.7 2.4 2.3 71.8 6.2 1.5 2.0 1.9 11.9 8.7 15.5 23.8 6.5 8.0 5.5 10.9 9.4 12.8 11.2 11.6 7.8 32.0 22.0 15.0 15.8 4.6 6.9 10.6 16.7 5.9 6.2 16.7 6.8 15.1 11.1 3.4 7.8 11.3 4.3 10.7 11.2 17.1 92.7 3.9 10.2 27.1 18.1 6.1 5.9 4.4 5.6 5.2 7.9 4.5 24.9 23.7 21.9 4.8 11.9 9.3 12.0 6.4 6.7 14.9 5.3 3.7 57.9 14.6 13.7 7.9 7.7 15.5 12.1 16.8 6.3 3.5 4.3 4.2 3.2 9.2 0.7 5.5 0.6 2.4 0.7 0.5 2.3 1.2 0.8 0.5 71.8 1.5 6.2 0.8 2.0 1.9 25.4 39.1 42.3 33.2 27.0 19.5 31.6 20.6 22.5 24.4 38.7 24.7 57.3 18.3 26.1 28.1 14.2 15.3 62.9 25.0 26.2 17.7 8.9 84.6 15.6 199.7 196.1 10.7 23.3 18.0 9.4 22.0 33.6 32.5 9.4 43.6 35.0 18.9 287.8 111.7 570.5 24.5 46.3 33.7 53.3 13.7 19.7 30.2 13.5 16.3 18.1 16.8 38.8 18.7 27.0 43.4 26.6 11.1 35.5 10.7 33.3 SEC14L2 "C22orf6, KIAA1186, KIAA1658, SPF, TAP, TAP1" ENSG00000100003 "SEC14 like lipid binding 2" O76054 22 30396857-30425317 "Predicted intracellular proteins" "Transcription, Transcription regulation, Transport" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 43.0;liver: 112.3" "Cell type enhanced" "Detected in many" 11 "Hepatocytes: 123.4;Muller glia cells: 99.0;Pancreatic endocrine cells: 69.1;Rod photoreceptor cells: 51.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory CD4 T-cell: 2.6;naive CD4 T-cell: 7.1;naive CD8 T-cell: 4.7" "Lineage enriched" "Detected in single" 8 "T-cells: 7.1" "Cell line enhanced" "Detected in many" "HBEC3-KT: 37.7;hTCEpi: 20.5;hTERT-RPE1: 24.0" HPA064466 Approved Supported Nucleoplasm,Cytosol NA NA 190000 Nucleoplasm Cytosol "HPA064466: AB_2685270" "prognostic favorable (3.05e-4)" "unprognostic (1.47e-1)" "unprognostic (1.98e-1)" "unprognostic (5.59e-3)" "unprognostic (6.51e-2)" "prognostic unfavorable (7.63e-6)" "unprognostic (1.25e-3)" "unprognostic (3.76e-3)" "unprognostic (2.23e-1)" "unprognostic (2.40e-1)" "unprognostic (2.76e-2)" "unprognostic (5.63e-3)" "unprognostic (1.17e-3)" "unprognostic (1.17e-1)" "unprognostic (1.52e-1)" "unprognostic (1.34e-3)" "unprognostic (2.01e-1)" 1.9 1.2 13.6 1.9 14.2 2.4 22.7 7.3 15.0 2.2 5.7 12.6 7.3 10.1 2.4 43.0 8.0 2.3 4.3 1.1 10.8 10.4 3.6 112.3 1.8 2.1 16.1 10.4 1.3 1.9 3.7 5.0 1.5 10.6 25.7 1.4 24.2 4.0 7.8 1.0 2.9 13.5 2.4 8.9 1.0 3.4 1.2 10.4 1.1 4.3 0.6 2.7 1.8 2.9 0.8 0.9 0.5 0.2 0.1 7.1 1.5 9.8 2.4 1.9 2.7 2.9 7.4 0.1 8.0 6.4 4.7 4.9 0.6 6.6 0.2 2.4 9.6 8.0 7.6 1.2 37.7 5.2 0.9 1.9 0.1 2.4 3.5 4.0 0.0 2.5 5.1 20.5 4.3 7.7 24.0 11.8 1.8 0.0 0.2 9.4 1.7 1.0 0.2 0.0 5.1 3.3 0.4 3.4 0.2 8.3 3.3 1.2 1.3 4.9 1.1 4.4 0.1 6.4 0.1 17.9 6.6 4.2 2.7 4.8 0.1 0.0 0.3 14.5 0.0 5.2 0.1 0.2 0.4 0.9 0.2 0.4 0.8 2.6 0.6 0.1 0.6 7.1 4.7 0.5 0.1 0.1 0.9 1.1 1.5 13.6 14.2 7.3 13.4 10.8 10.4 16.1 10.4 10.6 10.4 3.0 4.3 0.5 13.2 3.7 7.5 1.0 20.4 1.4 4.5 0.0 15.7 2.6 5.0 21.9 6.6 1.5 1.7 0.0 16.4 0.2 3.6 18.3 5.7 123.4 0.4 12.7 1.2 4.3 4.7 7.5 1.1 0.0 6.8 0.0 0.5 99.0 69.1 0.0 0.7 6.1 51.4 0.0 2.0 0.5 1.0 1.8 2.5 5.3 0.2 7.0 SEC14L6 ENSG00000214491 "SEC14 like lipid binding 6" B5MCN3 22 30522799-30546682 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 15.4;parathyroid gland: 20.9" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 8.0;Club cells: 6.8;Collecting duct cells: 12.2;Muller glia cells: 14.0" "Cancer enriched" "Detected in many" 7 "renal cancer: 12.6" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "K-562: 11.2;RPTEC TERT1: 21.1;SiHa: 6.2" HPA067695 Approved Nucleoplasm NA NA Nucleoplasm "HPA067695: AB_2685889" "unprognostic (3.49e-2)" "unprognostic (4.76e-2)" "unprognostic (4.79e-2)" "unprognostic (4.09e-2)" "unprognostic (3.04e-2)" "unprognostic (1.12e-1)" "unprognostic (7.28e-3)" "unprognostic (3.88e-2)" "unprognostic (3.13e-1)" "unprognostic (3.35e-1)" "unprognostic (1.29e-1)" "unprognostic (9.25e-2)" "unprognostic (8.69e-2)" "unprognostic (8.20e-2)" "unprognostic (2.12e-1)" "unprognostic (2.48e-2)" "unprognostic (6.02e-2)" 0.7 0.7 3.3 0.0 3.6 1.1 2.4 1.1 2.1 2.3 0.0 0.1 2.0 15.4 0.0 0.9 2.8 0.0 2.4 3.4 7.2 0.0 7.9 0.0 4.0 1.7 3.5 20.9 1.8 0.0 1.0 0.0 0.0 1.6 0.0 7.3 0.0 1.3 3.9 0.0 0.6 3.8 0.0 0.1 0.1 0.0 1.2 0.9 2.7 0.8 1.9 2.2 0.3 0.2 0.1 0.9 0.3 0.0 0.0 0.9 0.1 0.0 0.1 0.0 0.2 0.5 0.3 1.1 0.1 0.1 0.2 0.1 0.0 0.3 0.0 0.0 2.8 0.3 0.3 0.1 0.2 0.4 0.0 0.1 0.1 0.1 0.7 0.0 0.1 11.2 0.2 0.0 0.4 0.1 0.4 0.5 0.0 0.1 0.2 0.0 0.1 21.1 0.2 0.2 0.1 6.2 0.1 0.0 0.2 1.7 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.3 0.1 1.9 0.8 0.7 0.6 0.6 1.6 0.7 0.5 0.5 0.2 1.2 0.6 0.9 2.7 1.9 0.7 0.9 2.2 0.3 11.9 8.0 0.0 0.3 0.1 0.0 0.3 5.1 0.0 6.8 12.2 0.0 0.0 1.7 5.1 0.0 0.4 0.0 0.0 0.7 0.0 0.2 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 14.0 1.9 0.0 0.7 2.6 0.3 0.0 0.1 0.5 0.2 0.0 0.1 0.0 0.0 0.1 SEC22C "MGC13261, MGC5373, SEC22L3" ENSG00000093183 "SEC22 homolog C, vesicle trafficking protein" Q9BRL7 3 42547969-42601080 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031242 Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA031242: " "unprognostic (1.68e-1)" "unprognostic (4.86e-2)" "unprognostic (1.01e-1)" "unprognostic (2.67e-1)" "unprognostic (9.37e-3)" "unprognostic (2.11e-1)" "prognostic unfavorable (3.04e-5)" "unprognostic (1.15e-1)" "unprognostic (3.27e-1)" "unprognostic (1.44e-1)" "unprognostic (3.58e-2)" "unprognostic (2.57e-1)" "prognostic favorable (1.35e-7)" "unprognostic (2.59e-1)" "unprognostic (3.30e-1)" "unprognostic (7.51e-2)" "unprognostic (1.41e-3)" 25.3 20.9 27.6 13.4 30.5 28.0 28.8 19.0 30.5 24.1 21.1 32.8 17.4 28.4 26.2 25.8 16.4 22.2 17.4 22.6 27.5 25.4 22.5 14.1 24.6 18.9 34.7 24.6 29.0 26.6 23.8 23.7 17.7 27.6 36.4 14.5 25.7 23.3 25.1 15.4 14.5 31.6 24.9 49.2 15.8 20.7 32.0 25.6 14.5 23.5 11.8 15.2 18.4 17.6 11.5 10.3 18.8 10.7 9.9 19.4 9.2 12.3 11.6 16.2 14.5 32.5 30.7 4.5 22.4 20.7 21.5 22.7 8.2 18.4 12.0 9.2 23.2 15.5 6.6 12.5 18.9 19.4 16.7 14.2 18.7 19.6 9.3 25.7 10.3 19.2 18.2 23.2 26.9 28.7 20.6 24.5 19.3 18.5 21.1 21.1 8.0 12.3 9.5 10.2 6.8 17.3 6.3 11.5 10.5 17.7 10.1 9.5 13.7 17.1 12.6 15.7 12.4 24.5 9.6 22.3 19.6 15.6 29.7 21.7 17.8 26.9 11.3 21.3 13.2 18.2 8.7 10.7 18.8 13.7 7.7 19.4 11.5 17.7 16.1 9.9 9.8 15.2 13.4 6.0 9.9 8.0 10.3 14.2 9.2 27.6 30.5 19.0 30.5 27.5 25.4 34.7 24.6 27.6 25.6 23.8 25.9 19.9 14.3 13.4 15.4 16.9 25.5 18.7 18.2 10.4 27.5 18.6 34.9 26.6 32.1 31.2 4.2 70.0 28.5 17.2 32.7 23.5 48.5 10.6 28.2 25.4 8.6 27.6 18.3 9.9 30.2 19.3 38.8 45.1 4.4 31.0 23.7 0.0 40.3 22.3 31.8 38.8 31.4 75.8 54.1 8.9 8.8 28.7 6.7 5.4 SEC23A ENSG00000100934 "Sec23 homolog A, coat complex II component" Q15436 14 39031919-39109646 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043806, HPA069974" Uncertain Approved Nucleoplasm,Vesicles NA NA 54000 "Nucleoplasm, Vesicles" "HPA043806: , HPA069974: AB_2686223" "unprognostic (2.40e-1)" "prognostic unfavorable (5.75e-4)" "prognostic favorable (3.56e-4)" "unprognostic (3.30e-2)" "unprognostic (1.18e-1)" "unprognostic (6.39e-2)" "unprognostic (1.15e-2)" "unprognostic (5.85e-2)" "unprognostic (1.71e-1)" "unprognostic (2.69e-1)" "unprognostic (1.28e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (1.69e-4)" "prognostic unfavorable (2.94e-4)" "unprognostic (1.16e-1)" "unprognostic (2.73e-1)" "unprognostic (1.41e-3)" 23.9 23.5 10.2 16.8 19.1 7.1 22.1 18.6 20.6 21.4 29.6 8.4 14.0 30.2 30.0 16.8 20.3 19.0 17.2 26.5 11.0 14.8 14.4 55.7 13.5 15.5 12.5 12.8 24.3 8.5 4.7 17.2 15.5 19.8 18.6 18.6 16.2 9.8 31.0 31.7 9.6 38.3 52.8 8.3 11.8 16.9 12.3 6.9 12.9 11.8 11.3 11.3 31.9 18.9 15.6 19.8 38.1 21.6 26.0 26.1 17.9 10.8 20.5 17.9 15.8 32.7 37.6 5.4 43.8 37.9 31.2 39.0 20.5 9.2 2.6 10.7 61.1 13.0 8.7 22.4 17.7 45.7 8.3 7.7 4.5 16.3 66.5 25.0 7.5 6.9 28.7 9.5 21.6 16.0 24.2 26.1 6.0 3.3 6.3 24.3 10.1 6.7 3.1 4.0 16.8 19.6 9.8 24.6 3.9 16.4 16.5 1.9 4.3 30.4 9.0 9.7 15.2 11.1 2.3 29.1 16.6 12.7 24.1 11.0 6.1 7.5 12.3 11.2 6.4 15.8 38.1 21.6 24.2 18.2 18.6 26.1 15.6 23.0 23.4 19.8 14.5 24.2 19.6 19.6 26.0 16.3 17.4 24.0 17.9 10.2 19.1 18.6 20.6 11.0 14.8 12.5 12.8 19.8 6.9 14.9 30.6 32.3 28.2 23.0 39.5 49.2 15.3 2.7 17.0 29.6 64.8 13.2 6.6 7.8 13.7 33.8 75.3 0.0 4.8 35.6 56.3 32.7 27.6 112.9 22.6 28.6 23.5 113.0 33.6 13.4 69.3 27.2 23.6 14.4 25.3 17.0 13.0 30.0 67.1 31.8 52.0 38.8 60.4 16.7 14.3 21.0 20.7 29.8 20.9 29.1 SEC24B ENSG00000138802 "SEC24 homolog B, COPII coat complex component" O95487 4 109433772-109540896 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038181 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA038181: AB_10672472" "unprognostic (1.19e-1)" "unprognostic (4.31e-3)" "unprognostic (8.58e-3)" "unprognostic (9.95e-2)" "unprognostic (1.22e-1)" "unprognostic (1.46e-1)" "unprognostic (6.67e-2)" "unprognostic (3.18e-2)" "unprognostic (1.06e-1)" "unprognostic (1.85e-3)" "unprognostic (2.51e-3)" "unprognostic (7.47e-2)" "prognostic favorable (2.33e-6)" "unprognostic (2.67e-1)" "unprognostic (2.40e-1)" "unprognostic (6.02e-2)" "unprognostic (1.73e-1)" 25.5 20.2 15.8 18.3 16.5 26.6 34.5 26.9 18.9 21.4 20.0 16.8 19.9 15.5 26.2 19.2 22.6 18.9 18.7 20.5 14.2 12.1 18.9 49.5 20.4 17.8 15.7 11.8 24.9 20.4 30.7 27.7 22.3 15.1 19.1 18.3 22.5 20.2 28.3 37.0 25.8 17.4 25.5 14.8 17.4 18.0 12.1 16.7 31.7 20.8 18.3 21.9 24.9 31.1 13.9 15.7 14.6 13.7 15.7 16.1 10.6 12.1 11.1 17.7 13.2 21.5 21.6 10.1 15.9 19.5 13.6 12.1 10.1 14.1 11.3 8.4 24.1 11.7 10.3 19.7 15.9 20.1 13.8 9.8 11.7 10.2 11.1 14.5 15.4 13.8 21.2 20.4 15.5 18.8 19.3 20.0 11.7 17.8 10.3 20.0 9.9 22.3 7.2 6.7 15.1 9.0 14.5 15.6 6.5 16.5 15.2 12.5 10.0 12.3 26.2 9.4 19.0 7.7 6.0 18.4 16.0 10.7 13.9 11.3 10.0 12.5 10.8 14.2 6.2 12.8 8.2 12.3 14.6 12.3 13.7 13.7 13.9 13.7 12.8 15.7 11.6 16.1 13.2 12.3 15.7 13.2 6.2 11.9 10.6 15.8 16.5 26.9 18.9 14.2 12.1 15.7 11.8 15.1 16.7 23.8 12.5 8.6 17.6 31.5 21.9 25.7 17.8 13.4 17.0 5.2 5.9 10.9 5.0 8.9 3.3 20.2 15.4 23.3 11.2 7.7 14.2 18.4 10.5 24.5 10.7 15.9 15.0 17.8 22.5 5.9 19.0 12.9 16.9 3.6 15.3 19.7 10.8 15.6 20.5 8.4 20.7 12.9 15.0 13.0 13.6 32.0 13.5 12.5 13.2 27.8 SEC31B "DKFZP434M183, SEC31B-1, SEC31L2" ENSG00000075826 "SEC31 homolog B, COPII coat complex component" Q9NQW1 10 100486642-100519864 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Bipolar cells: 34.2;Collecting duct cells: 10.4;Cone photoreceptor cells: 37.3;Horizontal cells: 38.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 12.4;JURKAT: 12.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA035882, HPA040819, HPA060052" Uncertain Supported Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles, Cytosol" "HPA035882: AB_10795246, HPA040819: AB_10794151, HPA060052: " "unprognostic (1.23e-1)" "unprognostic (3.13e-3)" "unprognostic (3.39e-3)" "unprognostic (1.03e-2)" "unprognostic (4.85e-2)" "unprognostic (1.42e-3)" "unprognostic (1.97e-3)" "unprognostic (6.63e-2)" "unprognostic (2.22e-1)" "unprognostic (2.25e-2)" "unprognostic (1.10e-4)" "unprognostic (8.23e-3)" "prognostic unfavorable (6.41e-7)" "unprognostic (2.31e-2)" "unprognostic (2.54e-1)" "unprognostic (1.79e-1)" "unprognostic (1.01e-4)" 2.8 2.4 3.3 3.2 5.0 6.4 2.6 12.1 11.8 2.7 2.8 5.4 4.3 1.9 3.0 3.5 1.4 2.9 2.6 5.6 3.1 3.6 2.7 3.4 2.4 4.3 3.3 5.6 3.9 0.8 3.9 5.0 2.4 6.3 2.9 2.7 6.1 2.8 2.5 13.6 2.4 2.9 3.2 3.4 4.9 1.9 16.2 3.4 0.0 2.6 5.2 3.6 2.3 1.9 0.9 0.0 0.1 0.2 0.0 2.1 0.1 0.2 0.2 2.8 0.9 0.9 1.6 0.3 0.5 1.3 0.2 0.9 0.3 0.4 0.6 0.8 0.0 0.1 0.3 1.5 0.4 0.8 3.5 0.8 1.4 1.8 0.3 1.2 1.0 1.2 2.4 1.4 0.2 1.7 12.4 0.5 12.5 0.3 1.7 0.0 0.0 1.8 3.1 0.0 0.2 0.6 2.7 0.1 1.1 0.9 0.0 0.2 0.9 0.3 0.0 0.6 2.1 0.7 0.3 0.0 0.4 0.4 0.3 0.2 1.3 0.6 0.8 0.1 3.4 0.4 0.0 0.1 0.0 0.5 0.2 2.1 0.0 0.0 0.4 0.0 0.9 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.1 3.3 5.0 12.1 11.8 3.1 3.6 3.3 5.6 6.3 3.4 6.0 5.0 0.0 0.8 1.0 34.2 6.5 5.1 2.7 2.3 10.4 37.3 1.0 0.0 0.4 0.9 2.1 2.1 0.0 0.2 0.3 1.9 1.8 1.1 6.4 1.9 38.1 5.2 3.1 4.3 0.8 3.1 1.8 1.7 3.6 3.9 4.3 0.3 0.0 3.9 0.6 6.7 0.0 1.2 7.5 3.2 1.0 0.7 2.6 4.0 0.9 SECISBP2 SBP2 ENSG00000187742 "SECIS binding protein 2" Q96T21 9 89318506-89359662 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" RNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 257.7;Late spermatids: 318.0;Spermatocytes: 306.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044314, HPA054905" Approved Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA044314: AB_10964885, HPA054905: " "unprognostic (1.07e-1)" "unprognostic (4.24e-1)" "unprognostic (1.64e-1)" "unprognostic (3.54e-2)" "unprognostic (1.24e-1)" "unprognostic (1.21e-1)" "unprognostic (4.00e-1)" "unprognostic (8.80e-2)" "unprognostic (1.35e-2)" "unprognostic (7.18e-2)" "unprognostic (1.92e-2)" "unprognostic (1.16e-1)" "prognostic favorable (8.98e-9)" "unprognostic (5.44e-2)" "unprognostic (1.48e-1)" "unprognostic (1.98e-1)" "unprognostic (4.55e-3)" 17.3 24.8 19.5 23.1 26.6 26.4 30.0 28.3 28.9 22.1 22.5 21.7 19.8 20.5 28.1 26.0 16.7 23.3 17.7 13.4 22.5 15.9 26.8 25.4 30.0 25.6 20.6 16.2 36.7 34.3 26.9 33.9 29.9 21.0 21.0 24.9 21.3 26.8 21.3 32.6 25.8 23.6 21.3 24.7 29.7 23.2 58.2 22.8 26.6 31.5 11.8 23.4 19.9 26.3 14.1 11.7 21.5 9.5 9.1 16.1 5.9 13.4 9.2 25.3 14.6 11.9 13.0 18.3 7.8 9.7 9.4 9.3 5.1 11.4 20.2 6.9 7.3 15.0 17.1 17.0 7.9 8.7 13.3 10.1 9.9 7.2 13.0 10.4 19.8 14.9 8.1 15.0 7.9 9.5 10.4 11.6 27.2 12.6 24.0 8.9 12.5 27.1 10.2 26.2 34.0 9.1 13.1 12.4 13.2 10.5 10.4 18.5 18.2 7.1 15.8 20.5 17.6 14.0 17.2 10.7 9.1 10.6 12.2 12.0 29.3 18.6 8.4 15.9 12.9 13.1 12.2 7.6 12.7 10.4 7.9 10.1 12.9 10.7 10.2 6.7 14.1 16.1 13.5 21.5 9.1 9.5 11.7 12.5 5.9 19.5 26.6 28.3 28.9 22.5 15.9 20.6 16.2 21.0 22.8 41.7 47.6 35.6 60.3 17.3 105.5 15.1 20.4 41.5 39.8 38.4 86.4 55.5 36.5 33.4 257.7 36.0 38.4 23.3 27.3 41.2 27.2 56.9 34.7 33.3 23.6 54.0 35.8 27.0 31.8 318.0 37.2 26.3 20.3 27.9 51.3 45.0 31.3 46.0 24.1 44.6 111.0 32.3 24.5 306.3 193.7 22.2 76.8 43.3 47.0 55.5 SECISBP2L KIAA0256 ENSG00000138593 "SECIS binding protein 2 like" Q93073 15 48988476-49046563 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.1" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 2: 183.4;Syncytiotrophoblasts: 594.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039875 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA039875: AB_10673365" "unprognostic (7.86e-3)" "unprognostic (2.53e-2)" "unprognostic (1.33e-1)" "unprognostic (3.19e-3)" "unprognostic (9.29e-2)" "unprognostic (5.35e-2)" "unprognostic (1.58e-1)" "unprognostic (1.09e-1)" "unprognostic (1.12e-1)" "unprognostic (9.58e-3)" "unprognostic (2.16e-1)" "unprognostic (3.08e-2)" "prognostic favorable (5.65e-8)" "unprognostic (1.87e-2)" "unprognostic (1.27e-1)" "unprognostic (2.01e-2)" "unprognostic (2.28e-1)" 13.2 12.6 30.1 8.5 32.2 14.4 14.3 18.1 38.0 15.2 10.8 40.7 12.1 7.2 14.1 17.4 13.2 14.4 11.1 11.1 38.4 23.8 19.3 13.9 27.3 9.5 38.8 24.8 15.5 10.9 42.0 12.7 29.4 36.7 16.3 9.2 8.1 30.8 14.8 10.1 8.3 8.5 11.5 66.1 10.6 13.6 9.9 35.6 6.7 18.2 6.7 9.8 10.8 10.3 14.7 8.1 14.6 6.0 7.8 11.1 4.0 4.7 5.1 11.5 9.6 16.4 12.7 6.8 16.8 14.1 14.3 17.7 5.7 4.3 3.3 8.0 12.8 15.0 4.0 14.4 4.2 16.9 19.2 3.5 9.5 7.4 4.5 8.6 5.2 10.8 10.0 5.5 12.2 6.9 15.2 13.5 8.0 5.7 8.5 16.5 2.0 5.4 5.0 4.1 3.1 4.6 5.5 12.6 13.0 18.4 10.2 2.0 7.8 10.9 20.0 15.9 20.4 5.8 6.1 16.2 12.5 6.0 11.8 7.8 7.0 12.4 6.0 9.9 7.6 16.6 9.3 5.1 14.6 9.0 4.9 8.5 12.2 8.1 6.1 3.6 14.7 11.1 8.7 9.2 7.8 6.0 8.1 5.8 4.0 30.1 32.2 18.1 31.5 38.4 23.8 38.8 24.8 36.7 35.6 107.2 183.4 25.3 14.0 13.2 33.9 35.8 15.3 99.0 61.4 31.4 25.5 71.2 13.3 23.4 8.2 29.2 20.7 0.0 16.3 30.7 28.0 30.9 31.3 22.1 23.2 54.0 9.2 26.4 13.7 6.9 31.1 18.1 43.9 28.9 14.2 35.2 29.3 14.0 34.3 32.1 25.4 6.5 21.7 17.4 27.8 11.8 594.9 17.5 9.9 31.0 SEL1L3 KIAA0746 ENSG00000091490 "SEL1L family member 3" Q68CR1 4 25747427-25863760 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 48.0" "Cell type enhanced" "Detected in many" 4 "Mucus-secreting cells: 74.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 45.9" "Group enriched" "Detected in many" 5 "memory B-cell: 20.8;naive B-cell: 20.8;plasmacytoid DC: 17.9" "Group enriched" "Detected in many" 4 "B-cells: 20.8;dendritic cells: 17.9" "Cell line enhanced" "Detected in many" "Daudi: 65.9;OE19: 49.9;U-698: 43.0" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 191.0" "HPA040045, HPA058792" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA040045: AB_10796116, HPA058792: AB_2683822" "unprognostic (1.01e-2)" "unprognostic (2.03e-1)" "unprognostic (3.06e-3)" "unprognostic (1.44e-2)" "unprognostic (2.43e-3)" "unprognostic (1.80e-1)" "unprognostic (1.26e-2)" "unprognostic (1.39e-1)" "unprognostic (5.33e-2)" "unprognostic (7.24e-2)" "unprognostic (1.11e-1)" "unprognostic (5.11e-1)" "unprognostic (4.77e-2)" "unprognostic (7.21e-3)" "unprognostic (1.32e-1)" "unprognostic (2.28e-2)" "prognostic favorable (4.33e-4)" 5.4 3.3 4.0 36.3 5.6 2.3 3.8 45.9 6.4 13.7 19.3 1.5 1.5 19.3 2.2 18.1 6.2 3.6 22.0 2.4 3.3 2.8 6.9 3.6 14.3 27.7 2.1 1.7 3.1 48.0 10.9 2.9 13.7 3.0 4.2 16.7 12.9 23.1 1.0 1.3 1.7 30.3 3.4 2.1 33.5 24.6 2.2 1.1 2.8 12.5 3.8 46.7 14.8 2.2 20.8 17.9 0.4 0.1 3.7 4.3 1.4 4.8 5.3 3.9 1.3 0.6 0.8 0.6 2.4 6.6 1.8 6.0 3.3 22.7 65.9 11.7 16.6 15.9 3.1 2.9 10.5 2.5 3.5 1.7 0.7 8.8 4.5 17.1 9.0 0.4 1.3 8.5 6.6 2.6 7.5 24.8 1.3 4.3 0.0 1.3 3.7 0.0 0.6 11.4 49.9 4.7 0.3 21.7 9.1 14.5 16.4 9.8 1.9 16.1 0.2 1.6 5.7 0.8 11.2 10.8 0.1 7.9 0.1 6.9 0.4 0.1 43.0 30.0 3.8 4.5 0.4 0.1 0.0 2.8 0.0 3.4 20.8 3.5 3.1 0.7 20.8 1.5 2.4 0.3 3.7 0.1 17.9 4.3 1.4 4.0 5.6 45.9 6.4 3.3 2.8 2.1 1.7 3.0 1.1 11.9 29.0 65.6 3.0 0.8 2.1 1.2 63.7 8.1 55.7 3.5 0.0 23.3 0.0 64.6 46.5 8.4 31.3 23.3 28.5 1.3 1.5 12.0 2.3 1.7 4.6 0.0 11.1 13.5 16.0 58.1 1.4 6.4 8.5 15.4 74.5 32.9 37.4 24.6 0.4 9.7 29.0 0.0 1.4 0.6 2.4 1.4 13.7 26.1 35.6 4.2 SELENOH "C11orf31, SELH" ENSG00000211450 "Selenoprotein H" Q8IZQ5 11 57741250-57743554 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 376.4;Hofbauer cells: 352.0;Proximal tubular cells: 359.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048362 Uncertain Approved Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA048362: AB_2680370" "unprognostic (1.12e-2)" "unprognostic (3.05e-2)" "unprognostic (6.14e-2)" "unprognostic (1.18e-1)" "unprognostic (2.39e-1)" "unprognostic (1.69e-2)" "prognostic unfavorable (4.30e-4)" "unprognostic (3.61e-2)" "unprognostic (1.23e-2)" "prognostic favorable (1.80e-4)" "unprognostic (1.58e-1)" "unprognostic (7.56e-2)" "unprognostic (4.12e-3)" "unprognostic (1.43e-1)" "unprognostic (1.01e-1)" "unprognostic (1.78e-1)" "unprognostic (2.60e-1)" 27.5 49.3 34.8 35.6 49.9 36.2 30.4 17.0 52.5 23.6 30.6 14.8 23.3 38.5 22.1 38.1 36.3 26.9 28.7 32.7 29.7 31.9 33.8 49.5 26.4 40.1 29.3 40.0 28.4 41.5 9.7 30.7 28.9 22.2 32.8 16.2 22.8 48.2 26.0 52.7 21.1 37.8 15.5 19.5 49.3 36.8 30.8 18.7 44.4 43.2 25.4 35.5 21.6 23.3 61.7 83.7 39.6 71.7 29.9 53.1 71.6 32.3 23.7 25.6 14.7 3.9 12.5 4.7 13.1 11.1 11.2 6.6 6.4 16.4 15.6 36.6 7.2 10.4 14.4 11.9 15.9 7.5 22.7 25.7 20.7 15.1 15.6 23.0 30.5 40.6 13.2 13.5 13.2 12.4 16.8 19.5 22.5 19.7 14.8 13.3 31.1 26.3 46.9 45.4 10.5 31.1 33.6 24.7 29.7 10.7 15.1 13.8 28.1 11.5 10.8 33.6 15.8 29.7 22.9 19.4 12.7 28.0 25.0 18.9 74.4 53.4 10.3 27.4 24.3 30.1 39.6 71.7 34.5 29.9 71.0 28.2 59.7 39.7 31.3 71.2 61.7 53.1 37.6 5.4 29.9 65.4 83.7 29.4 71.6 34.8 49.9 17.0 52.5 29.7 31.9 29.3 40.0 22.2 18.7 154.9 129.2 0.0 0.0 0.0 0.0 0.0 0.0 262.3 136.5 143.1 0.0 264.9 376.4 215.3 0.0 0.0 0.0 0.0 273.6 236.1 0.0 0.0 123.2 0.0 352.0 0.0 0.0 0.0 0.0 0.0 0.0 84.9 0.0 178.5 0.0 0.0 265.5 0.0 0.0 359.8 0.0 0.0 0.0 0.0 0.0 0.0 123.1 0.0 0.0 0.0 SELENOK SELK ENSG00000113811 "Selenoprotein K" Q9Y6D0 3 53884410-53891988 "Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 244.0;Pancreatic endocrine cells: 237.2;Proximal tubular cells: 306.1;Syncytiotrophoblasts: 292.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 78.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 78.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008196 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA008196: AB_1856665" "unprognostic (1.29e-2)" "unprognostic (1.18e-2)" "unprognostic (3.85e-1)" "prognostic favorable (7.18e-4)" "unprognostic (9.92e-2)" "unprognostic (1.53e-1)" "unprognostic (3.02e-2)" "prognostic favorable (3.76e-4)" "unprognostic (2.75e-1)" "unprognostic (5.21e-2)" "unprognostic (8.34e-2)" "unprognostic (1.14e-1)" "unprognostic (3.40e-2)" "unprognostic (8.43e-2)" "unprognostic (8.12e-2)" "unprognostic (9.35e-2)" "unprognostic (2.56e-3)" 20.4 33.5 29.2 19.0 30.2 38.8 24.1 19.7 21.7 18.9 20.5 20.9 28.3 17.3 15.8 49.4 15.0 16.3 17.1 43.2 25.3 26.2 27.6 38.5 18.0 15.1 32.8 16.8 24.8 72.6 20.0 33.0 18.4 27.9 19.3 22.1 27.3 34.2 20.6 41.0 11.5 20.4 16.7 30.1 16.9 18.4 16.8 27.4 8.7 37.7 18.6 20.3 20.2 18.7 12.4 13.4 78.6 10.9 9.9 15.2 15.4 8.8 6.0 13.1 9.7 20.3 12.4 15.5 12.7 14.8 15.1 18.6 13.4 13.6 13.3 5.7 8.2 18.8 5.5 14.6 8.5 13.9 23.3 20.8 8.3 27.0 31.7 18.0 10.9 20.0 7.1 15.1 10.9 14.8 10.2 13.6 9.5 8.0 36.1 14.6 10.0 7.0 13.4 13.6 10.8 22.6 4.6 8.2 24.8 18.8 15.4 7.1 20.5 8.1 12.1 12.6 16.0 7.9 18.0 8.6 10.2 11.8 25.4 17.9 24.9 29.2 11.7 15.4 14.3 15.3 78.6 8.9 21.9 15.2 9.4 14.6 12.4 14.1 15.1 7.5 9.9 12.3 14.1 19.6 9.9 10.9 13.4 14.3 15.4 29.2 30.2 19.7 21.6 25.3 26.2 32.8 16.8 27.9 27.4 125.0 114.9 0.0 0.0 0.0 0.0 0.0 0.0 99.0 99.0 141.3 0.0 144.5 160.8 244.0 0.0 0.0 0.0 0.0 174.6 157.8 0.0 0.0 218.6 0.0 145.4 0.0 0.0 0.0 0.0 0.0 0.0 41.2 0.0 130.8 0.0 0.0 237.2 0.0 0.0 306.1 0.0 0.0 0.0 0.0 0.0 0.0 292.8 0.0 0.0 0.0 SELENOM "SELM, SEPM" ENSG00000198832 "Selenoprotein M" Q8WWX9 22 31104772-31120069 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Collecting duct cells: 293.1;Distal tubular cells: 261.9;Exocrine glandular cells: 512.5;Pancreatic endocrine cells: 240.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 23.0;MAIT T-cell: 29.7;memory B-cell: 32.4;memory CD4 T-cell: 38.3;memory CD8 T-cell: 27.4;naive B-cell: 24.2;naive CD4 T-cell: 51.6;naive CD8 T-cell: 30.4;T-reg: 34.7" "Group enriched" "Detected in all" 6 "B-cells: 32.4;T-cells: 51.6" "Cell line enhanced" "Detected in many" "BJ: 40.4;BJ hTERT+: 38.8;HHSteC: 51.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008667, HPA019601" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 110000 "Nucleoplasm, Cytosol" "CAB008667: AB_1622762, HPA019601: AB_1856666" "unprognostic (5.29e-3)" "unprognostic (1.68e-1)" "unprognostic (7.61e-2)" "unprognostic (1.32e-1)" "unprognostic (2.93e-2)" "unprognostic (1.02e-1)" "unprognostic (2.59e-3)" "unprognostic (1.45e-1)" "unprognostic (1.60e-2)" "unprognostic (1.60e-1)" "unprognostic (3.51e-3)" "unprognostic (8.31e-2)" "prognostic unfavorable (2.55e-6)" "unprognostic (1.32e-2)" "unprognostic (3.80e-1)" "unprognostic (5.20e-2)" "unprognostic (3.19e-2)" 35.9 19.5 19.8 31.3 20.6 2.4 33.4 13.5 20.8 83.5 66.2 9.1 38.3 22.0 67.5 34.2 53.4 46.1 67.2 25.5 19.1 20.6 19.2 6.6 18.2 35.1 20.7 11.7 49.9 38.1 18.1 27.2 22.1 15.9 59.5 10.7 41.4 57.3 89.1 29.4 11.6 24.0 76.2 14.1 18.2 35.2 21.9 8.8 1.4 45.7 12.2 12.8 92.5 36.1 32.4 1.3 2.4 7.5 7.5 51.6 21.9 3.2 6.8 2.0 11.4 19.1 22.4 22.3 40.4 38.8 18.8 13.7 0.2 0.5 0.4 8.4 23.7 8.5 0.3 1.8 2.4 1.3 1.8 6.8 0.7 2.1 3.4 51.1 0.0 3.5 21.8 7.3 8.9 3.4 9.0 2.4 0.6 0.6 3.9 4.7 1.7 0.1 0.4 2.6 3.0 7.3 0.0 0.0 4.6 2.9 0.0 4.4 9.7 12.6 11.2 0.1 0.7 15.5 0.2 8.2 5.7 16.1 21.1 0.0 3.6 1.6 0.2 22.8 0.0 3.6 2.4 2.2 0.9 23.0 3.8 29.7 32.4 38.3 27.4 1.3 24.2 51.6 30.4 1.6 7.5 7.5 0.4 34.7 21.9 19.8 20.6 13.5 20.8 19.1 20.6 20.7 11.7 15.9 8.8 50.6 112.8 0.0 0.0 0.0 0.0 0.0 0.0 37.5 59.1 293.1 0.0 11.2 261.9 97.3 0.0 0.0 0.0 0.0 512.5 132.0 0.0 0.0 27.9 0.0 20.8 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 74.9 0.0 0.0 240.3 0.0 0.0 109.7 0.0 0.0 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.0 SELENOP "SELP, SeP, SEPP, SEPP1" ENSG00000250722 "Selenoprotein P" P49908 5 42799880-42887392 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 248.3;liver: 403.8" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 416.9;Alveolar cells type 2: 429.0;Hofbauer cells: 658.5;Proximal tubular cells: 719.9" "Cancer enhanced" "Detected in all" "liver cancer: 116.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Hep G2: 92.9;HSkMC: 81.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036287 Approved Uncertain "Nucleoplasm,Golgi apparatus" "Secreted to blood" NA NA 2220000000 2300000000 "Nucleoplasm, Golgi apparatus" "HPA036287: AB_10794618" "unprognostic (7.96e-2)" "unprognostic (2.10e-1)" "unprognostic (4.28e-3)" "unprognostic (1.19e-3)" "unprognostic (6.67e-2)" "unprognostic (6.37e-2)" "unprognostic (9.22e-2)" "unprognostic (2.19e-2)" "unprognostic (1.44e-2)" "unprognostic (2.88e-1)" "unprognostic (2.07e-2)" "unprognostic (1.05e-1)" "prognostic favorable (6.97e-6)" "unprognostic (1.35e-2)" "unprognostic (4.19e-2)" "unprognostic (2.89e-1)" "unprognostic (1.42e-1)" 53.8 31.4 17.5 13.5 54.6 2.2 41.1 11.9 24.0 34.9 56.8 52.8 24.2 40.9 22.3 39.0 20.5 26.2 44.4 26.6 27.6 17.5 57.5 403.8 55.0 30.4 106.2 16.1 49.1 15.3 18.2 21.4 62.7 63.6 30.5 48.5 27.1 19.5 41.2 16.4 18.1 248.3 16.1 137.1 87.1 21.6 19.6 70.3 6.3 24.5 14.7 11.3 30.0 33.0 2.2 3.6 2.2 0.7 2.7 2.4 1.4 0.1 0.3 1.4 0.1 7.7 2.1 1.4 0.6 1.9 0.0 0.0 2.0 11.0 0.3 6.9 0.2 0.2 0.3 0.0 0.0 0.0 0.4 8.9 0.5 0.0 92.9 4.7 0.5 0.0 81.3 0.1 0.0 0.0 0.3 0.0 0.3 1.0 2.2 4.0 0.2 0.1 1.1 5.4 3.1 0.1 0.2 0.3 15.9 2.1 1.3 0.3 0.5 0.5 2.8 0.2 10.6 21.7 0.1 0.1 0.5 0.3 0.9 0.1 1.5 0.2 0.3 0.3 1.0 0.2 0.3 0.6 1.8 2.2 0.6 2.4 1.6 1.6 1.7 1.2 2.2 2.4 2.0 2.2 2.7 0.7 3.6 1.5 1.4 17.5 54.6 11.9 24.0 27.6 17.5 106.2 16.1 63.6 70.3 416.9 429.0 0.0 0.0 0.0 0.0 0.0 0.0 96.4 187.7 118.7 0.0 169.8 167.5 38.5 0.0 0.0 0.0 0.0 45.9 18.4 0.0 0.0 24.4 0.0 658.5 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 1.8 0.0 0.0 47.6 0.0 0.0 719.9 0.0 0.0 0.0 0.0 0.0 0.0 94.4 0.0 0.0 0.0 SEMA3A "coll-1, Hsema-I, SEMA1, SEMAD, SemD" ENSG00000075213 "Semaphorin 3A" Q14563 7 83955777-84492724 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 24.5" "Cell type enhanced" "Detected in many" 16 "Ciliated cells: 18.7;Club cells: 20.5;Cone photoreceptor cells: 43.2;Rod photoreceptor cells: 65.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "non-classical monocyte: 4.7" "Lineage enriched" "Detected in single" 15 "monocytes: 4.7" "Cell line enhanced" "Detected in many" "AF22: 42.8;BJ: 33.3;fHDF/TERT166: 36.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA029447, HPA052235" Approved Approved Nucleoplasm,Vesicles "Secreted in other tissues" NA NA 1200000 Vesicles Nucleoplasm "HPA029447: AB_10602302, HPA052235: AB_2681770" "unprognostic (1.20e-1)" "prognostic unfavorable (2.69e-5)" "unprognostic (1.51e-1)" "unprognostic (5.82e-2)" "unprognostic (1.37e-2)" "unprognostic (5.98e-3)" "unprognostic (2.92e-3)" "unprognostic (6.05e-3)" "unprognostic (1.13e-1)" "unprognostic (2.48e-1)" "unprognostic (1.46e-1)" "unprognostic (4.44e-2)" "unprognostic (6.18e-12)" "unprognostic (3.26e-2)" "unprognostic (2.41e-2)" "unprognostic (1.61e-2)" "unprognostic (1.47e-4)" 9.6 1.1 2.9 5.2 14.6 0.3 3.7 1.0 6.0 7.4 17.8 1.4 0.7 2.3 1.5 3.3 8.6 3.5 8.6 3.7 2.0 2.1 1.3 1.1 4.9 12.9 1.6 6.5 1.4 1.0 1.3 12.0 14.7 11.1 5.0 8.7 8.2 1.5 0.8 1.0 2.7 5.3 24.5 3.3 17.9 5.4 1.8 1.8 0.0 4.2 1.4 2.4 11.9 2.1 0.0 0.2 0.0 4.7 0.3 0.3 0.0 3.7 10.2 42.8 0.0 1.3 1.0 2.8 33.3 19.6 2.8 1.7 3.6 10.0 0.0 1.6 36.2 0.3 18.5 0.1 7.9 3.9 0.0 1.4 0.0 1.9 0.0 1.1 0.8 0.0 1.3 0.0 6.0 1.4 8.7 10.4 0.0 0.0 0.0 1.1 0.2 0.0 0.0 16.0 0.1 3.7 0.7 18.2 1.0 6.2 0.2 3.3 1.7 0.2 0.0 0.3 7.1 0.2 0.3 5.8 3.7 3.9 10.7 4.8 2.5 1.7 0.0 3.8 1.4 7.3 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.3 4.7 0.0 0.0 0.0 2.9 14.6 1.0 6.0 2.0 2.1 1.6 6.5 11.1 1.8 3.0 1.7 0.0 0.0 0.8 10.3 4.1 0.0 18.7 20.5 0.0 43.2 0.3 0.0 0.0 0.1 2.7 0.0 0.0 1.8 0.1 4.7 0.3 1.1 0.0 1.0 3.2 0.0 0.6 0.3 0.0 2.3 0.0 1.7 0.0 0.0 16.0 3.2 0.0 0.0 0.0 65.3 0.0 1.0 1.6 1.7 1.1 0.2 0.0 0.0 0.3 SEMA3E "coll-5, KIAA0331, M-SemaK, SEMAH" ENSG00000170381 "Semaphorin 3E" O15041 7 83363238-83649113 "Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 163.8;Alveolar cells type 2: 146.0;Ciliated cells: 62.9;Club cells: 75.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEK 293: 4.0;SK-BR-3: 20.6;U-2 OS: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA029419, HPA063804" Uncertain Approved Nucleoplasm,Vesicles "Secreted in other tissues" NA NA Vesicles Nucleoplasm "HPA029419: AB_10602090, HPA063804: AB_2685127" "unprognostic (4.42e-2)" "unprognostic (1.48e-2)" "unprognostic (7.82e-2)" "unprognostic (4.42e-2)" "unprognostic (2.60e-1)" "unprognostic (4.27e-2)" "unprognostic (9.36e-2)" "unprognostic (4.09e-2)" "unprognostic (3.25e-1)" "unprognostic (1.42e-1)" "unprognostic (9.09e-2)" "unprognostic (2.60e-1)" "unprognostic (1.46e-6)" "unprognostic (1.32e-2)" "unprognostic (1.14e-1)" "unprognostic (7.17e-3)" "unprognostic (2.62e-1)" 4.0 1.1 2.4 1.0 12.2 0.6 7.8 2.0 12.2 5.5 6.4 1.9 0.5 2.2 5.4 1.4 4.7 2.3 6.5 0.9 4.0 4.7 1.0 1.0 6.1 0.6 5.9 6.4 0.9 9.6 0.7 1.4 1.1 5.1 15.0 4.9 2.4 6.2 9.1 1.0 2.2 3.6 10.3 6.6 0.7 3.8 0.9 3.1 0.9 2.2 0.5 0.8 9.8 3.3 0.5 0.3 1.4 0.6 0.7 0.5 0.2 0.2 1.1 0.2 0.0 0.5 3.3 0.0 0.0 0.2 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.6 0.0 3.5 0.0 1.4 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.9 0.0 0.0 0.5 0.5 1.2 0.0 2.1 0.0 0.0 0.8 0.1 0.0 0.0 20.6 0.0 3.6 1.6 0.0 0.0 0.8 7.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.8 1.4 0.3 0.5 0.3 0.3 0.5 0.3 0.4 0.3 0.3 0.5 0.5 0.5 0.8 0.7 0.6 0.3 0.3 0.2 2.4 12.2 2.0 8.7 4.0 4.7 5.9 6.4 5.1 3.1 163.8 146.0 0.0 1.0 1.0 41.8 1.2 17.8 62.9 75.1 1.8 0.0 0.7 0.0 4.2 0.9 0.5 0.0 0.0 1.0 0.2 2.1 3.6 22.1 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.9 1.1 1.7 1.8 0.0 39.8 4.4 0.0 0.0 0.1 2.7 0.0 1.0 0.3 0.4 0.4 0.2 0.0 0.0 1.1 SEMA4B "KIAA1745, MGC131831, SEMAC, SemC" ENSG00000185033 "Semaphorin 4B" 15 90160604-90229679 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 69.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "memory B-cell: 14.7;naive B-cell: 11.8;neutrophil: 4.0" "Group enriched" "Detected in many" 5 "B-cells: 14.7;granulocytes: 4.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 52.8;RPTEC TERT1: 32.7;RT4: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013372 Approved Approved "Nucleoplasm,Vesicles,Cell Junctions" NA NA "Cell Junctions" "Nucleoplasm, Vesicles" "HPA013372: AB_1856670" "unprognostic (3.33e-2)" "unprognostic (5.96e-2)" "unprognostic (2.23e-2)" "unprognostic (2.50e-2)" "unprognostic (7.78e-2)" "unprognostic (4.48e-2)" "unprognostic (6.34e-3)" "prognostic unfavorable (1.25e-4)" "unprognostic (2.04e-1)" "unprognostic (9.31e-2)" "unprognostic (1.58e-3)" "unprognostic (4.67e-2)" "prognostic unfavorable (3.33e-8)" "unprognostic (1.66e-1)" "unprognostic (1.23e-2)" "unprognostic (3.57e-2)" "unprognostic (7.09e-2)" 7.0 19.8 13.1 13.7 16.7 7.1 13.6 9.1 13.1 16.2 21.7 9.4 18.2 24.0 9.0 12.3 56.7 16.3 20.3 13.8 13.3 7.6 18.6 32.1 11.6 10.0 13.4 11.1 17.0 19.8 9.4 10.8 14.6 15.4 18.1 10.0 15.4 21.3 15.7 4.0 29.0 22.2 13.5 18.8 16.3 22.4 8.3 14.8 12.8 32.7 15.5 27.2 31.6 24.6 14.7 0.9 4.0 2.0 0.3 0.7 1.0 5.9 16.2 1.2 3.8 1.1 0.8 8.9 1.8 4.0 2.3 2.4 1.9 52.8 4.2 20.4 1.3 13.3 28.3 1.0 26.3 1.9 24.0 3.4 5.5 4.0 2.6 4.5 0.6 2.5 3.2 11.5 2.5 5.2 9.6 2.5 1.2 2.6 6.7 1.2 4.4 1.5 2.3 5.5 13.2 14.9 1.8 0.9 9.2 32.7 35.5 3.9 3.9 6.4 10.4 2.4 2.8 7.2 1.7 5.7 1.8 3.4 3.8 4.1 9.7 11.8 2.1 17.4 4.5 1.8 0.0 2.0 0.3 0.7 1.2 0.5 14.7 0.5 0.4 0.9 11.8 0.4 0.5 4.0 0.3 2.0 0.1 0.1 1.0 13.1 16.7 9.1 13.1 13.3 7.6 13.4 11.1 15.4 14.8 14.9 22.7 19.3 32.9 57.8 2.9 5.5 10.2 17.4 40.9 15.7 23.6 11.3 3.3 21.9 0.9 4.5 26.4 0.0 31.3 69.5 4.8 31.7 0.0 11.5 10.7 15.9 4.1 4.3 5.1 0.7 12.0 6.0 5.0 1.0 13.0 31.5 34.3 19.0 11.3 3.3 45.7 19.4 15.5 0.3 3.2 49.9 10.4 4.4 14.9 45.4 SEMA4F "SEMAM, SEMAW" ENSG00000135622 "Ssemaphorin 4F" O95754 2 74654228-74683853 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 11.8;Horizontal cells: 11.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064095, HPA065969" Approved Approved "Nucleoplasm,Plasma membrane,Centrosome" NA NA Nucleoplasm "Plasma membrane, Centrosome" "HPA064095: AB_2732710, HPA065969: AB_2685590" "unprognostic (9.69e-2)" "unprognostic (8.88e-3)" "unprognostic (1.58e-2)" "prognostic unfavorable (5.94e-5)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.23e-2)" "unprognostic (1.61e-3)" "unprognostic (6.95e-2)" "unprognostic (9.01e-3)" "unprognostic (6.53e-2)" "unprognostic (2.21e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (9.74e-6)" "unprognostic (2.60e-2)" "unprognostic (8.08e-2)" "prognostic favorable (6.94e-4)" "unprognostic (4.69e-2)" 8.1 5.1 15.5 3.5 15.5 1.3 5.7 12.9 21.3 5.2 3.8 3.3 2.3 1.9 6.6 6.7 2.7 5.6 3.5 4.9 17.2 12.2 4.8 2.1 8.1 5.1 5.3 16.5 9.1 4.6 13.7 10.2 3.5 7.8 5.2 4.2 3.6 5.0 5.7 3.0 4.9 3.0 7.0 5.7 4.7 4.3 7.2 3.8 2.9 4.7 1.3 4.9 3.5 4.7 2.8 0.2 1.4 0.4 2.5 5.6 2.1 6.5 4.4 4.8 6.8 7.8 4.4 3.0 4.5 9.4 8.2 7.6 1.8 3.8 2.2 4.9 7.2 19.8 1.9 7.0 7.7 9.1 5.7 5.9 3.8 1.8 3.6 2.8 0.8 6.1 4.0 6.7 5.5 2.9 18.7 3.5 5.0 0.2 0.1 4.8 1.9 3.5 0.7 2.6 3.7 4.3 0.0 6.2 0.0 6.4 3.0 3.0 7.2 6.6 2.7 8.2 6.0 3.2 0.5 3.8 14.1 6.8 3.4 8.2 5.3 5.2 0.3 17.2 0.3 7.5 0.5 0.2 1.4 5.6 0.1 3.2 2.8 3.0 4.9 0.2 2.1 3.3 3.9 0.8 2.5 0.4 0.1 2.2 2.1 15.5 15.5 12.9 21.3 17.2 12.2 5.3 16.5 7.8 3.8 0.0 6.2 0.0 1.5 0.3 8.8 1.4 10.2 1.4 7.9 5.2 11.8 0.7 1.7 2.0 3.1 1.6 0.4 0.0 1.4 2.0 1.2 1.5 2.3 0.6 0.7 11.1 6.9 2.5 0.0 2.4 0.9 0.7 0.0 1.8 0.7 4.1 2.7 0.9 1.4 0.2 5.7 6.5 0.4 3.1 9.8 0.4 0.3 2.5 1.0 1.1 SEMA6A "HT018, KIAA1368, SEMA, SEMA6A1, SEMAQ" ENSG00000092421 "Semaphorin 6A" Q9H2E6 5 116443616-116574934 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.2" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 93.0;Horizontal cells: 130.3;Ito cells: 160.2;Syncytiotrophoblasts: 291.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 12.9;HAP1: 15.1;NTERA-2: 33.8;SuSa: 68.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031264, HPA031265, HPA031267" Approved Approved "Nucleoplasm,Nuclear bodies,Intermediate filaments" NA NA 180000 Nucleoplasm "Nuclear bodies, Intermediate filaments" "HPA031264: , HPA031265: AB_10610423, HPA031267: " "unprognostic (3.79e-2)" "unprognostic (3.91e-1)" "unprognostic (1.82e-2)" "unprognostic (6.81e-2)" "unprognostic (2.69e-2)" "unprognostic (3.77e-1)" "prognostic unfavorable (4.39e-4)" "unprognostic (1.64e-1)" "unprognostic (4.71e-2)" "unprognostic (5.82e-2)" "unprognostic (1.92e-2)" "unprognostic (1.13e-1)" "unprognostic (2.24e-1)" "unprognostic (3.62e-3)" "unprognostic (1.92e-1)" "unprognostic (6.21e-3)" "unprognostic (7.32e-3)" 12.7 37.4 12.6 4.9 34.7 3.6 10.6 18.7 26.5 6.9 19.6 31.2 0.8 19.2 6.1 3.4 3.9 6.2 12.8 5.0 17.2 12.9 6.1 6.0 17.8 4.5 35.9 13.9 13.1 10.3 2.2 4.4 30.2 32.2 6.6 17.5 2.6 15.1 3.2 7.6 5.6 24.0 6.3 48.2 8.2 5.4 6.6 31.4 0.5 6.7 1.6 2.7 4.6 5.9 1.6 0.7 0.1 0.4 0.0 1.3 0.0 0.1 0.0 10.9 12.9 0.0 0.0 11.3 0.2 0.1 0.0 0.0 0.6 0.4 0.4 0.5 0.1 0.2 0.1 15.1 0.0 0.0 0.4 2.2 0.2 0.2 3.6 0.1 0.1 0.7 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.2 1.1 33.8 0.0 0.1 1.9 7.1 0.5 5.6 9.7 3.0 1.1 0.0 0.2 5.8 68.7 4.2 0.7 0.2 1.0 0.9 0.1 0.4 0.2 0.1 0.2 0.1 0.5 4.0 0.0 0.4 0.0 1.2 0.0 0.1 1.6 1.3 0.0 0.3 1.2 0.4 0.5 0.1 0.0 0.2 0.7 0.1 0.0 12.6 34.7 18.7 24.0 17.2 12.9 35.9 13.9 32.2 31.4 0.0 1.1 0.8 0.7 5.8 8.1 6.7 48.4 0.0 0.0 14.0 2.0 93.0 0.0 26.5 9.7 56.5 45.5 0.0 1.1 3.7 16.0 1.5 0.0 0.6 10.8 130.3 26.9 160.2 15.5 1.4 6.1 1.3 23.6 0.0 31.1 5.1 2.5 42.1 1.8 3.7 3.2 0.0 6.2 0.5 1.4 3.6 291.1 1.3 32.4 0.5 SEMA6C KIAA1869 ENSG00000143434 "Semaphorin 6C" Q9H3T2 1 151131685-151146664 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 124.1;tongue: 43.4" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 15.3;Cone photoreceptor cells: 19.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 11.9;HUVEC TERT2: 20.9;TIME: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA076150, HPA077625" Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 290000 "Nucleoplasm, Plasma membrane" "Nucleoli fibrillar center, Cytosol" "HPA076150: , HPA077625: " "unprognostic (6.97e-2)" "unprognostic (8.40e-2)" "unprognostic (1.56e-3)" "prognostic unfavorable (3.27e-4)" "unprognostic (2.79e-1)" "unprognostic (2.88e-2)" "unprognostic (3.00e-2)" "unprognostic (1.24e-2)" "unprognostic (5.66e-3)" "unprognostic (4.25e-2)" "prognostic favorable (3.06e-5)" "unprognostic (3.72e-2)" "unprognostic (1.67e-2)" "unprognostic (6.12e-2)" "unprognostic (9.49e-2)" "unprognostic (1.10e-1)" "unprognostic (1.85e-1)" 3.2 1.9 2.3 1.5 3.0 1.3 3.4 16.8 5.8 4.2 2.6 1.5 0.8 6.7 4.1 3.5 3.2 2.9 3.9 12.7 2.3 3.5 3.0 3.3 1.9 3.4 1.7 3.3 4.8 1.7 1.7 4.3 1.6 2.7 2.8 1.6 3.4 3.1 1.9 124.1 3.4 5.2 3.6 1.1 1.3 1.6 15.0 0.6 0.5 1.3 43.4 2.9 2.2 3.6 0.9 0.6 0.7 0.0 0.1 1.4 0.2 0.8 0.8 11.9 4.6 5.1 1.7 1.1 0.8 0.4 0.8 1.1 0.2 0.5 0.5 3.4 2.7 1.7 1.2 1.1 0.4 0.7 1.0 3.5 6.2 0.5 1.0 0.7 0.1 2.3 2.9 1.4 1.0 0.5 2.4 20.9 3.4 0.5 0.6 2.0 0.4 1.0 0.8 5.4 0.1 1.4 7.4 2.6 0.3 0.4 0.3 6.1 7.9 1.1 0.5 1.0 3.1 1.3 1.0 9.7 2.0 2.9 3.0 0.4 5.0 0.9 5.1 0.5 0.2 0.7 0.0 0.0 0.7 0.1 0.0 1.4 0.0 0.2 0.0 0.0 0.9 0.5 0.0 0.5 0.1 0.0 0.6 0.3 0.2 2.3 3.0 16.8 5.8 2.3 3.5 1.7 3.3 2.7 0.6 0.0 3.2 1.7 0.8 1.4 4.2 15.3 2.5 0.0 1.2 0.0 19.6 0.2 0.0 0.3 0.5 3.1 0.3 0.0 0.4 0.4 2.1 0.5 0.0 2.4 0.3 6.4 0.0 4.9 1.6 2.1 5.2 0.0 1.7 0.0 0.0 1.7 0.4 0.0 2.5 2.7 6.9 0.0 2.0 2.8 1.1 0.9 0.1 0.0 0.2 0.5 SENP1 ENSG00000079387 "SUMO1/sentrin specific peptidase 1" Q9P0U3 12 48042898-48106308 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 60.2" "Cell type enhanced" "Detected in many" 10 "Spermatocytes: 64.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011765, HPA046491" Supported "Nucleoplasm,Focal adhesion sites" NA NA Nucleoplasm "Focal adhesion sites" "HPA011765: AB_1079907, HPA046491: AB_2679672" "unprognostic (2.66e-2)" "unprognostic (6.51e-2)" "unprognostic (3.14e-1)" "unprognostic (5.69e-2)" "unprognostic (2.83e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (7.72e-5)" "unprognostic (6.48e-2)" "unprognostic (2.44e-3)" "unprognostic (8.20e-3)" "unprognostic (2.57e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (8.37e-4)" "unprognostic (7.61e-2)" "unprognostic (3.02e-1)" "unprognostic (1.01e-1)" "unprognostic (1.28e-1)" 5.7 3.3 3.0 9.0 4.0 8.4 5.2 5.3 3.2 5.5 4.9 3.8 3.5 3.4 6.2 4.3 5.7 5.2 3.8 3.6 2.7 3.3 3.8 3.9 4.3 7.3 3.0 2.3 6.2 4.4 6.1 11.4 8.1 3.0 4.4 4.7 5.1 20.0 4.7 6.8 6.6 4.5 5.8 4.3 6.4 4.5 60.2 3.6 15.0 5.2 4.8 8.3 5.7 6.3 5.3 3.8 7.1 2.6 3.8 5.5 2.3 7.1 9.2 11.5 8.6 3.4 5.1 8.5 7.7 8.6 13.2 10.8 11.3 11.6 19.4 6.7 7.0 5.2 7.0 14.2 6.8 13.5 17.6 6.4 17.0 8.9 5.4 5.7 15.8 11.5 4.1 5.6 11.9 10.6 5.9 6.9 13.2 14.9 9.3 6.8 5.7 19.7 5.0 10.5 4.9 7.0 18.7 12.1 9.5 3.6 8.8 12.1 8.3 11.1 6.8 4.5 6.8 10.7 7.6 6.3 11.2 10.1 6.5 8.1 9.6 15.5 19.0 6.9 36.8 5.1 2.0 1.8 7.1 4.3 2.6 5.5 2.4 4.2 3.9 3.3 5.3 3.6 4.1 3.8 3.8 2.0 3.8 5.0 2.3 3.0 4.0 5.3 3.2 2.7 3.3 3.0 2.3 3.0 3.6 8.9 6.2 5.6 4.2 3.3 8.2 2.1 7.6 5.3 10.3 3.5 3.9 3.1 3.3 3.0 10.2 6.3 2.5 0.0 5.6 2.8 3.7 3.6 5.8 6.6 3.8 14.3 3.4 7.4 10.0 3.3 5.8 4.8 1.7 5.4 3.7 4.8 4.5 2.0 6.3 3.4 8.3 0.0 3.1 64.4 24.9 5.4 2.3 4.4 3.6 3.0 SENP3 "DKFZP586K0919, DKFZp762A152, SMT3IP1, SSP3, Ulp1" ENSG00000161956 "SUMO1/sentrin/SMT3 specific peptidase 3" Q9H4L4 17 7561875-7571969 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA060290 Supported Supported Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "HPA060290: AB_2684244" "unprognostic (5.68e-2)" "unprognostic (2.39e-1)" "unprognostic (1.65e-1)" "unprognostic (1.01e-1)" "unprognostic (3.34e-1)" "unprognostic (3.48e-1)" "unprognostic (1.30e-3)" "unprognostic (2.82e-1)" "unprognostic (7.37e-2)" "unprognostic (3.72e-2)" "prognostic favorable (6.22e-5)" "unprognostic (2.71e-2)" "unprognostic (1.96e-1)" "unprognostic (1.42e-1)" "unprognostic (1.37e-1)" "unprognostic (8.21e-2)" "unprognostic (2.56e-2)" 16.3 16.0 22.3 20.9 23.4 16.6 18.0 29.2 38.4 15.9 22.5 18.4 16.8 16.2 18.6 22.7 18.6 19.9 17.0 26.1 21.0 19.2 17.5 15.1 18.7 18.8 20.0 23.3 19.6 17.8 29.5 17.3 23.6 17.2 16.0 20.5 17.3 18.6 21.9 22.0 20.8 17.6 23.1 15.3 18.9 17.2 28.8 16.4 18.9 19.0 14.2 23.4 16.8 32.8 0.8 0.7 1.1 0.7 1.1 1.7 0.3 26.5 32.2 19.1 29.6 21.7 15.9 20.0 19.5 20.0 34.0 32.0 19.2 11.6 31.8 19.4 25.6 23.5 25.6 41.1 30.5 28.6 22.4 37.5 16.5 27.3 19.7 29.3 15.1 21.0 20.3 31.2 38.8 38.1 19.6 27.3 36.3 21.1 9.0 26.2 17.8 36.8 11.5 23.7 24.8 19.6 33.7 17.9 18.3 22.7 15.6 19.1 24.7 19.5 18.9 20.7 25.5 15.9 9.9 14.3 19.6 17.0 18.6 41.8 13.2 13.7 20.2 19.7 16.1 28.9 0.1 0.7 0.2 0.4 0.4 0.1 0.4 0.2 1.3 0.1 0.8 1.7 0.5 1.1 1.1 0.1 0.7 0.3 0.3 22.3 23.4 29.2 38.4 21.0 19.2 20.0 23.3 17.2 16.4 3.0 4.8 2.7 5.7 7.6 5.8 5.9 7.6 1.4 4.5 1.8 21.6 2.6 0.0 1.9 1.1 4.5 2.3 0.0 2.1 1.9 3.9 4.1 1.1 2.6 1.3 6.4 6.3 9.8 6.9 0.4 3.7 4.1 3.3 1.8 2.5 5.0 1.9 0.0 2.1 0.7 8.0 0.0 3.6 2.8 3.5 10.2 3.4 4.9 3.4 5.6 SENP5 MGC27076 ENSG00000119231 "SUMO1/sentrin specific peptidase 5" Q96HI0 3 196867856-196934714 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006575 Approved Nucleoplasm,Nucleoli,Centrosome,Cytosol NA NA "Nucleoplasm, Nucleoli" "Centrosome, Cytosol" "HPA006575: " "unprognostic (4.07e-2)" "unprognostic (4.91e-3)" "unprognostic (7.63e-2)" "prognostic unfavorable (4.04e-4)" "unprognostic (4.13e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (4.15e-4)" "unprognostic (2.95e-1)" "unprognostic (2.20e-1)" "unprognostic (2.88e-1)" "unprognostic (2.89e-1)" "unprognostic (9.57e-3)" "prognostic unfavorable (2.14e-5)" "unprognostic (2.02e-1)" "unprognostic (1.62e-1)" "unprognostic (1.62e-2)" "unprognostic (6.71e-2)" 13.8 13.5 20.0 15.3 20.0 25.7 16.1 28.3 23.8 15.0 15.1 16.1 14.5 11.3 14.6 16.2 16.3 12.9 14.4 15.9 18.9 21.7 13.6 19.5 15.2 15.9 19.4 18.4 17.5 15.7 19.8 21.5 17.8 23.5 15.1 14.0 12.0 13.2 15.9 17.8 16.4 13.0 16.8 18.2 17.1 14.0 36.6 16.4 19.3 14.1 9.2 21.1 14.9 20.1 8.9 7.8 15.8 8.7 7.6 8.9 4.2 13.3 6.1 9.8 8.8 8.3 9.9 7.8 8.5 9.1 9.3 15.0 10.6 5.3 12.5 23.8 9.3 15.9 9.2 10.1 4.5 15.1 6.7 6.6 16.9 9.1 7.4 9.6 14.0 8.0 8.5 12.3 9.5 10.1 6.7 9.0 11.2 11.2 19.4 10.8 11.5 13.1 8.2 7.6 7.3 12.0 8.5 7.9 8.5 4.5 7.6 6.1 8.1 9.5 10.8 10.5 10.3 18.1 10.7 10.1 9.1 9.3 12.4 17.4 20.8 36.3 27.0 12.2 11.3 10.3 15.8 7.6 7.1 8.9 8.1 8.1 8.9 8.6 8.8 5.0 8.5 8.0 8.6 14.9 7.6 8.7 7.8 6.9 4.2 20.0 20.0 28.3 23.8 18.9 21.7 19.4 18.4 23.5 16.4 20.8 13.0 17.1 20.7 54.0 26.0 12.5 10.2 9.4 14.8 8.7 15.7 15.8 10.0 14.8 27.7 20.4 12.4 0.0 12.2 12.8 21.0 19.3 25.5 16.6 12.0 27.0 20.7 13.5 16.1 36.8 15.0 18.8 13.5 14.4 13.2 15.4 20.6 17.5 15.6 14.7 27.7 25.8 24.0 36.7 40.5 54.3 19.1 26.7 10.1 28.1 SENP6 "KIAA0797, SUSP1" ENSG00000112701 "SUMO1/sentrin specific peptidase 6" Q9GZR1 6 75601509-75718278 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024376 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA024376: AB_1856678" "unprognostic (9.86e-2)" "unprognostic (1.20e-2)" "unprognostic (4.84e-2)" "unprognostic (1.87e-2)" "unprognostic (6.38e-3)" "unprognostic (7.33e-2)" "unprognostic (1.13e-2)" "unprognostic (2.97e-1)" "unprognostic (3.93e-2)" "unprognostic (5.32e-3)" "unprognostic (7.81e-2)" "unprognostic (9.24e-2)" "prognostic unfavorable (6.09e-4)" "unprognostic (1.78e-1)" "unprognostic (1.74e-1)" "prognostic unfavorable (2.83e-5)" "unprognostic (1.72e-1)" 25.9 20.0 24.3 21.8 24.5 27.1 25.9 35.0 24.3 32.5 27.7 23.5 24.9 16.8 37.7 21.2 21.0 27.4 21.5 20.0 22.8 19.8 24.1 22.5 22.5 21.1 29.6 20.3 38.7 21.8 40.1 44.2 26.8 27.0 27.7 21.8 23.0 20.4 25.7 27.8 22.0 24.1 43.0 27.2 24.7 21.3 26.1 28.6 28.5 34.8 15.8 23.9 27.1 34.0 9.9 10.9 19.4 13.1 9.8 11.2 5.5 10.9 11.5 26.2 18.7 20.4 27.2 19.5 19.8 22.1 16.8 21.0 15.8 10.6 18.6 18.8 22.8 19.8 14.1 24.6 13.2 26.0 27.4 21.3 28.2 13.9 14.7 28.4 24.5 20.8 21.0 22.1 15.7 35.1 20.4 27.7 15.6 34.1 20.7 20.5 13.4 9.7 13.2 15.9 14.8 9.8 18.3 13.8 27.2 17.9 16.4 22.9 23.7 16.9 15.0 17.2 22.0 13.5 23.4 23.1 15.0 16.4 7.7 20.4 23.8 23.6 14.9 7.5 23.4 15.8 5.2 7.4 19.4 7.7 7.9 11.2 9.3 7.8 10.2 8.7 9.9 11.2 9.9 14.7 9.8 13.1 10.9 6.5 5.5 24.3 24.5 35.0 24.3 22.8 19.8 29.6 20.3 27.0 28.6 62.5 112.5 47.7 47.5 41.3 58.8 66.9 35.7 56.2 105.8 27.9 86.4 28.4 14.9 28.8 30.6 40.8 33.0 0.0 28.8 23.6 46.3 54.5 61.4 29.8 25.4 57.2 26.5 36.8 38.9 28.6 65.6 37.8 33.7 39.7 33.3 61.0 28.0 24.6 59.4 24.5 62.7 25.8 62.7 116.1 58.3 42.3 34.4 34.8 39.8 53.1 SENP7 ENSG00000138468 "SUMO1/sentrin specific peptidase 7" Q9BQF6 3 101324205-101513241 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027259, HPA071998" Approved Supported "Nucleoplasm,Nuclear bodies,Centrosome,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Centrosome, Cytosol" "HPA027259: AB_1856679, HPA071998: " "unprognostic (1.50e-1)" "unprognostic (6.12e-2)" "unprognostic (2.78e-2)" "unprognostic (7.31e-2)" "unprognostic (2.44e-2)" "prognostic favorable (4.23e-4)" "unprognostic (1.38e-3)" "unprognostic (9.25e-3)" "unprognostic (8.80e-2)" "unprognostic (2.24e-1)" "unprognostic (7.77e-3)" "unprognostic (1.94e-1)" "unprognostic (9.85e-2)" "unprognostic (8.08e-3)" "unprognostic (3.27e-1)" "unprognostic (9.03e-2)" "unprognostic (2.23e-2)" 17.0 9.0 11.0 19.1 14.5 19.5 16.5 35.5 19.5 21.7 13.1 11.8 8.2 6.4 24.3 15.2 11.9 18.6 12.8 10.0 13.2 9.1 10.5 7.7 11.5 19.0 12.9 10.8 27.9 15.9 22.4 24.4 17.0 18.7 15.1 10.0 9.2 10.2 11.1 11.1 18.6 13.8 16.0 17.3 14.1 13.6 7.9 16.8 32.1 16.0 9.4 15.4 17.2 14.0 6.8 3.2 24.5 4.1 6.2 7.6 3.8 7.0 4.8 23.6 13.0 4.5 6.9 4.3 4.1 3.0 6.8 8.5 3.1 6.6 5.4 6.4 3.9 6.3 7.1 7.3 3.7 13.8 10.1 2.2 9.8 3.7 4.2 3.7 5.7 9.7 5.3 6.8 3.4 7.8 6.2 9.8 10.7 8.1 14.0 6.4 4.6 10.4 6.6 4.8 3.7 5.1 11.6 6.3 4.9 8.2 4.1 9.1 7.0 3.8 3.9 5.1 12.7 6.3 7.6 8.0 9.5 5.9 3.2 4.0 9.9 5.9 12.8 3.3 7.6 7.7 24.5 4.1 3.8 4.2 3.6 5.2 4.2 5.6 4.2 3.2 6.8 7.6 5.1 12.6 6.2 3.8 2.8 4.5 3.8 11.0 14.5 35.5 19.5 13.2 9.1 12.9 10.8 18.7 16.8 14.9 26.4 9.5 7.3 8.0 47.4 19.3 5.1 38.8 25.0 15.7 19.6 5.0 5.0 6.0 2.1 22.9 5.6 0.0 4.5 2.2 13.9 6.7 34.8 9.6 6.7 49.3 12.6 42.4 22.1 2.5 17.0 11.6 10.1 1.8 6.3 20.1 6.1 2.9 18.4 6.7 33.6 45.3 9.9 20.4 17.1 8.7 2.1 22.4 4.9 3.9 SENP8 "DEN1, HsT17512, NEDP1, PRSC2" ENSG00000166192 "SUMO/sentrin peptidase family member, NEDD8 specific" Q96LD8 15 72114258-72143688 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 26.5" "Group enriched" "Detected in many" 11 "Early spermatids: 71.2;Late spermatids: 177.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036273 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA036273: AB_10669985" "unprognostic (1.83e-2)" "unprognostic (1.78e-1)" "unprognostic (9.85e-4)" "unprognostic (5.43e-2)" "unprognostic (1.49e-1)" "unprognostic (6.09e-3)" "unprognostic (3.06e-2)" "unprognostic (4.35e-2)" "unprognostic (1.06e-1)" "unprognostic (2.04e-1)" "unprognostic (3.11e-2)" "unprognostic (1.19e-1)" "unprognostic (8.46e-12)" "unprognostic (1.24e-1)" "unprognostic (1.12e-1)" "unprognostic (1.85e-2)" "unprognostic (1.54e-2)" 2.5 4.8 6.4 3.4 8.1 5.0 4.4 5.7 8.0 4.0 4.0 3.9 6.4 3.8 3.9 6.7 4.8 5.1 4.2 7.7 7.3 6.9 9.3 5.0 3.3 3.1 6.2 7.7 5.3 6.2 3.9 12.7 3.7 8.0 5.9 4.3 4.2 5.6 6.6 11.0 3.5 3.3 4.2 5.0 3.1 4.3 26.5 4.3 2.2 12.0 4.5 2.7 4.9 3.0 3.0 5.7 2.1 5.6 7.1 3.7 2.1 1.9 3.3 6.4 5.0 7.7 9.3 3.6 5.0 3.2 3.1 2.8 2.7 4.6 1.9 7.5 3.2 5.4 4.6 9.8 7.8 4.5 2.1 5.3 3.1 4.6 2.2 5.4 3.6 1.7 4.5 7.9 1.9 8.5 4.0 2.8 5.9 4.6 3.7 7.2 4.9 3.7 4.8 5.1 4.5 3.3 2.4 5.4 4.1 8.0 3.4 7.8 2.6 5.3 4.4 5.3 8.0 6.8 2.8 2.9 6.2 2.3 10.2 2.6 3.0 3.6 2.3 2.9 5.0 4.4 2.1 1.9 1.4 1.6 3.9 2.3 3.0 2.8 2.5 5.7 1.4 3.1 3.7 0.7 7.1 5.6 1.7 2.1 2.1 6.4 8.1 5.7 8.0 7.3 6.9 6.2 7.7 8.0 4.3 6.0 4.0 0.0 2.0 0.2 4.0 5.2 2.5 8.1 5.7 1.8 3.9 6.1 11.6 2.8 71.2 0.9 1.6 0.0 1.6 3.1 2.1 1.4 0.0 1.0 1.9 1.6 1.2 1.8 1.5 177.0 1.7 2.1 0.0 4.6 1.3 7.2 1.4 1.9 1.1 5.7 3.2 0.0 0.5 10.4 11.4 0.4 6.5 0.5 2.1 0.9 SEPHS1 "SPS, SPS1" ENSG00000086475 "Selenophosphate synthetase 1" P49903 10 13317424-13348298 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037645, HPA062118" Enhanced Uncertain Nucleoplasm NA NA Nucleoplasm "HPA037645: AB_10671631, HPA062118: AB_2732676" "unprognostic (8.18e-3)" "unprognostic (1.79e-1)" "unprognostic (1.06e-3)" "unprognostic (2.07e-1)" "unprognostic (3.50e-2)" "unprognostic (2.99e-2)" "prognostic unfavorable (2.16e-7)" "unprognostic (2.66e-2)" "unprognostic (1.43e-1)" "unprognostic (2.61e-2)" "prognostic favorable (3.12e-4)" "unprognostic (1.09e-1)" "unprognostic (1.38e-2)" "unprognostic (1.10e-1)" "unprognostic (1.85e-1)" "unprognostic (1.66e-1)" "unprognostic (5.11e-2)" 15.1 21.9 19.8 11.4 18.0 11.5 33.2 17.3 16.2 14.4 16.0 14.6 10.4 11.9 17.5 20.2 15.4 19.1 15.1 16.1 18.3 15.4 30.5 39.1 20.0 24.3 16.3 11.2 19.8 37.3 23.2 16.6 14.2 17.3 14.4 17.6 15.1 20.6 14.0 20.5 11.8 13.0 17.7 16.6 17.9 15.1 13.7 16.1 44.7 29.8 22.2 17.2 14.1 17.0 8.1 13.2 8.7 19.6 12.7 10.9 6.6 27.5 20.1 41.2 39.7 13.7 10.5 19.4 12.3 9.5 26.3 22.4 22.8 26.0 26.9 15.3 14.3 12.7 17.7 43.6 20.3 27.6 40.4 18.0 14.7 15.0 28.8 14.2 19.8 9.4 9.1 14.6 15.3 9.0 12.3 21.2 57.1 19.3 22.0 18.6 36.5 48.9 8.4 68.1 26.1 9.1 38.2 20.1 16.0 14.2 11.2 14.6 27.2 37.7 16.7 16.8 37.5 21.1 21.1 14.1 11.7 22.3 15.2 25.6 16.2 29.9 49.8 9.4 14.8 9.3 8.7 9.7 7.1 7.1 14.5 8.6 8.1 7.3 8.0 11.6 6.3 9.4 8.7 1.5 12.7 19.6 13.2 10.9 6.6 19.8 18.0 17.3 16.2 18.3 15.4 16.3 11.2 17.3 16.1 11.9 12.5 6.0 14.0 15.2 15.5 10.8 17.8 10.7 15.9 21.0 0.0 28.1 28.2 26.2 8.6 19.0 12.4 23.3 26.1 37.4 15.8 15.2 15.1 27.1 18.2 20.6 16.0 16.5 7.5 11.1 13.8 14.2 15.1 7.2 10.4 22.9 27.4 14.0 17.3 32.7 11.3 6.5 20.6 18.2 15.4 14.8 21.4 11.4 14.6 12.1 SEPHS2 "SPS2, SPS2b" ENSG00000179918 "Selenophosphate synthetase 2" Q99611 16 30443631-30446181 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 52.8;liver: 111.2" "Cell type enhanced" "Detected in many" 11 "Distal tubular cells: 326.6;Proximal tubular cells: 285.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 96.4" "Low region specificity" "Detected in all" HPA047931 Approved Approved Nucleoplasm No No Nucleoplasm "HPA047931: AB_2680216" "unprognostic (5.33e-2)" "unprognostic (2.02e-1)" "unprognostic (1.92e-2)" "unprognostic (9.85e-2)" "unprognostic (2.67e-2)" "unprognostic (6.29e-2)" "unprognostic (5.67e-2)" "unprognostic (7.69e-3)" "unprognostic (2.38e-1)" "unprognostic (9.86e-2)" "unprognostic (9.66e-3)" "unprognostic (1.49e-1)" "prognostic favorable (4.35e-8)" "unprognostic (2.24e-2)" "unprognostic (1.35e-1)" "unprognostic (3.25e-2)" "unprognostic (3.62e-2)" 9.0 9.0 4.9 6.9 6.4 4.0 6.7 6.3 8.4 5.3 25.6 5.2 5.5 26.6 7.6 6.1 6.0 6.1 12.6 5.3 5.2 5.1 32.8 111.2 5.8 7.6 5.5 3.8 5.2 10.0 7.3 6.4 7.5 7.7 6.6 13.1 6.2 10.6 4.7 11.1 5.5 52.8 4.9 4.4 10.5 12.1 3.0 4.6 14.1 11.9 6.4 9.5 8.1 4.4 14.6 15.3 20.5 13.7 23.2 18.9 8.9 14.8 13.4 4.8 16.5 14.7 9.4 12.5 10.3 12.7 10.1 12.6 8.3 11.4 21.3 15.9 10.9 9.2 8.3 8.8 9.4 10.3 13.6 27.2 21.3 7.3 39.0 18.6 11.8 96.4 11.9 20.1 9.5 17.7 6.4 9.2 15.8 17.2 13.9 8.9 21.9 17.7 24.4 11.8 11.2 10.2 17.3 8.3 16.3 12.5 13.4 10.1 8.7 8.8 25.8 33.4 10.0 22.6 39.5 7.7 10.6 7.5 10.2 6.2 12.0 19.2 11.1 9.2 22.1 11.8 6.1 12.9 20.5 11.2 11.2 17.1 12.4 15.9 16.1 15.3 14.6 18.9 12.9 12.9 23.2 13.7 10.9 15.1 8.9 4.9 6.4 6.3 8.4 5.2 5.1 5.5 3.8 7.7 4.6 41.7 32.3 26.8 1.1 33.3 0.8 46.2 0.0 21.4 21.6 61.1 0.0 1.1 326.6 80.1 0.0 17.5 13.1 0.0 72.7 0.9 24.9 1.7 30.1 6.7 1.2 0.0 34.0 0.6 2.4 0.0 0.0 34.5 42.2 64.1 1.1 0.2 55.5 3.5 0.0 285.3 0.8 0.0 54.6 0.7 0.7 37.3 1.0 20.8 1.4 0.6 SEPT2 "DIFF6, hNedd5, KIAA0158, NEDD5, Pnutl3" ENSG00000168385 "Septin 2" Q15019 2 241315100-241354027 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB017190, HPA018481" Supported Enhanced "Nucleoplasm,Plasma membrane,Actin filaments,Cytokinetic bridge" Yes No 8800000 "Actin filaments" "Nucleoplasm, Plasma membrane, Cytokinetic bridge" "CAB017190: , HPA018481: AB_1856684" "unprognostic (6.31e-2)" "unprognostic (5.27e-2)" "unprognostic (2.95e-2)" "unprognostic (4.03e-2)" "prognostic favorable (8.21e-4)" "unprognostic (3.32e-1)" "prognostic unfavorable (3.66e-4)" "unprognostic (1.96e-3)" "unprognostic (1.83e-2)" "unprognostic (5.69e-2)" "unprognostic (1.11e-3)" "unprognostic (3.16e-1)" "unprognostic (9.58e-3)" "unprognostic (8.11e-2)" "unprognostic (9.53e-2)" "unprognostic (1.40e-1)" "unprognostic (2.17e-2)" 64.2 46.4 76.5 42.9 69.9 29.1 58.7 34.9 61.8 69.3 48.4 85.2 57.4 37.8 59.5 59.8 46.8 48.2 54.0 56.2 65.8 55.4 64.6 31.4 51.2 51.3 76.5 52.7 63.4 73.0 56.6 56.3 58.9 60.7 53.7 53.3 48.8 43.6 64.7 39.5 32.0 42.2 81.8 100.8 51.5 45.6 67.7 57.2 36.2 64.2 39.0 47.5 56.5 42.6 25.5 51.2 38.5 50.5 51.3 36.9 59.4 32.3 29.2 79.5 52.0 74.1 80.8 41.2 71.7 70.7 46.1 58.7 16.4 35.2 13.2 17.1 82.0 25.0 28.8 51.9 48.5 75.9 33.2 36.9 52.9 29.2 60.1 45.3 50.3 32.4 71.9 31.8 38.4 37.1 52.9 80.2 33.8 47.2 19.3 67.8 23.3 29.8 30.8 57.9 29.2 21.4 29.5 100.0 27.8 68.4 49.6 57.1 38.4 49.7 34.3 47.3 59.1 20.6 45.5 75.8 56.5 24.0 54.5 42.4 38.2 33.2 46.4 48.6 30.8 78.1 38.5 46.0 26.3 30.3 50.5 36.9 25.5 29.6 31.2 51.2 21.6 26.2 27.4 16.3 51.3 37.2 38.6 29.5 59.4 76.5 69.9 34.9 52.3 65.8 55.4 76.5 52.7 60.7 57.2 142.9 106.2 90.8 0.0 77.2 51.5 114.7 71.4 117.8 135.4 89.0 70.7 118.8 114.4 0.0 157.8 127.2 51.6 46.7 0.0 159.0 147.1 0.0 333.1 52.1 119.3 54.0 85.8 135.1 100.6 140.6 121.7 111.3 82.7 0.0 73.4 155.1 0.0 79.8 174.6 96.3 58.2 109.9 144.2 131.8 84.2 80.8 116.3 82.9 87.9 0.0 SEPT3 SEP3 ENSG00000100167 "Septin 3" Q9UH03 22 41969475-41998221 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 101.6" "Cell type enhanced" "Detected in some" 10 "Bipolar cells: 17.5;Early spermatids: 10.9;Extravillous trophoblasts: 21.5;Horizontal cells: 14.3;Late spermatids: 20.4" "Cancer enhanced" "Detected in many" "glioma: 24.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Group enriched" "Detected in many" 5 "dendritic cells: 1.2;granulocytes: 2.1" "Cell line enhanced" "Detected in many" "AF22: 13.8;SCLC-21H: 37.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003548, CAB017633" Supported Supported Approved "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Nucleoplasm, Plasma membrane" "Actin filaments" "CAB017633: AB_2301476, HPA003548: AB_1079908" "unprognostic (2.10e-1)" "unprognostic (4.67e-2)" "unprognostic (1.16e-2)" "prognostic unfavorable (1.78e-4)" "unprognostic (4.56e-2)" "unprognostic (1.13e-1)" "unprognostic (7.07e-3)" "unprognostic (2.37e-1)" "unprognostic (2.67e-3)" "unprognostic (3.09e-2)" "unprognostic (1.30e-2)" "unprognostic (6.30e-2)" "unprognostic (2.51e-2)" "unprognostic (9.15e-2)" "unprognostic (6.68e-2)" "unprognostic (5.50e-2)" "unprognostic (1.04e-1)" 1.3 4.4 31.3 1.4 26.9 1.3 2.0 35.9 101.6 1.4 1.5 5.6 0.0 1.4 1.4 2.2 1.3 1.2 1.5 1.2 28.9 17.2 1.4 1.2 1.7 1.5 13.2 24.3 1.2 2.0 10.7 1.0 4.9 13.4 2.1 1.5 1.0 1.3 1.2 1.2 2.2 1.4 1.4 7.3 1.3 1.5 2.4 5.3 0.0 1.7 0.0 1.5 1.4 0.1 0.3 1.2 2.1 0.0 0.1 0.2 0.0 0.7 0.8 13.8 10.3 0.1 0.0 6.9 0.1 0.1 0.9 0.4 0.2 1.6 11.1 0.4 0.1 5.9 0.0 7.2 0.0 0.3 4.6 2.3 0.0 0.2 0.0 0.1 0.0 0.5 0.1 0.5 0.0 0.0 0.0 0.0 6.2 0.0 1.7 0.0 1.2 1.8 0.1 9.4 0.1 0.3 8.9 0.0 0.6 0.0 1.3 37.2 7.7 5.5 0.0 9.1 1.4 1.3 3.3 0.0 0.0 4.9 0.4 0.5 7.3 6.4 0.1 0.1 4.5 1.4 2.1 0.0 0.1 0.1 0.0 0.2 0.3 0.2 0.0 1.2 0.0 0.2 0.1 0.0 0.1 0.0 0.9 0.2 0.0 31.3 26.9 35.9 42.1 28.9 17.2 13.2 24.3 13.4 5.3 0.0 0.0 0.0 0.0 0.3 17.5 0.4 0.0 0.0 2.3 0.0 3.9 1.5 0.0 0.0 10.9 0.0 0.0 0.0 0.0 21.5 0.1 0.0 0.0 0.0 1.4 14.3 1.2 0.0 0.0 20.4 0.3 0.3 1.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 1.6 0.3 4.6 0.0 0.0 0.0 SEPT4 "ARTS, CE5B3, H5, hCDCREL-2, hucep-7, MART, PNUTL2" ENSG00000108387 "Septin 4" O43236 17 58520250-58540818 "Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 77.8;brain: 94.8" "Cell type enriched" "Detected in many" 6 "Horizontal cells: 2070.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 11.0;hTERT-RPE1: 14.9;SK-MEL-30: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006855, HPA021587, HPA022905" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB006855: , HPA021587: AB_1856686, HPA022905: AB_1856687" "unprognostic (1.12e-1)" "unprognostic (5.54e-2)" "unprognostic (8.36e-3)" "unprognostic (8.01e-2)" "unprognostic (1.19e-1)" "unprognostic (2.96e-2)" "unprognostic (6.88e-3)" "unprognostic (2.73e-2)" "unprognostic (2.76e-1)" "unprognostic (8.02e-2)" "unprognostic (1.97e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (3.28e-7)" "unprognostic (6.40e-3)" "unprognostic (1.58e-1)" "unprognostic (8.26e-2)" "unprognostic (8.75e-3)" 14.8 77.8 70.5 2.6 80.0 0.9 7.2 44.3 82.7 4.0 3.3 92.4 0.0 2.7 3.5 3.9 3.2 2.7 8.3 14.3 84.8 49.9 8.5 25.0 9.5 5.9 94.8 32.3 5.4 3.9 4.8 2.4 9.9 49.7 2.5 3.1 10.0 4.4 3.8 4.2 3.9 2.9 6.0 84.0 18.0 2.8 7.3 56.5 0.0 4.5 0.5 3.8 5.1 1.3 1.7 5.5 2.9 5.5 1.4 7.6 5.6 0.0 0.4 0.9 2.6 1.1 0.1 0.4 0.1 0.3 1.6 1.9 0.1 0.1 0.0 3.9 0.6 2.4 0.2 1.4 1.1 0.4 0.1 0.7 0.9 0.2 5.5 11.0 0.1 0.5 5.7 2.2 0.4 2.0 14.9 0.5 1.4 0.0 2.6 0.1 0.0 0.0 0.1 0.5 0.0 0.7 0.1 0.0 1.2 0.0 0.0 2.8 1.6 0.0 0.1 24.2 1.3 0.4 0.3 0.0 0.1 1.2 0.0 1.0 0.8 0.4 0.0 0.9 0.0 0.3 0.0 5.5 1.1 7.6 0.7 2.4 1.7 1.6 2.0 5.5 0.6 2.9 2.3 2.9 1.4 0.0 0.3 1.0 5.6 70.5 80.0 44.3 50.5 84.8 49.9 94.8 32.3 49.7 56.5 0.0 0.6 0.0 0.0 5.5 93.8 45.3 0.0 0.0 0.0 7.0 329.9 3.6 14.9 0.0 62.0 12.7 0.0 23.3 0.0 0.3 7.0 0.0 1.1 20.8 4.7 2070.5 0.0 27.6 2.4 56.2 6.6 1.6 65.8 0.0 0.0 56.1 0.0 0.0 13.1 0.5 325.4 181.1 84.9 3.6 1.7 2.5 3.8 0.0 0.0 0.0 SEPT5 "H5, HCDCREL-1, PNUTL1" ENSG00000184702 "Septin 5" Q99719 22 19714464-19724224 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 86.2;parathyroid gland: 86.4" "Cell type enhanced" "Detected in many" 18 "Early spermatids: 9.2;Late spermatids: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "eosinophil: 11.9;neutrophil: 4.4" "Lineage enriched" "Detected in single" 46 "granulocytes: 11.9" "Cell line enhanced" "Detected in many" "K-562: 67.2;THP-1: 21.5" "CAB016120, HPA029095, HPA063885" Enhanced Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA 1600000 "Nucleoplasm, Cytosol" "Actin filaments" "CAB016120: AB_628240, HPA029095: AB_2672904, HPA063885: AB_2685141" "unprognostic (4.07e-2)" "unprognostic (1.47e-1)" "unprognostic (6.78e-3)" "unprognostic (1.39e-2)" "unprognostic (3.92e-1)" "unprognostic (1.86e-1)" "unprognostic (2.50e-2)" "unprognostic (3.77e-1)" "unprognostic (5.66e-2)" "unprognostic (6.19e-2)" "unprognostic (1.88e-3)" "unprognostic (4.34e-1)" "prognostic unfavorable (6.87e-6)" "unprognostic (3.39e-2)" "unprognostic (2.93e-1)" "unprognostic (1.53e-2)" "unprognostic (3.30e-2)" 4.2 6.4 60.7 2.3 62.9 12.5 5.1 31.2 86.2 12.2 3.0 5.5 1.1 2.2 7.4 17.0 15.0 14.1 5.5 50.9 52.9 14.6 2.0 1.1 3.7 3.0 12.4 38.7 9.0 5.5 86.4 11.1 4.4 14.9 4.3 2.7 5.3 3.6 4.0 2.8 42.9 2.5 6.4 3.6 2.2 3.4 6.2 9.5 1.9 6.7 4.1 3.1 3.5 5.6 0.0 0.2 11.9 0.1 0.0 0.2 6.3 0.1 3.1 12.2 18.9 1.2 4.0 0.1 4.7 5.9 5.3 3.1 0.2 1.6 0.4 1.8 10.4 7.8 1.7 8.9 1.7 2.7 3.2 1.1 0.2 0.6 0.0 4.9 0.2 13.0 5.3 2.2 1.7 0.7 1.5 2.2 6.7 67.2 0.2 8.3 1.2 1.3 7.5 1.6 0.3 3.3 13.6 0.4 2.1 0.3 0.4 19.6 16.0 0.7 1.0 0.8 3.2 4.9 21.5 0.8 14.0 18.8 0.6 0.9 1.3 0.0 0.1 1.7 0.6 4.5 0.0 0.1 11.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 4.4 0.0 0.0 0.2 0.0 6.3 60.7 62.9 31.2 86.2 52.9 14.6 12.4 38.7 14.9 9.5 0.0 3.4 0.0 0.0 0.8 4.8 3.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 9.2 0.5 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.0 0.1 3.2 5.1 1.3 0.0 35.9 2.6 0.0 3.3 0.0 0.0 1.9 0.0 0.0 3.2 0.0 0.3 0.0 7.2 2.3 2.7 7.0 0.0 0.0 0.0 0.0 SERF2 "4F5REL, FAM2C, H4F5rel, HsT17089" ENSG00000140264 "Small EDRK-rich factor 2" P84101 15 43777087-43802589 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056613 Uncertain Nucleoplasm,Nucleoli NA Yes Nucleoplasm Nucleoli "HPA056613: " "unprognostic (3.29e-1)" "unprognostic (7.29e-2)" "unprognostic (1.13e-3)" "prognostic favorable (5.33e-4)" "unprognostic (1.40e-1)" "unprognostic (3.91e-2)" "unprognostic (6.06e-2)" "unprognostic (1.61e-1)" "unprognostic (1.13e-1)" "unprognostic (2.50e-1)" "unprognostic (3.04e-1)" "unprognostic (1.36e-1)" "unprognostic (3.37e-2)" "unprognostic (2.84e-1)" "unprognostic (3.35e-2)" "unprognostic (2.76e-2)" "unprognostic (9.42e-2)" 78.4 109.1 61.4 103.2 58.1 110.6 115.0 33.0 45.9 71.2 107.6 45.1 99.7 59.2 65.1 121.7 109.6 60.0 128.9 166.4 56.1 48.2 97.5 153.1 79.7 81.4 72.9 42.6 51.8 125.4 23.5 62.5 102.9 89.4 84.7 87.6 63.0 134.3 106.7 98.7 59.9 86.4 68.5 66.7 79.5 79.5 65.5 45.8 77.0 122.5 116.7 82.9 84.8 116.3 146.1 259.3 225.7 218.7 91.4 142.8 413.5 34.8 58.0 43.3 59.0 150.7 111.1 33.4 62.2 78.0 40.5 51.9 74.4 35.1 18.1 51.6 106.7 53.7 46.4 33.8 46.7 20.3 49.5 40.1 43.7 84.4 142.7 73.9 40.7 94.4 104.9 60.6 32.8 35.2 63.3 59.0 51.4 45.0 119.6 79.4 106.8 52.0 96.5 36.9 136.5 67.6 53.4 28.7 83.0 110.5 127.6 32.5 35.0 33.3 140.1 31.8 39.2 117.3 174.4 49.9 69.4 35.4 104.1 45.4 44.2 59.2 125.6 74.8 74.1 71.8 127.3 218.7 225.7 113.6 194.5 103.1 142.2 125.7 116.0 185.9 146.1 116.7 118.3 129.1 91.4 166.0 259.3 142.8 413.5 61.4 58.1 33.0 45.9 56.1 48.2 72.9 42.6 89.4 45.8 470.5 717.5 1171.8 1145.4 1022.8 54.4 1942.2 1490.4 1019.8 757.5 1647.0 51.1 2342.3 3302.5 1581.0 331.8 1228.3 2242.3 817.7 1967.3 2747.0 1831.7 2360.8 754.3 2534.0 3171.2 44.5 1122.7 1502.0 1926.7 193.3 1134.5 1999.7 1724.2 2939.6 2776.8 318.1 1792.5 2080.9 932.7 3520.7 108.9 595.0 1152.9 641.0 342.8 1360.5 2739.6 1068.3 1696.1 2044.0 SERGEF "DelGEF, Gnefr" ENSG00000129158 "Secretion regulating guanine nucleotide exchange factor" Q9UGK8 11 17788048-18013162 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 115.8;Late spermatids: 197.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037811, HPA037812, HPA074086" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA037811: AB_10672726, HPA037812: AB_2675680, HPA074086: AB_2686658" "unprognostic (2.67e-2)" "unprognostic (7.15e-2)" "unprognostic (7.00e-2)" "unprognostic (9.04e-3)" "prognostic unfavorable (5.67e-4)" "unprognostic (6.94e-2)" "unprognostic (1.30e-3)" "unprognostic (1.87e-1)" "unprognostic (3.69e-2)" "unprognostic (1.70e-1)" "unprognostic (3.74e-3)" "unprognostic (5.56e-2)" "unprognostic (4.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.43e-1)" "unprognostic (1.24e-2)" "unprognostic (5.82e-2)" 8.2 14.2 30.1 7.5 22.3 4.7 15.2 24.4 31.4 13.1 10.7 9.5 4.3 6.1 11.8 17.7 9.6 13.9 10.3 9.9 28.6 24.1 15.6 12.3 10.0 8.0 27.9 18.1 26.1 17.4 17.7 19.3 4.8 23.0 13.6 11.5 10.1 12.3 17.1 11.8 11.1 6.2 14.4 10.4 7.6 10.1 3.9 10.7 7.8 25.3 8.8 11.8 9.5 15.6 15.4 14.4 8.9 11.8 11.3 22.0 14.1 6.4 7.4 7.1 13.3 12.3 12.7 4.3 5.1 11.6 6.0 7.9 5.3 2.1 5.8 6.7 6.5 17.4 8.4 25.1 16.5 5.2 12.7 20.4 8.9 6.8 21.9 13.8 7.8 10.3 11.4 18.1 2.9 12.9 18.7 6.5 13.2 5.4 11.2 9.2 10.0 7.6 17.1 5.4 21.9 8.9 11.0 7.8 6.4 14.6 9.7 16.6 3.9 9.6 9.6 9.7 15.0 4.5 7.4 3.3 6.3 7.3 8.2 6.1 7.7 9.3 7.5 9.7 9.1 6.0 7.2 11.8 8.9 21.1 9.3 17.4 15.4 21.3 16.0 14.4 11.1 21.7 19.2 1.2 11.3 9.4 5.9 22.0 14.1 30.1 22.3 24.4 31.4 28.6 24.1 27.9 18.1 23.0 10.7 6.0 5.0 11.3 18.7 23.6 13.1 10.4 10.2 5.3 7.9 10.4 2.0 6.2 33.2 14.7 115.8 11.3 7.9 0.0 21.5 10.6 11.8 15.5 13.9 12.3 12.5 11.1 46.6 7.4 15.5 197.3 18.1 11.9 20.3 10.8 13.0 15.2 13.8 7.0 20.1 30.0 8.2 6.5 20.0 6.2 5.6 17.7 2.6 20.6 12.4 17.2 SERINC2 "FKSG84, PRO0899, TDE2, TDE2L" ENSG00000168528 "Serine incorporator 2" Q96SA4 1 31409565-31434680 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 113.9" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 546.6;Enterocytes: 427.6;Pancreatic endocrine cells: 386.0;Syncytiotrophoblasts: 373.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "plasmacytoid DC: 12.0" "Lineage enriched" "Detected in many" 4 "dendritic cells: 12.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 47.3;HaCaT: 53.9;HBEC3-KT: 85.2;hTCEpi: 48.5;RT4: 58.3;SK-BR-3: 48.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA005974 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA005974: AB_10603239" "unprognostic (1.41e-1)" "unprognostic (3.70e-3)" "unprognostic (8.78e-3)" "prognostic favorable (1.69e-7)" "unprognostic (6.78e-2)" "unprognostic (5.31e-2)" "prognostic unfavorable (2.11e-4)" "prognostic unfavorable (5.70e-4)" "unprognostic (3.12e-2)" "unprognostic (3.19e-2)" "unprognostic (1.11e-2)" "unprognostic (1.09e-2)" "unprognostic (3.74e-2)" "unprognostic (1.39e-1)" "unprognostic (2.48e-1)" "unprognostic (4.63e-3)" "unprognostic (2.67e-2)" 2.0 6.6 0.6 13.5 1.2 1.1 12.1 0.8 0.8 17.3 32.9 0.8 52.1 27.4 3.7 26.5 32.5 4.3 34.4 2.0 1.0 0.6 57.5 113.9 10.3 7.1 1.8 0.5 1.7 12.9 5.7 5.1 33.9 1.4 17.0 12.8 5.0 58.6 74.4 20.2 14.2 73.0 6.7 1.2 1.7 20.7 3.5 0.8 5.7 13.1 12.7 19.1 31.1 19.9 0.2 12.0 2.3 2.7 0.0 0.0 0.5 13.0 3.1 2.7 8.9 6.0 8.1 7.6 25.2 18.7 1.6 2.0 4.7 47.3 8.6 33.2 23.6 2.0 53.9 0.3 85.2 0.3 0.8 2.0 0.0 2.7 2.4 6.8 0.0 10.1 7.4 48.5 10.4 22.9 7.2 1.0 1.0 0.3 0.0 2.8 2.1 0.3 0.3 2.8 26.1 6.6 0.0 5.4 2.9 9.0 58.3 1.2 6.7 6.4 48.8 1.0 1.4 28.5 1.5 6.2 0.4 2.1 0.2 0.5 0.4 0.3 0.4 0.2 0.2 2.1 0.0 2.7 2.3 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 12.0 0.0 0.5 0.6 1.2 0.8 0.8 1.0 0.6 1.8 0.5 1.4 0.8 14.9 6.2 0.5 97.8 11.0 0.0 0.6 127.4 8.1 21.6 111.7 0.0 323.0 61.3 546.6 3.9 4.4 427.6 0.0 288.5 86.2 3.3 137.4 0.0 45.6 43.7 0.0 111.9 8.6 7.6 6.6 2.0 6.8 38.8 83.8 168.4 0.6 386.0 170.9 0.0 57.4 0.0 0.0 1.4 0.6 3.6 18.4 373.5 0.0 116.2 257.8 SERPINA10 "PZI, ZPI" ENSG00000140093 "Serpin family A member 10" Q9UK55 14 94280455-94293271 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 223 "liver: 169.5" "Cell type enriched" "Detected in some" 9 "Hepatocytes: 200.2" "Cancer enriched" "Detected in some" 51 "liver cancer: 40.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 8 "Hep G2: 21.2" "Not detected" "Not detected" HPA048739 Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA 3960000000 5900000000 Nucleoplasm Cytosol "HPA048739: AB_2797237" "unprognostic (7.14e-2)" "unprognostic (2.03e-1)" "unprognostic (2.69e-2)" "unprognostic (2.01e-1)" "unprognostic (1.21e-1)" "unprognostic (1.45e-1)" "prognostic favorable (9.00e-4)" "unprognostic (6.11e-2)" "unprognostic (2.81e-4)" "unprognostic (2.31e-4)" "unprognostic (2.77e-2)" "unprognostic (2.91e-3)" "unprognostic (1.38e-1)" "unprognostic (1.58e-1)" "unprognostic (1.11e-1)" "unprognostic (7.93e-3)" 0.1 0.0 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 169.5 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.7 0.1 0.1 0.2 0.0 0.6 0.3 2.1 0.8 0.8 0.8 0.5 0.6 0.6 1.0 0.9 2.6 0.6 2.3 0.4 0.4 0.2 0.3 2.4 0.6 1.5 0.9 1.5 2.1 0.7 21.2 0.5 1.7 1.2 0.7 0.5 0.3 0.8 1.2 1.1 1.1 0.6 1.4 1.1 0.3 1.4 1.1 0.9 0.2 0.6 1.0 1.1 0.9 0.6 0.7 1.0 0.9 0.5 0.5 0.2 1.2 1.5 0.9 0.6 0.8 0.4 0.7 0.6 1.2 0.5 1.0 1.0 1.9 0.5 0.7 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 1.9 0.0 0.0 0.2 0.4 2.5 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 200.2 0.0 0.0 6.3 4.3 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SERPINB10 "bomapin, PI10" ENSG00000242550 "Serpin family B member 10" P48595 18 63897174-63936111 "Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 43.9;tongue: 15.3" "Group enriched" "Detected in some" 10 "Ciliated cells: 6.7;Club cells: 2.3;Kupffer cells: 3.2;monocytes: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "classical monocyte: 4.2;eosinophil: 3.3;neutrophil: 1.8;plasmacytoid DC: 2.1" "Group enriched" "Detected in many" 9 "dendritic cells: 2.1;granulocytes: 3.3;monocytes: 4.2" "Cell line enriched" "Detected in some" 7 "U-937: 48.6" "Low region specificity" "Detected in all" "HPA015480, HPA059582" Uncertain Supported Nucleoplasm,Cytosol NA NA 42000 Nucleoplasm Cytosol "HPA015480: AB_1855456, HPA059582: AB_2684072" "unprognostic (4.66e-1)" "unprognostic (5.11e-2)" "unprognostic (1.33e-2)" "unprognostic (1.19e-1)" "unprognostic (9.56e-2)" "unprognostic (2.56e-1)" "unprognostic (4.59e-1)" "unprognostic (1.10e-1)" "unprognostic (3.64e-1)" "unprognostic (1.25e-4)" 1.3 0.1 0.0 2.3 0.2 43.9 0.1 0.3 0.1 1.1 0.7 0.0 0.0 0.1 0.2 0.3 3.1 0.1 0.1 5.5 0.0 0.0 0.0 0.2 3.8 0.2 0.0 0.0 0.0 0.1 0.1 0.0 4.8 0.2 0.1 0.1 0.0 1.0 0.1 1.3 2.5 0.1 0.1 0.0 2.8 0.1 0.1 0.1 4.0 0.9 15.3 1.5 0.1 1.3 0.3 2.1 3.3 4.2 0.3 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 48.6 0.0 0.2 4.2 3.3 0.2 0.1 0.1 0.2 0.1 0.1 0.4 0.3 0.1 0.1 1.8 0.3 0.0 2.1 0.1 0.9 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 6.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.1 SERPINB8 "CAP2, PI8" ENSG00000166401 "Serpin family B member 8" P50452 18 63969925-64019779 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 36.6" "Cell type enhanced" "Detected in many" 5 "Suprabasal keratinocytes: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 37.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB034300 Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB034300: AB_2186486" "unprognostic (8.49e-2)" "unprognostic (4.87e-2)" "unprognostic (4.10e-3)" "unprognostic (2.86e-2)" "unprognostic (1.52e-2)" "unprognostic (7.71e-2)" "unprognostic (4.50e-2)" "unprognostic (2.19e-1)" "unprognostic (2.67e-1)" "unprognostic (2.98e-3)" "unprognostic (6.58e-3)" "unprognostic (1.50e-1)" "prognostic unfavorable (3.31e-5)" "unprognostic (8.73e-2)" "unprognostic (3.48e-2)" "unprognostic (1.25e-1)" "unprognostic (1.90e-1)" 12.4 7.4 2.9 9.3 4.2 16.0 6.1 1.3 5.5 7.7 7.4 7.1 0.0 3.7 4.1 4.3 20.6 3.7 13.7 4.5 3.1 3.3 7.1 23.7 8.2 10.1 4.7 4.0 8.1 4.2 1.1 5.0 9.5 7.4 4.2 6.1 3.4 8.1 2.1 4.5 36.6 8.7 4.4 6.0 9.8 4.2 2.9 3.5 4.2 5.0 17.5 11.3 9.6 11.0 5.1 25.3 5.9 20.5 2.1 4.2 5.0 7.6 1.5 1.3 9.4 4.7 6.6 0.6 24.7 24.0 15.7 15.7 0.3 3.4 0.1 9.1 14.7 7.7 12.4 0.2 15.6 22.5 10.5 0.3 0.0 2.9 0.8 10.7 37.9 3.3 6.3 13.6 21.1 6.9 10.2 16.6 1.6 0.2 4.4 10.8 0.6 0.6 4.2 0.5 1.3 7.6 0.5 3.4 0.6 7.0 8.7 0.7 0.7 4.9 0.7 9.1 1.1 0.3 14.3 25.8 24.0 5.1 2.9 9.9 1.9 0.3 0.0 24.6 22.1 20.6 1.1 20.5 0.8 3.8 16.1 3.4 3.6 3.1 2.3 25.3 5.1 1.7 2.6 5.9 2.1 8.0 13.7 4.2 5.0 2.9 4.2 1.3 5.5 3.1 3.3 4.7 4.0 7.4 3.5 3.0 11.7 4.7 24.0 36.5 0.2 1.2 7.6 6.7 12.5 0.0 0.0 2.9 0.0 27.3 0.6 8.8 8.1 0.0 16.7 4.1 9.3 12.1 4.6 10.4 15.0 0.0 1.7 4.9 24.1 1.1 0.9 25.5 15.1 16.2 3.1 1.6 29.4 2.0 0.0 1.6 0.2 0.0 8.6 2.3 1.0 42.3 26.2 3.9 2.8 32.4 SERPINB9 "CAP3, PI9" ENSG00000170542 "Serpin family B member 9" P50453 6 2887266-2903280 "Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 38.0;lymphoid tissue: 39.6" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 116.9;monocytes: 105.6;Syncytiotrophoblasts: 226.0" "Cancer enhanced" "Detected in all" "testis cancer: 46.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BEWO: 59.1;SuSa: 62.4;U-698: 25.4" "Low region specificity" "Detected in all" HPA030067 Uncertain Approved Nucleoplasm,Cytosol NA NA 4900000 Nucleoplasm Cytosol "HPA030067: AB_2673295" "unprognostic (6.82e-3)" "unprognostic (8.59e-2)" "unprognostic (1.39e-1)" "unprognostic (1.25e-1)" "unprognostic (4.06e-1)" "unprognostic (1.50e-1)" "unprognostic (3.12e-2)" "unprognostic (9.48e-2)" "unprognostic (2.12e-2)" "unprognostic (3.83e-3)" "unprognostic (1.06e-1)" "unprognostic (9.85e-2)" "prognostic unfavorable (1.66e-6)" "unprognostic (9.90e-2)" "unprognostic (8.56e-2)" "unprognostic (1.27e-1)" "unprognostic (3.76e-2)" 5.6 5.1 3.3 15.9 4.1 7.2 2.6 3.6 6.7 3.9 2.1 4.4 1.3 1.7 1.9 1.9 4.6 4.1 5.3 4.9 3.4 3.6 2.5 7.6 13.7 39.6 4.8 3.9 3.8 1.3 4.7 4.9 24.5 4.7 2.6 2.9 3.5 7.5 1.3 2.0 1.0 5.5 2.4 7.1 14.4 2.0 4.4 2.0 6.4 4.2 2.1 18.9 3.4 3.8 10.3 6.4 2.9 38.0 18.8 17.9 12.3 0.0 2.5 0.0 0.0 0.1 0.0 59.1 0.5 0.1 0.6 0.9 0.7 4.8 9.6 6.0 0.5 0.0 0.0 7.1 0.0 0.5 3.1 0.7 0.9 0.9 1.4 3.4 0.0 0.0 2.7 0.0 1.0 0.0 0.0 12.9 0.8 4.4 0.1 0.4 0.2 0.0 0.0 8.2 0.0 0.0 0.9 0.0 0.1 0.4 0.0 0.4 0.1 5.8 0.0 0.0 62.4 0.0 0.1 13.4 0.0 0.1 0.0 0.0 0.0 12.1 25.4 0.0 0.0 0.0 1.7 18.3 0.1 17.9 38.0 14.7 8.3 13.0 16.8 6.1 10.3 12.1 17.5 2.9 18.8 22.0 6.4 13.0 12.3 3.3 4.1 3.6 6.7 3.4 3.6 4.8 3.9 4.7 2.0 17.9 24.9 31.6 1.9 31.4 1.5 4.2 2.5 13.4 14.8 5.2 0.0 62.3 0.0 14.4 0.9 42.0 1.6 0.0 0.2 116.9 44.8 2.2 45.1 6.8 16.6 7.9 14.9 60.2 47.5 2.5 4.0 98.8 84.4 105.6 3.1 4.8 6.2 5.8 16.6 1.4 2.9 12.9 18.1 0.5 2.2 32.2 226.0 48.4 3.5 7.4 SERTAD1 "SEI1, TRIP-Br1" ENSG00000197019 "SERTA domain containing 1" Q9UHV2 19 40421592-40426025 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063323 Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA063323: AB_2684984" "unprognostic (2.23e-2)" "unprognostic (4.41e-1)" "unprognostic (1.59e-1)" "unprognostic (2.73e-1)" "unprognostic (1.29e-1)" "unprognostic (1.34e-1)" "unprognostic (1.55e-1)" "unprognostic (3.44e-3)" "unprognostic (1.01e-2)" "unprognostic (3.82e-2)" "unprognostic (1.62e-1)" "unprognostic (5.21e-2)" "unprognostic (1.28e-1)" "unprognostic (9.46e-2)" "unprognostic (9.43e-2)" "unprognostic (1.74e-1)" "unprognostic (3.08e-3)" 17.3 10.6 5.7 11.3 6.2 30.4 9.6 4.4 9.0 11.4 10.8 5.3 5.3 7.9 10.7 4.4 18.2 13.1 16.1 13.8 8.0 5.4 10.3 14.3 20.8 7.9 8.1 2.8 10.3 17.3 2.8 7.3 19.5 10.3 15.3 3.9 5.8 10.0 6.8 11.4 10.9 13.7 8.4 6.3 8.9 14.2 5.5 8.6 6.6 19.1 23.7 10.0 10.5 18.9 10.6 20.2 14.4 17.2 12.1 10.5 9.7 11.5 13.7 2.0 4.8 5.5 3.9 5.3 18.6 5.7 10.1 10.0 6.1 9.5 2.3 8.9 6.2 2.9 4.7 1.6 16.8 3.1 6.3 3.4 2.0 3.3 5.1 6.3 0.7 7.3 6.4 10.4 11.0 2.0 4.9 5.7 2.0 4.2 3.7 9.1 17.3 1.0 3.8 1.5 8.3 9.2 1.4 3.1 5.8 5.3 8.2 0.6 0.9 9.8 9.2 9.0 2.3 9.1 1.9 10.4 10.1 11.3 8.1 12.4 5.4 2.2 3.0 14.1 3.0 4.7 14.4 17.2 11.0 8.1 14.9 4.8 10.4 8.0 7.6 20.2 10.6 9.4 6.5 13.9 12.1 14.0 18.4 10.5 9.7 5.7 6.2 4.4 9.0 8.0 5.4 8.1 2.8 10.3 8.6 68.5 63.2 28.7 142.2 112.1 4.5 72.2 20.4 30.8 36.4 29.6 0.0 38.7 19.9 48.9 1.2 96.6 151.4 0.0 54.3 48.2 93.6 137.2 134.6 12.5 49.7 3.2 101.7 70.6 24.6 3.1 15.3 63.6 89.4 41.5 87.8 14.0 62.1 119.3 10.3 15.0 1.7 38.8 145.2 1.0 4.9 114.0 108.9 37.4 53.7 97.0 SERTAD2 "KIAA0127, Sei-2, TRIP-Br2" ENSG00000179833 "SERTA domain containing 2" Q14140 2 64631621-64751005 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 53.8" "Cell type enhanced" "Detected in all" 6 "Basal keratinocytes: 157.8;Suprabasal keratinocytes: 129.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019021, HPA020904" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA019021: AB_1856740, HPA020904: AB_1856741" "unprognostic (1.40e-2)" "unprognostic (7.41e-2)" "unprognostic (1.89e-2)" "prognostic unfavorable (4.03e-4)" "unprognostic (2.15e-2)" "unprognostic (8.15e-2)" "unprognostic (3.39e-3)" "unprognostic (1.06e-1)" "unprognostic (9.55e-2)" "unprognostic (5.95e-3)" "unprognostic (1.98e-3)" "unprognostic (7.04e-2)" "prognostic unfavorable (1.70e-4)" "unprognostic (3.21e-3)" "unprognostic (6.78e-2)" "unprognostic (4.98e-2)" "unprognostic (3.84e-1)" 14.3 5.5 4.3 11.3 5.5 52.1 10.4 6.4 5.9 12.4 8.6 9.1 5.6 4.6 9.6 7.6 24.7 7.8 8.4 10.9 4.7 3.5 6.7 11.0 11.8 12.5 7.2 4.4 12.1 5.8 8.4 6.2 17.4 6.0 8.6 6.5 10.2 18.4 7.5 10.8 18.8 9.9 9.5 6.7 24.5 7.2 7.4 8.4 53.8 7.6 16.7 25.7 22.0 16.7 5.4 8.8 3.8 3.1 2.6 4.2 1.4 14.6 4.3 8.2 8.1 7.0 18.0 9.4 11.8 11.4 7.0 6.6 11.1 11.3 12.4 6.5 19.2 9.8 5.8 5.3 7.2 14.9 1.1 8.0 8.2 4.1 8.0 1.5 7.2 4.2 12.2 9.5 16.0 10.5 10.5 4.2 6.2 5.1 6.9 16.3 3.5 7.7 7.9 4.5 8.1 11.6 6.8 14.0 4.8 9.5 13.5 9.5 3.7 8.3 5.8 14.8 8.0 3.9 5.8 12.7 38.0 19.6 22.2 9.5 11.9 4.5 14.4 14.1 13.3 14.8 2.3 2.7 3.8 1.8 2.8 1.1 4.7 1.8 2.0 2.8 5.4 4.2 3.1 3.8 2.6 3.1 8.8 0.9 1.4 4.3 5.5 6.4 5.8 4.7 3.5 7.2 4.4 6.0 8.4 6.0 23.4 29.1 32.3 157.8 20.0 20.7 38.2 14.7 23.9 8.7 17.7 31.4 1.7 11.5 39.6 24.5 17.4 46.7 8.6 22.2 26.8 30.6 8.1 23.2 19.8 9.5 10.9 25.2 34.9 27.3 15.8 37.9 37.1 12.6 14.8 16.7 14.4 17.5 9.9 7.8 23.0 12.9 34.0 5.4 2.7 129.6 50.2 17.5 11.5 61.7 SERTAD4 DJ667H12.2 ENSG00000082497 "SERTA domain containing 4" Q9NUC0 1 210232799-210246631 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 36.3" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 14.8;Ciliated cells: 14.7;Extravillous trophoblasts: 37.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 7.4;BEWO: 7.7;SCLC-21H: 7.7;SK-BR-3: 8.8;T-47d: 10.8;U-2 OS: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027344, HPA028514" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA027344: AB_10601770, HPA028514: AB_10611391" "unprognostic (1.75e-2)" "unprognostic (3.92e-2)" "unprognostic (3.83e-2)" "unprognostic (9.74e-2)" "unprognostic (1.98e-2)" "unprognostic (1.27e-1)" "unprognostic (6.46e-2)" "unprognostic (1.03e-1)" "unprognostic (7.74e-2)" "unprognostic (8.49e-2)" "unprognostic (1.69e-2)" "unprognostic (5.98e-2)" "unprognostic (6.24e-2)" "unprognostic (2.05e-1)" "unprognostic (3.85e-2)" "unprognostic (6.55e-2)" "unprognostic (4.24e-1)" 1.5 1.0 2.3 0.7 7.7 0.1 12.3 2.6 4.3 6.2 6.2 1.5 4.6 1.1 6.2 3.2 15.7 3.2 2.9 4.2 1.8 2.1 2.5 0.2 3.4 0.4 2.8 0.4 2.5 0.2 1.5 1.4 11.7 3.0 3.6 3.3 1.0 36.3 11.1 0.5 5.3 1.1 6.0 2.7 0.3 2.3 0.7 2.1 1.9 3.2 14.6 7.7 1.7 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.2 1.6 0.0 0.8 0.8 7.7 1.9 1.9 1.4 2.6 0.3 0.9 0.0 0.2 0.4 1.2 3.6 0.3 0.6 0.7 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.2 1.8 0.3 0.0 0.0 0.0 0.3 1.8 0.0 0.0 5.4 6.0 0.3 0.0 2.5 0.0 1.3 1.3 7.7 6.7 1.2 8.8 0.1 3.2 10.8 0.0 2.4 2.1 9.2 0.1 5.6 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 7.7 2.6 4.3 1.8 2.1 2.8 0.4 3.0 2.1 6.0 3.8 0.0 10.1 14.8 0.5 0.6 2.5 14.7 11.4 8.7 0.0 13.2 6.6 1.6 0.6 1.4 0.0 0.0 3.5 37.9 4.4 2.2 0.0 0.0 1.3 0.0 1.2 1.3 0.0 0.6 0.6 0.6 10.1 0.0 4.3 0.3 5.2 0.0 1.4 0.0 0.2 0.0 0.9 0.0 0.6 4.1 3.7 0.0 3.7 1.8 SESN1 "PA26, SEST1" ENSG00000080546 "Sestrin 1" Q9Y6P5 6 108986437-109094819 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 108.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 6 "B-cells: 21.0;NK-cells: 21.8;T-cells: 30.6" "Cell line enhanced" "Detected in all" "BEWO: 36.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073659 Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA073659: AB_2686622" "unprognostic (2.22e-1)" "unprognostic (5.97e-2)" "unprognostic (1.02e-1)" "unprognostic (3.52e-2)" "unprognostic (1.17e-1)" "prognostic favorable (6.47e-5)" "unprognostic (2.68e-1)" "unprognostic (6.91e-2)" "unprognostic (1.01e-1)" "unprognostic (8.33e-2)" "unprognostic (1.83e-3)" "prognostic favorable (2.07e-4)" "unprognostic (3.54e-2)" "unprognostic (1.65e-1)" "unprognostic (1.08e-1)" "unprognostic (5.72e-2)" "unprognostic (7.95e-2)" 23.5 14.2 14.5 11.0 23.7 22.7 39.3 21.2 18.9 13.2 16.9 10.2 17.3 10.3 17.1 14.4 11.9 15.2 10.0 32.4 13.0 11.3 8.8 14.1 17.5 54.1 12.2 14.6 33.0 16.1 18.1 25.6 26.8 13.0 15.2 12.8 9.5 10.0 17.2 69.2 19.7 18.6 17.9 13.7 19.3 14.9 20.8 13.6 9.6 18.2 15.4 16.4 16.1 15.3 21.0 2.1 3.9 3.0 21.8 30.6 7.8 1.5 2.5 11.6 5.4 14.8 19.0 36.5 6.1 7.0 2.1 4.1 4.7 1.6 12.8 5.2 4.5 1.6 1.8 3.1 12.2 2.6 1.1 15.5 5.6 3.2 17.7 9.1 2.2 5.8 20.4 19.5 3.8 6.2 9.3 11.0 3.7 4.1 9.2 10.4 3.0 4.8 7.0 4.7 2.4 1.6 3.9 3.3 5.8 4.6 7.7 2.8 5.8 3.3 2.1 2.4 19.6 2.0 14.6 6.7 1.6 3.2 1.5 1.9 9.3 5.3 5.2 3.6 5.6 3.5 3.9 1.0 1.2 14.2 2.3 30.6 4.4 13.3 11.1 1.0 21.0 16.6 8.8 3.9 21.8 3.0 2.1 5.6 7.8 14.5 23.7 21.2 18.9 13.0 11.3 12.2 14.6 13.0 13.6 59.6 15.3 22.2 3.5 5.8 21.5 24.9 17.8 34.8 22.7 14.0 43.2 39.6 8.3 3.4 108.0 6.3 7.9 0.0 4.7 11.8 13.0 7.1 3.5 11.6 35.8 25.4 14.9 11.1 30.9 78.2 31.9 10.8 15.1 9.0 9.7 36.4 2.9 8.6 33.2 5.8 42.4 25.8 13.3 13.2 15.7 7.3 37.3 34.6 11.5 2.3 SESN3 "MGC29667, SEST3" ENSG00000149212 "Sestrin 3" P58005 11 95165513-95232541 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 511.2;Late spermatids: 396.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 19.6;ASC TERT1: 21.5;SuSa: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037935 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA037935: AB_10670534" "unprognostic (2.72e-2)" "unprognostic (3.06e-1)" "unprognostic (2.67e-1)" "unprognostic (8.09e-3)" "unprognostic (5.45e-2)" "unprognostic (4.98e-2)" "unprognostic (1.18e-1)" "unprognostic (8.19e-3)" "unprognostic (1.38e-1)" "unprognostic (3.78e-1)" "unprognostic (2.34e-3)" "unprognostic (4.43e-2)" "unprognostic (1.67e-3)" "unprognostic (1.69e-1)" "unprognostic (1.96e-1)" "unprognostic (1.76e-2)" "unprognostic (9.42e-2)" 7.3 14.2 22.3 10.4 38.6 11.9 11.6 10.2 20.8 10.3 6.8 11.1 3.3 5.2 9.3 11.7 7.6 7.0 9.9 5.1 15.9 12.9 8.7 6.0 7.2 17.3 12.6 12.0 18.4 3.3 27.7 10.7 6.6 13.9 8.5 5.4 19.7 9.1 4.8 5.4 8.4 10.6 7.6 11.6 12.7 3.9 41.6 14.1 11.3 17.3 4.0 18.3 10.0 7.7 4.2 1.1 1.0 3.5 0.8 4.5 0.8 0.0 0.4 11.6 0.0 19.6 21.5 0.0 0.0 0.0 0.0 0.0 0.4 0.3 3.0 1.4 0.0 0.5 2.3 7.0 5.0 0.0 2.5 3.6 1.5 6.1 0.4 0.3 1.3 0.2 11.8 8.8 0.0 2.6 3.6 0.4 1.8 0.1 0.5 0.9 0.0 0.9 3.5 4.7 0.0 0.5 2.2 0.7 0.2 2.6 7.6 1.5 3.2 0.1 0.1 0.6 47.8 0.0 4.3 0.1 1.3 3.0 0.2 0.4 0.1 0.0 0.4 0.5 1.6 2.8 1.0 0.8 0.6 0.7 1.7 0.8 4.2 2.3 1.3 0.7 2.7 4.5 1.7 0.8 0.8 3.5 1.1 4.0 0.8 22.3 38.6 10.2 20.8 15.9 12.9 12.6 12.0 13.9 14.1 23.8 6.4 52.8 25.9 20.5 48.2 7.5 0.0 2.7 14.8 33.2 21.6 0.8 1.7 4.1 511.2 29.0 9.7 23.3 2.0 0.3 22.8 17.2 6.9 4.9 19.2 0.0 7.0 28.3 40.6 396.5 37.7 20.8 30.4 114.6 14.1 93.1 1.9 5.8 82.0 14.6 12.5 6.5 24.7 35.4 8.3 10.9 1.4 15.2 16.3 9.1 SET "2PP2A, IPP2A2, PHAPII" ENSG00000119335 "SET nuclear proto-oncogene" Q01105 9 128683424-128696400 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Chaperone, DNA-binding" "Cancer-related genes, Disease mutation, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB005232, HPA063683" Supported Enhanced "Nucleoplasm,Lipid droplets" NA NA 880000 Nucleoplasm "Lipid droplets" "CAB005232: AB_2185634, HPA063683: AB_2685088" "unprognostic (1.92e-1)" "unprognostic (2.22e-1)" "unprognostic (2.31e-1)" "unprognostic (3.77e-1)" "unprognostic (7.15e-2)" "unprognostic (4.37e-3)" "prognostic unfavorable (9.41e-7)" "unprognostic (2.00e-2)" "unprognostic (1.88e-2)" "unprognostic (3.62e-1)" "unprognostic (3.78e-2)" "unprognostic (3.27e-2)" "unprognostic (1.29e-1)" "unprognostic (7.57e-2)" "unprognostic (1.91e-1)" "unprognostic (2.09e-1)" "unprognostic (1.54e-2)" 47.2 49.7 66.5 59.3 65.8 71.8 56.5 64.2 61.2 54.4 51.3 55.3 45.6 40.1 64.8 33.1 71.6 51.6 48.9 81.6 63.6 57.3 51.7 57.8 51.2 91.1 65.4 56.1 76.5 61.3 55.0 38.7 65.4 47.3 59.2 56.4 36.3 52.1 46.9 76.3 53.6 45.7 59.0 73.5 62.8 46.8 34.8 58.6 152.9 69.1 46.2 92.7 74.4 84.1 72.2 66.4 43.2 56.5 78.8 77.9 69.7 51.4 58.8 84.6 66.9 25.2 39.6 78.0 42.5 47.1 61.5 42.4 80.7 63.2 133.1 36.0 43.7 48.1 96.5 124.9 63.9 70.3 60.7 53.2 76.6 91.4 65.6 56.5 139.7 50.2 33.0 50.1 52.3 105.0 49.5 57.5 71.6 148.6 54.0 50.3 86.8 117.0 51.6 141.2 78.7 62.6 107.0 105.1 107.8 47.4 58.1 86.2 54.1 93.6 62.9 50.8 62.8 78.4 43.6 55.0 72.7 54.5 44.8 70.3 42.5 122.1 158.5 34.6 74.5 69.2 34.5 53.9 43.2 58.9 56.5 72.1 72.2 67.9 62.8 52.7 66.3 65.8 77.9 35.4 78.8 45.6 66.4 52.3 69.7 66.5 65.8 64.2 61.2 63.6 57.3 65.4 56.1 47.3 58.6 113.2 124.3 265.7 328.1 598.4 174.9 190.6 209.0 89.7 129.7 186.7 41.2 273.8 330.0 223.2 30.8 200.0 100.9 93.5 188.0 401.9 250.8 373.4 128.3 164.3 210.2 117.6 245.8 160.2 212.7 25.3 151.8 217.3 310.4 235.4 230.5 205.1 229.0 108.7 163.0 257.3 97.8 129.4 279.5 127.7 287.7 613.8 263.1 219.3 275.8 519.4 SETBP1 "KIAA0437, SEB" ENSG00000152217 "SET binding protein 1" Q9Y6X0 18 44680173-45068510 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Leydig cells: 58.1;Peritubular cells: 37.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 4.9;naive B-cell: 7.5" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "AF22: 9.5;Karpas-707: 37.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049022, HPA057259" Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA049022: AB_2680602, HPA057259: AB_2683384" "unprognostic (1.25e-1)" "unprognostic (1.57e-1)" "unprognostic (1.11e-1)" "unprognostic (1.97e-2)" "unprognostic (4.63e-2)" "unprognostic (1.80e-1)" "unprognostic (1.91e-1)" "unprognostic (3.57e-2)" "unprognostic (3.49e-1)" "unprognostic (2.01e-2)" "unprognostic (2.71e-3)" "unprognostic (6.52e-2)" "prognostic favorable (6.34e-8)" "unprognostic (2.18e-2)" "unprognostic (2.29e-1)" "unprognostic (6.06e-2)" "unprognostic (7.81e-5)" 10.6 2.9 3.8 13.2 8.7 2.1 9.8 16.0 12.6 16.9 14.6 4.2 19.9 2.5 14.0 17.5 6.6 11.0 7.9 6.8 3.6 3.5 15.0 7.2 9.8 7.0 2.9 7.4 12.8 8.2 9.1 5.1 10.2 3.2 12.2 5.3 14.0 6.9 21.3 14.5 6.6 6.9 19.9 3.7 5.9 9.1 5.5 1.2 3.4 8.4 8.7 8.8 11.9 13.3 7.5 4.3 0.2 1.6 0.0 0.6 0.2 0.0 1.7 9.5 0.0 2.7 0.7 0.6 0.8 1.7 0.9 0.7 0.1 0.0 0.5 0.3 1.0 0.5 2.8 1.0 3.0 0.6 0.8 0.5 0.0 1.0 0.6 0.0 0.0 0.0 2.3 1.1 0.0 1.8 1.6 0.3 0.0 0.0 37.9 0.2 0.5 0.0 0.0 1.3 0.0 0.6 3.1 0.0 3.3 3.2 2.2 4.8 2.5 0.0 0.0 0.5 4.5 1.3 0.0 0.0 5.6 2.1 0.0 4.4 5.0 0.3 0.0 3.4 0.1 3.2 0.2 0.0 0.0 0.6 1.1 0.0 4.9 0.1 0.5 0.1 7.5 0.0 0.2 0.0 0.0 1.6 4.3 0.0 0.2 3.8 8.7 16.0 12.6 3.6 3.5 2.9 7.4 3.2 1.2 0.0 2.6 26.0 8.5 13.7 11.5 3.6 10.2 2.7 3.4 15.7 17.7 1.3 3.3 4.1 0.9 9.5 0.4 0.0 2.9 1.2 27.4 6.4 0.0 13.5 1.6 3.2 11.5 12.3 1.6 1.8 58.1 2.7 3.3 0.0 2.5 9.1 3.3 8.4 37.4 6.8 19.3 6.5 30.7 0.0 0.1 13.2 0.7 4.9 4.6 1.0 SETD1B "KIAA1076, KMT2G, Set1B" ENSG00000139718 "SET domain containing 1B" Q9UPS6 12 121804180-121832584 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021667, HPA059412" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021667: AB_1856753, HPA059412: AB_2684006" "unprognostic (1.69e-1)" "unprognostic (2.38e-2)" "unprognostic (6.32e-2)" "unprognostic (3.51e-1)" "unprognostic (2.06e-1)" "unprognostic (2.75e-2)" "unprognostic (5.32e-2)" "unprognostic (1.35e-1)" "unprognostic (1.28e-2)" "unprognostic (5.65e-2)" "unprognostic (1.59e-2)" "unprognostic (1.75e-1)" "unprognostic (7.33e-2)" "unprognostic (1.55e-1)" "unprognostic (1.28e-1)" "unprognostic (1.39e-1)" "unprognostic (2.13e-2)" 13.8 9.6 9.3 16.8 9.4 22.7 18.1 22.0 11.1 19.6 25.0 7.4 16.0 13.0 27.2 14.8 15.8 21.1 18.2 10.0 8.9 4.6 10.1 10.9 10.9 11.9 5.4 7.4 17.4 14.3 12.1 11.9 12.2 7.1 16.5 6.8 14.4 15.9 31.1 12.9 11.8 15.3 14.7 5.4 14.4 17.8 9.1 7.3 31.1 14.7 8.9 14.7 22.8 14.4 1.3 2.1 3.9 2.0 1.0 2.1 0.8 6.0 12.1 6.4 10.5 6.0 4.1 9.7 5.7 4.7 4.6 2.6 6.8 3.7 4.5 5.3 6.4 2.7 9.5 7.4 4.6 2.6 7.9 9.0 13.9 15.0 5.8 5.1 12.6 11.9 5.0 5.4 6.2 4.9 5.2 4.8 9.0 14.2 3.2 3.1 14.3 18.0 16.7 8.9 2.9 7.4 14.1 4.2 6.4 4.1 12.7 7.9 6.0 13.0 8.7 4.7 4.8 10.8 10.9 8.0 6.5 8.1 9.2 6.3 6.3 3.2 2.7 5.4 7.9 7.4 3.9 0.9 2.0 1.9 2.0 1.3 1.2 1.3 1.8 0.7 1.3 2.1 1.3 3.8 1.0 0.8 2.1 1.3 0.8 9.3 9.4 22.0 11.1 8.9 4.6 5.4 7.4 7.1 7.3 3.0 5.3 2.4 3.2 10.4 12.0 8.3 7.6 0.0 6.8 5.2 7.9 6.5 0.0 4.5 7.5 9.3 5.5 0.0 6.2 5.9 7.4 6.7 3.5 11.9 5.7 11.1 7.0 12.9 21.6 14.4 10.6 5.6 1.7 1.0 7.3 5.3 5.7 9.5 9.6 3.0 8.4 6.5 7.2 12.5 1.0 11.3 11.0 8.5 6.7 6.5 SETD5 FLJ10707 ENSG00000168137 "SET domain containing 5" Q9C0A6 3 9397615-9479240 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Autism, Autism spectrum disorder, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017093, HPA035574" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB017093: , HPA035574: AB_2674681" "unprognostic (6.46e-2)" "unprognostic (1.64e-1)" "unprognostic (3.44e-1)" "unprognostic (1.13e-1)" "unprognostic (1.22e-1)" "unprognostic (7.99e-2)" "prognostic unfavorable (6.21e-4)" "unprognostic (5.52e-2)" "unprognostic (2.29e-1)" "unprognostic (3.22e-1)" "unprognostic (1.65e-1)" "unprognostic (4.04e-2)" "prognostic unfavorable (4.27e-4)" "unprognostic (6.65e-2)" "unprognostic (1.67e-1)" "unprognostic (4.04e-2)" "unprognostic (5.15e-3)" 18.9 21.9 33.1 18.2 29.1 13.2 40.9 58.0 38.9 21.7 20.7 15.4 22.1 14.0 24.0 27.0 20.7 22.0 18.4 18.3 29.6 13.8 15.4 22.1 26.5 29.8 23.0 30.1 29.7 22.7 25.6 31.4 23.0 25.1 20.6 20.4 16.7 22.3 22.7 16.6 29.0 19.8 24.1 22.8 22.5 18.7 21.3 26.6 21.0 25.9 14.8 24.2 20.4 37.5 3.7 4.0 4.7 2.0 4.3 4.1 1.0 9.9 12.0 24.7 11.2 14.6 15.2 59.0 9.8 13.3 14.3 16.5 11.9 12.4 21.7 5.9 14.3 12.6 8.3 23.0 13.0 15.8 15.3 11.4 21.2 20.2 11.0 14.9 16.2 14.1 14.7 21.2 21.6 25.7 14.8 15.1 15.4 20.8 14.3 12.2 14.6 14.3 13.5 18.7 7.6 9.7 16.6 19.5 9.6 11.2 16.1 9.9 15.4 14.3 11.8 8.9 23.0 15.8 11.9 17.9 15.1 17.3 8.1 11.7 10.4 13.0 36.2 10.8 11.7 14.1 2.3 2.0 1.7 3.8 1.2 2.5 3.4 2.5 4.1 1.3 3.7 2.4 2.2 4.7 4.3 1.4 4.0 1.0 1.0 33.1 29.1 58.0 38.9 29.6 13.8 23.0 30.1 25.1 26.6 38.7 45.3 34.4 46.5 83.5 109.6 20.7 48.4 56.2 59.1 40.1 108.0 31.2 3.3 31.7 6.2 57.1 35.1 0.0 29.5 33.8 55.5 67.5 46.2 41.4 21.1 52.4 60.0 57.1 28.8 7.5 61.9 31.1 42.2 30.7 47.0 38.4 36.6 45.6 50.5 9.8 62.8 12.9 58.0 37.5 39.3 79.9 47.9 50.7 42.2 63.9 SETD6 FLJ21148 ENSG00000103037 "SET domain containing 6" Q8TBK2 16 58515479-58521181 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041481, HPA053546" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041481: AB_10804004, HPA053546: AB_2682182" "unprognostic (1.32e-1)" "unprognostic (2.98e-3)" "unprognostic (3.35e-1)" "unprognostic (2.81e-1)" "unprognostic (7.90e-3)" "unprognostic (1.95e-1)" "unprognostic (1.93e-3)" "unprognostic (1.65e-1)" "unprognostic (3.65e-2)" "unprognostic (1.50e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (3.54e-4)" "unprognostic (3.74e-3)" "unprognostic (2.14e-1)" "unprognostic (3.73e-1)" "unprognostic (5.93e-3)" "unprognostic (1.55e-1)" 7.8 11.3 7.7 7.4 8.8 4.3 12.6 18.6 11.8 8.4 7.1 6.6 17.0 7.0 10.2 14.0 11.5 10.3 9.6 8.6 8.8 7.0 11.7 12.1 7.9 7.9 8.9 9.0 9.0 20.0 22.1 17.1 7.0 8.3 12.2 8.2 7.2 15.5 19.7 14.7 14.4 7.8 9.2 7.7 9.2 9.6 10.2 9.7 5.5 13.6 9.5 8.8 7.4 10.3 3.2 3.9 3.8 3.0 8.6 4.9 2.7 1.8 3.8 0.8 7.3 2.8 2.0 13.7 3.1 3.4 4.4 2.6 6.5 3.8 13.6 5.0 3.1 0.6 5.7 5.7 4.1 3.2 1.7 20.6 0.6 6.3 11.6 2.9 9.9 6.2 2.5 8.3 3.7 5.7 3.2 3.2 0.1 10.8 1.7 0.9 6.6 0.2 11.9 15.5 5.9 8.4 0.2 1.7 18.5 4.6 0.2 13.6 9.6 13.6 10.4 5.1 4.1 6.7 1.2 2.7 1.7 4.9 2.1 5.2 9.4 5.7 10.1 3.5 4.8 3.3 3.8 2.4 0.2 4.6 3.0 3.3 3.2 3.9 4.9 3.9 3.1 4.8 4.8 0.1 8.6 2.9 3.8 3.2 2.7 7.7 8.8 18.6 11.8 8.8 7.0 8.9 9.0 8.3 9.7 6.0 5.8 7.9 8.7 12.4 13.5 7.6 10.2 13.4 7.9 8.7 13.7 14.4 1.7 7.0 6.6 6.7 4.9 0.0 10.5 7.4 5.2 8.3 1.1 6.2 3.2 11.1 4.6 3.7 3.5 14.2 8.3 4.5 5.0 7.2 4.0 12.1 5.3 2.9 9.6 8.4 11.9 12.9 6.3 9.8 20.4 10.7 10.5 5.3 6.8 5.4 SETD9 "C5orf35, MGC33648" ENSG00000155542 "SET domain containing 9" Q8NE22 5 56909260-56925532 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 23.8" "Group enriched" "Detected in many" 6 "Early spermatids: 523.2;Late spermatids: 284.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049936 Approved Nucleoplasm NA NA Nucleoplasm "HPA049936: " "unprognostic (1.13e-1)" "unprognostic (3.89e-2)" "unprognostic (1.28e-2)" "unprognostic (1.06e-1)" "unprognostic (3.14e-2)" "unprognostic (1.38e-1)" "unprognostic (1.05e-1)" "unprognostic (1.59e-1)" "unprognostic (2.29e-1)" "unprognostic (7.37e-2)" "unprognostic (8.75e-3)" "unprognostic (2.08e-1)" "unprognostic (1.18e-1)" "unprognostic (2.58e-2)" "unprognostic (1.49e-1)" "unprognostic (3.10e-1)" "unprognostic (1.06e-1)" 7.2 2.6 2.3 1.2 4.4 2.4 11.1 1.4 5.2 2.6 4.4 4.7 4.6 4.4 2.7 2.5 2.4 1.9 2.1 7.0 2.1 2.4 5.4 8.8 2.4 5.3 5.3 3.8 2.6 7.3 2.4 2.0 2.6 3.7 4.3 3.3 2.8 5.3 1.2 4.1 1.9 5.2 4.4 3.6 1.8 2.7 23.8 3.2 1.1 4.4 3.4 2.0 2.9 8.1 1.1 2.0 4.3 3.0 1.6 2.9 0.8 4.9 1.8 3.0 3.8 4.6 2.6 5.2 1.4 2.2 2.4 6.1 4.5 5.7 4.5 7.0 2.1 3.1 4.6 3.2 1.8 6.3 3.2 6.7 1.2 1.5 3.7 1.8 1.4 4.3 1.2 2.5 2.2 3.2 3.6 3.9 1.9 3.7 3.3 5.5 7.1 0.7 3.5 4.7 0.0 7.2 4.6 1.9 6.0 2.6 1.7 3.4 5.4 1.2 3.5 5.9 2.0 5.5 3.4 4.2 1.6 7.3 4.6 3.1 3.3 9.5 7.4 2.2 1.3 0.7 1.4 2.3 4.3 1.4 2.0 1.3 0.5 1.6 0.4 2.0 1.1 0.5 0.6 2.7 1.6 3.0 0.8 2.9 0.8 2.3 4.4 1.4 5.2 2.1 2.4 5.3 3.8 3.7 3.2 3.0 2.4 10.3 12.8 15.5 3.0 14.8 10.2 5.3 1.2 7.0 0.0 13.2 48.0 13.9 523.2 6.8 19.6 0.0 15.2 17.3 15.0 18.2 14.9 24.6 13.3 0.0 17.7 9.8 13.9 284.0 9.5 15.7 27.0 11.8 9.2 2.8 8.6 17.5 5.3 36.6 2.9 0.0 10.2 63.8 8.4 13.4 12.0 8.9 12.0 16.4 SETDB1 "ESET, KG1T, KIAA0067, KMT1E, TDRD21" ENSG00000143379 "SET domain bifurcated 1" Q15047 1 150926263-150964744 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "U-698: 90.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018142, HPA058484" Uncertain Supported Nucleoplasm,Vesicles Yes No Nucleoplasm Vesicles "HPA018142: AB_1856757, HPA058484: AB_2683731" "unprognostic (1.07e-1)" "unprognostic (4.08e-1)" "unprognostic (8.02e-2)" "unprognostic (2.24e-3)" "unprognostic (1.65e-2)" "unprognostic (9.57e-2)" "prognostic unfavorable (8.88e-4)" "unprognostic (6.03e-2)" "unprognostic (9.94e-3)" "unprognostic (7.13e-2)" "unprognostic (1.21e-1)" "unprognostic (6.65e-2)" "prognostic unfavorable (4.25e-4)" "unprognostic (1.59e-1)" "unprognostic (3.93e-2)" "unprognostic (3.14e-2)" "unprognostic (1.14e-1)" 16.9 15.4 9.5 21.2 15.9 16.9 17.7 21.6 18.2 18.6 15.4 25.2 18.6 13.0 22.8 18.9 15.6 16.8 14.0 10.9 9.6 8.5 13.3 12.7 15.6 20.7 15.3 13.2 23.9 17.6 21.0 15.4 18.4 13.7 14.9 16.8 20.6 16.1 18.5 20.0 18.0 17.1 17.9 13.7 21.9 15.0 33.5 14.2 24.5 18.6 12.0 20.7 18.6 16.3 11.2 12.8 6.9 14.9 7.6 9.1 5.3 5.9 6.9 10.0 6.6 4.8 6.4 16.7 4.9 5.7 7.1 6.1 4.6 8.2 11.6 6.8 5.4 2.8 7.4 9.3 5.3 5.6 5.6 11.5 6.6 7.1 5.3 6.8 11.6 6.3 8.4 5.9 5.8 9.5 7.2 8.3 7.5 11.0 9.5 5.0 11.4 8.0 6.8 13.7 8.3 5.5 9.3 6.5 8.6 5.4 6.8 7.3 13.3 7.5 8.8 5.9 12.6 9.5 15.7 5.6 4.1 4.3 4.5 6.8 9.9 10.6 90.6 4.3 4.1 4.0 6.8 10.7 6.9 8.3 14.9 8.7 8.7 7.4 9.1 12.8 11.2 8.3 8.3 6.5 7.6 10.6 8.6 4.7 5.3 9.5 15.9 21.6 18.2 9.6 8.5 15.3 13.2 13.7 14.2 6.0 12.3 5.3 7.2 4.8 10.9 4.1 5.1 9.4 6.8 7.0 17.7 11.4 3.3 6.6 23.5 6.9 6.2 0.0 5.0 7.2 4.9 6.2 7.0 6.2 8.8 6.4 3.5 10.4 14.2 21.8 9.5 10.4 1.7 7.2 10.3 6.3 7.3 10.7 9.2 5.4 10.1 6.5 5.9 22.4 14.5 4.4 8.4 7.0 9.3 6.4 SETDB2 "C13orf4, CLLD8, CLLL8, KMT1F" ENSG00000136169 "SET domain bifurcated 2" Q96T68 13 49444374-49495003 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Chromatin regulator, Developmental protein, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 25.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012190, HPA071677" Approved Approved Nucleoplasm No No Nucleoplasm "CAB012190: AB_2186195, HPA071677: AB_2686430" "unprognostic (1.77e-1)" "unprognostic (1.11e-2)" "unprognostic (1.58e-1)" "unprognostic (3.61e-2)" "unprognostic (4.20e-1)" "unprognostic (3.70e-3)" "unprognostic (3.74e-2)" "unprognostic (3.44e-3)" "unprognostic (7.29e-2)" "unprognostic (7.08e-2)" "unprognostic (1.09e-3)" "unprognostic (7.95e-2)" "prognostic favorable (1.92e-7)" "unprognostic (2.83e-2)" "unprognostic (1.64e-1)" "unprognostic (1.95e-1)" "unprognostic (1.85e-1)" 10.2 14.5 9.8 20.5 10.8 9.5 14.1 14.4 12.3 13.0 12.4 8.3 13.6 7.8 13.1 11.6 9.8 9.9 9.7 12.7 8.2 6.9 12.4 11.0 16.3 19.0 7.2 11.1 21.0 15.0 10.8 15.8 7.8 9.5 13.6 11.9 13.5 11.7 10.9 5.5 9.6 11.4 11.3 8.4 19.0 10.7 18.1 8.7 17.3 14.6 3.7 16.6 11.9 10.3 8.4 7.4 4.7 5.4 7.8 10.2 4.5 2.0 1.4 4.3 4.4 6.1 6.9 2.2 5.9 7.4 5.3 5.0 8.7 5.0 25.7 1.2 3.8 4.0 4.2 4.5 4.0 5.2 5.8 3.9 8.9 3.9 5.2 8.6 13.5 5.1 5.3 7.4 4.0 13.4 5.8 4.5 8.3 3.9 3.6 4.8 1.8 5.1 10.1 2.2 5.5 3.4 10.0 5.4 5.4 4.9 1.9 2.2 2.6 2.6 3.7 12.6 3.9 3.1 11.8 2.7 5.1 1.8 6.8 2.4 4.3 6.0 13.6 1.6 11.0 2.3 4.1 4.1 4.7 6.9 5.4 5.8 8.4 7.1 7.1 7.4 8.1 10.2 7.6 1.4 7.8 4.3 5.2 9.4 4.5 9.8 10.8 14.4 12.3 8.2 6.9 7.2 11.1 9.5 8.7 26.8 14.1 32.7 5.3 6.2 12.6 22.4 10.2 13.4 10.3 5.2 25.5 4.8 8.3 3.3 14.7 8.2 6.9 0.0 3.8 2.9 5.1 3.0 5.8 5.9 15.9 12.7 11.1 5.5 19.0 11.1 9.2 17.4 13.5 10.0 6.2 10.8 3.1 2.9 7.8 3.4 29.6 0.0 5.2 18.2 11.8 5.3 2.4 19.1 8.5 2.0 SETSIP SETP18 ENSG00000230667 "SET-like protein" P0DME0 1 92074533-92075441 "Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 1.8" "Cell type enhanced" "Detected in some" 11 "Cardiomyocytes: 3.1;granulocytes: 3.5" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MOLT-4: 2.3" HPA063683 Approved Supported "Nucleoplasm,Lipid droplets" NA NA Nucleoplasm "Lipid droplets" "HPA063683: AB_2685088" "unprognostic (2.31e-2)" "unprognostic (3.79e-3)" "unprognostic (7.59e-2)" "unprognostic (5.74e-2)" "unprognostic (5.60e-2)" "unprognostic (7.74e-2)" "unprognostic (1.88e-8)" "unprognostic (3.43e-1)" "unprognostic (1.65e-2)" "unprognostic (9.37e-2)" "unprognostic (4.35e-4)" "unprognostic (1.63e-2)" "unprognostic (2.58e-1)" "unprognostic (3.10e-2)" "unprognostic (4.93e-2)" "unprognostic (2.15e-2)" "unprognostic (1.74e-1)" 0.0 0.0 0.1 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.2 0.6 0.3 0.1 0.2 0.1 0.6 0.7 0.4 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 1.3 0.5 0.4 0.0 0.1 1.3 0.0 0.0 0.3 0.2 0.0 0.0 0.9 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.9 1.2 0.0 0.0 2.3 0.0 1.6 0.4 0.5 1.2 1.0 1.4 0.0 0.6 1.5 0.6 1.3 0.9 0.5 0.1 0.7 0.3 0.0 0.7 0.4 0.2 0.2 0.7 0.6 1.3 0.0 0.1 1.9 0.0 0.0 0.6 0.1 0.3 0.2 0.3 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.0 1.1 0.0 0.8 0.0 0.0 3.1 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.0 1.1 3.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.5 0.0 0.0 0.9 SETX "ALS4, AOA2, KIAA0625, SCAR1, Sen1" ENSG00000107290 Senataxin Q7Z333 9 132261356-132354985 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Differentiation, DNA damage, DNA recombination, DNA repair, Neurogenesis, Spermatogenesis" "Helicase, Hydrolase" "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024105, HPA057269" Approved Supported "Nucleoplasm,Cytokinetic bridge" Yes No Nucleoplasm "Cytokinetic bridge" "HPA024105: AB_2671437, HPA057269: AB_2683389" "unprognostic (2.16e-1)" "unprognostic (5.77e-2)" "unprognostic (3.23e-1)" "unprognostic (2.03e-1)" "unprognostic (9.99e-2)" "unprognostic (2.14e-2)" "unprognostic (4.86e-2)" "unprognostic (1.64e-2)" "unprognostic (2.06e-2)" "unprognostic (1.38e-2)" "unprognostic (2.36e-1)" "unprognostic (3.32e-1)" "unprognostic (6.76e-3)" "unprognostic (2.47e-1)" "unprognostic (1.13e-1)" "unprognostic (5.64e-3)" "unprognostic (6.42e-2)" 20.3 12.3 13.0 23.5 15.0 14.0 16.1 16.7 14.8 14.7 16.0 11.2 14.5 9.9 18.3 15.2 13.2 17.5 12.3 13.8 13.0 8.3 12.5 15.8 18.5 23.5 19.8 12.6 15.8 11.0 24.0 24.6 13.4 16.9 13.8 12.6 8.6 16.2 16.1 18.4 15.2 19.4 16.9 20.6 25.7 13.2 34.5 18.1 26.3 31.6 10.8 24.0 18.8 16.3 8.0 5.5 16.9 5.0 5.3 6.5 2.3 9.1 12.3 14.2 15.3 18.3 22.3 8.5 12.2 13.7 9.9 9.3 12.9 10.5 15.6 6.0 22.7 24.4 18.8 14.2 10.5 10.9 14.8 6.1 16.3 13.8 11.2 17.2 25.0 19.9 15.6 16.6 16.9 15.1 12.2 15.9 11.1 18.9 12.6 11.4 13.2 15.4 9.6 15.2 15.5 9.6 14.7 20.6 10.4 11.0 12.0 8.9 13.6 20.1 8.9 11.1 19.7 12.3 12.9 18.1 20.8 9.0 13.9 11.6 7.7 13.0 24.2 9.5 10.0 11.1 7.7 4.9 4.8 6.1 4.5 6.5 6.2 4.6 4.6 3.6 8.0 5.0 4.3 16.9 5.3 5.0 5.5 3.4 2.3 13.0 15.0 16.7 14.8 13.0 8.3 19.8 12.6 16.9 18.1 56.6 43.7 27.4 25.9 26.9 29.3 49.2 20.4 54.9 56.9 19.2 27.5 11.5 3.3 17.7 5.9 43.4 27.4 0.0 12.7 8.9 28.8 33.6 55.6 30.4 24.7 63.5 13.9 58.3 69.1 10.9 28.4 39.3 11.8 16.2 27.3 24.6 20.3 19.8 33.9 18.0 28.0 12.9 22.7 47.4 38.0 29.4 7.9 39.9 17.1 38.1 SF1 "ZCCHC25, ZFM1, ZNF162" ENSG00000168066 "Splicing factor 1" Q15637 11 64764606-64778786 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018883 Supported Supported Nucleoplasm NA NA 52000 Nucleoplasm "HPA018883: AB_1856763" "unprognostic (1.24e-1)" "unprognostic (2.42e-1)" "unprognostic (1.18e-1)" "unprognostic (4.01e-2)" "unprognostic (1.50e-1)" "unprognostic (4.35e-1)" "prognostic unfavorable (4.85e-5)" "unprognostic (3.72e-1)" "unprognostic (4.51e-3)" "unprognostic (1.39e-1)" "unprognostic (4.62e-3)" "unprognostic (6.20e-2)" "unprognostic (8.00e-2)" "unprognostic (2.18e-1)" "unprognostic (1.42e-1)" "unprognostic (2.62e-2)" "unprognostic (1.78e-1)" 43.4 36.1 35.7 50.0 37.7 124.4 43.7 61.9 49.0 45.3 41.8 51.8 40.6 38.9 48.2 42.9 39.1 49.2 44.3 39.7 34.3 26.9 38.5 39.3 38.8 54.2 37.8 32.9 66.9 47.2 40.7 43.6 33.7 33.3 47.1 28.1 46.5 47.2 56.4 60.9 47.0 44.8 43.7 28.6 59.6 41.5 65.2 44.6 75.0 45.4 30.9 52.5 39.8 56.1 11.1 12.2 15.9 11.7 9.7 15.5 8.9 35.6 43.4 39.9 34.6 22.4 17.9 47.2 25.6 21.9 34.7 26.9 37.0 40.6 57.3 32.2 28.8 31.8 42.6 45.3 44.6 29.8 42.8 30.7 36.7 28.0 27.3 35.7 39.2 38.2 23.4 23.1 44.0 46.4 20.6 31.1 37.6 54.2 37.4 26.4 38.0 75.4 54.7 54.1 32.3 31.8 64.5 27.7 44.8 23.2 39.8 31.6 41.8 35.9 31.8 35.1 26.7 47.8 41.7 27.0 39.0 35.4 35.7 40.7 43.7 34.4 52.6 34.5 33.7 47.2 3.7 10.5 11.1 15.5 11.7 15.4 11.1 11.6 14.9 10.7 9.4 13.9 14.1 15.9 9.7 10.1 12.2 11.4 8.9 35.7 37.7 61.9 49.0 34.3 26.9 37.8 32.9 33.3 44.6 56.6 87.9 136.8 165.4 163.6 259.4 54.8 84.1 45.5 62.6 52.4 212.1 99.0 31.5 61.5 121.8 127.5 112.6 23.3 63.6 98.9 95.3 151.4 106.1 101.0 85.9 165.3 201.4 128.3 93.7 49.3 145.9 99.3 91.1 90.2 89.1 158.1 70.1 95.1 106.4 46.2 309.2 77.6 131.8 104.4 88.7 160.7 124.4 132.1 95.8 170.1 SF3A1 "Prp21, PRPF21, SAP114, SF3a120" ENSG00000099995 "Splicing factor 3a subunit 1" Q15459 22 30331988-30356947 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000690, HPA030083" Enhanced Enhanced "Nucleoplasm,Nuclear speckles" NA NA 19000 "Nucleoplasm, Nuclear speckles" "HPA000690: AB_1079933, HPA030083: AB_10602183" "unprognostic (8.61e-2)" "unprognostic (1.60e-1)" "unprognostic (3.21e-2)" "unprognostic (7.54e-2)" "unprognostic (5.06e-3)" "unprognostic (1.79e-1)" "unprognostic (5.54e-3)" "unprognostic (3.30e-1)" "unprognostic (3.83e-1)" "unprognostic (2.59e-1)" "unprognostic (2.58e-1)" "unprognostic (3.26e-1)" "prognostic favorable (1.16e-4)" "unprognostic (2.25e-1)" "unprognostic (1.00e-1)" "unprognostic (6.97e-2)" "unprognostic (1.13e-1)" 32.6 30.2 23.3 37.3 25.6 44.6 35.0 33.6 37.3 29.2 26.4 24.8 27.7 26.1 36.3 23.0 32.2 29.4 30.7 26.2 21.5 16.6 24.9 29.7 28.5 48.2 23.5 26.1 45.7 31.4 44.4 27.2 25.9 19.6 27.2 24.5 29.7 31.8 33.1 45.5 36.3 29.5 27.6 18.7 34.6 29.1 78.4 25.7 50.9 32.9 26.6 34.9 32.7 42.6 13.2 10.6 16.2 13.7 12.1 16.6 8.3 26.4 18.6 25.6 24.8 15.2 13.7 30.6 21.0 13.4 22.9 17.1 24.6 17.7 33.1 14.5 14.8 18.1 25.5 32.4 22.3 25.2 30.0 28.4 30.9 23.1 20.1 13.8 61.9 34.4 13.7 15.8 28.9 23.6 13.0 16.4 18.0 34.1 34.7 16.6 15.2 30.1 14.1 42.3 20.4 15.6 43.0 32.1 26.8 13.1 29.4 26.6 24.3 26.7 16.3 24.2 17.8 19.9 20.4 22.9 29.4 26.2 20.9 38.7 26.9 32.4 33.5 22.6 23.0 30.2 7.6 9.8 15.0 13.5 11.3 13.7 12.8 13.5 14.4 10.6 13.2 15.3 13.7 16.2 12.1 13.7 6.4 16.6 8.3 23.3 25.6 33.6 37.3 21.5 16.6 23.5 26.1 19.6 25.7 53.6 60.9 28.0 23.1 23.2 17.9 26.6 35.7 48.2 37.5 29.6 15.7 28.2 14.9 22.6 85.6 29.2 25.3 46.7 25.3 33.8 23.4 23.0 50.8 23.6 34.7 25.4 24.1 28.3 35.7 91.2 32.5 26.1 16.9 63.1 29.8 24.6 24.5 31.6 35.3 14.6 17.4 45.3 23.9 54.7 41.0 23.8 28.9 30.5 28.2 22.2 SF3A2 "Prp11, PRPF11, SAP62, SF3a66" ENSG00000104897 "Splicing factor 3a subunit 2" Q15428 19 2236504-2248679 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042843, HPA049439" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA042843: AB_2678199, HPA049439: AB_2680766" "unprognostic (5.29e-2)" "prognostic favorable (7.16e-4)" "prognostic unfavorable (8.64e-4)" "unprognostic (3.09e-3)" "unprognostic (9.19e-2)" "unprognostic (7.98e-2)" "prognostic unfavorable (3.23e-5)" "unprognostic (1.85e-1)" "unprognostic (1.56e-1)" "unprognostic (1.71e-1)" "unprognostic (5.72e-3)" "unprognostic (7.94e-2)" "prognostic unfavorable (2.07e-4)" "unprognostic (4.09e-3)" "unprognostic (5.38e-2)" "unprognostic (2.85e-1)" "unprognostic (8.73e-2)" 21.1 12.0 12.1 27.1 16.6 35.7 21.3 25.7 22.3 29.2 19.7 20.5 13.2 29.7 32.5 18.2 22.4 23.7 19.5 13.8 10.9 9.0 15.7 13.5 17.4 28.7 13.5 13.1 39.3 25.1 7.5 17.7 24.9 12.1 22.9 7.0 18.4 29.9 21.6 24.8 36.0 26.0 22.8 12.8 27.9 21.0 45.3 14.6 54.2 19.6 20.3 27.0 30.3 24.2 3.4 4.2 9.3 4.3 2.1 5.5 2.8 26.0 11.5 15.9 15.8 4.6 6.9 27.5 9.0 8.4 14.6 14.1 16.8 9.1 28.4 10.7 7.4 9.6 20.9 15.4 11.7 3.2 21.8 23.5 18.2 11.4 13.7 12.4 22.6 23.6 9.7 10.5 12.6 9.9 7.5 14.3 22.7 21.5 26.9 5.4 14.2 29.5 22.0 31.2 10.5 9.6 49.9 9.0 24.7 6.2 7.6 19.5 32.3 13.8 10.7 11.6 7.1 14.9 26.0 14.2 15.2 16.7 31.6 28.7 30.0 29.6 28.5 11.1 17.7 15.0 1.2 2.9 9.3 5.1 4.3 3.5 2.8 3.9 5.5 2.9 3.4 3.5 3.1 2.9 2.1 2.8 4.2 4.6 2.8 12.1 16.6 25.7 19.6 10.9 9.0 13.5 13.1 12.1 14.6 3.0 5.0 30.0 23.2 34.7 6.8 2.0 7.6 1.4 4.5 10.4 3.9 57.9 21.6 20.6 52.3 20.2 18.8 0.0 8.2 72.3 27.1 10.2 16.1 3.8 28.9 7.9 12.6 28.8 21.4 70.4 42.6 20.0 30.4 18.0 20.0 5.2 9.4 21.6 30.1 16.5 11.9 12.9 17.1 53.5 60.0 22.1 49.3 50.8 23.3 18.2 SF3A3 "PRP9, PRPF9, SAP61, SF3a60" ENSG00000183431 "Splicing factor 3a subunit 3" Q12874 1 37956975-37990921 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032054, HPA032055" Supported Supported "Nucleoplasm,Nuclear speckles" NA NA "Nuclear speckles" Nucleoplasm "HPA032054: AB_10602184, HPA032055: AB_2674130" "unprognostic (1.56e-1)" "unprognostic (1.21e-1)" "unprognostic (7.08e-3)" "unprognostic (6.19e-3)" "unprognostic (1.06e-1)" "unprognostic (5.68e-2)" "prognostic unfavorable (2.11e-8)" "unprognostic (1.34e-1)" "unprognostic (2.74e-2)" "unprognostic (5.74e-3)" "unprognostic (9.18e-2)" "unprognostic (4.79e-1)" "unprognostic (1.23e-2)" "unprognostic (2.52e-3)" "unprognostic (8.39e-2)" "unprognostic (2.24e-1)" "unprognostic (3.68e-2)" 7.0 6.4 5.3 6.3 5.9 13.6 7.6 7.4 5.5 6.3 6.5 4.3 9.4 8.7 6.8 7.7 4.1 4.3 4.8 4.9 5.9 6.2 6.1 8.4 5.3 8.7 6.7 6.4 5.7 5.6 6.1 7.2 5.9 7.2 15.3 7.7 5.9 7.7 4.3 7.9 6.2 5.8 6.3 10.3 6.2 6.1 23.6 19.0 10.6 20.6 18.7 27.8 20.6 15.9 12.2 22.1 18.8 13.8 12.8 26.7 15.6 14.3 27.5 22.3 20.0 17.0 30.4 13.7 15.2 10.7 13.8 28.0 22.8 33.8 13.9 27.3 38.6 19.5 17.3 12.7 46.9 18.7 12.1 16.0 28.4 18.8 12.6 19.0 23.7 34.0 12.0 19.8 10.7 24.7 27.1 54.5 16.6 19.0 29.5 37.9 21.9 12.6 16.7 19.3 14.3 20.0 9.3 16.5 20.6 11.0 18.6 17.0 14.4 15.8 13.2 30.9 11.5 16.3 31.0 13.9 43.2 17.9 10.6 15.3 9.8 21.8 18.9 21.2 20.4 25.8 22.0 19.0 23.6 27.8 23.6 2.0 18.7 20.6 11.8 26.3 20.6 47.6 31.2 43.1 32.7 42.0 34.1 19.8 7.6 28.1 44.3 21.0 21.6 48.1 33.2 40.0 18.5 30.6 15.5 0.0 33.5 56.8 32.4 19.1 40.5 20.8 45.1 25.4 15.0 21.5 25.3 10.0 36.8 36.9 37.1 107.4 22.3 37.9 31.9 7.0 50.9 23.7 34.2 38.8 34.7 116.5 59.6 36.5 27.6 38.9 28.3 25.9 SF3B3 "KIAA0017, RSE1, SAP130, SF3b130" ENSG00000189091 "Splicing factor 3b subunit 3" Q15393 16 70523788-70577670 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041134, HPA042986" Supported Supported "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA041134: AB_2677317, HPA042986: AB_10960386" "unprognostic (3.39e-2)" "unprognostic (1.53e-1)" "unprognostic (7.47e-2)" "unprognostic (1.87e-1)" "unprognostic (2.05e-2)" "unprognostic (3.59e-2)" "unprognostic (1.06e-2)" "unprognostic (7.67e-2)" "unprognostic (2.07e-1)" "unprognostic (2.29e-1)" "unprognostic (6.97e-2)" "unprognostic (2.29e-1)" "unprognostic (3.28e-2)" "unprognostic (1.60e-1)" "unprognostic (8.76e-2)" "unprognostic (7.91e-2)" "unprognostic (1.73e-1)" 23.8 21.1 11.8 22.1 23.2 24.7 22.4 24.9 26.9 23.4 20.6 20.9 15.6 17.1 27.5 13.9 31.8 22.1 15.6 20.1 14.0 12.8 17.0 19.0 18.4 28.5 16.9 15.0 33.3 22.5 34.0 26.8 19.9 16.5 18.4 16.4 20.2 22.6 17.3 30.9 28.9 18.8 20.1 15.4 21.0 17.9 15.5 15.9 47.7 25.1 17.2 31.9 23.7 25.0 23.2 21.4 16.4 18.8 21.0 25.9 19.7 18.7 19.7 25.6 17.9 12.7 11.8 19.3 17.8 15.3 23.3 18.9 20.1 15.1 25.2 14.4 13.9 13.9 22.1 27.0 15.2 37.7 8.1 18.9 19.6 16.2 21.3 8.6 27.6 23.2 11.2 11.1 26.0 19.2 14.9 13.9 14.8 26.7 9.0 18.5 23.2 24.2 13.6 23.5 11.9 11.3 42.8 19.9 28.3 7.5 25.9 22.3 16.5 58.0 9.2 9.0 11.2 19.9 13.7 14.2 17.3 19.0 13.3 18.7 10.2 22.3 67.6 11.5 17.7 16.1 11.5 15.8 16.4 23.1 18.8 25.4 18.6 21.8 24.2 21.4 23.2 25.9 22.0 5.4 21.0 17.9 12.0 24.0 19.7 11.8 23.2 24.9 26.9 14.0 12.8 16.9 15.0 16.5 15.9 23.8 22.6 29.8 20.4 19.9 34.7 26.8 15.3 13.4 17.0 22.7 13.7 28.1 6.6 18.9 6.0 22.6 16.5 0.0 19.7 29.6 17.4 18.3 17.3 20.2 20.4 38.1 20.3 17.8 20.0 7.9 31.4 16.3 16.9 15.4 20.5 20.0 21.1 14.0 31.1 13.9 24.9 6.5 14.4 21.8 37.3 22.8 21.3 22.0 26.4 23.0 SF3B5 "MGC3133, SF3b10, Ysf3" ENSG00000169976 "Splicing factor 3b subunit 5" Q9BWJ5 6 144094881-144095573 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054408 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA054408: AB_2682479" "unprognostic (1.22e-1)" "unprognostic (7.12e-2)" "unprognostic (4.54e-2)" "unprognostic (6.86e-2)" "unprognostic (1.42e-1)" "unprognostic (3.08e-2)" "unprognostic (1.07e-3)" "unprognostic (1.74e-1)" "unprognostic (6.47e-3)" "unprognostic (1.43e-1)" "unprognostic (1.33e-3)" "unprognostic (2.47e-1)" "unprognostic (3.61e-2)" "unprognostic (1.92e-1)" "unprognostic (2.77e-1)" "unprognostic (1.90e-2)" "unprognostic (1.49e-1)" 31.0 52.5 32.9 34.0 37.2 76.6 41.7 18.6 35.8 36.9 42.6 23.8 45.3 33.1 34.5 42.6 46.9 47.1 39.8 47.7 32.0 31.1 54.4 84.8 30.3 62.4 32.5 26.0 40.9 100.7 22.3 48.4 31.3 28.0 32.1 40.6 26.5 43.1 60.4 47.4 39.8 40.3 33.2 30.6 38.7 33.9 47.3 24.7 56.7 47.7 63.7 43.4 35.3 30.2 42.7 76.4 38.4 80.7 38.6 48.6 68.5 22.6 30.8 35.4 65.4 41.6 47.4 21.1 23.6 39.8 48.6 55.7 32.6 20.8 37.9 42.5 38.3 47.2 27.0 40.6 54.2 34.4 39.1 57.3 41.3 27.5 71.6 40.0 80.4 26.6 48.3 73.3 53.3 53.4 31.5 58.8 52.5 52.9 55.4 43.5 80.5 51.9 72.6 22.7 35.7 37.3 32.4 46.4 38.3 52.8 20.5 48.7 30.8 32.9 40.4 43.9 18.7 29.3 49.5 31.7 25.0 34.2 44.7 50.9 41.7 50.2 35.6 40.5 67.6 30.8 30.6 80.7 38.4 38.4 56.1 47.2 42.7 43.6 45.2 68.8 39.1 43.5 43.3 21.6 38.6 49.8 76.4 48.6 68.5 32.9 37.2 18.6 35.8 32.0 31.1 32.5 26.0 28.0 24.7 83.4 145.5 165.3 123.3 240.9 44.9 77.9 196.1 116.4 94.4 116.9 11.8 202.6 388.0 204.2 171.0 134.9 248.1 210.2 274.2 179.7 208.8 158.9 174.4 239.5 289.2 41.3 257.0 153.4 220.2 84.0 124.8 193.2 239.6 242.5 242.8 104.3 226.1 234.4 102.2 429.7 46.6 103.5 144.3 82.1 55.6 283.4 172.7 200.5 251.5 180.0 SF3B6 "CGI-110, Ht006, P14, SAP14a, SF3B14a" ENSG00000115128 "Splicing factor 3b subunit 6" Q9Y3B4 2 24067584-24076443 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034829, HPA034830" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA034829: AB_10673104, HPA034830: AB_10669680" "unprognostic (6.37e-2)" "unprognostic (1.38e-1)" "unprognostic (3.59e-1)" "unprognostic (1.08e-2)" "unprognostic (1.03e-1)" "unprognostic (5.35e-3)" "prognostic unfavorable (5.57e-5)" "unprognostic (1.74e-2)" "unprognostic (8.75e-2)" "unprognostic (7.41e-2)" "prognostic unfavorable (8.92e-4)" "unprognostic (2.80e-2)" "prognostic unfavorable (1.74e-4)" "unprognostic (1.28e-1)" "unprognostic (1.42e-2)" "unprognostic (5.44e-2)" "unprognostic (2.91e-1)" 39.4 43.5 39.5 31.0 35.9 72.5 57.1 24.2 35.5 43.7 49.7 30.8 34.6 39.5 41.3 58.6 62.9 36.5 35.4 38.8 35.5 31.5 60.3 64.5 33.1 37.1 35.3 29.2 41.5 43.1 26.4 41.4 49.3 30.8 41.8 45.5 27.1 46.4 36.3 40.8 33.4 62.1 46.0 40.4 42.5 35.8 42.2 34.7 56.9 57.1 63.3 47.3 49.6 42.2 54.1 49.9 71.1 45.6 44.0 62.4 47.4 49.8 24.2 38.9 32.3 30.9 48.2 23.9 38.0 40.6 45.9 47.4 51.6 31.6 37.4 21.5 34.9 47.3 29.8 39.8 47.8 55.8 36.6 47.9 39.5 31.1 44.8 55.6 48.7 24.7 44.6 57.3 46.6 53.6 48.4 45.9 35.2 44.7 28.4 47.8 37.7 36.6 73.7 31.2 62.2 47.8 27.0 53.4 37.1 54.4 28.1 34.8 52.3 21.2 42.1 83.5 34.7 20.5 50.5 27.4 25.3 35.1 26.5 62.1 28.5 36.6 101.1 34.6 81.5 34.9 56.6 43.9 64.9 36.8 45.6 40.5 54.1 46.9 43.9 49.9 40.7 46.4 49.1 71.1 44.0 40.2 45.6 62.4 47.4 39.5 35.9 24.2 35.5 35.5 31.5 35.3 29.2 30.8 34.7 65.5 65.5 119.9 229.6 0.0 50.2 109.1 163.1 143.2 101.2 130.9 15.7 250.0 330.0 180.8 127.3 117.2 210.5 140.2 145.5 328.8 128.0 207.7 98.1 161.7 204.5 17.5 173.1 131.3 129.1 26.7 194.8 118.8 0.0 227.2 200.2 113.5 180.1 263.1 169.7 338.6 53.4 116.4 169.3 210.5 163.8 0.0 227.2 122.2 209.2 366.6 SFMBT1 "DKFZp434L243, RU1, SFMBT" ENSG00000163935 "Scm like with four mbt domains 1" Q9UHJ3 3 52903572-53046750 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 30.2" "Cell type enhanced" "Detected in many" 10 "Spermatocytes: 123.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036152, HPA064564" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA036152: AB_2674972, HPA064564: AB_2685288" "unprognostic (2.78e-2)" "unprognostic (9.96e-2)" "unprognostic (1.35e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (1.69e-1)" "unprognostic (2.71e-2)" "unprognostic (1.28e-2)" "unprognostic (9.39e-2)" "unprognostic (6.79e-2)" "unprognostic (3.55e-2)" "unprognostic (2.36e-1)" "unprognostic (2.57e-2)" "unprognostic (3.57e-3)" "unprognostic (7.15e-2)" "unprognostic (1.45e-1)" "unprognostic (2.19e-2)" "unprognostic (3.55e-2)" 3.1 2.4 5.1 7.0 3.7 5.5 6.8 10.5 5.8 3.2 4.9 3.1 2.7 3.1 2.8 5.2 4.9 3.7 3.8 4.8 4.1 2.4 4.5 6.3 7.3 6.3 2.6 4.3 2.4 11.8 15.1 12.0 3.1 3.1 4.6 5.4 2.9 4.6 2.1 17.7 4.8 4.4 4.1 4.1 5.9 4.2 30.2 2.4 3.9 5.1 2.7 5.6 3.2 12.9 8.2 0.9 10.9 2.1 3.6 5.3 2.4 15.3 4.2 6.9 12.4 1.5 1.1 14.0 3.4 3.2 10.3 12.8 8.6 13.3 7.9 4.0 2.1 11.3 1.3 6.8 4.3 12.5 14.3 4.3 6.6 8.9 3.8 2.4 10.4 6.9 1.0 6.3 7.0 4.8 1.1 1.8 9.1 2.2 11.9 3.4 4.8 6.5 4.2 3.6 5.9 4.5 5.9 6.3 4.4 1.4 16.6 8.1 5.1 14.5 6.0 7.3 0.8 3.9 9.7 1.1 4.6 10.4 7.9 10.4 5.7 19.9 16.9 4.2 4.3 7.7 2.0 2.1 10.9 3.4 1.1 4.5 8.2 5.2 3.1 0.9 6.9 4.8 5.3 3.8 3.6 1.1 0.9 2.5 2.4 5.1 3.7 10.5 5.8 4.1 2.4 2.6 4.3 3.1 2.4 8.9 6.5 14.7 7.5 10.3 13.3 13.7 12.7 13.4 6.8 1.8 43.2 8.8 6.6 6.0 33.8 4.5 6.2 23.3 11.7 8.3 4.2 7.6 9.2 12.4 5.6 7.9 5.8 3.7 5.3 43.6 2.0 5.4 0.0 4.6 8.5 6.0 8.6 8.6 7.1 6.9 21.2 6.5 5.9 123.8 23.2 7.5 4.5 12.5 10.6 4.2 SFMBT2 KIAA1617 ENSG00000198879 "Scm like with four mbt domains 2" Q5VUG0 10 7158624-7411486 "Predicted intracellular proteins" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.7" "Cell type enhanced" "Detected in many" 13 "Cone photoreceptor cells: 76.6;Rod photoreceptor cells: 33.6;T-cells: 24.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 7.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 16.4;REH: 14.7;RPMI-8226: 13.8;SH-SY5Y: 11.3;THP-1: 17.6;U-937: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035447, HPA035448, HPA070388" Uncertain Supported "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA035447: AB_2674628, HPA035448: AB_10669904, HPA070388: " "unprognostic (4.36e-2)" "unprognostic (2.29e-2)" "unprognostic (4.36e-2)" "unprognostic (1.42e-3)" "unprognostic (3.23e-2)" "unprognostic (2.05e-3)" "unprognostic (4.65e-1)" "unprognostic (4.56e-1)" "unprognostic (1.03e-1)" "unprognostic (6.51e-2)" "unprognostic (5.57e-2)" "unprognostic (1.38e-1)" "unprognostic (2.41e-2)" "unprognostic (1.26e-1)" "unprognostic (9.17e-3)" "unprognostic (5.37e-3)" "unprognostic (7.29e-2)" 3.0 4.2 9.6 5.9 11.7 6.1 6.2 6.6 13.7 2.5 2.8 26.7 1.1 2.0 4.3 3.7 2.3 3.7 3.6 3.9 12.6 6.9 2.7 1.1 4.1 7.2 14.6 7.4 11.2 3.8 10.1 6.6 3.7 10.8 6.5 3.4 3.9 4.6 3.6 3.9 1.2 3.5 3.4 10.6 9.0 2.9 1.5 9.7 2.0 7.8 1.1 6.2 3.7 4.1 0.1 5.4 1.7 7.4 1.3 1.8 0.4 0.0 3.4 0.2 0.0 0.0 0.2 3.2 0.1 0.0 0.0 0.0 0.0 0.9 5.3 0.0 0.1 0.0 1.6 6.0 0.0 0.0 0.3 5.4 0.0 8.9 0.0 0.4 5.8 0.7 0.8 0.2 0.0 0.2 0.0 0.0 7.3 9.0 16.4 0.0 2.3 4.6 9.1 1.1 0.0 0.0 14.7 1.8 13.8 0.0 0.5 1.3 11.3 0.0 0.0 0.0 1.5 0.8 17.6 0.0 0.0 1.8 0.2 0.1 7.0 10.1 0.0 0.7 11.1 0.1 0.1 0.4 1.7 1.4 3.8 0.8 0.1 0.5 0.9 0.7 0.1 1.8 1.1 0.2 1.3 7.4 5.4 0.0 0.4 9.6 11.7 6.6 13.7 12.6 6.9 14.6 7.4 10.8 9.7 0.0 6.9 6.7 1.2 1.3 5.8 9.6 2.5 1.4 1.2 0.0 76.6 5.9 0.0 0.4 0.1 6.7 0.0 0.0 0.2 2.0 1.7 9.3 4.6 0.5 14.1 0.0 4.1 7.4 11.5 0.4 4.6 9.2 5.0 9.0 0.0 12.9 0.2 0.0 2.1 0.1 33.6 0.0 1.0 0.4 3.6 1.1 3.7 24.1 0.0 0.6 SFPQ "PPP1R140, PSF" ENSG00000116560 "Splicing factor proline and glutamine rich" P23246 1 35176378-35193148 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009886, HPA047513, HPA054689" Enhanced Enhanced Nucleoplasm NA NA 280000 Nucleoplasm "CAB009886: AB_2186937, HPA047513: AB_2680073, HPA054689: AB_2682574" "prognostic favorable (9.56e-5)" "unprognostic (1.01e-1)" "unprognostic (1.02e-3)" "unprognostic (1.99e-1)" "unprognostic (5.53e-2)" "unprognostic (1.86e-2)" "prognostic unfavorable (7.91e-13)" "unprognostic (3.10e-1)" "unprognostic (4.00e-3)" "unprognostic (3.85e-2)" "unprognostic (2.20e-2)" "unprognostic (8.03e-3)" "unprognostic (1.25e-3)" "unprognostic (1.16e-2)" "unprognostic (3.97e-3)" "unprognostic (3.07e-1)" "unprognostic (3.77e-3)" 40.5 35.7 31.5 39.4 31.4 122.5 48.3 53.0 38.5 39.0 31.4 37.8 32.9 30.0 45.3 36.5 45.5 43.0 28.1 34.0 29.1 24.6 36.4 34.2 47.6 48.8 26.3 32.6 59.9 40.2 45.8 46.3 35.5 31.9 35.5 38.0 35.7 39.6 38.0 44.9 42.9 34.1 36.5 32.8 42.4 35.5 37.5 32.9 95.2 35.3 24.1 60.6 35.9 38.6 6.9 11.2 4.4 8.8 4.9 8.9 3.3 36.4 30.5 53.2 30.1 13.1 19.7 49.9 20.0 20.3 34.2 25.0 33.1 26.4 66.6 27.8 23.1 21.4 33.4 57.8 39.1 46.6 35.5 38.4 50.0 32.9 39.3 17.7 52.0 29.8 15.7 15.2 29.6 14.4 15.2 29.7 35.3 56.5 31.8 33.2 31.7 60.8 44.6 63.4 22.0 29.5 61.9 36.1 43.3 33.0 44.3 38.4 42.7 28.8 22.5 28.9 38.9 26.3 37.1 31.6 27.4 40.3 17.9 42.7 36.5 31.0 67.8 19.5 34.5 38.9 2.6 6.5 4.4 7.7 8.8 8.9 6.2 7.6 6.1 5.8 6.9 7.2 7.9 3.4 4.9 6.4 11.2 8.2 3.3 31.5 31.4 53.0 38.5 29.1 24.6 26.3 32.6 31.9 32.9 157.8 233.8 123.2 218.3 317.6 223.2 127.3 68.8 123.1 187.7 104.7 180.6 178.4 69.6 106.2 101.7 173.0 92.7 46.7 119.2 185.7 204.4 133.7 151.3 95.2 121.1 162.1 210.6 114.8 123.3 250.0 132.3 139.5 133.3 108.2 106.4 182.5 126.2 101.2 109.6 66.5 219.0 51.8 200.9 192.3 171.1 286.1 255.5 127.5 133.5 143.0 SFSWAP "SFRS8, SWAP" ENSG00000061936 "Splicing factor SWAP" Q12872 12 131711081-131799737 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039362, HPA040063" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA039362: AB_10794089, HPA040063: AB_10795413" "unprognostic (1.33e-2)" "unprognostic (2.53e-2)" "unprognostic (1.39e-3)" "unprognostic (2.04e-1)" "unprognostic (4.45e-2)" "unprognostic (2.39e-3)" "unprognostic (7.41e-3)" "unprognostic (2.31e-1)" "prognostic unfavorable (1.10e-4)" "unprognostic (3.44e-1)" "unprognostic (1.50e-2)" "unprognostic (3.30e-2)" "prognostic unfavorable (3.33e-8)" "unprognostic (7.50e-2)" "unprognostic (2.93e-2)" "unprognostic (3.48e-1)" "unprognostic (3.66e-2)" 20.2 15.0 17.7 23.2 24.0 47.1 17.9 31.1 23.8 16.6 15.7 31.1 11.6 20.4 25.7 15.1 15.7 15.7 16.5 11.9 20.5 15.9 15.7 12.3 16.4 20.7 27.0 17.2 21.4 19.8 19.5 18.0 16.6 16.6 14.7 9.9 16.9 22.1 15.5 27.4 30.0 19.0 17.3 21.1 23.7 18.4 17.5 26.4 21.9 17.1 15.9 16.8 16.7 20.5 6.6 11.0 8.5 6.4 8.4 5.5 2.6 13.8 12.5 8.9 9.4 7.1 5.9 20.0 10.8 7.5 12.8 8.8 12.2 6.7 17.1 10.1 8.0 6.6 13.0 12.5 9.9 7.5 5.2 19.7 15.5 6.8 14.2 7.6 19.9 15.3 6.7 11.4 11.5 14.0 10.2 7.9 13.3 21.4 6.8 5.7 17.4 16.7 30.3 23.2 7.5 20.9 19.6 9.0 13.4 7.3 10.2 14.0 15.8 10.2 8.6 12.8 7.3 12.4 15.6 10.1 10.6 14.0 8.2 12.0 19.5 21.2 17.2 10.5 13.7 14.2 3.0 6.4 2.6 5.2 4.4 5.0 3.5 4.6 4.2 4.5 6.6 4.9 5.5 8.5 8.4 5.0 11.0 3.8 2.6 17.7 24.0 31.1 23.8 20.5 15.9 27.0 17.2 16.6 26.4 68.5 35.6 23.8 31.0 34.6 46.7 18.0 30.6 41.5 52.4 14.0 62.8 26.1 0.0 18.1 18.1 30.8 17.4 0.0 22.9 26.0 25.5 26.3 36.9 13.9 19.7 39.7 20.7 21.5 25.9 9.6 27.9 25.3 21.9 30.7 20.8 35.2 22.5 16.7 28.0 9.9 59.1 45.3 25.8 31.1 42.7 40.9 36.5 37.1 19.3 46.4 SFT2D1 "C6orf83, MGC19825, pRGR1" ENSG00000198818 "SFT2 domain containing 1" Q8WV19 6 166319728-166342591 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014677 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA014677: AB_2238986" "unprognostic (8.45e-2)" "unprognostic (1.43e-3)" "unprognostic (2.29e-1)" "unprognostic (1.41e-2)" "unprognostic (6.77e-2)" "prognostic unfavorable (7.47e-4)" "prognostic unfavorable (2.19e-5)" "unprognostic (3.64e-1)" "unprognostic (1.68e-1)" "unprognostic (1.68e-1)" "unprognostic (6.53e-2)" "unprognostic (1.67e-1)" "prognostic unfavorable (3.59e-4)" "unprognostic (4.20e-2)" "unprognostic (5.05e-2)" "prognostic favorable (5.90e-4)" "unprognostic (2.75e-2)" 21.1 24.6 33.6 21.7 31.8 16.4 24.5 15.6 25.0 20.2 27.9 43.4 23.4 23.5 14.7 37.0 19.6 18.8 18.6 15.6 34.9 26.2 27.6 12.5 27.2 23.9 43.9 18.6 18.3 32.6 13.4 11.8 25.9 27.8 27.3 26.8 15.0 38.0 19.4 11.2 12.5 24.9 16.0 61.2 24.6 27.6 18.3 32.8 20.6 24.9 15.3 23.7 17.1 16.1 25.5 57.6 50.1 30.1 14.9 21.7 24.2 13.3 13.0 10.7 22.4 19.6 17.5 16.8 20.8 17.9 14.7 22.3 27.1 27.5 11.8 15.9 17.0 25.7 16.3 15.6 17.1 22.5 16.3 28.5 13.9 11.0 38.2 17.7 35.2 28.3 16.4 20.4 16.9 14.8 21.2 7.8 19.6 25.7 11.9 22.6 21.5 10.3 60.1 10.5 39.9 12.8 7.3 12.3 27.5 36.0 13.9 2.0 9.3 14.2 23.2 18.5 12.6 12.6 63.7 7.3 9.2 17.7 24.3 21.5 11.4 8.2 12.9 19.5 22.2 22.4 29.5 28.5 34.7 18.1 28.1 11.3 25.5 14.7 15.1 30.4 21.2 15.9 15.9 50.1 14.9 30.1 57.6 21.7 24.2 33.6 31.8 15.6 25.0 34.9 26.2 43.9 18.6 27.8 32.8 38.7 55.2 94.6 100.0 76.8 8.2 23.0 58.6 44.2 44.3 102.9 0.0 131.5 76.3 136.4 33.1 53.4 86.8 23.3 110.4 203.9 98.4 175.7 146.5 20.8 187.8 14.3 27.6 63.3 172.6 14.5 78.9 142.4 94.5 228.2 114.9 23.5 133.8 128.7 44.6 126.0 8.4 84.1 53.6 137.2 79.4 89.8 109.7 82.0 105.5 178.5 SFXN5 "BBG-TCC, SLC56A5" ENSG00000144040 "Sideroflexin 5" Q8TD22 2 72942036-73075619 "Predicted intracellular proteins, Predicted membrane proteins" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 28.3;liver: 31.4" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 100.9;Late spermatids: 111.2;Muller glia cells: 76.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015473, HPA056866" Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA015473: AB_1856794, HPA056866: AB_2683261" "unprognostic (7.75e-2)" "unprognostic (1.64e-2)" "unprognostic (1.40e-1)" "unprognostic (2.71e-3)" "unprognostic (1.16e-1)" "unprognostic (1.48e-3)" "unprognostic (1.21e-1)" "unprognostic (1.49e-1)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "prognostic favorable (2.26e-6)" "unprognostic (1.57e-1)" "unprognostic (8.51e-2)" "unprognostic (3.50e-1)" "unprognostic (3.23e-1)" "unprognostic (3.97e-1)" "unprognostic (1.43e-2)" 4.0 10.1 26.1 4.9 24.6 12.8 3.1 10.1 28.3 3.4 6.6 12.9 3.7 7.6 3.2 18.4 2.7 5.2 4.4 3.6 25.3 12.7 12.7 31.4 3.7 3.6 16.0 18.6 2.9 2.7 3.4 3.1 4.5 14.9 5.2 6.8 2.6 2.1 5.4 6.3 3.2 7.3 4.5 9.6 5.2 5.1 2.9 13.3 1.6 4.3 1.7 3.7 5.0 2.1 3.0 4.2 6.4 8.9 5.8 1.3 2.1 3.4 7.4 11.8 9.1 2.8 1.9 4.3 7.0 4.0 11.2 5.9 11.4 8.9 2.1 7.3 7.3 8.1 3.0 9.1 10.1 5.3 8.5 5.9 8.6 7.3 14.9 3.6 4.3 9.4 4.9 2.8 7.8 0.9 4.0 6.5 2.6 7.4 1.8 3.0 6.7 1.2 6.6 14.5 6.7 4.7 8.1 9.7 2.6 6.5 8.2 7.6 2.1 6.5 3.3 2.7 6.7 1.7 2.2 4.7 3.4 11.2 4.8 8.0 3.0 2.9 2.5 11.7 8.1 4.0 4.8 8.9 4.2 0.9 3.9 1.3 1.6 0.5 1.0 4.2 3.0 0.6 0.8 6.4 5.8 4.3 2.9 1.0 2.1 26.1 24.6 10.1 26.3 25.3 12.7 16.0 18.6 14.9 13.3 0.0 4.1 8.8 4.0 4.1 24.0 5.4 5.1 0.0 4.5 34.9 31.4 7.6 3.3 4.4 100.9 6.0 15.1 23.3 7.9 1.9 7.5 2.9 0.0 53.3 10.6 19.1 13.2 8.6 4.0 111.2 9.8 7.0 8.5 10.0 5.8 76.6 6.2 5.3 10.6 20.2 38.4 12.9 7.7 7.9 13.0 8.2 3.5 5.7 6.8 1.6 SGCE DYT11 ENSG00000127990 "Sarcoglycan epsilon" O43556 7 94524204-94656572 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 84.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 2.9;memory B-cell: 6.4;naive B-cell: 9.2" "Group enriched" "Detected in many" 4 "B-cells: 9.2;T-cells: 2.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074790 Approved "Nucleoplasm,Golgi apparatus,Vesicles,Plasma membrane" Yes No 50000 "Vesicles, Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA074790: AB_2686713" "unprognostic (3.16e-3)" "unprognostic (9.06e-2)" "unprognostic (1.20e-1)" "unprognostic (1.20e-3)" "unprognostic (1.12e-1)" "prognostic unfavorable (1.61e-5)" "unprognostic (1.19e-2)" "unprognostic (2.82e-2)" "unprognostic (6.93e-2)" "unprognostic (3.37e-1)" "unprognostic (6.80e-3)" "unprognostic (9.69e-2)" "unprognostic (5.71e-2)" "prognostic unfavorable (1.35e-4)" "unprognostic (1.43e-1)" "unprognostic (2.04e-1)" "unprognostic (2.44e-2)" 22.4 35.7 16.9 7.5 19.0 0.6 23.2 23.6 18.5 22.5 20.5 16.8 14.0 5.3 23.6 16.8 11.1 17.1 19.0 19.3 17.7 14.3 12.9 8.9 17.3 9.0 21.5 12.9 59.3 12.9 8.7 23.1 31.9 15.0 15.6 9.7 11.2 11.9 22.7 6.1 3.5 8.0 28.1 20.9 15.8 11.2 13.2 17.5 2.9 15.4 6.9 4.4 22.7 16.1 9.2 0.3 0.6 0.1 1.4 2.9 0.5 3.7 11.9 12.0 19.4 19.2 36.0 2.1 14.3 29.0 12.2 18.6 7.4 22.5 3.5 20.4 25.3 25.5 2.5 18.1 6.4 16.7 0.6 9.8 0.3 11.7 8.0 15.0 1.1 0.0 29.1 8.9 18.0 23.5 33.3 8.6 0.0 0.0 28.4 14.2 11.8 0.0 0.0 9.2 2.2 9.4 5.4 14.9 7.5 23.8 3.7 7.6 6.1 0.0 15.9 18.2 14.6 5.5 0.1 0.0 38.8 13.0 3.6 22.1 14.7 18.3 4.3 14.4 0.0 21.8 0.6 0.1 0.1 2.9 0.1 1.2 6.4 0.9 1.4 0.1 9.2 0.3 1.0 0.5 1.4 0.1 0.3 0.2 0.5 16.9 19.0 23.6 18.5 17.7 14.3 21.5 12.9 15.0 17.5 65.5 26.6 5.2 18.8 4.4 16.7 15.1 17.8 22.7 43.3 19.2 3.9 75.6 5.0 31.9 1.1 15.0 0.0 0.0 3.9 20.1 52.5 6.3 2.3 7.2 5.5 19.1 1.2 44.8 4.8 1.9 69.9 2.3 49.0 0.0 0.0 27.8 2.8 0.0 54.8 14.7 28.3 84.1 46.2 9.1 3.4 3.4 69.2 0.9 0.0 2.0 SGF29 "CCDC101, FLJ32446, TDRD29" ENSG00000176476 "SAGA complex associated factor 29" Q96ES7 16 28553915-28591790 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 8 "Early spermatids: 187.5;Late spermatids: 270.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052590, HPA053608" Enhanced Approved Nucleoplasm,Nucleoli Yes No Nucleoli Nucleoplasm "HPA052590: AB_2681875, HPA053608: AB_2682205" "unprognostic (1.38e-2)" "prognostic favorable (4.77e-4)" "unprognostic (1.73e-1)" "unprognostic (2.46e-3)" "unprognostic (2.80e-2)" "unprognostic (7.27e-3)" "unprognostic (1.48e-1)" "prognostic favorable (3.37e-4)" "unprognostic (1.98e-1)" "unprognostic (1.41e-1)" "prognostic favorable (2.99e-4)" "unprognostic (2.96e-1)" "unprognostic (1.35e-2)" "unprognostic (1.66e-1)" "unprognostic (2.19e-1)" "unprognostic (1.76e-1)" "unprognostic (5.42e-3)" 11.1 11.4 7.9 11.8 12.5 9.9 15.5 20.9 11.0 19.5 17.1 10.6 16.9 11.6 21.4 10.2 9.0 17.6 11.1 10.7 7.9 6.8 9.8 12.9 11.1 17.2 16.5 7.1 31.5 17.7 8.6 9.4 8.4 10.8 13.1 6.9 12.1 14.8 20.0 36.1 12.2 13.4 21.4 13.4 11.6 13.5 35.6 14.4 17.6 19.5 9.0 10.4 17.1 25.1 25.4 27.6 18.8 18.2 19.5 36.1 20.4 7.0 12.0 9.2 6.0 6.4 6.3 16.8 4.8 5.4 12.6 11.9 13.8 6.4 21.3 12.0 3.7 7.6 8.3 7.0 8.4 3.6 6.8 13.3 13.2 7.4 18.3 15.6 11.8 14.9 6.7 11.5 7.5 7.6 6.8 4.7 13.6 11.1 10.9 4.4 23.6 13.4 23.2 12.7 5.2 11.7 21.0 6.0 18.5 6.3 10.7 14.9 6.9 7.4 14.2 7.9 3.7 11.7 9.8 3.3 8.7 7.4 5.0 8.3 12.7 18.4 12.4 6.2 20.1 7.0 5.0 18.2 18.8 22.3 15.6 26.9 22.2 31.2 27.2 18.3 25.4 36.1 27.8 5.6 19.5 12.5 27.6 29.6 20.4 7.9 12.5 20.9 11.0 7.9 6.8 16.5 7.1 10.8 14.4 14.9 11.8 6.7 16.2 0.0 6.1 0.0 5.1 12.0 13.6 17.4 13.7 15.2 8.3 9.9 187.5 3.6 9.3 0.0 11.3 10.4 9.5 6.7 5.8 14.3 12.7 0.0 3.5 6.2 12.9 270.5 28.4 12.1 0.0 11.8 9.2 11.2 11.3 12.2 20.5 18.8 13.9 19.4 0.0 8.4 19.2 0.0 17.6 13.1 14.0 11.1 SGK2 ENSG00000101049 "SGK2, serine/threonine kinase 2" Q9HBY8 20 43558968-43588237 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.1;kidney: 39.1;liver: 32.9" "Cell type enhanced" "Detected in many" 15 "Distal tubular cells: 64.6;Enterocytes: 26.9;Hepatocytes: 26.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 10.3;CAPAN-2: 8.0;Hep G2: 10.4;OE19: 34.0;RPTEC TERT1: 14.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008859, HPA011387" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA008859: AB_2668159, HPA011387: AB_1856744" "unprognostic (1.82e-1)" "unprognostic (1.84e-1)" "unprognostic (4.53e-2)" "unprognostic (2.86e-1)" "unprognostic (6.27e-2)" "unprognostic (2.98e-4)" "unprognostic (2.05e-2)" "unprognostic (1.35e-1)" "unprognostic (4.30e-2)" "unprognostic (2.60e-1)" "unprognostic (1.05e-1)" "unprognostic (5.72e-4)" "unprognostic (4.15e-2)" "unprognostic (1.38e-1)" "unprognostic (2.56e-1)" "unprognostic (3.11e-2)" "prognostic favorable (5.65e-4)" 11.4 0.7 2.8 4.3 9.9 0.2 3.1 1.0 10.2 1.4 21.3 33.1 0.9 17.8 1.0 19.7 0.7 1.6 7.9 0.7 4.3 2.5 39.1 32.9 0.6 0.5 6.9 5.1 3.2 14.1 0.5 1.7 0.5 13.7 1.4 23.4 0.0 0.9 1.8 0.4 3.2 20.7 1.0 14.2 0.7 11.9 1.0 6.0 0.0 1.0 0.2 0.2 3.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.5 8.0 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 10.4 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 34.0 0.0 0.0 0.0 0.0 14.7 1.7 0.1 0.4 0.0 0.7 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 9.9 1.0 10.2 4.3 2.5 6.9 5.1 13.7 6.0 0.0 0.0 0.0 0.1 0.1 0.8 2.2 12.7 0.0 0.0 10.4 0.0 3.4 64.6 3.9 0.1 0.1 26.9 0.0 5.4 1.0 0.2 0.1 0.0 26.9 0.6 6.4 1.7 1.3 1.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 2.6 8.4 0.4 15.7 0.8 0.0 0.0 0.0 0.2 0.1 14.3 0.0 5.9 0.1 SGK3 "SGK2, SGKL" ENSG00000104205 "Serum/glucocorticoid regulated kinase family member 3" Q96BR1 8 66667596-66862022 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "monocytes: 45.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006699, HPA027146" Supported Supported Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA006699: , HPA027146: AB_1856745" "prognostic favorable (5.52e-6)" "prognostic favorable (8.28e-4)" "unprognostic (8.52e-3)" "unprognostic (1.10e-2)" "unprognostic (3.75e-1)" "unprognostic (1.37e-2)" "unprognostic (2.32e-1)" "unprognostic (1.69e-3)" "unprognostic (9.51e-2)" "unprognostic (8.86e-3)" "prognostic favorable (9.65e-4)" "unprognostic (1.94e-2)" "unprognostic (8.95e-2)" "unprognostic (4.55e-3)" "unprognostic (1.77e-1)" "unprognostic (1.01e-1)" "unprognostic (5.29e-3)" 6.5 5.9 13.9 8.7 20.9 7.7 23.9 9.8 14.8 12.0 10.0 24.0 8.7 8.6 8.0 10.3 7.6 7.8 7.8 5.4 16.1 10.2 14.9 13.6 9.9 8.5 28.8 9.3 9.8 15.6 29.2 14.8 5.9 14.6 7.8 10.7 17.2 7.0 7.7 6.1 12.4 10.8 6.0 32.8 8.2 7.2 8.9 21.9 8.3 17.3 4.3 6.8 6.1 8.0 5.8 13.8 21.4 15.7 6.9 13.3 8.0 11.6 3.0 0.5 1.9 3.5 7.0 6.5 7.4 7.1 4.1 4.3 5.3 7.8 8.8 1.8 8.1 11.0 3.8 6.1 4.3 5.1 4.9 10.3 7.9 2.2 5.2 3.5 7.1 9.4 3.3 3.9 1.9 6.8 3.8 6.5 7.0 1.5 4.2 7.7 1.8 5.6 4.4 1.7 6.7 4.1 9.8 4.4 5.9 5.4 2.6 2.5 2.0 3.3 5.0 11.2 5.2 23.5 14.2 7.7 3.9 3.4 3.3 2.8 5.2 10.1 10.1 4.5 12.0 4.0 21.4 15.7 6.2 8.1 9.3 13.3 3.7 8.4 8.5 13.8 5.8 9.0 6.9 2.5 6.9 4.4 7.7 5.3 8.0 13.9 20.9 9.8 14.8 16.1 10.2 28.8 9.3 14.6 21.9 6.0 22.6 7.8 5.6 11.7 1.7 5.6 7.6 16.0 11.4 10.4 17.7 7.0 13.3 5.8 0.6 9.8 10.5 0.0 15.8 1.2 4.5 8.9 14.0 18.3 21.3 0.0 15.5 17.2 34.8 1.1 3.7 32.9 8.5 45.1 7.0 3.5 12.1 9.7 7.4 30.7 1.6 0.0 3.1 4.1 11.3 13.8 4.0 15.8 8.2 4.7 SGK494 ENSG00000167524 "Uncharacterized serine/threonine-protein kinase SgK494" 17 28607964-28614200 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 89.8;Rod photoreceptor cells: 106.4;Spermatocytes: 85.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" HPA046590 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA046590: AB_2679710" "unprognostic (1.83e-1)" "unprognostic (9.42e-2)" "unprognostic (2.84e-2)" "unprognostic (2.30e-2)" "unprognostic (2.11e-1)" "unprognostic (2.06e-3)" "unprognostic (9.33e-3)" "unprognostic (2.63e-1)" "unprognostic (8.62e-4)" "unprognostic (2.09e-2)" "unprognostic (6.81e-2)" "unprognostic (3.45e-5)" "unprognostic (1.20e-7)" "unprognostic (2.67e-1)" "unprognostic (1.10e-1)" "unprognostic (1.28e-2)" "unprognostic (4.66e-3)" 1.6 4.7 10.3 3.5 25.3 10.6 2.3 17.8 25.8 1.9 1.8 0.9 0.4 0.7 2.0 4.5 1.3 2.4 0.8 2.1 8.6 3.7 5.6 1.6 3.2 3.3 2.5 10.7 3.7 1.3 2.0 5.6 3.1 11.2 2.3 4.0 6.3 1.9 3.2 3.8 6.3 2.3 1.9 2.9 3.4 1.3 8.5 4.1 0.1 2.5 0.1 3.5 1.9 2.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.4 5.1 6.1 5.7 1.9 2.5 4.4 0.8 0.3 2.1 1.9 6.1 0.7 7.0 0.9 2.8 3.1 3.1 4.5 2.4 2.7 3.9 6.7 7.3 4.0 3.6 0.2 9.8 5.2 1.2 7.3 7.4 4.2 1.7 2.3 9.7 7.0 0.6 1.3 7.1 2.4 6.5 6.1 3.2 0.9 7.1 8.7 4.6 1.2 6.7 3.7 3.5 4.3 2.4 3.6 8.6 3.6 5.5 3.0 4.1 3.5 4.1 5.0 3.8 3.6 8.5 3.0 7.1 3.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 25.3 17.8 25.8 8.6 3.7 2.5 10.7 11.2 4.1 0.0 1.3 5.2 5.5 0.0 89.8 0.3 10.2 0.0 1.2 5.2 21.6 5.6 0.0 2.0 10.6 2.9 4.2 0.0 1.3 2.0 1.0 5.8 0.0 5.8 3.6 33.4 1.2 8.6 5.7 2.2 2.0 3.2 0.0 3.6 2.7 6.8 1.9 7.0 1.8 1.4 106.4 0.0 0.3 85.6 14.7 0.0 20.7 5.0 3.2 3.4 SGMS1 "MGC17342, MOB, SMS1, TMEM23" ENSG00000198964 "Sphingomyelin synthase 1" 10 50305586-50625163 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Suprabasal keratinocytes: 72.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045191 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA045191: AB_10959605" "unprognostic (1.13e-1)" "unprognostic (5.75e-2)" "unprognostic (1.87e-1)" "unprognostic (9.08e-2)" "unprognostic (8.69e-3)" "unprognostic (8.34e-2)" "unprognostic (7.98e-2)" "unprognostic (2.29e-1)" "unprognostic (1.30e-2)" "unprognostic (5.75e-2)" "unprognostic (9.20e-2)" "unprognostic (2.05e-1)" "prognostic favorable (1.95e-7)" "unprognostic (8.38e-2)" "unprognostic (1.95e-1)" "unprognostic (3.31e-1)" "unprognostic (3.05e-1)" 14.7 19.6 16.9 12.3 19.4 17.6 13.2 17.5 20.1 15.8 12.8 24.0 11.9 11.7 12.5 18.1 13.7 14.8 13.6 16.6 18.2 14.6 17.9 23.5 18.6 11.6 22.9 14.0 16.9 19.1 64.6 22.9 20.7 18.6 17.6 10.7 15.5 19.8 15.8 13.2 25.6 13.7 15.2 31.7 13.6 12.8 9.6 24.9 11.4 21.5 8.7 14.9 15.2 21.3 5.3 3.7 20.1 6.7 7.6 11.0 4.2 16.1 7.7 2.3 5.0 8.2 10.8 10.5 10.8 10.9 7.6 7.2 6.4 16.8 12.0 6.3 14.1 6.9 10.3 5.3 11.3 8.0 10.4 5.6 17.2 10.3 4.8 9.5 3.9 4.3 6.9 13.3 10.1 12.4 4.9 10.7 4.4 33.1 18.0 8.1 6.8 1.7 2.2 5.1 7.4 7.4 2.9 10.3 4.6 11.1 17.1 3.4 2.7 7.9 7.9 4.1 6.6 11.9 1.5 14.9 8.3 10.1 7.9 7.9 6.1 4.8 3.4 10.3 6.5 6.7 2.4 6.7 20.1 3.7 3.4 8.2 5.3 4.9 5.4 3.7 5.0 6.8 4.3 12.5 7.6 2.7 2.3 11.0 4.2 16.9 19.4 17.5 20.1 18.2 14.6 22.9 14.0 18.6 24.9 41.7 27.0 11.0 24.2 48.3 16.3 20.6 7.6 25.4 38.7 27.9 3.9 8.7 13.3 15.3 12.1 17.0 9.3 23.3 18.7 6.6 21.6 31.8 19.7 14.5 23.8 4.8 14.3 20.9 40.7 21.3 15.0 16.6 11.8 5.4 11.2 16.5 10.7 3.5 9.9 7.9 35.9 0.0 15.5 8.1 1.9 72.9 4.1 10.7 11.5 23.2 SGO1 "NY-BR-85, SGOL1" ENSG00000129810 "Shugoshin 1" Q5FBB7 3 20160593-20186292 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 40.1" "Cell type enhanced" "Detected in some" 27 "Cytotrophoblasts: 5.4;Extravillous trophoblasts: 33.5;Hofbauer cells: 8.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA035501, HPA069302, HPA069857" Enhanced Enhanced Nucleoplasm,Kinetochore,Cytosol Yes Yes Nucleoplasm "Kinetochore, Cytosol" "HPA035501: AB_2732469, HPA069302: , HPA069857: AB_2686214" "unprognostic (6.87e-3)" "unprognostic (5.01e-2)" "unprognostic (2.25e-2)" "unprognostic (8.93e-3)" "unprognostic (2.51e-2)" "unprognostic (4.10e-2)" "unprognostic (2.55e-6)" "unprognostic (9.49e-3)" "unprognostic (2.45e-2)" "unprognostic (3.69e-2)" "unprognostic (1.65e-4)" "unprognostic (1.52e-2)" "unprognostic (0.00e+0)" "unprognostic (2.29e-2)" "unprognostic (4.95e-2)" "unprognostic (4.14e-1)" "unprognostic (1.64e-1)" 0.6 0.6 0.4 9.1 0.4 8.9 1.0 0.4 1.5 0.9 3.4 0.3 0.6 2.7 0.8 0.5 4.0 0.3 1.7 0.4 0.3 0.4 0.8 1.0 0.9 6.9 0.4 0.1 0.5 0.5 0.0 0.4 3.7 0.2 0.6 3.5 0.1 1.0 0.1 0.3 1.1 3.4 0.8 0.4 4.9 1.5 8.6 0.2 40.1 0.5 2.4 7.4 1.2 1.5 9.0 4.5 8.3 0.2 0.3 2.7 0.6 9.5 10.9 14.9 9.1 0.7 1.3 10.1 10.3 5.3 15.0 16.5 7.7 11.8 14.6 5.2 4.2 10.6 5.6 14.0 5.7 19.0 18.6 9.3 16.6 7.5 6.1 0.1 15.1 14.3 0.1 0.4 16.5 7.0 2.1 8.9 17.4 14.2 26.2 12.4 9.4 23.7 8.5 15.8 10.2 8.3 15.2 19.1 8.5 3.8 7.0 7.4 7.8 11.4 14.1 6.8 11.6 9.1 10.6 2.4 11.4 13.7 10.2 20.5 11.3 26.2 17.0 6.2 15.3 17.1 8.3 0.1 1.5 0.3 0.2 0.1 8.6 0.7 0.8 0.4 9.0 0.2 0.4 1.6 0.3 0.2 4.5 2.7 0.6 0.4 0.4 0.4 1.5 0.3 0.4 0.4 0.1 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 5.4 0.0 1.1 0.0 0.0 0.0 0.0 1.6 33.5 0.0 0.0 1.1 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 SGO2 "FLJ25211, SGOL2, TRIPIN" ENSG00000163535 "Shugoshin 2" Q562F6 2 200510008-200583782 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Meiosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 12.6;lymphoid tissue: 25.7;testis: 27.9" "Group enriched" "Detected in many" 4 "Ciliated cells: 14.7;Club cells: 11.4;Extravillous trophoblasts: 24.6;granulocytes: 10.5;Hofbauer cells: 11.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035163, HPA040817" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA Yes Nucleoplasm "Nuclear bodies" "HPA035163: AB_10602397, HPA040817: AB_2677149" "unprognostic (3.43e-1)" "unprognostic (1.70e-1)" "unprognostic (7.06e-3)" "unprognostic (6.71e-3)" "unprognostic (1.90e-1)" "unprognostic (1.77e-1)" "unprognostic (7.55e-6)" "unprognostic (1.12e-2)" "unprognostic (1.98e-3)" "unprognostic (4.87e-2)" "unprognostic (1.37e-4)" "unprognostic (9.49e-2)" "unprognostic (8.07e-9)" "unprognostic (5.21e-2)" "unprognostic (5.43e-2)" "unprognostic (9.86e-2)" "unprognostic (2.02e-1)" 5.3 1.7 1.5 8.6 2.3 5.3 3.5 4.0 3.1 1.6 2.7 0.7 0.3 2.1 1.6 1.0 3.7 1.6 1.3 1.4 1.9 1.5 1.8 1.0 1.9 6.5 2.7 3.7 2.2 1.2 1.1 0.9 2.2 3.2 1.4 2.9 0.1 1.7 1.5 1.0 2.0 2.8 1.7 3.5 3.9 1.7 27.9 2.3 25.7 1.5 4.1 7.0 2.0 1.8 3.8 2.1 12.6 1.9 2.4 4.2 1.4 15.7 7.4 17.9 8.0 2.4 3.9 11.1 18.1 7.6 15.6 15.7 11.4 10.7 10.3 8.5 8.6 16.5 11.8 15.7 9.4 26.7 20.6 7.8 19.4 10.7 8.1 0.7 20.2 15.7 1.5 1.1 15.7 8.1 3.8 13.8 14.7 14.9 15.2 29.5 7.0 16.2 8.3 12.7 11.2 18.5 12.8 23.6 9.4 6.5 6.2 10.5 7.2 13.3 6.5 7.9 15.1 6.9 11.9 8.3 16.4 16.3 15.0 15.8 6.9 14.4 22.4 10.3 13.6 23.4 12.6 1.8 5.1 2.8 1.7 1.9 3.0 3.2 2.8 1.0 3.8 2.4 3.0 1.3 2.4 1.9 2.1 4.2 1.4 1.5 2.3 4.0 3.1 1.9 1.5 2.7 3.7 3.2 2.3 3.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 14.7 11.4 0.0 0.0 3.2 3.3 3.1 0.0 0.0 0.0 0.0 2.3 24.6 0.0 0.0 10.5 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 2.8 0.0 0.0 2.5 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 SGPP1 ENSG00000126821 "Sphingosine-1-phosphate phosphatase 1" Q9BX95 14 63684214-63728039 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 49.4" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 48.8;Kupffer cells: 53.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 23.9;U-698: 31.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053149, HPA064908" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA053149: AB_2682057, HPA064908: AB_2797270" "unprognostic (1.57e-2)" "unprognostic (1.04e-2)" "unprognostic (5.40e-3)" "unprognostic (7.82e-2)" "unprognostic (9.09e-2)" "unprognostic (4.30e-2)" "unprognostic (6.49e-3)" "unprognostic (1.35e-2)" "unprognostic (1.64e-1)" "unprognostic (7.41e-2)" "unprognostic (1.51e-1)" "unprognostic (3.27e-1)" "unprognostic (8.59e-2)" "unprognostic (1.41e-1)" "unprognostic (1.92e-1)" "unprognostic (1.03e-1)" "unprognostic (1.31e-3)" 10.5 12.1 12.1 15.7 11.6 4.3 7.6 14.3 12.9 9.2 9.6 15.1 3.9 6.2 8.4 10.3 5.7 5.9 8.9 5.5 13.1 12.6 24.7 29.4 10.3 18.5 13.0 7.0 7.4 14.1 15.5 6.4 49.4 11.1 9.0 8.7 6.7 5.7 7.0 4.4 4.8 8.9 7.9 19.6 16.5 5.8 8.2 9.8 15.4 7.8 3.7 19.1 8.6 7.3 3.2 0.5 8.8 3.3 0.5 2.0 0.5 10.5 3.4 1.7 4.8 6.2 5.8 20.3 8.7 6.1 5.4 6.1 1.5 6.0 23.9 2.6 4.4 4.5 11.3 2.7 5.1 8.8 9.3 3.1 2.2 2.0 2.4 7.6 3.9 6.9 4.2 8.3 4.7 7.5 5.5 2.6 4.5 1.2 0.7 7.8 3.9 4.5 0.0 1.1 1.7 7.3 1.1 4.7 1.9 8.6 5.3 1.0 2.8 6.1 5.7 4.5 5.4 7.4 1.4 2.9 7.6 5.2 5.3 4.3 5.7 3.5 31.1 5.5 0.0 3.2 8.8 0.3 2.8 1.0 2.3 1.0 3.2 1.0 0.7 0.5 0.8 1.5 1.1 0.4 0.5 3.3 0.3 2.0 0.5 12.1 11.6 14.3 12.9 13.1 12.6 13.0 7.0 11.1 9.8 11.9 14.4 11.2 4.9 8.7 3.5 3.2 25.5 2.7 3.4 48.8 0.0 19.1 0.0 5.2 1.6 5.4 6.7 0.0 7.7 24.8 16.2 8.0 10.5 37.6 19.7 9.5 17.9 8.0 53.2 0.8 5.8 20.6 16.9 3.6 9.4 7.3 11.2 11.6 15.9 20.9 5.1 6.5 19.4 6.7 2.7 11.8 27.6 7.5 8.1 4.8 SGSM2 "KIAA0397, RUTBC1" ENSG00000141258 "Small G protein signaling modulator 2" O43147 17 2337498-2381058 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 127.6;Rod photoreceptor cells: 55.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "basophil: 8.6" "Lineage enriched" "Detected in many" 4 "granulocytes: 8.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021641, HPA024553" Approved Approved Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA021641: AB_2188702, HPA024553: AB_1856512" "unprognostic (1.06e-1)" "unprognostic (4.76e-2)" "unprognostic (2.87e-2)" "unprognostic (1.93e-2)" "unprognostic (4.88e-2)" "prognostic favorable (3.11e-4)" "unprognostic (1.49e-1)" "unprognostic (7.84e-2)" "unprognostic (7.63e-2)" "unprognostic (1.90e-1)" "prognostic favorable (9.00e-6)" "unprognostic (2.78e-2)" "unprognostic (8.27e-2)" "unprognostic (1.80e-1)" "unprognostic (2.58e-1)" "unprognostic (1.56e-1)" "unprognostic (3.07e-2)" 11.1 15.3 51.8 13.3 45.8 17.3 15.9 14.4 43.7 11.6 12.1 12.6 14.9 10.8 13.3 38.6 16.5 12.7 15.1 12.3 43.2 24.9 12.6 6.6 14.7 15.4 13.9 34.8 11.3 14.8 25.4 30.7 11.1 18.9 20.6 7.4 13.6 23.0 18.1 13.4 23.0 13.0 14.2 13.7 16.6 14.2 10.0 17.6 9.4 15.7 6.0 10.8 16.1 10.9 0.6 0.9 8.6 0.4 1.3 2.1 0.7 10.2 15.9 14.5 20.2 8.3 10.0 21.6 8.9 10.5 12.4 12.6 15.9 19.8 4.9 9.7 12.9 4.6 14.5 8.9 10.5 4.3 7.2 18.2 8.7 24.0 16.8 7.1 5.1 13.1 10.7 7.0 12.6 7.3 18.0 12.8 13.6 5.1 7.5 7.4 21.8 11.0 6.9 7.1 7.4 7.0 24.2 7.4 4.0 15.9 21.6 7.1 16.7 11.1 8.4 6.7 9.5 21.7 6.2 14.9 10.0 11.4 14.6 11.7 6.2 0.9 4.5 8.7 6.8 8.7 8.6 0.4 2.1 1.7 0.3 1.5 0.1 0.7 1.0 0.7 0.6 2.1 1.1 0.2 1.3 0.0 0.9 1.0 0.7 51.8 45.8 14.4 43.7 43.2 24.9 13.9 34.8 18.9 17.6 6.0 24.8 3.4 7.1 6.1 54.4 12.4 10.2 6.7 15.9 12.2 127.6 11.8 0.0 5.5 14.7 11.9 6.4 0.0 3.9 7.6 9.1 14.0 19.7 6.8 6.6 28.6 13.3 16.0 6.9 25.3 7.5 8.2 5.0 2.8 9.9 11.7 5.4 3.5 11.3 3.4 55.1 19.4 5.7 3.0 6.7 6.8 11.8 7.5 8.0 11.5 SGTA SGT ENSG00000104969 "Small glutamine rich tetratricopeptide repeat containing alpha" O43765 19 2754714-2783371 "Predicted intracellular proteins" "Host-virus interaction" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056309 Approved Approved Nucleoplasm NA NA 20000 Nucleoplasm "HPA056309: AB_2683096" "unprognostic (2.31e-2)" "prognostic favorable (9.70e-4)" "unprognostic (1.13e-1)" "prognostic favorable (1.04e-4)" "unprognostic (7.99e-2)" "unprognostic (1.06e-1)" "unprognostic (2.52e-3)" "unprognostic (1.47e-1)" "unprognostic (7.23e-2)" "unprognostic (1.97e-1)" "unprognostic (7.58e-3)" "unprognostic (2.89e-2)" "prognostic favorable (2.35e-4)" "unprognostic (1.87e-2)" "unprognostic (1.23e-1)" "unprognostic (4.04e-1)" "unprognostic (3.04e-1)" 19.1 18.6 28.6 16.7 28.8 27.3 15.7 25.8 44.4 17.3 19.3 46.8 21.1 26.8 18.7 18.9 23.9 23.9 16.0 44.6 30.6 24.7 21.6 29.5 15.6 18.9 28.8 27.0 30.2 41.8 14.9 23.9 30.4 27.0 20.4 11.4 22.2 31.9 22.4 62.9 16.2 24.0 18.4 35.7 20.9 19.6 28.9 21.0 33.2 25.0 18.6 15.9 16.6 19.7 16.4 22.5 22.9 29.7 19.6 23.1 19.0 28.4 23.5 21.5 20.6 8.9 9.3 17.9 19.3 13.9 29.7 25.5 37.3 12.9 26.7 15.6 15.0 17.8 20.4 27.2 30.2 11.7 0.1 24.2 15.1 12.3 27.3 21.3 20.6 17.4 15.4 16.2 22.3 20.0 11.7 19.9 22.7 39.1 22.4 14.8 17.3 31.6 22.5 37.3 19.3 22.7 39.7 19.5 30.2 15.9 17.7 40.3 31.2 14.8 21.2 27.5 10.0 25.1 24.8 16.6 19.2 19.8 36.6 34.6 39.0 38.7 32.0 24.7 43.0 29.6 13.4 21.1 20.6 18.5 26.0 21.0 16.4 19.4 20.1 22.5 15.0 15.7 15.4 22.9 19.6 29.7 19.4 23.1 19.0 28.6 28.8 25.8 44.4 30.6 24.7 28.8 27.0 27.0 21.0 8.9 20.7 20.8 21.0 21.1 40.9 41.9 17.8 4.0 10.3 17.4 23.6 45.8 29.9 34.2 66.8 24.8 37.6 0.0 38.9 44.3 23.5 22.7 27.7 21.5 33.6 36.5 30.9 12.9 22.5 34.2 20.4 20.3 18.6 38.7 27.5 40.1 31.5 38.6 25.8 21.7 40.8 12.9 22.8 31.7 20.6 21.5 77.6 17.5 30.2 26.4 SGTB "FLJ39002, Sgt2" ENSG00000197860 "Small glutamine rich tetratricopeptide repeat containing beta" Q96EQ0 5 65665928-65723035 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.8" "Cell type enhanced" "Detected in many" 9 "Horizontal cells: 66.7;Muller glia cells: 59.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044689, HPA063674" Enhanced Uncertain Nucleoplasm NA NA Nucleoplasm "HPA044689: AB_10960838, HPA063674: AB_2685084" "unprognostic (9.94e-2)" "unprognostic (2.28e-1)" "unprognostic (9.58e-2)" "unprognostic (1.23e-2)" "unprognostic (2.02e-1)" "unprognostic (1.49e-1)" "unprognostic (5.92e-5)" "unprognostic (4.27e-2)" "unprognostic (2.86e-1)" "unprognostic (2.41e-1)" "unprognostic (1.64e-2)" "unprognostic (5.35e-2)" "unprognostic (2.54e-3)" "unprognostic (6.82e-2)" "unprognostic (1.87e-1)" "unprognostic (6.34e-2)" "unprognostic (3.05e-3)" 5.9 4.0 14.5 9.4 17.1 11.1 4.0 14.0 40.8 4.6 3.2 4.2 0.2 2.4 6.5 3.2 4.3 2.9 4.4 5.6 13.4 13.4 3.8 3.7 5.3 9.3 14.8 11.9 4.4 2.8 3.7 3.9 5.1 16.9 6.8 3.8 3.0 2.4 3.3 3.5 3.1 2.6 7.2 12.2 6.0 2.7 2.8 4.9 3.1 5.8 0.9 6.4 5.1 3.0 1.5 2.4 8.5 6.6 1.0 13.4 3.1 4.7 3.0 5.8 5.9 8.8 11.6 5.7 19.9 6.2 6.7 9.2 4.1 2.0 6.4 10.8 15.4 11.8 4.8 8.3 7.6 10.9 4.8 8.1 2.8 8.4 8.2 22.8 2.1 4.7 8.6 6.7 14.5 19.2 4.7 6.4 5.1 4.8 4.4 10.4 1.7 4.5 3.3 3.9 0.4 1.6 5.4 10.2 6.6 3.0 1.7 9.1 4.9 8.1 1.4 9.3 6.1 2.0 3.2 9.6 8.8 9.5 9.4 4.4 3.5 5.3 8.7 4.5 6.1 3.4 8.5 5.7 1.3 2.9 6.6 2.7 1.5 6.8 3.8 2.4 1.4 7.4 4.2 6.1 1.0 5.5 0.6 13.4 3.1 14.5 17.1 14.0 29.9 13.4 13.4 14.8 11.9 16.9 4.9 14.9 5.6 1.4 2.4 5.7 6.0 3.2 5.1 2.7 6.8 1.8 0.0 1.3 0.0 2.7 1.9 6.8 0.0 0.0 1.7 3.5 7.5 3.6 20.7 3.8 20.5 66.7 1.7 1.8 20.2 1.4 3.7 16.4 11.8 19.0 1.5 59.7 3.6 1.4 3.9 1.8 4.2 12.9 10.8 4.1 4.8 4.0 1.0 10.2 0.6 1.3 SH2B1 "FLJ30542, SH2B" ENSG00000178188 "SH2B adaptor protein 1" Q9NRF2 16 28846600-28874212 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060663, HPA076175" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA060663: , HPA076175: AB_2686782" "unprognostic (3.60e-2)" "unprognostic (1.94e-2)" "unprognostic (8.94e-2)" "unprognostic (2.27e-1)" "unprognostic (3.27e-1)" "unprognostic (3.27e-3)" "unprognostic (6.10e-2)" "prognostic favorable (9.40e-4)" "unprognostic (3.94e-2)" "unprognostic (1.18e-1)" "prognostic favorable (4.38e-4)" "unprognostic (1.39e-2)" "prognostic favorable (2.81e-6)" "unprognostic (1.53e-1)" "unprognostic (1.05e-1)" "unprognostic (1.46e-1)" "prognostic favorable (1.60e-4)" 18.1 29.5 31.5 22.2 32.0 24.6 19.7 45.0 42.3 23.3 24.1 27.7 32.7 33.6 26.0 21.6 19.4 25.7 22.0 23.6 26.0 22.9 27.0 18.2 18.9 26.0 30.1 36.2 39.7 27.1 50.6 33.1 15.4 25.5 25.4 21.6 29.1 35.3 32.6 37.7 29.5 32.0 20.3 22.2 28.9 21.7 19.9 28.0 17.0 33.1 18.8 18.2 20.9 21.2 4.7 4.7 7.1 3.4 1.7 5.3 2.0 12.9 19.1 14.7 18.9 15.5 13.2 12.3 13.6 7.7 10.8 11.7 12.9 22.1 12.1 19.2 10.9 9.3 20.8 9.6 15.1 6.1 15.6 12.4 10.7 44.1 19.6 11.8 10.7 10.3 18.4 12.4 15.0 6.1 18.4 12.3 12.5 17.0 17.8 14.1 17.8 16.0 16.0 19.0 6.8 7.8 27.2 8.8 20.1 12.4 9.9 16.9 22.8 6.5 19.2 9.9 9.2 15.1 11.6 17.3 12.4 10.5 10.8 10.2 33.9 16.7 13.3 19.3 18.9 12.4 7.1 3.4 2.0 5.3 2.8 5.1 3.9 4.3 3.7 3.0 4.7 3.4 3.1 6.0 1.7 2.7 4.7 4.5 2.0 31.5 32.0 45.0 42.3 26.0 22.9 30.1 36.2 25.5 28.0 6.0 10.7 9.8 15.5 9.6 24.3 15.8 15.3 9.4 14.8 21.0 31.4 13.5 13.3 8.1 1.8 11.7 24.4 0.0 11.3 6.7 11.9 10.3 5.8 4.9 10.7 27.0 26.6 11.1 7.6 3.4 20.4 10.0 3.3 10.8 22.2 16.9 10.5 22.1 22.3 7.0 26.8 25.8 12.2 9.3 11.3 9.7 11.4 10.2 26.5 9.5 SH2B3 "IDDM20, LNK" ENSG00000111252 "SH2B adaptor protein 3" Q9UQQ2 12 111405948-111451623 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ito cells: 49.7;Kupffer cells: 110.0;Macrophages: 49.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 32.3;hTEC/SVTERT24-B: 37.0;U-87 MG: 56.2;WM-115: 42.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005483 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA005483: AB_1079260" "unprognostic (2.77e-1)" "unprognostic (1.74e-1)" "unprognostic (1.20e-1)" "unprognostic (1.12e-1)" "unprognostic (1.18e-1)" "unprognostic (9.09e-2)" "unprognostic (1.23e-1)" "unprognostic (2.42e-1)" "unprognostic (1.18e-1)" "unprognostic (4.65e-2)" "unprognostic (8.17e-3)" "unprognostic (9.08e-2)" "prognostic unfavorable (6.20e-4)" "unprognostic (2.86e-1)" "unprognostic (3.89e-3)" "unprognostic (1.11e-1)" "unprognostic (2.24e-2)" 17.6 9.0 7.9 13.7 7.9 34.4 19.8 3.8 9.3 8.9 7.5 7.2 3.1 5.3 8.0 7.1 5.6 7.5 12.7 15.3 5.8 5.5 9.2 12.5 17.6 27.8 6.6 4.0 8.2 11.0 4.7 7.6 16.1 5.2 8.4 9.3 8.7 5.0 4.2 10.2 3.6 10.3 9.1 7.8 31.7 5.5 13.3 6.8 9.5 10.2 3.2 11.8 10.0 5.8 1.8 6.1 3.8 10.3 2.3 1.7 1.9 2.3 1.4 1.8 1.9 6.4 9.6 1.2 7.5 20.6 5.7 6.2 2.1 1.3 3.9 5.4 11.4 19.5 0.4 1.4 4.3 9.4 3.3 0.7 13.4 0.6 1.5 6.3 5.8 32.3 5.7 1.0 37.0 3.3 12.8 30.9 3.3 9.6 1.6 20.9 0.8 2.4 11.7 2.8 0.6 5.4 2.4 4.2 2.5 2.7 0.9 1.2 1.3 1.3 0.1 10.7 1.7 0.9 8.4 23.9 5.3 3.0 4.5 12.1 3.6 3.8 4.5 56.2 4.2 42.8 1.1 4.3 1.5 1.6 10.3 1.4 1.8 1.4 1.7 5.9 0.7 1.0 1.3 3.8 2.3 7.6 6.1 0.5 1.9 7.9 7.9 3.8 9.3 5.8 5.5 6.6 4.0 5.2 6.8 3.0 31.9 11.5 1.3 6.1 4.1 14.9 5.1 0.0 2.3 1.8 2.0 0.4 1.7 3.1 9.6 32.1 3.8 0.0 7.5 1.1 9.8 2.4 37.0 9.4 35.5 3.2 3.4 49.7 110.0 4.0 2.6 49.7 15.1 34.3 2.6 0.9 6.9 7.0 3.9 1.4 3.1 0.0 17.6 9.4 4.0 3.6 0.8 11.8 1.7 0.8 SH2D3A NSP1 ENSG00000125731 "SH2 domain containing 3A" Q9BRG2 19 6752160-6767588 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 105.7;Urothelial cells: 79.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 18.8;HaCaT: 16.2;HBEC3-KT: 31.1;SK-BR-3: 15.7" "Not detected" "Not detected" "HPA035722, HPA064382" Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge" NA NA Microtubules "Nucleoplasm, Cytokinetic bridge" "HPA035722: AB_10670024, HPA064382: AB_2685251" "unprognostic (3.32e-2)" "unprognostic (5.48e-2)" "unprognostic (1.82e-2)" "unprognostic (1.39e-1)" "unprognostic (1.84e-1)" "unprognostic (1.09e-1)" "unprognostic (3.96e-1)" "unprognostic (2.60e-3)" "unprognostic (3.63e-1)" "unprognostic (8.41e-2)" "unprognostic (6.48e-3)" "prognostic unfavorable (6.21e-4)" "prognostic favorable (1.42e-4)" "unprognostic (7.31e-2)" "unprognostic (1.74e-1)" "unprognostic (1.32e-3)" "unprognostic (1.81e-3)" 0.5 0.2 0.4 9.2 0.9 1.9 5.3 0.6 0.5 4.7 19.7 0.5 8.7 10.9 3.8 6.7 20.0 3.0 15.8 0.4 0.4 0.0 9.6 1.7 13.4 5.4 0.6 0.4 1.1 18.8 4.9 3.4 14.3 0.9 11.0 4.3 1.6 24.0 13.3 0.8 15.3 18.0 2.2 1.0 3.8 11.0 2.5 0.4 5.0 10.9 11.0 17.2 9.0 9.4 5.6 0.4 0.0 0.1 1.9 9.2 1.0 18.8 2.7 0.0 0.1 0.0 0.0 9.3 0.1 0.0 0.0 0.0 6.8 14.6 2.9 8.6 0.0 0.0 16.2 1.1 31.1 0.0 1.4 2.7 0.1 2.3 1.0 0.0 0.2 4.0 0.0 13.0 0.0 3.2 0.4 0.0 6.6 3.1 7.2 0.0 6.6 1.4 0.0 0.7 10.2 5.3 0.5 0.0 11.5 5.6 12.0 0.0 0.0 1.1 15.7 0.0 0.4 10.4 0.1 0.3 0.3 1.1 0.2 0.1 6.2 6.7 3.6 0.1 2.0 0.1 0.0 0.0 0.0 3.0 0.1 5.2 3.9 6.8 6.2 0.1 5.6 9.2 4.7 0.0 1.9 0.1 0.4 3.3 1.0 0.4 0.9 0.6 0.5 0.4 0.0 0.6 0.4 0.9 0.4 17.9 13.9 36.4 105.7 27.2 3.5 1.7 30.6 17.4 30.7 38.4 9.8 19.1 1.7 53.7 0.9 2.6 48.5 23.3 31.9 46.8 3.3 55.3 5.7 2.6 3.1 0.0 11.6 1.8 0.0 0.0 0.6 4.3 3.3 5.4 27.1 0.8 56.0 66.2 0.0 9.1 4.5 0.0 2.1 7.5 8.9 34.9 9.0 13.8 21.5 79.6 SH2D7 LOC646892 ENSG00000183476 "SH2 domain containing 7" A6NKC9 15 78077808-78104909 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 7 "testis: 37.1" "Group enriched" "Detected in some" 4 "Early spermatids: 17.9;Late spermatids: 23.2" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.1;AN3-CA: 2.8;BEWO: 2.6;HEK 293: 2.0;SCLC-21H: 2.4;SH-SY5Y: 4.4;SuSa: 2.3" "Low region specificity" "Detected in all" "HPA051320, HPA058382, HPA076728" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA051320: AB_2681439, HPA058382: , HPA076728: " "unprognostic (1.22e-2)" "unprognostic (4.31e-2)" "unprognostic (2.24e-1)" "unprognostic (1.24e-2)" "unprognostic (2.53e-1)" "unprognostic (1.42e-1)" "unprognostic (2.99e-2)" "unprognostic (7.26e-2)" "unprognostic (1.38e-1)" "unprognostic (8.63e-3)" "unprognostic (4.73e-2)" "unprognostic (2.92e-1)" "unprognostic (2.32e-3)" "unprognostic (5.15e-3)" "unprognostic (1.01e-1)" "unprognostic (1.26e-1)" "unprognostic (1.04e-1)" 0.1 0.2 0.6 0.5 0.4 0.0 0.1 0.5 0.5 0.1 4.3 0.1 0.1 5.0 0.1 0.1 0.1 0.0 1.0 0.2 0.4 0.4 0.1 0.1 0.6 0.1 0.3 0.1 0.1 0.3 0.0 0.2 0.3 0.1 0.2 0.5 0.2 0.2 0.1 0.1 0.1 4.2 0.1 0.3 0.1 0.3 37.1 0.1 0.2 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.1 2.1 2.8 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 1.1 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.2 0.0 0.0 1.5 0.1 0.0 1.1 1.4 0.0 0.0 0.4 2.4 4.4 0.4 0.6 0.2 2.3 0.1 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.4 0.5 0.5 0.4 0.4 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 17.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 5.1 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 2.5 0.0 0.0 0.0 SH3BGRL2 ENSG00000198478 "SH3 domain binding glutamate rich protein like 2" Q9UJC5 6 79631283-79703659 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 104.4" "Cell type enhanced" "Detected in many" 4 "Mucus-secreting cells: 75.8;Paneth cells: 69.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 7.4;neutrophil: 2.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 7.4" "Cell line enhanced" "Detected in many" "CACO-2: 33.0;HEL: 16.8;OE19: 40.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047486 Approved Supported Nucleoplasm NA NA 4700000 Nucleoplasm "HPA047486: AB_2680065" "unprognostic (3.48e-2)" "unprognostic (1.95e-1)" "unprognostic (1.75e-2)" "unprognostic (2.28e-2)" "unprognostic (4.21e-1)" "unprognostic (7.77e-2)" "unprognostic (1.07e-1)" "unprognostic (1.60e-2)" "unprognostic (6.92e-2)" "unprognostic (6.53e-3)" "unprognostic (2.78e-1)" "unprognostic (7.94e-2)" "prognostic favorable (2.24e-4)" "unprognostic (1.60e-1)" "unprognostic (1.51e-1)" "unprognostic (2.11e-2)" "unprognostic (1.33e-1)" 21.0 3.9 11.6 6.5 10.7 1.1 29.3 9.7 18.3 14.6 24.7 2.6 7.9 17.3 9.1 13.0 29.8 9.3 14.2 7.4 12.3 13.8 8.2 27.6 8.0 4.1 14.6 7.8 3.5 11.6 17.9 12.6 14.4 22.4 13.8 24.1 9.6 104.4 6.4 8.3 7.1 17.3 8.2 13.9 3.8 34.1 3.7 2.4 0.4 38.3 11.1 15.0 8.7 12.6 0.0 0.2 7.4 0.3 0.0 1.2 10.8 3.4 0.6 3.2 0.6 2.8 2.4 7.6 0.2 2.3 0.8 1.7 33.0 6.7 0.0 4.8 0.2 0.6 1.6 2.9 3.7 2.8 0.0 4.2 16.8 0.7 6.3 1.2 0.6 0.4 1.3 3.0 2.4 1.4 1.1 9.8 0.0 6.6 0.0 0.2 0.5 0.0 0.0 2.7 40.3 1.1 0.0 0.9 0.0 0.8 11.1 8.5 9.4 0.2 1.0 0.2 4.5 0.1 1.4 5.5 2.2 1.4 0.0 1.9 5.0 2.3 0.0 0.3 0.0 0.7 7.4 0.3 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 1.2 2.7 0.0 0.0 0.2 0.0 10.8 11.6 10.7 9.7 18.3 12.3 13.8 14.6 7.8 22.4 2.4 6.0 19.0 0.9 3.7 1.9 12.6 5.2 66.2 25.4 27.3 21.0 7.9 33.0 0.0 15.1 10.8 29.8 58.0 0.0 11.3 1.9 3.6 27.2 0.0 61.0 3.7 12.7 12.1 35.0 4.1 14.7 0.6 1.1 15.1 1.8 75.8 8.3 14.8 69.1 4.2 8.4 11.7 0.0 5.3 1.7 0.9 0.6 44.1 0.0 59.5 25.7 SH3BP2 "CRBM, RES4-23" ENSG00000087266 "SH3 domain binding protein 2" P78314 4 2793023-2841098 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 83.9;Suprabasal keratinocytes: 72.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036790 Approved Approved "Nucleoplasm,Actin filaments" NA NA "Nucleoplasm, Actin filaments" "HPA036790: AB_10671712" "unprognostic (7.86e-2)" "unprognostic (3.45e-1)" "unprognostic (9.83e-2)" "prognostic unfavorable (5.42e-6)" "prognostic unfavorable (9.52e-4)" "prognostic favorable (1.57e-5)" "unprognostic (6.58e-2)" "unprognostic (3.16e-2)" "unprognostic (3.17e-2)" "unprognostic (6.41e-3)" "unprognostic (3.35e-2)" "unprognostic (3.30e-2)" "unprognostic (3.24e-3)" "unprognostic (1.78e-2)" "unprognostic (5.32e-1)" "unprognostic (1.78e-1)" "prognostic favorable (2.67e-4)" 17.5 7.0 9.7 20.4 14.5 30.2 13.1 6.1 10.1 9.0 11.6 9.8 7.5 8.9 7.9 18.7 10.8 8.7 9.5 9.9 9.3 8.8 26.3 18.3 20.2 18.5 12.0 3.5 8.8 10.1 3.6 7.6 20.8 15.4 8.4 7.4 11.6 9.3 7.8 11.0 31.2 14.2 8.9 14.5 46.8 10.8 5.0 12.2 5.2 8.0 6.9 17.4 11.6 10.9 4.4 8.6 16.7 21.9 3.8 7.0 5.4 5.3 3.2 3.7 5.2 3.1 7.9 3.5 8.5 7.0 6.6 5.9 2.3 16.7 8.4 9.7 7.1 5.5 2.5 0.2 5.6 4.0 4.3 3.4 19.7 6.6 2.7 10.3 8.1 13.9 14.9 5.3 3.7 3.3 7.2 14.4 7.5 1.1 19.5 7.8 4.3 1.2 9.7 6.0 11.5 6.3 0.4 3.4 3.6 11.2 8.4 11.3 8.4 6.2 5.9 4.2 3.5 9.0 13.5 18.3 6.4 4.9 2.3 6.3 8.2 3.8 1.7 7.5 21.9 6.8 1.8 10.5 6.7 7.0 18.6 4.4 1.4 1.9 4.6 8.6 4.4 1.0 2.7 16.7 3.8 21.9 3.5 3.5 5.4 9.7 14.5 6.1 10.1 9.3 8.8 12.0 3.5 15.4 12.2 3.0 4.3 12.4 8.1 33.9 0.8 6.1 7.6 2.7 9.1 38.4 0.0 0.9 3.3 6.3 7.4 27.2 19.0 0.0 19.1 1.2 11.3 12.4 9.2 40.4 43.6 0.0 9.8 39.9 83.9 5.8 12.7 47.9 18.6 7.2 13.3 30.8 21.0 23.4 9.6 30.1 5.1 38.8 17.5 1.6 3.4 72.9 3.5 17.3 12.1 17.0 SH3BP5 Sab ENSG00000131370 "SH3 domain binding protein 5" O60239 3 15254853-15341368 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 199.4;Extravillous trophoblasts: 335.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 94.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036445, HPA057988" Uncertain Enhanced "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA036445: AB_10670106, HPA057988: AB_2683572" "unprognostic (1.28e-3)" "unprognostic (2.99e-2)" "unprognostic (9.50e-2)" "unprognostic (6.97e-2)" "unprognostic (4.68e-2)" "unprognostic (1.56e-2)" "unprognostic (7.74e-2)" "unprognostic (7.81e-3)" "unprognostic (4.80e-2)" "unprognostic (4.09e-2)" "unprognostic (2.76e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (8.17e-4)" "unprognostic (4.76e-2)" "unprognostic (3.06e-2)" "unprognostic (4.34e-2)" "unprognostic (2.03e-1)" 38.6 72.5 12.7 20.0 13.4 29.9 35.7 34.8 22.3 30.5 12.7 20.7 42.0 7.5 33.9 20.4 11.9 32.2 29.0 9.6 17.2 11.2 19.6 9.9 38.8 25.1 13.0 18.9 49.6 7.1 30.0 14.7 19.5 15.1 13.5 4.9 12.4 22.4 45.1 61.7 10.1 10.3 21.0 19.0 14.8 7.2 17.0 10.8 9.3 20.8 7.7 18.9 25.3 44.3 13.3 4.8 8.0 3.9 13.0 28.9 9.5 7.4 3.7 1.7 3.5 16.1 13.6 94.1 4.1 2.7 2.2 2.8 2.4 3.4 6.2 1.7 10.8 4.7 0.9 0.8 3.5 1.9 4.8 3.4 4.2 16.9 0.4 6.1 1.1 2.1 10.9 2.6 10.2 2.2 10.6 31.4 8.1 4.6 2.1 3.0 26.6 14.8 6.9 3.7 0.9 5.6 0.2 8.4 28.1 2.7 12.4 4.2 2.2 5.6 5.1 5.9 7.2 4.6 3.1 24.1 6.0 8.4 5.7 3.1 0.8 1.7 4.3 11.5 4.1 8.1 3.5 3.9 4.5 28.9 1.3 9.1 10.9 13.7 19.9 4.8 13.3 7.5 9.8 8.0 13.0 2.1 2.2 5.7 9.5 12.7 13.4 34.8 19.2 17.2 11.2 13.0 18.9 15.1 10.8 0.0 18.9 87.1 5.5 15.0 40.9 0.5 7.6 6.7 17.0 64.6 13.7 9.5 3.3 2.9 199.4 71.8 1.4 0.0 7.7 335.6 62.1 6.6 2.3 5.1 28.9 62.0 2.4 138.1 68.8 76.3 45.5 65.1 32.1 17.2 1.8 4.7 3.6 0.0 111.4 22.1 45.9 6.5 7.7 2.1 3.0 10.7 144.9 40.5 0.9 8.1 SH3BP5L KIAA1720 ENSG00000175137 "SH3 binding domain protein 5 like" Q7L8J4 1 248810446-248826633 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038067, HPA038068" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus, Vesicles" "HPA038067: AB_2675814, HPA038068: AB_10670651" "unprognostic (2.48e-1)" "unprognostic (1.62e-1)" "unprognostic (5.53e-3)" "unprognostic (4.41e-1)" "unprognostic (2.78e-1)" "unprognostic (2.27e-3)" "unprognostic (1.99e-3)" "unprognostic (5.84e-2)" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "unprognostic (2.87e-3)" "unprognostic (1.50e-2)" "unprognostic (1.13e-1)" "unprognostic (2.05e-2)" "unprognostic (1.55e-1)" "unprognostic (4.99e-2)" "unprognostic (4.66e-2)" 4.1 5.0 5.3 4.0 4.8 3.0 3.3 10.3 8.7 4.1 4.9 6.2 4.9 2.5 7.2 4.7 3.3 6.5 5.5 4.0 4.1 4.5 3.9 4.2 4.2 3.9 4.2 5.9 2.4 5.0 3.9 2.9 5.1 5.7 13.6 8.0 5.6 4.3 5.0 5.4 4.3 3.6 3.6 4.0 4.1 3.7 1.1 1.2 6.2 1.8 0.4 1.5 1.0 10.0 6.3 8.4 9.6 12.0 8.1 11.0 22.7 7.8 13.3 10.1 6.1 8.9 5.0 13.8 19.0 3.3 10.8 7.9 9.7 6.4 11.5 2.8 8.2 6.8 4.9 7.3 8.9 9.9 6.6 10.5 14.7 5.6 9.4 8.8 9.5 14.0 5.3 8.9 3.3 8.4 6.1 14.7 11.2 16.2 9.6 5.9 10.2 9.1 4.5 9.7 13.4 7.0 8.7 7.5 6.6 9.4 18.4 12.1 16.4 7.0 6.6 34.5 13.2 14.7 4.5 12.2 10.3 6.9 5.5 1.8 5.4 1.1 1.0 1.1 0.5 1.5 0.9 1.2 1.1 0.5 0.4 6.2 0.4 0.4 0.8 0.2 1.0 0.0 1.3 3.0 1.7 4.0 8.1 8.9 2.5 0.0 0.0 10.4 0.0 7.5 1.7 7.2 1.1 3.1 12.6 0.0 5.1 4.0 5.1 3.0 0.0 7.4 5.2 7.9 7.5 4.3 5.7 0.4 4.0 3.7 3.3 5.4 7.2 3.7 8.3 8.7 5.3 5.8 3.3 0.0 3.3 8.0 6.0 4.1 9.5 5.2 5.2 2.7 SH3D19 "DKFZp434D0215, EBP, Eve-1, EVE1, Kryn, SH3P19" ENSG00000109686 "SH3 domain containing 19" Q5HYK7 4 151102751-151325632 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 2.3" "Lineage enriched" "Detected in single" 10 "dendritic cells: 2.3" "Cell line enhanced" "Detected in many" "ASC diff: 55.5;ASC TERT1: 47.4;HSkMC: 37.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016424, HPA058562" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA016424: AB_1856814, HPA058562: AB_2683758" "unprognostic (1.09e-1)" "unprognostic (6.14e-2)" "unprognostic (1.24e-3)" "unprognostic (1.37e-1)" "unprognostic (1.67e-1)" "unprognostic (2.84e-2)" "unprognostic (1.30e-2)" "unprognostic (5.09e-1)" "unprognostic (7.37e-2)" "unprognostic (1.48e-1)" "unprognostic (6.40e-3)" "unprognostic (1.86e-1)" "prognostic favorable (1.38e-5)" "unprognostic (7.90e-2)" "unprognostic (1.07e-1)" "unprognostic (1.62e-1)" "unprognostic (1.64e-2)" 56.0 9.5 6.8 11.2 14.2 0.0 24.2 4.4 9.2 19.2 28.5 20.1 10.7 20.3 22.8 13.9 23.6 17.3 29.6 31.7 7.8 5.1 12.8 23.1 26.1 3.7 13.6 5.5 27.2 7.8 15.4 6.0 16.8 12.7 18.8 23.0 12.4 14.1 19.8 12.8 17.4 35.9 26.6 7.7 3.1 14.6 12.3 15.1 0.3 15.6 12.8 6.7 27.7 23.8 0.0 2.3 0.0 0.0 0.0 0.2 0.0 7.1 5.3 3.4 2.6 55.5 47.4 7.4 8.9 9.5 3.9 4.1 6.8 8.9 0.0 3.6 8.3 6.5 5.3 3.6 10.2 3.9 0.0 2.8 0.0 6.5 7.3 13.4 0.0 0.0 37.6 7.9 5.9 9.2 6.8 23.0 0.0 0.0 0.0 10.4 2.9 0.0 0.1 6.9 11.1 7.7 0.0 0.2 0.1 4.9 5.0 0.2 4.7 6.3 6.5 5.2 7.4 2.1 0.0 16.6 12.5 4.5 5.5 3.5 0.0 0.0 0.0 6.5 0.0 15.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 6.8 14.2 4.4 9.2 7.8 5.1 13.6 5.5 12.7 15.1 20.8 30.4 2.9 11.9 25.3 5.6 85.4 28.1 40.2 40.9 15.7 13.7 21.5 5.0 10.4 3.7 29.2 75.0 0.0 13.3 16.3 37.6 28.4 19.8 40.8 6.5 6.4 17.9 27.6 5.7 4.7 57.5 5.6 25.3 0.0 33.2 19.1 18.2 54.7 45.3 23.1 11.4 12.9 20.6 2.1 6.6 33.6 22.8 5.0 42.0 28.8 SH3D21 "C1orf113, FLJ22938" ENSG00000214193 "SH3 domain containing 21" A4FU49 1 36306387-36324886 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 26.2" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 13.1;Late spermatids: 38.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.0;NK-cell: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 13.5;hTERT-RPE1: 22.0;SuSa: 11.2" "HPA042212, HPA042456, HPA066168" Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA042212: AB_10961180, HPA042456: AB_10959746, HPA066168: AB_2685627" "prognostic favorable (2.60e-4)" "unprognostic (8.35e-3)" "unprognostic (3.86e-3)" "unprognostic (9.01e-2)" "unprognostic (2.07e-3)" "unprognostic (7.32e-3)" "unprognostic (2.04e-4)" "unprognostic (7.47e-2)" "unprognostic (3.47e-2)" "unprognostic (1.01e-1)" "unprognostic (2.43e-2)" "unprognostic (7.38e-3)" "prognostic unfavorable (1.76e-6)" "unprognostic (8.88e-2)" "unprognostic (2.25e-1)" "unprognostic (7.99e-2)" "unprognostic (8.59e-2)" 1.6 1.1 11.6 3.4 9.5 1.9 10.1 12.2 11.3 4.4 5.3 1.1 1.4 16.6 2.8 2.7 7.1 1.9 3.0 2.2 5.2 2.2 8.6 1.4 4.5 2.8 1.9 7.0 4.0 1.0 1.3 2.2 19.4 7.4 7.0 6.0 12.4 12.7 2.6 1.0 16.2 24.3 2.0 2.4 1.6 2.3 6.6 1.9 0.0 26.2 4.1 4.5 3.7 6.7 0.1 0.3 2.0 0.5 2.7 0.6 0.0 8.3 0.2 1.6 1.9 0.5 1.0 9.1 4.0 0.8 3.0 1.3 4.7 3.4 1.5 4.4 1.7 0.3 13.5 1.4 3.0 2.5 0.4 0.6 1.3 2.9 3.7 1.3 0.7 2.0 0.5 2.5 2.0 1.5 22.0 1.1 4.1 0.2 2.6 1.4 4.9 1.4 0.7 1.0 2.2 1.6 2.0 0.1 1.0 3.4 1.0 3.4 1.7 0.9 10.1 3.1 11.2 0.3 0.3 2.3 1.2 0.7 4.0 0.4 3.0 0.9 1.7 3.4 0.7 0.3 0.0 0.5 0.0 0.4 0.0 0.0 0.1 0.6 0.0 0.3 0.0 0.0 0.0 2.0 2.7 0.0 0.0 0.0 0.0 11.6 9.5 12.2 11.3 5.2 2.2 1.9 7.0 7.4 1.9 0.0 1.3 0.8 1.5 2.7 5.2 0.9 0.0 0.0 0.0 5.2 0.0 2.5 1.7 0.5 13.1 0.9 11.8 0.0 0.3 2.1 1.4 2.0 1.1 0.0 7.0 11.1 0.0 0.6 3.2 38.8 1.1 4.7 3.3 3.6 2.0 1.0 2.7 0.8 2.5 0.8 1.1 0.0 1.7 2.1 1.5 2.8 4.8 0.0 1.6 1.1 SH3GLB2 KIAA1848 ENSG00000148341 "SH3 domain containing GRB2 like, endophilin B2" Q9NR46 9 129007036-129028303 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Cytotrophoblasts: 90.7;Syncytiotrophoblasts: 125.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 63.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021438, HPA024734" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA021438: AB_1856820, HPA024734: AB_1856821" "unprognostic (2.59e-1)" "prognostic favorable (1.56e-6)" "unprognostic (1.88e-1)" "unprognostic (7.51e-2)" "unprognostic (2.94e-1)" "unprognostic (1.09e-1)" "unprognostic (1.04e-1)" "unprognostic (8.54e-2)" "unprognostic (5.77e-2)" "unprognostic (4.70e-2)" "unprognostic (1.81e-2)" "unprognostic (6.25e-2)" "prognostic favorable (2.32e-4)" "unprognostic (1.42e-3)" "unprognostic (1.23e-1)" "unprognostic (1.46e-3)" "prognostic favorable (4.28e-4)" 9.3 18.8 36.9 11.7 27.0 30.4 16.6 31.3 47.2 15.8 16.4 33.0 43.7 25.7 14.4 14.2 29.5 21.0 13.6 14.8 34.2 24.4 15.8 6.6 14.9 13.6 28.8 37.9 20.0 35.9 29.1 26.8 45.2 26.3 21.3 10.1 13.4 30.0 33.8 19.4 46.6 20.4 16.6 30.9 14.9 25.8 7.8 24.1 16.9 16.4 15.0 15.8 27.8 18.1 7.7 7.6 6.6 4.6 5.0 4.9 2.8 13.4 11.4 5.6 7.6 3.4 4.3 16.8 4.7 10.7 9.4 8.6 7.1 23.3 14.2 3.7 8.3 7.2 33.2 1.7 10.2 2.7 9.1 7.7 3.6 18.2 6.2 7.1 3.2 8.7 3.1 11.7 4.8 4.3 10.3 7.8 18.8 4.8 19.0 4.7 33.1 18.2 8.5 5.0 22.8 8.0 37.1 10.6 63.5 10.4 16.3 17.7 14.3 6.8 17.8 7.3 4.9 25.5 4.8 7.1 4.4 7.5 11.1 10.3 18.5 9.0 9.0 10.1 4.0 2.3 4.4 3.3 6.6 4.1 1.6 4.9 7.7 4.7 3.8 2.7 3.8 3.4 3.0 2.7 5.0 4.6 7.6 3.9 2.8 36.9 27.0 31.3 47.2 34.2 24.4 28.8 37.9 26.3 24.1 14.9 30.8 10.4 24.5 18.4 20.3 9.0 12.7 5.3 19.4 45.4 7.9 90.7 13.3 12.2 8.2 11.3 41.2 23.3 22.8 15.3 16.4 24.4 5.8 7.8 17.9 44.5 24.3 11.6 11.6 14.9 17.5 9.8 13.5 4.6 31.4 26.6 19.7 49.9 19.1 6.2 15.6 12.9 16.5 6.1 6.6 46.9 125.1 10.4 29.9 48.9 SH3PXD2B "FLJ20831, KIAA1295" ENSG00000174705 "SH3 and PX domains 2B" A1X283 5 172325000-172454523 "Disease related genes, Predicted intracellular proteins" Differentiation "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 28.3;Leydig cells: 36.8;Peritubular cells: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 15 "classical monocyte: 1.3;myeloid DC: 1.7" "Group enriched" "Detected in many" 15 "dendritic cells: 1.7;monocytes: 1.3" "Cell line enhanced" "Detected in many" "ASC diff: 37.5;ASC TERT1: 31.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036471 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA036471: AB_10670799" "unprognostic (3.32e-1)" "unprognostic (1.95e-2)" "unprognostic (4.84e-1)" "unprognostic (2.96e-1)" "unprognostic (1.84e-1)" "unprognostic (2.38e-1)" "prognostic unfavorable (7.51e-5)" "unprognostic (5.38e-3)" "unprognostic (3.11e-1)" "unprognostic (1.53e-2)" "unprognostic (1.04e-2)" "unprognostic (1.76e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (1.87e-2)" "unprognostic (1.57e-1)" "unprognostic (5.25e-2)" "prognostic unfavorable (8.45e-4)" 26.9 17.8 6.9 12.4 10.1 0.7 28.0 13.3 8.7 28.0 10.0 16.6 13.4 3.1 26.4 19.6 12.3 14.6 21.4 5.8 7.6 4.1 2.8 2.6 13.2 11.4 16.0 4.5 18.1 7.9 16.7 4.3 10.2 10.9 10.6 6.9 15.9 14.8 16.8 5.1 15.0 8.2 25.8 10.0 7.7 11.1 10.9 9.6 1.8 6.5 4.3 4.2 17.0 14.9 0.0 1.7 0.0 1.3 0.0 0.0 0.0 0.3 5.4 20.1 13.2 37.5 31.8 17.1 3.2 11.2 2.1 4.2 1.5 0.5 0.0 4.4 12.5 6.4 3.0 7.1 3.7 2.0 0.3 1.3 0.0 5.1 1.0 12.1 0.0 14.1 20.3 5.8 8.6 2.5 2.0 14.4 1.4 0.0 0.1 9.1 1.1 0.0 1.7 7.7 3.0 1.2 6.3 3.2 1.8 2.2 0.5 1.7 11.3 2.2 1.4 4.1 6.6 0.5 0.8 15.4 13.0 5.2 7.9 1.4 0.0 0.0 0.0 8.8 0.8 10.6 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 10.1 13.3 8.4 7.6 4.1 16.0 4.5 10.9 9.6 0.0 0.6 0.0 2.8 9.0 0.6 1.6 7.6 0.0 2.3 0.0 0.0 3.9 0.0 8.4 0.8 5.8 0.3 0.0 13.8 28.3 12.8 5.6 0.0 2.0 2.7 1.6 2.4 2.5 19.6 1.3 36.8 8.6 13.5 1.0 1.8 4.5 18.6 0.0 25.5 1.4 0.2 12.9 10.5 0.7 4.1 7.0 1.8 0.0 2.8 5.0 SH3RF2 "FLJ23654, Hepp1, POSHER, PPP1R39, RNF158" ENSG00000156463 "SH3 domain containing ring finger 2" Q8TEC5 5 145936579-146081791 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Protein phosphatase inhibitor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 40.8" "Cell type enriched" "Detected in many" 5 "Late spermatids: 7204.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "basal ganglia: 11.5;cerebral cortex: 2.9" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 4 "dendritic cells: 1.4;T-cells: 1.6" "Cell line enhanced" "Detected in many" "CACO-2: 34.6;GAMG: 15.3;hTERT-RPE1: 17.2" "Region enriched" "Detected in single" 14 "basal ganglia: 23.9" "Region enhanced" "Detected in some" "basal ganglia: 14.5" "HPA035903, HPA058119" Uncertain Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA035903: AB_10696515, HPA058119: AB_2683611" "unprognostic (8.90e-3)" "unprognostic (2.00e-3)" "unprognostic (5.11e-3)" "unprognostic (1.66e-2)" "unprognostic (1.45e-3)" "unprognostic (1.47e-2)" "unprognostic (9.96e-3)" "unprognostic (8.22e-2)" "unprognostic (3.92e-1)" "unprognostic (7.37e-3)" "unprognostic (2.44e-3)" "unprognostic (1.66e-1)" "unprognostic (2.98e-2)" "unprognostic (5.21e-2)" "unprognostic (1.46e-1)" "unprognostic (2.64e-2)" "unprognostic (4.13e-3)" 2.6 0.6 1.2 6.2 11.5 0.0 2.9 0.2 2.9 6.4 19.1 0.4 0.4 9.2 2.9 2.2 22.2 3.6 40.8 23.5 0.8 0.3 0.8 4.6 1.9 0.0 0.3 1.1 1.0 14.3 0.0 3.3 0.3 0.1 2.2 8.5 0.9 16.9 1.0 21.7 33.1 21.4 1.2 0.5 0.2 11.9 6.4 0.6 0.6 3.8 19.6 16.1 0.9 10.0 0.0 1.4 0.3 0.1 0.0 1.6 0.3 10.2 2.8 0.1 0.6 0.0 0.0 0.0 0.1 0.8 2.1 0.8 34.6 9.5 0.0 5.4 0.4 15.3 9.5 0.0 11.2 2.0 0.1 0.1 0.0 4.1 4.6 0.6 0.0 0.0 0.1 6.0 3.2 7.6 17.2 0.1 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.8 8.5 0.7 0.0 0.1 0.0 4.4 1.0 0.0 0.0 0.6 0.2 0.2 0.5 3.3 0.0 4.9 0.4 8.9 0.7 3.3 0.0 0.0 0.0 5.5 0.0 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 1.6 0.7 1.4 0.0 0.0 1.5 0.2 0.0 0.1 0.0 0.8 0.3 1.2 11.5 0.2 2.9 0.8 0.3 0.3 1.1 0.1 0.6 14.9 2.9 0.0 4.5 48.9 0.6 414.9 2.5 2.7 2.3 1.8 0.0 0.0 0.0 6.5 1412.5 1.5 27.7 0.0 7.6 0.0 0.5 1.3 1.1 8.3 0.2 0.0 1.2 0.6 0.0 7204.3 23.9 0.0 8.5 1.0 12.2 1.9 13.6 17.5 32.5 0.6 0.0 12.9 1.4 32.0 16.2 43.7 0.0 0.0 27.1 6.4 SH3RF3 "FLJ00204, POSH2, SH3MD4" ENSG00000172985 "SH3 domain containing ring finger 3" Q8TEJ3 2 109129348-109504632 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 9.0;Horizontal cells: 9.5;Ito cells: 9.2;Sertoli cells: 12.9;Smooth muscle cells: 10.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HHSteC: 14.1;RPMI-8226: 13.4;TIME: 15.6;U-266/84: 18.2" "Low region specificity" "Detected in many" "HPA044822, HPA048444" Approved Supported Nucleoplasm Yes No Nucleoplasm "HPA044822: AB_2679103, HPA048444: AB_2680396" "unprognostic (1.97e-1)" "unprognostic (8.84e-3)" "unprognostic (8.04e-2)" "unprognostic (1.91e-1)" "unprognostic (2.55e-1)" "unprognostic (1.78e-1)" "unprognostic (8.00e-2)" "unprognostic (1.76e-1)" "unprognostic (2.98e-2)" "prognostic unfavorable (2.33e-4)" "unprognostic (4.57e-2)" "unprognostic (1.95e-1)" "unprognostic (3.54e-2)" "unprognostic (4.94e-2)" "unprognostic (2.72e-1)" "unprognostic (2.79e-2)" "unprognostic (1.39e-2)" 17.4 5.6 2.7 3.4 4.4 0.6 18.3 1.7 5.4 5.3 3.6 3.3 2.5 1.0 5.5 2.2 3.4 4.8 5.6 6.4 3.0 2.1 2.5 0.8 6.0 2.9 4.3 1.5 3.0 1.8 0.6 2.6 6.5 3.8 3.4 1.6 4.6 2.4 5.9 6.4 2.9 2.3 4.6 2.8 2.0 2.7 4.3 2.9 1.5 3.4 3.6 4.0 4.6 3.4 0.4 0.4 1.8 0.2 0.0 0.6 0.3 0.0 0.0 0.1 1.5 6.4 4.9 0.0 2.8 8.3 2.2 0.8 0.7 0.0 0.0 2.2 2.0 0.5 0.0 0.1 1.2 0.9 0.0 2.8 0.0 0.1 0.0 14.1 0.0 0.0 8.5 2.0 9.7 4.4 1.2 7.8 1.5 0.0 8.0 4.9 0.0 0.0 4.3 0.7 0.0 8.1 1.7 0.0 13.4 0.0 0.0 0.5 1.7 0.0 0.0 0.3 0.1 0.1 0.0 15.6 2.8 8.3 7.9 3.6 2.7 18.2 0.0 0.0 4.2 3.8 0.0 0.2 0.7 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.4 0.6 0.6 1.8 0.0 0.0 0.4 0.0 0.3 2.7 4.4 1.7 3.3 3.0 2.1 4.3 1.5 3.8 2.9 0.0 0.0 0.0 0.2 1.6 0.1 9.0 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.5 2.0 3.8 0.0 0.0 0.2 0.1 4.1 0.2 0.0 0.0 3.6 9.5 1.7 9.2 3.7 3.6 2.0 0.5 5.0 0.0 0.2 0.8 0.1 0.0 2.8 0.8 0.0 12.9 10.8 0.7 6.6 0.6 0.1 0.0 0.0 0.0 SH3TC1 FLJ20356 ENSG00000125089 "SH3 domain and tetratricopeptide repeats 1" Q8TE82 4 8182072-8241803 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ito cells: 36.2;Kupffer cells: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 14.5" "Group enriched" "Detected in many" 5 "B-cells: 6.5;dendritic cells: 14.5;monocytes: 8.6" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 15.3;MOLT-4: 26.5;SK-MEL-30: 15.2;U-2197: 11.5" "Low region specificity" "Detected in many" "HPA038132, HPA056807" Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Cytosol" "HPA038132: AB_10673041, HPA056807: AB_2683239" "unprognostic (2.46e-1)" "unprognostic (2.43e-1)" "unprognostic (1.61e-3)" "unprognostic (5.46e-2)" "unprognostic (2.26e-2)" "unprognostic (1.63e-1)" "unprognostic (1.04e-1)" "unprognostic (8.54e-2)" "unprognostic (8.21e-2)" "unprognostic (3.25e-1)" "unprognostic (1.46e-2)" "unprognostic (2.59e-2)" "unprognostic (4.24e-2)" "unprognostic (2.46e-1)" "unprognostic (3.77e-3)" "unprognostic (1.15e-2)" "unprognostic (4.29e-2)" 16.8 4.2 3.7 12.7 7.6 7.5 8.5 0.9 4.0 5.7 3.2 8.6 3.3 1.9 3.2 7.9 9.7 3.9 10.0 4.5 6.6 3.5 19.9 11.2 10.1 14.2 7.4 1.0 2.8 8.6 1.1 3.3 5.8 7.2 5.9 2.4 6.4 5.9 6.0 2.0 3.3 5.6 4.1 9.6 17.0 9.6 1.7 5.8 24.4 5.6 3.8 14.5 9.9 6.3 6.5 14.5 1.0 8.6 0.4 2.0 2.6 2.2 3.5 0.1 0.0 0.0 0.4 2.6 0.2 0.2 0.3 0.5 1.8 1.3 3.1 3.0 0.0 0.5 1.3 0.0 6.6 0.0 8.1 0.1 0.0 2.8 2.9 2.6 0.0 0.4 0.1 8.2 0.1 6.7 0.2 15.3 2.0 0.4 4.3 0.3 2.5 26.5 2.1 0.1 1.3 2.9 1.7 0.9 0.9 0.3 0.4 0.2 1.4 1.0 0.3 15.2 1.0 0.0 0.5 6.2 0.0 1.8 11.5 0.2 0.1 0.6 2.7 0.1 1.2 2.0 0.0 7.5 1.0 0.7 6.9 0.7 4.2 1.5 0.9 6.2 6.5 0.7 0.6 0.2 0.4 8.6 14.5 2.0 2.6 3.7 7.6 0.9 4.0 6.6 3.5 7.4 1.0 7.2 5.8 0.0 8.0 7.4 10.1 0.7 0.8 2.8 7.6 1.4 3.4 24.4 0.0 1.8 6.6 3.2 0.5 6.9 0.2 0.0 4.8 2.7 1.7 4.0 17.3 7.3 19.3 22.3 1.2 36.2 27.9 1.0 0.6 18.1 0.0 5.4 0.9 18.4 7.4 2.9 0.7 12.5 0.6 0.0 2.1 0.0 0.0 0.5 2.5 6.9 1.2 15.7 SH3TC2 "CMT4C, KIAA1985" ENSG00000169247 "SH3 domain and tetratricopeptide repeats 2" Q8TF17 5 148923639-149063163 "Disease related genes, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 32.1;placenta: 22.7;testis: 14.4" "Cell type enhanced" "Detected in many" 14 "Rod photoreceptor cells: 24.7;Syncytiotrophoblasts: 10.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 6.2;RT4: 9.9;SK-MEL-30: 8.9;WM-115: 9.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037683, HPA037684" Uncertain Approved Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA037683: AB_2675608, HPA037684: AB_10672603" "unprognostic (6.30e-2)" "unprognostic (4.07e-2)" "unprognostic (4.22e-2)" "unprognostic (5.52e-2)" "unprognostic (1.70e-1)" "unprognostic (1.92e-2)" "unprognostic (2.49e-1)" "unprognostic (2.17e-4)" "unprognostic (2.18e-2)" "unprognostic (4.53e-1)" "unprognostic (6.21e-3)" "unprognostic (2.20e-1)" "unprognostic (2.21e-1)" "unprognostic (6.48e-2)" "unprognostic (1.84e-1)" "unprognostic (6.62e-2)" "unprognostic (1.40e-1)" 1.3 0.8 3.3 0.8 15.4 1.2 1.4 0.9 8.6 2.2 1.0 32.1 0.0 0.6 1.0 1.7 2.0 1.3 1.3 3.7 6.0 3.0 0.6 0.7 1.0 0.7 22.7 4.6 0.6 0.5 0.8 0.5 22.7 12.0 0.9 1.8 0.0 1.4 1.4 1.5 1.1 0.7 1.3 12.9 1.0 0.7 14.4 15.6 0.0 0.8 0.0 1.0 2.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 4.7 0.2 0.0 0.0 0.0 0.1 0.1 2.9 1.3 0.5 0.2 6.2 5.1 0.0 5.6 0.3 1.7 4.3 0.0 4.1 0.3 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.2 0.4 2.0 1.8 1.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.1 3.1 5.7 0.0 3.9 0.0 2.1 9.9 0.0 0.0 0.0 0.3 8.9 0.2 0.0 0.0 0.3 0.2 1.1 0.2 3.5 0.0 0.0 0.0 0.2 1.3 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 3.3 15.4 0.9 8.6 6.0 3.0 22.7 4.6 12.0 15.6 3.0 5.9 0.0 0.6 0.8 1.1 1.7 2.5 1.4 4.5 0.0 3.9 0.7 0.0 0.7 4.8 1.4 0.0 0.0 0.2 0.2 0.9 1.0 2.3 0.0 0.3 0.0 0.0 1.3 2.4 1.5 0.3 0.0 0.0 0.0 0.0 1.9 1.2 0.0 0.0 0.0 24.7 0.0 0.4 1.4 0.8 0.6 10.0 0.0 0.0 2.6 SH3YL1 "DKFZP586F1318, Ray" ENSG00000035115 "SH3 and SYLF domain containing 1" Q96HL8 2 217730-266398 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 94.7" "Cell type enhanced" "Detected in many" 5 "Proximal tubular cells: 402.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 65.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030926, HPA030927" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA030926: AB_10670148, HPA030927: AB_10669874" "unprognostic (1.54e-1)" "unprognostic (1.33e-1)" "unprognostic (5.10e-2)" "unprognostic (2.28e-3)" "unprognostic (5.06e-3)" "unprognostic (1.82e-1)" "unprognostic (1.46e-1)" "unprognostic (6.57e-3)" "unprognostic (9.25e-2)" "unprognostic (6.40e-2)" "unprognostic (1.71e-2)" "unprognostic (2.81e-1)" "prognostic favorable (7.70e-4)" "unprognostic (1.95e-3)" "unprognostic (1.10e-1)" "unprognostic (1.47e-1)" "unprognostic (3.22e-3)" 3.6 11.7 10.3 8.7 10.1 2.6 16.0 8.7 9.7 9.6 12.9 8.6 16.1 9.8 7.9 12.4 17.4 12.8 22.9 4.1 10.5 8.0 42.5 3.8 14.9 10.4 10.9 11.8 9.9 94.7 13.9 20.7 11.4 7.9 17.7 15.8 7.3 35.3 26.9 3.2 21.5 32.1 7.6 13.1 5.5 23.6 6.0 8.2 5.7 22.5 15.3 14.4 18.0 9.5 7.2 3.3 14.0 2.3 12.4 20.6 5.2 3.6 0.7 4.1 1.8 5.6 5.3 2.7 4.7 5.3 1.8 1.8 9.9 13.9 0.1 2.3 4.1 1.2 15.5 1.0 20.3 1.7 3.1 0.7 0.9 1.1 3.1 4.5 0.4 1.2 5.9 21.0 1.0 3.4 8.8 2.6 5.1 0.2 0.6 3.6 10.7 3.9 2.0 1.3 65.8 0.8 1.8 1.2 0.2 12.6 21.0 1.7 2.8 0.7 19.6 3.3 5.7 13.4 3.1 1.9 0.9 0.2 5.2 2.0 0.5 0.0 0.3 9.0 6.2 3.0 14.0 1.3 1.0 2.6 1.6 8.4 7.2 13.3 6.7 3.3 5.5 20.6 11.9 0.8 12.4 2.3 2.9 16.2 5.2 10.3 10.1 8.7 9.7 10.5 8.0 10.9 11.8 7.9 8.2 53.6 103.8 28.7 161.2 73.5 18.5 5.7 280.2 57.6 78.5 96.0 21.6 132.4 247.1 104.8 113.4 15.7 68.8 0.0 125.5 61.0 27.7 132.4 15.1 6.8 23.1 25.4 47.1 18.4 6.9 92.8 33.9 14.8 69.2 14.4 79.9 7.7 99.4 91.2 38.5 402.5 8.7 25.8 18.6 61.2 23.6 100.7 206.5 17.5 106.3 210.4 SHANK2 "CORTBP1, CTTNBP1, ProSAP1, SHANK, SPANK-3" ENSG00000162105 "SH3 and multiple ankyrin repeat domains 2" Q9UPX8 11 70467856-71252577 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.1" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 38.7;Horizontal cells: 128.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "basophil: 2.1" "Lineage enriched" "Detected in single" 22 "granulocytes: 2.1" "Cell line enhanced" "Detected in many" "Karpas-707: 16.9;MCF7: 9.7;RT4: 15.6;T-47d: 12.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008174, HPA017220" Approved Uncertain "Nucleoplasm,Nuclear speckles,Vesicles" NA NA Nucleoplasm "Nuclear speckles, Vesicles" "HPA008174: AB_1856822, HPA017220: " "unprognostic (3.08e-1)" "unprognostic (1.31e-3)" "unprognostic (1.79e-1)" "unprognostic (1.51e-2)" "unprognostic (1.51e-1)" "unprognostic (7.23e-5)" "unprognostic (1.24e-1)" "unprognostic (6.67e-2)" "unprognostic (1.83e-2)" "unprognostic (8.42e-2)" "unprognostic (4.87e-2)" "unprognostic (4.01e-1)" "prognostic favorable (1.94e-6)" "unprognostic (3.46e-2)" "unprognostic (2.34e-1)" "unprognostic (4.03e-2)" "unprognostic (4.80e-2)" 2.1 1.7 16.8 0.8 22.6 0.0 7.3 6.1 24.1 2.8 3.1 2.3 1.9 2.4 1.8 3.1 5.1 7.9 1.1 0.2 12.2 8.1 7.0 4.7 5.5 0.3 3.6 12.9 0.2 11.3 0.0 7.3 2.7 8.7 4.6 2.8 1.4 12.7 3.3 0.1 1.2 2.0 0.6 1.5 1.5 4.7 1.2 3.7 0.0 8.5 0.0 0.5 2.3 0.4 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.4 7.8 4.3 0.0 0.5 0.7 3.1 0.6 0.3 0.0 0.0 8.2 2.9 5.1 1.5 0.0 0.2 0.8 0.0 2.9 0.0 0.0 0.2 0.0 0.0 8.5 0.0 0.0 1.7 0.2 1.5 0.0 0.0 1.1 0.0 0.1 0.0 16.9 1.6 9.7 0.0 0.0 3.3 7.4 0.3 0.0 7.7 7.6 3.9 15.6 2.5 1.0 0.0 6.2 0.0 3.6 12.0 0.0 0.0 0.1 1.2 0.3 0.0 0.1 0.6 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.8 22.6 6.1 24.1 12.2 8.1 3.6 12.9 8.7 3.7 38.7 14.2 0.0 2.7 0.0 16.0 2.4 10.2 20.1 5.7 7.0 0.0 9.5 3.3 7.0 1.4 1.0 0.9 0.0 1.9 2.4 0.6 8.4 2.3 19.0 1.0 128.7 0.0 0.0 0.0 1.6 0.0 0.5 5.0 0.0 8.2 5.0 7.6 3.5 0.7 8.7 0.9 0.0 1.4 0.6 0.7 0.5 12.2 0.0 5.2 3.8 SHANK3 "KIAA1650, prosap2, PSAP2, SPANK-2" ENSG00000251322 "SH3 and multiple ankyrin repeat domains 3" 22 50674415-50733298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.4" "Cell type enriched" "Detected in some" 5 "Ito cells: 90.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 6.4;TIME: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003446 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA003446: AB_1079958" "unprognostic (3.62e-1)" "unprognostic (1.08e-2)" "prognostic unfavorable (7.40e-4)" "unprognostic (6.02e-2)" "unprognostic (4.17e-1)" "unprognostic (1.72e-3)" "unprognostic (3.41e-2)" "unprognostic (3.13e-1)" "unprognostic (9.67e-2)" "unprognostic (5.62e-2)" "unprognostic (2.09e-2)" "unprognostic (7.52e-2)" "unprognostic (2.47e-2)" "unprognostic (7.81e-2)" "unprognostic (1.19e-1)" "unprognostic (4.89e-2)" "unprognostic (1.41e-1)" 9.5 5.4 23.5 1.3 26.1 2.6 8.7 13.0 32.4 3.5 2.0 2.4 0.1 5.2 3.8 3.4 2.5 2.8 1.1 4.4 21.6 2.4 2.9 5.1 5.3 2.9 2.5 18.1 1.6 7.6 7.9 1.0 1.7 2.6 1.9 1.9 0.6 8.5 3.4 3.6 3.1 6.6 1.5 2.0 12.3 1.3 3.4 6.4 0.2 4.1 1.4 2.6 5.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.9 0.6 2.9 0.5 0.5 0.0 0.6 0.0 0.2 0.0 0.6 1.7 0.0 1.2 0.2 1.7 0.6 0.9 0.4 0.0 0.0 0.0 6.4 0.4 1.7 1.5 0.8 0.3 1.6 1.1 0.1 0.3 0.1 2.0 0.7 0.1 0.1 0.1 0.9 0.5 0.2 1.3 0.7 1.8 1.7 0.0 0.7 0.3 0.5 1.3 1.9 1.7 0.0 0.8 0.4 0.3 0.4 10.2 0.2 1.7 0.7 0.4 0.1 0.1 0.0 0.1 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 26.1 13.0 32.4 21.6 2.4 2.5 18.1 2.6 6.4 0.0 1.4 0.0 0.0 0.2 0.5 19.6 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 1.8 16.8 0.0 0.0 0.0 0.0 0.2 0.1 0.0 5.6 0.3 0.0 2.4 90.2 5.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.4 0.7 0.0 0.0 0.9 0.2 0.4 0.3 0.0 0.0 0.0 0.3 SHB ENSG00000107338 "SH2 domain containing adaptor protein B" Q15464 9 37919134-38069211 "Predicted intracellular proteins" "Angiogenesis, Apoptosis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 74.8;Urothelial cells: 45.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 71 "basophil: 8.1" "Lineage enriched" "Detected in single" 71 "granulocytes: 8.1" "Cell line enhanced" "Detected in many" "OE19: 35.0" "CAB010161, HPA049911, HPA052108" Uncertain Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA Cytosol "Nucleoplasm, Cytoplasmic bodies" "CAB010161: AB_2187742, HPA049911: AB_2680949, HPA052108: AB_2681730" "unprognostic (4.57e-2)" "unprognostic (1.13e-1)" "unprognostic (5.45e-2)" "unprognostic (1.63e-2)" "unprognostic (1.08e-1)" "unprognostic (7.42e-2)" "unprognostic (2.10e-1)" "unprognostic (3.38e-1)" "unprognostic (1.38e-1)" "unprognostic (1.79e-1)" "unprognostic (5.96e-3)" "unprognostic (2.48e-2)" "unprognostic (3.31e-3)" "unprognostic (7.68e-3)" "unprognostic (1.01e-1)" "unprognostic (3.29e-1)" "unprognostic (1.10e-1)" 8.6 5.6 7.5 5.3 15.9 7.2 8.0 1.4 12.5 8.2 8.4 16.1 3.2 10.1 6.1 5.6 19.6 5.9 29.4 20.2 8.9 5.0 13.6 34.2 11.6 3.1 17.9 5.3 5.6 17.8 13.7 13.1 7.7 12.6 12.9 7.0 7.6 18.9 11.3 6.4 13.0 9.5 11.9 7.6 6.7 14.1 3.5 16.3 2.7 7.7 10.3 11.1 10.7 11.9 0.0 0.0 8.1 0.0 0.0 0.1 0.0 8.1 12.9 1.4 0.2 1.5 3.6 2.3 9.0 11.0 6.3 4.9 3.0 5.7 0.0 10.9 7.7 14.6 7.8 5.1 13.3 4.4 6.9 10.3 0.0 4.5 9.5 10.0 0.4 0.4 3.2 4.2 9.9 7.6 14.7 6.4 1.3 3.2 2.7 7.3 5.5 1.0 0.4 3.4 35.0 12.3 0.4 3.8 0.4 13.1 2.9 13.9 11.1 1.2 9.8 2.2 11.5 6.2 0.5 7.9 2.9 10.6 1.5 14.3 0.8 0.3 0.1 17.4 0.8 2.8 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 15.9 1.4 12.5 8.9 5.0 17.9 5.3 12.6 16.3 6.0 6.4 0.5 74.8 18.1 0.3 8.1 35.7 2.7 6.8 21.0 7.9 8.6 13.3 14.6 1.8 9.8 10.5 0.0 17.2 1.0 5.7 35.8 0.0 19.8 5.2 0.0 7.5 5.5 1.3 3.4 0.6 2.1 6.8 0.0 10.6 2.0 17.9 8.6 0.4 18.2 1.4 0.0 4.7 0.5 6.8 29.6 3.3 0.0 7.4 45.7 SHC3 "N-Shc, NSHC, SHCC" ENSG00000148082 "SHC adaptor protein 3" Q92529 9 89005771-89178767 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.1" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 2: 16.0;Bipolar cells: 7.0;Muller glia cells: 6.1" "Cancer enhanced" "Detected in some" "glioma: 5.1" "Group enriched" "Detected in many" 4 "amygdala: 15.7;basal ganglia: 20.8;cerebral cortex: 31.5;hippocampal formation: 14.2;olfactory region: 24.7" "Cell type enriched" "Detected in single" 14 "naive B-cell: 1.4" "Lineage enriched" "Detected in single" 14 "B-cells: 1.4" "Cell line enhanced" "Detected in some" "AF22: 17.1;hTERT-RPE1: 18.9;RT4: 6.3;SH-SY5Y: 6.3;U-87 MG: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031427, HPA046656, HPA072448" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA031427: AB_2673877, HPA046656: AB_2679740, HPA072448: AB_2686521" "unprognostic (6.22e-2)" "unprognostic (5.86e-2)" "unprognostic (1.26e-1)" "unprognostic (2.43e-1)" "unprognostic (1.04e-1)" "unprognostic (9.07e-4)" "unprognostic (2.70e-2)" "unprognostic (1.54e-2)" "unprognostic (1.51e-1)" "unprognostic (3.09e-1)" "unprognostic (2.72e-3)" "unprognostic (7.39e-2)" "unprognostic (1.53e-7)" "unprognostic (8.33e-2)" "unprognostic (1.05e-1)" "unprognostic (9.01e-2)" "unprognostic (9.84e-4)" 1.6 10.8 15.7 0.8 20.8 0.5 1.8 0.8 35.1 7.3 1.2 2.3 0.0 1.1 1.5 1.7 1.5 2.2 2.7 1.0 14.2 4.7 1.4 0.6 6.0 0.8 3.1 24.7 0.7 4.4 10.4 1.0 0.8 5.2 1.5 1.4 0.0 6.4 1.4 0.9 1.8 0.9 1.8 1.5 0.6 0.8 1.0 1.3 0.0 1.3 0.0 0.8 1.7 3.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.3 17.1 0.0 3.8 1.2 0.0 1.2 3.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.5 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.3 0.4 0.2 0.0 2.6 0.0 1.7 0.0 18.9 4.5 0.0 0.0 0.0 0.0 0.1 0.0 1.0 2.2 0.2 0.2 0.2 0.0 3.5 3.7 6.3 2.3 6.3 0.4 0.0 0.0 0.1 0.0 0.3 2.6 0.7 0.1 1.0 0.1 0.0 0.0 0.0 9.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 20.8 0.8 31.5 14.2 4.7 3.1 24.7 5.2 1.3 0.0 16.0 0.0 0.2 0.1 7.0 0.8 0.0 1.4 1.2 0.0 0.0 0.1 1.7 0.0 0.8 0.1 0.0 0.0 0.8 0.1 1.1 0.0 0.0 0.0 0.2 3.2 0.0 0.0 0.0 0.9 1.4 0.0 1.7 0.0 0.0 6.1 0.1 0.0 3.5 0.3 0.4 0.0 0.8 0.2 0.1 0.5 0.3 0.0 0.0 0.9 SHF ENSG00000138606 "Src homology 2 domain containing F" Q7M4L6 15 45167214-45201175 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 84.3" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 46.9" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 84.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 50.7;SH-SY5Y: 22.6" "Region enriched" "Detected in all" 5 "cerebellum: 269.9" HPA057381 Approved Nucleoplasm NA NA Nucleoplasm "HPA057381: AB_2683423" "unprognostic (4.05e-2)" "unprognostic (2.02e-3)" "unprognostic (7.59e-2)" "unprognostic (1.54e-1)" "unprognostic (1.88e-2)" "unprognostic (2.18e-1)" "unprognostic (2.38e-1)" "unprognostic (7.61e-2)" "unprognostic (2.18e-1)" "unprognostic (3.50e-2)" "unprognostic (6.88e-2)" "unprognostic (5.12e-2)" "unprognostic (6.89e-2)" "unprognostic (2.83e-2)" "unprognostic (1.17e-1)" "unprognostic (5.09e-3)" "unprognostic (1.83e-2)" 2.9 19.3 6.9 3.3 10.4 0.6 3.3 84.3 14.5 7.3 6.3 3.9 2.2 10.5 8.5 4.0 4.1 6.2 5.3 4.5 5.9 7.2 1.8 18.9 2.9 1.8 4.5 6.7 20.5 2.5 2.5 3.5 1.5 7.1 5.3 4.4 6.3 5.3 5.2 2.6 6.5 7.9 6.3 5.2 2.3 2.9 4.1 3.2 1.6 4.9 2.4 1.8 5.8 5.5 3.3 2.6 2.5 1.9 5.1 4.2 1.5 0.0 0.6 10.0 0.3 0.7 0.4 4.7 1.2 0.8 2.8 4.0 1.4 4.7 0.5 4.0 1.7 2.7 0.8 3.8 0.3 1.3 0.8 1.7 0.3 0.9 9.8 0.4 0.0 3.3 0.9 0.2 0.3 0.0 2.1 2.1 4.9 1.9 0.2 3.9 1.6 2.1 0.3 3.9 1.8 0.2 6.0 7.9 0.2 0.9 0.2 50.7 22.6 0.3 0.3 0.2 3.2 0.5 0.9 0.1 0.3 4.3 0.3 0.1 0.4 0.3 0.4 0.1 0.2 1.5 0.3 1.9 1.2 3.8 1.7 4.2 2.4 1.6 2.4 1.8 3.3 2.2 1.7 2.5 5.1 1.7 2.6 0.3 1.5 6.9 10.4 84.3 12.1 5.9 7.2 4.5 6.7 7.1 3.2 0.0 1.1 0.0 4.9 3.2 46.9 2.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.9 6.1 3.7 4.2 0.0 1.1 0.4 3.0 2.5 2.3 9.7 0.6 9.5 12.5 3.7 1.0 9.8 4.0 2.8 8.5 0.0 8.6 5.7 0.5 5.8 3.9 1.0 4.5 6.5 5.0 4.7 2.7 2.3 0.6 0.7 4.5 7.1 SHISA2 "bA398O19.2, C13orf13, hShisa, PRO28631, TMEM46, WGAR9166" ENSG00000180730 "Shisa family member 2" Q6UWI4 13 26044597-26051031 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 12.9;skeletal muscle: 10.2;thyroid gland: 20.8" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 2: 9.6;Basal glandular cells: 8.8;Urothelial cells: 18.2" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 18.9;JURKAT: 13.2;LHCN-M2: 13.2;NTERA-2: 9.6;RH-30: 30.7;U-2197: 19.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA049752, HPA050172" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" NA NA Nucleoplasm "Nuclear bodies, Vesicles" "HPA049752: , HPA050172: AB_2681041" "unprognostic (2.08e-2)" "unprognostic (3.00e-1)" "unprognostic (2.41e-1)" "unprognostic (9.71e-2)" "unprognostic (6.09e-2)" "unprognostic (2.52e-1)" "unprognostic (1.20e-1)" "prognostic favorable (3.30e-4)" "unprognostic (4.03e-2)" "unprognostic (3.10e-1)" "unprognostic (7.45e-2)" "unprognostic (2.17e-2)" "prognostic favorable (2.43e-4)" "unprognostic (5.56e-3)" "unprognostic (2.09e-1)" "unprognostic (3.46e-1)" "unprognostic (1.51e-2)" 0.3 0.0 0.7 0.0 2.0 0.0 12.9 0.0 0.5 1.5 0.0 0.4 0.0 7.9 0.0 0.0 0.3 0.0 2.0 0.6 3.0 0.0 3.7 0.1 1.1 0.0 0.0 0.0 1.7 0.0 0.4 0.0 1.9 0.0 10.2 1.0 0.3 0.0 3.5 0.0 1.6 0.9 20.8 0.3 0.0 0.0 0.8 0.6 2.2 1.1 1.0 5.6 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.2 2.5 1.0 0.0 0.0 1.2 18.9 0.7 13.2 0.0 0.0 13.2 0.7 1.3 0.3 9.6 5.5 4.8 0.0 30.7 0.1 1.2 4.3 0.3 0.0 0.2 0.0 3.4 2.0 0.4 0.1 1.0 0.0 0.5 19.2 4.2 0.0 0.0 0.0 0.0 0.0 2.6 2.2 0.4 1.7 0.6 0.7 1.0 0.6 1.7 0.7 0.3 0.8 3.9 5.6 1.6 1.0 1.1 0.6 0.7 0.4 0.0 9.6 0.0 8.8 4.7 0.0 0.4 0.0 1.4 0.0 3.5 0.0 0.2 0.0 4.0 1.5 1.2 0.0 0.0 0.2 0.3 0.7 2.4 0.0 0.0 0.6 0.0 0.0 1.8 0.0 0.7 0.0 0.2 1.7 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 1.2 0.3 3.6 1.5 0.1 0.0 0.0 18.2 SHISA6 FLJ45455 ENSG00000188803 "Shisa family member 6" Q6ZSJ9 17 11241263-11564063 "Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.6;cervix, uterine: 22.4" "Group enriched" "Detected in some" 4 "Late spermatids: 9.9;Peritubular cells: 27.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 22 "OE19: 34.1" "Low region specificity" "Detected in many" HPA023440 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA023440: AB_1848945" "unprognostic (1.70e-1)" "unprognostic (2.78e-2)" "unprognostic (1.44e-1)" "unprognostic (2.39e-3)" "prognostic unfavorable (8.41e-4)" "unprognostic (3.11e-2)" "unprognostic (1.71e-1)" "unprognostic (8.80e-2)" "unprognostic (1.84e-1)" "unprognostic (1.11e-1)" "unprognostic (9.63e-2)" "unprognostic (1.27e-1)" "unprognostic (2.40e-4)" "unprognostic (1.14e-1)" "unprognostic (1.32e-1)" "unprognostic (4.20e-2)" "unprognostic (2.47e-2)" 2.2 0.7 5.8 0.6 5.5 0.2 1.2 9.8 7.5 22.4 0.9 2.5 1.9 0.4 4.2 2.4 0.9 1.7 0.5 1.1 12.1 9.9 2.5 0.2 1.5 0.2 11.8 2.9 0.6 1.4 6.0 0.0 0.3 13.6 5.9 0.8 0.8 0.2 10.1 1.0 0.5 0.4 1.2 9.6 0.2 6.0 2.9 2.1 0.0 0.7 0.0 0.2 0.6 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 34.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 5.5 9.8 4.9 12.1 9.9 11.8 2.9 13.6 2.1 0.0 0.0 0.0 0.0 0.1 2.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.2 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.1 0.0 1.2 0.0 0.0 9.9 4.6 0.0 1.7 0.0 0.0 0.4 0.0 0.0 27.3 0.0 0.1 0.0 0.1 0.5 1.9 0.1 0.0 0.0 0.0 0.1 SHMT1 "CSHMT, MGC15229, MGC24556, SHMT" ENSG00000176974 "Serine hydroxymethyltransferase 1" P34896 17 18327860-18363563 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "One-carbon metabolism" Transferase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 57.8;liver: 108.3" "Cell type enhanced" "Detected in many" 14 "Hepatocytes: 213.8;Proximal tubular cells: 332.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA023314, HPA078682" Enhanced Supported Nucleoplasm,Cytosol NA NA 240000 Cytosol Nucleoplasm "HPA023314: AB_1856830, HPA078682: " "unprognostic (4.76e-2)" "unprognostic (1.98e-2)" "unprognostic (5.46e-2)" "unprognostic (3.76e-1)" "unprognostic (2.45e-1)" "unprognostic (8.44e-3)" "prognostic favorable (2.52e-4)" "unprognostic (7.55e-3)" "unprognostic (4.50e-1)" "unprognostic (2.42e-1)" "unprognostic (2.14e-1)" "unprognostic (1.70e-1)" "prognostic favorable (8.54e-6)" "unprognostic (1.70e-2)" "unprognostic (2.66e-1)" "unprognostic (2.57e-3)" "unprognostic (4.04e-2)" 10.9 3.2 2.2 4.9 4.1 2.1 10.4 6.5 3.0 4.6 15.2 5.3 7.3 12.3 2.8 7.4 16.3 3.9 4.0 2.0 2.6 1.8 57.8 108.3 4.3 3.8 3.5 1.9 4.1 3.5 30.1 1.6 2.8 3.6 3.4 3.5 7.2 9.8 8.0 5.7 6.2 15.1 2.3 2.9 8.6 3.9 6.3 3.8 11.1 10.9 10.8 8.7 4.3 6.3 8.6 6.7 6.2 10.6 13.0 18.7 7.9 22.6 23.0 7.3 11.4 18.6 11.6 27.0 4.8 5.9 16.1 17.8 22.8 10.1 17.6 14.3 4.1 11.7 22.4 15.2 19.3 9.2 10.5 22.2 7.9 18.0 17.2 4.7 5.2 8.6 9.7 7.6 12.5 5.6 6.5 11.0 22.7 6.6 4.0 5.7 16.7 26.1 7.3 9.1 34.5 7.5 21.4 28.9 14.9 25.6 15.4 10.0 5.3 32.6 6.2 8.2 38.7 25.4 7.5 2.6 3.1 9.3 28.4 15.1 8.2 7.8 7.1 6.1 12.4 7.4 6.0 8.2 6.2 10.1 10.6 17.1 8.6 12.3 12.8 6.7 6.9 12.3 13.0 0.1 13.0 7.5 3.1 18.7 7.9 2.2 4.1 6.5 3.0 2.6 1.8 3.5 1.9 3.6 3.8 11.9 26.5 19.1 16.8 9.2 2.8 2.2 25.5 2.7 9.1 34.9 3.9 17.7 69.6 11.6 4.9 4.3 8.4 0.0 7.0 62.1 4.8 6.6 8.1 213.8 31.1 0.0 1.2 10.4 27.9 4.1 5.5 5.0 11.8 5.4 10.3 31.2 5.1 7.0 2.8 332.8 3.9 19.4 3.8 15.6 21.8 9.3 7.1 10.0 29.5 4.8 SHOC2 "KIAA0862, SOC-2, SOC2, SUR-8, SUR8" ENSG00000108061 "SHOC2, leucine rich repeat scaffold protein" Q9UQ13 10 110919547-111013667 "Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009164, HPA048134" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA009164: AB_1079960, HPA048134: " "unprognostic (1.39e-1)" "unprognostic (3.52e-2)" "unprognostic (4.23e-3)" "unprognostic (3.27e-2)" "unprognostic (1.82e-2)" "unprognostic (1.76e-2)" "unprognostic (6.09e-2)" "unprognostic (5.56e-2)" "unprognostic (1.59e-1)" "unprognostic (1.07e-1)" "unprognostic (4.33e-2)" "unprognostic (1.01e-1)" "unprognostic (3.70e-3)" "unprognostic (6.97e-3)" "unprognostic (8.35e-2)" "unprognostic (2.95e-2)" "unprognostic (1.67e-1)" 22.9 13.2 22.3 17.2 32.4 31.2 18.0 24.9 25.2 19.3 16.7 8.9 12.1 12.5 17.3 17.4 19.1 14.1 15.8 14.6 19.0 24.8 20.9 18.2 16.8 20.9 22.3 20.1 21.9 15.7 26.5 33.4 17.9 17.7 18.1 17.0 9.8 13.9 14.4 21.7 15.8 24.2 25.0 23.3 23.2 13.9 26.7 17.7 29.4 21.5 9.4 23.3 23.7 17.1 16.4 11.3 34.6 13.7 9.8 9.6 11.2 11.4 7.2 9.2 15.4 21.1 21.6 5.9 14.0 20.9 13.1 15.9 6.5 10.3 24.9 7.0 25.0 8.1 9.7 11.1 10.0 19.1 13.5 6.6 11.3 11.2 6.3 15.4 19.2 20.4 23.9 15.9 15.1 28.5 17.9 13.2 8.8 7.0 17.8 18.5 6.1 9.4 15.4 5.7 6.1 7.5 13.6 18.5 7.0 13.7 7.8 4.8 9.6 12.2 6.1 13.6 11.0 31.2 16.4 13.3 10.6 9.4 13.3 9.5 16.5 16.8 39.9 12.6 19.9 7.5 20.9 12.0 16.7 7.0 13.7 8.4 16.4 8.3 8.1 11.3 13.0 8.8 8.5 34.6 9.8 13.5 8.1 9.6 11.2 22.3 32.4 24.9 25.2 19.0 24.8 22.3 20.1 17.7 17.7 50.6 40.8 46.7 30.7 49.6 25.8 74.4 40.8 61.6 47.8 29.6 15.7 18.3 54.7 41.5 33.1 58.5 52.5 46.7 51.5 19.5 32.4 33.4 70.6 59.6 26.2 28.6 25.2 48.5 70.5 69.4 60.7 61.5 47.2 51.3 31.7 24.7 51.5 29.4 76.0 48.4 31.4 71.1 53.3 95.1 56.7 61.1 50.7 52.9 26.9 47.7 SHOX "GCFX, PHOG, SHOXY, SS" ENSG00000185960 "Short stature homeobox" O15266 X 624344-659411 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.3;breast: 13.9" "Cell type enriched" "Detected in single" 6 "Cardiomyocytes: 1.4" "Not detected" "Not detected" "Region enhanced" "Detected in some" "pons and medulla: 6.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "BJ: 19.5;BJ hTERT+: 9.0" "HPA035141, HPA060931" Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA035141: AB_2674489, HPA060931: AB_2684388" "unprognostic (7.51e-3)" "unprognostic (1.99e-1)" "unprognostic (3.08e-2)" "unprognostic (2.23e-1)" "unprognostic (4.00e-1)" "unprognostic (6.82e-2)" "unprognostic (2.45e-2)" "unprognostic (2.34e-1)" "unprognostic (9.24e-2)" "unprognostic (9.95e-2)" "unprognostic (5.67e-6)" "unprognostic (1.99e-1)" "unprognostic (1.71e-1)" "unprognostic (9.14e-2)" "unprognostic (1.38e-1)" 3.8 1.0 0.3 0.7 0.3 3.0 13.9 1.8 0.8 0.3 0.4 0.2 0.2 1.4 0.3 0.6 0.3 0.4 0.4 0.4 0.7 0.3 0.3 0.3 0.3 0.6 0.3 1.4 0.3 0.9 0.0 0.3 4.8 6.3 0.8 0.3 0.2 1.4 0.2 2.8 1.4 1.0 0.2 0.4 1.6 0.4 0.4 0.2 0.2 0.5 0.2 0.2 0.3 0.3 2.2 1.9 5.5 1.8 2.5 1.5 0.8 0.1 0.2 0.1 0.2 0.2 0.1 3.2 19.5 9.0 2.9 3.2 0.3 0.3 0.3 0.1 0.4 0.8 0.3 0.2 0.0 1.0 0.2 0.1 0.1 1.3 0.1 0.1 0.1 0.4 0.6 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.8 0.1 0.2 0.1 0.2 0.1 0.0 0.4 0.1 0.3 0.2 0.0 0.2 0.2 0.0 0.1 0.1 0.1 0.2 0.6 0.0 0.1 0.3 0.2 0.1 0.1 0.9 0.1 0.3 0.1 0.2 0.1 5.5 1.8 1.8 1.4 1.1 1.5 1.6 1.1 1.2 0.5 2.2 1.5 1.5 5.2 2.5 1.5 1.9 1.0 0.8 0.3 0.3 1.8 0.4 0.7 0.3 0.3 1.4 6.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 SHPK "CARKL, SHK" ENSG00000197417 Sedoheptulokinase Q9UHJ6 17 3608262-3636322 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 15.7;Rod photoreceptor cells: 15.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA024361, HPA064939" Enhanced Approved "Nucleoplasm,Nuclear speckles" NA NA 150000 "Nucleoplasm, Nuclear speckles" "HPA024361: AB_1846030, HPA064939: AB_2685388" "unprognostic (1.75e-2)" "unprognostic (1.51e-2)" "unprognostic (3.53e-2)" "unprognostic (1.23e-2)" "unprognostic (3.57e-3)" "unprognostic (1.54e-2)" "unprognostic (1.95e-2)" "unprognostic (3.01e-2)" "unprognostic (1.56e-1)" "unprognostic (3.64e-2)" "unprognostic (1.08e-2)" "unprognostic (1.42e-1)" "unprognostic (3.82e-2)" "unprognostic (6.75e-2)" "unprognostic (1.55e-1)" "unprognostic (1.05e-1)" "unprognostic (1.12e-1)" 8.9 12.9 7.6 6.2 10.6 5.9 8.9 17.3 12.3 8.8 14.1 14.9 8.8 18.5 10.7 6.1 11.6 7.6 5.3 5.9 7.0 5.5 14.3 26.7 6.3 5.3 12.0 4.5 10.2 13.7 11.8 6.2 8.6 9.8 7.4 8.6 12.3 8.9 9.4 7.5 12.1 22.8 5.1 6.7 6.1 9.7 5.2 13.0 7.7 7.7 4.0 7.6 7.5 9.6 5.2 7.1 5.1 4.8 6.4 7.5 5.4 5.3 10.9 11.6 7.4 4.8 4.9 6.4 3.6 3.2 7.0 4.2 18.7 5.0 6.3 8.0 6.9 6.6 10.4 15.4 11.6 5.1 10.1 15.0 6.9 9.3 13.4 5.8 5.9 9.8 8.2 5.6 7.8 5.3 6.0 13.2 5.0 9.1 8.1 6.8 9.5 7.6 4.6 5.8 12.3 7.3 10.5 6.1 10.1 10.0 6.9 3.3 8.9 13.1 12.1 3.6 7.4 10.8 3.5 9.4 10.8 5.1 10.3 8.7 2.7 3.5 4.2 11.7 5.4 5.4 3.3 4.7 5.1 4.6 4.8 4.7 5.2 4.2 3.7 6.5 4.0 7.5 4.7 0.9 6.4 4.1 7.1 3.6 5.4 7.6 10.6 17.3 12.3 7.0 5.5 12.0 4.5 9.8 13.0 0.0 2.7 1.5 0.8 0.0 5.4 0.8 7.6 1.4 1.2 5.2 15.7 8.1 1.7 2.9 0.4 2.2 10.5 0.0 4.1 8.6 0.9 1.9 0.0 14.8 6.9 14.3 3.4 1.8 1.3 0.0 3.7 2.5 0.0 3.6 5.9 3.1 4.3 5.8 2.5 6.5 15.6 0.0 0.8 0.6 1.2 0.4 4.7 1.0 5.5 1.7 SHPRH "bA545I5.2, FLJ90837, KIAA2023" ENSG00000146414 "SNF2 histone linker PHD RING helicase" Q149N8 6 145864245-145964423 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Helicase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 198.3;Rod photoreceptor cells: 175.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034854, HPA044852" Approved Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Nuclear membrane, Cytosol" "HPA034854: AB_10964488, HPA044852: " "unprognostic (3.10e-2)" "unprognostic (4.46e-2)" "unprognostic (5.61e-3)" "unprognostic (1.53e-2)" "unprognostic (7.40e-3)" "unprognostic (2.20e-2)" "unprognostic (2.63e-1)" "unprognostic (1.83e-1)" "unprognostic (1.36e-1)" "unprognostic (8.66e-3)" "unprognostic (5.03e-1)" "unprognostic (7.90e-2)" "unprognostic (6.01e-3)" "unprognostic (3.29e-2)" "unprognostic (2.70e-1)" "unprognostic (1.13e-1)" "unprognostic (3.01e-1)" 10.9 7.3 8.3 11.0 10.0 5.5 10.4 38.0 11.5 10.6 8.0 4.5 10.8 6.0 14.1 9.2 8.5 9.8 6.7 7.2 7.2 4.2 8.4 6.5 7.1 9.0 7.6 5.9 18.8 8.7 11.4 19.7 6.6 8.5 8.3 7.4 7.3 10.2 13.7 11.4 13.9 8.2 11.0 10.3 8.8 8.5 10.7 8.7 8.4 12.5 7.2 8.0 10.7 11.5 6.7 4.8 4.4 2.4 3.4 4.3 1.2 3.0 2.3 11.7 6.8 5.4 5.8 5.6 3.6 2.9 4.5 5.8 5.3 2.1 10.6 4.5 2.7 3.5 5.2 7.1 5.1 5.9 4.7 8.1 10.7 5.3 4.4 4.0 22.4 6.7 4.0 5.9 4.2 6.2 4.4 4.8 7.6 14.8 6.0 3.8 2.7 14.4 8.3 7.8 5.0 4.1 10.4 18.1 3.6 6.1 3.0 9.6 6.7 6.4 5.9 4.0 8.4 3.1 10.8 5.3 2.9 5.4 5.6 4.2 4.9 7.0 12.7 3.0 9.6 4.4 1.6 2.3 4.4 4.3 2.4 3.7 3.9 3.6 2.9 2.7 6.7 4.1 3.3 0.1 3.4 2.4 4.8 3.3 1.2 8.3 10.0 38.0 11.5 7.2 4.2 7.6 5.9 8.5 8.7 26.8 18.9 20.8 15.3 18.8 113.2 15.9 17.8 12.0 23.9 21.0 198.3 12.7 6.6 15.4 8.3 19.7 10.0 0.0 11.1 5.8 14.4 13.4 12.7 14.8 10.2 89.0 18.5 14.1 21.8 5.1 46.9 15.5 13.5 15.4 14.3 57.4 13.0 10.5 32.2 4.5 175.4 71.1 21.7 76.9 67.5 17.2 5.5 20.3 15.0 9.6 SHQ1 "FLJ10539, Shq1p" ENSG00000144736 "SHQ1, H/ACA ribonucleoprotein assembly factor" Q6PI26 3 72749277-72861914 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 49.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042792 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA042792: AB_10959736" "unprognostic (1.10e-2)" "unprognostic (1.03e-1)" "prognostic favorable (2.83e-4)" "prognostic favorable (6.49e-4)" "unprognostic (2.05e-1)" "unprognostic (4.54e-3)" "unprognostic (9.21e-3)" "unprognostic (3.19e-2)" "unprognostic (8.89e-2)" "unprognostic (6.78e-3)" "unprognostic (3.76e-1)" "unprognostic (5.28e-2)" "unprognostic (7.30e-3)" "unprognostic (3.59e-3)" "unprognostic (3.21e-2)" "unprognostic (1.41e-2)" "unprognostic (1.28e-1)" 10.5 15.6 6.8 17.2 9.2 11.4 14.8 8.7 9.0 10.1 12.1 9.6 11.9 9.1 15.6 16.7 13.3 15.5 9.7 14.8 8.0 8.0 10.7 10.7 14.8 15.5 15.1 5.9 12.3 17.5 12.2 12.8 7.2 10.4 9.7 12.3 11.0 13.1 13.6 17.5 11.3 10.3 11.4 7.5 12.0 10.7 17.3 7.5 29.8 12.5 10.4 13.4 11.2 17.0 10.1 12.9 3.1 9.7 17.0 14.9 10.4 5.9 8.1 5.5 9.1 7.3 9.1 5.6 10.1 7.2 10.5 11.5 6.3 4.8 10.0 4.9 6.8 8.5 4.9 11.3 9.3 12.8 8.8 9.0 10.3 6.7 7.6 7.5 17.5 8.6 9.2 7.1 15.4 6.3 4.8 9.7 16.3 8.3 6.2 8.4 8.8 49.1 6.1 15.4 18.3 10.4 11.9 8.7 7.5 9.1 7.9 3.4 14.2 9.2 6.6 4.7 7.6 6.7 6.6 6.7 8.4 8.3 13.8 8.6 11.5 23.1 14.9 7.5 14.1 8.3 0.6 8.6 3.1 11.2 9.7 14.9 10.1 12.6 12.0 9.1 9.3 14.3 12.4 0.4 17.0 8.4 12.9 10.2 10.4 6.8 9.2 8.7 9.0 8.0 8.0 15.1 5.9 10.4 7.5 11.9 5.8 1.5 3.7 11.7 7.9 8.1 2.5 17.4 6.8 5.2 0.0 5.4 6.6 7.0 2.8 6.8 3.8 0.0 5.3 6.3 6.6 3.8 15.0 5.7 6.1 3.2 4.1 16.0 4.7 0.9 5.5 5.4 5.0 1.8 6.9 2.9 5.6 3.5 5.3 5.1 4.4 0.0 5.1 7.9 22.7 8.9 4.8 4.9 8.8 4.2 SHROOM4 KIAA1202 ENSG00000158352 "Shroom family member 4" Q9ULL8 X 50591647-50814302 "Disease related genes, Predicted intracellular proteins" "Actin-binding, Developmental protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 27.3" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 23.8;Alveolar cells type 2: 15.2;Endothelial cells: 36.5;Ito cells: 31.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "basophil: 1.6" "Lineage enriched" "Detected in single" 17 "granulocytes: 1.6" "Cell line enhanced" "Detected in some" "EFO-21: 6.1;HUVEC TERT2: 23.3;RH-30: 4.5;RPTEC TERT1: 5.0;TIME: 8.7;WM-115: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010089, HPA010565" Uncertain Approved "Nucleoplasm,Vesicles,Focal adhesion sites" NA NA "Focal adhesion sites" "Nucleoplasm, Vesicles" "HPA010089: , HPA010565: AB_1079961" "unprognostic (2.55e-2)" "unprognostic (1.43e-1)" "unprognostic (5.56e-2)" "prognostic unfavorable (8.37e-4)" "unprognostic (1.34e-1)" "unprognostic (1.60e-2)" "unprognostic (4.30e-3)" "unprognostic (4.55e-2)" "unprognostic (2.13e-1)" "unprognostic (2.93e-1)" "unprognostic (1.52e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (4.66e-4)" "unprognostic (7.30e-2)" "unprognostic (2.83e-1)" "unprognostic (1.74e-2)" "unprognostic (2.75e-1)" 13.1 3.5 5.9 3.6 12.1 2.4 10.1 1.9 7.7 6.4 2.9 27.3 1.6 2.4 6.8 3.6 5.2 4.3 5.7 8.5 8.3 4.8 9.7 1.9 21.4 1.9 15.9 6.5 2.5 1.9 3.6 3.7 15.3 13.0 3.6 3.0 4.8 3.5 3.7 6.0 3.2 2.6 7.4 19.7 2.1 2.4 1.5 15.8 0.0 6.3 6.7 2.1 4.8 4.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.5 0.1 0.0 6.1 0.8 0.0 0.6 3.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.4 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 4.5 0.0 5.0 2.2 0.1 0.0 0.0 0.8 1.3 3.3 0.0 0.1 8.7 0.0 0.0 0.0 0.6 0.4 0.0 0.0 1.2 0.2 4.5 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.9 12.1 1.9 7.7 8.3 4.8 15.9 6.5 13.0 15.8 23.8 15.2 0.0 1.7 3.2 0.1 2.5 0.0 2.7 2.3 5.2 0.0 0.4 3.3 0.6 0.0 36.5 0.3 0.0 0.2 2.3 1.9 0.8 3.5 1.0 0.5 0.0 2.9 31.3 3.8 0.0 1.1 1.5 0.0 0.0 2.3 2.8 1.3 0.0 1.1 2.6 0.3 0.0 1.4 0.0 0.9 2.8 0.2 0.0 2.6 1.4 SHTN1 "KIAA1598, shootin-1, shootin1" ENSG00000187164 "Shootin 1" A0MZ66 10 116881482-117126586 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "classical monocyte: 14.0;intermediate monocyte: 8.8;myeloid DC: 13.2;non-classical monocyte: 4.0;plasmacytoid DC: 8.9" "Group enriched" "Detected in many" 43 "dendritic cells: 13.2;monocytes: 14.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037942, HPA037943" Enhanced Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA037942: AB_2675748, HPA037943: AB_10671637" "unprognostic (1.00e-1)" "unprognostic (2.50e-2)" "unprognostic (6.77e-3)" "unprognostic (2.81e-1)" "unprognostic (7.85e-2)" "unprognostic (1.61e-1)" "unprognostic (2.42e-2)" "unprognostic (1.03e-1)" "unprognostic (2.56e-1)" "unprognostic (1.35e-1)" "unprognostic (2.49e-1)" "prognostic unfavorable (5.07e-4)" "unprognostic (2.17e-2)" "unprognostic (1.48e-1)" "unprognostic (2.47e-1)" "unprognostic (1.85e-1)" "prognostic unfavorable (5.08e-6)" 3.5 6.5 51.5 6.8 50.1 1.6 8.7 9.8 34.1 5.5 7.0 42.3 0.3 6.7 4.4 8.4 5.4 5.2 6.5 2.6 58.9 37.0 7.8 12.1 9.8 4.5 67.8 22.7 6.8 10.9 18.6 20.4 5.4 36.3 7.3 8.6 2.0 9.9 3.0 0.9 9.6 7.8 3.8 67.4 7.0 9.0 9.9 54.5 0.4 11.9 1.4 4.1 4.0 2.4 0.0 13.2 0.3 14.0 0.0 0.2 3.5 15.8 8.9 0.9 1.9 0.0 0.0 8.9 1.3 3.5 2.7 5.2 10.0 10.5 0.0 2.7 4.9 8.1 8.2 7.1 6.0 2.8 0.0 7.4 0.0 9.4 6.2 1.2 2.8 2.5 0.4 5.3 2.7 5.2 7.2 6.6 4.3 4.3 0.0 1.9 6.3 0.0 0.1 3.4 3.0 6.0 0.0 12.0 3.5 7.4 2.2 9.9 3.9 10.7 15.6 9.7 10.9 12.5 2.5 11.3 0.9 6.7 0.0 7.8 1.7 0.0 0.0 4.9 0.0 4.9 0.0 14.0 0.1 0.0 8.8 0.0 0.0 0.0 0.0 13.2 0.0 0.1 0.0 0.3 0.0 4.0 8.9 0.2 3.5 51.5 50.1 9.8 30.2 58.9 37.0 67.8 22.7 36.3 54.5 71.5 33.1 2.4 13.5 0.0 78.9 3.4 28.1 33.5 43.3 22.7 58.9 35.1 18.3 40.5 5.8 1.3 14.6 0.0 45.7 25.7 3.1 31.7 2.3 42.7 35.4 46.1 16.4 3.1 79.2 9.0 10.3 62.9 0.0 91.0 20.8 13.1 41.7 50.9 4.9 44.5 55.6 12.9 3.5 17.4 41.4 0.0 16.7 0.0 17.7 11.9 SIAH1 hSIAH1 ENSG00000196470 "Siah E3 ubiquitin protein ligase 1" Q8IUQ4 16 48356364-48448402 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Differentiation, Spermatogenesis, Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 102.6" "Group enriched" "Detected in many" 5 "Cytotrophoblasts: 161.7;Syncytiotrophoblasts: 624.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018724 Enhanced Uncertain Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB018724: AB_2188865" "unprognostic (7.08e-2)" "unprognostic (1.16e-1)" "unprognostic (4.88e-2)" "unprognostic (1.07e-1)" "unprognostic (2.92e-3)" "unprognostic (1.25e-2)" "unprognostic (7.93e-3)" "unprognostic (1.12e-2)" "unprognostic (9.22e-3)" "unprognostic (3.26e-1)" "unprognostic (8.02e-2)" "unprognostic (7.84e-3)" "unprognostic (7.67e-3)" "unprognostic (4.38e-2)" "unprognostic (4.00e-1)" "unprognostic (9.55e-2)" "unprognostic (1.26e-2)" 20.6 11.4 11.9 11.0 13.5 19.2 25.5 15.5 16.6 14.6 13.1 15.0 6.5 12.8 16.8 13.4 12.7 12.9 12.9 11.4 12.6 11.6 12.1 17.5 13.9 10.0 12.8 11.6 16.7 11.4 13.1 9.1 102.6 14.1 14.2 12.2 32.1 13.2 12.1 17.0 16.6 16.0 18.6 12.7 11.3 12.5 17.9 13.0 17.5 14.5 9.3 11.5 15.9 14.8 12.6 8.3 21.9 5.2 5.3 6.1 3.5 8.6 7.8 16.9 15.1 14.6 12.8 17.3 8.1 11.0 12.1 5.9 5.9 11.3 11.2 9.0 10.2 8.4 10.1 11.6 11.8 14.9 4.5 9.4 6.0 6.1 15.4 20.4 5.9 9.3 15.3 21.3 7.0 16.4 13.5 10.1 10.5 9.7 10.7 9.8 5.9 15.9 12.1 20.6 9.6 12.1 18.6 25.4 11.8 11.2 10.9 19.3 17.1 24.0 12.0 20.7 15.2 7.6 13.7 10.7 12.9 11.7 7.0 8.6 14.0 5.8 20.6 9.6 7.4 11.6 6.9 5.2 21.9 2.7 2.2 3.0 12.6 3.0 4.2 8.3 12.1 6.1 4.5 2.9 5.3 1.3 7.9 1.6 3.5 11.9 13.5 15.5 16.6 12.6 11.6 12.8 11.6 14.1 13.0 11.9 11.9 16.4 51.3 76.1 18.3 12.0 10.2 9.4 10.3 15.7 7.9 161.7 26.6 21.4 60.8 27.0 18.8 0.0 19.9 25.3 52.6 43.7 4.6 19.5 29.5 33.4 21.7 28.8 18.3 53.9 21.0 23.2 47.2 38.7 18.3 30.7 19.2 14.4 18.4 21.1 16.5 19.4 37.1 68.6 47.5 66.1 624.0 13.4 16.7 38.7 SIAH2 ENSG00000181788 "Siah E3 ubiquitin protein ligase 2" O43255 3 150741127-150763477 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Biological rhythms, Cell cycle, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Syncytiotrophoblasts: 325.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061293, CAB069930" Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB069930: AB_1217916, HPA061293: AB_2684470" "prognostic favorable (1.17e-4)" "unprognostic (1.04e-3)" "unprognostic (3.83e-2)" "unprognostic (9.15e-2)" "unprognostic (1.69e-1)" "unprognostic (6.91e-2)" "unprognostic (1.86e-2)" "unprognostic (5.68e-3)" "unprognostic (6.26e-2)" "unprognostic (1.95e-2)" "prognostic unfavorable (8.21e-5)" "unprognostic (1.34e-1)" "unprognostic (1.38e-1)" "unprognostic (2.38e-2)" "unprognostic (5.56e-1)" "unprognostic (1.66e-1)" "unprognostic (4.69e-2)" 9.6 48.0 7.6 11.8 10.3 22.7 23.5 10.9 17.2 30.0 10.5 8.4 20.3 7.9 23.5 13.9 28.8 14.9 11.0 10.7 7.2 7.3 8.4 35.5 11.8 19.1 9.9 7.5 19.0 14.6 6.4 8.1 31.4 7.9 18.8 9.2 8.3 11.2 21.7 8.3 19.3 9.5 17.4 9.4 16.9 12.0 8.7 8.6 23.6 11.4 10.6 25.1 22.7 25.6 3.0 3.1 10.0 2.7 1.6 3.6 1.1 16.9 4.2 3.3 6.6 11.3 8.5 13.3 7.1 8.2 8.6 10.4 8.6 7.6 9.4 10.4 7.3 7.2 10.5 8.8 6.3 8.1 7.9 6.3 18.5 5.1 28.4 16.2 10.2 5.5 7.7 14.7 5.1 11.7 6.8 6.6 18.6 4.6 37.4 5.3 20.3 18.6 5.2 10.7 15.8 8.4 13.7 7.1 33.9 5.4 5.9 12.7 6.0 5.3 5.0 12.5 7.8 33.4 15.4 4.6 5.9 5.3 12.8 9.5 44.5 16.9 13.2 5.6 14.7 3.0 9.5 2.7 10.0 2.1 1.5 3.2 2.5 3.6 3.2 2.4 3.0 1.9 1.9 5.9 1.6 1.5 3.1 2.0 1.1 7.6 10.3 10.9 17.2 7.2 7.3 9.9 7.5 7.9 8.6 6.0 3.7 47.8 71.4 130.4 40.0 14.9 15.3 17.4 7.9 21.0 35.3 144.9 11.6 5.6 2.0 9.2 26.2 46.7 5.7 18.3 47.9 44.4 10.3 47.4 28.4 33.4 36.8 16.5 64.5 1.5 40.9 27.9 42.2 16.2 31.8 33.5 8.9 10.5 29.0 13.0 2.2 12.9 39.1 0.5 6.6 124.5 325.6 52.4 29.9 65.9 SIAH3 FLJ39203 ENSG00000215475 "Siah E3 ubiquitin protein ligase family member 3" Q8IW03 13 45777243-45851736 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 10.2;fallopian tube: 11.8" "Cell type enhanced" "Detected in some" 23 "Bipolar cells: 9.0;Ciliated cells: 4.0;Collecting duct cells: 1.8;Cone photoreceptor cells: 2.0;Distal tubular cells: 1.7" "Cancer enhanced" "Detected in some" "ovarian cancer: 0.7" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 6 "EFO-21: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060576 Uncertain Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA060576: AB_2684325" "unprognostic (1.07e-3)" "unprognostic (1.26e-1)" "unprognostic (3.00e-2)" "unprognostic (1.14e-1)" "unprognostic (4.96e-2)" "unprognostic (1.00e-2)" "unprognostic (1.05e-1)" "unprognostic (7.53e-2)" "unprognostic (3.24e-4)" "unprognostic (1.11e-1)" "unprognostic (4.77e-3)" "unprognostic (3.24e-3)" "unprognostic (9.03e-4)" "unprognostic (2.03e-1)" "unprognostic (2.18e-1)" 0.6 1.3 5.1 0.9 8.3 0.9 0.6 5.6 10.2 4.1 0.6 0.0 0.1 0.8 1.7 2.0 0.6 11.8 0.7 0.6 4.0 2.8 1.7 0.6 0.8 0.8 3.4 6.6 0.7 0.6 0.5 0.4 0.5 8.9 0.6 0.7 2.8 1.7 3.6 0.6 0.8 0.8 0.8 1.3 0.8 0.7 0.8 0.7 0.4 0.6 0.0 0.9 0.7 0.4 0.1 0.1 0.5 0.1 0.2 1.5 0.0 0.1 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.0 5.0 0.0 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 1.5 0.7 0.5 0.2 0.0 0.1 0.0 0.0 5.1 8.3 5.6 10.2 4.0 2.8 3.4 6.6 8.9 0.7 0.0 0.0 0.0 0.0 0.0 9.0 0.3 0.0 4.0 0.0 1.8 2.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SIGLEC11 ENSG00000161640 "Sialic acid binding Ig like lectin 11" Q96RL6 19 49948985-49961172 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "lymphoid tissue: 11.3;ovary: 36.6" "Cell type enhanced" "Detected in some" 16 "Distal tubular cells: 16.6;Hofbauer cells: 6.3;Ito cells: 8.6;Kupffer cells: 19.6" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 15 "HEL: 15.4" "HPA052132, HPA060278" Approved Uncertain "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA052132: , HPA060278: AB_2684240" "unprognostic (1.07e-1)" "unprognostic (2.85e-3)" "unprognostic (1.56e-1)" "unprognostic (1.31e-1)" "unprognostic (1.09e-1)" "unprognostic (3.35e-2)" "unprognostic (9.93e-2)" "unprognostic (8.88e-2)" "unprognostic (1.27e-1)" "unprognostic (2.06e-1)" "unprognostic (3.63e-1)" "unprognostic (1.20e-1)" "unprognostic (8.79e-4)" "unprognostic (2.11e-1)" "unprognostic (1.41e-1)" "unprognostic (9.95e-3)" "unprognostic (5.38e-2)" 0.4 3.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.1 36.6 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 11.3 1.8 0.5 0.0 0.0 0.3 0.0 0.6 0.5 2.6 3.3 0.8 0.2 0.3 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.2 15.4 0.3 0.1 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.7 0.6 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.0 0.1 0.1 0.4 0.2 0.1 0.3 0.1 0.1 0.2 0.3 0.1 0.0 0.2 0.2 0.5 1.0 2.6 0.1 3.3 0.1 0.5 0.2 0.1 0.5 0.6 0.1 0.2 1.4 0.8 3.3 0.3 0.0 0.3 0.0 1.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.2 6.3 0.0 0.0 8.6 19.6 0.0 0.0 2.6 0.0 0.0 0.0 0.0 4.5 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.5 0.1 0.1 0.0 0.0 0.0 SIGLEC15 "CD33L3, HsT1361" ENSG00000197046 "Sialic acid binding Ig like lectin 15" Q6ZMC9 18 45825512-45844080 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 5.9" "Cell type enhanced" "Detected in some" 16 "Hofbauer cells: 8.2;Pancreatic endocrine cells: 2.1;Urothelial cells: 2.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "classical monocyte: 5.9;myeloid DC: 2.1" "Group enriched" "Detected in many" 40 "dendritic cells: 2.1;monocytes: 5.9" "Group enriched" "Detected in some" 7 "PC-3: 8.7;U-87 MG: 26.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA053509 Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA053509: " "unprognostic (3.89e-3)" "unprognostic (1.87e-2)" "unprognostic (1.77e-1)" "unprognostic (7.18e-3)" "unprognostic (2.27e-1)" "unprognostic (8.07e-2)" "unprognostic (5.91e-2)" "unprognostic (2.71e-1)" "unprognostic (9.63e-2)" "unprognostic (1.06e-1)" "unprognostic (1.77e-2)" "unprognostic (7.65e-2)" "unprognostic (6.55e-2)" "unprognostic (1.42e-1)" "unprognostic (6.06e-2)" "unprognostic (4.40e-2)" "prognostic favorable (9.14e-5)" 1.1 0.3 0.1 4.3 0.1 0.0 3.0 0.2 0.1 2.1 0.2 0.0 0.0 1.6 0.3 0.0 0.3 0.3 3.4 1.9 0.1 0.1 0.5 1.4 2.0 0.9 0.1 0.0 0.5 0.2 0.0 0.1 1.1 0.0 1.1 0.1 0.1 0.2 0.2 0.7 0.3 2.5 3.2 0.1 3.7 0.9 0.3 0.0 1.2 0.2 0.0 2.6 4.2 0.2 0.0 2.1 0.0 5.9 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 8.7 0.9 0.1 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.7 0.0 0.0 0.4 0.0 0.0 0.0 26.3 0.6 0.0 0.0 5.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.4 0.0 0.0 0.2 0.0 0.5 0.7 0.0 0.0 8.2 1.6 0.0 1.8 1.8 0.0 0.0 1.3 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.9 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.0 2.2 SIK1 "msk, SNF1LK" ENSG00000142178 "Salt inducible kinase 1" P57059 21 43414483-43427189 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Cell cycle, Differentiation" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Epilepsy, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 34.5" "Cell type enhanced" "Detected in many" 17 "Alveolar cells type 2: 112.3;Basal keratinocytes: 268.2;Melanocytes: 91.1;Suprabasal keratinocytes: 369.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 2.0;plasmacytoid DC: 1.6" "Group enriched" "Detected in many" 10 "B-cells: 2.0;dendritic cells: 1.6" "Cell line enhanced" "Detected in many" "HBEC3-KT: 16.9;HeLa: 28.1;hTCEpi: 21.8;LHCN-M2: 21.9;U-266/84: 15.9" "CAB023801, HPA038211, HPA078064" Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB023801: , HPA038211: AB_2675894, HPA078064: " "unprognostic (4.06e-2)" "unprognostic (9.38e-2)" "unprognostic (3.31e-3)" "unprognostic (3.00e-1)" "unprognostic (5.02e-2)" "unprognostic (7.97e-3)" "unprognostic (1.51e-1)" "unprognostic (7.30e-3)" "unprognostic (2.35e-3)" "unprognostic (4.97e-2)" "unprognostic (1.89e-2)" "unprognostic (1.30e-1)" "unprognostic (3.89e-1)" "unprognostic (9.94e-3)" "unprognostic (3.88e-2)" "unprognostic (2.89e-1)" "unprognostic (1.82e-1)" 8.8 2.3 3.0 3.6 3.0 5.9 7.5 3.0 3.0 13.5 3.0 3.0 3.0 0.0 3.0 3.0 12.9 5.5 10.7 7.1 3.0 0.8 3.0 12.3 5.4 3.0 3.0 3.0 13.7 7.3 3.5 5.7 8.2 3.0 3.9 0.1 3.0 4.6 9.8 5.0 34.5 3.0 3.3 3.0 4.0 5.3 3.0 3.0 3.0 3.9 3.0 3.0 10.5 6.1 2.0 1.6 0.0 0.1 0.0 0.1 0.1 0.5 1.7 2.0 0.0 0.1 0.8 0.8 0.9 0.3 1.7 1.3 2.4 0.0 2.5 0.7 0.2 9.5 11.2 1.6 16.9 1.0 0.1 0.5 0.7 28.1 0.9 2.3 0.7 0.1 1.0 21.8 0.4 5.2 9.9 0.3 0.0 0.1 0.5 21.9 0.1 0.4 1.7 0.8 0.0 1.5 0.0 0.3 2.5 1.9 6.3 0.0 0.0 11.0 1.9 0.4 0.3 1.1 0.3 3.7 0.4 2.0 0.1 0.0 4.3 15.9 0.5 4.7 2.1 0.4 0.0 0.1 0.0 0.1 0.0 0.1 2.0 0.0 0.1 0.5 0.9 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 3.0 3.0 3.0 3.0 3.0 0.8 3.0 3.0 3.0 3.0 26.8 112.3 2.4 0.6 268.2 0.2 9.3 7.6 9.4 17.0 12.2 0.0 0.5 0.0 2.8 0.0 2.2 14.2 0.0 1.8 1.0 5.2 0.4 18.5 7.8 1.7 0.0 26.6 1.8 3.7 0.0 0.0 4.0 91.1 2.8 15.1 0.5 5.0 23.0 0.0 0.0 0.1 0.0 10.8 0.0 0.5 369.5 2.1 1.3 18.6 1.0 SIK1B ENSG00000275993 "Salt inducible kinase 1B (putative)" 21 6111134-6123739 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 1: 23.8;Alveolar cells type 2: 19.8;Ciliated cells: 16.0;Club cells: 6.8" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 5.0" "Group enriched" "Detected in many" 6 "B-cells: 1.6;dendritic cells: 5.0;monocytes: 1.7" "Cell line enhanced" "Detected in many" "HeLa: 28.6;hTERT-RPE1: 38.8;Karpas-707: 39.0;LHCN-M2: 26.8;SiHa: 28.1" "HPA038211, HPA078064" Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA038211: AB_2675894, HPA078064: " "unprognostic (2.09e-2)" "unprognostic (1.01e-1)" "unprognostic (2.57e-2)" "unprognostic (8.85e-2)" "unprognostic (3.32e-2)" "unprognostic (2.44e-1)" "unprognostic (6.58e-3)" "unprognostic (2.62e-2)" "unprognostic (6.56e-2)" "unprognostic (3.15e-2)" "unprognostic (5.52e-3)" "unprognostic (1.01e-2)" "unprognostic (9.09e-2)" "unprognostic (2.88e-2)" "unprognostic (2.41e-1)" "unprognostic (2.69e-3)" "unprognostic (7.41e-2)" 9.7 13.7 0.4 3.0 1.7 8.4 5.2 0.4 3.1 2.9 3.0 1.3 4.6 0.9 3.1 1.9 6.8 1.0 15.5 6.2 1.5 1.7 12.3 8.5 1.2 1.8 0.6 10.2 11.2 1.6 2.2 3.2 2.6 5.1 2.3 7.6 3.9 14.3 9.1 2.9 6.1 1.7 2.1 2.0 5.0 1.7 1.0 1.0 0.9 5.6 3.2 7.1 2.7 1.6 5.0 0.0 1.7 0.3 0.5 0.1 3.0 15.1 1.1 0.9 0.2 0.1 2.7 0.3 0.2 0.6 0.3 16.8 2.2 1.0 0.5 0.0 2.4 0.3 1.8 0.0 0.2 2.7 0.5 2.3 28.6 3.2 1.0 0.3 0.2 0.4 13.3 1.5 8.7 38.8 0.6 0.4 0.9 39.0 26.8 1.4 0.3 0.7 1.6 2.7 1.7 0.6 6.9 4.5 1.5 5.1 1.4 0.7 28.1 1.8 1.5 0.8 0.3 1.2 0.7 0.4 1.5 0.6 6.2 5.4 11.7 0.5 4.3 1.0 1.8 0.0 0.1 0.0 0.1 0.8 0.5 1.6 0.0 0.1 0.7 1.6 0.1 0.1 0.0 0.3 1.7 5.0 0.0 0.1 23.8 19.8 0.0 0.0 0.0 0.0 0.0 0.0 16.0 6.8 1.8 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 5.8 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 SIK2 "DKFZp434K1115, KIAA0781, LOH11CR1I, QIK, SNF1LK2" ENSG00000170145 "Salt inducible kinase 2" Q9H0K1 11 111602391-111730853 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 62.8;Rod photoreceptor cells: 60.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016026, HPA071049" Approved Approved "Nucleoplasm,Nuclear speckles,Vesicles,Intermediate filaments,Cytosol" NA NA "Nucleoplasm, Vesicles" "Nuclear speckles, Intermediate filaments, Cytosol" "HPA016026: AB_1857321, HPA071049: " "unprognostic (2.35e-1)" "unprognostic (1.10e-1)" "unprognostic (1.08e-1)" "unprognostic (1.10e-2)" "unprognostic (1.59e-2)" "unprognostic (4.81e-2)" "prognostic favorable (4.93e-4)" "unprognostic (6.41e-2)" "unprognostic (1.87e-1)" "unprognostic (1.40e-2)" "unprognostic (3.72e-3)" "unprognostic (9.27e-2)" "prognostic favorable (1.17e-9)" "unprognostic (1.23e-1)" "unprognostic (2.79e-1)" "unprognostic (2.82e-3)" "unprognostic (2.13e-2)" 32.8 10.7 10.1 6.6 17.2 4.0 22.5 10.6 17.3 10.0 9.9 15.1 5.2 7.7 9.5 7.0 7.9 9.7 12.7 14.5 10.5 10.3 14.6 24.4 13.6 5.4 9.7 9.9 16.4 37.8 22.0 28.6 7.5 11.9 8.4 8.3 14.9 15.4 8.6 35.1 8.7 7.7 8.7 9.6 5.8 19.6 4.2 13.0 4.4 11.1 7.9 5.8 8.6 10.0 2.2 2.7 2.8 3.6 2.2 3.5 2.1 5.9 4.0 7.0 7.5 34.8 10.3 4.1 5.2 7.5 4.0 4.6 13.4 6.4 4.7 7.3 6.1 4.7 8.4 5.4 3.9 5.2 3.5 2.3 5.1 3.5 6.6 7.5 4.9 3.3 10.0 5.8 5.8 7.6 8.0 4.7 4.7 4.7 6.9 6.2 2.8 5.1 4.5 2.4 5.0 3.9 6.9 7.4 5.6 8.9 5.4 3.3 7.7 7.7 3.1 3.1 6.6 7.7 4.0 6.5 8.8 5.3 5.6 7.1 2.0 1.5 9.9 2.8 7.0 5.9 1.1 3.3 2.8 3.5 3.6 1.9 2.0 2.5 2.5 2.7 2.2 1.4 2.0 1.4 2.2 2.9 1.5 2.4 2.1 10.1 17.2 10.6 16.4 10.5 10.3 9.7 9.9 11.9 13.0 17.9 32.3 9.1 6.7 13.1 14.4 16.6 22.9 13.4 11.4 15.7 62.8 3.5 5.0 7.1 12.4 18.0 9.5 46.7 6.7 4.1 14.4 5.8 9.2 34.2 4.8 30.2 17.3 9.8 12.4 9.7 10.6 8.6 18.6 2.8 10.2 13.3 9.2 8.6 13.8 20.7 60.3 0.0 13.7 3.2 5.9 10.5 4.3 7.4 9.9 6.5 SIK3 "FLJ12240, KIAA0999, L19, QSK" ENSG00000160584 "SIK family kinase 3" 11 116843402-117098437 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 106.0;Late spermatids: 130.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045245, HPA048161" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA045245: AB_2679270, HPA048161: AB_2680293" "unprognostic (3.19e-2)" "unprognostic (3.31e-1)" "unprognostic (2.78e-2)" "unprognostic (8.21e-2)" "unprognostic (1.31e-1)" "unprognostic (2.30e-2)" "unprognostic (2.73e-1)" "unprognostic (2.33e-2)" "unprognostic (7.63e-2)" "unprognostic (2.46e-2)" "unprognostic (1.28e-3)" "unprognostic (1.89e-1)" "prognostic favorable (1.12e-5)" "unprognostic (1.82e-1)" "unprognostic (6.85e-2)" "unprognostic (1.02e-2)" "unprognostic (3.28e-2)" 13.0 12.2 24.7 13.8 36.9 14.3 13.5 24.0 34.4 13.5 16.6 40.5 10.4 10.9 18.6 9.9 13.7 16.6 12.8 16.0 23.7 16.2 13.9 17.6 13.7 11.9 25.8 24.4 22.4 19.5 29.4 18.4 16.3 23.9 11.4 11.7 10.6 11.7 15.6 16.9 11.3 14.0 18.4 17.2 14.2 14.5 26.0 38.0 10.4 22.1 6.9 12.9 14.5 12.9 2.4 1.7 3.9 3.7 1.6 1.8 0.7 7.9 6.1 9.7 10.2 8.4 9.1 15.6 6.0 10.9 4.8 5.4 14.8 9.2 9.4 9.9 11.1 10.6 12.5 8.0 8.7 6.7 25.8 5.1 21.1 6.7 9.1 7.8 7.5 8.3 10.0 5.1 10.2 16.5 6.1 6.4 6.3 10.1 7.0 6.5 2.7 6.7 8.1 5.4 5.4 4.5 8.7 5.6 7.4 6.6 1.5 9.5 7.6 16.3 7.2 3.2 7.8 4.7 8.0 7.3 5.9 7.5 9.8 6.0 5.0 3.6 12.0 5.5 12.4 7.9 3.9 1.1 0.0 1.0 1.5 1.8 0.4 0.9 0.4 1.7 2.4 0.3 0.1 2.6 1.6 3.7 0.1 0.1 0.7 24.7 36.9 24.0 32.2 23.7 16.2 25.8 24.4 23.9 38.0 8.9 26.1 22.2 23.4 23.6 42.8 19.3 12.7 18.7 15.9 5.2 106.0 7.4 5.0 6.7 76.2 16.5 9.7 0.0 6.4 2.6 20.8 17.6 17.3 18.4 6.8 44.5 16.6 14.1 21.4 130.5 9.5 18.7 15.1 4.6 12.0 47.3 7.9 8.6 13.4 5.6 64.0 0.0 20.6 20.4 11.3 21.2 24.8 25.9 10.3 24.3 SIM2 "bHLHe15, MGC119447, SIM" ENSG00000159263 "Single-minded family bHLH transcription factor 2" Q14190 21 36699133-36749917 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 31.3;kidney: 16.1;lymphoid tissue: 28.7;skeletal muscle: 15.7" "Cell type enhanced" "Detected in some" 10 "Basal glandular cells: 8.9;Collecting duct cells: 8.7;Distal tubular cells: 8.3;Glandular cells: 6.5" "Cancer enhanced" "Detected in many" "prostate cancer: 11.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 13.3;PC-3: 23.0;RPTEC TERT1: 28.9;RT4: 17.4" "Region enhanced" "Detected in single" "hypothalamus: 0.5" "Not detected" "Not detected" HPA029295 Approved Supported "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA029295: AB_10610425" "unprognostic (1.17e-3)" "unprognostic (6.46e-2)" "unprognostic (5.03e-2)" "prognostic unfavorable (2.10e-4)" "unprognostic (8.62e-2)" "unprognostic (1.43e-2)" "unprognostic (8.30e-2)" "unprognostic (5.46e-3)" "unprognostic (1.65e-2)" "unprognostic (1.09e-1)" "unprognostic (5.16e-3)" "unprognostic (9.18e-2)" "unprognostic (9.18e-7)" "unprognostic (2.98e-2)" "unprognostic (3.79e-2)" "unprognostic (1.07e-2)" "prognostic favorable (2.88e-4)" 0.5 0.3 0.8 0.1 2.3 0.0 0.1 2.4 2.3 2.8 0.2 0.2 0.0 0.1 0.3 1.5 31.3 0.3 0.2 0.1 2.5 1.1 16.1 0.1 0.1 0.1 1.4 0.7 0.1 0.1 1.2 1.7 0.1 0.3 6.8 0.0 0.2 0.4 0.0 15.7 0.3 0.1 0.0 0.4 0.1 5.5 0.2 1.3 0.0 0.2 11.0 28.7 1.5 0.4 0.3 0.7 0.0 0.0 0.0 0.8 0.0 3.2 5.0 0.2 0.2 0.0 0.0 5.0 0.1 0.0 0.4 0.0 2.6 7.6 0.1 4.6 0.1 9.0 1.7 2.5 0.0 0.2 3.9 7.9 0.1 7.2 0.2 0.0 0.0 0.0 0.8 0.7 0.0 1.4 13.3 0.0 0.1 0.1 0.0 8.4 1.9 0.0 0.0 0.2 3.2 23.0 0.0 0.1 0.1 28.9 17.4 0.2 0.3 8.2 0.0 0.7 0.8 2.1 0.2 0.3 0.0 1.4 0.5 0.2 0.1 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 2.3 2.4 2.3 2.5 1.1 1.4 0.7 0.3 1.3 0.0 0.0 0.0 8.9 0.2 0.2 2.0 0.0 0.0 0.0 8.7 0.0 0.0 8.3 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.7 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.5 0.2 0.2 0.4 0.0 0.0 0.0 1.8 SIMC1 "C5orf25, FLJ44216, OOMA1, PLEIAD" ENSG00000170085 "SUMO interacting motifs containing 1" Q8NDZ2 5 176238367-176345991 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 29.3;testis: 41.5" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 64.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037889, HPA037890" Uncertain Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA037889: AB_2675720, HPA037890: AB_2675721" "unprognostic (1.15e-1)" "unprognostic (9.97e-2)" "unprognostic (3.81e-3)" "prognostic unfavorable (2.32e-6)" "prognostic unfavorable (1.59e-4)" "unprognostic (7.20e-2)" "unprognostic (5.59e-2)" "unprognostic (2.75e-1)" "unprognostic (1.97e-3)" "unprognostic (1.60e-1)" "unprognostic (1.21e-2)" "unprognostic (1.74e-1)" "unprognostic (2.52e-2)" "unprognostic (1.21e-1)" "unprognostic (2.53e-1)" "unprognostic (3.59e-2)" "unprognostic (9.20e-2)" 3.1 15.1 5.4 5.0 3.9 2.0 3.3 10.2 5.4 7.5 4.5 2.0 2.9 3.9 8.0 6.8 3.1 9.3 5.3 2.0 6.2 4.4 1.8 5.1 3.1 3.5 2.5 3.0 29.3 3.4 4.2 7.6 3.3 3.4 6.1 4.9 4.0 3.8 4.7 5.5 2.3 5.1 6.2 3.0 5.5 5.1 41.5 3.7 4.5 2.1 2.7 3.4 4.4 5.4 7.1 8.1 10.5 5.3 10.8 6.3 3.5 1.8 5.0 16.3 13.0 8.5 8.4 8.2 6.9 6.8 7.2 9.0 17.5 5.4 0.0 8.6 8.0 14.8 1.7 17.6 12.3 9.0 3.1 13.1 8.8 3.3 2.2 19.1 9.6 6.8 5.6 5.1 4.8 8.7 5.3 6.7 3.2 22.0 8.5 8.5 8.6 9.4 7.6 5.9 2.3 5.5 14.0 10.8 12.1 4.8 3.7 10.7 11.6 7.6 1.1 6.6 5.9 4.4 18.4 4.7 8.8 4.7 8.0 5.9 2.1 2.4 13.8 3.5 6.4 5.0 7.0 5.3 10.5 5.2 5.2 6.3 7.1 6.3 4.0 8.1 6.9 5.3 4.1 0.7 10.8 4.0 3.9 4.1 3.5 5.4 3.9 10.2 5.4 6.2 4.4 2.5 3.0 3.4 3.7 8.9 3.5 2.7 4.8 2.6 15.3 3.1 2.5 2.7 3.4 1.8 3.9 0.2 1.7 3.2 27.6 2.1 5.3 0.0 3.2 2.1 4.3 3.7 0.0 7.5 2.0 17.5 12.7 4.9 4.1 9.8 27.6 2.8 5.0 4.6 9.3 5.8 4.1 7.0 32.5 2.1 4.5 32.3 5.3 64.2 24.7 2.3 0.7 5.0 8.9 2.6 SIN3A "DKFZP434K2235, KIAA0700" ENSG00000169375 "SIN3 transcription regulator family member A" Q96ST3 15 75369379-75455842 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" Repressor "Cancer-related genes, Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004506, HPA047213, HPA062123" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004506: AB_2187766, HPA047213: AB_2679984, HPA062123: AB_2684689" "unprognostic (1.94e-1)" "unprognostic (1.38e-1)" "unprognostic (1.48e-1)" "unprognostic (1.27e-1)" "unprognostic (1.99e-1)" "unprognostic (2.90e-1)" "unprognostic (4.74e-2)" "unprognostic (1.91e-1)" "unprognostic (2.26e-1)" "unprognostic (2.15e-1)" "unprognostic (8.52e-2)" "unprognostic (1.37e-1)" "unprognostic (1.17e-3)" "unprognostic (7.33e-2)" "unprognostic (2.19e-1)" "unprognostic (1.33e-1)" "unprognostic (3.52e-1)" 21.0 15.4 14.0 19.4 18.5 31.6 20.4 26.3 15.5 26.3 20.2 19.9 15.3 11.8 26.6 16.8 17.7 22.1 15.9 13.4 14.2 11.8 13.6 13.9 17.4 20.7 13.0 14.2 27.6 19.8 23.4 16.8 17.2 13.0 22.9 14.3 23.0 17.6 20.5 18.2 23.5 17.9 24.5 12.8 20.3 16.8 28.5 15.1 48.7 24.0 12.8 26.9 26.0 19.0 9.8 6.5 9.3 8.3 9.7 12.7 6.3 12.9 26.9 24.1 15.8 12.0 12.7 13.9 9.7 15.2 14.4 15.5 14.8 17.7 28.3 10.2 14.4 19.7 23.3 34.9 14.7 15.8 22.8 18.1 26.7 20.5 11.6 9.1 25.3 22.9 15.4 11.4 16.7 17.5 14.9 12.9 20.3 21.0 31.6 11.6 15.1 24.8 16.3 23.4 17.3 11.3 25.1 31.9 17.4 10.3 23.9 19.1 19.0 24.1 10.8 13.5 24.2 16.4 20.1 11.2 17.9 24.2 11.8 14.4 21.8 34.0 30.1 10.6 25.9 9.9 3.3 4.8 6.9 8.5 4.8 12.7 9.3 10.8 10.7 6.5 9.8 11.1 9.5 9.3 9.7 8.3 4.4 9.5 6.3 14.0 18.5 26.3 15.5 14.2 11.8 13.0 14.2 13.0 15.1 32.8 26.7 28.9 21.6 34.9 19.3 12.6 17.8 29.4 31.8 26.2 29.5 18.2 5.0 13.3 6.8 23.9 11.8 0.0 11.0 9.1 23.6 23.5 29.9 14.3 11.4 19.1 16.6 26.4 23.0 3.1 21.3 20.0 10.1 12.6 17.1 17.2 12.3 15.0 19.1 8.4 31.7 12.9 17.6 37.7 41.7 46.4 18.3 22.3 15.9 16.6 SIN3B KIAA0700 ENSG00000127511 "SIN3 transcription regulator family member B" O75182 19 16829400-16880353 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Peritubular cells: 62.6;Syncytiotrophoblasts: 104.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050329 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA050329: AB_2681089" "unprognostic (2.71e-3)" "unprognostic (8.89e-2)" "unprognostic (1.32e-3)" "unprognostic (6.22e-2)" "unprognostic (1.24e-1)" "unprognostic (2.05e-2)" "unprognostic (5.44e-2)" "unprognostic (9.89e-2)" "unprognostic (5.42e-3)" "unprognostic (2.77e-1)" "prognostic favorable (4.37e-4)" "prognostic unfavorable (3.58e-4)" "unprognostic (1.18e-3)" "unprognostic (8.45e-2)" "unprognostic (1.49e-1)" "unprognostic (9.36e-2)" "unprognostic (1.06e-1)" 19.1 17.9 22.2 17.2 28.1 9.8 21.5 25.1 38.6 24.4 16.0 20.8 50.0 12.8 37.5 21.5 14.5 23.3 17.3 15.7 24.2 20.8 15.9 9.8 21.7 20.8 16.5 30.4 32.5 16.2 60.8 17.7 53.2 24.8 22.7 11.0 15.5 20.2 54.7 17.1 22.7 17.7 26.5 14.8 25.1 13.7 30.2 13.4 9.3 22.5 9.6 15.8 17.2 22.2 4.8 2.6 6.1 6.7 1.9 2.0 2.3 14.7 7.9 13.4 17.2 11.1 10.2 42.4 12.6 10.4 17.5 15.6 19.4 13.9 13.3 14.1 14.5 14.8 12.7 11.1 11.3 16.2 13.8 20.0 14.2 17.3 8.8 14.6 8.3 11.5 16.8 14.9 11.7 10.1 13.9 15.8 10.7 11.5 8.2 12.2 17.7 11.2 13.4 16.6 7.7 25.4 14.9 12.3 8.7 9.9 12.6 9.9 12.4 15.9 12.3 9.9 18.8 8.6 7.8 20.7 17.0 10.4 24.5 14.0 11.8 8.6 13.3 11.8 10.9 12.6 0.1 6.7 6.1 1.8 6.0 1.2 4.8 1.7 2.0 2.1 3.8 2.0 1.4 3.3 1.9 5.3 2.6 0.5 2.3 22.2 28.1 25.1 38.6 24.2 20.8 16.5 30.4 24.8 13.4 20.8 14.8 10.7 8.6 7.0 18.1 6.9 2.5 5.3 7.9 3.5 13.7 17.1 3.3 9.2 7.9 11.7 4.7 0.0 7.4 24.5 8.6 10.0 4.7 5.6 15.1 9.5 4.7 8.0 13.0 18.2 46.9 6.6 5.0 10.0 7.9 8.7 12.5 3.5 62.6 4.5 15.7 6.5 6.6 9.3 10.4 7.0 104.5 6.4 5.8 11.2 SINHCAF "C12orf14, FAM60A, TERA" ENSG00000139146 "SIN3-HDAC complex associated factor" Q9NP50 12 31280584-31327058 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 108.4;Club cells: 103.5;Extravillous trophoblasts: 98.9;monocytes: 269.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 83.1" "Low region specificity" "Detected in all" "HPA038167, HPA057585" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038167: AB_10675629, HPA057585: AB_2732615" "unprognostic (2.89e-1)" "unprognostic (1.33e-2)" "unprognostic (1.85e-2)" "unprognostic (8.91e-2)" "unprognostic (2.80e-3)" "unprognostic (1.84e-2)" "prognostic unfavorable (5.78e-4)" "unprognostic (1.69e-1)" "unprognostic (1.21e-1)" "unprognostic (1.68e-1)" "prognostic unfavorable (5.57e-4)" "unprognostic (1.15e-1)" "prognostic favorable (7.89e-4)" "unprognostic (3.22e-1)" "unprognostic (2.49e-1)" "unprognostic (3.07e-1)" "unprognostic (9.75e-2)" 13.1 6.5 1.6 21.4 5.1 7.9 11.1 4.5 1.9 25.4 15.8 3.4 15.8 6.7 28.3 16.8 19.8 14.6 8.4 5.6 2.9 1.8 16.6 3.3 17.0 22.5 3.4 0.9 18.5 19.6 7.6 19.6 18.9 5.2 18.6 8.3 6.0 16.3 20.1 3.2 12.7 17.0 11.7 3.8 18.5 7.0 13.6 3.7 39.0 14.9 12.3 27.3 19.3 13.6 22.8 28.3 7.9 8.0 19.0 15.1 10.4 3.4 5.1 17.2 3.4 1.0 2.1 31.9 1.8 1.3 3.5 4.7 13.7 9.0 11.9 14.6 0.5 3.8 6.2 14.4 6.9 6.9 12.6 6.4 8.2 3.5 8.5 4.3 13.3 8.0 1.9 10.8 3.0 14.7 6.9 8.1 14.2 11.3 4.6 1.5 2.6 23.8 9.8 83.1 10.7 2.8 20.2 8.2 10.2 7.9 10.3 24.0 16.2 4.2 7.6 9.9 39.4 3.2 7.9 8.9 0.8 5.2 0.4 5.9 5.3 7.6 24.0 2.4 5.1 4.6 7.9 4.8 7.5 8.8 5.8 10.3 22.8 12.3 10.4 10.4 17.9 15.1 11.8 1.5 19.0 8.0 28.3 5.8 10.4 1.6 5.1 4.5 1.9 2.9 1.8 3.4 0.9 5.2 3.7 71.5 30.2 0.0 0.0 0.0 0.0 0.0 0.0 108.4 103.5 43.6 0.0 63.7 69.6 61.6 0.0 0.0 0.0 0.0 37.9 98.9 0.0 0.0 10.5 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 269.7 0.0 0.0 47.6 0.0 0.0 30.0 0.0 0.0 0.0 0.0 0.0 0.0 50.6 0.0 0.0 0.0 SIPA1 SPA1 ENSG00000213445 "Signal-induced proliferation-associated 1" Q96FS4 11 65638097-65650930 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 47.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020833, HPA039867" Enhanced Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane" NA NA Nucleoli "Nucleoplasm, Golgi apparatus, Plasma membrane" "CAB020833: , HPA039867: AB_2676716" "unprognostic (6.10e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (9.42e-4)" "unprognostic (1.35e-2)" "unprognostic (2.93e-1)" "unprognostic (2.32e-2)" "unprognostic (3.35e-2)" "unprognostic (1.09e-1)" "unprognostic (3.30e-2)" "unprognostic (6.44e-2)" "unprognostic (5.85e-2)" "unprognostic (4.86e-2)" "prognostic unfavorable (3.52e-6)" "unprognostic (1.60e-1)" "unprognostic (2.78e-2)" "unprognostic (1.14e-2)" "unprognostic (1.49e-1)" 10.5 9.1 7.5 27.1 12.0 29.8 10.0 2.6 8.7 8.9 10.8 9.4 2.9 7.7 10.9 3.0 7.6 9.0 9.9 8.0 8.4 4.6 9.5 7.8 17.6 33.2 11.5 4.7 7.7 4.6 2.7 4.2 11.9 10.3 8.6 3.9 8.2 8.7 6.8 5.4 4.2 17.2 9.0 14.3 47.1 8.1 3.0 10.5 25.3 7.7 4.6 32.7 8.5 7.8 6.6 2.8 14.1 5.2 5.8 7.4 3.0 0.7 6.2 4.5 9.6 2.6 5.5 10.6 7.2 6.1 5.6 5.5 1.9 6.9 9.9 16.2 3.5 0.2 3.6 1.6 2.4 1.9 10.7 4.0 24.2 9.2 3.4 4.7 9.8 10.5 5.6 1.1 7.8 1.0 5.6 16.4 10.4 13.7 4.6 2.8 2.7 3.9 16.7 3.0 2.5 5.8 17.8 2.5 8.8 2.1 0.5 1.7 10.3 3.5 6.1 14.6 4.3 4.6 15.1 23.0 6.9 14.1 7.6 1.4 6.9 5.4 22.3 9.5 15.6 20.1 4.0 4.1 10.2 7.4 4.8 5.5 5.3 3.7 4.8 2.8 6.6 2.9 4.4 14.1 5.8 5.2 2.7 3.5 3.0 7.5 12.0 2.6 8.7 8.4 4.6 11.5 4.7 10.3 10.5 6.0 6.9 45.9 21.9 6.1 1.7 3.7 25.5 0.0 2.3 22.7 0.0 7.8 31.5 18.4 2.6 16.8 17.3 23.3 13.0 17.8 8.2 22.9 6.9 19.8 31.9 4.8 20.2 39.9 38.3 5.4 7.5 26.7 10.1 10.8 11.7 4.8 23.9 11.5 12.4 14.6 1.6 12.9 14.0 0.7 17.9 9.7 11.3 33.2 11.4 27.8 SIPA1L3 KIAA0545 ENSG00000105738 "Signal induced proliferation associated 1 like 3" O60292 19 37907228-38208372 "Disease related genes, Predicted intracellular proteins" "GTPase activation" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 68.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 4.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "A549: 29.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042072, HPA045480, HPA074988" Uncertain Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA042072: AB_2677832, HPA045480: AB_2679342, HPA074988: " "unprognostic (4.24e-2)" "unprognostic (1.23e-1)" "unprognostic (1.86e-1)" "unprognostic (5.56e-2)" "unprognostic (9.99e-2)" "unprognostic (1.22e-2)" "unprognostic (1.31e-2)" "unprognostic (5.48e-2)" "unprognostic (3.11e-1)" "unprognostic (6.05e-2)" "unprognostic (3.15e-1)" "unprognostic (5.43e-2)" "unprognostic (9.26e-3)" "unprognostic (6.45e-2)" "unprognostic (4.94e-2)" "unprognostic (5.36e-2)" "unprognostic (1.96e-2)" 6.2 6.2 10.8 15.3 11.9 5.4 10.0 18.1 13.2 9.8 18.3 13.0 13.9 31.1 6.7 6.4 9.0 9.3 7.6 11.1 15.8 7.7 12.4 6.9 10.5 11.4 10.5 7.8 6.0 17.1 7.4 7.8 3.4 8.5 9.7 12.8 11.2 14.1 9.1 11.4 19.0 29.7 6.2 8.7 12.2 16.4 8.1 12.4 11.7 18.2 6.7 20.2 10.0 11.8 4.6 0.9 1.1 3.5 0.9 1.4 0.3 16.8 29.9 3.7 4.7 2.2 2.2 2.5 7.3 6.2 4.8 4.6 10.2 9.8 9.6 6.3 6.2 4.1 3.8 3.4 13.7 5.4 3.2 1.6 2.6 2.8 3.2 4.3 1.8 2.8 1.7 7.2 9.0 19.3 7.2 5.5 2.8 1.9 2.1 8.4 5.2 2.4 2.5 3.0 13.4 8.0 5.3 3.0 1.4 10.7 14.5 8.9 4.8 8.0 13.8 1.1 2.1 9.2 1.7 11.6 8.1 2.8 24.8 11.2 2.8 4.7 3.3 10.4 2.4 10.4 0.2 0.4 1.1 0.5 0.7 0.2 3.0 0.4 0.5 0.2 4.6 0.4 1.4 0.3 0.9 3.5 0.9 0.3 0.3 10.8 11.9 18.1 13.2 15.8 7.7 10.5 7.8 8.5 12.4 6.0 8.5 13.9 4.5 10.6 18.9 5.1 22.9 10.7 10.3 22.7 13.7 1.6 3.3 6.9 4.1 4.5 68.3 0.0 13.1 1.1 2.2 6.5 2.3 20.2 2.9 31.8 24.2 6.2 4.9 6.4 2.0 5.3 5.0 5.4 41.5 2.3 12.5 30.2 1.8 17.1 5.9 6.5 2.8 1.4 4.7 14.1 0.7 3.2 27.0 4.6 SIRT1 SIR2L1 ENSG00000096717 "Sirtuin 1" Q96EB6 10 67884669-67918390 "Predicted intracellular proteins" "Apoptosis, Biological rhythms, Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Early spermatids: 171.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003855, HPA006295, HPA052351" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Mitochondria,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Mitochondria, Cytosol" "CAB003855: AB_365497, HPA006295: AB_1079975, HPA052351: AB_2681796" "unprognostic (1.55e-1)" "unprognostic (2.78e-1)" "unprognostic (9.13e-2)" "unprognostic (1.05e-1)" "unprognostic (1.91e-1)" "unprognostic (2.05e-2)" "unprognostic (2.48e-1)" "unprognostic (4.95e-2)" "unprognostic (1.41e-1)" "unprognostic (4.64e-2)" "unprognostic (1.72e-1)" "unprognostic (9.61e-2)" "unprognostic (2.18e-2)" "unprognostic (2.83e-2)" "unprognostic (9.67e-2)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" 17.2 32.3 12.6 21.1 17.8 17.0 18.1 22.6 14.5 24.2 20.5 15.7 14.0 9.2 19.0 12.7 12.7 15.1 15.2 14.7 14.1 10.4 13.9 17.3 12.6 16.1 17.0 10.1 26.6 14.4 16.4 13.3 14.7 12.1 21.7 12.5 12.1 12.3 16.1 19.9 12.9 15.0 21.0 17.7 13.5 13.2 25.4 16.3 28.1 15.2 9.3 14.7 21.6 37.5 4.9 3.9 3.8 3.5 3.6 7.1 1.8 8.3 9.6 15.2 16.9 14.5 11.2 9.5 11.6 12.0 16.0 14.3 10.5 7.2 17.6 6.3 7.7 10.0 6.7 18.8 3.9 17.2 9.4 10.9 9.3 7.2 8.2 13.3 10.0 7.2 10.3 9.4 9.6 16.6 17.2 6.4 10.1 11.8 9.6 11.6 6.7 9.3 13.9 18.8 5.4 15.3 16.9 12.0 6.9 7.5 5.2 9.8 13.5 21.3 14.1 14.7 13.7 10.2 9.3 5.3 12.5 11.6 11.0 11.2 8.1 9.6 34.9 6.4 15.2 5.1 3.8 2.4 3.2 3.4 3.0 4.9 4.9 3.7 4.7 3.9 3.3 7.1 4.2 3.1 3.6 3.5 3.5 2.9 1.8 12.6 17.8 22.6 14.5 14.1 10.4 17.0 10.1 12.1 16.3 17.9 6.1 10.4 16.4 34.8 11.7 27.0 15.3 1.4 9.1 5.2 25.5 5.7 5.0 3.9 171.4 12.8 17.4 23.3 4.7 4.3 17.6 23.9 11.5 14.8 7.8 11.1 41.1 14.1 20.9 29.0 16.4 13.5 15.1 1.8 16.9 7.0 6.4 10.5 18.4 6.3 13.4 0.0 38.2 20.6 15.4 41.5 10.4 13.8 12.4 14.9 SIRT2 SIR2L ENSG00000068903 "Sirtuin 2" Q8IXJ6 19 38878555-38899862 "Cancer-related genes, Predicted intracellular proteins" "Autophagy, Cell cycle, Cell division, Differentiation, Immunity, Innate immunity, Meiosis, Mitosis, Neurogenesis, Transcription, Transcription regulation" Transferase "Cancer-related genes, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 86.6;skeletal muscle: 108.7" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 174.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004573, HPA011165" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" Nucleoplasm "CAB004573: AB_2188600, HPA011165: AB_1856900" "unprognostic (2.15e-2)" "unprognostic (2.24e-2)" "unprognostic (2.88e-1)" "prognostic unfavorable (7.20e-7)" "unprognostic (3.75e-3)" "unprognostic (1.28e-2)" "unprognostic (2.85e-2)" "unprognostic (2.44e-3)" "unprognostic (2.73e-1)" "unprognostic (4.83e-2)" "unprognostic (2.97e-3)" "unprognostic (1.02e-1)" "unprognostic (1.90e-1)" "unprognostic (3.60e-2)" "unprognostic (1.19e-1)" "unprognostic (8.73e-2)" "unprognostic (1.70e-1)" 14.1 11.0 30.2 8.1 36.0 10.7 9.1 14.3 38.8 11.0 8.4 78.1 4.0 9.3 9.7 7.8 17.1 12.9 10.7 20.3 36.9 23.5 9.0 12.0 10.8 8.8 52.3 20.5 17.3 9.5 10.1 6.2 7.7 40.8 9.8 7.6 5.8 14.9 11.2 108.7 13.7 9.3 12.8 86.6 9.9 9.0 7.9 46.3 3.2 10.1 23.4 8.9 10.6 7.1 13.2 21.5 28.0 33.0 16.6 23.5 22.1 8.2 5.2 4.4 11.1 25.6 17.6 3.0 6.1 10.9 9.5 12.3 9.3 5.3 2.9 13.3 11.3 7.3 4.5 8.1 13.1 5.8 13.2 8.4 5.6 5.9 5.6 18.1 3.9 12.4 18.4 15.8 7.8 9.4 11.8 16.7 9.4 5.2 22.9 14.5 4.7 7.8 3.0 0.7 14.1 7.3 10.4 12.6 8.0 7.7 7.4 11.3 5.1 7.1 9.5 6.7 3.9 4.3 10.1 15.8 12.9 2.8 19.9 9.0 9.4 4.5 6.6 10.3 9.8 11.9 19.5 27.3 28.0 23.5 33.0 14.6 12.2 11.4 16.1 21.1 13.2 7.5 12.5 20.7 16.6 25.8 21.5 15.5 22.1 30.2 36.0 14.3 38.8 36.9 23.5 52.3 20.5 40.8 46.3 14.9 20.8 11.4 27.5 45.8 26.8 30.8 7.6 29.4 20.5 12.2 33.4 28.9 31.5 27.0 174.5 26.3 34.2 23.3 15.3 12.8 23.1 19.4 25.3 16.2 56.7 28.6 16.8 23.9 33.7 57.6 28.7 34.2 43.9 14.4 20.4 20.6 21.1 18.6 38.5 23.3 27.0 19.4 35.0 12.7 5.9 52.6 35.4 43.6 15.8 22.6 SIRT6 ENSG00000077463 "Sirtuin 6" Q8N6T7 19 4174109-4182604 "Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 70.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049729, HPA071776" Supported Supported Nucleoplasm No No Nucleoplasm "HPA049729: AB_2680865, HPA071776: AB_2686445" "unprognostic (4.58e-1)" "unprognostic (3.41e-3)" "unprognostic (1.36e-1)" "prognostic favorable (2.85e-4)" "unprognostic (2.28e-1)" "unprognostic (4.14e-2)" "unprognostic (2.93e-3)" "unprognostic (8.32e-2)" "unprognostic (1.86e-1)" "unprognostic (6.13e-2)" "unprognostic (7.27e-3)" "unprognostic (4.42e-2)" "unprognostic (5.84e-2)" "prognostic favorable (9.13e-4)" "unprognostic (5.17e-2)" "unprognostic (1.63e-1)" "prognostic favorable (2.58e-4)" 9.5 11.7 9.4 14.6 11.5 17.8 8.0 15.2 16.3 9.0 26.3 11.0 14.8 19.3 10.6 11.9 11.1 8.9 9.9 11.4 9.5 9.0 12.1 14.2 8.7 12.7 10.8 8.5 8.1 17.3 9.4 13.4 12.1 8.2 12.0 15.3 10.9 12.1 11.9 10.2 13.0 18.4 8.0 7.9 15.1 15.3 6.6 7.0 14.4 10.7 10.0 11.9 8.1 8.9 10.7 14.1 12.4 16.2 5.1 12.0 8.0 14.1 9.6 4.9 6.1 3.8 3.5 7.6 6.9 5.2 5.9 5.2 6.4 5.4 9.2 7.6 4.6 5.4 9.1 2.7 7.6 0.9 17.3 5.4 3.8 5.1 5.8 8.6 9.7 14.9 4.8 6.0 6.1 3.8 4.7 5.2 8.7 8.4 21.1 3.1 10.7 13.4 10.2 8.3 5.3 8.9 10.5 4.5 10.4 5.6 6.4 6.5 10.5 6.2 5.9 13.3 2.0 5.9 12.9 7.9 6.0 6.1 21.0 10.2 26.7 14.0 10.0 12.0 15.6 7.2 5.2 13.4 11.3 11.6 16.2 6.5 10.5 7.8 9.3 14.1 10.7 6.9 6.5 12.4 5.1 12.5 11.9 12.0 8.0 9.4 11.5 15.2 16.3 9.5 9.0 10.8 8.5 8.2 7.0 11.9 8.2 13.7 8.9 9.2 10.5 2.8 10.2 8.1 9.1 5.2 17.7 19.3 11.6 28.5 1.3 6.6 70.3 0.0 23.0 20.0 8.5 7.5 5.7 6.6 21.6 12.7 25.3 14.1 8.7 1.4 10.6 14.0 5.0 34.3 23.1 10.3 25.4 29.8 7.8 11.6 13.0 0.0 8.5 7.0 9.1 11.0 21.4 10.5 24.3 11.1 SIRT7 ENSG00000187531 "Sirtuin 7" Q9NRC8 17 81911939-81921323 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Chromatin regulator, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "eosinophil: 17.4" "Lineage enriched" "Detected in all" 4 "granulocytes: 17.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027284, HPA028246, CAB037261, HPA053669" Approved Supported "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "CAB037261: AB_1079989, HPA027284: , HPA028246: , HPA053669: AB_2682224" "unprognostic (8.15e-3)" "unprognostic (3.24e-2)" "unprognostic (3.26e-2)" "unprognostic (2.41e-2)" "unprognostic (1.46e-1)" "unprognostic (3.36e-2)" "prognostic unfavorable (1.97e-5)" "unprognostic (3.03e-1)" "unprognostic (2.10e-1)" "unprognostic (2.46e-2)" "unprognostic (2.79e-1)" "unprognostic (1.71e-2)" "prognostic unfavorable (1.69e-7)" "unprognostic (4.34e-3)" "unprognostic (1.20e-1)" "unprognostic (4.77e-2)" "unprognostic (2.16e-2)" 6.2 5.9 6.7 10.1 12.8 22.6 6.4 17.0 11.4 8.2 12.9 7.0 9.0 14.3 5.5 4.6 28.8 7.2 10.6 3.9 6.7 2.6 7.9 9.8 7.9 11.3 11.0 6.6 4.8 18.7 4.9 7.8 8.8 7.6 7.1 6.7 3.7 12.7 7.0 5.3 15.7 15.3 5.1 5.7 14.1 18.4 8.9 8.8 8.3 6.7 7.3 16.4 8.3 12.3 3.9 1.8 17.4 3.4 1.3 2.6 1.2 15.3 12.8 1.6 5.6 4.2 4.0 10.3 7.8 6.6 9.2 8.7 11.0 12.3 6.9 6.1 4.3 5.8 11.1 6.3 4.8 3.0 5.9 13.6 6.0 6.2 17.3 12.8 7.8 12.4 4.0 15.2 8.8 7.3 3.8 6.8 3.8 6.4 3.4 4.3 12.1 8.3 11.1 4.0 23.9 13.3 5.6 3.3 6.4 8.9 10.1 6.7 8.8 9.0 21.7 10.0 3.2 9.0 18.7 5.3 4.1 9.1 7.7 14.1 5.7 1.8 5.0 10.1 10.7 6.7 3.0 2.3 17.4 2.6 3.4 0.9 3.3 2.0 2.1 1.2 3.9 1.8 0.6 3.8 1.3 2.6 1.8 1.0 1.2 6.7 12.8 17.0 11.4 6.7 2.6 11.0 6.6 7.6 8.8 11.9 9.8 27.4 19.4 33.8 22.2 4.0 20.4 16.0 3.4 17.4 53.0 25.1 8.3 18.8 17.0 15.3 59.6 0.0 12.0 29.1 12.9 25.0 11.5 14.7 23.3 28.6 19.5 14.1 19.8 9.1 13.3 24.8 23.6 45.9 28.5 19.3 36.4 49.1 9.6 10.5 35.9 0.0 17.5 37.1 38.4 48.6 41.2 44.8 31.8 44.5 SIVA1 "CD27BP, SIVA, Siva-1, Siva-2" ENSG00000184990 "SIVA1 apoptosis inducing factor" O15304 14 104753100-104768494 "Predicted intracellular proteins" "Apoptosis, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 82.2" "Low region specificity" "Detected in all" "HPA065398, HPA066693" Supported Nucleoplasm NA NA Nucleoplasm "HPA065398: AB_2685484, HPA066693: AB_2685703" "unprognostic (1.86e-1)" "prognostic favorable (5.95e-4)" "unprognostic (1.61e-1)" "unprognostic (1.51e-1)" "unprognostic (6.89e-2)" "unprognostic (2.27e-1)" "unprognostic (4.77e-3)" "unprognostic (2.89e-1)" "unprognostic (2.17e-2)" "unprognostic (7.19e-3)" "unprognostic (5.85e-3)" "unprognostic (3.21e-2)" "unprognostic (4.94e-2)" "unprognostic (3.06e-2)" "unprognostic (4.08e-1)" "unprognostic (3.51e-1)" "unprognostic (7.43e-2)" 20.4 17.6 16.1 25.2 15.2 53.5 18.2 16.6 16.8 19.2 24.1 11.1 21.7 24.4 19.8 32.2 19.3 19.5 25.5 25.9 13.0 12.5 18.4 34.4 15.5 22.5 16.3 12.9 23.7 50.0 5.8 23.7 17.7 14.1 20.6 5.1 20.3 32.7 28.3 66.5 15.0 25.0 19.8 10.3 21.5 21.6 32.2 14.0 51.6 30.0 29.5 18.0 20.6 32.6 38.4 95.6 46.4 33.4 17.9 38.4 35.6 25.4 38.6 10.6 17.4 3.7 4.6 27.9 13.9 7.7 17.3 15.1 29.4 22.5 24.4 20.9 5.0 11.1 25.3 3.9 14.0 1.3 19.1 38.8 9.7 23.2 35.1 9.2 16.3 16.5 5.7 6.4 7.9 2.4 2.4 9.8 70.6 9.6 13.9 3.9 82.2 55.9 37.1 16.0 15.5 53.6 32.9 21.9 19.3 3.7 22.1 27.6 14.0 19.5 11.8 18.1 1.7 22.6 18.7 10.6 13.8 17.3 33.1 22.6 11.4 12.2 29.5 16.2 19.1 15.6 32.9 27.6 46.4 28.6 31.2 32.1 38.4 34.5 31.1 20.6 36.9 38.4 32.5 26.2 17.9 33.4 95.6 35.7 35.6 16.1 15.2 16.6 16.8 13.0 12.5 16.3 12.9 14.1 14.0 56.6 107.8 116.9 166.9 103.5 33.0 44.5 81.5 165.9 100.1 97.7 11.8 237.3 117.7 67.8 87.6 89.4 120.5 70.0 148.8 291.1 153.0 148.7 142.0 188.9 156.4 36.5 87.5 157.8 74.2 29.2 130.3 100.2 102.9 129.0 130.7 119.2 90.2 121.0 116.7 146.6 37.8 109.9 138.3 289.6 290.9 102.1 232.8 109.3 175.3 150.2 SIX1 DFNA23 ENSG00000126778 "SIX homeobox 1" Q15475 14 60643415-60658259 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 39.1;salivary gland: 55.1;skeletal muscle: 59.0" "Cell type enhanced" "Detected in some" 19 "Basal glandular cells: 23.3;Ciliated cells: 65.6;Club cells: 33.0;Glandular cells: 24.0;Urothelial cells: 14.9" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "olfactory region: 1.2;pons and medulla: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 14.3;LHCN-M2: 53.4;RH-30: 29.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001893, CAB058690" Enhanced Supported Nucleoplasm,Nucleoli No No Nucleoplasm Nucleoli "CAB058690: AB_2665581, HPA001893: AB_1079991" "unprognostic (3.62e-1)" "unprognostic (5.44e-2)" "unprognostic (5.09e-2)" "prognostic unfavorable (8.92e-6)" "unprognostic (1.33e-2)" "unprognostic (1.44e-2)" "unprognostic (2.04e-3)" "prognostic favorable (3.94e-4)" "unprognostic (1.40e-1)" "unprognostic (9.15e-2)" "unprognostic (6.45e-2)" "unprognostic (1.89e-1)" "unprognostic (3.06e-8)" "unprognostic (8.61e-2)" "unprognostic (2.13e-1)" "unprognostic (1.94e-1)" "unprognostic (3.86e-1)" 7.1 0.4 0.3 0.1 0.5 0.1 4.7 0.3 0.6 7.4 0.2 0.2 0.0 0.1 0.2 2.1 1.3 0.5 0.4 0.4 0.3 0.3 0.3 0.2 1.8 0.3 0.4 1.2 0.3 0.3 16.8 39.1 0.1 4.5 8.7 0.1 2.0 55.1 0.2 59.0 0.4 0.2 0.7 0.5 0.2 0.5 1.6 0.0 6.5 2.4 22.5 3.0 1.4 9.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 8.3 1.9 0.2 11.9 6.9 8.1 0.1 2.0 4.5 2.3 2.0 0.0 3.8 0.0 1.1 0.4 1.1 2.7 3.9 3.6 0.8 0.0 9.5 0.9 0.8 2.7 0.0 0.0 0.1 6.0 1.8 1.6 0.3 14.3 0.1 0.7 2.6 0.0 53.4 1.3 0.0 0.2 0.0 0.0 4.8 0.0 29.2 0.0 2.3 6.5 1.1 0.1 2.3 0.1 2.4 0.2 1.4 0.2 6.8 3.2 3.2 3.7 3.0 0.2 0.0 0.0 0.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.3 0.5 0.3 0.3 0.4 1.2 4.5 0.0 3.0 1.0 0.0 23.3 0.1 0.0 0.8 0.0 65.6 33.0 1.8 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.7 0.4 0.8 24.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 1.1 0.0 0.3 0.0 0.2 0.0 2.5 0.1 0.2 0.0 0.0 14.9 SIX2 ENSG00000170577 "SIX homeobox 2" Q9NPC8 2 45005161-45009430 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 23.3;skeletal muscle: 21.0" "Cell type enhanced" "Detected in some" 9 "Cardiomyocytes: 2.2;Exocrine glandular cells: 1.9;Melanocytes: 1.7;Pancreatic endocrine cells: 1.2;Smooth muscle cells: 1.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 23.9;LHCN-M2: 22.0;RH-30: 15.1;SCLC-21H: 25.8;U-2197: 16.7;U-698: 19.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA056958 Supported "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA056958: AB_2683287" "unprognostic (1.14e-3)" "unprognostic (2.73e-2)" "unprognostic (3.09e-6)" "unprognostic (1.28e-2)" "unprognostic (3.28e-1)" "unprognostic (8.77e-2)" "unprognostic (4.06e-3)" "unprognostic (9.17e-2)" "unprognostic (1.48e-1)" "unprognostic (1.96e-1)" "unprognostic (1.02e-2)" "unprognostic (1.07e-2)" "unprognostic (4.53e-9)" "unprognostic (1.53e-1)" "unprognostic (1.23e-1)" "unprognostic (1.56e-5)" "unprognostic (1.05e-1)" 5.8 0.2 0.2 0.2 0.4 0.1 3.4 0.5 0.4 13.3 0.4 0.2 0.0 0.1 1.1 0.8 0.8 0.1 0.1 0.8 0.1 0.0 0.4 0.1 0.3 0.2 0.9 1.8 0.3 4.6 5.7 13.5 0.3 1.4 5.2 0.1 9.3 23.3 1.3 21.0 0.3 0.1 0.4 0.8 0.1 7.4 1.1 0.0 3.9 0.7 4.0 0.8 1.7 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 6.3 23.9 0.0 0.1 1.1 0.4 0.0 0.2 0.0 0.0 1.0 0.0 0.1 0.0 2.2 3.9 0.2 0.0 1.2 0.0 7.7 0.0 0.0 0.0 2.1 1.1 0.0 4.9 0.0 0.1 0.7 0.2 0.1 0.0 22.0 0.8 0.0 1.3 0.2 0.0 4.8 0.0 15.1 0.0 0.0 1.2 25.8 0.2 3.3 0.1 0.0 0.2 0.1 1.9 0.3 0.4 1.3 16.7 0.0 0.5 0.0 19.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.5 0.4 0.1 0.0 0.9 1.8 1.4 0.0 0.0 0.0 0.0 0.4 0.8 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 0.0 0.8 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.5 0.0 1.4 0.0 0.1 0.6 0.0 0.0 0.0 0.1 SIX3 HPE2 ENSG00000138083 "SIX homeobox 3" O95343 2 44941898-44946077 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Holoprosencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 40.2;parathyroid gland: 32.1;pituitary gland: 30.9;retina: 66.5" "Group enriched" "Detected in some" 18 "Bipolar cells: 197.9;Horizontal cells: 174.8;Muller glia cells: 357.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "basal ganglia: 40.2" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "hTERT-RPE1: 34.3;SCLC-21H: 31.9;SH-SY5Y: 12.7" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 38.7" HPA067988 Approved Nucleoplasm NA NA Nucleoplasm "HPA067988: AB_2685939" "unprognostic (1.19e-3)" "unprognostic (1.05e-2)" "unprognostic (4.76e-1)" "unprognostic (1.58e-2)" "unprognostic (1.11e-1)" "unprognostic (1.76e-2)" "unprognostic (1.31e-1)" "unprognostic (1.36e-1)" "unprognostic (1.44e-1)" "unprognostic (6.82e-2)" "unprognostic (1.22e-1)" "unprognostic (2.49e-3)" "unprognostic (3.91e-2)" "unprognostic (1.76e-1)" "unprognostic (2.73e-2)" 0.4 0.4 3.7 0.5 40.2 0.5 0.5 0.7 0.7 1.5 0.4 1.5 0.0 0.5 0.4 0.4 0.5 0.4 0.5 0.4 1.6 7.2 0.4 0.4 0.5 0.5 1.1 2.7 0.4 1.0 32.1 30.9 0.4 0.1 0.4 0.4 66.5 0.4 0.4 1.1 0.5 0.4 0.4 0.0 0.4 0.5 0.8 6.5 0.0 0.4 0.0 0.4 0.4 0.0 1.1 1.1 4.5 2.2 1.9 1.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.3 0.0 5.9 0.0 0.0 0.2 2.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 34.3 0.0 0.7 0.0 0.0 0.0 0.0 0.1 1.3 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 31.9 12.7 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.6 1.2 1.0 1.1 1.7 1.1 1.1 0.8 0.8 1.1 1.3 1.4 1.7 1.9 2.2 1.1 1.3 0.7 3.7 40.2 0.7 0.7 1.6 7.2 1.1 2.7 0.1 6.5 0.0 0.0 0.0 0.0 0.0 197.9 0.8 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 174.8 1.7 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 357.8 0.0 0.0 0.0 0.6 13.4 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 SIX4 AREC3 ENSG00000100625 "SIX homeobox 4" Q9UIU6 14 60709528-60724348 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 20.4;salivary gland: 16.4;skeletal muscle: 19.3" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 9.2;Ciliated cells: 20.1;Cone photoreceptor cells: 19.6;Glandular cells: 15.2;Urothelial cells: 10.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 20.7;hTERT-RPE1: 15.9;RH-30: 21.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA031794 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA031794: AB_10602928" "unprognostic (2.23e-1)" "unprognostic (9.50e-2)" "unprognostic (2.63e-4)" "unprognostic (9.74e-2)" "unprognostic (2.69e-2)" "unprognostic (1.03e-1)" "unprognostic (5.39e-2)" "unprognostic (1.28e-2)" "unprognostic (8.13e-2)" "unprognostic (2.33e-2)" "unprognostic (4.39e-2)" "unprognostic (5.38e-2)" "unprognostic (1.01e-1)" "unprognostic (2.99e-2)" "unprognostic (2.11e-1)" "unprognostic (1.51e-3)" "unprognostic (1.08e-1)" 2.0 1.5 0.9 0.6 0.9 0.3 4.8 4.3 4.5 3.3 0.7 0.1 3.3 0.4 1.6 1.3 0.5 3.5 1.1 1.5 1.0 1.0 1.4 0.5 2.1 0.2 1.0 2.2 2.9 3.3 20.4 6.3 2.1 3.6 4.0 0.3 0.8 16.4 2.7 19.3 0.5 0.5 0.9 1.8 0.3 2.0 0.7 1.1 0.8 3.9 2.4 1.4 1.7 14.3 0.2 0.1 1.0 0.1 0.3 0.2 0.0 20.7 1.5 1.2 5.6 4.9 6.2 9.8 4.7 7.1 1.4 2.0 1.0 6.6 0.0 3.1 2.3 1.4 7.9 5.6 3.8 3.3 1.6 4.6 0.6 2.1 1.4 1.6 2.1 0.2 2.9 1.8 1.3 6.6 15.9 1.2 0.4 4.1 0.0 7.2 5.2 0.0 0.2 3.6 0.1 8.9 1.3 21.0 0.0 2.5 11.9 3.4 0.3 3.0 4.7 1.2 2.0 6.4 0.1 4.1 4.4 9.7 2.9 4.2 1.4 0.0 0.0 1.5 0.0 0.8 0.3 0.1 0.2 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.1 1.0 0.3 0.1 0.1 0.0 0.0 0.9 0.9 4.3 4.5 1.0 1.0 1.0 2.2 3.6 1.1 3.0 0.3 0.0 9.2 0.3 0.2 1.6 0.0 20.1 6.8 1.8 19.6 4.7 0.0 0.1 0.0 0.3 0.0 0.0 0.9 3.3 1.9 15.2 1.1 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.3 0.1 1.7 0.0 0.0 1.7 2.7 0.0 1.4 0.3 0.4 0.0 0.3 0.1 0.9 0.5 2.6 0.0 0.0 10.5 SIX6 "OPTX2, Six9" ENSG00000184302 "SIX homeobox 6" O95475 14 60508951-60512850 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Cataract, Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "pituitary gland: 43.3" "Cell type enhanced" "Detected in some" 33 "Cone photoreceptor cells: 27.5;Horizontal cells: 46.1;Muller glia cells: 158.1" "Cancer enriched" "Detected in single" 8 "glioma: 1.0" "Region enriched" "Detected in single" 8 "hypothalamus: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "JURKAT: 9.3;MOLT-4: 29.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 12 "hypothalamus: 2.5" HPA001403 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA001403: AB_1079993" "unprognostic (2.76e-1)" "unprognostic (6.14e-2)" "unprognostic (8.18e-2)" "unprognostic (5.75e-2)" 0.1 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.3 0.0 0.0 0.4 0.0 10.6 0.3 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 29.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.8 0.8 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 158.1 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SKAP1 "SCAP1, SKAP55" ENSG00000141293 "Src kinase associated phosphoprotein 1" Q86WV1 17 48133440-48430275 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 50.9;lymphoid tissue: 52.1" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 48.5;granulocytes: 113.6;Late spermatids: 118.7;T-cells: 123.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 19.3;HDLM-2: 9.9;HMC-1: 8.5;JURKAT: 14.5;Karpas-707: 10.5;RPMI-8226: 12.4;RPTEC TERT1: 15.4;U-266/70: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA002969, CAB025882, CAB055513" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "CAB025882: , CAB055513: , HPA002969: AB_1079870" "prognostic favorable (5.07e-4)" "unprognostic (1.10e-2)" "unprognostic (2.19e-2)" "unprognostic (1.80e-2)" "unprognostic (2.28e-2)" "unprognostic (1.43e-2)" "unprognostic (2.61e-2)" "unprognostic (1.57e-2)" "unprognostic (8.39e-2)" "unprognostic (1.81e-1)" "unprognostic (3.38e-1)" "unprognostic (1.71e-1)" "unprognostic (5.71e-2)" "unprognostic (6.20e-2)" "unprognostic (2.72e-1)" "unprognostic (1.94e-1)" "prognostic favorable (3.14e-4)" 1.9 9.4 0.5 28.0 0.6 2.9 4.5 0.4 0.6 5.9 3.8 0.6 10.9 1.1 2.2 10.6 2.1 8.0 6.2 2.1 1.3 1.1 12.9 2.0 5.2 20.0 0.7 0.4 2.4 2.8 11.6 17.5 0.7 1.2 3.0 2.4 1.6 10.2 7.4 0.5 1.2 6.1 1.2 1.9 11.7 2.2 7.8 0.6 52.1 1.8 1.3 27.7 5.1 4.3 11.9 0.1 2.1 0.2 22.3 50.9 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 19.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.2 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 10.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 15.4 0.0 0.0 0.0 1.0 0.0 0.1 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 9.6 6.8 0.0 0.0 0.0 0.0 2.1 0.1 0.3 35.9 0.0 30.1 2.8 29.6 32.2 0.1 11.9 26.1 28.9 0.7 22.3 0.2 0.1 50.9 22.3 0.5 0.6 0.4 0.6 1.3 1.1 0.7 0.4 1.2 0.6 3.0 14.6 10.4 0.1 1.8 0.0 0.6 0.0 2.7 5.7 8.7 0.0 0.1 39.7 0.2 48.5 1.6 0.3 0.0 1.6 0.1 1.3 0.3 113.6 25.1 0.2 0.0 1.2 6.2 3.7 118.7 1.4 1.7 1.7 0.0 0.6 2.0 1.5 0.0 0.7 1.1 0.3 6.5 0.3 34.8 4.1 1.1 0.2 123.7 0.1 0.4 SKAP2 "RA70, SAPS, SCAP2, SKAP-HOM, SKAP55R" ENSG00000005020 "Src kinase associated phosphoprotein 2" O75563 7 26667062-26995239 "Predicted intracellular proteins" "B-cell activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 255.1;Kupffer cells: 178.5;Late spermatids: 271.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 47.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005560, HPA024045" Enhanced Supported Nucleoplasm,Cytosol NA NA 3200000 Nucleoplasm Cytosol "HPA005560: AB_2667360, HPA024045: AB_2671416" "unprognostic (8.52e-2)" "unprognostic (5.57e-2)" "unprognostic (3.76e-1)" "unprognostic (5.62e-2)" "unprognostic (7.91e-3)" "unprognostic (1.30e-1)" "unprognostic (1.07e-3)" "unprognostic (4.15e-3)" "unprognostic (1.82e-1)" "unprognostic (1.41e-2)" "unprognostic (1.26e-2)" "unprognostic (3.80e-2)" "unprognostic (1.94e-2)" "unprognostic (1.04e-1)" "unprognostic (1.89e-1)" "unprognostic (1.12e-1)" "unprognostic (3.51e-2)" 20.8 22.5 11.5 29.4 12.9 12.8 28.5 6.0 12.8 7.7 15.3 7.6 11.0 10.5 5.2 15.4 14.0 9.4 9.6 12.6 9.5 12.1 20.4 7.8 31.6 36.4 12.0 8.9 13.3 6.1 25.1 10.9 5.3 15.5 10.2 15.0 2.5 5.8 9.8 8.3 8.6 16.5 21.1 42.6 31.8 11.7 10.1 11.5 6.4 6.1 1.9 19.3 19.3 28.1 9.9 12.3 37.3 18.0 8.3 5.1 6.7 11.7 6.2 0.6 15.5 2.9 2.4 3.8 4.8 7.2 2.4 6.0 4.9 47.4 9.1 21.1 9.0 17.5 6.3 8.5 4.9 5.0 5.1 13.7 10.0 1.8 6.5 3.9 18.4 35.4 10.6 4.6 6.9 9.5 0.4 14.4 0.0 5.3 4.7 9.4 2.2 0.0 9.3 0.5 10.5 6.1 11.9 1.5 0.7 29.3 9.2 7.7 0.2 8.7 4.7 6.3 3.7 6.5 9.7 21.0 4.0 0.1 13.3 4.9 7.5 9.5 15.9 9.5 23.9 15.2 8.2 12.6 19.4 3.7 15.0 5.1 9.9 2.1 3.0 9.6 8.0 0.5 2.9 37.3 8.3 18.0 12.3 3.5 6.7 11.5 12.9 6.0 12.8 9.5 12.1 12.0 8.9 15.5 11.5 17.9 29.9 77.3 32.3 23.6 12.3 4.7 5.1 14.7 9.1 22.7 11.8 11.1 54.7 7.9 255.1 35.8 46.2 23.3 20.3 18.4 9.5 16.9 50.9 8.3 82.6 4.8 41.3 90.9 178.5 271.4 8.3 120.8 18.6 28.9 64.6 13.0 15.8 31.6 10.3 65.3 12.7 0.0 12.0 19.9 34.3 37.9 15.6 34.8 45.4 27.2 SKI ENSG00000157933 "SKI proto-oncogene" P12755 1 2228695-2310119 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Craniosynostosis, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010449, HPA066567" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB010449: AB_2187342, HPA066567: AB_2685692" "unprognostic (3.99e-2)" "unprognostic (3.81e-2)" "unprognostic (1.44e-1)" "unprognostic (5.42e-2)" "unprognostic (4.66e-2)" "unprognostic (7.32e-2)" "unprognostic (1.88e-1)" "unprognostic (9.14e-2)" "unprognostic (1.08e-1)" "unprognostic (4.76e-2)" "unprognostic (4.94e-2)" "unprognostic (1.21e-1)" "unprognostic (2.56e-3)" "unprognostic (1.88e-1)" "unprognostic (7.82e-2)" "unprognostic (9.69e-2)" "unprognostic (5.24e-3)" 12.5 4.7 11.8 7.1 22.5 4.8 8.1 34.5 21.2 9.8 8.2 5.5 3.1 4.6 11.9 4.4 5.9 9.1 8.0 9.0 11.0 4.1 4.4 6.1 11.1 6.9 6.2 10.1 10.4 9.6 4.2 6.2 7.4 8.5 8.4 3.5 4.0 12.0 11.9 6.8 11.7 5.9 9.3 5.3 9.3 6.0 7.2 5.3 3.6 6.9 8.1 5.1 7.6 7.8 0.8 0.3 3.0 0.6 1.3 0.6 0.4 10.3 6.0 14.5 14.1 24.3 14.6 9.6 15.5 8.7 9.7 7.1 9.1 8.0 6.5 11.7 19.9 4.0 12.2 8.1 12.6 9.0 7.2 17.6 16.5 9.1 12.8 16.3 9.2 17.8 15.7 7.0 14.6 10.9 18.0 11.8 2.8 9.3 5.1 11.9 6.6 1.1 10.3 14.7 6.8 11.6 5.1 9.2 5.4 8.2 4.1 20.9 13.6 15.1 13.5 15.0 9.7 4.6 12.0 21.4 16.7 10.5 23.5 12.0 4.0 2.8 6.1 8.9 16.2 6.8 0.6 0.5 0.3 0.5 0.6 0.5 0.3 0.4 0.5 0.3 0.8 0.6 0.5 3.0 1.3 0.3 0.1 0.4 0.4 11.8 22.5 34.5 21.2 11.0 4.1 6.2 10.1 8.5 5.3 8.9 9.3 3.9 12.4 41.8 8.0 12.0 15.3 2.7 6.8 7.0 0.0 6.2 1.7 6.9 0.5 30.3 7.0 23.3 5.9 13.9 21.2 11.5 12.7 18.7 12.5 11.1 5.8 34.4 12.9 2.4 46.1 20.1 15.1 1.0 13.5 10.3 9.7 9.3 51.9 5.0 4.4 45.3 30.6 2.6 13.4 39.4 13.6 13.8 9.3 8.4 SKIDA1 "C10orf140, FLJ45187" ENSG00000180592 "SKI/DACH domain containing 1" 10 21513478-21526368 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "thyroid gland: 9.6" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 13.7;Early spermatids: 13.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 23.1;AN3-CA: 5.9;BEWO: 10.7;SH-SY5Y: 5.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039208, HPA040439" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA039208: AB_10795034, HPA040439: AB_10796122" "unprognostic (5.36e-2)" "unprognostic (1.84e-1)" "unprognostic (5.32e-3)" "unprognostic (6.45e-4)" "unprognostic (9.97e-2)" "unprognostic (3.23e-3)" "unprognostic (3.61e-2)" "unprognostic (1.12e-2)" "unprognostic (1.59e-2)" "unprognostic (4.23e-1)" "unprognostic (9.35e-3)" "unprognostic (5.93e-2)" "unprognostic (3.38e-6)" "unprognostic (8.13e-2)" "unprognostic (1.50e-1)" "unprognostic (8.20e-2)" "unprognostic (8.52e-3)" 0.9 1.9 1.9 0.4 3.3 1.7 2.2 3.1 5.9 1.3 1.7 0.0 0.0 0.3 1.0 1.0 0.9 1.7 0.6 5.5 2.5 1.8 4.1 4.3 1.0 0.3 1.4 3.4 4.2 1.5 7.3 1.8 2.5 3.0 1.1 0.6 4.1 2.6 2.0 0.5 2.9 0.5 1.0 1.2 0.4 0.6 4.6 0.3 0.9 9.6 0.7 0.3 1.1 1.1 0.6 0.5 1.5 0.6 0.5 0.3 0.1 0.4 1.0 23.1 5.9 0.5 0.2 10.7 0.5 0.3 0.0 0.0 2.1 0.1 0.2 0.9 0.3 0.1 1.4 2.1 0.4 0.0 0.0 2.6 0.1 1.0 0.2 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.7 0.2 0.4 0.1 0.2 0.1 0.9 0.7 0.1 1.4 0.0 0.0 0.3 0.7 0.0 0.4 0.6 2.5 5.3 0.8 4.0 0.1 2.0 0.4 4.6 0.3 0.2 0.7 0.2 0.5 0.1 0.0 0.3 1.4 0.0 0.2 1.5 0.3 0.5 0.2 0.3 0.3 0.3 0.2 0.2 0.3 0.6 0.3 0.3 1.3 0.5 0.6 0.5 0.2 0.1 1.9 3.3 3.1 5.9 2.5 1.8 1.4 3.4 3.0 0.3 0.0 1.0 0.0 0.8 1.3 13.7 5.2 5.1 0.0 2.3 1.8 0.0 4.6 6.6 0.1 13.5 3.5 0.0 0.0 0.6 3.1 1.7 0.6 1.1 8.9 2.4 1.6 0.0 3.1 1.5 6.6 1.4 0.0 0.0 0.0 0.0 6.8 0.5 0.0 2.1 5.1 4.0 6.5 0.6 4.8 3.2 1.6 2.9 0.0 0.0 0.2 SKIL "SNO, SnoA, SnoN" ENSG00000136603 "SKI like proto-oncogene" P12757 3 170357678-170396835 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "granulocytes: 200.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008472, HPA014233" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA008472: AB_1856933, HPA014233: " "unprognostic (5.50e-2)" "unprognostic (1.71e-2)" "unprognostic (3.95e-2)" "unprognostic (3.51e-3)" "unprognostic (7.66e-2)" "unprognostic (6.45e-2)" "unprognostic (2.21e-2)" "unprognostic (1.68e-2)" "unprognostic (2.52e-2)" "unprognostic (7.79e-2)" "unprognostic (2.26e-3)" "unprognostic (3.25e-2)" "prognostic unfavorable (1.19e-7)" "unprognostic (2.94e-2)" "unprognostic (7.34e-2)" "unprognostic (8.73e-2)" "unprognostic (3.34e-1)" 16.2 15.0 10.5 21.1 14.7 22.8 12.4 5.0 18.2 14.0 11.8 12.2 13.4 15.9 17.1 12.7 14.4 12.0 26.8 21.7 11.2 11.4 15.0 18.0 23.8 15.2 11.6 10.6 17.8 11.4 9.6 21.1 26.6 16.0 15.8 11.7 14.8 14.2 17.0 19.5 10.3 28.0 13.5 17.3 12.6 17.9 14.4 8.3 14.0 18.9 13.5 21.1 15.3 16.3 5.7 2.9 5.4 11.3 3.2 2.6 2.3 8.3 10.3 6.9 4.4 8.9 3.9 12.7 8.4 5.8 5.8 4.6 2.1 18.1 10.4 27.0 7.6 9.9 19.2 4.2 3.9 9.3 17.9 4.1 13.8 10.0 4.5 7.7 5.8 7.6 6.7 3.8 8.5 6.6 19.4 14.7 1.0 6.1 11.7 12.2 8.9 2.4 1.8 26.9 9.3 3.6 5.7 23.2 2.1 8.8 13.2 5.1 6.3 20.9 21.3 4.4 14.6 14.2 6.3 28.1 16.9 15.8 14.3 15.6 15.7 7.3 19.9 6.4 3.0 7.8 3.4 4.3 2.0 1.6 9.8 2.3 4.6 1.4 2.1 2.9 5.7 2.5 2.6 5.4 3.2 11.3 2.0 0.5 2.3 10.5 14.7 5.0 18.2 11.2 11.4 11.6 10.6 16.0 8.3 68.5 62.7 31.1 75.8 64.6 24.9 9.5 10.2 92.3 77.3 33.2 51.1 7.8 13.3 46.2 69.5 57.1 35.2 0.0 98.8 47.2 82.2 47.0 200.8 27.0 26.1 50.9 22.8 70.6 59.0 24.0 35.1 68.2 33.7 39.7 42.7 11.8 128.3 18.2 64.0 35.6 30.1 25.8 66.2 51.9 26.9 83.9 34.4 25.5 13.8 127.8 SKIV2L "170A, DDX13, HLP, SKI2W, SKIV2, SKIV2L1" ENSG00000204351 "Ski2 like RNA helicase" Q15477 6 31959080-31969755 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 19.2" "Low region specificity" "Detected in all" "HPA047122, HPA051959, HPA054419" Uncertain Approved "Nucleoplasm,Nuclear bodies,Mitotic spindle,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" "Mitotic spindle, Cytosol" "HPA047122: , HPA051959: AB_2681672, HPA054419: AB_2682482" "unprognostic (1.43e-1)" "unprognostic (5.75e-2)" "unprognostic (3.41e-2)" "unprognostic (1.66e-2)" "unprognostic (6.43e-2)" "unprognostic (7.03e-2)" "prognostic unfavorable (6.58e-4)" "unprognostic (3.36e-2)" "unprognostic (2.14e-2)" "unprognostic (7.75e-2)" "unprognostic (7.99e-3)" "unprognostic (1.53e-3)" "prognostic unfavorable (3.02e-7)" "unprognostic (6.77e-2)" "unprognostic (2.23e-1)" "unprognostic (1.20e-1)" "unprognostic (9.06e-2)" 14.5 32.8 12.4 19.4 15.2 19.0 11.3 15.4 20.2 11.6 12.6 16.0 10.6 36.7 12.5 37.4 14.8 11.7 10.3 12.3 10.7 8.2 12.6 27.8 17.9 13.9 12.3 10.1 13.6 13.1 3.8 21.6 11.3 12.7 17.2 11.1 14.6 11.5 14.3 17.1 14.3 15.7 17.8 10.6 21.7 22.7 10.7 13.7 17.4 14.9 7.5 15.0 13.6 10.7 2.2 2.3 1.1 4.3 0.4 3.2 1.2 0.3 8.1 7.2 0.7 2.1 4.1 8.3 5.8 3.4 4.4 7.6 0.4 0.1 0.3 12.6 8.6 6.9 5.8 0.0 10.0 3.5 8.3 15.9 0.0 0.5 0.7 0.0 0.3 0.4 10.3 8.8 0.1 0.1 6.0 0.0 9.7 0.1 7.2 0.0 0.5 0.5 0.7 10.2 0.0 0.1 1.1 0.1 0.5 2.3 0.1 0.3 0.4 9.3 0.1 5.0 6.3 0.4 7.8 6.6 8.6 2.9 10.3 0.2 16.0 19.2 3.4 12.3 0.4 0.3 1.0 1.3 0.3 2.4 4.3 1.6 1.5 2.2 1.6 2.3 2.2 3.2 2.6 1.1 0.4 2.9 0.6 0.2 1.2 12.4 15.2 15.4 20.2 10.7 8.2 12.3 10.1 12.7 13.7 14.9 9.9 13.0 4.1 2.5 5.7 6.7 2.5 10.7 4.5 7.0 7.9 10.4 1.7 8.8 2.3 5.8 20.0 0.0 7.4 6.8 3.9 7.1 8.1 15.3 8.2 0.0 12.1 9.2 4.7 1.6 8.6 4.6 6.8 8.2 12.1 6.3 7.9 14.0 5.6 5.1 7.8 0.0 5.0 3.9 8.3 3.1 10.4 7.7 9.0 4.2 SKP1 "EMC19, MGC34403, OCP-II, OCP2, p19A, SKP1A, TCEB1L" ENSG00000113558 "S-phase kinase associated protein 1" P63208 5 134148935-134177038 "Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB012982, HPA053745, HPA058134" Approved Supported Nucleoplasm,Cytosol No No 600000 Nucleoplasm Cytosol "CAB012982: AB_2533076, HPA053745: AB_2682245, HPA058134: AB_2683617" "prognostic unfavorable (7.53e-4)" "unprognostic (1.97e-1)" "unprognostic (9.81e-3)" "unprognostic (1.07e-1)" "unprognostic (2.02e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (5.72e-4)" "unprognostic (4.47e-2)" "unprognostic (1.33e-1)" "unprognostic (1.72e-1)" "unprognostic (2.73e-1)" "unprognostic (3.07e-1)" "prognostic favorable (5.20e-4)" "unprognostic (1.02e-2)" "unprognostic (2.06e-1)" "unprognostic (8.26e-2)" "unprognostic (2.40e-1)" 63.7 90.2 101.8 35.1 113.6 59.2 110.3 109.3 152.1 94.0 70.5 78.8 55.7 43.6 73.9 99.3 72.9 84.5 64.4 116.0 112.7 100.7 113.8 83.5 52.8 52.3 109.9 121.7 98.4 44.6 116.8 81.4 83.1 114.2 84.8 69.1 68.5 54.7 113.4 141.7 59.9 55.2 82.3 106.3 47.0 58.8 69.3 79.7 57.5 108.0 82.1 60.9 71.8 58.2 113.5 78.4 136.3 90.7 96.4 157.1 209.1 67.3 52.7 78.5 105.5 121.7 99.4 56.0 78.6 100.0 92.4 95.7 80.8 65.8 49.9 118.0 105.9 105.7 37.7 78.4 118.8 107.7 45.6 55.5 39.3 82.7 57.4 57.4 30.2 48.9 85.0 95.8 80.9 64.1 115.4 98.7 64.7 47.4 44.1 138.1 53.3 65.0 32.4 45.5 64.4 56.7 36.0 84.0 61.1 103.1 75.9 64.3 50.4 106.6 27.3 71.7 106.8 79.0 47.3 74.1 59.7 37.1 62.3 79.6 27.5 45.7 74.2 83.1 57.9 64.6 132.3 83.2 136.3 91.3 78.3 102.0 113.5 131.3 111.8 78.4 99.8 157.1 123.5 78.0 96.4 90.7 69.6 130.2 209.1 101.8 113.6 109.3 152.1 112.7 100.7 109.9 121.7 114.2 79.7 265.0 270.4 263.0 830.1 598.8 220.4 653.1 438.2 570.2 337.8 563.5 68.7 766.8 1437.4 561.3 416.1 363.7 459.0 490.6 329.5 626.8 509.6 661.6 327.0 354.9 416.6 211.4 341.7 300.8 284.1 774.4 556.9 378.1 681.6 669.9 301.7 518.2 333.4 550.6 670.0 1023.7 167.2 498.0 623.8 684.9 643.7 564.2 1126.5 371.9 336.9 686.2 SKP2 "FBL1, FBXL1, p45" ENSG00000145604 "S-phase kinase associated protein 2" Q13309 5 36151989-36184319 "Cancer-related genes, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 49.1" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 117.2;Extravillous trophoblasts: 184.7;Syncytiotrophoblasts: 70.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 75.1;RH-30: 94.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013491, CAB013533, HPA051196, HPA054633" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB013491: AB_2533074, CAB013533: , HPA051196: AB_2681383, HPA054633: AB_2682550" "unprognostic (2.32e-2)" "unprognostic (2.87e-1)" "unprognostic (1.26e-1)" "unprognostic (5.74e-2)" "unprognostic (9.56e-2)" "unprognostic (1.52e-2)" "unprognostic (1.21e-3)" "unprognostic (2.22e-1)" "prognostic unfavorable (3.72e-7)" "prognostic favorable (8.57e-4)" "unprognostic (5.06e-2)" "unprognostic (2.71e-1)" "prognostic unfavorable (4.77e-15)" "unprognostic (2.50e-2)" "unprognostic (3.73e-1)" "unprognostic (1.63e-1)" "unprognostic (2.19e-1)" 6.5 6.9 7.8 8.0 7.5 12.9 6.5 11.5 9.0 7.5 7.7 10.3 3.7 10.2 9.9 6.3 13.5 8.1 4.9 4.1 7.3 5.1 4.2 14.0 5.8 9.4 8.8 7.4 7.7 6.1 3.9 12.5 49.1 6.5 7.2 9.5 6.1 6.3 5.4 3.4 7.6 7.7 6.4 7.4 9.4 5.3 3.9 7.4 19.5 5.0 7.5 11.7 7.9 8.4 6.5 16.0 14.7 7.9 7.7 8.5 5.0 7.6 3.8 16.2 18.0 3.9 6.4 75.1 9.9 7.5 25.4 19.2 21.0 6.0 11.0 2.7 8.0 4.6 8.0 18.0 12.5 27.3 4.9 10.4 6.4 14.1 9.9 1.9 14.2 2.9 5.8 3.3 4.6 3.2 2.6 7.0 9.9 11.0 2.5 9.1 3.7 16.5 8.2 14.7 7.5 5.8 16.3 94.3 7.0 1.8 8.0 13.9 16.6 31.0 6.8 4.3 12.4 6.8 8.0 3.2 9.5 11.0 3.5 6.8 3.2 3.0 13.6 4.3 17.5 6.8 10.3 7.9 14.7 5.4 7.2 8.5 5.6 5.7 5.8 16.0 6.5 7.9 6.0 1.5 7.7 4.1 4.3 5.3 5.0 7.8 7.5 11.5 9.0 7.3 5.1 8.8 7.4 6.5 7.4 20.8 9.9 6.7 3.2 3.3 7.4 1.1 2.5 6.7 0.0 1.8 9.8 117.2 1.7 2.4 0.4 3.6 2.3 0.0 2.6 184.7 4.7 0.7 2.3 8.6 29.3 0.0 2.9 1.3 9.2 0.0 3.7 2.6 1.7 7.2 3.6 2.3 2.6 3.5 6.0 1.1 6.8 0.0 2.3 0.7 4.0 3.4 70.1 6.4 7.4 0.9 SLA2 "C20orf156, FLJ21992, SLAP-2" ENSG00000101082 "Src like adaptor 2" Q9H6Q3 20 36612318-36646216 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.7;lymphoid tissue: 36.5" "Cell type enriched" "Detected in some" 8 "T-cells: 31.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 6 "gdT-cell: 13.9;MAIT T-cell: 11.7;memory CD4 T-cell: 11.5;memory CD8 T-cell: 12.9;naive CD4 T-cell: 10.8;naive CD8 T-cell: 14.5;NK-cell: 16.5;plasmacytoid DC: 21.7;T-reg: 14.9" "Group enriched" "Detected in many" 8 "dendritic cells: 21.7;NK-cells: 16.5;T-cells: 14.9" "Group enriched" "Detected in some" 7 "HEL: 41.9;JURKAT: 24.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA053746, HPA058217" Approved "Nucleoplasm,Golgi apparatus,Vesicles" No NA "Nucleoplasm, Golgi apparatus, Vesicles" "HPA053746: AB_2682246, HPA058217: AB_2683641" "unprognostic (4.16e-3)" "prognostic favorable (7.36e-4)" "unprognostic (4.52e-4)" "unprognostic (2.30e-6)" "unprognostic (3.37e-2)" "unprognostic (3.79e-3)" "unprognostic (2.15e-3)" "unprognostic (1.13e-2)" "unprognostic (1.32e-2)" "unprognostic (2.84e-2)" "unprognostic (3.22e-3)" "unprognostic (1.23e-1)" "prognostic unfavorable (6.77e-8)" "unprognostic (8.48e-2)" "unprognostic (1.73e-1)" "unprognostic (1.98e-2)" "unprognostic (6.45e-3)" 2.3 0.8 0.7 15.1 0.8 11.3 1.3 1.5 0.5 1.5 3.9 0.2 2.3 2.8 2.0 1.1 1.7 1.4 4.8 1.6 0.7 0.7 1.5 1.9 6.9 17.1 0.7 0.0 1.6 0.8 0.0 1.1 1.6 0.8 1.5 1.8 1.8 6.3 0.4 0.9 0.7 7.5 1.5 1.1 15.9 2.5 1.0 0.3 36.5 1.5 1.1 18.4 3.8 1.3 0.2 21.7 2.3 0.3 16.5 14.9 11.6 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.9 0.2 1.6 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.1 0.0 0.1 4.9 3.5 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 3.5 0.0 0.8 0.2 1.6 13.9 0.3 11.7 0.2 11.5 12.9 0.1 0.1 10.8 14.5 2.3 16.5 0.0 21.7 14.9 11.6 0.7 0.8 1.5 0.5 0.7 0.7 0.7 0.0 0.8 0.3 0.0 3.8 0.0 0.1 0.3 0.2 0.3 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.4 0.0 1.1 0.0 0.2 0.0 0.0 1.3 1.5 0.0 0.3 0.4 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.1 0.1 0.1 31.9 0.1 0.3 SLBP HBP ENSG00000163950 "Stem-loop binding protein" Q14493 4 1692800-1712555 "Predicted intracellular proteins" "mRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Spermatocytes: 268.0;Spermatogonia: 323.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019254, HPA061670" Supported Supported Nucleoplasm,Nucleoli,Cytosol Yes Yes Nucleoplasm "Nucleoli, Cytosol" "HPA019254: AB_1856951, HPA061670: AB_2684581" "unprognostic (1.81e-2)" "unprognostic (6.80e-3)" "unprognostic (2.05e-2)" "unprognostic (1.59e-1)" "unprognostic (1.94e-1)" "unprognostic (7.09e-3)" "prognostic unfavorable (2.29e-5)" "unprognostic (5.53e-2)" "unprognostic (1.94e-2)" "unprognostic (1.13e-2)" "unprognostic (9.81e-3)" "unprognostic (9.55e-3)" "unprognostic (4.58e-2)" "unprognostic (7.31e-2)" "unprognostic (1.95e-1)" "unprognostic (1.44e-1)" "unprognostic (7.07e-2)" 19.8 18.1 26.9 30.4 28.0 60.7 27.5 23.8 30.0 19.3 19.3 14.2 20.7 16.3 20.4 21.9 25.0 19.0 15.8 17.9 25.1 26.5 23.7 21.2 18.7 43.9 19.9 24.0 23.1 17.8 13.0 19.5 27.7 16.0 20.0 21.3 17.9 24.7 21.2 15.1 24.7 17.0 20.5 17.1 26.1 18.2 50.6 12.4 52.4 24.9 17.7 42.8 23.7 26.6 24.4 24.1 45.3 29.8 19.8 36.1 30.4 29.4 12.1 17.5 18.4 15.5 17.7 18.2 25.9 22.2 31.5 31.9 25.0 34.4 38.9 15.5 21.4 37.2 18.1 35.1 23.5 37.0 15.9 19.0 48.8 15.1 25.1 19.2 45.1 23.8 12.2 18.9 23.9 15.9 18.3 17.9 26.1 34.9 38.5 38.5 10.6 69.4 41.1 21.8 31.1 21.6 52.3 28.6 24.6 30.3 22.4 19.9 15.3 22.0 14.3 15.3 24.7 23.7 29.8 15.1 26.5 15.2 27.9 40.3 22.4 40.7 93.0 24.8 38.7 26.0 9.3 29.8 21.8 23.6 22.3 21.4 24.4 30.8 33.2 24.1 18.0 26.5 25.1 45.3 19.8 19.8 19.1 36.1 30.4 26.9 28.0 23.8 30.0 25.1 26.5 19.9 24.0 16.0 12.4 14.9 16.8 53.9 86.5 93.4 17.7 7.1 25.5 8.1 7.9 34.9 23.6 121.4 91.2 43.6 64.1 31.8 21.2 23.3 27.3 39.1 59.3 64.3 23.1 26.1 70.1 23.8 34.4 29.4 34.0 32.9 40.9 44.4 62.4 61.3 27.5 27.6 30.6 23.0 41.4 37.4 11.4 12.9 49.1 268.0 323.2 92.5 37.4 59.9 37.5 71.2 SLC12A1 NKCC2 ENSG00000074803 "Solute carrier family 12 member 1" Q13621 15 48178438-48304078 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Symport, Transport" "Bartter syndrome, Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 75 "kidney: 143.2" "Cell type enriched" "Detected in some" 5 "Distal tubular cells: 177.4" "Cancer enhanced" "Detected in single" "renal cancer: 1.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "basophil: 1.9;neutrophil: 1.5" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.9" "Cell line enriched" "Detected in single" 26 "RPTEC TERT1: 24.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA014967, HPA018107" Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA014967: AB_1854503, HPA018107: AB_1854504" "unprognostic (3.52e-2)" "unprognostic (1.30e-2)" "unprognostic (9.65e-2)" "unprognostic (1.74e-2)" "unprognostic (7.77e-2)" "unprognostic (1.04e-1)" "unprognostic (8.72e-2)" "unprognostic (2.06e-1)" "unprognostic (9.85e-3)" "unprognostic (2.81e-4)" "unprognostic (9.75e-2)" "unprognostic (2.61e-1)" "unprognostic (5.47e-2)" "unprognostic (2.03e-1)" "unprognostic (5.20e-4)" "unprognostic (8.52e-2)" 0.0 0.0 0.3 0.0 1.0 0.0 0.0 1.4 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 143.2 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.1 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.9 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.3 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 1.5 0.1 0.0 0.1 0.0 0.0 0.3 1.0 1.4 1.5 0.1 0.3 0.3 0.4 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 36.6 0.0 0.0 177.4 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 SLC12A8 CCC9 ENSG00000221955 "Solute carrier family 12 member 8" A0AV02 3 125082636-125212864 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.4;thyroid gland: 20.5" "Cell type enhanced" "Detected in many" 11 "Collecting duct cells: 22.7;granulocytes: 18.4;Mucus-secreting cells: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HHSteC: 18.2;OE19: 17.3;U-2197: 35.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA031123 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA031123: AB_2301872" "unprognostic (4.74e-2)" "unprognostic (1.46e-3)" "unprognostic (1.39e-1)" "unprognostic (5.91e-3)" "unprognostic (7.35e-3)" "unprognostic (1.79e-1)" "unprognostic (2.07e-1)" "unprognostic (3.76e-2)" "unprognostic (1.01e-1)" "unprognostic (7.84e-2)" "unprognostic (3.13e-2)" "unprognostic (1.13e-2)" "prognostic unfavorable (5.56e-4)" "unprognostic (7.18e-2)" "unprognostic (3.47e-2)" "unprognostic (2.57e-2)" "unprognostic (1.78e-2)" 1.1 1.1 11.1 0.7 19.4 0.0 2.0 0.8 7.0 1.2 3.0 1.7 0.4 4.9 0.4 2.9 3.5 1.7 8.1 0.5 3.8 1.2 2.1 5.7 1.9 0.4 1.0 3.6 0.5 9.0 8.2 1.9 2.2 8.6 2.5 4.1 6.2 10.0 0.4 1.8 1.0 3.4 0.4 1.3 0.4 3.8 4.6 2.0 0.4 20.5 0.4 0.7 1.9 1.7 0.2 0.2 1.8 0.5 0.0 0.2 0.0 8.2 0.0 1.4 0.0 1.7 2.4 4.1 0.4 1.0 0.4 0.9 10.7 3.9 0.0 1.0 3.7 1.4 5.0 0.0 0.0 0.2 0.0 0.0 0.0 3.6 0.0 18.2 0.0 0.6 4.7 5.0 1.4 0.5 9.7 0.0 0.0 0.0 0.3 0.6 2.2 0.0 0.0 5.7 17.3 0.4 0.0 0.1 0.0 4.2 0.6 2.4 0.0 4.8 5.1 0.1 0.6 9.1 0.2 0.1 0.1 0.7 35.3 0.0 0.1 1.0 2.7 1.7 0.0 0.7 1.8 0.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 19.4 0.8 7.0 3.8 1.2 1.0 3.6 8.6 2.0 0.0 0.3 0.0 1.1 0.9 0.0 1.0 0.0 0.0 1.2 22.7 0.0 0.3 0.0 3.9 0.2 0.0 2.0 0.0 2.9 6.2 1.3 5.0 18.4 6.4 0.8 0.0 5.2 0.0 0.0 0.0 0.0 0.6 0.0 3.6 28.6 0.0 4.3 2.9 0.0 1.1 0.0 0.0 0.3 0.7 0.4 0.3 2.5 0.0 5.0 0.9 SLC13A5 "INDY, NACT" ENSG00000141485 "Solute carrier family 13 member 5" Q86YT5 17 6684713-6713567 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Amelogenesis imperfecta, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 65 "liver: 150.4;salivary gland: 153.9" "Cell type enriched" "Detected in some" 16 "Hepatocytes: 374.3" "Cancer enriched" "Detected in some" 15 "liver cancer: 27.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 61 "Hep G2: 35.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044343 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA044343: AB_10961771" "unprognostic (8.46e-3)" "unprognostic (3.89e-2)" "unprognostic (3.24e-2)" "unprognostic (1.75e-2)" "unprognostic (7.33e-2)" "unprognostic (1.07e-1)" "unprognostic (6.79e-2)" "unprognostic (8.79e-3)" "unprognostic (1.32e-1)" "unprognostic (3.23e-1)" "unprognostic (1.26e-3)" "unprognostic (1.30e-3)" "unprognostic (3.78e-11)" "unprognostic (2.42e-2)" "unprognostic (2.46e-1)" "unprognostic (2.05e-2)" "unprognostic (2.04e-1)" 0.2 0.8 1.0 0.1 1.9 0.1 0.2 0.6 2.3 0.2 0.1 0.0 0.0 0.1 0.3 0.1 0.3 0.9 0.1 0.1 0.9 0.7 0.4 150.4 0.1 0.2 0.8 1.2 0.3 0.2 0.1 0.2 0.1 0.6 0.1 0.1 0.0 153.9 0.1 0.1 0.1 0.1 0.1 0.2 0.9 0.1 0.8 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 1.9 0.6 2.3 0.9 0.7 0.8 1.2 0.6 0.0 0.0 0.0 7.0 0.6 0.5 0.2 0.6 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 23.3 0.4 0.1 0.0 0.3 0.0 374.3 0.0 0.0 0.0 15.4 21.0 0.0 0.6 0.3 0.0 0.0 0.0 7.4 9.8 0.0 0.0 0.0 1.4 0.0 0.0 0.9 1.5 0.4 0.1 0.0 0.0 0.2 SLC15A1 "HPECT1, HPEPT1, PEPT1" ENSG00000088386 "Solute carrier family 15 member 1" P46059 13 98683801-98752654 "Predicted membrane proteins, Transporters" "Peptide transport, Protein transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "intestine: 134.9" "Cell type enhanced" "Detected in many" 16 "Cholangiocytes: 30.6;Enterocytes: 51.2;Hepatocytes: 29.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "CAPAN-2: 30.1;SK-BR-3: 29.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA002827 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA002827: AB_1856974" "unprognostic (8.76e-2)" "unprognostic (1.87e-1)" "unprognostic (4.72e-2)" "unprognostic (1.49e-1)" "unprognostic (6.76e-3)" "unprognostic (6.26e-2)" "unprognostic (7.83e-2)" "unprognostic (5.47e-2)" "unprognostic (1.92e-1)" "unprognostic (2.37e-1)" "unprognostic (6.79e-2)" "unprognostic (6.88e-4)" "unprognostic (2.11e-2)" "unprognostic (2.84e-1)" "unprognostic (2.64e-1)" "unprognostic (9.01e-2)" "unprognostic (3.87e-2)" 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 1.1 51.7 0.2 0.3 42.7 1.9 2.2 0.9 0.1 16.6 0.1 0.1 0.1 6.3 8.2 0.2 0.1 0.1 0.1 0.2 7.1 4.3 0.3 1.0 0.3 0.9 0.5 0.2 0.3 0.3 0.1 9.9 134.9 0.1 0.1 0.1 0.2 0.2 0.1 0.3 0.2 0.7 0.4 0.5 1.9 1.1 1.1 2.3 0.7 1.2 0.9 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.9 30.1 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.3 6.8 0.0 0.0 0.0 1.7 1.7 0.6 0.1 0.3 0.0 29.9 0.0 1.5 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.7 0.7 0.9 0.3 0.8 0.8 0.7 0.7 0.2 1.1 0.9 0.8 2.2 1.2 0.4 1.1 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 3.0 0.0 0.0 0.1 0.1 0.0 0.4 30.6 1.4 2.3 1.8 0.0 0.0 1.7 9.1 0.0 0.0 51.2 0.0 0.7 0.0 0.0 0.8 0.0 29.9 0.1 0.0 3.5 0.6 0.3 0.0 0.0 0.0 1.7 0.0 1.7 0.0 2.9 5.8 0.0 9.8 0.0 0.0 0.2 0.0 0.2 0.6 0.1 0.0 1.7 0.3 SLC15A4 "PHT1, PTR4" ENSG00000139370 "Solute carrier family 15 member 4" Q8N697 12 128793191-128823983 "Predicted membrane proteins, Transporters" "Peptide transport, Protein transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 67.3;Late spermatids: 84.4;Muller glia cells: 87.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 20.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016713 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA016713: AB_1856978" "unprognostic (3.12e-1)" "unprognostic (1.00e-1)" "unprognostic (3.63e-2)" "unprognostic (1.10e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (8.45e-4)" "prognostic unfavorable (6.78e-4)" "unprognostic (5.14e-3)" "unprognostic (6.39e-2)" "unprognostic (1.50e-1)" "unprognostic (2.26e-1)" "unprognostic (2.06e-2)" "prognostic unfavorable (7.56e-6)" "unprognostic (1.28e-1)" "unprognostic (2.06e-1)" "unprognostic (2.34e-2)" "unprognostic (2.57e-1)" 12.7 7.0 6.6 11.4 7.3 17.6 10.7 8.7 10.2 11.6 8.8 16.0 4.2 5.4 17.2 5.7 9.1 12.3 10.0 9.8 8.4 5.0 8.1 20.4 10.9 14.8 13.8 6.6 10.4 8.2 8.4 6.2 8.8 9.7 7.4 5.4 16.1 8.4 8.8 35.1 9.7 8.2 12.2 10.2 12.2 7.9 27.8 10.1 29.7 9.1 7.3 17.8 11.9 10.5 2.0 20.1 12.1 2.4 4.2 5.0 1.7 6.2 10.3 2.6 5.7 23.4 15.2 9.7 10.9 9.2 7.9 9.0 4.6 9.1 22.8 5.7 9.5 7.9 7.1 7.2 6.7 8.6 11.1 6.6 3.1 6.2 8.2 24.4 10.5 3.3 9.8 12.4 6.5 17.2 23.5 5.4 4.6 5.1 14.4 16.0 4.3 5.4 2.7 9.3 6.8 6.0 4.6 5.7 8.8 15.2 8.0 4.7 3.9 4.4 8.4 11.6 7.4 11.3 2.9 8.1 8.7 4.9 4.3 6.6 4.8 10.6 10.5 11.7 7.4 0.1 0.0 1.8 4.4 5.0 2.4 2.5 1.9 0.9 2.9 1.1 2.0 1.0 2.5 12.1 4.2 1.0 20.1 0.4 1.7 6.6 7.3 8.7 10.2 8.4 5.0 13.8 6.6 9.7 10.1 17.9 10.1 9.7 6.1 9.2 10.3 8.3 5.1 0.0 6.8 21.0 11.8 4.5 1.7 21.0 67.3 4.8 5.5 0.0 9.4 4.8 9.8 7.2 11.5 16.3 18.7 14.3 10.4 13.5 21.5 84.4 11.5 18.6 23.6 19.0 4.3 87.4 19.6 4.9 12.7 3.7 15.6 6.5 9.2 8.0 10.6 8.0 3.3 19.2 6.1 6.0 SLC16A7 MCT2 ENSG00000118596 "Solute carrier family 16 member 7" O60669 12 59596067-59789855 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 34.7" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 116.7;Cholangiocytes: 104.4;Early spermatids: 85.1;Late spermatids: 90.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 64.5" HPA005911 Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA005911: AB_1853659" "unprognostic (1.52e-2)" "unprognostic (9.47e-3)" "unprognostic (9.48e-2)" "unprognostic (3.22e-2)" "unprognostic (1.17e-1)" "unprognostic (1.29e-2)" "unprognostic (5.35e-2)" "unprognostic (8.09e-2)" "unprognostic (1.90e-1)" "unprognostic (1.04e-1)" "unprognostic (8.39e-2)" "unprognostic (9.79e-2)" "prognostic favorable (8.85e-5)" "unprognostic (2.19e-3)" "unprognostic (3.11e-1)" "unprognostic (9.35e-2)" "unprognostic (2.45e-2)" 20.1 10.0 2.2 9.2 4.3 4.5 9.2 6.4 8.3 5.4 4.8 1.1 1.1 2.2 8.6 2.7 12.3 4.4 8.9 34.7 2.0 1.9 16.4 5.7 9.4 12.1 3.2 3.3 4.7 13.7 2.2 9.5 2.1 5.5 3.8 3.7 2.7 6.2 2.6 4.2 9.4 4.6 10.5 3.7 16.8 12.8 6.2 2.3 12.8 4.0 8.6 9.4 9.7 8.5 5.8 2.8 0.3 9.1 3.0 7.2 2.4 0.1 2.3 0.5 0.3 10.7 16.3 0.1 9.9 6.4 3.4 3.1 0.2 5.9 5.1 2.3 16.7 3.2 0.5 0.6 1.2 5.2 1.4 0.3 9.2 10.4 0.3 5.6 14.9 0.1 8.4 3.2 0.9 9.8 6.1 1.2 6.2 0.1 11.2 5.5 2.1 4.3 2.2 0.6 1.0 3.1 0.3 0.0 2.4 7.6 14.4 2.6 0.6 0.0 0.2 4.7 0.6 0.3 1.8 0.0 8.1 2.7 14.8 0.3 10.8 0.1 8.6 9.3 0.0 1.3 0.3 2.0 0.0 5.4 3.7 7.2 2.4 4.3 4.8 2.1 5.8 4.9 6.9 0.2 3.0 9.1 2.8 4.8 2.4 2.2 4.3 6.4 8.3 2.0 1.9 3.2 3.3 5.5 2.3 26.8 21.3 14.7 5.7 9.0 23.7 116.7 104.4 24.1 15.9 43.6 9.8 0.2 19.9 46.2 85.1 7.1 0.7 0.0 57.0 0.2 12.5 1.9 9.3 10.5 3.0 7.9 0.0 11.1 27.7 90.6 6.4 8.4 3.3 1.8 24.4 1.3 30.7 0.0 9.6 1.0 5.3 6.5 16.0 4.1 3.0 11.0 0.6 20.8 0.9 2.8 SLC16A9 "C10orf36, FLJ43803, MCT9" ENSG00000165449 "Solute carrier family 16 member 9" Q7RTY1 10 59650761-59736002 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 58.0;kidney: 70.9" "Cell type enriched" "Detected in many" 7 "Proximal tubular cells: 218.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 8.7;NTERA-2: 16.4;SH-SY5Y: 7.9;SuSa: 8.8;U-251 MG: 8.3;U-937: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049286 Approved Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA049286: AB_2680699" "unprognostic (3.39e-2)" "unprognostic (6.91e-2)" "unprognostic (1.30e-1)" "unprognostic (1.27e-1)" "unprognostic (1.60e-3)" "unprognostic (1.76e-2)" "unprognostic (5.96e-2)" "unprognostic (3.50e-3)" "unprognostic (5.01e-2)" "unprognostic (2.11e-3)" "unprognostic (5.99e-2)" "unprognostic (4.60e-2)" "prognostic favorable (2.56e-6)" "unprognostic (7.57e-3)" "unprognostic (1.27e-2)" "unprognostic (3.72e-1)" "unprognostic (1.94e-1)" 0.7 58.0 5.7 2.0 4.6 0.7 0.9 9.9 4.4 8.2 4.6 9.6 1.6 0.3 12.6 2.2 5.3 8.6 3.3 1.4 10.0 2.6 70.9 1.1 0.6 0.8 6.7 5.5 13.4 1.3 11.8 6.4 0.2 8.2 3.2 6.4 5.2 1.6 4.2 9.2 0.5 0.8 3.0 6.0 14.3 2.4 3.4 6.5 0.0 11.2 4.4 3.1 0.9 4.8 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 4.2 5.6 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.6 0.0 0.0 0.7 8.7 0.0 0.0 0.0 1.4 0.1 0.2 0.0 0.1 1.8 0.0 0.4 0.1 0.0 2.3 0.1 0.3 4.4 6.1 0.1 0.4 3.3 2.3 0.0 16.4 1.6 7.5 2.7 0.2 5.7 0.0 0.2 2.8 7.9 0.1 0.3 0.0 8.8 2.8 3.6 2.6 0.4 0.9 0.1 8.3 0.0 0.0 0.0 0.0 14.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.7 4.6 9.9 4.3 10.0 2.6 6.7 5.5 8.2 6.5 0.0 0.0 0.0 1.1 0.1 4.7 2.8 0.0 4.0 9.1 7.0 0.0 0.0 21.6 0.7 0.1 0.0 17.7 0.0 0.0 0.8 1.2 12.7 0.0 0.0 0.1 3.2 19.3 0.0 10.5 0.4 12.7 0.0 3.3 1.0 15.5 11.2 0.2 30.3 11.3 218.2 0.8 0.0 2.8 0.3 0.1 0.1 0.0 0.0 12.8 5.7 SLC17A9 "C20orf59, FLJ23412, VNUT" ENSG00000101194 "Solute carrier family 17 member 9" Q9BYT1 20 62952647-62969585 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Exocytosis, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 42.7" "Cell type enhanced" "Detected in many" 11 "B-cells: 28.5;Hepatocytes: 35.4;Hofbauer cells: 16.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 7.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 16.0;CACO-2: 14.8;Hep G2: 30.7;NB-4: 16.5;RPMI-8226: 15.9;U-937: 19.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA047470 Approved Nucleoplasm NA NA Nucleoplasm "HPA047470: AB_2680060" "unprognostic (2.65e-3)" "unprognostic (2.13e-1)" "unprognostic (7.08e-2)" "unprognostic (1.97e-1)" "unprognostic (4.33e-3)" "unprognostic (5.33e-2)" "unprognostic (6.03e-2)" "unprognostic (6.84e-3)" "unprognostic (1.00e-2)" "unprognostic (1.45e-1)" "unprognostic (2.21e-1)" "unprognostic (7.11e-2)" "prognostic unfavorable (2.78e-15)" "unprognostic (6.06e-3)" "unprognostic (5.51e-2)" "unprognostic (5.96e-2)" "unprognostic (1.06e-1)" 4.2 1.3 1.6 11.4 3.4 11.9 2.2 0.4 1.4 1.9 4.8 0.6 0.1 6.4 1.7 1.2 1.5 2.1 7.3 1.5 1.5 0.7 1.5 42.7 5.7 6.6 4.8 0.0 1.9 3.4 0.0 2.5 1.9 3.4 1.6 3.8 1.1 3.6 1.2 3.4 0.9 3.9 1.4 3.9 10.5 10.7 0.8 2.9 0.5 1.4 0.5 11.8 5.6 2.4 4.0 4.2 0.0 2.7 7.3 1.3 1.2 0.0 0.0 0.0 0.1 0.1 1.3 0.0 16.0 4.6 5.3 8.4 14.8 0.0 11.5 0.0 12.8 0.0 0.0 2.3 0.0 1.2 0.0 0.0 5.0 0.4 30.7 3.6 9.0 0.0 1.2 0.0 6.3 0.0 0.0 3.4 0.0 0.0 6.7 0.0 0.0 0.3 16.5 0.0 5.7 0.0 11.9 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 1.1 0.0 0.0 0.5 0.0 2.3 0.1 6.2 0.0 19.4 0.0 0.0 1.6 0.0 1.3 2.7 0.9 4.0 0.0 0.6 4.2 3.2 0.0 0.6 0.0 7.3 0.6 0.0 0.1 1.2 1.6 3.4 0.4 1.4 1.5 0.7 4.8 0.0 3.4 2.9 0.0 0.6 28.5 0.0 0.8 0.2 1.2 12.7 0.0 1.2 0.0 0.0 0.3 0.0 0.2 0.6 0.7 1.6 0.0 0.3 0.6 5.8 0.5 4.7 35.4 16.2 0.0 2.9 2.5 4.0 0.0 1.1 9.1 5.0 1.0 7.7 0.0 1.1 0.0 0.7 0.0 0.0 0.0 3.1 0.3 0.9 1.0 0.7 4.1 9.1 0.4 SLC19A3 THTR2 ENSG00000135917 "Solute carrier family 19 member 3" Q9BZV2 2 227683763-227718031 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 48.2;breast: 78.2;placenta: 27.5" "Group enriched" "Detected in many" 8 "Cytotrophoblasts: 45.5;Syncytiotrophoblasts: 134.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 8.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC diff: 14.3;BEWO: 7.4;CACO-2: 18.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038898 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA038898: AB_10673481" "unprognostic (3.37e-2)" "unprognostic (3.59e-5)" "unprognostic (1.95e-3)" "unprognostic (1.24e-2)" "unprognostic (1.22e-1)" "unprognostic (6.82e-2)" "unprognostic (1.93e-2)" "unprognostic (1.67e-1)" "unprognostic (1.19e-1)" "unprognostic (2.04e-1)" "unprognostic (4.67e-2)" "unprognostic (3.12e-3)" "unprognostic (7.28e-2)" "unprognostic (8.20e-2)" "unprognostic (1.68e-1)" "unprognostic (1.71e-2)" "unprognostic (7.01e-3)" 48.2 0.6 2.2 1.8 2.4 1.2 78.2 1.5 1.9 0.5 6.1 1.0 0.5 7.7 0.6 0.4 0.6 0.6 8.9 1.9 2.3 2.4 2.1 16.0 5.6 1.3 3.0 0.7 0.9 1.3 0.2 0.3 27.5 2.6 0.5 1.6 0.7 0.9 0.2 0.7 1.6 4.5 0.5 2.6 0.5 0.5 0.6 1.5 0.0 0.5 0.4 0.4 1.0 2.3 2.6 1.8 8.6 1.8 4.3 1.1 0.4 0.3 1.6 0.3 1.0 14.3 0.4 7.4 0.1 0.2 0.3 0.6 18.7 0.5 0.4 0.2 0.1 4.6 0.5 0.5 0.5 0.8 0.1 1.2 0.1 1.0 0.8 1.7 0.2 0.2 3.3 0.4 0.1 0.9 0.3 0.0 0.3 0.2 0.9 0.0 1.8 0.1 0.7 3.2 0.6 0.3 0.3 0.2 0.2 0.2 0.3 1.1 0.1 0.6 2.1 0.5 2.7 0.3 0.2 0.5 0.5 0.5 4.2 0.4 0.2 0.1 0.7 1.4 0.3 0.5 8.6 1.8 1.7 1.0 1.2 0.6 1.6 0.8 0.9 0.4 2.6 1.0 1.1 6.1 4.3 1.1 1.8 0.4 0.4 2.2 2.4 1.5 1.9 2.3 2.4 3.0 0.7 2.6 1.5 8.9 3.2 0.0 0.4 0.0 2.9 0.3 0.0 0.0 0.0 1.8 0.0 45.5 1.7 1.7 0.3 0.5 6.4 0.0 0.0 7.0 0.9 0.3 0.0 11.4 4.6 0.0 1.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.8 0.6 0.0 0.0 2.2 0.1 0.0 1.0 0.0 0.1 0.0 134.3 0.0 5.6 0.3 SLC22A18AS "BWR1B, BWSCR1B, ORCTL2S, p27-BWR1B, SLC22A1LS" ENSG00000254827 "Solute carrier family 22 member 18 antisense" Q8N1D0 11 2887780-2903740 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 20.1;kidney: 13.4;liver: 13.6" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 89.5;Paneth cells: 107.4;Proximal tubular cells: 73.1;Syncytiotrophoblasts: 67.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 9.1" "Group enriched" "Detected in many" 10 "dendritic cells: 4.9;granulocytes: 5.2;monocytes: 9.1" "Cell line enhanced" "Detected in some" "A549: 7.1;CAPAN-2: 7.0;MCF7: 13.2;OE19: 6.7;SK-MEL-30: 24.5;WM-115: 11.0" HPA068288 Enhanced Approved Nucleoplasm No NA Nucleoplasm "HPA068288: AB_2685969" "unprognostic (1.43e-1)" "unprognostic (9.21e-2)" "unprognostic (3.36e-1)" "unprognostic (8.05e-2)" "unprognostic (1.33e-3)" "unprognostic (3.16e-2)" "unprognostic (5.14e-3)" "unprognostic (9.76e-2)" "unprognostic (1.45e-1)" "unprognostic (2.73e-1)" "unprognostic (1.10e-2)" "unprognostic (1.48e-2)" "unprognostic (9.52e-2)" "unprognostic (1.77e-1)" "unprognostic (2.39e-1)" "unprognostic (1.05e-1)" "unprognostic (1.62e-1)" 1.4 0.3 0.2 6.0 0.7 0.0 0.6 0.2 2.2 0.5 13.7 0.6 0.2 12.8 0.8 1.2 1.1 0.4 4.9 0.3 0.2 0.3 13.4 13.6 0.6 0.2 1.3 1.5 0.4 0.2 0.0 0.3 2.0 1.6 0.7 9.8 0.2 4.2 0.2 0.4 1.0 20.1 0.6 1.6 0.8 1.4 0.6 0.4 0.2 0.3 1.6 0.3 0.5 0.9 0.0 4.9 5.2 9.1 0.5 0.6 2.7 0.8 7.1 0.1 0.3 0.0 0.0 0.7 0.4 0.3 0.0 0.2 1.6 7.0 0.0 0.6 0.0 0.4 0.4 0.0 0.2 0.0 0.3 0.1 0.0 0.6 4.1 0.5 0.0 0.1 0.1 0.2 0.0 0.4 0.2 0.2 0.4 0.0 0.7 0.0 13.2 0.0 0.3 0.1 6.7 0.3 0.2 0.0 0.6 0.6 0.0 0.1 0.2 0.3 0.3 24.5 0.1 0.0 0.7 1.4 0.0 0.5 0.2 0.1 0.0 0.0 0.1 0.2 1.9 11.0 5.2 9.1 1.6 0.3 5.1 0.1 0.0 0.1 0.3 4.9 0.0 0.0 0.1 2.2 0.5 3.5 0.0 0.6 2.7 0.2 0.7 0.2 2.2 0.2 0.3 1.3 1.5 1.6 0.4 0.0 0.3 1.3 1.1 0.5 0.0 0.1 2.5 0.0 0.0 7.0 0.0 16.4 8.3 0.8 0.0 0.0 89.5 0.0 0.7 8.2 0.8 1.4 1.1 18.4 15.6 0.0 8.7 1.8 4.1 0.0 0.3 5.4 3.3 3.6 25.4 0.0 1.5 107.4 0.0 73.1 0.0 0.0 0.6 0.0 0.2 1.0 67.5 0.0 23.7 2.3 SLC22A23 "C6orf85, FLJ22174" ENSG00000137266 "Solute carrier family 22 member 23" A1A5C7 6 3268962-3457022 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 73.9;Late spermatids: 171.9;Mucus-secreting cells: 52.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014697 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA014697: AB_1844371" "unprognostic (4.58e-2)" "unprognostic (2.48e-1)" "unprognostic (1.05e-1)" "prognostic favorable (6.57e-4)" "unprognostic (5.16e-3)" "unprognostic (3.25e-3)" "unprognostic (1.40e-1)" "unprognostic (4.53e-3)" "unprognostic (9.74e-2)" "unprognostic (2.87e-2)" "unprognostic (1.07e-2)" "unprognostic (2.62e-2)" "prognostic unfavorable (2.39e-4)" "unprognostic (8.91e-2)" "unprognostic (4.30e-1)" "unprognostic (4.06e-2)" "unprognostic (1.74e-1)" 7.4 2.2 9.0 4.6 16.2 8.1 9.3 8.4 14.8 5.6 17.4 30.8 3.4 19.6 3.6 11.8 16.8 11.3 7.5 2.2 11.0 8.1 6.9 12.6 8.0 3.9 28.6 8.7 3.0 14.9 14.8 6.5 8.3 17.8 14.2 14.4 5.7 10.0 2.8 5.9 14.9 20.3 3.0 17.5 4.6 26.0 7.2 21.0 5.2 4.1 9.8 9.9 3.8 9.9 0.1 0.7 0.8 0.3 0.3 1.4 1.9 2.4 5.6 12.5 13.9 4.4 5.0 16.0 0.4 0.1 0.7 0.3 12.5 0.4 0.6 1.4 2.7 11.1 3.6 2.5 6.6 0.2 2.0 7.7 5.8 2.1 11.0 0.6 0.3 0.4 1.2 13.0 12.1 0.6 2.6 0.4 3.2 5.2 3.3 0.4 2.9 0.5 1.4 4.3 13.7 2.3 1.3 0.8 9.9 0.0 15.3 1.4 0.2 3.3 4.8 4.1 13.3 18.5 0.1 3.1 7.3 2.3 9.4 1.5 7.5 0.1 0.2 12.8 0.4 4.4 0.0 0.3 0.0 0.4 0.0 0.2 0.0 1.0 0.4 0.2 0.1 1.4 0.9 0.8 0.3 0.2 0.7 0.0 1.9 9.0 16.2 8.4 14.8 11.0 8.1 28.6 8.7 17.8 21.0 6.0 13.7 0.5 4.2 10.3 7.9 2.4 10.2 33.5 17.0 5.2 7.9 12.2 0.0 2.5 73.9 8.4 29.0 23.3 7.0 0.9 1.4 19.2 0.0 10.0 9.8 0.0 4.1 6.7 8.0 171.9 1.7 2.0 3.3 10.8 52.1 9.1 5.7 14.4 0.7 2.4 3.4 0.0 0.9 2.1 1.1 11.0 7.7 1.0 22.6 3.9 SLC23A3 "FLJ31168, SVCT3, Yspl1" ENSG00000213901 "Solute carrier family 23 member 3" Q6PIS1 2 219161465-219170095 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 11 "intestine: 36.5;kidney: 32.4" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 6.7;Proximal tubular cells: 8.9" "Cancer enriched" "Detected in some" 9 "renal cancer: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 9.0;U-266/70: 6.6" "Region enhanced" "Detected in some" "cerebral cortex: 1.3" "Not detected" "Not detected" HPA019059 Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA019059: AB_1857017" "unprognostic (2.49e-2)" "unprognostic (6.65e-2)" "unprognostic (2.05e-4)" "unprognostic (6.97e-2)" "unprognostic (8.41e-2)" "unprognostic (1.22e-2)" "unprognostic (9.07e-2)" "unprognostic (1.93e-1)" "unprognostic (4.01e-2)" "unprognostic (4.35e-2)" "unprognostic (3.10e-1)" "unprognostic (6.12e-4)" "unprognostic (9.42e-2)" "unprognostic (6.48e-2)" "unprognostic (2.41e-2)" "unprognostic (3.34e-1)" "unprognostic (6.52e-5)" 0.4 0.0 0.3 2.3 0.3 0.0 0.5 0.3 0.5 0.8 14.9 0.3 0.3 5.3 1.1 0.3 0.9 0.5 0.3 0.3 0.3 0.0 32.4 3.1 0.7 0.3 0.3 0.3 1.0 0.4 0.5 0.3 0.5 0.3 1.4 0.8 0.3 0.4 0.3 0.3 1.1 36.5 0.3 0.3 0.4 0.5 0.3 0.3 0.3 1.3 0.3 0.4 0.6 1.3 0.8 0.0 0.0 0.8 0.0 0.5 0.0 0.9 0.4 0.2 1.1 4.0 2.2 0.8 2.2 0.6 0.4 1.3 2.4 1.6 0.5 0.8 1.5 0.1 3.2 0.7 0.3 0.6 1.9 1.8 2.1 1.9 0.2 0.7 0.2 0.9 0.7 9.0 0.9 2.9 3.6 1.2 1.2 0.3 0.9 0.6 0.3 0.1 1.0 0.0 0.8 0.2 0.5 0.6 0.8 3.1 3.7 0.5 1.0 0.2 0.0 2.4 1.1 0.9 1.1 2.6 2.1 1.4 2.2 0.7 6.6 0.3 2.9 0.6 0.7 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.1 0.5 0.0 0.0 0.8 0.0 0.2 0.0 0.3 0.3 0.3 0.5 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.3 2.0 1.1 1.3 0.8 0.3 2.5 0.0 0.0 1.8 0.0 0.2 1.7 0.2 0.0 0.7 6.7 0.0 0.0 0.1 0.6 1.4 0.0 0.5 0.2 0.0 1.7 0.6 0.3 0.0 1.4 0.4 1.7 1.0 2.8 1.9 0.2 3.1 1.1 8.9 0.1 0.0 0.8 0.0 0.1 1.4 0.3 0.0 1.6 0.7 SLC25A10 DIC ENSG00000183048 "Solute carrier family 25 member 10" Q9UBX3 17 81712236-81721016 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 51.8" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 37.7;Late spermatids: 65.6;Proximal tubular cells: 75.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 3.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 50.4;SK-BR-3: 38.8" HPA023048 Supported Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA023048: AB_2301950" "unprognostic (7.17e-2)" "unprognostic (2.38e-2)" "unprognostic (2.36e-2)" "unprognostic (1.36e-1)" "unprognostic (9.50e-2)" "prognostic favorable (2.56e-4)" "unprognostic (5.66e-2)" "unprognostic (2.11e-1)" "unprognostic (1.78e-2)" "prognostic favorable (8.14e-4)" "unprognostic (6.73e-2)" "unprognostic (1.33e-1)" "unprognostic (6.02e-2)" "unprognostic (6.32e-2)" "unprognostic (2.76e-1)" "unprognostic (2.05e-1)" "prognostic favorable (1.31e-4)" 10.2 4.9 2.7 5.9 3.2 5.2 6.3 3.3 5.2 4.2 9.5 3.9 7.5 13.9 1.3 3.8 12.2 5.4 8.2 4.3 2.1 2.5 21.0 51.8 3.3 4.6 3.7 4.6 2.4 17.4 10.7 2.1 2.1 3.5 5.6 4.4 4.7 16.8 6.6 2.0 5.9 11.2 1.8 4.7 1.6 7.4 21.8 2.5 7.8 3.3 7.7 8.7 4.3 3.4 0.9 0.7 0.0 1.2 3.6 1.9 0.7 14.2 26.4 2.5 12.6 0.9 0.7 5.0 6.0 2.0 7.8 5.9 16.0 6.1 6.4 4.7 1.4 3.8 9.2 3.6 6.3 1.4 4.7 20.4 5.2 16.1 50.4 1.1 11.7 6.4 0.5 3.3 5.5 1.1 1.5 4.5 9.1 8.7 8.1 2.6 26.8 17.1 12.4 2.6 6.0 19.9 13.0 5.4 20.2 6.9 12.9 16.7 11.3 5.7 38.8 1.3 0.7 16.6 6.5 1.9 6.0 19.8 8.7 11.0 5.0 2.5 3.7 2.6 12.4 5.2 0.0 0.9 0.0 0.8 1.2 1.5 0.1 0.5 1.9 0.7 0.9 0.5 0.4 0.0 3.6 0.2 0.4 1.0 0.7 2.7 3.2 3.3 5.2 2.1 2.5 3.7 4.6 3.5 2.5 0.0 2.1 0.0 5.5 0.0 2.9 3.3 17.8 13.4 5.7 14.0 0.0 11.3 21.6 15.4 23.8 0.5 9.3 0.0 20.3 4.7 0.9 3.9 0.0 37.7 6.8 0.0 4.7 3.1 0.3 65.6 2.0 0.3 0.0 1.0 15.4 1.5 9.6 24.6 1.8 75.1 3.8 0.0 0.2 8.4 2.3 0.0 3.5 1.5 28.8 4.3 SLC25A18 ENSG00000182902 "Solute carrier family 25 member 18" Q9H1K4 22 17563439-17590994 "Plasma proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "adipose tissue: 13.1;brain: 49.0;liver: 50.0" "Cell type enhanced" "Detected in many" 18 "Alveolar cells type 1: 26.8;Alveolar cells type 2: 15.9;Ciliated cells: 28.1;Hepatocytes: 67.6" "Group enriched" "Detected in some" 5 "glioma: 10.6;liver cancer: 11.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 5.7;BEWO: 12.9" "Low region specificity" "Detected in all" HPA068110 Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA068110: " "unprognostic (2.15e-1)" "unprognostic (6.07e-2)" "unprognostic (4.95e-2)" "unprognostic (1.01e-1)" "unprognostic (3.79e-1)" "unprognostic (3.98e-2)" "unprognostic (1.00e-1)" "unprognostic (1.89e-1)" "unprognostic (1.45e-2)" "unprognostic (2.72e-2)" "unprognostic (8.70e-4)" "unprognostic (1.44e-1)" "unprognostic (3.92e-2)" "unprognostic (1.67e-2)" "unprognostic (1.29e-1)" "unprognostic (5.24e-2)" "unprognostic (1.62e-1)" 13.1 2.2 33.2 1.5 28.0 1.2 2.7 7.5 49.0 1.4 1.4 13.3 0.0 1.5 1.7 1.4 1.5 1.7 2.1 2.3 33.3 15.7 1.8 50.0 1.5 1.5 25.6 19.1 1.9 1.8 1.7 0.0 1.3 17.8 4.8 1.3 0.0 1.6 1.6 2.5 1.4 1.4 1.8 14.9 1.9 1.5 3.4 21.6 0.0 1.5 0.0 1.3 1.4 0.0 0.4 0.4 2.1 0.6 0.0 0.5 0.1 0.5 0.9 3.4 0.6 5.7 0.0 12.9 0.4 0.0 0.0 0.0 0.3 0.3 0.3 0.4 0.0 3.7 1.1 0.1 0.0 0.0 0.4 1.4 0.5 0.4 0.8 2.3 0.5 0.6 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.6 0.4 0.0 0.6 0.1 0.8 2.9 1.3 2.1 4.2 1.2 0.0 0.1 0.6 1.2 0.5 0.4 0.6 1.0 2.6 3.7 1.4 0.2 0.2 0.5 0.3 0.4 1.4 1.7 0.0 2.7 0.3 0.5 0.0 0.4 2.1 0.4 0.6 0.0 0.4 0.5 0.1 0.3 0.2 0.1 0.3 0.5 0.0 0.2 0.4 0.1 0.1 33.2 28.0 7.5 25.7 33.3 15.7 25.6 19.1 17.8 21.6 26.8 15.9 0.0 0.2 0.0 0.5 1.4 0.0 28.1 12.5 0.0 0.0 0.4 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.3 0.5 4.6 5.8 67.6 0.2 0.0 0.0 2.5 4.6 0.6 0.9 0.7 0.0 0.0 0.0 1.4 0.0 0.0 2.5 0.6 3.2 0.0 0.0 2.7 4.8 0.1 1.5 0.0 0.0 0.1 SLC25A22 "EIEE3, FLJ13044, GC1, NET44" ENSG00000177542 "Solute carrier family 25 member 22" Q9H936 11 790475-798333 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.0;pancreas: 43.0" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 147.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SCLC-21H: 44.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014662 Approved Uncertain Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA014662: AB_10600808" "unprognostic (1.01e-2)" "unprognostic (2.12e-1)" "unprognostic (7.28e-2)" "unprognostic (4.68e-2)" "unprognostic (2.09e-3)" "unprognostic (1.43e-1)" "unprognostic (2.72e-3)" "unprognostic (8.67e-3)" "unprognostic (4.19e-2)" "unprognostic (3.70e-1)" "unprognostic (2.46e-2)" "unprognostic (1.16e-1)" "unprognostic (8.97e-3)" "unprognostic (2.61e-2)" "unprognostic (8.47e-2)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" 4.9 5.2 23.3 8.3 19.0 5.7 2.7 32.2 45.0 3.5 4.1 3.4 2.5 10.3 3.2 2.3 4.4 5.0 3.8 3.2 27.8 13.2 4.1 14.2 4.6 7.5 9.6 22.8 4.8 43.0 4.0 13.4 4.4 13.5 5.2 2.9 4.6 11.4 4.2 1.1 5.8 8.5 3.3 2.8 5.3 6.8 6.6 2.6 3.5 3.1 3.0 5.1 4.5 2.4 2.5 3.1 4.0 5.7 3.6 7.2 2.3 23.4 15.2 8.9 8.0 3.8 6.8 8.4 11.2 9.4 12.5 7.9 15.0 16.1 7.0 8.4 9.3 14.2 20.8 9.8 13.5 2.8 13.2 18.1 6.4 7.5 9.2 16.2 10.4 10.9 6.8 8.2 9.5 10.2 3.9 5.7 8.3 13.1 11.1 5.5 14.2 10.8 9.8 19.3 14.5 23.4 12.8 4.9 16.6 7.4 3.9 44.3 19.9 6.4 15.5 8.0 1.4 7.5 5.3 5.6 14.0 9.4 6.4 10.5 9.7 5.7 9.0 16.8 9.3 8.3 0.0 2.4 4.0 6.6 5.6 4.2 2.5 4.1 7.2 3.1 2.1 2.5 4.2 1.5 3.6 5.7 0.9 2.2 2.3 23.3 19.0 32.2 37.4 27.8 13.2 9.6 22.8 13.5 2.6 6.0 10.4 2.2 6.3 11.2 147.0 1.8 5.1 2.7 4.5 8.7 31.4 5.9 3.3 22.2 11.5 4.9 7.0 0.0 17.0 8.9 7.4 13.6 2.3 15.3 4.0 41.3 12.5 1.8 1.8 5.6 4.4 2.6 3.3 6.4 7.3 13.4 14.1 7.0 4.6 5.6 29.9 0.0 6.1 1.4 6.3 11.7 2.6 5.2 5.0 8.1 SLC25A30 ENSG00000174032 "Solute carrier family 25 member 30" Q5SVS4 13 45393316-45418455 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 38.0;skeletal muscle: 43.1" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 39.7;Hepatocytes: 38.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045260 Approved Nucleoplasm NA NA Nucleoplasm "HPA045260: AB_10962505" "unprognostic (9.23e-2)" "unprognostic (9.92e-2)" "unprognostic (1.05e-1)" "unprognostic (4.28e-2)" "unprognostic (1.96e-1)" "unprognostic (2.63e-1)" "unprognostic (1.35e-2)" "unprognostic (3.16e-1)" "unprognostic (3.50e-2)" "prognostic unfavorable (3.32e-4)" "unprognostic (5.69e-2)" "unprognostic (1.58e-1)" "prognostic favorable (9.91e-8)" "unprognostic (2.24e-1)" "unprognostic (5.19e-2)" "unprognostic (4.12e-1)" "unprognostic (6.19e-3)" 7.7 6.3 6.2 4.7 5.7 5.3 7.1 3.6 6.3 6.5 4.2 2.1 9.7 2.5 7.7 7.2 5.3 3.9 4.5 38.0 5.8 3.8 24.6 19.5 5.9 9.3 5.4 4.3 10.8 7.5 2.4 5.7 3.4 8.1 8.0 3.5 9.5 6.8 9.1 43.1 4.4 3.5 9.4 7.6 6.1 4.0 5.0 4.9 1.2 6.5 6.7 4.4 6.6 9.0 1.6 5.3 4.3 3.4 1.7 2.7 1.1 2.3 5.1 3.0 13.1 15.4 9.8 1.0 10.9 6.4 9.5 5.7 5.3 6.3 0.0 9.6 11.1 7.0 4.5 7.0 11.0 11.3 7.6 5.7 8.6 3.3 14.1 9.1 12.3 11.7 6.4 7.5 13.9 10.4 11.2 16.4 8.7 5.2 0.0 19.1 2.7 4.5 8.5 4.5 2.7 6.5 11.2 5.1 4.5 20.5 1.9 0.6 3.1 6.1 9.4 8.7 5.5 7.3 16.6 6.0 8.9 5.1 9.8 7.5 2.3 4.5 0.1 9.7 11.7 13.6 0.0 2.8 4.3 2.2 3.4 1.5 1.6 2.2 2.2 4.0 1.5 2.7 1.2 0.0 1.7 1.5 5.3 0.8 1.1 6.2 5.7 3.6 6.3 5.8 3.8 5.4 4.3 8.1 4.9 6.0 2.1 1.5 1.9 11.4 1.7 39.7 10.2 0.0 1.2 14.0 3.9 0.7 19.9 2.2 7.6 4.1 1.4 0.0 1.2 0.8 2.2 2.8 4.7 38.9 3.7 0.0 2.4 7.4 10.0 2.3 4.6 5.9 5.0 6.4 3.9 0.8 2.4 0.0 6.0 22.1 1.1 6.5 2.2 0.0 1.4 5.4 0.5 4.4 3.3 1.1 SLC25A36 "FLJ10618, PNC2" ENSG00000114120 "Solute carrier family 25 member 36" Q96CQ1 3 140941830-140979933 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027036 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" Nucleoplasm "HPA027036: AB_1857048" "unprognostic (4.12e-2)" "unprognostic (9.98e-2)" "unprognostic (2.86e-1)" "unprognostic (1.37e-1)" "unprognostic (6.52e-2)" "unprognostic (3.46e-1)" "unprognostic (9.00e-2)" "unprognostic (1.71e-2)" "unprognostic (1.99e-2)" "unprognostic (2.47e-2)" "unprognostic (3.82e-1)" "unprognostic (2.10e-2)" "unprognostic (2.33e-1)" "unprognostic (1.20e-1)" "unprognostic (2.34e-1)" "unprognostic (6.03e-2)" "prognostic favorable (1.55e-4)" 20.2 16.9 14.9 13.4 20.5 36.5 25.2 18.7 31.3 23.5 19.4 18.3 17.3 22.3 25.6 37.3 12.2 25.1 13.7 29.5 15.9 19.0 29.0 3.1 22.4 18.6 15.6 16.7 32.6 33.9 29.7 26.3 19.1 21.6 20.6 14.8 21.1 17.5 17.7 60.6 16.2 17.2 20.4 18.5 14.1 23.6 24.4 12.2 15.4 23.7 15.1 12.7 20.7 18.5 17.0 14.9 15.7 13.1 18.1 16.6 10.9 23.8 5.4 17.5 14.3 16.1 20.6 22.1 9.0 11.5 10.1 14.3 14.9 11.4 19.9 22.4 7.6 14.5 16.0 21.2 8.8 20.7 15.2 17.2 16.4 13.0 9.4 24.2 23.4 10.2 23.2 29.6 7.4 22.7 22.7 10.6 14.7 8.7 12.9 14.7 10.3 13.9 16.1 17.4 5.9 10.1 15.1 15.6 28.2 11.9 8.2 11.3 18.5 12.2 22.2 39.1 16.0 15.4 13.3 10.7 14.1 7.9 24.9 8.6 26.2 17.0 23.2 18.2 9.8 6.9 10.5 10.4 15.7 11.4 13.1 13.3 17.0 11.7 12.5 14.9 16.0 16.6 15.7 1.8 18.1 13.1 10.9 10.2 10.9 14.9 20.5 18.7 31.3 15.9 19.0 15.6 16.7 21.6 12.2 92.3 107.7 22.2 58.2 60.7 96.5 82.2 38.2 133.8 62.6 68.0 125.7 48.2 54.7 22.9 5.0 40.0 22.6 0.0 33.6 33.4 49.8 72.0 63.6 0.4 22.8 87.4 57.0 29.4 35.2 11.5 55.3 36.5 54.0 29.7 27.0 70.1 26.8 17.5 55.9 52.8 122.5 58.2 54.2 29.3 61.1 47.6 41.3 41.1 40.3 64.7 SLC25A44 "FLJ90431, KIAA0446" ENSG00000160785 "Solute carrier family 25 member 44" Q96H78 1 156193932-156212796 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 115.9;Late spermatids: 71.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 33.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065411 Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA065411: AB_2685486" "unprognostic (1.58e-1)" "unprognostic (1.78e-1)" "unprognostic (4.62e-1)" "unprognostic (2.44e-3)" "unprognostic (2.75e-1)" "unprognostic (1.32e-1)" "unprognostic (5.72e-2)" "unprognostic (8.92e-2)" "unprognostic (1.97e-1)" "unprognostic (3.58e-1)" "prognostic favorable (2.49e-4)" "unprognostic (3.37e-2)" "unprognostic (2.55e-2)" "unprognostic (2.71e-1)" "unprognostic (2.67e-1)" "unprognostic (8.13e-2)" "unprognostic (2.37e-1)" 14.3 9.0 15.9 9.3 23.1 10.2 8.9 18.6 31.9 9.1 10.4 19.7 6.6 16.8 8.1 11.1 9.0 7.8 10.7 10.6 16.1 16.7 25.9 31.2 10.6 8.7 14.4 18.1 7.1 8.3 17.7 10.9 7.8 22.5 8.7 11.1 9.3 7.0 9.5 12.8 9.1 13.9 10.8 13.5 13.3 8.4 8.9 12.1 10.6 9.7 6.0 11.2 9.7 7.9 3.7 6.3 33.8 9.1 4.2 4.9 5.6 10.3 17.7 8.7 11.5 19.0 10.3 6.8 11.1 16.4 20.3 16.6 17.3 9.4 8.2 9.8 16.6 11.0 15.5 31.7 13.1 18.0 9.4 10.6 7.5 11.3 10.4 14.5 9.7 13.8 14.4 11.5 20.5 12.4 9.8 16.4 10.2 7.8 13.6 13.9 18.6 10.1 6.9 20.5 19.8 18.4 6.5 8.8 14.0 26.5 12.3 13.6 18.3 13.0 23.6 14.8 16.0 17.8 15.9 13.2 11.7 9.9 13.1 13.2 14.0 10.6 12.5 12.9 10.2 11.5 6.5 8.4 8.7 4.7 9.1 4.9 3.7 3.8 4.4 6.3 2.4 3.1 3.7 33.8 4.2 7.1 2.8 3.3 5.6 15.9 23.1 18.6 31.9 16.1 16.7 14.4 18.1 22.5 12.1 11.9 24.8 12.3 4.8 24.6 12.6 30.7 7.6 4.0 14.8 8.7 19.6 4.3 5.0 5.4 115.9 11.7 9.2 0.0 4.9 3.3 17.9 6.1 4.7 29.8 6.5 19.1 5.8 10.4 8.6 71.2 6.6 12.2 11.8 1.8 8.5 7.2 4.9 5.8 5.3 13.9 8.8 19.4 12.2 9.1 7.7 29.7 6.9 7.5 7.5 6.3 SLC25A45 ENSG00000162241 "Solute carrier family 25 member 45" Q8N413 11 65375192-65383701 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 60.5" "Cell type enhanced" "Detected in many" 5 "B-cells: 32.2;T-cells: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 13.8;Karpas-707: 18.7;RPMI-8226: 13.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA050821 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA050821: AB_2681249" "unprognostic (3.73e-2)" "unprognostic (2.19e-3)" "unprognostic (8.44e-4)" "unprognostic (6.17e-3)" "unprognostic (2.57e-2)" "unprognostic (2.84e-7)" "unprognostic (7.57e-3)" "unprognostic (4.59e-2)" "unprognostic (1.44e-1)" "unprognostic (4.06e-2)" "prognostic favorable (2.83e-4)" "unprognostic (1.96e-1)" "unprognostic (1.08e-2)" "unprognostic (1.45e-1)" "unprognostic (1.54e-1)" "unprognostic (6.18e-2)" "unprognostic (1.43e-1)" 2.2 1.8 2.1 4.0 2.3 3.1 3.2 1.0 2.6 1.7 4.5 4.0 4.7 4.1 1.0 5.4 1.5 1.3 1.3 2.8 2.5 1.1 3.9 7.7 5.3 9.4 1.8 2.3 1.3 60.5 4.2 4.7 1.2 2.3 2.5 1.2 3.5 5.0 1.3 4.1 2.0 11.0 1.5 2.3 9.6 1.9 2.4 2.0 5.8 9.0 2.8 8.2 1.9 1.7 10.8 19.2 6.0 10.1 13.5 11.4 2.5 0.3 4.7 0.2 6.9 1.3 0.6 3.5 0.8 2.1 0.4 0.4 1.0 2.2 4.1 3.9 1.9 1.8 0.6 0.5 0.3 0.0 13.8 1.0 4.5 2.5 0.3 0.8 1.4 4.8 1.6 0.1 0.5 0.4 0.4 0.7 8.0 0.6 18.7 0.7 1.5 3.3 0.1 0.3 0.2 2.2 6.1 0.9 13.6 0.7 0.0 2.3 3.1 1.4 3.7 0.7 0.4 1.9 0.7 1.3 0.5 1.8 4.5 0.3 7.8 4.9 1.2 1.4 1.0 2.7 6.0 5.5 3.9 7.9 9.0 8.4 8.9 7.0 7.5 5.7 10.8 11.4 8.5 3.3 13.5 10.1 19.2 6.3 2.5 2.1 2.3 1.0 2.6 2.5 1.1 1.8 2.3 2.3 2.0 0.0 3.5 32.2 5.2 2.5 9.0 5.5 10.2 17.4 4.5 12.2 0.0 1.4 0.0 4.9 5.2 2.9 23.9 0.0 4.7 1.0 3.3 7.8 4.6 12.1 6.3 6.4 6.4 7.4 7.0 3.3 6.4 13.8 5.0 18.0 12.9 7.7 4.3 8.6 3.5 6.2 0.3 6.5 2.5 2.3 0.2 1.8 1.3 35.9 7.4 3.5 SLC26A11 ENSG00000181045 "Solute carrier family 26 member 11" Q86WA9 17 80219699-80253500 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 55.0;Rod photoreceptor cells: 37.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "dendritic cells: 1.3;monocytes: 2.3;T-cells: 4.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029893 Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA029893: AB_10600809" "unprognostic (5.86e-2)" "unprognostic (6.66e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (1.55e-5)" "unprognostic (3.80e-2)" "unprognostic (2.63e-3)" "prognostic unfavorable (1.82e-6)" "unprognostic (2.05e-2)" "unprognostic (3.54e-2)" "unprognostic (1.03e-1)" "prognostic favorable (1.43e-5)" "unprognostic (2.86e-1)" "unprognostic (3.50e-1)" "unprognostic (9.54e-3)" "unprognostic (8.40e-2)" "unprognostic (8.69e-2)" "unprognostic (7.32e-2)" 9.9 30.9 10.2 10.2 19.3 16.3 8.4 9.1 18.0 11.6 8.2 12.6 14.1 8.7 11.6 14.6 6.9 9.2 10.0 5.1 9.4 30.5 12.4 6.9 12.8 14.3 10.5 17.4 18.3 7.9 14.9 25.6 21.1 17.2 11.8 5.1 15.6 12.2 14.8 6.5 13.1 11.9 11.6 9.3 17.3 7.3 4.8 7.3 1.8 18.1 4.9 6.7 9.8 14.1 0.4 1.3 0.1 2.3 0.1 4.9 1.9 0.5 8.2 9.7 7.5 4.9 3.6 11.2 4.7 5.9 10.6 6.6 9.4 1.7 0.1 9.6 4.9 7.7 3.1 5.4 3.5 4.2 11.2 9.7 0.0 10.4 8.7 12.9 0.0 1.5 6.6 5.7 5.1 2.3 1.0 8.9 1.9 4.0 11.9 6.2 7.7 0.4 0.2 4.3 2.3 8.0 0.4 1.0 4.3 9.6 9.0 3.8 11.9 4.7 11.8 12.2 15.8 14.1 0.2 6.6 8.6 5.0 7.3 0.5 13.5 5.1 1.3 4.4 0.0 6.8 0.0 2.3 0.0 1.8 0.9 2.6 0.4 3.2 2.6 1.3 0.2 4.9 2.0 0.1 0.1 0.3 0.0 4.0 1.9 10.2 19.3 9.1 18.0 9.4 30.5 10.5 17.4 17.2 7.3 6.0 12.0 0.9 9.3 4.0 28.0 2.0 0.0 2.7 5.7 12.2 55.0 12.2 1.7 6.3 0.4 14.1 3.9 0.0 5.3 7.0 8.2 9.4 1.1 2.0 14.0 3.2 9.8 6.2 5.9 0.2 15.8 8.3 3.3 2.8 2.5 21.0 3.9 3.5 11.7 4.8 37.6 32.3 4.7 0.2 1.5 4.1 21.7 5.7 2.8 5.2 SLC29A2 "DER12, ENT2, HNP36" ENSG00000174669 "Solute carrier family 29 member 2" Q14542 11 66362521-66372214 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 68.9" "Cell type enhanced" "Detected in many" 10 "Cytotrophoblasts: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 10 "B-cells: 1.6;dendritic cells: 1.6;T-cells: 4.1" "Cell line enhanced" "Detected in many" "BEWO: 16.7;CAPAN-2: 21.4;K-562: 16.1;T-47d: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018168 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA018168: AB_1857077" "unprognostic (3.20e-2)" "unprognostic (4.50e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (3.37e-1)" "unprognostic (5.08e-2)" "unprognostic (5.64e-2)" "unprognostic (1.60e-1)" "unprognostic (1.96e-1)" "unprognostic (2.09e-1)" "unprognostic (1.76e-1)" "unprognostic (5.28e-2)" "prognostic favorable (2.78e-4)" "unprognostic (2.55e-2)" "unprognostic (1.59e-1)" "unprognostic (1.13e-1)" "unprognostic (6.38e-3)" 5.4 1.3 2.5 2.8 3.2 1.2 13.2 10.3 5.1 1.9 4.0 3.1 4.8 5.6 1.2 5.2 2.7 3.0 3.2 9.0 2.9 3.3 6.4 1.5 3.4 2.5 3.3 3.5 1.0 7.8 11.3 5.9 3.3 7.0 4.2 2.3 2.2 6.0 6.3 68.9 1.9 4.3 0.9 1.7 2.0 6.6 0.9 2.0 1.6 4.2 18.0 2.5 1.5 2.2 1.6 1.6 0.2 0.1 0.1 4.1 1.2 5.8 4.4 3.5 0.7 0.3 0.0 16.7 0.2 0.0 0.2 0.3 7.0 21.4 2.6 5.5 0.0 1.1 5.9 3.3 4.2 0.0 0.1 9.6 5.7 5.4 0.5 0.7 9.5 0.1 0.3 1.7 0.6 1.9 1.7 0.3 2.0 16.1 0.0 0.0 12.1 0.7 13.4 10.1 7.3 4.6 0.7 0.0 12.1 8.9 4.4 7.1 3.2 0.3 9.2 0.6 0.4 26.0 2.1 0.0 0.1 5.8 0.1 0.0 0.1 0.3 0.2 0.4 0.2 0.2 0.0 0.1 0.0 3.5 0.0 1.1 0.6 2.2 4.1 0.8 1.6 4.1 4.1 0.2 0.1 0.1 1.6 0.4 1.2 2.5 3.2 10.3 5.1 2.9 3.3 3.3 3.5 7.0 2.0 3.0 4.6 1.4 4.4 0.6 2.5 9.7 5.1 5.3 7.9 14.0 11.8 40.5 3.3 4.3 0.0 0.7 2.1 0.0 5.8 12.3 1.0 2.8 4.6 0.5 3.8 4.8 2.4 0.0 0.6 0.0 0.0 0.0 0.0 1.0 8.5 2.3 3.2 3.5 0.4 0.6 3.3 0.0 2.3 0.1 0.2 0.0 11.3 1.3 10.7 2.5 SLC2A10 GLUT10 ENSG00000197496 "Solute carrier family 2 member 10" O95528 20 46709487-46736347 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 51.5" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 33.5;Hepatocytes: 41.2;Mucus-secreting cells: 60.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 44 "basophil: 13.8" "Lineage enriched" "Detected in single" 44 "granulocytes: 13.8" "Cell line enhanced" "Detected in many" "ASC diff: 19.5;HSkMC: 24.2;OE19: 20.0;SK-MEL-30: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041015 Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA041015: AB_2677252" "unprognostic (8.94e-3)" "unprognostic (2.62e-3)" "unprognostic (2.06e-1)" "unprognostic (1.85e-1)" "unprognostic (6.17e-3)" "unprognostic (1.04e-1)" "unprognostic (7.68e-2)" "unprognostic (2.80e-1)" "unprognostic (1.83e-1)" "unprognostic (8.06e-2)" "unprognostic (4.94e-3)" "unprognostic (1.70e-1)" "unprognostic (3.63e-3)" "unprognostic (1.25e-2)" "unprognostic (1.05e-1)" "unprognostic (3.00e-1)" "unprognostic (5.96e-2)" 4.7 4.6 2.6 4.3 3.3 0.1 8.7 2.1 3.1 11.4 6.7 2.7 6.7 2.6 5.4 6.6 4.8 5.6 10.2 6.7 3.3 1.4 2.6 51.5 4.8 3.4 2.2 2.0 7.1 22.9 15.0 4.2 8.3 3.8 18.0 8.8 9.8 11.5 11.0 2.1 2.4 3.0 9.7 2.3 1.9 12.4 3.4 1.0 0.8 18.1 4.5 4.6 7.1 5.7 0.0 0.0 13.8 0.0 0.3 0.0 0.0 0.0 0.0 4.7 4.8 19.5 16.7 14.3 9.1 12.4 4.2 5.1 0.3 16.0 0.0 6.9 16.5 0.0 0.1 0.0 0.4 2.0 0.0 0.1 1.3 0.0 7.6 13.8 0.0 0.0 24.2 0.4 2.6 0.0 4.9 1.7 0.0 0.1 0.0 7.2 16.6 0.0 0.4 1.7 20.0 1.2 0.0 0.7 0.0 0.0 4.3 0.0 0.7 1.8 3.0 24.8 3.5 2.3 3.7 1.0 9.1 4.0 7.2 1.1 0.1 0.0 0.0 0.0 0.0 1.9 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 2.6 3.3 2.1 3.1 3.3 1.4 2.2 2.0 3.8 1.0 6.0 4.6 0.0 6.8 0.6 0.0 2.2 10.2 33.5 11.4 1.8 0.0 1.9 0.0 5.2 0.1 4.1 2.2 0.0 4.9 12.8 11.7 28.1 5.8 41.2 0.9 0.0 3.5 9.2 2.8 0.9 24.5 0.3 1.7 0.0 60.1 5.6 5.1 2.9 16.3 0.7 0.5 12.9 3.9 0.4 0.2 0.9 1.7 0.0 6.6 10.2 SLC2A11 "GLUT10, GLUT11" ENSG00000133460 "Solute carrier family 2 member 11" Q9BYW1 22 23856703-23886309 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 280.8;Rod photoreceptor cells: 194.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 12.0" "HPA042960, HPA071184" Uncertain Uncertain "Nucleoplasm,Cell Junctions" NA NA "Cell Junctions" Nucleoplasm "HPA042960: AB_2678241, HPA071184: AB_2686355" "unprognostic (1.31e-1)" "unprognostic (1.14e-1)" "unprognostic (3.69e-2)" "unprognostic (6.97e-2)" "unprognostic (7.93e-2)" "unprognostic (1.32e-1)" "unprognostic (4.24e-2)" "unprognostic (1.60e-3)" "unprognostic (3.53e-1)" "unprognostic (4.89e-2)" "prognostic favorable (3.83e-4)" "unprognostic (2.32e-1)" "prognostic favorable (5.77e-7)" "unprognostic (1.25e-1)" "unprognostic (1.70e-1)" "unprognostic (3.85e-1)" "unprognostic (6.29e-2)" 4.3 7.8 8.5 6.1 15.3 3.5 6.2 22.9 17.0 4.1 4.9 6.4 17.2 3.9 7.7 9.0 2.8 5.0 5.2 8.5 11.0 13.4 19.5 4.9 4.5 7.1 9.5 10.9 6.6 28.8 18.6 14.0 21.0 9.7 7.6 6.0 10.4 6.1 11.4 13.6 4.2 4.8 10.4 9.6 5.3 6.1 4.5 6.2 1.6 9.2 2.4 6.4 4.5 5.3 2.2 4.6 1.5 1.1 1.2 1.6 0.3 2.6 1.3 1.7 7.6 1.6 3.4 0.7 1.6 2.0 1.8 1.3 1.8 1.8 3.4 0.9 2.2 1.6 2.2 3.2 0.9 0.9 2.3 2.9 1.7 2.8 2.6 2.5 1.6 1.8 1.3 3.2 2.7 2.3 8.4 0.7 2.7 0.7 7.6 1.0 2.8 0.3 0.7 2.5 1.7 2.1 4.6 0.2 3.8 5.6 0.7 4.1 2.3 0.8 12.0 2.7 2.1 6.2 0.8 0.5 0.7 1.2 0.7 0.8 7.1 1.9 3.3 1.5 1.2 1.8 1.5 0.4 0.9 0.9 1.1 0.7 2.1 0.8 0.8 0.2 2.2 1.6 1.1 1.2 1.2 0.7 4.6 0.2 0.3 8.5 15.3 22.9 17.0 11.0 13.4 9.5 10.9 9.7 6.2 17.9 12.9 16.6 8.2 2.9 57.0 29.0 7.6 8.1 4.5 24.4 280.8 7.0 11.6 4.7 5.9 3.3 3.4 0.0 4.9 7.6 4.5 8.0 2.3 5.8 5.2 35.0 10.4 4.9 3.1 8.5 8.6 4.2 3.3 2.8 4.9 15.4 3.5 2.9 9.2 20.7 194.1 0.0 6.2 3.9 5.1 2.8 16.7 7.5 7.3 5.4 SLC30A3 ZNT3 ENSG00000115194 "Solute carrier family 30 member 3" Q99726 2 27253684-27275817 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 28.7;epididymis: 41.0;testis: 19.5" "Group enriched" "Detected in some" 18 "Cardiomyocytes: 8.1;Early spermatids: 13.1;Late spermatids: 29.1;Peritubular cells: 14.2;Spermatocytes: 18.7;Spermatogonia: 9.4" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 9 "amygdala: 15.8;basal ganglia: 11.4;cerebral cortex: 28.7;hippocampal formation: 10.2;olfactory region: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 8.0;HAP1: 8.8;Hep G2: 11.7;REH: 19.0;RH-30: 9.9" "Group enriched" "Detected in many" 5 "amygdala: 135.1;basal ganglia: 48.1;cerebral cortex: 108.9;hippocampal formation: 75.6" "Group enriched" "Detected in many" 7 "amygdala: 43.9;cerebral cortex: 117.8;hippocampal formation: 91.9" "HPA060505, HPA067637, CAB079044" Enhanced Approved Approved Nucleoplasm,Nucleoli,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Nucleoli, Cytosol" "CAB079044: , HPA060505: AB_2684296, HPA067637: AB_2685875" "unprognostic (2.05e-4)" "unprognostic (1.17e-1)" "unprognostic (6.84e-4)" "unprognostic (5.26e-2)" "unprognostic (2.34e-1)" "unprognostic (1.13e-1)" "unprognostic (1.43e-2)" "unprognostic (2.93e-2)" "unprognostic (2.64e-2)" "unprognostic (3.05e-1)" "unprognostic (2.20e-1)" "unprognostic (1.89e-1)" "unprognostic (4.65e-12)" "unprognostic (3.23e-2)" "unprognostic (1.76e-1)" "unprognostic (2.74e-2)" "unprognostic (2.63e-4)" 0.5 1.9 15.8 0.5 11.4 0.5 0.4 0.4 28.7 0.5 0.5 0.0 1.9 0.4 0.5 41.0 0.4 0.7 0.4 5.0 10.2 0.8 0.4 0.5 0.5 0.8 1.1 12.1 0.5 0.4 0.6 0.4 0.4 1.6 0.6 0.5 0.7 0.4 0.9 0.4 0.4 0.5 0.5 0.7 0.5 0.4 19.5 0.0 0.0 0.4 0.0 0.4 0.5 0.4 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.3 1.1 0.0 1.5 0.0 0.2 0.1 0.0 0.0 1.0 1.0 0.3 0.4 0.0 0.0 0.0 8.0 0.2 8.8 0.0 0.2 0.0 1.0 5.0 0.2 11.7 0.2 0.1 2.0 0.0 0.0 0.5 0.0 0.1 0.7 2.4 1.4 0.0 0.1 3.8 0.0 0.3 1.5 0.2 0.0 19.0 9.9 1.0 0.0 0.0 0.0 0.6 2.3 0.0 0.0 0.0 0.0 0.7 0.0 0.2 4.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 15.8 11.4 0.4 28.7 10.2 0.8 1.1 12.1 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 29.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.3 18.7 9.4 0.1 0.1 0.0 0.0 0.0 SLC30A5 "FLJ12496, FLJ12756, MGC5499, ZnT-5, ZNT5, ZNTL1, ZTL1" ENSG00000145740 "Solute carrier family 30 member 5" Q8TAD4 5 69093646-69131069 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035373 Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA035373: AB_10794630" "unprognostic (9.81e-3)" "unprognostic (3.33e-1)" "unprognostic (2.82e-2)" "unprognostic (8.16e-2)" "unprognostic (1.65e-1)" "unprognostic (3.88e-2)" "unprognostic (1.16e-3)" "unprognostic (2.47e-2)" "unprognostic (4.65e-2)" "unprognostic (5.41e-2)" "unprognostic (3.57e-2)" "unprognostic (2.92e-1)" "unprognostic (1.49e-1)" "unprognostic (2.53e-2)" "unprognostic (2.07e-1)" "unprognostic (2.11e-2)" "unprognostic (1.40e-1)" 19.4 22.1 14.4 19.4 15.7 13.3 29.7 14.9 18.5 25.0 20.9 13.2 33.7 19.7 24.3 32.4 20.5 20.3 23.5 25.4 14.5 15.4 28.6 39.2 24.3 23.7 15.5 13.1 25.4 50.5 29.6 38.1 34.3 13.9 24.5 19.8 17.6 36.8 35.3 17.1 21.2 25.0 18.1 13.2 20.1 20.3 18.1 12.7 22.1 33.5 18.8 19.6 18.2 28.9 8.3 13.2 12.4 6.9 5.6 9.1 3.3 15.7 12.2 11.4 20.0 30.1 23.2 36.2 25.0 22.7 15.8 24.2 11.2 19.8 20.9 31.9 17.0 27.7 17.0 15.8 18.9 26.8 24.9 18.2 23.3 15.4 18.3 24.2 14.6 26.0 15.6 25.1 16.2 19.4 22.2 15.3 14.5 14.0 25.0 20.1 19.9 19.2 30.4 12.9 10.7 14.0 15.4 14.5 37.7 23.6 14.8 20.4 16.2 19.8 19.9 33.9 16.6 19.2 32.5 13.9 10.3 13.4 25.7 24.7 22.7 27.9 16.3 20.3 26.6 25.4 12.4 6.7 10.7 6.1 6.8 6.5 8.3 9.1 8.9 8.4 6.3 8.4 7.1 5.9 5.6 6.9 13.2 6.1 3.3 14.4 15.7 14.9 18.5 14.5 15.4 15.5 13.1 13.9 12.7 17.9 15.5 9.0 22.6 16.7 13.9 26.2 12.7 14.7 14.8 24.4 21.6 35.4 24.9 18.8 5.2 16.6 12.3 23.3 23.5 60.9 24.0 28.7 41.4 17.4 19.6 7.9 12.7 19.0 17.3 6.7 22.5 16.4 13.5 12.6 24.9 13.4 17.8 21.0 20.8 16.1 22.6 25.8 20.9 9.9 14.9 18.7 43.1 20.3 21.7 24.2 SLC33A1 "ACATN, AT-1, AT1, SPG42" ENSG00000169359 "Solute carrier family 33 member 1" O00400 3 155821024-155854456 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Cataract, Deafness, Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042430, HPA060345" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA042430: AB_10806238, HPA060345: AB_2732647" "unprognostic (5.12e-3)" "unprognostic (7.78e-2)" "unprognostic (1.13e-2)" "unprognostic (7.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.34e-1)" "unprognostic (2.73e-2)" "unprognostic (9.57e-2)" "unprognostic (5.65e-2)" "unprognostic (6.61e-2)" "unprognostic (4.36e-2)" "unprognostic (1.19e-1)" "unprognostic (1.93e-1)" "unprognostic (2.08e-2)" "unprognostic (2.92e-1)" "unprognostic (4.73e-2)" "unprognostic (5.74e-2)" 11.3 17.3 6.5 9.9 8.6 3.1 12.1 9.4 9.4 18.8 13.1 10.5 29.9 11.3 14.0 22.9 11.8 12.3 11.5 12.9 7.8 6.7 19.4 38.3 12.8 13.6 9.4 5.6 13.6 42.4 18.8 24.6 13.9 8.9 15.0 10.5 9.2 26.6 33.9 7.0 9.4 15.2 10.4 8.2 11.9 12.4 8.9 8.8 14.9 26.1 5.8 10.7 10.2 11.6 6.0 16.7 12.1 8.3 6.9 10.8 6.0 14.9 10.4 5.4 6.7 20.0 17.3 10.2 11.2 15.0 13.6 13.4 5.9 16.0 7.7 18.1 9.1 14.2 12.7 9.3 11.0 15.4 10.9 9.6 8.0 5.0 11.6 29.0 8.8 7.1 13.8 22.1 7.2 28.1 15.2 14.9 7.3 6.4 18.6 12.2 9.5 3.5 5.2 5.2 12.6 10.0 4.0 6.0 23.1 13.9 9.5 6.3 5.2 9.4 21.9 19.9 8.0 6.9 11.2 15.4 8.0 4.0 14.7 11.7 21.9 7.7 8.1 11.5 7.2 11.4 12.1 8.3 6.0 9.4 6.5 10.8 6.0 6.8 7.4 10.7 4.1 6.5 6.3 1.8 6.9 6.3 16.7 6.1 6.0 6.5 8.6 9.4 9.4 7.8 6.7 9.4 5.6 8.9 8.8 20.8 20.6 11.9 10.4 7.9 16.4 21.8 22.9 21.4 18.2 10.4 25.5 15.7 5.0 13.3 10.1 11.3 14.8 0.0 13.5 23.4 14.7 16.8 11.5 43.1 17.3 17.5 12.0 18.4 16.2 9.1 17.3 15.9 11.8 14.4 14.7 17.2 15.0 3.5 20.1 15.5 19.9 12.9 17.2 17.2 7.2 8.3 31.5 15.8 12.1 9.1 SLC34A1 "NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2" ENSG00000131183 "Solute carrier family 34 member 1" Q06495 5 177379235-177398848 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 79 "kidney: 94.5" "Cell type enriched" "Detected in some" 16 "Proximal tubular cells: 128.7" "Cancer enriched" "Detected in single" 12 "renal cancer: 1.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Group enriched" "Detected in some" 12 "HEL: 6.7;U-937: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA051255, HPA077175" Approved Approved "Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol" Yes NA "Nuclear speckles, Plasma membrane" "Nucleoplasm, Mitotic spindle, Cytosol" "HPA051255: AB_2681409, HPA077175: " "unprognostic (1.17e-1)" "unprognostic (3.33e-3)" "unprognostic (1.49e-1)" "unprognostic (3.49e-2)" "unprognostic (1.56e-3)" "unprognostic (2.28e-1)" "unprognostic (4.50e-2)" "unprognostic (4.43e-3)" "unprognostic (1.91e-1)" "unprognostic (1.14e-1)" "unprognostic (5.95e-2)" "unprognostic (1.23e-3)" "unprognostic (1.38e-1)" "unprognostic (2.01e-1)" "unprognostic (1.28e-2)" "unprognostic (4.66e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.2 0.0 6.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 7.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 128.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 SLC34A2 NAPI-3B ENSG00000157765 "Solute carrier family 34 member 2" O95436 4 25648011-25678748 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lung: 259.9;seminal vesicle: 69.1" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 443.7;Alveolar cells type 2: 1050.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 585.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 1.9" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 81 "BEWO: 12.6;EFO-21: 47.7;RPTEC TERT1: 34.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA037989, HPA066474" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA037989: AB_10670536, HPA066474: " "unprognostic (1.60e-2)" "unprognostic (1.12e-1)" "unprognostic (1.38e-1)" "unprognostic (4.25e-2)" "unprognostic (7.33e-2)" "unprognostic (9.83e-2)" "unprognostic (2.37e-2)" "unprognostic (6.60e-3)" "unprognostic (6.27e-2)" "unprognostic (1.89e-2)" "unprognostic (5.77e-2)" "unprognostic (2.24e-1)" "unprognostic (7.08e-3)" "unprognostic (3.25e-1)" "unprognostic (6.75e-2)" "unprognostic (2.57e-2)" "unprognostic (1.93e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 3.2 0.2 0.1 13.0 0.1 0.0 24.7 2.9 6.9 2.1 0.5 13.0 3.4 0.1 0.1 0.1 10.8 0.5 259.9 0.0 0.1 0.0 2.9 4.4 0.0 0.6 2.6 0.8 0.3 0.0 1.6 27.4 69.1 0.1 0.7 2.1 0.0 0.1 0.1 0.4 0.5 0.0 0.4 27.9 0.1 1.9 0.0 0.1 0.4 0.2 1.9 0.5 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 47.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 34.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.0 1.9 0.5 0.2 0.3 0.3 0.1 0.2 0.1 0.1 0.0 0.4 0.3 0.2 1.5 0.4 0.1 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.8 0.0 443.7 1050.6 0.0 0.1 0.0 0.0 0.6 40.8 125.8 178.6 19.2 0.0 1.6 5.0 57.7 3.5 0.0 0.0 0.0 7.1 0.0 0.0 3.5 26.7 0.0 0.2 0.0 0.0 0.0 0.0 14.0 1.1 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 2.9 0.0 0.0 0.1 0.5 0.1 0.0 0.2 0.0 0.0 0.1 SLC35A4 ENSG00000176087 "Solute carrier family 35 member A4" "L0R6Q1, Q96G79" 5 140564456-140569103 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 94.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062210 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA062210: AB_2684712" "unprognostic (3.01e-3)" "unprognostic (1.35e-2)" "unprognostic (5.88e-2)" "unprognostic (1.09e-1)" "unprognostic (2.46e-2)" "unprognostic (1.65e-2)" "unprognostic (1.91e-3)" "unprognostic (9.63e-2)" "unprognostic (3.61e-2)" "unprognostic (9.32e-2)" "unprognostic (1.78e-2)" "unprognostic (2.87e-1)" "prognostic favorable (4.56e-5)" "unprognostic (2.96e-2)" "unprognostic (3.04e-2)" "unprognostic (2.06e-2)" "unprognostic (1.55e-1)" 22.0 30.4 12.3 18.6 17.1 8.4 19.6 14.0 21.8 18.2 25.5 24.9 22.6 19.2 18.2 19.8 30.3 20.6 26.0 25.7 13.1 10.3 35.1 39.2 23.1 22.5 16.0 11.1 19.0 28.3 28.2 14.9 24.6 19.4 20.4 26.5 20.5 32.6 15.9 54.3 28.3 30.6 19.8 13.0 28.5 21.7 30.5 15.3 26.0 29.2 28.0 27.5 18.3 18.0 15.4 32.8 15.8 36.9 26.9 27.6 32.4 15.5 46.7 18.7 35.2 25.7 16.1 27.9 22.7 15.3 27.7 29.2 56.5 18.0 46.0 28.1 21.3 32.3 17.2 0.0 33.1 23.8 55.9 25.6 34.4 45.6 0.2 18.3 33.6 26.0 21.3 25.9 27.5 24.7 13.0 23.7 22.8 26.6 46.5 27.4 28.8 35.0 14.6 12.7 22.4 23.9 26.1 37.9 39.9 20.7 30.8 20.9 27.9 28.7 47.8 22.3 19.2 39.7 14.4 27.7 24.9 17.4 24.7 25.4 19.3 45.3 19.3 18.4 38.0 28.9 7.5 26.9 15.8 27.6 36.9 26.3 14.3 22.1 24.7 32.8 15.4 25.9 23.0 9.9 26.9 33.3 12.0 14.7 32.4 12.3 17.1 14.0 21.8 13.1 10.3 16.0 11.1 19.4 15.3 11.9 24.8 21.9 20.2 9.3 12.2 23.8 43.3 6.7 17.0 15.7 3.9 26.8 38.1 28.1 58.7 14.7 37.1 0.0 30.4 42.8 19.5 22.2 20.7 19.5 28.5 12.7 24.2 27.6 21.1 94.4 11.5 15.8 16.9 31.5 27.2 20.3 31.1 21.0 11.7 31.1 8.5 32.3 12.6 5.4 16.4 10.2 25.5 20.3 28.7 29.1 SLC35B1 UGTREL1 ENSG00000121073 "Solute carrier family 35 member B1" P78383 17 49700943-49709014 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048655, HPA057418" Approved Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum, Vesicles" Nucleoplasm "HPA048655: AB_2680481, HPA057418: AB_2683432" "unprognostic (1.35e-1)" "unprognostic (2.15e-2)" "unprognostic (1.09e-3)" "unprognostic (6.36e-2)" "unprognostic (8.31e-2)" "unprognostic (2.86e-3)" "unprognostic (6.17e-3)" "unprognostic (4.39e-2)" "unprognostic (2.47e-2)" "unprognostic (4.00e-3)" "unprognostic (3.37e-2)" "unprognostic (4.42e-2)" "prognostic unfavorable (5.69e-7)" "unprognostic (6.28e-2)" "unprognostic (7.88e-2)" "unprognostic (2.58e-1)" "unprognostic (1.44e-2)" 8.5 8.3 8.4 7.4 11.8 8.0 10.7 8.2 14.0 9.3 13.0 9.3 9.2 13.7 7.6 26.5 9.4 9.9 7.3 15.8 8.6 9.2 16.0 46.7 10.1 16.0 9.8 7.9 7.5 22.3 13.5 13.2 12.4 9.9 7.4 13.1 8.4 22.4 12.7 33.7 9.2 27.3 8.0 8.1 10.2 9.3 9.1 7.1 6.5 19.7 13.8 10.8 9.9 6.7 6.6 25.0 8.1 15.1 7.0 9.5 7.9 13.6 22.9 17.2 27.0 15.8 9.9 19.5 14.5 23.6 30.9 24.8 47.3 16.0 9.5 34.0 20.1 18.6 10.2 27.1 17.3 33.9 11.6 19.8 12.0 15.1 27.7 27.6 22.5 11.4 10.1 19.0 22.2 27.8 7.9 19.0 15.6 11.7 27.4 21.2 27.8 16.5 14.6 7.6 25.6 25.9 11.1 18.6 25.7 15.1 14.5 14.9 19.1 8.5 6.8 9.9 19.3 21.8 15.4 8.1 23.6 10.5 25.2 19.0 14.5 23.8 14.2 15.4 17.1 20.6 8.1 15.1 5.0 9.5 13.5 6.9 6.6 6.5 8.9 16.7 3.6 6.6 6.0 6.7 7.0 9.1 25.0 7.4 7.9 8.4 11.8 8.2 14.0 8.6 9.2 9.8 7.9 9.9 7.1 14.9 27.2 30.7 36.3 19.8 25.8 35.5 20.4 30.8 31.8 26.2 33.4 49.1 29.9 55.6 40.4 35.0 41.9 0.0 89.2 91.8 36.1 53.6 41.5 49.5 66.9 20.6 48.6 22.7 21.3 11.3 27.9 37.0 35.4 45.9 30.5 41.4 64.2 27.5 19.4 37.9 30.4 12.9 15.3 44.2 33.8 22.0 67.3 35.2 36.0 37.4 SLC35C2 "bA394O2.1, C20orf5, CGI-15, OVCOV1" ENSG00000080189 "Solute carrier family 35 member C2" Q9NQQ7 20 46345980-46364458 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027011 Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA027011: AB_2672082" "unprognostic (7.25e-2)" "unprognostic (1.78e-1)" "unprognostic (1.01e-1)" "unprognostic (2.27e-2)" "unprognostic (1.06e-2)" "unprognostic (2.90e-1)" "prognostic unfavorable (1.08e-4)" "unprognostic (1.34e-1)" "unprognostic (1.23e-1)" "unprognostic (2.56e-1)" "unprognostic (4.05e-2)" "unprognostic (1.29e-2)" "prognostic unfavorable (8.68e-4)" "unprognostic (9.31e-2)" "unprognostic (7.15e-2)" "unprognostic (1.18e-2)" "unprognostic (3.88e-1)" 16.8 25.9 19.4 26.7 24.0 25.6 17.5 30.3 25.0 19.1 19.3 22.8 21.3 22.0 19.2 20.9 23.4 24.3 20.2 13.5 19.0 12.9 20.7 26.7 17.4 22.9 19.9 13.6 21.0 30.5 18.0 23.7 29.8 17.7 23.6 12.2 28.9 30.9 17.3 13.4 25.6 20.7 15.8 19.3 26.1 21.6 19.6 23.3 19.7 23.0 13.5 23.4 19.1 19.3 17.4 42.9 26.8 21.9 18.3 28.3 23.5 14.3 17.4 8.1 6.4 11.3 10.9 15.0 7.8 14.9 8.8 10.5 24.3 22.9 9.6 26.8 9.3 11.9 20.3 4.6 17.7 3.3 7.8 13.6 8.5 10.6 19.4 21.5 11.0 10.1 15.7 22.7 12.5 14.6 9.7 7.3 10.6 13.3 17.7 6.5 34.8 7.8 16.5 10.5 15.4 16.9 7.3 8.7 18.6 11.1 14.2 12.0 16.6 7.3 38.1 24.4 5.2 22.5 19.3 7.0 22.7 14.5 11.4 12.4 23.7 19.4 9.9 25.7 12.6 10.1 19.0 21.9 26.8 23.8 21.5 22.2 17.4 24.4 24.0 23.9 16.9 28.3 25.5 19.5 18.3 16.7 42.9 22.1 23.5 19.4 24.0 30.3 25.0 19.0 12.9 19.9 13.6 17.7 23.3 14.9 15.5 28.6 25.7 12.8 31.2 5.9 17.8 12.0 18.2 26.2 39.3 80.2 11.6 34.0 4.6 13.5 26.5 0.0 53.8 43.9 23.9 32.4 14.9 23.7 33.9 17.5 20.2 28.3 19.1 4.3 17.8 17.0 20.3 45.1 31.2 21.9 31.3 30.6 18.0 15.4 29.4 19.4 14.4 15.6 21.0 14.4 66.2 25.9 27.7 28.5 SLC35E2 KIAA0447 ENSG00000215790 "Solute carrier family 35 member E2" P0CK97 1 1724838-1745999 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 26.8;Alveolar cells type 2: 22.1;Ciliated cells: 10.7;Club cells: 11.4;Horizontal cells: 12.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA006118, HPA062711" Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA006118: , HPA062711: AB_2684844" "unprognostic (3.03e-1)" "unprognostic (2.56e-1)" "unprognostic (4.54e-3)" "unprognostic (1.35e-1)" "unprognostic (1.16e-1)" "unprognostic (1.28e-4)" "unprognostic (9.52e-4)" "unprognostic (6.57e-2)" "unprognostic (2.36e-1)" "unprognostic (1.28e-1)" "unprognostic (9.15e-3)" "unprognostic (4.86e-1)" "unprognostic (2.05e-1)" "unprognostic (2.83e-1)" "unprognostic (8.41e-2)" "unprognostic (2.43e-3)" "unprognostic (4.87e-4)" 3.0 4.1 8.0 5.2 5.1 0.6 3.0 9.8 6.2 4.0 3.0 2.9 1.6 4.9 6.0 10.5 4.5 5.8 7.6 3.0 5.0 3.5 2.5 2.4 4.8 11.6 4.4 4.7 5.5 3.5 6.9 5.9 3.5 4.0 3.6 5.4 3.6 9.1 1.6 4.7 6.4 4.8 3.7 3.7 6.8 6.2 6.2 5.5 5.5 3.5 3.8 4.3 4.3 7.7 5.0 5.2 6.4 3.4 3.1 6.5 3.2 1.6 1.6 5.4 11.5 11.2 11.0 3.6 7.4 15.3 7.0 9.0 4.6 15.1 4.9 1.3 1.7 1.7 7.5 1.4 2.9 7.6 6.8 1.7 6.4 7.5 1.2 2.3 1.3 7.2 8.8 3.7 1.2 6.3 5.8 2.1 9.2 2.1 2.2 1.3 1.2 1.9 3.2 1.0 0.9 1.9 3.7 5.0 1.0 7.4 5.3 15.2 3.1 2.2 9.2 8.8 1.3 17.9 3.6 9.6 7.3 1.5 2.2 0.4 3.0 0.4 1.6 5.2 3.9 1.2 6.4 3.4 2.1 5.5 2.6 6.5 4.5 4.8 5.3 1.5 5.0 5.5 4.8 4.0 3.1 1.6 5.2 4.5 3.2 8.0 5.1 9.8 6.2 5.0 3.5 4.4 4.7 4.0 5.5 26.8 22.1 0.0 0.5 0.5 5.1 0.0 2.5 10.7 11.4 0.0 2.0 0.8 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.4 1.0 0.4 2.3 0.8 0.6 12.7 0.0 1.8 0.6 0.0 2.8 0.3 0.0 0.0 0.7 1.2 0.0 0.0 3.2 0.0 3.9 0.0 0.0 0.7 1.3 1.5 0.2 4.9 1.2 0.4 SLC35E2B ENSG00000189339 "Solute carrier family 35 member E2B" P0CK96 1 1659529-1692728 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 72.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045641, HPA062711" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045641: AB_2679402, HPA062711: AB_2684844" "unprognostic (9.00e-2)" "unprognostic (2.13e-1)" "unprognostic (8.74e-3)" "unprognostic (1.01e-1)" "unprognostic (1.82e-1)" "prognostic favorable (7.64e-4)" "unprognostic (1.18e-1)" "unprognostic (4.09e-2)" "unprognostic (5.70e-2)" "unprognostic (5.83e-2)" "unprognostic (2.04e-2)" "unprognostic (2.20e-1)" "unprognostic (2.92e-1)" "unprognostic (2.68e-2)" "unprognostic (6.61e-2)" "unprognostic (2.54e-2)" "prognostic favorable (5.15e-4)" 7.4 9.7 11.3 5.8 9.3 6.4 14.2 15.5 14.5 8.1 15.4 9.7 15.4 12.5 10.2 10.5 6.8 9.0 9.8 5.0 11.7 7.5 7.7 14.2 8.6 18.8 10.0 8.5 15.0 16.6 6.5 14.4 11.0 9.2 9.7 7.3 8.7 12.1 10.2 10.4 10.5 12.1 13.6 7.1 12.8 8.2 3.9 12.6 8.5 9.8 7.2 10.2 7.3 13.0 4.8 8.7 6.8 3.9 4.5 9.5 5.0 6.1 7.7 27.5 19.4 15.4 14.7 6.9 3.4 8.0 4.0 4.1 3.5 8.4 8.3 12.4 16.4 9.9 4.5 10.9 5.9 3.5 11.7 10.3 12.3 13.7 9.9 15.3 11.6 10.0 13.7 13.8 10.7 12.0 21.4 16.8 16.0 14.6 14.9 9.3 3.8 15.2 13.2 9.5 5.1 9.1 12.7 5.8 14.4 9.9 3.4 18.6 23.8 12.7 11.2 20.1 12.5 9.0 15.8 12.4 11.5 6.1 4.9 4.1 12.5 9.6 17.5 9.1 21.1 8.1 1.7 3.9 3.3 8.3 3.5 8.9 4.3 6.8 9.5 2.8 4.8 8.1 6.7 6.8 4.5 2.5 8.7 6.4 5.0 11.3 9.3 15.5 14.5 11.7 7.5 10.0 8.5 9.2 12.6 11.9 27.0 23.5 6.5 6.5 33.6 15.3 35.7 13.4 27.3 3.5 72.6 11.2 0.0 5.0 0.8 18.6 25.2 0.0 5.3 7.3 19.3 8.4 22.0 18.1 8.9 28.6 24.5 30.1 33.0 1.3 28.1 8.0 11.8 6.4 23.6 12.3 4.8 17.5 25.1 2.2 66.3 6.5 9.5 6.1 15.5 8.4 7.3 30.6 26.7 6.7 SLC35F1 "C6orf169, dJ230I3.1" ENSG00000196376 "Solute carrier family 35 member F1" Q5T1Q4 6 117907526-118317676 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 41.9" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 11.0;Early spermatids: 10.7;Horizontal cells: 15.9;Late spermatids: 17.4;Melanocytes: 13.5;Muller glia cells: 27.9" "Group enriched" "Detected in some" 16 "glioma: 15.1;melanoma: 3.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 9 "AF22: 23.9;WM-115: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019576 Enhanced Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA Nucleoplasm "Centriolar satellite, Cytosol" "HPA019576: AB_2190216" "unprognostic (1.46e-1)" "unprognostic (5.67e-2)" "unprognostic (7.08e-2)" "unprognostic (1.37e-3)" "unprognostic (3.31e-1)" "unprognostic (4.99e-2)" "unprognostic (1.39e-1)" "unprognostic (4.04e-1)" "unprognostic (3.64e-2)" "unprognostic (3.04e-2)" "unprognostic (4.44e-3)" "unprognostic (2.19e-1)" "unprognostic (8.83e-4)" "unprognostic (3.04e-3)" "unprognostic (6.03e-2)" "unprognostic (8.32e-2)" "unprognostic (2.02e-1)" 2.8 2.7 13.8 2.1 14.5 0.9 1.2 3.6 41.9 1.7 3.5 4.3 0.0 1.6 2.7 5.5 1.8 1.5 1.8 5.3 10.4 10.2 1.7 1.0 1.1 1.0 9.3 15.3 1.4 1.4 1.0 0.6 1.0 5.6 2.3 2.3 2.6 1.7 2.9 1.2 1.6 1.8 2.6 4.1 1.6 1.4 1.8 5.6 0.0 1.8 0.0 1.0 1.4 2.6 0.2 0.6 1.0 0.1 0.3 0.9 0.1 0.0 0.0 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.2 0.0 2.9 3.4 0.0 0.0 0.1 0.0 40.1 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 1.0 0.3 0.0 0.6 0.0 0.1 13.8 14.5 3.6 17.4 10.4 10.2 9.3 15.3 5.6 5.6 0.0 0.0 0.0 0.0 0.3 11.0 4.3 0.0 0.0 2.3 0.0 2.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.3 0.0 0.2 0.9 0.0 0.0 0.1 15.9 0.0 0.0 0.0 17.4 0.6 0.0 13.5 0.0 0.0 27.9 0.0 0.0 1.1 0.0 1.8 0.0 0.7 0.9 1.2 0.0 0.0 0.0 0.0 0.0 SLC35F6 "ANT2BP, C2orf18, FLJ20555, TANGO9" ENSG00000213699 "Solute carrier family 35 member F6" Q8N357 2 26764284-26781231 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 48.6;Karpas-707: 42.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034655 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA034655: AB_10696359" "unprognostic (2.26e-1)" "unprognostic (7.45e-2)" "unprognostic (1.74e-1)" "unprognostic (1.54e-1)" "unprognostic (7.71e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.11e-4)" "prognostic unfavorable (3.71e-4)" "unprognostic (3.44e-2)" "unprognostic (1.35e-1)" "unprognostic (3.24e-1)" "unprognostic (2.60e-1)" "unprognostic (3.84e-1)" "unprognostic (1.07e-2)" "unprognostic (9.95e-2)" "unprognostic (1.10e-1)" "unprognostic (1.06e-2)" 37.3 24.1 9.7 10.5 11.7 6.5 42.2 8.3 15.6 17.9 14.5 16.0 12.4 10.4 14.1 14.0 25.2 12.5 14.4 15.0 10.4 11.6 37.4 25.4 15.3 22.0 12.3 9.3 20.4 12.6 13.1 12.2 26.6 11.9 15.3 9.0 13.8 16.7 14.2 16.7 30.9 14.7 15.4 11.4 14.8 16.3 11.7 9.1 10.5 24.1 20.4 15.5 13.8 18.2 3.1 7.1 7.8 19.0 8.6 8.8 5.9 8.3 14.7 4.5 11.4 15.5 7.0 6.9 4.7 7.3 6.1 5.6 9.2 16.0 2.2 8.0 6.6 15.1 10.4 6.4 9.5 4.3 3.8 3.1 2.5 5.6 7.7 48.6 2.7 12.8 11.1 9.8 6.9 23.2 2.8 7.1 3.4 4.7 42.8 6.1 13.5 3.4 2.4 2.5 6.0 3.9 3.0 12.9 3.5 16.2 6.7 3.4 4.5 8.0 13.1 8.5 3.9 4.9 2.8 6.4 8.0 8.5 10.9 5.2 8.3 10.4 4.3 8.6 4.6 7.2 7.0 12.0 5.3 8.8 16.5 5.0 3.1 6.1 8.0 7.1 2.5 4.2 6.0 7.8 8.6 19.0 5.5 3.8 5.9 9.7 11.7 8.3 15.6 10.4 11.6 12.3 9.3 11.9 9.1 11.9 8.0 6.7 11.8 15.0 17.3 11.2 25.5 5.3 7.9 31.4 5.9 22.1 6.6 29.6 1.5 19.2 18.8 0.0 33.5 20.1 22.4 12.8 1.1 19.2 46.2 14.3 8.7 28.8 43.7 1.1 17.0 26.4 27.0 10.8 8.7 18.9 38.9 9.1 11.3 49.9 9.7 25.8 29.9 3.7 6.5 22.5 31.8 13.8 9.7 10.6 SLC38A7 FLJ10815 ENSG00000103042 "Solute carrier family 38 member 7" Q9NVC3 16 58665109-58685104 "Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 14 "Early spermatids: 273.8;Late spermatids: 600.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041777 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA041777: AB_10796782" "unprognostic (2.16e-3)" "unprognostic (2.30e-2)" "unprognostic (6.23e-3)" "prognostic favorable (6.87e-4)" "unprognostic (3.49e-1)" "unprognostic (8.08e-3)" "unprognostic (9.76e-3)" "unprognostic (6.34e-3)" "unprognostic (1.98e-2)" "unprognostic (2.02e-1)" "unprognostic (2.77e-1)" "unprognostic (4.90e-2)" "prognostic favorable (2.87e-4)" "unprognostic (1.85e-1)" "unprognostic (4.38e-2)" "unprognostic (7.50e-2)" "unprognostic (4.93e-3)" 7.0 11.1 10.6 6.7 10.0 2.7 7.2 7.7 13.7 6.2 5.3 10.6 6.8 4.8 6.0 7.4 6.0 4.2 6.5 13.8 7.2 7.2 7.4 12.1 5.2 4.3 6.1 11.0 4.7 5.0 16.9 10.2 8.4 8.3 5.2 6.9 8.9 6.1 5.6 9.6 5.3 4.9 8.5 5.8 10.3 5.4 27.1 6.6 4.2 8.0 8.1 5.1 6.5 6.3 2.8 6.1 2.5 8.6 2.3 5.2 6.6 4.4 7.0 6.9 10.6 14.4 8.7 13.0 10.5 12.2 14.8 10.3 6.5 6.9 2.8 6.0 14.6 11.9 10.8 6.6 7.3 8.8 1.8 6.0 3.2 5.8 10.5 21.9 6.6 9.2 17.4 15.4 10.3 6.8 8.0 15.1 6.7 9.4 4.3 10.7 5.3 2.6 3.9 7.5 4.7 10.4 9.6 7.5 7.6 6.5 10.2 5.1 7.7 15.8 10.8 4.6 9.7 5.1 2.8 11.8 8.1 6.2 14.0 3.1 6.3 4.1 3.2 11.0 4.0 6.0 0.2 8.6 2.5 5.2 8.4 3.1 1.9 3.3 3.8 6.1 2.8 2.7 2.9 0.8 2.3 7.5 2.1 2.2 6.6 10.6 10.0 7.7 13.7 7.2 7.2 6.1 11.0 8.3 6.6 3.0 4.1 0.5 3.9 3.4 9.7 11.2 2.5 4.0 3.4 10.4 11.8 7.3 3.3 12.6 273.8 4.7 3.9 0.0 7.4 7.9 5.7 3.0 1.1 8.5 31.3 15.9 12.6 8.6 8.6 600.3 8.9 7.1 8.5 2.8 3.6 8.0 10.5 3.5 8.1 4.6 7.1 6.5 5.1 6.2 6.1 3.8 12.8 1.8 5.1 2.7 SLC39A10 "DKFZp564L2123, FLJ90515, KIAA1265" ENSG00000196950 "Solute carrier family 39 member 10" Q9ULF5 2 195575977-195737702 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.0;thyroid gland: 39.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036512, HPA036513, HPA066087" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 49000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA036512: AB_2675165, HPA036513: AB_10670801, HPA066087: AB_2685613" "unprognostic (1.06e-1)" "unprognostic (3.87e-3)" "unprognostic (5.33e-2)" "unprognostic (1.33e-3)" "prognostic favorable (1.46e-5)" "unprognostic (7.40e-2)" "prognostic unfavorable (4.39e-5)" "unprognostic (2.10e-2)" "unprognostic (8.73e-2)" "unprognostic (2.84e-2)" "prognostic unfavorable (3.23e-4)" "unprognostic (8.46e-2)" "unprognostic (9.71e-2)" "unprognostic (1.34e-2)" "unprognostic (3.68e-1)" "unprognostic (2.47e-2)" "unprognostic (6.89e-2)" 6.6 10.9 16.0 6.0 24.8 3.7 6.2 10.8 41.0 9.8 3.8 4.2 4.9 3.6 9.4 3.3 3.5 8.5 7.6 4.7 15.0 11.2 7.8 2.1 6.3 6.5 8.5 24.4 7.4 5.7 5.8 5.7 10.7 15.7 16.7 4.0 1.4 4.8 6.5 3.3 5.7 5.7 6.7 10.2 14.4 4.3 7.9 6.2 10.6 39.9 1.7 6.4 6.1 4.9 9.4 18.4 19.3 2.7 11.0 4.6 1.5 2.9 9.9 18.9 5.2 3.7 8.8 9.8 13.7 6.7 6.6 3.3 14.8 10.6 4.1 20.9 7.8 5.1 4.2 11.5 12.6 8.4 2.1 8.6 4.6 15.4 12.1 4.1 16.8 1.9 5.2 1.8 7.3 8.4 23.4 14.8 4.2 13.3 5.8 10.6 2.8 4.8 5.2 22.0 17.2 7.8 11.3 6.6 10.2 28.8 4.9 7.3 10.0 13.7 28.0 7.2 34.5 4.5 10.5 14.5 12.1 14.0 7.9 7.1 2.0 1.2 2.4 9.7 7.9 12.2 19.3 2.7 1.9 4.5 2.5 3.5 6.8 4.0 3.7 3.3 9.4 3.5 4.6 0.5 11.0 1.8 18.4 3.9 1.5 16.0 24.8 10.8 39.7 15.0 11.2 8.5 24.4 15.7 6.2 3.0 10.9 18.2 9.3 22.8 21.9 7.3 7.6 6.7 29.6 34.9 7.9 41.3 1.7 17.6 23.2 27.0 2.9 23.3 9.5 54.8 20.3 18.5 12.7 2.5 21.6 7.9 15.0 24.5 18.1 11.5 17.5 29.7 6.8 8.2 5.1 15.6 17.5 2.9 17.7 14.9 19.9 12.9 13.8 47.8 27.0 17.9 19.6 21.5 4.5 6.4 SLC39A11 C17orf26 ENSG00000133195 "Solute carrier family 39 member 11" Q8N1S5 17 72645949-73092712 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 49.0;Mucus-secreting cells: 73.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 48.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021455 Approved Nucleoplasm NA NA Nucleoplasm "HPA021455: AB_2670710" "unprognostic (2.29e-2)" "unprognostic (2.75e-1)" "unprognostic (1.25e-1)" "unprognostic (2.19e-1)" "unprognostic (1.61e-1)" "unprognostic (1.82e-2)" "unprognostic (1.19e-1)" "unprognostic (3.44e-2)" "unprognostic (1.72e-1)" "unprognostic (1.37e-1)" "unprognostic (3.45e-3)" "unprognostic (2.30e-1)" "unprognostic (1.57e-3)" "unprognostic (5.26e-2)" "unprognostic (1.17e-1)" "unprognostic (4.96e-3)" "unprognostic (3.85e-2)" 10.4 7.4 12.4 7.8 17.9 10.7 10.8 5.3 14.4 9.3 13.3 19.8 6.6 11.5 4.8 9.6 13.0 5.6 8.6 4.2 13.3 6.3 7.9 21.9 8.2 4.8 27.8 6.6 2.8 23.8 3.1 3.8 7.0 15.3 5.3 13.8 6.7 16.6 5.2 3.7 11.2 12.7 5.7 15.7 6.5 27.6 4.1 22.5 6.0 20.6 3.6 8.6 8.3 7.6 6.0 14.9 9.8 16.2 8.7 6.9 6.3 4.3 7.9 0.9 3.8 6.9 5.6 5.4 4.6 4.1 2.1 2.9 2.9 19.7 5.4 4.8 4.7 3.4 3.7 1.3 2.3 3.3 5.8 2.8 5.0 2.1 3.4 4.1 5.3 48.4 4.8 4.5 4.4 2.6 2.3 2.2 2.8 2.6 6.8 2.7 6.1 3.4 11.6 0.7 13.3 3.4 2.3 3.6 4.5 3.5 4.5 2.2 3.1 2.5 18.7 2.8 3.9 12.8 7.4 1.8 4.2 4.0 3.6 2.8 5.5 2.5 3.8 6.9 10.8 2.4 5.5 16.2 9.8 6.9 15.4 4.6 6.0 5.3 5.2 14.9 3.9 3.8 5.2 2.5 8.7 11.9 10.5 6.5 6.3 12.4 17.9 5.3 14.4 13.3 6.3 27.8 6.6 15.3 22.5 0.0 4.6 3.7 4.4 3.9 2.3 2.0 7.6 6.7 7.9 3.5 0.0 4.7 0.0 6.8 19.2 3.6 19.9 23.3 12.3 14.7 3.6 5.1 29.9 25.0 25.0 4.8 8.1 4.3 15.5 49.0 3.7 7.6 10.1 15.4 73.3 3.9 8.3 20.4 3.2 9.8 1.5 12.9 6.1 1.9 2.5 3.9 4.1 3.2 14.7 6.3 SLC39A5 ENSG00000139540 "Solute carrier family 39 member 5" Q6ZMH5 12 56230049-56237846 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 77.8;liver: 38.2;pancreas: 101.1" "Group enriched" "Detected in many" 6 "Cone photoreceptor cells: 110.0;Enterocytes: 260.0;Hepatocytes: 140.6;Mucus-secreting cells: 92.0;Paneth cells: 142.5;Proximal tubular cells: 149.4;Undifferentiated cells: 142.6" "Cancer enhanced" "Detected in many" "liver cancer: 36.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 51 "CACO-2: 22.8;Hep G2: 32.9" "Region enhanced" "Detected in single" "basal ganglia: 0.9" "Not detected" "Not detected" HPA018423 Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA018423: AB_1857154" "unprognostic (5.94e-3)" "unprognostic (8.29e-2)" "unprognostic (1.82e-2)" "unprognostic (2.19e-7)" "unprognostic (1.73e-1)" "unprognostic (7.79e-2)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (1.08e-1)" "unprognostic (1.32e-1)" "unprognostic (7.33e-2)" "unprognostic (2.93e-3)" "prognostic favorable (5.05e-4)" "unprognostic (2.75e-1)" "unprognostic (1.15e-1)" "unprognostic (1.23e-1)" "unprognostic (1.96e-4)" 0.2 0.1 0.2 4.1 0.2 0.0 0.2 0.2 0.2 0.2 40.5 0.2 0.2 48.6 0.2 2.3 0.2 0.1 5.9 0.2 0.2 0.1 22.5 38.2 0.2 0.2 0.2 0.2 0.2 101.1 0.0 0.2 0.2 0.2 0.2 9.1 0.2 0.2 0.2 0.2 0.1 77.8 0.2 0.2 0.2 0.1 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 22.8 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.1 0.0 32.9 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.5 0.0 0.1 0.1 0.2 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 2.2 0.0 0.6 0.6 0.2 12.7 0.0 0.0 3.5 110.0 0.0 16.6 0.3 0.4 0.1 260.0 0.0 17.7 0.0 0.1 0.1 0.0 140.6 0.1 0.0 24.3 2.5 1.3 0.0 0.0 0.0 0.0 1.0 92.0 0.5 12.1 142.5 0.0 149.4 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 142.6 0.0 SLC39A6 LIV-1 ENSG00000141424 "Solute carrier family 39 member 6" Q13433 18 36108532-36129385 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Glandular cells: 212.3" "Cancer enhanced" "Detected in all" "breast cancer: 361.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042377 Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA042377: AB_2677968" "unprognostic (7.60e-2)" "unprognostic (2.27e-2)" "unprognostic (5.50e-3)" "unprognostic (2.58e-3)" "unprognostic (1.02e-1)" "unprognostic (4.87e-3)" "prognostic unfavorable (5.33e-4)" "unprognostic (1.79e-1)" "unprognostic (2.00e-1)" "unprognostic (1.18e-1)" "unprognostic (3.19e-1)" "unprognostic (4.50e-2)" "unprognostic (7.63e-3)" "unprognostic (2.16e-1)" "unprognostic (4.74e-2)" "unprognostic (1.45e-1)" "unprognostic (1.30e-1)" 11.1 12.6 14.3 8.6 13.4 4.3 63.5 19.4 14.7 15.7 8.7 16.0 68.7 4.1 24.7 24.5 9.8 27.7 10.3 8.2 14.2 17.5 12.3 7.7 7.9 8.2 18.3 8.7 30.5 15.5 32.1 23.9 52.5 16.0 55.2 5.9 25.1 15.5 51.5 7.7 22.6 5.7 12.7 21.7 11.2 8.1 9.9 13.5 8.0 15.7 10.7 11.3 23.8 20.2 12.6 25.2 22.2 14.6 12.9 15.6 9.7 10.4 13.2 31.7 18.6 33.5 24.8 8.3 28.5 33.8 19.1 22.5 7.3 11.6 11.3 14.4 27.4 13.3 25.5 27.6 26.7 29.1 25.1 10.0 4.9 18.6 10.6 21.3 16.5 12.4 22.6 59.1 29.0 25.3 17.6 2.8 9.4 2.5 22.8 26.8 16.0 16.2 3.7 7.6 5.7 7.5 16.8 18.1 14.8 21.3 35.2 33.4 29.4 35.1 10.3 48.1 13.6 14.0 7.8 4.6 46.7 7.8 8.8 14.3 21.5 20.8 8.6 16.1 11.7 24.5 19.5 9.8 22.2 13.0 14.6 15.6 12.6 11.1 11.5 12.2 12.3 9.8 14.2 7.5 12.9 13.7 25.2 12.2 9.7 14.3 13.4 19.4 12.4 14.2 17.5 18.3 8.7 16.0 13.5 35.7 16.0 13.7 44.4 40.8 40.2 16.6 10.2 42.8 60.3 40.1 31.4 5.4 1.7 46.8 16.8 10.8 2.8 0.0 32.7 50.5 40.3 212.3 23.1 7.9 18.4 22.3 24.5 7.4 15.6 14.6 34.5 25.1 64.1 24.4 6.7 35.8 34.0 0.0 44.9 13.9 25.8 38.8 37.6 43.4 22.9 65.1 19.9 16.0 4.1 55.4 SLC3A2 "4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE" ENSG00000168003 "Solute carrier family 3 member 2" P08195 11 62856102-62888875 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Syncytiotrophoblasts: 652.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 132.2;SiHa: 134.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010455, HPA017980" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA 210000000 "Plasma membrane" Nucleoplasm "CAB010455: AB_638288, HPA017980: AB_2669723" "unprognostic (1.79e-1)" "unprognostic (9.61e-3)" "unprognostic (3.59e-1)" "unprognostic (7.87e-3)" "unprognostic (2.06e-1)" "unprognostic (2.41e-3)" "prognostic unfavorable (8.17e-4)" "unprognostic (2.09e-3)" "unprognostic (2.62e-1)" "unprognostic (4.16e-2)" "unprognostic (2.29e-2)" "unprognostic (3.71e-1)" "prognostic favorable (8.22e-4)" "unprognostic (2.92e-2)" "unprognostic (5.52e-3)" "unprognostic (3.49e-3)" "prognostic unfavorable (1.48e-4)" 28.5 30.8 34.6 23.0 36.8 62.4 30.8 18.7 34.8 26.0 26.8 25.3 30.4 34.3 29.2 41.2 31.2 23.8 19.9 14.7 31.3 27.1 71.4 31.8 33.5 17.8 37.8 24.1 29.9 39.2 138.6 19.3 75.5 32.9 28.3 13.9 52.5 39.0 27.5 32.5 32.1 33.8 19.6 38.0 21.9 28.2 33.4 30.8 13.6 33.7 33.4 22.2 20.6 56.6 16.6 73.9 11.6 36.2 20.3 39.8 37.3 16.4 69.3 7.1 22.0 8.6 6.9 65.6 28.6 11.0 15.0 13.3 66.2 31.2 18.1 31.8 16.8 28.7 57.0 12.9 56.2 8.0 32.9 12.2 13.0 50.5 29.2 79.9 15.2 19.0 15.1 132.2 18.3 56.1 5.5 8.7 39.4 25.0 40.1 9.2 79.2 15.6 19.4 11.8 20.5 23.5 16.2 10.7 35.4 10.5 9.2 12.1 5.8 134.7 50.5 97.2 12.0 18.1 19.9 16.0 15.3 22.8 22.4 20.1 49.9 55.3 57.4 15.0 23.9 43.6 8.5 36.2 11.6 30.1 34.8 39.8 14.4 27.7 30.8 22.1 16.6 23.5 25.2 7.5 20.3 27.6 73.9 26.2 37.3 34.6 36.8 18.7 34.7 31.3 27.1 37.8 24.1 32.9 30.8 44.7 40.7 54.9 229.6 193.7 59.3 10.9 20.4 36.1 40.9 47.1 62.8 187.9 28.2 148.4 23.7 94.0 85.3 93.5 129.2 134.7 88.4 145.6 82.0 22.5 178.6 50.9 80.9 70.6 47.5 19.5 28.1 97.7 212.6 153.3 33.1 212.1 128.6 31.6 28.7 161.8 52.2 6.5 137.2 12.6 29.8 131.6 652.9 75.6 40.7 193.5 SLC40A1 "FPN1, HFE4, IREG1, MTP1, SLC11A3" ENSG00000138449 "Solute carrier family 40 member 1" Q9NP59 2 189560579-189583758 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 126.4;lymphoid tissue: 170.2" "Group enriched" "Detected in many" 5 "Kupffer cells: 1044.2;Syncytiotrophoblasts: 2060.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 64.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 93.2;CACO-2: 21.3;HEL: 75.5;HMC-1: 19.9;T-47d: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065634 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA065634: AB_2685524" "unprognostic (1.28e-2)" "unprognostic (1.73e-2)" "unprognostic (9.41e-2)" "unprognostic (1.83e-2)" "unprognostic (8.00e-3)" "unprognostic (1.36e-2)" "unprognostic (1.66e-1)" "unprognostic (6.22e-2)" "unprognostic (6.65e-2)" "unprognostic (1.84e-1)" "unprognostic (6.43e-2)" "unprognostic (6.44e-2)" "prognostic favorable (8.55e-5)" "unprognostic (4.66e-1)" "unprognostic (1.61e-1)" "unprognostic (8.96e-2)" "unprognostic (4.11e-2)" 18.2 126.4 3.9 10.1 5.5 3.9 47.4 1.8 3.5 20.0 25.7 3.7 13.9 34.4 24.7 24.3 6.3 25.9 25.2 37.1 4.1 4.3 14.4 42.1 45.9 170.2 5.1 1.9 50.9 24.0 4.6 9.8 51.3 6.4 18.4 15.8 11.6 10.2 16.6 12.3 4.9 44.7 13.6 5.8 76.4 11.3 16.2 3.5 17.0 20.8 6.4 8.8 11.1 20.4 0.1 22.7 64.7 20.8 0.8 17.3 20.1 0.0 1.3 0.1 0.0 93.2 0.6 4.5 0.0 1.1 0.3 0.5 21.3 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.0 0.2 0.0 0.3 75.5 0.3 7.8 0.3 0.2 19.9 6.5 0.0 0.2 0.0 2.1 2.2 2.9 7.7 0.2 1.1 0.0 3.1 4.9 0.2 16.0 0.3 0.0 0.8 0.4 0.9 3.1 0.1 0.9 0.1 6.2 0.0 7.4 36.8 1.1 0.0 0.1 2.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 20.3 20.8 32.9 0.4 4.7 0.6 0.0 11.3 1.0 22.7 0.1 17.3 3.7 64.7 0.8 0.4 3.7 1.0 20.1 3.9 5.5 1.8 3.5 4.1 4.3 5.1 1.9 6.4 3.5 116.1 32.3 28.1 45.3 8.1 3.7 37.5 142.7 53.5 39.8 31.4 3.9 335.3 41.4 23.9 6.9 30.8 119.4 70.0 64.9 10.7 46.3 32.2 9.2 223.5 72.3 6.4 17.9 211.8 1044.2 4.7 112.2 26.2 8.5 1.8 50.3 9.6 51.2 77.2 55.2 100.1 43.2 64.7 18.1 5.0 0.9 7.0 2060.1 8.4 30.8 19.7 SLC43A3 "DKFZp762A227, Eeg1, FOAP-13, PRO1659, SEEEG-1" ENSG00000134802 "Solute carrier family 43 member 3" Q8NBI5 11 57406954-57427580 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 149.9;thyroid gland: 69.0" "Cell type enhanced" "Detected in many" 5 "granulocytes: 63.7;Hofbauer cells: 71.5;Sertoli cells: 64.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 71.0;HMC-1: 62.7;RPMI-8226: 80.1;WM-115: 76.4" "Region enriched" "Detected in many" 4 "olfactory region: 12.7" "Low region specificity" "Detected in all" "HPA030551, HPA077244" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA Vesicles "Nucleoplasm, Plasma membrane" "HPA030551: AB_10604094, HPA077244: AB_2732335" "unprognostic (2.64e-1)" "unprognostic (7.63e-2)" "unprognostic (9.67e-3)" "unprognostic (7.41e-3)" "unprognostic (6.59e-3)" "unprognostic (5.30e-3)" "unprognostic (1.29e-1)" "unprognostic (4.91e-2)" "unprognostic (1.36e-1)" "unprognostic (2.26e-1)" "unprognostic (5.73e-2)" "unprognostic (3.97e-2)" "prognostic unfavorable (3.97e-13)" "unprognostic (8.16e-2)" "unprognostic (1.77e-1)" "unprognostic (8.34e-2)" "unprognostic (1.00e-1)" 32.3 6.3 2.5 12.4 4.3 18.8 16.8 2.2 3.0 11.9 9.6 3.6 2.4 2.7 10.1 6.5 12.6 8.9 11.4 12.5 3.1 1.5 4.2 149.9 16.5 8.8 4.0 1.8 16.0 7.2 1.2 1.8 5.1 3.4 11.6 4.2 9.4 12.2 3.1 15.4 11.0 6.2 10.3 4.7 11.6 6.9 6.8 2.3 10.4 69.0 11.5 13.8 20.3 15.4 2.7 23.6 6.1 36.8 1.1 7.8 14.0 40.0 0.0 2.3 0.0 7.8 11.5 0.1 3.1 13.3 4.6 7.9 0.0 8.8 23.1 1.4 7.3 2.4 23.1 6.7 4.1 9.3 0.1 0.0 36.0 13.7 0.0 15.9 71.0 62.7 34.5 0.1 44.6 0.5 3.3 12.9 10.7 41.1 22.4 17.8 0.0 14.9 45.6 3.5 0.0 0.7 30.9 0.4 80.1 11.0 0.0 5.5 0.0 8.8 0.2 37.4 0.2 3.4 10.8 6.8 0.2 12.0 30.4 8.7 0.0 0.1 5.8 27.5 25.8 76.4 3.2 28.8 6.1 5.7 34.5 6.5 2.7 4.0 7.8 23.6 2.0 3.1 3.2 2.5 1.1 36.8 23.6 6.9 14.0 2.5 4.3 2.2 3.0 3.1 1.5 4.0 1.8 3.4 2.3 14.9 41.4 4.5 6.7 41.6 0.5 2.8 30.6 5.3 34.2 1.8 0.0 0.5 0.0 47.0 1.0 23.3 0.0 0.0 5.5 2.2 20.2 3.4 63.7 53.8 71.5 0.0 0.0 11.6 17.3 1.4 9.2 55.1 28.7 0.0 0.5 0.9 10.9 0.0 11.7 0.0 0.0 64.7 18.4 1.0 0.2 15.4 0.7 15.0 0.6 2.5 SLC44A1 "CD92, CDw92, CHTL1, CTL1" ENSG00000070214 "Solute carrier family 44 member 1" Q8WWI5 9 105244622-105439171 "CD markers, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 111.6" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 221.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 73.5;ASC TERT1: 58.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064714, HPA074007" Enhanced Supported Nucleoplasm,Mitochondria NA NA 270000 Mitochondria Nucleoplasm "HPA064714: AB_2685334, HPA074007: " "unprognostic (3.49e-1)" "unprognostic (2.25e-1)" "unprognostic (1.27e-1)" "unprognostic (6.54e-3)" "unprognostic (4.77e-2)" "unprognostic (1.74e-2)" "unprognostic (2.21e-2)" "prognostic unfavorable (4.49e-4)" "unprognostic (2.48e-1)" "unprognostic (1.95e-1)" "unprognostic (1.64e-3)" "unprognostic (6.20e-2)" "prognostic favorable (1.85e-4)" "unprognostic (2.13e-1)" "unprognostic (2.07e-1)" "unprognostic (1.33e-1)" "unprognostic (2.07e-2)" 8.7 7.4 40.0 6.4 48.8 5.3 14.6 7.2 37.0 9.9 26.7 69.5 10.2 12.0 8.8 18.4 10.1 8.5 11.0 6.9 50.0 29.6 12.0 20.3 9.8 4.6 64.3 21.3 8.0 8.0 20.5 3.9 12.3 38.2 6.6 26.9 4.6 6.0 14.8 4.8 11.4 14.0 9.5 111.6 4.8 18.9 2.3 59.4 2.3 24.0 5.1 7.9 12.4 7.9 2.4 3.7 2.5 5.4 8.7 1.8 1.6 6.9 5.8 1.6 1.9 73.5 58.1 5.0 5.8 15.3 3.8 5.1 6.2 18.5 9.2 3.0 22.0 4.3 13.8 4.7 8.4 6.5 8.0 3.8 11.5 4.1 7.7 4.9 2.2 5.9 32.2 6.9 7.3 6.6 9.8 12.0 4.8 0.3 19.2 4.3 9.8 9.1 2.6 8.9 12.3 5.6 1.9 6.1 6.9 5.2 16.3 7.7 3.0 8.2 9.1 8.2 9.9 9.0 6.9 10.2 3.8 3.4 4.1 4.2 14.8 9.8 6.9 7.4 5.0 5.0 2.5 5.4 1.1 1.1 2.1 0.8 2.0 1.2 0.8 3.7 2.4 1.8 0.6 1.0 8.7 1.2 1.3 1.1 1.6 40.0 48.8 7.2 29.8 50.0 29.6 64.3 21.3 38.2 59.4 32.8 21.6 15.9 31.4 62.7 7.6 9.3 56.0 14.7 9.1 101.2 221.9 44.4 3.3 16.4 2.4 38.4 140.4 0.0 31.4 7.9 49.9 25.3 98.1 132.6 20.0 6.4 151.0 54.0 50.8 2.9 101.8 39.6 70.9 122.6 158.5 6.7 33.4 123.8 75.0 23.3 44.8 38.8 27.0 1.4 1.7 65.0 59.0 15.3 134.8 29.5 SLC45A3 "IPCA-2, IPCA-6, IPCA-8, PCANAP2, PCANAP6, PCANAP8, prostein" ENSG00000158715 "Solute carrier family 45 member 3" Q96JT2 1 205657851-205680459 "Cancer-related genes, Predicted membrane proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "prostate: 115.0" "Group enriched" "Detected in many" 11 "Glandular cells: 50.8;granulocytes: 117.6" "Cancer enriched" "Detected in all" 49 "prostate cancer: 539.9" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 226 "basophil: 22.6" "Lineage enriched" "Detected in single" 226 "granulocytes: 22.6" "Cell line enriched" "Detected in some" 30 "HMC-1: 141.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA019073, HPA019075" Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA019073: AB_1857177, HPA019075: AB_1857179" "unprognostic (1.80e-1)" "unprognostic (1.08e-3)" "unprognostic (3.13e-2)" "prognostic unfavorable (4.04e-5)" "unprognostic (6.93e-2)" "unprognostic (2.36e-2)" "unprognostic (1.15e-1)" "unprognostic (1.50e-1)" "unprognostic (1.84e-1)" "unprognostic (1.10e-1)" "unprognostic (2.90e-2)" "unprognostic (1.18e-1)" "unprognostic (3.03e-2)" "unprognostic (3.16e-1)" "unprognostic (1.55e-1)" "unprognostic (1.96e-1)" "prognostic favorable (7.33e-5)" 0.8 1.5 2.5 1.5 6.2 0.7 0.8 0.4 5.8 1.9 2.1 19.0 0.0 2.1 0.9 0.6 0.9 1.1 1.8 0.7 4.2 2.0 1.1 4.0 1.7 1.6 13.2 1.6 1.0 0.7 0.5 1.9 0.6 7.2 115.0 1.6 0.2 0.9 0.7 2.2 0.9 2.1 0.8 12.4 5.0 6.4 1.4 11.1 0.0 0.5 0.7 0.7 1.5 0.4 0.0 0.0 22.6 0.0 0.0 0.0 0.2 1.5 0.5 0.4 0.4 0.0 0.0 0.3 0.2 0.0 0.5 0.4 1.1 2.9 0.4 0.7 0.0 0.5 0.5 0.2 0.5 0.0 0.6 0.4 4.7 0.1 0.3 0.3 0.8 141.5 0.0 0.1 0.3 0.0 0.3 1.6 0.7 0.7 0.2 0.2 0.3 0.1 1.3 2.0 2.7 1.7 0.1 0.7 0.2 0.6 2.2 0.2 0.5 0.2 3.5 0.6 0.4 0.8 0.2 1.5 0.2 1.6 0.5 1.1 0.0 0.1 0.0 0.3 0.2 1.1 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 6.2 0.4 5.8 4.2 2.0 13.2 1.6 7.2 11.1 0.0 5.6 1.3 1.1 0.0 0.2 1.7 5.1 2.7 1.2 1.8 0.0 0.4 0.0 1.8 0.1 0.6 3.4 0.0 0.5 0.1 0.6 50.8 117.6 4.9 2.0 0.0 0.0 0.0 0.6 0.0 1.7 0.9 0.0 1.0 7.4 0.2 2.4 7.0 1.4 1.8 0.0 6.5 1.0 0.0 1.5 0.1 0.0 0.0 4.4 0.8 SLC4A11 "BTR1, CDPD1, CHED2, dJ794I6.2, FECD4, NaBC1" ENSG00000088836 "Solute carrier family 4 member 11" Q8NBS3 20 3227417-3239559 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Ion transport, Symport, Transport" "Corneal dystrophy, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 34.4;thyroid gland: 42.7" "Cell type enriched" "Detected in some" 4 "Collecting duct cells: 106.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "non-classical monocyte: 1.4;T-reg: 1.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 36.0;Hep G2: 21.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA018120, HPA058377" Uncertain Uncertain Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA018120: AB_1857186, HPA058377: " "unprognostic (2.33e-1)" "prognostic favorable (9.03e-4)" "unprognostic (1.18e-2)" "unprognostic (3.05e-2)" "unprognostic (1.00e-1)" "unprognostic (6.52e-2)" "unprognostic (9.66e-3)" "unprognostic (3.73e-2)" "unprognostic (3.10e-3)" "unprognostic (1.52e-3)" "unprognostic (2.94e-1)" "unprognostic (2.64e-1)" "prognostic favorable (6.21e-6)" "unprognostic (7.37e-2)" "unprognostic (4.30e-1)" "unprognostic (2.33e-1)" "unprognostic (6.89e-3)" 0.8 3.1 3.3 0.8 4.9 0.3 2.4 2.1 2.8 8.6 0.2 1.3 0.8 0.1 0.9 2.0 7.5 1.1 2.2 0.5 3.0 0.6 11.4 0.1 1.3 0.9 1.4 1.1 0.6 0.1 0.4 2.4 0.3 1.8 2.2 0.3 1.1 34.4 5.8 3.5 5.3 0.3 0.2 1.4 0.3 1.9 3.2 1.2 0.2 42.7 3.3 5.1 2.6 2.1 0.0 0.7 0.0 1.4 0.0 1.1 0.4 5.4 7.8 0.9 4.1 2.7 0.7 11.1 2.7 1.7 1.4 0.8 0.5 7.2 0.0 3.2 0.9 3.4 36.0 4.2 8.5 0.2 0.0 1.7 0.3 3.4 21.0 1.7 1.9 7.0 0.3 3.5 1.7 1.6 1.2 3.6 5.0 0.7 5.0 1.4 3.5 0.2 0.2 6.2 6.7 10.6 1.2 5.3 1.7 8.7 15.3 0.4 2.5 1.4 9.0 0.2 2.9 3.4 3.4 6.1 1.1 3.7 0.2 1.3 0.2 0.3 0.0 0.0 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.7 0.0 0.3 0.0 0.0 0.0 1.4 0.0 1.1 0.4 3.3 4.9 2.1 2.8 3.0 0.6 1.4 1.1 1.8 1.2 0.0 0.0 0.0 1.7 0.7 0.1 1.2 0.0 5.3 2.3 106.4 0.0 0.0 0.0 0.7 3.5 0.3 0.0 0.0 0.4 0.1 0.3 2.0 0.0 0.0 0.3 0.0 0.0 1.8 0.3 1.5 0.0 0.0 0.0 1.0 0.1 0.0 2.2 0.6 0.4 0.3 0.0 25.8 0.5 0.6 5.2 0.4 0.0 0.0 0.0 2.6 SLC4A1AP "HLC3, kanadaptin" ENSG00000163798 "Solute carrier family 4 member 1 adaptor protein" Q9BWU0 2 27663471-27694976 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 127.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036679 Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" NA NA Nucleoplasm "Vesicles, Plasma membrane" "HPA036679: AB_2675244" "unprognostic (5.63e-2)" "unprognostic (1.01e-1)" "unprognostic (4.62e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (2.21e-1)" "unprognostic (7.89e-3)" "prognostic unfavorable (3.76e-7)" "unprognostic (1.32e-1)" "unprognostic (7.74e-2)" "unprognostic (1.83e-2)" "unprognostic (1.06e-1)" "unprognostic (9.66e-2)" "unprognostic (9.68e-2)" "unprognostic (2.29e-2)" "unprognostic (1.42e-1)" "unprognostic (2.40e-2)" "prognostic unfavorable (1.79e-4)" 12.3 16.1 18.8 14.2 27.0 12.7 13.9 27.4 29.0 11.5 11.3 15.8 8.7 11.6 12.8 12.2 14.2 12.3 9.8 18.6 17.9 19.6 15.3 15.0 12.8 14.6 17.0 20.5 15.2 13.3 23.8 16.0 14.5 29.1 12.6 12.3 9.0 12.4 12.1 26.0 15.1 12.0 12.5 15.4 13.1 12.5 29.9 16.8 16.1 14.6 14.9 15.1 11.1 11.0 16.7 13.3 40.8 17.9 22.5 19.5 14.1 22.0 12.9 13.0 12.1 13.4 12.4 19.1 18.4 12.7 19.4 15.9 18.8 16.2 14.0 17.1 14.7 20.5 15.8 20.8 14.2 17.4 19.4 17.0 16.1 13.5 20.6 16.4 22.9 15.4 11.1 18.1 19.3 18.3 16.3 19.7 13.8 23.2 15.3 17.8 13.4 15.4 22.5 13.1 14.6 12.7 12.8 28.5 16.1 19.9 10.3 14.2 14.0 14.3 19.6 17.6 13.8 11.8 15.1 19.9 18.1 16.4 12.5 21.4 25.3 35.7 44.8 19.6 18.5 14.4 40.8 17.7 24.2 17.6 16.9 17.4 13.5 16.1 15.3 13.3 16.7 19.5 16.5 16.5 22.5 17.9 10.7 17.1 14.1 18.8 27.0 27.4 29.0 17.9 19.6 17.0 20.5 29.1 16.8 29.8 21.6 5.2 11.5 10.5 20.1 26.0 12.7 22.7 29.6 17.4 17.7 21.1 5.0 23.4 23.8 18.3 9.7 0.0 31.5 17.0 12.3 7.8 37.0 14.0 21.3 23.8 15.6 12.9 15.8 3.1 16.1 13.3 16.9 27.1 10.6 21.0 27.1 8.6 18.0 12.6 20.2 32.3 10.0 127.5 65.0 10.5 20.4 15.0 8.5 7.6 SLC4A3 "AE3, SLC2C" ENSG00000114923 "Solute carrier family 4 member 3" P48751 2 219627327-219641980 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 103.6;ovary: 30.2" "Group enriched" "Detected in many" 17 "Cardiomyocytes: 201.0;Horizontal cells: 527.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 36 "myeloid DC: 2.3;plasmacytoid DC: 8.9" "Lineage enriched" "Detected in single" 58 "dendritic cells: 8.9" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063498 Approved Nucleoplasm NA NA Nucleoplasm "HPA063498: AB_2685025" "unprognostic (9.49e-2)" "unprognostic (5.72e-3)" "unprognostic (8.92e-4)" "unprognostic (1.77e-2)" "unprognostic (6.61e-3)" "unprognostic (1.47e-1)" "unprognostic (2.60e-1)" "unprognostic (2.39e-2)" "unprognostic (4.13e-2)" "unprognostic (2.32e-2)" "unprognostic (1.01e-2)" "unprognostic (1.88e-1)" "unprognostic (8.15e-3)" "unprognostic (1.97e-1)" "unprognostic (3.27e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (4.12e-4)" 1.8 5.4 11.8 1.6 22.5 1.2 2.0 8.8 22.0 2.8 1.3 3.0 0.4 1.4 3.4 2.6 2.9 2.7 2.3 103.6 10.4 8.2 1.6 1.0 1.3 1.4 6.5 9.0 30.2 2.7 4.5 9.9 2.5 24.1 4.2 1.1 4.9 3.1 4.3 1.2 1.6 1.3 3.1 1.6 2.6 1.4 4.2 3.5 0.0 1.5 0.0 1.3 1.6 0.9 0.0 8.9 0.0 0.1 0.0 0.0 0.0 6.2 0.2 2.2 6.5 0.4 0.4 4.4 3.9 4.1 5.3 3.8 4.5 3.6 0.0 1.5 1.4 9.2 3.6 1.1 7.1 1.6 0.0 1.0 0.0 0.0 0.1 1.1 0.1 0.3 3.1 6.7 0.0 2.1 13.4 0.0 0.0 0.2 0.0 1.5 2.1 0.0 0.0 3.6 0.2 5.3 0.0 0.0 0.0 3.6 1.5 1.3 6.4 2.5 6.8 3.3 7.5 0.6 1.6 0.0 3.3 5.8 0.0 3.1 0.0 0.0 0.0 2.7 0.0 8.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 11.8 22.5 8.8 22.0 10.4 8.2 6.5 9.0 24.1 3.5 0.0 0.0 0.0 0.6 0.2 8.9 201.0 0.0 0.0 1.2 1.8 0.0 10.5 1.7 2.8 2.0 0.1 0.0 0.0 1.5 2.5 2.2 0.3 0.0 0.0 1.6 527.6 0.0 0.0 0.0 11.9 14.1 1.1 0.0 1.0 0.0 7.0 1.3 0.0 21.2 0.3 6.7 6.5 1.4 0.5 1.1 0.6 11.6 0.0 0.0 0.0 SLC5A1 "D22S675, NAGT, SGLT1" ENSG00000100170 "Solute carrier family 5 member 1" P13866 22 32043032-32113029 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "intestine: 274.9" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 111.5;Cholangiocytes: 117.2;Early spermatids: 40.8;Late spermatids: 54.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "OE19: 27.0" "Region enriched" "Detected in single" 26 "cerebellum: 8.6" "Not detected" "Not detected" "CAB015467, HPA051805, HPA055106" Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" "Nuclear membrane, Cytosol" "CAB015467: , HPA051805: AB_2681618, HPA055106: AB_2682695" "unprognostic (1.96e-1)" "unprognostic (1.04e-1)" "unprognostic (2.24e-2)" "prognostic favorable (2.59e-4)" "unprognostic (3.85e-2)" "unprognostic (2.75e-2)" "unprognostic (1.60e-2)" "unprognostic (2.15e-1)" "unprognostic (9.22e-2)" "unprognostic (4.83e-2)" "unprognostic (6.21e-2)" "unprognostic (9.53e-2)" "prognostic favorable (6.97e-7)" "unprognostic (4.68e-3)" "unprognostic (1.98e-1)" "unprognostic (6.00e-2)" "unprognostic (1.45e-2)" 0.2 0.0 0.2 1.3 0.2 0.0 1.5 0.2 0.2 2.2 181.5 0.2 2.9 95.5 0.3 0.8 1.9 0.0 14.1 24.5 0.2 0.0 1.0 0.9 0.3 0.2 0.2 0.2 0.2 0.4 0.0 1.0 0.2 0.2 0.8 1.6 0.2 5.7 3.5 0.2 4.6 274.9 0.2 0.2 0.7 1.2 0.8 0.2 0.2 0.2 3.5 1.5 0.2 2.0 0.3 0.1 0.6 0.8 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 27.0 0.0 0.0 0.0 1.6 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.2 0.6 0.3 0.8 0.1 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 1.8 0.6 0.0 111.5 117.2 0.0 4.5 0.0 0.0 0.0 0.0 2.4 40.8 0.0 26.1 0.0 1.2 0.0 0.2 19.7 0.0 0.0 0.0 0.0 24.5 0.0 0.0 54.9 1.1 0.0 0.0 0.0 8.7 0.0 0.6 14.7 1.4 1.9 0.0 0.0 0.0 4.2 0.5 4.8 0.0 0.0 19.6 4.8 SLC5A11 "KST1, SGLT6, SMIT2" ENSG00000158865 "Solute carrier family 5 member 11" Q8WWX8 16 24845841-24911628 "Predicted membrane proteins" "Apoptosis, Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 48.0;intestine: 21.8" "Group enriched" "Detected in some" 4 "Enterocytes: 1.7;Paneth cells: 2.9;Proximal tubular cells: 5.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Hep G2: 18.9;Karpas-707: 5.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035331 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA035331: AB_10601489" "unprognostic (2.57e-1)" "unprognostic (7.90e-3)" "unprognostic (1.34e-2)" "unprognostic (2.65e-2)" "unprognostic (2.00e-2)" "unprognostic (1.08e-1)" "unprognostic (1.27e-2)" "unprognostic (9.90e-2)" "unprognostic (8.08e-2)" "unprognostic (2.85e-1)" "unprognostic (2.85e-3)" "unprognostic (6.68e-2)" "unprognostic (1.17e-2)" "unprognostic (1.59e-1)" "unprognostic (1.58e-1)" "unprognostic (8.07e-2)" "unprognostic (1.45e-3)" 0.6 0.6 4.3 0.6 21.8 0.5 2.8 1.9 11.2 0.6 1.7 29.7 0.0 10.9 0.6 0.5 0.5 0.6 1.4 0.7 12.1 7.4 9.9 1.0 0.6 0.7 48.0 2.4 0.6 0.5 0.5 0.2 0.5 18.3 0.6 0.8 0.0 0.6 0.8 0.7 0.5 21.8 0.5 34.7 0.6 0.6 0.8 22.9 0.0 0.6 0.0 0.7 0.6 0.1 0.4 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 18.9 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 5.3 0.1 0.0 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.4 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.3 21.8 1.9 8.0 12.1 7.4 48.0 2.4 18.3 22.9 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.7 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 5.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 SLC5A12 "MGC52019, SMCT2" ENSG00000148942 "Solute carrier family 5 member 12" Q1EHB4 11 26667019-26723427 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 60.8;kidney: 90.3" "Cell type enriched" "Detected in some" 18 "Proximal tubular cells: 145.9" "Cancer enriched" "Detected in single" 26 "renal cancer: 9.0" "Region enriched" "Detected in single" 7 "basal ganglia: 1.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 5.2;NTERA-2: 3.8;SuSa: 7.8;T-47d: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA060904 Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA060904: AB_2684385" "unprognostic (3.69e-3)" "unprognostic (6.92e-2)" "unprognostic (1.79e-1)" "unprognostic (2.86e-1)" "unprognostic (2.01e-2)" "unprognostic (9.35e-3)" "unprognostic (4.21e-3)" "unprognostic (4.49e-2)" "unprognostic (2.36e-3)" "unprognostic (1.71e-1)" "unprognostic (2.03e-2)" "unprognostic (3.43e-1)" "unprognostic (2.91e-3)" "unprognostic (1.34e-1)" "unprognostic (8.53e-2)" "unprognostic (1.42e-2)" "unprognostic (9.40e-3)" 0.0 0.0 0.1 0.0 1.2 0.2 0.0 0.0 0.1 0.0 11.3 0.0 0.2 1.7 0.0 18.5 0.0 0.0 0.0 3.4 0.1 0.1 90.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.8 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.8 1.0 0.7 0.9 0.7 0.1 0.4 0.1 0.2 0.6 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.6 0.2 0.6 0.8 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.7 0.1 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.1 0.3 0.4 5.2 0.1 0.3 0.2 0.5 3.8 0.7 0.1 0.1 0.0 0.6 0.1 1.1 2.0 0.3 1.7 0.2 0.0 7.8 2.8 0.5 0.6 0.4 0.2 0.4 0.2 2.3 0.7 0.2 0.2 0.0 0.0 1.0 0.5 0.1 0.6 0.7 0.4 1.1 0.4 0.4 0.5 1.5 0.7 0.6 0.4 0.9 0.6 0.8 0.1 0.1 0.1 1.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 3.5 0.0 0.1 8.3 0.0 0.7 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.3 0.0 145.9 0.2 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.4 0.0 SLC6A11 GAT3 ENSG00000132164 "Solute carrier family 6 member 11" P48066 3 10816200-10940733 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 37.0;esophagus: 10.5;skin 1: 11.5" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 7.9;Extravillous trophoblasts: 6.2;Muller glia cells: 21.8;Peritubular cells: 6.3" "Cancer enhanced" "Detected in many" "glioma: 7.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 4.7;HaCaT: 12.7;Hep G2: 14.6;hTCEpi: 11.5;NTERA-2: 6.4;SH-SY5Y: 4.4;T-47d: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037981 Supported Supported Uncertain Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA037981: AB_10671383" "unprognostic (6.04e-2)" "unprognostic (8.01e-2)" "unprognostic (1.21e-7)" "unprognostic (8.60e-2)" "unprognostic (8.68e-2)" "unprognostic (9.72e-3)" "unprognostic (6.39e-3)" "unprognostic (9.77e-2)" "unprognostic (2.35e-1)" "unprognostic (3.92e-2)" "unprognostic (8.78e-2)" "unprognostic (1.51e-3)" "unprognostic (6.06e-2)" "unprognostic (4.44e-2)" "unprognostic (9.83e-2)" "unprognostic (2.31e-2)" 0.8 0.8 11.5 0.7 14.1 0.8 2.9 3.1 23.0 0.9 0.8 5.0 0.0 0.7 1.7 1.1 10.5 1.8 0.7 0.8 8.4 24.5 0.7 0.9 0.8 0.7 37.0 5.9 0.8 1.0 0.7 0.2 1.6 35.4 2.3 0.8 0.4 1.1 0.7 1.0 11.5 0.8 1.0 10.4 1.5 0.7 3.4 9.2 0.0 0.8 0.2 1.1 1.3 0.7 0.5 0.3 1.2 0.4 0.2 0.3 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 12.7 0.0 2.1 0.0 0.0 0.2 0.2 0.0 14.6 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 2.9 1.8 4.4 3.7 0.1 0.0 0.1 4.8 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.3 0.2 0.1 0.2 0.1 0.2 0.2 0.1 0.0 0.5 0.2 0.2 1.2 0.2 0.4 0.3 0.3 0.0 11.5 14.1 3.1 14.7 8.4 24.5 37.0 5.9 35.4 9.2 0.0 0.0 0.0 0.2 1.1 7.9 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 6.2 0.2 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 3.1 0.0 0.0 0.0 0.0 21.8 0.3 0.0 6.3 0.0 1.3 0.0 0.0 0.2 1.5 3.1 0.8 0.0 0.0 1.5 SLC6A13 GAT2 ENSG00000010379 "Solute carrier family 6 member 13" Q9NSD5 12 220621-262873 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "kidney: 77.6;retina: 95.9" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 261.2" "Cancer enriched" "Detected in some" 18 "renal cancer: 32.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "RPTEC TERT1: 10.0;SuSa: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036449, HPA052726" Supported Nucleoplasm,Nucleoli,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Nucleoli, Cytosol" "HPA036449: AB_2675130, HPA052726: AB_2681927" "unprognostic (8.45e-3)" "unprognostic (4.20e-1)" "unprognostic (5.44e-2)" "unprognostic (1.64e-5)" "unprognostic (1.13e-1)" "unprognostic (8.02e-2)" "unprognostic (1.32e-2)" "unprognostic (1.30e-1)" "unprognostic (1.75e-1)" "unprognostic (2.15e-1)" "unprognostic (7.21e-4)" "unprognostic (2.93e-1)" "unprognostic (1.25e-3)" "unprognostic (3.79e-2)" "unprognostic (2.62e-1)" "unprognostic (6.23e-2)" "unprognostic (1.91e-1)" 0.6 0.5 3.0 0.4 5.8 0.5 0.5 2.1 5.8 0.5 0.5 2.5 0.0 1.8 0.5 0.9 0.4 4.2 0.5 1.0 3.1 2.4 77.6 13.2 0.9 0.5 3.4 4.1 0.5 0.4 0.4 1.0 0.5 4.8 0.5 0.5 95.9 0.5 0.5 0.6 0.6 0.8 0.4 5.7 0.5 0.5 1.1 2.1 0.0 4.9 0.0 0.5 0.5 0.0 0.4 0.0 0.0 0.0 0.6 0.9 0.3 0.0 0.0 0.1 0.3 0.1 0.2 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.6 0.0 0.0 0.0 1.3 0.2 0.1 0.0 0.0 0.3 0.0 0.5 0.4 0.4 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.1 10.0 0.1 0.1 0.0 0.1 0.0 0.9 3.7 0.0 0.0 0.3 0.2 1.0 0.0 0.4 1.4 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.6 0.0 0.0 0.0 0.3 3.0 5.8 2.1 5.8 3.1 2.4 3.4 4.1 4.8 2.1 0.0 1.1 0.5 0.0 0.0 0.2 1.3 0.0 1.4 0.0 17.4 2.0 0.0 41.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 19.7 0.0 0.0 0.0 0.6 0.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 261.2 0.8 0.0 0.0 0.5 0.5 0.0 0.2 0.0 0.0 0.0 SLC6A9 GLYT1 ENSG00000196517 "Solute carrier family 6 member 9" P48067 1 43991500-44031467 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Neurotransmitter transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.2;skin 1: 38.2" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 26.6;Erythroid cells: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.4" "Lineage enriched" "Detected in single" 5 "T-cells: 1.4" "Cell line enhanced" "Detected in many" "HaCaT: 23.9;hTCEpi: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013977 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA013977: AB_1849835" "unprognostic (2.73e-2)" "unprognostic (1.92e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (9.50e-4)" "unprognostic (5.98e-2)" "unprognostic (6.83e-3)" "unprognostic (3.06e-2)" "unprognostic (9.72e-2)" "unprognostic (1.85e-2)" "unprognostic (3.52e-2)" "unprognostic (1.41e-1)" "unprognostic (5.72e-2)" "prognostic unfavorable (5.93e-4)" "unprognostic (5.36e-3)" "unprognostic (1.59e-1)" "unprognostic (2.53e-1)" "unprognostic (1.20e-2)" 2.9 22.8 8.8 4.6 18.3 8.6 5.4 5.5 14.3 6.0 7.9 38.1 2.6 2.5 6.2 1.5 16.5 9.6 4.9 1.3 9.9 10.0 2.0 4.9 5.6 1.4 29.5 4.5 4.0 7.8 2.1 1.0 1.7 26.8 2.6 6.2 24.0 7.9 6.1 1.3 38.2 5.6 8.9 42.2 1.1 3.5 1.2 26.3 0.0 4.9 7.2 4.3 6.6 10.9 0.2 0.0 0.2 0.1 0.0 1.4 0.2 7.3 5.5 2.7 7.0 4.4 1.5 6.2 5.9 15.9 9.6 11.9 1.8 2.9 0.1 0.6 16.3 0.0 23.9 4.2 4.7 1.9 0.0 0.7 6.5 13.1 2.1 20.2 1.4 0.3 4.5 41.9 4.7 11.2 6.0 0.2 4.7 5.0 18.8 0.4 4.0 1.0 0.0 2.1 2.8 7.4 0.8 0.0 8.4 0.9 0.8 1.7 1.6 3.0 13.7 2.7 0.7 3.6 3.9 0.1 1.1 4.5 0.9 3.0 20.8 14.3 1.6 3.6 0.0 1.4 0.0 0.0 0.2 0.4 0.1 0.2 0.2 0.4 0.0 0.0 0.0 1.4 0.3 0.2 0.0 0.0 0.0 0.0 0.2 8.8 18.3 5.5 9.4 9.9 10.0 29.5 4.5 26.8 26.3 0.0 1.3 0.9 0.7 6.6 26.6 0.6 5.1 8.1 0.0 1.8 15.7 0.4 0.0 3.2 5.8 0.4 9.8 70.0 7.9 0.7 0.9 1.0 0.0 0.0 0.3 1.6 0.0 0.0 0.0 0.4 1.4 0.0 3.3 1.8 2.9 1.2 4.2 2.0 1.4 1.0 10.2 6.5 6.3 0.0 0.4 11.3 0.5 0.0 1.3 2.5 SLC7A10 asc-1 ENSG00000130876 "Solute carrier family 7 member 10" Q9NS82 19 33208664-33225850 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 40.9;brain: 13.6;breast: 15.6" "Group enriched" "Detected in some" 5 "Muller glia cells: 1.8;Spermatogonia: 1.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 4.3;HHSteC: 2.6;HSkMC: 3.7;THP-1: 8.4;U-2 OS: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041884, HPA057036" Uncertain Uncertain Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA041884: AB_10794494, HPA057036: AB_2683317" "unprognostic (1.85e-2)" "unprognostic (1.69e-3)" "unprognostic (2.79e-2)" "unprognostic (1.79e-6)" "unprognostic (1.16e-1)" "unprognostic (2.08e-1)" "unprognostic (1.31e-1)" "unprognostic (4.98e-3)" "unprognostic (4.64e-2)" "unprognostic (1.96e-1)" "unprognostic (3.28e-3)" "unprognostic (1.10e-1)" "unprognostic (2.22e-2)" "unprognostic (1.34e-3)" "unprognostic (8.91e-2)" "unprognostic (3.47e-1)" "unprognostic (2.18e-2)" 40.9 1.0 9.8 1.9 13.6 1.0 15.6 2.4 12.1 1.0 2.2 0.8 0.0 1.0 1.0 1.0 1.0 1.0 1.0 1.1 4.7 6.2 1.3 1.0 1.0 1.2 7.6 5.0 1.0 1.2 1.0 0.0 1.2 9.0 1.0 1.0 8.4 2.3 1.0 1.0 1.1 1.0 1.1 0.8 1.0 1.0 1.4 1.8 0.0 1.4 0.0 1.4 1.0 1.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.2 8.4 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 9.8 13.6 2.4 12.1 4.7 6.2 7.6 5.0 9.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.1 0.0 0.0 0.0 SLC7A14 "KIAA1613, PPP1R142" ENSG00000013293 "Solute carrier family 7 member 14" Q8TBB6 3 170459584-170586074 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 33.4;pituitary gland: 14.5" "Group enriched" "Detected in some" 5 "Bipolar cells: 31.5;Horizontal cells: 27.0" "Group enriched" "Detected in some" 11 "glioma: 0.8;pancreatic cancer: 0.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "LHCN-M2: 7.2;SCLC-21H: 7.2;SH-SY5Y: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045929 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Cytosol" "Nucleoplasm, Plasma membrane" "HPA045929: AB_2679501" "unprognostic (1.00e-1)" "unprognostic (9.56e-2)" "unprognostic (1.03e-1)" "unprognostic (4.15e-2)" "unprognostic (1.43e-2)" "unprognostic (7.46e-2)" "unprognostic (9.16e-2)" "unprognostic (1.13e-1)" "unprognostic (1.29e-1)" "unprognostic (6.68e-3)" "unprognostic (6.36e-2)" "unprognostic (3.03e-6)" "unprognostic (1.54e-2)" "unprognostic (8.05e-2)" "unprognostic (1.71e-2)" "unprognostic (3.24e-3)" 1.1 5.8 12.1 1.9 17.7 1.4 1.1 14.9 33.4 1.0 1.8 8.0 0.0 1.6 1.1 1.2 1.1 1.1 1.3 1.1 11.5 12.1 1.3 1.2 1.1 1.1 6.7 12.8 1.3 2.4 1.1 14.5 1.1 11.8 1.2 1.9 0.1 1.1 1.1 1.2 1.3 1.7 1.3 9.0 1.1 1.5 1.3 6.3 0.0 1.1 0.0 1.1 1.1 0.3 1.0 0.6 2.1 0.5 0.7 0.6 0.1 0.0 0.0 0.4 0.1 1.3 2.0 0.1 0.6 0.2 0.8 0.8 0.1 0.1 0.1 0.0 0.8 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 1.8 0.0 0.1 1.3 0.8 0.2 0.1 0.0 0.2 7.2 0.0 0.0 0.2 1.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 7.2 2.1 0.0 0.1 0.0 0.3 0.1 0.1 1.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 2.1 0.5 0.5 0.4 0.3 0.3 0.8 0.3 0.3 0.1 1.0 0.6 0.5 1.2 0.7 0.3 0.6 0.3 0.1 12.1 17.7 14.9 16.9 11.5 12.1 6.7 12.8 11.8 6.3 3.0 2.1 0.0 0.3 0.3 31.5 0.8 0.0 5.3 4.5 0.0 2.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.5 0.2 2.3 1.0 0.0 27.0 1.7 0.0 0.0 0.4 2.0 0.9 3.3 0.0 0.0 1.8 0.1 0.0 2.5 0.0 3.9 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.1 SLC7A6OS FLJ13291 ENSG00000103061 "Solute carrier family 7 member 6 opposite strand" Q96CW6 16 68284503-68310946 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041533 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041533: AB_10794298" "unprognostic (1.43e-1)" "unprognostic (2.02e-2)" "unprognostic (7.59e-2)" "unprognostic (3.09e-1)" "unprognostic (5.51e-2)" "unprognostic (4.62e-4)" "unprognostic (2.44e-4)" "unprognostic (2.05e-1)" "unprognostic (3.41e-1)" "unprognostic (2.38e-1)" "unprognostic (2.61e-2)" "unprognostic (3.03e-2)" "prognostic favorable (2.35e-4)" "unprognostic (1.84e-1)" "unprognostic (3.93e-2)" "unprognostic (2.11e-1)" "unprognostic (1.68e-1)" 19.8 14.1 15.7 16.1 20.0 20.1 17.4 29.1 18.2 13.2 13.1 20.2 10.9 13.9 15.5 18.0 12.4 13.4 10.7 16.5 14.6 11.7 13.4 9.3 13.8 24.7 19.8 14.2 17.0 14.7 18.8 13.1 15.9 18.1 13.4 13.4 14.2 14.1 15.0 24.5 15.5 16.3 12.3 17.4 20.3 13.7 12.2 24.5 17.0 15.7 8.7 19.8 14.0 21.6 13.3 11.2 21.8 13.3 12.7 14.9 10.6 8.1 8.4 12.3 9.2 7.2 9.9 14.1 10.3 6.0 12.3 10.9 21.2 11.8 14.3 9.5 6.9 7.8 14.8 11.5 8.8 11.2 5.3 7.0 9.5 13.3 17.4 9.3 13.4 10.4 7.6 9.8 10.1 16.4 11.0 9.2 12.4 14.6 6.4 11.2 12.2 17.3 13.6 8.8 9.4 7.2 20.5 7.6 17.5 7.8 10.8 13.0 9.5 19.8 4.6 11.6 10.0 12.4 12.4 13.5 9.9 8.5 9.6 8.2 15.9 12.8 21.3 10.2 16.2 10.1 21.5 11.4 21.8 13.4 13.3 14.9 13.1 13.4 12.0 8.7 13.3 14.5 11.4 10.3 12.7 10.8 11.2 13.3 10.6 15.7 20.0 29.1 18.2 14.6 11.7 19.8 14.2 18.1 24.5 8.9 4.6 16.6 10.7 8.1 22.0 0.8 12.7 14.7 6.8 12.2 33.4 19.6 14.9 11.0 2.5 10.8 7.4 0.0 9.8 9.6 8.7 9.1 13.9 5.8 18.3 15.9 13.3 11.6 16.3 1.3 14.7 10.8 11.8 21.6 7.5 26.5 13.1 7.0 15.2 6.9 22.8 0.0 9.5 12.5 18.9 5.8 18.4 20.2 8.8 12.3 SLC8A1 NCX1 ENSG00000183023 "Solute carrier family 8 member A1" P32418 2 40097270-40611053 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sodium transport, Transport" Calmodulin-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 67.7" "Cell type enriched" "Detected in many" 11 "Cardiomyocytes: 601.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "neutrophil: 25.2" "Lineage enriched" "Detected in many" 4 "granulocytes: 25.2" "Cell line enhanced" "Detected in many" "BJ: 15.4;fHDF/TERT166: 37.3;hTERT-HME1: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022694, HPA070007" Uncertain Supported "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA "Nucleoplasm, Plasma membrane" "CAB022694: , HPA070007: AB_2686227" "unprognostic (2.46e-1)" "unprognostic (1.33e-2)" "unprognostic (1.42e-2)" "unprognostic (7.57e-6)" "unprognostic (1.56e-1)" "unprognostic (3.94e-1)" "unprognostic (2.28e-2)" "unprognostic (4.60e-2)" "unprognostic (1.31e-1)" "unprognostic (7.71e-2)" "unprognostic (1.21e-2)" "unprognostic (1.07e-1)" "unprognostic (3.66e-2)" "unprognostic (7.04e-3)" "unprognostic (3.93e-2)" "unprognostic (5.46e-2)" "unprognostic (6.77e-2)" 3.9 2.9 7.7 4.4 14.3 1.4 2.0 3.5 15.3 5.5 7.3 1.8 7.1 3.3 12.2 3.9 4.0 3.9 5.3 67.7 7.7 6.6 11.0 2.2 3.7 2.5 5.2 8.2 2.1 1.5 1.1 1.9 6.8 7.6 12.2 3.4 1.0 1.5 17.2 1.5 2.1 3.6 20.5 2.8 4.4 2.5 1.4 2.5 0.1 1.6 0.0 1.3 9.8 2.8 0.0 2.4 25.2 6.0 0.0 0.0 0.5 1.5 1.2 1.1 0.1 1.7 3.6 0.0 15.4 6.0 5.1 3.3 0.0 2.5 0.0 1.2 37.3 5.5 0.6 0.3 2.5 5.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.2 2.0 0.0 5.9 10.9 2.3 0.4 0.0 0.0 0.2 6.5 0.0 0.4 0.0 0.8 0.1 2.1 4.1 8.1 0.0 1.8 0.2 1.7 0.3 0.0 0.0 0.0 5.6 0.0 0.3 5.2 4.8 0.1 0.0 1.6 0.8 0.0 0.0 0.8 0.9 0.7 0.0 4.9 0.0 0.0 5.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 25.2 0.0 6.0 0.1 0.0 0.5 7.7 14.3 3.5 15.3 7.7 6.6 5.2 8.2 7.6 2.5 3.0 3.2 2.9 0.0 1.1 50.8 601.5 2.5 0.0 1.2 33.2 3.9 0.4 0.0 0.0 0.8 3.3 0.0 0.0 0.0 1.4 4.8 0.1 0.0 0.0 28.3 0.0 0.0 20.3 56.6 0.7 0.0 46.7 1.7 1.0 0.6 35.9 0.1 0.0 7.8 0.1 6.9 12.9 19.6 0.2 0.4 2.8 0.9 0.0 0.0 0.0 SLC9A4 NHE4 ENSG00000180251 "Solute carrier family 9 member A4" Q6AI14 2 102473303-102533972 "Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "gallbladder: 23.2;kidney: 12.3;stomach 1: 33.9" "Cell type enriched" "Detected in some" 8 "Collecting duct cells: 24.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 3.9;OE19: 11.4;RT4: 7.1" "Group enriched" "Detected in some" 18 "hippocampal formation: 11.6;olfactory region: 8.3" "Not detected" "Not detected" HPA036096 Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA036096: AB_2674939" "unprognostic (1.41e-1)" "unprognostic (3.76e-2)" "unprognostic (9.31e-2)" "unprognostic (3.09e-3)" "unprognostic (7.58e-2)" "unprognostic (1.46e-1)" "unprognostic (7.17e-2)" "unprognostic (5.35e-1)" "unprognostic (9.44e-3)" "unprognostic (3.26e-2)" "unprognostic (1.30e-1)" "unprognostic (2.46e-2)" "unprognostic (3.12e-1)" "unprognostic (5.04e-1)" "unprognostic (2.50e-1)" "unprognostic (1.98e-2)" 0.0 0.1 0.1 0.0 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.3 0.0 1.1 0.1 0.0 1.3 0.1 23.2 0.2 0.1 0.1 12.3 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.7 0.0 0.0 3.7 2.4 0.7 0.2 0.2 0.0 0.1 0.1 33.9 0.3 0.0 0.2 0.1 0.5 0.4 0.6 0.2 1.5 0.9 1.8 0.8 1.2 1.2 0.1 0.2 0.2 0.2 0.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.1 0.4 0.1 2.4 0.0 0.3 0.3 0.0 0.0 0.0 3.9 0.1 0.2 0.4 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.9 0.0 0.4 0.1 0.1 1.1 11.4 0.4 0.2 0.5 0.3 0.0 7.1 0.2 0.2 0.1 0.4 0.0 0.3 0.2 0.1 0.5 0.4 1.1 0.7 0.2 0.2 0.2 0.0 0.5 0.1 0.1 1.6 0.7 1.1 1.2 0.6 0.8 0.8 0.9 0.9 0.5 1.5 1.0 1.2 1.8 1.2 0.8 0.9 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 3.0 2.7 0.0 0.0 0.0 0.0 0.2 0.0 2.7 1.2 24.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 SLC9B2 "FLJ23984, NHA2, NHEDC2" ENSG00000164038 "Solute carrier family 9 member B2" Q86UD5 4 103019868-103085829 "Predicted membrane proteins, Transporters" "Antiport, Hydrogen ion transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 45.6" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 25.5;Exocrine glandular cells: 60.7;Hepatocytes: 33.1;Pancreatic endocrine cells: 60.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 5.6;NK-cells: 12.2;T-cells: 6.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047008 Uncertain Approved "Nucleoplasm,Cell Junctions" NA NA "Nucleoplasm, Cell Junctions" "HPA047008: AB_2679901" "unprognostic (1.85e-1)" "unprognostic (5.43e-2)" "unprognostic (2.68e-1)" "unprognostic (1.11e-1)" "unprognostic (8.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.43e-2)" "unprognostic (3.78e-2)" "unprognostic (3.26e-1)" "unprognostic (2.53e-2)" "unprognostic (3.53e-2)" "unprognostic (1.67e-1)" "unprognostic (2.51e-5)" "unprognostic (2.23e-1)" "unprognostic (1.28e-1)" "unprognostic (1.90e-2)" "unprognostic (2.35e-5)" 7.3 7.9 8.8 6.3 13.3 5.3 5.5 16.5 24.5 5.6 5.0 5.2 0.4 2.0 8.5 4.2 4.7 5.9 9.8 5.5 8.9 12.5 1.9 45.6 3.3 7.2 10.3 13.4 8.0 2.4 1.2 8.8 5.2 20.8 5.6 3.9 8.3 2.1 6.7 4.5 3.7 3.0 9.8 9.8 4.6 5.7 4.8 4.7 2.5 2.6 1.8 6.9 5.5 8.5 5.6 1.7 0.0 0.1 12.2 6.3 1.8 2.6 1.3 3.1 6.5 15.7 13.1 0.0 12.0 4.8 2.0 1.9 1.3 1.7 16.9 2.1 13.9 2.7 0.8 7.1 5.0 2.8 14.8 4.9 16.9 4.2 12.2 8.4 11.8 5.3 11.5 6.8 4.2 14.7 6.7 8.6 4.8 5.7 12.4 6.2 1.0 9.5 7.3 2.4 0.0 3.8 0.0 3.4 7.4 5.8 1.0 10.8 9.7 5.4 1.4 3.5 0.9 1.5 7.9 10.5 4.5 2.7 7.0 4.1 10.6 7.6 12.3 5.3 10.4 1.7 0.0 0.1 0.0 5.1 0.0 6.3 5.6 5.6 4.5 0.9 3.6 3.4 4.2 0.0 12.2 0.1 1.7 2.4 1.8 8.8 13.3 16.5 21.2 8.9 12.5 10.3 13.4 20.8 4.7 0.0 0.3 6.5 2.6 4.2 8.9 2.4 7.6 0.0 1.2 0.0 25.5 0.3 0.0 5.5 10.6 8.7 0.0 0.0 60.7 2.0 8.8 2.0 1.1 33.1 1.3 7.9 2.9 4.3 1.5 5.0 5.2 2.3 10.1 6.4 0.6 0.6 60.5 0.0 4.9 1.0 2.0 6.5 10.5 1.8 4.3 3.3 0.2 4.6 0.0 0.9 SLCO4C1 "OATP-H, OATP4C1, OATPX, SLC21A20" ENSG00000173930 "Solute carrier organic anion transporter family member 4C1" Q6ZQN7 5 102233986-102296549 "Predicted membrane proteins, Transporters" "Differentiation, Ion transport, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "kidney: 55.9" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 38.8;Proximal tubular cells: 28.3" "Cancer enriched" "Detected in many" 5 "renal cancer: 22.4" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 10.0" "Group enriched" "Detected in many" 5 "granulocytes: 10.0;NK-cells: 2.6;T-cells: 4.3" "Cell line enhanced" "Detected in some" "Karpas-707: 8.1;RPTEC TERT1: 45.9;U-937: 11.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA058249 Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA058249: " "unprognostic (1.63e-2)" "unprognostic (2.47e-2)" "unprognostic (4.48e-4)" "unprognostic (5.70e-6)" "unprognostic (7.43e-2)" "unprognostic (7.71e-3)" "unprognostic (3.24e-3)" "unprognostic (2.05e-3)" "unprognostic (2.13e-1)" "unprognostic (7.12e-2)" "unprognostic (3.87e-3)" "unprognostic (5.83e-2)" "prognostic favorable (1.12e-4)" "unprognostic (3.29e-2)" "unprognostic (1.07e-1)" "unprognostic (5.91e-2)" "unprognostic (8.22e-2)" 0.4 0.4 0.3 0.7 0.7 5.4 0.3 0.2 1.8 0.3 1.9 0.0 5.2 1.4 0.2 0.6 0.3 0.3 1.6 1.1 0.3 0.4 55.9 5.2 11.0 0.2 0.3 1.0 0.3 0.9 0.0 0.7 0.1 0.2 0.4 0.5 0.0 3.2 11.8 0.3 0.6 2.1 0.0 0.3 1.6 0.4 1.3 0.0 1.5 1.0 0.3 0.1 0.7 1.1 0.1 0.4 10.0 1.1 2.6 4.3 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.5 0.0 0.4 0.1 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.5 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.5 45.9 0.0 0.3 0.2 0.0 0.1 0.0 1.1 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 11.6 0.0 7.9 1.1 7.5 4.3 0.0 0.4 0.0 0.7 2.3 0.4 0.1 0.2 1.5 10.0 2.6 0.0 0.3 0.0 1.0 0.3 0.7 0.2 1.8 0.3 0.4 0.3 1.0 0.2 0.0 6.0 38.8 0.0 0.1 0.0 0.0 0.3 0.0 4.0 6.8 5.2 0.0 0.0 1.7 0.2 8.3 0.0 1.2 0.0 0.7 0.0 0.0 0.0 5.7 5.5 0.2 0.0 0.0 0.0 0.0 0.4 0.3 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 28.3 0.0 0.0 0.0 1.7 0.7 0.0 0.0 2.2 1.2 0.3 SLF1 "ANKRD32, BRCTD1, BRCTx, DKFZp564C0469, DKFZp761C121" ENSG00000133302 "SMC5-SMC6 complex localization factor 1" Q9BQI6 5 94618347-94739436 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Spermatocytes: 104.0;Spermatogonia: 128.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "HeLa: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040793, HPA054213" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA040793: AB_10796560, HPA054213: AB_2682419" "unprognostic (7.56e-2)" "unprognostic (1.45e-2)" "unprognostic (2.44e-3)" "unprognostic (1.02e-1)" "unprognostic (1.68e-2)" "unprognostic (1.67e-2)" "unprognostic (1.71e-5)" "unprognostic (1.23e-2)" "unprognostic (1.43e-2)" "unprognostic (6.55e-2)" "unprognostic (1.25e-1)" "unprognostic (2.22e-1)" "unprognostic (6.57e-6)" "unprognostic (3.27e-2)" "unprognostic (2.83e-1)" "unprognostic (1.77e-1)" "unprognostic (8.32e-2)" 3.4 3.6 9.8 4.5 14.1 6.3 4.0 17.6 14.7 3.4 4.0 2.1 2.7 4.3 3.7 3.3 3.7 4.8 4.6 4.7 6.1 6.2 3.8 3.1 3.4 6.5 3.1 9.8 6.3 4.7 3.3 7.9 3.4 5.3 3.0 5.2 1.7 3.4 3.1 3.4 7.8 6.7 3.3 5.1 5.9 3.2 14.8 4.8 9.2 4.0 3.4 5.2 3.5 3.4 5.3 1.9 10.8 1.9 1.5 4.6 1.0 3.0 4.1 5.8 5.4 1.8 2.3 3.7 4.8 2.5 5.6 7.8 2.1 4.3 4.9 3.2 1.4 6.9 4.3 4.7 3.9 7.6 1.7 3.9 3.3 34.8 1.8 0.5 1.7 3.7 1.1 1.1 4.9 2.2 1.8 2.3 3.0 3.5 3.0 4.8 2.8 4.6 2.2 6.0 1.7 2.2 2.8 6.5 5.4 1.8 2.4 5.9 5.9 5.9 2.5 2.0 4.8 3.4 4.8 1.6 2.7 3.7 3.8 6.3 2.3 4.7 4.0 4.1 4.8 5.3 1.0 1.9 1.1 2.6 1.5 1.4 3.1 3.9 4.6 1.2 5.3 1.8 2.4 10.8 1.5 1.2 1.9 2.2 1.0 9.8 14.1 17.6 14.7 6.1 6.2 3.1 9.8 5.3 4.8 3.0 5.4 20.2 5.1 0.0 24.2 0.0 2.5 37.5 13.6 5.2 25.5 12.2 1.7 6.4 6.2 7.1 4.2 46.7 6.1 12.5 3.2 2.7 14.0 5.8 6.9 19.1 2.4 10.4 5.4 6.7 5.2 5.1 0.0 4.6 5.4 6.5 7.5 5.5 5.6 9.1 31.0 0.0 0.0 104.0 128.8 0.0 5.1 21.7 5.2 1.6 SLF2 "C10orf6, FAM178A, FLJ10512, FLJ25012" ENSG00000119906 "SMC5-SMC6 complex localization factor 2" Q8IX21 10 100912569-100965136 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Leydig cells: 100.1;Peritubular cells: 99.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "RH-30: 59.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038499, HPA057568" Approved Supported Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA038499: AB_10672520, HPA057568: AB_2683471" "unprognostic (9.05e-2)" "unprognostic (1.18e-2)" "unprognostic (3.89e-2)" "unprognostic (4.54e-2)" "unprognostic (1.13e-1)" "unprognostic (6.19e-3)" "unprognostic (2.16e-2)" "unprognostic (7.87e-2)" "unprognostic (2.02e-1)" "unprognostic (1.30e-1)" "unprognostic (2.66e-2)" "unprognostic (1.54e-2)" "unprognostic (1.16e-3)" "unprognostic (2.85e-1)" "unprognostic (4.90e-2)" "unprognostic (1.39e-1)" "unprognostic (2.41e-1)" 9.8 20.2 19.5 17.1 26.6 12.1 11.3 21.4 21.4 12.2 10.7 22.0 13.0 9.4 20.9 56.1 9.4 17.3 9.6 11.6 17.8 14.2 10.9 10.2 11.6 15.6 29.4 17.3 29.4 12.3 11.6 26.8 17.4 18.3 14.5 12.1 7.8 10.3 16.0 17.9 15.1 11.5 12.9 22.7 22.0 9.9 26.7 31.3 14.7 11.3 10.5 13.2 10.8 19.9 13.8 9.5 8.6 8.9 10.9 14.0 5.6 9.9 8.2 12.1 12.5 6.4 8.7 4.6 10.5 7.4 9.9 12.0 5.9 6.9 9.2 6.5 4.4 7.3 10.1 8.3 3.5 12.0 10.4 6.6 8.5 5.5 11.6 4.6 10.9 10.2 4.0 5.1 7.6 8.1 9.9 6.3 5.9 6.0 9.1 14.4 6.6 7.3 6.0 5.4 3.8 6.1 7.2 59.5 3.2 3.9 5.1 2.6 5.2 6.6 1.8 12.1 6.0 10.5 4.0 8.1 11.6 9.7 7.2 12.0 7.4 10.9 7.6 7.9 12.6 6.0 6.8 8.9 8.6 14.0 8.8 12.2 11.1 10.8 11.5 6.5 13.8 12.0 10.6 4.6 10.9 8.8 9.5 9.8 5.6 19.5 26.6 21.4 21.4 17.8 14.2 29.4 17.3 18.3 31.3 23.8 13.9 5.3 7.4 0.0 33.7 0.0 2.5 25.4 15.9 24.4 23.6 14.6 11.6 8.2 6.9 15.7 3.8 0.0 6.8 5.6 11.3 9.9 22.1 13.2 15.4 36.5 11.7 31.3 15.3 3.2 100.1 11.9 0.0 4.6 13.3 23.8 6.6 10.5 99.3 5.8 29.7 19.4 0.0 29.3 40.5 0.0 4.2 17.5 8.7 5.4 SLFN11 FLJ34922 ENSG00000172716 "Schlafen family member 11" Q7Z7L1 17 35350305-35373701 "Predicted intracellular proteins" "Antiviral defense, DNA damage, Immunity" "Helicase, Hydrolase, RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Fibroblasts: 26.8;Hofbauer cells: 27.4;Kupffer cells: 33.5;Macrophages: 35.9;Smooth muscle cells: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 32.5" "HPA023030, HPA062062" Uncertain Supported Nucleoplasm,Cytosol No NA Nucleoplasm Cytosol "HPA023030: AB_1856613, HPA062062: AB_2684673" "unprognostic (1.93e-2)" "unprognostic (2.56e-1)" "unprognostic (3.04e-2)" "unprognostic (1.03e-2)" "unprognostic (3.48e-3)" "unprognostic (1.01e-1)" "unprognostic (5.19e-2)" "unprognostic (1.31e-1)" "unprognostic (1.34e-1)" "unprognostic (1.08e-1)" "unprognostic (1.39e-1)" "unprognostic (2.54e-1)" "prognostic unfavorable (9.93e-10)" "unprognostic (1.65e-1)" "unprognostic (5.71e-3)" "unprognostic (6.33e-2)" "unprognostic (8.81e-3)" 20.9 5.3 5.4 10.3 10.0 6.0 24.1 3.2 5.2 15.5 7.3 4.8 10.3 3.0 12.2 24.6 8.1 15.0 9.9 12.6 6.6 2.8 5.5 3.5 20.4 10.4 6.9 2.2 21.3 4.4 2.1 5.0 5.4 8.9 7.8 6.1 8.9 8.3 9.6 6.0 4.1 10.1 10.3 6.7 17.5 6.1 4.2 7.3 18.3 19.0 4.6 12.9 10.9 17.7 3.1 13.0 1.4 18.3 2.0 6.0 5.2 8.1 7.3 0.0 0.0 7.5 21.7 0.1 10.1 7.3 17.5 30.7 0.0 0.0 0.0 0.1 13.2 5.5 4.0 22.7 0.0 21.3 4.6 27.2 17.7 0.0 0.0 9.9 22.8 0.0 8.8 0.2 19.5 0.0 0.0 28.6 13.5 0.0 0.0 2.9 0.0 32.5 18.5 0.1 0.0 0.0 27.6 21.4 0.0 0.2 3.9 0.0 0.0 0.0 3.8 0.0 0.0 6.0 16.5 14.8 4.8 0.1 18.1 15.1 0.7 0.2 0.0 3.6 19.9 10.3 0.4 11.8 1.4 4.3 18.3 6.0 3.1 2.7 3.9 9.2 1.3 2.1 2.9 1.3 2.0 11.4 13.0 3.9 5.2 5.4 10.0 3.2 5.2 6.6 2.8 6.9 2.2 8.9 7.3 0.0 6.9 9.1 0.7 6.6 0.0 2.5 0.0 16.0 3.4 1.8 0.0 0.7 0.0 0.0 1.2 16.1 0.0 0.0 0.5 0.6 26.8 1.1 3.5 0.0 27.4 0.0 0.0 10.4 33.5 1.1 9.5 35.9 11.8 1.0 0.0 0.1 0.1 0.2 2.8 0.0 0.0 6.5 27.9 0.0 0.0 7.4 0.7 20.3 0.0 0.6 SLFN5 MGC19764 ENSG00000166750 "Schlafen family member 5" Q08AF3 17 35243036-35273655 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ciliated cells: 96.4;T-cells: 91.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 11.1;MAIT T-cell: 13.7;memory CD4 T-cell: 13.6;memory CD8 T-cell: 12.6;naive CD4 T-cell: 17.0;naive CD8 T-cell: 13.7;NK-cell: 16.8;T-reg: 27.8" "Group enriched" "Detected in many" 7 "NK-cells: 16.8;T-cells: 27.8" "Cell line enhanced" "Detected in many" "HHSteC: 33.8;hTERT-HME1: 45.1" "Low region specificity" "Detected in all" HPA017760 Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA017760: AB_2189993" "unprognostic (3.43e-1)" "unprognostic (3.26e-1)" "unprognostic (4.66e-2)" "unprognostic (1.60e-1)" "unprognostic (8.35e-2)" "unprognostic (1.15e-3)" "unprognostic (1.70e-2)" "unprognostic (2.29e-1)" "unprognostic (2.81e-1)" "unprognostic (7.01e-2)" "unprognostic (2.41e-3)" "unprognostic (2.39e-1)" "unprognostic (6.05e-3)" "unprognostic (3.27e-1)" "unprognostic (7.77e-2)" "unprognostic (3.92e-1)" "unprognostic (1.48e-1)" 32.9 12.8 2.8 21.2 2.6 2.8 11.5 1.7 3.0 18.9 7.7 6.6 25.3 4.0 13.6 7.7 10.0 9.3 8.3 6.4 3.6 2.8 5.9 4.0 18.6 20.9 4.8 1.2 10.7 5.0 4.5 3.2 9.9 6.0 15.9 5.0 7.9 15.4 43.1 27.5 5.0 8.5 10.9 6.1 25.3 7.6 3.8 2.2 51.4 7.6 7.2 22.3 17.0 8.5 0.7 1.4 1.9 3.0 16.8 27.8 7.1 6.1 3.2 0.4 0.5 9.2 16.3 1.2 16.1 25.5 13.5 15.1 0.0 4.0 0.7 10.4 15.9 3.6 26.0 0.3 7.2 9.5 0.1 0.5 0.1 3.3 0.3 33.8 0.4 0.1 18.5 18.4 10.3 45.1 8.1 6.1 6.4 0.0 9.3 9.4 0.5 7.5 0.3 0.5 1.3 2.4 0.0 5.4 0.0 3.5 15.3 1.0 0.0 1.8 1.7 28.7 1.9 10.7 0.2 24.1 5.4 2.1 3.9 3.6 1.7 0.1 0.1 15.9 0.0 7.7 1.9 1.7 1.1 11.1 2.7 13.7 0.4 13.6 12.6 1.4 0.7 17.0 13.7 0.7 16.8 3.0 0.5 27.8 7.1 2.8 2.6 1.7 3.0 3.6 2.8 4.8 1.2 6.0 2.2 56.6 61.3 2.2 22.6 4.0 0.9 7.8 25.5 96.4 69.4 17.4 0.0 0.2 1.7 58.0 1.5 67.1 1.4 0.0 33.7 1.5 15.3 77.2 57.9 3.9 12.1 6.4 1.2 57.1 21.5 0.0 6.9 15.8 11.8 45.1 4.5 5.8 62.6 2.9 1.4 1.3 4.3 12.9 17.3 0.4 1.9 3.4 0.2 91.8 0.4 70.5 SLITRK5 "bA364G4.2, KIAA0918, LRRC11" ENSG00000165300 "SLIT and NTRK like family member 5" O94991 13 87672615-87696272 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.2;fallopian tube: 6.7;salivary gland: 7.4" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 11.5;Horizontal cells: 20.6;Muller glia cells: 6.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 11.2;HeLa: 5.5;hTERT-RPE1: 5.1;U-138 MG: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013843 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA013843: AB_1857233" "unprognostic (1.92e-1)" "unprognostic (1.01e-2)" "unprognostic (3.82e-1)" "unprognostic (7.11e-4)" "unprognostic (6.94e-2)" "unprognostic (8.57e-3)" "unprognostic (1.63e-1)" "unprognostic (8.58e-3)" "unprognostic (1.18e-1)" "unprognostic (1.43e-1)" "unprognostic (2.24e-2)" "unprognostic (1.11e-1)" "unprognostic (2.10e-2)" "unprognostic (1.81e-2)" "unprognostic (2.82e-1)" "unprognostic (1.36e-2)" "unprognostic (1.60e-1)" 0.1 0.3 3.3 0.1 6.8 0.1 0.2 3.1 9.2 0.4 0.2 0.0 0.1 1.0 0.2 6.7 0.1 0.1 4.8 4.2 0.0 0.0 0.2 0.1 2.6 0.6 0.8 0.0 0.0 0.0 1.8 0.3 7.4 3.1 0.2 0.2 0.0 0.0 1.0 0.1 0.5 0.2 2.0 0.3 0.0 0.4 0.7 1.4 1.6 0.3 1.4 0.4 0.1 0.0 1.2 11.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.2 0.0 2.9 0.0 0.0 0.0 2.0 1.3 5.5 0.0 0.8 0.0 0.0 2.5 0.2 0.0 1.0 5.1 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 2.7 0.0 1.4 1.0 0.3 0.2 0.4 0.0 1.7 0.3 0.0 0.3 0.0 0.0 0.8 2.6 0.0 3.9 0.0 0.0 0.6 1.7 0.0 0.0 3.5 0.1 1.1 1.1 0.3 0.4 0.4 0.2 0.4 0.4 0.4 0.3 0.1 0.7 0.4 0.3 1.6 1.4 0.3 1.4 0.2 0.1 0.0 0.6 0.0 1.7 0.1 11.5 1.6 0.0 2.7 0.0 0.0 3.9 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.2 2.1 1.1 0.0 0.0 20.6 0.0 0.0 0.0 0.2 5.5 0.0 0.0 0.0 1.5 6.5 0.0 0.0 4.6 0.0 1.6 0.0 0.1 5.0 0.1 0.0 0.0 0.0 0.0 0.9 SLTM "FLJ13213, Met" ENSG00000137776 "SAFB like transcription modulator" Q9NWH9 15 58879045-58933653 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040256, HPA040381" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA040256: AB_10674990, HPA040381: AB_2676953" "unprognostic (2.36e-1)" "unprognostic (6.56e-2)" "unprognostic (2.23e-1)" "unprognostic (1.81e-1)" "unprognostic (2.52e-3)" "unprognostic (9.65e-2)" "unprognostic (1.00e-1)" "unprognostic (2.48e-1)" "unprognostic (2.82e-3)" "unprognostic (3.44e-1)" "unprognostic (2.09e-1)" "unprognostic (6.10e-3)" "unprognostic (8.03e-2)" "unprognostic (7.09e-2)" "unprognostic (3.69e-1)" "unprognostic (5.71e-2)" "unprognostic (3.24e-3)" 32.1 20.2 26.1 37.1 27.6 46.9 35.9 38.0 28.8 32.6 28.2 25.9 27.6 27.4 27.4 25.2 35.3 25.0 25.6 24.6 27.2 24.2 29.5 32.1 25.9 35.9 34.1 29.3 29.0 22.4 40.0 40.9 38.2 32.4 26.6 30.5 20.6 38.1 45.6 39.4 32.0 29.2 29.0 34.3 38.2 34.9 24.4 34.6 50.5 32.9 30.5 38.8 31.3 32.8 31.2 32.4 32.6 21.1 27.2 29.8 12.5 27.5 30.3 26.7 13.5 18.3 13.9 22.6 20.1 23.4 18.5 18.1 20.9 16.7 52.0 18.8 18.3 20.3 24.8 26.4 22.8 25.9 33.3 17.2 37.7 31.7 15.8 16.0 29.6 29.2 12.9 22.9 19.6 16.5 11.4 17.1 24.2 33.4 30.3 21.4 19.8 29.4 22.9 29.9 16.5 14.8 22.7 24.4 25.0 22.5 36.0 22.0 19.0 20.8 20.4 20.3 31.0 16.3 32.4 17.7 22.7 33.2 24.7 26.7 21.4 42.2 37.8 18.0 36.6 22.6 32.6 18.9 25.6 29.2 18.0 29.8 31.2 23.4 24.8 18.6 27.6 25.7 23.0 26.9 27.2 21.1 32.4 20.9 12.5 26.1 27.6 38.0 28.8 27.2 24.2 34.1 29.3 32.4 34.6 142.9 158.5 113.0 87.4 86.1 111.1 98.2 50.9 128.5 149.0 101.2 92.3 60.3 66.3 78.9 82.2 77.3 62.6 23.3 101.1 133.7 70.3 79.3 113.5 93.5 57.0 112.8 70.4 49.1 81.2 88.7 80.0 95.3 74.2 90.2 65.9 83.4 100.5 58.8 83.1 61.8 133.5 71.1 74.5 165.4 68.0 91.5 94.1 94.8 69.0 108.9 SLU7 9G8 ENSG00000164609 "SLU7 homolog, splicing factor" O95391 5 160401641-160421711 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035907, HPA058120" Uncertain Supported "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA035907: AB_10671717, HPA058120: AB_2683612" "unprognostic (3.70e-2)" "unprognostic (7.18e-2)" "unprognostic (1.86e-2)" "unprognostic (9.96e-3)" "unprognostic (8.01e-2)" "unprognostic (3.52e-1)" "unprognostic (3.38e-3)" "unprognostic (3.76e-2)" "unprognostic (2.22e-2)" "unprognostic (2.42e-1)" "unprognostic (1.93e-1)" "unprognostic (7.69e-2)" "prognostic favorable (1.98e-4)" "unprognostic (2.65e-1)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (1.25e-1)" 19.4 18.9 25.7 14.1 30.7 32.9 22.0 30.4 32.9 18.0 16.2 14.2 14.2 12.9 18.1 21.4 17.8 14.6 14.8 19.3 23.7 23.6 19.4 19.0 18.1 19.4 25.7 28.1 17.5 15.4 18.4 21.6 18.5 28.4 17.5 16.8 10.3 18.6 16.6 33.8 17.7 17.0 18.6 26.2 20.6 17.8 20.3 25.8 21.4 26.0 20.2 23.5 20.6 17.7 18.4 13.2 33.5 20.1 20.6 17.9 12.2 12.4 15.8 13.5 19.2 17.9 19.0 17.5 17.6 25.7 19.5 23.6 20.9 15.2 20.3 18.0 18.8 19.3 13.9 11.9 19.5 24.6 32.7 17.4 15.0 21.6 13.4 18.0 25.4 18.6 20.4 18.3 17.8 20.4 19.8 13.3 18.4 13.6 19.0 17.4 11.0 12.4 16.2 9.9 12.7 14.2 10.6 28.2 20.0 17.1 20.3 16.5 22.7 20.6 18.9 31.0 11.8 25.3 24.1 16.9 19.0 9.8 13.7 18.6 21.2 24.3 18.1 27.4 16.9 17.8 24.7 13.2 22.5 17.4 14.8 16.3 18.4 16.3 17.1 12.1 16.6 17.9 17.1 33.5 20.6 20.1 13.2 17.4 12.2 25.7 30.7 30.4 32.9 23.7 23.6 25.7 28.1 28.4 25.8 62.5 60.3 40.4 39.5 39.8 70.1 58.4 20.4 78.9 52.4 24.4 23.6 32.7 43.1 43.6 85.1 35.9 28.4 46.7 48.7 33.2 36.4 32.9 45.1 21.5 33.8 54.0 37.9 28.3 41.9 21.3 44.3 49.1 62.4 61.3 33.0 50.0 45.3 35.3 44.6 29.3 44.2 45.3 40.1 47.9 42.8 36.3 78.7 48.4 28.0 42.3 SLX1A GIYD1 ENSG00000132207 "SLX1 homolog A, structure-specific endonuclease subunit" Q9BQ83 16 30193887-30197561 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.2;intestine: 26.0" "Cell type enhanced" "Detected in many" 5 "Exocrine glandular cells: 10.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 44.5" HPA047038 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047038: AB_2679913" "unprognostic (3.46e-2)" "unprognostic (1.00e-1)" "unprognostic (1.05e-1)" "unprognostic (1.62e-1)" "unprognostic (1.84e-1)" "unprognostic (5.60e-2)" "unprognostic (6.04e-2)" "unprognostic (1.88e-1)" "unprognostic (1.41e-1)" "unprognostic (1.75e-1)" "unprognostic (2.67e-1)" "unprognostic (1.26e-6)" "unprognostic (2.52e-1)" "unprognostic (3.21e-1)" "unprognostic (1.53e-1)" "unprognostic (3.86e-1)" 3.4 5.2 2.9 7.7 1.7 7.7 3.7 0.7 1.9 2.0 8.2 26.0 1.6 0.0 5.4 1.0 2.7 4.2 2.7 2.5 7.1 13.1 3.5 5.4 3.0 0.5 6.7 0.9 2.3 2.9 1.8 2.6 2.9 1.5 4.9 3.1 19.6 1.5 2.8 9.5 12.6 0.3 2.1 3.7 3.7 1.9 19.4 35.8 41.6 44.2 17.7 30.6 26.4 15.5 9.8 3.6 3.9 1.0 0.8 22.1 3.5 3.3 1.4 1.4 2.0 11.2 6.4 14.2 2.2 3.9 12.4 1.0 1.8 1.6 11.5 11.3 6.6 3.3 19.3 2.2 7.9 18.1 0.9 3.0 1.2 1.7 2.9 1.3 2.4 5.8 12.4 1.3 15.7 10.2 27.3 11.3 7.2 6.6 30.1 0.6 34.3 3.4 5.0 7.1 19.1 0.0 30.5 7.2 1.2 5.4 6.8 0.0 9.4 10.7 9.3 5.2 44.5 17.1 5.9 10.4 8.2 6.4 5.8 44.2 41.6 23.5 40.9 16.7 19.4 17.6 19.1 35.8 18.1 8.8 14.9 16.1 17.7 32.5 18.3 30.6 26.4 0.0 0.6 0.0 0.9 0.6 0.7 2.0 0.0 0.0 0.0 3.5 0.0 5.1 0.0 5.4 0.2 1.6 4.9 0.0 10.4 1.8 1.5 0.8 0.0 2.5 2.5 0.0 3.5 1.8 7.5 0.0 0.9 3.3 6.8 2.8 3.6 0.2 7.8 5.8 0.0 2.4 0.2 0.0 2.3 0.3 0.4 1.9 3.4 3.8 4.0 0.4 SLX1B "GIYD2, MGC5178" ENSG00000181625 "SLX1 homolog B, structure-specific endonuclease subunit" Q9BQ83 16 29454501-29458219 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 26.5" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 10.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA047038 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047038: AB_2679913" "unprognostic (2.93e-1)" "unprognostic (1.11e-1)" "unprognostic (2.16e-2)" "unprognostic (5.12e-2)" "unprognostic (7.05e-2)" "unprognostic (1.78e-1)" "unprognostic (7.20e-2)" "unprognostic (2.72e-2)" "unprognostic (2.35e-3)" "unprognostic (3.63e-1)" "unprognostic (1.22e-1)" "unprognostic (3.64e-2)" "unprognostic (2.51e-7)" "unprognostic (4.84e-2)" "unprognostic (1.96e-1)" "unprognostic (4.44e-1)" "unprognostic (5.25e-3)" 4.6 2.9 0.2 3.9 0.5 8.8 4.9 2.0 2.7 5.6 6.6 14.1 5.4 2.7 3.0 4.4 1.1 2.2 0.4 0.5 3.3 11.1 5.7 3.0 0.6 4.2 3.1 3.4 2.2 5.4 4.0 4.6 8.0 5.4 11.2 5.7 13.4 2.9 1.8 6.3 4.7 0.0 6.1 6.6 5.7 3.9 3.2 20.8 26.5 24.7 3.7 6.5 6.7 6.8 5.9 15.4 0.7 3.2 4.6 21.2 6.4 15.0 14.6 12.4 1.6 10.5 17.3 5.6 4.5 2.3 2.6 5.7 9.2 3.5 1.0 4.3 7.1 3.1 9.2 9.9 7.2 2.9 6.1 6.6 9.6 6.5 9.2 16.2 20.4 3.7 7.1 6.8 9.7 1.3 7.2 1.3 15.4 8.6 7.0 12.2 15.5 12.3 4.2 2.5 14.8 2.7 30.2 1.4 2.4 1.4 4.1 10.8 4.9 1.5 2.9 1.1 3.2 20.1 11.0 5.4 5.5 2.1 3.3 24.7 26.5 2.8 20.7 0.8 3.2 2.5 2.8 20.8 2.5 1.2 1.6 14.8 3.7 11.9 1.2 6.5 6.7 0.0 0.3 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.6 0.0 0.1 1.0 0.0 1.3 0.6 0.4 0.2 0.0 0.5 1.0 0.0 0.0 0.6 1.2 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.8 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.9 0.1 0.1 SLX4 "BTBD12, FANCP, KIAA1784, KIAA1987" ENSG00000188827 "SLX4 structure-specific endonuclease subunit" Q8IY92 16 3581181-3611598 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 19.9;testis: 25.0" "Cell type enhanced" "Detected in many" 8 "Rod photoreceptor cells: 10.9;Spermatocytes: 18.6;Spermatogonia: 10.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049421, HPA066238" Approved Supported "Nucleoplasm,Cell Junctions,Cytosol" NA NA Nucleoplasm "Cell Junctions, Cytosol" "HPA049421: AB_2680759, HPA066238: AB_2685642" "unprognostic (1.04e-1)" "unprognostic (1.23e-1)" "unprognostic (4.06e-2)" "unprognostic (2.65e-2)" "unprognostic (4.62e-1)" "unprognostic (6.08e-3)" "unprognostic (8.28e-5)" "unprognostic (6.52e-2)" "unprognostic (2.49e-1)" "unprognostic (1.56e-1)" "unprognostic (1.97e-2)" "unprognostic (1.50e-1)" "unprognostic (4.32e-2)" "unprognostic (8.39e-3)" "unprognostic (1.20e-1)" "unprognostic (1.43e-3)" "unprognostic (5.74e-2)" 2.9 3.1 5.3 6.1 8.5 6.0 2.4 19.9 11.8 2.5 2.9 9.8 2.5 4.9 6.5 3.3 3.4 3.0 2.8 2.2 7.4 4.3 2.9 2.7 3.0 8.6 3.8 8.1 2.7 3.1 3.7 8.6 2.6 7.4 3.3 2.2 5.4 3.0 2.6 5.5 4.2 4.0 3.1 3.3 4.8 3.7 25.0 3.2 5.8 2.6 1.0 6.5 3.1 2.7 0.6 0.2 3.0 1.1 0.6 0.6 0.7 3.0 9.3 6.1 7.5 2.3 2.4 6.3 4.8 2.4 5.6 6.2 4.6 3.7 10.9 4.8 2.4 4.3 6.7 4.1 3.4 3.3 9.1 5.1 7.5 6.7 2.9 2.0 7.2 10.6 1.8 2.5 5.2 2.9 1.4 4.0 6.2 7.1 6.0 4.4 5.1 4.4 6.3 5.0 1.8 3.5 8.9 10.0 3.0 2.2 2.1 5.2 4.6 4.2 3.0 1.5 3.3 7.3 5.7 4.7 6.5 9.0 5.5 5.6 5.4 4.2 12.8 2.1 7.4 6.3 3.0 0.4 0.0 0.6 0.5 0.4 0.3 0.3 0.3 0.2 0.6 0.3 0.5 0.5 0.6 1.1 0.2 0.3 0.7 5.3 8.5 19.9 11.8 7.4 4.3 3.8 8.1 7.4 3.2 0.0 2.9 4.5 0.8 0.7 7.7 1.4 2.5 2.7 4.5 0.0 2.0 1.3 0.0 1.4 3.5 1.1 1.5 0.0 2.1 1.5 1.5 0.4 0.0 0.9 2.3 0.0 0.0 1.8 1.6 1.6 2.0 3.2 0.0 1.0 2.2 1.7 1.6 0.0 1.8 0.4 10.9 0.0 1.8 18.6 10.0 0.5 0.8 3.5 1.7 0.5 SMAD1 "JV4-1, MADH1, MADR1" ENSG00000170365 "SMAD family member 1" Q15797 4 145481194-145558079 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 132.8;Endothelial cells: 56.4;Late spermatids: 63.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 22.2;non-classical monocyte: 11.9" "Group enriched" "Detected in many" 4 "granulocytes: 22.2;monocytes: 11.9" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 46.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005389 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB005389: AB_656608" "unprognostic (8.20e-2)" "unprognostic (1.63e-1)" "unprognostic (2.76e-2)" "unprognostic (1.11e-1)" "unprognostic (3.74e-1)" "unprognostic (6.85e-2)" "unprognostic (1.70e-1)" "unprognostic (6.02e-2)" "unprognostic (2.30e-1)" "unprognostic (8.24e-2)" "unprognostic (5.31e-2)" "unprognostic (4.68e-2)" "unprognostic (1.73e-3)" "unprognostic (1.48e-1)" "unprognostic (5.88e-2)" "unprognostic (1.14e-3)" "unprognostic (3.15e-2)" 20.4 7.8 19.9 7.9 21.3 3.8 21.1 17.9 17.8 18.5 15.5 14.3 13.6 11.9 33.2 22.7 16.2 20.3 13.7 10.3 13.5 10.3 12.7 37.4 11.0 11.9 9.3 10.0 12.3 13.1 33.7 14.7 8.7 12.2 13.6 16.9 7.8 17.5 16.0 22.6 20.2 15.3 24.6 12.6 10.1 11.4 10.5 14.3 15.3 15.2 14.9 10.3 16.5 21.9 0.0 4.0 22.2 11.9 1.2 0.7 0.8 3.9 5.2 9.7 11.7 3.8 5.5 4.8 5.6 13.6 9.2 7.1 2.5 14.5 3.4 3.4 12.9 4.1 5.8 11.0 12.6 5.5 0.0 5.5 0.0 4.3 5.1 10.1 6.5 1.0 7.5 15.0 4.9 9.7 7.5 46.6 8.5 4.4 0.1 11.7 3.8 9.8 0.1 9.0 6.3 6.3 18.9 9.0 11.7 10.0 6.9 15.2 7.3 8.0 17.5 3.5 6.2 5.9 0.0 14.0 4.5 6.2 4.6 3.4 12.9 0.0 22.8 7.2 0.1 4.6 22.2 2.1 0.8 0.0 5.3 0.0 0.0 0.4 0.0 4.0 0.0 0.2 0.0 0.0 1.2 11.9 0.0 0.7 0.8 19.9 21.3 17.9 14.9 13.5 10.3 9.3 10.0 12.2 14.3 8.9 10.4 0.0 14.6 10.2 5.7 3.9 12.7 10.7 12.5 14.0 13.7 4.1 6.6 10.1 132.8 56.4 8.0 0.0 16.1 2.7 6.2 12.3 0.0 10.5 2.1 9.5 8.7 9.8 6.3 63.2 4.0 2.3 1.7 1.0 8.6 4.8 11.9 5.8 5.3 9.8 6.1 0.0 4.6 5.6 11.9 11.0 1.8 0.0 7.5 15.4 SMAD2 "JV18-1, MADH2, MADR2" ENSG00000175387 "SMAD family member 2" Q15796 18 47808957-47931146 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cone photoreceptor cells: 200.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025507, HPA067203, CAB073546" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli, Cytosol" "CAB025507: , CAB073546: , HPA067203: AB_2685803" "unprognostic (1.55e-1)" "unprognostic (2.49e-1)" "unprognostic (1.43e-2)" "unprognostic (9.82e-3)" "unprognostic (9.88e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (9.44e-5)" "unprognostic (1.91e-2)" "unprognostic (7.59e-2)" "unprognostic (1.41e-3)" "unprognostic (6.46e-2)" "unprognostic (4.91e-2)" "unprognostic (9.20e-3)" "unprognostic (2.68e-1)" "unprognostic (6.13e-2)" "unprognostic (3.20e-2)" "unprognostic (6.28e-2)" 38.5 39.2 29.0 26.2 25.9 19.6 31.4 19.5 28.9 28.8 34.2 29.4 28.9 21.5 26.6 26.3 33.5 28.8 25.7 31.1 26.1 27.1 26.4 20.9 28.3 23.8 30.9 24.3 36.6 28.1 25.7 24.4 34.8 28.6 27.8 29.8 31.7 29.7 28.7 33.9 28.0 26.4 34.6 35.4 34.1 26.3 29.2 26.2 60.7 46.1 23.6 31.5 35.1 35.7 12.0 21.8 28.9 24.7 24.5 25.9 19.7 22.2 32.0 19.5 18.9 31.2 38.2 22.3 24.3 29.2 25.4 29.7 12.2 21.4 34.6 17.5 30.8 35.6 24.6 21.9 27.1 34.1 37.6 11.2 29.4 48.3 19.8 36.4 40.8 30.1 28.2 35.0 21.7 50.3 29.6 28.0 28.2 13.6 29.0 31.2 14.5 28.0 19.6 9.6 1.1 7.6 20.5 28.5 23.6 57.0 38.4 18.1 21.2 29.2 20.1 23.8 19.9 15.2 27.2 31.3 37.7 21.8 10.2 17.6 28.5 27.3 30.2 26.1 27.9 27.5 28.9 22.6 25.0 16.9 24.7 21.2 12.0 23.1 20.9 21.8 9.4 25.8 19.8 22.7 24.5 20.8 15.5 25.9 19.7 29.0 25.9 19.5 28.9 26.1 27.1 30.9 24.3 28.6 26.2 41.7 29.7 22.0 39.2 48.3 44.4 40.0 40.8 30.8 45.5 73.3 200.3 37.8 33.2 31.7 53.8 44.7 32.0 46.7 38.2 33.2 34.3 51.4 20.8 22.6 38.9 33.4 49.0 57.7 52.1 97.0 38.6 38.2 49.0 44.1 42.5 37.9 37.5 24.6 50.2 32.1 82.1 32.3 35.9 26.3 39.6 54.1 58.1 38.1 35.7 55.8 SMAD3 "HsT17436, JV15-2, MADH3" ENSG00000166949 "SMAD family member 3" P84022 15 67063763-67195195 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" DNA-binding "Aortic aneurysm, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Glandular cells: 111.1;Urothelial cells: 247.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008094, HPA046386, HPA067203, CAB069409" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB008094: AB_2302271, CAB069409: AB_1622941, HPA046386: AB_2679647, HPA067203: AB_2685803" "unprognostic (1.04e-1)" "unprognostic (1.83e-1)" "unprognostic (1.06e-1)" "unprognostic (1.99e-2)" "unprognostic (1.61e-1)" "unprognostic (1.98e-2)" "unprognostic (8.40e-3)" "unprognostic (1.80e-2)" "unprognostic (7.62e-2)" "unprognostic (6.82e-2)" "prognostic unfavorable (2.48e-4)" "unprognostic (2.93e-1)" "unprognostic (2.14e-2)" "unprognostic (3.10e-1)" "unprognostic (1.79e-1)" "unprognostic (1.15e-1)" "unprognostic (5.97e-2)" 25.3 4.6 12.2 18.5 12.4 12.4 21.6 5.0 12.7 20.9 17.9 7.6 9.5 12.7 19.9 16.6 35.3 14.3 27.7 19.7 7.5 4.8 15.6 13.6 13.9 14.0 6.0 7.5 23.0 12.6 7.0 10.8 11.5 8.2 20.5 9.2 30.8 12.5 10.8 37.3 19.6 19.0 23.2 5.5 11.2 15.8 7.0 7.7 10.5 21.8 23.4 29.7 31.4 24.6 4.8 2.5 3.2 1.9 0.4 6.3 1.8 12.2 41.2 7.7 3.7 13.6 31.4 6.1 7.1 29.3 9.9 8.0 8.5 32.9 4.1 9.6 20.2 44.6 29.1 8.0 30.0 9.9 3.2 3.0 0.4 11.6 6.4 10.2 1.6 0.7 28.4 7.0 8.7 7.4 22.0 33.3 1.3 9.9 11.5 12.3 6.3 0.3 6.2 4.5 6.5 12.9 0.4 2.3 1.5 6.6 39.5 0.2 2.6 9.4 5.2 8.1 15.7 1.4 7.6 28.0 13.4 12.6 9.6 8.0 4.4 1.2 5.1 12.1 1.7 12.0 0.0 1.9 3.2 5.5 1.5 5.7 2.1 6.2 6.3 1.8 4.8 2.8 2.4 0.1 0.4 1.5 2.5 3.1 1.8 12.2 12.4 5.0 12.7 7.5 4.8 6.0 7.5 8.2 7.7 44.7 14.5 13.6 67.6 79.0 8.3 9.5 15.3 24.1 30.7 34.9 5.9 0.8 3.3 53.0 0.9 20.1 34.4 0.0 44.0 4.0 34.3 111.1 24.2 11.3 8.4 0.0 3.4 9.8 4.8 3.7 24.7 13.8 20.3 3.6 11.9 9.7 71.0 21.0 19.4 12.2 0.4 25.8 14.6 0.3 0.7 42.8 1.4 12.5 15.7 247.9 SMAD4 "DPC4, MADH4" ENSG00000141646 "SMAD family member 4" Q13485 18 51028394-51085045 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019154 Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA019154: AB_1853480" "unprognostic (1.58e-1)" "unprognostic (1.75e-1)" "unprognostic (1.25e-2)" "unprognostic (4.83e-2)" "unprognostic (1.17e-2)" "unprognostic (4.05e-1)" "unprognostic (7.29e-3)" "unprognostic (9.00e-2)" "unprognostic (4.01e-2)" "unprognostic (2.51e-2)" "unprognostic (1.03e-3)" "unprognostic (4.40e-2)" "prognostic favorable (1.92e-5)" "unprognostic (2.62e-2)" "unprognostic (4.23e-1)" "unprognostic (1.36e-1)" "unprognostic (1.44e-1)" 25.6 17.5 16.0 14.0 16.7 11.4 24.9 29.7 16.0 27.9 22.6 17.9 21.3 15.1 28.2 18.8 21.7 20.5 17.5 19.6 15.3 11.5 21.0 22.0 20.1 16.0 17.2 13.3 30.5 25.0 30.0 28.9 30.6 14.2 27.8 17.4 18.4 23.1 22.8 39.7 18.2 23.4 27.6 13.9 21.7 19.3 17.6 18.4 38.8 35.0 13.9 18.1 29.0 24.1 3.6 3.6 3.4 1.8 2.9 4.7 1.3 8.5 11.4 30.9 8.9 12.8 19.8 17.4 15.1 16.6 20.3 25.5 7.0 2.0 14.3 4.5 13.0 10.4 14.2 17.3 6.8 21.6 12.4 9.8 9.9 11.4 8.0 12.7 17.2 7.8 8.9 11.5 10.0 14.7 19.6 14.7 7.3 11.1 13.2 12.0 4.5 10.2 5.0 16.1 4.6 7.1 13.3 15.7 14.0 9.7 3.7 19.1 11.3 14.1 2.6 9.4 13.7 7.0 10.0 11.0 17.2 8.0 4.3 10.0 19.9 13.8 12.4 11.2 6.7 11.3 0.8 1.8 1.8 3.2 1.1 3.7 2.2 3.3 2.6 3.6 3.6 4.0 4.7 3.4 2.9 1.3 2.9 4.3 1.3 16.0 16.7 29.7 16.0 15.3 11.5 17.2 13.3 14.2 18.4 20.8 23.2 11.8 18.4 22.8 13.2 33.5 40.8 16.0 19.4 21.0 19.6 15.5 10.0 16.2 7.3 23.2 15.6 0.0 10.8 16.8 23.8 31.7 4.6 40.0 13.2 14.3 38.1 23.9 26.1 11.4 30.8 16.7 27.0 5.4 33.8 18.9 18.1 24.3 28.7 18.5 20.8 25.8 29.2 13.9 16.2 23.8 10.5 13.8 26.2 22.5 SMAD5 "Dwfc, JV5-1, MADH5" ENSG00000113658 "SMAD family member 5" Q99717 5 136132845-136188747 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 33.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058931 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA058931: AB_2683856" "unprognostic (6.04e-2)" "unprognostic (4.16e-2)" "unprognostic (9.99e-3)" "unprognostic (3.23e-1)" "unprognostic (5.98e-2)" "unprognostic (3.40e-1)" "unprognostic (1.87e-2)" "unprognostic (9.49e-2)" "unprognostic (4.23e-2)" "unprognostic (2.65e-1)" "unprognostic (1.27e-1)" "unprognostic (3.79e-2)" "unprognostic (4.69e-2)" "unprognostic (1.40e-3)" "unprognostic (3.22e-1)" "unprognostic (5.95e-2)" "unprognostic (2.15e-1)" 22.6 14.2 13.7 10.2 14.6 8.6 18.2 27.5 15.7 27.9 16.7 19.8 15.9 12.4 33.5 15.8 20.8 17.3 14.0 15.9 14.9 12.4 15.7 20.2 16.7 10.4 18.0 12.2 33.5 15.3 25.2 23.0 24.1 16.4 23.0 16.9 22.0 16.9 18.8 19.3 27.5 12.7 25.7 16.7 16.3 14.4 11.5 19.0 8.4 19.2 15.2 15.7 25.6 27.9 7.3 7.4 33.1 6.1 9.3 7.2 2.4 14.0 11.8 14.6 12.9 15.9 24.4 15.4 19.5 13.8 13.0 20.3 52.1 10.3 15.5 16.4 15.1 13.9 12.9 17.0 22.3 21.3 6.7 10.5 10.3 12.8 9.8 13.2 6.2 11.0 17.5 13.6 20.6 14.3 13.8 16.2 7.8 9.9 10.7 14.3 5.6 5.1 6.4 8.7 5.0 6.0 10.7 28.2 9.1 7.9 14.5 13.2 13.8 17.0 4.4 17.1 18.4 9.9 7.7 18.7 19.8 12.7 14.6 19.3 12.1 14.5 19.6 12.8 8.1 15.0 33.1 6.1 13.0 7.2 3.9 5.5 6.5 4.2 4.6 6.1 7.3 1.4 4.3 1.0 9.3 4.4 7.4 1.1 2.4 13.7 14.6 27.5 15.7 14.9 12.4 18.0 12.2 16.4 19.0 38.7 26.7 14.8 30.0 41.2 26.4 34.1 48.4 34.8 43.3 29.6 19.6 16.7 19.9 22.2 16.0 50.2 12.4 0.0 22.9 9.9 44.5 42.2 8.1 42.9 11.9 49.3 95.7 47.9 32.6 18.0 65.6 20.0 20.3 3.6 36.1 46.2 25.7 17.3 68.2 35.0 27.4 45.3 40.6 21.4 21.4 44.3 9.8 13.4 28.7 30.4 SMAD6 "HsT17432, MADH6, MADH7" ENSG00000137834 "SMAD family member 6" O43541 15 66702228-66782848 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 37.1" "Cell type enriched" "Detected in many" 6 "Ito cells: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 21.2;HaCaT: 12.6;HeLa: 17.4;U-2197: 12.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA061917 Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA061917: AB_2684637" "unprognostic (1.20e-1)" "unprognostic (7.43e-3)" "unprognostic (5.62e-2)" "unprognostic (1.26e-1)" "unprognostic (3.02e-1)" "unprognostic (3.50e-3)" "unprognostic (9.59e-2)" "unprognostic (4.50e-1)" "unprognostic (3.47e-2)" "unprognostic (1.50e-1)" "unprognostic (1.10e-3)" "unprognostic (1.68e-1)" "unprognostic (1.67e-2)" "unprognostic (1.55e-3)" "unprognostic (4.30e-2)" "unprognostic (1.33e-1)" "prognostic favorable (5.45e-5)" 9.8 1.9 2.5 3.1 4.6 0.6 5.1 0.8 2.8 6.3 4.7 2.6 2.1 3.8 5.2 1.9 3.1 4.4 11.6 21.6 3.0 2.0 6.1 6.2 37.1 1.2 3.6 2.3 5.1 3.1 2.3 2.8 13.8 4.5 9.7 2.5 18.5 1.6 22.1 1.8 1.6 3.8 3.1 2.9 3.2 8.0 1.7 2.0 0.0 16.7 0.6 0.8 6.8 7.3 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.9 7.0 1.1 2.4 4.3 1.1 6.7 4.9 0.1 0.8 0.0 1.4 3.1 0.5 21.2 4.2 0.6 12.6 1.5 0.0 0.1 1.5 5.8 10.9 17.4 1.1 0.5 0.0 0.8 1.4 0.0 0.0 0.0 2.4 0.9 3.6 0.9 0.7 0.3 1.3 0.1 3.0 2.1 7.1 2.6 0.0 1.3 1.5 2.4 5.5 2.6 1.1 2.7 3.0 0.5 4.3 1.0 2.0 4.2 3.1 4.0 12.3 0.9 0.4 1.2 0.2 2.2 3.9 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.5 4.6 0.8 2.8 3.0 2.0 3.6 2.3 4.5 2.0 11.9 5.9 1.4 1.0 0.7 0.0 4.5 5.1 0.0 4.5 1.8 2.0 0.5 3.3 4.3 2.8 19.4 2.8 0.0 5.0 0.7 4.3 1.5 4.6 2.8 1.7 0.0 0.0 107.4 9.5 1.0 2.6 0.8 0.0 1.0 2.0 11.1 5.6 0.0 7.8 1.5 0.3 0.0 1.0 0.2 0.6 0.1 0.7 0.5 5.3 0.3 SMAD7 "MADH7, MADH8" ENSG00000101665 "SMAD family member 7" O15105 18 48919853-48950711 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 50.6;Ito cells: 84.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 8.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 22.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026212, HPA028897" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB026212: , HPA028897: AB_10600811" "unprognostic (1.63e-1)" "unprognostic (3.72e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (5.61e-4)" "unprognostic (8.15e-2)" "unprognostic (5.35e-1)" "unprognostic (2.76e-1)" "unprognostic (6.02e-2)" "unprognostic (2.37e-1)" "unprognostic (1.87e-2)" "unprognostic (2.70e-1)" "unprognostic (2.09e-1)" "unprognostic (1.91e-1)" "unprognostic (1.56e-1)" "unprognostic (1.31e-1)" "unprognostic (1.50e-2)" "unprognostic (4.44e-1)" 9.5 3.3 3.1 7.4 4.3 8.6 11.6 8.0 7.7 11.4 11.5 4.2 5.1 5.5 6.5 3.0 2.8 4.2 5.7 27.0 5.8 3.1 7.4 6.5 13.7 2.8 6.1 4.4 4.5 5.6 14.6 3.9 11.2 6.0 9.3 7.0 7.1 5.3 11.5 4.9 4.4 15.0 5.0 6.3 2.9 7.2 3.2 2.8 3.6 10.0 5.7 3.4 6.8 19.4 0.1 0.3 8.3 0.8 2.6 1.9 0.4 2.2 1.9 1.6 5.2 9.1 3.8 13.1 10.4 4.4 4.1 1.9 0.5 3.2 0.2 19.7 7.6 3.6 11.9 3.7 3.5 2.2 22.6 5.9 0.1 5.6 4.9 1.6 4.5 11.3 3.2 3.2 4.6 4.9 19.5 0.7 0.3 3.8 14.8 6.2 0.7 0.0 1.3 10.9 15.6 0.7 1.3 1.6 5.0 6.3 2.4 2.9 6.3 4.7 2.2 4.5 13.2 1.8 3.5 9.9 11.0 6.0 3.1 10.2 8.0 4.0 1.3 4.8 2.9 1.7 5.8 0.2 8.3 1.4 0.8 1.2 0.1 1.4 1.3 0.3 0.0 0.4 0.9 0.0 2.6 0.2 0.0 1.9 0.4 3.1 4.3 8.0 7.7 5.8 3.1 6.1 4.4 6.0 2.8 50.6 10.3 1.4 3.2 11.4 5.1 7.9 2.5 4.0 18.2 10.4 5.9 7.9 8.3 12.6 0.1 10.0 22.7 0.0 12.2 2.7 15.4 3.0 17.4 2.6 9.0 0.0 12.2 84.7 16.0 0.2 1.4 7.9 0.0 8.2 17.6 1.3 21.6 17.3 3.2 5.0 2.5 6.5 10.3 0.0 0.1 10.3 10.8 8.4 12.8 2.2 SMAD9 "MADH6, MADH9, SMAD8, SMAD8/9" ENSG00000120693 "SMAD family member 9" O15198 13 36844831-36920765 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 38.9" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 26.8;Intestinal endocrine cells: 49.5;Ito cells: 47.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 8.8;SH-SY5Y: 28.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009119, HPA031162" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB009119: AB_2286517, HPA031162: AB_2673767" "unprognostic (2.88e-1)" "unprognostic (1.38e-1)" "unprognostic (9.68e-3)" "unprognostic (3.50e-3)" "prognostic favorable (5.99e-4)" "unprognostic (1.30e-1)" "unprognostic (1.34e-1)" "unprognostic (3.71e-3)" "unprognostic (4.23e-2)" "unprognostic (6.62e-2)" "unprognostic (4.07e-3)" "unprognostic (3.74e-2)" "unprognostic (9.70e-2)" "unprognostic (1.55e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (4.92e-4)" "unprognostic (2.47e-2)" 4.4 3.1 7.0 3.2 6.2 0.6 4.1 10.7 11.8 6.3 8.2 14.3 4.1 2.6 10.0 11.3 5.8 5.1 7.4 6.9 15.0 6.2 5.0 1.4 5.3 2.6 10.7 8.9 10.1 1.3 3.0 6.2 6.7 10.2 14.9 6.0 11.9 17.7 12.4 13.8 2.1 4.0 8.4 15.5 1.5 5.9 2.7 11.0 0.0 38.9 1.9 3.4 7.7 12.6 1.7 1.7 1.1 0.8 0.7 1.4 0.2 0.0 0.1 0.5 5.9 1.8 0.8 0.2 6.8 0.7 1.9 1.1 0.0 0.1 0.2 4.3 8.8 0.6 0.3 5.9 0.1 2.0 0.2 8.4 0.0 3.0 4.7 1.8 0.5 0.1 3.0 0.5 0.0 0.0 4.0 3.6 0.8 0.0 0.0 4.3 0.4 0.1 0.5 0.9 0.2 0.6 0.1 6.4 0.0 0.0 1.0 5.3 28.2 1.4 0.2 0.3 1.7 0.4 0.2 6.4 2.8 2.2 1.6 1.6 0.1 0.0 0.0 1.9 0.2 0.4 1.1 0.4 0.3 1.2 0.8 0.8 1.0 1.2 1.3 0.2 1.7 1.2 1.4 0.9 0.7 0.5 1.7 0.4 0.2 7.0 6.2 10.7 7.8 15.0 6.2 10.7 8.9 10.2 11.0 26.8 7.8 0.0 4.2 2.5 8.3 4.2 0.0 2.7 11.4 10.4 3.9 0.1 1.7 0.2 0.1 21.5 0.0 0.0 0.2 0.4 6.6 17.1 0.0 0.0 0.1 0.0 49.5 47.9 2.4 0.0 17.3 0.0 0.0 0.0 13.7 16.3 0.7 3.5 14.2 4.3 3.2 0.0 7.9 0.2 4.7 1.6 0.2 0.9 5.7 0.9 SMAGP "hSMAGP, MGC149453, MGC149454" ENSG00000170545 "Small cell adhesion glycoprotein" Q0VAQ4 12 51244558-51270890 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 53.4" "Group enriched" "Detected in many" 9 "Cytotrophoblasts: 1087.3;Syncytiotrophoblasts: 704.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 39.4;OE19: 47.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039711 Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA039711: AB_10674985" "unprognostic (2.55e-3)" "unprognostic (2.63e-1)" "unprognostic (3.96e-2)" "unprognostic (3.63e-3)" "prognostic unfavorable (5.36e-4)" "unprognostic (3.01e-1)" "unprognostic (1.63e-3)" "unprognostic (6.26e-2)" "unprognostic (7.48e-2)" "unprognostic (9.11e-2)" "prognostic unfavorable (4.38e-4)" "unprognostic (1.46e-1)" "prognostic favorable (2.24e-4)" "unprognostic (4.32e-3)" "unprognostic (1.60e-1)" "unprognostic (1.99e-2)" "unprognostic (1.52e-1)" 7.5 6.9 0.9 11.3 1.7 0.9 26.3 1.1 1.3 13.1 22.6 0.9 5.3 6.9 8.0 13.6 53.4 3.2 21.8 6.0 1.0 1.0 10.9 4.3 17.6 14.2 1.5 0.4 5.2 14.9 4.6 1.9 50.0 3.0 4.8 24.3 2.6 10.2 6.9 3.6 12.6 8.5 3.4 4.3 11.5 14.1 4.8 0.7 1.2 4.2 28.7 33.1 7.9 24.6 22.5 2.6 8.6 3.7 12.3 9.5 3.5 23.3 7.2 0.8 0.8 3.2 12.7 39.4 18.0 18.1 9.2 5.7 14.2 24.6 0.2 3.2 11.1 3.4 8.3 5.1 6.9 12.9 1.1 4.1 3.1 0.9 4.7 8.9 0.7 3.0 8.2 5.3 19.9 18.0 21.1 22.1 6.0 2.4 1.3 14.8 20.6 3.8 2.8 3.6 47.5 27.9 0.2 0.3 0.8 13.3 5.4 0.9 1.1 3.9 15.8 2.8 9.9 13.6 1.2 7.7 10.3 9.8 0.5 10.9 0.4 0.6 0.4 15.1 7.7 5.5 1.9 3.7 6.4 9.5 2.4 6.1 22.5 4.2 6.9 2.6 17.6 3.9 7.0 8.6 12.3 2.6 1.5 2.7 3.5 0.9 1.7 1.1 1.3 1.0 1.0 1.5 0.4 3.0 0.7 0.0 18.8 28.2 46.4 19.3 1.2 1.1 53.5 8.1 12.5 15.7 0.0 1087.3 41.4 27.1 6.5 53.4 61.6 0.0 95.9 65.5 13.8 46.6 12.7 5.8 83.3 1.6 19.7 38.1 5.4 2.1 12.0 6.7 13.5 5.4 100.2 2.5 97.3 73.7 9.2 15.3 1.2 25.8 8.1 5.2 28.8 26.0 704.6 15.2 97.4 72.3 SMARCA1 "hSNF2L, ISWI, NURF140, SNF2L, SNF2L1, SNF2LB, SWI" ENSG00000102038 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1" P28370 X 129446501-129523500 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Leydig cells: 132.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 4.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003335, HPA064712" Uncertain Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA003335: AB_1080024, HPA064712: AB_2685332" "unprognostic (1.40e-1)" "unprognostic (8.28e-3)" "unprognostic (2.30e-1)" "unprognostic (5.06e-2)" "unprognostic (6.21e-2)" "unprognostic (2.16e-2)" "unprognostic (5.44e-2)" "unprognostic (7.15e-2)" "unprognostic (3.41e-2)" "unprognostic (1.53e-1)" "prognostic favorable (3.03e-4)" "unprognostic (9.26e-2)" "prognostic favorable (5.09e-4)" "unprognostic (1.87e-3)" "unprognostic (1.28e-1)" "unprognostic (6.14e-2)" "unprognostic (2.33e-2)" 10.4 44.6 14.5 5.0 15.2 0.4 11.8 12.0 12.0 17.1 11.4 7.7 25.5 3.9 15.8 31.4 9.6 12.0 12.3 19.3 13.9 17.9 13.9 34.1 9.2 2.5 13.1 8.4 42.2 9.0 34.8 29.9 21.0 14.6 23.8 4.3 9.7 9.8 42.9 8.7 4.6 4.8 17.7 14.0 6.9 10.0 33.0 13.1 2.0 26.0 6.8 2.6 16.8 15.3 0.3 0.8 0.0 0.0 1.6 4.3 0.5 6.6 15.0 31.0 20.2 22.6 20.5 10.7 13.7 39.6 20.4 23.2 5.2 23.9 0.0 21.3 25.7 24.0 6.4 19.2 8.0 23.0 0.0 3.6 0.0 13.6 28.1 9.9 0.0 0.0 25.6 2.3 14.6 2.8 31.2 14.9 3.7 3.4 1.6 22.0 0.0 0.1 0.0 12.4 2.6 8.6 0.0 16.7 0.0 20.1 8.2 7.4 20.4 1.9 0.2 3.4 22.8 13.8 0.1 10.3 13.7 7.0 8.9 7.4 0.0 0.0 0.0 12.1 0.0 8.4 0.0 0.0 0.0 0.5 0.0 0.2 0.3 0.2 0.0 0.0 0.3 4.3 1.3 0.0 1.6 0.0 0.8 0.0 0.5 14.5 15.2 12.0 12.0 13.9 17.9 13.1 8.4 14.6 13.1 89.3 46.5 1.3 28.2 20.7 25.6 68.0 12.7 60.2 68.2 38.4 43.2 40.5 24.9 23.4 2.0 21.1 0.0 23.3 10.5 11.6 49.7 20.5 2.3 52.9 11.7 87.4 16.1 17.2 2.5 8.2 132.3 3.6 27.0 10.0 1.1 49.1 12.6 0.0 118.1 31.1 13.3 64.7 30.1 12.6 6.1 10.3 48.9 0.0 1.0 24.8 SMARCA2 "BAF190, BRM, hBRM, hSNF2a, SNF2, SNF2L2, SNF2LA, Sth1p, SWI2" ENSG00000080503 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2" P51531 9 1980290-2193624 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Helicase, Hydrolase" "Disease mutation, Hypotrichosis, Mental retardation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 6 "HDLM-2: 180.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029981, CAB037276" Enhanced Approved "Nucleoplasm,Vesicles,Intermediate filaments" NA NA "Nucleoplasm, Vesicles" "Intermediate filaments" "CAB037276: AB_477083, HPA029981: AB_10602406" "unprognostic (5.34e-2)" "unprognostic (1.99e-2)" "unprognostic (6.27e-2)" "unprognostic (6.53e-2)" "unprognostic (1.28e-1)" "unprognostic (1.13e-2)" "unprognostic (4.91e-2)" "unprognostic (2.80e-2)" "unprognostic (2.62e-1)" "unprognostic (3.97e-1)" "unprognostic (3.60e-3)" "unprognostic (9.64e-2)" "prognostic favorable (1.26e-6)" "unprognostic (3.09e-1)" "unprognostic (2.81e-1)" "unprognostic (8.32e-3)" "unprognostic (8.50e-2)" 23.6 29.6 38.8 21.3 43.6 40.7 30.1 41.6 44.0 23.8 17.3 20.0 38.4 10.3 26.4 30.1 20.4 29.4 22.8 21.2 30.2 30.8 23.4 28.9 20.2 29.5 25.9 32.4 85.0 18.5 104.1 35.0 23.2 24.7 23.2 15.9 22.8 26.1 44.8 41.3 27.0 18.3 26.6 19.7 23.9 15.8 26.5 23.4 20.6 28.0 24.8 27.1 23.7 22.0 9.9 11.3 20.4 8.3 8.6 12.5 4.2 5.4 4.0 3.0 4.3 6.2 7.3 9.0 6.8 5.5 3.1 2.4 0.0 2.2 9.3 2.8 6.2 1.7 2.3 1.6 5.7 2.2 180.9 2.5 25.2 11.1 1.9 2.4 10.5 14.8 4.8 2.2 3.1 5.9 5.7 5.0 4.4 0.8 32.1 5.3 2.2 2.6 8.8 3.0 3.3 1.5 11.8 3.8 8.4 7.3 4.9 1.9 1.7 4.4 1.0 1.9 4.5 2.0 6.8 6.0 5.1 2.5 3.2 3.3 2.9 3.7 4.2 5.6 4.0 1.4 20.4 4.6 13.1 10.3 6.2 9.9 9.9 9.9 10.5 5.6 8.0 12.5 10.0 13.5 8.6 8.3 11.3 10.4 4.2 38.8 43.6 41.6 44.0 30.2 30.8 25.9 32.4 24.7 23.4 68.5 60.6 20.6 16.9 52.1 54.6 85.9 25.5 107.1 55.7 101.2 35.3 80.6 26.6 21.1 24.7 47.7 25.6 0.0 19.4 19.6 52.6 19.1 45.2 54.3 27.1 33.4 35.7 35.0 45.5 17.2 71.1 37.2 47.2 35.1 32.1 44.7 15.3 7.0 81.7 15.9 34.9 12.9 28.8 18.6 13.6 46.0 74.1 47.1 24.0 12.4 SMARCA4 "BAF190, BRG1, FLJ39786, hSNF2b, SNF2, SNF2-BETA, SNF2L4, SNF2LB, SWI2" ENSG00000127616 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4" P51532 19 10960825-11079426 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, Helicase, Hydrolase, Repressor, RNA-binding" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cardiomyocytes: 219.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB004208 Supported Supported Nucleoplasm NA NA 260000 Nucleoplasm "CAB004208: AB_626762" "unprognostic (2.68e-1)" "unprognostic (4.85e-2)" "unprognostic (1.71e-1)" "unprognostic (3.43e-3)" "unprognostic (1.40e-1)" "unprognostic (6.33e-3)" "prognostic unfavorable (1.11e-4)" "unprognostic (7.19e-2)" "unprognostic (7.29e-2)" "unprognostic (1.73e-2)" "unprognostic (1.97e-1)" "unprognostic (1.15e-2)" "unprognostic (6.80e-3)" "unprognostic (6.83e-3)" "unprognostic (5.44e-2)" "unprognostic (1.01e-1)" "unprognostic (1.29e-1)" 10.3 12.4 15.5 18.0 21.3 20.5 10.9 29.1 28.0 13.2 12.8 16.6 9.7 14.3 16.6 9.4 24.7 15.7 12.8 11.6 14.4 17.7 13.0 9.9 13.0 18.1 17.1 16.8 13.6 13.4 18.1 11.5 14.6 16.1 13.3 9.4 17.3 18.2 12.5 21.9 20.4 12.0 10.6 16.1 13.2 14.5 22.2 12.4 58.2 15.5 10.1 21.5 15.2 12.6 9.8 11.2 8.6 13.5 11.4 13.7 5.9 20.5 1.1 36.7 34.7 7.2 6.1 16.1 14.3 8.6 17.5 13.0 28.7 0.9 48.3 22.2 12.5 0.7 15.1 28.6 17.7 9.7 19.8 21.4 38.4 18.2 33.3 10.9 27.8 19.2 10.2 8.6 14.7 15.2 7.8 15.6 21.1 34.4 18.2 13.7 41.9 46.2 23.9 37.2 10.0 31.1 49.2 23.2 25.0 11.2 26.1 41.8 37.9 15.2 19.6 16.3 12.3 16.6 20.9 20.6 26.1 13.6 23.8 23.6 37.7 41.8 47.9 14.8 26.7 22.1 8.1 8.3 8.6 13.7 9.5 12.2 7.4 10.4 11.6 8.5 9.8 11.4 11.2 5.2 11.4 13.5 11.2 8.8 5.9 15.5 21.3 29.1 28.0 14.4 17.7 17.1 16.8 16.1 12.4 62.5 67.7 32.7 32.8 32.7 82.3 219.1 43.3 46.8 51.2 41.8 66.8 57.1 34.9 75.0 39.4 30.8 34.6 23.3 53.1 46.8 38.0 38.3 29.0 19.2 36.4 95.3 60.6 22.7 21.0 29.3 24.2 23.3 15.1 57.7 37.3 37.2 60.6 38.6 12.7 19.3 63.8 12.9 30.3 93.0 96.0 45.2 51.0 28.4 50.9 40.7 SMARCA5 "hISWI, hSNF2H, ISWI" ENSG00000153147 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5" O60264 4 143513463-143557486 "Predicted intracellular proteins, Transcription factors" "Chromatin regulator, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 285.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005227, HPA008751, HPA074181" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" No No Nucleoplasm "Nucleoli fibrillar center" "CAB005227: AB_2191863, HPA008751: AB_1857268, HPA074181: " "unprognostic (9.21e-3)" "unprognostic (7.99e-2)" "unprognostic (4.99e-3)" "unprognostic (8.03e-2)" "unprognostic (8.96e-2)" "unprognostic (3.47e-1)" "prognostic unfavorable (1.61e-4)" "unprognostic (3.85e-2)" "unprognostic (8.84e-2)" "unprognostic (1.99e-1)" "unprognostic (4.19e-2)" "unprognostic (1.32e-1)" "unprognostic (1.87e-2)" "unprognostic (2.19e-1)" "unprognostic (1.61e-1)" "unprognostic (4.20e-2)" "unprognostic (1.82e-1)" 21.0 39.5 24.7 24.8 32.6 34.5 21.9 26.9 29.2 24.0 23.8 27.7 24.6 17.9 27.3 26.3 19.8 23.0 23.8 29.8 25.0 25.1 21.1 21.0 33.3 29.5 30.2 26.5 29.4 24.6 33.1 33.3 27.7 29.6 23.1 22.5 16.3 22.0 25.7 24.6 14.7 22.6 22.9 34.6 28.6 22.8 37.8 32.8 44.3 28.5 15.1 29.7 25.6 23.7 11.7 13.2 15.4 19.4 15.6 16.3 10.6 11.9 9.4 34.6 21.7 20.3 14.7 20.7 15.2 18.1 22.1 18.8 16.0 16.8 32.4 10.5 12.9 8.9 9.5 31.6 14.2 21.5 21.5 11.2 24.2 13.9 13.1 15.0 29.9 14.3 12.9 10.3 15.7 13.5 13.0 17.1 16.6 21.8 20.5 14.4 10.7 34.8 10.4 28.1 20.0 13.5 38.7 22.2 10.5 17.3 14.6 27.7 23.5 19.8 14.0 17.5 27.1 10.1 14.0 18.2 14.7 11.3 15.3 14.9 22.6 27.0 39.4 11.5 25.1 14.9 5.0 10.7 15.4 13.9 12.7 16.3 11.7 14.2 15.0 13.2 11.5 14.9 14.7 9.7 15.6 19.4 10.1 16.1 10.6 24.7 32.6 26.9 29.2 25.0 25.1 30.2 26.5 29.6 32.8 285.9 217.7 44.0 61.8 41.2 94.8 89.1 28.1 137.9 128.5 41.8 60.9 60.5 33.2 66.8 37.7 52.0 32.2 0.0 53.1 58.4 45.4 47.0 98.4 21.7 39.5 81.0 76.6 36.2 50.0 18.9 55.8 51.0 28.7 101.0 33.6 83.9 56.1 32.8 58.4 29.3 110.5 51.8 54.2 117.2 123.0 35.8 85.4 55.4 37.9 62.6 SMARCAD1 "DKFZP762K2015, ETL1, KIAA1122" ENSG00000163104 "SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1" Q9H4L7 4 94207611-94291292 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Ectodermal dysplasia, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016737 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA016737: AB_1857271" "unprognostic (5.01e-2)" "unprognostic (5.83e-2)" "unprognostic (2.59e-3)" "unprognostic (1.23e-1)" "unprognostic (8.41e-3)" "unprognostic (9.08e-3)" "prognostic unfavorable (3.22e-5)" "unprognostic (2.45e-1)" "unprognostic (3.49e-3)" "unprognostic (3.55e-1)" "unprognostic (2.57e-2)" "unprognostic (7.72e-2)" "unprognostic (2.99e-2)" "unprognostic (1.43e-1)" "unprognostic (1.95e-1)" "unprognostic (1.55e-1)" "unprognostic (3.20e-3)" 12.8 15.4 15.4 22.2 14.6 8.6 20.1 26.7 25.1 15.4 13.6 9.4 14.4 12.6 19.6 17.5 17.2 16.5 13.9 12.9 13.6 14.7 16.6 14.9 21.6 22.8 17.6 11.1 20.8 15.0 17.2 33.0 18.3 14.9 15.4 16.5 10.2 14.9 20.9 11.8 26.5 13.9 15.6 17.9 17.6 13.9 15.3 16.2 42.0 20.2 11.4 17.8 16.0 15.9 5.5 4.3 3.5 3.0 7.5 6.2 2.7 7.4 9.7 30.1 19.7 8.7 14.3 15.6 13.3 12.5 11.1 10.7 8.7 12.2 19.2 9.2 11.4 10.1 6.5 21.2 11.2 16.1 14.7 9.6 13.8 10.5 13.3 12.6 20.1 14.8 14.6 9.3 13.8 17.8 13.8 17.3 16.8 22.8 8.0 16.8 5.9 34.2 10.7 20.9 9.4 4.8 19.9 17.2 9.8 13.0 9.1 17.7 26.2 10.2 17.2 14.6 19.3 8.8 13.6 16.3 14.5 15.5 8.9 10.1 11.3 16.9 23.0 13.6 10.8 17.9 3.5 2.5 0.3 4.6 3.0 4.8 5.5 5.1 4.9 4.3 4.2 5.5 6.2 0.0 7.5 2.9 3.7 4.1 2.7 15.4 14.6 26.7 25.1 13.6 14.7 17.6 11.1 14.9 16.2 11.9 9.9 6.0 5.4 10.4 19.7 12.3 5.1 37.5 34.2 8.7 15.7 11.2 1.7 10.8 1.7 14.3 5.0 0.0 8.7 9.4 10.1 5.8 22.1 11.0 9.3 17.5 8.6 11.1 14.0 1.8 13.3 12.3 3.3 7.2 12.6 9.4 12.3 8.2 17.3 12.7 18.1 6.5 7.2 26.5 34.0 8.4 8.0 16.2 10.9 3.8 SMARCAL1 "HARP, HHARP" ENSG00000138375 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1" Q9NZC9 2 216412414-216483053 "Disease related genes, Predicted intracellular proteins" "Helicase, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020337 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA020337: AB_2670410" "unprognostic (4.56e-1)" "unprognostic (1.05e-1)" "unprognostic (1.65e-1)" "unprognostic (2.20e-2)" "unprognostic (3.39e-2)" "unprognostic (2.68e-2)" "prognostic unfavorable (5.22e-4)" "unprognostic (4.35e-3)" "unprognostic (3.31e-2)" "unprognostic (2.33e-1)" "unprognostic (1.36e-1)" "unprognostic (7.46e-2)" "unprognostic (2.00e-2)" "unprognostic (2.67e-1)" "unprognostic (1.41e-1)" "unprognostic (1.97e-1)" "unprognostic (3.16e-1)" 14.9 17.2 11.5 15.3 16.0 11.9 14.1 9.8 18.0 16.6 11.8 18.3 13.9 9.2 23.4 11.7 15.2 16.5 13.9 14.9 10.8 13.3 12.2 10.3 11.5 17.5 14.7 13.1 25.1 14.9 18.3 15.8 15.3 15.2 15.8 11.2 14.6 13.9 14.1 14.9 15.2 12.5 15.2 13.9 16.3 12.1 14.7 15.5 30.5 15.1 10.8 21.5 14.7 14.6 8.9 15.9 17.4 14.0 16.6 12.8 7.1 9.4 9.7 13.2 7.7 13.3 15.5 12.7 13.1 13.5 14.0 16.0 15.3 12.1 8.5 13.2 16.2 17.3 7.3 11.4 14.4 18.7 26.2 11.3 24.8 7.7 11.2 13.6 6.7 14.4 10.4 15.3 15.0 14.9 14.6 16.4 13.7 24.4 9.5 15.9 7.1 12.4 15.5 9.5 8.5 5.2 14.3 8.9 5.4 11.0 6.6 11.1 7.2 7.0 5.5 10.9 24.3 7.4 10.8 12.5 17.4 8.0 8.3 7.9 10.8 10.6 7.7 17.6 9.1 12.1 17.4 8.1 11.6 11.1 8.9 10.5 8.9 10.5 12.8 12.7 8.8 8.8 10.6 1.6 16.6 14.0 15.9 12.4 7.1 11.5 16.0 9.8 18.0 10.8 13.3 14.7 13.1 15.2 15.5 6.0 6.7 5.9 3.4 0.8 4.9 3.6 2.5 4.0 2.3 0.0 0.0 8.9 5.0 6.6 10.6 7.0 3.3 0.0 3.4 10.2 4.1 1.6 17.3 3.2 8.6 7.9 3.5 3.1 7.6 9.5 5.8 3.9 1.7 13.6 4.2 4.1 4.1 12.2 8.1 3.0 4.6 12.9 5.1 6.7 3.1 1.1 6.1 7.4 5.6 1.8 SMARCB1 "BAF47, hSNFS, Ini1, PPP1R144, RDT, Sfh1p, SNF5L1, Snr1" ENSG00000099956 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1" Q12824 22 23786931-23838008 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Host-virus interaction, Neurogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding" "Cancer-related genes, Disease mutation, Hypotrichosis, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009196, HPA018248, HPA019127" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "CAB009196: AB_2191983, HPA018248: AB_1851162, HPA019127: AB_1851165" "unprognostic (2.15e-1)" "unprognostic (5.62e-2)" "unprognostic (6.60e-3)" "unprognostic (1.63e-2)" "unprognostic (4.01e-3)" "unprognostic (2.14e-1)" "prognostic unfavorable (6.52e-4)" "unprognostic (4.10e-1)" "unprognostic (1.86e-1)" "unprognostic (1.03e-2)" "unprognostic (2.10e-2)" "unprognostic (4.43e-3)" "prognostic favorable (1.14e-6)" "unprognostic (1.24e-1)" "unprognostic (4.58e-2)" "unprognostic (4.57e-2)" "unprognostic (7.04e-2)" 11.0 15.2 14.6 33.2 15.4 16.9 12.1 30.4 21.9 13.4 25.1 16.4 11.4 41.1 17.2 11.0 15.6 12.3 15.0 12.6 13.2 14.2 14.6 11.7 14.0 32.8 13.0 13.8 21.3 16.1 7.9 15.7 20.8 12.8 11.0 9.4 16.7 40.9 13.1 28.1 14.7 27.4 10.6 12.8 19.8 24.1 37.7 12.9 29.4 15.7 12.0 16.0 21.1 12.2 19.5 9.9 4.8 11.6 7.0 7.5 5.9 1.5 1.0 19.2 1.8 1.8 0.5 3.9 6.1 1.8 1.8 2.9 2.2 1.8 15.7 5.3 0.8 2.0 2.9 4.6 3.0 3.0 2.6 6.7 13.0 1.8 1.3 2.1 13.8 3.8 1.1 2.2 2.1 4.7 0.9 0.9 1.9 3.5 8.7 1.1 3.9 11.2 3.2 5.7 4.7 3.8 7.0 15.5 7.0 1.6 3.0 9.1 6.9 1.4 0.4 10.3 10.4 1.5 2.1 1.6 1.6 6.7 2.6 1.7 9.6 8.8 10.4 1.3 7.6 4.6 4.0 10.0 4.8 3.8 10.2 5.2 19.5 4.6 4.6 9.3 6.4 3.8 2.5 0.8 7.0 11.6 9.9 7.5 5.9 14.6 15.4 30.4 21.9 13.2 14.2 13.0 13.8 12.8 12.9 6.0 10.4 102.1 57.3 44.6 51.7 3.7 38.2 18.7 6.8 45.4 19.6 106.2 71.3 80.0 26.9 31.5 31.9 23.3 67.3 185.0 45.7 53.3 33.5 17.7 66.6 63.5 68.9 36.8 19.7 12.4 33.1 35.4 54.0 63.1 50.5 72.3 62.0 51.8 30.1 65.4 36.9 19.4 58.2 125.7 116.1 46.3 133.9 35.0 61.6 56.7 SMARCC1 "BAF155, CRACC1, Rsc8, SRG3" ENSG00000173473 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1" Q92922 3 47585272-47782106 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011576, CAB016336, HPA024352, HPA026853" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB011576: AB_2191988, CAB016336: AB_671095, HPA024352: AB_1857274, HPA026853: AB_10603030" "unprognostic (3.47e-1)" "unprognostic (1.65e-1)" "prognostic favorable (3.34e-4)" "unprognostic (2.54e-1)" "unprognostic (1.83e-2)" "unprognostic (3.70e-2)" "prognostic unfavorable (3.37e-4)" "unprognostic (1.33e-2)" "unprognostic (4.28e-3)" "unprognostic (6.92e-2)" "unprognostic (5.53e-2)" "unprognostic (2.78e-2)" "unprognostic (1.66e-2)" "unprognostic (7.99e-2)" "unprognostic (3.84e-1)" "unprognostic (2.31e-2)" "unprognostic (2.45e-1)" 16.5 9.3 14.5 22.6 18.9 16.7 21.8 16.5 17.2 19.3 22.4 19.6 13.1 13.3 20.0 15.2 21.8 12.5 16.4 10.3 13.9 11.3 18.7 15.6 13.6 18.6 18.1 11.3 18.7 25.6 16.4 15.1 28.0 11.7 22.1 20.8 14.5 18.9 16.9 19.8 24.3 17.8 32.6 16.1 18.7 16.6 18.7 18.3 45.0 21.1 12.8 27.7 24.9 27.0 8.2 4.7 4.3 5.4 4.0 8.1 3.9 14.5 7.7 32.4 25.1 7.2 12.5 21.8 11.6 10.9 15.1 15.4 13.8 15.5 34.0 9.4 14.6 8.8 12.5 30.4 18.0 22.2 16.2 18.1 33.3 13.3 18.7 10.9 30.4 15.4 10.4 16.0 17.0 18.9 11.3 17.6 22.9 27.9 11.6 16.2 10.8 39.6 15.9 42.7 14.1 11.9 17.8 18.8 29.9 16.2 19.1 14.5 29.1 18.1 17.7 12.9 23.7 15.4 28.5 14.1 10.1 14.4 11.4 18.9 14.2 18.1 40.6 7.4 28.9 14.2 4.0 3.5 3.4 6.2 5.4 5.6 8.2 6.7 8.1 4.4 6.3 6.4 7.5 4.3 4.0 3.8 4.7 6.3 3.9 14.5 18.9 16.5 17.2 13.9 11.3 18.1 11.3 11.7 18.3 38.7 41.6 33.7 45.3 47.2 27.1 26.6 35.7 33.5 69.4 54.1 35.3 65.8 11.6 61.0 86.4 27.0 20.0 23.3 40.5 94.1 27.3 55.4 23.2 35.0 26.8 19.1 87.9 19.6 24.2 81.6 23.6 30.7 21.9 56.9 60.1 17.9 53.5 20.1 26.9 30.5 30.1 38.8 29.3 55.9 92.0 58.3 60.6 30.5 59.9 48.2 SMARCC2 "BAF170, CRACC2, Rsc8" ENSG00000139613 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2" Q8TAQ2 12 56162983-56189567 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004321, HPA021213, HPA061788" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004321: AB_2286337, HPA021213: AB_1857275, HPA061788: AB_2684608" "unprognostic (7.51e-2)" "unprognostic (1.08e-2)" "unprognostic (9.31e-2)" "unprognostic (4.93e-2)" "unprognostic (1.62e-1)" "unprognostic (1.02e-1)" "unprognostic (1.43e-2)" "unprognostic (1.83e-1)" "unprognostic (1.71e-2)" "unprognostic (2.81e-1)" "unprognostic (1.01e-1)" "unprognostic (1.04e-1)" "unprognostic (2.46e-1)" "unprognostic (1.35e-1)" "unprognostic (2.45e-1)" "unprognostic (6.74e-2)" "unprognostic (8.79e-2)" 25.0 22.2 34.5 17.4 36.5 15.7 22.5 43.7 40.7 24.9 20.4 29.9 17.1 21.5 29.1 16.6 18.2 25.5 18.6 19.0 35.0 22.7 19.8 14.1 21.6 20.9 29.2 24.2 38.4 21.8 36.1 21.1 19.9 27.5 24.6 19.0 26.7 26.1 28.2 32.3 26.8 21.7 27.2 22.6 23.4 20.6 17.7 32.1 21.3 30.2 13.2 23.2 27.5 22.7 8.8 7.0 19.0 12.2 6.2 12.7 9.6 19.6 30.4 32.5 23.4 20.2 21.2 13.5 17.6 18.9 21.3 20.7 17.5 24.7 28.6 17.0 20.5 20.0 22.9 20.9 17.8 19.3 21.8 19.5 45.4 20.6 11.0 10.9 21.3 33.8 19.7 13.4 20.1 10.2 38.5 26.9 22.3 25.8 24.0 19.6 20.6 36.0 19.2 11.0 15.7 20.8 21.4 26.0 22.4 15.9 25.8 24.0 24.9 29.9 20.9 8.1 17.7 35.3 19.0 23.0 18.2 22.3 16.2 12.9 22.8 16.6 20.0 18.9 14.3 19.3 13.7 7.6 19.0 11.9 10.0 12.7 8.6 8.4 8.4 7.0 8.8 6.2 7.8 6.6 6.2 12.2 5.0 8.2 9.6 34.5 36.5 43.7 40.7 35.0 22.7 29.2 24.2 27.5 32.1 62.5 38.7 25.3 36.7 18.2 55.0 23.4 20.4 29.4 47.8 40.1 37.3 16.4 6.6 21.2 1.3 30.1 17.6 0.0 15.7 10.2 22.4 27.0 61.4 14.3 14.3 36.5 21.8 26.4 15.9 2.8 63.9 18.0 18.6 33.3 19.9 50.0 18.7 17.3 51.9 14.2 58.8 19.4 28.4 43.6 29.4 19.7 11.1 32.4 19.9 32.5 SMARCD1 "BAF60A, CRACD1, Rsc6p" ENSG00000066117 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1" Q96GM5 12 50084972-50100712 "Cancer-related genes, Predicted intracellular proteins" Neurogenesis "Chromatin regulator" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004101 Supported Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA004101: AB_1080026" "unprognostic (1.88e-1)" "unprognostic (1.89e-1)" "unprognostic (1.51e-1)" "unprognostic (2.11e-2)" "unprognostic (1.02e-1)" "unprognostic (2.76e-1)" "prognostic unfavorable (2.53e-8)" "unprognostic (3.62e-2)" "unprognostic (1.44e-1)" "unprognostic (4.23e-2)" "unprognostic (1.16e-2)" "unprognostic (2.10e-2)" "unprognostic (1.20e-3)" "unprognostic (2.18e-1)" "unprognostic (3.45e-1)" "unprognostic (1.38e-1)" "unprognostic (5.04e-2)" 21.3 24.5 16.4 22.6 22.7 29.9 21.3 27.8 28.2 19.8 19.9 29.5 17.6 18.8 23.6 23.4 23.3 19.9 18.2 15.6 16.3 13.8 25.1 18.3 19.4 26.1 15.7 20.4 24.7 19.6 44.3 17.8 24.7 18.8 20.4 22.4 20.3 21.4 25.9 16.6 19.7 24.0 23.8 18.5 28.1 17.4 34.4 14.9 64.3 24.3 17.9 36.7 19.3 18.2 6.0 6.7 4.4 3.4 3.1 6.9 2.3 8.1 13.8 40.7 23.5 12.7 12.0 20.2 10.1 18.0 29.9 17.5 37.7 12.8 31.8 15.3 19.4 13.6 10.5 34.3 26.7 25.9 24.6 25.3 31.4 13.9 21.8 15.1 27.7 12.6 12.1 17.9 17.7 32.0 20.1 35.2 34.0 26.5 19.8 15.1 19.1 40.2 14.9 50.8 12.5 22.6 48.3 10.6 27.8 17.0 19.1 21.9 36.6 21.3 10.9 42.5 31.6 24.5 23.3 21.1 15.4 17.3 9.7 20.7 27.9 24.5 28.3 12.5 11.2 17.4 4.4 2.3 4.1 6.1 2.1 5.8 6.0 3.3 3.9 3.6 5.6 2.1 6.9 1.1 3.1 3.4 6.7 5.0 2.3 16.4 22.7 27.8 28.2 16.3 13.8 15.7 20.4 18.8 14.9 0.0 8.1 33.4 17.8 14.7 31.0 5.7 15.3 9.4 25.0 26.2 19.6 17.5 44.7 25.2 3.2 21.0 17.7 0.0 24.9 16.2 12.9 16.7 16.1 12.7 15.1 25.4 29.9 14.1 10.7 6.6 15.3 11.0 16.9 34.3 18.6 26.7 27.6 14.0 15.2 30.4 26.0 32.3 13.3 21.9 31.5 17.1 9.3 16.0 15.7 14.4 SMARCD2 "BAF60B, CRACD2, PRO2451, Rsc6p" ENSG00000108604 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2" Q92925 17 63832081-63843065 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059934, HPA061348" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059934: AB_2684170, HPA061348: AB_2684486" "unprognostic (1.70e-1)" "unprognostic (2.17e-2)" "unprognostic (8.04e-2)" "unprognostic (3.84e-2)" "unprognostic (1.59e-1)" "unprognostic (2.00e-2)" "unprognostic (7.84e-2)" "unprognostic (4.79e-1)" "prognostic unfavorable (3.51e-4)" "unprognostic (4.75e-1)" "unprognostic (1.26e-1)" "unprognostic (1.93e-1)" "prognostic unfavorable (9.94e-4)" "unprognostic (1.81e-2)" "unprognostic (1.26e-1)" "unprognostic (1.79e-3)" "unprognostic (6.80e-2)" 22.0 25.0 6.9 23.1 11.5 21.2 25.6 29.0 12.5 21.7 24.6 14.3 36.5 17.8 17.2 25.8 30.7 22.7 25.9 13.4 8.6 5.3 16.0 21.3 20.1 26.5 15.8 8.9 18.0 42.5 17.3 16.1 33.2 10.1 24.2 18.0 15.0 42.9 30.2 11.1 36.3 25.6 22.1 8.9 26.1 26.4 17.7 13.6 40.6 23.3 23.7 28.0 23.7 22.5 11.0 14.5 13.0 11.6 9.1 13.6 6.7 26.2 17.2 4.6 20.8 29.1 47.6 26.0 9.8 14.7 21.7 14.2 20.1 15.2 30.4 5.7 17.7 8.9 18.0 14.9 22.6 13.7 8.1 35.7 20.7 7.0 29.5 23.9 24.3 23.1 37.0 28.3 11.6 10.3 12.9 17.8 22.4 16.3 18.5 12.9 63.6 38.5 26.1 10.7 42.2 19.7 39.4 16.1 35.1 15.7 20.0 17.4 30.9 12.3 50.9 21.1 15.2 47.0 24.3 11.7 13.8 8.3 12.6 16.9 21.7 16.1 20.6 10.8 24.2 10.0 5.4 11.6 10.6 11.5 10.0 7.6 8.8 12.9 12.3 14.5 11.0 8.6 11.6 13.0 9.1 11.5 12.9 13.6 6.7 6.9 11.5 29.0 12.5 8.6 5.3 15.8 8.9 10.1 13.6 26.8 46.8 21.8 16.6 20.4 10.3 5.0 25.5 22.7 27.3 15.7 5.9 43.2 3.3 14.5 0.8 14.6 27.6 0.0 17.0 34.6 23.0 18.1 13.9 72.9 19.3 11.1 31.8 22.1 34.0 2.4 45.8 19.0 13.5 16.2 38.9 16.7 17.7 31.5 29.0 10.0 11.6 32.3 15.0 13.4 17.9 27.1 44.3 13.8 36.8 16.2 SMARCD3 "BAF60C, CRACD3, Rsc6p" ENSG00000082014 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3" Q6STE5 7 151238764-151277896 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 75.2" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 59.6;Peritubular cells: 83.1;Sertoli cells: 64.7;Smooth muscle cells: 51.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 8.8" "Group enriched" "Detected in many" 6 "dendritic cells: 2.6;granulocytes: 3.1;monocytes: 8.8" "Cell line enhanced" "Detected in many" "AN3-CA: 33.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063955, HPA065517" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063955: AB_2685159, HPA065517: AB_2685500" "unprognostic (1.23e-2)" "unprognostic (2.03e-1)" "prognostic unfavorable (5.50e-4)" "unprognostic (4.38e-3)" "unprognostic (4.67e-1)" "unprognostic (1.41e-3)" "unprognostic (2.24e-2)" "unprognostic (3.52e-2)" "unprognostic (1.63e-1)" "unprognostic (3.50e-1)" "unprognostic (2.08e-3)" "unprognostic (9.18e-2)" "unprognostic (1.02e-1)" "unprognostic (2.05e-3)" "unprognostic (1.34e-1)" "unprognostic (3.35e-3)" "unprognostic (1.29e-1)" 9.7 16.0 34.2 4.0 40.3 4.9 9.8 25.4 36.8 12.9 5.6 7.8 7.9 2.9 8.6 11.4 6.7 14.5 10.7 38.5 22.2 24.7 4.9 2.0 8.3 4.0 18.7 18.8 19.2 7.5 6.8 14.7 4.6 13.3 10.8 3.6 7.6 6.6 18.1 75.2 5.7 3.4 10.0 14.1 4.3 4.8 9.0 11.6 0.0 7.4 9.5 2.5 10.1 4.8 0.2 2.6 3.1 8.8 0.0 0.8 2.1 0.3 2.8 9.4 33.3 15.0 6.7 0.7 6.1 6.2 3.6 2.1 2.1 1.9 3.6 2.2 9.6 1.4 0.6 7.5 0.6 1.4 1.1 4.6 0.0 1.9 0.6 12.9 0.1 6.1 15.9 0.8 1.2 0.1 15.7 0.7 9.3 7.2 1.2 19.0 3.8 0.6 4.7 2.9 0.9 1.2 0.2 14.8 0.1 3.2 0.0 5.4 11.0 5.8 1.0 4.4 1.5 0.8 9.3 1.1 2.3 3.7 7.1 2.0 7.9 0.0 3.0 6.6 8.2 10.3 0.6 8.8 0.0 0.2 1.9 0.1 0.2 0.8 0.0 2.6 0.0 0.5 0.8 3.1 0.0 0.4 0.0 0.7 2.1 34.2 40.3 25.4 27.9 22.2 24.7 18.7 18.8 13.3 11.6 6.0 20.8 0.0 31.9 9.5 12.7 59.6 17.8 6.7 5.7 10.4 3.9 0.4 26.6 14.9 1.8 4.7 0.0 0.0 2.1 0.2 19.3 7.3 2.3 0.4 3.4 11.1 3.4 2.5 17.1 8.9 46.9 6.4 6.8 1.0 0.0 23.4 4.3 0.0 83.1 1.7 4.6 64.7 51.5 1.7 9.5 4.1 0.9 0.9 0.0 8.1 SMARCE1 BAF57 ENSG00000073584 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1" Q969G3 17 40624962-40648864 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" Neurogenesis "Chromatin regulator, DNA-binding" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003916, CAB037318" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB037318: AB_476780, HPA003916: AB_1857279" "unprognostic (7.91e-2)" "unprognostic (2.68e-2)" "unprognostic (2.09e-2)" "unprognostic (8.06e-3)" "unprognostic (1.87e-1)" "unprognostic (2.55e-2)" "unprognostic (4.48e-1)" "unprognostic (1.25e-2)" "unprognostic (2.20e-2)" "unprognostic (1.05e-1)" "unprognostic (2.53e-2)" "unprognostic (2.04e-1)" "unprognostic (9.80e-2)" "unprognostic (5.93e-2)" "unprognostic (7.63e-2)" "unprognostic (1.09e-1)" "unprognostic (1.27e-2)" 25.1 20.2 14.4 17.2 18.8 18.4 20.2 17.0 16.7 37.6 25.1 18.0 12.6 18.4 42.8 19.5 31.0 21.1 20.6 19.6 13.3 12.0 23.0 22.6 20.1 22.3 16.5 14.3 39.5 16.9 13.3 20.4 34.8 15.2 32.4 19.2 17.9 20.6 21.9 32.0 21.3 22.6 33.4 15.8 30.3 19.1 22.0 17.5 53.9 23.8 18.9 25.1 31.2 21.0 40.3 32.0 34.0 30.3 47.2 44.0 39.2 20.7 34.5 42.3 31.5 22.4 32.3 20.8 26.1 36.0 30.7 23.1 22.6 18.0 32.9 37.7 35.2 20.5 28.3 26.2 27.6 36.9 30.8 34.0 23.5 18.6 39.6 22.6 42.9 23.9 28.0 21.8 24.5 35.7 31.0 33.0 26.6 34.2 13.1 29.3 23.3 78.5 8.9 23.6 17.1 17.1 44.0 47.7 25.0 37.0 35.6 33.9 32.8 23.2 67.3 21.7 48.0 40.3 26.9 27.0 25.0 27.5 22.5 32.1 24.6 28.6 49.2 25.4 19.7 38.4 31.8 26.0 34.0 39.1 26.8 40.5 38.4 35.8 40.9 31.3 40.3 30.2 34.9 11.0 47.2 30.3 32.0 44.0 39.2 14.4 18.8 17.0 16.7 13.3 12.0 16.5 14.3 15.2 17.5 44.7 30.1 53.5 36.0 33.9 46.7 46.8 38.2 73.6 60.3 19.2 15.7 85.1 13.3 34.9 18.3 60.7 37.1 23.3 27.8 65.4 59.9 34.1 70.6 38.4 44.7 77.9 92.7 48.5 34.8 7.7 83.7 37.7 23.6 49.5 51.9 65.5 27.8 51.0 77.4 21.6 34.7 38.8 52.6 40.8 46.0 35.0 96.0 60.9 54.8 33.5 SMC1A "DXS423E, KIAA0178, SB1.8, SMC1L1, Smcb" ENSG00000072501 "Structural maintenance of chromosomes 1A" Q14683 X 53374149-53422728 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005499, CAB025404" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB025404: , HPA005499: AB_1080028" "unprognostic (2.00e-1)" "unprognostic (1.52e-1)" "unprognostic (4.00e-2)" "unprognostic (5.76e-2)" "unprognostic (1.04e-1)" "unprognostic (9.89e-2)" "unprognostic (1.29e-3)" "unprognostic (1.89e-1)" "unprognostic (9.80e-3)" "unprognostic (9.49e-2)" "unprognostic (4.48e-2)" "unprognostic (6.55e-2)" "unprognostic (2.58e-1)" "unprognostic (4.18e-3)" "unprognostic (6.28e-2)" "unprognostic (2.89e-1)" "unprognostic (9.39e-2)" 20.6 14.1 14.6 24.2 28.2 24.6 16.2 33.6 21.7 19.9 18.2 22.0 10.5 16.2 27.5 10.0 22.4 21.7 12.5 16.2 16.8 10.8 19.2 23.5 15.4 30.2 25.2 13.0 21.8 17.2 31.0 18.4 19.5 18.0 13.4 17.3 12.5 16.8 12.9 24.3 16.2 19.7 21.7 21.3 20.1 17.5 10.4 25.8 38.3 16.8 11.1 25.7 22.0 21.3 14.3 15.5 13.7 18.7 15.6 17.8 10.6 28.3 31.8 25.3 21.5 9.3 10.4 14.2 17.2 11.3 21.8 17.7 18.8 16.5 27.7 14.7 11.4 30.1 21.7 45.0 24.8 24.4 23.7 52.5 24.2 36.9 13.1 3.8 34.1 34.8 5.8 6.4 24.4 14.9 5.6 18.8 18.3 35.5 17.9 17.0 17.2 30.7 10.3 37.5 12.3 17.0 33.0 43.6 25.5 9.2 18.7 26.9 22.7 44.9 22.1 9.5 34.6 23.8 13.9 10.5 18.6 19.7 18.3 16.6 11.7 19.8 25.7 10.6 38.8 18.1 6.1 13.8 13.7 17.8 18.7 17.0 12.2 12.0 15.6 15.5 14.3 14.2 10.9 9.4 15.6 17.4 12.9 8.8 10.6 14.6 28.2 33.6 21.7 16.8 10.8 25.2 13.0 18.0 25.8 41.7 29.9 35.6 26.7 21.4 44.7 48.0 30.6 56.2 61.4 19.2 25.5 30.6 6.6 27.7 8.7 31.0 31.4 23.3 23.5 52.5 23.8 28.7 33.6 48.7 42.3 57.2 19.1 19.6 33.4 5.8 35.1 40.8 21.9 37.9 35.3 40.8 26.4 14.0 33.9 20.3 44.9 38.8 37.0 17.9 54.6 21.3 40.5 27.7 41.7 25.8 SMC1B "bK268H5, SMC1L2" ENSG00000077935 "Structural maintenance of chromosomes 1B" Q8NDV3 22 45344063-45413619 "Predicted intracellular proteins" "Cell cycle, Meiosis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 46 "testis: 35.4" "Group enriched" "Detected in some" 5 "Spermatocytes: 487.9;Spermatogonia: 418.0" "Cancer enriched" "Detected in many" 6 "cervical cancer: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 9.2;EFO-21: 4.4;SiHa: 19.1;U-266/70: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA001500 Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA001500: AB_1080030" "unprognostic (1.18e-2)" "unprognostic (6.16e-3)" "unprognostic (2.22e-1)" "unprognostic (3.38e-3)" "unprognostic (1.77e-1)" "unprognostic (3.21e-2)" "unprognostic (6.18e-2)" "unprognostic (1.87e-3)" "unprognostic (3.41e-2)" "unprognostic (3.65e-1)" "unprognostic (4.49e-2)" "unprognostic (3.79e-1)" "unprognostic (3.83e-9)" "unprognostic (2.10e-1)" "unprognostic (1.11e-2)" "unprognostic (1.78e-1)" "unprognostic (1.98e-3)" 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 35.4 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.7 0.2 0.0 0.5 0.0 9.2 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.8 0.1 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.2 0.2 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.4 0.2 0.1 0.0 19.1 0.1 0.0 0.0 0.1 1.6 0.1 0.0 0.0 0.5 0.0 4.3 0.0 0.0 0.0 0.3 2.0 0.0 0.2 0.7 0.4 0.0 0.4 0.0 0.2 0.5 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.7 0.0 0.0 0.1 0.1 0.1 0.3 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 63.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.3 28.8 5.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 3.2 0.0 1.0 97.0 0.0 487.9 418.0 0.0 0.7 0.0 0.0 0.1 SMC2 "CAP-E, hCAP-E, SMC2L1" ENSG00000136824 "Structural maintenance of chromosomes 2" O95347 9 104094260-104141417 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 56.1" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 96.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071309 Approved Supported Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA071309: AB_2686385" "unprognostic (1.51e-1)" "unprognostic (2.01e-3)" "unprognostic (2.26e-2)" "unprognostic (2.23e-2)" "unprognostic (3.04e-1)" "unprognostic (1.05e-1)" "unprognostic (5.57e-3)" "unprognostic (2.59e-3)" "unprognostic (1.47e-2)" "unprognostic (4.35e-1)" "unprognostic (1.24e-2)" "unprognostic (1.01e-1)" "unprognostic (5.56e-3)" "unprognostic (8.02e-3)" "unprognostic (1.65e-1)" "unprognostic (1.12e-1)" "unprognostic (1.32e-2)" 7.4 6.1 6.6 10.1 10.5 15.2 6.1 8.1 9.1 7.9 7.5 4.0 5.1 7.0 6.1 5.2 11.4 5.1 3.6 7.1 6.5 6.8 8.6 5.7 5.5 14.2 8.2 5.2 6.0 4.1 5.2 6.5 7.5 10.7 5.2 8.5 3.0 5.9 4.7 4.2 6.8 6.9 5.4 8.6 13.7 5.9 12.3 8.7 56.1 7.2 12.9 14.7 6.1 6.3 8.9 5.1 12.0 8.3 8.0 7.4 2.8 18.3 14.2 16.0 14.8 3.4 5.0 15.0 17.0 8.1 15.3 12.9 12.3 14.3 35.2 8.3 8.7 13.2 31.2 23.1 11.0 20.7 22.3 9.7 21.2 22.7 7.9 0.9 12.8 21.4 3.2 2.3 20.7 8.4 5.2 10.8 22.7 17.0 29.0 13.8 8.9 33.3 6.6 13.8 14.9 11.2 22.3 45.9 13.2 6.5 6.7 15.1 11.7 20.3 9.5 5.0 7.0 19.1 8.7 8.6 18.6 19.6 25.7 21.2 10.6 35.7 20.6 12.1 18.8 22.5 12.0 2.8 2.8 6.2 7.1 7.0 8.5 5.7 6.2 3.0 8.9 6.7 7.4 0.4 8.0 8.3 5.1 6.9 2.8 6.6 10.5 8.1 9.1 6.5 6.8 8.2 5.2 10.7 8.7 23.8 11.0 20.1 9.5 24.3 34.1 38.9 7.6 10.7 14.8 15.7 7.9 30.9 29.9 16.5 27.3 15.5 6.5 0.0 17.9 78.9 14.2 5.9 21.9 6.8 37.8 27.0 4.7 19.6 12.1 20.4 17.3 20.0 6.8 27.1 11.4 14.5 14.2 7.0 11.7 13.3 18.4 12.9 17.5 56.4 96.0 20.3 21.6 14.9 24.7 6.7 SMC3 "BAM, bamacan, CSPG6, HCAP, SMC3L1" ENSG00000108055 "Structural maintenance of chromosomes 3" Q9UQE7 10 110567691-110604636 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Sertoli cells: 181.1;Spermatocytes: 507.2;Spermatogonia: 682.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037411, HPA043206" Uncertain Supported Nucleoplasm NA NA 10000000 Nucleoplasm "HPA037411: AB_10671753, HPA043206: AB_2678362" "unprognostic (3.40e-1)" "unprognostic (1.73e-2)" "unprognostic (9.05e-2)" "unprognostic (3.00e-2)" "unprognostic (3.73e-2)" "unprognostic (8.89e-3)" "unprognostic (9.74e-3)" "unprognostic (8.06e-2)" "unprognostic (5.31e-2)" "unprognostic (6.32e-2)" "unprognostic (3.53e-2)" "unprognostic (1.17e-2)" "unprognostic (8.73e-3)" "unprognostic (7.22e-2)" "unprognostic (5.18e-2)" "unprognostic (7.95e-2)" "unprognostic (1.32e-1)" 17.1 13.4 16.8 15.4 22.9 32.7 21.3 37.8 18.0 19.2 15.1 9.9 10.7 13.3 20.1 14.3 19.7 15.6 9.9 11.9 16.7 11.2 16.6 17.2 12.6 23.7 18.6 15.4 26.5 18.4 22.2 36.6 22.9 17.7 14.6 15.1 8.8 15.3 14.3 18.4 18.4 18.8 19.6 22.2 18.1 13.5 32.0 23.2 47.4 19.4 11.4 20.8 20.7 19.7 13.2 11.0 19.1 10.5 15.1 17.7 7.4 27.3 17.1 37.2 26.4 12.4 10.7 16.1 22.2 22.1 20.5 20.2 21.5 23.1 35.6 9.7 14.8 15.8 21.8 26.6 13.4 31.4 29.1 22.9 28.8 21.6 19.3 12.5 40.8 22.3 8.4 11.0 22.7 35.8 19.1 15.1 12.2 22.9 27.6 17.7 14.3 31.4 21.7 25.6 14.6 13.7 26.7 67.4 19.3 12.7 12.2 21.2 24.3 23.9 6.9 18.2 25.4 11.1 20.0 15.4 16.6 26.2 18.6 31.9 16.1 14.3 38.7 14.8 39.5 13.5 19.1 7.7 18.6 13.0 10.5 16.1 13.2 15.1 14.0 8.4 13.1 15.5 15.1 8.4 15.1 8.9 11.0 17.7 7.4 16.8 22.9 37.8 18.0 16.7 11.2 18.6 15.4 17.7 23.2 74.5 53.1 60.6 45.3 53.8 75.4 47.3 28.1 87.0 72.8 52.4 70.7 92.8 21.6 81.3 36.8 60.7 29.7 46.7 39.8 102.4 54.0 32.7 54.4 25.2 51.1 57.2 39.0 35.6 33.5 26.9 106.7 45.1 35.4 99.2 34.6 52.6 45.0 30.8 107.1 25.1 76.1 181.1 50.5 507.2 682.8 56.3 41.1 65.4 42.0 32.5 SMC6 "FLJ22116, SMC6L1" ENSG00000163029 "Structural maintenance of chromosomes 6" Q96SB8 2 17663812-17800242 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 102.7;Spermatocytes: 151.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035057, CAB037186, HPA042733" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "CAB037186: AB_1080031, HPA035057: AB_2674435, HPA042733: AB_2678134" "unprognostic (1.75e-1)" "unprognostic (1.08e-1)" "unprognostic (1.50e-2)" "unprognostic (1.33e-3)" "unprognostic (1.70e-2)" "unprognostic (6.57e-2)" "unprognostic (1.38e-2)" "unprognostic (3.91e-2)" "unprognostic (2.03e-2)" "unprognostic (2.94e-3)" "unprognostic (9.33e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (3.15e-4)" "unprognostic (7.02e-2)" "unprognostic (1.57e-1)" "unprognostic (1.25e-1)" "unprognostic (5.25e-2)" 9.5 5.2 6.9 16.3 10.9 10.0 13.2 10.3 9.5 10.3 10.0 5.6 7.6 7.6 9.2 15.8 16.4 7.8 8.1 9.7 7.1 7.5 10.5 16.8 8.2 17.9 8.9 5.0 9.7 6.8 7.0 29.6 12.2 11.4 8.1 11.8 22.8 14.0 13.5 10.4 12.5 12.5 7.6 9.3 19.4 8.4 28.8 11.3 16.0 8.2 13.8 18.7 8.4 12.6 18.4 17.3 5.0 3.9 4.4 8.8 2.4 21.4 10.8 14.1 11.7 15.3 14.8 14.4 11.5 8.2 7.5 7.3 12.0 8.5 18.8 7.4 10.5 12.4 15.1 16.9 13.5 11.6 22.2 11.1 25.8 6.8 18.0 14.3 17.8 14.0 11.0 9.6 12.0 15.8 9.2 17.1 11.6 28.3 15.7 14.0 8.8 13.7 9.2 19.2 10.8 8.6 16.5 40.1 12.7 7.2 12.0 12.5 13.4 16.7 8.8 12.8 16.4 5.6 8.0 18.5 18.6 7.4 14.4 20.3 11.2 18.0 38.1 9.4 19.7 13.2 1.2 2.4 5.0 5.3 2.6 4.4 15.5 4.1 4.7 3.2 18.4 2.9 4.0 2.0 4.4 3.9 17.3 8.8 2.4 6.9 10.9 10.3 9.5 7.1 7.5 8.9 5.0 11.4 11.3 44.7 12.2 42.7 18.1 16.3 14.4 32.5 12.7 24.1 30.7 5.2 11.8 10.1 10.0 14.1 102.7 13.5 13.4 23.3 10.1 25.1 18.5 10.8 19.7 17.1 15.6 6.4 10.9 15.4 7.3 93.4 20.8 18.7 25.3 22.6 14.5 16.1 13.6 14.4 25.8 13.2 17.4 45.3 27.8 151.3 91.9 12.4 10.4 21.0 18.4 12.9 SMCHD1 "FSHD2, KIAA0650" ENSG00000101596 "Structural maintenance of chromosomes flexible hinge domain containing 1" A6NHR9 18 2655738-2805017 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Chromatin regulator, DNA-binding, Hydrolase" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 30.3" "Lineage enriched" "Detected in all" 7 "granulocytes: 30.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039441 Approved Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA039441: AB_10671042" "unprognostic (2.99e-2)" "unprognostic (5.14e-2)" "unprognostic (1.33e-2)" "unprognostic (9.03e-2)" "unprognostic (8.66e-2)" "unprognostic (1.36e-2)" "prognostic unfavorable (5.39e-4)" "unprognostic (1.32e-1)" "unprognostic (4.14e-2)" "unprognostic (3.11e-3)" "unprognostic (3.32e-2)" "unprognostic (2.70e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.35e-1)" "unprognostic (1.00e-1)" "unprognostic (8.92e-2)" "unprognostic (2.63e-2)" 19.8 8.1 9.1 29.9 11.1 35.6 17.2 18.0 11.3 21.9 17.3 8.2 16.0 13.7 19.2 12.3 12.4 15.6 13.3 12.6 8.3 8.0 9.3 10.2 21.5 31.3 12.7 8.6 20.0 21.2 15.9 14.8 16.2 9.4 15.6 15.3 11.6 14.0 14.0 12.9 10.8 23.7 23.1 9.8 32.0 14.0 13.7 11.5 34.4 12.1 9.6 22.1 25.7 23.5 4.1 1.2 30.3 1.2 1.1 3.2 0.5 10.9 5.0 17.0 10.6 7.3 10.7 12.2 11.0 7.9 10.5 13.4 9.3 3.6 23.7 4.9 9.8 11.8 6.0 13.7 6.3 16.6 4.8 7.1 14.8 9.8 8.9 8.2 42.4 11.6 7.0 5.8 13.3 11.0 8.1 8.6 11.9 17.2 14.8 10.0 3.9 17.7 10.9 6.8 5.9 5.8 14.5 13.8 10.4 6.5 16.9 14.0 8.8 14.9 5.0 8.6 9.9 3.7 18.1 8.1 13.0 18.0 17.6 20.2 9.0 13.5 21.7 8.4 7.9 11.3 1.9 1.2 3.1 1.9 0.8 1.4 2.9 2.5 2.2 0.4 4.1 3.2 2.0 30.3 1.1 1.1 1.2 2.5 0.5 9.1 11.1 18.0 11.3 8.3 8.0 12.7 8.6 9.4 11.5 41.7 46.8 107.2 33.5 24.2 88.8 43.9 12.7 22.7 35.2 17.4 94.2 30.4 5.0 20.1 88.0 41.1 49.1 23.3 16.7 19.9 31.9 43.1 38.3 13.9 17.4 93.8 21.8 28.8 68.9 26.8 38.9 61.6 28.7 64.1 29.6 37.0 20.6 59.6 35.7 6.3 91.7 38.8 36.3 85.4 79.0 21.8 39.2 79.1 25.5 40.9 SMCR8 FLJ34716 ENSG00000176994 "Smith-Magenis syndrome chromosome region, candidate 8" Q8TEV9 17 18315310-18328055 "Predicted intracellular proteins" "Autophagy, Transcription, Transcription regulation" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021557, HPA024646" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021557: AB_1857283, HPA024646: AB_1857284" "unprognostic (1.69e-1)" "unprognostic (2.25e-1)" "unprognostic (1.78e-1)" "unprognostic (4.69e-2)" "unprognostic (1.07e-1)" "unprognostic (4.34e-3)" "unprognostic (2.11e-3)" "unprognostic (3.02e-2)" "unprognostic (3.18e-1)" "unprognostic (1.48e-2)" "unprognostic (5.09e-3)" "unprognostic (7.11e-2)" "prognostic favorable (1.35e-4)" "unprognostic (9.41e-3)" "unprognostic (4.35e-2)" "unprognostic (1.55e-2)" "unprognostic (9.27e-2)" 10.4 10.0 6.1 11.1 11.4 25.0 10.5 13.9 15.8 8.7 8.5 11.2 10.6 8.0 12.2 6.9 10.4 9.1 7.8 7.3 7.2 6.3 9.6 7.9 10.7 12.4 6.7 5.7 10.8 9.6 14.0 17.1 11.6 9.3 9.7 9.3 12.0 13.6 7.9 13.3 10.4 13.0 7.9 7.1 16.1 10.9 8.8 8.8 15.8 9.5 4.7 15.8 12.5 10.9 1.1 1.2 5.2 2.2 1.1 1.2 0.9 5.8 8.1 4.1 4.7 5.8 3.9 7.5 4.2 5.6 7.4 7.2 12.4 2.5 3.4 3.2 5.1 8.4 7.8 8.0 4.9 6.9 7.0 6.8 6.4 8.1 3.5 6.2 2.5 15.9 4.9 6.4 8.5 5.4 4.9 5.3 5.0 5.3 3.3 4.4 3.5 4.2 3.7 3.9 7.5 3.4 4.7 10.5 5.4 3.4 6.7 2.2 5.0 4.7 6.1 9.0 22.6 12.4 5.1 5.2 4.3 5.2 11.1 5.5 5.0 5.6 1.8 5.9 4.0 4.3 5.2 1.7 1.5 1.0 1.2 0.9 1.1 0.8 1.1 1.2 0.8 1.2 1.1 2.1 1.1 2.2 1.0 0.7 0.9 6.1 11.4 13.9 15.8 7.2 6.3 6.7 5.7 9.3 8.8 6.0 11.2 3.2 2.9 0.3 7.2 2.8 5.1 4.0 10.3 10.4 2.0 3.2 0.0 4.4 2.9 4.5 4.3 0.0 4.7 2.5 3.0 4.9 8.1 4.9 7.5 6.4 3.5 11.1 15.5 1.5 3.7 8.3 0.0 7.2 8.7 2.7 5.5 3.5 3.9 5.7 6.0 0.0 2.8 6.7 7.0 0.5 5.0 5.0 6.3 5.7 SMDT1 "C22orf32, DDDD, dJ186O1.1, EMRE" ENSG00000183172 "Single-pass membrane protein with aspartate rich tail 1" Q9H4I9 22 42079691-42084284 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032117, HPA060340" Uncertain Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA032117: AB_10601093, HPA060340: AB_2684257" "unprognostic (1.11e-2)" "unprognostic (1.46e-3)" "unprognostic (5.77e-2)" "prognostic favorable (5.32e-8)" "unprognostic (1.25e-1)" "unprognostic (2.40e-1)" "unprognostic (1.03e-1)" "unprognostic (2.07e-2)" "unprognostic (2.55e-1)" "unprognostic (4.84e-2)" "prognostic favorable (5.87e-4)" "unprognostic (2.96e-1)" "prognostic favorable (2.36e-9)" "unprognostic (1.91e-1)" "unprognostic (2.65e-1)" "unprognostic (1.45e-1)" "unprognostic (9.72e-3)" 8.7 12.3 20.3 14.6 18.0 15.3 19.9 19.5 17.9 15.2 12.9 10.2 14.7 11.0 13.0 20.2 16.4 15.7 10.7 21.3 15.8 16.2 14.1 18.4 10.1 14.4 16.3 12.4 23.2 21.6 11.3 12.9 9.8 9.9 16.4 12.1 15.5 37.0 15.9 26.4 10.4 18.0 9.8 13.3 10.6 12.9 10.9 7.9 15.2 23.4 18.7 16.1 14.9 16.9 5.4 5.0 2.3 3.5 2.9 5.9 3.0 2.2 1.5 3.1 3.7 5.7 4.1 2.4 0.8 4.1 5.1 4.4 2.9 2.2 5.8 1.0 4.3 1.4 2.6 4.0 4.3 3.3 1.5 6.6 1.9 3.2 4.1 7.1 3.5 2.5 3.2 7.3 2.0 4.3 2.9 5.0 2.1 3.1 5.1 3.5 5.9 4.9 5.3 1.1 5.7 3.3 4.3 2.7 8.4 6.4 2.6 3.8 2.5 2.0 4.6 5.0 1.6 3.9 3.8 2.0 2.2 2.4 1.9 1.5 3.5 3.8 6.9 3.3 3.4 1.6 2.3 3.5 1.6 2.7 1.7 3.7 3.7 5.4 2.8 5.0 5.4 5.9 3.9 0.3 2.9 2.5 3.8 3.0 3.0 20.3 18.0 19.5 17.9 15.8 16.2 16.3 12.4 9.9 7.9 77.4 85.3 270.8 168.6 148.1 59.5 296.6 234.4 179.3 92.1 193.7 19.6 251.6 485.7 138.8 92.3 121.8 346.2 0.0 174.6 167.3 105.2 269.9 91.0 309.5 220.1 52.4 331.5 110.5 164.5 80.6 175.2 186.8 200.8 116.4 276.7 86.2 148.7 295.1 140.0 446.7 82.0 122.9 137.7 196.7 54.5 239.6 258.2 167.5 271.3 230.0 SMG1 "ATX, KIAA0421, LIP" ENSG00000157106 "SMG1, nonsense mediated mRNA decay associated PI3K related kinase" Q96Q15 16 18804853-18926454 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Nonsense-mediated mRNA decay" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006870, HPA031623, HPA073972" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA006870: AB_1079725, HPA031623: AB_2673962, HPA073972: AB_2686648" "unprognostic (6.34e-2)" "unprognostic (5.88e-2)" "unprognostic (5.98e-2)" "unprognostic (2.66e-1)" "unprognostic (2.44e-2)" "unprognostic (1.35e-2)" "unprognostic (1.03e-1)" "unprognostic (2.28e-1)" "unprognostic (1.22e-1)" "unprognostic (2.42e-1)" "unprognostic (8.32e-3)" "unprognostic (7.28e-2)" "unprognostic (1.05e-1)" "unprognostic (2.61e-2)" "unprognostic (1.15e-1)" "unprognostic (3.17e-2)" "unprognostic (2.45e-2)" 4.7 3.0 2.1 4.5 3.5 11.7 6.2 13.2 3.0 4.4 4.5 3.1 5.4 5.1 5.5 4.0 3.0 4.5 2.3 2.2 4.6 5.4 4.1 6.2 2.3 6.3 4.5 7.2 3.9 3.1 4.2 5.0 4.7 3.3 21.1 14.4 5.0 3.9 3.4 4.5 4.3 4.0 6.0 5.8 5.2 4.9 7.1 4.6 19.1 5.6 2.3 6.1 1.0 23.5 15.8 14.9 10.5 17.1 18.1 11.1 11.0 10.9 12.0 13.5 13.9 8.7 32.5 15.9 15.3 12.7 13.4 17.1 9.6 19.2 20.9 10.7 14.8 13.9 17.7 13.9 19.9 11.7 10.6 16.3 24.9 30.0 11.9 16.8 17.7 22.7 18.1 13.2 12.6 13.7 11.9 15.9 8.6 9.1 15.9 20.1 11.1 10.4 18.5 13.5 10.4 17.1 11.6 12.1 12.8 9.3 12.7 21.2 18.1 12.1 11.1 16.3 9.3 12.0 21.4 12.0 15.5 10.8 19.1 2.5 3.4 6.1 2.8 2.9 3.7 4.0 4.3 2.5 7.1 5.4 4.7 7.6 2.3 5.6 4.6 3.7 1.0 71.5 85.2 53.9 67.9 171.7 51.1 42.5 20.4 48.2 92.1 26.2 70.7 16.8 3.3 19.5 15.5 65.3 48.7 23.3 20.4 15.0 55.9 71.2 38.1 39.9 21.0 39.7 37.7 36.8 38.1 15.4 27.6 61.1 37.1 36.1 38.6 20.1 26.6 57.5 24.8 12.2 43.3 45.3 56.7 45.2 29.8 178.7 25.1 60.7 35.2 83.0 SMG8 "C17orf71, FLJ10587, FLJ23205" ENSG00000167447 "SMG8, nonsense mediated mRNA decay factor" Q8ND04 17 59209400-59215247 "Predicted intracellular proteins, Predicted membrane proteins" "Nonsense-mediated mRNA decay" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 5.3;granulocytes: 5.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024841 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA024841: AB_10600790" "unprognostic (2.68e-2)" "unprognostic (1.22e-1)" "unprognostic (6.51e-3)" "unprognostic (9.91e-2)" "unprognostic (8.59e-2)" "unprognostic (1.35e-2)" "prognostic unfavorable (3.72e-5)" "unprognostic (1.91e-1)" "unprognostic (1.15e-1)" "unprognostic (1.83e-1)" "unprognostic (3.18e-3)" "unprognostic (4.65e-2)" "unprognostic (9.37e-2)" "unprognostic (4.31e-2)" "unprognostic (1.55e-1)" "unprognostic (1.75e-1)" "unprognostic (2.75e-1)" 14.7 17.9 11.9 9.4 15.1 15.0 13.8 14.5 19.8 12.9 9.6 15.4 14.8 9.2 15.9 11.7 13.9 14.1 8.1 11.5 11.3 13.2 11.6 12.5 9.9 13.6 12.3 13.3 19.0 11.4 13.8 12.8 18.5 16.1 11.7 9.7 13.2 12.7 11.9 13.7 13.3 11.3 11.8 9.8 15.9 11.9 18.3 11.6 24.2 13.3 9.0 15.5 12.0 9.2 7.8 10.8 15.3 17.8 7.0 7.9 6.2 10.5 15.0 11.9 11.8 14.9 12.6 16.0 15.3 15.8 21.6 18.8 10.1 9.4 15.5 24.1 14.6 16.9 12.8 18.9 14.3 20.9 20.5 18.0 17.7 8.7 14.5 17.1 17.2 15.4 16.4 17.7 15.7 11.8 14.4 14.1 9.9 21.4 8.2 14.8 23.4 16.7 8.0 11.6 15.3 14.7 11.2 17.6 14.6 10.2 7.6 10.4 17.0 10.7 5.9 12.7 15.5 18.1 12.2 13.5 8.2 18.7 8.8 13.7 16.5 22.9 18.2 10.4 9.2 13.3 15.3 14.2 6.6 6.7 17.8 7.9 7.8 6.2 6.3 10.8 4.8 6.3 5.6 3.4 7.0 17.6 3.6 5.8 6.2 11.9 15.1 14.5 19.8 11.3 13.2 12.3 13.3 16.1 11.6 3.0 1.6 0.0 0.2 0.6 0.6 0.8 0.0 5.3 2.3 0.0 0.0 0.9 0.0 2.4 0.2 0.5 1.0 0.0 2.3 0.8 0.4 0.2 5.7 0.8 0.7 3.2 1.7 1.3 1.6 0.0 0.9 0.4 0.0 2.8 0.7 0.7 3.0 3.5 0.7 0.5 0.8 0.0 0.4 1.1 0.9 0.5 1.1 1.0 1.2 0.3 SMIM13 C6orf228 ENSG00000224531 "Small integral membrane protein 13" P0DJ93 6 11094033-11138733 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.4" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 66.6;Syncytiotrophoblasts: 54.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065706 Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus" NA NA "Nucleoplasm, Nuclear membrane, Golgi apparatus" "HPA065706: AB_2685539" "unprognostic (6.89e-2)" "unprognostic (1.22e-1)" "unprognostic (1.58e-1)" "unprognostic (7.11e-3)" "unprognostic (4.01e-1)" "unprognostic (2.57e-1)" "unprognostic (3.59e-2)" "unprognostic (2.10e-2)" "unprognostic (2.15e-1)" "unprognostic (6.66e-2)" "unprognostic (1.30e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (1.03e-5)" "unprognostic (1.04e-2)" "unprognostic (2.76e-1)" "unprognostic (9.22e-2)" "unprognostic (3.45e-2)" 5.7 4.2 7.5 2.8 13.0 2.0 4.5 13.3 26.4 4.3 3.2 7.7 1.1 3.1 4.6 3.2 8.5 3.0 3.7 5.7 6.5 2.8 3.9 8.7 5.2 2.3 9.5 8.3 3.8 3.2 7.6 2.8 11.4 14.3 4.3 3.3 2.8 5.3 4.6 9.1 13.7 3.9 4.7 4.9 5.1 3.4 9.4 8.1 1.7 3.9 2.1 2.6 3.3 4.9 0.5 2.4 1.3 0.4 1.2 1.0 0.4 5.7 5.0 7.8 6.5 8.1 9.2 8.1 16.2 7.0 8.4 9.4 6.6 1.9 7.3 22.1 5.2 8.3 5.1 16.1 5.7 15.1 4.0 11.7 7.5 5.6 5.2 10.8 13.9 1.8 11.0 15.9 8.6 11.3 6.6 8.8 6.6 10.6 3.0 15.8 3.2 5.9 8.1 3.6 3.9 4.4 7.9 14.3 10.1 5.1 4.6 18.1 10.0 3.4 11.2 18.9 11.3 2.7 5.8 12.5 12.7 9.2 5.2 10.8 5.6 18.7 10.4 3.0 5.9 19.4 1.3 0.3 0.3 1.0 0.4 0.8 0.5 0.4 0.5 0.6 0.3 0.1 0.9 0.1 1.2 0.3 2.4 0.6 0.4 7.5 13.0 13.3 19.6 6.5 2.8 9.5 8.3 14.3 8.1 11.9 1.0 11.2 14.5 66.6 17.0 10.5 5.1 1.4 2.3 10.4 19.6 24.9 3.3 4.9 6.3 10.5 4.0 0.0 6.5 30.2 12.4 11.5 10.4 20.8 12.3 28.6 3.5 7.4 5.3 3.8 2.6 9.5 15.1 4.6 6.9 7.1 7.9 3.5 3.9 6.6 13.9 0.0 10.3 11.3 17.0 34.5 54.5 6.9 7.4 14.0 SMIM18 ENSG00000253457 "Small integral membrane protein 18" P0DKX4 8 30638600-30646064 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 18.8;pituitary gland: 10.7" "Cell type enhanced" "Detected in some" 23 "Bipolar cells: 9.9;Horizontal cells: 4.8;Rod photoreceptor cells: 2.7" "Cancer enriched" "Detected in single" 8 "glioma: 1.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 14.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066648 Supported Uncertain Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA066648: AB_2685697" "unprognostic (2.19e-2)" "unprognostic (9.37e-2)" "unprognostic (3.31e-1)" "unprognostic (4.24e-2)" "unprognostic (1.66e-1)" "unprognostic (2.60e-1)" "unprognostic (7.29e-2)" "unprognostic (4.70e-1)" "unprognostic (8.91e-3)" "unprognostic (1.05e-1)" "unprognostic (2.36e-1)" "unprognostic (6.08e-2)" "unprognostic (4.01e-3)" "unprognostic (1.33e-1)" "unprognostic (3.25e-1)" "unprognostic (4.14e-1)" 0.6 3.2 5.2 0.7 6.6 2.7 0.6 18.8 18.7 0.6 0.7 0.4 0.0 0.6 0.7 0.6 0.7 0.7 0.8 0.9 10.9 10.7 2.9 0.7 0.6 0.6 5.7 7.5 0.7 1.8 0.6 10.7 0.6 11.7 0.7 0.8 0.2 0.6 0.6 0.6 0.7 0.7 0.6 4.6 0.7 0.8 0.7 1.4 0.0 0.7 0.0 0.6 0.6 0.0 2.9 4.1 3.0 2.3 0.2 4.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.5 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 1.4 0.0 0.0 0.0 3.0 1.9 1.9 3.7 1.3 3.6 2.9 2.3 2.1 0.9 2.9 3.0 4.3 2.1 0.2 2.3 4.1 2.9 0.3 5.2 6.6 18.8 9.7 10.9 10.7 5.7 7.5 11.7 1.4 0.0 0.0 0.0 0.0 0.0 9.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM2 "C13orf44, MGC5590" ENSG00000139656 "Small integral membrane protein 2" Q9BVW6 13 44143543-44161257 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 15.9" "Cell type enriched" "Detected in some" 8 "Early spermatids: 36.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+: 4.4;OE19: 12.1" "Low region specificity" "Detected in many" "HPA026891, HPA077071" Enhanced Uncertain "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA026891: AB_10602924, HPA077071: " "unprognostic (4.34e-2)" "unprognostic (8.70e-2)" "unprognostic (1.07e-1)" "unprognostic (4.87e-5)" "unprognostic (2.40e-1)" "unprognostic (1.68e-1)" "unprognostic (3.26e-1)" "unprognostic (1.26e-1)" "unprognostic (2.32e-1)" "unprognostic (1.85e-2)" "unprognostic (2.75e-2)" "unprognostic (3.11e-1)" "unprognostic (1.00e-1)" "unprognostic (2.10e-1)" "unprognostic (4.80e-2)" "unprognostic (2.39e-2)" "unprognostic (1.05e-2)" 0.1 0.1 0.2 0.0 0.3 0.0 0.1 0.1 0.2 0.2 0.8 0.9 0.1 2.9 0.1 0.2 0.3 1.2 0.2 0.2 0.9 0.4 0.1 0.0 0.2 0.1 0.7 0.0 0.3 0.2 0.2 0.0 0.6 0.0 1.0 0.1 2.2 0.2 0.2 0.1 0.4 15.9 0.1 0.0 0.2 0.1 0.5 0.0 0.0 0.2 1.8 0.4 0.0 0.9 0.8 0.9 0.2 0.0 0.0 1.1 0.0 4.4 1.0 0.0 1.5 0.2 1.7 1.1 0.0 1.2 2.7 0.0 1.7 1.2 0.0 1.7 0.0 1.9 0.0 1.7 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.2 1.1 0.0 0.7 12.1 1.2 1.0 0.0 0.2 0.0 0.5 2.3 1.2 3.4 1.5 2.2 1.9 0.0 0.2 0.4 0.0 0.8 1.2 0.2 0.0 0.0 0.7 1.3 0.4 0.8 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.3 0.0 0.0 0.5 0.0 0.1 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.5 0.0 0.0 0.0 SMIM20 "C4orf52, MITRAC7, PNX" ENSG00000250317 "Small integral membrane protein 20" Q8N5G0 4 25861830-25929874 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016552 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA016552: AB_1859536" "unprognostic (1.18e-1)" "unprognostic (3.73e-2)" "unprognostic (1.78e-1)" "unprognostic (6.52e-3)" "unprognostic (1.55e-2)" "unprognostic (2.12e-1)" "unprognostic (1.20e-3)" "unprognostic (7.01e-2)" "unprognostic (2.46e-1)" "unprognostic (1.02e-1)" "unprognostic (5.42e-2)" "unprognostic (2.86e-1)" "prognostic favorable (8.97e-5)" "unprognostic (5.51e-2)" "unprognostic (5.84e-2)" "unprognostic (1.53e-1)" "unprognostic (5.12e-3)" 14.9 20.5 21.8 15.6 26.7 7.1 25.0 11.4 28.0 12.9 16.4 8.3 12.8 24.1 13.7 46.4 11.9 15.1 22.5 33.7 17.9 16.2 27.1 22.7 18.5 26.0 19.2 14.3 19.5 50.0 8.7 10.0 9.5 22.8 13.6 16.1 11.3 20.4 15.7 51.3 6.9 23.8 24.0 22.6 12.7 18.8 17.7 13.5 9.3 21.3 15.3 14.5 14.5 15.9 27.1 21.4 13.3 20.3 18.1 31.1 18.2 12.9 10.9 14.6 14.1 16.2 35.4 19.6 12.7 15.4 10.9 14.0 9.6 23.1 21.4 22.1 14.0 22.7 3.8 17.0 16.2 15.3 12.1 13.5 12.3 7.9 18.3 27.6 14.6 8.2 25.0 32.6 13.9 21.2 21.4 8.4 14.5 19.7 7.0 13.4 8.3 15.8 24.9 27.6 17.3 16.3 13.1 19.1 13.7 24.3 9.5 18.9 17.6 8.1 5.7 27.9 16.8 11.8 20.9 13.9 11.9 14.1 13.3 16.1 13.8 11.3 22.4 18.0 15.6 15.0 13.3 18.2 8.4 15.7 20.3 20.5 27.1 22.7 19.7 20.5 26.8 31.1 24.7 9.2 18.1 15.2 21.4 23.2 18.2 21.8 26.7 11.4 28.0 17.9 16.2 19.2 14.3 22.8 13.5 8.9 35.3 39.7 30.7 19.5 7.0 54.2 58.6 29.4 35.2 34.9 7.9 53.4 111.0 55.9 8.3 17.8 60.0 0.0 54.3 51.6 39.2 34.0 10.4 52.1 61.7 1.6 18.6 19.0 49.0 18.9 34.8 47.0 42.2 36.1 53.7 55.6 48.1 35.1 45.3 134.2 16.1 71.1 36.2 42.9 40.5 16.9 36.6 25.9 63.5 25.3 SMIM22 ENSG00000267795 "Small integral membrane protein 22" K7EJ46 16 4788397-4796491 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 54.3" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 1586.1;Mucus-secreting cells: 1138.7;Paneth cells: 989.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 8 "CAPAN-2: 68.7;OE19: 58.6;RT4: 25.3;SCLC-21H: 17.9;SK-BR-3: 51.6" "Not detected" "Not detected" HPA077331 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA077331: AB_2686834" "unprognostic (6.55e-2)" "unprognostic (4.12e-2)" "unprognostic (4.84e-2)" "unprognostic (3.69e-3)" "unprognostic (7.82e-2)" "unprognostic (3.84e-2)" "unprognostic (4.63e-2)" "unprognostic (2.67e-2)" "unprognostic (6.20e-2)" "unprognostic (3.27e-1)" "unprognostic (2.41e-2)" "unprognostic (1.49e-1)" "unprognostic (1.59e-2)" "unprognostic (2.60e-1)" "unprognostic (1.25e-1)" "unprognostic (7.61e-2)" "unprognostic (1.73e-3)" 0.8 0.0 0.8 14.4 0.8 0.2 10.9 0.8 0.8 10.8 47.0 0.9 37.8 27.5 2.5 12.1 2.6 18.0 28.1 0.8 0.8 0.0 6.2 0.9 6.8 0.8 0.8 0.8 2.8 36.2 0.0 12.1 4.1 0.8 10.2 28.1 0.8 42.2 35.3 0.8 2.2 54.3 1.7 0.8 0.8 41.7 27.2 0.8 1.0 0.9 2.8 4.5 18.5 3.6 1.9 1.5 3.9 1.3 0.9 1.6 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 68.7 0.0 1.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.7 0.0 0.1 0.2 58.6 0.0 0.1 0.1 5.8 0.3 25.3 17.9 0.3 0.1 51.6 0.0 0.1 4.1 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.1 3.9 1.3 1.6 1.3 0.5 0.6 0.7 1.3 0.6 0.3 1.9 1.6 0.7 3.3 0.9 0.6 1.5 0.9 0.3 0.8 0.8 0.8 0.8 0.8 0.0 0.8 0.8 0.8 0.8 44.7 91.2 2.2 16.6 1.9 3.3 0.4 239.5 456.4 104.6 237.3 0.0 3.6 21.6 209.7 33.3 0.4 1586.1 0.0 336.4 0.4 0.3 47.7 18.4 0.0 0.3 1.6 452.3 0.0 0.0 89.0 0.6 2.7 21.9 9.0 1138.7 0.5 428.0 989.0 1.1 55.8 4.1 0.0 0.2 15.1 0.4 1.9 3.1 0.0 572.8 123.6 SMIM24 "C19orf77, HSPC323" ENSG00000095932 "Small integral membrane protein 24" O75264 19 3473986-3480542 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 160.8;intestine: 204.2;kidney: 76.9" "Cell type enriched" "Detected in many" 6 "Proximal tubular cells: 1384.0" "Cancer enhanced" "Detected in many" "renal cancer: 78.4" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "NK-cell: 8.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 42.4;HEL: 20.0;Hep G2: 31.7;MOLT-4: 30.2;OE19: 50.3;REH: 16.6;U-937: 23.7" "Low region specificity" "Detected in many" "HPA045046, HPA056027" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA045046: AB_10964444, HPA056027: AB_2683012" "unprognostic (2.18e-4)" "unprognostic (4.63e-1)" "unprognostic (5.68e-2)" "unprognostic (9.60e-2)" "unprognostic (1.93e-1)" "unprognostic (6.23e-2)" "unprognostic (1.03e-1)" "unprognostic (1.61e-1)" "unprognostic (1.64e-1)" "unprognostic (2.85e-1)" "unprognostic (2.84e-1)" "unprognostic (1.07e-1)" "prognostic favorable (4.13e-10)" "unprognostic (1.68e-2)" "unprognostic (2.14e-1)" "unprognostic (8.36e-2)" "unprognostic (3.11e-2)" 0.2 0.1 0.7 0.6 0.9 7.0 0.3 0.2 2.2 0.2 137.0 0.4 2.4 71.4 0.2 160.8 0.3 0.3 46.7 0.3 0.4 0.5 76.9 7.2 0.3 0.3 0.4 0.6 0.3 1.6 0.0 0.9 0.2 0.3 0.3 2.0 0.2 0.3 0.4 0.2 0.3 204.2 0.2 0.6 0.4 24.8 1.2 0.3 8.8 0.2 0.2 0.2 0.2 0.2 3.2 2.4 3.0 0.0 8.6 2.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 42.4 0.1 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.0 0.2 31.7 0.0 1.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.3 0.0 0.0 0.0 30.2 4.2 0.0 50.3 0.0 16.6 0.0 1.1 0.4 0.0 0.4 0.6 0.0 0.0 0.4 0.1 0.0 0.5 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.7 0.0 23.7 0.0 3.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.1 0.6 0.7 1.7 0.0 8.6 0.0 2.4 2.1 1.1 0.7 0.9 0.2 2.2 0.4 0.5 0.4 0.6 0.3 0.3 0.0 0.0 1.7 0.1 0.0 12.1 0.2 229.3 0.0 0.0 55.8 25.5 0.0 202.2 3.9 5.0 0.0 64.6 23.3 11.3 0.1 0.0 0.3 1.1 8.5 0.1 0.0 133.5 0.6 0.8 11.2 0.3 0.0 0.0 1.0 34.7 2.7 11.1 51.8 0.0 1384.0 32.6 0.0 0.0 0.7 0.4 0.0 0.0 1.0 35.7 0.2 SMIM26 "LINC00493, LOC388789" ENSG00000232388 "Small integral membrane protein 26" A0A096LP01 20 18567347-18569563 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 75.1" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 330.0;Proximal tubular cells: 358.7" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068733 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA068733: AB_2686024" "unprognostic (1.20e-2)" "unprognostic (5.85e-2)" "unprognostic (2.83e-1)" "unprognostic (8.06e-2)" "unprognostic (2.68e-1)" "unprognostic (1.65e-1)" "unprognostic (4.14e-3)" "unprognostic (1.01e-1)" "unprognostic (2.27e-1)" "unprognostic (5.75e-2)" "unprognostic (6.67e-3)" "unprognostic (2.16e-1)" "unprognostic (2.68e-2)" "unprognostic (2.40e-2)" "unprognostic (2.02e-1)" "unprognostic (3.18e-1)" "prognostic favorable (7.84e-5)" 6.8 13.2 8.4 6.8 11.6 9.9 15.6 9.2 13.2 8.8 8.8 5.0 11.9 8.6 9.0 20.4 9.3 11.2 10.8 15.0 9.2 13.2 16.4 6.7 13.4 9.2 10.9 17.2 29.4 6.9 10.6 7.4 14.7 9.5 9.7 6.9 16.8 15.7 32.3 7.7 10.9 11.7 8.9 6.2 8.3 5.4 10.8 7.7 12.0 18.7 9.6 11.4 12.6 49.2 52.0 75.1 42.9 29.6 49.8 37.5 23.6 30.7 23.0 24.2 21.3 29.3 27.3 17.7 20.9 20.5 23.5 19.0 27.3 23.4 20.3 18.9 36.9 26.0 21.7 28.8 23.3 10.0 27.5 31.1 14.3 62.5 40.8 20.4 23.9 24.9 38.5 23.2 37.5 35.7 30.7 29.0 22.8 22.0 25.3 29.0 24.0 56.3 13.3 44.5 37.2 15.7 27.3 32.0 45.9 23.7 23.2 24.7 18.5 35.8 68.1 21.3 26.2 30.1 16.0 14.5 15.3 17.9 18.5 21.4 51.7 26.0 13.1 13.2 10.9 34.8 42.9 32.2 33.2 36.2 34.7 49.2 45.0 37.6 52.0 45.1 49.8 46.7 75.1 29.6 33.3 48.6 45.4 37.5 119.1 61.5 0.0 0.0 0.0 0.0 0.0 0.0 160.6 66.0 162.3 0.0 177.5 330.0 123.9 0.0 0.0 0.0 0.0 185.9 113.7 0.0 0.0 32.5 0.0 161.8 0.0 0.0 0.0 0.0 0.0 0.0 33.4 0.0 115.4 0.0 0.0 172.0 0.0 0.0 358.7 0.0 0.0 0.0 0.0 0.0 0.0 173.9 0.0 0.0 0.0 SMIM4 C3orf78 ENSG00000168273 "Small integral membrane protein 4" Q8WVI0 3 52534013-52579237 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 90.6" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 211.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047771 Uncertain Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA047771: AB_2680150" "unprognostic (3.76e-3)" "unprognostic (3.19e-2)" "unprognostic (4.54e-2)" "unprognostic (4.89e-1)" "unprognostic (2.40e-1)" "unprognostic (1.48e-2)" "unprognostic (9.89e-2)" "prognostic favorable (1.78e-5)" "unprognostic (3.25e-2)" "unprognostic (4.25e-2)" "prognostic favorable (5.00e-4)" "unprognostic (6.35e-2)" "prognostic favorable (1.63e-4)" "unprognostic (8.72e-3)" "unprognostic (2.28e-1)" "unprognostic (1.67e-1)" "unprognostic (1.09e-2)" 11.1 47.3 6.8 9.3 12.0 4.1 15.9 10.3 13.4 6.0 8.7 3.2 16.0 7.5 5.2 16.3 5.5 5.0 13.0 90.6 8.4 6.1 12.2 9.3 21.7 26.5 8.5 6.9 19.1 28.3 6.2 22.1 4.1 17.4 10.6 6.7 10.5 25.8 19.1 66.8 6.7 7.9 17.0 9.1 5.7 8.5 14.1 7.6 1.8 17.3 30.8 5.3 7.0 5.3 13.7 26.2 8.8 24.7 11.0 16.9 10.4 23.0 8.1 9.5 24.0 11.2 5.8 19.4 10.5 4.9 12.1 10.6 9.9 6.2 10.0 4.8 4.4 12.2 12.2 3.1 8.4 4.9 6.6 24.6 9.4 23.2 19.9 17.0 11.1 13.1 12.5 5.2 10.2 7.4 6.6 11.0 11.0 12.4 15.0 8.1 10.0 10.3 15.6 16.1 12.7 17.3 7.1 9.1 19.7 6.7 10.1 10.3 13.0 20.5 6.8 19.8 5.6 7.0 9.4 9.7 6.7 22.0 31.6 21.3 17.5 19.0 21.9 36.8 20.9 9.2 3.5 24.7 8.8 10.8 18.7 10.5 13.7 15.6 13.2 26.2 12.5 16.9 15.2 0.9 11.0 7.5 14.0 14.9 10.4 6.8 12.0 10.3 13.4 8.4 6.1 8.5 6.9 17.4 7.6 44.7 44.8 30.4 29.5 24.2 16.1 211.3 61.1 62.9 77.3 50.6 11.8 35.0 180.8 36.8 15.8 36.5 60.3 0.0 74.3 16.7 27.7 17.7 56.7 143.5 98.6 3.2 76.2 60.8 84.6 8.0 60.1 52.8 35.4 17.2 57.4 43.6 50.1 28.1 95.1 134.6 12.7 45.3 51.1 7.7 15.8 30.2 23.1 25.9 67.6 18.2 SMIM6 C17orf110 ENSG00000259120 "Small integral membrane protein 6" P0DI80 17 75646243-75647977 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 22.0;fallopian tube: 19.1;stomach 1: 26.5;testis: 20.6" "Group enriched" "Detected in many" 4 "Early spermatids: 508.7;Late spermatids: 1038.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 46 "plasmacytoid DC: 22.0" "Lineage enriched" "Detected in single" 46 "dendritic cells: 22.0" "Cell line enhanced" "Detected in some" "A549: 12.6;CACO-2: 4.1;EFO-21: 9.8;HEL: 7.1;OE19: 11.6;RPTEC TERT1: 4.5" HPA065721 Uncertain Approved Nucleoplasm Yes NA Nucleoplasm "HPA065721: AB_2685546" "unprognostic (4.34e-2)" "unprognostic (3.08e-2)" "unprognostic (7.07e-2)" "prognostic favorable (1.49e-4)" "unprognostic (3.42e-1)" "unprognostic (1.22e-2)" "unprognostic (6.53e-2)" "unprognostic (1.94e-1)" "unprognostic (1.13e-3)" "unprognostic (1.01e-1)" "unprognostic (3.76e-2)" "unprognostic (8.06e-2)" "prognostic favorable (4.09e-4)" "unprognostic (2.77e-1)" "unprognostic (1.38e-1)" "unprognostic (2.58e-2)" "prognostic favorable (1.64e-4)" 0.2 0.1 2.4 0.6 4.1 0.6 0.1 0.6 6.1 1.8 5.3 12.3 3.2 7.9 0.9 2.2 0.2 19.1 15.8 0.1 4.0 2.1 13.5 5.2 1.8 0.3 5.3 4.1 0.4 7.3 1.7 0.1 0.4 5.4 0.3 5.5 0.1 0.2 2.9 0.1 0.2 9.4 0.0 9.1 0.2 26.5 20.6 3.1 0.0 0.1 0.2 0.2 1.1 0.8 0.0 22.0 0.0 0.0 0.4 0.0 0.2 0.7 12.6 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.1 3.9 0.0 9.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 7.1 0.3 3.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.4 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.2 4.5 2.1 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.3 0.0 0.2 0.2 0.2 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 22.0 0.0 0.2 2.4 4.1 0.6 6.1 4.0 2.1 5.3 4.1 5.4 3.1 3.0 1.9 0.8 3.2 0.1 0.0 0.0 30.6 44.2 6.8 33.2 0.0 0.0 116.0 27.9 508.7 0.1 26.2 0.0 14.7 2.6 0.2 1.8 0.0 5.4 0.6 0.0 189.1 0.0 0.0 1038.8 6.1 1.0 0.0 2.8 36.2 0.0 37.4 84.2 1.8 15.7 0.0 6.5 0.1 4.9 2.1 0.0 3.4 0.0 3.1 8.4 SMNDC1 "SMNR, SPF30, TDRD16C" ENSG00000119953 "Survival motor neuron domain containing 1" O75940 10 110290730-110304951 "Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061214, HPA070666" Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA061214: AB_2684451, HPA070666: " "unprognostic (4.65e-2)" "unprognostic (1.68e-2)" "unprognostic (2.64e-1)" "unprognostic (3.07e-2)" "unprognostic (3.63e-3)" "unprognostic (5.03e-3)" "prognostic unfavorable (8.08e-6)" "unprognostic (3.16e-3)" "unprognostic (1.21e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (7.20e-4)" "unprognostic (2.68e-3)" "unprognostic (6.88e-3)" "unprognostic (1.35e-1)" "unprognostic (2.82e-1)" "unprognostic (1.80e-1)" "unprognostic (2.00e-1)" 21.3 18.0 16.7 20.0 17.5 38.3 26.6 24.0 20.1 19.0 18.1 17.5 13.5 13.9 23.6 13.1 24.1 18.4 16.7 19.4 15.0 15.4 19.3 20.8 23.5 32.7 15.0 14.4 23.4 15.3 18.0 24.3 25.2 16.5 18.0 16.1 19.6 18.0 17.4 34.3 19.0 16.6 21.3 22.7 21.8 17.0 19.8 16.9 30.0 18.9 14.9 24.7 25.4 22.4 6.2 9.2 17.4 9.7 6.3 8.7 4.5 15.6 11.9 17.5 20.1 13.6 16.3 13.0 18.1 19.0 24.2 24.9 15.3 19.4 22.2 11.8 11.3 13.9 17.0 25.7 12.5 27.3 12.5 13.8 22.2 10.2 17.8 16.3 24.3 21.4 12.6 13.4 19.2 32.4 18.0 13.3 12.9 19.9 20.8 18.6 7.4 25.9 23.7 19.5 12.1 8.3 22.5 35.1 11.6 13.5 11.3 8.8 11.8 11.8 10.0 20.7 15.8 12.3 14.0 14.5 14.2 16.2 13.0 23.0 17.2 17.8 33.7 14.2 34.2 10.9 5.7 9.6 14.7 6.1 9.7 7.5 6.2 7.9 7.6 9.2 5.5 7.1 6.8 17.4 6.3 9.7 5.5 8.7 4.5 16.7 17.5 24.0 20.1 15.0 15.4 15.0 14.4 16.5 16.9 26.8 29.6 33.5 33.3 61.8 25.5 19.0 10.2 34.8 29.6 10.4 19.6 28.1 28.2 21.0 5.4 32.3 18.8 23.3 15.6 27.2 32.9 39.7 57.7 21.2 28.0 31.8 17.9 21.5 34.0 3.8 27.0 39.8 33.7 40.5 14.8 22.3 19.3 17.3 20.8 26.9 30.6 19.4 28.8 44.1 36.1 72.9 38.6 30.5 17.4 60.1 SMOX "C20orf16, dJ779E11.1, FLJ20746, MGC1010, PAO, PAOh1, SMO" ENSG00000088826 "Spermine oxidase" Q9NWM0 20 4120980-4187747 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ductal cells: 48.0;Pancreatic endocrine cells: 84.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 2.1;neutrophil: 3.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 35.5;Karpas-707: 60.7;RPTEC TERT1: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047117, HPA060198" Approved Supported "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Vesicles, Cytosol" "HPA047117: AB_2679940, HPA060198: AB_2684220" "unprognostic (1.24e-2)" "unprognostic (6.55e-2)" "unprognostic (7.24e-3)" "unprognostic (2.77e-1)" "unprognostic (1.40e-1)" "unprognostic (2.32e-1)" "prognostic unfavorable (3.33e-6)" "prognostic unfavorable (1.36e-4)" "unprognostic (4.92e-2)" "unprognostic (3.37e-1)" "unprognostic (7.18e-2)" "unprognostic (7.58e-2)" "prognostic unfavorable (1.06e-4)" "unprognostic (4.08e-2)" "unprognostic (2.64e-3)" "unprognostic (1.26e-2)" "unprognostic (3.07e-1)" 3.5 3.1 26.0 4.1 22.7 24.2 3.4 10.1 29.0 9.6 6.7 23.5 17.6 9.5 10.2 6.9 6.1 4.7 14.0 2.9 28.8 16.2 3.8 4.4 2.1 4.0 25.1 16.5 9.2 28.9 8.7 6.0 5.7 20.7 8.1 1.4 6.5 10.6 10.2 2.5 7.8 7.1 3.9 25.9 2.9 7.4 3.9 24.1 0.3 3.9 3.4 2.6 5.3 5.2 0.1 2.1 3.5 0.9 0.2 0.2 15.3 3.2 35.5 2.5 1.8 1.7 2.6 4.5 4.6 8.9 3.4 2.3 14.6 8.9 0.0 1.5 4.2 5.5 6.5 2.0 2.2 1.4 0.0 1.1 6.2 1.1 14.8 10.9 1.2 2.5 9.8 4.0 7.1 3.0 4.1 6.0 5.0 1.3 60.7 2.0 1.0 2.3 3.5 3.1 3.1 4.9 2.0 3.1 8.4 28.0 2.4 0.5 2.1 8.6 1.0 15.9 1.3 0.1 1.5 7.1 3.9 3.7 0.7 3.6 2.8 0.4 0.0 3.2 1.5 3.0 0.0 0.9 0.1 0.0 0.4 0.0 0.1 0.2 0.2 2.1 0.0 0.0 0.0 3.5 0.2 0.1 1.0 0.0 15.3 26.0 22.7 10.1 17.6 28.8 16.2 25.1 16.5 20.7 24.1 0.0 0.3 1.5 9.5 11.2 0.5 1.4 12.7 1.4 4.5 10.4 0.0 0.3 0.0 48.0 3.1 5.6 2.1 23.3 26.4 0.6 9.5 12.1 5.7 2.0 16.2 0.0 5.8 14.1 3.4 5.6 13.6 10.4 8.5 36.9 2.1 28.2 84.5 0.8 12.7 1.4 1.3 0.0 8.1 4.2 4.9 9.3 0.2 0.0 2.9 8.8 SMPDL3A "ASM3A, ASML3a, FLJ20177, yR36GH4.1" ENSG00000172594 "Sphingomyelin phosphodiesterase acid like 3A" Q92484 6 122789049-122809720 "Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 208.6;Proximal tubular cells: 122.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 10 "basophil: 31.2" "Lineage enriched" "Detected in many" 10 "granulocytes: 31.2" "Cell line enhanced" "Detected in many" "ASC diff: 22.3;hTCEpi: 18.3;OE19: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030148 Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria "Secreted to blood" No No 22000000 "Nucleoplasm, Nucleoli, Mitochondria" "HPA030148: AB_10601591" "unprognostic (2.60e-1)" "unprognostic (1.22e-1)" "prognostic favorable (6.11e-4)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (8.30e-3)" "unprognostic (3.37e-1)" "unprognostic (1.46e-1)" "unprognostic (1.83e-1)" "unprognostic (1.53e-1)" "unprognostic (1.39e-1)" "unprognostic (7.72e-2)" "unprognostic (2.27e-2)" "unprognostic (3.44e-2)" "unprognostic (8.46e-2)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" 8.8 15.9 4.0 8.3 5.4 8.1 24.9 9.7 9.9 35.3 46.7 3.8 8.0 19.2 10.0 9.8 9.6 5.1 8.5 11.9 4.5 4.1 20.1 36.9 13.0 29.1 4.7 5.6 6.2 24.6 16.1 7.0 23.2 6.5 19.6 28.5 7.6 9.5 13.7 56.1 32.1 63.6 10.9 4.9 37.7 13.1 3.8 3.2 3.3 7.2 18.0 7.6 18.7 24.3 0.1 0.4 31.2 3.2 0.0 0.0 0.5 0.1 1.2 3.0 1.4 22.3 10.1 9.6 5.0 13.5 1.5 3.3 1.6 1.3 0.0 0.7 3.1 4.1 2.4 0.8 2.5 1.3 0.0 2.6 1.1 5.1 4.2 14.3 0.0 0.0 12.3 18.3 1.4 2.7 6.0 2.7 0.0 1.8 0.0 6.2 4.4 0.0 0.1 0.5 28.0 3.9 0.0 5.3 0.1 7.4 2.0 2.2 0.0 0.7 9.1 12.7 2.0 1.5 0.7 5.2 3.0 1.7 0.3 3.2 0.0 0.0 0.0 4.3 2.3 6.7 31.2 1.7 0.4 0.0 1.9 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 3.2 0.0 0.0 0.5 4.0 5.4 9.7 9.9 4.5 4.1 4.7 5.6 6.5 3.2 3.0 16.2 2.2 20.4 47.7 2.8 3.6 22.9 5.3 3.4 5.2 3.9 117.9 48.0 19.1 0.1 5.8 208.6 0.0 22.5 35.4 27.9 13.5 9.3 67.1 54.3 3.2 46.8 24.5 86.5 1.1 14.4 9.9 33.7 1.0 51.3 11.4 17.1 87.7 13.4 122.4 5.9 12.9 8.3 0.9 3.9 66.5 96.2 4.3 33.0 12.8 SMTN ENSG00000183963 Smoothelin P53814 22 31064105-31104757 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 99.3" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 267.0;Ito cells: 149.1;Sertoli cells: 181.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "WM-115: 56.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB001721, HPA051778, HPA058590" Enhanced Supported "Nucleoplasm,Actin filaments" No Yes 11000 Nucleoplasm "Actin filaments" "CAB001721: , HPA051778: AB_2681607, HPA058590: AB_2683765" "unprognostic (1.36e-2)" "unprognostic (4.84e-3)" "unprognostic (5.59e-2)" "unprognostic (1.96e-1)" "unprognostic (1.04e-1)" "unprognostic (1.41e-1)" "unprognostic (2.38e-3)" "unprognostic (1.08e-3)" "unprognostic (2.05e-2)" "unprognostic (4.56e-1)" "unprognostic (2.15e-1)" "unprognostic (7.22e-2)" "prognostic unfavorable (2.73e-5)" "unprognostic (2.75e-2)" "unprognostic (1.84e-1)" "unprognostic (8.41e-3)" "unprognostic (6.34e-2)" 17.4 3.3 5.0 8.3 3.8 1.5 13.2 12.7 4.7 34.3 99.3 2.0 7.5 10.3 72.4 12.5 26.4 23.5 32.5 27.6 4.3 1.3 7.0 4.7 9.1 1.7 3.6 2.2 18.2 6.8 1.3 2.0 6.0 5.3 34.5 10.6 14.9 4.6 66.7 28.8 6.4 20.3 91.7 1.7 16.9 36.7 6.2 4.0 1.8 5.1 16.8 2.2 61.3 21.4 4.1 1.3 0.3 2.8 0.3 3.1 1.9 19.9 6.0 2.0 7.7 3.2 5.0 16.6 30.0 14.0 24.7 16.9 8.4 6.4 8.9 2.7 16.5 5.0 2.9 2.0 17.7 11.7 2.9 16.5 9.5 4.8 9.9 2.8 14.0 16.6 4.1 1.6 32.7 5.4 8.4 21.2 3.4 10.1 7.4 16.9 17.9 1.6 3.1 2.3 10.0 25.5 5.5 5.9 9.4 9.9 6.5 3.2 3.6 9.4 4.5 4.4 2.2 5.3 2.2 33.4 18.2 17.2 17.0 22.2 7.1 8.6 5.2 26.4 5.5 56.8 0.0 2.8 0.0 0.5 0.7 0.2 4.1 0.5 1.2 1.3 0.2 3.1 1.7 0.3 0.3 0.7 0.7 0.1 1.9 5.0 3.8 12.7 4.7 4.3 1.3 3.6 2.2 5.3 4.0 6.0 3.5 0.8 24.1 57.9 30.5 32.0 5.1 1.4 2.3 8.7 267.0 9.1 8.3 12.2 0.7 45.4 5.1 0.0 17.0 57.4 41.7 20.3 0.0 2.0 5.1 4.8 28.0 149.1 9.2 1.3 20.8 4.5 13.5 1.0 23.0 35.7 47.3 10.5 45.6 18.6 46.9 181.1 111.4 6.5 5.1 60.6 18.3 3.1 23.8 13.4 SMUG1 "FDG, HMUDG, UNG3" ENSG00000123415 "Single-strand-selective monofunctional uracil-DNA glycosylase 1" Q53HV7 12 54121277-54189008 "Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026804, HPA065892" Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA026804: , HPA065892: " "unprognostic (2.68e-1)" "unprognostic (2.86e-1)" "unprognostic (8.58e-2)" "unprognostic (7.68e-2)" "unprognostic (1.40e-1)" "unprognostic (3.30e-2)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.82e-1)" "unprognostic (6.12e-2)" "prognostic favorable (1.31e-4)" "unprognostic (1.67e-3)" "unprognostic (3.35e-1)" "unprognostic (2.41e-3)" "unprognostic (2.02e-1)" "unprognostic (1.60e-1)" "unprognostic (2.46e-1)" "unprognostic (1.73e-1)" 9.5 15.2 17.3 7.0 16.4 4.9 15.5 13.2 16.1 9.8 11.1 11.7 13.5 9.2 9.5 24.1 19.2 14.2 9.2 10.7 15.0 7.8 13.8 23.5 7.8 17.0 11.5 15.0 10.3 23.6 8.3 11.5 14.9 14.4 11.9 10.5 14.2 16.2 10.9 13.6 16.4 16.2 9.2 10.4 11.2 15.2 12.1 14.1 12.6 12.4 6.1 13.1 10.0 9.8 24.2 23.8 38.0 25.0 13.0 20.8 17.0 13.1 24.3 9.6 9.9 17.8 13.9 16.2 10.2 13.4 16.1 14.7 24.3 29.5 7.9 26.2 14.7 15.1 17.3 6.7 26.9 10.4 8.2 14.1 11.8 19.4 17.3 21.3 7.9 14.7 15.9 42.0 18.9 18.8 17.6 12.9 14.1 19.6 17.3 17.6 25.4 9.8 15.4 11.9 22.6 22.0 7.2 9.8 14.2 19.9 19.4 14.3 17.0 11.7 20.2 17.9 20.3 31.5 14.9 6.2 10.8 12.0 9.7 11.6 16.2 12.7 5.3 15.7 6.2 16.3 38.0 25.0 28.7 15.8 19.7 15.7 24.2 15.6 17.0 21.1 18.8 14.1 14.1 24.5 13.0 15.8 23.8 20.8 17.0 17.3 16.4 13.2 16.1 15.0 7.8 11.5 15.0 14.4 14.1 6.0 13.6 25.1 12.2 6.6 9.3 17.5 17.8 29.4 11.4 24.4 7.9 73.8 51.4 31.2 3.9 10.8 34.2 0.0 34.9 84.6 11.8 15.7 2.3 42.7 39.7 6.4 11.1 16.5 16.8 8.1 17.3 14.0 5.0 41.5 23.4 10.0 39.3 24.6 16.6 49.7 9.3 32.3 9.6 25.1 29.2 9.2 83.6 15.0 23.3 16.5 SMURF1 KIAA1625 ENSG00000198742 "SMAD specific E3 ubiquitin protein ligase 1" Q9HCE7 7 99027438-99144100 "Enzymes, Predicted intracellular proteins" "Differentiation, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Urothelial cells: 65.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019671, HPA055245" Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA019671: , HPA055245: AB_2682757" "unprognostic (2.21e-1)" "unprognostic (6.15e-2)" "unprognostic (8.88e-2)" "unprognostic (1.04e-1)" "unprognostic (1.96e-2)" "unprognostic (1.42e-1)" "unprognostic (1.29e-1)" "unprognostic (1.73e-1)" "unprognostic (2.00e-1)" "unprognostic (2.15e-2)" "unprognostic (3.92e-3)" "unprognostic (2.58e-1)" "unprognostic (1.46e-1)" "unprognostic (7.83e-2)" "unprognostic (1.68e-1)" "unprognostic (3.81e-1)" "unprognostic (4.62e-2)" 15.0 11.1 8.7 10.5 15.0 23.8 12.4 12.1 16.5 11.8 10.9 20.9 6.9 9.5 11.6 5.7 19.3 10.2 12.5 7.9 9.3 8.4 10.3 10.1 16.0 8.1 15.4 9.4 19.6 22.5 9.0 15.1 15.4 14.9 11.7 10.6 14.3 13.4 9.6 10.7 17.3 10.3 9.8 10.6 9.1 19.5 26.0 11.8 6.6 7.8 6.6 12.7 11.5 13.3 1.2 1.2 2.4 1.9 1.0 2.1 0.6 13.7 7.9 6.4 4.5 5.1 5.4 9.6 7.7 7.4 6.3 5.9 3.9 11.4 4.3 8.4 7.2 13.9 7.5 3.5 10.0 6.5 3.2 3.0 2.3 4.6 3.8 4.8 2.6 5.7 4.8 6.9 9.9 11.5 9.6 5.9 4.2 6.9 7.6 5.8 11.2 4.5 5.4 7.5 7.6 8.5 4.3 6.0 2.6 6.9 11.4 2.8 6.4 7.4 9.8 6.8 11.8 3.1 5.0 8.7 10.0 10.3 17.8 15.4 6.8 4.6 4.5 5.0 5.2 15.4 2.0 1.4 2.3 1.3 1.5 1.6 0.9 2.1 1.3 1.1 1.2 1.2 1.0 2.4 1.0 1.9 1.2 2.0 0.6 8.7 15.0 12.1 16.5 9.3 8.4 15.4 9.4 14.9 11.8 17.9 28.0 5.2 20.4 23.0 25.8 3.9 20.4 20.1 20.5 12.2 7.9 6.1 1.7 13.9 3.7 10.8 7.8 0.0 13.9 8.0 10.1 31.9 2.3 6.7 5.7 25.4 10.9 7.4 3.1 5.3 5.8 8.5 8.5 4.6 8.7 3.7 25.0 10.5 13.1 4.4 6.9 6.5 15.5 41.5 1.0 19.3 17.6 2.5 7.8 65.2 SMYD3 "KMT3E, ZMYND1, ZNFN3A1" ENSG00000185420 "SET and MYND domain containing 3" Q9H7B4 1 245749342-246507312 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Chromatin regulator, Methyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "granulocytes: 108.5;Late spermatids: 74.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 95.1;K-562: 35.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012229, HPA045821, HPA054352" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB012229: , HPA045821: AB_2679461, HPA054352: AB_2682458" "unprognostic (7.00e-3)" "unprognostic (7.45e-2)" "unprognostic (1.52e-1)" "unprognostic (6.18e-3)" "unprognostic (3.32e-2)" "unprognostic (5.08e-3)" "unprognostic (3.25e-3)" "unprognostic (1.72e-3)" "unprognostic (4.53e-2)" "unprognostic (1.57e-1)" "unprognostic (1.71e-1)" "unprognostic (2.10e-1)" "unprognostic (3.78e-5)" "unprognostic (9.03e-3)" "unprognostic (2.14e-1)" "unprognostic (1.08e-2)" "unprognostic (1.58e-1)" 6.0 12.0 9.9 9.7 16.2 7.6 10.6 25.9 14.7 8.9 6.5 6.4 3.7 4.5 8.7 21.8 6.1 10.0 7.7 5.8 10.3 12.0 8.9 5.5 9.2 6.3 12.0 10.2 8.0 7.2 6.7 11.9 4.6 15.3 6.8 8.3 9.5 5.3 5.9 9.5 6.7 5.2 7.6 6.8 5.3 6.1 10.5 8.1 7.5 18.8 3.6 9.3 8.3 6.6 11.3 5.9 8.3 3.4 19.4 12.9 8.7 4.7 2.9 4.2 3.6 4.8 6.6 4.2 6.7 5.0 7.9 17.8 3.7 5.5 7.7 5.4 6.2 4.9 3.1 3.8 7.5 26.5 4.0 3.9 4.5 4.3 4.5 9.0 4.6 95.1 17.7 1.8 10.4 6.7 6.0 5.4 5.5 35.9 2.7 7.7 1.6 8.7 8.8 3.7 6.6 4.7 8.1 5.1 11.2 5.7 6.9 10.0 4.8 3.1 0.4 6.1 4.7 3.9 7.8 4.1 3.8 2.6 2.7 7.9 13.6 3.7 4.0 7.3 6.3 4.4 8.1 3.4 8.3 10.5 3.0 10.8 11.3 11.1 12.8 5.9 11.1 12.3 12.9 2.4 19.4 3.3 3.8 11.8 8.7 9.9 16.2 25.9 14.7 10.3 12.0 12.0 10.2 15.3 8.1 6.0 27.8 5.3 13.2 10.9 5.8 7.7 2.5 44.2 13.6 12.2 21.6 7.8 13.3 20.6 46.2 11.7 4.2 0.0 28.1 33.5 15.4 5.4 108.5 4.2 10.3 9.5 24.1 9.2 3.8 74.1 10.3 6.0 11.8 1.8 8.3 9.1 16.5 2.9 16.3 14.6 13.9 0.0 15.1 17.3 24.7 10.0 6.1 13.6 9.2 6.4 SMYD4 "KIAA1936, ZMYND21" ENSG00000186532 "SET and MYND domain containing 4" Q8IYR2 17 1779485-1830634 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030059 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus, Vesicles" "Nucleoplasm, Cytosol" "HPA030059: AB_2191728" "unprognostic (1.45e-1)" "unprognostic (2.48e-1)" "unprognostic (2.47e-1)" "unprognostic (4.23e-2)" "unprognostic (1.13e-2)" "unprognostic (3.66e-2)" "unprognostic (4.03e-2)" "unprognostic (1.04e-1)" "unprognostic (1.79e-2)" "unprognostic (4.95e-2)" "unprognostic (1.83e-3)" "unprognostic (9.26e-3)" "unprognostic (3.63e-2)" "unprognostic (1.33e-2)" "unprognostic (7.35e-2)" "unprognostic (1.52e-1)" "unprognostic (1.18e-1)" 10.6 10.0 8.6 13.8 9.6 4.8 11.0 16.3 11.8 9.9 10.8 9.6 9.6 11.5 15.3 8.7 6.3 10.1 7.1 11.0 6.3 6.1 6.1 7.4 8.5 10.4 7.4 6.7 15.5 21.7 5.4 11.3 7.7 9.2 10.1 8.3 10.7 14.1 15.5 19.3 10.6 12.9 10.0 9.2 10.0 7.6 9.2 8.2 12.8 9.1 5.6 12.2 10.8 12.8 6.1 6.3 11.5 4.3 4.1 7.9 3.0 6.0 11.4 11.5 8.2 7.9 5.4 13.4 9.9 5.7 10.5 10.9 18.1 5.2 16.2 6.7 4.0 7.1 11.8 10.9 6.4 13.2 4.6 11.0 5.9 12.1 4.9 3.9 6.0 5.8 3.8 5.8 10.8 9.6 5.4 5.2 14.0 6.2 6.3 8.2 3.7 10.9 4.2 5.2 7.2 5.6 13.6 5.8 4.1 4.2 7.4 4.7 6.5 9.2 3.8 9.5 9.8 5.5 3.7 5.0 10.3 5.3 8.6 8.5 4.4 5.9 5.8 5.8 5.3 10.1 11.5 3.6 3.2 7.9 4.3 6.5 6.1 4.6 5.0 2.1 3.8 5.3 7.6 2.1 4.1 3.3 6.3 4.8 3.0 8.6 9.6 16.3 11.8 6.3 6.1 7.4 6.7 9.2 8.2 6.0 26.7 8.5 8.1 4.4 19.2 4.5 7.6 17.4 17.0 7.0 31.4 7.8 1.7 4.6 19.6 9.0 8.1 0.0 2.9 8.7 10.3 5.9 7.0 5.9 11.2 25.4 3.5 19.6 13.7 5.1 25.0 14.5 5.0 15.4 4.2 7.0 3.2 0.0 23.3 2.2 19.3 45.3 21.7 13.3 14.9 5.8 6.8 7.5 5.0 3.1 SNAI1 "SLUGH2, SNA, SNAH, SNAIL, SNAIL1" ENSG00000124216 "Snail family transcriptional repressor 1" O95863 20 49982999-49988886 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Endothelial cells: 26.5;Extravillous trophoblasts: 69.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.1" "Lineage enriched" "Detected in single" 6 "dendritic cells: 4.1" "Cell line enhanced" "Detected in many" "SiHa: 17.8;TIME: 24.9;WM-115: 16.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB005883, HPA056831, HPA069985, CAB078687" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB005883: AB_443967, CAB078687: AB_2665847, HPA056831: AB_2732606, HPA069985: AB_2732146" "unprognostic (4.60e-2)" "unprognostic (2.25e-2)" "prognostic unfavorable (4.76e-4)" "unprognostic (2.60e-2)" "unprognostic (1.15e-2)" "unprognostic (4.22e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (1.61e-5)" "unprognostic (3.34e-3)" "unprognostic (9.85e-3)" "unprognostic (1.76e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (2.63e-7)" "unprognostic (3.75e-3)" "unprognostic (1.53e-1)" "prognostic unfavorable (8.82e-7)" "unprognostic (1.88e-2)" 18.3 8.0 1.8 5.9 3.8 5.5 11.1 2.9 2.7 5.9 3.4 5.8 2.6 1.6 5.4 4.2 4.0 8.2 22.2 11.8 3.1 1.2 5.2 7.2 14.3 5.9 3.1 1.3 6.8 7.0 3.6 4.9 15.9 2.9 6.1 1.3 11.0 3.4 3.8 3.6 3.2 2.3 4.3 6.3 8.1 4.5 4.5 3.6 0.7 18.7 4.1 2.0 10.8 13.9 0.0 4.1 0.0 0.6 0.0 0.0 0.1 0.7 0.6 3.5 0.5 1.1 0.7 7.0 3.0 3.7 0.6 0.4 5.6 0.9 0.4 8.2 5.3 3.6 0.1 1.0 0.0 0.3 0.0 0.7 0.4 1.3 3.3 9.0 0.9 2.8 2.1 0.2 1.3 0.0 9.3 9.0 0.4 4.3 0.1 0.0 1.2 0.1 1.0 4.6 0.5 2.4 1.5 0.9 0.4 4.1 0.0 1.5 3.6 17.8 4.6 0.7 3.1 0.9 4.1 24.9 0.0 4.4 0.0 0.0 0.1 0.1 4.6 1.5 1.3 16.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.1 1.8 3.8 2.9 2.7 3.1 1.2 3.1 1.3 2.9 3.6 0.0 4.0 3.9 1.1 4.6 0.7 3.6 2.5 1.4 5.7 0.0 0.0 7.5 0.0 1.4 2.2 26.5 1.6 0.0 0.2 69.4 13.4 1.2 1.1 0.0 7.3 3.2 1.7 19.0 5.1 0.4 5.2 14.4 5.0 1.8 3.4 0.8 2.8 1.4 13.4 0.0 0.2 6.5 11.3 1.2 3.2 4.3 11.7 1.3 1.7 0.4 SNAI2 "SLUG, SLUGH, SLUGH1, SNAIL2" ENSG00000019549 "Snail family transcriptional repressor 2" O43623 8 48917604-48921740 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Deafness, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Basal glandular cells: 113.7;Basal keratinocytes: 144.6;Fibroblasts: 122.9;Ito cells: 49.1;Leydig cells: 68.1;Melanocytes: 82.7;Peritubular cells: 63.3;Sertoli cells: 51.8;Smooth muscle cells: 149.4;Suprabasal keratinocytes: 129.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 11 "basophil: 1.1" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.1" "Cell line enhanced" "Detected in many" "ASC diff: 55.8;ASC TERT1: 57.5;HSkMC: 42.4;hTERT-HME1: 39.6;LHCN-M2: 52.5;U-138 MG: 48.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" CAB011671 Supported Approved Nucleoplasm NA NA Nucleoplasm "CAB011671: AB_777968" "unprognostic (3.52e-2)" "unprognostic (3.95e-1)" "unprognostic (1.55e-1)" "unprognostic (1.89e-2)" "unprognostic (3.78e-2)" "unprognostic (1.74e-2)" "unprognostic (1.79e-1)" "unprognostic (1.04e-2)" "unprognostic (4.24e-2)" "unprognostic (1.92e-2)" "prognostic unfavorable (7.83e-4)" "unprognostic (2.38e-1)" "prognostic unfavorable (4.69e-8)" "unprognostic (1.65e-3)" "unprognostic (3.76e-2)" "unprognostic (1.87e-1)" "prognostic unfavorable (7.16e-4)" 13.9 6.1 1.0 13.7 1.4 0.0 60.3 4.8 1.8 52.9 7.8 2.0 14.4 2.2 31.3 17.3 15.6 20.7 12.8 12.5 1.0 0.8 17.8 4.8 6.7 14.2 1.9 1.6 27.6 5.8 1.2 2.5 11.5 3.4 34.4 4.6 20.5 11.0 18.8 6.1 21.7 6.3 21.7 3.9 10.6 5.5 9.0 0.9 4.7 6.0 11.6 8.2 22.4 37.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 3.7 0.1 9.4 0.0 55.8 57.5 0.0 8.7 14.9 8.7 11.9 0.0 3.8 0.0 0.0 10.9 13.0 6.5 0.0 25.6 9.6 0.0 0.1 0.0 2.0 0.0 19.7 0.0 0.0 42.4 26.9 7.3 39.6 1.2 0.2 0.0 0.0 4.0 52.5 0.0 0.0 0.0 0.4 0.0 7.4 0.0 26.6 0.0 0.0 1.5 1.1 0.8 0.7 0.0 13.6 4.4 0.0 0.0 2.3 48.1 1.6 8.0 4.4 0.0 0.0 0.8 16.8 0.0 16.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.4 4.8 1.8 1.0 0.8 1.9 1.6 3.4 0.9 0.0 0.0 0.0 113.7 144.6 1.1 0.8 0.0 0.0 9.1 0.0 0.0 1.5 0.0 3.4 0.5 9.0 0.0 0.0 2.1 0.4 122.9 18.4 0.0 5.5 1.4 0.0 0.0 49.1 1.0 0.6 68.1 0.8 82.7 0.0 0.0 0.0 5.1 0.0 63.3 0.0 0.1 51.8 149.4 0.2 0.2 129.4 1.8 0.0 0.0 11.1 SNAI3 "SMUC, Zfp293, ZNF293" ENSG00000185669 "Snail family transcriptional repressor 3" Q3KNW1 16 88677682-88686493 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 25.5;skeletal muscle: 33.9" "Cell type enhanced" "Detected in some" 9 "B-cells: 8.0;granulocytes: 9.2;Hofbauer cells: 7.0;Kupffer cells: 14.2;Macrophages: 10.3;T-cells: 10.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "NB-4: 14.7;RPMI-8226: 23.2" "Region enhanced" "Detected in single" "basal ganglia: 1.3" "Not detected" "Not detected" HPA071127 Approved Nucleoplasm NA NA Nucleoplasm "HPA071127: AB_2686346" "unprognostic (1.03e-2)" "prognostic favorable (1.39e-4)" "unprognostic (2.20e-2)" "unprognostic (6.19e-4)" "unprognostic (3.05e-1)" "unprognostic (2.85e-3)" "unprognostic (2.60e-1)" "unprognostic (1.98e-3)" "unprognostic (3.24e-2)" "unprognostic (7.79e-2)" "prognostic favorable (3.58e-4)" "unprognostic (9.09e-2)" "unprognostic (1.62e-1)" "unprognostic (8.46e-2)" "unprognostic (6.57e-2)" "unprognostic (1.11e-1)" "unprognostic (7.47e-2)" 0.9 0.8 2.4 6.3 2.3 2.3 0.8 1.9 2.9 1.3 3.4 2.1 0.2 2.2 0.8 1.3 1.3 1.4 2.6 2.4 2.5 1.7 1.3 1.0 5.3 4.5 3.1 0.8 1.5 6.1 2.1 1.0 0.9 2.2 1.6 0.8 1.4 3.6 0.7 33.9 1.1 4.6 1.1 2.4 9.2 3.5 2.1 2.2 2.1 3.0 9.5 13.0 2.7 2.4 4.6 9.2 25.5 7.7 0.5 11.6 5.4 0.2 0.8 0.2 1.1 0.0 0.0 0.5 0.2 0.0 0.0 0.1 2.9 0.2 1.9 0.5 0.0 0.7 0.6 0.2 0.2 0.0 0.3 1.1 0.9 0.1 0.9 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.1 0.0 1.2 1.7 3.6 0.0 2.6 0.1 14.7 0.3 0.3 0.3 3.2 0.2 23.2 0.0 0.4 1.4 0.2 0.6 0.0 0.2 0.4 1.0 1.8 0.3 0.1 0.9 0.2 0.0 0.6 3.3 3.3 0.2 4.0 0.4 2.8 7.7 25.5 6.1 2.9 10.9 4.6 9.9 5.7 9.2 3.8 6.1 3.8 17.1 0.5 0.7 6.5 11.6 5.4 2.4 2.3 1.9 2.4 2.5 1.7 3.1 0.8 2.2 2.2 3.0 0.0 8.0 0.1 0.5 0.2 2.0 0.0 0.0 1.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.1 9.2 0.0 7.0 0.0 0.0 0.6 14.2 0.0 0.0 10.3 5.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.4 0.0 0.8 0.0 1.1 0.3 0.1 10.9 0.0 0.0 SNAP29 "CEDNIK, SNAP-29" ENSG00000099940 "Synaptosome associated protein 29" O95721 22 20858983-20891218 "Disease related genes, Predicted intracellular proteins" "Autophagy, Cilium biogenesis/degradation, Protein transport, Transport" "Ichthyosis, Neuropathy, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 381.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 71.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031823, CAB037092, HPA056492" Supported Supported Nucleoplasm,Cytosol NA NA 34000 Cytosol Nucleoplasm "CAB037092: AB_477491, HPA031823: AB_10602407, HPA056492: AB_2683151" "unprognostic (1.76e-1)" "prognostic favorable (6.99e-4)" "unprognostic (3.72e-3)" "unprognostic (3.26e-2)" "unprognostic (7.83e-3)" "unprognostic (3.80e-1)" "unprognostic (1.66e-1)" "unprognostic (2.05e-2)" "unprognostic (1.34e-2)" "unprognostic (2.60e-2)" "unprognostic (3.68e-2)" "unprognostic (6.85e-2)" "unprognostic (1.22e-1)" "unprognostic (2.52e-1)" "unprognostic (1.45e-1)" "unprognostic (4.51e-3)" "unprognostic (6.08e-2)" 19.4 18.8 15.9 15.5 15.3 15.7 15.5 13.4 19.7 16.0 18.8 15.3 17.1 16.5 15.2 11.6 21.7 12.3 19.9 23.1 13.8 13.0 17.7 36.1 13.4 20.1 15.1 12.3 15.7 16.6 13.1 11.5 26.4 13.7 13.6 17.7 19.0 17.7 17.1 27.6 17.6 16.8 17.6 15.9 24.1 17.4 47.0 14.9 18.3 15.1 15.9 18.2 15.3 16.3 10.8 20.0 23.0 33.2 26.1 14.9 14.0 15.8 6.5 9.3 7.6 10.6 15.5 12.0 15.1 13.7 17.1 17.3 8.9 5.6 9.9 9.7 14.1 17.3 9.4 12.1 10.2 18.5 14.3 9.3 16.5 7.3 9.6 15.1 14.6 13.4 12.2 14.5 17.9 12.9 11.8 11.9 8.6 71.7 14.2 15.7 10.9 13.2 14.1 3.0 18.6 6.9 12.8 20.8 4.0 10.0 8.5 7.6 9.1 16.2 10.2 17.1 12.0 16.0 11.7 10.3 17.5 15.9 11.9 11.8 14.6 23.7 18.3 13.0 9.9 12.5 19.5 20.0 23.0 10.6 27.4 11.0 10.8 10.5 11.4 17.4 9.2 9.7 9.8 22.6 26.1 33.2 20.0 14.9 14.0 15.9 15.3 13.4 19.7 13.8 13.0 15.1 12.3 13.7 14.9 11.9 25.3 19.3 18.6 14.8 11.9 16.5 25.5 41.5 11.4 22.7 11.8 70.8 36.5 35.3 381.3 28.6 30.4 0.0 43.9 127.0 24.8 21.1 28.8 40.8 65.9 19.1 21.2 25.2 35.8 158.3 30.8 40.3 33.7 45.9 26.5 29.2 45.6 17.3 34.3 25.4 12.6 38.8 19.5 70.9 80.9 13.6 82.2 21.7 24.8 25.5 SNAPC1 "PTFgamma, SNAP43" ENSG00000023608 "Small nuclear RNA activating complex polypeptide 1" Q16533 14 61762357-61796428 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 120.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 41.4;hTERT-HME1: 41.6;U-2 OS: 55.1;U-251 MG: 38.0" "Low region specificity" "Detected in all" "HPA067076, HPA072276" Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA067076: AB_2732757, HPA072276: AB_2732199" "unprognostic (7.40e-2)" "unprognostic (5.04e-2)" "unprognostic (3.09e-2)" "unprognostic (1.11e-1)" "unprognostic (2.94e-1)" "unprognostic (8.55e-2)" "unprognostic (1.68e-3)" "unprognostic (1.88e-1)" "unprognostic (4.01e-2)" "unprognostic (5.18e-2)" "unprognostic (1.58e-1)" "unprognostic (1.99e-1)" "unprognostic (2.47e-3)" "unprognostic (1.58e-1)" "unprognostic (1.07e-1)" "unprognostic (3.10e-1)" "unprognostic (2.26e-1)" 9.9 12.3 7.5 8.6 10.3 7.0 8.4 12.1 8.0 14.4 6.8 5.6 11.6 4.9 10.3 15.8 9.2 8.7 10.4 11.2 7.8 7.6 8.7 7.0 10.5 9.7 11.8 5.4 12.1 5.0 8.8 27.2 11.3 14.2 10.3 4.2 5.7 7.2 19.8 5.6 8.7 5.2 6.9 14.5 9.5 5.4 24.9 9.4 9.1 9.8 8.2 8.9 17.4 14.3 12.0 9.3 7.5 7.0 9.6 13.1 5.1 14.6 2.8 2.8 6.0 3.2 3.7 3.4 12.4 8.3 14.3 8.5 1.0 3.0 3.0 16.6 5.2 41.4 4.6 2.8 3.7 23.6 3.3 2.0 1.8 1.5 2.0 8.4 1.9 4.0 3.5 2.5 12.0 41.6 5.6 5.4 4.2 2.0 2.8 13.6 1.8 4.6 3.0 2.7 1.6 9.5 3.5 7.5 1.1 11.7 2.3 2.0 4.9 8.2 1.4 9.8 3.7 2.9 3.0 8.3 15.8 55.1 10.2 38.0 1.8 1.9 2.7 10.7 2.4 9.3 7.5 7.0 5.8 6.4 5.9 8.3 12.0 8.1 5.5 7.0 12.0 13.1 8.5 7.1 9.6 4.9 9.3 8.7 5.1 7.5 10.3 12.1 8.0 7.8 7.6 11.8 5.4 14.2 9.4 32.8 16.5 17.9 48.3 84.6 10.6 18.8 5.1 57.6 28.4 27.9 2.0 14.9 6.6 20.7 35.6 28.5 4.0 0.0 14.0 21.4 31.0 23.1 40.5 5.8 15.6 7.9 4.1 27.6 12.6 8.2 20.4 19.5 16.9 13.6 4.5 42.6 16.7 0.0 19.1 8.2 11.7 19.4 30.3 120.2 67.0 56.3 4.7 15.2 6.4 22.2 SNAPC2 "PTFdelta, SNAP45" ENSG00000104976 "Small nuclear RNA activating complex polypeptide 2" Q13487 19 7920316-7923250 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049843, HPA077597" Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA049843: AB_2680910, HPA077597: AB_2732354" "unprognostic (4.56e-3)" "unprognostic (1.89e-1)" "unprognostic (7.98e-3)" "unprognostic (8.11e-3)" "unprognostic (2.03e-1)" "unprognostic (6.87e-2)" "prognostic unfavorable (4.89e-5)" "unprognostic (1.44e-1)" "unprognostic (1.32e-1)" "unprognostic (1.82e-1)" "unprognostic (5.45e-2)" "unprognostic (2.02e-1)" "unprognostic (1.31e-1)" "unprognostic (1.57e-1)" "unprognostic (3.22e-1)" "unprognostic (5.30e-2)" "unprognostic (9.78e-2)" 12.5 15.1 11.0 14.2 17.1 20.3 12.0 19.3 19.8 30.8 20.0 13.2 11.9 14.2 32.4 11.8 20.3 21.8 12.1 12.1 11.7 11.6 15.6 11.1 12.3 12.4 10.6 13.6 24.2 15.1 12.0 16.5 13.6 12.2 24.8 6.0 10.8 18.0 27.0 8.1 16.4 11.3 22.8 9.1 14.8 11.9 28.7 12.3 18.3 17.5 10.4 11.4 29.9 16.1 11.5 20.1 14.7 20.9 17.7 15.5 10.4 9.1 10.7 5.1 19.7 7.0 15.1 4.6 9.7 10.5 9.7 8.8 4.9 8.0 7.9 12.2 11.4 7.7 11.3 3.5 7.3 2.8 10.1 9.0 11.0 4.7 6.9 12.8 6.8 18.3 12.3 11.3 11.4 7.0 7.9 11.0 8.4 10.8 13.3 5.9 8.1 8.7 19.5 6.4 4.7 23.8 10.4 5.0 7.8 8.9 3.2 6.0 13.4 5.0 5.5 21.8 2.3 8.9 7.5 14.1 32.8 11.6 30.6 12.1 12.7 20.8 4.8 20.5 14.3 10.3 4.5 16.4 14.7 13.7 20.9 13.7 11.5 11.7 11.8 20.1 11.0 12.2 12.2 2.4 17.7 20.7 13.3 15.5 10.4 11.0 17.1 19.3 19.8 11.7 11.6 10.6 13.6 12.2 12.3 3.0 3.0 13.5 18.0 21.6 7.9 2.6 7.6 0.0 3.4 10.4 0.0 10.4 14.9 20.2 1.4 15.7 11.6 0.0 21.1 18.3 26.1 27.3 18.4 4.7 26.0 22.3 11.5 11.6 20.4 5.2 12.7 24.4 18.6 41.5 10.5 5.7 22.2 3.5 13.4 12.9 5.4 12.9 30.3 8.6 21.2 21.2 8.2 21.9 12.0 19.5 SNAPC3 "MGC132011, MGC33124, PTFbeta, SNAP50" ENSG00000164975 "Small nuclear RNA activating complex polypeptide 3" Q92966 9 15422704-15465953 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 98.3;Late spermatids: 162.5;Spermatocytes: 125.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053145, HPA066031" Supported "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" Nucleoli "HPA053145: AB_2682055, HPA066031: AB_2685600" "unprognostic (2.62e-1)" "unprognostic (4.26e-1)" "unprognostic (5.42e-3)" "unprognostic (2.09e-1)" "unprognostic (4.93e-3)" "unprognostic (6.08e-2)" "unprognostic (5.60e-3)" "unprognostic (4.15e-2)" "unprognostic (1.68e-2)" "unprognostic (1.67e-2)" "unprognostic (1.12e-2)" "unprognostic (2.64e-2)" "unprognostic (1.36e-3)" "unprognostic (3.07e-1)" "unprognostic (2.63e-1)" "unprognostic (4.38e-2)" "unprognostic (2.09e-2)" 9.8 18.5 18.7 10.3 21.1 4.6 10.4 26.3 21.2 17.9 13.2 10.4 10.3 11.6 16.5 15.5 12.6 10.8 10.8 17.5 18.0 14.0 12.3 8.6 10.0 11.2 15.2 16.3 17.4 11.1 12.8 18.4 16.7 21.8 13.3 14.6 9.6 10.5 11.3 19.3 13.7 14.2 12.8 15.2 12.8 10.5 14.7 15.9 11.9 11.3 6.8 10.8 12.9 15.1 12.2 7.7 5.0 21.2 5.0 8.2 5.5 3.9 5.1 10.8 4.1 8.7 9.1 6.3 6.2 2.8 3.7 4.4 2.4 1.7 2.8 2.4 3.9 5.2 2.4 5.7 2.9 4.6 13.1 6.7 10.1 10.8 3.3 4.3 2.2 7.8 5.9 5.9 2.6 3.0 15.7 6.8 6.7 2.8 4.6 8.4 1.2 2.7 7.2 3.4 3.0 13.5 5.5 1.3 1.5 6.4 2.4 11.6 8.2 2.1 1.9 1.4 9.9 4.6 4.6 5.6 6.2 2.5 2.6 7.9 6.1 7.3 3.5 4.0 3.0 2.8 3.4 10.1 5.0 5.7 16.7 5.5 9.9 5.7 5.1 7.7 12.2 8.2 7.9 1.2 5.0 21.2 6.3 7.9 5.5 18.7 21.1 26.3 21.2 18.0 14.0 15.2 16.3 21.8 15.9 17.9 11.0 17.8 12.4 8.5 19.2 37.1 5.1 13.4 5.7 19.2 29.5 10.6 11.6 16.6 98.3 16.4 21.6 0.0 8.2 10.8 16.4 10.3 17.3 12.4 13.8 33.4 14.5 19.0 22.1 162.5 31.4 10.0 18.6 17.2 14.1 15.1 11.3 27.7 28.7 24.2 17.8 12.9 21.7 125.8 27.9 10.5 8.1 17.1 16.2 10.2 SNAPC4 "FLJ13451, PTFalpha, SNAP190" ENSG00000165684 "Small nuclear RNA activating complex polypeptide 4" Q5SXM2 9 136375577-136400168 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046627, HPA073243" Uncertain Approved "Nucleoplasm,Nuclear membrane" No No "Nucleoplasm, Nuclear membrane" "HPA046627: AB_10961152, HPA073243: AB_2686585" "unprognostic (3.34e-2)" "unprognostic (2.12e-1)" "unprognostic (5.26e-2)" "unprognostic (1.75e-2)" "unprognostic (3.17e-2)" "unprognostic (2.22e-2)" "unprognostic (2.08e-2)" "unprognostic (1.52e-1)" "unprognostic (1.87e-1)" "unprognostic (2.40e-1)" "prognostic favorable (4.52e-5)" "unprognostic (3.15e-2)" "unprognostic (1.20e-2)" "unprognostic (1.09e-2)" "unprognostic (6.99e-2)" "unprognostic (1.06e-2)" "unprognostic (6.41e-2)" 6.8 5.8 7.6 9.5 15.4 12.7 7.6 20.1 19.4 8.0 6.6 10.9 8.7 9.5 9.9 10.1 6.6 14.5 9.2 6.3 10.1 8.0 8.6 11.5 8.0 10.8 7.7 10.1 11.2 17.8 13.4 13.3 6.7 10.4 9.1 7.2 11.8 10.8 8.5 7.2 13.5 7.8 8.0 8.2 11.7 8.1 20.0 10.2 11.2 10.0 5.7 10.2 9.4 7.1 3.4 1.7 3.7 1.6 2.3 2.6 0.6 6.1 7.2 7.4 10.3 4.8 9.4 13.7 8.0 5.4 8.5 6.8 16.5 5.7 9.5 5.8 6.3 5.9 20.0 9.0 10.4 5.1 13.3 14.1 6.4 18.3 7.8 4.3 13.5 7.7 7.4 8.7 7.3 7.0 7.4 7.5 7.9 13.1 7.1 5.9 13.8 7.8 15.2 15.4 9.8 9.5 12.8 7.5 13.5 4.9 11.2 21.5 15.0 8.1 13.4 4.3 6.7 13.7 7.9 10.6 8.8 8.0 15.7 11.4 4.4 5.1 7.7 6.1 6.3 5.1 0.0 1.6 1.3 2.6 1.3 1.2 2.0 1.1 1.1 0.6 3.4 0.9 0.7 3.7 2.3 0.5 1.7 0.9 0.6 7.6 15.4 20.1 19.4 10.1 8.0 7.7 10.1 10.4 10.2 6.0 7.0 2.9 1.9 4.7 7.5 3.2 2.5 17.4 3.4 3.5 2.0 2.4 0.0 5.9 2.6 3.6 3.6 23.3 3.8 1.7 2.7 2.2 1.1 6.4 2.8 3.2 5.1 5.5 1.6 1.5 4.6 2.8 0.0 1.0 5.2 4.8 5.3 6.0 4.6 4.2 11.5 0.0 2.3 8.6 8.8 5.9 1.1 3.2 5.6 2.8 SNAPC5 SNAP19 ENSG00000174446 "Small nuclear RNA activating complex polypeptide 5" O75971 15 66490135-66497813 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024379 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA024379: AB_2671552" "unprognostic (4.43e-2)" "unprognostic (1.53e-3)" "unprognostic (4.39e-3)" "unprognostic (4.56e-2)" "unprognostic (3.49e-2)" "unprognostic (2.31e-1)" "unprognostic (1.06e-1)" "unprognostic (8.07e-2)" "unprognostic (1.12e-2)" "unprognostic (3.39e-2)" "unprognostic (3.13e-1)" "unprognostic (6.28e-2)" "unprognostic (1.64e-2)" "unprognostic (1.25e-1)" "unprognostic (2.21e-1)" "unprognostic (9.40e-2)" "unprognostic (5.69e-2)" 16.6 20.7 30.9 17.0 29.8 7.5 16.7 29.1 30.5 13.9 18.7 15.2 15.5 12.6 17.2 33.0 13.4 17.6 13.5 32.2 21.8 26.6 22.2 27.4 15.3 16.3 22.8 25.0 16.8 14.1 28.8 21.6 12.6 20.0 18.7 15.6 15.8 16.0 24.5 34.1 9.4 14.5 19.1 15.6 16.1 14.3 25.2 17.2 14.0 22.1 17.3 17.4 15.7 12.4 26.4 25.2 23.9 28.9 26.9 35.5 19.8 7.0 26.3 9.8 12.0 14.0 13.0 10.5 8.1 11.8 11.1 8.4 15.2 17.1 8.4 23.9 10.3 11.2 15.0 27.3 11.8 11.9 14.5 16.2 11.6 25.9 19.9 16.3 29.0 12.7 11.0 14.3 9.2 23.5 7.9 9.3 16.4 37.1 16.1 7.9 16.6 12.4 10.4 10.5 31.0 11.7 13.4 10.2 31.0 14.4 9.9 12.2 9.2 9.1 17.9 35.8 23.6 17.2 21.2 6.5 9.3 19.0 10.2 15.6 13.3 20.2 14.4 9.7 36.2 19.8 23.9 16.1 23.6 22.5 26.7 30.2 26.4 27.2 30.0 14.3 19.9 35.5 31.5 8.3 26.9 28.9 25.2 30.0 19.8 30.9 29.8 29.1 30.5 21.8 26.6 22.8 25.0 20.0 17.2 20.8 16.3 16.6 14.8 8.4 13.9 46.2 15.3 48.2 21.6 26.2 9.8 29.2 71.3 23.0 93.9 22.4 13.1 23.3 41.7 22.0 17.1 22.3 18.5 43.2 40.4 17.5 13.4 11.1 13.4 80.2 24.7 21.1 25.3 36.9 15.5 11.1 24.5 7.0 26.2 60.2 15.7 0.0 19.8 98.4 31.1 8.4 18.7 26.1 16.2 14.0 SNCAIP SYPH1 ENSG00000064692 "Synuclein alpha interacting protein" Q9Y6H5 5 122311354-122464219 "Disease related genes, Predicted intracellular proteins" "Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 22.6;ovary: 32.3" "Cell type enhanced" "Detected in many" 19 "Ciliated cells: 26.8;Early spermatids: 55.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "basophil: 9.9" "Lineage enriched" "Detected in single" 21 "granulocytes: 9.9" "Cell line enhanced" "Detected in some" "AF22: 7.7;BJ hTERT+: 7.4;HBF TERT88: 4.7;OE19: 5.8;RPMI-8226: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064687 Uncertain Supported "Nucleoplasm,Cytoplasmic bodies" NA NA "Cytoplasmic bodies" Nucleoplasm "HPA064687: AB_2685324" "unprognostic (7.28e-3)" "unprognostic (1.02e-2)" "unprognostic (3.01e-1)" "unprognostic (6.56e-2)" "unprognostic (2.18e-2)" "unprognostic (1.56e-1)" "unprognostic (1.47e-2)" "unprognostic (4.95e-2)" "unprognostic (1.95e-2)" "unprognostic (3.73e-1)" "unprognostic (3.52e-2)" "unprognostic (3.00e-1)" "unprognostic (5.98e-2)" "unprognostic (1.82e-3)" "unprognostic (5.77e-2)" "unprognostic (2.82e-1)" "unprognostic (2.44e-1)" 3.9 1.2 2.2 2.1 5.8 0.7 4.1 15.4 6.4 16.0 1.6 3.7 4.0 1.6 22.6 4.3 0.9 4.5 2.4 1.5 3.4 2.2 1.6 0.4 1.4 4.5 1.6 2.4 32.3 0.7 0.3 1.6 2.1 3.2 2.6 1.1 2.3 0.8 2.7 0.7 1.9 1.1 10.6 1.5 6.1 1.2 11.6 2.1 0.5 1.2 3.3 1.4 4.6 4.1 0.4 0.4 9.9 0.3 0.1 0.4 0.0 0.0 0.1 7.7 0.2 0.0 0.5 0.5 3.4 7.4 1.3 0.4 0.5 0.6 0.1 0.2 3.3 0.7 0.2 3.0 0.5 4.7 2.8 1.0 0.0 0.6 0.4 0.1 0.0 0.4 0.6 0.1 0.6 0.4 0.0 2.2 0.3 0.0 2.0 0.0 0.0 0.2 0.1 3.6 5.8 0.6 0.2 0.0 7.9 0.3 1.0 1.5 0.3 0.0 0.7 0.0 2.4 0.6 0.2 0.8 0.4 1.0 0.5 0.8 0.2 0.2 0.3 0.4 0.0 0.5 9.9 0.3 0.0 0.2 0.1 0.2 0.1 0.2 0.2 0.0 0.4 0.2 0.4 1.7 0.1 0.1 0.4 0.1 0.0 2.2 5.8 15.4 4.3 3.4 2.2 1.6 2.4 3.2 2.1 0.0 0.3 0.0 3.7 1.5 0.0 0.8 0.0 26.8 2.3 0.0 0.0 0.0 0.0 6.2 55.3 6.8 0.0 0.0 0.0 0.1 2.5 1.8 1.1 0.0 0.2 0.0 0.0 9.2 0.3 11.7 4.9 0.2 1.7 0.0 0.0 0.3 0.6 0.0 5.3 0.0 0.0 0.0 1.7 1.4 1.6 2.4 0.1 0.0 0.0 1.2 SNF8 "Dot3, EAP30, VPS22" ENSG00000159210 "SNF8, ESCRT-II complex subunit" Q96H20 17 48929316-48945117 "Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059320 Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA059320: AB_2683977" "unprognostic (7.85e-3)" "unprognostic (3.97e-3)" "unprognostic (2.25e-2)" "unprognostic (1.73e-1)" "unprognostic (4.39e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (7.64e-4)" "unprognostic (1.91e-1)" "unprognostic (1.58e-1)" "unprognostic (2.64e-1)" "unprognostic (1.73e-2)" "unprognostic (5.36e-2)" "prognostic unfavorable (2.81e-7)" "unprognostic (1.56e-2)" "unprognostic (1.22e-1)" "unprognostic (3.52e-1)" "unprognostic (1.38e-1)" 22.5 27.8 24.9 20.6 26.2 25.2 32.4 12.9 22.6 17.9 23.5 16.6 29.7 22.1 18.9 28.7 23.0 17.7 24.9 31.5 20.1 19.2 30.8 39.0 18.2 27.3 23.9 21.5 22.3 26.7 17.9 17.4 21.7 19.0 17.6 26.8 18.3 25.2 23.1 40.7 19.2 24.0 25.7 18.2 20.7 24.7 19.8 16.0 28.3 24.0 30.9 26.2 20.5 33.8 5.2 8.3 11.2 6.7 1.7 5.7 1.5 16.2 32.6 20.3 26.0 21.3 12.3 32.1 13.7 19.0 26.9 24.2 80.0 17.0 14.9 24.1 25.8 29.8 10.8 18.9 19.4 30.1 21.3 30.6 16.5 41.3 33.7 18.6 22.3 18.8 15.2 19.4 25.7 19.8 19.7 25.2 19.8 16.3 15.2 27.4 32.5 23.9 19.1 10.0 37.4 27.8 15.8 37.1 17.6 16.1 18.2 13.5 26.9 16.5 7.8 19.5 36.9 19.7 27.6 20.9 29.2 23.2 18.1 25.6 22.4 25.5 17.8 25.7 12.1 22.5 2.3 5.7 11.2 3.2 6.2 1.8 5.2 4.8 3.7 6.4 5.2 3.2 2.7 2.3 1.7 6.7 8.3 5.7 1.5 24.9 26.2 12.9 22.6 20.1 19.2 23.9 21.5 19.0 16.0 41.7 27.2 74.6 57.6 53.0 60.3 44.8 58.6 22.7 21.6 61.1 13.7 113.8 126.0 110.9 94.7 52.8 126.5 46.7 189.8 142.2 81.0 77.8 42.7 60.4 132.7 23.8 68.0 52.2 59.1 220.7 58.1 82.3 81.0 155.1 68.0 59.1 136.4 75.9 58.4 173.8 74.5 45.3 80.6 58.1 73.3 63.2 79.5 65.1 79.7 77.0 SNIP1 PML1 ENSG00000163877 "Smad nuclear interacting protein 1" Q8TAD8 1 37534449-37554344 "Disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing, RNA-mediated gene silencing" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036896 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036896: AB_10670244" "unprognostic (1.37e-1)" "unprognostic (2.83e-1)" "unprognostic (1.65e-3)" "unprognostic (7.24e-2)" "unprognostic (5.83e-2)" "unprognostic (8.30e-3)" "unprognostic (3.26e-2)" "unprognostic (3.66e-2)" "unprognostic (7.74e-2)" "unprognostic (5.01e-2)" "unprognostic (9.30e-2)" "unprognostic (5.34e-3)" "unprognostic (3.06e-2)" "unprognostic (6.78e-3)" "unprognostic (2.63e-2)" "unprognostic (1.63e-1)" "unprognostic (1.86e-1)" 10.6 13.4 10.6 13.3 12.4 15.9 15.0 18.4 14.4 12.8 10.8 10.0 14.2 8.5 14.2 11.9 13.5 11.9 10.0 8.5 11.1 9.0 9.9 20.6 10.2 11.7 10.8 10.5 12.7 15.3 9.8 13.1 13.2 9.9 13.3 9.0 12.3 11.7 11.5 13.5 13.2 12.3 11.6 7.9 14.9 11.8 21.7 11.6 16.9 10.5 11.1 14.0 11.7 17.0 3.7 4.3 4.6 3.5 3.1 5.5 1.8 6.2 3.5 7.0 6.9 8.4 8.0 4.8 8.0 9.1 7.7 6.7 3.4 5.7 8.6 6.3 8.5 5.0 6.6 6.5 7.3 6.4 7.7 9.4 13.2 6.2 6.9 9.6 12.2 7.5 7.7 8.6 7.6 9.7 8.3 7.4 6.7 9.3 8.0 5.4 4.7 7.2 9.5 11.3 5.2 8.1 7.6 11.8 7.2 5.6 6.0 5.6 11.3 8.5 5.5 10.4 7.6 4.9 6.7 12.2 6.1 6.8 7.5 7.9 9.5 11.0 7.1 7.2 8.7 5.4 4.1 3.1 3.9 5.5 2.8 5.4 3.7 3.7 5.3 2.6 3.6 5.1 4.5 4.6 3.1 3.5 4.3 4.2 1.8 10.6 12.4 18.4 14.4 11.1 9.0 10.8 10.5 9.9 11.6 17.9 14.8 3.4 10.6 14.3 10.1 4.8 5.1 10.7 19.4 5.2 7.9 4.7 1.7 6.3 4.6 6.5 7.3 0.0 6.2 4.0 8.4 7.8 11.5 10.0 3.9 9.5 8.1 12.3 8.1 7.9 7.5 5.2 8.5 7.2 8.6 11.3 6.5 6.0 7.4 3.5 15.4 0.0 7.5 10.2 13.2 15.7 8.5 10.2 6.6 11.2 SNORC "ASCL830, C2orf82, UNQ830" ENSG00000182600 "Secondary ossification center associated regulator of chondrocyte maturation" Q6UX34 2 232857270-232878708 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 27.9;breast: 19.6" "Group enriched" "Detected in some" 4 "Distal tubular cells: 5.0;Pancreatic endocrine cells: 9.1;Proximal tubular cells: 7.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "basophil: 6.3" "Lineage enriched" "Detected in single" 18 "granulocytes: 6.3" "Cell line enriched" "Detected in some" 14 "Hep G2: 36.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA052824 Approved Approved Nucleoplasm,Nucleoli "Intracellular and membrane" NA NA "Nucleoplasm, Nucleoli" "HPA052824: AB_2681964" "unprognostic (4.58e-3)" "unprognostic (1.31e-1)" "unprognostic (2.47e-2)" "prognostic unfavorable (3.56e-4)" "unprognostic (1.27e-1)" "unprognostic (2.11e-1)" "unprognostic (3.06e-1)" "unprognostic (4.71e-1)" "unprognostic (1.23e-3)" "unprognostic (3.52e-1)" "unprognostic (1.79e-1)" "unprognostic (2.00e-1)" "unprognostic (4.30e-7)" "unprognostic (1.83e-3)" "unprognostic (8.15e-2)" "unprognostic (1.58e-2)" "unprognostic (1.33e-2)" 1.4 1.5 4.8 0.8 6.4 1.5 19.6 2.8 9.0 0.3 2.4 9.3 0.0 2.7 0.7 2.0 0.3 0.4 0.3 0.4 8.8 7.8 1.2 2.1 1.3 1.7 11.9 7.0 0.5 4.2 0.7 0.3 0.9 9.1 3.0 1.1 0.0 3.2 0.6 2.8 10.8 2.0 0.6 27.9 1.4 1.3 6.2 7.4 0.0 0.9 0.0 0.5 0.5 0.0 0.0 0.0 6.3 0.0 0.0 0.3 0.0 0.6 0.0 0.2 0.9 0.6 1.0 1.5 0.1 0.0 0.2 0.4 0.0 0.1 0.0 0.4 0.1 0.3 0.3 0.0 0.0 0.0 0.4 1.3 0.3 0.2 36.4 0.5 0.0 1.1 0.0 0.9 0.2 0.5 0.4 1.0 0.4 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.0 1.4 0.2 0.3 0.2 0.0 0.5 0.1 0.5 0.2 0.0 1.3 0.6 0.0 1.6 0.5 0.1 0.5 0.5 0.4 2.4 2.5 0.1 0.0 0.8 0.2 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 6.4 2.8 9.0 8.8 7.8 11.9 7.0 9.1 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 5.0 0.5 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 SNRK "FLJ20224, HSNFRK, KIAA0096" ENSG00000163788 "SNF related kinase" Q9NRH2 3 43286512-43424764 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ito cells: 86.5;Sertoli cells: 122.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 51.9;TIME: 30.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042163 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions" NA NA "Vesicles, Plasma membrane, Cell Junctions" Nucleoplasm "HPA042163: AB_10794645" "prognostic favorable (9.28e-4)" "unprognostic (8.46e-2)" "unprognostic (2.79e-3)" "unprognostic (6.41e-2)" "unprognostic (1.14e-1)" "unprognostic (1.16e-3)" "unprognostic (2.00e-2)" "unprognostic (1.08e-1)" "unprognostic (2.63e-3)" "unprognostic (4.25e-1)" "unprognostic (2.32e-1)" "unprognostic (4.68e-2)" "prognostic favorable (9.41e-5)" "unprognostic (9.21e-3)" "unprognostic (2.04e-1)" "unprognostic (7.06e-3)" "unprognostic (7.38e-2)" 31.5 8.8 9.8 13.1 14.4 41.0 22.6 34.5 21.1 17.6 14.4 7.9 5.9 12.8 20.9 10.5 16.2 11.5 16.4 13.9 11.0 11.0 16.8 20.3 24.7 19.8 11.4 10.6 15.1 18.0 18.4 16.2 26.2 22.5 12.1 9.9 14.7 10.7 9.4 12.5 24.5 17.0 18.7 9.8 25.4 11.2 13.9 7.2 48.4 24.8 13.5 14.4 15.8 19.3 3.2 3.0 20.9 5.5 8.1 10.7 6.5 3.3 2.0 3.8 3.6 11.3 4.0 3.6 3.6 6.1 3.9 3.8 2.8 4.8 5.3 2.8 4.5 2.6 2.1 4.4 7.7 4.1 6.0 3.6 6.0 3.8 3.2 5.9 6.7 6.7 4.5 5.3 4.4 7.5 4.0 51.9 6.1 2.6 6.1 3.5 1.7 6.8 5.9 4.2 1.8 9.3 4.7 2.8 5.5 10.1 5.7 2.7 5.6 3.1 3.3 4.3 3.4 2.3 8.6 30.2 3.4 3.5 3.9 4.1 9.9 7.1 4.5 2.4 8.1 4.9 4.8 2.8 5.4 7.6 5.5 10.7 2.8 6.7 7.6 3.0 3.2 10.1 10.1 20.9 8.1 5.0 0.9 7.1 6.5 9.8 14.4 34.5 21.1 11.0 11.0 11.4 10.6 22.5 7.2 29.8 30.3 12.9 9.7 46.9 49.8 14.5 22.9 16.0 18.2 15.7 15.7 6.3 10.0 9.2 40.0 52.3 28.4 0.0 7.8 2.7 11.8 9.9 13.9 21.3 11.3 28.6 10.4 86.5 27.6 4.9 11.5 16.6 21.9 4.6 8.9 15.6 8.4 8.2 11.0 10.4 17.2 122.9 26.4 10.7 15.7 44.8 6.9 41.7 8.5 15.4 SNRNP200 "ASCC3L1, BRR2, HELIC2, KIAA0788, RP33, U5-200KD" ENSG00000144028 "Small nuclear ribonucleoprotein U5 subunit 200" O75643 2 96274336-96305515 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029321 Approved Supported Nucleoplasm NA NA 6600 Nucleoplasm "HPA029321: AB_10604096" "unprognostic (2.63e-2)" "unprognostic (1.45e-1)" "unprognostic (1.44e-1)" "prognostic unfavorable (3.89e-4)" "unprognostic (1.50e-1)" "unprognostic (1.09e-1)" "unprognostic (2.48e-3)" "unprognostic (1.01e-1)" "unprognostic (1.75e-1)" "unprognostic (1.74e-1)" "unprognostic (3.10e-1)" "unprognostic (6.46e-2)" "unprognostic (2.61e-2)" "unprognostic (1.82e-1)" "unprognostic (2.69e-1)" "unprognostic (1.50e-1)" "unprognostic (1.03e-1)" 26.6 25.2 18.4 28.4 21.9 32.0 26.1 37.2 25.8 24.4 23.6 23.7 20.6 18.4 34.7 22.6 23.4 26.5 22.0 22.0 19.7 12.3 19.0 25.8 22.7 25.1 16.6 18.9 39.3 22.7 49.4 25.2 33.7 18.9 21.3 22.0 25.5 28.3 23.0 39.7 25.3 27.6 28.3 15.8 25.2 23.4 34.3 19.5 57.3 25.3 21.3 31.2 33.7 24.0 8.5 7.7 15.3 7.5 9.1 12.6 6.0 23.1 26.3 35.4 26.5 16.5 14.6 33.3 16.0 19.6 29.4 28.1 47.9 17.0 40.4 25.4 20.5 44.7 18.4 64.9 21.8 30.4 21.8 34.3 51.6 41.9 25.9 10.7 39.5 22.7 15.1 13.6 33.4 28.4 15.5 23.8 23.9 45.1 27.2 16.9 20.2 37.0 11.8 46.0 19.1 25.5 43.8 34.3 25.3 11.4 34.3 39.3 37.4 26.0 22.3 16.6 42.5 21.3 24.7 20.6 24.5 29.7 24.8 23.1 25.3 29.8 50.3 16.6 26.4 26.1 15.3 5.6 7.5 10.1 7.0 12.2 7.8 7.8 12.6 7.3 8.5 7.6 9.3 6.2 9.1 7.5 7.7 8.5 6.0 18.4 21.9 37.2 25.8 19.7 12.3 16.6 18.9 18.9 19.5 41.7 51.7 49.6 23.8 26.3 74.3 30.5 71.4 40.2 45.5 48.8 98.2 36.0 5.0 36.2 22.5 41.7 37.6 23.3 40.2 31.2 30.8 30.4 24.3 42.9 30.8 82.6 44.9 33.2 27.5 10.6 53.2 32.3 16.9 37.9 40.6 92.0 36.3 35.1 51.9 14.6 128.6 64.7 38.7 86.5 54.9 28.9 37.3 66.0 41.3 27.3 SNRNP25 "C16orf33, U11/U12-25K" ENSG00000161981 "Small nuclear ribonucleoprotein U11/U12 subunit 25" Q9BV90 16 53010-57669 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 56.9;skeletal muscle: 63.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 56.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041183, HPA044248" Uncertain Supported "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes No Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA041183: AB_2677353, HPA044248: AB_2678873" "unprognostic (7.87e-2)" "prognostic favorable (1.95e-4)" "unprognostic (6.04e-2)" "unprognostic (5.03e-2)" "unprognostic (2.04e-1)" "unprognostic (5.99e-2)" "unprognostic (1.17e-1)" "unprognostic (4.27e-2)" "unprognostic (1.64e-1)" "unprognostic (8.99e-2)" "unprognostic (4.32e-3)" "unprognostic (1.60e-1)" "prognostic favorable (1.16e-5)" "unprognostic (1.51e-1)" "unprognostic (1.52e-1)" "unprognostic (1.45e-1)" "unprognostic (6.03e-3)" 7.1 10.1 31.4 11.5 25.4 15.6 7.4 15.7 31.2 7.1 9.7 6.8 5.4 7.2 6.6 9.6 8.8 8.8 6.3 28.7 25.0 22.6 11.7 16.4 5.4 16.4 28.1 20.3 10.9 10.8 7.7 10.8 4.9 24.7 9.8 10.1 7.5 12.6 8.4 63.7 4.3 6.4 8.6 13.5 6.6 10.2 6.4 7.7 9.4 9.4 11.0 16.4 6.8 4.8 18.0 56.9 23.2 9.9 5.2 6.5 5.7 11.6 26.5 14.7 17.1 5.3 6.3 7.2 9.9 6.4 22.2 18.8 35.6 11.4 37.0 11.8 8.1 11.9 12.0 26.9 18.2 17.1 13.3 20.9 21.4 37.0 35.6 5.6 39.1 25.5 8.0 6.5 19.7 5.5 4.8 11.9 22.4 32.0 8.8 12.6 55.2 20.5 16.3 17.6 20.8 13.0 33.1 15.7 44.2 11.7 8.2 16.2 10.5 22.3 29.0 4.8 15.1 18.7 19.1 9.3 9.8 12.3 12.6 15.8 9.2 21.7 57.4 5.2 21.0 15.0 2.8 6.6 23.2 4.0 9.9 5.0 17.5 4.2 4.9 12.8 18.0 4.5 4.5 4.5 5.2 8.5 56.9 6.5 5.7 31.4 25.4 15.7 31.2 25.0 22.6 28.1 20.3 24.7 7.7 11.9 11.0 47.7 21.4 16.6 18.1 96.8 15.3 44.2 9.1 31.4 3.9 47.2 132.6 34.7 1.7 16.8 21.9 23.3 44.3 49.4 26.3 35.5 4.6 52.5 99.3 11.1 42.3 11.6 18.6 4.5 19.8 52.0 59.1 138.9 29.1 45.5 30.9 42.9 28.0 74.2 12.0 6.5 32.0 32.0 47.5 19.2 21.9 20.1 45.1 16.3 SNRNP27 "RY1, U4/U6.U5-27K" ENSG00000124380 "Small nuclear ribonucleoprotein U4/U6.U5 subunit 27" Q8WVK2 2 69893560-69905575 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034541 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA034541: AB_10602408" "unprognostic (2.24e-1)" "unprognostic (6.11e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (2.33e-4)" "unprognostic (4.89e-2)" "unprognostic (1.28e-2)" "unprognostic (1.03e-2)" "unprognostic (1.29e-1)" "unprognostic (1.61e-2)" "unprognostic (1.30e-2)" "unprognostic (1.26e-1)" "unprognostic (3.18e-1)" "unprognostic (4.35e-3)" "unprognostic (9.12e-2)" "unprognostic (2.16e-1)" "unprognostic (2.26e-1)" "unprognostic (1.86e-1)" 20.4 24.3 35.1 15.8 28.0 25.9 19.3 25.4 27.3 14.4 12.9 18.3 12.7 12.6 17.2 19.2 13.7 13.7 15.3 27.2 27.5 28.4 17.5 16.9 13.8 20.8 28.7 23.2 16.5 12.7 18.7 26.5 20.6 22.7 17.6 15.0 12.1 14.4 14.4 73.7 14.1 14.6 16.4 31.4 15.1 12.7 9.8 21.9 15.1 18.9 12.3 18.7 15.4 20.1 24.1 26.6 23.6 16.9 19.4 19.7 14.9 10.7 5.8 19.4 12.1 17.2 18.8 15.8 14.8 17.0 20.0 16.4 12.4 12.1 10.7 12.6 11.4 21.4 6.3 12.4 5.8 26.1 12.7 13.3 13.3 6.0 16.0 16.0 16.0 23.5 13.3 14.2 13.5 11.7 17.2 15.6 17.0 17.5 19.2 26.4 5.8 22.6 29.1 14.9 11.6 6.5 18.0 16.5 11.8 23.0 7.0 20.3 16.4 11.1 12.3 16.4 15.5 11.0 13.6 9.9 15.3 20.7 20.8 22.2 11.9 11.4 17.8 13.7 19.8 28.2 22.5 16.9 23.6 16.3 14.8 17.0 24.1 17.7 15.6 13.7 21.0 19.7 19.3 9.0 19.4 14.7 26.6 18.8 14.9 35.1 28.0 25.4 27.3 27.5 28.4 28.7 23.2 22.7 21.9 50.6 38.3 74.4 35.1 43.6 30.5 52.0 45.9 54.9 34.2 59.3 13.7 41.3 63.0 54.7 23.4 36.9 31.8 23.3 47.8 49.9 48.9 30.4 56.8 71.5 49.6 22.3 37.4 52.8 53.1 8.5 47.5 52.7 35.4 43.3 39.6 35.8 50.5 42.1 54.5 41.9 29.5 38.8 46.7 71.9 58.1 40.3 43.9 49.8 34.9 32.9 SNRNP48 "C6orf151, dJ336K20B.1, dJ512B11.2, FLJ32234" ENSG00000168566 "Small nuclear ribonucleoprotein U11/U12 subunit 48" Q6IEG0 6 7590199-7611967 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029234 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029234: AB_10604097" "prognostic unfavorable (8.30e-4)" "unprognostic (3.46e-2)" "unprognostic (2.65e-1)" "unprognostic (9.65e-2)" "unprognostic (1.07e-2)" "unprognostic (1.54e-1)" "unprognostic (9.46e-3)" "unprognostic (2.55e-1)" "unprognostic (9.87e-3)" "unprognostic (1.62e-2)" "unprognostic (1.57e-1)" "unprognostic (2.03e-1)" "prognostic unfavorable (4.16e-4)" "unprognostic (1.55e-1)" "unprognostic (8.70e-2)" "unprognostic (1.41e-2)" "unprognostic (1.03e-1)" 9.5 7.1 12.3 11.7 14.9 15.6 12.6 28.9 13.3 10.5 10.3 7.0 13.6 9.9 11.7 8.6 9.4 9.2 7.1 12.2 11.9 7.5 10.7 12.7 8.6 11.7 14.1 8.1 14.4 10.5 7.3 11.0 9.2 11.4 10.5 10.1 5.9 10.1 13.0 15.8 11.0 11.5 10.5 17.8 11.2 9.6 5.3 14.3 15.3 10.4 7.1 10.0 9.9 30.2 3.3 2.7 6.0 2.0 2.7 3.7 1.7 5.7 4.6 9.7 18.0 5.2 7.7 6.5 6.6 6.1 7.2 8.0 9.8 4.7 13.6 7.1 5.4 6.9 7.4 12.0 7.1 11.1 10.4 11.7 9.8 14.7 18.8 5.5 11.6 6.5 5.4 11.0 8.1 6.2 8.6 6.2 12.2 13.6 2.2 10.0 3.2 19.0 16.9 13.1 9.9 5.2 20.5 8.4 18.2 6.5 5.1 15.0 4.1 12.8 3.3 11.3 18.7 6.5 4.1 6.9 9.6 4.3 5.6 11.3 3.5 19.4 8.4 3.2 9.3 17.1 0.4 2.0 1.0 2.0 1.4 3.4 1.7 2.4 2.6 2.4 3.3 2.1 3.7 6.0 2.7 0.8 2.7 1.7 1.7 12.3 14.9 28.9 13.3 11.9 7.5 14.1 8.1 11.4 14.3 17.9 9.3 14.1 18.6 31.7 17.1 25.2 5.1 8.1 21.6 8.7 19.6 13.5 10.0 15.9 2.2 20.2 18.4 0.0 17.5 12.7 12.9 15.7 23.1 19.5 13.7 4.8 10.9 13.5 16.4 2.2 16.4 16.3 8.5 21.6 15.0 15.3 10.9 15.2 15.6 13.5 17.2 6.5 17.9 10.2 17.9 29.6 13.6 17.5 13.8 18.0 SNRNP70 "RNPU1Z, RPU1, Snp1, SNRP70, U1-70K" ENSG00000104852 "Small nuclear ribonucleoprotein U1 subunit 70" P08621 19 49085419-49108605 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001718, HPA042050, HPA043516" Supported Enhanced Nucleoplasm NA NA 30000 Nucleoplasm "CAB001718: , HPA042050: AB_2677821, HPA043516: AB_2678523" "unprognostic (2.22e-3)" "unprognostic (5.27e-2)" "unprognostic (9.13e-3)" "unprognostic (1.05e-1)" "unprognostic (6.66e-2)" "unprognostic (2.58e-2)" "unprognostic (4.01e-3)" "unprognostic (2.17e-1)" "unprognostic (1.15e-1)" "unprognostic (1.00e-1)" "prognostic favorable (4.59e-5)" "unprognostic (3.63e-3)" "prognostic unfavorable (6.12e-5)" "unprognostic (5.18e-3)" "unprognostic (6.87e-2)" "unprognostic (3.03e-1)" "prognostic favorable (5.35e-5)" 46.9 46.5 50.1 65.8 57.0 51.9 29.8 89.6 73.1 36.7 36.2 40.5 46.5 45.8 44.0 38.8 38.9 34.0 35.4 33.3 46.5 34.6 30.6 35.0 29.3 47.6 53.8 49.0 43.3 36.1 37.8 41.8 34.3 43.4 43.0 27.3 26.6 42.7 52.7 73.5 48.1 44.6 28.5 41.5 45.6 45.2 30.5 58.1 34.9 39.8 25.6 37.3 26.9 35.0 5.3 3.2 3.2 3.7 7.9 3.9 1.2 34.5 40.0 28.1 20.1 11.5 7.1 34.5 26.8 16.5 28.1 24.2 24.3 20.4 42.3 25.9 17.3 23.4 30.9 34.8 25.3 20.8 27.7 92.8 38.6 20.1 27.6 6.0 41.7 26.0 9.9 7.0 20.0 13.6 12.7 20.9 20.2 39.5 13.1 16.7 29.9 43.0 66.6 35.6 18.6 34.6 50.0 27.9 24.7 17.1 21.6 24.2 28.7 33.6 18.9 17.8 19.3 20.0 25.1 31.1 20.6 38.7 18.0 42.9 34.9 29.4 51.5 17.4 27.2 19.3 1.5 3.7 3.2 3.6 2.5 2.1 5.3 2.3 1.5 3.2 3.5 3.9 2.3 1.7 7.9 1.9 2.8 2.4 1.2 50.1 57.0 89.6 73.1 46.5 34.6 53.8 49.0 43.4 58.1 17.9 62.4 92.3 143.3 123.9 97.6 25.0 56.0 36.1 47.8 71.5 84.4 155.8 39.7 97.0 14.1 68.1 71.8 23.3 90.8 176.6 99.6 110.3 53.2 72.3 109.6 108.1 113.3 63.3 61.9 12.5 120.6 80.2 65.8 77.5 97.3 96.3 92.5 74.8 104.0 62.4 104.8 122.9 97.6 108.5 89.7 114.3 147.5 77.8 98.4 135.5 SNRPA "Mud1, U1-A, U1A" ENSG00000077312 "Small nuclear ribonucleoprotein polypeptide A" P09012 19 40750637-40765389 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004652, HPA046440, HPA054834" Supported Supported Nucleoplasm NA NA 23000 Nucleoplasm "CAB004652: AB_425687, HPA046440: AB_2679668, HPA054834: AB_2682619" "unprognostic (3.53e-2)" "prognostic favorable (2.50e-4)" "unprognostic (3.78e-2)" "unprognostic (2.10e-1)" "unprognostic (3.30e-1)" "unprognostic (5.19e-2)" "prognostic unfavorable (1.34e-5)" "unprognostic (1.03e-1)" "unprognostic (8.04e-2)" "unprognostic (9.08e-3)" "unprognostic (1.81e-1)" "unprognostic (3.38e-2)" "prognostic unfavorable (2.96e-9)" "unprognostic (2.52e-2)" "unprognostic (1.05e-1)" "unprognostic (4.80e-2)" "unprognostic (7.01e-3)" 27.6 25.0 28.1 35.8 30.8 44.0 39.2 28.8 32.6 31.9 31.8 16.7 33.8 31.2 35.2 35.5 32.8 31.3 27.0 23.6 23.4 19.2 26.9 26.6 28.2 56.3 26.9 19.7 44.7 34.8 16.1 30.6 23.4 25.1 32.3 29.0 19.5 29.7 37.4 43.1 26.6 36.2 41.8 36.4 40.4 27.2 30.9 29.8 49.8 35.1 34.0 37.9 33.2 47.4 14.8 29.9 3.8 17.2 14.2 18.2 11.9 35.0 31.1 35.6 28.6 9.5 11.9 30.4 12.1 16.9 32.6 35.5 25.6 29.1 42.9 18.1 16.1 17.0 26.7 35.1 31.5 30.0 23.6 38.3 31.3 25.7 32.0 14.7 35.7 20.7 11.2 7.6 20.9 35.1 18.1 28.6 38.4 34.8 23.6 21.7 28.8 67.2 56.8 38.1 27.7 26.3 58.8 24.7 33.8 21.7 18.7 27.9 28.4 23.8 25.5 19.8 20.5 25.4 33.0 15.6 17.3 31.1 18.3 30.4 26.2 29.1 63.2 17.7 39.5 22.1 1.6 15.1 3.8 16.1 17.2 16.8 14.8 16.5 18.2 29.9 13.9 16.9 15.9 1.4 14.2 8.1 18.3 16.2 11.9 28.1 30.8 28.8 32.6 23.4 19.2 26.9 19.7 25.1 29.8 11.9 17.5 38.8 43.7 31.9 7.3 6.7 10.2 10.7 9.1 24.4 2.0 85.1 36.5 38.9 27.1 32.1 28.5 23.3 42.4 104.6 31.5 29.9 32.3 19.0 53.5 4.8 31.8 26.4 24.7 11.0 34.5 31.3 21.9 53.3 40.3 13.4 36.0 23.0 26.5 26.9 4.0 19.4 25.8 49.2 68.5 29.0 55.5 38.3 59.0 33.6 SNRPA1 Lea1 ENSG00000131876 "Small nuclear ribonucleoprotein polypeptide A'" P09661 15 101281510-101295282 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045622, HPA048499" Supported Supported "Nucleoplasm,Nuclear speckles,Nuclear bodies" NA NA Nucleoplasm "Nuclear speckles, Nuclear bodies" "HPA045622: AB_2679394, HPA048499: AB_2680421" "unprognostic (2.73e-1)" "unprognostic (1.48e-1)" "unprognostic (8.09e-2)" "unprognostic (2.20e-1)" "unprognostic (8.08e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (8.56e-5)" "unprognostic (5.80e-2)" "unprognostic (1.66e-3)" "prognostic favorable (8.83e-5)" "unprognostic (4.74e-2)" "unprognostic (6.77e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.06e-2)" "unprognostic (2.84e-1)" "unprognostic (2.43e-1)" "unprognostic (1.37e-2)" 11.9 13.3 12.4 26.1 19.6 35.2 17.7 9.7 17.2 9.9 18.0 10.2 10.4 14.6 14.3 21.1 24.6 12.4 11.8 17.3 17.9 9.8 16.1 19.7 14.1 29.2 11.2 12.2 10.8 16.3 9.1 10.7 29.3 14.1 10.3 19.3 11.3 17.2 9.1 13.4 12.1 22.5 11.7 9.4 26.4 15.9 24.3 7.0 33.4 11.6 18.1 30.0 12.3 12.2 21.7 23.5 8.4 18.2 18.3 26.9 15.3 31.5 22.1 21.4 10.8 6.0 5.0 21.0 29.5 13.6 26.5 20.2 47.2 28.3 35.2 16.9 19.9 20.8 18.9 31.9 21.0 28.5 17.8 49.3 27.6 36.0 24.9 4.6 31.6 19.8 4.0 15.8 16.9 21.3 5.9 17.0 27.3 38.4 33.2 16.2 35.1 31.8 33.6 27.3 42.5 18.8 31.8 23.1 35.5 19.3 83.2 16.7 17.6 18.0 20.6 22.2 23.4 19.8 25.0 12.3 14.2 26.9 16.5 29.3 27.5 81.2 68.5 11.5 29.9 16.7 1.4 15.0 8.4 24.6 18.2 24.1 21.7 25.4 24.2 23.5 19.1 21.2 26.3 2.9 18.3 16.6 22.3 26.9 15.3 12.4 19.6 9.7 17.2 17.9 9.8 11.2 12.2 14.1 7.0 17.9 53.6 59.5 65.8 58.3 35.1 25.2 15.3 45.5 37.5 34.9 11.8 110.2 58.0 79.4 34.5 35.0 39.1 93.5 94.8 120.7 56.9 51.6 62.5 29.7 59.4 35.0 25.9 25.8 23.7 11.4 32.2 36.6 40.5 102.8 40.2 29.4 78.7 40.3 26.9 68.5 28.5 12.9 49.2 116.7 62.4 44.3 93.9 69.8 47.8 83.9 SNRPB "COD, Sm-B/B', SmB/SmB', snRNP-B, SNRPB1" ENSG00000125835 "Small nuclear ribonucleoprotein polypeptides B and B1" P14678 20 2461634-2470853 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003482, CAB009610, HPA067842" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB009610: AB_2193859, HPA003482: AB_1857337, HPA067842: AB_2685909" "unprognostic (2.33e-1)" "unprognostic (3.14e-2)" "unprognostic (5.64e-2)" "unprognostic (2.73e-2)" "unprognostic (9.47e-2)" "unprognostic (2.04e-2)" "prognostic unfavorable (1.07e-5)" "unprognostic (5.11e-2)" "unprognostic (3.66e-1)" "unprognostic (4.66e-2)" "unprognostic (7.30e-2)" "unprognostic (4.20e-2)" "unprognostic (2.21e-1)" "unprognostic (2.79e-1)" "unprognostic (1.13e-1)" "unprognostic (9.18e-2)" "unprognostic (9.47e-2)" 26.6 28.5 14.8 41.1 16.4 78.9 29.0 20.8 17.7 26.3 33.6 10.6 26.8 27.1 34.4 30.2 46.7 26.8 29.6 29.2 10.9 9.9 26.2 36.4 29.3 39.5 18.3 16.5 29.5 34.4 14.7 20.7 35.7 16.6 23.9 23.4 16.0 29.6 21.2 43.8 37.9 27.9 23.4 12.3 39.5 26.9 30.3 15.6 60.1 29.3 51.0 39.6 24.7 28.1 57.9 65.0 36.8 56.9 41.7 63.8 63.7 79.9 109.8 39.6 36.4 8.9 16.0 45.0 35.3 26.9 72.9 59.4 127.0 58.2 60.2 22.6 20.5 58.6 59.2 38.2 65.1 36.9 24.7 68.0 41.3 22.1 118.2 31.3 57.2 25.4 18.3 25.3 59.4 26.2 13.8 40.4 51.1 56.8 43.7 29.7 55.3 89.7 91.5 87.7 40.9 53.3 54.6 40.6 72.8 27.2 42.5 42.8 47.0 43.1 58.7 50.4 17.9 54.6 63.1 27.9 43.5 36.6 38.1 78.8 36.5 91.6 90.1 14.7 63.5 44.0 36.8 47.1 35.3 59.4 56.9 49.9 57.6 53.0 52.4 62.4 57.9 43.5 50.5 24.4 41.7 56.4 65.0 63.8 63.7 14.8 16.4 20.8 17.7 10.9 9.9 18.3 16.5 16.6 15.6 41.7 62.5 219.0 273.7 425.2 44.2 16.1 112.1 78.9 95.5 89.0 11.8 311.6 122.7 297.7 13.8 155.8 105.2 46.7 256.3 535.0 176.5 161.5 141.9 50.0 256.0 28.6 136.2 82.3 85.0 16.6 147.3 183.9 180.5 230.0 159.2 57.0 307.2 168.6 116.3 108.3 40.4 155.2 220.0 302.7 322.8 369.9 312.3 182.1 238.2 375.6 SNRPC "U1-C, Yhc1" ENSG00000124562 "Small nuclear ribonucleoprotein polypeptide C" P09234 6 34757406-34773794 "Plasma proteins, Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034338, HPA042419, HPA055490" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB034338: AB_2295245, HPA042419: AB_2677989, HPA055490: AB_2682833" "unprognostic (1.84e-1)" "unprognostic (3.73e-2)" "unprognostic (1.59e-1)" "unprognostic (2.32e-3)" "unprognostic (1.45e-1)" "unprognostic (3.93e-2)" "prognostic unfavorable (5.65e-4)" "unprognostic (1.48e-2)" "unprognostic (6.16e-2)" "unprognostic (1.16e-3)" "unprognostic (7.71e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (8.20e-5)" "unprognostic (4.39e-2)" "unprognostic (8.64e-2)" "unprognostic (1.52e-1)" "unprognostic (2.62e-2)" 20.9 24.6 28.3 25.5 29.5 56.2 23.5 19.0 26.7 20.3 28.2 19.0 26.9 26.6 28.5 33.7 28.1 32.1 31.6 56.8 24.4 22.4 26.7 34.9 25.3 36.3 27.4 28.3 26.3 62.5 18.5 19.5 27.1 23.8 22.9 24.3 19.7 30.6 26.5 54.9 20.7 27.3 25.0 29.3 28.6 25.5 66.6 26.3 39.8 36.9 47.2 33.7 24.1 21.0 58.6 53.4 32.6 56.7 38.4 58.3 55.5 47.4 29.4 38.7 50.4 21.0 20.5 29.8 27.2 30.0 54.6 46.2 50.6 18.8 53.4 36.5 33.8 38.2 22.9 58.2 40.7 44.5 35.6 61.4 41.2 25.1 69.7 36.5 52.3 26.3 25.3 39.7 55.4 39.5 21.7 34.5 52.2 66.1 31.2 39.3 39.8 62.6 86.6 42.2 70.8 35.9 43.4 32.7 51.3 35.2 20.3 48.0 34.4 24.4 25.2 59.6 26.2 38.7 79.3 22.9 33.6 39.4 27.3 66.2 34.7 90.1 75.1 15.2 91.7 56.9 26.8 43.8 32.6 35.3 50.1 40.4 58.6 43.5 40.4 50.3 51.0 47.4 43.0 7.9 38.4 56.7 53.4 58.3 55.5 28.3 29.5 19.0 26.7 24.4 22.4 27.4 28.3 23.8 26.3 113.2 104.2 62.5 63.3 39.0 23.7 207.1 84.1 131.2 119.4 64.6 23.6 209.0 160.8 134.3 96.2 66.7 54.9 23.3 135.8 171.0 97.6 66.3 77.5 85.5 197.4 27.0 87.2 63.8 66.9 49.1 51.2 87.8 60.8 201.0 86.3 68.5 129.0 73.7 39.3 158.4 33.1 64.7 62.8 146.4 108.6 39.1 94.7 91.6 100.0 62.6 SNRPD3 "Sm-D3, SMD3" ENSG00000100028 "Small nuclear ribonucleoprotein D3 polypeptide" P62318 22 24555503-24609980 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001170 Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 360000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA001170: AB_1080042" "unprognostic (3.30e-1)" "unprognostic (1.63e-2)" "unprognostic (9.15e-2)" "unprognostic (1.95e-1)" "unprognostic (3.01e-2)" "unprognostic (6.28e-3)" "unprognostic (4.49e-2)" "unprognostic (2.03e-1)" "unprognostic (4.44e-2)" "unprognostic (1.13e-3)" "unprognostic (1.20e-2)" "unprognostic (3.52e-2)" "unprognostic (3.64e-2)" "unprognostic (2.91e-1)" "unprognostic (1.44e-1)" "unprognostic (2.87e-1)" "unprognostic (1.65e-2)" 23.7 31.8 23.8 28.9 23.3 29.7 29.5 27.1 27.4 29.3 38.3 24.7 29.8 27.9 31.6 30.6 41.8 30.8 27.1 31.6 21.8 24.2 38.5 61.6 26.5 36.4 24.3 26.8 33.9 34.0 27.8 31.8 33.3 22.6 27.8 33.1 27.9 42.9 27.3 59.0 26.7 35.5 29.6 25.5 32.3 27.8 22.4 23.1 46.8 39.2 61.0 42.7 27.1 30.2 42.5 39.0 38.1 34.9 36.6 33.2 29.8 40.8 14.0 44.0 15.9 16.5 14.3 16.6 39.9 18.3 39.8 37.1 20.0 15.8 36.4 18.9 24.9 22.5 30.9 55.9 48.9 40.5 27.8 57.1 39.2 28.3 30.0 18.0 96.5 24.6 16.3 22.7 43.1 22.6 20.0 28.9 36.6 26.8 18.5 16.2 20.8 41.1 24.1 24.3 59.9 20.3 39.6 46.1 18.9 35.4 31.7 20.7 23.0 25.5 16.7 21.2 41.6 25.1 26.3 30.5 33.2 33.3 16.6 29.5 19.1 36.9 67.0 16.4 33.3 22.4 12.2 31.4 38.1 28.2 34.9 31.3 42.5 30.7 30.6 39.0 36.3 29.4 33.2 15.7 36.6 34.7 37.1 28.9 29.8 23.8 23.3 27.1 27.4 21.8 24.2 24.3 26.8 22.6 23.1 89.3 66.8 98.3 99.5 96.5 53.8 84.4 107.0 99.0 103.5 123.9 33.4 200.2 247.1 146.4 83.4 72.8 133.3 46.7 100.1 182.6 81.8 90.9 84.3 175.2 153.4 36.5 106.7 63.8 76.9 64.2 107.6 83.1 64.1 146.1 105.1 109.1 116.0 112.2 111.4 223.0 50.7 64.7 75.6 104.2 134.4 99.4 150.8 87.3 125.1 101.6 SNRPG Sm-G ENSG00000143977 "Small nuclear ribonucleoprotein polypeptide G" P62308 2 70281362-70293771 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA064152, HPA067814" Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA064152: AB_2685199, HPA067814: AB_2685903" "unprognostic (6.42e-2)" "unprognostic (7.89e-2)" "unprognostic (6.10e-2)" "unprognostic (5.42e-2)" "unprognostic (1.29e-1)" "unprognostic (1.11e-3)" "unprognostic (1.75e-3)" "unprognostic (2.28e-2)" "unprognostic (3.60e-3)" "unprognostic (6.19e-2)" "unprognostic (1.00e-2)" "unprognostic (9.14e-2)" "prognostic unfavorable (1.08e-6)" "unprognostic (4.37e-2)" "unprognostic (1.33e-1)" "unprognostic (8.96e-2)" "unprognostic (1.41e-2)" 24.8 40.2 22.8 36.4 26.4 40.3 34.8 16.7 23.1 21.1 34.3 14.3 29.0 25.5 25.4 42.8 40.3 19.5 28.5 33.6 24.0 18.6 35.2 38.9 25.5 36.3 30.5 25.0 22.7 37.7 10.0 29.5 36.1 27.4 22.8 32.8 16.7 38.9 33.2 57.3 17.6 26.0 24.6 34.0 33.8 26.1 33.9 27.9 33.8 28.8 42.2 36.6 22.1 47.3 51.2 69.6 43.1 55.0 33.2 57.2 63.6 48.9 51.4 53.0 30.6 19.1 20.6 47.6 32.2 28.9 42.5 39.6 88.6 32.7 44.0 24.5 25.0 52.2 32.5 52.1 44.4 45.7 40.7 51.0 58.4 35.1 109.4 25.4 73.6 41.9 18.3 25.2 40.0 39.8 17.4 42.7 38.0 77.8 32.5 33.4 58.3 63.8 118.2 57.0 60.5 42.9 43.5 65.2 51.6 60.5 45.7 30.5 27.2 29.8 25.6 35.5 33.7 25.7 60.1 29.3 30.5 58.6 31.9 64.2 25.5 26.5 90.0 27.4 63.3 33.1 31.0 43.8 43.1 40.4 55.0 40.7 51.2 56.0 46.3 51.0 40.9 45.6 53.7 21.9 33.2 54.9 69.6 57.2 63.6 22.8 26.4 16.7 23.1 24.0 18.6 30.5 25.0 27.4 27.9 187.6 179.7 207.0 263.9 265.7 86.8 143.2 165.6 295.8 176.3 191.9 31.4 575.2 452.6 350.1 21.6 194.3 190.4 163.5 341.1 649.7 230.3 272.1 204.8 326.8 339.5 62.0 179.0 173.1 183.0 38.3 162.8 237.5 212.6 352.5 202.6 251.2 356.9 212.7 149.6 501.2 70.3 181.1 181.0 261.1 342.4 278.2 436.2 244.5 250.8 301.5 SNRPN "HCERN3, PWCR, RT-LI, SM-D, SMN, SNRNP-N, SNURF-SNRPN" ENSG00000128739 "Small nuclear ribonucleoprotein polypeptide N" P63162 15 24823637-24978723 "Plasma proteins, Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 388.0;Horizontal cells: 314.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 117.7;SuSa: 79.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003482, HPA067842" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA003482: AB_1857337, HPA067842: AB_2685909" "unprognostic (9.91e-2)" "unprognostic (1.03e-3)" "unprognostic (2.79e-1)" "unprognostic (1.66e-2)" "unprognostic (3.71e-2)" "unprognostic (2.32e-2)" "unprognostic (1.08e-1)" "unprognostic (2.72e-2)" "unprognostic (9.44e-3)" "unprognostic (1.30e-1)" "unprognostic (1.04e-2)" "unprognostic (6.59e-2)" "prognostic favorable (8.93e-8)" "unprognostic (4.45e-2)" "unprognostic (1.63e-1)" "unprognostic (1.86e-1)" "unprognostic (6.74e-2)" 7.9 35.1 62.2 7.8 73.4 5.6 13.0 65.6 74.7 21.4 9.4 18.4 14.2 6.5 11.6 64.8 8.0 22.8 25.9 84.7 55.9 68.3 35.8 12.4 13.0 14.9 51.3 47.4 28.4 20.3 49.8 42.8 6.5 51.6 33.0 6.4 17.3 22.4 29.1 34.9 6.3 7.9 10.9 31.9 13.3 10.3 9.6 21.3 9.9 55.5 6.8 14.1 12.9 7.8 48.6 71.0 23.6 9.6 36.3 73.7 67.3 0.1 21.5 39.4 27.0 23.3 10.6 0.1 7.1 14.6 4.7 8.7 19.9 10.2 0.0 14.0 17.1 7.2 4.0 0.0 20.9 2.7 11.8 0.0 13.0 13.8 21.3 27.6 15.5 11.7 20.1 8.9 10.3 12.2 31.9 14.0 27.7 3.5 0.0 26.9 0.0 31.0 0.2 117.7 0.0 9.1 16.2 14.9 0.0 25.4 32.3 23.3 22.3 0.1 0.5 25.2 79.9 13.9 39.9 9.4 11.9 12.2 0.0 4.2 33.2 17.8 20.4 10.0 10.6 8.9 23.6 9.3 13.7 44.6 9.5 49.9 48.6 55.2 50.6 8.7 45.1 73.7 60.6 2.5 36.3 9.6 71.0 55.4 67.3 62.2 73.4 65.6 74.7 55.9 68.3 51.3 47.4 51.6 21.3 8.9 39.2 89.8 86.5 1.9 173.2 156.1 188.5 45.5 38.7 169.3 49.1 1.2 388.0 144.4 79.6 44.3 9.8 0.0 71.7 1.1 38.2 150.5 61.2 26.3 51.9 314.6 137.0 52.8 26.7 74.6 71.7 25.3 0.0 55.1 35.3 123.5 61.4 31.3 109.6 212.5 75.0 51.8 47.2 58.4 44.8 1.5 1.4 76.2 21.6 54.7 SNTB2 "D16S2531E, EST25263, SNT2B2, SNT3, SNTL" ENSG00000168807 "Syntrophin beta 2" Q13425 16 69187129-69309052 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Muller glia cells: 187.1;Rod photoreceptor cells: 126.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001394 Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA001394: AB_1080170" "unprognostic (4.86e-1)" "unprognostic (3.26e-2)" "unprognostic (2.77e-2)" "unprognostic (8.07e-3)" "unprognostic (6.46e-2)" "unprognostic (9.68e-2)" "unprognostic (1.89e-2)" "unprognostic (5.50e-2)" "unprognostic (1.22e-2)" "unprognostic (1.63e-2)" "unprognostic (1.65e-2)" "unprognostic (3.64e-2)" "unprognostic (5.77e-3)" "unprognostic (1.71e-2)" "unprognostic (7.43e-2)" "unprognostic (1.73e-2)" "unprognostic (1.88e-1)" 20.7 8.4 5.8 10.2 7.9 3.8 13.4 5.3 9.4 22.9 12.2 4.5 13.3 5.5 17.8 10.9 16.1 13.0 10.4 8.6 4.8 3.2 14.1 5.8 12.7 7.2 4.8 4.8 13.9 6.6 31.9 7.2 7.4 5.3 16.7 7.8 26.0 8.3 8.4 8.8 12.7 9.6 15.7 5.0 8.6 9.3 10.5 4.0 6.4 22.8 6.8 7.5 18.3 20.2 1.0 0.6 3.0 1.0 2.6 3.7 0.9 4.0 6.2 4.3 3.4 16.0 21.6 5.3 8.0 11.2 6.3 7.0 6.1 3.7 5.1 4.9 9.3 3.3 7.4 5.8 3.9 8.2 2.2 3.2 2.2 6.1 5.2 5.3 0.1 3.4 15.4 2.9 10.3 4.2 6.6 18.8 1.4 1.3 8.0 7.6 4.6 1.7 0.7 2.9 2.4 5.0 10.1 3.8 9.5 3.3 6.2 1.6 3.6 24.5 3.5 2.5 3.4 4.1 0.3 14.6 11.9 5.7 8.3 7.4 1.8 2.8 5.8 7.6 0.8 5.4 1.1 1.0 1.0 3.2 1.0 3.3 1.0 1.6 1.8 0.6 0.8 1.0 3.7 3.0 2.6 1.0 0.4 1.6 0.9 5.8 7.9 5.3 9.4 4.8 3.2 4.8 4.8 5.3 4.0 17.9 9.4 7.8 23.9 33.8 22.9 6.5 2.5 5.3 7.9 26.2 39.3 8.1 3.3 9.2 20.9 65.9 17.4 0.0 21.0 7.0 31.2 42.1 1.1 9.7 6.1 4.8 9.9 84.7 22.9 21.8 54.7 10.1 28.7 1.8 17.0 187.1 14.1 24.6 61.2 27.4 126.8 6.5 39.2 22.7 8.3 33.9 3.1 21.0 16.8 25.9 SNTG2 "G2SYN, SYN5" ENSG00000172554 "Syntrophin gamma 2" Q9NY99 2 950868-1367613 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 21 "Early spermatids: 58.0;Horizontal cells: 85.8;Late spermatids: 26.8;Spermatocytes: 17.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 3.7;HAP1: 4.1;JURKAT: 3.8;MOLT-4: 2.4;NTERA-2: 5.0;SCLC-21H: 4.9" "Low region specificity" "Detected in single" "HPA065258, HPA077904" Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA065258: , HPA077904: " "unprognostic (7.52e-3)" "unprognostic (7.52e-4)" "unprognostic (4.15e-1)" "unprognostic (3.50e-2)" "unprognostic (2.52e-2)" "unprognostic (1.39e-3)" "unprognostic (2.46e-3)" "unprognostic (2.05e-1)" "unprognostic (2.23e-1)" "unprognostic (3.26e-2)" "unprognostic (7.87e-3)" "unprognostic (3.58e-3)" "unprognostic (3.64e-1)" "unprognostic (2.52e-1)" "unprognostic (1.77e-2)" "unprognostic (5.05e-2)" 8.8 2.2 0.9 1.2 1.7 0.7 7.5 1.7 1.4 5.6 1.8 0.4 1.0 1.3 10.2 8.1 4.3 2.5 4.9 1.0 2.6 1.4 0.8 0.6 1.3 0.9 1.1 0.3 1.2 6.7 0.9 9.2 0.7 5.1 1.6 1.6 3.5 1.4 0.8 6.4 3.5 1.4 5.2 2.9 7.7 1.4 5.7 0.9 2.2 2.0 3.1 2.0 2.8 2.6 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.3 0.0 0.0 3.7 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 2.4 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.7 1.7 1.4 2.6 1.4 1.1 0.3 5.1 0.9 0.0 0.0 0.0 0.1 0.8 0.7 0.6 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 58.0 5.2 0.0 0.0 0.2 0.4 0.4 0.3 0.0 0.0 0.1 85.8 0.0 0.0 0.0 26.8 0.3 0.0 1.7 0.0 0.0 0.5 0.0 0.0 3.9 0.2 4.0 0.0 0.4 17.7 3.1 0.1 0.0 0.0 0.0 0.1 SNW1 "Bx42, FUN20, NCoA-62, Prp45, PRPF45, SKIIP, SKIP, SKIP1" ENSG00000100603 "SNW domain containing 1" Q13573 14 77717599-77761207 "Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Spermatocytes: 252.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002457, CAB009931, HPA017370" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB009931: AB_2302187, HPA002457: AB_1080047, HPA017370: AB_1857339" "unprognostic (1.24e-3)" "unprognostic (2.02e-1)" "unprognostic (2.40e-1)" "unprognostic (6.43e-2)" "unprognostic (3.04e-1)" "unprognostic (4.27e-3)" "prognostic unfavorable (1.96e-4)" "unprognostic (1.07e-1)" "unprognostic (8.09e-3)" "unprognostic (2.88e-2)" "unprognostic (3.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.67e-1)" "unprognostic (2.47e-1)" "unprognostic (1.55e-1)" "unprognostic (4.45e-3)" "unprognostic (1.22e-2)" 30.5 23.4 20.3 24.0 24.8 59.5 28.3 32.1 26.2 26.1 27.6 29.6 21.5 24.6 32.5 24.3 29.1 25.4 20.5 26.3 20.6 18.3 23.5 25.3 24.8 31.5 23.9 26.7 32.1 26.5 19.8 31.6 32.3 26.8 29.8 24.9 22.3 23.4 17.6 41.8 33.3 30.7 30.8 23.7 32.3 24.2 36.3 24.3 37.5 34.1 24.2 30.4 33.0 25.0 32.5 38.2 47.8 44.1 47.6 47.1 35.5 39.3 29.1 30.0 31.8 24.7 27.9 34.9 27.1 23.9 29.8 27.6 28.9 36.2 38.5 24.8 20.1 22.7 38.8 35.9 25.7 40.7 30.6 28.4 31.1 26.3 28.9 35.5 21.7 36.9 21.4 34.5 27.0 37.4 32.5 28.9 37.0 44.4 28.9 22.8 40.3 38.6 36.9 33.5 44.5 39.3 41.8 38.8 26.4 27.7 36.5 32.3 34.9 37.3 33.0 37.3 32.2 47.3 41.8 30.6 32.8 37.5 29.5 32.3 28.7 40.6 42.8 29.7 35.0 36.1 42.0 38.0 47.8 32.1 40.6 36.0 30.9 36.2 36.3 38.2 32.5 38.3 36.0 36.1 47.6 44.1 22.7 47.1 35.5 20.3 24.8 32.1 26.2 20.6 18.3 23.9 26.7 26.8 24.3 86.4 43.0 62.2 66.5 50.3 55.1 46.0 43.3 109.7 79.6 50.6 33.4 68.5 64.6 65.3 25.3 65.0 31.6 46.7 61.0 83.4 54.9 37.6 88.0 26.6 66.2 36.5 41.9 45.4 48.4 16.5 72.2 71.0 37.1 92.0 37.1 67.4 58.2 45.0 69.6 39.6 63.7 64.7 69.5 252.6 138.5 47.4 91.2 73.9 40.5 62.2 SNX10 ENSG00000086300 "Sorting nexin 10" Q9Y5X0 7 26291895-26374329 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Disease mutation, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 67.6;brain: 39.0;liver: 37.4" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 242.1;Hofbauer cells: 146.8;Kupffer cells: 156.1;Macrophages: 186.4;Muller glia cells: 262.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 67.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 27.2;U-937: 22.3;WM-115: 77.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015605, HPA064782" Approved Supported Nucleoplasm,Nucleoli,Microtubules NA NA "Nucleoplasm, Microtubules" Nucleoli "HPA015605: AB_1857342, HPA064782: AB_2685349" "unprognostic (6.42e-2)" "unprognostic (2.72e-3)" "unprognostic (2.45e-1)" "unprognostic (7.62e-2)" "prognostic unfavorable (1.16e-4)" "unprognostic (6.92e-2)" "unprognostic (2.48e-3)" "unprognostic (4.51e-2)" "unprognostic (4.87e-1)" "unprognostic (9.36e-2)" "unprognostic (1.59e-1)" "unprognostic (2.56e-1)" "prognostic unfavorable (8.06e-5)" "unprognostic (1.12e-2)" "unprognostic (3.21e-1)" "unprognostic (8.59e-2)" "unprognostic (1.50e-1)" 17.7 8.7 20.2 18.6 17.9 20.9 6.7 13.2 39.0 2.9 3.3 2.1 0.1 2.5 5.4 0.8 1.8 1.9 5.2 1.3 22.2 32.7 21.3 37.4 22.4 18.0 27.8 20.8 1.0 5.0 0.6 3.0 8.9 36.2 2.2 3.9 1.8 1.4 1.5 0.9 1.0 3.6 5.4 15.4 22.1 2.3 3.0 2.1 3.8 1.9 0.1 13.6 6.3 1.8 16.3 20.1 67.6 30.9 9.0 5.6 11.6 13.9 1.3 0.0 2.6 0.0 0.0 15.2 0.0 1.0 0.0 0.0 0.1 4.7 6.1 11.0 0.0 9.6 0.4 3.5 0.9 0.0 8.4 3.3 0.6 0.1 9.2 0.0 13.0 2.3 0.1 1.4 0.0 1.1 0.0 0.2 7.9 0.3 0.0 0.0 2.4 5.4 13.7 4.0 0.1 1.3 0.0 0.0 0.3 27.2 3.0 6.0 1.8 3.0 2.2 15.8 5.0 4.0 18.6 0.0 0.0 3.3 0.0 3.4 4.7 3.7 4.1 0.1 22.3 77.5 8.2 29.2 0.7 4.0 30.9 3.8 16.3 2.8 3.4 20.1 14.5 1.5 2.6 67.6 9.0 30.1 7.4 5.6 11.6 20.2 17.9 13.2 39.0 22.2 32.7 27.8 20.8 36.2 2.1 3.0 17.1 49.9 1.0 4.7 17.7 1.6 20.4 1.4 7.9 22.7 2.0 11.6 242.1 51.3 0.9 5.6 2.6 23.3 23.5 64.7 3.6 2.8 31.1 90.6 146.8 33.4 9.1 2.5 156.1 0.7 1.1 186.4 8.5 49.5 2.5 262.3 22.1 0.0 0.0 123.2 20.4 0.0 3.3 1.6 28.0 2.6 24.0 38.8 9.7 0.9 SNX20 "SLIC-1, SLIC1" ENSG00000167208 "Sorting nexin 20" Q7Z614 16 50666300-50681353 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 58.5;lymphoid tissue: 42.5" "Cell type enhanced" "Detected in some" 7 "B-cells: 16.1;Cardiomyocytes: 14.3;Hofbauer cells: 16.3;Kupffer cells: 17.3;Macrophages: 22.2;monocytes: 17.2;Sertoli cells: 12.9;T-cells: 22.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 13.3;HMC-1: 37.2;NB-4: 21.6;RPMI-8226: 9.2;THP-1: 9.7;U-266/70: 12.1;U-937: 12.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043649 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA043649: AB_10965697" "unprognostic (1.53e-2)" "prognostic favorable (9.07e-4)" "unprognostic (5.58e-2)" "unprognostic (5.06e-3)" "unprognostic (9.03e-2)" "prognostic favorable (6.56e-4)" "unprognostic (1.97e-1)" "unprognostic (1.26e-2)" "unprognostic (1.78e-2)" "unprognostic (1.04e-1)" "unprognostic (4.06e-2)" "unprognostic (1.84e-1)" "prognostic unfavorable (6.00e-6)" "unprognostic (3.24e-1)" "unprognostic (3.37e-2)" "unprognostic (1.53e-1)" "unprognostic (1.54e-1)" 2.0 1.4 2.5 12.7 5.7 10.7 1.3 1.2 2.7 1.3 1.7 1.4 0.1 1.8 1.2 2.4 1.7 1.7 3.1 2.7 1.5 1.5 1.9 1.5 5.7 21.1 2.6 0.2 1.1 1.0 0.1 1.1 1.8 3.1 1.8 2.3 1.3 3.0 0.2 0.7 1.4 7.4 1.6 3.0 23.6 2.1 0.6 3.3 42.5 1.5 0.8 22.3 4.7 1.2 5.5 27.9 58.5 30.7 11.1 30.1 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.3 0.0 2.3 0.0 0.0 0.0 3.3 37.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 1.1 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.1 0.0 0.0 0.0 0.0 12.1 6.3 2.9 0.0 12.9 0.0 58.5 15.1 45.5 10.1 26.6 12.6 5.5 18.0 12.2 27.9 5.2 14.0 9.5 14.1 11.1 30.7 7.7 30.1 15.8 2.5 5.7 1.2 2.7 1.5 1.5 2.6 0.2 3.1 3.3 0.0 0.0 16.1 0.0 0.7 0.0 14.3 2.5 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.4 0.0 4.7 0.0 16.3 1.6 0.0 0.0 17.3 0.0 0.0 22.2 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.5 0.3 22.4 0.0 0.0 SNX22 FLJ13952 ENSG00000157734 "Sorting nexin 22" Q96L94 15 64151715-64157481 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.2;thyroid gland: 41.1" "Cell type enriched" "Detected in many" 5 "Erythroid cells: 140.2" "Cancer enriched" "Detected in many" 7 "thyroid cancer: 47.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory B-cell: 6.6;naive B-cell: 11.5" "Lineage enriched" "Detected in many" 9 "B-cells: 11.5" "Cell line enriched" "Detected in some" 4 "Daudi: 19.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038470 Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA038470: AB_10673174" "prognostic favorable (2.89e-5)" "unprognostic (8.93e-3)" "unprognostic (2.89e-1)" "unprognostic (3.55e-2)" "unprognostic (3.24e-1)" "unprognostic (5.38e-3)" "unprognostic (2.29e-1)" "unprognostic (3.05e-2)" "unprognostic (1.94e-1)" "unprognostic (5.29e-2)" "unprognostic (2.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.27e-4)" "unprognostic (3.92e-1)" "unprognostic (2.52e-1)" "prognostic favorable (2.19e-4)" "unprognostic (1.74e-2)" 1.1 1.5 11.9 7.6 8.9 10.2 1.2 3.4 16.5 0.7 1.1 23.2 11.8 1.5 1.2 3.5 0.9 0.8 1.3 7.9 13.4 9.0 1.1 1.9 4.7 11.4 13.7 8.1 1.3 1.6 0.4 2.2 1.0 12.3 3.0 0.7 0.0 3.6 8.4 0.7 2.0 2.2 0.9 17.0 6.1 2.1 1.0 6.6 1.6 41.1 0.0 13.3 2.1 0.3 11.5 1.2 0.0 0.2 0.1 0.1 1.6 0.2 0.4 0.9 0.8 0.1 0.0 0.7 0.8 0.0 0.0 0.2 0.4 0.9 19.9 0.5 0.1 0.5 0.4 1.7 0.0 0.0 0.1 2.4 0.4 2.2 2.5 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.7 0.0 2.5 0.6 3.3 0.0 1.2 0.2 0.0 1.4 0.5 0.3 4.1 0.3 1.2 0.8 0.8 4.6 0.9 0.2 0.7 0.0 0.8 2.0 0.0 0.0 1.1 1.4 0.3 0.5 4.3 1.8 4.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 1.2 11.5 0.0 0.0 0.0 0.1 0.2 0.0 0.1 1.6 11.9 8.9 3.4 9.3 13.4 9.0 13.7 8.1 12.3 6.6 26.8 9.1 15.2 1.7 1.3 0.8 14.2 0.0 0.0 1.2 0.0 3.9 2.7 0.0 0.4 1.1 0.7 0.7 140.2 3.2 6.1 3.6 3.9 2.3 3.4 4.0 0.0 0.0 2.5 2.2 1.7 0.6 2.7 3.3 1.8 0.8 0.5 1.8 0.0 0.4 1.8 1.8 0.0 1.0 1.1 1.2 2.5 3.3 2.1 0.6 1.4 SNX27 "KIAA0488, MGC20471, MY014" ENSG00000143376 "Sorting nexin family member 27" Q96L92 1 151612006-151699091 "Plasma proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 9.5;classical monocyte: 18.6;intermediate monocyte: 16.1;myeloid DC: 8.4;neutrophil: 20.3;non-classical monocyte: 16.9" "Group enriched" "Detected in all" 4 "dendritic cells: 8.4;granulocytes: 20.3;monocytes: 18.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045816 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA045816: " "unprognostic (3.35e-1)" "unprognostic (4.76e-1)" "unprognostic (1.38e-1)" "unprognostic (2.13e-2)" "unprognostic (2.79e-2)" "unprognostic (3.42e-1)" "unprognostic (2.41e-2)" "unprognostic (1.48e-2)" "unprognostic (1.78e-1)" "unprognostic (1.96e-1)" "unprognostic (5.92e-2)" "unprognostic (1.63e-1)" "unprognostic (5.45e-2)" "unprognostic (2.81e-1)" "unprognostic (4.15e-1)" "unprognostic (7.30e-2)" "unprognostic (1.04e-1)" 10.9 12.5 21.5 12.5 28.6 13.4 12.6 25.0 27.7 14.8 15.9 23.4 13.5 9.1 12.1 16.2 12.1 13.9 11.5 12.1 23.0 21.3 24.2 12.8 13.6 10.4 23.7 19.2 17.2 10.0 26.0 14.8 17.5 20.3 14.8 13.0 13.1 9.7 20.6 25.6 16.0 10.1 21.3 23.1 17.0 11.2 12.8 18.7 8.8 12.8 7.7 10.8 17.4 21.7 2.5 8.4 20.3 18.6 1.7 3.6 7.3 5.9 8.9 9.5 11.9 15.0 11.1 21.1 3.2 6.7 5.7 6.2 7.2 8.0 5.7 7.1 5.2 6.2 7.5 12.1 6.5 7.2 8.1 4.5 9.1 5.2 8.1 10.0 10.8 6.3 8.8 4.9 6.5 7.5 5.8 6.4 9.1 5.5 35.1 7.5 10.7 6.4 7.5 16.7 11.8 5.8 6.7 9.2 7.3 8.9 9.0 9.5 8.1 8.7 16.2 6.2 10.7 10.4 9.2 8.5 8.1 5.5 8.4 6.7 7.4 7.4 11.5 9.7 7.0 9.0 9.5 18.6 2.6 2.6 16.1 3.6 1.8 3.2 2.3 8.4 2.5 3.1 2.5 20.3 1.7 16.9 2.1 2.5 7.3 21.5 28.6 25.0 24.6 23.0 21.3 23.7 19.2 20.3 18.7 11.9 21.9 11.2 13.8 18.8 42.4 25.5 20.4 8.1 15.9 27.9 25.5 40.5 21.6 21.5 23.7 16.1 12.3 23.3 18.3 18.4 17.5 15.0 3.5 17.9 37.8 38.1 18.0 22.7 76.7 6.6 28.1 28.6 28.7 32.5 15.2 22.7 21.5 10.5 37.4 51.8 27.3 32.3 19.4 41.7 29.4 21.7 87.6 12.9 15.8 13.2 SNX30 ATG24A ENSG00000148158 "Sorting nexin family member 30" Q5VWJ9 9 112750838-112881671 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 65.1;Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019346 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli, Cytosol" "HPA019346: AB_2286395" "unprognostic (1.67e-2)" "unprognostic (1.38e-1)" "unprognostic (1.08e-1)" "unprognostic (3.61e-1)" "unprognostic (3.61e-1)" "unprognostic (3.69e-1)" "unprognostic (8.05e-3)" "unprognostic (2.04e-3)" "unprognostic (4.48e-2)" "unprognostic (3.59e-3)" "unprognostic (3.39e-2)" "unprognostic (1.48e-1)" "prognostic favorable (1.01e-7)" "unprognostic (4.48e-3)" "unprognostic (1.18e-1)" "unprognostic (7.51e-2)" "unprognostic (1.41e-2)" 4.9 4.4 12.2 7.7 12.6 8.3 7.7 18.1 18.5 10.9 11.1 25.6 3.6 7.9 6.4 4.1 5.3 3.8 5.4 3.4 14.2 12.0 23.7 5.2 23.4 8.8 14.8 12.8 6.9 5.2 6.9 6.3 5.1 14.7 4.1 11.7 4.9 7.1 4.3 2.6 5.7 8.9 7.5 20.3 7.4 4.7 12.7 11.8 2.3 3.1 2.6 8.7 5.4 4.6 0.7 4.2 1.5 5.1 0.8 1.7 1.6 6.0 3.8 6.6 5.2 8.3 7.6 5.5 5.2 10.9 4.4 4.2 13.5 1.4 10.1 4.4 13.4 7.9 7.2 7.9 3.1 6.9 3.2 3.7 3.1 3.4 5.4 6.0 3.1 5.6 6.2 4.3 6.8 5.1 11.2 3.8 2.6 4.8 5.8 5.9 4.2 2.0 3.6 7.2 9.8 4.0 4.3 15.4 2.6 8.6 10.6 9.8 3.1 6.8 9.4 13.0 7.0 7.0 5.6 4.2 6.6 7.0 19.3 4.4 15.1 13.9 4.8 8.5 2.9 12.8 0.0 5.1 1.5 0.8 2.0 1.7 0.0 0.8 1.0 4.2 0.7 0.7 0.6 0.7 0.8 2.1 0.7 1.6 1.6 12.2 12.6 18.1 18.5 14.2 12.0 14.8 12.8 14.7 11.8 6.0 65.1 0.0 1.9 7.2 5.7 3.8 5.1 1.4 9.1 5.2 9.8 0.4 5.0 2.1 5.3 3.0 12.4 46.7 2.8 1.6 5.7 3.1 6.9 5.9 11.9 7.9 4.6 12.3 19.7 6.3 5.2 12.5 20.3 1.0 9.7 2.6 3.4 17.3 7.4 33.2 2.7 0.0 1.4 5.5 10.5 9.7 0.3 3.8 8.6 5.4 SNX31 MGC39715 ENSG00000174226 "Sorting nexin 31" Q8N9S9 8 100572882-100663415 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.4;prostate: 13.8;urinary bladder: 25.4;vagina: 16.0" "Cell type enriched" "Detected in some" 5 "Early spermatids: 73.9" "Cancer enriched" "Detected in many" 22 "urothelial cancer: 24.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 3.0" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 50 "RT4: 42.9" "Region enriched" "Detected in single" 5 "thalamus: 2.9" "Region enhanced" "Detected in single" "olfactory region: 3.1" "HPA024284, HPA053466" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA024284: AB_1853894, HPA053466: AB_2682161" "unprognostic (1.39e-1)" "unprognostic (3.83e-2)" "unprognostic (7.99e-2)" "unprognostic (1.52e-1)" "unprognostic (7.20e-5)" "unprognostic (1.04e-1)" "unprognostic (1.01e-2)" "unprognostic (2.44e-2)" "unprognostic (1.02e-1)" "unprognostic (2.21e-1)" "unprognostic (2.09e-2)" "unprognostic (1.69e-1)" "unprognostic (7.79e-3)" "unprognostic (1.66e-1)" "prognostic favorable (1.47e-4)" "unprognostic (2.54e-1)" "unprognostic (4.05e-2)" 0.5 0.0 0.6 0.1 0.7 0.1 0.4 0.6 2.3 1.7 0.3 0.3 0.1 0.2 0.3 0.2 6.2 0.3 0.9 1.8 0.8 0.7 0.3 0.4 0.3 0.3 0.9 0.3 0.3 0.2 0.1 0.2 0.1 0.6 13.8 0.1 0.4 1.4 0.1 1.0 0.5 0.1 7.4 0.8 0.1 0.6 3.3 0.5 0.1 0.4 2.6 21.4 25.4 16.0 1.1 0.3 3.0 0.5 1.6 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.9 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.1 2.5 0.5 0.2 0.3 0.2 0.1 1.1 0.1 0.2 0.2 0.5 0.1 0.3 3.0 1.6 0.0 0.3 0.0 0.0 0.6 0.7 0.6 0.3 0.8 0.7 0.9 0.3 0.6 0.5 0.0 0.0 0.0 3.6 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 73.9 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.0 0.4 0.4 0.4 0.0 0.0 0.0 1.0 SOBP FLJ10159 ENSG00000112320 "Sine oculis binding protein homolog" A7XYQ1 6 107489958-107660167 "Disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 68.3;Horizontal cells: 87.4;Late spermatids: 46.7;Peritubular cells: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 11 "memory B-cell: 3.0;naive B-cell: 4.5" "Lineage enriched" "Detected in single" 14 "B-cells: 4.5" "Cell line enhanced" "Detected in many" "AF22: 11.0;AN3-CA: 14.2;ASC diff: 13.5;HDLM-2: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029242 Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA029242: AB_10603340" "unprognostic (7.11e-2)" "unprognostic (1.35e-3)" "unprognostic (9.01e-2)" "unprognostic (2.04e-3)" "unprognostic (3.09e-1)" "unprognostic (1.12e-1)" "unprognostic (3.80e-2)" "unprognostic (5.63e-2)" "unprognostic (9.84e-2)" "unprognostic (5.35e-3)" "prognostic favorable (1.55e-5)" "unprognostic (6.64e-2)" "unprognostic (2.00e-3)" "unprognostic (5.41e-2)" "unprognostic (2.12e-1)" "unprognostic (1.39e-1)" "unprognostic (1.95e-3)" 7.6 12.0 19.3 4.4 15.6 1.3 3.6 15.1 30.2 12.7 12.8 11.0 2.5 3.7 9.0 5.5 5.6 6.2 7.6 17.0 18.0 12.4 5.8 3.6 5.0 2.9 12.5 14.9 21.6 3.9 10.9 12.0 6.1 9.6 13.0 4.2 7.4 21.1 7.0 22.1 1.5 3.4 14.3 9.6 4.7 5.6 9.1 11.1 1.0 6.1 4.1 3.3 14.8 8.0 4.5 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.3 11.0 14.2 13.5 5.2 1.3 0.1 0.0 0.3 0.6 0.0 0.0 5.8 0.4 0.0 1.0 0.0 7.3 0.2 0.2 9.3 6.9 0.7 0.0 6.8 1.8 3.0 0.6 5.4 0.0 5.3 0.0 1.1 4.4 2.7 0.0 0.3 0.0 2.9 1.4 0.3 2.6 0.2 0.9 3.3 1.4 0.0 0.0 0.2 3.6 5.9 1.3 0.0 0.1 0.5 0.5 2.1 0.1 3.5 1.2 6.0 0.5 2.8 0.5 3.8 0.1 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 3.0 0.0 0.2 0.0 4.5 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 19.3 15.6 15.1 20.6 18.0 12.4 12.5 14.9 9.6 11.1 3.0 9.8 8.5 8.9 0.5 36.8 20.2 28.1 16.0 5.7 22.7 0.0 0.1 0.0 1.9 68.3 2.8 0.0 0.0 0.2 0.6 7.3 8.4 0.0 0.6 2.3 87.4 10.4 3.7 7.4 46.7 41.7 1.6 3.3 0.0 0.0 6.9 0.5 0.0 46.0 9.8 9.8 25.8 16.1 3.0 2.2 0.6 0.1 0.0 0.0 0.7 SOCS1 "Cish1, JAB, SOCS-1, SSI-1, TIP3" ENSG00000185338 "Suppressor of cytokine signaling 1" O15524 16 11254405-11256200 "Cancer-related genes, Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 42.3;lymphoid tissue: 58.3" "Cell type enhanced" "Detected in many" 5 "T-cells: 63.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 6 "cerebellum: 15.2" "Cell type enhanced" "Detected in many" "basophil: 12.9" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "HDLM-2: 48.3" "Not detected" "Not detected" "Not detected" "Not detected" "CAB010355, HPA074108" Approved Supported "Nucleoplasm,Cytoplasmic bodies" NA NA Nucleoplasm "Cytoplasmic bodies" "CAB010355: AB_2193144, HPA074108: AB_2686661" "unprognostic (4.50e-3)" "unprognostic (3.30e-2)" "unprognostic (1.24e-1)" "unprognostic (1.66e-2)" "unprognostic (1.25e-2)" "prognostic favorable (1.10e-4)" "unprognostic (1.71e-2)" "unprognostic (4.09e-3)" "unprognostic (5.31e-3)" "unprognostic (4.82e-2)" "unprognostic (1.17e-1)" "unprognostic (5.39e-2)" "prognostic unfavorable (1.08e-6)" "unprognostic (1.56e-1)" "unprognostic (5.68e-2)" "unprognostic (6.08e-2)" "unprognostic (1.67e-1)" 10.9 2.8 0.7 19.2 1.5 13.9 37.9 15.2 1.1 15.8 6.3 0.3 2.2 3.3 4.9 7.6 5.6 4.2 11.0 3.6 0.6 1.0 11.1 42.3 9.6 25.8 0.8 0.0 9.3 3.8 0.7 16.8 9.3 2.4 5.3 1.8 3.2 3.7 3.9 2.3 6.0 11.0 6.5 1.1 14.7 6.6 7.1 0.4 58.3 5.1 4.8 14.7 5.4 8.3 4.4 1.3 12.9 0.1 5.5 2.7 0.4 1.2 0.2 0.5 0.1 1.6 0.2 1.9 1.0 7.5 0.4 0.6 0.3 0.2 2.9 2.2 0.4 1.4 0.5 0.2 0.1 0.1 48.3 0.3 0.8 0.0 3.9 0.7 0.0 8.9 0.7 0.1 1.0 0.1 0.2 0.1 0.3 6.4 0.8 0.0 1.1 3.2 1.8 5.4 0.0 0.8 0.3 0.3 0.3 0.5 0.2 0.7 0.1 0.2 1.7 0.5 1.5 0.0 0.4 0.0 0.6 3.2 0.4 0.6 0.2 0.2 4.5 1.2 0.3 0.6 12.9 0.1 8.8 2.2 0.0 2.0 1.4 2.5 2.7 0.0 4.4 2.7 2.5 0.3 5.5 0.0 1.3 2.6 0.4 0.7 1.5 15.2 0.6 0.6 1.0 0.8 0.0 2.4 0.4 0.0 4.1 11.5 14.7 10.9 1.9 9.2 5.1 2.7 0.0 48.8 5.9 21.5 19.9 11.3 40.7 3.6 23.6 0.0 7.3 4.3 30.9 5.9 54.0 2.4 4.0 0.0 25.0 10.4 6.5 17.6 6.6 8.4 28.7 24.4 12.9 7.4 6.9 9.1 39.3 7.0 4.2 0.0 16.5 0.9 2.0 5.9 48.3 63.1 6.6 10.8 SOCS4 SOCS7 ENSG00000180008 "Suppressor of cytokine signaling 4" Q8WXH5 14 55027230-55049488 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013478, HPA057961" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB013478: , HPA057961: AB_2683564" "unprognostic (7.18e-3)" "unprognostic (1.49e-1)" "unprognostic (9.74e-3)" "unprognostic (4.57e-2)" "unprognostic (3.36e-3)" "unprognostic (3.82e-3)" "unprognostic (3.69e-3)" "unprognostic (2.70e-1)" "unprognostic (9.70e-2)" "unprognostic (1.38e-1)" "unprognostic (1.21e-1)" "unprognostic (1.10e-1)" "unprognostic (1.17e-2)" "unprognostic (4.56e-2)" "unprognostic (7.61e-2)" "unprognostic (4.35e-3)" "unprognostic (1.13e-1)" 14.5 11.1 12.5 16.0 21.2 12.7 12.2 12.6 19.1 11.4 12.0 14.0 8.7 11.1 13.6 9.3 13.2 13.9 15.0 13.9 15.5 10.9 17.6 10.6 16.7 18.0 22.6 10.5 12.6 10.2 12.8 18.5 12.4 17.0 11.7 12.8 7.2 11.9 10.3 12.3 10.5 13.2 17.5 29.6 16.4 15.1 9.5 19.6 16.2 15.3 6.5 16.0 16.1 18.9 3.8 4.1 4.5 5.8 6.0 4.9 2.0 10.8 9.4 12.8 15.0 8.4 9.8 10.2 12.7 9.4 8.1 13.4 7.7 11.7 16.4 9.0 9.5 7.8 15.2 17.4 10.3 19.0 16.8 7.0 9.7 12.2 4.6 8.6 11.1 17.2 7.8 10.7 14.6 10.7 9.0 14.6 16.5 5.8 16.5 14.7 10.8 16.6 8.1 10.1 8.7 10.2 15.4 20.0 6.3 11.6 12.0 17.1 14.7 12.8 7.7 12.1 12.2 10.8 8.2 14.8 20.9 21.1 10.2 10.8 5.9 6.3 15.8 13.5 9.0 16.0 1.7 4.2 4.5 3.2 4.9 4.9 3.0 4.0 3.0 3.1 3.8 2.2 2.4 2.6 6.0 5.8 4.1 3.6 2.0 12.5 21.2 12.6 19.1 15.5 10.9 22.6 10.5 17.0 19.6 6.0 11.3 20.6 7.6 21.3 13.1 17.3 7.6 18.7 20.5 14.0 19.6 4.4 11.6 8.1 3.7 15.8 11.5 0.0 7.6 4.8 10.8 6.5 31.3 7.8 6.6 35.0 19.5 15.4 10.4 1.5 6.6 12.4 3.3 15.4 7.9 14.5 11.8 7.2 9.6 11.3 14.5 0.0 20.0 15.1 11.3 20.3 4.1 15.2 6.9 7.9 SOCS5 "CIS6, Cish5, CISH6, KIAA0671, SOCS-5" ENSG00000171150 "Suppressor of cytokine signaling 5" O75159 2 46698952-46763129 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+: 45.7;fHDF/TERT166: 44.5;U-138 MG: 30.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020884, CAB025510" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" No No Cytosol "Nucleoplasm, Plasma membrane" "CAB025510: , HPA020884: AB_1857356" "unprognostic (1.69e-1)" "unprognostic (1.98e-2)" "unprognostic (5.71e-2)" "unprognostic (1.64e-2)" "unprognostic (2.20e-2)" "unprognostic (2.67e-1)" "prognostic unfavorable (7.28e-4)" "unprognostic (4.52e-2)" "unprognostic (9.13e-2)" "prognostic unfavorable (7.53e-4)" "unprognostic (2.10e-3)" "unprognostic (3.01e-1)" "unprognostic (1.47e-3)" "unprognostic (8.29e-2)" "unprognostic (1.71e-1)" "unprognostic (1.17e-1)" "unprognostic (1.29e-1)" 12.2 10.1 16.9 5.6 24.9 6.2 21.3 26.4 14.9 13.6 9.4 6.3 7.6 4.8 14.0 8.8 8.2 9.6 11.2 11.2 11.9 8.1 9.1 6.3 10.1 9.9 9.1 10.8 23.8 6.0 14.8 9.0 6.9 11.8 9.9 6.5 5.8 9.3 13.0 8.8 6.9 6.8 13.6 10.8 8.1 7.2 9.5 8.8 10.9 9.8 5.0 6.1 9.4 9.0 4.8 1.3 6.3 3.7 2.3 3.3 1.6 5.2 4.0 3.5 5.1 11.2 16.2 4.3 24.7 45.7 12.1 7.1 3.8 2.6 2.7 4.8 44.5 3.7 2.6 3.8 3.9 15.4 2.6 3.5 4.2 3.7 4.5 7.0 2.4 4.7 12.8 5.9 10.3 4.1 13.5 4.1 1.1 3.6 2.9 7.7 1.8 2.1 3.9 3.9 5.5 3.3 2.8 5.9 3.4 4.9 4.0 2.7 7.5 6.0 4.0 4.6 3.5 1.6 3.5 4.6 30.2 6.8 10.0 4.8 3.7 2.2 2.3 13.8 4.8 9.3 1.2 1.1 6.3 2.4 1.0 3.0 4.5 1.5 1.6 1.2 4.8 2.7 3.3 1.1 2.3 3.7 1.3 2.5 1.6 16.9 24.9 26.4 14.9 11.9 8.1 9.1 10.8 11.8 8.8 3.0 6.7 6.0 6.3 14.7 12.1 13.6 15.3 5.3 9.1 3.5 21.6 3.1 5.0 6.3 8.5 22.4 6.3 0.0 5.9 1.9 12.1 8.8 16.2 6.4 4.0 17.5 10.4 20.3 6.3 5.1 16.1 7.2 6.8 6.4 7.6 8.9 5.5 7.0 15.9 6.3 5.3 12.9 17.9 11.9 15.6 12.7 2.3 4.4 6.0 4.8 SOD1 "ALS, ALS1, IPOA" ENSG00000142168 "Superoxide dismutase 1" P00441 21 31659622-31668931 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antioxidant, Oxidoreductase" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 282.6" "Cell type enhanced" "Detected in all" 5 "Hepatocytes: 2529.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001401, CAB008670" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 44900000 91000000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB008670: AB_1623312, HPA001401: AB_1080132" "unprognostic (1.73e-1)" "unprognostic (1.18e-2)" "unprognostic (4.43e-1)" "unprognostic (6.19e-2)" "unprognostic (1.39e-1)" "unprognostic (9.59e-3)" "unprognostic (8.34e-2)" "unprognostic (2.30e-1)" "unprognostic (3.47e-1)" "unprognostic (5.28e-2)" "unprognostic (9.33e-2)" "unprognostic (1.96e-1)" "unprognostic (1.03e-2)" "unprognostic (1.66e-1)" "unprognostic (1.74e-2)" "unprognostic (1.57e-1)" "unprognostic (3.26e-2)" 39.2 86.5 71.1 29.1 74.3 24.6 108.6 35.6 74.9 26.8 37.7 19.1 35.4 62.5 24.6 42.2 25.8 36.0 46.8 96.5 77.8 73.1 84.0 282.6 23.0 26.8 80.2 67.0 53.9 27.2 27.1 30.4 29.7 96.1 35.1 32.6 19.3 19.7 39.3 83.9 20.5 45.5 45.2 88.2 19.2 25.8 22.2 43.8 12.3 30.1 34.7 25.6 25.4 124.0 57.6 32.3 24.9 57.2 29.6 95.6 55.6 56.2 49.2 34.5 34.5 46.2 32.3 28.7 47.5 28.3 32.3 24.4 63.7 35.8 67.3 50.0 43.7 58.6 20.4 49.5 34.9 26.6 49.7 61.4 108.7 64.6 91.1 30.6 47.9 40.7 33.4 26.6 45.2 25.2 36.8 36.2 51.6 74.9 86.2 38.9 91.3 51.4 48.4 51.9 89.1 52.5 44.3 69.6 104.7 63.1 34.6 37.8 31.7 87.9 46.5 45.6 32.5 53.5 42.4 42.4 25.1 55.7 33.9 34.9 65.8 142.4 79.8 51.3 70.0 33.3 22.1 21.9 24.9 45.0 30.2 51.6 57.6 73.1 56.9 28.6 40.9 76.2 59.3 5.1 29.6 57.2 32.3 95.6 55.6 71.1 74.3 35.6 74.9 77.8 73.1 80.2 67.0 96.1 43.8 273.9 132.0 321.6 545.9 436.4 220.9 652.4 591.1 509.9 249.1 371.6 45.2 624.2 1382.7 369.6 242.1 264.2 846.2 327.1 713.9 544.4 341.5 540.9 215.8 2529.1 314.9 267.0 277.0 292.2 203.5 693.0 483.3 265.6 398.1 397.7 279.9 378.3 307.6 522.5 496.4 1894.8 157.7 433.4 418.2 79.3 538.3 305.8 607.1 266.4 526.4 451.3 SOGA3 "C6orf174, dJ403A15.3" ENSG00000214338 "SOGA family member 3" Q5TF21 6 127472794-127519191 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.3;pituitary gland: 11.9" "Group enriched" "Detected in some" 5 "Bipolar cells: 1.4;Horizontal cells: 3.2;Rod photoreceptor cells: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.3" "Lineage enriched" "Detected in single" 6 "T-cells: 2.3" "Cell line enhanced" "Detected in some" "AF22: 7.5;SCLC-21H: 24.3;SH-SY5Y: 13.9" "HPA035388, HPA035389" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA035388: AB_2674601, HPA035389: AB_10669857" "unprognostic (1.70e-1)" "unprognostic (3.56e-2)" "unprognostic (1.57e-1)" "unprognostic (2.53e-2)" "unprognostic (1.19e-1)" "unprognostic (8.58e-3)" "unprognostic (8.45e-2)" "unprognostic (7.31e-4)" "unprognostic (5.65e-3)" "unprognostic (1.58e-1)" "unprognostic (3.33e-2)" "unprognostic (1.59e-1)" "unprognostic (3.30e-2)" "unprognostic (1.72e-1)" "unprognostic (8.26e-3)" 0.8 2.8 5.0 1.8 5.3 0.4 0.4 11.4 15.3 1.0 0.8 3.7 0.0 0.5 2.1 0.2 2.0 1.0 1.9 0.8 4.2 4.5 0.6 0.6 1.7 0.8 6.7 5.0 3.3 1.7 0.2 11.9 1.2 7.9 1.1 0.6 0.7 1.1 0.5 0.3 1.0 1.9 0.6 11.4 1.4 3.9 1.8 4.3 0.0 1.9 0.0 0.3 1.6 0.8 0.3 0.2 0.0 0.0 0.0 2.3 0.0 0.2 3.3 7.5 1.1 0.0 0.6 0.3 0.7 0.9 0.9 2.4 0.2 0.3 0.4 0.2 0.1 6.2 0.0 0.8 0.0 0.7 0.7 0.1 0.6 0.0 0.1 0.0 0.2 0.1 1.2 0.0 3.7 0.0 0.8 0.0 1.1 0.3 0.2 0.5 0.5 4.9 0.0 3.4 0.0 0.8 0.4 1.8 0.0 0.1 0.0 24.3 13.9 0.0 0.0 0.2 0.9 0.0 0.3 0.2 6.0 1.2 0.4 1.7 0.2 0.1 0.1 4.5 1.1 5.9 0.0 0.0 0.0 0.3 0.0 0.4 0.3 2.3 0.8 0.2 0.2 0.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 5.0 5.3 11.4 8.2 4.2 4.5 6.7 5.0 7.9 4.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 SORCS2 KIAA1329 ENSG00000184985 "Sortilin related VPS10 domain containing receptor 2" Q96PQ0 4 7192538-7742836 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.1" "Cell type enhanced" "Detected in many" 19 "Bipolar cells: 66.5;Muller glia cells: 31.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 6.6;HaCaT: 16.6;HMC-1: 12.5;RPMI-8226: 7.4;SiHa: 12.0;THP-1: 7.0;U-937: 7.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061916 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA061916: AB_2684636" "unprognostic (1.38e-1)" "unprognostic (6.32e-2)" "unprognostic (1.91e-2)" "unprognostic (4.37e-2)" "unprognostic (4.91e-3)" "unprognostic (1.82e-2)" "unprognostic (4.60e-2)" "unprognostic (1.14e-2)" "unprognostic (1.49e-3)" "prognostic unfavorable (3.55e-4)" "unprognostic (1.52e-1)" "unprognostic (3.56e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (2.17e-3)" "unprognostic (5.37e-2)" "unprognostic (2.09e-1)" "unprognostic (7.27e-3)" 4.9 2.6 12.0 6.4 16.6 3.3 1.8 4.8 22.4 13.8 4.0 32.1 3.2 3.1 6.0 8.2 4.7 3.5 7.1 3.2 10.7 6.9 7.4 5.2 8.3 2.0 9.9 11.2 7.4 1.7 0.8 2.7 0.9 11.2 7.5 2.6 7.5 2.6 5.3 2.4 1.9 4.2 11.5 11.2 1.3 1.9 3.4 11.3 0.8 6.2 2.2 2.7 5.2 3.7 0.0 0.0 0.0 0.7 0.0 0.2 0.1 0.7 0.9 1.1 0.2 0.1 0.0 0.0 0.2 0.0 1.4 0.4 0.1 0.5 0.0 6.6 4.2 1.1 16.6 0.0 0.0 0.2 0.0 0.0 0.0 2.5 0.2 0.1 0.0 12.5 0.2 3.7 5.2 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.3 0.0 0.7 0.0 1.3 7.4 0.2 0.0 0.7 0.6 12.0 0.0 0.0 0.7 0.0 7.0 0.0 4.3 1.3 0.0 0.1 0.0 0.0 0.0 1.4 7.3 0.2 0.0 0.1 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 12.0 16.6 4.8 17.7 10.7 6.9 9.9 11.2 11.2 11.3 3.0 13.7 0.0 0.2 0.1 66.5 2.0 0.0 2.7 7.9 5.2 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.2 0.2 1.6 0.0 0.0 0.3 10.2 11.8 0.3 1.7 0.0 0.0 31.9 0.7 0.0 7.4 0.7 2.4 0.0 0.5 0.1 0.1 0.4 0.0 0.0 0.0 0.4 SOS2 ENSG00000100485 "SOS Ras/Rho guanine nucleotide exchange factor 2" Q07890 14 50117120-50231558 "Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004577, HPA047368, HPA052689" Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB004577: AB_628270, HPA047368: AB_2680014, HPA052689: AB_2681917" "unprognostic (7.99e-2)" "unprognostic (6.17e-2)" "unprognostic (7.80e-2)" "unprognostic (4.93e-2)" "unprognostic (2.81e-2)" "unprognostic (7.64e-2)" "unprognostic (1.56e-1)" "unprognostic (3.08e-1)" "unprognostic (2.01e-1)" "unprognostic (3.88e-1)" "unprognostic (9.99e-2)" "unprognostic (8.21e-2)" "prognostic favorable (8.48e-8)" "unprognostic (2.47e-2)" "unprognostic (1.91e-1)" "unprognostic (1.01e-1)" "unprognostic (6.57e-2)" 16.0 12.9 16.9 10.5 17.8 25.2 13.4 15.8 14.5 12.9 20.1 19.8 23.4 15.5 14.9 17.3 12.7 11.2 11.4 15.3 17.7 13.4 18.4 9.4 12.5 15.6 19.9 9.8 11.8 11.6 38.6 20.5 30.1 15.1 13.0 13.0 11.1 14.3 14.7 37.1 13.0 26.7 18.3 23.1 17.0 12.1 19.2 16.8 14.7 18.7 14.6 10.3 15.3 15.0 1.2 2.1 8.5 2.8 2.4 1.8 0.6 9.6 7.1 14.6 9.7 11.2 12.3 6.9 8.7 9.7 6.6 8.3 3.1 12.9 10.2 7.9 11.1 11.5 8.9 7.8 6.6 11.8 17.0 2.9 10.2 5.6 5.4 12.4 12.0 11.0 12.7 16.3 6.2 14.4 16.8 14.2 8.5 7.8 25.6 15.8 8.0 9.9 9.5 4.5 7.3 6.3 10.7 20.3 7.6 10.7 9.2 10.6 12.4 9.7 11.5 11.4 11.0 12.7 14.7 15.5 18.3 12.0 8.2 5.6 18.1 19.6 12.6 4.7 6.7 10.7 8.5 1.8 4.1 1.8 1.4 1.5 0.9 1.1 1.3 1.2 1.2 1.3 1.2 7.2 2.4 2.8 2.1 0.1 0.6 16.9 17.8 15.8 14.5 17.7 13.4 19.9 9.8 15.1 16.8 8.9 19.9 1.9 15.2 31.7 16.1 38.0 20.4 14.7 19.4 17.4 15.7 6.4 6.6 10.3 9.6 23.3 24.9 0.0 9.2 6.6 14.1 24.6 19.7 11.9 8.1 23.8 19.5 18.4 30.6 5.6 11.5 17.9 16.9 1.8 18.1 18.5 11.9 22.9 12.7 12.7 22.5 19.4 17.6 38.0 6.9 34.6 10.9 17.3 11.7 28.4 SOX10 "DOM, WS2E, WS4" ENSG00000100146 "SRY-box 10" P56693 22 37970686-37987422 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Deafness, Disease mutation, Hirschsprung disease, Kallmann syndrome, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 64.4;salivary gland: 98.4" "Cell type enriched" "Detected in some" 12 "Melanocytes: 33.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 704 "SK-MEL-30: 62.9;WM-115: 90.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003171, HPA068898" Enhanced Supported Nucleoplasm Yes NA Nucleoplasm "CAB003171: AB_2195374, HPA068898: AB_2686054" 3.3 4.0 21.0 3.7 33.1 1.6 18.7 3.2 32.8 3.2 8.1 64.4 0.5 2.9 1.8 2.8 2.8 1.9 3.4 3.9 26.9 15.2 1.7 1.7 1.6 1.6 41.3 13.7 2.4 2.2 1.7 0.7 1.6 24.7 2.3 3.9 22.8 98.4 7.1 1.8 15.8 3.8 3.2 46.6 1.8 2.4 3.1 42.5 0.0 1.7 0.0 1.6 2.5 3.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 90.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 33.1 3.2 24.6 26.9 15.2 41.3 13.7 24.7 42.5 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.6 0.0 0.0 0.0 0.0 SOX11 ENSG00000176887 "SRY-box 11" P35716 2 5692667-5701385 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 3.1;brain: 12.3;heart muscle: 5.3;intestine: 3.3;testis: 3.7" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 10.1;Ductal cells: 2.5" "Group enriched" "Detected in many" 6 "breast cancer: 2.0;glioma: 8.5;ovarian cancer: 1.8;testis cancer: 2.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 26.5;NTERA-2: 12.9;REH: 9.4;RH-30: 10.1;SCLC-21H: 16.3;SH-SY5Y: 24.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000448, HPA000536, CAB056152, CAB056153" Approved Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "CAB056152: AB_2665567, CAB056153: AB_2665568, HPA000448: , HPA000536: AB_1080060" "unprognostic (2.17e-2)" "unprognostic (2.02e-2)" "unprognostic (1.44e-2)" "unprognostic (7.35e-6)" "unprognostic (2.79e-1)" "unprognostic (1.19e-1)" "unprognostic (4.04e-8)" "unprognostic (2.79e-2)" "unprognostic (7.27e-2)" "unprognostic (3.17e-1)" "unprognostic (3.35e-3)" "unprognostic (2.42e-1)" "unprognostic (8.45e-8)" "unprognostic (1.35e-1)" "unprognostic (1.96e-1)" "unprognostic (5.50e-3)" "unprognostic (7.47e-2)" 0.5 0.5 4.2 0.5 7.1 0.6 0.6 0.3 12.3 0.4 3.3 5.8 0.0 0.6 0.7 0.6 0.5 0.5 0.6 5.3 4.4 5.1 0.5 0.5 0.6 0.5 3.3 5.0 0.5 0.4 0.5 0.7 0.5 4.5 0.5 0.8 0.0 0.9 0.4 1.0 0.6 0.7 1.3 6.3 1.0 0.6 3.7 3.6 0.0 0.6 0.0 0.6 0.5 0.1 1.1 0.8 3.1 1.5 1.6 1.1 0.5 0.0 0.0 26.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 1.3 0.0 0.0 2.4 0.0 0.0 0.0 12.9 0.0 0.0 9.4 10.1 0.4 0.0 0.0 16.3 24.6 0.0 0.1 0.0 4.8 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.8 0.3 0.6 0.0 0.0 6.1 3.1 0.5 1.0 0.5 0.8 1.1 1.1 0.6 0.7 0.6 0.7 0.9 0.9 1.6 1.6 1.5 0.8 0.9 0.5 4.2 7.1 0.3 6.4 4.4 5.1 3.3 5.0 4.5 3.6 0.0 0.0 0.0 0.0 0.0 1.3 10.1 0.0 0.0 1.2 0.0 0.0 0.1 0.0 2.5 0.7 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 SOX12 SOX22 ENSG00000177732 "SRY-box 12" O15370 20 325595-330224 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 53.0;Cone photoreceptor cells: 39.3;Horizontal cells: 30.2;Rod photoreceptor cells: 37.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 4 "B-cells: 1.8;dendritic cells: 1.5;T-cells: 1.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055052, HPA061627" Enhanced Nucleoplasm No No Nucleoplasm "HPA055052: AB_2682685, HPA061627: AB_2684571" "unprognostic (1.02e-1)" "unprognostic (1.33e-2)" "unprognostic (1.18e-3)" "unprognostic (1.30e-3)" "unprognostic (1.81e-3)" "unprognostic (8.80e-2)" "prognostic unfavorable (6.64e-5)" "unprognostic (1.90e-1)" "unprognostic (1.49e-3)" "unprognostic (3.55e-1)" "unprognostic (5.02e-3)" "unprognostic (4.66e-1)" "unprognostic (3.12e-3)" "unprognostic (7.91e-2)" "unprognostic (1.55e-1)" "unprognostic (8.36e-2)" "unprognostic (2.20e-2)" 5.2 7.4 11.0 4.9 10.2 5.4 10.3 27.5 14.1 8.2 7.8 10.1 11.0 4.1 10.9 11.3 5.8 10.2 5.2 6.8 10.9 8.8 8.3 4.7 5.3 5.1 11.3 5.7 14.6 12.6 7.7 7.0 5.0 8.4 8.7 3.0 7.8 8.8 13.8 2.3 9.0 4.8 8.5 6.9 7.6 5.0 8.2 10.9 12.1 8.2 2.0 3.8 7.8 9.0 1.8 1.5 0.3 0.2 0.2 1.3 0.2 3.7 13.2 12.9 8.7 6.3 4.6 3.9 5.2 4.5 4.7 4.7 2.6 3.9 8.4 4.0 6.0 9.9 4.4 9.4 1.7 2.7 4.2 6.5 5.4 5.1 26.3 8.1 7.4 1.4 6.3 5.4 4.0 1.6 7.8 6.2 5.8 12.7 4.4 3.0 9.1 2.5 18.3 21.1 2.1 17.4 13.2 3.3 6.8 6.7 0.4 15.9 18.5 3.5 15.3 19.2 5.6 14.5 10.4 7.0 18.4 18.3 0.5 4.5 12.8 13.4 8.7 3.4 7.4 3.5 0.3 0.2 0.3 0.5 0.1 0.2 1.7 0.6 0.8 0.2 1.8 1.3 1.1 0.1 0.2 0.0 1.5 0.8 0.2 11.0 10.2 27.5 10.7 10.9 8.8 11.3 5.7 8.4 10.9 0.0 2.7 0.8 2.1 3.1 53.0 11.0 5.1 1.4 1.2 7.0 39.3 1.2 13.3 1.1 0.6 3.8 1.1 0.0 0.3 0.4 4.3 2.6 0.0 4.7 1.8 30.2 8.7 8.6 1.9 1.7 9.5 0.7 5.0 0.0 4.0 8.3 0.4 0.0 11.7 4.8 37.2 0.0 5.7 0.9 7.0 1.0 0.6 2.1 3.7 0.3 SOX13 "ICA12, MGC117216, Sox-13" ENSG00000143842 "SRY-box 13" Q9UN79 1 204073115-204127743 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Sertoli cells: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 4.1" "Group enriched" "Detected in many" 6 "NK-cells: 4.1;T-cells: 2.6" "Cell line enhanced" "Detected in many" "BEWO: 24.0;SK-BR-3: 50.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051790, HPA054843" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA051790: AB_2681610, HPA054843: AB_2682622" "unprognostic (4.88e-3)" "unprognostic (6.01e-2)" "prognostic unfavorable (6.49e-4)" "unprognostic (4.74e-2)" "unprognostic (2.65e-1)" "unprognostic (3.08e-2)" "unprognostic (1.02e-1)" "unprognostic (1.27e-2)" "unprognostic (2.75e-1)" "unprognostic (2.95e-1)" "unprognostic (1.28e-2)" "unprognostic (1.25e-1)" "unprognostic (1.48e-3)" "unprognostic (1.04e-1)" "unprognostic (8.20e-2)" "unprognostic (7.98e-2)" "unprognostic (1.92e-1)" 22.2 10.7 11.0 6.9 8.6 0.8 18.4 9.2 9.9 37.0 17.2 14.4 16.1 13.5 30.3 12.4 10.9 22.3 16.4 9.7 11.0 6.9 19.0 12.3 20.5 4.3 13.7 7.0 13.5 12.8 34.2 5.6 27.3 14.3 23.5 8.3 13.7 13.1 18.7 14.2 9.9 16.8 18.2 12.1 8.4 8.2 8.7 13.3 0.1 10.4 7.5 7.0 19.5 19.2 0.0 0.0 0.5 0.0 4.1 2.6 0.3 8.5 5.5 11.9 0.8 11.4 3.4 24.0 3.3 2.0 5.3 3.3 4.6 6.4 0.0 11.0 2.1 1.4 13.9 4.5 4.3 2.5 3.9 2.2 0.0 3.7 5.1 2.6 0.0 5.0 3.5 2.2 3.3 2.9 2.6 7.6 0.1 0.0 0.0 1.1 10.5 0.0 0.0 15.7 13.9 6.7 0.1 4.0 5.2 4.0 19.8 1.8 0.9 3.4 50.1 15.0 11.1 22.3 1.0 4.4 1.2 3.2 5.1 2.3 0.0 0.0 0.0 1.9 0.1 3.1 0.2 0.0 0.5 2.5 0.0 2.6 0.0 1.2 1.4 0.0 0.0 0.0 1.0 0.3 4.1 0.0 0.0 0.0 0.3 11.0 8.6 9.2 9.9 11.0 6.9 13.7 7.0 14.3 13.3 6.0 11.4 0.8 7.9 1.9 0.5 24.3 10.2 1.4 4.5 8.7 0.0 4.3 1.7 2.7 8.5 12.7 12.6 0.0 1.3 5.0 5.0 6.6 16.2 5.9 1.2 0.0 7.5 8.0 0.0 20.2 19.2 0.7 1.7 0.0 5.5 6.3 2.9 7.6 18.4 3.5 0.9 38.8 15.5 0.2 0.7 1.4 1.6 1.9 5.4 5.7 SOX15 "SOX20, SOX26, SOX27" ENSG00000129194 "SRY-box 15" O60248 17 7588178-7590170 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 62.7;lymphoid tissue: 38.7;skin 1: 30.0;tongue: 59.0" "Cell type enhanced" "Detected in many" 13 "Basal keratinocytes: 185.8;Suprabasal keratinocytes: 148.4;Urothelial cells: 76.9" "Cancer enhanced" "Detected in many" "testis cancer: 67.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 7.1;non-classical monocyte: 10.8" "Lineage enriched" "Detected in many" 4 "monocytes: 10.8" "Group enriched" "Detected in some" 7 "A-431: 41.8;HaCaT: 47.0;HBEC3-KT: 18.8;hTCEpi: 18.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA067196, HPA074049" Enhanced Supported "Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles" Yes NA Nucleoplasm "Nucleoli, Golgi apparatus, Vesicles" "HPA067196: AB_2685802, HPA074049: AB_2686656" "unprognostic (5.79e-3)" "unprognostic (6.65e-2)" "unprognostic (1.40e-2)" "unprognostic (2.58e-2)" "unprognostic (2.72e-1)" "unprognostic (1.60e-1)" "unprognostic (6.02e-2)" "unprognostic (2.81e-2)" "unprognostic (5.00e-2)" "unprognostic (8.50e-2)" "unprognostic (1.59e-1)" "unprognostic (1.24e-1)" "unprognostic (8.61e-3)" "unprognostic (1.03e-1)" "unprognostic (1.96e-1)" "unprognostic (2.95e-2)" "unprognostic (2.97e-1)" 1.0 0.8 4.6 1.0 4.1 2.1 1.3 7.2 5.0 7.5 2.6 1.1 1.0 0.7 4.4 1.7 62.7 3.7 1.0 2.9 3.1 4.1 1.3 1.0 1.5 1.0 2.6 1.0 7.0 1.0 0.1 2.0 2.0 3.5 4.1 0.6 1.4 3.4 7.0 1.9 30.0 1.0 1.6 1.4 1.0 0.7 1.3 1.0 1.8 1.0 59.0 38.7 3.6 7.8 0.0 2.4 0.2 10.8 0.0 0.0 0.5 41.8 1.0 0.6 0.3 0.0 0.1 3.2 0.5 0.1 0.3 0.6 0.8 0.2 0.1 0.4 0.0 0.1 47.0 0.0 18.8 0.1 1.1 1.3 0.1 0.5 0.1 0.0 0.1 0.9 0.0 18.6 0.2 4.2 1.3 0.0 0.8 0.9 0.3 0.0 0.3 0.2 0.5 1.3 0.1 0.2 0.5 0.6 0.3 0.8 0.2 0.3 0.7 0.5 0.1 0.2 1.9 0.3 0.3 0.5 0.4 0.8 0.5 1.4 0.3 0.5 0.6 1.5 0.6 1.1 0.2 2.4 0.0 0.0 7.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 10.8 1.2 0.0 0.5 4.6 4.1 7.2 4.4 3.1 4.1 2.6 1.0 3.5 1.0 0.0 0.0 0.0 39.1 185.8 11.0 2.8 0.0 10.7 5.7 1.8 13.7 0.3 1.7 0.0 0.1 1.6 0.2 0.0 0.4 1.5 6.1 15.1 0.0 0.0 0.4 9.5 1.2 1.8 2.7 0.6 29.1 1.1 25.3 1.8 0.0 33.2 0.3 0.0 34.6 0.0 6.2 32.3 8.9 0.4 8.7 148.4 0.9 0.0 0.2 76.9 SOX17 ENSG00000164736 "SRY-box 17" Q9H6I2 8 54457935-54460888 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 23 "Endothelial cells: 80.4;Ito cells: 39.3;Melanocytes: 18.6" "Group enriched" "Detected in many" 12 "endometrial cancer: 122.8;ovarian cancer: 96.2;testis cancer: 25.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "EFO-21: 50.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB025594, HPA068399" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "CAB025594: , HPA068399: AB_2685981" "unprognostic (1.87e-1)" "unprognostic (1.13e-1)" "unprognostic (1.76e-3)" "prognostic favorable (2.76e-4)" "unprognostic (1.01e-1)" "unprognostic (3.85e-2)" "unprognostic (3.34e-2)" "unprognostic (1.28e-1)" "unprognostic (1.39e-2)" "unprognostic (7.90e-2)" "unprognostic (3.62e-2)" "unprognostic (1.18e-1)" "unprognostic (4.98e-2)" "unprognostic (7.28e-3)" "unprognostic (1.12e-1)" "unprognostic (3.76e-1)" "unprognostic (1.88e-1)" 26.7 2.0 1.2 9.1 1.8 0.6 31.3 0.6 2.9 25.7 7.9 1.5 1.0 1.4 23.9 7.1 11.6 23.1 20.2 20.6 1.5 1.3 3.0 2.2 8.7 1.5 2.0 1.0 13.0 1.5 1.7 1.5 9.9 2.3 7.6 1.6 3.6 2.4 3.0 13.3 3.1 3.3 5.9 1.8 15.7 3.7 5.8 0.4 0.8 3.6 6.2 1.3 12.3 5.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.1 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.8 0.6 2.9 1.5 1.3 2.0 1.0 2.3 0.4 0.0 0.0 0.0 0.1 12.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 80.4 0.0 0.0 0.2 0.1 1.0 0.6 0.0 0.0 0.1 0.0 0.0 39.3 1.6 1.5 2.3 0.0 18.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 3.1 0.4 0.6 11.8 0.0 0.0 0.0 1.5 SOX18 ENSG00000203883 "SRY-box 18" P35713 20 64047582-64049641 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation, Hypotrichosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 53.3" "Group enriched" "Detected in many" 15 "Endothelial cells: 106.0;Ito cells: 165.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 15.5;NB-4: 25.5;REH: 6.1;TIME: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA073703 Approved Nucleoplasm NA NA Nucleoplasm "HPA073703: AB_2686628" "unprognostic (2.51e-1)" "unprognostic (3.23e-1)" "unprognostic (9.98e-3)" "unprognostic (6.30e-2)" "unprognostic (1.07e-1)" "unprognostic (2.88e-2)" "unprognostic (2.71e-2)" "unprognostic (4.35e-3)" "unprognostic (1.62e-1)" "unprognostic (3.45e-2)" "unprognostic (1.33e-3)" "unprognostic (1.76e-1)" "unprognostic (1.13e-3)" "unprognostic (9.63e-3)" "unprognostic (1.41e-1)" "unprognostic (2.46e-1)" "unprognostic (5.40e-2)" 53.3 6.2 3.1 9.9 5.0 1.8 27.5 2.5 5.2 18.3 9.4 3.1 4.3 7.4 26.0 10.0 16.4 15.0 15.8 29.7 3.2 3.1 10.1 6.8 29.3 17.7 4.8 2.3 11.2 3.6 4.6 3.2 12.4 6.1 12.3 2.7 13.1 8.1 5.8 20.3 7.9 7.2 7.0 3.4 13.7 7.2 6.9 1.2 2.9 13.8 20.5 5.8 8.4 18.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.8 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.8 0.0 2.1 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 15.5 0.0 2.6 0.0 0.0 0.5 0.0 25.5 0.1 0.0 0.2 6.1 0.0 0.4 0.0 1.0 0.4 0.5 0.2 0.0 0.3 0.0 0.4 1.2 7.0 0.1 2.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 5.0 2.5 5.2 3.2 3.1 4.8 2.3 6.1 1.2 0.0 1.1 3.4 0.1 0.9 0.8 6.2 2.5 0.0 0.0 1.8 0.0 0.0 0.0 0.0 8.8 106.0 0.0 0.0 0.0 0.0 0.9 0.2 4.6 0.2 0.1 0.0 0.0 165.7 8.9 2.1 1.1 0.8 1.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 1.0 1.8 1.5 1.0 0.2 0.0 0.0 0.4 SOX2 ENSG00000181449 "SRY-box 2" P48431 3 181711924-181714436 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 80.1" "Cell type enriched" "Detected in some" 9 "Muller glia cells: 455.6" "Cancer enhanced" "Detected in many" "glioma: 136.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 68.9;HAP1: 29.3;NTERA-2: 56.2;U-251 MG: 12.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045725, HPA062851, HPA071379, CAB079745" Enhanced Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB079745: , HPA045725: AB_2679431, HPA062851: , HPA071379: " "unprognostic (1.80e-2)" "unprognostic (3.18e-3)" "unprognostic (5.69e-2)" "unprognostic (6.96e-2)" "unprognostic (2.74e-3)" "unprognostic (1.60e-1)" "unprognostic (1.79e-2)" "unprognostic (4.48e-3)" "unprognostic (1.71e-1)" "unprognostic (4.38e-3)" "unprognostic (1.83e-1)" "unprognostic (7.68e-2)" "unprognostic (3.81e-9)" "unprognostic (1.12e-1)" "unprognostic (2.12e-1)" "unprognostic (1.26e-1)" "unprognostic (1.12e-2)" 1.8 2.5 30.3 2.0 25.8 1.5 1.6 13.9 80.1 1.8 2.3 24.3 0.0 2.0 1.5 1.8 15.9 5.0 1.8 1.7 36.0 19.2 1.5 1.5 3.4 1.5 19.4 18.5 1.7 1.6 1.5 5.8 1.5 18.6 3.9 2.0 1.0 6.3 1.9 1.6 1.8 2.3 1.7 18.4 1.6 9.7 3.0 22.4 0.0 1.5 2.1 6.9 2.3 1.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.2 68.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.1 29.3 0.7 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 56.2 2.9 0.1 0.0 0.1 0.0 7.6 0.1 0.1 0.3 0.0 0.0 0.0 11.9 0.4 0.0 0.0 0.0 1.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.3 25.8 13.9 20.0 36.0 19.2 19.4 18.5 18.6 22.4 0.0 5.9 0.0 41.2 0.2 3.5 0.4 0.0 52.2 38.7 3.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 4.9 1.1 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.6 0.2 3.3 0.0 0.0 455.6 0.0 0.0 0.0 0.0 8.2 0.0 0.1 1.5 0.2 0.4 0.2 0.0 0.0 7.0 SOX21 SOX25 ENSG00000125285 "SRY-box 21" Q9Y651 13 94709622-94712399 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.2;skin 1: 18.3;stomach 1: 38.7" "Group enriched" "Detected in some" 5 "Basal keratinocytes: 4.7;Suprabasal keratinocytes: 8.0" "Cancer enhanced" "Detected in many" "glioma: 12.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 42.6;NTERA-2: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA048337, HPA064084" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA048337: AB_2732547, HPA064084: AB_2685187" "unprognostic (3.33e-1)" "prognostic favorable (7.60e-4)" "unprognostic (7.96e-2)" "prognostic favorable (8.79e-5)" "unprognostic (1.54e-2)" "unprognostic (3.87e-1)" "unprognostic (9.02e-2)" "unprognostic (2.11e-1)" "unprognostic (1.50e-1)" "unprognostic (2.90e-2)" "unprognostic (1.93e-1)" "unprognostic (6.05e-2)" "unprognostic (1.11e-1)" "unprognostic (3.51e-1)" "unprognostic (2.25e-1)" "unprognostic (1.35e-1)" 0.6 0.6 11.0 0.7 10.1 0.6 1.5 2.5 13.2 0.7 0.6 7.5 0.0 0.6 0.7 0.6 8.3 0.7 0.7 0.6 10.9 5.5 0.6 0.6 0.8 0.6 6.0 8.2 0.6 0.6 0.6 0.1 0.6 5.8 1.2 0.6 0.0 1.7 0.6 0.7 18.3 0.6 0.7 6.1 0.6 38.7 0.8 9.8 0.0 0.7 1.0 4.3 1.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 42.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 3.3 6.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 10.1 2.5 12.3 10.9 5.5 6.0 8.2 5.8 9.8 0.0 0.0 0.0 1.2 4.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 8.0 0.0 0.0 0.0 0.7 SOX3 PHP ENSG00000134595 "SRY-box 3" P41225 X 140502985-140505116 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 18.2;testis: 12.4" "Cell type enriched" "Detected in single" 8 "Muller glia cells: 4.3" "Cancer enhanced" "Detected in some" "glioma: 2.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.8;HEK 293: 8.3;NTERA-2: 18.6;SuSa: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA054720, HPA075003" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA054720: AB_2682584, HPA075003: AB_2686727" "unprognostic (6.04e-2)" "unprognostic (3.75e-1)" "unprognostic (8.62e-3)" "unprognostic (8.03e-2)" "unprognostic (1.57e-1)" "unprognostic (5.27e-3)" 0.3 0.5 2.6 0.3 2.7 0.3 0.3 0.6 2.6 1.5 0.3 5.0 0.0 0.3 0.6 0.3 0.3 18.2 0.3 0.3 2.2 5.0 0.3 0.3 0.3 0.3 2.0 1.8 4.7 0.3 0.4 3.2 0.3 3.6 0.3 0.3 0.5 0.3 0.3 0.4 0.3 0.3 0.3 2.3 0.3 0.3 12.4 0.6 0.0 0.5 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.7 0.6 2.6 2.2 5.0 2.0 1.8 3.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 SOX4 ENSG00000124766 "SRY-box 4" Q06945 6 21592768-21598619 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.8" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 757.4;Pancreatic endocrine cells: 1059.7" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 21.8" "Group enriched" "Detected in all" 4 "dendritic cells: 21.8;granulocytes: 12.8;monocytes: 10.0" "Cell line enhanced" "Detected in many" "AN3-CA: 55.4;MOLT-4: 47.6;SH-SY5Y: 31.2" "Region enriched" "Detected in many" 4 "olfactory region: 66.5" "Low region specificity" "Detected in many" HPA029901 Approved Supported Nucleoplasm,Mitochondria NA Yes Nucleoplasm Mitochondria "HPA029901: AB_10601592" "unprognostic (4.01e-2)" "unprognostic (3.06e-1)" "unprognostic (9.28e-2)" "unprognostic (5.18e-2)" "unprognostic (5.00e-2)" "unprognostic (1.08e-2)" "prognostic unfavorable (2.57e-5)" "unprognostic (1.78e-1)" "unprognostic (8.01e-3)" "unprognostic (1.98e-2)" "unprognostic (3.88e-3)" "unprognostic (1.18e-1)" "unprognostic (8.73e-3)" "unprognostic (3.66e-2)" "unprognostic (3.31e-1)" "unprognostic (2.01e-1)" "unprognostic (9.27e-2)" 4.2 0.7 2.0 1.9 0.9 6.0 6.3 3.0 6.3 6.7 2.8 3.0 18.0 4.1 2.3 4.2 5.5 2.0 1.1 1.8 4.3 1.3 5.1 0.8 0.6 18.1 5.3 0.0 1.8 1.0 4.1 3.7 9.6 1.4 0.3 4.1 2.7 4.9 0.3 1.0 4.4 2.5 3.4 1.4 6.2 3.6 3.1 21.8 12.8 10.0 3.3 1.1 2.0 1.8 5.2 13.3 55.4 4.9 1.2 21.7 0.8 1.7 1.0 0.9 3.5 3.5 0.6 22.2 1.3 0.7 5.4 6.9 3.8 0.7 7.6 14.5 0.5 2.4 2.3 0.8 1.8 0.4 2.1 3.9 0.4 1.6 14.2 15.6 30.0 0.1 0.0 1.1 4.3 47.6 4.5 9.9 2.6 5.0 21.0 1.1 0.0 9.6 16.7 17.4 31.2 7.7 9.0 2.9 17.3 4.4 6.5 11.9 1.5 5.2 0.3 3.9 0.3 0.0 15.4 0.5 6.5 6.1 12.8 9.8 0.9 0.2 5.5 0.0 2.8 0.1 0.1 4.1 3.1 1.1 0.8 0.4 3.3 10.0 21.8 0.9 2.0 184.6 59.8 33.5 82.0 99.9 88.8 228.6 341.4 161.9 235.4 146.5 11.8 61.5 56.3 757.4 3.9 238.0 78.0 0.0 523.0 358.6 243.9 126.1 56.8 5.8 33.0 46.1 327.2 70.6 85.2 8.3 11.2 56.1 231.2 80.2 156.9 228.7 1059.7 155.6 10.6 77.4 25.8 6.5 198.6 3.7 175.2 81.3 25.3 23.5 265.6 178.0 SOX5 "L-SOX5, MGC35153" ENSG00000134532 "SRY-box 5" P35711 12 23529500-24562544 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 52.0" "Group enriched" "Detected in many" 4 "Early spermatids: 153.3;Late spermatids: 165.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 4.3;naive B-cell: 3.7" "Lineage enriched" "Detected in single" 6 "B-cells: 4.3" "Cell line enhanced" "Detected in many" "AF22: 12.0;Daudi: 12.0;HDLM-2: 25.2;K-562: 10.9;WM-115: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060499 Supported Nucleoplasm NA NA Nucleoplasm "HPA060499: AB_2684294" "unprognostic (9.11e-4)" "unprognostic (4.64e-3)" "unprognostic (3.23e-1)" "unprognostic (6.83e-2)" "unprognostic (1.67e-1)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (1.03e-3)" "unprognostic (1.36e-1)" "unprognostic (8.40e-2)" "unprognostic (1.70e-4)" "unprognostic (6.95e-2)" "unprognostic (4.53e-4)" "unprognostic (3.12e-3)" "unprognostic (2.37e-1)" "unprognostic (9.59e-2)" "unprognostic (2.75e-2)" 8.5 2.4 9.2 3.1 5.4 0.7 4.4 3.8 10.5 10.6 2.9 3.0 2.7 1.1 8.7 1.8 2.6 4.5 3.8 3.6 10.0 2.8 2.9 12.9 3.3 4.2 4.1 6.4 9.1 2.5 0.7 6.9 9.9 7.2 2.8 1.8 5.2 4.0 4.9 2.7 7.1 2.7 4.3 5.1 2.5 2.9 52.0 5.5 0.0 3.3 1.6 3.7 2.9 5.4 4.3 0.7 0.1 0.0 0.7 0.1 0.2 0.1 0.1 12.0 0.0 6.8 3.6 0.0 0.1 0.0 0.1 0.4 2.1 0.1 12.0 0.6 0.0 0.0 0.1 6.8 0.0 0.1 25.2 1.7 2.5 0.0 5.6 4.6 0.0 0.1 1.9 0.0 0.6 0.0 1.5 0.0 0.4 10.9 0.5 0.3 0.0 4.6 0.1 3.6 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.5 0.5 0.0 0.0 4.9 3.3 0.2 2.4 0.0 0.2 1.6 0.0 1.1 0.3 0.0 0.7 2.7 0.0 10.2 0.1 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.1 0.0 3.7 0.0 0.1 0.1 0.7 0.0 0.7 0.0 0.2 9.2 5.4 3.8 10.5 10.0 2.8 4.1 6.4 7.2 5.5 6.0 8.3 1.3 0.1 11.7 11.5 2.8 2.5 25.4 5.7 3.5 0.0 0.1 0.0 0.1 153.3 1.5 0.0 0.0 0.0 0.1 7.4 0.2 1.1 18.1 0.3 0.0 5.2 4.3 1.2 165.2 9.5 0.0 11.8 10.0 0.0 17.5 0.0 0.0 6.3 0.5 1.8 19.4 11.7 38.4 1.2 10.7 0.2 0.0 0.0 0.1 SOX6 ENSG00000110693 "SRY-box 6" P35712 11 15966449-16739591 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 70.1;kidney: 28.4" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 221.4;Erythroid cells: 116.8;Muller glia cells: 66.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 30 "neutrophil: 5.4" "Lineage enriched" "Detected in single" 30 "granulocytes: 5.4" "Cell line enhanced" "Detected in some" "AF22: 4.4;CACO-2: 5.9;HAP1: 4.9;hTCEpi: 5.6;SK-MEL-30: 5.0;WM-115: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001923, HPA003908" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA001923: AB_1080065, HPA003908: AB_1080063" "unprognostic (3.40e-2)" "unprognostic (1.70e-1)" "unprognostic (1.20e-1)" "unprognostic (1.68e-1)" "unprognostic (4.17e-3)" "unprognostic (1.05e-2)" "unprognostic (6.47e-3)" "unprognostic (1.25e-2)" "unprognostic (1.31e-1)" "unprognostic (7.89e-4)" "unprognostic (9.08e-2)" "unprognostic (7.37e-3)" "prognostic favorable (6.47e-12)" "unprognostic (9.90e-2)" "unprognostic (5.02e-2)" "unprognostic (1.15e-1)" "unprognostic (3.04e-2)" 1.4 0.9 3.9 0.8 3.5 17.7 0.8 0.8 5.7 1.4 30.5 0.8 2.3 5.0 0.8 4.9 1.6 3.3 6.3 2.5 2.6 2.5 28.4 3.8 2.0 0.8 3.0 0.8 1.7 14.5 0.0 2.9 1.9 0.9 0.8 0.8 1.1 0.8 0.8 8.1 4.5 70.1 0.8 1.4 1.1 0.6 10.3 1.0 0.8 2.8 1.4 0.8 0.8 0.8 0.0 0.0 5.4 0.0 0.0 0.1 0.0 0.0 0.6 4.4 4.2 0.0 0.0 0.0 0.3 1.4 0.1 0.1 5.9 0.0 0.0 3.8 0.0 0.0 0.1 4.9 1.3 0.0 0.0 0.5 0.0 0.0 0.2 0.7 0.0 0.0 0.0 5.6 0.0 0.1 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.8 0.0 2.2 0.0 0.0 0.1 0.4 0.0 5.0 0.5 0.0 0.0 0.0 2.9 2.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.4 0.0 0.0 0.0 0.0 0.0 3.9 3.5 0.8 2.5 2.6 2.5 3.0 0.8 0.9 1.0 3.0 4.6 0.0 4.2 35.6 2.1 18.7 25.5 12.0 5.7 34.9 9.8 1.0 8.3 12.3 221.4 3.5 3.2 116.8 3.3 0.5 16.2 2.6 0.0 2.8 1.0 0.0 7.5 3.7 0.3 43.5 3.1 2.2 33.7 0.0 1.5 66.8 6.2 8.6 2.1 17.2 3.3 0.0 13.3 20.1 3.5 14.1 0.5 0.0 0.9 2.8 SOX8 ENSG00000005513 "SRY-box 8" P57073 16 981808-986979 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 64.9" "Cell type enriched" "Detected in some" 22 "Muller glia cells: 120.0" "Cancer enriched" "Detected in many" 6 "glioma: 46.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.2;naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 23 "T-cells: 2.2" "Cell line enriched" "Detected in some" 5 "RH-30: 51.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041640, HPA058665" Enhanced Nucleoplasm No NA Nucleoplasm "HPA041640: AB_10964357, HPA058665: AB_2683792" "unprognostic (1.40e-2)" "unprognostic (2.56e-3)" "unprognostic (1.59e-1)" "unprognostic (3.10e-2)" "unprognostic (4.58e-2)" "unprognostic (7.16e-3)" "unprognostic (6.05e-3)" "unprognostic (3.01e-2)" "unprognostic (2.53e-1)" "unprognostic (1.16e-1)" "unprognostic (4.53e-3)" "unprognostic (4.46e-2)" "unprognostic (1.20e-3)" "unprognostic (8.50e-2)" "unprognostic (6.18e-2)" "unprognostic (5.47e-1)" "unprognostic (9.09e-2)" 1.6 1.5 18.4 1.8 25.1 1.0 2.5 3.2 64.9 1.2 1.4 20.9 0.0 1.1 1.1 1.1 1.2 1.1 1.5 1.8 22.6 14.5 1.0 1.0 1.0 2.7 26.5 5.4 1.0 1.5 1.0 0.1 1.4 12.0 1.3 1.5 0.9 8.6 1.4 1.3 1.3 1.2 1.2 27.1 1.8 1.7 1.9 30.4 0.0 1.1 0.0 3.1 1.1 0.3 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.3 1.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.5 0.7 0.1 0.0 51.7 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.1 0.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 2.2 1.1 0.0 0.0 0.0 0.0 0.0 0.2 18.4 25.1 3.2 11.8 22.6 14.5 26.5 5.4 12.0 30.4 0.0 0.0 0.0 0.4 0.3 1.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.2 0.1 2.1 1.4 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 3.1 0.0 1.7 1.0 0.0 120.0 0.1 0.0 1.8 0.0 5.3 0.0 0.8 0.0 4.3 0.9 0.0 0.0 0.0 0.1 SOX9 "CMD1, CMPD1, SRA1" ENSG00000125398 "SRY-box 9" P48436 17 72121020-72126420 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 63.4" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 178.3;Muller glia cells: 170.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 28.5;Hep G2: 34.1;OE19: 26.3;U-251 MG: 23.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001758, CAB022456, CAB068240" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB022456: , CAB068240: AB_2665670, HPA001758: AB_1080067" "unprognostic (6.92e-2)" "unprognostic (1.73e-2)" "unprognostic (4.47e-3)" "unprognostic (4.43e-2)" "unprognostic (2.55e-2)" "unprognostic (7.96e-3)" "unprognostic (4.32e-3)" "prognostic unfavorable (2.07e-4)" "unprognostic (4.87e-2)" "unprognostic (3.31e-1)" "unprognostic (8.92e-3)" "unprognostic (1.21e-1)" "unprognostic (3.26e-3)" "unprognostic (2.77e-3)" "unprognostic (1.15e-1)" "unprognostic (8.88e-2)" "unprognostic (1.21e-2)" 3.1 2.6 32.2 4.3 31.6 1.1 23.4 20.3 32.4 7.4 14.6 28.4 8.1 16.6 3.5 1.9 7.7 7.4 11.7 9.5 35.5 15.7 11.7 3.9 3.4 1.9 14.6 13.7 1.2 31.9 1.2 7.0 1.4 21.3 21.7 15.7 12.9 63.4 14.4 3.0 13.1 12.9 2.1 15.6 1.3 35.2 25.2 20.2 0.0 17.8 5.3 5.0 1.9 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 6.9 14.3 28.5 1.4 0.4 0.0 1.7 1.5 3.0 1.6 9.6 14.8 0.0 1.1 0.4 16.2 11.2 0.0 6.7 2.8 0.0 0.9 0.0 1.5 34.1 0.1 0.0 0.0 0.2 0.6 3.5 3.3 17.4 0.0 0.0 0.0 0.0 4.2 0.1 0.0 0.0 0.5 26.3 10.6 0.0 11.6 0.1 12.9 0.7 0.7 0.7 1.4 1.7 0.0 8.1 6.1 0.1 0.0 5.9 15.9 3.1 23.5 0.0 0.0 0.0 4.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.2 31.6 20.3 26.7 35.5 15.7 14.6 13.7 21.3 20.2 11.9 3.5 2.2 77.1 49.2 1.4 13.8 178.3 26.8 20.5 34.9 0.0 0.2 6.6 53.5 3.4 1.4 28.2 0.0 41.0 0.0 3.8 85.0 4.6 3.9 0.2 0.0 57.4 0.0 0.0 7.1 4.0 2.6 11.8 1.8 90.5 170.2 39.9 21.0 0.4 46.9 6.5 6.5 6.2 12.5 1.5 15.6 0.1 0.5 78.3 71.8 SP1 ENSG00000185591 "Sp1 transcription factor" P08047 12 53380176-53416446 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000330, HPA001853, HPA012292" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB000330: AB_2171049, HPA001853: AB_1080069, HPA012292: AB_1857394" "unprognostic (1.12e-1)" "unprognostic (8.52e-3)" "unprognostic (6.11e-2)" "unprognostic (1.24e-1)" "unprognostic (2.03e-1)" "unprognostic (4.64e-3)" "unprognostic (1.08e-2)" "unprognostic (2.53e-1)" "unprognostic (1.01e-1)" "unprognostic (2.66e-2)" "prognostic unfavorable (1.43e-4)" "unprognostic (6.38e-2)" "unprognostic (5.14e-2)" "unprognostic (4.05e-2)" "unprognostic (1.37e-1)" "unprognostic (4.77e-2)" "unprognostic (2.12e-2)" 20.7 18.1 8.8 13.9 14.2 17.0 20.1 30.0 14.7 20.9 21.9 17.5 19.3 19.6 25.4 21.2 35.0 20.4 18.7 12.1 14.1 6.8 31.3 14.1 17.6 14.2 18.3 9.7 22.5 17.9 19.0 11.3 19.5 14.4 16.2 20.1 21.5 25.8 19.5 22.0 25.8 30.0 18.4 21.0 19.0 18.8 22.4 15.2 25.8 16.6 17.3 26.6 25.1 21.6 2.7 3.0 11.2 4.2 1.7 2.8 1.4 17.7 19.5 22.4 16.3 18.0 20.8 17.8 12.9 16.6 15.8 14.6 16.2 35.6 24.1 17.1 14.7 10.2 25.8 25.7 17.4 17.7 18.4 14.9 21.2 24.7 8.8 12.6 19.3 18.0 22.0 18.2 16.2 31.6 28.7 16.2 19.3 20.3 35.0 11.6 25.4 28.8 14.8 12.4 13.7 14.7 20.5 21.6 14.3 12.5 32.2 11.8 15.8 26.1 21.9 13.2 18.4 27.5 20.8 15.7 18.6 17.4 13.9 13.7 12.1 13.8 24.1 14.3 16.1 14.9 4.5 4.2 2.5 2.2 2.7 2.8 2.3 2.2 2.1 2.4 2.7 2.4 2.6 11.2 1.7 3.1 3.0 1.6 1.4 8.8 14.2 30.0 14.7 14.1 6.8 18.3 9.7 14.4 15.2 20.8 12.9 13.5 18.3 21.2 11.0 6.7 35.7 12.0 21.6 29.6 7.9 13.5 5.0 15.2 44.6 19.7 33.8 23.3 11.9 13.5 16.5 21.7 5.8 25.9 16.0 15.9 12.1 28.8 37.1 35.5 25.3 17.2 8.5 9.0 29.3 20.6 15.6 17.3 24.4 18.4 9.7 12.9 17.0 27.9 22.6 27.4 17.8 13.1 23.4 40.6 SP100 ENSG00000067066 "SP100 nuclear antigen" P23497 2 230415942-230544090 "Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 65.8" "HPA016707, HPA017384" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA016707: AB_1857398, HPA017384: AB_1857399" "unprognostic (8.04e-3)" "unprognostic (1.08e-2)" "unprognostic (3.34e-2)" "unprognostic (1.86e-3)" "unprognostic (5.48e-2)" "unprognostic (1.12e-2)" "unprognostic (1.44e-1)" "unprognostic (2.77e-2)" "unprognostic (6.25e-3)" "unprognostic (5.32e-3)" "unprognostic (1.11e-2)" "unprognostic (3.17e-1)" "prognostic unfavorable (1.61e-4)" "unprognostic (1.96e-2)" "unprognostic (1.48e-2)" "unprognostic (2.33e-2)" "unprognostic (3.25e-2)" 39.7 27.7 7.0 44.0 12.9 56.8 33.4 3.4 9.4 25.6 28.3 5.5 19.1 15.3 18.9 20.5 22.5 16.1 20.3 32.3 7.1 5.3 21.7 24.8 36.0 48.5 13.0 4.0 23.8 19.9 1.8 13.7 25.1 10.9 24.0 12.4 13.9 23.4 17.6 14.6 17.3 35.4 20.2 15.6 52.2 18.6 9.8 10.6 25.9 31.6 17.8 37.4 27.0 34.7 44.1 17.4 75.6 25.2 30.8 33.2 26.1 13.3 4.1 0.2 1.8 21.0 34.0 3.2 17.5 39.3 40.8 65.8 2.4 15.9 6.2 14.2 18.9 24.5 6.6 0.2 16.7 29.9 14.9 0.5 10.7 6.9 5.4 30.3 12.5 14.7 27.9 9.9 19.5 17.7 30.4 30.6 5.1 5.5 10.3 15.5 3.6 7.8 13.4 0.6 5.9 6.4 5.9 9.5 4.3 11.6 11.5 0.1 0.2 7.0 2.3 30.1 0.7 2.1 13.1 36.9 19.7 5.2 11.9 10.0 12.9 4.2 14.0 18.8 13.8 9.5 31.8 22.5 28.6 33.2 19.2 26.3 38.9 32.3 28.5 16.8 44.1 31.0 27.3 75.6 30.8 25.2 17.4 29.1 26.1 7.0 12.9 3.4 9.4 7.1 5.3 13.0 4.0 10.9 10.6 142.9 51.2 83.5 61.5 62.8 0.4 58.9 38.2 71.0 64.8 31.4 2.0 26.2 36.5 81.6 3.8 123.3 44.5 70.0 92.3 63.1 69.1 56.3 53.4 31.4 71.8 0.0 8.6 55.9 66.9 2.4 43.1 86.3 67.4 78.5 26.5 0.3 77.0 45.2 49.5 37.0 0.5 38.8 63.4 0.6 0.6 59.6 13.5 108.3 22.5 63.6 SP110 "IFI41, IFI75" ENSG00000135899 "SP110 nuclear body protein" Q9HB58 2 230167293-230225729 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 65.9" "Cell type enhanced" "Detected in many" 7 "B-cells: 109.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 40.1" "Low region specificity" "Detected in all" HPA058554 Supported Nucleoplasm No No Nucleoplasm "HPA058554: AB_2683754" "unprognostic (9.72e-2)" "unprognostic (1.15e-2)" "unprognostic (5.02e-2)" "unprognostic (8.33e-4)" "unprognostic (2.93e-1)" "unprognostic (1.80e-1)" "unprognostic (6.65e-2)" "unprognostic (9.44e-2)" "unprognostic (9.68e-2)" "unprognostic (1.46e-2)" "unprognostic (4.11e-3)" "unprognostic (2.55e-1)" "prognostic unfavorable (1.17e-5)" "unprognostic (2.38e-1)" "unprognostic (2.66e-2)" "unprognostic (2.99e-3)" "unprognostic (9.50e-3)" 21.4 8.9 6.5 29.9 12.1 17.6 12.3 3.1 7.5 10.2 8.9 11.6 3.2 7.6 13.5 8.0 11.1 8.1 11.7 8.6 6.0 5.7 10.0 10.4 14.6 43.4 10.7 4.6 12.7 10.0 8.9 13.0 11.2 8.9 12.2 9.4 9.3 10.3 5.4 8.0 7.9 18.6 9.5 12.7 45.2 9.2 4.0 10.3 32.7 8.4 5.7 35.1 14.3 13.2 36.0 21.3 65.9 31.7 13.2 16.5 10.4 3.1 1.7 1.0 1.8 5.6 9.3 3.3 5.9 11.9 28.0 40.1 0.0 4.9 13.4 5.5 6.0 26.5 2.0 3.7 9.1 10.5 12.0 2.2 5.6 2.5 3.3 5.8 8.2 6.8 13.2 4.6 8.1 11.7 5.2 9.6 9.1 1.9 4.8 7.9 1.8 12.3 16.0 3.4 1.5 2.0 7.6 10.0 5.0 22.5 4.3 0.2 2.2 2.2 4.8 11.9 0.4 3.7 7.0 7.1 5.1 3.2 1.2 2.8 5.2 1.7 6.7 5.7 7.8 4.1 18.6 12.0 29.1 14.7 20.4 12.6 36.0 14.1 12.9 10.6 34.5 14.6 15.2 65.9 13.2 31.7 21.3 16.5 10.4 6.5 12.1 3.1 7.5 6.0 5.7 10.7 4.6 8.9 10.3 41.7 22.1 109.7 4.3 8.9 0.2 3.2 7.6 20.1 14.8 10.4 0.0 2.8 11.6 18.1 4.1 15.5 9.2 0.0 24.9 10.5 12.5 3.9 36.9 4.9 23.3 0.0 6.4 18.4 45.6 3.6 10.9 46.0 18.6 25.2 8.7 10.4 21.2 10.2 9.6 10.3 4.5 6.5 10.3 5.2 2.6 8.8 3.9 59.7 5.2 2.6 SP140L ENSG00000185404 "SP140 nuclear body protein like" Q9H930 2 230327184-230403732 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA055864 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA055864: AB_2682949" "unprognostic (1.44e-2)" "unprognostic (8.91e-2)" "unprognostic (4.44e-2)" "unprognostic (9.70e-3)" "unprognostic (2.07e-1)" "unprognostic (1.42e-2)" "unprognostic (1.22e-3)" "unprognostic (1.77e-1)" "unprognostic (3.87e-1)" "unprognostic (2.31e-2)" "unprognostic (4.87e-3)" "unprognostic (3.19e-1)" "prognostic unfavorable (5.09e-10)" "unprognostic (9.15e-2)" "unprognostic (7.81e-2)" "unprognostic (9.49e-2)" "unprognostic (2.00e-3)" 11.0 10.5 2.2 24.3 4.6 9.6 9.3 1.0 2.8 11.2 10.0 4.3 8.7 8.5 12.5 12.0 8.4 7.7 9.7 6.0 3.3 2.2 7.7 14.5 12.3 19.3 4.8 1.4 12.3 5.1 1.9 6.1 10.8 4.8 9.1 7.5 5.1 16.0 12.5 5.4 3.5 16.2 9.4 6.7 25.0 6.8 2.8 4.3 15.7 6.3 6.4 22.7 10.5 16.0 21.0 5.1 11.2 7.1 14.5 13.4 6.0 7.7 1.4 1.8 5.6 9.7 10.6 10.3 11.5 13.3 9.7 15.4 0.8 9.0 5.9 12.1 8.9 17.0 1.4 0.0 8.4 15.9 15.4 0.0 10.4 6.2 5.7 18.2 8.5 12.0 8.7 4.5 14.0 9.4 8.1 14.1 9.1 2.5 5.6 17.4 4.2 12.7 11.9 6.5 5.3 4.0 4.5 17.1 4.7 8.8 9.8 0.3 1.8 2.8 5.8 6.4 12.1 8.5 9.2 15.4 8.6 6.3 4.9 8.7 8.2 5.0 8.4 11.4 8.7 15.0 11.2 4.9 2.4 10.4 6.5 12.5 16.9 9.5 8.3 5.1 21.0 13.4 12.0 5.0 14.5 7.1 2.1 5.8 6.0 2.2 4.6 1.0 2.8 3.3 2.2 4.8 1.4 4.8 4.3 29.8 32.3 27.9 13.3 1.6 2.9 3.6 12.7 33.5 21.6 15.7 17.7 8.2 0.0 18.2 11.1 25.1 11.3 0.0 15.9 13.8 7.0 8.3 39.5 8.2 17.4 0.0 3.5 11.1 13.7 3.2 4.0 14.8 5.0 6.4 7.9 2.0 17.5 21.0 7.8 2.9 1.9 6.5 6.9 0.5 1.4 2.3 10.0 28.7 6.6 18.4 SP2 KIAA0048 ENSG00000167182 "Sp2 transcription factor" Q02086 17 47896150-47928957 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003357, CAB010245" Supported Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB010245: AB_2121523, HPA003357: AB_1080070" "unprognostic (1.23e-1)" "unprognostic (1.66e-2)" "unprognostic (6.30e-3)" "unprognostic (5.85e-2)" "unprognostic (1.18e-1)" "unprognostic (6.91e-2)" "unprognostic (5.66e-2)" "unprognostic (2.46e-1)" "unprognostic (6.46e-2)" "unprognostic (2.52e-1)" "unprognostic (1.44e-1)" "unprognostic (5.39e-2)" "prognostic favorable (1.82e-5)" "unprognostic (5.34e-3)" "unprognostic (4.28e-2)" "unprognostic (3.37e-2)" "unprognostic (8.66e-2)" 18.8 15.0 16.9 21.9 20.5 19.1 21.0 28.5 23.4 17.3 16.3 26.9 12.5 16.9 20.5 16.2 19.9 18.3 14.9 20.2 13.8 11.8 17.2 13.3 17.4 22.3 14.1 13.0 20.5 19.7 31.0 14.5 21.4 18.5 16.2 15.8 26.9 18.7 18.2 30.2 19.2 20.8 16.6 17.6 22.2 16.5 23.2 16.3 31.9 21.7 16.0 28.3 18.9 18.0 8.3 6.3 14.3 9.3 12.7 11.5 7.8 16.5 19.2 13.2 11.1 6.5 6.1 12.6 9.8 7.2 10.2 9.2 20.9 8.4 14.4 8.8 12.8 10.3 12.8 9.2 8.5 10.7 20.9 12.9 14.6 12.9 10.8 6.1 13.0 17.3 8.8 10.1 11.9 11.3 7.2 9.6 13.4 15.8 24.6 9.8 22.5 32.1 8.2 5.9 15.0 12.8 14.6 18.1 9.0 7.1 26.9 13.2 15.8 8.5 9.1 9.7 8.5 13.1 12.4 15.8 17.9 9.6 12.4 15.0 21.9 24.2 12.9 9.7 8.8 14.4 14.3 8.0 12.1 11.5 9.3 10.1 7.0 8.8 10.7 6.3 8.3 10.2 10.3 14.3 12.7 8.1 6.1 8.8 7.8 16.9 20.5 28.5 23.4 13.8 11.8 14.1 13.0 18.5 16.3 8.9 21.6 8.3 13.7 5.6 8.4 8.3 2.5 12.0 5.7 10.4 0.0 9.2 13.3 5.9 7.9 10.0 7.7 0.0 6.7 7.7 6.0 10.4 12.7 5.8 7.8 11.1 15.0 5.5 8.5 7.5 9.8 9.2 8.5 7.2 8.9 11.3 5.4 11.5 3.2 5.9 5.9 6.5 7.8 9.1 7.2 6.6 17.2 12.5 7.3 14.5 SP3 SPR-2 ENSG00000172845 "Sp3 transcription factor" Q02447 2 173906459-173965702 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004580, HPA032145, HPA032146" Supported Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB004580: AB_628274, HPA032145: , HPA032146: AB_2732465" "unprognostic (1.94e-1)" "unprognostic (1.18e-1)" "unprognostic (1.85e-1)" "unprognostic (2.39e-3)" "unprognostic (2.50e-1)" "unprognostic (4.92e-2)" "unprognostic (5.54e-3)" "unprognostic (6.36e-2)" "unprognostic (2.76e-3)" "unprognostic (3.27e-1)" "unprognostic (5.01e-3)" "unprognostic (1.68e-1)" "prognostic unfavorable (2.46e-5)" "unprognostic (2.78e-1)" "unprognostic (2.07e-1)" "unprognostic (8.02e-2)" "unprognostic (1.69e-1)" 29.0 12.3 13.6 29.5 14.7 46.2 27.6 26.0 13.8 29.3 23.3 10.9 19.9 12.5 25.1 23.9 19.9 20.8 16.5 15.6 12.8 11.7 19.5 19.2 20.8 41.4 16.0 12.7 23.1 15.0 26.3 21.0 31.9 13.3 23.5 20.4 14.1 20.5 24.2 20.4 21.3 23.0 20.1 15.0 28.8 14.9 14.2 16.2 73.4 30.7 18.1 27.3 24.0 25.7 9.6 10.2 29.5 9.8 20.0 14.0 9.2 17.6 17.7 34.4 19.6 41.2 38.7 36.2 21.4 32.7 30.6 32.5 27.8 26.0 28.1 17.6 30.7 21.3 17.7 27.7 21.7 43.4 24.4 9.8 29.5 17.0 22.3 20.3 27.0 21.9 28.5 22.9 35.4 30.0 21.6 22.5 23.6 22.0 37.7 28.0 20.5 37.4 18.6 27.3 25.5 17.8 32.0 31.1 21.4 20.7 27.2 30.7 21.1 29.9 15.8 21.2 39.0 12.7 30.4 20.1 30.8 27.2 20.1 20.5 26.3 19.7 38.7 23.3 17.1 29.0 9.6 9.8 13.6 12.5 6.6 13.0 9.6 12.5 12.5 10.2 8.4 14.0 12.0 29.5 20.0 9.0 5.0 12.5 9.2 13.6 14.7 26.0 13.8 12.8 11.7 16.0 12.7 13.3 16.2 17.9 18.5 42.9 29.1 51.2 29.5 16.1 10.2 17.4 15.9 19.2 25.5 27.3 10.0 16.3 2.9 30.3 18.8 23.3 16.6 33.4 36.9 28.4 23.1 31.6 21.9 22.3 29.3 33.7 41.3 4.3 42.0 38.6 40.5 9.0 27.0 30.3 24.2 21.0 34.6 17.3 21.2 19.4 49.1 8.4 26.4 49.8 28.9 37.4 27.7 50.8 SP4 "HF1B, MGC130008, MGC130009, SPR-1" ENSG00000105866 "Sp4 transcription factor" Q02446 7 21428034-21514822 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010246, HPA040395" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB010246: AB_2194481, HPA040395: AB_2676959" "unprognostic (1.57e-1)" "unprognostic (1.09e-1)" "unprognostic (6.04e-2)" "unprognostic (8.28e-2)" "unprognostic (9.14e-2)" "unprognostic (8.51e-2)" "unprognostic (1.09e-2)" "unprognostic (7.85e-2)" "unprognostic (1.15e-1)" "unprognostic (4.06e-1)" "unprognostic (3.15e-3)" "unprognostic (1.89e-1)" "unprognostic (6.04e-3)" "unprognostic (2.26e-1)" "unprognostic (1.65e-1)" "unprognostic (6.18e-2)" "unprognostic (7.80e-3)" 5.8 4.7 7.9 8.9 11.0 10.2 6.3 25.9 9.5 8.6 4.4 6.4 3.8 3.1 9.2 5.8 4.1 7.8 4.6 6.5 8.3 6.1 5.4 3.4 6.0 11.7 8.6 6.9 19.8 5.2 17.1 11.8 3.7 6.7 7.3 4.3 6.0 5.0 5.7 10.5 5.0 5.6 5.3 6.8 9.1 4.9 6.0 10.0 27.0 13.1 4.8 11.2 6.8 6.3 5.4 1.5 7.2 1.8 3.5 8.3 3.1 2.2 1.7 5.1 8.1 1.5 1.0 1.5 2.3 1.7 2.7 3.7 3.5 2.7 9.2 1.4 1.5 7.2 2.8 7.5 2.2 5.3 2.7 2.8 4.8 3.3 1.5 1.1 4.0 5.7 1.1 1.9 2.9 3.3 1.4 5.4 6.7 6.0 7.0 2.2 1.0 9.3 2.9 12.3 4.3 2.1 20.9 8.7 3.3 0.9 1.6 6.6 8.2 5.3 2.4 1.8 5.1 2.6 2.9 2.3 4.4 5.5 2.7 4.2 9.3 7.3 14.4 2.5 6.4 6.1 4.3 0.8 7.2 6.8 0.9 8.3 3.7 6.4 6.6 0.9 5.4 7.6 7.1 1.9 3.5 1.8 1.5 7.6 3.1 7.9 11.0 25.9 9.5 8.3 6.1 8.6 6.9 6.7 10.0 3.0 7.0 5.0 11.4 11.2 15.9 7.6 10.2 1.4 7.9 0.0 7.9 1.0 0.0 1.7 5.5 5.8 1.1 0.0 1.8 1.0 6.1 7.1 4.7 4.0 1.5 17.5 10.3 11.6 6.5 4.1 5.2 5.9 6.8 2.8 1.8 9.8 1.4 8.6 6.3 1.4 18.8 0.0 4.1 7.9 8.3 9.7 1.3 14.6 2.8 4.3 SP5 ENSG00000204335 "Sp5 transcription factor" Q6BEB4 2 170715351-170718078 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 10 "Cardiomyocytes: 2.8;Collecting duct cells: 1.8;Distal tubular cells: 3.3;Fibroblasts: 2.3;Mucus-secreting cells: 4.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "Hep G2: 51.7" "Region enhanced" "Detected in single" "cerebellum: 1.2" "Group enriched" "Detected in many" 4 "cerebellum: 5.3;hippocampal formation: 1.2;olfactory region: 5.8;thalamus: 3.6" HPA074123 Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA074123: AB_2686664" "unprognostic (1.16e-2)" "unprognostic (6.99e-2)" "unprognostic (3.41e-2)" "unprognostic (2.10e-2)" "unprognostic (1.14e-1)" "unprognostic (9.52e-3)" "unprognostic (1.45e-1)" "unprognostic (4.60e-2)" "unprognostic (4.77e-1)" "unprognostic (8.97e-3)" "unprognostic (1.79e-2)" "unprognostic (3.09e-2)" "unprognostic (2.06e-8)" "unprognostic (8.05e-3)" "unprognostic (2.49e-1)" "unprognostic (2.41e-2)" "unprognostic (2.17e-1)" 8.7 1.8 0.5 2.5 0.6 0.1 7.4 1.6 1.0 11.4 3.9 1.4 3.2 3.1 7.2 3.0 1.9 3.0 5.1 0.8 0.6 1.4 0.8 5.9 4.6 3.1 0.2 0.8 1.5 0.5 0.1 0.1 2.1 0.4 7.2 1.0 3.8 2.1 0.9 0.7 6.6 3.1 3.1 0.1 0.2 7.3 2.4 0.0 0.2 0.1 0.8 6.5 3.2 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.9 0.0 0.0 0.2 0.0 0.2 0.6 0.1 0.0 0.0 1.5 0.1 0.2 0.0 51.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 1.6 1.0 0.6 1.4 0.2 0.8 0.4 0.0 0.0 0.0 0.0 0.1 0.7 0.0 2.8 0.0 0.0 0.0 1.8 0.0 0.9 3.3 0.0 0.1 0.5 0.0 0.0 0.0 0.0 2.3 0.1 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.2 0.0 0.9 0.0 SP6 "Epfn, KLF14" ENSG00000189120 "Sp6 transcription factor" Q3SY56 17 47844908-47855874 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 33.7;placenta: 24.7;seminal vesicle: 26.2" "Group enriched" "Detected in some" 9 "Cytotrophoblasts: 45.5;Syncytiotrophoblasts: 82.6" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "cerebellum: 1.3;pons and medulla: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "BEWO: 45.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA024516, HPA044469" Supported "Nucleoplasm,Mitotic spindle,Centrosome" Yes No Nucleoplasm "Mitotic spindle, Centrosome" "HPA024516: AB_10960551, HPA044469: AB_10966430" "unprognostic (3.06e-2)" "unprognostic (4.32e-2)" "unprognostic (1.07e-2)" "unprognostic (7.55e-3)" "unprognostic (6.79e-2)" "unprognostic (4.57e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (2.11e-6)" "unprognostic (1.22e-1)" "unprognostic (8.72e-2)" "unprognostic (3.92e-3)" "unprognostic (1.63e-1)" "unprognostic (9.59e-3)" "prognostic favorable (6.39e-4)" "unprognostic (3.33e-1)" "unprognostic (9.93e-2)" "prognostic favorable (5.72e-4)" 0.9 1.0 0.1 0.5 0.0 0.0 3.8 1.3 0.2 1.7 1.8 0.1 33.7 1.5 0.4 4.1 5.8 1.1 0.4 0.4 0.1 0.1 0.9 0.1 3.6 0.5 0.1 0.0 3.6 0.4 2.0 0.2 24.7 1.1 6.9 0.7 0.2 1.0 26.2 0.1 14.9 5.3 0.3 0.3 0.9 0.3 0.4 0.0 0.8 1.3 5.6 3.6 5.3 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.2 0.4 0.0 0.0 0.0 0.0 45.4 0.2 0.2 0.9 0.2 9.5 0.9 0.0 0.3 0.0 0.6 1.3 0.0 1.6 0.2 0.1 0.3 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.9 0.1 0.1 0.1 2.2 0.0 0.0 0.8 0.0 0.0 0.0 3.9 0.8 0.0 0.0 0.0 0.2 5.7 1.4 0.0 0.0 5.8 0.0 8.7 2.3 0.0 3.0 0.2 1.3 0.0 0.2 0.4 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.3 0.2 0.1 0.1 0.1 0.0 1.1 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.3 0.0 0.0 0.0 1.8 0.0 45.5 0.0 0.7 0.0 0.3 6.9 0.0 0.7 1.6 0.3 1.6 0.0 0.0 3.6 0.0 1.7 1.3 0.0 0.0 0.3 0.0 0.0 0.0 2.4 0.0 1.3 2.9 0.0 0.0 0.0 0.0 0.3 0.2 0.6 0.6 82.6 0.0 2.7 5.1 SP8 ENSG00000164651 "Sp8 transcription factor" Q8IXZ3 7 20782283-20786886 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "prostate: 14.3" "Cell type enhanced" "Detected in some" 16 "Basal glandular cells: 2.9;Glandular cells: 2.4;Spermatocytes: 1.2;Spermatogonia: 1.6" "Cancer enhanced" "Detected in many" "testis cancer: 7.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 4.3;HUVEC TERT2: 5.9;NTERA-2: 12.2;PC-3: 20.6" "Group enriched" "Detected in some" 13 "basal ganglia: 15.7;olfactory region: 66.8" "Region enriched" "Detected in some" 11 "olfactory region: 72.4" HPA054006 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA054006: AB_2682340" "unprognostic (1.56e-1)" "unprognostic (1.49e-1)" "unprognostic (2.91e-2)" "unprognostic (1.35e-1)" "unprognostic (7.90e-4)" "unprognostic (3.46e-1)" "unprognostic (5.49e-1)" "unprognostic (1.73e-2)" "unprognostic (2.42e-2)" "unprognostic (3.38e-1)" "unprognostic (7.44e-2)" 0.1 0.1 2.3 0.1 2.8 0.1 0.2 0.1 3.2 0.3 0.3 1.9 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.4 0.5 0.3 0.1 0.2 0.1 0.1 1.7 0.1 0.1 0.1 0.1 0.2 0.7 14.3 0.1 0.0 0.1 0.1 0.1 2.4 0.8 0.1 0.2 0.2 0.3 0.5 0.7 0.0 0.1 0.0 0.1 0.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.2 0.0 1.1 0.0 0.0 0.0 4.3 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.1 0.0 0.0 0.0 0.0 0.8 12.2 0.1 20.6 0.0 1.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.4 0.8 0.0 0.0 0.0 0.0 2.6 0.0 1.0 0.1 0.1 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 2.8 0.1 3.2 2.4 0.5 0.1 1.7 0.7 0.7 0.0 0.0 0.0 2.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.6 0.0 0.0 0.0 0.0 0.7 SPAG7 "ACRP, FSA-1, MGC20134" ENSG00000091640 "Sperm associated antigen 7" O75391 17 4959226-4967872 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 106.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024032, HPA052394" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA024032: AB_1857410, HPA052394: AB_2681810" "unprognostic (7.10e-2)" "unprognostic (8.82e-2)" "unprognostic (1.43e-2)" "unprognostic (1.24e-2)" "unprognostic (1.46e-2)" "unprognostic (2.92e-1)" "unprognostic (8.90e-2)" "unprognostic (9.83e-2)" "unprognostic (8.35e-2)" "unprognostic (1.27e-1)" "unprognostic (8.39e-3)" "unprognostic (1.96e-1)" "prognostic favorable (5.79e-5)" "unprognostic (4.66e-3)" "unprognostic (5.51e-2)" "unprognostic (7.07e-3)" "unprognostic (2.72e-2)" 18.1 19.8 23.5 15.7 24.4 15.5 16.1 14.4 30.9 15.9 19.4 10.5 20.0 14.7 23.2 22.9 18.5 27.6 17.0 53.7 20.5 19.4 25.2 24.4 17.9 15.6 19.8 21.8 14.8 19.4 19.4 13.2 24.8 22.6 17.7 15.5 16.6 18.9 20.1 106.4 14.3 17.6 20.1 21.8 17.4 17.7 15.0 12.8 13.9 22.5 47.9 16.0 15.7 15.4 38.0 42.8 30.8 35.5 24.3 41.9 33.2 12.3 27.3 36.1 20.0 25.1 36.6 20.9 24.6 27.9 24.0 18.5 15.9 16.2 15.7 36.3 30.1 16.9 17.8 18.0 37.3 10.9 23.0 16.0 17.0 22.4 22.1 35.1 9.4 25.6 40.1 27.0 20.5 38.5 36.9 30.2 20.4 11.3 16.3 29.2 19.6 17.1 21.0 20.5 17.2 8.8 18.2 22.9 11.2 41.1 15.5 10.2 20.1 20.9 8.4 20.1 19.4 18.1 15.0 29.1 16.4 10.7 8.0 20.0 14.5 11.4 9.6 32.3 13.5 21.1 28.1 35.5 30.8 35.4 29.2 38.4 38.0 33.4 33.0 41.7 31.4 41.9 36.6 9.4 24.3 27.8 42.8 37.2 33.2 23.5 24.4 14.4 30.9 20.5 19.4 19.8 21.8 22.6 12.8 53.6 52.4 68.0 80.5 49.1 57.7 115.7 86.6 87.0 45.5 94.2 43.2 162.3 275.2 131.6 20.1 62.6 81.8 0.0 126.2 143.9 62.5 71.5 70.6 62.5 122.0 87.4 54.9 52.8 58.5 16.1 42.6 80.2 99.5 332.8 62.3 64.8 123.9 74.6 39.6 178.0 53.9 71.1 68.4 48.3 44.6 43.8 193.0 63.3 64.9 81.3 SPANXA1 "CT11.1, NAP-X, SPAN-Xa, SPAN-Xb, SPANX" ENSG00000198021 "Sperm protein associated with the nucleus, X-linked, family member A1" Q9NS26 X 141583674-141585011 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 28 "testis: 14.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 2.0;PC-3: 1.5;U-2 OS: 5.7;U-2197: 1.2" "HPA046423, HPA073647" Supported Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA046423: AB_2679660, HPA073647: AB_2732232" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 1.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXA2 SPANX ENSG00000203926 "SPANX family member A2" Q9NS26 X 141589435-141590772 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 22 "testis: 15.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 2.0;PC-3: 1.5;U-2 OS: 5.7;U-2197: 1.2" "HPA046423, HPA073647" Supported Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA046423: AB_2679660, HPA073647: AB_2732232" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 1.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXB1 "CT11.2, SPANXB2, SPANXF1, SPANXF2" ENSG00000227234 "SPANX family member B1" Q9NS25 X 141002591-141003706 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 40 "testis: 38.5" "Group enriched" "Detected in some" 136 "Early spermatids: 450.0;Late spermatids: 1630.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 41.1;GAMG: 8.8;U-2 OS: 14.4" "HPA046423, HPA073647" Supported Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA046423: AB_2679660, HPA073647: AB_2732232" "unprognostic (8.55e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 41.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 14.4 1.0 0.3 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 450.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1630.4 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 6.5 0.0 7.6 4.0 0.0 0.0 0.0 0.0 0.0 SPANXC "CT11.3, CTp11" ENSG00000198573 "SPANX family member C" Q9NY87 X 141241463-141242496 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "testis: 27.3" "Group enriched" "Detected in some" 194 "Early spermatids: 365.4;Late spermatids: 1260.1" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "A-431: 13.3;U-2 OS: 6.5" "HPA046423, HPA073647" Supported Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA046423: AB_2679660, HPA073647: AB_2732232" "unprognostic (3.56e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 13.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.8 6.5 0.0 0.5 0.0 0.0 0.2 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 365.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1260.1 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 4.2 2.0 0.0 0.0 0.0 0.0 0.0 SPANXD "CT11.4, SPANXE" ENSG00000196406 "SPANX family member D" Q9BXN6 X 141697411-141698739 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 216 "testis: 21.5" "Group enriched" "Detected in some" 148 "Early spermatids: 386.5;Late spermatids: 1076.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "A-431: 5.1;U-2 OS: 9.8" "HPA046423, HPA073647" Supported Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA046423: AB_2679660, HPA073647: AB_2732232" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 9.8 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 386.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1076.8 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 4.1 1.5 0.0 0.0 0.0 0.0 0.0 SPANXN2 "CT11.7, SPANX-N2" ENSG00000268988 "SPANX family member N2" Q5MJ10 X 143711955-143721423 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 57 "testis: 5.6" "Group enriched" "Detected in some" 121 "Early spermatids: 41.8;Late spermatids: 95.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045652 Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA045652: AB_2679408" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 95.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 SPANXN3 "CT11.8, SPANX-N3" ENSG00000189252 "SPANX family member N3" Q5MJ09 X 143508735-143517475 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 31 "testis: 28.4" "Group enriched" "Detected in some" 116 "Early spermatids: 353.2;Late spermatids: 183.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-2 OS: 6.6" HPA045652 Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA045652: AB_2679408" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 28.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.6 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 353.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 183.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.3 1.1 0.0 0.0 0.0 0.0 0.0 SPAST "ADPSP, FSP2, KIAA1083, SPG4" ENSG00000021574 Spastin Q9UBP0 2 32063547-32157637 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Differentiation, Neurogenesis" "Allosteric enzyme, Developmental protein, Isomerase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017311 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA017311: AB_1857415" "unprognostic (1.89e-1)" "unprognostic (1.59e-2)" "unprognostic (5.33e-2)" "unprognostic (3.90e-2)" "unprognostic (3.75e-2)" "unprognostic (4.00e-2)" "prognostic unfavorable (1.62e-4)" "unprognostic (3.26e-2)" "unprognostic (2.35e-2)" "unprognostic (7.39e-2)" "unprognostic (5.98e-2)" "unprognostic (3.52e-1)" "prognostic unfavorable (4.15e-4)" "unprognostic (5.71e-2)" "unprognostic (3.04e-1)" "unprognostic (1.53e-2)" "unprognostic (1.13e-1)" 12.7 9.6 18.4 14.8 16.4 13.4 9.8 21.1 21.9 14.7 12.7 15.1 12.5 11.5 12.3 8.7 11.1 10.4 10.2 6.2 20.2 18.5 9.4 14.6 9.7 18.9 20.6 10.0 15.1 10.9 11.8 12.3 11.5 17.5 10.3 12.0 6.8 9.3 13.7 15.4 11.5 17.6 11.6 27.0 15.5 9.7 14.4 14.6 21.5 13.4 6.2 13.8 11.3 10.1 5.0 7.1 9.5 9.0 6.6 7.6 4.3 10.8 7.8 12.9 12.6 8.1 9.6 11.6 6.0 8.9 6.3 5.7 10.6 9.5 19.0 5.6 8.3 9.3 7.7 12.7 6.1 7.8 12.7 7.6 20.8 4.2 12.9 7.4 14.5 14.7 5.3 8.1 8.1 7.7 7.7 13.9 6.2 17.0 6.4 6.9 4.6 23.3 12.2 13.4 12.1 4.6 12.4 18.1 12.3 8.6 6.8 18.3 19.7 10.2 8.7 10.0 11.0 5.6 10.0 12.1 7.0 10.8 6.2 7.0 9.7 18.0 15.4 7.6 12.6 8.4 3.4 6.3 6.7 3.6 9.0 5.2 5.0 5.8 5.6 7.1 3.9 5.9 6.0 9.5 6.6 6.3 3.2 7.6 4.3 18.4 16.4 21.1 15.8 20.2 18.5 20.6 10.0 17.5 14.6 8.9 4.1 4.2 5.3 8.5 14.5 7.5 7.6 13.4 6.8 5.2 21.6 7.6 0.0 5.6 2.5 8.7 9.7 0.0 7.0 6.2 5.0 7.3 9.3 10.9 8.8 9.5 10.4 6.2 14.6 6.4 8.1 16.6 1.7 8.2 10.1 8.0 8.4 8.4 9.6 6.5 14.3 0.0 8.1 15.4 22.2 11.4 6.8 7.5 8.4 5.5 SPATA12 ENSG00000186451 "Spermatogenesis associated 12" Q7Z6I5 3 57060441-57075432 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 26.6" "Group enriched" "Detected in some" 125 "Early spermatids: 496.6;Late spermatids: 837.5" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "classical monocyte: 1.0" "Lineage enriched" "Detected in single" 10 "monocytes: 1.0" "Cell line enhanced" "Detected in some" "GAMG: 5.4;HUVEC TERT2: 2.4;RH-30: 3.1" "HPA043323, HPA075578" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" No No "Nucleoplasm, Cytosol" "Plasma membrane" "HPA043323: AB_10796792, HPA075578: " "unprognostic (2.31e-1)" "unprognostic (2.18e-4)" "unprognostic (3.47e-4)" "unprognostic (2.21e-2)" "unprognostic (2.66e-1)" "unprognostic (8.79e-3)" "unprognostic (1.69e-3)" "unprognostic (3.82e-2)" "unprognostic (1.35e-1)" "unprognostic (1.29e-1)" "unprognostic (6.80e-2)" "unprognostic (1.76e-2)" "unprognostic (4.71e-3)" "unprognostic (7.29e-2)" "unprognostic (1.62e-2)" "unprognostic (1.14e-1)" "unprognostic (2.44e-3)" 0.2 0.4 0.0 0.0 0.4 0.0 0.1 0.0 0.2 0.1 0.1 0.4 0.0 0.0 0.1 0.8 0.1 0.3 2.4 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.2 0.3 0.0 0.2 0.0 0.1 0.1 0.0 0.1 1.1 0.1 0.4 26.6 0.0 0.0 0.0 1.1 0.3 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.3 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.4 0.5 0.5 0.0 5.4 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.7 0.6 0.0 0.0 1.1 0.2 0.5 0.0 0.0 1.1 2.4 0.0 0.0 0.6 0.2 0.1 0.0 0.0 1.5 1.2 1.5 0.0 3.1 0.1 2.0 1.2 0.0 0.0 0.2 0.0 1.3 0.6 0.0 0.0 0.8 0.0 2.0 0.4 0.3 0.0 0.2 1.0 0.6 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 496.6 0.1 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.0 0.3 837.5 4.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 5.3 0.0 0.0 0.0 0.0 4.6 2.3 0.0 0.0 0.0 0.0 0.3 SPATA13 "ARHGEF29, FLJ31208" ENSG00000182957 "Spermatogenesis associated 13" Q96N96 13 23979805-24307074 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "granulocytes: 66.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 19.6;HDLM-2: 26.4" "HPA040185, HPA041208" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040185: AB_10795521, HPA041208: AB_10794193" "unprognostic (8.80e-2)" "unprognostic (9.32e-3)" "unprognostic (4.64e-2)" "unprognostic (1.05e-2)" "unprognostic (4.35e-1)" "unprognostic (2.66e-3)" "unprognostic (6.23e-2)" "unprognostic (1.82e-2)" "unprognostic (2.37e-1)" "unprognostic (1.27e-1)" "unprognostic (1.28e-1)" "unprognostic (2.00e-2)" "unprognostic (2.76e-3)" "unprognostic (9.15e-3)" "unprognostic (1.78e-1)" "unprognostic (4.21e-1)" "prognostic favorable (1.16e-4)" 5.5 11.8 14.7 13.9 23.7 21.4 11.8 5.5 15.2 9.2 8.8 33.7 10.9 9.4 7.8 11.9 3.2 8.2 9.8 6.4 15.3 10.5 13.1 17.8 15.3 16.8 27.9 7.4 12.1 29.7 6.1 8.3 13.7 17.7 12.1 10.2 7.5 6.8 9.8 2.4 6.3 11.5 6.2 25.7 47.8 13.8 5.2 27.2 11.9 10.7 3.1 12.8 6.5 4.5 1.2 2.5 19.3 4.7 9.6 17.7 5.8 1.8 2.9 15.3 1.9 0.5 1.3 0.6 4.5 19.6 2.3 2.0 3.7 7.7 11.7 2.4 4.1 1.2 3.4 4.3 1.3 5.9 26.4 5.2 2.8 2.2 4.3 0.7 4.5 2.2 1.7 0.2 2.5 1.4 2.0 3.8 6.3 0.0 9.9 2.4 6.4 8.2 1.5 5.0 12.4 3.8 7.2 5.9 6.2 10.4 5.8 5.6 4.3 0.9 9.7 8.7 3.5 1.4 2.6 4.4 3.0 2.4 0.2 3.2 2.3 0.0 0.0 2.6 4.3 14.4 2.4 3.1 0.0 17.3 4.0 13.5 1.2 14.7 17.7 2.2 1.0 15.6 16.0 19.3 9.6 4.7 2.5 13.8 5.8 14.7 23.7 5.5 15.2 15.3 10.5 27.9 7.4 17.7 27.2 3.0 25.8 4.5 1.9 4.7 0.7 3.6 0.0 45.5 27.3 14.0 0.0 1.0 3.3 16.3 8.1 18.2 21.2 0.0 13.6 11.9 11.0 26.3 66.1 0.0 10.1 0.0 31.0 0.0 0.0 5.1 6.9 13.4 5.0 1.0 24.3 20.0 17.3 31.7 7.1 4.7 0.5 0.0 7.1 1.9 1.9 5.4 18.7 13.1 22.8 7.8 SPATA17 IQCH ENSG00000162814 "Spermatogenesis associated 17" Q96L03 1 217631324-217871696 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 48.0" "Cell type enhanced" "Detected in many" 21 "Ciliated cells: 161.9;Early spermatids: 584.1;Late spermatids: 424.1;Spermatocytes: 138.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 4.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030099 Enhanced Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA030099: AB_2270988" "unprognostic (4.72e-2)" "unprognostic (7.58e-3)" "unprognostic (4.30e-2)" "unprognostic (3.66e-2)" "unprognostic (3.69e-2)" "unprognostic (2.41e-2)" "unprognostic (3.31e-3)" "unprognostic (3.25e-2)" "unprognostic (1.39e-1)" "unprognostic (2.58e-2)" "unprognostic (1.21e-3)" "unprognostic (2.80e-2)" "unprognostic (3.24e-4)" "unprognostic (2.07e-1)" "unprognostic (2.78e-2)" "unprognostic (2.77e-3)" "unprognostic (1.82e-1)" 0.5 0.6 1.4 0.3 5.2 2.4 0.9 0.5 1.2 1.0 0.5 2.7 2.9 0.6 0.7 9.7 0.5 6.8 0.8 1.1 2.3 2.2 2.8 0.4 3.0 0.3 0.8 1.6 3.3 0.6 3.0 10.8 0.4 11.1 0.7 0.3 1.2 0.6 1.2 2.9 1.0 0.7 0.2 0.7 0.4 0.6 48.0 1.4 0.0 3.1 0.3 0.2 0.5 0.5 1.3 0.6 2.3 0.6 0.6 1.0 0.1 0.6 1.2 1.2 1.2 0.3 2.0 0.9 0.5 0.7 0.6 0.3 0.8 3.2 0.6 1.0 0.4 0.4 2.2 0.8 1.1 0.7 0.6 1.2 0.5 1.5 0.8 0.6 0.3 0.5 0.7 2.3 1.2 1.2 1.4 0.1 0.7 0.7 1.3 0.6 2.5 0.4 1.0 2.3 1.6 1.2 0.4 0.4 0.4 2.3 0.9 4.8 1.9 0.7 0.8 0.6 2.0 1.5 0.6 0.6 0.8 0.6 0.9 0.5 1.3 0.8 0.3 1.9 0.5 1.1 2.3 0.5 0.5 0.9 0.5 0.8 0.7 0.7 0.7 0.3 1.3 0.9 1.0 1.5 0.6 0.6 0.6 0.3 0.1 1.4 5.2 0.5 1.2 2.3 2.2 0.8 1.6 11.1 1.4 3.0 0.0 0.0 0.8 0.6 0.4 1.4 0.0 161.9 25.0 3.5 19.6 0.7 5.0 1.7 584.1 0.5 0.0 0.0 0.6 0.5 0.7 1.6 0.0 0.0 0.2 0.0 1.7 0.0 0.0 424.1 8.1 0.7 1.7 0.0 1.0 5.1 0.2 0.0 6.3 8.4 18.5 0.0 0.1 138.2 8.1 0.9 0.2 0.0 0.6 0.4 SPATA2 "KIAA0757, PD1, PPP1R145, tamo" ENSG00000158480 "Spermatogenesis associated 2" Q9UM82 20 49903391-49915508 "Predicted intracellular proteins" Necrosis "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 41.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048581, HPA052224" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" No No "Nucleoli fibrillar center" Nucleoplasm "HPA048581: AB_2680449, HPA052224: AB_2681769" "unprognostic (4.02e-2)" "unprognostic (5.98e-2)" "unprognostic (8.26e-2)" "prognostic unfavorable (1.87e-4)" "unprognostic (1.76e-1)" "unprognostic (2.90e-2)" "unprognostic (3.25e-3)" "unprognostic (8.77e-2)" "prognostic favorable (9.08e-4)" "unprognostic (8.33e-2)" "unprognostic (6.45e-3)" "unprognostic (5.99e-2)" "unprognostic (4.89e-2)" "unprognostic (9.57e-2)" "unprognostic (4.38e-1)" "prognostic unfavorable (4.53e-4)" "unprognostic (2.52e-1)" 4.6 6.2 15.3 5.4 19.3 15.4 5.7 16.6 25.7 5.8 10.5 12.8 4.1 11.7 5.4 6.0 5.7 7.1 5.5 5.5 15.2 11.4 5.8 5.4 5.4 5.1 14.4 15.4 6.0 11.9 7.6 6.9 5.5 10.6 8.1 9.8 5.9 8.8 6.6 12.9 5.1 11.2 5.0 19.9 15.6 8.7 18.5 10.2 4.6 11.0 4.0 5.5 5.2 3.6 4.9 3.3 6.1 3.5 3.4 4.8 2.3 5.5 6.9 4.7 4.2 5.4 3.9 7.7 3.6 5.4 12.6 5.3 21.6 4.5 4.3 7.6 3.6 6.5 10.4 3.5 6.0 6.7 5.9 3.4 2.2 4.0 14.0 5.1 6.1 9.2 3.9 7.2 6.5 4.1 4.2 2.6 6.1 7.6 4.9 3.0 11.8 6.1 15.4 7.1 7.6 8.4 4.7 5.1 4.5 4.1 4.4 4.5 4.8 7.2 22.1 5.6 3.8 5.3 5.3 3.7 9.0 7.4 7.4 5.0 12.2 9.3 4.6 7.1 3.2 4.0 0.3 3.5 3.3 3.7 2.5 3.5 3.6 3.4 4.5 3.3 4.9 4.5 4.8 6.1 3.4 1.3 1.6 3.8 2.3 15.3 19.3 16.6 25.7 15.2 11.4 14.4 15.4 10.6 10.2 8.9 2.1 3.9 5.7 6.5 7.4 3.9 12.7 5.3 0.0 0.0 7.9 9.5 3.3 5.2 31.9 6.3 19.1 0.0 7.1 10.6 5.8 5.5 4.6 5.7 4.2 6.4 25.3 9.8 5.7 41.2 4.6 3.4 5.0 5.4 20.8 4.8 7.0 16.5 5.3 3.6 7.5 6.5 5.1 32.5 16.1 6.4 25.2 4.4 16.1 7.0 SPATA20 "FLJ21347, SSP411, Tisp78" ENSG00000006282 "Spermatogenesis associated 20" Q8TB22 17 50543058-50555852 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 24 "Early spermatids: 516.6;Late spermatids: 1225.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 27.1;MCF7: 26.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA022023, HPA027144, HPA031442" Enhanced Approved Nucleoplasm "Secreted in male reproductive system" NA NA Nucleoplasm "HPA022023: AB_1857417, HPA027144: AB_1857418, HPA031442: AB_10610557" "unprognostic (9.27e-3)" "unprognostic (1.90e-1)" "unprognostic (9.60e-2)" "unprognostic (9.74e-3)" "unprognostic (2.63e-3)" "unprognostic (7.23e-2)" "unprognostic (1.56e-1)" "unprognostic (3.07e-1)" "unprognostic (7.09e-2)" "unprognostic (8.71e-2)" "unprognostic (6.12e-3)" "unprognostic (4.93e-2)" "unprognostic (6.74e-2)" "unprognostic (1.75e-1)" "unprognostic (2.29e-1)" "unprognostic (2.66e-1)" "prognostic favorable (9.69e-5)" 9.7 29.0 14.9 15.2 13.1 4.6 8.2 17.7 22.8 11.7 13.4 11.4 16.8 9.8 16.0 21.1 10.7 13.5 25.4 36.3 9.8 14.3 15.7 13.1 11.2 8.7 15.0 18.3 20.4 22.4 11.9 10.4 6.9 13.3 15.4 5.8 29.0 18.9 15.0 17.9 8.7 9.9 12.7 13.0 14.1 22.8 62.7 6.8 2.5 22.3 8.5 9.9 13.1 7.9 3.2 8.9 1.1 4.7 9.3 2.6 2.9 3.4 16.0 0.9 10.5 2.4 7.5 2.9 5.9 6.8 2.8 2.2 11.9 5.1 3.7 14.3 4.2 3.1 2.7 0.6 2.9 1.4 5.0 2.3 2.5 3.5 27.1 11.1 0.9 7.4 11.9 3.9 1.5 4.4 3.7 3.6 0.6 0.3 6.9 2.5 26.8 0.0 0.9 1.1 7.3 7.0 1.5 2.5 1.0 13.7 17.0 1.8 4.3 5.2 3.9 6.3 1.1 7.5 0.4 8.1 2.8 8.9 1.6 1.2 13.2 4.0 0.0 5.9 0.5 2.9 0.0 4.5 1.1 2.0 4.7 2.6 3.2 1.5 1.5 8.9 2.2 2.0 2.2 0.3 9.3 4.0 2.0 0.8 2.9 14.9 13.1 17.7 22.8 9.8 14.3 15.0 18.3 13.3 6.8 6.0 5.3 3.4 11.9 9.5 3.4 26.6 17.8 4.0 12.5 22.7 3.9 14.5 23.2 29.1 516.6 10.5 20.1 0.0 34.6 8.5 19.4 14.3 17.3 19.8 30.3 11.1 36.5 9.8 22.6 1225.1 35.4 15.4 20.3 19.0 31.6 24.6 24.1 25.9 35.7 30.1 1.9 6.5 20.6 8.1 10.4 7.8 8.2 10.2 20.5 12.0 SPATA24 "CCDC161, T6441" ENSG00000170469 "Spermatogenesis associated 24" Q86W54 5 139396563-139404088 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 52.2" "Group enriched" "Detected in many" 20 "Early spermatids: 924.4;Late spermatids: 2355.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 41.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044000 Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA044000: AB_10959668" "unprognostic (2.19e-3)" "unprognostic (1.18e-1)" "unprognostic (2.09e-1)" "unprognostic (9.30e-2)" "unprognostic (3.82e-1)" "unprognostic (7.71e-2)" "prognostic unfavorable (2.75e-4)" "unprognostic (1.26e-2)" "unprognostic (1.58e-1)" "unprognostic (2.87e-2)" "unprognostic (5.36e-3)" "unprognostic (1.07e-1)" "unprognostic (6.11e-2)" "unprognostic (1.24e-1)" "unprognostic (3.44e-1)" "unprognostic (1.46e-1)" "unprognostic (1.64e-1)" 1.0 2.8 3.6 1.0 3.2 0.3 1.4 1.5 2.7 1.3 1.6 2.7 1.8 2.5 1.6 9.4 1.4 6.4 2.9 8.5 3.4 2.6 6.2 1.9 1.9 2.5 2.4 2.1 1.6 2.2 6.1 7.0 1.0 3.2 2.2 0.9 1.7 3.2 1.5 8.7 0.9 2.6 1.9 2.7 1.9 1.5 52.2 2.1 1.8 2.9 3.4 1.9 1.8 3.5 5.7 3.6 2.0 3.1 2.4 7.7 2.5 6.5 4.1 5.9 3.1 1.7 3.3 4.7 1.6 3.1 3.4 6.1 9.4 8.7 10.4 4.9 3.2 11.7 3.6 4.4 7.2 3.8 41.6 5.1 3.2 7.7 7.1 6.5 0.7 5.7 2.8 3.6 5.1 6.2 3.9 4.1 6.7 3.1 18.3 4.6 3.7 6.5 5.0 4.3 2.6 3.6 15.4 3.9 14.1 8.1 3.3 4.5 4.1 6.3 12.3 2.9 14.8 3.5 7.2 7.6 2.0 2.8 3.9 4.7 4.5 4.2 9.6 4.0 5.4 1.7 0.0 3.1 2.0 4.6 2.3 6.5 5.7 4.9 5.5 3.6 3.3 5.5 7.7 0.2 2.4 0.9 2.1 2.4 2.5 3.6 3.2 1.5 2.7 3.4 2.6 2.4 2.1 3.2 2.1 0.0 2.6 9.0 5.0 1.4 0.2 20.1 7.6 24.1 3.4 5.2 7.9 5.0 11.6 4.0 924.4 4.2 3.2 0.0 1.6 2.8 2.1 3.1 0.0 3.4 4.1 1.6 0.0 4.9 2.1 2355.8 13.3 1.4 1.7 1.0 1.1 2.0 3.3 2.9 12.7 23.3 1.3 25.8 3.6 81.7 16.6 1.6 3.8 2.5 3.3 4.8 SPATA2L "C16orf76, MGC26885, tamo" ENSG00000158792 "Spermatogenesis associated 2 like" Q8IUW3 16 89696343-89701705 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 29.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 24.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041182, HPA042453" Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA041182: AB_2677352, HPA042453: AB_2678005" "unprognostic (1.22e-1)" "unprognostic (9.04e-2)" "unprognostic (5.23e-2)" "unprognostic (9.13e-3)" "unprognostic (2.21e-1)" "unprognostic (6.62e-2)" "unprognostic (2.72e-2)" "unprognostic (2.13e-1)" "unprognostic (4.86e-2)" "unprognostic (9.25e-2)" "unprognostic (1.40e-3)" "unprognostic (5.32e-2)" "unprognostic (2.36e-3)" "unprognostic (8.86e-2)" "unprognostic (4.19e-2)" "unprognostic (5.84e-2)" "unprognostic (2.55e-1)" 6.8 5.3 6.3 5.4 10.3 8.8 3.7 6.8 14.1 4.1 6.9 1.6 4.9 12.3 4.7 7.2 3.9 4.6 7.7 2.8 7.2 4.9 7.5 11.4 6.3 3.6 3.4 7.6 5.4 17.0 5.1 12.9 6.5 2.8 4.2 2.2 4.9 6.1 3.4 1.8 5.0 10.7 3.3 2.0 5.6 7.7 4.6 2.6 6.7 5.6 0.7 5.4 4.0 2.2 5.8 5.9 16.5 7.8 2.4 7.3 4.7 5.3 4.2 1.5 7.0 1.2 1.2 8.2 3.7 1.7 1.7 1.1 8.0 4.5 1.8 5.0 1.2 2.3 9.3 1.3 2.0 0.3 1.7 15.1 1.2 1.5 10.8 3.9 1.0 3.7 1.2 2.6 2.8 0.8 2.0 1.9 2.1 5.5 1.3 1.2 24.2 3.1 5.7 4.3 5.4 5.7 6.8 0.7 5.2 2.5 1.9 8.3 5.4 3.9 4.0 4.5 0.7 10.3 4.1 4.8 1.7 6.4 0.3 1.7 3.2 1.9 1.6 5.3 3.0 3.2 3.3 4.9 6.0 7.3 7.8 5.1 4.8 5.2 5.3 5.3 5.8 4.6 4.9 16.5 2.4 5.8 5.9 3.9 4.7 6.3 10.3 6.8 14.1 7.2 4.9 3.4 7.6 2.8 2.6 3.0 0.3 1.4 16.6 14.0 6.6 0.4 5.1 0.0 0.0 10.4 0.0 7.5 1.7 11.7 4.4 4.9 29.5 0.0 11.8 4.1 5.7 10.1 4.6 5.0 6.8 3.2 22.8 5.5 7.5 1.0 2.6 7.2 8.5 3.6 6.8 5.1 10.5 17.3 2.1 8.4 7.4 0.0 9.2 1.0 2.5 17.3 20.8 5.0 6.2 11.6 SPATA33 "C16orf55, FLJ31606" ENSG00000167523 "Spermatogenesis associated 33" Q96N06 16 89657802-89671272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 70.4" "Group enriched" "Detected in many" 10 "Early spermatids: 1519.3;Late spermatids: 2991.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045648, HPA073096" Enhanced Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA045648: AB_2679405, HPA073096: AB_2686570" "unprognostic (1.05e-2)" "prognostic favorable (1.06e-4)" "unprognostic (1.04e-1)" "unprognostic (1.03e-3)" "unprognostic (2.42e-1)" "unprognostic (1.58e-1)" "unprognostic (7.18e-3)" "unprognostic (1.37e-1)" "unprognostic (3.97e-1)" "unprognostic (3.63e-2)" "unprognostic (2.03e-3)" "unprognostic (8.82e-2)" "unprognostic (4.02e-2)" "unprognostic (4.52e-2)" "unprognostic (3.26e-1)" "unprognostic (2.04e-1)" "unprognostic (1.60e-1)" 2.0 2.7 6.9 2.8 7.3 3.3 3.2 7.8 7.7 2.9 2.9 4.3 1.8 4.8 3.2 9.2 2.7 14.8 3.7 2.1 6.0 5.7 5.3 2.9 4.3 2.3 4.7 6.5 2.1 3.0 4.0 7.3 1.9 5.3 3.2 3.4 2.5 2.4 2.8 1.5 4.1 5.7 2.6 3.6 3.0 3.8 70.4 4.3 2.4 5.1 2.2 3.1 2.1 2.5 5.7 5.5 5.8 3.3 7.3 6.3 3.6 10.3 9.9 12.3 4.4 3.3 2.9 4.3 7.0 2.9 10.2 4.4 9.3 8.7 1.1 3.8 4.7 6.9 14.0 5.4 3.8 7.7 2.0 7.6 1.7 12.0 13.7 1.5 2.2 4.2 3.0 4.5 7.0 3.0 3.9 2.3 9.6 11.1 1.5 6.6 12.1 6.5 5.6 6.8 6.2 7.6 13.3 6.8 3.4 6.0 3.5 11.5 6.3 15.6 2.9 3.8 5.8 12.7 3.0 2.1 7.9 9.8 6.6 5.6 3.6 5.3 4.1 7.7 12.4 2.8 5.8 3.3 5.4 5.2 3.2 6.3 5.7 4.7 6.2 2.6 3.2 5.2 4.1 4.1 7.3 2.9 5.5 3.5 3.6 6.9 7.3 7.8 7.7 6.0 5.7 4.7 6.5 5.3 4.3 6.0 8.9 5.1 7.9 6.4 17.7 5.2 10.2 109.7 13.6 27.9 60.9 3.2 19.9 12.3 1519.3 10.2 15.9 0.0 15.4 4.9 10.5 5.5 1.1 9.8 7.9 22.3 16.8 8.6 2.7 2991.1 28.1 7.3 16.9 4.6 8.9 16.6 11.2 8.6 22.3 26.7 69.1 12.9 12.3 232.7 101.0 6.1 1.1 12.5 12.0 5.5 SPATA5L1 "FLJ12286, MGC5347" ENSG00000171763 "Spermatogenesis associated 5 like 1" Q9BVQ7 15 45402331-45421419 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043679 Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA043679: AB_10964179" "unprognostic (6.22e-2)" "unprognostic (3.34e-2)" "unprognostic (7.03e-2)" "unprognostic (1.57e-2)" "unprognostic (9.67e-2)" "unprognostic (6.85e-2)" "unprognostic (2.46e-2)" "unprognostic (3.13e-2)" "unprognostic (3.69e-2)" "unprognostic (3.69e-1)" "unprognostic (4.97e-2)" "prognostic unfavorable (7.88e-4)" "unprognostic (5.40e-2)" "unprognostic (2.98e-2)" "unprognostic (2.55e-2)" "unprognostic (2.72e-2)" "unprognostic (4.80e-2)" 9.0 8.7 10.7 12.3 10.7 11.1 9.5 21.3 8.2 10.3 9.9 10.0 10.2 12.1 9.8 8.4 17.5 8.8 8.3 9.6 9.6 5.9 10.8 14.8 11.2 14.1 13.5 5.8 12.9 12.0 7.6 7.6 10.6 8.9 9.9 10.2 7.2 9.4 12.8 15.9 16.1 13.2 9.4 7.1 8.6 8.2 12.1 12.0 9.9 11.2 12.3 10.9 10.2 11.9 3.6 3.3 4.8 6.4 3.3 4.7 0.7 7.1 5.5 7.4 5.4 6.1 6.0 9.0 6.4 5.8 7.0 6.9 12.6 4.7 5.2 7.1 4.2 12.8 16.5 11.0 8.0 7.9 7.1 6.1 6.8 8.8 9.8 7.0 9.1 2.9 4.9 9.2 5.7 7.7 8.0 5.5 6.9 11.0 8.5 7.8 4.8 6.3 17.5 5.3 18.0 7.1 7.0 10.4 4.9 8.7 7.1 10.2 5.2 5.3 11.6 5.7 9.2 10.2 16.7 3.4 3.4 5.2 20.8 13.6 7.2 14.4 8.1 8.8 15.1 6.1 0.1 2.8 4.8 4.1 2.6 1.5 1.9 2.8 4.7 3.3 3.6 2.9 3.0 4.2 3.3 6.4 2.5 2.6 0.7 10.7 10.7 21.3 8.2 9.6 5.9 13.5 5.8 8.9 12.0 0.0 1.4 5.4 5.2 4.4 5.7 5.6 10.2 0.0 4.5 3.5 15.7 10.2 3.3 5.6 17.3 6.0 5.5 0.0 6.4 8.8 4.6 3.8 4.6 5.0 6.8 6.4 3.5 0.6 4.3 5.3 7.2 4.1 3.3 6.4 7.2 4.4 4.8 0.0 3.5 4.9 6.5 0.0 4.7 5.4 5.7 5.9 5.6 4.9 7.5 7.0 SPATA6 "FLJ10007, SRF-1, SRF1" ENSG00000132122 "Spermatogenesis associated 6" Q9NWH7 1 48295372-48472208 "Cancer-related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 61.8" "Group enriched" "Detected in many" 31 "Early spermatids: 1331.5;Late spermatids: 2941.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 8.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 10.5;ASC TERT1: 17.7;HSkMC: 12.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028234 Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA028234: AB_2672532" "unprognostic (1.36e-2)" "unprognostic (2.96e-2)" "unprognostic (3.38e-2)" "unprognostic (2.87e-2)" "unprognostic (3.22e-1)" "unprognostic (1.68e-1)" "unprognostic (1.77e-2)" "unprognostic (4.69e-3)" "unprognostic (2.40e-2)" "unprognostic (2.61e-2)" "unprognostic (8.41e-2)" "unprognostic (6.50e-2)" "unprognostic (3.41e-3)" "unprognostic (1.15e-1)" "unprognostic (1.01e-1)" "unprognostic (7.89e-2)" "unprognostic (5.71e-3)" 5.8 8.9 6.2 3.0 12.9 1.5 8.4 2.4 8.9 7.5 5.0 12.9 10.1 3.3 6.9 7.9 4.1 16.2 5.9 4.7 7.8 5.6 6.9 2.4 7.5 7.0 14.9 3.9 9.0 5.2 12.8 21.5 5.3 8.5 6.4 4.6 6.6 6.9 12.2 3.8 5.0 3.7 8.3 10.0 4.1 7.3 61.8 13.4 1.1 10.3 2.4 2.2 6.5 12.2 0.2 1.7 5.2 8.2 0.3 0.6 0.7 0.1 0.9 9.5 10.5 8.8 17.7 1.3 1.0 4.0 0.8 0.7 0.1 0.7 0.0 0.6 1.7 5.1 0.2 0.8 2.3 0.7 0.7 1.3 0.1 0.4 0.4 1.8 0.0 0.7 12.6 1.8 1.5 0.5 5.2 3.8 1.5 0.1 0.0 4.0 0.3 0.1 0.1 4.0 0.7 1.0 2.9 0.0 0.9 5.8 1.6 2.3 5.2 3.8 0.4 9.1 8.2 2.3 0.5 1.1 1.4 1.4 2.2 1.5 0.0 0.0 0.0 5.8 0.1 6.3 0.0 1.8 5.2 0.1 4.3 0.0 0.2 0.4 0.0 1.7 0.1 0.6 0.5 0.3 0.3 8.2 0.8 0.0 0.7 6.2 12.9 2.4 8.9 7.8 5.6 14.9 3.9 8.5 13.4 3.0 7.7 0.0 15.5 4.9 17.1 2.8 15.3 68.3 17.0 15.7 43.2 0.3 14.9 7.4 1331.5 8.1 2.1 0.0 9.1 0.6 10.3 7.2 16.1 2.1 4.2 30.2 9.2 9.2 17.5 2941.6 33.9 13.4 18.6 1.8 5.2 21.5 4.5 3.4 23.7 7.7 44.9 19.4 9.2 58.1 20.0 4.5 0.2 0.9 5.2 8.8 SPATA7 "HSD3, LCA3" ENSG00000042317 "Spermatogenesis associated 7" Q9P0W8 14 88384924-88470350 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 55.6" "Group enriched" "Detected in many" 24 "Early spermatids: 817.6;Late spermatids: 902.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038082, HPA038083" Enhanced Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA038082: AB_10671738, HPA038083: AB_10671519" "unprognostic (2.09e-2)" "unprognostic (6.72e-2)" "unprognostic (1.10e-1)" "unprognostic (6.50e-3)" "unprognostic (3.22e-2)" "unprognostic (6.75e-2)" "unprognostic (1.29e-3)" "unprognostic (4.70e-2)" "unprognostic (1.70e-1)" "unprognostic (5.45e-3)" "prognostic favorable (4.16e-5)" "unprognostic (2.88e-1)" "prognostic favorable (2.50e-5)" "unprognostic (8.41e-2)" "unprognostic (1.29e-2)" "unprognostic (6.09e-2)" "unprognostic (2.81e-2)" 6.3 7.2 7.8 2.8 10.3 2.2 7.1 18.0 12.5 6.1 4.5 6.5 4.5 2.9 7.7 8.5 3.7 9.6 6.5 5.3 8.1 7.4 10.5 5.9 5.0 3.0 6.4 9.7 13.6 6.9 9.2 15.0 3.6 13.3 5.8 4.1 5.5 4.6 5.9 4.7 6.6 2.8 6.4 5.8 3.7 4.3 55.6 5.9 3.3 13.5 3.9 2.0 5.7 4.4 3.7 4.4 1.7 3.0 0.9 5.6 2.2 2.1 3.3 4.9 6.8 8.1 15.4 5.0 3.7 8.4 4.7 3.1 0.9 4.1 1.5 2.3 5.0 3.5 2.1 2.3 3.5 4.4 2.5 1.6 0.1 1.6 1.1 12.1 3.4 0.3 7.3 5.9 1.9 3.6 15.4 8.6 4.2 1.1 2.4 4.3 2.5 1.5 3.1 0.6 2.6 4.2 3.5 5.1 0.8 7.5 1.3 2.9 4.5 4.7 6.4 3.8 5.1 5.5 3.7 4.4 2.9 3.8 4.8 2.0 2.4 1.2 0.5 5.8 1.0 2.4 0.0 2.2 0.6 4.8 3.0 5.6 3.7 4.0 2.2 4.4 0.9 2.2 4.2 1.7 0.9 1.8 4.3 1.4 2.2 7.8 10.3 18.0 12.5 8.1 7.4 6.4 9.7 13.3 5.9 11.9 5.3 0.8 8.2 2.2 10.8 10.9 5.1 36.1 10.3 3.5 19.6 2.1 8.3 7.6 817.6 5.2 1.1 0.0 6.3 3.2 6.4 3.4 1.1 3.4 5.0 14.3 15.6 6.2 8.6 902.3 19.0 3.3 8.5 4.6 4.4 10.6 5.8 4.8 15.9 19.9 19.4 6.5 5.0 18.2 13.5 1.8 0.9 3.8 4.6 2.7 SPATS1 "FLJ25442, SPATA8, SRSP1" ENSG00000249481 "Spermatogenesis associated serine rich 1" Q496A3 6 44342660-44377167 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "fallopian tube: 9.0;testis: 33.5" "Cell type enhanced" "Detected in some" 26 "Ciliated cells: 17.4;Early spermatids: 25.7;Late spermatids: 6.2" "Not detected" "Not detected" "Region enhanced" "Detected in some" "pons and medulla: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SK-MEL-30: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA030897, HPA049722" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA030897: AB_2673647, HPA049722: AB_2680861" "unprognostic (2.30e-3)" 0.0 0.0 0.6 0.0 1.0 0.0 0.0 0.0 0.4 0.3 0.0 1.5 0.0 0.0 0.1 4.8 0.1 9.0 0.0 0.0 0.7 0.7 0.0 0.0 1.5 0.0 0.4 0.0 1.6 0.0 0.2 0.3 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 33.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 1.0 0.0 0.4 0.7 0.7 0.4 0.0 3.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 SPC24 "FLJ90806, SPBC24" ENSG00000161888 "SPC24, NDC80 kinetochore complex component" Q8NBT2 19 11131520-11155808 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 58.0" "Cell type enriched" "Detected in many" 5 "Erythroid cells: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA051234 Approved Supported Nucleoplasm,Nucleoli NA Yes Nucleoplasm Nucleoli "HPA051234: AB_2681397" "unprognostic (1.57e-1)" "prognostic favorable (3.59e-4)" "unprognostic (6.79e-2)" "unprognostic (1.07e-3)" "unprognostic (4.04e-1)" "unprognostic (2.98e-2)" "prognostic unfavorable (1.46e-4)" "unprognostic (1.21e-2)" "unprognostic (1.69e-2)" "unprognostic (1.12e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (6.12e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.62e-2)" "unprognostic (3.52e-2)" "unprognostic (2.25e-1)" "unprognostic (8.82e-2)" 2.8 3.2 1.1 9.0 1.0 19.4 3.8 0.4 1.9 2.8 4.0 0.8 0.9 3.5 2.2 2.8 8.4 1.4 2.4 8.2 1.0 0.4 1.8 2.6 4.2 4.9 0.6 1.0 1.1 1.0 0.1 1.0 5.9 0.6 1.4 3.5 0.8 2.4 1.5 2.7 3.2 4.4 6.7 0.7 5.5 4.0 13.3 0.7 58.0 0.9 12.8 12.2 2.3 3.2 1.9 1.3 7.2 1.4 4.2 3.7 0.7 26.2 9.9 13.7 11.1 1.9 3.6 6.2 15.4 5.7 14.6 16.6 10.4 9.0 20.8 17.6 6.8 8.5 14.3 10.6 11.0 10.8 11.0 9.1 28.0 23.0 15.4 0.4 19.6 12.5 0.7 0.4 10.4 4.8 3.8 12.8 23.0 14.9 43.9 10.1 17.3 26.7 11.9 9.6 7.3 16.0 21.4 21.0 6.7 4.3 8.7 14.3 10.3 13.5 8.4 3.6 6.8 8.3 7.1 12.1 13.8 14.7 18.5 18.4 26.8 13.8 20.0 10.2 19.4 11.2 4.1 1.4 1.5 1.4 1.2 1.2 1.9 2.3 3.4 0.5 1.9 2.7 1.7 7.2 4.2 1.3 1.3 3.7 0.7 1.1 1.0 0.4 1.9 1.0 0.4 0.6 1.0 0.6 0.7 0.0 0.3 0.0 0.8 1.0 0.0 7.0 2.5 0.0 1.2 5.2 5.9 3.0 0.0 0.2 0.1 0.1 0.7 70.0 0.0 13.5 4.0 0.3 5.7 0.0 11.2 0.0 2.4 2.5 2.8 1.7 0.6 1.3 0.0 0.0 1.1 0.9 0.2 0.0 0.4 0.4 0.3 0.0 0.3 6.5 10.1 0.3 1.7 2.2 2.9 0.4 SPCS2 KIAA0102 ENSG00000118363 "Signal peptidase complex subunit 2" Q15005 11 74949247-74979031 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013386 Approved Approved Nucleoplasm NA NA 220000 Nucleoplasm "HPA013386: AB_1857426" "unprognostic (2.43e-1)" "unprognostic (7.01e-2)" "unprognostic (1.65e-2)" "unprognostic (7.09e-3)" "unprognostic (9.30e-2)" "unprognostic (2.31e-2)" "unprognostic (7.04e-3)" "unprognostic (9.61e-2)" "unprognostic (8.83e-2)" "unprognostic (2.02e-3)" "unprognostic (1.25e-2)" "unprognostic (1.74e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-2)" "unprognostic (5.70e-2)" "unprognostic (1.37e-1)" "unprognostic (8.62e-2)" 21.8 32.8 29.1 25.8 29.2 13.4 28.7 20.0 26.8 36.5 30.4 26.8 49.5 23.2 32.3 61.6 23.3 25.8 21.4 25.2 29.8 27.5 30.0 46.5 24.0 25.3 33.4 33.5 24.0 75.5 41.6 26.7 28.5 32.9 29.2 31.1 18.6 55.9 34.9 26.4 17.2 24.0 24.8 33.4 30.1 26.5 24.2 27.6 20.3 43.9 14.9 38.7 23.8 21.4 78.2 89.7 86.4 45.9 47.9 65.4 71.8 22.3 26.3 35.2 31.5 31.0 20.9 19.2 32.1 31.4 29.6 26.0 51.7 50.8 36.4 40.7 27.1 35.4 41.3 30.4 23.5 37.0 30.0 22.3 36.9 32.0 42.6 35.3 39.1 26.0 18.5 30.7 24.9 41.0 26.1 28.3 26.9 42.4 95.0 26.8 34.0 27.8 25.0 21.5 88.9 25.1 34.7 54.2 82.5 34.1 37.4 28.6 28.7 32.0 43.1 105.2 25.5 41.7 30.0 22.8 33.8 21.0 35.0 28.3 40.6 41.0 67.6 13.9 27.8 34.1 86.4 45.9 41.3 58.3 44.4 65.4 78.2 54.0 55.9 43.4 62.1 41.4 49.6 29.6 47.9 38.2 89.7 50.9 71.8 29.1 29.2 20.0 26.8 29.8 27.5 33.4 33.5 32.9 27.6 80.4 121.2 168.1 276.8 270.4 92.5 52.0 203.8 105.7 150.2 226.8 49.1 294.6 160.8 248.0 23.5 169.0 110.2 186.9 251.0 262.7 270.0 340.7 151.3 327.2 251.3 90.6 120.3 149.8 135.4 21.2 222.9 194.9 494.3 215.6 135.9 198.0 231.8 129.8 183.9 236.3 72.2 168.1 200.5 94.2 127.2 200.6 388.7 197.1 133.3 256.7 SPDEF "bA375E1.3, PDEF" ENSG00000124664 "SAM pointed domain containing ETS transcription factor" O95238 6 34537802-34556333 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 55.8;salivary gland: 98.0" "Group enriched" "Detected in many" 6 "Glandular cells: 80.8;Mucus-secreting cells: 228.3" "Group enriched" "Detected in many" 10 "breast cancer: 103.4;endometrial cancer: 78.1;prostate cancer: 388.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "MCF7: 68.7;OE19: 28.3;SK-BR-3: 47.5;T-47d: 38.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA055707 Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA055707: AB_2682894" "unprognostic (2.98e-1)" "unprognostic (9.68e-2)" "unprognostic (2.84e-1)" "prognostic favorable (9.26e-9)" "unprognostic (1.57e-1)" "unprognostic (7.10e-3)" "unprognostic (2.56e-2)" "unprognostic (1.15e-1)" "unprognostic (1.63e-1)" "unprognostic (7.39e-3)" "unprognostic (3.48e-3)" "unprognostic (2.92e-1)" "unprognostic (6.16e-11)" "unprognostic (8.04e-2)" "unprognostic (1.85e-1)" "unprognostic (1.47e-1)" "unprognostic (1.12e-2)" 0.1 0.0 0.4 2.4 0.2 0.0 28.5 0.3 0.7 12.0 6.5 0.2 0.3 4.4 4.0 0.3 0.9 2.4 16.1 0.1 0.4 0.3 0.1 0.1 5.5 0.1 0.3 0.1 0.6 1.3 0.0 0.1 0.2 0.1 55.8 4.0 0.2 98.0 4.5 0.1 3.0 7.8 0.1 0.1 0.1 10.8 0.1 0.1 0.2 0.1 7.8 22.9 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.7 0.0 0.1 0.0 28.3 9.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 47.5 0.0 0.0 38.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.3 0.7 0.4 0.3 0.3 0.1 0.1 0.1 0.0 2.1 0.0 12.1 0.1 0.0 0.1 2.5 0.0 3.4 0.0 0.0 0.0 0.0 3.2 1.1 0.0 8.1 0.0 1.1 0.0 0.0 80.8 0.0 0.0 0.0 0.0 5.2 0.6 0.0 2.9 0.0 0.0 3.3 0.0 228.3 0.0 12.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 26.3 9.7 SPDYA "Ringo3, SPDY1, SPY1" ENSG00000163806 "Speedy/RINGO cell cycle regulator family member A" Q5MJ70 2 28782517-28850611 "Predicted intracellular proteins" "Cell cycle, DNA damage" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 50 "testis: 93.4" "Cell type enriched" "Detected in many" 5 "Spermatocytes: 226.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 6.1;THP-1: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035162, HPA066214" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA035162: AB_2674501, HPA066214: AB_2685636" "unprognostic (3.41e-2)" "unprognostic (3.20e-3)" "unprognostic (2.45e-1)" "unprognostic (3.53e-2)" "unprognostic (4.21e-2)" "unprognostic (4.04e-3)" "unprognostic (1.10e-4)" "unprognostic (3.04e-3)" "unprognostic (1.95e-2)" "unprognostic (6.54e-3)" "unprognostic (1.45e-1)" "unprognostic (1.99e-2)" "unprognostic (1.66e-13)" "unprognostic (8.56e-2)" "unprognostic (1.07e-1)" "unprognostic (1.85e-1)" "unprognostic (5.55e-5)" 0.4 0.7 0.7 0.4 0.8 0.7 0.4 1.8 0.6 0.7 0.4 0.5 0.4 0.6 0.4 0.8 0.4 0.3 0.7 0.4 0.8 0.6 0.5 0.6 0.4 0.7 0.6 0.4 0.9 0.6 0.1 0.8 0.4 0.4 1.0 0.2 0.4 0.6 0.4 0.5 1.8 0.5 0.5 0.5 1.1 0.3 93.4 0.4 0.8 0.7 0.4 0.4 0.6 0.4 0.6 1.4 0.0 0.3 0.6 1.0 0.0 1.0 0.5 1.7 3.8 0.0 0.0 2.1 0.9 0.1 0.3 0.1 1.0 0.8 0.9 1.2 0.0 1.0 2.4 0.4 0.0 0.4 0.5 1.1 0.8 2.2 3.0 0.1 1.1 1.7 0.3 0.2 0.2 0.5 0.9 0.0 0.7 0.5 1.5 0.8 0.4 0.4 6.1 0.5 0.3 0.4 0.8 2.9 0.9 1.1 0.7 1.3 0.8 1.9 2.5 0.7 1.7 0.7 5.7 0.2 3.0 2.3 1.6 1.4 0.9 1.5 1.5 0.8 0.8 0.6 0.0 0.3 0.0 1.0 0.3 0.2 0.5 0.5 0.5 0.1 0.6 0.7 0.8 0.0 0.6 0.2 1.4 0.1 0.0 0.7 0.8 1.8 0.6 0.8 0.6 0.6 0.4 0.4 0.4 3.0 0.3 0.5 0.9 0.2 0.6 0.5 0.0 0.0 1.2 1.8 5.9 0.1 0.0 0.4 42.2 1.1 0.6 0.0 0.4 0.1 0.4 1.2 2.3 0.0 0.3 0.0 0.0 1.8 0.0 22.3 2.3 1.0 0.0 0.0 0.0 0.0 0.8 0.0 2.1 0.0 1.3 6.5 0.2 226.6 2.6 0.1 0.5 0.0 0.3 1.7 SPECC1 "CYTSB, FLJ36955, HCMOGT-1, NSP" ENSG00000128487 "Sperm antigen with calponin homology and coiled-coil domains 1" Q5M775 17 20009344-20319026 "Disease related genes, Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.9" "Cell type enhanced" "Detected in many" 5 "granulocytes: 111.1;monocytes: 103.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 35.6;SuSa: 58.4" "Low region specificity" "Detected in all" "HPA021421, HPA021430, HPA061073" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" NA NA "Nucleoplasm, Vesicles" "Nucleoli fibrillar center, Cytosol" "HPA021421: AB_1857431, HPA021430: AB_1857432, HPA061073: " "unprognostic (1.13e-3)" "unprognostic (2.39e-1)" "unprognostic (1.98e-2)" "unprognostic (8.10e-3)" "unprognostic (8.32e-2)" "unprognostic (1.38e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.06e-5)" "unprognostic (9.29e-2)" "unprognostic (5.81e-2)" "unprognostic (6.23e-3)" "unprognostic (2.65e-1)" "unprognostic (3.15e-1)" "unprognostic (6.86e-2)" "unprognostic (1.79e-1)" "unprognostic (1.40e-1)" "unprognostic (2.04e-1)" 10.7 8.3 21.3 7.2 38.0 29.9 8.1 16.0 30.8 7.0 14.9 49.9 0.7 9.5 15.4 6.1 11.4 7.3 20.0 4.1 23.1 15.4 4.3 2.0 5.6 5.7 35.8 21.2 17.0 8.3 3.0 6.8 4.8 29.3 7.3 15.5 3.0 5.9 4.9 4.3 4.8 11.4 11.5 28.2 17.3 9.8 25.8 41.5 0.2 6.7 1.4 6.0 7.0 4.2 2.9 14.7 18.9 9.4 8.5 3.4 3.0 14.2 14.8 8.0 2.6 6.1 3.1 17.4 5.8 4.8 5.8 7.2 24.2 12.7 0.8 18.9 5.0 8.7 10.6 6.1 13.8 2.9 4.3 6.5 5.8 16.2 2.6 2.2 0.6 3.4 3.3 14.0 8.2 9.3 35.6 0.0 2.4 0.7 7.2 4.5 12.1 0.1 3.2 6.4 6.3 3.6 3.5 16.2 8.2 14.3 7.1 2.6 2.7 30.4 14.6 6.4 58.4 12.9 3.8 0.4 0.7 8.9 0.8 15.7 2.8 3.5 1.1 8.6 4.9 3.3 18.9 9.4 17.8 3.1 5.3 2.9 2.4 1.9 3.4 14.7 2.9 1.8 2.4 8.1 8.5 4.6 4.4 0.9 3.0 21.3 38.0 16.0 30.8 23.1 15.4 35.8 21.2 29.3 41.5 20.8 14.3 3.2 11.9 4.8 5.9 6.1 7.6 12.0 6.8 17.4 64.8 3.9 8.3 26.9 75.7 5.2 32.8 23.3 31.4 10.8 9.5 14.6 111.1 0.2 18.6 0.0 7.5 3.1 9.7 40.7 4.6 14.0 20.3 103.6 44.0 19.3 54.5 28.3 42.1 2.4 32.8 58.2 31.9 72.4 64.5 2.3 1.8 10.2 18.6 22.1 SPEN "KIAA0929, MINT, RBM15C, SHARP" ENSG00000065526 "Spen family transcriptional repressor" Q96T58 1 15847864-15940460 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Notch signaling pathway, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015825, HPA050257" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA015825: AB_1856823, HPA050257: AB_2681065" "unprognostic (3.91e-1)" "unprognostic (1.74e-1)" "unprognostic (3.76e-1)" "unprognostic (2.04e-1)" "unprognostic (1.48e-1)" "unprognostic (3.06e-2)" "unprognostic (6.93e-3)" "unprognostic (2.26e-1)" "unprognostic (4.26e-2)" "unprognostic (4.88e-3)" "unprognostic (1.71e-1)" "unprognostic (5.98e-2)" "unprognostic (1.06e-3)" "unprognostic (1.49e-1)" "unprognostic (1.66e-1)" "unprognostic (2.26e-1)" "unprognostic (1.83e-1)" 18.2 11.2 18.2 18.2 22.2 27.2 17.3 38.2 25.9 18.5 13.4 20.7 17.7 11.9 19.0 12.7 16.7 19.4 11.8 13.5 17.6 11.5 14.4 13.2 17.8 16.6 23.4 17.5 31.2 23.9 35.1 17.5 16.2 19.0 14.9 13.3 11.6 16.2 16.2 24.0 22.8 16.0 15.1 22.0 16.5 13.7 13.6 23.3 18.3 20.1 8.7 18.0 17.1 41.9 5.0 2.7 7.7 2.4 1.3 1.7 0.6 12.7 10.8 13.5 10.1 13.6 8.3 7.3 6.6 8.7 7.2 6.1 9.8 10.0 18.0 7.9 13.0 8.5 18.5 12.7 11.8 11.6 16.2 35.2 22.6 9.6 6.2 6.1 18.5 10.8 6.1 8.5 10.7 15.6 6.8 8.2 13.8 23.5 18.6 5.8 7.1 15.3 7.3 6.1 7.4 8.3 14.8 13.2 11.1 4.0 11.5 10.5 10.6 18.6 9.1 7.9 6.4 3.2 9.1 14.7 6.6 8.2 12.8 9.4 11.2 7.3 20.6 6.5 15.0 9.2 7.7 1.5 0.9 1.6 2.4 1.3 1.8 1.7 1.4 0.7 5.0 0.9 1.3 4.2 1.3 1.2 2.7 1.1 0.6 18.2 22.2 38.2 25.9 17.6 11.5 23.4 17.5 19.0 23.3 74.5 74.0 31.3 47.9 93.0 64.6 48.1 20.4 38.8 66.0 5.2 49.1 10.9 3.3 16.9 3.4 55.5 30.7 23.3 15.0 12.0 46.5 43.4 59.1 26.3 13.3 90.6 30.4 13.5 30.8 3.6 25.3 30.1 20.3 25.2 24.4 29.6 18.0 23.2 33.6 6.5 54.5 19.4 54.6 34.9 51.9 88.8 13.2 20.2 18.7 49.2 SPHK2 ENSG00000063176 "Sphingosine kinase 2" Q9NRA0 19 48619291-48630717 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 66.9;Cone photoreceptor cells: 72.6;Rod photoreceptor cells: 83.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 33.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049062 Supported Nucleoplasm NA NA Nucleoplasm "HPA049062: " "unprognostic (5.33e-2)" "unprognostic (4.11e-2)" "unprognostic (9.61e-2)" "prognostic unfavorable (5.19e-4)" "unprognostic (2.10e-1)" "unprognostic (7.19e-3)" "unprognostic (3.04e-1)" "unprognostic (4.45e-3)" "unprognostic (7.28e-2)" "unprognostic (2.80e-1)" "prognostic favorable (9.30e-4)" "unprognostic (1.25e-1)" "prognostic favorable (2.59e-5)" "unprognostic (1.18e-2)" "unprognostic (9.97e-2)" "unprognostic (4.21e-2)" "unprognostic (7.06e-2)" 9.3 8.9 12.6 9.9 13.0 5.2 5.1 13.6 22.0 7.2 12.9 13.4 4.9 33.2 7.4 4.2 4.9 7.3 7.8 4.7 22.5 14.8 19.3 15.2 6.1 8.7 26.3 14.9 9.1 7.2 15.0 9.5 4.1 22.3 8.7 6.2 7.2 7.5 8.0 6.1 4.3 22.2 4.9 14.1 8.4 11.3 17.2 13.7 4.0 9.1 3.1 5.3 6.2 12.4 10.4 7.4 12.5 9.4 7.2 7.0 4.2 4.1 11.9 4.4 8.1 4.9 2.0 8.4 4.5 3.8 5.2 6.3 20.3 5.4 7.7 3.1 2.9 3.1 3.1 4.1 3.6 0.7 8.7 9.8 8.5 5.2 7.0 7.7 5.4 9.4 3.7 2.0 3.6 2.5 2.5 2.9 10.5 5.5 6.9 2.6 4.3 12.8 33.8 5.9 3.1 5.8 11.8 3.6 5.0 2.4 2.8 16.1 12.7 4.3 6.8 4.3 2.6 3.7 3.7 4.5 7.5 4.2 5.8 8.9 13.3 15.3 8.5 4.3 6.3 6.7 12.5 8.3 3.6 6.0 9.4 5.9 6.5 4.8 5.8 7.4 10.4 6.6 7.0 3.3 7.2 7.4 6.6 4.6 4.2 12.6 13.0 13.6 22.0 22.5 14.8 26.3 14.9 22.3 13.7 6.0 7.7 5.4 4.8 3.0 66.9 1.0 7.6 2.7 4.5 10.4 72.6 5.9 1.7 5.3 8.2 6.4 28.6 0.0 4.4 5.3 5.2 5.4 4.6 17.3 7.6 42.9 15.5 4.9 10.7 9.0 15.3 6.3 3.3 7.2 9.2 22.9 6.0 11.5 12.0 13.5 83.3 6.5 5.4 18.7 6.4 2.5 3.8 16.6 12.8 3.6 SPI1 "OF, PU.1, SFPI1, SPI-1, SPI-A" ENSG00000066336 "Spi-1 proto-oncogene" P17947 11 47354860-47378576 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, RNA-binding" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 100.3;lymphoid tissue: 70.2" "Group enriched" "Detected in many" 5 "Hofbauer cells: 391.4;Kupffer cells: 374.7;Macrophages: 436.5;monocytes: 317.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 45.4;neutrophil: 24.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 45.4" "Cell line enhanced" "Detected in some" "HEL: 19.2;HL-60: 33.6;HMC-1: 62.7;NB-4: 56.7;THP-1: 44.2;U-698: 17.9;U-937: 25.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004079, HPA044653" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB004079: AB_10692379, HPA044653: AB_2679036" "unprognostic (4.45e-2)" "unprognostic (3.31e-3)" "unprognostic (2.92e-2)" "unprognostic (1.66e-2)" "unprognostic (5.97e-2)" "unprognostic (3.33e-2)" "unprognostic (5.28e-2)" "unprognostic (1.07e-1)" "unprognostic (2.35e-2)" "unprognostic (2.79e-1)" "unprognostic (3.36e-1)" "unprognostic (1.78e-1)" "prognostic unfavorable (2.07e-5)" "unprognostic (1.20e-1)" "unprognostic (4.95e-2)" "unprognostic (2.40e-1)" "unprognostic (4.92e-2)" 24.4 8.1 6.7 35.7 15.2 100.3 9.0 1.5 6.6 3.6 5.2 8.6 0.0 7.6 3.2 6.2 4.0 8.5 7.7 15.7 5.6 5.1 5.8 11.9 37.2 51.1 12.6 1.6 6.1 3.5 0.9 3.6 10.1 9.6 4.5 3.9 3.9 6.4 2.6 3.3 5.0 10.5 7.6 12.1 70.2 5.8 5.4 10.5 9.6 3.7 2.7 16.8 9.1 5.7 1.0 4.6 45.4 9.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 33.6 62.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.0 56.7 0.0 0.0 0.0 10.3 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 44.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 17.9 0.0 25.0 0.0 3.6 5.4 45.4 0.0 7.8 0.0 1.0 0.0 0.0 4.6 0.8 0.0 0.0 24.8 0.0 9.1 0.2 0.0 1.5 6.7 15.2 1.5 6.6 5.6 5.1 12.6 1.6 9.6 10.5 3.0 0.6 71.3 0.5 9.3 1.5 2.0 7.6 1.4 1.2 5.2 0.0 1.9 16.6 0.0 5.9 2.2 0.3 0.0 0.3 2.5 5.9 0.4 34.5 1.3 391.4 0.0 4.1 11.1 374.7 20.0 1.7 436.5 10.1 317.4 0.1 4.0 0.0 0.0 0.0 1.3 1.0 12.9 2.1 5.5 2.5 8.7 3.5 2.5 0.4 0.4 SPIDR KIAA0146 ENSG00000164808 "Scaffolding protein involved in DNA repair" Q14159 8 47260575-47736306 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA027201, HPA041582" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA027201: AB_10603774, HPA041582: AB_2677563" "unprognostic (5.58e-2)" "unprognostic (2.24e-2)" "unprognostic (2.71e-2)" "unprognostic (7.45e-2)" "unprognostic (4.72e-3)" "unprognostic (7.99e-2)" "unprognostic (3.17e-2)" "unprognostic (2.15e-3)" "unprognostic (2.93e-2)" "prognostic unfavorable (8.91e-4)" "unprognostic (1.74e-1)" "unprognostic (1.92e-2)" "prognostic unfavorable (2.04e-6)" "unprognostic (5.30e-1)" "unprognostic (1.97e-1)" "unprognostic (8.43e-2)" "unprognostic (1.35e-2)" 21.1 21.6 24.0 22.4 20.7 15.6 23.8 47.5 32.1 18.2 18.9 15.5 17.1 12.8 29.7 18.9 28.6 19.5 25.1 14.4 20.1 17.5 15.3 16.3 21.4 18.0 15.9 18.7 28.4 20.5 19.4 39.8 21.4 22.4 20.8 18.5 19.9 20.6 15.8 15.7 24.0 15.1 21.4 18.6 23.3 20.2 16.7 15.3 12.7 23.2 10.5 25.2 21.0 24.8 7.9 9.6 5.2 11.1 8.6 11.4 5.5 8.4 14.3 9.0 14.2 10.4 12.8 7.4 10.8 8.0 8.6 12.4 7.7 19.9 17.0 13.0 9.5 8.6 4.6 9.4 8.2 13.0 5.0 8.9 11.8 12.5 14.5 11.2 8.8 7.4 7.0 8.0 6.8 10.3 9.5 6.3 10.7 8.6 6.1 8.5 20.7 16.5 22.0 11.1 18.8 3.5 8.2 5.2 0.9 11.8 31.8 4.6 10.8 16.0 13.4 6.0 9.2 12.8 16.5 11.0 6.9 10.0 8.4 7.3 7.3 12.9 11.9 7.2 12.1 6.6 4.8 11.1 3.5 11.4 7.2 11.3 7.9 5.1 6.9 9.6 7.4 5.7 5.1 5.2 8.6 8.2 1.6 10.0 5.5 24.0 20.7 47.5 32.1 20.1 17.5 15.9 18.7 22.4 15.3 32.8 28.9 6.2 14.3 9.5 10.9 16.1 15.3 25.4 14.8 12.2 17.7 15.1 6.6 7.0 7.4 14.7 6.3 0.0 7.7 9.5 13.0 15.5 11.6 6.8 9.7 12.7 11.1 11.6 29.4 6.6 13.6 18.6 8.5 1.8 11.6 8.2 6.7 8.5 13.8 3.7 10.7 6.5 13.7 22.3 29.5 7.5 13.7 13.8 11.0 15.9 SPIN1 "SPIN, TDRD24" ENSG00000106723 "Spindlin 1" Q9Y657 9 88388419-88478694 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Meiosis, Wnt signaling pathway" "Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 158.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000162, HPA068784" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA000162: AB_1080079, HPA068784: AB_2686033" "unprognostic (1.53e-1)" "unprognostic (2.29e-1)" "unprognostic (2.74e-1)" "unprognostic (1.01e-1)" "unprognostic (2.91e-1)" "unprognostic (1.53e-1)" "unprognostic (6.11e-2)" "unprognostic (1.19e-2)" "unprognostic (2.08e-2)" "unprognostic (8.96e-2)" "unprognostic (8.78e-2)" "unprognostic (8.32e-2)" "prognostic favorable (8.69e-6)" "unprognostic (4.73e-3)" "unprognostic (1.20e-1)" "unprognostic (1.05e-1)" "unprognostic (1.56e-1)" 12.2 15.0 28.3 9.4 34.2 7.0 19.7 22.6 38.0 34.9 14.4 23.7 10.2 10.4 34.4 44.0 15.5 28.6 17.5 15.6 27.1 28.7 24.9 11.3 14.1 8.3 21.7 27.2 32.2 12.2 28.4 19.6 26.9 26.3 21.6 14.1 16.8 12.9 24.6 3.5 13.4 12.1 25.7 22.0 9.9 11.6 18.5 15.9 12.7 22.9 6.8 9.1 15.4 21.3 4.5 8.1 8.1 4.2 4.2 7.8 4.9 23.6 11.8 19.5 16.5 13.3 15.7 22.9 23.8 22.1 27.3 20.0 8.7 13.8 13.2 14.1 29.1 17.6 36.4 14.5 21.6 31.4 13.8 8.9 6.3 24.9 9.2 12.3 14.3 6.9 13.0 22.6 18.4 26.0 26.9 15.5 16.8 8.0 0.0 30.5 16.3 24.2 6.5 32.1 19.8 11.1 32.5 21.2 4.2 24.6 16.7 27.7 20.8 28.2 17.8 10.4 23.6 13.7 11.4 14.7 18.1 19.3 26.8 16.8 5.5 8.2 11.4 21.9 13.3 16.8 8.1 4.2 6.4 6.7 3.8 7.1 4.5 5.0 6.9 8.1 3.4 7.1 7.8 0.6 4.2 3.3 3.8 4.5 4.9 28.3 34.2 22.6 38.0 27.1 28.7 21.7 27.2 26.3 15.9 47.6 12.5 2.9 22.2 35.5 21.1 34.1 33.1 20.1 19.4 41.8 23.6 24.0 21.6 21.8 158.1 21.1 19.0 23.3 15.9 38.4 35.2 28.1 33.5 15.5 28.0 23.8 39.6 20.3 31.4 87.6 31.1 18.9 20.3 11.8 26.4 39.4 21.2 18.7 41.8 39.9 13.7 25.8 26.2 24.7 65.2 39.1 20.8 10.2 19.5 25.7 SPIN2A "DXF34, SPIN2, TDRD25" ENSG00000147059 "Spindlin family member 2A" Q99865 X 57134530-57137625 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 5.2;Cardiomyocytes: 5.0;Cone photoreceptor cells: 3.9;Rod photoreceptor cells: 4.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HeLa: 5.8;HSkMC: 7.2" "HPA000162, HPA069835" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA000162: AB_1080079, HPA069835: AB_2686211" "unprognostic (3.18e-1)" "unprognostic (1.72e-2)" "unprognostic (7.32e-2)" "unprognostic (1.10e-4)" "unprognostic (1.02e-1)" "unprognostic (2.61e-3)" "unprognostic (1.55e-1)" "unprognostic (4.00e-2)" "unprognostic (1.12e-1)" "unprognostic (4.35e-2)" "unprognostic (8.01e-2)" "unprognostic (1.48e-1)" "unprognostic (7.95e-5)" "unprognostic (3.63e-2)" "unprognostic (8.61e-2)" "unprognostic (2.75e-1)" "unprognostic (5.07e-3)" 1.8 1.4 1.8 2.3 1.6 0.2 1.7 5.0 2.9 2.4 1.5 1.9 2.1 0.7 1.0 1.4 1.7 0.9 1.9 1.9 1.7 1.1 1.5 3.2 1.2 3.2 1.4 1.6 2.7 1.2 2.1 2.0 2.1 1.7 0.5 3.5 1.5 2.2 1.2 2.7 1.9 0.8 2.5 2.1 1.5 2.7 1.4 0.5 0.0 0.8 0.0 0.8 0.2 0.9 1.8 5.0 0.9 0.9 1.0 1.3 1.8 0.7 0.4 0.8 0.9 1.5 0.4 0.8 3.1 0.5 1.2 1.1 1.0 0.4 0.6 0.7 0.8 5.8 0.9 1.7 0.8 1.0 7.2 0.8 0.3 0.3 2.3 0.5 0.8 0.7 2.4 1.0 1.2 0.5 2.3 1.8 0.1 0.8 0.9 1.2 0.7 0.8 0.9 3.2 0.9 0.9 0.5 0.2 1.7 0.9 0.9 0.7 2.6 1.1 1.1 0.6 2.4 0.3 0.3 0.7 2.1 0.9 0.0 0.8 0.0 0.5 0.3 0.8 1.4 0.3 0.5 0.0 0.4 0.7 0.1 0.0 0.0 0.3 0.5 0.7 0.2 0.0 0.3 0.0 0.3 0.2 5.2 5.0 0.0 0.0 0.0 0.0 3.9 0.1 1.7 0.4 0.0 0.7 0.0 0.0 0.0 0.1 1.5 0.5 1.1 0.0 0.2 1.6 0.0 1.8 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 4.8 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 SPIN2B "SPIN-2, TDRD26" ENSG00000186787 "Spindlin family member 2B" Q9BPZ2 X 57118551-57121546 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA000162, HPA069835" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA000162: AB_1080079, HPA069835: AB_2686211" "unprognostic (3.21e-2)" "unprognostic (7.92e-2)" "unprognostic (2.34e-1)" "unprognostic (1.01e-1)" "unprognostic (8.28e-2)" "unprognostic (2.30e-2)" "unprognostic (8.42e-4)" "unprognostic (1.73e-3)" "unprognostic (2.24e-2)" "prognostic favorable (3.43e-4)" "prognostic favorable (3.39e-4)" "unprognostic (9.04e-3)" "prognostic favorable (1.78e-5)" "unprognostic (3.41e-2)" "unprognostic (2.40e-1)" "unprognostic (1.71e-1)" "unprognostic (2.26e-3)" 8.9 11.8 14.6 11.1 19.4 5.6 16.1 17.0 24.3 13.0 13.9 8.5 9.9 6.4 12.3 16.2 8.5 9.8 12.0 11.5 14.4 17.3 11.1 8.4 9.3 13.1 15.7 15.8 12.2 9.6 11.6 14.3 9.1 14.4 15.9 16.6 8.2 10.6 15.3 12.0 12.1 9.0 18.2 15.1 12.4 11.1 6.3 13.4 8.8 12.5 6.6 11.9 10.9 14.2 10.8 9.4 1.2 6.1 11.3 13.1 8.3 11.6 8.8 10.5 8.0 10.9 12.3 7.1 7.9 5.1 10.3 6.8 11.4 9.8 2.5 13.3 7.2 9.0 1.8 12.2 4.0 10.7 4.6 14.6 7.1 25.9 14.9 8.9 6.0 5.5 10.2 7.7 6.6 6.9 10.1 8.0 6.5 8.6 8.3 10.7 16.7 8.7 10.9 10.3 3.3 9.9 8.5 13.8 10.7 10.9 5.5 7.2 7.4 13.8 3.4 6.8 16.8 7.6 4.2 8.1 8.7 8.4 14.9 4.7 8.3 5.7 7.3 6.8 11.7 4.8 1.2 5.3 0.6 9.0 6.1 13.0 10.8 11.4 12.3 6.5 8.5 13.1 10.5 0.3 11.3 5.5 9.4 13.1 8.3 14.6 19.4 17.0 24.3 14.4 17.3 15.7 15.8 14.4 13.4 17.9 5.3 4.7 6.7 4.7 10.0 8.4 0.0 1.4 1.2 10.4 0.0 6.7 13.3 5.2 0.0 10.5 5.5 0.0 4.6 4.8 9.3 5.0 10.5 2.9 4.4 11.1 11.1 5.5 2.5 0.0 11.2 2.6 8.5 1.8 7.8 5.2 2.9 10.5 17.7 8.5 5.4 25.8 8.6 0.0 0.4 7.9 2.5 10.1 10.5 4.8 SPIN3 TDRD27 ENSG00000204271 "Spindlin family member 3" Q5JUX0 X 56818298-56995827 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 7.0;Sertoli cells: 6.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 17.0" "Low region specificity" "Detected in all" HPA000727 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA000727: AB_2196121" "unprognostic (3.12e-3)" "unprognostic (2.32e-1)" "unprognostic (7.45e-3)" "prognostic unfavorable (3.49e-4)" "unprognostic (1.20e-2)" "unprognostic (1.67e-2)" "unprognostic (6.85e-4)" "prognostic favorable (6.79e-4)" "unprognostic (1.70e-2)" "unprognostic (1.30e-1)" "unprognostic (2.48e-2)" "unprognostic (1.16e-2)" "unprognostic (1.02e-2)" "unprognostic (6.53e-2)" "unprognostic (8.51e-2)" "unprognostic (1.98e-2)" "prognostic favorable (6.30e-4)" 5.7 7.6 10.5 4.8 10.7 0.4 9.4 28.6 14.2 7.8 4.6 7.3 9.2 4.8 10.4 8.3 4.5 7.4 5.5 3.8 9.2 6.6 5.3 5.0 5.4 6.7 6.6 10.3 11.3 10.2 4.4 12.4 4.1 9.6 10.4 7.0 6.5 7.5 7.5 4.2 4.7 6.6 7.6 5.0 6.1 7.5 4.3 8.3 0.3 6.0 1.4 6.9 8.2 6.2 2.7 1.6 3.3 1.5 4.7 4.5 2.2 4.3 6.4 3.6 0.0 7.0 6.2 2.8 3.8 2.0 2.6 3.0 3.7 5.5 0.0 2.6 3.2 7.3 5.1 5.6 2.3 3.2 0.0 1.3 0.5 17.0 2.6 3.8 0.0 4.8 5.4 4.7 2.7 4.3 4.0 1.6 0.0 2.6 8.5 4.4 2.8 0.0 3.5 7.4 2.5 6.1 0.0 3.1 1.7 3.4 5.1 7.3 5.0 4.0 3.9 4.1 5.9 9.7 1.0 1.1 4.4 6.7 7.2 2.0 3.5 2.5 0.0 4.3 0.0 3.3 3.3 1.0 1.9 0.2 1.5 1.7 2.7 3.9 1.6 1.6 0.9 4.5 1.1 0.0 4.7 0.1 0.2 1.0 2.2 10.5 10.7 28.6 13.4 9.2 6.6 6.6 10.3 9.6 8.3 0.0 3.0 0.0 3.6 0.2 2.0 1.0 2.5 1.4 3.4 7.0 0.0 1.9 1.7 3.2 0.0 1.1 0.8 0.0 2.4 1.7 1.8 1.6 1.1 1.1 0.8 1.6 0.0 1.8 1.8 0.0 3.7 1.0 1.7 1.8 0.7 1.0 3.1 0.0 2.5 2.7 2.4 6.5 1.4 0.0 0.0 0.4 0.3 0.0 1.1 2.0 SPINK13 "HESPINTOR, LiESP6, MGC149260, SPINK5L3" ENSG00000214510 "Serine peptidase inhibitor, Kazal type 13 (putative)" Q1W4C9 5 148268180-148286254 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 14 "ductus deferens: 85.5;epididymis: 86.8;seminal vesicle: 26.7" "Group enriched" "Detected in some" 7 "Leydig cells: 36.8;Peritubular cells: 25.1" "Group enriched" "Detected in some" 6 "cervical cancer: 0.9;lung cancer: 0.9;renal cancer: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 20 "HeLa: 102.0" HPA036456 Uncertain Approved "Nucleoplasm,Plasma membrane" "Secreted in male reproductive system" NA NA "Plasma membrane" Nucleoplasm "HPA036456: AB_10673496" "unprognostic (5.22e-2)" "unprognostic (2.03e-1)" "unprognostic (1.44e-1)" "unprognostic (2.51e-1)" "unprognostic (1.22e-1)" "unprognostic (1.41e-2)" "unprognostic (6.43e-3)" "unprognostic (1.25e-3)" "unprognostic (5.01e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (4.03e-10)" "unprognostic (4.31e-2)" "unprognostic (1.72e-1)" "unprognostic (2.43e-1)" "unprognostic (2.95e-2)" 0.1 4.6 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 2.2 0.0 85.5 0.0 0.4 86.8 0.1 1.0 0.1 0.8 0.0 0.1 2.1 0.0 0.1 0.1 0.0 0.0 1.4 0.4 0.0 1.0 0.1 0.0 4.0 0.0 0.0 0.1 26.7 0.1 0.2 0.0 0.1 0.0 0.0 2.9 2.7 0.0 0.0 0.4 0.1 0.1 0.4 0.1 0.4 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 102.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 5.1 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.4 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 36.8 0.0 0.0 0.0 0.0 0.0 1.7 0.0 25.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPINK4 "MGC133107, PEC-60" ENSG00000122711 "Serine peptidase inhibitor, Kazal type 4" O60575 9 33218365-33248567 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "gallbladder: 35.8;intestine: 120.9;lymphoid tissue: 24.3" "Cell type enriched" "Detected in some" 24 "Mucus-secreting cells: 2251.6" "Group enriched" "Detected in many" 20 "colorectal cancer: 237.5;pancreatic cancer: 269.7;stomach cancer: 111.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "basophil: 5.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 5.1" "Group enriched" "Detected in some" 11 "HMC-1: 38.2;OE19: 100.1" "Region enhanced" "Detected in single" "pons and medulla: 1.1" "Not detected" "Not detected" HPA007286 Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Secreted to digestive system" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA007286: AB_1080083" "unprognostic (3.49e-2)" "unprognostic (2.32e-1)" "prognostic favorable (8.85e-5)" "unprognostic (3.09e-4)" "unprognostic (1.49e-1)" "unprognostic (1.00e-1)" "unprognostic (9.66e-2)" "unprognostic (2.43e-1)" "unprognostic (1.24e-1)" "unprognostic (3.25e-1)" "unprognostic (2.42e-3)" 0.2 0.4 0.2 24.3 0.3 0.0 0.2 0.2 0.2 0.2 69.3 0.2 0.2 28.8 0.2 0.2 0.3 0.2 35.8 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.4 0.0 0.4 0.2 0.2 0.3 110.5 2.5 0.2 0.2 0.3 0.2 120.9 4.6 0.2 0.3 0.5 0.3 0.2 0.2 0.2 0.2 0.2 3.4 0.2 0.0 0.0 5.1 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 6.2 0.2 0.0 0.0 38.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.8 0.0 0.4 0.0 100.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.3 3.2 0.6 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.1 0.2 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.2 20.7 0.0 0.0 0.0 0.0 5.2 11.8 0.0 0.0 0.1 0.7 0.0 94.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 84.6 0.0 0.0 2.4 0.0 0.0 0.0 0.0 2251.6 15.3 0.1 40.3 0.0 0.0 80.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.8 0.1 SPINK9 ENSG00000204909 "Serine peptidase inhibitor, Kazal type 9" Q5DT21 5 148321203-148339849 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "tongue: 65.0" "Group enriched" "Detected in some" 54 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 27.5;Ciliated cells: 26.8;Club cells: 27.3;granulocytes: 9.3" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 18.5;U-266/84: 19.6" "Low region specificity" "Detected in single" HPA038288 Uncertain Approved Nucleoplasm,Vesicles "Secreted in other tissues" NA NA "Nucleoplasm, Vesicles" "HPA038288: AB_10795400" "unprognostic (1.84e-1)" "unprognostic (4.87e-3)" "unprognostic (2.88e-1)" "unprognostic (9.02e-2)" "unprognostic (5.49e-3)" "unprognostic (3.04e-2)" "unprognostic (3.04e-1)" "unprognostic (1.35e-1)" "unprognostic (1.51e-3)" "unprognostic (2.82e-2)" "unprognostic (1.91e-2)" "unprognostic (3.93e-1)" "unprognostic (2.01e-1)" "unprognostic (3.99e-2)" "unprognostic (1.90e-1)" 1.0 2.3 2.3 2.2 4.0 6.2 1.0 1.3 3.2 1.0 1.2 1.0 1.0 1.1 2.0 1.5 1.5 0.5 1.0 2.3 2.2 3.3 1.3 1.0 1.0 1.9 1.5 1.0 1.4 1.4 0.5 1.4 2.5 1.0 1.8 1.2 1.0 1.0 1.0 2.4 2.7 1.7 1.0 1.1 1.1 2.0 3.8 1.0 2.7 1.0 65.0 1.1 1.2 1.0 3.4 2.7 10.7 2.9 5.8 2.8 0.2 11.1 2.1 2.9 3.0 0.4 1.1 2.4 3.0 0.1 0.2 0.5 4.6 8.6 3.3 18.5 0.2 1.6 2.3 0.9 0.6 0.8 4.7 2.2 6.5 6.9 2.0 0.2 2.3 2.7 0.1 0.6 0.3 0.1 1.7 0.0 2.3 3.9 14.4 0.4 9.5 2.2 3.4 11.4 4.2 4.4 2.9 2.9 3.6 1.4 9.1 5.2 6.0 3.0 6.5 2.0 8.3 10.6 2.1 7.0 3.4 10.7 3.3 3.5 9.1 19.6 3.3 2.8 2.0 4.6 10.7 2.9 1.3 1.8 1.6 2.1 1.3 2.0 2.1 0.7 3.4 2.6 2.8 10.5 5.8 2.8 2.7 1.3 0.2 2.3 4.0 1.3 3.2 2.2 3.3 1.5 1.0 1.0 1.0 14.9 27.5 0.0 0.1 0.0 0.0 0.3 0.0 26.8 27.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 SPINT1 "HAI, MANSC2" ENSG00000166145 "Serine peptidase inhibitor, Kunitz type 1" O43278 15 40844018-40858207 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 121.0" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 913.5;Syncytiotrophoblasts: 1399.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 52.1;HaCaT: 59.5;hTCEpi: 42.4;RT4: 48.2;SK-BR-3: 89.3;T-47d: 42.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA006903, HPA031178" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" NA NA 3400000 "Plasma membrane, Cytosol" Nucleoplasm "HPA006903: AB_1079038, HPA031178: AB_2732463" "prognostic unfavorable (6.97e-4)" "unprognostic (1.00e-3)" "unprognostic (3.00e-3)" "unprognostic (5.03e-2)" "unprognostic (6.06e-2)" "unprognostic (3.19e-1)" "unprognostic (5.94e-2)" "unprognostic (6.04e-2)" "unprognostic (8.24e-3)" "unprognostic (1.46e-2)" "unprognostic (1.09e-3)" "unprognostic (1.01e-1)" "prognostic favorable (1.37e-7)" "unprognostic (5.37e-2)" "unprognostic (2.22e-1)" "unprognostic (6.45e-3)" "unprognostic (2.17e-2)" 2.2 0.5 0.9 11.6 1.2 0.0 12.6 2.9 0.8 12.9 64.4 1.2 38.6 31.9 3.6 25.5 71.1 6.4 30.7 0.8 0.8 0.7 27.9 1.5 18.5 3.7 0.9 0.6 3.4 25.0 28.8 9.7 85.5 1.3 17.5 17.9 3.2 50.8 24.0 0.6 39.1 121.0 2.3 1.0 3.1 17.6 1.9 0.7 4.8 15.4 26.9 44.3 12.8 21.5 5.1 19.0 15.3 10.9 3.6 1.8 3.8 19.0 0.1 0.0 0.1 0.0 0.0 52.1 0.3 0.4 0.6 0.3 30.4 32.0 0.0 22.8 0.0 0.5 59.5 4.9 28.6 0.4 0.1 1.6 0.8 0.5 1.6 0.3 3.3 15.1 0.0 42.4 0.6 2.7 0.5 2.3 1.9 0.4 0.1 0.0 14.8 0.1 2.5 5.9 32.2 2.8 1.9 0.0 3.7 28.8 48.2 12.8 0.6 1.4 89.3 2.3 9.6 42.7 2.5 0.0 0.0 0.3 0.1 0.0 0.1 3.6 0.1 0.1 2.5 0.1 0.0 10.9 7.9 0.3 9.3 0.5 5.1 1.8 0.8 19.0 3.9 0.7 0.2 15.3 3.6 9.6 2.3 0.2 3.8 0.9 1.2 2.9 0.8 0.8 0.7 0.9 0.6 1.3 0.7 53.6 17.1 2.7 86.0 67.5 0.0 0.4 109.5 4.0 18.2 127.4 0.0 913.5 21.6 354.0 0.5 0.7 428.8 0.0 224.2 67.1 7.5 132.0 10.3 0.4 125.6 0.0 141.5 0.0 13.6 0.8 3.4 17.8 13.5 101.8 147.7 0.0 241.9 199.9 0.0 40.0 0.1 0.0 5.2 0.6 5.2 76.9 1399.8 2.2 145.0 168.6 SPIRE1 "KIAA1135, spir-1" ENSG00000134278 "Spire type actin nucleation factor 1" Q08AE8 18 12446512-12658134 "Predicted intracellular proteins" "Protein transport, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 147.7;Late spermatids: 226.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 41.1;U-2197: 31.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040737, HPA040942" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA040737: AB_10960987, HPA040942: AB_10960492" "unprognostic (3.39e-1)" "unprognostic (4.77e-2)" "unprognostic (9.18e-2)" "prognostic unfavorable (2.07e-4)" "unprognostic (2.09e-2)" "unprognostic (1.90e-1)" "unprognostic (1.09e-1)" "unprognostic (1.60e-1)" "unprognostic (9.49e-2)" "unprognostic (1.04e-1)" "unprognostic (1.46e-2)" "unprognostic (4.60e-1)" "unprognostic (3.66e-3)" "prognostic unfavorable (7.92e-4)" "unprognostic (1.41e-1)" "unprognostic (2.54e-1)" "unprognostic (1.44e-1)" 8.4 20.2 20.6 4.7 16.2 1.7 10.6 20.5 35.3 10.8 6.5 15.0 3.4 2.5 9.2 7.0 8.8 5.6 8.6 22.0 21.6 14.8 12.7 5.5 12.2 3.3 21.3 20.5 9.8 8.5 15.7 8.2 7.5 17.3 10.1 4.3 9.4 10.0 9.9 17.5 7.7 3.5 9.9 17.7 5.3 5.5 34.8 17.5 0.4 15.0 3.6 4.9 8.8 10.7 1.0 1.0 0.0 1.1 0.9 0.6 0.2 7.5 3.3 7.4 8.2 8.3 7.4 0.4 8.2 8.5 8.1 7.8 0.3 1.7 3.6 9.4 10.6 13.6 1.7 9.9 7.3 10.3 5.3 4.9 2.2 7.0 4.3 17.1 1.5 5.7 5.1 14.0 14.0 41.1 9.4 10.8 1.2 5.6 0.1 12.0 10.1 0.4 2.0 3.1 2.7 8.3 0.0 9.1 7.5 9.8 10.3 10.9 4.4 8.9 7.4 18.6 3.4 2.3 4.7 13.2 13.5 4.0 31.5 9.7 2.7 0.3 0.2 10.8 1.0 3.6 0.0 1.1 0.0 0.4 0.8 0.2 0.0 0.2 0.6 1.0 1.0 0.0 0.4 0.0 0.9 1.1 0.0 0.0 0.2 20.6 16.2 20.5 24.3 21.6 14.8 21.3 20.5 17.3 17.5 23.8 39.2 0.0 8.2 3.3 52.8 25.0 7.6 6.7 15.9 12.2 7.9 0.1 18.3 7.4 147.7 7.1 0.0 0.0 4.2 0.7 7.4 18.7 15.1 5.0 11.5 25.4 2.9 6.7 12.7 226.2 5.5 6.0 16.9 2.8 1.0 14.3 8.9 0.0 10.3 1.1 11.8 19.4 9.5 10.5 19.2 1.9 0.5 1.3 0.0 8.9 SPIRE2 "KIAA1832, spir-2" ENSG00000204991 "Spire type actin nucleation factor 2" Q8WWL2 16 89818179-89871319 "Predicted intracellular proteins" "Protein transport, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 40.6" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 40.0;Mucus-secreting cells: 37.2;Paneth cells: 34.2;Syncytiotrophoblasts: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 21.5;T-47d: 14.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041413, HPA049415" Uncertain Approved "Nucleoplasm,Vesicles,Intermediate filaments" NA NA Nucleoplasm "Vesicles, Intermediate filaments" "HPA041413: AB_2677464, HPA049415: AB_2680755" "unprognostic (2.92e-1)" "unprognostic (1.39e-1)" "unprognostic (6.07e-3)" "unprognostic (6.96e-2)" "unprognostic (7.40e-2)" "unprognostic (7.31e-2)" "prognostic unfavorable (9.77e-5)" "unprognostic (2.10e-1)" "unprognostic (7.75e-2)" "unprognostic (5.34e-2)" "unprognostic (1.08e-2)" "unprognostic (6.95e-3)" "unprognostic (7.21e-3)" "unprognostic (6.65e-2)" "unprognostic (1.30e-1)" "unprognostic (3.27e-2)" "unprognostic (1.59e-2)" 1.5 2.1 7.2 3.9 9.3 2.2 1.7 19.5 11.2 2.1 14.8 2.1 5.9 10.9 2.5 3.2 2.5 9.1 7.6 0.8 6.2 7.8 1.9 4.0 3.2 1.0 5.5 6.1 1.6 3.0 8.4 18.4 40.6 7.4 3.5 11.7 2.7 2.2 5.0 1.2 2.0 12.6 1.9 2.5 1.5 20.2 3.8 1.4 0.0 5.0 0.9 1.3 6.4 4.9 2.1 1.6 5.5 1.4 1.7 1.2 0.6 0.2 6.2 3.9 3.3 1.1 0.7 13.2 2.1 1.2 2.9 1.2 2.4 6.6 4.1 0.9 0.6 3.1 6.6 1.7 0.2 0.9 1.6 7.6 0.8 5.1 6.3 1.0 0.2 1.4 1.4 1.5 0.9 0.8 0.3 0.1 0.3 6.3 1.2 0.8 9.2 0.1 1.4 4.3 21.5 3.8 3.1 1.4 0.9 1.5 6.3 10.3 5.3 8.6 3.8 3.7 3.4 14.2 2.2 0.3 1.7 3.7 2.4 1.8 0.5 2.6 0.4 2.6 1.5 3.5 4.6 1.4 0.9 1.1 0.7 0.8 1.2 0.9 0.7 0.3 2.1 1.2 1.2 5.5 1.7 1.3 1.6 0.5 0.6 7.2 9.3 19.5 11.2 6.2 7.8 5.5 6.1 7.4 1.4 6.0 3.7 0.8 3.6 0.8 11.1 2.0 7.6 5.3 1.2 12.2 3.9 11.0 3.3 1.2 2.4 0.5 40.0 0.0 0.3 2.8 1.3 4.5 0.0 1.8 2.2 22.3 15.1 0.0 1.8 1.7 0.9 1.1 0.0 0.0 37.2 2.4 1.0 34.2 1.8 0.8 10.1 0.0 1.0 4.6 8.4 0.5 58.9 0.8 30.5 25.1 SPOCD1 "FLJ25348, PPP1R146" ENSG00000134668 "SPOC domain containing 1" Q6ZMY3 1 31790422-31816051 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 28.9;urinary bladder: 13.7" "Cell type enhanced" "Detected in some" 19 "Ductal cells: 9.9;Hofbauer cells: 13.9;Pancreatic endocrine cells: 18.9;Urothelial cells: 44.4" "Group enriched" "Detected in many" 7 "glioma: 13.9;urothelial cancer: 5.6" "Region enhanced" "Detected in many" "pons and medulla: 8.2" "Cell type enriched" "Detected in single" 15 "neutrophil: 1.9" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 18.9;hTEC/SVTERT24-B: 19.7;RT4: 33.2;TIME: 17.3;U-87 MG: 32.7" "Low region specificity" "Detected in some" "HPA031713, HPA031714, HPA031715" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA031713: AB_10604099, HPA031714: AB_2674007, HPA031715: AB_2674008" "unprognostic (7.78e-2)" "unprognostic (2.58e-2)" "unprognostic (1.85e-3)" "unprognostic (2.70e-3)" "unprognostic (1.29e-2)" "unprognostic (1.56e-2)" "unprognostic (2.15e-3)" "unprognostic (2.60e-2)" "unprognostic (3.51e-1)" "unprognostic (2.18e-1)" "unprognostic (3.01e-2)" "unprognostic (3.00e-1)" "unprognostic (0.00e+0)" "unprognostic (1.97e-1)" "unprognostic (1.06e-1)" "unprognostic (1.54e-2)" "prognostic favorable (4.05e-5)" 28.9 0.5 1.8 5.1 1.6 0.3 1.6 0.4 3.9 2.0 0.7 1.5 0.1 1.6 2.4 2.8 0.3 2.1 1.6 0.4 1.2 1.6 0.5 0.2 12.9 0.9 2.6 0.3 1.8 0.1 0.1 1.6 3.5 8.2 1.8 0.9 1.8 0.1 0.3 0.4 0.1 0.9 2.4 3.1 1.9 1.1 11.9 0.6 0.1 0.4 0.8 0.2 13.7 2.1 0.0 0.0 1.9 0.1 0.0 0.0 7.3 10.7 0.3 0.0 0.0 0.2 1.5 0.5 14.1 18.9 13.7 9.2 0.2 0.6 0.1 1.9 15.9 5.6 1.4 0.0 0.2 4.3 0.0 0.0 0.0 1.9 0.0 0.6 0.0 0.2 6.9 0.2 19.7 0.6 11.1 9.3 0.7 0.2 0.2 8.1 0.0 0.1 0.0 0.2 0.1 0.3 0.0 1.4 0.0 0.0 33.2 0.0 0.0 0.3 0.0 0.9 0.4 8.2 0.0 17.3 14.5 1.4 9.3 5.3 0.0 0.1 0.0 32.7 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 7.3 1.8 1.6 0.4 0.6 1.2 1.6 2.6 0.3 8.2 0.6 0.0 5.9 0.0 4.0 0.1 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.2 0.0 9.9 0.2 0.1 0.0 0.0 8.9 0.5 0.4 1.7 1.1 0.0 13.9 0.0 1.7 0.6 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 18.9 0.0 0.4 0.0 0.0 0.0 1.4 0.0 4.3 0.0 0.2 0.0 0.0 44.4 SPON1 "f-spondin, KIAA0762" ENSG00000262655 "Spondin 1" Q9HCB6 11 13962689-14267884 "Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 40.2" "Cell type enriched" "Detected in many" 5 "Muller glia cells: 163.5" "Cancer enhanced" "Detected in all" "ovarian cancer: 199.1" "Cell type enriched" "Detected in some" 5 "MAIT T-cell: 7.3" "Lineage enriched" "Detected in single" 74 "T-cells: 7.3" "Group enriched" "Detected in some" 35 "EFO-21: 42.0;RPTEC TERT1: 118.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038584, HPA077546" Uncertain Approved "Nucleoplasm,Nucleoli,Actin filaments,Microtubule ends,Cytokinetic bridge" "Secreted to blood" Yes No 11500000 27000000 "Nucleoli, Microtubule ends" "Nucleoplasm, Actin filaments, Cytokinetic bridge" "HPA038584: AB_10697394, HPA077546: AB_2732351" "unprognostic (1.66e-1)" "unprognostic (1.03e-2)" "unprognostic (8.36e-2)" "unprognostic (8.72e-2)" "unprognostic (1.52e-1)" "unprognostic (3.76e-2)" "unprognostic (1.82e-1)" "unprognostic (8.20e-2)" "unprognostic (1.05e-1)" "unprognostic (5.93e-2)" "unprognostic (6.45e-2)" "unprognostic (1.07e-1)" "prognostic favorable (3.12e-4)" "unprognostic (7.22e-3)" "unprognostic (7.89e-2)" "unprognostic (4.65e-2)" "prognostic unfavorable (1.88e-4)" 16.8 5.1 8.3 5.2 12.5 0.0 3.3 4.8 10.7 15.7 9.7 7.6 0.0 9.6 12.0 4.6 5.3 20.3 40.2 4.9 7.2 5.4 0.1 8.1 0.7 5.1 8.8 12.0 0.8 0.0 2.0 12.3 7.5 7.2 15.0 8.5 0.9 2.5 0.0 1.6 12.4 15.7 3.2 1.8 3.9 0.8 5.7 0.0 0.8 0.6 0.0 15.6 9.9 0.0 0.0 0.0 0.0 0.0 7.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 42.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 118.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 7.3 0.0 1.3 0.7 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.9 10.4 12.6 0.0 8.9 1.2 2.5 1.4 0.0 0.0 2.0 2.6 3.3 3.3 1.3 1.0 19.8 0.0 1.8 3.1 18.3 5.0 2.3 0.0 1.6 1.6 16.0 3.7 0.3 1.2 4.0 0.0 0.0 0.0 18.6 163.5 4.5 10.5 28.3 0.8 29.7 6.5 5.4 0.2 0.6 0.0 4.1 5.0 35.1 8.0 SPPL2B "IMP4, KIAA1532, PSL1" ENSG00000005206 "Signal peptide peptidase like 2B" Q8TCT7 19 2328615-2354806 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 82.4" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005592, HPA039292" Approved Approved "Nucleoplasm,Plasma membrane,Centrosome" NA NA "Nucleoplasm, Plasma membrane" Centrosome "CAB005592: AB_325074, HPA039292: AB_2676429" "unprognostic (4.16e-2)" "unprognostic (2.97e-2)" "unprognostic (2.48e-2)" "prognostic favorable (5.00e-5)" "unprognostic (2.34e-1)" "unprognostic (1.54e-3)" "unprognostic (1.74e-1)" "unprognostic (7.93e-3)" "unprognostic (3.00e-1)" "unprognostic (1.72e-1)" "prognostic favorable (1.33e-4)" "unprognostic (3.29e-3)" "prognostic unfavorable (6.45e-4)" "unprognostic (2.26e-2)" "unprognostic (2.45e-1)" "unprognostic (3.02e-1)" "unprognostic (3.40e-2)" 5.4 4.6 5.0 11.7 5.4 11.7 4.0 6.9 6.9 3.4 9.0 7.9 9.6 19.3 4.7 10.0 3.2 5.2 9.8 3.3 5.6 4.2 3.9 3.5 10.3 7.1 4.7 3.4 13.8 6.3 11.0 6.8 7.1 4.7 3.9 6.0 10.5 8.7 7.5 8.7 16.2 5.0 7.0 8.1 13.8 20.1 6.4 9.3 3.0 3.7 5.7 2.3 2.0 14.4 17.4 9.3 7.7 6.2 8.2 5.9 8.3 13.4 5.8 10.2 4.8 4.9 14.8 11.0 3.2 4.0 4.3 9.4 9.6 8.0 10.4 5.1 3.8 11.3 1.9 3.8 1.2 9.3 8.4 5.3 21.0 12.5 9.0 9.3 7.0 7.1 4.3 3.8 2.7 6.3 5.6 16.8 8.6 20.5 2.4 9.3 10.1 11.9 10.8 7.5 5.5 16.9 3.0 22.1 4.4 21.1 10.3 9.8 11.0 6.7 8.4 3.9 11.2 15.7 12.5 7.4 5.3 18.6 8.6 27.1 9.7 8.4 9.2 10.9 12.8 9.3 7.7 7.0 6.6 7.5 4.8 9.0 6.0 6.5 9.4 14.4 7.8 8.2 3.4 6.2 5.1 17.4 5.9 5.9 3.0 15.0 22.0 6.2 0.0 23.4 5.1 28.1 20.1 9.1 24.4 45.2 44.0 1.7 13.7 36.9 9.0 59.3 0.0 10.0 18.3 4.6 7.2 6.9 10.6 10.4 30.2 39.1 14.7 9.5 82.4 13.8 5.3 0.0 5.4 51.1 13.7 10.1 30.8 14.9 6.2 39.6 0.0 8.1 41.9 12.4 0.0 35.8 4.5 38.9 4.3 SPR SDR38C1 ENSG00000116096 "Sepiapterin reductase" P35270 2 72887360-72892158 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 61.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 9.3;intermediate monocyte: 2.6;myeloid DC: 9.9" "Group enriched" "Detected in many" 13 "dendritic cells: 9.9;monocytes: 9.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039505 Uncertain Supported Nucleoplasm,Cytosol NA NA 52000 "Nucleoplasm, Cytosol" "HPA039505: AB_10795466" "unprognostic (4.09e-1)" "unprognostic (1.22e-1)" "unprognostic (7.72e-3)" "unprognostic (1.97e-1)" "unprognostic (2.46e-2)" "unprognostic (1.06e-2)" "unprognostic (1.36e-1)" "unprognostic (1.47e-1)" "unprognostic (1.12e-1)" "unprognostic (9.79e-2)" "unprognostic (1.62e-1)" "unprognostic (1.37e-1)" "unprognostic (1.80e-1)" "unprognostic (7.50e-3)" "unprognostic (2.87e-1)" "unprognostic (1.43e-3)" "unprognostic (1.95e-1)" 13.3 22.6 6.3 6.1 8.2 0.0 36.2 2.0 6.4 6.0 17.1 3.1 8.9 11.4 5.7 19.1 13.4 13.2 11.4 16.1 6.4 6.0 20.3 43.5 7.2 5.3 7.9 5.0 8.7 61.7 16.7 5.5 3.9 7.9 17.3 16.2 4.5 20.9 8.8 16.0 3.3 15.1 9.5 4.9 4.7 15.4 4.9 7.2 1.0 31.7 6.2 3.6 9.5 41.4 0.0 9.9 0.7 9.3 0.0 0.4 2.5 13.5 38.0 0.2 5.9 15.6 5.7 9.5 6.4 9.3 4.8 4.5 24.2 14.1 9.9 7.7 7.5 24.1 12.9 17.0 10.2 4.0 2.8 13.2 14.9 9.4 24.8 5.8 2.3 4.1 5.0 11.4 5.2 5.9 9.8 12.5 7.4 15.3 2.0 6.2 28.5 0.9 8.8 3.2 40.2 36.4 0.0 24.7 5.8 25.2 21.2 2.4 4.4 11.7 26.5 8.7 5.2 11.9 2.8 15.3 5.2 12.8 9.1 11.2 2.2 4.8 0.6 7.5 5.0 9.1 0.0 9.3 0.7 0.4 2.6 0.4 0.0 0.2 0.1 9.9 0.0 0.2 0.4 0.0 0.0 1.0 0.9 0.0 2.5 6.3 8.2 2.0 6.4 6.4 6.0 7.9 5.0 7.9 7.2 11.9 5.3 1.9 19.7 7.4 0.6 40.5 40.8 6.7 7.9 40.1 0.0 14.2 18.3 46.9 0.2 17.6 68.6 0.0 71.1 9.3 12.5 27.5 4.6 52.9 35.3 1.6 10.9 11.6 4.7 0.9 8.6 9.4 13.5 34.3 31.7 8.6 48.5 51.8 5.3 75.1 0.5 6.5 12.5 0.3 6.6 5.6 3.7 1.7 50.4 13.2 SPRED1 "FLJ33903, PPP1R147" ENSG00000166068 "Sprouty related EVH1 domain containing 1" Q7Z699 15 38252326-38357249 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 92.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.3;non-classical monocyte: 4.0" "Lineage enriched" "Detected in many" 4 "monocytes: 4.0" "Cell line enhanced" "Detected in many" "AF22: 28.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042193, HPA061805" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA042193: AB_10794079, HPA061805: AB_2684617" "unprognostic (1.30e-1)" "unprognostic (1.28e-2)" "unprognostic (2.46e-1)" "prognostic favorable (7.08e-4)" "unprognostic (1.20e-1)" "unprognostic (2.38e-1)" "unprognostic (1.21e-3)" "unprognostic (5.71e-2)" "unprognostic (3.84e-2)" "unprognostic (2.81e-3)" "unprognostic (9.27e-3)" "unprognostic (3.33e-1)" "prognostic unfavorable (7.37e-5)" "prognostic unfavorable (8.29e-5)" "unprognostic (6.04e-2)" "unprognostic (5.77e-2)" "unprognostic (1.01e-1)" 17.6 9.5 21.2 9.5 24.2 1.1 12.4 8.6 24.6 13.9 12.3 14.7 2.9 9.1 12.5 7.2 7.1 8.1 15.3 8.0 18.2 14.0 10.4 6.3 18.9 7.5 16.1 12.9 10.0 5.3 11.7 6.2 15.3 13.8 10.2 12.3 10.2 8.0 10.3 4.1 6.9 9.4 10.6 16.5 9.8 11.5 9.0 13.7 2.3 33.7 5.4 5.5 9.2 11.8 0.0 1.0 0.2 4.0 0.2 0.3 0.1 5.0 4.0 28.8 5.2 10.1 18.5 2.3 12.1 11.8 6.2 7.8 3.5 4.0 0.0 4.5 9.6 4.6 4.1 2.9 7.8 12.2 0.7 0.9 5.8 2.6 3.3 12.4 3.1 16.7 12.0 3.9 11.7 10.9 15.5 4.8 3.1 5.3 5.7 14.6 1.3 1.2 2.3 5.7 17.5 10.4 0.0 6.1 3.2 9.7 8.0 1.3 6.3 3.3 1.6 12.2 4.6 1.3 0.7 8.6 15.1 7.7 9.1 7.1 4.9 3.2 7.6 10.7 1.3 24.1 0.0 0.6 0.0 0.0 2.3 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.2 0.2 4.0 0.0 0.0 0.1 21.2 24.2 8.6 20.3 18.2 14.0 16.1 12.9 13.8 13.7 92.3 24.0 2.7 22.3 25.1 11.3 6.5 28.1 13.4 18.2 1.8 5.9 1.1 1.7 8.4 29.1 25.0 9.2 0.0 4.3 0.9 23.6 9.9 40.5 3.6 47.9 4.8 6.4 32.5 32.7 6.8 20.1 41.2 27.0 7.2 19.7 23.7 10.0 5.8 28.7 11.1 5.2 6.5 28.6 3.4 3.2 8.4 1.1 2.5 11.7 14.0 SPRED2 "FLJ21897, FLJ31917, Spred-2" ENSG00000198369 "Sprouty related EVH1 domain containing 2" Q7Z698 2 65310851-65432637 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "NK-cell: 3.2;plasmacytoid DC: 7.7" "Group enriched" "Detected in many" 4 "dendritic cells: 7.7;NK-cells: 3.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038256, HPA064394" Approved Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038256: , HPA064394: AB_2732712" "unprognostic (1.49e-1)" "unprognostic (5.95e-3)" "unprognostic (3.46e-2)" "unprognostic (4.40e-3)" "unprognostic (8.94e-2)" "unprognostic (1.63e-1)" "unprognostic (2.90e-2)" "unprognostic (9.94e-2)" "unprognostic (9.07e-2)" "unprognostic (4.25e-1)" "unprognostic (5.05e-2)" "unprognostic (1.92e-1)" "unprognostic (2.37e-2)" "unprognostic (3.82e-2)" "unprognostic (1.58e-1)" "unprognostic (7.21e-3)" "unprognostic (5.43e-2)" 25.1 13.5 21.0 19.3 17.8 6.7 26.2 26.2 28.9 16.9 18.9 9.0 5.8 17.2 20.1 12.3 12.8 13.8 18.3 17.5 19.0 14.3 16.1 28.1 22.0 14.8 15.3 19.0 18.3 20.6 29.5 15.1 18.1 20.5 15.1 18.7 15.1 17.9 13.6 9.6 13.6 20.7 13.7 16.5 11.0 22.6 8.1 12.9 40.3 22.1 10.4 17.1 21.2 30.5 0.1 7.7 1.2 1.2 3.2 1.2 1.5 27.0 14.3 15.6 15.9 20.4 20.4 11.3 8.1 12.0 5.2 7.2 18.8 7.7 20.9 4.3 10.0 15.1 9.1 8.9 18.2 10.7 23.9 6.5 4.3 3.8 20.3 10.3 13.3 8.9 16.3 10.8 18.7 17.9 11.4 3.3 11.7 18.6 8.2 8.4 18.3 10.3 12.4 7.8 21.1 16.8 8.2 14.1 10.8 16.3 22.9 6.7 23.8 8.5 7.3 21.7 10.1 6.9 11.3 5.1 13.3 17.9 11.8 12.9 16.2 6.5 34.1 21.6 12.8 25.6 0.0 0.4 0.0 1.2 1.2 0.1 0.0 0.2 1.0 0.8 0.1 0.2 0.3 1.2 3.2 0.6 7.7 0.0 1.5 21.0 17.8 26.2 26.7 19.0 14.3 15.3 19.0 20.5 12.9 17.9 16.5 2.2 27.6 35.4 14.1 6.5 17.8 6.7 4.5 8.7 5.9 10.2 11.6 10.1 1.3 9.8 16.0 0.0 7.4 7.2 13.1 21.2 1.1 12.7 5.9 23.8 10.9 15.4 6.5 2.5 15.8 7.8 18.6 44.1 19.7 8.9 9.7 15.8 11.7 5.7 10.7 25.8 15.4 2.8 9.8 14.6 2.5 0.7 10.1 22.0 SPRED3 ENSG00000188766 "Sprouty related EVH1 domain containing 3" Q2MJR0 19 38388421-38399587 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.7" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 7.3;Intestinal endocrine cells: 10.4" "Cancer enhanced" "Detected in many" "glioma: 3.6" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 12.3;TIME: 14.7;U-87 MG: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071521 Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA071521: " "unprognostic (1.09e-1)" "unprognostic (1.88e-3)" "unprognostic (8.71e-3)" "unprognostic (3.35e-3)" "unprognostic (3.70e-2)" "unprognostic (2.00e-3)" "unprognostic (2.09e-3)" "unprognostic (7.77e-3)" "unprognostic (1.49e-1)" "unprognostic (9.22e-3)" "unprognostic (1.69e-2)" "unprognostic (3.09e-2)" "unprognostic (1.40e-11)" "unprognostic (6.21e-4)" "unprognostic (3.67e-1)" "unprognostic (1.04e-3)" "unprognostic (8.45e-3)" 2.0 1.2 4.3 2.7 10.1 0.9 1.2 2.8 10.7 0.9 0.6 1.7 0.0 4.7 1.2 1.2 0.9 0.7 2.0 1.1 5.0 4.7 1.2 0.4 0.9 0.5 2.8 4.6 0.5 2.9 4.5 5.8 0.8 4.7 1.2 0.8 0.9 0.8 1.1 0.9 2.3 3.7 2.3 1.7 0.5 1.3 1.7 0.9 0.0 1.8 0.0 0.6 0.9 0.8 0.8 0.7 2.2 0.6 0.9 0.5 0.3 0.2 1.1 3.8 3.1 0.6 1.8 2.1 7.5 5.0 2.5 2.3 0.4 0.8 0.2 2.7 2.5 2.0 0.1 0.6 0.9 2.3 0.7 1.4 0.0 0.2 0.4 1.3 2.0 0.1 1.3 0.9 5.9 1.7 12.3 7.8 0.6 0.6 1.4 7.6 0.4 0.0 0.1 1.7 0.5 3.8 0.9 1.3 0.1 5.4 0.6 0.2 2.9 0.1 0.2 0.3 1.7 0.6 0.1 14.7 2.8 8.6 2.3 4.1 0.6 0.2 0.5 9.4 0.3 4.7 1.6 0.6 0.4 0.4 0.2 0.3 0.3 0.5 0.3 0.1 0.8 0.4 0.3 2.2 0.9 0.5 0.7 0.2 0.3 4.3 10.1 2.8 9.8 5.0 4.7 2.8 4.6 4.7 0.9 0.0 0.0 0.0 1.1 0.0 7.3 1.0 0.0 0.0 0.0 1.8 2.0 0.4 0.0 0.8 0.3 0.1 0.7 0.0 0.5 0.2 0.0 1.1 0.0 0.0 0.1 1.6 10.4 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.3 2.5 2.2 0.0 0.0 0.0 0.2 0.0 1.0 0.9 0.6 0.1 0.7 0.0 0.6 0.6 SPRR4 ENSG00000184148 "Small proline rich protein 4" Q96PI1 1 152970666-152972574 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "skin 1: 51.9;tongue: 18.9" "Group enriched" "Detected in some" 27 "Early spermatids: 9.1;Late spermatids: 36.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 17.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HaCaT: 3.6;hTCEpi: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA055963 Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA055963: AB_2682988" "unprognostic (4.40e-2)" "unprognostic (7.38e-3)" "unprognostic (1.45e-1)" "unprognostic (6.75e-2)" 0.1 0.0 0.1 0.7 0.1 0.0 4.9 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.4 0.1 0.8 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 51.9 0.1 0.1 0.1 0.1 0.0 2.9 0.1 1.8 0.1 18.9 0.4 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.3 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 SPRTN "C1orf124, DKFZP547N043, DVC1, Spartan" ENSG00000010072 "SprT-like N-terminal domain" Q9H040 1 231337104-231355023 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 80.5;Rod photoreceptor cells: 58.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025073 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA025073: AB_1847695" "unprognostic (2.63e-1)" "unprognostic (5.41e-2)" "unprognostic (1.59e-1)" "unprognostic (1.04e-1)" "unprognostic (1.56e-2)" "unprognostic (2.00e-1)" "unprognostic (5.69e-3)" "unprognostic (1.72e-1)" "unprognostic (1.33e-2)" "unprognostic (4.75e-3)" "unprognostic (1.26e-1)" "unprognostic (3.25e-1)" "unprognostic (7.51e-3)" "unprognostic (1.19e-1)" "unprognostic (3.21e-2)" "unprognostic (3.60e-2)" "unprognostic (5.35e-2)" 8.0 8.3 7.5 7.7 9.4 16.2 9.0 7.3 10.0 8.4 7.1 12.4 8.2 6.4 8.5 7.2 11.2 7.3 7.3 8.4 7.7 7.1 8.1 9.6 6.1 9.4 9.9 7.1 7.2 6.3 9.0 12.7 12.5 10.9 6.6 6.3 7.1 8.7 7.2 18.5 9.3 7.0 8.1 10.1 9.2 7.3 23.3 9.3 16.1 8.3 10.9 9.6 7.8 7.6 6.7 6.5 13.8 9.1 8.6 10.1 5.0 11.2 9.8 9.0 9.8 8.4 6.0 10.8 10.3 9.0 11.9 10.3 11.1 10.0 10.2 11.1 8.4 4.7 16.8 12.7 10.2 12.8 8.5 22.0 6.3 9.5 7.7 9.0 10.6 9.4 8.1 11.0 12.8 10.5 5.4 11.8 9.2 15.5 10.1 11.7 6.1 11.3 6.2 8.8 13.0 8.4 10.0 11.9 12.1 10.2 8.4 11.3 10.9 10.8 8.6 11.6 4.2 15.5 16.3 8.7 10.3 10.5 14.6 16.3 7.8 8.1 13.9 8.0 9.4 17.3 9.3 6.6 13.0 7.7 9.1 8.7 6.7 7.8 9.1 6.5 5.2 9.3 10.1 13.8 8.6 6.5 6.1 8.1 5.0 7.5 9.4 7.3 10.0 7.7 7.1 9.9 7.1 10.9 9.3 14.9 3.4 13.7 9.7 28.4 22.3 3.9 2.5 16.0 10.3 3.5 80.5 10.5 8.3 7.5 16.8 14.6 9.0 0.0 8.3 9.5 11.2 7.3 26.4 6.4 8.2 14.3 11.5 10.4 6.1 7.8 8.3 10.3 6.8 13.6 6.4 12.4 8.8 5.9 7.4 6.2 58.4 12.9 12.0 47.2 18.5 24.8 12.7 20.3 6.6 14.5 SPRY1 hSPRY1 ENSG00000164056 "Sprouty RTK signaling antagonist 1" O43609 4 123396795-123403760 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 139.1" "Cell type enhanced" "Detected in many" 11 "Endothelial cells: 160.4;Leydig cells: 414.8;Muller glia cells: 173.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 29.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 30.2;AN3-CA: 61.1;ASC diff: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013538, HPA051369, HPA070554" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" Nucleoplasm "CAB013538: AB_2533452, HPA051369: AB_2681457, HPA070554: AB_2686280" "unprognostic (1.27e-1)" "unprognostic (9.08e-2)" "unprognostic (2.06e-1)" "unprognostic (7.15e-2)" "unprognostic (5.33e-2)" "unprognostic (2.19e-2)" "unprognostic (1.36e-1)" "unprognostic (9.43e-2)" "unprognostic (6.99e-2)" "unprognostic (4.32e-1)" "unprognostic (4.06e-1)" "unprognostic (3.11e-2)" "unprognostic (8.77e-3)" "unprognostic (1.21e-3)" "unprognostic (4.48e-2)" "unprognostic (1.54e-2)" "unprognostic (1.27e-1)" 139.1 12.6 3.3 14.7 4.3 5.8 69.0 4.9 3.5 28.5 24.8 1.9 18.0 4.5 18.6 28.0 38.1 19.1 27.1 34.1 2.6 1.7 10.2 6.4 23.1 9.1 3.3 2.8 32.2 9.8 17.0 9.5 15.6 2.9 25.0 8.8 11.8 14.6 16.5 48.1 25.5 8.1 20.7 2.8 7.1 11.6 28.4 1.5 13.0 29.6 16.3 8.6 60.8 39.9 29.9 0.7 2.8 0.1 6.1 15.5 0.9 1.9 0.5 30.2 61.1 24.8 16.9 2.0 0.1 1.5 0.1 0.6 1.8 3.2 0.0 13.6 0.9 0.1 0.3 0.8 1.4 0.2 0.0 3.1 0.6 0.0 9.4 7.0 4.2 0.0 6.8 0.8 0.2 0.6 3.3 2.5 0.7 0.5 0.5 1.4 0.2 4.9 10.5 7.2 6.9 10.0 2.1 3.2 0.0 4.1 4.4 4.6 3.9 0.0 6.1 5.8 3.3 0.6 0.0 6.2 0.4 0.0 0.1 0.9 0.3 0.0 0.0 0.4 0.8 1.0 0.0 0.1 2.8 0.5 0.0 15.5 9.6 1.8 4.2 0.0 29.9 2.7 2.9 0.1 6.1 0.0 0.7 0.0 0.9 3.3 4.3 4.9 3.5 2.6 1.7 3.3 2.8 2.9 1.5 26.8 27.0 15.2 13.8 44.1 75.2 10.9 35.7 13.4 27.3 26.2 31.4 10.0 68.0 3.5 1.7 160.4 6.3 0.0 9.4 1.5 42.7 12.9 9.2 4.4 8.2 6.4 25.4 120.9 11.6 4.0 414.8 9.7 43.9 1.0 13.1 173.3 8.4 3.5 54.5 12.6 80.4 148.8 86.8 1.9 1.5 37.9 2.6 25.5 14.1 12.5 SPRYD3 FLJ14800 ENSG00000167778 "SPRY domain containing 3" Q8NCJ5 12 53064316-53079420 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039426, HPA039685" Enhanced Approved "Nucleoplasm,Vesicles,Plasma membrane,Actin filaments,Cytosol" NA NA "Nucleoplasm, Cytosol" "Vesicles, Plasma membrane, Actin filaments" "HPA039426: AB_10673358, HPA039685: AB_2676623" "unprognostic (7.73e-3)" "unprognostic (6.55e-2)" "unprognostic (1.37e-2)" "unprognostic (5.05e-3)" "unprognostic (1.52e-2)" "prognostic unfavorable (9.46e-4)" "unprognostic (1.27e-3)" "unprognostic (2.58e-1)" "unprognostic (1.83e-2)" "unprognostic (1.43e-2)" "unprognostic (2.64e-2)" "unprognostic (3.14e-2)" "prognostic favorable (1.78e-15)" "unprognostic (9.82e-2)" "unprognostic (5.27e-2)" "unprognostic (7.44e-3)" "unprognostic (1.41e-1)" 16.8 15.7 30.4 10.1 51.9 3.3 11.6 27.1 59.3 15.3 11.4 14.9 10.6 10.8 14.1 21.7 15.9 26.8 11.7 23.1 28.3 27.0 11.3 8.0 13.1 8.8 21.5 34.9 26.4 20.4 26.5 20.3 8.0 34.2 18.3 10.0 15.6 23.3 25.1 7.4 13.0 9.8 18.3 14.0 9.8 13.4 4.9 12.2 3.7 20.2 6.6 11.4 12.4 11.4 9.4 9.4 26.7 18.4 9.7 21.0 15.6 12.5 19.6 2.5 5.2 20.9 10.4 3.3 19.4 10.0 7.3 4.7 3.2 10.6 8.1 16.1 23.6 8.9 11.7 3.4 14.7 4.8 8.8 5.2 5.2 11.9 7.3 15.7 9.7 9.2 9.4 23.2 10.4 16.1 14.5 15.0 4.3 4.4 20.6 12.7 27.2 6.9 5.0 1.4 10.2 13.8 3.1 4.3 16.7 9.2 10.1 4.4 4.2 16.6 15.4 7.8 1.4 14.4 7.6 20.8 8.3 8.5 18.8 13.1 11.6 10.3 2.4 24.5 8.6 10.1 15.5 9.8 26.7 21.0 17.5 20.1 9.4 14.5 16.9 9.4 7.5 12.5 14.6 15.5 9.7 18.4 4.5 8.0 15.6 30.4 51.9 27.1 59.3 28.3 27.0 21.5 34.9 34.2 12.2 3.0 8.5 12.3 16.4 5.0 40.6 16.7 22.9 21.4 9.1 17.4 7.9 5.4 10.0 26.1 0.2 16.6 10.3 0.0 31.6 11.7 12.3 17.1 9.3 8.1 10.7 41.3 11.1 15.4 10.0 1.1 15.0 8.1 10.1 16.2 11.7 29.5 23.5 8.2 31.1 12.6 20.2 19.4 23.4 3.0 4.5 8.3 3.5 10.2 7.3 13.7 SPRYD4 DKFZp686N0877 ENSG00000176422 "SPRY domain containing 4" Q8WW59 12 56468567-56479707 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 58.4" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 141.7;Proximal tubular cells: 76.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053469 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA053469: AB_2682162" "unprognostic (1.14e-1)" "unprognostic (1.20e-1)" "unprognostic (8.00e-2)" "prognostic unfavorable (8.85e-5)" "unprognostic (7.76e-2)" "unprognostic (1.20e-1)" "unprognostic (3.06e-3)" "prognostic favorable (4.52e-4)" "unprognostic (5.59e-3)" "unprognostic (1.19e-2)" "unprognostic (3.14e-2)" "unprognostic (9.98e-2)" "unprognostic (1.27e-3)" "unprognostic (1.81e-1)" "unprognostic (1.69e-1)" "unprognostic (3.44e-1)" "unprognostic (1.14e-1)" 3.8 9.6 3.3 6.0 4.6 4.4 6.2 4.2 6.1 3.8 5.1 6.0 6.7 4.2 4.5 6.3 7.1 3.8 7.4 7.2 3.6 3.6 12.0 58.4 3.1 3.5 4.4 4.3 4.9 12.3 5.0 7.0 4.3 3.7 5.2 6.5 5.8 8.2 6.3 10.5 4.6 6.4 4.3 3.3 4.8 5.0 2.6 3.3 3.8 7.6 7.3 6.1 5.2 4.1 4.6 5.0 3.8 3.8 4.8 3.2 2.5 2.8 3.7 3.2 2.5 2.9 1.8 4.4 2.3 2.4 4.9 3.0 3.4 5.0 3.5 3.1 3.0 3.4 4.9 2.7 4.0 3.1 1.7 5.7 5.1 3.8 5.1 2.8 3.5 5.1 4.1 2.6 3.6 2.9 2.6 5.0 2.4 2.7 15.2 4.1 4.6 1.7 2.5 2.1 3.2 4.3 2.1 2.4 7.3 5.2 3.6 3.3 1.5 4.5 5.4 3.4 2.1 9.2 1.0 2.4 2.2 4.0 3.1 1.8 2.6 1.4 1.2 1.8 3.0 2.6 3.8 3.8 2.0 3.0 3.0 3.2 3.8 2.8 3.0 3.3 4.6 3.2 3.2 3.8 4.8 3.2 5.0 1.2 2.5 3.3 4.6 4.2 6.1 3.6 3.6 4.4 4.3 3.7 3.3 0.0 6.1 11.9 15.2 4.2 13.4 14.0 12.7 2.7 3.4 21.0 15.7 33.1 46.4 21.4 1.0 5.8 18.7 23.3 18.6 19.0 6.1 9.3 10.3 141.7 18.2 15.9 16.8 8.0 10.7 0.5 8.3 5.4 5.0 13.6 14.3 10.1 19.6 7.0 9.9 76.7 17.4 0.0 5.1 4.7 9.7 4.5 30.1 5.2 16.1 17.8 SPSB4 SSB-4 ENSG00000175093 "SplA/ryanodine receptor domain and SOCS box containing 4" Q96A44 3 141051402-141148611 "Predicted intracellular proteins" "Biological rhythms, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pancreas: 22.0" "Cell type enhanced" "Detected in some" 22 "Early spermatids: 18.4;Kupffer cells: 4.1;Late spermatids: 6.3;Spermatocytes: 7.6" "Group enriched" "Detected in some" 5 "glioma: 4.6;testis cancer: 2.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 16.2;NTERA-2: 4.6;RH-30: 5.5;SH-SY5Y: 4.6;U-2 OS: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA062793 Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA062793: AB_2732689" "unprognostic (5.07e-1)" "unprognostic (1.54e-1)" "unprognostic (1.12e-1)" "unprognostic (1.23e-3)" "prognostic favorable (3.72e-4)" "unprognostic (7.49e-2)" "unprognostic (6.58e-2)" "unprognostic (1.76e-1)" "unprognostic (8.48e-2)" "unprognostic (2.47e-1)" "unprognostic (1.15e-1)" "unprognostic (2.36e-1)" "unprognostic (1.06e-2)" "unprognostic (1.47e-3)" "unprognostic (2.30e-2)" "unprognostic (2.46e-4)" "unprognostic (9.80e-3)" 0.8 0.9 1.0 0.2 1.5 0.2 0.2 0.2 2.0 0.1 0.3 0.7 0.0 0.2 0.1 0.3 0.2 0.1 0.2 2.2 1.1 1.1 0.4 0.3 1.3 3.2 1.5 0.6 0.1 22.0 0.1 4.6 0.2 1.2 0.2 0.1 0.0 0.1 0.1 1.7 0.2 0.2 0.2 1.9 2.5 0.1 3.6 0.2 0.1 0.1 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 16.2 0.3 0.0 0.0 2.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.5 1.1 0.0 4.6 0.0 0.0 0.0 5.5 0.8 0.0 0.0 1.4 4.6 0.0 0.0 0.0 2.7 0.3 0.4 0.0 0.0 3.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 1.5 0.2 1.2 1.1 1.1 1.5 0.6 1.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.1 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 7.6 0.7 0.0 0.1 0.0 0.0 0.0 SPTBN4 "KIAA1642, SPTBN3" ENSG00000160460 "Spectrin beta, non-erythrocytic 4" Q9H254 19 40466241-40576464 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Deafness, Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 36.3" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 55.4;Cone photoreceptor cells: 53.0;Horizontal cells: 69.9;Rod photoreceptor cells: 67.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 3.5;Karpas-707: 5.1;SCLC-21H: 8.0;SH-SY5Y: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054481 Enhanced Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA054481: AB_2682502" "unprognostic (1.97e-3)" "unprognostic (1.02e-1)" "unprognostic (5.65e-4)" "unprognostic (3.72e-4)" "unprognostic (7.79e-3)" "unprognostic (9.77e-2)" "unprognostic (2.62e-1)" "unprognostic (2.50e-2)" "unprognostic (3.19e-2)" "unprognostic (1.65e-1)" "unprognostic (1.78e-4)" "unprognostic (4.54e-1)" "unprognostic (2.55e-2)" "unprognostic (6.79e-2)" "unprognostic (1.42e-1)" "unprognostic (1.85e-2)" "unprognostic (2.02e-1)" 3.1 5.9 13.4 1.2 15.3 1.2 1.2 36.3 27.1 1.4 1.3 1.8 0.0 1.7 2.3 1.3 1.6 2.0 1.8 3.3 9.8 10.8 1.9 1.3 1.2 1.0 7.5 13.0 4.1 3.0 3.3 8.0 1.0 10.4 2.8 1.1 2.6 2.2 2.0 5.1 1.3 1.5 1.8 2.8 1.3 2.5 3.5 3.7 0.0 1.6 0.0 1.0 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.6 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.4 2.3 2.0 0.4 0.1 0.0 0.0 0.0 0.0 0.4 2.4 0.5 0.0 0.0 0.3 0.0 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.3 3.5 5.1 0.0 1.3 0.0 0.0 0.2 0.3 0.9 0.5 0.0 1.1 0.0 0.0 8.0 4.9 0.1 0.2 0.0 0.1 0.7 0.0 0.0 0.0 1.5 0.8 0.0 0.2 0.3 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 15.3 36.3 22.7 9.8 10.8 7.5 13.0 10.4 3.7 0.0 0.0 0.0 0.1 0.1 55.4 4.4 0.0 0.0 0.0 0.0 53.0 0.0 0.0 0.1 3.5 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.8 0.2 69.9 15.6 0.6 0.3 0.9 7.5 0.0 1.7 1.0 0.3 4.7 0.2 0.0 6.7 1.4 67.0 0.0 0.9 3.2 4.6 0.4 0.0 0.0 0.2 0.1 SPTY2D1 "DKFZp686I068, FLJ39441, Spt2" ENSG00000179119 "SPT2 chromatin protein domain containing 1" Q68D10 11 18606401-18634791 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039372, HPA040177, HPA047957" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA039372: AB_2676472, HPA040177: , HPA047957: AB_2680224" "unprognostic (8.43e-2)" "unprognostic (1.50e-1)" "unprognostic (8.62e-2)" "unprognostic (2.16e-1)" "unprognostic (1.73e-2)" "unprognostic (1.03e-1)" "unprognostic (1.51e-2)" "unprognostic (5.42e-2)" "unprognostic (1.74e-1)" "unprognostic (2.48e-1)" "prognostic unfavorable (2.59e-4)" "unprognostic (2.03e-1)" "prognostic favorable (2.07e-4)" "unprognostic (1.33e-2)" "unprognostic (1.75e-1)" "unprognostic (1.21e-1)" "unprognostic (3.33e-1)" 14.0 12.7 6.2 9.7 9.2 33.6 11.9 10.9 10.9 13.7 10.9 6.9 9.9 8.3 11.9 8.6 15.5 12.5 12.2 9.9 5.8 6.5 14.9 25.1 9.7 8.7 6.0 6.8 16.7 16.9 13.6 14.0 15.3 8.5 12.5 9.7 7.9 13.3 13.9 16.3 12.5 13.7 9.3 7.6 15.0 11.0 7.1 5.5 17.7 12.8 8.0 13.3 12.5 11.8 2.7 3.4 7.8 5.7 7.3 8.7 3.3 8.2 8.1 6.5 9.1 10.9 11.4 10.0 12.2 13.4 10.2 12.3 7.2 3.6 18.5 6.9 11.5 8.0 8.6 10.8 9.6 14.7 9.7 10.1 7.4 4.9 6.6 10.5 15.6 14.8 9.4 10.0 6.5 13.3 7.4 11.2 11.1 10.3 29.5 11.3 8.9 10.4 6.2 5.9 16.2 9.1 9.6 18.1 7.9 10.7 11.9 6.3 8.9 10.9 12.7 8.5 8.9 7.9 6.7 9.8 10.0 8.5 19.4 7.4 10.3 12.7 14.5 11.9 8.7 8.4 7.8 4.1 5.8 5.7 5.7 8.7 2.6 5.6 5.7 3.4 2.7 5.2 5.6 6.0 7.3 5.4 2.9 6.0 3.3 6.2 9.2 10.9 10.9 5.8 6.5 6.0 6.8 8.5 5.5 23.8 45.0 23.8 18.6 49.6 12.8 23.6 12.7 61.6 34.2 26.2 9.8 12.3 14.9 21.5 1.6 21.9 22.7 0.0 21.7 19.7 31.0 20.1 56.6 25.6 14.3 11.1 42.5 21.5 27.0 1.7 17.5 31.7 15.1 13.6 24.2 13.8 21.6 22.1 13.1 12.6 11.2 32.3 23.0 10.7 14.2 58.1 23.0 35.5 18.6 29.3 SRA1 "SRA, STRAA1" ENSG00000213523 "Steroid receptor RNA activator 1" Q9HD15 5 140537340-140558252 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Activator, Receptor, Ribonucleoprotein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 26.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044598, HPA050153" Approved Supported Nucleoplasm,Microtubules,Cytosol NA NA Nucleoplasm "Microtubules, Cytosol" "HPA044598: AB_2679013, HPA050153: AB_2681033" "unprognostic (1.51e-1)" "unprognostic (1.04e-2)" "unprognostic (8.69e-2)" "prognostic favorable (8.01e-6)" "unprognostic (9.32e-2)" "unprognostic (2.56e-1)" "unprognostic (2.90e-1)" "unprognostic (2.43e-1)" "unprognostic (9.38e-2)" "unprognostic (7.41e-2)" "unprognostic (5.58e-3)" "unprognostic (2.61e-1)" "unprognostic (5.34e-2)" "unprognostic (3.10e-2)" "unprognostic (3.01e-2)" "unprognostic (3.71e-1)" "unprognostic (1.04e-1)" 4.8 9.9 2.5 4.8 3.0 5.6 2.7 13.3 3.5 2.5 3.3 3.1 3.0 4.1 2.5 2.6 3.5 4.3 2.7 3.0 3.5 14.4 4.4 3.5 2.2 4.9 2.7 4.5 7.7 3.7 3.7 3.0 5.5 4.4 4.4 3.9 3.4 3.4 2.1 5.7 4.6 6.8 4.1 3.1 2.3 2.3 9.0 15.6 26.9 16.4 7.5 11.3 14.2 6.2 15.0 8.0 8.3 3.9 5.3 11.2 10.7 6.1 7.0 7.4 27.4 3.9 5.3 7.9 4.1 3.7 4.2 1.4 7.9 2.8 8.2 9.3 4.7 16.3 10.4 8.3 8.4 6.4 10.2 4.1 3.7 1.9 6.2 3.2 9.2 4.7 8.2 4.6 19.1 6.8 13.2 2.4 3.4 12.1 7.6 6.8 5.1 3.6 7.5 5.7 6.6 6.2 5.7 7.2 2.9 7.0 9.6 5.0 6.7 3.5 5.7 8.6 10.3 6.8 5.6 8.2 11.0 4.3 8.1 16.4 12.0 7.0 14.3 6.5 9.0 6.8 6.7 15.6 7.4 5.6 6.4 26.9 7.5 13.3 9.3 11.3 14.2 6.0 53.3 35.8 43.2 46.5 23.0 70.0 68.8 34.8 30.7 31.4 7.9 84.2 96.2 79.1 75.5 39.4 72.4 0.0 128.7 102.6 52.4 64.7 66.9 57.8 81.7 14.3 36.9 43.6 67.7 108.8 23.3 67.0 64.1 111.0 51.7 47.0 131.8 77.2 28.0 111.7 19.5 25.8 48.6 45.0 29.2 40.1 149.7 55.1 40.7 117.5 SRARP "C1orf64, ERRF, MGC24047" ENSG00000183888 "Steroid receptor associated and regulated protein" Q8NEQ6 1 16004236-16008807 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.0;breast: 14.7" "Cell type enriched" "Detected in single" 763 "Distal tubular cells: 76.3" "Cancer enhanced" "Detected in some" "breast cancer: 7.7;prostate cancer: 6.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 5.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 5.3" "Group enriched" "Detected in some" 12 "Hep G2: 9.2;SK-BR-3: 16.5;T-47d: 5.3" "Low region specificity" "Detected in all" HPA026676 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA026676: AB_1853866" "unprognostic (8.55e-2)" "unprognostic (1.01e-1)" "prognostic favorable (1.68e-6)" "unprognostic (3.32e-2)" "unprognostic (1.09e-2)" "unprognostic (1.45e-2)" "unprognostic (1.41e-2)" "unprognostic (3.49e-1)" "unprognostic (8.25e-2)" "unprognostic (1.40e-2)" "unprognostic (1.81e-1)" "unprognostic (2.53e-1)" "unprognostic (1.65e-3)" "unprognostic (6.32e-2)" 0.9 1.1 12.8 1.2 19.9 2.2 14.7 7.5 19.3 6.6 0.8 3.5 0.0 1.3 3.8 1.2 1.1 0.8 1.1 1.5 14.1 6.4 2.7 0.9 0.9 1.3 12.8 7.2 1.1 1.1 0.6 0.3 1.0 22.0 2.5 0.8 0.0 8.6 0.8 2.2 2.2 0.9 0.6 7.8 1.1 1.4 1.1 16.6 0.0 3.8 0.0 0.7 1.2 0.3 0.8 0.5 5.3 0.4 1.0 0.6 0.1 0.4 0.1 0.4 0.5 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.1 0.4 0.5 0.2 0.0 0.4 0.3 0.0 0.0 0.0 0.2 0.1 0.5 0.7 9.2 0.0 0.4 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.5 0.7 0.7 0.0 0.5 0.3 0.4 0.1 0.2 0.2 0.2 0.3 0.2 0.0 0.1 0.5 0.8 0.3 16.5 0.3 0.6 5.3 0.5 0.2 0.6 0.4 0.5 0.1 0.3 0.6 0.3 0.2 0.3 0.7 2.0 0.4 0.5 0.5 0.3 0.4 0.4 0.4 0.5 0.1 0.8 0.6 0.6 5.3 1.0 0.3 0.5 0.2 0.1 12.8 19.9 7.5 19.3 14.1 6.4 12.8 7.2 22.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 76.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SRC "ASV, c-src, SRC1" ENSG00000197122 "SRC proto-oncogene, non-receptor tyrosine kinase" P12931 20 37344685-37406050 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell adhesion, Cell cycle, Host-virus interaction, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 5.3;non-classical monocyte: 4.4" "Group enriched" "Detected in many" 6 "dendritic cells: 3.0;monocytes: 5.3" "Cell line enhanced" "Detected in many" "A549: 35.9;HBEC3-KT: 33.4;RT4: 34.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004023, HPA030875" Approved Supported "Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol" NA NA 20000000 "Plasma membrane, Cell Junctions" "Nucleoplasm, Cytosol" "CAB004023: AB_2106059, HPA030875: AB_2673640" "unprognostic (5.58e-2)" "unprognostic (9.83e-2)" "unprognostic (3.56e-1)" "unprognostic (4.54e-3)" "unprognostic (1.52e-1)" "unprognostic (1.54e-2)" "prognostic unfavorable (4.90e-5)" "unprognostic (3.89e-2)" "unprognostic (7.04e-2)" "unprognostic (8.13e-2)" "unprognostic (1.54e-2)" "prognostic unfavorable (1.63e-4)" "prognostic unfavorable (1.22e-4)" "unprognostic (2.33e-2)" "unprognostic (4.72e-2)" "unprognostic (3.65e-2)" "prognostic favorable (5.22e-5)" 6.9 17.5 12.8 11.1 12.0 5.4 9.9 6.4 16.0 16.0 16.4 3.5 15.1 29.5 20.3 9.7 16.2 14.2 42.1 5.8 11.3 6.6 13.4 2.9 10.4 7.0 3.3 9.9 15.8 19.1 6.6 11.3 6.3 5.1 19.9 13.1 13.1 7.5 22.5 3.4 7.7 28.1 27.2 3.6 12.2 29.8 27.3 4.8 4.0 6.6 10.5 10.4 26.4 20.0 0.3 3.0 0.1 5.3 0.6 0.1 1.6 7.7 35.9 8.3 7.4 3.1 5.0 17.2 7.2 6.2 8.8 5.6 13.5 7.0 0.2 4.5 13.0 10.0 14.2 4.9 33.4 3.4 0.0 4.5 2.0 1.3 20.9 7.5 0.1 3.1 5.3 11.4 5.7 7.7 9.8 8.0 4.6 0.2 0.0 1.4 5.3 1.9 0.2 3.9 21.5 32.6 8.4 2.2 0.2 3.7 34.4 7.7 27.9 8.1 11.4 8.9 6.6 10.2 2.8 11.6 10.5 7.1 3.8 6.4 0.1 0.2 0.1 7.4 0.0 7.8 0.0 2.6 0.0 0.0 5.3 0.0 0.3 0.0 0.1 1.1 0.3 0.0 0.0 0.1 0.6 4.4 3.0 0.1 1.6 12.8 12.0 6.4 16.0 11.3 6.6 3.3 9.9 5.1 4.8 3.0 1.7 4.4 10.8 7.2 5.4 1.6 15.3 1.4 0.0 12.2 2.0 1.6 1.7 9.7 1.3 1.4 30.0 0.0 16.2 7.0 8.2 11.2 0.0 0.9 5.8 3.2 16.1 1.3 6.9 1.5 10.0 12.1 1.7 7.2 25.9 4.1 29.0 18.1 16.3 9.5 4.7 12.9 6.4 0.2 0.7 8.0 1.9 0.0 14.9 27.7 SRCAP "DOMO1, EAF1, KIAA0309, SWR1" ENSG00000080603 "Snf2 related CREBBP activator protein" Q6ZRS2 16 30698209-30741409 "Disease related genes, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 21.9;Suprabasal keratinocytes: 50.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA028929 Approved Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA028929: AB_10601265" "unprognostic (1.26e-1)" "unprognostic (1.35e-1)" "unprognostic (5.07e-1)" "unprognostic (6.57e-2)" "unprognostic (1.78e-1)" "unprognostic (6.95e-2)" "unprognostic (8.59e-2)" "unprognostic (2.34e-2)" "unprognostic (3.77e-1)" "unprognostic (6.45e-2)" "unprognostic (4.36e-2)" "unprognostic (8.57e-2)" "unprognostic (1.16e-2)" "unprognostic (2.09e-1)" "unprognostic (4.11e-2)" "unprognostic (7.71e-2)" "unprognostic (1.07e-1)" 13.5 15.5 15.4 17.1 15.6 23.6 13.6 24.8 18.1 14.8 16.3 20.4 14.0 14.1 23.6 12.0 13.0 15.1 16.0 11.9 11.5 9.3 10.5 9.3 11.6 13.9 18.2 10.8 17.2 17.8 31.2 18.2 16.3 13.0 14.1 10.3 17.5 17.2 13.4 23.5 14.8 18.0 13.4 12.6 16.0 15.9 22.4 14.0 20.5 17.4 10.1 15.1 21.4 12.7 3.2 2.3 6.2 3.2 1.7 2.4 1.5 13.8 27.4 16.5 16.8 13.0 9.3 17.8 10.5 9.7 12.1 9.7 13.0 10.2 28.8 14.5 13.3 8.3 13.9 17.1 13.1 10.0 18.6 39.3 18.3 24.0 11.1 5.8 21.2 22.2 9.7 6.5 18.1 14.9 6.2 12.3 9.7 28.1 16.3 8.8 17.1 18.1 8.4 17.2 5.8 12.3 25.3 13.0 16.5 3.8 16.0 16.0 16.6 11.7 15.3 4.5 5.8 17.3 12.0 19.8 17.2 12.6 9.7 14.0 18.6 15.7 21.2 13.8 11.2 13.1 0.7 1.8 6.2 2.4 3.2 1.9 1.8 1.3 2.4 1.3 3.2 1.3 1.1 5.4 1.7 0.8 2.3 2.1 1.5 15.4 15.6 24.8 18.1 11.5 9.3 18.2 10.8 13.0 14.0 3.0 3.0 1.9 1.7 21.9 7.6 1.4 2.5 0.0 2.3 1.8 7.9 2.0 0.0 1.0 0.8 1.7 4.7 0.0 2.7 1.1 1.7 2.4 2.3 2.9 2.0 7.9 10.9 1.8 0.3 0.5 2.6 1.7 10.1 2.8 2.8 2.9 1.5 1.7 1.1 0.5 5.5 0.0 3.9 4.7 5.1 50.8 2.1 4.3 2.7 2.5 SREBF1 "bHLHd1, SREBP-1c, SREBP1, SREBP1a" ENSG00000072310 "Sterol regulatory element binding transcription factor 1" P36956 17 17810399-17837002 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.7" "Group enriched" "Detected in many" 4 "granulocytes: 4.7;T-cells: 2.2" "Cell line enhanced" "Detected in many" "RPMI-8226: 50.5;SK-BR-3: 49.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005406, HPA043343, HPA043878" Uncertain Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus, Cytosol" "CAB005406: AB_2194226, HPA043343: AB_2678439, HPA043878: AB_2678710" "unprognostic (9.29e-2)" "unprognostic (1.12e-1)" "unprognostic (2.28e-2)" "prognostic favorable (2.66e-4)" "unprognostic (4.50e-2)" "unprognostic (1.05e-2)" "unprognostic (9.85e-2)" "unprognostic (1.15e-1)" "unprognostic (3.14e-2)" "unprognostic (9.02e-3)" "prognostic favorable (9.05e-4)" "unprognostic (3.12e-1)" "unprognostic (9.02e-3)" "unprognostic (1.11e-2)" "unprognostic (1.20e-1)" "unprognostic (7.65e-2)" "unprognostic (2.36e-3)" 34.0 78.2 16.4 9.3 17.9 14.8 15.5 5.8 22.3 15.7 13.8 31.9 30.4 28.9 8.6 23.4 20.5 15.7 17.6 10.2 13.5 10.3 9.0 49.9 11.9 14.4 20.3 16.7 20.5 7.7 9.6 12.5 16.0 11.8 18.0 6.4 15.1 72.7 33.0 16.8 14.5 27.4 7.1 13.1 7.3 13.6 16.8 16.2 15.2 9.5 13.6 13.8 11.9 15.0 0.6 0.4 4.7 0.8 0.4 2.2 0.5 14.0 33.0 4.1 25.4 8.4 15.4 7.1 5.2 16.5 4.5 11.0 6.7 27.3 8.8 4.9 4.1 4.2 40.0 4.7 13.8 1.1 5.4 2.0 4.8 27.4 7.0 10.5 0.6 9.2 12.0 5.9 6.3 3.9 3.5 5.1 20.1 9.3 31.6 1.0 34.5 11.6 8.1 5.5 10.8 6.6 8.3 3.0 50.5 3.6 7.3 4.9 20.2 6.1 49.0 14.5 3.0 16.6 9.3 5.8 2.4 12.2 5.8 3.2 9.3 0.8 4.0 14.2 6.9 12.6 0.0 0.8 0.4 1.8 0.5 0.4 0.6 0.8 0.3 0.4 0.4 1.6 2.2 4.7 0.4 0.6 0.3 0.2 0.5 16.4 17.9 5.8 22.3 13.5 10.3 20.3 16.7 11.8 16.2 6.0 17.5 8.2 12.6 8.2 22.4 7.3 17.8 5.3 11.4 19.2 27.5 4.6 1.7 13.5 1.8 8.9 29.9 0.0 20.4 13.9 14.1 19.0 14.9 58.7 10.6 55.6 28.7 12.9 10.4 3.0 27.6 8.3 8.5 13.6 18.3 29.8 13.8 13.5 10.3 5.4 29.3 12.9 10.4 11.3 5.8 15.9 16.6 7.5 21.1 21.3 SREBF2 "bHLHd2, SREBP2" ENSG00000198911 "Sterol regulatory element binding transcription factor 2" Q12772 22 41833079-41907308 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031962, HPA031963" Approved Supported "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA "Nucleoplasm, Vesicles" "Endoplasmic reticulum" "HPA031962: AB_10601266, HPA031963: AB_2674090" "unprognostic (6.53e-2)" "unprognostic (6.07e-2)" "unprognostic (1.75e-2)" "unprognostic (1.50e-3)" "unprognostic (3.41e-3)" "unprognostic (9.08e-2)" "unprognostic (5.04e-2)" "unprognostic (1.31e-1)" "unprognostic (4.78e-1)" "unprognostic (1.04e-2)" "unprognostic (2.30e-1)" "unprognostic (9.85e-2)" "prognostic favorable (1.37e-4)" "unprognostic (4.68e-2)" "unprognostic (1.92e-2)" "unprognostic (3.22e-1)" "unprognostic (7.93e-3)" 13.9 45.2 42.9 19.6 41.7 18.2 16.3 51.9 66.5 16.5 27.7 32.7 22.3 26.1 19.4 41.5 42.4 18.9 28.7 33.9 37.3 33.6 18.9 20.4 27.9 21.1 21.7 38.4 22.7 29.7 34.2 17.4 15.8 34.2 22.8 20.9 25.4 29.0 20.0 17.2 32.9 22.3 19.8 24.7 16.0 30.2 13.5 21.0 15.6 14.3 20.5 26.1 17.1 19.0 9.6 8.4 2.0 5.5 1.8 6.4 4.9 18.4 13.2 35.2 32.7 20.7 27.7 19.7 6.2 20.8 7.3 15.1 15.5 24.5 33.0 8.8 15.1 27.1 31.8 20.1 41.0 5.2 9.2 21.9 16.5 23.3 15.4 34.6 24.0 11.2 25.9 23.3 19.2 24.1 16.9 14.4 18.7 16.9 39.9 7.7 23.5 17.4 18.2 22.3 23.1 10.2 20.2 20.1 52.9 30.5 19.5 14.3 10.7 14.2 26.2 26.3 21.5 16.4 42.9 15.3 9.9 18.6 4.6 7.3 29.2 14.8 26.3 9.7 18.3 15.1 0.0 5.5 2.0 6.4 4.9 4.4 9.6 3.5 4.6 6.6 7.3 3.2 3.6 1.0 1.8 4.0 8.4 2.1 4.9 42.9 41.7 51.9 66.5 37.3 33.6 21.7 38.4 34.2 21.0 41.7 33.4 16.0 10.9 14.4 35.6 26.3 38.2 21.4 18.2 55.8 9.8 22.2 3.3 17.6 15.3 9.8 40.6 0.0 37.7 17.9 14.6 18.9 12.7 20.4 12.4 54.0 47.2 6.7 13.8 5.3 29.1 8.0 6.8 21.6 38.3 18.8 30.8 24.6 25.8 4.5 16.2 19.4 18.4 7.7 15.8 24.6 30.6 13.1 31.8 20.2 SREK1 "DKFZp564B176, SFRS12, SRrp508, SRrp86" ENSG00000153914 "Splicing regulatory glutamic acid and lysine rich protein 1" Q8WXA9 5 66139971-66183615 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037673, HPA037674, HPA059332" Enhanced Enhanced "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA037673: AB_2675598, HPA037674: AB_10671376, HPA059332: AB_2683983" "unprognostic (1.38e-1)" "unprognostic (2.51e-1)" "unprognostic (6.16e-2)" "unprognostic (1.52e-1)" "unprognostic (9.40e-2)" "prognostic favorable (2.54e-4)" "unprognostic (1.29e-2)" "unprognostic (7.67e-2)" "unprognostic (5.66e-3)" "unprognostic (2.19e-1)" "unprognostic (2.66e-2)" "unprognostic (5.48e-2)" "prognostic unfavorable (5.77e-4)" "unprognostic (1.63e-1)" "unprognostic (3.08e-1)" "unprognostic (6.76e-2)" "unprognostic (6.69e-2)" 11.1 13.4 12.8 15.6 14.5 38.0 16.3 24.2 14.7 12.9 10.1 8.9 17.3 10.9 18.5 15.9 9.6 13.6 10.6 8.2 12.4 13.3 10.6 10.5 12.5 12.7 11.1 12.0 12.2 14.3 23.4 30.3 12.2 11.4 12.2 10.7 11.9 12.4 16.5 11.9 20.2 12.6 13.7 11.3 14.9 11.0 11.0 11.4 19.5 14.3 9.8 9.5 10.6 10.5 6.5 6.0 8.5 5.6 7.7 6.0 2.8 5.1 6.3 8.9 5.3 4.2 7.9 8.8 6.0 3.5 3.3 3.5 9.3 6.0 7.7 7.7 4.6 4.4 6.9 4.5 6.0 5.8 5.4 10.2 7.3 16.2 6.8 3.7 6.6 8.6 4.6 6.0 4.0 4.5 6.9 5.2 4.5 6.6 5.6 3.5 5.0 6.9 15.5 4.7 2.1 3.2 9.3 4.1 5.5 5.7 9.3 10.5 7.1 5.7 2.7 4.9 6.9 6.8 8.6 5.5 5.3 3.2 7.2 6.1 6.0 4.1 8.7 5.2 10.7 5.7 8.5 5.6 5.2 5.0 3.9 5.4 6.2 4.7 6.0 4.2 6.5 5.6 5.6 4.1 7.7 3.7 6.0 4.4 2.8 12.8 14.5 24.2 13.8 12.4 13.3 11.1 12.0 11.4 11.4 86.4 149.8 64.8 77.1 58.6 59.7 64.9 66.2 132.5 117.2 43.6 110.0 73.9 31.5 45.7 31.9 85.0 41.6 70.0 48.3 73.9 67.2 73.1 94.7 57.6 44.0 63.5 74.7 58.3 48.5 44.8 77.3 55.5 40.5 37.9 43.9 86.7 44.4 37.0 72.2 27.8 96.5 45.3 63.8 65.4 57.5 60.6 100.9 61.0 47.2 68.6 SREK1IP1 "FLJ36754, P18SRP, SFRS12IP1" ENSG00000153006 "SREK1 interacting protein 1" Q8N9Q2 5 64718144-64768685 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 266.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045677, HPA062853" Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045677: AB_10964635, HPA062853: AB_2684881" "unprognostic (1.19e-1)" "unprognostic (3.61e-1)" "unprognostic (2.17e-2)" "unprognostic (1.06e-1)" "unprognostic (1.51e-1)" "unprognostic (1.22e-1)" "prognostic unfavorable (9.03e-4)" "unprognostic (1.51e-1)" "unprognostic (2.13e-1)" "unprognostic (8.60e-3)" "unprognostic (8.67e-2)" "unprognostic (1.20e-2)" "prognostic unfavorable (9.68e-4)" "unprognostic (2.67e-1)" "unprognostic (8.39e-2)" "unprognostic (3.85e-2)" "unprognostic (1.99e-1)" 16.3 12.1 12.2 10.9 16.5 8.3 13.8 13.9 12.8 17.0 16.1 4.1 10.8 8.6 12.5 12.4 25.3 10.8 11.6 13.1 12.3 10.7 18.0 13.1 13.2 12.1 10.6 9.5 14.6 11.7 10.8 20.5 20.2 11.9 15.5 10.4 4.7 10.3 15.0 15.7 18.7 15.2 12.6 15.5 19.0 10.9 11.7 11.5 19.2 13.9 17.9 12.3 24.1 14.6 4.0 8.2 3.8 4.1 4.1 4.7 2.1 7.0 3.6 9.2 7.0 8.3 13.7 5.5 10.7 8.6 7.3 9.8 6.7 7.7 7.3 11.0 8.5 7.0 4.6 8.3 16.1 12.9 8.7 10.1 8.0 6.7 5.9 8.5 8.5 8.1 9.0 15.3 10.2 13.3 7.8 10.8 9.2 7.0 4.5 8.6 2.5 15.1 8.6 4.7 1.9 4.9 7.3 7.5 11.6 12.5 5.6 4.0 5.9 6.7 4.8 10.2 6.7 6.1 16.5 10.9 5.4 3.2 6.4 11.0 6.7 11.3 6.5 10.2 13.4 7.2 3.8 4.1 1.7 4.5 3.0 4.7 3.9 4.6 4.2 3.4 4.0 4.5 4.7 1.6 4.1 1.9 8.2 4.0 2.1 12.2 16.5 13.9 12.8 12.3 10.7 10.6 9.5 11.9 11.5 44.7 36.1 35.8 47.3 72.7 50.8 26.2 76.5 41.5 43.3 82.0 29.5 62.3 76.3 67.8 266.8 54.7 61.7 46.7 64.6 64.7 50.4 43.7 52.0 85.5 55.9 92.2 58.6 78.5 70.9 129.9 88.6 70.4 37.1 46.9 60.5 43.1 140.5 64.5 68.2 63.3 36.0 64.7 57.4 32.7 40.7 90.8 40.7 54.9 45.7 82.3 SRF MCM1 ENSG00000112658 "Serum response factor" P11831 6 43171299-43181507 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 98.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001819, CAB005416" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB005416: AB_2255249, HPA001819: AB_1079928" "unprognostic (1.44e-3)" "unprognostic (1.09e-1)" "unprognostic (5.39e-3)" "unprognostic (2.66e-2)" "unprognostic (1.19e-1)" "unprognostic (1.47e-2)" "unprognostic (4.60e-2)" "unprognostic (9.84e-2)" "unprognostic (4.28e-2)" "unprognostic (2.21e-2)" "unprognostic (6.72e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (2.01e-5)" "unprognostic (5.31e-2)" "unprognostic (1.59e-1)" "unprognostic (5.10e-2)" "unprognostic (1.97e-2)" 17.7 8.1 10.7 15.6 12.3 14.1 12.9 11.6 14.5 24.9 38.1 10.6 17.9 8.1 35.3 14.9 28.2 24.8 23.7 30.6 9.4 6.5 10.5 11.3 13.9 11.8 7.8 6.2 25.6 13.1 13.8 10.1 14.1 7.5 26.9 9.4 15.4 8.7 29.9 29.7 10.2 16.8 47.9 5.4 18.2 20.8 10.0 8.1 16.1 14.9 14.6 13.2 36.0 17.7 1.9 3.7 4.7 2.9 1.1 3.1 1.0 16.6 6.7 15.5 10.2 9.2 7.6 22.9 15.3 12.6 13.3 8.3 17.8 5.0 21.1 14.0 16.3 16.8 13.5 15.8 13.4 11.7 23.2 15.5 19.1 13.1 17.5 17.6 17.8 23.3 13.0 14.7 20.4 15.1 12.6 11.0 18.4 13.5 16.6 10.0 17.9 22.0 15.6 10.8 37.6 8.2 16.9 15.9 7.5 9.7 10.8 9.1 8.3 12.5 9.6 15.1 12.5 9.8 33.2 13.3 15.8 12.1 15.1 26.1 11.6 9.5 35.5 9.8 12.8 10.6 1.7 1.7 2.9 3.1 2.9 2.5 1.9 1.8 2.3 1.8 1.9 1.4 2.4 4.7 1.1 2.3 3.7 2.1 1.0 10.7 12.3 11.6 14.5 9.4 6.5 7.8 6.2 7.5 8.1 35.7 22.7 0.8 54.0 69.3 5.9 70.5 17.8 14.7 22.7 10.4 19.6 7.6 0.0 11.9 2.0 17.6 20.9 23.3 17.1 18.5 16.9 16.7 7.0 42.9 11.0 9.5 98.0 16.5 14.3 1.1 11.5 7.2 23.6 4.6 25.7 8.7 18.4 17.5 27.3 2.8 7.3 12.9 18.4 3.0 3.2 58.5 10.2 6.9 18.3 29.6 SRGAP2 "ARHGAP34, FNBP2, KIAA0456, SRGAP2A" ENSG00000266028 "SLIT-ROBO Rho GTPase activating protein 2" O75044 1 206203345-206464443 "Disease related genes, Predicted intracellular proteins" Neurogenesis "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 14.1" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 53.8" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA028191, HPA028196, HPA078079" Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA028191: AB_10600309, HPA028196: AB_10601113, HPA078079: " "unprognostic (2.57e-2)" "unprognostic (5.92e-2)" "unprognostic (2.40e-3)" "unprognostic (1.67e-2)" "unprognostic (5.20e-2)" "unprognostic (4.22e-2)" "prognostic unfavorable (9.61e-5)" "unprognostic (1.98e-1)" "unprognostic (2.02e-1)" "unprognostic (2.09e-2)" "unprognostic (3.06e-2)" "unprognostic (6.08e-2)" "prognostic unfavorable (4.61e-7)" "unprognostic (2.70e-2)" "unprognostic (5.02e-2)" "unprognostic (1.45e-1)" "unprognostic (4.18e-3)" 3.5 2.4 2.2 3.3 0.7 4.3 1.3 0.0 0.0 1.4 2.0 1.2 1.7 1.5 0.5 0.7 0.5 2.4 1.9 3.1 0.5 7.4 3.4 0.1 0.1 0.0 0.9 0.0 8.5 0.0 2.3 4.2 0.6 1.0 0.0 1.8 1.1 4.8 12.7 14.1 9.9 1.4 3.0 2.2 19.1 12.9 43.9 11.1 20.9 18.9 17.2 16.6 12.4 14.5 15.9 8.8 14.7 7.5 9.6 18.3 19.4 15.6 13.0 10.9 14.6 9.3 10.6 15.4 23.1 13.2 8.7 10.6 17.3 17.1 9.5 18.6 13.0 15.8 25.1 9.8 12.6 24.4 9.2 13.3 8.4 9.4 14.1 3.4 14.9 19.1 18.0 17.7 6.2 3.5 14.6 6.7 14.1 10.6 20.6 17.2 13.1 18.9 24.9 14.3 17.3 17.5 15.2 16.2 14.5 7.1 17.2 14.8 34.7 0.6 9.3 0.5 2.6 9.4 1.0 2.2 2.1 2.6 6.3 4.8 0.8 1.8 14.1 1.4 9.9 12.7 3.0 2.2 8.9 15.5 13.7 5.2 21.2 41.0 3.3 12.7 4.0 7.9 10.4 3.9 2.9 0.0 5.7 53.8 24.8 0.3 0.0 1.8 17.0 12.3 3.6 8.1 1.5 15.6 1.6 1.2 35.6 37.7 28.5 7.2 27.3 15.1 17.2 1.5 8.2 3.3 0.2 2.5 0.5 5.3 0.0 11.5 7.9 9.4 31.9 3.5 7.5 1.2 4.9 SRI ENSG00000075142 Sorcin P30626 7 88205118-88226993 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 140.7" "Cell type enhanced" "Detected in all" 7 "Enterocytes: 1052.9;Paneth cells: 1613.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019004, HPA073666" Enhanced Supported Nucleoplasm,Cytosol No No 1400000 "Nucleoplasm, Cytosol" "HPA019004: AB_2670006, HPA073666: AB_2686623" "unprognostic (1.86e-2)" "unprognostic (2.31e-3)" "unprognostic (1.89e-2)" "unprognostic (1.73e-2)" "unprognostic (1.31e-1)" "unprognostic (4.42e-3)" "unprognostic (1.24e-3)" "prognostic favorable (3.08e-4)" "unprognostic (9.87e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (9.03e-4)" "unprognostic (1.36e-1)" "unprognostic (2.10e-2)" "unprognostic (1.29e-2)" "unprognostic (9.87e-2)" "unprognostic (8.44e-2)" "unprognostic (3.14e-3)" 20.6 22.0 47.7 24.6 53.5 18.7 22.4 18.9 43.6 24.1 140.7 32.5 7.0 45.3 18.1 33.1 15.6 39.4 14.2 19.4 35.9 40.2 21.7 14.6 21.9 16.6 45.0 44.8 23.3 18.4 12.1 18.3 21.2 36.9 19.5 115.0 11.1 17.7 18.4 8.7 11.1 62.8 25.2 41.9 14.6 16.2 10.0 28.0 9.2 19.7 9.4 19.4 27.0 18.7 29.7 34.5 95.4 42.1 36.3 36.4 32.7 34.4 13.2 35.8 36.8 58.0 49.0 18.0 20.7 33.5 23.4 27.8 12.3 78.2 38.3 21.9 31.4 57.4 34.9 44.9 46.8 30.6 30.8 20.2 19.8 36.4 0.0 35.1 26.4 21.3 50.1 42.9 24.7 36.0 42.0 70.0 24.5 17.5 33.2 32.0 21.7 38.5 18.2 31.4 48.9 26.7 16.0 50.7 21.2 43.5 34.5 25.9 30.7 63.1 36.3 28.8 35.7 17.1 11.8 43.7 43.9 36.8 40.2 36.8 31.1 14.4 41.0 43.1 25.3 74.2 86.5 26.1 95.4 31.0 36.5 36.4 29.7 34.5 35.2 34.5 24.9 25.8 29.8 16.3 36.3 42.1 27.5 34.7 32.7 47.7 53.5 18.9 43.6 35.9 40.2 45.0 44.8 36.9 28.0 80.4 103.8 93.1 338.4 84.4 36.4 95.1 30.6 495.2 193.3 148.3 11.8 123.5 374.7 201.2 45.8 112.5 1052.9 210.2 371.4 826.3 181.0 282.1 132.7 33.9 132.6 44.5 90.6 92.1 77.3 23.0 159.3 104.1 99.5 215.6 393.6 112.7 336.5 1613.2 133.0 124.1 19.7 109.9 144.4 65.6 106.7 94.6 165.0 117.6 448.6 382.7 SRM "SPS1, SRML1" ENSG00000116649 "Spermidine synthase" P19623 1 11054584-11060024 "Enzymes, Predicted intracellular proteins" "Polyamine biosynthesis, Spermidine biosynthesis" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 107.4" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 175.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015746 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA015746: AB_1857472" "unprognostic (4.97e-2)" "unprognostic (1.55e-1)" "unprognostic (1.80e-1)" "unprognostic (2.52e-2)" "unprognostic (1.75e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (2.25e-5)" "unprognostic (2.11e-2)" "unprognostic (2.44e-1)" "unprognostic (3.58e-2)" "unprognostic (3.01e-1)" "unprognostic (3.45e-1)" "prognostic unfavorable (3.80e-8)" "unprognostic (1.74e-2)" "unprognostic (8.98e-3)" "unprognostic (1.36e-1)" "unprognostic (2.98e-2)" 26.7 17.7 20.3 29.0 35.4 15.2 16.9 10.2 30.8 14.3 13.3 14.0 11.5 10.8 18.8 9.8 17.7 15.8 14.2 24.9 19.6 16.9 13.9 45.3 14.0 31.0 15.3 15.0 22.8 107.4 8.0 14.5 14.8 15.6 13.1 11.7 15.0 36.0 17.6 43.6 18.2 9.8 22.9 11.7 21.1 14.5 14.4 14.1 17.9 11.9 21.2 20.8 20.2 19.8 10.7 10.2 0.3 6.0 5.0 10.3 2.0 24.9 36.4 12.1 40.4 24.2 26.2 19.0 38.8 19.9 55.5 29.8 44.8 15.1 48.3 22.9 33.6 17.4 19.6 38.6 31.2 18.5 23.7 58.4 30.4 40.3 50.4 35.6 51.0 27.9 26.2 22.6 53.7 47.2 13.0 23.4 31.6 49.4 40.9 27.0 54.8 43.5 44.5 26.4 23.0 70.5 32.7 12.5 78.8 19.7 9.9 23.3 22.3 20.1 43.3 30.3 9.8 15.1 25.9 19.4 36.3 28.6 62.8 43.5 33.0 33.3 72.3 25.2 68.6 41.7 0.0 5.4 0.3 7.0 6.0 10.3 10.7 7.1 9.1 6.4 9.3 8.4 9.7 0.2 5.0 3.1 10.2 7.5 2.0 20.3 35.4 10.2 30.8 19.6 16.9 15.3 15.0 15.6 14.1 0.0 2.9 57.4 63.7 84.3 27.7 26.4 30.6 2.7 1.2 27.9 19.6 62.5 64.6 20.3 3.4 46.6 5.1 23.3 36.6 175.3 66.1 60.8 27.5 47.6 85.0 28.6 26.4 35.6 21.8 10.5 66.4 35.3 64.1 8.2 27.0 28.1 26.0 7.0 49.8 69.0 12.3 0.0 49.9 12.8 74.2 98.9 30.1 23.5 26.6 92.1 SRP14 "ALURBP, MGC14326" ENSG00000140319 "Signal recognition particle 14" P37108 15 40035739-40039188 "Plasma proteins, Predicted intracellular proteins, Transporters" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053738, HPA065118" Approved Nucleoplasm,Nucleoli NA NA 400000 Nucleoli Nucleoplasm "HPA053738: , HPA065118: " "unprognostic (2.52e-1)" "unprognostic (1.65e-1)" "unprognostic (8.20e-3)" "unprognostic (1.01e-2)" "unprognostic (1.04e-1)" "unprognostic (5.39e-3)" "unprognostic (2.97e-1)" "unprognostic (2.67e-1)" "unprognostic (1.07e-1)" "unprognostic (7.99e-2)" "unprognostic (1.46e-1)" "unprognostic (1.28e-1)" "prognostic favorable (5.31e-4)" "unprognostic (2.20e-1)" "unprognostic (8.03e-3)" "unprognostic (1.41e-3)" "unprognostic (4.94e-2)" 63.0 81.2 100.0 46.0 102.8 85.9 75.4 65.4 91.3 87.8 62.6 67.9 54.7 50.7 83.0 115.7 75.6 87.8 64.2 114.2 80.7 95.4 107.2 79.6 52.2 60.8 103.5 86.3 99.1 59.1 69.6 82.3 68.8 84.3 84.1 65.0 61.0 71.3 66.4 107.5 44.4 65.7 67.2 86.5 67.5 56.0 43.4 68.9 58.7 98.9 56.6 65.0 80.9 72.7 78.7 151.5 111.2 69.3 63.6 96.4 135.1 24.2 30.4 73.8 55.1 55.3 50.1 36.0 44.7 47.4 38.8 39.9 54.7 20.8 20.4 46.6 54.2 62.1 39.3 58.6 46.5 36.8 48.6 41.9 48.6 97.1 64.0 42.4 43.2 39.7 52.1 53.3 32.1 39.4 73.9 65.2 55.9 50.8 37.4 62.0 36.8 63.8 51.0 40.2 94.1 55.2 43.9 33.7 34.3 83.7 72.4 53.8 48.0 45.1 44.8 29.3 47.6 61.6 80.2 56.1 45.2 30.7 42.6 32.6 30.5 85.1 50.5 43.9 47.2 41.8 76.2 69.3 111.2 68.5 62.5 66.4 78.7 77.7 76.3 74.5 66.1 75.4 72.8 60.7 63.6 56.5 151.5 96.4 135.1 100.0 102.8 65.4 91.3 80.7 95.4 103.5 86.3 84.3 68.9 428.8 342.1 635.3 745.6 592.5 436.3 765.2 639.5 717.4 483.4 943.9 117.8 766.6 2161.9 1141.2 204.6 898.5 667.3 467.2 948.8 912.5 754.8 783.4 543.5 639.1 894.6 328.9 532.2 609.5 565.3 236.1 962.8 751.5 749.0 1439.1 546.1 918.4 1056.2 782.0 927.8 1642.5 369.6 614.4 716.0 645.9 602.6 620.9 634.6 518.4 577.5 829.8 SRPK1 SFRSK1 ENSG00000096063 "SRSF protein kinase 1" Q96SB4 6 35832966-35921342 "Enzymes, Predicted intracellular proteins" "Chromosome partition, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 311.7;Late spermatids: 401.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016431, HPA056486" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA016431: AB_1857478, HPA056486: AB_2683148" "unprognostic (4.65e-3)" "unprognostic (6.82e-3)" "unprognostic (2.54e-3)" "unprognostic (1.01e-3)" "unprognostic (7.74e-2)" "unprognostic (3.31e-2)" "prognostic unfavorable (7.90e-6)" "unprognostic (1.23e-2)" "unprognostic (2.54e-3)" "unprognostic (2.36e-2)" "prognostic unfavorable (6.53e-5)" "unprognostic (7.28e-2)" "unprognostic (2.21e-3)" "unprognostic (9.24e-2)" "unprognostic (4.43e-1)" "unprognostic (1.01e-1)" "unprognostic (7.55e-3)" 13.5 7.1 8.1 15.4 11.7 32.1 11.7 22.5 17.8 12.8 23.8 7.8 10.8 20.3 15.2 7.9 24.9 8.9 10.8 8.7 8.9 7.8 17.8 18.9 14.9 14.6 8.0 8.3 9.5 26.0 11.7 17.7 27.9 9.6 10.5 28.7 12.4 17.6 9.4 19.9 26.2 25.7 11.3 7.9 19.0 13.9 32.7 7.6 21.0 8.5 17.0 19.8 15.2 15.7 4.3 2.8 24.6 3.4 5.0 6.7 2.9 29.9 11.4 16.8 25.0 9.4 12.3 21.2 18.4 17.8 17.2 18.3 32.0 10.1 40.0 15.6 11.3 20.0 15.4 32.8 21.9 31.0 27.3 23.6 21.0 13.4 27.7 8.3 31.1 10.4 7.9 12.0 19.8 26.0 13.7 21.6 22.9 44.5 17.0 14.4 10.6 32.0 24.2 13.7 18.3 12.5 22.5 20.1 24.7 17.3 50.4 35.8 13.1 18.9 18.0 12.7 17.8 10.1 20.7 15.6 16.2 12.7 11.0 23.1 10.0 22.1 37.6 6.4 36.1 14.4 24.5 2.1 13.7 4.3 2.5 6.1 4.3 5.7 5.7 2.8 3.3 4.8 5.2 24.6 5.0 3.4 1.6 6.7 2.9 8.1 11.7 22.5 17.8 8.9 7.8 8.0 8.3 9.6 7.6 8.9 26.3 24.4 65.1 37.5 33.6 21.8 12.7 32.1 38.7 21.0 35.3 43.2 24.9 50.7 311.7 24.1 38.6 23.3 58.8 43.3 21.3 68.6 7.0 40.0 19.1 9.5 44.4 11.1 17.1 401.7 20.4 16.9 15.1 36.1 44.8 13.4 78.7 42.1 23.3 44.4 84.4 6.5 23.1 154.9 90.6 36.5 33.2 34.8 87.4 132.9 SRPK2 SFRSK2 ENSG00000135250 "SRSF protein kinase 2" P78362 7 105110704-105399308 "Enzymes, Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 69.3" "Group enriched" "Detected in many" 6 "Early spermatids: 1076.1;Late spermatids: 1865.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 58.2" "Lineage enriched" "Detected in all" 5 "granulocytes: 58.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015522, HPA020876" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA015522: AB_1857479, HPA020876: AB_1857480" "unprognostic (9.75e-2)" "unprognostic (1.68e-2)" "unprognostic (1.12e-1)" "unprognostic (4.64e-2)" "unprognostic (3.54e-1)" "unprognostic (1.30e-1)" "unprognostic (5.14e-2)" "unprognostic (1.54e-1)" "unprognostic (2.28e-2)" "unprognostic (1.92e-1)" "unprognostic (2.19e-1)" "unprognostic (2.31e-1)" "unprognostic (5.38e-2)" "unprognostic (7.95e-2)" "unprognostic (4.72e-2)" "unprognostic (2.87e-2)" "unprognostic (3.44e-1)" 9.9 12.1 24.8 10.1 27.6 7.1 13.3 28.4 47.1 12.7 9.4 21.0 7.8 8.2 13.2 11.9 11.9 10.9 11.6 10.4 26.4 28.6 10.3 10.1 9.2 11.5 27.2 30.2 13.0 10.5 11.9 15.3 12.0 27.3 14.0 10.9 7.9 10.1 11.1 7.9 16.9 8.2 13.3 23.1 12.0 11.3 69.3 32.3 22.1 11.3 4.7 14.0 13.6 9.7 12.2 7.3 58.2 8.1 10.0 11.9 6.0 13.3 8.9 14.2 28.1 15.2 17.2 7.9 13.1 15.3 13.1 15.3 6.9 11.4 8.5 16.7 16.9 14.7 8.0 14.3 13.8 16.8 14.7 12.7 12.0 8.4 6.0 17.6 11.4 18.0 11.9 25.7 11.1 20.9 12.7 22.5 20.3 11.8 34.8 14.5 25.2 42.2 8.7 11.7 7.6 9.7 13.7 15.6 18.4 18.9 20.7 20.8 14.4 14.8 22.3 13.8 19.6 8.3 8.0 14.7 24.2 17.6 23.0 12.2 38.2 37.6 20.9 9.5 11.8 18.0 11.2 8.1 26.0 11.9 5.5 7.1 12.2 9.0 8.9 7.3 11.6 8.5 9.7 58.2 10.0 6.2 6.4 10.1 6.0 24.8 27.6 28.4 38.7 26.4 28.6 27.2 30.2 27.3 32.3 26.8 28.5 33.3 51.2 189.1 70.3 20.1 33.1 48.2 27.3 22.7 47.1 40.1 23.2 44.1 1076.1 52.5 12.9 0.0 40.5 30.6 44.1 65.7 40.4 25.1 41.0 117.6 27.6 43.0 45.7 1865.0 71.1 31.8 55.6 40.5 32.1 65.3 32.7 21.0 90.2 21.7 65.2 45.3 45.3 237.2 50.3 90.3 53.9 56.8 23.6 46.7 SRRT "ARS2, Asr2, serrate" ENSG00000087087 "Serrate, RNA effector molecule" Q9BXP5 7 100875111-100888664 "Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Early spermatids: 199.7;Late spermatids: 241.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042858, HPA058379" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA042858: AB_2678201, HPA058379: AB_2683697" "unprognostic (5.83e-2)" "unprognostic (3.72e-3)" "unprognostic (5.89e-2)" "unprognostic (1.77e-1)" "unprognostic (1.45e-2)" "unprognostic (1.31e-2)" "prognostic unfavorable (1.90e-5)" "unprognostic (4.36e-2)" "unprognostic (4.99e-3)" "unprognostic (2.35e-2)" "unprognostic (4.25e-3)" "unprognostic (2.74e-2)" "prognostic unfavorable (1.01e-6)" "unprognostic (6.30e-3)" "unprognostic (2.77e-2)" "unprognostic (9.98e-2)" "unprognostic (1.10e-3)" 18.8 25.2 23.0 32.4 26.7 62.8 22.0 43.4 28.2 25.5 20.7 27.6 37.6 24.3 25.9 27.9 26.5 23.0 22.3 19.3 26.0 15.5 24.2 29.6 20.2 36.5 26.7 20.0 31.6 25.7 26.4 32.6 25.2 24.1 30.8 17.2 23.5 32.4 39.1 23.8 44.2 24.3 18.8 17.4 31.8 22.4 67.6 28.9 39.9 27.9 24.3 32.6 18.9 26.2 10.4 9.9 13.2 14.9 6.1 26.1 12.3 24.9 30.0 31.3 30.2 13.4 9.6 28.9 27.8 14.2 28.8 24.8 39.1 28.4 41.7 19.2 20.3 21.4 23.8 37.6 25.0 14.5 36.8 30.8 39.6 34.6 32.1 12.1 51.1 67.9 14.3 9.8 25.6 7.2 13.1 15.6 25.6 34.6 34.0 19.8 43.4 47.1 56.3 32.0 21.6 26.4 44.2 23.9 25.1 18.4 27.7 24.7 23.9 27.4 34.3 18.0 16.7 21.5 31.4 23.5 32.6 31.3 27.4 37.5 21.5 30.6 44.3 18.1 34.2 30.5 4.6 9.2 13.2 19.7 14.9 12.3 8.4 12.9 26.1 9.9 10.4 11.3 15.9 6.8 6.1 10.4 9.0 6.2 12.3 23.0 26.7 43.4 28.2 26.0 15.5 26.7 20.0 24.1 28.9 23.8 51.7 19.3 25.8 34.2 21.3 19.7 15.3 38.8 48.9 15.7 13.7 32.7 6.6 21.3 199.7 19.9 14.2 23.3 27.6 41.8 23.3 18.3 25.5 11.4 23.3 25.4 31.6 9.8 10.5 241.6 31.4 23.9 15.1 29.7 17.9 26.9 21.0 14.4 26.2 9.9 45.7 19.4 29.9 83.4 63.9 38.0 45.3 29.9 26.2 17.0 SRSF1 "ASF, MGC5228, SF2, SF2p33, SFRS1, SRp30a" ENSG00000136450 "Serine and arginine rich splicing factor 1" Q07955 17 58003360-58007346 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013073, HPA061301" Supported Supported Nucleoplasm NA NA 1100000 Nucleoplasm "CAB013073: AB_2533079, HPA061301: AB_2684474" "unprognostic (9.86e-2)" "prognostic favorable (7.00e-4)" "prognostic favorable (4.56e-5)" "unprognostic (8.11e-2)" "unprognostic (2.00e-1)" "unprognostic (3.88e-3)" "prognostic unfavorable (1.64e-6)" "unprognostic (8.28e-2)" "unprognostic (2.60e-3)" "unprognostic (3.07e-2)" "unprognostic (1.98e-1)" "unprognostic (5.48e-2)" "prognostic unfavorable (2.95e-5)" "unprognostic (1.02e-2)" "unprognostic (1.44e-1)" "unprognostic (4.50e-1)" "unprognostic (1.59e-2)" 27.0 30.0 25.4 41.0 31.7 19.1 29.9 58.3 32.9 43.8 41.1 26.3 41.7 32.2 44.9 29.3 28.6 43.2 30.2 24.0 23.9 15.8 29.0 30.9 31.4 47.1 34.6 21.6 73.1 28.5 40.8 52.3 28.5 30.1 44.9 32.4 28.7 32.9 31.7 40.7 24.7 38.9 42.2 27.4 38.4 29.2 26.0 32.1 57.0 44.7 30.7 50.7 32.1 44.1 19.8 41.8 16.5 36.1 24.8 23.2 22.3 52.3 46.8 56.5 34.1 15.7 15.9 39.6 48.9 24.6 50.2 45.5 54.6 40.9 89.6 29.9 31.8 31.1 42.2 65.1 52.0 54.4 53.1 45.0 71.3 56.6 51.2 20.2 70.5 38.7 15.4 19.5 47.3 33.5 15.1 32.4 31.0 77.2 31.0 33.7 42.6 83.8 42.0 56.0 35.9 42.3 81.9 55.6 49.6 31.4 44.1 46.6 44.0 39.3 28.6 26.2 24.7 40.6 41.2 42.2 36.5 43.3 27.2 59.4 27.5 54.0 86.1 36.0 60.6 45.5 9.8 27.3 16.5 23.2 36.1 23.1 19.8 17.8 21.8 41.8 14.6 19.5 19.5 12.7 24.8 23.8 21.3 19.2 22.3 25.4 31.7 58.3 32.9 23.9 15.8 34.6 21.6 30.1 32.1 32.8 42.4 89.7 106.8 118.7 59.2 26.2 28.1 41.5 38.7 41.8 29.5 60.7 59.7 56.4 40.6 42.3 58.0 23.3 52.0 95.3 69.1 84.9 58.8 42.3 52.2 49.3 63.2 34.4 54.2 25.9 77.9 51.1 52.3 35.1 65.7 45.0 49.8 75.5 56.6 41.6 79.0 103.5 84.9 82.4 62.6 120.2 50.9 59.6 80.2 105.0 SRSF10 "FUSIP1, FUSIP2, PPP1R149, SFRS13, SFRS13A, SRp38, SRrp40, TASR1, TASR2" ENSG00000188529 "Serine and arginine rich splicing factor 10" O75494 1 23964804-23980927 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053805, HPA053831" Uncertain Supported Nucleoplasm NA Yes 28000 Nucleoplasm "HPA053805: AB_2682269, HPA053831: AB_2682275" "unprognostic (2.49e-1)" "unprognostic (3.10e-1)" "unprognostic (1.34e-2)" "unprognostic (1.77e-1)" "unprognostic (1.46e-1)" "unprognostic (1.06e-2)" "prognostic unfavorable (1.18e-6)" "unprognostic (2.05e-2)" "unprognostic (1.68e-3)" "unprognostic (1.30e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.74e-4)" "prognostic unfavorable (1.01e-5)" "unprognostic (2.69e-2)" "unprognostic (1.59e-1)" "unprognostic (2.76e-1)" "unprognostic (2.40e-2)" 34.1 41.8 23.7 34.3 27.1 69.0 34.5 35.5 28.7 35.0 29.2 24.6 35.0 26.8 44.1 34.4 30.6 36.2 24.8 27.1 25.3 21.7 33.0 41.0 32.0 41.6 24.0 22.3 42.8 33.6 29.5 47.9 33.7 24.9 32.5 34.3 23.1 31.1 32.9 30.0 27.1 32.5 30.7 29.8 40.0 31.2 32.4 29.2 73.8 42.9 22.0 41.2 31.4 33.1 51.9 44.1 53.3 50.1 47.7 47.1 41.6 32.1 25.8 44.4 28.1 25.1 21.2 27.8 37.6 16.2 34.9 30.9 26.2 32.2 70.1 24.4 18.0 22.1 28.1 50.5 26.5 44.8 38.2 36.1 42.2 44.6 34.1 19.1 46.2 30.5 13.3 20.5 22.7 22.5 19.7 27.3 25.8 53.9 26.8 29.3 22.8 50.4 33.7 56.7 38.2 25.6 46.3 32.5 35.2 29.2 26.0 32.4 25.3 28.6 25.4 27.6 29.6 27.3 37.3 26.1 29.0 28.3 26.5 36.2 27.1 37.0 56.6 25.0 51.8 31.9 53.3 43.0 44.3 36.4 50.1 45.8 51.9 41.9 42.3 36.4 42.9 47.1 41.6 27.4 47.7 48.9 44.1 46.9 41.6 23.7 27.1 35.5 28.7 25.3 21.7 24.0 22.3 24.9 29.2 104.2 84.9 121.8 101.4 37.8 151.3 50.9 63.7 155.2 142.1 75.0 151.2 94.2 66.3 76.4 85.5 99.4 62.3 23.3 77.4 141.6 73.7 80.8 89.2 54.2 71.8 93.8 117.0 76.1 48.7 91.5 118.2 72.5 25.3 92.0 73.8 132.6 67.9 81.6 104.0 60.5 285.3 103.5 89.5 166.6 159.0 39.6 53.0 96.9 93.0 74.0 SRSF2 "PR264, SC-35, SC35, SFRS2, SFRS2A" ENSG00000161547 "Serine and arginine rich splicing factor 2" Q01130 17 76734115-76737374 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049905 Supported Approved Nucleoplasm,Cytosol NA NA 140000 Nucleoplasm Cytosol "HPA049905: AB_2680945" "unprognostic (2.50e-1)" "unprognostic (2.16e-3)" "unprognostic (2.73e-3)" "prognostic unfavorable (8.73e-4)" "unprognostic (1.75e-2)" "unprognostic (4.19e-2)" "prognostic unfavorable (3.53e-8)" "unprognostic (1.19e-1)" "unprognostic (7.79e-3)" "unprognostic (7.03e-3)" "unprognostic (1.92e-1)" "unprognostic (1.07e-3)" "prognostic unfavorable (1.05e-7)" "unprognostic (3.85e-2)" "unprognostic (8.05e-2)" "unprognostic (1.95e-1)" "prognostic favorable (9.87e-4)" 35.4 40.2 20.6 56.6 30.3 73.1 35.3 33.3 36.2 42.1 37.7 34.0 19.5 41.8 37.0 33.6 51.1 35.1 34.8 32.4 19.9 22.6 36.9 66.7 37.3 64.3 21.6 24.0 47.1 34.2 29.1 33.8 51.2 29.5 31.3 36.5 35.5 35.6 40.5 44.9 41.1 46.6 25.5 23.9 52.5 35.6 29.2 18.9 105.3 41.1 41.3 64.5 30.6 35.7 11.1 30.2 4.2 23.5 15.6 12.7 12.2 48.2 38.9 46.2 32.2 11.3 9.6 48.0 31.2 23.1 36.2 33.6 40.8 33.8 74.4 22.8 29.3 26.1 43.7 45.8 36.0 36.5 31.1 79.8 55.8 37.7 47.4 12.9 61.6 33.4 10.6 8.2 30.0 8.7 14.7 28.2 33.3 56.7 32.9 28.3 38.6 67.6 67.3 54.1 28.1 55.5 68.5 49.7 54.9 24.2 34.8 39.4 56.3 35.6 30.6 16.8 25.4 37.5 45.0 29.5 33.5 43.1 22.2 50.4 43.3 32.5 86.0 30.1 49.0 27.6 1.0 17.5 4.2 12.3 23.5 12.6 11.1 8.5 12.7 30.2 9.8 9.8 9.0 2.1 15.6 14.7 22.4 10.6 12.2 20.6 30.3 33.3 36.2 19.9 22.6 21.6 24.0 29.5 18.9 110.2 104.2 263.7 359.4 409.3 143.7 75.1 117.2 84.3 119.4 83.7 86.4 268.2 132.6 175.8 190.8 186.2 246.5 140.2 136.4 478.7 232.5 241.3 217.7 110.3 220.7 93.8 255.6 111.1 135.5 118.5 147.3 197.1 268.2 218.2 170.4 153.0 146.8 241.8 119.9 87.2 188.9 116.4 279.5 292.6 343.6 387.6 264.3 196.1 264.9 438.8 SRSF3 "SFRS3, SRp20" ENSG00000112081 "Serine and arginine rich splicing factor 3" P84103 6 36594353-36605600 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012986, HPA056981" Supported Supported Nucleoplasm NA NA 1600000 Nucleoplasm "CAB012986: AB_2533150, HPA056981: AB_2683299" "unprognostic (3.25e-1)" "unprognostic (1.08e-3)" "prognostic favorable (2.56e-4)" "unprognostic (8.19e-2)" "unprognostic (2.06e-2)" "unprognostic (2.77e-2)" "prognostic unfavorable (6.22e-5)" "unprognostic (2.92e-2)" "prognostic unfavorable (1.95e-4)" "prognostic favorable (1.37e-4)" "unprognostic (9.61e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (2.02e-4)" "unprognostic (9.88e-2)" "unprognostic (3.33e-2)" "unprognostic (8.33e-2)" "unprognostic (1.06e-2)" 45.3 27.4 37.4 42.1 38.3 69.5 43.5 42.6 39.1 36.4 41.7 32.9 34.0 25.5 37.2 31.8 42.9 40.8 27.4 37.5 33.0 28.1 34.3 36.9 32.3 51.8 35.8 27.0 53.9 31.3 22.4 47.2 37.4 38.1 40.1 46.6 30.1 30.2 33.0 29.2 36.2 35.8 43.1 31.9 36.4 35.2 27.2 36.7 67.5 35.9 46.7 67.0 49.6 38.6 28.0 73.9 12.9 38.0 37.6 37.6 53.9 52.3 35.0 61.8 47.2 23.9 18.8 38.2 37.5 31.5 63.3 48.8 41.1 37.7 88.1 27.1 41.0 41.4 41.6 81.1 59.7 67.7 41.1 49.9 52.9 27.8 46.2 29.2 70.9 44.8 16.6 20.3 41.2 46.1 20.2 48.0 53.7 63.7 37.4 45.9 40.9 87.1 67.2 65.1 61.6 36.8 77.8 59.2 52.8 44.8 43.7 47.8 45.2 41.7 41.0 56.7 46.2 41.5 76.3 31.3 32.4 47.3 32.4 56.3 36.9 54.6 120.8 27.8 66.1 44.9 12.9 38.0 11.5 32.9 36.2 37.1 28.0 31.1 34.5 73.9 24.0 31.4 32.3 3.7 37.6 24.4 43.7 37.6 53.9 37.4 38.3 42.6 39.1 33.0 28.1 35.8 27.0 38.1 36.7 187.6 233.6 318.3 350.5 417.2 149.0 207.3 150.3 167.3 258.2 118.7 51.1 416.8 308.4 279.1 130.6 291.5 222.5 70.0 281.9 659.0 372.0 205.6 389.0 176.1 317.5 93.8 319.4 203.1 270.2 235.9 196.2 343.3 317.2 322.0 216.3 322.7 247.9 247.6 161.9 198.3 123.9 200.5 442.5 331.9 315.7 389.7 439.9 330.0 297.7 236.4 SRSF5 "HRS, SFRS5, SRP40" ENSG00000100650 "Serine and arginine rich splicing factor 5" Q13243 14 69726900-69772005 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043484, HPA056523" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA043484: AB_10797143, HPA056523: AB_2683164" "unprognostic (2.08e-3)" "prognostic favorable (7.91e-4)" "unprognostic (1.89e-1)" "unprognostic (1.19e-1)" "unprognostic (1.19e-1)" "unprognostic (1.79e-2)" "unprognostic (1.86e-1)" "unprognostic (2.06e-2)" "unprognostic (3.32e-2)" "unprognostic (1.61e-1)" "unprognostic (9.30e-3)" "unprognostic (1.07e-3)" "unprognostic (2.37e-2)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "unprognostic (2.42e-1)" "unprognostic (1.00e-2)" 66.6 60.1 67.1 60.9 74.4 131.5 70.3 111.7 88.8 54.3 63.3 67.8 77.1 42.6 71.3 74.6 66.3 79.3 50.1 48.5 66.2 43.0 40.5 60.8 69.4 63.3 86.4 62.1 76.6 41.0 56.4 124.8 59.2 74.0 59.0 54.7 69.2 68.5 75.6 76.0 78.1 74.1 59.7 68.6 66.5 62.0 35.3 75.6 47.8 70.8 52.3 69.1 69.6 55.8 41.2 37.4 60.8 45.1 30.8 38.2 24.4 70.0 20.5 50.2 22.6 31.0 26.9 27.9 33.8 36.4 27.6 29.3 25.7 45.0 72.6 17.9 45.8 28.4 33.5 38.0 48.3 32.6 62.0 20.9 54.7 54.9 28.1 36.1 51.0 41.5 55.7 30.8 31.8 34.1 41.5 38.2 63.2 38.0 43.3 17.1 56.9 58.6 34.6 29.4 55.3 18.9 50.3 23.9 27.9 35.1 86.3 26.2 37.4 57.3 34.8 43.6 31.4 37.9 43.0 47.2 16.2 43.4 17.6 31.6 42.1 27.5 117.5 38.1 43.5 22.2 39.0 24.1 37.2 37.3 43.4 38.2 41.2 33.2 33.4 26.2 40.6 33.2 31.5 60.8 30.8 45.1 37.4 27.4 24.4 67.1 74.4 111.7 88.8 66.2 43.0 86.4 62.1 74.0 75.6 235.2 245.0 272.6 618.6 122.6 370.2 163.3 193.6 401.5 253.6 174.5 225.8 335.9 271.9 173.3 146.9 251.5 417.9 163.5 148.9 193.0 195.8 288.7 459.5 204.3 193.9 357.6 290.6 219.1 193.0 84.2 319.9 251.8 126.5 254.3 249.3 292.6 182.8 399.8 251.0 172.0 307.5 271.7 240.9 175.1 136.3 127.2 626.6 371.3 207.8 495.2 SRSF7 "9G8, AAG3, HSSG1, RBM37, SFRS7, ZCCHC20, ZCRB2" ENSG00000115875 "Serine and arginine rich splicing factor 7" Q16629 2 38743599-38751494 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043850, HPA056926" Supported Enhanced Nucleoplasm NA NA 1400000 Nucleoplasm "HPA043850: AB_10964495, HPA056926: AB_2683277" "unprognostic (2.74e-1)" "unprognostic (1.53e-3)" "unprognostic (1.24e-1)" "unprognostic (1.56e-1)" "unprognostic (1.86e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (2.90e-5)" "unprognostic (3.24e-2)" "unprognostic (2.53e-2)" "unprognostic (2.61e-1)" "unprognostic (3.75e-1)" "unprognostic (4.44e-3)" "prognostic unfavorable (3.18e-8)" "unprognostic (1.02e-2)" "unprognostic (1.87e-1)" "unprognostic (1.72e-1)" "unprognostic (3.07e-3)" 42.2 32.2 32.8 51.1 37.3 76.7 39.2 34.7 38.9 26.8 37.2 21.4 34.8 20.4 34.1 27.3 50.2 36.9 25.9 29.8 26.9 24.6 25.1 34.9 34.3 45.5 37.5 23.8 31.7 38.2 20.4 50.4 34.3 32.8 27.4 37.2 25.0 32.8 32.4 31.7 26.2 37.7 36.6 33.4 34.8 38.8 35.9 33.0 44.1 26.1 38.6 59.2 28.2 40.7 20.9 47.6 8.8 33.4 20.8 22.9 22.3 44.4 38.7 52.0 33.5 16.0 12.7 36.8 38.1 16.4 38.4 31.0 45.6 34.3 72.7 26.1 24.7 35.7 25.1 65.4 46.6 46.3 45.2 40.9 43.8 27.7 46.5 13.6 53.7 31.9 7.5 15.9 26.4 51.1 16.1 31.8 30.4 63.2 29.1 32.5 49.5 68.0 47.6 56.8 51.9 35.5 60.4 43.6 41.2 28.5 43.2 35.7 34.7 36.4 32.2 25.5 34.2 29.4 49.1 27.4 23.3 36.5 19.9 53.0 32.1 48.1 108.6 27.7 56.4 32.0 6.4 23.1 8.8 21.3 33.4 22.9 20.9 16.4 21.0 47.6 14.1 18.6 21.1 2.3 20.8 19.6 28.6 17.4 22.3 32.8 37.3 34.7 38.9 26.9 24.6 37.5 23.8 32.8 33.0 74.5 215.1 214.9 400.1 230.6 113.1 58.5 71.4 103.1 134.2 61.1 111.9 262.6 132.6 156.5 100.6 205.2 175.7 93.5 114.8 395.5 179.8 170.8 309.8 83.0 212.6 114.4 170.8 124.0 110.1 27.4 128.3 171.7 145.1 221.8 114.8 196.9 126.7 138.2 103.3 87.8 205.4 116.4 213.8 249.3 306.4 212.9 209.3 335.6 161.8 319.7 SRSF8 "SFRS2B, SRP46" ENSG00000263465 "Serine and arginine rich splicing factor 8" Q9BRL6 11 95067197-95071224 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA049905 Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA049905: AB_2680945" "unprognostic (2.03e-2)" "unprognostic (2.51e-1)" "unprognostic (5.23e-2)" "unprognostic (2.00e-2)" "unprognostic (1.00e-1)" "unprognostic (1.68e-1)" "unprognostic (2.62e-1)" "unprognostic (2.08e-2)" "unprognostic (2.12e-1)" "unprognostic (3.00e-1)" "unprognostic (1.55e-2)" "unprognostic (1.05e-1)" "prognostic favorable (9.99e-7)" "unprognostic (2.26e-1)" "unprognostic (1.88e-1)" "unprognostic (5.39e-2)" "unprognostic (2.75e-3)" 5.5 6.4 6.1 4.9 9.6 5.3 9.6 6.0 14.3 8.7 6.9 8.0 9.2 7.1 8.0 8.0 6.8 7.4 6.8 6.4 6.5 9.5 6.8 6.1 8.7 6.1 9.5 10.7 10.4 9.7 8.2 6.5 7.2 9.4 7.5 10.1 11.4 8.6 5.4 6.6 7.8 7.1 4.8 9.0 7.1 3.0 5.0 3.7 11.6 5.3 6.5 6.1 5.5 7.9 3.8 7.0 2.0 5.6 12.4 3.7 4.4 4.7 11.8 0.0 15.8 10.0 13.3 6.7 7.5 3.2 3.4 11.0 14.7 23.8 20.0 10.2 5.8 9.8 9.9 14.7 3.7 14.4 10.7 20.2 5.5 9.8 11.6 20.1 11.0 12.9 15.7 3.4 15.9 9.4 9.9 11.1 15.1 13.3 6.2 6.1 10.4 18.1 6.2 11.8 13.1 13.1 3.6 19.0 12.5 15.0 15.0 15.4 8.3 14.9 9.7 7.8 5.9 11.2 9.1 6.2 8.3 8.3 6.8 7.1 10.9 12.8 3.2 13.6 13.5 7.0 2.0 0.6 5.7 1.1 8.2 7.9 9.6 8.2 3.8 6.9 12.4 9.5 0.6 5.6 1.0 3.5 9.9 3.7 41.7 24.8 82.8 42.9 0.0 45.6 20.1 61.1 17.4 21.6 31.4 31.4 33.1 127.6 32.0 1.3 32.2 43.1 23.3 40.0 43.0 21.6 37.7 10.3 52.9 23.7 17.5 54.6 35.6 22.7 4.2 38.0 25.1 0.0 34.3 75.6 40.4 26.3 42.1 57.3 77.7 48.0 32.3 29.9 3.7 5.9 0.0 42.8 65.1 58.5 30.7 SRSF9 "SFRS9, SRp30c" ENSG00000111786 "Serine and arginine rich splicing factor 9" Q13242 12 120461668-120469793 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049849 Supported Supported Nucleoplasm,Nucleoli No No Nucleoplasm Nucleoli "HPA049849: AB_2680911" "unprognostic (3.80e-1)" "unprognostic (3.84e-1)" "unprognostic (1.50e-1)" "unprognostic (1.75e-2)" "unprognostic (2.41e-1)" "unprognostic (2.50e-3)" "prognostic unfavorable (9.85e-7)" "unprognostic (9.65e-3)" "prognostic unfavorable (7.80e-4)" "unprognostic (2.31e-2)" "unprognostic (4.35e-1)" "unprognostic (1.19e-2)" "unprognostic (1.19e-3)" "unprognostic (9.57e-2)" "unprognostic (3.13e-1)" "unprognostic (2.57e-1)" "unprognostic (1.60e-1)" 25.8 50.7 29.5 37.9 28.5 33.8 31.2 24.9 30.6 31.5 36.4 21.7 35.5 29.8 26.7 37.4 53.6 32.6 42.3 20.7 26.7 27.9 37.2 42.5 27.2 41.4 31.6 25.3 37.1 68.5 34.9 36.5 49.3 27.9 33.1 35.8 29.3 33.9 30.4 17.0 32.4 31.0 25.1 23.8 39.6 33.0 52.5 25.0 53.1 43.7 36.8 51.0 26.5 35.7 22.1 18.7 28.8 15.4 15.7 14.8 5.1 55.7 39.0 59.9 38.5 27.4 27.6 64.1 38.3 34.5 49.3 42.4 46.8 26.3 54.4 44.9 32.1 26.8 33.4 53.9 54.5 54.4 40.7 55.4 46.4 26.2 45.6 35.4 57.1 42.4 29.1 35.2 42.8 37.3 52.9 44.8 35.6 58.2 16.5 42.3 78.0 56.3 111.5 75.0 37.9 34.1 62.9 25.1 52.5 42.6 71.2 53.2 38.0 44.9 23.9 44.3 40.8 72.1 50.4 39.0 36.7 43.5 27.5 41.4 50.7 38.0 68.0 38.6 43.1 38.2 12.3 10.7 28.8 14.8 11.7 11.2 22.1 11.7 13.0 13.9 17.7 11.5 12.8 12.2 15.7 15.4 18.7 11.9 5.1 29.5 28.5 24.9 30.6 26.7 27.9 31.6 25.3 27.9 25.0 23.8 30.4 155.5 203.9 235.3 77.2 1.3 147.7 20.1 26.1 153.5 27.5 301.6 414.4 172.1 51.9 119.1 86.4 23.3 135.5 354.8 182.5 290.8 33.4 118.4 178.0 68.3 138.9 108.1 103.3 17.4 115.3 184.7 190.6 190.2 126.0 96.8 139.8 80.7 145.6 272.7 44.3 51.8 162.7 260.2 249.1 273.9 397.6 97.9 129.8 332.4 SS18 "SSXT, SYT" ENSG00000141380 "SS18, nBAF chromatin remodeling complex subunit" Q15532 18 26016253-26091217 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055741, HPA059539" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA055741: AB_2682901, HPA059539: AB_2684055" "unprognostic (2.03e-2)" "unprognostic (1.76e-1)" "unprognostic (1.48e-2)" "unprognostic (1.95e-2)" "unprognostic (3.39e-1)" "unprognostic (8.74e-2)" "unprognostic (4.59e-2)" "unprognostic (1.53e-2)" "unprognostic (1.63e-2)" "unprognostic (1.45e-2)" "unprognostic (1.04e-1)" "unprognostic (2.47e-1)" "prognostic favorable (4.86e-4)" "unprognostic (1.03e-1)" "unprognostic (3.50e-2)" "unprognostic (1.40e-2)" "unprognostic (1.30e-1)" 26.1 40.5 18.7 30.4 26.4 15.5 26.6 17.6 20.2 24.8 21.4 31.8 32.1 14.0 31.7 32.7 29.8 27.2 23.4 22.4 21.6 16.1 30.0 30.9 21.9 25.8 32.6 16.3 39.4 20.6 39.4 41.8 43.2 25.3 28.6 18.7 26.1 26.0 33.5 10.3 31.3 22.6 31.0 23.7 24.7 22.5 28.3 32.6 27.8 35.6 24.7 35.2 25.5 25.9 15.9 13.1 19.9 17.1 20.7 17.6 13.1 19.2 14.0 34.4 16.8 27.4 24.8 17.4 23.7 21.6 21.0 20.1 9.2 16.0 33.7 19.0 27.7 19.0 25.3 18.6 23.0 26.0 21.5 8.9 16.7 20.5 14.8 21.7 25.5 25.9 31.8 27.2 26.3 28.9 21.0 15.7 9.8 12.2 17.3 28.9 19.4 10.4 14.8 6.5 18.1 13.5 12.1 26.7 16.2 22.2 22.8 14.7 22.2 36.2 16.8 10.2 25.8 17.1 15.1 18.0 44.2 8.8 10.2 23.2 31.3 20.8 24.3 20.7 17.8 23.4 19.9 11.7 16.5 15.1 17.1 17.6 15.9 14.6 15.7 13.1 13.0 15.5 17.4 5.6 20.7 16.7 7.4 15.7 13.1 18.7 26.4 17.6 20.2 21.6 16.1 32.6 16.3 25.3 32.6 26.8 21.3 28.3 27.1 7.9 28.5 14.1 17.8 36.1 23.9 22.7 15.7 57.3 18.3 26.4 40.7 25.3 17.2 0.0 22.5 41.2 19.5 22.9 36.8 30.1 23.9 82.6 23.7 24.5 20.0 31.2 30.8 17.1 5.0 12.6 21.1 51.6 26.7 14.0 38.5 23.8 29.7 38.8 27.1 23.4 19.0 11.5 71.2 25.4 14.5 21.7 SS18L1 "CREST, KIAA0693" ENSG00000184402 "SS18L1, nBAF chromatin remodeling complex subunit" O75177 20 62143795-62182484 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011827, HPA059046" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB011827: AB_778216, HPA059046: AB_2683888" "unprognostic (4.12e-2)" "unprognostic (5.82e-2)" "unprognostic (1.54e-1)" "unprognostic (3.03e-2)" "unprognostic (6.57e-2)" "prognostic favorable (8.00e-5)" "unprognostic (1.39e-1)" "prognostic favorable (3.74e-4)" "unprognostic (1.01e-1)" "unprognostic (1.87e-1)" "unprognostic (2.47e-3)" "unprognostic (6.43e-2)" "unprognostic (2.42e-1)" "unprognostic (1.06e-1)" "unprognostic (2.66e-1)" "unprognostic (1.01e-1)" "unprognostic (9.94e-3)" 6.6 8.9 11.9 7.7 12.7 7.7 8.6 35.9 15.8 7.0 7.0 9.9 12.2 9.5 9.7 10.9 9.3 6.9 7.2 6.4 11.5 10.9 11.5 33.3 8.2 7.4 11.2 14.5 10.0 10.4 8.4 10.7 8.8 13.1 8.7 7.8 7.4 8.6 11.8 19.2 23.7 9.0 7.7 9.9 9.2 8.8 10.7 10.9 6.0 8.3 6.7 7.1 6.8 8.6 3.6 1.3 2.5 2.7 1.6 2.8 0.5 6.5 7.8 10.9 9.9 4.9 5.7 7.9 6.2 2.4 10.4 5.2 26.8 6.1 4.0 8.3 3.5 5.4 17.0 6.7 5.9 9.5 2.7 4.4 17.8 16.4 13.8 3.6 6.5 15.9 3.4 13.0 5.3 4.4 6.1 4.7 6.9 11.9 7.7 5.8 7.8 9.8 10.1 4.4 6.6 9.0 10.9 14.1 4.5 7.8 8.3 20.7 11.5 11.1 13.6 9.3 7.2 12.7 10.4 5.5 19.9 12.0 7.3 8.6 8.6 7.7 3.6 9.9 6.4 6.5 0.3 1.6 0.6 1.7 1.1 1.1 0.7 0.9 1.4 1.3 3.6 2.8 0.9 2.5 1.6 2.7 0.8 0.8 0.5 11.9 12.7 35.9 15.8 11.5 10.9 11.2 14.5 13.1 10.9 8.9 6.5 6.0 4.4 14.5 14.4 7.7 2.5 4.0 11.4 7.0 21.6 4.5 3.3 4.1 8.6 7.4 6.8 0.0 2.3 2.7 10.4 7.3 1.1 33.3 4.2 14.3 13.7 8.0 11.9 16.0 6.9 7.4 11.8 3.6 6.6 4.9 6.3 7.0 3.2 7.3 17.7 6.5 8.9 3.9 10.6 15.3 6.4 5.0 5.3 4.7 SS18L2 KIAA-iso ENSG00000008324 "SS18 like 2" Q9UHA2 3 42581840-42595114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047377 Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria Yes No "Nucleoli, Mitochondria" Nucleoplasm "HPA047377: AB_2680020" "unprognostic (4.09e-3)" "unprognostic (1.90e-3)" "unprognostic (1.54e-1)" "unprognostic (1.19e-1)" "unprognostic (2.36e-1)" "unprognostic (1.57e-1)" "unprognostic (1.64e-2)" "prognostic favorable (7.03e-4)" "unprognostic (6.55e-2)" "unprognostic (4.51e-2)" "unprognostic (2.62e-2)" "unprognostic (2.94e-2)" "unprognostic (1.09e-3)" "unprognostic (1.44e-1)" "unprognostic (1.09e-1)" "unprognostic (1.96e-1)" "unprognostic (2.24e-3)" 12.7 11.6 24.5 17.8 26.4 29.9 20.8 25.2 23.8 14.0 14.8 14.4 9.1 19.4 9.1 20.6 16.6 10.6 11.8 10.8 23.5 20.6 15.8 26.2 11.9 34.8 20.5 15.9 13.5 29.0 10.9 16.1 10.7 17.4 22.2 15.5 11.3 18.6 10.8 10.1 14.9 19.3 8.4 24.0 19.7 15.6 6.4 14.9 20.4 18.7 14.7 32.0 16.0 11.1 48.0 30.0 32.8 25.9 31.0 53.5 32.9 16.1 7.4 14.9 13.5 19.2 15.6 9.3 10.5 12.0 15.7 17.8 14.2 14.8 22.1 9.6 7.2 16.5 9.1 17.8 14.7 17.3 11.0 20.8 24.0 14.5 23.8 13.8 31.3 18.9 12.2 9.5 12.6 11.9 10.9 17.1 19.7 21.7 33.4 12.6 15.3 22.0 38.9 23.6 21.8 18.2 11.7 10.9 30.7 17.4 20.4 8.4 12.0 8.9 14.0 14.1 16.8 18.3 29.3 10.0 9.2 15.1 22.1 19.1 24.3 38.4 37.5 13.6 34.4 8.8 19.0 23.5 32.8 38.4 25.9 51.6 48.0 50.5 45.3 24.9 40.8 43.9 44.1 31.1 31.0 19.2 30.0 53.5 32.9 24.5 26.4 25.2 23.8 23.5 20.6 20.5 15.9 17.4 14.9 11.9 11.8 77.1 64.6 95.1 14.4 16.1 38.2 14.7 15.9 26.2 7.9 47.4 48.0 38.3 2.3 39.4 43.1 23.3 43.1 65.4 37.6 63.9 45.0 58.7 58.5 22.3 52.9 28.3 37.6 2.5 31.9 41.0 49.0 61.3 42.2 24.6 41.3 53.7 14.9 68.9 23.5 12.9 39.1 13.2 24.0 120.8 31.2 95.9 48.0 96.2 SSB "La, La/SSB, LARP3" ENSG00000138385 "Sjogren syndrome antigen B" P05455 2 169791933-169812064 "Predicted intracellular proteins" RNA-binding "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004643, HPA017287" Supported Approved Nucleoplasm NA NA Nucleoplasm "CAB004643: AB_425691, HPA017287: AB_1852672" "unprognostic (5.58e-2)" "unprognostic (2.50e-1)" "unprognostic (1.40e-1)" "unprognostic (9.05e-3)" "unprognostic (6.60e-2)" "prognostic unfavorable (5.99e-4)" "prognostic unfavorable (8.30e-8)" "unprognostic (1.09e-2)" "unprognostic (1.45e-2)" "unprognostic (9.81e-3)" "unprognostic (3.24e-3)" "unprognostic (2.57e-1)" "prognostic unfavorable (6.17e-6)" "unprognostic (9.92e-2)" "unprognostic (2.43e-1)" "unprognostic (1.21e-3)" "unprognostic (2.38e-2)" 52.4 38.5 39.7 35.1 41.8 43.8 38.2 45.8 48.4 37.8 32.7 18.9 24.2 23.7 34.7 42.4 35.8 31.7 28.9 32.7 37.2 42.9 54.0 44.9 27.0 41.3 36.0 34.3 46.5 21.8 40.3 76.9 39.8 51.1 44.5 28.9 19.8 23.5 35.0 44.6 22.4 30.7 38.2 42.4 45.6 26.6 19.4 35.7 35.9 48.1 30.0 38.1 49.3 29.1 32.4 21.0 22.4 33.2 32.3 38.5 22.5 30.8 18.2 39.4 29.3 42.8 39.8 49.3 38.0 25.4 35.7 33.3 55.0 33.9 69.3 43.5 24.8 32.5 33.2 53.2 33.2 49.1 37.6 43.6 83.0 23.0 52.8 38.3 66.6 31.1 30.5 32.0 45.3 27.1 29.4 39.6 26.2 96.4 16.2 74.7 24.3 44.1 69.9 63.5 29.8 18.7 43.8 42.0 50.0 45.1 34.2 37.7 28.8 30.1 22.5 41.9 40.1 25.8 48.1 35.6 26.1 31.1 26.2 36.5 18.9 36.4 59.1 25.8 62.9 28.3 22.4 16.9 19.8 26.9 27.8 38.5 32.4 38.2 33.9 19.6 27.1 34.9 36.8 2.7 32.3 33.2 21.0 33.9 22.5 39.7 41.8 45.8 48.4 37.2 42.9 36.0 34.3 51.1 35.7 80.4 66.3 99.4 177.0 81.5 115.4 84.5 53.5 274.4 111.5 106.4 25.5 182.8 159.2 164.1 16.1 133.2 32.6 46.7 128.2 168.7 141.2 127.2 195.7 71.0 164.6 128.7 70.2 94.5 76.4 34.1 170.6 138.1 75.9 92.0 78.5 142.4 108.6 38.6 175.7 143.3 76.2 213.4 162.9 173.1 145.9 77.2 138.3 109.7 93.4 140.8 SSBP2 HSPC116 ENSG00000145687 "Single stranded DNA binding protein 2" P81877 5 81413021-81751797 "Predicted intracellular proteins, Predicted membrane proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 89.9" "Cell type enhanced" "Detected in many" 6 "Muller glia cells: 139.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 38.3;MOLT-4: 35.5;REH: 53.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020834, HPA068605, HPA071780" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB020834: , HPA068605: AB_2732116, HPA071780: " "unprognostic (4.62e-2)" "unprognostic (1.96e-3)" "unprognostic (1.12e-1)" "unprognostic (1.46e-2)" "unprognostic (1.24e-1)" "unprognostic (1.43e-1)" "unprognostic (1.30e-1)" "unprognostic (6.54e-2)" "unprognostic (1.56e-1)" "unprognostic (7.78e-3)" "unprognostic (2.36e-3)" "unprognostic (6.01e-2)" "unprognostic (1.01e-2)" "unprognostic (3.04e-3)" "unprognostic (6.56e-2)" "unprognostic (9.81e-2)" "unprognostic (4.39e-3)" 18.9 11.5 16.3 11.1 24.3 11.0 20.0 49.8 21.3 26.5 18.8 13.6 11.1 5.2 27.0 27.2 21.3 26.4 14.2 26.3 16.1 22.8 10.3 3.2 11.3 15.4 19.9 16.2 33.1 8.7 42.4 31.0 11.7 20.9 16.1 11.7 20.0 14.6 19.5 16.3 19.6 10.3 26.1 20.6 8.9 13.6 6.9 21.5 89.9 12.8 11.7 19.9 19.0 18.5 16.2 8.1 26.2 12.2 25.6 15.2 7.9 1.0 1.9 24.2 13.7 14.0 21.3 1.5 5.0 4.6 4.7 4.9 0.0 2.0 16.7 0.3 5.9 2.3 0.1 6.6 2.7 4.6 7.1 2.8 3.5 4.1 0.0 7.9 1.7 9.3 21.8 23.5 0.8 4.5 10.2 2.0 38.3 2.2 8.2 5.0 2.3 35.5 2.8 3.3 0.0 1.0 53.5 5.5 12.7 2.4 0.9 12.6 11.4 5.3 5.9 1.8 10.2 8.7 4.9 1.3 1.8 3.0 3.5 1.3 8.7 6.7 28.0 6.2 3.1 1.2 20.7 8.6 26.2 2.4 7.6 3.8 9.9 7.7 4.3 8.1 16.2 15.2 5.3 12.5 25.6 12.2 2.6 3.4 7.9 16.3 24.3 49.8 21.3 16.1 22.8 19.9 16.2 20.9 21.5 8.9 18.1 15.4 39.3 31.0 60.9 38.4 7.6 29.4 33.0 27.9 25.5 5.9 14.9 10.5 5.4 19.6 2.3 0.0 8.8 2.8 30.8 11.9 24.3 1.6 16.4 39.7 14.5 18.4 15.4 3.4 35.1 18.7 33.7 5.4 4.7 139.7 6.3 10.2 45.6 4.1 43.9 51.8 68.0 6.3 20.3 31.7 6.2 14.4 3.5 26.4 SSBP3 "CSDP, FLJ10355, SSDP, SSDP1" ENSG00000157216 "Single stranded DNA binding protein 3" Q9BWW4 1 54225432-54413479 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 6.6" "Lineage enriched" "Detected in many" 6 "T-cells: 6.6" "Cell line enhanced" "Detected in all" "BEWO: 52.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071780 Approved Nucleoplasm NA NA Nucleoplasm "HPA071780: " "unprognostic (1.44e-2)" "prognostic favorable (2.48e-9)" "unprognostic (1.06e-2)" "prognostic unfavorable (2.10e-4)" "unprognostic (1.94e-1)" "unprognostic (1.36e-2)" "unprognostic (1.11e-2)" "unprognostic (6.59e-2)" "unprognostic (3.93e-2)" "unprognostic (3.34e-1)" "unprognostic (7.08e-2)" "unprognostic (1.43e-1)" "unprognostic (6.81e-3)" "unprognostic (2.50e-1)" "unprognostic (6.45e-2)" "unprognostic (2.08e-1)" "unprognostic (1.96e-1)" 12.3 19.9 17.4 11.1 18.8 21.3 12.2 27.8 35.8 24.7 15.7 11.2 12.0 14.5 26.1 7.3 17.2 21.9 17.2 13.1 15.3 13.5 10.6 14.7 10.7 9.6 13.7 21.1 51.9 13.5 6.1 7.8 13.9 11.0 16.4 10.7 12.5 13.6 21.1 13.9 16.7 14.9 16.5 15.1 12.1 26.2 12.8 9.6 40.7 9.9 8.5 9.3 15.4 18.9 0.5 0.7 1.1 0.4 0.3 6.6 1.3 3.9 2.5 22.8 14.4 9.0 5.8 52.8 7.7 6.6 3.2 2.5 4.5 3.5 2.7 14.7 6.8 3.3 12.5 11.3 5.3 3.2 20.3 5.3 26.4 8.3 5.1 8.2 6.9 13.1 10.1 3.9 5.6 1.6 5.6 15.9 16.2 25.8 4.9 3.8 3.7 41.4 8.3 43.6 15.3 11.4 29.6 6.3 10.7 4.4 3.0 34.5 19.5 9.2 18.7 5.0 20.2 9.8 8.0 13.3 6.6 11.6 8.2 5.4 11.1 8.9 6.2 11.0 24.0 2.7 0.0 0.4 1.1 2.3 0.2 2.1 0.5 3.7 3.0 0.7 0.3 6.6 5.2 0.1 0.3 0.4 0.6 0.2 1.3 17.4 18.8 27.8 35.8 15.3 13.5 13.7 21.1 11.0 9.6 11.9 8.9 3.0 36.3 26.4 85.6 15.1 45.9 21.4 13.6 22.7 7.9 45.2 8.3 27.5 29.8 31.7 34.9 46.7 22.5 38.4 36.8 27.8 7.0 84.4 22.8 39.7 107.4 44.2 31.0 27.5 84.8 16.2 21.9 6.4 73.5 53.9 41.6 34.5 128.7 8.9 45.8 25.8 41.2 2.5 14.3 22.6 19.8 9.5 46.0 25.7 SSBP4 ENSG00000130511 "Single stranded DNA binding protein 4" Q9BWG4 19 18418864-18434562 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071780 Approved Nucleoplasm NA NA Nucleoplasm "HPA071780: " "unprognostic (2.81e-2)" "unprognostic (8.47e-3)" "unprognostic (4.94e-1)" "unprognostic (1.14e-1)" "unprognostic (1.52e-1)" "unprognostic (2.44e-2)" "unprognostic (3.38e-2)" "unprognostic (1.56e-2)" "unprognostic (3.67e-1)" "unprognostic (7.85e-2)" "prognostic favorable (1.01e-4)" "unprognostic (3.32e-2)" "prognostic unfavorable (2.04e-10)" "unprognostic (4.50e-2)" "unprognostic (1.97e-1)" "unprognostic (4.26e-2)" "unprognostic (1.05e-2)" 20.7 15.9 25.4 17.6 39.9 12.2 8.7 16.3 30.1 15.1 12.5 8.0 15.3 16.7 19.9 8.5 8.7 23.2 7.4 8.6 21.1 15.2 9.7 8.2 14.8 16.2 7.7 16.2 15.0 16.1 6.9 28.6 12.7 10.0 13.3 5.0 11.9 12.4 24.1 25.6 11.6 20.1 8.0 5.7 35.5 23.3 12.1 11.4 11.7 11.1 6.9 9.9 7.2 10.3 10.8 5.4 0.5 17.8 3.4 9.4 3.2 11.6 9.0 8.6 15.2 1.6 6.1 12.1 16.4 3.3 3.7 3.9 3.7 13.0 10.3 14.4 3.5 4.0 13.5 2.2 3.0 1.5 11.0 25.2 18.0 11.0 8.3 6.7 8.3 33.2 5.2 2.4 2.3 0.9 5.1 10.9 20.2 36.0 5.1 1.1 17.5 22.1 27.7 7.0 5.5 26.5 15.2 6.9 10.5 5.6 3.7 15.3 26.3 2.5 7.8 21.6 1.7 8.5 19.6 13.8 6.3 16.7 38.2 10.4 7.6 2.2 6.8 16.5 26.2 12.7 0.0 4.3 0.2 9.4 10.8 6.4 10.8 7.9 8.1 5.4 8.7 4.7 8.1 0.5 3.4 17.8 3.4 4.1 3.2 25.4 39.9 16.3 30.1 21.1 15.2 7.7 16.2 10.0 11.4 6.0 18.1 39.5 27.2 15.2 13.5 5.2 7.6 76.3 19.4 50.6 23.6 17.6 21.6 11.4 7.1 33.8 5.6 0.0 18.2 37.9 45.1 23.7 36.9 10.6 31.0 39.7 57.5 23.9 27.9 21.3 54.1 31.1 18.6 8.2 16.9 21.3 11.8 10.5 48.4 17.3 14.1 38.8 35.9 18.2 59.4 12.8 15.8 51.1 17.8 24.0 SSC5D "FLJ35258, S5D-SRCRB" ENSG00000179954 "Scavenger receptor cysteine rich family member with 5 domains" A1L4H1 19 55488404-55519098 "Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Leydig cells: 16.7;Peritubular cells: 14.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 18.9;BJ: 17.8;fHDF/TERT166: 18.0;hTERT-RPE1: 17.6;U-87 MG: 19.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA042008, HPA053316" Approved Approved Nucleoplasm,Cytosol "Secreted in other tissues" Yes NA 44000000 "Nucleoplasm, Cytosol" "HPA042008: AB_10804124, HPA053316: " "unprognostic (1.23e-1)" "unprognostic (1.29e-1)" "unprognostic (1.78e-2)" "unprognostic (1.28e-2)" "unprognostic (4.55e-2)" "unprognostic (6.65e-2)" "unprognostic (3.68e-1)" "unprognostic (1.16e-1)" "unprognostic (2.85e-2)" "unprognostic (1.34e-3)" "unprognostic (1.40e-1)" "unprognostic (6.20e-3)" "prognostic unfavorable (4.26e-8)" "unprognostic (7.73e-3)" "unprognostic (1.51e-1)" "unprognostic (1.20e-2)" "unprognostic (2.21e-3)" 10.7 2.1 3.3 4.9 1.8 0.1 8.1 3.5 1.9 33.0 18.4 1.6 6.3 2.1 33.1 15.2 9.8 11.0 30.9 10.6 1.4 0.6 2.5 1.8 5.8 1.2 1.2 1.6 17.0 1.8 0.3 13.4 2.5 3.0 6.8 3.2 4.7 1.9 15.7 4.7 3.8 5.8 23.8 3.2 7.3 6.9 5.7 1.4 0.5 2.4 4.2 1.6 19.3 10.9 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.8 0.3 0.0 2.2 18.9 0.0 17.8 4.0 2.5 3.0 0.2 0.0 0.7 0.2 18.0 0.8 0.0 0.0 0.0 1.3 0.0 0.1 3.1 0.8 0.0 3.7 0.1 5.6 8.9 0.0 3.3 0.0 17.6 0.0 0.4 0.1 0.2 0.3 0.0 0.0 0.4 0.6 0.0 0.1 0.4 0.9 0.1 2.0 0.0 1.9 0.2 0.2 0.0 0.3 0.3 0.2 0.7 7.2 0.8 1.0 0.7 2.8 0.2 0.0 0.1 19.3 0.2 3.9 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.3 1.8 3.5 1.9 1.4 0.6 1.2 1.6 3.0 1.4 3.0 1.1 0.0 0.2 1.6 5.4 1.8 0.0 0.0 0.0 0.0 2.0 0.1 1.7 0.1 0.4 1.5 1.6 0.0 0.0 0.1 6.0 0.3 0.0 0.0 1.2 3.2 0.0 3.7 0.0 0.4 16.7 1.1 1.7 1.0 0.6 3.2 0.1 0.0 14.9 0.0 1.9 0.0 5.7 0.7 1.1 1.6 0.0 0.0 1.7 0.1 SSFA2 "CS-1, KIAA1927, KRAP, SPAG13" ENSG00000138434 "Sperm specific antigen 2" P28290 2 181891833-181930738 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 85.5" "Cell type enhanced" "Detected in many" 4 "Suprabasal keratinocytes: 167.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 4 "dendritic cells: 3.8;granulocytes: 8.1;monocytes: 6.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034665, HPA039989" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA034665: AB_2674271, HPA039989: AB_2676788" "unprognostic (1.68e-1)" "unprognostic (3.27e-2)" "unprognostic (2.17e-2)" "unprognostic (4.70e-2)" "unprognostic (8.77e-2)" "unprognostic (8.87e-2)" "unprognostic (2.13e-1)" "unprognostic (4.74e-2)" "unprognostic (5.63e-2)" "unprognostic (1.23e-2)" "prognostic unfavorable (8.19e-4)" "unprognostic (6.95e-2)" "prognostic favorable (2.91e-5)" "unprognostic (3.39e-1)" "unprognostic (5.54e-2)" "unprognostic (4.95e-2)" "prognostic unfavorable (5.79e-5)" 14.2 10.1 23.3 11.8 27.0 16.1 21.6 25.8 22.5 17.7 24.4 26.2 9.4 17.5 13.0 8.9 12.0 10.7 18.7 13.6 23.7 19.1 22.8 36.0 23.0 11.2 31.3 17.7 7.2 85.5 10.5 10.2 40.9 24.8 18.1 24.1 22.3 29.2 10.0 16.6 50.6 19.5 14.2 27.8 14.7 26.0 16.7 23.8 9.3 19.6 12.2 7.9 14.3 23.5 1.2 3.8 8.1 6.4 1.0 1.4 1.8 16.4 8.2 24.0 4.0 21.0 17.4 6.8 29.2 28.4 10.3 13.7 8.5 19.1 0.4 9.5 20.5 12.7 14.3 5.8 14.0 19.9 7.5 6.6 16.6 35.3 6.8 15.5 8.5 15.6 10.3 20.7 17.7 24.1 24.4 53.7 8.0 7.4 9.2 28.6 8.3 7.5 11.9 1.6 15.3 19.4 5.6 9.7 5.7 29.0 5.0 4.2 3.7 17.1 6.1 26.1 9.5 4.4 18.6 21.3 24.4 11.8 8.7 15.1 6.3 2.7 6.6 11.4 5.1 18.2 8.1 3.9 5.7 1.4 3.9 0.9 0.6 1.0 0.9 3.8 1.2 1.3 1.1 6.6 1.0 6.4 3.1 0.6 1.8 23.3 27.0 25.8 22.5 23.7 19.1 31.3 17.7 24.8 23.8 134.0 40.6 11.2 36.2 97.1 18.5 23.0 35.7 33.5 35.2 31.4 35.3 19.9 14.9 15.8 9.0 52.6 132.6 0.0 62.2 21.0 25.9 46.7 22.0 89.3 18.4 25.4 105.7 36.8 47.5 13.4 17.5 29.8 55.6 15.4 57.0 17.2 54.1 41.9 16.3 36.3 33.6 38.8 24.5 22.3 25.4 167.2 27.9 12.9 39.3 84.6 SSH1 KIAA1298 ENSG00000084112 "Slingshot protein phosphatase 1" Q8WYL5 12 108778192-108857590 "Enzymes, Predicted intracellular proteins" "Actin-binding, Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 34.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019845 Uncertain Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA019845: AB_1857497" "unprognostic (1.18e-3)" "unprognostic (3.00e-1)" "unprognostic (2.49e-1)" "unprognostic (2.70e-2)" "unprognostic (9.40e-2)" "unprognostic (7.45e-2)" "prognostic unfavorable (5.80e-5)" "unprognostic (3.28e-2)" "unprognostic (3.69e-2)" "unprognostic (1.72e-3)" "unprognostic (7.12e-2)" "unprognostic (3.42e-1)" "unprognostic (1.71e-2)" "unprognostic (1.41e-1)" "unprognostic (8.66e-2)" "unprognostic (9.55e-2)" "unprognostic (6.22e-2)" 7.3 7.8 8.5 7.4 8.1 10.6 9.3 20.3 8.8 7.4 8.5 6.8 13.1 4.4 9.8 7.9 7.6 8.2 8.3 10.1 8.0 6.9 5.8 7.4 10.1 8.7 7.7 5.2 7.9 8.0 9.7 6.8 7.8 8.4 6.5 6.5 15.0 5.9 8.0 21.4 7.1 6.5 10.4 8.1 8.6 7.1 5.2 6.6 2.0 7.0 7.9 6.6 10.0 13.3 1.8 2.0 5.7 4.0 2.1 2.9 1.2 5.1 6.8 4.5 3.5 8.5 7.3 4.0 6.6 14.2 6.1 5.4 3.4 2.5 2.4 4.7 15.5 10.4 5.1 2.7 11.2 5.0 5.0 2.6 5.7 3.1 2.1 4.6 2.9 15.2 10.0 3.8 5.5 12.3 15.1 5.6 3.0 1.3 2.0 15.9 2.9 3.3 4.2 3.1 2.0 5.5 2.4 5.3 3.2 2.4 9.2 3.3 4.5 5.8 1.6 12.8 6.5 2.1 2.6 4.4 10.9 4.7 6.5 3.8 3.9 3.5 3.0 5.7 2.4 34.4 4.2 2.4 4.8 2.9 4.0 2.7 1.6 1.5 2.5 1.6 1.8 1.4 1.6 5.7 2.1 3.2 2.0 1.7 1.2 8.5 8.1 20.3 8.8 8.0 6.9 7.7 5.2 8.4 6.6 8.9 17.3 4.7 15.4 8.4 10.6 21.2 12.7 8.1 14.8 14.0 15.7 4.7 5.0 7.7 1.6 37.5 3.5 0.0 7.0 3.7 10.3 7.2 19.7 13.4 11.2 11.1 5.2 25.8 24.7 2.6 6.1 17.8 11.8 43.3 6.6 8.8 10.1 0.0 12.0 4.9 20.7 6.5 17.6 1.1 6.6 7.9 1.9 15.4 5.7 12.2 SSPN "KRAG, SPN1, SPN2" ENSG00000123096 Sarcospan Q14714 12 26121991-26299290 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Leydig cells: 172.0;Peritubular cells: 251.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "memory B-cell: 29.7" "Lineage enriched" "Detected in many" 21 "B-cells: 29.7" "Cell line enhanced" "Detected in many" "ASC diff: 13.0;hTERT-RPE1: 46.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066432 Approved "Nucleoplasm,Nuclear membrane" No No "Nuclear membrane" Nucleoplasm "HPA066432: AB_2685669" "unprognostic (4.82e-2)" "unprognostic (1.63e-1)" "unprognostic (2.03e-1)" "unprognostic (6.49e-2)" "unprognostic (2.04e-1)" "unprognostic (2.45e-1)" "unprognostic (6.11e-2)" "unprognostic (1.44e-2)" "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" "unprognostic (2.71e-2)" "unprognostic (1.37e-2)" "prognostic unfavorable (2.77e-5)" "unprognostic (2.64e-3)" "unprognostic (3.86e-2)" "unprognostic (1.40e-1)" "unprognostic (1.21e-1)" 12.5 6.8 13.9 6.6 12.6 0.1 11.5 16.5 11.4 24.9 12.7 11.1 4.1 2.7 14.6 10.3 11.4 15.0 14.3 26.2 21.0 6.1 3.8 1.4 5.4 4.5 17.2 8.7 21.5 4.7 2.9 4.8 2.5 20.9 14.5 7.3 7.8 6.8 21.1 38.7 3.6 6.3 20.1 20.4 4.9 6.7 5.8 19.0 3.2 10.0 15.4 6.5 18.2 10.8 29.7 0.0 1.4 0.0 0.0 0.2 0.3 0.3 0.7 2.0 0.0 13.0 7.4 0.1 3.8 5.3 0.5 1.5 0.0 4.7 0.0 0.8 5.2 3.0 1.5 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 4.6 0.4 1.7 0.4 46.8 0.2 0.0 0.0 0.0 4.0 0.8 0.2 1.1 4.4 0.2 1.2 0.1 5.3 1.4 1.2 4.0 0.2 3.8 1.4 0.3 3.7 2.1 0.4 0.1 1.4 1.8 1.0 1.8 0.9 0.1 0.5 0.0 2.8 0.0 4.6 0.0 0.0 1.2 0.0 0.0 0.2 29.7 0.0 0.0 0.0 6.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 13.9 12.6 16.5 11.4 21.0 6.1 17.2 8.7 20.9 19.0 3.0 2.7 20.9 16.5 12.0 1.7 79.0 7.6 6.7 19.4 17.4 0.0 63.3 5.0 8.5 3.3 8.3 8.4 0.0 6.5 5.6 56.4 10.8 0.0 0.0 12.1 6.4 4.7 8.6 0.0 3.1 172.0 7.9 18.6 32.5 9.1 35.9 2.4 7.0 251.4 2.2 2.6 38.8 42.9 0.3 0.9 6.1 23.2 1.0 5.8 17.1 SSRP1 FACT80 ENSG00000149136 "Structure specific recognition protein 1" Q08945 11 57325985-57335877 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002697 Approved Approved Nucleoplasm,Cytosol NA NA 8300 Cytosol Nucleoplasm "HPA002697: AB_1857509" "unprognostic (1.67e-1)" "unprognostic (3.21e-1)" "unprognostic (2.96e-2)" "unprognostic (3.54e-1)" "unprognostic (2.84e-1)" "unprognostic (3.52e-2)" "prognostic unfavorable (4.03e-7)" "unprognostic (3.22e-2)" "unprognostic (1.96e-1)" "unprognostic (1.49e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.06e-1)" "prognostic unfavorable (5.63e-4)" "unprognostic (5.92e-2)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" "unprognostic (3.52e-2)" 25.3 23.2 23.5 37.7 25.1 32.0 38.4 28.5 27.6 27.2 30.5 19.4 28.8 23.0 34.9 28.2 34.6 34.4 33.1 28.4 22.7 20.3 22.6 27.8 26.5 33.7 21.6 20.7 41.8 39.3 39.7 31.2 34.8 22.0 26.6 33.0 17.2 32.8 27.5 47.7 32.9 26.2 28.9 17.1 28.3 29.3 28.3 25.2 44.0 45.9 37.0 42.5 28.7 51.7 10.2 10.3 4.5 5.2 6.9 12.0 4.7 57.5 55.7 52.8 38.6 16.7 18.6 25.9 31.7 30.7 55.5 39.8 38.2 43.1 70.0 33.9 27.8 35.3 44.6 83.7 49.4 70.1 48.8 47.0 44.7 41.0 41.0 26.3 74.0 33.6 18.7 30.2 57.0 79.4 25.8 36.2 54.2 60.7 35.5 37.7 39.0 74.9 65.5 69.4 30.7 34.3 63.3 89.3 68.0 25.9 41.6 55.3 46.9 44.9 38.6 46.8 28.3 46.8 29.2 27.2 37.9 50.1 51.0 54.2 41.4 41.0 72.4 32.1 41.8 49.9 0.8 4.3 4.5 9.4 5.2 9.1 8.7 8.1 10.2 6.1 10.2 8.9 12.0 1.2 6.9 5.0 10.3 9.6 4.7 23.5 25.1 28.5 27.6 22.7 20.3 21.6 20.7 22.0 25.2 71.5 73.4 41.0 69.0 66.5 23.9 23.5 33.1 148.5 102.4 27.9 23.6 89.5 11.6 62.9 64.9 43.6 26.8 0.0 86.1 90.2 43.5 42.4 38.3 31.8 50.8 23.8 27.6 32.5 32.2 93.2 39.4 40.0 27.0 44.1 40.8 23.8 58.2 35.1 41.8 20.2 16.4 19.4 46.2 55.9 93.5 66.7 56.5 36.3 68.4 62.2 SSU72 HSPC182 ENSG00000160075 "SSU72 homolog, RNA polymerase II CTD phosphatase" Q9NP77 1 1541673-1574869 "Enzymes, Predicted intracellular proteins" "mRNA processing" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 520.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069290, HPA070604" Supported Approved Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA069290: AB_2686108, HPA070604: AB_2686285" "unprognostic (3.33e-2)" "unprognostic (2.79e-2)" "unprognostic (6.37e-2)" "unprognostic (2.27e-2)" "unprognostic (2.41e-1)" "unprognostic (9.84e-2)" "unprognostic (2.40e-3)" "unprognostic (2.43e-2)" "unprognostic (3.23e-1)" "unprognostic (3.23e-1)" "unprognostic (6.75e-2)" "unprognostic (1.36e-1)" "unprognostic (6.56e-3)" "unprognostic (1.19e-1)" "unprognostic (8.51e-2)" "unprognostic (3.77e-1)" "unprognostic (1.06e-1)" 44.1 32.5 48.0 33.6 51.5 29.3 73.9 42.3 51.5 37.2 40.1 25.4 39.3 41.3 32.6 51.8 45.7 46.2 35.3 44.4 40.7 42.5 38.0 50.9 37.5 49.0 39.4 39.0 38.0 61.8 33.9 39.9 35.8 36.9 33.9 35.9 34.1 54.2 35.8 107.1 36.9 40.8 35.4 35.0 41.7 38.5 28.0 28.4 37.0 50.9 45.3 36.3 30.8 42.2 35.5 30.1 62.0 28.8 20.7 46.5 28.1 41.4 26.6 19.2 29.6 33.1 32.0 19.7 36.1 28.2 31.5 32.9 24.9 48.2 42.2 19.8 28.4 30.8 32.4 31.0 29.7 30.8 35.1 36.6 26.5 23.3 39.3 37.5 33.5 23.2 28.5 25.1 33.7 32.2 26.5 29.4 25.7 45.8 32.7 24.9 36.9 38.3 53.8 33.6 40.9 40.4 30.5 31.0 59.0 34.5 12.8 35.6 24.4 24.4 62.7 106.5 34.0 32.7 29.2 22.4 30.4 19.3 34.2 30.9 39.9 47.9 52.7 31.8 53.4 14.7 37.1 28.3 53.6 25.9 28.8 31.9 35.5 34.4 30.7 30.1 33.1 42.2 34.1 62.0 20.7 25.4 19.0 46.5 28.1 48.0 51.5 42.3 51.5 40.7 42.5 39.4 39.0 36.9 28.4 26.8 71.4 136.9 121.9 165.4 98.0 80.5 117.2 36.1 37.5 96.0 19.6 178.0 247.1 62.6 202.0 95.1 177.2 0.0 92.6 189.0 93.0 151.4 60.0 123.8 125.1 106.5 136.4 90.9 152.3 520.2 97.0 118.3 158.6 91.0 137.9 96.8 78.9 168.6 80.6 258.7 57.5 58.2 97.3 81.2 147.4 192.6 205.2 116.7 134.0 129.8 SSX1 CT5.1 ENSG00000126752 "SSX family member 1" Q16384 X 48255317-48267444 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 12.6" "Group enriched" "Detected in some" 12 "Sertoli cells: 6.5;Spermatocytes: 9.8;Spermatogonia: 22.6" "Cancer enhanced" "Detected in many" "liver cancer: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 28.8;Karpas-707: 41.8;U-2197: 9.7" HPA045683 Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418" "unprognostic (2.25e-1)" "unprognostic (3.51e-3)" "unprognostic (2.36e-1)" "unprognostic (4.32e-3)" "unprognostic (3.38e-1)" "unprognostic (5.41e-2)" "unprognostic (6.94e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.9 0.4 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 41.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 9.7 0.0 0.0 2.0 0.0 2.4 0.0 0.0 0.9 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 9.8 22.6 0.0 0.0 0.0 0.0 0.0 SSX2 "CT5.2a, HD21, HOM-MEL-40, MGC119055, MGC15364, MGC3884, SSX" ENSG00000241476 "SSX family member 2" Q16385 X 52696896-52707189 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 57 "testis: 24.1" "Cell type enriched" "Detected in single" 28 "Spermatogonia: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "PC-3: 3.2;U-2197: 1.9" "HPA045683, CAB046020" Enhanced Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "CAB046020: AB_2194010, HPA045683: AB_2679418" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.3 0.0 0.0 0.0 0.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.9 0.0 0.6 0.1 0.6 1.9 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 SSX2B CT5.2b ENSG00000268447 "SSX family member 2B" Q16385 X 52751132-52790305 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 24 "testis: 13.5" "Cell type enriched" "Detected in single" 10 "Spermatogonia: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.8;HMC-1: 5.4;PC-3: 5.2;T-47d: 2.3;U-2197: 3.3" HPA045683 Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.9 0.0 0.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.7 0.6 0.5 0.1 0.0 0.0 0.2 0.0 5.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.0 2.3 0.0 1.0 0.0 0.5 3.3 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.4 0.0 0.0 0.0 0.0 0.0 SSX3 CT5.3 ENSG00000165584 "SSX family member 3" Q99909 X 48346428-48356707 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 18.0" "Cell type enriched" "Detected in some" 9 "Spermatogonia: 144.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "Karpas-707: 6.9" HPA045683 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418" "unprognostic (1.86e-1)" "unprognostic (2.13e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 1.6 0.2 0.4 0.4 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.9 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.4 0.0 1.6 0.5 0.2 0.2 0.0 0.0 1.6 0.2 0.8 0.3 0.1 0.2 0.8 0.3 0.4 0.0 0.9 0.4 0.4 0.2 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 16.7 144.8 0.0 0.0 0.0 0.0 0.0 SSX4 CT5.4 ENSG00000268009 "SSX family member 4" O60224 X 48383516-48393347 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 6.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "BEWO: 3.6;Karpas-707: 8.8;U-266/70: 5.2;U-266/84: 9.5" HPA045683 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.1 0.7 0.3 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 8.8 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.0 0.0 5.2 9.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSX4B OTTHUMT00000056510 ENSG00000269791 "SSX family member 4B" O60224 X 48402078-48411910 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "BEWO: 3.6;Karpas-707: 8.8;U-266/70: 5.2;U-266/84: 9.5" HPA045683 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.1 0.7 0.3 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 8.8 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.0 0.0 5.2 9.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSX5 ENSG00000165583 "SSX family member 5" O60225 X 48186220-48196763 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 4.3;thyroid gland: 2.9" "Cell type enriched" "Detected in single" 14 "Spermatogonia: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "BEWO: 10.8" HPA045683 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418" "unprognostic (1.20e-1)" "unprognostic (2.96e-1)" "unprognostic (1.23e-1)" 0.4 0.0 0.1 0.1 0.4 1.0 0.1 0.1 0.1 0.1 1.2 0.1 0.1 0.0 0.5 0.2 0.1 0.8 0.1 0.8 0.1 0.1 0.1 0.1 0.2 0.3 0.1 0.1 0.3 0.1 1.6 0.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.6 0.2 0.1 0.1 0.8 0.0 4.3 0.1 0.1 2.9 0.1 0.1 0.1 0.1 0.5 0.2 0.9 0.2 0.6 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.7 1.3 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.2 0.4 0.3 0.4 0.1 0.5 0.1 0.4 0.9 0.6 0.0 0.2 0.2 0.0 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.8 0.0 0.0 0.0 0.0 0.0 SSX7 ENSG00000187754 "SSX family member 7" Q7RTT5 X 52644090-52654900 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEL: 1.7;HMC-1: 8.1;RT4: 4.3" HPA045683 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418" "unprognostic (1.29e-1)" 0.1 0.2 0.2 0.4 0.1 0.7 0.1 0.1 1.0 0.1 0.2 0.6 0.2 0.0 1.5 0.3 0.5 0.1 0.1 0.2 0.1 0.1 0.5 0.3 0.1 0.8 0.1 0.0 0.1 0.0 0.1 0.0 1.8 0.0 0.1 1.5 0.1 0.0 0.1 0.6 0.4 1.0 0.4 0.0 0.2 0.1 0.0 0.2 1.0 0.7 0.3 0.4 0.0 0.4 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.9 0.0 0.1 0.1 0.6 0.3 1.7 0.7 0.3 0.0 0.0 8.1 0.0 0.2 0.2 0.0 0.3 0.1 0.4 0.2 1.4 0.1 1.0 0.7 0.2 0.0 0.2 0.0 0.4 0.5 0.0 0.0 4.3 0.3 0.0 0.1 0.0 0.0 0.4 0.0 0.5 0.3 0.1 0.0 0.0 0.3 0.4 0.6 0.1 0.0 0.1 0.1 0.1 0.5 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.0 0.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 ST14 "HAI, MT-SP1, PRSS14, SNC19, TMPRSS14" ENSG00000149418 "Suppression of tumorigenicity 14" Q9Y5Y6 11 130159562-130210376 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease mutation, Hypotrichosis, Ichthyosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 94.1" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 295.9;Mucus-secreting cells: 176.7;Paneth cells: 178.5;Urothelial cells: 230.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 18.2" "Lineage enriched" "Detected in many" 5 "dendritic cells: 18.2" "Cell line enhanced" "Detected in some" "CACO-2: 36.0;CAPAN-2: 72.5;HaCaT: 50.8;OE19: 38.5;RPMI-8226: 47.5;SK-BR-3: 33.6;T-47d: 50.8;U-698: 34.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA047014 Approved Nucleoplasm,Vesicles NA NA 220000 "Nucleoplasm, Vesicles" "HPA047014: AB_2679902" "unprognostic (1.17e-1)" "unprognostic (1.15e-1)" "unprognostic (9.62e-2)" "unprognostic (1.32e-1)" "unprognostic (2.17e-2)" "unprognostic (7.94e-2)" "unprognostic (1.20e-1)" "unprognostic (3.97e-2)" "unprognostic (5.29e-1)" "unprognostic (3.21e-1)" "unprognostic (1.03e-3)" "unprognostic (2.25e-1)" "prognostic favorable (5.03e-11)" "unprognostic (1.92e-2)" "unprognostic (2.71e-1)" "unprognostic (1.28e-2)" "unprognostic (5.60e-2)" 10.1 1.8 0.7 21.9 1.8 0.5 5.5 0.8 1.4 8.9 48.6 0.5 23.8 33.8 2.8 16.9 38.9 9.7 32.4 1.1 0.5 0.5 30.5 3.2 9.5 7.5 1.8 0.6 3.6 34.3 8.4 9.5 12.7 1.5 12.1 15.4 0.7 25.1 15.8 0.7 17.8 94.1 1.2 1.8 4.0 16.7 2.1 1.5 5.2 24.0 20.1 28.4 8.3 14.9 3.8 18.2 2.3 2.7 0.0 0.1 0.8 26.4 0.0 0.0 0.1 0.0 0.0 14.4 0.0 0.0 0.0 0.0 36.0 72.5 26.1 2.7 0.0 0.0 50.8 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.1 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.0 0.1 0.2 38.5 0.1 0.0 0.0 47.5 4.7 21.7 2.9 0.0 0.2 33.6 0.0 0.2 50.8 5.1 0.0 0.0 0.4 0.1 0.1 0.0 0.0 34.6 0.0 8.0 0.0 0.0 2.7 2.3 0.0 1.5 0.1 3.8 0.0 0.0 4.5 2.3 0.0 0.0 0.3 0.0 0.2 18.2 0.0 0.8 0.7 1.8 0.8 1.4 0.5 0.5 1.8 0.6 1.5 1.5 29.8 25.8 9.3 31.0 36.4 0.0 0.8 38.2 17.4 20.5 59.3 0.0 40.3 3.3 108.8 27.9 0.4 295.9 0.0 80.1 11.6 2.6 89.5 11.5 1.9 60.1 0.0 118.5 0.0 25.4 11.5 1.7 19.0 6.8 8.2 176.7 0.0 114.4 178.5 0.7 10.5 0.0 6.5 1.4 0.2 0.1 38.3 33.2 1.3 155.8 230.3 ST5 "DENND2B, HTS1, p126" ENSG00000166444 "Suppression of tumorigenicity 5" P78524 11 8693351-8910951 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 538.0;Rod photoreceptor cells: 371.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 5.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 36.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046796 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA046796: AB_2679812" "unprognostic (1.88e-3)" "unprognostic (2.18e-2)" "unprognostic (2.19e-1)" "unprognostic (1.88e-2)" "unprognostic (4.17e-2)" "unprognostic (2.46e-1)" "unprognostic (6.42e-2)" "unprognostic (1.17e-1)" "unprognostic (1.72e-1)" "unprognostic (5.56e-2)" "unprognostic (3.67e-2)" "unprognostic (1.28e-1)" "unprognostic (1.09e-1)" "unprognostic (1.37e-1)" "unprognostic (8.77e-2)" "unprognostic (1.60e-1)" "unprognostic (1.54e-1)" 9.6 25.4 9.5 14.9 11.9 1.3 11.0 16.3 13.2 45.1 29.3 14.1 20.4 11.9 71.3 22.2 27.0 41.1 22.4 13.9 8.5 7.5 10.8 10.4 11.0 5.9 7.9 9.7 49.5 14.4 6.5 14.8 19.2 11.6 24.5 11.7 28.9 21.0 28.3 8.4 8.4 17.8 51.4 8.5 22.8 22.4 34.5 8.6 4.5 15.8 9.2 8.6 26.5 19.7 1.3 1.6 1.0 5.9 0.0 0.2 0.6 12.4 1.8 20.6 3.4 6.9 7.2 0.9 11.3 36.7 10.9 10.1 2.5 13.5 0.4 6.8 20.4 4.8 12.6 3.8 16.4 4.3 1.7 5.0 0.0 6.4 8.6 10.4 0.0 0.1 24.5 4.6 6.2 8.3 22.6 2.1 2.0 2.6 1.1 17.6 1.3 0.7 0.5 3.0 12.5 3.0 0.4 12.4 0.7 15.2 9.1 3.9 12.2 9.7 12.7 7.8 7.1 2.1 0.4 5.7 5.9 10.0 19.2 8.8 3.0 5.7 0.1 9.8 0.0 11.9 0.0 0.1 0.0 0.1 0.8 0.0 1.3 0.0 0.0 1.6 1.2 0.1 0.1 1.0 0.0 5.9 0.0 0.2 0.6 9.5 11.9 16.3 13.2 8.5 7.5 7.9 9.7 11.6 8.6 11.9 38.5 0.0 42.4 15.8 27.4 4.4 38.2 28.1 40.9 17.4 538.0 3.3 3.3 35.5 32.9 10.1 19.7 23.3 28.3 1.8 23.7 23.4 1.1 9.6 5.2 1.6 16.7 8.6 3.1 23.3 74.5 3.6 23.6 6.4 22.8 94.1 32.0 7.0 93.7 1.5 371.0 64.7 36.4 18.0 16.6 6.8 2.4 0.0 19.8 25.8 ST6GAL2 "KIAA1877, SIAT2, St6gal2, St6GalII" ENSG00000144057 "ST6 beta-galactoside alpha-2,6-sialyltransferase 2" Q96JF0 2 106801600-106887108 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.7;thyroid gland: 34.0" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 7.7;Ito cells: 2.5;Mucus-secreting cells: 2.3" "Cancer enriched" "Detected in many" 7 "thyroid cancer: 16.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 5.7;hTERT-RPE1: 7.2;NTERA-2: 4.9;PC-3: 6.4;RPMI-8226: 10.2;SCLC-21H: 6.8;U-138 MG: 8.3;U-266/70: 10.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014459 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA014459: AB_1857528" "unprognostic (2.08e-1)" "unprognostic (5.80e-2)" "unprognostic (1.55e-1)" "unprognostic (4.63e-2)" "unprognostic (6.44e-3)" "unprognostic (1.62e-1)" "unprognostic (2.35e-2)" "unprognostic (1.10e-2)" "unprognostic (1.29e-4)" "unprognostic (4.56e-3)" "unprognostic (7.04e-2)" "unprognostic (1.84e-2)" "unprognostic (7.01e-4)" "unprognostic (4.70e-4)" "unprognostic (4.06e-2)" "unprognostic (2.83e-1)" "unprognostic (2.07e-2)" 1.2 0.7 14.1 0.7 5.6 1.5 1.3 2.3 16.7 2.1 1.5 4.1 1.7 0.7 3.7 1.9 2.7 1.2 12.7 1.9 5.4 4.0 1.1 3.4 1.2 0.9 3.8 7.1 0.9 0.5 0.5 0.3 2.3 4.2 1.6 3.3 0.0 1.6 1.6 0.7 1.3 0.7 2.8 1.9 0.6 0.9 7.9 1.5 0.0 34.0 1.6 0.8 1.5 1.4 0.7 0.6 1.8 0.5 1.0 0.7 0.5 0.0 5.7 3.1 0.1 0.0 0.0 0.1 0.3 0.0 1.3 0.4 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 1.1 0.0 7.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 4.9 0.0 6.4 0.0 0.0 10.2 0.2 0.0 6.8 4.4 0.0 0.1 0.0 0.3 0.0 0.1 0.0 8.3 0.1 0.2 0.0 10.9 0.2 0.1 0.0 0.0 0.0 1.4 0.5 0.4 0.6 0.3 0.5 0.4 0.4 0.5 0.2 0.7 0.5 0.7 1.8 1.0 0.3 0.6 0.5 0.5 14.1 5.6 2.3 14.8 5.4 4.0 3.8 7.1 4.2 1.5 0.0 0.0 0.0 0.1 0.8 7.7 1.2 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.2 0.0 1.2 2.5 0.0 0.0 0.3 0.0 0.0 0.0 2.3 0.8 0.0 0.0 0.7 0.6 0.5 0.0 1.4 0.0 1.3 0.0 0.2 0.0 1.2 0.0 ST6GALNAC1 "SIAT7A, ST6GalNAcI" ENSG00000070526 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1" Q9NSC7 17 76624761-76643838 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 69.4" "Cell type enriched" "Detected in many" 6 "Mucus-secreting cells: 708.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 11.2;naive CD4 T-cell: 4.2" "Lineage enriched" "Detected in single" 25 "T-cells: 11.2" "Group enriched" "Detected in some" 4 "K-562: 23.7;OE19: 44.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA014767, HPA014975" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA 1200000 "Golgi apparatus" Nucleoplasm "HPA014767: , HPA014975: AB_1857529" "unprognostic (4.59e-2)" "unprognostic (8.60e-3)" "unprognostic (5.32e-3)" "unprognostic (1.86e-3)" "unprognostic (6.31e-3)" "prognostic favorable (2.54e-5)" "unprognostic (1.39e-2)" "unprognostic (1.63e-2)" "unprognostic (2.45e-1)" "unprognostic (2.58e-2)" "unprognostic (8.64e-3)" "unprognostic (2.81e-1)" "unprognostic (1.67e-1)" "unprognostic (2.75e-1)" "unprognostic (1.18e-1)" "unprognostic (5.87e-3)" "unprognostic (5.58e-2)" 1.4 0.3 1.2 13.9 2.6 0.7 1.3 0.8 3.2 20.4 50.9 3.1 0.3 19.8 6.3 1.8 19.6 1.5 26.6 4.1 1.6 1.3 0.4 1.1 5.7 1.1 1.8 1.2 2.0 1.1 0.1 0.4 1.7 3.7 2.6 69.4 0.1 20.8 1.4 0.9 0.6 49.0 1.9 1.5 6.0 23.9 4.0 0.6 0.0 0.5 4.5 21.6 1.9 2.6 0.0 0.0 0.4 0.0 0.0 11.2 1.1 0.0 1.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 4.4 0.0 0.0 4.9 0.0 1.3 0.0 0.0 0.0 7.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 23.7 0.0 0.0 0.0 0.1 0.0 0.0 44.4 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 11.2 0.2 0.0 0.0 4.2 0.0 0.4 0.0 0.0 0.0 1.4 1.1 1.2 2.6 0.8 3.2 1.6 1.3 1.8 1.2 3.7 0.6 14.9 6.9 0.0 5.2 0.1 0.0 1.5 30.6 112.4 76.2 0.0 0.0 0.1 0.0 1.6 0.2 14.2 50.8 0.0 16.6 0.1 0.6 3.2 0.0 0.0 0.2 0.0 31.7 4.3 0.0 0.5 1.4 0.3 0.0 0.0 708.1 0.0 27.0 66.2 0.0 0.0 1.1 0.0 0.1 0.3 0.0 0.1 0.1 0.0 108.2 20.7 ST6GALNAC3 SIAT7C ENSG00000184005 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3" Q8NDV1 1 76074719-76634601 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 23 "Endothelial cells: 21.6;Ito cells: 57.1;Kupffer cells: 11.7;Muller glia cells: 11.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 18.6;HUVEC TERT2: 23.6;SK-MEL-30: 32.2;TIME: 10.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054566, HPA055399" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA054566: AB_2682526, HPA055399: AB_2682806" "unprognostic (7.85e-2)" "unprognostic (1.78e-1)" "unprognostic (2.99e-2)" "unprognostic (2.70e-4)" "unprognostic (2.76e-2)" "unprognostic (2.21e-2)" "unprognostic (6.55e-3)" "unprognostic (7.31e-2)" "unprognostic (2.14e-1)" "unprognostic (4.57e-1)" "unprognostic (1.50e-1)" "unprognostic (5.95e-2)" "unprognostic (9.97e-4)" "unprognostic (3.33e-4)" "unprognostic (5.44e-2)" "unprognostic (1.92e-1)" "unprognostic (3.44e-4)" 20.7 2.9 7.0 3.6 13.0 5.3 13.9 3.8 9.7 4.3 4.0 13.4 2.0 1.8 10.7 2.1 3.8 4.2 4.7 7.8 8.8 6.0 14.9 3.9 7.5 5.1 16.3 3.6 4.7 2.2 12.6 4.3 5.7 12.9 2.5 4.7 2.8 2.3 3.5 3.3 1.9 2.7 8.3 19.0 3.0 3.0 1.2 12.5 0.0 23.2 1.5 1.7 5.5 5.2 5.9 3.0 5.2 8.3 0.4 1.9 2.6 0.1 0.0 18.6 0.0 0.3 0.0 0.0 0.0 2.2 0.3 0.2 6.0 0.0 0.3 1.2 0.1 1.2 0.0 0.0 0.2 0.1 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.5 23.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 1.4 0.0 0.9 0.8 0.0 0.0 0.0 1.4 4.6 0.0 0.0 32.2 4.5 0.0 0.1 10.4 0.1 1.5 0.0 1.7 0.0 0.0 0.0 0.0 4.2 2.8 0.0 8.3 3.7 0.0 2.9 0.0 3.3 0.5 0.8 3.0 5.9 1.9 1.9 5.2 0.4 5.3 0.0 0.0 2.6 7.0 13.0 3.8 9.7 8.8 6.0 16.3 3.6 12.9 12.5 3.0 1.0 1.3 0.1 0.2 3.0 1.1 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.4 0.8 0.0 0.0 57.1 11.7 0.4 0.0 1.5 5.0 0.0 0.3 11.0 0.2 3.2 0.0 0.0 0.5 0.0 0.3 0.2 0.4 0.4 0.1 0.0 0.0 0.1 ST6GALNAC4 "SIAT3C, SIAT7D, ST6GALNACIV" ENSG00000136840 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4" Q9H4F1 9 127907886-127917038 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 58.8;pancreas: 61.0" "Cell type enhanced" "Detected in many" 6 "Intestinal endocrine cells: 65.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "plasmacytoid DC: 58.8" "Lineage enriched" "Detected in many" 9 "dendritic cells: 58.8" "Cell line enhanced" "Detected in many" "HDLM-2: 35.5;RPMI-8226: 50.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009042 Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA009042: AB_1079963" "unprognostic (2.05e-3)" "unprognostic (2.32e-1)" "unprognostic (2.22e-1)" "unprognostic (1.53e-2)" "unprognostic (3.18e-1)" "unprognostic (2.32e-1)" "prognostic unfavorable (8.63e-7)" "unprognostic (1.62e-2)" "unprognostic (4.26e-1)" "prognostic unfavorable (5.12e-4)" "unprognostic (1.04e-1)" "unprognostic (3.04e-1)" "prognostic unfavorable (8.39e-4)" "unprognostic (1.30e-3)" "unprognostic (2.72e-1)" "unprognostic (2.64e-2)" "unprognostic (2.03e-2)" 8.0 7.8 5.6 7.9 5.6 26.2 12.1 9.8 8.5 9.2 9.3 4.8 28.9 11.7 8.7 9.6 6.9 8.7 12.2 18.4 5.2 3.4 9.4 5.0 13.5 9.7 4.2 4.7 14.9 61.0 2.4 9.4 4.3 4.8 6.1 5.4 4.8 9.3 30.0 12.6 4.0 9.7 6.1 3.9 18.2 7.2 4.3 4.7 4.7 6.3 5.9 12.5 8.9 8.3 6.7 58.8 0.8 3.2 4.3 3.4 2.4 3.2 5.5 1.4 7.0 9.9 7.6 1.0 5.6 6.2 5.7 3.3 3.1 5.9 20.5 8.5 7.0 8.1 7.9 2.9 5.9 0.9 35.5 2.4 6.5 17.6 11.6 12.1 0.5 6.8 9.2 6.3 5.1 4.6 4.6 15.2 3.9 4.6 13.7 2.7 1.5 1.2 0.7 1.6 10.5 13.6 6.2 3.7 50.3 5.8 0.1 12.0 2.7 8.1 17.6 1.0 0.5 3.6 4.2 10.8 4.7 5.4 14.6 8.7 22.4 11.5 6.4 9.4 2.9 0.6 0.8 2.1 0.0 2.9 1.9 3.3 6.7 1.8 3.4 2.8 4.9 2.3 3.1 0.2 4.3 3.2 58.8 3.3 2.4 5.6 5.6 9.8 8.5 5.2 3.4 4.2 4.7 4.8 4.7 8.9 24.5 43.4 11.9 1.9 2.4 10.3 10.2 5.3 4.5 1.8 0.0 0.9 1.7 14.0 0.1 10.8 19.6 23.3 12.5 14.4 11.9 2.0 8.1 1.5 22.1 0.0 65.1 4.9 11.4 0.0 16.1 8.5 6.8 12.6 13.1 14.1 11.9 6.5 40.3 17.3 1.7 12.9 8.9 0.2 1.3 2.8 3.8 10.2 16.4 10.0 ST7 "ETS7q, FAM4A, FAM4A1, HELG, RAY1, SEN4, TSG7" ENSG00000004866 "Suppression of tumorigenicity 7" Q9NRC1 7 116953238-117230103 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 107.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 52.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038325, HPA038326" Approved Supported Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA038325: AB_10671740, HPA038326: AB_10672644" "unprognostic (3.40e-2)" "unprognostic (1.04e-1)" "unprognostic (1.33e-1)" "unprognostic (4.70e-2)" "unprognostic (1.09e-1)" "unprognostic (8.18e-2)" "unprognostic (3.32e-2)" "unprognostic (1.74e-2)" "unprognostic (1.02e-1)" "unprognostic (4.45e-3)" "unprognostic (1.46e-1)" "unprognostic (2.48e-2)" "prognostic favorable (3.39e-5)" "unprognostic (1.80e-1)" "unprognostic (1.96e-1)" "unprognostic (8.41e-2)" "unprognostic (3.40e-2)" 11.1 20.0 12.9 5.0 18.0 12.0 12.3 63.0 25.7 16.7 10.7 9.2 21.6 9.8 12.3 31.2 8.5 15.8 10.0 19.8 10.9 12.3 23.1 31.5 20.0 5.4 11.1 18.7 15.9 30.8 17.6 30.1 21.8 14.9 11.7 10.1 11.0 24.9 19.3 10.1 9.7 9.7 11.3 8.1 9.1 13.5 15.9 8.2 2.9 23.8 7.6 7.0 10.0 9.8 2.6 6.2 1.6 3.3 7.6 10.6 3.2 13.1 7.6 12.4 10.8 14.4 9.9 5.7 10.4 13.2 10.7 16.0 10.2 15.6 3.4 11.4 9.1 16.3 10.8 10.6 11.1 14.6 4.6 15.3 10.3 12.7 9.0 10.0 11.6 17.7 7.6 11.3 13.9 9.7 10.5 11.2 2.3 15.2 24.8 10.1 7.6 0.1 8.9 12.0 17.0 9.1 2.9 8.4 14.5 11.5 7.0 18.6 15.2 11.8 52.1 13.8 10.0 4.5 9.6 8.5 12.6 5.0 13.6 10.2 15.7 11.9 13.0 10.2 10.4 12.6 1.6 3.3 0.4 8.3 1.2 5.9 2.6 5.1 7.3 6.2 0.9 3.5 3.6 0.1 7.6 1.2 6.2 10.6 3.2 12.9 18.0 63.0 25.7 10.9 12.3 11.1 18.7 14.9 8.2 20.8 30.2 7.2 7.2 6.6 10.2 10.1 12.7 4.0 12.5 5.2 0.0 17.1 5.0 5.8 107.8 6.7 2.6 0.0 11.6 18.9 8.8 8.0 18.5 22.6 7.9 3.2 3.5 6.2 13.0 35.2 10.3 5.8 6.8 9.0 5.9 11.8 8.4 3.4 5.6 14.6 0.6 0.0 6.1 14.0 5.6 4.8 17.7 3.1 3.9 7.8 ST8SIA2 "HsT19690, SIAT8B, ST8SIA-II, STX" ENSG00000140557 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2" Q92186 15 92393828-92468728 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 17.7;heart muscle: 10.0" "Group enriched" "Detected in some" 12 "Cardiomyocytes: 4.5;Muller glia cells: 2.0" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "pons and medulla: 17.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 22.2;LHCN-M2: 6.5;RH-30: 10.1;RPMI-8226: 7.3;SH-SY5Y: 4.3;WM-115: 6.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA054518, HPA057819" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA054518: AB_2682514, HPA057819: " "unprognostic (4.70e-2)" "unprognostic (2.48e-2)" "unprognostic (1.26e-1)" "unprognostic (9.32e-3)" "unprognostic (1.03e-1)" "unprognostic (2.87e-2)" "unprognostic (2.32e-1)" "unprognostic (1.28e-5)" "unprognostic (3.91e-2)" "unprognostic (5.39e-3)" "unprognostic (1.59e-2)" "unprognostic (4.44e-3)" "unprognostic (4.78e-2)" "unprognostic (2.29e-1)" "unprognostic (3.16e-1)" "unprognostic (3.00e-1)" 0.3 1.1 1.3 0.2 2.2 0.1 1.2 1.5 3.7 2.6 0.3 0.0 0.0 0.1 1.3 2.5 0.4 0.1 0.7 10.0 3.0 3.6 0.3 0.1 0.1 0.2 2.2 1.4 0.1 0.1 0.1 0.9 0.1 17.7 0.3 0.2 1.0 0.8 0.5 2.1 0.1 0.4 0.2 0.2 0.1 0.2 0.8 0.1 2.5 0.2 1.5 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.2 0.0 3.5 0.0 0.0 0.0 10.1 7.3 0.0 0.0 0.5 4.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 3.7 0.3 0.0 0.2 0.8 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.2 1.5 2.6 3.0 3.6 2.2 1.4 17.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 STAB1 "CLEVER-1, FEEL-1, FELE-1, FEX1, KIAA0246, SCARH2, STAB-1" ENSG00000010327 "Stabilin 1" Q9NY15 3 52495338-52524495 "Predicted membrane proteins" "Inflammatory response" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 90.8" "Cell type enriched" "Detected in many" 5 "Ito cells: 1114.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 68 "classical monocyte: 10.8;intermediate monocyte: 6.6;myeloid DC: 2.8" "Group enriched" "Detected in many" 69 "dendritic cells: 2.8;monocytes: 10.8" "Group enriched" "Detected in some" 47 "HUVEC TERT2: 33.9;NB-4: 46.8;TIME: 41.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA005434 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 60000000 Cytosol "Nucleoplasm, Plasma membrane" "HPA005434: AB_1080097" "unprognostic (1.18e-1)" "unprognostic (2.89e-1)" "prognostic unfavorable (7.59e-4)" "unprognostic (3.63e-2)" "unprognostic (1.21e-1)" "unprognostic (1.49e-2)" "unprognostic (1.08e-2)" "unprognostic (2.23e-1)" "unprognostic (2.38e-1)" "unprognostic (4.00e-3)" "unprognostic (2.66e-2)" "unprognostic (3.19e-1)" "prognostic unfavorable (3.88e-7)" "unprognostic (3.16e-2)" "unprognostic (9.40e-2)" "unprognostic (4.70e-2)" "unprognostic (1.08e-1)" 39.5 37.6 8.0 26.7 12.8 6.5 41.3 3.2 6.8 13.1 23.4 6.9 4.2 16.1 13.6 26.4 9.7 15.5 16.8 19.7 5.4 4.2 19.2 35.8 21.7 80.7 9.1 2.7 9.9 7.1 4.9 11.9 32.1 10.2 13.5 18.0 23.7 10.4 9.7 8.0 5.1 18.7 18.3 7.2 90.8 11.6 9.7 8.7 2.6 11.9 11.4 11.1 15.9 15.4 0.0 2.8 0.0 10.8 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 33.9 0.0 0.1 0.0 0.0 0.0 0.0 46.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 41.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 6.6 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 8.0 12.8 3.2 6.8 5.4 4.2 9.1 2.7 10.2 8.7 0.0 6.7 12.3 0.5 5.4 1.0 2.0 12.7 0.0 0.0 3.5 0.0 1.3 0.0 0.0 0.4 14.5 0.0 46.7 0.0 1.5 3.8 0.0 17.4 8.3 103.3 0.0 1.2 1114.7 238.9 1.9 4.0 46.3 11.8 0.0 0.0 0.5 0.0 0.0 19.1 0.3 0.0 19.4 1.5 0.7 1.1 4.3 1.8 4.3 0.0 0.2 STAC STAC1 ENSG00000144681 "SH3 and cysteine rich domain" Q99469 3 36380344-36548007 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 22 "Distal tubular cells: 5.0;Early spermatids: 4.5;granulocytes: 5.8;Muller glia cells: 21.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 21.3" "Group enriched" "Detected in some" 5 "eosinophil: 3.2;NK-cell: 2.8;T-reg: 3.8" "Group enriched" "Detected in many" 5 "granulocytes: 3.2;NK-cells: 2.8;T-cells: 3.8" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 22.0;HaCaT: 16.2;hTERT-RPE1: 13.5;SH-SY5Y: 23.2;U-251 MG: 14.1;U-87 MG: 23.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035143 Uncertain Uncertain "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA035143: AB_10603892" "unprognostic (5.29e-2)" "unprognostic (7.61e-2)" "unprognostic (2.58e-1)" "unprognostic (1.44e-6)" "unprognostic (4.24e-2)" "unprognostic (1.83e-2)" "unprognostic (3.06e-2)" "unprognostic (3.89e-1)" "unprognostic (2.02e-1)" "unprognostic (3.31e-3)" "unprognostic (1.77e-3)" "unprognostic (5.82e-2)" "unprognostic (8.07e-2)" "unprognostic (1.73e-4)" "unprognostic (8.93e-2)" "unprognostic (1.95e-1)" "unprognostic (7.94e-3)" 3.7 6.4 1.4 1.1 5.4 0.6 5.7 21.3 0.8 9.2 4.6 1.2 4.7 0.3 9.0 2.2 3.3 4.0 5.1 0.7 0.9 3.9 3.3 1.8 15.0 0.7 1.6 0.2 3.2 0.6 18.8 1.8 0.6 5.2 17.2 1.1 1.9 1.8 5.7 4.0 1.6 0.6 12.5 1.2 0.9 1.5 2.4 0.2 0.7 1.0 4.4 0.5 8.4 15.5 0.0 0.6 3.2 0.4 2.8 3.8 0.2 3.5 1.5 0.8 0.0 3.2 1.0 0.0 9.0 0.2 1.9 2.3 0.0 0.0 0.0 3.7 22.0 6.3 16.2 1.1 3.9 2.0 0.0 2.8 0.5 4.9 0.1 0.0 9.0 0.1 1.2 0.1 0.0 0.3 13.5 0.0 0.9 0.0 0.2 0.2 0.0 1.8 0.1 6.7 0.0 1.4 0.0 0.0 0.0 5.1 0.0 3.0 23.2 3.6 2.5 0.0 7.0 0.0 0.9 4.0 0.2 9.4 0.3 14.1 0.0 0.0 0.0 23.9 3.6 4.0 0.0 0.1 3.2 0.0 0.4 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 2.8 0.1 0.0 3.8 0.2 1.4 5.4 21.3 0.8 0.9 3.9 1.6 0.2 5.2 0.2 0.0 0.3 0.0 0.0 0.0 0.7 1.1 0.0 0.0 2.3 0.0 0.0 0.0 5.0 0.1 4.5 0.1 0.0 0.0 0.0 0.1 0.2 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 1.8 0.0 0.0 0.0 21.3 0.1 0.0 0.0 0.0 0.6 0.0 2.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 STAC3 MGC2793 ENSG00000185482 "SH3 and cysteine rich domain 3" Q96MF2 12 57243453-57251193 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "skeletal muscle: 222.7;tongue: 107.8" "Cell type enhanced" "Detected in many" 11 "Hofbauer cells: 36.5;Kupffer cells: 32.7;Macrophages: 17.2;monocytes: 16.2" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "intermediate monocyte: 8.0" "Group enriched" "Detected in many" 6 "dendritic cells: 4.9;monocytes: 8.0" "Cell line enriched" "Detected in some" 23 "RH-30: 230.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA039285, HPA039527" Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039285: AB_2676427, HPA039527: AB_10673424" "unprognostic (6.16e-2)" "prognostic favorable (2.01e-4)" "prognostic unfavorable (7.10e-4)" "unprognostic (1.05e-2)" "unprognostic (1.31e-1)" "unprognostic (5.25e-2)" "unprognostic (1.62e-1)" "unprognostic (1.19e-1)" "unprognostic (2.05e-2)" "unprognostic (1.31e-1)" "unprognostic (9.12e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (7.11e-6)" "unprognostic (4.58e-2)" "unprognostic (3.36e-1)" "unprognostic (2.09e-1)" "unprognostic (1.14e-3)" 3.7 0.2 0.1 0.6 0.1 1.6 0.2 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.1 10.3 3.2 0.2 0.1 0.1 0.1 0.1 0.2 0.4 0.6 0.7 0.2 0.0 0.1 0.1 0.4 0.2 0.2 0.0 2.3 0.2 0.1 5.4 0.0 222.7 0.2 0.3 0.1 0.3 1.1 0.1 1.2 0.0 0.1 1.2 107.8 3.8 0.1 0.1 1.1 4.9 0.5 8.0 0.0 0.3 1.8 0.0 0.0 0.2 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.3 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 2.7 0.0 0.0 0.0 1.6 9.8 1.0 0.1 0.0 0.0 0.1 0.0 0.6 0.2 0.2 0.7 0.5 0.1 3.5 0.0 0.0 0.1 1.2 230.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 4.7 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.9 0.1 3.2 0.0 0.0 6.1 0.5 0.0 8.0 0.1 1.1 0.0 0.3 4.9 0.5 0.0 0.1 0.3 0.0 4.0 1.4 0.3 1.8 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 1.1 0.5 0.4 1.3 6.4 0.2 2.5 1.4 0.0 0.0 2.0 0.9 0.0 0.8 9.3 0.0 1.1 0.0 0.9 0.5 0.9 0.6 5.7 0.6 36.5 1.6 2.4 2.5 32.7 7.6 1.1 17.2 0.0 16.2 1.1 2.2 1.0 0.0 0.7 0.5 1.9 0.0 0.3 2.4 1.1 0.3 1.1 1.3 1.1 0.3 STAG1 "SA-1, SA1, SCC3A" ENSG00000118007 "Stromal antigen 1" Q8WVM7 3 136336233-136752403 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035015, HPA058653" Supported Enhanced "Nucleoplasm,Nuclear bodies" No No Nucleoplasm "Nuclear bodies" "HPA035015: AB_10603117, HPA058653: AB_2683787" "unprognostic (1.82e-1)" "unprognostic (1.11e-2)" "unprognostic (1.41e-1)" "unprognostic (5.37e-2)" "unprognostic (4.05e-2)" "unprognostic (1.92e-1)" "unprognostic (4.62e-2)" "unprognostic (5.26e-2)" "unprognostic (1.74e-1)" "unprognostic (7.22e-3)" "unprognostic (1.29e-2)" "unprognostic (1.71e-1)" "unprognostic (5.81e-2)" "unprognostic (2.70e-1)" "unprognostic (1.58e-1)" "unprognostic (5.97e-2)" "unprognostic (2.83e-2)" 26.0 10.9 13.3 12.9 15.6 12.9 17.9 46.5 14.3 24.8 14.9 11.2 12.0 9.1 21.3 10.8 12.8 16.8 10.5 12.3 12.9 7.4 12.0 10.2 13.3 12.9 14.0 7.2 22.6 13.8 17.3 20.4 20.5 14.3 16.3 14.3 13.0 14.5 14.0 20.8 17.2 12.7 16.8 9.5 14.5 12.2 9.5 18.9 29.7 15.6 11.7 18.6 17.0 29.0 8.9 6.7 13.2 4.8 8.0 7.4 2.9 17.6 9.2 15.5 13.3 11.7 20.4 8.3 19.9 25.5 18.7 17.8 15.6 7.8 13.8 12.6 20.6 15.1 12.3 16.7 9.0 25.6 16.9 7.8 14.7 13.4 8.6 8.9 25.6 14.9 12.8 10.3 13.7 15.4 10.9 14.5 15.1 9.4 28.0 11.8 15.1 16.8 8.3 10.1 12.2 7.3 15.1 16.9 18.4 10.2 12.7 7.6 12.2 21.3 8.5 8.9 8.4 12.1 10.9 12.1 21.6 15.8 19.2 17.5 20.9 14.3 31.4 13.3 8.8 13.8 4.8 4.4 6.5 7.0 4.6 7.4 8.9 5.9 6.3 4.1 7.3 6.7 5.2 13.2 8.0 4.8 6.7 6.9 2.9 13.3 15.6 46.5 14.3 12.9 7.4 14.0 7.2 14.3 18.9 23.8 21.6 31.2 28.0 35.5 41.8 8.9 12.7 16.0 29.6 15.7 37.3 24.5 10.0 17.5 1.9 25.1 29.0 23.3 19.2 22.1 23.6 19.6 21.9 17.8 15.8 27.0 18.0 32.5 14.6 2.3 45.8 19.5 15.1 24.4 23.3 29.1 21.6 17.3 30.4 8.4 65.9 25.8 27.2 32.7 43.2 32.0 26.5 27.7 21.2 21.7 STAG3 ENSG00000066923 "Stromal antigen 3" Q9UJ98 7 100177563-100221488 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Chromosome partition, Meiosis" "Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 85.4" "Cell type enhanced" "Detected in many" 10 "B-cells: 79.6;Spermatocytes: 87.4;Spermatogonia: 38.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 8 "memory B-cell: 4.8;naive B-cell: 7.6" "Lineage enriched" "Detected in single" 10 "B-cells: 7.6" "Group enriched" "Detected in some" 6 "BEWO: 27.0;HMC-1: 34.2;U-698: 9.8" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA049106, HPA058330" Enhanced Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA049106: AB_2680634, HPA058330: AB_2683681" "unprognostic (6.56e-4)" "prognostic favorable (8.45e-4)" "unprognostic (1.25e-2)" "unprognostic (7.54e-2)" "unprognostic (1.73e-1)" "unprognostic (1.86e-3)" "unprognostic (3.59e-2)" "unprognostic (4.62e-2)" "unprognostic (1.12e-1)" "unprognostic (3.46e-1)" "unprognostic (3.31e-4)" "unprognostic (4.26e-4)" "unprognostic (7.48e-2)" "unprognostic (6.80e-2)" "unprognostic (2.72e-1)" "unprognostic (3.13e-2)" "unprognostic (5.07e-4)" 0.4 0.7 0.4 0.9 1.0 0.3 0.2 0.6 3.8 0.3 0.3 1.1 0.5 0.1 0.5 0.4 0.3 7.8 0.4 0.5 0.6 0.2 0.2 3.9 0.3 1.2 0.5 0.6 0.4 1.4 0.0 0.2 0.4 0.5 0.3 0.2 0.5 0.2 0.5 4.1 0.5 2.2 0.4 0.7 5.1 0.1 85.4 0.8 0.7 0.3 0.2 1.6 0.3 0.2 7.6 0.5 0.2 0.7 0.2 0.5 0.3 0.0 2.0 0.8 0.1 0.1 0.0 27.0 1.4 0.0 0.1 0.1 0.0 0.0 0.9 0.2 0.3 0.0 0.0 0.0 0.1 0.0 3.8 0.4 0.0 0.0 0.6 0.0 0.0 34.2 0.0 0.0 0.6 0.1 0.0 0.1 0.8 0.4 0.0 0.0 0.5 1.6 0.1 0.8 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.5 1.5 0.6 0.4 0.0 0.4 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 9.8 0.5 0.2 0.4 0.0 0.0 0.0 0.0 0.7 0.1 4.8 0.2 0.5 0.5 7.6 0.4 0.3 0.2 0.2 0.3 0.1 0.0 0.3 0.4 1.0 0.6 0.7 0.6 0.2 0.5 0.6 0.5 0.8 0.0 2.4 79.6 8.0 6.1 7.0 1.8 2.5 14.7 1.2 7.0 2.0 1.7 11.6 0.1 19.3 2.9 1.1 0.0 0.2 2.7 3.3 7.0 1.1 22.9 2.1 19.1 1.2 3.7 2.1 18.4 4.4 4.8 5.0 4.6 4.1 3.2 0.2 0.0 1.8 3.4 7.3 0.0 7.5 87.4 38.7 7.4 2.4 10.4 1.6 9.6 STAM2 Hbp ENSG00000115145 "Signal transducing adaptor molecule 2" O75886 2 152116801-152175992 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 107.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035528, HPA035529" Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA035528: AB_10601606, HPA035529: AB_10672868" "unprognostic (1.53e-1)" "unprognostic (1.79e-1)" "unprognostic (4.81e-2)" "unprognostic (1.73e-1)" "unprognostic (2.31e-1)" "unprognostic (5.16e-2)" "unprognostic (2.76e-2)" "unprognostic (3.15e-2)" "unprognostic (6.54e-2)" "unprognostic (1.20e-1)" "unprognostic (1.22e-1)" "unprognostic (7.92e-2)" "unprognostic (1.11e-2)" "unprognostic (1.28e-1)" "unprognostic (1.76e-1)" "unprognostic (2.82e-1)" "unprognostic (1.03e-2)" 17.8 19.1 17.2 12.4 19.9 4.9 21.3 16.1 19.5 19.6 16.7 17.6 17.2 15.1 18.5 16.0 17.8 21.6 15.6 16.1 15.3 15.4 24.6 17.8 17.6 13.0 19.9 14.4 20.6 20.5 23.1 34.0 16.7 20.4 22.1 18.4 14.5 19.5 19.3 14.3 17.6 19.6 19.8 20.0 14.0 18.8 24.3 21.2 16.0 23.8 13.2 14.7 19.5 16.6 2.3 3.3 14.0 6.5 2.5 2.2 1.7 5.4 5.3 5.0 6.0 13.1 15.7 5.3 11.4 13.2 7.4 9.5 5.2 5.2 7.2 9.2 16.2 6.5 5.6 5.5 10.5 12.0 8.8 4.4 5.1 3.7 7.9 15.0 7.5 10.1 11.9 10.2 13.8 18.7 10.8 7.9 4.9 3.3 5.1 15.1 5.4 4.0 5.9 3.1 4.1 7.7 3.2 6.1 3.9 11.6 9.5 2.6 4.1 6.3 5.7 9.4 5.8 7.6 7.0 10.4 16.6 5.3 13.0 6.9 4.3 4.3 4.6 12.5 6.1 9.0 14.0 3.5 4.4 1.9 4.7 1.8 1.7 2.0 2.0 2.7 2.3 1.7 2.1 8.8 2.5 6.5 3.3 2.2 1.7 17.2 19.9 16.1 19.5 15.3 15.4 19.9 14.4 20.4 21.2 23.8 24.4 5.2 9.3 12.2 10.1 27.1 7.6 68.3 35.2 15.7 15.7 6.6 19.9 12.8 107.8 9.8 14.8 0.0 12.2 11.8 13.1 14.9 25.5 13.5 14.5 1.6 7.9 20.3 24.5 38.6 14.7 14.8 13.5 17.2 16.2 13.6 17.2 17.3 14.5 11.4 12.0 25.8 11.3 26.5 19.2 11.5 16.9 6.9 11.9 13.1 STAMBP AMSH ENSG00000124356 "STAM binding protein" O95630 2 73828916-73873659 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 12 "LHCN-M2: 162.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035800, HPA035801" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 11000 Nucleoplasm "Plasma membrane, Cytosol" "HPA035800: AB_10670591, HPA035801: AB_2732470" "unprognostic (1.86e-2)" "unprognostic (1.14e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (4.70e-5)" "unprognostic (6.13e-2)" "unprognostic (2.08e-3)" "unprognostic (3.73e-2)" "unprognostic (1.71e-1)" "unprognostic (6.58e-2)" "unprognostic (2.96e-2)" "prognostic unfavorable (5.79e-4)" "unprognostic (1.01e-1)" "unprognostic (2.29e-1)" "unprognostic (7.72e-2)" "unprognostic (2.63e-1)" "unprognostic (1.43e-1)" "unprognostic (2.89e-1)" 12.9 12.8 22.1 13.9 23.0 10.5 17.8 20.1 21.8 18.1 18.4 35.0 13.6 17.8 23.1 15.4 22.7 16.5 14.7 19.0 23.3 21.2 19.6 16.9 13.4 15.3 33.0 14.3 16.3 15.1 20.9 17.8 20.6 26.3 20.2 20.7 14.6 18.3 15.7 30.1 14.4 25.2 19.0 54.7 13.8 15.6 13.3 22.3 18.4 20.1 15.9 19.0 16.8 16.4 17.6 16.9 27.8 17.8 16.7 20.7 12.3 5.4 6.3 5.0 4.6 4.7 5.7 5.8 3.3 4.6 6.2 6.0 10.5 5.2 4.6 5.3 2.8 8.3 4.3 5.3 11.8 7.1 8.0 6.0 6.1 4.4 8.2 6.5 5.0 7.4 4.5 8.5 7.3 10.6 7.9 3.6 6.3 6.6 7.0 162.7 6.6 7.7 4.5 8.0 7.8 3.4 5.4 13.2 6.5 6.6 6.2 9.2 6.8 4.1 5.0 7.1 5.6 4.7 3.0 3.1 5.6 6.7 3.3 5.9 6.6 6.4 3.5 6.9 5.4 6.5 22.6 16.2 27.8 14.4 17.8 15.4 17.6 16.7 14.0 16.9 16.2 17.5 13.2 24.1 16.7 15.7 16.4 20.7 12.3 22.1 23.0 20.1 21.2 23.3 21.2 33.0 14.3 26.3 22.3 17.9 15.3 14.1 25.1 14.4 19.9 35.5 35.7 25.4 27.3 24.4 11.8 35.2 41.4 32.4 59.2 21.7 40.9 46.7 31.9 28.3 22.6 34.8 51.9 34.7 29.0 25.4 9.9 20.3 24.7 104.7 30.2 29.2 6.8 36.9 31.9 21.5 36.9 38.6 32.5 47.1 19.2 38.8 20.6 32.3 49.5 18.9 37.2 19.5 31.2 23.0 STAP1 "BRDG1, STAP-1" ENSG00000035720 "Signal transducing adaptor family member 1" Q9ULZ2 4 67558728-67607337 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 36.8;ductus deferens: 12.3;intestine: 9.3;kidney: 20.0;lymphoid tissue: 30.4" "Cell type enhanced" "Detected in some" 23 "B-cells: 31.9;granulocytes: 75.5;Melanocytes: 15.1" "Cancer enriched" "Detected in many" 7 "renal cancer: 13.0" "Region enriched" "Detected in single" 7 "hippocampal formation: 3.2" "Cell type enhanced" "Detected in many" "memory B-cell: 28.1;naive B-cell: 36.8" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Daudi: 63.5;U-698: 28.4" "Region enriched" "Detected in single" 5 "cerebellum: 2.6" "Low region specificity" "Detected in many" HPA038529 Enhanced Uncertain Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA038529: AB_10673011" "unprognostic (1.14e-4)" "unprognostic (1.49e-3)" "unprognostic (2.30e-2)" "unprognostic (2.17e-1)" "unprognostic (1.63e-3)" "unprognostic (6.30e-4)" "unprognostic (1.95e-3)" "unprognostic (6.95e-3)" "unprognostic (5.18e-2)" "unprognostic (6.38e-3)" "unprognostic (1.47e-1)" "unprognostic (8.43e-3)" "unprognostic (3.11e-2)" "unprognostic (1.49e-2)" "unprognostic (4.69e-2)" "unprognostic (2.71e-2)" "unprognostic (1.40e-1)" 0.7 0.3 0.4 27.8 0.3 2.9 0.6 0.3 0.4 0.7 2.1 0.0 12.3 0.8 0.6 1.2 2.4 0.4 0.7 0.4 3.2 0.3 20.0 0.5 2.7 23.9 0.4 0.0 0.3 0.6 0.0 0.4 0.1 0.2 1.0 1.3 0.3 2.6 5.1 0.4 0.5 9.3 0.1 0.4 26.5 1.1 2.1 0.0 5.9 0.7 0.7 30.4 4.6 0.6 36.8 1.7 7.7 0.0 12.6 2.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 8.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.4 0.0 9.2 0.0 1.2 0.0 7.7 0.3 0.0 0.7 28.1 0.7 0.3 0.4 36.8 2.9 0.1 0.3 12.6 0.0 1.7 0.1 1.7 0.4 0.3 0.3 0.4 3.2 0.3 0.4 0.0 0.2 0.0 0.0 10.1 31.9 0.0 0.2 0.0 0.0 0.0 1.4 1.2 5.2 0.0 0.0 8.3 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.5 0.0 0.6 0.0 0.0 0.0 0.0 5.2 0.3 0.6 15.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 4.9 0.0 0.0 STARD3 "es64, MLN64" ENSG00000131748 "StAR related lipid transfer domain containing 3" Q14849 17 39637065-39663484 "Cancer-related genes, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 6 "SK-BR-3: 89.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017021, HPA024307, HPA073948" Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA "Nucleoplasm, Vesicles" "Endoplasmic reticulum" "CAB017021: , HPA024307: , HPA073948: " "unprognostic (1.11e-1)" "unprognostic (2.14e-2)" "unprognostic (6.35e-2)" "unprognostic (8.92e-3)" "unprognostic (2.09e-2)" "unprognostic (2.94e-1)" "prognostic unfavorable (3.60e-5)" "unprognostic (2.26e-1)" "unprognostic (1.77e-1)" "unprognostic (1.48e-1)" "unprognostic (6.25e-3)" "unprognostic (5.88e-2)" "prognostic unfavorable (7.70e-4)" "unprognostic (1.33e-1)" "unprognostic (5.22e-2)" "unprognostic (8.51e-3)" "unprognostic (3.00e-2)" 22.2 34.8 23.3 27.5 28.0 33.5 22.8 27.7 30.1 17.1 23.7 38.1 21.7 26.6 20.6 20.7 22.4 25.6 27.7 17.8 21.0 16.8 18.2 24.0 27.0 31.5 28.5 25.7 21.5 32.7 21.9 23.7 26.9 25.7 19.0 9.7 17.9 21.4 26.7 20.8 24.5 34.2 15.8 27.8 32.3 25.3 26.7 26.1 33.0 21.1 15.1 24.8 28.8 18.7 15.3 23.2 35.3 21.2 21.4 25.3 17.4 7.9 12.6 5.7 10.1 6.9 8.4 8.5 6.5 8.5 8.5 7.8 7.4 13.1 7.1 14.2 5.9 10.5 15.2 3.4 7.7 1.9 9.6 12.9 4.8 5.5 8.6 9.7 9.7 10.8 9.1 6.3 9.6 4.6 6.5 8.2 9.9 11.1 9.2 7.8 7.0 9.1 9.2 6.3 5.4 6.9 7.2 9.8 10.5 5.8 9.0 7.2 7.7 4.9 89.9 16.1 4.0 10.6 11.6 7.7 12.0 8.3 13.1 12.2 8.8 10.8 5.7 10.7 10.5 12.3 12.5 21.2 29.3 25.3 19.6 18.5 11.9 18.3 19.0 23.2 15.3 18.4 16.9 35.3 21.4 15.6 10.8 20.4 17.4 23.3 28.0 27.7 30.1 21.0 16.8 28.5 25.7 25.7 26.1 3.0 9.8 21.7 11.2 14.7 13.5 3.0 20.4 5.3 3.4 10.4 35.3 24.1 8.3 20.7 2.3 23.3 21.4 0.0 30.9 31.1 16.0 17.5 18.5 10.6 45.2 17.5 26.4 42.4 36.6 4.1 15.8 20.8 5.0 17.2 11.7 17.0 30.5 15.8 12.4 8.7 13.2 12.9 9.5 8.4 13.9 14.8 33.4 34.8 12.4 16.9 STAT1 "ISGF-3, STAT91" ENSG00000115415 "Signal transducer and activator of transcription 1" P42224 2 190964358-191020960 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+ SV40 Large T+: 90.5;BJ hTERT+ SV40 Large T+ RasG12V: 101.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000931, HPA000982, CAB004049" Approved Enhanced Nucleoplasm,Cytosol NA NA 22000 "Nucleoplasm, Cytosol" "CAB004049: AB_2197984, HPA000931: AB_1080100, HPA000982: AB_1080099" "unprognostic (6.90e-2)" "unprognostic (6.47e-2)" "unprognostic (4.27e-2)" "unprognostic (2.47e-2)" "unprognostic (2.51e-1)" "unprognostic (2.91e-2)" "unprognostic (8.50e-2)" "unprognostic (1.02e-2)" "unprognostic (1.35e-1)" "prognostic favorable (1.75e-4)" "prognostic unfavorable (4.23e-4)" "unprognostic (1.35e-1)" "prognostic unfavorable (1.22e-5)" "unprognostic (2.43e-1)" "unprognostic (4.17e-2)" "unprognostic (3.35e-3)" "unprognostic (3.93e-2)" 27.9 27.2 17.4 47.8 17.8 19.5 20.4 15.0 21.7 21.0 19.8 14.9 17.5 22.7 17.1 27.4 23.3 14.5 29.0 25.5 15.6 22.2 34.9 35.7 29.4 57.9 16.9 18.8 24.3 18.7 20.0 24.0 24.3 23.6 23.6 20.3 17.9 47.5 18.0 20.1 17.4 24.6 24.8 21.8 49.0 24.2 13.5 10.4 58.7 36.2 18.5 30.2 29.3 16.5 10.8 16.2 55.0 47.1 22.7 54.1 44.6 8.9 9.6 4.5 7.5 19.9 26.9 14.6 13.7 41.9 90.5 101.9 15.2 10.4 3.7 8.7 29.3 30.1 7.6 5.1 10.9 18.0 30.7 4.2 16.6 7.6 8.9 13.8 8.5 10.4 17.8 7.0 16.7 5.9 9.9 10.8 6.5 9.0 22.0 16.6 7.3 6.4 10.8 6.3 5.8 15.8 5.4 12.4 4.5 11.9 11.2 6.3 6.1 16.1 6.2 41.9 6.7 6.4 10.6 9.5 18.0 10.6 15.5 8.8 37.4 54.8 3.5 13.7 7.3 8.3 13.0 36.9 27.0 14.7 47.1 19.9 10.8 35.1 21.0 16.2 8.6 35.8 26.0 55.0 22.7 27.6 7.4 54.1 44.6 17.4 17.8 15.0 21.7 15.6 22.2 16.9 18.8 23.6 10.4 68.5 26.4 26.1 13.6 19.7 12.8 39.2 48.4 49.5 50.0 50.6 23.6 11.6 6.6 40.3 8.8 23.9 22.2 0.0 32.6 47.9 29.1 25.0 50.7 45.1 91.4 3.2 20.2 25.8 63.7 2.6 20.1 70.4 16.9 25.2 23.9 14.3 30.0 22.8 28.0 36.2 16.5 38.8 21.7 18.5 24.5 27.4 7.0 25.4 27.4 24.1 STAT3 APRF ENSG00000168610 "Signal transducer and activator of transcription 3" P40763 17 42313324-42388568 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Diabetes mellitus, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001671, CAB003859, HPA058603, CAB068241, CAB068242" Supported Supported Nucleoplasm,Cytosol NA NA 220000 "Nucleoplasm, Cytosol" "CAB003859: AB_347629, CAB068241: AB_2665663, CAB068242: AB_2665662, HPA001671: AB_1080102, HPA058603: AB_2683772" "unprognostic (1.83e-2)" "unprognostic (2.42e-1)" "unprognostic (9.23e-3)" "unprognostic (2.91e-1)" "unprognostic (5.59e-3)" "unprognostic (1.78e-2)" "unprognostic (8.26e-2)" "unprognostic (1.51e-1)" "unprognostic (1.32e-1)" "unprognostic (1.77e-1)" "unprognostic (2.21e-1)" "unprognostic (1.26e-1)" "unprognostic (6.47e-3)" "unprognostic (7.75e-3)" "unprognostic (2.21e-2)" "unprognostic (7.63e-2)" "unprognostic (1.61e-1)" 44.6 30.7 23.2 34.4 27.5 35.3 49.3 15.7 23.5 25.1 31.5 18.4 21.7 20.5 33.2 27.4 36.4 32.7 34.0 82.9 20.1 14.7 34.5 90.0 45.7 45.5 26.0 11.1 40.6 32.1 18.6 27.9 24.6 27.6 28.9 21.8 24.3 29.3 22.9 53.4 28.4 28.6 49.7 25.1 41.4 29.4 15.4 25.7 16.8 38.0 31.2 28.8 40.4 53.1 10.8 13.7 69.7 20.2 13.9 21.7 26.7 17.0 32.3 14.3 14.1 30.5 29.2 10.4 20.0 25.4 17.3 16.9 8.5 16.5 5.3 19.8 19.8 26.2 26.0 12.9 20.4 14.2 43.9 8.9 36.9 19.6 17.4 22.6 9.0 24.1 45.5 20.1 13.8 20.0 18.2 23.5 9.8 22.6 17.0 11.4 12.0 33.3 9.0 8.3 17.4 0.0 7.4 38.2 7.8 27.4 22.1 13.1 8.5 23.0 54.6 8.2 17.9 28.7 13.5 19.7 26.9 13.7 15.9 16.3 26.2 20.4 4.5 16.6 9.5 11.9 26.2 19.4 24.9 21.7 20.2 17.3 10.8 16.0 16.8 13.7 10.4 16.6 15.8 69.7 13.9 18.7 7.5 12.0 26.7 23.2 27.5 15.7 23.5 20.1 14.7 26.0 11.1 27.6 25.7 86.4 150.9 56.2 91.3 115.1 87.1 46.2 43.3 85.6 108.1 127.4 265.1 21.1 14.9 68.7 27.3 107.9 156.0 0.0 83.8 34.3 140.9 148.0 138.6 102.5 60.4 23.8 119.1 104.3 64.9 11.1 66.4 84.8 69.2 88.4 68.1 108.0 75.8 94.7 57.3 38.3 352.3 64.7 221.4 32.2 15.1 139.9 26.1 86.3 72.7 78.8 STAT5A "MGF, STAT5" ENSG00000126561 "Signal transducer and activator of transcription 5A" P42229 17 42287547-42311943 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Lactation, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 43.3;Peritubular cells: 38.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 25.8;HEL: 39.1;HMC-1: 22.8;K-562: 65.1;MOLT-4: 47.2;NB-4: 18.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB003860, HPA027873, HPA042128, HPA049883, HPA051156" Approved Enhanced Nucleoplasm,Cytosol NA NA 140000 "Nucleoplasm, Cytosol" "CAB003860: AB_562347, HPA027873: AB_10603893, HPA042128: AB_2677864, HPA049883: AB_2680931, HPA051156: AB_2681366" "prognostic favorable (5.87e-4)" "unprognostic (3.09e-3)" "unprognostic (2.31e-2)" "unprognostic (1.76e-1)" "unprognostic (1.43e-1)" "unprognostic (3.41e-3)" "unprognostic (2.15e-1)" "unprognostic (6.22e-2)" "unprognostic (3.33e-1)" "unprognostic (6.82e-3)" "unprognostic (2.76e-1)" "unprognostic (2.11e-1)" "unprognostic (3.85e-2)" "unprognostic (5.74e-2)" "unprognostic (1.90e-2)" "unprognostic (1.98e-1)" "unprognostic (5.49e-3)" 44.0 21.5 3.6 16.5 8.1 30.0 24.1 3.4 4.0 12.6 12.8 6.3 10.5 5.1 11.0 11.4 11.6 9.6 15.3 9.8 3.9 4.7 8.9 5.5 12.8 26.7 9.1 3.2 15.6 8.3 1.9 7.0 11.3 6.1 13.9 5.8 11.9 11.9 11.7 18.3 9.7 11.6 13.6 7.4 17.3 7.9 8.5 6.1 21.9 8.6 9.1 17.0 19.9 20.2 7.2 15.0 15.2 18.5 14.3 16.2 8.8 1.1 1.3 0.1 0.0 9.3 4.5 0.0 0.5 2.0 1.0 0.6 0.1 1.0 0.0 2.4 2.1 0.0 0.0 0.2 0.0 0.3 25.8 0.0 39.1 2.9 0.3 3.8 3.3 22.8 10.4 0.7 0.4 0.5 0.0 3.1 0.9 65.1 0.0 0.5 0.1 47.2 18.6 0.3 0.6 0.0 1.1 0.3 3.3 0.3 0.7 0.1 0.0 2.3 1.2 4.3 0.3 0.7 4.2 1.7 2.4 0.6 1.1 0.0 0.0 0.0 0.0 0.2 6.4 0.6 6.8 11.8 5.9 9.1 15.1 12.8 7.2 15.8 13.2 15.0 6.7 16.2 13.0 15.2 14.3 18.5 5.7 11.2 8.8 3.6 8.1 3.4 4.0 3.9 4.7 9.1 3.2 6.1 6.1 0.0 11.7 17.9 3.4 6.5 1.5 20.2 5.1 5.3 2.3 5.2 0.0 1.2 5.0 4.9 0.3 21.8 3.8 0.0 11.8 2.1 15.5 6.7 22.0 2.6 19.4 0.0 0.0 5.5 19.7 2.1 30.2 22.7 8.5 43.3 4.2 5.1 8.2 7.0 38.5 8.4 0.3 6.5 18.7 0.0 0.7 6.8 1.1 19.1 6.2 4.1 STAT6 "D12S1644, IL-4-STAT" ENSG00000166888 "Signal transducer and activator of transcription 6" P42226 12 57095408-57132139 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001861 Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA001861: AB_1080106" "unprognostic (3.43e-3)" "unprognostic (1.87e-1)" "unprognostic (1.37e-1)" "prognostic favorable (1.69e-4)" "unprognostic (4.14e-2)" "unprognostic (2.51e-1)" "unprognostic (2.22e-1)" "unprognostic (6.70e-2)" "unprognostic (1.88e-2)" "unprognostic (3.65e-1)" "unprognostic (5.39e-2)" "unprognostic (1.00e-2)" "unprognostic (2.81e-2)" "unprognostic (1.67e-1)" "unprognostic (1.55e-1)" "prognostic favorable (7.76e-4)" "prognostic favorable (1.14e-4)" 33.6 34.9 10.4 35.9 12.8 12.8 27.9 4.6 11.6 37.8 47.3 6.2 28.4 23.9 44.5 26.6 40.8 31.8 33.8 20.9 10.2 3.9 35.0 31.0 34.9 25.2 13.3 12.0 41.9 21.2 18.1 9.2 22.0 9.8 42.3 26.2 23.3 30.1 26.5 11.4 39.1 59.4 43.8 12.2 48.4 32.1 13.3 7.9 29.3 31.1 24.4 42.8 43.1 34.0 6.2 9.6 27.6 13.0 4.7 5.9 14.0 16.7 16.7 4.1 6.8 40.8 39.7 11.9 13.3 29.4 14.9 10.9 7.5 22.8 40.2 20.9 29.6 0.1 23.4 5.1 25.9 11.0 18.0 1.9 9.2 17.8 9.4 24.4 10.7 30.4 55.3 21.5 18.0 16.0 39.3 26.2 13.2 6.5 5.7 19.1 5.7 11.7 12.0 6.3 20.9 3.4 13.6 0.3 13.7 25.7 28.0 0.1 0.4 12.5 10.4 12.6 5.9 15.5 24.6 21.7 0.3 8.7 15.5 0.2 0.1 0.4 10.0 13.4 10.4 17.9 9.8 12.5 6.8 5.9 13.0 5.2 6.2 4.8 4.8 9.6 6.2 4.7 4.3 27.6 4.7 11.0 4.6 4.9 14.0 10.4 12.8 4.6 11.6 10.2 3.9 13.3 12.0 9.8 7.9 44.7 57.5 34.4 35.4 26.6 1.0 12.0 22.9 45.5 46.6 47.1 0.0 1.6 13.3 32.2 6.4 29.9 63.9 0.0 31.0 8.4 26.5 42.7 55.6 33.4 31.9 0.0 31.8 38.6 76.0 8.6 55.0 54.0 20.3 52.3 38.2 3.3 38.1 49.1 47.7 21.9 1.0 25.8 27.8 0.9 1.1 28.7 5.3 29.9 37.3 48.9 STAU2 39K2 ENSG00000040341 "Staufen double-stranded RNA binding protein 2" Q9NUL3 8 73420369-73747708 "Predicted intracellular proteins" Transport RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 56.6" "Low region specificity" "Detected in all" "HPA019155, CAB020836" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB020836: , HPA019155: AB_1857565" "unprognostic (5.75e-2)" "unprognostic (3.39e-1)" "unprognostic (2.31e-3)" "unprognostic (2.47e-2)" "unprognostic (3.76e-1)" "unprognostic (6.27e-2)" "unprognostic (1.07e-2)" "unprognostic (1.18e-1)" "unprognostic (6.36e-2)" "unprognostic (4.01e-2)" "unprognostic (3.31e-2)" "unprognostic (1.89e-1)" "unprognostic (3.62e-3)" "unprognostic (9.94e-2)" "unprognostic (2.98e-1)" "unprognostic (6.44e-3)" "unprognostic (4.25e-2)" 17.8 15.0 25.5 10.3 24.4 14.0 11.7 27.2 46.1 10.8 12.1 13.2 8.4 9.3 11.9 12.8 22.6 11.0 15.7 42.7 24.3 23.0 18.9 15.9 11.4 11.0 27.9 15.4 12.2 10.2 17.8 19.9 11.1 27.3 13.9 12.0 10.0 13.0 14.0 60.3 9.5 15.4 14.9 18.1 13.3 10.1 10.3 16.3 18.6 14.7 21.3 13.4 14.8 10.4 11.9 15.9 26.1 13.3 27.6 19.2 7.9 12.6 15.0 24.0 13.1 14.0 10.3 7.4 11.6 10.6 10.5 14.0 5.9 13.7 20.1 11.9 9.0 9.0 10.3 16.3 10.9 15.6 20.5 8.2 27.3 8.0 9.6 7.5 10.3 9.9 7.1 8.5 8.9 5.9 21.0 20.5 18.6 18.3 9.5 14.1 8.6 56.6 8.2 12.1 20.4 10.0 16.3 11.4 17.5 22.5 14.0 9.2 15.3 6.1 16.9 10.3 18.5 19.4 12.3 15.9 10.6 18.0 10.2 8.5 14.9 14.2 19.2 11.6 15.7 8.2 13.9 11.7 26.1 19.2 11.4 14.6 10.1 13.1 16.4 11.6 11.9 11.7 15.1 19.8 27.6 13.3 15.9 15.9 7.9 25.5 24.4 27.2 46.1 24.3 23.0 27.9 15.4 27.3 16.3 8.9 23.6 31.8 12.5 9.4 26.5 66.9 22.9 33.5 42.1 19.2 39.3 14.9 36.5 17.3 17.3 23.3 25.3 0.0 18.9 8.4 12.4 10.7 19.7 47.1 13.9 27.0 28.7 39.3 27.2 26.1 8.3 16.9 15.1 12.6 16.6 21.2 15.1 16.7 8.9 28.7 21.2 0.0 12.2 8.6 10.4 16.8 10.2 22.3 12.8 15.8 STEAP4 "FLJ23153, SchLAH, STAMP2, TIARP, TNFAIP9" ENSG00000127954 "STEAP4 metalloreductase" Q687X5 7 88270892-88306891 "Predicted membrane proteins, Transporters" "Electron transport, Ion transport, Iron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 122.8" "Cell type enhanced" "Detected in many" 15 "Alveolar cells type 2: 320.5;Club cells: 178.6;Sertoli cells: 452.7" "Cancer enhanced" "Detected in many" "prostate cancer: 45.9" "Group enriched" "Detected in some" 5 "midbrain: 1.7;pons and medulla: 6.4" "Cell type enriched" "Detected in some" 13 "neutrophil: 48.9" "Lineage enriched" "Detected in many" 13 "granulocytes: 48.9" "Group enriched" "Detected in some" 6 "HSkMC: 39.3;SiHa: 36.9;U-2197: 52.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA065201 Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA065201: " "unprognostic (3.76e-2)" "unprognostic (2.16e-2)" "unprognostic (8.82e-2)" "unprognostic (1.43e-1)" "unprognostic (1.62e-1)" "unprognostic (9.96e-2)" "prognostic favorable (2.97e-4)" "unprognostic (7.40e-2)" "unprognostic (3.12e-1)" "unprognostic (4.66e-2)" "unprognostic (4.21e-1)" "unprognostic (2.98e-1)" "unprognostic (7.51e-3)" "prognostic unfavorable (5.77e-4)" "unprognostic (1.72e-1)" "unprognostic (2.00e-1)" "unprognostic (4.53e-2)" 122.8 29.3 0.3 12.7 0.8 2.4 55.6 0.6 0.7 15.9 14.0 1.1 5.3 1.4 10.7 22.3 23.7 17.1 9.3 18.7 0.5 0.3 10.8 71.7 27.5 49.4 1.7 0.2 17.8 13.3 12.0 35.1 45.0 6.4 25.8 3.9 4.9 14.6 4.6 22.1 10.5 5.2 13.9 1.8 5.3 5.7 27.3 0.4 0.4 40.9 8.4 5.2 28.4 26.3 0.0 0.3 48.9 3.8 0.0 0.0 0.7 1.4 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.1 5.8 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 39.3 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 36.9 3.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 52.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.8 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 48.9 0.0 0.0 0.0 0.0 0.7 0.3 0.8 0.6 0.7 0.5 0.3 1.7 0.2 6.4 0.4 50.6 320.5 0.0 6.3 8.4 1.1 4.0 0.0 97.7 178.6 0.0 2.0 0.3 0.0 11.7 12.9 8.9 0.0 0.0 8.2 9.0 11.1 62.8 15.1 0.4 2.1 0.0 0.0 19.0 5.1 1.9 106.4 7.7 5.0 0.0 0.0 2.4 16.5 0.0 8.5 0.0 0.2 452.7 115.4 0.9 0.2 16.4 9.2 0.0 0.0 12.2 STIP1 "HOP, STI1" ENSG00000168439 "Stress induced phosphoprotein 1" P31948 11 64185272-64204543 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 168.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017448, HPA039291, HPA044062" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 3700000 "Nucleoplasm, Plasma membrane" Cytosol "CAB017448: AB_10618972, HPA039291: AB_2676428, HPA044062: AB_2678795" "unprognostic (2.49e-3)" "unprognostic (6.04e-2)" "unprognostic (1.57e-1)" "unprognostic (4.65e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.23e-4)" "prognostic unfavorable (6.18e-8)" "unprognostic (2.16e-3)" "unprognostic (4.56e-2)" "unprognostic (1.12e-2)" "unprognostic (3.56e-2)" "unprognostic (3.04e-3)" "unprognostic (1.70e-1)" "unprognostic (6.72e-2)" "unprognostic (8.23e-2)" "unprognostic (7.16e-2)" "unprognostic (2.99e-2)" 27.3 49.7 32.2 32.0 40.5 25.8 41.5 45.3 41.9 28.3 25.5 29.2 20.6 19.2 30.1 25.2 31.5 36.2 21.6 34.4 32.2 42.8 24.7 27.8 25.4 31.9 47.7 22.5 34.1 24.1 39.1 38.3 37.0 40.7 30.1 28.5 20.3 22.6 29.5 51.9 27.6 20.7 33.2 39.7 26.5 24.4 56.4 49.0 29.8 46.1 23.4 41.2 26.0 168.2 32.2 26.8 20.9 39.6 39.5 35.9 39.5 49.3 77.1 48.7 40.5 27.1 18.1 43.8 44.9 24.2 65.2 38.0 56.4 42.4 59.1 52.9 35.5 77.2 52.5 122.1 44.9 71.8 46.4 49.8 83.2 51.8 51.9 23.6 43.9 52.6 18.4 28.3 54.0 40.7 26.6 45.9 44.1 82.2 34.0 37.4 72.3 66.0 59.9 58.6 47.6 65.2 65.0 46.4 59.8 45.5 43.8 39.7 35.3 51.2 54.2 41.7 53.4 57.6 30.4 41.1 41.5 51.3 54.1 60.4 31.0 66.9 62.4 53.7 44.2 59.6 19.0 25.3 20.9 35.9 36.2 35.7 32.2 27.2 32.0 26.8 26.0 30.5 33.8 7.7 39.5 39.6 22.2 24.0 39.5 32.2 40.5 45.3 41.9 32.2 42.8 47.7 22.5 40.7 49.0 41.7 29.9 44.0 125.4 71.4 35.5 38.9 30.6 104.4 56.9 19.2 39.3 105.5 41.4 70.8 21.1 33.5 27.4 23.3 47.8 125.3 57.5 60.1 78.4 24.1 80.9 60.4 64.5 15.4 15.0 52.9 25.3 54.0 59.1 71.3 20.5 32.1 57.8 21.6 37.4 29.8 29.8 25.8 88.2 82.3 133.5 63.0 176.4 42.1 24.4 89.5 STK10 "LOK, PRO2729" ENSG00000072786 "Serine/threonine kinase 10" O94804 5 172042073-172188386 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 40.9" "Cell type enhanced" "Detected in many" 7 "Kupffer cells: 78.5;T-cells: 70.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 27.5" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 52.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015083, CAB020840" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 24000 "Nucleoplasm, Plasma membrane" "CAB020840: , HPA015083: AB_2669151" "unprognostic (1.17e-1)" "unprognostic (5.43e-2)" "prognostic favorable (2.76e-4)" "unprognostic (2.88e-1)" "unprognostic (6.96e-3)" "unprognostic (1.02e-1)" "unprognostic (5.25e-3)" "unprognostic (3.07e-2)" "unprognostic (1.07e-1)" "unprognostic (1.03e-1)" "unprognostic (2.65e-1)" "unprognostic (3.43e-1)" "prognostic unfavorable (1.63e-4)" "unprognostic (1.09e-1)" "unprognostic (1.01e-2)" "unprognostic (3.10e-1)" "unprognostic (1.84e-1)" 15.0 4.7 2.6 25.8 4.4 38.3 13.5 27.5 3.0 3.6 5.0 4.8 3.4 4.7 4.4 4.4 3.6 4.2 11.0 9.0 2.4 2.5 5.3 4.5 15.4 40.9 5.4 1.9 3.5 4.1 2.5 3.7 16.2 4.5 4.3 4.0 5.6 7.8 2.5 3.1 9.0 12.2 5.7 4.6 33.0 6.2 13.1 3.5 20.6 4.6 3.1 23.7 9.5 11.3 5.0 10.3 22.3 30.8 7.4 18.0 15.6 7.8 7.3 4.5 6.8 5.3 6.6 11.6 10.2 8.5 7.4 6.9 3.8 10.4 9.5 5.4 12.6 15.7 9.2 2.0 12.5 4.8 12.3 3.4 11.4 3.0 2.1 7.6 11.5 13.5 6.5 2.7 10.1 8.4 2.7 6.4 3.7 1.0 13.3 5.2 12.6 8.2 25.8 1.8 3.9 5.8 13.6 3.6 6.2 3.0 9.9 3.1 3.8 5.9 8.3 28.0 5.9 2.9 24.4 8.9 8.3 4.2 5.8 5.5 11.2 16.5 6.0 10.9 17.7 52.3 7.1 10.8 10.0 18.0 21.4 13.3 5.0 9.4 12.8 10.3 4.4 5.6 9.6 22.3 7.4 30.8 3.2 12.2 15.6 2.6 4.4 27.5 3.0 2.4 2.5 5.4 1.9 4.5 3.5 3.0 12.8 25.0 7.9 6.0 3.8 3.6 2.5 5.3 5.7 1.8 5.9 2.8 1.7 4.4 1.7 17.8 8.4 0.0 5.3 25.1 7.4 6.7 26.7 2.1 30.8 44.5 11.5 20.3 78.5 2.7 2.6 39.2 8.5 9.0 15.0 3.1 7.9 7.0 1.4 1.5 2.2 12.9 8.2 5.7 6.8 3.6 4.2 70.5 4.7 9.5 STK11 "LKB1, PJS" ENSG00000118046 "Serine/threonine kinase 11" Q15831 19 1177558-1228435 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Autophagy, Cell cycle, Differentiation, DNA damage, Spermatogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 124.0;Late spermatids: 234.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 11.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016231, HPA017254, CAB022105, HPA067481" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB016231: AB_627890, CAB022105: , HPA017254: AB_1852924, HPA067481: AB_2685847" "unprognostic (8.60e-2)" "unprognostic (1.68e-1)" "unprognostic (5.00e-2)" "prognostic favorable (3.69e-5)" "unprognostic (2.04e-2)" "prognostic favorable (1.96e-4)" "unprognostic (9.11e-3)" "unprognostic (3.19e-1)" "unprognostic (9.08e-2)" "unprognostic (1.26e-1)" "unprognostic (1.95e-3)" "unprognostic (7.70e-3)" "unprognostic (3.54e-2)" "unprognostic (3.16e-2)" "unprognostic (1.60e-1)" "unprognostic (3.31e-1)" "unprognostic (3.12e-3)" 13.4 13.7 13.5 11.8 12.4 19.3 16.7 17.8 16.0 12.2 16.1 8.3 19.8 18.1 10.8 8.7 15.1 10.0 11.8 15.3 12.6 9.8 10.7 22.1 9.4 12.5 9.7 10.4 11.0 16.8 10.7 11.6 12.2 9.9 12.2 5.3 11.9 16.0 12.2 49.2 16.8 18.0 7.7 7.6 16.9 15.5 59.8 7.5 11.8 12.4 14.5 19.0 11.4 9.8 2.7 1.9 11.7 6.3 1.9 1.8 0.5 21.2 10.3 7.8 14.8 7.4 6.7 16.5 10.4 10.9 9.8 10.4 8.4 14.9 13.9 11.5 10.8 4.4 13.8 7.7 16.0 3.0 26.0 18.8 14.2 0.6 10.5 16.0 14.3 23.9 12.2 11.7 7.5 11.2 8.9 9.8 11.1 26.6 19.2 5.5 15.9 13.7 14.5 15.0 7.3 12.7 21.8 8.4 15.6 8.8 15.6 18.1 13.1 0.0 7.7 11.2 4.7 12.1 23.5 13.2 10.1 11.5 19.8 16.5 37.8 15.9 10.4 10.1 19.1 10.4 2.0 4.2 4.5 0.6 6.0 0.4 2.7 1.0 1.8 1.9 1.0 1.0 0.9 11.7 1.9 6.3 1.0 0.7 0.5 13.5 12.4 17.8 16.0 12.6 9.8 9.7 10.4 9.9 7.5 6.0 13.6 11.1 6.4 14.8 23.6 11.8 17.8 2.7 6.8 22.7 17.7 6.7 6.6 8.1 124.0 14.7 29.5 0.0 11.9 4.5 10.4 14.2 2.3 25.2 12.9 17.5 14.5 16.0 22.2 234.7 22.7 10.4 15.1 17.2 29.2 19.3 13.0 25.9 19.4 8.6 19.8 12.9 20.8 49.9 19.4 13.6 7.3 8.6 33.0 10.9 STK16 "MPSK, PKL12" ENSG00000115661 "Serine/threonine kinase 16" O75716 2 219245455-219250337 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029450 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA029450: AB_10603118" "unprognostic (1.99e-1)" "unprognostic (2.08e-1)" "unprognostic (5.84e-2)" "prognostic favorable (6.09e-4)" "unprognostic (6.21e-2)" "unprognostic (5.55e-2)" "unprognostic (4.98e-3)" "unprognostic (4.25e-1)" "unprognostic (1.48e-1)" "unprognostic (4.22e-2)" "unprognostic (1.73e-2)" "unprognostic (3.17e-1)" "unprognostic (4.39e-3)" "unprognostic (1.76e-1)" "unprognostic (2.00e-1)" "unprognostic (2.68e-1)" "unprognostic (1.34e-1)" 10.2 19.0 15.7 12.8 20.3 13.3 14.6 8.8 21.0 11.5 16.2 15.2 20.5 17.2 11.4 22.1 16.0 18.3 15.5 13.0 14.5 11.9 19.5 30.1 11.4 24.6 14.2 13.2 13.2 24.5 16.5 15.1 14.0 13.3 14.3 13.7 12.8 19.0 16.3 9.9 12.2 14.2 11.5 12.3 15.9 16.8 18.9 12.7 27.2 19.8 12.8 17.0 12.9 10.3 7.9 7.8 5.8 7.6 14.5 11.2 9.7 7.4 9.8 8.6 7.3 21.5 21.0 9.9 9.6 13.3 8.2 8.2 11.4 16.6 4.3 13.5 16.0 13.1 7.7 10.0 16.0 4.4 10.5 11.5 9.7 8.9 9.8 19.5 9.2 11.4 22.4 25.7 11.3 29.9 16.2 9.9 10.1 12.1 11.8 14.0 13.7 10.0 20.1 8.0 13.5 6.0 9.5 9.7 12.6 17.1 8.6 6.9 8.8 3.4 13.7 19.7 6.5 14.3 19.5 7.6 11.2 7.9 9.1 9.2 14.6 6.2 10.3 12.4 9.8 9.8 2.0 7.6 5.8 6.0 4.2 6.8 7.8 7.5 11.2 7.8 7.9 7.8 10.0 5.2 14.5 3.6 6.7 8.4 9.7 15.7 20.3 8.8 21.0 14.5 11.9 14.2 13.2 13.3 12.7 6.0 6.4 22.9 15.0 8.8 7.4 7.8 28.1 5.3 5.7 7.0 15.7 20.2 58.0 33.5 69.7 11.7 27.6 0.0 51.6 21.3 17.4 15.1 8.1 39.4 25.1 12.7 24.8 11.6 19.1 56.4 14.1 15.7 20.3 43.3 36.3 18.3 30.3 42.9 12.7 72.1 18.4 0.0 12.2 38.1 6.9 9.8 10.8 30.5 35.9 14.0 STK26 "MASK, MST4" ENSG00000134602 "Serine/threonine kinase 26" Q9P289 X 132023265-132075943 "Enzymes, Predicted intracellular proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 44.8;Syncytiotrophoblasts: 49.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 41.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059921 Approved Uncertain "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" Yes No Nucleoplasm "Golgi apparatus, Centrosome, Cytosol" "HPA059921: AB_2684163" "unprognostic (6.53e-2)" "unprognostic (7.83e-2)" "unprognostic (1.77e-1)" "unprognostic (1.02e-3)" "unprognostic (4.42e-1)" "unprognostic (1.03e-2)" "prognostic unfavorable (6.82e-4)" "unprognostic (1.18e-1)" "unprognostic (1.93e-1)" "unprognostic (1.31e-1)" "unprognostic (1.42e-3)" "unprognostic (2.49e-1)" "prognostic unfavorable (6.87e-5)" "unprognostic (4.76e-2)" "unprognostic (1.83e-1)" "unprognostic (1.77e-1)" "unprognostic (2.88e-1)" 5.4 1.4 1.1 13.5 5.1 25.9 3.3 3.8 1.1 18.0 6.4 0.3 34.8 3.7 42.3 29.6 11.7 6.0 5.2 1.9 1.2 2.3 3.5 3.2 6.7 12.8 1.2 0.3 4.7 4.0 10.2 5.8 50.7 1.2 11.5 4.8 2.2 6.3 22.4 1.2 5.1 6.1 19.1 1.5 8.5 4.7 5.2 0.8 44.7 2.3 6.8 10.2 18.0 6.6 8.4 6.2 26.4 11.6 22.0 13.3 10.2 9.1 3.2 0.4 0.0 1.5 1.4 21.0 0.3 1.1 0.1 0.1 8.4 8.3 12.5 5.7 2.0 6.5 10.4 23.4 14.7 0.0 10.8 19.1 18.0 7.9 7.9 1.4 37.6 1.5 2.0 8.8 0.0 9.9 4.4 4.1 17.2 8.0 11.8 3.5 8.1 38.7 35.0 18.8 6.2 1.2 28.0 11.6 16.1 9.5 14.8 7.8 8.6 5.5 5.0 0.2 17.0 6.4 9.9 0.1 3.8 4.0 11.4 13.5 9.1 14.2 13.9 3.4 41.0 1.9 26.4 5.1 16.6 13.3 6.7 13.0 8.4 9.1 11.3 6.2 7.3 11.8 12.2 10.0 22.0 11.6 2.3 4.0 10.2 1.1 5.1 3.8 1.1 1.2 2.3 1.2 0.3 1.2 0.8 20.8 14.1 8.6 27.8 0.0 0.0 1.1 5.1 12.0 14.8 10.4 0.0 44.8 3.3 4.4 0.4 0.4 0.9 0.0 6.3 28.5 4.9 17.5 10.5 3.0 10.7 0.0 1.2 0.6 10.1 0.0 3.1 7.2 0.0 9.0 6.4 0.0 8.6 3.5 2.1 1.2 0.0 6.5 2.9 1.1 2.3 0.0 49.4 17.5 6.3 15.3 STK32B "HSA250839, STK32, STKG6, YANK2" ENSG00000152953 "Serine/threonine kinase 32B" Q9NY57 4 5051442-5500998 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 23.6;lymphoid tissue: 33.6" "Cell type enhanced" "Detected in some" 25 "Distal tubular cells: 14.9;Early spermatids: 83.1;Late spermatids: 31.4;Proximal tubular cells: 13.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "naive B-cell: 1.3;plasmacytoid DC: 3.5" "Group enriched" "Detected in many" 4 "B-cells: 1.3;dendritic cells: 3.5" "Cell line enhanced" "Detected in some" "GAMG: 11.9;HUVEC TERT2: 11.7;REH: 10.3;U-2197: 18.7;WM-115: 47.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA015820 Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA015820: AB_1858913" "unprognostic (4.48e-2)" "unprognostic (1.02e-1)" "unprognostic (6.08e-2)" "unprognostic (1.35e-1)" "unprognostic (8.12e-3)" "unprognostic (9.96e-2)" "unprognostic (1.64e-4)" "unprognostic (1.27e-1)" "unprognostic (1.27e-1)" "unprognostic (1.70e-1)" "unprognostic (2.54e-1)" "unprognostic (8.82e-2)" "prognostic favorable (1.63e-8)" "unprognostic (8.10e-3)" "unprognostic (5.04e-2)" "unprognostic (3.62e-2)" "unprognostic (1.67e-3)" 5.2 0.8 6.0 2.1 4.8 2.3 7.3 1.0 5.8 6.0 2.1 5.2 1.6 1.2 5.7 1.6 2.3 2.5 4.7 0.9 4.5 7.6 23.6 0.5 1.3 2.8 5.3 2.2 1.2 4.9 0.8 0.8 5.1 4.2 2.3 2.2 3.0 2.9 1.9 2.1 3.6 1.6 7.0 3.9 0.6 9.5 7.1 2.9 33.6 2.8 2.1 1.9 4.2 6.1 1.3 3.5 0.0 0.5 0.0 0.0 0.0 0.0 5.8 0.3 0.0 0.2 0.4 0.0 4.0 0.5 2.7 0.1 0.0 0.0 0.0 0.9 8.2 11.9 0.0 0.6 0.0 1.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.1 11.7 0.6 0.0 0.0 1.4 0.0 0.0 0.8 1.7 0.0 0.0 10.3 0.0 0.0 2.6 0.0 0.1 0.0 0.0 0.0 3.5 0.3 0.0 0.0 3.0 0.0 1.2 18.7 0.0 0.4 0.0 0.0 0.0 0.0 47.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 6.0 4.8 1.0 5.8 4.5 7.6 5.3 2.2 4.2 2.9 0.0 0.6 0.0 0.1 2.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.8 83.1 1.6 0.0 0.0 0.0 0.1 3.8 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 31.4 1.4 0.9 5.0 0.0 0.0 0.0 0.3 0.0 1.1 13.3 0.0 0.0 0.3 0.9 3.0 0.9 0.0 0.0 0.0 0.0 STK33 ENSG00000130413 "Serine/threonine kinase 33" Q9BYT3 11 8391868-8594289 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 34.4" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 245.0;Late spermatids: 113.1;Rod photoreceptor cells: 83.4;Spermatocytes: 126.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 7.1;naive B-cell: 4.4" "Lineage enriched" "Detected in many" 5 "B-cells: 7.1" "Cell line enhanced" "Detected in many" "Daudi: 14.0;hTERT-RPE1: 14.2;Karpas-707: 13.1;SCLC-21H: 14.7;U-251 MG: 14.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA015742, HPA056855" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA015742: AB_1857592, HPA056855: AB_2683257" "unprognostic (2.57e-2)" "unprognostic (2.80e-1)" "unprognostic (2.23e-3)" "unprognostic (2.76e-3)" "unprognostic (3.57e-1)" "unprognostic (1.40e-1)" "unprognostic (7.28e-2)" "unprognostic (3.85e-4)" "unprognostic (1.23e-1)" "unprognostic (8.06e-2)" "unprognostic (1.33e-3)" "unprognostic (9.46e-2)" "prognostic favorable (4.89e-6)" "unprognostic (2.39e-2)" "unprognostic (1.37e-1)" "unprognostic (3.49e-2)" "unprognostic (2.90e-2)" 0.9 6.1 4.7 1.6 7.5 1.1 0.6 6.1 4.4 5.4 5.3 6.8 7.7 2.6 9.6 15.3 2.3 30.7 4.5 11.4 6.6 6.1 7.7 0.4 5.3 2.3 4.9 2.7 10.3 4.6 20.4 29.9 0.3 17.7 5.3 1.3 14.8 1.6 8.9 2.6 0.3 2.5 7.0 6.7 1.2 4.4 34.4 4.6 4.5 14.6 1.5 1.8 3.7 1.4 7.1 0.7 0.0 0.0 0.2 1.4 0.3 0.0 2.0 9.7 0.0 0.0 0.0 0.0 1.7 1.9 4.2 3.9 1.1 0.0 14.0 7.3 0.3 5.5 0.0 4.3 1.3 3.7 0.0 11.9 0.0 2.6 3.3 1.6 7.8 0.0 0.4 0.0 0.1 0.0 14.2 0.3 6.9 0.0 13.1 0.1 0.0 0.2 0.0 6.9 0.0 0.0 5.2 1.3 8.8 3.8 0.0 14.7 3.9 0.0 0.0 0.1 2.7 0.0 0.8 0.0 0.0 6.6 0.1 14.8 3.1 12.4 0.2 4.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 7.1 0.0 1.4 0.0 4.4 0.0 1.1 0.0 0.2 0.0 0.7 0.2 0.3 4.7 7.5 6.1 4.4 6.6 6.1 4.9 2.7 17.7 4.6 17.9 12.6 5.4 1.1 0.0 19.2 34.4 10.2 245.0 47.8 19.2 66.8 0.1 3.3 7.5 72.9 1.3 0.0 0.0 4.4 2.7 0.3 0.2 1.1 0.0 0.2 1.6 8.7 0.0 0.0 113.1 4.0 0.4 0.0 0.0 1.3 30.6 4.5 0.0 15.9 11.9 83.4 0.0 0.2 126.9 25.1 0.0 0.0 0.0 2.9 0.0 STK35 "bA550O8.2, CLIK1" ENSG00000125834 "Serine/threonine kinase 35" Q8TDR2 20 2101611-2177038 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 27.8;testis: 37.6" "Cell type enhanced" "Detected in many" 18 "Early spermatids: 169.1;Horizontal cells: 278.1;Late spermatids: 665.5;Muller glia cells: 155.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026452, HPA051673" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA026452: AB_2671861, HPA051673: AB_2681569" "unprognostic (2.25e-2)" "unprognostic (2.97e-1)" "unprognostic (2.87e-2)" "unprognostic (1.30e-2)" "unprognostic (3.25e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (9.46e-6)" "unprognostic (6.53e-2)" "unprognostic (1.82e-1)" "unprognostic (3.05e-2)" "unprognostic (1.37e-1)" "unprognostic (2.07e-1)" "unprognostic (4.39e-2)" "unprognostic (1.74e-1)" "unprognostic (4.67e-1)" "unprognostic (1.40e-1)" "unprognostic (4.99e-2)" 5.3 6.0 10.3 3.6 14.3 4.3 5.1 6.1 13.7 3.7 4.3 3.1 2.5 4.2 4.5 3.5 8.0 5.1 4.3 5.2 5.9 4.8 4.4 5.7 4.2 3.3 4.4 7.6 3.9 5.9 5.3 6.5 3.5 4.0 3.8 5.2 27.8 6.1 4.0 3.5 6.3 4.6 4.9 4.5 4.1 4.1 37.6 4.4 1.7 5.4 6.1 4.5 4.1 3.7 1.8 2.0 3.2 1.4 0.8 2.7 1.2 15.1 12.9 10.0 17.2 4.6 6.4 12.2 6.2 7.7 8.3 8.6 16.9 11.8 10.4 5.1 7.7 13.0 22.9 11.8 14.3 9.5 4.1 5.6 9.9 4.5 18.3 5.9 8.9 4.6 5.5 12.6 13.3 11.5 7.7 7.9 10.1 9.5 8.6 5.4 6.7 11.1 12.6 18.6 12.1 8.7 9.7 9.0 6.6 7.5 15.2 16.7 8.1 11.1 19.9 9.9 12.2 9.8 8.9 6.6 14.3 9.8 7.1 9.8 7.6 9.8 7.3 7.6 9.7 6.2 0.0 1.2 0.7 1.9 1.0 2.5 1.7 2.7 1.3 2.0 1.8 2.6 2.2 3.2 0.8 1.4 1.7 1.3 1.2 10.3 14.3 6.1 13.7 5.9 4.8 4.4 7.6 4.0 4.4 11.9 9.8 1.9 4.0 10.3 110.1 11.0 0.0 0.0 6.8 3.5 141.4 6.0 1.7 5.5 169.1 7.7 8.1 0.0 5.9 9.9 6.4 5.1 9.2 7.8 5.0 278.1 5.8 4.3 6.0 665.5 6.4 3.9 6.8 1.8 7.6 155.8 8.1 11.5 5.6 3.1 88.5 0.0 4.6 14.9 11.5 10.3 4.8 6.4 9.9 5.1 STK39 "DCHT, SPAK" ENSG00000198648 "Serine/threonine kinase 39" Q9UEW8 2 167954020-168248141 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 35.5" "Cell type enhanced" "Detected in many" 5 "Glandular cells: 65.7;Urothelial cells: 55.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046022, HPA061803, HPA062802" Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "CAB046022: AB_2196960, HPA061803: AB_2684616, HPA062802: AB_2684870" "prognostic favorable (3.96e-4)" "unprognostic (2.97e-2)" "unprognostic (4.40e-2)" "unprognostic (4.22e-2)" "unprognostic (4.36e-1)" "unprognostic (6.14e-2)" "prognostic unfavorable (5.67e-5)" "unprognostic (3.04e-2)" "unprognostic (8.86e-2)" "unprognostic (9.43e-2)" "unprognostic (3.20e-2)" "unprognostic (1.38e-1)" "unprognostic (2.06e-1)" "unprognostic (9.45e-2)" "unprognostic (8.61e-3)" "unprognostic (1.14e-1)" "unprognostic (6.20e-3)" 6.2 2.1 8.4 4.6 11.0 1.3 3.5 9.3 14.1 4.3 9.1 8.3 1.7 10.5 2.3 4.7 14.1 1.9 5.9 7.6 9.8 7.4 2.9 0.8 2.4 7.3 12.3 9.7 3.2 9.9 5.0 8.2 1.2 14.2 9.9 11.7 7.1 22.8 3.8 2.2 3.4 6.1 4.3 19.0 2.5 11.2 35.5 5.5 7.2 2.2 1.8 8.0 5.6 5.3 0.7 1.0 0.0 0.7 1.9 3.4 0.5 6.7 4.1 15.5 4.9 9.5 14.1 1.5 17.0 12.5 11.4 10.6 0.0 22.0 18.7 4.7 11.0 9.9 17.7 9.9 12.4 14.3 5.9 6.1 7.7 4.5 13.8 17.8 10.4 0.8 9.7 17.7 13.5 14.1 13.8 7.7 14.7 0.1 0.0 23.9 3.9 18.1 3.7 10.7 14.0 8.6 25.8 6.1 1.5 8.6 16.8 22.9 9.7 5.9 0.9 6.9 7.7 3.1 7.6 7.3 13.8 4.3 9.7 11.1 0.0 0.0 15.0 10.5 9.3 9.3 0.0 0.7 0.0 2.5 0.4 1.3 0.7 1.9 3.4 1.0 0.7 0.4 2.0 0.0 1.9 0.3 0.3 3.3 0.5 8.4 11.0 9.3 14.1 9.8 7.4 12.3 9.7 14.2 5.5 3.0 12.3 0.8 21.2 3.4 13.8 25.8 22.9 6.7 7.9 5.2 15.7 0.1 18.3 9.7 21.3 3.5 23.2 0.0 19.9 0.0 7.3 65.7 0.0 0.0 3.5 19.1 21.9 3.1 5.1 13.5 9.5 5.2 16.9 1.0 13.9 26.9 26.4 17.3 10.6 3.8 25.3 6.5 7.2 19.9 7.7 3.9 0.2 15.2 20.4 55.5 STK4 "KRS2, MST1, YSK3" ENSG00000101109 "Serine/threonine kinase 4" Q13043 20 44966474-45079959 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "monocytes: 469.7;T-cells: 231.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004038, HPA015270" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "CAB004038: AB_2144632, HPA015270: AB_1854150" "unprognostic (2.77e-1)" "unprognostic (1.10e-1)" "unprognostic (8.83e-2)" "unprognostic (8.49e-3)" "unprognostic (2.95e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (8.04e-4)" "unprognostic (1.70e-1)" "unprognostic (2.51e-1)" "unprognostic (1.05e-1)" "unprognostic (1.96e-1)" "unprognostic (2.70e-2)" "prognostic unfavorable (1.84e-5)" "unprognostic (1.28e-1)" "unprognostic (5.70e-2)" "unprognostic (3.96e-1)" "unprognostic (1.18e-2)" 9.5 8.8 10.4 24.5 11.5 39.5 8.1 7.5 13.4 7.8 8.6 10.3 5.4 8.1 9.3 6.5 8.9 7.3 9.4 6.1 9.3 8.8 6.3 7.4 18.8 30.6 10.5 9.1 8.3 6.4 5.9 9.3 8.2 7.7 7.5 10.6 7.4 9.3 8.7 4.2 11.4 16.1 8.2 12.0 29.1 9.6 7.4 9.6 32.3 8.0 4.9 36.6 11.5 8.7 10.8 6.9 40.6 13.3 10.3 14.5 7.9 11.8 8.0 10.3 7.3 6.3 7.9 7.1 10.5 16.0 17.7 16.1 22.7 6.5 28.9 9.1 7.4 14.9 12.6 10.8 14.0 22.8 12.9 5.7 21.1 11.7 16.0 11.1 27.1 30.0 6.4 11.6 16.6 18.2 8.9 6.5 19.6 9.7 16.7 8.9 9.3 20.2 18.3 6.2 7.7 5.5 13.1 11.3 13.4 6.5 8.1 4.9 6.0 15.5 9.0 11.8 8.2 8.2 17.1 8.3 13.4 13.0 15.4 12.0 21.8 17.1 32.3 13.1 13.0 9.8 24.4 7.6 20.5 14.5 7.7 14.4 10.3 13.8 13.3 6.9 10.8 14.3 11.9 40.6 10.3 13.3 3.9 13.3 7.9 10.4 11.5 7.5 13.4 9.3 8.8 10.5 9.1 7.7 9.6 14.9 24.0 181.6 40.4 49.5 24.2 7.0 15.3 16.0 18.2 40.1 49.1 20.3 8.3 14.1 4.8 32.3 20.5 0.0 15.3 21.4 24.3 25.1 129.5 19.1 53.0 41.3 24.6 22.7 103.3 3.6 21.0 108.8 126.5 469.7 17.4 20.3 16.0 25.9 15.9 10.9 64.0 12.9 30.2 36.4 43.8 46.3 16.2 231.2 17.4 36.3 STK40 "MGC4796, SgK495" ENSG00000196182 "Serine/threonine kinase 40" Q8N2I9 1 36339624-36385896 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 181.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 19.2" "Group enriched" "Detected in all" 5 "granulocytes: 19.2;monocytes: 8.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008026 Uncertain Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA008026: AB_1857603" "unprognostic (3.32e-1)" "unprognostic (3.00e-1)" "unprognostic (6.47e-2)" "unprognostic (4.55e-1)" "unprognostic (1.38e-1)" "unprognostic (4.43e-2)" "unprognostic (2.69e-3)" "unprognostic (6.09e-2)" "unprognostic (2.09e-1)" "unprognostic (5.96e-2)" "prognostic favorable (5.59e-4)" "unprognostic (1.19e-1)" "unprognostic (2.75e-2)" "unprognostic (7.06e-2)" "unprognostic (2.64e-1)" "unprognostic (1.07e-2)" "unprognostic (2.51e-2)" 22.9 7.2 9.8 15.3 9.4 9.2 26.5 8.9 11.1 10.2 19.1 7.4 16.7 9.4 11.8 12.2 22.3 11.3 18.2 25.6 10.0 7.1 14.3 23.5 16.6 15.4 13.1 7.4 22.2 34.4 9.2 14.7 19.2 12.1 15.7 9.1 9.0 25.1 17.7 53.9 17.2 10.8 26.0 10.3 17.2 17.0 32.0 8.9 9.2 14.6 20.7 16.6 19.5 26.6 2.4 2.7 19.2 8.5 1.6 2.9 2.4 7.1 3.1 15.7 16.3 11.1 6.5 8.8 7.2 9.8 8.8 9.5 17.2 10.3 30.2 5.9 6.7 9.3 7.2 14.3 3.1 6.5 13.1 11.2 19.7 2.9 21.9 11.1 11.5 26.3 5.8 11.9 6.7 3.5 4.7 5.5 23.4 24.2 11.0 5.4 11.2 11.9 15.2 10.1 12.9 4.3 13.7 10.7 20.0 5.5 8.0 19.3 9.8 5.5 8.7 24.1 10.4 5.9 13.6 9.1 5.5 11.6 16.2 15.9 11.5 6.4 25.5 28.9 10.1 18.1 1.0 3.0 4.9 2.6 6.7 2.9 2.3 1.7 1.7 2.7 2.4 1.0 1.5 19.2 1.6 8.5 2.6 1.0 2.4 9.8 9.4 8.9 11.1 10.0 7.1 13.1 7.4 12.1 8.9 11.9 18.3 19.8 48.5 54.5 12.0 21.1 2.5 6.7 7.9 10.4 3.9 4.7 14.9 14.5 92.4 11.0 27.7 0.0 27.1 8.3 15.3 55.1 12.7 19.5 21.4 9.5 22.4 12.9 20.3 181.6 21.3 21.3 28.7 14.4 12.9 4.5 23.4 14.4 31.5 10.5 9.5 25.8 30.9 12.6 8.7 65.9 47.8 14.6 10.8 43.7 STN1 "bA541N10.2, FLJ22559, OBFC1" ENSG00000107960 "STN1, CST complex subunit" Q9H668 10 103882542-103918205 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cytotrophoblasts: 30.7;Distal tubular cells: 34.9;Exocrine glandular cells: 68.6;Pancreatic endocrine cells: 48.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037924, HPA037925" Supported Nucleoplasm NA NA Nucleoplasm "HPA037924: AB_10671636, HPA037925: AB_10672469" "unprognostic (1.50e-1)" "unprognostic (4.22e-2)" "unprognostic (2.18e-2)" "unprognostic (5.58e-3)" "unprognostic (6.01e-2)" "unprognostic (1.53e-2)" "unprognostic (1.59e-1)" "unprognostic (1.29e-1)" "unprognostic (5.93e-2)" "unprognostic (1.72e-1)" "unprognostic (1.12e-3)" "unprognostic (3.76e-1)" "prognostic favorable (1.12e-6)" "unprognostic (1.21e-1)" "unprognostic (1.74e-1)" "unprognostic (1.20e-1)" "unprognostic (1.83e-2)" 13.6 21.0 7.4 10.4 12.6 8.8 13.2 10.7 12.7 13.2 10.9 14.4 10.1 9.1 12.9 10.7 35.6 9.9 18.5 25.4 7.9 9.2 18.6 9.6 21.3 15.6 11.6 6.8 17.6 30.1 23.3 15.3 12.9 17.0 13.0 12.8 13.1 17.2 10.8 19.0 11.8 11.0 14.0 11.9 13.4 16.3 26.8 9.1 19.7 13.9 18.2 24.2 18.0 15.9 9.2 14.4 38.5 12.0 23.5 38.4 16.8 13.2 10.5 11.7 9.7 9.8 29.4 4.1 6.8 17.7 8.2 7.5 6.2 21.1 8.5 12.2 8.0 7.7 12.3 4.4 15.5 7.7 12.4 6.6 7.9 3.5 11.6 13.4 6.1 6.4 19.4 25.9 8.1 23.0 21.3 15.8 15.9 4.3 17.3 13.6 10.4 14.2 10.6 2.6 19.2 15.2 11.3 8.4 8.9 20.2 15.6 6.9 8.3 4.7 7.3 12.2 7.3 6.2 5.3 22.5 10.3 7.5 7.2 9.4 24.9 6.9 8.7 15.3 12.9 4.3 10.8 12.0 38.5 24.6 7.7 38.4 9.1 27.3 22.3 14.4 9.2 20.2 23.9 17.6 23.5 7.8 13.2 34.2 16.8 7.4 12.6 10.7 12.7 7.9 9.2 11.6 6.8 17.0 9.1 20.8 18.1 0.0 0.0 0.0 0.0 0.0 0.0 13.4 9.1 8.7 0.0 30.7 34.9 22.7 0.0 0.0 0.0 0.0 68.6 11.3 0.0 0.0 4.7 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 23.4 0.0 0.0 48.9 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 STOX1 "C10orf24, FLJ25162" ENSG00000165730 "Storkhead box 1" Q6ZVD7 10 68827541-68895432 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.8;fallopian tube: 19.1" "Cell type enriched" "Detected in many" 4 "Ciliated cells: 48.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.0;plasmacytoid DC: 3.5" "Group enriched" "Detected in many" 4 "dendritic cells: 3.5;T-cells: 3.0" "Cell line enhanced" "Detected in many" "AN3-CA: 10.9;HAP1: 10.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037844, HPA037845" Uncertain Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Intracellular and membrane" No NA Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA037844: AB_2675700, HPA037845: AB_10671369" "prognostic favorable (3.37e-5)" "unprognostic (5.53e-3)" "unprognostic (6.62e-2)" "unprognostic (1.06e-1)" "unprognostic (4.63e-3)" "unprognostic (1.95e-2)" "unprognostic (2.24e-3)" "prognostic favorable (2.08e-4)" "unprognostic (1.52e-1)" "unprognostic (2.45e-3)" "unprognostic (5.33e-3)" "unprognostic (5.29e-2)" "unprognostic (3.87e-2)" "unprognostic (8.77e-2)" "unprognostic (3.06e-2)" "unprognostic (2.33e-1)" "unprognostic (3.46e-2)" 8.7 6.4 17.8 1.7 13.4 0.6 4.8 1.8 13.4 2.0 2.6 6.8 1.3 2.0 2.8 11.9 2.5 19.1 1.7 0.9 16.1 9.3 4.5 0.9 2.2 1.8 11.5 10.2 1.9 1.6 6.1 8.8 1.5 5.6 2.3 2.8 5.0 2.6 2.1 1.9 1.4 2.8 2.5 2.4 0.9 2.2 3.8 7.3 3.3 8.7 0.0 1.7 1.6 0.9 0.7 3.5 0.0 0.0 0.2 3.0 0.2 2.2 2.4 5.4 10.9 2.3 0.0 3.2 0.2 0.1 1.6 1.7 2.3 3.3 2.1 3.1 0.0 4.2 0.6 10.1 0.0 0.8 2.5 4.2 0.2 0.5 3.1 0.3 2.7 3.9 0.2 0.2 0.3 0.0 0.3 0.1 5.6 0.5 0.3 0.2 2.2 4.6 3.4 1.8 0.5 1.5 3.4 0.1 0.0 3.2 5.8 1.7 5.0 3.9 1.0 0.7 3.6 2.4 2.2 0.0 0.0 0.3 0.0 1.5 1.0 1.9 2.2 0.0 0.6 0.1 0.0 0.0 0.0 0.3 0.0 0.7 0.4 0.8 0.6 0.0 0.7 3.0 1.4 0.0 0.2 0.0 3.5 0.3 0.2 17.8 13.4 1.8 12.5 16.1 9.3 11.5 10.2 5.6 7.3 0.0 0.3 0.5 3.2 1.3 0.9 0.3 0.0 48.2 9.1 1.8 0.0 1.1 3.3 0.0 0.2 0.1 0.4 0.0 0.3 0.2 0.6 1.8 2.3 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 1.6 1.5 0.2 0.0 0.0 1.2 0.3 6.5 5.7 1.6 11.1 0.4 1.0 0.0 5.6 1.7 STOX2 DKFZp762K222 ENSG00000173320 "Storkhead box 2" Q9P2F5 4 183797692-184023526 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 30.6;Horizontal cells: 31.8;Ito cells: 22.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 11.6;HeLa: 9.9;NTERA-2: 14.7;SH-SY5Y: 14.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049776, HPA065002" Uncertain Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA "Nucleoplasm, Cytosol" "Actin filaments" "HPA049776: AB_2680875, HPA065002: " "unprognostic (9.79e-3)" "unprognostic (3.46e-1)" "unprognostic (2.10e-1)" "unprognostic (6.57e-3)" "unprognostic (3.33e-1)" "unprognostic (6.41e-2)" "unprognostic (4.57e-4)" "unprognostic (8.97e-3)" "unprognostic (1.25e-1)" "unprognostic (1.86e-1)" "unprognostic (3.75e-2)" "unprognostic (1.86e-1)" "unprognostic (7.06e-2)" "unprognostic (1.64e-1)" "unprognostic (1.71e-1)" "unprognostic (2.52e-3)" "unprognostic (2.49e-1)" 3.0 2.8 12.0 1.2 12.6 8.4 3.1 20.3 17.5 3.9 2.1 18.2 1.6 1.6 3.2 5.9 8.2 4.7 4.5 4.9 9.6 8.3 3.4 4.0 3.5 1.1 16.2 18.0 5.8 10.6 12.0 8.1 2.4 11.8 4.1 1.7 2.5 11.0 4.2 3.2 6.2 1.8 3.2 9.2 6.2 3.7 1.6 16.4 0.8 9.6 0.8 1.9 4.3 3.4 0.0 0.1 0.2 0.0 0.0 0.0 0.2 1.7 3.7 11.6 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.2 1.5 0.0 2.3 0.0 2.4 0.2 6.4 1.0 0.0 0.0 5.1 0.0 9.9 0.0 0.0 0.7 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.4 0.0 1.5 0.0 0.5 0.0 0.1 14.7 0.0 0.5 0.1 4.3 0.0 2.8 3.5 6.0 14.0 2.7 0.0 0.0 4.4 0.2 0.3 0.0 0.0 2.5 0.0 0.1 0.1 3.2 1.8 0.6 0.4 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 12.0 12.6 20.3 16.6 9.6 8.3 16.2 18.0 11.8 16.4 11.9 16.6 0.0 5.8 3.8 30.6 19.3 5.1 20.1 12.5 7.0 0.0 2.3 3.3 3.9 0.8 18.3 0.0 0.0 2.7 1.7 1.5 4.2 0.0 4.9 0.9 31.8 1.7 22.1 2.6 2.2 0.6 0.2 1.7 0.0 0.0 15.1 2.4 0.0 4.2 1.9 3.4 0.0 1.0 0.5 2.4 2.9 0.6 0.0 0.0 2.6 STPG1 "C1orf201, FLJ33340, MAPO2" ENSG00000001460 "Sperm tail PG-rich repeat containing 1" Q5TH74 1 24356999-24416934 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 29.2" "Group enriched" "Detected in many" 5 "Early spermatids: 225.3;Late spermatids: 476.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA024301 Approved Nucleoplasm NA NA Nucleoplasm "HPA024301: AB_1845634" "unprognostic (2.63e-2)" "unprognostic (3.35e-1)" "unprognostic (1.36e-2)" "prognostic favorable (1.33e-4)" "unprognostic (6.06e-4)" "unprognostic (5.14e-2)" "unprognostic (2.91e-3)" "unprognostic (5.53e-2)" "unprognostic (1.46e-1)" "unprognostic (3.40e-2)" "unprognostic (1.08e-1)" "unprognostic (3.48e-2)" "prognostic favorable (2.31e-4)" "unprognostic (9.14e-2)" "unprognostic (3.93e-2)" "unprognostic (5.21e-2)" "unprognostic (1.42e-1)" 5.5 4.3 6.0 2.6 12.8 1.5 4.2 13.6 23.3 4.7 7.9 12.0 2.4 4.4 4.8 7.1 4.9 20.8 4.2 4.0 6.7 8.7 5.9 1.9 6.2 2.5 6.5 8.0 5.6 4.8 13.0 9.2 1.6 14.2 5.8 6.9 9.9 3.5 4.6 1.5 4.3 5.5 6.4 6.1 2.1 5.1 29.2 7.9 2.5 5.9 1.2 3.4 4.5 3.9 5.2 2.7 1.1 1.4 0.0 4.3 1.9 5.9 3.5 0.5 6.5 4.8 6.9 3.5 8.7 8.4 8.4 8.8 1.5 8.9 0.7 6.0 9.1 7.0 2.4 5.6 6.1 9.7 7.0 5.6 1.0 1.9 1.6 9.8 2.9 1.5 4.1 12.5 12.1 16.0 8.9 6.6 0.0 2.1 0.0 6.3 2.1 0.0 2.4 5.3 6.3 6.0 1.6 0.0 0.2 11.2 2.0 5.4 3.7 4.7 1.8 13.5 5.7 4.8 5.2 4.5 3.0 3.5 1.2 2.5 3.8 3.6 2.1 3.4 0.3 4.8 0.0 0.1 1.1 1.5 1.4 0.2 5.2 1.2 4.3 0.6 3.4 1.4 1.7 0.1 0.0 0.2 2.7 2.5 1.9 6.0 12.8 13.6 23.3 6.7 8.7 6.5 8.0 14.2 7.9 8.9 8.1 2.2 11.4 4.0 12.4 4.8 0.0 65.6 17.0 10.4 13.7 3.8 13.3 6.5 225.3 4.2 16.3 23.3 6.2 7.0 3.8 6.7 11.5 1.3 3.3 9.5 4.6 5.5 1.0 476.4 6.1 4.6 15.1 4.6 5.2 7.4 7.7 10.5 4.2 7.1 16.7 6.5 5.1 14.2 9.4 4.8 3.8 3.9 5.0 51.2 STPG4 "C2orf61, FLJ40172" ENSG00000239605 "Sperm-tail PG-rich repeat containing 4" Q8N801 2 47045538-47155378 "Predicted intracellular proteins" "Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 29.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.0;plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 6.6;RT4: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA047366, HPA052691" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA047366: , HPA052691: AB_2681918" "unprognostic (6.74e-3)" "unprognostic (5.81e-4)" "unprognostic (3.43e-2)" "unprognostic (1.23e-3)" "unprognostic (1.72e-1)" "unprognostic (1.55e-3)" "unprognostic (4.36e-2)" "unprognostic (3.03e-2)" "unprognostic (1.41e-1)" "unprognostic (2.78e-2)" "unprognostic (2.36e-3)" "unprognostic (6.23e-2)" "unprognostic (3.64e-6)" "unprognostic (5.14e-2)" "unprognostic (6.00e-2)" "unprognostic (1.39e-1)" "unprognostic (2.53e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 29.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 1.5 2.0 0.6 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.6 0.1 0.0 0.3 0.4 0.1 0.2 0.8 0.5 0.5 0.4 0.4 0.5 0.0 0.2 0.0 0.7 0.5 0.5 0.6 0.0 0.1 0.0 0.0 0.6 0.0 1.1 1.0 0.1 0.8 0.3 0.2 0.1 6.6 0.9 0.1 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.1 0.4 1.8 0.4 0.1 0.0 0.4 0.1 0.3 0.0 0.2 0.6 0.3 0.9 0.1 0.2 0.8 0.2 0.0 0.0 0.6 0.2 0.0 0.1 0.9 0.0 0.6 0.0 0.1 0.0 0.0 0.4 0.4 0.0 0.0 2.0 0.0 0.1 1.5 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STRADA "LYK5, NY-BR-96, Stlk, STRAD" ENSG00000266173 "STE20-related kinase adaptor alpha" Q7RTN6 17 63682336-63741986 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "monocytes: 29.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031637 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA031637: AB_10601718" "unprognostic (1.59e-1)" "unprognostic (2.19e-1)" "unprognostic (5.59e-3)" "unprognostic (5.52e-2)" "unprognostic (8.91e-2)" "unprognostic (7.56e-5)" "unprognostic (6.79e-4)" "unprognostic (3.68e-2)" "unprognostic (1.70e-1)" "unprognostic (2.28e-1)" "prognostic favorable (5.34e-5)" "unprognostic (7.29e-2)" "prognostic unfavorable (6.08e-7)" "unprognostic (1.40e-1)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "prognostic favorable (6.43e-4)" 13.3 17.7 19.4 14.6 23.7 17.5 13.0 25.0 28.4 15.2 13.2 27.1 8.7 9.5 16.1 20.6 14.3 20.9 14.5 15.1 18.9 20.2 14.7 13.0 13.9 19.6 20.9 21.7 18.5 12.5 21.9 17.5 14.4 26.0 13.8 13.1 22.2 12.6 16.7 10.3 20.1 12.0 19.1 19.4 20.7 12.6 55.4 21.4 16.2 13.3 8.9 21.3 12.9 12.8 11.2 16.2 18.6 10.0 15.6 11.7 7.5 7.2 21.7 18.9 19.0 18.6 13.9 7.4 13.8 12.7 19.9 17.8 5.7 8.4 11.0 8.6 11.7 9.9 6.0 12.5 13.3 19.8 12.2 12.1 21.8 15.2 13.4 13.2 20.6 15.7 14.5 11.5 22.6 13.1 13.3 22.0 17.3 13.9 11.8 18.8 13.4 24.2 14.1 9.4 6.2 12.4 15.8 30.1 13.5 17.8 14.3 20.7 23.2 9.4 15.5 15.1 20.4 11.4 15.0 17.6 19.0 13.5 15.3 11.4 11.8 12.6 13.9 14.2 12.5 14.9 18.6 9.5 8.6 10.5 7.1 9.7 11.2 9.7 11.7 16.2 9.0 9.6 8.5 11.4 15.6 10.0 13.7 7.2 7.5 19.4 23.7 25.0 28.4 18.9 20.2 20.9 21.7 26.0 21.4 8.9 8.2 2.2 0.1 0.0 1.5 0.5 0.0 2.7 4.5 8.7 0.0 1.5 0.0 6.0 1.1 0.6 1.6 0.0 2.5 0.7 0.7 0.3 2.3 0.0 1.3 1.6 0.0 0.6 0.3 1.6 0.6 4.6 0.0 29.7 1.6 1.0 3.9 2.5 1.4 0.6 3.7 0.0 1.4 2.7 0.5 0.4 2.1 1.0 1.9 0.1 STRN "PPP2R6A, STRN1" ENSG00000115808 Striatin O43815 2 36843640-36966472 "Cancer-related genes, Predicted intracellular proteins" Calmodulin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 51.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017286 Approved Approved Nucleoplasm,Cytosol No No 11000 Cytosol Nucleoplasm "HPA017286: AB_1857618" "unprognostic (1.65e-1)" "unprognostic (1.65e-1)" "unprognostic (3.57e-3)" "unprognostic (2.23e-2)" "unprognostic (3.25e-1)" "unprognostic (1.53e-1)" "unprognostic (1.63e-3)" "unprognostic (7.37e-2)" "unprognostic (1.25e-1)" "unprognostic (2.42e-1)" "unprognostic (1.77e-3)" "unprognostic (1.33e-1)" "prognostic favorable (2.27e-4)" "unprognostic (1.13e-1)" "unprognostic (6.43e-2)" "unprognostic (2.11e-1)" "unprognostic (3.43e-2)" 11.8 8.1 11.4 11.0 22.1 17.4 13.3 16.4 14.2 11.2 14.0 10.9 8.9 10.1 8.6 7.1 25.9 6.8 8.4 25.7 16.2 10.2 11.6 10.2 10.3 9.6 16.9 9.4 9.9 7.1 11.3 6.3 12.6 10.5 8.1 13.7 5.6 16.2 6.9 16.0 16.1 13.2 11.1 34.3 10.9 11.4 9.8 14.8 18.6 8.1 15.5 16.7 11.3 14.4 1.5 0.8 3.7 1.5 0.5 2.1 0.4 23.3 11.8 15.8 6.6 8.7 12.2 15.8 9.5 8.9 9.2 8.5 12.0 7.6 15.5 7.6 11.9 13.2 11.1 13.3 10.4 11.4 17.5 10.2 25.1 10.4 6.2 8.3 15.0 14.1 7.3 9.1 14.7 11.6 6.8 11.7 6.2 18.7 12.3 11.3 6.7 14.9 6.6 12.6 9.5 6.0 9.7 25.0 6.7 7.6 19.3 2.9 9.6 14.1 10.9 8.9 9.2 7.8 5.8 15.5 16.5 16.7 10.2 12.4 12.5 18.8 13.7 8.4 15.1 11.4 3.4 0.8 1.4 2.1 1.5 0.7 1.5 1.5 1.3 0.4 0.9 0.8 0.9 3.7 0.5 1.4 0.8 0.3 0.4 11.4 22.1 16.4 13.0 16.2 10.2 16.9 9.4 10.5 14.8 8.9 7.7 5.2 9.0 18.3 11.7 51.7 10.2 1.4 17.0 22.7 19.6 6.9 8.3 8.8 1.7 17.5 17.3 0.0 7.2 7.9 7.9 14.5 4.7 7.3 7.6 17.5 10.9 15.4 22.2 0.9 8.9 11.0 8.5 10.8 16.4 9.3 12.8 10.5 11.7 7.7 15.4 0.0 10.3 10.3 18.1 29.1 13.6 10.2 13.8 29.3 STRN3 "PPP2R6B, S/G2NA, SG2NA" ENSG00000196792 "Striatin 3" Q13033 14 30893799-31026401 "Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003392, HPA004636, CAB069925" Approved Supported "Nucleoplasm,Actin filaments,Cytosol" NA NA 15000 Cytosol "Nucleoplasm, Actin filaments" "CAB069925: AB_1146988, HPA003392: AB_1079942, HPA004636: AB_1079940" "unprognostic (4.08e-1)" "unprognostic (8.66e-2)" "unprognostic (8.08e-2)" "unprognostic (4.22e-2)" "unprognostic (3.06e-2)" "unprognostic (7.74e-3)" "unprognostic (3.37e-2)" "unprognostic (2.83e-1)" "unprognostic (3.05e-1)" "unprognostic (9.53e-2)" "unprognostic (1.03e-1)" "unprognostic (1.61e-1)" "prognostic favorable (9.66e-4)" "unprognostic (8.74e-2)" "unprognostic (7.85e-2)" "unprognostic (4.83e-2)" "unprognostic (1.01e-2)" 18.5 14.3 15.9 12.1 16.2 10.9 13.5 23.4 17.7 15.8 17.4 11.5 16.5 8.8 14.7 14.8 16.5 10.8 14.0 21.5 14.4 12.1 15.2 22.7 11.6 7.2 12.9 10.1 12.6 13.1 18.0 20.2 14.1 13.9 16.2 14.0 11.4 12.6 17.2 52.0 12.6 11.3 22.0 11.8 11.9 12.9 22.4 14.6 9.3 14.9 13.5 9.7 25.1 20.5 7.0 10.5 8.5 7.9 7.4 10.0 2.4 18.0 15.5 17.4 12.4 14.9 11.2 14.4 17.2 12.7 14.4 14.6 20.7 12.2 10.5 12.6 12.5 7.3 9.9 19.3 11.0 21.4 9.1 6.5 10.4 10.6 40.0 16.1 8.9 11.6 11.9 11.5 11.5 14.1 12.9 11.5 9.8 12.5 10.0 13.9 12.3 11.5 8.6 8.5 12.9 14.5 8.5 20.4 2.8 21.6 25.9 10.9 9.0 19.1 14.0 9.3 17.5 16.0 7.6 13.9 14.2 12.7 8.9 6.8 9.5 10.8 10.3 7.0 6.5 11.3 6.3 7.1 8.3 6.8 7.9 8.9 7.0 8.5 7.7 5.8 6.9 8.6 10.0 8.5 7.4 6.2 10.5 6.4 2.4 15.9 16.2 23.4 17.7 14.4 12.1 12.9 10.1 13.9 14.6 20.8 21.9 13.7 39.9 87.1 24.8 45.2 22.9 24.1 22.7 29.6 25.5 19.0 10.0 31.6 16.6 27.5 18.7 0.0 23.0 16.4 24.9 45.1 8.1 36.5 11.3 35.0 30.7 33.7 22.1 10.5 24.7 21.2 42.2 16.2 16.6 25.1 30.6 14.2 26.2 21.4 28.8 25.8 45.3 61.6 46.8 84.3 27.8 16.0 14.0 41.0 STT3A "ITM1, MGC9042, STT3-A, TMC" ENSG00000134910 "STT3A, catalytic subunit of the oligosaccharyltransferase complex" P46977 11 125591712-125625215 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes, Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 202.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030735 Approved Uncertain Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA030735: AB_10603342" "unprognostic (8.25e-3)" "unprognostic (5.45e-2)" "unprognostic (3.02e-2)" "prognostic favorable (1.32e-4)" "unprognostic (5.10e-2)" "unprognostic (1.72e-2)" "prognostic unfavorable (3.57e-4)" "unprognostic (8.40e-2)" "unprognostic (4.80e-2)" "unprognostic (1.16e-2)" "unprognostic (8.96e-3)" "unprognostic (1.31e-1)" "prognostic unfavorable (4.96e-4)" "unprognostic (2.60e-2)" "unprognostic (6.38e-2)" "unprognostic (1.28e-1)" "unprognostic (1.82e-2)" 20.6 20.5 8.3 13.1 11.7 8.3 16.9 10.7 13.9 27.8 19.3 17.7 39.6 12.0 30.5 41.4 19.6 20.8 15.1 19.5 8.3 9.1 26.2 67.1 18.7 14.9 9.3 7.7 30.1 59.0 202.3 27.5 35.9 11.6 22.2 17.4 20.8 50.7 41.4 9.5 12.9 19.8 17.1 12.3 21.8 17.7 17.1 6.7 19.2 38.6 13.6 20.8 19.5 18.0 15.0 53.2 27.0 15.5 17.2 27.5 13.4 21.0 19.2 24.5 33.6 46.2 35.8 26.3 38.5 46.0 31.3 39.2 58.2 56.9 27.4 46.7 56.6 44.4 38.9 33.9 33.7 41.7 21.3 18.0 64.5 13.2 40.2 51.1 38.6 30.3 27.6 24.5 43.4 84.8 36.9 34.9 12.3 27.1 41.1 39.5 15.5 15.5 12.3 15.7 42.1 20.9 18.4 20.9 41.2 34.2 32.7 15.2 13.2 27.2 44.5 13.7 30.0 52.2 27.8 31.2 45.2 16.3 19.0 30.2 12.9 15.1 21.1 17.4 39.1 35.8 27.0 15.5 11.6 19.7 14.8 27.5 15.0 19.1 18.2 21.6 11.6 13.8 16.0 5.4 17.2 13.0 53.2 14.1 13.4 8.3 11.7 10.7 13.9 8.3 9.1 9.3 7.7 11.6 6.7 26.8 23.5 18.2 11.3 14.3 10.2 18.6 12.7 14.7 14.8 15.7 19.6 40.7 1.7 26.7 7.6 11.9 13.5 23.3 23.5 56.2 25.7 16.7 16.2 32.7 27.0 1.6 15.0 33.2 22.3 2.6 19.8 13.2 23.6 8.2 32.3 15.2 29.5 14.0 17.7 11.9 13.8 19.4 10.3 29.9 10.9 12.9 38.1 13.3 22.9 12.9 STUB1 "CHIP, HSPABP2, NY-CO-7, SDCCAG7, UBOX1" ENSG00000103266 "STIP1 homology and U-box containing protein 1" Q9UNE7 16 680224-682870 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037202, CAB037209, HPA041222, HPA043531" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB037202: AB_1840759, CAB037209: AB_1840757, HPA041222: AB_2677368, HPA043531: AB_2678533" "unprognostic (5.70e-2)" "unprognostic (2.53e-1)" "unprognostic (1.90e-1)" "unprognostic (3.89e-1)" "unprognostic (9.00e-2)" "unprognostic (3.06e-1)" "unprognostic (4.09e-3)" "unprognostic (2.21e-1)" "unprognostic (2.23e-1)" "unprognostic (8.31e-2)" "unprognostic (5.78e-2)" "unprognostic (6.77e-2)" "prognostic favorable (6.49e-9)" "unprognostic (9.67e-2)" "unprognostic (3.57e-1)" "unprognostic (1.55e-1)" "unprognostic (1.30e-1)" 29.4 43.7 52.2 20.1 43.2 19.3 40.5 39.1 53.3 25.1 24.8 18.1 27.6 24.1 19.7 34.9 35.2 31.1 25.5 45.2 43.2 38.6 24.0 25.9 23.6 28.1 42.0 42.5 29.4 43.4 39.8 27.2 12.1 35.0 23.4 17.7 18.6 37.7 29.7 92.5 33.7 20.9 24.5 34.5 19.7 22.8 13.8 25.4 13.1 29.1 30.2 19.4 22.3 35.9 18.0 21.0 19.4 14.5 10.3 16.9 6.9 18.0 24.5 16.6 28.0 37.9 34.7 9.5 24.6 29.0 29.3 26.1 30.4 23.1 18.3 17.5 41.3 18.9 15.4 20.4 37.1 12.2 20.1 67.6 11.4 35.3 25.4 54.6 19.1 22.7 41.3 39.8 34.3 21.7 23.1 29.6 17.9 18.3 30.6 45.3 71.5 20.7 18.8 18.5 29.0 26.8 32.1 10.9 45.0 39.1 18.0 28.9 23.5 19.8 43.5 30.9 11.0 27.7 36.7 23.4 26.9 23.6 22.2 29.6 30.3 31.3 29.5 21.2 17.3 30.3 11.9 14.5 19.4 16.9 11.9 15.4 18.0 14.6 14.7 11.7 17.3 13.6 12.9 14.0 10.3 12.4 21.0 12.2 6.9 52.2 43.2 39.1 53.3 43.2 38.6 42.0 42.5 35.0 25.4 35.7 24.7 77.5 88.5 102.0 92.7 1.1 101.9 28.1 22.7 123.9 49.1 67.7 242.1 127.5 6.6 66.9 130.5 23.3 147.7 75.3 72.2 130.8 20.7 112.4 99.1 79.4 72.9 61.4 56.4 11.8 100.9 74.8 111.3 200.2 92.2 123.1 150.1 93.1 105.4 269.6 58.7 71.1 101.9 23.5 69.3 105.3 84.2 61.0 87.3 99.9 STX12 "STX13, STX14" ENSG00000117758 "Syntaxin 12" Q86Y82 1 27773183-27824452 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041038, HPA055300" Approved Enhanced "Nucleoplasm,Golgi apparatus,Vesicles" No No "Nucleoplasm, Golgi apparatus, Vesicles" "HPA041038: AB_10794261, HPA055300: AB_2682778" "unprognostic (3.47e-1)" "unprognostic (1.27e-1)" "unprognostic (1.60e-1)" "unprognostic (8.16e-3)" "unprognostic (2.83e-1)" "unprognostic (2.85e-1)" "unprognostic (1.26e-2)" "unprognostic (3.52e-1)" "unprognostic (1.14e-2)" "unprognostic (2.78e-2)" "unprognostic (9.35e-2)" "unprognostic (3.55e-1)" "unprognostic (1.91e-2)" "unprognostic (8.43e-2)" "unprognostic (2.06e-1)" "unprognostic (1.47e-1)" "unprognostic (2.24e-1)" 38.5 20.2 32.2 16.3 29.6 6.3 22.9 25.8 35.9 20.3 19.4 27.3 23.5 22.9 20.4 42.1 25.7 15.0 25.9 15.3 31.2 31.9 23.2 18.5 31.2 16.3 35.5 29.0 15.2 19.5 16.7 19.6 21.1 32.3 20.8 21.4 11.6 17.7 22.2 14.2 17.1 20.9 23.1 36.9 20.0 38.7 9.0 19.9 6.3 67.0 11.0 13.9 19.4 14.8 7.6 14.2 10.1 21.7 5.2 6.4 8.3 8.8 4.2 11.5 7.5 21.9 26.7 5.9 18.7 27.6 17.2 19.6 5.2 11.5 9.6 20.1 25.0 7.4 7.4 7.5 9.3 17.3 8.5 9.0 5.5 4.7 5.2 17.2 6.0 11.6 25.0 11.4 24.2 13.9 14.2 27.6 5.6 7.2 9.7 18.7 3.2 5.2 4.6 4.8 13.1 6.0 3.3 9.2 5.8 15.2 14.6 12.9 7.0 8.8 7.6 13.5 9.7 5.2 5.4 29.6 8.8 5.0 19.9 6.4 5.8 4.2 5.6 14.2 9.3 12.3 10.1 19.6 7.5 3.7 21.7 6.4 7.6 4.4 5.7 14.2 6.5 4.9 4.1 9.3 5.2 21.0 7.0 4.4 8.3 32.2 29.6 25.8 31.8 31.2 31.9 35.5 29.0 32.3 19.9 50.6 27.6 22.7 84.1 97.1 42.7 15.9 28.1 17.4 38.7 54.1 29.5 25.5 31.5 43.8 1.6 48.9 48.7 0.0 51.3 28.6 42.2 58.3 22.0 15.5 45.8 25.4 39.6 55.3 69.4 1.5 33.4 58.6 50.6 19.8 27.1 61.7 52.7 46.0 44.6 44.7 48.6 38.8 58.4 14.9 17.5 86.7 65.2 22.3 26.7 83.3 STX5 "SED5, STX5A" ENSG00000162236 "Syntaxin 5" Q13190 11 62806897-62832088 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001358 Uncertain Supported "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA001358: AB_1080119" "unprognostic (3.51e-2)" "unprognostic (4.23e-2)" "unprognostic (1.79e-1)" "unprognostic (1.91e-3)" "unprognostic (1.54e-1)" "unprognostic (1.04e-1)" "unprognostic (1.71e-2)" "unprognostic (3.30e-1)" "unprognostic (1.13e-1)" "unprognostic (3.34e-2)" "unprognostic (1.01e-1)" "unprognostic (2.19e-1)" "unprognostic (1.67e-2)" "unprognostic (3.42e-2)" "unprognostic (2.79e-1)" "unprognostic (2.86e-2)" "unprognostic (8.22e-3)" 21.3 20.0 17.5 16.2 17.0 28.3 22.6 33.0 24.2 26.9 19.6 17.6 40.9 17.2 21.6 36.4 22.3 23.7 20.1 17.7 17.6 15.7 22.3 42.6 21.0 17.7 18.6 16.7 29.3 33.7 22.8 20.2 37.4 17.4 27.9 18.2 20.6 47.3 32.2 17.1 26.4 23.0 19.2 16.0 24.0 22.1 16.1 19.7 29.1 33.7 16.4 29.0 22.5 22.3 9.4 10.0 24.9 10.4 9.5 9.7 4.7 17.6 11.3 15.1 13.4 20.9 23.1 14.1 17.4 24.6 29.4 23.8 8.4 17.5 11.3 16.3 24.8 17.4 18.6 13.1 16.6 21.8 26.3 12.6 9.8 15.2 17.2 25.3 11.6 15.0 19.0 18.8 26.1 31.8 22.7 14.2 16.6 8.8 31.5 15.6 21.3 15.7 18.9 5.1 15.9 16.7 16.2 14.7 30.1 13.2 9.3 11.5 9.7 14.1 22.3 26.6 12.1 24.7 15.7 15.3 21.5 11.3 24.7 11.1 28.8 16.2 11.9 17.3 8.2 13.0 8.2 8.8 24.9 8.5 10.4 7.4 8.7 6.7 8.2 8.1 9.4 6.4 6.2 14.0 9.5 9.1 10.0 9.7 4.7 17.5 17.0 33.0 24.2 17.6 15.7 18.6 16.7 17.4 19.7 20.8 27.7 62.4 62.4 59.6 17.5 5.3 17.8 18.7 14.8 10.4 25.5 47.3 24.9 37.5 99.8 34.9 32.1 23.3 52.1 66.0 46.9 54.7 52.9 23.6 41.5 17.5 31.6 25.2 33.5 98.9 36.2 32.1 43.9 64.1 31.6 29.4 37.9 31.7 23.7 26.4 17.6 32.3 51.8 27.9 31.3 56.1 148.5 46.7 21.7 66.2 STX6 ENSG00000135823 "Syntaxin 6" O43752 1 180972712-181023121 "Plasma proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038557, HPA038558" Approved Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA038557: AB_2676082, HPA038558: AB_10672716" "unprognostic (1.11e-2)" "unprognostic (3.22e-2)" "unprognostic (1.47e-1)" "unprognostic (9.09e-3)" "unprognostic (2.23e-1)" "unprognostic (1.05e-2)" "prognostic unfavorable (6.24e-5)" "unprognostic (2.12e-1)" "unprognostic (6.12e-2)" "unprognostic (4.48e-3)" "unprognostic (4.18e-2)" "unprognostic (1.62e-1)" "prognostic unfavorable (1.93e-8)" "unprognostic (2.59e-1)" "unprognostic (1.59e-1)" "unprognostic (2.46e-1)" "unprognostic (1.00e-1)" 12.2 10.4 17.6 14.1 18.9 2.9 12.4 21.7 25.5 13.4 10.4 15.5 7.2 9.8 11.3 10.7 22.2 10.3 9.6 8.1 18.6 13.2 11.6 6.5 15.3 12.7 18.5 13.1 11.5 5.5 9.2 6.8 15.0 16.1 10.1 11.1 6.4 10.7 9.6 5.7 16.5 9.9 11.8 15.0 11.6 10.5 7.3 20.0 14.1 15.3 7.3 17.8 16.3 15.6 1.7 5.1 5.9 3.6 0.4 3.2 1.4 9.8 11.1 11.0 14.6 11.6 13.7 18.6 12.7 16.4 10.0 8.6 10.3 9.9 10.0 17.6 13.9 6.3 17.7 9.9 22.4 11.8 7.2 7.3 6.7 8.4 10.0 11.5 9.5 8.7 12.4 20.6 16.9 17.5 18.1 20.2 9.4 12.2 7.1 13.3 14.2 9.1 9.0 17.1 12.4 5.6 8.0 13.4 14.4 11.9 24.8 15.6 16.6 13.3 25.7 13.9 19.7 15.6 8.7 16.6 13.9 7.3 12.9 10.1 12.1 6.7 7.3 6.8 9.4 8.1 5.9 3.6 4.5 1.8 2.9 1.9 1.7 2.6 2.7 5.1 1.7 3.2 2.4 3.4 0.4 2.5 1.7 3.2 1.4 17.6 18.9 21.7 19.1 18.6 13.2 18.5 13.1 16.1 20.0 14.9 15.2 3.7 16.3 43.5 11.7 5.6 0.0 13.4 11.4 17.4 5.9 22.0 10.0 9.1 6.4 22.4 7.8 0.0 8.5 21.8 11.5 17.4 11.5 4.3 24.6 7.9 22.4 11.1 21.9 8.0 7.8 30.2 6.8 19.0 12.7 6.0 11.1 14.0 12.4 6.7 10.1 6.5 13.3 4.7 14.5 33.0 17.2 13.3 9.8 18.7 STXBP1 "hUNC18, MUNC18-1, rbSec1, UNC18" ENSG00000136854 "Syntaxin binding protein 1" P61764 9 127579370-127696027 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 127.4" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 111.5;Cone photoreceptor cells: 147.3;Horizontal cells: 79.4;Rod photoreceptor cells: 147.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 3.4" "Lineage enriched" "Detected in single" 7 "T-cells: 3.4" "Cell line enhanced" "Detected in many" "SCLC-21H: 47.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008209, HPA023483, CAB034434" Enhanced Approved Nucleoplasm,Cytosol NA NA 6400 "Nucleoplasm, Cytosol" "CAB034434: AB_2196699, HPA008209: AB_1857624, HPA023483: AB_1857625" "unprognostic (2.32e-2)" "unprognostic (7.33e-2)" "unprognostic (3.85e-2)" "prognostic unfavorable (4.78e-4)" "unprognostic (1.80e-1)" "prognostic unfavorable (1.47e-4)" "prognostic unfavorable (5.73e-4)" "unprognostic (2.87e-2)" "unprognostic (2.31e-1)" "unprognostic (3.08e-3)" "prognostic favorable (9.81e-4)" "unprognostic (1.30e-2)" "unprognostic (1.67e-1)" "unprognostic (2.68e-2)" "unprognostic (5.51e-2)" "unprognostic (7.66e-2)" "unprognostic (3.36e-3)" 14.1 16.0 32.4 4.7 42.2 1.5 5.1 86.8 127.4 8.1 4.6 6.5 1.9 3.7 13.2 4.7 6.3 17.9 6.7 12.7 35.0 31.5 7.1 2.7 16.8 3.7 24.6 55.5 14.3 13.2 8.1 22.3 7.9 61.9 6.5 5.3 12.6 8.1 6.6 5.0 5.6 4.6 11.7 13.3 5.9 5.2 5.4 5.3 0.0 10.7 0.9 4.3 5.7 7.6 0.0 0.5 0.0 0.4 0.0 3.4 0.6 4.1 8.6 8.3 9.3 18.8 16.2 7.5 14.5 7.4 8.7 7.7 0.4 4.9 4.0 8.1 9.4 24.3 1.5 7.2 8.9 10.7 9.3 4.9 5.5 23.4 1.5 9.5 0.5 4.8 12.2 5.0 22.8 11.1 14.0 10.3 13.9 5.5 6.3 14.6 7.6 3.9 1.7 7.1 6.7 11.9 2.3 3.9 9.8 7.2 0.2 47.7 23.2 24.4 12.1 41.2 7.7 1.8 1.7 15.4 9.9 5.0 19.5 5.4 13.6 22.3 5.5 19.5 5.9 9.1 0.0 0.4 0.0 0.8 0.1 0.3 0.0 2.2 3.4 0.5 0.0 1.4 1.7 0.0 0.0 0.1 0.3 0.3 0.6 32.4 42.2 86.8 87.7 35.0 31.5 24.6 55.5 61.9 5.3 23.8 57.7 0.8 7.5 10.3 111.5 13.2 0.0 17.4 12.5 3.5 147.3 2.1 6.6 12.0 1.6 21.6 0.0 0.0 7.4 4.6 12.7 9.7 4.7 0.4 3.7 79.4 43.8 20.9 2.7 1.5 19.0 3.2 10.1 1.0 8.8 24.1 5.7 0.0 41.8 8.6 147.7 12.9 12.3 17.7 6.8 6.6 20.5 0.9 0.6 5.5 STXBP3 UNC-18C ENSG00000116266 "Syntaxin binding protein 3" O00186 1 108746674-108809526 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027225 Approved Approved Nucleoplasm,Cytosol NA NA 160000 Nucleoplasm Cytosol "HPA027225: AB_1857627" "unprognostic (3.14e-3)" "unprognostic (4.33e-2)" "unprognostic (7.18e-3)" "unprognostic (4.88e-2)" "unprognostic (6.54e-2)" "unprognostic (9.78e-3)" "unprognostic (2.00e-3)" "unprognostic (1.94e-1)" "unprognostic (1.71e-2)" "unprognostic (2.32e-2)" "unprognostic (6.56e-2)" "unprognostic (8.21e-2)" "unprognostic (1.25e-2)" "unprognostic (1.65e-1)" "unprognostic (8.08e-2)" "unprognostic (1.08e-1)" "unprognostic (4.55e-2)" 18.3 18.4 29.8 18.7 42.1 15.2 20.9 21.9 27.1 19.4 20.5 26.3 15.6 18.7 20.3 19.9 18.8 16.0 20.8 14.3 30.4 22.1 30.2 17.8 16.8 18.2 48.0 28.0 16.2 20.5 31.9 18.0 20.3 31.4 18.1 21.9 9.8 17.5 21.3 15.4 19.7 23.8 18.4 56.6 19.8 18.0 11.3 42.5 20.0 27.8 14.6 17.8 20.2 18.3 5.9 8.3 26.2 11.6 8.7 10.2 5.9 22.3 8.9 15.3 8.0 18.7 18.1 21.6 20.8 19.3 14.1 14.4 8.2 9.0 19.9 14.2 16.8 12.8 13.5 10.3 12.3 19.8 22.1 14.3 16.4 12.1 10.6 14.8 25.5 28.2 14.0 17.4 15.7 17.3 17.4 17.3 12.8 12.1 19.6 19.4 15.2 16.1 20.6 16.3 14.8 14.1 13.5 22.3 10.9 22.8 18.7 9.2 8.5 25.5 24.7 30.2 14.6 9.9 24.3 19.4 18.4 10.8 25.5 17.8 13.2 11.4 16.5 33.1 19.7 27.9 26.2 8.8 20.8 7.8 10.6 9.9 5.9 9.2 7.8 8.3 5.4 7.9 7.5 24.3 8.7 11.6 3.9 10.2 5.9 29.8 42.1 21.9 27.1 30.4 22.1 48.0 28.0 31.4 42.5 11.9 25.1 16.6 33.8 39.0 22.8 30.7 25.5 28.1 34.2 19.2 19.6 36.5 38.1 31.9 4.1 26.9 28.6 0.0 24.1 27.4 24.9 28.7 68.1 15.3 28.0 25.4 20.2 14.7 42.9 2.5 31.1 37.2 37.1 42.3 29.5 38.2 25.3 23.0 29.7 42.3 18.4 19.4 27.8 20.9 24.3 35.3 79.9 26.1 24.1 35.8 STYK1 "DKFZp761P1010, NOK, SuRTK106" ENSG00000060140 "Serine/threonine/tyrosine kinase 1" Q6J9G0 12 10618939-10674318 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 15.8;stomach 1: 16.0" "Cell type enhanced" "Detected in some" 8 "Ciliated cells: 8.1;Enterocytes: 12.5;Mucus-secreting cells: 8.3;Paneth cells: 9.5;Undifferentiated cells: 6.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "NK-cell: 12.5" "Lineage enriched" "Detected in many" 7 "NK-cells: 12.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 18.5;HDLM-2: 10.9;HMC-1: 12.1;HUVEC TERT2: 16.6;TIME: 15.4" "Region enhanced" "Detected in single" "basal ganglia: 2.3" "Not detected" "Not detected" "HPA040468, HPA048569" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA040468: AB_2676998, HPA048569: AB_2680446" "unprognostic (2.30e-1)" "unprognostic (2.22e-1)" "unprognostic (1.21e-1)" "unprognostic (1.75e-1)" "unprognostic (3.11e-2)" "unprognostic (3.35e-2)" "unprognostic (6.85e-2)" "unprognostic (5.08e-3)" "unprognostic (3.37e-1)" "unprognostic (3.50e-1)" "unprognostic (2.21e-3)" "unprognostic (1.02e-1)" "unprognostic (1.70e-14)" "unprognostic (5.18e-3)" "unprognostic (1.22e-1)" "unprognostic (2.33e-1)" "unprognostic (1.45e-2)" 0.6 0.3 2.6 2.3 10.6 1.0 3.8 0.1 13.4 2.2 14.4 0.7 0.5 2.1 0.5 1.1 8.9 1.9 6.2 0.1 1.8 1.6 0.5 0.3 1.2 2.4 1.8 4.2 0.4 0.3 0.0 8.4 3.4 2.1 10.6 15.8 0.0 7.8 2.6 0.2 2.6 10.3 0.6 0.6 1.0 16.0 0.3 0.7 0.0 0.4 0.6 2.8 4.3 3.6 0.0 0.0 0.4 0.0 12.5 1.9 0.2 3.0 0.1 0.0 0.4 0.0 0.0 0.9 4.9 0.5 2.3 2.2 1.6 18.5 0.2 3.1 1.2 2.9 0.8 1.0 5.1 4.9 10.9 0.3 0.7 1.3 0.1 0.0 1.4 12.1 0.2 0.3 3.4 0.2 0.4 16.6 0.1 0.2 0.2 5.3 1.7 0.1 0.8 2.7 7.5 1.3 0.0 1.4 0.2 1.6 9.5 0.6 0.0 2.8 2.9 0.0 4.5 2.3 0.3 15.4 0.6 2.6 0.3 0.6 0.0 0.6 0.1 2.1 0.1 3.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.3 0.4 12.5 0.0 0.0 0.0 0.2 2.6 10.6 0.1 13.4 1.8 1.6 1.8 4.2 2.1 0.7 0.0 2.1 0.0 0.6 0.2 0.4 0.4 2.5 8.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 12.5 0.0 0.2 0.5 0.0 5.9 1.1 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 3.6 9.5 0.0 0.0 0.3 0.0 0.1 0.0 0.9 0.9 0.2 0.7 6.8 4.8 STYX ENSG00000198252 "Serine/threonine/tyrosine interacting protein" Q8WUJ0 14 52730180-52774998 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 77.4;Late spermatids: 67.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040290 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA040290: AB_10963686" "unprognostic (5.24e-2)" "unprognostic (2.48e-1)" "unprognostic (2.22e-1)" "unprognostic (9.56e-2)" "unprognostic (2.43e-1)" "unprognostic (2.16e-1)" "unprognostic (2.81e-1)" "unprognostic (2.37e-1)" "unprognostic (3.00e-3)" "unprognostic (1.91e-2)" "unprognostic (3.21e-2)" "unprognostic (2.26e-1)" "unprognostic (1.57e-3)" "unprognostic (6.89e-2)" "unprognostic (6.82e-2)" "unprognostic (2.48e-2)" "unprognostic (6.84e-3)" 12.2 6.4 7.6 14.8 8.3 6.4 19.6 9.9 7.4 9.7 10.1 8.5 8.2 7.1 10.8 6.4 13.2 8.1 9.6 11.5 7.2 5.4 7.5 32.2 12.6 23.5 10.2 5.8 9.7 11.8 7.0 9.4 11.6 7.2 9.9 8.4 7.1 10.2 11.5 26.6 10.9 9.0 15.5 10.0 11.7 11.2 13.9 8.6 16.7 7.7 12.2 14.9 13.4 10.7 7.1 5.4 6.6 6.8 5.4 13.4 6.3 10.5 5.8 8.1 9.6 13.8 19.8 15.4 12.8 9.5 9.4 9.5 8.4 7.8 13.1 10.9 12.0 7.9 8.4 10.0 10.4 16.6 11.6 3.8 6.7 6.5 11.1 11.4 10.6 8.9 14.1 12.7 12.3 12.8 8.4 16.9 11.9 7.9 12.7 12.8 14.5 11.8 7.0 9.7 12.0 12.1 10.1 10.9 7.7 12.2 12.1 1.8 5.4 13.0 8.8 8.3 11.8 21.4 10.8 15.5 16.4 10.5 17.7 7.9 4.7 6.3 8.2 5.3 7.2 13.8 6.6 5.0 4.0 6.8 6.8 9.0 7.1 11.2 9.1 5.4 4.8 13.4 9.9 2.6 5.4 6.1 4.1 12.2 6.3 7.6 8.3 9.9 7.4 7.2 5.4 10.2 5.8 7.2 8.6 6.0 8.6 13.7 9.8 14.7 4.6 19.4 7.6 17.4 9.1 5.2 5.9 11.8 11.6 11.3 77.4 14.3 5.3 0.0 15.9 25.9 11.3 14.4 19.7 51.3 14.2 4.8 4.6 15.4 13.1 67.5 8.9 17.9 3.3 15.4 5.3 6.7 12.5 8.6 10.6 9.2 6.5 25.8 14.0 53.9 23.3 17.1 17.6 20.0 7.5 10.0 SUB1 "p14, p15, PC4" ENSG00000113387 "SUB1 homolog, transcriptional regulator" P53999 5 32531633-32604079 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 165.5" "Low region specificity" "Detected in all" "HPA001311, CAB015351" Supported Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "CAB015351: AB_2197157, HPA001311: AB_1080123" "unprognostic (5.19e-2)" "unprognostic (1.58e-1)" "unprognostic (5.25e-2)" "unprognostic (1.71e-1)" "unprognostic (2.26e-1)" "unprognostic (6.87e-2)" "prognostic unfavorable (5.25e-6)" "unprognostic (8.31e-2)" "prognostic unfavorable (2.79e-4)" "unprognostic (3.46e-3)" "unprognostic (5.04e-2)" "unprognostic (1.95e-1)" "unprognostic (1.02e-3)" "unprognostic (2.12e-1)" "unprognostic (2.99e-1)" "unprognostic (2.43e-1)" "unprognostic (2.45e-1)" 54.4 40.8 64.1 50.9 69.8 87.6 52.3 28.2 82.4 48.9 44.4 21.5 23.2 36.2 36.8 36.3 52.7 27.4 31.3 46.9 79.3 53.5 54.7 60.7 36.3 58.4 45.8 57.5 30.7 26.9 26.5 49.0 47.0 51.6 34.5 46.0 17.4 32.3 29.1 39.6 26.8 47.5 33.2 39.6 67.2 38.7 28.1 29.8 72.4 42.2 54.2 54.6 39.8 29.7 61.1 69.4 92.0 24.6 25.9 59.5 49.2 22.1 18.3 36.4 34.1 22.2 39.5 22.9 38.7 28.2 35.1 32.4 26.5 35.0 11.2 27.0 26.7 35.9 15.1 30.5 31.7 47.3 46.8 28.1 37.7 44.7 50.2 31.5 65.6 51.6 27.6 27.5 37.2 26.7 19.4 26.2 43.1 43.7 165.5 30.9 19.7 61.9 104.8 24.0 26.3 37.6 27.5 47.6 71.7 34.8 20.1 19.8 16.4 60.0 28.3 27.5 24.0 31.3 61.0 27.1 38.0 41.3 32.0 29.1 64.8 111.6 19.6 35.0 71.3 23.1 92.0 23.9 54.9 31.5 24.6 28.4 61.1 41.4 41.2 46.8 35.1 32.9 37.6 29.2 25.9 21.9 69.4 59.5 49.2 64.1 69.8 28.2 82.4 79.3 53.5 45.8 57.5 51.6 29.8 134.0 164.3 396.8 516.1 519.5 114.4 178.2 247.1 151.3 121.7 294.8 41.2 431.0 855.4 544.4 65.7 278.7 291.1 256.9 284.6 652.5 391.4 435.3 302.3 359.4 432.3 81.0 269.9 203.1 322.6 51.2 222.1 419.5 501.0 571.7 258.1 146.4 357.5 396.3 323.9 714.8 66.1 200.5 303.1 377.2 414.8 494.2 699.8 467.7 329.5 537.0 SUFU "PRO1280, SUFUH, SUFUXL" ENSG00000107882 "SUFU negative regulator of hedgehog signaling" Q9UMX1 10 102503987-102633535 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Developmental protein" "Cancer-related genes, Ciliopathy, Disease mutation, Joubert syndrome, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 8 "Early spermatids: 126.0;Late spermatids: 78.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008700 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA008700: AB_1080125" "unprognostic (1.55e-1)" "unprognostic (4.00e-2)" "unprognostic (5.14e-2)" "unprognostic (1.33e-1)" "unprognostic (4.69e-2)" "unprognostic (5.68e-2)" "unprognostic (3.69e-2)" "unprognostic (5.99e-2)" "unprognostic (1.64e-1)" "unprognostic (3.15e-3)" "unprognostic (9.60e-2)" "unprognostic (2.13e-1)" "unprognostic (3.72e-3)" "unprognostic (1.82e-1)" "unprognostic (1.44e-1)" "unprognostic (5.10e-2)" "unprognostic (3.82e-3)" 10.7 12.8 15.0 15.2 12.8 3.9 18.3 23.0 15.3 13.4 10.4 11.3 12.1 7.7 14.4 13.3 14.7 14.2 16.2 11.0 11.8 7.8 10.8 10.0 21.4 20.5 11.9 11.0 18.0 8.9 20.0 7.8 13.9 10.0 15.4 8.8 11.9 12.6 16.7 14.1 23.1 9.4 14.3 10.7 13.1 7.9 21.1 13.1 19.9 6.2 12.7 15.0 15.2 15.0 2.3 4.5 6.2 5.5 2.8 3.1 2.8 6.3 6.7 10.9 15.7 11.3 9.5 5.3 6.6 12.8 9.6 8.7 6.2 4.7 6.5 18.8 7.3 3.9 4.5 13.4 7.3 6.3 4.0 10.4 15.5 3.9 5.9 5.4 5.6 11.2 10.9 5.8 7.1 5.8 17.6 12.3 6.4 3.4 6.0 5.8 5.3 10.6 8.5 3.1 4.1 5.1 11.5 11.8 3.4 6.3 9.5 3.7 5.9 5.2 4.9 5.9 10.5 10.8 3.7 13.5 4.3 6.1 4.5 7.2 4.9 3.2 4.7 5.3 11.0 2.9 4.2 4.5 6.2 2.5 5.5 2.0 2.3 3.1 2.8 4.5 2.1 2.2 2.5 1.1 2.8 5.5 2.5 1.9 2.8 15.0 12.8 23.0 15.3 11.8 7.8 11.9 11.0 10.0 13.1 0.0 3.0 0.9 2.2 2.7 3.4 3.6 0.0 4.0 4.5 3.5 7.9 6.9 1.7 3.9 126.0 4.3 4.0 0.0 2.6 3.1 5.4 1.9 3.5 4.9 10.4 1.6 1.2 12.9 10.2 78.9 4.6 5.6 0.0 7.2 2.2 2.9 3.5 0.0 6.3 4.4 3.9 0.0 3.4 4.2 4.5 5.6 5.8 5.1 2.8 1.1 SUGP1 "DKFZp434E2216, F23858, RBP, SF4" ENSG00000105705 "SURP and G-patch domain containing 1" Q8IWZ8 19 19276018-19320844 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 83.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004890 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA004890: AB_1079935" "unprognostic (1.08e-1)" "unprognostic (4.51e-3)" "unprognostic (5.21e-2)" "unprognostic (9.88e-2)" "unprognostic (1.87e-1)" "unprognostic (7.34e-3)" "unprognostic (1.67e-2)" "unprognostic (4.90e-3)" "unprognostic (2.14e-2)" "unprognostic (1.26e-1)" "unprognostic (1.37e-3)" "unprognostic (4.25e-2)" "unprognostic (3.52e-2)" "unprognostic (2.06e-3)" "unprognostic (5.51e-2)" "unprognostic (1.50e-2)" "unprognostic (3.42e-3)" 6.8 8.2 14.8 9.2 13.4 5.6 7.0 16.4 17.0 7.3 8.6 9.1 7.8 9.7 9.0 6.9 9.2 8.3 7.1 11.2 12.1 8.7 8.6 8.6 8.3 7.9 11.0 9.1 7.1 10.5 9.0 8.1 6.4 10.3 8.4 6.6 8.2 11.2 8.7 19.7 7.4 8.5 8.5 10.8 8.1 8.7 20.2 10.9 9.8 6.5 6.8 8.8 8.6 6.2 12.9 14.1 14.1 21.9 15.8 17.0 14.4 12.0 2.5 5.9 7.2 5.9 5.7 15.4 8.6 11.4 12.3 8.9 5.6 9.0 11.8 11.8 11.3 7.7 8.3 6.6 10.0 6.0 8.3 5.5 9.8 3.1 4.0 6.9 6.8 10.6 10.9 4.8 10.7 4.5 6.2 8.8 9.0 12.6 6.3 10.1 9.6 17.1 10.4 12.6 12.1 7.8 14.3 8.8 13.5 9.0 5.1 10.1 13.1 8.4 7.1 14.1 6.6 8.1 12.6 14.1 8.8 9.1 11.3 10.5 11.2 11.1 13.6 11.0 9.1 10.9 7.8 14.1 14.1 16.2 16.8 12.6 12.9 12.7 17.0 14.1 11.9 11.9 12.6 12.8 15.8 21.9 13.0 12.4 14.4 14.8 13.4 16.4 17.0 12.1 8.7 11.0 9.1 10.3 10.9 14.9 16.0 8.8 6.7 4.1 11.0 18.7 12.7 6.7 14.8 14.0 3.9 15.8 14.9 12.9 33.1 9.0 13.3 0.0 12.4 11.5 6.1 3.0 9.2 7.3 12.4 1.6 9.2 6.7 6.3 83.0 10.3 10.8 10.1 22.6 9.1 13.8 11.3 11.2 11.7 13.6 7.6 6.5 9.2 27.8 16.4 5.0 14.1 12.8 9.4 3.1 SUGP2 "KIAA0365, SFRS14" ENSG00000064607 "SURP and G-patch domain containing 2" Q8IX01 19 18990888-19034023 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 170.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041557, HPA061111" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA041557: AB_10794301, HPA061111: AB_2684432" "unprognostic (1.35e-1)" "unprognostic (2.94e-1)" "unprognostic (3.59e-2)" "unprognostic (1.13e-1)" "unprognostic (1.85e-1)" "unprognostic (1.91e-3)" "prognostic unfavorable (3.21e-4)" "unprognostic (1.94e-2)" "unprognostic (4.60e-2)" "unprognostic (3.28e-1)" "unprognostic (4.41e-3)" "unprognostic (2.29e-2)" "unprognostic (1.00e-1)" "unprognostic (1.17e-2)" "unprognostic (1.51e-1)" "unprognostic (5.11e-2)" "unprognostic (3.60e-2)" 7.8 13.9 27.2 11.8 27.0 24.5 9.9 36.0 34.4 9.0 10.1 15.4 10.8 11.8 14.8 15.0 7.8 13.5 9.0 18.2 23.0 17.0 9.9 7.4 9.4 15.0 16.8 24.2 13.8 9.1 13.3 22.8 9.8 16.0 16.1 11.7 14.5 14.1 11.9 19.5 12.2 10.6 11.2 15.1 13.9 11.4 56.5 16.9 11.0 19.0 6.7 13.6 10.7 9.7 4.3 4.1 5.3 3.2 9.0 4.7 1.7 12.9 12.3 31.6 22.7 14.8 14.7 15.9 16.3 12.2 19.0 16.4 8.0 11.5 25.6 13.5 12.9 22.5 9.6 25.6 9.8 17.4 9.0 23.1 16.1 18.2 10.4 10.7 13.5 16.3 15.2 10.5 11.6 9.5 25.5 9.9 20.1 24.3 18.5 20.5 10.9 15.8 25.5 16.3 15.2 18.1 15.9 16.2 14.2 9.7 13.1 35.1 14.4 14.3 10.1 7.1 25.4 10.5 12.7 10.8 18.8 11.4 21.8 19.0 23.6 17.9 19.0 18.9 21.4 19.7 5.3 3.1 2.4 4.7 3.2 2.5 2.5 2.9 2.7 3.1 4.3 2.7 3.2 2.8 9.0 2.8 4.1 2.7 1.7 27.2 27.0 36.0 34.4 23.0 17.0 16.8 24.2 16.0 16.9 38.7 39.7 19.0 19.9 15.7 80.7 31.9 17.8 41.5 39.8 26.2 88.4 13.2 8.3 14.7 63.8 22.6 13.7 0.0 9.3 8.6 20.8 23.4 25.5 24.6 19.8 100.1 39.9 27.6 18.0 97.3 37.4 23.8 11.8 16.2 21.7 49.8 15.7 24.3 35.3 7.8 102.0 51.8 15.7 170.1 42.8 16.4 6.3 26.1 24.1 20.2 SUGT1 SGT1 ENSG00000165416 "SGT1 homolog, MIS12 kinetochore complex assembly cochaperone" Q9Y2Z0 13 52652709-52700909 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015942, HPA043949" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB015942: , HPA043949: AB_2678745" "unprognostic (3.66e-2)" "unprognostic (3.98e-2)" "unprognostic (3.57e-1)" "unprognostic (1.22e-1)" "unprognostic (3.77e-2)" "prognostic unfavorable (8.69e-4)" "unprognostic (2.24e-1)" "unprognostic (2.96e-1)" "unprognostic (3.76e-1)" "unprognostic (1.96e-3)" "unprognostic (9.51e-2)" "unprognostic (1.12e-1)" "unprognostic (6.83e-2)" "unprognostic (2.82e-3)" "unprognostic (9.05e-2)" "unprognostic (2.93e-2)" "unprognostic (1.56e-1)" 22.7 29.9 40.0 23.1 44.8 26.2 27.9 39.7 42.7 17.9 24.0 23.0 14.9 25.8 19.4 20.6 27.1 19.2 18.9 33.8 34.0 28.8 30.8 34.3 19.8 23.5 35.9 28.9 20.8 28.6 14.0 39.8 24.4 36.0 18.1 26.5 14.2 22.5 16.8 26.1 23.1 24.8 21.4 31.1 21.3 23.1 31.2 43.5 15.2 21.6 19.5 27.4 21.8 48.3 17.5 23.4 29.0 19.1 17.5 25.3 13.6 14.4 15.8 23.4 17.7 23.2 19.0 22.5 31.8 21.1 19.9 16.0 34.4 36.4 31.8 9.0 19.7 29.0 25.0 28.9 18.3 29.4 26.2 12.0 29.5 20.7 26.0 16.9 22.9 22.2 13.2 16.7 20.6 15.7 25.7 33.4 20.5 27.5 10.5 30.4 10.2 21.3 42.1 27.4 57.1 15.2 24.5 13.6 13.7 34.6 16.3 7.8 9.9 16.4 13.5 14.9 28.0 13.9 21.9 23.9 16.7 19.5 19.1 27.1 8.3 11.7 28.3 10.0 18.4 24.0 29.0 16.8 26.8 14.9 19.1 14.6 17.5 19.4 20.0 18.6 16.3 14.9 16.5 2.3 17.5 18.2 23.4 25.3 13.6 40.0 44.8 39.7 42.7 34.0 28.8 35.9 28.9 36.0 43.5 35.7 29.0 35.8 53.8 35.3 49.1 109.5 25.5 52.2 44.3 48.8 23.6 57.7 66.3 74.9 142.6 65.3 46.8 70.0 78.0 119.0 50.9 41.8 35.8 37.6 84.7 47.7 32.7 35.6 39.5 64.1 54.4 48.2 45.5 144.3 43.5 84.8 75.8 48.9 56.3 76.3 51.1 25.8 66.5 100.6 92.8 37.8 62.2 49.8 45.0 44.3 SULT1B1 ST1B2 ENSG00000173597 "Sulfotransferase family 1B member 1" O43704 4 69721162-69787961 "Plasma proteins, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "intestine: 137.6" "Group enriched" "Detected in many" 4 "Enterocytes: 232.6;Paneth cells: 154.2" "Group enriched" "Detected in some" 11 "colorectal cancer: 7.6;liver cancer: 2.6;pancreatic cancer: 5.5;stomach cancer: 5.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 21.9" "Lineage enriched" "Detected in many" 6 "granulocytes: 21.9" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 48.3;OE19: 11.1;TIME: 15.6;U-2197: 13.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA002107 Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA002107: AB_2666542" "unprognostic (9.58e-2)" "unprognostic (4.05e-2)" "unprognostic (1.66e-2)" "unprognostic (1.16e-1)" "unprognostic (2.33e-1)" "unprognostic (1.14e-2)" "unprognostic (1.50e-1)" "unprognostic (4.77e-2)" "unprognostic (5.14e-2)" "unprognostic (8.78e-2)" "unprognostic (2.81e-2)" "unprognostic (3.27e-1)" "unprognostic (1.15e-3)" "unprognostic (1.89e-1)" "unprognostic (1.06e-2)" "unprognostic (6.93e-2)" "unprognostic (5.46e-2)" 1.2 0.6 0.9 9.3 1.8 1.3 1.1 0.5 1.5 1.1 38.6 0.5 0.7 31.8 0.8 0.6 1.0 1.5 1.2 1.2 0.9 0.9 1.1 24.8 2.4 12.9 1.2 0.7 0.7 0.5 0.0 0.4 0.6 2.0 0.6 20.3 1.3 0.6 0.2 0.4 0.4 137.6 1.4 3.6 13.3 13.9 0.5 0.7 2.0 0.6 0.3 2.0 0.7 1.2 0.2 1.8 21.9 3.2 1.8 3.6 1.6 0.3 0.2 0.3 0.4 0.8 0.9 0.6 0.4 0.2 0.1 0.1 0.3 0.3 0.6 0.3 0.4 0.4 0.5 0.0 0.1 0.3 0.7 0.4 0.5 0.5 0.2 1.2 0.6 0.7 5.5 0.0 0.1 0.2 0.5 48.3 0.7 0.3 1.1 0.4 0.3 0.3 0.5 0.4 11.1 0.2 0.2 1.7 0.3 0.1 0.8 0.7 0.4 0.2 0.2 0.2 0.3 0.7 0.3 15.6 0.5 0.8 13.9 0.3 0.9 0.4 0.2 0.2 1.4 0.6 5.8 3.2 0.8 0.7 1.9 0.2 0.1 1.1 0.3 1.8 0.2 3.6 1.7 21.9 1.8 2.2 0.2 0.5 1.6 0.9 1.8 0.5 1.5 0.9 0.9 1.2 0.7 2.0 0.7 17.9 17.3 2.2 0.0 0.2 0.0 0.4 0.0 22.7 12.5 0.0 0.0 0.0 0.0 0.2 0.0 0.5 232.6 0.0 4.0 0.1 0.2 0.1 15.1 42.3 0.3 0.0 32.4 4.3 35.4 0.0 0.0 5.4 0.0 0.0 38.4 0.0 11.4 154.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 3.8 43.0 0.1 SUMO1 "GMP1, OFC10, PIC1, SMT3C, SMT3H3, SUMO-1, UBL1" ENSG00000116030 "Small ubiquitin-like modifier 1" P63165 2 202206180-202238608 "Disease related genes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004269, HPA056956" Supported Supported "Nucleoplasm,Nuclear membrane,Nucleoli,Nuclear bodies" NA NA "Nucleoplasm, Nuclear membrane" "Nucleoli, Nuclear bodies" "CAB004269: AB_628300, HPA056956: AB_2683285" "unprognostic (7.15e-2)" "unprognostic (2.34e-2)" "unprognostic (1.49e-1)" "unprognostic (2.52e-3)" "unprognostic (2.89e-1)" "unprognostic (9.56e-3)" "unprognostic (1.76e-2)" "unprognostic (8.08e-2)" "unprognostic (1.78e-3)" "prognostic favorable (7.93e-4)" "unprognostic (7.06e-3)" "unprognostic (1.16e-1)" "unprognostic (4.64e-3)" "unprognostic (1.31e-2)" "unprognostic (7.58e-2)" "unprognostic (2.82e-2)" "unprognostic (2.19e-1)" 27.1 37.8 44.4 21.6 37.9 41.8 31.6 47.7 49.2 26.9 29.7 19.9 27.2 26.2 24.7 33.4 26.9 24.7 26.6 28.3 38.0 39.6 43.5 62.6 24.6 28.7 34.6 40.6 23.4 29.8 26.6 28.7 30.4 32.3 28.8 31.2 21.6 35.6 24.5 42.4 21.6 33.2 27.6 29.6 25.1 26.4 28.7 27.1 32.2 38.4 28.1 33.6 26.9 23.1 74.8 63.0 77.0 63.7 65.8 89.0 94.0 33.7 17.1 62.4 33.1 34.8 37.2 27.9 35.9 45.4 44.8 59.5 36.8 43.0 23.1 33.4 41.4 41.9 24.7 51.1 49.9 70.5 21.6 39.2 42.7 33.6 43.2 25.2 48.1 40.7 28.6 48.3 35.1 26.8 42.2 41.7 46.2 39.3 37.6 47.9 28.7 60.5 80.0 75.0 34.8 36.4 39.2 35.0 40.7 54.3 28.1 43.4 47.4 29.3 28.5 48.0 70.7 25.6 46.1 29.2 33.1 33.4 30.3 31.7 32.8 64.7 58.6 36.9 34.3 29.0 56.6 63.7 77.0 51.1 62.6 53.5 74.8 63.7 59.8 63.0 58.4 60.2 62.8 73.6 65.8 62.8 52.9 89.0 94.0 44.4 37.9 47.7 49.2 38.0 39.6 34.6 40.6 32.3 27.1 104.2 49.5 141.2 176.9 375.0 93.7 54.1 96.8 83.0 78.5 179.7 60.9 228.3 407.8 216.2 44.0 153.6 150.3 46.7 152.2 246.7 239.6 215.1 91.1 181.0 182.5 82.6 136.7 118.4 134.8 20.6 120.3 156.9 200.8 294.0 123.6 118.9 175.8 178.5 120.2 378.6 73.5 109.9 205.0 172.2 119.7 371.1 175.4 191.9 139.7 207.2 SUMO2 "SMT3B, SMT3H2" ENSG00000188612 "Small ubiquitin-like modifier 2" P61956 17 75165586-75182983 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037314, HPA042123, HPA048064" Supported Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB037314: AB_796170, HPA042123: AB_2677860, HPA048064: AB_2680244" "unprognostic (6.49e-2)" "unprognostic (1.01e-2)" "unprognostic (4.23e-2)" "prognostic unfavorable (1.88e-5)" "unprognostic (1.32e-1)" "unprognostic (1.23e-3)" "prognostic unfavorable (2.12e-4)" "unprognostic (9.80e-2)" "unprognostic (6.02e-3)" "unprognostic (2.58e-3)" "unprognostic (5.07e-2)" "unprognostic (2.29e-2)" "prognostic unfavorable (5.23e-6)" "unprognostic (2.15e-1)" "unprognostic (1.25e-1)" "unprognostic (1.14e-2)" "unprognostic (4.89e-3)" 69.0 70.0 77.8 62.6 70.9 63.5 62.6 105.3 73.1 75.4 55.4 50.4 44.5 52.3 69.5 55.7 77.2 58.8 64.3 51.7 68.2 59.4 67.8 60.9 58.0 63.4 57.5 48.3 81.0 62.3 27.9 51.0 60.4 41.5 65.6 48.8 49.7 54.7 53.8 66.9 51.0 53.9 69.9 59.0 69.2 65.8 59.7 44.8 92.6 65.5 50.7 72.1 80.3 61.6 90.7 107.4 130.6 89.3 73.9 119.0 122.6 81.1 33.5 119.0 61.0 34.9 33.7 56.0 64.3 31.5 44.5 41.3 38.4 44.8 71.1 46.1 36.7 58.1 39.7 53.4 39.6 52.6 41.0 81.1 71.1 33.8 65.7 22.9 93.2 64.1 34.1 22.6 39.5 21.7 71.5 45.8 71.0 58.5 58.2 32.8 35.1 142.1 80.6 72.5 61.2 50.7 99.4 113.5 59.3 44.5 68.5 73.1 85.6 77.9 64.8 51.6 96.4 70.1 73.6 51.4 64.9 67.4 49.3 103.1 41.0 37.0 108.9 40.8 55.9 51.8 113.4 76.1 130.6 73.2 84.7 75.9 90.7 92.3 84.5 78.8 77.6 85.6 83.0 68.0 73.9 89.3 107.4 119.0 122.6 77.8 70.9 105.3 73.1 68.2 59.4 57.5 48.3 41.5 44.8 151.8 131.7 396.7 508.4 626.5 212.3 52.6 267.5 252.9 166.1 336.8 47.1 464.8 820.7 515.3 191.2 443.3 254.6 163.5 464.8 790.2 521.7 552.5 345.8 247.7 547.3 220.9 424.4 377.5 577.0 387.5 560.1 510.2 438.6 716.9 336.1 326.4 540.6 399.5 568.9 627.1 118.6 562.7 497.4 793.1 668.9 649.2 472.7 438.0 415.6 703.2 SUMO3 "SMT3A, SMT3H1" ENSG00000184900 "Small ubiquitin-like modifier 3" P55854 21 44805617-44818779 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "monocytes: 368.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012180, HPA042123, HPA048064" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB012180: AB_304041, HPA042123: AB_2677860, HPA048064: AB_2680244" "unprognostic (2.77e-2)" "unprognostic (2.52e-1)" "unprognostic (5.79e-2)" "prognostic unfavorable (7.88e-5)" "unprognostic (1.96e-1)" "unprognostic (1.21e-1)" "unprognostic (6.81e-2)" "unprognostic (7.13e-2)" "unprognostic (1.43e-1)" "unprognostic (1.32e-1)" "unprognostic (2.09e-2)" "unprognostic (7.15e-2)" "unprognostic (1.09e-2)" "unprognostic (3.00e-2)" "unprognostic (1.62e-1)" "unprognostic (7.50e-2)" "unprognostic (1.80e-2)" 32.2 23.8 37.4 17.7 43.8 50.0 25.0 31.6 43.4 26.9 28.0 17.5 19.4 24.0 21.7 23.9 23.4 22.1 21.9 36.6 27.6 38.7 24.4 29.2 26.2 32.0 30.8 29.0 26.3 26.2 14.6 15.6 21.7 26.6 21.8 15.5 30.6 28.3 30.2 62.4 18.9 28.9 17.4 19.7 28.2 27.7 17.3 17.3 23.9 26.1 18.4 20.8 22.5 20.3 23.8 46.0 14.0 35.7 18.5 27.6 38.4 45.6 18.5 17.4 7.2 20.2 23.4 18.2 31.9 35.0 45.2 36.3 27.5 18.2 16.2 50.6 29.7 21.4 9.1 15.0 24.8 11.1 22.4 22.6 66.4 13.2 21.8 22.1 37.4 32.9 26.4 23.6 26.4 15.1 10.4 18.3 34.0 37.9 27.0 18.1 58.8 31.8 25.9 41.4 30.1 37.1 37.1 1.5 36.1 11.8 17.8 17.0 32.8 28.5 21.0 22.1 4.8 28.2 26.9 36.0 13.5 29.7 28.8 32.8 33.5 46.8 40.9 12.2 51.3 18.7 0.6 34.6 14.0 23.5 35.7 23.9 23.8 22.8 22.8 37.5 21.5 27.6 24.8 4.1 18.5 32.0 46.0 24.7 38.4 37.4 43.8 31.6 43.4 27.6 38.7 30.8 29.0 26.6 17.3 59.6 47.4 74.9 104.6 85.3 68.8 55.4 53.5 20.1 38.7 90.7 19.6 109.8 140.9 91.8 47.0 107.9 85.0 46.7 98.1 85.9 94.3 117.4 28.9 88.9 177.5 58.8 56.7 85.3 119.6 80.4 66.7 155.6 92.8 368.9 80.7 78.5 112.8 93.7 68.2 95.9 44.8 58.2 77.3 58.8 72.0 68.1 114.0 79.9 86.4 112.9 SUMO4 "dJ281H8.4, IDDM5, SMT3H4" ENSG00000177688 "Small ubiquitin-like modifier 4" Q6EEV6 6 149400227-149401292 "Predicted intracellular proteins" "Ubl conjugation pathway" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 9.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 2.9;HeLa: 4.2" "HPA042123, HPA048064" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA042123: AB_2677860, HPA048064: AB_2680244" "unprognostic (1.16e-1)" "unprognostic (1.76e-1)" "unprognostic (2.16e-2)" "unprognostic (3.24e-3)" "unprognostic (8.61e-2)" "unprognostic (6.84e-2)" "unprognostic (2.24e-1)" "unprognostic (7.75e-2)" "unprognostic (4.32e-2)" "unprognostic (1.35e-1)" "unprognostic (4.72e-2)" "unprognostic (5.36e-2)" "unprognostic (2.44e-11)" "unprognostic (4.94e-3)" "unprognostic (5.88e-2)" "unprognostic (1.14e-1)" "unprognostic (1.19e-2)" 1.5 0.8 0.7 1.9 1.7 3.6 2.7 5.1 6.5 2.1 1.1 1.2 1.4 1.6 3.0 3.2 1.7 0.7 1.5 3.6 1.0 0.8 2.3 6.6 2.8 3.9 0.7 1.7 2.9 2.2 1.2 2.6 1.8 2.8 3.1 1.7 1.7 2.5 1.1 2.3 1.3 1.4 1.9 1.9 2.2 1.5 2.0 0.2 1.4 2.1 0.7 1.8 1.4 3.5 1.9 0.7 5.6 1.1 3.2 2.6 0.5 0.2 0.0 0.2 0.2 0.4 0.0 0.5 0.8 0.2 0.4 0.3 0.3 0.3 1.6 0.3 0.0 0.3 0.3 0.0 0.6 0.4 2.9 0.3 0.3 4.2 0.3 0.3 0.2 0.3 0.3 0.2 0.5 1.0 0.2 0.0 0.0 0.6 1.2 0.2 0.0 0.5 0.6 0.5 0.0 0.3 0.4 0.6 0.5 0.0 1.5 0.9 0.2 0.6 0.0 0.0 0.7 0.0 1.7 1.4 0.8 0.7 0.7 0.5 0.6 0.1 0.1 0.5 0.6 0.0 0.3 0.5 0.9 1.3 0.6 0.7 1.1 2.6 1.9 0.7 1.9 1.7 2.4 5.6 3.2 1.1 0.5 2.5 0.5 0.7 1.7 5.1 6.5 1.0 0.8 0.7 1.7 2.8 0.2 3.0 1.0 0.0 1.3 2.6 4.3 9.2 0.0 1.4 1.2 1.8 3.9 0.7 0.0 0.6 0.0 2.1 1.0 0.0 0.8 0.3 1.7 3.5 1.1 1.5 0.9 0.0 1.7 1.3 1.0 0.7 2.0 4.4 0.0 4.6 0.2 2.3 0.9 0.0 1.1 0.0 4.2 6.5 1.4 1.4 0.9 0.6 0.2 1.7 0.4 2.2 SUPT16H "CDC68, FACT, FACTP140, FLJ10857, FLJ14010, SPT16/CDC68" ENSG00000092201 "SPT16 homolog, facilitates chromatin remodeling subunit" Q9Y5B9 14 21351472-21384266 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022551, HPA049787" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "CAB022551: , HPA049787: AB_2680881" "unprognostic (1.65e-1)" "unprognostic (2.22e-1)" "unprognostic (3.52e-2)" "unprognostic (7.12e-2)" "unprognostic (7.32e-2)" "unprognostic (1.22e-2)" "unprognostic (1.38e-3)" "unprognostic (1.86e-1)" "unprognostic (7.65e-2)" "unprognostic (4.91e-2)" "unprognostic (1.09e-1)" "unprognostic (1.26e-1)" "unprognostic (6.48e-3)" "unprognostic (1.02e-1)" "unprognostic (7.58e-3)" "unprognostic (9.05e-2)" "unprognostic (5.87e-3)" 21.6 18.3 16.3 21.6 26.2 21.5 21.3 39.1 27.9 22.8 21.3 14.4 20.7 13.5 31.5 18.5 20.9 23.7 14.5 15.9 17.9 16.2 17.7 14.1 17.1 28.0 18.8 22.8 29.0 15.7 40.3 24.0 18.9 28.6 18.8 21.5 11.3 19.3 20.5 21.4 22.1 19.9 27.4 18.9 22.6 19.1 24.9 19.0 32.7 20.3 17.0 29.5 24.6 20.7 23.3 17.1 21.1 20.4 23.2 26.8 16.7 30.4 28.8 39.9 29.2 18.1 18.1 28.4 27.6 22.0 33.7 31.8 27.8 27.5 64.7 10.6 20.0 21.7 32.6 50.5 24.9 51.1 20.6 21.5 39.2 26.3 39.0 18.5 55.4 29.2 15.9 15.3 28.1 31.8 16.3 22.8 36.9 32.2 27.9 27.8 19.7 51.7 16.9 44.6 28.0 28.6 56.0 45.6 35.0 13.5 33.7 40.0 34.1 44.6 26.8 16.7 26.9 14.8 26.3 19.2 29.6 24.7 18.3 29.8 27.8 46.5 65.2 10.9 32.7 22.4 21.1 13.1 19.6 22.8 17.3 26.8 23.3 21.8 25.3 17.1 21.3 25.0 25.1 11.0 23.2 20.4 16.1 20.3 16.7 16.3 26.2 39.1 27.9 17.9 16.2 18.8 22.8 28.6 19.0 59.6 49.3 32.0 29.5 31.6 44.4 58.8 33.1 42.8 59.1 50.6 45.2 48.1 21.6 50.6 100.7 39.8 13.9 23.3 52.8 51.4 33.7 25.7 81.0 29.7 36.5 52.4 22.4 28.3 36.2 67.9 55.3 36.3 16.9 116.4 31.1 49.8 52.6 10.5 56.3 25.0 40.5 19.4 44.2 130.3 136.3 36.3 38.1 45.9 38.2 26.4 SUPT3H "SPT3, SPT3L" ENSG00000196284 "SPT3 homolog, SAGA and STAGA complex component" O75486 6 44809317-45377953 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 115.4;Late spermatids: 129.6;T-cells: 33.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024371 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA024371: AB_1857660" "unprognostic (5.72e-3)" "unprognostic (7.92e-2)" "unprognostic (1.23e-2)" "unprognostic (1.34e-1)" "prognostic favorable (3.55e-4)" "unprognostic (1.07e-2)" "unprognostic (6.15e-5)" "unprognostic (7.46e-2)" "unprognostic (1.75e-1)" "prognostic favorable (1.72e-4)" "unprognostic (1.49e-1)" "unprognostic (2.30e-1)" "unprognostic (2.05e-2)" "unprognostic (3.08e-2)" "unprognostic (1.23e-1)" "unprognostic (8.13e-3)" "unprognostic (4.31e-2)" 6.0 11.2 7.4 6.7 7.1 2.8 6.1 20.3 9.2 9.4 9.6 7.9 11.5 5.1 10.0 11.4 4.7 11.7 6.6 4.4 6.1 4.6 8.5 4.2 6.9 3.9 6.3 7.7 11.7 10.2 11.4 15.4 7.1 8.3 10.4 5.4 7.7 7.6 8.1 3.0 3.8 4.3 7.1 10.1 3.7 5.3 14.8 8.8 6.0 9.5 2.6 4.7 6.6 6.5 1.2 3.3 0.3 0.4 5.0 17.1 5.4 3.7 3.6 11.8 3.2 2.2 8.5 2.1 1.8 2.7 8.7 7.6 5.0 2.1 2.2 2.7 1.8 3.1 0.6 9.4 8.1 9.5 2.2 4.2 1.7 2.2 13.1 5.5 2.2 1.0 5.9 7.2 6.7 10.0 16.0 3.6 5.4 3.6 3.2 6.2 1.9 4.3 6.8 4.4 10.6 1.8 5.4 2.7 1.1 11.9 4.6 4.4 2.8 0.6 0.3 5.3 10.3 2.4 3.1 1.8 2.4 0.1 2.7 4.9 4.3 1.1 9.6 4.3 6.3 2.0 0.3 0.4 0.0 8.5 0.4 13.9 1.1 12.4 10.9 1.3 1.2 17.1 13.4 0.3 5.0 0.4 3.3 5.4 5.4 7.4 7.1 20.3 9.2 6.1 4.6 6.3 7.7 8.3 8.8 3.0 4.5 5.6 13.2 1.5 7.1 2.8 2.5 9.4 6.8 7.0 5.9 9.3 10.0 6.5 115.4 5.8 0.8 0.0 2.8 10.3 4.2 6.5 3.5 2.6 8.1 3.2 8.1 7.4 1.6 129.6 7.2 3.5 5.0 14.4 2.8 2.2 4.1 2.8 4.9 7.7 14.2 12.9 7.2 21.3 17.9 1.1 6.9 33.1 3.3 8.8 SUPT4H1 "Spt4, SPT4H, Supt4a, SUPT4H" ENSG00000213246 "SPT4 homolog, DSIF elongation factor subunit" P63272 17 58345175-58353093 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059748 Approved Nucleoplasm NA NA Nucleoplasm "HPA059748: " "unprognostic (1.32e-1)" "unprognostic (1.04e-2)" "unprognostic (1.69e-1)" "unprognostic (2.43e-2)" "unprognostic (2.02e-1)" "unprognostic (1.41e-2)" "prognostic unfavorable (7.69e-5)" "unprognostic (6.71e-2)" "unprognostic (7.05e-2)" "unprognostic (2.37e-3)" "unprognostic (1.57e-2)" "unprognostic (9.52e-2)" "unprognostic (1.28e-2)" "unprognostic (1.07e-1)" "unprognostic (1.25e-1)" "unprognostic (1.19e-2)" "unprognostic (2.54e-1)" 33.3 41.5 34.2 29.8 32.0 67.5 37.4 36.0 53.3 35.1 34.9 29.4 23.9 24.3 36.4 32.0 36.2 31.3 27.5 31.7 29.3 26.7 43.1 52.5 29.7 44.5 30.0 27.3 34.8 34.4 25.5 23.1 41.7 33.5 33.0 32.0 33.0 33.5 31.6 37.4 33.7 36.7 30.3 27.9 41.5 30.5 35.1 20.5 44.1 46.2 37.4 35.9 33.4 29.6 17.8 33.2 73.0 41.4 11.9 21.1 41.7 20.8 39.1 20.3 14.4 21.7 18.8 26.7 22.8 23.1 32.1 31.1 11.7 20.2 21.9 40.0 33.4 24.8 12.6 27.0 27.3 39.1 35.3 29.5 32.9 22.7 47.1 20.7 41.5 24.0 26.4 24.4 23.4 22.0 29.5 25.8 25.9 34.8 25.7 25.7 31.1 43.7 29.3 17.5 26.1 32.9 33.5 28.3 21.7 26.6 22.6 17.9 32.2 12.1 10.6 22.8 27.7 28.8 33.1 20.1 27.7 23.6 14.3 28.0 37.4 81.8 30.2 22.8 14.3 18.7 38.3 39.0 46.3 17.4 41.4 17.0 17.8 16.7 18.1 33.2 14.7 13.5 16.3 73.0 11.9 40.4 18.3 21.1 41.7 34.2 32.0 36.0 53.3 29.3 26.7 30.0 27.3 33.5 20.5 11.9 7.8 101.3 56.0 63.4 27.2 35.4 61.1 12.0 4.5 57.6 0.0 120.6 165.8 108.7 26.1 83.9 83.9 46.7 85.3 139.0 71.9 57.7 88.5 94.4 161.8 12.7 65.8 83.4 132.9 30.6 87.8 149.1 104.6 187.6 59.5 85.7 101.4 71.9 88.8 185.1 22.3 38.8 55.1 55.3 44.8 73.1 125.6 97.2 58.1 65.7 SUPT5H "FLJ34157, SPT5, SPT5H" ENSG00000196235 "SPT5 homolog, DSIF elongation factor subunit" O00267 19 39436156-39476670 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029273, CAB034370" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB034370: AB_2196394, HPA029273: AB_10603896" "unprognostic (3.96e-2)" "unprognostic (3.51e-1)" "unprognostic (1.32e-2)" "unprognostic (5.53e-3)" "unprognostic (4.19e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (7.00e-5)" "unprognostic (7.30e-2)" "unprognostic (4.35e-1)" "unprognostic (1.68e-2)" "unprognostic (1.94e-2)" "unprognostic (6.42e-2)" "unprognostic (1.37e-3)" "unprognostic (1.74e-1)" "unprognostic (2.68e-1)" "unprognostic (3.32e-1)" "unprognostic (2.38e-1)" 27.7 26.2 39.4 28.9 41.0 64.2 23.5 46.8 50.7 26.2 29.2 34.2 21.0 27.7 33.0 22.3 24.2 26.9 26.7 27.8 34.9 28.6 22.6 28.4 25.5 32.9 28.7 42.3 39.8 34.2 39.3 42.9 26.3 31.3 27.8 21.7 25.7 37.6 27.5 55.9 27.7 29.7 24.4 34.4 30.1 27.9 77.8 37.2 22.2 30.1 17.5 27.9 30.3 31.1 10.8 23.4 25.9 12.2 8.2 8.0 6.9 33.5 54.4 20.1 20.1 19.2 13.5 17.1 29.3 18.6 17.7 19.7 35.5 21.0 40.9 27.7 27.2 14.7 13.2 26.9 19.2 13.9 40.0 26.4 45.8 26.0 21.6 17.5 37.2 31.3 21.5 14.5 22.5 23.2 19.5 16.8 36.2 34.4 21.2 17.4 34.1 27.3 11.3 25.1 28.2 13.8 27.8 29.6 20.8 18.3 55.8 19.1 26.0 34.5 27.6 18.8 17.9 16.8 20.3 35.8 18.0 21.0 22.4 37.3 35.0 56.8 50.4 22.1 21.5 22.1 18.5 12.2 9.6 8.0 6.5 8.0 10.8 5.6 6.5 5.8 8.7 6.4 5.1 25.9 8.2 8.2 23.4 6.0 6.9 39.4 41.0 46.8 50.7 34.9 28.6 28.7 42.3 31.3 37.2 41.7 79.1 45.9 20.1 45.8 45.3 52.6 30.6 68.3 56.9 41.8 80.5 32.5 11.6 31.8 50.0 42.9 54.2 23.3 30.4 37.8 29.7 29.1 44.0 52.8 32.5 46.1 85.6 32.5 25.7 57.1 41.7 36.3 38.8 35.1 48.8 26.7 41.7 38.2 38.9 18.8 55.7 19.4 32.0 67.0 46.5 43.3 45.2 48.4 40.2 24.7 SUPT6H "KIAA0162, SPT6H" ENSG00000109111 "SPT6 homolog, histone chaperone" Q7KZ85 17 28662091-28702684 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012416, HPA036382" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB012416: , HPA036382: AB_2675094" "unprognostic (8.18e-2)" "unprognostic (2.27e-1)" "unprognostic (2.72e-1)" "unprognostic (1.75e-2)" "unprognostic (1.06e-1)" "unprognostic (8.23e-2)" "prognostic unfavorable (3.68e-5)" "unprognostic (1.02e-1)" "unprognostic (2.18e-2)" "unprognostic (9.97e-3)" "unprognostic (1.29e-2)" "unprognostic (1.17e-1)" "prognostic favorable (4.36e-5)" "unprognostic (4.75e-2)" "unprognostic (1.05e-1)" "unprognostic (4.17e-2)" "unprognostic (1.06e-2)" 27.6 30.0 30.0 24.1 32.8 56.3 25.6 31.9 35.7 28.0 30.1 28.5 23.2 19.9 38.6 28.4 24.4 24.1 25.0 23.8 25.7 22.0 24.1 32.6 26.3 26.0 25.7 32.8 33.1 28.8 40.7 34.5 31.9 24.3 26.9 21.8 33.2 28.2 29.2 50.1 38.6 28.7 40.0 29.8 33.1 28.5 23.4 29.0 27.2 27.6 18.4 29.4 30.7 27.1 5.7 8.2 14.4 6.1 5.4 5.6 3.4 18.0 37.8 19.0 21.7 23.2 15.6 14.7 24.8 26.6 29.3 26.3 35.1 8.1 19.2 13.0 24.8 22.6 21.6 27.8 18.0 30.5 35.7 24.7 26.8 30.6 21.7 19.4 28.1 30.0 21.4 10.9 31.1 20.8 19.4 19.2 18.9 26.3 22.8 20.8 21.5 27.7 12.0 14.7 15.9 12.3 14.2 35.0 15.6 14.5 35.8 14.5 19.2 29.1 46.0 15.7 27.3 28.2 20.0 30.2 23.2 19.2 22.0 31.6 29.0 22.2 28.2 26.2 12.7 19.1 14.4 5.9 5.4 5.2 3.9 5.5 5.6 4.3 5.6 4.8 5.7 4.4 3.8 9.0 5.4 6.1 8.2 3.8 3.4 30.0 32.8 31.9 35.7 25.7 22.0 25.7 32.8 24.3 29.0 35.7 51.4 21.7 18.1 19.9 27.9 43.2 22.9 33.5 36.4 19.2 53.0 21.0 5.0 19.2 3.9 24.0 22.2 23.3 18.3 17.3 18.8 16.3 47.6 30.2 20.6 28.6 29.7 19.0 21.5 14.4 23.9 20.4 8.5 27.9 19.2 20.5 25.9 16.7 25.1 9.4 40.8 32.3 22.2 18.4 16.2 21.2 41.6 20.8 17.7 21.8 SUPT7L "KIAA0764, SPT7L, STAF65, STAF65gamma" ENSG00000119760 "SPT7 like, STAGA complex gamma subunit" O94864 2 27650812-27663840 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039565, HPA063643" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA039565: AB_10795109, HPA063643: AB_2685070" "unprognostic (1.10e-1)" "unprognostic (1.15e-1)" "unprognostic (3.07e-2)" "prognostic unfavorable (2.28e-4)" "unprognostic (7.54e-2)" "unprognostic (3.70e-1)" "prognostic unfavorable (4.46e-7)" "unprognostic (5.15e-2)" "unprognostic (1.43e-3)" "unprognostic (2.27e-2)" "unprognostic (1.97e-3)" "unprognostic (9.75e-3)" "prognostic unfavorable (1.53e-4)" "unprognostic (2.26e-1)" "unprognostic (4.86e-1)" "unprognostic (3.79e-1)" "unprognostic (5.23e-3)" 24.5 27.5 23.5 23.3 39.7 33.9 25.3 38.6 47.6 22.4 21.8 35.6 21.4 25.0 31.4 29.3 20.5 27.3 22.9 31.0 26.6 28.0 25.1 28.5 23.9 27.6 25.8 27.2 33.4 23.9 33.2 39.3 29.6 36.7 26.7 29.0 28.8 19.3 26.0 26.1 18.7 24.8 31.7 23.2 32.5 22.9 19.5 25.9 34.7 29.7 18.4 26.0 21.8 23.1 12.5 17.3 20.2 13.0 18.2 18.1 10.9 18.1 15.8 23.2 17.9 21.3 17.5 27.8 17.7 17.2 16.1 17.4 20.3 20.5 15.9 18.8 18.7 22.7 19.9 20.8 19.7 15.8 18.2 20.1 21.6 22.4 23.0 27.9 17.4 21.3 24.4 24.8 23.8 25.1 29.9 20.8 19.6 24.4 19.2 20.8 12.4 15.0 28.7 15.4 18.2 14.0 14.5 24.8 20.2 20.6 17.1 18.5 24.0 15.9 16.7 29.1 30.9 11.5 15.2 15.9 22.5 16.6 11.2 16.8 34.6 25.1 33.1 17.4 21.7 15.2 20.2 12.4 10.7 16.4 13.0 18.1 9.2 12.8 16.6 17.3 12.5 15.6 14.7 3.3 18.2 11.1 11.6 14.1 10.9 23.5 39.7 38.6 47.6 26.6 28.0 25.8 27.2 36.7 25.9 20.8 17.9 6.7 12.2 7.4 16.9 18.1 12.7 24.1 21.6 21.0 39.3 29.5 18.3 16.2 5.9 16.4 10.5 0.0 12.7 24.6 13.6 9.2 18.5 14.0 21.4 14.3 10.4 14.1 11.5 1.9 12.7 12.4 3.3 14.4 11.5 17.2 14.1 7.0 14.5 15.7 23.9 19.4 14.4 22.4 18.3 7.5 35.4 17.0 12.7 9.5 SURF2 ENSG00000148291 "Surfeit 2" Q15527 9 133356552-133361169 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 50.1" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 358.5;Late spermatids: 675.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 43.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044340, HPA052213, HPA059710" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoli, Nucleoli rim" Nucleoplasm "HPA044340: AB_2678900, HPA052213: AB_2681763, HPA059710: " "unprognostic (1.53e-1)" "unprognostic (6.10e-3)" "unprognostic (1.24e-3)" "unprognostic (2.25e-2)" "unprognostic (2.50e-1)" "unprognostic (6.27e-2)" "unprognostic (1.92e-2)" "unprognostic (2.01e-1)" "unprognostic (1.05e-1)" "unprognostic (1.85e-1)" "unprognostic (5.46e-3)" "unprognostic (8.28e-2)" "unprognostic (1.07e-3)" "unprognostic (1.09e-2)" "unprognostic (3.15e-2)" "unprognostic (1.12e-1)" "unprognostic (2.86e-1)" 8.3 9.2 15.8 9.0 13.2 8.2 10.7 13.1 14.5 5.7 8.8 7.4 10.8 13.2 6.4 12.0 11.0 10.7 11.2 8.9 13.4 11.0 14.3 12.0 6.5 12.1 13.1 8.7 9.0 17.5 7.1 11.3 5.9 10.3 7.7 5.7 7.7 14.2 8.8 11.5 14.8 11.4 6.9 9.4 8.6 9.3 50.1 6.6 10.6 10.1 14.9 9.8 6.5 8.3 17.5 15.6 13.1 16.2 13.2 26.9 14.1 7.2 12.5 5.3 6.5 3.8 3.0 11.1 3.7 3.3 5.9 3.1 17.1 6.0 7.2 5.4 2.4 5.1 19.9 8.3 9.0 2.7 6.9 11.5 5.7 14.3 6.3 7.7 9.3 4.3 3.6 10.7 8.4 12.4 2.1 2.7 8.9 9.0 5.0 4.0 43.6 9.6 6.2 16.6 17.4 24.2 10.7 7.9 16.9 5.0 8.3 19.7 9.9 8.2 13.8 11.0 3.4 14.7 4.4 5.1 9.0 9.1 9.2 13.1 6.2 12.3 7.8 5.7 5.6 9.0 13.1 16.2 12.0 17.8 16.2 23.1 15.6 21.9 20.2 13.8 17.5 20.8 19.7 7.1 13.2 11.6 15.6 26.9 14.1 15.8 13.2 13.1 14.5 13.4 11.0 13.1 8.7 10.3 6.6 11.9 7.8 21.6 25.7 74.8 17.9 12.4 45.9 48.2 17.0 21.0 2.0 33.0 89.5 56.4 358.5 19.4 48.7 0.0 70.1 21.0 22.4 21.1 9.2 21.5 25.8 12.7 35.1 20.3 25.9 675.3 24.2 22.4 40.5 27.9 17.1 13.2 50.2 28.1 23.0 64.0 18.9 64.7 32.0 140.5 86.5 77.0 21.4 26.1 23.8 17.8 SURF6 "FLJ30322, RRP14" ENSG00000148296 "Surfeit 6" O75683 9 133328774-133336398 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023608, HPA074622" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "HPA023608: AB_1857671, HPA074622: AB_2686703" "unprognostic (5.27e-3)" "unprognostic (8.67e-3)" "unprognostic (5.41e-3)" "unprognostic (3.69e-2)" "unprognostic (2.61e-1)" "unprognostic (3.20e-1)" "unprognostic (1.26e-3)" "unprognostic (3.60e-2)" "unprognostic (1.18e-1)" "unprognostic (9.37e-2)" "unprognostic (6.18e-3)" "unprognostic (9.32e-3)" "prognostic favorable (7.31e-5)" "unprognostic (1.50e-2)" "unprognostic (1.86e-1)" "unprognostic (2.06e-1)" "unprognostic (2.66e-1)" 14.8 16.8 19.9 15.0 22.7 16.2 15.7 16.4 25.8 13.9 16.2 14.0 11.9 21.7 18.6 10.9 17.4 18.5 15.9 13.9 19.1 17.9 14.5 16.2 12.6 17.6 19.6 22.9 27.4 23.1 16.5 11.8 12.5 24.6 15.8 13.1 11.6 18.3 19.5 47.3 17.8 22.3 18.0 23.6 18.8 13.6 16.5 19.8 8.6 14.4 11.1 13.5 15.3 19.1 7.7 8.9 3.9 4.7 4.6 8.5 3.6 4.1 6.4 5.0 7.4 3.1 2.9 8.3 6.5 3.9 5.8 3.7 10.1 7.1 11.9 5.1 3.6 4.3 12.5 6.4 6.9 2.2 7.9 7.2 8.2 7.4 6.0 5.6 13.8 7.1 4.1 6.1 6.1 5.7 5.3 3.0 11.7 17.8 6.5 5.2 10.7 11.2 11.4 14.5 16.8 11.7 11.8 6.9 12.1 5.1 4.0 10.5 8.9 6.4 10.5 5.7 3.2 9.2 7.8 6.2 13.4 7.1 6.7 8.9 4.8 6.8 15.5 5.0 9.5 7.8 3.9 4.7 1.9 6.8 4.4 7.0 7.1 6.2 6.1 4.9 7.7 8.5 7.0 1.3 4.6 3.7 8.9 5.0 3.6 19.9 22.7 16.4 25.8 19.1 17.9 19.6 22.9 24.6 19.8 41.7 23.5 25.1 10.6 21.1 24.6 26.3 30.6 17.4 35.2 21.0 5.9 26.9 18.3 29.0 1.1 20.3 37.7 0.0 16.8 19.1 14.3 11.8 24.3 29.2 18.5 20.6 32.3 12.9 11.1 2.4 25.6 14.2 6.8 21.6 37.2 16.4 23.6 28.1 26.2 11.9 20.1 0.0 17.0 18.9 21.0 24.1 15.9 16.6 47.0 10.5 SUSD1 DKFZP761E1824 ENSG00000106868 "Sushi domain containing 1" Q6UWL2 9 112040785-112175408 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Kupffer cells: 24.1;monocytes: 18.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 24.9" "Lineage enriched" "Detected in many" 4 "dendritic cells: 24.9" "Cell line enhanced" "Detected in many" "HDLM-2: 22.7;HEL: 25.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA048554 Approved Approved Nucleoplasm "Intracellular and membrane" NA NA 530000 Nucleoplasm "HPA048554: AB_2680439" "unprognostic (2.25e-1)" "unprognostic (4.02e-2)" "unprognostic (1.42e-2)" "unprognostic (1.62e-1)" "unprognostic (9.29e-3)" "unprognostic (5.27e-2)" "unprognostic (1.69e-2)" "unprognostic (3.73e-2)" "unprognostic (1.23e-2)" "unprognostic (1.29e-3)" "unprognostic (2.67e-1)" "unprognostic (3.31e-1)" "prognostic favorable (3.63e-6)" "unprognostic (2.14e-3)" "unprognostic (8.38e-2)" "unprognostic (2.39e-1)" "unprognostic (1.30e-1)" 9.6 13.9 9.1 9.7 13.9 14.1 8.4 3.1 15.3 7.6 10.2 2.7 11.6 8.6 5.7 9.8 4.8 6.7 7.6 11.2 6.1 16.4 15.5 4.4 11.5 15.7 8.3 8.2 3.3 8.1 9.4 8.2 23.3 7.4 5.8 11.4 8.1 10.7 12.8 2.9 3.6 9.9 9.3 5.1 14.5 12.2 5.8 3.5 9.6 5.6 1.4 6.6 13.1 4.6 0.2 24.9 5.8 2.7 1.7 1.6 1.1 1.3 8.5 6.1 0.0 4.5 3.0 19.5 5.4 7.3 7.7 9.9 16.9 11.4 0.1 6.1 9.5 0.5 3.9 2.1 1.0 5.8 22.7 1.8 25.7 6.2 11.4 5.4 6.7 8.3 3.7 0.8 4.3 0.1 5.3 17.9 3.8 13.9 1.1 4.8 1.6 0.9 4.1 2.0 21.0 1.3 5.7 1.4 0.0 1.8 4.5 2.1 5.2 3.0 0.6 0.0 3.5 1.0 7.3 13.6 0.1 2.9 0.8 0.0 0.3 0.3 0.5 5.3 2.6 1.6 3.5 1.4 5.8 1.6 1.6 0.5 0.1 0.4 1.1 1.0 0.2 0.2 1.2 0.5 1.7 2.7 24.9 0.1 1.1 9.1 13.9 3.1 15.3 6.1 16.4 8.3 8.2 7.4 3.5 0.0 4.5 1.5 1.2 0.5 0.0 1.9 2.5 6.7 5.7 12.2 0.0 7.4 0.0 5.6 1.7 2.3 4.7 0.0 6.2 8.8 4.0 1.8 5.7 0.0 14.2 0.0 4.1 10.4 24.1 1.2 0.0 10.8 0.0 18.0 4.5 0.0 8.8 3.5 1.8 1.7 1.6 0.0 3.8 0.3 0.3 0.6 7.2 4.9 5.6 7.3 SUSD6 KIAA0247 ENSG00000100647 "Sushi domain containing 6" Q92537 14 69611596-69715142 "Predicted membrane proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030464 Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA Nucleoplasm "Intermediate filaments" "HPA030464: AB_10601128" "unprognostic (1.04e-1)" "unprognostic (2.29e-1)" "unprognostic (7.34e-2)" "unprognostic (1.58e-2)" "unprognostic (6.94e-2)" "unprognostic (3.46e-2)" "unprognostic (2.17e-1)" "unprognostic (2.73e-2)" "unprognostic (1.57e-1)" "unprognostic (3.66e-3)" "unprognostic (1.10e-2)" "unprognostic (6.70e-2)" "prognostic favorable (2.16e-4)" "unprognostic (1.10e-2)" "unprognostic (5.35e-2)" "unprognostic (1.30e-2)" "unprognostic (2.34e-1)" 25.4 17.4 9.2 26.0 11.9 40.2 19.5 36.4 12.3 12.1 25.0 15.5 14.8 17.2 13.0 31.0 27.0 16.1 19.6 13.2 11.4 8.4 16.7 11.6 30.9 25.3 15.1 8.2 13.4 20.9 13.7 14.6 14.1 13.9 16.0 13.4 14.6 26.6 17.5 10.6 22.5 36.7 14.0 14.1 30.9 17.3 9.1 12.9 12.7 23.4 14.8 27.4 16.4 15.3 4.1 5.3 23.1 9.1 2.9 4.2 5.0 10.8 2.8 4.1 3.7 8.4 6.2 7.5 6.2 13.1 3.5 3.4 3.3 9.7 12.8 7.0 7.7 2.8 15.3 2.3 12.7 3.3 21.8 1.7 10.4 2.2 5.5 13.6 1.7 27.0 9.9 12.7 5.9 11.1 3.8 7.2 4.0 3.1 11.4 4.9 5.3 2.5 4.5 0.8 6.4 2.9 4.3 3.6 5.1 6.8 5.6 1.7 2.8 5.1 14.8 2.2 3.1 6.0 4.7 11.1 8.2 4.9 5.1 2.5 8.0 1.7 9.1 5.3 5.8 4.3 8.9 7.5 8.3 4.1 7.3 4.2 3.9 3.6 2.5 5.3 4.1 3.5 2.5 23.1 2.9 9.1 3.0 3.2 5.0 9.2 11.9 36.4 12.3 11.4 8.4 15.1 8.2 13.9 12.9 11.9 28.8 5.7 25.4 0.0 16.6 11.8 35.7 20.1 20.5 17.4 19.6 3.8 6.6 22.7 0.6 24.8 36.2 23.3 21.3 1.5 7.9 43.6 8.1 12.8 21.0 14.3 7.0 19.6 57.1 1.5 4.9 22.6 0.0 2.8 14.9 3.8 31.1 21.2 6.3 13.3 21.3 25.8 14.4 4.4 14.6 0.0 7.7 13.8 7.8 41.2 SUZ12 "CHET9, JJAZ1, KIAA0160" ENSG00000178691 "SUZ12 polycomb repressive complex 2 subunit" Q15022 17 31937018-32001045 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057436 Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies" Yes No "Nucleoplasm, Nucleoli, Nucleoli rim, Nuclear bodies" "HPA057436: AB_2683439" "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (3.65e-3)" "unprognostic (1.23e-1)" "unprognostic (2.49e-1)" "unprognostic (7.31e-2)" "unprognostic (2.66e-3)" "unprognostic (8.05e-2)" "unprognostic (7.27e-2)" "unprognostic (3.06e-2)" "unprognostic (6.29e-2)" "unprognostic (8.70e-2)" "unprognostic (3.28e-2)" "unprognostic (2.25e-1)" "unprognostic (1.28e-1)" "unprognostic (5.91e-2)" "unprognostic (1.31e-1)" 10.1 10.8 13.4 15.4 10.4 25.5 33.5 16.0 13.8 11.2 11.4 7.5 13.6 10.1 12.5 8.1 12.3 9.8 7.7 9.7 9.1 7.6 10.9 11.5 10.6 19.9 9.3 9.9 10.0 10.1 15.5 10.4 15.3 9.5 10.7 10.9 6.9 10.1 9.6 8.7 9.9 12.2 9.6 7.7 15.2 10.7 17.1 12.5 31.8 12.0 6.5 18.9 10.8 19.5 5.5 4.6 4.1 2.6 4.4 5.5 1.2 14.3 12.7 12.0 13.7 6.9 8.9 12.3 14.0 12.4 17.2 20.8 9.6 8.1 31.3 10.8 8.7 14.7 12.7 17.8 8.0 28.0 11.0 17.3 21.7 10.8 6.9 8.2 34.1 22.3 6.2 9.1 17.1 13.2 10.4 10.5 15.0 20.9 43.6 14.7 5.0 40.5 19.8 6.8 10.1 7.8 24.2 30.8 25.4 10.1 14.0 15.4 12.0 22.5 7.3 13.5 8.7 21.1 28.5 7.7 13.7 12.5 16.3 21.5 23.8 29.6 38.8 10.0 21.1 12.3 1.4 1.9 3.8 3.8 2.6 3.0 5.5 4.1 4.0 1.4 4.4 3.9 5.5 4.1 4.4 1.8 4.6 4.2 1.2 13.4 10.4 16.0 13.8 9.1 7.6 9.3 9.9 9.5 12.5 38.7 37.9 23.1 41.1 52.0 74.2 24.8 35.7 28.1 37.5 33.2 102.1 49.4 14.9 23.6 8.9 34.9 15.6 23.3 19.1 45.9 33.8 46.2 15.1 37.5 27.9 58.8 28.3 38.6 41.9 10.7 24.7 37.6 23.6 86.6 31.9 41.7 22.6 10.5 24.1 24.5 76.3 12.9 32.5 100.7 141.1 62.7 58.1 39.9 33.0 48.2 SV2C ENSG00000122012 "Synaptic vesicle glycoprotein 2C" Q496J9 5 76083172-76353939 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 52.2" "Cell type enriched" "Detected in some" 4 "Intestinal endocrine cells: 19.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basal ganglia: 52.2;pons and medulla: 26.6" "Cell type enriched" "Detected in single" 14 "basophil: 4.2" "Lineage enriched" "Detected in single" 21 "granulocytes: 4.2" "Group enriched" "Detected in some" 5 "Karpas-707: 12.2;SCLC-21H: 5.0;SH-SY5Y: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040722, HPA040770" Supported Supported Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA040722: AB_10795624, HPA040770: AB_10805828" "unprognostic (7.91e-2)" "unprognostic (2.33e-1)" "unprognostic (2.05e-1)" "unprognostic (2.41e-2)" "unprognostic (1.07e-1)" "unprognostic (9.93e-2)" "unprognostic (1.09e-2)" "unprognostic (2.57e-1)" "unprognostic (2.57e-1)" "unprognostic (2.14e-1)" "unprognostic (1.44e-1)" "unprognostic (2.34e-2)" "unprognostic (1.60e-3)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" "unprognostic (6.66e-2)" "unprognostic (1.16e-1)" 0.5 5.5 0.8 1.3 52.2 0.7 1.2 1.2 9.5 0.7 0.8 0.5 0.0 1.0 0.7 0.9 0.6 1.8 0.6 0.8 0.6 8.3 0.4 0.4 0.4 0.5 5.6 1.9 2.6 0.8 0.9 0.8 0.4 26.6 1.0 1.1 1.1 1.7 1.2 0.3 0.7 1.3 1.0 5.8 0.6 1.6 1.0 6.7 0.0 0.5 0.0 0.4 0.6 0.4 0.1 0.1 4.2 0.2 0.1 0.2 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 12.2 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.0 11.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 4.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.1 0.2 0.2 0.8 52.2 1.2 9.5 0.6 8.3 5.6 1.9 26.6 6.7 0.0 0.0 0.0 0.5 0.0 3.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.1 1.1 0.0 0.0 0.1 0.0 19.0 0.6 0.0 0.7 0.0 0.0 3.3 0.0 0.5 0.8 0.0 0.0 0.0 0.0 4.4 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 1.1 SVBP "CCDC23, MGC45441" ENSG00000177868 "Small vasohibin binding protein" Q8N300 1 42807052-42817252 "Predicted intracellular proteins, Predicted secreted proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 164.4;Spermatogonia: 149.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008507 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Secreted to blood" Yes No "Nucleoplasm, Nuclear bodies, Cytosol" "HPA008507: AB_2072066" "prognostic favorable (6.33e-4)" "unprognostic (2.68e-2)" "unprognostic (2.91e-1)" "unprognostic (4.60e-2)" "unprognostic (2.05e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (1.18e-4)" "unprognostic (3.15e-2)" "unprognostic (3.35e-3)" "unprognostic (1.59e-2)" "unprognostic (6.73e-3)" "unprognostic (2.16e-1)" "unprognostic (5.37e-3)" "unprognostic (1.17e-3)" "unprognostic (7.07e-2)" "unprognostic (2.44e-3)" "unprognostic (2.31e-3)" 20.1 14.1 25.6 11.1 18.9 32.3 20.1 24.0 20.4 16.2 15.7 17.6 10.4 9.7 20.5 23.9 13.0 20.1 15.5 19.6 21.8 19.7 16.0 15.9 13.8 17.8 23.5 22.3 34.4 9.1 10.7 20.0 23.5 20.4 16.8 14.5 13.6 11.6 14.5 21.1 10.1 11.8 17.1 26.9 14.3 11.5 38.2 18.7 29.2 15.5 16.1 19.4 16.2 15.1 24.5 16.0 30.2 16.8 14.3 44.8 9.7 10.2 4.9 32.3 11.6 13.1 20.9 15.7 8.8 7.3 12.0 12.4 9.0 8.2 11.1 9.7 11.8 9.4 7.1 5.7 9.4 16.2 19.7 9.8 22.3 4.9 17.9 10.6 16.7 14.6 13.1 15.1 6.7 6.9 13.0 12.1 22.4 17.3 6.0 15.3 4.8 16.7 20.0 17.7 9.8 6.0 12.2 24.6 7.8 12.7 11.2 19.3 17.3 10.5 6.1 12.6 35.9 4.8 47.3 9.2 10.6 12.0 8.5 14.2 5.8 7.1 8.0 6.8 11.4 10.0 20.8 16.6 30.2 11.4 15.9 10.3 22.1 20.4 14.0 16.0 24.5 19.2 16.4 29.3 14.3 16.8 13.4 44.8 9.7 25.6 18.9 24.0 20.4 21.8 19.7 23.5 22.3 20.4 18.7 8.9 4.6 32.1 27.2 0.0 5.5 0.0 28.1 13.4 17.0 19.2 2.0 47.5 46.4 41.3 113.1 20.3 12.5 93.5 21.4 53.4 17.5 19.3 10.5 31.8 64.1 6.4 17.5 31.3 40.5 49.2 39.7 28.7 0.0 64.1 23.7 13.2 34.6 28.5 50.5 34.8 13.5 58.2 0.0 164.4 149.9 0.0 51.5 20.0 30.2 25.4 SWI5 "bA395P17.9, C9orf119, SAE3" ENSG00000175854 "SWI5 homologous recombination repair protein" Q1ZZU3 9 128275379-128288990 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 9 "Early spermatids: 892.4;Late spermatids: 836.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA052032 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA052032: AB_2681702" "unprognostic (1.27e-2)" "unprognostic (1.74e-2)" "unprognostic (3.56e-3)" "unprognostic (3.21e-2)" "unprognostic (1.42e-3)" "unprognostic (3.28e-2)" "prognostic unfavorable (6.78e-4)" "unprognostic (2.11e-1)" "unprognostic (1.19e-1)" "unprognostic (1.81e-1)" "unprognostic (4.58e-3)" "unprognostic (1.15e-1)" "prognostic favorable (9.39e-4)" "unprognostic (1.43e-1)" "unprognostic (6.73e-2)" "unprognostic (2.40e-1)" "unprognostic (7.38e-2)" 10.2 11.7 14.7 11.8 15.9 6.0 17.9 18.0 13.2 18.2 9.0 12.3 48.0 9.9 13.0 44.8 13.5 20.4 12.7 14.8 12.5 13.2 14.2 18.0 12.5 8.7 16.7 11.0 19.6 13.2 26.5 23.8 10.7 13.6 14.6 8.1 14.1 15.2 50.7 14.1 10.3 9.5 12.8 13.7 7.7 9.2 57.1 16.2 8.9 27.8 12.5 10.5 12.4 17.1 12.6 14.2 28.1 9.6 13.4 15.3 10.0 9.5 17.1 10.2 11.8 27.6 25.3 11.5 16.9 22.5 22.0 14.9 21.9 11.3 9.1 22.6 27.5 13.6 16.1 16.2 22.5 15.0 13.7 12.1 6.9 32.8 17.1 35.6 4.4 6.5 21.2 10.8 36.6 19.8 19.5 21.0 33.6 16.3 14.8 22.4 39.0 9.6 6.4 6.9 22.2 35.7 9.0 14.0 14.5 14.7 5.0 11.7 6.5 21.0 13.5 20.0 11.8 22.4 4.8 13.0 16.0 13.3 30.9 14.2 15.7 23.5 12.1 21.8 6.9 17.2 28.1 9.6 16.4 10.2 5.7 12.0 12.6 10.1 10.2 9.8 12.5 12.2 15.3 6.4 13.4 5.6 14.2 10.0 10.0 14.7 15.9 18.0 13.2 12.5 13.2 16.7 11.0 13.6 16.2 6.0 19.5 14.5 34.6 21.8 13.1 30.0 30.6 14.7 18.2 34.9 11.8 55.7 56.3 21.8 892.4 21.5 27.0 0.0 33.5 35.4 41.0 29.6 9.2 68.6 29.0 1.6 24.5 27.6 19.7 836.9 40.0 17.2 35.4 27.1 23.4 24.7 25.7 20.1 29.7 53.2 17.7 32.3 26.4 56.3 38.7 19.2 97.8 18.3 20.5 27.5 SWSAP1 "C19orf39, FLJ35119, SWS1AP1, ZSWIM7AP1" ENSG00000173928 "SWIM-type zinc finger 7 associated protein 1" Q6NVH7 19 11374685-11376951 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052712 Uncertain Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA052712: AB_2681925" "unprognostic (6.45e-2)" "unprognostic (3.99e-2)" "unprognostic (1.48e-1)" "unprognostic (2.75e-1)" "unprognostic (1.92e-1)" "unprognostic (1.79e-2)" "unprognostic (5.03e-1)" "unprognostic (1.34e-2)" "unprognostic (4.65e-2)" "unprognostic (8.62e-3)" "unprognostic (1.40e-3)" "unprognostic (2.53e-1)" "unprognostic (1.34e-2)" "prognostic favorable (4.07e-4)" "unprognostic (1.61e-1)" "unprognostic (1.78e-1)" "unprognostic (4.18e-3)" 2.9 7.8 1.9 3.6 2.7 5.8 8.3 5.0 2.5 5.3 4.3 2.7 5.9 4.5 4.8 6.0 6.2 5.4 3.9 3.8 2.1 2.0 6.9 12.8 5.8 6.1 2.8 1.8 6.0 10.2 2.9 5.3 11.9 3.5 4.7 3.2 4.5 6.8 5.1 10.7 5.4 5.1 2.0 2.5 10.5 5.0 15.3 2.7 12.2 7.6 4.8 7.8 5.0 3.4 10.6 11.9 13.5 16.4 8.8 9.6 5.9 4.8 3.9 2.6 2.0 2.7 2.2 3.7 1.3 1.4 2.8 2.6 4.3 3.9 9.1 6.2 1.2 2.1 3.7 2.2 5.0 0.3 3.1 5.3 4.6 2.4 5.8 2.1 7.4 8.1 3.6 4.6 1.6 1.4 2.1 3.4 4.4 5.0 4.7 1.5 9.9 4.1 9.1 6.0 3.8 5.8 3.4 1.2 9.5 5.2 3.4 5.0 4.0 2.0 6.1 3.5 1.6 8.0 7.9 3.4 2.9 1.9 3.5 2.6 6.4 8.0 6.0 1.5 7.9 2.0 2.0 16.4 4.0 7.1 14.6 6.8 10.6 7.4 7.5 11.9 10.2 9.6 8.0 13.5 8.8 13.5 8.3 6.7 5.9 1.9 2.7 5.0 2.5 2.1 2.0 2.8 1.8 3.5 2.7 3.0 1.3 12.6 8.4 2.4 7.1 2.8 2.5 5.3 1.2 15.7 7.9 15.4 34.9 5.9 7.7 5.0 8.4 0.0 9.3 9.5 3.7 5.2 1.1 11.3 10.5 9.5 2.4 4.9 7.1 1.3 10.9 7.6 6.8 6.4 12.0 12.1 5.1 11.5 7.4 13.4 11.0 6.5 4.9 10.3 11.9 2.8 26.5 6.2 7.4 4.7 SYAP1 "FLJ14495, PRO3113" ENSG00000169895 "Synapse associated protein 1" Q96A49 X 16719632-16765336 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000175, HPA000882, HPA048047" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA000175: AB_1080142, HPA000882: AB_2666128, HPA048047: AB_2680240" "unprognostic (4.66e-2)" "unprognostic (2.99e-2)" "unprognostic (1.25e-2)" "unprognostic (5.44e-2)" "unprognostic (1.89e-1)" "unprognostic (1.52e-2)" "unprognostic (9.53e-2)" "unprognostic (1.27e-1)" "unprognostic (2.06e-1)" "prognostic favorable (3.18e-4)" "unprognostic (1.82e-1)" "unprognostic (1.62e-2)" "unprognostic (1.95e-1)" "unprognostic (3.95e-3)" "unprognostic (1.14e-2)" "unprognostic (8.10e-2)" "unprognostic (5.28e-3)" 17.6 31.3 13.1 12.9 12.3 26.2 16.5 10.2 14.0 17.1 23.8 12.2 16.1 20.6 17.0 13.7 18.5 14.4 20.7 25.7 13.5 13.7 28.7 51.4 17.6 11.4 15.8 11.0 19.9 14.3 22.8 15.9 18.9 18.4 16.2 16.1 10.7 15.9 21.3 22.5 12.6 33.0 12.3 17.3 13.7 16.9 10.1 11.2 15.3 16.2 13.3 15.1 17.9 13.5 12.6 11.1 17.8 15.0 13.8 15.2 9.1 15.9 13.5 9.8 18.3 13.3 15.2 4.5 12.8 9.2 10.7 10.7 12.6 13.3 12.5 18.8 12.5 21.9 9.6 11.9 16.7 14.4 8.1 23.8 5.0 14.6 12.0 9.5 8.5 7.8 10.3 7.9 18.5 15.8 12.5 14.7 3.9 10.7 7.1 14.4 18.8 4.5 9.2 11.4 8.9 14.9 5.0 12.4 12.6 15.9 10.6 10.0 12.3 23.8 17.0 12.6 13.3 22.6 7.7 11.6 13.8 7.3 28.0 10.3 7.7 6.6 14.6 13.6 4.3 11.2 9.2 10.5 12.7 15.2 11.3 12.3 12.6 13.0 13.9 11.1 10.8 13.1 13.6 17.8 13.8 15.0 9.2 14.4 9.1 13.1 12.3 10.2 14.0 13.5 13.7 15.8 11.0 18.4 11.2 59.6 59.3 59.9 76.6 56.9 18.5 68.5 81.5 190.1 93.3 75.0 21.6 57.3 94.5 102.2 188.0 47.2 124.9 23.3 115.1 64.1 49.1 85.9 200.3 200.6 44.7 22.3 101.7 67.5 63.9 250.6 39.1 90.0 64.1 53.3 93.6 45.0 138.4 150.8 51.2 108.8 19.3 58.2 83.4 13.3 21.5 45.9 125.9 62.3 95.4 91.2 SYCE1 "bA108K14.6, C10orf94, CT76" ENSG00000171772 "Synaptonemal complex central element protein 1" Q8N0S2 10 133553901-133569835 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" "Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 75.4" "Group enriched" "Detected in some" 5 "Early spermatids: 103.1;Late spermatids: 85.3;Spermatocytes: 250.9;Spermatogonia: 112.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 8 "K-562: 17.4;U-2 OS: 16.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA040208 Enhanced Uncertain Nucleoplasm,Vesicles,Cytosol No No Nucleoplasm "Vesicles, Cytosol" "HPA040208: AB_10796450" "unprognostic (5.04e-2)" "unprognostic (1.96e-1)" "unprognostic (1.03e-2)" "unprognostic (1.85e-1)" "unprognostic (9.05e-2)" "unprognostic (1.61e-1)" "unprognostic (3.20e-1)" "unprognostic (5.75e-1)" "unprognostic (5.38e-2)" "unprognostic (3.36e-1)" "unprognostic (2.22e-2)" "unprognostic (7.17e-3)" "unprognostic (2.95e-2)" "unprognostic (1.27e-1)" "unprognostic (1.69e-1)" "unprognostic (2.42e-1)" 1.8 1.8 4.9 0.7 5.4 0.3 1.3 8.1 8.2 0.4 0.7 0.9 0.0 0.4 0.8 0.5 0.6 1.4 1.6 0.7 4.0 3.3 0.9 3.9 0.5 1.1 1.5 6.7 1.1 1.5 0.2 0.3 8.6 3.5 1.8 0.6 0.2 0.4 0.6 0.9 0.3 0.5 0.7 1.7 0.8 0.5 75.4 0.0 0.1 1.4 0.1 0.7 0.4 0.0 1.3 2.0 0.3 2.6 0.2 3.2 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.7 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 17.4 0.0 0.0 0.1 0.0 0.5 0.3 0.0 0.3 1.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.2 0.1 0.1 0.1 16.1 0.2 0.3 0.2 0.3 0.4 0.0 0.1 0.0 0.0 1.7 0.3 3.2 1.8 3.0 0.9 2.4 0.8 1.2 1.3 1.4 2.7 0.0 0.2 2.6 2.0 2.2 1.8 4.9 5.4 8.1 8.2 4.0 3.3 1.5 6.7 3.5 0.0 0.0 1.0 0.0 1.5 0.9 1.8 0.2 2.5 2.7 2.3 0.0 0.0 0.3 0.0 0.0 103.1 0.1 0.0 0.0 0.9 0.1 0.8 0.4 0.0 5.1 0.6 9.5 0.0 0.0 0.0 85.3 4.9 0.6 0.0 0.0 0.0 0.3 0.7 0.0 3.5 0.3 1.6 25.8 0.4 250.9 112.4 0.9 0.2 0.0 0.0 0.3 SYCE2 CESC1 ENSG00000161860 "Synaptonemal complex central element protein 2" Q6PIF2 19 12898786-12919276 "Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 41.2" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 21.3;Late spermatids: 19.1;Sertoli cells: 25.8;Spermatocytes: 102.1;Spermatogonia: 38.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in some" 4 "NK-cell: 6.3" "Lineage enriched" "Detected in many" 4 "NK-cells: 6.3" "Cell line enhanced" "Detected in many" "EFO-21: 11.7;JURKAT: 10.3;MOLT-4: 10.5;SiHa: 11.5;U-266/70: 12.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA042080, HPA062919" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA042080: AB_10794411, HPA062919: AB_2684905" "unprognostic (3.00e-1)" "prognostic favorable (3.85e-5)" "unprognostic (9.99e-3)" "prognostic unfavorable (9.91e-4)" "unprognostic (1.75e-1)" "unprognostic (3.48e-2)" "unprognostic (2.19e-1)" "unprognostic (1.75e-1)" "unprognostic (1.78e-1)" "unprognostic (8.28e-3)" "unprognostic (1.30e-2)" "unprognostic (8.39e-4)" "unprognostic (1.79e-10)" "unprognostic (7.55e-3)" "unprognostic (9.93e-2)" "unprognostic (1.09e-1)" "unprognostic (7.87e-5)" 0.4 0.4 0.3 0.3 0.4 2.9 0.3 2.0 1.6 0.5 0.4 0.3 0.3 0.2 0.3 0.6 0.3 0.4 0.3 0.3 0.5 0.2 0.3 1.1 0.5 1.0 0.3 0.3 0.8 0.4 0.0 0.4 0.8 0.4 0.6 0.1 0.3 0.6 0.3 0.3 1.1 0.3 0.3 0.4 0.5 0.3 41.2 0.3 2.6 0.4 0.3 0.7 0.5 0.4 0.1 0.2 1.4 0.1 6.3 0.6 0.1 5.6 1.1 2.9 1.8 0.3 0.8 3.2 1.3 0.6 0.8 1.0 0.2 0.8 4.4 11.7 0.8 1.0 1.1 1.0 0.3 0.9 1.6 0.7 1.2 2.5 0.5 0.1 2.8 4.0 0.8 0.2 0.3 0.6 1.4 0.2 10.3 1.1 1.3 0.5 2.3 10.5 1.9 1.9 0.2 3.3 3.2 1.4 1.1 0.5 0.8 2.1 1.4 11.5 0.6 0.6 0.9 2.2 3.0 0.8 0.8 1.5 4.3 0.3 12.1 1.5 4.9 1.0 3.8 5.4 0.0 0.1 1.4 0.2 0.0 0.1 0.0 0.6 0.0 0.2 0.1 0.2 0.4 0.0 6.3 0.0 0.0 0.5 0.1 0.3 0.4 2.0 0.6 0.5 0.2 0.3 0.3 0.4 0.3 0.0 0.0 0.5 0.3 1.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 21.3 0.1 0.0 0.0 0.3 1.6 0.4 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.6 19.1 2.8 0.0 0.0 0.0 0.0 0.7 0.1 0.0 1.1 0.0 0.2 25.8 0.2 102.1 38.1 0.4 0.2 0.0 0.0 0.1 SYCE3 C22orf41 ENSG00000217442 "Synaptonemal complex central element protein 3" A1L190 22 50551112-50562905 "Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 61.5" "Group enriched" "Detected in many" 6 "Early spermatids: 349.3;Spermatocytes: 429.3;Spermatogonia: 109.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "neutrophil: 8.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 8.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 8.8;Karpas-707: 7.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA047813 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Nucleoplasm, Nucleoli, Golgi apparatus" "HPA047813: AB_2797234" "unprognostic (2.55e-1)" "unprognostic (2.52e-1)" "unprognostic (2.06e-2)" "unprognostic (2.64e-1)" "unprognostic (1.33e-1)" "unprognostic (1.63e-1)" "unprognostic (1.73e-2)" "unprognostic (2.22e-1)" "unprognostic (2.98e-3)" "unprognostic (1.68e-2)" "unprognostic (4.05e-2)" "unprognostic (3.43e-2)" "unprognostic (4.81e-2)" "unprognostic (2.57e-1)" "unprognostic (1.60e-1)" "unprognostic (1.55e-2)" "unprognostic (5.20e-2)" 0.4 0.4 0.7 0.5 0.9 0.1 0.7 0.2 0.6 0.2 0.4 0.5 0.4 0.1 0.2 1.1 0.2 0.8 0.6 0.1 0.5 0.7 1.0 0.8 0.4 0.9 0.9 0.3 0.1 0.2 0.2 0.4 0.4 0.7 0.1 0.0 0.2 0.7 0.1 0.0 0.2 0.0 0.5 0.7 0.1 0.2 61.5 0.4 0.0 1.1 0.2 0.3 0.7 0.0 0.5 1.9 8.0 1.3 0.0 0.3 0.3 0.4 0.7 0.1 0.3 0.6 0.5 0.4 0.5 0.0 0.0 0.0 0.0 8.8 0.4 3.2 0.0 1.8 0.0 0.9 1.0 0.0 0.0 0.5 0.0 0.6 0.0 4.0 0.0 1.6 2.3 2.0 0.3 1.4 0.5 0.0 1.8 0.0 7.4 0.4 3.3 0.0 0.0 0.3 3.7 0.0 0.0 0.0 3.9 1.2 2.6 0.8 2.3 0.0 2.2 1.4 0.3 2.1 1.8 0.0 0.7 0.8 0.0 0.1 1.9 0.4 1.1 0.9 0.3 0.2 0.0 1.3 1.5 0.0 1.1 0.3 0.0 0.0 0.0 1.9 0.5 0.0 0.2 8.0 0.0 0.9 0.0 0.0 0.3 0.7 0.9 0.2 0.6 0.5 0.7 0.9 0.3 0.7 0.4 0.0 0.0 0.0 0.4 0.1 0.5 0.4 5.1 0.0 0.0 1.8 0.0 4.2 3.3 1.3 349.3 0.1 0.3 0.0 0.6 2.6 0.1 0.3 0.0 1.6 1.4 0.0 0.0 0.6 1.2 52.2 10.0 0.0 0.0 4.6 0.0 0.9 1.2 0.0 6.7 2.1 0.4 45.3 0.0 429.3 109.7 0.1 3.1 0.0 0.3 0.9 SYCP2 SCP2 ENSG00000196074 "Synaptonemal complex protein 2" Q9BX26 20 59863563-59933655 "Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "breast: 11.1;testis: 41.7" "Cell type enriched" "Detected in many" 6 "Spermatocytes: 330.2" "Group enriched" "Detected in many" 6 "breast cancer: 6.7;cervical cancer: 11.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "JURKAT: 19.1;MOLT-4: 21.1;SiHa: 37.2;T-47d: 33.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA062401, HPA065613" Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA062401: AB_2684752, HPA065613: AB_2685519" "unprognostic (8.10e-3)" "unprognostic (8.28e-3)" "unprognostic (1.62e-1)" "unprognostic (2.48e-2)" "unprognostic (1.57e-1)" "unprognostic (1.19e-3)" "unprognostic (2.50e-2)" "unprognostic (2.18e-1)" "unprognostic (4.11e-2)" "unprognostic (1.44e-1)" "unprognostic (3.74e-1)" "unprognostic (7.02e-3)" "unprognostic (4.84e-3)" "unprognostic (8.48e-2)" "unprognostic (2.46e-1)" "unprognostic (7.87e-3)" "unprognostic (1.21e-1)" 2.2 0.5 1.3 0.9 2.3 1.4 11.1 2.5 5.7 1.3 1.2 1.0 0.8 1.1 1.1 0.9 0.8 0.8 2.0 2.1 1.2 1.2 3.3 0.8 1.6 3.1 1.8 2.7 0.4 4.9 1.3 3.0 2.9 3.9 2.9 0.8 0.6 3.0 0.7 0.8 2.0 1.7 0.6 1.6 2.3 4.5 41.7 0.8 3.0 1.9 0.2 1.5 1.3 1.0 0.9 0.1 2.6 0.3 0.0 2.7 0.5 0.1 0.5 0.1 0.5 0.2 0.3 0.6 1.6 0.4 0.7 0.1 10.2 1.0 0.0 1.6 0.7 0.3 0.2 0.2 0.0 0.4 3.2 0.2 0.1 2.0 0.1 0.0 0.1 7.6 0.1 0.1 0.1 0.0 0.4 0.0 19.1 0.1 0.0 0.3 4.9 21.1 1.1 0.2 0.6 0.1 0.0 0.0 0.1 0.9 2.4 0.1 1.8 37.2 5.4 1.1 0.7 33.6 1.9 0.2 0.0 1.1 4.5 0.0 0.0 0.0 0.0 0.0 0.7 2.1 2.5 0.3 2.3 2.6 0.0 2.7 0.7 1.5 1.7 0.1 0.9 0.9 1.5 2.6 0.0 0.1 0.1 1.0 0.5 1.3 2.3 2.5 5.7 1.2 1.2 1.8 2.7 3.9 0.8 0.0 0.6 0.5 1.0 0.9 1.3 3.6 2.5 14.7 10.3 1.8 2.0 0.5 1.7 0.6 36.7 2.3 0.0 0.0 3.1 0.2 1.2 2.0 2.3 0.0 0.5 0.0 0.0 3.1 0.6 13.5 4.4 1.1 5.0 0.0 0.0 2.2 1.6 0.2 1.8 2.6 1.0 51.8 1.9 330.2 31.3 0.0 0.3 1.3 0.2 1.1 SYCP2L "C6orf177, dJ62D2.1, NO145" ENSG00000153157 "Synaptonemal complex protein 2 like" Q5T4T6 6 10886831-10979320 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "parathyroid gland: 54.0" "Cell type enhanced" "Detected in some" 10 "Early spermatids: 10.8;granulocytes: 10.4;Spermatogonia: 8.1" "Cancer enhanced" "Detected in single" "testis cancer: 1.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "basophil: 2.9;eosinophil: 5.5;plasmacytoid DC: 7.6" "Group enriched" "Detected in many" 17 "dendritic cells: 7.6;granulocytes: 5.5" "Cell line enhanced" "Detected in some" "HL-60: 9.1;HMC-1: 28.4;K-562: 7.1;NB-4: 9.7;SuSa: 6.0;THP-1: 7.3" HPA034679 Supported Nucleoplasm NA NA Nucleoplasm "HPA034679: AB_10669729" "unprognostic (3.25e-1)" "unprognostic (2.58e-2)" "unprognostic (3.23e-1)" "unprognostic (3.72e-5)" "unprognostic (2.20e-1)" "unprognostic (1.21e-2)" "unprognostic (5.57e-3)" "unprognostic (4.23e-1)" "unprognostic (6.03e-2)" "unprognostic (2.16e-1)" "unprognostic (1.40e-1)" "unprognostic (3.04e-1)" "unprognostic (1.21e-3)" "unprognostic (1.07e-2)" "unprognostic (1.86e-1)" "unprognostic (3.85e-2)" "unprognostic (2.74e-2)" 0.9 0.4 0.9 0.8 1.0 0.7 0.7 2.6 1.5 0.5 1.1 0.8 3.7 0.4 1.1 8.9 0.6 0.5 0.7 3.0 0.8 0.7 1.6 0.4 10.1 0.5 1.0 0.5 1.5 5.5 54.0 0.7 4.0 0.6 0.8 0.4 2.9 1.2 0.5 1.9 0.6 0.3 0.5 0.9 0.6 0.4 5.1 0.6 0.7 2.5 0.0 2.2 0.5 0.3 0.0 7.6 5.5 0.3 0.0 0.0 0.0 0.0 0.7 1.4 0.0 0.1 0.0 3.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.1 0.1 4.3 0.0 0.0 0.0 0.0 9.1 28.4 0.0 0.6 0.0 0.0 0.1 0.0 0.3 7.1 0.0 0.0 0.0 2.3 9.7 0.5 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.4 2.5 0.0 2.4 0.0 6.0 0.1 7.3 0.0 0.0 0.5 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.8 2.9 0.1 5.5 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.9 1.0 2.6 1.5 0.8 0.7 1.0 0.5 0.6 0.6 0.0 2.2 0.0 0.0 0.1 2.4 0.3 0.0 1.4 0.0 0.0 0.0 2.1 0.0 0.1 10.8 0.1 0.0 0.0 0.2 1.6 0.3 0.3 10.4 0.0 0.4 3.2 0.0 0.0 0.0 2.3 1.1 0.9 0.0 0.0 0.0 0.5 0.6 0.0 1.4 0.0 0.0 0.0 0.0 3.9 8.1 0.0 1.1 0.0 0.0 0.1 SYDE1 "7h3, FLJ13511, SYD1" ENSG00000105137 "Synapse defective Rho GTPase homolog 1" Q6ZW31 19 15107403-15114988 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 60.0" "Cell type enhanced" "Detected in many" 12 "Extravillous trophoblasts: 126.4;Sertoli cells: 84.1;Syncytiotrophoblasts: 112.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-138 MG: 41.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013328 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA013328: AB_1848705" "unprognostic (9.99e-2)" "unprognostic (3.73e-2)" "unprognostic (8.17e-3)" "unprognostic (1.65e-2)" "unprognostic (6.33e-2)" "unprognostic (1.03e-1)" "unprognostic (1.07e-2)" "unprognostic (2.46e-2)" "unprognostic (2.96e-1)" "unprognostic (5.01e-3)" "unprognostic (1.43e-1)" "unprognostic (1.80e-1)" "prognostic unfavorable (5.63e-7)" "unprognostic (1.82e-2)" "unprognostic (7.57e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (8.27e-4)" 15.6 7.7 3.5 5.9 4.3 0.1 19.9 2.0 3.5 19.5 13.9 4.4 3.8 4.3 18.6 6.8 10.7 12.2 10.5 9.3 4.0 1.8 9.6 3.3 9.4 4.9 3.1 2.4 17.9 4.6 2.3 3.8 60.0 5.0 11.8 2.9 22.0 3.3 13.6 5.9 4.4 5.7 14.2 2.5 7.6 7.9 7.4 4.3 0.9 8.2 5.8 2.8 12.9 12.8 0.2 0.3 0.0 0.0 0.0 0.5 0.0 4.1 6.4 3.5 9.0 7.9 7.3 2.7 17.5 12.9 17.2 14.7 1.4 2.5 0.0 11.6 17.6 5.9 2.6 2.7 3.1 9.7 0.1 3.0 0.6 11.9 2.8 15.0 0.0 0.0 12.7 2.3 10.3 4.7 10.5 3.1 0.0 0.0 0.0 12.8 2.0 0.0 0.0 5.7 0.1 6.6 0.0 8.6 0.0 4.2 0.5 0.1 6.9 9.8 6.0 11.7 3.5 0.7 0.4 6.6 41.5 12.6 19.0 18.8 0.0 0.1 0.0 11.2 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 4.3 2.0 3.5 4.0 1.8 3.1 2.4 5.0 4.3 3.0 1.4 0.5 0.6 2.2 0.3 3.9 2.5 0.0 1.2 1.8 0.0 4.9 0.0 3.9 8.8 12.6 0.0 0.0 0.3 126.4 14.7 0.5 0.0 0.0 3.0 1.6 0.0 19.0 1.3 12.0 27.3 0.8 13.5 0.0 0.0 13.2 1.5 0.0 39.6 5.5 0.4 84.1 29.9 1.2 0.5 2.3 112.5 0.0 0.0 0.1 SYMPK "SPK, SYM" ENSG00000125755 Symplekin Q92797 19 45815410-45863290 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion, mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 114.2;Late spermatids: 108.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041756, HPA042449" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA041756: AB_10963544, HPA042449: AB_2678003" "unprognostic (1.24e-1)" "unprognostic (1.23e-1)" "unprognostic (1.21e-1)" "unprognostic (2.59e-1)" "unprognostic (1.59e-2)" "unprognostic (3.11e-2)" "unprognostic (2.33e-3)" "unprognostic (9.93e-2)" "unprognostic (9.78e-2)" "unprognostic (1.23e-1)" "unprognostic (9.16e-3)" "unprognostic (1.67e-2)" "unprognostic (1.44e-1)" "unprognostic (2.34e-1)" "unprognostic (1.29e-1)" "unprognostic (2.58e-1)" "unprognostic (6.38e-2)" 14.7 15.9 15.3 23.7 24.2 20.7 15.2 25.1 32.2 17.1 18.2 25.3 20.3 18.6 22.6 18.9 17.4 19.3 17.6 14.6 17.3 18.0 15.0 21.6 15.6 27.2 19.3 16.8 21.6 16.3 20.5 24.0 34.8 19.9 17.4 12.2 16.1 21.5 17.5 33.4 21.1 18.0 13.9 18.7 23.0 19.4 38.0 22.0 28.5 20.5 11.6 23.4 16.8 16.7 7.9 9.2 6.5 7.1 4.2 5.2 2.7 19.5 34.6 14.2 10.7 13.9 17.8 23.9 15.6 11.0 16.0 18.3 15.3 18.0 34.5 10.7 17.6 9.1 16.1 19.0 17.0 14.4 26.7 21.3 19.9 23.7 16.1 16.0 21.8 23.4 12.9 10.4 17.2 19.6 11.0 16.5 18.3 26.2 22.6 13.9 18.3 20.2 23.1 12.1 17.1 8.0 21.7 16.5 21.4 11.4 35.4 16.2 20.5 19.1 12.5 12.6 14.9 17.1 30.2 18.2 13.3 21.3 10.2 22.7 29.9 56.5 28.0 15.2 14.7 21.8 2.1 5.1 2.2 3.4 3.8 3.2 4.7 3.0 5.2 4.2 7.9 2.6 2.4 6.5 4.2 7.1 9.2 2.3 2.7 15.3 24.2 25.1 32.2 17.3 18.0 19.3 16.8 19.9 22.0 0.0 7.7 30.4 14.0 18.5 20.9 5.9 22.9 5.3 5.7 24.4 33.4 28.3 46.4 19.9 114.2 15.7 30.0 0.0 14.8 27.8 19.9 17.1 12.7 31.6 15.8 20.6 34.9 31.3 25.6 108.4 17.8 20.1 13.5 41.5 31.6 9.8 17.3 23.0 19.8 10.3 28.0 19.4 14.2 22.9 39.6 18.6 47.9 13.8 27.0 18.6 SYN2 "SYNII, SYNIIa, SYNIIb" ENSG00000157152 "Synapsin II" 3 12004402-12191400 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 20 "brain: 72.5" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 14.6;Cone photoreceptor cells: 5.9;Horizontal cells: 12.7;Spermatocytes: 4.9;Spermatogonia: 6.6" "Cancer enhanced" "Detected in many" "glioma: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.5;HEK 293: 3.3;HMC-1: 6.1;NTERA-2: 5.2;SCLC-21H: 4.2;SH-SY5Y: 16.5;SuSa: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037012, CAB079005" Supported Approved Nucleoplasm NA NA Nucleoplasm "CAB079005: , HPA037012: AB_2675431" "unprognostic (1.62e-3)" "unprognostic (1.60e-2)" "unprognostic (7.54e-2)" "unprognostic (9.87e-3)" "unprognostic (1.73e-1)" "unprognostic (3.19e-1)" "unprognostic (6.32e-3)" "unprognostic (1.08e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (3.68e-2)" "unprognostic (1.24e-1)" "unprognostic (9.77e-2)" "unprognostic (4.89e-4)" "unprognostic (9.94e-2)" "unprognostic (7.35e-2)" "unprognostic (1.78e-2)" 3.7 2.7 28.2 0.7 23.3 0.5 1.4 9.2 72.5 1.0 0.8 0.2 0.0 0.8 1.2 1.2 0.5 0.8 0.7 0.7 15.4 1.4 0.4 0.8 0.5 0.0 33.4 1.5 0.5 1.8 0.0 2.3 15.3 0.7 0.9 0.0 0.9 0.6 0.9 0.9 1.2 1.9 2.2 0.8 1.2 2.4 1.6 0.0 0.5 0.0 0.5 0.5 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.3 0.7 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 3.5 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 6.1 0.1 0.0 0.1 0.4 0.0 0.5 1.5 0.0 0.4 0.0 0.0 0.0 0.0 5.2 0.1 0.4 0.0 0.0 0.0 0.0 0.2 4.2 16.5 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 14.6 1.0 0.0 0.0 0.0 0.0 5.9 1.4 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.5 12.7 0.0 0.0 1.6 1.3 0.0 0.0 0.0 0.0 0.0 2.0 0.3 0.0 0.0 2.3 2.6 0.0 0.0 4.9 6.6 0.0 0.7 0.0 0.0 0.1 SYNCRIP "dJ3J17.2, GRY-RBP, hnRNP-Q, HNRNPQ, HNRPQ1, NSAP1" ENSG00000135316 "Synaptotagmin binding cytoplasmic RNA interacting protein" O60506 6 85607785-85643792 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Translation regulation" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010895, HPA041275, HPA069241" Supported Approved Nucleoplasm,Vesicles,Cytosol NA NA 77000 Nucleoplasm "Vesicles, Cytosol" "CAB010895: AB_261964, HPA041275: AB_2677389, HPA069241: " "unprognostic (1.01e-1)" "unprognostic (3.49e-2)" "unprognostic (1.02e-2)" "unprognostic (1.20e-1)" "unprognostic (1.49e-2)" "unprognostic (6.22e-2)" "prognostic unfavorable (6.28e-5)" "unprognostic (6.84e-2)" "unprognostic (6.48e-2)" "prognostic favorable (5.59e-4)" "unprognostic (1.58e-2)" "unprognostic (1.43e-1)" "unprognostic (4.86e-2)" "unprognostic (1.37e-1)" "unprognostic (2.34e-1)" "unprognostic (1.00e-1)" "unprognostic (4.11e-1)" 29.1 28.3 27.9 31.3 36.2 30.4 28.4 35.6 37.9 32.9 29.4 19.2 31.8 20.4 32.7 18.9 48.8 24.5 21.9 31.3 29.3 19.0 25.2 31.3 25.7 35.0 31.9 23.1 26.2 34.9 37.5 27.9 31.3 28.2 23.1 29.6 17.3 31.4 32.8 41.4 27.2 23.7 53.5 28.1 24.7 25.4 19.8 30.1 38.1 42.0 29.8 41.7 31.2 39.4 13.2 20.9 4.6 20.0 18.1 18.6 12.6 32.2 24.2 40.4 23.5 26.6 31.7 25.6 47.9 39.5 43.5 43.2 39.6 21.3 76.3 34.9 46.1 34.6 31.3 59.1 47.5 76.3 26.2 27.1 68.0 29.2 27.2 22.5 83.0 29.3 25.9 27.4 49.7 51.2 23.5 45.8 22.9 68.1 36.0 50.2 35.5 38.8 35.4 38.7 31.2 25.8 58.3 64.6 32.4 35.6 51.8 38.1 30.9 33.3 28.2 19.6 25.2 24.4 51.7 42.0 29.5 24.1 30.9 57.2 22.5 44.4 50.3 27.0 50.2 41.0 1.0 13.0 4.6 17.7 18.6 18.6 13.2 16.8 15.9 20.9 11.9 15.3 16.6 1.6 18.1 20.0 15.5 16.7 12.6 27.9 36.2 35.6 37.9 29.3 19.0 31.9 23.1 28.2 30.1 107.2 97.5 44.7 111.8 131.7 43.4 77.5 48.4 87.0 134.2 43.6 15.7 88.7 46.4 116.0 77.9 92.0 42.3 0.0 85.9 107.5 80.8 88.9 59.0 74.1 86.4 58.8 54.4 52.8 60.2 17.6 68.1 69.2 50.6 61.3 65.0 37.9 106.5 45.6 60.5 62.1 40.3 19.4 102.9 77.7 58.0 123.8 98.7 52.5 77.4 123.7 SYNE1 "8B, ARCA1, C6orf98, CPG2, dJ45H2.2, enaptin, KIAA0796, MYNE1, Nesp1, Nesprin-1, SCAR8, SYNE-1B" ENSG00000131018 "Spectrin repeat containing nuclear envelope protein 1" Q8NF91 6 152121684-152637801 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" Actin-binding "Cancer-related genes, Disease mutation, Emery-Dreifuss muscular dystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 182.4;Bipolar cells: 303.5;Ciliated cells: 222.1;Cone photoreceptor cells: 188.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "eosinophil: 33.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 33.8" "Cell line enhanced" "Detected in many" "U-266/70: 19.2" HPA019113 Approved Supported "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA019113: AB_1857707" "unprognostic (9.99e-2)" "unprognostic (1.91e-1)" "unprognostic (2.22e-2)" "unprognostic (1.75e-1)" "unprognostic (2.28e-1)" "unprognostic (9.58e-3)" "unprognostic (1.11e-1)" "unprognostic (3.55e-3)" "unprognostic (1.58e-1)" "unprognostic (9.85e-2)" "unprognostic (8.87e-3)" "unprognostic (2.70e-1)" "unprognostic (4.14e-3)" "unprognostic (5.83e-2)" "unprognostic (1.82e-1)" "unprognostic (1.42e-1)" "unprognostic (2.78e-1)" 12.7 11.5 18.2 9.1 30.2 41.7 9.0 62.0 25.0 16.8 7.3 9.8 12.4 2.7 15.2 18.4 6.2 12.9 7.9 22.7 21.0 17.5 18.4 11.2 16.1 13.7 13.2 15.1 27.7 10.6 37.3 37.0 4.7 19.7 10.1 6.3 10.5 3.6 12.5 22.0 16.9 5.3 19.1 9.7 15.5 9.0 8.3 11.6 9.0 20.6 9.5 12.1 10.0 12.3 3.2 0.8 33.8 1.5 4.7 6.4 1.4 0.1 4.0 2.8 3.2 4.0 8.8 1.1 9.0 4.7 2.3 4.3 0.9 0.1 8.4 0.5 4.9 7.7 0.2 1.0 2.3 2.4 10.1 2.8 3.5 2.7 2.7 9.2 0.6 1.6 5.6 0.5 5.1 10.5 6.5 4.5 4.4 0.0 9.7 6.3 0.4 1.4 0.1 0.6 0.7 1.5 1.9 5.6 2.4 9.0 0.1 1.7 2.7 1.5 0.6 6.2 2.6 0.5 0.3 6.0 10.9 14.7 3.8 4.9 19.2 8.2 13.5 6.0 2.0 3.1 3.0 1.1 33.8 6.4 0.7 4.1 2.9 4.2 6.1 0.8 3.2 4.0 5.1 1.1 4.7 1.5 0.7 5.1 1.4 18.2 30.2 62.0 25.0 21.0 17.5 13.2 15.1 19.7 11.6 154.9 182.4 21.6 6.0 11.3 303.5 110.2 2.5 222.1 95.5 41.8 188.5 0.8 3.3 20.2 8.3 87.0 0.0 0.0 6.6 5.4 44.0 3.0 14.0 19.5 7.2 130.3 2.9 65.7 9.2 9.0 30.8 11.2 15.1 1.0 6.7 24.3 4.5 0.0 37.4 14.1 150.7 25.8 40.0 2.9 5.8 8.4 1.0 49.8 0.2 1.6 SYNGAP1 "KIAA1938, RASA5, SYNGAP" ENSG00000197283 "Synaptic Ras GTPase activating protein 1" Q96PV0 6 33419661-33457541 "Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Autism, Autism spectrum disorder, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.9" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 21.8;Horizontal cells: 36.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.9" "Group enriched" "Detected in many" 6 "B-cells: 1.5;T-cells: 1.9" "Cell line enhanced" "Detected in many" "AF22: 20.9;HMC-1: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038373 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA038373: AB_10670779" "unprognostic (3.72e-1)" "unprognostic (3.13e-2)" "unprognostic (4.74e-2)" "unprognostic (2.23e-2)" "unprognostic (4.35e-2)" "prognostic favorable (2.80e-4)" "unprognostic (3.66e-2)" "unprognostic (8.65e-2)" "unprognostic (4.02e-1)" "unprognostic (1.68e-2)" "unprognostic (1.17e-2)" "unprognostic (9.81e-2)" "prognostic unfavorable (1.34e-6)" "unprognostic (9.48e-3)" "unprognostic (1.73e-1)" "unprognostic (1.83e-2)" "unprognostic (2.47e-2)" 4.5 5.0 29.7 11.9 28.6 6.2 4.3 27.2 33.7 7.8 5.9 5.5 2.4 6.0 13.0 5.3 4.2 11.9 6.1 4.4 37.9 7.6 4.0 2.2 5.9 10.3 4.1 38.9 12.8 3.5 10.0 26.1 6.2 7.9 6.3 4.7 3.2 3.7 7.1 2.3 6.2 5.7 11.1 8.7 9.7 4.9 8.7 9.3 8.9 5.6 0.2 7.0 6.9 6.4 1.5 0.1 0.1 0.2 0.0 1.9 0.0 2.0 0.9 20.9 7.7 4.4 4.5 2.7 5.1 3.2 2.8 2.2 8.7 0.9 5.9 1.3 2.4 2.6 3.0 2.6 2.9 2.0 3.4 1.7 14.7 2.3 0.5 2.9 2.2 17.2 3.1 0.9 5.3 2.5 10.8 2.1 4.9 4.6 2.7 2.1 4.4 3.5 3.4 10.5 0.9 2.2 13.8 0.5 2.4 2.1 1.5 5.1 4.1 1.9 3.6 1.6 4.9 7.9 2.1 0.6 6.0 5.9 2.4 0.9 3.2 1.1 4.3 3.4 2.6 1.4 0.0 0.2 0.1 0.3 0.0 0.8 0.1 1.9 0.9 0.0 1.5 0.9 0.2 0.1 0.0 0.1 0.1 0.1 0.0 29.7 28.6 27.2 33.7 37.9 7.6 4.1 38.9 7.9 9.3 0.0 1.3 2.2 1.7 3.2 21.8 1.4 7.6 9.4 4.5 3.5 9.8 0.8 1.7 1.6 4.4 6.2 1.3 0.0 1.2 1.0 8.9 1.5 4.7 0.8 1.6 36.5 9.2 8.6 3.7 1.1 10.6 2.5 3.3 2.8 1.7 5.6 1.7 0.0 12.7 1.9 7.4 19.4 7.8 7.1 6.7 3.8 0.7 12.2 2.8 1.4 SYNJ1 "INPP5G, PARK20" ENSG00000159082 "Synaptojanin 1" O43426 21 32628759-32728048 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Endocytosis "Hydrolase, RNA-binding" "Disease mutation, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.0" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 43.2;Rod photoreceptor cells: 40.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011916 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA011916: AB_1857692" "unprognostic (6.84e-2)" "unprognostic (8.64e-2)" "unprognostic (5.76e-2)" "unprognostic (6.44e-2)" "unprognostic (1.27e-1)" "prognostic favorable (4.43e-4)" "unprognostic (1.45e-1)" "unprognostic (3.73e-3)" "unprognostic (1.63e-1)" "unprognostic (6.22e-3)" "unprognostic (1.84e-2)" "prognostic unfavorable (2.58e-4)" "unprognostic (1.28e-1)" "unprognostic (6.36e-2)" "unprognostic (5.97e-2)" "unprognostic (1.79e-1)" "unprognostic (2.92e-1)" 5.5 6.8 13.6 5.0 25.9 20.6 4.2 19.5 39.0 4.8 4.8 6.5 0.8 3.9 4.6 5.3 3.9 4.0 5.2 5.2 18.3 18.2 7.4 5.5 6.5 5.7 16.6 18.4 4.6 4.5 10.6 10.9 9.3 33.5 3.6 5.5 7.0 3.8 4.0 4.4 5.0 4.6 5.0 7.3 6.0 4.2 9.0 5.7 3.2 6.8 1.5 4.8 4.7 3.3 0.4 3.1 11.5 6.0 0.5 3.0 1.1 5.6 2.8 5.2 5.7 9.1 7.3 10.6 11.7 6.7 7.2 6.0 6.4 2.6 2.1 3.9 7.0 9.6 5.3 9.3 6.8 8.6 6.7 8.9 14.1 9.2 3.5 4.9 5.8 12.5 4.1 5.1 12.4 6.3 5.9 11.2 7.5 10.5 12.1 9.2 5.7 5.4 4.8 3.7 6.2 6.5 5.9 11.3 7.4 7.6 4.1 5.9 4.6 14.4 9.2 5.6 7.4 7.9 7.5 12.3 11.1 5.5 8.9 6.4 6.3 7.3 4.4 8.4 11.0 8.8 3.7 3.4 7.9 1.6 6.0 2.7 0.2 2.4 2.6 3.1 0.4 2.9 2.8 11.5 0.5 5.3 1.6 3.0 1.1 13.6 25.9 19.5 28.7 18.3 18.2 16.6 18.4 33.5 5.7 6.0 4.8 2.9 2.0 4.2 21.5 7.3 5.1 4.0 2.3 1.8 43.2 13.3 5.0 1.6 14.8 7.9 4.9 0.0 1.2 7.9 3.7 2.2 3.5 3.6 8.6 9.5 2.9 8.6 19.0 8.6 2.6 7.5 1.7 1.0 2.7 19.5 2.1 3.5 4.2 5.0 40.7 6.5 3.4 16.4 10.9 2.9 31.8 6.9 4.0 4.1 SYNPO KIAA1029 ENSG00000171992 Synaptopodin Q8N3V7 5 150601080-150659220 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 66.1;placenta: 63.4;skeletal muscle: 222.7" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 219.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 25 "memory B-cell: 2.9;naive B-cell: 3.3" "Lineage enriched" "Detected in single" 27 "B-cells: 3.3" "Cell line enhanced" "Detected in many" "BEWO: 26.4;EFO-21: 21.8;HUVEC TERT2: 21.3;TIME: 51.7;U-87 MG: 45.9" "Group enriched" "Detected in many" 6 "amygdala: 75.9;basal ganglia: 61.9;cerebral cortex: 93.2;hippocampal formation: 69.5;olfactory region: 42.1" "Low region specificity" "Detected in all" "CAB033265, HPA034631, CAB037325, HPA071347" Enhanced Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA "Nucleoplasm, Cytosol" "Actin filaments" "CAB033265: AB_2201163, CAB037325: , HPA034631: AB_10669994, HPA071347: AB_2732179" "unprognostic (2.09e-2)" "unprognostic (7.72e-3)" "unprognostic (3.95e-2)" "unprognostic (2.78e-3)" "unprognostic (3.07e-2)" "unprognostic (1.66e-2)" "unprognostic (1.76e-1)" "unprognostic (1.41e-2)" "unprognostic (1.90e-1)" "unprognostic (1.21e-1)" "unprognostic (1.17e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (1.53e-6)" "unprognostic (1.23e-1)" "unprognostic (5.72e-2)" "unprognostic (2.21e-2)" "unprognostic (6.35e-2)" 17.3 14.6 17.7 4.4 18.9 0.6 5.7 1.4 24.9 4.3 5.5 2.4 0.8 6.6 5.1 4.8 6.7 4.4 6.8 66.1 16.6 4.0 15.8 7.8 11.7 2.4 4.5 5.6 23.3 6.8 2.5 2.8 63.4 3.7 7.6 4.1 16.4 2.6 6.7 222.7 1.8 7.6 8.2 4.8 14.5 4.7 17.4 3.9 0.5 4.0 5.7 2.6 6.2 17.0 3.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 7.0 0.0 0.1 1.0 0.9 26.4 4.0 5.5 1.4 1.1 6.2 2.8 0.0 21.8 5.7 8.7 2.6 0.0 3.9 0.5 0.0 0.0 0.0 10.6 1.3 6.0 0.0 0.2 1.1 6.3 1.5 1.1 8.2 21.3 0.0 0.0 0.0 1.3 0.4 0.0 0.2 0.8 2.6 3.4 0.1 0.2 0.0 1.0 0.5 2.5 11.7 5.8 6.4 0.2 9.7 0.4 1.9 51.7 5.2 16.3 0.1 1.0 0.2 0.0 0.3 45.9 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.7 18.9 1.4 24.9 16.6 4.0 4.5 5.6 3.7 3.9 32.8 13.5 0.9 2.8 4.0 1.3 219.1 35.7 5.3 14.8 7.0 2.0 9.9 0.0 44.4 1.6 40.9 50.6 0.0 30.5 5.8 12.3 1.6 0.0 38.0 1.9 0.0 13.3 42.4 6.7 1.9 2.6 1.1 5.0 41.5 9.9 6.1 29.3 25.9 26.2 3.3 0.6 45.3 32.0 0.7 0.4 1.9 21.6 1.3 9.1 3.0 SYT10 ENSG00000110975 "Synaptotagmin 10" Q6XYQ8 12 33374238-33439819 "Predicted membrane proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.6;fallopian tube: 8.1" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 2.0;Club cells: 4.5;Distal tubular cells: 6.6;Ito cells: 2.5;Spermatogonia: 4.5" "Cancer enriched" "Detected in single" 5 "renal cancer: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.8;K-562: 2.2;MCF7: 7.7;NTERA-2: 1.9;RPTEC TERT1: 2.0;RT4: 3.0;SCLC-21H: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA055426 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA055426: AB_2682812" "unprognostic (3.60e-1)" "unprognostic (4.93e-2)" "unprognostic (9.34e-4)" "unprognostic (5.53e-2)" "unprognostic (3.67e-1)" "unprognostic (4.74e-3)" "unprognostic (3.19e-1)" "unprognostic (1.97e-6)" "unprognostic (4.00e-1)" "unprognostic (2.39e-1)" "unprognostic (2.41e-1)" "unprognostic (1.91e-1)" 0.3 1.5 0.6 0.7 10.1 0.1 0.3 0.2 4.1 2.9 3.6 0.9 3.0 1.0 0.3 0.8 0.3 8.1 0.4 0.5 0.8 3.1 3.3 1.4 0.2 0.1 0.6 3.4 0.4 0.2 0.1 5.8 0.2 14.6 1.6 1.6 0.1 1.8 3.2 0.2 0.2 1.3 0.6 2.7 0.2 1.6 0.6 0.3 0.0 0.2 0.0 0.1 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 7.7 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.0 3.0 4.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 10.1 0.2 4.1 0.8 3.1 0.6 3.4 14.6 0.3 0.0 0.0 0.0 0.0 0.0 2.0 0.5 0.0 1.4 4.5 0.0 0.0 0.0 6.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 4.5 0.0 0.1 0.0 0.0 0.0 SYT17 ENSG00000103528 "Synaptotagmin 17" Q9BSW7 16 19167971-19268334 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.2" "Cell type enhanced" "Detected in many" 5 "Collecting duct cells: 21.0;Distal tubular cells: 23.2;Intestinal endocrine cells: 20.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "intermediate monocyte: 4.1;memory B-cell: 5.1;naive B-cell: 14.7;non-classical monocyte: 13.4" "Group enriched" "Detected in many" 8 "B-cells: 14.7;monocytes: 13.4" "Cell line enhanced" "Detected in many" "BEWO: 10.4;CAPAN-2: 20.2;Daudi: 8.9;MCF7: 15.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042059 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA042059: AB_2677827" "unprognostic (3.43e-1)" "unprognostic (2.75e-1)" "unprognostic (2.29e-2)" "unprognostic (1.49e-2)" "unprognostic (2.74e-1)" "unprognostic (1.11e-2)" "unprognostic (9.31e-2)" "unprognostic (2.43e-1)" "unprognostic (6.76e-2)" "unprognostic (1.97e-1)" "unprognostic (3.15e-1)" "unprognostic (6.59e-2)" "unprognostic (3.00e-3)" "unprognostic (4.53e-2)" "unprognostic (3.38e-1)" "unprognostic (7.32e-2)" "unprognostic (4.95e-3)" 3.8 5.2 16.5 1.4 9.2 0.4 4.7 1.0 25.2 3.5 2.4 6.1 1.2 4.3 1.2 3.1 4.0 2.5 1.3 1.3 15.5 16.5 3.8 12.1 7.8 3.2 13.9 10.2 0.8 2.5 21.3 13.4 3.9 7.5 9.7 3.0 7.6 1.5 3.8 0.4 9.9 2.1 1.0 5.5 1.4 4.3 0.6 7.4 0.0 7.1 0.8 4.7 4.2 3.8 14.7 1.6 0.4 13.4 0.0 0.0 0.6 0.0 7.4 0.1 0.0 0.2 0.5 10.4 0.0 0.0 0.1 0.0 0.3 20.2 8.9 2.5 0.0 2.8 3.6 0.5 0.3 0.0 0.0 1.5 0.0 7.4 0.1 0.0 0.0 0.0 0.7 1.8 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.9 5.8 4.1 0.0 0.8 0.7 2.5 4.4 1.6 0.9 2.9 8.0 0.4 5.1 7.9 1.9 0.0 0.0 5.3 0.1 0.0 1.5 0.0 8.2 0.0 0.0 0.0 0.4 0.5 0.0 0.0 4.1 0.0 5.1 0.0 0.0 1.6 14.7 0.0 0.0 0.1 0.0 13.4 0.2 0.0 0.6 16.5 9.2 1.0 22.9 15.5 16.5 13.9 10.2 7.5 7.4 6.0 9.4 2.7 10.1 3.4 0.6 1.4 0.0 5.3 3.4 21.0 0.0 4.2 23.2 3.4 0.1 1.6 1.3 0.0 0.6 11.3 2.4 8.2 0.0 12.4 4.0 1.6 20.7 3.1 1.9 0.0 1.4 2.0 11.8 9.0 9.1 13.2 2.7 7.0 0.7 0.0 0.3 0.0 0.7 0.5 1.7 8.4 3.3 0.0 3.1 6.3 SYTL2 "CHR11SYT, exophilin-4, FLJ20163, FLJ21219, KIAA1597, MGC102768, PPP1R151, SGA72M, SLP2" ENSG00000137501 "Synaptotagmin like 2" Q9HCH5 11 85694224-85811159 "Plasma proteins, Predicted intracellular proteins, Transporters" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "stomach 1: 65.2" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 139.2;granulocytes: 122.9;Mucus-secreting cells: 160.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 10.5;MAIT T-cell: 17.9" "Lineage enriched" "Detected in many" 6 "T-cells: 17.9" "Cell line enhanced" "Detected in many" "MCF7: 25.3;OE19: 41.5;RH-30: 51.1;RPTEC TERT1: 36.5" "Low region specificity" "Detected in many" HPA039651 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Nucleoplasm, Golgi apparatus" "Plasma membrane" "HPA039651: AB_10795153" "unprognostic (8.07e-3)" "unprognostic (6.72e-3)" "prognostic favorable (2.67e-4)" "unprognostic (9.34e-4)" "unprognostic (6.60e-3)" "unprognostic (2.19e-4)" "unprognostic (2.24e-2)" "unprognostic (5.37e-2)" "unprognostic (5.56e-2)" "unprognostic (5.45e-2)" "unprognostic (1.92e-2)" "unprognostic (2.97e-2)" "unprognostic (2.85e-2)" "unprognostic (4.03e-1)" "unprognostic (1.87e-2)" "unprognostic (9.72e-2)" "prognostic favorable (9.07e-4)" 12.8 5.5 27.6 11.8 13.9 1.8 9.7 6.8 32.0 6.5 26.3 6.8 2.1 11.4 7.6 11.8 9.6 6.3 15.0 5.7 13.8 9.0 14.5 3.9 8.1 5.7 8.4 21.5 3.7 2.5 7.2 5.5 9.8 12.4 9.9 39.8 5.7 8.4 5.8 3.7 4.6 17.7 7.8 12.8 5.4 65.2 3.2 5.1 5.8 4.2 5.0 3.8 17.2 11.3 0.1 0.7 0.0 0.0 3.0 17.9 1.7 0.9 2.2 3.5 0.3 0.8 4.6 0.0 8.6 11.3 7.6 17.4 9.7 1.3 0.2 3.2 6.0 11.1 6.3 0.2 0.7 10.1 0.6 0.0 0.0 0.0 0.1 0.5 0.7 0.1 5.8 1.1 16.5 0.2 1.8 0.0 0.2 0.1 0.1 9.6 25.3 0.0 0.2 5.9 41.5 3.9 0.3 51.1 0.0 36.5 13.2 0.1 0.1 1.9 1.5 0.8 3.1 0.1 0.1 0.0 12.0 4.6 7.5 0.4 0.0 0.0 4.5 12.3 0.1 7.3 0.0 0.0 0.0 10.5 0.0 17.9 0.0 2.1 6.3 0.0 0.1 1.7 3.1 0.0 3.0 0.0 0.7 0.8 1.7 27.6 13.9 6.8 32.0 13.8 9.0 8.4 21.5 12.4 5.1 20.8 30.4 1.4 10.2 3.2 8.3 1.6 10.2 139.2 38.7 64.6 7.9 0.7 0.0 8.4 1.1 3.6 40.7 0.0 14.7 0.2 9.3 37.7 122.9 0.4 0.5 1.6 18.5 7.4 4.7 0.4 1.7 3.9 10.1 1.0 160.5 13.4 13.2 34.8 28.3 7.7 8.1 32.3 29.7 3.3 2.1 5.0 0.3 30.0 35.7 46.4 SYTL5 ENSG00000147041 "Synaptotagmin like 5" Q8TDW5 X 38006582-38128819 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 17.0" "Cell type enhanced" "Detected in some" 11 "Club cells: 5.7;Mucus-secreting cells: 10.5;Syncytiotrophoblasts: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 19 "non-classical monocyte: 1.8" "Lineage enriched" "Detected in single" 19 "monocytes: 1.8" "Cell line enhanced" "Detected in some" "CACO-2: 5.6;MCF7: 5.2;OE19: 7.5;SK-MEL-30: 13.4;SuSa: 19.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA026074 Uncertain Approved Nucleoplasm,Microtubules,Cytosol NA NA Nucleoplasm "Microtubules, Cytosol" "HPA026074: AB_1857697" "unprognostic (3.60e-2)" "unprognostic (1.71e-1)" "unprognostic (2.35e-1)" "unprognostic (6.68e-2)" "unprognostic (3.09e-3)" "unprognostic (3.22e-2)" "unprognostic (2.01e-2)" "unprognostic (1.94e-1)" "unprognostic (1.72e-1)" "unprognostic (3.35e-1)" "unprognostic (1.10e-1)" "unprognostic (6.72e-2)" "unprognostic (1.30e-2)" "unprognostic (5.21e-2)" "unprognostic (1.51e-1)" "unprognostic (1.47e-2)" "unprognostic (2.96e-2)" 0.5 6.0 10.5 3.4 11.0 0.0 2.9 0.5 2.5 7.0 7.3 0.5 0.5 2.3 2.6 1.0 12.2 0.2 2.9 0.9 9.2 8.9 1.0 6.1 2.4 0.5 2.4 0.5 0.5 6.4 0.0 1.1 17.0 0.5 2.0 3.5 1.5 7.1 1.7 0.5 0.0 14.3 3.9 1.3 0.8 13.8 0.7 0.5 0.7 0.9 1.2 5.9 1.3 0.5 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 5.6 1.3 0.0 0.0 0.5 2.1 0.6 0.0 0.0 0.0 0.0 0.6 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.7 0.1 0.0 0.1 0.1 0.2 5.2 0.0 0.0 2.3 7.5 0.0 0.0 1.9 0.0 0.0 0.4 2.9 0.0 0.3 1.1 13.4 19.0 0.0 0.0 0.0 0.1 4.5 0.0 3.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 10.5 11.0 0.5 2.5 9.2 8.9 2.4 0.5 0.5 0.5 0.0 1.3 0.0 0.2 0.0 0.0 0.3 0.0 1.4 5.7 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.1 0.0 0.8 3.1 0.1 0.9 0.0 0.9 0.2 0.0 2.9 0.6 0.0 0.0 0.6 0.0 0.0 0.0 10.5 0.0 3.5 2.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.6 0.6 SYVN1 "DER3, HRD1" ENSG00000162298 "Synoviolin 1" Q86TM6 11 65121780-65134533 "Enzymes, Predicted membrane proteins" "Stress response, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Hepatocytes: 60.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 56.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005480, HPA024300, CAB037030" Enhanced Supported "Nucleoplasm,Endoplasmic reticulum,Plasma membrane" NA NA Nucleoplasm "Endoplasmic reticulum, Plasma membrane" "CAB037030: AB_1840939, HPA005480: AB_1079084, HPA024300: AB_1851073" "unprognostic (1.12e-1)" "unprognostic (3.10e-1)" "unprognostic (1.22e-1)" "unprognostic (2.17e-2)" "unprognostic (2.85e-2)" "prognostic favorable (6.88e-4)" "unprognostic (7.67e-2)" "unprognostic (2.50e-2)" "unprognostic (2.64e-2)" "unprognostic (1.30e-1)" "unprognostic (1.59e-1)" "unprognostic (1.12e-1)" "unprognostic (1.77e-2)" "unprognostic (1.56e-2)" "unprognostic (4.89e-1)" "unprognostic (3.85e-2)" "unprognostic (1.16e-1)" 13.8 20.8 11.0 33.0 15.3 13.8 14.9 13.3 19.3 15.1 14.2 21.0 20.2 13.2 16.0 21.1 14.4 16.1 15.3 12.9 11.3 10.0 16.4 78.0 14.2 28.9 18.2 8.7 17.1 68.1 24.4 21.0 20.9 14.4 15.0 15.4 13.3 48.9 22.6 16.7 14.4 19.6 13.6 12.8 27.1 18.3 14.4 14.9 10.3 23.5 8.0 42.2 13.3 12.6 17.5 13.0 11.6 5.4 2.2 5.5 3.8 8.6 11.1 6.7 9.0 17.1 9.8 6.7 9.0 9.3 11.5 8.2 6.0 15.2 49.0 12.3 11.5 15.2 13.5 7.3 9.1 9.5 7.6 5.5 7.7 12.9 13.4 20.8 11.5 14.0 12.4 16.5 10.1 23.0 10.3 7.4 5.2 9.6 25.1 6.7 12.9 5.0 8.3 7.2 9.1 7.7 8.5 5.7 19.7 7.2 8.6 4.4 9.0 8.3 20.7 14.5 6.2 15.4 7.6 7.1 8.0 5.3 14.3 6.0 50.2 34.7 56.6 10.8 5.9 8.9 11.6 5.4 9.3 5.5 3.3 5.0 15.4 3.9 5.1 3.1 17.5 2.9 3.0 5.2 2.2 3.2 13.0 3.6 3.8 11.0 15.3 13.3 19.3 11.3 10.0 18.2 8.7 14.4 14.9 14.9 21.3 22.2 6.0 15.7 10.2 3.4 33.1 9.4 20.5 10.4 31.4 11.5 1.7 10.5 4.3 8.3 15.8 23.3 16.3 12.6 12.1 13.4 1.1 60.4 13.6 12.7 8.1 14.1 14.8 3.5 19.0 11.6 11.8 6.4 25.0 10.8 17.1 12.4 12.4 7.2 17.1 12.9 7.5 21.0 10.9 14.1 35.8 10.2 14.5 11.6 SZRD1 "C1orf144, DKFZp566C0424" ENSG00000055070 "SUZ RNA binding domain containing 1" Q7Z422 1 16352575-16398145 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024221 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA024221: AB_10603450" "unprognostic (3.52e-2)" "unprognostic (1.28e-1)" "unprognostic (1.41e-1)" "unprognostic (1.53e-1)" "unprognostic (1.09e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (5.98e-6)" "unprognostic (2.53e-1)" "unprognostic (9.07e-2)" "unprognostic (1.48e-1)" "unprognostic (1.31e-1)" "unprognostic (7.43e-2)" "unprognostic (1.25e-2)" "unprognostic (1.21e-1)" "unprognostic (2.17e-1)" "unprognostic (2.76e-2)" "unprognostic (7.60e-2)" 34.9 30.7 23.1 25.0 26.3 37.5 33.1 17.1 20.6 30.7 29.0 20.8 15.4 23.0 38.5 23.2 33.7 26.5 30.5 37.0 23.5 14.3 39.8 41.4 26.2 27.2 27.4 11.8 36.3 25.1 32.2 16.8 46.4 22.4 24.8 20.9 27.9 20.8 23.7 55.2 24.9 39.3 31.3 20.9 40.6 27.1 18.3 25.0 32.1 35.0 27.6 33.6 34.3 35.1 30.4 19.2 34.3 36.7 20.0 25.5 29.6 37.4 28.8 39.9 27.6 34.1 39.4 13.2 38.4 50.0 45.7 35.6 28.8 33.4 32.9 43.1 51.2 25.1 20.7 35.7 42.3 33.9 56.6 30.9 37.7 31.0 22.6 30.8 36.6 37.2 39.7 35.5 49.8 33.4 32.3 39.5 28.6 33.8 31.0 41.7 36.4 35.7 28.0 27.8 27.8 33.0 36.7 42.1 38.7 31.0 17.6 31.7 33.0 33.7 21.8 48.6 17.2 22.5 24.2 44.0 31.2 36.5 48.6 38.1 17.2 18.9 39.6 34.8 50.1 41.2 15.0 24.3 34.3 24.5 33.2 24.2 28.3 21.2 22.8 19.2 30.4 19.6 21.1 27.1 20.0 36.7 14.9 25.5 29.6 23.1 26.3 17.1 20.6 23.5 14.3 27.4 11.8 22.4 25.0 17.9 24.2 44.6 45.3 40.5 19.7 39.9 48.4 8.1 12.5 38.4 2.0 50.0 59.7 57.9 17.5 35.9 61.6 23.3 46.5 67.2 40.6 49.4 36.8 45.6 64.1 41.3 45.9 29.4 42.2 39.0 33.4 33.2 42.2 108.2 41.3 23.4 53.3 42.1 33.6 40.9 17.7 38.8 49.1 20.2 19.8 51.1 70.3 40.6 41.6 56.6 SZT2 "C1orf84, FLJ10387, FLJ34502, KIAA0467, RP11-506B15.1, SZT2A, SZT2B" ENSG00000198198 "SZT2, KICSTOR complex subunit" Q5T011 1 43389882-43454247 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029012 Approved Approved "Nucleoplasm,Vesicles,Actin filaments" NA NA "Nucleoplasm, Vesicles, Actin filaments" "HPA029012: AB_10600817" "unprognostic (1.35e-1)" "unprognostic (2.55e-1)" "unprognostic (4.14e-1)" "unprognostic (6.61e-2)" "unprognostic (1.29e-1)" "prognostic favorable (1.47e-7)" "prognostic unfavorable (2.53e-4)" "prognostic favorable (6.20e-4)" "unprognostic (1.54e-1)" "unprognostic (1.81e-2)" "unprognostic (5.96e-2)" "unprognostic (1.03e-1)" "unprognostic (1.05e-2)" "unprognostic (1.84e-3)" "unprognostic (8.28e-2)" "unprognostic (7.19e-2)" "unprognostic (2.61e-2)" 10.0 8.4 9.0 15.9 12.8 13.5 10.3 16.1 12.9 10.2 10.2 21.7 12.8 8.8 13.7 8.3 9.4 11.3 8.2 8.6 8.7 6.8 7.9 6.1 10.3 11.1 12.4 9.1 14.9 10.8 23.6 16.1 8.1 10.9 10.9 8.9 13.5 11.4 11.6 10.9 17.4 11.6 12.1 9.9 11.0 10.0 12.2 11.1 13.9 16.3 5.9 12.6 12.3 9.6 1.8 3.0 4.9 1.8 1.3 3.0 1.2 6.3 5.9 6.0 5.3 15.4 9.2 8.4 4.9 7.0 6.8 6.7 2.0 7.8 5.9 6.5 8.6 4.4 7.7 5.0 9.0 5.2 7.5 5.0 10.7 11.4 3.7 6.1 8.5 8.8 8.2 7.2 11.2 10.3 8.0 7.4 7.0 4.7 9.3 5.1 3.2 5.8 3.0 4.9 4.3 6.4 7.4 6.5 7.9 4.3 8.0 5.8 5.4 9.8 9.0 6.7 7.7 5.4 13.1 9.6 7.4 9.3 10.3 8.5 9.7 3.8 4.7 7.7 5.9 5.4 3.8 1.8 4.9 1.5 1.5 3.0 1.4 0.8 0.8 1.5 1.8 1.7 1.3 3.7 1.3 1.7 3.0 1.7 1.2 9.0 12.8 16.1 12.9 8.7 6.8 12.4 9.1 10.9 11.1 23.8 20.0 9.3 3.1 1.6 15.1 4.4 5.1 6.7 7.9 5.2 58.9 5.4 0.0 5.2 11.0 6.0 8.5 0.0 5.7 4.3 5.1 3.8 13.9 9.5 4.8 12.7 3.5 9.8 7.8 11.5 8.6 6.9 5.0 9.0 5.7 7.8 5.7 3.5 5.6 7.1 22.6 19.4 4.3 7.0 6.6 1.6 4.6 12.8 6.4 3.2 TACC2 AZU-1 ENSG00000138162 "Transforming acidic coiled-coil containing protein 2" O95359 10 121989174-122254545 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 109.4" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 186.1;Syncytiotrophoblasts: 191.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 36.6" "Low region specificity" "Detected in all" "HPA031020, HPA031021, HPA061394" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 110000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA031020: AB_10669988, HPA031021: AB_2673701, HPA061394: AB_2684500" "unprognostic (3.28e-2)" "unprognostic (4.88e-2)" "unprognostic (1.75e-2)" "unprognostic (7.07e-2)" "unprognostic (2.26e-1)" "unprognostic (1.14e-1)" "unprognostic (9.15e-2)" "unprognostic (8.43e-3)" "unprognostic (1.14e-1)" "unprognostic (3.51e-1)" "unprognostic (2.13e-1)" "unprognostic (1.83e-2)" "prognostic favorable (2.50e-10)" "unprognostic (7.02e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (8.45e-4)" "unprognostic (1.61e-1)" 8.2 5.8 9.6 2.4 11.7 0.6 7.8 17.7 16.6 6.9 17.2 2.6 4.0 6.3 8.4 4.3 13.4 9.6 7.7 43.3 8.0 4.8 19.3 3.8 54.1 0.8 3.1 9.0 4.7 6.3 11.9 41.0 45.4 6.8 12.0 8.6 4.8 18.5 6.0 109.4 28.9 8.2 8.9 3.2 1.3 10.2 2.2 3.9 0.1 19.6 4.4 2.5 15.1 8.8 0.1 0.1 0.3 0.0 0.1 0.2 0.0 7.2 22.8 11.2 6.4 3.2 3.2 13.6 3.2 8.6 4.4 3.1 9.3 12.0 0.0 2.9 5.0 5.1 24.3 3.5 8.6 4.6 1.2 1.8 0.0 2.8 17.7 4.9 0.0 0.1 1.4 36.6 2.4 15.6 3.6 9.2 0.0 1.8 0.2 4.3 9.5 0.0 4.0 6.6 11.2 10.4 0.1 6.4 3.4 12.0 11.1 7.5 6.1 5.2 21.8 11.6 3.4 4.3 0.1 8.5 2.0 1.5 4.9 5.9 1.0 4.5 0.1 3.7 0.0 5.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 9.6 11.7 17.7 16.6 8.0 4.8 3.1 9.0 6.8 3.9 77.4 80.3 0.8 44.9 29.9 18.8 186.1 7.6 88.3 50.0 34.9 0.0 36.8 1.7 7.5 1.6 14.3 44.5 0.0 12.6 2.8 12.8 69.9 6.9 14.5 5.4 41.3 28.8 7.4 0.0 2.1 6.4 3.5 6.8 0.0 35.8 1.1 14.9 38.5 7.1 9.8 2.5 12.9 35.4 0.5 4.3 47.2 191.1 2.5 36.7 77.4 TADA1 "ADA1, hADA1, HFI1, STAF42, TADA1L" ENSG00000152382 "Transcriptional adaptor 1" Q96BN2 1 166856510-166876327 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028651 Approved Supported "Nucleoplasm,Focal adhesion sites,Cytosol" No No Nucleoplasm "Focal adhesion sites, Cytosol" "HPA028651: AB_10602476" "unprognostic (9.53e-3)" "unprognostic (2.31e-1)" "unprognostic (1.05e-2)" "unprognostic (4.10e-2)" "unprognostic (1.55e-1)" "unprognostic (7.09e-2)" "unprognostic (5.99e-3)" "unprognostic (7.31e-2)" "unprognostic (3.35e-2)" "unprognostic (1.22e-2)" "unprognostic (1.40e-1)" "unprognostic (1.98e-2)" "unprognostic (3.64e-2)" "unprognostic (2.73e-2)" "unprognostic (6.35e-2)" "unprognostic (1.07e-1)" "unprognostic (1.26e-2)" 6.5 10.6 13.8 7.1 18.5 17.8 10.2 18.2 20.0 11.3 9.1 17.0 3.4 8.3 10.5 8.6 10.1 9.8 6.6 9.2 13.2 14.6 12.9 28.9 6.7 10.1 11.1 14.3 12.7 7.5 11.3 13.7 12.5 15.0 9.2 10.2 13.4 8.7 8.4 10.7 8.5 9.0 8.5 10.8 7.3 8.0 12.0 10.3 16.7 11.5 7.1 10.9 8.6 7.8 13.4 13.0 8.1 8.2 16.2 19.5 15.1 8.2 7.9 14.9 8.8 4.5 5.8 8.9 4.3 5.3 7.3 6.3 7.2 6.7 15.7 8.5 5.1 5.9 6.3 12.0 7.7 5.9 9.9 11.5 5.2 6.8 11.8 6.7 14.6 9.6 4.4 8.9 4.3 11.0 5.2 5.9 11.9 18.5 9.6 5.6 5.7 18.0 11.6 22.7 13.3 8.9 15.2 6.6 19.9 9.7 11.1 9.6 16.8 7.8 10.1 9.1 14.3 13.8 15.4 4.4 6.0 6.9 6.5 9.1 13.6 18.5 29.4 4.1 6.7 5.6 1.8 8.1 8.1 14.0 8.2 15.5 13.1 15.2 15.8 13.0 13.4 19.5 15.3 1.3 16.2 6.2 8.5 14.3 15.1 13.8 18.5 18.2 20.0 13.2 14.6 11.1 14.3 15.0 10.3 8.9 2.4 2.9 4.3 5.5 7.4 9.4 0.0 4.0 4.5 3.5 7.9 5.3 5.0 3.2 3.4 3.7 3.8 0.0 3.5 6.3 4.0 4.4 4.7 17.1 3.7 1.6 6.9 3.7 5.1 1.3 4.0 2.5 1.7 5.4 5.3 6.6 3.0 0.0 2.8 5.0 5.7 0.0 3.8 4.7 12.9 4.4 6.1 5.3 5.1 3.2 TADA3 "ADA3, FLJ20221, FLJ21329, hADA3, NGG1, TADA3L" ENSG00000171148 "Transcriptional adaptor 3" O75528 3 9779860-9793011 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042250 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA042250: AB_10794043" "unprognostic (5.77e-2)" "unprognostic (1.72e-2)" "unprognostic (2.78e-1)" "unprognostic (2.00e-3)" "unprognostic (6.83e-2)" "unprognostic (4.70e-2)" "unprognostic (9.15e-3)" "unprognostic (2.71e-1)" "unprognostic (4.90e-2)" "unprognostic (1.33e-1)" "unprognostic (1.47e-2)" "unprognostic (6.56e-2)" "prognostic favorable (5.47e-5)" "unprognostic (1.10e-2)" "unprognostic (2.03e-1)" "unprognostic (1.14e-1)" "unprognostic (1.51e-3)" 21.9 39.3 37.3 28.1 35.2 22.0 44.2 16.8 43.4 29.7 25.8 23.4 30.6 23.1 29.6 25.5 25.1 35.8 34.2 34.1 33.6 30.3 26.1 34.2 32.1 40.8 29.7 26.2 46.8 21.0 25.8 30.3 18.9 27.5 34.2 21.5 23.0 25.9 34.6 39.0 20.0 24.7 26.1 25.3 25.6 24.9 48.0 21.6 32.7 33.9 22.5 28.5 29.6 27.1 13.3 18.3 46.4 31.2 18.7 23.8 18.1 13.8 14.3 23.3 13.2 21.3 19.6 50.0 13.7 25.7 20.0 25.2 14.8 16.5 15.0 17.3 32.5 25.4 8.3 13.5 19.8 9.2 18.1 14.9 32.8 18.1 15.9 30.4 11.6 55.7 19.9 25.9 28.4 20.7 25.5 13.3 22.3 21.8 18.9 24.5 39.5 11.7 11.3 21.5 18.3 13.8 5.7 11.6 19.2 20.4 13.5 8.8 26.2 12.1 6.6 23.7 13.6 24.5 30.3 18.2 26.7 21.9 13.9 19.7 15.2 16.9 25.6 38.7 21.7 21.1 20.6 15.8 46.4 23.8 24.9 12.1 13.3 17.0 19.4 18.3 12.5 15.2 16.4 20.3 18.7 31.2 11.3 20.7 18.1 37.3 35.2 16.8 43.4 33.6 30.3 29.7 26.2 27.5 21.6 11.9 13.8 35.0 74.0 14.9 28.0 7.5 28.1 6.7 9.1 31.4 13.7 41.7 56.3 55.8 69.5 16.1 57.7 23.3 56.6 44.6 38.5 44.3 47.2 35.9 58.1 23.8 34.1 29.4 41.1 62.8 33.9 37.5 30.4 121.8 57.0 61.9 53.4 59.6 40.3 52.5 22.3 71.1 30.9 64.0 73.4 14.4 30.8 64.3 47.2 48.8 TAF1 "BA2R, CCG1, CCGS, DYT3, DYT3/TAF1, KAT4, NSCL2, TAF2A, TAFII250" ENSG00000147133 "TATA-box binding protein associated factor 1" P21675 X 71366239-71532374 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Acyltransferase, DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Dystonia, Mental retardation, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 76.6;Erythroid cells: 70.0;Rod photoreceptor cells: 71.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA001075, CAB016283" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB016283: AB_671202, HPA001075: AB_1080179" "unprognostic (2.95e-2)" "unprognostic (1.77e-1)" "unprognostic (6.45e-3)" "unprognostic (1.91e-2)" "unprognostic (1.88e-2)" "unprognostic (1.23e-1)" "unprognostic (1.44e-1)" "prognostic favorable (6.54e-4)" "unprognostic (2.68e-2)" "unprognostic (3.43e-2)" "unprognostic (2.03e-1)" "unprognostic (5.59e-2)" "prognostic unfavorable (6.03e-4)" "unprognostic (1.14e-2)" "unprognostic (1.41e-1)" "unprognostic (1.82e-2)" "unprognostic (2.56e-2)" 20.1 16.2 15.0 17.1 19.8 16.3 17.7 20.7 18.0 20.7 15.5 23.8 17.1 10.0 25.4 17.1 14.4 19.1 16.1 12.9 15.4 12.0 11.9 12.9 13.8 17.8 18.5 16.5 23.9 17.5 25.5 19.3 15.4 17.3 16.9 15.4 20.8 14.5 16.1 19.6 16.8 17.1 18.3 17.2 21.3 15.8 12.2 21.3 19.4 20.1 12.0 18.7 18.4 15.8 5.0 4.7 5.2 4.8 4.2 4.9 1.8 11.4 10.0 11.4 7.7 9.1 15.9 7.1 8.6 8.0 9.0 7.5 7.5 6.9 10.7 7.3 9.5 8.0 10.9 15.9 6.8 11.6 7.1 13.9 12.8 13.1 7.3 6.6 24.2 12.3 9.2 6.9 9.7 18.4 8.1 9.4 8.3 17.3 26.0 9.1 8.1 13.4 10.7 13.1 12.8 13.1 12.3 23.2 13.1 6.1 14.9 6.1 9.4 23.9 8.4 10.5 9.4 6.1 12.9 11.8 10.7 9.0 8.6 5.9 11.2 10.3 13.8 5.9 19.5 7.9 4.4 4.1 1.1 4.4 2.8 3.8 3.0 4.6 4.5 4.7 5.0 4.4 4.9 5.2 4.2 4.8 3.5 3.1 1.8 15.0 19.8 20.7 18.0 15.4 12.0 18.5 16.5 17.3 21.3 29.8 25.3 10.9 8.1 10.5 33.8 14.8 5.1 13.4 34.2 3.5 76.6 6.7 1.7 5.1 2.0 23.9 8.4 70.0 6.0 4.9 10.4 8.4 22.0 12.1 7.7 15.9 10.9 19.0 15.4 1.8 20.4 17.0 5.0 6.4 15.4 18.7 6.4 14.0 20.8 3.6 71.6 0.0 14.2 6.0 8.9 15.2 4.8 13.8 14.6 7.6 TAF10 "TAF2A, TAF2H, TAFII30" ENSG00000166337 "TATA-box binding protein associated factor 10" Q12962 11 6606296-6612667 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 282.6;Late spermatids: 670.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004148, CAB022405" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB022405: , HPA004148: AB_1857736" "unprognostic (1.69e-3)" "unprognostic (2.32e-1)" "unprognostic (3.19e-2)" "unprognostic (6.21e-3)" "unprognostic (9.10e-2)" "unprognostic (6.99e-2)" "unprognostic (5.24e-3)" "unprognostic (9.03e-3)" "unprognostic (1.12e-1)" "unprognostic (1.24e-2)" "unprognostic (3.46e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.84e-5)" "unprognostic (1.38e-1)" "unprognostic (2.55e-1)" "unprognostic (9.64e-3)" "unprognostic (3.80e-3)" 23.4 33.7 30.7 25.4 25.6 40.1 28.4 8.8 30.9 21.5 28.8 26.9 28.5 21.9 23.8 53.4 32.6 20.8 32.4 26.9 28.4 22.5 35.6 63.1 28.4 47.2 26.4 15.4 25.7 46.4 26.5 30.5 31.3 17.5 24.3 28.5 18.2 43.6 30.5 46.0 15.7 30.1 20.2 26.0 44.1 24.7 44.2 14.8 55.7 37.6 29.5 37.5 21.8 19.0 9.0 18.5 21.8 11.7 6.1 8.7 3.1 21.8 38.1 23.9 21.0 40.1 39.3 19.2 17.0 37.5 27.7 27.9 27.8 39.6 12.0 22.7 30.3 38.5 18.4 17.3 27.2 27.5 25.2 26.4 17.2 26.1 33.1 65.4 22.7 27.6 45.2 34.8 21.7 45.9 46.9 30.6 37.3 17.7 21.9 43.7 43.1 32.3 20.9 17.3 35.1 29.9 19.0 12.9 21.2 44.6 29.4 17.3 23.6 23.0 26.4 28.5 37.5 18.5 27.0 17.3 18.4 22.3 26.4 23.7 26.7 17.6 19.3 30.6 11.5 29.8 7.9 7.6 8.1 7.6 11.7 7.1 7.8 7.6 8.7 8.2 9.0 7.1 6.1 21.8 6.1 11.5 18.5 8.3 3.1 30.7 25.6 8.8 30.9 28.4 22.5 26.4 15.4 17.5 14.8 3.0 21.8 29.7 47.7 19.1 22.4 42.5 50.9 14.7 14.8 34.9 19.6 41.7 16.6 14.3 282.6 31.3 65.1 0.0 28.5 42.2 26.2 74.6 4.7 49.7 58.2 22.3 33.4 26.4 63.3 670.6 22.7 40.5 25.3 17.2 46.5 43.6 28.8 53.5 18.0 35.3 22.6 0.0 16.7 58.2 30.0 25.5 44.9 44.0 34.8 73.2 TAF11 "TAF2I, TAFII28" ENSG00000064995 "TATA-box binding protein associated factor 11" Q15544 6 34877778-34888089 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029326, HPA049127" Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA029326: AB_2672999, HPA049127: AB_2680645" "unprognostic (4.02e-2)" "unprognostic (5.36e-3)" "unprognostic (7.41e-2)" "unprognostic (5.18e-3)" "unprognostic (6.65e-3)" "unprognostic (1.70e-1)" "unprognostic (2.56e-3)" "unprognostic (1.45e-2)" "unprognostic (1.68e-3)" "prognostic favorable (5.87e-4)" "unprognostic (2.91e-1)" "unprognostic (6.77e-3)" "unprognostic (1.89e-2)" "unprognostic (3.24e-1)" "unprognostic (1.87e-2)" "unprognostic (4.92e-1)" "unprognostic (3.32e-1)" 20.6 25.5 22.2 26.8 28.1 43.1 27.2 30.1 29.8 23.0 23.2 17.5 26.7 21.1 23.6 24.2 23.5 22.7 22.0 33.3 21.5 17.9 20.7 28.7 23.2 28.6 24.8 22.1 27.9 25.4 16.7 18.8 30.6 26.7 23.8 25.3 20.4 20.3 31.0 39.3 31.2 24.2 26.8 23.4 31.1 22.6 32.7 29.0 29.4 23.3 24.6 28.7 22.8 22.6 14.9 20.1 26.5 23.6 13.2 16.7 12.8 14.7 6.5 21.3 37.5 13.3 14.2 18.8 11.9 10.0 20.5 19.8 14.9 9.5 20.3 15.9 11.3 9.9 9.4 26.1 11.0 16.7 12.2 21.0 22.7 13.4 25.0 18.8 28.7 16.0 15.9 18.0 13.8 11.3 12.5 24.9 22.7 35.8 15.7 9.8 26.9 18.3 24.0 19.0 31.0 11.1 20.0 18.9 15.9 15.1 9.6 25.7 23.2 14.0 15.4 26.8 19.1 24.9 36.1 14.3 14.2 18.7 8.2 14.4 14.2 35.0 29.1 5.3 34.4 20.5 26.5 23.6 19.3 12.6 21.0 12.1 11.6 13.4 13.5 20.1 14.9 15.7 14.0 14.6 13.2 16.8 17.7 16.7 12.8 22.2 28.1 30.1 29.8 21.5 17.9 24.8 22.1 26.7 29.0 26.8 15.0 26.1 25.7 40.9 27.7 20.1 17.8 9.4 27.3 40.1 11.8 61.7 54.7 36.9 4.5 33.1 30.6 46.7 54.7 56.3 29.1 24.0 21.9 52.1 38.6 30.2 37.9 55.9 51.2 5.7 31.4 34.5 23.6 33.3 34.7 36.0 41.8 49.1 35.0 24.2 31.6 32.3 23.1 88.2 45.3 51.1 64.2 35.9 39.2 25.5 TAF13 "TAF2K, TAFII18" ENSG00000197780 "TATA-box binding protein associated factor 13" Q15543 1 109062486-109076002 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044492 Approved Enhanced Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA044492: AB_10962871" "unprognostic (8.54e-2)" "unprognostic (2.02e-2)" "unprognostic (2.82e-2)" "unprognostic (1.15e-1)" "unprognostic (2.85e-1)" "unprognostic (1.33e-2)" "prognostic unfavorable (8.74e-6)" "unprognostic (1.73e-2)" "unprognostic (2.18e-1)" "prognostic favorable (2.42e-5)" "unprognostic (1.85e-1)" "unprognostic (6.78e-2)" "unprognostic (2.43e-1)" "unprognostic (2.11e-2)" "unprognostic (1.91e-1)" "unprognostic (7.61e-3)" "unprognostic (7.22e-3)" 23.5 13.4 24.6 14.3 23.4 27.7 14.7 14.0 33.7 18.0 16.6 19.5 15.3 10.0 13.9 14.7 22.1 9.9 18.0 19.2 25.3 26.9 22.3 21.0 11.5 8.6 32.2 22.6 6.6 15.9 14.6 21.2 21.0 35.8 16.9 18.2 7.7 14.5 11.7 40.9 13.0 12.8 22.2 36.1 7.7 14.0 10.3 20.7 4.1 18.2 16.6 14.8 16.4 11.0 1.3 3.0 7.9 4.6 0.5 2.3 0.8 20.6 5.4 8.3 12.1 24.0 22.5 13.8 49.1 20.8 20.0 20.3 8.6 4.7 7.9 18.8 32.6 11.9 8.7 14.6 17.7 30.2 13.5 3.3 7.9 13.2 8.9 19.0 13.9 12.1 20.0 21.3 33.5 18.3 10.8 17.1 7.3 15.1 7.7 27.0 11.9 7.3 3.8 16.6 9.6 11.3 5.7 15.0 3.1 23.6 18.0 8.7 10.8 24.1 15.6 17.7 15.5 5.3 9.9 22.3 33.1 12.6 23.3 26.8 9.4 23.7 10.6 35.2 7.4 49.1 2.6 4.6 3.7 1.7 3.3 1.5 1.2 1.1 1.7 1.5 1.3 1.1 1.6 7.9 0.5 2.8 3.0 2.3 0.8 24.6 23.4 14.0 33.7 25.3 26.9 32.2 22.6 35.8 20.7 17.9 21.1 8.2 9.3 62.4 4.5 57.2 10.2 16.0 26.1 7.0 0.0 15.5 11.6 14.4 29.0 19.7 31.6 23.3 18.1 26.6 20.6 18.8 13.9 35.8 16.4 6.4 30.6 24.5 29.7 2.9 8.6 18.4 13.5 12.6 26.1 10.8 24.9 20.1 12.0 26.2 7.5 6.5 26.2 9.8 15.7 72.0 45.9 7.7 10.5 25.9 TAF15 "hTAFII68, Npl3, RBP56, TAF2N" ENSG00000270647 "TATA-box binding protein associated factor 15" Q92804 17 35713791-35864615 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "DNA-binding, RNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052059, HPA063647" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA052059: AB_2681711, HPA063647: AB_2685072" "unprognostic (1.26e-1)" "unprognostic (2.66e-3)" "unprognostic (1.10e-1)" "unprognostic (1.63e-2)" "unprognostic (1.82e-1)" "unprognostic (1.27e-1)" "unprognostic (8.48e-3)" "unprognostic (4.75e-2)" "unprognostic (8.06e-3)" "unprognostic (2.08e-2)" "unprognostic (2.33e-1)" "unprognostic (1.44e-2)" "unprognostic (1.79e-2)" "unprognostic (1.39e-2)" "unprognostic (5.41e-2)" "unprognostic (3.35e-2)" "unprognostic (2.99e-1)" 14.0 12.9 12.7 15.3 16.2 13.9 11.0 13.7 14.1 10.5 11.7 15.0 13.2 12.7 10.2 11.0 12.6 8.0 11.5 13.1 11.8 9.8 15.0 8.9 19.4 14.7 8.3 10.7 11.3 14.6 18.1 11.1 11.1 11.4 10.1 9.2 9.8 15.3 26.9 14.7 13.4 17.5 15.9 12.7 11.0 11.3 15.5 21.1 9.4 12.8 15.8 12.0 9.8 3.7 3.2 3.8 3.6 4.7 7.2 2.2 29.2 48.1 25.7 24.9 20.6 11.7 16.9 33.4 11.4 15.3 15.0 32.2 21.2 58.2 24.1 21.6 18.3 31.1 34.1 33.7 22.0 16.4 44.7 33.5 34.9 33.7 20.4 54.0 22.5 18.6 17.7 23.1 36.3 17.7 20.6 36.2 31.4 24.1 17.2 34.9 58.8 13.1 15.9 27.3 13.8 35.1 38.3 21.8 19.3 52.6 19.5 19.2 41.6 12.6 13.2 31.4 29.5 18.6 27.7 11.8 25.8 16.9 40.1 22.8 27.8 42.4 23.3 26.7 19.3 3.8 3.5 3.5 4.9 3.4 7.2 3.0 3.5 3.8 2.5 3.7 3.3 3.7 2.0 4.7 3.6 3.2 3.9 2.2 14.9 50.3 37.4 49.0 32.1 54.1 35.5 43.3 50.9 64.8 57.6 39.3 72.7 3.3 35.9 4.6 49.6 37.7 46.7 25.7 39.3 25.9 36.3 54.3 53.9 37.4 57.2 47.1 33.2 42.9 8.9 28.4 36.7 32.1 34.3 49.4 55.6 28.8 28.1 38.2 26.6 42.8 45.3 31.9 60.1 72.8 32.5 65.2 42.4 50.6 42.6 TAF1A "SL1, TAFI48" ENSG00000143498 "TATA-box binding protein associated factor, RNA polymerase I subunit A" Q15573 1 222557902-222589933 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054334 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA054334: AB_2682453" "unprognostic (3.01e-1)" "prognostic unfavorable (9.26e-6)" "unprognostic (7.98e-2)" "unprognostic (9.59e-3)" "unprognostic (1.22e-1)" "unprognostic (8.98e-3)" "unprognostic (3.88e-3)" "unprognostic (3.10e-3)" "unprognostic (4.79e-2)" "unprognostic (2.93e-1)" "unprognostic (3.86e-3)" "unprognostic (2.25e-1)" "unprognostic (2.41e-4)" "unprognostic (8.43e-2)" "unprognostic (1.76e-1)" "unprognostic (2.35e-3)" "unprognostic (9.06e-2)" 7.3 6.9 5.5 8.6 8.2 4.8 6.4 7.6 8.1 7.3 4.7 8.2 5.0 4.8 8.0 6.1 5.9 6.4 5.5 5.6 4.3 6.7 4.2 6.3 5.5 11.5 7.3 3.8 13.7 5.3 5.3 16.9 8.4 8.0 6.6 5.2 6.4 5.5 5.6 2.8 4.1 6.1 6.5 8.9 8.3 6.5 11.7 8.0 6.4 10.0 3.3 10.2 7.4 7.0 10.5 7.1 2.7 3.3 4.0 6.7 2.4 8.4 4.6 12.4 4.3 4.3 3.8 11.0 5.7 4.4 6.9 8.5 4.8 9.3 7.7 11.2 2.0 5.5 8.5 8.2 3.5 9.8 5.0 6.2 4.6 3.7 4.6 4.9 11.1 2.1 2.0 3.8 7.7 9.8 3.3 2.8 5.4 14.0 3.5 9.4 3.1 12.9 7.8 25.0 9.7 13.2 8.0 24.8 7.4 2.9 4.5 7.0 14.8 8.7 5.1 6.0 6.6 2.9 5.6 3.7 7.0 7.0 12.3 14.1 4.3 3.9 10.0 6.2 7.1 9.2 1.5 2.1 2.7 4.6 3.3 6.7 7.3 4.1 4.2 2.0 10.5 4.9 6.0 0.4 4.0 3.2 7.1 3.4 2.4 5.5 8.2 7.6 8.1 4.3 6.7 7.3 3.8 8.0 8.0 0.0 0.6 2.2 5.2 7.6 9.1 1.4 2.5 1.4 1.2 3.5 5.9 6.6 1.7 2.7 1.2 1.5 1.2 0.0 0.6 5.7 6.8 3.7 1.1 2.1 3.9 6.4 1.2 1.8 4.5 0.4 5.2 2.8 0.0 1.8 1.8 3.1 1.1 1.9 2.1 1.3 7.3 6.5 3.1 7.7 10.2 2.5 4.9 3.2 2.8 7.8 TAF1B "RAF1B, RAFI63, SL1, TAFI63" ENSG00000115750 "TATA-box binding protein associated factor, RNA polymerase I subunit B" Q53T94 2 9843354-9934416 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071254 Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA071254: " "unprognostic (1.12e-1)" "unprognostic (1.74e-1)" "prognostic favorable (8.58e-5)" "unprognostic (1.44e-3)" "unprognostic (5.43e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (6.94e-7)" "unprognostic (9.17e-2)" "unprognostic (3.29e-2)" "unprognostic (2.63e-2)" "unprognostic (1.40e-1)" "unprognostic (2.98e-1)" "prognostic favorable (8.55e-4)" "unprognostic (2.59e-1)" "unprognostic (2.49e-1)" "unprognostic (2.79e-2)" "unprognostic (1.49e-2)" 13.4 11.7 10.2 10.7 11.1 7.8 12.1 14.0 12.7 12.3 7.4 8.4 15.9 7.1 19.2 14.5 16.5 13.6 9.7 8.5 9.3 11.7 17.9 9.9 11.5 13.9 9.2 9.5 12.7 8.9 22.6 19.5 20.2 10.7 12.6 8.1 11.6 10.1 20.1 7.2 11.3 7.5 11.1 8.5 13.9 8.4 17.1 9.2 23.3 14.9 10.9 15.8 9.9 14.4 9.8 11.3 4.9 13.1 8.5 12.9 4.6 12.2 12.2 16.9 5.2 8.5 13.1 27.3 13.4 13.4 14.7 12.7 11.3 9.9 14.4 7.1 10.9 14.3 7.0 14.7 16.6 16.3 14.0 16.0 15.5 5.2 15.1 11.0 12.2 17.4 10.3 9.7 10.8 15.9 11.6 22.0 7.9 10.3 15.4 14.7 8.1 9.1 10.4 20.4 7.9 9.0 5.5 14.3 4.5 14.9 11.0 7.2 18.4 11.5 15.6 11.8 11.7 5.4 9.7 10.2 17.7 20.9 17.3 18.5 7.5 9.0 20.5 10.7 14.1 15.1 2.6 8.4 4.9 11.5 13.1 10.9 9.5 9.5 12.9 11.3 9.8 6.3 9.4 0.4 8.5 10.0 9.4 9.4 4.6 10.2 11.1 14.0 12.7 9.3 11.7 9.2 9.5 10.7 9.2 17.9 19.5 12.3 24.6 14.3 21.2 3.7 2.5 40.2 38.7 12.2 25.5 22.4 11.6 17.0 4.7 12.8 1.6 0.0 16.3 29.6 12.8 9.4 8.1 4.9 11.3 14.3 1.7 8.6 12.9 1.5 17.5 12.3 0.0 14.4 2.9 23.3 13.4 3.5 12.4 19.9 20.2 19.4 13.4 35.8 32.4 11.5 19.8 13.1 4.0 20.2 TAF1C "MGC:39976, SL1, TAFI110, TAFI95" ENSG00000103168 "TATA-box binding protein associated factor, RNA polymerase I subunit C" Q15572 16 84177847-84187070 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ito cells: 29.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA072229 Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA072229: AB_2686499" "unprognostic (9.39e-2)" "unprognostic (1.13e-1)" "unprognostic (6.86e-3)" "unprognostic (8.20e-3)" "unprognostic (4.45e-2)" "unprognostic (3.47e-2)" "unprognostic (6.21e-2)" "unprognostic (1.26e-1)" "unprognostic (2.52e-1)" "unprognostic (3.53e-1)" "prognostic favorable (1.76e-4)" "unprognostic (1.06e-2)" "prognostic unfavorable (8.08e-6)" "unprognostic (5.60e-2)" "unprognostic (2.22e-1)" "unprognostic (1.82e-1)" "prognostic favorable (3.22e-4)" 19.0 11.6 19.0 16.7 18.5 22.8 18.9 21.8 17.8 17.3 12.3 16.4 14.3 15.5 20.4 14.9 16.7 16.9 19.5 15.5 16.2 9.1 15.8 9.7 13.1 19.8 18.2 13.0 30.4 19.1 13.0 16.9 12.4 15.5 17.5 6.3 17.2 22.7 17.8 13.6 21.3 14.2 12.1 12.0 25.1 14.9 13.0 17.0 12.7 15.2 10.3 15.6 14.3 16.3 3.1 4.0 1.0 3.4 3.5 4.7 2.2 5.9 6.6 3.7 13.2 3.3 3.4 19.2 7.2 2.9 5.9 2.1 7.1 4.6 6.7 9.7 2.7 3.4 11.8 2.3 2.9 1.4 5.8 9.9 3.8 9.9 4.9 2.4 4.0 12.2 5.2 3.8 5.0 1.9 2.4 11.6 11.0 9.2 2.3 3.0 13.2 6.3 13.4 15.2 2.2 6.8 16.0 3.2 5.3 2.5 5.3 19.2 9.3 14.6 4.1 24.2 2.6 16.2 4.2 4.5 11.0 9.4 10.8 6.5 11.1 8.5 13.9 5.6 4.9 7.0 0.0 3.2 1.0 4.1 3.4 4.7 2.3 1.6 2.6 4.0 3.1 1.9 3.4 0.2 3.5 1.4 1.5 2.3 2.2 19.0 18.5 21.8 17.8 16.2 9.1 18.2 13.0 15.5 17.0 17.9 18.6 9.0 6.3 5.8 9.1 2.5 2.5 5.3 7.9 3.5 19.6 7.5 5.0 4.4 0.4 13.9 7.4 0.0 6.1 5.3 6.5 3.3 5.8 10.9 5.8 1.6 6.9 29.4 11.3 1.8 10.9 5.4 6.8 5.4 7.5 9.4 4.5 3.5 8.5 3.8 9.7 6.5 4.4 8.8 10.9 4.5 6.2 6.4 7.6 2.6 TAF1D "JOSD3, MGC5306, TAF(I)41" ENSG00000166012 "TATA-box binding protein associated factor, RNA polymerase I subunit D" Q9H5J8 11 93729948-93784391 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030703, HPA055935, HPA060385" Uncertain Supported "Nucleoplasm,Nucleoli,Mitotic spindle,Centriolar satellite" Yes No Nucleoplasm "Nucleoli, Mitotic spindle, Centriolar satellite" "HPA030703: , HPA055935: AB_2682974, HPA060385: AB_2684271" "unprognostic (9.91e-3)" "unprognostic (4.38e-2)" "unprognostic (6.80e-2)" "unprognostic (1.71e-1)" "unprognostic (5.40e-3)" "unprognostic (6.46e-2)" "unprognostic (3.68e-3)" "unprognostic (9.70e-2)" "unprognostic (5.24e-3)" "unprognostic (3.55e-2)" "unprognostic (4.50e-3)" "unprognostic (1.09e-2)" "prognostic unfavorable (3.17e-7)" "unprognostic (1.95e-1)" "unprognostic (2.51e-1)" "unprognostic (2.34e-1)" "unprognostic (6.37e-2)" 13.9 10.6 12.5 19.9 18.4 14.2 12.9 17.3 20.1 15.1 14.7 4.3 17.3 16.8 15.2 9.7 16.0 11.5 18.1 11.1 12.0 7.6 13.6 18.7 15.8 19.0 14.4 13.6 20.9 30.5 9.3 24.3 18.5 13.6 16.4 13.4 3.9 12.3 11.4 31.5 14.5 17.8 18.1 22.1 18.4 13.0 8.0 13.6 13.1 13.2 12.9 12.2 28.1 17.1 24.1 14.3 22.3 9.2 9.0 16.3 2.7 3.9 3.1 4.2 4.2 4.1 16.2 7.6 4.4 3.3 5.7 4.1 10.6 10.7 9.5 8.5 4.3 1.9 11.7 4.9 6.9 6.3 2.6 2.0 9.7 17.5 6.3 4.1 8.8 5.2 4.5 7.5 4.5 7.4 9.0 7.1 5.0 6.6 18.8 7.8 1.2 7.4 17.0 3.2 2.9 2.4 3.5 4.7 8.1 6.5 6.3 3.0 6.3 2.6 9.6 3.0 6.1 11.9 2.2 6.9 8.6 5.7 12.9 6.5 8.4 9.5 8.0 3.1 9.4 2.9 17.4 9.2 14.8 10.0 6.5 10.0 19.5 13.8 10.9 6.2 24.1 16.3 13.6 22.3 9.0 5.2 14.3 9.4 2.7 12.5 18.4 17.3 20.1 12.0 7.6 14.4 13.6 13.6 13.6 83.4 80.4 125.3 241.5 216.9 84.2 23.0 129.9 91.0 139.9 27.9 37.3 149.3 38.1 80.3 12.9 79.2 61.0 0.0 125.2 151.7 105.8 205.9 100.6 46.5 62.1 65.2 105.6 52.2 91.2 12.3 119.0 105.3 75.9 66.7 101.9 39.6 109.2 66.6 63.6 64.8 75.6 71.1 94.7 37.0 70.9 177.4 134.6 106.5 115.9 265.8 TAF3 "TAF140, TAFII140" ENSG00000165632 "TATA-box binding protein associated factor 3" Q5VWG9 10 7818504-8016627 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066184 Supported "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA066184: AB_2685631" "unprognostic (3.82e-2)" "unprognostic (2.87e-3)" "unprognostic (6.60e-2)" "unprognostic (4.23e-1)" "unprognostic (6.88e-2)" "unprognostic (2.38e-1)" "prognostic unfavorable (2.14e-7)" "unprognostic (2.97e-1)" "unprognostic (1.45e-1)" "unprognostic (2.71e-2)" "unprognostic (9.71e-2)" "unprognostic (6.30e-3)" "prognostic unfavorable (5.01e-4)" "unprognostic (8.59e-2)" "unprognostic (3.44e-1)" "unprognostic (9.44e-2)" "unprognostic (1.74e-1)" 11.2 11.2 10.6 13.5 13.9 13.1 9.5 24.5 13.0 10.7 10.0 11.1 12.7 6.4 11.7 6.0 7.9 8.3 8.2 11.5 11.5 12.1 9.3 8.2 8.6 12.0 12.8 8.4 16.1 9.5 16.1 15.9 9.9 11.6 9.6 8.1 9.6 7.6 13.3 20.8 10.6 9.6 9.5 12.4 11.4 8.1 15.8 14.2 17.4 9.7 7.3 9.9 10.0 14.4 8.8 4.7 7.7 8.6 8.3 10.8 5.0 7.0 6.6 7.5 3.9 8.5 6.0 10.4 8.4 3.3 6.3 7.3 14.1 5.3 12.1 6.5 4.9 2.6 7.7 8.2 7.3 8.0 9.7 9.0 10.3 4.6 8.9 7.4 6.9 9.5 4.0 7.3 8.9 4.4 4.0 6.0 13.3 11.5 12.6 7.2 13.3 15.6 4.9 5.7 10.3 3.9 12.7 7.1 8.1 3.7 4.4 4.0 5.7 9.1 6.6 8.2 7.7 12.1 7.3 7.4 5.8 10.1 15.2 8.2 7.5 8.9 13.3 5.6 7.9 5.2 7.3 5.6 7.7 9.3 5.0 10.8 7.6 8.4 9.0 4.7 8.8 10.5 9.0 2.2 8.3 8.6 4.6 6.9 5.0 10.6 13.9 24.5 13.0 11.5 12.1 12.8 8.4 11.6 14.2 26.8 28.5 29.8 19.4 28.4 28.0 36.6 10.2 24.1 9.1 26.2 33.4 22.7 0.0 15.2 30.9 22.2 17.1 0.0 12.7 30.6 16.8 12.5 20.9 11.9 17.4 25.4 18.0 13.5 17.5 17.0 25.3 21.9 23.6 16.2 12.1 29.9 12.3 2.9 26.9 3.4 40.5 25.8 28.4 48.9 42.1 37.6 16.7 30.9 11.5 17.3 TAF4 "TAF2C, TAF2C1, TAF4A, TAFII130, TAFII135" ENSG00000130699 "TATA-box binding protein associated factor 4" O00268 20 61953469-62065810 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008599, CAB031484" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB031484: AB_671207, HPA008599: AB_1080183" "unprognostic (3.38e-2)" "unprognostic (1.21e-2)" "unprognostic (1.38e-1)" "unprognostic (6.29e-2)" "unprognostic (3.14e-1)" "unprognostic (9.67e-2)" "prognostic unfavorable (3.31e-4)" "unprognostic (2.16e-1)" "unprognostic (1.91e-1)" "unprognostic (2.74e-1)" "unprognostic (3.34e-1)" "unprognostic (1.00e-3)" "unprognostic (4.39e-3)" "unprognostic (1.10e-1)" "unprognostic (1.81e-1)" "unprognostic (3.92e-2)" "unprognostic (9.99e-2)" 7.7 11.4 8.5 7.8 9.5 9.8 6.2 16.5 9.6 8.9 9.8 8.5 4.2 10.1 8.5 3.8 7.6 7.0 7.0 4.9 7.7 4.5 6.6 8.9 6.2 7.1 9.6 6.0 16.7 12.4 4.3 6.4 6.8 6.4 6.8 4.6 6.4 6.6 7.6 13.2 7.7 10.4 6.8 5.8 9.7 10.9 17.9 8.7 16.5 6.8 4.3 5.8 7.7 9.9 0.1 0.2 2.7 0.6 0.0 1.4 0.2 5.6 5.3 3.2 3.6 1.5 1.1 6.4 2.8 1.2 4.7 2.5 17.6 4.7 4.6 7.2 1.5 3.5 7.3 2.8 3.3 2.0 3.9 4.1 10.5 5.8 8.1 1.6 5.0 9.5 0.8 3.0 2.1 2.2 1.3 1.8 5.7 8.5 4.1 0.8 6.0 14.0 6.1 4.7 4.0 7.5 13.0 7.3 4.8 1.5 5.2 5.4 4.7 8.5 9.1 2.9 2.4 5.5 6.1 2.3 6.0 8.8 6.0 5.1 5.7 5.3 7.2 3.5 3.0 4.1 0.0 0.6 0.7 0.1 0.2 0.0 0.0 0.3 0.4 0.2 0.1 0.3 0.5 2.7 0.0 0.1 0.1 1.4 0.2 8.5 9.5 16.5 9.6 7.7 4.5 9.6 6.0 6.4 8.7 6.0 16.0 5.6 2.8 6.8 6.2 6.7 5.1 8.1 3.4 5.2 2.0 5.1 0.0 5.1 12.7 4.5 6.8 0.0 3.3 4.2 5.9 5.8 1.1 10.0 4.9 14.3 3.5 5.5 10.7 4.2 8.6 6.1 3.3 1.8 10.9 3.9 5.0 10.5 9.9 4.7 8.6 6.5 8.1 8.9 12.5 8.4 7.0 3.8 9.5 5.6 TAF4B "TAF2C2, TAFII105" ENSG00000141384 "TATA-box binding protein associated factor 4b" Q92750 18 26225936-26391685 "Disease related genes, Predicted intracellular proteins" "Differentiation, Oogenesis, Spermatogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 71.3;Suprabasal keratinocytes: 68.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 25.3;U-266/70: 12.0;U-698: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028937 Uncertain Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA028937: AB_10603034" "unprognostic (2.46e-2)" "unprognostic (1.03e-1)" "unprognostic (1.38e-1)" "unprognostic (1.19e-3)" "unprognostic (1.74e-1)" "unprognostic (2.13e-1)" "unprognostic (5.01e-2)" "unprognostic (2.67e-1)" "unprognostic (3.29e-2)" "unprognostic (2.21e-1)" "unprognostic (4.66e-3)" "unprognostic (3.14e-2)" "prognostic unfavorable (3.08e-4)" "unprognostic (7.38e-2)" "unprognostic (9.56e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (1.72e-4)" 5.0 5.0 1.9 7.8 7.0 5.7 5.8 4.9 7.1 3.5 3.6 1.7 0.6 1.5 4.8 1.7 5.1 4.2 3.4 2.6 2.0 3.1 3.5 0.9 2.6 11.8 2.3 3.4 8.1 5.2 2.3 2.7 11.5 5.8 2.8 3.3 2.6 4.1 2.1 6.4 5.6 3.9 2.8 1.9 12.8 4.7 9.9 1.4 6.5 3.8 2.4 9.1 4.6 3.5 4.4 1.8 0.0 1.0 0.8 4.0 1.0 1.8 0.2 0.1 0.4 0.5 0.9 1.0 0.5 0.4 0.3 0.6 0.3 0.8 25.3 2.3 0.1 0.9 1.9 1.3 1.2 1.2 7.7 5.1 2.7 0.6 0.3 0.7 6.9 1.7 1.3 0.5 0.2 3.8 0.2 0.5 2.9 4.5 3.2 0.1 1.2 3.9 1.2 1.4 0.8 3.0 0.0 3.0 6.8 0.3 0.1 2.6 1.2 1.3 1.8 0.9 0.6 0.8 1.2 0.2 1.0 0.8 1.3 2.0 12.0 8.0 9.3 0.4 4.3 0.9 0.0 0.6 0.0 0.2 1.0 1.9 3.9 1.2 1.8 1.8 4.4 4.0 2.2 0.0 0.8 0.4 0.8 0.2 1.0 1.9 7.0 4.9 7.1 2.0 3.1 2.3 3.4 5.8 1.4 6.0 4.5 18.2 8.4 71.3 1.0 1.7 0.0 1.4 3.4 0.0 0.0 15.3 14.9 1.2 0.5 1.4 1.1 0.0 1.7 3.1 10.4 8.3 1.1 0.0 2.2 4.8 0.0 1.8 0.6 1.0 3.1 2.5 21.9 1.0 4.7 0.1 1.8 2.9 3.9 2.8 1.0 0.0 14.4 11.4 23.4 68.9 8.1 0.7 4.6 5.8 TAF5 "TAF2D, TAFII100" ENSG00000148835 "TATA-box binding protein associated factor 5" Q15542 10 103367967-103389065 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 25.5" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 27.4;Spermatogonia: 43.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006195, HPA006474" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA006195: AB_1080188, HPA006474: AB_1080185" "unprognostic (3.09e-2)" "unprognostic (2.44e-3)" "unprognostic (2.95e-1)" "unprognostic (3.18e-3)" "unprognostic (3.59e-2)" "unprognostic (1.35e-1)" "unprognostic (1.19e-1)" "unprognostic (1.10e-1)" "unprognostic (5.36e-3)" "unprognostic (2.21e-1)" "unprognostic (1.18e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (1.36e-9)" "prognostic favorable (7.39e-5)" "unprognostic (2.79e-2)" "unprognostic (1.37e-1)" "unprognostic (2.44e-1)" 5.3 3.6 4.0 5.8 5.9 7.9 6.3 13.8 7.7 5.3 5.8 3.8 3.7 5.5 5.2 3.5 5.0 4.1 3.2 3.4 5.2 3.5 3.5 5.0 3.9 7.6 3.8 3.9 6.1 7.9 3.4 7.5 6.6 6.3 4.2 6.1 2.1 4.4 4.5 5.5 4.7 4.7 4.4 5.4 6.2 4.3 25.5 5.6 14.0 4.4 2.5 7.9 4.1 7.3 3.2 1.3 2.5 1.8 1.1 3.4 0.6 6.7 3.1 7.7 13.9 4.4 3.6 9.0 4.8 5.5 7.0 8.8 6.1 3.5 16.1 2.8 2.5 4.0 6.8 12.9 2.6 8.9 5.9 11.2 7.4 3.6 6.0 2.0 14.2 8.0 1.6 1.9 4.1 4.4 2.9 5.2 7.2 10.5 8.1 4.6 4.4 11.5 18.7 9.4 8.6 4.1 9.8 9.4 4.9 1.9 2.0 5.4 6.0 3.1 2.3 2.8 7.7 2.7 5.9 3.0 4.1 5.2 4.6 8.5 4.6 5.5 9.9 2.3 17.0 2.6 0.6 1.8 2.5 1.5 0.6 1.3 0.4 1.4 2.8 1.0 3.2 3.4 2.0 0.3 1.1 1.1 1.3 3.4 0.6 4.0 5.9 13.8 7.7 5.2 3.5 3.8 3.9 6.3 5.6 6.0 1.6 8.0 4.6 12.8 6.2 2.4 2.5 0.0 3.4 1.8 5.9 3.9 3.3 2.3 13.3 3.6 2.6 0.0 1.9 7.3 3.8 2.9 9.2 2.6 3.2 1.6 2.4 1.8 1.5 10.2 1.7 4.5 1.7 1.0 2.4 1.8 1.6 2.9 2.5 0.6 6.6 0.0 6.9 27.4 43.6 12.4 5.7 5.0 3.3 2.7 TAF6 "MGC:8964, TAF2E, TAFII70, TAFII80, TAFII85" ENSG00000106290 "TATA-box binding protein associated factor 6" P49848 7 100107070-100119841 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006566 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA006566: AB_1080194" "unprognostic (5.60e-2)" "unprognostic (3.11e-2)" "unprognostic (1.73e-2)" "unprognostic (2.10e-1)" "unprognostic (7.79e-2)" "unprognostic (4.20e-2)" "prognostic unfavorable (6.06e-5)" "unprognostic (2.02e-1)" "unprognostic (1.89e-1)" "unprognostic (1.29e-1)" "unprognostic (3.70e-3)" "unprognostic (1.68e-1)" "unprognostic (4.55e-2)" "unprognostic (1.95e-1)" "unprognostic (3.38e-1)" "unprognostic (4.78e-1)" "unprognostic (1.37e-1)" 14.1 19.8 21.5 15.4 23.6 13.9 12.0 23.5 35.8 19.4 17.5 12.7 12.6 12.1 24.1 17.6 16.8 23.6 16.8 17.2 20.5 16.3 16.1 10.2 12.9 14.3 13.1 15.9 26.2 16.6 22.6 21.7 19.5 19.3 15.8 13.7 15.6 17.9 23.3 23.1 17.9 13.2 23.7 13.1 14.6 14.0 27.3 14.7 21.7 21.3 11.5 17.0 19.6 14.9 15.3 14.3 13.2 25.7 14.0 18.7 13.1 17.1 32.2 20.9 34.2 27.5 14.6 29.3 18.9 21.2 24.4 22.6 23.9 21.0 15.7 21.6 28.9 41.9 14.6 28.6 22.5 26.3 25.6 18.6 15.1 31.3 15.8 27.4 14.6 14.3 14.9 14.1 35.7 39.5 19.7 19.7 27.9 26.1 29.1 22.0 61.0 31.0 23.7 30.8 15.5 26.0 22.9 25.7 23.3 17.4 14.0 19.0 27.6 23.9 37.1 15.8 31.5 13.5 14.5 19.5 37.0 38.1 47.8 24.4 18.0 31.1 26.4 25.1 20.5 31.8 12.7 11.0 13.2 15.6 11.4 18.7 10.2 15.0 15.7 14.3 15.3 15.3 14.3 6.4 14.0 25.7 8.5 13.9 13.1 21.5 23.6 23.5 35.8 20.5 16.3 13.1 15.9 19.3 14.7 8.9 10.2 11.1 17.3 10.1 12.5 0.9 15.3 16.0 6.8 24.4 0.0 61.4 14.9 20.7 21.7 10.8 11.9 0.0 14.6 30.0 16.7 12.7 0.0 6.4 18.1 12.7 15.0 10.4 7.8 34.8 20.1 9.7 11.8 24.4 11.8 16.7 14.1 14.2 29.4 17.8 11.6 25.8 18.9 24.5 61.1 10.3 28.8 17.5 14.3 12.2 TAF6L PAF65A ENSG00000162227 "TATA-box binding protein associated factor 6 like" Q9Y6J9 11 62771303-62787342 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067239 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA067239: AB_2685809" "unprognostic (5.41e-2)" "unprognostic (1.37e-1)" "unprognostic (3.23e-1)" "unprognostic (1.46e-2)" "unprognostic (1.35e-1)" "prognostic favorable (8.98e-5)" "unprognostic (1.03e-1)" "unprognostic (2.47e-1)" "unprognostic (9.37e-2)" "unprognostic (2.83e-3)" "unprognostic (5.45e-3)" "unprognostic (9.65e-2)" "unprognostic (4.38e-2)" "unprognostic (1.63e-3)" "unprognostic (1.04e-1)" "unprognostic (3.66e-1)" "unprognostic (2.61e-3)" 10.7 11.0 9.3 10.0 13.1 8.8 14.0 8.7 14.5 10.4 11.2 13.2 7.0 11.6 12.6 11.8 8.7 9.8 9.0 7.8 8.7 9.1 11.9 19.5 7.2 8.5 12.1 13.1 11.7 13.5 12.4 14.1 12.1 9.6 9.9 6.0 13.8 10.0 9.8 20.6 18.4 8.5 8.8 7.6 12.4 8.6 5.9 10.5 9.8 13.8 8.4 8.1 9.7 7.4 3.1 3.4 3.3 2.7 3.4 3.5 0.8 8.4 7.9 11.3 8.9 5.0 4.2 9.5 6.7 4.9 8.2 6.4 4.7 9.6 11.3 14.9 5.1 7.4 11.1 7.7 7.3 2.5 15.2 16.7 6.0 9.3 7.7 7.1 7.4 11.0 5.6 5.4 6.5 4.3 4.3 6.7 12.2 12.4 8.5 5.1 16.5 11.0 21.5 11.8 4.0 11.4 13.7 7.6 14.5 5.5 5.8 12.1 11.7 6.9 7.3 10.8 5.0 13.0 5.5 6.5 8.2 10.5 13.2 7.8 9.1 15.2 12.8 7.3 5.7 7.6 2.7 2.7 3.3 2.2 2.7 2.5 3.1 1.7 1.7 3.2 2.9 3.5 2.3 0.7 3.4 1.1 3.4 1.3 0.8 9.3 13.1 8.7 14.5 8.7 9.1 12.1 13.1 9.6 10.5 3.0 4.8 7.5 4.0 5.5 7.3 2.4 15.3 4.0 1.2 1.8 0.0 12.6 13.3 4.6 4.6 4.3 8.6 23.3 2.7 7.3 3.9 3.3 0.0 10.5 8.4 3.2 5.1 5.5 8.2 3.2 4.9 6.7 8.5 2.8 6.7 8.7 3.5 7.0 4.6 15.4 5.4 0.0 5.8 1.5 10.0 5.5 16.2 6.9 7.5 3.5 TAF7 "TAF2F, TAFII55" ENSG00000178913 "TATA-box binding protein associated factor 7" Q15545 5 141260225-141320821 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006429 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA006429: AB_1080196" "unprognostic (5.79e-2)" "unprognostic (1.64e-1)" "unprognostic (4.79e-2)" "unprognostic (4.28e-2)" "unprognostic (8.17e-2)" "unprognostic (1.15e-3)" "unprognostic (1.66e-1)" "unprognostic (5.78e-2)" "unprognostic (6.75e-2)" "unprognostic (9.43e-2)" "unprognostic (1.16e-1)" "unprognostic (4.28e-2)" "unprognostic (1.02e-1)" "unprognostic (2.88e-1)" "unprognostic (2.85e-1)" "unprognostic (1.21e-1)" "unprognostic (5.76e-2)" 33.2 29.9 29.2 28.8 32.2 31.6 38.7 39.6 33.6 28.6 24.1 26.0 21.0 20.2 34.6 39.8 24.9 35.0 22.2 46.4 30.3 30.8 28.6 29.7 25.3 32.9 32.0 26.1 50.7 24.8 20.1 47.1 38.8 28.9 34.8 26.5 21.3 26.8 28.0 69.5 26.9 30.0 31.8 32.9 37.0 23.9 33.5 28.9 65.5 45.7 33.9 39.1 32.3 53.6 18.8 17.8 49.6 16.5 27.1 29.8 19.8 20.1 16.9 38.6 28.2 34.5 32.1 24.1 26.4 23.6 37.6 36.8 23.7 22.8 54.5 53.0 26.8 40.8 17.4 24.3 24.5 38.0 23.8 27.1 9.8 20.9 19.7 31.5 13.4 20.7 29.2 36.6 14.6 26.0 29.7 27.0 25.0 20.8 42.8 36.0 25.4 30.1 32.7 13.9 25.7 6.2 38.6 51.7 39.8 27.6 27.3 31.0 35.5 21.6 31.2 29.4 30.9 44.4 44.3 24.7 5.3 18.3 17.3 32.0 11.6 47.0 49.4 23.2 31.4 21.2 44.7 11.4 49.6 18.3 13.9 23.7 18.8 21.5 20.3 16.1 18.7 29.8 24.6 34.6 27.1 16.5 17.8 17.9 19.8 29.2 32.2 39.6 33.6 30.3 30.8 32.0 26.1 28.9 28.9 80.4 57.2 110.4 280.4 107.0 136.8 146.1 48.4 112.4 73.9 78.5 90.3 83.2 69.6 99.8 22.8 91.5 110.7 23.3 66.3 65.8 100.9 202.5 150.3 64.8 46.3 114.4 80.8 81.6 47.6 26.8 136.1 79.3 106.3 113.6 89.5 127.1 95.5 150.8 121.3 60.6 90.0 161.7 131.0 119.8 145.9 149.1 118.2 132.3 79.0 199.6 TAF7L "CT40, TAF2Q" ENSG00000102387 "TATA-box binding protein associated factor 7 like" Q5H9L4 X 101268253-101293057 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 36.1" "Group enriched" "Detected in some" 6 "Early spermatids: 20.1;Late spermatids: 11.5;Spermatocytes: 29.8;Spermatogonia: 20.2" "Cancer enhanced" "Detected in some" "cervical cancer: 2.4" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 10 "basophil: 1.6" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.6" "Cell line enriched" "Detected in some" 17 "SiHa: 36.0" "Low region specificity" "Detected in all" "HPA001879, HPA072008" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA001879: AB_1857751, HPA072008: " "unprognostic (1.70e-2)" "prognostic favorable (8.71e-4)" "unprognostic (1.26e-1)" "unprognostic (1.33e-1)" "unprognostic (2.52e-2)" "unprognostic (4.97e-3)" "unprognostic (3.87e-3)" "unprognostic (1.72e-1)" "unprognostic (4.67e-3)" "unprognostic (2.16e-1)" "unprognostic (3.29e-1)" "unprognostic (1.36e-1)" "unprognostic (3.49e-3)" "unprognostic (6.76e-2)" "unprognostic (2.88e-1)" "unprognostic (5.97e-2)" "unprognostic (1.12e-2)" 0.1 0.0 1.4 0.1 1.7 0.2 0.1 0.1 0.6 1.6 0.5 0.2 0.1 0.0 0.7 3.5 0.1 0.0 0.1 0.1 0.8 0.2 0.3 0.5 0.1 0.1 0.1 0.8 0.1 0.1 2.5 0.2 0.4 0.3 1.8 0.0 0.4 0.1 1.8 0.1 0.6 0.3 0.1 0.4 0.1 0.1 36.1 0.1 0.1 0.1 0.1 0.1 0.2 0.5 0.1 0.1 1.6 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.1 0.1 0.0 0.7 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.1 0.6 0.0 0.1 0.2 0.1 1.7 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.4 36.0 0.2 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.4 1.7 0.1 0.6 0.8 0.2 0.1 0.8 0.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.1 20.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 2.4 0.1 0.0 0.0 0.6 0.0 11.5 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.2 0.0 0.0 0.0 0.2 29.8 20.2 0.1 1.4 0.0 0.0 0.0 TAF8 "FLJ32821, TAF(II)43, TBN" ENSG00000137413 "TATA-box binding protein associated factor 8" Q7Z7C8 6 42050513-42087461 "Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031730, HPA031731, HPA031734" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA031730: AB_2674016, HPA031731: AB_2674017, HPA031734: AB_10603994" "unprognostic (7.41e-2)" "unprognostic (1.45e-1)" "unprognostic (1.98e-1)" "unprognostic (3.46e-3)" "unprognostic (3.08e-1)" "unprognostic (2.23e-2)" "unprognostic (2.46e-1)" "unprognostic (3.53e-1)" "unprognostic (2.01e-3)" "unprognostic (6.74e-2)" "unprognostic (8.22e-2)" "unprognostic (1.44e-1)" "unprognostic (8.49e-2)" "unprognostic (1.36e-1)" "unprognostic (1.67e-1)" "unprognostic (2.42e-2)" "unprognostic (2.26e-2)" 24.7 17.4 11.9 17.1 13.2 25.5 17.4 9.6 15.1 15.6 19.0 15.2 21.4 14.9 16.1 17.6 15.6 11.4 12.1 22.8 11.5 9.9 18.7 14.1 16.2 19.9 15.0 13.2 13.8 14.0 22.3 12.3 19.1 12.4 15.6 13.3 16.4 16.4 19.6 25.5 12.8 14.1 14.7 12.2 20.6 17.2 18.9 12.2 36.0 24.3 11.2 20.1 16.7 15.6 15.4 19.8 19.7 24.6 8.4 13.2 7.3 9.5 10.5 8.7 9.7 9.8 9.1 8.0 4.5 7.8 11.9 12.4 17.9 5.8 14.7 9.7 6.5 12.2 7.2 14.1 9.5 9.3 12.7 13.6 18.5 12.6 8.8 12.1 10.7 13.6 12.4 7.6 8.5 10.8 6.0 13.2 18.3 22.8 15.5 6.6 12.7 9.8 16.3 5.4 25.5 4.9 20.2 10.3 11.2 10.5 7.9 9.0 8.0 8.2 6.4 9.1 7.5 9.7 13.2 12.3 10.7 11.2 4.9 9.1 13.5 13.1 31.1 4.9 11.9 6.0 13.4 12.1 19.7 13.2 12.8 9.3 14.1 12.0 10.3 13.0 15.4 12.5 12.1 15.2 8.4 24.6 19.8 10.1 7.3 11.9 13.2 9.6 15.1 11.5 9.9 15.0 13.2 12.4 12.2 17.9 22.6 10.4 11.0 6.3 15.6 24.5 15.3 9.4 19.4 10.4 29.5 19.6 26.6 8.9 8.2 15.8 9.2 0.0 8.4 6.8 10.4 12.4 18.5 7.4 11.5 20.6 8.6 7.4 14.2 13.8 13.8 10.9 6.8 12.6 11.1 11.7 7.4 7.0 11.0 12.9 23.1 12.9 10.8 7.9 14.5 7.3 18.0 12.8 9.0 11.5 TAF9 "AD-004, CGI-137, MGC1603, MGC3647, MGC5067, TAF2G, TAFII31, TAFII32, TAFIID32" ENSG00000273841 "TATA-box binding protein associated factor 9" Q16594 5 69364743-69370013 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 444.4;Late spermatids: 626.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028930, HPA053429, HPA058961, HPA072658" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA028930: AB_2672832, HPA053429: AB_2682148, HPA058961: AB_2683863, HPA072658: " "unprognostic (1.25e-3)" "unprognostic (9.52e-2)" "unprognostic (1.76e-3)" "unprognostic (8.38e-3)" "unprognostic (5.40e-2)" "unprognostic (1.77e-2)" "prognostic unfavorable (1.48e-5)" "unprognostic (1.19e-1)" "unprognostic (1.69e-1)" "unprognostic (1.66e-1)" "unprognostic (9.45e-2)" "unprognostic (2.71e-1)" "prognostic unfavorable (9.20e-4)" "unprognostic (2.58e-1)" "unprognostic (1.97e-1)" "unprognostic (3.02e-2)" "unprognostic (1.79e-1)" 11.3 7.2 6.8 5.5 8.4 16.6 8.8 6.5 9.5 6.7 8.0 4.0 6.3 6.3 5.9 10.0 10.9 5.1 5.7 9.2 5.6 11.5 18.0 6.5 8.2 6.8 6.2 7.3 7.4 4.4 10.8 8.6 9.4 7.1 9.1 4.4 5.2 5.2 11.0 5.3 9.7 6.9 5.7 8.7 6.1 30.1 6.8 10.2 9.8 9.8 9.8 7.8 5.0 24.9 21.8 29.8 28.8 14.9 25.0 31.2 16.9 17.8 11.4 19.1 18.2 23.9 29.8 16.9 25.4 28.4 38.0 18.9 20.8 23.0 12.7 24.2 53.7 12.5 15.2 33.9 37.3 10.4 18.8 18.8 29.7 23.8 44.5 18.5 27.3 28.2 22.5 19.6 44.0 19.9 22.9 21.0 18.8 18.4 26.7 23.3 20.9 29.0 13.6 6.4 14.0 13.6 18.9 26.0 24.1 18.6 18.9 13.5 16.0 9.8 29.2 19.8 15.5 27.3 16.0 11.0 16.8 11.7 27.8 17.1 20.5 28.9 16.1 22.5 12.6 28.4 28.8 29.8 14.9 26.1 22.4 24.9 22.2 18.3 21.8 19.7 25.0 21.4 4.5 14.9 20.6 13.5 23.2 31.2 17.9 30.6 51.1 138.1 154.5 21.2 61.3 43.3 33.5 31.8 22.7 13.7 101.8 76.3 62.8 444.4 55.3 36.5 23.3 69.7 133.9 64.7 69.2 37.0 41.2 94.4 19.1 29.6 34.4 40.6 626.5 60.4 60.8 94.5 53.3 53.5 24.2 76.7 31.6 32.2 66.6 33.1 32.3 93.7 328.5 65.8 142.7 87.4 36.2 61.0 135.9 TAF9B "DN-7, DN7, TAF9L, TAFII31L, TFIID-31" ENSG00000187325 "TATA-box binding protein associated factor 9b" Q9HBM6 X 78129748-78139706 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045275, HPA058961" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA045275: AB_10962831, HPA058961: AB_2683863" "unprognostic (3.62e-3)" "prognostic favorable (5.40e-5)" "unprognostic (1.91e-1)" "unprognostic (1.78e-1)" "unprognostic (4.20e-2)" "unprognostic (6.43e-2)" "unprognostic (1.02e-1)" "unprognostic (5.67e-2)" "unprognostic (3.46e-2)" "unprognostic (2.37e-3)" "unprognostic (5.68e-2)" "unprognostic (9.56e-2)" "unprognostic (8.42e-3)" "unprognostic (8.71e-2)" "unprognostic (9.34e-3)" "unprognostic (9.47e-2)" "unprognostic (2.62e-1)" 15.5 12.4 25.6 10.3 23.5 10.7 16.6 20.1 27.5 21.5 15.5 20.2 9.9 6.9 24.8 15.6 20.2 17.4 14.2 23.6 21.6 23.0 19.2 14.4 11.5 11.0 21.2 22.1 17.7 11.6 24.4 19.6 13.6 21.3 21.5 10.9 12.9 10.5 19.2 20.7 12.8 9.3 31.9 23.9 10.6 14.0 10.7 19.2 15.9 20.0 11.3 10.9 22.4 12.4 4.5 4.9 1.4 3.3 10.3 13.3 7.2 10.9 9.5 23.5 10.3 9.2 9.4 3.5 9.8 9.1 16.0 8.9 13.2 19.0 12.6 14.1 10.6 13.0 8.7 35.0 8.1 16.7 19.5 12.2 6.8 13.5 12.1 9.2 10.8 7.6 12.0 4.3 17.5 12.1 10.1 9.6 12.6 14.0 27.2 14.1 16.6 16.9 8.4 27.6 14.4 17.9 14.7 30.6 11.5 10.8 22.2 15.0 14.9 27.3 11.9 10.6 12.8 19.2 7.8 10.2 12.4 18.9 13.5 11.8 11.7 23.7 9.3 21.5 21.8 17.3 0.6 3.1 0.9 5.5 3.3 10.2 4.5 12.5 9.5 4.0 4.4 12.8 9.4 1.4 10.3 2.4 4.9 13.3 7.2 25.6 23.5 20.1 27.5 21.6 23.0 21.2 22.1 21.3 19.2 8.9 5.6 4.7 19.7 13.9 13.5 23.0 5.1 2.7 6.8 19.2 7.9 14.7 6.6 5.9 0.8 15.3 0.9 0.0 7.4 13.7 11.2 13.8 2.3 5.5 5.9 7.9 12.1 13.5 3.8 1.1 9.8 5.0 21.9 9.0 4.4 22.1 3.7 3.4 13.1 13.6 9.0 19.4 22.8 2.9 30.4 7.8 7.1 6.5 3.5 8.6 TAL1 "bHLHa17, SCL, TCL5" ENSG00000162367 "TAL bHLH transcription factor 1, erythroid differentiation factor" P17542 1 47216290-47232220 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 33.1" "Cell type enhanced" "Detected in some" 22 "Endothelial cells: 18.0;Erythroid cells: 93.5;granulocytes: 35.8;Ito cells: 30.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 3.2;neutrophil: 1.2" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.2" "Cell line enhanced" "Detected in some" "HEL: 52.8;HMC-1: 25.4;HUVEC TERT2: 11.0;JURKAT: 21.1;K-562: 16.5;TIME: 12.0" "Region enriched" "Detected in some" 5 "midbrain: 17.1" "Low region specificity" "Detected in many" "CAB017805, HPA047866, HPA073983" Approved Enhanced Nucleoplasm Yes NA Nucleoplasm "CAB017805: , HPA047866: AB_2680192, HPA073983: AB_2732246" "unprognostic (2.63e-1)" "unprognostic (2.62e-2)" "unprognostic (1.22e-1)" "unprognostic (2.40e-2)" "unprognostic (1.59e-1)" "unprognostic (8.80e-3)" "unprognostic (3.95e-3)" "unprognostic (1.33e-1)" "unprognostic (4.15e-2)" "unprognostic (1.99e-2)" "unprognostic (5.42e-3)" "unprognostic (3.68e-1)" "unprognostic (1.02e-2)" "unprognostic (2.76e-2)" "unprognostic (2.19e-1)" "unprognostic (1.51e-1)" "unprognostic (1.18e-2)" 9.1 2.7 7.0 1.8 5.7 33.1 7.1 1.6 6.9 3.3 2.4 12.0 2.3 1.6 3.7 3.3 2.5 4.1 4.2 3.9 8.8 3.5 4.5 2.4 14.6 2.2 11.1 4.4 1.5 1.3 2.2 2.1 9.8 7.3 2.4 2.4 2.1 1.4 3.0 3.1 2.0 3.3 4.4 9.4 8.5 2.1 1.8 9.2 0.0 6.7 4.1 1.5 2.5 5.5 0.3 0.1 3.2 0.3 0.4 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 52.8 0.0 0.0 0.0 0.0 25.4 0.0 0.0 0.0 0.0 0.0 11.0 21.1 16.5 0.0 0.0 0.0 8.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.3 0.4 0.1 1.2 0.4 0.1 0.1 0.1 2.2 7.0 5.7 1.6 6.9 8.8 3.5 11.1 4.4 7.3 9.2 0.0 0.0 0.0 0.0 0.8 0.0 1.7 2.5 0.0 2.3 1.8 0.0 0.1 0.0 0.0 4.8 18.0 0.0 93.5 0.0 0.1 0.9 0.0 35.8 0.0 7.9 0.0 0.0 30.7 2.1 10.2 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.4 0.9 0.0 0.0 0.0 0.0 TALDO1 ENSG00000177156 "Transaldolase 1" P37837 11 747329-765024 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Pentose shunt" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 204.6" "Cell type enhanced" "Detected in all" 6 "monocytes: 1009.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 148.6;neutrophil: 204.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048089 Approved Nucleoplasm,Cytosol NA NA 39000000 Nucleoplasm Cytosol "HPA048089: AB_2680260" "unprognostic (5.29e-2)" "unprognostic (1.78e-2)" "unprognostic (3.47e-1)" "unprognostic (9.65e-3)" "unprognostic (2.97e-2)" "unprognostic (4.15e-2)" "prognostic unfavorable (2.29e-4)" "unprognostic (9.78e-2)" "unprognostic (4.27e-2)" "unprognostic (1.74e-1)" "unprognostic (7.97e-3)" "unprognostic (2.94e-1)" "unprognostic (1.59e-1)" "unprognostic (9.99e-2)" "unprognostic (1.20e-1)" "unprognostic (2.37e-1)" "unprognostic (1.16e-3)" 39.0 24.2 26.6 34.8 31.3 117.4 44.2 20.6 38.3 27.7 28.5 51.2 18.8 34.2 20.4 20.7 90.0 23.2 33.2 37.5 29.2 23.6 45.8 48.4 37.9 60.0 46.5 26.6 23.4 31.9 14.6 15.8 34.3 30.7 28.3 23.7 15.5 38.3 19.5 31.2 38.4 29.4 40.4 47.5 45.6 35.8 14.8 33.0 34.1 42.2 82.4 43.1 51.4 37.5 8.5 36.1 204.6 60.8 5.9 10.4 45.3 42.2 53.5 15.5 29.3 32.1 18.7 45.7 32.1 41.4 31.8 26.3 22.7 92.2 23.6 43.7 42.1 24.6 45.7 24.5 34.7 16.6 30.8 49.7 40.8 20.7 79.4 34.3 65.2 60.9 15.3 28.0 21.4 17.4 23.0 43.7 29.8 52.9 39.5 29.5 40.4 37.9 77.3 24.3 62.0 43.4 31.6 18.2 84.5 57.8 24.6 38.3 13.4 30.0 62.0 31.1 14.4 29.4 49.6 58.0 14.6 13.7 11.5 30.1 16.7 16.2 28.0 32.4 57.0 58.9 64.7 60.8 148.6 5.6 23.2 6.1 8.5 7.5 6.8 36.1 6.8 6.1 5.7 204.6 5.9 23.2 14.8 10.4 45.3 26.6 31.3 20.6 38.3 29.2 23.6 46.5 26.6 30.7 33.0 131.0 100.4 88.6 136.2 65.4 45.6 40.9 122.3 141.8 86.4 143.1 13.7 355.3 212.2 199.7 61.7 74.4 141.1 280.4 236.4 383.3 78.6 213.8 155.0 128.2 368.8 47.7 97.4 79.8 301.9 17.2 109.0 235.0 133.3 1009.1 137.9 126.1 238.1 181.4 97.9 218.5 43.3 71.1 73.5 122.7 154.7 72.6 440.3 79.1 199.9 251.7 TAOK2 "KIAA0881, MAP3K17, PSK, PSK1, TAO1, TAO2" ENSG00000149930 "TAO kinase 2" Q9UL54 16 29973641-29992261 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ito cells: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010650 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA010650: AB_1080204" "unprognostic (7.30e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (2.51e-4)" "prognostic favorable (3.87e-5)" "unprognostic (8.46e-2)" "unprognostic (2.14e-3)" "unprognostic (6.08e-2)" "unprognostic (1.12e-3)" "unprognostic (1.01e-2)" "unprognostic (1.60e-1)" "prognostic favorable (4.78e-4)" "unprognostic (3.85e-3)" "prognostic favorable (3.66e-4)" "unprognostic (7.42e-3)" "unprognostic (3.17e-1)" "unprognostic (7.47e-2)" "unprognostic (1.37e-1)" 27.8 24.1 26.2 15.1 26.7 12.3 17.7 29.2 30.6 13.5 13.6 21.5 11.8 18.5 16.8 13.0 12.4 14.1 15.1 17.6 25.0 18.2 13.9 10.4 23.0 14.4 22.1 22.7 15.8 16.3 26.2 18.7 22.5 20.7 13.6 9.6 15.0 17.1 15.9 22.8 20.0 19.3 14.8 14.9 26.3 16.0 21.2 20.2 14.0 15.9 9.8 11.5 12.8 18.0 2.6 3.3 4.8 2.8 2.0 3.2 2.0 11.2 21.5 11.8 18.6 13.9 9.3 18.1 20.7 11.1 14.0 13.1 17.2 15.1 12.2 17.6 14.9 9.4 17.6 10.7 10.4 7.6 18.9 22.7 13.1 21.7 17.2 10.1 12.9 25.3 10.9 9.1 14.9 6.0 9.8 23.4 11.7 11.8 12.4 13.3 20.8 15.0 18.3 11.4 8.4 14.5 27.7 17.1 11.3 8.8 10.6 13.9 11.2 11.8 15.8 6.2 7.9 19.8 14.6 32.6 24.2 11.2 17.1 11.9 18.1 11.6 11.5 14.8 14.8 17.6 1.3 2.8 1.5 2.9 2.7 3.1 2.0 2.9 2.6 1.8 2.6 1.6 1.4 4.8 2.0 1.4 3.3 3.2 2.0 26.2 26.7 29.2 30.6 25.0 18.2 22.1 22.7 20.7 20.2 8.9 11.5 2.2 4.2 9.5 13.3 8.1 5.1 4.0 7.9 8.7 37.3 6.7 1.7 7.6 3.1 27.6 23.3 0.0 10.2 4.8 9.3 5.8 3.5 9.7 8.4 9.5 12.6 44.2 12.4 2.1 11.5 5.5 6.8 4.6 14.9 8.7 12.7 14.2 12.0 6.4 19.2 6.5 7.6 21.1 17.2 8.4 10.1 9.2 13.3 5.7 TARBP2 Trbp ENSG00000139546 "TARBP2, RISC loading complex RNA binding subunit" Q15633 12 53500921-53506431 "Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051181, HPA061454, CAB069406" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "CAB069406: AB_1622301, HPA051181: AB_2681376, HPA061454: AB_2684526" "unprognostic (1.71e-1)" "unprognostic (1.24e-1)" "unprognostic (1.85e-1)" "unprognostic (1.06e-1)" "unprognostic (1.53e-1)" "unprognostic (6.61e-3)" "prognostic unfavorable (3.09e-4)" "unprognostic (2.04e-1)" "unprognostic (4.72e-3)" "unprognostic (1.44e-1)" "unprognostic (1.31e-2)" "unprognostic (5.58e-2)" "prognostic unfavorable (4.75e-6)" "unprognostic (8.06e-2)" "unprognostic (1.32e-1)" "unprognostic (8.02e-2)" "unprognostic (4.31e-1)" 7.3 12.0 7.5 11.5 8.0 6.1 18.6 24.0 9.5 10.7 11.6 11.0 11.0 10.9 8.3 15.7 11.8 14.7 15.8 8.0 7.0 6.1 14.8 27.3 10.3 15.7 9.5 6.3 9.8 17.0 8.6 8.2 23.5 6.6 10.2 7.1 10.3 13.4 11.1 10.9 12.2 10.3 7.6 6.9 13.9 10.3 18.3 6.9 14.8 15.5 8.6 12.9 10.2 12.8 11.1 12.7 5.5 9.8 9.5 12.7 10.7 10.1 29.5 10.6 11.7 6.9 9.4 15.4 8.7 8.5 15.0 8.9 23.9 14.0 9.2 19.0 10.1 9.1 8.1 14.4 13.6 9.0 12.0 22.7 10.8 11.6 17.6 14.4 18.4 12.8 10.2 9.3 14.8 7.5 10.1 17.7 14.9 14.4 16.2 10.9 41.9 12.8 25.9 21.6 7.7 15.3 9.7 6.3 13.1 9.6 11.1 14.3 10.0 4.6 12.0 24.3 8.7 16.5 27.2 8.7 12.9 11.7 4.8 11.0 7.4 14.8 9.8 15.2 9.8 14.8 1.7 9.8 5.5 12.6 9.7 12.1 10.5 12.0 10.9 12.7 11.1 12.7 11.4 0.4 9.5 5.9 11.3 9.9 10.7 7.5 8.0 24.0 9.5 7.0 6.1 9.5 6.3 6.6 6.9 0.0 8.0 13.8 10.6 5.7 7.9 5.5 7.6 4.0 5.7 8.7 9.8 40.0 18.3 18.6 7.5 7.7 8.0 0.0 22.9 39.5 8.5 7.8 10.4 16.8 22.3 1.6 5.2 6.7 7.5 19.2 5.2 7.3 13.5 13.6 9.0 9.5 16.3 10.5 3.9 20.3 11.4 0.0 6.2 10.9 12.9 4.1 26.9 10.2 12.4 7.5 TARDBP "ALS10, TDP-43" ENSG00000120948 "TAR DNA binding protein" Q13148 1 11012344-11026420 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003703, HPA017284" Supported Enhanced Nucleoplasm NA Yes 13000 Nucleoplasm "CAB003703: AB_425904, HPA017284: AB_1857775" "unprognostic (3.72e-3)" "prognostic favorable (1.15e-5)" "unprognostic (1.06e-1)" "unprognostic (1.22e-1)" "unprognostic (8.52e-2)" "unprognostic (4.10e-2)" "prognostic unfavorable (1.20e-7)" "unprognostic (1.06e-1)" "unprognostic (3.41e-3)" "unprognostic (4.75e-3)" "unprognostic (2.24e-1)" "unprognostic (2.54e-2)" "unprognostic (2.27e-3)" "unprognostic (2.27e-1)" "unprognostic (1.87e-1)" "unprognostic (2.86e-1)" "unprognostic (2.71e-2)" 36.1 38.1 52.3 43.3 62.9 31.7 42.8 86.2 61.8 38.7 39.8 47.6 37.5 39.8 45.8 47.2 47.8 37.9 32.4 40.8 49.5 36.7 39.3 48.3 40.2 52.8 59.0 45.2 53.0 39.1 60.2 68.1 44.2 46.5 43.3 52.9 38.4 41.7 45.3 57.1 43.0 43.4 50.5 44.7 46.1 38.1 34.5 62.6 52.2 46.7 38.0 63.5 38.1 47.9 29.4 31.7 16.5 24.8 33.6 31.1 17.0 52.6 36.2 62.1 31.8 33.7 28.4 36.7 36.2 32.0 59.6 44.6 42.7 38.9 70.2 26.6 40.2 35.0 37.8 75.2 42.1 78.6 37.6 36.3 53.2 60.1 56.7 27.6 63.7 35.4 23.1 47.9 41.8 34.3 33.5 42.2 27.7 68.3 39.6 50.4 42.5 46.6 51.7 49.5 50.5 32.4 55.3 49.8 44.6 42.9 39.0 42.4 35.0 49.3 39.1 27.9 47.4 39.1 45.0 38.5 40.0 47.0 32.9 52.0 29.6 36.5 74.3 26.2 64.1 42.4 16.3 19.6 16.5 25.4 24.8 31.1 29.4 26.0 24.6 31.7 21.2 25.9 27.7 7.9 33.6 23.6 22.2 26.8 17.0 52.3 62.9 86.2 61.8 49.5 36.7 59.0 45.2 46.5 62.6 29.8 67.3 58.2 67.5 101.8 36.2 65.0 33.1 64.3 60.3 27.9 27.5 55.0 28.2 39.9 5.6 56.1 37.9 46.7 47.0 69.3 45.5 61.8 39.5 45.1 43.8 35.0 63.7 35.6 47.5 7.8 43.7 40.0 33.7 38.7 45.1 35.8 42.4 31.6 48.4 33.2 37.8 32.3 50.6 50.2 31.1 100.1 61.4 41.7 47.8 60.0 TARS2 "FLJ12528, TARSL1" ENSG00000143374 "Threonyl-tRNA synthetase 2, mitochondrial" Q9BW92 1 150487364-150507609 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028626 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA028626: AB_10601719" "unprognostic (2.48e-1)" "unprognostic (7.75e-2)" "unprognostic (6.68e-2)" "unprognostic (3.75e-3)" "unprognostic (2.03e-1)" "unprognostic (1.62e-1)" "unprognostic (4.93e-2)" "unprognostic (2.14e-1)" "unprognostic (9.35e-2)" "unprognostic (4.26e-2)" "unprognostic (2.25e-1)" "unprognostic (3.76e-2)" "unprognostic (9.23e-2)" "unprognostic (9.29e-3)" "unprognostic (4.19e-2)" "unprognostic (1.14e-2)" "unprognostic (5.55e-2)" 10.7 21.1 16.5 10.5 17.8 9.2 11.3 17.5 21.4 10.2 10.9 14.8 12.9 9.4 10.5 14.7 15.7 13.0 11.8 20.9 18.1 12.3 15.6 26.8 9.1 14.0 15.0 19.7 13.3 11.5 20.4 12.2 9.4 16.5 9.8 12.5 13.3 11.3 10.9 36.0 13.3 10.5 10.9 13.8 15.1 12.4 10.7 16.6 10.6 12.3 12.2 15.7 12.5 10.8 21.5 17.4 20.4 18.6 21.5 20.9 12.2 17.2 14.4 9.7 14.7 11.0 10.1 18.5 8.4 9.2 16.7 16.8 11.7 16.1 25.0 18.6 6.3 11.5 18.0 23.6 19.5 12.8 15.0 20.5 11.8 13.7 11.8 10.9 16.3 18.1 8.9 16.4 12.6 17.2 10.9 10.7 14.0 20.5 17.6 11.6 20.8 13.7 13.3 12.0 23.9 21.5 14.2 12.4 30.9 11.3 8.1 13.8 16.2 12.7 28.2 19.8 14.4 22.7 25.5 6.3 9.7 10.4 8.0 14.1 17.0 20.0 18.8 14.5 19.0 9.4 15.1 11.0 20.4 15.7 18.3 15.6 21.5 15.4 15.5 17.4 18.6 15.1 15.8 1.7 21.5 18.6 11.7 20.9 12.2 16.5 17.8 17.5 21.4 18.1 12.3 15.0 19.7 16.5 16.6 3.0 13.8 7.2 4.6 3.0 15.8 19.0 12.7 10.7 12.5 7.0 19.6 21.6 10.0 9.9 0.9 6.3 6.6 0.0 8.6 11.4 6.0 3.8 21.9 15.3 11.8 14.3 4.1 7.4 6.5 2.1 7.8 8.0 3.3 16.2 8.9 8.4 9.9 0.0 6.7 6.3 15.4 6.5 7.2 15.4 11.1 3.4 11.8 7.0 10.8 4.1 TAS2R42 "hT2R55, T2R24, T2R55, TAS2R55" ENSG00000186136 "Taste 2 receptor member 42" Q7RTR8 12 11185993-11186937 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA036149 Uncertain Approved "Nucleoplasm,Actin filaments,Focal adhesion sites" NA NA "Nucleoplasm, Actin filaments" "Focal adhesion sites" "HPA036149: AB_10672080" "unprognostic (2.45e-2)" "unprognostic (4.17e-2)" 0.0 0.7 0.2 0.2 0.4 0.0 0.0 1.0 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.6 0.0 0.7 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.4 0.2 0.4 0.1 0.0 0.0 0.0 0.7 0.4 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.5 0.0 0.0 0.1 0.0 0.5 0.0 0.4 0.7 0.1 0.6 0.4 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R5 T2R5 ENSG00000127366 "Taste 2 receptor member 5" Q9NYW4 7 141790217-141791367 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 8.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 10.6" HPA053742 Approved "Nucleoplasm,Nucleoli,Cytoplasmic bodies" NA NA "Nucleoplasm, Nucleoli" "Cytoplasmic bodies" "HPA053742: " "unprognostic (5.48e-3)" "unprognostic (3.90e-3)" "unprognostic (6.07e-2)" "unprognostic (8.00e-3)" "unprognostic (7.56e-2)" "unprognostic (4.87e-2)" "unprognostic (1.90e-1)" "unprognostic (1.71e-1)" "unprognostic (2.65e-2)" "unprognostic (1.67e-1)" "unprognostic (3.13e-5)" "unprognostic (1.13e-2)" "unprognostic (8.29e-7)" "unprognostic (1.29e-1)" "unprognostic (3.28e-1)" "unprognostic (6.92e-2)" "unprognostic (1.39e-2)" 1.0 1.0 0.4 1.4 1.1 0.2 3.2 4.9 0.7 2.5 0.9 0.8 2.8 6.1 1.1 3.0 0.8 0.8 0.6 0.7 1.0 0.5 1.1 1.2 0.4 4.6 1.5 0.1 2.9 1.0 1.7 1.2 1.6 1.0 2.6 8.8 1.7 1.2 1.2 1.9 0.7 1.4 1.7 1.2 1.3 2.4 1.0 0.6 0.5 0.2 0.4 1.4 0.1 0.5 0.2 1.4 0.6 0.9 2.7 1.7 0.6 0.6 0.5 0.9 2.1 0.4 1.1 0.9 0.3 0.0 0.3 1.5 0.8 0.3 0.6 1.7 0.3 1.2 2.7 0.9 1.7 1.3 2.3 10.6 1.2 2.9 3.0 1.0 1.5 2.6 0.4 0.1 1.7 0.6 3.9 1.3 0.2 0.3 0.2 0.1 2.8 0.4 0.7 2.0 1.3 0.3 0.4 0.2 1.7 0.1 0.4 0.3 1.0 0.7 0.6 1.2 1.9 0.4 1.4 0.8 0.8 0.5 0.5 0.2 0.0 1.0 0.0 0.0 0.9 0.3 0.4 0.0 1.0 0.9 1.4 0.0 0.4 0.0 0.6 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TATDN1 CDA11 ENSG00000147687 "TatD DNase domain containing 1" Q6P1N9 8 124488485-124539458 "Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023634, HPA053045" Uncertain Supported Nucleoplasm NA NA 2000000 Nucleoplasm "HPA023634: AB_1857779, HPA053045: AB_2682024" "unprognostic (2.19e-3)" "unprognostic (3.78e-2)" "unprognostic (1.74e-1)" "unprognostic (1.87e-2)" "unprognostic (1.65e-1)" "unprognostic (1.23e-2)" "unprognostic (1.54e-3)" "unprognostic (2.28e-2)" "unprognostic (1.56e-1)" "unprognostic (1.45e-2)" "prognostic unfavorable (2.53e-4)" "unprognostic (2.50e-1)" "unprognostic (6.33e-3)" "unprognostic (3.44e-2)" "unprognostic (4.30e-2)" "unprognostic (2.24e-1)" "unprognostic (5.12e-2)" 16.6 14.1 16.1 13.0 18.6 9.9 27.4 22.7 18.8 14.9 14.4 11.7 9.9 12.3 16.7 15.3 15.5 16.8 10.1 16.4 14.9 14.4 19.4 17.1 16.3 14.7 22.7 17.0 28.9 34.7 13.2 18.4 10.5 19.4 13.8 16.0 8.1 18.6 11.1 40.4 14.0 11.9 16.9 21.2 8.2 16.3 8.3 18.3 15.1 26.2 14.5 13.3 15.2 13.3 10.5 10.0 13.7 7.2 11.1 18.1 8.9 20.0 14.2 13.6 9.5 12.3 23.3 10.3 11.0 12.2 14.1 13.1 13.9 22.0 15.3 25.0 12.1 10.9 16.6 16.4 16.4 23.4 19.5 10.9 14.1 11.8 12.0 23.4 10.7 5.3 17.4 26.2 20.5 43.4 15.7 11.2 15.0 11.5 10.0 18.7 61.0 16.0 6.7 13.6 41.2 18.4 10.7 10.1 17.1 19.8 14.2 11.4 16.0 12.3 25.1 25.9 13.3 16.8 11.6 8.7 10.0 26.6 18.3 30.0 12.9 19.6 19.2 18.8 19.1 8.6 13.7 7.2 2.8 8.2 6.0 12.7 10.5 12.5 10.1 10.0 10.4 18.1 16.6 1.5 11.1 4.5 7.5 12.9 8.9 16.1 18.6 22.7 18.8 14.9 14.4 22.7 17.0 19.4 18.3 14.9 21.9 35.0 84.7 57.6 17.6 15.3 28.1 22.7 30.7 26.2 13.7 55.3 91.2 43.0 5.1 28.0 20.7 23.3 53.6 54.4 44.2 63.1 19.7 35.5 48.7 15.9 15.5 22.1 39.4 4.7 46.1 38.8 45.5 49.5 34.9 18.4 41.4 24.6 32.5 91.6 17.1 19.4 47.2 30.9 37.3 50.8 49.9 35.5 57.5 61.6 TATDN3 ENSG00000203705 "TatD DNase domain containing 3" Q17R31 1 212791828-212816626 "Predicted intracellular proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032092 Approved Approved "Nucleoplasm,Golgi apparatus,Focal adhesion sites" NA NA Nucleoplasm "Golgi apparatus, Focal adhesion sites" "HPA032092: AB_10671086" "unprognostic (9.81e-2)" "unprognostic (1.57e-2)" "unprognostic (1.20e-1)" "unprognostic (3.17e-1)" "unprognostic (1.46e-1)" "unprognostic (1.74e-1)" "unprognostic (9.38e-2)" "unprognostic (4.16e-2)" "unprognostic (3.80e-1)" "unprognostic (3.88e-2)" "unprognostic (3.34e-3)" "unprognostic (5.02e-3)" "prognostic favorable (1.59e-4)" "unprognostic (1.93e-1)" "unprognostic (2.44e-1)" "unprognostic (3.13e-3)" "unprognostic (2.96e-3)" 13.0 14.8 14.4 10.9 24.7 11.9 11.0 12.5 22.9 7.6 8.8 16.6 6.8 7.0 8.5 15.2 8.3 8.7 8.3 20.7 13.7 15.2 18.3 11.1 8.5 16.2 14.5 18.9 10.1 11.3 12.8 11.9 8.0 22.1 8.0 8.6 11.4 9.4 8.2 29.4 7.4 8.1 11.6 15.5 11.5 11.9 10.5 12.0 11.3 13.1 8.3 10.8 10.6 6.5 15.6 30.1 23.8 24.1 5.3 6.9 8.7 6.6 6.6 5.8 8.6 9.4 14.1 13.4 7.4 8.0 5.9 7.4 1.7 9.4 14.7 7.0 6.3 3.4 4.3 7.1 10.0 6.4 9.0 9.2 7.4 5.5 3.2 10.9 17.7 9.3 11.3 7.2 8.0 19.9 6.4 8.5 21.0 14.4 12.3 6.5 3.1 15.1 5.9 7.8 8.2 4.3 8.7 11.0 26.3 6.1 3.3 12.4 10.6 8.1 13.8 16.2 11.0 14.7 11.0 5.8 4.5 6.0 9.3 7.2 11.0 16.9 24.4 11.6 14.1 6.7 8.5 15.6 23.8 5.5 23.7 4.9 15.6 6.9 6.6 18.4 12.7 5.5 6.6 17.5 5.3 24.1 30.1 6.4 8.7 14.4 24.7 12.5 22.9 13.7 15.2 14.5 18.9 22.1 12.0 6.0 15.2 14.3 8.7 3.9 14.8 33.0 10.2 10.7 3.4 3.5 17.7 10.9 34.9 14.4 7.5 6.3 3.9 0.0 14.5 14.4 6.0 4.5 6.9 5.5 16.4 14.3 9.8 4.3 25.0 2.9 4.9 17.6 13.5 30.7 4.0 14.9 11.0 7.0 4.6 20.7 27.3 6.5 6.9 21.3 16.9 3.9 7.8 10.2 5.8 5.5 TAX1BP1 "CALCOCO3, TXBP151" ENSG00000106052 "Tax1 binding protein 1" Q86VP1 7 27739331-27844564 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024432 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA024432: AB_1857783" "unprognostic (1.38e-2)" "unprognostic (5.52e-2)" "unprognostic (3.55e-2)" "unprognostic (2.71e-2)" "unprognostic (2.55e-1)" "unprognostic (9.83e-3)" "unprognostic (1.81e-2)" "unprognostic (2.36e-1)" "unprognostic (4.59e-2)" "unprognostic (6.72e-2)" "prognostic unfavorable (1.06e-4)" "unprognostic (3.69e-1)" "prognostic favorable (2.80e-6)" "unprognostic (1.76e-1)" "unprognostic (4.76e-2)" "unprognostic (1.21e-1)" "unprognostic (3.03e-1)" 28.5 63.0 31.1 19.5 49.8 34.9 30.7 33.5 48.4 33.8 33.4 16.1 26.7 23.7 27.4 35.5 46.6 30.7 28.2 47.4 30.8 31.9 51.0 35.3 28.7 23.0 41.0 34.8 32.0 29.7 46.3 69.4 65.8 54.1 36.4 31.1 18.7 32.3 32.6 50.3 23.5 41.0 48.8 41.7 34.5 30.3 30.3 35.2 34.2 44.5 27.0 24.6 51.3 29.0 21.1 17.5 59.7 31.3 17.3 33.0 22.5 39.8 22.1 22.6 21.4 35.9 26.2 15.4 29.8 36.7 22.4 28.1 17.9 32.5 8.5 28.2 43.5 38.7 28.4 21.2 19.5 35.1 15.9 11.0 23.0 23.7 35.5 34.0 33.5 27.4 22.1 40.6 26.0 29.9 27.0 24.1 14.8 25.5 26.2 45.2 14.7 14.7 33.1 25.5 52.3 20.8 12.3 24.3 17.4 31.7 45.2 15.0 24.5 41.8 54.7 62.2 45.5 25.5 50.6 25.9 21.2 33.2 26.3 19.6 48.2 33.4 15.9 24.8 63.7 48.4 37.4 24.2 59.7 21.8 29.3 26.3 21.1 25.9 25.3 17.5 17.9 24.0 24.0 48.9 17.3 31.3 16.2 33.0 22.5 31.1 49.8 33.5 48.4 30.8 31.9 41.0 34.8 54.1 35.2 199.5 169.7 106.1 180.8 162.8 267.0 498.7 129.9 654.5 232.0 122.1 90.3 129.6 349.8 187.1 99.7 143.3 138.9 70.0 229.8 91.8 123.1 243.4 143.4 96.2 109.6 151.0 134.4 76.7 127.2 72.2 108.1 171.8 108.0 226.4 131.6 177.5 242.3 125.6 139.7 231.8 140.4 103.5 117.9 217.7 133.4 167.7 519.6 133.7 103.0 398.4 TBC1D12 KIAA0608 ENSG00000108239 "TBC1 domain family member 12" O60347 10 94402504-94535930 "Cancer-related genes, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.6" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 44.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 2.2" "Group enriched" "Detected in many" 13 "B-cells: 1.4;dendritic cells: 2.2;monocytes: 1.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038277, HPA038645" Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA038277: AB_10672584, HPA038645: AB_10672650" "unprognostic (7.23e-3)" "unprognostic (1.58e-2)" "prognostic favorable (1.79e-5)" "unprognostic (7.83e-2)" "unprognostic (1.76e-1)" "unprognostic (4.91e-2)" "unprognostic (1.21e-2)" "unprognostic (7.34e-2)" "unprognostic (6.56e-2)" "unprognostic (9.43e-2)" "unprognostic (1.81e-1)" "unprognostic (1.59e-1)" "unprognostic (2.27e-2)" "unprognostic (9.43e-2)" "unprognostic (3.71e-1)" "unprognostic (1.29e-1)" "unprognostic (1.12e-1)" 6.9 4.9 8.9 4.0 18.1 1.2 8.1 7.5 14.8 5.3 8.4 39.2 7.1 6.2 5.6 4.0 4.7 4.3 5.1 4.4 12.4 8.5 5.8 4.1 5.2 3.0 25.5 8.7 5.8 7.1 16.8 3.2 7.8 23.1 6.0 9.7 5.9 3.6 6.5 4.3 5.7 6.9 6.0 41.6 5.6 4.2 10.9 21.3 0.2 4.3 1.5 3.5 5.7 4.9 1.4 2.2 0.0 1.1 0.0 0.1 0.2 7.6 3.4 4.5 6.7 6.3 7.7 5.9 5.0 10.3 5.6 5.3 13.6 3.4 0.0 3.0 7.3 5.5 4.3 5.4 3.7 7.2 0.0 6.1 2.4 3.1 4.3 4.8 0.0 1.9 5.2 4.7 5.9 7.6 9.5 6.0 0.0 3.5 8.0 9.0 4.2 0.0 0.0 1.4 5.5 3.6 0.0 5.8 4.0 5.0 3.4 1.9 4.5 5.0 4.3 4.0 4.3 9.4 4.6 5.9 3.9 5.4 6.3 3.9 5.7 5.4 0.0 3.9 0.0 2.1 0.0 1.1 0.0 0.0 0.7 0.0 0.5 0.0 0.0 2.2 1.4 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.2 8.9 18.1 7.5 13.4 12.4 8.5 25.5 8.7 23.1 21.3 8.9 4.0 4.5 4.9 17.3 17.2 4.8 2.5 2.7 4.5 8.7 9.8 14.8 0.0 5.2 13.8 10.5 13.6 0.0 4.4 10.7 13.8 9.3 5.7 3.4 16.5 7.9 8.1 9.2 18.7 7.4 7.8 18.3 15.1 10.8 7.6 8.1 6.2 10.5 9.9 5.2 26.8 12.9 11.8 44.7 10.8 16.8 20.4 0.0 11.2 7.6 TBC1D14 KIAA1322 ENSG00000132405 "TBC1 domain family member 14" Q9P2M4 4 6909242-7033118 "Plasma proteins, Predicted intracellular proteins" Autophagy "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 64.3" "Low region specificity" "Detected in all" "HPA036930, HPA067398" Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" Yes No "Golgi apparatus, Vesicles" Nucleoplasm "HPA036930: AB_10670155, HPA067398: AB_2685833" "unprognostic (3.05e-2)" "unprognostic (7.48e-3)" "unprognostic (4.80e-3)" "unprognostic (8.13e-2)" "unprognostic (2.83e-1)" "unprognostic (1.78e-3)" "unprognostic (9.63e-2)" "unprognostic (5.25e-2)" "unprognostic (9.71e-2)" "unprognostic (7.65e-2)" "unprognostic (1.80e-1)" "unprognostic (2.90e-1)" "prognostic favorable (5.28e-10)" "unprognostic (1.56e-1)" "unprognostic (3.50e-1)" "unprognostic (5.13e-3)" "unprognostic (4.12e-2)" 20.0 31.2 31.9 24.4 33.8 10.6 22.0 18.1 32.8 16.0 20.2 22.5 17.0 17.3 16.2 21.9 24.3 18.8 15.0 22.9 28.6 27.5 32.1 21.6 20.7 48.4 28.8 20.5 23.3 19.3 23.6 20.7 18.0 29.0 19.6 20.7 26.1 23.2 16.7 35.1 37.3 20.0 17.8 37.3 26.2 35.8 22.4 29.3 24.0 14.9 17.9 19.9 16.7 15.4 5.3 7.5 26.4 8.2 5.5 8.9 6.0 10.5 11.5 13.0 14.5 10.8 9.1 7.9 8.5 9.3 8.0 6.8 11.9 22.1 17.0 5.0 10.1 20.3 7.7 21.8 19.5 9.8 4.7 7.1 28.5 7.6 12.4 7.5 12.8 64.3 7.0 27.7 7.5 12.4 10.2 7.5 16.2 26.9 6.1 9.6 6.9 19.7 13.0 17.6 12.7 13.0 24.8 17.1 18.4 11.9 7.5 19.9 14.2 7.0 7.7 26.1 10.6 10.6 12.3 7.4 8.8 6.7 7.7 12.5 11.8 27.4 17.5 8.3 16.6 8.4 1.7 8.2 3.5 5.9 5.3 8.9 5.2 6.4 6.3 6.9 5.3 4.9 4.5 26.4 5.5 2.4 7.5 7.5 6.0 31.9 33.8 18.1 28.0 28.6 27.5 28.8 20.5 29.0 29.3 6.0 15.3 5.2 6.6 8.0 8.4 3.4 10.2 5.3 11.4 14.0 13.7 10.5 16.6 9.8 45.7 4.7 10.4 0.0 8.7 6.1 5.1 11.2 7.0 21.7 20.9 23.8 6.3 7.4 37.2 22.1 6.6 13.2 18.6 6.4 15.6 10.6 9.0 14.0 8.1 19.2 6.3 0.0 5.2 15.8 18.9 10.5 13.7 15.0 16.6 9.1 TBC1D19 FLJ11082 ENSG00000109680 "TBC1 domain family member 19" Q8N5T2 4 26576437-26755351 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 40.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039592 Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA039592: AB_10671043" "unprognostic (2.64e-2)" "unprognostic (2.71e-2)" "unprognostic (2.94e-1)" "unprognostic (8.65e-2)" "unprognostic (1.03e-1)" "unprognostic (1.57e-1)" "unprognostic (2.86e-1)" "unprognostic (3.60e-2)" "unprognostic (1.03e-1)" "unprognostic (2.90e-1)" "unprognostic (3.29e-2)" "unprognostic (4.28e-2)" "prognostic favorable (1.21e-7)" "unprognostic (1.04e-1)" "unprognostic (1.53e-2)" "prognostic unfavorable (4.06e-4)" "unprognostic (3.51e-1)" 6.1 13.9 8.6 5.4 10.2 2.8 6.8 11.5 11.2 11.8 8.8 8.7 7.7 3.1 22.4 11.0 4.8 11.9 11.8 10.7 6.6 9.0 24.9 4.6 6.6 3.5 9.3 7.7 13.9 7.7 21.9 23.4 6.1 14.8 8.7 5.1 8.4 5.8 10.4 5.7 4.2 3.8 13.5 8.6 4.4 6.9 10.0 7.1 33.3 12.1 2.9 4.2 8.3 7.0 4.1 2.4 2.3 0.9 6.6 8.7 1.8 1.4 1.3 4.6 2.8 6.8 10.5 1.4 5.9 4.6 2.7 3.0 2.1 3.4 3.2 5.3 8.3 8.8 0.6 2.5 3.3 2.6 1.0 1.3 0.7 3.7 0.7 3.6 1.6 0.7 5.1 2.5 5.4 3.1 11.2 3.7 4.2 2.5 0.0 40.9 0.0 3.4 1.9 2.1 1.7 4.9 2.5 4.7 0.3 10.5 1.3 4.6 1.9 2.8 0.6 2.8 3.7 1.2 0.7 3.3 3.5 1.0 2.6 1.4 0.8 1.7 1.4 12.2 0.9 3.6 1.6 0.9 2.3 8.1 0.9 8.7 3.2 6.2 8.3 1.4 4.1 4.9 5.1 0.1 6.6 0.8 2.4 3.0 1.8 8.6 10.2 11.5 11.2 6.6 9.0 9.3 7.7 14.8 7.1 3.0 2.6 4.7 4.8 3.2 7.5 5.3 2.5 18.7 0.0 19.2 13.7 3.6 5.0 4.8 4.8 5.7 0.4 0.0 2.8 1.7 6.2 2.5 9.2 1.8 1.6 4.8 9.1 6.7 1.6 1.9 8.3 2.3 10.1 1.0 1.9 8.2 2.1 0.0 8.5 11.3 19.4 0.0 4.7 22.0 5.7 4.0 1.6 17.5 1.3 1.6 TBC1D2 "Armus, PARIS1, TBC1D2A" ENSG00000095383 "TBC1 domain family member 2" Q9BYX2 9 98198999-98255721 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 53.6;Hofbauer cells: 31.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 18.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 27.5;HaCaT: 36.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030871, HPA076521" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA Yes "Nucleoplasm, Plasma membrane, Cytosol" "HPA030871: AB_10670046, HPA076521: " "unprognostic (2.32e-2)" "unprognostic (1.11e-1)" "unprognostic (1.06e-2)" "unprognostic (6.36e-3)" "unprognostic (2.02e-2)" "prognostic unfavorable (2.77e-4)" "unprognostic (1.86e-1)" "unprognostic (2.11e-1)" "unprognostic (1.74e-1)" "unprognostic (9.21e-3)" "unprognostic (6.40e-3)" "unprognostic (2.30e-1)" "unprognostic (6.07e-2)" "unprognostic (4.32e-1)" "prognostic unfavorable (5.62e-4)" "unprognostic (1.30e-2)" "unprognostic (4.30e-1)" 13.1 4.1 6.6 7.0 15.6 14.5 7.6 7.7 7.6 7.8 12.0 17.8 6.0 15.5 4.4 4.3 25.3 4.4 5.3 2.2 9.5 7.4 4.6 12.6 27.4 4.5 15.2 5.3 4.3 3.0 4.5 3.1 11.9 9.0 8.1 5.9 6.2 10.1 8.8 3.3 18.8 15.2 5.7 14.3 6.7 5.1 3.1 12.2 4.7 7.1 14.7 16.8 14.7 11.6 0.9 7.0 8.1 18.4 0.7 3.9 6.4 27.5 4.0 0.2 0.9 3.1 6.1 9.1 12.2 6.8 8.9 7.4 2.6 12.1 0.4 9.3 7.1 1.9 36.4 0.2 13.6 3.1 0.9 0.5 0.2 14.1 2.0 14.6 0.6 1.1 8.4 22.5 8.9 22.3 15.8 3.1 0.7 0.8 0.3 7.0 3.5 0.1 1.6 0.6 2.7 2.3 0.4 1.8 0.0 13.6 17.2 0.3 0.5 4.1 9.1 1.2 0.6 3.0 0.9 19.0 10.9 3.3 1.8 4.9 0.6 0.5 0.2 11.1 1.0 1.2 1.1 18.4 5.5 1.9 10.8 1.3 0.9 2.8 1.6 7.0 0.6 1.2 1.4 8.1 0.7 8.0 0.9 3.9 6.4 6.6 15.6 7.7 7.6 9.5 7.4 15.2 5.3 9.0 12.2 53.6 12.2 1.9 11.4 7.3 2.4 0.6 7.6 5.3 20.5 3.5 0.0 18.5 3.3 3.7 1.5 3.1 15.0 0.0 2.8 9.4 2.1 3.8 0.0 4.7 31.3 1.6 7.5 0.6 19.8 1.0 1.7 9.3 3.3 3.6 11.1 2.9 8.7 7.0 0.7 2.5 2.2 0.0 2.0 1.6 2.8 9.5 14.5 1.9 4.2 11.1 TBC1D22A C22orf4 ENSG00000054611 "TBC1 domain family member 22A" Q8WUA7 22 46762617-47175699 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001173 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA001173: AB_1080212" "unprognostic (1.62e-1)" "unprognostic (5.90e-3)" "unprognostic (1.10e-1)" "unprognostic (4.79e-3)" "unprognostic (3.65e-2)" "unprognostic (7.07e-2)" "prognostic unfavorable (2.42e-4)" "unprognostic (5.95e-2)" "unprognostic (8.17e-2)" "prognostic unfavorable (6.94e-4)" "unprognostic (1.69e-1)" "unprognostic (9.17e-2)" "unprognostic (4.68e-2)" "unprognostic (4.93e-2)" "unprognostic (4.14e-1)" "unprognostic (1.09e-1)" "unprognostic (2.39e-1)" 18.1 17.6 18.3 36.5 16.0 14.0 16.4 10.8 18.5 14.6 23.1 22.4 16.5 22.8 20.6 17.8 24.8 19.6 22.1 15.1 16.1 15.4 18.1 14.8 18.5 26.6 17.3 17.0 16.1 20.5 18.8 15.9 23.2 16.9 12.5 15.3 17.0 23.5 15.5 23.7 22.6 26.3 13.0 18.4 27.2 22.8 14.2 18.2 21.1 17.8 16.5 36.3 16.5 17.3 11.7 10.8 13.2 15.0 4.4 8.6 5.6 13.4 9.4 6.0 7.2 8.7 12.3 7.3 9.2 12.6 10.5 11.4 10.5 10.5 11.8 10.4 14.0 6.6 15.0 5.1 14.4 7.4 5.1 14.3 6.7 8.2 20.2 13.4 14.5 5.4 14.3 17.0 7.2 10.2 12.7 17.3 7.5 4.3 12.7 9.5 6.9 6.4 7.5 5.8 12.7 10.6 8.3 7.0 12.7 12.2 7.0 4.9 9.1 8.5 3.2 14.3 7.8 7.7 9.7 13.9 8.1 11.6 8.5 5.8 8.5 2.7 7.6 20.1 7.5 5.0 2.1 9.0 5.3 5.9 13.0 5.7 10.8 5.5 5.5 10.8 11.7 3.6 4.0 13.2 4.4 15.0 5.3 8.6 5.6 18.3 16.0 10.8 18.5 16.1 15.4 17.3 17.0 16.9 18.2 23.8 16.5 38.9 10.0 5.7 16.7 6.9 10.2 16.0 21.6 7.0 17.7 19.9 10.0 21.8 10.3 16.1 28.0 0.0 20.6 15.8 9.4 9.0 16.2 7.8 29.2 20.6 3.5 20.9 20.7 2.2 9.2 25.5 10.1 51.3 15.2 12.9 26.2 21.2 11.0 16.5 28.1 12.9 7.1 4.9 9.7 6.9 24.3 10.2 16.6 10.2 TBC1D22B "C6orf197, dJ744I24.2, FLJ20337" ENSG00000065491 "TBC1 domain family member 22B" Q9NU19 6 37257772-37332970 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027908, HPA027909, HPA027910" Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA027908: AB_10602073, HPA027909: AB_10601857, HPA027910: AB_10602203" "unprognostic (9.83e-2)" "unprognostic (5.36e-2)" "unprognostic (2.17e-2)" "prognostic unfavorable (8.15e-5)" "unprognostic (2.70e-1)" "unprognostic (1.45e-1)" "unprognostic (2.29e-2)" "unprognostic (1.44e-1)" "unprognostic (9.48e-2)" "unprognostic (6.06e-3)" "unprognostic (3.10e-2)" "unprognostic (1.46e-1)" "unprognostic (3.53e-3)" "unprognostic (9.87e-2)" "unprognostic (2.71e-1)" "unprognostic (3.19e-1)" "unprognostic (9.73e-2)" 11.5 17.9 9.6 11.0 12.1 26.0 12.8 15.2 17.1 9.7 13.1 11.2 14.3 13.1 13.9 13.0 19.8 14.1 16.8 11.2 10.5 10.5 13.3 8.7 11.7 9.0 8.9 9.9 15.0 20.9 16.8 11.8 13.3 13.1 12.3 13.3 12.2 21.6 11.8 32.7 20.7 16.1 11.5 8.3 11.1 10.6 19.9 8.2 20.7 13.0 10.5 14.4 10.4 13.3 4.6 7.7 8.0 6.6 5.7 6.2 4.6 7.0 3.0 5.6 6.1 5.2 5.2 8.0 4.0 8.3 7.5 9.2 6.8 4.7 6.6 4.2 5.0 10.1 4.9 7.0 6.3 8.4 10.7 5.7 10.5 5.0 9.2 7.5 5.9 9.0 4.4 9.3 7.3 8.7 7.1 10.4 11.2 11.9 1.7 5.3 6.4 8.7 4.5 7.2 8.1 2.8 5.8 5.1 5.2 7.6 5.2 7.3 4.7 4.3 6.3 7.7 7.8 4.5 10.7 10.1 4.5 7.0 3.0 5.2 6.3 6.5 43.8 3.1 9.0 7.0 2.4 5.0 8.0 4.8 6.6 5.6 3.6 5.3 4.6 7.7 4.6 6.2 5.0 2.2 5.7 2.9 2.2 3.6 4.6 9.6 12.1 15.2 17.1 10.5 10.5 8.9 9.9 13.1 8.2 3.0 6.4 2.7 7.2 7.2 5.1 3.5 2.5 12.0 9.1 1.8 3.9 5.5 3.3 10.8 4.4 4.9 11.1 23.3 13.4 7.1 4.1 7.9 5.7 3.6 4.9 0.0 1.7 4.3 4.3 2.9 2.8 4.3 1.7 7.2 5.1 3.8 13.3 5.8 1.1 7.7 4.6 0.0 2.5 5.5 5.1 13.9 5.6 4.9 4.7 10.1 TBC1D8 "AD3, GRAMD8, HBLP1, VRP" ENSG00000204634 "TBC1 domain family member 8" O95759 2 101007617-101252866 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 76.0;skeletal muscle: 66.3" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 32.5;Ciliated cells: 41.5;Glandular cells: 38.4;monocytes: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 16.6;non-classical monocyte: 20.6" "Lineage enriched" "Detected in many" 5 "monocytes: 20.6" "Cell line enhanced" "Detected in many" "ASC diff: 36.7;ASC TERT1: 26.1;BJ hTERT+: 22.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015211, HPA037496" Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "CAB015211: , HPA037496: AB_2675507" "unprognostic (1.82e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (6.73e-4)" "unprognostic (4.25e-3)" "unprognostic (3.98e-1)" "unprognostic (2.12e-2)" "unprognostic (1.08e-2)" "unprognostic (2.74e-1)" "unprognostic (5.80e-2)" "unprognostic (2.38e-1)" "unprognostic (8.53e-2)" "unprognostic (1.82e-1)" "unprognostic (2.25e-2)" "unprognostic (8.02e-2)" "unprognostic (1.26e-1)" "unprognostic (6.73e-2)" "unprognostic (7.98e-3)" 14.4 4.0 3.0 5.5 4.2 7.3 14.1 10.1 5.1 7.6 19.6 2.2 52.8 4.3 7.8 12.2 8.4 13.2 12.0 24.1 4.8 2.7 8.9 12.8 11.8 6.8 3.0 3.8 5.1 27.5 3.9 8.5 4.4 6.1 25.7 3.8 6.7 15.1 76.0 66.3 15.2 22.7 7.7 5.0 11.3 13.3 11.3 2.8 3.3 5.3 8.3 8.0 8.7 8.6 0.6 4.0 0.2 20.6 0.0 0.3 1.8 2.0 12.8 1.0 3.7 36.7 26.1 10.5 1.2 22.5 0.9 1.1 4.5 3.3 0.9 11.5 0.9 18.0 6.5 2.1 9.9 0.6 0.6 1.9 0.6 4.3 15.6 2.5 0.1 11.0 12.1 9.4 1.2 9.4 0.7 13.1 1.8 0.2 1.1 1.1 5.6 1.1 6.4 2.8 1.4 13.8 2.5 3.2 0.2 7.5 13.7 8.1 3.9 1.7 3.1 4.4 1.8 0.9 9.4 10.8 0.5 1.9 1.9 0.8 2.1 0.1 0.0 4.7 3.2 3.3 0.0 5.1 0.2 0.1 16.6 0.2 0.2 0.1 0.1 2.8 0.6 0.3 0.2 0.2 0.0 20.6 4.0 0.1 1.8 3.0 4.2 10.1 5.1 4.8 2.7 3.0 3.8 6.1 2.8 3.0 2.9 0.0 32.5 3.7 5.8 10.6 20.4 41.5 20.5 5.2 3.9 3.9 0.0 5.9 4.8 4.9 1.3 0.0 2.6 2.5 2.3 38.4 6.9 5.0 3.6 1.6 2.9 7.4 11.2 8.6 2.8 12.2 5.0 33.3 1.7 0.9 2.8 0.6 1.8 0.7 3.6 6.5 4.2 1.4 1.9 5.5 2.9 0.0 0.9 24.3 TBC1D9 "GRAMD9, KIAA0882, MDR1" ENSG00000109436 "TBC1 domain family member 9" Q6ZT07 4 140620765-140756120 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 52.4" "Cancer enriched" "Detected in all" 7 "breast cancer: 85.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 9.0" "Group enriched" "Detected in many" 38 "B-cells: 9.0;dendritic cells: 4.6;monocytes: 2.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000262, HPA006503" Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA000262: AB_2665956, HPA006503: AB_2667604" "unprognostic (1.41e-1)" "unprognostic (1.35e-2)" "unprognostic (2.41e-1)" "unprognostic (6.49e-2)" "unprognostic (3.00e-1)" "unprognostic (1.22e-2)" "unprognostic (9.17e-2)" "unprognostic (2.11e-3)" "unprognostic (2.64e-1)" "unprognostic (2.66e-1)" "unprognostic (2.96e-3)" "unprognostic (6.77e-2)" "prognostic favorable (1.61e-6)" "unprognostic (2.17e-2)" "unprognostic (1.11e-1)" "unprognostic (6.72e-2)" "unprognostic (2.16e-2)" 15.9 6.2 8.1 9.2 10.0 1.0 33.6 37.6 13.7 9.2 6.7 3.8 32.1 5.2 5.5 6.4 5.9 6.7 9.4 5.7 7.5 13.9 10.7 8.0 10.4 9.6 9.6 8.2 10.9 6.0 9.9 5.7 13.1 11.0 9.8 4.3 10.6 7.3 27.4 1.7 2.8 9.9 5.0 5.3 20.4 10.0 2.9 3.8 1.6 4.3 3.0 12.2 11.1 8.9 9.0 4.6 0.1 2.4 0.1 0.0 0.9 0.4 6.4 6.0 5.1 14.6 13.8 12.2 8.1 8.8 5.9 7.6 1.3 5.6 0.0 5.2 10.6 7.4 1.2 7.4 5.8 5.6 0.0 4.1 3.6 4.6 5.5 5.3 0.5 0.5 11.3 9.7 5.1 20.6 17.3 16.4 2.0 0.0 0.0 5.5 6.3 0.8 0.0 0.9 6.7 5.6 3.9 9.8 9.3 6.8 11.8 8.8 6.2 8.5 15.0 5.5 10.6 3.5 0.2 25.4 15.7 4.7 10.2 7.0 0.0 0.0 0.0 9.5 0.7 8.5 0.0 2.4 0.0 0.0 1.9 0.0 9.0 0.0 0.0 4.0 4.0 0.0 0.0 0.1 0.1 0.7 4.6 0.0 0.9 8.1 10.0 37.6 13.7 7.5 13.9 9.6 8.2 11.0 3.8 50.6 9.4 15.7 8.9 4.0 33.1 6.5 17.8 5.3 6.8 52.4 3.9 10.8 6.6 13.3 0.4 24.1 4.1 0.0 15.0 3.9 11.5 19.8 0.0 14.5 15.9 9.5 7.5 17.8 30.7 0.0 12.0 30.7 8.5 25.2 4.5 40.9 13.2 5.9 25.1 3.8 7.0 0.0 9.5 0.7 1.5 3.3 36.2 0.5 1.7 8.4 TBC1D9B "GRAMD9B, KIAA0676" ENSG00000197226 "TBC1 domain family member 9B" Q66K14 5 179862066-179907859 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038350 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nucleoli fibrillar center" "HPA038350: AB_10673170" "unprognostic (5.06e-2)" "unprognostic (1.37e-1)" "unprognostic (1.60e-2)" "unprognostic (9.53e-2)" "unprognostic (9.45e-3)" "unprognostic (4.25e-1)" "unprognostic (1.06e-1)" "unprognostic (2.84e-1)" "unprognostic (1.10e-1)" "unprognostic (5.08e-2)" "unprognostic (2.01e-1)" "unprognostic (2.28e-2)" "unprognostic (3.95e-2)" "unprognostic (1.86e-1)" "unprognostic (4.01e-2)" "prognostic unfavorable (3.99e-4)" "unprognostic (8.22e-2)" 30.4 28.7 31.2 14.3 29.8 17.0 21.2 27.0 37.9 21.7 17.8 36.7 20.6 16.4 18.9 24.5 21.7 20.7 19.0 15.2 31.4 26.6 20.7 22.4 18.3 16.8 34.9 23.3 24.8 24.6 22.7 13.3 14.8 29.0 18.2 14.5 17.5 25.6 21.9 20.3 24.0 18.9 19.1 42.3 18.0 16.1 12.2 24.1 12.0 23.3 12.5 17.2 17.4 19.7 5.4 9.4 5.0 8.1 3.7 5.5 4.9 10.7 16.6 7.6 17.6 23.3 14.9 17.7 13.1 13.6 13.2 13.2 11.1 10.8 7.4 16.2 15.9 17.3 10.3 9.1 30.6 6.1 24.6 10.2 6.6 12.2 7.4 12.5 8.7 23.0 17.2 13.3 10.4 7.5 12.3 14.5 14.8 4.4 8.7 11.8 27.0 5.6 7.2 5.3 8.2 9.5 9.7 5.8 7.3 12.4 17.6 10.9 8.0 12.4 14.8 15.0 8.5 11.7 14.1 14.7 19.3 8.6 9.2 11.5 4.4 5.7 5.8 18.3 11.2 13.6 4.5 5.9 5.0 5.5 8.1 4.5 5.4 4.0 4.7 7.8 5.1 3.9 3.1 0.8 3.7 7.9 9.4 3.4 4.9 31.2 29.8 27.0 37.9 31.4 26.6 34.9 23.3 29.0 24.1 20.8 19.2 17.1 8.5 14.7 25.0 8.4 17.8 10.7 9.1 26.2 7.9 15.5 11.6 18.4 1.7 23.8 22.6 0.0 15.6 18.8 15.9 12.8 10.5 30.0 27.4 58.8 17.3 23.4 26.1 5.4 30.0 21.0 15.1 19.0 21.9 15.8 21.8 23.0 26.9 18.1 17.7 25.8 11.0 6.9 17.5 13.7 11.8 13.1 18.2 11.9 TBCK "HSPC302, MGC16169" ENSG00000145348 "TBC1 domain containing kinase" Q8TEA7 4 106041599-106321495 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 25.3;BJ hTERT+ SV40 Large T+ RasG12V: 44.5;HBF TERT88: 30.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039951, HPA051611" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA039951: AB_10795300, HPA051611: AB_2681550" "unprognostic (1.65e-1)" "unprognostic (2.60e-2)" "unprognostic (8.47e-2)" "unprognostic (1.12e-1)" "unprognostic (8.06e-2)" "unprognostic (1.13e-3)" "unprognostic (1.55e-1)" "unprognostic (3.81e-1)" "unprognostic (8.68e-2)" "unprognostic (1.85e-1)" "unprognostic (3.67e-2)" "unprognostic (1.80e-1)" "prognostic favorable (3.20e-4)" "unprognostic (8.17e-3)" "unprognostic (1.69e-1)" "unprognostic (1.12e-1)" "unprognostic (2.29e-1)" 12.8 19.0 14.2 7.6 15.2 3.4 10.0 16.3 15.2 13.5 8.3 10.0 11.0 4.4 10.9 14.9 10.6 13.0 13.2 9.3 12.1 11.1 17.8 10.5 9.6 6.9 15.0 8.5 17.5 8.2 12.6 24.2 13.7 12.1 11.9 9.1 9.0 9.1 14.6 4.2 8.5 7.2 13.3 10.3 8.5 8.1 12.0 13.8 18.5 13.9 4.6 8.9 14.5 10.7 10.7 6.3 11.9 6.8 5.9 8.4 4.2 0.9 2.5 5.2 1.9 19.6 12.3 0.9 3.9 6.3 25.3 44.5 4.5 3.9 1.7 5.9 13.2 3.7 2.3 3.5 4.8 30.4 2.4 1.0 5.4 2.1 4.7 5.1 2.2 3.2 11.4 4.0 2.3 4.0 11.1 6.6 3.2 4.2 2.1 7.7 3.4 2.8 2.1 1.2 6.6 1.8 2.1 3.2 3.6 6.6 4.5 2.8 2.2 3.4 2.4 3.4 7.3 3.4 4.9 3.7 4.5 2.2 1.0 1.9 1.0 2.8 3.7 6.2 3.3 2.3 11.9 6.4 6.3 6.2 6.8 7.2 6.2 6.8 8.4 6.3 10.7 7.4 6.7 0.5 5.9 4.6 6.1 6.7 4.2 14.2 15.2 16.3 15.2 12.1 11.1 15.0 8.5 12.1 13.8 17.9 28.0 8.9 5.8 2.1 19.0 6.7 5.1 14.7 20.5 14.0 19.6 9.6 3.3 3.8 35.4 8.2 3.8 0.0 0.8 5.5 7.0 4.2 10.5 4.4 5.8 11.1 5.2 9.8 4.7 28.9 10.3 4.3 5.0 2.8 6.4 10.1 2.1 5.8 12.0 6.9 15.8 0.0 3.8 10.4 8.2 2.0 6.2 6.9 5.5 4.2 TBK1 NAK ENSG00000183735 "TANK binding kinase 1" Q9UHD2 12 64451880-64502108 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Amyotrophic lateral sclerosis, Disease mutation, Glaucoma, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045797, HPA060211" Uncertain Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA045797: AB_2679457, HPA060211: AB_2684222" "unprognostic (4.73e-2)" "unprognostic (8.46e-2)" "unprognostic (6.07e-3)" "unprognostic (1.90e-1)" "unprognostic (1.94e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (3.30e-4)" "unprognostic (1.26e-1)" "prognostic unfavorable (3.48e-4)" "unprognostic (1.69e-1)" "unprognostic (2.54e-2)" "unprognostic (1.24e-2)" "prognostic unfavorable (4.20e-6)" "unprognostic (4.35e-2)" "unprognostic (1.30e-1)" "unprognostic (1.26e-2)" "unprognostic (9.56e-3)" 19.1 23.3 13.7 16.8 17.1 32.3 19.1 17.8 20.5 14.9 18.3 10.0 14.1 18.0 17.0 15.1 15.3 13.8 15.6 11.7 14.7 15.6 15.4 20.8 17.8 18.3 20.2 13.6 15.6 11.1 13.1 27.2 40.6 21.1 16.3 12.9 10.1 15.0 18.3 24.8 12.1 21.4 17.2 18.8 24.6 14.5 27.9 16.9 3.4 13.3 12.6 16.7 18.4 19.6 9.7 8.2 22.5 11.9 16.3 11.8 5.9 13.4 15.4 8.8 12.8 15.8 16.0 19.4 14.7 21.5 13.9 13.2 8.7 8.2 18.8 12.8 15.9 20.1 12.7 11.3 12.4 16.4 17.3 10.8 20.2 11.2 12.0 17.3 20.6 25.2 12.0 11.3 13.9 13.4 24.1 18.5 7.2 15.4 27.4 17.9 16.4 0.6 16.1 17.6 12.3 9.0 9.6 9.8 18.1 15.1 24.4 7.4 10.7 19.4 20.0 14.3 15.3 20.4 15.0 17.1 12.5 12.1 10.0 14.4 17.4 30.2 18.3 15.8 11.4 16.1 22.5 7.3 16.6 11.0 11.9 11.8 9.7 8.0 11.0 8.2 7.6 2.8 7.1 15.1 16.3 10.6 1.9 9.5 5.9 13.7 17.1 17.8 20.5 14.7 15.6 20.2 13.6 21.1 16.9 17.9 15.6 14.7 23.9 9.7 18.4 10.0 7.6 18.7 19.4 21.0 9.8 24.9 10.0 17.0 24.8 24.1 10.7 0.0 20.6 24.3 13.6 35.1 41.6 14.3 18.1 17.5 16.6 16.5 19.0 20.1 17.8 26.2 13.5 27.9 8.0 13.0 14.3 10.2 19.4 11.6 15.8 25.8 17.8 49.9 12.9 13.0 77.5 25.8 9.3 32.4 TBKBP1 "KIAA0775, ProSAPiP2" ENSG00000198933 "TBK1 binding protein 1" A7MCY6 17 47694081-47712050 "Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 13.0;Horizontal cells: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 5.7" "Group enriched" "Detected in many" 5 "granulocytes: 5.7;NK-cells: 2.2;T-cells: 2.8" "Cell line enhanced" "Detected in many" "CACO-2: 32.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062347, HPA064856" Approved Approved Nucleoplasm NA Yes Nucleoplasm "HPA062347: AB_2684744, HPA064856: AB_2685371" "unprognostic (2.14e-3)" "unprognostic (1.15e-1)" "unprognostic (2.42e-2)" "unprognostic (1.92e-2)" "unprognostic (2.39e-1)" "unprognostic (3.09e-2)" "unprognostic (3.72e-1)" "unprognostic (1.05e-1)" "unprognostic (1.51e-1)" "unprognostic (3.24e-1)" "prognostic favorable (8.14e-6)" "unprognostic (5.83e-2)" "unprognostic (1.14e-1)" "unprognostic (3.03e-1)" "unprognostic (4.22e-1)" "unprognostic (1.56e-1)" "prognostic favorable (1.59e-5)" 12.6 7.8 16.1 8.7 8.4 5.6 6.0 13.5 20.1 11.2 7.3 3.9 5.4 3.1 9.7 5.9 10.9 6.7 7.8 12.2 16.3 14.6 6.3 3.2 7.8 5.3 11.2 15.2 17.9 15.0 9.2 6.4 9.2 8.0 7.4 2.4 12.2 18.2 9.8 30.1 4.6 3.6 12.1 4.2 11.0 5.4 8.5 2.8 2.8 9.1 6.5 6.7 8.0 9.6 0.6 0.5 5.7 0.5 2.2 2.8 0.3 0.2 5.2 9.7 10.3 5.0 5.1 6.3 5.3 5.5 2.6 3.1 32.5 0.8 0.1 5.3 6.5 4.7 0.6 7.6 1.3 1.5 6.3 17.1 13.7 4.6 5.4 11.6 2.6 3.0 10.2 3.5 0.6 0.9 8.2 9.1 3.8 11.8 0.0 1.4 1.4 1.6 12.8 13.5 0.2 3.7 6.1 3.0 5.4 3.3 0.4 8.5 15.8 2.5 0.6 2.7 9.6 5.8 5.9 10.5 8.1 9.6 9.7 0.6 3.6 0.3 6.4 4.7 4.9 2.0 0.0 0.5 0.9 2.8 0.2 1.5 0.0 0.7 2.0 0.5 0.6 0.3 1.0 5.7 2.2 0.0 0.5 0.5 0.3 16.1 8.4 13.5 17.9 16.3 14.6 11.2 15.2 8.0 2.8 0.0 1.4 0.5 3.3 3.5 13.0 2.8 0.0 0.0 1.2 3.5 2.0 0.1 1.7 0.9 5.9 5.2 0.0 0.0 1.5 0.1 3.7 4.7 0.0 1.1 2.7 27.0 5.1 9.8 3.3 4.1 8.1 1.7 1.7 1.0 0.1 4.1 1.1 0.0 8.1 3.7 3.5 0.0 4.2 4.4 5.1 2.6 0.2 1.5 0.0 1.7 TBL1X "EBI, TBL1" ENSG00000101849 "Transducin beta like 1 X-linked" O60907 X 9463295-9741037 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Activator "Congenital hypothyroidism, Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 65.3;Hepatocytes: 59.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 17.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 17.3" "Low cell line specificity" "Detected in many" "CAB005363, HPA067703" Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "CAB005363: AB_2240272, HPA067703: AB_2685892" "prognostic unfavorable (8.50e-4)" "unprognostic (2.03e-1)" "unprognostic (2.12e-1)" "unprognostic (2.89e-2)" "unprognostic (2.44e-1)" "unprognostic (1.40e-2)" "unprognostic (2.21e-3)" "unprognostic (3.09e-1)" "unprognostic (2.70e-1)" "unprognostic (3.27e-1)" "prognostic favorable (1.32e-4)" "unprognostic (2.66e-1)" "prognostic favorable (4.58e-4)" "unprognostic (6.71e-2)" "unprognostic (6.38e-2)" "unprognostic (3.40e-3)" "unprognostic (1.53e-1)" 6.5 7.1 10.1 6.0 12.3 4.5 8.1 3.3 8.1 21.4 7.9 13.2 18.0 2.1 33.0 26.4 8.3 12.4 6.7 5.2 8.6 9.0 12.5 11.0 5.2 9.5 7.6 6.0 13.8 11.3 21.0 24.3 14.5 7.5 24.7 4.1 9.8 5.5 33.0 4.9 5.8 4.2 22.4 9.0 5.7 7.0 9.9 8.5 14.7 9.4 3.4 7.1 15.3 24.5 3.2 3.1 17.3 4.2 0.3 3.1 1.7 0.0 13.5 8.6 22.9 8.0 8.4 8.5 5.2 11.6 10.0 10.5 10.1 9.3 14.3 0.3 10.3 4.3 3.1 18.8 4.0 14.6 5.9 9.2 9.0 16.5 11.8 11.3 3.2 32.3 7.4 4.7 10.4 5.5 5.4 9.2 7.9 15.7 25.0 5.7 11.4 7.8 12.1 17.1 6.4 14.5 17.6 6.8 17.6 13.5 7.6 11.0 5.0 12.5 3.1 7.4 23.6 6.1 7.0 13.3 3.5 8.7 0.3 2.0 15.3 11.8 11.4 12.9 7.8 3.3 4.4 4.2 4.9 2.1 2.6 1.7 2.0 1.6 1.9 3.1 3.2 3.1 2.8 17.3 0.3 1.7 0.3 2.5 1.7 10.1 12.3 3.3 8.1 8.6 9.0 7.6 6.0 7.5 8.5 0.0 5.0 15.2 9.4 5.8 11.5 9.5 22.9 12.0 6.8 29.6 21.6 65.3 11.6 9.9 0.8 9.4 2.6 0.0 6.7 2.4 10.0 18.9 10.5 59.7 10.0 6.4 21.9 11.6 32.3 1.7 13.3 19.9 5.0 10.8 4.8 38.8 8.5 3.5 26.9 17.0 22.7 0.0 25.9 1.4 17.9 10.8 37.6 10.7 4.7 22.3 TBL1XR1 "C21, DC42, FLJ12894, IRA1, TBLR1" ENSG00000177565 "Transducin beta like 1 X-linked receptor 1" Q9BZK7 3 177019340-177228000 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Chromatin regulator, Repressor" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 71.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019182 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA019182: AB_1857800" "unprognostic (4.11e-2)" "unprognostic (3.00e-1)" "unprognostic (1.33e-2)" "unprognostic (1.27e-3)" "prognostic favorable (5.16e-5)" "unprognostic (4.44e-2)" "prognostic unfavorable (1.08e-7)" "unprognostic (3.75e-1)" "unprognostic (4.84e-2)" "unprognostic (3.04e-1)" "unprognostic (3.13e-3)" "unprognostic (2.50e-1)" "prognostic unfavorable (4.25e-5)" "unprognostic (5.83e-2)" "unprognostic (1.69e-1)" "unprognostic (1.50e-1)" "unprognostic (1.17e-1)" 20.7 26.0 27.4 24.3 26.8 27.3 20.3 27.5 28.1 28.9 29.9 22.6 15.4 24.0 23.9 20.5 23.8 21.9 22.7 30.3 26.2 20.7 19.9 21.8 30.8 27.8 21.4 25.9 26.5 19.9 30.6 11.3 24.0 19.7 24.4 23.2 24.7 21.3 17.7 21.1 17.8 24.3 21.9 19.6 24.7 21.3 17.4 22.3 28.4 45.6 14.9 32.1 29.1 25.5 7.4 13.3 12.9 4.6 6.8 8.3 4.1 23.9 12.3 16.0 9.0 13.6 14.8 9.6 7.6 11.8 6.6 9.1 14.1 19.9 24.6 35.9 10.9 17.5 14.8 11.9 15.8 13.3 25.8 3.7 13.8 21.0 8.4 11.7 21.9 8.2 21.8 8.2 9.7 24.1 13.0 10.3 17.3 10.3 43.6 8.5 8.6 20.4 3.0 10.1 15.4 8.3 11.7 20.4 26.2 5.9 34.0 5.8 9.2 10.2 8.0 9.5 10.5 29.3 16.8 15.7 10.8 9.1 6.0 16.4 23.8 30.5 71.1 7.3 16.4 12.3 11.4 3.0 3.8 5.8 4.6 5.1 7.3 5.7 6.6 4.0 7.4 5.0 6.4 12.9 6.8 3.9 13.3 8.3 4.1 27.4 26.8 27.5 28.1 26.2 20.7 21.4 25.9 19.7 22.3 68.5 47.1 43.4 46.9 81.4 116.0 84.2 48.4 61.6 62.6 99.5 117.8 22.3 24.9 43.8 5.7 62.9 42.8 23.3 37.3 28.5 65.8 123.0 24.3 58.7 32.8 109.7 81.9 55.9 85.4 5.2 59.2 54.6 62.4 31.5 74.5 41.8 53.4 23.0 68.6 46.2 81.2 45.3 41.5 8.4 53.9 97.7 23.0 49.8 75.7 61.8 TBL1Y TBL1 ENSG00000092377 "Transducin beta like 1 Y-linked" Q9BQ87 Y 6910686-7091683 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Activator "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 15.1;thyroid gland: 10.8" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "prostate cancer: 1.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 14 "MAIT T-cell: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Cell line enriched" "Detected in some" 6 "U-698: 14.5" "HPA050857, HPA060073" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA050857: , HPA060073: AB_2684196" "unprognostic (2.81e-3)" "unprognostic (2.94e-1)" "unprognostic (3.06e-1)" "unprognostic (7.76e-2)" "unprognostic (1.17e-2)" "unprognostic (1.28e-1)" "unprognostic (2.77e-2)" "unprognostic (1.47e-1)" "unprognostic (3.24e-2)" 1.0 0.0 0.1 0.2 0.5 0.1 1.0 0.1 0.4 0.0 0.4 0.5 0.0 0.2 0.1 1.5 1.3 0.1 3.8 0.1 0.1 0.2 1.4 3.3 3.0 0.8 0.1 0.0 0.1 15.1 0.0 0.1 0.3 0.7 7.2 0.4 1.6 5.8 0.7 1.3 0.6 0.3 0.1 0.0 0.1 0.7 3.5 0.0 0.1 10.8 2.9 1.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 2.2 0.0 2.4 1.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.4 0.1 0.2 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 1.0 TBP "GTF2D1, SCA17, TFIID" ENSG00000112592 "TATA-box binding protein" P20226 6 170554302-170572870 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" DNA-binding "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 53.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009442, HPA049805" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB009442: AB_632480, HPA049805: AB_2680890" "unprognostic (2.86e-3)" "unprognostic (1.73e-2)" "unprognostic (3.90e-2)" "unprognostic (4.55e-3)" "unprognostic (7.10e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (1.51e-7)" "unprognostic (1.46e-1)" "unprognostic (4.28e-1)" "unprognostic (1.17e-2)" "unprognostic (1.06e-2)" "unprognostic (1.34e-2)" "unprognostic (1.54e-2)" "unprognostic (8.13e-2)" "unprognostic (2.62e-1)" "unprognostic (3.70e-2)" "unprognostic (3.05e-1)" 11.9 12.3 10.2 14.9 15.8 18.4 13.1 18.1 19.3 13.9 12.7 17.5 15.2 11.4 16.1 12.1 13.3 14.0 11.7 11.5 10.3 10.5 12.3 12.4 11.8 16.8 11.5 13.8 17.3 14.0 10.1 13.2 20.0 18.0 13.1 12.1 14.4 13.7 15.5 14.5 14.5 14.7 13.9 11.7 17.7 13.2 51.4 9.9 15.7 13.7 11.7 15.9 13.1 13.1 32.0 26.3 30.8 25.6 19.6 31.9 12.4 7.4 8.4 14.8 18.5 7.9 8.8 13.8 12.3 9.0 11.8 12.3 16.6 7.5 15.5 9.7 9.6 16.7 11.2 18.9 9.9 13.2 17.9 13.0 16.2 9.6 14.4 10.7 18.3 14.0 8.8 11.3 13.9 15.7 9.4 9.0 21.1 27.7 9.8 10.5 11.8 18.8 18.5 15.1 14.7 6.4 16.5 12.0 13.6 8.9 4.0 6.1 14.3 14.3 10.7 9.5 12.8 7.6 23.5 10.4 8.3 11.9 13.6 18.4 14.7 19.7 25.0 11.3 15.8 13.2 30.8 19.9 23.5 25.0 19.4 28.9 30.9 24.3 25.1 18.5 32.0 31.9 26.6 28.6 19.6 25.6 26.3 22.0 12.4 10.2 15.8 18.1 19.3 10.3 10.5 11.5 13.8 18.0 9.9 8.9 8.6 8.3 4.8 4.8 7.5 8.3 15.3 4.0 9.1 12.2 7.9 13.8 3.3 6.2 14.2 8.7 6.2 0.0 4.0 10.9 7.2 7.0 1.1 7.3 9.0 0.0 6.9 13.5 15.6 3.2 10.0 5.1 1.7 4.6 7.4 6.6 5.4 8.4 9.9 5.8 6.4 12.9 5.7 53.3 16.6 5.8 11.3 6.4 7.5 5.3 TBPL1 "STUD, TLF, TLP, TRF2" ENSG00000028839 "TATA-box binding protein like 1" P62380 6 133952170-133990432 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 71.2" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 221.6;Spermatocytes: 178.1;Syncytiotrophoblasts: 204.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071810, HPA071813" Enhanced Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA071810: AB_2686451, HPA071813: AB_2686452" "unprognostic (2.21e-3)" "unprognostic (1.95e-2)" "unprognostic (5.11e-2)" "unprognostic (6.67e-3)" "prognostic favorable (7.22e-4)" "unprognostic (5.16e-3)" "prognostic unfavorable (7.91e-5)" "unprognostic (1.19e-1)" "unprognostic (3.94e-2)" "unprognostic (4.66e-2)" "prognostic favorable (7.23e-4)" "unprognostic (2.56e-1)" "prognostic unfavorable (4.14e-4)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (2.82e-1)" "unprognostic (8.16e-2)" 7.1 7.7 10.8 8.9 11.7 19.3 12.2 16.4 16.6 7.3 7.3 5.2 7.8 8.1 7.9 5.6 7.1 8.5 7.4 7.9 15.9 14.2 5.7 8.5 6.6 12.0 10.0 11.8 8.3 6.0 4.7 8.2 9.2 11.1 8.0 9.3 4.6 5.7 9.2 4.4 5.9 7.7 7.2 8.5 7.6 7.2 71.2 8.0 11.7 10.7 5.0 10.2 9.2 12.0 27.8 14.7 43.1 14.9 21.1 30.8 25.3 6.3 7.8 17.9 11.6 13.7 14.2 10.1 12.1 12.8 16.2 21.3 9.1 5.1 19.8 8.3 9.6 18.0 8.4 11.4 13.0 19.6 15.1 14.2 34.8 4.7 10.0 13.9 18.2 13.6 8.7 13.3 18.1 19.6 12.3 15.3 17.5 50.2 13.6 11.5 14.5 15.2 10.9 20.0 9.3 10.2 10.6 10.8 7.6 9.5 5.7 23.3 23.2 7.1 9.4 14.9 15.6 4.3 7.3 13.8 9.3 13.5 20.5 13.2 11.0 11.9 12.9 15.6 11.9 11.1 43.1 13.7 32.7 28.5 13.8 30.8 27.8 24.1 29.9 12.4 25.0 23.4 27.3 31.4 21.1 14.9 14.7 24.6 25.3 10.8 11.7 16.4 16.6 15.9 14.2 10.0 11.8 11.1 8.0 6.0 12.6 23.3 25.8 62.8 20.7 9.2 20.4 12.0 7.9 7.0 17.7 36.2 24.9 25.0 221.6 33.3 12.0 0.0 22.1 57.3 32.7 32.8 40.3 8.9 21.4 14.3 68.1 17.2 16.7 29.8 19.5 20.0 30.4 19.0 22.4 12.3 24.3 21.0 17.3 18.9 9.4 19.4 34.0 178.1 63.9 57.5 204.8 47.3 23.6 36.7 TBRG1 "FLJ14621, NIAM, TB-5" ENSG00000154144 "Transforming growth factor beta regulator 1" Q3YBR2 11 124622836-124635398 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055645, HPA068022" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA055645: AB_2682873, HPA068022: AB_2685942" "unprognostic (1.64e-2)" "unprognostic (3.24e-2)" "unprognostic (7.81e-2)" "unprognostic (1.37e-2)" "unprognostic (9.21e-2)" "unprognostic (3.66e-1)" "unprognostic (1.03e-1)" "unprognostic (4.58e-2)" "unprognostic (1.18e-3)" "unprognostic (1.52e-1)" "unprognostic (7.40e-2)" "unprognostic (3.72e-3)" "unprognostic (1.78e-1)" "unprognostic (1.70e-1)" "unprognostic (1.22e-1)" "unprognostic (3.83e-1)" "unprognostic (7.13e-3)" 13.3 16.0 13.8 15.9 24.8 7.9 9.8 10.3 33.1 9.2 10.9 13.6 8.0 18.7 10.2 14.4 11.0 8.8 11.8 8.7 12.8 9.3 12.9 17.5 14.0 17.1 15.3 18.0 9.4 17.2 11.4 12.7 12.2 15.8 12.9 15.3 8.3 12.1 10.7 18.9 16.0 17.3 9.5 12.2 19.0 15.2 7.4 16.5 7.6 13.4 6.6 16.3 10.8 9.3 24.2 17.7 25.5 19.5 11.1 22.6 9.3 4.9 4.1 4.7 4.2 8.6 6.4 4.4 9.6 5.9 3.2 3.4 7.0 4.1 6.2 5.9 6.6 7.7 8.5 5.5 7.1 5.5 4.3 5.1 24.1 2.1 5.6 7.7 11.5 23.1 6.5 12.7 4.4 6.4 4.9 5.3 6.6 9.2 6.2 7.8 2.5 4.9 9.5 5.8 12.2 6.4 3.2 5.7 3.6 5.6 5.3 3.2 4.9 4.3 6.0 5.7 4.7 9.1 6.8 10.0 8.4 2.7 5.3 5.6 4.7 5.4 6.8 4.4 11.0 5.4 20.5 19.5 25.5 20.4 17.6 15.6 22.5 20.9 17.3 11.5 24.2 22.6 18.0 24.9 11.1 15.5 17.7 19.5 9.3 13.8 24.8 10.3 33.1 12.8 9.3 15.3 18.0 15.8 16.5 41.7 50.4 29.8 40.9 41.0 19.1 20.6 35.7 34.8 46.6 22.7 11.8 28.8 44.7 33.4 41.8 42.9 45.1 23.3 41.6 24.3 42.1 68.1 68.3 58.7 32.8 28.6 27.2 28.3 39.1 4.3 35.1 58.3 32.1 33.3 38.1 26.2 46.7 42.1 31.5 48.0 18.7 25.8 39.2 28.1 22.3 42.0 40.4 49.6 30.4 63.5 TBX15 TBX14 ENSG00000092607 "T-box 15" Q96SF7 1 118883046-118989556 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 23.3;skeletal muscle: 84.9;tongue: 37.5" "Group enriched" "Detected in some" 4 "Early spermatids: 6.3;Hepatocytes: 11.3;Melanocytes: 6.8;Smooth muscle cells: 7.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 28.2;ASC TERT1: 12.0;BJ hTERT+ SV40 Large T+ RasG12V: 10.8;fHDF/TERT166: 14.4;HSkMC: 20.3;RH-30: 15.3;U-2197: 14.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA052245, HPA053713" Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA052245: AB_2681771, HPA053713: " "unprognostic (1.94e-1)" "unprognostic (2.75e-3)" "unprognostic (1.92e-2)" "unprognostic (3.94e-2)" "unprognostic (5.72e-3)" "unprognostic (7.79e-2)" "unprognostic (5.82e-2)" "unprognostic (2.46e-1)" "unprognostic (3.00e-3)" "unprognostic (1.39e-1)" "unprognostic (3.81e-3)" "unprognostic (5.03e-2)" "prognostic unfavorable (5.57e-8)" "unprognostic (2.63e-2)" "unprognostic (3.90e-2)" "unprognostic (1.88e-3)" "unprognostic (2.31e-1)" 18.1 0.1 0.2 0.1 0.5 0.1 12.5 0.4 0.8 0.1 0.1 0.2 0.0 0.0 0.1 2.1 1.2 0.1 0.3 1.2 0.5 0.0 0.1 23.3 0.2 1.3 0.2 0.2 0.1 0.1 0.2 0.5 0.1 2.1 0.7 0.0 0.2 2.8 0.1 84.9 3.6 0.1 0.2 0.6 0.0 0.1 0.4 0.4 0.0 1.9 37.5 2.4 0.2 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 28.2 12.0 0.0 2.4 3.3 6.4 10.8 0.0 0.0 0.0 1.4 14.4 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.7 0.0 0.0 0.2 0.0 20.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 7.3 0.0 0.0 0.1 1.2 0.0 0.1 0.0 15.3 0.2 1.6 0.7 0.3 0.0 0.8 0.0 0.3 0.3 0.0 0.3 0.0 3.5 2.1 14.3 0.1 0.2 0.1 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.4 0.8 0.5 0.0 0.2 0.2 2.1 0.4 0.0 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 11.3 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.9 0.2 0.1 1.8 0.0 0.0 0.0 0.0 TBX18 ENSG00000112837 "T-box 18" O95935 6 84687351-84764519 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "vagina: 23.3" "Cell type enhanced" "Detected in some" 16 "Basal keratinocytes: 4.8;Fibroblasts: 5.3;Melanocytes: 8.5;Smooth muscle cells: 16.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 26.5;ASC diff: 19.3;ASC TERT1: 20.2;RH-30: 17.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA006807 Supported Nucleoplasm NA NA Nucleoplasm "HPA006807: " "unprognostic (8.04e-2)" "unprognostic (7.06e-3)" "unprognostic (9.71e-2)" "unprognostic (2.31e-1)" "unprognostic (4.00e-1)" "unprognostic (1.62e-1)" "unprognostic (2.19e-1)" "unprognostic (3.24e-1)" "unprognostic (2.57e-1)" "unprognostic (7.92e-2)" "unprognostic (3.50e-1)" "unprognostic (1.12e-1)" "unprognostic (1.88e-14)" "unprognostic (4.81e-5)" "unprognostic (1.86e-1)" "unprognostic (3.07e-3)" "unprognostic (1.78e-1)" 14.5 4.9 1.7 2.1 4.0 0.3 16.1 1.8 3.6 4.4 1.9 4.1 0.5 0.5 2.4 2.1 7.3 2.7 3.6 9.9 3.4 1.8 1.0 0.8 0.7 3.9 6.3 5.5 5.0 1.4 1.3 2.6 4.1 5.0 4.9 1.3 8.9 3.9 2.9 2.5 8.0 2.7 11.1 4.0 0.3 1.0 2.5 1.8 0.0 2.8 2.0 3.0 7.6 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.5 0.0 0.0 19.3 20.2 0.0 10.9 5.4 8.3 8.0 0.1 0.0 0.0 0.0 4.5 0.0 1.4 0.0 6.4 6.8 0.0 10.8 0.0 0.0 0.0 2.5 0.0 11.0 8.3 0.6 5.7 12.3 0.0 9.5 0.0 13.7 0.1 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.0 0.1 0.0 0.1 0.5 0.0 0.4 4.2 0.7 0.0 14.3 8.4 0.0 2.3 8.4 0.0 0.1 0.0 0.0 5.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 4.0 1.8 3.6 3.4 1.8 6.3 5.5 5.0 1.8 0.0 0.0 0.0 0.0 4.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 2.6 1.1 0.0 8.5 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 16.7 0.3 1.9 3.9 0.1 0.0 0.0 0.0 TBX2 ENSG00000121068 "T-box 2" Q13207 17 61399896-61409466 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 76.5;Collecting duct cells: 90.7;Muller glia cells: 126.1;Sertoli cells: 168.1;Smooth muscle cells: 66.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 48.6;MCF7: 28.5;SH-SY5Y: 22.7;SK-MEL-30: 15.5;WM-115: 16.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA008586, CAB013636" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB013636: , HPA008586: AB_1080222" "unprognostic (6.18e-2)" "unprognostic (8.51e-2)" "unprognostic (4.50e-1)" "unprognostic (2.09e-1)" "unprognostic (1.36e-1)" "unprognostic (8.45e-2)" "unprognostic (3.27e-1)" "unprognostic (1.82e-1)" "unprognostic (3.49e-2)" "unprognostic (9.29e-2)" "unprognostic (2.10e-2)" "unprognostic (2.10e-1)" "unprognostic (2.32e-3)" "unprognostic (1.97e-1)" "unprognostic (1.37e-1)" "unprognostic (1.45e-1)" "unprognostic (6.34e-3)" 11.5 3.4 2.0 2.9 3.1 0.4 9.9 1.3 2.3 14.8 4.4 1.9 30.4 4.9 12.2 37.0 5.9 11.3 16.8 6.8 1.8 1.8 28.9 4.6 35.7 1.3 3.6 1.5 8.3 1.8 1.8 3.7 30.4 3.6 15.1 2.2 33.7 2.2 38.1 5.8 2.9 5.5 16.4 1.7 8.8 8.1 9.6 1.5 0.0 8.6 5.0 1.8 19.5 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 48.6 1.6 1.7 5.9 7.5 7.9 0.4 0.1 1.3 0.1 0.0 0.6 1.2 0.9 0.0 0.9 0.0 0.1 0.0 2.9 0.8 0.0 2.3 5.4 0.1 0.7 3.1 0.1 8.9 0.5 0.1 0.0 0.0 0.1 0.0 0.5 28.5 0.0 0.1 0.0 0.0 3.4 0.0 1.9 0.2 0.0 11.5 0.1 22.7 0.0 0.0 15.5 0.1 0.6 0.9 0.0 1.1 0.0 2.8 1.7 0.0 0.1 0.0 6.7 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 3.1 1.3 2.3 1.8 1.8 3.6 1.5 3.6 1.5 0.0 1.1 0.0 0.2 0.6 76.5 6.7 0.0 0.0 0.0 90.7 21.6 0.3 1.7 0.0 0.7 4.2 0.0 0.0 0.0 0.2 3.7 0.6 0.0 0.0 0.8 1.6 0.0 14.1 1.8 0.0 36.5 1.7 1.7 0.0 0.0 126.1 0.0 0.0 44.6 23.8 11.5 168.1 66.5 0.4 0.6 0.3 0.2 0.0 0.0 0.1 TBX3 "TBX3-ISO, UMS, XHL" ENSG00000135111 "T-box 3" O15119 12 114670254-114684164 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 117.7" "Cell type enriched" "Detected in many" 6 "Syncytiotrophoblasts: 513.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 34.0;BJ hTERT+: 32.4;RT4: 42.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA005799, HPA075876" Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005799: AB_1857817, HPA075876: " "unprognostic (3.27e-1)" "unprognostic (2.64e-1)" "unprognostic (2.84e-1)" "unprognostic (1.11e-1)" "unprognostic (3.40e-2)" "unprognostic (5.97e-3)" "unprognostic (1.56e-1)" "unprognostic (2.99e-2)" "unprognostic (9.43e-2)" "unprognostic (1.15e-1)" "unprognostic (3.35e-1)" "unprognostic (3.06e-1)" "unprognostic (3.64e-3)" "unprognostic (1.09e-3)" "unprognostic (1.43e-1)" "unprognostic (1.01e-1)" "prognostic favorable (3.28e-4)" 4.3 60.5 0.9 3.3 1.9 0.0 19.9 0.7 2.3 18.2 12.2 1.7 69.6 14.2 13.1 18.7 1.9 7.5 5.0 6.2 1.2 1.5 4.1 15.1 12.6 0.8 1.2 0.5 15.6 1.1 0.3 5.3 67.8 1.6 32.3 1.5 2.6 7.3 117.7 4.2 4.8 19.4 9.7 1.4 2.6 2.2 3.5 1.2 0.5 36.3 7.3 3.5 24.6 25.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 6.0 0.0 0.0 9.0 12.4 13.5 34.0 32.4 13.2 13.1 5.3 1.4 0.0 0.5 5.9 0.8 1.5 2.8 1.2 16.3 0.0 4.1 0.0 1.5 15.5 2.9 0.0 0.0 5.5 0.8 4.4 9.1 0.0 0.1 0.0 1.2 0.0 1.1 0.5 0.0 0.1 0.0 17.2 1.8 0.0 0.0 0.8 0.0 42.4 2.2 6.6 4.8 2.2 1.1 15.8 1.7 0.0 0.0 4.0 2.6 2.3 11.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.9 0.7 2.3 1.2 1.5 1.2 0.5 1.6 1.2 0.0 3.4 0.9 88.0 8.8 6.3 9.8 0.0 0.0 0.0 33.2 3.9 39.8 0.0 0.4 1.3 26.5 25.4 0.0 0.0 5.9 9.5 74.0 0.0 31.0 5.4 1.6 4.7 0.6 1.6 1.8 4.9 0.8 3.3 0.0 13.8 1.5 0.5 23.0 5.6 0.0 2.0 38.8 34.1 0.1 4.7 8.5 513.4 0.7 4.5 62.6 TBX5 HOS ENSG00000089225 "T-box 5" Q99593 12 114353931-114408442 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Atrial fibrillation, Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 44.5;lung: 14.0;placenta: 19.7" "Cell type enriched" "Detected in some" 11 "Cardiomyocytes: 62.0" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "hippocampal formation: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 13.1;BJ hTERT+: 29.2;BJ hTERT+ SV40 Large T+: 6.8;BJ hTERT+ SV40 Large T+ RasG12V: 8.3;HAP1: 11.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA008786, HPA064683" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA008786: AB_10601720, HPA064683: AB_2685320" "unprognostic (3.09e-2)" "unprognostic (1.53e-1)" "unprognostic (3.79e-2)" "unprognostic (2.75e-1)" "unprognostic (1.62e-1)" "unprognostic (1.42e-1)" "unprognostic (1.66e-1)" "unprognostic (1.09e-1)" "unprognostic (8.67e-2)" "unprognostic (3.36e-7)" "unprognostic (2.29e-2)" "unprognostic (1.68e-2)" "unprognostic (7.34e-2)" "unprognostic (4.38e-3)" 2.2 0.1 0.1 0.0 0.1 0.0 3.8 0.8 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.1 6.4 0.1 0.0 44.5 2.2 0.1 0.1 0.1 14.0 1.6 0.1 0.1 0.1 0.1 0.0 0.1 19.7 0.5 5.4 0.0 1.4 0.1 0.0 0.1 0.5 0.1 6.6 0.2 0.1 0.1 0.1 0.0 0.0 1.0 0.0 0.0 6.5 1.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 13.1 29.2 6.8 8.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 11.5 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.2 2.2 0.1 0.1 0.1 0.5 0.0 0.0 1.1 0.0 0.0 0.1 3.6 62.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 TBX6 ENSG00000149922 "T-box 6" O95947 16 30085793-30091887 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 22.8;lymphoid tissue: 16.3;pancreas: 19.8" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 7.9;Sertoli cells: 6.5;Urothelial cells: 6.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 9.9;U-266/70: 10.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA062498 Approved Nucleoplasm NA NA Nucleoplasm "HPA062498: AB_2732686" "unprognostic (2.47e-1)" "unprognostic (1.32e-3)" "unprognostic (5.62e-5)" "unprognostic (1.49e-1)" "unprognostic (4.76e-2)" "unprognostic (2.35e-2)" "unprognostic (3.35e-1)" "unprognostic (5.80e-2)" "unprognostic (1.84e-1)" "unprognostic (1.29e-1)" "unprognostic (1.77e-2)" "unprognostic (3.87e-1)" "unprognostic (2.76e-2)" "unprognostic (2.95e-1)" "unprognostic (4.21e-2)" "unprognostic (5.05e-3)" "unprognostic (4.26e-2)" 1.2 1.4 1.4 1.0 1.5 0.6 0.9 0.9 1.5 2.7 1.2 0.9 0.9 1.8 0.9 1.0 22.8 1.6 1.3 0.9 1.5 1.0 1.8 1.2 1.2 1.2 1.7 0.9 1.9 19.8 3.2 2.3 0.9 2.1 3.2 0.3 2.3 3.9 2.2 2.8 5.0 1.7 0.9 1.5 1.8 7.8 2.4 1.2 1.6 2.3 5.1 16.3 5.5 8.6 4.4 1.3 3.3 2.6 1.3 1.9 1.1 0.9 1.1 0.6 1.1 1.5 0.8 0.8 0.3 0.2 0.0 0.2 1.3 4.3 1.9 2.3 0.2 0.2 1.3 0.5 0.9 0.0 1.4 0.8 1.2 1.7 0.9 1.1 0.2 2.6 0.3 1.2 0.3 0.5 0.9 0.6 4.2 0.1 4.3 0.1 3.6 0.7 0.5 0.9 5.9 0.9 2.8 0.1 3.1 0.0 9.9 1.4 2.0 0.2 0.9 1.2 0.5 1.8 1.7 0.5 1.2 0.7 0.6 0.0 10.4 2.4 0.3 1.2 1.8 0.4 3.1 2.6 0.8 1.8 2.3 1.2 1.3 0.9 1.3 1.3 4.4 1.9 1.7 3.3 1.3 0.8 1.1 1.8 1.1 1.4 1.5 0.9 1.4 1.5 1.0 1.7 0.9 2.1 1.2 0.0 1.1 0.8 2.9 1.0 1.4 0.4 0.0 1.4 0.0 1.8 7.9 1.4 0.0 0.7 0.0 1.4 0.7 0.0 1.0 0.6 0.6 2.9 0.0 0.2 0.5 0.0 0.0 0.6 1.0 0.0 0.9 1.0 0.0 0.0 0.9 1.9 2.1 1.4 1.1 0.4 3.1 6.5 0.1 1.7 2.3 0.9 1.9 0.0 0.7 6.4 TBXT T ENSG00000164458 "T-box transcription factor T" O15178 6 166157656-166168700 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "parathyroid gland: 12.2;pituitary gland: 5.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 22 "testis cancer: 6.2" "Region enhanced" "Detected in single" "pons and medulla: 3.0" "Group enriched" "Detected in some" 24 "naive B-cell: 2.3;NK-cell: 2.5" "Group enriched" "Detected in many" 24 "B-cells: 2.3;NK-cells: 2.5" "Cell line enriched" "Detected in some" 4 "HeLa: 18.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA003322 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA003322: AB_1080176" "unprognostic (5.68e-2)" "unprognostic (4.59e-2)" "unprognostic (6.21e-3)" "unprognostic (8.64e-3)" "unprognostic (9.34e-3)" 0.3 0.0 0.1 2.0 0.0 0.0 0.1 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 12.2 5.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.4 0.0 1.9 0.0 0.0 1.2 0.0 0.6 0.0 0.0 2.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 18.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 1.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.5 0.9 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TC2N "C14orf47, C2CD1, FLJ36557, MTAC2D1, Tac2-N" ENSG00000165929 "Tandem C2 domains, nuclear" Q8N9U0 14 91779751-91867536 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 100.1" "Cell type enhanced" "Detected in many" 7 "Exocrine glandular cells: 183.3;Pancreatic endocrine cells: 110.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "MAIT T-cell: 32.2" "Group enriched" "Detected in many" 46 "NK-cells: 12.9;T-cells: 32.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.8;OE19: 31.5;RT4: 18.5;SK-BR-3: 22.5;T-47d: 11.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA027549 Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA027549: AB_10603346" "unprognostic (5.36e-2)" "unprognostic (1.95e-1)" "unprognostic (4.70e-2)" "unprognostic (1.51e-1)" "unprognostic (7.17e-3)" "unprognostic (3.34e-2)" "unprognostic (2.38e-1)" "unprognostic (2.78e-2)" "unprognostic (3.44e-1)" "unprognostic (8.56e-2)" "prognostic unfavorable (9.86e-4)" "unprognostic (3.00e-1)" "prognostic favorable (4.13e-5)" "unprognostic (6.82e-2)" "unprognostic (1.65e-1)" "unprognostic (3.01e-1)" "unprognostic (1.09e-2)" 6.6 1.5 0.9 15.8 0.9 1.9 12.3 0.4 1.9 8.9 10.2 0.6 16.7 5.4 7.6 7.0 11.6 5.4 24.9 4.7 0.9 1.0 3.7 6.8 13.5 11.3 0.8 0.5 5.5 100.1 12.4 8.4 13.1 1.6 9.3 7.0 6.6 29.8 20.1 2.1 6.9 11.7 3.2 1.1 12.3 10.8 4.9 0.1 8.7 10.3 5.8 27.9 8.3 9.5 0.2 0.0 0.4 0.0 12.9 32.2 7.7 4.5 0.7 0.0 0.0 0.8 0.0 6.3 0.0 0.1 0.0 0.0 3.2 9.8 3.0 0.2 0.0 0.1 0.5 4.5 4.6 0.0 0.0 2.4 0.0 1.2 0.0 0.0 0.0 0.0 0.1 4.7 0.0 0.2 0.0 0.0 0.2 0.0 2.4 0.0 8.1 0.0 0.0 0.6 31.5 0.0 0.0 0.0 0.0 2.2 18.5 3.4 0.0 0.4 22.5 0.0 1.3 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.7 0.0 32.2 0.2 16.2 18.6 0.0 0.1 13.3 11.0 0.4 12.9 0.0 0.0 5.2 7.7 0.9 0.9 0.4 1.9 0.9 1.0 0.8 0.5 1.6 0.1 38.7 70.6 6.7 26.4 47.5 0.0 0.7 30.6 68.3 59.1 24.4 0.0 0.9 1.7 55.7 12.8 4.0 23.4 0.0 183.3 3.0 10.8 49.3 6.9 0.8 0.2 0.0 30.5 5.5 1.0 21.7 52.6 2.2 57.3 1.0 54.7 3.7 110.5 40.8 12.0 7.7 0.0 0.0 4.3 35.2 8.1 72.1 4.6 54.6 33.0 58.8 TCEA1 "GTF2S, SII, TCEA, TF2S, TFIIS" ENSG00000187735 "Transcription elongation factor A1" P23193 8 53966552-54022529 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043786 Approved Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA043786: AB_10959468" "unprognostic (5.35e-2)" "unprognostic (9.90e-2)" "unprognostic (2.39e-1)" "unprognostic (2.11e-3)" "unprognostic (3.34e-2)" "unprognostic (1.17e-1)" "unprognostic (3.72e-2)" "unprognostic (1.77e-1)" "unprognostic (4.14e-2)" "unprognostic (1.00e-2)" "unprognostic (1.56e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (3.75e-5)" "unprognostic (3.80e-3)" "unprognostic (1.10e-1)" "unprognostic (1.13e-1)" "unprognostic (3.05e-2)" 26.7 25.3 30.7 40.5 31.5 29.6 31.1 26.1 27.4 26.0 28.3 21.9 26.6 20.3 27.3 20.9 27.5 23.6 24.7 21.4 27.8 24.2 26.5 56.8 22.3 39.2 29.7 17.6 28.5 38.4 32.2 28.7 21.1 27.1 31.3 22.5 20.6 25.4 25.4 21.8 22.8 22.4 38.9 36.8 30.0 26.1 17.3 31.3 39.9 54.6 18.6 46.9 39.6 37.3 60.0 31.9 20.5 17.8 25.2 40.1 17.8 27.3 27.7 24.8 25.5 17.6 21.9 17.8 21.7 25.5 25.7 28.7 15.8 22.9 67.2 24.7 24.9 27.4 21.1 31.3 19.9 37.5 38.4 15.7 50.8 13.5 23.3 55.3 19.9 21.9 15.7 53.8 24.2 106.8 21.3 21.9 23.2 32.2 58.4 23.3 13.0 41.1 13.9 40.3 44.5 8.3 31.9 8.7 12.0 35.4 18.7 23.3 16.9 17.9 15.8 58.3 24.2 22.8 22.3 19.4 18.9 17.4 21.2 19.5 36.1 22.6 45.5 33.3 22.8 26.6 18.1 17.8 20.5 30.1 16.8 28.6 60.0 31.4 27.7 22.1 44.4 28.0 29.1 6.4 25.2 15.6 31.9 40.1 17.8 30.7 31.5 26.1 27.4 27.8 24.2 29.7 17.6 27.1 31.3 83.4 82.6 150.6 116.2 120.3 70.8 20.7 79.0 139.2 124.0 94.2 84.4 99.1 142.6 96.9 85.2 85.7 52.6 93.5 95.8 104.8 89.7 121.1 94.9 140.5 76.9 54.0 83.7 48.5 68.2 129.1 124.8 89.2 111.3 118.2 83.8 139.0 101.0 71.9 124.8 130.8 97.6 77.6 122.7 77.9 84.3 131.6 93.7 107.1 78.7 109.8 TCEA2 TFIIS ENSG00000171703 "Transcription elongation factor A2" Q15560 20 64049836-64072347 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043836 Approved Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA043836: AB_2678694" "unprognostic (6.51e-2)" "unprognostic (2.02e-1)" "unprognostic (3.91e-2)" "unprognostic (2.16e-2)" "unprognostic (2.80e-1)" "unprognostic (4.91e-3)" "unprognostic (2.38e-1)" "unprognostic (2.91e-1)" "unprognostic (1.65e-3)" "unprognostic (9.03e-3)" "unprognostic (2.49e-2)" "unprognostic (9.67e-2)" "unprognostic (1.17e-1)" "unprognostic (3.81e-3)" "unprognostic (2.70e-1)" "unprognostic (2.28e-1)" "unprognostic (3.79e-1)" 14.8 19.5 31.4 7.9 32.8 6.6 9.3 34.7 40.4 18.3 11.7 17.7 11.0 5.6 18.8 10.9 8.4 24.5 13.5 19.1 27.7 30.0 14.8 27.5 10.9 9.2 27.2 32.8 30.3 16.1 18.6 17.9 14.7 26.5 16.9 3.2 14.5 17.9 22.3 30.7 10.4 7.8 11.7 18.3 16.2 10.5 32.0 18.9 8.7 15.0 6.1 5.2 10.9 15.4 9.7 3.0 4.4 2.6 3.6 5.5 1.6 7.6 8.3 13.2 22.4 11.8 7.4 5.4 8.0 8.9 14.1 6.8 4.9 13.6 8.7 18.0 9.2 8.1 20.5 5.2 6.8 2.8 5.4 10.5 3.3 14.5 12.8 17.6 3.6 4.6 11.5 6.1 3.6 4.7 18.9 9.6 10.9 5.7 16.4 4.3 16.6 14.8 17.7 8.5 9.3 20.0 14.5 10.0 22.5 7.1 5.1 13.1 22.1 8.1 5.5 20.0 4.4 15.2 9.1 13.7 25.5 13.5 14.3 4.9 19.1 12.5 4.6 22.7 4.2 5.0 2.4 1.7 4.4 3.6 1.6 1.6 9.7 3.2 2.6 2.1 5.0 5.5 3.4 0.8 3.6 2.6 3.0 5.4 1.6 31.4 32.8 34.7 37.6 27.7 30.0 27.2 32.8 26.5 18.9 0.0 1.9 12.3 28.6 20.0 50.6 26.9 22.9 6.7 7.9 68.0 25.5 21.6 91.2 30.0 85.6 40.8 1.7 0.0 13.9 11.1 39.4 27.1 2.3 35.5 14.9 62.0 18.3 33.7 14.8 118.7 48.1 23.3 59.1 21.6 2.8 84.3 20.7 2.5 46.3 82.3 30.1 25.8 42.9 95.9 31.9 17.7 17.4 13.8 1.7 17.4 TCEA3 TFIIS.H ENSG00000204219 "Transcription elongation factor A3" O75764 1 23381061-23424740 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 114.0" "Cell type enhanced" "Detected in many" 6 "Mucus-secreting cells: 307.1;Undifferentiated cells: 204.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 8.5;naive CD4 T-cell: 14.3" "Lineage enriched" "Detected in many" 5 "T-cells: 14.3" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.0;Hep G2: 33.2;OE19: 17.1;SiHa: 11.0;T-47d: 17.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA044960, HPA055811" Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA044960: AB_10964053, HPA055811: AB_2682932" "unprognostic (1.58e-1)" "unprognostic (1.75e-3)" "unprognostic (9.18e-2)" "unprognostic (3.82e-2)" "unprognostic (2.77e-3)" "prognostic favorable (2.56e-4)" "unprognostic (2.86e-2)" "unprognostic (4.70e-3)" "unprognostic (7.37e-3)" "unprognostic (2.85e-1)" "unprognostic (2.22e-2)" "unprognostic (3.27e-1)" "unprognostic (2.23e-1)" "unprognostic (4.01e-1)" "unprognostic (5.20e-2)" "unprognostic (3.15e-1)" "unprognostic (5.58e-2)" 5.4 17.8 2.5 10.7 1.9 0.1 3.6 1.5 1.5 9.1 12.2 2.2 12.0 4.6 3.8 14.5 12.0 6.2 13.0 20.3 2.4 0.8 12.1 38.0 6.0 1.3 1.2 2.3 19.8 60.4 4.5 3.3 2.5 2.2 16.7 12.5 8.7 32.7 15.9 114.0 8.9 11.9 13.7 2.0 1.6 11.5 2.6 1.3 0.5 8.6 58.3 16.0 8.4 6.9 0.0 2.8 0.0 0.7 0.2 14.3 2.5 0.0 0.1 0.3 0.3 1.7 10.0 5.5 3.9 2.5 2.1 1.2 2.5 0.3 0.1 0.4 4.8 0.6 5.4 0.4 0.0 1.8 0.0 0.0 0.0 4.1 33.2 1.2 0.4 0.0 6.5 1.8 1.8 0.0 4.5 0.2 0.0 0.0 0.0 0.6 0.9 0.2 3.6 0.0 17.1 1.2 0.0 0.0 0.1 0.0 0.0 0.3 0.1 11.0 0.5 0.4 1.0 17.5 1.6 0.2 0.0 0.1 0.4 0.0 0.3 2.9 0.0 0.3 0.3 0.3 0.0 0.1 0.0 0.5 0.7 0.5 0.0 8.5 1.2 2.8 0.0 14.3 6.3 0.0 0.2 0.2 0.9 0.7 2.5 2.5 1.9 1.5 1.5 2.4 0.8 1.2 2.3 2.2 1.3 116.1 83.2 2.2 44.3 24.4 1.5 92.9 68.8 45.5 71.7 40.1 2.0 3.0 169.1 22.0 4.7 12.7 145.7 0.0 86.0 28.5 32.8 62.5 9.2 177.9 1.2 23.8 53.7 9.8 7.3 7.2 15.8 16.2 23.6 2.8 307.1 2.9 40.2 98.2 14.5 173.6 1.5 19.4 20.6 0.5 3.5 47.9 1.8 6.1 204.2 55.5 TCEAL1 "p21, pp21, SIIR, WEX9" ENSG00000172465 "Transcription elongation factor A like 1" Q15170 X 103628704-103630953 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Leydig cells: 262.6;Peritubular cells: 364.5;Sertoli cells: 148.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057345, HPA060384, HPA076762" Approved Enhanced Nucleoplasm No No Nucleoplasm "HPA057345: , HPA060384: AB_2732648, HPA076762: " "unprognostic (1.98e-2)" "unprognostic (2.53e-2)" "unprognostic (1.50e-1)" "unprognostic (1.20e-1)" "unprognostic (1.99e-1)" "unprognostic (5.30e-2)" "unprognostic (1.38e-1)" "unprognostic (5.60e-3)" "unprognostic (6.09e-2)" "unprognostic (2.03e-2)" "unprognostic (9.85e-3)" "unprognostic (6.54e-2)" "unprognostic (4.80e-2)" "unprognostic (2.62e-1)" "unprognostic (2.56e-1)" "unprognostic (5.56e-2)" "unprognostic (8.76e-2)" 10.5 24.7 23.8 9.1 20.8 4.2 19.5 19.9 45.1 29.6 17.1 5.5 29.7 7.3 45.8 20.2 18.4 32.1 17.6 13.5 27.0 18.6 10.6 7.5 10.1 7.8 12.2 25.3 59.1 9.0 13.5 11.2 8.5 19.9 25.4 8.4 6.1 6.4 40.3 22.4 8.1 8.7 49.2 23.5 9.3 13.3 9.3 13.2 3.1 15.5 10.5 4.7 33.9 24.7 18.3 16.6 11.3 8.4 13.4 14.7 8.2 9.5 9.2 5.2 7.2 22.7 15.7 7.0 13.6 13.7 13.3 14.5 4.0 9.5 4.4 14.1 17.5 20.2 9.6 8.7 7.2 9.9 0.0 10.8 6.0 12.9 7.8 10.2 0.0 9.1 19.2 14.0 10.2 5.7 22.1 13.6 5.1 2.2 2.5 26.6 10.5 5.2 0.1 1.7 8.5 15.0 5.4 16.9 0.0 18.3 9.5 7.2 6.1 13.8 6.6 14.9 4.0 6.1 5.6 10.8 9.7 3.5 22.6 6.9 2.5 7.9 0.1 12.7 0.0 9.6 11.3 8.4 0.5 10.4 5.7 14.7 18.3 9.4 8.6 16.6 16.1 12.5 14.3 0.9 13.4 2.3 13.0 8.0 8.2 23.8 20.8 19.9 45.1 27.0 18.6 12.2 25.3 19.9 13.2 14.9 24.5 11.9 44.6 26.4 19.2 25.8 30.6 56.2 44.3 24.4 2.0 27.4 48.0 19.4 1.6 35.2 7.3 0.0 21.7 28.5 38.1 16.0 25.5 17.1 30.3 20.6 26.5 36.8 17.8 4.2 262.6 22.6 18.6 24.4 13.1 29.3 11.5 18.2 364.5 39.9 12.0 148.8 69.3 3.9 7.5 18.6 6.1 17.1 18.1 10.2 TCEAL3 "MGC15737, WEX8" ENSG00000196507 "Transcription elongation factor A like 3" Q969E4 X 103607451-103629690 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Peritubular cells: 240.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA045564, HPA058982" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045564: AB_2679369, HPA058982: AB_2683870" "unprognostic (2.55e-1)" "unprognostic (2.64e-1)" "unprognostic (2.20e-2)" "unprognostic (1.46e-1)" "unprognostic (1.61e-1)" "unprognostic (1.58e-2)" "unprognostic (2.41e-1)" "prognostic favorable (4.05e-4)" "unprognostic (2.26e-1)" "prognostic favorable (8.33e-4)" "unprognostic (6.35e-3)" "unprognostic (2.30e-1)" "unprognostic (2.22e-3)" "unprognostic (7.19e-3)" "unprognostic (1.79e-1)" "unprognostic (1.53e-1)" "unprognostic (2.64e-1)" 14.8 36.9 36.8 11.0 34.2 9.9 18.3 30.2 47.4 35.0 15.5 24.9 33.7 9.3 42.8 24.9 17.8 27.4 17.9 21.0 33.7 40.7 16.0 5.1 12.5 7.3 43.4 29.1 49.8 22.6 28.3 35.2 13.5 40.3 45.5 7.9 11.9 21.9 55.4 9.7 8.0 8.9 48.3 44.0 18.5 14.5 15.2 23.6 0.8 17.7 4.0 6.4 44.3 23.0 9.6 9.7 4.5 6.9 14.7 12.2 5.3 24.3 2.6 6.6 5.4 23.1 11.8 0.2 36.6 17.3 16.5 22.1 0.0 2.4 0.0 4.5 26.2 29.5 9.6 4.7 14.2 12.1 0.0 1.2 1.8 10.4 0.0 22.2 0.0 8.1 15.2 4.4 11.7 16.7 23.5 11.2 8.5 0.0 7.1 22.4 20.3 1.1 0.1 2.9 0.0 7.0 8.5 4.2 0.1 7.8 4.8 10.2 8.3 1.6 2.1 8.4 3.4 10.0 5.6 14.6 8.7 4.5 17.7 11.2 7.6 3.5 0.0 21.5 0.0 19.0 4.5 6.9 3.8 11.1 3.5 12.2 7.3 9.7 8.8 7.6 9.6 9.7 11.8 1.1 14.7 0.3 9.7 12.2 5.3 36.8 34.2 30.2 31.1 33.7 40.7 43.4 29.1 40.3 23.6 14.9 45.8 12.7 75.4 23.0 50.9 40.8 28.1 71.0 45.5 71.5 17.7 2.8 121.0 35.9 2.5 42.8 1.5 0.0 34.1 1.9 50.3 86.9 94.6 3.4 51.9 17.5 41.8 54.6 26.4 9.3 145.6 40.9 15.1 39.7 22.5 116.7 22.7 8.6 240.8 25.8 28.7 25.8 47.6 2.1 1.5 14.8 2.3 16.0 4.4 34.1 TCEAL5 WEX4 ENSG00000204065 "Transcription elongation factor A like 5" Q5H9L2 X 103273691-103276872 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.4;testis: 45.9" "Group enriched" "Detected in some" 4 "Bipolar cells: 41.1;Muller glia cells: 64.8;Peritubular cells: 33.6" "Cancer enhanced" "Detected in many" "glioma: 13.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "SCLC-21H: 7.5;SH-SY5Y: 23.4" "HPA045564, HPA058982" Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA045564: AB_2679369, HPA058982: AB_2683870" "unprognostic (1.30e-3)" "unprognostic (2.41e-1)" "prognostic unfavorable (9.09e-4)" "unprognostic (9.68e-2)" "unprognostic (8.75e-4)" "unprognostic (1.21e-1)" "unprognostic (8.11e-2)" "prognostic favorable (8.60e-4)" "unprognostic (1.28e-2)" "unprognostic (1.96e-2)" "unprognostic (1.08e-3)" "unprognostic (1.74e-1)" "unprognostic (6.30e-2)" "unprognostic (6.03e-4)" 2.0 11.2 21.9 2.1 31.8 1.3 3.3 32.7 56.4 4.7 2.2 6.6 0.0 1.9 6.0 7.8 1.5 1.6 2.0 2.0 22.3 23.1 1.5 1.3 1.5 1.3 13.0 24.0 5.0 2.1 1.3 23.1 1.3 19.8 3.7 2.0 1.4 2.3 5.4 1.4 1.3 2.4 4.3 11.0 1.3 1.5 45.9 8.4 0.0 3.4 0.0 1.3 2.1 1.1 0.7 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 23.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.2 0.0 0.2 0.0 0.1 0.0 0.0 21.9 31.8 32.7 31.9 22.3 23.1 13.0 24.0 19.8 8.4 0.0 0.0 0.0 0.3 0.1 41.1 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.6 0.4 0.0 0.0 0.0 0.3 0.6 0.2 0.0 0.0 0.2 1.6 0.0 0.0 0.0 11.5 7.8 0.6 0.0 0.0 0.0 64.8 0.0 0.0 33.6 0.0 5.6 0.0 0.9 2.8 1.7 0.3 0.3 0.0 0.0 0.1 TCEAL6 WEX2 ENSG00000204071 "Transcription elongation factor A like 6" Q6IPX3 X 102140476-102142970 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 14.3;brain: 48.4;pituitary gland: 20.7;testis: 21.9" "Group enriched" "Detected in some" 5 "Bipolar cells: 30.0;Horizontal cells: 14.3" "Cancer enriched" "Detected in single" 9 "glioma: 3.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 1.1;SCLC-21H: 2.0" "HPA045564, HPA058982" Supported Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045564: AB_2679369, HPA058982: AB_2683870" "unprognostic (5.43e-2)" "unprognostic (6.54e-2)" "unprognostic (1.87e-3)" "unprognostic (6.69e-3)" "unprognostic (1.39e-1)" "unprognostic (2.69e-2)" "unprognostic (1.88e-2)" "unprognostic (3.89e-2)" "unprognostic (1.41e-1)" "unprognostic (2.18e-2)" "unprognostic (3.33e-2)" "unprognostic (1.18e-1)" 1.1 14.3 16.6 1.3 15.2 1.0 1.1 31.4 48.4 1.2 1.4 2.5 0.0 1.3 5.3 2.8 1.1 3.2 1.1 1.1 11.3 26.0 1.2 1.0 1.0 1.0 15.2 7.5 6.1 1.3 1.1 20.7 1.0 12.5 1.9 1.3 2.0 3.1 1.9 1.0 1.0 1.3 1.9 7.5 1.0 1.0 21.9 2.8 0.0 1.8 0.0 1.0 1.0 1.7 0.7 0.6 0.1 0.5 1.3 0.7 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.6 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.4 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.3 0.0 0.0 0.7 0.0 0.3 0.1 0.5 0.1 0.5 0.3 0.7 0.4 0.2 0.3 0.5 0.7 0.4 0.6 0.0 1.3 0.0 0.6 0.6 0.6 16.6 15.2 31.4 26.0 11.3 26.0 15.2 7.5 12.5 2.8 0.0 0.0 0.0 0.2 0.1 30.0 4.0 0.0 0.0 0.0 3.5 2.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.1 14.3 0.0 0.0 0.0 2.6 2.3 0.0 1.7 0.0 0.0 2.0 0.7 0.0 0.7 0.0 4.3 0.0 1.9 1.1 0.8 0.3 0.0 0.0 0.0 0.0 TCEAL7 "MGC23947, WEX5" ENSG00000182916 "Transcription elongation factor A like 7" Q9BRU2 X 103330196-103332326 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 70.4" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 34.8;Horizontal cells: 46.1;Leydig cells: 40.6;Muller glia cells: 77.7;Peritubular cells: 36.7;Smooth muscle cells: 31.7" "Cancer enriched" "Detected in many" 10 "glioma: 39.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.3" "Lineage enhanced" "Detected in single" "NK-cells: 1.3" "Cell line enhanced" "Detected in some" "AF22: 23.0;BJ hTERT+ SV40 Large T+ RasG12V: 20.7;GAMG: 31.8;hTEC/SVTERT24-B: 23.0;SCLC-21H: 58.2;U-87 MG: 21.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA051507, HPA065080" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA051507: AB_2681512, HPA065080: AB_2685419" "unprognostic (1.09e-2)" "unprognostic (4.36e-2)" "unprognostic (5.54e-2)" "unprognostic (2.26e-1)" "unprognostic (1.17e-1)" "unprognostic (4.52e-2)" "unprognostic (2.17e-1)" "unprognostic (2.23e-1)" "unprognostic (3.26e-2)" "unprognostic (1.12e-1)" "unprognostic (4.18e-1)" "unprognostic (1.12e-2)" "prognostic unfavorable (4.31e-4)" "prognostic unfavorable (3.53e-4)" "unprognostic (2.62e-1)" "unprognostic (2.28e-2)" "unprognostic (1.35e-3)" 4.9 22.1 31.7 3.8 33.4 1.0 7.8 33.0 70.4 16.8 6.4 20.1 1.8 3.9 36.4 14.7 5.1 5.4 9.7 9.5 31.1 44.2 4.6 2.6 3.8 2.5 34.4 27.4 23.2 1.3 1.3 14.0 2.5 51.8 10.3 6.9 2.0 2.9 11.3 2.9 1.5 4.9 23.3 45.1 5.0 2.6 3.2 19.4 0.0 3.0 2.2 1.9 7.5 5.7 0.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 23.0 0.0 10.1 15.6 4.1 3.2 16.9 7.2 20.7 0.0 0.0 0.0 0.0 3.4 31.8 0.0 0.0 0.4 12.5 0.0 0.2 0.1 0.0 0.0 5.1 0.0 0.0 13.1 0.0 23.0 0.0 0.0 7.5 0.0 0.1 0.0 19.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.6 0.0 0.0 0.0 58.2 15.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 10.7 0.4 0.1 0.0 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 31.7 33.4 33.0 46.7 31.1 44.2 34.4 27.4 51.8 19.4 0.0 2.2 0.0 5.2 2.3 34.8 14.1 0.0 0.0 1.2 3.5 3.9 1.2 5.0 0.2 0.2 1.9 0.0 0.0 0.0 0.3 6.1 0.9 0.0 0.0 0.5 46.1 0.0 2.5 0.0 1.4 40.6 0.8 8.5 0.0 0.0 77.7 0.5 0.0 36.7 1.0 10.2 12.9 31.7 3.1 0.9 2.8 0.2 0.0 0.0 0.9 TCEAL8 "MGC45400, WEX3" ENSG00000180964 "Transcription elongation factor A like 8" Q8IYN2 X 103252995-103255203 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059115 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA059115: AB_2683909" "unprognostic (1.51e-2)" "unprognostic (4.56e-2)" "unprognostic (9.24e-2)" "unprognostic (7.13e-3)" "unprognostic (1.03e-1)" "prognostic unfavorable (8.53e-6)" "unprognostic (3.71e-3)" "unprognostic (1.88e-2)" "unprognostic (5.52e-2)" "unprognostic (4.80e-3)" "unprognostic (4.03e-2)" "unprognostic (1.01e-1)" "unprognostic (1.12e-2)" "unprognostic (3.26e-2)" "unprognostic (7.22e-2)" "unprognostic (9.12e-2)" "unprognostic (9.32e-2)" 24.6 30.9 37.3 16.8 32.5 12.4 30.0 34.5 38.5 34.8 25.1 25.6 25.8 14.9 29.6 67.9 26.7 22.7 27.9 43.9 33.4 32.4 33.9 20.2 20.8 20.6 34.5 25.8 36.7 25.0 32.2 64.5 32.9 39.4 31.6 24.7 26.0 29.7 28.6 8.8 19.8 19.9 31.1 34.6 24.3 21.5 21.0 22.5 30.7 35.2 18.8 20.9 31.7 22.4 17.5 28.7 16.3 9.4 33.3 30.3 15.2 9.7 5.1 23.6 11.3 34.9 59.0 11.4 20.3 31.6 18.3 29.8 4.0 20.3 4.8 13.6 24.1 30.3 6.7 4.0 24.5 24.3 0.1 12.7 22.1 7.0 6.1 21.9 22.1 22.8 40.1 14.7 16.3 0.0 39.5 26.1 14.1 27.2 5.3 46.0 0.0 18.5 9.3 26.3 0.7 10.8 7.6 31.5 1.5 26.2 7.6 12.5 16.6 11.2 3.9 26.3 22.9 7.2 7.8 16.4 11.8 15.2 35.1 6.8 5.3 8.8 0.2 19.1 12.2 18.9 16.3 9.4 5.5 19.7 8.2 23.5 17.5 23.9 21.2 16.9 14.8 26.5 22.8 0.9 33.3 6.2 28.7 30.3 15.2 37.3 32.5 34.5 38.5 33.4 32.4 34.5 25.8 39.4 22.5 47.6 65.5 63.1 70.6 54.0 53.1 66.3 114.7 38.8 45.5 92.5 9.8 163.9 232.1 105.5 3.9 69.9 39.3 23.3 96.4 155.7 110.9 59.3 67.1 92.3 87.5 47.7 75.3 154.1 81.0 6.2 116.5 69.4 114.7 83.8 113.8 74.4 76.7 52.6 114.5 208.3 30.0 84.1 75.7 3.7 4.0 51.9 112.8 60.9 77.5 59.9 TCEAL9 "DKFZp313K1940, WBP5, WEX6" ENSG00000185222 "Transcription elongation factor A like 9" Q9UHQ7 X 103356489-103358462 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 939.8;Distal tubular cells: 305.1;Extravillous trophoblasts: 389.4;Syncytiotrophoblasts: 652.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 18.6" "Lineage enriched" "Detected in many" 5 "dendritic cells: 18.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011790 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA011790: AB_2214932" "unprognostic (1.26e-1)" "unprognostic (9.24e-2)" "unprognostic (3.35e-2)" "unprognostic (1.67e-3)" "unprognostic (5.52e-2)" "unprognostic (1.00e-3)" "unprognostic (1.31e-3)" "unprognostic (5.85e-2)" "unprognostic (7.64e-2)" "unprognostic (7.50e-3)" "unprognostic (1.59e-2)" "unprognostic (4.32e-2)" "unprognostic (1.10e-3)" "unprognostic (4.33e-3)" "unprognostic (1.26e-1)" "unprognostic (3.28e-2)" "unprognostic (2.58e-2)" 28.2 61.0 17.9 14.7 20.9 3.7 42.1 20.7 24.0 30.8 20.6 10.9 35.0 7.6 32.3 59.6 21.4 20.1 25.6 29.4 19.5 20.5 38.8 12.6 25.9 9.5 23.7 15.0 93.4 15.7 19.6 54.5 67.1 40.3 27.6 17.7 15.2 15.7 45.4 7.8 12.1 11.7 30.2 44.1 26.4 23.1 27.5 23.6 5.4 58.6 18.5 7.6 35.5 75.7 1.8 18.6 0.9 1.3 1.1 3.5 1.3 17.8 8.8 28.0 14.3 60.7 59.2 21.0 37.7 50.5 26.8 43.9 17.0 19.1 0.0 56.0 30.8 49.5 10.8 4.8 24.0 36.1 0.0 10.4 18.3 21.6 10.9 41.8 0.0 0.0 40.5 23.4 35.7 35.8 46.9 44.4 7.8 16.2 1.3 63.4 0.0 8.9 0.1 17.4 0.0 17.0 0.0 55.9 0.0 32.3 33.3 12.7 15.3 23.7 0.7 24.6 31.5 3.8 1.0 36.1 23.9 10.4 71.9 10.4 0.0 1.0 0.1 58.1 0.0 19.0 0.9 1.3 0.0 0.2 0.7 0.0 1.8 1.5 0.5 1.0 1.0 3.5 2.9 0.0 1.1 0.1 18.6 0.9 1.3 17.9 20.9 20.7 24.0 19.5 20.5 23.7 15.0 40.3 23.6 160.8 68.5 0.0 0.0 0.0 0.0 0.0 0.0 18.7 86.4 221.6 0.0 939.8 305.1 198.1 0.0 0.0 0.0 0.0 124.7 389.4 0.0 0.0 10.5 0.0 127.3 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 6.4 0.0 0.0 126.5 0.0 0.0 165.0 0.0 0.0 0.0 0.0 0.0 0.0 652.4 0.0 0.0 0.0 TCEANC2 "C1orf83, FLJ32112" ENSG00000116205 "Transcription elongation factor A N-terminal and central domain containing 2" Q96MN5 1 54053587-54112519 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 24.1;Early spermatids: 22.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046918 Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA046918: AB_2679864" "unprognostic (2.80e-1)" "unprognostic (6.19e-2)" "unprognostic (6.56e-3)" "unprognostic (2.34e-1)" "unprognostic (5.12e-3)" "unprognostic (1.35e-3)" "unprognostic (1.73e-5)" "unprognostic (8.64e-2)" "unprognostic (7.93e-3)" "unprognostic (6.59e-2)" "unprognostic (3.55e-1)" "unprognostic (3.52e-2)" "unprognostic (9.63e-2)" "unprognostic (2.26e-3)" "unprognostic (8.57e-2)" "unprognostic (7.51e-3)" "unprognostic (2.08e-1)" 5.9 5.9 7.9 7.6 11.1 6.5 5.9 3.0 7.9 6.1 5.4 13.4 6.6 6.8 5.3 6.2 7.9 5.2 4.4 4.4 8.3 6.4 7.2 4.7 4.8 9.4 10.2 4.5 4.3 6.4 6.6 6.2 6.0 8.8 5.1 8.1 6.5 5.5 4.1 9.4 6.8 6.4 6.3 14.1 8.2 5.2 15.4 8.8 15.7 5.7 3.0 10.8 7.3 5.1 7.8 7.6 10.1 8.9 10.2 6.3 3.8 5.2 2.3 5.9 4.9 4.0 6.3 5.7 5.6 4.3 6.3 5.6 1.4 3.3 4.6 4.9 2.4 6.3 5.3 7.8 4.3 8.0 10.2 4.2 6.8 5.5 2.7 2.5 5.0 6.9 4.7 3.7 5.5 3.2 2.8 8.1 10.6 6.7 4.3 5.2 1.9 10.0 3.7 13.7 5.8 3.9 10.0 10.8 6.8 2.3 3.1 5.1 5.4 3.6 5.6 6.7 8.7 5.5 9.5 4.2 5.7 3.6 5.5 6.8 10.0 14.3 6.4 4.8 6.9 7.1 5.9 7.3 10.1 4.7 8.9 4.6 7.3 5.4 5.8 7.6 7.8 6.3 6.2 9.4 10.2 6.5 6.9 4.1 3.8 7.9 11.1 3.0 7.9 8.3 6.4 10.2 4.5 8.8 8.8 8.9 9.1 0.8 1.5 0.6 3.0 7.5 10.2 24.1 7.9 10.4 11.8 4.9 1.7 2.9 22.3 4.4 3.3 0.0 1.6 5.2 3.1 1.7 2.3 4.0 4.2 7.9 3.5 2.5 6.3 18.0 2.8 3.7 1.7 6.4 4.4 3.1 3.2 3.5 2.8 3.4 3.1 0.0 2.5 12.7 2.6 0.9 3.3 5.1 4.4 1.4 TCERG1 "CA150, TAF2S, Urn1" ENSG00000113649 "Transcription elongation regulator 1" O14776 5 146447311-146511961 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064854, HPA069752, HPA069808" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA064854: AB_2685370, HPA069752: AB_2686190, HPA069808: AB_2686204" "unprognostic (2.73e-1)" "unprognostic (5.11e-2)" "unprognostic (1.27e-3)" "unprognostic (8.58e-2)" "unprognostic (1.32e-1)" "unprognostic (9.32e-2)" "prognostic unfavorable (5.34e-5)" "unprognostic (1.07e-1)" "unprognostic (3.38e-2)" "unprognostic (2.13e-2)" "unprognostic (2.41e-1)" "unprognostic (1.35e-3)" "prognostic unfavorable (4.70e-11)" "unprognostic (1.52e-2)" "unprognostic (7.76e-2)" "unprognostic (3.98e-2)" "unprognostic (1.24e-3)" 15.7 12.1 16.8 20.9 28.1 34.2 16.7 36.3 22.7 14.2 15.3 13.7 10.1 15.3 19.6 13.9 18.6 17.5 14.8 14.5 16.3 12.7 10.7 10.0 14.7 23.8 12.4 19.1 20.5 12.6 14.4 18.5 17.8 17.2 15.0 16.4 13.0 16.1 19.0 34.9 19.0 15.2 17.5 12.7 16.6 16.8 19.5 14.9 21.9 14.7 14.9 23.9 18.7 16.5 6.5 10.5 2.6 11.6 10.5 8.3 5.8 19.4 14.5 22.5 15.3 6.2 9.8 28.3 14.8 12.0 16.5 19.6 23.3 20.8 33.6 11.1 12.0 11.9 17.5 27.1 18.6 25.3 19.8 21.8 22.2 16.3 14.1 6.6 32.7 17.4 6.8 11.0 15.9 17.5 9.2 14.6 28.7 25.8 12.4 12.6 13.9 28.5 18.5 22.2 11.2 16.5 28.0 26.4 22.4 10.4 15.4 14.6 18.0 16.4 17.6 10.8 14.2 18.6 16.5 16.1 14.4 17.0 12.2 22.8 12.9 14.3 45.3 13.5 28.0 16.1 1.0 6.4 2.6 6.7 9.6 7.9 6.5 7.8 8.3 10.5 6.0 8.2 8.1 0.5 10.5 11.6 5.4 6.9 5.8 16.8 28.1 36.3 22.7 16.3 12.7 12.4 19.1 17.2 14.9 50.6 36.7 36.9 37.7 40.0 54.0 32.3 17.8 40.2 43.3 22.7 58.9 41.0 1.7 22.8 2.2 28.7 13.8 23.3 28.9 50.1 36.0 30.8 35.9 16.6 26.8 33.4 27.1 23.9 27.2 4.1 26.4 26.8 23.6 23.4 32.9 21.2 32.4 24.6 23.0 5.5 36.8 19.4 33.0 77.9 60.0 40.0 36.7 24.9 41.3 51.5 TCERG1L FLJ38950 ENSG00000176769 "Transcription elongation regulator 1 like" Q5VWI1 10 131092391-131311721 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.7;thyroid gland: 24.1" "Cell type enriched" "Detected in some" 10 "Horizontal cells: 96.9" "Cancer enriched" "Detected in some" 14 "thyroid cancer: 20.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 9.4;NTERA-2: 1.4;RPMI-8226: 2.2;SuSa: 4.3;U-2 OS: 2.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030816 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030816: AB_10601721" "unprognostic (6.61e-2)" "unprognostic (1.29e-1)" "unprognostic (8.99e-2)" "unprognostic (1.45e-2)" "unprognostic (3.03e-1)" "unprognostic (6.69e-2)" "unprognostic (1.62e-1)" "unprognostic (4.96e-1)" "unprognostic (9.71e-2)" "unprognostic (2.02e-1)" "unprognostic (5.01e-2)" "unprognostic (1.08e-5)" "unprognostic (1.28e-1)" "unprognostic (2.83e-1)" "unprognostic (2.96e-2)" "unprognostic (2.03e-1)" 0.4 1.9 2.7 0.4 4.1 0.4 0.6 3.0 9.7 0.5 0.4 0.0 0.0 0.4 0.6 1.1 0.6 0.4 0.4 0.4 3.8 3.5 0.4 0.4 0.5 0.4 0.9 3.9 5.5 0.8 0.4 4.8 0.4 1.5 1.4 0.4 3.8 0.3 1.3 0.3 1.2 0.4 0.4 2.2 0.6 0.5 1.8 0.0 0.6 24.1 0.0 0.6 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 4.3 0.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 2.7 4.1 3.0 9.7 3.8 3.5 0.9 3.9 1.5 0.0 0.0 0.0 0.0 0.1 0.6 4.5 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.6 0.0 0.0 0.0 96.9 0.0 0.0 0.0 0.0 4.4 0.0 10.1 0.0 0.0 0.8 0.1 0.0 4.2 0.0 3.6 0.0 0.0 0.1 4.7 0.5 0.1 0.0 0.0 0.0 TCF12 "bHLHb20, HEB, HsT17266, HTF4" ENSG00000140262 "Transcription factor 12" Q99081 15 56918623-57299281 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 89.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004432, HPA065827" Approved Supported "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "CAB004432: AB_671267, HPA065827: AB_2685564" "unprognostic (1.19e-1)" "unprognostic (1.11e-1)" "unprognostic (8.26e-2)" "unprognostic (1.65e-1)" "unprognostic (2.07e-3)" "unprognostic (1.11e-1)" "unprognostic (6.63e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (8.89e-4)" "unprognostic (7.83e-2)" "unprognostic (7.26e-3)" "unprognostic (5.57e-3)" "prognostic unfavorable (5.24e-5)" "unprognostic (2.03e-1)" "unprognostic (2.93e-1)" "unprognostic (3.15e-2)" "unprognostic (1.41e-1)" 20.9 14.3 24.9 12.6 37.5 10.9 18.4 32.7 41.8 48.2 16.5 33.6 14.0 16.0 28.1 15.0 14.8 28.2 21.4 15.7 28.4 16.4 17.0 14.4 17.3 13.7 33.9 15.3 26.2 12.5 29.2 15.7 19.1 27.9 26.3 17.9 14.7 20.1 17.5 18.1 16.0 15.8 25.8 25.3 13.6 17.3 14.7 41.3 89.4 17.0 9.6 15.8 23.3 21.2 11.8 15.9 16.0 19.3 12.2 17.6 10.2 6.5 12.3 54.1 17.4 24.7 21.7 9.5 13.5 23.7 12.0 15.9 7.9 5.3 9.0 11.1 20.4 8.6 7.9 21.1 9.7 15.3 11.8 7.9 18.0 13.3 9.5 17.0 11.3 9.5 19.0 17.6 11.0 29.2 16.0 21.4 40.5 20.1 11.3 16.2 2.2 26.7 6.3 14.6 6.8 5.3 36.5 62.8 8.4 16.5 12.2 11.0 32.0 14.5 5.3 13.1 18.0 8.2 22.3 16.4 19.3 14.8 8.2 19.6 6.5 11.6 15.0 10.8 22.1 23.1 16.0 11.2 8.7 15.0 14.3 12.4 10.8 12.2 13.6 15.9 11.8 14.1 12.7 1.3 12.2 19.3 6.6 17.6 10.2 24.9 37.5 32.7 26.9 28.4 16.4 33.9 15.3 27.9 41.3 50.6 15.8 14.2 18.0 23.7 12.8 14.5 20.4 16.0 27.3 15.7 33.4 8.5 11.6 15.2 19.4 27.4 15.8 0.0 10.3 12.7 31.5 19.7 22.0 16.0 23.5 12.7 8.6 22.7 34.0 15.6 23.9 26.0 13.5 10.0 16.5 26.9 13.8 17.5 32.5 13.6 25.1 45.3 20.6 18.9 12.5 29.5 10.9 16.0 16.4 15.6 TCF19 SC1 ENSG00000137310 "Transcription factor 19" Q9Y242 6 31158542-31167159 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.3" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 12.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 33.2;GAMG: 19.8;HEK 293: 18.7;JURKAT: 17.0;Karpas-707: 16.2;SCLC-21H: 20.6;U-138 MG: 20.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA065994 Approved Nucleoplasm,Nucleoli NA Yes Nucleoplasm Nucleoli "HPA065994: " "unprognostic (1.41e-2)" "unprognostic (4.92e-2)" "unprognostic (4.00e-2)" "unprognostic (5.16e-3)" "unprognostic (1.99e-2)" "unprognostic (6.04e-2)" "prognostic unfavorable (5.66e-4)" "unprognostic (7.04e-2)" "unprognostic (1.35e-2)" "unprognostic (5.92e-2)" "unprognostic (1.74e-3)" "unprognostic (1.56e-2)" "prognostic unfavorable (3.54e-10)" "unprognostic (3.11e-2)" "unprognostic (1.05e-1)" "unprognostic (1.36e-2)" "unprognostic (1.21e-1)" 4.3 1.5 1.3 12.4 4.1 2.3 5.2 8.2 3.9 7.0 5.6 2.3 3.7 9.2 4.2 6.2 11.2 3.2 3.8 3.4 1.7 1.1 4.3 1.6 4.8 18.0 3.0 1.0 4.6 3.6 0.4 0.9 1.5 2.0 5.5 4.0 2.3 4.1 6.7 2.5 11.5 6.0 3.9 1.8 8.6 5.9 3.1 1.8 31.3 2.8 14.4 13.8 4.8 6.7 2.0 0.9 0.2 0.3 1.2 3.8 1.2 33.2 0.3 0.3 0.0 2.3 3.0 0.3 0.2 0.0 0.0 0.0 2.1 0.0 0.0 7.5 8.2 19.8 0.0 0.0 12.4 0.0 0.2 18.7 2.9 1.9 0.8 0.0 0.1 8.8 1.2 0.0 0.9 0.0 1.8 7.4 17.0 0.0 16.2 3.2 0.1 0.4 5.3 0.0 0.0 0.0 0.4 2.0 0.2 2.9 0.1 20.6 0.2 0.2 0.0 0.2 2.7 0.0 2.4 0.0 20.6 0.1 0.1 0.1 5.3 6.0 10.2 0.0 0.1 0.1 0.0 0.3 0.0 0.7 0.0 3.8 1.6 1.9 3.4 0.9 2.0 2.4 0.9 0.2 1.2 0.1 0.0 2.6 1.2 1.3 4.1 8.2 3.9 1.7 1.1 3.0 1.0 2.0 1.8 3.0 1.1 6.0 2.1 4.5 2.6 1.2 0.0 0.0 3.4 3.5 0.0 0.6 6.6 1.6 0.3 3.3 1.1 0.0 1.6 7.2 2.7 1.0 1.1 0.2 7.5 1.6 1.2 1.3 1.9 0.4 4.6 4.3 11.8 10.0 3.3 3.3 0.8 0.0 6.0 0.3 0.5 0.0 6.8 0.5 12.8 3.3 0.3 5.1 7.7 0.9 TCF20 "AR1, SPBP" ENSG00000100207 "Transcription factor 20" Q9UGU0 22 42160013-42343616 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 5 "Early spermatids: 125.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017849, HPA036786" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "CAB017849: , HPA036786: AB_2675313" "unprognostic (2.17e-1)" "unprognostic (2.12e-2)" "prognostic favorable (1.88e-4)" "unprognostic (2.19e-2)" "unprognostic (1.19e-1)" "unprognostic (2.69e-2)" "prognostic unfavorable (4.89e-4)" "unprognostic (1.77e-1)" "unprognostic (2.36e-1)" "unprognostic (1.40e-2)" "unprognostic (2.16e-3)" "unprognostic (7.30e-2)" "unprognostic (1.17e-3)" "unprognostic (3.07e-3)" "unprognostic (4.94e-1)" "unprognostic (2.52e-1)" "unprognostic (1.92e-1)" 4.1 4.3 10.2 5.5 16.4 5.4 4.6 6.6 17.1 5.4 5.6 22.6 4.4 5.7 6.1 4.3 10.9 5.6 4.2 2.7 7.3 5.4 4.9 4.6 4.7 6.5 14.7 14.6 5.7 6.7 6.9 10.2 4.3 10.5 4.4 6.1 9.9 6.5 4.2 3.1 8.5 6.4 4.6 5.8 5.5 6.0 9.3 12.2 3.5 9.2 2.3 7.5 5.5 6.8 0.3 0.3 0.9 0.3 0.0 0.5 0.0 6.4 3.7 5.5 5.0 2.9 2.7 5.7 3.0 3.5 3.5 4.6 5.4 2.7 10.8 2.7 2.6 5.0 6.5 5.4 6.0 4.4 7.7 4.3 3.1 3.9 3.6 3.1 7.1 4.2 2.4 6.0 3.9 7.7 2.6 2.6 4.2 4.6 5.7 1.9 5.8 7.2 3.9 4.1 5.7 3.0 4.1 3.1 5.7 3.5 6.0 5.5 2.3 5.1 4.9 5.0 5.4 2.6 4.4 3.2 4.4 7.1 2.6 3.3 4.6 5.6 5.5 2.7 4.4 3.0 0.0 0.1 0.0 0.4 0.0 0.4 0.2 0.5 0.1 0.0 0.3 0.5 0.4 0.9 0.0 0.3 0.3 0.3 0.0 10.2 16.4 6.6 17.1 7.3 5.4 14.7 14.6 10.5 12.2 0.0 8.1 6.5 9.2 20.0 23.2 5.2 12.7 9.4 5.7 8.7 17.7 5.9 0.0 9.9 125.1 8.3 11.7 0.0 6.6 4.6 8.2 12.2 1.1 11.9 5.4 9.5 16.1 8.0 6.6 27.6 11.5 6.9 6.8 10.0 13.1 5.1 11.5 14.0 6.0 5.6 11.9 6.5 5.1 17.2 13.4 19.9 3.8 11.4 17.9 14.1 TCF3 "bHLHb21, E2A, E47, ITF1, MGC129647, MGC129648, VDIR" ENSG00000071564 "Transcription factor 3" P15923 19 1609290-1652605 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 76.6;REH: 76.2;U-698: 96.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018351, HPA049808, HPA062476" Approved Enhanced Nucleoplasm No No Nucleoplasm "CAB018351: AB_675504, HPA049808: AB_2680892, HPA062476: AB_2684775" "unprognostic (8.82e-2)" "unprognostic (4.74e-2)" "unprognostic (1.26e-2)" "unprognostic (1.25e-1)" "unprognostic (1.91e-2)" "unprognostic (8.25e-3)" "prognostic unfavorable (2.46e-4)" "unprognostic (2.07e-2)" "unprognostic (7.99e-2)" "unprognostic (2.35e-1)" "unprognostic (2.42e-1)" "unprognostic (9.29e-3)" "prognostic unfavorable (1.53e-4)" "unprognostic (4.87e-3)" "unprognostic (1.88e-1)" "unprognostic (3.07e-1)" "unprognostic (8.05e-2)" 13.0 8.8 12.8 31.6 9.8 33.2 17.4 8.3 11.9 15.5 16.2 11.9 9.4 18.1 16.6 11.3 16.7 12.1 19.0 9.4 11.2 6.2 11.9 8.9 13.2 42.0 10.7 6.0 18.2 13.5 6.3 13.9 10.8 11.0 17.1 9.7 12.4 13.6 6.9 11.2 16.7 23.0 8.8 10.4 33.1 14.9 36.0 11.2 63.2 15.9 11.6 38.0 15.2 13.9 11.3 12.1 2.9 2.8 2.3 4.2 1.6 15.9 8.2 22.6 20.3 3.2 8.6 10.1 9.9 7.8 11.4 10.1 16.2 12.6 76.6 11.3 8.1 2.1 16.6 13.8 10.8 6.7 46.4 9.2 7.2 10.3 17.6 7.4 17.6 10.1 5.5 12.5 8.9 6.9 10.2 13.7 28.5 29.6 26.6 7.2 28.2 48.6 17.1 31.4 9.7 8.6 76.2 10.4 17.3 7.7 14.1 21.6 30.3 9.4 9.3 11.5 8.8 11.8 31.4 16.4 15.0 17.8 18.5 16.9 64.8 31.6 96.6 9.8 22.5 13.4 2.9 1.3 0.9 3.5 1.4 3.7 10.8 2.2 3.2 2.7 11.3 3.2 4.2 0.4 2.3 2.8 12.1 2.1 1.6 12.8 9.8 8.3 11.9 11.2 6.2 10.7 6.0 11.0 11.2 6.0 7.8 26.7 4.5 12.4 10.7 8.9 2.5 0.0 10.3 1.8 25.5 3.4 1.7 9.4 6.7 9.5 13.5 0.0 5.9 7.4 11.5 8.0 6.9 3.9 6.7 4.8 15.5 8.6 7.2 3.9 12.7 6.5 10.1 5.4 13.0 9.0 14.7 14.0 9.6 4.5 13.6 19.4 10.5 3.7 15.8 11.5 2.4 8.6 18.4 6.7 TCF4 "bHLHb19, E2-2, ITF2, SEF2-1B" ENSG00000196628 "Transcription factor 4" P15884 18 55222331-55664787 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding" "Corneal dystrophy, Disease mutation, Epilepsy, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 85.8" "Cell type enhanced" "Detected in many" 6 "Endothelial cells: 425.9;Muller glia cells: 397.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 14 "memory B-cell: 29.7;naive B-cell: 22.0;plasmacytoid DC: 85.8" "Group enriched" "Detected in many" 36 "B-cells: 29.7;dendritic cells: 85.8" "Cell line enhanced" "Detected in many" "HDLM-2: 42.4;SH-SY5Y: 53.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020722, HPA025958" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB020722: , HPA025958: AB_1857849" "unprognostic (2.11e-1)" "unprognostic (9.10e-2)" "unprognostic (8.69e-2)" "unprognostic (7.89e-3)" "unprognostic (1.42e-1)" "unprognostic (1.36e-3)" "unprognostic (3.03e-2)" "unprognostic (8.64e-2)" "unprognostic (1.79e-2)" "unprognostic (3.29e-2)" "unprognostic (2.77e-1)" "unprognostic (8.44e-2)" "prognostic unfavorable (7.24e-5)" "unprognostic (1.99e-3)" "unprognostic (2.68e-2)" "unprognostic (2.76e-3)" "prognostic unfavorable (9.95e-4)" 34.6 16.0 20.3 14.4 17.0 10.7 23.5 48.7 32.4 35.4 13.5 14.9 12.0 6.6 27.4 9.6 12.5 16.9 20.4 19.9 23.5 11.9 6.0 6.2 21.9 16.8 16.7 20.3 31.8 7.2 16.2 15.7 32.8 16.1 9.5 10.1 9.2 9.4 13.2 12.1 12.2 10.7 28.4 15.0 14.6 7.4 17.0 17.5 6.4 16.4 12.7 17.0 18.3 14.5 29.7 85.8 0.3 1.2 1.5 0.1 1.7 0.0 1.1 12.0 3.6 2.8 5.0 0.0 6.0 13.4 4.3 5.7 7.4 1.1 9.2 0.0 13.3 0.9 1.5 5.5 5.3 3.0 42.4 4.1 3.6 0.0 0.0 1.3 1.6 0.9 6.5 1.7 6.0 0.2 2.9 15.6 0.5 5.9 6.9 3.7 0.0 2.2 0.0 3.5 0.0 0.7 13.5 5.0 20.5 0.0 0.2 4.2 53.7 0.0 0.5 0.0 3.8 0.5 0.4 15.7 16.3 5.7 0.6 4.7 5.2 9.7 8.2 3.6 1.6 4.7 0.1 1.1 0.1 0.1 1.2 0.1 29.7 0.0 0.0 3.3 22.0 0.0 0.0 0.3 1.5 1.1 85.8 0.1 1.7 20.3 17.0 48.7 26.9 23.5 11.9 16.7 20.3 16.1 17.5 6.0 19.1 128.9 31.3 103.9 238.0 27.8 2.5 30.8 38.7 21.0 78.5 1.9 0.0 1.2 78.3 425.9 0.0 0.0 6.2 1.2 151.6 15.4 12.8 4.4 33.4 23.8 5.2 251.0 98.7 90.2 190.1 63.0 60.8 33.3 0.0 397.9 3.2 0.0 171.1 1.7 54.4 232.8 142.8 6.7 4.4 73.8 2.2 1.9 0.0 10.9 TCF7 TCF-1 ENSG00000081059 "Transcription factor 7" P36402 5 134114711-134151865 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "lymphoid tissue: 326.1" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 68.7;Rod photoreceptor cells: 53.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "MAIT T-cell: 10.3;memory CD4 T-cell: 17.8;memory CD8 T-cell: 10.4;naive CD4 T-cell: 35.8;naive CD8 T-cell: 21.8;NK-cell: 14.2" "Group enriched" "Detected in many" 19 "NK-cells: 14.2;T-cells: 35.8" "Cell line enriched" "Detected in many" 6 "MOLT-4: 170.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "CAB019403, HPA058863, HPA070505" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB019403: AB_2199302, HPA058863: AB_2683837, HPA070505: AB_2686275" "unprognostic (3.63e-3)" "unprognostic (1.98e-3)" "unprognostic (1.03e-1)" "unprognostic (5.08e-3)" "unprognostic (1.70e-1)" "unprognostic (6.74e-2)" "unprognostic (1.12e-1)" "unprognostic (6.38e-2)" "unprognostic (2.31e-1)" "unprognostic (1.65e-1)" "unprognostic (5.35e-2)" "unprognostic (2.32e-1)" "unprognostic (3.04e-1)" "unprognostic (1.50e-2)" "unprognostic (2.33e-2)" "unprognostic (1.90e-1)" "unprognostic (4.10e-2)" 1.8 3.6 1.3 21.8 1.5 5.2 3.1 0.9 1.2 2.1 3.3 2.5 2.2 5.6 1.4 16.3 2.7 16.1 2.6 1.6 1.5 1.2 2.7 3.7 4.0 41.8 1.3 1.0 2.5 7.2 0.2 6.1 1.4 4.7 2.9 2.3 3.6 7.9 1.8 0.9 2.9 15.1 0.9 3.3 14.4 3.7 2.4 1.1 326.1 4.4 2.2 32.5 3.3 1.5 1.2 0.1 1.0 0.1 14.2 35.8 6.9 0.0 1.0 1.1 3.9 0.5 2.1 1.5 0.3 0.5 0.1 0.1 8.0 2.5 0.0 1.9 1.7 4.3 0.1 1.7 0.4 0.0 0.3 1.7 0.0 1.1 6.0 0.0 0.0 0.2 0.1 0.0 1.6 0.0 0.7 0.2 29.0 1.0 0.0 0.1 0.0 170.0 0.1 1.2 2.5 1.4 0.2 0.0 0.1 0.4 0.1 0.4 3.4 0.8 0.2 0.2 0.9 0.2 0.9 0.2 11.0 0.0 5.0 0.3 0.1 0.0 0.0 5.8 0.0 0.5 0.7 0.1 1.0 4.4 0.0 10.3 1.2 17.8 10.4 0.0 0.4 35.8 21.8 0.7 14.2 0.0 0.1 2.1 6.9 1.3 1.5 0.9 1.2 1.5 1.2 1.3 1.0 4.7 1.1 3.0 3.4 22.9 24.6 14.0 27.8 2.7 10.2 1.4 0.0 3.5 68.7 20.0 0.0 5.8 2.4 4.7 21.4 0.0 8.9 23.4 10.8 11.6 20.7 3.2 6.4 9.5 12.1 6.7 5.2 1.7 5.8 4.9 10.1 9.0 12.7 8.3 15.8 17.3 4.2 0.8 53.0 0.0 16.9 3.9 9.4 9.9 25.1 47.5 14.4 12.3 TCF7L1 TCF3 ENSG00000152284 "Transcription factor 7 like 1" Q9HCS4 2 85133410-85310388 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 37.8;Ito cells: 37.4;Leydig cells: 60.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 18.2;NTERA-2: 42.5;RH-30: 19.3;T-47d: 18.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071298 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA071298: AB_2686383" "unprognostic (1.59e-1)" "unprognostic (1.86e-1)" "unprognostic (3.64e-3)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.05e-2)" "unprognostic (1.17e-1)" "prognostic unfavorable (6.16e-5)" "unprognostic (1.79e-2)" "unprognostic (3.59e-3)" "unprognostic (2.73e-1)" "unprognostic (5.17e-3)" "unprognostic (1.69e-1)" "prognostic unfavorable (2.06e-4)" "prognostic unfavorable (2.72e-4)" "unprognostic (1.70e-1)" "unprognostic (3.52e-2)" "prognostic unfavorable (5.38e-4)" 21.0 3.9 3.3 6.5 6.4 4.2 28.7 5.1 5.3 28.2 14.7 7.5 14.5 4.1 21.2 11.8 13.8 10.4 9.1 11.6 6.0 3.0 9.3 7.6 11.1 5.5 4.5 3.8 20.3 3.2 11.6 5.7 4.8 6.3 14.0 4.3 16.8 8.8 19.6 13.4 8.3 6.9 17.8 5.9 7.9 6.8 7.3 5.5 2.2 18.6 8.7 6.1 18.0 20.4 3.7 2.0 8.4 1.2 1.8 2.2 0.4 0.9 0.7 14.5 11.0 5.5 1.1 8.8 1.0 3.6 2.5 2.3 2.1 0.9 0.4 1.7 2.3 2.8 2.3 11.0 18.2 1.7 0.8 1.8 0.3 0.8 0.9 0.5 0.8 2.2 0.9 3.4 0.2 0.6 1.2 4.8 0.7 0.3 0.8 2.9 0.6 0.0 0.8 42.5 0.5 0.4 0.3 19.3 0.2 1.2 1.6 0.5 4.5 1.7 7.4 0.5 11.7 18.9 0.3 5.2 2.8 4.2 0.2 1.3 0.5 0.2 0.3 0.1 0.5 2.2 8.4 1.2 2.2 1.2 1.0 1.5 2.1 1.4 1.6 0.4 3.7 1.7 2.2 3.4 1.8 1.0 2.0 1.1 0.4 3.3 6.4 5.1 4.0 6.0 3.0 4.5 3.8 6.3 5.5 6.0 37.8 0.0 11.9 5.4 0.0 6.2 5.1 9.4 11.4 15.7 0.0 5.3 0.0 3.0 22.5 21.0 0.7 0.0 5.0 4.0 12.1 7.6 4.7 5.9 1.5 0.0 0.0 37.4 6.6 3.6 60.4 2.8 3.3 1.8 1.7 5.2 1.3 0.0 26.9 1.4 0.2 6.5 18.1 1.9 10.9 3.0 1.1 0.5 1.2 2.2 TCF7L2 "TCF-4, TCF4" ENSG00000148737 "Transcription factor 7 like 2" Q9NQB0 10 112950250-113167678 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 184.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "intermediate monocyte: 12.1;non-classical monocyte: 33.1" "Lineage enriched" "Detected in many" 13 "monocytes: 33.1" "Low cell line specificity" "Detected in many" "Group enriched" "Detected in many" 8 "midbrain: 84.5;thalamus: 98.3" "Group enriched" "Detected in all" 5 "midbrain: 190.1;pons and medulla: 104.8;thalamus: 169.1" "CAB013535, HPA038800" Supported Approved "Nucleoplasm,Nuclear bodies,Cytosol" Yes No Nucleoplasm "Nuclear bodies, Cytosol" "CAB013535: AB_2533167, HPA038800: " "unprognostic (1.79e-2)" "unprognostic (3.36e-1)" "unprognostic (1.11e-1)" "unprognostic (2.31e-2)" "unprognostic (4.59e-3)" "unprognostic (1.72e-1)" "unprognostic (2.09e-1)" "unprognostic (9.84e-2)" "unprognostic (5.09e-1)" "unprognostic (7.10e-2)" "unprognostic (6.10e-3)" "unprognostic (3.46e-2)" "unprognostic (7.25e-3)" "unprognostic (1.60e-1)" "unprognostic (1.55e-1)" "unprognostic (3.64e-1)" "unprognostic (7.36e-3)" 27.4 10.3 8.7 18.7 10.0 7.3 46.4 5.4 10.3 27.4 34.2 15.4 28.1 21.0 26.6 14.9 12.6 18.2 15.3 13.5 8.1 17.9 10.2 22.9 26.9 13.9 8.5 9.0 25.6 13.9 16.5 17.9 24.0 10.2 14.4 23.7 13.9 14.9 52.8 13.7 17.6 40.4 18.0 13.9 27.3 24.0 10.6 10.1 6.6 14.3 9.3 7.0 21.5 16.3 0.0 1.7 2.5 33.1 0.0 0.6 1.1 7.1 18.6 20.4 19.7 10.7 7.1 24.4 5.1 9.9 3.5 4.3 12.3 21.6 0.0 5.7 9.5 4.8 5.1 6.9 8.8 4.5 0.8 6.4 5.0 12.4 11.3 11.4 1.9 1.8 12.6 3.2 5.5 9.4 15.1 5.9 4.2 5.2 0.3 4.1 13.9 3.2 1.2 14.6 8.0 10.7 9.0 15.0 3.2 7.7 9.9 0.4 6.3 7.7 7.6 8.1 16.5 4.9 1.1 13.7 3.3 9.6 8.5 10.4 1.3 0.1 0.1 3.3 4.2 7.4 0.1 1.8 0.1 0.6 12.1 0.4 0.0 0.1 0.5 1.7 0.0 0.1 0.3 2.5 0.0 33.1 0.0 0.0 1.1 8.7 10.0 5.4 10.3 8.1 17.9 8.5 9.0 10.2 10.1 20.8 21.6 4.7 23.8 37.8 2.4 10.6 35.7 20.1 34.2 38.4 5.9 36.9 10.0 28.5 5.5 37.0 121.0 0.0 38.6 184.2 40.4 33.1 0.0 57.7 15.1 4.8 19.0 55.3 68.7 2.7 54.7 21.0 30.4 1.0 68.2 36.6 41.7 91.2 45.6 13.4 5.7 90.5 44.3 3.0 23.4 34.8 23.8 4.3 42.7 42.0 TCFL5 "bHLHe82, CHA, E2BP-1, Figlb" ENSG00000101190 "Transcription factor like 5" Q9UL49 20 62841115-62861763 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 32.9;testis: 55.7" "Cell type enriched" "Detected in many" 5 "Spermatocytes: 62.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055223, HPA076419" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA055223: AB_2682745, HPA076419: " "unprognostic (4.05e-2)" "unprognostic (3.14e-1)" "unprognostic (2.19e-1)" "prognostic unfavorable (3.24e-4)" "unprognostic (2.78e-1)" "unprognostic (2.72e-3)" "unprognostic (3.95e-2)" "unprognostic (1.09e-1)" "unprognostic (2.10e-1)" "unprognostic (2.79e-1)" "unprognostic (1.14e-1)" "unprognostic (3.88e-1)" "unprognostic (1.54e-1)" "unprognostic (9.77e-2)" "unprognostic (4.89e-1)" "unprognostic (1.33e-3)" "unprognostic (1.01e-2)" 5.4 3.9 18.6 4.0 18.9 3.7 6.4 4.6 14.8 6.5 4.1 22.5 6.1 3.2 5.7 6.6 6.0 5.9 5.0 5.5 20.0 15.5 5.0 4.6 3.6 4.7 25.4 10.7 8.3 4.8 7.5 3.0 4.8 17.0 4.9 3.8 6.3 4.9 6.3 4.5 10.9 3.5 5.5 32.9 4.1 3.7 55.7 12.0 8.3 14.9 2.1 5.0 4.6 3.2 1.4 1.9 2.9 1.6 1.2 3.2 0.7 12.9 3.9 8.6 9.9 18.6 18.9 7.7 8.4 11.7 16.4 9.2 9.5 8.0 6.6 9.7 7.4 8.8 14.3 8.6 9.5 14.4 4.6 7.2 5.4 11.2 14.0 7.3 7.9 6.6 6.9 14.2 4.6 9.7 7.1 7.4 10.2 6.0 2.5 7.6 15.7 34.7 10.0 5.6 10.8 12.4 19.2 15.1 9.2 4.4 3.8 12.4 6.7 14.9 6.1 22.7 6.3 10.4 14.8 7.9 13.1 8.6 11.4 9.8 6.4 4.3 5.5 7.9 9.9 7.1 0.5 1.6 2.9 3.2 1.5 1.9 1.3 2.3 2.1 1.2 1.4 2.5 1.7 2.8 1.2 1.5 1.9 2.3 0.7 18.6 18.9 4.6 14.8 20.0 15.5 25.4 10.7 17.0 12.0 0.0 1.0 0.0 1.2 9.3 9.2 3.6 2.5 0.0 1.2 7.0 5.9 0.5 1.7 1.2 11.4 3.6 1.4 0.0 1.1 0.8 3.1 1.4 0.0 2.9 0.9 7.9 2.4 3.1 4.4 5.9 7.2 1.7 3.3 1.0 2.4 9.7 0.8 1.9 6.7 1.7 6.7 0.0 2.1 62.7 8.4 12.4 0.2 1.0 2.6 0.9 TCIM "C8orf4, hTC-1, TC-1, TC1" ENSG00000176907 "Transcriptional and immune response regulator" Q9NR00 8 40153455-40155308 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 21 "Alveolar cells type 2: 796.6;Collecting duct cells: 190.1;Distal tubular cells: 164.2;Ductal cells: 262.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 14.6;AF22: 41.5;BJ: 15.6;BJ hTERT+: 40.9;EFO-21: 27.2;HeLa: 26.1;RPTEC TERT1: 20.7;SuSa: 16.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027188 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA027188: AB_10601150" "unprognostic (8.88e-2)" "unprognostic (2.76e-2)" "unprognostic (7.89e-3)" "unprognostic (7.95e-2)" "unprognostic (7.33e-3)" "unprognostic (1.87e-3)" "unprognostic (2.11e-1)" "unprognostic (2.32e-1)" "unprognostic (2.93e-2)" "unprognostic (8.15e-2)" "unprognostic (6.23e-2)" "unprognostic (8.19e-2)" "unprognostic (2.54e-2)" "unprognostic (5.32e-3)" "unprognostic (1.39e-1)" "unprognostic (9.13e-3)" "unprognostic (4.48e-2)" 23.5 5.9 1.8 23.2 4.5 0.0 16.0 0.6 5.9 32.1 24.1 1.0 15.6 6.0 14.3 20.3 22.2 4.3 22.1 38.3 2.0 1.7 44.5 54.7 96.5 5.0 2.7 4.3 11.9 24.4 28.9 6.2 50.2 2.3 29.6 15.2 7.9 89.9 16.3 20.2 4.0 21.2 72.4 4.3 26.7 10.7 4.9 1.4 1.3 15.8 14.4 4.8 35.8 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 41.5 0.0 0.0 0.0 0.1 15.6 40.9 0.0 0.2 0.2 0.0 0.0 27.2 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 26.1 6.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.0 0.0 1.4 0.0 16.3 0.0 0.0 13.1 0.0 0.4 0.1 0.2 0.3 0.4 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 4.5 0.6 5.9 2.0 1.7 2.7 4.3 2.3 1.4 92.3 796.6 0.0 0.0 0.0 0.0 0.0 0.0 16.0 142.1 190.1 0.0 1.4 164.2 262.6 0.0 0.0 0.0 0.0 95.4 11.4 0.0 0.0 24.4 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 8.2 0.0 0.0 112.8 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 TCL1A TCL1 ENSG00000100721 "T cell leukemia/lymphoma 1A" P56279 14 95709967-95714196 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "blood: 179.4;lymphoid tissue: 63.7" "Group enriched" "Detected in some" 5 "B-cells: 166.3;Spermatogonia: 48.5" "Cancer enriched" "Detected in many" 18 "testis cancer: 64.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 381 "memory B-cell: 45.6;naive B-cell: 179.4;plasmacytoid DC: 79.8" "Group enriched" "Detected in many" 487 "B-cells: 179.4;dendritic cells: 79.8" "Group enriched" "Detected in some" 157 "Daudi: 71.1;REH: 92.4;U-698: 94.4" "Not detected" "Not detected" "CAB004045, HPA016604" Enhanced Enhanced "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoplasm "CAB004045: AB_2179419, HPA016604: AB_1857859" "unprognostic (1.27e-3)" "unprognostic (3.12e-4)" "unprognostic (2.61e-4)" "unprognostic (2.01e-2)" "unprognostic (1.27e-1)" "unprognostic (4.75e-4)" "unprognostic (7.70e-2)" "unprognostic (9.67e-3)" "unprognostic (1.03e-1)" "unprognostic (3.35e-1)" "unprognostic (1.14e-1)" "unprognostic (2.14e-2)" "unprognostic (2.64e-2)" "unprognostic (1.87e-1)" "unprognostic (3.94e-1)" "unprognostic (2.06e-1)" "unprognostic (4.55e-1)" 0.4 0.2 0.2 53.4 0.2 4.8 0.3 0.2 0.2 0.2 0.9 0.0 0.2 0.0 0.3 0.0 0.8 0.3 0.6 0.3 0.2 0.2 1.1 0.4 3.2 63.7 0.2 0.0 0.3 0.2 0.0 0.2 0.6 0.0 0.4 0.2 0.1 2.9 0.0 0.2 0.2 10.4 0.1 0.2 33.5 0.5 5.3 0.0 4.7 0.8 1.2 53.6 3.6 0.3 179.4 79.8 0.2 0.1 0.0 0.1 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.5 94.4 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 45.6 0.0 0.0 0.1 179.4 0.1 0.0 0.2 0.0 0.1 79.8 0.0 6.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 2.2 166.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 20.6 48.5 0.0 0.0 0.0 0.0 0.0 TCTN1 "FLJ21127, JBTS13, TECT1" ENSG00000204852 "Tectonic family member 1" Q2MV58 12 110614027-110649430 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein" "Ciliopathy, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 186.0;Spermatocytes: 102.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 29.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039687, HPA040036" Approved Approved "Nucleoplasm,Actin filaments" "Intracellular and membrane" NA NA "Nucleoplasm, Actin filaments" "HPA039687: AB_10795293, HPA040036: AB_10794759" "unprognostic (2.54e-1)" "unprognostic (7.22e-3)" "unprognostic (2.28e-1)" "prognostic favorable (1.13e-5)" "unprognostic (2.89e-2)" "unprognostic (6.53e-2)" "unprognostic (2.11e-1)" "unprognostic (3.05e-2)" "unprognostic (6.02e-2)" "unprognostic (4.54e-2)" "unprognostic (5.20e-3)" "unprognostic (9.60e-2)" "unprognostic (9.97e-2)" "unprognostic (2.15e-2)" "unprognostic (8.41e-2)" "unprognostic (1.24e-1)" "unprognostic (4.27e-2)" 8.0 12.4 11.2 5.1 13.8 3.0 8.9 5.6 10.1 17.7 5.4 12.3 20.6 4.1 10.3 28.7 5.4 35.4 12.3 14.4 11.0 13.0 16.1 7.2 11.6 5.5 11.0 5.3 15.5 9.1 24.1 32.9 8.4 22.1 14.5 4.0 16.3 10.2 20.6 8.0 5.3 4.1 10.3 8.9 6.0 7.2 24.7 8.0 4.4 25.5 3.9 5.2 8.8 12.2 13.7 5.0 8.4 3.5 1.1 2.9 1.9 6.9 8.8 6.2 16.9 17.7 15.4 3.1 4.9 10.2 4.6 4.0 2.0 2.1 1.4 4.4 12.2 4.5 4.9 3.6 3.7 3.3 3.0 5.7 0.4 3.6 4.2 8.4 0.7 0.7 9.6 5.7 6.0 7.3 29.2 3.3 2.2 4.8 2.9 5.6 10.1 0.5 2.4 3.0 3.7 11.8 1.7 3.3 9.9 14.1 1.6 5.3 7.0 8.5 2.0 4.1 4.8 14.2 8.0 3.6 7.9 2.0 2.8 4.2 2.8 1.3 1.9 7.9 0.7 6.3 0.3 2.4 0.4 1.3 3.5 2.9 6.3 1.9 2.7 3.7 13.7 2.9 2.4 8.4 1.1 2.0 5.0 0.6 1.9 11.2 13.8 5.6 10.1 11.0 13.0 11.0 5.3 22.1 8.0 3.0 13.1 7.7 24.6 12.2 10.1 10.2 22.9 186.0 23.9 15.7 29.5 22.5 8.3 18.4 56.3 9.8 0.4 0.0 4.2 7.8 27.9 22.4 3.5 6.8 10.3 3.2 17.3 8.6 3.2 9.5 15.8 7.6 21.9 1.0 5.6 27.8 5.2 0.0 26.9 32.2 30.2 6.5 15.6 102.1 36.2 9.8 15.3 2.2 3.9 12.4 TDG ENSG00000139372 "Thymine DNA glycosylase" Q13569 12 103965804-103988874 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, Chromatin regulator, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052263 Supported Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA052263: AB_2681777" "unprognostic (3.15e-1)" "unprognostic (1.36e-1)" "unprognostic (9.89e-3)" "unprognostic (6.93e-2)" "unprognostic (3.66e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (6.27e-5)" "unprognostic (1.56e-2)" "prognostic unfavorable (6.90e-5)" "unprognostic (5.37e-2)" "unprognostic (1.82e-1)" "unprognostic (8.48e-2)" "prognostic unfavorable (1.90e-10)" "unprognostic (3.68e-1)" "unprognostic (2.90e-1)" "unprognostic (1.11e-1)" "unprognostic (1.16e-1)" 12.3 16.6 7.0 17.9 11.1 15.9 12.8 10.7 13.4 17.7 14.7 10.0 11.3 11.0 15.8 17.8 23.8 12.4 12.8 12.0 7.7 6.9 13.4 17.4 13.7 19.7 8.7 7.9 14.4 13.2 11.0 21.0 27.9 10.8 13.0 16.8 10.9 13.2 11.3 11.1 16.3 18.7 17.8 8.8 19.8 13.1 5.8 8.1 33.4 12.4 15.3 19.6 13.3 14.7 18.9 41.4 18.8 24.3 14.2 13.6 7.2 13.3 6.8 21.5 12.5 5.3 4.8 21.7 10.1 4.2 14.2 8.0 11.6 6.1 31.6 6.2 8.4 2.3 9.0 25.6 11.9 11.2 12.9 20.7 24.8 10.3 5.2 5.0 30.7 18.8 5.6 15.9 10.5 8.5 8.7 13.9 18.7 27.7 5.3 6.8 14.0 34.3 17.3 26.0 9.9 10.9 35.4 11.1 11.2 15.5 19.8 28.3 19.6 12.3 14.5 9.0 13.2 23.2 16.6 8.4 4.4 7.3 4.7 12.0 11.6 15.3 27.1 4.9 16.6 8.5 18.5 24.3 18.8 13.6 16.3 10.3 17.7 13.0 11.2 14.9 18.9 13.5 12.1 16.0 14.2 15.9 41.4 12.6 7.2 7.0 11.1 10.7 13.4 7.7 6.9 8.7 7.9 10.8 8.1 35.7 18.4 41.0 33.6 70.2 45.5 23.0 35.7 40.2 40.9 31.4 25.5 58.2 31.5 66.4 3.9 43.9 26.9 23.3 46.9 70.7 38.1 38.3 38.3 30.1 39.3 33.4 78.4 36.2 38.6 2.1 25.3 39.1 15.1 39.7 39.8 23.0 64.5 34.5 28.3 18.0 37.1 45.3 30.7 9.9 25.0 89.8 131.0 39.9 38.9 48.0 TDP1 "FLJ11090, SCAN1" ENSG00000042088 "Tyrosyl-DNA phosphodiesterase 1" Q9NUW8 14 89954939-90044768 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 97.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071317 Approved Supported "Nucleoplasm,Plasma membrane" No No Nucleoplasm "Plasma membrane" "HPA071317: AB_2686388" "unprognostic (5.60e-3)" "unprognostic (3.53e-1)" "unprognostic (7.03e-3)" "unprognostic (1.34e-1)" "unprognostic (7.45e-2)" "unprognostic (7.22e-2)" "prognostic unfavorable (8.99e-5)" "unprognostic (2.61e-1)" "unprognostic (1.46e-2)" "unprognostic (5.84e-3)" "unprognostic (2.51e-1)" "unprognostic (6.46e-2)" "unprognostic (1.10e-1)" "unprognostic (3.41e-1)" "unprognostic (1.64e-1)" "unprognostic (2.91e-2)" "unprognostic (1.26e-1)" 5.5 6.3 6.9 10.8 10.4 11.4 8.3 11.0 10.8 6.6 7.1 7.3 8.4 5.9 9.1 5.6 11.1 8.8 6.2 3.5 5.5 6.3 6.8 5.9 5.5 16.1 6.2 8.1 6.8 7.0 5.5 11.0 7.5 6.3 5.7 9.6 6.1 8.1 4.2 3.1 7.7 7.9 5.8 5.7 11.7 7.0 23.3 3.7 29.8 4.5 4.4 21.0 7.6 7.0 16.4 11.2 15.5 10.6 16.3 23.2 10.7 13.8 7.9 17.6 15.9 4.4 6.1 14.0 13.3 11.0 16.5 15.0 5.7 15.0 17.7 10.0 9.1 5.5 14.3 7.7 12.4 24.1 17.9 8.3 17.9 7.2 6.9 3.8 29.9 10.4 4.4 5.6 11.6 10.8 9.5 20.9 24.3 12.3 18.6 19.5 14.6 22.8 16.1 4.2 16.5 18.6 17.4 33.3 14.0 10.6 11.4 13.2 9.0 11.3 33.2 4.2 12.2 13.2 12.8 16.6 7.2 6.8 9.8 11.9 13.7 23.8 21.6 15.4 13.5 10.4 15.5 6.6 10.7 14.5 10.6 14.3 16.4 15.7 16.3 10.4 13.5 17.7 18.2 4.5 16.3 9.7 11.2 23.2 10.7 6.9 10.4 11.0 10.8 5.5 6.3 6.2 8.1 6.3 3.7 0.0 1.4 6.7 4.6 4.1 3.0 1.1 2.5 12.0 3.4 14.0 7.9 9.1 5.0 7.3 97.8 2.7 2.3 0.0 4.8 12.5 3.9 3.6 2.3 2.9 7.8 3.2 3.5 4.3 5.6 25.8 2.6 6.1 1.7 9.0 5.0 0.6 5.0 3.2 2.8 5.7 2.2 0.0 4.7 26.1 23.8 4.0 8.5 8.7 7.6 2.6 TDP2 TTRAP ENSG00000111802 "Tyrosyl-DNA phosphodiesterase 2" O95551 6 24649977-24667033 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" "Hydrolase, Nuclease" "Mental retardation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 57.3;intestine: 55.7" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 434.9;Paneth cells: 431.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 15.6;neutrophil: 57.3" "Lineage enriched" "Detected in all" 7 "granulocytes: 57.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB073398, HPA074011" Enhanced Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" No No "Nucleoplasm, Nuclear bodies" "CAB073398: , HPA074011: AB_2686651" "unprognostic (2.46e-2)" "unprognostic (2.10e-3)" "unprognostic (1.83e-1)" "unprognostic (2.19e-2)" "unprognostic (2.58e-1)" "unprognostic (4.66e-3)" "unprognostic (4.13e-3)" "unprognostic (3.24e-1)" "unprognostic (5.78e-3)" "prognostic favorable (2.53e-7)" "unprognostic (1.20e-2)" "prognostic unfavorable (1.86e-4)" "unprognostic (1.40e-2)" "unprognostic (1.42e-1)" "unprognostic (9.70e-3)" "unprognostic (1.14e-1)" "prognostic favorable (1.47e-5)" 6.8 4.8 8.2 15.4 9.2 3.7 5.6 10.8 7.5 6.1 36.0 3.7 4.9 25.8 4.9 5.2 4.9 4.5 6.2 8.1 6.8 6.9 16.4 10.4 6.5 7.1 7.7 6.3 5.7 5.9 4.4 9.4 5.7 6.5 12.3 27.9 3.6 4.9 4.8 5.0 4.8 55.7 6.1 5.8 6.3 5.1 21.1 5.7 8.2 5.3 4.1 7.3 9.6 7.0 5.3 3.3 57.3 3.9 6.9 8.3 5.7 17.7 14.1 16.2 18.6 25.1 25.7 12.6 15.8 20.4 15.2 20.4 19.4 10.1 21.4 27.9 16.6 35.4 13.1 19.6 18.0 20.8 27.4 20.6 20.0 15.0 31.5 16.0 30.7 19.4 17.1 17.0 15.8 14.4 18.1 24.5 20.8 17.9 9.2 22.7 12.7 23.8 19.6 14.4 20.5 12.2 20.8 17.0 23.0 26.1 25.3 20.4 11.7 12.9 32.8 25.8 17.2 15.1 17.8 18.2 14.8 12.4 11.0 23.1 13.3 39.1 29.2 10.2 40.5 23.6 15.6 3.5 7.1 6.9 3.7 8.3 5.3 8.0 7.5 3.3 3.5 6.6 7.2 57.3 6.9 3.9 3.1 7.9 5.7 8.2 9.2 10.8 7.5 6.8 6.9 7.7 6.3 6.5 5.7 6.0 14.7 22.2 25.0 12.6 10.6 16.2 30.6 26.8 20.5 21.0 5.9 16.0 41.4 30.3 141.5 21.2 434.9 0.0 31.2 20.7 17.0 29.4 23.1 27.3 64.5 6.4 50.6 22.7 22.6 63.7 16.7 28.7 11.8 84.8 117.3 17.2 19.7 431.3 21.9 159.2 13.9 32.3 20.6 8.9 20.2 14.4 37.1 27.7 86.0 22.3 TDRD3 FLJ21007 ENSG00000083544 "Tudor domain containing 3" Q9H7E2 13 60396457-60573878 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "granulocytes: 143.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034925, HPA067153" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "CAB034925: AB_2240523, HPA067153: AB_2732759" "unprognostic (8.52e-2)" "unprognostic (3.19e-1)" "unprognostic (2.23e-1)" "prognostic favorable (2.77e-4)" "unprognostic (5.21e-2)" "unprognostic (2.62e-1)" "unprognostic (7.37e-2)" "unprognostic (5.79e-2)" "unprognostic (1.03e-1)" "unprognostic (1.11e-1)" "unprognostic (1.84e-1)" "unprognostic (6.18e-3)" "unprognostic (9.62e-2)" "unprognostic (9.95e-2)" "unprognostic (3.68e-2)" "unprognostic (4.40e-2)" "unprognostic (1.27e-3)" 13.7 12.0 13.0 10.3 14.7 6.9 16.9 13.8 14.2 16.7 17.2 11.7 14.2 12.9 15.2 14.2 16.5 14.4 12.7 16.7 12.9 10.6 16.2 13.5 16.9 11.3 13.5 14.8 20.6 21.3 15.3 15.4 12.4 17.7 15.5 15.5 11.1 12.5 14.8 42.4 15.2 16.7 19.0 16.8 12.9 14.8 15.9 15.0 18.7 16.9 18.6 12.1 19.0 15.4 3.8 7.2 2.3 3.5 3.0 6.9 2.1 4.4 4.9 10.9 25.4 4.4 9.5 6.5 5.1 5.8 6.0 3.9 3.2 7.4 10.9 2.1 7.5 5.1 6.3 8.9 7.5 6.5 8.2 6.8 20.3 9.4 6.2 8.5 14.2 10.6 6.4 10.7 3.5 10.6 12.5 8.1 9.0 4.5 6.7 6.5 4.8 12.7 7.4 8.3 16.1 3.8 6.8 5.3 7.2 8.2 5.9 9.7 11.6 7.4 9.0 18.5 7.8 4.6 6.2 6.8 3.8 3.9 4.3 5.6 13.3 11.5 9.4 3.6 7.4 11.7 0.5 2.3 2.3 5.5 3.5 3.8 3.8 6.2 6.2 3.3 2.7 5.2 6.4 0.1 3.0 2.5 7.2 6.9 2.1 13.0 14.7 13.8 14.2 12.9 10.6 13.5 14.8 17.7 15.0 20.8 28.8 13.4 9.0 7.0 29.0 40.4 5.1 33.5 25.0 10.4 51.1 7.3 18.3 11.5 16.8 12.8 9.3 0.0 15.4 8.8 8.3 6.1 143.8 7.2 6.3 19.1 16.7 8.0 9.4 17.0 17.5 11.6 18.6 8.2 13.8 13.4 9.6 15.3 17.3 9.9 28.8 6.5 7.5 33.9 15.5 5.8 5.6 13.8 13.8 6.3 TDRD7 PCTAIRE2BP ENSG00000196116 "Tudor domain containing 7" Q8NHU6 9 97411950-97496125 "Disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" RNA-binding "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 33.9;Rod photoreceptor cells: 41.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 26.9;HDLM-2: 25.1;THP-1: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020800, HPA022250, HPA024529" Enhanced Supported "Nucleoplasm,Cytoplasmic bodies" NA NA "Cytoplasmic bodies" Nucleoplasm "CAB020800: , HPA022250: , HPA024529: AB_1857869" "unprognostic (8.22e-2)" "unprognostic (1.62e-2)" "unprognostic (3.28e-3)" "unprognostic (1.03e-1)" "unprognostic (2.88e-1)" "unprognostic (3.07e-1)" "prognostic unfavorable (5.91e-4)" "unprognostic (2.88e-2)" "unprognostic (9.86e-2)" "unprognostic (2.00e-1)" "unprognostic (1.06e-1)" "unprognostic (2.74e-2)" "prognostic favorable (4.76e-5)" "unprognostic (4.03e-2)" "unprognostic (2.90e-1)" "unprognostic (1.17e-2)" "unprognostic (2.67e-1)" 9.5 7.1 10.6 9.1 11.5 8.9 7.7 7.1 10.2 8.8 12.8 8.9 3.7 14.0 9.8 6.0 10.5 8.2 9.2 5.7 8.6 6.6 6.4 7.3 9.8 7.0 10.2 8.8 8.3 9.7 12.5 9.3 7.9 11.6 7.1 12.7 19.0 8.8 7.0 5.1 6.1 16.5 9.6 12.6 8.8 7.6 31.1 9.8 9.3 7.3 4.7 7.3 12.1 8.6 4.3 4.6 9.8 6.1 1.6 2.9 1.8 7.7 5.4 0.0 1.8 4.2 5.5 4.6 4.9 12.4 17.0 19.1 6.9 6.6 0.5 2.4 6.9 26.9 5.9 4.5 2.5 4.6 25.1 3.9 3.5 2.7 5.0 3.8 7.9 8.5 1.8 5.0 5.6 0.5 5.1 7.3 3.8 1.9 0.4 4.4 4.6 3.9 3.9 0.8 9.1 2.9 1.7 2.8 0.1 4.1 5.2 0.8 2.3 6.8 3.1 18.6 3.0 1.8 24.8 7.4 2.1 2.1 5.4 3.7 2.6 3.0 0.4 5.0 4.3 5.5 2.4 3.1 9.8 1.7 6.1 2.4 4.3 2.4 1.8 4.6 3.4 1.8 2.9 5.7 1.6 5.8 0.9 1.6 1.8 10.6 11.5 7.1 10.2 8.6 6.6 10.2 8.8 11.6 9.8 0.0 4.0 4.5 2.4 1.4 6.5 5.2 2.5 16.0 4.5 3.5 17.7 1.3 5.0 4.0 33.9 4.3 8.3 0.0 4.3 1.9 1.5 2.0 0.0 2.4 4.3 4.8 5.8 3.1 3.7 19.8 4.0 4.6 1.7 11.8 7.0 7.8 5.2 7.6 3.5 2.9 41.7 6.5 1.4 19.1 13.6 1.9 0.6 2.6 6.3 3.2 TEAD1 "AA, TCF13, TEF-1" ENSG00000187079 "TEA domain transcription factor 1" P28347 11 12674591-12944483 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057339, HPA062471" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA057339: AB_2683413, HPA062471: AB_2684773" "unprognostic (1.00e-1)" "unprognostic (2.53e-2)" "unprognostic (8.84e-2)" "unprognostic (9.93e-3)" "unprognostic (2.05e-2)" "unprognostic (4.50e-1)" "unprognostic (1.50e-1)" "unprognostic (1.75e-1)" "unprognostic (1.43e-1)" "unprognostic (4.40e-3)" "unprognostic (8.39e-2)" "unprognostic (4.76e-2)" "unprognostic (1.41e-2)" "unprognostic (7.08e-3)" "unprognostic (2.52e-1)" "unprognostic (3.14e-1)" "unprognostic (2.18e-2)" 16.3 6.6 8.2 6.7 6.6 0.0 23.5 7.8 7.7 13.6 12.6 7.3 9.5 4.1 14.1 7.9 16.4 11.4 10.9 16.5 10.6 4.2 13.1 8.4 8.2 1.9 8.0 4.9 12.1 8.6 25.2 18.5 17.5 7.9 13.9 6.7 11.9 8.8 10.4 41.4 7.5 7.3 21.4 7.2 4.1 9.1 5.9 8.2 0.2 9.6 12.8 5.0 22.2 20.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 22.0 21.9 16.7 19.4 18.4 19.2 28.7 30.4 23.3 23.5 21.9 20.4 19.4 0.1 8.3 36.0 10.4 12.7 19.2 11.4 36.9 0.0 7.5 0.0 36.9 6.3 17.3 0.0 1.7 16.5 5.8 17.1 21.4 18.3 4.7 1.4 9.7 0.0 33.0 4.2 0.0 0.1 6.2 4.5 8.7 0.1 22.6 10.8 15.4 14.1 9.2 10.9 32.1 14.9 18.7 23.6 7.3 1.4 10.4 34.2 27.3 28.1 20.6 3.2 6.6 4.0 13.4 0.0 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 6.6 7.8 7.7 10.6 4.2 8.0 4.9 7.9 8.2 83.4 14.2 0.8 28.4 88.3 12.7 55.4 33.1 56.2 40.9 47.1 11.8 18.1 1.7 14.0 5.7 23.3 7.0 0.0 10.9 45.4 42.9 45.8 0.0 35.5 3.2 1.6 44.9 20.9 2.4 5.6 21.9 2.5 23.6 0.0 10.4 29.8 25.0 7.0 22.6 24.5 18.8 6.5 34.0 3.2 26.9 47.9 10.3 0.0 8.7 49.8 TEAD2 "ETF, TEF-4, TEF4" ENSG00000074219 "TEA domain transcription factor 2" Q15562 19 49340595-49362457 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 45.7;Early spermatids: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 25 "memory B-cell: 4.1;naive B-cell: 5.2" "Lineage enriched" "Detected in single" 27 "B-cells: 5.2" "Cell line enhanced" "Detected in many" "AF22: 42.8;AN3-CA: 46.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066292, HPA069963" Supported Nucleoplasm NA NA Nucleoplasm "HPA066292: AB_2685651, HPA069963: AB_2686222" "unprognostic (2.69e-2)" "unprognostic (1.08e-1)" "unprognostic (2.09e-1)" "unprognostic (1.03e-2)" "unprognostic (8.58e-3)" "unprognostic (4.39e-1)" "prognostic unfavorable (8.66e-4)" "unprognostic (2.91e-1)" "unprognostic (4.47e-3)" "unprognostic (1.11e-1)" "unprognostic (3.96e-3)" "unprognostic (1.24e-1)" "unprognostic (4.39e-2)" "unprognostic (2.39e-2)" "unprognostic (1.08e-1)" "unprognostic (1.31e-1)" "unprognostic (6.78e-2)" 17.6 8.1 4.5 9.3 4.3 0.0 19.5 2.1 3.4 21.7 21.6 3.9 11.6 3.9 20.2 12.4 12.8 14.4 12.8 25.6 4.1 1.5 11.3 18.3 19.9 8.7 5.6 1.8 25.2 18.1 4.9 4.5 10.5 5.2 19.0 6.3 19.0 10.0 13.6 6.1 4.8 8.1 21.8 7.5 11.8 14.7 10.9 3.2 1.8 9.5 8.9 5.1 16.3 26.4 5.2 0.0 0.0 0.1 0.0 0.1 0.1 3.7 8.8 42.8 46.3 4.6 6.8 7.6 7.0 7.5 8.1 9.5 0.7 2.1 0.3 9.4 11.9 4.1 4.3 11.7 2.4 4.5 0.0 5.4 0.0 8.4 5.8 8.0 0.0 0.1 8.0 5.6 5.5 2.7 16.1 28.8 0.0 6.5 0.0 11.3 4.7 0.0 0.0 14.4 10.8 11.3 0.0 12.9 0.0 7.4 0.0 0.0 26.0 11.8 1.7 3.1 15.3 12.7 1.0 16.9 14.7 9.1 3.1 0.5 0.0 0.0 1.4 0.5 0.1 5.7 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.1 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.5 4.3 2.1 3.4 4.1 1.5 5.6 1.8 5.2 3.2 3.0 2.7 0.0 5.0 3.0 0.0 0.8 7.6 1.4 3.4 12.2 0.0 0.7 1.7 45.7 59.6 26.5 0.0 0.0 22.7 19.4 13.2 6.2 0.0 2.0 0.6 0.0 6.8 18.4 1.2 22.0 14.1 0.6 5.0 0.0 4.5 7.8 25.8 3.5 20.8 0.0 0.4 32.3 24.5 2.5 1.5 1.4 1.0 0.0 5.2 2.4 TEAD4 "EFTR-2, RTEF-1, TCF13L1, TEF-3, TEFR-1" ENSG00000197905 "TEA domain transcription factor 4" Q15561 12 2959330-3040673 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 60.1" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 37.4;Exocrine glandular cells: 32.8;Ito cells: 31.3;Syncytiotrophoblasts: 28.9" "Cancer enriched" "Detected in all" 5 "testis cancer: 78.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 86.2" "Region enriched" "Detected in single" 4 "cerebellum: 3.5" "Low region specificity" "Detected in some" HPA056896 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA056896: AB_2683268" "unprognostic (3.68e-1)" "unprognostic (3.98e-1)" "unprognostic (2.17e-1)" "unprognostic (1.55e-3)" "unprognostic (1.33e-1)" "unprognostic (3.68e-1)" "unprognostic (9.20e-3)" "unprognostic (2.21e-3)" "unprognostic (3.01e-1)" "unprognostic (1.24e-1)" "unprognostic (2.50e-2)" "unprognostic (2.03e-1)" "prognostic unfavorable (9.78e-9)" "unprognostic (5.05e-3)" "unprognostic (8.43e-2)" "unprognostic (2.42e-2)" "unprognostic (1.23e-3)" 7.6 1.9 1.2 4.5 1.8 0.5 11.1 2.0 2.5 3.6 3.1 0.7 7.4 3.2 4.4 5.1 4.2 3.1 4.3 9.7 1.4 1.1 9.2 5.5 10.3 5.3 2.4 0.4 4.4 27.5 1.1 1.5 6.8 3.2 3.8 2.9 3.9 3.5 7.1 60.1 6.2 5.2 5.7 1.9 7.2 3.6 2.2 1.4 0.5 16.4 13.3 2.5 3.1 10.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 8.6 12.2 3.1 8.6 0.9 2.1 33.4 6.9 3.7 12.0 6.7 23.2 9.2 0.0 5.4 5.2 8.1 12.4 12.1 86.2 11.2 0.0 9.8 13.7 10.0 20.0 4.6 2.9 2.6 3.0 3.5 10.4 16.1 5.0 10.2 5.5 8.7 0.1 4.1 12.2 0.1 0.0 23.9 11.0 7.2 6.3 17.7 6.7 5.6 3.6 1.8 3.2 8.6 21.6 6.3 23.6 14.6 5.0 11.6 7.0 24.4 4.8 3.6 0.0 0.0 0.0 5.6 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.8 2.0 2.5 1.4 1.1 2.4 0.4 3.2 1.4 11.9 6.6 0.0 9.5 10.9 0.0 1.7 7.6 1.4 2.3 7.0 0.0 37.4 5.0 11.6 0.1 19.7 6.5 0.0 32.8 12.7 8.2 15.2 5.7 0.0 4.5 0.0 0.0 31.3 1.5 1.3 0.0 0.4 8.5 0.0 3.2 0.0 21.6 0.0 0.4 14.3 0.0 0.0 12.7 0.2 6.4 6.8 28.9 0.0 4.1 3.1 TECPR2 KIAA0329 ENSG00000196663 "Tectonin beta-propeller repeat containing 2" O15040 14 102362963-102502481 "Disease related genes, Predicted intracellular proteins" Autophagy "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 47.1;Rod photoreceptor cells: 39.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 9 "neutrophil: 10.5" "Lineage enriched" "Detected in single" 14 "granulocytes: 10.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000658 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA000658: AB_1079191" "unprognostic (6.81e-2)" "unprognostic (1.21e-1)" "unprognostic (3.77e-2)" "unprognostic (2.62e-1)" "unprognostic (4.46e-1)" "unprognostic (1.63e-3)" "prognostic unfavorable (5.66e-5)" "unprognostic (1.17e-1)" "unprognostic (3.22e-2)" "unprognostic (1.64e-1)" "unprognostic (5.76e-3)" "unprognostic (3.78e-2)" "prognostic favorable (6.53e-9)" "unprognostic (1.39e-2)" "unprognostic (1.48e-1)" "unprognostic (1.91e-1)" "unprognostic (1.56e-3)" 8.5 7.0 15.4 8.4 19.3 8.3 7.4 13.5 23.3 10.0 8.5 28.3 6.3 6.2 9.6 11.3 8.2 10.7 7.4 11.0 15.9 12.1 7.0 4.6 7.1 6.8 23.6 14.3 10.2 6.9 17.5 8.4 9.1 14.4 9.8 5.5 12.0 15.2 12.5 12.4 6.2 5.6 13.9 16.3 6.6 6.5 16.9 17.3 7.6 8.7 2.6 4.7 9.1 5.6 0.3 0.3 10.5 0.7 0.2 0.5 0.6 3.8 7.9 7.7 6.3 16.0 12.1 4.3 8.8 10.3 8.9 7.5 1.6 2.9 2.9 5.5 9.2 6.6 7.1 5.3 6.6 7.5 10.7 3.5 3.5 4.2 3.4 7.5 1.9 3.4 7.9 5.9 8.0 5.4 8.5 8.7 3.3 1.7 6.7 8.2 7.4 1.7 2.1 2.9 4.0 8.3 4.1 5.4 0.9 4.5 6.6 6.1 5.7 7.6 2.0 4.9 5.2 9.0 2.6 8.9 6.9 1.7 18.4 3.7 7.0 4.1 0.6 6.7 5.1 7.1 0.5 0.7 1.1 0.4 0.5 0.3 0.1 0.3 0.2 0.3 0.3 0.5 0.2 10.5 0.2 0.1 0.2 0.5 0.6 15.4 19.3 13.5 23.3 15.9 12.1 23.6 14.3 14.4 17.3 8.9 5.8 2.4 2.5 1.8 16.7 11.8 5.1 5.3 5.7 3.5 47.1 5.1 5.0 6.3 22.1 5.8 4.7 0.0 6.2 4.9 4.9 3.1 0.0 5.1 4.3 12.7 4.1 8.0 6.5 19.1 13.3 3.6 3.3 5.4 3.0 20.6 6.4 3.4 17.7 5.7 39.8 19.4 5.0 19.9 15.0 1.4 5.0 2.5 4.3 2.8 TEDC1 C14orf80 ENSG00000185347 "Tubulin epsilon and delta complex 1" Q86SX3 14 105489855-105499575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Exocrine glandular cells: 11.1;Extravillous trophoblasts: 21.4;Hofbauer cells: 12.7;monocytes: 20.8;Pancreatic endocrine cells: 10.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039049, HPA039050" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" No No "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039049: AB_2676320, HPA039050: AB_10670918" "unprognostic (8.06e-2)" "unprognostic (1.06e-2)" "unprognostic (9.17e-2)" "unprognostic (1.65e-1)" "unprognostic (3.06e-1)" "unprognostic (1.57e-2)" "prognostic unfavorable (3.54e-4)" "unprognostic (5.19e-2)" "unprognostic (1.49e-1)" "unprognostic (3.12e-1)" "unprognostic (3.81e-2)" "unprognostic (2.91e-2)" "unprognostic (1.12e-3)" "unprognostic (8.73e-3)" "unprognostic (2.88e-1)" "unprognostic (1.17e-1)" "unprognostic (6.18e-3)" 5.1 2.0 10.5 8.5 13.6 10.8 5.2 5.1 10.3 3.3 7.6 10.7 2.0 9.4 5.5 5.0 5.2 4.0 5.5 3.4 10.3 7.4 2.9 4.0 6.2 8.8 7.9 4.6 2.7 6.4 2.5 4.5 7.9 7.1 3.7 3.2 3.9 5.8 4.6 3.9 10.1 8.3 2.1 7.4 5.9 10.6 9.1 9.5 16.0 5.1 7.1 11.8 6.1 3.5 0.8 5.7 1.4 2.2 0.1 3.7 0.7 7.9 18.5 4.4 6.6 0.4 0.7 12.0 6.4 2.5 7.7 7.4 6.6 15.1 12.1 13.4 1.0 3.0 21.3 1.5 6.8 1.5 14.3 7.6 3.2 10.2 6.5 0.3 6.1 8.9 0.1 2.3 5.2 1.6 1.0 3.0 11.3 5.0 15.2 1.2 30.8 12.7 13.9 5.7 6.8 19.6 10.4 6.8 8.4 2.1 6.8 12.6 7.4 6.6 7.8 4.6 1.0 12.4 6.1 3.8 5.4 9.2 16.4 10.5 8.9 3.7 7.3 6.9 7.0 8.7 0.0 1.2 1.4 1.5 2.2 1.0 0.3 2.2 3.7 1.7 0.8 1.4 0.4 0.4 0.1 2.0 5.7 1.6 0.7 10.5 13.6 5.1 10.3 10.3 7.4 7.9 4.6 7.1 9.5 3.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 6.7 1.2 1.8 0.0 3.9 3.3 8.1 0.0 0.0 0.0 0.0 11.1 21.4 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 20.8 0.0 0.0 10.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 TEDC2 "C16orf59, FLJ13909" ENSG00000162062 "Tubulin epsilon and delta complex 2" Q7L2K0 16 2460080-2464963 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 15.3;testis: 12.5" "Cell type enhanced" "Detected in some" 16 "Cytotrophoblasts: 7.9;Extravillous trophoblasts: 12.0;Hofbauer cells: 3.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051394, HPA055389" Approved Approved "Nucleoplasm,Cell Junctions" NA NA "Nucleoplasm, Cell Junctions" "HPA051394: AB_2681465, HPA055389: AB_2732595" "unprognostic (3.23e-1)" "unprognostic (1.03e-2)" "unprognostic (2.14e-2)" "unprognostic (7.46e-3)" "unprognostic (1.27e-1)" "unprognostic (1.38e-3)" "prognostic unfavorable (2.43e-5)" "prognostic unfavorable (7.58e-4)" "unprognostic (4.04e-3)" "unprognostic (8.85e-2)" "unprognostic (3.74e-2)" "unprognostic (3.72e-2)" "unprognostic (1.16e-4)" "unprognostic (1.28e-3)" "unprognostic (1.56e-1)" "unprognostic (1.24e-2)" "unprognostic (1.03e-1)" 0.8 1.8 2.3 6.2 4.1 9.3 1.1 2.8 4.6 1.2 2.6 0.8 0.0 4.3 1.2 1.4 4.5 1.2 1.4 1.3 2.3 2.7 2.2 1.7 1.0 5.6 2.1 1.9 1.0 1.9 0.3 2.4 3.8 2.0 1.3 2.2 1.0 1.3 0.8 1.0 2.6 3.8 1.1 1.4 2.5 2.2 12.5 0.8 15.3 0.9 4.2 3.9 0.6 2.2 1.2 1.4 0.0 1.0 0.0 2.1 0.7 5.2 16.7 9.6 11.2 0.1 0.6 9.7 4.2 2.5 6.8 6.6 11.5 4.4 7.3 7.0 1.8 3.7 8.1 6.9 4.2 1.6 8.1 9.2 6.6 11.8 11.8 0.2 6.4 8.9 0.6 0.5 6.0 1.6 0.5 3.1 12.3 11.3 2.8 2.3 10.1 11.2 11.9 21.3 5.1 6.1 27.4 8.3 16.6 1.4 2.3 9.1 14.9 4.9 5.2 3.6 2.6 7.6 7.4 1.1 7.3 10.6 6.9 9.5 6.2 10.2 14.7 3.7 6.4 9.9 0.0 0.0 0.0 0.1 0.1 0.0 0.6 2.1 0.0 0.3 1.2 0.7 1.3 0.0 0.0 1.0 1.4 1.9 0.7 2.3 4.1 2.8 4.6 2.3 2.7 2.1 1.9 2.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 7.9 1.7 2.8 0.0 0.0 0.0 0.0 1.1 12.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 TEN1 "C17orf106, FLJ39785" ENSG00000257949 "TEN1, CST complex subunit" Q86WV5 17 75979220-76000586 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Exocrine glandular cells: 77.6;monocytes: 64.9;Pancreatic endocrine cells: 72.5;Proximal tubular cells: 75.9;Suprabasal keratinocytes: 46.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065069 Supported Nucleoplasm NA NA Nucleoplasm "HPA065069: AB_2685418" "unprognostic (1.61e-1)" "unprognostic (1.16e-1)" "unprognostic (3.34e-2)" "unprognostic (1.07e-1)" "unprognostic (3.02e-2)" "unprognostic (3.07e-3)" "unprognostic (1.33e-3)" "unprognostic (2.95e-1)" "unprognostic (2.85e-2)" "unprognostic (9.03e-2)" "unprognostic (8.61e-3)" "unprognostic (3.17e-2)" "unprognostic (1.64e-2)" "unprognostic (1.64e-1)" "unprognostic (1.13e-1)" "unprognostic (2.94e-1)" "unprognostic (2.85e-4)" 8.8 12.1 7.3 11.9 9.1 17.2 11.4 9.6 8.6 8.8 11.7 7.7 19.3 14.7 7.2 9.4 17.4 9.9 12.8 6.4 7.1 6.2 11.8 18.5 10.6 17.2 9.4 8.1 8.2 15.6 4.6 11.2 13.0 8.5 13.1 5.5 8.6 20.3 17.5 5.2 21.1 15.8 5.4 6.5 13.0 10.8 7.3 9.7 4.6 10.1 13.6 12.3 15.3 13.5 30.2 28.8 35.5 30.0 22.3 22.6 19.8 9.3 9.4 6.8 8.4 8.3 10.9 19.6 6.6 8.8 10.7 11.0 9.4 16.0 12.0 10.4 7.2 11.5 9.9 4.2 9.2 3.1 6.7 15.0 14.9 11.7 10.0 9.9 9.1 23.6 9.9 12.7 6.0 6.0 9.4 14.1 7.7 6.7 12.1 6.1 16.3 11.4 22.3 6.7 9.5 13.8 11.3 6.4 11.2 13.1 16.6 12.4 22.9 4.8 40.7 7.7 5.4 22.6 14.8 8.4 22.4 13.3 10.0 13.5 14.2 5.3 7.2 11.3 6.9 6.8 35.5 30.0 17.0 22.6 26.6 18.6 30.2 18.3 19.2 26.3 25.8 14.2 16.7 18.1 22.3 14.7 28.8 19.3 19.8 7.3 9.1 9.6 8.6 7.1 6.2 9.4 8.1 8.5 9.7 0.0 3.4 0.0 0.0 34.7 0.0 0.0 0.0 1.4 1.2 5.2 0.0 0.0 33.2 34.8 0.0 0.0 0.0 0.0 77.6 0.1 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 13.8 28.7 64.9 0.0 0.0 72.5 0.0 0.0 75.9 0.0 0.0 11.3 0.0 0.0 46.0 0.0 0.0 0.0 0.1 TENM3 "KIAA1455, ODZ3, Ten-M3" ENSG00000218336 "Teneurin transmembrane protein 3" Q9P273 4 182143987-182803024 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Differentiation" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Bipolar cells: 28.4;Cytotrophoblasts: 88.5;Extravillous trophoblasts: 46.4;Syncytiotrophoblasts: 111.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 24.4;BEWO: 23.3;HDLM-2: 31.7;T-47d: 31.4" "Low region specificity" "Detected in many" HPA047043 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA047043: AB_2679914" "unprognostic (5.79e-2)" "unprognostic (3.01e-2)" "unprognostic (6.62e-2)" "unprognostic (4.43e-2)" "unprognostic (1.46e-2)" "unprognostic (1.08e-1)" "unprognostic (8.28e-2)" "unprognostic (8.68e-3)" "unprognostic (1.82e-1)" "unprognostic (2.31e-2)" "unprognostic (4.85e-2)" "unprognostic (2.54e-1)" "unprognostic (4.10e-2)" "unprognostic (1.47e-3)" "unprognostic (8.59e-2)" "unprognostic (1.07e-2)" "unprognostic (5.25e-4)" 9.5 10.8 11.3 3.7 12.5 1.0 9.3 8.5 17.8 3.9 8.5 1.5 5.7 2.4 6.4 2.6 2.4 2.9 5.3 3.5 11.8 9.4 2.7 1.4 2.4 2.3 3.5 15.4 8.4 3.2 17.0 15.0 24.5 5.4 8.3 2.5 6.4 2.0 8.0 4.3 1.4 2.5 5.2 6.1 4.8 2.2 4.7 2.3 0.8 12.3 1.8 3.0 3.7 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 24.4 0.1 5.0 8.9 23.3 2.8 1.0 2.5 2.2 12.1 6.3 0.0 0.3 18.8 10.6 1.2 5.8 1.2 2.5 31.7 9.7 0.0 0.0 0.0 0.5 0.0 0.0 11.7 0.4 7.9 5.5 5.7 3.5 0.0 0.0 0.1 3.8 0.8 0.0 0.0 7.8 0.0 1.0 0.0 6.3 0.0 0.0 0.0 10.0 9.3 1.4 0.1 0.0 13.8 31.4 1.2 7.6 20.0 14.4 0.0 14.1 0.0 0.0 0.0 10.5 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 12.5 8.5 17.8 11.8 9.4 3.5 15.4 5.4 2.3 0.0 0.0 0.0 0.2 0.3 28.4 3.3 0.0 0.0 0.0 3.5 3.9 88.5 1.7 0.0 8.3 0.3 0.0 0.0 1.5 46.4 3.1 0.2 0.0 0.6 9.0 4.8 5.1 0.6 0.0 1.8 7.8 0.0 1.7 0.0 0.0 11.8 0.6 0.0 2.5 0.1 2.8 0.0 1.0 3.7 7.1 0.0 111.6 0.0 0.0 0.0 TEP1 "p240, TLP1, TP1, TROVE1, VAULT2" ENSG00000129566 "Telomerase associated protein 1" Q99973 14 20365667-20413429 "Plasma proteins, Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA029206 Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA029206: AB_10601271" "unprognostic (4.53e-2)" "unprognostic (2.81e-2)" "unprognostic (1.26e-1)" "prognostic favorable (9.58e-4)" "unprognostic (2.27e-1)" "unprognostic (2.76e-1)" "unprognostic (2.66e-2)" "unprognostic (1.43e-1)" "unprognostic (6.81e-2)" "unprognostic (1.42e-2)" "unprognostic (1.92e-1)" "unprognostic (1.05e-1)" "unprognostic (1.46e-1)" "unprognostic (1.10e-1)" "unprognostic (2.18e-1)" "unprognostic (6.18e-2)" "unprognostic (3.00e-1)" 14.7 10.4 5.4 22.0 8.7 4.5 11.4 5.8 6.6 8.9 24.1 11.2 7.7 27.7 12.9 11.3 9.4 7.9 15.7 9.3 6.3 3.5 9.4 9.2 14.1 15.0 7.7 3.0 9.2 8.7 28.2 11.7 7.0 7.3 10.8 18.1 8.1 11.4 8.3 13.4 10.0 38.3 10.9 12.2 19.5 11.1 3.6 8.7 14.2 11.2 6.6 20.8 9.7 10.9 4.2 8.3 7.8 4.4 0.9 1.8 0.5 7.0 2.8 3.2 3.5 19.9 8.3 5.6 4.8 4.5 2.9 4.1 6.1 7.4 5.5 3.3 13.4 5.7 7.0 2.6 9.5 5.1 6.9 2.7 6.7 6.1 4.1 6.0 5.5 12.1 11.5 9.0 6.0 4.6 13.4 13.5 5.2 2.3 4.4 10.6 4.3 4.1 3.8 1.3 19.8 2.6 9.1 7.8 1.9 9.8 10.1 1.0 1.3 3.8 9.8 3.1 8.9 5.3 3.7 13.8 11.6 8.1 4.3 1.4 9.9 5.6 3.6 2.7 5.2 4.2 4.1 4.0 0.2 1.8 4.4 1.7 2.9 0.8 1.6 1.3 4.2 0.9 1.1 7.8 0.9 4.4 8.3 1.3 0.5 5.4 8.7 5.8 6.6 6.3 3.5 7.7 3.0 7.3 8.7 8.9 13.1 6.2 4.1 2.5 0.1 2.8 7.6 13.4 5.7 1.8 2.0 1.7 1.7 3.6 0.2 3.6 18.8 0.0 4.4 2.0 1.7 5.2 10.4 4.2 5.7 0.0 4.1 8.0 8.9 0.0 4.6 11.8 5.0 3.6 11.6 3.7 5.2 11.9 3.5 2.9 2.1 0.0 3.3 0.0 0.7 1.3 1.6 4.4 7.4 4.2 TERB2 "C15orf43, MGC33951" ENSG00000167014 "Telomere repeat binding bouquet formation protein 2" Q8NHR7 15 44956702-44979229 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "testis: 51.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041780 Uncertain Nucleoplasm,Nucleoli No NA Nucleoli Nucleoplasm "HPA041780: AB_10796460" "unprognostic (1.42e-3)" "unprognostic (4.19e-2)" "unprognostic (1.29e-1)" "unprognostic (3.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TERF2 "TRBF2, TRF2" ENSG00000132604 "Telomeric repeat binding factor 2" Q15554 16 69355561-69408571 "Predicted intracellular proteins" "Cell cycle" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001907, HPA002735, CAB010451" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB010451: AB_2201333, HPA001907: AB_1080246, HPA002735: AB_1857898" "unprognostic (2.61e-2)" "unprognostic (2.61e-2)" "unprognostic (3.05e-1)" "unprognostic (1.60e-1)" "unprognostic (1.54e-1)" "unprognostic (1.13e-2)" "unprognostic (6.07e-2)" "unprognostic (3.45e-2)" "unprognostic (3.42e-1)" "unprognostic (1.64e-1)" "unprognostic (1.07e-1)" "unprognostic (1.23e-1)" "unprognostic (1.00e-1)" "unprognostic (5.79e-2)" "unprognostic (2.92e-1)" "unprognostic (2.00e-2)" "unprognostic (1.04e-1)" 15.6 14.9 22.1 18.2 24.4 16.1 14.1 32.2 30.0 16.2 15.2 20.0 13.3 13.4 19.2 16.4 15.3 16.1 14.0 14.7 21.2 22.1 13.2 14.9 12.6 32.6 19.6 21.6 20.5 22.2 26.9 13.4 15.8 17.1 15.5 15.0 14.5 12.0 15.3 28.9 15.3 13.6 19.6 17.3 14.9 12.6 15.8 16.5 23.0 16.9 9.6 42.2 17.2 21.5 15.2 5.4 11.2 4.1 4.9 7.5 2.9 8.2 13.5 12.2 12.2 11.6 8.6 10.4 8.4 10.6 20.1 15.6 12.2 11.3 37.9 11.5 10.3 7.2 13.4 14.8 10.3 18.9 7.1 11.7 10.9 7.1 11.1 9.9 10.8 9.2 8.8 10.5 16.0 19.6 9.0 13.8 15.1 20.6 5.5 12.9 11.2 21.4 13.9 14.0 9.1 6.5 30.0 8.1 21.8 8.6 6.1 13.8 10.8 28.0 6.4 7.5 11.5 12.1 12.6 8.4 12.6 11.1 8.6 10.0 14.8 15.4 47.8 10.9 9.8 12.1 11.2 4.1 4.5 6.8 3.4 5.1 15.2 6.8 5.9 4.1 8.7 7.5 7.5 4.7 4.9 3.5 5.4 5.2 2.9 22.1 24.4 32.2 30.0 21.2 22.1 19.6 21.6 17.1 16.5 14.9 12.2 20.8 10.2 11.1 23.2 13.5 10.2 8.1 4.5 8.7 17.7 6.7 1.7 4.5 25.7 16.5 10.2 0.0 6.6 6.5 8.5 11.9 13.9 16.6 10.3 42.9 9.8 14.7 15.4 16.2 8.6 10.1 3.3 2.8 10.0 17.6 7.0 7.0 13.4 7.0 12.8 19.4 10.8 7.7 12.0 11.3 7.0 8.7 10.0 11.2 TERF2IP RAP1 ENSG00000166848 "TERF2 interacting protein" Q9NYB0 16 75647786-75761872 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006719, CAB018660, CAB018749" Supported Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB018660: AB_628202, CAB018749: AB_2269341, HPA006719: AB_1858267" "unprognostic (3.20e-1)" "unprognostic (5.72e-2)" "unprognostic (2.06e-3)" "unprognostic (7.83e-2)" "unprognostic (3.30e-1)" "unprognostic (1.99e-2)" "unprognostic (2.33e-1)" "unprognostic (1.59e-2)" "unprognostic (8.80e-2)" "prognostic favorable (6.14e-5)" "prognostic favorable (1.46e-4)" "unprognostic (1.81e-1)" "prognostic favorable (2.15e-5)" "unprognostic (6.26e-2)" "unprognostic (1.85e-1)" "unprognostic (5.30e-2)" "unprognostic (2.99e-1)" 22.5 45.0 51.0 17.9 71.8 35.3 18.2 70.1 64.9 20.9 12.6 30.5 12.5 12.5 21.7 28.3 13.6 17.4 17.2 30.0 44.2 68.4 21.5 19.6 17.2 28.4 47.5 53.5 30.9 16.7 37.6 41.8 12.6 48.3 23.4 13.0 18.9 15.5 22.3 18.5 15.1 12.7 18.5 39.4 22.3 14.0 24.3 32.5 20.5 26.2 10.5 27.6 16.2 15.6 20.4 8.9 40.5 12.4 17.1 23.9 7.2 6.5 6.2 14.0 10.8 15.9 16.7 4.4 19.9 17.2 17.0 12.7 6.8 7.2 33.5 26.7 13.4 8.4 9.5 13.8 5.7 14.5 12.5 20.0 17.0 9.6 15.5 20.8 22.9 24.4 14.1 16.2 13.6 21.2 18.8 11.4 22.2 19.9 14.2 19.4 19.3 27.6 29.3 7.0 8.5 14.4 31.4 9.0 27.5 12.6 6.0 34.0 20.5 25.9 6.1 15.8 5.3 14.0 22.6 12.4 16.3 8.6 14.0 15.2 59.4 51.6 47.1 17.1 15.7 15.4 20.2 9.1 40.5 13.1 8.0 16.3 16.9 20.1 21.6 8.9 20.4 23.9 15.4 14.6 17.1 12.4 8.7 18.6 7.2 51.0 71.8 70.1 58.6 44.2 68.4 47.5 53.5 48.3 32.5 44.7 58.4 95.8 104.6 173.7 401.9 88.0 58.6 66.9 62.6 89.0 88.4 58.2 114.4 66.6 5.3 93.4 31.5 373.8 44.4 27.1 105.9 83.9 122.3 51.2 54.5 267.0 93.8 76.7 65.2 15.0 107.0 85.4 114.7 101.0 37.4 289.1 40.5 40.2 122.7 55.7 146.1 135.8 124.6 277.5 103.3 169.9 102.3 207.5 28.1 86.4 TERT "EST2, hEST2, TCS1, TP2, TRT" ENSG00000164362 "Telomerase reverse transcriptase" O14746 5 1253147-1295069 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "DNA-binding, Nucleotidyltransferase, Ribonucleoprotein, RNA-directed DNA polymerase, Transferase" "Cancer-related genes, Disease mutation, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 3.4;lymphoid tissue: 12.0;testis: 5.0" "Cell type enhanced" "Detected in some" 24 "Cardiomyocytes: 1.2;Spermatogonia: 1.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 62.6;fHDF/TERT166: 59.4;HBEC3-KT: 120.8;hTEC/SVTERT24-B: 76.3;LHCN-M2: 34.4;TIME: 98.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA054641, HPA065897" Supported Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA Nucleoplasm "Nuclear speckles, Cytosol" "HPA054641: AB_2682554, HPA065897: AB_2685576" "unprognostic (1.21e-2)" "unprognostic (2.88e-2)" "unprognostic (1.24e-3)" "unprognostic (1.53e-1)" "unprognostic (1.43e-3)" "unprognostic (6.42e-3)" "unprognostic (1.85e-2)" "unprognostic (2.21e-1)" "unprognostic (6.91e-2)" "unprognostic (1.89e-1)" "unprognostic (3.59e-1)" "unprognostic (9.16e-4)" "unprognostic (8.84e-11)" "unprognostic (1.92e-1)" "unprognostic (2.15e-1)" "unprognostic (3.35e-1)" 0.0 0.0 0.0 7.1 0.9 3.4 0.0 0.0 0.2 0.1 1.1 0.0 0.0 1.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 2.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 1.0 0.4 5.0 0.0 12.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 31.3 62.6 0.5 0.0 23.8 4.3 8.0 0.1 0.1 0.7 0.0 59.4 0.0 0.0 0.2 120.8 5.1 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.3 0.0 3.1 76.3 0.8 0.1 0.2 0.5 0.6 0.1 34.4 0.0 0.2 1.7 0.4 0.0 0.2 0.9 0.0 0.8 3.5 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 98.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.2 0.0 TESC "CHP3, FLJ20607, TSC" ENSG00000088992 Tescalcin Q96BS2 12 117038923-117099479 "Predicted intracellular proteins" "Differentiation, Protein transport, Transport" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 55.8;salivary gland: 92.6" "Cell type enhanced" "Detected in many" 11 "Cholangiocytes: 186.0;Exocrine glandular cells: 427.3;Late spermatids: 257.6;Pancreatic endocrine cells: 170.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 55.8" "Lineage enriched" "Detected in all" 5 "monocytes: 55.8" "Cell line enhanced" "Detected in many" "HMC-1: 64.5;NB-4: 103.8;OE19: 43.8;U-937: 34.5" "Low region specificity" "Detected in all" HPA053200 Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA053200: AB_2682079" "unprognostic (4.53e-3)" "unprognostic (5.98e-2)" "unprognostic (6.50e-2)" "unprognostic (2.23e-3)" "unprognostic (6.31e-2)" "unprognostic (2.05e-3)" "unprognostic (4.98e-3)" "unprognostic (3.35e-1)" "unprognostic (4.35e-1)" "unprognostic (1.62e-1)" "unprognostic (4.37e-2)" "unprognostic (7.43e-2)" "unprognostic (1.69e-2)" "unprognostic (8.65e-2)" "unprognostic (2.57e-1)" "unprognostic (1.56e-2)" "unprognostic (5.67e-3)" 1.8 8.4 5.0 2.4 12.1 25.5 2.3 1.2 6.8 1.8 1.2 1.8 19.4 1.8 1.3 32.9 1.3 1.3 45.8 13.2 6.2 2.2 4.6 1.9 2.9 1.8 2.4 3.3 1.5 40.5 0.7 4.0 2.5 2.2 2.5 0.7 0.3 92.6 24.4 1.3 1.8 1.7 1.4 1.6 2.7 34.4 5.0 2.2 1.2 2.1 1.2 2.5 6.5 2.3 1.9 8.5 11.3 55.8 2.5 2.3 3.9 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 2.3 0.7 0.0 0.0 0.1 1.2 0.0 0.0 6.3 4.1 17.7 1.4 12.1 0.0 7.5 64.5 0.0 0.0 0.0 0.0 0.0 0.0 2.9 8.4 0.1 0.0 0.3 14.6 103.8 1.4 43.8 0.0 0.0 0.0 8.3 9.0 2.3 2.7 0.9 0.0 0.0 0.5 0.1 0.0 8.1 0.0 0.0 0.2 0.0 0.0 2.7 6.1 0.0 0.0 34.5 0.0 0.0 11.9 11.3 1.8 14.9 0.1 1.3 0.6 2.3 8.5 1.9 0.0 1.0 3.0 2.5 55.8 0.6 0.7 3.9 5.0 12.1 1.2 6.8 6.2 2.2 2.4 3.3 2.2 2.2 0.0 0.0 14.1 0.2 2.4 0.6 39.2 186.0 0.0 1.2 12.2 0.0 0.4 63.0 131.7 86.8 9.5 0.0 116.8 427.3 0.6 1.2 3.9 71.4 0.2 36.5 0.0 1.7 1.8 23.5 257.6 2.8 6.3 69.2 10.0 0.1 0.0 170.4 0.0 3.2 2.8 1.4 142.3 48.4 44.5 16.4 1.8 1.0 33.7 0.2 0.7 TESK2 ENSG00000070759 "Testis-specific kinase 2" Q96S53 1 45343883-45491166 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 13.1;RT4: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027257, HPA063869" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA027257: AB_10602477, HPA063869: AB_2685137" "unprognostic (2.95e-1)" "prognostic favorable (2.22e-4)" "unprognostic (3.90e-2)" "unprognostic (5.04e-3)" "unprognostic (6.03e-2)" "unprognostic (1.87e-3)" "unprognostic (3.22e-2)" "unprognostic (1.43e-2)" "unprognostic (5.15e-2)" "unprognostic (2.96e-1)" "unprognostic (2.28e-1)" "unprognostic (2.86e-1)" "unprognostic (4.36e-2)" "unprognostic (2.49e-2)" "unprognostic (1.13e-1)" "unprognostic (4.37e-2)" "unprognostic (2.01e-1)" 5.5 3.3 6.1 5.9 17.4 12.6 9.6 7.8 12.6 7.7 8.4 25.7 4.0 11.9 4.7 5.7 9.1 4.1 3.9 5.8 9.6 5.1 3.5 9.7 5.5 6.0 19.2 4.7 14.4 4.6 6.7 4.1 8.3 13.2 22.1 10.1 7.6 11.2 5.7 10.1 17.1 14.8 4.4 18.7 6.3 5.6 11.7 14.8 4.2 5.1 3.2 7.2 8.2 9.7 7.5 2.0 15.9 5.9 1.1 3.7 2.6 1.6 0.0 0.8 0.0 3.2 1.7 13.1 0.6 4.3 1.9 3.2 3.6 1.5 5.3 0.6 1.6 4.9 2.0 3.4 2.7 1.5 3.7 4.3 3.6 1.8 2.7 1.7 1.2 9.9 1.8 2.9 2.1 3.0 2.9 1.5 7.1 0.6 10.9 1.3 0.6 3.0 2.4 3.4 1.5 1.5 4.4 0.1 1.4 1.7 12.8 0.3 1.4 3.4 6.4 12.2 8.1 10.0 1.5 0.0 0.2 2.0 1.6 1.1 7.2 4.2 1.0 1.0 0.0 0.8 9.4 3.8 10.6 2.4 2.8 1.7 7.5 2.2 1.6 2.0 5.7 3.7 2.1 15.9 1.1 5.9 1.1 1.5 2.6 6.1 17.4 7.8 12.6 9.6 5.1 19.2 4.7 13.2 14.8 0.0 3.2 2.4 6.5 6.9 2.3 1.1 5.1 1.4 3.4 0.0 13.7 6.5 0.0 1.0 18.1 2.9 12.4 0.0 2.3 2.5 2.2 12.9 6.9 5.5 5.9 0.0 4.1 1.3 4.6 5.2 2.6 4.5 3.3 2.8 5.3 1.1 1.0 7.4 1.8 0.6 2.8 6.5 4.7 26.8 5.7 7.4 12.4 4.4 4.9 7.3 TESMIN "CXCDC2, MTL5" ENSG00000132749 "Testis expressed metallothionein like protein" Q9Y4I5 11 68707440-68751564 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "testis: 81.0" "Cell type enhanced" "Detected in some" 9 "Distal tubular cells: 5.0;Ductal cells: 5.8;Exocrine glandular cells: 3.4;Extravillous trophoblasts: 3.7;Pancreatic endocrine cells: 5.1;Proximal tubular cells: 7.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 10.7;T-47d: 21.2" "Not detected" "Not detected" HPA018539 Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA018539: " "unprognostic (1.99e-1)" "unprognostic (3.97e-3)" "unprognostic (1.34e-2)" "prognostic unfavorable (1.75e-5)" "unprognostic (3.22e-2)" "unprognostic (6.71e-2)" "unprognostic (1.76e-2)" "unprognostic (6.99e-3)" "unprognostic (2.54e-1)" "unprognostic (5.33e-2)" "unprognostic (2.19e-2)" "unprognostic (8.47e-2)" "unprognostic (5.27e-2)" "unprognostic (6.39e-2)" "unprognostic (2.99e-1)" "unprognostic (9.85e-2)" "unprognostic (3.17e-1)" 0.3 0.5 0.3 1.6 1.4 4.8 3.3 0.1 0.6 0.6 1.9 0.0 3.8 1.0 0.5 1.2 1.3 1.3 1.0 0.4 0.2 0.9 3.2 0.3 0.4 0.9 0.6 0.4 0.8 2.6 2.6 1.9 0.4 1.8 1.7 2.2 0.6 2.5 5.2 0.1 0.5 1.2 0.3 0.7 1.2 0.6 81.0 0.1 5.5 1.5 0.9 2.0 0.5 0.7 0.4 0.1 2.8 1.1 0.0 1.1 0.4 6.2 2.7 1.2 0.0 0.0 0.0 3.2 1.4 0.7 2.0 0.9 0.8 6.3 2.5 1.4 0.2 0.0 3.0 0.9 1.2 1.6 2.6 2.2 1.8 0.9 0.0 0.0 1.3 10.7 0.0 3.4 0.1 2.0 2.7 0.6 3.0 3.8 4.8 0.3 4.1 0.7 3.6 6.5 2.9 2.8 1.6 0.3 0.7 2.3 0.1 4.0 4.3 0.0 1.3 0.0 3.5 21.2 8.7 2.3 0.2 0.4 0.1 0.1 1.9 1.7 2.4 0.1 3.7 1.7 0.0 1.0 1.0 0.3 0.4 0.6 0.0 1.1 0.2 0.1 0.4 0.4 0.3 2.8 0.0 1.1 0.1 0.8 0.4 0.3 1.4 0.1 0.6 0.2 0.9 0.6 0.4 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.2 0.0 0.0 0.7 5.0 5.8 0.0 0.0 0.0 0.0 3.4 3.7 0.0 0.0 2.3 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 5.1 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 TET1 "bA119F7.1, CXXC6, KIAA1676, LCX" ENSG00000138336 "Tet methylcytosine dioxygenase 1" Q8NFU7 10 68560656-68694482 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 59.1;Horizontal cells: 33.4;Leydig cells: 23.9" "Cancer enriched" "Detected in some" 15 "testis cancer: 10.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 15.3;HAP1: 17.4;K-562: 9.7;NTERA-2: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019032, HPA057273" Supported "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA019032: AB_1847363, HPA057273: AB_2683391" "unprognostic (1.60e-1)" "unprognostic (8.30e-2)" "unprognostic (9.85e-2)" "unprognostic (1.67e-2)" "unprognostic (1.27e-1)" "unprognostic (8.15e-2)" "unprognostic (3.60e-3)" "unprognostic (1.12e-1)" "unprognostic (2.00e-1)" "unprognostic (7.90e-3)" "unprognostic (1.83e-1)" "unprognostic (1.71e-1)" "unprognostic (1.18e-3)" "unprognostic (2.88e-4)" "unprognostic (4.02e-2)" "unprognostic (2.54e-1)" "unprognostic (9.52e-3)" 4.4 1.6 3.3 4.3 2.6 1.6 3.1 4.4 4.3 5.1 2.4 5.8 3.2 1.2 6.0 3.4 2.4 2.9 3.5 2.4 3.5 2.3 1.8 1.5 1.6 1.7 2.5 2.6 6.1 1.6 7.4 2.2 5.8 2.9 3.2 2.0 8.1 15.9 4.8 4.0 2.2 1.8 6.5 3.6 1.7 2.2 1.4 5.9 1.2 3.2 3.2 1.8 5.1 5.4 1.3 1.1 1.0 0.0 0.9 2.3 0.2 0.6 0.7 6.9 7.8 0.7 0.6 15.3 0.4 0.8 0.6 1.1 4.6 0.2 0.0 0.2 0.7 0.1 0.0 17.4 0.0 0.7 0.2 2.8 1.8 0.0 4.1 1.0 1.6 0.9 0.9 0.1 0.4 0.0 1.4 0.1 2.9 9.7 1.2 0.6 0.5 2.7 1.2 10.2 0.0 0.9 2.7 2.2 0.2 0.3 0.7 1.9 3.1 0.3 0.4 1.4 7.2 0.9 1.2 0.2 0.6 1.4 0.0 0.5 0.5 0.5 2.7 0.1 0.0 0.1 0.0 0.0 1.0 1.5 0.0 2.0 1.3 0.8 1.3 0.2 0.5 1.4 1.1 0.0 0.9 0.0 1.1 2.3 0.2 3.3 2.6 4.4 2.6 3.5 2.3 2.5 2.6 2.9 5.9 3.0 3.8 0.0 1.9 1.0 2.2 4.5 2.5 1.4 4.5 0.0 9.8 16.6 0.0 1.4 0.4 3.3 0.0 0.0 0.3 59.1 11.8 2.1 0.0 2.1 3.3 33.4 13.2 7.4 0.0 0.6 23.9 0.1 1.7 0.0 0.0 17.3 0.9 0.0 19.4 0.8 10.8 6.5 3.8 0.5 0.7 1.0 23.3 1.7 0.4 0.3 TET2 "FLJ20032, KIAA1546" ENSG00000168769 "Tet methylcytosine dioxygenase 2" Q6N021 4 105145875-105279816 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 29.0" "Lineage enriched" "Detected in all" 4 "granulocytes: 29.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043135 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA043135: AB_10794177" "unprognostic (6.83e-2)" "unprognostic (3.52e-2)" "unprognostic (1.69e-2)" "unprognostic (9.42e-2)" "unprognostic (4.15e-2)" "unprognostic (5.88e-2)" "unprognostic (6.12e-2)" "unprognostic (1.19e-3)" "unprognostic (1.15e-2)" "unprognostic (1.57e-2)" "unprognostic (5.77e-2)" "unprognostic (7.29e-2)" "unprognostic (2.70e-3)" "unprognostic (6.10e-2)" "unprognostic (1.89e-1)" "unprognostic (9.15e-2)" "unprognostic (7.84e-2)" 9.9 6.1 8.7 11.9 11.4 26.3 8.0 4.1 10.0 9.6 7.4 10.1 5.8 8.2 10.1 7.4 16.2 9.2 6.6 6.8 9.0 4.2 6.7 5.5 9.9 9.8 13.7 5.7 8.5 7.0 7.4 29.0 12.4 9.1 6.5 8.0 4.7 13.5 8.2 9.8 16.0 10.2 7.8 15.5 12.9 6.8 3.2 14.6 9.3 7.2 6.9 8.7 9.8 12.3 2.8 5.1 29.0 7.0 2.6 2.1 1.4 4.8 3.1 10.6 10.8 1.9 4.3 4.3 3.5 4.7 5.0 4.9 3.1 6.5 0.5 4.0 4.3 2.4 4.6 10.2 6.1 5.7 6.2 2.7 6.8 6.0 1.1 5.4 15.4 11.3 3.7 8.3 4.8 6.2 8.1 6.6 3.7 7.2 12.7 4.3 3.6 2.5 4.2 2.3 6.4 1.9 7.9 5.3 1.0 4.6 10.2 7.6 6.2 3.8 9.9 0.6 6.0 4.5 11.1 8.5 7.6 6.9 2.2 5.9 8.5 6.1 6.4 4.6 3.8 7.4 10.8 7.0 7.2 2.1 5.5 0.8 2.6 1.2 1.2 5.1 2.8 1.0 1.6 29.0 2.6 6.4 4.5 1.5 1.4 8.7 11.4 4.1 10.0 9.0 4.2 13.7 5.7 9.1 14.6 23.8 26.1 5.6 9.4 12.8 21.1 21.6 7.6 21.4 20.5 8.7 15.7 16.9 6.6 5.6 0.2 12.9 15.8 0.0 6.6 4.8 7.5 10.8 26.6 6.6 13.0 33.4 22.3 9.2 49.2 0.4 7.5 43.4 5.0 11.8 15.9 5.6 6.6 17.3 6.7 2.4 23.8 12.9 8.2 0.2 0.6 31.5 28.6 17.5 12.7 22.5 TET3 "hCG_40738, MGC22014" ENSG00000187605 "Tet methylcytosine dioxygenase 3" O43151 2 73986404-74108176 "Enzymes, Predicted intracellular proteins" "Chromatin regulator, Developmental protein, Dioxygenase, DNA-binding, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 44.0;Suprabasal keratinocytes: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050845 Uncertain Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA050845: AB_2681256" "unprognostic (1.07e-2)" "unprognostic (1.21e-2)" "unprognostic (3.08e-1)" "unprognostic (1.12e-2)" "unprognostic (4.44e-2)" "unprognostic (2.75e-2)" "unprognostic (1.72e-3)" "unprognostic (1.46e-1)" "unprognostic (1.01e-1)" "unprognostic (9.83e-2)" "unprognostic (7.74e-2)" "unprognostic (2.03e-1)" "prognostic unfavorable (3.58e-5)" "unprognostic (2.05e-1)" "unprognostic (5.30e-1)" "unprognostic (1.55e-2)" "unprognostic (1.10e-1)" 2.9 2.3 7.2 6.1 10.8 20.9 3.9 26.0 17.1 3.2 5.1 20.6 0.5 6.7 2.9 1.9 10.2 3.0 3.3 1.6 7.1 3.3 2.6 5.1 5.6 4.3 12.0 9.5 2.9 3.6 3.5 4.2 5.7 12.4 3.6 5.5 5.9 5.9 1.8 1.8 18.9 7.2 2.7 5.3 5.5 5.3 2.1 11.7 0.6 3.4 1.7 5.1 4.0 5.0 1.1 1.4 2.5 2.2 0.4 0.9 0.9 6.2 5.5 10.5 6.4 0.9 1.0 19.4 1.3 1.7 2.5 2.0 11.8 5.8 10.5 2.6 1.7 1.1 6.7 9.3 3.7 2.6 4.5 3.7 13.4 4.6 4.0 3.9 14.0 8.3 1.5 9.8 3.1 7.3 3.1 3.8 7.4 9.1 3.5 1.4 10.3 6.9 9.2 5.9 5.4 1.9 10.5 6.6 3.6 2.8 11.7 13.2 11.3 2.8 7.5 3.6 4.4 4.8 11.4 4.8 2.7 11.4 1.3 4.7 3.1 1.3 9.1 1.8 9.8 3.5 0.5 2.0 1.0 0.4 2.2 0.9 1.1 0.5 0.5 1.4 0.9 0.7 0.6 2.5 0.4 0.7 1.4 0.0 0.9 7.2 10.8 26.0 17.1 7.1 3.3 12.0 9.5 12.4 11.7 6.0 7.0 0.0 3.0 44.0 14.5 2.8 5.1 10.7 9.1 1.8 19.6 5.5 0.0 3.0 2.9 5.6 9.5 23.3 3.8 27.5 6.6 4.8 2.3 4.4 8.9 9.5 5.8 3.7 27.8 0.6 0.6 13.8 10.1 9.0 8.4 1.5 5.1 10.5 2.8 1.2 5.8 0.0 5.3 0.5 3.1 59.6 2.1 4.3 6.4 4.8 TEX10 "bA208F1.2, FLJ20287, Ipi1" ENSG00000136891 "Testis expressed 10" Q9NXF1 9 100302077-100352939 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 44.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045434 Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA045434: AB_10965650" "unprognostic (2.88e-2)" "unprognostic (1.73e-2)" "unprognostic (2.80e-1)" "unprognostic (1.21e-1)" "unprognostic (8.28e-2)" "unprognostic (5.26e-2)" "prognostic unfavorable (4.46e-5)" "unprognostic (2.43e-2)" "unprognostic (3.74e-2)" "unprognostic (7.73e-2)" "unprognostic (1.43e-2)" "unprognostic (3.25e-2)" "unprognostic (2.07e-1)" "unprognostic (7.39e-2)" "unprognostic (3.27e-1)" "unprognostic (2.66e-3)" "unprognostic (9.63e-3)" 11.1 8.5 7.6 14.0 10.1 12.2 11.3 12.6 11.1 12.2 9.5 7.7 7.5 6.1 14.2 9.9 12.5 12.1 10.3 10.4 7.7 7.1 7.5 7.9 9.7 15.1 7.3 5.9 14.9 10.3 9.8 13.5 25.4 9.4 10.2 8.1 6.3 10.2 9.1 25.4 16.2 8.7 11.8 9.9 14.4 9.2 24.5 7.2 32.9 10.0 10.2 15.0 11.2 11.9 13.0 9.3 12.4 9.0 9.9 12.6 7.2 11.7 12.9 17.0 19.0 6.2 11.1 26.3 14.8 15.4 19.4 18.1 13.2 13.9 33.4 8.0 9.6 17.9 16.0 24.2 19.1 22.8 13.4 10.7 18.1 8.4 11.5 13.4 26.2 13.6 9.6 10.8 19.7 20.9 9.6 10.5 11.9 20.2 11.0 25.0 18.4 19.1 16.8 34.7 22.9 15.6 18.7 29.0 10.1 14.3 7.7 15.1 12.8 8.1 13.5 13.1 10.9 5.6 7.7 10.7 13.0 11.5 17.3 13.8 7.8 13.2 13.4 13.2 11.8 13.4 12.4 7.6 2.5 9.8 9.0 10.7 12.7 10.0 9.8 9.3 13.0 10.7 12.6 1.9 9.9 6.7 5.4 11.4 7.2 7.6 10.1 12.6 11.1 7.7 7.1 7.3 5.9 9.4 7.2 3.0 9.4 10.0 8.3 19.7 6.7 10.6 0.0 6.7 17.0 8.7 11.8 44.5 3.3 5.8 9.9 8.3 2.1 0.0 7.5 12.7 13.0 6.1 16.2 6.8 8.4 7.9 5.1 6.7 3.8 10.0 8.1 7.5 16.9 7.2 5.2 3.4 6.3 5.3 7.4 3.0 5.9 0.0 12.8 28.4 34.5 19.7 38.6 6.5 6.0 7.1 TEX15 CT42 ENSG00000133863 "Testis expressed 15, meiosis and synapsis associated" Q9BXT5 8 30831544-30913003 "Predicted intracellular proteins" "Differentiation, DNA damage, DNA repair, Meiosis, Spermatogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 5.4;endometrium 1: 10.0;pituitary gland: 6.9;smooth muscle: 8.5;testis: 21.3" "Group enriched" "Detected in some" 4 "Early spermatids: 73.5;Late spermatids: 38.7;Spermatogonia: 62.1" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 8.9;HEL: 20.1;K-562: 5.6;NTERA-2: 3.8;OE19: 4.1;SCLC-21H: 4.3" "Not detected" "Not detected" HPA036800 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA036800: AB_10671714" "unprognostic (3.10e-1)" "unprognostic (2.56e-1)" "unprognostic (3.30e-4)" "unprognostic (3.54e-1)" "unprognostic (2.45e-2)" "unprognostic (2.15e-3)" "unprognostic (2.80e-3)" "unprognostic (4.52e-2)" "unprognostic (5.83e-2)" "unprognostic (2.28e-1)" "unprognostic (1.61e-5)" "unprognostic (8.88e-3)" "unprognostic (1.39e-1)" "unprognostic (2.09e-1)" "unprognostic (4.92e-1)" 0.1 0.1 0.7 0.2 5.4 0.1 0.1 0.1 1.1 1.2 0.1 0.0 0.0 0.1 10.0 0.6 0.2 0.1 0.8 0.1 1.7 0.5 0.1 0.1 0.1 0.1 0.3 0.3 0.4 0.1 0.1 6.9 0.1 0.9 0.1 0.1 0.3 0.1 0.5 0.1 0.1 0.2 8.5 0.4 0.4 0.9 21.3 1.4 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 1.0 0.0 8.9 1.1 0.0 1.2 3.2 20.1 0.0 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 5.6 0.0 0.0 0.1 0.1 0.1 3.8 4.1 0.3 0.0 0.0 0.0 0.0 0.0 4.3 1.4 0.0 0.0 3.7 0.3 0.2 1.1 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 5.4 0.1 1.1 1.7 0.5 0.3 0.3 0.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 38.7 1.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 4.2 0.0 0.0 12.9 0.0 14.2 62.1 0.0 0.1 0.0 0.0 0.0 TEX2 "HT008, KIAA1738, TMEM96" ENSG00000136478 "Testis expressed 2" Q8IWB9 17 64147227-64263301 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 41.1;Late spermatids: 38.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "plasmacytoid DC: 18.1" "Lineage enriched" "Detected in many" 7 "dendritic cells: 18.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020648, HPA057116" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA020648: AB_1857908, HPA057116: AB_2683341" "unprognostic (6.13e-2)" "unprognostic (1.35e-1)" "prognostic favorable (3.90e-6)" "unprognostic (1.69e-2)" "unprognostic (3.84e-2)" "unprognostic (8.34e-2)" "unprognostic (6.97e-2)" "unprognostic (1.59e-1)" "unprognostic (1.24e-1)" "unprognostic (2.53e-1)" "unprognostic (8.39e-2)" "unprognostic (1.11e-1)" "unprognostic (7.97e-2)" "unprognostic (7.00e-2)" "unprognostic (1.87e-1)" "unprognostic (4.53e-3)" "unprognostic (5.59e-3)" 11.7 18.1 22.3 5.0 25.1 11.8 14.3 18.9 22.5 14.0 8.8 22.9 4.2 7.3 10.8 8.7 12.6 10.2 15.8 19.2 23.0 20.1 14.6 23.4 10.7 4.1 29.0 13.8 12.0 21.1 27.2 10.7 8.7 20.5 12.3 10.0 46.2 17.7 13.2 28.1 11.1 7.2 10.8 26.3 8.7 9.1 35.7 17.2 4.9 29.3 10.9 4.9 8.1 8.2 0.6 18.1 0.7 2.6 2.6 1.6 1.4 13.2 6.4 4.0 8.2 19.6 11.6 4.9 18.4 20.9 16.8 11.6 6.0 3.3 4.7 4.8 23.3 10.4 6.6 7.2 22.4 19.1 6.8 5.0 31.6 4.4 11.2 7.3 9.1 5.3 8.5 12.4 11.4 23.4 11.9 8.0 8.0 8.6 5.8 12.5 14.9 8.3 4.2 2.3 10.4 11.6 5.1 36.7 6.6 9.7 6.3 6.2 10.2 9.2 23.6 10.1 23.3 11.1 7.9 9.4 15.7 9.2 12.1 10.6 6.0 8.2 3.1 6.2 8.7 14.1 0.0 2.6 0.7 1.4 0.8 1.6 0.3 1.5 1.6 2.5 0.6 1.6 1.5 0.3 2.6 1.5 18.1 1.0 1.4 22.3 25.1 18.9 22.3 23.0 20.1 29.0 13.8 20.5 17.2 3.0 7.2 2.2 5.5 7.8 4.1 28.9 7.6 8.1 5.7 12.2 5.9 2.1 1.7 4.3 41.1 8.7 5.5 0.0 7.1 1.6 6.4 5.5 3.5 28.6 11.1 9.5 11.6 8.6 7.5 38.4 6.1 3.8 6.8 1.8 10.2 6.0 6.1 2.9 12.0 7.9 18.4 0.0 6.1 14.6 9.5 7.9 1.1 2.2 10.6 4.2 TEX261 "MGC32043, TEG-261" ENSG00000144043 "Testis expressed 261" Q6UWH6 2 70985938-70994945 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 68.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA016631 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA016631: AB_2240434" "unprognostic (3.22e-3)" "unprognostic (2.06e-2)" "unprognostic (2.42e-1)" "prognostic unfavorable (6.17e-4)" "unprognostic (1.05e-1)" "unprognostic (2.97e-2)" "prognostic unfavorable (4.23e-4)" "unprognostic (5.52e-3)" "unprognostic (2.40e-1)" "unprognostic (1.75e-2)" "unprognostic (3.15e-2)" "unprognostic (3.70e-3)" "unprognostic (3.36e-1)" "unprognostic (5.59e-2)" "unprognostic (1.78e-1)" "unprognostic (1.02e-1)" "unprognostic (1.99e-1)" 22.9 27.1 14.5 11.1 15.4 9.3 22.2 13.4 21.4 19.9 15.9 21.6 20.9 13.8 17.3 27.2 17.3 20.9 21.2 21.6 14.4 12.0 25.1 36.9 19.8 16.1 17.0 10.9 23.7 50.8 36.1 20.1 19.3 15.0 18.9 18.9 28.7 22.3 21.0 33.5 12.9 23.6 19.6 17.4 16.0 18.4 23.8 15.3 15.5 31.7 14.3 16.3 14.9 13.9 3.8 4.4 12.0 5.3 3.4 6.7 2.8 20.0 19.0 13.3 16.9 40.7 20.8 15.1 23.2 22.2 27.1 17.1 22.2 16.7 16.4 8.8 40.7 25.6 15.2 25.3 27.7 39.5 12.3 21.1 19.6 9.8 23.5 24.0 22.8 16.5 18.7 18.5 26.0 17.8 14.9 27.5 17.1 24.3 10.9 31.6 15.7 19.6 12.6 8.8 32.6 22.4 14.0 41.2 14.1 19.7 17.6 21.9 11.5 24.1 24.1 15.1 9.4 15.6 13.5 22.0 33.4 28.9 17.7 30.8 8.5 7.5 19.5 29.1 30.1 27.9 12.0 5.3 10.0 5.1 5.3 4.3 2.6 5.4 6.7 4.0 3.8 6.2 4.9 4.0 3.4 5.2 4.4 4.3 2.8 14.5 15.4 13.4 21.4 14.4 12.0 17.0 10.9 15.0 15.3 3.0 17.1 18.2 9.4 7.3 13.4 19.8 17.8 1.4 7.9 22.7 35.3 14.3 6.6 21.9 12.0 14.6 19.3 0.0 20.5 14.3 14.1 13.7 2.3 30.4 17.3 7.9 8.1 18.4 15.1 21.6 14.7 8.4 18.6 9.0 17.0 20.6 18.7 13.6 17.3 14.1 68.9 0.0 16.0 46.6 10.9 6.6 15.0 9.2 16.5 7.1 TEX47 "C7orf62, MGC26647" ENSG00000164645 "Testis expressed 47" Q8TBZ9 7 88794106-88795721 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 158 "testis: 26.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA023817, HPA024163" Uncertain Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA023817: AB_1853868, HPA024163: AB_1853869" "unprognostic (1.43e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TFAP2A "AP-2, AP2TF, TFAP2" ENSG00000137203 "Transcription factor AP-2 alpha" P05549 6 10393186-10419659 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 130.5;retina: 48.1" "Cell type enhanced" "Detected in many" 17 "Cytotrophoblasts: 245.7;Extravillous trophoblasts: 224.5;Syncytiotrophoblasts: 585.5" "Cancer enhanced" "Detected in many" "melanoma: 45.6" "Region enhanced" "Detected in single" "cerebellum: 2.2" "Cell type enriched" "Detected in single" 10 "myeloid DC: 1.0" "Lineage enriched" "Detected in single" 10 "dendritic cells: 1.0" "Cell line enhanced" "Detected in many" "AN3-CA: 28.0;HDLM-2: 31.3;hTCEpi: 30.2;SuSa: 31.6" "Region enhanced" "Detected in single" "cerebellum: 4.3" "Region enhanced" "Detected in single" "cerebellum: 8.6" "CAB000326, HPA056871" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB000326: AB_667767, HPA056871: AB_2683262" "unprognostic (5.97e-2)" "unprognostic (2.18e-1)" "unprognostic (1.31e-2)" "unprognostic (1.14e-1)" "unprognostic (3.87e-2)" "unprognostic (1.27e-1)" "unprognostic (7.62e-5)" "prognostic unfavorable (1.09e-4)" "unprognostic (1.45e-1)" "unprognostic (2.76e-2)" "unprognostic (3.33e-3)" "unprognostic (2.82e-1)" "unprognostic (1.40e-11)" "unprognostic (1.46e-2)" "unprognostic (2.14e-1)" "unprognostic (1.72e-4)" "unprognostic (2.25e-2)" 0.4 0.3 0.3 0.0 0.3 0.0 19.0 2.2 0.5 4.4 0.8 0.0 18.7 0.2 0.5 17.8 18.3 0.4 1.7 0.7 0.3 0.2 6.4 0.2 0.5 0.1 0.2 0.2 0.3 0.3 0.0 0.4 130.5 0.6 5.8 0.2 48.1 19.4 26.7 0.2 36.0 0.4 0.1 0.4 0.2 0.7 1.6 0.0 0.1 0.4 16.6 9.9 2.4 9.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 16.3 6.3 0.0 28.0 0.1 0.0 6.0 12.1 9.3 9.9 9.8 0.6 6.1 0.9 1.6 3.5 5.7 17.5 1.5 20.7 9.5 31.3 15.8 0.1 14.8 0.0 0.0 0.4 0.4 0.0 30.2 0.0 22.0 5.6 0.0 0.3 0.9 0.0 0.1 3.6 0.0 5.1 0.1 1.0 7.8 1.7 1.5 0.6 5.6 6.6 4.1 0.1 14.9 26.2 23.8 31.6 17.3 0.5 0.0 3.0 0.8 2.1 7.6 0.0 1.4 0.2 1.6 0.5 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 2.2 0.3 0.3 0.2 0.2 0.2 0.6 0.0 0.0 0.0 0.0 37.5 116.1 3.1 2.2 0.0 8.1 15.9 29.6 2.0 245.7 6.6 2.0 4.6 0.8 0.0 0.0 0.3 224.5 5.3 38.8 0.0 0.0 17.7 76.3 1.2 0.0 0.0 2.1 0.6 0.2 118.1 0.0 0.5 2.4 2.2 0.0 0.0 0.2 4.2 0.0 2.1 3.9 11.8 120.9 585.5 0.0 0.4 39.3 TFAP2B AP2-B ENSG00000008196 "Transcription factor AP-2 beta" Q92481 6 50818723-50847613 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "epididymis: 65.5" "Cell type enriched" "Detected in some" 4 "Horizontal cells: 413.2" "Cancer enriched" "Detected in some" 8 "breast cancer: 12.1" "Group enriched" "Detected in some" 41 "cerebellum: 4.7;pons and medulla: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 32.4;SH-SY5Y: 60.4" "Region enhanced" "Detected in some" "cerebellum: 11.2" "Low region specificity" "Detected in many" "HPA034683, HPA062942" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA034683: AB_10670966, HPA062942: AB_2684909" "unprognostic (2.02e-1)" "unprognostic (2.29e-2)" "unprognostic (4.27e-2)" "unprognostic (5.88e-4)" "unprognostic (9.76e-2)" "unprognostic (2.10e-1)" "unprognostic (1.00e-1)" "unprognostic (4.57e-1)" "unprognostic (6.58e-6)" "unprognostic (1.13e-2)" "unprognostic (1.88e-1)" "unprognostic (7.17e-3)" 0.2 3.0 0.0 0.0 0.0 0.0 9.4 4.7 0.0 0.2 0.2 0.0 8.8 0.0 0.0 65.5 5.8 0.0 0.0 0.1 0.0 0.1 6.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.2 6.3 0.1 0.0 12.2 7.0 0.6 0.0 6.3 0.0 0.0 1.1 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 60.4 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.1 0.1 0.0 6.3 0.0 0.0 0.0 0.0 0.0 10.4 6.9 0.6 0.0 0.0 0.0 48.8 7.9 10.5 46.4 0.0 11.5 0.3 0.0 0.0 0.0 3.7 0.3 0.0 0.0 0.0 1.0 413.2 0.0 0.0 0.0 0.5 0.0 0.0 101.3 0.0 0.0 2.3 0.0 0.0 0.4 0.7 9.7 0.0 0.0 0.5 0.0 3.8 4.1 0.0 0.0 0.0 TFAP2C "AP2-GAMMA, ERF1, hAP-2g, TFAP2G" ENSG00000087510 "Transcription factor AP-2 gamma" Q92754 20 56629302-56639283 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 53.9;skin 1: 32.5" "Cell type enhanced" "Detected in many" 11 "Basal keratinocytes: 117.7;Cytotrophoblasts: 77.5;Extravillous trophoblasts: 49.1;Suprabasal keratinocytes: 130.6;Syncytiotrophoblasts: 88.3" "Cancer enhanced" "Detected in many" "testis cancer: 54.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "BEWO: 45.8;MCF7: 38.8;SK-BR-3: 73.8;T-47d: 20.6;WM-115: 27.1" "Region enriched" "Detected in single" 13 "olfactory region: 2.9" "Low region specificity" "Detected in many" "CAB016061, CAB016079, HPA055179, HPA057076" Enhanced Supported Nucleoplasm Yes NA Nucleoplasm "CAB016061: AB_667770, CAB016079: AB_2199447, HPA055179: AB_2682729, HPA057076: AB_2683329" "unprognostic (1.74e-2)" "prognostic favorable (6.90e-4)" "unprognostic (2.24e-2)" "unprognostic (2.02e-2)" "unprognostic (1.52e-2)" "unprognostic (6.75e-2)" "unprognostic (2.54e-2)" "unprognostic (8.26e-2)" "unprognostic (2.97e-1)" "unprognostic (1.61e-1)" "unprognostic (3.14e-3)" "unprognostic (2.63e-1)" "unprognostic (9.04e-5)" "unprognostic (2.31e-1)" "unprognostic (1.85e-1)" "unprognostic (6.71e-2)" "unprognostic (3.28e-2)" 1.1 0.3 0.7 0.2 0.4 0.0 16.1 0.4 0.9 17.3 2.4 0.2 7.7 0.0 3.7 3.4 19.6 1.6 2.0 0.4 1.4 0.2 0.7 0.1 2.8 0.0 0.2 0.5 0.3 1.6 0.0 0.6 53.9 0.4 5.7 0.7 1.9 19.7 7.9 1.0 32.5 0.3 0.6 0.4 0.1 0.3 0.7 0.2 0.3 4.2 21.0 10.1 2.1 11.1 0.1 0.2 0.8 0.1 0.2 0.2 0.0 2.9 3.7 0.0 0.0 0.0 0.0 45.8 4.7 8.6 6.0 1.1 0.7 0.0 0.0 0.3 3.1 3.2 10.0 6.4 1.3 4.1 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.4 0.0 5.1 1.7 1.7 0.0 0.0 1.9 0.0 0.7 0.0 38.8 4.7 0.2 2.2 2.3 4.9 0.0 0.0 1.6 0.0 2.3 1.2 0.0 3.1 73.8 4.8 7.1 20.6 1.0 0.0 3.9 0.1 2.0 3.5 0.0 0.0 0.0 0.9 0.0 27.1 0.4 0.1 0.2 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.8 0.2 0.1 0.2 0.1 0.0 0.7 0.4 0.4 0.9 1.4 0.2 0.2 0.5 0.4 0.2 0.0 7.4 0.0 26.2 117.7 0.4 0.9 0.0 5.3 4.5 8.7 0.0 77.5 0.0 0.2 0.2 1.0 0.0 0.0 0.0 49.1 11.3 18.8 0.0 0.0 6.8 0.0 2.9 1.3 0.3 0.0 0.0 0.9 20.3 0.0 1.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 3.6 0.0 1.5 130.6 88.3 0.0 1.7 12.8 TFAP2D TFAP2BL1 ENSG00000008197 "Transcription factor AP-2 delta" Q7Z6R9 6 50713828-50772988 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "brain: 4.4" "Cell type enhanced" "Detected in single" 24 "Horizontal cells: 1.6" "Cancer enriched" "Detected in single" 10 "lung cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HAP1: 5.2;U-2197: 1.6" "Region enriched" "Detected in many" 4 "midbrain: 14.1" "Region enriched" "Detected in many" 7 "midbrain: 16.3" HPA048962 Uncertain "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "HPA048962: AB_2680573" 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TFAP4 "AP-4, bHLHc41" ENSG00000090447 "Transcription factor AP-4" Q01664 16 4257186-4273075 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Collecting duct cells: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 1.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001912 Supported Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA001912: AB_1080251" "unprognostic (1.61e-2)" "unprognostic (1.36e-1)" "unprognostic (5.10e-2)" "unprognostic (4.42e-3)" "unprognostic (8.61e-2)" "unprognostic (1.15e-2)" "prognostic unfavorable (3.32e-4)" "unprognostic (8.05e-2)" "unprognostic (8.97e-2)" "unprognostic (4.60e-1)" "unprognostic (5.75e-2)" "unprognostic (7.68e-2)" "prognostic unfavorable (4.31e-6)" "unprognostic (1.08e-2)" "unprognostic (3.25e-1)" "unprognostic (2.39e-2)" "unprognostic (1.30e-1)" 8.2 7.0 9.6 11.8 9.6 3.4 7.3 31.6 15.6 10.0 6.8 6.6 5.7 11.1 10.1 3.7 9.9 12.5 7.0 4.8 8.0 6.3 4.4 6.3 5.5 11.1 11.1 7.1 18.7 22.2 6.3 6.7 6.9 8.8 9.0 3.9 6.1 13.2 7.0 8.6 12.2 10.1 5.5 12.8 10.2 8.3 3.1 14.9 13.0 8.4 4.5 7.3 7.4 11.0 1.7 0.5 0.9 0.1 0.1 1.2 1.0 7.0 7.4 6.4 9.4 2.7 7.3 10.7 2.7 7.3 4.8 5.2 3.8 11.1 24.2 7.2 2.7 2.2 10.5 11.7 9.4 1.5 14.2 8.3 7.4 6.9 9.9 3.8 13.0 4.3 6.7 6.1 5.2 14.7 2.2 3.1 8.2 13.7 6.5 1.8 11.1 18.3 21.5 14.7 7.1 9.8 16.1 14.3 25.1 1.8 5.3 13.3 10.0 9.2 9.8 9.0 1.0 4.8 10.2 2.0 6.6 5.1 22.9 7.1 10.6 8.8 20.4 4.4 13.0 4.5 0.0 0.0 0.9 0.4 0.0 1.2 1.7 0.2 0.0 0.3 0.4 0.3 0.7 0.0 0.1 0.1 0.5 0.2 1.0 9.6 9.6 31.6 15.6 8.0 6.3 11.1 7.1 8.8 14.9 3.0 0.0 9.1 8.8 19.2 4.4 2.0 10.2 1.4 1.2 26.2 0.0 7.1 6.6 3.4 0.0 2.9 5.4 0.0 4.9 10.4 8.4 3.9 0.0 2.4 3.7 0.0 7.5 4.9 4.1 0.0 10.9 2.9 3.3 0.0 13.4 1.9 2.7 3.5 4.9 3.8 2.1 6.5 6.6 0.9 0.7 19.4 1.8 8.7 15.8 3.3 TFCP2 "CP2, LBP-1C, LSF, TFCP2C" ENSG00000135457 "Transcription factor CP2" Q12800 12 51093663-51173134 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070247 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA070247: AB_2686239" "unprognostic (6.27e-2)" "unprognostic (6.77e-2)" "unprognostic (6.90e-2)" "unprognostic (1.42e-1)" "unprognostic (4.68e-2)" "unprognostic (1.66e-1)" "prognostic unfavorable (1.83e-4)" "unprognostic (1.93e-1)" "prognostic unfavorable (1.18e-4)" "unprognostic (1.14e-1)" "unprognostic (1.32e-1)" "unprognostic (9.69e-2)" "unprognostic (4.91e-3)" "unprognostic (1.01e-1)" "unprognostic (3.20e-1)" "unprognostic (5.58e-2)" "unprognostic (5.31e-2)" 17.4 16.7 21.1 29.3 21.6 9.6 17.7 22.7 21.6 20.2 19.0 20.5 20.8 15.7 19.3 18.9 16.7 21.1 20.7 17.7 20.0 18.7 17.2 12.5 14.1 20.4 19.4 24.9 20.8 14.6 29.2 23.2 22.4 15.4 20.3 21.7 16.4 17.8 19.0 26.6 15.4 15.9 23.8 21.3 18.4 16.1 11.2 18.6 32.1 17.9 12.9 25.9 19.0 18.1 4.5 8.2 9.1 9.4 9.4 6.1 5.0 7.5 13.0 19.5 17.5 11.2 14.1 28.6 14.7 8.0 12.9 7.7 24.8 16.3 0.7 12.9 12.8 10.3 14.5 24.9 15.8 12.9 16.2 14.4 22.9 12.5 10.3 9.4 25.9 22.2 9.6 14.3 13.3 21.2 15.3 12.0 7.5 23.1 0.0 13.6 0.0 23.3 17.2 28.2 17.8 23.6 18.0 10.8 0.1 16.8 18.2 18.6 16.2 18.2 14.9 11.9 19.0 5.6 21.6 12.1 11.9 12.9 12.3 12.7 14.1 23.8 0.0 11.3 16.1 8.5 9.1 9.2 9.0 3.9 7.7 6.1 4.5 4.1 4.2 8.2 3.4 4.9 4.0 3.5 9.4 9.4 3.5 5.4 5.0 21.1 21.6 22.7 19.4 20.0 18.7 19.4 24.9 15.4 18.6 8.9 16.0 9.8 6.7 6.0 19.0 21.8 7.6 2.7 5.7 12.2 19.6 10.4 5.0 8.7 0.4 9.2 9.2 0.0 6.7 8.9 8.4 9.3 10.4 8.9 11.7 9.5 10.4 9.8 24.1 0.4 11.2 12.1 10.1 16.2 11.9 8.7 9.6 8.6 10.3 7.2 25.6 0.0 7.5 6.1 11.1 4.5 14.0 8.7 14.0 5.4 TFDP1 "DILC, Dp-1, DP1, DRTF1" ENSG00000198176 "Transcription factor Dp-1" Q14186 13 113584721-113641470 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 20.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB033605, HPA044754, HPA068909" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB033605: AB_783105, HPA044754: AB_2679074, HPA068909: AB_2686056" "unprognostic (4.28e-2)" "unprognostic (9.50e-3)" "unprognostic (1.77e-2)" "unprognostic (1.09e-1)" "unprognostic (7.01e-2)" "unprognostic (2.10e-2)" "prognostic unfavorable (1.03e-4)" "unprognostic (5.50e-3)" "unprognostic (1.68e-2)" "unprognostic (3.96e-1)" "unprognostic (2.04e-2)" "unprognostic (2.43e-2)" "prognostic favorable (7.57e-4)" "prognostic favorable (6.17e-4)" "unprognostic (2.30e-1)" "unprognostic (1.34e-1)" "unprognostic (9.32e-2)" 16.0 13.3 20.1 28.0 21.1 71.6 16.4 24.4 22.4 19.3 19.6 16.3 28.6 16.0 16.8 20.5 36.2 18.0 27.0 26.3 19.0 16.8 17.9 20.9 16.5 32.5 18.0 12.7 14.4 26.7 9.9 16.3 21.8 15.2 16.0 23.0 20.2 18.9 24.2 26.9 22.3 21.3 18.4 23.5 25.6 16.4 37.5 10.3 38.8 21.7 32.7 34.4 18.5 20.8 3.6 4.7 20.4 4.0 1.6 5.4 2.0 62.0 15.3 19.8 16.8 26.9 24.0 22.5 35.0 31.8 45.5 42.1 31.8 29.2 57.9 11.7 33.5 24.9 29.9 34.3 31.1 44.7 39.4 39.9 33.6 25.0 19.9 16.9 84.3 29.7 19.8 28.0 28.8 16.8 16.3 30.5 21.7 27.6 15.6 40.4 21.3 37.0 32.8 18.2 59.1 19.7 25.3 17.6 33.1 17.3 23.8 51.2 15.1 15.7 43.2 10.5 15.0 29.7 68.0 21.2 14.8 23.6 31.3 38.5 13.3 16.3 59.7 33.0 52.3 25.0 20.4 2.3 3.6 2.6 3.0 2.9 3.6 3.5 3.1 4.7 2.6 5.4 2.7 3.1 1.6 4.0 2.4 4.2 2.0 20.1 21.1 24.4 22.4 19.0 16.8 18.0 12.7 15.2 10.3 8.9 18.6 29.0 26.5 53.0 10.1 22.2 20.4 17.4 14.8 27.9 13.7 64.5 68.0 8.5 3.4 21.1 23.1 93.5 10.3 105.6 35.0 28.2 20.7 49.1 42.0 6.4 38.6 31.3 34.8 7.9 26.4 29.8 33.7 6.4 30.0 8.6 15.2 21.0 26.5 46.4 19.9 6.5 21.2 62.4 52.9 52.4 55.7 23.5 39.7 26.8 TFDP2 Dp-2 ENSG00000114126 "Transcription factor Dp-2" Q14188 3 141944428-142149544 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 140.3" "Cell type enhanced" "Detected in all" 12 "Early spermatids: 731.6;Late spermatids: 294.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "JURKAT: 42.8;MOLT-4: 80.4;REH: 42.9;U-698: 70.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018396, HPA070399" Supported Supported "Nucleoplasm,Vesicles,Mitotic spindle" Yes No Nucleoplasm "Vesicles, Mitotic spindle" "CAB018396: AB_2287284, HPA070399: " "unprognostic (1.35e-2)" "prognostic favorable (6.32e-4)" "unprognostic (8.08e-3)" "unprognostic (2.90e-2)" "unprognostic (4.69e-2)" "unprognostic (1.18e-1)" "unprognostic (1.14e-3)" "unprognostic (2.60e-3)" "unprognostic (5.42e-2)" "unprognostic (1.46e-1)" "unprognostic (5.04e-2)" "unprognostic (2.04e-1)" "prognostic favorable (9.84e-4)" "unprognostic (6.04e-2)" "unprognostic (3.91e-2)" "unprognostic (2.45e-1)" "unprognostic (1.08e-1)" 8.4 8.4 6.1 6.3 8.7 20.7 9.3 9.9 8.6 8.9 11.1 6.5 6.5 10.4 9.9 8.6 8.3 7.2 11.6 12.0 7.5 4.9 14.3 9.5 6.8 5.3 6.0 5.0 11.6 8.8 10.4 19.4 13.5 8.0 9.9 6.6 8.8 7.9 6.9 14.5 8.0 14.6 11.8 8.5 5.3 8.6 51.9 5.4 140.3 10.6 4.8 6.4 9.7 8.0 9.3 16.5 24.6 4.5 18.0 14.7 5.7 6.3 2.9 12.3 9.8 4.1 4.5 27.1 3.2 3.7 5.1 8.3 3.7 6.3 22.5 15.0 3.6 9.0 3.8 3.1 6.1 7.2 9.0 5.6 27.1 4.4 4.9 4.0 8.2 9.6 4.2 4.3 5.6 5.4 4.8 3.5 42.8 10.1 1.2 8.8 4.8 80.4 3.1 9.9 3.3 4.0 42.9 8.5 5.2 5.9 3.3 5.4 5.0 10.8 4.0 5.5 9.6 9.3 4.2 2.3 4.9 4.5 3.9 4.0 4.2 3.8 70.6 3.9 2.2 2.3 24.6 2.1 22.3 14.7 3.4 5.7 6.6 6.7 7.6 4.8 9.3 10.1 11.8 2.4 18.0 4.5 16.5 6.1 5.7 6.1 8.7 9.9 8.6 7.5 4.9 6.0 5.0 8.0 5.4 29.8 20.4 15.7 43.3 22.2 30.3 70.0 38.2 54.9 33.0 45.4 31.4 191.4 79.6 29.5 731.6 22.4 31.6 116.8 23.1 95.8 33.4 41.8 31.3 35.9 24.4 35.0 37.2 20.9 9.2 294.5 71.4 15.0 5.0 17.2 32.3 24.6 24.5 32.3 70.7 74.6 34.6 25.8 21.4 52.6 55.1 17.6 83.0 35.5 42.3 22.7 TFE3 "bHLHe33, TFEA" ENSG00000068323 "Transcription factor binding to IGHM enhancer 3" P19532 X 49028726-49043486 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Adaptive immunity, Immunity, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 10.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023881 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA023881: AB_1857931" "unprognostic (2.68e-2)" "unprognostic (2.89e-3)" "unprognostic (2.40e-2)" "unprognostic (5.36e-2)" "unprognostic (2.71e-2)" "unprognostic (1.81e-1)" "prognostic unfavorable (6.03e-5)" "unprognostic (2.40e-1)" "unprognostic (1.26e-1)" "unprognostic (4.32e-2)" "unprognostic (5.41e-2)" "unprognostic (1.16e-1)" "prognostic unfavorable (2.19e-8)" "unprognostic (1.93e-1)" "unprognostic (8.77e-2)" "unprognostic (4.19e-2)" "unprognostic (6.25e-1)" 31.3 20.9 12.6 18.2 14.4 22.6 53.1 16.5 18.1 22.6 17.7 16.6 30.0 9.9 22.8 21.9 20.5 18.8 16.4 15.1 11.3 11.8 21.6 14.1 22.8 10.3 13.2 9.4 24.4 15.9 16.5 16.3 22.0 15.9 21.2 10.4 15.7 12.6 30.6 13.6 14.1 13.5 21.2 14.8 23.0 14.7 10.4 15.2 4.2 21.7 10.8 10.5 28.6 20.5 1.2 1.9 10.5 4.4 0.4 1.4 1.6 11.8 15.3 5.1 14.7 16.6 15.1 5.1 15.7 18.2 16.0 13.7 9.3 9.5 4.5 6.7 23.0 17.7 9.8 9.6 14.1 13.0 9.8 5.2 4.1 11.3 8.7 22.4 4.3 10.2 13.0 9.1 26.3 18.8 14.9 7.7 3.1 7.9 19.6 13.6 7.0 2.8 4.0 13.9 3.5 13.8 4.3 8.8 10.1 10.2 5.5 4.9 4.8 16.7 7.2 5.5 18.0 10.2 3.9 16.2 17.6 18.8 17.5 8.6 12.1 11.3 3.7 21.0 5.3 12.0 0.0 3.5 1.6 0.5 4.3 0.9 0.6 0.9 0.5 1.9 1.2 0.6 0.4 10.5 0.4 4.4 0.4 1.4 1.6 12.6 14.4 16.5 14.9 11.3 11.8 13.2 9.4 15.9 15.2 14.9 9.1 5.2 18.6 17.5 6.5 6.2 17.8 4.0 11.4 19.2 3.9 13.6 8.3 16.6 0.6 14.6 11.8 0.0 13.7 7.4 16.4 16.4 5.7 13.9 19.2 17.5 12.0 9.8 23.8 1.3 25.3 13.0 8.5 10.0 8.5 9.6 17.6 14.0 23.0 8.6 5.3 12.9 13.3 2.6 0.9 19.3 31.0 8.6 6.5 15.8 TFEB "bHLHe35, TCFEB" ENSG00000112561 "Transcription factor EB" P19484 6 41683978-41736259 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Adaptive immunity, Autophagy, Immunity, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Syncytiotrophoblasts: 100.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 29.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 30.2;Daudi: 19.1;OE19: 25.5;U-698: 28.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049532 Supported Nucleoplasm NA NA Nucleoplasm "HPA049532: AB_2680807" "unprognostic (3.63e-3)" "unprognostic (1.51e-3)" "unprognostic (1.75e-2)" "unprognostic (4.48e-3)" "unprognostic (1.95e-1)" "unprognostic (1.05e-1)" "unprognostic (1.64e-1)" "unprognostic (4.22e-3)" "unprognostic (1.39e-2)" "unprognostic (4.13e-2)" "prognostic favorable (4.77e-4)" "unprognostic (2.12e-2)" "prognostic favorable (1.06e-5)" "unprognostic (1.44e-1)" "unprognostic (3.51e-2)" "unprognostic (2.46e-1)" "unprognostic (1.31e-2)" 8.6 6.4 10.2 16.8 20.7 8.9 6.8 8.6 15.0 6.4 10.5 34.4 8.2 6.8 7.1 4.3 9.3 7.2 9.1 19.3 14.6 8.2 12.2 5.0 8.3 24.1 30.0 6.8 6.7 11.4 26.1 14.9 18.5 16.2 10.7 5.3 6.9 18.0 8.6 45.2 7.9 15.5 8.4 27.4 27.3 7.9 2.5 24.0 2.8 11.1 10.9 18.3 10.8 11.1 22.2 8.5 29.0 9.6 0.8 2.6 4.4 1.7 1.8 0.4 7.0 2.4 1.4 30.2 2.7 5.5 2.4 1.8 4.0 2.0 19.1 3.7 2.9 1.8 4.8 1.1 2.8 0.6 17.5 1.9 0.0 6.9 7.3 4.7 0.5 2.6 0.5 5.4 2.8 1.8 5.8 1.8 2.1 2.3 4.7 0.9 1.2 1.1 1.4 0.1 25.5 0.9 12.6 0.2 2.6 4.3 1.4 7.9 2.3 2.3 4.9 0.6 1.8 1.4 9.5 3.8 0.9 1.9 0.1 1.9 12.3 1.9 28.2 1.4 8.1 0.9 0.1 9.6 8.8 2.6 9.3 0.4 22.2 0.7 1.0 8.5 15.1 0.2 0.9 29.0 0.8 6.5 1.7 0.4 4.4 10.2 20.7 8.6 15.0 14.6 8.2 30.0 6.8 16.2 24.0 8.9 9.4 20.8 7.5 12.6 5.8 16.4 12.7 4.0 1.2 12.2 11.8 37.8 18.3 3.0 0.7 7.7 14.0 0.0 6.2 3.4 5.2 6.4 1.1 3.9 25.2 25.4 12.7 8.6 22.7 4.0 3.1 12.9 0.0 4.6 8.4 16.7 6.9 17.3 10.3 2.4 4.7 6.5 6.2 0.5 0.9 12.7 100.7 5.4 7.9 6.0 TFEC "bHLHe34, TCFEC, TFECL" ENSG00000105967 "Transcription factor EC" O14948 7 115935148-116159896 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 22.6" "Group enriched" "Detected in some" 6 "Hofbauer cells: 40.9;Kupffer cells: 42.8;Macrophages: 48.6;Proximal tubular cells: 52.2" "Cancer enhanced" "Detected in many" "renal cancer: 5.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 8.7;myeloid DC: 7.7" "Group enriched" "Detected in many" 32 "B-cells: 4.9;dendritic cells: 7.7;monocytes: 8.7" "Cell line enhanced" "Detected in some" "HEL: 12.3;HUVEC TERT2: 8.6;THP-1: 16.3;TIME: 9.6;U-937: 18.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB032260, HPA063577" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB032260: AB_2202845, HPA063577: AB_2685047" "unprognostic (1.36e-1)" "unprognostic (1.08e-2)" "unprognostic (8.70e-2)" "unprognostic (1.91e-2)" "unprognostic (1.44e-1)" "unprognostic (2.79e-2)" "unprognostic (1.13e-1)" "unprognostic (8.26e-2)" "unprognostic (2.15e-1)" "unprognostic (6.54e-2)" "unprognostic (2.36e-1)" "unprognostic (1.72e-1)" "unprognostic (2.05e-3)" "unprognostic (2.92e-1)" "unprognostic (4.14e-2)" "unprognostic (1.51e-1)" "unprognostic (3.60e-2)" 11.2 3.5 5.8 15.4 9.2 12.3 7.6 0.8 4.6 1.8 3.7 1.4 0.6 3.4 1.6 6.1 2.4 2.6 4.2 2.5 6.0 2.1 22.6 2.8 15.7 17.0 13.0 2.2 1.6 1.8 0.4 1.8 3.9 8.8 1.9 3.6 0.8 3.1 0.7 1.2 1.3 11.6 2.6 15.2 16.4 2.3 1.7 9.4 1.6 2.1 1.1 10.0 3.8 1.7 4.9 7.7 0.2 8.7 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 2.8 0.0 1.3 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 8.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 16.3 9.6 1.7 0.1 1.0 0.0 4.3 0.0 0.0 0.0 18.5 0.9 0.0 8.7 0.0 0.0 3.7 0.0 4.9 0.0 0.0 7.7 2.1 0.0 0.0 0.2 0.0 0.5 3.9 0.0 1.7 5.8 9.2 0.8 4.6 6.0 2.1 13.0 2.2 8.8 9.4 0.0 2.1 5.0 0.0 0.5 0.0 0.7 2.5 0.0 0.0 3.5 0.0 0.1 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.2 0.3 0.0 2.3 0.0 40.9 0.0 0.0 0.0 42.8 2.7 0.0 48.6 0.0 8.2 0.0 0.0 0.1 0.0 0.0 52.2 0.0 0.0 0.0 0.2 0.4 0.4 0.7 0.0 0.0 0.0 TFF3 "HITF, ITF" ENSG00000160180 "Trefoil factor 3" 21 42311667-42315651 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 230.9;thyroid gland: 258.3" "Cell type enriched" "Detected in many" 21 "Mucus-secreting cells: 36697.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 30 "eosinophil: 9.5" "Lineage enriched" "Detected in single" 63 "granulocytes: 9.5" "Cell line enhanced" "Detected in some" "MCF7: 28.4;OE19: 44.4;SCLC-21H: 8.7;T-47d: 13.3;TIME: 36.9" "Region enriched" "Detected in single" 20 "cerebellum: 1.7" "Not detected" "Not detected" "CAB020681, HPA035464" Enhanced Approved Nucleoplasm,Nucleoli "Secreted to blood" No NA 151000000 Nucleoplasm Nucleoli "CAB020681: , HPA035464: AB_2674636" "unprognostic (2.84e-2)" "unprognostic (3.61e-3)" "unprognostic (1.07e-1)" "prognostic favorable (5.60e-6)" "unprognostic (1.28e-1)" "unprognostic (2.35e-2)" "unprognostic (2.13e-1)" "unprognostic (5.03e-2)" "unprognostic (1.58e-1)" "unprognostic (1.05e-1)" "unprognostic (3.71e-1)" "unprognostic (6.90e-2)" "unprognostic (4.31e-2)" "unprognostic (1.25e-1)" "unprognostic (2.04e-1)" "unprognostic (2.44e-2)" "unprognostic (3.86e-2)" 2.2 1.2 0.2 16.8 0.2 0.0 4.3 0.2 0.2 45.1 66.3 0.2 0.5 40.8 2.8 1.2 5.1 8.0 230.9 0.7 0.2 0.3 1.0 0.6 12.6 0.6 0.4 0.2 2.0 4.8 0.0 0.5 0.5 0.2 3.6 63.3 0.3 54.8 0.7 0.6 1.6 70.6 1.5 0.5 5.0 1.1 0.4 0.2 0.3 258.3 14.4 72.6 1.1 1.6 0.0 0.0 9.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 28.4 0.0 0.5 0.1 44.4 4.3 0.0 3.2 0.3 0.0 0.0 8.7 0.1 0.0 0.8 0.0 0.0 13.3 0.0 36.9 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.3 0.4 0.2 0.2 0.2 14.9 22.3 0.9 17.0 37.0 0.0 13.4 1110.8 464.4 316.2 21.0 0.0 0.3 0.0 9.0 0.0 51.4 1768.3 0.0 62.1 0.6 20.3 103.0 60.8 0.9 1.9 4.8 740.8 82.9 2.6 0.8 2.3 2.5 91.1 0.0 36697.4 0.0 28.0 1779.2 7.4 0.0 0.0 0.0 6.1 0.3 0.3 33.8 0.7 1.0 1243.2 29.6 TFIP11 "DKFZP434B194, Spp382, TIP39" ENSG00000100109 "Tuftelin interacting protein 11" Q9UBB9 22 26491225-26512505 "Plasma proteins, Predicted intracellular proteins" "Biomineralization, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027085 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA027085: AB_1857964" "unprognostic (1.53e-1)" "unprognostic (1.86e-1)" "unprognostic (4.87e-2)" "unprognostic (9.14e-2)" "unprognostic (3.24e-2)" "unprognostic (3.86e-2)" "unprognostic (6.28e-2)" "unprognostic (2.63e-1)" "unprognostic (1.76e-1)" "unprognostic (3.01e-1)" "unprognostic (4.38e-2)" "unprognostic (2.34e-1)" "unprognostic (2.96e-3)" "unprognostic (1.46e-2)" "unprognostic (9.24e-2)" "unprognostic (1.18e-1)" "unprognostic (2.62e-1)" 11.8 13.5 12.7 12.7 13.8 43.9 10.9 13.8 15.4 9.4 9.5 13.1 8.9 9.9 11.8 8.9 14.5 10.7 10.3 11.8 13.2 9.6 12.3 24.7 11.0 17.7 15.5 12.0 10.3 16.3 11.1 12.0 11.5 12.2 10.5 9.8 11.9 10.9 8.7 34.2 16.3 12.7 10.2 10.6 17.8 11.1 40.6 12.3 23.8 15.4 11.0 19.0 11.1 11.5 23.8 15.5 35.4 23.8 19.6 25.5 17.8 11.1 13.2 11.4 12.9 18.3 11.1 11.5 13.7 17.5 21.5 20.4 9.9 8.1 21.8 8.6 17.0 14.2 16.6 16.3 13.2 15.9 15.9 15.5 13.4 8.5 10.1 16.8 31.0 17.2 14.2 18.0 20.4 16.1 11.6 16.4 11.3 18.0 20.8 14.3 13.7 14.1 17.0 11.0 16.3 11.0 21.4 17.6 19.3 12.4 11.3 8.7 12.5 16.4 11.8 16.1 11.8 9.6 14.7 16.1 18.2 29.7 11.4 12.6 15.4 19.6 43.1 14.4 12.5 13.5 35.4 16.9 28.6 23.8 18.2 22.1 22.9 21.1 22.2 15.5 23.8 20.2 18.4 26.8 19.6 23.8 9.7 25.5 17.8 12.7 13.8 13.8 15.4 13.2 9.6 15.5 12.0 12.2 12.3 8.9 8.9 8.2 9.4 14.9 8.0 2.8 15.3 9.4 10.3 12.2 7.9 14.9 11.6 12.8 41.4 9.5 11.9 0.0 17.8 11.7 7.3 6.8 8.1 9.7 11.7 14.3 15.5 11.1 5.6 5.4 10.3 7.4 6.8 10.0 9.6 7.3 21.6 7.6 9.2 8.0 6.4 0.0 5.9 15.6 21.3 14.6 16.2 11.7 7.1 10.0 TFPT "amida, FB1, INO80F" ENSG00000105619 "TCF3 fusion partner" P0C1Z6 19 54107013-54115675 "Disease related genes, Predicted intracellular proteins" "Apoptosis, DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.4" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 114.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034958, HPA058534" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA034958: AB_10603036, HPA058534: AB_2683745" "unprognostic (1.76e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (5.13e-4)" "unprognostic (6.56e-2)" "unprognostic (2.13e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (5.25e-4)" "unprognostic (3.85e-1)" "unprognostic (2.85e-1)" "unprognostic (2.71e-1)" "prognostic favorable (3.13e-4)" "unprognostic (1.80e-2)" "unprognostic (1.15e-1)" "unprognostic (2.00e-2)" "unprognostic (2.61e-1)" "unprognostic (3.43e-1)" "unprognostic (3.66e-2)" 5.9 6.5 33.4 8.9 17.0 7.9 5.1 9.6 22.9 7.9 5.3 8.7 4.3 10.1 5.9 5.3 4.1 5.1 7.1 7.7 24.4 15.5 4.3 3.6 7.9 11.6 18.3 16.1 4.2 4.0 3.3 4.2 6.4 10.8 15.9 2.9 4.8 12.9 5.2 10.8 6.8 10.7 4.7 9.7 14.1 14.5 4.6 12.8 9.6 5.2 3.2 4.8 5.3 3.9 4.4 24.7 5.0 3.9 10.4 13.3 5.5 2.5 2.2 2.2 4.3 0.4 0.8 2.1 2.4 1.8 2.2 2.7 2.6 8.2 2.5 6.0 2.4 1.1 2.7 0.8 1.3 0.7 6.6 11.8 3.0 4.1 3.4 6.3 4.0 6.6 1.7 0.8 1.5 1.1 2.0 3.5 6.2 2.7 3.7 3.5 9.4 7.2 12.7 2.5 4.9 5.0 5.9 1.5 3.4 1.6 11.9 6.0 5.1 0.8 9.7 13.1 0.6 2.5 14.3 8.0 16.5 3.3 1.2 3.4 6.4 6.7 1.9 7.0 11.1 13.9 5.0 3.7 3.6 8.1 3.9 7.7 4.4 11.6 10.7 9.5 4.2 9.0 9.5 2.4 10.4 1.2 24.7 13.3 5.5 33.4 17.0 9.6 22.9 24.4 15.5 18.3 16.1 10.8 12.8 14.9 7.4 21.5 10.2 15.0 9.5 1.6 12.7 6.7 12.5 21.0 2.0 19.5 13.3 17.6 6.1 25.2 20.0 0.0 23.9 22.7 13.1 34.2 15.0 7.4 114.8 0.0 15.0 37.4 28.0 4.0 11.2 38.7 37.1 65.9 29.8 13.4 41.2 17.3 15.9 19.6 9.4 6.5 9.2 6.0 12.3 15.2 21.9 19.7 13.4 9.0 TGDS "SDR2E1, TDPGD" ENSG00000088451 "TDP-glucose 4,6-dehydratase" O95455 13 94574051-94596257 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Lyase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 42.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039927, HPA040857" Approved Approved Nucleoplasm,Nucleoli,Cytosol Yes No Nucleoplasm "Nucleoli, Cytosol" "HPA039927: AB_10795238, HPA040857: AB_10794867" "unprognostic (4.07e-2)" "unprognostic (3.56e-1)" "unprognostic (2.66e-2)" "unprognostic (2.76e-1)" "unprognostic (1.27e-1)" "unprognostic (2.25e-2)" "unprognostic (1.60e-1)" "unprognostic (2.87e-1)" "unprognostic (9.99e-2)" "unprognostic (1.96e-1)" "unprognostic (9.17e-2)" "prognostic unfavorable (2.48e-4)" "unprognostic (5.51e-2)" "unprognostic (1.13e-2)" "unprognostic (2.26e-1)" "unprognostic (1.71e-2)" "unprognostic (1.09e-1)" 11.1 12.2 7.9 11.4 11.8 5.8 13.4 8.0 7.8 11.9 9.0 9.0 13.4 11.1 13.7 13.2 10.3 10.5 8.7 7.7 7.0 7.0 11.8 31.9 7.8 12.5 11.8 6.8 13.9 14.1 6.2 24.3 10.8 10.1 10.5 10.6 15.4 12.5 12.7 7.6 7.9 11.1 10.3 12.6 11.9 9.8 7.2 12.6 27.1 15.8 8.9 12.5 10.9 9.2 9.9 8.0 10.5 7.0 10.4 17.4 6.7 7.4 3.1 5.2 4.7 7.7 6.2 6.5 6.8 6.5 6.4 6.2 8.5 7.3 11.4 6.9 4.7 4.2 4.7 9.2 5.3 6.6 9.0 3.6 9.2 3.6 7.9 9.8 31.4 6.3 7.2 4.2 3.6 10.3 5.1 5.9 8.4 9.0 4.0 5.8 4.5 8.6 16.2 6.9 12.0 4.0 7.3 5.3 6.7 8.1 3.3 7.4 4.1 5.1 10.8 19.0 9.1 4.8 17.1 5.5 2.6 6.8 3.9 5.6 9.1 4.9 42.1 7.0 11.7 7.0 10.5 5.3 9.6 9.6 6.2 14.5 9.9 11.3 10.5 8.0 7.3 17.4 12.4 1.5 10.4 7.0 7.1 12.5 6.7 7.9 11.8 8.0 7.8 7.0 7.0 11.8 6.8 10.1 12.6 11.9 5.0 15.6 9.5 2.2 4.5 4.7 0.0 10.7 10.3 7.0 2.0 12.9 8.3 9.8 1.1 6.3 5.5 0.0 8.0 15.4 12.0 9.9 10.5 19.8 10.0 1.6 5.2 9.2 7.6 0.4 13.3 9.6 8.5 12.6 8.1 6.3 8.2 7.0 7.8 13.3 4.0 25.8 6.4 12.0 10.4 3.1 8.7 8.7 8.0 8.7 TGIF1 "HPE4, TGIF" ENSG00000177426 "TGFB induced factor homeobox 1" Q15583 18 3411608-3459978 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Holoprosencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 533.4;Basal keratinocytes: 319.4;Urothelial cells: 322.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA062160 Supported Nucleoplasm NA Yes Nucleoplasm "HPA062160: AB_2684701" "unprognostic (1.11e-2)" "unprognostic (5.20e-2)" "unprognostic (2.40e-1)" "unprognostic (1.97e-1)" "unprognostic (3.57e-3)" "unprognostic (3.10e-2)" "unprognostic (2.75e-1)" "unprognostic (4.34e-2)" "unprognostic (1.94e-2)" "unprognostic (1.96e-3)" "prognostic unfavorable (6.47e-4)" "unprognostic (9.60e-2)" "unprognostic (1.12e-2)" "unprognostic (9.81e-2)" "unprognostic (4.60e-1)" "unprognostic (7.07e-2)" "unprognostic (2.48e-3)" 31.9 16.6 6.9 17.2 9.3 11.2 22.0 2.7 6.2 26.8 23.8 15.5 48.4 9.6 32.7 47.3 27.1 24.8 31.4 12.9 6.5 7.2 24.7 33.6 27.9 10.6 8.1 5.9 23.0 20.2 5.3 10.2 49.6 9.9 33.2 22.4 15.3 25.1 29.8 21.2 22.9 16.6 18.5 8.6 23.1 19.8 23.1 9.2 18.1 60.2 11.2 21.0 40.5 29.0 18.2 14.0 20.4 17.3 7.4 27.5 12.7 6.2 28.5 18.7 6.0 19.1 25.8 45.7 12.0 46.0 9.8 12.6 11.2 28.6 0.3 4.0 9.8 33.0 6.4 7.1 13.4 13.0 2.5 3.0 0.8 13.6 21.2 35.9 9.0 7.5 17.9 57.8 17.8 47.5 27.0 20.9 4.3 6.4 0.1 19.2 12.2 5.8 11.0 47.6 22.6 6.3 6.2 8.4 2.0 40.3 30.7 5.2 5.2 31.6 24.8 17.5 32.7 5.7 8.1 8.9 15.4 13.4 18.1 7.5 1.0 0.1 2.8 15.8 3.4 19.3 20.4 17.3 2.9 25.9 6.5 27.5 18.2 21.6 25.2 14.0 12.8 15.5 18.0 7.8 7.4 6.1 1.4 11.4 12.7 6.9 9.3 2.7 6.2 6.5 7.2 8.1 5.9 9.9 9.2 32.8 38.1 22.9 533.4 319.4 0.0 4.8 61.1 58.9 46.6 116.9 0.0 126.0 41.4 90.1 18.0 35.0 23.5 23.3 65.8 139.4 114.7 314.8 67.9 27.2 66.3 1.6 44.5 17.2 38.3 5.0 26.4 53.4 72.6 105.6 69.3 6.0 95.9 60.4 14.5 79.5 0.0 32.3 126.7 5.0 13.2 224.7 125.7 55.4 72.7 322.0 TGIF2 ENSG00000118707 "TGFB induced factor homeobox 2" Q9GZN2 20 36573488-36593950 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Basal keratinocytes: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA053786, HPA064522" Enhanced Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA053786: AB_2682261, HPA064522: " "unprognostic (1.42e-2)" "unprognostic (8.27e-2)" "unprognostic (2.80e-1)" "unprognostic (2.10e-3)" "unprognostic (4.50e-2)" "unprognostic (2.10e-1)" "unprognostic (7.19e-2)" "unprognostic (4.88e-2)" "unprognostic (2.70e-2)" "unprognostic (1.77e-1)" "unprognostic (6.73e-2)" "unprognostic (1.51e-1)" "unprognostic (3.75e-2)" "unprognostic (8.53e-2)" "unprognostic (1.22e-1)" "unprognostic (8.79e-3)" "unprognostic (1.14e-2)" 14.0 6.1 2.8 20.0 3.1 4.1 7.8 1.3 3.5 13.7 8.8 4.0 3.5 3.2 23.7 7.9 6.8 18.0 10.2 7.6 2.7 2.5 9.2 13.2 13.7 16.6 4.4 1.6 17.9 33.3 10.5 3.4 9.1 3.9 9.3 3.7 12.1 14.9 5.7 4.1 5.6 8.1 13.7 3.2 20.3 7.0 16.9 2.8 26.7 12.9 6.9 22.1 10.0 7.2 8.2 7.7 14.7 5.4 4.2 7.6 3.8 7.0 1.7 20.3 23.0 3.0 2.7 7.4 4.0 4.7 9.7 7.3 10.4 9.0 19.0 10.7 3.9 4.4 7.3 16.5 10.5 9.5 8.9 5.9 23.8 4.1 13.7 4.6 10.0 5.8 4.3 7.0 2.0 7.6 8.8 9.6 9.2 11.4 11.7 4.7 10.0 17.0 19.2 17.0 10.3 5.1 14.7 24.3 10.3 6.4 4.7 6.1 18.1 1.3 10.8 10.1 17.0 12.9 22.5 6.9 1.5 6.4 0.1 7.6 13.4 5.0 17.9 0.1 12.1 7.6 14.7 5.4 1.7 4.8 4.9 5.2 8.2 4.4 4.9 7.4 6.5 7.6 6.3 2.2 4.2 3.4 7.7 4.2 3.8 2.8 3.1 1.3 3.5 2.7 2.5 4.4 1.6 3.9 2.8 8.9 9.1 6.5 26.2 39.6 0.1 11.2 12.7 5.3 9.1 7.0 2.0 5.2 6.6 16.4 2.0 14.3 0.0 0.0 6.7 1.0 16.9 15.0 16.1 5.9 8.7 0.0 6.3 11.6 7.0 1.9 5.8 8.8 13.5 7.2 2.6 7.2 13.3 6.2 7.1 6.1 1.9 6.5 15.6 2.3 25.6 22.2 7.6 12.8 3.3 13.9 TGIF2LX ENSG00000153779 "TGFB induced factor homeobox 2 like, X-linked" Q8IUE1 X 89921882-89922883 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 13.3" "Group enriched" "Detected in some" 57 "Early spermatids: 59.2;Late spermatids: 39.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "SH-SY5Y: 10.2;U-2 OS: 12.0;U-266/84: 18.5" HPA034543 Supported Approved Nucleoplasm No No Nucleoplasm "HPA034543: AB_10603037" "unprognostic (1.45e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 12.0 0.3 0.0 1.0 18.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.0 TGOLN2 "TGN38, TGN46, TGN48, TGN51, TTGN2" ENSG00000152291 "Trans-golgi network protein 2" O43493 2 85318020-85328425 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB011489, HPA012609, HPA012723" Enhanced Enhanced "Nucleoplasm,Golgi apparatus" NA NA 9800000 "Golgi apparatus" Nucleoplasm "CAB011489: AB_443302, HPA012609: AB_1857976, HPA012723: AB_1857975" "unprognostic (3.03e-2)" "unprognostic (1.82e-2)" "unprognostic (2.35e-1)" "unprognostic (4.39e-2)" "unprognostic (3.90e-2)" "unprognostic (2.66e-1)" "unprognostic (5.50e-3)" "unprognostic (2.49e-1)" "unprognostic (2.98e-1)" "unprognostic (1.52e-2)" "unprognostic (5.19e-2)" "unprognostic (2.72e-2)" "unprognostic (6.30e-2)" "unprognostic (2.83e-2)" "unprognostic (3.22e-2)" "unprognostic (2.04e-2)" "unprognostic (5.37e-2)" 40.0 40.7 34.3 38.4 38.0 55.6 36.5 51.7 43.1 33.3 50.0 38.7 31.5 53.2 41.2 31.1 23.9 33.3 44.9 43.2 31.9 34.4 59.6 66.2 44.1 37.4 35.4 36.7 36.1 34.4 39.5 21.8 50.4 35.8 34.0 50.1 26.9 38.9 36.5 23.7 23.7 63.1 36.0 40.3 47.1 36.8 22.3 33.2 31.8 44.8 17.0 37.7 39.9 32.9 9.4 14.9 34.2 34.1 8.6 12.3 22.7 11.3 29.4 12.5 16.5 30.2 31.7 29.2 34.6 40.4 23.5 18.9 24.5 34.5 14.3 27.4 47.8 32.3 18.6 9.0 16.9 39.1 23.3 9.0 20.4 10.4 26.3 16.4 39.5 47.4 23.4 10.8 30.4 18.4 36.6 34.0 12.1 11.8 23.5 34.7 10.3 12.7 20.1 11.1 25.4 12.0 13.5 46.0 10.5 25.3 17.9 11.8 9.8 30.2 22.8 20.0 15.4 12.7 17.8 36.0 50.5 18.8 38.1 41.4 15.3 19.7 13.9 37.4 30.7 32.9 17.6 27.5 23.5 12.3 26.9 9.6 9.4 9.2 8.3 14.9 9.1 9.6 9.1 34.2 8.6 34.1 5.6 7.2 22.7 34.3 38.0 51.7 43.1 31.9 34.4 35.4 36.7 35.8 33.2 95.3 89.8 56.6 49.3 34.0 49.1 62.0 180.9 111.1 77.3 171.0 37.3 50.3 8.3 79.9 4.7 71.6 170.0 0.0 81.2 69.6 67.3 78.0 151.6 221.1 103.3 197.0 86.0 81.6 146.0 5.6 45.8 116.6 57.3 39.7 94.6 52.5 79.1 98.9 65.0 89.4 34.5 64.7 48.7 22.3 32.7 30.6 37.3 74.8 88.0 60.7 THAP1 "4833431A01Rik, DYT6, FLJ10477" ENSG00000131931 "THAP domain containing 1" Q9NVV9 8 42836674-42843325 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" DNA-binding "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071310 Supported Nucleoplasm No No Nucleoplasm "HPA071310: AB_2686386" "unprognostic (8.99e-3)" "unprognostic (3.97e-3)" "unprognostic (7.15e-3)" "unprognostic (1.87e-2)" "unprognostic (2.55e-1)" "unprognostic (6.38e-2)" "unprognostic (1.20e-1)" "unprognostic (4.03e-1)" "unprognostic (3.91e-2)" "unprognostic (5.95e-2)" "unprognostic (9.43e-2)" "unprognostic (9.19e-2)" "unprognostic (2.94e-2)" "unprognostic (1.28e-1)" "unprognostic (2.82e-1)" "unprognostic (1.95e-1)" "unprognostic (3.16e-2)" 12.7 12.8 12.0 11.5 12.6 12.8 19.7 16.7 12.5 14.3 14.2 9.2 9.8 10.5 13.3 11.7 13.2 13.6 9.3 15.9 12.3 11.6 14.3 15.9 9.7 15.2 12.4 9.4 15.5 11.9 11.6 16.3 12.3 13.4 15.7 10.0 6.8 10.4 11.7 21.8 7.1 15.3 12.8 13.7 16.1 10.7 16.2 14.1 26.4 17.7 8.9 14.5 13.9 30.1 16.1 15.6 23.3 14.9 14.7 24.7 13.8 9.1 8.3 7.8 7.5 11.9 13.6 9.4 12.8 9.8 11.8 10.9 7.1 12.0 11.3 10.5 9.4 17.5 9.6 12.7 10.8 15.1 10.9 9.4 11.0 7.7 8.3 14.7 9.1 11.7 10.6 16.3 13.0 16.9 11.5 15.0 15.4 12.2 13.5 13.7 5.7 21.8 10.6 15.4 15.0 6.7 9.9 14.0 9.0 12.8 7.0 6.3 7.5 14.0 8.8 17.6 10.8 12.4 10.3 9.0 10.4 7.7 13.8 12.7 11.0 11.8 10.9 10.4 12.1 11.3 17.2 14.9 23.3 16.6 12.9 18.1 16.1 19.7 18.4 15.6 13.3 23.4 18.3 17.7 14.7 13.3 7.7 24.7 13.8 12.0 12.6 16.7 12.5 12.3 11.6 12.4 9.4 13.4 14.1 8.9 6.5 22.3 8.0 11.9 10.3 17.9 2.5 13.4 9.1 5.2 0.0 17.8 19.9 15.8 28.0 12.4 8.0 0.0 10.0 19.6 12.1 9.2 16.1 9.9 13.5 22.3 13.7 7.4 10.3 15.2 10.6 9.5 6.8 19.0 6.4 11.8 10.7 3.5 13.1 17.0 8.0 0.0 16.0 27.2 46.2 12.0 6.8 21.8 8.6 6.0 THAP10 ENSG00000129028 "THAP domain containing 10" Q9P2Z0 15 70881342-70892785 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 17.0;Collecting duct cells: 10.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "non-classical monocyte: 7.3" "Lineage enriched" "Detected in many" 6 "monocytes: 7.3" "Cell line enhanced" "Detected in many" "U-2197: 27.6" "HPA041416, HPA073220" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA041416: AB_10795592, HPA073220: " "unprognostic (1.00e-1)" "unprognostic (3.51e-1)" "unprognostic (5.42e-2)" "unprognostic (2.43e-2)" "unprognostic (1.34e-1)" "unprognostic (6.15e-2)" "unprognostic (6.25e-2)" "unprognostic (2.16e-2)" "unprognostic (2.99e-2)" "unprognostic (6.47e-2)" "unprognostic (1.55e-3)" "unprognostic (3.71e-2)" "prognostic favorable (3.05e-5)" "unprognostic (1.25e-2)" "unprognostic (2.12e-2)" "unprognostic (7.46e-2)" "unprognostic (9.44e-3)" 3.3 4.6 7.5 2.5 10.9 0.3 3.9 13.4 16.0 4.8 4.1 9.9 0.8 4.3 4.2 4.0 3.9 6.3 3.0 9.4 7.8 10.3 5.8 3.7 3.6 1.8 9.5 6.5 7.8 3.7 8.7 4.6 3.6 11.7 5.7 3.8 7.0 3.7 6.5 3.8 2.4 2.4 4.1 11.6 1.8 5.1 6.2 7.6 0.2 7.0 1.8 1.6 5.5 3.8 0.6 1.1 0.0 7.3 0.8 0.4 0.2 4.7 8.2 5.3 6.8 2.7 3.2 0.1 9.2 4.0 7.9 9.4 1.2 6.5 0.0 5.8 2.4 9.9 7.3 11.2 2.1 7.0 0.0 5.8 1.7 4.7 0.5 1.4 0.4 3.5 1.1 3.5 4.4 4.2 5.6 3.8 0.0 0.5 0.0 5.2 3.6 0.0 1.6 7.8 3.5 3.2 0.0 6.7 0.2 3.1 3.9 5.7 6.1 6.3 2.7 3.9 5.5 3.2 3.8 3.0 5.6 3.8 27.6 6.4 2.3 2.7 0.0 3.3 0.6 7.8 0.0 0.6 0.0 0.1 0.9 0.1 0.6 0.4 0.0 1.1 0.3 0.0 0.3 0.0 0.8 7.3 0.0 0.3 0.2 7.5 10.9 13.4 16.0 7.8 10.3 9.5 6.5 11.7 7.6 0.0 0.3 0.0 3.6 1.5 17.0 5.5 0.0 4.0 1.2 10.4 0.0 0.1 8.3 2.5 6.1 2.2 0.8 0.0 1.0 0.2 2.2 1.8 0.0 1.0 1.2 1.6 2.9 0.6 0.3 4.7 2.3 0.9 0.0 0.0 1.3 4.7 0.7 2.9 4.6 4.8 4.1 0.0 2.0 9.9 1.9 1.3 0.1 0.0 2.9 3.7 THAP11 "CTG-B43a, CTG-B45d, HRIHFB2206" ENSG00000168286 "THAP domain containing 11" Q96EK4 16 67842082-67844195 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041434, HPA042189, HPA072537" Supported Supported Nucleoplasm,Cytosol NA No Nucleoplasm Cytosol "HPA041434: AB_10960385, HPA042189: AB_10964636, HPA072537: " "unprognostic (1.43e-1)" "unprognostic (2.51e-1)" "unprognostic (2.82e-1)" "unprognostic (1.54e-3)" "unprognostic (1.93e-3)" "unprognostic (1.40e-2)" "unprognostic (1.56e-3)" "unprognostic (1.00e-1)" "unprognostic (1.26e-1)" "unprognostic (2.34e-1)" "unprognostic (1.66e-1)" "unprognostic (9.51e-2)" "unprognostic (2.97e-1)" "unprognostic (2.11e-1)" "unprognostic (2.10e-2)" "unprognostic (4.59e-2)" "unprognostic (5.87e-2)" 15.2 12.1 13.4 13.5 14.5 8.5 31.4 15.0 17.2 23.8 19.1 16.7 13.0 12.0 19.9 13.3 18.9 18.0 16.7 29.5 12.4 12.4 13.9 13.5 14.9 22.2 11.8 9.7 22.6 23.1 17.2 13.3 14.2 12.7 20.4 11.0 17.2 14.8 20.6 40.7 17.7 16.0 19.8 10.4 21.0 15.8 11.8 9.8 30.2 29.0 17.3 18.0 21.7 27.1 10.3 8.7 8.5 10.8 11.5 19.9 10.6 12.5 16.4 11.5 10.8 16.1 11.0 12.1 6.5 11.2 15.6 13.5 21.0 9.8 27.5 13.4 6.5 9.4 14.8 20.1 11.9 8.9 10.2 23.0 10.9 9.5 25.5 14.7 13.9 12.5 10.1 11.8 10.7 9.4 11.4 11.4 19.0 15.7 6.4 9.4 19.6 15.0 25.0 23.1 15.0 14.4 29.7 13.7 24.7 7.8 8.2 16.1 18.2 18.8 6.8 13.5 8.6 16.7 14.3 9.1 10.0 12.2 9.0 7.9 25.8 25.6 27.1 7.7 15.4 10.7 3.5 8.4 8.5 16.8 10.8 13.4 8.9 15.4 15.4 8.7 10.3 19.9 15.8 2.5 11.5 9.7 7.0 18.4 10.6 13.4 14.5 15.0 17.2 12.4 12.4 11.8 9.7 12.7 9.8 20.8 12.5 18.4 21.0 26.0 25.3 13.7 10.2 5.3 4.5 10.4 3.9 17.7 44.7 7.4 0.8 21.5 10.9 0.0 8.1 20.8 20.6 18.6 7.0 10.9 19.5 7.9 12.7 17.2 15.0 1.7 21.9 13.4 10.1 15.4 14.6 27.8 6.0 0.0 29.4 16.5 13.5 19.4 23.6 17.9 25.4 34.3 11.3 30.5 16.0 14.7 THAP12 "DAP4, P52rIPK, PRKRIR, THAP0" ENSG00000137492 "THAP domain containing 12" O43422 11 76349956-76380971 "Plasma proteins, Predicted membrane proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 23.8;Alveolar cells type 2: 25.9;Exocrine glandular cells: 22.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 71.5" "Low region specificity" "Detected in all" HPA008758 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA008758: AB_1855714" "unprognostic (2.79e-1)" "unprognostic (9.79e-2)" "unprognostic (1.16e-3)" "unprognostic (6.47e-2)" "unprognostic (8.85e-3)" "unprognostic (1.23e-1)" "unprognostic (4.03e-3)" "unprognostic (1.08e-1)" "unprognostic (6.68e-3)" "unprognostic (1.48e-1)" "unprognostic (1.57e-2)" "unprognostic (2.65e-2)" "unprognostic (7.98e-2)" "unprognostic (2.06e-1)" "unprognostic (3.95e-2)" "unprognostic (1.54e-1)" "unprognostic (4.79e-2)" 17.0 15.4 19.4 15.5 16.9 17.1 26.4 28.8 15.5 14.6 14.5 7.1 7.2 11.9 17.9 13.7 12.5 14.9 10.2 20.6 13.6 11.2 17.0 25.3 13.2 18.5 11.7 8.7 15.2 32.3 10.4 16.2 20.1 14.2 12.8 16.3 8.2 12.4 12.6 20.6 9.3 14.5 13.8 12.7 21.9 13.8 14.4 13.4 43.2 16.3 11.6 17.2 11.9 23.3 5.1 2.9 2.0 2.1 7.5 7.7 2.4 10.7 8.7 16.6 9.3 11.3 16.2 10.0 11.2 11.7 14.2 12.6 17.3 11.6 29.5 17.2 10.7 12.4 10.7 20.2 13.3 22.8 22.1 6.4 21.0 6.2 8.0 12.5 26.6 10.5 11.5 17.6 12.6 23.7 8.6 12.2 21.1 24.3 16.7 12.6 11.7 22.9 15.0 6.8 28.9 9.5 17.2 37.9 30.5 8.2 11.5 16.2 10.8 10.9 12.1 5.9 11.6 12.2 10.5 10.9 17.0 27.9 34.5 9.8 14.9 15.7 71.5 4.1 14.9 9.1 1.1 2.1 2.0 6.6 2.1 7.7 4.9 6.9 7.2 2.9 5.1 5.1 6.6 0.6 7.5 2.0 1.3 6.3 2.4 19.4 16.9 28.8 15.5 13.6 11.2 11.7 8.7 14.2 13.4 23.8 25.9 0.0 0.0 0.0 0.0 0.0 0.0 10.7 11.4 10.4 0.0 12.3 11.6 9.5 0.0 0.0 0.0 0.0 22.9 18.1 0.0 0.0 7.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 14.4 0.0 0.0 13.9 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 THAP2 DKFZP564I0422 ENSG00000173451 "THAP domain containing 2" Q9H0W7 12 71663009-71680639 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 335.0;Late spermatids: 120.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039790 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA039790: AB_10795157" "unprognostic (5.62e-2)" "unprognostic (2.01e-1)" "unprognostic (5.55e-2)" "unprognostic (2.90e-2)" "unprognostic (1.80e-2)" "unprognostic (1.51e-4)" "unprognostic (1.24e-4)" "unprognostic (7.00e-2)" "unprognostic (1.02e-1)" "unprognostic (7.20e-2)" "unprognostic (3.73e-3)" "unprognostic (6.83e-2)" "unprognostic (3.13e-2)" "unprognostic (7.82e-2)" "unprognostic (1.25e-1)" "unprognostic (2.38e-1)" "unprognostic (4.80e-2)" 19.8 31.3 10.9 9.9 13.3 14.2 6.1 24.1 14.1 7.7 6.4 7.3 6.2 6.6 7.1 20.0 10.0 6.9 10.2 7.9 11.6 8.1 6.7 5.9 6.8 7.9 16.3 10.4 9.9 6.1 5.5 20.6 7.9 12.6 8.4 6.8 2.5 5.4 5.5 5.7 6.5 6.3 5.3 18.2 7.4 8.2 21.0 16.0 7.0 8.0 4.2 7.7 7.8 11.6 6.5 3.8 2.8 4.1 8.4 11.4 3.1 3.7 4.8 11.3 8.5 8.4 7.0 5.6 6.0 5.5 5.8 4.9 4.6 4.9 2.6 4.1 3.9 7.0 6.8 10.8 3.4 7.5 11.1 5.9 7.3 8.1 7.6 7.5 4.4 3.4 5.2 14.5 5.6 12.2 12.0 8.9 12.9 5.4 5.6 7.7 1.2 3.6 4.4 5.6 7.7 8.0 5.2 3.7 12.7 6.7 5.9 7.9 12.5 6.3 3.9 5.2 8.2 7.1 4.7 3.9 6.0 2.8 5.1 3.9 7.0 8.6 6.0 3.4 5.2 3.6 2.0 2.8 2.8 5.0 3.9 8.2 5.7 7.0 4.8 3.8 6.5 11.4 7.6 2.5 8.4 4.1 1.9 6.8 3.1 10.9 13.3 24.1 14.1 11.6 8.1 16.3 10.4 12.6 16.0 0.0 11.2 16.7 23.3 17.4 11.7 8.7 5.1 10.7 4.5 3.5 3.9 3.4 8.3 6.8 335.0 7.1 11.8 0.0 4.8 6.0 13.1 14.5 57.7 3.9 11.9 12.7 5.2 8.0 7.5 120.5 10.6 15.9 74.2 10.0 7.2 9.8 6.1 10.2 5.3 12.4 7.0 0.0 22.7 17.6 6.8 25.7 2.5 15.0 7.3 21.8 THAP3 ENSG00000041988 "THAP domain containing 3" Q8WTV1 1 6624866-6635586 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067114 Approved Approved Nucleoplasm,Nucleoli,Mitochondria No No Nucleoplasm "Nucleoli, Mitochondria" "HPA067114: AB_2685782" "unprognostic (1.82e-2)" "unprognostic (9.63e-2)" "prognostic unfavorable (1.33e-4)" "unprognostic (2.89e-2)" "unprognostic (2.87e-1)" "unprognostic (1.61e-1)" "unprognostic (2.14e-3)" "unprognostic (1.13e-1)" "unprognostic (2.70e-1)" "unprognostic (4.63e-2)" "unprognostic (3.50e-3)" "unprognostic (4.30e-2)" "unprognostic (1.11e-2)" "unprognostic (4.51e-2)" "unprognostic (1.08e-1)" "unprognostic (2.67e-1)" "unprognostic (2.26e-3)" 14.2 17.2 16.4 11.4 16.8 12.9 31.4 21.5 20.3 16.5 16.6 13.8 11.8 12.0 15.2 13.6 11.8 16.3 11.9 19.0 16.0 14.5 17.2 17.3 10.8 15.5 18.1 14.1 23.7 28.8 12.1 14.2 11.4 17.6 17.0 7.2 11.5 24.8 16.7 20.9 14.2 11.4 12.7 13.0 15.3 12.0 11.9 16.3 11.6 22.6 9.0 12.9 17.2 21.6 22.2 18.0 10.6 14.7 17.0 22.0 15.0 9.9 9.4 8.6 12.4 14.3 12.9 8.3 9.0 11.8 24.0 15.0 12.6 6.3 8.8 12.2 9.9 8.9 7.9 13.6 8.0 8.4 15.1 22.3 10.1 12.6 11.2 17.9 7.1 10.5 12.0 10.3 15.1 13.3 14.7 10.3 15.5 10.2 11.4 8.8 6.9 12.4 16.2 7.4 11.7 16.0 11.9 10.5 12.7 10.7 2.4 11.4 12.9 11.0 15.2 20.8 7.5 9.7 12.9 9.3 12.8 7.7 8.7 14.0 12.9 13.7 11.6 10.8 15.4 7.2 10.2 14.7 10.6 20.1 11.7 20.2 17.1 19.7 20.8 18.0 22.2 22.0 18.5 9.0 17.0 9.1 16.4 19.3 15.0 16.4 16.8 21.5 20.3 16.0 14.5 18.1 14.1 17.6 16.3 0.0 6.9 9.8 10.6 12.5 10.9 5.6 7.6 14.7 3.4 8.7 5.9 12.9 16.6 9.6 5.3 14.0 11.6 23.3 9.0 15.6 14.6 13.0 5.7 10.0 13.4 4.8 7.5 10.4 13.2 2.3 17.3 8.3 10.1 22.6 7.7 9.8 9.8 8.4 21.9 15.1 6.9 12.9 20.6 8.1 16.0 12.9 13.7 9.2 11.5 13.7 THAP4 CGI-36 ENSG00000176946 "THAP domain containing 4" Q8WY91 2 241584405-241637449 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "DNA-binding, Isomerase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 189.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044982, HPA053448" Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA044982: AB_10959786, HPA053448: AB_2682154" "unprognostic (3.17e-2)" "unprognostic (1.70e-2)" "unprognostic (6.56e-2)" "unprognostic (1.36e-2)" "unprognostic (8.35e-2)" "unprognostic (7.23e-2)" "unprognostic (1.16e-3)" "unprognostic (3.61e-2)" "unprognostic (7.56e-2)" "unprognostic (2.18e-1)" "unprognostic (3.24e-1)" "unprognostic (2.21e-1)" "prognostic favorable (1.46e-4)" "unprognostic (2.57e-1)" "unprognostic (1.78e-1)" "unprognostic (5.06e-1)" "unprognostic (1.07e-1)" 11.9 11.5 19.3 13.0 22.5 13.3 26.3 13.8 27.5 12.8 21.3 13.5 10.8 23.7 12.7 19.1 23.6 15.3 16.9 52.4 15.4 18.1 38.2 25.1 13.6 11.9 18.3 11.7 16.7 25.0 30.9 15.0 11.2 15.6 17.1 15.4 12.5 19.7 17.4 55.8 18.5 20.4 13.7 11.3 10.3 18.5 22.7 11.4 16.0 19.0 26.1 15.7 19.4 18.3 14.3 13.9 22.9 12.7 12.5 30.2 9.8 15.3 19.3 11.7 21.6 15.7 16.5 18.3 10.1 15.6 17.5 15.5 17.5 14.4 13.7 5.9 18.1 20.0 17.8 23.4 25.8 6.6 10.3 27.4 14.1 13.3 49.8 21.0 16.7 9.9 16.9 20.5 18.6 25.9 12.1 16.1 22.0 24.1 4.8 13.3 30.1 17.0 40.7 20.0 15.7 16.4 19.5 16.3 18.4 36.2 20.5 27.8 18.3 8.5 27.9 23.1 7.5 13.8 19.7 14.0 18.6 13.0 17.6 20.5 11.3 6.6 14.1 14.3 14.3 14.2 15.4 9.3 22.9 17.5 10.8 18.5 13.8 19.4 16.2 9.7 14.3 18.7 14.9 6.5 12.5 12.7 13.9 30.2 9.8 19.3 22.5 13.8 27.5 15.4 18.1 18.3 11.7 15.6 11.4 17.9 14.2 19.1 33.6 17.7 10.1 47.6 35.7 21.4 26.1 38.4 3.9 20.4 189.0 35.2 14.5 15.5 59.6 0.0 24.5 22.1 17.9 31.3 6.9 31.1 15.9 7.9 27.6 13.5 11.0 4.8 16.7 12.4 11.8 18.0 46.5 9.0 25.0 37.4 18.4 59.2 5.1 32.3 17.5 19.3 21.1 22.6 23.0 10.2 47.2 39.1 THAP5 DKFZp313O1132 ENSG00000177683 "THAP domain containing 5" Q7Z6K1 7 108554543-108569750 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 8 "Early spermatids: 374.3;Late spermatids: 414.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043170, HPA051488" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA043170: AB_10964500, HPA051488: AB_2681504" "unprognostic (2.53e-2)" "unprognostic (1.91e-1)" "unprognostic (2.88e-1)" "unprognostic (2.05e-1)" "unprognostic (2.68e-2)" "unprognostic (1.51e-1)" "unprognostic (1.79e-1)" "unprognostic (5.84e-2)" "unprognostic (3.33e-2)" "unprognostic (3.94e-1)" "unprognostic (3.67e-2)" "unprognostic (3.20e-1)" "prognostic favorable (8.99e-4)" "unprognostic (6.00e-2)" "unprognostic (3.39e-2)" "unprognostic (5.96e-3)" "unprognostic (2.79e-2)" 12.8 16.9 17.8 13.2 18.9 5.3 16.2 22.9 22.3 16.4 11.3 11.1 16.1 12.1 16.3 16.5 10.0 12.9 9.9 16.5 18.0 17.6 20.4 25.8 12.7 16.1 24.5 18.7 22.5 16.0 22.7 29.4 14.8 20.2 16.8 10.6 8.1 11.5 24.3 19.6 10.3 11.9 12.3 22.3 14.7 12.4 28.9 22.0 19.4 27.9 9.4 16.0 16.7 15.1 16.8 10.5 21.2 11.4 8.9 15.5 6.2 9.2 7.2 9.3 21.0 6.1 8.6 4.9 8.6 9.8 9.6 10.2 3.6 7.8 11.3 15.4 5.9 12.4 4.0 9.5 6.7 12.5 14.5 7.4 8.5 7.5 3.4 13.0 15.1 11.2 5.3 13.2 5.8 13.9 10.2 5.8 12.9 13.2 24.6 9.6 9.3 22.8 6.6 10.9 5.5 7.1 7.2 13.2 26.3 5.8 5.4 10.9 19.3 12.3 14.6 16.8 7.6 6.1 5.7 5.7 18.2 10.0 14.2 10.5 28.5 24.5 20.9 10.0 9.2 16.3 12.4 6.8 10.7 10.0 8.2 13.3 14.6 11.7 9.5 6.1 16.8 15.5 12.9 21.2 8.9 11.4 10.5 8.8 6.2 17.8 18.9 22.9 22.3 18.0 17.6 24.5 18.7 20.2 22.0 14.9 18.1 27.0 11.6 10.9 38.1 25.4 17.8 33.5 15.9 24.4 7.9 11.7 39.7 12.9 374.3 21.4 12.3 23.3 14.6 7.7 14.3 12.6 30.2 22.1 8.3 44.5 15.1 18.4 10.8 414.2 26.2 19.5 33.7 7.2 15.1 47.9 13.0 12.2 26.5 21.5 33.5 25.8 19.6 31.6 24.4 15.7 12.0 21.8 10.6 5.7 THAP6 MGC30052 ENSG00000174796 "THAP domain containing 6" Q8TBB0 4 75513946-75550473 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 108.2;Spermatocytes: 56.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035767 Uncertain Approved Nucleoplasm,Centrosome NA NA Centrosome Nucleoplasm "HPA035767: AB_10696510" "unprognostic (9.62e-2)" "unprognostic (2.25e-1)" "unprognostic (2.44e-2)" "unprognostic (1.45e-1)" "unprognostic (2.52e-1)" "unprognostic (6.89e-2)" "unprognostic (8.96e-2)" "unprognostic (3.37e-3)" "unprognostic (1.31e-1)" "unprognostic (1.84e-1)" "unprognostic (1.92e-2)" "unprognostic (1.06e-1)" "unprognostic (9.93e-3)" "unprognostic (1.08e-1)" "unprognostic (3.47e-2)" "unprognostic (8.54e-2)" "unprognostic (2.38e-2)" 15.7 14.9 11.5 18.7 17.6 14.4 18.6 21.2 17.0 18.4 17.0 24.4 16.5 14.9 20.2 23.8 15.5 15.6 13.5 17.2 12.0 11.9 17.8 21.9 13.1 17.9 21.9 14.0 19.3 14.9 19.9 30.9 24.3 17.8 18.3 14.5 17.3 17.0 13.3 20.3 20.8 21.1 18.8 19.2 17.8 13.1 26.5 21.3 18.0 20.4 16.9 15.2 16.5 14.3 10.7 7.1 18.5 8.7 6.8 13.6 6.5 6.9 5.0 11.1 7.7 12.7 12.5 6.3 16.6 8.6 8.7 9.1 6.3 17.4 10.1 8.6 5.4 9.8 7.4 9.9 7.9 10.7 11.5 6.9 7.3 8.2 8.0 17.5 9.8 8.3 10.5 13.8 9.9 15.4 14.0 4.7 12.1 12.6 20.9 9.2 8.1 8.9 6.7 6.3 9.7 5.1 8.7 12.2 7.0 8.1 5.9 8.5 8.8 7.8 10.7 9.2 9.7 11.6 8.2 5.7 14.9 9.9 17.2 8.5 18.7 9.2 9.6 10.4 7.9 12.5 14.6 8.7 12.2 9.8 7.5 13.0 8.9 11.9 9.2 7.1 10.7 13.6 10.4 18.5 6.8 8.0 5.9 13.0 6.5 11.5 17.6 21.2 16.5 12.0 11.9 21.9 14.0 17.8 21.3 11.9 8.3 14.8 14.8 7.3 20.4 15.1 10.2 22.7 9.1 21.0 29.5 8.4 13.3 7.2 108.2 7.9 9.3 0.0 5.6 7.9 10.4 10.1 10.4 8.5 6.5 15.9 12.1 8.6 13.9 18.2 13.0 10.9 6.8 6.4 10.3 14.3 6.5 7.8 10.6 10.2 17.2 0.0 9.9 56.5 15.1 5.9 6.4 10.1 7.4 6.4 THAP7 MGC10963 ENSG00000184436 "THAP domain containing 7" Q9BT49 22 20999104-21002196 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 123.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 49.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003083 Approved Supported "Nucleoplasm,Nuclear membrane,Vesicles" NA NA Nucleoplasm "Nuclear membrane, Vesicles" "HPA003083: AB_1080264" "unprognostic (6.48e-2)" "unprognostic (2.13e-3)" "unprognostic (3.28e-1)" "unprognostic (4.89e-3)" "unprognostic (1.92e-2)" "unprognostic (1.82e-3)" "unprognostic (5.56e-2)" "unprognostic (1.40e-2)" "unprognostic (2.82e-1)" "unprognostic (2.74e-3)" "unprognostic (1.27e-3)" "unprognostic (2.23e-2)" "unprognostic (9.15e-2)" "unprognostic (2.29e-2)" "unprognostic (1.83e-1)" "unprognostic (3.72e-2)" "unprognostic (3.51e-3)" 11.2 17.1 12.0 10.5 11.5 9.7 11.5 14.8 24.1 16.6 15.0 14.0 19.8 15.6 14.3 11.7 11.6 13.6 16.6 12.5 11.3 11.4 13.1 22.5 11.1 14.8 12.0 11.5 20.2 20.5 11.7 26.8 12.4 11.4 18.8 5.8 18.7 30.2 19.8 44.5 15.0 14.4 12.2 8.9 16.2 15.3 28.6 11.7 12.3 22.1 14.6 14.2 13.0 12.0 23.9 15.7 4.3 11.6 11.0 24.7 12.4 10.6 12.0 3.2 5.5 2.9 3.6 7.2 6.1 5.4 7.4 7.0 6.1 6.2 9.0 5.8 3.4 4.0 7.3 2.8 5.6 1.1 8.4 17.7 10.5 9.1 7.1 8.9 10.0 6.6 3.4 7.0 6.5 6.0 3.3 3.9 6.0 49.9 9.2 4.0 13.6 10.7 6.7 4.7 7.2 12.1 8.9 6.5 4.8 3.9 5.5 7.3 6.1 7.0 9.0 9.5 1.5 10.4 6.8 2.5 12.2 9.6 7.2 6.1 13.4 7.6 6.8 13.1 6.4 10.4 1.0 11.5 4.3 14.3 11.6 19.0 23.9 17.6 14.8 10.7 18.4 24.7 19.7 1.0 11.0 11.4 15.7 14.5 12.4 12.0 11.5 14.8 24.1 11.3 11.4 12.0 11.5 11.4 11.7 14.9 22.6 29.8 17.2 16.9 31.2 10.0 38.2 18.7 10.3 24.4 13.7 26.0 54.7 21.0 23.7 22.4 23.1 0.0 33.0 27.5 22.8 23.6 20.8 30.8 24.2 12.7 21.4 15.4 10.5 35.5 38.6 16.3 38.8 28.9 19.4 37.0 21.8 17.6 30.4 35.1 21.3 38.8 25.9 123.0 55.1 14.3 24.7 22.4 21.5 10.6 THAP8 FLJ32891 ENSG00000161277 "THAP domain containing 8" Q8NA92 19 36034985-36054762 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 19.3;Spermatogonia: 19.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA064056, HPA070139" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA064056: AB_2685184, HPA070139: AB_2686230" "unprognostic (1.33e-3)" "unprognostic (2.24e-1)" "unprognostic (8.03e-2)" "unprognostic (1.08e-2)" "unprognostic (3.10e-2)" "unprognostic (3.52e-2)" "prognostic unfavorable (1.32e-4)" "unprognostic (9.01e-3)" "unprognostic (3.94e-1)" "unprognostic (1.27e-1)" "prognostic favorable (3.19e-4)" "unprognostic (2.50e-1)" "unprognostic (2.10e-2)" "unprognostic (9.11e-2)" "unprognostic (1.26e-1)" "unprognostic (2.48e-2)" "unprognostic (2.48e-1)" 4.6 5.3 9.1 3.9 10.3 1.3 3.3 6.0 8.7 5.7 11.2 10.1 3.9 4.9 6.4 6.3 5.2 6.8 6.5 4.8 6.5 6.6 5.4 5.6 4.6 4.3 8.5 8.1 6.3 3.4 5.6 6.1 6.4 9.9 5.6 4.1 3.6 5.7 7.5 12.7 8.5 5.0 7.5 9.0 5.0 4.8 15.8 13.3 10.1 5.2 2.6 3.5 7.8 5.0 5.9 6.2 10.4 9.3 7.0 8.4 5.3 2.5 7.9 3.9 3.3 10.5 6.6 2.8 2.3 4.1 4.6 7.6 3.5 2.0 3.8 8.1 3.6 4.7 1.3 2.3 2.9 1.7 2.9 1.9 2.4 2.0 4.0 12.0 1.1 2.3 5.5 4.5 3.1 1.8 5.5 2.3 7.4 2.2 4.7 4.7 4.9 3.1 3.1 3.6 4.8 2.9 3.0 1.3 3.6 3.9 2.4 6.9 5.2 4.0 3.3 2.4 5.5 3.5 1.7 1.5 6.5 4.2 3.4 1.8 3.9 3.3 2.7 6.9 2.3 3.9 10.4 8.6 9.5 7.2 9.3 8.1 5.9 7.5 7.2 6.2 4.9 6.1 8.4 4.0 7.0 8.0 6.2 7.0 5.3 9.1 10.3 6.0 8.7 6.5 6.6 8.5 8.1 9.9 13.3 3.0 3.0 2.7 1.0 1.0 2.1 3.1 5.1 0.0 2.3 7.0 2.0 9.3 1.7 4.0 1.8 1.6 2.6 0.0 0.5 4.0 3.3 0.9 5.7 2.9 13.5 3.2 6.3 2.5 5.1 3.9 1.7 1.8 1.7 5.4 1.3 4.3 3.7 1.5 3.9 7.4 2.2 0.0 2.5 19.3 19.8 1.9 8.8 3.2 2.3 1.0 THBD CD141 ENSG00000178726 Thrombomodulin P07204 20 23045633-23049741 "Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins" "Blood coagulation, Hemostasis" Receptor "Disease mutation, Hemolytic uremic syndrome, Thrombophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Endothelial cells: 100.4;Leydig cells: 121.1;Peritubular cells: 243.6;Suprabasal keratinocytes: 86.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 17.7" "Group enriched" "Detected in many" 7 "dendritic cells: 7.8;granulocytes: 17.7;monocytes: 6.2" "Cell line enhanced" "Detected in many" "ASC diff: 12.8;CAPAN-2: 19.9;EFO-21: 17.3;HaCaT: 16.7;hTCEpi: 22.0;hTERT-RPE1: 11.9;OE19: 14.8;THP-1: 12.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002425, HPA002982" Supported Approved Nucleoplasm,Cytosol NA NA 5550000 690000 "Nucleoplasm, Cytosol" "CAB002425: AB_563497, HPA002982: AB_1078444" "unprognostic (1.96e-1)" "unprognostic (2.93e-3)" "unprognostic (8.70e-2)" "unprognostic (3.00e-2)" "unprognostic (3.07e-2)" "unprognostic (1.88e-1)" "unprognostic (7.81e-3)" "unprognostic (4.70e-2)" "unprognostic (1.38e-1)" "unprognostic (1.52e-2)" "unprognostic (2.30e-1)" "unprognostic (5.33e-2)" "unprognostic (2.23e-2)" "unprognostic (7.35e-3)" "unprognostic (3.01e-2)" "unprognostic (7.58e-3)" "unprognostic (9.71e-2)" 27.0 6.3 1.4 10.5 6.7 6.9 11.8 1.2 2.7 13.2 14.4 1.4 4.3 2.9 9.7 11.5 21.7 15.8 18.2 24.3 5.0 1.5 7.0 10.0 61.9 26.8 2.5 0.1 10.2 7.2 10.0 10.9 16.4 6.2 6.1 3.3 8.8 6.0 4.2 55.5 32.4 14.1 8.5 7.7 44.4 14.4 15.8 2.4 2.1 18.3 32.2 10.4 14.2 10.4 0.0 7.8 17.7 6.2 1.5 0.0 1.1 5.6 5.0 0.1 0.0 12.8 0.7 0.1 0.1 0.0 0.0 0.0 0.0 19.9 0.0 17.3 1.7 0.8 16.7 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 2.4 0.0 0.1 0.5 22.0 0.3 1.4 11.9 5.6 0.0 2.1 0.0 0.5 0.4 0.0 2.0 0.0 14.8 0.8 0.0 0.0 2.4 0.1 8.1 0.3 0.0 4.7 0.6 8.6 1.6 0.0 12.3 10.9 0.0 0.3 1.6 0.0 0.0 0.0 0.0 1.0 2.9 0.4 0.0 2.8 0.0 0.0 6.2 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 17.7 1.5 5.8 7.8 0.0 1.1 1.4 6.7 1.2 2.7 5.0 1.5 2.5 0.1 6.2 2.4 20.8 30.8 2.2 6.9 30.5 0.0 9.0 0.0 2.7 18.2 0.0 0.0 2.5 0.0 1.4 0.7 100.4 0.0 0.0 0.2 35.7 22.8 3.0 7.0 0.8 14.1 0.0 0.0 52.2 38.0 4.5 121.1 62.8 15.1 1.0 0.0 0.0 5.3 0.0 243.6 0.2 0.0 6.5 63.8 0.2 0.9 86.2 35.5 0.0 0.0 32.5 THEMIS "bA325O24.3, bA325O24.4, C6orf190, C6orf207, FLJ40584, TSEPA" ENSG00000172673 "Thymocyte selection associated" Q8N1K5 6 127708072-127918631 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 109.6" "Cell type enriched" "Detected in some" 6 "T-cells: 40.2" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebral cortex: 7.1" "Group enriched" "Detected in many" 23 "gdT-cell: 11.3;MAIT T-cell: 14.5;memory CD4 T-cell: 14.5;memory CD8 T-cell: 20.5;naive CD4 T-cell: 13.1;naive CD8 T-cell: 25.2" "Lineage enriched" "Detected in single" 88 "T-cells: 25.2" "Group enriched" "Detected in some" 4 "HDLM-2: 16.8;JURKAT: 28.7;MOLT-4: 26.2;RPMI-8226: 11.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA031422, HPA031425" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA031422: AB_2673874, HPA031425: AB_10670129" "unprognostic (1.47e-4)" "unprognostic (2.50e-3)" "unprognostic (1.31e-2)" "unprognostic (1.41e-4)" "unprognostic (1.41e-1)" "unprognostic (5.20e-3)" "unprognostic (7.48e-3)" "unprognostic (9.01e-3)" "unprognostic (1.47e-1)" "unprognostic (7.41e-3)" "unprognostic (1.24e-1)" "unprognostic (1.28e-1)" "unprognostic (2.65e-4)" "unprognostic (2.04e-1)" "unprognostic (3.91e-2)" "unprognostic (4.98e-2)" "unprognostic (1.60e-2)" 1.4 0.6 1.9 9.6 0.8 2.4 0.8 0.2 7.1 1.0 2.8 0.1 0.5 2.2 0.9 0.9 1.2 0.8 2.4 0.5 1.8 0.6 0.9 0.9 3.6 13.2 1.1 0.1 0.9 0.6 0.0 0.4 0.2 0.5 0.9 1.3 0.8 5.2 0.9 0.3 0.5 5.0 0.8 1.5 5.8 2.0 0.4 0.4 109.6 1.3 1.6 10.4 2.3 1.2 0.0 0.0 0.2 0.0 0.0 25.2 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.7 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.3 0.0 14.5 0.0 14.5 20.5 0.0 0.0 13.1 25.2 0.2 0.0 0.0 0.0 0.7 7.4 1.9 0.8 0.2 7.1 1.8 0.6 1.1 0.1 0.5 0.4 0.0 4.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.1 0.0 0.0 1.8 0.3 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 40.2 0.0 0.1 THEMIS2 "C1orf38, ICB-1" ENSG00000130775 "Thymocyte selection associated family member 2" Q5TEJ8 1 27872543-27886685 "Predicted intracellular proteins" "Immunity, Inflammatory response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 72.0;bone marrow: 72.3;lymphoid tissue: 73.0" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 60.6;Kupffer cells: 120.5;Macrophages: 117.1;monocytes: 154.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 5 "dendritic cells: 43.6;granulocytes: 72.0;monocytes: 62.6" "Cell line enhanced" "Detected in many" "Karpas-707: 48.2;U-266/70: 37.4;U-937: 21.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027513, HPA031096" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA027513: , HPA031096: AB_10599254" "unprognostic (7.38e-2)" "unprognostic (6.56e-2)" "unprognostic (5.07e-2)" "unprognostic (1.99e-3)" "unprognostic (4.51e-2)" "unprognostic (5.56e-3)" "unprognostic (4.13e-1)" "unprognostic (8.21e-2)" "unprognostic (1.77e-2)" "unprognostic (3.05e-2)" "unprognostic (1.38e-2)" "unprognostic (8.96e-2)" "unprognostic (7.21e-3)" "unprognostic (5.07e-2)" "unprognostic (1.42e-2)" "unprognostic (2.24e-3)" "unprognostic (4.52e-3)" 13.4 5.2 4.3 27.2 7.2 72.3 5.8 0.9 4.6 3.6 7.2 10.7 0.3 4.1 3.0 6.6 4.6 5.4 9.5 6.5 7.1 4.6 5.9 7.5 22.1 39.0 11.5 2.7 3.8 2.7 1.0 2.7 7.1 7.8 2.8 4.2 6.0 6.0 1.8 2.3 2.3 12.7 6.0 16.4 73.0 4.8 9.9 6.7 12.5 5.3 1.1 25.2 7.8 3.3 6.5 43.6 72.0 62.6 8.5 11.3 40.5 3.2 0.1 1.2 0.2 4.1 5.7 0.5 0.6 7.0 10.3 14.6 0.4 0.8 4.5 0.4 2.2 5.7 0.4 1.8 0.4 1.6 0.6 0.4 6.3 0.1 0.9 8.2 7.8 10.3 2.9 0.1 5.3 0.0 0.5 3.9 0.3 8.8 48.2 0.7 2.1 0.3 6.8 4.1 0.1 0.7 1.4 4.6 7.9 3.0 0.1 0.0 1.8 0.0 0.2 9.0 0.7 0.1 6.9 2.4 0.6 0.0 2.0 0.1 37.4 2.1 0.3 11.6 21.9 0.1 4.4 54.1 47.1 11.3 62.6 10.3 6.5 8.2 9.1 43.6 2.9 7.1 7.3 72.0 8.5 60.9 17.7 7.9 40.5 4.3 7.2 0.9 4.6 7.1 4.6 11.5 2.7 7.8 6.7 3.0 30.7 30.5 1.4 2.9 0.3 0.5 5.1 1.4 5.7 0.0 0.0 0.6 0.0 0.5 0.9 2.2 0.0 0.0 7.5 1.0 1.8 2.2 12.7 0.8 60.6 0.0 10.3 5.5 120.5 3.6 0.6 117.1 16.9 154.1 0.1 0.0 7.4 0.0 0.4 0.3 0.2 0.0 0.5 0.7 1.9 1.0 2.1 49.0 0.0 3.8 THOC2 "CXorf3, dJ506G2.1, MRX12, MRX35, THO2" ENSG00000125676 "THO complex 2" Q8NI27 X 123600561-123733056 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047921 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA047921: AB_10960388" "unprognostic (2.12e-2)" "unprognostic (5.64e-2)" "unprognostic (3.49e-1)" "unprognostic (3.74e-2)" "unprognostic (2.22e-2)" "unprognostic (3.08e-1)" "prognostic unfavorable (5.77e-5)" "unprognostic (1.43e-2)" "unprognostic (1.04e-2)" "unprognostic (2.24e-2)" "unprognostic (3.24e-1)" "unprognostic (6.29e-2)" "unprognostic (4.27e-3)" "unprognostic (6.43e-3)" "unprognostic (1.05e-1)" "unprognostic (1.06e-2)" "unprognostic (1.35e-1)" 25.9 22.7 25.2 23.3 28.2 21.6 26.6 36.0 29.8 30.1 22.5 17.8 24.8 22.5 27.4 39.8 24.7 21.6 19.9 17.7 25.2 19.2 28.0 20.3 24.0 29.4 28.9 21.9 30.1 23.6 28.3 45.4 22.8 24.9 26.3 23.4 17.2 18.9 24.6 20.6 29.0 31.1 27.0 31.7 27.4 20.0 15.2 29.7 45.3 26.2 20.7 26.3 27.0 21.2 13.5 15.2 9.7 12.7 11.7 16.0 8.2 21.2 17.8 22.8 24.6 16.8 16.2 12.3 14.5 14.4 16.1 21.6 12.4 21.9 21.8 16.7 15.9 15.5 16.3 27.6 10.8 27.4 20.7 25.0 30.5 24.9 16.9 15.7 35.2 21.8 32.0 13.6 18.4 21.3 14.1 14.8 33.4 45.6 19.9 16.2 22.4 30.3 34.6 12.7 28.9 17.6 30.9 14.3 18.0 25.2 24.1 17.6 15.7 40.7 11.3 13.5 19.1 11.2 21.6 15.3 14.5 7.5 20.6 24.4 13.8 20.2 18.8 13.0 31.6 15.8 9.6 9.2 9.7 13.4 12.4 15.6 12.3 14.6 14.4 8.9 13.5 16.0 15.4 5.6 11.7 12.7 15.2 11.1 8.2 25.2 28.2 36.0 29.8 25.2 19.2 28.9 21.9 24.9 29.7 128.1 126.8 63.2 59.8 74.0 64.6 45.3 17.8 91.0 105.8 61.1 149.2 37.4 10.0 44.3 3.8 61.2 57.2 46.7 44.2 29.9 59.6 56.4 77.5 31.4 34.3 50.9 64.8 51.5 45.7 5.4 86.3 57.9 28.7 73.1 47.7 39.1 39.9 35.1 85.9 22.2 106.7 122.9 70.0 45.4 36.7 67.2 36.5 61.8 46.1 67.0 THOC3 "MGC5469, TEX1" ENSG00000051596 "THO complex 3" Q96J01 5 175917873-176034680 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 41.4" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 149.1;Spermatocytes: 102.0" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042764, HPA044009, HPA045071" Approved Enhanced Nucleoplasm,Vesicles No No Nucleoplasm Vesicles "HPA042764: AB_10965055, HPA044009: AB_10959603, HPA045071: AB_10959461" "unprognostic (1.13e-1)" "unprognostic (1.44e-1)" "unprognostic (1.85e-3)" "unprognostic (6.48e-3)" "unprognostic (8.60e-2)" "unprognostic (3.57e-2)" "unprognostic (3.06e-3)" "unprognostic (2.02e-2)" "unprognostic (3.41e-2)" "unprognostic (1.11e-2)" "unprognostic (1.04e-1)" "unprognostic (4.04e-2)" "unprognostic (8.80e-3)" "unprognostic (3.20e-1)" "unprognostic (2.86e-1)" "unprognostic (3.16e-2)" "unprognostic (2.91e-1)" 2.3 3.5 8.5 2.3 5.8 8.3 6.0 12.5 6.4 4.7 7.3 3.0 3.4 20.0 21.5 4.0 1.6 1.7 8.5 3.2 4.4 6.0 2.8 7.3 2.6 5.3 3.4 0.4 3.7 4.5 3.8 5.9 5.5 4.1 2.6 7.2 4.1 3.0 2.0 4.3 4.5 11.9 5.1 12.5 5.1 7.6 24.0 13.9 4.7 10.5 12.6 41.4 19.2 22.3 12.5 13.3 29.1 12.8 11.5 48.6 13.5 12.6 29.9 34.8 17.7 18.3 29.2 19.6 7.7 32.3 19.3 20.2 57.5 31.6 20.0 29.5 15.7 12.4 19.2 4.2 25.7 14.2 9.7 24.5 25.7 13.0 6.7 16.4 27.5 23.8 13.2 18.8 26.9 17.3 15.8 11.4 22.3 45.8 30.2 16.9 30.4 21.3 16.8 25.8 14.9 28.0 13.7 13.8 20.2 15.6 23.6 12.5 10.3 11.8 15.9 24.1 6.6 11.6 17.5 7.7 25.0 8.0 4.4 9.0 4.7 13.7 10.5 16.5 16.5 28.3 16.8 13.9 24.0 34.9 21.9 1.3 12.6 9.4 12.9 41.4 19.2 11.9 7.5 18.0 23.9 39.5 12.1 3.1 7.6 8.1 5.7 24.4 9.8 43.8 34.9 21.6 149.1 14.1 7.8 46.7 16.8 69.7 17.4 13.6 11.5 19.0 21.6 6.4 16.1 16.5 9.9 84.4 13.6 13.4 8.5 15.4 15.9 7.8 19.7 7.0 18.0 35.5 10.9 19.4 18.4 102.0 45.3 35.8 16.7 23.5 28.5 21.7 THOC5 "C22orf19, Fmip, fSAP79, KIAA0983, PK1.3" ENSG00000100296 "THO complex 5" Q13769 22 29505879-29555216 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 98.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048402 Supported Nucleoplasm NA NA Nucleoplasm "HPA048402: AB_2680387" "unprognostic (1.16e-1)" "unprognostic (3.05e-1)" "unprognostic (7.77e-2)" "unprognostic (2.27e-2)" "unprognostic (7.20e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (3.76e-6)" "unprognostic (6.34e-2)" "unprognostic (5.54e-2)" "unprognostic (2.55e-1)" "unprognostic (2.45e-1)" "unprognostic (8.81e-2)" "prognostic unfavorable (3.65e-4)" "unprognostic (9.53e-2)" "unprognostic (1.24e-1)" "unprognostic (1.24e-1)" "unprognostic (2.97e-1)" 16.8 11.3 10.2 12.2 16.4 14.7 15.1 14.7 26.8 16.5 29.7 20.0 11.6 10.2 30.3 12.9 17.1 19.9 15.6 20.4 10.8 7.2 12.9 12.1 13.3 12.5 12.5 12.1 20.4 13.6 12.4 14.8 10.7 18.9 16.6 12.9 16.8 15.4 19.8 35.7 12.2 15.1 26.7 10.9 14.1 18.7 21.1 14.9 18.8 10.7 9.4 15.9 25.7 16.4 7.5 10.0 25.0 13.1 5.6 10.5 7.2 15.9 10.9 10.0 29.9 19.0 15.6 12.7 30.2 17.9 26.8 26.8 17.5 7.2 9.9 11.8 24.0 16.0 14.4 14.3 16.2 26.4 11.3 14.8 16.2 15.4 19.7 12.9 36.9 13.9 16.2 15.2 26.4 20.5 22.0 19.6 9.9 18.4 10.2 16.6 17.8 11.4 11.5 20.8 13.7 8.5 16.8 24.1 12.2 9.8 12.2 20.5 33.1 16.8 13.5 18.3 13.8 7.6 13.2 13.4 47.5 27.8 11.1 19.6 16.2 15.4 24.2 15.8 15.4 20.1 3.8 9.0 22.0 8.8 11.3 8.8 7.5 7.3 6.4 10.0 6.1 7.8 7.1 25.0 5.6 13.1 2.4 10.5 7.2 10.2 16.4 14.7 26.8 10.8 7.2 12.5 12.1 18.9 14.9 20.8 9.3 4.5 6.7 4.7 11.6 14.7 7.6 13.4 7.9 3.5 19.6 17.1 11.6 18.7 35.0 10.5 9.5 0.0 12.7 19.6 9.2 7.0 10.5 6.7 12.8 7.9 8.6 6.2 7.6 98.6 11.8 8.6 8.5 14.4 4.9 7.3 14.4 7.0 12.0 14.0 24.9 0.0 15.9 40.3 17.6 5.4 14.5 11.3 10.5 4.5 THOC6 "fSAP35, MGC2655, WDR58" ENSG00000131652 "THO complex 6" Q86W42 16 3024027-3027755 "Disease related genes, Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing, mRNA transport, Transport" "Developmental protein, RNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 98.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052953 Uncertain Supported "Nucleoplasm,Nuclear speckles" No No "Nucleoplasm, Nuclear speckles" "HPA052953: AB_2681997" "unprognostic (2.07e-2)" "unprognostic (4.13e-3)" "unprognostic (1.70e-1)" "unprognostic (2.04e-1)" "unprognostic (2.08e-1)" "unprognostic (2.91e-1)" "unprognostic (7.82e-3)" "unprognostic (1.81e-1)" "unprognostic (1.31e-1)" "unprognostic (2.20e-2)" "unprognostic (5.15e-2)" "unprognostic (3.44e-2)" "prognostic unfavorable (4.40e-4)" "unprognostic (3.59e-1)" "unprognostic (1.43e-1)" "unprognostic (6.17e-2)" "unprognostic (9.43e-2)" 10.5 12.0 7.8 14.6 8.2 16.7 12.8 7.0 9.8 10.0 13.7 9.1 11.9 15.5 15.7 8.6 13.7 10.4 19.3 9.5 7.0 5.6 12.9 17.5 12.4 15.5 11.0 4.8 13.2 20.7 11.8 13.2 28.0 9.0 15.1 8.6 7.2 16.6 11.0 17.0 20.6 17.6 10.5 6.5 16.9 10.5 9.0 6.8 27.3 12.7 19.4 17.9 10.0 11.6 17.8 34.5 5.0 24.4 14.3 16.4 16.3 12.8 20.9 15.2 16.0 7.8 9.0 26.8 3.9 9.2 9.3 13.8 13.8 15.2 24.3 13.0 6.6 6.9 17.7 16.5 12.6 5.1 21.5 21.2 13.2 19.3 20.1 13.3 19.2 29.0 9.0 15.3 11.3 28.3 11.8 8.6 14.1 19.1 13.1 4.6 30.0 10.8 35.7 27.3 7.4 9.0 29.3 11.4 28.4 9.7 6.5 31.3 14.8 11.3 17.9 7.2 6.9 12.8 21.0 7.1 9.7 22.6 10.9 14.3 9.5 8.0 29.5 2.5 13.2 9.7 0.8 24.4 5.0 14.8 23.7 14.9 15.3 13.7 14.3 34.5 17.8 16.0 16.4 1.8 14.3 13.1 29.1 14.2 16.3 7.8 8.2 7.0 9.8 7.0 5.6 11.0 4.8 9.0 6.8 17.9 9.0 19.5 75.5 60.7 3.6 2.8 10.2 4.0 9.1 17.4 2.0 92.0 29.9 28.5 4.9 9.0 19.6 0.0 20.6 98.4 42.7 41.2 11.5 9.2 45.3 3.2 24.8 7.4 23.0 2.2 13.8 29.1 23.6 44.1 22.9 3.0 19.1 27.5 11.3 22.4 2.0 6.5 38.1 0.9 24.8 39.3 64.5 17.5 41.3 38.7 THRSP "Lpgp, LPGP1, S14, SPOT14, THRP" ENSG00000151365 "Thyroid hormone responsive" Q92748 11 78063861-78068351 "Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 62.0;liver: 92.5;salivary gland: 45.6" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 65.3" "Cancer enhanced" "Detected in many" "liver cancer: 44.1" "Region enriched" "Detected in single" 10 "cerebellum: 1.0" "Cell type enhanced" "Detected in some" "NK-cell: 1.5" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 13 "ASC diff: 42.5" "Low region specificity" "Detected in all" HPA040642 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA040642: AB_10794878" "unprognostic (1.19e-1)" "unprognostic (2.88e-1)" "unprognostic (2.84e-1)" "unprognostic (2.73e-2)" "unprognostic (3.07e-1)" "unprognostic (9.91e-3)" "unprognostic (1.59e-2)" "unprognostic (9.60e-2)" "unprognostic (1.07e-2)" "unprognostic (8.23e-2)" "unprognostic (1.68e-1)" "unprognostic (2.58e-1)" "prognostic unfavorable (1.16e-4)" "unprognostic (9.64e-2)" "unprognostic (1.57e-1)" "prognostic favorable (3.28e-4)" "unprognostic (1.69e-3)" 62.0 1.6 0.0 18.3 0.0 0.0 22.7 1.0 0.0 0.0 12.2 0.0 2.8 0.0 0.1 1.2 0.1 0.3 16.5 11.7 0.0 0.0 2.1 92.5 0.0 2.9 0.1 0.0 0.0 1.1 0.3 0.0 0.0 0.1 0.0 0.1 0.2 45.6 2.0 9.3 7.2 1.3 0.2 0.1 0.0 0.1 0.0 0.0 0.0 1.6 4.3 0.3 5.7 0.3 0.5 0.1 0.0 0.2 1.5 1.0 0.0 0.0 0.0 0.0 0.0 42.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.5 0.1 0.5 0.2 1.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 65.3 0.0 0.0 0.0 0.6 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 THSD7B KIAA1679 ENSG00000144229 "Thrombospondin type 1 domain containing 7B" Q9C0I4 2 136765545-137677717 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.2;epididymis: 11.6;retina: 14.9" "Group enriched" "Detected in some" 7 "Cone photoreceptor cells: 23.6;Horizontal cells: 85.8;Rod photoreceptor cells: 31.7" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 7 "pons and medulla: 24.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "Daudi: 10.3;SCLC-21H: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA051416, HPA056745" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051416: AB_2681477, HPA056745: AB_2683224" "unprognostic (4.65e-3)" "unprognostic (2.25e-1)" "unprognostic (8.98e-2)" "unprognostic (1.24e-2)" "unprognostic (1.59e-3)" "unprognostic (1.12e-1)" "unprognostic (6.50e-2)" "unprognostic (7.80e-3)" "unprognostic (2.89e-1)" "unprognostic (1.65e-1)" "unprognostic (3.20e-1)" "unprognostic (6.56e-2)" "unprognostic (4.47e-6)" "unprognostic (2.42e-3)" "unprognostic (1.89e-1)" "unprognostic (4.31e-2)" "unprognostic (4.30e-2)" 4.7 0.3 1.7 0.3 1.6 0.1 2.6 0.7 3.2 0.9 0.5 1.1 0.8 0.3 0.9 11.6 1.6 2.8 0.8 1.4 1.8 3.3 2.7 0.6 0.5 0.2 1.8 1.5 0.4 0.3 1.3 3.0 0.7 24.2 2.1 0.3 14.9 1.2 0.7 0.3 0.2 1.5 2.2 3.2 0.2 0.3 1.1 0.3 0.1 2.1 0.0 0.3 0.8 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 10.3 0.0 0.4 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.5 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.4 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.6 0.7 3.2 1.8 3.3 1.8 1.5 24.2 0.3 0.0 0.0 0.0 0.4 0.1 1.2 0.6 0.0 0.0 0.0 0.0 23.6 0.0 1.7 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 85.8 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 31.7 6.5 0.3 0.5 0.6 0.0 0.0 0.0 0.0 0.1 THTPA THTPASE ENSG00000259431 "Thiamine triphosphatase" Q9BU02 14 23555988-23560271 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028876 Approved Uncertain Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA028876: AB_10600731" "unprognostic (3.50e-3)" "unprognostic (1.51e-1)" "unprognostic (1.20e-1)" "unprognostic (7.11e-2)" "unprognostic (2.25e-1)" "unprognostic (2.12e-1)" "unprognostic (4.13e-1)" "unprognostic (1.58e-3)" "unprognostic (1.98e-1)" "unprognostic (1.57e-1)" "unprognostic (4.47e-2)" "unprognostic (1.50e-1)" "prognostic favorable (1.70e-9)" "unprognostic (3.47e-2)" "unprognostic (2.32e-1)" "unprognostic (3.62e-2)" "unprognostic (5.40e-2)" 14.9 19.5 27.7 12.2 23.3 7.6 12.9 16.4 24.3 12.3 14.0 20.7 15.9 15.7 13.3 18.4 10.1 17.7 16.8 16.3 23.3 17.4 16.3 12.1 10.7 10.7 21.9 13.3 15.4 12.7 25.0 12.4 7.6 16.1 18.8 12.3 17.1 18.0 23.5 21.9 7.4 11.7 13.7 19.5 11.3 11.6 18.8 14.3 14.1 15.9 12.3 11.2 9.9 7.9 14.3 17.0 11.1 14.4 6.9 11.6 8.7 2.7 17.1 8.4 9.1 19.3 10.9 4.6 8.0 7.1 7.9 7.9 3.5 11.3 5.2 7.0 9.6 9.0 8.5 8.8 10.0 5.9 10.9 9.6 7.0 12.1 9.3 9.8 6.4 6.4 14.8 7.4 12.1 8.9 16.7 9.5 8.4 5.3 11.4 11.5 8.2 10.1 2.6 3.0 14.6 14.6 6.9 5.7 9.4 13.9 5.4 16.2 7.7 7.9 16.2 4.6 5.2 10.8 3.1 7.4 5.2 5.5 10.7 4.7 13.5 8.2 2.9 5.4 2.9 8.0 11.1 14.4 7.3 9.6 10.6 9.5 9.6 6.9 7.5 13.2 14.3 11.6 9.9 1.5 6.9 13.4 17.0 5.4 8.7 27.7 23.3 16.4 24.3 23.3 17.4 21.9 13.3 16.1 14.3 6.0 6.9 15.9 5.8 0.0 27.6 0.0 10.2 5.3 6.8 7.0 7.9 9.0 46.4 13.0 16.7 2.9 8.4 0.0 10.7 4.4 7.2 8.5 23.1 7.6 15.9 7.9 5.8 8.0 10.0 16.8 10.6 8.2 0.0 11.8 6.4 18.8 8.1 8.6 7.1 24.6 9.4 12.9 0.1 19.6 8.7 0.0 5.6 6.4 8.5 5.4 THUMPD2 "C2orf8, MGC2454" ENSG00000138050 "THUMP domain containing 2" Q9BTF0 2 39736060-39779267 "Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043042, HPA058025" Approved Uncertain Nucleoplasm Yes No Nucleoplasm "HPA043042: AB_10964424, HPA058025: " "unprognostic (6.30e-2)" "unprognostic (9.12e-3)" "unprognostic (2.48e-2)" "unprognostic (4.62e-3)" "unprognostic (2.16e-1)" "unprognostic (1.39e-2)" "prognostic unfavorable (6.05e-4)" "unprognostic (1.22e-1)" "unprognostic (2.31e-2)" "unprognostic (1.30e-1)" "unprognostic (2.72e-1)" "unprognostic (2.54e-2)" "prognostic unfavorable (7.27e-5)" "unprognostic (2.17e-1)" "unprognostic (1.61e-1)" "unprognostic (1.49e-1)" "unprognostic (1.14e-3)" 6.9 7.1 6.3 8.2 7.4 13.3 9.3 21.1 7.9 8.5 6.0 5.0 4.5 7.7 12.0 6.8 9.2 4.3 5.1 8.7 6.0 6.8 7.9 7.3 5.8 9.4 7.1 5.0 10.8 5.9 5.4 19.7 4.3 6.7 6.9 5.1 6.4 6.0 6.4 14.5 5.8 6.5 6.4 5.5 6.6 6.7 3.8 6.4 13.5 7.8 5.1 9.3 6.0 9.6 6.1 9.9 0.3 4.5 8.6 5.2 3.1 9.2 6.0 2.1 8.9 2.9 4.7 4.7 3.9 4.3 4.3 4.7 7.5 6.9 11.9 4.3 2.8 9.9 3.3 11.5 6.7 5.0 14.6 13.8 8.7 4.2 7.3 6.5 10.2 5.4 4.9 4.3 4.1 1.6 4.6 6.4 2.7 9.4 4.1 8.3 3.1 8.8 8.6 0.2 16.9 4.2 6.7 7.8 7.0 4.6 5.5 9.0 6.6 3.3 8.4 5.9 0.7 3.7 5.7 3.9 7.2 6.2 3.2 8.1 6.6 7.6 12.5 4.2 16.3 5.5 0.0 4.5 0.2 3.3 3.2 3.9 6.1 5.2 3.4 5.5 4.7 4.8 4.2 0.3 8.6 2.1 9.9 4.2 3.1 6.3 7.4 21.1 7.9 6.0 6.8 7.1 5.0 6.7 6.4 23.8 19.4 14.8 22.9 12.7 22.1 20.6 7.6 13.4 25.0 14.0 17.7 10.0 16.6 15.0 1.9 11.7 7.3 0.0 12.0 11.4 8.6 13.8 6.9 7.6 9.5 6.4 9.2 9.8 12.4 2.8 25.9 10.6 5.0 7.2 8.4 11.5 13.2 13.3 24.1 11.5 18.3 6.5 12.2 8.9 16.9 11.8 5.7 10.2 11.8 22.1 THY1 CD90 ENSG00000154096 "Thy-1 cell surface antigen" P04216 11 119417378-119424985 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.7;smooth muscle: 91.5" "Cell type enhanced" "Detected in many" 8 "Fibroblasts: 117.3;Leydig cells: 89.2;Muller glia cells: 84.4;Peritubular cells: 72.9;Proximal tubular cells: 127.2;Smooth muscle cells: 114.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.7" "Lineage enriched" "Detected in single" 17 "T-cells: 1.7" "Cell line enhanced" "Detected in many" "ASC diff: 53.5;BJ: 83.7;BJ hTERT+: 93.7;fHDF/TERT166: 146.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003733, CAB068243, CAB068244" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 9800000 Nucleoplasm "Plasma membrane" "CAB068243: AB_2665687, CAB068244: AB_2665688, HPA003733: AB_1846340" "unprognostic (9.98e-2)" "unprognostic (2.71e-1)" "unprognostic (5.13e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (6.87e-4)" "unprognostic (7.43e-2)" "unprognostic (1.43e-3)" "unprognostic (2.38e-2)" "unprognostic (1.29e-1)" "unprognostic (2.90e-3)" "unprognostic (3.38e-2)" "unprognostic (3.52e-1)" "prognostic unfavorable (2.40e-6)" "unprognostic (1.75e-2)" "unprognostic (1.90e-2)" "unprognostic (3.03e-2)" "unprognostic (1.14e-2)" 28.7 5.9 42.0 23.2 72.4 0.4 7.0 17.6 97.7 26.9 9.0 7.2 2.1 3.5 20.3 13.9 9.8 7.5 31.6 4.3 63.4 41.1 46.6 2.6 6.5 10.9 29.8 34.8 3.2 5.0 7.3 5.5 19.1 53.8 4.6 13.6 8.5 2.9 15.7 1.4 4.2 4.6 91.5 9.3 6.7 5.7 4.0 6.9 3.1 12.0 1.0 10.8 36.9 7.2 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.3 12.5 0.0 53.5 38.7 0.0 83.7 93.7 30.0 33.3 0.0 0.0 0.0 0.0 146.5 14.5 0.1 0.4 0.1 22.9 7.1 0.0 4.4 1.5 0.0 16.5 0.0 0.0 28.7 0.0 38.1 1.3 41.7 0.0 2.6 0.0 0.0 23.1 0.0 0.0 0.0 20.0 0.0 0.1 0.0 5.9 0.0 0.0 0.0 2.1 5.7 0.0 0.0 0.0 4.0 0.1 0.2 0.0 43.2 14.4 12.4 12.3 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 42.0 72.4 17.6 97.7 63.4 41.1 29.8 34.8 53.8 6.9 0.0 2.6 0.0 0.4 15.8 13.9 0.8 0.0 0.0 0.0 8.7 0.0 1.5 18.3 1.1 0.8 14.3 0.0 0.0 0.0 2.3 117.3 0.2 1.1 0.0 3.6 30.2 0.0 27.0 0.0 0.9 89.2 1.4 16.9 0.0 0.0 84.4 0.5 0.0 72.9 127.2 19.0 32.3 114.6 0.4 0.4 15.4 3.3 0.0 0.0 0.1 THYN1 THY28 ENSG00000151500 "Thymocyte nuclear protein 1" Q9P016 11 134248279-134253370 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038732, HPA038733" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA038732: AB_10697397, HPA038733: AB_2676183" "unprognostic (5.91e-2)" "unprognostic (6.22e-3)" "unprognostic (4.54e-2)" "unprognostic (3.48e-3)" "unprognostic (2.32e-2)" "unprognostic (8.99e-2)" "unprognostic (2.12e-1)" "prognostic favorable (1.01e-5)" "unprognostic (3.32e-2)" "unprognostic (1.99e-2)" "unprognostic (1.02e-1)" "unprognostic (1.13e-1)" "unprognostic (2.37e-1)" "unprognostic (1.71e-1)" "unprognostic (6.92e-2)" "unprognostic (1.66e-2)" "unprognostic (2.61e-2)" 20.1 22.4 36.7 13.3 39.3 21.4 26.1 29.6 43.6 22.8 22.7 16.0 20.8 16.8 22.8 45.2 16.0 27.9 17.3 27.8 30.2 30.4 22.4 31.6 15.8 20.4 24.9 38.1 37.6 15.6 13.6 25.2 12.3 24.5 29.7 26.0 17.5 14.3 32.7 14.3 15.5 16.7 24.5 23.2 17.7 18.7 24.3 23.1 35.0 29.9 15.6 23.9 22.6 15.7 27.8 30.6 74.0 24.4 29.7 50.7 34.4 7.9 4.8 18.1 14.4 17.6 20.1 10.7 6.9 15.2 16.2 15.3 26.9 19.6 14.9 23.2 9.5 17.4 12.4 27.3 20.9 15.9 15.2 7.7 41.4 6.9 24.2 25.2 32.8 13.7 15.2 11.2 19.2 12.7 21.2 25.4 51.0 19.0 7.2 14.5 4.4 38.1 60.5 21.0 31.8 18.1 18.1 13.4 12.6 22.2 14.0 17.3 14.0 14.2 3.5 8.1 13.8 20.2 16.7 13.4 7.0 10.8 6.3 10.4 8.1 8.4 31.6 10.4 42.9 8.0 37.6 21.7 74.0 36.0 24.4 43.1 27.8 38.3 36.2 23.1 21.8 44.3 50.7 11.3 29.7 22.5 30.6 44.7 34.4 36.7 39.3 29.6 43.6 30.2 30.4 24.9 38.1 24.5 23.1 29.8 30.3 34.7 31.3 21.2 28.4 47.5 45.9 57.6 36.4 34.9 13.7 48.6 72.9 41.7 18.7 37.2 24.6 0.0 48.8 45.0 39.0 15.9 39.3 41.5 45.5 27.0 55.3 25.2 23.0 14.4 46.6 30.2 38.8 40.5 38.5 42.7 42.8 31.6 45.6 69.9 17.8 45.3 31.6 74.4 76.8 18.1 11.6 37.3 53.4 22.6 TIA1 ENSG00000116001 "TIA1 cytotoxic granule associated RNA binding protein" P31483 2 70209444-70248660 "Disease related genes, Predicted intracellular proteins" Apoptosis RNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056961 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA056961: AB_2683289" "unprognostic (1.04e-1)" "unprognostic (1.74e-1)" "unprognostic (3.68e-2)" "unprognostic (1.07e-1)" "unprognostic (7.64e-3)" "unprognostic (2.51e-3)" "unprognostic (3.37e-3)" "prognostic favorable (6.79e-5)" "unprognostic (5.09e-3)" "unprognostic (1.13e-1)" "unprognostic (1.09e-1)" "unprognostic (3.15e-2)" "prognostic unfavorable (8.05e-7)" "unprognostic (4.00e-1)" "unprognostic (1.79e-1)" "unprognostic (1.25e-1)" "prognostic favorable (1.02e-5)" 15.6 20.4 15.9 29.3 20.5 14.8 28.2 36.3 22.0 30.2 23.6 25.3 24.6 20.6 42.1 43.5 15.9 28.4 21.6 16.0 17.2 14.7 20.7 18.0 19.1 26.4 21.9 16.5 46.9 24.3 26.0 48.7 21.2 19.0 26.2 24.1 27.1 27.8 24.2 13.2 23.4 25.9 24.9 21.0 30.8 20.8 13.4 25.2 65.3 29.3 15.1 21.2 23.1 23.5 9.7 11.6 12.4 7.9 10.9 9.8 5.6 7.2 8.1 42.4 23.7 12.0 20.5 20.5 12.9 9.2 12.6 12.6 10.8 11.3 16.5 11.2 9.7 7.3 11.9 20.5 7.0 17.9 15.3 9.0 16.9 14.0 25.8 9.7 16.9 9.6 15.2 10.5 7.2 8.0 30.0 23.2 13.3 13.1 15.1 17.6 6.2 31.2 26.9 34.5 10.4 9.7 38.3 23.1 16.8 19.3 14.3 25.8 22.1 15.4 18.2 12.4 22.9 10.9 12.6 18.9 15.5 16.3 7.2 12.7 12.6 12.6 30.4 9.1 21.6 20.6 12.4 7.9 10.8 8.3 6.5 7.8 9.7 8.0 8.2 11.6 8.0 7.3 7.9 3.0 10.9 3.8 6.0 9.8 5.6 15.9 20.5 36.3 22.0 17.2 14.7 21.9 16.5 19.0 25.2 77.4 52.4 36.5 27.5 22.6 49.4 26.2 30.6 77.6 72.8 19.2 45.2 26.3 0.0 23.1 17.7 28.7 20.4 0.0 23.5 27.5 28.6 28.9 53.2 25.6 18.8 33.4 50.5 36.8 32.1 7.1 33.4 26.5 15.1 32.5 33.0 38.0 25.1 27.9 33.6 9.1 53.0 25.8 26.9 28.1 16.2 21.0 20.7 39.8 28.1 23.8 TIAL1 TIAR ENSG00000151923 "TIA1 cytotoxic granule associated RNA binding protein like 1" Q01085 10 119571802-119597029 "Predicted intracellular proteins" Apoptosis RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060962 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA060962: " "unprognostic (1.61e-2)" "unprognostic (9.30e-2)" "unprognostic (1.26e-1)" "unprognostic (3.76e-1)" "unprognostic (5.33e-2)" "unprognostic (3.91e-2)" "prognostic unfavorable (7.81e-6)" "unprognostic (5.54e-2)" "unprognostic (9.21e-2)" "unprognostic (3.89e-3)" "unprognostic (3.74e-1)" "unprognostic (1.32e-3)" "unprognostic (6.48e-3)" "unprognostic (6.35e-2)" "unprognostic (1.83e-1)" "unprognostic (8.26e-2)" "unprognostic (2.26e-2)" 30.0 29.6 31.4 29.4 44.4 39.2 46.6 72.8 47.3 27.7 27.3 26.7 26.9 23.8 35.0 37.9 43.9 27.1 27.9 30.1 32.5 20.4 25.7 35.3 30.2 39.5 48.2 25.0 34.6 35.5 40.2 30.7 33.2 33.6 27.7 34.3 20.3 33.6 32.0 51.5 31.7 32.5 30.3 39.3 33.3 32.5 28.1 47.8 38.0 33.3 23.6 40.9 29.5 45.8 5.7 6.6 4.9 5.9 7.8 8.6 2.6 35.2 23.4 40.0 43.7 24.2 33.3 26.7 31.5 39.8 38.6 37.2 27.9 42.7 35.2 19.5 28.6 25.0 33.5 39.2 25.6 50.5 34.4 17.5 26.4 25.9 29.1 29.0 39.9 32.4 28.5 31.5 30.6 51.5 54.2 37.7 26.4 26.4 37.7 35.8 30.6 35.1 36.9 20.0 31.3 19.5 30.2 31.5 23.3 32.0 20.0 14.4 16.9 21.2 20.4 28.1 33.3 21.2 23.8 26.1 24.5 20.8 20.0 33.2 24.8 31.1 28.3 23.1 38.0 17.9 3.7 4.5 3.9 7.2 3.6 7.3 5.4 7.4 6.7 4.6 5.7 7.9 8.3 4.9 7.8 5.9 6.6 8.6 2.6 31.4 44.4 72.8 47.3 32.5 20.4 48.2 25.0 33.6 47.8 41.7 52.6 50.7 60.2 56.4 52.2 33.9 40.8 45.5 53.4 22.7 29.5 57.7 39.7 44.1 8.8 46.0 41.6 70.0 47.3 83.1 46.4 58.7 33.6 41.9 50.6 42.9 50.6 47.3 55.6 5.2 56.7 50.2 35.4 66.7 45.7 43.3 56.5 40.3 42.5 39.4 46.3 51.8 43.6 45.1 43.1 56.1 64.8 68.2 49.4 75.8 TIAM1 ENSG00000156299 "T cell lymphoma invasion and metastasis 1" Q13009 21 31118416-31559977 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 110.1" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 74.4;Horizontal cells: 69.9;Suprabasal keratinocytes: 125.3;Urothelial cells: 72.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 8 "cerebellum: 110.1" "Group enriched" "Detected in many" 5 "classical monocyte: 10.7;intermediate monocyte: 9.6;memory CD4 T-cell: 8.3;myeloid DC: 5.9;naive CD4 T-cell: 10.9;NK-cell: 6.9;non-classical monocyte: 12.4;T-reg: 16.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 19.4;HEL: 18.7;HMC-1: 16.4;RT4: 19.4;SCLC-21H: 18.3" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 574.6" "CAB010416, HPA034853" Enhanced Supported "Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol" NA NA "Nucleoplasm, Cell Junctions" "Nuclear membrane, Cytokinetic bridge, Cytosol" "CAB010416: AB_2240410, HPA034853: " "unprognostic (9.59e-2)" "unprognostic (7.44e-3)" "unprognostic (5.64e-3)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (2.81e-3)" "unprognostic (2.84e-2)" "unprognostic (3.73e-1)" "unprognostic (8.08e-2)" "unprognostic (2.70e-3)" "unprognostic (7.97e-3)" "unprognostic (9.52e-2)" "unprognostic (1.20e-3)" "unprognostic (2.38e-3)" "unprognostic (1.61e-1)" "unprognostic (1.04e-2)" "unprognostic (2.21e-1)" 3.3 11.4 13.4 5.3 12.4 2.1 4.4 110.1 15.1 10.1 2.2 9.7 0.5 1.5 7.9 3.0 18.9 9.4 4.0 2.1 11.6 7.0 1.7 3.7 4.1 8.8 6.2 7.9 1.5 1.9 0.3 4.2 4.4 8.9 3.7 2.8 7.0 2.2 3.1 0.7 20.4 1.7 10.0 6.4 4.2 2.1 5.9 7.1 6.2 1.3 5.3 9.3 8.1 5.0 0.1 5.9 0.6 12.4 6.9 16.8 3.6 1.5 0.5 12.1 0.7 0.2 2.8 19.4 0.0 0.0 1.5 0.5 0.1 2.2 4.1 0.8 0.3 2.2 2.8 1.4 2.4 2.4 0.3 6.7 18.7 0.3 0.1 0.3 0.0 16.4 1.2 0.8 8.2 3.3 1.4 0.0 6.2 0.0 6.1 6.1 7.9 2.8 0.1 3.9 2.9 5.2 3.7 3.8 0.0 1.8 19.4 18.3 4.5 0.8 6.3 0.7 4.4 2.6 0.0 0.1 1.7 7.1 0.0 0.8 6.9 5.1 3.7 4.0 1.4 13.4 0.6 10.7 0.0 0.3 9.6 2.1 0.1 8.3 1.6 5.9 0.0 10.9 0.6 0.6 6.9 12.4 0.3 16.8 3.6 13.4 12.4 110.1 14.4 11.6 7.0 6.2 7.9 8.9 7.1 3.0 2.9 0.8 40.5 74.4 1.2 1.1 2.5 0.0 18.2 0.0 2.0 7.6 0.0 1.5 10.0 15.8 0.0 0.0 0.6 25.1 7.6 16.1 23.1 3.6 8.2 69.9 5.2 50.3 22.7 9.0 31.9 28.4 10.1 18.0 0.3 39.3 1.1 10.7 54.8 0.0 4.4 6.5 2.1 1.4 6.1 125.3 8.9 6.9 0.9 72.7 TIAM2 STEF ENSG00000146426 "T cell lymphoma invasion and metastasis 2" Q8IVF5 6 154832697-155257723 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 11.3;brain: 21.1;intestine: 27.4;testis: 15.6;thyroid gland: 7.8" "Group enriched" "Detected in many" 6 "Cone photoreceptor cells: 76.6;Early spermatids: 131.1;Late spermatids: 220.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 11.3" "Group enriched" "Detected in many" 4 "B-cells: 3.3;granulocytes: 8.3;monocytes: 11.3" "Cell line enhanced" "Detected in many" "AF22: 35.1;HDLM-2: 15.0;RH-30: 22.9" "Group enriched" "Detected in many" 5 "amygdala: 20.4;basal ganglia: 31.5;cerebral cortex: 23.6;hippocampal formation: 19.4;olfactory region: 70.6" "Low region specificity" "Detected in all" "HPA011134, HPA013903" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" No No "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA011134: AB_1858005, HPA013903: AB_1858004" "unprognostic (9.14e-2)" "unprognostic (5.79e-2)" "unprognostic (1.44e-1)" "unprognostic (6.38e-2)" "unprognostic (1.08e-1)" "unprognostic (1.69e-1)" "unprognostic (4.36e-2)" "unprognostic (1.89e-1)" "unprognostic (5.74e-2)" "unprognostic (1.81e-2)" "unprognostic (1.84e-2)" "unprognostic (1.36e-2)" "unprognostic (1.38e-3)" "unprognostic (1.82e-1)" "unprognostic (8.13e-2)" "unprognostic (6.04e-2)" "unprognostic (1.05e-1)" 0.6 2.1 5.3 1.7 9.4 0.7 1.5 7.9 21.1 1.5 11.6 0.7 0.1 11.0 1.2 0.8 1.0 1.2 4.0 3.5 4.7 2.0 0.7 0.7 0.9 2.0 1.7 9.5 0.9 1.8 0.2 1.8 0.8 0.6 3.0 1.1 1.3 2.4 3.6 3.0 1.0 27.4 1.4 0.9 1.2 4.0 15.6 1.9 0.0 7.8 0.0 2.5 2.3 1.2 3.3 0.9 8.3 11.3 0.8 1.8 0.4 4.3 0.8 35.1 4.1 1.5 4.3 0.4 1.8 1.1 1.7 2.9 0.5 2.6 1.0 1.9 3.2 0.6 0.7 1.2 0.0 1.2 15.0 1.9 0.3 0.6 2.0 0.9 0.3 1.1 2.9 0.1 0.6 0.1 1.6 2.4 0.5 0.5 0.1 3.9 0.4 0.4 0.9 2.5 0.2 1.0 4.5 22.9 0.4 0.1 0.2 0.9 8.0 0.1 0.4 0.2 6.9 0.3 0.5 0.8 0.3 8.9 0.3 0.9 0.2 1.7 0.2 0.1 0.5 2.2 0.4 0.2 3.1 0.2 3.2 0.3 3.3 0.5 0.3 0.9 1.0 0.6 0.4 8.3 0.8 11.3 0.3 1.8 0.4 5.3 9.4 7.9 21.1 4.7 2.0 1.7 9.5 0.6 1.9 3.0 1.6 8.1 16.3 2.7 13.8 7.3 7.6 2.7 1.2 1.8 76.6 1.2 0.0 4.7 131.1 3.0 2.9 0.0 2.7 2.1 4.7 7.7 19.6 0.9 1.7 22.3 0.0 7.4 2.1 220.7 9.2 4.7 11.8 14.4 4.2 6.9 4.2 2.0 7.4 0.7 25.2 0.0 3.8 5.2 5.5 2.3 0.3 4.8 2.6 7.4 TICAM1 "MGC35334, PRVTIRB, TICAM-1, TRIF" ENSG00000127666 "Toll like receptor adaptor molecule 1" Q8IUC6 19 4815932-4831704 "Disease related genes, Predicted intracellular proteins" "Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Inflammatory response, Innate immunity" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Urothelial cells: 129.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA042460 Uncertain Uncertain "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA042460: AB_10806240" "unprognostic (2.09e-2)" "unprognostic (1.48e-1)" "unprognostic (1.86e-2)" "prognostic favorable (4.81e-4)" "unprognostic (3.52e-2)" "unprognostic (2.88e-2)" "unprognostic (7.60e-3)" "prognostic unfavorable (3.48e-4)" "unprognostic (9.86e-2)" "unprognostic (1.59e-1)" "unprognostic (6.16e-2)" "unprognostic (2.82e-1)" "unprognostic (4.43e-2)" "unprognostic (2.30e-2)" "unprognostic (5.02e-2)" "unprognostic (3.53e-2)" "unprognostic (6.48e-2)" 10.5 6.9 7.3 9.4 9.5 18.2 9.4 5.9 15.8 10.2 15.4 7.0 3.4 20.3 8.3 5.2 35.6 8.0 11.4 7.7 5.9 5.4 11.0 15.2 14.1 9.0 6.4 6.1 8.0 14.8 4.2 7.8 6.8 7.1 8.2 5.2 6.1 11.8 5.7 15.3 15.8 21.3 5.2 6.5 11.6 15.2 2.8 6.5 4.4 8.5 12.1 21.7 9.3 13.3 5.3 5.0 7.8 9.1 1.5 3.1 5.4 21.3 4.2 0.0 3.7 3.2 4.1 2.0 7.0 7.3 5.7 6.4 4.3 7.7 14.6 4.0 8.1 5.7 14.6 2.0 7.4 2.2 15.6 3.9 3.6 8.5 4.1 9.0 1.3 9.5 6.6 9.3 7.1 5.2 4.4 5.9 5.1 7.8 3.1 3.1 8.0 3.6 0.7 0.6 3.8 16.9 8.1 0.9 9.5 5.1 6.7 2.9 5.5 4.3 13.1 7.2 0.0 5.9 3.0 11.6 7.0 4.8 17.6 10.6 12.7 11.1 10.1 8.1 5.0 5.3 7.8 5.3 2.3 2.6 7.8 2.4 5.3 2.6 3.0 5.0 4.0 1.7 1.0 1.6 1.5 9.1 3.6 3.1 5.4 7.3 9.5 5.9 15.8 5.9 5.4 6.4 6.1 7.1 6.5 6.0 11.1 7.8 63.8 61.6 0.7 2.1 17.8 4.0 9.1 5.2 0.0 5.3 6.6 27.1 0.0 10.5 58.5 0.0 15.3 9.5 9.3 51.3 10.4 12.5 12.1 1.6 28.0 11.1 8.6 0.0 3.4 18.8 13.5 23.4 15.2 0.8 36.4 38.6 4.9 7.0 0.2 6.5 8.9 0.3 1.1 62.2 2.9 7.9 11.0 129.1 TICRR "C15orf42, FLJ41618, MGC45866, SLD3, Treslin" ENSG00000140534 "TOPBP1 interacting checkpoint and replication regulator" Q7Z2Z1 15 89575482-89631056 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 9.0;lymphoid tissue: 21.7;tongue: 9.5" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 1.6;Extravillous trophoblasts: 4.8;Spermatogonia: 5.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046746, HPA049454" Supported Nucleoplasm NA Yes Nucleoplasm "HPA046746: AB_2732533, HPA049454: AB_2680773" "unprognostic (3.52e-2)" "unprognostic (1.41e-1)" "unprognostic (3.77e-1)" "prognostic unfavorable (4.44e-4)" "unprognostic (3.41e-1)" "unprognostic (1.10e-1)" "unprognostic (6.22e-5)" "unprognostic (7.73e-3)" "prognostic unfavorable (2.87e-6)" "unprognostic (1.64e-1)" "unprognostic (1.31e-4)" "unprognostic (5.87e-2)" "unprognostic (0.00e+0)" "unprognostic (3.54e-2)" "unprognostic (7.38e-2)" "unprognostic (4.53e-2)" "unprognostic (3.59e-2)" 0.9 0.4 0.3 3.5 0.4 6.9 0.6 0.1 0.4 1.0 2.5 0.1 0.1 2.2 1.0 0.1 9.0 0.7 0.5 0.3 0.2 0.3 0.3 0.2 0.7 2.9 0.4 0.1 0.9 0.1 0.0 0.3 3.9 0.1 0.5 2.6 0.2 1.2 0.1 0.1 1.0 3.2 0.4 0.2 2.9 0.9 7.7 0.1 21.7 0.4 9.5 12.2 0.8 2.3 0.0 0.0 0.0 0.4 0.0 0.7 0.0 7.1 9.8 12.8 7.3 0.5 1.0 7.2 5.2 2.4 7.4 7.8 10.7 5.5 9.5 2.8 1.7 6.2 14.3 17.5 4.6 6.8 4.8 16.9 14.2 9.5 5.6 0.0 10.1 5.2 0.3 0.3 6.0 4.5 1.1 3.6 8.5 13.5 11.1 4.3 6.7 8.8 8.6 8.5 7.1 5.1 12.7 11.5 7.7 1.7 10.2 5.5 5.4 12.5 7.1 2.1 9.8 5.3 6.8 2.2 8.1 10.2 16.4 10.7 2.6 5.0 8.2 2.8 8.6 4.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.4 0.1 0.3 0.2 0.3 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.6 0.0 0.0 0.0 0.0 4.8 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 5.7 0.1 0.8 0.0 0.3 0.1 TIFA "MGC20791, T2BP, T6BP, TIFAA" ENSG00000145365 "TRAF interacting protein with forkhead associated domain" Q96CG3 4 112274542-112285903 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 66.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 46.1;U-266/70: 28.9;U-698: 39.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA045889 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA Yes "Nucleoplasm, Nucleoli" Cytosol "HPA045889: AB_10963785" "unprognostic (2.41e-2)" "unprognostic (2.47e-2)" "unprognostic (4.13e-2)" "unprognostic (3.23e-2)" "unprognostic (2.86e-1)" "unprognostic (4.98e-3)" "unprognostic (1.05e-1)" "unprognostic (2.25e-1)" "unprognostic (2.48e-2)" "unprognostic (2.14e-2)" "unprognostic (4.60e-3)" "unprognostic (5.26e-2)" "unprognostic (6.44e-3)" "unprognostic (1.52e-1)" "unprognostic (2.56e-1)" "unprognostic (2.99e-1)" "unprognostic (8.49e-3)" 5.7 6.4 3.3 16.7 3.8 19.2 7.4 6.1 4.5 7.0 3.9 2.0 8.4 3.4 3.6 2.3 14.3 4.0 4.2 7.9 4.7 2.1 4.1 14.6 6.7 22.9 5.4 1.6 9.2 32.2 4.1 3.3 7.4 3.9 6.6 3.7 5.4 21.3 4.5 4.0 9.0 8.7 4.7 4.0 20.3 7.1 3.0 4.8 12.5 14.8 7.8 23.2 7.2 7.3 23.2 7.0 11.3 3.8 9.1 17.7 6.1 7.0 1.8 2.6 4.4 3.2 2.6 5.3 5.6 10.6 3.6 6.1 0.9 6.3 21.5 4.6 2.2 5.3 2.1 3.6 4.3 7.5 17.4 2.1 2.1 4.3 2.0 2.2 6.7 2.9 3.5 2.4 3.8 4.2 6.1 5.6 6.0 2.1 46.1 4.7 3.5 11.8 3.7 0.5 4.3 2.3 20.6 6.7 14.3 7.9 4.8 6.1 6.3 4.5 9.5 2.2 1.2 4.0 9.7 4.2 5.7 6.7 4.7 4.4 28.9 26.5 39.8 5.3 4.5 4.1 2.9 3.8 2.0 6.3 2.7 10.3 21.2 11.7 11.0 7.0 23.2 5.4 6.6 11.3 9.1 3.2 6.5 17.7 6.1 3.3 3.8 6.1 4.5 4.7 2.1 5.4 1.6 3.9 4.8 17.9 20.6 34.4 9.9 18.9 1.0 14.1 10.2 6.7 11.4 12.2 0.0 42.8 16.6 12.7 0.0 14.5 5.8 0.0 21.2 17.8 22.6 27.2 3.5 8.5 16.0 0.0 8.6 4.9 10.7 0.0 8.3 11.2 32.1 6.4 7.0 11.3 12.9 3.6 10.3 6.3 0.6 6.5 13.4 0.9 3.0 22.7 66.4 27.3 6.5 10.7 TIGD1 EEYORE ENSG00000221944 "Tigger transposable element derived 1" Q96MW7 2 232547968-232550592 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA041717 Approved Approved "Nucleoplasm,Nucleoli rim,Nuclear bodies,Mitotic chromosome" Yes No "Nucleoli rim, Mitotic chromosome" "Nucleoplasm, Nuclear bodies" "HPA041717: AB_2677636" "unprognostic (2.48e-1)" "unprognostic (1.77e-2)" "unprognostic (2.10e-2)" "unprognostic (1.86e-1)" "unprognostic (2.58e-2)" "unprognostic (2.81e-1)" "unprognostic (1.62e-2)" "unprognostic (1.24e-1)" "unprognostic (1.21e-2)" "unprognostic (1.20e-2)" "unprognostic (4.40e-2)" "unprognostic (6.86e-2)" "prognostic unfavorable (4.41e-5)" "unprognostic (3.77e-2)" "unprognostic (1.85e-2)" "unprognostic (2.77e-1)" "unprognostic (3.21e-3)" 3.9 5.9 13.3 9.2 15.3 19.4 8.9 10.1 11.7 5.4 5.1 10.7 2.0 5.9 8.5 10.1 5.6 7.4 6.9 4.9 13.8 8.2 10.1 5.0 6.9 12.5 9.1 8.0 13.2 5.8 6.3 21.2 6.5 8.6 8.3 6.7 8.3 7.3 7.9 7.5 13.6 6.8 4.3 8.8 11.1 8.1 9.7 10.8 14.2 9.6 4.8 10.6 5.5 5.9 7.1 3.8 7.0 4.8 4.5 9.8 1.9 6.9 5.2 11.3 16.7 4.2 5.5 8.5 5.0 2.8 6.1 7.0 6.6 7.9 11.5 3.8 3.7 6.5 6.6 9.3 2.9 9.5 7.0 8.1 10.3 15.3 7.5 2.6 8.6 6.9 6.1 2.7 6.4 4.0 6.4 3.8 14.3 8.1 12.2 5.3 10.5 10.5 17.3 6.7 4.1 6.3 9.7 10.2 5.2 3.6 8.3 13.5 13.5 5.5 4.8 5.2 8.7 7.2 8.4 6.5 10.2 10.5 6.5 5.1 10.9 7.6 10.8 5.9 8.6 6.4 4.0 4.8 5.3 6.7 4.3 6.1 4.9 6.5 4.3 3.4 7.1 9.8 7.7 7.0 4.5 4.8 3.8 4.5 1.9 13.3 15.3 10.1 11.7 13.8 8.2 9.1 8.0 8.6 10.8 8.9 3.8 2.7 3.6 1.1 4.9 1.2 2.5 0.0 2.3 3.5 7.9 1.8 0.0 1.9 1.3 1.6 2.1 0.0 1.3 1.0 1.9 2.0 0.0 0.6 1.3 6.4 1.2 1.3 1.5 0.0 4.4 2.7 1.7 2.8 1.9 8.2 1.4 3.2 1.8 0.6 6.2 6.5 0.8 2.8 6.1 1.8 1.1 3.5 3.3 2.4 TIGD3 ENSG00000173825 "Tigger transposable element derived 3" Q6B0B8 11 65354767-65357613 "Predicted intracellular proteins" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 14.9;brain: 8.6" "Cell type enhanced" "Detected in some" 16 "Spermatocytes: 16.6;Spermatogonia: 5.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "basophil: 6.5;eosinophil: 8.4;neutrophil: 14.9" "Lineage enriched" "Detected in many" 12 "granulocytes: 14.9" "Cell line enhanced" "Detected in many" "SCLC-21H: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA040016 Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA040016: AB_10805600" "unprognostic (1.33e-1)" "unprognostic (1.81e-2)" "unprognostic (1.88e-2)" "unprognostic (1.60e-1)" "unprognostic (1.15e-1)" "unprognostic (2.47e-3)" "unprognostic (9.04e-4)" "unprognostic (1.48e-4)" "unprognostic (6.97e-2)" "unprognostic (1.47e-1)" "unprognostic (3.94e-3)" "unprognostic (7.40e-2)" "unprognostic (3.20e-2)" "unprognostic (7.55e-3)" "unprognostic (1.01e-1)" "unprognostic (2.11e-1)" "unprognostic (1.75e-3)" 0.1 0.7 1.8 0.8 2.7 1.3 3.0 8.6 4.6 0.3 4.1 0.9 0.0 2.6 0.4 0.8 0.4 0.5 0.6 0.4 2.0 1.9 0.8 0.7 1.1 1.1 1.2 0.0 1.0 1.5 1.5 1.9 0.4 3.1 0.5 0.4 1.1 0.5 0.5 0.3 0.2 6.4 0.3 2.0 2.6 1.0 6.9 0.4 3.0 0.4 1.0 0.8 0.6 0.0 0.3 1.2 14.9 1.2 0.1 0.1 0.1 1.4 2.6 2.3 6.0 0.0 0.0 0.8 0.1 0.3 0.6 0.8 2.1 0.3 1.0 1.0 0.2 1.0 1.4 2.3 0.1 0.2 1.8 2.3 0.4 1.4 4.7 0.1 0.9 4.4 0.0 0.2 0.3 0.0 0.1 0.3 2.3 1.4 3.1 0.0 3.4 2.9 1.9 1.3 1.3 1.1 4.2 1.0 4.0 0.1 1.3 6.7 4.2 1.7 2.6 1.1 0.2 4.3 1.4 0.0 0.2 1.1 1.6 1.0 6.4 4.1 1.3 0.1 1.8 0.7 6.5 0.5 8.4 0.0 0.3 0.0 0.3 0.0 0.0 0.8 0.2 0.1 0.0 14.9 0.1 1.2 1.2 0.0 0.1 1.8 2.7 8.6 4.6 2.0 1.9 1.2 0.0 3.1 0.4 0.0 0.6 0.0 0.2 1.3 3.7 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 2.2 0.0 1.0 0.0 0.5 0.3 0.3 0.6 0.0 0.2 0.2 0.0 0.0 0.0 0.8 1.8 0.0 0.9 1.7 1.0 0.3 1.0 0.6 0.0 0.4 0.5 3.8 0.0 0.8 16.6 5.3 1.4 0.7 0.0 0.4 0.1 TIGD4 ENSG00000169989 "Tigger transposable element derived 4" Q8IY51 4 152769354-152779764 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 14.1;testis: 11.8" "Group enriched" "Detected in some" 4 "Early spermatids: 76.3;Rod photoreceptor cells: 29.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 4.6;U-266/70: 6.8;U-266/84: 13.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035649, HPA073768" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA035649: AB_10670956, HPA073768: " "unprognostic (1.71e-1)" "unprognostic (5.97e-2)" "unprognostic (4.01e-2)" "unprognostic (1.23e-4)" "unprognostic (6.19e-3)" "unprognostic (1.82e-2)" "unprognostic (1.61e-5)" "unprognostic (1.75e-1)" "unprognostic (1.14e-1)" "unprognostic (3.89e-3)" "unprognostic (1.16e-2)" "unprognostic (3.36e-2)" "unprognostic (1.43e-2)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "unprognostic (8.90e-2)" "unprognostic (4.47e-2)" 0.7 1.0 2.2 0.7 8.6 0.2 2.1 3.5 3.6 2.5 0.8 2.1 3.9 1.1 2.0 4.2 0.6 5.5 0.8 1.0 4.8 2.1 2.0 0.6 3.5 0.5 1.6 3.2 1.7 0.9 5.4 14.1 0.5 5.8 1.3 0.9 5.4 2.0 1.1 1.2 1.3 0.8 0.9 2.7 0.8 1.0 11.8 1.3 0.3 2.1 0.6 0.5 1.0 0.8 0.4 0.0 1.6 1.1 2.1 1.3 0.0 0.6 0.5 3.0 1.2 0.2 0.4 0.3 0.1 0.7 0.3 0.6 0.6 1.3 1.0 0.1 0.1 1.4 0.5 1.1 0.5 0.5 1.0 0.2 1.5 0.7 0.3 0.2 0.6 0.3 0.1 0.5 0.5 0.3 0.6 0.1 2.2 0.4 4.6 0.3 0.3 2.9 0.4 1.4 0.4 0.4 0.5 0.6 0.0 2.0 0.1 1.4 1.6 0.2 0.3 2.9 1.4 0.7 0.2 0.0 0.4 0.6 0.5 0.6 6.8 13.2 0.6 1.0 1.6 2.2 0.0 0.3 0.8 0.0 1.1 0.2 0.0 0.3 1.3 0.0 0.4 0.1 0.4 1.6 2.1 0.2 0.0 0.0 0.0 2.2 8.6 3.5 3.6 4.8 2.1 1.6 3.2 5.8 1.3 0.0 1.0 0.0 0.4 0.0 6.7 0.0 0.0 12.0 0.0 1.8 11.8 0.1 0.0 0.5 76.3 0.1 0.0 0.0 1.0 0.1 0.1 0.3 0.0 0.0 0.5 1.6 1.2 0.0 0.0 8.5 0.3 0.0 0.0 0.0 0.1 12.1 0.4 0.0 0.4 1.5 29.0 0.0 0.0 5.1 1.7 0.0 0.2 0.0 0.4 0.3 TIGD6 DKFZp761E2110 ENSG00000164296 "Tigger transposable element derived 6" Q17RP2 5 149993118-150001167 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 16.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA044599 Uncertain Approved "Nucleoplasm,Vesicles,Actin filaments" NA NA Nucleoplasm "Vesicles, Actin filaments" "HPA044599: AB_10961286" "unprognostic (1.06e-1)" "unprognostic (3.25e-1)" "prognostic favorable (5.35e-4)" "unprognostic (1.94e-2)" "unprognostic (8.18e-2)" "unprognostic (3.00e-2)" "unprognostic (1.30e-3)" "unprognostic (7.48e-2)" "unprognostic (5.96e-2)" "unprognostic (3.85e-2)" "prognostic favorable (5.88e-4)" "unprognostic (1.94e-3)" "unprognostic (1.85e-3)" "unprognostic (1.55e-2)" "unprognostic (1.46e-1)" "unprognostic (1.33e-3)" "unprognostic (1.18e-1)" 6.9 10.5 5.9 3.9 10.7 2.8 9.9 9.3 9.4 5.8 6.1 10.0 8.9 4.7 6.5 11.1 5.0 6.9 5.1 4.5 6.4 4.7 7.7 7.0 5.3 3.9 7.3 7.1 8.6 6.8 28.0 10.5 5.5 7.1 8.8 5.7 6.4 8.1 12.6 3.8 7.2 5.2 5.9 7.6 5.8 6.1 9.8 8.0 6.1 6.5 3.6 4.3 6.2 6.1 3.5 3.3 2.1 4.0 6.3 8.0 2.6 2.3 6.4 4.3 9.2 12.4 10.2 6.7 6.7 7.1 5.3 5.3 4.1 4.2 1.1 6.0 7.9 6.4 4.2 3.8 4.9 6.3 5.0 3.2 2.0 3.3 2.2 11.0 2.8 5.0 10.5 9.4 6.8 8.9 6.2 4.1 4.6 2.7 5.4 6.5 5.5 3.7 1.3 1.8 3.0 5.4 4.2 4.9 3.0 5.0 3.4 3.3 4.3 4.7 7.6 9.5 5.5 8.5 4.9 5.4 4.3 3.3 4.7 4.9 4.0 1.5 3.0 6.8 3.1 6.6 0.2 4.0 2.1 2.8 3.9 2.5 2.7 3.8 2.8 3.3 3.5 8.0 5.1 0.0 6.3 2.2 2.2 3.7 2.6 5.9 10.7 9.3 9.4 6.4 4.7 7.3 7.1 7.1 8.0 11.9 2.4 0.0 5.8 1.9 4.8 4.6 2.5 2.7 4.5 3.5 0.0 4.6 6.6 4.3 1.1 2.3 2.5 0.0 4.2 2.2 2.5 6.1 3.5 1.3 3.7 3.2 2.9 3.1 1.2 1.9 4.0 2.2 3.3 7.2 2.5 6.1 3.4 2.3 3.2 6.7 5.6 0.0 3.9 16.4 5.5 1.0 3.0 0.9 2.3 3.8 TIMELESS "hTIM, TIM, TIM1" ENSG00000111602 "Timeless circadian regulator" Q9UNS1 12 56416373-56449403 "Predicted intracellular proteins" "Biological rhythms, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 30.7;Spermatogonia: 22.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 9.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA060655 Enhanced Supported Nucleoplasm No No Nucleoplasm "HPA060655: AB_2684338" "unprognostic (3.94e-2)" "unprognostic (1.10e-2)" "unprognostic (1.29e-2)" "unprognostic (2.18e-2)" "unprognostic (2.36e-1)" "unprognostic (3.06e-2)" "prognostic unfavorable (3.61e-4)" "unprognostic (1.43e-3)" "prognostic unfavorable (1.06e-5)" "unprognostic (7.03e-2)" "unprognostic (2.53e-1)" "unprognostic (1.48e-2)" "prognostic unfavorable (2.61e-5)" "unprognostic (9.47e-3)" "unprognostic (1.72e-1)" "unprognostic (1.92e-2)" "unprognostic (5.01e-2)" 4.5 6.1 3.3 13.4 9.9 19.2 13.9 4.8 8.7 5.5 6.6 5.3 6.7 5.9 5.9 4.9 10.9 4.1 3.9 3.1 4.4 3.0 5.8 14.0 6.0 14.3 9.2 2.6 3.4 7.8 7.3 9.8 10.7 6.7 4.8 8.8 7.8 6.3 3.7 5.2 5.4 7.9 5.6 7.0 10.8 5.9 7.8 6.6 30.4 6.5 4.8 17.3 5.9 5.8 9.1 2.0 0.6 2.5 2.4 3.0 1.7 12.7 29.5 37.6 17.4 3.4 3.4 21.3 13.9 8.4 19.8 15.7 14.9 18.8 37.0 14.1 8.0 10.0 10.9 27.4 10.8 18.3 17.5 15.4 28.3 15.8 10.9 1.7 21.3 21.1 2.4 3.4 14.2 8.6 5.4 10.5 22.5 26.3 33.4 16.6 24.9 30.1 16.6 26.6 16.1 12.4 30.3 19.2 18.1 7.7 16.3 29.0 20.0 25.9 14.7 4.1 16.2 25.9 16.8 6.2 15.5 15.6 14.1 11.3 12.6 16.1 20.7 7.2 13.1 18.5 0.1 1.0 0.6 3.0 2.5 0.6 5.7 1.9 2.1 1.6 9.1 1.5 0.6 0.3 2.4 1.7 2.0 2.6 1.7 3.3 9.9 4.8 8.7 4.4 3.0 9.2 2.6 6.7 6.6 0.0 5.3 6.0 2.6 3.0 30.7 1.4 2.5 4.0 10.3 7.0 2.0 9.0 0.0 4.0 4.3 5.8 1.0 0.0 4.9 18.9 1.9 3.1 5.7 9.6 7.2 6.4 1.7 4.3 3.3 2.2 1.1 5.4 0.0 5.4 3.4 5.2 3.5 0.0 1.1 1.9 17.1 0.0 1.2 1.1 22.8 1.3 7.7 4.3 6.5 2.6 TIMM17A "TIM17, TIM17A" ENSG00000134375 "Translocase of inner mitochondrial membrane 17A" Q99595 1 201955491-201970661 "Cancer-related genes, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010083 Approved Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA010083: AB_10602899" "prognostic unfavorable (1.98e-5)" "unprognostic (3.28e-1)" "unprognostic (1.32e-1)" "unprognostic (1.09e-1)" "unprognostic (1.14e-1)" "unprognostic (1.80e-3)" "unprognostic (7.58e-2)" "unprognostic (4.15e-2)" "unprognostic (7.45e-2)" "unprognostic (1.64e-2)" "unprognostic (8.54e-3)" "unprognostic (2.02e-2)" "unprognostic (2.01e-1)" "unprognostic (6.45e-3)" "unprognostic (1.21e-1)" "unprognostic (1.44e-2)" "unprognostic (2.81e-1)" 16.6 27.6 22.7 18.7 23.2 16.9 16.8 16.3 29.3 16.5 19.3 9.9 19.2 17.2 15.0 24.1 17.9 11.8 10.7 39.0 32.3 19.6 25.1 53.7 13.5 15.3 20.6 27.0 11.2 18.7 21.5 14.8 17.4 25.0 14.5 21.8 11.7 24.8 17.1 42.1 11.5 13.0 19.6 13.4 14.4 16.3 13.7 14.2 11.3 21.6 30.4 18.9 15.9 12.7 17.6 28.9 16.0 24.9 15.9 20.6 17.8 26.4 27.0 24.5 29.3 20.7 21.7 41.4 42.3 30.3 34.8 31.3 31.6 27.6 36.7 15.6 36.2 25.5 21.2 44.9 25.3 37.5 26.9 28.1 20.2 35.9 29.9 21.4 43.1 21.8 25.0 28.2 35.5 29.8 25.1 36.3 23.2 51.0 20.6 40.8 16.9 23.1 23.4 31.1 26.7 14.6 22.9 28.5 46.0 42.7 25.2 37.0 26.2 25.9 66.4 39.1 32.5 36.7 29.3 29.0 23.3 24.7 27.0 43.9 31.3 33.7 30.8 24.8 32.9 25.9 8.9 19.0 16.0 13.6 24.9 17.5 17.6 14.9 17.2 28.9 12.7 14.2 16.7 4.4 15.9 24.7 19.3 20.6 17.8 22.7 23.2 16.3 29.3 32.3 19.6 20.6 27.0 25.0 14.2 35.7 37.0 55.2 74.7 81.9 22.9 117.0 40.8 46.8 42.1 36.6 33.4 102.6 116.0 97.2 44.4 41.4 33.9 0.0 74.9 170.0 67.6 57.0 54.3 165.4 105.8 33.4 32.6 35.6 45.4 26.9 31.1 72.6 50.6 99.2 41.2 32.7 83.8 23.0 36.0 93.3 25.4 25.8 62.2 38.1 50.8 86.4 222.1 56.4 49.3 91.8 TIMM29 C19orf52 ENSG00000142444 "Translocase of inner mitochondrial membrane 29" Q9BSF4 19 10928733-10933535 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 31.3;Extravillous trophoblasts: 25.5;Hofbauer cells: 19.8;monocytes: 26.2;Syncytiotrophoblasts: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041858 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA041858: AB_10963429" "unprognostic (8.45e-2)" "prognostic favorable (9.93e-5)" "unprognostic (8.99e-2)" "unprognostic (5.21e-2)" "unprognostic (9.31e-2)" "unprognostic (8.10e-2)" "unprognostic (2.82e-3)" "unprognostic (1.42e-2)" "unprognostic (1.81e-1)" "unprognostic (5.92e-2)" "unprognostic (5.26e-3)" "unprognostic (1.80e-1)" "unprognostic (3.79e-3)" "prognostic favorable (7.03e-7)" "unprognostic (1.10e-1)" "unprognostic (2.35e-1)" "unprognostic (7.26e-3)" 13.4 11.4 13.8 11.0 18.0 18.4 8.0 19.9 16.4 8.5 9.9 10.3 7.6 17.5 11.3 7.1 13.8 8.6 9.4 12.5 15.1 8.9 10.5 13.5 8.1 11.6 13.5 9.3 8.3 17.1 7.0 10.8 12.2 11.9 9.9 5.1 11.3 16.8 9.5 30.9 12.1 12.4 10.3 8.3 11.7 15.0 11.3 13.2 12.0 9.2 8.9 9.7 10.1 10.6 13.6 10.3 8.7 8.7 10.9 12.0 3.2 10.7 3.9 3.1 5.2 2.7 2.6 8.9 7.5 3.8 5.4 5.0 7.0 3.5 9.1 13.3 3.4 2.9 10.0 1.6 4.4 0.9 10.9 13.1 10.5 4.0 4.7 4.3 7.5 8.0 2.2 4.3 3.7 1.5 2.1 3.2 7.8 11.4 7.7 2.0 8.8 8.5 14.6 11.3 3.2 17.4 11.6 4.5 11.0 2.2 4.1 8.1 8.4 8.6 4.5 8.8 1.2 6.5 8.2 5.4 8.7 5.3 11.1 11.4 26.7 26.0 9.7 5.4 9.6 7.2 3.5 7.9 8.7 5.6 8.7 8.8 13.6 10.8 12.0 5.6 10.6 10.1 8.5 1.7 10.9 6.7 10.3 11.0 3.2 13.8 18.0 19.9 16.4 15.1 8.9 13.5 9.3 11.9 13.2 3.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.3 15.7 0.0 31.3 16.6 17.6 0.0 0.0 0.0 0.0 9.2 25.5 0.0 0.0 1.1 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 26.2 0.0 0.0 13.2 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.0 0.0 0.0 TIMM50 TIM50L ENSG00000105197 "Translocase of inner mitochondrial membrane 50" Q3ZCQ8 19 39480412-39493785 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" RNA-binding "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Late spermatids: 445.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048843, HPA056448" Enhanced Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA048843: , HPA056448: AB_2683137" "unprognostic (1.49e-1)" "unprognostic (6.97e-2)" "unprognostic (4.90e-2)" "unprognostic (2.80e-3)" "unprognostic (4.62e-2)" "unprognostic (1.45e-1)" "unprognostic (3.11e-2)" "unprognostic (7.91e-2)" "unprognostic (2.76e-1)" "unprognostic (3.11e-2)" "unprognostic (9.43e-2)" "unprognostic (2.01e-2)" "unprognostic (4.14e-3)" "unprognostic (3.04e-2)" "unprognostic (9.87e-2)" "unprognostic (3.82e-2)" "unprognostic (4.04e-2)" 21.3 20.2 17.9 17.0 25.8 23.0 15.7 14.3 38.2 13.4 18.4 18.0 14.4 18.0 19.0 11.7 22.6 15.8 12.5 42.2 17.6 17.4 23.9 28.0 14.2 16.6 17.8 20.2 16.4 19.8 16.4 13.4 20.0 22.0 15.3 12.0 18.1 18.3 14.6 58.1 14.0 16.1 16.5 12.7 15.1 16.9 40.4 14.7 18.5 24.0 25.5 16.9 16.9 18.2 19.3 27.4 10.3 25.3 17.0 19.9 27.8 26.5 63.9 11.9 29.6 10.5 9.5 21.6 21.0 10.8 25.0 20.4 45.7 18.8 30.1 22.4 14.2 14.0 15.3 23.8 21.7 13.3 26.2 34.6 27.9 18.7 31.6 15.9 54.3 19.3 12.2 15.5 18.7 17.1 7.1 16.2 35.8 44.6 18.1 15.7 35.2 33.2 20.9 20.7 31.3 24.4 33.9 23.7 23.2 17.2 36.7 31.5 17.7 25.3 36.8 43.2 8.6 17.2 29.6 16.2 31.0 28.9 25.5 48.9 17.1 31.4 45.4 23.3 27.3 34.4 10.3 25.3 6.1 16.9 24.0 17.3 19.3 16.2 18.5 27.4 18.1 18.4 17.0 2.1 17.0 22.4 20.6 19.9 27.8 17.9 25.8 14.3 38.2 17.6 17.4 17.8 20.2 22.0 14.7 20.8 24.2 14.2 35.2 23.1 10.0 41.2 22.9 12.0 23.9 24.4 11.8 72.5 56.3 52.0 155.0 24.1 24.2 0.0 44.6 67.0 29.8 28.0 39.2 29.6 59.4 27.0 22.4 19.6 11.8 445.2 21.6 26.0 28.7 22.6 20.3 12.8 42.9 14.4 19.8 53.1 10.4 6.5 34.0 92.9 48.7 23.3 79.1 17.5 42.6 40.9 TIMMDC1 "C3orf1, FLJ22597" ENSG00000113845 "Translocase of inner mitochondrial membrane domain containing 1" Q9NPL8 3 119498532-119525090 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053214, HPA055846" Uncertain Enhanced Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA053214: AB_2682081, HPA055846: AB_2682941" "unprognostic (3.95e-2)" "unprognostic (8.85e-2)" "unprognostic (1.73e-1)" "unprognostic (2.53e-2)" "unprognostic (2.88e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (1.12e-5)" "unprognostic (9.60e-2)" "unprognostic (6.25e-2)" "unprognostic (3.39e-1)" "unprognostic (4.67e-3)" "unprognostic (1.05e-1)" "unprognostic (3.87e-2)" "unprognostic (8.89e-2)" "unprognostic (1.31e-1)" "unprognostic (2.76e-1)" "unprognostic (1.05e-1)" 13.6 17.2 18.1 10.4 16.7 5.9 13.8 8.6 16.2 16.4 12.2 20.4 21.5 9.2 13.3 19.4 18.5 13.6 14.9 43.9 15.9 15.4 22.8 20.5 13.0 15.9 20.9 11.9 11.8 12.5 20.4 17.4 21.4 16.4 15.2 14.5 14.0 14.3 21.6 37.2 16.0 15.3 12.7 21.9 14.3 12.3 13.3 15.6 9.9 19.9 20.3 14.5 16.7 11.1 12.4 13.8 16.3 15.5 8.5 15.8 15.5 14.3 13.5 6.7 5.8 26.2 17.7 15.2 4.2 14.1 12.2 14.0 9.1 8.8 10.5 7.3 14.8 8.4 6.8 16.9 13.7 20.0 8.8 6.1 7.7 6.3 10.2 13.8 6.0 5.1 15.5 21.1 9.8 12.8 7.8 17.2 9.9 10.5 10.1 22.4 17.8 6.3 12.7 9.0 12.1 16.8 5.3 4.7 13.8 18.3 7.2 8.9 16.6 4.3 6.6 16.1 9.5 10.8 16.5 8.6 6.9 5.2 6.3 7.3 6.5 6.1 14.3 11.7 15.3 10.8 6.8 13.8 16.3 8.4 13.0 10.1 12.2 8.3 10.3 13.8 12.4 10.4 9.0 3.4 8.5 15.5 11.9 15.8 15.5 18.1 16.7 8.6 16.2 15.9 15.4 20.9 11.9 16.4 15.6 23.8 35.3 16.0 40.6 33.3 24.2 144.4 40.8 61.6 37.5 38.4 13.7 129.0 127.6 61.0 5.3 55.2 40.2 23.3 54.8 92.7 41.0 35.4 40.4 45.5 75.0 20.6 27.6 31.3 30.4 5.2 43.7 39.7 42.2 83.0 41.1 57.9 47.3 40.1 51.2 112.8 25.9 71.1 52.6 99.3 50.0 36.8 148.4 31.6 44.9 43.4 TIRAP "Mal, wyatt" ENSG00000150455 "TIR domain containing adaptor protein" P58753 11 126283065-126298845 "Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054431 Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" NA NA "Nucleoplasm, Cytokinetic bridge, Cytosol" "HPA054431: AB_2682486" "unprognostic (9.30e-3)" "unprognostic (7.39e-2)" "unprognostic (1.21e-1)" "prognostic favorable (1.24e-4)" "unprognostic (2.73e-2)" "unprognostic (5.77e-2)" "unprognostic (1.27e-1)" "unprognostic (6.89e-2)" "unprognostic (2.40e-1)" "unprognostic (2.28e-1)" "unprognostic (4.65e-2)" "unprognostic (1.42e-1)" "unprognostic (3.34e-3)" "unprognostic (4.29e-3)" "unprognostic (3.62e-2)" "unprognostic (3.47e-1)" "unprognostic (2.57e-1)" 8.8 10.4 5.2 11.9 5.4 3.9 16.8 7.2 8.0 11.9 18.9 4.6 13.2 11.6 11.1 11.1 9.7 8.7 14.2 11.6 4.4 6.5 9.2 14.8 16.8 17.6 6.5 5.8 13.4 18.7 14.0 8.8 9.2 5.1 11.1 8.9 10.5 15.3 21.1 10.5 8.4 17.3 13.6 4.7 13.4 8.7 3.5 2.4 3.3 8.0 6.4 9.8 11.8 7.3 6.5 8.7 8.8 10.5 4.4 8.3 6.2 1.9 6.2 3.3 5.6 5.7 8.0 4.0 5.1 8.3 3.6 3.4 9.7 7.4 5.0 8.8 5.2 6.3 5.6 3.5 3.9 1.4 13.2 3.3 13.5 3.5 6.2 4.6 8.2 7.3 6.0 5.5 6.7 4.7 4.3 5.9 4.1 3.6 11.6 4.1 3.5 0.2 1.3 1.5 13.9 5.7 1.7 0.9 4.7 2.8 6.9 4.1 5.3 6.0 6.0 4.2 4.6 16.4 4.3 5.8 2.0 1.9 4.1 3.8 3.2 4.6 3.7 3.1 6.6 6.2 7.7 10.5 4.9 7.7 8.7 7.4 4.3 6.1 8.3 8.7 6.5 5.0 4.9 8.8 4.4 5.7 5.9 6.1 6.2 5.2 5.4 7.2 8.0 4.4 6.5 6.5 5.8 5.1 2.4 6.0 1.6 1.3 1.4 0.3 3.0 0.8 0.0 1.4 3.4 3.5 0.0 2.8 0.0 2.5 0.0 1.5 4.2 0.0 3.5 4.1 1.6 1.9 1.1 4.9 4.4 3.2 1.2 2.5 4.0 0.0 4.4 2.7 1.7 0.0 2.6 2.4 3.0 4.2 4.2 1.7 2.3 0.0 1.2 0.1 0.6 0.1 2.2 1.9 2.4 1.3 TJP2 "DFNA51, X104, ZO-2, ZO2" ENSG00000119139 "Tight junction protein 2" Q9UDY2 9 69121264-69255208 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 241.2;Rod photoreceptor cells: 273.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 4.0" "Lineage enriched" "Detected in single" 8 "monocytes: 4.0" "Cell line enhanced" "Detected in many" "A-431: 53.3" "HPA001813, CAB009228, HPA070714" Supported Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA 790000 "Plasma membrane, Cell Junctions" Nucleoplasm "CAB009228: AB_2203583, HPA001813: AB_1080764, HPA070714: AB_2732161" "unprognostic (1.30e-1)" "unprognostic (7.69e-2)" "unprognostic (1.23e-3)" "unprognostic (7.68e-2)" "unprognostic (2.01e-1)" "unprognostic (8.83e-3)" "unprognostic (1.94e-2)" "unprognostic (1.86e-1)" "unprognostic (4.82e-2)" "unprognostic (3.30e-2)" "unprognostic (2.93e-3)" "unprognostic (3.60e-1)" "prognostic favorable (1.78e-14)" "unprognostic (3.29e-2)" "unprognostic (6.42e-2)" "unprognostic (8.15e-3)" "unprognostic (5.85e-2)" 25.2 9.5 23.7 8.0 29.7 5.7 20.7 35.6 24.9 9.0 20.0 50.3 20.6 27.2 11.9 7.3 28.9 12.6 13.2 19.8 35.1 12.7 23.3 34.5 23.9 5.8 39.7 20.5 20.9 13.2 43.2 3.6 18.0 32.0 13.5 16.7 19.1 18.0 23.1 8.3 18.6 25.7 15.3 39.7 3.5 30.4 17.8 41.1 11.1 22.5 9.0 10.8 26.5 26.6 0.0 0.2 0.4 4.0 0.0 0.5 0.5 53.3 1.7 4.3 4.8 20.1 19.7 23.3 8.1 6.0 13.0 7.1 6.5 19.5 7.7 8.1 4.5 7.0 32.9 6.9 17.1 14.8 27.3 5.0 7.4 4.6 32.9 5.7 3.0 14.1 15.3 12.3 10.1 6.1 3.7 27.2 2.1 4.5 5.2 6.8 7.5 1.1 0.4 10.4 33.4 11.7 3.9 6.1 0.8 33.4 35.6 1.9 3.3 2.9 20.8 0.6 9.9 6.7 1.6 39.0 9.7 10.5 7.5 8.3 5.4 1.1 0.1 11.2 4.3 3.6 0.0 0.7 0.0 0.0 1.5 0.4 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.4 0.0 4.0 0.1 0.5 0.5 23.7 29.7 35.6 17.5 35.1 12.7 39.7 20.5 32.0 41.1 41.7 21.4 1.4 65.1 57.9 241.2 34.6 50.9 9.4 5.7 3.5 33.4 24.0 0.0 27.8 2.7 42.7 67.5 0.0 20.8 23.1 14.7 83.3 5.7 92.7 4.9 17.5 11.1 25.2 17.0 3.6 27.0 2.8 27.0 4.6 41.5 123.0 32.6 42.5 13.1 1.4 273.3 0.0 10.3 21.3 11.1 56.0 36.2 3.1 36.2 146.9 TJP3 ZO-3 ENSG00000105289 "Tight junction protein 3" O95049 19 3708109-3750813 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 47.0" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 259.3;Enterocytes: 138.3;Paneth cells: 101.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 4 "gdT-cell: 2.0;MAIT T-cell: 6.2;memory CD4 T-cell: 4.8;memory CD8 T-cell: 3.8;naive CD4 T-cell: 5.3;naive CD8 T-cell: 1.9;T-reg: 5.5" "Lineage enriched" "Detected in many" 6 "T-cells: 6.2" "Cell line enhanced" "Detected in some" "BEWO: 22.2;CAPAN-2: 22.3;MCF7: 9.8;OE19: 17.4;SK-BR-3: 13.0;T-47d: 27.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB013244, HPA046863, HPA053337" Enhanced Enhanced "Nucleoplasm,Cell Junctions" NA NA "Nucleoplasm, Cell Junctions" "CAB013244: AB_2533257, HPA046863: AB_2679845, HPA053337: AB_2682118" "unprognostic (2.22e-1)" "unprognostic (1.39e-1)" "unprognostic (2.80e-1)" "prognostic favorable (1.83e-6)" "unprognostic (2.78e-1)" "prognostic favorable (9.52e-4)" "unprognostic (1.30e-1)" "unprognostic (1.25e-1)" "unprognostic (2.52e-1)" "unprognostic (6.52e-2)" "unprognostic (2.15e-2)" "unprognostic (1.78e-1)" "prognostic favorable (9.36e-8)" "unprognostic (8.58e-3)" "unprognostic (5.03e-2)" "unprognostic (1.31e-1)" "unprognostic (4.62e-3)" 0.2 0.0 0.3 8.4 0.4 0.0 3.6 0.2 0.3 3.3 34.9 0.7 15.0 23.0 0.7 5.0 16.0 7.9 22.8 0.6 0.5 0.1 4.4 8.0 10.1 0.6 0.2 0.2 2.2 5.9 2.0 1.6 2.7 1.1 2.6 7.7 1.6 26.1 20.5 0.4 4.3 47.0 0.6 0.2 0.4 15.2 1.4 0.2 0.6 5.5 2.6 8.3 4.5 3.4 1.0 0.0 0.0 0.0 0.0 6.2 1.7 0.1 3.3 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.0 0.0 6.5 22.3 4.0 0.6 0.0 0.0 5.2 0.3 0.0 0.0 0.2 0.1 0.0 0.5 1.6 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 9.8 0.0 0.1 0.4 17.4 0.1 0.0 0.0 2.9 0.7 3.4 0.1 0.1 0.8 13.0 0.0 1.7 27.4 0.1 0.0 0.0 0.5 0.0 0.0 0.8 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.0 6.2 0.7 4.8 3.8 0.0 1.0 5.3 1.9 0.0 0.0 0.0 0.0 5.5 1.7 0.3 0.4 0.2 0.3 0.5 0.1 0.2 0.2 1.1 0.2 8.9 10.7 0.0 6.7 0.0 0.0 0.8 30.6 34.8 12.5 29.6 0.0 26.9 16.6 16.8 259.3 0.0 138.3 0.0 21.0 3.5 0.2 4.8 4.6 4.9 2.4 0.0 12.0 0.0 0.0 10.7 1.7 0.1 3.3 0.0 40.6 0.0 16.7 101.7 1.1 5.1 0.0 0.0 0.2 2.1 3.3 0.1 33.6 1.5 46.1 23.1 TKFC "DAK, DKFZP586B1621, NET45" ENSG00000149476 "Triokinase and FMN cyclase" Q3LXA3 11 61333210-61353295 "Enzymes, Predicted intracellular proteins" "Kinase, Lyase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 90.2;liver: 42.8" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 92.7;Proximal tubular cells: 63.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 40.5;RPMI-8226: 42.7;T-47d: 42.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039486, HPA048186" Enhanced Approved Nucleoplasm,Cytosol NA NA 4800000 Cytosol Nucleoplasm "HPA039486: AB_10795402, HPA048186: AB_2680305" "unprognostic (4.00e-1)" "unprognostic (3.13e-1)" "unprognostic (7.42e-2)" "prognostic favorable (1.32e-5)" "unprognostic (1.07e-1)" "unprognostic (1.19e-1)" "unprognostic (3.02e-2)" "unprognostic (2.81e-3)" "unprognostic (1.49e-1)" "unprognostic (2.47e-1)" "unprognostic (1.51e-1)" "unprognostic (2.15e-1)" "prognostic favorable (8.38e-5)" "unprognostic (2.07e-2)" "unprognostic (8.96e-2)" "unprognostic (3.30e-1)" "unprognostic (4.02e-1)" 3.1 34.7 3.6 6.1 5.3 5.3 4.6 3.7 7.3 3.4 43.4 7.6 8.0 69.5 4.6 7.8 6.2 5.9 8.8 2.8 3.1 2.6 17.4 42.8 3.5 5.2 3.3 5.3 4.5 9.8 3.0 5.5 3.9 4.4 5.0 2.3 7.3 7.2 7.1 4.6 6.1 90.2 2.6 3.1 5.4 5.7 17.1 3.4 5.5 6.4 6.3 6.7 5.4 3.9 9.7 18.4 5.4 11.4 5.3 10.9 7.8 6.1 15.6 2.7 9.5 3.4 3.7 7.7 3.6 3.9 3.4 2.2 7.1 14.8 7.6 12.6 2.6 3.5 8.6 5.1 6.7 1.1 13.1 6.8 4.7 8.2 40.5 5.9 3.9 7.9 5.9 4.6 3.2 11.2 2.9 3.3 5.3 8.2 14.8 2.4 27.9 3.5 3.6 7.5 5.8 10.7 6.2 4.3 42.7 5.4 10.9 10.6 9.5 6.6 11.6 6.0 1.9 42.8 2.8 4.0 6.7 7.0 5.3 2.1 27.4 22.6 6.9 6.9 3.7 6.1 2.3 11.4 5.4 6.7 6.8 8.6 9.7 7.8 6.5 18.4 9.7 5.6 5.9 0.9 5.3 5.3 9.0 10.9 7.8 3.6 5.3 3.7 7.3 3.1 2.6 3.3 5.3 4.4 3.4 0.0 12.6 6.7 10.8 0.0 12.9 3.4 12.7 20.1 12.5 14.0 13.7 25.7 24.9 15.5 7.9 4.5 5.4 0.0 12.8 4.4 3.0 11.6 7.0 92.7 14.9 7.9 12.9 6.2 18.3 9.3 14.1 5.9 0.0 27.9 13.9 8.7 12.3 18.1 21.2 63.4 16.0 6.5 2.4 39.2 14.5 0.0 12.7 5.7 18.4 10.6 TKT ENSG00000163931 Transketolase P29401 3 53224707-53256052 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 216.3" "Cell type enhanced" "Detected in all" 5 "Kupffer cells: 587.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "classical monocyte: 63.0;eosinophil: 41.5;intermediate monocyte: 31.0;myeloid DC: 32.5;neutrophil: 60.1;non-classical monocyte: 35.5" "Group enriched" "Detected in all" 8 "dendritic cells: 32.5;granulocytes: 60.1;monocytes: 63.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029480, HPA029481" Enhanced Enhanced Nucleoplasm NA NA 190000000 Nucleoplasm "HPA029480: AB_10599307, HPA029481: AB_10601895" "unprognostic (5.05e-2)" "unprognostic (3.34e-2)" "unprognostic (1.02e-2)" "unprognostic (1.77e-2)" "unprognostic (2.06e-1)" "unprognostic (1.02e-2)" "prognostic unfavorable (7.21e-6)" "unprognostic (6.78e-2)" "unprognostic (1.70e-1)" "unprognostic (4.73e-2)" "unprognostic (3.06e-3)" "unprognostic (1.36e-2)" "unprognostic (2.08e-1)" "unprognostic (2.99e-1)" "unprognostic (1.07e-1)" "unprognostic (3.29e-1)" "unprognostic (9.90e-3)" 53.6 37.0 21.2 24.1 26.0 216.3 70.1 18.1 24.3 19.0 24.3 21.1 9.9 31.8 16.9 9.5 60.4 21.8 36.5 15.3 19.4 23.0 51.9 27.4 50.1 45.6 33.4 16.0 35.2 69.9 22.5 16.9 29.8 28.7 25.2 19.6 17.5 21.0 21.6 5.2 16.8 22.5 34.5 28.2 45.6 24.5 10.8 23.3 44.8 67.7 37.9 25.1 58.2 57.3 6.8 32.5 60.1 63.0 4.7 5.7 37.6 31.4 159.3 22.8 25.3 50.9 62.2 46.6 21.3 37.0 37.0 35.4 44.0 81.1 39.6 10.3 31.1 71.5 45.6 39.5 80.3 11.0 13.2 21.9 26.4 111.4 66.0 62.3 32.2 17.8 45.0 46.2 44.2 22.8 101.2 46.5 33.7 18.7 17.3 15.0 38.5 33.6 36.1 77.4 61.4 38.5 20.3 10.4 73.6 57.8 53.5 14.8 11.0 39.7 63.6 38.3 72.9 19.8 44.6 34.8 11.4 17.7 33.7 40.7 10.0 18.7 23.7 25.0 32.7 21.2 7.0 63.0 41.5 3.0 31.0 3.8 6.8 4.4 3.4 32.5 3.5 4.6 3.4 60.1 4.7 35.5 5.5 5.7 37.6 21.2 26.0 18.1 24.3 19.4 23.0 33.4 16.0 28.7 23.3 125.0 107.1 122.7 318.5 70.5 32.5 12.0 68.8 60.2 69.4 59.3 27.5 317.9 68.0 167.6 5.0 48.1 125.0 23.3 233.6 204.0 47.6 102.3 61.2 73.1 233.2 35.0 50.5 56.4 587.5 2.7 145.6 247.7 72.6 160.5 113.7 78.1 222.7 69.1 100.4 170.5 36.1 51.8 72.1 14.1 21.1 58.6 345.9 84.1 213.7 357.0 TLDC1 KIAA1609 ENSG00000140950 "TBC/LysM-associated domain containing 1" Q6P9B6 16 84476421-84554033 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 115.8;Rod photoreceptor cells: 65.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 29.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041020 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA041020: AB_10794184" "unprognostic (8.35e-3)" "unprognostic (4.27e-2)" "unprognostic (1.48e-1)" "unprognostic (5.45e-2)" "unprognostic (1.49e-2)" "unprognostic (3.39e-3)" "unprognostic (5.97e-4)" "prognostic unfavorable (1.03e-5)" "unprognostic (3.94e-1)" "unprognostic (2.85e-2)" "prognostic unfavorable (7.05e-5)" "unprognostic (2.92e-2)" "unprognostic (6.78e-3)" "unprognostic (9.87e-2)" "unprognostic (1.83e-1)" "unprognostic (1.56e-2)" "unprognostic (2.16e-2)" 5.5 4.9 7.6 7.1 10.7 1.8 7.3 8.1 11.5 8.1 7.1 6.3 5.2 6.0 14.0 8.8 24.4 6.9 6.5 4.7 6.3 4.5 7.6 5.1 6.4 6.1 5.0 9.4 8.7 5.2 11.3 4.4 15.8 10.7 7.8 7.8 12.9 7.7 6.1 4.5 11.0 9.3 10.7 4.0 5.4 6.8 8.1 3.4 8.3 7.6 6.5 10.0 10.4 12.1 3.3 2.7 13.6 3.5 3.1 8.7 2.6 14.7 10.4 9.1 4.9 4.2 7.4 4.3 10.9 9.8 11.3 3.3 5.9 17.9 2.0 5.9 21.0 8.3 16.5 2.5 29.3 14.9 1.1 2.2 1.6 5.1 5.1 5.2 1.2 5.1 5.1 12.7 10.5 13.9 9.2 4.7 5.9 2.7 2.5 7.6 3.5 1.1 1.2 2.8 7.7 3.6 4.5 2.3 0.7 10.0 8.3 3.0 2.1 9.9 7.1 4.9 10.0 10.2 2.0 11.5 7.9 3.6 4.2 4.5 2.0 3.5 5.4 4.7 0.6 2.7 13.6 3.1 4.4 3.8 2.7 3.7 3.3 6.8 5.5 2.7 2.7 7.6 4.7 3.1 3.1 3.5 0.8 8.7 2.6 7.6 10.7 8.1 11.5 6.3 4.5 5.0 9.4 10.7 3.4 3.0 4.5 2.7 8.9 2.1 14.1 3.3 5.1 8.1 6.8 12.2 115.8 28.9 5.0 15.5 1.4 5.8 13.6 0.0 7.5 8.8 5.1 7.2 4.7 1.5 7.3 4.8 2.9 5.5 4.8 1.2 7.5 2.7 3.3 10.8 4.5 8.1 14.4 7.0 5.3 6.1 65.7 0.0 5.1 4.6 3.9 3.0 39.4 3.2 4.8 20.0 TLE1 "ESG, ESG1, GRG1" ENSG00000196781 "Transducin like enhancer of split 1" Q04724 9 81583683-81689305 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 116.4;Spermatogonia: 119.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011482, HPA071396" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB011482: AB_443210, HPA071396: AB_2686392" "unprognostic (5.86e-2)" "unprognostic (2.59e-1)" "unprognostic (3.71e-1)" "unprognostic (8.49e-2)" "unprognostic (2.62e-1)" "unprognostic (4.18e-2)" "unprognostic (1.49e-2)" "unprognostic (2.19e-3)" "unprognostic (3.59e-2)" "unprognostic (3.75e-2)" "unprognostic (4.95e-2)" "unprognostic (3.65e-1)" "prognostic favorable (8.07e-4)" "unprognostic (2.56e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (7.60e-4)" "unprognostic (4.09e-1)" 26.4 20.1 27.5 12.2 23.1 24.3 23.0 20.3 22.0 25.7 15.2 9.7 13.8 4.0 22.8 19.2 12.7 18.6 19.3 8.1 31.8 9.3 8.6 33.9 9.1 18.8 14.0 20.0 18.1 37.2 5.6 7.9 12.1 14.2 14.6 12.5 13.3 29.0 18.1 54.1 11.8 11.9 20.1 10.5 22.6 15.4 15.0 20.5 2.1 11.0 15.3 8.3 12.9 24.7 6.9 2.0 8.7 0.1 4.9 3.5 0.6 22.9 15.6 15.1 0.0 16.1 9.0 33.6 1.4 4.2 2.5 3.7 2.4 8.5 0.0 15.3 9.6 21.5 12.7 0.2 7.4 2.7 0.0 14.4 0.0 3.2 24.1 9.2 0.0 0.4 4.3 16.6 8.7 17.5 7.6 10.8 6.7 0.0 7.7 8.8 24.5 2.7 0.1 29.6 12.9 9.3 21.3 12.7 1.7 16.0 11.4 8.7 10.9 1.2 12.4 7.5 15.7 9.4 10.7 9.2 6.8 7.5 3.6 10.7 0.2 0.0 0.5 9.6 0.0 12.6 8.7 0.0 5.0 2.5 0.0 3.5 6.9 0.2 1.0 0.6 6.6 0.0 0.2 0.0 4.9 0.1 2.0 0.0 0.6 27.5 23.1 20.3 22.0 31.8 9.3 14.0 20.0 14.2 20.5 0.0 6.2 33.3 18.3 48.4 28.0 5.3 40.8 18.7 13.6 14.0 15.7 52.9 13.3 37.5 0.7 37.2 25.3 0.0 20.3 62.7 23.8 31.9 0.0 54.2 6.9 15.9 27.6 23.9 3.5 2.4 21.0 8.2 43.9 13.6 21.1 35.7 43.9 31.7 32.2 2.5 6.3 116.4 40.6 1.6 119.9 38.1 42.4 26.1 31.2 27.2 TLE3 "ESG, ESG3, GRG3, HsT18976, KIAA1547" ENSG00000140332 "Transducin like enhancer of split 3" Q04726 15 70047790-70098176 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Suprabasal keratinocytes: 116.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 27.1" "Lineage enriched" "Detected in all" 4 "granulocytes: 27.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054116 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA054116: AB_2682386" "unprognostic (5.57e-2)" "prognostic favorable (2.09e-5)" "unprognostic (5.18e-2)" "unprognostic (5.13e-2)" "unprognostic (1.15e-1)" "unprognostic (4.05e-2)" "unprognostic (1.35e-2)" "unprognostic (5.53e-2)" "unprognostic (6.74e-2)" "unprognostic (3.11e-2)" "unprognostic (1.72e-1)" "unprognostic (6.07e-2)" "unprognostic (4.90e-2)" "unprognostic (2.43e-1)" "unprognostic (6.71e-2)" "unprognostic (6.29e-2)" "unprognostic (2.74e-1)" 18.7 5.5 10.1 28.8 6.3 62.9 13.1 6.1 11.2 16.0 16.5 10.4 14.2 16.5 9.9 9.2 24.1 8.6 11.3 8.6 8.6 6.9 10.9 13.8 16.8 15.4 7.6 5.7 12.3 14.7 5.2 9.2 34.4 9.5 19.4 7.2 11.3 15.7 18.1 7.6 21.6 27.4 7.5 12.5 20.9 14.1 18.4 6.5 30.7 14.8 12.8 28.0 10.2 15.8 6.0 4.8 27.1 2.7 1.5 2.0 0.8 2.9 9.4 5.8 8.3 4.7 4.4 30.6 1.0 2.1 1.3 0.9 13.0 8.5 7.7 12.9 1.0 1.8 5.3 14.5 5.3 1.4 10.9 17.8 12.6 19.2 2.3 4.5 4.2 19.8 7.6 2.1 4.8 3.8 8.0 6.8 18.1 9.5 35.4 2.2 8.1 14.3 10.8 5.2 2.4 9.7 13.4 5.1 8.9 2.4 17.6 7.4 10.8 23.4 10.7 10.5 7.9 11.9 9.2 4.4 3.9 7.6 11.5 6.6 33.7 21.3 13.3 5.6 13.0 9.4 1.3 2.7 1.3 1.1 2.6 1.0 6.0 1.5 1.4 1.6 2.9 1.6 2.0 27.1 1.5 2.7 4.8 0.9 0.8 10.1 6.3 6.1 8.7 8.6 6.9 7.6 5.7 9.5 6.5 11.9 29.6 50.2 43.6 102.2 21.8 9.0 5.1 9.4 18.2 59.3 29.5 21.7 6.6 11.4 32.7 16.3 38.3 23.3 4.8 49.1 25.2 38.0 50.9 20.2 34.5 0.0 27.6 27.6 44.2 62.0 13.0 43.9 33.7 21.6 27.2 29.6 7.4 24.6 17.3 10.3 3.6 0.0 28.1 4.7 26.5 116.1 68.9 13.8 28.6 28.4 TLE4 "E(spI), ESG, GRG4" ENSG00000106829 "Transducin like enhancer of split 4" Q04727 9 79571773-79726882 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 66.2" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 722.1;Late spermatids: 937.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 33.0;BJ hTERT+: 32.9;BJ hTERT+ SV40 Large T+: 31.0;fHDF/TERT166: 51.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065357 Supported Nucleoplasm NA NA Nucleoplasm "HPA065357: AB_2685479" "unprognostic (6.68e-2)" "unprognostic (8.50e-3)" "unprognostic (2.13e-3)" "unprognostic (2.92e-1)" "unprognostic (1.91e-1)" "unprognostic (9.79e-2)" "unprognostic (1.24e-2)" "unprognostic (4.83e-1)" "unprognostic (2.83e-1)" "unprognostic (1.62e-1)" "unprognostic (9.94e-3)" "unprognostic (1.04e-1)" "prognostic favorable (6.94e-4)" "unprognostic (1.49e-1)" "unprognostic (3.04e-1)" "unprognostic (2.02e-1)" "unprognostic (1.82e-1)" 6.1 11.6 11.6 11.6 25.3 40.0 6.9 22.5 21.2 7.4 7.3 28.8 3.6 6.0 11.4 5.5 12.8 10.3 13.0 6.2 14.7 11.3 5.6 4.4 8.9 10.8 28.9 15.0 26.1 5.3 14.0 45.2 14.6 20.4 4.9 8.6 8.6 7.5 7.1 23.8 13.5 8.0 11.2 31.2 12.4 10.5 66.2 30.3 18.8 8.1 5.1 14.2 12.2 9.3 1.2 2.2 17.3 4.7 2.3 4.8 2.0 0.0 5.9 24.1 0.1 4.4 3.7 7.4 33.0 32.9 31.0 12.3 0.8 3.4 2.7 0.0 51.5 4.5 6.9 1.6 5.8 15.0 11.8 10.2 0.0 2.9 0.1 4.7 7.0 4.3 4.2 4.3 8.8 1.7 8.8 8.0 4.7 0.5 7.2 10.3 0.2 9.1 3.0 7.6 4.2 1.5 8.3 12.7 2.3 1.9 0.9 9.9 14.7 4.6 0.6 0.0 11.8 0.0 8.1 11.5 12.0 0.0 0.2 1.6 4.7 7.6 3.5 4.2 6.1 5.5 17.3 3.4 12.9 3.9 4.7 4.8 1.1 2.1 2.9 2.2 1.2 1.2 2.1 9.2 2.3 3.6 0.8 0.5 2.0 11.6 25.3 22.5 21.2 14.7 11.3 28.9 15.0 20.4 30.3 6.0 20.8 54.1 48.8 107.4 74.6 15.3 61.1 24.1 25.0 14.0 119.8 55.1 3.3 11.6 722.1 49.7 119.6 0.0 19.5 58.1 45.9 27.8 20.7 12.8 42.0 206.6 24.2 36.8 152.5 937.0 97.8 71.8 40.5 27.9 68.5 23.4 25.3 203.4 43.9 15.3 271.5 71.1 60.8 39.3 150.1 79.4 54.3 87.1 54.2 84.6 TLK1 "KIAA0137, PKU-BETA" ENSG00000198586 "Tousled like kinase 1" Q9UKI8 2 170990823-171231314 "Enzymes, Predicted intracellular proteins" "Cell cycle, DNA damage" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016043 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA016043: AB_1858027" "unprognostic (2.13e-2)" "unprognostic (3.87e-1)" "unprognostic (7.36e-2)" "unprognostic (6.00e-3)" "unprognostic (2.00e-1)" "unprognostic (6.78e-2)" "unprognostic (2.47e-2)" "unprognostic (7.60e-2)" "unprognostic (1.61e-1)" "unprognostic (5.26e-2)" "unprognostic (2.57e-1)" "unprognostic (1.11e-1)" "unprognostic (6.13e-2)" "unprognostic (2.08e-1)" "unprognostic (1.55e-1)" "unprognostic (2.63e-1)" "unprognostic (1.53e-1)" 13.8 20.1 22.0 32.9 21.0 14.4 26.2 18.3 23.2 19.6 20.2 8.4 22.3 13.7 16.1 16.1 14.1 14.4 16.2 12.7 20.6 19.3 19.5 21.4 22.1 33.7 21.7 20.8 21.5 19.8 37.8 21.0 36.0 18.3 18.0 18.2 10.8 16.4 30.3 18.6 15.4 18.9 20.5 18.7 26.0 19.9 24.2 12.2 28.0 25.7 11.1 21.7 21.9 19.1 10.5 5.3 11.3 5.5 9.5 12.3 6.6 8.6 8.5 12.3 9.6 8.8 8.8 13.6 12.1 17.6 12.2 10.2 11.7 14.2 18.0 9.9 18.1 13.2 7.4 15.6 13.5 13.4 21.4 7.8 20.8 10.6 15.1 9.5 26.3 10.5 9.6 13.8 24.2 16.0 13.0 13.3 11.6 21.3 15.4 7.3 10.8 22.1 8.4 11.3 8.4 4.8 16.7 14.9 18.6 10.0 16.7 14.0 10.9 13.1 9.3 8.9 8.7 7.6 9.2 18.1 10.9 13.4 7.1 9.4 12.9 21.7 32.7 13.5 10.9 10.9 11.3 3.9 6.5 6.6 3.0 9.1 10.5 10.7 7.2 3.5 10.5 12.3 8.1 5.0 9.5 5.5 5.3 10.0 6.6 22.0 21.0 18.3 23.2 20.6 19.3 21.7 20.8 18.3 12.2 47.6 23.8 55.6 30.2 36.7 31.7 26.5 28.1 33.5 29.6 48.8 56.9 70.8 74.6 24.8 57.8 27.4 38.0 23.3 28.2 44.9 25.5 42.8 26.5 30.0 23.9 42.9 23.0 12.3 25.7 21.5 40.0 26.9 35.4 15.4 31.6 25.5 28.4 34.8 42.1 38.3 72.6 0.0 28.8 29.9 22.6 34.3 146.2 48.0 28.0 31.4 TLNRD1 "MESDC1, MGC99595" ENSG00000140406 "Talin rod domain containing 1" Q9H1K6 15 81000944-81005788 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Exocrine glandular cells: 27.2;Extravillous trophoblasts: 28.3;Hofbauer cells: 29.4;Pancreatic endocrine cells: 35.9;Proximal tubular cells: 22.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 25.9;SK-MEL-30: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071716 Approved "Nucleoplasm,Cytoplasmic bodies" NA NA "Nucleoplasm, Cytoplasmic bodies" "HPA071716: AB_2732183" "unprognostic (1.32e-2)" "unprognostic (5.30e-2)" "unprognostic (9.29e-2)" "unprognostic (5.37e-3)" "unprognostic (9.10e-3)" "unprognostic (1.24e-2)" "unprognostic (1.61e-2)" "prognostic unfavorable (1.47e-5)" "unprognostic (1.68e-2)" "unprognostic (6.82e-2)" "unprognostic (1.81e-1)" "unprognostic (3.24e-1)" "prognostic unfavorable (1.87e-7)" "unprognostic (1.91e-1)" "unprognostic (1.44e-1)" "unprognostic (8.32e-2)" "unprognostic (3.82e-3)" 24.4 13.1 5.8 11.8 19.2 13.7 11.1 18.5 12.6 8.2 12.0 7.0 10.3 8.8 9.7 8.2 9.6 8.7 14.4 10.0 5.9 6.0 9.2 10.1 17.9 12.5 5.8 4.6 6.5 11.9 4.4 7.3 10.7 5.9 7.2 7.4 10.8 7.5 6.6 5.6 4.5 10.1 6.2 8.2 21.4 15.7 2.8 4.6 15.0 6.5 11.0 10.4 7.8 8.7 3.0 2.2 2.0 1.9 4.7 2.9 1.2 6.1 2.0 5.4 3.9 2.4 1.4 9.0 5.7 1.6 3.6 2.6 3.5 5.6 6.8 8.0 1.4 2.1 8.0 3.3 1.8 2.0 25.9 9.7 13.2 1.2 3.8 1.8 4.6 9.6 1.5 2.4 2.2 2.1 1.3 5.3 5.8 7.4 16.8 2.4 3.1 7.2 5.4 8.6 4.0 2.9 9.4 5.5 15.2 2.2 6.3 8.5 7.2 3.2 3.5 25.1 4.9 3.1 4.1 6.3 4.1 13.0 5.7 8.4 11.7 11.5 7.2 2.8 6.7 4.2 2.0 1.3 1.4 2.7 1.9 2.0 3.0 2.9 2.8 0.9 2.3 1.5 2.1 2.0 4.7 1.6 2.2 1.2 1.2 5.8 19.2 18.5 12.6 5.9 6.0 5.8 4.6 5.9 4.6 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 4.0 7.9 12.2 0.0 7.5 1.7 12.2 0.0 0.0 0.0 0.0 27.2 28.3 0.0 0.0 2.3 0.0 29.4 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 5.4 0.0 0.0 35.9 0.0 0.0 22.1 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 TLR2 "CD282, TIL4" ENSG00000137462 "Toll like receptor 2" O60603 4 153684070-153705702 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 72.9" "Group enriched" "Detected in many" 5 "Alveolar cells type 2: 64.7;Kupffer cells: 106.5;Macrophages: 52.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 29.5;intermediate monocyte: 28.1;myeloid DC: 19.1;neutrophil: 72.9;non-classical monocyte: 18.4" "Group enriched" "Detected in many" 46 "dendritic cells: 19.1;granulocytes: 72.9;monocytes: 29.5" "Cell line enhanced" "Detected in some" "HL-60: 6.9;HSkMC: 7.5;hTCEpi: 7.5;RPTEC TERT1: 7.7;RT4: 9.5;THP-1: 36.3;U-937: 6.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA060231, HPA071546" Supported Nucleoplasm,Mitochondria No NA "Nucleoplasm, Mitochondria" "HPA060231: , HPA071546: " "unprognostic (4.15e-1)" "unprognostic (3.29e-2)" "unprognostic (5.32e-2)" "unprognostic (1.52e-2)" "unprognostic (3.46e-2)" "unprognostic (4.88e-2)" "unprognostic (1.39e-2)" "unprognostic (4.24e-2)" "unprognostic (2.48e-1)" "unprognostic (2.02e-2)" "unprognostic (2.04e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.11e-4)" "unprognostic (7.87e-2)" "unprognostic (3.80e-3)" "unprognostic (1.42e-1)" "unprognostic (5.93e-3)" 16.3 6.9 6.9 30.0 11.1 34.6 7.3 1.4 5.3 4.7 4.7 3.0 9.3 2.2 3.1 8.0 3.2 7.2 10.0 7.2 6.7 3.3 9.8 7.3 31.1 37.8 12.4 1.4 4.2 5.1 1.1 4.4 6.4 9.9 5.5 1.9 3.3 15.0 9.9 2.5 3.1 4.0 6.6 21.9 29.3 3.9 4.8 9.5 0.9 3.3 1.0 8.5 7.3 3.5 0.2 19.1 72.9 29.5 0.8 0.2 9.3 4.0 0.0 0.2 0.0 0.5 1.6 0.0 0.0 0.3 0.3 0.5 1.9 0.2 0.0 0.4 0.0 0.0 3.6 0.4 0.3 0.2 0.0 0.0 0.1 0.0 0.4 0.0 6.9 0.5 7.5 7.5 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.4 0.0 1.6 0.1 0.0 0.0 7.7 9.5 0.0 0.2 0.4 0.0 1.8 0.2 0.0 36.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.9 0.9 6.2 29.5 0.2 0.0 28.1 0.0 0.0 0.1 0.0 19.1 0.2 0.2 0.0 72.9 0.8 18.4 0.1 0.0 9.3 6.9 11.1 1.4 5.3 6.7 3.3 12.4 1.4 9.9 9.5 6.0 64.7 0.8 1.1 1.0 0.0 1.2 5.1 2.7 12.5 3.5 0.0 0.1 0.0 4.8 0.3 0.6 0.0 0.0 3.2 0.1 0.9 2.0 3.5 0.9 16.3 0.0 0.0 2.5 106.5 0.0 0.6 52.5 1.7 0.0 0.1 0.0 3.1 0.0 0.4 1.0 0.3 12.9 0.4 0.2 0.4 1.0 0.1 0.7 0.0 1.4 TLR5 "FLJ10052, MGC126430, MGC126431, SLEB1, TIL3" ENSG00000187554 "Toll like receptor 5" O60602 1 223109406-223143282 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 17.8;Collecting duct cells: 21.0;Kupffer cells: 23.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 9 "classical monocyte: 17.0;intermediate monocyte: 15.7;myeloid DC: 12.8;neutrophil: 13.4;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 10 "dendritic cells: 12.8;granulocytes: 13.4;monocytes: 17.0" "Cell line enhanced" "Detected in some" "A-431: 4.4;HaCaT: 6.7;OE19: 3.9;SK-BR-3: 4.3;T-47d: 4.8" "Low region specificity" "Detected in many" CAB009013 Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB009013: AB_2240732" "unprognostic (2.43e-2)" "unprognostic (1.04e-2)" "unprognostic (2.05e-1)" "unprognostic (2.25e-2)" "unprognostic (3.81e-2)" "unprognostic (3.09e-2)" "unprognostic (6.83e-2)" "unprognostic (1.49e-2)" "unprognostic (2.71e-1)" "unprognostic (4.23e-3)" "unprognostic (1.46e-1)" "unprognostic (3.69e-2)" "prognostic unfavorable (4.95e-4)" "unprognostic (1.06e-3)" "unprognostic (5.60e-2)" "unprognostic (1.27e-1)" "unprognostic (1.43e-1)" 3.8 2.4 5.3 4.8 7.3 0.4 9.7 0.8 5.3 7.1 2.7 3.4 1.7 1.7 2.4 6.2 9.0 5.6 4.8 5.8 5.0 2.6 4.6 2.2 6.5 12.5 7.0 0.8 22.5 5.3 6.6 6.3 3.5 6.8 6.2 2.3 3.2 12.6 2.9 1.4 3.7 2.3 3.7 12.8 6.7 4.5 2.3 8.1 1.2 4.3 3.5 5.7 5.9 7.8 0.1 12.8 13.4 17.0 0.2 1.4 5.7 4.4 0.4 0.7 0.4 0.3 0.0 0.6 0.2 0.0 0.1 0.1 0.0 1.3 0.0 0.9 0.4 0.1 6.7 0.1 0.5 0.4 1.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.1 1.9 0.5 0.2 1.7 0.9 0.0 0.0 0.6 1.0 0.3 2.5 3.9 0.0 0.1 0.0 0.2 2.1 0.8 1.8 0.4 1.3 4.3 0.1 1.0 4.8 0.0 0.0 0.1 0.1 0.0 1.2 0.2 0.0 0.2 0.0 0.7 0.5 0.0 17.0 0.2 0.1 15.7 0.2 0.1 0.9 0.2 12.8 0.0 1.4 0.4 13.4 0.2 6.3 0.2 0.6 5.7 5.3 7.3 0.8 5.3 5.0 2.6 7.0 0.8 6.8 8.1 3.0 10.5 0.0 5.9 0.5 0.0 1.7 17.8 8.1 15.9 21.0 2.0 1.2 3.3 3.0 3.3 1.0 0.0 0.0 3.4 0.3 5.0 3.3 2.3 0.6 15.6 0.0 1.2 0.6 23.7 4.0 8.6 11.1 3.3 0.0 0.3 1.1 2.0 0.0 8.1 0.0 0.1 0.0 1.4 4.3 4.5 1.4 0.7 0.0 1.2 6.5 TLX2 "Enx, HOX11L1, NCX, Tlx2" ENSG00000115297 "T cell leukemia homeobox 2" O43763 2 74513463-74517147 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 8.0;brain: 4.3;retina: 3.8" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 19.6;Rod photoreceptor cells: 16.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "SH-SY5Y: 38.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA062254 Approved Nucleoplasm NA NA Nucleoplasm "HPA062254: AB_2684727" "unprognostic (7.30e-2)" "unprognostic (3.03e-4)" "unprognostic (9.54e-4)" "unprognostic (2.86e-2)" "unprognostic (2.33e-1)" "unprognostic (1.69e-2)" "unprognostic (6.77e-2)" "unprognostic (1.36e-1)" "unprognostic (9.00e-2)" "unprognostic (3.91e-2)" "unprognostic (1.39e-1)" "unprognostic (5.40e-1)" "unprognostic (3.92e-7)" "unprognostic (2.51e-1)" "unprognostic (6.86e-2)" "unprognostic (5.04e-2)" "unprognostic (1.18e-1)" 0.1 8.0 1.7 1.7 4.0 0.2 0.1 0.8 4.3 0.1 2.7 0.0 0.0 1.9 0.1 0.1 0.5 0.1 0.6 0.1 0.4 0.7 0.1 0.1 0.1 0.5 0.8 0.0 0.1 0.6 0.5 0.0 0.2 3.5 0.1 0.7 3.8 0.1 0.1 0.1 0.4 2.5 0.2 0.3 0.2 0.9 3.3 0.6 2.5 0.1 0.0 0.3 2.1 0.4 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 2.0 0.0 0.0 0.0 0.0 2.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.3 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 4.0 0.8 4.3 0.4 0.7 0.8 0.0 3.5 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 16.5 0.0 0.0 1.7 3.2 0.0 0.0 0.0 0.0 0.0 TLX3 "HOX11L2, RNX" ENSG00000164438 "T cell leukemia homeobox 3" O43711 5 171309284-171312134 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 59 "brain: 46.6" "Cell type enriched" "Detected in some" 5 "Extravillous trophoblasts: 5.2" "Cancer enhanced" "Detected in some" "cervical cancer: 1.7" "Region enriched" "Detected in some" 22 "cerebellum: 46.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 24.6" "Region enriched" "Detected in single" 7 "cerebellum: 2.5" "Region enriched" "Detected in some" 10 "cerebellum: 48.1" "HPA030504, HPA060957, HPA069359" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA030504: AB_2732458, HPA060957: AB_2732655, HPA069359: AB_2732130" "unprognostic (3.52e-2)" "unprognostic (2.43e-2)" "unprognostic (2.09e-1)" "unprognostic (3.11e-1)" "unprognostic (9.80e-2)" "unprognostic (2.76e-2)" "unprognostic (4.48e-2)" 0.4 0.5 0.0 0.0 0.0 0.0 0.0 46.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.2 0.0 0.0 24.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.6 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 TM2D1 BBP ENSG00000162604 "TM2 domain containing 1" Q9BX74 1 61681046-61725423 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046058, HPA055621" Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA046058: AB_2679519, HPA055621: AB_2682865" "unprognostic (1.80e-1)" "unprognostic (1.99e-3)" "unprognostic (1.68e-1)" "unprognostic (2.20e-2)" "unprognostic (5.79e-1)" "unprognostic (5.23e-2)" "prognostic unfavorable (2.02e-7)" "unprognostic (1.08e-1)" "unprognostic (1.52e-1)" "unprognostic (1.19e-1)" "unprognostic (2.00e-1)" "unprognostic (2.28e-2)" "unprognostic (1.15e-2)" "unprognostic (4.60e-2)" "unprognostic (1.13e-1)" "unprognostic (1.19e-1)" "unprognostic (1.09e-1)" 24.2 30.7 32.5 20.0 42.8 16.2 30.1 24.7 50.1 26.2 22.1 25.3 21.2 16.6 26.3 38.9 19.3 25.1 23.7 36.5 27.9 28.3 32.3 23.5 35.9 27.0 32.7 22.2 31.4 27.6 25.9 24.0 28.8 33.6 28.3 23.9 24.4 23.1 25.6 29.6 16.0 20.1 24.2 45.6 20.3 23.4 27.0 22.3 20.2 33.7 16.6 16.0 21.9 20.5 15.3 22.6 27.2 15.7 14.7 15.2 12.5 11.7 5.8 9.0 7.1 27.5 27.0 11.5 21.1 21.6 10.4 14.0 3.7 15.1 9.6 28.2 17.6 20.9 13.5 11.4 15.3 16.2 15.6 13.4 10.6 9.5 8.2 27.0 15.3 19.0 30.0 26.5 12.0 15.2 25.6 19.7 13.0 12.2 18.7 25.2 3.8 7.7 12.1 9.8 10.5 8.3 6.7 17.0 11.8 30.8 9.3 10.1 12.3 12.6 25.1 37.9 12.6 13.7 16.6 17.4 14.1 7.1 7.8 15.9 15.8 14.5 11.8 24.5 15.0 12.4 26.6 12.6 27.2 11.2 14.6 11.1 15.3 13.0 13.5 11.8 13.0 12.3 14.1 7.6 14.7 15.7 22.6 15.2 12.5 32.5 42.8 24.7 50.1 27.9 28.3 32.7 22.2 33.6 22.3 38.7 38.1 38.9 83.1 69.5 54.4 36.2 38.2 58.9 37.5 75.0 56.9 45.4 33.2 46.4 4.1 53.0 41.7 23.3 39.6 53.3 78.6 77.5 60.0 45.7 45.3 65.2 42.2 74.3 58.7 6.8 73.9 51.2 86.0 39.7 38.7 80.4 42.9 56.0 49.8 58.8 62.9 38.8 59.7 165.1 61.8 66.9 44.7 47.9 41.6 90.1 TM2D2 BLP1 ENSG00000169490 "TM2 domain containing 2" Q9BX73 8 38988808-38996824 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 172.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047152, HPA050547" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Nucleoplasm, Vesicles, Plasma membrane" "HPA047152: AB_2679957, HPA050547: AB_2681168" "prognostic unfavorable (7.49e-4)" "unprognostic (1.49e-1)" "prognostic favorable (1.71e-4)" "unprognostic (2.55e-2)" "unprognostic (7.02e-2)" "unprognostic (2.98e-1)" "unprognostic (5.17e-2)" "unprognostic (1.41e-1)" "unprognostic (3.69e-2)" "unprognostic (2.43e-3)" "unprognostic (4.58e-2)" "unprognostic (1.18e-2)" "unprognostic (1.14e-1)" "unprognostic (1.41e-1)" "unprognostic (1.61e-1)" "unprognostic (1.07e-2)" "unprognostic (8.61e-2)" 21.6 26.2 19.9 14.9 24.3 11.3 24.5 18.8 29.6 21.0 15.3 18.4 25.4 17.5 20.1 27.6 17.2 17.9 22.9 19.4 18.7 20.4 32.6 29.0 21.1 18.1 20.5 17.3 23.3 26.8 25.9 17.5 32.6 25.7 22.8 16.6 22.9 18.8 23.4 14.6 18.5 20.7 17.7 16.4 24.3 19.2 26.1 13.9 11.1 39.7 14.9 14.9 16.7 19.5 14.4 33.5 27.2 18.8 17.4 22.8 19.2 14.0 22.7 10.6 14.6 24.8 16.7 14.6 29.9 18.4 22.7 20.6 17.3 12.2 4.9 23.6 22.1 25.5 15.3 11.2 18.1 24.8 5.9 8.6 11.3 13.3 18.6 22.0 3.3 14.7 20.3 17.8 17.8 8.7 16.6 29.1 8.4 12.4 14.7 30.2 8.7 8.2 11.4 13.4 21.2 9.0 7.0 13.7 8.3 25.9 11.2 3.5 6.9 11.4 8.0 14.7 19.6 19.6 7.1 26.1 18.4 13.8 26.8 15.0 10.3 22.7 8.7 14.0 7.7 12.8 27.2 16.2 14.5 18.0 18.8 19.6 14.3 21.2 19.6 17.0 14.4 20.2 19.6 4.5 17.4 15.6 33.5 22.8 19.2 19.9 24.3 18.8 29.6 18.7 20.4 20.5 17.3 25.7 13.9 11.9 14.3 17.6 48.8 31.1 21.6 15.1 30.6 20.1 20.5 48.8 19.6 78.2 24.9 57.6 44.6 26.6 11.9 0.0 33.5 82.1 36.1 49.2 21.9 33.7 172.6 22.3 9.9 66.3 32.3 35.5 33.4 33.8 25.3 106.4 10.7 40.2 58.6 15.2 23.3 48.2 29.3 0.0 18.1 33.0 59.4 13.6 66.8 22.0 14.9 50.4 TM2D3 "BLP2, FLJ22604" ENSG00000184277 "TM2 domain containing 3" Q9BRN9 15 101621444-101652391 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054064 Uncertain Approved Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA054064: AB_2682366" "unprognostic (1.41e-1)" "unprognostic (8.76e-2)" "unprognostic (2.06e-2)" "unprognostic (2.55e-3)" "unprognostic (1.15e-1)" "unprognostic (8.37e-2)" "unprognostic (2.29e-1)" "unprognostic (8.62e-2)" "unprognostic (2.51e-2)" "unprognostic (5.40e-2)" "unprognostic (4.09e-2)" "unprognostic (1.06e-1)" "unprognostic (3.14e-2)" "unprognostic (2.92e-2)" "unprognostic (2.63e-1)" "unprognostic (3.78e-2)" "unprognostic (2.78e-2)" 17.8 25.1 32.8 14.1 33.1 15.4 26.0 30.7 46.7 24.9 16.9 21.3 15.3 15.2 26.3 29.1 15.3 22.5 18.7 28.3 35.3 49.8 20.6 32.8 17.5 23.0 28.2 35.8 37.6 28.2 23.5 25.7 19.6 26.8 21.5 15.6 19.1 20.9 24.0 22.6 16.8 15.0 20.7 22.7 17.0 15.8 20.6 19.1 16.0 29.1 14.2 19.2 19.2 16.1 21.4 14.3 38.4 20.2 24.1 24.1 18.0 8.5 21.3 11.4 20.6 32.9 24.5 14.0 11.3 18.8 13.5 15.1 11.4 24.4 14.0 15.7 15.4 22.7 20.2 17.7 14.6 10.7 13.3 39.0 20.9 18.5 19.3 21.7 16.2 25.0 20.3 29.6 8.1 16.9 18.9 18.5 18.2 17.1 21.2 21.2 17.3 11.8 17.2 17.6 38.9 7.2 14.5 14.5 21.7 27.2 22.6 15.4 14.1 15.6 16.6 22.5 20.5 15.7 21.5 14.7 14.3 14.7 9.5 12.4 20.1 29.7 15.1 12.1 20.4 11.7 14.8 20.2 38.4 21.7 19.9 24.1 15.5 17.9 16.5 14.3 21.4 23.9 22.1 34.4 24.1 15.0 12.1 18.0 18.0 32.8 33.1 30.7 46.7 35.3 49.8 28.2 35.8 26.8 19.1 23.8 33.2 37.0 49.5 58.8 44.9 33.5 22.9 16.0 28.4 40.1 31.4 64.8 16.6 54.9 5.7 52.5 22.0 0.0 37.4 54.4 51.9 46.9 24.3 51.6 29.9 65.2 25.9 53.4 45.9 8.8 68.1 37.2 25.3 39.7 23.1 57.0 28.6 23.2 59.1 32.7 43.7 71.1 42.7 85.4 85.7 48.4 76.1 47.2 25.4 34.6 TM4SF5 ENSG00000142484 "Transmembrane 4 L six family member 5" O14894 17 4771884-4783213 "Predicted membrane proteins" "Cell cycle" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "intestine: 80.9;liver: 69.8" "Cell type enhanced" "Detected in many" 14 "Enterocytes: 55.9;Hepatocytes: 125.4;Intestinal endocrine cells: 110.5;Mucus-secreting cells: 76.1;Paneth cells: 190.0" "Cancer enriched" "Detected in many" 9 "liver cancer: 219.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "non-classical monocyte: 1.1" "Lineage enriched" "Detected in single" 5 "monocytes: 1.1" "Group enriched" "Detected in some" 13 "CACO-2: 23.4;Hep G2: 40.5;OE19: 25.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA055674 Uncertain "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "HPA055674: " "unprognostic (1.81e-1)" "unprognostic (1.61e-1)" "unprognostic (1.31e-1)" "unprognostic (4.44e-2)" "unprognostic (9.33e-2)" "unprognostic (3.57e-2)" "unprognostic (1.95e-1)" "unprognostic (5.21e-3)" 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 45.1 0.1 0.1 50.5 0.1 0.2 0.1 0.1 7.0 0.1 0.1 0.1 3.1 69.8 0.1 0.1 0.1 0.1 0.1 0.9 4.1 0.1 0.6 0.1 0.1 1.6 0.1 0.1 0.1 0.1 0.1 80.9 0.1 0.1 0.1 8.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.1 0.0 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 23.4 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 40.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.3 0.0 25.7 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 25.5 0.0 0.0 1.8 0.0 0.0 5.0 1.1 1.5 0.0 55.9 0.0 8.1 1.2 0.0 0.0 4.6 125.4 0.1 0.0 110.5 6.2 3.2 1.3 0.0 0.0 0.0 0.0 76.1 0.0 4.9 190.0 0.0 47.6 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.9 34.5 0.0 TM7SF3 ENSG00000064115 "Transmembrane 7 superfamily member 3" Q9NS93 12 26973195-27014434 "Predicted intracellular proteins, Predicted membrane proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Late spermatids: 123.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057640 Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA057640: " "unprognostic (4.24e-1)" "unprognostic (1.90e-2)" "unprognostic (1.04e-3)" "unprognostic (8.80e-2)" "unprognostic (5.82e-2)" "unprognostic (5.10e-2)" "unprognostic (1.83e-1)" "unprognostic (5.79e-2)" "unprognostic (2.86e-1)" "unprognostic (1.28e-1)" "unprognostic (1.01e-2)" "unprognostic (1.16e-1)" "prognostic favorable (1.32e-4)" "unprognostic (1.24e-2)" "unprognostic (1.53e-1)" "unprognostic (2.16e-1)" "unprognostic (1.58e-1)" 12.0 27.6 12.1 8.1 17.4 18.5 15.9 7.9 18.9 12.4 17.2 18.1 13.1 10.7 10.9 16.6 27.8 12.7 16.4 10.6 11.7 11.6 69.8 39.9 15.9 15.0 13.0 11.6 12.1 52.6 15.4 33.2 11.0 10.7 14.5 19.7 20.5 21.9 14.2 5.8 15.4 12.8 13.2 13.9 12.0 14.9 11.0 10.6 31.2 14.1 12.3 17.1 15.3 16.5 10.5 10.6 16.0 6.9 11.8 11.4 3.9 8.4 20.1 12.0 14.5 18.3 12.1 63.1 10.5 17.0 8.6 14.9 11.1 36.2 11.4 13.5 9.8 7.8 9.3 12.5 70.9 12.0 11.1 7.4 17.0 25.3 21.0 12.1 61.3 12.0 7.4 60.5 18.5 16.7 26.3 22.7 30.9 7.3 7.8 13.0 17.3 29.9 35.7 24.4 32.7 12.0 28.0 18.9 20.1 15.0 38.7 2.0 10.7 12.9 6.9 18.4 59.2 19.1 13.0 8.5 7.6 12.4 20.7 12.9 4.7 12.1 21.3 14.6 20.9 11.4 8.6 6.9 16.0 6.0 6.9 5.7 7.3 7.6 7.8 10.2 10.5 10.9 7.2 7.8 11.8 3.5 10.6 11.4 3.9 12.1 17.4 7.9 18.9 11.7 11.6 13.0 11.6 10.7 10.6 11.9 22.2 20.8 43.3 25.5 44.9 8.6 94.3 5.3 25.0 40.1 41.2 35.0 14.9 48.9 75.7 18.9 16.7 23.3 35.2 13.0 17.5 22.1 13.9 37.8 34.8 22.3 12.7 15.4 19.7 123.7 14.4 20.3 62.4 21.6 21.2 29.6 27.4 31.6 21.5 79.2 34.9 6.5 12.8 6.2 26.2 24.3 13.6 20.3 29.9 34.1 TMA16 "C4orf43, FLJ11184" ENSG00000198498 "Translation machinery associated 16 homolog" Q96EY4 4 163494442-163520539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041571, HPA052688" Uncertain Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA041571: AB_10794381, HPA052688: AB_2681916" "unprognostic (6.02e-2)" "unprognostic (1.19e-1)" "unprognostic (4.63e-2)" "unprognostic (1.18e-1)" "unprognostic (4.00e-1)" "unprognostic (2.92e-3)" "prognostic unfavorable (2.70e-5)" "prognostic unfavorable (4.40e-4)" "unprognostic (2.30e-3)" "unprognostic (1.33e-2)" "unprognostic (1.17e-3)" "unprognostic (2.69e-2)" "prognostic unfavorable (7.70e-4)" "unprognostic (6.98e-2)" "unprognostic (2.30e-1)" "unprognostic (1.40e-2)" "unprognostic (2.56e-2)" 16.1 13.1 7.1 25.3 9.6 10.2 16.0 8.9 11.5 17.5 11.5 8.9 11.8 9.4 18.5 17.7 16.1 12.8 13.5 12.0 8.7 7.4 13.5 16.8 10.2 22.1 7.6 8.8 16.0 19.3 7.2 12.4 12.6 9.9 11.6 11.0 8.8 16.9 12.2 17.2 15.1 9.8 13.1 11.1 21.1 13.0 30.0 8.5 28.2 10.6 15.0 18.3 15.6 13.5 21.4 28.2 3.3 21.9 13.5 14.0 7.4 15.7 8.3 13.4 12.2 5.6 9.6 13.8 18.5 9.3 10.1 8.6 8.0 21.6 35.0 7.7 9.8 8.3 8.0 15.6 13.2 12.8 18.0 13.4 48.8 7.9 12.7 12.4 38.5 15.2 6.2 12.0 8.5 10.7 8.4 11.0 11.3 17.1 25.7 11.0 14.2 23.1 20.0 14.9 8.6 12.2 22.1 12.7 22.1 8.0 7.8 7.8 11.5 11.7 15.7 13.8 8.9 9.4 15.0 19.3 8.1 15.3 7.7 19.5 18.7 24.0 40.7 16.0 20.5 24.2 3.3 14.5 1.3 7.7 21.9 11.4 21.4 14.0 9.9 16.5 19.9 13.2 11.1 0.5 13.5 17.7 28.2 11.5 7.4 7.1 9.6 8.9 11.5 8.7 7.4 7.6 8.8 9.9 8.5 20.8 28.2 49.6 29.7 29.2 13.2 32.7 50.9 14.7 27.3 31.4 3.9 47.8 54.7 39.8 141.5 25.9 10.6 23.3 60.9 76.4 30.6 17.5 27.8 47.0 32.6 14.3 29.3 38.6 33.4 132.5 51.5 37.8 25.3 35.1 34.4 14.7 45.8 28.1 30.1 37.2 13.4 38.8 30.6 59.7 38.5 34.6 25.5 21.7 37.6 23.0 TMA7 "CCDC72, HSPC016" ENSG00000232112 "Translation machinery associated 7 homolog" Q9Y2S6 3 48440257-48444208 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 204.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047397 Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies" Yes No "Nucleoli, Nucleoli rim" "Nucleoplasm, Nuclear bodies" "HPA047397: AB_2680029" "unprognostic (1.26e-3)" "unprognostic (1.21e-1)" "unprognostic (9.10e-2)" "unprognostic (1.18e-2)" "unprognostic (2.06e-1)" "unprognostic (5.02e-2)" "unprognostic (3.55e-2)" "prognostic favorable (8.33e-4)" "unprognostic (1.14e-2)" "unprognostic (3.85e-3)" "unprognostic (1.92e-2)" "unprognostic (2.55e-2)" "unprognostic (1.14e-2)" "unprognostic (9.31e-3)" "unprognostic (3.13e-2)" "unprognostic (1.14e-1)" "unprognostic (8.64e-3)" 38.7 54.0 76.1 41.7 82.7 72.5 49.8 41.7 55.8 35.3 49.0 22.6 44.7 37.8 28.4 72.6 43.0 30.5 40.3 49.8 61.4 61.6 50.3 50.3 36.6 50.3 63.6 46.0 41.7 59.5 21.6 45.4 28.7 53.3 36.9 47.0 39.2 39.6 37.4 107.4 28.4 41.1 36.5 57.4 41.5 39.0 35.0 41.0 37.9 38.3 67.6 56.6 29.9 37.7 125.7 139.0 192.1 98.7 79.4 146.7 204.3 65.2 47.4 76.9 55.0 63.8 62.3 53.0 54.0 42.6 51.8 51.5 38.5 47.3 42.7 38.6 46.9 67.6 25.6 67.0 60.9 57.9 52.5 57.1 80.5 102.1 98.1 49.7 91.3 54.0 57.0 65.5 48.9 47.7 50.8 65.3 76.4 43.0 45.7 73.8 67.6 106.2 124.3 102.5 71.0 76.5 30.4 48.2 72.3 89.0 88.5 25.3 64.3 60.8 44.5 81.2 74.5 42.9 135.7 48.8 44.0 79.1 67.9 105.3 76.3 112.4 102.9 56.4 88.3 45.5 141.0 98.7 192.1 110.7 89.8 119.5 125.7 146.7 132.9 104.9 100.5 146.3 140.0 188.5 79.4 87.7 139.0 143.8 204.3 76.1 82.7 41.7 55.8 61.4 61.6 63.6 46.0 53.3 41.0 223.4 369.4 511.1 446.0 636.3 196.3 594.9 570.7 348.0 349.2 854.9 100.1 706.5 1455.6 502.0 547.1 428.3 899.7 443.9 893.2 693.8 535.7 516.2 437.2 865.9 741.4 112.8 610.5 535.9 636.7 794.0 598.9 617.4 737.2 776.3 895.2 244.7 727.5 821.9 436.7 886.4 223.1 349.3 415.1 507.5 743.5 785.4 368.1 657.2 795.4 485.3 TMC5 FLJ13593 ENSG00000103534 "Transmembrane channel like 5" Q6UXY8 16 19410496-19499113 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "intestine: 108.7" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 547.4;Club cells: 299.1;Pancreatic endocrine cells: 236.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "CAPAN-2: 37.3;OE19: 21.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA040810, HPA042037" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA040810: AB_10795627, HPA042037: AB_10804126" "unprognostic (2.47e-2)" "unprognostic (3.68e-1)" "unprognostic (3.50e-2)" "unprognostic (2.74e-3)" "unprognostic (1.01e-1)" "unprognostic (3.64e-2)" "prognostic unfavorable (7.96e-4)" "unprognostic (1.21e-1)" "unprognostic (1.59e-1)" "unprognostic (9.74e-2)" "unprognostic (3.27e-2)" "unprognostic (3.71e-1)" "unprognostic (2.28e-2)" "unprognostic (2.69e-1)" "unprognostic (7.88e-2)" "unprognostic (8.88e-3)" "unprognostic (1.75e-1)" 0.7 0.3 0.3 4.8 0.3 0.1 5.6 0.3 0.7 3.8 66.1 0.6 0.6 19.1 2.1 16.9 1.4 1.9 15.9 0.4 0.4 0.3 0.3 1.8 17.6 0.2 0.3 0.4 1.8 5.4 4.5 1.0 3.7 1.0 8.4 9.8 1.7 18.9 0.2 0.3 0.8 108.7 0.3 0.2 0.3 19.5 2.6 0.2 0.2 0.8 1.7 4.1 1.5 1.1 0.5 0.7 2.2 0.6 0.9 0.8 0.3 3.5 5.8 0.0 0.1 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 37.3 0.0 0.2 0.0 0.1 2.3 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 1.3 21.6 1.6 0.0 0.0 1.3 0.1 0.1 0.3 0.1 0.0 1.1 0.0 0.6 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.6 0.2 0.3 0.3 0.2 0.4 0.8 0.3 0.2 0.5 0.2 0.3 2.2 0.9 0.4 0.7 0.1 0.3 0.3 0.3 0.3 0.7 0.4 0.3 0.3 0.4 1.0 0.2 145.9 125.6 0.0 19.6 0.7 0.1 0.8 122.3 547.4 299.1 21.0 2.0 31.1 0.0 107.5 21.7 0.4 170.3 0.0 144.9 1.6 0.8 88.4 5.7 0.0 2.3 3.2 37.4 0.6 0.0 28.2 0.3 0.9 1.7 1.8 97.1 0.1 236.7 190.0 0.7 0.4 1.5 0.0 0.9 1.8 1.1 1.5 13.6 0.0 77.1 46.1 TMCO6 "FLJ39769, PRO1580" ENSG00000113119 "Transmembrane and coiled-coil domains 6" Q96DC7 5 140639427-140645408 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037473, HPA037474" Uncertain Approved Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA037473: AB_10671049, HPA037474: AB_10671050" "unprognostic (1.03e-1)" "unprognostic (3.40e-1)" "unprognostic (3.95e-2)" "unprognostic (1.38e-2)" "unprognostic (6.10e-3)" "unprognostic (1.31e-2)" "unprognostic (1.65e-1)" "unprognostic (2.11e-1)" "unprognostic (4.89e-2)" "unprognostic (1.69e-1)" "unprognostic (2.75e-2)" "unprognostic (6.24e-2)" "prognostic unfavorable (6.37e-4)" "unprognostic (7.21e-2)" "unprognostic (1.77e-1)" "unprognostic (1.96e-2)" "unprognostic (1.20e-2)" 9.0 15.9 4.0 10.2 6.0 4.9 9.1 9.9 7.9 10.0 10.3 9.6 5.8 5.6 9.6 8.0 9.6 11.8 9.0 5.2 4.4 5.2 6.1 21.4 5.8 9.9 6.1 5.8 13.2 9.9 6.1 7.2 10.5 6.0 7.5 4.3 6.0 16.9 5.9 5.4 7.4 8.5 5.6 6.6 12.0 6.7 19.0 5.2 14.7 8.4 5.5 11.4 7.7 7.7 9.1 7.6 13.4 10.2 4.3 11.3 4.8 3.0 5.9 4.0 5.8 4.0 4.2 14.8 2.5 2.7 3.0 3.2 9.1 5.5 12.1 6.4 1.8 3.5 6.0 3.1 6.7 1.4 4.4 11.2 9.3 2.7 6.3 5.4 5.3 3.5 6.9 1.6 3.8 6.0 2.1 7.1 10.2 3.8 4.0 3.6 5.9 12.1 11.9 4.5 6.9 9.2 10.3 8.3 12.2 3.6 2.7 7.0 2.9 6.9 13.1 6.1 2.5 10.6 6.1 3.3 0.1 2.9 1.1 0.9 7.0 4.1 5.5 1.9 8.2 3.6 10.6 7.3 5.8 6.1 9.9 6.8 9.1 8.1 6.2 7.6 6.4 11.3 4.8 13.4 4.3 10.2 2.1 8.7 4.8 4.0 6.0 9.9 7.9 4.4 5.2 6.1 5.8 6.0 5.2 6.0 1.3 5.1 6.5 1.6 5.0 0.6 2.5 5.3 0.0 10.4 5.9 6.3 0.0 3.2 1.7 4.2 3.5 0.0 2.1 6.8 2.8 3.2 0.0 8.5 4.1 0.0 7.0 6.2 4.1 0.9 3.7 2.7 1.7 4.6 3.7 3.9 3.4 4.3 4.6 1.6 4.2 6.5 2.2 16.6 15.1 1.9 5.3 9.6 6.8 5.7 TMEM100 "FLJ10970, FLJ37856" ENSG00000166292 "Transmembrane protein 100" Q9NV29 17 55719627-55732121 "Predicted membrane proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 52.8;lung: 99.5" "Cell type enhanced" "Detected in some" 12 "Fibroblasts: 20.4;Leydig cells: 37.7;Peritubular cells: 49.5;Sertoli cells: 32.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 18.1;ASC TERT1: 12.3;HHSteC: 28.0;HSkMC: 12.9;U-87 MG: 8.5;WM-115: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055936 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA055936: AB_2682975" "unprognostic (1.35e-1)" "unprognostic (2.75e-1)" "unprognostic (1.57e-1)" "unprognostic (4.02e-2)" "unprognostic (6.78e-3)" "unprognostic (3.07e-1)" "prognostic favorable (2.67e-5)" "unprognostic (5.74e-2)" "unprognostic (1.87e-2)" "unprognostic (4.66e-1)" "unprognostic (1.89e-2)" "unprognostic (8.11e-3)" "prognostic unfavorable (1.32e-4)" "unprognostic (4.91e-3)" "unprognostic (1.12e-1)" "unprognostic (2.07e-2)" "unprognostic (1.26e-3)" 24.7 2.0 3.4 1.5 3.9 0.0 52.8 0.7 5.3 5.1 10.5 0.7 8.8 2.7 1.6 16.7 4.6 3.6 4.8 5.8 1.6 2.8 1.2 5.8 99.5 1.5 3.4 0.6 10.1 1.9 0.0 3.3 23.5 2.6 7.4 5.1 2.6 2.2 11.7 7.0 1.3 6.6 5.2 1.4 2.3 10.7 3.9 0.6 0.5 3.8 3.7 1.3 5.3 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 18.1 12.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 28.0 0.0 0.0 12.9 0.0 0.9 0.1 0.1 0.0 0.2 0.5 0.1 0.3 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.2 1.2 2.4 0.0 0.5 0.0 0.1 8.5 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 3.9 0.7 1.7 1.6 2.8 3.4 0.6 2.6 0.6 0.0 5.1 0.0 0.3 2.3 0.8 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 14.1 0.0 0.0 0.0 0.0 20.4 0.1 1.1 13.9 0.1 0.0 0.0 7.4 0.0 0.0 37.7 0.6 6.8 0.0 0.0 0.0 0.2 0.0 49.5 0.5 0.0 32.3 12.2 0.0 0.0 2.3 0.1 0.0 0.0 0.1 TMEM101 "FLJ23987, MGC4251" ENSG00000091947 "Transmembrane protein 101" Q96IK0 17 44011188-44023946 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039739, HPA075651" Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA039739: AB_2676657, HPA075651: " "unprognostic (1.40e-3)" "unprognostic (1.75e-1)" "unprognostic (1.67e-1)" "prognostic favorable (4.29e-4)" "unprognostic (5.91e-2)" "unprognostic (3.91e-3)" "prognostic unfavorable (7.10e-4)" "unprognostic (1.80e-2)" "unprognostic (2.43e-1)" "unprognostic (2.03e-1)" "unprognostic (1.53e-1)" "unprognostic (1.61e-1)" "prognostic favorable (4.10e-5)" "unprognostic (1.59e-2)" "unprognostic (2.02e-1)" "unprognostic (1.48e-1)" "unprognostic (2.32e-2)" 11.0 10.9 8.4 7.3 14.2 5.1 58.9 6.3 16.5 22.7 11.4 13.7 7.7 8.4 33.3 14.5 15.1 19.2 15.4 12.4 8.7 8.6 37.2 12.0 11.4 16.1 9.5 9.4 13.0 27.8 10.7 8.5 17.8 11.6 13.9 8.6 11.5 20.9 59.7 15.5 13.8 9.5 11.6 10.1 11.0 13.6 16.9 8.9 10.0 25.4 12.9 13.2 12.5 11.6 23.8 25.9 11.7 25.0 23.8 27.2 17.8 9.8 24.2 8.6 7.2 20.6 19.9 8.7 10.3 15.7 20.5 19.6 17.9 25.7 11.1 2.9 10.6 16.0 15.2 10.0 17.9 15.7 12.0 20.2 8.3 19.4 36.2 17.8 13.4 14.5 17.8 20.5 14.5 20.6 18.5 17.9 19.5 17.1 21.9 12.7 13.2 14.4 15.4 4.0 10.8 27.3 12.5 18.8 20.1 17.1 8.0 11.3 9.0 6.6 0.2 24.5 11.4 11.9 25.8 10.7 18.8 12.7 8.2 20.2 22.8 15.7 5.1 19.7 12.7 16.7 11.7 24.9 8.6 19.4 25.0 21.8 22.7 24.5 22.3 25.9 23.8 27.2 22.1 9.1 23.8 17.8 25.2 25.1 17.8 8.4 14.2 6.3 16.5 8.7 8.6 9.5 9.4 11.6 8.9 17.9 12.5 26.3 26.3 18.3 10.4 28.5 20.4 22.7 13.6 38.4 5.9 59.3 31.5 30.3 10.8 20.2 20.8 0.0 43.1 35.2 18.8 20.8 23.0 18.6 33.4 11.1 22.5 31.3 25.9 8.7 12.0 20.9 32.1 47.7 31.6 16.0 40.2 17.5 11.7 25.6 11.4 6.5 16.0 48.6 17.9 19.7 37.3 17.9 43.5 22.6 TMEM104 "FLJ00021, FLJ20255" ENSG00000109066 "Transmembrane protein 104" Q8NE00 17 74776483-74839779 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 36.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044330 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA044330: AB_10960543" "unprognostic (1.05e-1)" "unprognostic (1.42e-1)" "unprognostic (2.70e-1)" "unprognostic (1.71e-2)" "unprognostic (5.95e-2)" "unprognostic (4.99e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (7.46e-2)" "unprognostic (2.86e-2)" "unprognostic (4.75e-1)" "prognostic favorable (1.97e-5)" "unprognostic (8.14e-2)" "unprognostic (6.17e-2)" "unprognostic (8.46e-2)" "unprognostic (7.95e-2)" "unprognostic (2.82e-3)" "unprognostic (1.00e-2)" 11.5 15.5 10.6 11.6 12.1 15.4 7.7 10.5 13.9 8.1 7.9 19.1 9.5 7.6 7.4 8.9 9.3 6.8 9.6 9.0 11.4 8.2 10.9 19.9 14.7 19.0 17.3 9.1 9.4 18.7 21.0 14.7 12.5 13.1 8.0 6.7 10.0 15.1 9.1 7.5 9.7 7.7 9.4 18.5 10.4 8.3 17.4 14.2 7.5 11.7 6.5 10.2 10.6 6.1 4.9 8.8 5.7 7.7 3.9 7.9 5.0 6.3 15.6 8.4 9.4 11.9 7.4 5.0 11.0 11.1 14.1 15.7 12.8 6.9 3.4 3.5 12.5 14.4 7.2 8.4 6.1 7.5 2.5 11.9 8.4 6.3 8.8 8.7 13.7 7.8 5.9 6.8 14.3 3.1 4.2 10.0 8.3 4.8 5.3 9.6 6.0 8.2 5.6 4.6 8.4 12.5 5.2 13.2 5.6 6.3 5.6 7.1 9.3 6.1 7.9 8.1 6.6 10.1 21.4 7.9 29.8 7.6 11.3 14.2 3.6 3.1 3.8 11.5 14.4 11.3 2.2 7.7 5.7 7.9 6.5 4.0 4.9 7.6 7.2 8.3 1.6 6.3 4.4 3.6 3.9 6.6 8.8 7.5 5.0 10.6 12.1 10.5 13.9 11.4 8.2 17.3 9.1 13.1 14.2 6.0 7.2 0.8 1.0 2.3 2.3 36.1 10.2 0.0 3.4 5.2 2.0 3.3 0.0 3.9 1.6 2.3 3.9 0.0 4.8 3.3 2.7 2.1 1.1 11.5 10.6 0.0 7.9 3.1 6.3 1.7 2.6 5.5 0.0 4.6 4.0 4.0 5.3 3.1 2.1 1.6 3.0 0.0 1.4 4.3 4.1 1.9 3.2 2.9 2.6 1.3 TMEM107 MGC10744 ENSG00000179029 "Transmembrane protein 107" Q6UX40 17 8173237-8176399 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Developmental protein" "Ciliopathy, Disease mutation, Meckel syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 171.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052555, HPA059653" Approved Approved "Nucleoplasm,Plasma membrane,Midbody ring" Yes No "Nucleoplasm, Plasma membrane" "Midbody ring" "HPA052555: AB_2681870, HPA059653: AB_2684096" "unprognostic (2.87e-2)" "unprognostic (2.67e-1)" "unprognostic (2.85e-2)" "prognostic favorable (9.39e-5)" "unprognostic (1.94e-2)" "unprognostic (8.83e-2)" "unprognostic (5.70e-3)" "unprognostic (1.24e-1)" "unprognostic (2.15e-1)" "unprognostic (6.02e-3)" "unprognostic (1.83e-2)" "unprognostic (1.87e-1)" "unprognostic (2.66e-3)" "unprognostic (1.26e-1)" "unprognostic (4.99e-1)" "unprognostic (2.66e-1)" "unprognostic (1.49e-1)" 8.6 11.8 13.7 7.1 19.6 17.5 13.0 7.3 23.2 11.7 8.3 9.9 10.7 4.2 10.0 30.1 8.8 38.7 9.4 8.8 11.0 13.4 12.1 4.0 12.8 17.7 10.9 17.1 7.5 9.6 17.8 20.8 10.0 15.6 5.9 7.8 12.6 8.7 10.1 1.7 12.7 6.0 10.1 10.5 11.9 7.1 15.9 8.2 7.8 19.1 4.3 9.6 9.5 7.8 33.1 18.7 28.4 29.9 14.5 20.8 12.7 31.6 10.0 15.5 7.1 9.4 14.2 3.1 7.4 7.0 6.5 8.6 1.2 18.2 8.7 9.5 7.4 4.6 22.1 6.3 14.5 10.3 10.7 7.4 4.7 17.4 3.4 3.8 1.8 5.2 6.9 9.2 17.1 8.3 13.7 10.8 10.8 4.0 17.1 15.3 9.4 4.3 5.0 1.6 3.9 4.6 7.9 4.2 12.5 12.0 2.4 4.5 7.1 8.6 1.8 6.3 3.7 5.4 6.4 6.8 3.3 6.3 5.2 3.9 6.7 3.7 3.4 19.0 7.1 5.3 10.5 13.3 28.4 18.8 15.8 16.3 26.7 18.1 20.0 11.8 33.1 20.0 20.8 10.9 14.5 29.9 18.7 14.3 12.7 13.7 19.6 7.3 23.2 11.0 13.4 10.9 17.1 15.6 8.2 8.9 9.8 33.9 18.2 17.1 17.7 6.2 40.8 171.3 25.0 31.4 43.2 15.0 11.6 14.4 7.1 20.4 10.3 0.0 9.6 17.4 16.6 14.7 34.8 17.8 39.4 11.1 8.7 23.9 38.4 6.3 11.8 29.7 32.1 21.6 12.1 32.1 11.5 14.4 14.2 15.3 60.3 0.0 11.3 47.4 49.2 25.0 11.1 34.5 15.3 9.7 TMEM116 FLJ90167 ENSG00000198270 "Transmembrane protein 116" Q8NCL8 12 111931282-112013185 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 48.7;Spermatocytes: 128.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in all" 4 "T-cells: 14.9" "Cell line enhanced" "Detected in many" "RT4: 23.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040720 Approved Approved Nucleoplasm,Microtubules NA NA Microtubules Nucleoplasm "HPA040720: AB_10795623" "unprognostic (8.91e-2)" "unprognostic (1.95e-3)" "unprognostic (1.18e-2)" "unprognostic (1.71e-1)" "unprognostic (5.48e-2)" "unprognostic (3.25e-1)" "unprognostic (2.93e-2)" "unprognostic (6.03e-2)" "unprognostic (2.00e-2)" "unprognostic (1.34e-1)" "unprognostic (3.27e-3)" "unprognostic (9.12e-2)" "prognostic favorable (1.08e-4)" "unprognostic (2.41e-1)" "unprognostic (1.33e-1)" "unprognostic (2.85e-2)" "unprognostic (3.19e-3)" 3.7 10.7 4.4 3.0 8.4 1.0 10.2 6.7 6.6 5.3 4.1 11.2 9.1 9.5 3.9 6.4 4.9 4.2 5.8 20.2 5.3 3.7 26.8 10.0 7.2 3.7 8.7 5.5 4.7 4.1 31.2 9.6 2.7 14.0 4.5 3.4 5.9 12.5 7.0 5.0 11.8 9.0 5.1 8.2 3.9 8.7 20.8 7.3 6.0 6.6 3.6 5.6 8.6 4.5 2.5 3.0 3.0 3.3 1.5 14.9 3.4 4.2 4.4 6.3 7.0 6.3 5.0 4.3 3.4 5.6 4.5 4.9 3.3 3.5 4.9 2.2 2.6 5.5 4.3 3.5 3.7 3.9 11.7 2.8 3.1 4.2 4.1 10.1 1.2 0.5 6.1 6.4 5.8 10.1 4.8 1.5 9.4 5.9 4.0 4.6 6.3 1.8 10.0 7.8 10.2 2.9 5.0 2.5 8.4 14.1 23.9 6.0 4.0 3.7 3.3 5.8 8.9 11.9 16.5 1.1 4.3 1.3 3.8 1.5 4.7 8.2 4.6 6.0 3.9 6.0 0.8 1.8 3.0 6.5 3.3 5.2 2.1 14.9 12.1 2.1 2.5 7.9 8.6 0.3 1.5 2.4 3.0 13.5 3.4 4.4 8.4 6.7 6.6 5.3 3.7 8.7 5.5 14.0 7.3 3.0 14.4 1.5 6.8 4.8 10.6 21.6 5.1 12.0 2.3 27.9 15.7 16.1 19.9 3.0 48.7 3.4 7.8 0.0 3.6 4.8 5.6 3.6 5.7 5.0 4.5 9.5 0.0 1.8 5.2 26.7 8.6 3.7 6.8 2.8 2.4 13.0 3.0 1.9 4.6 8.8 17.6 6.5 4.2 128.4 21.3 4.6 33.5 12.9 2.6 5.9 TMEM121B CECR6 ENSG00000183307 "Transmembrane protein 121B" Q9BXQ6 22 17116299-17121367 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.1;prostate: 14.1" "Group enriched" "Detected in some" 8 "granulocytes: 1.1;Hofbauer cells: 2.2" "Cancer enhanced" "Detected in some" "prostate cancer: 6.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 3.2;intermediate monocyte: 1.4;neutrophil: 4.3" "Group enriched" "Detected in many" 7 "granulocytes: 4.3;monocytes: 3.2" "Cell line enhanced" "Detected in some" "AF22: 6.3;SCLC-21H: 15.0;THP-1: 12.1;U-937: 10.0" "Group enriched" "Detected in many" 8 "amygdala: 22.5;basal ganglia: 24.0;cerebral cortex: 29.3;hippocampal formation: 26.2;olfactory region: 20.0" "Low region specificity" "Detected in many" HPA068790 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA Vesicles "Nucleoplasm, Plasma membrane" "HPA068790: AB_2686036" "unprognostic (2.30e-1)" "unprognostic (1.05e-1)" "unprognostic (7.11e-3)" "unprognostic (4.49e-3)" "unprognostic (3.36e-1)" "unprognostic (7.14e-3)" "unprognostic (1.12e-3)" "unprognostic (5.32e-2)" "unprognostic (1.97e-1)" "unprognostic (2.01e-2)" "unprognostic (6.88e-4)" "unprognostic (6.08e-2)" "unprognostic (3.10e-4)" "unprognostic (1.02e-2)" "unprognostic (4.37e-2)" "unprognostic (3.49e-3)" "unprognostic (1.71e-1)" 1.3 1.8 7.4 2.2 12.0 2.2 2.0 8.1 19.1 1.0 0.8 2.4 0.0 1.1 1.1 2.3 0.8 1.2 1.0 2.3 7.1 4.0 0.8 0.8 0.9 0.8 2.9 6.9 0.9 2.7 0.8 2.0 1.9 2.3 14.1 1.0 0.2 1.2 1.0 2.8 1.5 0.9 1.3 2.5 1.1 1.0 2.4 4.2 0.0 0.6 0.0 0.8 1.0 0.3 0.0 0.5 4.3 3.2 0.0 0.0 0.6 0.0 0.0 6.3 0.9 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.2 0.0 0.2 0.1 0.0 0.2 0.0 0.7 0.0 0.2 0.1 1.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.1 0.1 0.3 0.0 0.8 3.2 2.2 0.0 0.1 0.2 3.1 0.0 0.3 0.1 15.0 2.3 0.0 0.0 0.3 0.9 0.0 12.1 0.6 0.7 0.3 0.2 0.0 0.2 0.3 0.9 0.0 10.0 0.3 0.0 3.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.6 7.4 12.0 8.1 18.0 7.1 4.0 2.9 6.9 2.3 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM126A "DKFZp586C1924, OPA7" ENSG00000171202 "Transmembrane protein 126A" Q9H061 11 85647967-85656547 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046648 Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA046648: AB_2679737" "unprognostic (3.79e-2)" "unprognostic (4.75e-3)" "unprognostic (2.08e-3)" "unprognostic (1.08e-3)" "unprognostic (2.08e-1)" "unprognostic (1.79e-1)" "prognostic unfavorable (8.60e-5)" "unprognostic (8.25e-2)" "unprognostic (6.00e-3)" "unprognostic (2.66e-2)" "unprognostic (1.02e-2)" "unprognostic (6.93e-2)" "unprognostic (1.25e-1)" "unprognostic (1.87e-2)" "unprognostic (2.70e-1)" "unprognostic (6.94e-2)" "unprognostic (2.17e-1)" 18.3 17.4 24.9 15.9 23.3 23.7 20.0 13.2 30.0 13.9 16.2 9.5 15.6 19.8 13.2 20.6 17.2 12.5 16.0 44.4 20.9 20.7 22.0 28.5 12.6 15.0 21.8 22.9 13.7 27.7 13.1 19.9 14.1 19.9 14.0 18.3 8.9 25.2 15.7 49.5 12.2 15.1 16.5 18.0 14.1 19.1 21.4 18.8 10.5 16.5 36.4 15.6 14.0 18.7 14.5 19.1 6.3 15.3 8.4 16.5 11.1 14.7 18.6 16.7 11.5 22.5 22.7 13.6 17.6 19.2 26.4 26.1 22.9 23.8 8.5 21.0 21.1 10.1 16.2 17.2 18.6 24.5 21.6 9.6 23.3 22.1 24.9 28.3 29.4 19.7 19.6 22.9 23.3 25.0 14.2 24.1 23.2 16.4 14.0 29.3 19.6 15.9 37.5 17.1 56.2 21.2 16.3 16.8 27.5 18.5 19.5 12.0 12.2 15.9 25.1 14.6 16.2 31.2 20.2 14.2 25.7 18.3 48.0 20.1 9.4 16.5 22.3 13.5 21.2 30.4 2.9 13.4 6.3 12.5 15.3 16.5 14.5 16.4 14.6 19.1 13.2 15.6 15.4 1.2 8.4 13.1 14.4 14.1 11.1 24.9 23.3 13.2 30.0 20.9 20.7 21.8 22.9 19.9 18.8 26.8 18.7 34.9 49.1 28.2 13.7 101.5 20.4 36.1 39.8 36.6 5.9 57.3 124.3 42.5 119.6 29.2 27.0 0.0 80.4 63.4 39.0 59.0 36.9 66.1 83.8 7.9 20.8 21.5 49.7 48.6 27.3 53.8 32.1 67.7 42.7 22.6 54.2 31.6 25.1 79.5 15.1 19.4 51.4 99.1 51.5 36.8 44.3 39.2 55.6 50.7 TMEM132E DFNB99 ENSG00000181291 "Transmembrane protein 132E" Q6IEE7 17 34579487-34639318 "Disease related genes, Predicted membrane proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.0;kidney: 8.8" "Cell type enriched" "Detected in some" 7 "Proximal tubular cells: 9.0" "Group enriched" "Detected in some" 8 "glioma: 7.6;renal cancer: 1.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.6" "Group enriched" "Detected in many" 20 "NK-cells: 1.4;T-cells: 2.6" "Cell line enriched" "Detected in some" 9 "RPMI-8226: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070608 Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol" NA NA 140000 "Nucleoplasm, Golgi apparatus" "Nuclear bodies, Cytosol" "HPA070608: AB_2686286" "unprognostic (1.92e-1)" "unprognostic (1.68e-1)" "unprognostic (3.29e-5)" "unprognostic (3.37e-1)" "unprognostic (1.37e-1)" "unprognostic (8.61e-2)" "unprognostic (1.06e-3)" "unprognostic (1.72e-1)" "unprognostic (1.80e-1)" "unprognostic (1.56e-2)" "unprognostic (2.16e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.55e-4)" "unprognostic (1.67e-2)" "unprognostic (1.51e-2)" "unprognostic (2.65e-1)" "unprognostic (8.71e-2)" 0.4 0.5 4.9 0.4 4.1 0.2 0.3 17.3 8.7 1.2 0.4 1.7 0.3 4.9 0.6 0.5 0.4 0.4 0.8 0.5 2.9 5.1 8.8 1.3 0.4 0.7 4.5 2.8 0.5 0.2 0.3 0.0 0.9 5.3 0.4 0.5 0.0 0.8 0.8 0.3 0.8 2.8 0.6 20.0 0.7 0.6 2.4 2.2 0.0 0.4 0.0 0.6 0.7 0.1 0.0 0.0 0.0 0.0 1.4 2.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.8 3.4 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.2 0.0 0.4 0.5 0.0 0.0 2.6 1.8 0.0 1.4 0.0 0.0 0.0 0.4 4.9 4.1 17.3 6.9 2.9 5.1 4.5 2.8 5.3 2.2 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 1.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.4 0.7 1.3 0.0 0.0 0.0 0.0 0.0 TMEM14A "C6orf73, PTD011" ENSG00000096092 "Transmembrane protein 14A" Q9Y6G1 6 52671109-52686588 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "A-431: 67.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072536 Approved Approved "Nucleoplasm,Endoplasmic reticulum" NA NA "Nucleoplasm, Endoplasmic reticulum" "HPA072536: AB_2686531" "unprognostic (6.75e-2)" "unprognostic (3.65e-2)" "unprognostic (2.04e-1)" "unprognostic (8.10e-3)" "unprognostic (3.55e-2)" "unprognostic (1.06e-1)" "unprognostic (8.05e-2)" "unprognostic (4.10e-2)" "unprognostic (1.45e-1)" "unprognostic (2.56e-3)" "unprognostic (8.88e-2)" "unprognostic (1.17e-1)" "unprognostic (3.52e-2)" "unprognostic (9.60e-2)" "unprognostic (5.44e-2)" "unprognostic (3.37e-1)" "unprognostic (2.64e-1)" 8.7 24.4 26.7 6.2 32.0 4.3 12.9 25.7 40.0 13.9 12.5 13.5 5.8 18.9 14.3 19.3 18.0 16.3 12.6 8.1 25.5 40.7 25.8 52.7 9.0 8.8 28.3 22.6 21.0 23.8 9.2 12.9 7.9 31.7 19.0 13.3 25.7 9.6 11.7 2.0 6.8 17.4 13.4 29.1 6.5 20.3 8.4 10.7 5.8 14.6 11.1 11.6 14.1 11.6 22.3 14.3 6.4 0.2 4.0 25.7 11.9 67.3 10.2 7.6 21.5 20.8 16.1 6.4 13.6 18.7 12.6 19.6 15.6 17.5 8.3 15.2 17.1 26.6 25.8 16.8 22.8 21.3 33.3 13.8 12.2 16.7 25.5 6.8 6.2 15.3 14.4 16.1 13.8 3.1 16.7 17.0 10.6 2.5 23.7 14.9 13.7 12.1 7.1 4.5 44.7 17.9 9.6 10.8 6.5 24.4 13.0 39.6 19.2 15.2 12.2 25.4 9.9 18.8 12.0 12.5 17.5 23.6 6.8 21.9 11.4 9.6 12.5 24.6 3.9 13.9 6.4 0.2 6.4 16.4 0.0 10.6 22.3 21.2 17.2 7.8 13.2 16.4 17.5 0.9 4.0 0.0 14.3 25.7 11.9 26.7 32.0 25.7 40.0 25.5 40.7 28.3 22.6 31.7 10.7 23.8 14.5 18.0 51.6 42.9 20.8 12.5 50.9 61.6 33.0 48.8 7.9 51.8 54.7 95.2 1.1 42.1 22.0 0.0 122.4 120.9 88.8 80.6 25.3 119.7 38.4 4.8 32.1 33.7 7.3 2.0 40.3 16.9 84.4 6.4 47.0 24.6 77.7 28.8 47.0 136.7 10.1 6.5 75.2 4.4 24.5 33.4 12.9 22.7 47.2 49.8 TMEM154 FLJ32028 ENSG00000170006 "Transmembrane protein 154" Q6P9G4 4 152618632-152680165 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 75.4;esophagus: 36.1;lymphoid tissue: 38.0" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 65.9;Ciliated cells: 60.2;granulocytes: 97.2;Suprabasal keratinocytes: 169.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 7 "basophil: 49.8;eosinophil: 44.8;neutrophil: 75.4" "Lineage enriched" "Detected in many" 9 "granulocytes: 75.4" "Cell line enhanced" "Detected in many" "HBEC3-KT: 24.7;HMC-1: 28.5;Karpas-707: 22.2;U-266/70: 27.8;U-937: 22.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA019184, HPA055411" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "HPA019184: AB_2670088, HPA055411: " "unprognostic (1.09e-1)" "unprognostic (3.56e-1)" "unprognostic (5.17e-2)" "unprognostic (3.09e-2)" "unprognostic (3.00e-1)" "unprognostic (1.52e-1)" "unprognostic (2.24e-1)" "unprognostic (2.96e-1)" "unprognostic (2.64e-1)" "unprognostic (1.65e-1)" "unprognostic (5.00e-3)" "unprognostic (7.67e-2)" "unprognostic (2.23e-3)" "unprognostic (1.50e-1)" "unprognostic (5.08e-2)" "unprognostic (1.13e-1)" "unprognostic (3.53e-1)" 1.4 0.7 0.8 12.5 0.8 8.3 2.0 0.7 0.7 5.0 1.4 1.3 0.9 1.0 1.1 1.2 36.1 1.1 2.4 1.7 0.8 0.8 1.0 4.8 7.9 20.4 1.3 0.1 0.7 0.8 0.1 3.5 3.5 0.8 3.9 1.1 0.5 16.1 2.5 1.3 28.7 3.0 2.2 1.2 16.2 2.7 0.6 0.1 8.2 1.5 26.0 38.0 7.1 6.3 8.3 2.9 75.4 6.0 0.1 3.4 2.2 12.2 0.0 0.1 0.0 0.2 3.5 5.6 3.1 11.5 3.4 6.5 0.1 1.6 12.6 1.3 2.8 3.7 9.0 0.0 24.7 6.3 0.0 0.0 0.7 0.1 0.0 3.7 9.7 28.5 3.4 11.9 10.9 9.5 0.0 8.4 7.8 0.0 22.2 0.2 0.8 3.8 3.0 0.6 0.0 2.9 0.4 0.0 0.0 19.5 7.5 0.0 0.5 0.7 2.4 0.4 3.5 0.3 6.9 3.4 0.5 2.0 0.3 4.3 27.8 9.4 6.9 4.7 22.1 2.6 49.8 5.8 44.8 0.8 5.9 1.5 8.3 1.8 1.3 2.9 7.2 1.8 1.2 75.4 0.1 6.0 0.3 3.4 2.2 0.8 0.8 0.7 0.7 0.8 0.8 1.3 0.1 0.8 0.1 11.9 22.9 42.2 7.7 65.9 0.0 1.4 0.0 60.2 19.4 21.0 2.0 21.8 0.0 6.1 0.0 5.7 0.0 0.0 3.3 12.7 5.5 5.3 97.2 3.9 4.2 3.2 1.2 0.6 8.7 0.0 0.6 15.0 5.0 0.0 0.6 0.0 12.8 9.1 0.0 0.3 0.4 0.0 1.9 0.0 0.2 169.9 21.6 15.8 3.1 23.5 TMEM169 FLJ34263 ENSG00000163449 "Transmembrane protein 169" Q96HH4 2 216081866-216102783 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.8" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 14.3;Cone photoreceptor cells: 21.6;Rod photoreceptor cells: 11.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 8.4;LHCN-M2: 6.9;RPTEC TERT1: 12.5;SCLC-21H: 10.7;SH-SY5Y: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062462, HPA062797, HPA070657, HPA074877" Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA062462: AB_2732684, HPA062797: AB_2732690, HPA070657: AB_2686293, HPA074877: " "unprognostic (5.15e-2)" "unprognostic (2.93e-1)" "unprognostic (7.87e-3)" "unprognostic (4.69e-7)" "unprognostic (4.26e-2)" "unprognostic (1.17e-1)" "unprognostic (1.97e-1)" "unprognostic (4.43e-1)" "unprognostic (7.16e-2)" "unprognostic (5.72e-2)" "unprognostic (1.00e-1)" "unprognostic (1.35e-1)" "unprognostic (2.79e-2)" "unprognostic (7.51e-3)" "unprognostic (4.69e-2)" "unprognostic (1.54e-1)" "unprognostic (1.02e-1)" 1.7 2.9 5.9 2.5 6.2 1.3 0.9 9.7 16.8 2.1 1.3 3.9 1.6 1.9 1.1 1.9 0.9 2.9 2.5 1.1 5.5 6.3 4.9 4.2 2.1 2.4 5.5 4.8 1.1 1.0 0.8 2.4 0.7 9.1 1.4 1.2 4.9 0.9 1.1 1.5 1.6 1.7 1.2 6.6 2.6 1.0 1.3 2.5 0.7 6.7 0.0 2.0 1.1 0.7 3.0 0.2 4.3 5.7 0.7 6.3 1.3 0.1 0.4 8.4 0.2 1.0 0.1 0.0 0.3 0.2 0.2 0.8 0.4 2.5 0.1 6.3 0.4 0.5 0.2 1.1 0.0 0.2 1.2 0.4 2.7 0.1 1.5 1.8 0.2 0.6 0.6 0.6 0.6 0.8 2.0 0.0 0.9 0.0 0.4 6.9 0.7 0.2 0.3 4.4 0.0 0.1 1.5 2.5 0.2 12.5 0.0 10.7 15.4 0.3 0.2 6.1 4.2 0.4 1.1 0.1 0.2 0.5 0.2 0.4 1.9 2.0 0.4 1.9 0.2 1.6 1.3 1.8 0.3 2.3 1.5 1.7 2.4 4.0 2.7 0.0 3.0 4.2 1.9 4.3 0.7 5.7 0.2 6.3 1.3 5.9 6.2 9.7 11.5 5.5 6.3 5.5 4.8 9.1 2.5 0.0 0.0 0.5 0.0 0.0 14.3 0.6 5.1 0.0 0.0 5.2 21.6 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.3 0.0 4.7 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.4 2.4 11.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 TMEM173 "ERIS, FLJ38577, MITA, MPYS, NET23, STING" ENSG00000184584 "Transmembrane protein 173" Q86WV6 5 139475534-139482935 "Disease related genes, Predicted membrane proteins" "Autophagy, Host-virus interaction, Immunity, Innate immunity" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 152.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 25.3;EFO-21: 38.2;HDLM-2: 81.1;Karpas-707: 25.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038116, HPA038534" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA038116: AB_2675841, HPA038534: AB_2676067" "unprognostic (1.45e-1)" "unprognostic (4.10e-3)" "unprognostic (1.29e-1)" "unprognostic (2.23e-2)" "unprognostic (2.70e-2)" "unprognostic (1.71e-2)" "unprognostic (7.66e-2)" "unprognostic (2.77e-2)" "unprognostic (6.30e-2)" "unprognostic (1.01e-1)" "unprognostic (5.69e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (3.59e-8)" "unprognostic (9.18e-3)" "unprognostic (4.14e-2)" "unprognostic (4.45e-2)" "unprognostic (1.34e-1)" 22.9 6.5 6.3 17.4 6.7 18.1 15.9 1.2 4.5 22.5 9.4 6.0 13.3 6.4 16.7 18.1 16.0 24.4 13.5 26.3 3.8 3.1 12.5 8.1 32.0 41.3 7.9 2.3 30.7 3.9 1.9 8.1 13.9 6.8 20.3 8.8 14.7 16.6 14.6 10.3 9.6 10.9 16.2 7.1 35.8 8.0 11.1 6.3 15.8 13.0 16.5 29.7 17.7 17.9 0.3 26.9 5.8 29.1 39.8 28.9 26.1 1.2 0.5 0.0 0.0 1.3 4.1 0.1 6.6 25.3 3.2 10.5 0.0 9.1 0.0 38.2 19.7 0.7 4.8 0.1 9.7 1.2 81.1 0.9 5.5 2.5 0.3 2.2 1.6 0.1 5.8 0.4 2.2 2.6 4.4 11.3 0.6 1.7 25.4 11.8 0.0 0.8 8.5 0.0 0.2 1.9 0.3 2.4 7.5 2.9 2.5 2.5 0.0 2.2 2.4 6.3 0.2 0.3 22.0 8.2 0.9 0.4 2.5 1.9 0.0 7.7 0.0 0.1 23.7 2.9 5.8 29.1 0.0 28.8 19.4 14.2 0.3 28.2 23.2 26.9 0.2 19.4 17.5 2.4 39.8 7.8 9.2 28.9 26.1 6.3 6.7 1.2 4.5 3.8 3.1 7.9 2.3 6.8 6.3 41.7 56.7 6.7 69.0 27.4 0.1 22.6 2.5 152.6 59.1 7.0 0.0 0.7 0.0 26.9 1.0 87.0 0.5 0.0 14.2 0.7 35.0 14.4 48.7 0.0 55.0 0.0 8.1 57.7 62.8 0.4 47.8 46.4 33.7 45.9 13.3 0.0 50.6 5.8 34.3 0.0 0.3 45.3 78.8 0.0 0.3 14.6 1.5 66.0 28.2 26.1 TMEM175 MGC4618 ENSG00000127419 "Transmembrane protein 175" Q9BSA9 4 932387-958656 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057160 Approved Approved "Nucleoplasm,Nuclear membrane" No No "Nucleoplasm, Nuclear membrane" "HPA057160: AB_2683356" "unprognostic (3.84e-1)" "unprognostic (4.27e-2)" "unprognostic (1.28e-2)" "unprognostic (9.61e-3)" "unprognostic (2.43e-1)" "unprognostic (2.33e-3)" "unprognostic (1.12e-2)" "unprognostic (3.25e-3)" "unprognostic (1.22e-2)" "unprognostic (1.50e-2)" "prognostic favorable (9.85e-5)" "unprognostic (4.71e-2)" "unprognostic (5.08e-2)" "unprognostic (1.07e-1)" "unprognostic (3.74e-1)" "unprognostic (1.96e-1)" "unprognostic (7.51e-3)" 17.2 22.9 20.5 13.5 24.0 17.8 12.2 29.0 27.6 17.4 10.8 23.5 16.8 13.6 13.4 14.9 13.4 12.9 16.0 13.3 18.4 19.8 11.7 24.2 14.1 21.9 16.9 25.4 9.3 26.3 18.7 26.4 11.8 20.4 15.0 6.2 17.1 26.8 16.8 14.5 25.8 12.4 10.4 17.2 18.7 14.8 11.8 17.9 13.0 19.7 9.2 12.0 16.2 9.6 13.8 29.3 16.9 23.4 9.5 13.6 11.8 3.3 6.1 3.5 4.8 17.0 8.9 8.2 8.2 6.0 5.0 7.5 2.8 13.4 2.5 5.1 8.6 8.8 5.5 3.2 6.5 2.2 6.2 7.5 5.2 9.0 2.8 9.8 2.7 9.7 12.6 7.9 4.5 3.0 3.6 3.1 5.4 5.2 20.9 4.4 10.9 6.9 11.2 2.2 3.9 17.2 4.8 2.1 7.2 4.8 3.2 9.6 8.5 5.7 3.6 5.4 1.8 16.0 7.5 4.1 9.3 2.1 10.7 6.3 14.2 3.7 4.9 9.0 6.0 7.5 16.9 19.8 15.5 13.6 23.4 9.1 12.5 11.7 10.1 17.2 13.8 8.4 11.9 16.4 9.5 21.6 29.3 11.0 11.8 20.5 24.0 29.0 27.6 18.4 19.8 16.9 25.4 20.4 17.9 11.9 9.9 12.9 8.5 5.6 24.5 8.7 5.1 4.0 5.7 14.0 3.9 21.7 1.7 7.4 4.4 8.2 12.4 0.0 10.0 9.3 12.7 8.2 6.9 23.8 13.5 44.5 15.5 8.6 15.3 3.2 11.5 11.0 18.6 4.6 8.1 43.7 8.0 14.4 15.2 6.7 25.4 12.9 9.5 22.3 10.2 6.8 15.8 13.1 7.0 5.4 TMEM176B "LR8, MS4B2" ENSG00000106565 "Transmembrane protein 176B" Q3YBM2 7 150791285-150801360 "Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 92.3;liver: 247.9" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 572.0;Hepatocytes: 1056.4;monocytes: 841.4;Paneth cells: 725.5;Proximal tubular cells: 817.7" "Cancer enhanced" "Detected in all" "liver cancer: 537.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 92.3;intermediate monocyte: 68.0" "Lineage enriched" "Detected in many" 5 "monocytes: 92.3" "Group enriched" "Detected in some" 17 "HSkMC: 120.5;THP-1: 38.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047509 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus" "Nucleoplasm, Plasma membrane" "HPA047509: AB_2680072" "unprognostic (5.21e-2)" "unprognostic (7.86e-2)" "unprognostic (1.30e-2)" "unprognostic (8.27e-2)" "unprognostic (3.35e-2)" "unprognostic (6.96e-2)" "unprognostic (7.23e-2)" "unprognostic (2.74e-2)" "unprognostic (5.31e-2)" "unprognostic (1.47e-1)" "unprognostic (5.72e-3)" "unprognostic (7.50e-2)" "unprognostic (3.11e-3)" "unprognostic (5.56e-2)" "unprognostic (2.17e-2)" "unprognostic (1.53e-1)" "unprognostic (4.05e-2)" 13.9 5.5 7.8 19.8 10.7 1.1 11.7 2.1 6.3 8.6 27.6 5.7 2.0 18.3 3.8 15.2 9.6 9.0 50.2 26.8 7.6 5.2 62.9 247.9 11.2 22.9 10.5 3.3 20.3 6.8 0.3 3.2 12.5 8.4 6.1 27.9 22.0 5.1 3.2 2.5 4.2 53.1 10.7 13.2 23.5 10.6 5.2 8.7 4.3 4.9 7.0 10.5 14.7 11.6 0.2 20.0 5.7 92.3 0.0 0.4 42.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 4.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 120.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 38.4 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 92.3 5.7 0.2 68.0 0.4 0.2 0.0 0.0 20.0 0.0 0.0 0.0 1.1 0.0 36.2 0.9 0.0 42.0 7.8 10.7 2.1 6.3 7.6 5.2 10.5 3.3 8.4 8.7 3.0 12.4 33.9 0.5 11.2 135.3 52.1 175.8 12.0 19.4 355.9 2.0 0.8 140.9 63.8 13.3 17.2 572.0 0.0 29.9 1.1 82.5 3.5 52.1 1056.4 94.1 6.4 123.0 27.0 68.8 9.8 40.3 84.1 15.1 841.4 193.4 69.9 82.8 725.5 3.2 817.7 17.3 0.0 22.6 3.2 3.4 13.7 2.3 14.6 213.0 1.0 TMEM177 MGC10993 ENSG00000144120 "Transmembrane protein 177" Q53S58 2 119679167-119686507 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 56.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036689, HPA053816" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA036689: AB_2675253, HPA053816: AB_2682272" "unprognostic (1.24e-1)" "unprognostic (2.65e-1)" "unprognostic (1.62e-2)" "unprognostic (2.31e-2)" "unprognostic (9.81e-3)" "unprognostic (2.05e-3)" "unprognostic (3.17e-2)" "unprognostic (8.05e-2)" "unprognostic (1.39e-1)" "unprognostic (3.03e-2)" "unprognostic (1.07e-1)" "unprognostic (4.90e-1)" "unprognostic (6.73e-2)" "unprognostic (5.29e-2)" "unprognostic (2.48e-1)" "unprognostic (1.58e-1)" "unprognostic (1.02e-1)" 3.5 9.5 10.0 6.0 11.4 1.3 8.8 10.4 16.9 6.7 13.5 9.0 6.1 20.1 8.1 11.9 6.7 13.5 9.4 9.2 9.5 8.7 15.2 27.9 4.6 7.6 7.6 9.8 10.5 10.4 7.7 19.2 4.1 6.6 7.2 11.7 7.3 9.1 9.0 13.5 8.3 16.5 8.1 6.6 5.1 7.7 9.0 8.8 6.7 7.3 4.9 6.4 6.3 5.7 7.4 4.9 2.1 2.3 5.7 15.9 5.3 11.2 10.0 8.8 8.4 2.4 2.4 4.5 4.2 5.3 12.5 9.6 25.1 6.3 18.7 10.5 3.7 10.3 6.9 14.2 14.5 7.3 8.8 26.4 9.6 5.9 27.8 5.3 6.0 7.1 6.5 10.4 9.9 6.5 4.8 8.0 11.4 14.8 2.5 6.7 9.3 10.5 12.0 22.5 8.3 15.3 9.6 8.6 11.0 12.5 5.9 17.4 10.2 5.7 11.8 13.1 8.7 9.0 10.4 6.4 6.2 15.2 4.7 8.3 2.5 1.8 11.4 2.3 7.6 11.1 0.0 2.3 2.1 7.7 1.9 7.8 6.0 6.6 7.6 4.3 7.4 15.9 9.8 0.7 5.7 1.1 4.9 6.2 5.3 10.0 11.4 10.4 16.9 9.5 8.7 7.6 9.8 6.6 8.8 3.0 0.0 3.7 5.8 2.6 11.5 13.4 15.3 5.3 10.3 5.2 13.7 11.2 56.3 13.6 1.9 4.1 9.8 0.0 12.5 8.5 4.7 5.0 0.0 23.7 5.4 11.1 2.4 2.5 0.8 1.3 6.9 2.2 13.5 7.2 5.3 8.4 10.6 7.0 11.7 28.6 19.9 0.0 3.1 7.2 4.8 1.8 1.7 2.5 12.4 3.8 TMEM178A "MGC33926, TMEM178" ENSG00000152154 "Transmembrane protein 178A" Q8NBL3 2 39664982-39717963 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 87.4" "Cell type enhanced" "Detected in some" 11 "Collecting duct cells: 12.2;Cone photoreceptor cells: 5.9;Intestinal endocrine cells: 15.4;Rod photoreceptor cells: 5.8" "Cancer enhanced" "Detected in many" "prostate cancer: 19.0" "Region enriched" "Detected in all" 5 "cerebellum: 87.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "AF22: 56.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052128 Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA052128: AB_2681738" "unprognostic (3.35e-2)" "unprognostic (3.18e-1)" "unprognostic (5.94e-2)" "unprognostic (2.86e-1)" "unprognostic (1.04e-1)" "unprognostic (5.85e-2)" "unprognostic (3.24e-3)" "unprognostic (1.82e-3)" "unprognostic (2.22e-1)" "unprognostic (9.74e-2)" "unprognostic (5.11e-4)" "unprognostic (1.13e-1)" "unprognostic (6.01e-3)" "unprognostic (2.80e-3)" "unprognostic (3.46e-2)" "unprognostic (2.83e-2)" "unprognostic (3.01e-3)" 2.9 4.2 13.3 0.9 10.6 0.6 6.8 87.4 35.6 1.6 1.9 6.4 0.0 2.3 3.8 2.0 1.8 3.3 3.1 3.6 16.4 7.4 18.9 2.7 5.8 0.8 10.7 10.9 1.8 2.2 1.3 2.5 3.6 17.0 12.2 2.2 3.7 3.8 2.1 2.3 3.5 2.4 2.9 22.6 1.6 3.5 1.2 5.3 0.0 5.7 0.8 2.2 1.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 1.5 0.0 0.0 0.1 1.8 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.1 0.1 0.0 0.1 1.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 7.1 0.1 0.0 0.6 0.0 0.0 0.4 0.1 10.4 0.2 0.0 0.2 0.1 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 10.6 87.4 18.8 16.4 7.4 10.7 10.9 17.0 5.3 0.0 1.3 0.0 0.6 0.3 2.1 3.7 0.0 4.0 1.2 12.2 5.9 0.3 0.0 0.3 0.3 3.1 0.4 0.0 0.2 0.0 0.2 4.1 0.0 0.2 0.2 1.6 15.4 1.3 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.3 0.3 0.0 0.0 0.7 5.8 0.0 0.4 0.2 0.2 0.5 0.5 0.0 0.4 0.1 TMEM181 "GPR178, KIAA1423" ENSG00000146433 "Transmembrane protein 181" Q9P2C4 6 158536436-158635428 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 49.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040189, HPA040228" Enhanced Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Vesicles "Nucleoplasm, Golgi apparatus" "HPA040189: AB_10793959, HPA040228: " "unprognostic (1.93e-2)" "prognostic unfavorable (7.26e-4)" "unprognostic (9.87e-2)" "unprognostic (6.51e-2)" "unprognostic (3.09e-1)" "unprognostic (1.49e-2)" "unprognostic (1.09e-2)" "unprognostic (1.16e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (1.09e-4)" "unprognostic (1.14e-1)" "unprognostic (2.34e-1)" "unprognostic (4.07e-2)" "unprognostic (1.46e-1)" "unprognostic (1.93e-1)" "unprognostic (4.36e-1)" "unprognostic (3.26e-1)" 7.1 5.6 32.4 4.8 49.2 3.1 8.6 5.3 36.6 13.4 10.1 4.2 6.5 10.9 8.4 3.9 6.3 5.8 7.3 5.3 18.5 8.7 3.3 6.4 6.7 3.4 5.5 23.3 5.6 18.5 8.1 21.5 6.5 11.2 9.4 11.5 4.3 22.4 10.0 4.9 7.0 12.6 7.8 7.3 7.6 16.3 16.0 8.5 2.3 9.7 2.1 3.2 9.9 7.0 1.0 2.1 7.7 3.4 3.9 4.7 1.4 10.2 5.9 8.4 12.9 22.3 20.5 16.1 23.2 13.6 12.1 13.9 10.0 12.6 4.3 12.0 19.2 26.0 15.2 12.4 15.3 19.3 6.3 8.9 8.0 8.8 21.1 18.2 10.0 7.7 16.9 15.1 13.5 18.3 18.3 19.4 6.2 15.2 5.4 19.8 6.2 4.4 12.5 6.5 20.4 7.6 4.3 9.7 4.9 11.6 8.0 24.9 17.1 17.0 16.0 11.1 12.1 6.1 14.1 18.4 12.6 8.5 20.8 20.0 3.2 2.2 4.8 15.2 12.6 11.9 7.7 2.2 5.7 4.7 2.3 3.6 0.9 2.7 3.7 1.6 1.0 2.4 3.2 1.6 3.9 3.4 2.1 2.6 1.4 32.4 49.2 5.3 36.6 18.5 8.7 5.5 23.3 11.2 8.5 11.9 31.5 2.4 11.3 18.1 13.4 14.8 20.4 5.3 7.9 15.7 17.7 7.7 3.3 22.0 3.2 24.0 29.3 0.0 28.2 10.9 15.0 29.8 10.5 18.6 8.9 19.1 42.6 20.3 14.2 4.0 12.0 13.6 13.5 4.6 34.5 6.0 36.3 28.1 16.6 4.8 14.4 6.5 17.1 14.2 22.6 18.3 4.3 20.1 24.4 29.1 TMEM182 FLJ30294 ENSG00000170417 "Transmembrane protein 182" Q6ZP80 2 102736905-103019900 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "heart muscle: 40.3;skeletal muscle: 53.9;tongue: 37.8" "Cell type enriched" "Detected in many" 6 "Cardiomyocytes: 134.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA045861 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA045861: AB_2679475" "unprognostic (1.39e-1)" "unprognostic (3.42e-2)" "unprognostic (5.10e-2)" "unprognostic (1.12e-4)" "unprognostic (5.35e-2)" "unprognostic (7.01e-2)" "unprognostic (1.13e-2)" "unprognostic (1.10e-1)" "unprognostic (7.03e-3)" "unprognostic (2.34e-1)" "unprognostic (4.19e-2)" "unprognostic (3.42e-2)" "unprognostic (9.88e-2)" "unprognostic (4.61e-2)" "unprognostic (1.10e-1)" "unprognostic (3.53e-1)" "unprognostic (2.36e-2)" 2.4 1.1 1.2 1.0 1.3 0.3 1.1 1.7 1.8 1.4 1.0 0.5 1.5 1.0 0.6 2.3 1.8 1.1 0.8 40.3 1.2 1.9 1.4 1.7 0.6 0.8 1.2 0.5 1.0 1.1 1.5 6.8 0.8 2.8 1.9 1.0 0.9 3.8 1.2 53.9 0.5 0.9 1.1 1.2 0.8 1.0 0.8 0.4 1.8 2.0 37.8 4.0 1.2 0.7 4.4 3.1 0.3 0.3 2.4 4.1 1.1 4.9 2.8 2.1 6.6 2.7 2.7 7.7 2.7 2.4 2.7 3.9 9.2 6.9 4.1 9.2 0.9 4.4 2.9 2.3 3.7 5.7 9.1 1.8 6.1 1.3 5.8 3.2 5.5 4.9 3.4 6.8 4.3 3.8 1.9 0.4 5.9 4.3 1.6 2.7 3.6 2.9 5.3 3.6 4.7 3.0 3.1 5.6 3.9 3.8 4.3 5.5 1.9 3.6 3.9 8.6 2.9 3.3 2.9 0.3 4.3 3.1 3.3 3.3 4.0 10.0 3.4 4.4 9.1 6.5 0.0 0.0 0.3 3.9 0.3 3.2 4.4 2.8 2.2 1.3 1.9 3.8 4.1 0.1 2.4 0.3 3.1 0.8 1.1 1.2 1.3 1.7 1.8 1.2 1.9 1.2 0.5 2.8 0.4 20.8 10.5 5.9 0.8 0.3 0.1 134.4 0.0 17.4 23.9 3.5 0.0 1.9 0.0 1.3 0.6 0.0 0.4 23.3 2.9 2.1 1.0 1.0 3.5 1.9 1.0 0.0 6.3 0.0 0.6 0.4 0.6 0.7 6.8 0.0 2.2 2.3 1.7 0.0 0.7 2.4 0.3 0.0 0.9 0.9 2.2 0.5 0.9 1.0 1.7 2.7 TMEM183A C1orf37 ENSG00000163444 "Transmembrane protein 183A" Q8IXX5 1 203007386-203024848 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072607 Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA072607: AB_2686539" "unprognostic (2.94e-3)" "unprognostic (1.60e-1)" "unprognostic (1.30e-1)" "unprognostic (1.33e-1)" "unprognostic (3.41e-2)" "unprognostic (5.99e-2)" "prognostic unfavorable (2.62e-4)" "unprognostic (6.46e-2)" "unprognostic (3.21e-2)" "unprognostic (4.82e-3)" "unprognostic (5.28e-2)" "unprognostic (7.84e-2)" "unprognostic (4.83e-2)" "unprognostic (6.01e-3)" "unprognostic (9.55e-2)" "unprognostic (3.65e-2)" "unprognostic (1.32e-1)" 12.2 12.6 22.4 13.5 20.8 50.1 17.2 31.9 30.4 14.4 21.1 12.4 6.7 20.0 13.6 15.2 19.3 12.0 15.0 11.5 19.8 21.0 16.0 21.1 13.4 20.2 19.3 14.8 15.0 29.9 12.0 8.2 10.9 20.8 15.0 23.6 11.1 22.2 13.6 8.8 16.1 18.8 17.6 12.4 14.5 15.8 27.7 12.3 23.3 20.5 14.8 17.7 15.3 20.7 17.4 27.2 35.6 24.4 26.4 23.7 24.3 12.7 12.4 15.9 26.1 21.1 15.9 26.3 12.8 12.7 14.9 13.1 15.0 13.5 31.9 9.3 16.5 6.0 16.2 21.3 18.0 12.4 10.3 25.9 15.7 14.5 16.5 15.3 28.1 13.9 15.6 20.1 12.2 24.8 15.1 18.7 25.8 32.2 11.6 13.8 28.4 22.9 28.9 43.8 17.3 19.8 17.7 27.2 25.6 23.0 12.5 20.5 25.7 19.2 32.1 18.4 26.5 22.9 22.2 13.8 10.1 14.1 17.2 14.0 11.8 18.9 24.7 11.1 21.9 10.6 21.1 24.4 35.6 18.1 20.4 17.9 16.6 20.5 20.5 27.2 17.4 23.7 19.3 21.3 26.4 18.5 19.5 21.2 24.3 22.4 20.8 31.9 30.4 19.8 21.0 19.3 14.8 20.8 12.3 14.9 15.6 44.9 49.0 65.3 20.7 10.9 48.4 28.1 28.4 33.2 9.8 46.3 59.7 71.4 117.2 35.8 68.3 23.3 66.2 74.0 37.9 74.7 17.3 45.7 54.3 17.5 50.6 32.5 53.2 96.3 25.0 47.0 37.1 59.5 68.9 18.9 55.2 56.1 27.6 74.5 26.2 19.4 47.6 72.3 76.8 71.8 43.1 44.7 83.1 77.4 TMEM184A "MGC9712, SDMG1" ENSG00000164855 "Transmembrane protein 184A" Q6ZMB5 7 1542235-1560821 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.2;intestine: 39.3" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 57.2;Mucus-secreting cells: 31.0;Paneth cells: 31.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "MCF7: 15.2;RT4: 17.3;SCLC-21H: 17.8;SK-BR-3: 27.6;T-47d: 24.4" "Low region specificity" "Detected in many" "HPA053790, HPA071312" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA053790: AB_2682263, HPA071312: AB_2686387" "unprognostic (3.67e-1)" "unprognostic (4.83e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (2.38e-1)" "unprognostic (4.41e-3)" "unprognostic (1.07e-1)" "unprognostic (2.36e-1)" "unprognostic (1.17e-1)" "unprognostic (1.77e-1)" "unprognostic (1.69e-1)" "unprognostic (1.53e-1)" "unprognostic (1.31e-1)" "unprognostic (6.70e-2)" "unprognostic (2.77e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (9.94e-4)" "unprognostic (5.47e-2)" 0.4 0.1 0.2 3.5 0.2 0.1 1.6 0.2 0.3 8.6 15.6 0.2 8.0 15.1 1.7 2.9 40.2 4.4 9.6 0.2 0.2 0.1 5.3 18.0 1.5 0.2 0.2 0.3 0.9 24.7 3.1 5.4 14.3 0.4 5.1 4.0 0.3 10.3 12.0 2.3 17.9 39.3 1.2 0.2 0.2 7.5 3.8 0.2 0.5 0.3 22.9 31.9 10.0 15.8 0.8 0.8 2.0 0.5 0.4 0.5 0.0 9.7 6.6 0.0 0.0 0.0 0.0 2.2 0.3 0.1 0.4 0.0 8.9 11.7 0.2 3.4 0.1 3.6 7.5 0.0 4.4 0.1 0.1 0.2 0.0 6.0 4.0 0.1 0.0 0.0 0.0 4.3 0.1 3.9 0.2 0.0 2.9 0.1 0.0 0.0 15.2 0.0 0.0 0.3 6.0 8.6 0.2 0.0 4.7 3.3 17.3 17.8 0.0 2.9 27.6 0.0 0.2 24.4 0.0 0.0 0.0 3.7 4.6 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.5 0.2 0.5 0.1 0.3 0.2 0.3 0.2 0.1 0.8 0.4 0.3 2.0 0.4 0.2 0.8 0.3 0.0 0.2 0.2 0.2 0.3 0.2 0.1 0.2 0.3 0.4 0.2 3.0 4.1 0.8 5.3 3.5 0.9 2.5 17.8 13.4 10.3 8.7 0.0 6.6 1.7 11.9 0.0 0.7 57.2 0.0 9.6 7.7 1.3 11.9 1.1 12.4 0.7 0.0 6.9 0.0 1.2 0.0 0.0 1.7 0.0 1.0 31.0 0.0 12.3 31.6 0.0 3.8 0.4 0.0 1.0 0.0 0.0 8.2 14.1 0.0 13.3 11.3 TMEM184B "C22orf5, DKFZP586A1024, FM08, HS5O6A" ENSG00000198792 "Transmembrane protein 184B" Q9Y519 22 38219291-38273034 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 65.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 60.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024076 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" Nucleoplasm "HPA024076: AB_1858106" "unprognostic (1.52e-1)" "unprognostic (9.17e-2)" "unprognostic (1.86e-1)" "unprognostic (8.96e-2)" "unprognostic (3.82e-1)" "unprognostic (2.77e-2)" "prognostic unfavorable (5.94e-6)" "unprognostic (1.14e-2)" "unprognostic (5.18e-2)" "unprognostic (4.52e-2)" "unprognostic (9.20e-2)" "unprognostic (1.77e-2)" "unprognostic (1.52e-1)" "unprognostic (5.67e-2)" "unprognostic (1.65e-1)" "unprognostic (1.06e-1)" "unprognostic (2.96e-1)" 21.8 16.5 23.9 14.7 24.1 6.0 27.5 26.4 40.0 22.4 14.4 31.2 12.2 18.5 12.1 9.5 11.0 14.2 16.1 17.8 25.8 21.5 13.0 7.4 20.5 8.6 26.1 22.2 10.8 18.0 27.3 21.9 41.2 23.8 12.3 12.5 20.1 16.8 17.3 19.0 10.9 16.5 15.7 41.2 14.1 19.3 5.8 20.9 3.9 16.7 10.6 9.2 20.0 15.4 1.6 7.3 12.4 3.1 6.2 5.8 2.6 17.3 15.2 9.0 7.1 17.9 14.4 20.8 18.8 26.8 15.5 13.8 11.1 8.1 3.3 14.8 28.0 14.0 21.6 8.1 18.5 10.5 11.8 14.5 6.6 11.1 9.2 18.9 5.1 9.2 12.0 16.5 18.2 20.4 16.0 19.3 5.1 4.1 11.7 13.4 9.9 3.2 4.3 7.3 13.0 14.0 5.6 8.1 3.3 11.5 19.3 19.5 3.4 14.1 20.7 10.0 10.9 11.4 3.8 28.4 15.8 16.2 13.8 11.4 24.3 60.1 2.7 22.9 3.8 13.5 12.4 3.1 4.6 5.8 2.4 5.3 1.6 3.3 4.3 4.7 1.2 2.3 2.7 11.2 6.2 1.6 7.3 1.0 2.6 23.9 24.1 26.4 35.4 25.8 21.5 26.1 22.2 23.8 20.9 6.0 15.0 1.5 15.0 11.0 17.0 14.6 10.2 4.0 9.1 14.0 2.0 27.6 3.3 15.0 4.9 26.7 7.5 0.0 19.1 38.8 21.0 27.4 2.3 3.4 13.3 14.3 24.9 16.0 7.5 1.7 10.9 10.2 13.5 16.2 16.0 40.7 22.7 7.0 12.7 4.2 8.1 19.4 23.4 2.3 6.6 8.4 65.6 10.1 9.4 30.1 TMEM184C "FLJ10846, TMEM34" ENSG00000164168 "Transmembrane protein 184C" Q9NVA4 4 147617383-147672044 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 107.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054013 Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA054013: AB_2682343" "unprognostic (5.45e-3)" "unprognostic (2.49e-2)" "unprognostic (3.93e-3)" "unprognostic (3.58e-2)" "unprognostic (2.02e-1)" "unprognostic (8.14e-2)" "unprognostic (1.32e-2)" "unprognostic (7.72e-3)" "unprognostic (1.48e-1)" "unprognostic (1.99e-1)" "prognostic unfavorable (6.37e-4)" "unprognostic (1.13e-1)" "prognostic favorable (2.31e-7)" "unprognostic (4.68e-2)" "unprognostic (3.03e-1)" "unprognostic (2.20e-1)" "unprognostic (4.31e-3)" 10.4 18.4 11.3 9.6 13.1 5.5 10.0 12.3 15.9 11.8 13.0 12.3 14.3 11.8 12.4 9.8 10.7 10.0 9.6 14.3 11.8 11.3 18.0 18.7 9.2 7.7 16.1 11.8 15.7 11.6 107.2 10.5 14.0 12.7 12.0 11.6 9.3 12.1 12.8 16.2 9.5 14.8 10.1 14.0 10.0 10.6 8.3 14.1 11.7 32.9 10.3 9.4 11.8 11.2 12.8 17.3 17.7 18.1 14.7 22.8 11.6 9.2 14.5 18.4 14.0 25.2 24.6 12.1 17.3 20.3 12.9 15.0 11.9 17.7 8.6 8.7 13.5 12.8 11.1 14.9 13.3 14.3 19.1 8.7 11.1 11.2 8.6 19.4 14.8 16.6 18.3 18.0 14.2 14.9 18.8 16.6 9.8 14.2 24.3 18.0 13.8 12.8 5.4 11.8 21.1 8.5 12.8 6.3 14.8 14.3 17.3 14.3 18.5 9.4 14.7 15.1 14.9 14.7 9.3 16.2 16.4 8.9 13.3 11.0 26.6 34.8 11.5 19.2 8.9 17.7 17.7 14.1 15.5 18.0 18.0 22.8 12.3 16.7 16.4 17.3 12.8 15.9 14.8 11.0 14.7 18.1 11.9 15.3 11.6 11.3 13.1 12.3 15.9 11.8 11.3 16.1 11.8 12.7 14.1 8.9 5.7 6.4 6.6 4.0 7.7 16.5 10.2 5.3 14.8 5.2 11.8 12.5 1.7 10.6 19.6 9.8 8.5 0.0 11.1 10.6 8.4 7.2 20.8 8.5 9.0 11.1 5.2 6.7 10.4 10.3 10.0 8.8 5.0 4.6 8.3 7.8 7.5 3.5 13.8 5.3 6.2 6.5 7.3 5.4 4.9 3.0 7.2 6.4 9.9 6.4 TMEM189-UBE2V1 "CROC-1B, Kua-UEV" ENSG00000124208 "TMEM189-UBE2V1 readthrough" 20 50081124-50153637 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 4.5;Ciliated cells: 9.4;Club cells: 9.1;granulocytes: 5.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA052535, HPA053186" Supported Nucleoplasm NA NA Nucleoplasm "HPA052535: AB_2681863, HPA053186: AB_2682073" "unprognostic (3.69e-1)" "unprognostic (1.27e-1)" "unprognostic (2.41e-3)" "unprognostic (2.71e-2)" "unprognostic (1.52e-1)" "unprognostic (6.05e-3)" "unprognostic (2.40e-1)" "unprognostic (8.19e-2)" 9.2 4.4 4.6 7.5 9.7 1.2 5.1 6.1 7.1 4.3 3.9 14.2 6.8 2.0 4.7 3.0 5.9 2.9 3.1 3.9 4.4 4.5 3.4 8.4 5.0 3.6 14.0 3.0 4.3 9.1 5.5 4.3 15.0 8.3 3.8 1.6 2.0 3.7 4.6 8.4 4.0 4.4 4.8 7.9 4.6 7.6 12.2 10.2 3.5 3.2 4.0 5.6 4.5 3.5 6.1 9.1 11.3 15.3 8.0 8.7 9.9 3.4 5.8 2.1 5.4 8.9 6.1 6.4 5.9 3.9 8.1 4.6 12.4 7.3 1.7 8.2 3.2 7.4 14.9 3.2 6.6 1.4 0.8 1.1 2.5 10.2 7.5 4.1 4.3 4.6 6.1 12.2 6.0 2.2 0.6 8.0 0.8 4.1 5.2 3.6 4.2 3.2 0.4 1.5 1.3 1.4 3.1 1.7 2.9 2.3 9.4 3.3 1.5 2.8 12.3 2.6 0.1 2.6 4.0 12.4 9.5 3.6 2.6 3.8 1.3 1.7 0.6 4.2 1.1 6.2 7.5 9.4 11.3 8.7 13.5 7.6 4.1 7.9 8.6 9.1 6.1 7.4 7.8 1.3 8.0 15.3 5.5 8.2 9.9 4.6 9.7 6.1 7.1 4.4 4.5 14.0 3.0 8.3 10.2 8.9 4.5 0.0 0.0 0.0 0.0 0.0 0.0 9.4 9.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM192 FLJ38482 ENSG00000170088 "Transmembrane protein 192" Q8IY95 4 165070608-165208549 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014717, HPA024110" Enhanced Supported Nucleoplasm,Endosomes,Lysosomes NA NA "Endosomes, Lysosomes" Nucleoplasm "HPA014717: AB_1844373, HPA024110: AB_2204898" "prognostic unfavorable (9.52e-4)" "unprognostic (5.38e-3)" "unprognostic (9.16e-2)" "unprognostic (4.39e-2)" "unprognostic (2.60e-2)" "unprognostic (1.55e-2)" "unprognostic (2.91e-3)" "unprognostic (8.43e-2)" "unprognostic (2.83e-2)" "unprognostic (3.10e-1)" "unprognostic (3.27e-2)" "unprognostic (5.06e-2)" "prognostic favorable (2.33e-14)" "unprognostic (2.09e-2)" "unprognostic (1.37e-1)" "unprognostic (2.76e-2)" "unprognostic (9.30e-2)" 12.6 14.4 11.3 7.4 13.6 5.3 12.1 12.0 11.9 11.6 9.7 10.5 6.2 8.3 9.7 10.0 7.8 10.1 8.9 10.4 9.9 9.4 40.7 37.7 9.1 8.5 13.0 10.6 21.8 21.3 20.3 14.2 9.3 13.1 19.4 11.7 24.7 11.3 7.8 19.0 7.4 8.2 8.6 13.3 10.8 10.5 8.6 11.3 3.1 22.9 5.2 6.6 12.1 7.3 18.2 12.0 3.4 12.5 13.4 12.8 7.7 6.3 9.6 3.5 8.8 9.1 3.2 8.1 9.7 14.3 10.1 11.3 5.6 10.5 14.0 5.8 6.2 16.5 5.7 13.0 9.9 11.7 9.0 6.7 7.8 7.2 6.3 23.3 19.1 10.5 11.7 21.2 9.1 18.6 8.8 8.2 7.6 13.2 23.6 12.4 13.8 3.3 5.6 7.3 13.3 8.3 7.5 3.0 12.7 8.2 9.4 7.5 7.8 15.1 24.1 15.3 5.4 11.7 8.8 6.1 4.5 5.5 14.0 10.9 23.2 30.6 19.5 10.7 10.6 17.8 2.0 12.5 3.4 9.7 10.9 12.8 18.2 7.5 9.9 11.6 15.2 8.3 10.0 1.4 13.4 5.8 12.0 6.0 7.7 11.3 13.6 12.0 11.9 9.9 9.4 13.0 10.6 13.1 11.3 29.8 33.4 17.1 16.9 8.7 34.9 28.7 48.4 12.0 22.7 52.4 15.7 23.8 10.0 18.4 13.5 19.6 13.2 0.0 22.3 16.3 19.5 28.7 38.3 68.1 32.6 35.0 20.8 27.0 24.1 7.5 36.8 24.0 27.0 9.0 15.9 31.7 12.7 14.0 31.5 49.7 25.3 6.5 13.2 13.1 11.9 11.3 28.1 19.8 22.9 12.3 TMEM196 MGC42090 ENSG00000173452 "Transmembrane protein 196" Q5HYL7 7 19719310-19773598 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 15.0;pituitary gland: 12.6" "Cell type enriched" "Detected in some" 10 "Bipolar cells: 51.1" "Cancer enhanced" "Detected in single" "glioma: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "ASC diff: 8.8;ASC TERT1: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043163 Uncertain Uncertain "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA "Nucleoplasm, Golgi apparatus" "HPA043163: AB_10794772" "unprognostic (6.08e-3)" "unprognostic (1.88e-2)" "unprognostic (2.14e-2)" "unprognostic (9.30e-2)" "unprognostic (5.63e-2)" 0.7 3.7 8.0 0.6 8.6 0.4 0.4 0.3 15.0 1.2 0.6 0.3 0.0 0.4 3.8 1.5 0.5 1.2 0.4 0.4 3.6 10.1 0.6 0.4 0.4 0.4 2.9 7.4 0.4 3.0 0.7 12.6 0.4 5.0 0.5 0.5 0.5 0.4 0.4 0.4 0.4 0.4 1.0 1.4 0.4 2.6 0.5 2.8 0.0 0.4 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 8.8 8.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 8.6 0.3 7.3 3.6 10.1 2.9 7.4 5.0 2.8 0.0 0.0 0.0 0.0 0.0 51.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.8 0.4 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM201 "Ima1, NET5, RP13-15M17.2, SAMP1" ENSG00000188807 "Transmembrane protein 201" Q5SNT2 1 9588922-9614873 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 37.0" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 25.5;Rod photoreceptor cells: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 4.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB039039 Approved Supported "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "CAB039039: " "unprognostic (1.75e-2)" "prognostic favorable (5.36e-4)" "unprognostic (1.89e-1)" "unprognostic (1.80e-1)" "unprognostic (4.88e-1)" "unprognostic (1.27e-2)" "prognostic unfavorable (9.61e-8)" "unprognostic (2.22e-1)" "unprognostic (3.60e-1)" "unprognostic (3.87e-2)" "unprognostic (5.59e-3)" "unprognostic (1.63e-1)" "unprognostic (9.38e-2)" "unprognostic (3.87e-2)" "unprognostic (6.25e-2)" "unprognostic (7.99e-2)" "unprognostic (1.45e-1)" 6.2 7.3 9.6 5.7 9.4 10.3 4.0 8.7 11.9 4.4 3.9 10.5 4.4 5.4 6.9 5.1 5.9 5.8 4.0 13.2 9.3 7.9 5.7 2.7 4.5 5.0 9.4 8.3 9.0 9.2 5.5 12.6 4.5 7.9 4.9 2.8 12.6 6.7 5.6 37.0 7.1 3.9 4.9 6.7 5.3 4.0 8.2 7.1 6.9 4.5 13.9 5.4 3.8 4.3 1.4 4.3 0.0 0.8 0.4 1.9 1.0 7.7 10.5 6.6 15.5 2.8 1.9 5.9 9.1 2.8 10.9 7.7 19.3 7.1 13.5 11.6 3.1 5.3 16.2 7.3 7.2 3.7 8.9 18.3 9.5 10.0 9.8 5.1 11.5 9.9 3.4 3.3 14.6 2.4 2.3 4.3 6.4 12.1 3.9 4.3 9.2 10.0 8.4 6.7 6.0 9.8 21.2 11.3 11.1 3.9 4.3 15.9 11.9 7.2 17.6 7.9 2.4 5.4 7.3 3.9 13.0 11.3 14.3 17.1 6.6 5.5 12.1 9.0 19.0 11.4 0.0 0.8 0.0 1.1 0.6 0.6 1.4 1.4 1.9 1.1 1.1 1.0 0.7 0.0 0.4 0.4 4.3 1.8 1.0 9.6 9.4 8.7 11.9 9.3 7.9 9.4 8.3 7.9 7.1 3.0 1.3 1.9 1.7 6.3 14.7 10.6 2.5 2.7 2.3 0.0 25.5 2.8 1.7 2.0 1.1 4.5 0.7 0.0 0.8 1.8 2.3 1.4 4.6 1.5 3.0 9.5 6.4 4.3 3.7 1.3 3.7 2.5 3.3 0.0 3.6 4.8 1.3 0.0 4.2 1.9 16.3 0.0 3.8 4.7 5.3 4.8 0.7 1.0 4.0 1.7 TMEM205 "MBC3205, UNQ501" ENSG00000105518 "Transmembrane protein 205" Q6UW68 19 11342776-11346518 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 396.4;Hepatocytes: 417.5;Late spermatids: 488.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041504 Approved Approved "Nucleoplasm,Nuclear membrane,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "Nucleoplasm, Nuclear membrane" "HPA041504: AB_10795595" "unprognostic (2.54e-2)" "unprognostic (2.60e-2)" "unprognostic (7.19e-2)" "unprognostic (1.57e-2)" "unprognostic (6.83e-2)" "unprognostic (1.80e-1)" "unprognostic (5.04e-3)" "unprognostic (3.77e-2)" "unprognostic (1.01e-2)" "unprognostic (5.56e-3)" "unprognostic (2.70e-2)" "unprognostic (1.19e-1)" "unprognostic (8.10e-2)" "unprognostic (5.78e-2)" "unprognostic (8.18e-2)" "unprognostic (1.20e-1)" "unprognostic (1.45e-1)" 15.8 40.5 25.7 10.6 29.4 14.5 19.3 16.2 36.3 30.3 19.2 19.8 34.6 18.7 15.5 29.7 14.6 25.9 27.8 31.7 24.5 23.6 36.1 90.8 19.4 22.9 25.2 21.9 21.7 50.5 52.4 21.7 17.5 20.6 24.3 11.3 31.8 28.6 28.4 30.0 15.0 18.2 16.9 21.4 14.2 17.2 23.1 13.2 11.1 46.6 15.4 13.3 21.3 13.1 21.9 43.1 11.0 71.0 10.4 14.8 32.1 19.3 48.1 5.9 20.1 11.8 14.2 11.2 7.4 17.1 16.2 12.7 14.6 6.2 17.4 44.9 14.9 16.1 19.9 8.5 22.2 10.9 20.4 8.1 4.6 16.7 23.9 29.8 7.8 14.9 13.4 22.7 10.4 17.4 16.3 19.5 16.7 14.0 74.6 10.0 49.0 11.7 21.9 10.6 25.3 36.9 11.1 9.2 46.0 39.4 35.1 10.7 16.3 7.8 32.1 18.0 7.4 27.9 22.8 11.4 20.4 7.8 22.2 16.4 44.5 44.3 10.3 19.7 35.1 15.6 5.2 71.0 7.1 14.6 29.8 14.8 21.9 12.2 12.8 43.1 18.4 9.8 11.8 11.0 10.4 17.5 31.0 14.6 32.1 25.7 29.4 16.2 36.3 24.5 23.6 25.2 21.9 20.6 13.2 62.5 59.8 25.2 116.9 45.7 27.8 62.3 178.3 58.9 89.9 144.8 11.8 101.4 51.4 137.3 396.4 66.1 62.3 0.0 143.8 66.1 80.7 116.5 28.8 417.5 85.9 25.4 113.0 63.3 78.3 488.1 74.8 50.9 91.1 31.5 72.5 72.5 99.5 66.6 64.0 180.1 27.1 45.3 59.3 30.7 14.9 47.2 80.9 37.9 73.4 104.8 TMEM215 ENSG00000188133 "Transmembrane protein 215" Q68D42 9 32783499-32787399 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "endometrium 1: 8.0;retina: 6.5;testis: 17.9" "Cell type enhanced" "Detected in some" 32 "Bipolar cells: 564.3;Early spermatids: 108.6;Late spermatids: 188.4" "Cancer enriched" "Detected in single" 14 "thyroid cancer: 4.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "NTERA-2: 6.6;SH-SY5Y: 2.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA052804, HPA063207" Supported "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA Nucleoplasm "Endoplasmic reticulum, Vesicles" "HPA052804: AB_2681957, HPA063207: AB_2732697" "unprognostic (1.31e-2)" "unprognostic (4.57e-2)" "unprognostic (1.07e-1)" "unprognostic (2.92e-2)" "unprognostic (5.85e-2)" "unprognostic (4.38e-3)" "unprognostic (2.17e-3)" "unprognostic (2.82e-1)" "unprognostic (2.72e-1)" "unprognostic (2.64e-1)" "unprognostic (3.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.54e-1)" "unprognostic (2.32e-2)" 0.1 0.0 1.8 0.4 1.5 0.0 0.1 0.1 0.9 1.9 0.0 0.0 0.0 0.0 8.0 0.9 0.1 0.1 0.0 0.9 0.9 1.5 0.0 0.0 0.1 0.0 1.7 0.2 0.7 0.0 0.0 0.1 0.0 0.6 0.1 0.0 6.5 0.1 0.0 0.3 0.1 0.1 0.0 1.0 0.0 0.0 17.9 0.0 0.0 3.0 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.5 0.1 0.8 0.9 1.5 1.7 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 564.3 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 108.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 188.4 2.6 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.7 0.0 21.9 0.0 0.0 1.9 0.7 0.0 0.0 0.0 0.0 0.0 TMEM220 ENSG00000187824 "Transmembrane protein 220" Q6QAJ8 17 10699015-10730316 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 58.2" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 146.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 11.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047680 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA047680: " "unprognostic (1.71e-2)" "unprognostic (4.60e-2)" "unprognostic (6.31e-3)" "unprognostic (4.04e-3)" "unprognostic (1.05e-3)" "unprognostic (1.84e-4)" "prognostic favorable (2.23e-5)" "unprognostic (4.58e-2)" "unprognostic (4.96e-3)" "unprognostic (2.81e-1)" "prognostic favorable (1.72e-4)" "unprognostic (2.97e-1)" "unprognostic (4.34e-3)" "unprognostic (2.25e-1)" "unprognostic (2.63e-2)" "unprognostic (7.80e-3)" "unprognostic (5.97e-2)" 6.5 7.4 4.5 2.4 4.6 3.3 7.8 1.3 2.8 4.7 6.1 3.8 14.3 8.1 4.9 11.1 3.3 3.9 10.1 6.3 3.8 2.4 6.4 58.2 4.6 3.1 2.9 1.2 4.8 6.0 2.4 2.4 1.7 4.9 12.0 2.8 6.6 3.5 18.5 4.1 3.7 15.4 5.4 2.5 4.7 7.1 17.2 3.5 0.6 9.4 2.6 2.4 4.1 3.4 11.6 2.9 2.3 2.5 4.5 9.0 1.9 0.5 3.5 1.3 8.3 5.2 5.2 1.0 6.9 7.3 4.7 6.8 0.0 0.3 1.2 0.5 4.3 0.4 0.4 3.4 0.6 3.5 0.4 1.5 0.5 0.2 2.9 7.6 0.9 0.8 3.4 0.4 1.5 0.3 1.0 2.2 3.0 0.4 0.3 3.0 0.4 1.1 1.5 5.0 0.4 0.0 4.8 0.2 0.6 11.1 0.2 0.5 6.0 0.3 0.1 0.7 1.9 0.4 1.8 4.8 0.4 1.3 2.6 0.4 0.8 0.3 0.3 4.9 1.4 0.6 1.4 2.5 2.3 0.9 1.8 1.1 4.2 2.2 1.3 2.9 11.6 9.0 6.1 2.1 4.5 0.8 2.3 0.4 1.9 4.5 4.6 1.3 2.8 3.8 2.4 2.9 1.2 4.9 3.5 3.0 8.3 5.6 13.2 8.5 1.5 8.8 56.0 8.1 11.4 17.4 7.9 10.1 18.3 13.7 72.2 7.9 60.8 23.3 20.8 20.6 12.0 37.1 39.3 146.5 20.4 0.0 2.9 10.4 11.8 12.5 16.7 5.4 23.6 6.4 15.2 44.1 14.9 28.8 9.2 20.3 22.1 19.4 9.6 52.0 7.5 6.9 3.8 2.5 10.0 21.1 TMEM223 MGC3196 ENSG00000168569 "Transmembrane protein 223" A0PJW6 11 62771629-62792021 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014504 Approved Approved "Nucleoplasm,Nuclear membrane,Mitochondria" NA NA "Nucleoplasm, Nuclear membrane, Mitochondria" "HPA014504: AB_1853881" "unprognostic (1.35e-2)" "unprognostic (1.60e-1)" "unprognostic (1.87e-1)" "unprognostic (3.15e-2)" "unprognostic (1.00e-1)" "unprognostic (2.21e-2)" "unprognostic (3.20e-3)" "unprognostic (1.97e-1)" "unprognostic (4.35e-1)" "unprognostic (1.70e-3)" "unprognostic (1.29e-1)" "unprognostic (2.50e-1)" "unprognostic (5.20e-2)" "unprognostic (7.26e-2)" "unprognostic (1.66e-1)" "unprognostic (1.14e-3)" "unprognostic (9.75e-2)" 10.9 20.6 12.8 13.4 19.5 8.7 11.6 11.1 25.5 11.7 15.2 13.4 12.0 16.6 12.7 15.5 12.3 11.9 11.8 21.7 12.6 12.8 19.5 20.4 10.5 16.2 12.4 15.6 12.5 38.7 10.4 13.0 10.9 13.2 14.8 11.6 13.9 22.4 15.0 21.3 16.2 18.2 8.4 11.1 16.1 16.2 8.2 11.6 19.0 13.4 10.6 14.2 11.1 10.2 32.4 28.0 8.9 16.6 23.1 30.7 15.3 15.3 13.2 7.9 10.8 6.3 7.3 10.8 8.3 7.3 9.4 7.9 11.5 18.9 11.6 20.5 5.9 12.4 23.5 9.5 10.2 5.4 18.3 17.8 8.6 14.8 13.7 11.7 10.5 10.2 7.8 10.4 6.2 7.8 11.1 7.2 15.4 13.0 8.7 6.9 22.4 10.5 23.4 15.6 16.1 16.0 13.1 9.6 25.8 14.5 9.8 13.5 17.9 8.7 17.7 21.9 8.4 26.4 9.9 7.5 11.3 13.6 10.3 9.8 17.9 14.2 13.2 13.4 9.5 11.7 7.3 16.1 8.9 28.4 16.6 27.2 28.2 28.1 27.6 17.5 32.4 30.7 29.8 7.5 23.1 10.5 28.0 23.9 15.3 12.8 19.5 11.1 25.5 12.6 12.8 12.4 15.6 13.2 11.6 11.9 3.5 22.6 13.7 11.9 18.5 16.8 40.8 36.1 13.6 19.2 11.8 41.9 53.0 32.8 1.9 17.5 26.1 0.0 38.3 35.7 20.6 16.0 19.6 34.8 32.6 6.4 19.8 31.3 19.6 2.6 30.2 16.6 18.6 16.2 29.2 14.8 31.4 14.0 24.8 47.6 17.3 19.4 9.6 6.3 21.2 12.2 11.9 29.9 38.6 14.5 TMEM233 IFITMD2 ENSG00000224982 "Transmembrane protein 233" B4DJY2 12 119593459-119643066 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skeletal muscle: 88.0" "Cell type enriched" "Detected in some" 4 "granulocytes: 76.3" "Cancer enriched" "Detected in many" 6 "thyroid cancer: 12.6" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 11.5;hTERT-RPE1: 4.7;RH-30: 6.1;U-2197: 9.2;U-87 MG: 37.0" "Not detected" "Not detected" "HPA047506, HPA075435" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047506: AB_10963068, HPA075435: " "unprognostic (1.46e-2)" "unprognostic (1.16e-2)" "unprognostic (1.39e-3)" "unprognostic (1.03e-2)" "unprognostic (1.99e-3)" "unprognostic (1.71e-2)" "unprognostic (5.86e-2)" "unprognostic (1.55e-2)" "unprognostic (2.06e-2)" "unprognostic (1.39e-1)" "unprognostic (1.63e-2)" "unprognostic (4.41e-2)" "unprognostic (6.06e-2)" "unprognostic (3.10e-3)" "unprognostic (2.94e-1)" "unprognostic (4.38e-2)" "unprognostic (3.66e-1)" 0.6 0.3 0.8 0.0 0.4 0.0 0.6 0.1 8.8 0.2 0.2 0.0 0.0 0.1 0.9 0.6 0.2 0.2 1.0 0.7 0.2 0.5 0.5 0.3 0.6 0.2 0.1 1.4 0.6 0.1 1.7 0.4 0.0 0.4 0.4 0.1 0.7 0.5 0.3 88.0 0.1 0.2 0.5 0.3 0.2 0.2 0.2 0.0 0.1 11.1 5.2 0.3 0.4 1.8 0.3 0.3 0.7 0.1 0.6 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.0 11.5 0.0 4.7 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.3 0.1 0.0 0.2 0.1 0.2 0.3 0.3 0.2 0.0 0.3 0.2 0.5 0.7 0.6 0.1 0.3 0.1 0.1 0.8 0.4 0.1 1.5 0.2 0.5 0.1 1.4 0.4 0.0 3.0 1.4 0.0 0.3 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.6 7.2 6.8 0.0 0.0 7.8 0.0 0.4 0.3 76.3 0.0 0.1 7.9 0.0 18.4 1.2 2.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 2.1 0.0 0.2 2.3 0.2 0.1 0.1 0.0 0.0 0.2 TMEM250 "bA83N9.1, C9orf69" ENSG00000238227 "Transmembrane protein 250" H0YL14 9 136114581-136118863 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 14.0;Cytotrophoblasts: 14.7;Extravillous trophoblasts: 18.7;Hofbauer cells: 13.1;Pancreatic endocrine cells: 13.9;Proximal tubular cells: 12.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066070 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA066070: AB_2685608" "unprognostic (2.79e-2)" "unprognostic (3.47e-1)" "unprognostic (1.34e-2)" "prognostic favorable (1.09e-4)" "unprognostic (4.99e-2)" "unprognostic (2.34e-2)" "unprognostic (4.34e-2)" "unprognostic (1.27e-3)" "unprognostic (2.41e-1)" "unprognostic (1.48e-1)" "unprognostic (6.31e-2)" "unprognostic (2.66e-1)" "unprognostic (1.99e-2)" "unprognostic (9.33e-3)" "unprognostic (1.09e-2)" "unprognostic (2.41e-2)" "unprognostic (1.64e-1)" 16.4 11.4 16.1 15.0 19.4 5.5 25.3 13.8 28.4 12.4 19.3 9.2 8.2 22.5 12.2 10.9 22.2 14.2 13.8 10.7 17.1 9.5 13.0 17.6 15.2 15.2 9.4 14.2 15.9 12.7 9.4 10.1 15.2 9.8 13.4 11.4 7.4 18.3 13.0 33.9 26.8 18.9 14.1 7.7 14.0 17.3 12.8 10.0 15.4 11.2 12.9 12.0 13.2 11.8 3.0 4.6 5.3 6.3 4.7 9.9 3.0 11.0 21.0 8.2 12.2 11.7 10.7 25.7 13.3 9.6 8.1 5.8 11.9 16.2 8.2 15.7 14.2 12.9 28.4 5.8 9.4 2.5 35.3 11.1 6.9 21.9 8.3 16.3 12.5 9.0 9.6 18.1 8.7 9.2 10.4 12.8 8.2 15.5 8.7 7.0 25.5 15.2 10.1 18.2 19.4 23.0 6.2 11.4 13.5 8.8 8.1 14.2 10.8 14.4 10.0 11.4 5.1 9.1 18.9 14.4 14.2 6.3 18.5 14.7 5.1 4.9 4.9 14.2 9.0 13.3 4.9 4.6 2.7 9.9 6.2 7.4 3.0 7.6 8.3 4.6 2.4 3.7 6.9 5.3 4.7 6.3 3.0 3.8 3.0 16.1 19.4 13.8 28.4 17.1 9.5 9.4 14.2 9.8 10.0 6.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.3 14.0 0.0 14.7 3.3 10.6 0.0 0.0 0.0 0.0 9.1 18.7 0.0 0.0 2.3 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 6.4 0.0 0.0 13.9 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 TMEM254 "bA369J21.6, C10orf57, FLJ13263" ENSG00000133678 "Transmembrane protein 254" Q8TBM7 10 80078646-80092557 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029105, HPA072613" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA029105: AB_2672909, HPA072613: AB_2732205" "unprognostic (9.40e-2)" "unprognostic (1.76e-1)" "unprognostic (9.52e-2)" "unprognostic (5.74e-3)" "unprognostic (5.39e-2)" "unprognostic (6.04e-2)" "unprognostic (3.66e-1)" "unprognostic (3.90e-1)" "unprognostic (1.64e-2)" "unprognostic (1.87e-3)" "unprognostic (3.68e-2)" "unprognostic (1.46e-1)" "unprognostic (7.65e-2)" "unprognostic (2.46e-1)" "unprognostic (1.21e-1)" "unprognostic (3.45e-3)" "unprognostic (5.96e-2)" 8.4 13.4 10.8 6.0 14.1 4.7 15.9 6.9 13.5 14.1 13.1 11.7 14.7 10.1 12.4 40.1 35.8 17.3 10.5 4.8 9.4 6.3 10.0 30.8 6.8 9.0 7.7 9.0 8.7 12.1 8.3 10.1 14.8 9.5 25.8 13.7 10.7 16.3 9.1 3.0 43.9 13.4 6.6 8.2 6.9 9.0 21.5 8.8 8.6 11.8 12.4 15.4 13.0 20.5 12.6 14.7 27.7 18.1 9.8 22.9 11.9 7.3 7.0 11.9 9.1 14.6 18.3 18.1 7.1 5.2 5.2 5.3 5.3 22.7 5.6 12.1 9.0 4.9 7.8 4.8 5.9 5.5 9.2 8.5 1.5 2.3 7.4 6.6 6.9 7.5 11.8 26.9 4.6 4.0 11.3 4.6 4.8 4.1 12.2 5.2 14.9 5.6 5.1 6.4 6.4 23.0 6.9 1.4 4.8 7.2 6.1 4.2 6.9 6.6 16.5 7.1 8.3 23.4 4.6 6.7 4.1 7.1 6.9 4.0 8.4 11.9 0.4 10.3 7.1 3.4 27.7 16.2 7.4 11.9 18.1 14.9 12.6 13.8 12.3 13.2 9.6 22.9 15.6 1.7 9.8 17.6 14.7 16.0 11.9 10.8 14.1 6.9 13.5 9.4 6.3 7.7 9.0 9.5 8.8 8.9 8.1 6.0 5.0 7.2 7.4 2.6 15.3 37.5 14.8 8.7 15.7 33.9 18.3 12.1 3.1 5.2 10.5 0.0 7.5 30.9 5.3 21.9 5.7 28.8 17.1 15.9 8.1 5.5 11.1 5.9 8.6 9.2 3.3 16.2 22.8 14.5 9.5 18.2 11.0 17.0 11.1 12.9 3.8 24.2 8.7 21.0 19.0 6.9 18.7 6.5 TMEM255A "FAM70A, FLJ20716" ENSG00000125355 "Transmembrane protein 255A" Q5JRV8 X 120258650-120311556 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 30.4;ovary: 29.6" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 1: 3.0;Melanocytes: 5.0;monocytes: 5.4" "Group enriched" "Detected in many" 10 "glioma: 21.3;melanoma: 8.0;renal cancer: 7.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "gdT-cell: 5.9;MAIT T-cell: 3.3;memory CD8 T-cell: 2.2;naive CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 10 "T-cells: 5.9" "Cell line enhanced" "Detected in some" "Karpas-707: 17.3;NTERA-2: 6.0;RPMI-8226: 11.1;SK-MEL-30: 18.1;U-2 OS: 7.8;U-87 MG: 19.8" "Low region specificity" "Detected in all" HPA048470 Approved Uncertain "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA048470: AB_2680406" "unprognostic (3.41e-2)" "unprognostic (8.96e-2)" "unprognostic (1.62e-2)" "unprognostic (2.04e-1)" "unprognostic (3.38e-1)" "unprognostic (1.56e-1)" "unprognostic (8.55e-4)" "unprognostic (7.08e-2)" "unprognostic (1.04e-1)" "unprognostic (1.36e-1)" "unprognostic (1.49e-3)" "unprognostic (2.02e-1)" "unprognostic (1.32e-2)" "unprognostic (3.13e-2)" "unprognostic (1.45e-1)" "unprognostic (6.17e-2)" "unprognostic (2.55e-4)" 3.9 5.5 6.8 3.4 14.4 1.5 5.4 6.8 7.8 11.2 3.5 12.4 1.7 1.9 3.2 2.9 4.4 6.3 2.1 2.4 5.3 25.4 2.4 1.5 4.8 5.0 30.4 4.4 29.6 1.1 0.6 6.6 0.8 18.4 3.8 3.9 7.1 1.3 3.3 2.4 4.0 2.8 2.0 13.0 2.8 2.1 0.9 7.8 6.4 0.9 1.8 5.7 1.6 8.0 0.5 0.3 0.0 0.6 0.0 5.9 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.3 0.1 0.0 0.1 0.2 0.0 1.8 0.0 1.1 0.4 0.5 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 17.3 0.3 0.0 0.0 0.1 6.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 3.5 0.2 0.3 0.0 18.1 0.2 0.0 0.2 0.0 0.0 7.8 0.0 2.8 0.0 3.3 2.4 19.8 0.0 0.0 0.0 0.6 0.0 5.9 0.2 3.3 0.5 0.4 2.2 0.3 0.1 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.9 6.8 14.4 6.8 3.9 5.3 25.4 30.4 4.4 18.4 7.8 3.0 0.0 0.0 0.0 0.3 0.6 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.2 0.0 0.0 0.6 0.6 1.1 0.6 0.7 5.0 5.4 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.1 1.1 0.1 0.0 0.0 0.0 TMEM255B "FAM70B, MGC20579" ENSG00000184497 "Transmembrane protein 255B" Q8WV15 13 113759240-113816995 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Endothelial cells: 51.3;granulocytes: 39.2;Ito cells: 111.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.0" "Group enriched" "Detected in many" 7 "granulocytes: 17.0;monocytes: 4.8" "Cell line enhanced" "Detected in many" "HMC-1: 15.7;HUVEC TERT2: 20.4;PC-3: 20.7;RPMI-8226: 13.2;TIME: 19.1;U-87 MG: 21.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA043334 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA043334: AB_10795982" "unprognostic (2.20e-1)" "unprognostic (2.57e-3)" "unprognostic (2.05e-2)" "unprognostic (1.36e-1)" "unprognostic (4.90e-2)" "unprognostic (1.05e-1)" "unprognostic (2.88e-1)" "unprognostic (1.13e-1)" "unprognostic (1.99e-1)" "unprognostic (4.49e-3)" "unprognostic (3.00e-2)" "unprognostic (9.39e-2)" "prognostic unfavorable (4.12e-5)" "unprognostic (4.65e-2)" "unprognostic (1.84e-1)" "unprognostic (4.00e-1)" "unprognostic (2.83e-1)" 18.5 6.6 3.9 7.1 4.5 1.5 11.8 2.0 4.7 11.1 3.9 2.3 4.3 3.5 10.1 5.3 3.9 6.6 7.5 7.3 6.5 3.7 9.0 6.6 11.7 7.9 5.4 2.1 4.6 4.7 3.1 8.0 2.4 6.1 8.8 3.2 3.3 3.8 5.1 4.6 6.0 4.5 10.4 4.9 9.5 4.4 4.6 4.0 0.1 12.4 2.4 3.7 8.1 29.9 1.5 1.3 17.0 4.8 0.0 0.0 1.0 5.3 0.0 0.3 0.0 1.5 0.0 0.0 2.5 5.7 2.9 1.8 0.2 0.1 0.1 0.0 3.9 6.8 0.8 0.5 0.3 1.2 0.0 0.6 0.1 0.2 0.0 0.9 1.4 15.7 1.1 1.3 6.3 2.4 8.4 20.4 0.3 0.0 0.1 6.3 0.1 0.7 0.4 0.6 0.8 20.7 0.9 0.4 13.2 2.9 0.2 1.2 2.8 0.1 0.7 0.0 0.6 0.3 4.2 19.1 0.8 5.8 0.3 0.9 0.0 0.0 1.0 21.8 1.4 0.1 17.0 4.8 0.6 0.0 4.5 0.0 0.8 0.0 0.0 1.3 1.5 0.0 0.0 2.2 0.0 3.2 0.0 0.0 1.0 3.9 4.5 2.0 4.7 6.5 3.7 5.4 2.1 6.1 4.0 6.0 7.4 0.5 1.1 5.3 0.7 6.7 0.0 0.0 0.0 1.8 0.0 0.0 1.7 8.3 0.6 51.3 0.0 23.3 1.5 0.1 3.7 1.3 39.2 0.4 11.0 0.0 1.2 111.1 17.8 0.4 7.2 14.4 8.5 4.6 0.0 0.5 1.5 0.0 2.8 0.0 0.7 6.5 4.1 1.4 17.0 4.1 0.0 0.0 0.4 0.6 TMEM260 "C14orf101, FLJ20392" ENSG00000070269 "Transmembrane protein 260" Q9NX78 14 56488354-56650606 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 61.0" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 69.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003502 Uncertain Approved "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA "Nucleoplasm, Cytosol" "Focal adhesion sites" "HPA003502: AB_1078314" "unprognostic (4.63e-2)" "unprognostic (2.41e-2)" "unprognostic (1.98e-1)" "unprognostic (1.73e-2)" "unprognostic (2.51e-1)" "unprognostic (3.58e-2)" "unprognostic (2.04e-1)" "prognostic favorable (7.11e-4)" "unprognostic (7.14e-2)" "unprognostic (1.89e-1)" "unprognostic (1.95e-3)" "unprognostic (3.22e-1)" "unprognostic (2.23e-3)" "unprognostic (5.81e-2)" "unprognostic (8.11e-2)" "unprognostic (1.32e-1)" "unprognostic (3.84e-2)" 7.8 7.4 7.3 11.0 10.6 3.8 9.1 13.3 9.9 61.0 8.8 13.7 11.6 8.1 11.8 12.1 6.7 11.4 10.3 6.0 8.9 8.6 10.7 8.7 8.4 8.8 10.8 7.5 14.8 13.6 12.4 17.2 8.7 9.7 8.7 9.1 8.7 7.4 13.0 5.2 8.6 10.7 8.9 12.2 9.2 8.4 10.1 8.3 17.6 12.6 4.6 8.8 10.1 9.7 2.0 4.6 2.9 2.8 6.3 3.5 2.0 7.4 5.2 4.0 8.6 14.4 11.9 7.9 7.9 8.8 5.2 6.3 2.4 5.5 6.0 7.8 5.9 5.9 8.6 9.3 5.8 8.3 7.5 4.7 3.9 2.4 3.3 10.1 5.4 9.4 14.5 10.4 2.9 10.1 9.6 6.8 4.7 4.8 6.5 6.8 4.9 2.8 2.0 3.7 12.2 8.3 4.0 6.4 2.0 8.8 11.0 8.5 4.2 8.9 6.5 5.2 7.9 8.2 8.4 9.5 10.6 4.1 7.9 3.9 3.9 3.1 3.5 6.7 4.0 5.2 0.0 2.8 2.9 3.5 1.9 2.4 1.8 2.4 1.8 2.2 2.0 3.2 2.3 1.4 6.3 1.7 4.6 2.9 2.0 7.3 10.6 13.3 9.9 8.9 8.6 10.8 7.5 9.7 8.3 17.9 12.1 4.2 7.4 4.7 14.2 2.9 0.0 17.4 5.7 21.0 3.9 7.9 1.7 6.8 69.7 4.7 6.3 0.0 3.3 6.5 6.7 8.2 11.5 7.5 5.5 6.4 17.2 8.6 13.9 25.8 14.1 7.8 1.7 5.4 10.8 5.6 5.0 7.0 10.3 3.7 17.1 0.0 4.2 7.9 8.5 4.8 9.3 5.7 10.8 6.8 TMEM267 "C5orf28, FLJ21657" ENSG00000151881 "Transmembrane protein 267" Q0VDI3 5 43444252-43483893 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 15.7;Cytotrophoblasts: 23.5;Distal tubular cells: 23.2;Ductal cells: 13.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059946, HPA072991" Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA059946: AB_2684175, HPA072991: " "unprognostic (8.20e-2)" "unprognostic (2.02e-2)" "unprognostic (7.60e-2)" "unprognostic (8.11e-3)" "unprognostic (1.57e-1)" "unprognostic (2.05e-1)" "prognostic unfavorable (1.59e-4)" "unprognostic (2.82e-2)" "unprognostic (4.77e-3)" "unprognostic (9.32e-2)" "unprognostic (1.76e-1)" "unprognostic (1.25e-1)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.47e-2)" "unprognostic (3.35e-1)" "unprognostic (1.07e-2)" "unprognostic (4.40e-3)" 9.9 8.1 9.0 7.8 9.4 3.9 14.2 13.8 12.5 11.7 7.7 5.7 6.8 7.1 11.1 11.7 9.4 8.9 7.5 8.3 6.3 8.5 12.1 7.1 8.1 9.0 9.9 11.2 10.9 17.3 9.9 23.0 6.3 11.6 9.6 9.7 8.9 12.3 9.9 7.1 9.8 8.6 9.2 9.4 9.5 9.1 7.9 7.9 6.1 36.8 7.6 8.8 10.4 9.0 11.6 9.7 9.0 11.6 13.7 18.0 11.0 10.1 9.3 5.0 11.2 9.5 19.1 5.7 14.6 9.0 7.9 5.8 4.0 21.8 11.3 20.1 14.8 8.3 8.6 4.8 6.6 11.5 13.5 7.8 6.5 20.1 4.5 17.4 13.3 9.5 15.6 18.9 11.8 16.8 8.0 8.8 13.6 8.5 21.0 17.3 8.7 7.3 7.9 2.2 10.2 9.2 5.0 12.4 13.7 9.8 10.3 7.0 5.0 29.1 16.7 14.2 4.8 24.2 9.7 11.4 12.9 10.5 7.9 7.2 9.0 12.8 11.1 9.7 19.3 11.3 9.0 8.6 3.1 12.3 10.0 18.0 11.6 16.4 13.0 9.7 9.6 16.9 14.0 1.6 13.7 11.6 7.5 13.0 11.0 9.0 9.4 13.8 12.5 6.3 8.5 9.9 11.2 11.6 7.9 6.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 12.0 3.4 15.7 0.0 23.5 23.2 13.2 0.0 0.0 0.0 0.0 12.1 8.1 0.0 0.0 2.3 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 5.4 0.0 0.0 10.7 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 TMEM35B ZMYM6NB ENSG00000243749 "Transmembrane protein 35B" Q8NCS4 1 34981535-34985353 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 16 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 8.3;Ciliated cells: 28.1;Club cells: 11.4;granulocytes: 8.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 43.0;CAPAN-2: 40.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051024 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA051024: AB_2681316" "unprognostic (3.34e-3)" "unprognostic (2.77e-3)" "unprognostic (4.25e-1)" "unprognostic (2.12e-2)" "unprognostic (5.52e-2)" "unprognostic (2.08e-2)" "unprognostic (2.06e-1)" "unprognostic (4.31e-2)" "unprognostic (1.06e-1)" "unprognostic (7.51e-3)" "unprognostic (2.32e-1)" "unprognostic (9.41e-2)" "unprognostic (2.03e-2)" "unprognostic (1.86e-1)" "unprognostic (5.49e-2)" "unprognostic (4.53e-3)" "unprognostic (1.07e-1)" 23.1 20.6 6.4 10.7 8.0 5.3 24.4 5.7 7.9 23.7 13.8 9.3 12.6 7.4 22.3 19.0 15.2 19.7 26.1 17.6 6.4 5.8 27.5 24.4 25.3 28.0 9.9 7.6 20.0 20.5 9.2 14.6 29.5 9.6 29.6 12.6 26.6 14.2 17.4 10.5 7.2 16.0 18.3 10.2 19.0 12.9 21.4 7.8 17.9 48.7 9.8 18.4 22.0 19.1 24.9 37.3 29.4 26.8 36.4 53.1 38.4 9.1 7.0 1.7 2.8 43.0 25.5 3.5 10.0 16.8 7.2 9.8 6.9 40.6 4.7 15.6 10.3 11.1 9.9 3.1 8.5 5.8 17.3 4.7 9.8 3.7 8.2 23.6 6.5 10.3 25.3 8.0 6.4 13.6 14.5 14.0 9.7 6.3 13.4 12.5 5.6 4.7 6.5 7.6 0.0 4.9 6.4 13.8 1.5 19.2 9.1 4.2 1.4 15.2 0.2 13.4 8.3 3.8 9.9 14.2 9.6 9.0 8.4 5.7 7.8 4.4 3.2 9.7 10.6 8.0 29.4 24.5 25.4 47.3 26.8 50.7 24.9 52.3 51.9 16.8 21.0 46.1 46.3 7.6 36.4 21.9 37.3 53.1 38.4 6.4 8.0 5.7 7.9 6.4 5.8 9.9 7.6 9.6 7.8 20.8 8.3 0.0 0.0 0.0 0.0 0.0 0.0 28.1 11.4 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 8.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TMEM37 "PR, PR1" ENSG00000171227 "Transmembrane protein 37" Q8WXS4 2 119429901-119438520 "Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 110.5;kidney: 82.5" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 276.4;Hepatocytes: 166.8;Muller glia cells: 140.1;Proximal tubular cells: 167.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "intermediate monocyte: 2.8;naive CD4 T-cell: 3.3" "Group enriched" "Detected in many" 31 "monocytes: 2.8;T-cells: 3.3" "Group enriched" "Detected in some" 5 "EFO-21: 13.4;Hep G2: 35.1;RPTEC TERT1: 29.4" "Low region specificity" "Detected in many" HPA053794 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA053794: AB_2682265" "unprognostic (2.54e-2)" "unprognostic (3.10e-2)" "unprognostic (1.01e-1)" "unprognostic (4.59e-3)" "unprognostic (2.56e-1)" "unprognostic (9.60e-2)" "unprognostic (5.20e-2)" "unprognostic (1.20e-1)" "unprognostic (2.18e-1)" "unprognostic (1.38e-1)" "unprognostic (1.32e-1)" "unprognostic (1.36e-1)" "unprognostic (2.83e-2)" "unprognostic (7.30e-3)" "unprognostic (1.93e-2)" "unprognostic (2.99e-1)" "unprognostic (2.61e-2)" 18.5 5.2 0.6 5.9 1.0 0.0 10.0 0.5 1.2 6.7 60.3 1.8 3.8 16.2 3.1 3.8 2.8 1.4 18.5 5.7 1.0 0.4 82.5 40.8 9.5 8.7 0.9 0.7 5.9 5.8 20.1 0.7 13.4 1.3 4.5 5.6 6.3 2.8 6.5 1.6 4.4 110.5 1.9 1.4 11.5 6.6 6.4 0.7 1.2 21.0 1.6 2.2 3.4 2.4 0.0 0.0 0.0 2.8 0.0 3.3 0.6 0.0 3.5 0.3 0.1 2.2 0.2 0.5 0.1 0.0 0.0 0.0 5.4 3.1 0.0 13.4 1.6 0.3 0.8 1.4 0.0 0.0 0.0 1.4 0.4 2.0 35.1 3.0 0.0 0.0 4.9 0.0 0.0 0.0 0.1 2.8 0.0 0.1 5.3 0.0 0.3 0.0 0.3 2.6 0.0 0.1 0.0 0.0 4.6 29.4 2.3 0.4 0.2 0.1 1.4 0.0 2.6 0.6 0.8 1.8 0.0 5.3 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.6 1.0 0.5 1.2 1.0 0.4 0.9 0.7 1.3 0.7 23.8 8.1 15.4 0.2 1.8 2.6 1.2 86.6 1.4 3.4 17.4 0.0 40.2 43.1 18.4 0.1 2.9 276.4 0.0 47.2 3.4 14.1 0.1 1.1 166.8 54.9 6.4 8.7 82.3 51.8 0.9 46.1 4.3 1.7 1.0 14.5 140.1 16.0 45.6 3.5 167.4 17.7 0.0 1.9 0.0 1.0 2.5 87.1 1.8 12.4 1.6 TMEM38A "MGC3169, TRIC-A" ENSG00000072954 "Transmembrane protein 38A" Q9H6F2 19 16661127-16690029 "Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 158.8" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 21.6;Cardiomyocytes: 22.4;Cone photoreceptor cells: 80.5;Peritubular cells: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 20.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 20.3" "Cell line enhanced" "Detected in many" "Daudi: 12.1;U-266/70: 12.2;U-698: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048100, HPA050463" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA048100: , HPA050463: AB_2681137" "unprognostic (1.56e-1)" "unprognostic (1.04e-2)" "unprognostic (3.39e-1)" "unprognostic (1.28e-3)" "unprognostic (3.87e-1)" "unprognostic (2.99e-1)" "unprognostic (3.49e-1)" "prognostic favorable (2.78e-5)" "unprognostic (2.94e-2)" "prognostic unfavorable (7.96e-4)" "unprognostic (1.06e-1)" "unprognostic (2.68e-1)" "prognostic favorable (2.99e-10)" "unprognostic (1.93e-1)" "unprognostic (1.80e-1)" "unprognostic (4.50e-3)" "unprognostic (1.96e-2)" 1.3 1.6 3.6 1.1 7.9 2.3 1.2 5.1 12.2 1.3 1.4 2.1 3.1 1.3 1.1 6.6 3.5 1.8 1.0 5.4 3.0 3.8 2.0 2.7 2.1 1.3 5.2 3.7 1.2 1.3 1.7 2.2 0.9 4.8 2.9 1.5 8.3 2.7 2.4 158.8 1.0 1.1 1.1 1.9 1.0 5.3 1.6 1.4 0.0 1.8 30.1 1.9 1.1 0.4 3.9 0.5 20.3 2.9 2.1 0.5 0.6 3.0 0.6 0.8 4.7 2.6 0.3 0.4 1.1 0.6 0.7 1.5 0.9 4.4 12.1 1.9 0.2 4.2 2.5 6.2 1.3 0.7 0.8 1.8 0.0 1.8 1.0 0.7 0.1 0.2 1.1 4.8 0.9 0.5 3.6 0.3 2.2 0.1 1.1 0.5 4.6 0.1 1.2 1.2 11.3 7.2 6.3 1.1 3.2 4.6 2.3 7.8 5.4 3.3 0.4 1.5 0.4 2.3 1.0 0.0 0.9 2.3 2.9 0.5 12.2 8.8 20.3 1.1 7.2 0.9 20.3 2.9 8.2 0.0 1.1 0.0 2.8 0.4 0.0 0.2 3.9 0.1 0.1 1.6 2.1 0.7 0.5 0.5 0.6 3.6 7.9 5.1 12.2 3.0 3.8 5.2 3.7 4.8 1.4 3.0 1.0 0.8 2.8 1.0 21.6 22.4 0.0 1.4 1.2 0.0 80.5 0.0 1.7 3.1 0.0 3.3 0.7 0.0 2.2 0.1 2.1 3.6 0.0 6.7 0.4 12.7 4.1 8.0 5.6 0.5 9.8 0.0 3.3 0.0 5.8 12.1 7.1 0.0 21.2 1.0 10.2 0.0 2.8 0.5 0.4 0.3 0.1 0.0 2.4 0.9 TMEM39A FLJ10902 ENSG00000176142 "Transmembrane protein 39A" Q9NV64 3 119429500-119468830 "Predicted membrane proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039140 Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA039140: AB_10673303" "unprognostic (2.16e-1)" "unprognostic (8.75e-2)" "unprognostic (4.25e-2)" "unprognostic (6.86e-2)" "unprognostic (1.56e-2)" "unprognostic (2.81e-1)" "prognostic unfavorable (3.26e-4)" "unprognostic (9.68e-2)" "unprognostic (6.35e-2)" "unprognostic (2.12e-1)" "unprognostic (1.32e-2)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.00e-5)" "unprognostic (4.07e-1)" "unprognostic (2.52e-2)" "unprognostic (1.88e-1)" "unprognostic (6.41e-2)" 13.7 12.7 5.6 13.0 8.8 9.3 13.2 10.5 6.4 18.3 8.7 10.4 27.0 9.6 20.8 18.3 10.9 13.5 13.4 14.4 5.1 3.8 9.7 16.7 15.2 11.0 8.9 2.4 17.6 37.5 8.3 47.9 19.5 7.6 13.9 9.5 12.1 30.2 30.0 8.7 10.7 10.6 9.6 8.4 11.8 11.5 15.4 8.0 11.3 17.4 9.5 19.2 11.9 13.0 8.6 18.1 11.5 11.2 11.9 13.8 9.2 15.9 8.0 14.3 10.1 28.5 26.7 15.1 15.8 27.1 17.1 23.8 14.0 12.2 6.7 15.0 14.5 21.2 16.6 14.7 6.2 18.9 6.6 5.7 8.2 6.1 14.2 19.2 15.2 12.3 16.1 10.4 12.4 30.3 19.5 11.3 10.4 8.0 19.3 9.5 7.3 8.0 5.5 13.7 15.9 16.0 8.7 7.4 14.3 5.0 6.2 6.2 8.7 14.9 8.6 21.3 10.5 8.1 14.3 9.7 10.6 10.1 7.4 9.9 22.2 6.2 15.9 15.9 11.0 15.1 11.5 11.2 8.0 13.5 6.2 13.8 8.5 8.4 11.3 13.2 8.6 7.0 7.1 4.7 11.9 4.8 18.1 9.8 9.2 5.6 8.8 10.5 6.4 5.1 3.8 8.9 2.4 7.6 8.0 8.9 12.0 7.5 13.8 20.3 4.5 9.8 2.5 12.0 7.9 7.0 5.9 22.9 5.0 10.2 19.6 8.0 5.6 0.0 12.5 45.9 30.1 16.5 1.1 9.8 12.1 1.6 10.4 7.4 21.0 4.2 15.8 13.2 10.1 45.9 14.6 4.8 9.1 3.5 12.4 3.4 6.3 6.5 13.9 23.2 14.7 19.1 50.0 15.8 10.8 17.5 TMEM41A MGC15397 ENSG00000163900 "Transmembrane protein 41A" Q96HV5 3 185476496-185499057 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 54.4" "Cell type enhanced" "Detected in many" 4 "monocytes: 100.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059101, HPA059790" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA059101: AB_2683905, HPA059790: AB_2684125" "unprognostic (2.17e-2)" "unprognostic (7.94e-2)" "unprognostic (1.99e-2)" "prognostic unfavorable (6.70e-6)" "unprognostic (2.67e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.04e-4)" "unprognostic (2.84e-1)" "unprognostic (1.39e-1)" "unprognostic (1.79e-1)" "prognostic unfavorable (4.72e-4)" "unprognostic (3.63e-2)" "unprognostic (2.56e-2)" "unprognostic (3.73e-1)" "unprognostic (3.68e-1)" "unprognostic (1.46e-2)" "unprognostic (1.02e-2)" 8.1 23.9 7.8 4.8 10.2 9.3 10.1 4.9 11.5 10.6 26.8 11.7 6.3 24.5 9.1 11.1 20.6 9.0 8.6 8.3 7.5 8.4 15.8 26.1 11.3 9.0 8.1 5.4 14.2 10.7 6.7 5.7 9.0 8.6 10.1 8.6 11.9 11.2 9.4 8.3 16.6 54.4 8.0 8.7 12.4 8.7 11.2 7.4 11.3 9.0 18.1 16.7 8.8 12.5 12.8 16.4 7.8 8.4 8.5 16.7 6.5 20.9 7.6 5.1 6.2 8.1 8.7 15.0 8.1 7.1 10.2 7.5 19.8 8.3 6.5 15.5 7.5 14.5 14.6 14.0 8.6 10.4 10.9 12.9 11.3 4.6 19.9 9.0 12.1 6.4 8.1 12.9 9.2 10.6 6.5 7.8 8.3 20.0 16.3 6.5 8.1 7.4 7.0 8.4 16.6 12.1 7.5 7.8 11.9 8.8 15.4 5.1 6.6 7.0 18.0 12.3 7.6 21.5 9.5 5.6 6.1 7.6 12.6 16.8 24.0 36.6 13.1 9.3 7.3 7.3 7.8 6.3 5.1 13.2 6.6 16.7 12.8 13.6 14.3 7.0 12.4 15.0 16.1 2.4 8.5 8.4 16.4 11.1 6.5 7.8 10.2 4.9 11.5 7.5 8.4 8.1 5.4 8.6 7.4 8.9 26.2 17.6 29.0 47.2 17.7 11.3 22.9 4.0 14.8 19.2 17.7 23.4 6.6 28.6 0.4 17.9 38.7 0.0 48.5 20.2 16.7 43.7 8.1 34.2 16.5 15.9 17.9 14.1 11.1 1.8 13.3 14.3 8.5 100.0 26.4 14.6 45.8 15.9 12.7 22.4 29.5 19.4 17.2 23.7 14.2 74.0 38.4 15.2 30.8 81.8 TMEM42 MGC29956 ENSG00000169964 "Transmembrane protein 42" Q69YG0 3 44861869-44865670 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 73.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052569 Uncertain Uncertain Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA052569: AB_2681871" "prognostic favorable (5.23e-4)" "unprognostic (1.06e-1)" "unprognostic (1.91e-1)" "unprognostic (3.73e-2)" "unprognostic (2.32e-1)" "unprognostic (7.93e-2)" "unprognostic (6.99e-3)" "unprognostic (1.64e-2)" "unprognostic (9.16e-2)" "unprognostic (9.23e-3)" "unprognostic (1.11e-1)" "unprognostic (1.87e-1)" "prognostic favorable (1.10e-5)" "unprognostic (1.31e-2)" "unprognostic (3.30e-1)" "unprognostic (1.38e-1)" "unprognostic (1.19e-1)" 11.1 14.6 18.6 5.7 26.1 4.6 13.4 7.8 17.3 12.7 8.5 17.7 8.5 6.1 10.4 25.9 7.2 16.8 8.9 10.2 18.4 19.7 12.9 19.1 9.7 9.3 19.1 14.1 17.1 17.5 12.7 16.5 8.9 16.4 12.7 8.5 8.5 10.9 12.7 16.6 8.6 6.2 9.2 19.8 8.7 9.9 20.0 15.5 11.6 17.1 6.5 9.1 7.5 8.7 13.9 11.8 4.2 10.2 9.1 15.9 9.2 4.1 4.2 1.2 2.4 16.1 12.7 0.1 3.4 4.8 4.2 4.2 0.9 8.2 2.8 6.7 6.6 1.9 2.8 0.3 5.2 4.2 4.4 0.0 1.7 5.4 4.4 17.1 2.0 0.1 13.1 13.4 4.3 9.7 9.0 7.1 7.2 0.1 5.8 6.3 3.2 1.7 3.4 2.3 5.0 1.9 1.5 0.7 0.6 9.1 1.6 1.3 1.7 4.1 1.4 1.6 4.2 3.0 3.5 4.6 3.7 0.4 5.4 3.7 2.0 1.5 0.8 7.4 2.4 1.6 3.7 8.6 4.2 7.8 7.7 8.2 13.9 11.6 7.2 10.6 11.9 15.9 12.6 1.6 9.1 10.2 11.8 9.2 9.2 18.6 26.1 7.8 17.3 18.4 19.7 19.1 14.1 16.4 15.5 20.8 4.8 10.7 14.4 5.5 8.0 10.1 15.3 16.0 4.5 31.4 2.0 17.6 11.6 15.3 56.7 9.3 5.2 0.0 8.9 11.3 14.2 14.8 3.5 15.3 19.8 17.5 11.5 11.6 13.3 73.6 25.3 10.3 6.8 9.0 9.1 20.9 11.7 8.4 18.4 17.0 15.9 6.5 6.9 36.1 19.3 7.9 8.1 13.1 11.8 6.2 TMEM45B "BC016153, FLJ40787" ENSG00000151715 "Transmembrane protein 45B" Q96B21 11 129815819-129860003 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 106.6" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 253.0;Paneth cells: 150.7;Undifferentiated cells: 102.5;Urothelial cells: 96.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 7 "memory CD4 T-cell: 3.6;naive CD4 T-cell: 4.3;neutrophil: 13.1" "Group enriched" "Detected in many" 12 "granulocytes: 13.1;T-cells: 4.3" "Group enriched" "Detected in some" 5 "OE19: 82.8;RT4: 33.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015474, HPA015878" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA015474: , HPA015878: AB_2205046" "unprognostic (4.92e-3)" "unprognostic (7.94e-2)" "unprognostic (5.98e-2)" "unprognostic (1.81e-1)" "unprognostic (5.44e-3)" "unprognostic (7.11e-2)" "unprognostic (1.17e-1)" "unprognostic (6.53e-2)" "unprognostic (1.76e-1)" "unprognostic (1.02e-3)" "unprognostic (1.33e-1)" "unprognostic (1.27e-1)" "unprognostic (1.04e-1)" "unprognostic (1.42e-2)" "unprognostic (2.24e-1)" "unprognostic (1.68e-2)" "unprognostic (1.52e-1)" 0.2 0.2 0.6 9.0 0.9 0.0 4.0 0.3 0.7 6.6 50.3 0.5 1.7 40.4 1.2 4.1 29.5 6.5 9.3 0.4 1.2 0.6 9.6 13.2 4.5 1.9 0.4 0.7 1.4 3.1 0.0 2.9 1.2 2.3 4.0 29.0 0.3 7.3 2.4 0.2 10.9 106.6 1.5 0.5 0.6 7.4 0.7 0.2 0.5 9.1 21.9 19.9 9.4 10.9 0.6 0.4 13.1 0.6 0.7 4.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 9.7 4.2 0.0 1.8 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.1 0.0 0.5 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.3 0.0 82.8 12.6 0.0 0.0 0.6 5.4 33.4 1.0 0.1 0.0 2.7 0.0 0.0 9.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.0 0.6 0.1 0.3 0.2 0.3 0.2 3.6 0.9 0.0 0.6 4.3 0.7 13.1 0.7 0.2 0.4 0.6 1.3 0.6 0.9 0.3 0.7 1.2 0.6 0.4 0.7 2.3 0.2 17.9 8.4 0.5 10.0 3.0 0.0 0.6 22.9 68.3 21.6 43.6 0.0 4.0 11.6 20.5 0.2 0.3 253.0 0.0 7.3 0.6 0.9 18.6 2.3 2.6 0.5 0.0 53.3 0.0 1.6 0.0 0.3 1.9 3.3 0.0 64.7 0.0 32.6 150.7 0.0 1.2 0.3 0.0 1.0 0.0 0.0 18.2 0.3 0.7 102.5 96.6 TMEM51 "C1orf72, FLJ10199" ENSG00000171729 "Transmembrane protein 51" Q9NW97 1 15152532-15220480 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Urothelial cells: 98.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 22 "classical monocyte: 1.8;intermediate monocyte: 2.3;myeloid DC: 1.7;non-classical monocyte: 2.8" "Group enriched" "Detected in many" 23 "dendritic cells: 1.7;monocytes: 2.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014547, HPA019441" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA014547: AB_1858121, HPA019441: AB_2670142" "unprognostic (1.21e-1)" "unprognostic (1.84e-1)" "unprognostic (8.74e-2)" "unprognostic (1.89e-2)" "unprognostic (3.61e-2)" "unprognostic (8.01e-2)" "unprognostic (1.47e-2)" "unprognostic (7.81e-3)" "unprognostic (7.84e-2)" "unprognostic (1.39e-1)" "unprognostic (3.00e-2)" "unprognostic (8.91e-2)" "prognostic favorable (8.16e-8)" "unprognostic (1.11e-1)" "unprognostic (1.22e-1)" "unprognostic (5.58e-2)" "unprognostic (1.67e-3)" 4.6 14.1 4.7 7.7 4.4 0.4 7.0 14.2 5.1 9.7 22.4 4.5 14.3 15.9 5.3 7.6 12.0 7.2 25.3 3.7 5.0 2.2 23.5 3.9 10.4 7.4 4.1 3.4 15.4 36.7 14.5 5.2 7.5 4.2 12.3 7.8 16.1 7.5 15.5 1.2 5.3 22.9 8.9 5.7 7.1 18.9 3.4 3.9 2.0 3.8 12.3 8.4 18.5 22.2 0.0 1.7 0.0 2.8 0.0 0.0 0.3 19.1 10.3 5.9 1.4 1.0 2.2 0.0 2.2 9.3 6.8 9.3 13.5 21.6 0.0 7.3 1.4 9.8 18.6 2.0 7.2 3.9 0.0 5.1 0.4 0.5 13.3 8.6 0.0 18.8 0.7 6.4 8.9 9.8 4.4 6.3 0.8 2.9 0.0 3.5 6.6 0.0 0.0 1.0 15.3 3.9 2.7 3.7 3.3 17.3 19.9 0.9 17.5 1.8 7.6 18.4 3.7 1.0 2.0 4.4 7.1 6.3 3.1 6.9 0.2 0.3 0.0 7.0 0.3 8.3 0.0 1.8 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.3 4.7 4.4 14.2 5.1 5.0 2.2 4.1 3.4 4.2 3.9 0.0 1.6 2.7 51.9 16.3 0.0 1.8 20.4 6.7 4.5 47.1 0.0 4.2 5.0 64.9 0.4 8.7 12.9 0.0 64.3 0.7 5.6 48.2 0.0 0.4 43.7 0.0 18.4 8.6 24.2 0.0 2.6 18.8 13.5 19.8 16.3 0.0 65.3 25.9 13.1 11.8 0.0 32.3 39.4 0.5 1.9 18.4 1.1 0.0 13.2 98.9 TMEM62 FLJ23375 ENSG00000137842 "Transmembrane protein 62" Q0P6H9 15 43123279-43185146 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 28.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 29.2;U-266/84: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044461, HPA062359" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Cytoplasmic bodies" NA NA "Nucleoplasm, Nucleoli fibrillar center, Nuclear bodies, Cytoplasmic bodies" "HPA044461: AB_2678950, HPA062359: AB_2684747" "unprognostic (7.43e-2)" "unprognostic (4.96e-2)" "unprognostic (4.56e-2)" "prognostic favorable (9.72e-7)" "unprognostic (2.53e-1)" "unprognostic (1.98e-1)" "unprognostic (2.39e-2)" "unprognostic (1.41e-2)" "unprognostic (4.83e-2)" "unprognostic (3.30e-1)" "unprognostic (3.90e-2)" "unprognostic (1.77e-1)" "unprognostic (8.61e-2)" "unprognostic (1.20e-1)" "unprognostic (6.48e-2)" "unprognostic (1.20e-1)" "unprognostic (6.67e-2)" 11.6 8.6 7.6 9.5 12.0 9.6 28.6 21.1 13.9 10.4 15.5 15.1 9.8 15.5 9.9 15.4 10.7 9.4 14.0 7.3 7.8 9.8 9.5 12.3 13.0 10.5 10.2 8.2 6.1 12.0 16.5 10.8 12.3 12.7 8.6 17.6 11.9 16.9 9.2 14.5 8.5 17.3 11.0 11.9 9.6 12.0 3.1 7.8 4.6 10.5 8.9 13.7 13.2 9.0 2.5 4.6 2.6 1.8 3.8 5.0 0.9 7.0 3.8 1.7 3.3 2.1 2.8 18.2 6.8 8.6 12.1 16.9 6.0 14.0 7.1 3.9 6.4 10.9 13.6 7.3 5.3 4.4 8.4 3.2 5.8 8.4 4.5 4.7 6.0 5.3 2.0 6.4 5.2 3.7 3.4 6.6 1.8 5.1 6.2 1.3 1.6 0.0 1.4 0.6 29.2 1.6 3.5 1.8 3.8 6.4 9.0 11.1 4.7 5.3 13.4 3.2 2.0 7.2 6.1 3.8 6.0 2.5 4.2 10.9 5.2 31.3 5.0 5.5 6.7 5.2 1.5 1.8 2.6 2.4 0.8 2.9 1.9 3.2 2.7 2.0 2.5 1.9 2.6 0.5 3.8 1.0 4.6 5.0 0.9 7.6 12.0 21.1 13.9 7.8 9.8 10.2 8.2 12.7 7.8 14.9 2.9 8.3 3.5 2.1 5.3 2.4 10.2 5.3 4.5 12.2 9.8 18.1 5.0 11.3 1.1 4.7 10.7 0.0 12.9 21.2 3.1 2.2 4.7 5.8 6.7 1.6 4.1 3.7 6.5 2.4 2.3 5.7 5.0 7.2 9.7 7.5 11.1 9.0 1.1 2.9 9.5 6.5 4.7 1.8 0.8 2.5 28.5 3.1 9.1 3.7 TMEM69 "C1orf154, FLJ21029" ENSG00000159596 "Transmembrane protein 69" Q5SWH9 1 45687214-45694443 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026993 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA026993: AB_10601824" "prognostic favorable (2.24e-4)" "unprognostic (2.47e-1)" "unprognostic (5.25e-2)" "unprognostic (1.85e-2)" "unprognostic (2.40e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (3.66e-8)" "unprognostic (4.05e-2)" "unprognostic (1.59e-3)" "unprognostic (5.17e-2)" "unprognostic (3.98e-3)" "unprognostic (1.98e-1)" "unprognostic (1.14e-3)" "unprognostic (1.49e-2)" "unprognostic (1.96e-1)" "unprognostic (4.41e-3)" "unprognostic (3.65e-2)" 6.0 9.0 7.0 5.8 11.0 2.6 12.2 6.8 13.8 5.3 7.5 7.3 2.9 8.3 5.6 9.9 12.1 6.0 5.6 11.6 6.3 6.2 8.4 7.6 8.3 8.8 6.9 5.0 8.9 7.8 10.7 5.5 6.8 10.8 7.0 8.4 4.7 7.9 5.7 8.2 7.7 8.2 6.2 9.1 7.8 5.7 12.1 9.4 10.1 7.5 8.8 9.3 8.4 11.1 8.7 10.9 5.4 15.6 4.6 8.2 6.1 13.1 3.2 9.1 7.4 7.0 9.0 22.4 8.6 10.2 14.6 14.2 9.0 6.9 16.0 6.0 8.2 10.8 17.8 7.3 19.6 15.0 11.1 8.5 32.6 8.0 9.7 12.4 15.6 16.1 10.5 20.4 13.4 8.5 9.4 11.9 15.4 19.5 11.1 9.1 4.8 8.6 11.2 21.7 8.0 8.8 13.5 8.3 16.2 15.4 14.0 10.6 9.5 9.1 24.6 14.7 16.6 12.8 16.0 8.9 6.7 11.5 14.8 10.3 8.9 11.0 12.2 9.4 11.7 9.8 5.0 12.2 5.0 5.1 12.7 6.4 8.7 7.2 5.7 10.9 8.3 8.2 6.3 5.4 4.6 15.6 6.8 6.8 6.1 7.0 11.0 6.8 13.8 6.3 6.2 6.9 5.0 10.8 9.4 0.0 12.2 15.7 21.6 17.9 11.2 7.9 7.6 13.4 17.0 17.4 0.0 53.1 36.5 19.2 1.5 11.6 17.1 0.0 15.4 28.9 13.5 20.5 5.8 12.5 33.1 6.4 23.1 14.1 39.0 3.0 17.3 26.0 16.9 12.6 21.0 12.4 13.5 10.5 12.0 27.2 10.5 12.9 8.6 18.4 14.9 22.7 49.9 14.9 23.6 18.4 TMEM70 FLJ20533 ENSG00000175606 "Transmembrane protein 70" Q9BUB7 8 73972437-73982783 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 43.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023187, CAB034226" Uncertain Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB034226: AB_2205189, HPA023187: AB_2671101" "unprognostic (2.26e-3)" "unprognostic (4.87e-1)" "unprognostic (1.38e-2)" "unprognostic (1.11e-2)" "unprognostic (1.51e-3)" "unprognostic (8.22e-3)" "unprognostic (9.17e-2)" "unprognostic (1.01e-1)" "unprognostic (7.37e-2)" "unprognostic (7.04e-2)" "unprognostic (2.88e-2)" "unprognostic (9.14e-2)" "unprognostic (3.65e-3)" "unprognostic (6.86e-2)" "unprognostic (5.08e-2)" "unprognostic (2.13e-1)" "unprognostic (2.70e-2)" 9.5 12.3 7.6 7.4 8.0 7.0 9.4 7.1 12.8 6.0 7.4 3.6 3.9 4.8 6.1 9.0 6.2 9.1 7.4 13.3 9.3 7.9 9.7 38.8 6.2 9.6 6.8 7.3 7.3 17.0 5.1 6.3 8.1 10.0 6.3 8.0 3.8 7.1 5.3 81.1 4.8 6.9 7.7 6.3 9.9 10.6 10.9 5.1 8.5 6.5 13.4 7.9 6.7 5.9 18.4 12.3 7.5 11.0 6.2 12.7 12.7 11.2 9.0 7.2 7.5 8.5 7.3 7.4 9.6 8.7 10.7 8.7 8.4 6.5 15.2 8.3 6.4 9.1 10.2 13.8 9.2 12.1 9.8 9.4 15.2 5.9 11.2 8.5 8.2 8.1 6.8 8.6 6.8 3.6 4.1 9.0 7.7 11.4 7.5 11.4 8.3 18.8 15.6 6.7 14.4 11.2 13.3 7.1 12.9 11.3 10.6 16.4 7.3 5.9 43.0 12.1 6.0 8.9 7.6 5.7 6.3 7.6 11.4 9.0 11.2 9.6 14.9 9.1 6.4 6.9 6.3 10.8 7.0 9.5 11.0 10.9 18.4 10.9 10.8 10.5 10.8 12.7 11.8 7.5 6.2 8.1 12.3 8.6 12.7 7.6 8.0 7.1 12.8 9.3 7.9 6.8 7.3 10.0 5.1 14.9 36.2 37.2 32.5 59.8 24.1 39.1 15.3 42.8 23.9 21.0 7.9 61.6 56.3 28.4 11.2 35.3 22.8 0.0 55.5 44.6 47.0 32.0 38.2 44.2 119.9 9.5 13.3 28.3 89.0 5.6 27.6 68.1 38.8 36.1 27.6 19.7 38.3 37.1 27.3 55.5 15.9 38.8 44.8 32.9 28.3 52.1 58.8 34.8 29.0 23.3 TMEM74B "C20orf46, FLJ11190" ENSG00000125895 "Transmembrane protein 74B" Q9NUR3 20 1180561-1185415 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.9;intestine: 16.0" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 10.3;Horizontal cells: 17.5;Intestinal endocrine cells: 15.0;Sertoli cells: 19.4" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 7.9;Hep G2: 9.9;K-562: 16.8;Karpas-707: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045213 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA045213: AB_10961999" "unprognostic (1.51e-1)" "unprognostic (4.38e-2)" "unprognostic (2.37e-1)" "unprognostic (2.05e-3)" "unprognostic (5.73e-2)" "unprognostic (1.03e-2)" "unprognostic (6.91e-3)" "unprognostic (1.97e-1)" "unprognostic (1.77e-4)" "unprognostic (9.58e-2)" "prognostic favorable (3.07e-5)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.55e-7)" "unprognostic (1.20e-1)" "unprognostic (9.77e-2)" "unprognostic (8.37e-2)" "unprognostic (5.07e-3)" 2.3 0.3 4.3 0.3 13.9 0.0 1.1 2.3 7.3 0.1 0.7 12.5 0.6 0.3 0.7 3.9 2.5 3.9 2.3 6.9 0.6 1.0 9.4 0.9 2.3 0.0 0.6 0.2 3.5 12.2 0.5 0.9 3.3 11.3 2.9 4.6 16.0 1.1 1.1 0.6 2.7 0.9 1.6 0.4 0.7 0.0 1.6 0.1 0.0 0.1 0.0 0.5 0.3 0.0 5.0 2.8 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 7.9 0.7 0.1 1.0 0.0 2.9 0.3 3.7 0.5 0.1 0.0 4.7 1.1 0.0 9.9 0.0 0.0 1.4 0.0 1.1 0.0 0.2 0.2 0.1 0.7 16.8 7.6 0.0 0.1 0.1 0.1 3.4 1.2 0.4 0.0 0.2 0.0 0.8 0.7 0.7 2.1 0.1 0.0 0.1 1.2 0.0 0.1 2.0 0.0 3.3 0.1 0.2 3.3 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 1.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.0 0.0 0.0 0.4 0.2 10.3 1.6 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.5 0.8 3.6 2.0 0.0 0.2 1.0 0.2 0.7 0.0 0.6 0.0 17.5 15.0 3.1 0.8 0.4 0.0 0.0 1.7 1.8 2.7 0.2 1.4 1.7 0.0 0.3 2.7 19.4 5.7 0.2 0.2 0.6 1.1 0.0 0.8 0.4 TMEM82 ENSG00000162460 "Transmembrane protein 82" A0PJX8 1 15742422-15747982 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 35.6;liver: 30.1" "Group enriched" "Detected in some" 9 "Enterocytes: 86.8;Hepatocytes: 38.2;Paneth cells: 57.5;Proximal tubular cells: 47.1" "Cancer enhanced" "Detected in some" "liver cancer: 10.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "CACO-2: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA060282 Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA060282: AB_2684241" "unprognostic (2.46e-2)" "unprognostic (7.96e-2)" "unprognostic (4.88e-2)" "unprognostic (1.40e-2)" "unprognostic (6.45e-2)" "unprognostic (6.90e-2)" "unprognostic (4.80e-2)" "prognostic favorable (3.80e-7)" "unprognostic (1.41e-1)" "unprognostic (5.80e-2)" "unprognostic (4.75e-2)" "unprognostic (1.09e-1)" 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 18.9 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 7.5 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 35.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 1.1 6.6 0.0 0.0 0.0 86.8 0.0 0.2 1.9 0.0 0.0 0.0 38.2 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.5 57.5 0.0 47.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 6.3 0.0 TMEM86A FLJ90119 ENSG00000151117 "Transmembrane protein 86A" Q8N2M4 11 18693122-18704785 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Hofbauer cells: 34.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 6.5" "Group enriched" "Detected in many" 12 "dendritic cells: 6.5;monocytes: 3.7;T-cells: 1.7" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057119 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA057119: AB_2683342" "unprognostic (1.25e-1)" "unprognostic (1.09e-3)" "unprognostic (8.08e-3)" "unprognostic (1.89e-1)" "unprognostic (2.53e-1)" "unprognostic (1.10e-1)" "unprognostic (4.05e-2)" "unprognostic (2.94e-1)" "unprognostic (3.73e-1)" "unprognostic (1.74e-1)" "unprognostic (8.14e-2)" "unprognostic (2.67e-1)" "unprognostic (2.36e-1)" "unprognostic (1.50e-2)" "unprognostic (7.92e-2)" "unprognostic (4.20e-1)" "unprognostic (3.24e-1)" 6.9 4.9 4.7 3.6 5.7 0.7 5.6 3.4 9.7 3.8 3.3 7.0 1.2 2.5 4.0 3.8 3.9 4.4 6.6 8.1 6.9 3.7 15.3 6.7 5.7 11.1 6.7 3.2 12.3 8.2 7.0 3.9 7.1 5.0 2.9 3.2 16.7 4.6 2.7 4.7 24.4 3.2 3.4 7.2 9.2 3.3 4.1 3.7 5.3 3.7 3.9 4.2 5.2 5.4 0.2 6.5 0.3 3.7 0.2 1.7 1.4 0.0 0.2 0.7 3.4 3.1 0.0 0.1 0.7 0.6 0.6 0.5 0.0 0.4 0.0 1.3 0.6 3.4 0.3 0.2 0.1 0.4 0.2 2.0 0.2 0.1 0.0 2.4 0.0 3.0 4.3 1.3 0.1 0.3 0.8 1.8 1.9 0.6 0.0 1.4 1.8 0.0 0.0 0.2 0.5 1.8 0.0 5.6 0.0 19.2 4.1 1.1 1.4 1.0 3.5 1.5 1.3 4.2 0.4 2.1 0.6 0.3 0.2 0.1 3.5 2.7 0.0 1.2 0.0 1.2 0.0 3.7 0.3 0.4 2.8 1.0 0.0 0.4 0.9 6.5 0.2 1.0 1.7 0.0 0.2 0.9 3.8 1.0 1.4 4.7 5.7 3.4 9.7 6.9 3.7 6.7 3.2 5.0 3.7 0.0 0.0 0.0 0.6 0.1 3.9 2.0 0.0 0.0 0.0 10.4 7.9 0.4 6.6 5.3 6.8 0.6 0.0 0.0 6.9 0.3 0.8 0.9 0.0 1.0 34.1 0.0 3.4 4.3 6.4 6.3 2.0 5.7 0.0 1.8 0.6 2.9 7.5 0.0 1.8 5.6 4.5 6.5 0.1 6.5 0.7 0.3 1.9 0.0 0.0 0.3 TMEM8A "M83, PGAP6, TMEM6, TMEM8" ENSG00000129925 "Transmembrane protein 8A" Q9HCN3 16 370773-387113 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Enterocytes: 67.7;Syncytiotrophoblasts: 83.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 24.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA051281, HPA064673" Approved Supported "Nucleoplasm,Cytokinetic bridge" Yes No Nucleoplasm "Cytokinetic bridge" "HPA051281: AB_2681418, HPA064673: AB_2685317" "unprognostic (5.84e-2)" "unprognostic (6.13e-2)" "unprognostic (3.85e-2)" "unprognostic (3.21e-2)" "unprognostic (5.77e-2)" "unprognostic (3.19e-2)" "unprognostic (1.13e-3)" "unprognostic (1.56e-2)" "unprognostic (8.89e-2)" "unprognostic (7.73e-2)" "unprognostic (3.43e-1)" "unprognostic (1.38e-2)" "prognostic favorable (1.29e-5)" "unprognostic (4.20e-3)" "unprognostic (3.19e-2)" "unprognostic (4.93e-2)" "unprognostic (2.48e-1)" 8.4 9.3 6.9 9.5 7.8 15.2 13.5 7.7 7.9 6.8 16.6 7.3 24.1 17.7 7.3 29.6 11.8 6.5 15.2 10.0 5.6 4.3 28.7 33.5 13.0 10.7 7.1 3.2 8.3 44.2 11.5 10.7 45.5 6.7 11.4 6.0 8.8 22.5 8.8 12.8 3.7 25.0 5.0 4.7 13.2 17.5 26.3 6.0 12.6 12.3 5.2 14.6 9.3 8.8 2.0 2.9 24.3 5.5 0.9 7.6 3.3 4.4 11.8 6.8 12.5 9.3 8.4 13.6 12.9 13.5 6.6 9.5 46.4 21.1 4.8 17.5 12.4 10.1 6.4 3.0 14.2 1.8 13.6 11.3 7.9 8.0 26.4 21.6 5.9 15.0 9.7 4.3 10.1 2.9 6.7 15.2 5.4 12.6 7.4 8.2 27.8 8.3 11.7 10.8 7.2 4.7 18.1 7.8 10.9 10.7 11.5 8.1 9.3 7.2 7.3 37.9 3.7 13.1 11.9 22.1 18.8 20.3 13.0 6.8 14.9 7.4 9.5 9.5 6.3 11.9 4.6 5.0 6.3 7.4 5.5 5.9 1.8 5.8 5.8 2.5 2.0 7.6 5.5 24.3 0.9 3.8 2.9 4.3 3.3 6.9 7.8 7.7 7.9 5.6 4.3 7.1 3.2 6.7 6.0 14.9 12.5 10.7 3.2 2.6 5.7 12.5 10.2 1.4 1.2 22.7 9.8 46.7 5.0 27.5 15.5 8.7 67.7 23.3 36.8 5.9 6.6 11.5 1.1 25.5 24.7 17.5 26.6 14.7 14.5 58.4 2.6 10.1 6.8 8.2 26.1 8.2 42.6 38.6 1.8 9.9 7.8 12.9 6.1 1.1 2.5 2.8 83.8 7.5 18.9 6.8 TMEM92 FLJ33318 ENSG00000167105 "Transmembrane protein 92" Q6UXU6 17 50271406-50281485 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 74.7" "Cell type enhanced" "Detected in many" 15 "Pancreatic endocrine cells: 31.5;Urothelial cells: 92.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 21 "neutrophil: 5.5" "Lineage enriched" "Detected in single" 21 "granulocytes: 5.5" "Cell line enhanced" "Detected in some" "A549: 9.1;CACO-2: 15.5;CAPAN-2: 14.8;EFO-21: 30.9;OE19: 17.9;SuSa: 20.9" "Low region specificity" "Detected in all" "HPA063009, HPA069820" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063009: AB_2684921, HPA069820: AB_2686208" "unprognostic (3.54e-3)" "unprognostic (2.39e-2)" "unprognostic (9.85e-2)" "unprognostic (1.45e-1)" "unprognostic (2.63e-1)" "prognostic unfavorable (8.35e-4)" "unprognostic (4.37e-3)" "unprognostic (2.45e-2)" "unprognostic (1.11e-1)" "unprognostic (4.39e-1)" "unprognostic (3.88e-3)" "unprognostic (2.97e-2)" "prognostic unfavorable (1.14e-6)" "unprognostic (3.44e-2)" "unprognostic (1.40e-1)" "unprognostic (1.73e-1)" "unprognostic (7.81e-2)" 0.2 0.1 0.3 1.9 0.3 0.4 0.3 0.3 0.3 3.3 27.9 0.3 0.1 23.3 1.2 0.3 1.0 0.7 11.7 0.1 0.8 0.3 0.4 10.2 6.1 0.1 0.3 0.2 2.4 1.2 0.0 0.1 0.3 0.9 1.2 1.8 1.1 4.3 1.2 0.1 0.2 74.7 0.4 0.4 0.3 17.9 0.5 0.3 0.1 0.1 0.4 1.6 2.2 3.7 0.1 0.2 5.5 0.1 0.0 0.0 0.0 0.9 9.1 0.2 0.0 0.0 0.4 2.0 0.2 0.3 0.0 0.0 15.5 14.8 0.0 30.9 0.6 3.5 0.0 0.2 1.7 0.0 2.4 0.1 0.0 0.9 1.5 0.1 0.1 0.1 0.1 1.7 0.1 0.5 1.4 0.0 0.4 1.4 0.0 0.0 0.0 0.0 0.2 3.4 17.9 4.0 0.2 0.0 3.8 3.3 0.0 0.0 0.0 0.0 0.1 0.0 20.9 1.9 0.5 0.0 0.1 2.1 0.0 0.0 0.0 0.1 0.1 0.2 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.3 0.3 0.8 0.3 0.3 0.2 0.9 0.3 3.0 17.1 0.0 6.4 0.5 0.0 0.1 22.9 2.7 1.2 7.0 0.0 0.0 0.0 6.2 0.0 0.0 8.0 0.0 17.8 1.2 1.0 16.8 0.0 11.3 0.4 0.0 5.2 1.8 0.3 0.0 0.0 0.0 0.0 1.8 20.4 0.0 31.5 16.4 0.0 0.0 0.0 0.0 0.1 0.1 1.7 0.9 0.0 0.0 14.9 92.2 TMEM94 KIAA0195 ENSG00000177728 "Transmembrane protein 94" Q12767 17 75441159-75500090 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 39.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008423, HPA050660" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA008423: AB_1852283, HPA050660: AB_2681207" "unprognostic (4.05e-2)" "unprognostic (3.43e-1)" "unprognostic (5.78e-2)" "unprognostic (4.32e-2)" "unprognostic (1.01e-1)" "unprognostic (1.97e-1)" "unprognostic (1.32e-3)" "unprognostic (1.70e-1)" "unprognostic (1.42e-1)" "unprognostic (7.27e-2)" "prognostic favorable (2.26e-4)" "unprognostic (9.71e-2)" "unprognostic (1.14e-1)" "unprognostic (1.21e-2)" "unprognostic (3.33e-1)" "unprognostic (1.44e-2)" "unprognostic (4.96e-2)" 14.6 25.6 26.6 11.2 32.0 13.9 9.8 24.4 32.7 11.7 16.7 30.3 8.2 15.4 13.0 8.5 14.5 27.4 13.7 21.1 21.7 13.3 14.0 9.6 17.0 10.6 24.0 23.0 17.1 13.9 17.2 18.6 18.6 21.9 12.5 11.5 25.4 11.8 12.5 40.4 16.2 15.2 9.4 15.9 14.3 14.8 16.5 23.4 10.7 18.4 9.6 9.2 13.7 7.1 4.6 6.2 5.5 4.6 4.3 7.1 4.5 7.6 20.1 16.6 26.1 8.3 9.5 23.9 4.6 10.2 7.9 8.1 6.7 12.1 10.9 15.4 8.0 12.2 10.1 8.0 12.7 4.4 9.6 11.3 11.0 9.0 10.1 11.3 12.2 24.0 16.4 7.1 7.8 6.9 6.9 14.3 9.3 11.4 12.7 10.3 8.9 25.3 7.6 6.9 9.4 7.8 18.0 19.7 10.0 7.7 20.2 14.8 15.7 5.5 23.9 13.8 12.8 14.8 14.6 8.2 7.9 10.0 8.2 6.5 27.5 7.8 5.9 9.3 11.3 10.7 0.2 4.6 5.5 7.1 2.9 5.4 2.0 3.3 4.7 4.6 4.6 2.8 4.4 1.2 4.3 2.7 6.2 4.1 4.5 26.6 32.0 24.4 32.7 21.7 13.3 24.0 23.0 21.9 23.4 11.9 12.0 0.0 3.8 0.0 39.1 0.0 7.6 5.3 11.4 8.7 29.5 12.8 0.0 6.3 3.5 3.6 13.2 0.0 8.1 8.9 1.3 3.8 5.8 7.2 13.1 19.1 7.0 14.1 8.9 1.6 6.4 3.6 0.0 2.8 11.6 14.5 5.6 10.5 8.5 3.3 33.4 6.5 0.0 13.3 7.8 0.0 16.8 2.5 11.0 2.4 TMEM98 DKFZP564K1964 ENSG00000006042 "Transmembrane protein 98" Q9Y2Y6 17 32927910-32945106 "Disease related genes, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 96.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 7.9" "Lineage enriched" "Detected in single" 12 "dendritic cells: 7.9" "Cell line enhanced" "Detected in many" "CACO-2: 58.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040473, HPA053385" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA040473: AB_10794876, HPA053385: AB_2682134" "unprognostic (1.55e-2)" "unprognostic (5.15e-2)" "unprognostic (4.36e-3)" "unprognostic (7.20e-2)" "unprognostic (1.19e-1)" "unprognostic (7.93e-2)" "prognostic unfavorable (8.14e-4)" "prognostic favorable (7.10e-4)" "unprognostic (6.38e-2)" "unprognostic (2.22e-1)" "unprognostic (3.41e-1)" "unprognostic (9.18e-3)" "prognostic favorable (3.85e-4)" "unprognostic (5.16e-2)" "unprognostic (1.44e-1)" "unprognostic (1.30e-2)" "unprognostic (2.58e-1)" 15.5 15.9 11.8 7.1 36.8 0.9 13.3 6.5 28.3 21.6 26.1 55.5 5.6 29.7 30.5 23.0 8.2 29.6 27.7 13.5 17.0 9.4 10.8 7.7 17.0 3.1 50.4 18.5 60.2 25.7 6.3 7.4 8.0 40.8 24.7 28.7 96.8 14.8 7.4 2.6 7.1 34.0 19.0 37.1 5.7 29.7 9.7 37.7 0.6 14.2 7.4 3.5 15.6 13.3 0.5 7.9 0.6 0.1 0.2 0.6 0.1 1.5 5.8 25.2 0.0 34.6 31.2 0.2 24.4 33.1 13.0 28.0 58.9 1.7 0.3 0.3 30.6 0.4 0.2 16.0 6.4 7.6 5.1 19.7 0.9 0.0 26.1 16.0 0.0 0.3 26.0 6.5 16.3 2.6 7.0 33.4 8.7 16.0 0.0 35.2 0.0 0.0 0.1 16.7 17.5 9.0 0.0 23.6 0.1 2.9 10.4 2.1 34.8 0.5 0.0 19.0 16.7 7.9 0.0 27.3 18.5 17.4 0.2 0.0 2.0 0.8 0.0 9.4 0.0 9.9 0.5 0.1 0.1 0.1 0.0 0.3 0.2 0.1 0.6 0.0 0.5 0.1 0.2 0.6 0.2 0.1 7.9 0.1 0.1 11.8 36.8 6.5 28.3 17.0 9.4 50.4 18.5 40.8 37.7 38.7 19.0 0.0 70.6 22.2 1.7 10.9 73.9 40.2 30.7 43.6 0.0 8.6 5.0 78.8 13.2 5.7 130.7 0.0 58.1 7.3 109.2 105.0 3.5 8.5 5.0 0.0 94.1 22.1 0.6 9.5 111.7 2.8 42.2 0.0 153.0 80.2 76.7 84.2 142.5 30.0 4.4 64.7 32.5 36.8 26.0 11.0 5.9 3.5 154.7 59.9 TMOD2 NTMOD ENSG00000128872 "Tropomodulin 2" Q9NZR1 15 51751561-51816368 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 68.6" "Cell type enhanced" "Detected in many" 11 "Horizontal cells: 82.6" "Cancer enhanced" "Detected in many" "glioma: 7.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 12.8" "Group enriched" "Detected in all" 4 "granulocytes: 12.8;monocytes: 8.8" "Cell line enhanced" "Detected in many" "SCLC-21H: 26.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041365 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA041365: AB_10794665" "unprognostic (1.09e-1)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (1.34e-3)" "unprognostic (9.11e-2)" "unprognostic (3.74e-2)" "unprognostic (1.18e-1)" "unprognostic (1.81e-1)" "unprognostic (3.32e-1)" "unprognostic (5.33e-4)" "prognostic favorable (4.53e-4)" "unprognostic (2.82e-1)" "unprognostic (1.39e-3)" "unprognostic (2.36e-2)" "unprognostic (6.86e-2)" "unprognostic (2.62e-1)" "unprognostic (2.89e-1)" 5.9 6.3 25.4 6.1 29.6 1.6 5.1 22.0 68.6 7.0 6.1 9.1 4.6 3.1 6.0 4.4 4.9 6.0 5.2 4.9 21.6 18.1 3.5 2.2 4.5 4.9 16.9 22.6 6.5 3.1 6.7 4.4 3.0 29.5 3.7 5.1 2.9 3.8 9.6 2.7 4.6 4.7 6.7 11.4 4.5 3.7 3.1 9.6 1.2 4.3 0.2 4.7 4.7 4.6 2.5 1.6 12.8 8.8 1.3 2.2 1.1 0.8 0.5 1.7 4.0 8.2 8.9 0.3 4.5 1.5 3.5 3.7 0.0 0.4 3.6 0.1 3.5 3.6 2.4 7.2 4.0 1.1 0.0 3.5 0.0 0.7 0.0 1.4 1.4 0.2 5.1 5.5 0.5 1.0 4.6 0.7 9.6 0.0 0.1 4.3 0.6 2.9 0.5 1.1 0.0 0.8 2.3 1.0 0.1 0.5 1.2 26.5 6.5 4.2 0.0 1.2 2.3 1.0 0.2 1.6 9.4 0.7 5.9 3.2 0.0 0.0 0.0 2.9 9.8 4.3 0.1 5.9 7.8 2.2 2.3 1.0 2.5 1.3 1.0 1.6 1.8 1.7 0.7 12.8 1.3 8.8 1.2 0.4 1.1 25.4 29.6 22.0 38.3 21.6 18.1 16.9 22.6 29.5 9.6 0.0 5.5 3.0 2.9 4.2 24.2 5.4 0.0 4.0 2.3 10.4 21.6 0.1 6.6 3.4 20.6 11.4 0.3 0.0 1.5 0.0 2.8 1.7 0.0 0.2 4.2 82.6 22.4 13.5 7.8 15.1 10.3 5.7 1.7 27.9 0.3 11.6 2.1 0.0 5.3 1.0 19.7 6.5 4.2 6.3 4.7 6.6 0.2 4.4 0.4 1.8 TMPPE FLJ45032 ENSG00000188167 "Transmembrane protein with metallophosphoesterase domain" Q6ZT21 3 33090421-33096801 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 5 "Alveolar cells type 2: 2.2;Rod photoreceptor cells: 2.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 5.5" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 6 "BEWO: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027019 Approved Approved Nucleoplasm,Mitochondria Yes No "Nucleoplasm, Mitochondria" "HPA027019: AB_1848942" "unprognostic (1.14e-2)" "unprognostic (1.48e-1)" "unprognostic (1.00e-1)" "unprognostic (1.37e-1)" "unprognostic (5.03e-2)" "unprognostic (2.96e-2)" "unprognostic (6.34e-3)" "unprognostic (8.14e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-1)" "unprognostic (1.25e-3)" "unprognostic (9.58e-2)" "unprognostic (1.60e-7)" "unprognostic (1.61e-1)" "unprognostic (5.40e-2)" "unprognostic (2.13e-1)" "unprognostic (4.33e-2)" 6.3 5.4 3.7 6.8 5.2 20.3 6.8 5.3 7.4 4.5 6.9 4.1 7.4 6.4 6.5 12.0 7.0 5.4 9.9 4.4 3.6 3.7 13.9 13.1 9.3 9.6 3.5 3.0 5.7 9.7 12.1 5.2 8.4 4.9 4.6 6.5 9.0 7.7 6.5 3.8 10.3 11.0 4.6 3.8 7.2 6.8 3.2 2.3 2.4 9.5 2.2 7.2 5.3 5.0 0.8 2.2 4.2 5.5 0.1 1.4 0.9 1.3 1.7 1.0 1.6 1.2 1.0 25.5 0.6 0.9 1.5 0.9 2.5 3.5 0.7 1.1 1.6 0.8 1.4 1.6 1.4 2.5 3.8 0.6 3.1 1.7 1.9 0.8 2.6 4.5 1.1 1.2 1.9 1.3 0.7 1.8 1.6 2.3 2.7 1.1 1.2 1.1 1.2 1.0 0.3 1.0 1.3 0.5 1.7 1.4 1.7 0.2 0.6 0.8 2.4 0.6 1.3 1.3 3.8 2.5 2.3 2.9 1.2 2.4 2.2 1.4 0.4 2.9 2.0 1.5 0.0 2.3 0.7 0.4 5.5 1.4 0.8 0.5 0.1 2.2 0.3 0.0 0.0 4.2 0.1 2.3 0.4 0.5 0.9 3.7 5.2 5.3 7.4 3.6 3.7 3.5 3.0 4.9 2.3 0.0 2.2 0.0 0.0 0.7 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.1 1.3 0.0 0.7 1.2 0.3 0.2 0.0 0.2 0.8 1.6 0.0 0.6 1.2 0.0 0.0 0.5 0.0 0.0 0.2 0.4 0.4 0.9 0.4 0.3 2.1 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.6 0.1 TMPRSS2 PRSS10 ENSG00000184012 "Transmembrane serine protease 2" O15393 21 41464551-41531116 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 75.6;pancreas: 64.5;prostate: 68.2" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 190.3;Glandular cells: 290.4;Paneth cells: 127.7;Urothelial cells: 115.9" "Cancer enriched" "Detected in many" 7 "prostate cancer: 250.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 14.1;MCF7: 6.1;OE19: 20.6;RT4: 33.9;SK-BR-3: 6.9" "Not detected" "Not detected" "HPA034493, HPA035787" Enhanced Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" Nucleoplasm "HPA034493: , HPA035787: AB_2674782" "unprognostic (4.80e-3)" "unprognostic (3.49e-1)" "unprognostic (2.16e-1)" "prognostic favorable (2.56e-4)" "unprognostic (1.72e-1)" "unprognostic (1.05e-2)" "unprognostic (4.28e-2)" "unprognostic (1.51e-3)" "unprognostic (9.43e-2)" "unprognostic (9.02e-3)" "unprognostic (6.24e-2)" "unprognostic (6.43e-2)" "prognostic favorable (7.86e-6)" "unprognostic (2.00e-2)" "unprognostic (1.68e-1)" "unprognostic (1.41e-1)" "unprognostic (2.15e-2)" 0.2 0.1 0.2 15.5 0.4 0.0 6.1 0.2 0.5 1.3 38.7 0.4 24.4 17.5 0.5 0.9 10.7 2.2 17.3 0.2 0.3 0.1 19.4 18.4 20.7 0.2 0.2 0.2 0.7 64.5 0.0 1.3 1.0 0.4 68.2 18.5 0.3 52.3 35.7 0.2 2.1 75.6 0.9 0.2 0.3 36.7 0.8 0.3 0.5 19.9 3.9 10.2 5.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 14.1 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.1 0.5 1.2 20.6 0.0 0.0 0.0 1.3 0.5 33.9 0.0 0.4 0.0 6.9 0.1 0.2 5.2 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.4 0.2 0.5 0.3 0.1 0.2 0.2 0.4 0.3 47.6 88.6 0.0 31.0 0.2 0.0 0.6 25.5 14.7 38.7 45.4 0.0 0.5 19.9 30.0 19.4 0.0 190.3 0.0 52.6 0.1 0.6 290.4 6.9 28.7 0.1 0.0 17.3 0.0 0.8 3.5 0.0 1.5 10.1 1.0 79.6 0.0 53.4 127.7 0.0 3.7 0.0 0.0 1.0 0.2 0.0 0.1 0.2 0.0 73.2 115.9 TMPRSS4 "MT-SP2, TMPRSS3" ENSG00000137648 "Transmembrane serine protease 4" Q9NRS4 11 118077012-118121890 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 60.9;gallbladder: 45.4;lymphoid tissue: 41.0;urinary bladder: 43.9" "Cell type enhanced" "Detected in many" 18 "Enterocytes: 108.9;Paneth cells: 61.7;Undifferentiated cells: 54.6;Urothelial cells: 226.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "basophil: 4.5" "Lineage enriched" "Detected in single" 6 "granulocytes: 4.5" "Group enriched" "Detected in some" 5 "CAPAN-2: 37.9;HaCaT: 16.2;OE19: 64.5;RPTEC TERT1: 26.6;RT4: 33.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA006238 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA006238: AB_1080316" "unprognostic (1.48e-1)" "unprognostic (3.27e-2)" "unprognostic (1.19e-2)" "unprognostic (1.23e-1)" "unprognostic (5.23e-2)" "unprognostic (5.50e-2)" "unprognostic (8.17e-3)" "unprognostic (1.95e-2)" "unprognostic (2.41e-1)" "unprognostic (9.62e-2)" "prognostic unfavorable (3.14e-4)" "unprognostic (2.87e-3)" "unprognostic (2.80e-1)" "unprognostic (4.58e-2)" "unprognostic (1.06e-1)" "unprognostic (1.10e-2)" "unprognostic (9.96e-3)" 0.3 0.3 0.2 14.2 0.3 0.0 0.3 0.3 0.2 11.4 23.5 0.1 0.0 16.1 3.1 2.8 60.9 0.6 45.4 0.3 0.3 0.3 17.7 0.3 3.2 0.0 0.2 0.0 0.3 0.4 0.0 0.3 0.8 0.1 9.9 26.2 0.2 4.0 0.0 0.3 2.4 27.4 4.2 0.2 0.3 13.7 0.7 0.0 0.6 0.3 13.7 41.0 43.9 22.3 0.5 0.1 4.5 0.7 0.2 0.1 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.7 37.9 0.0 1.4 0.0 0.0 16.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 1.1 0.0 64.5 0.0 0.0 0.0 0.0 26.6 33.2 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.1 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.5 0.1 0.1 0.9 0.2 0.7 0.1 0.1 0.0 0.2 0.3 0.3 0.2 0.3 0.3 0.2 0.0 0.1 0.0 0.0 1.7 0.0 21.5 1.0 0.0 0.6 0.0 17.4 36.4 10.4 0.0 0.1 0.0 0.1 2.6 0.0 108.9 0.0 6.6 1.6 0.2 6.8 5.7 0.0 0.2 0.0 4.1 0.0 0.0 1.3 0.0 1.0 0.0 0.0 49.1 0.0 30.7 61.7 0.0 1.4 0.0 0.0 0.7 0.0 0.1 5.5 0.2 0.0 54.6 226.3 TMPRSS5 "MGC141886, MGC148044" ENSG00000166682 "Transmembrane serine protease 5" Q9H3S3 11 113687546-113706373 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 24.0;salivary gland: 15.0;skeletal muscle: 6.0" "Cell type enhanced" "Detected in some" 14 "Collecting duct cells: 1.8;Cone photoreceptor cells: 2.0;Horizontal cells: 4.8;Muller glia cells: 3.4" "Cancer enhanced" "Detected in some" "glioma: 5.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.3;CAPAN-2: 7.1;WM-115: 5.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010992 Approved Nucleoplasm NA NA Nucleoplasm "HPA010992: AB_1858152" "unprognostic (1.53e-2)" "unprognostic (3.81e-2)" "unprognostic (2.97e-1)" "unprognostic (1.05e-1)" "unprognostic (1.93e-1)" "unprognostic (8.73e-2)" "unprognostic (2.99e-3)" "unprognostic (3.08e-1)" "unprognostic (5.19e-3)" "unprognostic (8.49e-2)" "unprognostic (8.13e-2)" "unprognostic (3.38e-2)" "unprognostic (1.96e-3)" "unprognostic (1.18e-1)" "unprognostic (1.75e-1)" "unprognostic (1.80e-1)" "unprognostic (4.04e-3)" 2.1 1.7 10.8 1.0 24.0 3.2 2.2 2.1 14.8 1.2 1.0 21.6 0.0 1.0 1.2 0.9 1.8 1.1 2.2 1.2 11.5 5.7 0.9 0.9 0.9 1.1 11.6 12.7 1.4 1.2 0.6 1.5 1.2 16.5 1.2 1.3 0.9 15.0 1.4 6.0 2.7 0.7 1.2 16.9 1.1 2.4 2.3 8.8 0.0 1.1 0.4 1.3 0.9 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.8 4.3 2.5 0.5 0.4 0.6 1.2 0.5 0.6 0.9 2.5 7.1 0.3 3.2 0.5 0.8 0.8 0.3 0.4 0.3 0.4 1.3 1.0 0.6 0.0 0.3 1.0 0.8 0.6 0.6 0.5 1.2 0.5 0.8 1.7 0.8 0.5 0.9 0.0 0.8 1.2 0.5 4.3 0.2 0.9 0.5 0.0 0.7 0.4 0.6 1.0 0.5 0.1 3.5 0.6 0.5 0.5 0.5 0.9 1.7 0.6 0.7 0.5 0.2 0.1 0.4 0.9 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 24.0 2.1 12.3 11.5 5.7 11.6 12.7 16.5 8.8 0.0 0.0 0.0 0.2 0.2 0.5 0.4 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.1 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.4 0.5 0.0 0.0 0.0 1.3 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.1 TMSB4X "TB4X, TMSB4" ENSG00000205542 "Thymosin beta 4, X-linked" P62328 X 12975108-12977227 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "blood: 1074.5" "Cell type enhanced" "Detected in all" 9 "Hofbauer cells: 27421.6;monocytes: 60748.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" CAB033806 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA 400000000 "Nucleoplasm, Vesicles, Cytosol" "CAB033806: AB_2256019" "unprognostic (1.60e-1)" "unprognostic (1.00e-1)" "unprognostic (4.09e-3)" "unprognostic (1.16e-3)" "unprognostic (8.72e-2)" "unprognostic (3.27e-2)" "unprognostic (7.98e-3)" "unprognostic (1.71e-2)" "unprognostic (2.75e-1)" "unprognostic (2.28e-2)" "unprognostic (1.66e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (6.20e-4)" "unprognostic (5.98e-2)" "unprognostic (2.68e-1)" "unprognostic (3.77e-2)" "unprognostic (1.98e-1)" 122.3 97.5 79.8 105.4 76.4 169.0 87.1 33.2 74.8 92.3 93.3 62.0 59.7 38.5 83.7 67.2 62.7 53.0 92.5 54.9 90.8 67.8 69.6 50.8 134.4 205.2 111.4 84.0 61.9 51.0 4.4 23.4 53.4 74.3 46.6 86.6 31.2 42.3 100.4 28.9 39.6 71.5 75.1 195.6 205.7 98.9 26.4 63.8 96.8 34.4 48.6 154.5 112.2 62.1 296.5 495.3 775.0 554.0 272.7 521.9 1074.5 144.7 121.2 238.2 375.3 292.0 320.2 0.5 76.7 200.8 59.6 102.7 24.9 121.8 34.7 74.2 232.8 107.2 63.8 35.2 51.4 80.2 202.6 2.0 43.2 71.9 0.3 68.1 168.5 358.6 149.0 73.7 70.5 61.7 146.2 358.0 92.6 5.4 0.5 210.8 51.5 200.3 365.8 85.6 69.8 83.6 154.4 84.3 141.5 354.7 42.4 25.3 10.8 111.2 5.2 14.1 184.0 139.7 171.2 287.9 87.0 43.2 493.2 76.2 113.1 82.0 67.2 133.1 69.9 62.7 544.9 512.5 775.0 364.8 524.7 309.6 296.5 407.3 391.0 495.3 275.6 345.8 349.0 576.0 272.7 554.0 204.1 521.9 1074.5 79.8 76.4 33.2 74.8 90.8 67.8 111.4 84.0 74.3 63.8 4880.5 5161.6 6027.5 2141.8 7849.2 355.4 69.7 3189.8 1104.2 2643.4 6528.7 21.6 260.6 1848.6 14106.6 104.1 8207.2 4374.5 256.9 19960.8 448.9 5187.8 2457.6 4102.8 814.3 27421.6 58.8 1698.6 5862.6 15729.2 176.0 3640.8 24463.6 6022.8 60748.0 4889.5 45.5 20394.3 5909.2 5673.8 362.6 82.8 5639.7 7491.8 44.2 114.3 8329.0 380.3 13550.6 2818.5 7177.4 TMTC1 "ARG99, FLJ31400, FLJ41625, OLF" ENSG00000133687 "Transmembrane and tetratricopeptide repeat containing 1" Q8IUR5 12 29500840-29784759 "Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 23.2;Endothelial cells: 46.9;Ito cells: 33.2;Sertoli cells: 45.3;Smooth muscle cells: 28.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "non-classical monocyte: 2.3" "Lineage enriched" "Detected in single" 5 "monocytes: 2.3" "Cell line enhanced" "Detected in many" "HHSteC: 29.2;HSkMC: 19.9;hTERT-HME1: 35.8;LHCN-M2: 19.9;RH-30: 41.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016720 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA016720: AB_1858155" "unprognostic (1.67e-1)" "unprognostic (6.35e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (1.63e-3)" "unprognostic (4.53e-2)" "unprognostic (3.88e-2)" "unprognostic (8.36e-2)" "unprognostic (1.77e-1)" "unprognostic (8.90e-3)" "unprognostic (3.08e-3)" "unprognostic (1.21e-1)" "prognostic unfavorable (5.49e-4)" "unprognostic (5.89e-3)" "unprognostic (6.38e-2)" "unprognostic (2.90e-1)" "unprognostic (4.51e-3)" 29.3 12.8 12.9 4.6 30.8 0.5 25.8 2.2 9.0 11.4 8.4 2.9 4.3 3.0 7.4 2.9 6.1 12.6 6.2 15.7 15.2 8.1 13.1 2.4 6.7 2.4 5.4 7.8 8.7 2.9 10.0 18.7 2.7 9.1 6.4 5.4 7.1 3.7 8.3 13.7 2.9 4.6 12.7 4.9 34.1 7.4 2.8 6.2 0.8 3.7 4.4 2.0 8.9 10.5 0.1 0.1 0.4 2.3 0.1 0.1 0.3 0.0 0.0 5.2 0.0 16.6 11.2 0.0 5.4 11.1 1.4 1.2 0.0 0.0 0.0 2.7 3.4 6.1 0.0 0.1 0.1 0.0 0.1 1.6 0.0 15.7 0.2 29.2 0.7 0.0 19.9 1.9 13.8 35.8 4.2 0.8 0.0 0.0 0.7 19.9 0.0 0.0 0.0 4.0 0.0 7.2 0.0 41.8 0.7 0.0 0.1 0.4 0.4 0.6 0.0 1.3 2.0 0.0 0.2 2.2 1.3 0.8 0.7 4.3 7.3 0.0 0.0 9.5 0.0 0.1 0.2 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 2.3 0.1 0.0 0.3 12.9 30.8 2.2 7.6 15.2 8.1 5.4 7.8 9.1 6.2 3.0 1.1 0.0 1.0 3.0 7.1 23.2 0.0 1.4 0.0 3.5 0.0 0.0 0.0 0.0 6.5 46.9 0.0 0.0 0.0 0.0 7.5 2.4 0.0 4.9 0.5 0.0 0.0 33.2 14.6 4.8 7.5 2.4 10.1 0.0 0.0 0.4 0.0 0.0 17.3 0.6 1.2 45.3 28.9 0.5 0.4 1.8 1.6 0.0 0.0 0.1 TMUB1 "C7orf21, SB144" ENSG00000164897 "Transmembrane and ubiquitin like domain containing 1" Q9BVT8 7 151081080-151083546 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029429 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029429: AB_10601825" "unprognostic (8.14e-2)" "unprognostic (2.19e-2)" "unprognostic (2.76e-3)" "unprognostic (1.30e-1)" "unprognostic (7.23e-3)" "unprognostic (7.04e-2)" "unprognostic (2.12e-3)" "unprognostic (7.73e-2)" "unprognostic (1.25e-1)" "unprognostic (2.93e-2)" "unprognostic (1.74e-2)" "unprognostic (2.24e-1)" "unprognostic (1.97e-2)" "unprognostic (2.49e-3)" "unprognostic (2.74e-1)" "unprognostic (1.03e-1)" "unprognostic (3.31e-2)" 10.6 15.2 10.3 16.1 11.0 13.7 17.8 9.1 16.0 9.7 27.5 9.0 17.0 31.8 10.4 15.4 21.6 9.6 18.0 17.3 10.6 9.6 25.5 35.5 12.9 15.6 10.2 10.0 13.1 51.5 9.5 21.1 18.9 8.3 16.1 6.0 12.7 29.6 12.9 33.8 15.1 39.2 12.8 8.7 16.1 24.0 11.5 8.5 23.9 23.6 12.9 19.1 18.7 11.8 8.0 4.2 18.2 3.6 3.1 9.5 1.8 24.4 22.1 5.2 26.8 3.4 4.2 19.5 10.0 8.5 9.0 10.0 19.0 29.9 16.4 21.6 4.9 11.6 16.7 5.8 8.9 2.0 30.0 20.5 7.0 20.5 28.8 8.8 8.6 24.8 6.5 7.4 7.5 2.0 6.8 6.6 17.0 43.7 22.4 4.0 39.5 28.7 37.2 22.3 14.4 13.4 18.0 6.6 30.3 9.3 19.0 19.1 21.3 8.1 12.5 13.1 3.2 9.8 12.0 8.0 11.4 8.4 14.3 16.5 35.3 19.4 11.2 26.4 16.2 14.4 3.5 2.7 18.2 5.4 3.6 4.7 4.4 8.0 5.8 2.8 8.0 7.8 4.5 4.7 3.1 2.2 4.2 9.5 1.8 10.3 11.0 9.1 16.0 10.6 9.6 10.2 10.0 8.3 8.5 6.0 5.6 49.1 25.7 23.5 14.7 8.1 22.9 0.0 0.0 21.0 13.7 83.6 29.9 61.9 8.5 23.9 135.7 0.0 95.6 50.7 20.3 31.1 16.1 44.1 39.1 19.1 39.6 21.5 20.8 2.5 11.5 25.8 30.4 58.7 75.9 22.0 80.5 108.7 15.6 34.6 14.8 38.8 29.9 25.1 10.6 32.2 79.1 52.4 64.5 33.0 TMX2 "PDIA12, TXNDC14" ENSG00000213593 "Thioredoxin related transmembrane protein 2" Q9Y320 11 57712600-57740973 "Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Lissencephaly, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040282, HPA063763" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Nucleoplasm, Cytosol" "HPA040282: AB_10697715, HPA063763: AB_2685116" "unprognostic (3.66e-3)" "unprognostic (6.96e-2)" "unprognostic (6.69e-3)" "unprognostic (2.73e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (3.64e-4)" "prognostic unfavorable (4.11e-4)" "unprognostic (4.48e-2)" "unprognostic (2.98e-1)" "unprognostic (7.26e-3)" "unprognostic (1.90e-2)" "unprognostic (2.22e-1)" "prognostic favorable (1.55e-5)" "unprognostic (5.88e-3)" "unprognostic (4.19e-2)" "unprognostic (3.40e-1)" "prognostic unfavorable (3.37e-4)" 29.5 40.5 33.6 21.0 39.0 13.7 30.8 26.5 60.5 28.0 40.6 50.7 29.0 33.3 22.5 36.7 32.7 25.5 20.0 33.0 32.6 32.1 47.4 71.7 24.4 22.1 40.4 30.4 25.9 40.6 49.8 25.8 26.2 45.3 31.1 49.3 38.4 27.9 34.4 21.9 21.9 34.0 26.1 42.3 25.4 29.9 19.1 31.3 24.0 34.4 25.8 27.0 22.2 22.6 17.7 23.1 17.9 37.5 16.5 21.8 18.8 28.5 33.5 19.3 34.7 36.0 19.3 21.1 34.5 26.8 34.0 28.9 31.8 49.2 26.8 38.6 27.7 50.6 52.8 48.8 27.6 36.1 19.2 21.2 25.9 27.1 31.8 29.7 36.1 35.7 23.6 40.4 37.6 60.0 18.7 19.3 22.6 44.4 31.7 37.9 14.6 21.3 41.2 37.3 53.3 46.0 29.0 24.2 56.7 42.3 32.3 22.1 31.6 26.6 61.9 38.3 19.6 55.3 23.9 16.1 32.1 21.0 42.7 35.6 31.2 60.8 27.1 36.1 25.7 47.5 15.9 19.6 17.9 17.1 33.1 21.6 17.7 17.3 20.0 19.0 15.3 21.8 21.8 5.2 16.5 37.5 23.1 14.3 18.8 33.6 39.0 26.5 60.5 32.6 32.1 40.4 30.4 45.3 31.3 35.7 30.6 38.1 36.3 28.5 43.9 38.7 40.8 34.8 34.2 47.1 29.5 94.9 36.5 67.4 1.6 34.9 38.2 0.0 37.5 68.8 35.4 39.2 42.7 45.2 57.0 28.6 27.6 33.7 27.3 1.9 45.1 35.0 45.5 31.5 45.0 90.9 45.2 35.1 41.1 38.0 52.4 38.8 26.2 56.1 68.8 28.5 83.3 22.4 61.2 41.0 TNFAIP2 "B94, EXOC3L3" ENSG00000185215 "TNF alpha induced protein 2" Q03169 14 103123442-103137439 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Angiogenesis, Differentiation" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "monocytes: 414.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 25.9" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 5 "RT4: 128.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB004598, HPA030624" Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "Nucleoplasm, Nuclear membrane" "CAB004598: AB_628370, HPA030624: AB_2673552" "unprognostic (5.01e-3)" "unprognostic (4.93e-2)" "unprognostic (1.56e-3)" "unprognostic (8.02e-3)" "unprognostic (3.39e-2)" "unprognostic (2.98e-2)" "unprognostic (5.52e-3)" "unprognostic (5.97e-2)" "unprognostic (1.94e-1)" "unprognostic (7.02e-2)" "unprognostic (1.22e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (4.10e-4)" "prognostic favorable (2.79e-5)" "unprognostic (1.75e-2)" "unprognostic (3.83e-2)" "prognostic favorable (7.17e-5)" 27.3 17.0 3.8 58.2 5.7 20.1 19.3 2.5 3.6 23.5 12.9 2.8 4.7 8.1 16.7 18.7 35.5 14.3 30.9 12.7 2.9 3.6 18.8 13.6 32.0 17.9 4.6 3.0 9.7 9.0 17.4 3.5 33.0 6.1 21.7 6.1 16.3 25.1 7.1 12.5 13.2 11.3 28.0 3.8 35.9 8.3 13.0 2.9 11.0 8.5 31.4 48.6 39.8 16.3 0.1 5.0 25.9 9.8 0.1 0.1 1.9 5.5 27.4 0.2 0.1 1.8 7.9 9.2 1.6 7.0 4.4 1.5 0.3 24.9 0.0 20.5 8.0 23.4 17.7 1.9 0.0 2.1 0.9 0.1 2.5 19.1 0.1 3.4 1.2 3.4 3.0 0.2 1.4 0.0 1.7 2.3 1.3 2.5 6.0 0.6 0.5 0.0 1.9 1.6 3.2 2.2 1.1 3.1 4.0 14.0 128.9 0.2 0.3 25.2 8.8 0.3 1.0 14.2 8.1 4.7 0.9 2.4 5.1 5.0 5.4 0.4 0.1 6.7 5.6 2.6 2.5 8.8 4.6 0.0 9.8 0.0 0.0 0.0 0.0 5.0 0.1 0.0 0.1 25.9 0.1 6.9 0.2 0.0 1.9 3.8 5.7 2.5 3.6 2.9 3.6 4.6 3.0 6.1 2.9 0.0 33.8 0.5 27.9 25.1 0.6 12.5 40.8 25.4 30.7 26.2 0.0 0.8 0.0 129.0 29.4 40.9 0.4 0.0 39.8 58.7 62.7 91.7 33.4 6.4 46.3 0.0 16.6 22.1 116.0 36.8 7.8 125.1 28.7 414.8 0.0 8.0 86.0 6.5 2.1 5.5 0.4 19.4 41.0 1.1 2.8 29.2 4.0 2.5 0.2 83.4 TNFAIP8 "GG2-1, MDC-3.13, SCC-S2" ENSG00000145779 "TNF alpha induced protein 8" O95379 5 119268692-119399688 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 73.4;lymphoid tissue: 83.1" "Cell type enhanced" "Detected in many" 6 "granulocytes: 208.8;monocytes: 266.9;Syncytiotrophoblasts: 244.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 44.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA054434, HPA057089" Uncertain Enhanced Nucleoplasm No Yes 270000 Nucleoplasm "HPA054434: AB_2682487, HPA057089: AB_2683331" "prognostic favorable (2.45e-4)" "unprognostic (6.06e-2)" "unprognostic (9.81e-2)" "unprognostic (1.57e-1)" "unprognostic (6.32e-2)" "unprognostic (1.08e-1)" "unprognostic (2.86e-3)" "unprognostic (4.92e-1)" "unprognostic (1.55e-1)" "unprognostic (4.45e-2)" "unprognostic (5.81e-3)" "unprognostic (4.47e-1)" "unprognostic (1.16e-1)" "unprognostic (1.18e-2)" "unprognostic (1.88e-3)" "unprognostic (1.64e-1)" "unprognostic (1.73e-2)" 21.1 2.1 1.6 49.9 3.0 17.8 18.9 1.5 1.7 11.3 8.0 1.6 4.7 4.3 9.7 9.2 15.0 4.6 9.7 8.5 1.8 1.7 8.7 8.4 22.0 71.3 2.9 1.8 4.2 12.5 5.2 1.7 36.1 12.2 11.8 5.5 4.2 13.7 5.8 2.2 14.4 21.4 6.9 3.6 37.5 13.1 4.7 2.2 83.1 9.3 8.6 41.1 12.7 12.8 50.3 25.2 73.4 19.7 19.7 54.4 36.5 7.5 5.3 2.8 4.6 6.1 5.1 26.0 4.2 11.4 3.2 6.6 2.9 8.8 14.2 1.3 4.7 5.1 10.8 2.3 12.8 4.5 15.5 4.9 22.5 11.9 4.9 2.9 27.1 25.0 5.7 12.1 9.6 4.6 6.2 4.3 28.3 8.7 44.5 4.4 2.9 23.0 35.4 4.3 4.4 2.5 7.0 12.6 20.6 12.8 15.2 1.5 2.2 15.8 3.1 1.5 9.7 2.7 31.0 2.1 5.8 2.2 4.0 4.9 21.9 24.0 28.6 6.7 29.0 3.4 73.4 18.6 55.3 22.6 19.7 43.9 50.3 45.5 33.2 25.2 44.2 54.4 34.9 10.6 19.7 14.8 12.1 34.8 36.5 1.6 3.0 1.5 1.7 1.8 1.7 2.9 1.8 12.2 2.2 8.9 16.0 115.2 57.1 142.5 0.1 8.9 15.3 48.2 25.0 17.4 0.0 133.6 14.9 46.4 1.9 18.9 1.3 0.0 87.0 135.2 42.9 45.5 208.8 0.5 45.7 0.0 1.2 6.2 52.3 1.1 2.0 76.8 35.4 266.9 7.6 3.9 105.8 2.9 1.8 11.0 0.5 45.3 34.0 0.4 14.9 104.3 244.7 119.6 3.8 58.5 TNFAIP8L3 FLJ41287 ENSG00000183578 "TNF alpha induced protein 8 like 3" Q5GJ75 15 51056598-51105276 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 47.0;smooth muscle: 47.0" "Cell type enhanced" "Detected in many" 9 "Intestinal endocrine cells: 9.9;Leydig cells: 8.3;Smooth muscle cells: 9.2;Spermatocytes: 16.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 12.9;ASC TERT1: 32.9;HSkMC: 12.1;HUVEC TERT2: 28.1;LHCN-M2: 26.4;TIME: 37.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA077484 Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA077484: AB_2732347" "unprognostic (1.38e-1)" "unprognostic (6.22e-2)" "unprognostic (1.12e-3)" "unprognostic (6.63e-2)" "unprognostic (2.54e-1)" "unprognostic (1.35e-2)" "unprognostic (3.08e-2)" "unprognostic (2.15e-2)" "unprognostic (4.21e-2)" "unprognostic (4.70e-3)" "unprognostic (6.54e-2)" "unprognostic (9.35e-2)" "unprognostic (7.12e-2)" "unprognostic (1.04e-2)" "unprognostic (1.96e-1)" "unprognostic (1.37e-3)" "prognostic unfavorable (3.51e-4)" 4.6 2.4 11.8 4.1 3.8 0.8 10.5 0.6 5.8 9.8 4.1 1.8 2.8 1.2 47.0 9.9 11.5 20.9 3.7 5.5 11.4 3.1 1.9 1.5 6.6 5.4 1.9 5.6 17.5 1.6 0.6 1.8 1.4 3.3 6.6 5.0 0.6 1.9 3.5 2.1 10.7 3.2 47.0 1.5 14.7 2.9 3.4 1.1 0.0 2.5 4.7 2.4 12.3 18.8 1.4 1.0 3.7 1.5 1.7 0.8 0.3 0.0 0.1 0.0 0.0 12.9 32.9 0.1 0.1 0.0 0.3 0.5 0.0 0.3 0.0 0.6 1.8 4.1 0.0 0.4 0.3 0.1 0.0 0.3 0.0 0.9 2.1 3.4 0.1 0.7 12.1 2.6 2.4 9.5 2.2 28.1 0.0 0.0 0.0 26.4 0.3 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.4 0.1 0.2 37.7 2.9 0.2 9.7 0.7 0.1 0.0 0.0 6.1 0.0 0.0 2.8 1.5 0.7 0.5 0.7 0.6 0.8 0.6 0.5 0.3 1.4 0.6 0.8 3.7 1.7 1.0 1.0 0.4 0.3 11.8 3.8 0.6 5.8 11.4 3.1 1.9 5.6 3.3 1.1 0.0 0.3 0.0 0.6 3.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.5 0.0 0.0 0.3 0.0 3.7 0.4 0.0 0.0 2.7 0.0 9.9 2.5 2.5 0.4 8.3 2.8 1.7 1.0 2.8 0.0 0.1 1.1 4.9 0.0 0.2 6.5 9.2 16.8 0.4 7.3 0.0 0.0 2.6 0.4 TNFRSF10A "Apo2, CD261, DR4, TRAILR-1, TRAILR1" ENSG00000104689 "TNF receptor superfamily member 10a" O00220 8 23190452-23225126 "Cancer-related genes, CD markers, Predicted membrane proteins" Apoptosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Suprabasal keratinocytes: 24.0;Urothelial cells: 27.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA050958, HPA054475" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA050958: AB_2681290, HPA054475: AB_2682500" "unprognostic (3.66e-1)" "unprognostic (1.02e-1)" "unprognostic (2.19e-2)" "unprognostic (4.89e-2)" "unprognostic (9.44e-2)" "unprognostic (8.39e-2)" "unprognostic (5.32e-2)" "unprognostic (2.18e-2)" "unprognostic (2.72e-1)" "unprognostic (4.48e-2)" "prognostic unfavorable (1.00e-4)" "unprognostic (1.49e-1)" "unprognostic (1.99e-3)" "unprognostic (1.91e-2)" "unprognostic (1.61e-2)" "unprognostic (2.35e-1)" "unprognostic (2.87e-1)" 11.9 4.0 2.1 13.0 3.4 8.4 9.7 2.0 2.8 6.0 10.9 1.4 4.5 5.9 5.3 5.6 13.6 4.1 12.7 6.3 2.2 2.0 10.9 10.6 11.0 12.4 3.0 0.7 2.7 12.9 3.6 1.8 6.9 4.0 5.1 7.2 2.1 8.2 4.3 3.8 7.1 10.2 3.8 2.9 13.2 6.1 2.6 3.0 9.5 5.8 14.9 25.4 6.7 8.7 13.2 4.5 3.8 4.3 3.9 13.9 4.2 8.0 14.5 0.7 0.0 0.5 3.0 0.0 1.6 1.0 0.8 2.4 11.2 14.2 18.6 19.0 1.0 4.1 15.3 13.1 20.8 1.4 4.6 0.1 9.8 8.8 6.3 7.5 5.2 9.4 5.0 17.2 18.5 16.0 2.5 9.8 0.6 15.1 6.7 3.9 6.3 0.2 3.3 10.1 14.3 8.9 0.1 0.0 13.4 11.1 17.4 0.4 0.5 4.1 10.3 0.0 3.2 5.5 4.0 13.8 0.0 0.1 0.8 0.0 7.9 11.1 14.4 0.1 1.7 0.2 2.0 4.3 3.8 3.8 1.9 10.3 10.4 12.3 7.7 4.5 13.2 12.1 7.0 0.5 3.9 1.7 0.0 13.9 4.2 2.1 3.4 2.0 2.8 2.2 2.0 3.0 0.7 4.0 3.0 3.0 8.3 6.4 16.2 20.9 0.1 0.8 12.7 6.7 19.4 10.4 0.0 0.1 0.0 9.2 0.0 11.8 6.2 0.0 3.5 0.4 1.3 10.0 7.0 4.0 3.0 0.0 2.4 1.3 2.1 0.0 0.0 7.1 3.3 1.8 6.0 0.0 14.3 7.4 0.0 2.4 0.0 0.0 1.1 0.0 0.2 24.0 0.0 2.9 6.3 27.1 TNFRSF19 "TAJ, TAJ-alpha, TRADE, TROY" ENSG00000127863 "TNF receptor superfamily member 19" Q9NS68 13 23570370-23676104 "Plasma proteins, Predicted membrane proteins" Apoptosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 60.5;skin 1: 47.9" "Cell type enhanced" "Detected in many" 11 "Basal keratinocytes: 55.3;Ciliated cells: 84.3;Suprabasal keratinocytes: 70.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "naive B-cell: 1.9;T-reg: 4.0" "Group enriched" "Detected in many" 4 "B-cells: 1.9;T-cells: 4.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 16.5;BJ hTERT+: 26.9;fHDF/TERT166: 20.4;Hep G2: 27.9;SK-MEL-30: 46.5;WM-115: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010135 Approved Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA010135: AB_1079797" "unprognostic (5.70e-2)" "unprognostic (1.28e-1)" "unprognostic (1.17e-2)" "unprognostic (2.42e-1)" "unprognostic (2.04e-1)" "unprognostic (1.86e-3)" "unprognostic (2.01e-2)" "prognostic favorable (3.87e-4)" "unprognostic (3.74e-1)" "unprognostic (5.47e-2)" "unprognostic (4.41e-2)" "unprognostic (6.56e-2)" "prognostic favorable (9.13e-7)" "unprognostic (3.44e-2)" "unprognostic (6.05e-2)" "unprognostic (3.25e-3)" "unprognostic (5.38e-3)" 1.3 1.3 1.0 0.4 1.4 0.6 4.6 0.8 2.0 3.4 1.5 3.0 17.1 0.7 5.3 7.3 5.1 14.3 2.3 14.7 1.5 1.5 7.1 0.5 7.9 0.6 3.0 1.3 3.4 2.2 0.1 8.0 3.8 2.8 12.7 0.8 11.4 60.5 13.0 1.2 47.9 0.9 4.1 1.9 2.5 2.4 2.7 1.1 0.8 5.7 8.0 3.7 2.7 4.0 1.9 0.7 0.7 0.0 0.6 4.0 0.2 0.0 1.0 1.2 0.0 1.6 16.5 1.2 1.2 26.9 0.6 0.9 7.8 0.0 0.0 0.0 20.4 0.1 0.0 1.1 0.9 1.2 0.0 0.9 0.2 0.8 27.9 0.7 0.0 0.3 7.8 0.2 7.8 0.1 0.5 0.0 0.0 0.0 0.0 4.4 0.3 0.0 0.0 0.7 9.6 1.7 0.0 4.5 0.0 2.8 0.1 10.7 1.8 0.0 0.0 46.5 1.3 0.0 0.1 0.0 3.9 0.2 0.0 1.1 0.0 0.0 0.0 1.5 0.0 28.9 0.0 0.0 0.7 0.0 0.0 0.4 0.7 0.4 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.0 0.7 4.0 0.2 1.0 1.4 0.8 2.0 1.5 1.5 3.0 1.3 2.8 1.1 0.0 17.3 0.0 3.6 55.3 0.6 19.1 2.5 84.3 14.8 8.7 7.9 0.2 0.0 9.9 1.1 2.9 0.0 0.0 0.9 0.0 9.8 18.5 1.1 0.6 0.1 0.0 0.0 0.0 0.0 0.8 10.6 0.2 13.5 0.0 0.0 3.0 7.4 0.0 13.1 18.8 2.5 0.0 5.7 0.9 2.1 70.1 0.0 0.5 0.0 0.5 TNFRSF25 "APO-3, DDR3, DR3, LARD, TNFRSF12, TR3, TRAMP, WSL-1, WSL-LR" ENSG00000215788 "TNF receptor superfamily member 25" Q93038 1 6461151-6466195 "Predicted membrane proteins, Predicted secreted proteins" Apoptosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.2;lymphoid tissue: 26.0;skin 1: 24.1" "Cell type enhanced" "Detected in many" 7 "Suprabasal keratinocytes: 25.0;T-cells: 36.2;Undifferentiated cells: 28.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 11 "cerebellum: 19.2" "Cell type enhanced" "Detected in many" "T-reg: 9.5" "Lineage enriched" "Detected in single" 10 "T-cells: 9.5" "Cell line enhanced" "Detected in many" "HDLM-2: 20.2;NB-4: 8.0;RPMI-8226: 19.7" "Group enriched" "Detected in some" 6 "amygdala: 1.2;cerebral cortex: 1.3;hippocampal formation: 2.3" "Not detected" "Not detected" HPA069834 Approved "Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites" "Secreted - unknown location" NA NA "Plasma membrane, Actin filaments, Focal adhesion sites" Nucleoplasm "HPA069834: " "unprognostic (8.09e-3)" "unprognostic (6.91e-3)" "prognostic unfavorable (4.46e-4)" "unprognostic (1.97e-1)" "unprognostic (9.63e-3)" "prognostic favorable (3.09e-4)" "unprognostic (2.16e-1)" "unprognostic (1.46e-1)" "unprognostic (2.04e-1)" "unprognostic (2.07e-1)" "unprognostic (6.01e-2)" "unprognostic (3.98e-2)" "prognostic unfavorable (1.65e-7)" "unprognostic (1.21e-1)" "unprognostic (1.61e-1)" "unprognostic (3.44e-1)" "unprognostic (8.68e-3)" 2.2 1.6 1.2 20.3 1.6 0.4 1.4 19.2 1.8 1.4 13.4 0.7 0.6 2.8 1.2 0.6 4.1 2.4 2.1 2.3 1.8 0.9 1.4 2.3 6.3 13.9 1.1 0.6 1.1 0.6 1.4 14.0 4.1 1.3 1.9 1.3 1.1 10.5 2.3 0.8 24.1 11.2 0.6 0.6 18.9 0.8 1.0 0.8 11.7 1.1 3.2 26.0 3.2 1.5 0.0 0.4 0.0 0.9 0.6 9.5 1.3 1.4 0.3 0.8 1.6 0.0 0.4 0.8 0.6 0.4 0.2 0.0 1.3 2.2 0.0 3.0 0.0 1.0 3.2 0.4 3.7 0.0 20.2 1.5 0.8 1.1 0.0 0.6 0.0 0.0 0.0 2.4 1.2 3.2 1.9 3.2 0.9 0.0 0.0 0.0 1.6 0.0 8.0 1.0 1.1 5.5 0.6 0.2 19.7 0.8 0.5 3.9 5.4 0.0 1.9 0.1 0.3 1.7 2.2 1.7 1.0 1.5 0.0 1.5 0.0 3.6 0.0 1.9 0.0 0.0 0.0 0.0 0.0 1.7 0.3 8.0 0.0 6.9 3.2 0.4 0.0 6.4 1.1 0.0 0.6 0.9 0.0 9.5 1.3 1.2 1.6 19.2 1.8 1.8 0.9 1.1 0.6 1.3 0.8 3.0 5.3 0.5 1.8 21.9 0.8 0.8 2.5 2.7 2.3 1.8 2.0 0.4 0.0 0.1 0.3 5.5 16.9 0.0 0.4 1.6 3.2 1.1 6.9 1.1 3.2 4.8 6.4 9.8 1.6 0.0 2.6 2.1 6.8 1.0 17.6 11.2 0.9 11.5 8.9 0.3 9.3 0.0 0.8 0.5 1.1 25.0 0.1 36.2 28.4 6.7 TNFSF15 "MGC129934, MGC129935, TL1, TL1A, VEGI, VEGI192A" ENSG00000181634 "TNF superfamily member 15" O95150 9 114784635-114806126 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 15.0;kidney: 16.2;salivary gland: 28.7" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 8.9;monocytes: 9.0;Proximal tubular cells: 9.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "myeloid DC: 2.8" "Group enriched" "Detected in many" 5 "dendritic cells: 2.8;granulocytes: 1.2;monocytes: 1.8" "Cell line enhanced" "Detected in some" "HaCaT: 11.1;hTEC/SVTERT24-B: 7.3;HUVEC TERT2: 14.0;OE19: 13.1;RT4: 13.7;TIME: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA012948, HPA046522" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Secreted to blood" NA NA 1110000 "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA012948: AB_1858024, HPA046522: AB_2679683" "unprognostic (3.41e-1)" "unprognostic (2.06e-2)" "unprognostic (3.76e-1)" "unprognostic (1.52e-2)" "unprognostic (3.26e-2)" "unprognostic (1.67e-2)" "unprognostic (1.64e-1)" "unprognostic (2.29e-2)" "unprognostic (5.40e-2)" "unprognostic (1.38e-1)" "unprognostic (7.78e-2)" "unprognostic (2.09e-1)" "unprognostic (8.64e-5)" "unprognostic (1.97e-2)" "unprognostic (1.87e-3)" "unprognostic (1.68e-3)" "unprognostic (4.46e-3)" 1.2 1.3 0.3 3.1 0.5 0.0 0.7 0.2 0.9 1.9 7.3 0.1 1.3 10.8 0.9 1.3 2.8 0.8 2.0 0.3 1.7 0.3 16.2 0.5 5.2 0.5 0.4 0.1 0.7 1.4 0.2 0.5 6.0 0.7 9.8 2.2 0.6 28.7 4.4 0.3 0.6 15.0 2.0 0.4 1.5 3.0 0.6 0.1 0.9 1.3 1.8 2.4 6.4 1.6 0.3 2.8 1.2 1.8 0.3 0.1 0.4 0.4 3.6 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.1 0.2 2.5 1.3 0.0 0.0 0.4 11.1 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 7.3 0.0 0.0 14.0 0.0 0.0 0.8 0.4 0.5 0.0 0.0 0.2 13.1 0.0 0.0 0.0 0.0 0.0 13.7 0.1 0.0 0.0 0.6 0.0 5.0 1.0 0.0 6.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.8 0.1 0.1 1.8 0.0 0.3 0.1 0.0 2.8 0.3 0.1 0.1 1.2 0.3 0.2 1.5 0.0 0.4 0.3 0.5 0.2 0.9 1.7 0.3 0.4 0.1 0.7 0.1 11.9 8.9 0.0 4.4 0.5 0.1 0.5 0.0 0.0 1.2 7.0 0.0 0.5 0.0 4.0 0.2 0.0 6.9 0.0 1.8 0.1 0.8 4.6 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 1.2 0.0 9.0 1.8 0.2 1.1 0.0 0.4 9.6 0.1 0.0 1.0 0.0 0.0 0.5 0.2 0.0 3.9 5.1 TNFSF4 "CD252, gp34, OX-40L, TXGP1" ENSG00000117586 "TNF superfamily member 4" P23510 1 173183734-173207313 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins" Cytokine "Cancer-related genes, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 11.5;testis: 14.4" "Group enriched" "Detected in some" 4 "Early spermatids: 4.3;monocytes: 12.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 18.7;HHSteC: 8.1;HUVEC TERT2: 36.8;LHCN-M2: 30.6" HPA059579 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA059579: AB_2684071" "unprognostic (1.88e-2)" "unprognostic (1.20e-1)" "unprognostic (4.58e-2)" "unprognostic (2.74e-1)" "unprognostic (1.73e-2)" "unprognostic (1.74e-1)" "unprognostic (1.13e-3)" "unprognostic (2.13e-1)" "unprognostic (8.65e-2)" "unprognostic (5.17e-2)" "unprognostic (1.26e-2)" "unprognostic (1.18e-1)" "unprognostic (1.11e-7)" "unprognostic (3.73e-3)" "unprognostic (2.66e-1)" "unprognostic (9.49e-2)" "unprognostic (2.98e-2)" 2.1 4.0 1.7 8.2 2.3 0.9 3.7 4.5 3.4 1.7 1.8 1.0 0.8 0.3 1.5 1.5 1.6 1.4 2.1 2.1 3.0 2.0 1.5 1.6 2.5 11.5 1.9 0.8 2.7 2.1 1.0 3.3 1.2 1.2 2.8 2.5 1.0 0.8 1.0 0.8 0.3 2.5 1.6 1.9 9.7 1.4 14.4 1.2 9.3 0.8 0.8 3.7 1.6 1.6 1.3 2.6 1.7 0.2 3.4 1.2 6.5 0.0 0.0 0.2 0.5 1.3 6.7 0.0 1.8 0.4 0.1 0.1 0.0 0.0 0.0 0.3 18.7 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.7 8.1 0.1 0.0 2.9 0.1 0.9 0.1 0.6 36.8 0.7 0.0 0.2 30.6 0.0 0.3 0.1 0.1 0.0 0.3 0.9 0.0 0.2 0.3 0.0 0.0 0.3 0.1 0.1 0.3 0.6 0.0 0.3 0.3 0.0 0.0 0.1 0.1 0.4 0.6 0.1 0.1 3.4 2.0 0.0 0.2 0.3 1.1 0.1 0.8 1.1 0.7 0.9 0.8 1.3 1.2 1.1 1.7 3.4 0.1 2.6 0.9 6.5 1.7 2.3 4.5 3.4 3.0 2.0 1.9 0.8 1.2 1.2 0.0 0.3 0.0 0.4 0.7 0.0 1.2 0.0 1.4 0.0 1.8 0.0 0.1 0.0 0.0 4.3 0.7 0.0 0.0 0.0 0.1 1.2 0.5 0.0 0.9 0.4 0.0 0.0 0.0 0.8 0.9 0.3 0.2 1.7 12.6 0.0 1.0 0.2 0.0 1.8 0.0 0.3 0.0 1.9 0.2 0.2 0.5 0.0 1.5 0.0 0.1 TNIK KIAA0551 ENSG00000154310 "TRAF2 and NCK interacting kinase" Q9UKE5 3 171061339-171460408 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Neurogenesis, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.9" "Cell type enhanced" "Detected in many" 7 "granulocytes: 79.9;Muller glia cells: 79.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 23 "basophil: 4.4;eosinophil: 10.5;gdT-cell: 4.2;MAIT T-cell: 5.2;memory CD4 T-cell: 5.0;memory CD8 T-cell: 3.7;naive CD4 T-cell: 6.7;naive CD8 T-cell: 3.8;NK-cell: 2.7;T-reg: 5.3" "Group enriched" "Detected in many" 29 "granulocytes: 10.5;NK-cells: 2.7;T-cells: 6.7" "Cell line enhanced" "Detected in many" "AF22: 19.9;HEL: 27.0;HMC-1: 30.8;WM-115: 23.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012128, HPA012297" Approved Supported Nucleoplasm,Cytosol NA NA 9100 Nucleoplasm Cytosol "HPA012128: AB_1858226, HPA012297: AB_1858225" "unprognostic (2.29e-1)" "unprognostic (1.12e-2)" "unprognostic (1.32e-1)" "unprognostic (5.90e-2)" "unprognostic (5.25e-2)" "unprognostic (9.23e-2)" "unprognostic (4.91e-2)" "unprognostic (2.41e-3)" "unprognostic (1.91e-1)" "unprognostic (7.81e-2)" "unprognostic (5.91e-2)" "unprognostic (1.96e-2)" "unprognostic (3.34e-3)" "unprognostic (2.41e-1)" "unprognostic (1.64e-1)" "unprognostic (2.13e-2)" "unprognostic (3.97e-2)" 2.2 5.4 29.0 7.4 30.9 4.9 3.6 21.1 26.1 1.9 10.9 12.2 4.1 25.8 4.3 2.1 5.6 4.3 7.1 11.2 30.9 14.8 5.6 4.6 11.3 7.9 11.4 18.3 2.6 5.2 0.7 9.0 3.1 13.6 5.6 9.5 3.5 2.9 7.3 23.2 1.6 25.6 6.0 14.5 5.8 9.2 10.7 21.1 3.7 7.1 2.2 6.9 6.4 2.6 0.2 0.0 10.5 0.1 2.7 6.7 1.1 0.3 0.5 19.9 2.1 0.3 0.0 4.7 4.1 1.2 3.3 2.2 17.8 7.4 0.0 1.5 3.8 3.0 6.1 2.8 1.1 3.6 0.1 4.4 27.0 1.5 0.0 9.5 5.3 30.8 2.9 3.0 1.9 0.4 7.7 19.8 4.5 9.7 0.0 0.5 0.4 1.7 6.8 8.2 14.2 7.7 0.0 5.1 7.1 6.4 0.0 0.9 1.0 2.5 0.2 4.4 2.2 9.0 1.3 0.2 0.0 3.5 9.0 3.0 0.0 0.0 0.0 0.9 6.0 23.0 4.4 0.1 10.5 4.2 0.0 5.2 0.0 5.0 3.7 0.0 0.2 6.7 3.8 0.1 2.7 0.1 0.0 5.3 1.1 29.0 30.9 21.1 22.2 30.9 14.8 11.4 18.3 13.6 21.1 6.0 37.9 0.5 1.4 2.3 9.3 25.7 25.5 2.7 12.5 8.7 13.7 4.7 5.0 9.2 29.5 1.6 26.2 0.0 6.8 1.8 4.4 0.6 79.9 6.8 2.5 0.0 12.7 1.3 5.6 33.0 2.3 3.3 1.7 0.0 9.4 79.4 4.8 16.5 6.0 14.9 27.7 0.0 7.6 2.8 1.0 1.4 2.1 31.2 15.3 2.4 TNIP1 "ABIN-1, KIAA0113, NAF1, VAN" ENSG00000145901 "TNFAIP3 interacting protein 1" Q15025 5 151029945-151093577 "Predicted intracellular proteins" "Inflammatory response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "monocytes: 370.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 82.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037893, HPA037894, HPA071950" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA037893: AB_10672468, HPA037894: AB_2675723, HPA071950: AB_2686476" "prognostic favorable (5.69e-4)" "unprognostic (1.08e-1)" "unprognostic (1.10e-1)" "prognostic favorable (6.86e-5)" "unprognostic (7.45e-3)" "unprognostic (2.94e-1)" "unprognostic (5.35e-3)" "unprognostic (1.45e-2)" "unprognostic (2.82e-1)" "unprognostic (3.42e-1)" "unprognostic (2.25e-2)" "unprognostic (1.96e-1)" "unprognostic (7.68e-3)" "unprognostic (1.47e-1)" "unprognostic (4.69e-2)" "unprognostic (2.29e-1)" "unprognostic (9.84e-2)" 49.8 16.8 8.9 32.2 10.7 35.8 68.8 10.1 11.4 16.5 38.8 10.2 22.9 23.8 13.6 21.2 28.9 11.2 33.2 30.1 8.9 8.7 27.8 34.3 29.0 35.1 11.2 7.2 14.6 42.2 16.4 9.5 15.7 10.6 18.5 17.4 13.9 18.2 27.6 61.7 19.5 37.2 21.0 10.7 39.5 20.6 9.9 10.9 21.0 19.6 27.7 41.9 20.6 35.0 10.9 7.7 26.0 7.4 7.0 12.5 5.3 23.2 16.6 3.1 11.4 12.4 12.6 8.4 11.3 36.1 10.1 19.1 15.8 31.8 19.5 38.2 15.1 59.6 14.1 5.1 82.9 12.4 33.3 7.2 7.8 9.3 10.2 23.8 8.7 35.5 18.0 15.4 16.8 34.9 28.1 14.4 7.8 4.8 19.4 25.1 8.7 9.4 12.0 2.9 8.2 9.2 7.8 24.5 25.9 31.6 17.1 4.5 10.5 8.7 27.3 11.5 9.0 14.0 11.0 22.1 34.4 11.3 5.9 16.0 39.0 20.1 8.7 37.2 12.9 8.2 9.7 7.4 20.4 7.8 6.8 9.1 8.4 9.0 7.7 5.6 10.9 4.7 5.1 26.0 7.0 6.1 7.7 12.5 5.3 8.9 10.7 10.1 11.4 8.9 8.7 11.2 7.2 10.6 10.9 53.6 47.9 57.0 38.7 26.4 14.5 44.5 43.3 34.8 43.3 26.2 3.9 15.1 61.3 215.3 2.7 46.5 218.6 23.3 121.4 25.8 41.8 84.1 47.3 52.9 35.3 17.5 35.8 41.7 42.7 5.6 25.0 50.8 25.3 370.7 58.2 18.6 194.1 86.5 22.3 40.4 14.0 32.3 51.5 2.3 13.4 25.0 40.3 63.3 62.8 120.2 TNIP2 "ABIN-2, FLIP1, KLIP, MGC4289" ENSG00000168884 "TNFAIP3 interacting protein 2" Q8NFZ5 4 2741648-2756376 "Predicted intracellular proteins" "Apoptosis, Inflammatory response, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020818, HPA049886, HPA063197" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB020818: , HPA049886: AB_2680934, HPA063197: AB_2684960" "unprognostic (1.22e-1)" "unprognostic (2.09e-1)" "unprognostic (2.44e-1)" "prognostic favorable (1.13e-4)" "unprognostic (3.64e-1)" "unprognostic (9.87e-2)" "unprognostic (4.36e-2)" "prognostic unfavorable (5.73e-4)" "unprognostic (2.77e-1)" "unprognostic (2.47e-2)" "unprognostic (8.34e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (2.94e-5)" "unprognostic (3.00e-1)" "unprognostic (7.23e-2)" "unprognostic (1.97e-3)" "unprognostic (4.02e-3)" 16.7 10.3 7.8 14.5 14.0 18.9 32.5 3.4 12.4 9.8 26.4 7.3 7.1 16.4 11.9 10.1 14.5 9.6 13.7 26.6 7.4 6.5 23.4 16.6 16.0 17.9 11.2 4.7 12.3 24.2 3.5 11.4 15.3 12.4 13.6 10.1 9.7 10.7 13.5 21.9 10.5 37.2 23.9 12.2 17.8 15.3 11.7 11.1 8.1 14.2 12.3 18.2 15.1 33.7 9.8 7.3 20.9 11.8 4.4 11.2 4.7 12.2 16.7 5.3 8.0 17.0 11.7 23.0 13.4 12.0 12.5 12.2 19.1 19.9 11.2 15.2 14.6 28.1 8.1 9.5 15.4 7.4 8.7 11.9 13.4 9.9 21.1 21.2 10.9 17.0 15.1 14.0 13.8 12.5 9.7 17.8 10.3 13.6 15.9 8.6 25.4 14.3 27.0 13.9 18.3 28.6 9.5 8.1 5.8 13.4 13.8 8.0 9.0 10.4 10.9 14.7 9.6 12.0 16.1 20.6 9.7 10.7 15.1 20.5 16.5 11.2 8.1 17.7 19.8 10.4 6.4 7.2 20.9 6.7 11.2 7.2 7.8 10.2 11.2 7.3 9.8 8.4 7.0 7.1 4.4 11.8 3.4 10.2 4.7 7.8 14.0 3.4 12.4 7.4 6.5 11.2 4.7 12.4 11.1 6.0 9.8 20.6 45.8 54.5 2.1 12.0 5.1 6.7 11.4 14.0 2.0 44.9 11.6 51.5 2.1 31.7 65.3 0.0 52.5 89.5 32.8 52.4 12.7 14.9 31.4 0.0 18.4 28.8 18.9 5.4 19.8 35.5 25.3 104.6 33.4 10.0 53.3 52.6 16.6 33.2 6.5 19.4 37.0 15.8 60.0 69.1 80.0 34.8 32.9 71.1 TNKS "PARP-5a, PARP5A, pART5, TIN1, TINF1, TNKS1" ENSG00000173273 Tankyrase O95271 8 9555914-9782346 "Enzymes, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport, Wnt signaling pathway" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 118.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025690 Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear bodies" NA NA Nucleoplasm "Nuclear membrane, Nuclear bodies" "HPA025690: AB_10602249" "unprognostic (2.07e-1)" "unprognostic (1.72e-2)" "unprognostic (5.45e-3)" "unprognostic (8.22e-2)" "unprognostic (2.42e-1)" "unprognostic (1.27e-2)" "unprognostic (4.75e-2)" "unprognostic (1.13e-1)" "unprognostic (9.06e-2)" "unprognostic (8.01e-2)" "unprognostic (6.21e-2)" "unprognostic (9.10e-2)" "unprognostic (4.14e-2)" "unprognostic (1.12e-1)" "unprognostic (5.43e-1)" "unprognostic (7.76e-2)" "unprognostic (5.36e-2)" 9.1 13.4 17.8 8.7 19.6 14.6 14.0 26.5 22.3 18.1 8.9 17.0 12.5 8.5 14.9 25.3 7.7 11.9 8.9 9.5 18.6 17.9 9.0 9.1 10.3 12.9 28.7 17.2 19.2 10.2 23.9 20.0 11.0 20.1 11.5 10.0 10.9 9.4 11.7 22.1 15.6 9.8 11.0 21.0 8.7 10.1 26.3 21.8 15.6 13.7 4.4 11.7 10.8 13.6 6.8 3.6 7.4 2.8 2.9 4.8 1.2 6.1 8.1 20.8 12.5 13.2 17.7 7.7 9.5 10.8 7.7 8.8 4.8 4.9 13.2 3.9 9.3 10.4 6.5 11.8 8.9 11.2 3.4 6.1 9.2 7.4 10.8 11.9 4.7 5.7 12.5 10.8 8.0 15.8 12.6 10.4 10.3 8.6 14.1 14.2 4.0 11.9 7.2 13.6 6.7 4.7 9.6 12.9 3.8 9.3 12.5 21.2 15.6 7.4 7.1 13.4 13.2 4.7 7.1 13.9 12.7 7.8 8.6 7.0 4.9 7.9 9.4 13.7 6.7 12.2 4.8 2.3 1.8 4.4 2.2 2.4 4.2 3.5 4.2 2.8 6.8 4.2 4.8 7.4 2.9 2.8 3.6 1.7 1.2 17.8 19.6 26.5 22.3 18.6 17.9 28.7 17.2 20.1 21.8 14.9 9.4 11.0 11.2 10.2 32.0 14.3 17.8 26.8 9.1 8.7 13.7 9.0 1.7 9.8 118.1 10.9 9.0 0.0 7.4 7.7 14.9 11.9 9.3 15.8 6.2 39.7 13.3 20.9 9.4 58.4 15.5 7.3 11.8 1.8 13.5 18.4 11.2 13.1 17.0 6.0 36.2 0.0 9.9 30.7 13.5 13.6 10.3 11.5 11.7 10.2 TNNC1 TNNC ENSG00000114854 "Troponin C1, slow skeletal and cardiac type" P63316 3 52451102-52454070 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Muscle protein" "Cardiomyopathy, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "heart muscle: 431.6;skeletal muscle: 765.7" "Cell type enriched" "Detected in many" 8 "Cardiomyocytes: 2506.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 4.0" "Lineage enriched" "Detected in single" 7 "T-cells: 4.0" "Cell line enhanced" "Detected in some" "CACO-2: 24.3;CAPAN-2: 12.2;EFO-21: 24.4;HeLa: 16.0;Hep G2: 16.2;HSkMC: 25.3;U-2 OS: 37.5" "Region enriched" "Detected in many" 4 "cerebral cortex: 88.3" "Not detected" "Not detected" "CAB002450, HPA044848, HPA056897" Enhanced Approved "Nucleoplasm,Actin filaments,Mitochondria" NA NA 260000 "Nucleoplasm, Actin filaments, Mitochondria" "CAB002450: AB_564152, HPA044848: AB_2679110, HPA056897: AB_2683269" "unprognostic (2.18e-2)" "unprognostic (1.70e-1)" "unprognostic (8.66e-2)" "unprognostic (3.43e-1)" "unprognostic (4.00e-2)" "unprognostic (1.88e-2)" "unprognostic (1.11e-1)" "unprognostic (1.43e-1)" "unprognostic (1.53e-1)" "unprognostic (3.92e-1)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (2.15e-2)" "unprognostic (4.95e-2)" "unprognostic (2.31e-1)" "unprognostic (4.15e-2)" "unprognostic (4.86e-1)" 2.0 0.3 0.1 0.0 0.1 0.0 0.7 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.1 17.8 12.8 0.1 0.0 431.6 0.1 0.1 0.6 0.1 2.6 0.0 0.1 0.0 0.1 0.2 0.0 0.6 0.2 0.5 5.5 0.1 0.7 10.4 0.0 765.7 0.4 0.1 0.1 0.7 0.1 0.1 0.7 0.0 0.0 3.0 86.9 8.7 0.4 0.2 0.2 0.6 0.0 0.0 0.0 4.0 0.5 0.2 1.8 1.3 0.2 0.0 0.2 2.9 0.1 0.1 0.1 0.1 24.3 12.2 0.2 24.4 3.5 0.0 0.1 0.0 0.1 0.0 0.4 0.6 0.1 16.0 16.2 0.1 0.1 0.0 25.3 0.4 0.0 0.2 0.2 0.0 0.7 0.0 1.9 0.7 0.0 0.0 0.2 0.2 5.4 0.2 0.0 1.0 0.8 1.2 4.6 0.0 0.0 0.1 2.5 0.0 1.5 9.8 0.2 0.0 0.0 37.5 0.3 0.0 1.0 0.4 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.7 0.0 4.0 0.2 0.9 0.5 0.0 0.1 1.4 0.5 0.0 0.0 0.0 0.6 2.5 0.5 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.5 0.0 116.1 13.0 0.0 0.6 1.3 0.2 2506.5 0.0 0.0 7.9 3.5 2.0 44.2 23.2 6.6 0.6 0.0 0.7 0.0 11.8 4.0 14.0 0.6 0.0 0.6 4.1 0.0 318.5 0.6 0.0 3.6 20.8 1.0 5.0 0.0 0.3 1.5 4.4 0.0 166.9 0.5 0.0 0.0 15.5 1.2 0.4 0.6 26.0 0.8 1.5 4.1 TNNC2 ENSG00000101470 "Troponin C2, fast skeletal type" P02585 20 45823214-45833745 "FDA approved drug targets, Predicted intracellular proteins" "Muscle protein" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skeletal muscle: 851.6" "Group enriched" "Detected in many" 6 "Enterocytes: 242.7;Mucus-secreting cells: 94.6;Paneth cells: 103.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "memory B-cell: 6.0" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "Hep G2: 9.9;HSkMC: 15.7;SCLC-21H: 11.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043174, HPA058481" Enhanced Approved Nucleoplasm,Vesicles No NA 63000 Nucleoplasm Vesicles "HPA043174: AB_10806380, HPA058481: AB_2683729" "unprognostic (1.13e-1)" "unprognostic (7.25e-2)" "unprognostic (3.43e-1)" "unprognostic (1.27e-1)" "unprognostic (3.21e-5)" "unprognostic (1.80e-2)" "unprognostic (5.72e-3)" "unprognostic (3.12e-3)" "unprognostic (2.19e-1)" "unprognostic (2.06e-1)" "unprognostic (2.38e-1)" "unprognostic (1.05e-1)" "unprognostic (9.03e-3)" "unprognostic (7.15e-3)" "unprognostic (4.79e-1)" "unprognostic (5.23e-2)" "unprognostic (1.13e-1)" 12.0 0.2 0.1 0.1 0.4 0.1 0.3 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.1 2.7 4.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.0 1.4 0.1 0.0 7.8 0.1 851.6 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.0 1.6 169.1 6.6 0.1 0.1 6.0 0.8 2.4 1.1 0.3 4.1 11.9 0.1 0.0 0.3 0.5 1.7 1.2 1.8 0.2 0.4 0.0 0.1 0.2 1.2 0.4 1.2 1.0 0.4 0.4 0.0 0.4 0.0 0.0 0.3 0.0 1.0 9.9 0.4 0.3 0.2 15.7 0.2 0.1 0.8 0.4 0.0 1.2 0.1 0.5 0.2 1.2 0.7 0.1 0.0 0.4 0.6 0.3 0.6 0.2 0.3 0.1 11.8 0.6 1.7 0.1 0.4 0.5 1.4 0.4 0.5 0.3 0.4 0.9 0.2 1.6 0.4 0.3 1.6 0.1 0.2 0.0 0.7 1.4 0.2 1.1 0.7 6.0 1.5 0.2 0.3 3.8 0.0 0.3 2.4 0.3 0.8 0.8 4.1 11.9 0.1 0.4 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 3.0 1.1 4.2 0.5 0.7 1.3 0.4 2.5 0.0 4.5 3.5 0.0 2.1 3.3 1.3 2.9 0.1 242.7 0.0 4.7 0.2 2.6 0.7 0.0 0.8 0.2 0.0 22.0 0.0 0.0 26.3 1.1 0.5 0.0 0.0 94.6 1.4 2.5 103.7 2.8 0.7 1.7 0.0 3.6 2.3 5.8 7.3 0.1 0.0 25.8 0.5 TNNI1 ENSG00000159173 "Troponin I1, slow skeletal type" P19237 1 201403768-201429866 "Predicted intracellular proteins" "Actin-binding, Muscle protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skeletal muscle: 559.6" "Cell type enriched" "Detected in some" 10 "Cardiomyocytes: 50.9" "Group enriched" "Detected in many" 5 "head and neck cancer: 9.6;prostate cancer: 3.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 9 "RH-30: 106.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA028190 Approved Uncertain Nucleoplasm,Nucleoli NA NA 25000 Nucleoplasm Nucleoli "HPA028190: AB_10600831" "unprognostic (2.82e-2)" "unprognostic (2.27e-1)" "unprognostic (2.91e-1)" "unprognostic (5.39e-2)" "unprognostic (2.31e-2)" "prognostic unfavorable (9.27e-4)" "unprognostic (1.93e-2)" "unprognostic (2.37e-1)" "unprognostic (4.25e-1)" "unprognostic (3.81e-2)" "unprognostic (1.75e-1)" "unprognostic (2.92e-2)" "unprognostic (1.05e-2)" "unprognostic (2.59e-2)" "unprognostic (3.52e-1)" "unprognostic (2.11e-1)" "unprognostic (1.71e-1)" 1.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 22.9 9.5 0.0 0.1 6.6 0.1 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.0 0.0 0.0 6.8 0.0 559.6 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 2.7 83.8 10.7 0.0 0.1 0.2 0.6 1.7 0.4 0.4 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 106.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.4 0.3 0.3 0.3 0.1 0.2 0.2 0.2 0.6 0.2 0.3 0.5 1.7 0.4 0.3 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 50.9 0.0 0.0 0.0 0.0 0.0 0.2 5.0 0.0 2.7 0.0 0.8 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 TNNT1 "ANM, FLJ98147, MGC104241, NEM5, STNT, TNT, TNTS" ENSG00000105048 "Troponin T1, slow skeletal type" P13805 19 55132794-55149354 "Disease related genes, Predicted intracellular proteins" "Muscle protein" "Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "skeletal muscle: 1047.7" "Cell type enhanced" "Detected in many" 11 "Basal keratinocytes: 54.4;Cardiomyocytes: 49.6;Spermatogonia: 26.7;Suprabasal keratinocytes: 26.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 5 "eosinophil: 53.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 53.3" "Cell line enhanced" "Detected in many" "HMC-1: 121.8;RH-30: 91.7" "Region enriched" "Detected in many" 5 "thalamus: 136.6" "Low region specificity" "Detected in some" "CAB015168, HPA058448" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus, Cytosol" "CAB015168: AB_2206426, HPA058448: AB_2683720" "unprognostic (1.88e-1)" "unprognostic (7.23e-2)" "prognostic unfavorable (4.66e-4)" "prognostic unfavorable (4.66e-4)" "unprognostic (3.47e-3)" "unprognostic (3.92e-3)" "unprognostic (1.35e-3)" "unprognostic (1.03e-3)" "unprognostic (2.46e-1)" "unprognostic (1.95e-1)" "prognostic unfavorable (2.53e-4)" "unprognostic (3.23e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (4.91e-2)" "unprognostic (4.01e-2)" "unprognostic (4.58e-2)" "unprognostic (2.14e-2)" 3.2 0.0 1.6 0.0 1.0 0.1 0.1 0.1 1.0 0.0 0.1 0.0 0.0 0.1 0.0 24.4 22.3 0.4 0.1 6.1 0.9 0.4 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.2 0.0 7.2 0.0 0.0 11.5 0.0 1047.7 1.8 0.0 0.0 0.1 0.1 0.1 0.5 0.0 0.0 9.2 124.4 17.8 0.3 0.1 0.1 9.9 53.3 11.6 0.1 0.1 2.6 24.8 14.6 0.1 3.2 0.0 0.2 4.8 1.1 4.3 1.6 4.8 5.3 16.6 0.3 9.7 0.4 13.0 12.7 3.4 10.8 1.3 1.6 27.6 4.7 1.5 0.9 0.5 0.3 121.8 5.4 17.6 0.5 18.7 18.5 0.0 5.0 23.6 23.1 1.5 23.7 0.4 0.0 3.1 6.3 29.0 15.9 91.7 2.9 3.8 0.8 0.9 7.2 1.5 0.2 8.0 1.3 15.1 14.5 0.5 24.1 35.9 0.9 1.8 0.1 0.9 1.2 25.4 3.7 7.3 0.5 11.6 53.3 0.0 5.9 0.1 0.0 0.1 0.0 9.9 0.1 0.1 0.1 0.5 0.1 2.6 0.2 0.0 2.6 1.6 1.0 0.1 1.0 0.9 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.4 1.5 49.6 0.0 6.7 0.0 0.0 0.0 1.3 0.0 1.8 1.3 0.0 0.0 0.0 0.0 14.0 8.0 0.0 0.0 0.0 13.2 0.0 2.4 1.8 12.0 6.0 0.3 4.2 3.3 0.0 0.2 0.8 0.4 0.0 0.0 0.0 0.6 0.0 0.9 2.8 26.7 26.6 3.0 0.0 0.3 0.1 TNNT2 "CMD1D, CMH2, CMPD2" ENSG00000118194 "Troponin T2, cardiac type" P45379 1 201359008-201377762 "Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins" "Muscle protein" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 241 "heart muscle: 679.2" "Cell type enriched" "Detected in many" 289 "Cardiomyocytes: 11884.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "RH-30: 189.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB015371, HPA015774, HPA017888" Enhanced Uncertain "Nucleoplasm,Nucleoli,Focal adhesion sites" No No 50000 "Nucleoplasm, Nucleoli" "Focal adhesion sites" "CAB015371: AB_630390, HPA015774: AB_1858354, HPA017888: AB_1858355" "unprognostic (1.45e-1)" "unprognostic (2.74e-1)" "unprognostic (2.33e-4)" "unprognostic (1.85e-1)" "unprognostic (7.29e-2)" "unprognostic (1.79e-1)" "unprognostic (1.80e-1)" "unprognostic (1.24e-1)" "unprognostic (1.42e-1)" "unprognostic (2.91e-2)" "unprognostic (1.38e-1)" "unprognostic (8.63e-2)" "unprognostic (5.50e-3)" "unprognostic (2.94e-1)" "unprognostic (1.61e-1)" "unprognostic (4.76e-2)" "unprognostic (9.98e-2)" 0.1 0.3 0.1 0.1 0.7 0.0 0.8 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.2 679.2 0.9 0.0 1.9 0.0 0.7 0.3 0.1 1.1 0.1 0.3 0.0 0.2 0.7 0.1 0.7 0.0 0.0 0.2 0.1 2.0 1.3 0.0 2.8 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.1 0.0 0.0 0.4 0.5 0.0 0.0 189.8 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 10.5 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 2.1 0.9 0.0 0.1 1.1 0.1 0.0 3.0 4.0 0.0 1.1 3.1 1.0 11884.8 0.0 0.0 1.2 1.8 0.0 2.3 0.0 0.5 9.4 0.0 1.6 0.0 0.3 0.9 41.1 0.5 0.0 0.0 2.7 0.0 0.0 0.0 0.0 13.6 0.6 0.0 0.0 4.6 0.5 0.0 0.7 0.8 1.1 0.8 0.5 0.0 0.4 0.0 0.2 6.4 3.5 0.0 2.8 1.4 TNPO1 "IPO2, KPNB2, MIP, MIP1, TRN" ENSG00000083312 "Transportin 1" Q92973 5 72816312-72916733 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB016325 Approved Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA 47000 Nucleoplasm "Cytosol, Cytoplasmic bodies" "CAB016325: AB_675691" "unprognostic (1.16e-1)" "unprognostic (1.18e-2)" "unprognostic (1.65e-3)" "unprognostic (1.43e-1)" "unprognostic (3.15e-1)" "unprognostic (6.43e-3)" "prognostic unfavorable (6.55e-5)" "unprognostic (8.93e-3)" "unprognostic (9.03e-2)" "unprognostic (3.40e-3)" "unprognostic (2.09e-1)" "unprognostic (3.07e-1)" "unprognostic (1.48e-1)" "unprognostic (1.23e-1)" "unprognostic (1.76e-1)" "unprognostic (1.27e-2)" "unprognostic (2.49e-2)" 23.9 29.3 20.1 26.2 24.5 20.7 52.3 18.5 21.9 18.5 21.6 15.7 32.3 16.4 25.4 25.4 26.5 17.9 22.8 21.9 22.5 16.5 26.2 20.8 24.2 22.4 22.9 16.4 22.5 28.9 54.1 36.5 34.9 27.0 21.2 24.4 19.4 26.1 35.3 38.0 15.9 19.9 32.0 31.2 21.7 25.3 30.9 20.8 25.2 32.6 18.0 23.6 27.5 30.8 11.1 10.7 8.9 13.3 14.1 18.3 10.6 21.8 28.8 42.0 25.1 31.3 38.9 24.8 25.9 35.4 25.9 26.6 24.5 18.8 25.6 17.8 40.7 30.9 16.0 28.6 23.1 37.4 14.8 15.8 15.8 38.3 12.4 21.2 17.4 11.6 28.1 16.7 34.6 49.2 18.7 62.7 10.8 23.5 13.7 73.4 10.4 15.8 6.6 22.6 8.1 22.1 19.2 37.8 16.0 15.9 29.3 21.8 22.5 41.7 13.4 30.6 24.1 16.5 14.3 59.4 22.0 25.8 33.1 29.0 12.6 19.5 34.2 17.4 17.8 40.2 7.3 8.3 6.9 13.4 11.5 18.3 11.1 12.2 10.0 10.7 11.0 13.4 13.4 8.9 14.1 13.3 5.0 8.1 10.6 20.1 24.5 18.5 21.9 22.5 16.5 22.9 16.4 27.0 20.8 11.9 20.6 52.7 32.3 52.5 99.6 47.6 35.7 16.0 21.6 26.2 92.3 65.2 14.9 34.0 73.5 57.3 27.7 23.3 35.6 40.7 52.1 43.3 20.9 35.0 37.7 84.2 51.1 55.3 37.6 46.9 43.1 33.6 23.6 44.1 45.5 134.9 48.6 21.0 56.6 30.6 174.6 25.8 39.2 47.7 78.6 46.5 109.8 24.9 30.8 51.9 TNPO2 "FLJ12155, IPO3, KPNB2B, TRN2" ENSG00000105576 "Transportin 2" O14787 19 12699194-12724011 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 94.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046446, HPA071498" Approved Approved Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "CAB046446: AB_10603392, HPA071498: AB_2686405" "unprognostic (1.88e-1)" "unprognostic (1.07e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (7.16e-5)" "unprognostic (2.25e-1)" "unprognostic (3.64e-2)" "unprognostic (2.72e-2)" "unprognostic (6.75e-2)" "unprognostic (3.44e-1)" "unprognostic (1.79e-1)" "unprognostic (1.79e-2)" "unprognostic (4.63e-2)" "prognostic favorable (8.18e-4)" "unprognostic (2.76e-3)" "unprognostic (6.00e-2)" "unprognostic (3.50e-3)" "unprognostic (7.63e-2)" 21.7 19.8 37.1 16.0 35.7 17.8 13.5 33.1 44.7 17.9 13.9 23.2 12.7 13.4 20.7 20.9 22.9 22.4 15.9 20.0 31.1 24.9 14.3 10.1 13.7 16.6 24.8 36.6 32.9 16.0 26.6 19.1 16.1 22.2 16.8 15.9 18.2 15.1 20.0 15.2 36.6 12.5 23.3 25.2 15.3 12.9 24.1 20.9 14.9 17.8 9.9 17.8 18.9 14.7 1.6 4.3 2.6 1.2 0.4 3.3 0.7 17.6 13.5 20.8 26.5 12.7 16.8 13.5 20.4 13.5 29.6 20.9 18.4 9.6 12.0 16.0 17.2 8.3 23.6 36.8 20.2 16.5 14.8 29.5 18.5 21.2 22.3 14.3 32.6 17.8 14.9 16.0 19.6 20.9 19.2 13.8 24.4 28.7 11.5 16.3 30.6 27.3 22.5 24.1 13.1 40.8 26.3 16.2 22.0 17.5 12.9 51.0 25.3 16.6 21.1 10.1 14.7 14.7 11.6 13.8 45.5 12.0 24.3 29.9 22.9 22.0 20.5 13.5 29.7 16.1 0.6 0.9 0.3 2.1 0.8 3.0 1.5 1.5 1.7 1.2 1.6 2.7 3.3 2.6 0.4 1.2 4.3 0.5 0.7 37.1 35.7 33.1 42.1 31.1 24.9 24.8 36.6 22.2 20.9 6.0 19.9 11.8 8.5 27.5 38.9 15.9 17.8 6.7 9.1 21.0 94.2 9.1 5.0 8.3 9.5 17.5 10.5 0.0 7.3 5.6 14.7 12.6 3.5 15.3 8.9 54.0 22.0 18.4 11.3 15.4 28.7 9.5 8.5 10.8 17.0 24.7 13.1 5.8 30.4 14.6 32.2 6.5 17.8 24.7 10.0 36.3 12.1 11.5 15.0 8.0 TNRC18 "CAGL79, KIAA1856, TNRC18A" ENSG00000182095 "Trinucleotide repeat containing 18" O15417 7 5306790-5425414 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 56.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 17.6" "Lineage enriched" "Detected in all" 4 "granulocytes: 17.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020730, HPA024251" Uncertain Supported "Nucleoplasm,Nuclear membrane,Mitochondria,Cytosol" NA NA "Nucleoplasm, Nuclear membrane, Mitochondria" Cytosol "HPA020730: AB_2670506, HPA024251: AB_2671498" "unprognostic (1.66e-1)" "unprognostic (3.17e-3)" "unprognostic (2.67e-3)" "unprognostic (4.44e-1)" "unprognostic (1.81e-1)" "unprognostic (6.67e-2)" "unprognostic (1.13e-2)" "unprognostic (1.79e-1)" "unprognostic (3.01e-1)" "unprognostic (2.11e-2)" "unprognostic (6.08e-2)" "unprognostic (1.36e-1)" "unprognostic (9.29e-3)" "unprognostic (2.14e-1)" "unprognostic (2.94e-1)" "unprognostic (1.02e-1)" "unprognostic (4.34e-2)" 17.9 11.8 18.1 17.9 17.2 29.4 20.6 35.1 23.6 35.0 29.9 16.7 17.9 16.4 36.0 19.5 19.6 27.5 29.2 13.6 14.2 9.6 15.6 11.8 19.2 12.9 15.5 16.7 30.3 18.4 36.9 14.7 19.7 13.2 25.4 15.1 25.2 17.0 24.4 13.6 18.9 16.9 40.1 12.6 15.3 21.4 14.0 16.6 7.2 20.6 12.8 9.4 27.0 21.4 2.0 4.3 17.6 3.2 2.6 1.5 0.1 21.7 19.4 16.2 13.6 13.7 16.3 41.9 15.5 14.6 8.6 9.2 8.0 19.2 14.9 15.3 22.7 19.2 24.4 9.3 18.5 7.3 6.5 5.9 9.4 16.6 12.9 11.9 31.0 34.9 16.4 21.9 17.1 19.9 12.5 9.6 13.5 13.4 8.4 10.9 36.1 7.3 38.0 1.4 14.3 14.9 8.1 8.0 11.0 7.0 27.8 7.1 16.9 12.0 31.9 11.5 7.6 33.3 32.2 24.0 24.9 35.1 14.8 11.1 12.1 12.5 14.1 14.0 22.1 29.0 9.4 3.2 2.7 1.4 1.2 1.0 1.6 1.0 0.8 1.1 2.0 0.7 1.5 17.6 2.6 1.5 4.3 1.4 0.1 18.1 17.2 35.1 23.6 14.2 9.6 15.5 16.7 13.2 16.6 8.9 31.9 1.4 3.1 8.2 56.8 6.2 15.3 6.7 11.4 14.0 2.0 12.8 1.7 4.5 12.0 10.7 16.9 0.0 5.5 3.6 11.3 4.6 13.9 22.9 9.5 47.7 30.1 29.4 40.0 12.0 17.0 11.9 5.0 3.6 27.0 23.8 8.0 5.8 18.7 4.2 3.7 19.4 11.9 0.5 2.0 7.8 8.4 6.4 21.8 2.6 TNRC6A "CAGH26, GW182, KIAA1460, TNRC6" ENSG00000090905 "Trinucleotide repeat containing 6A" Q8NDV7 16 24610209-24827632 "Plasma proteins, Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" RNA-binding Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Horizontal cells: 166.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015305, HPA017869" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus, Vesicles" "HPA015305: AB_1850454, HPA017869: AB_1850456" "unprognostic (2.64e-1)" "unprognostic (2.11e-1)" "unprognostic (1.77e-1)" "unprognostic (1.86e-1)" "unprognostic (5.00e-2)" "unprognostic (1.10e-3)" "unprognostic (1.62e-1)" "unprognostic (3.22e-3)" "unprognostic (5.49e-2)" "unprognostic (2.74e-1)" "unprognostic (7.44e-3)" "unprognostic (2.63e-3)" "unprognostic (1.78e-1)" "unprognostic (9.18e-2)" "unprognostic (5.77e-2)" "unprognostic (2.31e-1)" "unprognostic (3.35e-2)" 17.3 23.6 14.7 23.2 15.1 10.2 17.0 25.0 19.3 20.8 17.0 15.6 17.2 10.5 26.6 23.1 12.5 20.2 12.6 13.4 11.3 9.4 13.0 17.0 14.0 16.7 14.5 10.9 26.7 20.1 42.6 25.4 12.6 16.2 16.4 12.8 17.8 16.6 18.6 26.5 16.5 16.0 27.5 19.4 14.2 15.8 11.4 14.7 15.9 19.6 14.9 13.8 16.4 16.4 5.4 5.2 2.3 2.7 3.3 3.9 1.3 11.5 16.2 19.2 10.4 16.6 22.1 10.9 19.8 16.1 14.5 15.9 11.8 9.7 11.7 8.6 19.8 14.9 13.1 23.8 16.7 21.9 11.9 12.3 11.7 17.8 16.2 14.3 11.9 8.3 22.1 8.7 18.9 12.5 17.9 19.8 7.8 17.7 7.5 18.7 13.6 10.0 7.9 27.4 5.6 8.1 19.6 14.9 10.6 11.0 10.8 9.4 13.1 13.9 8.6 7.6 15.2 9.9 7.9 18.1 18.6 12.8 9.1 13.9 16.5 13.0 19.6 17.3 7.5 13.3 2.3 2.7 1.9 3.0 1.6 2.5 5.2 2.9 2.7 1.0 5.4 3.9 2.7 1.5 3.3 1.6 5.2 2.9 1.3 14.7 15.1 25.0 19.3 11.3 9.4 14.5 10.9 16.2 14.7 35.7 51.8 48.1 14.8 31.0 84.5 67.4 58.6 22.7 38.7 43.6 111.9 18.0 14.9 20.3 16.0 35.8 32.0 23.3 21.0 12.6 36.1 20.9 38.1 104.9 18.0 166.8 53.7 65.1 54.2 8.1 63.9 27.5 28.7 23.4 36.7 48.9 23.3 33.4 76.4 12.2 83.3 19.4 26.9 44.2 27.2 25.1 6.9 31.7 32.1 14.0 TNRC6C "FLJ20015, KIAA1582" ENSG00000078687 "Trinucleotide repeat containing 6C" Q9HCJ0 17 77959240-78108835 "Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 119.8;Cone photoreceptor cells: 223.8;Rod photoreceptor cells: 142.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "basophil: 12.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 12.9" "Cell line enhanced" "Detected in many" "MOLT-4: 24.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022007, HPA062051" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA022007: AB_2670877, HPA062051: AB_2684670" "unprognostic (4.21e-2)" "unprognostic (1.88e-2)" "unprognostic (2.34e-1)" "unprognostic (1.13e-3)" "unprognostic (2.66e-1)" "unprognostic (8.11e-3)" "unprognostic (2.54e-1)" "unprognostic (2.89e-3)" "unprognostic (2.59e-1)" "unprognostic (7.83e-2)" "prognostic favorable (6.56e-5)" "unprognostic (1.36e-1)" "unprognostic (1.17e-2)" "unprognostic (1.07e-1)" "unprognostic (1.84e-1)" "unprognostic (3.04e-1)" "unprognostic (5.70e-2)" 5.5 3.6 8.9 7.4 15.1 3.6 5.1 13.3 13.8 6.0 3.8 14.5 4.4 2.3 6.9 7.6 3.1 6.9 4.7 6.9 8.5 7.6 3.3 3.4 4.2 7.5 13.3 6.3 9.1 4.4 6.1 7.6 1.9 12.2 6.1 3.0 10.9 6.0 4.9 11.1 3.3 3.8 5.6 7.5 6.0 3.6 13.2 14.3 3.4 4.1 6.1 5.5 3.6 4.1 1.1 0.7 12.9 0.3 3.1 2.7 0.5 3.1 3.0 5.4 5.8 2.3 1.8 0.0 4.8 4.0 3.4 2.8 3.1 0.9 0.0 2.0 3.6 2.4 0.3 4.0 0.1 2.1 2.5 4.1 11.1 1.0 3.5 2.1 2.6 5.7 1.5 1.5 1.3 3.2 1.5 7.1 11.0 2.1 5.6 3.5 4.2 24.9 1.4 2.8 1.4 2.2 3.3 10.9 2.1 0.8 4.5 6.7 12.3 5.7 7.4 2.6 2.8 5.6 3.9 5.2 7.6 2.6 3.9 5.8 4.3 0.7 3.2 2.1 4.1 5.4 12.9 0.3 1.3 1.9 0.2 2.2 1.0 2.1 2.0 0.2 1.1 2.3 2.7 1.2 3.1 0.3 0.7 0.9 0.5 8.9 15.1 13.3 12.5 8.5 7.6 13.3 6.3 12.2 14.3 26.8 26.7 6.1 8.5 19.6 119.8 26.0 30.6 6.7 9.1 8.7 223.8 0.1 1.7 6.2 7.2 25.7 5.3 23.3 5.1 0.3 19.5 13.9 22.0 15.5 2.0 69.9 38.3 29.4 12.9 5.3 47.5 6.1 15.1 2.8 9.0 33.0 6.8 3.5 40.3 4.3 142.8 0.0 31.6 23.5 19.9 12.4 0.2 36.3 5.9 3.8 TOB1 "APRO5, TOB, TROB, TROB1" ENSG00000141232 "Transducer of ERBB2, 1" P50616 17 50862223-50867978 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 66.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047839 Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA047839: AB_2680175" "unprognostic (3.46e-1)" "unprognostic (1.09e-1)" "unprognostic (2.45e-1)" "unprognostic (6.78e-3)" "unprognostic (1.19e-1)" "unprognostic (8.27e-2)" "unprognostic (3.50e-3)" "unprognostic (1.53e-1)" "unprognostic (3.56e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (5.04e-5)" "prognostic unfavorable (3.37e-4)" "unprognostic (3.92e-3)" "unprognostic (9.44e-2)" "unprognostic (1.09e-1)" "unprognostic (4.13e-2)" "unprognostic (6.97e-2)" 14.3 68.4 10.5 10.4 15.7 19.6 29.5 11.3 13.4 20.9 24.2 23.6 24.2 16.9 7.9 12.9 30.2 17.4 42.7 21.7 12.0 11.8 22.5 57.5 17.7 7.5 12.0 10.2 21.5 74.4 30.2 20.0 5.6 13.9 24.5 18.3 36.5 32.4 56.0 60.4 44.7 26.3 23.7 11.9 6.1 28.8 9.0 13.1 8.9 30.3 31.0 13.8 38.8 22.9 7.8 21.3 63.0 25.1 4.8 51.2 25.2 11.0 22.8 7.4 3.0 14.0 7.0 5.6 8.3 20.6 5.4 6.7 9.1 14.3 10.1 16.0 11.3 5.4 15.8 5.0 14.1 5.7 5.0 7.3 1.2 26.7 15.0 19.5 5.1 5.0 14.9 17.5 6.2 32.3 7.3 2.6 3.1 4.1 8.9 11.4 30.1 4.0 4.9 2.6 27.8 8.7 3.5 9.4 12.0 21.4 23.0 4.3 10.6 14.1 42.1 4.9 11.9 66.4 6.9 3.4 6.3 4.4 6.9 3.9 13.6 14.2 4.7 5.1 2.6 2.4 63.0 10.5 49.9 46.6 18.6 51.2 7.8 43.4 36.4 21.3 6.2 38.4 46.2 23.6 4.8 25.1 6.9 35.9 25.2 10.5 15.7 11.3 13.4 12.0 11.8 12.0 10.2 13.9 13.1 107.2 101.9 31.7 161.4 251.6 130.0 101.0 127.4 71.0 51.2 64.6 53.0 14.5 87.9 38.8 73.3 29.2 99.6 23.3 47.3 1.2 76.4 113.9 61.3 179.4 31.5 17.5 195.2 33.2 33.0 32.8 24.5 54.0 67.4 26.2 199.4 88.3 38.3 178.0 56.3 51.2 56.2 161.7 81.2 43.1 8.3 201.7 9.2 75.9 142.2 265.3 TOE1 hCaf1z ENSG00000132773 "Target of EGR1, exonuclease" Q96GM8 1 45339670-45343975 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 33.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053775, HPA069119" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA053775: AB_2682259, HPA069119: AB_2686090" "unprognostic (7.20e-2)" "unprognostic (1.20e-1)" "unprognostic (7.15e-3)" "unprognostic (1.90e-2)" "unprognostic (3.33e-1)" "prognostic favorable (9.05e-4)" "prognostic unfavorable (6.12e-9)" "unprognostic (4.67e-2)" "unprognostic (4.84e-2)" "unprognostic (2.37e-2)" "unprognostic (6.03e-2)" "unprognostic (2.24e-1)" "prognostic unfavorable (2.71e-4)" "prognostic favorable (9.98e-4)" "unprognostic (1.81e-1)" "unprognostic (1.41e-2)" "unprognostic (2.08e-1)" 7.4 9.2 8.9 8.0 10.6 9.7 8.1 11.6 9.4 7.4 8.9 8.7 11.2 9.8 10.8 11.0 8.3 8.9 8.7 7.5 6.4 5.6 7.1 7.9 9.4 8.7 5.1 7.4 9.4 7.4 10.8 7.8 8.2 7.7 8.8 9.2 10.0 9.9 7.7 4.3 6.9 9.4 10.0 9.4 11.0 9.4 18.7 5.0 14.6 10.3 6.1 8.8 9.1 7.3 8.7 6.0 13.8 6.8 3.2 9.6 4.7 8.2 4.5 6.4 7.6 3.8 3.1 11.5 6.7 6.0 12.4 11.8 5.6 4.4 14.5 6.8 7.9 11.0 7.5 10.0 11.6 8.7 9.2 8.2 15.3 8.8 6.2 3.3 9.2 8.4 4.5 2.0 12.5 8.0 4.3 9.9 12.0 12.0 8.0 8.5 6.4 16.4 7.8 14.2 9.2 6.2 11.8 11.3 6.3 4.9 11.0 6.8 7.0 6.8 17.5 13.0 11.0 4.4 14.7 6.7 5.3 11.2 9.6 11.9 5.7 7.6 9.2 7.9 12.1 6.8 13.8 5.7 5.7 7.9 6.8 9.6 6.2 7.7 8.4 5.5 8.7 6.9 8.3 0.8 3.2 5.9 6.0 8.5 4.7 8.9 10.6 11.6 9.4 6.4 5.6 5.1 7.4 7.7 5.0 6.0 3.7 9.5 5.0 1.5 9.9 1.4 7.6 4.0 9.1 7.0 11.8 33.5 6.6 4.8 8.9 9.0 6.7 0.0 5.5 10.3 5.2 5.5 11.5 4.5 8.0 7.9 2.9 7.4 3.5 6.5 6.4 4.9 3.3 13.6 5.9 12.3 2.8 10.5 6.0 5.8 17.6 12.9 7.2 31.0 18.1 1.3 19.0 7.0 5.7 3.7 TOGARAM1 "crescerin, Crescerin-1, FAM179B, KIAA0423" ENSG00000198718 "TOG array regulator of axonemal microtubules 1" Q9Y4F4 14 44962208-45074431 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Ciliated cells: 71.0;Club cells: 37.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 6.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050849, HPA053559" Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA050849: AB_2681257, HPA053559: AB_2682190" "unprognostic (2.91e-1)" "unprognostic (4.07e-2)" "unprognostic (2.04e-2)" "unprognostic (1.05e-2)" "unprognostic (1.40e-1)" "unprognostic (1.17e-1)" "unprognostic (4.88e-2)" "unprognostic (2.67e-2)" "unprognostic (2.69e-1)" "unprognostic (1.21e-1)" "unprognostic (5.63e-2)" "unprognostic (6.49e-2)" "prognostic favorable (8.38e-4)" "unprognostic (1.62e-1)" "unprognostic (2.15e-1)" "unprognostic (3.02e-2)" "unprognostic (1.60e-1)" 6.9 11.6 13.6 7.0 17.5 6.0 9.0 16.3 34.4 12.3 6.7 10.0 9.8 4.8 10.3 9.9 8.1 17.5 8.3 13.7 14.5 10.5 14.0 8.0 12.9 8.4 13.1 17.0 13.9 11.1 15.5 20.1 9.9 11.0 9.9 6.6 6.8 7.8 11.5 19.1 6.5 5.9 9.2 13.0 7.1 6.4 9.3 12.5 9.1 15.4 5.2 6.7 8.6 6.7 1.7 1.8 6.9 1.0 1.9 1.4 0.8 3.1 5.1 5.0 1.3 11.4 13.6 3.5 4.4 9.7 8.5 10.2 2.1 3.4 2.9 5.1 7.1 4.4 5.9 9.0 2.8 9.6 2.6 3.3 2.4 2.7 2.5 8.4 4.2 2.6 7.8 5.3 4.6 8.3 10.2 6.7 1.6 1.7 3.5 8.8 4.7 5.4 2.3 1.7 4.6 4.0 2.7 12.2 2.0 8.1 11.0 5.2 2.0 5.2 7.9 7.9 5.5 5.8 3.4 5.0 5.8 4.5 7.5 3.2 3.5 2.4 3.4 3.3 0.8 4.9 6.9 1.0 2.2 1.1 0.9 1.3 1.0 1.4 1.1 1.3 1.7 1.4 0.9 0.1 1.9 0.9 1.8 1.4 0.8 13.6 17.5 16.3 34.4 14.5 10.5 13.1 17.0 11.0 12.5 14.9 12.2 0.0 0.0 0.0 0.0 0.0 0.0 71.0 37.5 15.7 0.0 8.3 1.7 8.9 0.0 0.0 0.0 0.0 5.0 6.5 0.0 0.0 9.3 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 11.8 0.0 0.0 7.4 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 TOGARAM2 "Crescerin-2, FAM179A, FLJ43249, LOC165186" ENSG00000189350 "TOG array regulator of axonemal microtubules 2" Q6ZUX3 2 28956611-29061373 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.3;epididymis: 14.4;fallopian tube: 15.7;lung: 14.2" "Cell type enriched" "Detected in some" 5 "Ciliated cells: 56.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 3.7" "Lineage enriched" "Detected in single" 5 "T-cells: 3.7" "Cell line enhanced" "Detected in some" "HMC-1: 3.8;NB-4: 3.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA037561, HPA037562, HPA075216" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA037561: AB_10670384, HPA037562: AB_2675545, HPA075216: " "unprognostic (8.35e-5)" "unprognostic (2.85e-3)" "unprognostic (1.41e-1)" "unprognostic (7.01e-3)" "unprognostic (6.41e-2)" "unprognostic (1.23e-2)" "unprognostic (1.11e-1)" "unprognostic (2.53e-3)" "unprognostic (3.93e-1)" "unprognostic (6.83e-2)" "unprognostic (2.32e-3)" "unprognostic (5.92e-2)" "unprognostic (3.94e-11)" "unprognostic (3.75e-2)" "unprognostic (4.46e-1)" "unprognostic (2.01e-2)" "unprognostic (2.81e-3)" 0.3 2.3 3.0 1.7 8.4 2.6 0.4 3.4 1.7 0.6 0.6 7.1 0.0 0.8 1.1 14.4 0.7 15.7 0.5 2.6 3.3 3.9 0.3 0.5 14.2 1.1 2.1 2.0 4.5 0.8 0.1 6.1 0.6 15.3 0.5 0.4 0.1 0.5 0.1 1.7 0.6 0.7 0.8 2.5 2.2 1.5 3.2 6.1 0.0 0.3 0.3 1.3 0.4 0.3 0.3 0.3 0.6 0.3 0.6 3.7 1.0 0.2 0.2 0.3 0.2 0.3 0.0 0.7 0.1 2.3 0.7 2.2 0.4 0.3 0.3 0.3 0.0 0.3 0.9 0.4 0.0 0.7 0.4 1.4 0.2 2.0 0.5 0.9 2.0 3.8 0.2 0.3 0.0 0.0 0.8 0.3 2.7 0.3 1.0 0.8 0.2 0.8 3.6 2.7 1.2 0.7 0.1 0.7 1.5 1.1 0.3 2.6 1.8 0.1 0.1 0.1 0.4 0.4 0.2 0.2 0.2 0.5 0.2 0.3 0.5 0.5 0.2 1.7 1.3 0.1 0.5 0.3 0.3 3.7 0.1 2.0 0.2 0.6 2.9 0.1 0.3 0.4 1.0 0.6 0.6 0.2 0.3 1.5 1.0 3.0 8.4 3.4 1.2 3.3 3.9 2.1 2.0 15.3 6.1 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 56.2 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 TONSL "IKBR, NFKBIL2" ENSG00000160949 "Tonsoku like, DNA repair protein" Q96HA7 8 144428775-144444444 "Predicted intracellular proteins, Transcription factors" "DNA damage, DNA repair" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 31.4;Enterocytes: 32.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.9" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA024679, HPA046494" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA Yes Nucleoplasm "Nuclear bodies" "HPA024679: AB_1854441, HPA046494: AB_2679673" "unprognostic (6.68e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-1)" "unprognostic (2.88e-2)" "unprognostic (7.35e-2)" "unprognostic (2.10e-3)" "prognostic unfavorable (2.84e-4)" "unprognostic (1.04e-3)" "unprognostic (7.81e-2)" "unprognostic (4.39e-2)" "unprognostic (3.38e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (2.62e-7)" "unprognostic (3.24e-2)" "unprognostic (1.78e-1)" "unprognostic (9.11e-3)" "unprognostic (7.96e-2)" 1.4 2.8 1.4 11.0 1.8 11.7 1.9 6.1 2.7 1.9 5.5 1.4 3.2 5.5 2.2 1.8 5.6 1.7 1.3 1.6 1.2 1.1 2.0 2.3 2.6 3.7 1.9 1.2 2.4 2.3 1.1 1.1 2.6 2.9 2.1 1.7 0.8 3.1 2.2 1.0 4.0 6.8 1.4 1.9 5.6 3.5 4.8 2.1 10.3 3.3 3.6 5.3 3.9 5.1 0.6 0.1 0.0 0.2 1.9 0.6 0.1 6.9 6.2 4.7 7.4 0.3 0.6 11.4 5.9 1.1 3.6 2.8 5.0 6.1 6.5 6.1 0.9 1.7 4.8 4.6 3.6 0.8 6.7 9.1 15.4 8.0 5.2 0.2 4.7 9.7 0.6 0.5 3.7 0.7 0.9 1.7 9.0 17.3 4.9 1.4 14.4 11.6 8.0 6.7 6.8 9.2 14.1 3.1 6.7 2.0 7.6 7.9 4.5 6.2 4.2 2.6 1.9 6.0 4.4 2.0 4.4 18.4 5.0 7.2 1.7 3.2 3.9 4.3 10.0 5.1 0.0 0.0 0.0 0.3 0.2 0.0 0.6 0.2 0.6 0.1 0.6 0.5 0.4 0.0 1.9 0.0 0.0 0.2 0.1 1.4 1.8 6.1 2.7 1.2 1.1 1.9 1.2 2.9 2.1 6.0 31.4 5.2 3.3 7.9 2.4 2.1 10.2 6.7 5.7 1.8 2.0 2.5 0.0 1.0 0.2 2.3 32.9 0.0 0.9 4.4 4.1 3.1 2.3 8.6 3.7 1.6 2.4 4.3 1.6 0.2 0.3 5.8 13.5 1.0 8.4 0.8 0.8 5.7 1.1 3.7 2.5 6.5 3.3 2.8 8.1 9.8 1.0 3.9 9.6 3.1 TOP1 ENSG00000198900 "DNA topoisomerase I" P11387 20 41028818-41124487 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction" "DNA-binding, Isomerase, Topoisomerase" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Syncytiotrophoblasts: 670.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009058, HPA019039" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" No Yes "Nucleoplasm, Nucleoli fibrillar center" "CAB009058: AB_2303554, HPA019039: AB_1858187" "unprognostic (1.46e-1)" "unprognostic (8.65e-2)" "unprognostic (1.33e-2)" "unprognostic (1.92e-3)" "unprognostic (5.05e-2)" "unprognostic (1.49e-3)" "prognostic unfavorable (6.42e-4)" "unprognostic (5.86e-2)" "unprognostic (1.51e-1)" "unprognostic (4.60e-2)" "unprognostic (3.74e-3)" "unprognostic (6.51e-2)" "unprognostic (8.65e-2)" "unprognostic (4.70e-2)" "unprognostic (5.14e-1)" "unprognostic (3.64e-1)" "unprognostic (1.29e-1)" 26.6 31.0 24.6 46.3 25.3 55.3 37.4 39.6 31.1 21.3 30.0 11.1 26.7 29.7 22.9 22.5 36.0 20.5 29.2 21.0 23.0 18.3 31.8 32.7 37.9 38.6 21.9 20.9 25.5 22.5 22.2 39.9 43.9 25.2 23.3 27.2 13.6 25.3 34.3 26.2 24.6 48.4 23.1 27.4 36.9 26.7 14.2 24.2 54.2 31.5 25.1 40.6 25.2 41.7 9.0 17.2 18.4 11.1 5.8 8.2 4.6 22.0 15.4 28.9 23.7 11.7 14.0 28.7 20.0 17.6 23.2 21.2 40.5 27.8 62.9 21.4 10.3 24.8 21.5 34.7 31.9 34.1 13.6 17.7 80.2 12.4 28.7 30.6 34.5 27.6 15.8 17.0 22.6 37.2 20.8 24.2 23.0 34.7 21.9 26.2 49.0 48.8 21.9 23.3 22.1 28.8 41.7 27.2 33.4 24.8 20.5 24.1 16.7 31.3 19.4 20.3 21.8 21.6 30.9 23.7 18.8 16.0 17.4 21.4 13.9 15.6 73.3 25.3 19.4 17.8 9.1 9.2 14.3 6.5 9.2 8.2 9.0 7.2 6.8 8.6 8.7 7.7 6.9 18.4 5.8 11.1 17.2 7.9 4.6 24.6 25.3 39.6 31.1 23.0 18.3 21.9 20.9 25.2 24.2 110.2 181.3 71.6 274.4 218.4 93.3 38.9 84.1 73.6 228.6 94.2 56.9 139.0 63.0 78.8 6.3 78.8 108.1 210.2 57.1 149.4 129.3 136.7 76.2 114.3 86.4 68.3 88.0 63.8 84.7 6.5 55.3 93.8 69.2 72.1 73.8 94.4 93.7 112.2 65.4 91.4 80.4 84.1 77.1 95.2 57.3 187.2 670.2 61.2 78.0 206.2 TOP2A TOP2 ENSG00000131747 "DNA topoisomerase II alpha" P11388 17 40388516-40417950 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Biological rhythms" "DNA-binding, Isomerase, Topoisomerase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 146.3;testis: 36.8" "Group enriched" "Detected in many" 4 "Erythroid cells: 280.4;Spermatocytes: 527.8;Spermatogonia: 241.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 5.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB002448, HPA006458, HPA026773" Enhanced Approved Supported Nucleoplasm,Nucleoli Yes Yes Nucleoplasm Nucleoli "CAB002448: AB_564035, HPA006458: AB_1858189, HPA026773: AB_1858190" "unprognostic (2.09e-1)" "unprognostic (1.24e-1)" "unprognostic (2.28e-3)" "unprognostic (9.42e-3)" "unprognostic (1.80e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.92e-6)" "prognostic unfavorable (4.99e-4)" "unprognostic (6.21e-3)" "unprognostic (2.09e-1)" "prognostic unfavorable (3.83e-5)" "unprognostic (5.03e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.46e-2)" "unprognostic (1.07e-1)" "unprognostic (2.18e-1)" "unprognostic (2.29e-1)" 2.7 2.0 0.4 20.0 0.5 14.6 4.1 0.4 0.5 3.0 6.9 0.5 0.5 7.0 2.0 3.4 18.2 0.7 2.4 2.3 0.6 0.5 1.4 1.9 5.5 15.4 0.6 0.4 1.2 1.1 0.0 0.4 10.7 0.6 1.2 8.0 0.6 3.2 0.3 0.6 5.9 9.2 2.6 1.8 7.3 4.5 36.8 0.3 146.3 0.9 11.8 16.7 3.2 5.7 1.3 0.3 0.3 0.3 3.2 5.7 1.1 34.3 45.6 58.1 26.6 2.9 5.9 12.9 47.1 25.4 43.4 38.5 21.4 26.3 55.4 24.0 15.9 26.0 54.7 44.6 18.8 58.3 29.5 29.8 36.6 29.2 35.6 0.2 51.2 39.0 1.3 1.5 30.5 31.1 9.4 22.8 36.1 39.5 38.0 46.8 11.9 59.3 34.4 24.1 24.9 18.2 50.4 90.2 23.0 10.4 22.0 34.3 24.7 38.0 47.5 15.0 35.3 39.8 23.6 14.9 28.6 40.4 33.0 45.2 21.8 24.6 48.3 16.1 35.3 47.7 0.3 0.0 0.0 0.6 0.0 0.0 1.3 0.9 0.9 0.3 0.4 0.2 0.1 0.3 3.2 0.3 0.0 5.7 1.1 0.4 0.5 0.4 0.5 0.6 0.5 0.6 0.4 0.6 0.3 0.0 1.3 28.7 1.4 10.4 0.0 1.1 2.5 0.0 6.8 0.0 0.0 8.4 0.0 0.9 12.5 0.7 2.1 280.4 0.0 81.4 9.7 1.2 0.0 3.9 64.5 0.0 0.0 27.6 30.0 15.2 4.4 13.1 1.7 2.8 5.9 0.0 0.2 3.6 1.8 0.0 0.0 71.1 1.4 527.8 241.9 5.4 7.4 7.7 24.2 2.6 TOP2B ENSG00000077097 "DNA topoisomerase II beta" Q02880 3 25597905-25664907 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "DNA-binding, Isomerase, Topoisomerase" "Autism spectrum disorder, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 106.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004601, HPA024120, HPA050441" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004601: AB_628384, HPA024120: AB_1858191, HPA050441: AB_2681127" "unprognostic (2.90e-2)" "unprognostic (5.17e-2)" "unprognostic (7.21e-3)" "unprognostic (2.42e-1)" "unprognostic (1.60e-1)" "unprognostic (1.43e-2)" "prognostic unfavorable (1.86e-7)" "unprognostic (7.86e-2)" "unprognostic (1.89e-1)" "unprognostic (2.84e-1)" "unprognostic (7.14e-2)" "unprognostic (1.08e-1)" "prognostic favorable (2.43e-4)" "unprognostic (1.01e-1)" "unprognostic (1.59e-1)" "unprognostic (1.49e-1)" "unprognostic (7.93e-2)" 19.3 18.8 23.4 23.1 29.7 26.5 21.1 48.4 33.5 24.1 22.4 21.1 18.9 17.1 29.6 25.6 21.1 20.6 20.7 22.7 22.0 19.9 20.3 18.4 17.7 28.2 21.0 28.5 26.8 17.2 43.0 21.6 22.3 26.4 24.7 20.8 17.6 21.3 22.3 31.3 20.9 19.3 24.4 23.4 24.6 20.1 11.3 22.7 60.2 28.3 20.7 27.3 34.8 21.5 5.5 5.6 5.3 4.6 7.8 7.2 2.2 10.7 11.1 24.6 30.1 8.2 10.4 9.8 10.4 13.4 9.7 10.6 5.7 8.5 33.3 7.3 15.0 6.0 9.1 20.3 11.6 16.3 15.9 10.9 50.4 13.8 9.5 5.8 39.4 27.0 7.4 5.8 10.8 9.5 9.8 15.7 22.8 16.9 16.4 12.4 11.9 25.5 9.7 18.6 7.2 8.5 106.6 13.8 15.4 8.7 37.9 12.4 21.5 15.5 11.1 9.5 14.8 11.5 35.3 15.0 13.5 10.5 10.7 11.1 25.4 14.4 35.3 8.8 29.5 8.9 4.2 2.9 5.3 6.3 3.3 6.9 4.3 6.1 6.4 4.3 5.5 7.2 6.4 2.0 7.8 4.6 5.6 4.4 2.2 23.4 29.7 48.4 33.5 22.0 19.9 21.0 28.5 26.4 22.7 59.6 57.9 25.1 36.1 34.8 53.5 109.0 43.3 34.8 40.9 24.4 53.0 41.2 11.6 29.3 2.9 32.2 17.7 23.3 28.8 20.8 35.0 47.5 31.4 33.5 23.1 57.2 57.0 21.5 40.9 4.8 36.2 38.8 21.9 21.6 32.6 46.4 32.0 17.5 31.5 21.9 89.3 32.3 36.7 66.2 27.0 33.0 39.0 45.0 37.9 57.7 TOP3B ENSG00000100038 "DNA topoisomerase III beta" O95985 22 21957025-21982816 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA-binding, Isomerase, Topoisomerase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 49.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072114 Approved Nucleoplasm NA NA Nucleoplasm "HPA072114: " "unprognostic (1.03e-1)" "unprognostic (2.05e-2)" "unprognostic (1.44e-1)" "unprognostic (1.68e-2)" "unprognostic (3.37e-1)" "unprognostic (5.04e-2)" "unprognostic (2.27e-1)" "unprognostic (3.93e-1)" "unprognostic (2.15e-2)" "unprognostic (2.89e-2)" "unprognostic (1.95e-1)" "unprognostic (1.29e-2)" "unprognostic (1.96e-2)" "unprognostic (1.69e-2)" "unprognostic (1.21e-1)" "unprognostic (3.53e-2)" "unprognostic (1.11e-4)" 10.4 11.7 12.1 16.1 17.4 20.8 10.9 17.2 17.1 12.5 11.0 16.9 14.9 15.4 16.1 11.0 14.2 11.0 11.2 10.1 12.7 5.5 13.4 15.3 12.7 17.0 18.7 6.5 20.2 12.1 13.5 21.0 12.1 16.2 15.6 14.9 14.1 13.3 13.3 13.4 17.5 16.1 14.5 17.4 23.6 11.8 11.1 16.9 13.1 14.2 5.7 18.9 10.5 14.3 9.0 8.8 2.7 6.8 6.1 9.3 5.2 9.7 9.3 19.1 7.6 7.1 5.9 11.9 6.5 8.1 15.0 13.3 10.1 4.2 13.4 4.9 6.7 6.3 17.9 8.6 11.5 12.1 6.8 20.6 10.5 12.0 10.4 9.6 14.3 6.9 2.9 17.6 12.4 6.0 8.7 12.5 7.8 49.2 7.3 7.0 9.9 8.9 11.1 7.8 7.1 8.9 14.1 12.7 2.1 7.4 13.0 12.5 9.1 7.9 7.1 6.0 8.0 5.5 9.2 9.0 6.2 13.0 5.8 7.9 10.8 8.8 12.7 4.8 8.7 6.4 2.5 6.7 2.7 9.3 6.8 6.5 7.5 5.8 6.5 7.4 9.0 5.9 5.7 2.3 6.1 3.8 8.8 6.7 5.2 12.1 17.4 17.2 17.1 12.7 5.5 18.7 6.5 16.2 16.9 0.0 1.6 4.7 2.3 1.5 4.5 0.0 12.7 5.3 1.2 3.5 9.8 4.1 1.7 4.1 0.9 2.5 4.1 0.0 3.7 3.0 2.8 3.6 1.1 4.4 3.5 1.6 4.6 7.4 3.7 1.1 9.8 2.7 5.0 2.8 3.9 2.4 5.2 3.5 7.1 2.2 5.3 6.5 1.4 5.4 4.7 1.4 3.3 5.7 5.6 2.5 TOPBP1 "KIAA0259, TOP2BP1" ENSG00000163781 "DNA topoisomerase II binding protein 1" Q92547 3 133598175-133662380 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 79.9;Spermatocytes: 68.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022451, HPA036738, HPA036739" Approved Supported Nucleoplasm No No Nucleoplasm "CAB022451: , HPA036738: AB_2675280, HPA036739: AB_2675281" "unprognostic (7.72e-2)" "unprognostic (8.54e-2)" "unprognostic (2.77e-2)" "prognostic unfavorable (5.76e-5)" "unprognostic (2.05e-1)" "unprognostic (3.05e-2)" "prognostic unfavorable (4.66e-5)" "unprognostic (8.03e-2)" "unprognostic (3.98e-2)" "unprognostic (2.59e-2)" "prognostic unfavorable (1.88e-4)" "unprognostic (2.74e-3)" "unprognostic (8.65e-3)" "unprognostic (7.97e-2)" "unprognostic (2.52e-1)" "unprognostic (7.64e-2)" "unprognostic (1.60e-1)" 13.0 8.2 9.7 16.1 11.7 32.9 17.2 14.4 13.8 9.6 10.8 5.4 8.2 9.7 11.5 10.3 15.0 9.7 8.8 12.1 9.2 7.8 7.4 8.6 10.2 21.3 8.8 9.2 11.0 12.6 10.0 9.8 14.0 10.7 9.5 14.0 5.1 12.0 7.2 10.8 13.6 13.0 11.0 13.1 18.9 10.9 24.6 8.8 38.0 10.3 11.5 20.9 11.0 11.1 2.8 3.1 6.1 2.7 3.0 4.4 1.2 16.0 10.0 16.3 13.2 3.1 4.1 12.2 12.5 10.0 15.5 20.1 13.9 10.2 29.1 11.1 9.1 18.8 18.7 23.4 8.3 24.0 17.6 10.4 27.3 14.5 8.5 3.0 29.1 21.6 4.8 5.2 15.2 9.1 5.8 10.6 17.3 16.9 20.9 12.2 11.0 28.5 15.5 13.4 18.4 8.5 19.3 20.3 21.2 5.5 11.1 15.5 17.2 15.4 8.5 12.9 16.6 14.2 27.2 7.3 16.4 14.9 16.6 13.7 12.6 18.9 56.1 9.7 15.6 14.4 4.6 2.0 6.1 2.2 2.7 3.3 2.8 2.3 2.2 2.0 1.9 2.2 2.3 2.4 3.0 1.5 3.1 4.4 1.2 9.7 11.7 14.4 13.8 9.2 7.8 8.8 9.2 10.7 8.8 20.8 24.5 14.2 6.9 11.0 14.7 7.9 15.3 12.0 30.7 10.4 2.0 15.8 8.3 9.3 56.8 13.2 6.5 23.3 11.5 18.3 8.0 7.5 7.0 8.6 9.8 3.2 6.9 7.4 11.9 79.9 9.5 14.0 8.5 20.8 10.1 10.4 11.7 10.5 9.2 5.0 8.5 12.9 5.2 68.9 51.3 10.0 11.7 13.8 12.4 8.8 TOPORS "LUN, RP31, TP53BPL" ENSG00000197579 "TOP1 binding arginine/serine rich protein" Q9NS56 9 32540544-32552553 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, Ubl conjugation pathway" Transferase "Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 148.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 33.4" "Lineage enriched" "Detected in all" 5 "granulocytes: 33.4" "Cell line enhanced" "Detected in all" "HEL: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060640, HPA065661" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA060640: AB_2684334, HPA065661: AB_2685527" "unprognostic (1.75e-1)" "unprognostic (1.73e-1)" "unprognostic (1.20e-2)" "unprognostic (1.14e-2)" "unprognostic (1.29e-1)" "unprognostic (1.01e-1)" "unprognostic (1.45e-1)" "unprognostic (1.37e-2)" "unprognostic (9.94e-2)" "prognostic favorable (7.07e-4)" "unprognostic (2.70e-1)" "unprognostic (3.61e-1)" "prognostic favorable (6.64e-6)" "unprognostic (1.22e-1)" "unprognostic (5.95e-2)" "unprognostic (3.13e-1)" "unprognostic (2.92e-1)" 16.0 12.5 12.7 8.5 16.0 22.9 13.7 18.6 15.1 14.0 12.2 9.6 9.5 8.8 12.9 11.4 13.1 10.5 11.7 9.3 15.9 9.6 14.6 17.4 10.6 10.0 20.1 5.2 17.5 13.2 19.6 19.5 17.9 14.8 13.1 10.3 9.2 11.0 10.8 10.9 10.2 16.8 12.3 17.8 12.4 10.7 18.9 15.0 15.5 15.6 9.8 10.5 16.3 16.0 5.2 4.9 33.4 5.9 7.1 7.4 3.4 8.2 7.6 10.5 9.2 12.9 11.7 6.7 10.5 9.9 8.7 10.2 4.7 4.2 13.4 6.1 10.5 7.7 5.5 12.4 11.9 12.3 11.1 6.8 45.2 13.3 5.9 8.0 12.8 12.5 9.4 13.4 12.6 8.9 10.9 10.6 10.2 7.8 7.0 14.2 4.4 11.4 23.6 14.0 6.1 7.8 11.8 9.4 6.0 11.7 8.7 5.2 8.4 10.5 5.7 6.8 12.4 5.8 7.3 11.1 9.6 9.8 5.0 7.7 4.9 7.8 14.5 8.9 7.4 4.3 14.6 4.9 10.0 5.0 4.6 5.4 4.6 5.4 5.8 4.9 5.2 7.4 7.2 33.4 7.1 5.9 4.0 6.3 3.4 12.7 16.0 18.6 15.1 15.9 9.6 20.1 5.2 14.8 15.0 50.6 20.6 26.5 37.9 41.9 48.4 16.8 28.1 18.7 38.7 24.4 35.3 25.9 16.6 21.0 148.7 37.9 22.0 0.0 16.2 14.5 27.8 32.6 40.5 20.2 15.7 52.4 44.0 22.1 16.6 13.0 30.8 27.2 18.6 27.9 18.4 48.5 18.7 22.9 30.8 19.1 38.4 19.4 37.1 51.9 49.7 41.7 42.4 34.1 19.0 41.6 TOR4A "C9orf167, FLJ20245" ENSG00000198113 "Torsin family 4 member A" Q9NXH8 9 137277749-137282641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Undifferentiated cells: 28.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 22.9;TIME: 20.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA044913 Enhanced Approved Nucleoplasm NA NA 1500000 Nucleoplasm "HPA044913: AB_10965030" "unprognostic (1.95e-1)" "unprognostic (1.51e-2)" "prognostic unfavorable (6.48e-4)" "unprognostic (1.99e-1)" "unprognostic (3.56e-2)" "unprognostic (4.59e-2)" "prognostic unfavorable (3.44e-4)" "unprognostic (5.42e-3)" "unprognostic (1.69e-1)" "unprognostic (1.47e-1)" "unprognostic (1.11e-2)" "unprognostic (2.24e-1)" "unprognostic (5.20e-2)" "unprognostic (2.00e-3)" "unprognostic (4.39e-3)" "unprognostic (7.93e-3)" "unprognostic (2.56e-1)" 8.7 3.0 1.6 9.1 3.1 3.2 3.8 0.6 1.7 6.0 12.9 2.8 7.6 12.5 5.0 4.7 8.4 4.6 23.2 12.4 1.5 1.3 8.0 6.6 14.8 7.5 2.8 1.1 9.4 4.0 0.4 2.1 4.9 2.3 3.4 5.8 5.5 1.8 9.7 1.8 2.0 14.5 1.9 2.4 19.4 15.6 1.9 2.0 2.9 5.0 1.4 13.3 4.5 3.9 0.9 1.6 3.7 3.5 0.7 0.7 0.9 8.0 10.6 0.0 0.3 0.1 0.8 0.8 13.4 9.2 6.2 3.3 1.3 15.3 0.8 18.9 4.7 0.4 16.7 0.0 4.4 2.1 0.6 0.7 8.8 7.3 7.1 13.4 3.8 22.9 0.5 4.7 1.2 2.4 7.1 8.4 0.0 13.2 1.0 1.0 0.8 0.0 10.6 1.3 8.7 11.9 2.1 2.9 5.4 7.4 0.0 0.4 0.1 9.7 0.1 0.2 0.3 0.8 11.9 20.5 0.3 7.4 1.4 2.2 0.1 0.5 5.1 2.3 3.5 3.0 1.6 2.3 3.7 0.5 2.1 0.6 0.7 0.4 0.1 1.6 0.9 0.0 0.1 1.4 0.7 3.5 0.2 0.7 0.9 1.6 3.1 0.6 1.7 1.5 1.3 2.8 1.1 2.3 2.0 0.0 5.1 3.9 2.1 2.4 0.0 5.6 25.5 1.4 2.3 12.2 0.0 0.1 0.0 9.4 0.1 3.8 20.6 0.0 1.9 0.1 0.9 1.4 10.3 0.8 12.7 0.0 6.9 26.4 25.2 0.0 2.3 8.2 0.0 11.8 23.9 0.8 14.0 24.9 3.9 0.4 0.5 19.4 3.1 0.0 0.9 2.0 0.0 2.2 28.7 10.8 TOX "KIAA0808, TOX1" ENSG00000198846 "Thymocyte selection associated high mobility group box" O94900 8 58805418-59119208 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 88.8" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 30.6;Intestinal endocrine cells: 44.1;Mucus-secreting cells: 25.4;T-cells: 35.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 21.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "JURKAT: 27.9;MOLT-4: 52.6;SH-SY5Y: 16.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA018322, HPA073241" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA018322: AB_1858199, HPA073241: AB_2686584" "unprognostic (7.60e-4)" "unprognostic (6.16e-3)" "unprognostic (5.65e-2)" "unprognostic (2.27e-1)" "unprognostic (9.53e-2)" "unprognostic (4.52e-1)" "unprognostic (1.22e-1)" "prognostic favorable (5.20e-4)" "unprognostic (1.46e-1)" "unprognostic (3.46e-3)" "unprognostic (6.73e-3)" "unprognostic (4.66e-2)" "prognostic unfavorable (1.90e-7)" "unprognostic (1.12e-1)" "unprognostic (1.75e-1)" "unprognostic (2.03e-1)" "unprognostic (1.97e-1)" 1.3 1.2 10.5 15.7 6.3 2.8 1.5 1.9 15.6 2.1 13.4 1.5 1.2 10.0 1.5 1.1 3.7 1.1 5.0 0.9 6.3 9.8 3.2 1.7 4.9 17.7 4.8 12.0 6.6 2.4 2.9 3.7 1.5 2.2 2.4 9.3 2.6 1.8 1.3 0.5 1.0 10.7 2.8 2.3 5.7 10.0 6.5 2.5 88.8 1.5 0.8 19.4 2.6 2.3 3.4 0.8 10.2 0.1 10.4 21.0 3.1 0.3 0.0 5.8 0.0 0.6 1.3 0.0 1.2 2.8 0.7 0.1 0.0 0.0 0.0 0.0 5.2 0.3 0.4 1.4 0.0 0.1 0.2 0.5 0.0 1.1 0.0 4.9 1.0 0.2 0.7 0.1 0.8 1.1 0.3 9.5 27.9 0.0 0.0 0.4 0.0 52.6 0.0 1.0 0.0 0.1 1.1 4.0 0.0 0.1 0.1 5.4 16.5 0.0 0.0 0.0 1.4 0.0 0.0 0.1 1.5 0.7 4.8 1.6 0.0 0.0 3.6 0.1 0.0 1.0 10.2 0.1 1.8 7.5 0.0 3.4 3.4 5.5 11.3 0.8 0.6 2.1 6.3 0.2 10.4 0.0 0.0 21.0 3.1 10.5 6.3 1.9 15.6 6.3 9.8 4.8 12.0 2.2 2.5 8.9 30.6 6.0 0.1 1.1 15.4 1.2 2.5 18.7 4.5 1.8 0.0 2.6 0.0 0.7 1.3 1.6 4.0 0.0 0.6 0.2 1.9 0.1 16.1 0.0 2.9 0.0 44.1 0.0 0.0 1.7 0.9 1.5 0.0 0.0 25.4 12.4 2.1 2.9 0.4 0.7 1.9 0.0 1.0 1.2 0.4 1.1 0.7 35.8 5.1 0.1 TOX2 "C20orf100, dJ1108D11.2, GCX-1" ENSG00000124191 "TOX high mobility group box family member 2" Q96NM4 20 43914864-44069616 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 77.2" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 21.1;Ito cells: 39.3;Late spermatids: 14.0;Smooth muscle cells: 12.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 9.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 45.8;PC-3: 20.5;U-266/70: 29.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA049900, HPA058396" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA049900: AB_2680942, HPA058396: AB_2683704" "unprognostic (2.15e-2)" "unprognostic (1.82e-2)" "unprognostic (8.97e-3)" "prognostic unfavorable (2.60e-4)" "unprognostic (1.33e-1)" "unprognostic (1.01e-1)" "unprognostic (7.53e-3)" "unprognostic (6.29e-2)" "unprognostic (1.66e-1)" "unprognostic (1.86e-1)" "unprognostic (1.75e-2)" "unprognostic (2.78e-2)" "prognostic unfavorable (7.45e-8)" "unprognostic (1.60e-1)" "unprognostic (2.00e-1)" "unprognostic (7.60e-2)" "unprognostic (3.12e-1)" 7.0 4.4 8.0 9.9 5.2 2.4 4.8 0.8 14.5 6.7 4.8 2.6 3.5 2.3 3.6 3.5 12.2 3.0 4.7 2.0 7.8 20.6 2.4 4.1 20.1 19.2 13.7 7.0 1.8 2.7 17.3 14.9 4.6 7.3 9.9 4.2 3.0 2.4 5.3 0.8 2.9 5.3 12.0 4.5 7.1 5.7 17.6 2.0 77.2 4.8 2.4 11.8 9.7 6.5 0.1 3.7 9.7 0.3 1.9 2.0 0.2 4.5 5.7 1.8 0.3 2.0 5.8 0.0 5.7 2.4 3.6 4.5 0.0 1.8 0.0 8.3 6.5 16.3 2.3 1.4 0.1 3.3 7.3 1.5 0.0 0.4 0.0 45.8 0.0 8.7 15.7 6.8 12.7 0.6 11.6 4.4 4.2 0.0 5.4 2.2 4.8 1.7 1.6 1.4 0.1 20.5 0.0 4.4 7.5 0.0 0.5 2.0 15.5 1.0 0.0 7.3 0.2 0.0 3.9 5.4 0.0 3.6 0.1 0.0 29.6 6.4 3.9 7.5 0.0 12.1 0.0 0.3 9.7 0.0 0.1 0.0 0.1 0.5 0.2 0.0 0.1 0.2 0.1 1.0 1.9 0.0 3.7 2.0 0.2 8.0 5.2 0.8 14.5 7.8 20.6 13.7 7.0 7.3 2.0 0.0 1.1 4.5 0.7 0.9 0.4 0.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 8.7 0.0 0.0 0.2 0.1 0.6 0.3 0.0 0.8 1.1 3.2 0.0 39.3 4.3 14.0 1.7 0.0 1.7 0.0 0.0 4.3 0.1 0.0 0.7 0.0 0.0 0.0 12.6 1.1 1.4 1.1 0.2 3.2 0.6 0.3 TOX3 "CAGF9, TNRC9" ENSG00000103460 "TOX high mobility group box family member 3" O15405 16 52438005-52547802 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 18.7" "Cell type enhanced" "Detected in many" 16 "Cholangiocytes: 40.8;Intestinal endocrine cells: 59.2;Muller glia cells: 158.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 20.0;HAP1: 9.8;Hep G2: 8.7;OE19: 10.4;RT4: 38.0;SCLC-21H: 13.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA040240, HPA040376" Enhanced Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040240: , HPA040376: AB_10795522" "unprognostic (1.14e-2)" "unprognostic (9.75e-3)" "unprognostic (9.08e-3)" "unprognostic (3.32e-2)" "unprognostic (3.50e-1)" "unprognostic (2.31e-1)" "unprognostic (4.74e-3)" "unprognostic (1.28e-1)" "unprognostic (2.00e-1)" "unprognostic (2.94e-2)" "unprognostic (2.59e-1)" "unprognostic (4.60e-3)" "prognostic favorable (3.08e-12)" "unprognostic (1.19e-1)" "unprognostic (1.31e-1)" "prognostic favorable (3.95e-4)" 0.7 3.1 7.1 5.0 4.7 0.0 3.9 0.6 6.0 7.0 13.5 6.0 0.2 9.4 1.3 9.2 0.9 3.0 14.8 0.2 3.2 5.3 9.5 5.8 2.7 0.1 5.4 3.6 1.0 7.8 0.0 5.8 0.3 5.1 1.8 15.1 2.7 11.0 0.7 0.3 1.1 13.5 0.9 7.0 0.2 18.7 0.7 4.7 0.0 0.2 0.3 2.1 7.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 20.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 1.7 0.0 0.1 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 10.4 0.0 0.0 3.4 0.1 4.7 38.0 13.4 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 4.7 0.6 4.3 3.2 5.3 5.4 3.6 5.1 4.7 6.0 5.1 0.0 0.2 0.9 2.6 0.6 40.8 17.4 6.8 33.2 0.0 0.0 3.3 1.4 2.5 0.0 22.3 0.0 4.4 0.0 0.3 13.0 0.0 4.9 0.1 38.1 59.2 1.3 0.0 0.8 0.6 0.1 0.0 0.0 31.7 158.0 9.8 8.6 0.0 8.6 1.5 0.0 0.3 0.0 0.7 0.3 0.0 0.0 28.7 1.1 TOX4 "C14orf92, KIAA0737, LCP1" ENSG00000092203 "TOX high mobility group box family member 4" O94842 14 21476597-21499175 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 222.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017880, HPA027551" Approved Approved Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA017880: AB_1845573, HPA027551: AB_10601701" "unprognostic (9.56e-2)" "unprognostic (2.54e-2)" "unprognostic (2.81e-1)" "unprognostic (7.46e-2)" "unprognostic (9.30e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (3.46e-4)" "unprognostic (8.05e-3)" "unprognostic (2.58e-1)" "unprognostic (5.00e-2)" "unprognostic (3.23e-2)" "unprognostic (2.94e-1)" "prognostic favorable (8.38e-5)" "unprognostic (1.84e-1)" "unprognostic (2.48e-1)" "unprognostic (9.03e-2)" "unprognostic (2.48e-3)" 16.5 15.1 18.0 13.4 24.7 18.8 16.9 19.9 29.8 19.8 17.3 21.0 10.9 12.7 18.9 16.2 21.8 15.6 14.7 19.2 17.0 18.4 14.3 15.8 15.8 13.7 19.3 15.9 17.0 17.0 23.2 15.5 21.3 25.3 15.6 15.9 16.0 19.7 19.2 46.0 20.2 20.0 20.5 17.3 14.7 16.9 18.0 13.3 19.5 17.7 16.6 21.6 18.2 14.4 18.4 23.7 34.1 19.9 19.1 21.4 17.6 13.1 14.0 11.7 11.0 17.0 16.3 15.6 12.8 25.3 27.3 26.4 13.5 16.0 8.0 9.0 21.0 21.8 16.0 19.1 19.7 35.0 14.1 7.7 8.9 9.5 18.7 22.0 16.5 14.7 21.2 20.4 21.4 20.6 18.7 19.3 15.3 11.0 13.8 19.4 11.2 16.2 9.1 6.5 19.7 22.1 14.6 12.1 9.3 12.7 16.8 10.8 11.1 12.6 13.5 11.0 16.2 12.8 6.3 12.6 13.8 13.0 12.4 11.2 18.2 19.6 18.0 6.7 8.0 14.6 25.2 19.6 27.0 17.3 19.9 18.6 17.0 15.3 16.2 17.7 18.4 16.4 17.9 34.1 19.1 17.7 23.7 21.4 17.6 18.0 24.7 19.9 29.8 17.0 18.4 19.3 15.9 25.3 13.3 62.5 50.7 37.3 55.5 77.5 75.7 44.9 30.6 56.2 53.4 43.6 27.5 65.5 53.0 41.6 55.4 48.4 49.5 0.0 45.0 53.5 45.5 50.9 59.0 40.3 38.8 39.7 66.1 33.2 39.0 26.6 45.1 51.1 37.1 54.1 38.1 47.5 41.6 40.7 41.4 44.0 47.2 32.3 52.0 104.2 54.7 77.7 222.3 66.1 37.7 58.6 TP53 "LFS1, p53" ENSG00000141510 "Tumor protein p53" P04637 17 7661779-7687550 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters" "Apoptosis, Biological rhythms, Cell cycle, Host-virus interaction, Necrosis, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 102.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002973, CAB039238, CAB039239, HPA051244, HPA063532, CAB072876" Enhanced Enhanced Nucleoplasm Yes No Nucleoplasm "CAB002973: AB_2206626, CAB039238: , CAB039239: , CAB072876: AB_2665731, HPA051244: AB_2681403, HPA063532: " "unprognostic (2.29e-2)" "unprognostic (8.83e-3)" "unprognostic (1.26e-2)" "prognostic favorable (1.35e-4)" "unprognostic (9.95e-2)" "unprognostic (4.00e-2)" "unprognostic (2.79e-3)" "unprognostic (4.99e-2)" "unprognostic (2.75e-2)" "unprognostic (2.55e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (5.01e-4)" "unprognostic (1.86e-3)" "unprognostic (7.89e-3)" "unprognostic (8.05e-2)" "unprognostic (2.74e-1)" "unprognostic (1.08e-1)" 18.5 11.1 6.0 28.6 6.8 9.0 17.5 2.5 7.3 18.5 14.6 6.8 8.3 9.7 20.3 15.0 25.3 16.7 22.6 8.1 5.0 3.8 10.6 20.8 11.2 26.0 6.6 3.1 33.8 13.8 4.9 6.0 22.8 6.9 16.5 14.5 9.9 15.3 16.1 12.5 24.6 14.0 12.8 6.2 24.2 12.0 14.1 6.9 102.6 13.2 23.5 31.2 16.9 15.0 15.2 19.6 2.2 14.1 11.0 11.3 8.2 19.4 36.0 19.7 14.2 9.2 11.0 20.8 7.0 15.8 19.4 24.6 1.0 10.0 45.8 31.9 13.8 18.9 43.0 28.5 19.3 18.2 10.2 19.1 18.5 20.2 17.1 27.7 0.4 9.6 13.9 22.5 9.4 26.1 11.2 19.0 6.2 0.9 1.8 9.9 34.6 31.1 22.7 19.8 2.5 0.7 60.4 13.9 15.9 14.5 21.6 11.7 20.3 23.1 15.6 5.9 10.2 27.0 1.7 24.6 23.3 7.7 0.3 11.8 12.1 8.8 19.7 6.0 2.4 19.6 0.8 13.3 2.2 9.1 14.1 11.1 15.2 9.4 10.2 19.6 14.5 9.9 10.8 1.7 11.0 11.9 17.9 11.3 8.2 6.0 6.8 2.5 6.4 5.0 3.8 6.6 3.1 6.9 6.9 8.9 10.9 24.4 8.9 25.4 2.3 2.0 22.9 8.1 12.5 19.2 0.0 30.5 8.3 19.1 7.8 19.6 10.2 0.0 15.7 35.3 17.1 11.3 1.1 16.1 21.7 0.0 29.6 20.3 27.8 2.1 21.3 14.4 11.8 15.4 37.2 6.1 19.5 0.0 15.9 6.5 2.2 12.9 20.1 0.5 4.2 28.7 18.8 15.7 50.6 7.4 TP53BP1 "53BP1, p202, TDRD30" ENSG00000067369 "Tumor protein p53 binding protein 1" Q12888 15 43403061-43510728 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ciliated cells: 69.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004083, HPA008788, HPA022133" Supported Supported "Nucleoplasm,Nuclear bodies" No No "Nuclear bodies" Nucleoplasm "CAB004083: AB_10694558, HPA008788: AB_1078070, HPA022133: AB_1844382" "unprognostic (2.12e-1)" "unprognostic (7.96e-2)" "unprognostic (1.11e-1)" "unprognostic (1.85e-2)" "unprognostic (4.42e-3)" "unprognostic (2.32e-1)" "unprognostic (2.03e-2)" "unprognostic (3.96e-1)" "unprognostic (2.17e-1)" "unprognostic (2.81e-2)" "unprognostic (3.34e-2)" "unprognostic (4.07e-1)" "unprognostic (8.06e-2)" "unprognostic (9.11e-2)" "unprognostic (1.52e-1)" "unprognostic (6.99e-2)" "unprognostic (3.38e-2)" 7.2 12.9 13.4 9.0 20.7 8.9 9.6 21.9 22.9 17.2 10.0 12.5 10.1 5.7 14.6 15.1 7.0 13.8 9.8 10.7 13.9 12.9 8.6 4.1 8.0 7.2 7.1 14.8 15.9 7.4 30.0 34.8 10.7 17.9 11.4 9.5 7.9 9.8 12.3 7.9 8.2 7.2 15.0 7.9 7.2 7.7 18.3 9.3 15.2 16.2 4.9 10.8 11.5 11.1 5.4 3.5 3.7 1.9 2.1 4.8 1.8 5.9 10.2 29.8 18.6 12.4 15.4 7.2 10.3 15.6 14.6 18.7 8.7 7.2 6.4 9.1 17.5 31.5 14.8 21.4 12.6 17.4 17.4 7.3 12.2 17.8 5.2 8.1 13.4 17.6 11.9 8.9 19.6 14.7 24.4 17.2 11.1 11.9 5.7 16.9 4.1 10.4 6.3 19.1 10.9 6.3 11.2 11.2 4.1 10.9 14.1 26.9 12.5 14.8 6.6 4.0 23.8 13.7 7.6 12.3 15.7 10.7 12.4 9.1 4.6 9.9 15.1 13.1 6.6 8.0 3.7 1.2 2.5 4.1 1.9 3.5 5.4 4.4 4.1 2.9 4.9 4.8 4.4 1.4 2.1 1.2 3.5 3.4 1.8 13.4 20.7 21.9 22.9 13.9 12.9 7.1 14.8 17.9 9.3 20.8 18.2 11.5 8.9 5.7 34.5 12.5 7.6 69.6 28.4 27.9 45.2 11.0 8.3 12.2 30.9 14.8 3.5 0.0 6.2 9.4 15.3 10.6 25.5 3.0 9.2 44.5 40.2 11.6 3.8 13.9 21.9 6.0 1.7 1.8 14.2 12.9 7.1 3.5 16.6 5.9 54.7 12.9 8.1 30.7 34.0 4.5 15.4 11.7 12.0 7.0 TP63 "EEC3, KET, NBP, OFC8, p51, p53CP, p63, p73H, p73L, SHFM4, TP53CP, TP53L, TP73L" ENSG00000073282 "Tumor protein p63" Q9H3D4 3 189631416-189897279 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Notch signaling pathway, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 83.2;skin 1: 54.2" "Group enriched" "Detected in many" 12 "Basal keratinocytes: 244.6;Suprabasal keratinocytes: 247.4" "Group enriched" "Detected in many" 11 "cervical cancer: 37.9;head and neck cancer: 73.3;lung cancer: 37.3;urothelial cancer: 21.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HaCaT: 23.8;HBEC3-KT: 45.6;hTCEpi: 34.6;hTERT-HME1: 33.1;RT4: 50.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB000083, HPA006288, HPA006289, HPA007009, HPA007010" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB000083: AB_2207187, HPA006288: AB_1080334, HPA006289: , HPA007009: , HPA007010: AB_1080336" "prognostic favorable (1.07e-4)" "unprognostic (1.30e-1)" "unprognostic (1.44e-1)" "unprognostic (3.02e-1)" "unprognostic (4.38e-2)" "unprognostic (3.50e-1)" "unprognostic (1.29e-1)" "unprognostic (5.17e-2)" "unprognostic (2.78e-1)" "unprognostic (5.37e-2)" "unprognostic (2.09e-3)" "unprognostic (1.54e-1)" "unprognostic (1.87e-5)" "unprognostic (1.86e-1)" "unprognostic (1.05e-1)" "unprognostic (1.62e-1)" "unprognostic (2.74e-3)" 2.9 0.1 0.2 0.7 0.1 0.0 7.2 0.1 0.2 9.5 0.1 0.1 5.7 0.0 0.3 8.0 33.7 0.3 0.0 0.2 0.1 0.1 0.4 0.1 1.2 0.2 0.1 0.2 0.1 0.1 0.0 0.3 7.8 0.8 9.6 0.0 0.3 9.0 7.8 83.2 54.2 0.1 2.7 0.6 0.1 0.1 1.2 0.0 9.0 0.4 36.7 26.1 9.6 19.2 3.7 1.3 3.0 0.9 1.2 1.2 0.2 0.6 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.1 0.0 0.0 23.8 0.0 45.6 0.0 0.3 0.0 0.5 0.3 0.1 0.0 0.0 0.1 0.0 34.6 0.0 33.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 50.1 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.1 0.3 0.1 0.0 0.2 2.0 0.4 1.1 0.9 0.5 0.7 3.7 1.2 1.0 0.4 1.7 0.8 0.7 3.0 1.2 0.9 1.3 0.8 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.8 0.0 0.0 4.0 0.0 20.4 244.6 0.0 0.6 0.0 1.4 5.7 0.0 0.0 18.7 0.0 0.2 0.7 0.3 0.0 0.0 0.2 1.8 1.0 2.6 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 8.5 1.0 0.0 0.0 1.2 0.0 1.1 0.0 0.0 0.0 0.5 0.3 2.6 247.4 7.4 0.0 0.0 10.1 TP73 P73 ENSG00000078900 "Tumor protein p73" O15350 1 3652520-3736201 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.7" "Cell type enhanced" "Detected in some" 13 "Ciliated cells: 17.4;Club cells: 7.9;Early spermatids: 18.5;Late spermatids: 10.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 8 "cerebellum: 25.7" "Cell type enhanced" "Detected in some" "eosinophil: 1.2;memory B-cell: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MOLT-4: 11.4;RH-30: 9.3;SCLC-21H: 14.6;U-698: 14.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB002514, CAB003022, HPA027314, HPA044516" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA Yes Nucleoplasm "Golgi apparatus" "CAB002514: AB_563940, CAB003022: , HPA027314: AB_2672215, HPA044516: AB_2678971" "unprognostic (5.71e-3)" "prognostic favorable (2.98e-4)" "unprognostic (2.71e-1)" "prognostic favorable (1.82e-4)" "unprognostic (5.58e-2)" "prognostic favorable (9.50e-4)" "unprognostic (5.25e-2)" "unprognostic (2.18e-1)" "unprognostic (4.27e-1)" "unprognostic (1.99e-1)" "unprognostic (5.33e-2)" "unprognostic (3.99e-1)" "unprognostic (1.26e-7)" "unprognostic (1.77e-2)" "unprognostic (1.10e-1)" "unprognostic (7.33e-2)" "unprognostic (1.65e-1)" 0.5 0.3 1.1 3.4 2.3 1.0 1.1 25.7 0.4 1.5 0.7 2.4 1.3 0.3 0.4 6.2 4.8 12.8 1.4 0.3 1.9 1.2 0.2 2.1 3.8 2.0 0.5 0.0 2.6 1.5 0.3 0.7 1.7 3.2 3.6 0.4 0.4 5.5 1.4 0.4 11.9 0.5 0.3 0.9 4.2 0.8 9.8 0.3 2.5 0.4 0.8 7.1 0.6 3.9 1.4 0.1 1.2 0.1 0.0 0.6 0.1 2.0 0.1 0.2 6.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 8.5 3.2 2.0 1.6 0.0 0.7 3.4 2.1 0.7 0.0 0.6 6.9 0.1 3.2 2.0 0.0 0.0 2.3 0.0 1.4 0.0 0.1 0.0 0.0 0.0 4.2 0.0 0.6 1.5 11.4 1.5 0.4 0.0 0.1 0.0 9.3 0.1 0.2 3.0 14.6 6.8 0.3 0.0 0.6 0.0 8.7 7.1 0.0 2.3 6.2 0.0 4.5 2.7 0.5 14.6 0.4 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.5 1.4 0.4 0.6 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 1.1 2.3 25.7 0.3 1.9 1.2 0.5 0.0 3.2 0.3 0.0 1.0 0.0 3.9 2.7 0.5 1.2 0.0 17.4 7.9 0.0 0.0 0.2 0.0 0.0 18.5 0.0 0.0 0.0 0.2 0.2 0.3 0.1 0.0 0.0 0.2 0.0 2.4 0.0 0.0 10.0 0.6 0.0 1.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.9 0.2 0.0 0.0 0.1 TPBG "5T4, 5T4-AG" ENSG00000146242 "Trophoblast glycoprotein" Q13641 6 82363206-82370828 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 67.5;Urothelial cells: 71.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "MAIT T-cell: 3.2" "Lineage enriched" "Detected in single" 16 "T-cells: 3.2" "Cell line enhanced" "Detected in many" "BJ hTERT+: 24.9;hTCEpi: 30.5;hTEC/SVTERT24-B: 27.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010554 Enhanced Approved Nucleoplasm NA NA 330000 Nucleoplasm "HPA010554: AB_1858206" "unprognostic (3.03e-1)" "unprognostic (1.46e-2)" "prognostic unfavorable (6.68e-4)" "unprognostic (1.06e-1)" "unprognostic (4.52e-3)" "unprognostic (7.47e-3)" "unprognostic (8.55e-2)" "unprognostic (3.55e-3)" "unprognostic (8.39e-2)" "unprognostic (3.42e-2)" "unprognostic (8.02e-2)" "unprognostic (4.94e-1)" "unprognostic (3.77e-1)" "unprognostic (7.46e-2)" "unprognostic (1.06e-1)" "unprognostic (1.54e-1)" "unprognostic (5.57e-2)" 10.2 2.9 0.4 4.8 15.7 1.2 10.2 0.0 8.8 22.0 4.6 1.9 12.1 4.2 12.6 4.6 35.2 8.4 9.3 5.3 0.7 2.0 6.6 1.7 4.1 3.0 4.3 1.4 5.8 4.8 4.1 11.2 16.9 17.6 14.1 4.6 5.1 11.5 9.4 2.6 12.6 4.9 16.2 4.5 5.7 6.2 3.3 7.9 4.2 13.0 6.8 4.5 22.9 25.5 0.0 0.0 0.0 0.1 0.0 3.2 0.0 4.5 6.8 2.5 5.0 9.1 13.1 4.3 21.4 24.9 4.3 5.9 0.8 6.4 0.0 2.3 11.7 12.1 8.9 2.8 11.7 4.6 0.0 3.6 2.6 3.3 0.2 7.4 0.2 2.2 8.3 30.5 27.9 10.4 3.9 1.0 0.2 0.4 0.0 1.1 9.3 0.0 0.0 2.9 2.0 5.4 0.0 4.8 0.0 6.3 6.4 1.2 3.9 4.7 6.8 0.0 4.9 11.3 0.9 3.1 3.7 3.7 7.9 4.6 0.0 0.0 0.0 18.2 0.3 3.9 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 15.7 0.0 8.8 0.7 2.0 4.3 1.4 17.6 7.9 11.9 6.2 0.0 63.5 60.3 0.1 2.0 12.7 5.3 18.2 52.4 0.0 36.6 0.0 30.7 6.2 17.9 2.6 0.0 40.7 67.5 22.6 45.6 0.0 0.0 3.2 1.6 1.2 6.7 1.2 4.1 11.8 4.0 16.9 0.0 16.1 1.7 26.7 16.4 5.6 0.4 0.2 32.3 19.1 1.9 5.3 27.4 55.2 2.9 9.7 71.2 TPI1 ENSG00000111669 "Triosephosphate isomerase 1" P60174 12 6867119-6870948 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Gluconeogenesis, Glycolysis" "Isomerase, Lyase" "Cancer-related genes, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 234.8;skeletal muscle: 211.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050924, HPA053568" Uncertain Approved Nucleoplasm,Vesicles NA NA 270000000 Nucleoplasm Vesicles "HPA050924: AB_2681276, HPA053568: AB_2682193" "unprognostic (2.85e-1)" "unprognostic (5.58e-3)" "unprognostic (1.65e-1)" "unprognostic (1.62e-2)" "unprognostic (6.94e-2)" "unprognostic (2.31e-2)" "prognostic unfavorable (1.04e-5)" "unprognostic (4.14e-3)" "unprognostic (7.49e-2)" "unprognostic (2.13e-2)" "unprognostic (2.11e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (6.54e-4)" "unprognostic (7.04e-2)" "unprognostic (1.82e-1)" "unprognostic (1.53e-1)" "unprognostic (1.11e-2)" 20.2 41.2 41.2 24.3 46.9 27.4 83.4 93.2 196.1 27.1 39.1 12.8 18.6 40.1 17.2 22.6 51.0 22.1 33.3 94.9 36.7 33.1 43.1 40.8 48.8 140.2 34.0 34.6 19.9 87.0 32.1 16.8 27.1 70.7 19.0 43.5 21.1 26.0 28.7 211.0 25.8 37.8 29.4 20.8 20.1 21.6 15.7 19.4 14.2 20.2 38.4 38.0 23.0 28.0 55.4 170.3 145.5 148.2 81.2 67.1 234.8 115.0 103.1 54.7 84.5 53.6 56.6 96.6 83.3 92.0 157.5 191.0 106.5 63.3 67.6 16.8 82.2 81.5 57.3 130.0 139.2 174.7 89.1 96.8 87.5 75.6 70.2 39.9 99.6 71.9 61.4 58.1 121.4 104.7 221.1 95.7 34.4 45.2 26.0 120.8 84.7 52.3 84.2 134.8 98.1 65.8 30.7 90.0 69.3 98.6 82.2 38.9 64.8 72.7 75.6 40.3 119.8 17.3 74.9 59.1 84.5 72.3 54.6 122.1 50.8 20.8 100.9 169.5 62.0 60.6 87.7 146.1 145.5 56.1 148.2 57.0 55.4 56.5 54.5 170.3 44.3 39.9 49.3 61.1 81.2 127.8 30.7 67.1 234.8 41.2 46.9 93.2 196.1 36.7 33.1 34.0 34.6 70.7 19.4 125.0 186.6 268.1 429.8 608.3 247.2 505.0 410.2 145.9 159.3 369.9 104.1 935.0 1278.3 1116.4 147.7 369.6 973.7 70.0 686.0 1611.5 538.5 310.9 357.6 425.4 827.4 281.3 408.6 284.8 382.5 523.4 258.3 552.8 639.4 1545.5 419.4 603.3 953.1 852.2 247.5 1236.2 208.3 194.1 473.8 15.1 66.8 538.4 1279.9 363.9 717.3 571.4 TPRG1 "FAM79B, FLJ41238, FLJ43694" ENSG00000188001 "Tumor protein p63 regulated 1" Q6ZUI0 3 188947214-189325304 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 43.3;lymphoid tissue: 32.9" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 35.7;Early spermatids: 102.2" "Cancer enhanced" "Detected in many" "breast cancer: 7.0" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 8.8;Karpas-707: 4.5;OE19: 21.7;U-266/70: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA044751, HPA060187" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA044751: AB_2679073, HPA060187: AB_2684217" "prognostic favorable (5.43e-4)" "unprognostic (8.71e-3)" "unprognostic (2.10e-3)" "unprognostic (2.36e-2)" "unprognostic (3.84e-3)" "unprognostic (1.33e-3)" "unprognostic (1.55e-2)" "unprognostic (9.88e-2)" "unprognostic (2.66e-1)" "unprognostic (2.71e-1)" "unprognostic (1.40e-2)" "unprognostic (3.79e-1)" "unprognostic (3.52e-8)" "unprognostic (8.50e-2)" "unprognostic (9.53e-2)" "unprognostic (1.38e-1)" "unprognostic (3.73e-2)" 16.1 1.0 0.3 0.9 0.8 0.0 14.4 1.7 0.8 19.7 1.2 0.1 1.0 0.0 5.0 1.6 43.3 5.2 1.6 2.4 0.2 0.2 0.6 5.1 2.7 0.3 0.3 0.5 1.9 0.3 0.0 0.8 1.0 0.5 2.5 0.0 0.8 3.7 0.7 5.0 14.5 0.5 1.9 0.3 0.7 0.4 2.6 0.3 7.9 0.8 25.5 32.9 2.3 17.8 0.2 0.7 1.3 2.3 0.0 6.3 1.3 0.8 0.2 0.3 0.0 2.0 1.7 0.0 0.0 0.0 0.0 0.1 1.0 2.1 1.2 3.3 0.1 0.5 0.2 0.0 0.0 0.0 8.8 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.5 0.4 0.0 0.0 0.5 0.0 0.0 0.0 4.5 0.2 0.3 0.0 0.0 0.6 21.7 0.3 0.0 0.0 1.5 0.0 1.7 0.0 0.0 0.2 0.5 0.0 0.7 3.9 0.6 0.0 0.1 0.3 0.0 0.3 4.2 3.3 0.3 0.1 0.0 0.1 0.0 2.3 0.0 6.0 1.8 0.9 0.2 4.9 6.3 0.7 0.0 1.0 2.5 1.3 0.0 1.6 0.1 5.4 1.3 0.3 0.8 1.7 0.8 0.2 0.2 0.3 0.5 0.5 0.3 35.7 1.7 5.7 16.1 4.9 0.2 0.7 0.0 1.4 10.3 0.0 0.0 0.3 0.0 0.3 102.2 0.7 0.0 0.0 0.5 0.2 1.4 1.5 1.1 6.6 5.0 0.0 0.0 0.0 1.9 7.8 6.6 2.2 0.0 0.0 0.0 0.0 4.6 0.0 2.8 0.0 0.0 0.0 0.7 1.2 1.1 5.1 0.2 13.4 0.2 5.1 TPX2 "C20orf1, C20orf2, DIL-2, p100" ENSG00000088325 "TPX2, microtubule nucleation factor" Q9ULW0 20 31739271-31801805 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 92.7" "Group enriched" "Detected in many" 5 "Erythroid cells: 70.0;Extravillous trophoblasts: 57.2;Spermatocytes: 121.8;Spermatogonia: 68.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 10.4" "Group enriched" "Detected in many" 5 "granulocytes: 4.0;NK-cells: 4.8;T-cells: 10.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005487 Enhanced Supported "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" Yes Yes Nucleoplasm "Cytokinetic bridge, Mitotic spindle" "HPA005487: AB_1858223" "unprognostic (2.18e-2)" "unprognostic (1.77e-1)" "unprognostic (1.97e-2)" "prognostic unfavorable (2.43e-6)" "unprognostic (2.99e-1)" "unprognostic (7.56e-2)" "prognostic unfavorable (8.07e-7)" "prognostic unfavorable (6.46e-4)" "unprognostic (3.70e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.68e-5)" "unprognostic (5.99e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (4.56e-2)" "unprognostic (2.30e-1)" "unprognostic (1.76e-2)" "unprognostic (1.39e-1)" 1.8 1.7 1.0 13.4 2.0 21.7 1.2 2.2 1.7 2.2 5.7 0.5 0.3 4.6 1.2 2.3 13.3 0.5 1.9 1.5 0.8 0.7 1.2 2.7 2.6 12.9 0.7 1.1 0.8 0.5 0.0 0.7 6.6 0.9 0.7 7.4 0.5 2.3 0.5 2.2 5.9 4.7 3.2 0.9 5.9 3.2 22.0 0.6 92.7 0.7 11.0 16.2 2.2 3.8 1.0 1.4 4.0 0.1 4.8 10.4 1.3 70.8 23.8 28.8 22.5 2.3 4.2 27.8 29.8 16.9 43.3 32.7 50.5 30.7 33.4 17.6 16.6 32.4 37.5 32.8 27.0 49.5 14.4 12.7 65.4 22.8 34.4 0.7 25.1 16.8 1.4 1.5 27.1 19.8 6.2 23.3 25.3 48.3 30.5 33.9 29.1 41.9 19.5 32.1 27.4 25.8 23.9 77.8 20.2 11.6 11.6 20.9 14.1 45.6 17.3 13.5 20.7 30.0 15.3 15.7 48.6 29.9 22.2 45.7 12.2 21.1 29.9 15.2 89.5 31.6 4.0 0.0 0.5 0.6 0.0 0.3 1.0 1.9 2.3 0.6 0.4 0.4 0.7 0.4 4.8 0.1 1.4 10.4 1.3 1.0 2.0 2.2 1.7 0.8 0.7 0.7 1.1 0.9 0.6 0.0 6.2 16.2 0.8 6.2 0.8 0.8 7.6 0.0 5.7 0.0 0.0 4.4 0.0 1.0 6.4 0.3 0.6 70.0 0.4 57.2 2.9 0.6 0.0 2.5 15.9 1.6 1.2 9.8 5.3 10.6 0.9 5.1 0.0 3.6 2.6 0.3 1.2 0.6 0.0 0.0 0.3 0.0 2.1 121.8 68.8 5.4 3.9 6.9 7.3 1.4 TRA2A "AWMS1, htra-2-alpha, tra2a" ENSG00000164548 "Transformer 2 alpha homolog" Q13595 7 23504780-23532041 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054018 Uncertain Supported Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoli "Nucleoplasm, Vesicles" "HPA054018: AB_2682344" "unprognostic (2.55e-2)" "unprognostic (2.16e-1)" "unprognostic (1.24e-1)" "unprognostic (6.77e-3)" "unprognostic (8.05e-2)" "unprognostic (3.41e-2)" "prognostic unfavorable (2.07e-5)" "unprognostic (1.28e-2)" "unprognostic (2.50e-2)" "unprognostic (4.64e-2)" "unprognostic (1.87e-3)" "unprognostic (6.04e-2)" "prognostic unfavorable (1.79e-6)" "unprognostic (1.46e-2)" "unprognostic (1.52e-2)" "unprognostic (8.74e-2)" "unprognostic (1.36e-3)" 23.4 29.4 27.8 29.5 34.1 70.6 27.4 38.1 27.5 30.3 22.9 29.0 31.6 19.8 32.7 34.5 29.4 25.9 17.6 18.7 28.6 29.3 21.3 21.8 28.6 32.2 35.8 18.5 36.8 27.4 14.9 46.6 24.4 28.2 26.4 30.1 23.7 21.9 26.7 15.7 31.6 22.6 35.2 30.4 33.8 21.1 25.9 37.3 35.6 24.7 20.5 38.0 25.0 31.8 15.5 23.9 20.4 23.0 14.7 21.7 8.2 19.3 21.4 33.3 52.1 17.9 11.3 21.5 24.7 11.7 24.8 20.5 17.6 26.6 36.6 14.3 18.3 29.6 32.2 39.9 23.0 31.3 22.0 23.3 22.4 23.7 27.8 18.7 26.1 21.1 13.3 15.9 18.7 23.5 22.5 28.2 16.3 43.5 18.0 28.1 18.9 31.5 43.8 29.9 24.0 22.2 36.1 26.3 21.9 28.7 28.0 28.9 23.5 23.1 26.7 16.5 25.7 21.0 29.4 25.4 19.8 28.3 18.1 28.6 20.1 25.1 30.0 17.0 35.6 26.3 11.5 14.9 18.5 21.7 23.0 18.7 15.5 20.3 19.8 16.8 14.4 17.7 20.9 20.4 14.7 20.4 23.9 20.0 8.2 27.8 34.1 38.1 27.5 28.6 29.3 35.8 18.5 28.2 37.3 56.6 68.2 70.3 85.9 92.7 49.7 37.0 48.4 77.6 60.3 83.7 49.1 76.6 21.6 48.0 48.5 63.2 67.9 70.0 38.1 71.1 87.2 68.2 83.3 62.7 48.6 35.0 113.5 70.0 86.5 17.7 60.1 73.9 54.0 60.5 57.4 42.4 49.0 80.7 63.6 32.1 101.0 71.1 79.3 92.3 54.5 98.9 98.6 97.5 61.7 73.5 TRA2B "Htra2-beta, PPP1R156, SFRS10" ENSG00000136527 "Transformer 2 beta homolog" P62995 3 185915906-185938136 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011692, HPA063597, HPA064972" Supported Enhanced Nucleoplasm,Cytosol NA NA 40000 Nucleoplasm Cytosol "CAB011692: AB_778565, HPA063597: AB_2685054, HPA064972: AB_2685396" "unprognostic (9.37e-2)" "unprognostic (1.42e-2)" "unprognostic (1.22e-2)" "unprognostic (7.58e-3)" "unprognostic (1.48e-1)" "unprognostic (2.10e-2)" "prognostic unfavorable (8.51e-4)" "unprognostic (1.92e-1)" "unprognostic (2.65e-3)" "prognostic favorable (2.15e-4)" "unprognostic (1.07e-1)" "unprognostic (3.22e-3)" "unprognostic (1.71e-3)" "unprognostic (1.28e-2)" "unprognostic (2.64e-1)" "unprognostic (4.38e-1)" "unprognostic (4.36e-2)" 36.2 38.0 34.9 52.5 32.4 34.5 34.1 29.8 29.1 30.5 39.5 20.3 31.7 22.4 37.8 32.3 36.5 27.1 31.0 26.4 29.9 30.1 33.0 37.1 27.1 36.9 29.8 21.9 28.9 31.0 28.6 31.3 38.0 20.9 31.6 27.5 26.1 26.6 32.3 50.8 22.7 24.9 35.7 27.1 31.9 28.7 38.4 25.1 57.2 29.6 47.3 42.8 34.0 50.3 34.5 37.0 30.7 21.0 20.6 25.0 10.7 31.8 13.1 33.0 16.8 9.6 7.6 18.2 25.8 16.7 28.5 22.6 21.1 16.8 30.8 31.1 13.2 19.7 20.8 36.1 25.1 33.6 25.9 22.9 28.8 11.9 28.0 12.8 30.5 23.3 7.3 12.5 16.8 16.3 9.2 21.8 15.4 27.5 19.7 21.8 16.7 75.5 44.3 49.2 31.1 20.5 45.9 26.6 35.9 27.7 13.9 24.5 24.4 17.0 24.0 30.4 17.7 24.2 33.9 12.4 19.3 25.3 16.1 38.8 36.3 88.4 57.5 19.9 35.5 30.4 30.7 21.0 16.1 20.2 17.1 18.1 31.7 19.8 18.7 18.3 34.5 25.0 22.7 22.1 20.6 18.6 37.0 18.5 10.7 34.9 32.4 29.8 29.1 29.9 30.1 29.8 21.9 20.9 25.1 59.6 114.4 168.3 155.0 229.4 101.5 57.6 104.4 62.9 102.4 66.3 184.6 157.7 61.3 105.4 125.7 154.8 106.8 233.6 94.8 196.4 163.4 151.8 191.8 78.1 151.9 68.3 218.4 179.9 244.9 31.1 118.2 213.7 128.2 216.4 142.0 89.2 85.0 121.0 110.3 42.8 196.4 103.5 173.1 132.6 147.0 227.8 179.8 202.0 165.8 133.4 TRABD PP2447 ENSG00000170638 "TraB domain containing" Q9H4I3 22 50185915-50199598 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000822 Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA000822: AB_10959384" "unprognostic (9.37e-2)" "unprognostic (1.36e-2)" "unprognostic (1.18e-1)" "prognostic favorable (1.19e-5)" "unprognostic (2.80e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-3)" "unprognostic (6.12e-2)" "unprognostic (2.40e-1)" "unprognostic (4.68e-3)" "unprognostic (1.65e-1)" "unprognostic (3.27e-2)" "prognostic unfavorable (1.85e-4)" "unprognostic (1.08e-3)" "unprognostic (1.19e-1)" "unprognostic (2.87e-2)" "unprognostic (2.98e-3)" 8.9 10.3 8.3 28.8 13.4 45.5 12.0 15.3 11.4 10.6 14.7 7.4 19.9 15.9 9.3 15.6 19.9 9.2 18.1 10.0 9.0 4.9 13.4 20.0 13.1 25.6 12.4 6.1 10.2 42.9 5.9 12.0 9.6 9.5 14.8 6.0 8.4 24.6 19.5 14.0 13.0 18.3 9.3 9.6 19.5 16.5 9.7 11.8 21.0 13.2 13.2 33.1 11.5 13.1 6.9 33.0 23.0 14.2 14.7 13.6 9.2 22.6 15.0 5.4 8.9 2.9 3.5 13.7 7.9 5.2 6.6 5.6 9.5 10.9 14.1 7.8 3.6 5.2 14.2 6.9 14.0 1.3 9.8 32.5 8.0 23.3 16.0 11.7 16.4 16.1 5.6 8.6 4.8 6.6 3.8 6.4 13.6 9.9 23.0 2.8 25.1 11.3 18.6 7.9 7.6 14.3 31.7 7.4 29.6 5.1 22.0 6.3 10.7 6.8 24.6 11.2 2.4 10.5 16.6 7.1 5.6 13.8 7.2 8.8 28.1 4.9 16.8 6.8 11.4 8.6 7.0 14.2 23.0 10.9 12.5 10.2 6.9 9.8 9.8 15.4 3.6 6.7 7.7 19.5 14.7 7.6 33.0 13.6 9.2 8.3 13.4 15.3 11.4 9.0 4.9 12.4 6.1 9.5 11.8 8.9 22.9 69.8 39.9 37.4 31.1 8.3 12.7 13.4 18.2 31.4 17.7 22.9 23.2 46.8 13.0 20.2 51.8 0.0 54.3 43.7 24.4 43.9 27.6 21.2 42.8 41.3 17.3 12.3 48.9 6.3 30.0 57.1 40.5 126.2 38.4 28.4 67.6 66.2 30.4 24.5 29.9 19.4 25.5 52.8 29.8 39.9 25.6 58.6 43.9 81.4 TRAF1 EBI6 ENSG00000056558 "TNF receptor associated factor 1" Q13077 9 120902393-120929173 "Cancer-related genes, Predicted intracellular proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 15 "monocytes: 550.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 2.8;T-cells: 11.1" "Group enriched" "Detected in many" 6 "HDLM-2: 35.9;WM-115: 45.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001852, CAB009593" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "CAB009593: , HPA001852: AB_1080344" "unprognostic (1.45e-3)" "unprognostic (4.51e-2)" "unprognostic (1.21e-2)" "unprognostic (3.17e-3)" "unprognostic (2.32e-2)" "unprognostic (1.48e-3)" "unprognostic (1.03e-1)" "unprognostic (1.94e-1)" "unprognostic (1.02e-2)" "unprognostic (1.39e-1)" "prognostic favorable (2.19e-5)" "unprognostic (3.23e-1)" "prognostic unfavorable (4.42e-5)" "unprognostic (1.85e-3)" "unprognostic (5.70e-3)" "unprognostic (2.64e-1)" "unprognostic (9.87e-3)" 5.4 8.6 9.5 21.6 20.5 8.7 5.7 4.7 13.7 5.3 6.5 17.5 9.2 4.3 6.6 7.4 5.2 6.7 8.6 7.5 11.4 5.5 7.8 4.9 7.4 33.1 14.8 11.2 10.9 3.9 5.3 11.0 3.6 12.5 10.0 5.0 9.4 10.3 7.2 2.4 8.2 8.9 7.8 7.6 15.5 6.6 3.1 19.1 3.5 7.9 2.2 24.0 9.0 10.0 0.2 2.8 0.0 0.4 1.4 11.1 2.0 1.2 0.8 0.1 0.0 1.5 3.7 0.0 0.3 2.0 0.6 1.1 0.1 0.7 2.4 0.4 0.4 6.0 0.5 0.2 0.1 0.7 35.9 0.0 0.2 0.8 0.1 1.1 0.1 2.8 1.8 1.9 2.3 1.7 0.7 0.3 0.7 0.0 4.9 0.3 0.1 0.0 1.0 0.4 0.5 0.1 0.6 0.6 4.9 0.2 0.1 0.4 0.0 0.3 0.1 0.1 1.1 0.3 0.4 0.3 0.5 0.3 2.0 6.4 3.8 1.3 1.2 1.2 0.2 45.4 0.0 0.3 0.0 3.6 0.4 6.4 0.2 8.8 7.4 0.4 0.2 2.7 4.0 0.0 1.4 0.3 2.8 11.1 2.0 9.5 20.5 4.7 13.7 11.4 5.5 14.8 11.2 12.5 19.1 6.0 0.0 6.7 4.1 8.7 0.3 2.3 2.5 0.0 6.8 3.5 17.7 0.0 1.7 24.7 0.5 2.7 0.5 0.0 1.6 0.0 2.8 2.0 36.8 1.8 2.8 0.0 1.7 0.6 3.4 0.6 1.7 14.8 6.8 550.0 0.5 1.0 9.9 0.0 1.8 0.7 6.6 0.0 5.1 1.4 0.5 9.2 0.0 25.9 0.6 1.7 TRAF4 "CART1, MLN62, RNF83" ENSG00000076604 "TNF receptor associated factor 4" Q9BUZ4 17 28743984-28750958 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Urothelial cells: 265.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 27.7" "Lineage enriched" "Detected in many" 5 "dendritic cells: 27.7" "Cell line enhanced" "Detected in all" "SK-BR-3: 54.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009055, HPA021904, HPA052377" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "CAB009055: AB_2209701, HPA021904: , HPA052377: AB_2681804" "unprognostic (1.77e-1)" "unprognostic (9.05e-2)" "unprognostic (1.31e-2)" "unprognostic (2.51e-3)" "unprognostic (1.76e-1)" "unprognostic (7.38e-3)" "unprognostic (1.09e-2)" "unprognostic (1.24e-1)" "unprognostic (1.09e-2)" "unprognostic (2.33e-1)" "unprognostic (7.13e-2)" "unprognostic (7.55e-2)" "unprognostic (1.74e-3)" "unprognostic (6.98e-2)" "unprognostic (9.26e-2)" "unprognostic (2.77e-2)" "unprognostic (5.58e-3)" 5.0 8.1 13.8 13.1 14.5 19.9 15.9 6.3 12.4 7.9 22.2 24.7 14.0 32.8 6.8 5.7 15.4 9.5 17.1 2.8 12.7 7.6 20.7 30.1 13.5 12.5 17.9 7.7 7.2 33.8 3.1 8.1 11.8 12.4 16.7 16.0 6.0 32.2 10.4 0.9 7.5 31.4 5.1 10.9 10.2 21.7 7.4 16.4 5.9 16.4 7.1 16.5 15.9 6.0 5.3 27.7 2.7 0.6 0.8 1.4 0.9 11.4 18.4 25.3 12.4 3.6 4.3 39.5 7.8 6.7 8.5 11.3 14.6 14.8 18.0 11.6 8.7 5.7 17.5 11.6 17.9 3.5 5.6 16.2 6.4 30.4 16.6 14.1 3.1 7.2 8.1 17.7 10.0 12.0 7.7 6.5 8.6 16.7 1.6 7.7 19.3 9.7 6.4 19.7 23.1 4.2 14.4 11.6 8.8 24.1 33.8 16.0 18.5 12.3 54.3 23.5 22.9 20.6 4.9 4.4 5.3 11.3 6.1 10.9 2.4 5.8 22.4 4.2 5.1 24.2 2.7 0.2 0.9 0.6 0.6 1.4 5.3 1.0 1.0 1.5 5.3 0.7 0.7 0.1 0.8 0.4 27.7 0.5 0.9 13.8 14.5 6.3 12.4 12.7 7.6 17.9 7.7 12.4 16.4 20.8 24.1 21.9 160.2 122.2 2.8 0.4 38.2 29.4 23.9 19.2 5.9 92.4 36.5 78.4 44.7 11.2 113.0 0.0 94.8 110.0 25.1 171.6 6.9 35.6 12.1 7.9 80.7 9.2 1.2 8.6 3.4 4.6 37.1 10.8 58.2 18.9 100.9 95.4 1.4 24.8 1.7 0.0 33.0 5.7 20.4 68.6 104.0 6.4 64.4 265.8 TRAFD1 FLN29 ENSG00000135148 "TRAF-type zinc finger domain containing 1" O14545 12 112125501-112153609 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "monocytes: 186.7;Spermatocytes: 51.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039254, HPA039266" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039254: AB_10805358, HPA039266: AB_10795142" "unprognostic (7.80e-2)" "prognostic favorable (5.73e-4)" "unprognostic (6.12e-2)" "unprognostic (1.44e-1)" "unprognostic (9.46e-2)" "unprognostic (2.51e-2)" "prognostic unfavorable (4.87e-4)" "unprognostic (1.21e-3)" "unprognostic (1.69e-1)" "unprognostic (1.78e-1)" "unprognostic (3.09e-1)" "unprognostic (2.20e-1)" "prognostic unfavorable (9.26e-6)" "unprognostic (1.07e-1)" "unprognostic (6.15e-2)" "unprognostic (3.33e-3)" "prognostic favorable (3.92e-5)" 15.1 13.1 11.0 21.9 19.2 20.5 16.6 11.9 19.8 15.6 31.6 42.1 15.2 12.7 15.1 12.8 26.0 12.8 14.0 16.9 12.2 10.8 12.7 12.5 21.2 25.5 26.2 10.7 15.3 10.2 15.3 14.9 15.5 22.2 18.5 16.8 22.7 16.4 16.7 10.3 28.1 16.0 20.5 25.0 25.0 15.2 30.9 23.4 28.2 13.0 13.0 29.7 25.6 17.4 13.2 11.4 59.1 21.4 14.8 13.8 19.3 10.7 12.2 19.8 18.4 13.5 12.9 10.2 12.3 17.9 17.5 13.9 13.1 9.8 12.2 10.6 13.0 7.5 21.9 19.2 12.1 11.8 21.3 18.3 19.9 17.3 7.1 23.5 12.3 31.0 16.6 20.5 12.4 17.0 17.5 15.2 7.7 22.2 7.6 11.0 18.1 13.5 16.9 16.2 13.1 14.4 19.2 12.1 20.6 11.3 40.6 16.8 13.0 25.6 25.3 6.8 15.5 16.4 17.1 9.7 8.0 5.7 7.8 6.5 18.5 16.3 13.1 8.5 9.7 8.6 59.1 21.4 48.3 10.7 19.4 7.3 13.2 10.5 9.6 11.4 12.2 9.7 8.9 42.8 14.8 20.0 7.5 13.8 19.3 11.0 19.2 11.9 19.8 12.2 10.8 26.2 10.7 22.2 23.4 17.9 9.6 8.8 6.8 10.9 7.0 8.9 7.6 4.0 13.6 12.2 23.6 17.2 5.0 18.4 1.0 9.5 9.3 0.0 18.2 12.6 12.4 16.5 11.5 4.0 13.2 14.3 15.0 8.6 12.5 1.7 10.9 14.1 6.8 186.7 9.2 8.8 21.6 14.0 12.0 4.2 10.9 0.0 6.4 51.7 15.3 13.2 22.1 9.6 9.7 9.0 TRAK1 "KIAA1042, MILT1, OIP106" ENSG00000182606 "Trafficking kinesin protein 1" Q9UPV9 3 42013802-42225889 "Predicted intracellular proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 71.9;skeletal muscle: 101.1" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 240.0;Rod photoreceptor cells: 131.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 57.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005853, HPA011367" Approved Approved "Nucleoplasm,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" Nucleoplasm "HPA005853: AB_1854778, HPA011367: AB_2668495" "unprognostic (5.55e-2)" "unprognostic (1.38e-2)" "unprognostic (5.49e-2)" "unprognostic (2.52e-2)" "unprognostic (1.26e-1)" "unprognostic (1.49e-1)" "unprognostic (1.80e-2)" "unprognostic (1.95e-1)" "unprognostic (1.39e-1)" "unprognostic (2.13e-2)" "unprognostic (3.01e-2)" "unprognostic (3.56e-3)" "prognostic favorable (4.84e-8)" "unprognostic (3.65e-2)" "unprognostic (1.70e-1)" "unprognostic (1.00e-2)" "unprognostic (4.61e-3)" 11.3 5.9 14.7 8.3 15.7 7.6 8.6 20.5 20.1 7.1 23.5 15.4 4.2 15.5 6.1 8.0 14.9 9.6 21.9 71.9 15.1 12.4 9.5 7.7 11.0 9.8 14.3 15.6 4.1 6.5 16.8 11.0 9.7 16.2 7.8 11.9 23.8 22.9 7.7 101.1 21.6 23.7 7.9 11.7 12.2 26.9 7.0 10.6 4.9 14.4 31.9 14.2 19.1 10.5 7.1 4.8 1.6 4.3 1.7 1.8 1.1 7.5 6.6 13.1 5.6 9.2 9.0 17.2 10.2 11.5 6.7 7.3 4.3 10.7 14.8 5.4 25.3 7.3 3.6 9.1 23.5 7.3 13.4 6.5 10.2 6.7 12.1 4.6 11.6 8.1 7.7 10.1 14.8 13.6 9.7 13.4 4.0 5.2 11.9 8.5 3.1 1.2 6.1 5.7 20.6 5.1 5.4 4.9 12.4 9.2 57.0 8.5 9.9 3.9 5.7 5.4 11.4 5.1 9.8 13.7 5.8 6.9 34.8 5.9 8.9 7.5 13.4 6.4 10.2 5.6 1.6 2.5 1.0 1.2 4.3 1.1 5.0 1.8 1.5 2.8 7.1 0.8 1.8 1.1 1.7 2.4 4.8 0.8 1.1 14.7 15.7 20.5 20.1 15.1 12.4 14.3 15.6 16.2 10.6 29.8 26.7 25.6 13.5 33.8 21.5 240.0 28.1 84.3 35.2 14.0 94.2 20.3 1.7 9.5 1.0 20.2 61.3 0.0 10.9 15.7 10.1 17.2 10.4 8.5 13.4 31.8 21.9 4.3 13.9 2.7 1.7 23.7 23.6 4.6 35.6 32.5 17.2 36.5 2.5 7.9 131.7 32.3 18.4 0.7 3.6 37.8 13.2 5.3 28.1 23.2 TRAK2 "ALS2CR3, CALS-C, GRIF-1, KIAA0549, MILT2, OIP98" ENSG00000115993 "Trafficking kinesin protein 2" O60296 2 201377207-201451579 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 96.9" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 130.8;Cone photoreceptor cells: 68.7;Horizontal cells: 73.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015827, HPA062163" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Nucleoplasm, Nuclear bodies" Vesicles "HPA015827: AB_1858238, HPA062163: AB_2684702" "unprognostic (2.10e-1)" "unprognostic (1.39e-1)" "unprognostic (2.56e-2)" "unprognostic (4.31e-2)" "unprognostic (2.78e-1)" "unprognostic (1.76e-1)" "unprognostic (2.38e-2)" "unprognostic (3.08e-2)" "unprognostic (2.24e-1)" "unprognostic (1.76e-2)" "unprognostic (1.68e-1)" "unprognostic (1.31e-1)" "prognostic favorable (7.42e-5)" "unprognostic (1.48e-1)" "unprognostic (3.24e-1)" "unprognostic (1.40e-2)" "unprognostic (9.82e-3)" 16.9 13.4 20.4 9.9 23.9 28.0 14.5 11.8 19.4 11.3 14.1 31.5 5.4 7.8 9.1 9.4 10.6 8.9 11.5 42.7 25.6 21.8 15.8 9.2 12.9 9.8 43.1 12.2 6.7 9.0 17.2 11.8 15.0 31.0 8.4 15.5 9.6 14.0 10.2 8.4 5.9 9.4 13.1 96.9 10.8 8.0 4.7 23.2 5.6 22.1 7.1 8.6 10.1 18.8 14.6 3.9 4.6 6.4 10.3 11.3 5.3 3.9 5.7 3.8 13.9 25.9 37.4 4.1 14.4 12.7 10.6 12.4 8.3 3.7 2.5 5.9 20.0 10.6 3.9 8.0 4.5 18.3 7.3 4.3 5.7 10.4 6.2 14.3 4.4 6.9 20.0 4.4 11.1 9.0 11.7 15.4 3.9 4.5 11.0 22.5 5.7 3.5 2.7 4.2 4.4 11.5 4.4 9.3 4.0 9.1 5.6 7.0 9.2 7.8 6.3 24.4 6.0 4.5 4.6 18.0 17.1 6.4 11.7 8.9 6.1 10.5 3.1 14.5 7.0 8.8 1.8 4.7 4.6 7.6 6.4 6.9 8.0 9.6 6.5 3.9 14.6 6.5 7.0 2.6 10.3 5.4 2.2 11.3 5.3 20.4 23.9 11.8 19.4 25.6 21.8 43.1 12.2 31.0 23.2 14.9 24.3 7.1 3.4 7.3 34.1 130.8 30.6 17.4 15.9 8.7 68.7 8.1 6.6 12.5 1.5 13.7 23.4 0.0 12.6 3.8 11.8 6.3 18.5 11.4 9.4 73.1 28.4 17.8 11.4 2.4 7.5 9.4 25.3 10.0 20.9 3.7 9.9 10.5 12.0 8.2 21.7 12.9 16.9 7.1 14.4 3.6 4.7 10.2 20.4 5.4 TRANK1 "KIAA0342, LBA1" ENSG00000168016 "Tetratricopeptide repeat and ankyrin repeat containing 1" O15050 3 36826820-36945098 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 42.3" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 14.9;Enterocytes: 15.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 42.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 42.3" "Cell line enhanced" "Detected in many" "Daudi: 38.8;HMC-1: 15.6" "Low region specificity" "Detected in all" HPA035508 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA035508: AB_10671105" "unprognostic (7.11e-3)" "unprognostic (1.55e-2)" "unprognostic (3.05e-2)" "unprognostic (2.34e-1)" "unprognostic (4.84e-2)" "unprognostic (2.04e-3)" "unprognostic (9.13e-2)" "unprognostic (3.22e-1)" "unprognostic (1.76e-1)" "unprognostic (8.59e-2)" "unprognostic (3.83e-1)" "unprognostic (2.01e-1)" "prognostic unfavorable (2.52e-5)" "unprognostic (1.31e-1)" "unprognostic (3.69e-1)" "unprognostic (1.82e-3)" "unprognostic (1.07e-3)" 4.1 3.6 4.5 10.4 11.2 6.9 4.7 21.5 12.0 8.5 14.2 1.7 3.1 8.6 12.3 4.5 3.1 19.3 7.3 4.1 3.3 3.9 3.2 7.9 6.2 13.9 2.9 6.6 9.0 2.8 5.0 3.8 3.7 6.0 7.9 10.9 4.4 4.9 5.0 2.6 2.9 23.1 10.5 3.2 9.9 6.0 2.9 1.7 15.1 5.8 1.1 16.2 9.8 6.0 5.2 0.5 42.3 1.3 2.8 5.7 0.9 0.7 0.9 0.2 0.0 2.4 9.7 0.0 0.7 5.1 2.3 4.5 0.0 3.9 38.8 1.6 2.9 7.7 0.2 0.1 0.5 0.4 1.9 0.0 6.3 2.6 0.0 3.1 1.7 15.6 3.2 2.0 1.7 0.1 0.5 2.8 4.2 5.0 5.6 1.7 0.0 4.9 0.7 0.2 0.0 1.0 1.4 0.1 0.7 0.8 1.7 0.3 0.0 3.9 1.0 0.3 0.4 0.6 2.2 1.9 1.8 0.7 0.1 0.6 5.5 1.1 8.6 0.3 1.4 0.2 2.5 0.6 3.9 5.6 0.9 4.2 4.0 4.8 5.7 0.5 5.2 4.4 4.2 42.3 2.8 1.3 0.0 4.0 0.9 4.5 11.2 21.5 12.0 3.3 3.9 2.9 6.6 6.0 1.7 14.9 5.6 3.9 1.2 0.7 1.1 2.4 2.5 5.3 4.5 3.5 2.0 1.0 0.0 2.2 0.2 3.3 15.2 0.0 1.6 1.1 3.0 1.9 5.8 13.9 4.2 0.0 5.2 6.2 6.3 0.0 4.0 3.6 5.0 1.0 8.8 1.4 3.0 12.2 5.6 0.6 0.7 0.0 1.7 0.2 0.2 0.6 0.6 13.8 3.8 1.4 TRAPPC12 "CGI-87, TTC-15, TTC15" ENSG00000171853 "Trafficking protein particle complex 12" Q8WVT3 2 3379675-3485094 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Transport" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 239.6;Late spermatids: 372.4;Spermatocytes: 93.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034799, HPA043196" Uncertain Supported "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA034799: AB_10600920, HPA043196: " "prognostic favorable (1.80e-5)" "unprognostic (9.21e-2)" "unprognostic (1.01e-2)" "unprognostic (1.97e-2)" "unprognostic (7.96e-2)" "unprognostic (1.32e-2)" "unprognostic (1.57e-2)" "unprognostic (1.80e-2)" "unprognostic (1.38e-1)" "unprognostic (4.27e-1)" "prognostic favorable (9.15e-4)" "unprognostic (3.23e-2)" "prognostic unfavorable (2.44e-4)" "unprognostic (1.26e-1)" "unprognostic (1.49e-1)" "unprognostic (1.53e-1)" "unprognostic (7.18e-2)" 18.2 17.3 15.2 19.7 19.7 14.6 12.8 18.3 25.3 20.3 16.4 21.1 15.2 15.8 19.7 14.4 16.7 14.8 17.9 26.8 16.0 15.6 16.1 29.2 16.8 22.0 15.4 15.6 19.3 16.4 16.5 20.4 12.8 20.6 18.5 8.3 16.3 24.4 16.9 40.7 41.3 17.6 16.4 13.1 19.9 17.1 50.8 12.2 23.2 16.8 17.3 18.6 16.9 14.1 1.0 7.5 6.0 5.5 1.4 3.9 1.2 8.4 14.7 4.8 5.5 10.9 13.6 12.8 13.9 3.4 4.1 2.2 9.2 7.1 9.7 15.4 4.7 3.6 10.9 5.6 6.2 1.6 11.6 21.0 8.3 4.2 31.2 4.9 10.4 15.0 9.9 4.8 4.5 11.5 3.1 3.5 11.3 12.9 5.3 7.2 11.8 10.4 17.9 11.9 3.7 20.8 7.9 6.6 7.7 4.4 7.0 12.5 20.3 5.5 6.3 9.1 2.2 7.3 8.4 9.0 10.1 5.7 10.0 12.2 15.3 11.2 7.6 11.7 8.2 5.5 1.2 1.8 6.0 1.4 4.1 3.6 0.9 2.3 3.8 2.4 1.0 1.6 1.9 1.7 1.4 5.5 7.5 3.9 1.2 15.2 19.7 18.3 25.3 16.0 15.6 15.4 15.6 20.6 12.2 8.9 10.9 22.3 14.0 10.2 31.0 55.8 20.4 10.7 4.5 12.2 31.4 18.9 49.7 18.3 239.6 14.6 14.7 0.0 15.7 12.5 15.8 12.4 5.7 13.1 22.8 25.4 3.4 10.4 12.6 372.4 24.5 13.7 15.1 30.7 15.7 39.8 19.8 10.5 22.6 22.6 37.7 25.8 18.6 93.2 21.0 15.6 14.8 7.1 14.0 10.5 TRAPPC13 "C5orf44, FLJ13611, FLJ26957, MGC48585" ENSG00000113597 "Trafficking protein particle complex 13" A5PLN9 5 65624716-65666233 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037777 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA037777: AB_10672464" "unprognostic (3.66e-2)" "unprognostic (3.27e-1)" "unprognostic (1.54e-2)" "unprognostic (7.22e-2)" "unprognostic (4.79e-2)" "unprognostic (1.16e-2)" "unprognostic (2.55e-2)" "unprognostic (2.49e-2)" "unprognostic (5.70e-2)" "unprognostic (5.75e-2)" "unprognostic (3.49e-2)" "unprognostic (1.92e-1)" "prognostic favorable (8.66e-4)" "unprognostic (2.89e-1)" "unprognostic (2.58e-2)" "unprognostic (2.53e-2)" "unprognostic (6.25e-2)" 10.4 12.9 16.1 10.3 22.5 7.5 14.0 14.5 22.7 12.1 11.3 12.8 10.2 9.8 11.9 10.4 13.4 9.7 9.8 17.7 17.1 17.7 21.6 16.9 11.0 10.2 17.3 14.2 10.1 8.2 20.6 22.4 11.8 19.5 20.6 14.3 10.5 9.9 12.4 15.2 8.0 13.3 13.9 18.9 10.7 11.0 10.6 15.1 18.0 18.7 11.7 10.8 11.5 9.9 6.6 10.1 14.7 13.7 9.1 13.1 9.8 12.8 8.7 13.8 24.8 10.7 13.7 13.3 15.3 13.9 18.9 20.8 7.4 18.2 13.1 16.9 12.3 20.4 11.9 15.6 15.9 22.4 9.1 11.5 8.4 10.9 6.8 14.6 10.2 12.7 9.7 12.6 14.7 19.0 11.5 16.7 19.2 10.0 12.5 16.7 13.5 17.0 3.9 6.3 7.6 4.7 14.9 17.3 15.2 13.8 14.7 17.4 12.5 18.7 11.3 14.0 8.0 16.4 13.4 11.4 6.7 9.3 14.8 15.4 8.3 16.0 20.9 14.1 18.5 12.7 14.7 9.4 3.8 10.1 10.1 13.1 6.6 9.9 8.4 10.1 5.4 9.9 9.9 3.6 9.1 13.7 7.6 10.4 9.8 16.1 22.5 14.5 22.7 17.1 17.7 17.3 14.2 19.5 15.1 17.9 10.9 3.7 6.2 5.0 12.2 5.9 15.3 9.4 6.8 7.0 9.8 10.4 13.3 10.8 15.5 11.2 7.9 0.0 9.3 8.2 8.5 9.8 3.5 9.7 10.9 12.7 14.9 8.6 12.6 7.9 6.9 9.9 6.8 10.0 8.4 11.8 8.6 3.5 12.4 18.9 14.3 6.5 10.1 15.1 8.0 5.9 12.7 8.3 8.3 10.8 TRAPPC2 "hYP38334, MIP-2A, SEDL, SEDT, TRS20, ZNF547L" ENSG00000196459 "Trafficking protein particle complex 2" "P0DI81, P0DI82" X 13712244-13734635 "Disease related genes, Predicted intracellular proteins" "ER-Golgi transport, Transcription, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB004665, HPA063308" Approved Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum, Vesicles" Nucleoplasm "CAB004665: AB_425678, HPA063308: AB_2684982" "unprognostic (1.97e-1)" "prognostic favorable (8.09e-4)" "unprognostic (2.13e-1)" "unprognostic (4.18e-1)" "unprognostic (2.11e-1)" "unprognostic (2.70e-2)" "unprognostic (1.04e-2)" "unprognostic (2.08e-3)" "unprognostic (1.76e-2)" "prognostic favorable (6.35e-4)" "unprognostic (3.50e-2)" "unprognostic (8.24e-2)" "unprognostic (1.93e-1)" "unprognostic (2.09e-1)" "unprognostic (4.53e-2)" "unprognostic (2.36e-1)" "prognostic favorable (7.89e-5)" 6.5 6.4 15.6 9.5 13.7 9.5 9.4 24.1 16.1 10.5 9.4 10.1 8.8 8.2 16.4 8.7 8.5 9.4 7.6 6.4 14.4 14.2 10.1 10.1 7.8 16.1 10.4 13.0 11.7 11.2 8.9 19.5 7.2 11.5 8.9 9.1 10.2 8.1 8.3 4.9 10.3 8.8 16.0 11.5 11.1 10.7 4.3 11.1 4.3 8.8 4.2 16.4 8.1 9.4 11.2 10.7 13.7 6.6 18.5 16.1 9.0 6.8 5.3 8.2 20.9 6.3 4.8 3.3 6.4 5.5 5.1 5.5 4.5 8.5 11.6 10.3 5.3 6.7 9.0 10.8 9.2 7.0 11.7 16.2 8.6 12.5 3.6 4.8 11.8 16.6 6.3 5.2 10.9 14.9 10.3 4.5 8.5 10.8 20.0 5.2 11.3 11.6 15.6 7.9 5.7 9.5 11.4 10.8 11.3 8.0 5.1 8.7 11.6 11.8 9.5 8.2 13.0 11.8 7.9 5.9 5.2 4.6 9.2 4.0 10.3 10.1 14.5 4.8 8.4 5.2 13.7 4.9 8.6 16.1 6.6 16.0 11.2 12.8 15.8 4.3 11.1 10.8 15.5 10.0 18.5 5.4 10.7 15.3 9.0 15.6 13.7 24.1 16.1 14.4 14.2 10.4 13.0 11.5 11.1 8.9 6.2 22.8 8.2 13.5 14.5 9.8 20.4 4.0 11.4 8.7 11.8 12.7 18.3 9.2 12.6 7.7 9.1 0.0 11.8 15.8 11.6 9.3 9.2 11.3 10.0 19.1 11.6 11.1 9.5 3.8 11.8 9.5 8.5 9.0 14.7 8.3 15.9 17.6 10.6 20.2 13.6 6.5 11.4 4.5 3.3 15.4 15.0 27.7 13.4 10.5 TRAPPC2B "MIP-2A, SEDLP, SEDLP1, TRAPPC2P1" ENSG00000256060 "Trafficking protein particle complex 2B" P0DI82 19 57363511-57365353 "Predicted intracellular proteins" "ER-Golgi transport, Transcription, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 32.7;Syncytiotrophoblasts: 76.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA063308 Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum, Vesicles" Nucleoplasm "HPA063308: AB_2684982" "unprognostic (8.55e-2)" "unprognostic (1.07e-2)" "unprognostic (4.24e-1)" "unprognostic (5.27e-2)" "unprognostic (1.93e-1)" "unprognostic (6.69e-2)" "unprognostic (1.12e-1)" "unprognostic (4.47e-2)" "unprognostic (4.57e-2)" "unprognostic (3.24e-2)" "unprognostic (1.47e-1)" "unprognostic (2.05e-1)" "prognostic favorable (1.28e-4)" "unprognostic (1.26e-1)" "unprognostic (4.49e-2)" "unprognostic (9.74e-2)" "unprognostic (1.39e-2)" 14.6 23.3 13.4 9.9 17.1 11.6 17.2 23.8 16.7 11.5 12.5 6.7 12.1 7.0 12.2 15.1 15.4 11.4 13.7 26.5 18.0 14.0 12.9 14.5 12.4 15.0 11.6 14.5 15.8 9.7 12.2 16.4 16.9 18.1 14.3 7.9 9.0 11.4 10.4 28.8 11.5 8.6 12.7 15.1 14.3 10.2 31.2 9.6 12.7 17.6 16.8 13.7 15.4 9.5 26.7 21.5 32.2 13.2 22.8 15.5 13.4 9.2 7.6 10.4 6.6 9.7 10.9 9.5 6.2 14.6 9.6 29.1 3.6 7.1 7.1 9.0 8.5 16.6 3.3 5.2 10.5 10.3 3.4 36.4 7.4 12.4 8.0 10.2 7.8 11.4 11.8 13.2 7.6 5.3 11.2 7.0 8.1 2.2 0.1 11.3 2.6 11.4 6.8 3.5 0.6 15.0 5.7 9.9 10.6 10.7 14.5 11.1 8.6 6.6 6.7 5.7 9.4 10.6 10.1 7.5 8.9 7.8 4.4 10.3 11.4 14.5 14.2 12.8 4.8 9.1 32.2 13.2 16.3 7.5 11.6 14.7 25.0 15.5 12.3 14.8 26.7 15.0 12.0 15.3 22.8 10.3 21.5 13.4 13.4 13.4 17.1 23.8 16.7 18.0 14.0 11.6 14.5 18.1 9.6 8.9 12.5 0.0 0.0 0.0 0.0 20.1 0.0 24.1 18.2 17.4 0.0 32.7 21.6 26.8 0.0 0.0 0.0 0.0 19.3 17.8 10.3 0.0 19.8 0.0 27.9 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 20.8 0.0 0.0 21.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 76.9 0.0 0.0 0.0 TRAPPC9 "IKBKBBP, KIAA1882, MRT13, NIBP, T1, TRS120" ENSG00000167632 "Trafficking protein particle complex 9" Q96Q05 8 139730343-140458579 "Disease related genes, Predicted intracellular proteins" Differentiation "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 44.7;Late spermatids: 78.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026579 Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus, Vesicles" "HPA026579: AB_1854459" "unprognostic (1.82e-2)" "unprognostic (1.06e-1)" "unprognostic (1.41e-1)" "unprognostic (1.48e-2)" "unprognostic (2.30e-1)" "unprognostic (1.12e-1)" "unprognostic (2.15e-1)" "unprognostic (8.14e-2)" "unprognostic (1.03e-1)" "unprognostic (1.96e-1)" "unprognostic (2.76e-2)" "unprognostic (2.31e-1)" "prognostic favorable (5.11e-6)" "unprognostic (2.09e-1)" "unprognostic (9.97e-2)" "unprognostic (2.40e-1)" "unprognostic (1.62e-1)" 9.7 12.0 13.0 14.7 17.9 13.8 8.3 18.3 22.0 11.3 10.3 17.2 12.5 11.3 11.4 9.8 12.1 17.4 12.8 14.7 13.0 13.7 12.2 10.0 9.5 10.6 14.5 11.7 11.5 15.4 42.0 28.2 14.1 15.1 10.4 9.0 17.2 12.7 12.7 38.3 8.8 12.7 10.5 13.2 10.5 11.1 7.9 9.1 24.8 14.2 10.0 15.3 10.1 8.3 6.3 6.3 14.2 5.0 7.5 7.1 4.6 6.7 12.0 5.5 14.8 11.7 7.0 3.7 4.2 7.2 2.4 3.9 4.3 7.9 8.2 10.3 8.6 3.5 8.6 7.3 6.9 2.5 11.8 4.4 13.0 7.1 4.3 8.2 3.3 10.4 6.7 6.6 1.9 6.1 8.2 9.4 9.5 4.6 7.2 3.8 18.6 19.8 4.1 1.6 21.8 10.6 8.5 2.0 13.4 8.2 8.2 13.7 7.8 7.1 3.4 7.4 5.9 10.9 4.7 5.5 3.3 5.9 7.7 3.4 10.1 7.5 5.6 7.0 7.0 5.3 14.2 4.9 4.0 6.5 5.0 7.1 4.5 4.5 5.1 5.1 6.3 4.7 5.5 7.8 7.5 4.7 6.3 3.3 4.6 13.0 17.9 18.3 22.0 13.0 13.7 14.5 11.7 15.1 9.1 3.0 8.8 3.7 3.6 2.1 12.5 11.7 2.5 16.0 5.7 10.4 19.6 9.3 8.3 6.3 44.7 7.1 12.3 0.0 5.3 3.7 2.7 4.9 8.1 8.2 6.4 27.0 29.2 4.3 9.9 78.2 5.5 4.1 10.1 1.0 10.4 12.8 5.3 5.9 7.4 17.6 12.9 6.5 4.3 2.6 5.9 2.6 12.2 9.6 8.5 4.7 TRERF1 "BCAR2, dJ139D8.5, HSA277276, RAPA, TReP-132" ENSG00000124496 "Transcriptional regulating factor 1" Q96PN7 6 42224931-42452051 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Peritubular cells: 20.8;Sertoli cells: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 55.1" "Low region specificity" "Detected in all" "HPA027771, HPA051273, HPA059943" Enhanced Enhanced "Nucleoplasm,Nucleoli fibrillar center,Cytosol" No No Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA027771: AB_2672381, HPA051273: AB_2681416, HPA059943: AB_2684173" "unprognostic (5.85e-3)" "unprognostic (4.38e-2)" "unprognostic (2.39e-1)" "unprognostic (3.28e-3)" "unprognostic (6.64e-2)" "unprognostic (3.92e-3)" "unprognostic (1.19e-1)" "unprognostic (1.58e-2)" "unprognostic (2.05e-4)" "unprognostic (2.67e-1)" "unprognostic (1.16e-2)" "unprognostic (1.97e-2)" "prognostic unfavorable (3.67e-5)" "unprognostic (8.60e-2)" "unprognostic (5.39e-2)" "unprognostic (6.05e-2)" "unprognostic (2.78e-2)" 4.9 8.7 9.3 7.7 8.7 16.7 4.0 18.1 10.8 12.0 5.1 2.9 9.7 4.2 10.0 4.0 12.6 7.2 6.9 2.8 4.5 3.9 5.2 1.4 4.0 9.2 2.5 4.7 10.2 2.5 7.5 9.3 3.4 3.5 8.8 4.7 7.3 3.7 5.2 1.3 8.4 6.6 8.6 4.9 9.0 5.6 11.2 4.8 23.4 3.3 3.6 12.7 13.3 11.0 0.4 1.4 8.1 1.1 2.7 3.0 1.1 5.2 3.6 4.1 5.2 1.9 4.3 5.8 4.0 6.4 4.6 3.8 0.0 2.8 4.9 0.8 6.0 6.3 6.3 5.2 4.9 3.7 55.1 0.4 5.2 3.0 0.0 1.3 9.6 16.9 1.7 6.9 4.1 1.6 4.1 0.0 3.3 0.0 1.6 2.0 1.1 2.4 16.4 4.5 3.8 3.8 4.5 0.3 1.8 2.7 6.5 3.3 1.7 2.4 0.0 0.4 2.3 2.3 13.1 1.7 2.6 3.0 4.2 1.1 0.6 3.5 5.3 1.7 8.8 0.0 2.1 1.1 8.1 3.0 0.4 2.9 0.4 2.2 2.7 1.4 0.0 1.9 2.0 3.8 2.7 0.2 1.2 2.1 1.1 9.3 8.7 18.1 10.8 4.5 3.9 2.5 4.7 3.5 4.8 3.0 2.2 0.8 2.6 7.3 10.8 1.6 2.5 4.0 5.7 5.2 0.0 2.7 0.0 1.3 2.3 3.8 2.3 0.0 0.9 0.7 7.0 1.7 11.5 0.0 2.7 7.9 2.9 8.0 4.4 2.0 13.0 5.8 3.3 1.8 1.9 4.9 0.9 2.9 20.8 0.2 0.5 25.8 4.4 2.4 6.1 6.5 1.0 7.0 2.8 3.4 TRIAP1 "HSPC132, MDM35, P53CSV, WF-1" ENSG00000170855 "TP53 regulated inhibitor of apoptosis 1" O43715 12 120443961-120446412 "Predicted intracellular proteins, Transporters" "Apoptosis, Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 113.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053640 Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA053640: AB_2682213" "unprognostic (8.74e-3)" "unprognostic (9.44e-2)" "unprognostic (5.24e-2)" "unprognostic (4.06e-2)" "unprognostic (3.07e-1)" "unprognostic (1.40e-1)" "unprognostic (1.19e-2)" "unprognostic (3.31e-2)" "prognostic unfavorable (2.22e-4)" "unprognostic (9.87e-3)" "unprognostic (4.39e-2)" "unprognostic (9.93e-2)" "prognostic unfavorable (8.77e-4)" "unprognostic (8.81e-2)" "unprognostic (2.00e-1)" "unprognostic (6.44e-2)" "unprognostic (4.97e-2)" 11.7 16.8 10.6 12.5 13.1 14.6 20.6 9.1 12.4 9.4 12.5 8.0 12.0 10.0 9.9 11.6 15.4 9.3 12.7 17.3 13.6 8.3 12.5 34.5 14.2 13.6 15.5 11.9 7.7 36.5 5.7 8.6 17.8 13.5 12.4 17.0 6.8 19.3 8.6 29.1 16.8 12.1 11.1 10.4 12.3 12.3 11.2 11.6 11.7 11.2 21.5 13.9 12.0 10.0 17.4 28.2 9.0 24.8 22.2 25.5 19.6 15.9 21.9 20.1 13.7 17.5 27.1 48.2 21.0 15.0 18.7 15.5 18.2 8.9 31.7 17.9 17.1 7.5 11.0 23.3 34.7 19.8 14.0 26.0 19.2 15.3 47.8 26.1 32.2 14.9 27.9 43.8 18.3 26.3 18.8 38.6 17.6 30.7 8.2 27.2 20.1 24.1 43.5 28.7 19.6 17.8 20.1 19.0 32.8 24.0 17.9 19.8 13.0 24.2 8.3 17.9 33.2 27.8 18.9 21.8 12.1 18.2 12.1 12.7 21.2 33.4 34.0 18.5 25.0 21.0 9.0 22.0 8.0 20.7 24.8 24.9 17.4 20.3 19.7 28.2 15.8 25.5 22.0 1.9 22.2 16.5 25.4 17.6 19.6 10.6 13.1 9.1 12.4 13.6 8.3 15.5 11.9 13.5 11.6 3.0 14.6 36.3 21.1 45.4 8.2 10.2 45.9 17.4 6.8 7.0 5.9 113.6 56.3 43.3 5.9 25.3 16.1 0.0 43.5 66.9 27.2 25.9 17.3 49.7 46.9 3.2 21.2 22.7 22.8 3.9 15.3 20.8 37.1 53.3 21.2 9.4 40.3 14.0 17.3 36.6 9.3 19.4 26.9 34.9 34.6 62.4 63.0 29.9 38.3 23.3 TRIB2 "GS3955, TRB2" ENSG00000071575 "Tribbles pseudokinase 2" Q92519 2 12716889-12742734 "Enzymes, Predicted membrane proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Exocrine glandular cells: 89.7;Muller glia cells: 115.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 24.8" "Group enriched" "Detected in many" 9 "B-cells: 7.1;NK-cells: 9.5;T-cells: 24.8" "Cell line enhanced" "Detected in many" "AN3-CA: 41.0;HEL: 40.3;K-562: 54.8;SK-MEL-30: 40.0;WM-115: 54.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001305 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA001305: AB_1080371" "unprognostic (1.84e-1)" "unprognostic (2.49e-2)" "unprognostic (4.31e-3)" "unprognostic (1.86e-3)" "unprognostic (6.68e-3)" "unprognostic (3.93e-2)" "unprognostic (4.10e-1)" "unprognostic (1.53e-1)" "unprognostic (2.80e-2)" "unprognostic (3.32e-2)" "unprognostic (2.52e-3)" "unprognostic (1.67e-2)" "unprognostic (1.08e-3)" "unprognostic (1.30e-1)" "unprognostic (8.71e-2)" "unprognostic (9.59e-2)" "unprognostic (2.13e-2)" 19.6 30.9 13.2 17.7 13.3 7.0 23.2 23.2 23.0 10.8 12.3 10.5 6.7 8.7 23.0 22.6 8.1 11.6 14.5 18.2 15.0 10.8 24.8 10.6 18.9 33.0 13.4 16.2 52.3 14.4 6.6 11.3 23.0 15.5 16.3 6.9 35.7 9.9 13.6 6.9 8.2 11.9 17.6 10.4 38.9 19.5 13.9 10.1 37.3 12.1 6.2 33.4 21.9 23.2 7.1 0.6 1.5 0.1 9.5 24.8 4.5 0.0 0.0 31.3 41.0 11.3 10.4 0.0 1.7 1.6 1.1 1.8 0.2 3.4 3.5 1.2 3.7 0.2 0.5 2.3 3.5 0.9 3.9 6.4 40.3 0.1 0.6 14.0 2.2 15.4 9.6 3.6 4.5 1.2 11.1 4.9 5.3 54.8 0.0 1.7 0.3 5.1 9.6 14.8 1.5 4.0 0.0 10.4 1.4 7.1 5.1 26.9 12.8 0.2 1.6 40.0 9.8 0.0 0.2 3.0 14.9 7.5 0.1 3.8 0.0 0.0 5.0 8.0 7.9 54.9 0.8 0.1 1.5 7.3 0.0 8.8 5.3 14.4 7.7 0.6 7.1 8.5 5.2 0.3 9.5 0.1 0.0 24.8 4.5 13.2 13.3 23.2 23.0 15.0 10.8 13.4 16.2 15.5 10.1 3.0 8.8 8.0 10.2 5.5 46.7 13.3 20.4 6.7 11.4 15.7 29.5 1.9 6.6 13.3 3.9 36.4 0.0 0.0 89.7 0.1 7.1 10.3 33.5 5.4 4.4 19.1 0.0 63.3 5.3 10.7 71.7 2.5 28.7 1.8 0.0 115.1 49.1 0.0 70.0 0.7 66.1 51.8 22.5 0.9 2.7 4.6 0.7 20.8 0.0 11.1 TRIB3 "C20orf97, dJ1103G7.3, TRB3" ENSG00000101255 "Tribbles pseudokinase 3" Q96RU7 20 362835-397559 "Enzymes, Predicted intracellular proteins" "Apoptosis, Stress response, Transcription, Transcription regulation" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 39.0;salivary gland: 47.5" "Cell type enhanced" "Detected in many" 8 "Ductal cells: 49.9;Hepatocytes: 25.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 88.9;hTCEpi: 55.1;hTERT-HME1: 64.0;SK-MEL-30: 80.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015272, HPA055442" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA015272: AB_1858269, HPA055442: AB_2682818" "unprognostic (5.40e-2)" "unprognostic (1.89e-1)" "unprognostic (1.57e-1)" "unprognostic (2.25e-3)" "unprognostic (1.92e-1)" "prognostic unfavorable (1.70e-4)" "prognostic unfavorable (6.75e-5)" "unprognostic (1.52e-3)" "unprognostic (1.76e-1)" "unprognostic (1.24e-1)" "unprognostic (7.95e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (2.07e-13)" "unprognostic (7.62e-2)" "unprognostic (2.79e-2)" "unprognostic (2.31e-1)" "unprognostic (4.05e-3)" 4.8 8.7 1.6 2.8 1.5 9.7 6.0 3.8 4.2 2.5 1.8 1.2 3.6 1.0 2.1 3.1 9.8 1.1 2.7 3.0 1.4 2.0 3.3 39.0 8.2 7.3 1.0 2.4 4.4 13.8 2.0 10.5 6.2 1.6 3.9 1.6 3.7 47.5 5.3 1.5 6.5 2.5 1.3 0.7 7.9 4.4 2.7 0.6 6.7 27.2 4.1 7.0 2.7 5.3 15.5 4.7 3.3 4.4 6.6 11.4 5.1 11.1 5.7 0.7 1.6 1.9 2.5 4.8 3.3 8.9 3.2 6.6 11.7 5.6 4.8 3.3 3.0 14.3 9.0 3.1 14.9 2.9 1.8 2.2 3.7 1.2 19.1 88.9 9.4 1.8 10.3 55.1 6.0 64.0 2.2 6.1 12.2 12.9 21.7 0.3 10.4 0.5 11.4 1.7 16.5 18.5 2.1 0.9 10.4 3.7 4.5 2.1 3.3 0.7 27.1 80.8 1.0 7.8 25.0 3.5 1.7 3.0 0.0 5.1 7.6 9.8 8.6 1.5 8.3 6.1 2.5 4.4 1.0 10.0 3.4 7.1 15.5 9.3 11.4 4.7 10.2 10.7 7.6 3.3 6.6 1.7 2.1 6.4 5.1 1.6 1.5 3.8 4.2 1.4 2.0 1.0 2.4 1.6 0.6 3.0 1.0 7.6 7.2 6.1 3.8 1.2 10.2 2.7 1.2 1.8 3.9 13.1 0.0 49.9 0.0 5.8 0.0 23.3 19.2 4.3 1.5 10.5 4.7 25.3 5.6 0.0 1.2 8.0 2.1 0.0 1.7 4.0 6.8 1.8 6.5 0.5 23.3 2.3 1.4 0.0 6.7 6.5 4.1 1.9 2.2 4.6 5.9 5.0 0.6 4.8 TRIM11 "BIA1, RNF92" ENSG00000154370 "Tripartite motif containing 11" Q96F44 1 228393673-228406840 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 105.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028541, HPA043879" Approved Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA028541: AB_10600833, HPA043879: AB_2678711" "unprognostic (1.73e-1)" "unprognostic (9.73e-3)" "unprognostic (5.48e-3)" "unprognostic (7.73e-2)" "unprognostic (3.27e-1)" "unprognostic (2.33e-1)" "prognostic unfavorable (7.42e-5)" "unprognostic (1.08e-1)" "unprognostic (9.74e-2)" "unprognostic (2.04e-1)" "unprognostic (1.40e-1)" "unprognostic (3.15e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (3.40e-2)" "unprognostic (4.89e-2)" "unprognostic (2.04e-1)" "unprognostic (1.22e-2)" 8.8 9.2 8.9 13.8 16.5 33.2 23.8 45.2 11.5 8.7 11.2 6.4 15.1 10.1 8.7 10.6 13.3 9.4 13.9 6.9 9.2 8.5 7.7 7.1 27.5 18.6 9.0 8.0 9.0 11.9 8.5 7.2 9.4 7.1 10.5 9.7 6.0 14.4 18.2 5.0 12.5 11.8 8.6 6.0 16.5 12.6 9.5 7.8 20.0 9.0 9.7 13.1 9.5 24.3 6.4 6.9 10.0 11.4 9.4 11.8 5.4 13.9 13.2 7.1 9.7 5.4 4.4 33.6 9.1 6.1 10.6 8.5 16.1 12.2 10.5 10.2 6.1 7.0 22.7 8.6 8.8 4.5 11.6 20.6 8.7 12.2 8.6 14.6 10.9 13.2 6.0 14.0 11.0 5.5 5.4 5.2 17.2 19.7 13.5 5.4 9.0 13.2 17.2 18.1 11.8 11.7 13.0 6.4 12.6 6.9 17.1 11.9 21.8 7.6 21.6 12.0 3.0 15.3 18.3 5.8 6.8 9.5 15.7 18.8 13.9 9.2 9.2 8.4 8.8 10.6 6.1 6.9 8.3 9.6 8.2 10.2 5.8 10.7 11.8 6.9 6.4 6.3 8.4 10.0 9.4 11.4 5.5 9.8 5.4 8.9 16.5 45.2 11.5 9.2 8.5 9.0 8.0 7.1 7.8 3.0 7.2 3.9 12.3 14.1 12.6 2.8 7.6 4.0 7.9 1.8 2.0 13.8 14.9 13.0 105.9 8.3 22.7 0.0 9.7 12.0 7.0 15.1 5.7 4.9 10.0 4.8 13.8 6.7 10.0 12.4 8.9 9.7 5.0 25.2 16.1 8.1 14.3 17.3 7.1 6.3 1.7 6.5 9.7 5.5 11.8 16.9 47.9 24.9 13.4 22.9 TRIM21 "RNF81, Ro/SSA, RO52, SSA1" ENSG00000132109 "Tripartite motif containing 21" P19474 11 4384897-4393696 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Ubl conjugation pathway" "DNA-binding, Ribonucleoprotein, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 72.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB004566, HPA005673" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "CAB004566: AB_628286, HPA005673: AB_1080090" "prognostic favorable (4.83e-5)" "unprognostic (4.55e-2)" "unprognostic (3.64e-2)" "unprognostic (3.01e-2)" "unprognostic (1.50e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.87e-4)" "unprognostic (1.20e-1)" "unprognostic (5.04e-2)" "unprognostic (1.27e-1)" "unprognostic (2.49e-2)" "unprognostic (3.31e-1)" "unprognostic (1.82e-2)" "unprognostic (6.27e-2)" "unprognostic (4.69e-2)" "prognostic favorable (2.26e-6)" "unprognostic (9.12e-3)" 18.2 12.1 4.9 13.7 6.5 15.0 9.8 2.5 6.4 15.0 11.7 6.4 6.0 12.5 11.6 10.3 14.6 10.4 10.8 8.5 5.0 5.3 12.9 14.9 14.6 21.4 6.8 4.0 17.4 10.7 4.3 9.9 19.9 8.6 18.0 12.0 8.5 11.9 8.6 4.5 6.9 21.8 12.0 4.7 28.3 13.5 6.0 4.7 21.5 19.1 6.8 17.0 11.6 13.5 10.9 22.0 72.4 27.5 14.5 19.5 28.6 5.7 6.8 3.4 3.2 7.1 10.7 4.8 7.4 14.0 29.4 32.6 3.1 16.8 8.8 3.4 10.9 30.4 8.3 6.0 11.3 9.1 14.8 6.7 13.6 3.9 2.8 15.8 16.0 13.6 10.4 6.8 5.9 4.1 10.7 17.9 7.7 4.2 9.7 9.7 5.1 8.4 11.8 2.9 6.6 3.5 5.9 4.5 4.9 11.6 5.4 0.0 1.5 6.1 6.8 8.2 5.8 2.3 11.0 16.1 7.2 5.6 3.7 2.7 5.1 4.0 5.6 6.5 12.7 5.1 18.8 26.9 60.1 19.3 27.5 16.8 10.5 16.6 17.1 22.0 10.9 14.9 15.7 72.4 14.5 24.4 7.4 19.5 28.6 4.9 6.5 2.5 6.4 5.0 5.3 6.8 4.0 8.6 4.7 8.9 4.6 4.7 4.4 1.8 0.5 2.5 5.1 10.7 11.4 5.2 0.0 5.5 6.6 10.3 0.0 6.2 6.7 0.0 7.4 7.2 2.8 3.4 11.6 7.6 8.6 1.6 2.4 9.8 11.0 0.4 4.0 7.2 1.7 10.0 6.9 1.4 9.9 5.8 6.7 3.1 0.0 12.9 4.2 0.3 0.4 1.5 7.6 8.3 4.8 2.8 TRIM22 "GPSTAF50, RNF94, STAF50" ENSG00000132274 "Tripartite motif containing 22" Q8IYM9 11 5689689-5737089 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "B-cells: 76.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 37.6;BJ hTERT+ SV40 Large T+ RasG12V: 48.4;HSkMC: 42.4;TIME: 33.7" "HPA003307, HPA003575" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA003307: AB_1080381, HPA003575: AB_1080378" "unprognostic (1.47e-2)" "unprognostic (5.27e-3)" "unprognostic (4.00e-2)" "unprognostic (4.21e-3)" "unprognostic (2.21e-1)" "unprognostic (1.21e-2)" "unprognostic (1.24e-1)" "unprognostic (1.23e-1)" "unprognostic (1.19e-1)" "unprognostic (1.86e-3)" "unprognostic (2.93e-2)" "unprognostic (2.10e-1)" "unprognostic (1.98e-2)" "unprognostic (1.30e-1)" "unprognostic (2.50e-2)" "unprognostic (1.15e-1)" "unprognostic (9.16e-2)" 34.3 6.9 8.8 32.8 13.3 22.2 17.3 3.2 10.3 14.4 12.2 10.6 15.1 6.5 20.0 18.9 17.6 17.2 20.2 12.4 10.3 6.6 13.9 19.3 29.8 62.2 15.5 6.5 21.9 5.6 2.1 8.1 9.4 13.3 20.4 13.7 15.0 17.2 14.6 7.1 7.8 28.7 13.5 22.9 65.4 11.2 6.3 12.0 35.6 15.5 13.4 40.6 19.8 13.5 49.0 55.2 33.0 50.3 18.0 58.1 47.3 0.8 0.2 3.4 0.6 18.7 37.6 1.1 11.0 19.3 21.0 48.4 0.3 2.2 23.2 3.4 15.6 4.9 2.3 7.7 11.5 2.1 0.5 0.0 1.3 1.3 0.4 24.5 3.5 2.2 42.4 10.9 4.2 1.9 26.0 25.8 0.2 0.5 1.2 22.8 0.4 12.1 3.7 9.9 0.1 1.2 15.0 0.8 0.5 11.0 3.6 0.4 0.8 1.0 1.0 0.5 13.6 1.2 3.9 33.7 13.0 7.1 0.6 0.6 1.3 1.1 2.6 16.3 6.5 1.7 27.4 35.7 23.8 35.8 43.5 47.0 46.5 39.0 37.8 42.8 49.0 35.2 33.7 33.0 18.0 50.3 55.2 58.1 47.3 8.8 13.3 3.2 10.3 10.3 6.6 15.5 6.5 13.3 12.0 62.5 55.5 76.7 13.5 11.2 0.6 5.6 7.6 41.5 44.3 27.9 0.0 1.0 5.0 10.5 0.1 36.1 2.0 0.0 7.2 3.3 14.7 9.9 16.3 4.9 18.1 1.6 4.1 26.4 62.2 0.2 33.4 49.6 5.0 13.6 7.8 8.0 3.9 5.8 28.3 2.6 0.9 12.9 14.5 0.5 0.2 7.5 1.9 55.8 3.8 16.3 TRIM24 "hTIF1, RNF82, TIF1, Tif1a" ENSG00000122779 "Tripartite motif containing 24" O15164 7 138460334-138589993 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Repressor, Transferase" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "AF22: 43.3;HMC-1: 58.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043495, HPA061717" Approved Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA043495: AB_10962915, HPA061717: AB_2684592" "unprognostic (2.40e-1)" "unprognostic (9.52e-3)" "unprognostic (2.23e-1)" "unprognostic (3.96e-2)" "unprognostic (1.20e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (9.94e-4)" "prognostic favorable (6.57e-4)" "unprognostic (4.01e-2)" "unprognostic (8.93e-2)" "unprognostic (2.53e-1)" "unprognostic (2.02e-1)" "unprognostic (4.62e-2)" "unprognostic (1.62e-1)" "unprognostic (2.25e-2)" "unprognostic (5.54e-2)" "unprognostic (6.34e-2)" 10.3 31.4 10.4 11.2 10.6 8.8 8.8 8.5 10.7 9.4 9.2 14.6 5.7 9.4 9.0 8.5 11.3 7.0 10.3 9.7 8.4 8.5 9.6 21.5 10.7 8.5 10.5 8.0 29.9 11.6 20.7 7.3 13.5 8.4 13.6 9.1 7.5 10.1 7.1 16.0 9.8 14.1 9.4 8.0 8.5 10.8 24.1 11.3 34.8 8.8 9.2 8.9 11.3 11.2 1.3 1.9 3.7 2.5 2.2 2.7 0.8 4.2 5.2 43.3 12.5 2.9 2.7 3.3 3.9 4.2 3.1 3.0 8.2 3.9 8.1 3.9 3.8 6.4 2.3 21.0 3.3 4.6 6.2 5.2 17.9 3.9 25.2 3.9 13.9 58.5 2.4 3.5 2.6 4.1 2.2 7.3 4.5 20.2 5.0 3.7 8.2 23.7 12.6 16.5 22.1 4.7 18.8 5.1 6.8 6.9 12.6 9.0 20.5 7.3 6.6 2.1 15.7 4.5 9.2 3.1 3.6 3.0 6.3 5.4 4.6 5.0 13.8 6.0 9.2 5.2 1.1 2.3 3.6 2.2 2.5 0.4 0.9 1.9 1.2 1.9 1.3 1.8 2.0 3.7 2.2 1.1 1.4 2.7 0.8 10.4 10.6 8.5 9.7 8.4 8.5 10.5 8.0 8.4 11.3 47.6 42.2 4.5 11.6 12.4 13.3 38.8 15.3 17.4 20.5 7.0 15.7 25.9 5.0 6.3 45.5 13.2 8.0 0.0 10.6 11.7 11.8 10.1 38.3 28.4 9.2 38.1 9.7 14.1 11.2 28.3 13.0 12.4 13.5 4.6 8.2 28.0 10.1 9.3 15.2 7.7 20.8 12.9 9.9 43.1 8.5 10.3 18.5 10.2 15.5 12.2 TRIM25 "EFP, RNF147, ZNF147" ENSG00000121060 "Tripartite motif containing 25" Q14258 17 56887909-56914038 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway" "Ligase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 20.0" "Lineage enriched" "Detected in many" 8 "granulocytes: 20.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA005909 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 35000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA005909: AB_1078722" "unprognostic (8.73e-3)" "unprognostic (1.57e-2)" "unprognostic (2.06e-2)" "unprognostic (6.06e-2)" "unprognostic (2.69e-1)" "unprognostic (3.78e-2)" "prognostic unfavorable (9.37e-4)" "unprognostic (1.53e-1)" "unprognostic (4.23e-1)" "unprognostic (1.15e-1)" "prognostic favorable (3.36e-4)" "unprognostic (3.23e-1)" "unprognostic (3.11e-2)" "prognostic favorable (9.35e-4)" "unprognostic (5.21e-2)" "unprognostic (5.13e-2)" "unprognostic (7.39e-2)" 20.0 19.7 7.5 23.6 8.9 32.6 19.3 11.6 7.8 15.3 22.5 5.0 8.0 15.3 13.4 12.6 17.7 15.3 18.4 8.3 5.8 6.3 10.1 27.0 20.8 15.9 6.7 5.5 13.3 15.3 13.6 11.5 55.0 7.4 12.2 14.3 12.5 14.5 11.5 11.7 23.1 20.7 10.1 5.2 35.8 14.1 12.8 6.5 26.2 11.8 15.1 18.5 10.6 35.9 1.7 2.4 20.0 2.3 0.8 1.5 0.7 28.5 14.2 3.5 11.8 26.5 22.4 0.0 11.3 22.9 27.1 23.3 13.8 15.7 27.9 23.5 10.8 29.6 17.0 17.0 15.2 15.2 23.8 13.5 18.0 11.0 15.3 22.7 21.5 13.0 10.0 25.6 14.1 30.0 12.9 17.9 19.2 4.4 17.1 13.7 19.1 24.0 15.5 2.2 23.7 27.6 17.2 11.7 17.6 15.8 22.6 6.8 6.4 8.9 14.3 26.2 2.3 19.4 17.5 11.9 12.7 9.1 19.5 11.7 9.7 18.5 4.6 12.3 14.8 4.9 3.0 2.3 0.9 0.9 1.9 1.1 1.7 0.8 0.8 2.4 1.4 0.6 0.8 20.0 0.8 1.4 1.7 1.5 0.7 7.5 8.9 11.6 7.8 5.8 6.3 6.7 5.5 7.4 6.5 32.8 17.5 11.5 7.3 16.5 8.7 7.0 12.7 20.1 20.5 8.7 27.5 4.1 0.0 16.7 2.1 22.4 32.6 0.0 18.7 8.3 7.8 14.6 3.5 28.7 12.5 3.2 17.9 28.3 31.6 1.2 8.9 23.3 13.5 5.4 26.1 5.2 26.1 26.4 8.9 6.3 19.2 6.5 6.4 0.3 0.0 26.7 13.3 8.6 21.8 16.6 TRIM26 "RNF95, ZNF173" ENSG00000234127 "Tripartite motif containing 26" Q12899 6 30184455-30213427 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 23.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044975, HPA050456" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA044975: AB_2679162, HPA050456: AB_2681133" "unprognostic (1.93e-1)" "unprognostic (5.41e-2)" "unprognostic (8.53e-2)" "unprognostic (1.96e-3)" "unprognostic (1.52e-1)" "unprognostic (5.50e-2)" "unprognostic (2.02e-1)" "unprognostic (1.40e-2)" "unprognostic (2.85e-1)" "unprognostic (3.08e-2)" "unprognostic (1.97e-1)" "unprognostic (7.00e-3)" "unprognostic (1.37e-2)" "unprognostic (1.63e-3)" "unprognostic (5.21e-2)" "unprognostic (8.82e-2)" "prognostic favorable (3.25e-5)" 11.9 12.6 10.6 20.0 12.2 13.8 13.2 17.6 14.9 10.7 16.1 15.9 14.5 18.5 12.9 18.4 21.5 21.1 18.6 8.4 10.8 11.3 19.5 19.2 12.2 21.3 13.1 8.1 10.9 15.3 16.3 11.5 10.8 12.3 13.4 9.8 17.7 18.4 20.6 9.9 21.5 21.9 14.2 13.1 17.6 15.2 10.9 14.0 13.7 15.8 10.7 21.7 14.7 24.6 3.6 3.8 1.7 4.2 2.1 4.1 3.6 10.2 2.2 0.0 14.5 4.8 2.9 4.8 2.8 3.3 7.3 7.2 0.0 0.4 23.0 8.3 7.1 10.1 11.7 0.0 10.0 2.3 0.0 6.7 3.6 1.6 8.3 4.5 4.5 2.9 3.0 3.5 7.3 4.6 0.0 4.5 11.0 1.6 0.0 0.0 0.0 7.5 11.1 0.0 0.0 3.9 9.9 6.9 3.4 6.0 9.6 0.4 6.2 10.6 4.6 2.9 2.5 3.6 1.5 7.6 5.6 3.9 0.0 0.1 9.2 16.4 12.1 0.0 13.0 9.0 1.7 3.1 0.5 3.9 4.2 3.2 3.2 2.9 3.8 3.8 3.6 1.8 2.7 1.7 2.1 2.6 1.9 4.1 3.6 10.6 12.2 17.6 14.9 10.8 11.3 13.1 8.1 12.3 14.0 26.8 17.1 17.1 21.1 26.8 20.4 11.8 22.9 28.1 13.6 12.2 15.7 16.4 10.0 13.3 0.3 16.1 16.5 0.0 13.7 10.8 12.8 21.2 4.7 45.0 12.2 12.7 21.5 8.6 13.2 1.3 6.9 20.9 16.9 17.2 13.7 11.2 10.2 14.2 11.3 13.0 18.9 6.5 12.5 2.4 12.6 29.6 14.8 22.4 13.3 19.5 TRIM27 "RFP, RNF76" ENSG00000204713 "Tripartite motif containing 27" P14373 6 28903002-28923989 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Transport, Ubl conjugation pathway" "DNA-binding, Repressor, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048684, HPA053408" Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA048684: AB_2680493, HPA053408: AB_2682139" "unprognostic (1.57e-1)" "unprognostic (1.48e-2)" "unprognostic (2.36e-1)" "unprognostic (1.14e-2)" "unprognostic (1.70e-2)" "unprognostic (2.56e-1)" "unprognostic (2.00e-3)" "unprognostic (1.17e-2)" "unprognostic (1.01e-2)" "unprognostic (1.12e-3)" "unprognostic (4.76e-3)" "unprognostic (1.16e-2)" "prognostic unfavorable (3.50e-6)" "unprognostic (1.27e-1)" "unprognostic (1.41e-1)" "unprognostic (1.47e-1)" "prognostic favorable (2.71e-4)" 11.5 10.6 8.8 25.5 9.7 7.9 9.3 10.1 12.2 11.2 10.2 8.7 20.2 23.8 12.1 13.2 7.8 12.1 11.4 8.1 8.2 9.6 10.1 22.5 10.4 17.4 12.6 8.3 14.7 31.0 7.4 13.9 13.7 10.6 13.7 4.6 7.7 17.0 25.2 12.2 9.7 19.4 9.2 8.4 18.6 18.5 9.2 9.2 16.7 12.5 7.9 12.1 9.9 11.8 12.5 12.5 13.8 13.9 11.2 15.9 13.8 3.3 2.3 1.0 6.1 0.8 1.7 0.7 4.6 1.1 1.4 1.7 1.7 1.4 7.7 8.0 1.3 3.0 7.4 1.1 2.7 0.1 3.0 13.1 11.0 0.5 2.3 1.3 4.6 1.7 1.3 1.7 1.2 0.5 0.1 1.2 8.0 10.6 3.3 0.4 1.3 6.4 2.4 0.0 2.1 7.4 9.1 7.0 14.3 1.1 1.1 3.3 13.1 5.6 3.4 7.4 0.3 3.3 3.6 4.0 3.5 7.1 6.3 2.7 12.2 14.6 12.2 1.8 11.7 5.2 12.6 13.8 8.8 12.7 13.9 15.9 12.5 12.6 14.4 12.5 10.5 11.8 12.1 13.8 11.2 12.1 9.8 10.4 13.8 8.8 9.7 10.1 12.2 8.2 9.6 12.6 8.3 10.6 9.2 14.9 21.9 30.9 26.1 25.2 11.0 14.9 30.6 24.1 19.4 27.9 15.7 41.3 18.3 35.7 9.4 29.1 15.7 23.3 37.7 49.1 24.4 31.4 20.8 36.5 36.4 7.9 26.5 25.2 23.8 4.4 22.2 24.5 8.5 25.2 24.4 9.8 42.8 19.5 17.3 24.1 13.1 19.4 21.1 5.1 11.2 17.1 38.1 26.2 24.4 24.0 TRIM28 "KAP1, PPP1R157, RNF96, TF1B, TIF1B" ENSG00000130726 "Tripartite motif containing 28" Q13263 19 58544091-58550722 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 221.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010066, HPA064033" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA 140000 Nucleoplasm "CAB010066: AB_2209905, HPA064033: AB_2685179" "unprognostic (2.76e-1)" "unprognostic (1.40e-1)" "unprognostic (1.16e-1)" "unprognostic (1.19e-1)" "unprognostic (1.34e-1)" "unprognostic (2.99e-1)" "prognostic unfavorable (1.85e-6)" "unprognostic (1.20e-2)" "unprognostic (2.10e-2)" "unprognostic (2.66e-1)" "unprognostic (4.92e-3)" "unprognostic (9.28e-2)" "unprognostic (2.47e-2)" "unprognostic (4.67e-2)" "unprognostic (7.34e-2)" "unprognostic (4.22e-1)" "unprognostic (3.28e-2)" 24.2 26.4 17.9 40.1 20.6 52.2 30.6 34.5 26.3 46.7 36.5 26.2 26.2 26.8 43.3 30.0 34.1 34.5 38.5 28.4 18.5 16.4 27.3 42.3 29.5 38.1 29.2 22.7 69.3 47.0 30.7 25.7 45.6 22.8 37.6 18.5 21.5 31.8 32.4 56.5 41.2 27.5 38.4 17.9 34.9 32.9 48.1 23.1 119.9 50.6 33.5 33.5 34.0 46.4 13.7 14.6 5.0 7.6 16.0 16.9 6.3 36.5 78.7 42.3 31.2 18.5 14.2 47.2 24.0 21.8 23.5 18.0 54.8 30.8 40.2 15.9 20.7 43.6 25.1 47.8 34.6 15.4 20.6 221.1 69.2 35.7 43.6 19.7 43.9 44.5 19.2 19.3 30.0 23.5 19.8 21.9 47.6 33.6 22.7 21.6 54.1 61.3 54.1 29.6 37.7 50.7 58.2 25.6 43.2 21.0 60.7 42.4 33.2 25.1 32.7 13.4 13.1 22.4 42.7 20.2 55.3 21.9 12.0 43.0 29.3 47.7 45.0 25.0 32.8 35.0 1.3 7.1 5.0 8.9 7.6 11.6 11.5 12.8 12.3 9.0 13.7 16.9 15.1 3.8 16.0 4.9 14.6 8.2 6.3 17.9 20.6 34.5 26.3 18.5 16.4 29.2 22.7 22.8 23.1 11.9 15.2 37.3 46.8 57.1 60.0 8.4 40.8 8.1 17.0 31.4 25.5 50.7 19.9 38.6 75.8 40.5 45.0 0.0 47.9 51.6 41.1 44.2 21.8 31.0 40.2 52.4 62.0 26.4 32.9 81.1 60.9 36.2 27.0 29.7 61.8 50.0 49.3 45.6 38.9 32.1 31.8 58.2 46.4 124.7 74.6 53.1 46.9 30.5 58.1 39.7 TRIM29 "ATDC, FLJ36085" ENSG00000137699 "Tripartite motif containing 29" Q14134 11 120111275-120185529 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 176.3;lymphoid tissue: 93.6;skin 1: 90.1;tongue: 113.6" "Cell type enhanced" "Detected in many" 17 "Basal glandular cells: 97.6;Basal keratinocytes: 241.7;Suprabasal keratinocytes: 402.6;Urothelial cells: 144.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 93.4" "Region enriched" "Detected in single" 8 "pons and medulla: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 54.2;hTCEpi: 72.1;RT4: 28.5;SiHa: 40.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA020053, HPA074841" Enhanced Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA "Intermediate filaments" "Nucleoplasm, Cytosol" "HPA020053: AB_1858280, HPA074841: " "unprognostic (1.10e-1)" "unprognostic (6.22e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (2.88e-4)" "unprognostic (9.79e-3)" "unprognostic (3.08e-2)" "unprognostic (3.30e-1)" "unprognostic (5.24e-3)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (4.46e-4)" "unprognostic (9.37e-2)" "unprognostic (4.29e-3)" "prognostic favorable (4.93e-4)" "unprognostic (2.59e-1)" "unprognostic (2.91e-2)" "unprognostic (4.15e-2)" 0.3 0.2 0.1 0.0 0.1 0.1 7.3 0.0 0.1 30.4 0.6 0.2 1.6 0.3 3.1 2.9 176.3 3.7 0.8 0.1 0.1 0.1 0.5 0.4 1.4 0.0 0.0 0.0 0.4 0.2 0.0 2.2 24.4 1.1 11.1 0.5 0.0 25.5 4.8 0.9 90.1 0.2 1.6 0.3 0.0 0.2 0.7 0.0 7.5 0.1 113.6 93.6 9.6 42.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 3.4 0.0 0.8 0.0 0.1 54.2 0.0 12.4 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.1 0.0 72.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 28.5 0.2 0.9 40.5 5.7 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 1.1 0.0 0.0 1.0 0.0 97.6 241.7 0.0 1.1 2.5 33.5 13.6 0.0 0.0 37.9 0.0 1.3 21.4 0.4 2.1 0.0 3.9 5.0 5.4 34.5 1.1 0.0 4.4 0.0 2.4 0.0 0.0 78.0 0.6 1.7 21.9 0.0 2.3 0.0 33.2 0.8 0.0 0.2 0.0 0.0 7.2 0.6 1.4 402.6 20.7 0.0 1.4 144.0 TRIM33 "FLJ11429, KIAA1113, PTC7, RFG7, TF1G, TIF1G, TIF1GAMMA, TIFGAMMA" ENSG00000197323 "Tripartite motif containing 33" Q9UPN9 1 114392777-114511160 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 155.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 49.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004345 Supported Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA004345: AB_1858287" "unprognostic (8.90e-2)" "unprognostic (5.86e-2)" "prognostic favorable (6.20e-4)" "unprognostic (1.09e-2)" "unprognostic (8.42e-3)" "prognostic favorable (8.93e-4)" "unprognostic (1.34e-2)" "unprognostic (1.83e-1)" "unprognostic (6.75e-2)" "unprognostic (4.58e-2)" "unprognostic (2.14e-1)" "unprognostic (1.08e-1)" "unprognostic (2.27e-2)" "unprognostic (4.84e-2)" "unprognostic (1.99e-1)" "unprognostic (1.40e-1)" "unprognostic (1.68e-1)" 15.2 12.8 16.9 18.4 19.9 27.1 17.1 38.3 21.8 16.9 14.3 11.0 21.9 10.9 19.8 38.3 16.4 15.0 15.6 10.8 18.1 12.5 17.3 15.0 14.3 15.2 12.1 18.0 19.8 15.7 21.8 22.4 27.2 15.2 16.5 13.0 10.7 16.4 19.1 14.3 19.5 14.8 20.2 12.9 14.9 14.1 29.0 16.3 20.5 17.9 9.8 16.6 17.9 28.7 3.4 4.0 12.2 2.8 4.7 4.4 1.0 13.1 7.1 13.4 10.0 5.7 6.0 22.9 6.7 7.2 9.4 10.0 8.0 5.6 14.1 7.0 7.8 6.1 7.6 12.2 7.8 13.0 10.6 7.2 13.6 9.4 9.3 6.3 17.1 11.3 5.7 5.8 11.1 11.4 7.2 7.8 12.0 16.9 10.0 8.9 49.4 17.2 7.3 18.1 5.0 7.2 14.9 20.5 4.6 6.7 20.7 9.3 9.8 12.7 15.4 12.1 9.0 7.0 9.4 8.8 6.5 10.6 15.1 9.4 7.0 6.5 14.7 9.2 10.0 18.5 12.2 1.6 7.4 3.5 1.8 3.1 3.4 3.7 3.7 2.0 2.2 2.9 4.4 4.8 4.7 2.8 4.0 2.0 1.0 16.9 19.9 38.3 21.8 18.1 12.5 12.1 18.0 15.2 16.3 17.9 29.5 19.1 25.9 46.9 71.6 22.0 25.5 10.7 25.0 52.4 92.3 49.7 1.7 18.3 155.1 31.1 23.6 23.3 20.5 27.8 32.1 38.2 36.9 40.5 26.3 25.4 50.1 37.4 44.7 78.9 45.5 39.2 18.6 17.2 31.4 33.5 25.3 32.6 34.6 12.6 58.2 32.3 23.7 54.0 29.6 48.4 73.3 35.5 28.9 48.8 TRIM35 "HLS5, KIAA1098, MAIR" ENSG00000104228 "Tripartite motif containing 35" Q9UPQ4 8 27284887-27311319 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 23.3;Ito cells: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 38.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019647 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA019647: AB_1858291" "unprognostic (7.67e-3)" "unprognostic (6.53e-2)" "unprognostic (1.61e-2)" "unprognostic (9.64e-3)" "unprognostic (9.35e-2)" "prognostic favorable (1.38e-4)" "unprognostic (8.79e-2)" "unprognostic (8.02e-2)" "unprognostic (5.72e-2)" "unprognostic (2.30e-1)" "unprognostic (1.12e-1)" "unprognostic (4.86e-2)" "prognostic favorable (5.59e-7)" "unprognostic (1.74e-2)" "unprognostic (1.69e-1)" "unprognostic (3.99e-2)" "unprognostic (1.92e-1)" 10.6 7.2 5.7 8.1 8.9 8.6 17.7 5.7 12.9 8.2 7.9 8.7 17.3 7.2 10.2 6.6 11.7 8.2 6.3 6.9 10.9 5.9 11.3 14.6 8.4 12.7 7.3 7.3 8.7 11.6 6.8 5.1 7.1 7.0 8.3 5.4 5.4 23.4 27.7 5.8 32.7 7.3 9.7 12.6 7.8 6.8 10.4 6.6 10.2 6.1 7.4 9.0 8.6 10.8 5.2 5.9 8.7 3.0 7.8 12.8 4.8 9.0 6.5 3.8 4.9 38.1 9.5 8.8 5.5 4.3 5.1 5.5 9.2 1.8 8.0 5.7 6.0 4.5 9.0 5.4 10.6 3.9 4.5 4.1 7.9 5.1 7.8 9.9 4.2 6.8 13.7 24.1 7.2 14.4 2.7 5.0 7.7 5.5 9.0 4.1 4.6 14.2 5.9 6.6 5.8 5.3 7.2 4.9 6.9 3.5 7.1 6.5 6.2 4.6 4.4 7.6 3.8 2.8 6.9 5.9 4.7 9.7 14.7 5.3 4.1 4.3 5.9 6.7 6.3 4.5 8.7 2.8 3.4 8.6 2.7 9.7 5.2 11.2 9.5 3.5 3.7 7.7 11.3 1.1 7.8 3.0 5.9 12.8 4.8 5.7 8.9 5.7 12.9 10.9 5.9 7.3 7.3 7.0 6.6 3.0 5.0 2.2 5.6 18.5 3.3 3.6 7.6 0.0 4.5 12.2 5.9 3.0 0.0 3.5 0.6 4.7 3.4 23.3 4.5 2.1 3.8 3.7 5.7 17.4 2.5 4.8 2.4 25.8 8.4 0.4 11.8 4.1 6.8 5.4 2.8 2.2 4.1 0.0 10.3 5.0 3.6 0.0 5.2 1.4 4.3 19.4 1.3 5.0 3.0 2.7 TRIM36 "HAPRIN, RBCC728, RNF98" ENSG00000152503 "Tripartite motif containing 36" Q9NQ86 5 115124762-115180546 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 88.8" "Group enriched" "Detected in many" 39 "Early spermatids: 1875.0;Late spermatids: 3810.8" "Cancer enhanced" "Detected in many" "prostate cancer: 9.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "myeloid DC: 7.5;non-classical monocyte: 7.7" "Group enriched" "Detected in many" 43 "dendritic cells: 7.5;granulocytes: 4.2;monocytes: 7.7" "Cell line enhanced" "Detected in many" "RH-30: 17.8;SCLC-21H: 19.9;SH-SY5Y: 14.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA061321 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA061321: AB_2684479" "unprognostic (6.36e-2)" "unprognostic (2.99e-1)" "unprognostic (4.54e-2)" "unprognostic (1.32e-1)" "unprognostic (1.55e-1)" "unprognostic (2.31e-2)" "unprognostic (5.33e-6)" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (1.94e-1)" "unprognostic (1.84e-1)" "unprognostic (1.90e-1)" "unprognostic (2.82e-13)" "unprognostic (4.95e-2)" "unprognostic (1.38e-1)" "unprognostic (2.19e-1)" "unprognostic (6.80e-3)" 1.0 1.4 6.8 1.4 7.6 0.8 3.2 0.6 11.7 1.4 4.8 7.7 0.0 8.2 1.1 1.0 0.8 1.9 1.0 0.7 10.1 7.2 0.9 0.9 1.6 0.8 7.1 8.6 3.5 1.5 0.7 8.2 1.3 18.3 5.7 4.8 5.1 1.0 1.0 0.7 1.0 7.9 1.1 8.7 0.9 2.0 88.8 4.7 0.0 0.8 0.0 0.9 0.8 1.0 0.1 7.5 4.2 7.7 0.0 0.0 0.8 2.4 0.7 1.2 6.2 0.1 0.1 1.5 0.5 2.1 1.1 1.3 0.9 1.2 0.0 1.0 0.1 8.8 0.6 5.8 1.1 0.8 0.4 1.9 4.3 2.5 1.2 0.2 4.2 3.6 0.1 1.1 0.5 1.5 1.4 0.0 8.2 0.1 5.9 1.7 3.3 1.1 3.8 4.9 0.4 2.8 0.9 17.8 1.4 0.6 0.0 19.9 14.5 3.8 0.4 2.3 0.6 4.3 5.4 0.5 1.7 1.3 1.3 1.9 0.9 0.5 0.0 1.9 2.4 0.8 0.0 1.7 4.2 0.0 1.6 0.0 0.0 0.0 0.0 7.5 0.1 0.0 0.0 0.3 0.0 7.7 1.6 0.0 0.8 6.8 7.6 0.6 11.7 10.1 7.2 7.1 8.6 18.3 4.7 0.0 4.3 0.0 0.8 2.1 4.8 2.0 0.0 6.7 0.0 1.8 53.0 0.0 0.0 0.4 1875.0 0.7 21.6 0.0 1.6 0.4 0.6 8.8 1.1 0.0 2.5 4.8 3.4 0.6 1.6 3810.8 13.8 6.3 8.5 5.4 11.8 5.7 1.4 9.1 12.0 0.0 73.6 6.5 2.8 33.1 23.0 1.1 0.2 0.0 7.0 0.1 TRIM42 "FLJ40097, PPP1R40, T4A1" ENSG00000155890 "Tripartite motif containing 42" Q8IWZ5 3 140678039-140701150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 85 "testis: 43.2" "Group enriched" "Detected in some" 113 "Early spermatids: 249.5;Late spermatids: 89.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CACO-2: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA003581, HPA022481" Uncertain Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA003581: AB_1080383, HPA022481: AB_1858301" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 249.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 89.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.5 0.5 0.0 0.0 0.0 0.0 0.0 TRIM49D1 "TRIM49D, TRIM49D1P, TRIM49DP" ENSG00000223417 "Tripartite motif containing 49D1" C9J1S8 11 89911111-89921767 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "blood: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 199 "basophil: 19.8" "Lineage enriched" "Detected in single" 199 "granulocytes: 19.8" "Cell line enhanced" "Detected in single" "U-2 OS: 2.1" HPA072153 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA072153: " 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM49D2 "TRIM49D2P, TRIM49L, TRIM49L1" ENSG00000233802 "Tripartite motif containing 49D2" C9J1S8 11 89924064-89933063 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "blood: 15.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 160 "basophil: 15.9" "Lineage enriched" "Detected in single" 160 "granulocytes: 15.9" "Cell line enriched" "Detected in single" 6 "U-2 OS: 3.5" HPA072153 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA072153: " 0.0 0.0 0.1 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM56 RNF109 ENSG00000169871 "Tripartite motif containing 56" Q9BRZ2 7 101085439-101097967 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024358 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA024358: AB_1858308" "unprognostic (6.47e-2)" "unprognostic (1.34e-1)" "unprognostic (1.99e-2)" "unprognostic (1.62e-1)" "unprognostic (9.44e-3)" "unprognostic (8.30e-2)" "prognostic unfavorable (3.87e-4)" "unprognostic (2.63e-1)" "unprognostic (4.11e-1)" "unprognostic (3.90e-1)" "unprognostic (1.91e-1)" "unprognostic (1.43e-1)" "unprognostic (2.35e-2)" "unprognostic (2.47e-3)" "unprognostic (8.13e-2)" "unprognostic (1.49e-1)" "prognostic favorable (2.13e-4)" 14.3 12.0 6.2 15.7 9.3 4.7 24.5 3.2 11.1 14.9 15.0 6.8 22.3 9.7 14.3 13.1 12.9 12.8 13.7 8.7 7.5 5.2 10.8 10.4 23.7 11.7 15.8 5.2 17.3 10.8 10.7 15.2 14.0 8.8 12.5 8.3 7.5 12.2 22.1 8.7 13.2 12.8 15.2 8.5 17.2 10.3 5.6 12.0 9.7 14.0 9.1 12.0 13.6 22.0 3.3 2.1 7.4 2.4 7.7 3.6 1.0 9.9 12.5 5.4 6.9 12.5 13.0 6.5 8.3 7.4 13.5 12.6 5.9 14.5 11.8 9.0 6.9 18.8 11.5 2.2 7.6 9.1 11.8 3.5 7.4 15.7 4.4 11.2 13.1 16.9 8.2 11.1 8.8 14.4 13.2 7.1 7.6 12.9 15.0 9.3 13.6 11.0 14.6 5.4 5.3 10.4 10.2 8.8 7.7 7.1 10.4 0.3 0.2 9.2 25.8 7.0 7.2 5.9 8.6 13.4 19.0 16.9 14.2 8.9 7.4 7.4 9.3 9.4 10.7 14.8 2.5 2.4 2.1 3.6 1.5 2.6 2.0 2.7 2.3 0.8 3.3 2.6 3.4 7.4 7.7 2.1 2.1 1.1 1.0 6.2 9.3 3.2 11.1 7.5 5.2 15.8 5.2 8.8 12.0 68.5 72.4 41.5 67.9 4.6 3.2 19.1 89.2 77.6 52.4 48.8 2.0 33.7 3.3 51.6 1.8 75.8 45.5 23.3 41.2 22.2 26.5 58.9 14.0 41.9 17.0 9.5 28.1 86.5 38.1 0.8 122.6 36.3 1.7 21.6 43.9 23.6 46.8 49.1 88.8 6.7 2.8 64.7 27.4 4.7 6.6 2.9 24.9 62.3 41.9 50.8 TRIM60 "FLJ35882, RNF129, RNF33" ENSG00000176979 "Tripartite motif containing 60" Q495X7 4 165031953-165041744 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "placenta: 5.0;testis: 6.6" "Cell type enhanced" "Detected in some" 11 "Cytotrophoblasts: 4.8;Extravillous trophoblasts: 8.2;Spermatocytes: 3.8;Spermatogonia: 6.4;Syncytiotrophoblasts: 4.7" "Cancer enriched" "Detected in single" 103 "testis cancer: 5.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "BEWO: 18.0" "Not detected" "Not detected" "HPA035809, HPA035810, HPA061496" Uncertain Uncertain Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA035809: AB_2674794, HPA035810: AB_10601827, HPA061496: AB_2684540" "unprognostic (1.10e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.7 1.1 0.2 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.4 0.1 0.2 1.1 0.2 0.3 0.0 0.5 0.3 0.2 1.1 0.1 0.1 0.7 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.5 0.0 1.4 0.0 0.0 0.0 4.8 0.0 0.0 1.6 0.0 0.0 0.0 0.0 8.2 0.2 0.2 0.0 0.8 0.4 0.0 0.0 0.0 2.2 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.3 0.0 0.0 3.8 6.4 0.3 4.7 0.5 0.0 0.0 TRIM65 ENSG00000141569 "Tripartite motif containing 65" Q6PJ69 17 75880335-75897003 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021575, HPA021578, HPA064820" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA021575: AB_1858314, HPA021578: AB_1858315, HPA064820: AB_2685359" "unprognostic (1.82e-1)" "unprognostic (1.47e-1)" "unprognostic (3.47e-2)" "unprognostic (1.36e-1)" "unprognostic (1.96e-1)" "unprognostic (1.36e-2)" "prognostic unfavorable (4.74e-6)" "unprognostic (5.36e-2)" "unprognostic (8.71e-2)" "unprognostic (1.78e-1)" "unprognostic (5.82e-2)" "unprognostic (6.00e-3)" "prognostic unfavorable (1.82e-5)" "unprognostic (2.86e-3)" "unprognostic (7.18e-2)" "unprognostic (4.24e-3)" "unprognostic (7.50e-3)" 15.5 8.2 12.8 12.1 20.0 10.8 13.6 26.7 16.6 15.7 12.7 17.6 11.9 13.9 15.7 9.3 14.0 14.4 12.9 11.0 16.5 12.3 11.3 8.2 13.3 14.6 22.4 8.1 17.7 15.7 14.9 12.7 8.1 16.1 12.4 12.0 15.8 14.7 15.2 16.5 21.6 12.8 13.0 11.4 17.2 12.7 5.4 21.3 11.7 13.1 11.0 14.8 12.7 15.4 5.3 3.4 4.4 3.0 5.2 5.9 1.6 13.6 14.8 5.3 14.9 9.8 13.6 2.6 5.5 7.3 9.3 6.9 5.3 11.7 14.7 4.0 5.8 10.5 9.5 11.1 12.3 4.0 6.6 19.8 11.9 13.5 7.9 10.4 12.5 12.7 9.8 9.8 6.2 10.0 6.6 20.5 18.5 18.2 14.8 5.6 14.7 22.6 20.1 12.2 13.3 12.3 21.1 7.1 23.2 6.8 5.1 11.9 11.4 8.7 13.3 14.6 6.8 15.8 15.1 11.0 19.5 9.0 8.7 10.2 12.5 4.6 3.8 12.4 20.2 8.3 2.8 3.0 4.4 5.2 2.7 5.9 4.1 3.9 5.3 2.7 5.3 4.3 4.2 3.1 5.2 1.5 3.4 3.5 1.6 12.8 20.0 26.7 16.6 16.5 12.3 22.4 8.1 16.1 21.3 6.0 4.5 7.6 5.3 2.6 15.0 3.4 5.1 1.4 3.4 8.7 11.8 0.7 1.7 3.3 0.3 5.2 2.3 23.3 3.0 3.0 4.1 4.2 6.9 3.2 8.0 4.8 0.0 6.2 5.6 0.0 12.7 7.9 8.5 1.0 6.9 7.1 4.7 2.9 8.9 4.0 12.2 0.0 3.8 0.5 2.5 3.1 0.5 5.0 4.8 2.5 TRIM66 "C11orf29, KIAA0298, TIF1D" ENSG00000166436 "Tripartite motif containing 66" O15016 11 8612037-8682694 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 38.1;Late spermatids: 22.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027420 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA027420: AB_1858316" "unprognostic (1.26e-1)" "unprognostic (1.97e-1)" "unprognostic (2.43e-1)" "unprognostic (7.54e-2)" "unprognostic (3.99e-2)" "unprognostic (1.37e-3)" "unprognostic (8.01e-2)" "unprognostic (1.18e-1)" "unprognostic (8.49e-2)" "unprognostic (6.79e-2)" "prognostic favorable (8.89e-4)" "unprognostic (1.42e-1)" "prognostic unfavorable (3.96e-4)" "unprognostic (1.67e-1)" "unprognostic (4.26e-1)" "unprognostic (4.67e-2)" "unprognostic (4.31e-1)" 5.6 8.0 4.1 7.0 12.1 4.5 8.3 10.5 11.3 4.9 6.0 12.5 13.2 6.1 9.9 19.4 6.7 5.7 6.1 3.2 4.4 5.2 5.6 12.9 4.8 8.6 3.5 5.8 5.5 11.3 7.8 17.3 4.1 8.3 5.6 8.3 9.3 5.7 11.3 5.7 19.9 6.9 6.3 5.3 7.7 6.4 19.8 3.7 8.8 9.2 4.5 12.3 5.9 5.3 2.5 3.8 0.9 3.5 1.9 3.3 0.7 5.8 5.3 3.2 11.6 7.1 5.4 4.0 3.6 4.1 2.5 3.3 6.8 11.1 5.7 2.4 3.1 2.3 7.7 3.5 3.1 3.1 6.6 2.7 5.4 8.5 3.7 2.9 4.4 4.5 8.4 3.2 2.2 7.4 2.8 3.3 14.7 3.0 6.1 3.3 6.4 2.3 3.7 1.7 2.9 4.9 3.3 2.5 2.3 3.7 7.1 2.4 2.3 5.2 3.6 2.4 3.4 4.8 1.1 2.6 4.9 4.5 2.7 3.1 2.6 3.9 7.2 3.3 5.2 2.7 0.1 1.4 0.9 1.9 0.4 1.2 1.5 2.1 2.5 2.0 2.5 1.9 3.3 0.7 1.9 3.5 3.8 1.4 0.7 4.1 12.1 10.5 11.3 4.4 5.2 3.5 5.8 8.3 3.7 3.0 3.5 2.2 2.3 1.5 8.8 1.7 7.6 2.7 5.7 5.2 11.8 2.8 0.0 3.2 38.1 1.7 4.2 0.0 2.8 1.5 2.0 1.4 1.1 7.4 2.2 11.1 5.8 5.5 2.4 22.4 1.7 2.7 0.0 5.4 3.3 5.8 3.2 3.5 2.1 1.5 9.2 12.9 1.1 10.2 6.6 1.0 1.1 2.5 4.1 0.9 TRIM68 "FLJ10369, RNF137, SS-56" ENSG00000167333 "Tripartite motif containing 68" Q6AZZ1 11 4598672-4608259 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023455 Uncertain Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA023455: AB_1858319" "unprognostic (4.77e-2)" "unprognostic (5.15e-2)" "unprognostic (1.18e-1)" "unprognostic (4.10e-2)" "unprognostic (4.13e-2)" "unprognostic (8.63e-2)" "unprognostic (2.01e-2)" "unprognostic (1.28e-1)" "unprognostic (2.01e-1)" "unprognostic (6.70e-2)" "unprognostic (2.75e-2)" "unprognostic (7.78e-2)" "prognostic favorable (4.14e-6)" "unprognostic (4.23e-2)" "unprognostic (2.98e-1)" "unprognostic (1.61e-1)" "unprognostic (1.37e-1)" 7.7 11.3 11.1 8.0 11.1 3.1 10.6 15.2 12.8 16.3 10.9 12.6 18.2 10.3 10.6 12.2 8.0 12.6 10.3 9.4 9.6 7.9 14.9 12.7 11.7 7.6 13.1 10.5 17.3 9.9 12.6 10.5 9.8 10.0 16.8 10.1 9.9 12.0 17.5 8.7 7.6 9.8 9.8 11.9 10.7 12.4 13.2 9.5 10.0 17.8 6.7 8.9 11.7 8.4 9.1 5.9 8.9 5.2 5.5 12.8 7.6 8.4 9.5 3.9 6.4 6.4 10.5 0.0 9.3 6.9 8.5 7.8 1.2 8.8 5.8 5.7 4.7 8.1 10.0 3.9 6.5 7.3 14.4 7.6 7.1 2.4 0.0 7.4 11.3 10.0 8.1 9.6 5.0 7.6 8.9 10.7 5.4 6.5 3.0 7.6 2.0 9.3 3.1 4.6 5.9 7.9 7.5 5.6 0.2 5.5 3.8 2.1 3.8 0.0 9.5 5.9 8.1 4.1 5.7 8.6 11.4 7.9 11.5 4.1 11.9 12.9 8.4 7.9 5.0 10.7 6.4 2.7 8.9 9.0 5.1 10.1 9.1 9.9 10.0 5.9 7.9 12.8 10.1 0.3 5.5 5.2 4.0 8.7 7.6 11.1 11.1 15.2 12.8 9.6 7.9 13.1 10.5 10.0 9.5 0.0 2.2 0.9 1.1 0.7 3.7 4.3 0.0 0.0 6.8 5.2 2.0 4.9 5.0 2.5 0.4 2.2 2.3 0.0 2.9 2.1 1.6 1.8 3.5 4.5 2.0 0.0 6.4 3.1 2.2 0.0 1.7 1.5 0.0 2.8 5.9 3.7 2.4 0.0 1.8 1.7 2.7 6.5 2.1 2.6 4.3 0.9 3.7 1.3 4.3 0.5 TRIM7 "GNIP, RNF90" ENSG00000146054 "Tripartite motif containing 7" Q9C029 5 181193924-181205293 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 81.8;tongue: 34.0" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 15.9;Cardiomyocytes: 22.9;Sertoli cells: 12.9;Suprabasal keratinocytes: 24.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 16 "cerebellum: 21.7" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "monocytes: 4.9;T-cells: 2.2" "Cell line enhanced" "Detected in many" "HaCaT: 11.4;HDLM-2: 24.1;PC-3: 13.3;TIME: 11.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039213 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA039213: AB_10795173" "unprognostic (6.58e-2)" "unprognostic (1.17e-1)" "unprognostic (5.20e-2)" "unprognostic (1.10e-2)" "unprognostic (6.85e-2)" "unprognostic (1.80e-2)" "unprognostic (3.89e-4)" "unprognostic (3.45e-2)" "unprognostic (3.72e-1)" "unprognostic (1.64e-1)" "unprognostic (3.48e-2)" "unprognostic (1.97e-1)" "unprognostic (7.16e-3)" "unprognostic (1.26e-1)" "unprognostic (3.90e-2)" "unprognostic (6.17e-2)" "unprognostic (1.15e-2)" 1.3 0.9 0.1 0.9 0.5 0.5 3.4 21.7 1.3 2.5 0.8 0.3 1.1 0.5 1.0 6.4 13.0 0.6 1.7 2.2 0.1 0.8 2.2 0.5 0.9 0.6 0.2 0.2 0.6 4.2 1.6 1.9 0.5 0.5 2.0 0.6 0.6 5.9 1.1 81.8 9.5 0.6 0.9 0.3 0.8 1.4 0.9 0.2 0.1 3.3 34.0 13.5 1.6 2.9 0.7 0.8 0.1 4.9 0.5 2.2 1.1 6.1 3.0 0.0 0.3 0.5 0.5 0.2 1.4 0.0 0.5 1.2 0.3 8.1 0.4 4.3 1.7 2.6 11.4 3.3 9.3 0.1 24.1 1.3 0.5 7.9 0.1 1.6 0.0 1.4 0.1 7.2 0.2 4.6 1.8 2.6 1.1 0.3 1.3 0.2 0.8 0.3 0.2 0.0 9.7 13.3 0.3 4.2 0.9 3.3 0.0 0.3 0.7 2.9 0.2 4.1 0.1 0.7 0.2 11.0 0.1 2.4 0.4 4.3 1.9 0.2 0.7 0.3 0.4 1.0 0.0 4.9 0.1 1.4 1.9 2.2 0.4 1.2 1.4 0.8 0.7 2.2 1.8 0.1 0.5 1.4 0.6 2.2 1.1 0.1 0.5 21.7 1.3 0.1 0.8 0.2 0.2 0.5 0.2 0.0 1.4 0.0 3.9 15.9 5.7 22.9 0.0 0.0 0.0 3.5 0.0 0.0 5.0 0.4 0.6 1.4 2.4 0.0 2.0 0.4 0.8 1.8 0.0 0.2 1.1 0.0 0.0 1.8 9.4 0.0 0.9 1.6 1.7 0.0 3.1 0.5 3.2 8.5 1.4 1.1 2.7 12.9 9.0 0.9 0.4 24.8 0.0 0.0 2.2 2.4 TRIM72 MG53 ENSG00000177238 "Tripartite motif containing 72" Q6ZMU5 16 31214021-31231537 "Predicted intracellular proteins, Transporters" "Exocytosis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "skeletal muscle: 71.6;tongue: 37.7" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 6.7;Club cells: 4.5" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 12 "cerebellum: 3.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HL-60: 4.8;LHCN-M2: 8.9;RH-30: 23.1;U-266/70: 14.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA054909 Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA054909: AB_2682639" "unprognostic (2.61e-1)" "unprognostic (3.21e-3)" "unprognostic (5.07e-2)" "unprognostic (9.77e-2)" "unprognostic (3.71e-1)" "unprognostic (3.13e-1)" "unprognostic (2.01e-3)" "unprognostic (2.80e-1)" "unprognostic (6.57e-2)" "unprognostic (4.90e-1)" "unprognostic (1.90e-1)" "unprognostic (2.49e-2)" "unprognostic (2.24e-10)" "unprognostic (7.70e-2)" "unprognostic (6.72e-2)" "unprognostic (4.15e-1)" "unprognostic (4.30e-4)" 2.3 0.1 0.1 0.1 0.2 0.3 0.1 3.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 5.5 1.8 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.8 0.0 0.0 1.0 0.0 71.6 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 1.2 37.7 1.9 0.0 0.0 2.0 1.9 4.9 1.3 2.1 1.3 0.4 0.1 0.2 0.2 0.3 0.1 0.1 0.4 0.2 0.1 0.0 0.0 0.2 0.4 0.2 0.1 0.1 0.2 0.2 0.1 0.0 0.0 0.2 0.1 0.2 0.7 0.3 0.2 4.8 0.2 1.0 0.1 0.0 0.1 0.1 0.0 0.2 0.3 0.5 8.9 0.2 0.1 0.4 0.2 0.1 0.3 0.3 23.1 3.0 0.0 0.3 1.9 0.2 0.2 0.3 0.1 0.3 0.2 2.0 0.1 0.2 0.3 0.2 0.1 14.4 1.2 0.2 0.2 0.4 0.2 4.5 1.3 1.5 1.1 1.2 1.0 1.3 1.0 0.9 0.8 2.0 1.3 1.3 4.9 2.1 1.2 1.9 0.8 0.4 0.1 0.2 3.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 3.0 6.7 0.0 2.0 0.1 0.8 2.6 0.0 0.0 4.5 0.0 2.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.2 1.4 1.1 0.0 0.2 0.0 0.0 0.6 1.9 0.0 0.0 0.6 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.5 1.6 TRIM8 "GERP, RNF27" ENSG00000171206 "Tripartite motif containing 8" Q9BZR9 10 102642310-102660680 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023560, HPA023561" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA023560: AB_10600414, HPA023561: AB_10601861" "unprognostic (4.32e-2)" "unprognostic (6.90e-2)" "unprognostic (3.02e-3)" "unprognostic (1.45e-1)" "unprognostic (1.78e-1)" "unprognostic (5.03e-1)" "unprognostic (3.82e-2)" "unprognostic (1.03e-1)" "unprognostic (2.15e-3)" "unprognostic (4.62e-2)" "unprognostic (5.41e-2)" "unprognostic (1.52e-1)" "unprognostic (9.55e-2)" "unprognostic (1.48e-1)" "unprognostic (3.12e-2)" "unprognostic (8.34e-2)" "unprognostic (1.36e-2)" 31.7 18.4 26.1 23.9 25.2 17.0 18.0 26.1 31.6 31.8 19.5 22.9 15.4 15.8 18.0 14.3 17.8 21.6 19.8 25.0 23.2 18.0 27.2 21.9 23.0 25.4 20.1 20.0 19.3 35.9 24.7 14.7 17.5 16.3 17.4 8.1 19.4 28.5 18.5 34.8 14.6 23.7 13.6 15.7 22.5 21.2 11.7 21.9 48.3 26.6 14.5 30.3 21.4 15.9 9.0 11.9 17.8 5.3 5.5 7.2 3.9 26.9 6.3 6.3 10.2 6.9 14.1 5.8 9.7 19.7 10.5 8.5 11.4 32.6 8.7 26.0 21.5 4.6 9.9 4.2 13.0 8.7 8.8 8.2 21.9 5.3 26.0 17.6 4.9 8.8 16.1 7.2 23.1 13.7 35.0 14.0 4.5 4.1 13.1 8.2 17.5 9.3 16.4 3.4 9.8 12.9 4.6 14.1 4.3 12.5 19.0 3.8 7.4 5.3 6.6 12.8 7.4 18.8 9.8 25.9 14.2 6.3 7.9 21.7 11.9 7.8 5.0 21.6 12.3 3.6 10.7 4.8 2.6 6.8 4.4 6.7 9.0 7.2 5.3 4.1 7.0 6.4 5.5 17.8 5.5 5.3 11.9 6.9 3.9 26.1 25.2 26.1 31.6 23.2 18.0 20.1 20.0 16.3 21.9 53.6 64.6 14.3 12.5 27.9 37.2 34.1 33.1 37.5 36.4 83.7 7.9 10.3 34.9 50.3 0.9 21.5 18.8 0.0 39.1 2.9 23.8 18.6 8.1 24.1 21.7 27.0 20.7 26.4 31.7 0.4 28.7 27.1 16.9 46.9 30.1 22.7 48.9 17.5 32.2 40.0 14.3 12.9 24.3 2.3 5.3 19.9 9.2 17.5 20.4 18.7 TRIP10 "CIP4, HSTP, STOT, STP" ENSG00000125733 "Thyroid hormone receptor interactor 10" Q15642 19 6737925-6751526 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 103.7" "Cell type enhanced" "Detected in many" 10 "monocytes: 342.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 19.4" "Lineage enriched" "Detected in many" 12 "dendritic cells: 19.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041934, HPA072625, HPA073886" Approved Supported Nucleoplasm,Vesicles NA NA 15000 Vesicles Nucleoplasm "HPA041934: AB_2677754, HPA072625: AB_2732206, HPA073886: AB_2732244" "unprognostic (5.75e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (3.61e-4)" "unprognostic (2.19e-2)" "unprognostic (6.57e-2)" "prognostic favorable (1.76e-4)" "unprognostic (6.73e-3)" "unprognostic (1.10e-3)" "unprognostic (1.51e-1)" "unprognostic (3.41e-1)" "unprognostic (7.87e-3)" "unprognostic (3.28e-1)" "prognostic unfavorable (4.66e-4)" "unprognostic (1.14e-2)" "unprognostic (1.42e-1)" "unprognostic (8.93e-2)" "unprognostic (8.83e-2)" 19.7 10.7 6.0 9.2 7.2 2.3 16.8 3.7 5.4 25.6 19.1 4.5 20.6 9.7 17.8 16.7 44.8 12.0 17.6 18.1 6.5 1.9 14.0 4.5 19.5 5.4 6.7 3.5 22.4 12.9 7.0 4.8 25.4 7.0 19.2 6.6 20.2 16.1 18.3 103.7 10.4 10.1 20.9 6.7 7.1 11.3 8.7 5.4 2.8 31.7 21.6 21.7 24.3 26.5 1.5 19.4 0.1 0.7 1.6 0.9 0.4 26.8 16.3 5.7 8.6 22.5 23.7 20.6 17.4 20.1 19.9 17.4 22.1 15.5 0.5 23.5 14.6 16.1 20.0 12.9 25.3 11.8 16.9 5.2 8.7 15.4 16.8 18.5 0.4 2.8 27.3 17.2 17.7 13.6 26.3 20.4 1.2 12.7 7.4 14.5 9.1 2.3 6.0 12.1 16.8 13.9 3.9 11.8 7.8 16.7 13.4 0.0 6.6 22.8 10.3 6.5 13.9 10.7 4.7 39.7 13.4 24.0 34.9 18.2 7.8 4.2 2.6 21.7 2.5 8.7 0.0 0.7 0.0 0.5 0.1 0.7 1.2 0.2 0.9 3.8 1.5 0.3 0.2 0.1 1.6 0.1 19.4 0.0 0.4 6.0 7.2 3.7 5.4 6.5 1.9 6.7 3.5 7.0 5.4 26.8 20.3 3.7 99.7 75.9 13.2 7.5 17.8 9.4 30.7 15.7 35.3 6.1 5.0 41.3 9.7 37.9 25.1 0.0 33.6 32.8 73.7 86.2 27.8 3.4 8.7 0.0 7.5 38.1 4.0 10.0 51.8 30.9 35.4 342.7 15.5 11.4 60.8 24.3 33.9 18.2 16.8 32.3 85.5 1.9 5.9 72.8 11.9 4.3 21.7 106.3 TRIP11 "CEV14, GMAP-210, GMAP210, Trip230" ENSG00000100815 "Thyroid hormone receptor interactor 11" Q15643 14 91965991-92040896 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002570, HPA070684" Supported Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA002570: AB_1078995, HPA070684: AB_2686295" "unprognostic (1.65e-1)" "unprognostic (2.81e-2)" "unprognostic (7.14e-2)" "unprognostic (1.12e-1)" "unprognostic (6.89e-2)" "unprognostic (1.39e-1)" "unprognostic (3.49e-3)" "unprognostic (1.60e-1)" "unprognostic (1.46e-1)" "unprognostic (7.33e-3)" "unprognostic (2.04e-1)" "unprognostic (1.21e-1)" "prognostic favorable (1.78e-6)" "unprognostic (1.78e-1)" "unprognostic (5.08e-1)" "unprognostic (7.74e-2)" "unprognostic (5.55e-2)" 13.0 15.0 10.5 10.8 12.5 7.7 12.1 18.5 14.1 17.4 13.0 8.8 15.2 11.1 13.3 12.7 14.7 11.4 11.2 12.9 9.2 6.7 15.5 16.1 10.6 9.4 12.2 11.1 16.0 27.1 27.1 34.9 24.4 15.2 14.5 11.0 9.4 15.1 15.3 24.0 12.4 15.9 11.2 10.7 15.2 16.2 14.0 13.5 16.4 18.4 11.1 11.9 15.8 12.5 20.0 12.7 17.0 13.0 12.1 14.1 3.9 12.5 12.8 8.3 8.8 14.7 22.8 12.6 20.0 15.4 10.0 11.4 7.7 20.5 8.8 14.8 17.6 7.8 16.6 10.9 9.7 21.8 13.4 3.3 9.9 11.5 7.3 11.2 11.6 9.9 8.7 11.9 17.6 15.1 11.1 15.8 4.9 6.5 10.2 15.5 17.6 6.6 2.9 3.8 12.3 9.2 8.2 16.0 4.4 8.9 20.6 6.1 5.5 16.2 9.5 6.2 8.8 20.8 5.9 20.9 11.6 8.2 12.0 9.0 9.1 13.9 8.0 13.6 6.6 14.5 8.2 8.8 17.0 13.3 8.0 12.8 11.8 14.1 12.1 6.9 20.0 13.5 14.1 8.7 12.1 13.0 12.7 12.2 3.9 10.5 12.5 18.5 14.1 9.2 6.7 12.2 11.1 15.2 13.5 50.6 65.6 24.1 27.5 14.7 56.7 99.6 35.7 71.0 62.6 36.6 68.7 34.2 14.9 55.0 10.9 42.7 24.5 0.0 40.6 23.8 31.0 32.3 35.9 30.6 22.0 41.3 30.9 30.7 25.7 8.5 57.5 21.2 6.8 33.3 38.0 54.1 40.4 28.1 50.9 21.4 64.7 58.2 23.7 107.2 64.1 14.9 60.6 21.0 28.1 33.1 TRIP13 16E1BP ENSG00000071539 "Thyroid hormone receptor interactor 13" Q15645 5 892643-919357 "Disease related genes, Predicted intracellular proteins" "Differentiation, Meiosis, Oogenesis, Spermatogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.4;testis: 52.9" "Group enriched" "Detected in many" 5 "Ciliated cells: 109.7;Early spermatids: 114.7;Late spermatids: 165.0;Spermatocytes: 66.2;Spermatogonia: 77.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA005727, HPA053093" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA005727: AB_10603220, HPA053093: AB_2682042" "unprognostic (1.65e-2)" "unprognostic (1.65e-1)" "unprognostic (8.59e-2)" "prognostic unfavorable (3.93e-4)" "unprognostic (2.34e-2)" "unprognostic (3.96e-2)" "prognostic unfavorable (1.30e-6)" "unprognostic (4.44e-3)" "unprognostic (1.73e-3)" "prognostic favorable (1.39e-4)" "unprognostic (4.25e-2)" "unprognostic (2.24e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (5.04e-2)" "unprognostic (1.99e-1)" "unprognostic (1.31e-1)" "unprognostic (3.34e-1)" 1.5 0.9 1.7 8.6 1.2 3.4 1.7 0.6 1.6 1.6 2.7 0.4 1.4 2.4 1.6 1.9 5.3 4.9 2.4 1.2 1.4 1.7 1.3 0.8 1.5 4.7 0.6 0.6 2.1 1.0 0.0 1.9 2.8 1.0 1.0 4.5 0.4 1.3 1.0 0.6 1.4 2.5 2.5 0.7 3.8 1.4 52.9 0.3 16.4 0.5 8.8 6.3 1.1 1.8 2.7 2.3 0.0 0.3 3.3 4.8 0.9 19.5 22.6 14.7 20.8 1.3 3.3 15.4 20.6 10.3 32.8 30.8 21.2 13.5 17.6 14.8 12.1 28.5 14.3 31.1 14.7 41.0 26.3 24.2 12.3 42.5 15.4 0.3 19.9 7.3 1.4 1.0 27.3 11.9 3.4 16.0 14.2 18.0 15.6 22.3 13.3 19.3 16.5 16.1 11.5 19.7 11.6 27.3 32.8 8.7 10.5 14.6 15.0 31.3 11.3 6.0 13.3 21.8 9.3 8.1 17.5 21.7 14.2 22.9 9.2 20.0 19.1 10.3 22.8 19.0 0.0 0.1 0.0 1.0 0.1 0.5 2.7 1.4 1.9 0.3 2.1 0.6 0.2 0.0 3.3 0.3 2.3 4.8 0.9 1.7 1.2 0.6 1.6 1.4 1.7 0.6 0.6 1.0 0.3 0.0 1.4 3.7 3.5 3.1 0.6 0.2 0.0 109.7 4.5 0.0 0.0 3.6 0.0 3.1 114.7 1.4 0.8 0.0 1.6 20.1 1.9 2.1 5.7 0.2 6.2 3.2 4.1 3.1 1.5 165.0 2.0 3.2 0.0 1.8 2.4 0.8 1.8 1.5 2.1 1.0 0.7 6.5 0.3 66.2 77.5 1.3 2.9 4.3 2.8 2.0 TRIP4 "HsT17391, ZC2HC5" ENSG00000103671 "Thyroid hormone receptor interactor 4" Q15650 15 64387748-64455303 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Congenital muscular dystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016605, HPA050666" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA016605: AB_1858339, HPA050666: AB_2681211" "unprognostic (1.56e-1)" "unprognostic (1.14e-1)" "unprognostic (2.62e-1)" "unprognostic (4.50e-2)" "unprognostic (5.79e-2)" "unprognostic (1.08e-1)" "unprognostic (7.16e-2)" "unprognostic (3.01e-2)" "unprognostic (4.98e-2)" "unprognostic (2.83e-1)" "unprognostic (1.25e-1)" "unprognostic (2.37e-2)" "prognostic favorable (6.34e-6)" "unprognostic (2.41e-1)" "unprognostic (2.96e-1)" "unprognostic (2.61e-2)" "unprognostic (1.25e-1)" 17.1 14.7 14.2 18.8 15.1 13.7 18.3 15.9 19.6 14.3 20.8 16.6 23.5 17.5 17.1 14.6 22.6 15.3 15.6 15.5 12.4 11.2 28.5 15.8 15.3 15.0 17.1 14.6 15.9 19.9 22.9 19.6 19.3 15.3 15.7 20.4 12.7 16.5 13.6 14.6 20.6 26.2 17.3 15.7 20.0 17.4 15.0 14.4 28.0 27.1 17.4 18.6 16.8 17.5 8.6 10.4 30.9 19.7 9.7 11.5 8.3 10.6 15.9 14.0 9.9 11.6 15.3 13.2 11.3 14.7 19.7 19.2 13.2 24.0 7.7 3.8 17.2 16.1 15.2 22.7 13.0 18.9 15.5 6.4 11.2 11.4 13.9 20.7 12.0 21.3 19.0 17.0 15.6 16.4 11.3 17.2 11.4 12.8 9.7 18.0 12.2 7.6 12.5 8.2 19.0 8.5 11.7 10.6 12.7 19.3 20.5 7.6 11.9 10.2 12.4 20.5 27.5 15.6 18.2 15.1 14.1 9.6 9.3 16.0 8.1 14.5 7.7 11.7 12.4 17.6 30.9 11.4 26.6 11.3 14.6 9.6 8.4 10.8 11.4 10.4 8.6 9.2 9.7 16.1 9.7 19.7 8.2 11.5 8.3 14.2 15.1 15.9 19.6 12.4 11.2 17.1 14.6 15.3 14.4 20.8 10.4 9.0 8.2 7.4 10.6 8.5 7.6 29.4 12.5 12.2 11.8 19.6 11.6 20.2 14.3 13.9 11.8 0.0 23.8 22.2 11.5 5.7 18.5 3.2 19.0 14.3 10.9 9.8 12.5 1.8 10.9 14.9 13.5 32.5 7.3 9.5 25.4 10.2 12.0 30.0 16.4 6.5 9.9 19.3 19.2 5.5 20.3 15.3 8.0 7.2 TRIR "C19orf43, fSAP18, MGC2803, TERCIR" ENSG00000123144 "Telomerase RNA component interacting RNase" Q9BQ61 19 12730640-12734775 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 325.2;Exocrine glandular cells: 329.0;Extravillous trophoblasts: 428.3;monocytes: 432.0;Pancreatic endocrine cells: 322.0;Proximal tubular cells: 402.3;Syncytiotrophoblasts: 484.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059965 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA059965: AB_2684182" "unprognostic (5.57e-2)" "unprognostic (2.73e-3)" "unprognostic (3.69e-2)" "unprognostic (1.12e-1)" "unprognostic (1.48e-2)" "unprognostic (1.99e-1)" "unprognostic (3.17e-3)" "unprognostic (1.93e-2)" "unprognostic (1.74e-1)" "unprognostic (9.33e-3)" "unprognostic (2.43e-3)" "unprognostic (9.43e-2)" "unprognostic (1.60e-2)" "unprognostic (4.84e-2)" "unprognostic (1.30e-1)" "unprognostic (2.63e-3)" "unprognostic (1.02e-2)" 58.6 48.6 51.6 64.7 48.9 62.7 53.7 46.3 51.2 61.9 66.0 33.6 45.5 46.8 49.7 68.4 60.0 37.8 59.2 51.5 45.8 41.4 49.1 97.1 45.4 51.8 47.1 39.3 62.3 53.8 31.4 40.2 62.1 31.3 60.4 40.4 36.7 55.6 48.0 77.3 42.5 55.6 47.6 45.1 65.1 48.4 45.8 32.6 87.1 59.5 39.0 59.1 62.2 80.7 24.7 13.6 33.8 10.9 10.6 16.1 5.6 44.5 24.1 30.2 22.3 24.4 26.0 29.2 38.0 23.4 29.2 28.6 31.8 15.7 35.4 49.8 22.5 23.9 30.9 30.2 24.1 23.7 40.2 58.2 23.7 27.4 51.6 23.8 34.1 45.0 26.3 29.7 22.2 17.8 24.6 27.6 25.7 32.7 14.8 26.9 96.4 56.5 80.4 34.4 26.0 68.6 49.2 23.7 35.4 34.1 30.5 34.3 45.8 26.0 26.7 42.7 20.8 23.2 52.6 28.5 35.2 28.2 54.7 48.5 49.6 53.2 39.5 29.8 41.7 24.6 8.0 10.9 33.8 11.4 9.3 13.3 24.7 14.8 14.6 9.7 17.5 14.0 12.5 21.0 10.6 8.7 13.6 16.1 5.6 51.6 48.9 46.3 51.2 45.8 41.4 47.1 39.3 31.3 32.6 65.5 65.4 0.0 0.0 0.0 0.0 0.0 0.0 56.2 62.6 174.5 0.0 325.2 230.5 276.3 0.0 0.0 0.0 0.0 329.0 428.3 0.0 0.0 23.3 0.0 314.8 0.0 0.0 0.0 0.0 0.0 0.0 44.7 0.0 432.0 0.0 0.0 322.0 0.0 0.0 402.3 0.0 0.0 0.0 0.0 0.0 0.0 484.5 0.0 0.0 0.0 TRMO "C9orf156, HSPC219" ENSG00000136932 "TRNA methyltransferase O" Q9BU70 9 97904489-97922570 "Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 27.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021281, HPA052197" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA021281: AB_2670649, HPA052197: AB_2681758" "unprognostic (2.53e-1)" "unprognostic (5.66e-2)" "unprognostic (2.13e-1)" "unprognostic (1.63e-3)" "unprognostic (1.12e-1)" "unprognostic (6.28e-2)" "unprognostic (1.08e-2)" "unprognostic (7.27e-3)" "unprognostic (1.64e-1)" "unprognostic (8.67e-2)" "unprognostic (3.12e-2)" "unprognostic (2.99e-2)" "prognostic favorable (4.81e-10)" "unprognostic (1.97e-1)" "unprognostic (1.78e-1)" "unprognostic (1.74e-2)" "unprognostic (4.39e-2)" 12.2 15.9 13.6 22.5 14.2 20.4 19.3 15.9 14.9 13.5 10.0 19.2 14.9 9.4 15.1 17.3 12.9 15.0 10.6 9.1 13.0 12.3 13.9 17.6 17.9 23.0 14.2 16.3 13.9 13.7 15.7 26.7 10.4 13.3 14.0 11.6 13.4 19.7 11.7 14.1 15.0 14.8 10.1 15.0 20.8 12.8 18.2 14.2 22.8 26.1 10.3 19.1 11.9 10.7 15.8 13.4 28.8 13.7 11.9 25.8 12.0 14.9 9.6 5.2 6.3 6.5 5.4 9.0 7.7 8.8 12.2 9.2 13.3 10.9 9.5 5.3 7.4 13.8 14.2 8.4 6.1 9.6 11.2 6.9 7.6 11.6 11.8 13.6 14.7 12.8 9.5 13.6 6.6 5.7 7.4 5.4 7.6 12.2 12.1 8.4 21.7 6.2 10.2 7.2 16.3 10.8 7.6 11.5 6.9 11.4 12.2 9.4 8.2 5.8 12.2 12.4 4.6 5.3 8.2 8.1 6.8 6.8 14.1 11.5 13.4 9.5 4.8 7.1 7.7 5.9 20.1 12.8 28.8 12.9 13.7 15.9 11.9 19.8 15.5 13.4 15.8 25.8 17.9 20.9 11.9 9.1 7.8 20.2 12.0 13.6 14.2 15.9 14.9 13.0 12.3 14.2 16.3 13.3 14.2 11.9 4.0 7.8 13.4 0.0 8.7 0.0 7.6 10.7 12.5 5.2 0.0 7.7 6.6 7.8 27.5 3.7 2.6 0.0 8.5 6.1 4.1 4.9 0.0 6.4 9.5 6.4 2.4 3.1 8.9 10.5 4.6 2.8 0.0 8.2 7.0 11.6 8.4 7.0 6.7 7.0 4.2 6.5 0.0 14.8 14.5 0.0 15.3 10.2 4.9 6.4 TRMT1 "FLJ20244, TRM1" ENSG00000104907 "TRNA methyltransferase 1" Q9NXH9 19 13104902-13117567 "Enzymes, Plasma proteins, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 88.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041130, HPA041380" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA041130: AB_10803995, HPA041380: AB_10793873" "unprognostic (2.10e-2)" "unprognostic (2.40e-3)" "unprognostic (2.23e-2)" "unprognostic (1.01e-1)" "unprognostic (1.12e-2)" "unprognostic (5.54e-2)" "unprognostic (1.08e-3)" "unprognostic (2.19e-2)" "unprognostic (1.59e-1)" "unprognostic (7.62e-2)" "unprognostic (1.91e-2)" "unprognostic (8.74e-3)" "prognostic unfavorable (9.87e-7)" "unprognostic (1.19e-3)" "unprognostic (3.47e-2)" "unprognostic (2.22e-1)" "unprognostic (2.49e-2)" 15.5 15.0 19.1 19.8 23.5 23.1 16.6 19.5 22.6 15.0 16.3 17.3 15.5 14.9 19.2 19.0 17.6 19.6 19.4 13.2 15.7 13.4 14.4 17.3 13.5 26.8 22.1 14.7 29.1 23.8 16.3 14.4 14.4 21.9 18.1 14.5 10.9 14.9 15.6 21.4 22.1 16.1 16.5 12.4 25.0 16.3 16.8 20.1 12.2 15.6 12.1 19.6 17.3 18.8 11.2 14.9 3.1 15.7 4.3 10.2 8.5 15.4 10.4 11.3 19.2 11.5 14.8 16.2 17.4 8.7 19.2 16.7 11.1 12.7 19.4 22.8 9.3 10.0 14.3 18.9 15.3 8.9 12.6 26.4 15.4 26.8 18.7 20.9 30.8 18.2 20.9 20.6 19.9 18.8 12.3 14.1 14.5 33.3 6.2 11.9 17.1 12.5 33.3 26.8 9.8 24.5 21.1 14.6 26.7 11.9 15.7 26.9 12.2 10.8 22.6 18.1 8.6 8.8 17.3 15.6 27.7 10.8 16.7 30.4 10.8 20.8 17.9 12.9 32.7 14.4 1.2 15.7 0.5 8.1 11.9 7.7 10.4 8.6 7.7 14.9 11.2 10.2 7.7 3.1 4.3 7.5 8.8 5.6 8.5 19.1 23.5 19.5 22.6 15.7 13.4 22.1 14.7 21.9 20.1 11.9 16.2 35.0 22.3 21.3 8.0 6.4 12.7 10.7 4.5 12.2 2.0 19.4 5.0 14.1 16.4 17.5 6.3 0.0 12.8 18.8 13.9 10.4 28.9 8.6 41.5 7.9 6.9 7.4 88.1 36.5 13.0 39.6 16.9 23.4 9.6 5.8 12.2 5.8 12.0 11.2 11.1 12.9 16.5 21.7 18.3 18.1 12.9 18.7 17.4 18.4 TRMT10A "MGC27034, RG9MTD2, TRM10" ENSG00000145331 "TRNA methyltransferase 10A" Q8TBZ6 4 99546709-99564032 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Methyltransferase, Transferase" "Diabetes mellitus, Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 76.6;Spermatogonia: 51.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047601, HPA058241" Uncertain Supported "Nucleoplasm,Nucleoli,Actin filaments,Cytosol" NA NA "Nucleoplasm, Nucleoli, Actin filaments" Cytosol "HPA047601: AB_2680099, HPA058241: AB_2683651" "unprognostic (5.24e-2)" "unprognostic (1.69e-1)" "unprognostic (1.34e-1)" "unprognostic (1.96e-3)" "unprognostic (2.10e-1)" "unprognostic (5.65e-2)" "unprognostic (1.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.59e-2)" "unprognostic (3.65e-2)" "unprognostic (1.57e-1)" "unprognostic (3.51e-1)" "unprognostic (7.49e-3)" "unprognostic (3.32e-2)" "unprognostic (2.78e-2)" "prognostic unfavorable (2.14e-4)" "unprognostic (1.68e-2)" 7.0 8.9 6.5 7.5 8.9 3.3 13.1 6.1 8.7 4.6 6.0 9.3 7.5 7.3 5.5 7.2 9.2 10.1 6.1 5.0 7.9 6.7 9.1 16.8 4.9 7.4 9.2 6.1 6.6 12.4 6.7 12.2 10.0 9.7 7.4 6.9 2.5 7.3 4.7 9.3 6.5 10.4 5.1 10.5 7.0 7.6 16.7 10.1 10.7 10.8 5.1 8.0 7.2 10.8 8.8 10.0 9.2 7.6 5.8 7.1 4.0 6.7 4.8 9.3 4.8 5.5 7.8 6.7 8.2 3.2 5.8 4.3 3.9 8.4 9.3 3.2 4.8 5.2 3.9 10.8 5.2 8.9 11.8 4.8 6.4 4.1 6.4 5.3 16.2 6.9 4.9 13.4 5.8 12.7 3.4 5.8 8.5 14.7 8.4 4.9 7.8 13.6 3.3 5.5 12.1 4.6 7.9 8.9 5.9 7.8 5.5 5.8 5.1 4.5 24.9 8.2 8.1 8.1 7.0 4.2 5.9 6.1 4.8 9.3 5.8 9.8 8.5 4.5 9.5 4.1 4.0 7.6 3.7 3.8 7.1 3.1 6.3 6.5 6.4 10.0 8.8 6.7 6.2 9.2 5.8 6.2 5.6 7.1 4.0 6.5 8.9 6.1 8.7 7.9 6.7 9.2 6.1 9.7 10.1 3.0 9.3 6.0 5.1 7.2 4.6 5.9 12.7 20.1 4.5 10.4 3.9 14.6 36.5 11.9 34.0 6.7 10.7 0.0 16.6 14.7 5.4 5.0 8.1 24.2 7.1 4.8 6.9 9.2 7.9 11.7 6.1 4.7 5.0 5.4 9.8 7.8 14.8 11.0 7.1 17.0 5.9 12.9 7.1 76.6 51.2 8.3 14.6 4.8 9.6 5.9 TRMT10B "bA3J10.9, FLJ31455, RG9MTD3" ENSG00000165275 "TRNA methyltransferase 10B" Q6PF06 9 37753803-37778972 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021800 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA021800: AB_1856214" "unprognostic (1.00e-2)" "unprognostic (1.78e-1)" "unprognostic (3.35e-2)" "unprognostic (3.89e-2)" "unprognostic (2.42e-2)" "unprognostic (7.68e-2)" "unprognostic (7.78e-2)" "prognostic favorable (3.91e-4)" "unprognostic (5.49e-3)" "unprognostic (1.71e-2)" "prognostic favorable (5.34e-4)" "unprognostic (1.40e-1)" "unprognostic (6.62e-2)" "unprognostic (1.76e-2)" "unprognostic (1.68e-1)" "unprognostic (9.58e-2)" "unprognostic (2.33e-3)" 7.4 10.3 9.9 10.9 10.3 10.1 9.8 13.7 12.3 10.6 11.8 12.7 12.8 8.3 17.3 9.5 10.4 9.6 10.6 7.0 9.9 9.2 8.2 8.0 8.6 13.1 16.4 9.8 15.4 10.5 9.0 13.8 7.4 10.0 14.8 7.1 12.1 10.3 12.1 7.8 20.4 9.7 11.8 12.7 12.1 10.8 5.0 10.4 10.0 12.4 5.6 13.6 14.8 10.1 9.2 4.6 6.6 5.3 4.6 7.6 2.7 5.3 6.3 8.2 7.3 5.0 4.1 3.8 5.3 3.8 5.4 4.7 3.8 4.7 10.0 3.9 4.0 3.2 6.2 3.9 6.4 4.9 4.3 6.9 8.7 15.6 3.9 9.2 8.9 6.3 4.7 6.6 4.7 9.1 6.5 5.5 12.1 7.0 4.4 4.1 3.8 9.1 7.0 7.3 5.6 7.8 9.3 2.9 5.2 5.2 4.9 11.2 10.8 4.3 5.4 4.7 5.4 5.9 6.5 5.4 4.2 6.1 6.7 4.6 5.0 6.8 7.9 2.5 7.1 8.5 6.6 5.3 2.8 6.7 4.6 7.6 6.6 6.0 6.3 2.5 9.2 7.3 6.7 5.4 4.6 3.2 4.6 3.9 2.7 9.9 10.3 13.7 12.3 9.9 9.2 16.4 9.8 10.0 10.4 3.0 6.2 23.8 10.8 6.5 15.5 7.4 10.2 8.1 9.1 3.5 5.9 13.3 10.0 9.6 1.6 12.0 7.8 23.3 11.0 7.0 7.4 11.1 13.9 6.6 7.2 15.9 13.3 9.2 11.4 0.2 13.6 12.3 10.1 7.2 12.9 12.8 8.8 7.0 22.3 6.7 12.8 25.8 8.6 4.4 3.2 6.6 10.2 19.2 9.0 7.8 TRMT10C "FLJ20432, MRPP1, RG9MTD1" ENSG00000174173 "TRNA methyltransferase 10C, mitochondrial RNase P subunit" Q7L0Y3 3 101561862-101566446 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036671 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA036671: AB_10602085" "unprognostic (7.42e-2)" "unprognostic (2.68e-1)" "unprognostic (9.08e-3)" "unprognostic (4.47e-3)" "unprognostic (5.01e-2)" "unprognostic (5.55e-2)" "prognostic unfavorable (6.56e-5)" "unprognostic (1.67e-2)" "unprognostic (8.48e-2)" "unprognostic (5.42e-2)" "unprognostic (4.70e-2)" "unprognostic (3.28e-2)" "prognostic favorable (3.32e-5)" "unprognostic (2.77e-2)" "unprognostic (1.37e-1)" "unprognostic (1.04e-1)" "unprognostic (1.05e-2)" 18.0 21.2 13.1 13.6 14.1 14.4 19.7 16.4 19.1 16.1 15.3 5.5 12.9 11.6 14.6 13.1 20.9 15.0 10.7 20.4 13.0 13.4 26.6 34.6 10.0 19.3 12.5 16.7 18.8 12.1 9.9 19.9 18.2 18.5 16.2 14.2 5.5 14.5 13.0 35.2 15.2 16.5 15.3 14.3 19.6 15.6 14.7 10.6 23.0 16.6 30.5 18.5 15.6 11.3 21.6 15.4 27.4 14.8 12.2 23.1 11.8 21.0 10.3 13.7 13.8 12.6 10.8 12.8 12.6 12.3 16.4 18.4 15.6 14.3 43.8 16.4 7.8 13.3 21.3 26.4 19.2 22.7 15.6 13.0 29.4 8.2 11.3 9.7 25.8 12.5 12.6 20.0 14.3 13.4 8.8 15.9 16.8 24.9 9.8 17.6 14.4 20.6 18.9 25.5 27.4 22.4 15.4 11.2 19.5 21.0 17.9 34.2 19.5 9.8 20.9 27.6 12.6 27.6 28.4 10.5 9.0 17.0 5.9 13.2 11.4 20.8 42.0 15.2 18.6 13.4 27.4 11.2 7.3 13.6 14.4 18.8 21.6 16.8 15.8 13.5 20.4 23.1 21.1 4.9 12.2 14.8 15.4 15.0 11.8 13.1 14.1 16.4 19.1 13.0 13.4 12.5 16.7 18.5 10.6 20.8 20.0 45.2 114.9 83.8 27.3 45.1 15.3 44.2 47.8 27.9 13.7 57.1 44.7 44.7 22.0 33.0 12.7 0.0 29.3 34.7 35.1 33.3 46.1 46.1 28.0 20.6 34.3 28.8 19.4 6.3 34.5 28.4 13.5 36.9 26.7 27.5 31.9 14.0 35.3 55.3 29.1 32.3 41.5 61.4 51.3 91.8 54.8 41.7 40.3 115.3 TRMT112 "HSPC152, HSPC170, hTrm112, TRM112, TRMT11-2" ENSG00000173113 "TRNA methyltransferase subunit 11-2" Q9UI30 11 64316460-64318084 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039901, HPA040006" Uncertain Approved Nucleoplasm,Microtubules NA NA Microtubules Nucleoplasm "HPA039901: AB_10796334, HPA040006: AB_10793859" "unprognostic (1.48e-1)" "unprognostic (2.08e-1)" "unprognostic (1.18e-1)" "unprognostic (1.10e-1)" "unprognostic (2.44e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (6.08e-3)" "unprognostic (2.30e-1)" "unprognostic (3.81e-1)" "unprognostic (1.44e-3)" "unprognostic (6.28e-3)" "unprognostic (2.56e-1)" "prognostic unfavorable (2.78e-4)" "unprognostic (2.53e-1)" "unprognostic (1.73e-1)" "unprognostic (3.15e-3)" "unprognostic (1.32e-2)" 44.2 77.0 41.9 40.9 37.6 48.3 57.9 30.9 48.5 52.8 39.2 33.5 38.4 25.9 50.9 58.6 54.2 68.1 49.4 47.4 37.4 51.8 47.4 68.6 41.7 58.2 42.8 34.3 81.9 53.4 36.3 54.0 54.5 35.1 55.7 26.9 50.0 44.5 50.5 53.6 38.6 28.6 50.3 38.7 52.7 35.6 54.6 31.0 64.7 85.5 55.2 57.3 56.2 62.8 132.1 97.2 92.4 58.5 53.2 98.2 112.6 55.2 81.2 27.2 41.5 26.2 21.5 28.3 25.0 24.9 25.3 20.3 41.6 54.4 39.1 80.5 20.8 49.3 46.9 40.9 45.4 19.4 48.8 45.9 43.6 73.3 97.6 29.2 34.9 30.6 25.7 46.4 22.8 43.3 33.7 25.6 29.3 36.6 53.7 23.7 147.4 52.5 71.2 75.8 38.5 71.1 31.6 30.4 58.3 29.3 58.0 18.2 85.4 34.6 43.0 75.3 26.5 69.3 33.4 24.2 32.4 41.1 56.1 49.0 44.7 73.3 65.1 44.2 36.2 34.4 92.4 58.5 81.7 67.6 47.2 69.2 132.1 88.5 74.6 59.3 112.8 98.2 85.3 69.7 53.2 42.3 97.2 77.4 112.6 41.9 37.6 30.9 48.5 37.4 51.8 42.8 34.3 35.1 31.0 148.9 141.4 296.9 372.8 310.8 83.7 116.1 109.5 184.7 136.5 260.0 21.6 493.9 416.1 187.8 41.9 242.2 75.4 93.5 194.0 407.3 280.9 262.1 212.4 203.5 342.2 49.3 148.3 151.6 168.6 45.5 277.3 210.4 318.9 410.2 121.7 120.6 209.3 112.3 205.4 428.2 59.7 213.4 272.5 160.9 491.0 346.4 344.5 233.3 139.2 362.3 TRMT12 "FLJ20772, Trm12, TYW2" ENSG00000183665 "TRNA methyltransferase 12 homolog" Q53H54 8 124450820-124462150 "Enzymes, Predicted intracellular proteins" "tRNA processing" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 37.2" "Low region specificity" "Detected in all" HPA023939 Approved Approved Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA023939: AB_1848793" "unprognostic (2.54e-2)" "unprognostic (2.20e-1)" "unprognostic (7.81e-2)" "unprognostic (1.02e-2)" "unprognostic (8.75e-2)" "prognostic unfavorable (2.99e-5)" "prognostic unfavorable (5.10e-4)" "unprognostic (6.89e-2)" "unprognostic (1.99e-1)" "unprognostic (1.28e-1)" "unprognostic (1.51e-1)" "unprognostic (6.56e-2)" "unprognostic (4.72e-3)" "unprognostic (3.39e-2)" "unprognostic (2.40e-1)" "prognostic unfavorable (9.25e-4)" "unprognostic (1.04e-2)" 10.8 11.6 16.7 8.4 20.9 4.1 15.0 13.8 18.3 11.8 9.5 8.0 6.8 7.5 11.9 10.7 9.6 13.2 8.6 9.9 19.4 9.9 12.9 9.8 9.8 11.8 13.6 14.3 8.8 10.1 14.7 17.7 8.9 14.7 12.0 11.2 7.8 12.0 11.0 18.0 9.9 9.6 14.3 12.9 11.0 10.6 11.7 13.4 9.1 14.9 12.0 10.7 10.2 8.5 5.8 5.0 6.3 6.1 5.1 7.6 4.4 7.4 6.5 5.4 4.2 10.3 5.3 1.3 4.7 5.6 7.0 6.0 4.0 5.2 7.6 6.6 4.8 4.5 5.2 7.7 7.8 8.3 7.5 5.9 7.3 6.2 1.3 8.1 0.0 6.0 6.6 10.4 6.8 8.7 2.0 5.8 8.0 10.2 5.3 4.3 37.2 8.6 3.1 0.0 17.4 6.1 2.7 3.6 5.0 6.4 8.1 9.2 7.4 7.0 26.2 9.8 4.8 7.4 3.1 4.6 4.9 12.8 3.6 5.3 5.5 7.7 2.9 4.4 2.6 3.9 0.5 6.1 6.3 4.5 4.9 5.6 4.0 6.1 4.6 5.0 5.8 7.6 7.4 2.4 5.1 5.5 1.5 3.7 4.4 16.7 20.9 13.8 18.3 19.4 9.9 13.6 14.3 14.7 13.4 8.9 6.9 5.9 5.4 4.6 5.6 2.7 7.6 8.1 1.2 3.5 15.7 5.8 5.0 4.9 11.1 5.2 3.6 0.0 5.4 4.5 3.3 3.4 9.2 5.1 4.5 7.9 2.9 3.7 3.2 14.2 3.7 3.3 5.0 2.8 4.2 3.9 3.6 3.5 5.6 6.6 8.3 0.0 5.5 10.7 3.8 3.8 4.1 4.3 3.7 4.3 TRMT13 "CCDC76, FLJ10287, FLJ11219" ENSG00000122435 "TRNA methyltransferase 13 homolog" Q9NUP7 1 100133150-100150497 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028494 Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" "Nuclear bodies, Cytosol" "HPA028494: AB_10601254" "unprognostic (1.12e-1)" "unprognostic (3.33e-1)" "unprognostic (5.76e-2)" "unprognostic (2.37e-1)" "unprognostic (9.17e-3)" "unprognostic (4.97e-2)" "prognostic unfavorable (5.81e-5)" "unprognostic (1.16e-3)" "unprognostic (3.28e-2)" "unprognostic (8.08e-2)" "unprognostic (3.22e-1)" "unprognostic (1.02e-3)" "prognostic unfavorable (6.89e-6)" "unprognostic (3.12e-2)" "unprognostic (7.71e-2)" "unprognostic (1.99e-2)" "unprognostic (1.70e-3)" 13.0 12.2 13.9 21.7 24.1 5.9 18.3 26.5 22.5 17.4 13.1 18.2 24.2 13.6 17.4 15.4 13.7 13.9 9.6 12.0 14.4 9.0 12.1 13.0 9.6 20.9 23.1 12.8 21.4 18.1 23.8 26.8 13.2 15.6 14.9 14.4 10.8 14.3 17.4 16.9 17.9 14.2 14.3 19.4 16.5 12.6 11.1 25.8 17.8 16.5 12.0 17.6 13.9 15.8 15.1 9.6 2.2 4.5 5.4 13.6 3.9 10.7 6.3 10.6 7.4 5.7 11.3 11.7 11.4 4.5 8.7 7.3 7.5 4.5 17.8 14.2 9.0 5.8 9.8 19.5 8.8 15.1 17.9 15.5 10.6 13.9 7.2 10.4 18.3 10.0 7.8 10.1 16.4 21.7 5.5 7.9 13.3 22.2 11.5 8.7 4.1 14.9 9.7 14.8 10.4 12.7 16.0 16.1 9.7 7.1 8.6 6.9 11.6 10.5 10.1 13.4 10.9 5.9 16.3 8.2 11.6 7.8 9.7 15.1 14.8 11.9 21.1 13.1 14.7 4.4 0.1 4.5 2.2 8.5 4.4 10.4 14.8 9.0 8.3 5.2 15.1 13.6 11.1 1.9 5.4 3.5 9.6 6.2 3.9 13.9 24.1 26.5 22.5 14.4 9.0 23.1 12.8 15.6 25.8 23.8 13.4 31.3 12.1 8.7 36.7 10.0 17.8 25.4 28.4 14.0 27.5 11.7 11.6 9.2 7.7 11.7 9.1 0.0 5.2 8.8 10.8 10.7 20.8 9.9 6.7 27.0 19.5 17.2 6.1 4.3 23.0 9.9 10.1 8.2 8.1 19.7 7.8 12.5 17.3 8.4 45.1 19.4 12.2 36.3 22.8 10.5 6.1 19.7 13.2 8.4 TRMT1L C1orf25 ENSG00000121486 "TRNA methyltransferase 1 like" Q7Z2T5 1 185118098-185157072 "Predicted intracellular proteins" "Behavior, tRNA processing" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 83.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026728 Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA026728: AB_1845641" "unprognostic (1.07e-2)" "unprognostic (1.31e-1)" "unprognostic (8.55e-3)" "unprognostic (2.96e-1)" "unprognostic (1.46e-2)" "unprognostic (8.95e-2)" "unprognostic (2.38e-1)" "unprognostic (4.41e-2)" "unprognostic (2.32e-1)" "unprognostic (2.46e-3)" "unprognostic (1.32e-1)" "unprognostic (8.75e-2)" "unprognostic (1.16e-2)" "unprognostic (7.44e-2)" "unprognostic (9.45e-2)" "unprognostic (7.87e-2)" "unprognostic (2.26e-1)" 7.6 12.9 9.4 10.1 12.8 5.9 8.9 14.2 11.3 10.5 10.0 9.6 9.6 9.6 9.3 11.3 10.5 12.6 8.2 13.2 10.3 10.6 15.3 16.0 10.3 11.1 11.2 9.1 13.7 8.3 18.0 26.9 9.7 11.9 11.7 8.5 5.2 7.6 10.0 27.4 5.5 8.7 8.5 12.4 12.8 8.4 29.4 12.8 16.5 12.4 7.6 13.0 11.8 12.2 16.2 12.1 19.0 15.8 11.0 12.7 8.1 7.8 14.5 10.0 7.5 14.8 13.6 14.2 7.6 6.9 10.4 11.0 13.1 15.2 8.6 19.1 5.2 16.0 10.2 16.8 10.0 10.3 10.2 7.3 8.2 11.0 13.3 10.3 12.1 13.7 6.5 13.6 10.6 10.8 11.1 11.4 11.7 21.6 11.9 12.4 6.6 9.2 7.1 16.5 16.2 3.0 10.9 14.4 13.7 10.0 8.8 8.9 7.9 14.8 14.5 10.3 23.9 14.8 6.8 11.0 9.6 7.7 6.6 10.2 19.1 25.6 13.7 6.3 10.8 9.2 16.8 9.8 19.0 7.4 13.4 7.9 11.7 9.7 8.9 12.1 16.2 12.2 9.5 11.1 11.0 15.8 5.1 12.7 8.1 9.4 12.8 14.2 11.3 10.3 10.6 11.2 9.1 11.9 12.8 11.9 10.4 9.8 7.8 2.4 8.7 25.8 10.2 45.5 15.9 15.7 7.9 13.5 23.2 9.3 32.0 7.0 7.9 0.0 5.3 9.1 7.4 5.4 8.1 20.2 11.2 3.2 5.8 8.6 13.7 15.5 11.5 12.8 1.7 18.0 7.9 9.5 6.6 10.5 11.3 18.8 8.2 0.0 5.2 83.9 26.0 2.0 9.5 7.5 7.1 4.7 TRMT2A HTF9C ENSG00000099899 "TRNA methyltransferase 2 homolog A" Q8IZ69 22 20111866-20117392 "Plasma proteins, Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 119.6;Late spermatids: 166.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 38.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001077 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA001077: AB_1079092" "unprognostic (5.01e-2)" "unprognostic (2.45e-2)" "unprognostic (1.17e-2)" "unprognostic (9.70e-2)" "unprognostic (1.17e-1)" "unprognostic (8.05e-3)" "unprognostic (2.19e-3)" "unprognostic (5.93e-3)" "unprognostic (4.04e-1)" "unprognostic (1.11e-1)" "unprognostic (1.32e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (2.99e-8)" "unprognostic (4.54e-2)" "unprognostic (1.58e-1)" "unprognostic (3.80e-1)" "unprognostic (1.14e-3)" 14.3 22.5 12.6 18.8 13.6 14.3 13.4 16.3 19.7 13.9 16.6 17.4 15.4 18.2 13.1 15.6 16.1 15.3 17.1 12.8 13.1 11.4 13.2 22.8 11.1 22.8 12.4 14.4 15.2 23.6 10.8 18.5 15.8 11.2 16.8 6.1 14.2 36.5 16.1 14.8 18.4 16.2 12.4 12.7 23.2 16.7 16.9 13.4 26.8 15.6 12.7 18.3 13.1 11.0 9.7 14.0 7.0 14.9 9.5 15.2 11.5 6.4 7.5 2.9 4.7 2.9 2.2 10.0 5.8 3.0 4.6 4.1 8.9 5.6 8.9 5.0 2.7 3.6 10.1 2.1 3.3 0.6 9.2 24.4 10.3 10.0 8.0 8.0 16.1 10.3 3.9 4.3 4.9 1.8 3.2 4.8 7.7 38.5 6.2 3.2 10.2 9.1 10.2 5.5 7.3 9.5 10.5 5.0 3.7 2.6 7.3 7.7 5.9 3.6 9.3 9.3 1.3 6.4 13.7 4.5 5.7 7.6 4.4 5.0 22.2 9.9 6.8 7.6 6.9 5.7 6.6 11.5 7.0 10.5 14.9 15.2 9.7 10.9 12.1 14.0 6.8 12.2 11.5 1.5 9.5 12.0 12.4 8.5 11.5 12.6 13.6 16.3 19.7 13.1 11.4 12.4 14.4 11.2 13.4 11.9 17.3 11.5 8.8 8.8 13.6 5.2 12.7 6.7 10.3 10.4 7.9 21.8 11.6 9.3 119.6 8.7 12.3 0.0 11.3 15.3 11.3 9.1 25.3 15.5 22.1 14.3 17.9 7.4 20.8 166.9 16.4 12.7 6.8 14.4 10.6 21.7 11.7 10.1 13.4 8.4 12.4 6.5 8.8 17.3 12.1 9.8 23.8 17.8 15.1 8.5 TRMT2B "CXorf34, FLJ12687" ENSG00000188917 "TRNA methyltransferase 2 homolog B" Q96GJ1 X 101009346-101052116 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003745, HPA035120, HPA040814" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA003745: AB_2667047, HPA035120: AB_10601702, HPA040814: " "prognostic unfavorable (1.58e-5)" "unprognostic (6.72e-3)" "unprognostic (3.28e-1)" "unprognostic (1.54e-2)" "unprognostic (4.44e-1)" "unprognostic (8.74e-2)" "unprognostic (3.52e-2)" "unprognostic (8.16e-3)" "unprognostic (5.77e-2)" "unprognostic (2.01e-1)" "unprognostic (8.80e-2)" "unprognostic (2.78e-2)" "prognostic favorable (2.30e-7)" "unprognostic (4.58e-2)" "unprognostic (4.82e-1)" "unprognostic (5.03e-2)" "unprognostic (1.60e-2)" 7.6 10.4 6.9 8.9 10.3 9.1 8.5 7.0 14.2 9.6 11.4 6.9 10.7 8.1 8.1 8.6 12.9 7.4 7.3 13.0 10.7 6.6 12.3 9.5 9.4 12.6 9.5 6.6 11.3 10.4 18.5 17.6 5.9 10.7 10.1 12.6 13.4 15.3 10.4 17.6 9.5 13.5 7.9 8.4 16.6 11.4 4.0 7.9 18.2 12.8 5.3 17.7 9.9 9.5 16.5 8.1 14.8 8.2 14.4 19.2 11.5 15.3 13.3 2.7 6.3 6.3 3.3 8.4 8.0 10.7 8.9 13.4 14.3 12.3 13.6 15.9 7.3 18.2 9.6 12.2 11.1 11.3 11.7 7.7 8.6 11.0 6.7 5.6 15.3 14.1 4.2 6.6 12.9 6.0 6.3 17.2 14.8 8.8 13.0 8.2 15.5 19.0 8.1 3.7 18.9 9.9 15.6 13.1 13.0 6.6 9.1 4.0 5.2 13.6 9.9 7.9 7.8 6.5 7.4 10.1 11.4 6.9 10.5 7.1 8.3 12.5 12.7 8.8 17.6 8.7 9.6 8.2 14.8 13.8 6.5 14.6 14.9 16.1 13.3 7.4 16.5 19.2 16.1 4.8 14.4 7.0 8.1 13.0 11.5 6.9 10.3 7.0 14.2 10.7 6.6 9.5 6.6 10.7 7.9 6.0 7.5 4.4 5.2 2.1 0.4 9.0 2.5 5.3 3.4 14.0 2.0 5.0 6.6 3.6 0.0 3.7 4.2 0.0 3.1 2.6 1.6 4.2 12.7 3.0 3.0 1.6 6.4 2.5 3.5 0.0 3.1 2.8 1.7 2.8 5.2 4.5 3.9 6.0 3.5 5.6 1.8 0.0 1.4 0.2 3.6 1.4 4.2 8.7 5.6 4.7 TRMT44 "C4orf23, FLJ35725, METTL19, TRM44" ENSG00000155275 "TRNA methyltransferase 44 homolog" Q8IYL2 4 8436140-8493531 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 23.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045461 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA045461: AB_10961276" "unprognostic (1.50e-1)" "unprognostic (1.65e-3)" "unprognostic (3.47e-1)" "unprognostic (1.01e-2)" "unprognostic (2.06e-1)" "unprognostic (1.34e-2)" "unprognostic (1.75e-1)" "unprognostic (1.78e-2)" "unprognostic (3.46e-1)" "unprognostic (8.13e-2)" "unprognostic (3.44e-3)" "unprognostic (2.69e-3)" "unprognostic (1.49e-1)" "unprognostic (1.16e-2)" "unprognostic (1.28e-1)" "unprognostic (6.76e-2)" "unprognostic (8.34e-3)" 11.5 7.6 13.3 7.3 17.5 13.1 15.4 20.3 16.2 10.1 9.2 14.1 10.1 7.1 16.3 10.7 13.6 12.3 8.6 9.8 12.1 6.3 7.1 8.9 8.8 9.8 12.2 14.7 17.1 9.7 11.3 10.9 10.2 8.7 10.8 7.2 9.4 12.4 8.7 11.5 17.2 7.6 9.7 6.7 8.1 11.3 15.8 13.8 7.8 9.9 9.0 10.7 10.8 11.4 2.1 2.1 0.4 2.1 0.8 3.0 0.5 5.6 6.0 7.4 8.8 8.0 7.8 16.2 6.8 4.8 8.9 8.0 7.3 8.1 7.7 3.3 2.7 7.2 4.3 10.8 6.6 7.9 3.9 5.3 7.2 9.3 5.7 6.9 12.4 6.0 4.7 9.1 6.8 7.5 7.6 9.5 5.3 11.0 8.4 5.6 3.7 10.3 9.1 8.5 7.2 9.0 7.7 8.0 4.9 7.7 6.9 8.1 5.6 4.4 4.0 5.9 8.8 3.6 4.8 5.6 5.5 3.0 5.1 10.4 9.8 6.1 7.1 6.1 11.7 5.3 0.4 1.2 0.1 2.3 1.2 1.6 0.8 2.1 2.5 2.1 2.1 3.0 0.9 0.2 0.8 2.1 1.7 0.2 0.5 13.3 17.5 20.3 16.2 12.1 6.3 12.2 14.7 8.7 13.8 8.9 5.3 2.2 3.7 6.1 7.8 2.6 12.7 5.3 2.3 7.0 23.6 8.6 5.0 4.2 3.0 3.9 2.3 0.0 3.9 5.3 5.1 3.9 4.7 2.9 4.0 3.2 1.7 3.1 4.6 1.4 5.5 2.9 1.7 4.6 2.3 3.2 3.6 2.5 3.5 2.2 10.9 0.0 1.8 6.2 6.1 5.1 13.6 3.2 2.8 7.0 TRMT5 "KIAA1393, TRM5" ENSG00000126814 "TRNA methyltransferase 5" Q32P41 14 60971451-60981358 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Early spermatids: 162.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000943 Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA000943: AB_1080388" "unprognostic (1.58e-2)" "unprognostic (3.62e-2)" "unprognostic (6.63e-3)" "unprognostic (1.11e-2)" "unprognostic (7.70e-3)" "unprognostic (2.26e-2)" "unprognostic (7.82e-3)" "unprognostic (4.50e-2)" "unprognostic (3.95e-1)" "unprognostic (1.78e-1)" "unprognostic (1.47e-1)" "unprognostic (2.84e-2)" "unprognostic (1.60e-3)" "unprognostic (1.82e-1)" "unprognostic (1.97e-2)" "unprognostic (2.10e-2)" "unprognostic (1.40e-1)" 15.8 10.1 7.9 13.8 12.1 5.4 12.9 9.3 11.8 10.9 8.6 5.7 11.9 7.5 12.0 10.9 11.1 10.0 6.7 6.8 7.7 7.1 12.5 13.9 6.6 7.3 6.7 8.3 17.1 11.1 15.9 13.1 10.8 9.0 10.6 8.1 4.8 11.5 9.9 14.8 9.7 7.4 9.2 6.3 8.6 8.1 24.9 5.9 12.4 10.4 12.1 7.2 13.3 9.0 7.2 7.4 0.9 7.5 2.0 6.0 3.7 28.9 7.4 10.9 15.2 9.7 14.5 11.9 10.9 8.4 11.7 9.4 5.4 17.4 14.9 12.2 7.9 8.8 13.4 13.7 15.8 15.4 14.7 6.9 10.9 5.0 6.0 15.8 19.3 6.1 11.4 15.3 10.6 15.8 10.4 10.2 13.0 14.2 5.4 17.1 10.9 9.9 9.7 10.0 11.3 12.3 3.2 25.3 12.6 9.9 9.9 13.4 13.3 12.1 12.2 9.7 9.9 20.4 11.6 9.6 13.6 16.5 9.6 10.4 3.3 6.1 7.0 9.5 4.2 12.6 0.1 4.6 0.9 3.5 7.5 5.0 7.2 5.2 5.2 4.2 4.9 5.6 5.1 0.4 2.0 7.5 7.4 6.0 3.7 7.9 12.1 9.3 11.8 7.7 7.1 6.7 8.3 9.0 5.9 6.0 7.5 8.3 16.7 5.7 5.0 7.1 0.0 18.7 25.0 10.4 3.9 11.0 1.7 7.1 162.4 8.6 2.9 0.0 6.5 11.6 7.7 5.7 5.8 5.9 9.5 3.2 5.2 11.6 6.1 35.3 10.3 8.2 6.8 4.6 7.3 10.4 7.2 3.5 7.1 8.8 4.5 12.9 6.2 10.9 10.9 3.8 16.0 4.6 7.1 10.7 TRMT6 "CGI-09, GCD10, Gcd10p, MGC5029" ENSG00000089195 "TRNA methyltransferase 6" Q9UJA5 20 5937235-5950558 "Predicted intracellular proteins" "tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatogonia: 110.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047032, HPA050408" Approved Enhanced "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA047032: AB_2679911, HPA050408: AB_2681117" "unprognostic (1.78e-1)" "unprognostic (4.51e-2)" "unprognostic (1.65e-1)" "unprognostic (4.26e-2)" "unprognostic (2.11e-1)" "unprognostic (6.81e-2)" "prognostic unfavorable (4.70e-12)" "unprognostic (5.37e-2)" "unprognostic (3.53e-2)" "unprognostic (1.14e-1)" "unprognostic (6.27e-2)" "unprognostic (1.22e-1)" "unprognostic (7.65e-3)" "unprognostic (2.52e-2)" "unprognostic (1.76e-1)" "unprognostic (3.87e-3)" "unprognostic (4.96e-2)" 10.5 12.9 10.5 11.3 12.1 20.6 8.5 15.0 10.5 7.3 7.4 5.7 47.8 5.1 9.1 7.9 11.9 7.9 5.6 13.2 8.4 9.5 10.2 10.1 7.2 13.2 8.3 11.8 9.6 9.6 9.8 13.9 9.4 13.6 7.2 8.2 5.1 8.2 33.9 24.4 9.9 8.6 8.0 8.2 12.2 7.5 15.5 7.9 10.3 8.7 10.6 12.7 8.8 7.9 9.2 17.8 5.9 8.7 13.9 11.6 7.1 25.5 12.6 8.5 13.0 4.8 6.2 11.9 12.3 6.3 12.1 10.1 16.6 11.3 30.5 6.4 6.8 15.8 19.6 17.0 19.6 20.2 6.3 11.9 25.1 5.8 14.8 9.5 23.0 6.6 6.2 10.3 21.5 16.2 4.1 5.1 11.9 15.1 9.5 13.8 7.1 23.9 12.5 19.2 16.5 15.9 15.9 16.9 16.7 8.2 16.3 16.6 25.7 15.0 19.4 19.7 8.5 10.3 11.2 5.0 14.3 13.4 13.2 24.7 15.5 29.9 35.7 6.3 19.0 14.0 2.0 7.9 5.9 9.6 8.7 11.0 9.2 10.8 11.6 17.8 8.2 11.2 11.6 0.8 13.9 7.6 8.1 11.3 7.1 10.5 12.1 15.0 10.5 8.4 9.5 8.3 11.8 13.6 7.9 6.0 16.9 15.9 15.9 19.1 17.7 21.3 12.7 34.8 34.2 27.9 9.8 23.4 29.9 18.1 3.0 15.3 3.9 0.0 26.5 20.1 12.3 14.0 34.6 16.3 15.9 25.4 13.2 3.7 13.2 6.3 10.6 27.0 16.9 9.0 8.2 12.2 17.8 7.0 6.7 17.9 9.8 12.9 20.5 59.7 110.3 21.0 24.5 17.5 9.9 14.2 TRMT9B "C8orf79, FLJ36980, hTRM9L, KIAA1456, TRM9L" ENSG00000250305 "TRNA methyltransferase 9B (putative)" Q9P272 8 12945642-13031503 "Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 64.7;thyroid gland: 26.5" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 26.8;Club cells: 18.2;Collecting duct cells: 14.0;Distal tubular cells: 10.0" "Cancer enhanced" "Detected in some" "thyroid cancer: 3.2" "Group enriched" "Detected in all" 7 "cerebellum: 64.7;pons and medulla: 31.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 7.1;BJ: 10.2;fHDF/TERT166: 13.7;RPTEC TERT1: 4.8;SCLC-21H: 5.2;U-266/84: 4.9" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 77.4" HPA024673 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA024673: AB_1845788" "unprognostic (9.85e-3)" "unprognostic (1.20e-1)" "unprognostic (5.54e-4)" "unprognostic (1.06e-2)" "unprognostic (4.08e-2)" "unprognostic (1.31e-2)" "unprognostic (1.64e-1)" "unprognostic (1.44e-1)" "unprognostic (1.93e-1)" "unprognostic (8.89e-2)" "unprognostic (1.96e-2)" "unprognostic (1.88e-1)" "prognostic favorable (2.77e-7)" "unprognostic (2.22e-1)" "unprognostic (4.63e-2)" "unprognostic (4.27e-3)" "unprognostic (3.34e-2)" 2.1 0.9 2.0 1.1 4.1 1.2 3.5 64.7 6.0 2.0 1.8 6.6 0.8 1.4 1.9 2.5 1.3 2.4 2.7 6.0 6.7 2.9 2.7 1.7 1.7 1.0 2.0 2.8 0.6 1.7 2.3 1.2 7.1 31.5 1.2 2.1 5.8 2.3 1.9 4.4 5.1 1.5 0.9 1.9 1.6 1.5 1.8 1.0 0.0 26.5 1.3 0.7 1.3 0.9 1.0 0.6 2.8 0.6 1.9 0.6 0.0 0.1 0.2 7.1 0.0 0.0 0.0 1.7 10.2 2.3 1.4 0.7 0.1 0.3 0.2 0.5 13.7 1.3 0.3 0.1 0.3 1.5 0.1 0.4 0.4 0.4 0.1 0.0 0.2 0.7 0.2 3.6 0.0 0.1 0.1 0.0 0.1 0.1 0.2 0.3 0.3 0.1 0.2 0.8 0.1 0.0 1.1 0.1 0.1 4.8 0.2 5.2 0.1 0.1 0.1 0.2 2.4 0.2 0.0 0.0 0.2 0.9 1.0 0.2 0.4 4.9 0.1 0.1 0.2 1.8 2.6 0.6 0.4 0.5 0.4 0.4 0.5 0.4 0.5 0.2 1.0 0.5 0.6 2.8 1.9 0.3 0.6 0.2 0.0 2.0 4.1 64.7 5.0 6.7 2.9 2.0 2.8 31.5 1.0 6.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 26.8 18.2 14.0 0.0 0.9 10.0 0.9 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TRNAU1AP "FLJ20503, SECP43, TRSPAP1" ENSG00000180098 "TRNA selenocysteine 1 associated protein 1" Q9NX07 1 28553085-28578545 "Predicted intracellular proteins" "Protein biosynthesis" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032068, HPA032069" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA032068: AB_2674135, HPA032069: AB_10603998" "unprognostic (4.06e-2)" "unprognostic (1.62e-2)" "unprognostic (3.28e-2)" "prognostic favorable (2.22e-4)" "unprognostic (4.93e-2)" "unprognostic (2.28e-2)" "prognostic unfavorable (8.64e-5)" "unprognostic (5.79e-3)" "unprognostic (9.48e-3)" "unprognostic (2.24e-2)" "unprognostic (1.37e-1)" "unprognostic (2.28e-3)" "prognostic unfavorable (1.16e-5)" "unprognostic (1.84e-1)" "unprognostic (2.72e-1)" "prognostic favorable (9.45e-4)" "unprognostic (2.76e-1)" 11.4 10.5 12.6 11.3 14.7 9.3 13.4 19.6 14.1 12.4 10.9 15.4 12.0 7.0 11.7 14.8 10.8 13.2 8.7 12.3 11.7 12.1 11.4 8.7 13.2 15.7 19.3 13.3 12.8 11.6 14.0 9.2 10.8 13.6 10.3 11.6 10.7 10.5 14.0 7.9 17.3 9.4 14.0 12.8 11.1 10.2 7.2 17.1 15.4 8.4 9.0 16.9 12.9 9.5 4.8 4.3 9.1 5.9 12.9 7.5 2.7 4.5 2.7 8.0 5.4 7.4 14.1 3.8 6.2 12.5 11.5 10.3 4.2 7.2 7.0 2.4 6.8 5.4 3.5 8.7 9.8 11.5 6.1 9.9 5.2 9.6 2.8 6.8 4.0 4.5 15.1 8.5 8.9 7.0 8.1 16.2 7.2 6.1 5.7 11.1 3.1 6.8 4.7 5.7 4.9 6.0 4.9 5.6 4.9 12.4 4.6 4.7 6.2 7.3 6.5 6.7 9.0 7.1 4.9 4.6 3.0 2.9 4.6 5.5 7.5 9.4 4.3 7.2 8.8 8.4 6.9 3.5 9.1 5.7 5.9 6.0 4.8 6.2 7.2 4.3 4.7 7.5 4.8 2.2 12.9 3.5 2.8 4.0 2.7 12.6 14.7 19.6 14.1 11.7 12.1 19.3 13.3 13.6 17.1 32.8 33.0 23.2 18.6 15.7 33.7 18.5 22.9 54.9 35.2 17.4 33.4 27.7 14.9 32.7 9.3 19.6 14.6 23.3 28.3 39.5 19.7 18.5 33.6 7.8 29.5 22.3 9.9 25.2 25.4 3.2 26.7 27.0 13.5 36.1 13.0 23.6 32.8 13.6 21.2 15.0 33.0 32.3 25.7 15.4 24.9 17.9 57.2 30.0 15.1 26.0 TROVE2 "Ro60, SSA2" ENSG00000116747 "TROVE domain family member 2" P10155 1 193059422-193091777 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 316.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002835, HPA005142" Uncertain Approved Nucleoplasm,Cytosol NA NA 28000 Cytosol Nucleoplasm "HPA002835: AB_1857490, HPA005142: AB_2667307" "unprognostic (1.91e-2)" "unprognostic (5.11e-2)" "unprognostic (3.94e-3)" "unprognostic (7.34e-2)" "unprognostic (2.34e-2)" "unprognostic (1.41e-1)" "unprognostic (3.62e-2)" "unprognostic (1.17e-1)" "unprognostic (3.77e-2)" "unprognostic (1.16e-2)" "unprognostic (8.45e-3)" "unprognostic (1.52e-1)" "unprognostic (1.05e-3)" "unprognostic (6.32e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (3.31e-4)" "unprognostic (5.62e-2)" 21.2 13.7 13.3 11.4 16.2 29.7 18.5 13.7 16.5 16.9 12.3 13.2 11.7 8.4 15.3 10.9 16.8 11.3 10.9 18.0 13.9 7.7 14.3 13.6 15.0 13.0 19.6 11.8 19.8 12.1 16.8 13.0 13.6 15.1 17.3 9.4 11.4 14.8 14.7 23.4 16.5 11.6 22.7 20.4 14.7 10.9 24.3 17.0 15.1 14.9 8.7 12.9 19.9 19.8 19.1 13.9 38.3 14.6 19.6 24.3 14.5 8.8 15.8 18.3 17.1 15.9 14.7 11.1 13.5 12.6 9.4 12.7 8.1 12.1 18.3 12.5 15.1 8.9 13.6 14.4 10.2 16.6 22.6 11.0 22.1 15.1 10.8 14.6 25.7 16.2 13.7 12.2 17.2 19.2 9.5 15.2 8.0 24.0 24.6 16.1 14.4 15.4 6.8 13.8 7.5 5.2 12.8 15.8 20.8 9.1 18.4 6.5 12.9 16.5 20.2 17.3 13.2 16.6 8.8 20.4 18.0 6.6 16.9 17.2 14.4 14.7 17.4 9.6 12.9 27.6 38.3 13.9 17.4 24.3 13.1 23.4 19.1 17.9 20.3 13.9 17.2 19.0 21.2 22.7 19.6 14.6 12.2 17.9 14.5 13.3 16.2 13.7 16.0 13.9 7.7 19.6 11.8 15.1 17.0 71.5 25.9 47.7 45.1 63.0 52.6 45.3 35.7 34.8 28.4 45.4 117.8 40.8 34.9 43.8 316.3 70.0 20.6 46.7 33.6 38.5 64.8 51.1 57.8 29.4 29.3 44.5 32.6 40.5 33.7 126.5 78.9 44.3 45.5 49.5 21.2 163.1 32.0 20.1 97.9 43.8 149.2 129.4 76.9 43.9 41.4 67.5 40.2 59.1 19.9 30.7 TRPM4 FLJ20041 ENSG00000130529 "Transient receptor potential cation channel subfamily M member 4" Q8TD43 19 49157741-49211836 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Adaptive immunity, Immunity, Ion transport, Transport" "Calmodulin-binding, Ion channel" "Disease mutation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 120.1;Mucus-secreting cells: 88.2;Paneth cells: 80.4;Undifferentiated cells: 78.1" "Cancer enhanced" "Detected in all" "prostate cancer: 85.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 5.4;granulocytes: 4.9;monocytes: 6.8" "Cell line enhanced" "Detected in many" "OE19: 15.6;RT4: 32.4;SK-BR-3: 21.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA041169 Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA 6500 "Nucleoplasm, Plasma membrane" "HPA041169: AB_2677343" "unprognostic (8.20e-3)" "unprognostic (1.41e-1)" "unprognostic (7.86e-2)" "prognostic favorable (2.88e-7)" "unprognostic (1.62e-2)" "unprognostic (9.78e-2)" "unprognostic (1.77e-2)" "unprognostic (2.90e-1)" "unprognostic (3.33e-2)" "unprognostic (3.38e-2)" "unprognostic (2.94e-2)" "unprognostic (2.79e-1)" "prognostic favorable (2.53e-7)" "unprognostic (8.46e-3)" "unprognostic (2.16e-1)" "unprognostic (5.70e-2)" "unprognostic (1.00e-2)" 6.7 3.8 3.5 13.7 3.7 4.3 8.5 3.0 6.8 8.2 25.2 4.5 8.6 20.6 7.9 9.1 7.7 5.4 24.8 9.3 2.7 2.2 14.2 23.6 9.4 3.5 2.6 5.7 2.7 17.4 3.4 3.3 5.0 6.9 20.2 11.4 10.6 16.2 13.2 16.4 16.1 26.8 9.4 2.5 3.4 18.3 4.2 2.2 0.4 10.1 11.5 6.8 9.9 8.6 1.1 5.4 4.9 6.8 1.0 0.7 2.1 6.0 4.5 1.1 5.0 3.8 3.6 3.6 5.1 3.0 1.4 1.9 3.3 9.5 0.2 1.3 3.4 1.9 7.9 0.7 1.5 0.6 0.1 1.6 1.0 1.9 2.0 3.4 0.1 6.6 4.3 7.0 2.6 1.2 1.7 2.4 0.5 2.4 1.2 3.5 9.0 0.4 0.5 0.6 15.6 6.9 2.2 1.0 0.3 2.4 32.4 0.4 1.1 2.1 21.3 1.1 0.4 11.6 2.0 6.1 7.6 4.2 4.2 0.1 2.2 2.2 0.2 4.3 3.9 2.8 2.7 6.8 1.1 0.6 4.0 0.5 0.8 0.5 0.4 5.4 1.1 0.6 0.7 4.9 1.0 1.5 4.9 0.3 2.1 3.5 3.7 3.0 6.8 2.7 2.2 2.6 5.7 6.9 2.2 29.8 1.6 11.7 13.4 11.1 2.1 14.9 22.9 2.7 3.4 14.0 0.0 5.3 16.6 7.6 2.1 9.2 120.1 0.0 16.1 5.7 6.6 47.1 5.7 64.7 16.1 0.0 20.8 15.4 9.7 3.1 6.4 7.9 37.1 14.4 88.2 6.3 25.2 80.4 6.7 3.8 2.4 32.3 9.1 6.6 11.9 10.0 2.9 0.0 78.1 25.3 TRPS1 "GC79, LGCR" ENSG00000104447 "Transcriptional repressor GATA binding 1" Q9UHF7 8 115408496-115809673 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 65.9" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 77.5;Late spermatids: 117.5" "Cancer enriched" "Detected in many" 8 "breast cancer: 49.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 8.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 13.7;SK-BR-3: 23.4;T-47d: 73.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060380, HPA071767" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA060380: AB_2684270, HPA071767: AB_2732185" "unprognostic (4.34e-2)" "unprognostic (4.65e-2)" "unprognostic (1.73e-2)" "unprognostic (2.57e-1)" "unprognostic (1.87e-1)" "prognostic favorable (9.42e-4)" "unprognostic (2.23e-3)" "unprognostic (2.08e-1)" "unprognostic (9.31e-2)" "unprognostic (3.26e-1)" "prognostic unfavorable (3.16e-4)" "unprognostic (3.02e-1)" "unprognostic (2.17e-2)" "unprognostic (1.93e-2)" "unprognostic (1.64e-1)" "unprognostic (1.78e-2)" "unprognostic (3.07e-3)" 6.7 4.5 11.4 6.8 12.0 8.2 65.9 7.0 8.9 16.8 7.7 7.5 9.2 2.0 11.7 6.8 16.3 7.2 11.7 5.9 14.0 4.3 9.8 3.3 6.5 5.9 8.7 8.1 6.8 2.4 9.1 9.7 4.0 10.8 11.7 4.1 4.1 16.0 10.6 4.1 13.5 3.6 12.6 20.6 5.2 4.7 13.2 8.6 1.8 7.2 14.8 9.2 9.6 17.6 1.8 3.1 1.6 8.5 1.8 2.1 1.3 0.8 0.1 1.7 0.0 1.6 6.2 0.1 1.4 3.3 0.9 1.6 0.1 1.4 0.7 0.0 3.7 0.8 0.0 6.8 1.2 1.1 0.0 2.0 0.0 2.8 0.0 2.2 0.0 0.0 2.9 1.3 2.6 4.8 2.7 0.8 0.1 0.3 11.3 1.8 13.7 0.0 0.0 0.3 0.3 1.4 0.0 0.0 8.6 1.5 0.0 1.5 1.2 0.7 23.4 0.9 0.9 73.3 0.6 0.0 4.1 2.1 1.2 2.8 3.0 0.0 1.3 4.4 0.0 2.7 0.0 8.5 0.0 1.7 3.5 2.0 1.0 2.1 2.0 3.1 1.8 1.9 1.8 1.6 1.8 2.5 1.1 0.8 1.3 11.4 12.0 7.0 8.9 14.0 4.3 8.7 8.1 10.8 8.6 6.0 4.0 11.5 20.1 8.4 6.6 3.5 5.1 0.0 3.4 17.4 41.2 0.1 10.0 2.3 77.5 4.5 0.0 0.0 2.5 0.1 11.8 17.3 12.7 0.9 14.3 0.0 0.0 3.1 46.8 117.5 23.3 45.2 20.3 2.8 0.0 10.0 1.9 0.0 26.5 20.3 36.6 6.5 24.5 1.7 9.4 10.9 0.2 11.5 0.0 8.9 TRRAP "PAF400, TR-AP, Tra1" ENSG00000196367 "Transformation/transcription domain associated protein" Q9Y4A5 7 98877933-99050831 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator" "Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054376 Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA054376: AB_2682467" "unprognostic (2.10e-1)" "unprognostic (7.79e-2)" "unprognostic (2.21e-1)" "unprognostic (4.35e-2)" "unprognostic (2.02e-1)" "unprognostic (2.02e-1)" "prognostic unfavorable (8.77e-4)" "unprognostic (1.40e-2)" "unprognostic (2.39e-2)" "unprognostic (3.99e-2)" "unprognostic (9.45e-2)" "unprognostic (7.02e-2)" "unprognostic (2.21e-3)" "unprognostic (1.59e-1)" "unprognostic (1.98e-1)" "unprognostic (1.04e-1)" "unprognostic (2.96e-1)" 9.6 14.2 10.7 18.4 13.4 18.8 14.9 22.8 14.4 14.1 11.3 15.4 10.0 10.6 15.1 10.1 11.3 17.1 11.4 11.4 10.7 9.5 10.8 11.0 13.1 17.1 12.4 9.4 22.4 16.2 26.7 29.9 12.2 9.6 11.8 10.2 13.7 11.8 16.7 11.7 16.9 13.3 16.9 14.2 14.5 11.5 19.3 12.1 37.1 16.6 7.7 19.3 12.8 11.5 2.7 3.1 5.7 0.9 1.3 2.7 0.3 12.3 14.4 15.0 12.7 7.4 7.6 7.5 5.4 7.3 8.6 8.3 11.2 5.5 17.2 8.7 10.1 16.6 6.4 15.5 7.5 9.5 9.9 15.2 10.5 10.5 6.5 5.5 18.8 7.8 7.1 4.4 14.0 12.0 6.0 11.0 15.6 17.9 32.7 8.0 23.8 23.0 7.5 11.4 7.5 8.9 17.0 8.6 13.1 4.5 13.8 11.9 14.8 13.8 9.1 4.6 12.8 4.6 8.5 11.5 11.6 16.9 15.3 12.7 13.5 15.3 25.5 8.2 9.7 11.4 5.7 0.9 0.6 1.5 0.6 2.7 2.0 2.7 1.3 0.9 2.7 1.9 1.8 2.9 1.3 0.9 3.1 2.0 0.3 10.7 13.4 22.8 14.4 10.7 9.5 12.4 9.4 9.6 12.1 14.9 13.9 4.5 3.7 14.1 13.1 9.2 5.1 4.0 10.3 14.0 25.5 7.7 0.0 6.7 3.0 9.0 6.1 0.0 5.7 4.3 8.0 6.5 5.7 10.9 7.0 20.6 12.1 9.2 8.7 4.0 8.1 8.4 8.5 5.4 10.6 5.8 7.9 3.5 8.1 4.3 8.5 0.0 6.1 14.4 8.0 18.6 9.2 9.2 9.5 6.0 TSACC "C1orf182, SIP, SSTK-IP" ENSG00000163467 "TSSK6 activating cochaperone" Q96A04 1 156337314-156346995 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "testis: 262.0" "Group enriched" "Detected in many" 10 "Early spermatids: 5429.3;Late spermatids: 13574.2" "Cancer enhanced" "Detected in many" "testis cancer: 5.3" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 5 "basophil: 12.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 12.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029897 Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA029897: AB_2756315" "unprognostic (3.95e-1)" "unprognostic (5.82e-3)" "unprognostic (8.24e-2)" "unprognostic (9.34e-2)" "unprognostic (1.04e-1)" "unprognostic (8.36e-3)" "unprognostic (1.18e-2)" "unprognostic (5.95e-2)" "unprognostic (1.10e-2)" "unprognostic (1.02e-1)" "unprognostic (3.53e-2)" "unprognostic (4.85e-2)" "unprognostic (2.63e-6)" "unprognostic (1.05e-1)" "unprognostic (6.78e-2)" "unprognostic (2.44e-1)" "unprognostic (3.28e-2)" 0.0 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.2 0.1 0.0 1.6 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.1 0.0 262.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 2.0 2.1 12.0 0.6 2.3 2.1 0.4 3.3 4.5 2.0 2.2 1.5 2.7 3.7 1.6 0.9 2.2 2.4 4.1 2.4 4.8 2.6 0.9 2.4 3.8 3.8 0.5 2.1 2.8 8.3 3.3 6.6 4.4 1.0 3.0 2.9 1.0 6.4 2.2 2.9 1.2 0.7 4.8 9.0 3.1 0.4 5.7 2.9 1.8 6.2 8.1 5.5 3.4 0.8 4.7 5.7 2.0 3.1 1.7 2.3 6.3 2.5 9.1 3.4 3.2 1.6 1.4 2.3 1.2 2.2 5.7 9.1 7.3 0.9 1.7 1.2 12.0 0.5 0.1 1.5 0.3 0.7 1.7 1.1 1.3 0.3 2.0 2.1 1.8 0.2 2.3 0.6 2.1 1.2 0.4 0.0 0.2 0.0 0.3 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.8 0.2 0.2 0.2 0.6 0.0 4.0 2.3 3.5 0.0 4.6 1.7 1.0 5429.3 0.0 0.0 0.0 0.6 1.1 0.3 0.4 0.0 3.0 0.9 0.0 0.0 0.0 0.3 13574.2 103.3 0.0 0.0 0.0 0.4 0.3 1.3 0.0 80.6 3.7 0.9 51.8 0.1 941.5 81.3 0.4 2.3 0.0 0.4 0.6 TSC22D1 "MGC17597, TGFB1I4, TSC22" ENSG00000102804 "TSC22 domain family member 1" Q15714 13 44432143-44577147 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 989.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.7" "Group enriched" "Detected in all" 5 "dendritic cells: 8.9;granulocytes: 17.7;NK-cells: 7.9" "Cell line enhanced" "Detected in many" "HEL: 58.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077414 Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA077414: AB_2686839" "unprognostic (6.61e-2)" "unprognostic (1.66e-1)" "unprognostic (4.00e-1)" "unprognostic (6.40e-2)" "unprognostic (5.22e-2)" "unprognostic (4.78e-3)" "unprognostic (6.30e-2)" "unprognostic (2.04e-1)" "unprognostic (2.56e-1)" "prognostic unfavorable (7.97e-4)" "unprognostic (4.24e-2)" "unprognostic (9.08e-2)" "prognostic favorable (4.54e-4)" "unprognostic (8.14e-2)" "unprognostic (6.52e-2)" "unprognostic (1.83e-2)" "unprognostic (4.48e-2)" 43.1 38.6 71.6 23.7 82.3 6.6 56.6 32.6 94.8 73.7 49.9 27.9 14.1 27.3 68.3 62.5 46.4 67.6 49.7 54.1 64.2 63.9 46.3 36.7 37.7 14.1 71.2 49.2 63.7 15.5 44.7 36.4 40.8 54.6 72.6 47.7 56.6 31.0 39.5 49.6 20.4 48.6 64.4 46.0 11.1 36.7 27.9 38.6 31.7 38.2 24.3 17.4 39.7 31.6 1.1 8.9 17.7 2.3 7.9 2.5 24.6 5.1 16.4 16.1 6.5 10.2 12.8 18.7 5.7 23.5 6.3 6.7 18.4 18.4 8.5 12.0 13.6 13.6 13.1 6.9 46.5 8.8 1.6 5.4 58.6 30.0 5.6 9.5 3.3 7.5 19.2 20.3 16.7 40.8 48.9 14.0 4.7 1.6 0.0 11.7 5.2 10.5 2.7 11.4 35.8 15.4 7.6 3.2 2.5 12.4 8.6 8.4 11.3 15.7 15.6 4.5 17.4 7.6 4.7 12.2 7.0 6.4 14.5 8.3 0.1 1.5 2.7 17.7 2.8 16.2 17.7 1.0 2.7 2.5 0.9 2.4 0.7 0.8 1.1 0.9 1.1 0.9 1.3 4.8 7.9 2.3 8.9 1.5 24.6 71.6 82.3 32.6 94.8 64.2 63.9 71.2 49.2 54.6 38.6 110.2 291.2 23.4 328.2 392.6 138.9 236.4 86.6 290.4 395.8 413.5 108.0 484.2 313.4 140.3 674.0 250.8 383.6 0.0 140.7 189.0 164.9 477.0 312.3 64.8 94.3 120.8 215.8 101.3 19.7 989.9 84.8 43.1 381.3 11.8 181.4 229.5 176.7 143.7 128.3 121.8 134.1 439.8 322.5 50.2 24.5 533.2 978.5 27.4 139.7 385.5 TSEN15 C1orf19 ENSG00000198860 "TRNA splicing endonuclease subunit 15" Q8WW01 1 184051651-184123978 "Disease related genes, Predicted intracellular proteins" "mRNA processing, tRNA processing" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029237 Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA029237: AB_10671361" "unprognostic (4.54e-1)" "unprognostic (2.29e-1)" "unprognostic (2.05e-1)" "unprognostic (1.04e-2)" "unprognostic (8.72e-3)" "unprognostic (8.04e-3)" "prognostic unfavorable (2.07e-5)" "unprognostic (1.82e-2)" "unprognostic (4.11e-2)" "prognostic favorable (4.59e-4)" "unprognostic (3.82e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (3.66e-10)" "unprognostic (1.62e-1)" "unprognostic (1.42e-1)" "unprognostic (2.93e-2)" "unprognostic (2.20e-1)" 14.2 17.5 20.6 13.2 22.1 16.2 17.3 14.0 34.0 16.4 16.8 25.4 7.8 11.2 16.7 24.5 12.7 13.9 12.3 17.2 22.1 19.0 12.8 14.2 15.9 16.3 27.6 16.6 15.0 19.2 13.0 13.4 16.0 20.7 16.3 11.8 13.2 13.9 14.5 31.8 13.7 10.3 15.0 34.5 13.4 13.9 12.4 24.2 20.8 19.4 15.4 15.2 13.7 12.5 14.0 20.2 15.9 14.2 28.2 21.9 17.6 22.7 7.6 9.9 12.2 8.3 7.9 28.2 10.9 19.6 16.5 16.3 7.1 9.9 14.8 12.0 12.2 10.1 10.5 10.7 9.2 16.9 21.7 6.8 6.7 5.7 9.4 15.3 26.4 9.4 5.4 17.9 7.2 15.1 6.7 9.2 25.6 14.9 41.5 14.6 11.0 26.3 13.4 21.2 27.1 8.6 16.7 16.5 31.3 10.5 7.6 10.3 15.2 14.3 11.4 27.6 10.9 14.4 16.6 4.7 11.0 24.8 7.5 17.4 56.5 38.6 22.6 10.5 14.8 23.9 15.9 9.8 13.5 20.4 14.2 17.6 14.0 19.3 20.9 20.2 10.4 15.0 20.4 1.8 28.2 13.0 18.1 21.9 17.6 20.6 22.1 14.0 34.0 22.1 19.0 27.6 16.6 20.7 24.2 44.7 7.2 17.1 10.6 9.8 8.6 28.6 10.2 6.7 14.8 12.2 3.9 38.5 46.4 27.7 1.2 12.0 3.3 0.0 36.4 40.6 19.8 10.9 31.2 33.9 27.3 3.2 6.4 17.8 13.1 1.7 20.1 20.1 32.1 24.4 7.9 13.0 30.5 3.5 18.4 51.8 12.1 12.9 20.6 40.8 50.7 11.5 18.9 35.9 10.2 9.5 TSEN2 "MGC2776, SEN2, SEN2L" ENSG00000154743 "TRNA splicing endonuclease subunit 2" Q8NCE0 3 12484432-12539623 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, tRNA processing" Lyase "Neurodegeneration, Pontocerebellar hypoplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 41.2;Rod photoreceptor cells: 33.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027120, HPA027125, HPA027268" Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA027120: AB_10600197, HPA027125: AB_10601896, HPA027268: AB_10601347" "unprognostic (5.58e-2)" "unprognostic (4.49e-1)" "unprognostic (1.49e-1)" "unprognostic (3.71e-2)" "unprognostic (9.59e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (1.13e-5)" "unprognostic (1.42e-1)" "unprognostic (5.66e-2)" "unprognostic (1.28e-1)" "unprognostic (2.71e-1)" "unprognostic (6.15e-2)" "unprognostic (1.41e-2)" "unprognostic (6.99e-2)" "unprognostic (4.90e-2)" "unprognostic (6.06e-2)" "prognostic favorable (3.49e-4)" 8.8 10.6 9.7 8.8 19.1 6.7 10.9 16.5 14.0 10.4 9.8 12.7 8.4 5.8 14.0 9.9 7.9 12.8 10.3 14.3 10.5 12.3 9.8 7.3 7.3 10.9 11.5 7.6 18.0 11.9 14.3 15.3 4.9 10.2 10.5 10.9 13.5 7.2 13.1 16.7 15.3 6.1 12.3 12.3 6.1 8.5 11.3 9.1 9.9 12.5 9.6 8.1 8.6 8.3 8.5 7.1 2.6 4.2 5.0 13.7 5.6 7.8 13.7 7.4 9.6 12.5 13.3 17.0 7.4 6.6 8.0 5.8 7.7 8.4 9.4 5.2 6.0 9.5 7.3 12.3 12.7 9.1 7.4 15.2 10.3 18.3 7.9 9.6 16.2 4.0 11.5 14.8 14.5 17.8 5.9 6.4 13.8 15.3 5.2 9.2 14.8 12.4 7.4 10.4 22.2 16.5 9.4 5.1 18.9 11.9 8.1 4.8 8.4 6.9 6.2 5.8 5.3 11.2 11.3 5.7 5.1 5.0 6.9 11.5 4.9 12.5 11.8 6.8 16.4 6.3 2.4 4.2 0.3 6.4 4.2 10.9 8.5 9.8 7.4 5.9 8.3 13.7 11.7 2.6 5.0 3.6 7.1 3.5 5.6 9.7 19.1 16.5 14.0 10.5 12.3 11.5 7.6 10.2 9.1 3.0 3.5 10.9 9.7 2.6 27.2 6.2 15.3 9.4 2.3 10.4 41.2 7.4 1.7 4.9 1.3 5.6 2.6 0.0 3.7 3.2 3.8 5.0 4.7 5.5 4.1 9.5 4.1 3.1 4.0 2.1 8.3 3.2 3.3 1.0 4.7 8.7 3.5 3.5 9.6 5.0 33.9 6.5 5.1 10.3 19.3 4.3 1.6 5.7 8.2 8.0 TSEN34 "LENG5, SEN34, SEN34L" ENSG00000170892 "TRNA splicing endonuclease subunit 34" Q9BSV6 19 54189938-54194536 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, tRNA processing" Lyase "Disease mutation, Neurodegeneration, Pontocerebellar hypoplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 24.8" "Group enriched" "Detected in many" 6 "granulocytes: 24.8;monocytes: 8.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041111, HPA048208" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA041111: AB_10794263, HPA048208: AB_2680313" "unprognostic (3.24e-2)" "unprognostic (2.95e-2)" "unprognostic (1.59e-1)" "unprognostic (3.88e-2)" "unprognostic (3.48e-2)" "unprognostic (4.82e-2)" "prognostic unfavorable (1.44e-7)" "unprognostic (2.38e-1)" "unprognostic (7.35e-2)" "unprognostic (1.51e-1)" "unprognostic (5.04e-3)" "unprognostic (8.98e-2)" "unprognostic (4.55e-3)" "unprognostic (2.02e-3)" "unprognostic (1.81e-1)" "unprognostic (2.81e-1)" "unprognostic (1.12e-1)" 12.3 28.0 10.4 10.8 10.2 8.2 15.4 4.0 12.8 19.8 19.5 9.4 19.2 3.0 17.3 23.4 20.2 25.3 18.1 20.0 8.8 9.8 15.4 20.0 13.4 18.2 8.7 8.9 31.8 27.3 19.2 14.3 22.0 8.7 23.2 12.3 15.7 17.8 29.5 15.7 14.7 9.8 18.6 7.8 18.0 13.0 27.3 7.7 12.9 28.5 19.6 14.9 19.8 15.5 1.4 2.6 24.8 8.1 0.8 2.4 1.5 29.2 4.3 11.9 17.0 7.1 14.4 13.0 3.6 7.4 8.8 8.3 2.2 4.2 2.2 1.0 5.7 15.3 20.6 16.2 21.5 6.5 7.6 24.6 2.6 0.8 2.4 6.7 0.8 3.6 23.2 9.9 6.0 7.1 7.4 18.1 0.0 5.9 1.4 18.8 3.6 1.5 0.0 2.7 18.6 3.2 7.3 8.1 1.0 25.5 2.5 0.6 6.9 0.8 21.8 8.0 7.7 17.3 2.1 1.2 0.0 12.3 12.8 22.4 8.3 8.0 2.1 21.3 1.3 13.5 4.1 8.1 17.8 0.9 3.3 1.8 1.0 1.3 2.4 2.3 1.4 2.3 0.9 24.8 0.8 5.2 2.6 0.7 1.5 10.4 10.2 4.0 12.8 8.8 9.8 8.7 8.9 8.7 7.7 11.9 20.1 13.7 83.2 65.4 36.0 10.5 50.9 33.5 6.8 41.8 27.5 85.1 81.2 59.2 19.5 32.8 50.1 0.0 52.3 87.0 54.1 67.1 26.5 33.9 49.4 15.9 73.7 33.7 31.5 13.0 62.7 44.3 43.9 23.4 79.0 62.4 50.8 51.8 62.6 85.1 41.1 58.2 56.2 46.1 66.6 61.4 92.8 29.7 61.7 51.5 TSEN54 "SEN54, SEN54L" ENSG00000182173 "TRNA splicing endonuclease subunit 54" Q7Z6J9 17 75516060-75524739 "Disease related genes, Predicted intracellular proteins" "mRNA processing, tRNA processing" "Disease mutation, Neurodegeneration, Pontocerebellar hypoplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "granulocytes: 79.7;T-cells: 62.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024543, HPA053097" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA024543: , HPA053097: AB_2682043" "unprognostic (3.52e-2)" "unprognostic (2.52e-3)" "unprognostic (9.60e-3)" "unprognostic (2.55e-3)" "unprognostic (1.81e-1)" "unprognostic (1.83e-3)" "prognostic unfavorable (8.06e-6)" "unprognostic (2.33e-2)" "unprognostic (8.37e-2)" "unprognostic (9.04e-2)" "prognostic favorable (2.62e-5)" "unprognostic (7.26e-3)" "unprognostic (5.01e-2)" "prognostic favorable (7.78e-5)" "unprognostic (8.69e-2)" "unprognostic (2.03e-2)" "prognostic favorable (8.54e-4)" 6.2 7.9 8.1 9.7 11.0 12.9 7.1 24.6 9.0 8.0 12.4 10.9 8.6 18.9 7.2 6.1 12.8 9.1 27.0 4.9 12.2 5.0 12.3 9.8 9.5 10.4 15.8 9.4 7.3 21.6 7.6 10.7 5.9 11.7 11.0 7.3 4.7 13.6 11.5 7.9 19.5 17.3 7.4 9.5 15.2 17.4 7.4 10.5 10.9 10.4 8.6 13.1 8.5 8.9 4.6 10.5 7.5 3.4 17.0 34.0 9.6 14.9 17.1 4.8 9.7 1.6 1.9 12.7 3.9 2.5 8.0 6.4 20.2 12.3 19.3 5.2 1.5 5.6 13.9 6.2 5.8 3.6 5.1 22.5 14.8 10.5 12.5 4.0 6.0 30.5 2.3 7.5 3.6 3.3 1.8 5.4 12.3 17.4 6.9 2.3 26.0 19.8 17.3 6.5 14.4 17.1 14.6 15.2 14.3 4.3 8.3 16.3 12.6 8.6 23.2 6.2 6.7 16.5 8.6 2.6 8.5 13.4 10.6 8.2 17.0 7.8 10.3 4.7 19.7 3.9 7.5 1.6 5.0 34.0 3.4 22.5 4.6 13.8 25.2 3.9 2.9 11.1 21.2 0.2 17.0 3.2 10.5 7.7 9.6 8.1 11.0 24.6 9.0 12.2 5.0 15.8 9.4 11.7 10.5 8.9 8.1 6.7 11.3 23.5 13.9 2.0 10.2 2.7 7.9 8.7 3.9 10.6 10.0 14.6 4.6 8.7 16.8 0.0 15.1 14.6 8.9 7.7 79.7 7.7 11.2 30.2 18.0 6.2 4.6 4.2 4.4 4.5 15.1 17.2 15.7 15.2 12.5 16.7 7.1 9.8 6.8 12.9 8.7 15.8 26.0 21.2 6.3 62.1 19.6 7.3 TSFM "EF-TS, EF-Tsmt" ENSG00000123297 "Ts translation elongation factor, mitochondrial" P43897 12 57782589-57808071 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Cardiomyopathy, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 7 "RH-30: 157.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006204 Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA006204: AB_1080405" "unprognostic (1.17e-1)" "unprognostic (6.84e-3)" "unprognostic (1.93e-2)" "unprognostic (6.87e-2)" "unprognostic (1.87e-1)" "unprognostic (2.56e-3)" "unprognostic (2.49e-2)" "unprognostic (1.53e-1)" "unprognostic (8.52e-2)" "unprognostic (1.80e-1)" "unprognostic (1.49e-1)" "unprognostic (1.49e-3)" "prognostic favorable (8.82e-4)" "unprognostic (3.05e-1)" "unprognostic (6.97e-2)" "unprognostic (1.39e-1)" "unprognostic (1.23e-1)" 14.5 46.2 16.6 14.7 21.5 15.3 18.5 18.2 24.3 12.7 18.8 13.3 17.6 17.8 11.6 13.7 16.1 12.4 10.3 27.7 14.6 15.6 27.0 30.2 10.1 14.6 15.4 20.8 10.3 19.6 17.0 13.1 11.6 17.8 11.7 18.3 11.1 13.5 14.1 33.5 14.7 13.4 17.7 11.6 12.5 14.0 23.2 13.6 11.3 15.4 26.9 13.4 14.4 13.0 18.5 18.7 9.0 16.8 20.0 23.5 16.0 8.4 9.8 5.9 8.8 5.5 5.5 8.6 7.1 6.3 11.6 8.1 11.4 11.2 21.2 13.6 6.2 6.5 10.0 9.9 10.2 8.8 8.6 12.0 12.9 8.3 10.0 8.4 16.4 7.8 6.4 10.5 8.8 5.0 8.9 7.1 12.0 16.6 11.5 8.7 9.8 9.7 17.9 9.1 12.3 13.1 11.8 157.2 19.0 11.0 9.6 12.8 7.9 7.6 13.4 12.9 5.5 23.2 12.0 5.2 6.3 8.9 9.2 7.6 8.5 17.4 16.5 8.9 9.9 7.5 3.7 14.8 9.0 18.6 13.8 23.5 18.5 20.9 18.4 18.7 16.4 21.2 21.7 4.2 20.0 16.8 14.7 18.1 16.0 16.6 21.5 18.2 24.3 14.6 15.6 15.4 20.8 17.8 13.6 17.9 9.6 15.6 12.7 23.0 19.8 29.9 35.7 20.1 13.6 43.6 13.7 59.0 81.2 56.0 69.4 9.6 12.7 23.3 75.2 41.0 20.6 14.1 21.9 32.5 31.6 14.3 13.3 17.8 7.3 33.2 21.0 18.6 25.3 102.8 18.4 20.6 51.6 17.5 22.6 110.7 16.3 58.2 17.6 36.4 60.1 31.7 39.8 15.0 32.8 9.2 TSHZ1 "NY-CO-33, SDCCAG33, TSH1" ENSG00000179981 "Teashirt zinc finger homeobox 1" Q6ZSZ6 18 75210755-75289950 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Peritubular cells: 176.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 27.9" "Region enriched" "Detected in many" 5 "olfactory region: 81.2" "Low region specificity" "Detected in all" HPA006982 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA006982: AB_1079886" "unprognostic (2.02e-1)" "unprognostic (2.61e-2)" "unprognostic (4.03e-1)" "unprognostic (5.89e-2)" "unprognostic (1.66e-1)" "unprognostic (1.23e-2)" "unprognostic (1.27e-1)" "unprognostic (1.24e-1)" "unprognostic (4.12e-2)" "unprognostic (9.05e-2)" "unprognostic (5.64e-2)" "unprognostic (1.69e-1)" "unprognostic (3.43e-3)" "unprognostic (1.26e-1)" "unprognostic (8.00e-2)" "prognostic unfavorable (1.71e-5)" "unprognostic (3.42e-3)" 16.2 9.4 13.8 10.3 16.8 3.6 25.6 25.9 23.2 20.9 22.4 8.5 9.3 15.3 13.1 11.3 11.7 19.0 11.9 13.6 11.9 9.2 13.9 9.3 9.3 10.0 9.9 7.7 41.6 8.9 12.6 18.5 32.1 12.7 10.8 10.8 13.7 13.3 13.6 9.4 12.0 17.5 13.5 19.0 10.2 11.5 8.7 7.9 14.3 9.7 5.2 6.2 14.7 19.9 1.2 1.7 1.2 1.2 3.2 5.1 1.4 3.3 4.0 1.4 8.2 12.4 6.0 1.4 15.3 14.5 2.5 4.9 2.0 8.2 6.7 2.0 13.9 2.9 3.0 1.8 4.4 0.9 27.9 15.1 5.2 9.3 2.6 3.2 12.2 6.1 6.0 4.7 2.1 4.2 4.0 6.5 7.9 2.9 12.1 4.2 3.2 8.7 6.9 0.5 3.9 5.0 8.0 4.2 8.0 4.9 2.4 10.4 7.9 4.3 5.6 4.2 0.6 1.3 6.4 4.9 5.7 3.9 3.9 2.4 4.0 9.5 5.5 5.5 10.4 5.1 0.0 1.2 1.2 4.8 0.5 3.4 1.0 2.4 4.2 1.7 1.2 3.7 5.1 0.8 3.2 0.5 1.7 1.0 1.4 13.8 16.8 25.9 23.2 11.9 9.2 9.9 7.7 12.7 7.9 11.9 12.3 6.2 4.8 15.0 42.4 21.6 22.9 12.0 10.3 3.5 2.0 3.7 3.3 4.4 1.0 26.9 17.4 0.0 8.8 1.7 35.1 6.4 6.9 18.1 5.4 11.1 16.3 18.4 12.9 2.4 59.8 10.0 8.5 1.8 17.0 16.6 3.3 10.5 176.0 16.7 10.9 25.8 11.8 0.7 4.9 11.5 3.0 15.8 16.4 5.2 TSHZ2 "C20orf17, OVC10-2, TSH2, ZABC2, ZNF218" ENSG00000182463 "Teashirt zinc finger homeobox 2" Q9NRE2 20 52972407-53495330 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 7 "Leydig cells: 433.5;Peritubular cells: 755.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 6.1" "Lineage enriched" "Detected in many" 4 "T-cells: 6.1" "Cell line enhanced" "Detected in some" "AN3-CA: 19.9;ASC diff: 8.7;HeLa: 17.4;SiHa: 11.3;U-2197: 10.2" "Low region specificity" "Detected in many" HPA038123 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA038123: AB_10670657" "unprognostic (9.24e-3)" "unprognostic (1.58e-1)" "unprognostic (9.35e-2)" "unprognostic (1.13e-1)" "unprognostic (1.21e-4)" "unprognostic (3.30e-1)" "unprognostic (4.30e-1)" "unprognostic (1.28e-1)" "unprognostic (2.16e-1)" "unprognostic (3.23e-2)" "unprognostic (3.33e-1)" "unprognostic (3.14e-2)" "unprognostic (9.88e-8)" "unprognostic (6.26e-2)" "unprognostic (3.81e-2)" "unprognostic (3.37e-7)" "unprognostic (2.97e-3)" 16.2 12.3 2.8 5.7 3.5 0.2 10.3 1.0 9.8 12.9 7.4 1.8 27.7 2.0 11.8 15.9 7.6 7.3 11.4 3.9 4.8 3.5 2.7 11.1 3.0 3.6 3.5 5.8 17.2 3.4 2.1 2.6 1.2 4.6 7.6 1.9 0.1 11.2 35.8 3.9 4.9 3.1 8.3 14.3 4.4 4.4 9.6 2.5 0.0 5.0 5.8 3.0 9.0 16.5 0.9 0.3 1.3 0.1 0.2 6.1 1.0 0.0 0.0 1.3 19.9 8.7 2.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 3.7 1.1 0.0 17.4 0.0 0.2 0.0 0.4 3.1 2.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.3 11.3 0.1 0.0 0.5 0.0 0.0 0.0 0.0 2.0 10.2 0.0 0.0 0.2 0.0 2.1 0.0 0.1 0.5 0.1 0.1 0.1 0.0 0.1 0.8 4.1 0.2 0.0 0.9 6.1 0.4 1.3 0.2 0.1 0.3 4.3 1.0 2.8 3.5 1.0 9.8 4.8 3.5 3.5 5.8 4.6 2.5 0.0 1.1 5.4 18.1 40.3 4.5 2.8 43.3 5.3 10.3 34.9 2.0 1.0 0.0 36.1 8.8 67.1 0.0 0.0 8.9 0.6 19.5 29.7 1.1 80.0 1.1 0.0 6.3 12.3 1.0 6.7 433.5 1.5 11.8 1.0 0.6 53.3 10.9 0.6 755.6 0.1 1.3 38.8 7.8 1.8 1.7 35.4 0.7 8.7 1.5 6.7 TSHZ3 "KIAA1474, TSH3, ZNF537" ENSG00000121297 "Teashirt zinc finger homeobox 3" Q63HK5 19 31274945-31349547 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Fibroblasts: 18.6;Ito cells: 19.6;Leydig cells: 16.4;Peritubular cells: 27.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.9" "Group enriched" "Detected in many" 35 "granulocytes: 4.9;monocytes: 2.2;T-cells: 3.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 13.0;RH-30: 26.7;U-138 MG: 18.9;U-87 MG: 12.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "cerebral cortex: 20.4;hippocampal formation: 16.8" "HPA008834, HPA071010" Approved Enhanced "Nucleoplasm,Plasma membrane" No No Nucleoplasm "Plasma membrane" "HPA008834: AB_1080731, HPA071010: " "unprognostic (2.56e-1)" "unprognostic (3.88e-1)" "unprognostic (4.56e-2)" "unprognostic (3.66e-1)" "unprognostic (1.66e-3)" "unprognostic (4.07e-2)" "unprognostic (1.67e-1)" "unprognostic (2.46e-1)" "unprognostic (1.76e-1)" "unprognostic (3.58e-3)" "unprognostic (2.23e-1)" "unprognostic (3.91e-2)" "prognostic unfavorable (2.92e-4)" "unprognostic (8.76e-3)" "unprognostic (8.22e-2)" "unprognostic (1.91e-2)" "unprognostic (1.73e-3)" 5.7 3.3 4.4 4.0 6.6 1.0 5.2 1.1 17.3 13.0 11.6 0.7 2.4 2.5 19.4 8.5 5.6 9.5 11.5 4.6 3.3 2.0 2.8 1.3 4.9 1.2 1.6 8.0 28.0 1.5 1.1 7.2 4.8 2.8 9.5 3.7 4.9 2.8 8.9 1.6 2.5 4.3 16.4 3.3 4.5 6.1 3.3 1.2 0.0 8.5 1.7 0.7 11.1 11.4 0.0 0.0 4.9 2.2 0.0 3.2 0.7 0.0 1.1 0.4 0.0 5.9 13.0 0.0 3.4 4.9 2.1 3.8 0.0 0.7 0.0 0.0 8.4 4.4 0.5 1.5 3.1 4.7 0.0 1.3 0.0 0.0 0.0 11.4 2.8 5.3 7.6 2.8 7.8 3.9 0.0 0.0 2.5 0.0 0.0 9.8 0.5 0.0 0.0 0.5 0.0 0.0 3.3 26.7 0.0 0.0 0.0 0.0 8.1 0.0 0.0 2.6 2.7 0.0 2.0 0.0 18.9 6.0 2.1 4.8 0.0 0.0 0.0 12.2 4.9 0.5 0.0 2.2 0.0 3.2 0.8 0.1 0.0 0.9 1.0 0.0 0.0 0.3 0.8 4.9 0.0 0.4 0.0 0.7 0.7 4.4 6.6 1.1 17.3 3.3 2.0 1.6 8.0 2.8 1.2 3.0 0.6 0.0 6.8 4.2 13.9 1.6 0.0 1.4 6.8 3.5 0.0 0.3 0.0 0.3 0.1 6.7 0.0 0.0 0.6 0.2 18.6 3.3 1.1 0.0 9.1 15.9 0.0 19.6 11.6 0.0 16.4 6.1 5.0 0.0 0.0 0.2 0.5 0.0 27.6 0.0 0.1 0.0 10.3 0.0 5.0 1.5 0.7 0.5 0.0 2.4 TSKU "E2IG4, LRRC54, TSK" ENSG00000182704 "Tsukushi, small leucine rich proteoglycan" Q8WUA8 11 76782251-76798154 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 86.8" "Cell type enriched" "Detected in many" 7 "Hepatocytes: 427.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 41.4;ASC diff: 70.9;OE19: 44.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA008164 Approved Approved "Nucleoplasm,Nuclear bodies" "Secreted - unknown location" NA NA 2100000 Nucleoplasm "Nuclear bodies" "HPA008164: AB_1853327" "unprognostic (1.07e-2)" "unprognostic (2.29e-3)" "unprognostic (6.15e-2)" "prognostic favorable (3.66e-4)" "unprognostic (7.05e-2)" "unprognostic (2.39e-1)" "unprognostic (3.08e-1)" "unprognostic (2.17e-3)" "unprognostic (4.81e-2)" "unprognostic (4.62e-2)" "prognostic unfavorable (2.87e-4)" "prognostic favorable (1.66e-4)" "prognostic unfavorable (2.80e-8)" "unprognostic (1.47e-1)" "unprognostic (4.93e-2)" "unprognostic (6.71e-2)" "unprognostic (3.88e-2)" 33.1 2.8 1.0 3.6 1.4 0.6 26.9 1.5 2.0 38.8 16.1 1.8 6.4 11.5 13.2 25.5 17.8 15.3 8.6 9.3 1.2 0.3 31.8 86.8 5.1 3.7 1.7 1.3 27.8 12.2 2.6 4.3 43.0 3.4 15.7 4.5 48.5 9.3 10.8 7.0 15.0 21.4 13.0 0.8 3.0 8.7 9.0 0.8 1.5 12.2 16.0 12.4 18.2 27.9 1.8 0.7 2.1 0.4 0.7 1.3 0.2 0.8 41.4 4.6 4.5 70.9 9.1 8.5 1.4 7.8 3.1 3.0 5.3 11.4 0.1 8.1 5.1 13.2 16.6 2.6 10.2 0.9 8.5 1.4 2.0 10.7 14.8 13.4 0.7 3.1 9.3 11.2 5.5 4.5 5.9 3.8 1.5 4.5 0.3 2.8 19.1 0.1 1.5 6.1 44.7 1.8 1.3 4.4 6.5 7.3 7.2 4.2 6.9 7.9 6.2 3.8 4.1 8.3 0.6 1.1 8.7 6.9 21.1 3.3 0.3 0.1 0.3 4.1 2.1 1.5 1.8 0.4 0.5 0.9 0.2 0.4 1.8 0.8 0.7 0.4 1.8 0.9 1.3 2.1 0.7 0.4 0.7 0.8 0.2 1.0 1.4 1.5 2.0 1.2 0.3 1.7 1.3 3.4 0.8 0.0 0.3 0.0 13.0 15.3 3.2 3.9 15.3 2.7 5.7 1.8 0.0 42.8 0.0 5.8 0.2 3.6 20.6 23.3 19.6 58.8 39.7 6.5 1.1 427.8 8.4 0.0 7.5 8.6 9.5 1.2 34.5 1.6 5.0 2.8 14.2 10.4 17.7 20.1 42.5 21.9 0.5 0.0 13.4 0.4 2.3 19.7 36.6 4.4 11.3 17.0 TSN "BCLF-1, REHF-1, TRSLN" ENSG00000211460 Translin Q15631 2 121737103-121767853 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "DNA-binding, Endonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059561 Uncertain Supported "Nucleoplasm,Endoplasmic reticulum" NA NA 320000 "Nucleoplasm, Endoplasmic reticulum" "HPA059561: AB_2684063" "unprognostic (3.15e-2)" "unprognostic (1.83e-1)" "unprognostic (3.53e-1)" "prognostic unfavorable (7.05e-4)" "unprognostic (7.13e-3)" "unprognostic (3.12e-2)" "prognostic unfavorable (3.06e-4)" "unprognostic (2.32e-2)" "unprognostic (7.58e-2)" "unprognostic (2.39e-2)" "unprognostic (1.10e-1)" "unprognostic (2.24e-1)" "unprognostic (1.62e-1)" "unprognostic (6.48e-2)" "unprognostic (1.04e-2)" "unprognostic (3.42e-2)" "unprognostic (3.18e-1)" 14.9 18.7 23.1 13.0 24.6 43.0 25.6 17.8 27.7 18.6 23.1 23.7 11.8 17.2 17.9 19.1 18.2 15.2 16.3 18.7 20.6 23.0 24.7 22.0 15.0 22.6 22.8 20.1 17.5 20.7 19.3 17.9 13.8 23.3 15.0 18.9 16.5 16.3 18.2 29.4 18.9 16.4 14.3 22.0 17.5 15.4 33.9 17.6 28.3 17.2 18.7 17.4 13.9 14.2 22.1 22.7 22.0 24.4 19.6 23.1 20.7 21.4 9.8 14.4 12.1 13.4 10.6 8.0 18.4 16.7 19.4 19.2 27.2 11.9 30.0 21.7 16.6 11.5 10.1 21.0 16.9 26.9 16.6 17.2 17.7 14.0 24.3 15.0 24.7 12.6 9.0 18.8 21.9 14.5 8.5 15.8 14.6 26.7 14.4 17.5 11.1 15.0 27.7 17.5 11.4 18.6 25.3 16.2 22.1 23.4 14.2 18.9 11.8 12.0 17.4 20.7 11.6 11.6 18.4 11.8 14.0 23.8 9.2 17.4 13.3 37.9 33.6 16.2 16.7 16.9 17.2 24.4 22.0 19.6 22.2 22.7 22.1 20.4 17.0 22.7 18.0 23.1 20.1 7.9 19.6 19.0 16.5 20.2 20.7 23.1 24.6 17.8 27.7 20.6 23.0 22.8 20.1 23.3 17.6 29.8 26.1 37.9 30.5 34.8 31.1 31.9 35.7 21.4 25.0 40.1 21.6 29.5 36.5 47.5 50.8 37.3 18.6 23.3 52.8 29.2 29.4 23.8 39.3 39.9 31.5 15.9 19.1 60.8 29.8 10.8 33.6 31.9 64.1 36.9 25.3 80.9 38.3 21.0 29.4 48.2 26.8 25.8 37.1 109.7 104.5 38.3 23.8 36.3 34.9 22.0 TSNAX TRAX ENSG00000116918 "Translin associated factor X" Q99598 1 231528653-231566524 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA024613, HPA031054, HPA031055, CAB034263" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 100000 Nucleoplasm "Golgi apparatus, Cytosol" "CAB034263: AB_2272293, HPA024613: , HPA031054: AB_10600415, HPA031055: AB_10602314" "unprognostic (6.28e-3)" "unprognostic (5.48e-2)" "unprognostic (1.62e-1)" "unprognostic (1.12e-1)" "unprognostic (5.55e-2)" "unprognostic (2.27e-1)" "unprognostic (2.96e-2)" "unprognostic (2.05e-1)" "unprognostic (1.22e-1)" "unprognostic (2.42e-3)" "unprognostic (4.51e-2)" "unprognostic (1.91e-1)" "unprognostic (2.16e-1)" "unprognostic (1.27e-1)" "unprognostic (4.98e-2)" "unprognostic (6.52e-3)" "unprognostic (2.70e-2)" 27.4 29.9 23.9 17.1 26.7 12.0 23.4 28.0 33.1 19.7 16.2 21.9 17.2 15.8 20.0 24.6 18.0 16.4 16.7 22.7 25.1 23.9 29.1 23.0 18.4 22.6 22.1 22.1 18.6 14.6 32.3 36.0 18.3 28.5 21.3 18.0 19.6 17.5 19.9 52.5 20.6 14.8 18.9 28.2 24.0 15.5 17.5 24.4 24.5 26.7 25.4 22.0 19.1 17.3 10.0 11.7 54.6 17.5 18.7 13.5 11.0 11.0 9.1 13.9 11.4 10.3 12.7 15.8 12.6 19.1 16.2 14.0 7.8 15.6 15.6 21.3 13.7 6.0 12.1 11.0 11.4 21.1 13.9 19.2 15.0 9.4 10.3 14.2 24.7 31.9 15.5 12.6 15.6 12.1 10.2 11.7 11.4 24.2 11.1 21.9 4.5 15.9 12.1 20.5 9.3 11.1 15.8 15.3 21.1 18.1 12.8 13.3 25.6 13.1 16.7 42.4 5.9 24.3 42.0 10.9 11.2 10.2 22.4 22.6 18.9 24.9 17.4 18.3 19.6 30.6 54.6 11.2 29.2 11.4 13.5 10.8 10.0 12.3 11.2 11.7 9.9 13.2 12.7 11.4 18.7 17.5 6.8 13.5 11.0 23.9 26.7 28.0 33.1 25.1 23.9 22.1 22.1 28.5 24.4 26.8 32.9 25.4 17.9 38.9 58.2 20.9 38.2 26.8 17.0 40.1 27.5 39.1 46.4 25.0 7.5 33.3 20.5 46.7 27.1 39.0 28.8 14.4 75.1 26.0 42.6 62.0 27.7 27.6 51.1 7.5 31.1 45.0 25.3 37.9 29.8 64.5 23.0 23.4 33.9 36.6 45.9 38.8 35.6 28.1 70.9 44.9 30.3 35.8 22.4 12.2 TSNAXIP1 TXI1 ENSG00000102904 "Translin associated factor X interacting protein 1" Q2TAA8 16 67806765-67832148 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 14.2;testis: 40.6" "Group enriched" "Detected in many" 7 "Ciliated cells: 46.8;Early spermatids: 85.4;Late spermatids: 137.1;Spermatocytes: 56.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 7.1;SiHa: 4.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA053516 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA053516: AB_2682175" "unprognostic (9.78e-3)" "unprognostic (2.05e-1)" "unprognostic (4.65e-2)" "prognostic favorable (2.22e-4)" "unprognostic (1.92e-1)" "unprognostic (2.82e-3)" "unprognostic (2.73e-1)" "unprognostic (7.09e-2)" "unprognostic (2.93e-1)" "unprognostic (6.66e-2)" "unprognostic (1.81e-3)" "unprognostic (1.94e-1)" "unprognostic (4.74e-3)" "unprognostic (1.16e-1)" "unprognostic (1.14e-1)" "unprognostic (9.49e-3)" "unprognostic (1.59e-3)" 0.9 1.9 4.8 1.1 9.2 0.6 0.9 2.0 3.9 1.3 0.9 3.3 1.9 0.5 1.8 3.6 0.7 14.2 1.2 0.7 3.8 3.3 1.6 0.8 2.1 0.7 1.2 3.7 2.5 2.2 2.9 6.9 0.7 6.3 1.0 0.7 1.0 1.0 2.0 0.5 0.8 0.6 1.2 0.9 0.8 1.2 40.6 2.5 0.0 1.1 0.0 0.7 0.9 0.5 0.0 0.0 0.1 0.0 0.0 0.3 0.4 1.1 0.4 2.5 7.1 3.5 0.9 0.9 0.0 1.6 0.5 2.4 0.7 0.8 1.1 1.1 0.2 0.8 1.4 1.0 1.1 1.5 0.4 0.9 0.0 0.8 0.1 1.1 1.7 0.2 0.9 0.9 3.6 0.5 0.5 0.0 1.4 0.5 0.3 0.0 0.0 0.3 0.6 0.7 0.2 0.4 1.7 0.7 0.1 3.6 0.7 2.0 2.1 4.5 0.1 0.4 0.9 1.8 0.1 0.9 0.4 0.1 0.3 0.2 1.3 2.1 0.2 0.3 0.2 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 4.8 9.2 2.0 3.9 3.8 3.3 1.2 3.7 6.3 2.5 0.0 2.4 0.0 0.4 0.1 3.1 8.1 0.0 46.8 5.7 5.2 3.9 0.4 0.0 0.6 85.4 0.6 0.0 0.0 0.0 0.2 0.5 0.3 0.0 0.8 0.2 3.2 0.0 0.6 0.0 137.1 2.6 0.5 0.0 0.0 0.0 3.5 0.1 0.0 1.8 2.1 10.0 6.5 0.3 56.4 11.2 0.3 0.5 0.0 0.0 0.1 TSPAN1 "NET-1, TSPAN-1" ENSG00000117472 "Tetraspanin 1" O60635 1 46175073-46185958 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 70.0;testis: 119.0" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 1113.5;Collecting duct cells: 549.6;Enterocytes: 573.6;Late spermatids: 654.5;Paneth cells: 587.5" "Cancer enhanced" "Detected in all" "prostate cancer: 455.6" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 90 "plasmacytoid DC: 8.9" "Lineage enriched" "Detected in single" 90 "dendritic cells: 8.9" "Cell line enhanced" "Detected in some" "A-431: 21.3;CAPAN-2: 36.8;HaCaT: 25.7;hTCEpi: 29.8;OE19: 42.8;RPTEC TERT1: 107.8;RT4: 51.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA011909 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA011909: AB_2668565" "unprognostic (1.21e-1)" "unprognostic (3.11e-1)" "unprognostic (3.67e-2)" "unprognostic (4.12e-1)" "unprognostic (2.69e-2)" "unprognostic (1.35e-1)" "unprognostic (4.41e-2)" "unprognostic (4.68e-2)" "unprognostic (2.52e-2)" "unprognostic (1.44e-1)" "unprognostic (1.88e-3)" "unprognostic (8.73e-2)" "prognostic favorable (9.28e-6)" "unprognostic (5.90e-2)" "unprognostic (2.61e-1)" "unprognostic (4.90e-2)" "unprognostic (4.30e-2)" 1.7 0.6 1.7 4.8 2.4 0.0 1.5 11.4 3.5 9.0 59.9 1.8 1.5 2.2 1.8 4.6 1.9 13.9 2.6 2.6 2.2 0.0 46.0 1.9 5.7 2.1 2.4 1.7 1.5 1.5 15.4 3.3 1.5 2.1 22.7 70.0 3.3 16.1 7.8 1.5 0.1 18.3 1.9 1.8 1.6 24.6 119.0 1.9 1.6 13.9 1.8 1.9 21.0 1.5 0.0 8.9 0.0 0.0 0.0 0.0 0.0 21.3 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 36.8 0.0 6.9 0.0 0.0 25.7 0.0 18.8 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 29.8 0.1 10.6 0.6 0.0 0.2 0.0 0.0 0.2 0.8 0.0 0.0 0.0 42.8 1.3 0.0 0.0 0.2 107.8 51.7 0.3 0.0 0.0 2.2 0.1 0.1 1.5 0.0 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 1.7 2.4 11.4 3.5 2.2 0.0 2.4 1.7 2.1 1.9 23.8 19.0 15.7 180.5 0.9 0.0 0.6 15.3 1113.5 208.1 549.6 0.0 0.1 39.7 40.8 130.9 1.2 573.6 0.0 480.2 0.1 1.0 212.2 11.5 2.6 0.2 0.0 193.7 2.5 0.3 654.5 4.6 4.0 5.0 2.8 525.2 0.0 292.8 587.5 1.8 400.8 0.0 0.0 0.3 4.2 1.9 1.1 0.0 0.8 136.2 439.3 TSPAN13 "NET-6, TM4SF13" ENSG00000106537 "Tetraspanin 13" O95857 7 16753535-16784536 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 461.6;Mucus-secreting cells: 362.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 24.7;plasmacytoid DC: 51.3" "Group enriched" "Detected in many" 41 "B-cells: 24.7;dendritic cells: 51.3" "Cell line enhanced" "Detected in many" "OE19: 74.3;SCLC-21H: 34.3;SK-BR-3: 49.6;T-47d: 92.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007426 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA007426: AB_10603137" "unprognostic (3.22e-1)" "unprognostic (1.45e-2)" "unprognostic (1.48e-1)" "unprognostic (3.52e-2)" "prognostic unfavorable (3.56e-5)" "unprognostic (2.63e-2)" "prognostic unfavorable (2.94e-4)" "unprognostic (5.69e-2)" "unprognostic (6.63e-2)" "prognostic favorable (2.20e-4)" "unprognostic (1.50e-1)" "unprognostic (3.07e-1)" "prognostic unfavorable (2.43e-4)" "unprognostic (1.15e-1)" "unprognostic (2.37e-1)" "unprognostic (1.01e-2)" "unprognostic (1.42e-1)" 20.8 24.2 17.7 7.6 24.9 6.2 25.6 10.7 33.0 18.6 23.6 3.0 21.0 25.2 5.9 12.3 8.8 5.7 16.0 6.8 14.5 21.7 3.3 22.2 53.4 14.8 12.0 15.9 2.1 55.2 4.6 48.0 19.0 14.0 15.1 29.1 8.5 49.1 19.2 4.1 4.7 27.8 5.9 3.6 12.9 31.3 3.1 3.4 3.6 13.0 7.1 18.5 12.1 10.6 24.7 51.3 0.9 0.0 0.8 0.0 1.2 7.1 5.9 7.6 8.0 0.9 0.0 2.1 15.4 2.5 0.4 0.7 20.8 11.1 0.2 3.9 5.5 1.9 11.1 8.7 12.9 3.4 0.2 9.4 3.0 2.4 2.2 2.1 0.2 0.6 0.9 5.6 0.8 0.9 4.4 4.7 3.2 10.0 0.0 0.4 20.4 0.4 0.4 5.3 74.3 7.2 8.2 0.0 7.4 24.0 13.6 34.3 5.2 2.8 49.6 0.7 11.3 92.8 0.8 0.4 0.2 2.7 0.2 5.0 4.5 0.1 0.1 7.1 0.1 10.8 0.1 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.2 24.7 0.0 0.0 0.9 0.8 0.0 51.3 0.0 1.2 17.7 24.9 10.7 33.0 14.5 21.7 12.0 15.9 14.0 3.4 461.6 65.1 58.0 67.1 37.8 65.4 15.8 38.2 25.4 58.0 27.9 7.9 258.0 6.6 62.2 1.0 52.8 83.8 46.7 178.4 88.6 42.3 128.5 9.2 25.9 34.7 14.3 103.4 9.8 15.8 1.8 0.6 4.3 30.4 105.6 362.8 2.3 99.4 94.7 0.7 0.7 7.4 32.3 10.8 0.7 16.8 34.6 168.2 8.7 117.0 107.7 TSPAN17 "FBX23, FBXO23, TM4SF17" ENSG00000048140 "Tetraspanin 17" Q96FV3 5 176647387-176659054 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Exocrine glandular cells: 49.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030447 Approved Nucleoplasm NA NA Nucleoplasm "HPA030447: AB_2673484" "unprognostic (1.70e-2)" "unprognostic (7.92e-2)" "unprognostic (2.91e-1)" "unprognostic (3.47e-2)" "unprognostic (3.97e-2)" "unprognostic (3.71e-3)" "unprognostic (1.21e-3)" "unprognostic (3.82e-1)" "unprognostic (2.30e-1)" "unprognostic (3.60e-1)" "unprognostic (5.87e-2)" "unprognostic (1.04e-1)" "unprognostic (6.41e-2)" "unprognostic (7.11e-3)" "unprognostic (2.32e-1)" "unprognostic (4.50e-1)" "unprognostic (1.46e-1)" 11.1 29.3 18.7 12.8 12.6 39.1 14.7 18.3 20.9 8.7 14.7 7.1 12.4 13.1 9.0 10.5 16.6 11.2 16.8 16.5 13.3 10.4 16.4 15.0 13.5 19.8 9.2 9.2 8.6 30.5 12.3 19.5 10.3 10.4 12.4 11.8 9.1 11.7 15.8 30.2 11.2 14.6 11.7 6.6 15.7 15.3 18.4 11.2 3.4 11.9 13.7 15.8 14.5 9.4 2.6 3.1 0.8 4.9 3.7 9.3 3.4 16.0 16.3 10.9 19.9 15.2 13.1 17.0 12.1 17.7 17.9 17.9 4.9 18.5 7.2 22.1 20.8 37.0 12.3 5.4 28.1 11.0 53.0 11.4 2.7 7.1 5.8 13.9 5.8 10.1 15.5 15.9 14.2 8.7 12.2 24.5 5.6 13.5 7.8 18.1 26.5 1.2 2.5 8.8 15.7 17.9 6.1 9.3 4.0 16.8 11.9 16.6 11.7 13.1 15.3 16.3 9.5 12.5 7.4 18.9 19.5 20.3 14.6 15.1 4.4 5.7 3.1 21.3 12.4 11.3 0.0 3.1 0.8 5.4 3.1 4.3 1.6 4.1 8.8 3.1 2.6 2.9 3.9 0.5 3.7 4.9 0.8 9.3 3.4 18.7 12.6 18.3 20.9 13.3 10.4 9.2 9.2 10.4 11.2 11.9 9.8 8.2 9.5 2.6 9.7 12.3 12.7 1.4 5.7 10.4 11.8 0.8 5.0 32.2 0.8 7.9 26.0 23.3 49.2 16.3 9.1 11.8 0.0 11.6 13.6 1.6 13.8 12.3 8.9 0.4 6.4 8.6 6.8 14.4 19.4 6.5 35.7 19.5 6.7 11.0 24.8 0.0 8.6 1.1 2.4 4.6 1.0 13.1 20.4 11.9 TSPAN2 "FLJ12082, TSN2, TSPAN-2" ENSG00000134198 "Tetraspanin 2" O60636 1 115048011-115089500 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 44.6" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 22.5;Intestinal endocrine cells: 37.7;Smooth muscle cells: 20.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "pons and medulla: 11.9" "Cell type enhanced" "Detected in many" "neutrophil: 35.0" "Group enriched" "Detected in many" 4 "granulocytes: 35.0;NK-cells: 25.9" "Cell line enhanced" "Detected in many" "EFO-21: 35.1;hTERT-RPE1: 9.8;U-937: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015640, HPA073306" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA015640: AB_1858405, HPA073306: " "unprognostic (4.56e-2)" "unprognostic (6.86e-2)" "unprognostic (2.60e-1)" "prognostic unfavorable (8.89e-4)" "unprognostic (1.57e-3)" "unprognostic (1.64e-1)" "unprognostic (9.73e-6)" "unprognostic (6.06e-3)" "unprognostic (3.07e-2)" "unprognostic (4.74e-2)" "unprognostic (7.66e-2)" "unprognostic (1.80e-1)" "prognostic unfavorable (8.48e-7)" "unprognostic (5.40e-2)" "unprognostic (1.59e-1)" "unprognostic (1.48e-3)" "unprognostic (7.80e-3)" 3.7 0.6 1.1 4.7 2.5 9.6 3.2 0.9 2.0 20.1 31.0 1.5 8.9 2.5 30.6 6.9 12.3 14.2 10.6 6.1 1.1 2.6 4.0 0.6 3.0 1.5 1.9 1.9 6.5 2.0 6.4 2.0 1.5 11.9 15.2 6.2 1.9 2.2 15.7 2.0 1.6 7.0 44.6 1.6 2.2 10.0 4.4 0.8 2.6 4.0 4.9 0.9 25.4 7.0 0.2 1.2 35.0 2.9 25.9 7.4 3.8 8.5 0.1 0.7 0.0 0.0 0.1 0.0 1.4 0.5 1.4 2.2 1.7 5.2 0.0 35.1 1.9 1.9 1.2 1.1 0.0 1.5 1.7 0.7 0.3 0.6 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 9.8 0.0 6.9 0.0 0.5 0.0 0.4 4.6 0.7 8.0 1.7 0.9 0.0 0.5 0.0 0.2 3.2 1.8 2.9 2.1 0.9 0.1 4.9 0.1 0.3 0.1 0.1 3.4 0.2 8.0 7.3 0.2 0.0 0.0 15.4 3.8 27.8 2.9 16.6 5.9 0.0 1.9 0.2 7.0 7.4 1.2 0.1 1.2 6.0 35.0 25.9 0.0 1.2 0.9 3.8 1.1 2.5 0.9 2.0 1.1 2.6 1.9 1.9 11.9 0.8 0.0 1.1 0.0 22.5 7.1 0.2 9.2 0.0 10.7 2.3 10.4 0.0 0.1 0.0 16.3 10.8 15.0 0.0 0.0 2.2 3.1 3.1 10.9 0.0 0.0 0.6 0.0 37.7 5.5 0.8 2.7 0.6 0.9 3.3 0.0 0.8 0.0 7.7 0.0 2.8 1.0 0.4 6.5 20.2 0.1 0.9 2.4 0.2 5.0 1.0 9.2 TSPAN3 "TM4-A, TM4SF8, TSPAN-3" ENSG00000140391 "Tetraspanin 3" O60637 15 77041404-77083984 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Muller glia cells: 483.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 69.4;naive B-cell: 69.7;plasmacytoid DC: 46.7" "Group enriched" "Detected in all" 5 "B-cells: 69.7;dendritic cells: 46.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015996 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA015996: AB_1858406" "unprognostic (5.94e-2)" "unprognostic (3.05e-1)" "unprognostic (7.32e-2)" "unprognostic (2.15e-2)" "unprognostic (4.16e-2)" "unprognostic (1.38e-1)" "unprognostic (1.92e-2)" "unprognostic (1.31e-1)" "unprognostic (1.09e-1)" "unprognostic (5.41e-3)" "unprognostic (3.51e-3)" "unprognostic (2.90e-2)" "unprognostic (2.11e-2)" "unprognostic (1.51e-1)" "unprognostic (1.75e-1)" "unprognostic (3.79e-3)" "unprognostic (1.35e-1)" 64.0 31.4 71.6 16.9 66.5 6.0 43.3 36.8 67.5 31.4 75.3 49.4 74.2 70.6 28.4 95.9 16.8 53.8 39.4 24.6 58.1 63.7 44.9 17.8 41.9 22.9 64.4 45.8 33.0 31.6 53.6 44.0 23.1 54.1 21.3 82.7 44.3 30.8 60.9 79.3 16.3 71.2 27.6 49.2 19.1 46.1 21.3 40.4 14.2 43.0 24.7 25.4 23.2 15.2 69.7 46.7 1.5 10.8 8.3 6.9 12.1 20.8 56.9 47.3 29.8 83.1 51.2 15.6 33.4 36.4 41.2 45.1 34.6 43.6 20.5 49.7 34.5 39.4 47.4 44.8 22.9 31.0 22.9 67.9 14.6 43.6 32.7 40.3 18.8 10.8 48.1 27.7 22.7 20.3 63.0 50.4 13.7 15.4 18.1 40.3 7.9 16.6 17.9 33.4 67.0 25.3 21.0 58.8 21.6 67.8 11.9 42.9 47.5 22.9 19.4 62.1 47.4 20.8 35.7 47.7 38.3 15.0 23.0 46.7 39.9 54.2 10.9 33.9 28.2 21.8 0.8 7.5 1.5 5.1 9.9 5.4 69.4 2.6 3.7 14.8 69.7 6.9 6.3 0.7 8.3 10.8 46.7 0.6 12.1 71.6 66.5 36.8 64.2 58.1 63.7 64.4 45.8 54.1 40.4 104.2 182.8 49.0 53.9 30.8 241.7 81.1 112.1 176.7 158.1 64.6 172.8 77.0 21.6 218.3 24.0 52.8 344.7 0.0 309.7 26.2 81.8 155.9 22.0 27.0 57.7 120.8 87.8 60.2 53.5 44.3 59.5 31.1 69.2 23.4 234.6 483.1 209.9 302.5 48.4 50.7 133.3 25.8 63.7 84.0 50.0 29.9 63.5 26.1 164.4 170.4 TSPAN31 SAS ENSG00000135452 "Tetraspanin 31" Q12999 12 57738013-57750211 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "glioma: 54.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 60.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030758, HPA057489" Approved Approved "Nucleoplasm,Golgi apparatus,Cytokinetic bridge,Cytosol" Yes No "Golgi apparatus" "Nucleoplasm, Cytokinetic bridge, Cytosol" "HPA030758: , HPA057489: AB_2683447" "unprognostic (2.66e-2)" "unprognostic (1.50e-1)" "unprognostic (1.91e-1)" "unprognostic (1.82e-1)" "unprognostic (8.96e-3)" "prognostic unfavorable (1.09e-4)" "unprognostic (4.31e-3)" "unprognostic (1.19e-1)" "unprognostic (6.51e-3)" "unprognostic (5.31e-2)" "unprognostic (2.68e-1)" "unprognostic (2.79e-1)" "prognostic favorable (9.91e-5)" "unprognostic (1.68e-1)" "unprognostic (1.59e-1)" "unprognostic (6.32e-2)" "unprognostic (1.58e-1)" 27.0 26.4 19.4 18.2 22.5 5.4 21.8 14.3 20.5 21.9 20.1 30.5 23.0 16.3 23.1 37.6 21.3 27.7 23.3 23.3 19.1 17.8 32.1 29.2 20.7 14.5 20.3 16.0 32.0 32.1 31.4 22.7 31.5 19.4 23.3 19.0 32.1 24.6 22.0 19.8 15.2 24.0 17.5 24.3 23.1 18.2 11.4 17.1 14.6 42.4 16.5 20.7 20.2 16.8 17.6 35.4 18.6 24.8 23.7 22.0 18.8 3.6 8.8 9.1 2.3 21.0 13.9 5.9 5.8 7.6 3.1 3.1 6.1 19.6 3.3 12.8 13.2 3.8 7.6 2.4 12.2 4.4 8.7 6.5 4.4 7.3 2.5 20.8 4.4 7.8 12.3 14.5 6.0 12.7 9.4 8.1 1.7 3.2 9.6 9.9 7.3 3.4 2.6 1.9 6.6 2.8 4.2 60.0 8.5 12.7 7.4 3.1 7.8 6.2 9.1 4.5 2.2 17.1 6.9 11.1 5.0 4.1 2.7 3.0 11.9 2.6 1.6 13.5 3.0 7.6 18.6 15.7 11.1 22.0 15.7 21.3 17.6 17.8 18.9 15.6 16.8 17.8 16.7 5.3 23.7 24.8 35.4 12.1 18.8 19.4 22.5 14.3 18.5 19.1 17.8 20.3 16.0 19.4 17.1 44.7 25.9 22.0 37.5 10.0 39.9 4.2 22.9 25.4 21.6 29.6 39.3 16.4 8.3 31.1 0.9 23.2 21.6 0.0 34.1 12.3 23.7 26.6 43.9 17.4 19.7 20.6 25.4 20.3 15.6 2.1 23.9 24.1 30.4 24.4 20.3 54.9 31.7 21.0 16.3 15.9 55.1 19.4 23.6 8.7 4.8 11.0 20.5 14.9 21.2 28.5 TSPAN32 "PHEMX, TSSC6" ENSG00000064201 "Tetraspanin 32" Q96QS1 11 2301997-2318200 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.3;bone marrow: 17.5;heart muscle: 11.9;lymphoid tissue: 11.5" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 2: 10.7;Cardiomyocytes: 13.4;granulocytes: 29.0;Macrophages: 13.0;T-cells: 23.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 8 "HEL: 15.8;HL-60: 6.9;NB-4: 5.7;THP-1: 6.1;U-937: 9.6" "Low region specificity" "Detected in many" HPA024135 Uncertain Approved Nucleoplasm NA NA 37000 Nucleoplasm "HPA024135: AB_1858409" "unprognostic (7.50e-3)" "unprognostic (4.88e-4)" "unprognostic (1.58e-2)" "unprognostic (1.74e-1)" "unprognostic (4.45e-3)" "unprognostic (2.10e-4)" "unprognostic (7.72e-3)" "unprognostic (8.25e-3)" "unprognostic (9.74e-2)" "unprognostic (2.62e-1)" "unprognostic (2.70e-2)" "unprognostic (1.02e-1)" "unprognostic (2.28e-7)" "unprognostic (1.07e-1)" "unprognostic (4.20e-1)" "unprognostic (4.35e-1)" "unprognostic (8.13e-2)" 1.2 0.4 0.3 6.3 0.5 17.5 0.5 0.4 1.0 1.3 1.3 2.1 0.0 0.2 1.6 1.6 0.9 0.6 1.4 11.9 0.3 0.4 0.9 0.8 3.1 5.1 0.5 0.3 0.8 0.4 0.0 0.4 0.9 0.5 1.2 0.1 1.7 5.6 0.9 0.3 0.5 1.1 1.8 0.8 5.8 1.4 0.4 1.1 7.4 0.5 2.1 11.5 1.0 0.8 1.1 14.9 17.9 19.3 25.3 13.2 9.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 15.8 0.0 0.1 0.7 6.9 1.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 9.6 0.0 17.9 15.2 2.0 13.0 17.9 8.1 1.1 4.7 11.1 14.9 0.6 3.7 13.2 8.4 25.3 19.3 0.7 5.8 9.5 0.3 0.5 0.4 1.0 0.3 0.4 0.5 0.3 0.5 1.1 0.0 10.7 2.7 0.0 0.8 0.0 13.4 0.0 2.7 1.2 0.0 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.2 0.9 0.0 29.0 0.0 4.4 0.0 0.0 0.0 6.6 3.5 0.9 13.0 1.7 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.5 0.0 23.5 0.0 0.0 TSPAN9 NET-5 ENSG00000011105 "Tetraspanin 9" O75954 12 3077355-3286564 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.2;heart muscle: 58.5" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 66.4;Extravillous trophoblasts: 79.2;Syncytiotrophoblasts: 67.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 58.2" "Cell type enhanced" "Detected in single" "gdT-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "RH-30: 63.6" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 125.3" HPA014002 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 1900000 "Nucleoplasm, Golgi apparatus" Cytosol "HPA014002: AB_2304038" "unprognostic (1.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.40e-2)" "unprognostic (1.41e-2)" "unprognostic (1.08e-2)" "unprognostic (3.53e-2)" "unprognostic (3.11e-2)" "unprognostic (7.30e-2)" "prognostic unfavorable (4.67e-4)" "unprognostic (1.08e-2)" "unprognostic (2.88e-2)" "unprognostic (1.26e-2)" "unprognostic (1.89e-1)" "unprognostic (6.70e-2)" "unprognostic (1.57e-1)" "unprognostic (2.68e-2)" "unprognostic (1.04e-2)" 12.7 5.3 2.6 4.0 5.9 0.3 16.2 58.2 11.5 17.6 6.6 3.0 16.1 3.6 20.9 11.2 6.8 8.8 13.8 58.5 2.9 2.7 21.3 25.3 13.6 3.9 2.8 3.3 15.3 6.5 17.4 3.8 27.7 4.5 10.7 2.7 21.8 8.4 17.7 7.1 13.3 5.4 9.5 2.6 8.4 5.6 5.7 2.3 6.0 9.4 9.4 4.3 8.1 13.6 0.0 0.0 0.6 0.1 0.0 1.1 3.6 0.4 3.5 6.0 5.1 4.9 4.7 14.1 6.8 20.6 4.4 5.8 8.2 3.2 0.2 6.8 3.9 4.2 0.9 2.4 2.5 2.6 1.1 2.7 9.3 2.7 5.8 13.5 0.0 0.7 6.0 2.2 9.1 4.2 14.8 15.0 0.3 0.2 0.2 3.8 5.3 0.0 0.2 8.4 2.1 1.9 2.7 63.6 0.8 18.4 1.6 10.7 7.2 4.5 11.5 4.4 12.9 4.0 0.0 8.8 2.4 7.3 3.9 6.4 0.0 0.0 0.0 6.1 0.1 2.6 0.0 0.1 0.0 1.1 0.1 0.3 0.0 0.2 0.6 0.0 0.0 0.2 0.3 0.6 0.0 0.0 0.0 0.0 3.6 2.6 5.9 58.2 11.5 2.9 2.7 2.8 3.3 4.5 2.3 0.0 2.6 0.9 10.8 17.1 66.4 45.8 10.2 1.4 3.4 12.2 2.0 49.9 5.0 16.1 1.4 32.2 2.4 0.0 7.8 79.2 21.2 16.1 0.0 33.3 5.4 31.8 5.8 38.1 3.3 2.4 16.1 0.9 11.8 1.0 2.6 3.3 9.1 0.0 16.3 18.2 4.2 19.4 19.5 1.4 3.4 10.5 67.5 0.0 1.9 9.7 TSPYL1 TSPYL ENSG00000189241 "TSPY like 1" Q9H0U9 6 116276578-116279903 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031970 Supported Supported Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA031970: AB_2674092" "unprognostic (1.05e-2)" "unprognostic (1.09e-1)" "unprognostic (6.11e-2)" "unprognostic (9.99e-2)" "unprognostic (1.70e-1)" "unprognostic (3.54e-2)" "unprognostic (2.46e-1)" "unprognostic (1.04e-1)" "unprognostic (2.76e-1)" "unprognostic (9.18e-3)" "prognostic favorable (5.40e-4)" "unprognostic (5.12e-1)" "prognostic favorable (1.48e-13)" "unprognostic (1.61e-1)" "unprognostic (1.81e-1)" "unprognostic (2.34e-2)" "unprognostic (2.47e-1)" 14.0 34.1 38.3 9.8 67.2 18.5 14.4 49.1 64.5 15.2 12.8 9.8 20.1 14.7 13.9 21.4 15.4 20.3 12.9 21.4 34.6 36.6 31.5 23.5 12.9 11.8 21.8 49.8 22.9 17.6 41.3 17.2 9.7 31.1 27.1 11.3 13.3 17.2 22.6 61.6 11.2 12.9 17.1 11.5 15.6 15.3 12.9 12.2 9.8 25.0 15.5 15.2 14.6 12.9 30.7 24.6 52.9 29.4 17.4 36.2 17.0 13.2 13.0 16.8 30.6 29.8 19.7 14.1 21.3 21.3 19.6 22.5 16.8 9.7 28.4 26.8 24.6 17.6 23.5 13.2 36.4 21.0 11.5 34.4 11.4 19.3 30.4 18.9 18.7 6.9 23.0 28.5 20.1 19.6 20.4 18.6 12.6 20.1 22.1 27.2 29.1 12.4 11.0 8.3 12.7 12.2 11.5 14.5 15.5 33.8 25.9 14.8 14.6 17.7 23.8 10.2 19.9 31.3 23.3 22.4 13.2 11.8 10.6 23.0 12.1 13.1 15.6 21.8 12.2 8.5 52.9 17.8 27.2 24.2 27.7 36.2 25.9 31.7 26.7 14.3 30.7 31.3 30.4 13.5 17.4 29.4 24.6 23.7 17.0 38.3 67.2 49.1 64.5 34.6 36.6 21.8 49.8 31.1 12.2 32.8 41.6 47.2 90.2 147.6 76.3 93.6 53.5 20.1 39.8 99.5 25.5 48.1 131.0 34.9 24.0 35.6 43.4 0.0 38.5 23.1 50.3 71.7 31.1 71.3 35.6 36.5 71.6 63.3 55.3 16.8 69.9 47.1 82.7 28.9 56.9 82.6 40.7 56.1 89.8 169.2 50.8 129.4 74.1 48.1 24.5 141.5 49.9 52.4 55.2 61.6 TSPYL6 ENSG00000178021 "TSPY like 6" Q8N831 2 54253184-54256272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 54 "testis: 41.1" "Group enriched" "Detected in some" 9 "Spermatocytes: 27.4;Spermatogonia: 22.4" "Cancer enriched" "Detected in single" 27 "testis cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 66 "K-562: 13.4" "HPA034699, HPA034700" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA034699: AB_2674288, HPA034700: AB_10670159" "unprognostic (8.21e-2)" "unprognostic (4.25e-1)" "unprognostic (1.06e-2)" "unprognostic (1.00e-1)" "unprognostic (5.54e-6)" "unprognostic (4.50e-2)" "unprognostic (1.77e-1)" "unprognostic (5.73e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 41.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 27.4 22.4 0.0 0.0 0.0 0.0 0.0 TSR1 FLJ10534 ENSG00000167721 "TSR1, ribosome maturation factor" Q2NL82 17 2322503-2337507 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024434, HPA053087" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA024434: AB_1858413, HPA053087: AB_2682040" "unprognostic (1.45e-2)" "unprognostic (1.43e-2)" "unprognostic (1.36e-1)" "unprognostic (1.53e-1)" "unprognostic (4.76e-2)" "unprognostic (2.74e-1)" "unprognostic (1.95e-3)" "unprognostic (9.80e-3)" "unprognostic (6.16e-2)" "unprognostic (2.38e-1)" "unprognostic (6.74e-2)" "unprognostic (1.60e-2)" "unprognostic (8.61e-2)" "unprognostic (1.40e-1)" "unprognostic (5.60e-2)" "unprognostic (1.70e-2)" "unprognostic (9.46e-3)" 15.6 11.8 11.2 14.0 14.1 11.8 14.7 12.5 15.9 10.3 12.8 12.1 11.7 7.9 15.9 10.8 20.0 12.5 10.5 14.8 11.5 9.3 10.6 18.5 9.8 13.3 13.3 12.7 14.5 23.8 14.2 9.6 13.7 11.1 12.6 12.9 10.5 12.8 15.7 42.2 16.2 9.8 20.1 10.6 11.6 12.7 18.3 11.4 14.4 10.7 25.0 15.4 14.2 12.3 8.3 11.4 1.4 10.7 5.6 11.8 5.7 26.8 27.7 12.9 26.0 10.5 12.3 27.2 21.2 11.7 12.9 9.9 44.1 11.2 27.3 19.6 16.6 12.3 23.1 27.8 24.6 16.6 12.9 32.9 20.1 22.3 20.3 14.6 18.6 14.7 12.4 15.4 24.8 28.5 14.1 12.5 14.9 26.5 15.3 15.9 15.5 18.4 9.0 31.8 19.1 16.7 19.9 17.7 19.1 15.9 16.9 9.4 20.9 18.5 14.4 14.5 12.8 13.5 8.1 13.9 18.2 15.3 22.1 40.4 11.5 15.0 16.8 17.8 21.2 22.6 1.4 6.7 1.4 8.9 10.7 11.8 7.5 7.2 7.6 11.4 8.3 7.6 9.0 1.1 5.6 10.3 4.3 8.7 5.7 11.2 14.1 12.5 15.9 11.5 9.3 13.3 12.7 11.1 11.4 29.8 30.6 20.8 29.5 30.6 17.1 16.9 15.3 30.8 42.1 14.0 17.7 25.6 3.3 19.5 61.9 13.5 3.3 0.0 14.2 34.6 17.5 16.0 41.6 12.1 14.1 17.5 9.9 11.1 8.6 57.0 12.0 12.2 15.1 19.0 10.1 11.2 18.8 7.0 11.3 9.8 18.9 19.4 24.7 23.8 50.8 36.0 20.3 12.2 14.4 26.7 TSR2 "DT1P1A10, RP1-112K5.2, WGG1" ENSG00000158526 "TSR2, ribosome maturation factor" Q969E8 X 54440401-54445487 "Disease related genes, Predicted intracellular proteins" "rRNA processing" "Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030514 Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Nucleoli" "Cell Junctions, Cytosol" "HPA030514: AB_10603457" "unprognostic (1.05e-1)" "unprognostic (1.80e-2)" "unprognostic (1.77e-2)" "unprognostic (1.58e-2)" "unprognostic (2.64e-2)" "unprognostic (5.91e-2)" "unprognostic (7.15e-3)" "unprognostic (8.29e-2)" "unprognostic (4.39e-1)" "unprognostic (1.31e-1)" "unprognostic (2.94e-2)" "unprognostic (6.19e-2)" "prognostic favorable (1.21e-6)" "unprognostic (2.27e-1)" "unprognostic (1.13e-1)" "unprognostic (7.93e-3)" "unprognostic (1.80e-3)" 20.8 25.0 52.9 13.8 53.1 15.3 19.2 27.6 44.3 18.2 17.2 30.8 16.9 13.9 18.4 33.9 16.2 21.1 14.8 22.2 45.3 46.2 26.5 23.7 17.5 14.9 53.8 34.4 22.9 17.2 30.7 19.0 19.8 31.0 20.8 20.6 19.0 16.6 25.4 35.5 17.2 14.7 19.7 54.3 18.1 16.5 8.4 27.5 10.2 23.9 10.8 22.0 17.7 16.8 39.6 15.4 28.7 21.2 24.7 41.4 21.1 20.3 26.1 19.1 17.4 17.3 12.5 17.1 20.2 16.5 18.9 16.2 24.6 22.3 22.3 14.0 17.7 33.7 21.1 46.7 28.0 25.2 29.0 23.1 18.2 19.5 19.2 10.7 31.4 19.0 11.6 15.4 26.3 27.2 14.9 13.1 18.8 18.5 16.7 19.2 37.4 23.9 24.8 30.4 18.4 29.7 21.5 35.6 18.9 20.1 18.1 24.2 16.8 38.5 19.3 21.4 34.7 39.2 11.0 17.9 13.9 24.5 29.1 17.2 17.9 27.0 26.7 20.4 25.0 20.8 24.5 15.3 28.7 35.1 20.5 28.8 38.7 33.3 31.8 13.9 39.6 41.4 31.7 9.4 24.7 21.2 15.4 35.5 21.1 52.9 53.1 27.6 44.3 45.3 46.2 53.8 34.4 31.0 27.5 23.8 23.8 40.1 37.8 29.1 55.8 44.8 22.9 45.5 39.8 33.2 25.5 86.7 106.1 35.8 0.8 36.5 26.0 0.0 28.8 60.7 42.6 34.1 43.9 22.9 39.7 54.0 17.4 23.4 12.3 2.1 32.2 27.9 38.8 70.3 30.8 56.3 30.9 28.6 42.5 51.9 48.8 45.3 43.4 12.2 43.7 27.7 63.5 41.1 28.8 29.1 TSSC4 ENSG00000184281 "Tumor suppressing subtransferable candidate 4" Q9Y5U2 11 2400488-2403878 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041801, HPA058763" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041801: AB_10793934, HPA058763: AB_2683811" "unprognostic (1.98e-1)" "unprognostic (9.22e-2)" "unprognostic (8.66e-2)" "unprognostic (1.57e-1)" "unprognostic (3.42e-3)" "unprognostic (8.13e-2)" "prognostic unfavorable (9.91e-4)" "unprognostic (1.06e-1)" "unprognostic (1.97e-1)" "unprognostic (1.13e-1)" "unprognostic (3.29e-2)" "unprognostic (2.80e-1)" "unprognostic (1.33e-1)" "unprognostic (1.27e-1)" "unprognostic (6.50e-2)" "unprognostic (1.32e-2)" "unprognostic (7.38e-2)" 25.6 11.7 12.1 13.9 12.5 33.0 13.2 10.7 20.9 17.5 21.5 12.7 10.9 15.9 20.6 13.3 16.7 16.4 15.1 23.2 11.9 11.0 14.1 19.4 13.8 16.8 15.2 12.7 17.7 20.9 10.3 14.7 19.8 11.2 18.2 5.6 13.1 20.2 19.0 32.5 16.2 16.1 19.0 10.5 18.5 14.0 29.1 10.7 21.7 22.7 25.2 14.7 20.2 36.2 54.0 44.9 55.3 44.7 43.0 49.0 37.3 19.6 24.6 8.1 12.8 6.9 5.0 15.5 13.4 9.3 16.4 11.3 18.1 25.5 14.3 11.9 10.6 18.6 19.5 9.4 15.6 3.1 16.4 25.7 8.3 13.1 18.4 18.8 14.3 17.6 12.0 22.5 10.5 10.0 7.1 11.3 14.6 18.9 16.1 7.7 25.4 17.0 26.0 23.5 15.0 29.0 19.3 7.2 12.8 8.2 16.5 21.0 21.4 11.5 26.0 15.7 4.5 13.6 16.9 14.9 21.7 11.3 20.1 15.5 32.5 27.9 12.0 18.6 14.7 22.5 55.3 44.7 43.8 46.1 38.2 49.0 43.5 45.9 47.2 44.9 54.0 41.4 39.0 43.2 43.0 40.1 43.3 47.8 37.3 12.1 12.5 10.7 20.9 11.9 11.0 15.2 12.7 11.2 10.7 17.9 16.2 42.7 41.3 59.8 34.6 18.3 10.2 4.0 9.1 12.2 11.8 43.5 43.1 51.7 56.0 37.9 61.3 0.0 43.9 40.6 30.5 45.3 17.3 25.6 34.2 27.0 54.9 31.9 25.2 132.0 41.1 33.6 30.4 52.3 30.7 42.1 51.2 49.1 31.8 36.6 29.3 38.8 55.1 87.9 67.3 72.0 68.7 43.7 31.2 45.8 TSSK3 "SPOGA3, STK22C" ENSG00000162526 "Testis specific serine kinase 3" Q96PN8 1 32351521-32364312 "Enzymes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 68.1" "Group enriched" "Detected in some" 52 "Early spermatids: 242.3;Late spermatids: 839.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HeLa: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA037516 Approved "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Nucleoplasm, Nucleoli" "Nuclear bodies" "HPA037516: AB_2675517" "unprognostic (5.71e-2)" "unprognostic (1.42e-1)" "unprognostic (2.32e-1)" "unprognostic (1.37e-1)" "unprognostic (7.69e-2)" "unprognostic (2.02e-4)" "unprognostic (2.06e-1)" "unprognostic (1.98e-3)" "unprognostic (2.05e-2)" "unprognostic (1.11e-1)" "unprognostic (1.46e-2)" "unprognostic (9.20e-2)" "unprognostic (1.02e-3)" "unprognostic (1.11e-2)" "unprognostic (1.51e-1)" "unprognostic (1.88e-1)" "unprognostic (2.68e-3)" 1.1 2.0 0.8 1.7 0.8 8.2 1.1 3.9 0.8 1.3 0.9 0.8 1.4 2.5 1.8 2.9 0.8 1.3 1.0 0.9 0.8 0.0 0.9 1.3 1.4 2.4 0.8 0.8 2.0 1.2 0.0 0.8 0.8 1.0 1.0 0.0 0.8 1.4 0.8 1.7 3.4 2.9 0.8 0.8 3.4 1.2 68.1 0.8 0.8 1.3 0.8 0.8 0.9 1.1 0.6 0.1 0.1 0.7 0.3 2.3 0.1 2.3 2.3 6.0 3.5 0.0 1.2 5.4 0.7 1.1 0.0 0.0 0.5 1.2 1.2 0.9 0.0 1.0 3.7 0.0 0.0 0.0 3.5 7.2 2.7 9.8 3.7 4.4 1.1 3.4 0.1 0.9 0.0 1.3 6.3 0.0 4.6 3.1 5.8 0.0 0.6 1.4 1.5 1.5 0.4 1.2 1.9 1.7 4.4 0.0 1.9 1.8 3.8 0.8 2.8 4.1 4.4 1.9 2.7 2.9 2.1 3.4 3.0 2.4 8.5 2.8 1.8 3.7 3.9 0.5 0.0 0.1 0.0 1.1 0.7 0.0 0.0 0.2 0.0 0.1 0.6 2.3 0.9 0.1 0.3 0.5 0.0 0.0 0.1 0.8 0.8 3.9 0.8 0.8 0.0 0.8 0.8 1.0 0.8 0.0 0.3 0.0 0.4 0.1 0.1 0.3 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.2 242.3 0.0 0.0 0.0 0.6 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 839.4 8.6 0.0 0.0 0.0 0.3 0.9 0.2 0.0 8.9 0.6 1.4 6.5 0.0 10.3 3.8 0.0 0.2 0.0 0.2 0.2 TSTA3 "FX, P35B, SDR4E1" ENSG00000104522 "Tissue specific transplantation antigen P35B" Q13630 8 143612618-143618048 "Enzymes, Predicted intracellular proteins" "Isomerase, Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023361 Approved Approved Nucleoplasm,Cytosol Yes No 600000 Cytosol Nucleoplasm "HPA023361: AB_1858420" "unprognostic (1.37e-2)" "unprognostic (5.35e-2)" "unprognostic (8.62e-3)" "unprognostic (3.55e-2)" "unprognostic (2.90e-1)" "unprognostic (5.82e-2)" "unprognostic (2.48e-2)" "unprognostic (1.98e-1)" "unprognostic (8.62e-2)" "prognostic favorable (2.41e-4)" "unprognostic (6.62e-3)" "unprognostic (6.89e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (4.23e-2)" "unprognostic (2.78e-2)" "unprognostic (1.87e-2)" "unprognostic (3.27e-2)" 9.4 12.0 7.0 9.5 10.1 16.3 10.2 6.1 13.8 8.6 18.7 8.4 16.6 24.8 8.4 9.9 28.0 7.7 23.7 15.7 8.1 7.8 11.7 40.0 8.9 16.5 6.8 8.1 9.7 60.1 6.4 14.2 21.9 12.2 13.9 14.9 9.5 35.4 14.2 16.8 28.4 20.2 6.9 4.7 11.3 35.5 24.6 5.6 14.7 13.0 17.8 24.8 9.8 10.4 18.7 25.6 17.7 21.0 28.1 26.9 20.5 16.4 12.0 6.0 18.0 5.1 4.9 11.2 13.6 13.4 9.7 7.3 14.6 17.5 7.2 13.4 9.6 4.0 11.8 9.1 18.5 4.4 18.6 13.2 10.6 21.2 16.9 10.4 7.1 12.2 6.1 9.6 6.5 23.3 7.9 15.7 12.9 11.8 10.5 7.3 49.8 9.2 10.8 8.2 47.2 16.4 10.6 4.6 22.1 19.6 16.5 12.4 9.7 9.3 18.4 13.7 4.5 23.4 10.4 13.1 6.4 25.6 7.6 13.1 7.9 5.6 5.3 9.9 16.3 9.6 10.5 15.9 17.7 21.0 21.0 21.2 16.1 22.7 22.6 18.0 18.7 16.9 18.7 16.3 28.1 16.3 25.6 26.9 20.5 7.0 10.1 6.1 13.8 8.1 7.8 6.8 8.1 12.2 5.6 14.9 27.3 38.0 42.2 74.1 12.6 12.5 61.1 18.7 12.5 8.7 5.9 73.8 46.4 110.8 79.5 30.8 86.0 46.7 170.3 125.9 25.3 69.4 25.3 62.7 61.4 12.7 59.5 26.4 25.1 197.6 38.0 25.2 28.7 33.3 168.9 16.3 123.1 69.1 32.2 68.8 9.3 12.9 27.2 56.2 48.1 108.3 73.3 42.9 88.1 73.3 TSTD2 "C9orf97, PP4189" ENSG00000136925 "Thiosulfate sulfurtransferase like domain containing 2" Q5T7W7 9 97600080-97633575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022537, HPA024241, HPA064304" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA022537: AB_1845850, HPA024241: AB_1845851, HPA064304: AB_2685238" "unprognostic (7.24e-2)" "unprognostic (5.56e-2)" "unprognostic (1.88e-1)" "unprognostic (2.98e-1)" "unprognostic (4.18e-2)" "unprognostic (1.39e-2)" "unprognostic (1.38e-1)" "unprognostic (7.07e-2)" "unprognostic (1.10e-1)" "unprognostic (1.23e-3)" "unprognostic (9.67e-2)" "unprognostic (1.51e-1)" "prognostic favorable (5.75e-4)" "unprognostic (2.21e-2)" "unprognostic (5.31e-2)" "unprognostic (1.12e-1)" "unprognostic (1.10e-1)" 11.9 11.8 11.9 7.4 11.6 3.3 12.1 18.9 15.1 14.2 12.4 14.9 10.6 6.9 14.8 10.6 10.0 12.7 11.0 14.9 9.8 8.4 12.8 14.4 11.0 8.9 12.4 9.5 17.2 15.7 19.8 17.0 13.9 12.5 12.2 11.3 11.1 10.2 13.1 21.1 9.2 9.7 14.4 13.8 8.7 11.2 11.6 12.4 10.6 16.2 12.1 12.0 14.4 9.7 6.2 6.5 5.2 7.0 11.2 10.4 5.3 10.9 8.6 13.8 8.9 9.3 7.8 12.1 7.2 8.8 9.9 10.4 8.5 3.6 11.4 3.5 9.1 11.9 15.1 12.3 7.0 11.2 7.6 5.5 7.8 9.9 6.4 10.9 11.5 10.3 10.3 12.0 9.6 17.0 9.0 7.5 11.9 13.9 8.6 8.5 5.3 13.6 5.7 11.3 14.0 8.4 11.3 20.4 5.9 6.8 5.0 10.0 7.8 9.2 6.4 8.4 11.1 4.9 6.5 7.9 8.6 8.3 10.1 8.1 12.3 16.1 5.9 7.2 5.8 6.2 4.3 3.9 5.2 6.4 7.0 10.4 5.8 6.4 7.7 6.5 6.2 7.2 6.9 1.6 11.2 5.2 2.9 3.6 5.3 11.9 11.6 18.9 15.1 9.8 8.4 12.4 9.5 12.5 12.4 17.9 11.7 7.8 3.6 1.4 25.8 15.2 7.6 21.4 23.9 1.8 23.6 5.9 14.9 7.4 15.6 6.7 4.9 23.3 6.3 3.6 5.4 4.5 19.7 11.6 4.6 20.6 18.4 6.2 5.7 5.9 7.5 3.5 5.0 4.6 5.1 12.0 9.0 4.3 9.9 6.4 20.3 19.4 5.4 19.0 25.6 3.6 9.2 5.3 4.9 3.3 TTBK1 KIAA1855 ENSG00000146216 "Tau tubulin kinase 1" Q5TCY1 6 43243680-43288259 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.9" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 6.7;Horizontal cells: 4.8;Proximal tubular cells: 1.9" "Cancer enhanced" "Detected in some" "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "SCLC-21H: 21.3;SH-SY5Y: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031735, HPA031736" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA031735: AB_2674019, HPA031736: AB_10670294" "unprognostic (1.68e-1)" "unprognostic (7.88e-3)" "unprognostic (7.01e-2)" "unprognostic (1.62e-3)" "unprognostic (2.18e-1)" "unprognostic (2.24e-4)" "unprognostic (2.46e-3)" "unprognostic (3.01e-2)" "unprognostic (3.09e-1)" "unprognostic (1.85e-1)" "unprognostic (3.01e-2)" "unprognostic (2.12e-4)" "unprognostic (7.42e-2)" "unprognostic (3.68e-1)" "unprognostic (1.32e-1)" "unprognostic (2.64e-3)" "unprognostic (3.04e-4)" 1.1 3.9 12.4 1.3 12.9 0.9 1.0 14.9 28.9 1.0 1.4 8.2 0.0 4.6 1.0 1.0 1.0 1.1 1.4 1.3 10.3 7.5 1.7 3.5 1.1 1.2 7.1 12.5 1.0 1.4 1.6 7.7 1.0 9.0 1.3 1.3 0.7 1.0 1.2 1.0 1.0 6.8 1.1 6.2 1.2 1.3 2.3 8.3 0.0 1.0 0.0 1.3 1.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.1 0.0 0.3 0.0 0.0 0.7 0.0 0.2 0.1 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.6 0.0 0.1 0.0 0.0 0.0 0.0 21.3 8.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 12.4 12.9 14.9 21.7 10.3 7.5 7.1 12.5 9.0 8.3 0.0 0.0 0.0 0.0 0.0 6.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.1 4.8 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.9 0.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 TTC12 "FLJ13859, FLJ20535, TPARM" ENSG00000149292 "Tetratricopeptide repeat domain 12" Q9H892 11 113314529-113383544 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 44.8" "Group enriched" "Detected in many" 6 "Ciliated cells: 78.9;Early spermatids: 130.7;Late spermatids: 140.2;Spermatocytes: 51.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA038542, HPA038543, HPA061364" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA038542: AB_2676072, HPA038543: AB_10674686, HPA061364: AB_2684492" "unprognostic (2.32e-1)" "unprognostic (1.17e-1)" "prognostic favorable (3.14e-4)" "prognostic favorable (2.48e-5)" "unprognostic (2.11e-2)" "unprognostic (3.27e-1)" "unprognostic (1.13e-3)" "unprognostic (3.33e-3)" "unprognostic (7.67e-2)" "unprognostic (1.57e-1)" "unprognostic (6.03e-2)" "unprognostic (5.46e-2)" "prognostic favorable (5.95e-5)" "unprognostic (3.04e-2)" "unprognostic (1.44e-1)" "unprognostic (1.26e-1)" "unprognostic (1.35e-2)" 3.1 6.1 3.8 8.8 5.2 1.3 8.1 3.1 4.4 9.0 4.7 7.3 16.3 2.8 10.8 14.9 4.3 13.1 6.8 5.4 3.5 4.5 7.2 4.4 4.9 9.8 3.9 2.1 6.9 5.1 17.5 25.7 3.4 5.7 9.8 5.1 10.0 9.5 13.1 3.5 4.7 4.2 11.5 4.0 4.2 4.6 44.8 4.7 2.5 12.1 5.9 8.4 7.2 4.6 6.4 4.0 3.1 1.8 2.9 5.7 2.2 3.8 2.4 5.9 6.2 4.3 5.4 3.5 3.5 6.7 4.8 4.6 2.9 10.6 2.0 5.2 0.1 3.9 8.3 0.0 17.0 7.1 2.2 2.7 0.8 7.7 4.3 8.7 0.0 1.4 5.9 6.7 0.0 10.4 9.1 3.4 0.0 3.5 1.4 8.5 4.8 0.0 0.7 3.8 13.3 4.5 0.0 1.0 3.6 8.7 2.8 5.2 7.0 18.2 6.6 3.5 8.4 11.6 2.4 1.2 0.8 4.2 3.6 6.1 1.2 2.0 0.1 4.0 0.4 0.0 0.0 1.8 3.0 3.5 1.8 5.4 4.5 4.7 3.8 4.0 6.4 5.7 5.0 3.1 2.9 1.8 3.3 1.8 2.2 3.8 5.2 3.1 4.4 3.5 4.5 3.9 2.1 5.7 4.7 0.0 4.8 0.5 3.5 1.1 6.7 5.4 7.6 78.9 18.2 5.2 2.0 6.2 5.0 4.9 130.7 1.6 2.6 0.0 4.2 1.5 2.9 2.5 2.3 2.0 2.3 1.6 4.6 0.6 0.6 140.2 3.1 1.2 1.7 1.0 3.2 5.6 4.3 2.6 3.5 7.2 8.7 6.5 1.7 51.6 5.1 1.5 2.3 0.5 3.6 1.8 TTC13 FLJ22584 ENSG00000143643 "Tetratricopeptide repeat domain 13" Q8NBP0 1 230906243-230978875 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018022, HPA051558" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA018022: AB_2211524, HPA051558: AB_2681534" "unprognostic (2.68e-1)" "unprognostic (1.64e-1)" "unprognostic (3.42e-1)" "unprognostic (9.59e-3)" "unprognostic (8.10e-2)" "prognostic favorable (7.66e-4)" "unprognostic (2.60e-2)" "unprognostic (5.40e-3)" "unprognostic (1.97e-1)" "unprognostic (1.80e-2)" "prognostic favorable (4.59e-5)" "unprognostic (2.29e-1)" "prognostic unfavorable (1.60e-11)" "unprognostic (4.48e-2)" "unprognostic (3.01e-1)" "unprognostic (5.96e-2)" "unprognostic (7.54e-3)" 10.5 7.1 8.9 16.6 26.7 13.1 9.6 11.2 12.4 7.3 13.6 12.5 8.6 10.5 9.3 9.2 8.5 9.2 8.9 7.0 9.9 7.9 6.9 9.0 12.2 23.4 13.3 9.3 8.2 13.7 13.5 15.5 9.9 12.6 8.1 21.6 7.9 9.6 9.5 15.6 12.8 15.6 8.4 14.7 21.3 15.6 3.9 13.7 18.4 9.8 6.2 18.9 8.0 9.1 4.2 10.8 7.6 7.7 11.9 10.0 5.1 7.6 7.8 7.7 14.9 7.2 4.7 15.8 11.2 8.8 6.3 7.1 11.4 8.3 14.1 10.3 6.7 6.3 12.3 5.0 4.1 4.2 15.7 15.4 4.2 8.3 7.7 7.6 8.6 3.9 4.1 7.3 5.9 5.5 6.3 11.1 6.1 4.4 8.2 5.8 3.9 4.5 8.2 8.7 25.5 9.7 7.4 11.0 19.6 6.6 5.3 10.6 9.2 8.5 8.8 14.9 3.5 9.4 11.2 5.6 7.5 1.0 10.0 19.7 10.2 16.7 4.3 7.3 5.5 12.2 7.6 7.6 6.8 10.0 5.8 6.8 4.2 7.0 8.2 10.8 3.9 5.7 6.8 2.9 11.9 7.7 7.4 5.4 5.1 8.9 26.7 11.2 12.4 9.9 7.9 13.3 9.3 12.6 13.7 6.0 9.0 9.9 1.2 3.0 4.0 2.5 0.0 0.0 4.5 1.8 5.9 3.7 1.7 4.4 1.4 4.5 2.6 0.0 7.5 4.4 2.8 1.5 9.2 5.9 4.6 11.1 5.8 2.5 7.0 1.7 2.6 7.1 1.7 1.0 10.7 4.0 3.5 8.6 6.3 1.1 10.0 6.5 3.9 2.3 2.4 2.4 1.4 12.8 7.0 1.0 TTC14 "FLJ00166, KIAA1980" ENSG00000163728 "Tetratricopeptide repeat domain 14" Q96N46 3 180602130-180617828 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009295 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA009295: AB_1858425" "unprognostic (2.72e-1)" "unprognostic (4.85e-1)" "unprognostic (1.11e-1)" "unprognostic (1.59e-2)" "unprognostic (1.48e-2)" "unprognostic (1.54e-1)" "unprognostic (2.43e-2)" "unprognostic (1.39e-1)" "unprognostic (1.91e-2)" "unprognostic (2.01e-1)" "unprognostic (3.63e-1)" "unprognostic (2.22e-3)" "unprognostic (2.27e-3)" "unprognostic (1.95e-1)" "unprognostic (2.08e-1)" "unprognostic (8.07e-2)" "unprognostic (2.33e-3)" 17.2 20.3 30.0 30.4 32.0 23.1 20.5 18.2 32.4 22.8 20.8 15.8 25.6 19.3 29.0 37.9 12.7 25.2 16.9 16.8 25.6 15.4 22.3 14.1 18.6 30.7 22.8 28.7 41.9 24.3 33.7 49.0 18.0 22.1 26.4 19.0 15.9 15.5 28.7 11.9 17.8 20.7 17.5 23.8 25.7 19.8 16.6 24.3 41.1 35.2 11.1 23.0 20.3 23.4 14.2 18.2 17.1 13.7 14.3 15.0 5.9 8.7 7.0 11.0 6.4 15.0 12.9 10.5 12.7 10.3 9.3 15.3 9.6 11.8 13.3 13.7 9.1 21.0 12.7 10.3 6.7 12.5 24.4 10.4 12.4 16.2 22.3 11.1 13.2 11.5 16.6 13.1 9.2 4.6 15.3 7.3 17.0 5.2 2.6 10.4 2.5 10.0 1.0 7.8 11.2 14.2 11.8 6.9 14.1 5.3 6.7 9.4 9.3 12.2 6.2 12.0 11.9 22.7 12.9 11.5 18.9 9.7 8.5 23.4 19.9 30.2 29.7 9.0 16.8 8.2 17.1 9.8 10.4 11.6 10.7 14.1 14.2 12.2 11.4 7.4 12.5 15.0 11.9 7.8 14.3 13.7 18.2 10.4 5.9 30.0 32.0 18.2 32.4 25.6 15.4 22.8 28.7 22.1 24.3 8.9 32.3 41.3 27.4 15.8 104.5 11.7 48.4 33.5 31.8 62.8 110.0 27.3 3.3 22.4 5.0 35.9 27.6 0.0 28.2 16.2 30.9 22.4 58.8 23.5 20.7 76.3 37.5 39.9 24.9 4.0 85.7 28.0 28.7 28.9 19.8 67.7 26.1 30.8 76.4 5.6 125.3 84.1 27.8 33.0 28.7 13.4 20.6 50.7 18.3 18.0 TTC21A "IFT139A, STI2" ENSG00000168026 "Tetratricopeptide repeat domain 21A" Q8NDW8 3 39107704-39138903 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 51.9" "Group enriched" "Detected in many" 4 "Ciliated cells: 41.5;Early spermatids: 60.9;Late spermatids: 68.3;Spermatocytes: 73.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 2.0;naive B-cell: 2.7" "Group enriched" "Detected in many" 6 "B-cells: 2.7;monocytes: 1.7" "Cell line enhanced" "Detected in some" "Karpas-707: 3.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035510, HPA035511" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA035510: AB_2674659, HPA035511: AB_10671514" "unprognostic (1.85e-3)" "unprognostic (6.95e-3)" "unprognostic (7.74e-3)" "prognostic favorable (1.79e-4)" "unprognostic (1.55e-1)" "unprognostic (1.58e-5)" "unprognostic (2.29e-2)" "unprognostic (4.93e-2)" "unprognostic (1.33e-1)" "unprognostic (1.15e-1)" "unprognostic (3.01e-4)" "unprognostic (2.19e-2)" "unprognostic (1.29e-3)" "unprognostic (6.54e-2)" "unprognostic (3.35e-1)" "unprognostic (9.76e-2)" "unprognostic (3.91e-4)" 0.9 0.8 2.5 2.2 4.1 0.7 0.8 1.0 2.9 0.9 0.9 2.2 1.9 0.9 1.8 3.0 0.9 2.0 0.7 0.9 2.4 0.8 0.9 0.9 1.0 1.0 0.9 3.6 1.0 2.1 0.9 7.0 0.7 2.9 0.9 0.7 1.4 1.0 0.8 1.0 0.9 0.8 0.6 0.9 0.8 0.9 51.9 1.9 0.0 0.9 0.0 1.6 0.8 0.9 2.7 0.3 0.3 1.7 0.0 0.0 0.1 0.6 1.1 0.3 0.7 0.0 0.7 0.9 1.2 0.9 0.9 0.5 0.0 0.6 2.6 0.0 0.4 0.2 0.5 0.4 1.7 0.2 1.1 0.5 0.1 1.1 0.0 1.3 1.0 0.8 0.9 0.9 0.0 1.3 1.1 0.0 0.7 0.0 3.8 0.0 1.2 0.1 0.4 0.1 0.0 0.0 0.2 0.2 0.4 0.0 1.1 1.3 0.5 1.2 3.0 1.3 0.3 2.9 0.1 0.6 0.3 0.5 2.5 0.5 2.7 0.3 0.2 1.0 0.0 0.6 0.0 0.5 0.0 0.0 1.7 0.0 2.0 0.0 0.0 0.3 2.7 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.1 2.5 4.1 1.0 2.9 2.4 0.8 0.9 3.6 2.9 1.9 0.0 4.0 3.2 3.9 0.6 3.8 5.6 2.5 41.5 5.7 1.8 7.9 1.2 0.0 1.3 60.9 1.8 2.0 0.0 1.6 1.5 1.7 1.9 1.1 1.0 1.3 4.8 4.1 3.7 1.8 68.3 6.6 2.1 3.3 1.0 2.2 3.1 1.4 2.5 5.6 0.8 13.9 6.5 2.3 73.9 3.4 0.5 3.1 1.3 1.9 2.1 TTC24 ENSG00000187862 "Tetratricopeptide repeat domain 24" A2A3L6 1 156579727-156586770 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 13.3;lymphoid tissue: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 13.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "JURKAT: 12.4;MOLT-4: 3.7;REH: 13.9;U-698: 2.7" HPA029799 Approved Nucleoplasm NA NA Nucleoplasm "HPA029799: AB_10601684" "unprognostic (2.43e-3)" "unprognostic (5.61e-5)" "unprognostic (5.86e-2)" "unprognostic (1.39e-1)" "unprognostic (2.62e-1)" "unprognostic (4.48e-6)" "unprognostic (6.26e-2)" "unprognostic (1.49e-2)" "unprognostic (1.17e-1)" "unprognostic (1.20e-1)" "unprognostic (4.42e-1)" "unprognostic (7.96e-2)" "unprognostic (4.87e-9)" "unprognostic (1.07e-2)" "unprognostic (5.19e-2)" "unprognostic (2.22e-2)" "unprognostic (9.76e-4)" 0.2 0.0 0.2 2.7 0.3 2.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.4 0.2 0.1 0.2 0.2 0.2 0.0 0.2 0.2 0.2 8.4 0.2 0.2 0.2 0.2 0.0 3.6 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.6 0.0 2.6 0.2 0.2 5.1 0.4 0.2 0.2 1.4 0.2 0.2 7.5 0.2 0.2 2.2 13.3 0.3 0.0 3.8 1.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 3.7 0.6 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.3 0.0 1.1 0.1 2.2 0.2 1.9 0.3 3.8 0.0 13.3 0.0 0.6 0.2 0.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 TTC3 "DCRR1, RNF105, TPRD, TPRDI, TPRDII, TPRDIII" ENSG00000182670 "Tetratricopeptide repeat domain 3" P53804 21 37073226-37203112 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016810, HPA023964, HPA036304" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "HPA016810: AB_1858434, HPA023964: AB_1858435, HPA036304: AB_2675049" "unprognostic (3.90e-2)" "unprognostic (1.65e-1)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "unprognostic (1.53e-1)" "unprognostic (1.37e-2)" "unprognostic (8.52e-2)" "unprognostic (9.29e-2)" "unprognostic (8.71e-2)" "unprognostic (1.61e-1)" "unprognostic (2.05e-2)" "unprognostic (1.99e-1)" "unprognostic (9.10e-2)" "unprognostic (1.02e-1)" "unprognostic (1.60e-1)" "unprognostic (1.39e-1)" "unprognostic (6.74e-2)" 22.9 22.1 34.0 18.7 36.5 12.0 23.4 39.2 40.0 34.9 20.6 15.9 26.7 13.0 21.6 33.3 15.3 19.5 19.0 21.5 29.1 16.5 21.4 17.0 15.4 14.3 17.7 27.5 34.5 25.8 27.4 50.4 15.2 34.7 28.9 19.9 16.1 24.5 25.4 21.6 16.1 16.8 21.6 21.7 13.6 21.3 19.5 19.9 19.7 35.4 11.1 15.1 23.3 18.9 10.6 12.8 4.8 5.7 9.1 18.6 3.8 21.7 7.8 36.3 6.8 35.0 51.1 12.6 24.0 29.9 10.8 14.7 10.2 11.0 18.8 8.4 40.2 10.1 7.2 10.9 14.8 15.3 19.9 7.8 38.0 11.6 13.4 12.8 21.2 12.3 26.4 9.1 11.0 9.8 21.8 16.0 16.7 22.8 22.1 20.3 16.8 20.6 5.5 10.3 14.5 13.2 27.6 17.4 9.9 12.6 16.9 27.7 21.1 29.8 17.1 15.4 8.7 19.4 8.3 20.9 15.5 6.2 19.0 9.0 22.2 15.9 18.8 25.6 21.2 11.7 2.9 4.4 4.8 9.1 4.8 13.6 9.5 10.6 12.3 7.9 10.6 18.6 11.3 0.7 9.1 5.7 12.8 7.2 3.8 34.0 36.5 39.2 40.0 29.1 16.5 17.7 27.5 34.7 19.9 116.1 118.5 109.7 81.2 58.5 344.6 127.3 56.0 75.0 101.2 71.5 214.0 39.6 140.9 74.9 160.4 67.6 60.1 0.0 65.5 79.7 132.8 164.9 62.4 80.5 56.3 311.4 182.6 102.5 80.0 149.3 194.5 74.4 200.8 61.3 133.8 187.6 72.0 84.2 245.4 81.7 228.9 51.8 103.8 264.1 280.4 54.8 44.1 76.7 118.3 90.4 TTC30A "FLJ13946, IFT70A" ENSG00000197557 "Tetratricopeptide repeat domain 30A" Q86WT1 2 177612992-177618966 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.5" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 29.4;Early spermatids: 31.2;Spermatocytes: 33.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA051714, HPA052100, HPA052487" Supported Approved Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA051714: AB_2681583, HPA052100: AB_2681726, HPA052487: AB_2681848" "unprognostic (7.75e-2)" "unprognostic (3.83e-3)" "unprognostic (2.16e-1)" "unprognostic (3.00e-2)" "unprognostic (1.17e-3)" "unprognostic (1.36e-2)" "unprognostic (1.24e-1)" "unprognostic (3.79e-1)" "unprognostic (4.10e-2)" "unprognostic (1.58e-1)" "unprognostic (1.10e-1)" "unprognostic (1.78e-2)" "unprognostic (1.85e-1)" "unprognostic (5.84e-3)" "unprognostic (1.41e-1)" "unprognostic (4.67e-3)" "unprognostic (6.07e-2)" 2.7 4.1 3.8 1.5 7.1 0.4 5.6 2.2 7.1 4.2 3.4 5.9 7.8 2.2 5.0 10.9 2.4 8.4 4.8 4.4 3.7 4.2 6.9 4.6 3.7 1.4 3.6 6.6 5.5 4.4 11.6 8.1 1.9 4.8 3.9 3.3 5.0 8.1 4.0 3.5 1.9 2.5 3.6 3.0 1.7 3.6 24.5 2.1 2.6 9.6 4.6 1.7 3.1 1.7 0.5 1.6 1.9 1.6 0.2 2.7 1.0 5.7 3.3 3.3 0.0 6.7 5.6 2.4 2.8 8.1 5.0 5.3 1.0 4.2 1.3 5.4 4.8 6.8 4.8 2.2 6.1 5.5 0.4 1.8 1.1 1.6 1.4 2.7 1.4 1.3 3.4 4.0 2.8 1.1 4.8 2.3 2.9 0.8 0.5 3.5 2.9 4.4 2.6 1.8 2.0 1.2 2.9 8.8 0.6 6.3 1.5 10.8 7.2 2.5 4.9 3.0 8.1 2.8 1.4 2.1 3.1 1.9 3.4 2.3 2.2 2.1 0.4 7.7 0.1 3.0 0.0 1.3 1.9 0.4 1.6 0.1 0.4 0.1 0.4 1.6 0.5 2.7 1.2 0.7 0.2 1.3 0.6 1.0 1.0 3.8 7.1 2.2 7.1 3.7 4.2 3.6 6.6 4.8 2.1 8.9 1.9 0.0 1.1 0.7 2.2 3.1 2.5 29.4 4.5 7.0 2.0 0.8 1.7 4.1 31.2 1.4 1.7 0.0 3.5 0.7 1.5 1.0 0.0 2.9 0.7 15.9 6.9 4.3 0.3 6.8 2.0 0.2 1.7 0.0 2.5 10.6 2.4 0.0 2.1 3.8 11.3 0.0 0.9 33.6 4.6 0.4 0.2 0.0 2.3 0.3 TTC30B "fleer, FLJ30990, IFT70B" ENSG00000196659 "Tetratricopeptide repeat domain 30B" Q8N4P2 2 177548998-177553014 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 42.8;Spermatocytes: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA051714, HPA052100, HPA052487" Supported Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA051714: AB_2681583, HPA052100: AB_2681726, HPA052487: AB_2681848" "unprognostic (5.76e-2)" "unprognostic (5.29e-2)" "unprognostic (2.15e-2)" "unprognostic (9.10e-2)" "unprognostic (1.03e-1)" "unprognostic (1.99e-1)" "unprognostic (3.89e-2)" "unprognostic (3.26e-1)" "unprognostic (5.45e-2)" "unprognostic (2.75e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-1)" "unprognostic (5.27e-2)" "unprognostic (9.77e-2)" "unprognostic (9.61e-2)" "unprognostic (9.25e-3)" "unprognostic (1.65e-1)" 2.4 4.6 4.4 1.9 4.9 0.7 10.5 3.2 5.1 4.8 4.0 7.7 3.8 3.1 4.9 8.9 3.7 13.2 4.5 2.3 3.9 3.8 10.8 4.3 5.5 2.5 3.1 1.5 6.0 5.2 8.0 7.0 3.3 3.4 3.5 3.7 4.5 4.4 4.2 1.2 3.0 3.7 3.1 5.2 3.1 4.7 11.5 2.9 7.7 10.4 1.6 2.8 3.3 2.2 3.2 3.9 6.5 3.4 1.9 2.2 1.6 2.8 4.3 5.7 1.1 5.1 6.0 3.9 1.8 5.3 4.7 5.0 2.4 7.1 1.1 4.7 3.3 5.4 7.0 6.8 7.2 4.5 1.6 3.4 2.0 2.7 2.1 4.3 2.5 3.5 4.9 6.8 4.6 3.5 5.7 3.7 5.4 2.6 1.0 2.8 4.8 5.0 3.9 2.6 3.9 1.1 3.9 4.9 1.2 7.0 3.1 13.9 7.8 2.1 4.9 3.3 8.1 5.0 4.8 3.2 2.6 1.4 3.3 1.5 2.6 2.9 0.3 5.9 1.0 4.3 6.5 3.4 2.8 1.7 3.3 1.1 1.4 1.2 1.8 3.9 3.2 2.2 2.2 2.0 1.9 2.2 2.8 1.0 1.6 4.4 4.9 3.2 5.1 3.9 3.8 3.1 1.5 3.4 2.9 3.0 2.9 0.5 0.4 0.6 2.1 0.8 5.1 42.8 9.1 0.0 2.0 2.1 5.0 3.6 6.2 1.6 2.3 0.0 2.5 1.1 2.1 0.5 1.1 2.4 1.1 4.8 1.2 2.5 1.8 4.0 1.4 1.0 1.7 0.0 2.5 6.6 2.4 0.0 2.1 3.7 11.0 0.0 1.3 23.3 3.4 0.6 0.5 0.5 2.3 0.1 TTC31 FLJ12788 ENSG00000115282 "Tetratricopeptide repeat domain 31" Q49AM3 2 74483073-74494886 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041783 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA041783: AB_10794306" "unprognostic (2.38e-2)" "unprognostic (7.44e-2)" "unprognostic (3.87e-2)" "prognostic unfavorable (6.70e-4)" "unprognostic (2.64e-1)" "unprognostic (7.78e-2)" "unprognostic (1.05e-1)" "unprognostic (2.89e-2)" "unprognostic (6.56e-2)" "unprognostic (7.22e-2)" "unprognostic (7.61e-2)" "unprognostic (1.13e-2)" "unprognostic (1.46e-3)" "unprognostic (9.61e-2)" "unprognostic (3.24e-1)" "unprognostic (4.83e-2)" "prognostic favorable (2.49e-4)" 9.2 8.9 7.4 12.3 11.7 11.5 8.6 13.8 9.3 9.0 15.7 8.6 5.3 10.5 11.6 9.4 8.7 7.9 14.5 7.4 8.9 3.7 9.9 23.6 8.2 10.4 10.4 7.7 9.7 13.4 13.2 10.0 13.7 8.3 8.0 9.5 10.5 8.1 7.5 6.5 11.1 16.2 9.3 7.0 13.6 11.6 8.6 12.2 11.5 7.7 9.7 11.5 10.6 8.5 9.3 9.7 8.1 10.2 7.5 9.0 7.8 11.1 10.1 6.6 3.4 3.8 11.3 7.7 6.2 8.6 11.3 7.9 8.6 8.3 15.7 4.9 4.9 10.4 8.1 6.1 6.7 5.6 17.2 6.3 16.7 9.0 14.7 7.5 6.8 11.1 8.2 9.0 9.6 6.0 7.6 7.6 7.2 11.1 6.7 7.0 10.3 10.1 4.0 4.1 8.2 5.0 10.0 17.3 7.4 6.2 8.3 3.3 12.2 5.8 9.1 6.3 3.8 6.8 3.8 14.0 7.8 12.9 4.8 9.1 9.9 7.9 10.2 9.6 7.9 7.2 6.4 10.2 8.1 8.4 10.2 9.0 9.3 6.5 8.0 9.7 7.3 6.3 6.8 1.4 7.5 10.2 5.7 8.3 7.8 7.4 11.7 13.8 9.3 8.9 3.7 10.4 7.7 8.3 12.2 14.9 8.6 11.5 3.5 2.5 10.2 2.9 12.7 4.0 9.1 8.7 37.3 7.1 1.7 4.7 3.3 4.5 8.1 0.0 4.8 4.3 3.5 2.7 18.5 18.6 7.3 4.8 5.8 4.3 7.3 3.8 5.8 7.8 3.3 10.8 5.3 8.1 4.8 5.5 5.3 5.0 22.2 6.5 4.1 8.9 8.7 2.9 6.8 7.5 6.3 3.3 TTC32 ENSG00000183891 "Tetratricopeptide repeat domain 32" Q5I0X7 2 19896643-19901986 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 86.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036024 Approved Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA036024: AB_10673493" "unprognostic (2.77e-3)" "unprognostic (5.44e-2)" "unprognostic (8.85e-2)" "unprognostic (8.80e-3)" "unprognostic (1.08e-1)" "unprognostic (2.62e-1)" "unprognostic (5.25e-2)" "prognostic favorable (9.44e-4)" "unprognostic (4.46e-2)" "unprognostic (1.48e-2)" "unprognostic (4.92e-3)" "unprognostic (6.22e-2)" "prognostic unfavorable (5.45e-6)" "unprognostic (1.21e-1)" "unprognostic (1.40e-1)" "unprognostic (1.72e-2)" "unprognostic (2.27e-2)" 11.8 8.9 12.8 10.8 24.7 30.1 17.4 24.1 18.9 10.8 11.0 17.5 11.9 11.5 13.6 28.5 7.8 11.8 11.8 7.3 14.9 11.8 9.4 12.6 10.1 13.7 29.6 9.2 16.9 8.7 13.4 17.0 8.2 16.9 16.6 10.4 14.5 11.4 13.1 19.6 14.2 12.1 9.4 18.4 13.9 10.6 12.9 23.6 15.5 13.7 12.9 9.5 11.9 11.7 9.3 5.4 21.6 5.9 4.5 12.8 3.8 14.4 9.2 8.3 6.1 3.8 8.3 1.7 3.1 5.3 5.3 3.5 4.6 16.7 9.1 1.8 3.3 6.4 9.2 3.9 10.3 3.4 13.3 15.8 9.3 12.3 8.3 8.2 9.1 16.8 7.8 6.3 5.8 14.1 4.2 4.9 15.0 17.3 18.8 4.4 4.4 6.5 13.5 6.5 5.6 16.3 7.8 5.6 15.3 14.5 5.7 13.7 12.8 10.8 5.8 11.5 10.2 7.9 3.5 3.4 7.4 8.2 7.7 4.2 19.0 17.3 15.4 12.0 8.9 4.3 6.1 5.9 16.5 5.9 4.3 6.7 8.8 9.2 6.1 5.4 9.3 12.8 9.7 21.6 4.5 4.8 3.8 10.9 3.8 12.8 24.7 24.1 18.9 14.9 11.8 29.6 9.2 16.9 23.6 8.9 11.8 18.3 25.0 16.8 36.8 13.2 12.7 44.2 14.8 12.2 13.7 11.6 38.1 9.2 12.5 15.7 9.3 0.0 21.9 9.3 13.9 17.2 8.1 23.3 8.0 39.7 27.2 5.5 7.1 4.6 18.4 17.0 6.8 11.8 16.5 44.9 10.9 15.0 9.2 18.7 34.7 12.9 16.5 86.3 21.3 22.8 8.0 17.3 13.6 17.4 TTC33 OSRF ENSG00000113638 "Tetratricopeptide repeat domain 33" Q6PID6 5 40512333-40755975 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038252, HPA038253" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "HPA038252: AB_10674551, HPA038253: AB_10671739" "unprognostic (2.86e-1)" "unprognostic (1.11e-1)" "unprognostic (1.18e-2)" "unprognostic (1.17e-1)" "unprognostic (2.70e-2)" "unprognostic (1.13e-1)" "unprognostic (3.41e-3)" "unprognostic (1.04e-3)" "unprognostic (3.01e-2)" "unprognostic (1.99e-1)" "unprognostic (2.01e-1)" "unprognostic (2.60e-1)" "prognostic favorable (1.83e-4)" "unprognostic (8.50e-2)" "unprognostic (1.29e-1)" "unprognostic (2.04e-2)" "unprognostic (4.28e-3)" 11.0 11.8 13.5 6.9 27.7 1.5 11.0 20.4 20.1 11.7 9.9 6.4 8.1 8.2 12.3 7.8 9.1 10.1 9.0 13.4 11.5 12.1 14.7 15.0 9.0 8.9 8.8 19.4 15.2 8.6 15.6 15.1 9.0 13.1 11.5 9.2 7.3 9.3 10.6 24.2 6.4 9.1 10.5 9.5 8.4 8.7 9.0 9.8 14.3 12.8 5.5 9.2 10.8 9.0 7.2 5.3 15.9 10.8 7.8 10.0 8.2 5.2 4.6 9.0 11.5 6.3 9.1 4.1 7.2 7.6 7.9 8.1 2.3 5.5 16.6 4.4 5.4 9.3 2.8 8.6 3.9 13.1 18.7 6.5 3.6 15.6 6.5 6.4 9.3 5.3 5.4 7.4 7.4 7.6 9.9 10.9 10.5 8.4 12.8 9.5 1.3 16.4 9.1 2.7 3.6 4.5 15.9 17.9 9.3 8.4 3.2 6.5 7.4 18.1 8.9 9.7 7.3 7.1 10.6 7.5 9.5 8.6 6.0 5.9 10.5 11.3 9.0 6.4 12.5 7.5 15.9 6.1 11.1 8.1 9.0 8.7 7.2 8.5 7.5 5.3 6.9 10.0 8.0 9.0 7.8 10.8 3.9 9.0 8.2 13.5 27.7 20.4 20.1 11.5 12.1 8.8 19.4 13.1 9.8 14.9 6.1 11.5 4.6 12.8 12.1 15.9 5.1 14.7 4.5 7.0 5.9 4.5 16.6 6.9 9.6 11.3 5.8 0.0 5.4 3.4 12.8 5.9 12.7 7.9 4.6 4.8 2.9 11.1 8.2 5.9 13.0 6.3 10.1 18.0 6.8 17.3 6.6 7.0 13.1 8.5 20.6 12.9 11.3 27.0 15.7 15.9 2.2 7.5 5.8 4.0 TTC36 HBP21 ENSG00000172425 "Tetratricopeptide repeat domain 36" A6NLP5 11 118527472-118531197 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 53.9" "Group enriched" "Detected in some" 12 "Hepatocytes: 410.0;Proximal tubular cells: 138.6" "Group enriched" "Detected in some" 7 "breast cancer: 5.0;liver cancer: 12.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.4" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "SK-BR-3: 12.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038731 Enhanced Uncertain Nucleoplasm NA NA 20000 Nucleoplasm "HPA038731: AB_10672651" "unprognostic (1.57e-3)" "unprognostic (2.58e-3)" "unprognostic (1.16e-1)" "unprognostic (6.50e-2)" "unprognostic (1.02e-2)" "unprognostic (2.17e-1)" "prognostic favorable (1.81e-5)" "unprognostic (6.32e-2)" "unprognostic (8.80e-2)" "unprognostic (6.14e-2)" "unprognostic (4.77e-3)" "unprognostic (3.38e-2)" "unprognostic (5.77e-7)" "unprognostic (5.60e-2)" "unprognostic (2.24e-1)" "unprognostic (1.59e-1)" "unprognostic (8.95e-3)" 2.9 0.4 0.2 0.4 0.3 0.0 3.7 0.6 0.2 0.1 5.5 0.1 0.1 3.4 0.3 8.3 0.1 0.1 0.6 0.7 0.1 0.2 3.2 53.9 0.2 0.1 0.1 0.1 0.1 0.3 0.0 0.5 0.1 0.1 0.2 0.0 0.1 1.0 0.6 0.4 0.1 2.4 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.8 2.4 0.0 0.0 0.7 0.5 0.0 0.2 0.2 0.2 0.8 0.0 0.0 2.7 0.4 0.0 0.0 0.0 0.2 0.5 0.3 1.7 0.0 0.0 0.8 0.1 0.0 0.0 1.5 2.0 0.1 0.1 0.5 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.8 0.2 0.0 0.0 0.5 0.0 0.5 0.0 2.7 0.6 0.5 1.3 0.0 0.0 0.7 1.7 0.6 12.4 0.0 0.1 2.2 0.0 0.3 0.0 0.9 0.0 0.2 1.1 1.4 1.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.8 0.2 0.3 0.2 0.1 0.5 0.0 0.0 0.7 0.0 2.4 0.0 0.0 0.2 0.3 0.6 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 4.3 0.6 0.2 0.0 0.3 7.6 0.0 0.0 12.2 0.0 0.8 14.9 0.3 0.0 0.0 1.7 23.3 0.4 0.2 0.0 3.0 0.0 410.0 0.1 0.0 2.4 10.4 11.0 0.0 0.3 0.0 0.0 1.0 2.6 0.5 0.3 0.2 0.0 138.6 0.7 0.0 0.1 0.2 0.0 0.1 1.7 0.0 1.0 1.0 TTC37 "KIAA0372, THES" ENSG00000198677 "Tetratricopeptide repeat domain 37" Q6PGP7 5 95463895-95555007 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037905 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA037905: AB_10673034" "unprognostic (5.99e-2)" "unprognostic (7.65e-3)" "prognostic favorable (2.62e-4)" "unprognostic (8.48e-2)" "unprognostic (9.49e-2)" "unprognostic (5.39e-2)" "unprognostic (1.40e-2)" "unprognostic (2.18e-1)" "unprognostic (6.88e-2)" "unprognostic (5.97e-2)" "unprognostic (6.81e-3)" "unprognostic (2.51e-1)" "unprognostic (3.30e-3)" "unprognostic (6.88e-3)" "unprognostic (3.91e-1)" "unprognostic (3.98e-2)" "unprognostic (7.90e-3)" 29.6 21.8 18.9 16.1 19.4 6.9 19.2 35.7 37.9 21.1 19.7 8.2 20.7 15.6 17.3 15.5 27.5 14.8 13.7 17.5 20.2 14.1 28.2 25.2 17.1 13.8 21.5 21.5 21.3 22.2 40.2 42.1 20.7 26.5 21.1 16.8 6.6 16.8 17.4 33.1 23.9 22.7 21.5 29.8 16.0 18.8 9.1 25.0 25.2 19.7 23.5 15.3 28.1 16.1 10.3 14.8 3.5 7.4 8.2 12.0 3.7 12.4 13.3 16.9 5.8 28.4 38.7 15.1 23.8 19.3 15.5 23.4 14.1 9.2 22.0 15.8 22.6 16.2 12.3 21.3 28.8 26.1 12.8 17.4 14.8 27.0 9.3 24.3 9.5 10.7 25.6 14.8 19.8 27.8 24.0 24.5 7.4 11.6 14.5 29.3 7.1 12.4 7.7 9.5 5.7 11.3 10.6 23.7 23.1 17.2 9.8 21.2 16.6 19.6 9.7 21.8 14.8 15.1 8.2 33.7 21.3 12.2 16.7 18.2 14.0 17.6 20.5 21.5 14.1 27.3 3.5 6.0 2.1 9.9 7.4 12.0 9.6 9.7 8.0 7.2 10.3 10.0 10.4 0.2 8.2 6.7 14.8 8.8 3.7 18.9 19.4 35.7 37.9 20.2 14.1 21.5 21.5 26.5 25.0 71.5 37.6 23.1 17.3 17.3 59.4 74.7 12.7 45.5 47.8 26.2 47.1 24.9 13.3 32.7 1.2 35.9 25.6 0.0 34.8 37.4 22.4 24.3 39.4 30.6 23.4 55.6 31.2 33.2 29.8 1.5 57.8 23.5 8.5 54.1 32.2 20.3 37.0 14.0 60.8 25.9 34.0 38.8 24.7 6.5 8.3 28.7 16.6 21.8 31.5 16.5 TTC39C "C18orf17, FLJ33761, HsT2697" ENSG00000168234 "Tetratricopeptide repeat domain 39C" Q8N584 18 23992773-24135610 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 92.2" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 120.1;Hepatocytes: 148.6;Late spermatids: 236.0;Rod photoreceptor cells: 233.7" "Cancer enhanced" "Detected in all" "liver cancer: 19.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in many" 4 "T-cells: 35.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065705, HPA065713" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA065705: AB_2685538, HPA065713: AB_2685542" "prognostic favorable (1.48e-4)" "unprognostic (6.37e-2)" "unprognostic (3.66e-1)" "unprognostic (9.97e-2)" "unprognostic (4.37e-2)" "unprognostic (2.20e-3)" "unprognostic (1.13e-2)" "unprognostic (1.30e-3)" "unprognostic (2.31e-1)" "unprognostic (1.03e-1)" "unprognostic (1.78e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (2.60e-5)" "unprognostic (2.32e-1)" "unprognostic (3.51e-1)" "unprognostic (8.94e-3)" "unprognostic (4.48e-3)" 9.0 14.2 6.2 12.0 4.9 17.7 10.9 5.1 12.2 8.7 6.3 2.4 1.5 5.1 9.8 6.5 9.4 9.0 17.2 3.9 5.3 2.7 3.3 92.2 7.1 14.1 2.2 6.7 5.9 9.8 1.3 13.4 1.5 6.2 9.7 4.6 20.8 11.8 3.9 4.7 24.2 6.2 5.3 2.2 6.7 6.1 14.3 1.0 12.0 3.7 5.7 20.9 8.3 9.3 5.2 8.8 0.5 1.9 5.7 35.5 4.2 6.6 4.9 3.3 2.2 21.1 22.3 12.1 9.5 21.8 7.6 7.8 0.6 3.7 10.9 9.4 16.6 5.7 8.3 6.5 8.3 6.1 16.3 6.7 3.2 23.9 12.3 4.1 17.1 8.5 18.0 11.3 4.3 6.1 14.1 0.5 7.9 0.1 0.1 4.8 5.1 2.8 5.2 8.2 2.9 12.7 15.7 5.0 4.2 7.9 10.1 8.8 7.0 18.4 6.1 5.8 3.6 4.8 6.3 4.2 6.7 5.0 5.1 4.8 0.2 0.0 15.9 9.0 17.9 4.5 0.5 1.9 0.0 11.2 1.9 28.8 5.2 24.9 14.0 2.5 3.3 10.7 9.0 0.5 5.7 1.5 8.8 35.5 4.2 6.2 4.9 5.1 12.2 5.3 2.7 2.2 6.7 6.2 1.0 0.0 4.3 22.3 15.8 40.9 14.4 3.1 53.5 12.0 2.3 7.0 43.2 0.5 0.0 9.7 120.1 3.0 2.2 0.0 10.1 12.5 12.4 19.8 2.3 148.6 11.3 12.7 4.1 4.9 24.7 236.0 10.3 20.8 13.5 1.8 9.0 20.5 8.2 0.0 7.4 1.1 233.7 0.0 8.3 23.8 1.7 75.3 0.5 59.9 4.6 16.7 TTC5 Strap ENSG00000136319 "Tetratricopeptide repeat domain 5" Q8N0Z6 14 20256558-20305994 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045008, HPA054198" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA045008: AB_10960209, HPA054198: AB_2682414" "unprognostic (2.19e-3)" "unprognostic (1.00e-1)" "unprognostic (1.94e-1)" "unprognostic (1.47e-1)" "unprognostic (1.39e-2)" "unprognostic (6.48e-2)" "unprognostic (8.15e-2)" "unprognostic (6.82e-2)" "unprognostic (4.68e-2)" "unprognostic (1.03e-1)" "unprognostic (8.32e-2)" "unprognostic (3.29e-1)" "prognostic favorable (8.54e-4)" "unprognostic (3.01e-1)" "unprognostic (1.77e-1)" "unprognostic (1.10e-1)" "unprognostic (5.07e-2)" 5.6 7.2 11.2 4.6 13.1 5.7 8.7 9.6 11.7 7.6 4.9 7.3 3.1 4.9 8.7 7.6 5.5 13.0 5.0 4.2 10.5 10.0 8.2 3.3 5.8 6.5 6.9 7.2 7.9 7.6 15.3 12.3 5.5 9.2 8.9 5.5 5.2 6.9 7.3 2.8 7.6 4.8 6.7 6.0 5.2 5.5 5.7 9.0 6.5 11.1 2.5 7.6 5.6 6.0 7.1 5.2 6.7 6.0 6.5 6.8 4.9 3.9 6.5 8.1 0.8 6.0 8.8 4.4 5.2 6.1 7.9 8.2 3.0 9.2 8.5 3.3 5.5 4.1 3.4 7.8 3.6 12.3 7.4 3.0 7.1 2.9 5.1 6.0 12.8 4.4 5.3 8.2 6.9 9.0 7.2 7.7 6.3 5.0 4.3 7.8 5.5 7.5 5.4 6.7 6.6 6.2 4.0 5.9 6.2 7.0 4.3 2.8 5.4 5.9 6.3 3.6 3.5 5.0 6.3 7.9 3.1 5.1 4.2 2.8 6.2 5.5 10.7 2.5 5.5 7.3 2.5 4.7 6.7 6.8 4.8 5.8 6.5 5.0 5.5 5.2 7.1 5.3 6.4 2.0 6.5 6.0 3.7 5.8 4.9 11.2 13.1 9.6 11.7 10.5 10.0 6.9 7.2 9.2 9.0 11.9 7.4 12.6 8.6 5.7 14.7 3.9 12.7 21.4 4.5 17.4 15.7 15.9 10.0 8.9 1.2 10.9 2.4 0.0 5.7 10.8 9.4 4.6 11.5 4.7 13.2 4.8 8.6 10.4 9.1 1.9 9.5 7.9 6.8 9.0 6.1 10.6 5.6 3.5 9.2 11.0 19.9 6.5 11.1 24.0 36.1 7.5 3.9 14.9 7.8 5.5 TTC9B FLJ30373 ENSG00000174521 "Tetratricopeptide repeat domain 9B" Q8N6N2 19 40216058-40218399 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "brain: 47.9" "Cell type enhanced" "Detected in some" 26 "Bipolar cells: 37.7;Horizontal cells: 17.5;Rod photoreceptor cells: 7.3" "Cancer enriched" "Detected in single" 15 "glioma: 4.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.1" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 19 "SCLC-21H: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042496 Approved Approved Nucleoplasm,Vesicles,Mitochondria "Secreted in brain" NA NA "Nucleoplasm, Mitochondria" Vesicles "HPA042496: AB_10795506" "unprognostic (2.31e-1)" "unprognostic (1.39e-4)" "unprognostic (5.09e-2)" "unprognostic (5.24e-2)" "unprognostic (8.47e-2)" "unprognostic (1.05e-1)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (7.95e-2)" "unprognostic (2.78e-1)" "unprognostic (1.54e-2)" "unprognostic (3.69e-1)" "unprognostic (8.75e-6)" "unprognostic (1.39e-1)" "unprognostic (8.23e-2)" "unprognostic (1.95e-1)" "unprognostic (5.24e-2)" 1.0 1.8 45.5 1.4 10.3 1.0 1.0 24.6 47.9 1.0 1.2 1.2 0.0 1.1 1.0 1.0 1.0 1.0 1.0 1.0 22.3 14.0 1.0 1.0 1.0 1.0 7.5 9.9 1.0 1.0 1.0 0.0 1.0 7.1 1.0 1.0 0.3 1.0 1.0 1.0 1.0 1.2 1.1 2.5 1.0 1.1 1.1 1.0 0.0 1.0 0.0 1.0 1.0 0.0 0.1 0.5 0.0 1.1 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 25.1 1.3 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.2 0.4 0.1 0.0 0.3 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.3 0.0 45.5 10.3 24.6 31.3 22.3 14.0 7.5 9.9 7.1 1.0 0.0 0.0 0.0 0.0 0.0 37.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 17.5 1.7 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 1.3 0.1 0.2 0.7 0.0 7.3 0.0 0.0 1.0 2.3 0.0 0.0 0.0 0.2 0.1 TTC9C MGC29649 ENSG00000162222 "Tetratricopeptide repeat domain 9C" Q8N5M4 11 62728069-62740293 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055169 Approved Approved Nucleoplasm NA Yes Nucleoplasm "HPA055169: AB_2682724" "unprognostic (1.47e-1)" "unprognostic (1.02e-1)" "unprognostic (2.71e-2)" "unprognostic (7.23e-3)" "unprognostic (2.17e-1)" "unprognostic (6.56e-3)" "unprognostic (1.86e-3)" "unprognostic (1.52e-1)" "unprognostic (5.66e-2)" "unprognostic (6.90e-3)" "unprognostic (1.33e-3)" "unprognostic (1.57e-1)" "prognostic unfavorable (4.67e-7)" "prognostic favorable (4.15e-5)" "unprognostic (7.49e-2)" "unprognostic (3.55e-2)" "unprognostic (1.53e-2)" 17.1 19.0 23.4 20.9 24.2 6.5 18.4 26.2 29.3 19.1 19.3 15.8 21.2 25.0 22.9 21.6 18.0 22.6 18.7 13.2 21.5 22.6 20.9 17.2 16.4 28.2 20.4 20.0 32.9 22.3 12.3 18.3 23.1 22.3 18.5 18.8 16.7 21.6 20.0 21.1 24.4 18.2 19.0 17.0 23.2 18.4 17.0 17.5 31.1 24.3 13.3 27.9 21.3 18.0 25.2 20.2 31.0 23.9 16.8 22.7 14.0 20.2 17.5 14.6 14.3 20.1 24.4 10.8 20.8 21.4 25.7 21.2 15.5 20.2 15.4 39.8 14.6 22.3 18.4 21.6 6.5 20.0 40.1 10.8 17.0 25.6 18.6 23.1 11.4 19.0 16.1 13.9 20.8 21.1 18.6 18.8 18.6 12.3 15.6 24.4 14.8 18.1 24.3 12.4 16.5 13.9 14.4 18.6 23.3 16.2 8.0 12.8 10.5 18.0 16.0 25.2 13.5 21.0 11.0 16.2 26.3 15.3 29.0 14.9 16.4 24.6 17.1 14.3 8.8 13.6 31.0 23.9 23.1 14.4 21.3 11.0 25.2 15.4 14.2 20.2 22.6 15.4 13.9 15.3 16.8 13.8 20.2 22.7 14.0 23.4 24.2 26.2 29.3 21.5 22.6 20.4 20.0 22.3 17.5 14.9 10.4 25.9 12.6 26.3 17.1 7.0 7.6 13.4 15.9 17.4 7.9 29.1 23.2 20.0 18.9 21.4 16.9 0.0 13.1 36.2 23.8 13.9 8.1 7.8 33.4 27.0 5.8 13.5 24.8 15.9 26.2 19.0 15.1 42.3 12.6 13.2 18.1 18.2 25.8 20.6 16.8 32.3 18.4 27.7 26.6 29.1 19.9 20.8 15.3 17.6 TTF1 ENSG00000125482 "Transcription termination factor 1" Q15361 9 132375548-132406851 "Predicted intracellular proteins" "Transcription, Transcription regulation, Transcription termination" "DNA replication inhibitor, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054837 Supported Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA054837: AB_2682621" "unprognostic (7.07e-2)" "unprognostic (5.62e-3)" "unprognostic (9.12e-2)" "unprognostic (6.05e-2)" "unprognostic (1.66e-1)" "unprognostic (1.22e-1)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.07e-1)" "unprognostic (9.21e-3)" "unprognostic (3.08e-1)" "unprognostic (1.33e-1)" "unprognostic (6.95e-3)" "unprognostic (2.09e-2)" "unprognostic (5.93e-3)" "unprognostic (8.38e-2)" "unprognostic (3.44e-1)" "unprognostic (4.71e-2)" 10.3 6.6 9.9 12.6 14.6 18.0 12.5 15.0 13.4 10.3 12.1 8.5 13.8 6.2 11.9 12.1 8.5 9.6 6.8 16.6 9.8 8.5 8.3 6.2 8.9 12.2 10.4 11.3 11.8 8.7 8.7 15.4 8.3 14.1 13.4 8.8 6.8 9.0 10.1 18.0 9.3 8.6 9.5 13.5 9.7 8.7 11.6 12.7 15.1 16.9 7.0 12.3 13.4 11.5 12.3 10.2 19.4 6.3 7.3 9.1 3.0 7.4 7.1 10.1 9.2 5.7 7.3 9.2 8.4 6.5 9.8 7.2 7.3 8.3 12.3 7.1 6.2 11.2 18.0 11.2 6.5 10.6 7.9 7.8 5.6 10.7 5.5 5.6 15.0 9.2 4.4 7.7 8.5 6.3 7.8 8.4 20.4 11.2 10.8 7.6 11.2 34.6 9.1 18.6 13.3 11.0 22.1 14.0 14.6 7.8 6.1 9.0 15.4 11.8 9.0 6.0 10.1 11.0 8.0 8.0 16.1 9.9 13.5 9.8 5.1 14.4 15.0 9.1 12.3 15.3 11.3 5.4 10.3 6.5 5.2 8.3 11.2 8.2 7.4 3.3 12.3 9.1 6.9 19.4 7.3 6.3 10.2 8.4 3.0 9.9 14.6 15.0 13.4 9.8 8.5 10.4 11.3 14.1 12.7 23.8 16.3 52.5 19.7 8.8 26.4 37.0 20.4 24.1 13.6 17.4 56.9 21.3 16.6 23.7 13.3 29.0 11.8 46.7 18.3 18.6 14.6 18.1 22.0 7.3 16.3 28.6 11.6 25.8 18.6 5.6 21.9 22.5 1.7 22.6 13.5 19.1 21.2 20.3 24.4 12.9 53.5 25.8 18.4 48.9 61.5 7.4 21.1 34.9 16.6 19.5 TTI1 "KIAA0406, smg-10" ENSG00000101407 "TELO2 interacting protein 1" O43156 20 37983007-38033468 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034230, HPA068338" Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "CAB034230: AB_1564322, HPA068338: AB_2685975" "unprognostic (7.14e-3)" "unprognostic (3.15e-1)" "unprognostic (6.61e-2)" "prognostic unfavorable (3.30e-5)" "unprognostic (1.11e-1)" "unprognostic (5.37e-2)" "prognostic unfavorable (2.40e-7)" "unprognostic (5.05e-2)" "unprognostic (1.41e-1)" "unprognostic (1.70e-1)" "unprognostic (4.49e-2)" "unprognostic (2.36e-1)" "unprognostic (9.03e-2)" "unprognostic (1.94e-1)" "unprognostic (5.80e-2)" "unprognostic (7.56e-3)" "unprognostic (1.34e-1)" 9.2 14.2 16.6 10.5 16.2 9.5 11.1 15.5 16.3 10.8 9.8 16.0 9.2 7.4 12.7 12.7 10.2 12.8 7.3 11.3 10.2 9.0 10.7 15.2 9.6 13.4 14.9 12.9 15.4 24.5 16.6 22.8 13.2 15.6 12.8 13.5 13.9 11.7 14.9 22.0 10.4 9.8 13.8 15.8 12.5 11.3 13.0 14.1 17.6 15.4 4.9 15.3 13.7 10.0 10.2 12.9 17.0 11.6 10.3 13.9 9.1 9.8 14.6 16.2 6.1 6.6 9.3 17.4 11.2 6.6 16.7 14.3 34.1 12.9 16.2 11.7 6.3 18.6 15.7 18.1 23.4 16.6 6.4 7.1 22.2 14.5 17.5 7.5 17.7 10.5 7.1 15.5 16.6 10.1 6.4 12.4 17.3 23.3 11.1 12.6 10.1 23.9 12.4 15.9 15.4 15.4 15.7 26.1 19.0 6.4 10.6 14.8 13.2 17.1 30.4 3.9 17.5 17.2 8.6 8.1 22.6 15.0 12.0 11.4 9.7 8.4 18.3 13.2 11.7 11.6 12.9 9.8 17.0 11.9 11.6 13.4 10.2 9.3 11.7 12.9 9.7 13.9 11.1 6.2 10.3 6.9 6.3 11.7 9.1 16.6 16.2 15.5 16.3 10.2 9.0 14.9 12.9 15.6 14.1 8.9 12.3 4.9 2.9 2.7 7.3 11.5 10.2 20.1 9.1 3.5 9.8 12.3 1.7 3.9 5.3 4.6 2.9 0.0 2.8 8.9 3.5 5.2 2.3 6.8 4.6 7.9 2.9 5.5 0.6 2.7 6.1 3.8 3.3 7.2 5.0 6.4 3.7 4.8 6.3 3.7 8.2 0.0 3.6 13.1 11.5 2.6 12.0 5.0 4.5 3.5 TTL MGC46235 ENSG00000114999 "Tubulin tyrosine ligase" Q8NG68 2 112482154-112541739 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066819 Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA066819: AB_2685728" "unprognostic (1.05e-2)" "unprognostic (3.90e-3)" "unprognostic (2.25e-1)" "unprognostic (3.95e-3)" "unprognostic (9.75e-2)" "unprognostic (1.81e-2)" "prognostic unfavorable (5.65e-4)" "unprognostic (2.95e-1)" "unprognostic (3.65e-1)" "unprognostic (2.10e-1)" "unprognostic (5.48e-2)" "unprognostic (7.19e-2)" "unprognostic (6.12e-2)" "unprognostic (1.30e-1)" "unprognostic (1.45e-1)" "unprognostic (2.01e-1)" "unprognostic (4.55e-2)" 4.4 4.0 9.9 4.2 11.9 7.1 11.3 5.0 12.5 3.3 4.1 9.2 2.5 3.1 4.6 4.2 5.2 3.2 4.9 10.3 9.4 6.5 3.9 3.3 5.9 4.4 8.1 5.3 3.2 3.8 4.1 2.4 5.3 5.9 3.2 3.9 2.6 3.0 3.7 13.1 6.0 3.2 5.8 5.4 4.0 3.2 3.0 6.5 5.1 4.2 5.2 3.8 4.8 2.9 1.8 1.2 2.7 1.3 1.0 1.3 0.5 3.7 2.9 3.7 8.2 4.4 6.3 1.4 6.4 5.3 6.9 5.9 3.5 1.4 3.5 3.6 5.5 4.5 2.6 6.4 3.3 8.3 2.4 3.6 2.9 4.1 4.4 2.0 4.1 1.5 2.8 2.3 10.0 5.3 3.1 5.8 2.4 4.8 2.8 5.4 1.9 3.6 2.3 3.2 1.1 5.8 3.9 4.1 1.9 2.1 2.9 7.8 5.4 5.0 1.7 8.9 2.5 1.7 2.4 5.8 8.2 6.0 6.4 4.8 1.6 3.1 2.9 9.0 3.1 3.5 2.7 1.3 1.0 1.3 0.8 1.1 0.8 1.0 1.0 0.4 1.8 0.9 1.1 2.4 1.0 1.1 1.2 0.8 0.5 9.9 11.9 5.0 12.5 9.4 6.5 8.1 5.3 5.9 6.5 11.9 8.3 3.7 4.2 18.0 16.4 32.0 5.1 2.7 7.9 12.2 11.8 2.6 0.0 6.0 6.1 13.0 5.0 46.7 8.3 2.1 9.4 5.0 0.0 9.4 10.2 7.9 10.9 20.9 24.8 3.6 2.8 15.5 6.8 10.8 5.5 9.1 8.6 5.8 5.3 4.9 21.2 6.5 9.0 1.9 4.3 15.7 1.0 6.1 5.2 3.7 TTLL9 "C20orf125, dJ310O13.1" ENSG00000131044 "Tubulin tyrosine ligase like 9" Q3SXZ7 20 31870702-31944963 "Cancer-related genes, Predicted intracellular proteins" Ligase "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.0;epididymis: 8.9;fallopian tube: 9.2;testis: 11.0" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 2: 30.5;Ciliated cells: 65.6;Early spermatids: 31.2;Late spermatids: 53.4" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 1.8;REH: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA041772, HPA055676" Uncertain Uncertain Nucleoplasm,Microtubules NA NA "Nucleoplasm, Microtubules" "HPA041772: AB_10959904, HPA055676: AB_2682881" "unprognostic (8.77e-2)" "unprognostic (8.19e-3)" "unprognostic (1.18e-1)" "unprognostic (1.48e-1)" "unprognostic (4.63e-1)" "unprognostic (1.53e-3)" "unprognostic (1.80e-1)" "unprognostic (1.44e-1)" "unprognostic (1.06e-1)" "unprognostic (4.59e-1)" "unprognostic (9.05e-3)" "unprognostic (6.17e-2)" "unprognostic (8.35e-3)" "unprognostic (1.84e-1)" "unprognostic (1.70e-1)" "unprognostic (1.25e-3)" "unprognostic (2.23e-2)" 0.4 0.6 3.4 0.5 8.9 0.4 1.3 1.0 2.8 0.6 0.5 10.9 1.8 0.6 1.1 8.9 0.6 9.2 0.8 0.5 4.8 3.7 0.8 0.5 1.7 0.7 5.2 0.6 1.8 0.4 2.8 2.8 0.7 16.0 0.6 0.5 0.0 0.5 1.8 0.4 0.6 0.4 0.6 4.5 0.5 0.6 11.0 4.0 0.0 2.1 0.0 0.6 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.1 0.0 0.2 0.2 0.2 0.0 0.0 0.3 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.0 1.8 0.0 0.9 0.0 0.8 0.0 0.4 0.0 0.0 0.0 1.9 0.0 0.0 0.3 0.0 0.4 0.7 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.3 0.5 0.3 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 8.9 1.0 2.7 4.8 3.7 5.2 0.6 16.0 4.0 11.9 30.5 0.0 0.9 0.1 1.7 0.8 0.0 65.6 13.6 0.0 3.9 0.1 0.0 0.1 31.2 0.4 0.0 0.0 0.0 0.0 0.0 0.4 7.0 0.0 0.0 4.8 0.0 0.6 0.0 53.4 1.4 0.8 0.0 1.0 0.0 0.3 0.2 0.0 1.1 0.0 0.5 0.0 0.0 9.7 1.1 0.1 0.0 0.0 0.0 0.3 TUBD1 "FLJ12709, TUBD" ENSG00000108423 "Tubulin delta 1" Q9UJT1 17 59859482-59892945 "FDA approved drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 45.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 42.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004609, HPA023980, HPA027090" Approved Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB004609: AB_628416, HPA023980: AB_1858456, HPA027090: AB_1858457" "unprognostic (1.92e-1)" "unprognostic (5.95e-2)" "prognostic favorable (2.04e-4)" "unprognostic (1.39e-1)" "unprognostic (1.32e-2)" "unprognostic (5.64e-2)" "prognostic unfavorable (1.00e-5)" "unprognostic (2.86e-2)" "unprognostic (8.87e-3)" "unprognostic (1.02e-1)" "unprognostic (1.77e-3)" "unprognostic (2.59e-1)" "prognostic unfavorable (6.06e-4)" "unprognostic (4.97e-2)" "unprognostic (1.63e-1)" "unprognostic (1.36e-1)" "unprognostic (8.83e-2)" 8.7 8.0 9.3 8.1 13.8 6.8 12.4 19.9 12.2 12.3 11.2 13.5 16.6 6.7 13.6 16.4 18.2 10.0 8.3 8.4 8.9 7.2 8.5 9.3 8.8 10.2 16.1 8.5 16.3 13.2 10.4 18.7 7.2 12.3 12.3 8.2 11.7 11.4 12.2 9.9 11.6 7.5 9.3 13.4 9.3 9.6 9.2 16.4 16.2 15.5 10.3 13.8 14.1 13.0 10.1 8.8 14.1 7.6 8.1 17.6 6.9 6.0 8.3 6.5 6.8 3.7 2.6 5.5 4.7 2.8 6.3 5.2 9.0 3.9 5.5 8.1 1.1 4.3 5.1 9.1 2.8 6.0 3.2 11.1 6.4 7.0 10.6 2.0 3.8 3.5 1.4 4.5 5.4 2.0 2.2 4.9 5.5 13.8 3.8 2.1 42.9 7.8 4.4 5.7 6.7 3.7 8.4 9.6 8.6 2.4 2.8 6.1 3.7 3.4 2.7 3.2 8.2 6.4 3.7 1.5 4.5 10.1 3.1 5.1 4.5 6.8 8.4 2.1 4.3 4.0 5.6 7.6 14.1 10.9 5.0 12.4 10.1 13.5 11.5 5.2 8.6 17.6 14.2 8.2 8.1 5.3 8.8 14.1 6.9 9.3 13.8 19.9 12.2 8.9 7.2 16.1 8.5 12.3 16.4 11.9 45.1 5.4 12.7 14.0 7.1 4.8 7.6 12.0 20.5 3.5 5.9 5.1 10.0 4.6 1.3 7.7 2.6 0.0 4.2 6.5 8.2 11.1 10.5 3.2 3.5 3.2 9.9 6.7 4.8 0.4 5.2 6.2 6.8 3.6 5.5 7.7 3.3 4.9 7.8 3.1 7.7 6.5 10.3 11.4 28.1 14.8 3.3 13.6 5.4 5.7 TUBGCP2 "GCP2, SPBC97, Spc97p" ENSG00000130640 "Tubulin gamma complex associated protein 2" Q9BSJ2 10 133278630-133312337 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Ciliated cells: 143.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037885 Approved Supported Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA037885: AB_10672397" "unprognostic (3.57e-2)" "unprognostic (5.53e-2)" "unprognostic (6.17e-2)" "unprognostic (1.64e-2)" "unprognostic (1.50e-1)" "unprognostic (1.96e-1)" "unprognostic (7.72e-2)" "unprognostic (3.35e-1)" "unprognostic (3.09e-2)" "unprognostic (1.64e-1)" "unprognostic (5.71e-2)" "unprognostic (1.95e-2)" "unprognostic (3.52e-1)" "unprognostic (4.24e-2)" "unprognostic (5.21e-2)" "unprognostic (1.41e-1)" "unprognostic (4.89e-2)" 20.3 26.7 16.7 17.3 25.6 29.4 21.4 28.6 33.4 20.3 19.3 22.5 25.2 19.2 23.2 18.9 19.8 35.1 21.7 18.6 21.9 17.2 24.4 22.2 22.8 27.7 16.3 26.5 28.3 30.9 31.9 23.0 17.0 22.3 20.8 16.0 19.0 26.8 22.3 30.4 24.1 19.7 17.6 16.7 25.6 20.1 33.5 15.4 25.6 23.0 18.3 19.5 19.3 18.2 6.1 14.3 17.3 11.9 12.1 10.4 8.7 18.3 25.5 9.4 9.6 10.1 11.0 12.1 14.4 23.4 17.8 18.0 26.6 12.9 13.9 8.1 16.4 6.5 12.4 12.6 11.8 7.9 13.0 24.1 8.9 12.6 14.6 12.7 19.0 16.4 11.4 10.3 16.5 20.6 18.1 11.7 9.2 10.8 11.3 14.4 25.1 10.4 21.0 8.2 12.0 20.3 8.3 11.0 6.0 11.6 9.6 6.5 12.8 10.3 11.6 11.5 6.0 8.4 9.7 14.1 8.7 7.8 11.4 12.8 11.3 7.7 16.2 34.9 8.6 5.5 5.0 11.9 11.9 7.6 11.2 8.5 6.0 7.6 8.0 14.3 6.1 8.7 9.0 17.3 12.1 11.8 6.5 10.4 8.7 16.7 25.6 28.6 33.4 21.9 17.2 16.3 26.5 22.3 15.4 44.7 36.3 20.8 22.9 12.4 41.4 30.5 22.9 143.2 43.3 38.4 29.5 33.5 19.9 30.5 19.9 21.8 31.4 23.3 32.0 27.4 24.7 25.0 38.2 26.3 41.0 36.5 28.2 28.3 39.5 22.0 31.4 45.0 13.5 75.7 32.6 38.3 28.6 31.7 33.2 44.0 69.1 32.3 15.9 63.2 56.2 12.0 35.6 26.1 32.4 26.7 TULP3 TUBL3 ENSG00000078246 "Tubby like protein 3" O75386 12 2877223-2941140 "Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015285, HPA018496" Uncertain Supported "Nucleoplasm,Nucleoli,Plasma membrane" "Secreted - unknown location" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA015285: AB_1858460, HPA018496: AB_2669889" "unprognostic (5.33e-2)" "unprognostic (1.57e-1)" "unprognostic (4.80e-2)" "prognostic favorable (2.99e-4)" "unprognostic (2.45e-1)" "unprognostic (1.78e-2)" "prognostic unfavorable (7.97e-5)" "unprognostic (2.44e-1)" "unprognostic (4.09e-2)" "unprognostic (1.73e-1)" "unprognostic (1.50e-1)" "unprognostic (3.37e-1)" "prognostic unfavorable (7.18e-4)" "unprognostic (7.52e-2)" "unprognostic (1.94e-1)" "unprognostic (2.36e-2)" "unprognostic (3.19e-2)" 14.0 12.0 8.1 6.9 12.9 2.4 13.0 21.2 11.1 22.7 13.6 19.6 12.6 5.3 27.7 11.7 14.1 20.9 11.5 12.7 12.1 5.3 12.1 6.5 9.5 7.2 11.0 7.7 37.1 6.8 13.5 15.4 12.7 10.9 12.5 8.1 17.2 9.8 14.0 9.9 19.8 7.0 17.5 9.7 7.3 11.7 13.2 13.8 4.4 13.3 6.3 9.2 11.6 28.4 3.5 2.8 0.6 1.5 4.8 6.3 1.7 9.1 7.8 14.9 12.3 15.0 22.4 14.1 14.4 24.2 15.6 17.3 9.9 8.5 6.8 2.2 21.2 13.3 7.7 8.8 9.3 18.1 8.8 6.5 4.1 9.7 6.3 19.4 4.3 4.7 13.1 11.0 23.6 32.3 19.2 12.0 8.7 3.8 6.4 13.0 8.2 6.4 3.8 20.1 7.3 5.8 6.9 14.6 2.5 9.8 7.7 3.8 10.0 12.6 7.5 8.2 28.4 9.4 4.3 9.6 11.5 13.9 23.3 13.9 2.0 2.4 5.9 11.6 2.4 17.5 0.0 1.5 0.5 4.0 1.5 6.3 2.9 3.1 4.0 1.3 3.5 3.8 5.2 0.6 4.8 0.8 2.8 5.5 1.7 8.1 12.9 21.2 11.1 12.1 5.3 11.0 7.7 10.9 13.8 6.0 8.0 4.2 14.7 18.0 5.6 5.0 12.7 52.2 17.0 1.8 2.0 7.8 19.9 14.2 2.5 13.6 3.2 0.0 6.4 8.8 23.1 19.1 0.0 3.8 4.6 38.1 3.5 19.0 2.2 2.4 37.7 4.7 18.6 9.0 5.0 46.7 9.7 0.0 23.3 13.5 9.5 38.8 23.7 30.7 52.5 17.7 9.7 5.3 5.6 11.1 TUSC1 "CCDC89B, TSG-9" ENSG00000198680 "Tumor suppressor candidate 1" Q2TAM9 9 25676389-25678440 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 89.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEL: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051426 Approved Approved Nucleoplasm,Vesicles NA Yes Vesicles Nucleoplasm "HPA051426: AB_2681481" "unprognostic (9.84e-2)" "unprognostic (3.56e-1)" "unprognostic (2.58e-1)" "unprognostic (2.11e-3)" "unprognostic (9.41e-3)" "unprognostic (1.78e-1)" "unprognostic (4.79e-3)" "unprognostic (1.72e-2)" "unprognostic (5.71e-2)" "unprognostic (1.85e-3)" "unprognostic (9.14e-3)" "unprognostic (1.03e-2)" "unprognostic (1.89e-3)" "unprognostic (2.88e-2)" "unprognostic (1.08e-1)" "unprognostic (2.37e-1)" "unprognostic (2.21e-2)" 19.8 13.1 10.9 6.2 12.2 3.6 13.8 9.9 17.4 15.3 13.2 10.7 9.7 11.3 17.6 14.0 9.3 15.0 11.0 11.0 10.4 10.5 13.8 12.2 9.3 4.3 12.3 11.3 16.5 10.3 9.6 9.1 17.9 10.4 15.8 8.4 10.2 14.9 14.2 15.6 14.8 11.9 12.1 8.6 7.5 11.8 32.0 11.9 2.9 20.0 11.4 6.7 11.0 14.9 0.6 1.8 0.0 0.8 0.0 0.1 0.0 6.6 1.4 1.5 0.0 4.9 4.1 0.0 5.1 0.0 2.0 2.4 0.1 2.4 0.0 1.6 6.0 5.3 0.0 3.6 6.4 1.2 0.0 7.1 25.9 7.7 0.0 2.4 0.0 0.0 5.0 9.0 2.2 5.1 0.0 2.1 0.0 0.0 0.0 2.3 3.3 0.0 0.1 1.3 5.3 6.6 0.0 1.0 0.1 2.7 3.1 0.5 11.7 6.3 5.3 5.2 3.0 4.6 7.3 4.5 0.0 9.5 0.1 0.0 0.0 0.0 0.0 6.2 1.7 6.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.6 0.1 0.0 0.0 0.0 0.8 1.8 0.0 0.0 10.9 12.2 9.9 17.4 10.4 10.5 12.3 11.3 10.4 11.9 11.9 5.4 0.0 35.5 54.0 25.2 9.7 17.8 2.7 5.7 15.7 3.9 24.7 56.3 6.4 50.7 21.8 8.0 0.0 10.7 12.0 22.0 30.2 0.0 16.4 8.1 20.6 12.6 15.4 2.2 5.0 28.4 5.3 27.0 1.0 12.7 29.9 6.4 10.5 20.5 18.1 13.4 32.3 39.6 89.6 11.5 33.1 24.3 0.0 12.8 15.6 TUT1 "FLJ21850, FLJ22267, FLJ22347, PAPD2, RBM21, TUTase" ENSG00000149016 "Terminal uridylyl transferase 1, U6 snRNA-specific" Q9H6E5 11 62575045-62592177 "Enzymes, Predicted intracellular proteins" "mRNA processing" "Nucleotidyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA069055, HPA071838" Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA069055: AB_2686075, HPA071838: AB_2686456" "unprognostic (3.81e-2)" "unprognostic (3.54e-2)" "prognostic unfavorable (9.51e-4)" "unprognostic (2.43e-1)" "unprognostic (1.01e-1)" "unprognostic (7.59e-2)" "unprognostic (1.83e-1)" "unprognostic (2.59e-2)" "unprognostic (1.83e-1)" "unprognostic (5.79e-3)" "unprognostic (1.59e-2)" "unprognostic (2.71e-1)" "unprognostic (7.20e-3)" "unprognostic (1.03e-2)" "unprognostic (4.41e-1)" "unprognostic (1.35e-1)" "unprognostic (3.97e-3)" 10.9 12.1 10.7 9.9 13.6 7.8 12.9 13.5 13.3 10.5 8.7 15.9 13.0 12.9 11.5 10.8 10.0 16.9 13.7 10.7 13.6 8.3 12.2 22.7 9.6 18.1 15.5 9.5 14.5 26.2 15.5 16.2 12.3 13.0 13.9 6.2 11.9 16.4 11.9 20.5 13.9 11.7 10.2 11.4 14.6 12.5 18.6 13.2 17.1 14.0 8.8 13.6 11.5 9.8 13.1 9.4 6.6 7.3 9.8 16.0 7.2 7.3 9.2 6.4 8.9 7.8 4.5 8.3 7.9 4.8 6.7 5.8 8.2 14.4 11.7 18.2 3.8 8.4 13.8 11.7 9.2 3.4 9.0 6.2 12.0 9.4 7.8 8.7 8.5 5.5 6.3 9.9 8.3 12.8 6.3 6.4 15.2 18.0 12.1 5.6 16.0 12.0 18.1 7.3 4.8 11.3 13.5 10.2 28.4 6.2 4.2 10.6 14.9 6.0 11.4 9.8 5.6 15.9 8.3 5.7 7.6 6.8 8.8 6.0 21.1 18.5 14.4 8.9 6.7 6.2 5.9 5.9 6.6 10.5 7.3 14.6 9.8 9.9 8.4 7.8 13.1 16.0 12.5 3.6 9.8 5.3 9.4 8.9 7.2 10.7 13.6 13.5 13.3 13.6 8.3 15.5 9.5 13.0 13.2 0.0 7.9 8.1 4.8 2.4 7.4 3.2 10.2 9.4 2.3 10.4 5.9 10.6 5.0 7.3 25.9 13.4 5.6 0.0 6.4 6.5 3.8 6.1 2.3 16.2 5.0 1.6 6.9 12.3 4.0 12.8 6.6 3.1 10.1 2.8 6.0 9.3 5.4 3.5 3.2 4.9 8.7 0.0 1.4 9.2 14.8 1.9 11.7 6.9 6.0 2.8 TWIST2 "bHLHa39, Dermo-1, DERMO1" ENSG00000233608 "Twist family bHLH transcription factor 2" Q8WVJ9 2 238848032-238910543 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 34.6" "Group enriched" "Detected in many" 6 "Basal glandular cells: 14.2;Fibroblasts: 25.5;Leydig cells: 44.5;Peritubular cells: 36.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 21 "eosinophil: 11.2" "Lineage enriched" "Detected in single" 52 "granulocytes: 11.2" "Cell line enhanced" "Detected in many" "ASC diff: 33.5;ASC TERT1: 21.3;BJ: 27.2;BJ hTERT+: 85.8;fHDF/TERT166: 38.9;U-2197: 33.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA062870 Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA062870: AB_2684888" "unprognostic (1.62e-2)" "unprognostic (1.33e-1)" "unprognostic (3.45e-1)" "unprognostic (3.81e-2)" "unprognostic (2.53e-4)" "unprognostic (1.83e-2)" "unprognostic (4.06e-2)" "unprognostic (1.13e-2)" "unprognostic (2.75e-2)" "unprognostic (2.33e-1)" "unprognostic (2.24e-1)" "unprognostic (1.17e-1)" "unprognostic (2.40e-9)" "unprognostic (1.59e-2)" "unprognostic (2.06e-1)" "unprognostic (1.98e-2)" "unprognostic (4.48e-2)" 25.8 1.3 0.2 4.7 0.6 0.6 21.7 0.1 0.4 34.6 8.4 0.4 4.3 0.6 14.3 6.2 9.1 7.4 5.8 4.3 0.6 0.2 0.7 0.3 4.2 0.9 1.1 0.0 15.6 0.7 0.0 2.1 9.1 0.4 13.1 1.9 3.9 2.2 7.1 4.3 9.7 2.3 12.4 1.7 1.2 3.3 4.6 0.5 0.0 4.0 6.4 3.4 15.9 18.6 0.2 0.0 11.2 0.1 0.0 0.0 0.0 0.0 1.8 0.1 0.0 33.5 21.3 0.0 27.2 85.8 12.7 19.2 0.0 0.0 0.0 0.8 38.9 1.0 0.2 0.3 2.2 9.3 0.0 2.9 0.0 1.6 0.1 5.7 0.0 0.6 4.9 1.2 6.1 5.1 1.5 1.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.3 0.0 0.3 4.7 0.5 0.9 33.2 0.3 0.0 0.0 0.0 0.1 0.8 1.7 0.0 0.1 11.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.1 0.3 0.6 0.2 1.1 0.0 0.4 0.5 0.0 1.6 0.0 14.2 1.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.7 25.5 2.5 1.1 0.0 2.0 0.0 0.0 4.3 0.0 0.2 44.5 0.0 1.7 0.0 0.0 0.0 0.1 0.0 36.7 0.0 0.0 0.0 5.1 0.5 1.7 1.5 1.4 0.0 0.0 3.0 TWISTNB ENSG00000105849 "TWIST neighbor" Q3B726 7 19695462-19709087 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019071, HPA022416" Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA019071: AB_1858465, HPA022416: AB_1858466" "unprognostic (5.66e-3)" "unprognostic (3.43e-3)" "unprognostic (2.38e-1)" "unprognostic (1.25e-1)" "unprognostic (3.98e-3)" "unprognostic (1.85e-2)" "prognostic unfavorable (1.85e-4)" "unprognostic (1.16e-1)" "unprognostic (5.87e-2)" "unprognostic (2.03e-1)" "unprognostic (5.02e-2)" "unprognostic (4.93e-2)" "unprognostic (6.16e-2)" "unprognostic (1.23e-1)" "unprognostic (9.06e-2)" "unprognostic (4.95e-3)" "unprognostic (2.96e-1)" 16.4 13.9 11.5 13.6 17.6 21.5 15.8 13.2 20.8 16.1 14.0 9.9 12.3 8.5 20.4 9.4 14.8 14.3 9.7 14.6 13.5 12.5 13.3 15.9 9.9 16.6 13.1 11.7 17.5 12.6 15.4 12.0 16.4 13.5 15.3 11.0 6.4 11.4 14.5 25.5 13.8 11.4 22.7 13.4 17.7 12.4 10.8 11.3 20.8 13.6 14.1 18.8 20.2 14.4 10.8 7.7 3.5 5.0 14.6 11.6 5.0 11.7 9.0 6.6 9.9 7.8 9.6 5.2 6.8 5.1 8.0 9.3 7.3 10.4 13.2 19.9 8.4 10.1 10.7 13.5 12.7 14.9 4.1 10.4 12.2 7.2 5.6 11.9 24.9 8.9 8.7 9.0 8.7 10.5 5.4 13.0 9.3 18.8 11.9 11.4 4.3 13.7 23.3 17.3 12.3 10.2 11.2 11.5 13.9 13.1 6.1 4.8 7.3 6.2 16.9 8.4 11.4 6.8 22.4 10.8 16.6 8.9 15.3 16.4 15.3 9.4 33.6 11.2 37.5 24.2 3.5 3.9 1.1 7.2 5.0 10.8 10.8 8.6 9.5 6.0 10.4 10.0 11.6 0.3 14.6 4.7 7.7 7.8 5.0 11.5 17.6 13.2 20.8 13.5 12.5 13.1 11.7 13.5 11.3 14.9 23.5 21.4 59.8 110.2 25.7 20.1 10.2 24.1 37.5 8.7 11.8 32.6 36.5 21.9 4.1 30.8 6.3 23.3 23.7 26.9 40.3 29.1 118.6 27.1 30.4 31.8 23.4 29.4 15.2 2.5 29.7 41.4 59.1 25.2 16.5 19.0 19.5 14.0 32.9 24.5 12.1 19.4 57.7 25.0 44.7 125.0 13.8 37.3 21.5 43.6 TXLNA DKFZp451J0118 ENSG00000084652 "Taxilin alpha" P40222 1 32179686-32198285 "Cancer-related genes, Predicted intracellular proteins" Exocytosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045383, HPA072477" Supported Approved Nucleoplasm,Centrosome,Cytosol NA NA Cytosol "Nucleoplasm, Centrosome" "HPA045383: AB_10967649, HPA072477: AB_2686525" "prognostic favorable (6.24e-4)" "unprognostic (1.19e-2)" "unprognostic (3.01e-1)" "unprognostic (1.99e-1)" "unprognostic (5.04e-2)" "prognostic favorable (5.53e-4)" "prognostic unfavorable (1.57e-6)" "unprognostic (3.67e-3)" "unprognostic (2.75e-1)" "unprognostic (5.25e-3)" "prognostic favorable (8.69e-5)" "unprognostic (5.06e-2)" "prognostic unfavorable (7.21e-7)" "unprognostic (3.94e-3)" "unprognostic (3.28e-1)" "unprognostic (7.24e-2)" "unprognostic (1.03e-1)" 22.5 29.4 20.2 19.4 27.5 14.0 17.9 23.2 26.4 20.3 23.7 17.0 23.4 16.6 30.4 24.7 24.2 25.0 24.6 16.4 18.5 13.9 20.9 44.8 19.0 19.9 25.6 13.4 26.5 23.6 31.5 35.9 19.3 21.8 24.6 18.5 20.8 23.9 23.3 16.5 31.0 18.9 28.3 19.9 23.5 21.2 38.4 22.9 17.0 22.8 18.8 26.0 19.3 23.5 8.0 14.3 8.4 12.2 14.2 13.9 9.0 19.5 16.8 17.5 19.7 22.8 30.0 14.2 28.1 22.4 27.2 26.1 18.7 21.3 22.4 11.5 27.2 8.9 22.2 23.9 18.4 24.8 25.6 18.5 35.5 24.4 24.4 24.2 25.7 28.2 30.0 24.8 28.7 13.6 20.1 21.4 27.3 14.4 23.2 22.2 10.9 18.8 16.6 25.5 14.0 15.5 22.2 26.6 19.7 18.6 25.1 18.4 18.9 29.1 18.5 29.8 22.5 17.1 15.7 22.2 28.8 24.9 37.9 35.8 34.7 26.8 20.4 29.8 35.1 26.5 8.4 9.0 4.5 13.9 9.7 11.9 7.3 9.6 10.3 6.9 8.0 8.4 9.1 1.3 14.2 12.2 14.3 7.0 9.0 20.2 27.5 23.2 26.4 18.5 13.9 25.6 13.4 21.8 22.9 20.8 21.3 7.7 9.2 7.8 13.9 7.7 10.2 28.1 19.4 14.0 37.3 8.8 1.7 15.8 11.5 15.8 11.9 0.0 14.2 12.0 17.1 10.3 12.7 28.6 15.9 25.4 25.2 16.0 12.4 13.3 22.2 11.7 5.0 20.8 15.4 13.8 18.6 2.9 19.4 11.8 24.5 12.9 21.1 21.8 24.5 10.7 5.7 10.2 12.1 6.7 TXN TRX ENSG00000136810 Thioredoxin P10599 9 110243811-110256640 "Plasma proteins, Predicted intracellular proteins" "Electron transport, Transcription, Transcription regulation, Transport" Activator Allergen "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 447.3" "Cell type enriched" "Detected in all" 10 "monocytes: 27271.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 127.1;granulocytes: 104.5" "Cell line enhanced" "Detected in all" "OE19: 265.0" "Low region specificity" "Detected in all" "CAB008678, HPA047478, HPA055752" Enhanced Enhanced Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 25000000 "Nucleoplasm, Cytosol" "CAB008678: AB_1623676, HPA047478: AB_2680063, HPA055752: AB_2682907" "unprognostic (2.12e-2)" "unprognostic (1.27e-1)" "unprognostic (9.77e-2)" "prognostic favorable (3.40e-6)" "unprognostic (1.80e-2)" "unprognostic (2.13e-2)" "unprognostic (5.52e-3)" "unprognostic (1.37e-2)" "unprognostic (1.75e-1)" "unprognostic (3.36e-2)" "unprognostic (5.93e-3)" "unprognostic (1.66e-1)" "unprognostic (4.96e-3)" "unprognostic (7.80e-2)" "unprognostic (8.55e-2)" "unprognostic (2.99e-2)" "unprognostic (8.51e-2)" 23.6 16.7 26.6 18.2 16.9 35.8 25.9 10.8 19.7 30.8 57.9 7.7 17.5 40.7 15.5 20.4 162.3 27.5 22.2 11.7 20.9 19.0 65.8 69.4 39.0 19.4 21.3 14.1 18.2 22.0 5.3 8.0 41.2 28.7 15.5 50.6 8.0 50.2 16.3 16.0 26.3 58.9 21.9 17.6 19.8 26.3 9.2 7.0 40.0 18.9 447.3 82.0 31.3 27.1 12.8 127.1 104.5 25.1 14.2 26.0 18.8 45.9 63.1 17.1 18.8 43.2 56.3 25.2 55.9 52.2 39.0 29.7 40.9 55.4 40.9 24.0 51.6 85.4 103.8 24.3 74.5 38.3 60.7 54.1 20.5 59.2 70.8 49.4 50.9 62.7 39.9 49.1 57.0 43.2 36.3 34.2 26.1 34.5 39.4 53.3 37.2 42.3 76.4 36.4 265.0 77.0 17.8 58.0 47.6 49.8 32.6 37.2 13.3 60.3 49.0 37.9 34.4 47.0 35.2 41.0 40.2 26.0 75.4 69.2 20.0 56.4 34.8 58.3 44.4 55.8 32.2 25.1 104.5 14.5 15.1 13.9 12.8 20.5 17.4 37.1 5.6 7.7 11.5 99.7 14.2 9.6 127.1 26.0 18.8 26.6 16.9 10.8 19.7 20.9 19.0 21.3 14.1 28.7 7.0 363.3 237.5 189.1 832.3 1158.8 34.8 96.1 504.4 436.3 374.2 249.5 19.6 560.0 824.0 1017.1 20.9 327.5 1162.8 233.6 1150.3 840.4 409.8 774.5 261.1 685.2 516.6 27.0 534.8 206.2 278.9 11.1 373.3 793.2 723.7 27271.2 934.3 40.9 1608.6 1292.8 268.3 2636.4 24.8 142.3 563.4 10.6 70.3 1303.3 391.5 213.2 1478.0 1356.2 TXNL4A "DIB1, DIM1, HsT161, SNRNP15, TXNL4, U5-15kD" ENSG00000141759 "Thioredoxin like 4A" P83876 18 79970811-80033949 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, mRNA processing, mRNA splicing" Deafness "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041324 Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Nuclear membrane" Cytosol "HPA041324: AB_2677410" "unprognostic (7.56e-2)" "unprognostic (1.06e-3)" "unprognostic (5.94e-2)" "unprognostic (2.67e-2)" "unprognostic (6.99e-3)" "unprognostic (3.26e-1)" "prognostic unfavorable (3.38e-4)" "unprognostic (1.45e-1)" "unprognostic (9.39e-2)" "unprognostic (3.31e-3)" "unprognostic (7.61e-2)" "unprognostic (4.94e-2)" "unprognostic (3.11e-2)" "unprognostic (1.35e-1)" "unprognostic (1.34e-1)" "unprognostic (1.02e-1)" "unprognostic (1.18e-1)" 28.2 35.8 57.2 27.7 43.9 36.7 30.2 21.7 43.4 22.0 29.4 30.7 22.9 23.9 15.8 38.9 26.5 21.0 21.8 33.5 47.9 42.7 29.0 42.5 18.4 35.1 52.6 25.4 14.1 64.9 22.1 38.4 23.2 32.7 21.1 25.2 24.0 46.8 20.5 35.5 26.6 25.1 19.0 37.7 26.9 23.2 41.6 20.8 40.2 28.8 26.8 32.2 23.5 16.9 12.7 25.0 8.4 9.6 11.3 12.7 4.4 21.8 29.5 26.3 25.0 21.5 22.7 23.3 23.8 19.3 32.4 29.5 27.4 15.6 26.7 8.9 22.7 22.0 18.6 31.6 27.7 21.5 31.1 40.1 19.1 44.8 64.4 27.5 54.8 31.4 21.1 24.6 23.0 29.6 20.7 30.4 33.2 16.7 39.0 22.5 39.6 38.8 37.2 20.5 16.7 63.9 23.7 17.6 55.0 31.8 34.7 40.3 29.3 11.8 35.2 43.4 23.7 17.2 32.7 14.3 28.6 35.1 13.0 29.0 17.3 65.0 43.9 26.8 41.8 26.2 8.4 8.4 6.8 12.2 9.6 8.4 12.3 10.0 9.6 11.4 12.7 10.2 11.9 6.8 11.3 9.5 25.0 12.7 4.4 57.2 43.9 21.7 43.4 47.9 42.7 52.6 25.4 32.7 20.8 17.9 41.8 50.0 60.5 77.4 32.4 73.1 63.7 25.4 52.4 62.8 33.4 96.1 305.1 118.9 207.4 51.7 39.3 23.3 108.6 136.0 58.6 137.6 10.5 80.8 109.4 42.9 54.1 37.4 48.3 186.2 38.9 65.4 89.4 102.8 78.3 48.2 121.8 56.1 42.5 211.1 37.3 45.3 91.2 74.9 65.0 96.0 80.9 50.7 65.4 100.5 TXNL4B "Dim2, DLP, FLJ20511" ENSG00000140830 "Thioredoxin like 4B" Q9NX01 16 72044289-72094431 "Predicted intracellular proteins" "Cell cycle, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 42.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065865 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA065865: AB_2685571" "unprognostic (1.45e-1)" "unprognostic (1.11e-1)" "unprognostic (1.05e-1)" "unprognostic (1.55e-2)" "unprognostic (3.78e-2)" "unprognostic (8.72e-2)" "unprognostic (4.75e-2)" "unprognostic (2.65e-1)" "unprognostic (8.91e-2)" "unprognostic (4.75e-2)" "unprognostic (1.04e-1)" "unprognostic (3.00e-2)" "unprognostic (1.14e-1)" "unprognostic (1.62e-1)" "unprognostic (2.11e-1)" "unprognostic (1.26e-1)" "unprognostic (1.62e-1)" 11.1 10.0 14.1 11.5 16.3 15.6 12.3 18.6 17.0 11.0 11.7 18.5 10.4 12.8 10.2 10.3 12.2 13.3 11.2 9.3 13.2 12.2 9.8 20.8 8.8 13.0 20.9 13.6 27.8 12.6 11.0 19.9 9.4 13.7 9.8 10.8 9.8 10.7 10.3 11.3 10.1 10.4 8.7 17.2 10.0 10.0 18.9 15.3 14.0 10.9 6.0 11.9 8.6 13.7 10.8 9.4 18.3 14.2 5.0 13.7 9.9 6.9 10.5 5.8 7.9 4.3 5.1 12.9 9.2 7.5 16.1 12.2 10.7 6.4 10.2 6.7 4.7 7.5 9.5 10.2 5.4 12.6 5.1 9.6 9.4 8.0 16.0 9.2 11.1 8.2 5.3 3.8 14.2 13.4 6.2 6.8 11.4 22.6 6.2 7.6 13.3 13.3 9.7 10.5 4.4 9.7 13.8 7.3 13.7 5.9 5.3 13.2 11.4 8.6 4.0 11.9 4.6 9.4 7.1 6.5 7.7 11.2 6.4 8.6 12.3 19.8 42.5 8.7 7.6 7.6 18.3 9.8 12.9 9.2 10.9 13.7 10.8 9.5 7.8 8.5 9.0 13.1 12.7 13.9 5.0 14.2 9.4 10.5 9.9 14.1 16.3 18.6 17.0 13.2 12.2 20.9 13.6 13.7 15.3 3.0 8.8 13.1 6.9 7.6 3.4 1.4 7.6 8.1 5.7 5.2 2.0 11.7 5.0 9.4 1.6 7.9 8.4 0.0 8.8 14.7 6.5 6.9 9.2 11.9 10.8 9.5 8.6 8.0 8.7 3.2 10.9 7.4 6.8 9.0 8.4 5.8 6.2 3.5 8.5 9.9 4.5 0.0 8.2 7.4 7.5 7.2 16.2 7.5 7.3 5.7 TXNRD1 "GRIM-12, Trxr1, TXNR" ENSG00000198431 "Thioredoxin reductase 1" Q16881 12 104215779-104350305 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport" Oxidoreductase "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 272.3;Urothelial cells: 489.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "fHDF/TERT166: 144.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001395, CAB004607, CAB015834, HPA043871" Approved Supported Nucleoplasm NA NA 5900000 Nucleoplasm "CAB004607: AB_628405, CAB015834: , HPA001395: AB_1858377, HPA043871: AB_2678709" "unprognostic (2.52e-2)" "unprognostic (1.16e-1)" "unprognostic (5.48e-2)" "unprognostic (1.01e-1)" "unprognostic (3.15e-1)" "unprognostic (1.94e-2)" "prognostic unfavorable (1.12e-5)" "unprognostic (5.55e-2)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (6.42e-2)" "unprognostic (2.21e-1)" "prognostic unfavorable (1.20e-5)" "unprognostic (2.13e-1)" "unprognostic (1.27e-1)" "unprognostic (1.18e-2)" "unprognostic (8.80e-2)" 19.1 79.2 14.1 15.6 16.9 22.6 18.5 11.1 13.7 13.0 21.8 9.7 19.7 23.5 23.5 14.7 16.7 19.0 23.2 32.4 11.0 11.7 25.3 19.6 29.3 18.1 12.0 10.9 16.4 7.9 10.5 16.2 30.8 16.4 25.3 19.1 18.1 10.6 26.5 30.0 5.7 17.0 99.6 10.9 14.9 24.2 14.8 8.9 15.6 16.5 16.9 13.2 73.2 72.0 8.1 14.2 37.6 16.2 8.3 10.2 8.7 22.2 103.7 12.1 11.3 58.1 32.6 42.0 41.4 26.2 18.7 19.4 10.9 33.2 16.7 19.3 144.9 70.2 7.8 23.8 15.9 22.2 8.1 10.3 14.1 81.4 46.1 93.3 21.9 15.4 18.5 16.4 41.4 13.2 57.6 64.1 23.0 19.3 7.9 28.0 10.7 22.4 10.0 11.6 44.8 106.9 22.3 8.4 14.5 21.8 12.3 18.8 11.4 33.5 53.0 33.0 23.9 12.5 13.0 85.6 9.2 19.1 20.6 33.9 8.7 17.0 25.1 19.3 12.2 54.4 33.0 10.6 24.7 9.1 14.0 10.2 8.1 8.4 9.0 14.2 5.2 7.6 6.6 37.6 8.3 16.2 9.2 7.1 8.7 14.1 16.9 11.1 11.2 11.0 11.7 12.0 10.9 16.4 8.9 59.6 55.0 27.6 272.3 92.4 28.0 55.7 38.2 104.4 96.7 15.7 21.6 22.9 34.9 73.1 34.3 40.9 44.4 23.3 68.7 28.0 34.6 217.3 50.9 45.7 36.8 27.0 19.7 50.3 37.2 13.4 63.0 64.0 18.6 55.9 17.9 23.3 183.4 20.3 27.6 28.5 19.7 0.0 58.8 11.6 28.8 63.7 42.9 23.5 24.1 489.6 TXNRD3 "TGR, TR2, TRXR3" ENSG00000197763 "Thioredoxin reductase 3" Q86VQ6 3 126607052-126655155 "Enzymes, Predicted intracellular proteins" "Differentiation, Electron transport, Spermatogenesis, Transport" "Developmental protein, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 27.8" "Cell type enhanced" "Detected in many" 13 "Spermatocytes: 54.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 4.0" "Lineage enriched" "Detected in single" 4 "T-cells: 4.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020802, HPA036109" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB020802: , HPA036109: AB_2674945" "unprognostic (1.41e-1)" "unprognostic (1.55e-2)" "unprognostic (3.92e-1)" "prognostic unfavorable (3.35e-4)" "unprognostic (3.90e-1)" "unprognostic (2.96e-1)" "unprognostic (3.01e-1)" "unprognostic (3.39e-2)" "unprognostic (1.07e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (2.86e-4)" "unprognostic (3.14e-1)" "prognostic favorable (2.72e-4)" "unprognostic (5.94e-2)" "unprognostic (1.74e-1)" "unprognostic (1.03e-2)" "unprognostic (2.51e-1)" 5.4 5.9 4.9 2.4 4.7 0.9 7.2 5.5 5.7 7.3 4.2 4.6 5.5 1.6 8.3 7.1 6.4 4.7 5.2 4.9 4.0 2.9 6.7 10.0 7.0 5.2 4.6 3.5 8.8 7.1 12.3 8.5 3.3 7.0 5.2 3.6 6.4 5.7 5.1 7.3 4.8 2.6 8.1 5.1 3.3 4.9 27.8 5.8 5.0 7.4 3.6 2.1 6.6 5.3 0.3 0.7 0.5 0.9 0.9 4.0 0.3 14.0 3.6 4.6 7.2 8.5 13.0 2.3 6.2 5.6 5.1 7.2 6.4 7.9 0.0 7.9 8.5 3.1 5.6 5.7 6.4 6.5 0.0 4.2 1.6 3.3 4.9 7.4 5.7 0.5 11.9 5.6 1.7 11.8 7.0 3.7 4.6 3.4 0.0 8.2 10.1 1.2 3.1 6.5 3.8 2.7 0.4 4.0 2.3 5.4 7.0 8.0 4.9 17.8 5.2 9.0 3.7 7.2 2.2 6.1 6.3 1.5 8.5 2.9 3.7 1.6 0.0 3.4 2.0 5.3 0.0 0.9 0.5 0.5 0.8 0.1 0.0 0.2 0.6 0.7 0.3 4.0 1.3 0.0 0.9 0.2 0.0 0.0 0.3 4.9 4.7 5.5 5.7 4.0 2.9 4.6 3.5 7.0 5.8 3.0 7.4 0.0 4.8 0.9 1.9 3.6 5.1 2.7 3.4 3.5 2.0 7.5 3.3 4.3 15.1 1.5 0.0 0.0 3.4 4.6 3.7 2.1 5.7 7.3 2.6 0.0 4.1 1.3 0.3 2.9 4.4 0.3 0.0 0.0 2.3 2.3 3.9 0.0 8.1 2.8 0.5 0.0 2.7 54.7 15.3 0.5 6.1 0.0 1.5 2.5 TYSND1 "MGC34695, NET41" ENSG00000156521 "Trypsin domain containing 1" Q2T9J0 10 70137981-70146676 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 40.7" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 90.7;Late spermatids: 154.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 18.0;PC-3: 27.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030304 Approved Uncertain Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Centrosome" Cytosol "HPA030304: AB_10670560" "unprognostic (4.75e-3)" "unprognostic (4.30e-2)" "unprognostic (2.44e-2)" "unprognostic (7.69e-2)" "unprognostic (1.84e-1)" "unprognostic (4.53e-2)" "unprognostic (2.02e-2)" "unprognostic (1.55e-1)" "unprognostic (1.33e-1)" "unprognostic (1.10e-1)" "unprognostic (1.59e-2)" "unprognostic (2.80e-1)" "unprognostic (1.37e-1)" "unprognostic (9.26e-3)" "unprognostic (1.91e-1)" "unprognostic (1.30e-1)" "unprognostic (1.69e-2)" 15.2 8.2 4.7 7.0 6.8 3.0 8.0 6.7 7.3 6.0 6.7 5.9 6.9 10.1 5.3 8.4 13.9 5.4 5.2 3.5 3.7 2.8 7.4 7.4 3.5 7.2 3.7 3.6 5.6 9.0 3.3 4.5 4.7 3.5 6.9 2.7 6.9 8.0 5.7 5.3 12.5 8.5 4.8 4.7 9.0 8.2 40.7 3.4 6.2 8.5 6.6 10.1 6.5 7.6 6.1 1.4 1.2 1.6 2.9 6.3 2.3 9.5 6.9 0.5 4.1 0.8 0.6 2.5 1.2 0.9 1.4 1.3 4.3 6.1 8.6 4.0 0.3 0.3 18.0 0.7 2.7 0.3 5.4 6.2 0.5 1.9 2.1 1.7 0.7 0.0 1.3 5.2 1.2 2.2 0.8 1.0 3.1 0.0 2.6 0.6 4.2 3.2 3.5 2.2 2.3 27.7 5.7 1.6 3.8 0.6 1.6 5.0 2.6 4.2 9.4 3.6 0.2 6.1 0.7 1.7 1.6 1.1 3.0 5.4 9.8 5.9 4.2 1.9 3.6 1.2 0.0 1.3 1.2 6.3 1.6 4.1 5.1 3.7 4.9 1.4 6.1 5.3 4.4 0.4 2.9 1.1 1.0 4.0 2.3 4.7 6.8 6.7 7.3 3.7 2.8 3.7 3.6 3.5 3.4 8.9 4.0 13.7 13.8 12.7 6.8 4.3 25.5 1.4 5.7 10.4 0.0 30.0 14.9 6.8 90.7 6.7 14.8 0.0 8.3 6.8 6.3 10.9 13.8 14.3 10.7 0.0 13.7 6.7 9.5 154.7 8.6 8.0 11.8 2.8 10.6 6.2 5.1 10.5 7.4 12.4 4.5 6.5 4.7 41.1 11.1 16.2 14.0 11.8 20.3 5.2 TYW1 "FLJ10900, MGC23001, MGC60291, RSAFD1, TYW1A, YPL207W" ENSG00000198874 "TRNA-yW synthesizing protein 1 homolog" Q9NV66 7 66995173-67239519 "Enzymes, Predicted membrane proteins" "tRNA processing" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA013568, HPA014118, HPA015535, HPA043136, HPA047029, HPA047052, HPA052097" Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA013568: AB_2668852, HPA014118: AB_2668941, HPA015535: AB_1856487, HPA043136: AB_2678333, HPA047029: AB_2679909, HPA047052: AB_2679918, HPA052097: AB_2681723" "unprognostic (1.53e-1)" "unprognostic (5.49e-3)" "unprognostic (1.62e-1)" "unprognostic (3.05e-2)" "unprognostic (1.84e-2)" "unprognostic (2.20e-1)" "unprognostic (1.83e-2)" "unprognostic (1.79e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (1.73e-4)" "unprognostic (4.86e-2)" "unprognostic (1.30e-1)" "unprognostic (1.85e-2)" "unprognostic (4.70e-2)" "unprognostic (1.60e-1)" "unprognostic (1.36e-2)" "unprognostic (1.79e-2)" 15.4 19.1 10.2 12.3 15.4 11.9 15.1 14.9 15.3 18.8 12.9 21.2 18.2 14.1 22.7 15.3 12.0 15.5 10.8 12.9 10.8 9.8 15.2 17.7 11.1 15.5 14.1 10.8 19.4 23.9 22.9 28.0 13.2 14.5 14.9 16.5 17.8 15.3 14.7 26.2 14.4 12.8 14.0 13.9 15.1 12.6 13.7 13.4 19.7 19.0 13.6 23.3 15.3 15.2 9.6 8.3 3.6 9.1 11.2 11.8 5.3 10.6 13.6 8.3 17.2 12.5 8.7 9.7 11.4 8.7 9.0 8.5 15.5 13.9 18.5 17.5 10.5 12.7 12.6 17.2 14.0 13.1 14.5 13.2 8.0 11.3 10.5 12.4 18.4 10.6 8.9 14.2 12.2 18.8 7.1 8.2 13.5 21.0 11.2 10.3 10.5 11.6 15.5 14.6 18.0 12.2 13.2 11.6 23.3 12.2 10.8 12.8 12.7 13.7 26.6 11.4 16.6 18.1 13.1 9.6 10.4 7.4 8.2 15.5 11.3 15.9 22.3 8.5 17.4 14.3 2.0 7.0 3.6 8.6 7.8 11.7 8.5 9.4 9.8 8.3 9.6 11.5 11.8 2.0 11.2 9.1 6.6 6.8 5.3 10.2 15.4 14.9 15.3 10.8 9.8 14.1 10.8 14.5 13.4 6.0 15.4 4.5 4.9 9.3 9.0 8.1 10.2 9.4 4.5 10.4 3.9 16.5 0.0 6.6 5.5 6.7 4.7 0.0 6.0 10.7 7.7 4.9 33.5 12.5 6.9 3.2 4.6 6.7 4.3 3.1 7.8 8.9 8.5 10.0 12.1 7.7 6.1 3.5 7.8 2.1 11.7 19.4 7.1 17.0 22.7 14.8 12.7 8.5 9.7 2.8 TYW1B "LINC00069, MGC87315, NCRNA00069, RSAFD2" ENSG00000277149 "TRNA-yW synthesizing protein 1 homolog B" 7 72558744-72828198 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 9.8;Rod photoreceptor cells: 8.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA013568, HPA014118, HPA043136, HPA047029, HPA047052, HPA052097" Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA013568: AB_2668852, HPA014118: AB_2668941, HPA043136: AB_2678333, HPA047029: AB_2679909, HPA047052: AB_2679918, HPA052097: AB_2681723" "unprognostic (2.61e-1)" "unprognostic (3.54e-1)" "unprognostic (1.92e-1)" "unprognostic (1.64e-1)" "unprognostic (1.91e-2)" "unprognostic (6.22e-3)" "unprognostic (3.88e-2)" "unprognostic (1.64e-2)" "unprognostic (1.19e-2)" "unprognostic (8.96e-3)" "unprognostic (5.78e-2)" "unprognostic (2.90e-2)" "unprognostic (4.33e-4)" "unprognostic (1.02e-1)" "unprognostic (2.41e-1)" "unprognostic (1.85e-1)" "unprognostic (5.90e-2)" 2.7 1.6 1.8 4.5 3.8 4.4 4.2 6.0 3.3 5.6 2.9 5.8 7.4 1.5 6.0 5.2 3.4 4.1 1.5 2.3 1.9 3.1 7.9 2.9 2.4 3.9 1.7 10.1 5.7 2.0 11.6 3.0 3.4 4.1 4.4 4.7 4.1 5.9 4.4 2.5 2.9 3.6 4.7 3.0 3.1 7.2 3.8 6.0 5.9 1.8 6.0 3.1 1.1 7.5 5.4 5.7 3.5 2.4 3.0 0.9 2.3 2.5 1.0 2.0 1.6 0.5 1.1 1.2 0.5 1.1 1.1 8.0 4.2 7.3 0.7 0.8 1.0 1.1 1.9 0.8 1.3 7.9 2.3 0.7 1.2 4.7 0.8 7.4 2.1 3.8 0.6 1.3 0.9 0.7 0.7 1.6 10.0 7.7 1.1 1.0 2.4 3.8 1.8 3.1 4.6 1.4 5.5 2.6 1.1 0.8 1.8 0.9 1.5 8.4 4.3 3.3 2.1 2.6 3.2 1.8 4.3 9.7 1.4 6.7 8.1 8.3 0.5 2.1 9.7 4.0 3.5 5.7 3.0 1.8 2.8 7.5 2.0 1.8 1.4 5.2 2.3 2.7 4.3 2.4 1.7 5.4 2.0 0.9 0.0 1.3 4.7 1.8 0.0 3.4 4.8 2.5 2.7 1.2 0.0 9.8 3.5 0.0 2.0 3.3 1.4 1.2 0.0 0.6 1.5 2.1 1.6 1.1 1.5 2.9 1.6 0.0 1.3 1.5 0.4 0.9 0.7 0.0 2.8 2.3 1.6 1.0 0.3 0.7 0.5 8.1 0.0 1.7 5.5 5.1 0.0 1.6 2.2 1.1 0.9 U2AF1 "RN, RNU2AF1, U2AF35, U2AFBP" ENSG00000160201 "U2 small nuclear RNA auxiliary factor 1" Q01081 21 43092956-43107587 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Basal keratinocytes: 437.9;Melanocytes: 192.3;Suprabasal keratinocytes: 379.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA044833, HPA052083" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA044833: AB_10960990, HPA052083: AB_2681720" "unprognostic (1.10e-1)" "unprognostic (1.28e-1)" "unprognostic (5.98e-2)" "unprognostic (2.87e-2)" "unprognostic (1.36e-1)" "unprognostic (8.06e-2)" "unprognostic (2.76e-2)" "unprognostic (4.29e-4)" "unprognostic (4.81e-4)" "unprognostic (3.42e-2)" "unprognostic (2.31e-3)" "unprognostic (8.85e-2)" "unprognostic (2.14e-6)" "unprognostic (1.08e-1)" "unprognostic (1.40e-2)" "unprognostic (1.72e-1)" "unprognostic (1.26e-2)" 20.0 15.1 20.8 19.2 21.1 48.5 61.0 25.6 20.8 16.1 21.5 9.7 12.3 17.6 28.8 26.5 19.3 27.6 17.1 19.5 19.7 15.8 14.6 17.1 35.2 33.5 25.7 2.9 22.1 48.3 15.3 27.8 21.2 20.8 23.9 13.7 9.6 44.5 19.8 33.0 16.6 20.4 38.7 23.9 21.0 17.5 33.9 22.7 20.6 27.3 26.5 20.0 22.9 31.7 58.4 82.8 81.2 54.1 33.1 55.5 53.8 25.3 27.8 15.1 11.4 8.9 6.4 35.5 22.0 15.3 18.0 16.1 64.6 9.3 43.4 12.0 14.3 24.7 12.4 31.6 23.4 9.3 34.0 71.5 70.2 14.2 24.3 21.7 30.2 17.3 8.8 14.4 29.1 18.6 6.5 14.8 26.6 38.5 19.6 12.5 47.7 24.9 33.5 32.1 21.7 32.1 41.2 14.6 21.8 12.0 10.7 23.0 17.6 23.6 14.3 11.7 4.3 17.4 17.6 18.5 15.0 20.4 13.5 23.0 26.3 30.9 35.9 14.4 55.6 23.1 48.4 52.6 50.9 42.2 52.5 41.4 55.9 46.4 42.1 54.1 58.4 46.4 44.8 81.2 33.1 54.1 82.8 55.5 53.8 20.8 21.1 25.6 20.8 19.7 15.8 25.7 2.9 20.8 22.7 17.9 17.8 8.9 29.0 437.9 21.8 2.8 7.6 21.4 27.3 1.8 41.2 16.3 1.7 4.5 1.9 22.2 22.9 0.0 5.1 15.6 26.8 31.7 26.7 17.8 19.6 17.5 17.5 28.8 21.4 2.0 17.0 27.1 192.3 2.8 16.7 13.0 4.0 17.5 21.2 2.8 59.6 6.5 29.2 14.4 17.7 379.0 19.9 20.0 22.2 30.1 U2AF1L4 "MGC33901, U2AF1L3, U2af26" ENSG00000161265 "U2 small nuclear RNA auxiliary factor 1 like 4" Q8WU68 19 35742464-35745445 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA052083, HPA061644" Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA052083: AB_2681720, HPA061644: AB_2684574" "prognostic favorable (2.44e-4)" "unprognostic (1.31e-1)" "unprognostic (2.39e-3)" "unprognostic (1.31e-2)" "unprognostic (2.35e-1)" "prognostic favorable (2.58e-5)" "unprognostic (3.95e-2)" "unprognostic (1.29e-1)" "unprognostic (1.95e-1)" "unprognostic (3.67e-2)" "prognostic favorable (8.58e-5)" "unprognostic (8.44e-2)" "prognostic unfavorable (9.73e-5)" "unprognostic (1.06e-1)" "unprognostic (7.21e-2)" "unprognostic (1.92e-1)" "prognostic favorable (7.05e-4)" 5.3 9.7 12.1 4.5 15.0 4.6 4.5 9.3 12.5 4.8 5.7 8.7 8.0 2.7 5.7 6.0 4.9 6.1 5.1 24.3 11.1 10.2 7.0 4.4 4.7 2.8 9.5 10.3 10.7 4.7 11.7 6.6 5.8 8.7 6.7 2.8 10.9 2.5 9.1 19.8 3.4 5.8 6.8 8.5 5.0 4.1 10.7 6.0 2.7 7.4 4.3 5.3 4.2 3.1 9.2 8.4 2.2 3.2 0.8 9.9 5.2 3.7 13.6 1.8 3.2 0.0 1.7 3.1 3.4 3.5 8.7 8.6 5.4 3.1 1.6 6.7 7.8 7.8 1.9 6.9 5.3 5.4 10.4 1.0 1.7 3.4 5.8 10.9 2.5 5.6 2.0 2.3 3.6 2.1 3.2 1.6 4.9 4.1 4.7 5.5 8.0 7.6 2.6 3.0 9.0 2.4 1.9 3.2 0.0 2.0 0.6 4.6 4.5 5.0 3.3 0.9 4.9 3.8 5.0 2.9 5.5 2.4 1.2 5.6 5.5 6.4 3.5 3.6 5.7 6.6 0.0 2.1 1.5 3.1 3.2 3.0 9.2 6.0 5.9 2.0 6.9 9.0 8.6 2.2 0.8 2.4 8.4 9.9 5.2 12.1 15.0 9.3 12.3 11.1 10.2 9.5 10.3 8.7 6.0 17.9 23.1 37.4 12.7 9.2 24.6 4.4 5.1 8.1 5.7 8.7 13.7 13.1 23.2 9.0 9.3 13.6 20.3 23.3 11.0 8.2 16.2 10.7 33.7 13.2 17.4 19.1 12.1 9.8 13.9 11.0 14.4 21.2 28.7 36.9 12.1 10.3 8.1 23.0 11.7 22.6 28.0 12.9 12.8 37.9 13.4 7.8 24.7 42.6 10.1 10.7 U2AF1L5 ENSG00000275895 "U2 small nuclear RNA auxiliary factor 1 like 5" P0DN76 21 6484623-6499261 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 74.4" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 20.7;Ciliated cells: 18.7;Club cells: 26.1;granulocytes: 27.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044833, HPA052083" Supported Uncertain Nucleoplasm NA NA Nucleoplasm "HPA044833: AB_10960990, HPA052083: AB_2681720" "unprognostic (6.54e-2)" "unprognostic (2.42e-1)" "unprognostic (2.75e-2)" "unprognostic (8.31e-3)" "unprognostic (2.80e-1)" "unprognostic (5.99e-2)" "unprognostic (2.02e-1)" "unprognostic (4.54e-2)" "unprognostic (1.48e-1)" "unprognostic (2.19e-2)" "unprognostic (1.70e-1)" "unprognostic (3.42e-2)" "unprognostic (5.39e-3)" "unprognostic (3.14e-1)" "unprognostic (2.79e-2)" "unprognostic (5.98e-2)" "unprognostic (8.20e-2)" 4.7 5.3 0.5 5.3 6.4 7.0 6.2 6.2 21.0 4.7 6.0 7.3 6.8 3.7 9.5 8.6 8.9 4.5 8.5 8.2 3.0 7.4 5.8 6.6 6.0 0.5 12.0 11.9 8.5 3.9 0.5 14.9 6.4 4.0 6.5 8.1 12.8 5.3 4.3 4.2 3.5 11.0 4.6 5.0 3.2 11.2 0.8 10.6 14.2 0.5 11.4 4.2 7.7 40.6 63.8 74.4 41.8 33.3 47.6 47.0 25.6 10.6 55.2 24.0 15.4 14.1 24.6 15.3 18.2 29.6 20.5 39.0 17.3 57.8 13.2 21.2 32.7 17.9 44.6 22.0 42.8 11.4 4.2 74.1 24.9 48.4 25.4 80.5 25.8 10.7 13.7 19.8 21.3 15.0 27.1 27.3 58.3 33.7 30.1 24.7 56.1 51.0 57.5 41.5 3.4 88.1 30.3 33.2 33.6 39.1 29.0 19.3 27.0 27.3 27.3 13.9 19.2 45.1 24.0 21.5 28.9 11.4 33.8 41.1 34.6 67.0 19.4 49.1 29.3 35.8 41.8 36.9 29.9 34.6 36.4 37.9 38.7 35.2 43.5 40.6 43.8 37.0 74.4 33.3 26.1 63.8 47.6 47.0 11.9 20.7 0.5 1.5 0.0 0.1 0.0 2.5 18.7 26.1 0.0 0.0 1.3 1.7 4.2 0.6 0.0 0.2 0.0 6.1 1.5 0.8 2.9 27.9 0.8 0.9 0.0 2.4 1.8 0.6 0.0 0.3 1.3 0.0 4.6 1.9 0.4 5.4 2.3 1.1 1.3 0.4 0.0 0.0 1.7 1.9 0.0 1.7 0.0 1.7 1.1 U2AF2 U2AF65 ENSG00000063244 "U2 small nuclear RNA auxiliary factor 2" P26368 19 55654146-55674715 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010910, HPA041943, HPA043562" Supported Supported Enhanced "Nucleoplasm,Nuclear speckles" NA NA "Nuclear speckles" Nucleoplasm "CAB010910: AB_262122, HPA041943: AB_2677760, HPA043562: AB_2678555" "unprognostic (2.37e-1)" "unprognostic (2.22e-1)" "unprognostic (3.12e-1)" "unprognostic (9.60e-2)" "unprognostic (6.94e-2)" "unprognostic (4.01e-2)" "prognostic unfavorable (1.54e-6)" "unprognostic (9.46e-2)" "unprognostic (1.36e-2)" "unprognostic (8.00e-2)" "unprognostic (3.33e-2)" "unprognostic (4.25e-3)" "unprognostic (2.19e-2)" "unprognostic (4.80e-2)" "unprognostic (9.88e-2)" "unprognostic (1.14e-1)" "unprognostic (3.08e-2)" 32.1 39.3 40.0 51.9 40.0 68.2 34.1 53.4 44.1 39.6 43.7 41.2 37.0 46.2 45.0 32.5 47.9 43.6 35.4 33.8 35.0 29.4 36.5 39.1 35.6 59.6 41.1 33.7 51.4 38.3 37.7 48.1 42.9 31.5 36.8 29.7 35.9 36.4 39.5 33.3 42.7 43.0 34.7 32.4 58.1 37.4 104.4 41.4 68.4 42.0 34.0 50.4 36.3 42.9 3.0 4.1 5.5 4.0 1.4 3.0 1.7 44.2 72.7 44.5 36.5 21.1 21.4 48.0 35.9 33.8 61.8 60.2 42.2 42.2 53.6 29.2 30.4 30.6 36.3 55.2 50.0 27.5 40.3 92.3 44.9 32.5 38.7 34.3 51.0 51.5 29.1 30.3 46.1 30.5 23.2 35.5 36.3 53.5 34.6 31.2 41.6 70.8 44.9 49.0 38.3 57.9 77.3 28.7 42.8 33.9 51.9 52.9 41.1 39.4 37.3 22.7 26.0 36.4 54.0 30.3 54.4 39.5 25.0 75.8 31.5 42.6 63.6 24.2 50.6 46.2 0.2 2.6 2.2 3.0 4.0 2.6 2.1 2.7 2.4 2.4 3.0 2.2 2.0 5.5 1.4 2.6 4.1 2.9 1.7 40.0 40.0 53.4 44.1 35.0 29.4 41.1 33.7 31.5 41.4 3.0 7.8 30.2 34.6 40.3 39.4 2.0 28.1 2.7 10.3 26.2 29.5 50.4 16.6 27.1 3.6 25.3 37.1 0.0 20.6 50.3 29.4 26.5 34.5 24.6 32.5 33.4 43.7 25.2 23.2 5.2 41.1 28.1 18.6 39.7 38.5 23.8 24.5 21.0 32.2 19.6 49.8 0.0 31.7 23.3 28.8 34.4 60.1 33.7 38.2 39.4 U2SURP "fSAPa, SR140" ENSG00000163714 "U2 snRNP associated SURP domain containing" O15042 3 142964497-143060546 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037545, HPA037546, HPA061407" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA037545: AB_10672598, HPA037546: AB_2675535, HPA061407: AB_2684506" "unprognostic (2.01e-1)" "unprognostic (9.78e-2)" "unprognostic (8.09e-2)" "prognostic unfavorable (8.44e-4)" "unprognostic (3.11e-2)" "unprognostic (4.30e-2)" "prognostic unfavorable (3.15e-5)" "unprognostic (3.72e-2)" "unprognostic (1.98e-2)" "unprognostic (9.61e-2)" "prognostic unfavorable (8.92e-4)" "unprognostic (2.85e-3)" "prognostic unfavorable (8.86e-7)" "unprognostic (6.71e-2)" "unprognostic (2.19e-1)" "unprognostic (3.12e-1)" "prognostic favorable (6.78e-4)" 21.2 17.7 21.3 17.6 30.8 48.2 24.0 29.7 27.9 26.3 20.3 18.8 18.0 12.9 24.3 22.2 22.3 19.2 12.7 16.6 18.4 16.4 17.8 22.1 17.9 26.8 24.5 24.8 28.4 22.8 22.3 39.6 21.7 25.8 21.2 20.7 19.2 18.6 15.8 26.4 21.9 22.1 26.0 26.6 23.5 18.3 19.2 27.3 32.3 21.2 16.5 24.5 23.2 19.0 33.8 31.2 19.9 25.7 18.4 26.6 11.3 38.0 12.8 14.3 9.6 7.6 7.1 24.9 17.2 11.1 19.9 14.9 17.0 11.7 44.0 18.5 11.1 38.2 13.8 29.4 15.3 22.8 11.9 20.6 47.7 11.8 13.5 7.9 46.2 18.0 8.6 7.7 15.4 19.7 8.9 10.7 28.2 29.3 14.1 9.2 10.7 22.9 20.2 23.1 12.2 12.0 23.4 28.1 18.4 10.0 24.1 18.5 10.8 34.6 11.4 20.2 15.5 20.3 20.0 11.7 10.8 12.7 8.4 27.6 16.9 21.6 75.4 8.6 16.8 14.8 18.9 19.7 18.3 25.2 18.6 22.0 31.7 23.1 22.3 15.4 33.8 26.6 22.8 19.9 18.4 25.7 31.2 22.1 11.3 21.3 30.8 29.7 27.9 18.4 16.4 24.5 24.8 25.8 27.3 110.2 113.9 58.8 76.8 54.0 118.7 107.4 50.9 109.7 113.7 59.3 62.8 66.9 44.7 59.1 24.0 69.2 40.4 23.3 69.1 74.2 66.7 59.6 93.8 51.4 53.1 87.4 53.0 59.5 57.8 14.6 100.7 82.2 49.0 103.6 66.5 100.5 72.4 56.1 75.0 46.0 116.0 77.6 76.2 174.5 202.9 56.7 66.1 72.6 70.6 61.5 UACA "FLJ10128, KIAA1561" ENSG00000137831 "Uveal autoantigen with coiled-coil domains and ankyrin repeats" Q9BZF9 15 70654554-70763593 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 68.0" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 148.5;Leydig cells: 115.9;Peritubular cells: 132.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "classical monocyte: 2.2;intermediate monocyte: 4.3;memory B-cell: 1.2;myeloid DC: 2.0;naive B-cell: 3.4;non-classical monocyte: 2.9" "Group enriched" "Detected in many" 11 "B-cells: 3.4;dendritic cells: 2.0;monocytes: 4.3" "Cell line enhanced" "Detected in many" "BJ: 62.0;BJ hTERT+: 37.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041412, HPA043503, HPA056006" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041412: AB_10966708, HPA043503: AB_2678517, HPA056006: " "unprognostic (1.58e-1)" "unprognostic (1.05e-1)" "unprognostic (2.56e-2)" "unprognostic (1.54e-1)" "unprognostic (2.79e-1)" "unprognostic (1.16e-1)" "unprognostic (1.19e-1)" "unprognostic (1.43e-2)" "unprognostic (1.12e-1)" "unprognostic (2.80e-1)" "prognostic unfavorable (7.01e-5)" "unprognostic (4.95e-2)" "prognostic unfavorable (1.62e-4)" "unprognostic (1.14e-3)" "unprognostic (1.45e-1)" "unprognostic (2.42e-2)" "prognostic unfavorable (1.03e-4)" 21.7 8.9 4.7 8.6 8.1 0.4 25.9 2.9 5.8 15.4 14.1 8.4 22.8 10.6 17.2 22.3 15.6 10.5 15.7 18.0 6.1 4.2 16.4 8.2 23.7 7.5 9.0 4.6 17.5 8.6 8.2 6.5 13.7 9.6 15.5 7.6 26.7 18.8 26.9 68.0 10.1 16.9 11.4 14.9 15.7 8.4 10.1 7.1 1.0 18.6 32.4 5.3 9.9 13.5 3.4 2.0 0.2 4.3 0.1 0.3 0.7 10.5 8.7 3.9 5.1 7.9 34.2 0.0 62.0 37.9 16.2 14.1 14.6 15.6 7.2 17.1 15.4 4.7 12.2 8.8 4.9 20.5 0.0 3.9 4.0 6.8 3.0 10.3 0.1 1.5 16.1 2.8 9.6 7.3 26.9 17.2 1.7 1.0 0.0 20.1 3.4 0.0 0.6 3.2 4.8 4.6 0.0 28.3 0.0 7.8 3.6 1.0 2.0 11.7 1.8 12.5 8.2 3.4 1.2 33.0 0.9 6.5 5.3 9.8 0.6 2.1 0.0 8.2 1.1 7.0 0.2 2.2 0.0 0.0 4.3 0.0 1.2 0.1 0.0 2.0 3.4 0.3 0.1 0.2 0.1 2.9 0.1 0.0 0.7 4.7 8.1 2.9 5.8 6.1 4.2 9.0 4.6 9.6 7.1 6.0 8.3 4.7 14.2 10.1 7.0 148.5 12.7 87.0 22.7 47.1 3.9 0.8 3.3 42.5 15.2 80.4 36.5 0.0 42.6 1.0 25.7 13.4 15.0 14.8 8.6 23.8 8.7 43.6 19.1 8.1 115.9 9.6 28.7 11.8 23.3 55.9 56.3 28.5 132.6 3.0 3.4 51.8 46.4 38.5 29.6 11.4 0.8 3.2 20.0 9.6 UAP1 "AgX, AGX1, SPAG2" ENSG00000117143 "UDP-N-acetylglucosamine pyrophosphorylase 1" Q16222 1 162561506-162599842 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 107.8;U-251 MG: 70.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014659 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" No Yes 19000 "Nucleoplasm, Plasma membrane, Cytosol" "HPA014659: AB_1857409" "unprognostic (2.32e-2)" "unprognostic (2.45e-1)" "unprognostic (2.07e-2)" "unprognostic (1.28e-2)" "unprognostic (2.71e-2)" "unprognostic (1.46e-2)" "unprognostic (1.37e-2)" "unprognostic (1.47e-1)" "unprognostic (2.09e-1)" "unprognostic (1.30e-1)" "unprognostic (1.29e-3)" "unprognostic (4.96e-2)" "prognostic unfavorable (5.12e-5)" "unprognostic (1.59e-1)" "unprognostic (2.04e-1)" "unprognostic (3.51e-1)" "unprognostic (3.45e-2)" 38.4 18.5 7.0 17.4 9.8 17.2 24.8 9.0 13.4 16.1 26.9 5.7 45.7 17.2 10.9 19.4 23.6 15.7 18.3 22.5 7.7 7.8 11.0 67.1 16.0 7.4 6.6 8.9 20.4 31.4 5.1 16.0 21.5 9.1 13.9 26.9 7.8 43.9 62.5 19.4 12.4 33.4 28.8 7.1 8.1 23.0 37.7 3.7 5.6 12.4 13.5 15.3 24.4 16.7 8.3 5.6 8.1 1.6 6.2 16.1 4.8 30.5 2.2 6.1 4.9 29.8 23.9 4.2 44.9 16.6 34.7 28.3 5.8 14.4 1.2 10.1 34.4 12.5 5.3 6.9 13.1 57.2 4.8 10.3 5.4 7.0 11.4 14.0 9.2 3.7 11.0 6.2 38.0 107.8 15.9 21.2 9.6 30.5 12.6 46.4 5.6 5.3 5.9 4.5 31.4 10.0 4.8 11.9 14.9 5.4 3.6 6.6 6.8 19.6 12.2 10.4 7.5 6.0 10.5 36.0 17.5 16.1 44.0 70.2 21.2 7.4 10.1 10.0 4.3 11.0 1.0 1.6 8.1 13.0 1.6 16.1 8.3 7.9 13.3 3.4 6.5 7.6 9.5 1.6 6.2 0.8 5.6 3.9 4.8 7.0 9.8 9.0 13.4 7.7 7.8 6.6 8.9 9.1 3.7 6.0 30.4 17.9 120.0 119.7 10.0 26.6 17.8 53.5 38.7 15.7 7.9 22.4 61.3 24.8 36.3 23.3 84.7 0.0 56.9 52.1 141.3 91.8 33.4 88.9 14.0 6.4 52.6 21.5 7.0 11.8 46.9 15.2 81.0 27.9 124.5 14.0 55.8 69.1 38.9 20.2 12.3 19.4 160.3 182.9 121.8 71.5 81.7 20.1 59.9 111.6 UBA1 "A1S9T, CFAP124, GXP1, POC20, UBE1, UBE1X" ENSG00000130985 "Ubiquitin like modifier activating enzyme 1" P22314 X 47190861-47215128 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Ligase "Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000289, HPA001506, CAB019435, CAB073410" Approved Supported Nucleoplasm NA NA 16000000 Nucleoplasm "CAB019435: AB_2211440, CAB073410: , HPA000289: AB_1080443, HPA001506: AB_2756305" "unprognostic (7.18e-3)" "unprognostic (1.52e-1)" "unprognostic (7.54e-2)" "unprognostic (2.40e-1)" "unprognostic (9.29e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (6.10e-5)" "unprognostic (7.22e-2)" "unprognostic (2.42e-3)" "unprognostic (3.43e-2)" "unprognostic (8.50e-3)" "unprognostic (2.17e-3)" "unprognostic (1.85e-3)" "unprognostic (1.13e-1)" "unprognostic (5.38e-2)" "prognostic favorable (1.78e-4)" "unprognostic (1.21e-2)" 45.6 63.0 56.0 47.2 50.6 42.0 38.3 58.1 75.7 48.0 39.3 55.9 44.9 36.3 52.9 34.1 59.4 56.0 39.9 48.7 49.5 39.9 51.1 60.0 42.0 48.2 47.7 62.3 57.6 34.9 78.8 55.5 39.1 47.6 40.2 35.5 41.0 47.5 45.7 77.7 56.1 37.9 59.4 35.5 53.4 38.7 36.0 48.6 52.7 65.0 43.9 54.0 39.2 52.7 28.9 30.6 32.6 36.0 25.6 29.0 24.1 46.0 47.9 54.8 83.2 37.5 34.2 24.2 30.7 32.7 44.2 36.0 38.0 35.2 34.4 20.4 61.4 65.4 44.6 68.7 65.3 32.4 28.5 69.8 21.5 53.1 30.5 26.4 36.2 46.5 32.1 34.2 64.2 50.1 31.6 57.8 41.4 23.3 30.9 43.8 58.4 34.1 32.0 58.4 27.9 74.9 39.8 38.3 58.5 35.3 49.7 35.5 26.7 91.4 44.5 20.4 61.4 61.8 22.6 42.2 33.2 38.5 47.7 28.6 21.2 22.0 49.1 34.1 25.9 39.6 17.4 27.0 27.4 29.0 36.0 25.4 28.9 24.0 25.9 30.6 22.0 19.1 23.4 32.6 25.6 32.8 20.8 28.2 24.1 56.0 50.6 58.1 75.7 49.5 39.9 47.7 62.3 47.6 48.6 47.6 32.5 35.6 30.6 29.9 25.4 44.0 71.4 29.4 29.6 78.5 15.7 42.1 29.9 67.7 29.3 28.1 83.5 23.3 78.8 52.0 36.1 52.8 17.4 40.8 53.6 11.1 55.2 46.1 45.1 41.8 39.1 34.8 18.6 66.7 64.2 20.0 108.7 57.9 61.9 49.5 24.4 38.8 40.3 8.8 19.6 36.8 59.5 26.6 52.5 48.1 UBA2 "ARX, FLJ13058, HRIHFB2115, SAE2" ENSG00000126261 "Ubiquitin like modifier activating enzyme 2" Q9UBT2 19 34428352-34471251 "Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Sertoli cells: 265.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041436 Supported Supported Nucleoplasm NA NA 9400000 Nucleoplasm "HPA041436: AB_2677479" "unprognostic (2.37e-1)" "unprognostic (3.17e-1)" "unprognostic (2.13e-2)" "unprognostic (1.36e-3)" "unprognostic (6.39e-3)" "unprognostic (8.72e-3)" "prognostic unfavorable (3.76e-4)" "unprognostic (1.96e-2)" "unprognostic (2.14e-2)" "unprognostic (1.21e-1)" "unprognostic (2.58e-1)" "unprognostic (2.65e-2)" "prognostic unfavorable (8.02e-4)" "unprognostic (1.63e-2)" "unprognostic (2.11e-2)" "unprognostic (2.00e-1)" "unprognostic (1.88e-1)" 49.2 23.5 25.1 29.5 28.4 30.6 70.9 44.3 30.4 26.5 25.4 20.7 24.0 17.8 32.3 24.2 27.4 25.1 23.7 31.0 25.6 27.7 22.8 25.5 24.5 37.8 26.9 23.2 30.3 29.4 28.8 26.8 39.1 25.1 25.1 23.9 20.7 20.9 31.5 56.3 29.2 20.4 28.8 27.4 28.6 20.9 56.7 19.9 55.9 25.9 27.1 34.4 29.2 38.9 8.6 10.8 7.7 6.2 8.5 13.0 3.6 28.9 42.4 43.5 18.0 23.6 19.3 17.8 22.6 19.5 29.3 32.8 36.3 17.7 54.2 35.0 18.4 18.2 11.8 46.0 17.6 41.4 38.8 31.1 57.5 21.7 36.2 30.5 45.6 25.0 13.9 22.5 20.7 36.5 19.7 22.9 23.4 56.9 30.8 25.7 28.9 35.1 25.3 32.6 45.3 14.7 28.0 30.0 24.1 20.6 30.3 37.0 36.3 20.6 19.0 30.4 29.6 13.6 56.0 14.8 33.0 23.0 21.0 40.5 32.5 46.1 52.5 20.9 34.9 29.0 5.9 4.8 7.7 8.4 5.0 11.2 8.5 10.5 12.1 6.0 8.6 13.0 10.4 0.6 8.5 6.2 10.8 8.0 3.6 25.1 28.4 44.3 30.4 25.6 27.7 26.9 23.2 25.1 19.9 23.8 33.6 45.4 55.0 77.3 59.3 31.9 22.9 29.4 30.7 17.4 39.3 60.6 28.2 38.5 10.7 46.7 15.5 23.3 36.4 83.5 49.3 42.2 38.1 23.6 41.7 44.5 44.2 20.3 31.3 18.0 40.3 35.2 72.6 45.1 28.5 45.3 35.2 21.0 49.8 28.3 35.0 265.1 176.3 193.3 196.1 81.2 77.6 35.2 44.9 68.2 UBA3 "hUba3, NAE2, UBE1C" ENSG00000144744 "Ubiquitin like modifier activating enzyme 3" Q8TBC4 3 69054730-69080408 "Predicted intracellular proteins" "Cell cycle, Ubl conjugation pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034873, HPA034874, HPA065335" Supported Approved "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" NA NA 9600 "Plasma membrane, Cytosol" "Nucleoplasm, Centrosome" "HPA034873: AB_10670578, HPA034874: AB_2674368, HPA065335: AB_2685473" "unprognostic (2.31e-1)" "unprognostic (1.75e-1)" "unprognostic (5.56e-3)" "unprognostic (9.26e-2)" "unprognostic (9.35e-3)" "unprognostic (5.53e-2)" "prognostic unfavorable (8.57e-4)" "unprognostic (1.08e-1)" "unprognostic (6.18e-2)" "unprognostic (1.60e-3)" "unprognostic (9.40e-2)" "unprognostic (2.71e-2)" "unprognostic (1.39e-3)" "unprognostic (2.61e-3)" "unprognostic (9.24e-2)" "unprognostic (7.80e-3)" "unprognostic (2.52e-1)" 19.1 25.3 29.7 22.2 31.0 53.7 26.8 30.9 31.4 20.3 19.7 31.3 15.9 16.1 22.8 25.4 25.4 19.5 18.4 38.2 23.8 22.7 24.7 17.6 19.3 28.7 37.5 21.2 20.4 15.1 17.9 28.0 27.8 40.8 22.6 22.6 21.8 28.0 20.4 25.0 27.6 21.9 24.0 30.2 27.8 17.3 13.5 31.9 28.4 18.2 17.2 31.0 22.9 20.4 18.9 22.3 35.6 27.8 20.2 22.2 26.0 26.8 11.4 28.1 17.1 26.3 34.9 21.7 24.1 27.3 26.3 26.5 14.1 19.0 20.5 7.0 25.9 26.5 15.5 21.6 27.6 30.0 37.3 13.7 27.7 21.5 14.2 20.3 27.1 23.3 27.4 18.5 24.8 20.8 32.4 33.8 16.9 11.4 17.6 34.6 9.6 17.8 18.3 24.9 34.1 9.8 13.9 20.8 18.8 41.9 34.4 12.1 16.9 25.4 18.5 20.6 31.6 12.6 26.7 25.6 20.0 17.6 25.9 33.4 20.2 32.3 24.4 20.5 30.2 25.4 34.7 25.4 35.6 14.3 27.8 16.1 18.9 18.9 17.6 22.3 16.0 17.9 18.0 24.4 20.2 27.7 11.4 22.2 26.0 29.7 31.0 30.9 31.4 23.8 22.7 37.5 21.2 40.8 31.9 32.8 28.9 17.1 23.8 30.0 21.0 57.2 20.4 37.5 23.9 33.2 37.3 64.4 16.6 30.4 10.9 27.1 14.3 0.0 20.5 47.2 31.1 21.5 40.5 16.2 30.1 31.8 17.9 20.3 43.2 7.9 37.4 39.1 28.7 53.3 15.3 27.7 25.3 8.6 35.7 26.4 44.9 25.8 29.3 32.3 33.0 37.4 47.5 33.8 16.6 28.2 UBA52 "CEP52, HUBCEP52, L40, MGC126879, MGC126881, MGC57125, RPL40" ENSG00000221983 "Ubiquitin A-52 residue ribosomal protein fusion product 1" P62987 19 18571730-18577550 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Late spermatids: 9484.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA041344, HPA049132, HPA056624" Supported Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "Nucleoplasm, Plasma membrane" "HPA041344: AB_2677422, HPA049132: AB_2680646, HPA056624: AB_2683196" "unprognostic (1.98e-2)" "unprognostic (9.35e-2)" "unprognostic (1.46e-1)" "unprognostic (4.72e-2)" "unprognostic (5.36e-3)" "unprognostic (9.35e-2)" "unprognostic (1.74e-3)" "unprognostic (4.00e-2)" "unprognostic (7.44e-2)" "unprognostic (1.72e-1)" "unprognostic (1.27e-1)" "unprognostic (2.87e-1)" "unprognostic (2.52e-3)" "unprognostic (1.87e-1)" "unprognostic (5.61e-2)" "unprognostic (2.43e-1)" "unprognostic (2.23e-1)" 84.7 73.8 71.1 76.4 76.5 167.0 101.5 32.8 71.1 83.2 73.0 48.7 67.8 47.7 79.0 93.2 102.7 78.8 82.0 85.9 58.2 50.2 74.1 135.5 67.7 182.7 64.0 59.0 150.3 225.2 56.5 62.8 71.6 55.5 75.8 74.0 51.6 96.0 75.2 191.4 104.6 68.0 91.9 72.0 101.1 75.5 89.5 52.1 121.2 97.6 131.7 145.1 99.9 161.7 200.5 157.0 75.1 132.4 109.7 205.0 246.6 104.4 83.5 62.7 104.6 163.0 155.1 155.6 80.7 112.1 134.1 107.1 151.2 97.9 151.5 83.5 133.0 52.8 70.9 121.3 143.5 126.9 40.6 189.4 82.9 129.9 170.4 118.7 179.8 106.3 179.4 196.4 91.9 133.7 117.4 134.3 97.0 131.1 210.1 114.3 174.9 143.6 161.4 140.3 199.6 180.9 118.8 62.6 173.5 129.2 158.9 81.8 99.0 58.6 142.1 139.9 97.9 63.0 232.8 99.7 67.3 56.3 141.7 142.6 129.4 171.7 149.9 91.6 204.3 91.1 50.7 132.4 69.8 119.4 107.2 162.2 200.5 178.5 142.6 147.6 199.1 205.0 165.6 75.1 109.7 96.1 157.0 138.5 246.6 71.1 76.5 32.8 71.1 58.2 50.2 64.0 59.0 55.5 52.1 431.7 622.2 2582.1 1573.2 1686.3 110.3 294.0 1008.9 451.1 705.2 621.1 64.8 1723.9 1331.3 1227.6 2621.0 1327.6 1318.3 1448.3 1974.2 2396.3 1301.0 1468.3 776.0 1485.4 2254.1 98.5 1063.9 1146.6 2650.9 9484.0 1736.3 2494.7 1186.1 2394.1 1524.2 239.6 1703.1 1730.2 972.7 1715.5 163.6 685.6 1317.8 523.4 597.0 1957.5 1909.1 1690.5 1603.6 1847.3 UBA6 "FLJ10808, UBE1L2" ENSG00000033178 "Ubiquitin like modifier activating enzyme 6" A0AVT1 4 67612652-67701179 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Urothelial cells: 126.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037001 Approved Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA037001: AB_10672787" "unprognostic (2.52e-1)" "unprognostic (4.89e-2)" "unprognostic (3.97e-3)" "unprognostic (2.81e-1)" "unprognostic (3.67e-2)" "unprognostic (4.92e-2)" "unprognostic (3.55e-3)" "unprognostic (6.06e-3)" "unprognostic (1.09e-1)" "unprognostic (1.10e-2)" "unprognostic (3.38e-2)" "unprognostic (5.30e-2)" "prognostic unfavorable (7.01e-5)" "unprognostic (2.35e-1)" "unprognostic (1.83e-1)" "unprognostic (4.33e-2)" "unprognostic (4.05e-3)" 16.8 12.6 14.1 14.1 16.6 22.7 13.0 18.0 16.0 17.0 10.5 14.6 7.0 12.2 16.7 10.0 20.5 9.9 12.4 9.5 12.0 12.0 10.2 16.4 14.5 17.3 18.7 11.2 14.3 10.9 17.4 44.8 18.5 17.7 12.7 13.2 7.5 13.7 10.4 10.1 12.6 15.3 13.4 20.7 16.9 13.9 14.6 18.6 27.1 12.3 13.3 19.9 15.7 19.5 5.6 5.1 9.3 4.0 9.7 5.8 1.9 15.1 8.5 14.1 11.0 7.0 8.2 9.5 31.4 12.3 14.4 16.9 8.9 20.5 19.2 11.2 12.9 14.7 9.0 14.5 15.6 21.8 22.1 4.0 12.3 15.0 8.3 6.0 21.6 9.5 5.9 5.0 18.6 11.3 9.9 12.7 9.9 29.2 11.4 17.0 5.7 22.4 4.9 8.3 10.8 10.3 13.3 28.9 7.1 11.8 17.2 6.9 8.7 17.7 12.6 5.9 12.3 8.4 5.8 18.3 13.4 15.1 10.8 13.7 8.2 6.4 19.4 23.8 6.0 12.8 9.3 3.0 4.6 4.4 3.9 4.8 5.6 5.1 5.8 3.7 5.2 3.9 4.5 2.2 9.7 4.0 5.1 4.2 1.9 14.1 16.6 18.0 16.0 12.0 12.0 18.7 11.2 17.7 18.6 23.8 20.8 33.8 52.9 62.3 46.2 14.4 12.7 25.4 20.5 15.7 51.1 22.4 3.3 21.4 1.4 34.4 21.2 0.0 14.8 12.9 28.2 64.5 30.1 17.3 20.5 31.8 31.0 17.8 27.9 4.0 19.8 35.3 23.6 33.3 24.7 19.8 36.7 21.0 18.7 10.2 42.3 19.4 23.0 37.9 35.1 40.4 49.2 29.9 19.6 126.8 UBA7 "D8, UBA1B, UBE1L, UBE2" ENSG00000182179 "Ubiquitin like modifier activating enzyme 7" P41226 3 49805207-49813946 "Plasma proteins, Predicted membrane proteins" "Ubl conjugation pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "granulocytes: 80.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 22.7;HEL: 21.2;HMC-1: 41.2;HSkMC: 19.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB015444, HPA058182" Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA 1400000 "Nucleoplasm, Vesicles" Cytosol "CAB015444: AB_793598, HPA058182: AB_2683631" "prognostic favorable (1.55e-4)" "unprognostic (7.07e-3)" "unprognostic (1.59e-2)" "unprognostic (1.61e-2)" "unprognostic (3.77e-1)" "unprognostic (2.31e-2)" "unprognostic (5.08e-3)" "unprognostic (3.61e-2)" "unprognostic (6.33e-2)" "unprognostic (2.00e-1)" "unprognostic (1.40e-1)" "unprognostic (2.17e-1)" "prognostic unfavorable (1.04e-5)" "unprognostic (9.11e-2)" "unprognostic (3.81e-2)" "unprognostic (1.57e-1)" "prognostic favorable (1.48e-4)" 11.3 12.1 6.8 22.0 7.5 16.0 11.5 2.0 6.7 10.8 12.7 14.4 25.4 19.6 17.2 31.6 17.7 12.9 33.1 9.1 6.7 3.9 15.9 11.9 18.8 28.2 6.0 6.2 19.1 9.5 1.4 8.4 8.9 9.4 18.5 12.1 14.2 24.5 34.2 3.3 9.0 25.5 11.3 7.7 35.9 13.2 3.4 5.9 20.4 17.8 18.4 23.5 12.6 13.1 12.4 14.3 24.8 21.7 11.1 11.8 13.0 4.3 0.0 0.3 0.1 12.2 12.9 1.4 2.3 10.6 16.9 22.7 0.0 9.3 0.1 1.9 8.6 7.3 2.4 0.0 4.2 1.5 11.3 0.0 21.2 0.2 1.3 9.0 2.0 41.2 19.8 0.2 6.6 0.4 11.8 8.5 0.7 0.0 1.3 3.9 0.1 4.3 5.1 0.0 0.0 0.4 5.5 0.4 0.7 3.5 8.6 0.0 0.3 2.8 4.2 1.4 0.2 0.4 14.1 3.7 3.3 0.4 1.4 0.9 0.0 0.0 0.1 9.2 7.5 0.7 13.9 14.7 24.8 11.8 21.7 10.3 12.3 10.8 10.5 14.3 12.4 9.9 8.9 4.6 11.1 17.2 5.2 10.6 13.0 6.8 7.5 2.0 6.7 6.7 3.9 6.0 6.2 9.4 5.9 29.8 23.6 22.9 5.9 3.4 0.1 6.9 15.3 2.7 13.6 12.2 0.0 4.5 0.0 7.6 4.5 14.3 35.5 0.0 6.9 2.2 8.9 5.1 80.8 6.7 18.2 0.0 9.1 17.8 21.9 24.1 10.3 10.6 0.0 10.8 19.5 2.9 5.1 12.9 10.6 4.1 1.1 6.5 7.1 0.9 0.4 4.1 2.4 27.4 15.3 5.0 UBALD1 FAM100A ENSG00000153443 "UBA like domain containing 1" Q8TB05 16 4608883-4615027 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA066771 Approved Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cytosol" "Cell Junctions" "HPA066771: AB_2685717" "unprognostic (7.09e-2)" "unprognostic (2.21e-2)" "unprognostic (1.55e-1)" "unprognostic (7.67e-3)" "unprognostic (1.27e-1)" "unprognostic (1.37e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-1)" "unprognostic (2.54e-1)" "unprognostic (4.37e-3)" "unprognostic (2.63e-3)" "unprognostic (8.06e-2)" "unprognostic (1.95e-3)" "unprognostic (2.35e-1)" "unprognostic (3.99e-2)" "unprognostic (6.20e-2)" "unprognostic (1.35e-2)" 23.0 16.7 20.5 17.9 25.0 37.5 11.9 32.4 39.2 12.1 19.3 15.1 11.7 23.7 20.4 11.0 15.0 13.9 12.4 14.8 20.9 14.2 19.6 32.9 15.7 13.8 12.0 22.2 14.8 27.2 9.0 12.1 27.9 16.9 18.9 5.3 13.6 19.4 18.1 38.3 16.7 19.5 14.2 11.5 23.9 25.9 13.2 13.0 9.9 17.3 11.3 11.6 17.8 12.8 1.9 2.8 11.3 4.5 1.5 2.6 1.5 5.4 15.9 3.8 5.9 2.5 3.3 17.0 8.3 3.4 3.2 4.6 7.8 6.5 8.2 9.3 2.6 2.4 15.2 2.4 8.4 0.9 17.1 24.2 7.6 16.6 12.0 5.2 4.7 13.1 4.7 6.3 4.9 2.4 3.7 3.4 6.3 11.5 8.6 1.2 27.1 7.9 26.0 14.2 4.9 14.1 11.4 4.7 26.4 2.8 8.0 11.0 10.1 9.8 15.2 13.0 2.3 9.7 7.8 10.1 6.5 7.4 26.1 5.3 16.8 13.5 9.2 2.6 6.5 3.4 1.3 2.3 11.3 2.5 3.5 1.6 1.9 2.0 2.6 2.8 1.8 2.1 2.2 3.9 1.5 4.5 1.8 2.4 1.5 20.5 25.0 32.4 39.2 20.9 14.2 12.0 22.2 16.9 13.0 8.9 8.0 9.8 49.6 97.9 8.9 3.6 7.6 2.7 7.9 17.4 3.9 58.7 26.6 19.0 30.4 15.8 17.3 0.0 20.4 54.1 23.1 30.9 10.4 31.6 20.8 9.5 81.1 15.4 16.8 89.2 15.0 18.1 20.3 17.2 21.3 12.0 21.6 17.5 18.7 33.8 8.7 45.3 30.6 11.5 17.7 89.8 90.2 15.3 12.8 32.8 UBASH3A "CLIP4, STS-2, TULA" ENSG00000160185 "Ubiquitin associated and SH3 domain containing A" P57075 21 42403447-42447681 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 17.6;lymphoid tissue: 62.3" "Cell type enriched" "Detected in some" 14 "T-cells: 16.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 11 "gdT-cell: 6.9;MAIT T-cell: 12.1;memory CD4 T-cell: 15.1;memory CD8 T-cell: 13.1;naive CD4 T-cell: 17.6;naive CD8 T-cell: 12.8;T-reg: 13.6" "Lineage enriched" "Detected in many" 15 "T-cells: 17.6" "Group enriched" "Detected in some" 6 "HEL: 13.4;JURKAT: 23.5;MOLT-4: 27.5" "Region enriched" "Detected in single" 13 "hippocampal formation: 0.5" "Low region specificity" "Detected in all" HPA035367 Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA035367: AB_2732466" "unprognostic (5.14e-4)" "unprognostic (3.91e-4)" "unprognostic (1.57e-2)" "unprognostic (4.10e-5)" "unprognostic (4.33e-2)" "unprognostic (1.85e-6)" "unprognostic (5.54e-4)" "unprognostic (1.46e-3)" "unprognostic (6.17e-4)" "unprognostic (2.47e-3)" "unprognostic (1.94e-2)" "unprognostic (1.81e-1)" "unprognostic (2.37e-6)" "unprognostic (1.65e-1)" "unprognostic (7.96e-2)" "unprognostic (3.24e-2)" "unprognostic (4.17e-2)" 1.1 0.7 0.3 19.7 0.3 2.6 0.8 0.3 0.3 0.9 2.8 0.1 0.0 1.9 0.8 0.8 1.2 1.3 3.2 1.1 0.3 0.4 1.4 1.1 6.0 23.1 0.4 0.0 0.7 0.6 0.0 0.6 0.4 0.3 1.2 1.0 1.1 5.0 0.2 0.3 0.5 5.9 0.6 0.7 10.8 2.2 0.4 0.0 62.3 1.4 1.1 14.1 2.6 1.1 0.0 0.0 0.3 0.0 1.1 17.6 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 13.4 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 23.5 2.5 0.0 0.0 0.0 27.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 12.1 0.0 15.1 13.1 0.0 0.0 17.6 12.8 0.3 1.1 0.0 0.0 13.6 5.1 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.1 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 16.2 0.0 0.0 UBD FAT10 ENSG00000213886 "Ubiquitin D" O15205 6 29555515-29559925 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 53.2" "Group enriched" "Detected in some" 16 "Ductal cells: 316.2;Exocrine glandular cells: 231.1;monocytes: 265.1;Pancreatic endocrine cells: 685.5" "Cancer enhanced" "Detected in all" "liver cancer: 75.1" "Region enriched" "Detected in single" 5 "pons and medulla: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 13 "RT4: 13.8" "Not detected" "Not detected" HPA043710 Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA043710: AB_2756303" "unprognostic (2.99e-3)" "unprognostic (4.16e-2)" "unprognostic (6.37e-2)" "unprognostic (2.61e-2)" "unprognostic (3.93e-2)" "unprognostic (3.53e-3)" "unprognostic (1.60e-1)" "unprognostic (9.47e-2)" "unprognostic (1.44e-2)" "prognostic favorable (7.35e-4)" "unprognostic (1.28e-2)" "unprognostic (6.43e-2)" "prognostic unfavorable (2.40e-5)" "unprognostic (4.04e-2)" "unprognostic (6.02e-2)" "unprognostic (8.40e-2)" "unprognostic (1.21e-2)" 3.4 0.4 0.0 53.2 0.0 0.4 1.8 0.0 0.4 0.7 1.8 0.0 0.0 1.5 0.6 1.6 4.2 1.2 2.9 1.8 0.0 0.0 13.4 16.3 5.1 26.3 0.0 0.0 0.5 14.6 0.4 0.7 0.4 1.0 5.6 3.0 1.0 11.3 0.7 3.1 0.6 15.5 0.7 0.2 18.6 3.5 0.4 0.0 26.3 2.7 4.5 50.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 3.0 1.9 0.0 0.0 0.1 0.0 0.0 22.9 16.0 15.9 0.0 0.0 0.0 1.7 316.2 0.0 0.0 3.3 0.0 231.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 3.5 0.0 0.8 0.0 0.0 0.0 0.0 265.1 3.1 0.0 685.5 6.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 UBE2A "HHR6A, RAD6A, UBC2" ENSG00000077721 "Ubiquitin conjugating enzyme E2 A" P49459 X 119574467-119591083 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Chromatin regulator, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Syncytiotrophoblasts: 425.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003875, HPA051765, HPA065898" Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" "Vesicles, Cytosol" "HPA003875: AB_2667061, HPA051765: AB_2681597, HPA065898: AB_2685577" "unprognostic (2.27e-3)" "prognostic favorable (2.16e-4)" "unprognostic (1.12e-1)" "unprognostic (9.09e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (9.07e-4)" "unprognostic (1.66e-3)" "unprognostic (1.96e-2)" "unprognostic (6.54e-2)" "unprognostic (2.96e-2)" "unprognostic (3.49e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (2.20e-6)" "unprognostic (9.54e-2)" "unprognostic (3.06e-2)" "unprognostic (1.21e-1)" "unprognostic (7.92e-2)" 24.8 20.6 26.7 23.1 24.6 16.8 32.5 20.2 24.2 23.7 32.8 23.9 20.2 21.7 23.8 26.7 37.2 20.3 21.2 42.2 23.6 22.1 32.2 26.6 22.8 26.3 26.8 19.7 18.7 17.2 24.3 18.2 112.4 24.7 20.4 30.2 20.0 21.0 22.6 46.8 23.6 29.2 27.9 29.1 25.1 20.4 17.0 19.5 36.3 23.2 32.8 31.5 26.7 24.0 21.0 29.0 34.1 36.3 12.8 21.2 17.4 31.1 26.3 16.6 14.0 29.0 35.8 15.5 32.4 28.9 38.5 36.6 13.6 21.5 24.7 32.9 35.6 64.7 22.5 23.6 17.1 37.2 34.2 14.0 10.9 21.0 12.1 26.6 27.2 18.8 24.4 24.5 37.0 16.1 27.2 26.7 22.1 13.4 22.1 43.6 33.0 42.0 25.8 27.6 32.9 29.8 21.5 17.6 23.0 31.1 20.5 12.7 13.1 43.0 19.8 23.5 21.6 17.3 23.9 26.0 24.8 11.1 48.9 36.5 21.4 34.8 24.3 26.4 34.6 19.3 16.5 22.7 34.1 18.1 35.4 14.3 21.0 15.7 15.8 29.0 18.8 10.0 14.3 30.1 12.8 36.3 23.0 21.2 17.4 26.7 24.6 20.2 24.2 23.6 22.1 26.8 19.7 24.7 19.5 95.3 39.2 51.3 71.2 110.8 14.0 62.9 48.4 83.0 53.4 38.4 29.5 150.4 86.2 88.0 32.0 62.8 76.2 46.7 89.2 129.6 86.9 77.3 55.4 31.6 116.0 7.9 43.7 44.2 59.6 10.6 34.2 89.3 79.2 168.7 43.9 37.6 102.2 80.7 38.2 92.2 34.3 45.3 103.2 39.1 30.0 111.8 425.3 58.0 43.9 88.5 UBE2B "HHR6B, RAD6B, UBC2" ENSG00000119048 "Ubiquitin conjugating enzyme E2 B" P63146 5 134371179-134391992 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 106.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 83.3" "Lineage enriched" "Detected in all" 6 "granulocytes: 83.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003875, HPA051765, HPA065898" Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" "Vesicles, Cytosol" "HPA003875: AB_2667061, HPA051765: AB_2681597, HPA065898: AB_2685577" "unprognostic (1.98e-1)" "unprognostic (1.35e-1)" "unprognostic (7.39e-2)" "unprognostic (6.66e-2)" "unprognostic (1.44e-1)" "unprognostic (1.48e-2)" "unprognostic (2.56e-1)" "unprognostic (1.27e-1)" "unprognostic (1.91e-1)" "unprognostic (2.44e-1)" "unprognostic (2.49e-1)" "unprognostic (8.39e-2)" "unprognostic (1.64e-3)" "unprognostic (6.30e-3)" "unprognostic (3.42e-2)" "unprognostic (2.04e-1)" "unprognostic (5.52e-2)" 17.7 27.7 20.4 17.0 16.6 25.9 22.8 16.2 28.3 13.8 18.0 7.9 11.6 14.4 19.4 17.0 25.6 13.6 18.3 59.2 20.3 16.4 17.8 19.8 21.8 18.7 13.8 18.7 16.7 26.4 7.8 16.2 27.8 17.6 15.4 15.1 10.2 16.1 18.5 106.5 15.9 16.2 21.6 15.1 16.6 14.1 21.7 12.7 13.2 18.2 34.0 16.3 19.2 22.8 9.6 8.8 83.3 14.1 9.6 14.6 10.5 35.5 9.3 19.6 18.6 17.1 18.5 31.6 26.7 14.1 17.2 20.5 28.3 23.9 19.4 32.3 17.0 47.0 14.2 14.8 19.7 18.8 30.7 16.0 10.6 25.9 30.3 20.0 12.6 21.9 15.9 27.0 15.6 13.2 23.2 14.7 16.2 19.5 35.3 15.5 20.7 20.0 33.4 8.4 10.6 8.9 20.2 21.6 27.0 15.4 27.5 26.5 20.6 21.0 9.9 46.4 22.2 21.3 34.8 29.1 20.0 14.0 26.9 29.2 29.5 40.3 27.4 22.6 23.9 19.9 34.7 11.5 31.2 9.4 12.5 8.6 9.6 12.0 9.5 7.9 9.6 14.6 12.3 83.3 9.6 14.1 8.8 14.1 10.5 20.4 16.6 16.2 28.3 20.3 16.4 13.8 18.7 17.6 12.7 68.5 53.6 80.6 311.1 324.0 73.3 287.9 109.5 50.9 37.5 71.5 76.6 127.7 145.9 138.0 194.0 119.9 104.0 210.2 148.2 103.0 162.4 304.2 116.3 90.1 106.8 82.6 126.4 82.3 121.3 244.2 143.5 139.6 215.9 189.4 109.5 124.2 180.7 129.8 106.4 130.7 89.5 148.8 178.2 201.6 171.6 323.2 605.1 89.5 82.7 405.3 UBE2E1 UbcH6 ENSG00000170142 "Ubiquitin conjugating enzyme E2 E1" P51965 3 23805903-23891316 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030445, CAB073413" Approved Approved Nucleoplasm NA NA Nucleoplasm "CAB073413: , HPA030445: AB_10669599" "unprognostic (7.50e-2)" "unprognostic (2.78e-2)" "unprognostic (7.91e-3)" "unprognostic (7.13e-2)" "unprognostic (6.74e-3)" "unprognostic (1.74e-1)" "prognostic unfavorable (9.97e-7)" "unprognostic (3.69e-2)" "unprognostic (3.53e-2)" "unprognostic (1.34e-2)" "unprognostic (5.36e-3)" "unprognostic (2.70e-2)" "unprognostic (2.40e-2)" "unprognostic (1.94e-1)" "unprognostic (2.94e-1)" "unprognostic (2.75e-1)" "unprognostic (1.93e-1)" 32.0 28.1 50.8 34.7 44.4 56.1 52.6 38.7 43.4 41.9 40.6 32.4 27.5 23.9 35.3 35.6 57.9 29.5 29.9 58.5 47.3 43.2 33.6 34.0 34.9 44.9 52.0 36.9 36.5 32.0 41.6 22.5 44.5 38.1 38.5 37.8 23.2 30.3 36.4 52.2 33.3 25.8 44.1 55.6 36.3 29.9 24.3 43.3 33.8 41.4 38.0 47.3 52.2 46.3 6.7 7.6 6.8 9.1 7.0 7.2 4.1 33.9 21.4 33.7 16.8 20.6 30.1 29.5 25.7 40.0 28.9 38.8 16.1 37.6 30.1 21.8 24.8 24.6 11.0 39.8 31.8 37.9 36.3 44.5 41.5 16.1 19.6 29.7 40.9 22.1 28.4 30.0 36.8 49.5 34.0 45.9 21.1 29.0 33.5 23.1 17.5 28.7 44.5 49.5 18.7 54.9 32.0 14.8 86.5 45.0 24.3 9.8 35.1 23.0 21.4 37.0 35.2 24.0 54.1 29.8 21.2 26.3 15.7 19.1 28.0 16.5 59.5 22.9 39.3 16.4 2.4 8.4 6.8 4.5 9.1 6.5 6.5 5.4 3.8 7.3 6.7 7.2 4.3 3.3 7.0 5.8 7.6 3.9 4.1 50.8 44.4 38.7 43.4 47.3 43.2 52.0 36.9 38.1 43.3 41.7 28.2 30.6 52.3 64.2 26.4 54.9 28.1 46.8 28.4 17.4 3.9 83.0 48.0 80.0 20.6 53.7 35.4 0.0 68.5 82.1 57.3 58.6 40.3 19.1 88.2 19.1 44.5 42.4 63.6 39.3 37.7 75.5 92.8 111.0 36.1 49.9 62.2 59.6 45.6 32.6 20.9 51.8 80.2 36.3 62.2 78.9 60.3 35.4 44.6 59.6 UBE2E2 "FLJ25157, UbcH8" ENSG00000182247 "Ubiquitin conjugating enzyme E2 E2" Q96LR5 3 23203020-23591793 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 15.2;intermediate monocyte: 17.8;memory B-cell: 12.3;myeloid DC: 20.9;naive B-cell: 14.8;non-classical monocyte: 18.3;plasmacytoid DC: 27.1" "Group enriched" "Detected in many" 6 "B-cells: 14.8;dendritic cells: 27.1;monocytes: 18.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003303, HPA028872, HPA030445, CAB073417" Approved Approved Nucleoplasm No No Nucleoplasm "CAB073417: , HPA003303: AB_1858521, HPA028872: AB_10966277, HPA030445: AB_10669599" "unprognostic (2.20e-1)" "unprognostic (2.30e-1)" "unprognostic (1.52e-2)" "unprognostic (3.68e-3)" "unprognostic (3.74e-2)" "unprognostic (1.70e-1)" "unprognostic (9.19e-3)" "unprognostic (3.11e-3)" "unprognostic (1.32e-1)" "unprognostic (1.20e-1)" "unprognostic (4.20e-1)" "unprognostic (4.59e-2)" "unprognostic (1.60e-1)" "unprognostic (1.44e-2)" "unprognostic (2.68e-2)" "unprognostic (3.11e-2)" "unprognostic (6.11e-3)" 22.7 11.4 19.2 12.0 23.3 7.6 15.9 18.8 32.7 22.4 14.5 20.8 7.5 5.9 17.7 31.9 19.7 12.0 18.5 23.4 21.3 21.8 19.1 15.8 16.7 17.7 14.1 19.7 19.0 9.8 15.5 14.4 9.0 20.9 18.2 6.4 8.4 11.2 17.0 32.0 14.8 7.2 22.4 17.6 15.9 11.1 17.8 13.3 14.8 16.8 11.1 14.5 17.0 16.2 14.8 27.1 0.4 18.3 0.8 3.6 5.2 17.1 6.2 16.3 0.3 14.5 16.2 14.8 10.8 18.5 10.2 14.4 1.7 14.1 14.9 7.5 9.5 14.1 1.7 11.8 16.9 13.2 0.1 11.9 0.0 7.3 2.0 10.4 0.0 12.0 12.8 17.8 14.7 24.8 10.5 9.8 11.8 0.8 15.9 9.2 2.7 7.8 3.3 11.6 9.8 9.0 16.4 6.3 17.1 10.0 0.4 4.2 8.7 11.9 7.0 0.2 12.3 15.0 9.9 8.5 10.1 14.3 6.7 12.2 15.3 5.0 22.0 9.5 6.7 2.8 0.0 15.2 0.0 0.2 17.8 0.3 12.3 0.5 0.2 20.9 14.8 3.6 1.3 0.4 0.8 18.3 27.1 0.2 5.2 19.2 23.3 18.8 32.7 21.3 21.8 14.1 19.7 20.9 13.3 20.8 9.8 36.3 10.5 22.8 22.7 32.7 20.4 5.3 4.5 29.6 15.7 28.0 58.0 12.3 17.6 20.4 0.0 0.0 25.6 33.5 29.3 47.2 0.0 38.4 44.7 30.2 1.7 14.7 43.5 12.0 36.5 55.4 74.2 35.1 0.7 10.9 13.5 0.3 49.8 98.2 2.9 32.3 50.9 33.5 99.2 36.9 32.3 2.5 0.5 5.1 UBE2G1 "UBC7, UBE2G" ENSG00000132388 "Ubiquitin conjugating enzyme E2 G1" P62253 17 4269259-4366628 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 95.6" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 254.1;Suprabasal keratinocytes: 209.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045681, HPA050551" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA045681: AB_2679417, HPA050551: AB_2681171" "unprognostic (1.57e-3)" "unprognostic (1.94e-1)" "unprognostic (2.34e-2)" "unprognostic (1.80e-2)" "unprognostic (5.16e-2)" "unprognostic (5.84e-2)" "unprognostic (1.87e-1)" "unprognostic (2.64e-2)" "unprognostic (5.13e-2)" "unprognostic (1.86e-1)" "unprognostic (2.80e-1)" "unprognostic (1.67e-2)" "unprognostic (9.99e-2)" "unprognostic (2.16e-1)" "unprognostic (4.58e-2)" "unprognostic (3.97e-2)" "unprognostic (6.50e-2)" 10.8 11.1 12.6 17.8 13.5 14.3 11.2 11.6 15.3 13.0 19.4 17.8 8.9 11.9 13.3 8.5 27.4 9.2 9.7 26.9 13.5 11.2 14.6 17.7 8.9 18.7 15.2 9.7 9.1 17.1 12.0 6.0 11.4 14.5 14.0 13.3 8.8 11.9 12.0 95.6 14.1 16.6 14.6 19.4 15.0 11.9 11.8 13.6 21.3 12.5 20.7 23.3 17.7 16.5 23.7 13.1 24.4 11.5 20.5 20.6 13.1 21.2 23.1 21.6 15.8 17.7 18.7 30.8 20.8 16.7 19.8 17.5 15.9 10.9 33.4 21.8 20.4 16.2 23.1 26.8 19.3 32.0 17.5 21.8 12.5 12.3 18.1 17.4 18.1 23.7 15.9 28.9 18.8 27.4 14.0 26.5 22.5 21.8 36.2 16.3 9.5 23.0 16.6 23.8 15.8 12.0 29.9 11.4 30.5 23.1 14.0 9.3 17.4 19.6 17.1 16.1 33.3 16.7 11.9 19.8 19.9 15.2 23.3 23.2 14.1 16.5 47.2 15.3 17.0 15.3 8.1 10.3 24.4 15.4 10.8 20.6 23.7 20.1 20.1 13.1 15.5 20.2 20.5 18.6 20.5 11.5 9.6 18.3 13.1 12.6 13.5 11.6 15.3 13.5 11.2 15.2 9.7 14.5 13.6 20.8 11.8 63.6 34.1 254.1 16.5 62.6 30.6 13.4 13.6 24.4 5.9 36.7 69.6 27.6 105.5 28.7 35.4 0.0 23.2 45.9 34.4 47.3 20.7 52.9 41.3 14.3 36.9 32.5 36.1 173.0 18.1 34.1 64.1 33.3 32.7 23.0 32.9 27.5 19.8 61.3 13.9 6.5 47.9 63.9 47.7 209.5 55.8 43.3 26.8 53.3 UBE2L3 UBCH7 ENSG00000185651 "Ubiquitin conjugating enzyme E2 L3" P68036 22 21549447-21624034 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 110.3" "HPA045609, HPA062415" Approved Approved Nucleoplasm,Cytosol NA NA 8800000 "Nucleoplasm, Cytosol" "HPA045609: AB_10961322, HPA062415: AB_2684756" "unprognostic (4.90e-2)" "unprognostic (3.05e-1)" "unprognostic (1.92e-2)" "unprognostic (1.07e-2)" "unprognostic (2.74e-2)" "unprognostic (9.99e-3)" "prognostic unfavorable (1.29e-4)" "unprognostic (3.28e-2)" "unprognostic (3.65e-2)" "prognostic favorable (3.82e-6)" "unprognostic (3.53e-2)" "unprognostic (4.55e-2)" "unprognostic (3.18e-2)" "unprognostic (4.66e-2)" "unprognostic (5.09e-2)" "unprognostic (2.77e-1)" "unprognostic (3.15e-3)" 27.8 34.9 34.8 23.5 29.6 31.3 24.9 25.5 36.9 25.9 27.7 38.4 22.8 26.4 25.6 29.2 38.0 26.9 23.0 33.0 30.7 30.8 27.4 36.0 23.5 32.5 34.3 33.1 24.3 23.9 24.3 21.7 30.1 36.9 27.5 31.7 29.3 30.6 26.7 43.5 23.9 34.4 33.1 36.2 28.5 25.1 35.7 22.6 25.3 25.0 32.4 33.9 28.4 22.2 34.7 49.9 46.1 45.8 34.6 46.9 54.9 24.9 14.4 21.1 16.5 23.1 20.7 12.2 21.1 24.1 27.1 25.8 16.4 12.1 23.6 10.6 27.9 20.5 21.4 28.1 22.9 27.1 23.5 30.4 27.3 14.1 19.5 15.4 39.0 19.7 18.2 20.0 19.7 14.3 19.6 30.4 14.7 110.3 12.7 29.3 18.4 20.2 28.2 15.5 28.0 15.2 16.6 31.8 6.4 25.4 20.1 19.0 14.1 16.8 21.2 19.4 20.3 13.2 21.6 21.8 19.3 24.8 16.2 21.4 12.4 20.0 21.6 26.1 18.1 18.2 30.8 40.4 46.1 41.4 45.8 38.8 34.7 39.6 44.2 49.9 31.2 34.5 41.6 34.2 34.6 37.6 48.4 46.9 54.9 34.8 29.6 25.5 36.9 30.7 30.8 34.3 33.1 36.9 22.6 101.3 71.0 116.9 138.6 111.5 51.2 50.6 107.0 125.8 95.5 68.0 15.7 283.0 167.5 270.4 53.8 105.0 174.1 140.2 335.7 335.1 102.8 131.4 126.9 137.0 262.0 65.2 120.8 104.3 125.9 41.0 80.8 163.0 119.8 326.4 95.3 76.6 339.4 136.8 97.6 204.5 41.2 103.5 83.5 134.5 117.6 113.3 311.1 142.4 115.8 190.0 UBE2L5 UBE2L5P ENSG00000236444 "Ubiquitin conjugating enzyme E2 L5" 13 30422488-30428616 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "testis: 31.5" "Cell type enriched" "Detected in single" 4 "Ciliated cells: 1.4" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA045609, HPA062415" Approved Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA045609: AB_10961322, HPA062415: AB_2684756" "unprognostic (2.09e-1)" "unprognostic (1.18e-2)" "unprognostic (8.01e-3)" "unprognostic (6.41e-4)" "unprognostic (1.78e-1)" "unprognostic (7.13e-2)" "unprognostic (2.20e-1)" "unprognostic (1.65e-1)" "unprognostic (1.19e-1)" "unprognostic (6.49e-3)" "unprognostic (1.78e-1)" "unprognostic (8.00e-2)" "unprognostic (3.50e-2)" "unprognostic (9.37e-2)" "unprognostic (2.60e-1)" "unprognostic (2.44e-2)" "unprognostic (8.75e-2)" 0.2 0.0 0.0 0.0 0.7 0.1 0.0 0.3 0.3 0.0 0.1 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.7 0.3 0.2 0.2 0.1 0.2 0.5 0.3 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 31.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.2 1.9 2.7 3.6 1.9 2.0 2.8 0.7 0.3 1.3 1.6 0.6 0.7 0.7 1.2 0.6 0.4 0.2 0.0 3.1 1.4 0.6 1.3 1.3 0.6 0.8 0.4 1.1 2.5 0.6 0.4 0.8 0.2 0.2 0.7 1.5 0.2 0.3 0.6 0.2 1.4 0.9 0.9 0.8 1.3 0.3 0.0 1.6 2.6 1.4 0.2 0.2 0.4 0.6 0.4 0.9 1.5 1.2 0.3 0.4 0.1 1.8 0.9 0.6 2.4 0.0 0.7 0.5 0.7 1.1 1.5 0.3 1.6 1.0 0.9 0.4 1.8 1.1 1.9 1.4 3.6 1.2 3.2 1.5 1.6 1.5 1.7 1.4 2.0 2.7 1.9 1.6 1.9 2.0 2.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UBE2M "hUbc12, UBC12" ENSG00000130725 "Ubiquitin conjugating enzyme E2 M" P61081 19 58555712-58558960 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 134.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004993, HPA054551, HPA057800" Approved Enhanced "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" Yes No Nucleoplasm "Nucleoli, Nuclear bodies, Cytosol" "CAB004993: AB_436983, HPA054551: AB_2682520, HPA057800: AB_2683531" "unprognostic (1.42e-1)" "unprognostic (1.99e-1)" "unprognostic (1.63e-2)" "unprognostic (1.39e-1)" "unprognostic (8.35e-2)" "unprognostic (1.77e-1)" "unprognostic (1.17e-3)" "unprognostic (3.90e-3)" "unprognostic (4.86e-2)" "unprognostic (1.09e-2)" "unprognostic (3.05e-3)" "unprognostic (1.96e-1)" "unprognostic (1.81e-1)" "unprognostic (8.63e-3)" "unprognostic (1.76e-1)" "unprognostic (5.85e-2)" "unprognostic (8.42e-3)" 18.1 26.0 51.8 16.3 38.9 32.1 13.6 28.4 52.4 15.2 20.4 17.0 20.5 17.8 17.3 19.6 24.9 19.3 17.4 43.2 35.1 33.9 19.6 19.1 16.5 18.1 32.1 30.5 19.4 20.2 25.9 22.8 32.0 26.4 18.4 16.7 15.0 20.9 22.6 61.9 19.2 15.9 19.2 19.8 18.5 17.9 31.8 16.1 32.7 22.2 21.2 19.9 18.2 23.5 3.8 7.6 10.9 4.3 1.8 3.8 2.1 21.5 39.3 19.9 18.9 10.6 12.7 14.5 22.5 19.8 16.3 14.1 23.7 16.8 22.7 17.0 15.9 32.7 14.1 22.1 22.2 12.3 25.8 134.3 33.0 25.3 15.4 26.0 29.8 26.2 13.6 17.4 24.8 29.5 17.9 19.6 21.5 16.0 28.7 21.6 22.1 23.8 27.1 12.6 25.2 34.4 22.2 16.6 29.2 18.8 27.2 35.1 28.7 19.5 23.9 21.0 7.6 14.3 27.4 14.6 51.1 10.4 16.0 39.8 34.8 52.5 24.3 32.5 26.5 33.3 6.8 4.3 4.1 3.5 2.8 2.7 3.4 3.8 3.7 3.1 3.8 3.7 2.5 10.9 1.8 2.7 7.6 3.1 2.1 51.8 38.9 28.4 52.4 35.1 33.9 32.1 30.5 26.4 16.1 6.0 15.4 10.4 28.7 35.8 101.5 34.7 17.8 12.0 6.8 17.4 19.6 18.8 6.6 15.3 18.8 19.0 45.1 23.3 26.0 17.2 20.9 42.6 19.6 28.7 30.5 103.3 39.5 20.3 27.6 27.8 16.1 18.1 33.7 11.8 28.6 85.9 31.9 25.4 13.1 25.9 58.3 25.8 25.5 26.4 7.9 49.7 43.8 15.2 31.9 47.5 UBE2N "MGC8489, UBC13, UbcH-ben" ENSG00000177889 "Ubiquitin conjugating enzyme E2 N" P61088 12 93405673-93442262 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 15 "Early spermatids: 2177.0;Late spermatids: 6552.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA044976 Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA 4600000 Nucleoplasm "Nucleoli fibrillar center" "HPA044976: AB_2679163" "unprognostic (1.74e-2)" "unprognostic (5.53e-1)" "unprognostic (1.26e-2)" "unprognostic (2.30e-1)" "unprognostic (1.07e-1)" "unprognostic (8.09e-2)" "prognostic unfavorable (2.41e-4)" "unprognostic (8.49e-3)" "unprognostic (2.72e-1)" "unprognostic (4.28e-3)" "unprognostic (1.07e-1)" "unprognostic (9.28e-2)" "unprognostic (1.03e-1)" "unprognostic (3.31e-2)" "unprognostic (1.29e-1)" "unprognostic (1.48e-1)" "unprognostic (1.30e-3)" 24.7 25.0 29.0 28.7 39.1 29.0 21.2 29.2 44.3 18.4 26.6 15.6 15.1 20.7 23.2 20.0 30.4 19.7 17.0 27.7 31.0 33.7 25.4 22.3 19.3 36.1 27.6 34.5 17.4 17.6 13.9 18.2 24.2 34.9 23.4 22.6 13.7 18.0 18.5 35.7 19.1 20.4 21.3 24.6 21.5 19.3 83.7 17.4 32.2 15.5 16.8 35.1 22.7 18.8 53.8 35.5 29.9 39.2 29.5 57.3 51.9 36.5 26.5 44.7 28.6 17.3 17.2 31.2 51.1 27.3 41.1 34.5 47.1 15.9 74.4 11.6 29.9 27.2 29.1 49.3 37.5 39.2 61.9 25.6 50.0 14.6 41.5 22.2 59.7 33.4 18.0 15.5 24.5 30.6 29.2 31.6 29.2 55.6 11.6 42.6 30.0 59.0 55.6 58.2 32.3 37.1 45.9 36.3 36.4 34.2 55.3 43.8 39.9 27.0 31.8 25.0 25.2 41.6 36.8 32.6 27.9 23.3 25.0 36.8 20.0 54.3 63.2 10.9 31.9 33.9 29.9 27.1 28.9 31.7 35.4 36.9 53.8 40.2 39.2 35.5 38.6 36.0 34.4 8.2 29.5 39.2 26.7 57.3 51.9 29.0 39.1 29.2 44.3 31.0 33.7 27.6 34.5 34.9 17.4 35.7 44.5 137.9 175.3 286.2 65.4 70.5 33.1 62.9 66.0 85.5 25.5 212.3 162.5 138.2 2177.0 83.9 61.7 70.0 87.1 187.9 124.3 118.3 92.3 44.8 144.3 82.6 71.7 46.1 58.9 6552.8 86.9 108.4 140.0 201.0 50.2 87.6 106.5 77.7 80.9 127.4 40.9 45.3 165.8 246.5 216.4 281.9 238.1 122.0 65.5 190.8 UBE2O E2-230K ENSG00000175931 "Ubiquitin conjugating enzyme E2 O" Q9C0C9 17 76389451-76453206 "Enzymes, Predicted intracellular proteins" "Transport, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 42.3;Horizontal cells: 42.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023605 Uncertain Supported "Nucleoplasm,Nuclear bodies" No No 1600000 Nucleoplasm "Nuclear bodies" "HPA023605: AB_2671257" "unprognostic (8.75e-2)" "unprognostic (2.04e-1)" "unprognostic (7.44e-2)" "unprognostic (8.68e-2)" "unprognostic (1.17e-1)" "unprognostic (3.22e-2)" "prognostic unfavorable (6.84e-8)" "unprognostic (3.54e-1)" "unprognostic (2.68e-1)" "unprognostic (7.61e-2)" "unprognostic (1.32e-3)" "unprognostic (1.18e-2)" "prognostic unfavorable (4.34e-9)" "unprognostic (7.22e-2)" "unprognostic (9.64e-2)" "unprognostic (9.12e-2)" "unprognostic (2.07e-1)" 8.5 8.5 13.8 10.2 22.6 19.2 7.3 25.2 38.1 9.4 7.2 12.2 7.4 9.9 9.9 8.2 11.7 10.8 7.1 15.4 12.7 15.2 6.5 7.6 6.6 12.8 11.7 14.6 13.9 14.4 16.4 14.3 9.8 30.6 9.4 6.0 10.5 13.4 10.4 23.0 15.2 8.2 8.0 8.0 10.8 10.8 18.1 12.2 10.9 15.8 6.9 9.2 8.6 9.1 4.9 4.1 2.7 1.7 1.5 4.0 1.9 13.1 15.1 15.5 19.0 9.7 6.2 13.4 6.2 6.7 10.1 9.9 13.1 6.7 18.7 4.4 7.7 15.9 13.4 18.0 10.7 7.2 5.3 22.2 18.9 9.9 21.9 8.0 11.4 11.5 6.3 8.7 9.6 8.3 8.8 13.6 10.4 15.7 16.7 5.1 10.8 22.5 13.2 14.3 7.9 20.3 22.3 20.0 20.6 4.5 11.3 23.0 20.7 9.0 23.6 12.4 14.8 13.5 8.2 8.0 11.9 11.2 10.0 10.2 13.8 4.5 15.8 13.0 9.6 7.7 0.0 1.7 2.7 4.0 0.8 2.2 2.6 2.6 2.0 1.0 4.9 2.1 3.0 0.4 1.5 1.0 4.1 2.3 1.9 13.8 22.6 25.2 38.1 12.7 15.2 11.7 14.6 30.6 12.2 3.0 7.7 17.1 5.1 7.7 42.3 23.4 7.6 4.0 6.8 7.0 39.3 5.0 0.0 5.2 1.1 7.5 4.7 0.0 8.0 6.4 7.7 7.2 6.9 5.0 7.0 42.9 22.4 8.6 7.9 1.1 8.9 3.9 5.0 9.0 8.7 8.2 6.5 7.0 7.4 3.1 23.7 6.5 10.0 16.6 18.4 10.8 4.3 6.4 7.9 4.8 UBE2Q1 "NICE-5, PRO3094, UBE2Q" ENSG00000160714 "Ubiquitin conjugating enzyme E2 Q1" Q7Z7E8 1 154548577-154559028 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063368 Approved Approved Nucleoplasm,Centrosome No No Nucleoplasm Centrosome "HPA063368: AB_2684996" "unprognostic (3.88e-1)" "unprognostic (2.13e-1)" "unprognostic (4.44e-3)" "unprognostic (3.64e-3)" "unprognostic (5.32e-3)" "unprognostic (6.10e-3)" "prognostic unfavorable (8.74e-4)" "unprognostic (2.92e-1)" "unprognostic (2.07e-1)" "unprognostic (9.92e-3)" "unprognostic (3.79e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (4.84e-7)" "unprognostic (2.20e-1)" "unprognostic (4.46e-1)" "prognostic favorable (1.86e-5)" "unprognostic (1.04e-2)" 17.3 18.7 26.5 16.2 29.4 24.2 19.4 26.4 29.0 20.0 21.2 18.7 8.2 16.2 18.3 25.4 20.9 21.8 18.2 17.6 24.5 25.8 25.7 27.4 23.0 26.3 22.8 21.0 21.7 27.2 21.4 29.3 24.5 27.2 21.4 25.7 18.5 19.0 19.8 19.1 21.6 21.4 21.9 19.1 26.0 20.5 30.0 22.0 25.1 21.0 14.0 29.9 19.3 18.5 3.2 5.1 8.1 3.1 4.7 6.2 1.6 17.2 14.9 21.1 16.1 21.7 22.4 18.3 17.1 26.0 22.0 17.8 16.7 18.4 21.2 24.6 23.8 18.4 15.0 24.8 19.8 19.0 21.3 15.7 16.8 13.3 16.1 27.4 27.3 27.1 21.5 26.3 17.8 20.7 24.0 28.2 19.7 14.1 26.3 28.1 26.7 16.6 20.1 28.8 41.3 25.4 19.2 14.7 22.3 24.2 18.3 21.5 30.1 17.3 32.6 27.9 37.7 19.9 41.7 19.6 14.3 15.9 16.9 18.2 32.2 23.8 28.1 16.0 19.4 21.5 8.1 2.8 5.6 4.8 3.1 4.3 3.0 4.5 5.9 2.5 3.2 5.0 5.7 4.4 4.7 2.6 5.1 6.2 1.6 26.5 29.4 26.4 29.0 24.5 25.8 22.8 21.0 27.2 22.0 29.8 21.6 22.7 16.5 14.3 38.7 26.9 25.5 34.8 20.5 15.7 3.9 15.3 10.0 13.0 2.7 27.8 23.7 0.0 18.0 14.1 15.8 22.6 10.4 34.2 23.2 57.2 32.3 32.5 41.4 4.3 16.4 19.3 13.5 15.4 30.4 45.6 21.9 11.5 18.0 15.1 19.3 12.9 13.2 30.7 24.4 16.7 16.4 20.8 20.4 22.9 UBE2QL1 FLJ25076 ENSG00000215218 "Ubiquitin conjugating enzyme E2 Q family like 1" A1L167 5 6448623-6494909 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 28.1;heart muscle: 11.3;retina: 8.2;seminal vesicle: 8.6;skeletal muscle: 21.3" "Group enriched" "Detected in some" 4 "Bipolar cells: 23.6;Cardiomyocytes: 25.0;Horizontal cells: 42.9;Rod photoreceptor cells: 49.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "eosinophil: 1.2" "Lineage enhanced" "Detected in single" "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "Karpas-707: 18.2;PC-3: 15.2;SCLC-21H: 14.2;U-266/70: 34.1;U-266/84: 30.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057414 Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA057414: " "unprognostic (1.45e-2)" "unprognostic (1.58e-2)" "unprognostic (1.79e-2)" "unprognostic (2.10e-1)" "unprognostic (1.08e-2)" "unprognostic (7.43e-2)" "unprognostic (1.15e-2)" "unprognostic (1.36e-1)" "unprognostic (3.10e-1)" "unprognostic (7.16e-2)" "unprognostic (2.15e-3)" "unprognostic (8.41e-2)" "prognostic favorable (6.81e-8)" "unprognostic (3.18e-3)" "unprognostic (2.81e-1)" "unprognostic (1.27e-2)" "unprognostic (1.41e-2)" 0.6 2.3 8.6 0.8 4.2 0.3 0.9 20.7 28.1 1.0 1.8 1.0 0.5 0.7 1.4 1.8 1.0 0.5 0.8 11.3 12.6 8.2 2.6 1.1 0.4 0.7 5.2 4.6 3.6 0.8 0.3 1.3 0.3 8.7 3.1 0.8 8.2 1.0 8.6 21.3 2.4 1.0 1.3 1.4 0.4 2.2 0.9 0.0 0.0 1.9 2.0 0.5 0.5 0.9 0.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 18.2 0.0 3.1 0.0 0.0 0.2 0.0 15.2 0.1 0.0 6.7 0.0 0.0 14.2 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 34.1 30.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 4.2 20.7 19.4 12.6 8.2 5.2 4.6 8.7 0.0 0.0 0.0 0.0 0.6 1.1 23.6 25.0 0.0 0.0 0.0 0.0 5.9 0.0 5.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.5 0.7 0.0 0.8 0.1 42.9 5.2 0.0 0.3 0.0 3.7 0.0 0.0 0.0 0.0 8.4 0.2 0.0 6.3 0.0 49.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 UBE2R2 "CDC34B, FLJ20419, MGC10481, UBC3B" ENSG00000107341 "Ubiquitin conjugating enzyme E2 R2" Q712K3 9 33817567-33920404 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 295.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 21.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061000, HPA074334" Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA061000: AB_2684408, HPA074334: " "unprognostic (1.51e-1)" "unprognostic (1.50e-1)" "unprognostic (7.08e-2)" "unprognostic (1.53e-1)" "unprognostic (6.55e-2)" "unprognostic (5.15e-2)" "prognostic unfavorable (4.37e-4)" "unprognostic (1.82e-3)" "unprognostic (4.61e-3)" "unprognostic (3.05e-3)" "unprognostic (2.22e-2)" "unprognostic (4.19e-1)" "unprognostic (2.01e-2)" "unprognostic (4.18e-2)" "unprognostic (1.22e-1)" "unprognostic (5.72e-2)" "unprognostic (1.43e-1)" 26.1 19.7 29.4 19.7 26.8 13.9 39.3 23.7 32.3 25.6 24.1 27.9 16.3 28.0 26.1 18.4 25.3 22.3 21.8 29.2 25.5 20.3 22.1 34.5 23.0 27.1 30.5 23.2 29.8 44.5 15.7 13.9 24.6 21.6 21.0 21.4 19.3 18.7 20.8 56.1 28.1 25.7 28.5 24.2 21.6 20.8 34.5 29.6 36.7 19.5 22.5 25.7 35.8 30.5 3.3 4.2 21.9 11.6 5.0 2.1 2.4 16.5 18.1 35.0 15.2 19.3 31.5 10.8 14.7 20.5 17.3 17.3 14.5 12.4 14.1 6.0 20.5 12.6 7.4 18.3 16.8 19.0 23.2 9.7 12.2 20.0 18.4 27.5 14.4 13.3 26.7 25.0 14.1 26.8 27.7 29.0 17.0 11.4 15.2 17.1 9.6 27.1 38.0 19.9 14.2 15.1 25.3 10.6 7.3 18.3 12.5 16.4 19.7 17.2 15.4 11.0 23.2 13.5 17.6 21.7 16.7 15.2 11.5 13.6 9.7 9.1 19.8 15.9 8.4 35.9 12.4 7.5 4.1 2.0 7.5 1.3 3.1 1.9 1.6 4.2 3.3 1.9 1.7 21.9 5.0 11.6 2.6 2.1 2.4 29.4 26.8 23.7 32.3 25.5 20.3 30.5 23.2 21.6 29.6 20.8 30.7 29.5 39.6 93.8 61.0 106.8 56.0 22.7 25.0 21.0 13.7 52.6 13.3 43.8 295.7 77.1 60.6 23.3 59.7 65.2 54.0 68.4 12.7 72.1 68.5 57.2 69.2 77.3 105.2 195.4 62.2 81.9 33.7 49.5 57.3 87.1 69.4 38.6 71.5 49.6 30.1 58.2 41.9 90.2 66.2 105.3 69.2 30.5 49.0 79.7 UBE2S E2-EPF ENSG00000108106 "Ubiquitin conjugating enzyme E2 S" Q16763 19 55399745-55407777 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 68.0;lymphoid tissue: 60.2;testis: 69.4" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 226.9;Spermatocytes: 216.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015228, HPA057150" Approved Approved "Nucleoplasm,Plasma membrane" NA Yes "Plasma membrane" Nucleoplasm "CAB015228: , HPA057150: AB_2683351" "unprognostic (2.79e-1)" "unprognostic (2.42e-1)" "unprognostic (2.57e-1)" "prognostic unfavorable (2.05e-4)" "unprognostic (9.54e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (8.00e-6)" "unprognostic (1.42e-3)" "unprognostic (2.32e-1)" "unprognostic (2.31e-1)" "unprognostic (8.08e-2)" "unprognostic (4.52e-2)" "prognostic unfavorable (8.16e-8)" "unprognostic (1.05e-1)" "unprognostic (9.51e-2)" "unprognostic (1.58e-1)" "unprognostic (1.75e-1)" 10.2 9.2 18.0 19.5 15.9 68.0 4.7 11.4 21.6 6.1 12.0 9.1 4.5 8.4 7.1 7.2 17.1 6.0 9.7 18.0 18.7 18.1 5.9 5.6 6.3 22.9 13.7 14.4 6.4 6.0 3.7 12.9 9.8 12.9 7.0 7.1 6.2 4.9 5.3 7.3 6.2 7.3 10.7 15.3 11.0 10.6 69.4 8.2 60.2 5.9 14.3 21.1 10.0 7.1 4.5 3.1 6.0 1.9 0.6 2.6 0.3 60.3 32.7 28.8 22.9 1.8 2.6 5.1 49.2 14.9 30.4 27.7 22.1 21.6 58.8 20.4 12.3 36.6 17.8 28.8 12.8 13.5 46.0 95.7 35.1 18.8 7.1 5.5 42.0 34.2 2.9 3.6 22.3 21.6 6.6 11.9 32.1 34.9 41.2 19.0 16.0 56.8 21.8 72.2 16.9 55.5 50.1 22.2 21.1 8.1 12.9 73.1 39.6 62.7 15.6 27.9 9.1 11.1 22.8 18.2 18.3 52.1 15.6 116.9 33.2 79.7 69.0 19.2 29.7 66.3 1.1 1.9 2.9 1.8 1.5 1.2 4.5 2.6 2.6 1.5 1.6 2.5 1.5 6.0 0.6 0.9 3.1 1.0 0.3 18.0 15.9 11.4 21.6 18.7 18.1 13.7 14.4 12.9 8.2 0.0 4.3 37.3 136.4 144.5 56.5 2.4 7.6 0.0 0.0 19.2 51.1 34.3 13.3 44.4 86.7 31.2 25.8 70.0 26.4 226.9 94.9 63.2 18.4 9.6 55.5 30.2 88.9 22.7 24.7 27.7 16.1 39.9 70.9 55.1 28.4 76.7 57.6 28.1 11.7 14.8 59.0 12.9 96.6 216.2 140.8 101.4 50.0 44.7 30.4 121.0 UBE2T "FANCT, HSPC150" ENSG00000077152 "Ubiquitin conjugating enzyme E2 T" Q9NPD8 1 202331657-202341980 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 46.8" "Cell type enhanced" "Detected in many" 12 "Erythroid cells: 186.9;Extravillous trophoblasts: 82.9;Spermatocytes: 115.5;Spermatogonia: 96.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA002831 Approved Nucleoplasm,Nucleoli NA Yes Nucleoli Nucleoplasm "HPA002831: AB_1080445" "unprognostic (2.38e-3)" "unprognostic (6.37e-2)" "unprognostic (5.27e-2)" "unprognostic (5.19e-2)" "unprognostic (2.81e-1)" "unprognostic (6.13e-3)" "prognostic unfavorable (4.79e-6)" "unprognostic (1.71e-2)" "unprognostic (2.32e-2)" "prognostic favorable (6.90e-6)" "unprognostic (6.28e-3)" "unprognostic (2.85e-2)" "prognostic unfavorable (2.22e-16)" "unprognostic (5.37e-3)" "unprognostic (1.58e-1)" "unprognostic (1.20e-1)" "unprognostic (4.86e-2)" 1.9 4.2 9.6 8.5 12.2 20.8 3.9 4.4 13.5 3.5 11.2 0.7 17.2 7.5 4.3 4.1 10.3 2.9 3.0 8.8 8.8 11.2 4.5 2.8 3.1 15.2 8.7 8.2 1.3 0.9 2.4 3.1 8.7 8.2 2.2 13.9 1.9 2.8 7.0 13.1 4.5 6.9 8.1 3.4 6.7 4.0 16.0 1.8 46.8 2.6 12.8 15.3 6.3 4.5 9.0 3.6 1.7 8.6 1.1 11.1 2.9 30.4 29.1 43.3 20.4 4.0 7.4 24.8 33.3 18.6 38.1 26.9 20.7 37.4 35.5 13.2 12.1 28.4 24.9 40.0 19.5 34.4 32.2 22.9 21.7 15.8 23.6 1.8 25.9 26.4 2.6 4.7 29.9 12.5 9.1 22.1 40.1 27.3 29.3 29.8 28.3 46.4 33.1 16.8 31.7 14.8 36.0 46.1 30.8 14.6 14.6 34.1 34.8 23.3 28.7 11.1 13.5 30.2 16.4 10.8 17.2 27.5 30.0 39.5 14.9 29.1 45.2 17.0 27.0 35.6 0.0 0.8 1.7 3.7 2.4 2.8 9.0 5.0 3.9 1.7 6.3 7.3 8.0 0.0 1.1 8.6 3.6 11.1 2.9 9.6 12.2 4.4 13.5 8.8 11.2 8.7 8.2 8.2 1.8 0.0 2.1 10.4 11.0 12.7 5.2 12.2 0.0 6.7 7.9 5.2 0.0 33.9 5.0 11.2 13.0 1.9 2.7 186.9 6.6 82.9 4.8 2.2 8.1 1.7 23.5 9.5 1.2 4.3 1.8 6.6 2.8 5.2 3.3 3.6 9.0 1.3 7.8 0.0 3.9 7.9 0.9 6.5 1.9 115.5 96.9 9.5 18.8 9.5 19.6 4.1 UBE2V1 "CROC-1, CROC1, UBE2V, UEV-1, UEV1A" ENSG00000244687 "Ubiquitin conjugating enzyme E2 V1" Q13404 20 50081124-50115959 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 76.3;Club cells: 55.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA052535, HPA053186" Enhanced Nucleoplasm NA NA 4000000 Nucleoplasm "HPA052535: AB_2681863, HPA053186: AB_2682073" "unprognostic (1.39e-1)" "unprognostic (3.13e-3)" "unprognostic (1.52e-1)" "unprognostic (1.01e-3)" "unprognostic (2.16e-1)" "unprognostic (2.00e-2)" "unprognostic (2.81e-3)" "unprognostic (4.35e-2)" "unprognostic (3.48e-2)" "unprognostic (5.32e-2)" "unprognostic (2.02e-2)" "unprognostic (2.54e-2)" "prognostic unfavorable (4.58e-5)" "unprognostic (2.58e-2)" "unprognostic (1.95e-1)" "unprognostic (1.31e-1)" "unprognostic (1.01e-1)" 35.2 35.3 44.9 31.7 52.4 25.6 29.7 36.9 61.7 27.4 37.7 33.8 19.3 34.2 29.1 32.7 43.6 27.4 28.7 38.1 37.5 39.3 39.2 61.8 34.1 36.8 36.4 33.3 37.2 60.8 36.7 23.2 45.9 44.7 30.3 37.3 38.7 38.6 35.0 46.0 37.8 40.1 43.7 29.0 40.2 33.3 23.2 23.2 35.0 30.2 32.0 50.7 49.0 31.7 37.4 40.1 33.9 39.1 54.2 57.4 70.2 29.8 18.7 35.3 21.1 29.0 50.0 19.6 34.0 33.6 72.4 34.9 93.2 22.5 29.1 31.5 44.0 31.5 26.5 25.8 46.6 63.1 20.3 16.3 28.4 14.0 41.2 26.2 34.6 23.1 39.8 28.1 35.6 23.7 40.9 48.8 24.1 35.4 17.7 40.4 20.1 31.1 27.5 24.6 40.0 33.1 17.2 40.3 26.5 49.9 21.5 20.7 25.0 34.6 60.5 25.6 36.9 23.2 31.4 42.3 40.2 37.2 34.0 27.3 17.6 22.6 23.6 43.8 18.1 27.8 25.5 39.1 33.9 56.6 38.5 57.4 37.4 47.0 53.9 40.1 31.0 48.3 52.4 13.8 54.2 33.0 31.6 44.4 70.2 44.9 52.4 36.9 61.7 37.5 39.3 36.4 33.3 44.7 23.2 47.6 19.1 17.1 2.6 5.3 4.5 6.9 12.7 76.3 55.7 10.4 5.9 5.2 19.9 9.5 14.5 6.3 7.4 0.0 9.7 4.6 4.1 2.1 33.7 11.0 6.1 0.0 9.8 16.5 20.0 15.2 7.2 7.7 8.5 19.8 4.2 3.0 15.6 7.0 4.6 12.6 4.9 6.5 5.0 10.3 6.4 7.4 5.9 10.2 4.3 3.5 UBE2V2 "DDVit-1, DDVIT1, EDAF-1, EDPF-1, EDPF1, MMS2, UEV-2, UEV2" ENSG00000169139 "Ubiquitin conjugating enzyme E2 V2" Q15819 8 48008400-48064708 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052535, HPA053186" Supported Nucleoplasm NA NA 1500000 Nucleoplasm "HPA052535: AB_2681863, HPA053186: AB_2682073" "unprognostic (3.50e-3)" "unprognostic (3.27e-1)" "unprognostic (1.53e-1)" "unprognostic (3.07e-2)" "unprognostic (1.69e-1)" "unprognostic (5.83e-2)" "unprognostic (2.94e-3)" "unprognostic (1.21e-2)" "unprognostic (1.65e-3)" "unprognostic (4.97e-2)" "unprognostic (1.77e-2)" "unprognostic (2.73e-1)" "prognostic unfavorable (4.96e-6)" "unprognostic (1.42e-1)" "unprognostic (1.42e-1)" "unprognostic (2.45e-1)" "unprognostic (9.62e-2)" 22.4 28.3 38.8 19.3 34.5 12.5 23.1 28.3 51.1 17.9 22.8 13.8 12.9 22.0 21.7 17.8 31.8 15.3 17.7 14.6 40.5 41.7 22.7 37.8 14.6 22.5 40.1 43.4 16.5 12.3 19.2 36.4 21.4 48.5 22.5 23.7 13.0 13.8 21.0 29.3 15.9 20.4 24.6 26.7 14.3 19.0 20.5 20.6 20.8 24.0 18.5 24.1 25.0 17.2 37.9 42.2 34.6 40.1 51.7 49.4 42.8 31.5 18.4 41.1 22.7 22.6 25.4 14.5 33.1 23.3 33.6 29.5 23.2 24.7 38.9 19.5 31.6 28.7 19.1 37.3 31.0 45.2 13.2 26.1 34.9 22.5 19.2 28.3 18.9 10.5 23.9 32.5 27.0 43.2 25.5 28.2 33.4 42.6 24.2 42.3 24.1 60.5 36.9 38.1 47.2 12.2 30.4 18.2 19.1 35.7 25.6 45.1 29.5 27.9 24.8 29.1 32.1 41.7 25.4 15.5 28.5 26.0 25.4 30.7 24.3 41.0 48.8 37.0 33.6 30.1 30.6 35.9 34.6 31.0 40.1 37.0 37.9 38.8 37.8 42.2 32.8 39.1 43.8 22.3 51.7 38.2 35.1 49.4 42.8 38.8 34.5 28.3 51.1 40.5 41.7 40.1 43.4 48.5 20.6 44.7 25.9 50.8 66.9 40.2 91.0 49.4 28.1 37.5 27.3 48.8 15.7 87.6 109.5 74.8 42.0 43.3 32.6 23.3 77.1 128.9 61.8 54.4 50.7 44.8 79.3 76.3 31.0 30.1 41.4 22.1 52.0 50.8 35.4 85.6 45.1 79.9 73.1 57.1 68.9 99.0 48.9 58.2 102.9 123.8 75.9 49.9 125.2 39.8 54.9 64.8 UBE2Z "FLJ13855, USE1" ENSG00000159202 "Ubiquitin conjugating enzyme E2 Z" Q9H832 17 48908369-48929056 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007922 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA007922: AB_1858551" "unprognostic (6.85e-2)" "unprognostic (5.72e-3)" "prognostic favorable (4.62e-4)" "unprognostic (9.11e-2)" "unprognostic (3.71e-3)" "unprognostic (1.76e-1)" "prognostic unfavorable (5.57e-4)" "unprognostic (2.32e-2)" "unprognostic (5.26e-2)" "unprognostic (8.66e-2)" "unprognostic (9.17e-3)" "unprognostic (3.48e-2)" "prognostic unfavorable (1.05e-4)" "unprognostic (2.63e-2)" "unprognostic (2.11e-2)" "unprognostic (1.91e-2)" "unprognostic (1.52e-1)" 27.1 40.6 29.2 27.7 37.0 22.2 28.8 34.4 50.2 33.7 28.9 59.9 45.1 26.6 36.2 49.5 37.2 36.0 28.0 28.7 30.5 29.2 32.1 25.6 29.2 30.9 46.6 28.0 32.5 29.5 36.6 28.0 35.0 39.7 32.9 32.5 28.4 33.3 43.2 24.1 35.9 30.5 39.1 32.7 36.6 29.4 22.4 43.4 29.4 39.8 22.2 44.2 28.8 32.2 12.8 10.1 11.0 14.5 7.4 13.1 8.6 24.9 30.9 11.6 11.0 29.6 28.8 15.9 27.3 33.5 32.8 31.6 38.5 21.6 20.3 39.2 33.5 41.2 16.2 14.6 25.5 41.9 67.1 15.8 18.4 20.5 23.9 34.2 13.0 19.8 24.5 28.3 26.7 34.6 35.1 24.0 9.7 13.4 26.5 35.1 39.8 14.0 12.9 10.8 30.5 27.1 11.3 29.6 11.5 25.6 24.6 12.0 18.2 18.5 10.0 18.6 27.4 27.6 10.3 28.1 49.0 23.7 16.0 22.2 20.2 19.2 12.0 24.0 9.6 21.2 6.5 11.0 8.1 13.1 14.5 10.7 9.4 11.4 13.0 8.0 12.8 11.1 12.0 11.0 7.4 13.0 10.1 11.5 8.6 29.2 37.0 34.4 50.2 30.5 29.2 46.6 28.0 39.7 43.4 23.8 16.3 32.1 40.1 46.9 52.1 29.9 30.6 18.7 10.3 34.9 39.3 29.1 18.3 38.9 1.4 40.2 31.5 0.0 46.7 25.9 26.8 61.1 5.8 22.9 22.6 41.3 46.7 39.9 23.9 2.9 25.9 27.7 28.7 52.3 35.4 30.6 59.6 28.1 27.3 20.7 33.6 32.3 35.3 21.4 22.7 49.8 35.8 22.3 24.7 60.4 UBE3A "ANCR, AS, E6-AP, EPVE6AP, FLJ26981, HPVE6A" ENSG00000114062 "Ubiquitin protein ligase E3A" Q05086 15 25333728-25439056 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Host-virus interaction, Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009723, HPA039410, HPA040380" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB009723: AB_639982, HPA039410: AB_10671997, HPA040380: AB_2676952" "unprognostic (7.95e-2)" "unprognostic (2.61e-2)" "unprognostic (1.58e-1)" "unprognostic (2.99e-1)" "unprognostic (1.13e-1)" "unprognostic (3.55e-2)" "unprognostic (1.44e-1)" "unprognostic (3.05e-1)" "unprognostic (5.07e-2)" "unprognostic (1.69e-1)" "unprognostic (3.40e-2)" "unprognostic (4.83e-2)" "unprognostic (6.31e-2)" "unprognostic (3.08e-2)" "unprognostic (1.42e-1)" "unprognostic (1.15e-1)" "unprognostic (8.17e-2)" 19.3 19.4 20.3 23.1 25.0 17.8 20.2 30.0 25.1 21.7 19.9 14.3 19.8 14.1 21.0 22.1 19.8 18.5 17.2 24.0 22.2 20.8 20.2 24.6 19.7 23.1 19.1 19.5 23.0 17.2 26.1 24.6 20.1 20.9 20.6 17.9 13.3 19.3 21.5 70.2 18.4 18.8 21.2 19.9 18.8 16.9 26.4 16.4 36.4 25.0 26.6 19.5 19.9 26.6 15.6 11.9 11.6 14.8 21.1 16.0 5.7 19.6 11.1 28.1 16.7 16.4 19.5 13.8 30.3 19.0 21.5 19.6 25.7 9.8 35.4 23.0 22.6 21.2 18.2 35.5 21.4 26.3 18.2 11.9 29.3 18.8 15.2 24.7 35.3 21.7 23.1 20.1 20.3 26.0 22.4 16.9 31.1 29.5 25.3 33.7 10.7 29.3 10.3 18.2 21.5 16.2 30.0 42.0 15.6 19.5 31.0 28.9 21.8 24.6 26.7 34.9 19.0 21.8 20.0 21.6 37.7 31.2 18.1 22.1 28.9 34.1 47.7 21.6 19.3 19.6 8.6 8.7 11.6 13.3 7.6 15.2 12.0 14.0 15.9 11.9 15.6 16.0 14.2 2.0 21.1 14.8 11.1 10.1 5.7 20.3 25.0 30.0 25.1 22.2 20.8 19.1 19.5 20.9 16.4 89.3 73.3 52.7 60.3 63.2 78.1 154.5 43.3 71.0 67.1 36.6 53.0 43.4 16.6 42.2 101.1 45.8 39.4 0.0 43.1 41.8 44.5 85.9 62.2 52.0 41.5 76.3 65.9 47.3 56.6 43.8 52.6 44.6 50.6 37.9 48.7 54.8 47.5 42.1 60.8 44.0 56.4 77.6 54.5 143.0 88.7 79.3 61.9 44.9 47.9 87.8 UBE3C "KIAA0010, KIAA10" ENSG00000009335 "Ubiquitin protein ligase E3C" Q15386 7 157138913-157269372 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039915 Approved Approved "Nucleoplasm,Plasma membrane,Mitochondria" NA NA "Nucleoplasm, Mitochondria" "Plasma membrane" "HPA039915: AB_10795264" "unprognostic (2.83e-2)" "unprognostic (9.27e-3)" "unprognostic (2.41e-1)" "unprognostic (2.29e-1)" "unprognostic (1.19e-2)" "unprognostic (3.14e-2)" "unprognostic (1.36e-1)" "unprognostic (7.02e-2)" "unprognostic (2.34e-2)" "unprognostic (1.58e-1)" "unprognostic (3.01e-3)" "unprognostic (8.64e-2)" "prognostic favorable (9.18e-6)" "unprognostic (9.74e-2)" "unprognostic (1.86e-1)" "unprognostic (1.87e-1)" "unprognostic (3.60e-2)" 24.7 21.0 14.0 17.9 23.1 12.4 19.8 25.5 29.9 21.3 23.4 17.2 15.3 17.4 28.8 16.8 26.8 18.8 24.8 31.8 14.4 13.8 21.2 30.5 16.7 16.7 14.5 15.1 20.7 22.1 29.6 20.3 21.3 22.3 19.0 21.0 20.2 31.7 21.5 51.2 21.2 23.9 25.7 16.1 20.5 21.8 35.9 11.1 20.3 15.6 24.5 24.4 23.1 19.1 2.5 4.0 2.1 4.6 3.7 6.6 2.9 22.8 18.2 11.7 23.3 21.0 22.1 12.9 25.3 21.9 21.4 21.7 16.3 19.1 12.4 22.5 27.9 27.9 14.5 18.1 23.3 25.4 22.5 16.6 12.6 12.7 11.7 20.9 18.8 18.5 19.5 21.6 23.7 19.7 16.3 24.9 10.4 18.3 13.8 30.2 20.0 18.4 11.9 18.5 20.5 21.9 10.6 13.1 25.4 22.1 25.2 18.7 19.3 24.9 21.5 18.5 13.6 11.1 13.2 22.3 27.0 5.8 66.1 31.3 13.9 13.9 12.5 31.0 28.1 30.8 0.5 3.5 2.1 4.8 4.6 6.6 2.5 5.2 5.2 4.0 2.5 4.9 5.9 1.3 3.7 4.5 3.6 5.2 2.9 14.0 23.1 25.5 29.9 14.4 13.8 14.5 15.1 22.3 11.1 20.8 19.5 9.7 13.9 24.5 31.4 31.5 28.1 16.0 9.1 24.4 62.8 12.2 8.3 17.0 8.4 19.9 22.1 0.0 15.2 14.4 14.7 19.9 9.2 39.2 13.9 30.2 23.5 24.5 21.2 8.5 14.4 15.0 5.0 12.6 20.6 10.9 22.5 10.5 24.1 16.5 42.8 0.0 17.6 20.4 27.4 29.1 12.6 13.8 22.4 27.3 UBFD1 "FLJ38870, FLJ42145, UBPH" ENSG00000103353 "Ubiquitin family domain containing 1" O14562 16 23557362-23574389 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 54.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051746 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA051746: AB_2681587" "unprognostic (2.70e-2)" "unprognostic (1.84e-1)" "unprognostic (9.45e-3)" "unprognostic (2.31e-2)" "unprognostic (1.47e-1)" "unprognostic (4.91e-2)" "unprognostic (2.86e-3)" "unprognostic (1.63e-1)" "unprognostic (2.17e-1)" "unprognostic (3.86e-1)" "unprognostic (8.28e-2)" "unprognostic (8.06e-2)" "unprognostic (6.20e-3)" "unprognostic (2.21e-1)" "unprognostic (7.11e-2)" "unprognostic (3.13e-1)" "unprognostic (1.46e-1)" 10.2 16.2 11.9 8.9 13.0 7.1 10.0 23.1 19.5 11.7 9.2 9.4 15.2 6.1 16.4 14.9 9.6 13.9 11.8 21.2 11.3 17.6 12.3 15.4 7.6 8.7 13.0 11.8 14.5 17.5 28.5 17.2 16.5 13.6 12.5 9.4 12.3 12.3 12.6 52.8 7.6 7.0 14.6 7.4 9.1 8.1 27.6 7.0 16.2 16.4 11.1 11.7 10.9 12.9 2.8 4.1 1.0 1.9 3.0 4.0 1.1 6.5 14.8 21.1 15.2 24.2 30.2 19.8 20.2 16.6 16.1 15.2 11.2 11.2 14.5 31.6 24.7 10.9 9.0 33.2 13.4 20.8 24.0 19.6 7.5 13.4 24.4 12.9 7.9 14.6 21.5 10.1 15.7 14.8 24.9 15.5 11.8 19.1 8.0 17.7 13.6 11.2 14.3 50.3 10.7 6.6 20.5 13.0 11.9 15.1 5.5 21.0 19.2 6.7 13.1 11.8 21.1 17.9 11.7 16.4 9.1 10.5 9.8 10.5 12.0 12.0 8.8 16.6 9.5 13.7 0.0 1.3 1.0 4.0 1.9 2.3 1.6 2.8 3.9 3.0 2.8 1.7 2.3 0.0 3.0 1.0 4.1 2.3 1.1 11.9 13.0 23.1 19.5 11.3 17.6 13.0 11.8 13.6 7.0 6.0 1.6 3.0 8.4 7.8 11.4 31.3 10.2 5.3 3.4 19.2 21.6 16.4 13.3 11.9 38.7 10.5 5.5 0.0 9.9 21.4 13.5 12.6 0.0 16.6 11.5 6.4 6.9 4.3 7.5 54.1 17.3 4.3 10.1 10.8 9.3 10.8 9.0 7.6 9.2 13.6 14.1 25.8 8.2 20.4 22.5 12.4 30.1 5.3 8.6 10.7 UBL4A "DXS254E, GDX, GET5, MDY2, TMA24, UBL4" ENSG00000102178 "Ubiquitin like 4A" P11441 X 154483717-154486670 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003617 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA003617: AB_1080450" "unprognostic (2.75e-2)" "unprognostic (3.39e-3)" "unprognostic (5.52e-2)" "unprognostic (2.88e-2)" "unprognostic (2.62e-1)" "unprognostic (2.13e-1)" "prognostic unfavorable (8.64e-4)" "unprognostic (4.83e-2)" "unprognostic (3.56e-2)" "unprognostic (2.24e-2)" "unprognostic (8.26e-3)" "unprognostic (4.50e-1)" "unprognostic (4.41e-2)" "unprognostic (2.74e-2)" "unprognostic (6.01e-2)" "unprognostic (2.10e-1)" "unprognostic (3.49e-2)" 11.5 15.3 14.1 7.3 16.0 6.6 12.4 11.9 28.2 11.7 12.2 8.7 11.0 12.2 10.2 13.8 14.0 10.9 10.5 26.5 14.1 11.0 10.6 13.7 10.9 12.1 11.2 16.9 11.2 25.4 11.3 8.3 9.4 13.6 15.4 9.0 8.0 18.8 15.7 59.2 13.3 9.3 14.8 8.6 9.8 10.9 4.3 6.1 8.2 12.2 20.6 11.7 14.9 10.4 10.1 9.9 32.9 10.0 14.3 22.9 17.9 29.1 18.4 5.5 15.0 11.7 11.6 18.5 13.0 9.4 13.5 14.4 18.2 11.6 22.5 39.3 11.8 11.4 11.3 27.4 14.3 7.5 14.7 17.4 16.1 17.6 10.7 14.4 19.0 17.4 9.1 17.1 8.9 15.6 13.5 9.6 16.6 17.7 11.2 10.9 24.1 17.1 18.9 6.4 25.8 30.7 15.4 16.5 23.7 11.4 12.6 10.6 16.0 7.2 24.0 20.8 7.1 11.1 14.4 9.6 13.7 15.6 22.0 27.0 22.7 21.9 40.0 14.4 32.9 15.8 32.9 10.0 9.6 16.5 8.5 22.9 10.1 15.4 17.3 9.9 8.3 13.3 14.9 3.4 14.3 7.1 5.8 15.0 17.9 14.1 16.0 11.9 28.2 14.1 11.0 11.2 16.9 13.6 6.1 3.0 7.9 15.9 10.0 8.5 16.9 28.1 12.7 4.0 9.1 15.7 3.9 22.4 36.5 22.3 0.2 14.8 17.7 0.0 27.8 38.0 13.6 14.1 9.2 14.7 21.3 17.5 8.2 8.0 14.0 0.8 11.5 11.1 27.0 20.8 16.2 14.5 24.7 14.1 17.7 19.5 9.8 0.0 12.3 0.0 6.3 10.7 10.9 18.4 16.6 7.2 UBL7 "BMSC-UbP, MGC14421" ENSG00000138629 "Ubiquitin like 7" Q96S82 15 74445977-74461182 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 133.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040423, HPA041897" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040423: AB_10673442, HPA041897: AB_2677732" "unprognostic (4.21e-2)" "prognostic favorable (6.37e-5)" "unprognostic (2.93e-3)" "unprognostic (5.56e-2)" "unprognostic (1.83e-1)" "unprognostic (1.60e-1)" "unprognostic (3.43e-2)" "unprognostic (1.29e-1)" "unprognostic (1.80e-1)" "unprognostic (6.71e-2)" "unprognostic (5.80e-2)" "unprognostic (2.62e-1)" "unprognostic (4.47e-3)" "unprognostic (8.94e-3)" "unprognostic (7.05e-2)" "unprognostic (2.75e-1)" "unprognostic (3.43e-2)" 14.4 18.0 30.0 16.6 31.8 16.4 17.0 20.8 58.4 20.7 19.4 22.7 15.2 18.2 17.9 19.6 18.4 22.0 15.9 27.6 29.0 21.1 18.6 17.2 16.4 23.1 26.8 26.1 18.4 21.4 30.2 14.3 18.9 33.0 17.5 20.7 15.0 19.8 21.4 45.5 23.0 16.1 23.0 28.3 22.5 18.5 34.8 16.1 36.9 28.2 18.6 34.9 17.7 14.4 26.6 75.5 32.8 28.7 25.8 31.6 23.1 11.5 12.6 20.6 27.6 21.6 28.4 13.9 18.8 23.1 24.8 30.6 15.4 16.9 17.0 20.3 23.1 32.1 18.9 57.3 25.5 23.6 22.4 35.0 22.2 21.1 27.6 20.8 13.7 19.2 21.7 23.2 20.5 28.3 21.3 20.5 38.6 19.0 25.5 25.1 15.9 17.0 21.4 49.2 19.8 15.5 18.4 16.2 37.9 21.2 13.5 20.3 40.2 18.4 17.4 25.1 29.7 18.4 23.0 11.9 22.9 13.5 11.4 23.3 25.7 48.9 18.9 14.9 25.1 19.7 13.6 26.2 28.5 18.8 28.7 17.9 26.6 18.9 19.5 35.1 26.4 18.5 21.8 32.8 25.8 25.7 75.5 31.6 23.1 30.0 31.8 20.8 58.4 29.0 21.1 26.8 26.1 33.0 16.1 29.8 12.8 34.0 19.7 14.1 5.1 24.3 17.8 14.7 9.1 14.0 7.9 57.5 49.7 32.9 58.1 18.2 27.7 23.3 30.3 57.0 17.9 16.9 18.5 15.8 37.4 4.8 22.5 19.6 32.9 133.3 22.7 32.8 20.3 111.8 22.7 16.2 27.8 26.6 19.8 36.8 7.7 19.4 20.0 48.1 27.4 22.0 57.2 32.0 28.2 21.8 UBLCP1 "CPUB1, MGC10067" ENSG00000164332 "Ubiquitin like domain containing CTD phosphatase 1" Q8WVY7 5 159263081-159286040 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039615 Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA039615: AB_10674425" "unprognostic (1.25e-1)" "unprognostic (3.10e-1)" "unprognostic (6.04e-3)" "unprognostic (3.45e-2)" "unprognostic (7.08e-2)" "unprognostic (6.82e-2)" "prognostic unfavorable (4.46e-5)" "unprognostic (4.01e-1)" "unprognostic (2.14e-2)" "unprognostic (1.98e-1)" "unprognostic (1.91e-2)" "unprognostic (5.43e-2)" "unprognostic (1.16e-1)" "unprognostic (1.87e-1)" "unprognostic (1.18e-1)" "unprognostic (6.39e-2)" "unprognostic (2.51e-2)" 17.1 16.0 16.7 18.4 19.7 16.7 16.3 20.2 33.0 18.5 12.5 12.2 11.4 9.8 22.5 13.1 22.2 14.7 14.5 13.1 20.9 19.1 17.5 14.4 17.8 24.1 19.7 22.7 16.8 12.6 18.0 23.9 19.6 36.7 14.7 14.7 10.9 15.4 17.6 15.3 14.2 13.8 19.5 20.4 22.2 13.3 24.2 15.4 26.8 14.4 16.1 30.1 18.8 16.8 11.9 10.8 21.9 13.9 25.5 19.2 8.2 14.6 10.7 22.2 24.1 23.1 21.4 13.1 16.0 24.5 16.5 22.0 8.7 10.2 13.1 17.7 20.0 23.7 11.2 13.7 30.8 28.8 26.2 13.5 10.1 9.4 7.9 29.2 22.8 15.9 18.9 28.9 14.9 29.9 13.2 15.6 13.9 13.8 17.8 22.9 4.7 12.3 6.9 15.4 7.3 6.5 15.7 21.8 15.3 16.3 11.3 11.8 15.7 16.2 10.8 37.7 14.0 11.4 15.2 16.7 17.0 14.2 8.8 20.2 14.3 14.3 20.0 18.0 15.8 25.1 21.9 6.5 16.1 16.6 13.5 18.6 11.9 15.8 17.3 8.5 10.9 18.5 19.2 19.4 25.5 13.9 10.8 16.9 8.2 16.7 19.7 20.2 33.0 20.9 19.1 19.7 22.7 36.7 15.4 11.9 38.2 22.7 8.2 14.2 9.9 12.2 10.2 34.8 30.7 14.0 3.9 27.7 29.9 18.9 3.4 20.0 9.5 46.7 21.7 14.9 21.7 11.4 43.9 14.0 33.1 19.1 10.3 30.7 42.1 2.2 19.0 27.8 16.9 25.2 14.0 17.9 18.8 8.6 23.3 23.8 13.4 19.4 14.4 70.2 48.5 18.1 14.9 21.7 13.9 7.9 UBN1 ENSG00000118900 "Ubinuclein 1" Q9NPG3 16 4846665-4882360 "Predicted intracellular proteins" "Host-virus interaction" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 111.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "neutrophil: 15.1" "Lineage enriched" "Detected in many" 9 "granulocytes: 15.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061029, HPA069036, HPA069045" Supported Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA061029: AB_2684420, HPA069036: , HPA069045: AB_2686072" "unprognostic (8.20e-2)" "unprognostic (1.01e-1)" "unprognostic (8.99e-3)" "unprognostic (1.75e-1)" "unprognostic (1.65e-1)" "unprognostic (1.33e-1)" "unprognostic (1.47e-3)" "unprognostic (6.53e-3)" "unprognostic (1.35e-1)" "unprognostic (1.02e-2)" "prognostic unfavorable (3.84e-4)" "unprognostic (1.38e-1)" "unprognostic (1.10e-1)" "unprognostic (1.25e-1)" "unprognostic (1.49e-1)" "unprognostic (1.41e-2)" "unprognostic (6.89e-2)" 14.1 12.4 10.5 16.6 11.5 38.2 19.8 20.2 15.4 12.6 12.4 11.0 18.1 13.4 13.1 11.8 24.5 11.7 16.6 15.5 11.2 6.5 10.4 15.3 19.1 16.5 9.4 10.8 14.4 12.9 17.6 12.3 10.4 9.1 11.7 13.4 15.9 15.9 14.5 20.9 15.1 15.2 12.8 6.6 21.2 12.5 36.7 10.1 27.1 12.0 13.8 13.7 11.6 15.8 1.2 1.7 15.1 1.2 0.9 1.6 0.9 9.2 11.5 13.3 13.2 11.9 11.0 11.0 11.7 10.9 13.4 13.0 9.5 11.1 17.3 10.9 11.1 14.6 12.5 17.1 10.4 11.4 17.0 9.0 14.1 15.3 7.5 11.4 17.0 15.6 7.5 14.0 15.6 16.8 10.2 17.5 17.1 23.3 14.7 9.9 13.3 18.6 7.9 11.5 9.6 9.0 30.0 16.7 16.3 7.1 10.6 18.3 10.1 20.0 16.4 10.1 10.4 16.1 15.3 17.8 14.4 13.9 46.5 14.3 14.3 14.9 34.5 8.5 10.9 24.2 1.4 1.2 0.9 1.6 1.2 1.1 0.9 1.2 1.4 0.8 1.2 1.3 0.8 15.1 0.9 0.9 1.7 0.8 0.9 10.5 11.5 20.2 15.4 11.2 6.5 9.4 10.8 9.1 10.1 8.9 15.7 27.8 19.9 16.0 51.1 22.6 22.9 8.1 9.1 8.7 104.1 20.7 6.6 15.5 36.6 25.1 29.2 0.0 15.6 20.6 17.1 24.2 7.0 24.6 19.9 47.7 29.6 25.2 29.7 42.8 27.0 21.1 25.3 14.4 24.1 26.6 21.6 28.8 21.2 11.3 98.8 12.9 17.8 91.9 111.7 19.4 24.4 26.7 23.3 22.9 UBN2 "FLJ25778, KIAA2030" ENSG00000157741 "Ubinuclein 2" Q6ZU65 7 139230356-139308236 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 109.8;Late spermatids: 132.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 9.0;NK-cell: 3.4" "Group enriched" "Detected in many" 5 "granulocytes: 9.0;NK-cells: 3.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019743, HPA020122, HPA020124" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA019743: AB_1848851, HPA020122: AB_1848847, HPA020124: AB_2212202" "unprognostic (1.96e-1)" "unprognostic (2.49e-1)" "unprognostic (2.48e-2)" "unprognostic (1.44e-2)" "unprognostic (2.41e-1)" "prognostic favorable (4.49e-4)" "unprognostic (1.24e-3)" "unprognostic (1.22e-2)" "unprognostic (1.30e-3)" "unprognostic (9.88e-2)" "unprognostic (1.65e-1)" "unprognostic (4.96e-2)" "unprognostic (3.65e-2)" "unprognostic (4.54e-3)" "unprognostic (2.95e-1)" "unprognostic (2.91e-2)" "unprognostic (1.05e-2)" 5.4 7.8 11.9 5.3 13.0 10.4 9.7 20.8 13.7 7.6 5.9 8.7 12.6 5.0 10.0 14.1 7.0 7.3 5.7 5.8 11.5 6.9 6.3 7.0 6.0 5.1 10.2 7.6 11.5 10.7 10.5 16.9 6.2 8.6 8.2 6.9 8.1 8.1 12.7 11.1 18.6 5.9 7.9 8.4 6.3 6.3 25.5 9.7 6.9 10.4 3.1 5.2 6.4 13.6 1.2 1.2 9.0 1.0 3.4 0.8 0.1 3.9 3.7 6.1 7.6 4.9 4.5 4.7 2.3 3.4 2.1 2.5 4.5 3.9 6.7 4.3 2.8 5.2 3.7 7.8 1.9 3.7 3.4 4.5 5.0 6.7 4.9 2.8 9.7 3.9 3.1 5.5 2.7 4.4 3.8 4.0 3.6 11.6 5.2 2.7 6.0 7.0 11.3 8.7 4.0 2.7 4.0 5.7 4.7 2.9 2.9 10.1 7.3 7.0 4.9 3.3 6.0 3.1 6.5 4.5 2.6 3.0 3.8 2.9 6.0 6.6 11.8 4.2 5.9 3.8 9.0 1.0 0.1 0.5 0.5 0.4 1.0 0.5 0.6 0.3 1.2 0.8 0.5 1.0 3.4 0.4 1.2 0.3 0.1 11.9 13.0 20.8 13.7 11.5 6.9 10.2 7.6 8.6 9.7 6.0 20.5 7.1 15.7 20.7 52.5 24.3 15.3 29.4 15.9 21.0 88.4 7.1 6.6 6.4 109.8 13.8 13.1 23.3 6.1 7.6 17.4 29.6 11.5 16.8 6.2 42.9 22.4 16.5 14.0 132.0 20.8 13.4 8.5 4.6 16.7 25.5 8.4 14.7 20.1 7.9 57.3 19.4 21.5 26.9 30.1 25.2 12.2 8.7 12.1 18.6 UBOX5 "KIAA0860, RNF37, Ubce7ip5, UIP5" ENSG00000185019 "U-box domain containing 5" O94941 20 3107573-3160196 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028871 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA028871: AB_10603140" "unprognostic (4.11e-2)" "unprognostic (2.01e-2)" "unprognostic (1.77e-1)" "unprognostic (1.04e-1)" "unprognostic (2.18e-1)" "prognostic favorable (4.52e-5)" "unprognostic (2.58e-2)" "unprognostic (1.02e-1)" "unprognostic (3.11e-2)" "unprognostic (1.61e-1)" "prognostic favorable (1.80e-5)" "unprognostic (4.02e-2)" "unprognostic (9.71e-3)" "unprognostic (3.33e-1)" "unprognostic (5.58e-2)" "unprognostic (1.07e-2)" "unprognostic (1.61e-2)" 10.1 9.9 9.6 10.0 13.0 17.7 15.4 14.9 16.3 11.6 12.7 12.3 9.0 8.6 14.1 8.8 11.2 13.9 8.8 10.8 10.0 9.1 13.7 12.2 10.1 19.6 10.0 10.2 15.2 17.8 12.8 11.6 11.1 11.9 11.8 8.8 9.5 13.2 13.6 34.1 16.3 10.7 12.2 7.9 10.4 10.8 15.1 9.3 14.9 10.4 11.1 11.5 12.8 9.7 8.7 7.0 11.4 7.0 7.5 8.4 5.5 6.3 6.5 5.2 3.3 6.8 3.8 2.7 5.4 4.9 6.5 6.5 6.1 5.5 4.8 2.1 4.5 7.5 8.8 3.4 8.1 4.0 1.4 2.9 8.3 2.0 5.7 5.5 3.5 3.3 4.9 6.1 5.2 6.7 5.3 4.2 4.0 6.8 4.7 3.8 4.2 7.1 5.2 4.0 6.7 3.9 4.8 6.5 3.4 4.1 6.6 6.4 6.2 3.4 20.0 4.2 4.2 8.5 2.6 4.7 4.4 2.8 4.8 4.3 6.4 9.3 4.3 2.4 3.6 3.1 11.1 7.0 11.4 7.1 7.0 7.3 8.7 8.0 5.8 7.0 6.8 8.4 8.1 11.4 7.5 5.9 5.6 7.6 5.5 9.6 13.0 14.9 16.3 10.0 9.1 10.0 10.2 11.9 9.3 11.9 5.9 4.4 3.4 1.6 6.8 1.0 2.5 1.4 2.3 0.0 5.9 6.2 0.0 3.2 1.1 2.2 4.0 0.0 3.7 3.3 3.3 4.1 2.3 3.8 4.3 6.4 9.8 6.2 4.8 1.2 6.4 2.9 3.3 5.4 5.1 3.9 3.6 3.5 3.5 4.4 4.7 6.5 2.0 8.6 4.2 2.0 8.5 2.9 5.0 5.6 UBP1 LBP-1a ENSG00000153560 "Upstream binding protein 1" Q9NZI7 3 33388336-33441371 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003967 Supported Nucleoplasm NA NA Nucleoplasm "HPA003967: AB_10601829" "unprognostic (3.11e-1)" "unprognostic (2.10e-1)" "prognostic favorable (1.81e-4)" "unprognostic (4.64e-2)" "unprognostic (9.35e-2)" "unprognostic (3.92e-2)" "prognostic unfavorable (9.45e-4)" "unprognostic (6.67e-3)" "unprognostic (3.92e-2)" "unprognostic (1.11e-2)" "unprognostic (2.01e-1)" "unprognostic (7.48e-3)" "unprognostic (1.23e-1)" "unprognostic (3.14e-2)" "unprognostic (1.45e-1)" "unprognostic (2.90e-1)" "unprognostic (1.88e-2)" 19.3 18.7 22.6 25.0 30.7 14.8 19.9 39.1 28.8 21.0 26.4 14.8 20.0 21.1 26.1 20.3 24.6 19.7 22.5 21.9 16.5 17.0 15.9 23.1 21.7 29.2 13.6 22.1 22.2 23.6 20.1 26.0 15.7 15.4 21.5 25.5 20.4 18.1 30.3 14.6 18.7 23.4 36.3 15.0 25.1 22.6 13.8 17.8 36.0 20.9 16.6 30.3 28.0 30.9 2.8 5.7 6.5 5.2 4.9 6.3 3.6 17.7 21.7 16.7 27.6 25.5 18.8 8.2 21.5 23.9 25.7 26.3 20.9 15.8 33.4 12.7 31.2 18.5 12.4 49.9 25.0 31.8 18.2 15.3 35.8 21.1 25.0 17.9 26.0 15.5 15.4 20.7 24.9 25.3 21.1 30.7 18.5 32.6 18.4 24.7 16.7 20.5 15.4 39.8 14.2 22.5 21.7 12.3 30.9 18.2 26.8 11.6 13.8 17.0 29.5 18.6 23.2 22.4 31.8 25.5 22.8 17.6 25.6 29.7 14.8 26.5 34.3 19.6 30.2 16.8 6.5 3.9 3.7 5.3 4.0 5.0 2.8 5.3 5.2 5.7 2.1 6.3 5.1 1.0 4.9 5.2 4.8 3.3 3.6 22.6 30.7 39.1 28.8 16.5 17.0 13.6 22.1 15.4 17.8 6.0 18.1 9.1 7.5 22.7 22.6 26.4 22.9 5.3 6.8 10.4 13.7 6.5 3.3 10.8 1.3 21.5 18.7 23.3 12.5 8.2 13.8 14.7 2.3 34.5 13.3 22.3 11.6 18.4 30.1 1.6 9.2 20.9 25.3 17.2 27.8 7.5 12.2 14.0 16.6 9.1 17.0 12.9 17.6 12.2 12.6 27.1 4.6 14.6 24.3 11.5 UBQLN1 "DA41, DSK2, PLIC-1, XDRP1" ENSG00000135018 "Ubiquilin 1" Q9UMX0 9 83659963-83708203 "Plasma proteins, Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037256, HPA054143" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB037256: AB_1858556, HPA054143: AB_2682398" "unprognostic (4.72e-3)" "unprognostic (9.61e-2)" "unprognostic (1.69e-1)" "unprognostic (1.49e-1)" "unprognostic (2.77e-2)" "unprognostic (2.87e-2)" "unprognostic (1.55e-1)" "unprognostic (2.80e-3)" "unprognostic (2.35e-1)" "unprognostic (1.01e-1)" "unprognostic (6.98e-2)" "unprognostic (1.60e-1)" "prognostic favorable (1.07e-5)" "unprognostic (3.11e-2)" "unprognostic (9.49e-2)" "unprognostic (1.44e-3)" "unprognostic (2.29e-2)" 26.8 33.9 27.2 26.2 38.7 41.1 38.1 35.0 42.2 24.9 24.4 21.2 27.8 21.9 29.1 22.2 30.5 21.4 21.0 34.5 28.9 32.1 31.6 40.8 23.3 25.8 30.0 27.8 21.5 28.1 36.0 29.5 30.4 37.2 26.5 23.7 15.2 23.8 28.9 79.1 27.8 27.6 26.9 33.9 28.6 23.1 22.9 23.3 59.8 25.7 16.2 34.8 24.8 27.3 16.0 19.2 23.4 25.0 24.7 18.8 14.9 43.9 40.7 29.9 23.1 24.9 26.6 49.6 41.1 36.5 43.7 33.2 16.7 31.4 43.7 26.6 34.3 41.7 50.6 41.4 29.2 45.5 23.0 19.2 26.8 31.3 25.9 33.0 32.5 29.5 22.0 36.8 36.8 51.3 27.0 32.6 21.0 28.9 31.3 35.7 26.1 45.4 18.0 39.1 41.6 37.4 33.7 33.5 22.8 28.5 19.2 27.0 30.2 38.0 38.2 29.3 30.9 19.1 23.6 32.3 28.0 26.1 46.2 41.1 43.9 62.0 21.4 41.6 24.0 33.8 23.4 17.1 17.6 16.6 25.0 16.2 16.0 14.5 15.2 19.2 15.5 14.7 16.0 18.5 24.7 23.1 8.2 18.8 14.9 27.2 38.7 35.0 38.7 28.9 32.1 30.0 27.8 37.2 23.3 32.8 35.6 44.2 53.6 91.8 58.5 67.1 20.4 26.8 45.5 21.0 19.6 52.3 16.6 46.7 25.2 35.9 44.6 0.0 46.1 65.6 43.2 59.5 49.6 65.2 47.2 71.5 49.3 27.0 44.2 14.7 22.7 44.6 40.5 33.3 38.0 27.6 56.0 40.3 26.2 29.3 30.6 38.8 45.3 69.1 46.4 80.8 137.4 30.9 34.3 72.7 UBQLN4 "A1U, C1orf6, UBIN" ENSG00000160803 "Ubiquilin 4" Q9NRR5 1 156035301-156053794 "Predicted intracellular proteins, Transporters" "Autophagy, DNA damage, DNA repair" "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061797 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA061797: AB_2684613" "unprognostic (3.91e-2)" "unprognostic (2.01e-2)" "unprognostic (1.95e-1)" "unprognostic (1.29e-3)" "unprognostic (1.52e-2)" "unprognostic (6.75e-2)" "unprognostic (1.58e-3)" "unprognostic (5.48e-2)" "unprognostic (1.53e-1)" "unprognostic (1.32e-2)" "unprognostic (1.91e-2)" "unprognostic (1.01e-2)" "unprognostic (2.54e-2)" "unprognostic (7.25e-3)" "unprognostic (7.65e-2)" "unprognostic (4.73e-1)" "unprognostic (1.57e-1)" 7.1 6.7 13.8 7.4 19.9 3.9 12.4 23.1 25.2 9.9 7.8 6.5 4.2 7.2 11.9 8.9 11.6 10.2 6.2 9.3 17.7 9.7 7.9 10.2 8.5 7.3 15.0 18.7 15.1 14.1 10.6 3.6 8.4 12.4 8.9 8.8 6.4 12.4 11.8 24.3 11.6 7.4 13.1 8.7 6.8 9.4 6.9 13.7 7.9 6.8 6.6 8.9 8.2 8.4 1.9 2.0 9.7 1.2 1.7 3.2 1.1 16.2 19.6 18.8 18.4 12.9 8.0 18.6 13.7 7.6 13.8 10.4 17.6 14.8 27.7 12.6 12.5 7.5 18.3 19.0 14.8 13.2 23.3 20.1 15.2 11.2 16.9 8.3 16.3 28.8 6.0 19.1 19.0 15.5 12.2 16.4 8.9 28.4 15.5 12.4 20.0 17.9 16.5 25.8 41.9 18.3 23.0 13.9 27.4 11.2 16.5 13.9 40.2 13.8 34.3 14.1 19.1 33.1 18.0 15.8 12.8 17.0 13.0 14.7 34.5 27.4 30.2 7.8 16.5 17.9 9.7 1.1 0.6 2.5 1.2 3.2 1.9 2.0 2.7 0.9 1.5 1.5 2.1 0.0 1.7 0.2 2.0 1.6 1.1 13.8 19.9 23.1 25.2 17.7 9.7 15.0 18.7 12.4 13.7 6.0 4.0 4.5 7.5 11.8 5.9 4.3 15.3 2.7 4.5 22.7 5.9 7.1 3.3 10.9 0.7 6.8 6.6 0.0 9.3 8.1 7.9 16.4 1.1 19.4 8.6 6.4 10.3 9.8 7.2 2.3 6.1 7.4 16.9 17.2 9.7 6.1 11.1 5.8 8.5 9.2 5.2 0.0 8.0 3.6 5.1 12.8 6.9 5.7 13.3 10.5 UBR1 ENSG00000159459 "Ubiquitin protein ligase E3 component n-recognin 1" Q8IWV7 15 42942897-43106113 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038838, HPA038839" Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA038838: AB_10673120, HPA038839: " "unprognostic (1.07e-2)" "unprognostic (5.02e-2)" "unprognostic (9.77e-2)" "unprognostic (1.55e-2)" "unprognostic (1.89e-2)" "unprognostic (1.29e-1)" "unprognostic (2.67e-1)" "unprognostic (1.49e-1)" "unprognostic (4.79e-1)" "unprognostic (2.97e-2)" "unprognostic (1.93e-2)" "unprognostic (1.79e-1)" "unprognostic (1.27e-3)" "unprognostic (5.78e-2)" "unprognostic (1.52e-1)" "unprognostic (2.00e-1)" "unprognostic (1.89e-1)" 16.7 13.2 13.7 18.3 16.7 28.4 18.8 21.8 18.1 18.2 16.2 14.8 10.5 11.3 21.0 12.9 10.8 15.9 14.2 19.7 10.0 15.4 14.4 10.6 16.6 14.9 11.8 10.5 16.3 16.4 26.3 25.6 16.2 18.9 15.3 12.9 12.5 11.8 16.8 23.6 11.0 14.4 18.2 12.1 14.7 13.8 13.7 14.7 23.2 18.8 9.7 14.3 17.3 19.7 4.6 5.0 5.5 4.2 6.2 7.2 1.8 5.0 7.3 8.4 6.9 13.4 10.4 8.0 12.4 13.6 10.9 14.1 9.3 3.9 5.9 7.3 12.6 13.7 8.8 12.2 10.8 13.0 12.1 5.9 23.3 14.7 4.5 9.3 16.4 11.2 11.2 6.1 13.4 10.9 10.7 12.3 12.0 13.3 9.0 13.5 2.8 8.8 4.9 4.8 13.4 7.6 11.7 11.6 5.1 11.0 11.9 8.6 7.6 16.2 8.6 5.7 10.2 8.3 8.6 16.8 13.5 8.3 12.0 12.5 10.6 18.0 17.1 9.2 10.4 12.1 4.4 3.0 5.2 5.7 4.2 6.5 4.1 5.9 6.9 2.9 4.6 5.9 7.2 5.5 6.2 3.4 5.0 4.1 1.8 13.7 16.7 21.8 18.1 10.0 15.4 11.8 10.5 18.9 14.7 44.7 27.8 14.6 10.3 9.4 26.8 24.5 17.8 17.4 25.0 8.7 25.5 10.4 0.0 8.8 11.6 17.9 10.8 0.0 12.5 6.2 15.0 9.4 27.7 8.5 7.3 30.2 13.8 14.7 16.2 13.2 15.0 10.5 8.5 10.0 10.0 15.6 8.9 9.1 19.4 6.7 39.2 12.9 19.1 25.3 14.9 6.4 30.9 20.8 10.0 7.4 UBR2 "bA49A4.1, C6orf133, dJ392M17.3, KIAA0349" ENSG00000024048 "Ubiquitin protein ligase E3 component n-recognin 2" Q8IWV8 6 42564062-42693504 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Erythroid cells: 93.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 25.2" "Lineage enriched" "Detected in all" 4 "granulocytes: 25.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027869, HPA027880" Approved Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA027869: AB_10600416, HPA027880: AB_10601217" "unprognostic (3.26e-1)" "unprognostic (1.29e-1)" "unprognostic (8.33e-2)" "unprognostic (2.95e-2)" "unprognostic (1.08e-2)" "unprognostic (4.23e-2)" "unprognostic (1.32e-1)" "unprognostic (7.24e-2)" "unprognostic (5.05e-2)" "prognostic favorable (1.65e-4)" "unprognostic (1.12e-1)" "unprognostic (7.53e-2)" "unprognostic (1.30e-2)" "unprognostic (3.88e-1)" "unprognostic (1.81e-1)" "unprognostic (5.78e-2)" "unprognostic (7.77e-3)" 19.8 18.8 14.4 21.8 16.7 22.1 18.6 26.6 20.4 17.2 19.3 17.8 17.8 20.1 29.5 16.8 16.2 15.6 16.2 16.8 13.8 13.2 17.8 24.0 19.3 18.0 16.7 12.9 20.8 24.6 28.0 26.3 16.3 17.2 16.5 20.1 15.8 18.3 15.6 33.5 18.0 24.6 19.9 15.9 21.3 18.2 9.2 17.2 26.1 20.1 14.9 17.7 18.9 29.8 3.6 3.5 25.2 5.7 3.9 4.4 1.9 14.4 7.3 8.5 13.3 17.5 16.9 11.5 11.1 12.0 9.9 10.3 10.5 6.0 9.9 8.9 12.0 11.5 14.6 12.2 9.5 12.6 13.3 8.6 15.7 10.8 13.6 14.2 15.1 10.8 11.9 10.4 9.8 10.8 12.2 11.1 14.4 18.3 12.6 9.4 11.6 11.8 13.4 7.7 28.5 7.1 10.6 12.7 14.8 11.3 12.6 10.1 8.0 11.2 10.8 10.9 13.5 10.6 14.7 16.0 9.0 7.1 11.0 8.0 11.7 10.3 15.3 4.7 11.4 5.4 10.4 4.6 9.2 4.4 4.8 3.7 3.4 2.9 3.4 3.5 3.6 3.0 3.3 25.2 3.9 5.7 2.6 3.3 1.9 14.4 16.7 26.6 20.4 13.8 13.2 16.7 12.9 17.2 17.2 14.9 21.1 12.8 17.4 14.7 41.6 32.9 22.9 25.4 22.7 19.2 56.9 14.8 14.9 14.7 4.6 21.1 31.4 93.5 13.2 11.0 18.8 19.9 19.7 28.1 12.0 60.4 12.1 18.4 28.9 3.9 23.6 24.6 18.6 17.2 19.6 23.5 14.1 22.9 22.6 9.6 50.0 38.8 23.4 9.2 8.1 14.2 14.4 32.0 18.0 18.7 UBR3 "DKFZp434P117, FLJ37422, KIAA2024, ZNF650" ENSG00000144357 "Ubiquitin protein ligase E3 component n-recognin 3 (putative)" Q6ZT12 2 169827458-170084131 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 76.3" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 97.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035390 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA035390: AB_10670699" "unprognostic (1.35e-2)" "unprognostic (1.24e-1)" "unprognostic (1.59e-2)" "unprognostic (1.27e-1)" "unprognostic (2.07e-2)" "unprognostic (1.24e-1)" "unprognostic (1.00e-1)" "unprognostic (3.91e-2)" "unprognostic (1.05e-1)" "unprognostic (1.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.26e-1)" "unprognostic (3.19e-2)" "unprognostic (5.56e-2)" "unprognostic (2.01e-1)" "unprognostic (3.38e-1)" "unprognostic (2.18e-1)" 11.9 15.5 10.9 6.1 18.3 5.4 9.6 15.5 18.9 9.9 10.0 9.8 9.1 6.7 11.5 7.1 10.7 8.1 7.8 23.1 10.3 7.2 12.9 16.9 9.2 5.6 11.9 14.0 8.9 9.8 20.9 14.9 7.2 14.7 11.2 7.3 8.0 11.1 9.2 76.3 11.5 8.4 9.6 10.2 6.9 9.2 7.9 11.4 6.3 14.9 10.9 6.0 12.8 8.7 2.0 2.8 1.9 2.1 2.4 4.3 1.2 8.9 7.6 8.1 10.7 16.2 12.9 6.8 16.2 9.4 9.4 7.6 11.7 5.7 10.2 14.1 12.6 7.6 11.9 9.7 8.2 11.7 10.5 8.3 37.1 8.1 12.3 8.1 12.2 12.0 7.7 7.7 12.3 8.2 7.5 9.2 5.1 19.3 11.1 16.0 8.4 7.9 6.0 6.3 9.1 6.4 7.6 13.3 10.8 6.8 12.7 16.0 8.7 11.4 10.5 6.5 6.8 6.9 6.9 11.7 14.2 5.7 11.1 10.2 9.0 7.0 9.4 11.7 7.2 7.8 0.0 2.1 1.7 3.2 1.8 4.2 2.0 1.9 2.7 2.8 1.2 3.3 4.3 1.9 2.4 1.6 2.4 3.1 1.2 10.9 18.3 15.5 18.6 10.3 7.2 11.9 14.0 14.7 11.4 41.7 21.1 7.5 11.4 23.0 40.4 97.6 15.3 9.4 19.4 12.2 76.6 14.8 3.3 8.0 6.6 23.7 13.4 23.3 9.5 6.8 18.3 22.3 16.1 32.7 8.9 60.4 16.0 31.9 21.5 7.4 23.9 16.8 15.1 4.6 12.5 63.3 9.4 14.0 18.0 10.2 53.7 25.8 26.4 13.0 7.6 25.3 19.2 13.1 9.9 12.3 UBR4 "KIAA0462, KIAA1307, RBAF600, ZUBR1" ENSG00000127481 "Ubiquitin protein ligase E3 component n-recognin 4" Q5T4S7 1 19074506-19210276 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Ubl conjugation pathway" "Calmodulin-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Basal keratinocytes: 240.8;Suprabasal keratinocytes: 220.9;Urothelial cells: 215.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013394, HPA021046" Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA013394: , HPA021046: AB_1858578" "unprognostic (1.37e-1)" "unprognostic (2.57e-2)" "unprognostic (2.82e-2)" "unprognostic (2.02e-1)" "unprognostic (8.78e-2)" "unprognostic (9.77e-2)" "unprognostic (1.14e-3)" "unprognostic (3.09e-1)" "unprognostic (1.96e-1)" "unprognostic (9.14e-3)" "unprognostic (7.48e-2)" "unprognostic (2.53e-1)" "unprognostic (7.68e-3)" "unprognostic (4.30e-1)" "unprognostic (1.19e-1)" "unprognostic (5.58e-2)" "unprognostic (1.52e-1)" 24.4 25.4 22.4 29.0 25.4 58.3 23.7 28.5 32.5 22.4 28.5 26.3 31.5 18.2 34.0 32.5 22.7 20.3 27.3 20.5 23.3 15.9 25.5 29.7 31.2 20.3 21.0 20.9 35.5 21.0 40.9 31.4 28.4 25.0 30.7 20.5 30.6 24.7 27.1 55.9 69.0 25.5 39.3 20.2 26.5 30.2 41.1 21.6 37.7 26.1 17.3 25.9 43.4 29.0 4.6 9.1 18.3 18.5 2.7 3.4 4.6 22.2 22.5 20.4 15.0 38.1 19.7 17.6 17.3 18.4 18.9 17.3 35.9 19.2 13.4 16.3 22.9 16.6 15.3 15.9 17.3 17.7 11.1 14.1 30.7 21.7 23.3 26.9 18.8 20.4 17.6 22.2 38.5 37.2 18.5 20.7 23.9 21.0 12.5 17.9 15.9 8.9 22.9 16.5 45.7 12.7 12.4 15.9 11.2 17.1 13.1 14.4 14.3 20.5 11.8 14.8 19.5 8.2 14.8 32.0 22.2 13.9 26.2 19.4 14.9 9.0 15.6 15.2 29.1 18.8 18.3 18.5 2.9 3.4 3.8 2.9 4.6 3.0 1.9 9.1 2.9 2.7 2.5 9.8 2.7 1.3 4.3 2.1 4.6 22.4 25.4 28.5 32.5 23.3 15.9 21.0 20.9 25.0 21.6 32.8 42.3 16.3 79.1 240.8 54.0 15.6 40.8 30.8 26.1 29.6 143.3 19.2 11.6 31.4 14.7 21.1 36.4 23.3 35.5 14.1 29.1 39.1 18.5 77.9 54.8 74.7 16.8 28.8 47.4 19.9 28.4 42.8 47.2 36.1 30.4 30.7 51.2 14.0 33.6 88.2 48.0 19.4 26.8 37.4 17.9 220.9 28.4 21.0 19.5 215.5 UBR5 "DD5, EDD, EDD1, HYD, KIAA0896" ENSG00000104517 "Ubiquitin protein ligase E3 component n-recognin 5" O95071 8 102253012-102412841 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053688 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA053688: AB_2682230" "unprognostic (3.79e-3)" "unprognostic (7.44e-3)" "unprognostic (1.25e-1)" "unprognostic (2.10e-2)" "unprognostic (2.44e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (1.26e-4)" "unprognostic (2.50e-1)" "unprognostic (1.75e-2)" "unprognostic (7.54e-3)" "unprognostic (8.29e-3)" "unprognostic (3.84e-2)" "unprognostic (6.64e-2)" "unprognostic (3.16e-1)" "unprognostic (1.94e-1)" "unprognostic (1.69e-2)" "unprognostic (2.45e-1)" 27.0 16.7 27.1 29.5 31.7 30.3 29.2 40.8 32.8 24.9 25.0 19.1 21.1 14.4 26.8 24.0 23.8 22.0 17.6 22.7 25.5 15.3 17.9 17.0 24.2 29.6 21.9 20.6 29.7 22.2 32.4 25.5 25.0 23.6 20.2 17.1 19.7 22.9 21.8 39.9 29.7 22.4 29.3 17.5 21.9 21.1 39.7 28.3 37.9 20.3 15.9 27.0 27.5 28.6 5.0 4.0 6.3 5.5 2.4 7.1 2.1 23.6 10.6 20.5 10.4 20.2 20.6 18.9 17.9 15.8 14.0 12.3 10.6 15.9 47.1 15.5 16.7 9.2 14.4 17.5 15.5 19.7 20.4 8.6 39.3 14.5 19.0 18.0 12.2 21.7 23.6 15.5 14.4 25.2 16.0 16.8 13.5 18.9 26.8 13.7 21.4 31.0 14.6 15.4 22.9 12.0 18.1 12.1 22.3 12.8 23.2 15.1 12.6 12.5 12.1 12.4 18.6 19.6 13.0 16.8 15.0 17.5 13.4 12.4 14.4 13.8 48.5 14.8 19.1 12.1 3.1 3.4 5.0 5.6 3.4 5.6 5.0 6.0 5.9 4.0 3.9 4.8 7.1 6.3 2.4 5.5 3.6 7.1 2.1 27.1 31.7 40.8 32.8 25.5 15.3 21.9 20.6 23.6 28.3 23.8 27.7 29.8 38.5 46.4 48.4 35.8 5.1 40.2 63.7 29.6 64.8 19.1 8.3 15.1 25.0 38.3 17.3 0.0 13.1 14.9 48.2 37.7 28.9 15.8 15.4 54.0 32.0 23.4 29.4 20.2 36.8 28.9 42.2 27.1 17.9 31.5 16.2 17.3 34.3 6.7 44.0 12.9 38.7 64.7 30.4 53.3 58.2 30.5 17.7 46.9 UBR7 C14orf130 ENSG00000012963 "Ubiquitin protein ligase E3 component n-recognin 7 (putative)" Q8N806 14 93207056-93229215 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 7 "Early spermatids: 246.4;Late spermatids: 271.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000861 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA000861: AB_1078321" "unprognostic (9.60e-2)" "unprognostic (5.12e-3)" "unprognostic (1.11e-1)" "unprognostic (9.20e-2)" "unprognostic (3.30e-1)" "unprognostic (2.12e-1)" "prognostic unfavorable (8.12e-5)" "unprognostic (1.14e-1)" "unprognostic (9.83e-2)" "unprognostic (1.04e-2)" "unprognostic (4.30e-2)" "unprognostic (5.94e-2)" "prognostic favorable (9.76e-5)" "unprognostic (3.61e-2)" "unprognostic (2.91e-1)" "unprognostic (2.86e-1)" "unprognostic (1.78e-1)" 14.1 12.3 16.4 12.5 22.9 17.0 17.5 20.0 25.8 17.1 15.7 17.7 11.3 11.1 14.9 13.4 14.8 13.7 11.9 19.0 14.2 12.8 15.3 13.2 11.9 18.0 14.0 17.1 17.0 20.4 28.2 11.5 11.4 13.3 13.9 17.1 13.6 13.7 14.9 19.9 15.2 12.7 14.1 16.9 13.8 14.1 21.1 14.3 31.9 15.4 12.9 23.3 13.4 13.3 18.1 10.7 15.8 9.5 11.5 16.5 8.2 6.5 8.7 13.5 11.2 6.3 6.8 4.8 13.8 9.8 15.4 11.7 6.3 7.4 15.5 11.6 7.0 6.7 7.9 14.4 7.7 15.8 12.0 7.8 11.2 9.4 6.0 2.9 16.4 12.6 4.1 5.4 8.5 5.4 5.7 8.6 14.9 10.4 15.6 14.7 19.1 26.6 9.0 6.2 17.2 15.9 20.5 24.1 8.5 5.2 10.7 16.9 12.1 9.9 8.3 4.1 8.3 15.0 11.3 6.5 11.3 6.1 9.7 14.2 18.1 27.7 16.0 9.9 12.7 9.6 15.8 7.3 11.8 12.7 9.1 13.3 18.1 11.4 11.7 7.8 14.8 10.0 10.6 11.5 11.5 9.5 10.7 16.5 8.2 16.4 22.9 20.0 25.8 14.2 12.8 14.0 17.1 13.3 14.3 14.9 5.4 14.3 6.6 17.6 5.8 15.3 10.2 2.7 10.3 10.4 9.8 7.8 10.0 8.8 246.4 8.2 9.2 23.3 11.2 13.2 10.2 4.3 4.7 10.4 11.8 3.2 5.2 14.1 10.1 271.2 8.6 8.5 13.5 7.2 7.6 12.6 8.2 5.8 11.7 7.0 13.4 6.5 10.7 34.9 27.7 11.8 5.5 10.7 10.7 3.3 UBXN1 "2B28, LOC51035, SAKS1, UBXD10" ENSG00000162191 "UBX domain protein 1" Q04323 11 62676498-62679117 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012669, HPA076932" Approved Supported Nucleoplasm,Cytosol NA NA 12000 Cytosol Nucleoplasm "HPA012669: AB_1853149, HPA076932: " "unprognostic (1.76e-3)" "unprognostic (8.72e-3)" "unprognostic (3.67e-3)" "unprognostic (2.94e-2)" "unprognostic (9.39e-2)" "unprognostic (8.72e-2)" "unprognostic (2.96e-2)" "unprognostic (1.15e-1)" "unprognostic (1.15e-1)" "unprognostic (4.36e-2)" "unprognostic (1.73e-1)" "unprognostic (1.07e-1)" "unprognostic (3.81e-2)" "unprognostic (3.52e-2)" "unprognostic (1.43e-1)" "unprognostic (3.34e-3)" "unprognostic (2.42e-1)" 40.4 37.8 33.1 33.8 35.1 27.6 44.1 27.7 37.8 36.0 36.6 36.3 32.3 36.1 38.0 33.7 36.7 37.8 42.3 38.2 30.8 27.2 30.4 26.1 27.3 46.9 33.7 28.5 62.3 41.7 31.4 25.0 29.3 27.2 37.6 19.5 26.6 29.5 32.1 115.3 42.8 31.2 51.5 36.6 37.9 35.0 35.8 29.0 58.9 56.6 40.9 41.2 43.5 67.2 84.1 54.9 27.8 64.2 44.6 85.4 77.8 19.6 31.7 23.8 33.2 33.2 35.7 21.8 17.3 31.9 33.1 22.6 22.6 25.4 31.4 31.9 23.0 29.2 28.1 19.0 29.5 15.4 28.1 24.4 21.9 28.2 30.4 65.1 34.5 24.3 46.1 45.9 29.1 45.0 35.5 30.7 39.7 33.7 20.2 20.6 44.0 26.0 63.7 1.2 15.2 22.0 19.7 26.0 30.6 26.6 19.9 23.7 41.1 16.5 25.3 74.9 10.7 35.3 42.8 30.2 26.9 20.3 27.3 19.5 26.0 19.7 28.1 31.1 14.8 24.4 21.0 51.1 24.4 46.3 53.1 58.9 83.4 70.6 54.2 54.9 84.1 85.4 62.3 27.8 44.6 64.2 43.7 84.9 77.8 33.1 35.1 27.7 37.8 30.8 27.2 33.7 28.5 27.2 29.0 86.4 85.3 236.7 136.4 234.5 60.3 74.7 104.4 105.7 99.0 71.5 43.2 143.5 132.6 157.2 130.0 200.5 201.1 93.5 159.6 151.0 161.2 139.3 157.2 69.5 190.4 28.6 121.1 125.2 291.0 195.1 193.3 259.6 173.7 301.2 133.8 117.2 161.2 178.9 134.7 178.9 48.1 194.1 250.4 238.0 204.7 264.7 271.5 236.6 131.7 176.3 UBXN2B p37 ENSG00000215114 "UBX domain protein 2B" Q14CS0 8 58411264-58451501 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 27.6" "Group enriched" "Detected in all" 5 "granulocytes: 27.6;monocytes: 7.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045278 Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA045278: AB_10963578" "unprognostic (1.98e-3)" "unprognostic (1.10e-1)" "unprognostic (1.48e-2)" "unprognostic (2.15e-3)" "unprognostic (1.63e-1)" "unprognostic (2.22e-1)" "unprognostic (2.46e-1)" "unprognostic (8.71e-2)" "unprognostic (3.36e-1)" "unprognostic (5.97e-2)" "unprognostic (1.58e-2)" "unprognostic (1.54e-1)" "unprognostic (6.48e-3)" "unprognostic (1.26e-1)" "unprognostic (8.22e-2)" "unprognostic (2.00e-1)" "unprognostic (1.42e-2)" 9.6 11.7 20.2 14.1 18.8 17.8 13.9 27.2 25.4 8.9 11.1 9.8 7.4 9.3 10.4 14.0 8.4 10.9 10.7 12.0 25.5 13.3 19.6 22.7 12.1 11.6 16.0 20.0 12.0 11.4 22.0 11.7 9.1 14.7 12.3 11.6 6.7 15.0 11.2 12.1 7.8 9.3 14.4 19.7 14.9 10.8 11.1 16.9 11.7 17.7 6.5 11.2 11.4 13.1 2.3 3.6 27.6 7.3 3.0 3.2 3.0 7.1 14.7 10.9 13.3 2.0 1.3 8.1 4.3 7.8 5.6 7.0 5.5 15.8 8.6 9.3 5.2 14.3 7.2 15.9 7.6 7.5 7.9 8.1 10.0 13.2 7.5 8.3 8.8 9.7 3.6 12.2 3.0 12.3 12.7 6.4 12.4 7.3 15.2 4.7 7.0 15.7 9.9 15.4 24.0 3.0 9.4 5.2 7.7 17.1 10.6 4.7 16.5 7.3 7.9 12.3 11.2 15.7 11.0 1.4 5.1 11.0 8.8 9.0 8.0 9.3 12.0 13.5 8.4 5.9 7.0 7.1 12.3 2.8 6.9 3.1 2.3 2.7 2.4 3.6 2.1 3.1 2.9 27.6 3.0 7.3 2.0 3.2 3.0 20.2 18.8 27.2 25.4 25.5 13.3 16.0 20.0 14.7 16.9 8.9 8.3 17.9 8.9 5.0 14.8 17.1 5.1 5.3 5.7 10.4 21.6 13.5 8.3 10.6 27.9 5.3 12.7 0.0 9.6 13.2 6.8 12.6 23.1 16.3 20.8 11.1 11.5 5.5 30.4 45.3 9.8 28.9 8.5 5.4 8.7 10.9 9.0 7.0 13.8 24.3 26.1 0.0 7.6 17.2 14.7 5.8 7.2 10.1 10.4 7.3 UBXN7 "KIAA0794, UBXD7" ENSG00000163960 "UBX domain protein 7" O94888 3 196347662-196432474 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048441, HPA049442" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA048441: AB_2680394, HPA049442: AB_2680769" "unprognostic (8.36e-3)" "unprognostic (4.89e-2)" "unprognostic (1.01e-1)" "unprognostic (1.90e-3)" "unprognostic (1.05e-1)" "unprognostic (6.64e-2)" "unprognostic (5.12e-3)" "unprognostic (1.49e-1)" "unprognostic (9.60e-2)" "unprognostic (6.45e-2)" "unprognostic (2.11e-2)" "unprognostic (2.91e-2)" "unprognostic (2.52e-2)" "unprognostic (1.78e-1)" "unprognostic (3.40e-1)" "unprognostic (7.58e-2)" "unprognostic (1.32e-1)" 13.8 12.7 14.0 11.2 17.6 29.9 13.3 30.4 16.3 14.5 13.1 19.2 13.5 9.0 17.3 14.3 13.4 14.4 9.9 9.6 15.6 12.1 11.4 10.4 13.3 13.3 16.3 12.9 21.4 12.9 23.1 23.4 14.9 16.2 12.4 11.5 11.4 12.8 13.3 10.3 17.5 12.9 13.4 14.0 13.5 10.8 17.9 19.0 24.7 13.2 6.7 13.6 13.9 17.2 9.6 6.3 10.4 6.5 7.6 9.5 2.8 15.1 4.4 18.9 10.0 9.9 17.5 7.9 12.7 8.4 7.3 6.7 12.4 6.6 14.1 26.1 8.5 9.7 12.3 14.1 7.6 13.6 5.8 8.7 22.7 10.3 6.7 7.6 11.2 7.3 10.4 8.6 10.2 12.8 13.1 11.7 10.4 10.7 9.9 8.5 6.6 11.7 6.1 11.0 6.3 6.1 13.6 14.2 9.6 6.0 6.4 12.9 9.7 19.7 5.7 10.1 15.8 15.3 9.6 14.7 8.5 7.5 7.5 13.5 13.5 18.5 20.7 7.7 13.3 6.1 10.2 5.9 8.9 6.1 4.9 5.8 9.6 5.4 4.0 6.3 7.5 9.5 8.3 10.4 7.6 6.5 2.9 8.7 2.8 14.0 17.6 30.4 16.3 15.6 12.1 16.3 12.9 16.2 19.0 41.7 16.8 11.7 12.6 42.0 34.6 16.1 15.3 25.4 23.9 19.2 66.8 14.0 5.0 9.9 30.5 22.2 11.2 0.0 8.7 8.8 21.7 21.2 8.1 10.5 11.1 30.2 44.6 21.5 20.6 19.6 27.6 19.9 21.9 15.4 16.7 21.5 10.8 8.6 26.5 9.4 45.6 32.3 20.8 29.8 21.3 47.8 15.8 27.3 15.5 14.1 UBXN8 "D8S2298E, REP8, UBXD6" ENSG00000104691 "UBX domain protein 8" O00124 8 30732247-30767006 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 30.6" "Group enriched" "Detected in many" 4 "Early spermatids: 162.1;Hepatocytes: 56.2;Late spermatids: 132.0" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017725, HPA077538" Enhanced Supported "Nucleoplasm,Nucleoli,Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "Nucleoplasm, Nucleoli" "HPA017725: AB_1847462, HPA077538: AB_2686844" "unprognostic (3.00e-2)" "unprognostic (2.30e-1)" "prognostic favorable (6.13e-4)" "unprognostic (7.71e-2)" "unprognostic (2.24e-1)" "unprognostic (1.03e-1)" "unprognostic (2.41e-1)" "unprognostic (1.84e-2)" "unprognostic (1.90e-1)" "unprognostic (5.13e-2)" "unprognostic (1.58e-1)" "unprognostic (1.06e-2)" "prognostic unfavorable (5.25e-5)" "unprognostic (2.49e-1)" "unprognostic (1.96e-1)" "unprognostic (1.51e-1)" "unprognostic (6.88e-2)" 5.0 5.3 3.9 1.4 4.8 1.4 4.3 1.5 9.2 3.0 3.5 4.0 6.7 3.1 3.8 14.3 4.1 3.6 3.8 2.8 5.7 8.2 21.5 2.1 3.9 7.6 4.0 30.6 10.3 6.2 3.5 6.2 6.2 4.8 4.7 1.6 1.8 6.1 1.7 4.1 2.9 2.9 7.1 5.7 3.3 11.5 6.1 0.9 9.1 2.8 2.3 2.9 3.7 6.0 8.2 1.0 6.1 3.3 8.4 3.4 7.6 7.7 5.6 5.8 9.1 12.2 6.3 13.7 8.0 7.5 9.2 12.2 2.8 12.2 11.3 11.1 12.4 6.8 1.1 7.6 11.6 6.4 12.5 34.3 6.3 14.9 13.7 7.8 19.4 9.6 7.9 12.0 5.9 6.4 6.5 5.6 33.5 9.2 16.5 7.2 7.9 6.0 10.8 22.8 5.8 9.5 5.4 8.5 12.8 10.0 3.2 8.1 3.8 11.3 24.7 7.0 8.4 13.6 8.3 8.5 3.7 3.8 12.7 4.0 12.5 9.2 7.6 12.6 12.1 0.0 6.0 0.7 8.4 6.1 7.3 6.0 4.5 8.0 6.7 2.9 4.4 7.4 1.0 3.3 3.0 8.2 4.3 3.4 3.0 8.0 3.0 4.1 0.0 1.9 3.2 15.3 1.4 5.7 14.0 19.6 20.6 6.6 7.1 162.1 6.2 6.3 0.0 4.5 16.0 9.4 4.1 13.9 56.2 19.0 11.1 8.2 27.0 14.2 132.0 13.3 6.9 0.0 10.0 6.4 6.6 3.9 3.5 9.2 22.0 1.8 6.5 3.9 14.1 20.4 0.0 12.7 7.2 10.0 2.4 UCHL1 "PARK5, PGP9.5, Uch-L1" ENSG00000154277 "Ubiquitin C-terminal hydrolase L1" P09936 4 41256413-41268455 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 225.8" "Cell type enhanced" "Detected in many" 14 "Collecting duct cells: 109.9;Distal tubular cells: 218.8;Horizontal cells: 138.2;Spermatogonia: 90.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 3.6" "Lineage enriched" "Detected in single" 37 "B-cells: 3.6" "Cell line enhanced" "Detected in many" "EFO-21: 99.0;SCLC-21H: 98.8;U-251 MG: 90.4;U-266/84: 87.2;U-87 MG: 96.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002580, HPA005993, CAB079024" Enhanced Supported Supported Nucleoplasm,Cytosol NA NA 440000 Cytosol Nucleoplasm "CAB002580: AB_563981, CAB079024: , HPA005993: AB_1858560" "unprognostic (1.54e-1)" "unprognostic (1.96e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (4.08e-5)" "unprognostic (2.34e-1)" "unprognostic (1.98e-1)" "unprognostic (6.28e-3)" "unprognostic (1.09e-2)" "unprognostic (4.31e-2)" "unprognostic (8.77e-3)" "unprognostic (3.56e-3)" "unprognostic (3.70e-2)" "unprognostic (1.82e-3)" "unprognostic (1.24e-2)" "unprognostic (7.12e-3)" "unprognostic (2.10e-2)" "prognostic unfavorable (1.93e-4)" 8.2 40.2 52.4 8.9 65.1 2.0 3.1 17.5 225.8 4.5 6.3 11.5 0.0 5.5 6.0 1.8 2.7 5.7 6.5 5.4 53.4 97.4 14.0 2.0 2.7 6.5 62.0 57.1 15.4 6.3 1.8 30.5 2.7 100.6 5.3 4.7 6.0 3.0 4.4 7.5 2.7 8.6 5.2 38.6 2.3 2.8 8.0 8.3 0.0 3.9 0.0 4.5 5.6 2.8 3.6 0.0 0.0 0.0 0.0 0.0 0.6 0.2 56.1 11.6 0.0 1.5 1.9 0.0 58.7 30.3 20.8 21.0 11.3 0.0 0.0 99.0 29.9 31.4 0.1 21.4 0.0 8.5 0.1 8.7 0.0 0.3 0.0 44.9 0.0 0.0 10.8 0.2 16.7 0.0 34.7 0.1 0.0 0.0 0.2 11.0 0.0 0.0 0.9 33.6 0.0 63.4 0.0 24.8 0.0 31.4 0.0 98.8 62.0 0.3 0.2 0.2 13.9 0.0 0.5 0.3 1.3 0.4 0.0 90.4 46.4 87.2 0.2 96.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 52.4 65.1 17.5 92.6 53.4 97.4 62.0 57.1 100.6 8.3 0.0 1.9 0.8 0.8 1.4 19.7 2.5 0.0 12.0 5.7 109.9 7.9 2.5 218.8 3.6 2.0 2.1 0.0 0.0 0.7 0.8 15.8 2.8 2.3 0.4 4.7 138.2 4.1 11.1 0.3 4.4 34.2 1.7 3.3 1.0 0.0 22.6 4.0 0.0 16.3 7.9 39.1 0.0 7.3 6.6 90.2 1.4 1.3 0.0 0.0 0.6 UCHL3 ENSG00000118939 "Ubiquitin C-terminal hydrolase L3" P15374 13 75549480-75606020 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019678, CAB037139, CAB037208" Approved Supported Nucleoplasm,Cytosol No No 490000 "Nucleoplasm, Cytosol" "CAB037139: AB_1841234, CAB037208: AB_1841235, HPA019678: AB_1858583" "unprognostic (4.16e-1)" "unprognostic (3.84e-2)" "unprognostic (8.83e-3)" "unprognostic (1.14e-1)" "unprognostic (5.15e-2)" "unprognostic (6.46e-3)" "prognostic unfavorable (6.41e-4)" "unprognostic (1.19e-1)" "unprognostic (5.59e-2)" "unprognostic (9.71e-2)" "unprognostic (1.24e-1)" "unprognostic (7.09e-2)" "unprognostic (4.47e-2)" "unprognostic (3.97e-1)" "unprognostic (2.76e-2)" "unprognostic (8.84e-2)" "unprognostic (3.26e-2)" 13.7 39.1 23.6 11.9 37.6 17.4 21.4 17.5 18.7 10.6 21.2 11.4 12.8 12.8 9.0 40.5 37.7 8.1 12.4 15.5 20.6 12.6 20.7 36.8 10.3 12.2 18.2 13.5 7.7 20.8 9.5 28.9 26.3 14.7 12.4 25.0 6.1 24.0 14.9 31.7 28.8 15.0 16.9 13.3 15.3 14.5 24.6 18.6 18.9 28.1 29.8 20.2 16.0 16.2 17.4 46.0 15.8 43.5 20.5 23.4 17.3 51.7 8.7 7.6 5.2 14.2 17.0 21.9 19.6 19.5 25.6 28.7 48.0 25.2 26.8 14.2 20.6 19.5 28.6 17.7 47.7 38.9 14.3 15.5 16.9 14.4 30.6 20.5 40.3 12.7 15.0 33.1 20.0 32.2 10.8 24.9 21.8 18.5 7.7 38.4 18.6 16.4 26.4 11.3 60.9 26.2 13.1 12.2 17.6 30.1 21.1 22.9 6.7 11.2 21.8 9.0 17.1 12.5 11.5 19.2 11.2 13.3 11.9 26.2 10.8 12.0 31.2 22.6 43.7 8.0 15.6 24.1 15.8 10.9 43.5 14.2 17.4 19.9 15.5 33.6 16.0 19.8 18.3 5.4 20.5 36.2 46.0 23.4 17.3 23.6 37.6 17.5 18.7 20.6 12.6 18.2 13.5 14.7 18.6 8.9 22.6 16.0 62.8 67.9 8.8 22.6 35.7 28.1 42.1 43.6 2.0 84.6 77.9 139.8 157.4 22.0 32.0 0.0 124.1 137.9 25.4 82.5 23.1 42.0 76.8 15.9 23.1 17.2 26.4 26.7 15.5 32.1 25.3 20.8 45.7 8.6 125.1 31.7 11.0 96.2 8.8 19.4 18.6 110.6 30.9 69.3 141.3 20.3 55.3 79.8 UCHL5 "CGI-70, INO80R, UCH37" ENSG00000116750 "Ubiquitin C-terminal hydrolase L5" Q9Y5K5 1 193012250-193060080 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005908, HPA006069" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA005908: AB_1858585, HPA006069: " "unprognostic (3.66e-2)" "unprognostic (3.84e-3)" "unprognostic (5.17e-2)" "unprognostic (5.98e-2)" "unprognostic (1.20e-2)" "unprognostic (1.20e-1)" "unprognostic (3.50e-2)" "unprognostic (7.41e-2)" "unprognostic (1.96e-2)" "unprognostic (1.04e-3)" "unprognostic (3.44e-3)" "unprognostic (6.92e-2)" "unprognostic (6.41e-3)" "unprognostic (1.51e-1)" "unprognostic (7.15e-2)" "prognostic unfavorable (7.10e-5)" "unprognostic (4.33e-2)" 15.7 18.3 20.1 16.1 26.2 16.0 18.2 30.1 34.8 10.9 17.7 11.5 12.6 19.0 12.5 14.7 26.1 10.7 11.9 22.0 21.6 20.6 21.6 28.3 12.4 19.9 21.3 29.4 13.4 24.8 15.6 16.2 17.8 33.3 17.8 18.8 10.3 19.3 12.9 29.1 16.7 18.0 13.9 20.1 17.3 14.0 9.9 17.5 20.0 15.1 19.1 23.0 14.8 14.8 22.5 20.8 23.8 21.1 35.6 30.9 20.9 33.6 18.7 16.2 16.6 9.5 9.6 19.3 19.8 10.1 19.0 16.5 17.7 22.9 26.4 19.2 11.0 11.5 20.9 21.6 25.6 25.2 27.2 15.5 31.3 24.2 23.4 15.2 49.1 17.6 8.9 11.4 27.3 24.2 8.7 18.7 26.6 68.6 21.6 16.1 27.2 36.1 18.2 15.0 23.1 11.8 21.0 18.2 51.4 17.7 19.8 16.5 20.3 17.8 25.8 27.6 17.9 21.0 24.8 12.2 17.8 5.4 18.0 31.5 16.8 26.0 29.8 10.7 30.6 30.3 23.8 16.5 19.0 28.3 19.5 30.9 22.5 25.9 26.9 19.4 18.0 28.2 30.5 10.0 35.6 21.1 20.8 24.8 20.9 20.1 26.2 30.1 34.8 21.6 20.6 21.3 29.4 33.3 17.5 8.9 24.6 13.7 12.3 21.6 18.3 68.2 15.3 26.8 29.6 26.2 41.2 31.3 38.1 21.6 1.8 20.4 19.5 0.0 24.6 27.1 16.4 17.3 53.3 22.2 24.8 23.8 10.4 18.4 20.3 3.4 13.8 24.5 16.9 19.8 18.3 25.7 20.3 7.0 16.3 30.8 41.8 19.4 17.0 14.0 16.8 26.2 21.1 27.7 20.6 10.5 UCK1 "FLJ12255, URK1" ENSG00000130717 "Uridine-cytidine kinase 1" Q9HA47 9 131523801-131531268 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050969, HPA070526" Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA050969: AB_2681294, HPA070526: " "unprognostic (2.20e-1)" "prognostic favorable (3.19e-4)" "unprognostic (1.16e-2)" "unprognostic (1.74e-3)" "unprognostic (7.29e-2)" "unprognostic (1.43e-1)" "unprognostic (8.71e-2)" "unprognostic (1.78e-1)" "unprognostic (2.44e-1)" "unprognostic (1.18e-1)" "unprognostic (1.36e-3)" "unprognostic (1.54e-1)" "prognostic favorable (2.21e-7)" "unprognostic (5.11e-2)" "unprognostic (3.29e-2)" "unprognostic (1.74e-1)" "unprognostic (1.07e-1)" 13.2 15.9 21.7 13.7 22.5 13.7 15.6 29.9 23.2 15.0 15.6 17.3 20.8 11.4 12.2 19.3 14.5 17.6 16.5 21.0 19.6 18.4 18.3 26.7 12.7 12.9 20.4 19.1 21.3 24.0 17.6 14.4 16.4 14.8 14.9 9.2 17.6 24.1 18.3 30.0 12.0 12.2 14.8 19.9 12.1 13.4 15.7 15.6 12.5 18.5 10.8 11.5 13.6 9.4 7.9 6.6 9.4 7.8 6.8 13.5 6.1 7.0 15.7 18.2 23.3 12.9 9.2 15.5 11.5 17.0 20.0 15.2 15.6 6.5 7.7 7.0 13.8 15.6 13.8 16.9 14.7 8.6 14.1 15.7 7.2 23.6 9.8 18.5 11.8 10.7 10.3 13.9 16.1 11.7 12.1 12.2 19.2 9.0 5.9 14.6 28.2 16.0 6.0 21.5 13.9 15.7 15.4 28.1 12.9 12.8 6.7 24.6 15.5 16.6 12.7 17.9 8.7 24.8 7.0 8.9 22.2 11.3 13.7 11.2 12.2 15.6 9.8 11.0 8.3 15.4 2.3 6.2 9.4 8.5 7.8 11.3 7.9 10.1 7.6 5.7 7.9 13.5 6.8 4.1 6.8 2.7 6.6 12.3 6.1 21.7 22.5 29.9 23.2 19.6 18.4 20.4 19.1 14.8 15.6 14.9 5.3 14.9 10.3 12.7 17.5 12.9 7.6 0.0 3.4 14.0 7.9 26.0 24.9 19.6 15.1 13.4 17.0 0.0 22.9 12.0 15.5 11.2 2.3 19.4 22.3 25.4 11.6 11.1 11.1 20.2 16.4 8.2 15.1 27.1 11.8 17.7 15.6 11.6 18.7 23.7 10.2 19.4 18.9 29.3 29.4 10.9 21.5 9.6 11.8 7.1 UCK2 UMPK ENSG00000143179 "Uridine-cytidine kinase 2" Q9BZX2 1 165827531-165911618 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 65.8" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 94.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057128 Approved Nucleoplasm NA NA Nucleoplasm "HPA057128: AB_2683346" "unprognostic (5.37e-2)" "unprognostic (1.75e-2)" "unprognostic (2.51e-1)" "unprognostic (1.20e-2)" "unprognostic (4.54e-2)" "unprognostic (6.83e-3)" "prognostic unfavorable (9.22e-8)" "prognostic unfavorable (4.98e-4)" "prognostic unfavorable (6.70e-4)" "unprognostic (3.04e-2)" "unprognostic (1.49e-1)" "unprognostic (1.13e-2)" "prognostic unfavorable (5.12e-13)" "unprognostic (2.49e-3)" "unprognostic (1.14e-1)" "unprognostic (2.01e-3)" "unprognostic (1.83e-1)" 12.5 7.1 6.5 11.1 8.6 11.6 17.5 16.9 9.6 9.3 18.4 8.9 11.0 15.3 10.1 15.3 20.5 8.8 9.0 9.6 6.4 6.6 6.6 14.6 11.1 10.3 10.5 6.6 7.5 17.6 7.9 9.4 65.8 11.2 8.1 19.9 5.0 16.1 9.9 20.9 15.0 24.8 10.0 8.2 7.7 13.2 7.2 7.9 13.1 6.4 12.4 12.3 9.0 11.1 3.4 14.7 0.8 5.6 3.4 3.9 2.0 25.2 26.3 14.2 12.7 7.3 12.2 23.1 27.9 20.6 29.8 34.0 24.9 27.8 12.5 19.9 17.3 12.1 20.8 26.6 32.8 26.7 22.9 22.4 14.5 22.6 25.6 18.2 28.3 11.1 11.5 16.9 56.2 35.0 7.2 19.6 24.1 38.3 18.0 26.7 18.3 25.1 18.2 38.9 35.2 25.5 11.5 15.6 42.5 13.8 16.5 21.4 25.3 19.9 39.4 19.3 28.3 24.3 27.0 20.4 16.7 23.3 18.9 29.5 24.2 36.0 46.3 14.4 18.8 12.7 0.8 5.6 0.1 1.8 3.7 3.9 3.4 1.7 2.4 14.7 3.4 0.0 1.4 0.2 3.4 3.2 14.0 2.2 2.0 6.5 8.6 16.9 9.6 6.4 6.6 10.5 6.6 11.2 7.9 0.0 1.4 3.0 24.7 20.4 4.3 4.1 12.7 1.4 4.5 8.7 0.0 1.2 6.6 15.0 94.9 15.3 22.2 0.0 19.1 46.9 11.0 10.1 0.0 4.9 11.9 0.0 6.4 4.9 3.5 31.3 6.1 7.1 10.1 17.2 13.7 4.0 38.8 14.4 3.2 5.8 4.2 0.0 9.0 5.2 11.5 26.0 22.1 4.8 18.3 20.9 UCP3 SLC25A9 ENSG00000175564 "Uncoupling protein 3" P55916 11 74000281-74009435 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Diabetes mellitus, Disease mutation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skeletal muscle: 99.6" "Group enriched" "Detected in some" 5 "Early spermatids: 14.7;Late spermatids: 10.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 4 "cerebellum: 1.1" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in many" 4 "HDLM-2: 18.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB010771, HPA072225" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB010771: AB_261839, HPA072225: AB_2686498" "unprognostic (3.76e-3)" "unprognostic (1.24e-1)" "unprognostic (2.82e-1)" "unprognostic (5.98e-2)" "unprognostic (1.12e-1)" "unprognostic (2.49e-2)" "unprognostic (3.95e-3)" "unprognostic (6.61e-2)" "unprognostic (1.25e-1)" "unprognostic (8.58e-2)" "unprognostic (2.13e-4)" "unprognostic (1.61e-2)" "unprognostic (3.25e-6)" "unprognostic (2.68e-1)" "unprognostic (1.66e-1)" "unprognostic (1.76e-1)" "unprognostic (2.50e-4)" 0.9 0.2 0.2 0.3 0.2 0.6 0.2 1.1 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.5 0.9 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.2 1.0 0.2 99.6 0.3 0.2 0.2 0.2 0.5 0.1 0.6 0.2 0.2 0.6 6.4 0.8 0.2 0.2 0.8 0.1 0.7 0.3 0.2 2.1 0.4 0.2 2.1 2.1 1.8 0.8 0.4 0.4 0.5 0.5 0.5 0.3 0.5 0.4 1.1 0.3 0.4 0.3 2.2 0.8 0.4 0.8 18.3 0.7 0.4 2.4 0.2 0.6 1.2 1.7 0.5 1.4 1.3 0.1 0.4 0.7 1.0 0.5 1.4 0.7 1.2 0.8 1.6 1.0 1.6 1.4 1.6 4.3 0.6 1.1 0.6 1.2 1.3 0.5 0.9 0.7 0.4 0.2 1.1 0.4 0.3 1.4 0.7 1.3 1.6 1.7 0.8 0.3 1.1 0.7 0.0 0.3 0.7 2.1 0.1 0.9 0.0 1.5 1.8 0.0 0.8 0.6 1.2 0.1 0.2 0.0 0.1 0.4 0.4 0.2 0.2 1.1 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.5 0.1 0.1 2.2 0.5 0.0 2.7 1.2 0.0 0.0 0.3 0.0 0.3 14.7 0.1 0.0 0.0 0.4 0.1 0.2 0.1 0.0 0.0 0.5 0.0 0.0 0.6 0.8 10.7 0.0 0.0 0.0 0.0 0.6 0.7 0.3 0.0 0.7 0.0 1.6 0.0 0.1 1.2 0.7 0.3 0.2 2.2 0.6 0.0 UEVLD "Attp, UEV3" ENSG00000151116 "UEV and lactate/malate dehyrogenase domains" Q8IX04 11 18529609-18588747 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047134 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA047134: AB_10960698" "unprognostic (1.05e-1)" "unprognostic (6.76e-2)" "prognostic favorable (7.07e-4)" "unprognostic (5.94e-3)" "unprognostic (1.56e-1)" "unprognostic (1.45e-1)" "unprognostic (1.38e-3)" "unprognostic (9.08e-3)" "unprognostic (9.81e-2)" "unprognostic (2.87e-2)" "unprognostic (1.26e-3)" "unprognostic (1.71e-2)" "unprognostic (1.61e-3)" "unprognostic (2.65e-1)" "unprognostic (3.22e-1)" "unprognostic (8.23e-2)" "unprognostic (3.39e-1)" 17.3 15.0 13.3 11.6 12.9 5.5 20.8 9.7 13.3 17.1 18.2 16.4 12.9 15.1 15.0 16.3 17.8 12.6 13.0 13.2 13.1 12.1 21.8 17.2 13.3 12.3 15.6 10.9 13.8 11.8 19.1 14.2 16.2 15.5 17.9 20.0 11.4 14.8 13.9 20.4 20.2 15.9 18.3 23.0 12.5 13.4 10.0 15.0 14.3 15.2 11.8 11.5 16.5 13.5 5.2 7.1 11.1 8.5 8.7 7.6 3.8 9.2 11.1 5.3 5.1 17.2 15.4 5.1 10.0 14.1 13.3 12.9 4.6 2.6 2.8 5.6 11.8 11.6 14.3 4.7 10.3 15.3 8.3 6.3 4.1 5.2 5.1 7.7 6.3 6.2 10.6 11.0 6.5 9.3 9.5 12.4 0.2 3.1 2.8 16.9 6.9 0.2 2.1 1.4 14.2 11.5 1.0 12.2 3.5 16.0 14.6 2.2 4.7 11.0 14.1 8.8 6.8 11.2 3.8 9.3 12.3 6.5 20.4 9.8 0.6 6.3 0.6 10.6 5.0 12.5 6.9 8.3 5.0 7.6 8.5 7.1 4.5 5.5 6.1 5.5 5.2 3.6 4.7 11.1 8.7 6.6 7.1 3.8 3.8 13.3 12.9 9.7 13.3 13.1 12.1 15.6 10.9 15.5 15.0 14.9 17.1 0.8 5.1 5.6 8.9 8.5 2.5 21.4 13.6 22.7 9.8 7.4 3.3 9.2 2.3 7.1 18.7 0.0 11.4 6.2 6.9 7.6 5.8 13.0 10.8 14.3 8.7 12.9 15.3 1.4 7.5 10.4 6.8 6.4 14.4 12.3 11.0 7.0 17.3 11.4 11.0 12.9 7.5 6.5 5.9 8.2 6.4 6.9 13.0 6.5 UFD1 UFD1L ENSG00000070010 "Ubiquitin recognition factor in ER associated degradation 1" Q92890 22 19449910-19479215 "Predicted intracellular proteins, Transporters" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 105.1;Ductal cells: 98.8;Exocrine glandular cells: 123.6;monocytes: 132.6;Pancreatic endocrine cells: 115.9;Syncytiotrophoblasts: 142.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 131.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030286, HPA030287" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA030286: , HPA030287: AB_10601830" "unprognostic (2.52e-1)" "unprognostic (5.41e-2)" "unprognostic (1.95e-3)" "unprognostic (7.61e-2)" "unprognostic (3.50e-2)" "unprognostic (2.70e-2)" "prognostic unfavorable (2.59e-4)" "unprognostic (9.79e-2)" "unprognostic (1.60e-1)" "unprognostic (1.02e-3)" "unprognostic (8.82e-2)" "unprognostic (1.73e-2)" "prognostic unfavorable (4.50e-8)" "unprognostic (1.45e-1)" "unprognostic (1.08e-1)" "unprognostic (1.46e-1)" "unprognostic (1.30e-2)" 27.8 28.0 22.7 24.3 38.0 38.7 23.9 25.3 30.4 21.1 28.9 23.3 24.7 21.7 32.8 40.3 31.6 21.3 21.7 35.6 21.9 22.9 28.0 46.6 24.6 34.8 44.3 15.9 22.4 34.7 22.5 22.6 31.6 33.0 21.7 27.7 21.9 26.7 24.4 57.9 27.3 24.7 28.3 39.7 26.7 26.2 31.8 29.9 37.8 27.8 26.9 31.7 23.9 23.7 27.7 35.3 53.5 42.8 31.1 67.6 37.5 31.8 23.2 19.8 30.0 16.3 11.5 15.2 26.4 26.4 36.5 33.8 25.7 13.9 22.3 20.5 22.1 16.8 27.7 23.2 23.1 31.8 41.0 24.5 23.5 16.4 20.3 15.5 37.2 32.1 10.5 23.8 31.1 15.3 10.7 29.2 11.8 131.8 43.0 22.2 46.3 23.9 22.8 14.2 40.2 19.7 29.1 46.9 8.6 22.4 30.1 16.3 18.3 20.7 22.5 20.7 21.6 13.5 17.9 31.7 30.8 41.9 25.6 28.3 18.4 36.6 29.0 25.9 19.0 28.1 39.8 29.0 47.8 36.1 42.8 34.7 27.7 41.6 37.3 25.5 23.9 35.9 35.1 53.5 31.1 41.1 35.3 67.6 37.5 22.7 38.0 25.3 30.4 21.9 22.9 44.3 15.9 33.0 29.9 23.8 34.6 0.0 0.0 0.0 0.0 0.0 0.0 50.9 30.7 26.2 0.0 105.1 71.3 98.8 0.0 0.0 0.0 0.0 123.6 90.9 0.0 0.0 25.6 0.0 79.3 0.0 0.0 0.0 0.0 0.0 0.0 26.0 0.0 132.6 0.0 0.0 115.9 0.0 0.0 61.9 0.0 0.0 0.0 0.0 0.0 0.0 142.5 0.0 0.0 0.0 UFSP2 "C4orf20, FLJ11200" ENSG00000109775 "UFM1 specific peptidase 2" Q9NUQ7 4 185399540-185425985 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 125.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039985, HPA043298" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA039985: AB_10794206, HPA043298: AB_10795037" "unprognostic (8.87e-2)" "unprognostic (1.85e-2)" "unprognostic (1.52e-1)" "unprognostic (1.97e-1)" "unprognostic (1.17e-1)" "unprognostic (1.29e-1)" "unprognostic (3.63e-2)" "unprognostic (3.19e-2)" "unprognostic (3.69e-1)" "unprognostic (1.50e-1)" "unprognostic (2.04e-2)" "unprognostic (2.56e-1)" "prognostic favorable (1.07e-8)" "unprognostic (1.92e-1)" "unprognostic (8.12e-2)" "unprognostic (9.36e-3)" "unprognostic (6.70e-3)" 15.8 20.3 12.5 10.3 14.9 4.1 18.7 11.3 20.3 17.3 17.4 16.3 17.0 11.0 19.4 17.4 20.1 17.3 13.5 24.2 11.4 11.7 28.1 19.2 13.2 11.6 14.6 11.3 30.5 20.1 18.3 22.8 12.3 17.0 18.4 12.6 13.7 14.4 20.3 40.8 16.6 13.6 16.9 20.2 14.2 17.3 23.7 14.6 15.8 23.5 19.2 12.2 20.8 13.3 15.6 13.0 5.5 7.9 13.9 17.9 8.2 12.2 7.5 21.1 15.2 19.1 19.8 11.7 12.7 12.9 15.2 14.4 12.5 15.7 12.3 5.9 15.3 11.4 9.7 16.4 20.6 15.8 13.2 9.5 6.5 7.3 11.3 21.1 9.9 8.1 11.6 16.1 13.3 13.7 19.6 24.3 16.0 16.5 24.9 19.6 7.4 13.2 7.4 5.4 8.9 10.8 13.0 8.3 14.8 14.6 7.1 12.6 11.8 7.9 12.9 15.4 13.1 9.9 7.0 14.1 6.3 11.2 4.4 9.8 22.7 8.7 5.9 20.5 6.2 16.1 5.5 7.9 5.4 16.3 6.8 17.1 15.6 16.5 17.6 9.8 11.0 17.8 17.9 0.4 13.9 6.6 13.0 14.0 8.2 12.5 14.9 11.3 20.3 11.4 11.7 14.6 11.3 17.0 14.6 6.0 19.2 16.7 28.0 19.6 46.6 23.8 10.2 28.1 29.6 19.2 62.8 22.2 94.5 25.2 125.0 22.7 9.1 23.3 28.8 24.6 26.8 16.4 27.8 14.9 23.8 17.5 18.6 14.1 16.7 32.5 32.8 19.1 33.7 14.4 16.8 50.3 19.5 19.3 39.6 62.7 79.4 64.7 30.1 53.7 53.4 16.6 35.0 21.5 15.3 15.4 UGDH ENSG00000109814 "UDP-glucose 6-dehydrogenase" O60701 4 39498755-39528311 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism" "Allosteric enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 125.8" "Cell type enhanced" "Detected in many" 6 "Exocrine glandular cells: 293.1;Hepatocytes: 215.1;Pancreatic endocrine cells: 205.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 85.7;Hep G2: 99.2;U-2197: 61.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034444, HPA036656, HPA036657" Enhanced Supported Nucleoplasm Yes No 42000 Nucleoplasm "CAB034444: AB_2019602, HPA036656: AB_10671706, HPA036657: AB_10672360" "unprognostic (1.22e-2)" "unprognostic (1.62e-1)" "unprognostic (2.73e-2)" "unprognostic (3.96e-2)" "unprognostic (5.54e-2)" "unprognostic (1.63e-1)" "unprognostic (8.78e-3)" "unprognostic (6.07e-2)" "unprognostic (1.34e-1)" "unprognostic (1.41e-1)" "unprognostic (9.81e-3)" "unprognostic (6.86e-2)" "prognostic unfavorable (5.51e-10)" "unprognostic (2.48e-1)" "unprognostic (2.04e-1)" "unprognostic (1.66e-1)" "unprognostic (4.97e-2)" 25.9 11.3 4.4 24.7 3.2 0.2 12.7 4.0 3.1 13.0 29.3 3.8 10.2 13.7 11.5 9.7 22.9 9.9 12.9 10.1 3.6 3.5 28.2 125.8 13.5 4.7 4.0 2.2 20.6 24.9 5.1 4.7 26.8 5.3 13.2 23.3 7.5 8.2 7.3 7.5 5.5 24.2 17.7 3.7 3.3 14.1 5.0 3.8 1.7 16.7 12.7 7.1 30.2 24.1 12.0 12.3 17.1 12.0 21.8 22.4 10.2 4.9 85.7 9.4 12.3 30.9 34.4 7.9 16.3 19.4 16.1 14.8 12.0 18.5 3.1 10.2 22.6 14.8 5.1 9.8 4.6 16.9 4.0 1.7 3.5 11.1 99.2 12.2 4.3 3.5 11.5 2.5 27.6 8.7 13.0 10.3 2.5 4.6 2.6 11.1 14.6 4.2 4.7 7.6 32.4 6.3 7.2 14.6 3.1 8.9 19.7 4.8 7.1 10.0 5.9 6.8 7.2 3.3 3.6 12.0 16.6 7.7 61.6 7.8 6.0 4.3 3.1 14.0 3.6 8.6 17.1 12.0 10.9 14.3 10.6 22.4 10.9 11.4 14.8 10.7 12.0 9.8 12.0 2.3 21.8 6.1 12.3 7.3 10.2 4.4 3.2 4.0 3.0 3.6 3.5 4.0 2.2 5.3 3.8 23.8 22.2 19.5 56.0 103.1 7.7 7.3 22.9 72.3 30.7 19.2 13.7 18.5 59.7 44.3 0.9 20.2 111.9 0.0 293.1 59.3 101.2 100.0 35.7 215.1 16.1 9.5 108.6 23.4 18.5 0.9 30.8 17.2 28.7 26.2 69.3 5.2 205.5 85.2 27.3 54.9 8.6 32.3 92.4 2.4 4.0 35.0 24.3 11.5 88.0 69.0 UGP2 "UGP1, UGPP1" ENSG00000169764 "UDP-glucose pyrophosphorylase 2" Q16851 2 63840940-63891562 "Enzymes, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 185.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 93.6;T-reg: 29.9" "Group enriched" "Detected in all" 5 "granulocytes: 93.6;T-cells: 29.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034696, HPA034697, HPA064836" Enhanced Approved Nucleoplasm,Centrosome,Mitochondria NA NA 12000000 "Centrosome, Mitochondria" Nucleoplasm "HPA034696: AB_10670171, HPA034697: AB_2674287, HPA064836: AB_2685365" "unprognostic (1.00e-2)" "unprognostic (6.93e-2)" "unprognostic (5.12e-2)" "unprognostic (1.06e-1)" "unprognostic (2.65e-2)" "unprognostic (1.91e-1)" "prognostic favorable (2.50e-5)" "unprognostic (2.20e-1)" "unprognostic (3.01e-1)" "unprognostic (1.84e-1)" "unprognostic (1.57e-2)" "unprognostic (8.31e-2)" "unprognostic (1.03e-1)" "unprognostic (1.25e-2)" "unprognostic (3.93e-2)" "unprognostic (3.81e-1)" "unprognostic (8.44e-2)" 58.2 14.7 23.3 13.6 22.5 7.8 25.2 12.4 30.4 13.3 38.2 6.7 7.4 12.3 15.5 12.5 19.8 12.7 12.2 46.3 18.8 13.2 33.0 185.5 12.7 15.2 17.3 18.3 12.0 13.4 17.1 22.9 31.0 19.3 11.0 33.1 5.7 18.5 12.9 104.1 11.0 17.2 16.8 8.6 9.9 13.0 8.1 10.5 31.0 17.4 75.5 12.7 19.7 19.5 6.4 5.9 93.6 7.8 12.7 29.9 11.0 27.5 14.5 13.9 9.3 47.4 61.5 58.3 35.6 29.1 19.2 22.9 37.1 23.4 28.9 10.7 38.2 17.5 12.1 16.8 22.3 31.2 19.3 7.1 18.3 10.3 25.3 22.7 16.1 16.1 40.3 40.9 18.0 18.6 25.9 26.6 9.8 9.1 11.7 80.1 10.8 21.8 15.2 33.3 45.0 10.2 17.9 27.6 16.6 34.0 16.0 7.3 6.0 28.4 36.6 13.5 44.1 10.4 11.5 36.3 20.1 31.7 29.9 18.7 21.0 9.4 36.6 24.1 25.3 61.3 93.6 7.0 9.7 9.9 7.8 10.3 6.4 11.4 10.3 5.9 6.2 12.6 11.2 9.0 12.7 7.6 5.5 29.9 11.0 23.3 22.5 12.4 30.4 18.8 13.2 17.3 18.3 19.3 10.5 26.8 52.5 51.7 74.0 67.3 48.5 238.8 89.2 73.6 69.4 45.4 60.9 359.1 205.6 116.3 61.0 61.3 412.6 0.0 90.6 369.3 148.4 77.6 65.8 448.9 107.3 82.6 42.9 66.3 100.6 64.7 73.4 90.8 91.1 173.1 112.3 37.4 81.0 167.8 72.9 209.2 49.4 71.1 124.3 71.2 57.5 50.6 395.3 112.8 144.5 90.3 UGT3A2 ENSG00000168671 "UDP glycosyltransferase family 3 member A2" Q3SY77 5 36035017-36071358 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 37.0;skin 1: 14.4;testis: 13.2" "Group enriched" "Detected in some" 5 "Collecting duct cells: 3.5;Early spermatids: 3.6;Late spermatids: 5.7;Proximal tubular cells: 3.3" "Cancer enriched" "Detected in some" 5 "testis cancer: 4.4" "Region enhanced" "Detected in single" "pons and medulla: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 5.2;MOLT-4: 9.3;REH: 21.8;SuSa: 9.8;T-47d: 5.7;THP-1: 12.8" HPA059475 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" Yes NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA059475: AB_2684031" "unprognostic (1.83e-4)" "unprognostic (9.94e-2)" "unprognostic (8.87e-2)" "unprognostic (4.82e-4)" "unprognostic (3.18e-1)" "unprognostic (3.52e-2)" "unprognostic (1.56e-1)" "unprognostic (6.08e-2)" "unprognostic (2.04e-1)" "unprognostic (8.13e-2)" "unprognostic (7.49e-2)" "unprognostic (4.17e-2)" "unprognostic (1.36e-3)" "unprognostic (6.65e-2)" "unprognostic (7.52e-2)" "unprognostic (7.38e-2)" "unprognostic (4.52e-3)" 0.1 1.1 0.1 0.0 0.2 6.4 1.6 0.1 0.6 0.1 0.1 0.5 0.4 0.0 0.1 0.8 0.1 0.1 0.2 0.2 0.1 0.6 5.6 0.8 0.1 0.0 0.5 0.0 0.2 0.0 0.0 1.7 0.2 2.0 0.6 0.0 2.9 0.1 0.0 0.1 14.4 0.1 0.0 0.3 1.4 0.1 13.2 0.0 37.0 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 1.0 0.0 0.4 5.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 9.3 0.0 3.9 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 5.7 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.6 0.1 0.6 0.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 UHMK1 "KIS, Kist" ENSG00000152332 "U2AF homology motif kinase 1" Q8TAS1 1 162497251-162529629 "Enzymes, Predicted intracellular proteins" "Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071190 Approved "Nucleoplasm,Golgi apparatus,Midbody" Yes No "Nucleoplasm, Golgi apparatus" Midbody "HPA071190: AB_2686358" "unprognostic (6.69e-2)" "unprognostic (1.28e-1)" "unprognostic (1.05e-1)" "unprognostic (1.46e-1)" "unprognostic (1.28e-1)" "unprognostic (1.33e-1)" "unprognostic (2.08e-2)" "unprognostic (8.16e-2)" "unprognostic (9.63e-2)" "unprognostic (1.82e-1)" "unprognostic (7.81e-3)" "unprognostic (9.10e-2)" "unprognostic (3.11e-1)" "unprognostic (3.44e-2)" "unprognostic (9.08e-2)" "unprognostic (8.77e-2)" "unprognostic (4.66e-2)" 21.6 22.0 23.5 18.9 26.2 30.1 23.5 10.8 30.5 14.3 16.3 17.2 30.8 16.3 11.5 12.9 16.0 12.9 12.1 11.4 27.0 31.8 27.9 32.4 16.9 24.3 30.6 20.3 12.1 11.8 25.0 12.5 16.5 33.4 14.7 17.4 14.1 15.9 22.9 30.6 11.5 21.8 9.6 20.5 21.3 16.8 10.4 14.1 23.0 17.1 11.7 24.1 16.1 12.8 5.7 4.3 4.5 9.2 5.9 8.5 4.0 21.1 9.9 5.2 12.7 14.9 11.8 11.7 28.0 15.3 23.0 16.6 6.4 13.3 17.3 24.5 20.9 11.2 12.3 9.9 15.5 37.1 23.7 7.2 17.1 12.3 5.8 11.5 24.9 20.0 12.1 16.4 22.6 21.7 16.1 13.2 12.0 14.9 24.1 39.4 8.9 13.2 6.6 6.9 15.9 13.4 8.5 23.3 14.4 15.3 21.9 9.5 8.8 24.7 23.0 18.0 7.5 19.9 28.0 20.5 26.3 14.9 18.1 39.0 25.0 34.7 20.5 21.9 12.2 23.8 4.5 3.3 3.7 8.2 8.6 8.5 5.4 6.2 6.8 3.6 5.7 6.3 7.1 2.0 5.9 9.2 4.3 4.9 4.0 23.5 26.2 10.8 30.5 27.0 31.8 30.6 20.3 33.4 14.1 17.9 32.1 50.1 25.7 26.2 21.7 29.4 56.0 41.5 50.0 50.6 11.8 22.6 48.0 23.2 35.7 30.8 40.7 0.0 20.2 32.6 19.3 44.8 45.0 71.0 27.6 22.3 32.1 35.0 64.6 34.6 19.8 51.7 27.0 44.1 35.0 13.6 28.8 34.8 18.4 49.4 21.6 0.0 27.3 23.4 22.0 21.5 18.8 52.2 31.1 52.1 UHRF1 "FLJ21925, ICBP90, Np95, RNF106, TDRD22" ENSG00000276043 "Ubiquitin like with PHD and ring finger domains 1" Q96T88 19 4903080-4962154 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, DNA-binding, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 75.6" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 5.8;Hofbauer cells: 7.5;Spermatogonia: 6.9" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 8.2" "Group enriched" "Detected in many" 4 "dendritic cells: 8.2;T-cells: 4.2" "Cell line enhanced" "Detected in many" "MOLT-4: 63.9;REH: 145.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA049408, HPA055446" Enhanced Supported Nucleoplasm No Yes Nucleoplasm "HPA049408: AB_2756317, HPA055446: AB_2732597" "unprognostic (3.83e-2)" "unprognostic (6.83e-3)" "unprognostic (5.13e-2)" "unprognostic (1.69e-1)" "unprognostic (1.40e-1)" "unprognostic (7.21e-2)" "prognostic unfavorable (1.63e-4)" "unprognostic (4.30e-2)" "prognostic unfavorable (6.81e-4)" "unprognostic (2.82e-1)" "prognostic unfavorable (4.52e-5)" "unprognostic (2.33e-3)" "unprognostic (0.00e+0)" "unprognostic (3.75e-3)" "unprognostic (2.45e-1)" "unprognostic (2.01e-1)" "unprognostic (2.02e-1)" 0.7 0.0 0.7 8.2 3.7 16.5 0.7 0.3 4.2 0.3 1.5 1.6 0.0 2.1 0.3 0.2 2.0 0.0 1.0 0.9 1.2 0.1 0.1 0.3 10.0 4.3 0.7 0.3 0.6 0.0 0.0 1.0 1.4 0.0 1.4 0.0 0.0 0.0 0.3 1.9 2.2 0.8 0.7 2.2 1.9 3.1 4.0 75.6 0.0 4.0 6.6 1.1 0.0 0.4 8.2 1.5 0.4 0.9 4.2 0.9 15.9 11.6 17.5 12.4 0.5 2.0 2.8 13.0 6.2 13.6 13.2 13.8 8.1 9.1 3.2 5.7 4.9 8.0 12.0 7.0 9.6 14.7 13.7 7.8 10.8 14.7 0.2 19.3 11.9 1.0 0.5 7.3 1.9 2.1 4.0 14.4 11.2 10.5 8.1 12.5 63.9 11.8 7.8 5.8 12.5 145.0 39.1 6.6 3.7 11.7 13.0 10.3 10.2 5.6 1.8 2.9 10.1 18.4 5.0 14.4 11.7 18.6 15.7 4.5 4.6 26.8 8.3 18.8 18.3 0.6 0.4 0.2 1.1 0.1 0.1 0.3 1.5 1.9 2.2 0.4 0.4 1.5 1.5 0.9 0.3 8.2 4.2 0.9 0.0 0.0 1.5 0.6 0.0 2.6 1.6 2.5 1.4 1.2 0.0 0.0 1.7 0.0 1.7 2.5 0.0 0.9 0.0 0.3 5.8 0.5 0.5 0.0 0.6 7.5 3.2 0.0 0.0 2.1 0.9 0.6 0.7 0.0 2.8 1.5 0.5 2.6 1.9 0.4 0.0 0.8 0.0 1.5 4.2 6.9 0.0 1.1 0.0 4.7 0.7 UHRF1BP1 "C6orf107, dJ349A12.1, FLJ20302, ICBP90" ENSG00000065060 "UHRF1 binding protein 1" Q6BDS2 6 34792015-34883138 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032099, HPA032100" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Nuclear membrane" Cytosol "HPA032099: AB_10696057, HPA032100: AB_10671087" "unprognostic (2.30e-2)" "unprognostic (9.52e-2)" "unprognostic (4.58e-3)" "unprognostic (1.28e-2)" "unprognostic (3.42e-2)" "unprognostic (7.01e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (3.58e-2)" "unprognostic (4.39e-3)" "unprognostic (9.82e-2)" "unprognostic (4.68e-1)" "unprognostic (1.30e-1)" "unprognostic (1.47e-1)" "unprognostic (1.04e-1)" "unprognostic (1.98e-1)" "unprognostic (1.90e-1)" "unprognostic (4.24e-2)" 7.6 9.3 7.6 7.6 8.2 18.7 6.7 18.5 10.9 4.8 5.9 7.1 4.7 5.1 5.5 4.4 6.0 5.3 4.5 13.7 6.1 5.8 6.1 10.9 8.0 6.9 5.5 6.8 6.6 13.1 15.1 9.5 8.1 7.7 6.0 6.3 6.8 8.6 5.1 22.2 4.9 5.5 6.4 7.6 6.8 7.2 22.5 5.5 8.5 9.4 3.2 6.8 5.9 10.8 1.5 1.2 1.1 4.5 1.4 1.3 0.8 8.5 6.1 5.5 17.7 2.9 2.1 9.9 5.0 3.4 4.9 7.0 12.1 2.3 12.9 5.5 5.2 8.6 6.5 19.9 2.8 6.7 6.6 6.4 11.4 5.9 10.1 11.8 10.3 7.2 4.8 8.3 3.9 8.4 4.6 6.1 11.3 19.0 5.1 2.1 8.1 7.9 6.7 2.5 6.2 4.3 4.8 8.8 7.7 6.6 7.9 6.6 6.7 12.6 6.6 16.9 5.9 12.7 13.5 3.7 2.4 9.0 3.8 5.5 7.7 11.9 8.2 1.3 14.4 6.0 0.5 1.2 1.1 1.3 1.7 1.3 1.3 1.2 1.3 1.2 1.5 0.6 1.0 0.7 1.4 4.5 0.5 0.4 0.8 7.6 8.2 18.5 10.9 6.1 5.8 5.5 6.8 7.7 5.5 14.9 4.6 1.5 2.5 0.9 9.5 14.6 5.1 4.0 10.3 0.0 19.6 5.6 1.7 5.1 8.0 4.5 3.5 0.0 5.0 3.0 3.5 8.1 1.1 5.1 12.9 4.8 9.1 17.8 11.7 11.0 5.2 8.2 0.0 10.8 3.4 5.6 7.9 2.9 2.5 3.8 11.3 12.9 3.4 13.7 11.9 2.5 4.1 2.6 3.7 5.4 UHRF1BP1L KIAA0701 ENSG00000111647 "UHRF1 binding protein 1 like" A0JNW5 12 100028455-100142848 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039671, HPA075150" Uncertain Uncertain Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA039671: AB_10794201, HPA075150: " "unprognostic (4.80e-2)" "unprognostic (3.17e-1)" "unprognostic (2.34e-2)" "unprognostic (1.14e-1)" "unprognostic (8.96e-2)" "unprognostic (7.36e-2)" "unprognostic (8.10e-2)" "unprognostic (5.75e-3)" "unprognostic (2.06e-1)" "unprognostic (5.43e-2)" "unprognostic (1.88e-2)" "unprognostic (2.53e-1)" "unprognostic (2.94e-3)" "unprognostic (6.84e-2)" "unprognostic (1.25e-1)" "unprognostic (3.81e-2)" "unprognostic (1.28e-2)" 14.9 13.9 15.9 11.4 19.9 31.9 10.8 16.9 26.0 9.5 10.0 8.7 5.3 9.9 9.3 8.8 10.2 8.0 10.6 10.4 18.0 13.7 14.7 28.0 10.6 9.7 14.8 12.0 11.1 4.7 21.5 15.3 13.7 22.6 11.1 9.6 6.9 8.7 11.2 26.2 8.4 11.1 11.2 13.7 11.8 9.0 15.2 9.8 10.0 13.0 8.1 8.1 16.7 8.4 3.8 8.4 22.9 8.4 3.7 3.7 3.4 11.3 12.4 6.9 7.1 10.7 15.3 13.8 17.8 17.9 14.4 10.6 9.2 3.9 9.9 4.7 18.1 8.4 4.4 12.9 6.0 14.0 26.2 6.4 6.6 9.9 10.6 9.9 12.4 10.8 8.6 5.1 17.3 12.0 13.4 10.0 6.9 5.2 10.3 14.0 6.3 7.9 10.7 11.9 3.9 11.3 9.0 12.3 9.7 7.4 20.1 11.8 7.4 13.5 15.6 5.3 6.2 13.9 14.2 7.9 16.0 8.5 13.7 12.4 12.2 20.8 13.9 8.0 9.4 9.6 12.5 7.6 4.9 2.6 8.4 3.7 3.8 2.9 2.9 8.4 3.4 2.5 3.0 22.9 3.7 6.8 5.1 3.2 3.4 15.9 19.9 16.9 26.0 18.0 13.7 14.8 12.0 22.6 9.8 26.8 8.3 9.8 13.2 11.3 10.8 11.5 2.5 30.8 19.4 8.7 3.9 3.9 5.0 4.8 17.2 6.8 8.0 0.0 5.0 7.4 14.6 16.5 23.1 17.4 9.8 14.3 5.2 6.2 17.7 2.1 6.6 20.6 10.1 8.2 2.8 5.8 4.2 7.0 7.4 12.2 11.3 0.0 9.7 19.8 21.5 10.2 9.2 12.5 4.7 10.2 UHRF2 "MGC33463, NIRF, RNF107, TDRD23, URF2" ENSG00000147854 "Ubiquitin like with PHD and ring finger domains 2" Q96PU4 9 6413151-6507054 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Ubl conjugation pathway" "DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026633, HPA026697" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA026633: AB_2732431, HPA026697: AB_2732432" "unprognostic (1.08e-1)" "unprognostic (1.13e-1)" "unprognostic (1.52e-1)" "unprognostic (1.68e-1)" "unprognostic (1.12e-1)" "unprognostic (8.40e-2)" "unprognostic (4.35e-3)" "unprognostic (4.12e-2)" "unprognostic (1.53e-1)" "unprognostic (4.17e-2)" "unprognostic (1.73e-1)" "unprognostic (5.69e-3)" "unprognostic (2.14e-2)" "unprognostic (6.21e-2)" "unprognostic (8.77e-2)" "unprognostic (7.42e-2)" "unprognostic (1.50e-1)" 14.1 12.9 10.6 25.4 12.2 49.1 19.0 24.8 11.8 18.6 15.6 12.7 17.6 7.9 17.5 15.1 13.3 12.0 11.9 11.3 10.2 10.6 10.1 9.8 13.5 19.3 12.3 10.5 18.9 14.5 12.7 12.7 14.6 11.4 19.3 12.0 10.7 13.0 16.4 15.7 11.0 12.0 17.1 12.2 14.1 11.6 10.6 14.8 40.3 15.2 10.2 19.8 18.7 18.2 5.1 2.5 7.5 1.4 1.2 3.6 1.2 6.7 7.7 11.1 4.7 9.1 13.2 8.1 15.6 9.6 9.8 17.2 4.9 4.9 10.3 3.4 7.7 9.1 4.4 10.2 9.1 15.0 18.7 4.7 18.0 15.0 7.8 7.5 8.4 6.1 5.9 5.9 7.6 18.8 18.8 38.2 10.6 1.7 10.1 23.1 2.3 14.1 32.7 4.3 9.9 5.7 16.0 5.1 3.6 7.3 4.6 10.0 3.9 6.7 4.5 9.7 14.1 5.6 16.9 32.2 10.5 3.8 4.3 13.0 2.7 8.0 12.1 5.1 7.4 4.1 7.5 1.1 4.3 2.3 0.9 1.7 3.5 3.6 1.8 0.7 5.1 2.3 3.0 1.3 1.2 1.4 2.5 3.5 1.2 10.6 12.2 24.8 11.8 10.2 10.6 12.3 10.5 11.4 14.8 6.0 11.8 25.0 9.7 19.2 22.6 42.0 5.1 5.3 9.1 12.2 29.5 10.8 1.7 5.1 16.0 20.4 8.1 23.3 3.4 8.5 12.4 13.9 17.3 11.3 9.2 27.0 6.8 15.4 11.7 5.9 17.8 11.0 20.3 6.4 12.4 6.7 6.0 12.9 13.8 5.1 34.9 12.9 13.7 37.2 17.2 16.7 4.9 13.8 11.3 7.1 UIMC1 RAP80 ENSG00000087206 "Ubiquitin interaction motif containing 1" Q96RL1 5 176905005-177022633 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 111.3;Spermatogonia: 78.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 32.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037503, HPA037504" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA037503: AB_10671373, HPA037504: AB_10671760" "unprognostic (2.96e-1)" "unprognostic (9.57e-2)" "unprognostic (2.48e-3)" "unprognostic (4.40e-2)" "unprognostic (1.69e-1)" "unprognostic (9.88e-3)" "prognostic unfavorable (7.67e-6)" "unprognostic (1.85e-1)" "unprognostic (1.12e-2)" "unprognostic (6.62e-2)" "unprognostic (1.30e-1)" "unprognostic (5.91e-2)" "unprognostic (1.33e-3)" "unprognostic (8.51e-2)" "unprognostic (5.52e-1)" "unprognostic (7.23e-2)" "unprognostic (1.44e-1)" 12.7 11.1 11.8 17.3 13.7 35.3 12.6 27.8 12.7 12.2 13.8 7.8 12.0 6.4 14.9 11.7 8.9 10.7 8.8 16.0 9.5 6.6 8.7 8.1 12.1 36.7 11.2 8.9 18.2 12.7 7.0 10.6 8.7 10.4 10.5 9.0 8.8 8.5 10.8 22.9 10.9 10.9 13.7 7.8 15.0 10.4 47.5 11.5 22.1 11.8 7.3 29.5 13.6 28.2 8.5 4.9 32.5 6.3 7.4 7.8 3.3 11.1 11.1 11.6 14.8 11.0 10.3 17.0 12.0 13.2 15.0 15.9 13.1 13.1 45.9 14.4 9.5 16.3 8.9 11.8 25.9 18.0 38.3 10.6 14.5 12.3 11.1 12.1 18.2 9.7 7.2 12.4 11.4 31.1 11.7 17.4 20.1 12.9 11.1 12.4 10.6 19.4 11.9 8.3 9.4 6.8 19.0 16.6 19.4 15.7 7.4 12.6 10.0 25.3 8.6 12.5 12.8 7.5 11.0 13.8 8.7 9.5 7.7 15.7 19.8 20.6 24.6 8.5 19.7 9.4 7.0 6.3 16.8 5.0 4.0 5.5 6.4 5.8 4.8 3.8 8.5 5.6 4.6 32.5 7.4 2.8 4.9 7.8 3.3 11.8 13.7 27.8 12.7 9.5 6.6 11.2 8.9 10.4 11.5 11.9 16.0 17.9 15.5 9.3 19.7 16.2 7.6 25.4 22.7 8.7 13.7 11.1 6.6 11.6 15.8 17.5 6.7 0.0 11.4 10.7 12.4 10.1 17.4 6.6 9.1 15.9 12.6 10.4 16.2 7.5 14.4 12.6 1.7 12.6 6.4 10.0 14.2 8.6 11.7 6.4 35.0 12.9 12.1 111.3 78.8 10.5 5.7 15.3 7.5 12.4 ULK4 "FAM7C1, FLJ20574, REC01035" ENSG00000168038 "Unc-51 like kinase 4" Q96C45 3 41246599-41962430 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 279.5;Late spermatids: 329.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA017930 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA017930: AB_1858615" "unprognostic (3.16e-2)" "unprognostic (2.98e-3)" "unprognostic (9.72e-3)" "unprognostic (3.46e-2)" "unprognostic (2.58e-1)" "unprognostic (8.68e-2)" "unprognostic (1.87e-1)" "unprognostic (3.50e-2)" "unprognostic (1.80e-1)" "unprognostic (1.41e-1)" "unprognostic (3.75e-3)" "unprognostic (3.43e-1)" "unprognostic (1.91e-2)" "unprognostic (5.46e-2)" "unprognostic (1.61e-1)" "unprognostic (2.53e-1)" "unprognostic (6.12e-2)" 4.3 4.8 5.1 4.7 8.3 10.3 4.2 4.3 5.4 11.9 2.8 5.9 6.0 2.1 10.7 10.9 2.8 12.3 3.1 13.1 5.2 3.0 5.4 3.4 5.5 4.2 3.1 4.2 4.5 3.6 13.5 19.7 9.0 5.8 4.4 2.8 6.7 4.2 4.5 1.4 3.5 3.3 5.1 5.7 4.4 3.4 27.5 3.4 6.3 7.1 1.7 8.4 4.0 6.0 6.4 5.1 10.7 6.3 2.6 10.3 5.2 7.3 1.7 2.7 3.0 1.1 1.7 4.6 2.5 2.6 3.1 2.6 0.9 2.2 8.6 1.4 5.8 3.0 3.7 3.2 1.9 2.8 1.1 0.9 1.6 5.4 2.9 3.9 5.6 1.7 1.6 2.2 15.0 3.1 3.9 2.1 5.9 1.9 7.2 2.2 5.9 7.0 4.5 3.3 1.8 3.1 1.6 8.5 3.7 6.5 7.1 1.4 9.9 2.6 1.2 2.1 1.8 3.0 1.8 6.2 2.0 2.2 13.2 2.1 4.3 8.0 3.6 11.0 5.9 2.4 5.7 5.8 5.8 8.0 6.3 6.5 5.6 8.6 7.2 5.1 6.4 6.5 9.2 10.7 2.6 3.2 4.6 10.3 5.2 5.1 8.3 4.3 5.4 5.2 3.0 3.1 4.2 5.8 3.4 8.9 5.8 1.9 2.8 1.8 5.4 12.8 5.1 53.5 4.5 3.5 51.1 2.8 0.0 2.3 279.5 4.4 1.1 0.0 2.1 3.9 3.3 1.2 1.1 5.9 6.5 11.1 1.7 1.8 4.1 329.6 6.1 5.6 0.0 6.4 1.1 11.2 2.8 0.0 3.9 5.0 25.1 6.5 3.3 29.9 8.7 3.1 3.5 4.4 1.7 0.8 UMAD1 "RPA3-AS1, RPA3OS" ENSG00000219545 "UBAP1-MVB12-associated (UMA) domain containing 1" 7 7640711-7968020 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044806 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA044806: AB_10961141" "unprognostic (4.86e-2)" "unprognostic (1.48e-1)" "unprognostic (1.68e-1)" "unprognostic (1.23e-1)" "unprognostic (9.08e-3)" "unprognostic (9.24e-2)" "unprognostic (6.86e-3)" "unprognostic (4.87e-1)" "unprognostic (2.56e-1)" "unprognostic (6.57e-2)" "unprognostic (1.19e-1)" "unprognostic (2.43e-1)" "prognostic favorable (1.73e-8)" "unprognostic (6.66e-3)" "unprognostic (8.34e-2)" "unprognostic (7.69e-2)" "unprognostic (3.58e-1)" 4.1 8.7 7.0 6.5 8.5 3.8 6.7 6.8 8.8 4.2 6.1 5.3 9.6 7.6 6.2 7.8 4.2 5.0 5.1 6.6 5.5 8.7 7.0 6.6 6.9 7.5 8.3 7.2 18.7 12.5 17.0 4.2 8.1 10.0 5.8 6.1 11.4 11.9 3.5 2.6 8.1 6.3 7.3 5.1 11.6 2.4 6.3 8.6 12.9 3.5 6.3 7.1 8.4 17.0 9.7 27.4 13.0 10.1 22.0 10.9 14.1 10.5 5.4 6.2 7.8 9.2 6.2 8.8 10.1 6.9 10.6 4.4 10.6 7.7 9.3 5.4 28.0 9.2 6.1 8.8 8.7 5.8 4.7 4.2 8.0 5.1 8.7 7.7 9.9 8.7 11.1 10.0 7.7 8.1 4.2 10.2 8.6 23.9 9.1 11.5 7.0 4.2 9.7 9.5 8.8 7.8 12.7 12.3 12.6 6.5 2.2 8.9 12.3 15.9 12.4 16.7 12.4 9.5 4.6 7.1 16.7 13.9 8.8 17.2 18.8 8.9 16.0 11.1 21.8 22.8 9.7 24.6 12.1 12.4 15.0 17.0 17.3 15.1 8.1 16.2 20.5 15.3 27.4 10.1 13.0 9.7 22.0 10.9 23.8 11.0 5.3 24.5 0.0 6.5 10.1 12.7 17.4 18.2 14.0 13.7 14.4 33.2 7.4 6.3 6.0 11.2 0.0 12.8 17.6 9.6 27.0 14.0 8.9 14.4 14.3 5.8 4.9 9.8 2.8 12.4 9.3 0.0 7.2 14.3 11.3 9.3 11.0 7.4 26.2 9.4 25.8 7.4 3.0 4.6 0.0 17.7 10.2 9.9 19.2 UNC13B "hmunc13, UNC13, Unc13h2" ENSG00000198722 "Unc-13 homolog B" O14795 9 35161992-35405338 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 53.6;Alveolar cells type 2: 55.9;Cone photoreceptor cells: 90.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.9" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024493, HPA062300" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles,Intermediate filaments" Yes No Vesicles "Nucleoplasm, Golgi apparatus, Intermediate filaments" "HPA024493: AB_1858618, HPA062300: AB_2684742" "unprognostic (9.73e-3)" "unprognostic (2.33e-1)" "prognostic favorable (4.96e-4)" "unprognostic (6.56e-2)" "unprognostic (9.93e-2)" "prognostic favorable (8.51e-5)" "unprognostic (7.64e-2)" "prognostic favorable (6.59e-5)" "unprognostic (3.80e-1)" "unprognostic (1.64e-1)" "prognostic favorable (3.71e-4)" "unprognostic (1.74e-1)" "prognostic favorable (4.34e-11)" "unprognostic (2.40e-1)" "unprognostic (1.89e-1)" "unprognostic (1.48e-1)" "unprognostic (2.80e-2)" 11.9 12.1 9.3 9.0 18.3 1.4 10.4 16.6 18.8 12.2 21.4 10.1 35.0 11.5 10.6 8.4 14.9 11.1 14.6 11.1 9.2 7.1 22.1 21.5 37.6 2.2 9.5 9.5 7.9 28.7 21.7 13.7 6.3 10.1 20.5 25.1 27.2 20.7 33.6 21.1 14.6 13.0 12.2 9.4 5.0 15.8 16.2 9.1 0.8 12.5 11.6 5.8 8.6 10.4 0.9 1.9 0.0 0.4 0.0 0.3 0.4 5.4 7.2 8.1 13.0 15.6 8.7 6.8 8.9 4.0 6.6 9.0 6.0 2.5 0.0 4.1 11.6 11.7 2.6 20.3 10.3 8.5 0.0 6.5 3.3 20.6 7.7 7.5 1.2 3.7 6.9 8.1 10.4 10.8 10.6 21.3 9.0 7.4 4.6 7.7 4.1 1.1 0.1 7.3 16.9 7.6 0.0 5.0 1.9 9.1 7.1 8.7 9.1 6.2 3.9 6.5 14.0 6.6 4.2 19.5 4.6 4.3 7.1 6.8 7.4 8.8 0.0 5.0 10.3 4.6 0.0 0.4 0.0 0.0 0.3 0.0 0.9 0.3 0.3 1.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 9.3 18.3 16.6 18.8 9.2 7.1 9.5 9.5 10.1 9.1 53.6 55.9 0.8 1.2 2.7 37.4 11.0 17.8 10.7 25.0 8.7 90.3 3.2 3.3 6.0 5.6 6.7 14.8 0.0 10.6 1.9 3.1 10.8 2.3 11.1 4.1 6.4 23.6 4.9 2.2 8.5 2.0 3.1 6.8 0.0 28.6 6.7 8.2 14.1 2.8 6.8 42.9 6.5 4.7 7.5 8.3 6.5 2.4 0.0 16.7 2.6 UNC79 KIAA1409 ENSG00000133958 "Unc-79 homolog, NALCN channel complex subunit" Q9P2D8 14 93333219-93707876 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.6;pituitary gland: 18.9" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 42.7;Early spermatids: 28.8;Horizontal cells: 38.1;Late spermatids: 12.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "REH: 8.5;SCLC-21H: 6.3;SH-SY5Y: 4.0;U-937: 3.0" "Low region specificity" "Detected in all" HPA071881 Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA071881: AB_2732189" "unprognostic (8.42e-2)" "unprognostic (2.07e-1)" "unprognostic (6.70e-2)" "unprognostic (6.91e-2)" "unprognostic (1.06e-1)" "unprognostic (7.73e-2)" "unprognostic (2.99e-2)" "unprognostic (1.17e-1)" "unprognostic (2.31e-1)" "unprognostic (5.73e-3)" "unprognostic (8.03e-3)" "unprognostic (2.87e-1)" "unprognostic (3.39e-2)" "unprognostic (2.66e-2)" "unprognostic (5.57e-2)" "unprognostic (3.03e-2)" "unprognostic (7.47e-2)" 1.1 3.9 7.1 1.0 12.1 0.9 1.0 17.6 14.6 1.0 1.1 4.5 0.0 1.1 1.1 1.1 1.2 2.0 1.1 1.2 6.7 5.8 1.4 1.1 1.0 1.0 3.2 9.1 1.1 5.0 1.4 18.9 1.0 6.8 1.0 1.1 1.3 1.0 1.0 1.6 1.0 1.1 1.2 3.0 0.9 1.9 7.0 3.5 0.0 1.3 0.0 1.0 1.0 0.3 0.1 0.2 0.6 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.1 1.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 1.1 0.0 0.0 8.5 0.0 0.0 0.2 0.2 6.3 4.0 0.1 0.0 0.0 0.2 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 3.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 7.1 12.1 17.6 14.6 6.7 5.8 3.2 9.1 6.8 3.5 0.0 0.0 0.0 0.2 0.2 42.7 2.0 0.0 0.0 0.0 0.0 9.8 0.1 0.0 0.3 28.8 0.3 0.4 0.0 0.2 0.1 0.2 0.3 0.0 0.0 0.2 38.1 0.0 0.0 0.6 12.6 0.6 0.0 0.0 0.0 0.0 1.9 0.3 0.0 0.4 1.4 4.7 0.0 1.0 3.3 1.6 0.3 0.6 0.0 0.1 0.3 UNC93B1 UNC93 ENSG00000110057 "Unc-93 homolog B1, TLR signaling regulator" Q9H1C4 11 67991104-68004982 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 28.6" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 87.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 13.6" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "CAPAN-2: 31.3;RPMI-8226: 87.0;SK-BR-3: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038716, HPA038717, HPA042803" Approved Approved Nucleoplasm No No Nucleoplasm "HPA038716: AB_2676169, HPA038717: AB_10674836, HPA042803: AB_2678176" "unprognostic (3.32e-2)" "unprognostic (1.75e-1)" "unprognostic (3.32e-2)" "unprognostic (2.52e-1)" "unprognostic (1.14e-1)" "unprognostic (7.66e-2)" "unprognostic (1.29e-2)" "unprognostic (9.36e-2)" "unprognostic (5.82e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (1.73e-4)" "unprognostic (4.76e-2)" "prognostic unfavorable (7.38e-4)" "unprognostic (1.73e-2)" "unprognostic (1.85e-2)" "unprognostic (7.05e-3)" "unprognostic (5.23e-3)" 8.0 2.7 5.7 9.7 7.4 9.2 5.0 6.2 7.0 4.7 11.9 5.3 6.9 11.8 2.3 5.7 5.5 4.1 13.9 4.6 8.7 6.0 5.9 7.1 13.4 20.8 3.6 0.4 3.0 5.2 0.8 3.3 6.7 2.7 5.3 1.2 5.0 12.3 9.0 6.1 3.7 16.9 2.7 3.5 28.6 10.7 4.1 2.2 2.6 5.3 2.4 13.3 5.9 2.8 2.5 13.6 5.7 6.6 1.8 0.2 0.9 4.5 8.2 0.6 3.3 1.8 0.6 7.1 2.0 1.8 3.2 2.9 0.6 31.3 10.0 7.8 0.9 2.7 10.9 0.2 1.7 0.1 3.5 2.3 1.0 2.6 1.5 2.8 7.1 5.7 1.5 1.8 0.9 0.3 1.2 0.6 1.5 0.7 4.7 0.5 4.3 0.0 5.6 1.5 11.0 4.4 5.9 0.0 87.0 2.8 2.5 0.9 1.4 3.4 23.4 4.5 0.2 8.7 9.3 2.2 2.1 3.1 3.1 0.2 3.3 4.4 1.6 4.0 7.3 2.5 0.1 3.6 5.7 0.1 6.6 0.2 2.4 0.2 0.2 4.7 2.5 0.0 0.0 3.1 1.8 6.6 13.6 0.0 0.9 5.7 7.4 6.2 7.0 8.7 6.0 3.6 0.4 2.7 2.2 8.9 7.8 29.4 21.8 3.5 0.0 1.6 35.7 36.1 6.8 15.7 0.0 9.0 1.7 33.6 0.6 5.8 24.2 0.0 20.5 41.1 8.3 14.1 6.9 4.0 87.3 4.8 4.1 5.5 53.9 0.0 4.0 51.3 21.9 53.3 14.2 4.8 34.0 21.0 3.9 5.7 0.3 0.0 4.2 0.0 0.9 5.6 6.1 9.6 18.7 30.4 UNCX Uncx4.1 ENSG00000164853 "UNC homeobox" A6NJT0 7 1232907-1237318 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "brain: 44.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 20 "cerebellum: 44.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 20 "NB-4: 47.2" "Region enriched" "Detected in single" 5 "cerebellum: 3.6" "Region enriched" "Detected in many" 8 "cerebellum: 19.3" HPA063294 Approved Nucleoplasm NA NA Nucleoplasm "HPA063294: AB_2684977" "unprognostic (1.15e-1)" "unprognostic (9.71e-2)" 0.1 0.1 0.0 0.2 0.0 0.1 0.1 44.8 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.1 3.5 0.1 0.1 0.1 0.9 0.0 0.1 0.1 0.1 0.3 0.1 2.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.8 0.0 0.0 1.1 0.9 0.0 2.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UPF1 "HUPF1, KIAA0221, NORF1, pNORF1, RENT1, smg-2" ENSG00000005007 "UPF1, RNA helicase and ATPase" Q92900 19 18831938-18868236 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Nonsense-mediated mRNA decay" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019587, HPA020857" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA019587: AB_1856174, HPA020857: AB_1856175" "unprognostic (1.03e-1)" "unprognostic (2.58e-2)" "unprognostic (3.77e-2)" "unprognostic (1.10e-1)" "unprognostic (1.66e-1)" "unprognostic (7.77e-2)" "unprognostic (2.09e-1)" "unprognostic (7.98e-2)" "prognostic unfavorable (2.72e-4)" "unprognostic (2.94e-1)" "unprognostic (3.31e-1)" "unprognostic (3.71e-3)" "prognostic favorable (2.97e-6)" "unprognostic (4.48e-2)" "unprognostic (1.71e-1)" "unprognostic (8.90e-3)" "unprognostic (1.01e-2)" 22.5 22.4 18.0 22.4 19.9 23.2 20.4 40.9 25.4 21.5 20.0 24.5 27.8 21.9 24.9 16.7 23.4 19.6 27.0 19.2 14.6 13.5 17.3 20.8 20.5 23.4 20.3 19.3 23.6 42.7 38.1 21.1 28.7 17.7 22.4 11.4 17.9 36.3 25.3 27.9 26.4 20.3 20.1 15.9 23.7 23.7 46.9 20.8 24.9 25.9 13.0 22.9 25.4 24.4 0.9 1.3 4.7 2.3 2.6 1.1 0.8 23.8 15.9 11.2 13.3 17.4 11.4 36.8 20.3 12.6 19.7 15.5 30.5 21.7 21.5 27.0 12.7 10.5 24.1 15.7 22.1 7.5 11.4 30.9 23.6 14.4 19.5 15.0 26.1 14.2 12.7 16.1 15.3 16.7 11.3 12.5 18.8 29.6 20.9 10.4 26.0 30.3 16.4 18.6 16.6 39.0 24.3 18.1 20.1 8.7 21.6 23.8 18.3 18.6 21.2 10.9 9.4 12.7 16.8 17.5 17.6 12.3 21.5 22.6 13.5 10.4 33.2 12.5 25.2 19.4 0.0 1.7 3.0 0.8 0.9 0.7 0.4 1.1 0.2 1.3 0.9 0.7 0.5 4.7 2.6 2.3 0.6 0.5 0.8 18.0 19.9 40.9 25.4 14.6 13.5 20.3 19.3 17.7 20.8 20.8 12.8 14.5 11.7 14.0 27.5 13.7 15.3 12.0 7.9 26.2 13.7 13.9 0.0 10.0 8.4 14.3 22.7 0.0 8.4 12.1 8.6 15.5 0.0 20.2 11.9 35.0 20.7 14.7 16.1 6.3 13.6 11.0 11.8 9.0 23.0 19.7 13.5 17.3 18.0 9.1 19.2 12.9 9.2 19.3 19.8 16.3 17.2 8.9 19.6 24.2 UPF3A "HUPF3A, RENT3A, UPF3" ENSG00000169062 "UPF3A, regulator of nonsense mediated mRNA decay" Q9H1J1 13 114281584-114305817 "Predicted intracellular proteins" "mRNA transport, Nonsense-mediated mRNA decay, Transport" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 503.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018325, HPA061316" Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA018325: AB_1858638, HPA061316: AB_2684477" "unprognostic (9.08e-3)" "unprognostic (1.99e-1)" "unprognostic (1.93e-1)" "unprognostic (3.43e-2)" "unprognostic (2.51e-2)" "unprognostic (1.16e-2)" "unprognostic (6.48e-2)" "unprognostic (1.98e-1)" "unprognostic (9.80e-3)" "unprognostic (1.44e-1)" "prognostic favorable (7.09e-5)" "unprognostic (1.39e-3)" "unprognostic (1.52e-2)" "unprognostic (2.34e-2)" "unprognostic (9.21e-3)" "unprognostic (1.76e-1)" "prognostic favorable (3.71e-4)" 11.3 16.3 16.9 10.9 20.2 11.9 10.9 32.8 21.9 10.4 9.9 18.6 13.0 13.8 13.1 12.3 10.1 13.2 9.2 7.1 16.1 14.9 11.0 7.5 9.2 12.0 20.2 16.0 12.7 15.4 8.1 12.8 8.5 17.2 12.1 8.7 10.0 11.9 16.1 16.1 11.9 11.9 10.2 23.6 11.8 11.2 34.5 16.7 10.7 24.0 7.4 7.9 11.2 9.3 11.7 15.6 4.1 5.5 11.1 9.5 4.3 23.3 6.9 15.3 13.7 7.3 12.8 9.8 18.1 13.1 11.6 13.0 10.4 8.3 23.0 5.3 8.3 7.8 12.6 7.5 6.0 14.7 16.8 14.8 19.8 19.6 11.4 12.8 34.3 8.9 8.6 12.5 7.8 9.2 12.3 9.2 6.0 12.0 10.7 11.6 7.1 13.9 9.2 20.4 15.6 6.9 18.3 8.6 13.4 10.4 7.5 17.4 19.2 14.4 22.3 12.9 10.8 16.5 30.9 11.8 12.4 20.7 6.7 11.3 23.4 16.2 31.9 22.8 19.8 10.1 1.9 5.5 4.1 6.8 4.4 5.3 11.7 7.1 7.0 6.0 9.1 7.4 6.7 0.8 11.1 5.1 15.6 9.5 4.3 16.9 20.2 32.8 21.9 16.1 14.9 20.2 16.0 17.2 16.7 62.5 46.2 54.7 55.8 61.0 74.4 18.2 43.3 133.8 69.4 55.8 78.5 57.6 87.9 47.2 134.0 84.2 27.6 0.0 61.9 38.0 72.4 48.5 52.2 59.5 40.0 74.7 55.2 57.7 33.2 66.4 93.2 41.0 52.3 48.7 45.2 66.8 45.9 35.1 82.4 45.3 72.8 84.1 54.5 503.7 176.2 62.9 33.9 57.5 58.3 32.4 UPF3B "HUPF3B, MRX62, RENT3B, UPF3BP1, UPF3BP2, UPF3BP3, UPF3X" ENSG00000125351 "UPF3B, regulator of nonsense mediated mRNA decay" Q9BZI7 X 119805311-119852998 "Disease related genes, Predicted intracellular proteins" "mRNA transport, Nonsense-mediated mRNA decay, Transport" RNA-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001592, HPA001800, HPA001882" Approved Enhanced Nucleoplasm,Nucleoli,Cytosol No No Cytosol "Nucleoplasm, Nucleoli" "HPA001592: AB_2666373, HPA001800: AB_1080476, HPA001882: AB_1080474" "unprognostic (1.79e-1)" "unprognostic (5.41e-2)" "unprognostic (1.21e-2)" "unprognostic (3.64e-3)" "unprognostic (8.58e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (1.52e-6)" "unprognostic (6.61e-2)" "prognostic unfavorable (5.39e-4)" "unprognostic (5.74e-2)" "unprognostic (4.51e-2)" "unprognostic (8.63e-3)" "prognostic unfavorable (1.44e-7)" "unprognostic (8.67e-2)" "unprognostic (1.04e-1)" "unprognostic (2.34e-1)" "unprognostic (8.95e-2)" 9.7 10.3 19.4 11.5 21.9 14.5 10.8 34.1 24.0 10.2 13.0 9.3 12.8 14.2 14.6 13.5 13.0 8.8 8.4 7.8 16.9 17.5 10.0 12.4 9.0 17.2 16.5 21.7 14.8 8.7 14.3 26.7 10.5 17.2 12.4 13.2 9.1 9.7 14.4 14.5 18.6 11.1 14.2 21.7 12.9 9.9 15.0 21.0 9.9 12.5 11.5 18.3 12.6 12.9 17.5 10.0 7.1 5.9 7.9 8.1 2.7 11.9 7.2 15.1 12.2 6.9 4.5 9.7 11.5 6.5 9.0 8.0 13.5 8.6 21.5 9.8 4.8 12.9 11.4 19.5 6.9 11.5 12.2 14.3 19.9 24.0 7.1 7.9 21.5 9.9 3.9 5.3 15.4 18.8 8.2 8.3 12.9 19.2 18.0 7.5 14.5 15.1 27.0 29.1 15.3 19.8 14.8 17.3 15.8 7.3 6.0 20.1 13.9 23.5 9.5 17.2 16.4 5.0 12.6 7.2 9.4 7.2 15.0 24.3 9.9 11.0 29.1 7.5 31.7 10.9 7.1 5.3 6.8 7.5 5.1 5.7 13.8 7.0 5.9 3.8 17.5 7.6 8.1 5.9 7.9 5.9 10.0 7.8 2.7 19.4 21.9 34.1 24.0 16.9 17.5 16.5 21.7 17.2 21.0 29.8 25.5 28.9 28.2 33.5 47.9 17.1 15.3 42.8 47.8 24.4 53.0 33.2 5.0 27.3 107.2 24.5 27.1 0.0 22.8 39.7 29.2 18.5 57.7 19.2 25.4 27.0 26.6 20.3 15.4 17.6 28.1 32.2 23.6 49.5 21.8 39.5 18.6 31.7 30.8 12.4 94.7 12.9 36.2 32.2 32.4 33.2 53.8 34.8 32.2 21.3 UPP1 "UDRPASE, UP, UPASE, UPP" ENSG00000183696 "Uridine phosphorylase 1" Q16831 7 48088628-48108733 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 206.2;Macrophages: 205.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 26.4;hTERT-HME1: 103.9;SK-MEL-30: 24.1;WM-115: 23.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA054040, HPA055394" Enhanced Enhanced Nucleoplasm No No Nucleoplasm "HPA054040: AB_2682352, HPA055394: AB_2682805" "unprognostic (1.16e-1)" "prognostic unfavorable (1.02e-4)" "unprognostic (5.96e-2)" "unprognostic (1.01e-1)" "unprognostic (3.21e-3)" "unprognostic (6.36e-2)" "unprognostic (1.78e-3)" "prognostic unfavorable (1.97e-4)" "unprognostic (3.81e-2)" "unprognostic (1.91e-1)" "unprognostic (1.53e-1)" "unprognostic (2.59e-1)" "unprognostic (1.52e-3)" "unprognostic (2.95e-2)" "unprognostic (1.30e-1)" "unprognostic (1.30e-1)" "unprognostic (1.39e-1)" 16.7 8.4 2.8 12.6 4.2 17.6 7.1 5.7 3.8 10.3 8.0 1.7 2.1 7.5 2.8 4.2 37.7 3.3 8.5 7.0 2.3 3.3 12.4 9.1 18.3 17.4 5.8 1.4 2.9 5.8 2.4 5.0 28.9 5.5 3.0 7.6 2.9 7.5 2.1 5.1 2.0 9.7 5.2 3.9 13.9 2.5 1.8 4.8 1.2 6.2 34.0 19.4 7.9 19.6 0.6 8.2 15.7 22.0 5.7 19.7 16.0 6.5 7.9 0.8 1.6 2.7 1.2 8.1 3.2 4.5 4.1 5.1 3.3 3.2 0.0 1.2 2.6 26.4 4.6 1.5 13.1 2.7 1.3 1.4 0.2 1.9 1.3 2.4 0.2 0.5 1.6 6.4 1.9 103.9 1.9 2.7 0.2 0.4 3.9 2.2 0.7 0.0 1.1 3.1 1.1 6.9 0.0 1.7 1.7 9.5 3.4 0.7 0.7 3.3 0.9 24.1 8.9 0.8 0.2 3.8 9.7 8.3 2.6 8.2 7.5 10.0 1.1 9.8 1.0 23.6 15.7 22.0 15.1 19.7 16.7 12.5 0.2 12.6 13.5 8.2 0.6 13.0 12.0 9.1 5.7 15.9 0.7 11.2 16.0 2.8 4.2 5.7 3.8 2.3 3.3 5.8 1.4 5.5 4.8 17.9 64.1 14.6 17.3 41.6 27.8 10.4 22.9 8.1 13.6 10.4 31.4 6.0 59.7 36.9 0.6 58.5 53.1 0.0 35.8 206.2 39.5 10.1 24.4 15.1 111.9 15.9 12.5 78.5 137.0 1.5 4.9 205.8 82.7 43.3 11.6 13.5 73.7 52.6 2.1 15.4 28.8 6.5 33.0 0.0 3.0 26.1 65.8 46.7 13.3 29.6 UPP2 "UDRPASE2, UP2, UPASE2" ENSG00000007001 "Uridine phosphorylase 2" O95045 2 157876702-158136154 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 40.1;liver: 22.1" "Group enriched" "Detected in some" 4 "Distal tubular cells: 11.6;Proximal tubular cells: 23.3" "Cancer enriched" "Detected in some" 6 "liver cancer: 3.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.8;GAMG: 2.0;hTERT-RPE1: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA035225, HPA035226" Approved Nucleoplasm,Vesicles,Mitochondria NA NA Nucleoplasm "Vesicles, Mitochondria" "HPA035225: AB_10604002, HPA035226: AB_10696503" "unprognostic (1.87e-1)" "unprognostic (2.33e-1)" "unprognostic (4.22e-3)" "unprognostic (1.36e-3)" "unprognostic (2.29e-1)" "unprognostic (1.55e-1)" "unprognostic (3.53e-2)" "unprognostic (5.51e-2)" "unprognostic (5.11e-2)" "unprognostic (1.23e-2)" "unprognostic (4.65e-3)" "unprognostic (2.34e-1)" "unprognostic (2.23e-2)" "unprognostic (4.89e-2)" "unprognostic (2.78e-2)" "unprognostic (1.78e-2)" "unprognostic (1.16e-2)" 1.2 0.4 1.8 0.3 4.1 0.3 1.6 6.9 2.0 0.4 0.3 1.5 0.7 0.3 1.2 2.4 1.0 0.4 2.5 0.8 2.9 1.2 40.1 22.1 0.3 0.4 1.2 0.9 0.6 0.4 0.3 3.9 0.4 1.3 2.3 0.3 1.1 1.7 0.7 0.3 0.6 0.4 0.3 2.3 0.3 0.3 0.4 1.0 0.0 0.5 0.0 0.7 0.4 0.2 0.8 0.0 1.0 0.1 0.0 0.2 0.0 0.3 0.2 0.6 0.6 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 1.8 0.2 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.5 0.0 0.0 1.9 0.0 0.7 0.8 0.9 0.0 0.0 0.0 0.1 1.1 0.6 1.2 1.4 0.3 0.0 0.3 0.6 0.6 0.4 0.4 0.5 0.0 0.4 0.8 0.1 0.0 0.2 0.2 0.0 0.0 1.2 0.1 0.4 0.3 1.2 0.4 1.0 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.0 0.8 0.1 0.2 0.2 0.0 0.0 0.0 0.1 0.0 1.8 4.1 6.9 2.0 2.9 1.2 1.2 0.9 1.3 1.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.6 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 UPRT "DKFZp781E1243, FUR1, MGC23937, RP11-311P8.3" ENSG00000094841 "Uracil phosphoribosyltransferase homolog" Q96BW1 X 75274085-75304600 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000805 Uncertain Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA000805: AB_1080482" "unprognostic (3.12e-3)" "unprognostic (5.85e-2)" "unprognostic (1.40e-1)" "unprognostic (2.67e-2)" "unprognostic (2.43e-1)" "unprognostic (1.18e-2)" "unprognostic (4.62e-2)" "unprognostic (1.04e-3)" "unprognostic (9.64e-2)" "unprognostic (1.37e-2)" "unprognostic (1.05e-2)" "unprognostic (2.62e-1)" "prognostic favorable (4.14e-4)" "unprognostic (6.09e-2)" "unprognostic (2.54e-2)" "unprognostic (2.74e-1)" "unprognostic (4.53e-3)" 8.8 15.3 14.6 7.9 15.8 14.9 10.7 20.3 18.7 11.5 9.9 10.8 10.8 14.2 10.0 12.5 13.0 10.2 8.4 12.0 13.1 17.7 15.5 11.3 10.0 10.7 14.9 9.6 8.7 14.1 18.7 19.5 7.6 13.2 12.8 11.0 9.1 13.1 8.6 13.3 7.4 10.5 14.0 10.9 11.0 13.9 3.0 12.4 10.6 13.9 6.5 11.9 9.1 7.9 8.3 11.1 8.9 16.4 14.7 13.3 7.4 7.8 5.6 6.2 5.8 6.7 7.3 5.9 5.5 6.6 6.0 6.7 4.9 5.3 11.0 4.8 5.7 10.6 3.4 14.3 5.0 9.7 10.0 5.7 6.9 5.9 6.2 6.5 13.5 14.4 5.5 3.5 8.3 4.3 9.5 10.4 9.1 8.0 11.1 15.6 3.3 15.3 8.3 12.6 5.8 9.2 7.2 16.4 5.3 15.3 4.6 0.4 6.5 7.8 8.1 7.6 11.5 3.6 8.6 8.7 7.6 4.6 13.9 4.7 7.6 24.6 10.7 8.1 14.9 4.8 5.1 7.4 8.9 8.3 10.7 9.5 8.3 8.3 8.5 11.1 7.2 10.5 9.3 1.3 14.7 16.4 5.0 13.3 7.4 14.6 15.8 20.3 18.7 13.1 17.7 14.9 9.6 13.2 12.4 6.0 5.3 8.2 7.9 5.6 6.2 5.2 0.0 1.4 6.8 8.7 0.0 6.4 23.2 7.6 1.4 7.1 5.2 0.0 5.3 11.5 5.6 6.9 24.2 5.8 10.5 9.5 5.8 14.1 10.8 0.5 4.0 11.0 13.5 4.6 5.9 8.8 4.7 2.9 3.2 13.4 6.3 6.5 7.2 0.4 1.7 5.3 10.2 8.9 6.0 5.6 UQCC1 "BFZB, C20orf44, CBP3, FLJ10850, UQCC" ENSG00000101019 "Ubiquinol-cytochrome c reductase complex assembly factor 1" Q9NVA1 20 35302566-35412141 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 70.2" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 51.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034875 Approved Approved "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Plasma membrane" "Nucleoplasm, Actin filaments" "HPA034875: AB_10603226" "unprognostic (9.66e-2)" "unprognostic (3.93e-1)" "unprognostic (3.45e-1)" "unprognostic (8.72e-3)" "unprognostic (4.01e-1)" "unprognostic (1.31e-1)" "unprognostic (5.73e-2)" "unprognostic (2.75e-1)" "unprognostic (2.82e-2)" "unprognostic (7.66e-2)" "unprognostic (3.42e-2)" "unprognostic (7.01e-2)" "unprognostic (6.72e-3)" "unprognostic (3.23e-1)" "unprognostic (3.60e-1)" "unprognostic (5.27e-2)" "unprognostic (1.34e-2)" 12.6 19.2 13.7 10.6 24.5 2.5 10.1 19.6 23.9 10.9 13.3 15.7 12.1 13.0 14.2 14.2 10.5 11.7 8.4 34.3 13.5 15.9 20.0 17.2 8.7 10.9 16.6 18.2 11.9 10.8 19.8 17.0 10.1 20.1 11.9 17.5 15.8 12.1 12.9 70.2 9.2 11.3 15.5 15.5 11.2 12.2 13.2 13.4 8.9 14.2 17.1 13.8 11.0 9.9 13.5 13.5 16.3 11.9 19.7 15.2 9.6 6.9 10.1 11.4 10.5 11.6 12.7 1.6 13.2 14.4 23.7 16.5 32.7 13.8 22.3 25.1 8.3 20.1 18.5 20.1 22.9 18.1 6.6 7.9 29.9 13.5 26.2 7.4 17.9 8.9 12.5 23.5 12.7 15.9 17.6 8.0 18.1 12.8 7.4 16.5 9.1 20.4 6.4 9.6 13.8 20.8 11.2 17.9 12.2 21.9 7.9 16.1 10.8 11.3 54.1 11.7 10.1 8.0 11.4 7.5 16.2 10.3 8.5 12.0 11.4 12.3 9.2 29.0 10.4 13.0 16.3 7.7 11.0 12.7 11.9 15.2 10.3 12.1 12.5 13.5 13.5 14.6 13.2 0.3 19.7 7.7 11.5 11.2 9.6 13.7 24.5 19.6 23.9 13.5 15.9 16.6 18.2 20.1 13.4 0.0 5.6 3.7 8.0 5.7 19.3 39.9 7.6 13.4 5.7 15.7 7.9 18.9 51.4 16.0 8.7 7.0 10.5 0.0 11.2 11.9 8.0 6.7 8.1 12.5 10.1 17.5 11.5 4.3 5.9 7.9 9.8 7.0 13.5 17.2 8.9 14.0 16.8 3.5 11.3 14.0 21.4 6.5 8.2 18.4 16.4 4.5 14.5 7.0 12.8 8.8 UQCC3 "C11orf83, UNQ655" ENSG00000204922 "Ubiquinol-cytochrome c reductase complex assembly factor 3" Q6UW78 11 62670273-62673687 "Disease related genes, Predicted membrane proteins" "ATP synthesis" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046851 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA046851: AB_2679839" "unprognostic (5.89e-2)" "unprognostic (1.95e-1)" "unprognostic (1.60e-1)" "unprognostic (3.42e-2)" "unprognostic (3.91e-1)" "unprognostic (7.41e-2)" "prognostic unfavorable (2.55e-4)" "unprognostic (2.18e-1)" "unprognostic (1.67e-1)" "unprognostic (8.70e-3)" "unprognostic (7.84e-2)" "unprognostic (8.96e-2)" "unprognostic (7.07e-2)" "unprognostic (7.21e-3)" "unprognostic (1.48e-1)" "unprognostic (3.20e-1)" "unprognostic (1.36e-1)" 10.0 13.4 8.9 11.4 8.5 10.6 14.7 8.7 9.9 7.3 15.4 4.7 19.7 16.5 7.3 8.5 14.5 6.5 12.4 13.2 8.0 8.7 10.7 13.4 5.6 8.3 8.5 8.7 9.5 15.4 5.3 7.6 6.2 7.7 12.3 4.9 7.1 22.9 14.1 27.8 8.6 14.8 6.0 6.2 9.6 12.2 5.7 5.4 6.4 13.5 12.3 9.1 8.0 18.1 23.7 21.2 15.2 20.8 14.0 19.4 15.5 12.0 24.5 3.6 5.6 2.2 2.2 3.0 4.8 1.6 3.6 3.6 14.3 10.5 7.8 10.0 1.6 4.9 12.0 3.4 5.6 1.1 3.9 12.7 4.4 12.8 9.1 3.0 7.1 3.6 2.1 4.8 3.2 3.6 2.3 2.8 3.8 9.4 5.7 2.0 36.8 6.9 17.5 4.0 4.8 13.9 8.1 5.5 13.9 2.7 6.0 7.3 7.4 5.3 19.4 7.1 1.1 18.4 6.7 3.6 7.9 9.3 8.2 10.6 8.8 4.8 8.1 6.5 6.2 5.7 9.1 20.8 15.2 18.1 14.4 17.1 23.5 18.0 15.9 15.8 23.7 16.6 13.3 8.9 14.0 12.7 21.2 19.4 15.5 8.9 8.5 8.7 9.9 8.0 8.7 8.5 8.7 7.7 5.4 41.7 23.5 61.4 42.6 0.0 20.8 31.7 66.2 22.7 29.6 61.1 15.7 44.7 119.3 51.7 1.4 26.8 115.3 46.7 67.1 41.2 21.0 70.4 4.7 99.1 47.7 17.5 33.9 39.9 38.4 2.3 44.8 22.9 0.0 43.3 98.1 39.6 57.0 91.2 33.9 137.3 26.2 38.8 31.1 2.7 33.7 0.0 24.3 25.9 101.8 45.4 URI1 "C19orf2, FLJ10575, NNX3, PPP1R19, RMP, URI" ENSG00000105176 "URI1, prefoldin like chaperone" O94763 19 29923644-30016608 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Protein phosphatase inhibitor, Repressor" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 391.0;Late spermatids: 335.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071709 Approved Supported Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA071709: AB_2686434" "unprognostic (4.22e-2)" "unprognostic (2.75e-1)" "unprognostic (6.44e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (2.96e-2)" "unprognostic (2.98e-1)" "unprognostic (1.40e-3)" "unprognostic (8.12e-2)" "unprognostic (1.26e-2)" "unprognostic (4.42e-3)" "unprognostic (1.57e-1)" "unprognostic (3.71e-1)" "unprognostic (1.33e-1)" "unprognostic (6.14e-2)" "unprognostic (1.23e-2)" "unprognostic (1.42e-1)" "unprognostic (4.47e-2)" 16.4 21.2 19.7 15.9 21.5 17.8 21.0 21.7 19.8 18.4 18.0 18.9 16.6 12.9 19.7 19.4 20.5 17.7 14.2 17.5 19.2 16.5 16.6 22.9 13.0 20.7 22.7 15.4 26.3 21.8 21.8 28.8 15.0 21.1 22.6 18.8 12.7 16.7 18.5 45.0 25.3 17.7 15.7 28.3 18.7 14.0 69.2 22.8 21.0 32.1 14.5 20.3 18.6 17.2 6.6 3.1 3.8 2.5 3.7 6.2 1.4 22.7 31.0 14.6 22.6 10.4 15.2 24.6 14.9 12.6 10.9 12.6 16.3 15.1 35.5 29.6 17.3 8.7 16.2 30.8 19.1 24.9 24.6 17.6 32.2 15.4 21.0 15.0 31.0 13.8 13.3 26.2 9.5 35.8 11.8 8.1 21.2 38.2 10.0 13.7 19.5 20.2 13.1 13.6 29.7 9.5 20.0 27.1 14.3 7.2 27.1 23.5 18.5 17.0 20.7 21.8 16.2 8.6 19.6 10.5 27.0 24.0 13.1 22.5 27.6 29.7 24.0 13.3 27.4 16.2 3.8 2.4 3.2 5.7 2.5 4.8 3.5 5.1 5.8 2.0 6.6 6.2 6.1 0.3 3.7 2.3 3.1 3.8 1.4 19.7 21.5 21.7 19.8 19.2 16.5 22.7 15.4 21.1 22.8 41.7 32.1 25.5 69.0 50.6 54.2 48.9 40.8 46.8 36.4 38.4 23.6 16.4 89.5 13.7 391.0 26.4 17.0 0.0 23.9 21.7 30.1 73.3 29.0 41.9 13.6 49.3 27.7 27.6 28.0 335.1 40.6 27.0 30.4 9.0 34.9 44.1 17.2 24.6 38.9 64.7 59.6 12.9 29.4 63.7 50.0 64.4 11.0 35.4 30.6 76.8 URM1 "C9orf74, MGC2668" ENSG00000167118 "Ubiquitin related modifier 1" Q9BTM9 9 128371319-128392016 "Predicted intracellular proteins" "tRNA processing, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053645, HPA065160" Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA053645: AB_2682215, HPA065160: AB_2685423" "unprognostic (7.42e-2)" "unprognostic (1.69e-2)" "unprognostic (2.42e-1)" "unprognostic (8.94e-3)" "unprognostic (1.53e-1)" "unprognostic (1.59e-1)" "prognostic unfavorable (6.91e-4)" "unprognostic (3.04e-2)" "unprognostic (9.19e-2)" "unprognostic (5.61e-3)" "unprognostic (2.39e-2)" "unprognostic (2.36e-1)" "prognostic favorable (7.43e-6)" "unprognostic (1.77e-3)" "unprognostic (1.93e-1)" "unprognostic (2.47e-1)" "unprognostic (6.17e-2)" 27.2 28.9 25.4 22.4 25.5 31.3 23.2 19.4 40.9 23.4 26.3 36.0 19.7 30.9 25.0 24.4 26.5 26.9 22.9 32.3 25.0 21.4 25.5 39.1 20.8 28.5 29.2 22.9 23.4 53.2 21.2 19.6 28.6 32.0 23.7 25.2 22.2 29.2 23.9 34.9 24.4 36.6 26.4 31.8 30.6 25.6 19.2 21.4 34.9 28.0 29.7 28.8 23.0 20.5 12.4 16.7 10.2 17.7 11.3 15.5 11.5 9.0 17.7 16.0 10.8 16.3 16.1 14.5 8.3 14.7 21.4 14.7 14.0 14.5 18.1 7.0 18.9 14.1 30.3 20.3 18.8 10.8 12.8 14.0 15.3 21.3 16.4 15.9 18.5 15.4 20.8 16.8 16.7 14.4 15.5 25.9 21.0 20.6 12.9 15.2 20.3 26.3 27.3 20.0 36.6 21.2 21.6 20.7 22.8 17.3 8.1 14.4 19.0 15.8 26.8 20.3 10.0 25.7 15.4 14.6 15.8 15.0 15.7 14.4 12.4 22.9 18.6 16.5 16.1 19.5 5.6 14.3 10.2 15.5 17.7 13.1 12.3 13.5 14.2 16.7 12.4 13.5 14.4 3.7 11.3 16.1 12.4 14.9 11.5 25.4 25.5 19.4 40.9 25.0 21.4 29.2 22.9 32.0 21.4 14.9 23.2 41.0 28.6 20.1 18.6 19.3 15.3 14.7 10.3 26.2 13.7 74.6 59.7 60.6 1.9 40.5 64.5 0.0 97.1 67.0 38.6 29.5 36.9 19.5 72.0 9.5 21.4 36.2 33.2 2.7 28.7 35.3 50.6 87.4 43.2 22.6 72.9 43.2 29.4 39.9 14.1 19.4 24.2 21.3 25.3 20.8 60.0 45.0 55.7 26.7 UROD ENSG00000126088 "Uroporphyrinogen decarboxylase" P06132 1 45012147-45015575 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Heme biosynthesis, Porphyrin biosynthesis" "Decarboxylase, Lyase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 11 "Erythroid cells: 607.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 81.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027468, HPA028668, HPA030350" Uncertain Supported Nucleoplasm,Cytosol NA NA 5200000 "Nucleoplasm, Cytosol" "HPA027468: AB_1858654, HPA028668: AB_10603458, HPA030350: AB_2673440" "unprognostic (5.90e-2)" "unprognostic (2.94e-2)" "unprognostic (2.49e-1)" "unprognostic (9.61e-2)" "unprognostic (7.94e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (2.48e-4)" "unprognostic (2.31e-2)" "unprognostic (4.76e-2)" "unprognostic (6.75e-2)" "unprognostic (7.72e-3)" "unprognostic (3.92e-1)" "unprognostic (1.24e-1)" "unprognostic (4.68e-2)" "unprognostic (1.41e-1)" "unprognostic (8.73e-2)" "unprognostic (8.12e-2)" 20.7 50.2 23.1 12.2 26.2 67.5 20.7 14.2 28.6 17.7 24.2 16.5 25.9 11.2 27.8 22.6 17.8 20.8 17.4 34.0 21.1 20.3 29.6 58.1 14.3 14.8 21.6 22.9 27.4 18.4 35.9 17.6 25.8 16.2 19.2 12.3 24.3 45.6 19.2 28.8 12.1 13.2 22.9 18.9 16.6 15.0 16.3 11.5 17.2 26.3 23.6 16.0 15.0 13.0 25.7 48.6 20.6 36.3 26.0 27.4 35.6 12.7 8.4 13.4 17.7 23.3 21.9 6.5 15.6 40.4 33.0 25.4 12.1 6.8 9.1 16.6 23.7 23.3 6.6 25.6 30.5 23.0 8.1 26.9 47.0 19.4 39.9 27.1 14.3 8.7 22.7 19.4 31.4 25.5 24.4 42.3 17.6 81.5 10.0 31.4 10.7 9.7 12.4 20.9 10.2 29.7 14.7 20.0 13.1 28.7 10.9 14.4 11.3 17.1 12.9 26.4 15.9 10.1 15.0 27.3 18.8 14.7 6.5 25.2 10.4 11.1 7.6 29.4 21.7 9.4 17.6 36.3 20.6 19.7 25.8 20.0 25.7 23.8 19.2 48.6 23.7 22.3 20.3 6.6 26.0 15.5 32.4 27.4 35.6 23.1 26.2 14.2 28.6 21.1 20.3 21.6 22.9 16.2 11.5 41.7 38.9 45.2 26.1 20.4 23.6 60.9 40.8 22.7 18.2 26.2 15.7 83.3 76.3 62.1 7.2 47.7 22.7 607.3 55.7 45.2 63.6 19.5 50.8 86.0 88.6 12.7 17.2 30.7 34.3 12.5 73.6 37.9 45.5 163.3 18.4 80.8 47.4 21.8 52.6 99.3 21.8 38.8 41.5 35.1 38.5 21.7 41.6 21.8 17.4 22.2 UROS ENSG00000188690 "Uroporphyrinogen III synthase" P10746 10 125784980-125823248 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Heme biosynthesis, Porphyrin biosynthesis" Lyase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Erythroid cells: 186.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044038 Approved Approved Nucleoplasm,Cytosol NA NA 15000 Nucleoplasm Cytosol "HPA044038: AB_10966692" "unprognostic (8.86e-2)" "unprognostic (7.64e-2)" "unprognostic (2.77e-1)" "unprognostic (7.19e-2)" "unprognostic (1.90e-1)" "unprognostic (2.41e-1)" "unprognostic (1.08e-1)" "unprognostic (5.82e-2)" "unprognostic (1.27e-1)" "unprognostic (4.35e-3)" "unprognostic (4.23e-3)" "unprognostic (2.00e-2)" "prognostic unfavorable (6.27e-4)" "unprognostic (1.58e-1)" "unprognostic (1.50e-1)" "unprognostic (1.68e-1)" "unprognostic (3.93e-1)" 13.8 16.1 48.6 9.0 46.6 33.2 13.9 12.8 35.3 8.9 11.4 15.7 12.8 13.2 9.3 41.2 10.5 11.3 11.5 31.4 36.9 20.4 22.6 25.5 10.0 16.8 22.7 23.4 14.5 14.1 14.4 12.0 7.9 20.0 12.9 12.4 14.0 18.1 14.0 45.6 9.8 12.0 13.0 12.5 11.7 12.5 13.8 13.8 10.8 16.4 14.4 12.7 9.4 6.3 17.3 27.1 2.4 15.6 24.7 21.3 17.8 17.7 19.3 14.1 31.2 18.8 19.1 19.0 23.0 39.8 16.2 16.2 8.3 21.6 24.8 10.7 28.5 11.3 10.2 8.1 16.3 15.2 30.6 15.5 52.7 10.9 13.7 26.6 22.2 12.4 23.9 9.4 11.3 30.3 22.5 14.8 18.4 9.1 23.6 27.0 21.2 19.4 25.0 15.3 13.3 20.1 13.8 15.5 14.7 21.2 11.0 11.0 19.0 23.0 17.8 31.2 15.0 15.8 21.2 14.7 21.5 8.0 16.5 19.5 21.8 15.8 16.9 29.9 9.0 10.1 2.4 15.6 2.2 16.1 15.4 18.5 15.7 16.0 20.4 27.1 17.3 21.3 16.3 1.2 24.7 14.6 12.9 14.2 17.8 48.6 46.6 12.8 35.3 36.9 20.4 22.7 23.4 20.0 13.8 17.9 20.2 41.0 10.4 8.2 45.4 60.5 33.1 20.1 17.0 34.9 43.2 49.6 86.2 49.2 45.5 19.3 27.7 186.9 52.4 38.4 25.6 22.0 11.5 53.9 68.9 44.5 13.9 27.6 41.0 95.8 33.1 23.1 59.1 66.7 19.6 51.6 42.5 10.5 38.2 117.1 33.3 6.5 28.2 41.5 71.3 11.2 16.7 38.9 37.7 19.7 USB1 "C16orf57, FLJ13154, HVSL1, Mpn1" ENSG00000103005 "U6 snRNA biogenesis phosphodiesterase 1" Q9BQ65 16 57999546-58021618 "Disease related genes, Predicted intracellular proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041791, HPA059854" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA041791: AB_10793933, HPA059854: AB_2684143" "unprognostic (2.79e-1)" "unprognostic (3.84e-2)" "unprognostic (1.21e-2)" "unprognostic (9.65e-2)" "unprognostic (2.03e-1)" "unprognostic (2.23e-3)" "prognostic unfavorable (6.69e-7)" "unprognostic (4.30e-3)" "unprognostic (2.92e-1)" "unprognostic (4.98e-2)" "unprognostic (1.95e-1)" "unprognostic (1.78e-2)" "prognostic unfavorable (2.02e-4)" "unprognostic (2.18e-1)" "unprognostic (1.56e-1)" "unprognostic (1.06e-3)" "unprognostic (5.04e-2)" 23.7 26.3 19.5 28.7 20.3 29.0 16.1 8.2 30.5 17.4 19.1 16.8 10.3 15.2 19.1 18.6 16.6 14.7 16.1 22.4 19.9 21.4 18.0 47.5 19.6 20.6 19.0 16.5 18.4 16.6 18.5 13.7 18.8 26.1 16.5 20.8 13.4 14.3 21.3 13.5 16.1 16.8 26.7 14.2 27.6 18.5 18.1 15.5 18.5 21.8 14.3 21.7 25.4 19.3 6.2 16.7 50.0 26.5 12.8 18.5 9.0 18.0 38.0 13.0 24.6 16.9 11.9 20.5 15.2 20.5 24.5 17.5 24.6 10.9 11.2 20.3 22.6 21.9 13.5 20.5 32.7 35.3 10.6 11.5 13.9 15.7 35.5 19.3 18.3 40.9 17.0 19.6 31.2 18.3 16.2 26.8 24.4 18.6 5.5 20.5 19.1 16.8 21.2 21.5 16.4 31.1 16.9 11.7 18.6 17.4 22.2 6.3 14.8 40.0 10.5 9.6 21.5 5.2 18.7 28.8 14.5 21.4 15.4 20.8 8.4 12.2 20.5 17.4 17.6 17.6 25.2 18.0 25.0 18.5 20.3 12.1 6.2 10.9 14.1 16.7 4.3 6.8 12.1 50.0 12.8 26.5 7.3 13.1 9.0 19.5 20.3 8.2 30.5 19.9 21.4 19.0 16.5 26.1 15.5 0.0 11.6 11.0 14.3 16.1 2.7 10.5 17.8 8.1 5.7 8.7 3.9 26.4 10.0 36.0 0.9 11.3 16.6 0.0 40.5 46.4 16.0 12.5 16.1 12.1 37.6 6.4 12.1 22.1 22.1 1.3 7.5 20.9 13.5 44.1 13.9 5.7 40.0 14.8 11.0 11.6 3.1 6.5 18.4 9.8 18.8 11.4 17.2 25.5 8.9 12.6 USF1 "bHLHb11, MLTFI, UEF" ENSG00000158773 "Upstream transcription factor 1" P22415 1 161039251-161045977 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001480, HPA036233, HPA036535" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB001480: AB_2213986, HPA036233: AB_2675012, HPA036535: AB_2675178" "unprognostic (3.66e-2)" "unprognostic (2.79e-2)" "unprognostic (9.12e-3)" "unprognostic (2.17e-1)" "unprognostic (9.40e-2)" "prognostic favorable (8.70e-4)" "unprognostic (1.59e-3)" "unprognostic (2.94e-2)" "unprognostic (3.57e-1)" "unprognostic (1.03e-3)" "unprognostic (3.05e-1)" "unprognostic (2.44e-2)" "prognostic unfavorable (6.01e-12)" "unprognostic (1.24e-3)" "unprognostic (3.29e-1)" "unprognostic (4.08e-1)" "prognostic favorable (1.95e-5)" 15.4 17.0 21.6 16.9 24.4 14.3 13.8 31.0 27.6 15.2 17.6 15.6 15.6 17.7 15.1 15.5 12.6 17.1 16.2 17.4 21.6 22.1 15.2 19.1 16.7 23.8 19.7 19.4 17.2 9.8 19.0 12.3 17.3 17.1 14.4 18.0 14.7 13.8 19.0 27.4 14.6 17.8 18.0 18.3 26.7 13.7 8.5 18.7 21.9 16.1 13.5 30.3 18.5 13.8 3.9 5.7 8.6 4.7 2.0 4.0 2.0 8.2 12.6 15.1 17.5 20.4 11.7 20.3 7.0 15.1 21.8 17.0 8.8 10.5 10.7 14.8 11.5 9.5 10.4 17.8 11.0 12.3 9.9 10.5 9.2 10.5 9.2 11.9 12.8 12.9 9.5 11.1 15.7 12.8 13.9 20.3 18.4 15.1 11.6 13.6 9.7 19.7 14.0 31.1 18.1 16.5 17.2 11.8 13.0 10.8 13.3 8.5 16.4 12.7 16.5 8.8 22.8 13.7 41.8 11.9 10.9 6.9 6.6 11.2 9.8 12.4 17.0 9.4 12.5 8.3 4.7 4.7 2.7 4.0 4.5 2.4 3.4 2.5 2.9 5.4 3.9 2.7 2.6 8.6 2.0 4.2 5.7 2.7 2.0 21.6 24.4 31.0 27.6 21.6 22.1 19.7 19.4 17.1 18.7 6.0 8.6 3.2 0.6 2.1 3.6 0.7 0.0 8.1 2.3 3.5 2.0 1.9 1.7 1.6 0.3 1.9 6.3 0.0 1.2 3.3 1.8 1.0 10.5 0.4 2.8 4.8 2.9 0.0 1.9 0.0 0.3 3.2 5.0 2.8 2.7 2.0 2.1 7.0 0.0 2.5 3.4 6.5 1.4 0.5 0.4 1.6 2.9 4.6 3.2 1.3 USF2 "bHLHb12, FIP" ENSG00000105698 "Upstream transcription factor 2, c-fos interacting" Q15853 19 35268978-35279821 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029764, HPA046567" Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA029764: AB_2673190, HPA046567: AB_2679702" "unprognostic (6.10e-3)" "unprognostic (2.27e-1)" "unprognostic (1.06e-2)" "unprognostic (5.03e-3)" "unprognostic (4.60e-2)" "unprognostic (1.72e-1)" "unprognostic (2.45e-1)" "unprognostic (2.87e-1)" "unprognostic (2.10e-1)" "unprognostic (7.07e-2)" "prognostic favorable (5.12e-5)" "unprognostic (7.75e-2)" "unprognostic (8.12e-2)" "unprognostic (7.47e-2)" "unprognostic (5.75e-2)" "unprognostic (6.90e-2)" "prognostic favorable (3.28e-4)" 40.6 48.6 50.9 42.7 56.8 52.8 53.0 52.5 60.5 23.4 26.2 41.2 25.9 36.5 26.3 23.4 25.8 23.6 23.1 52.6 50.8 35.5 22.1 47.9 29.1 48.8 48.6 43.6 54.1 41.8 34.9 36.4 22.1 40.2 22.5 19.7 31.7 34.0 21.6 108.9 35.1 35.8 24.4 48.5 42.9 30.6 13.0 51.2 22.7 29.9 24.9 32.5 26.8 35.6 7.1 27.3 17.8 5.8 5.8 7.2 3.7 38.7 39.0 20.4 19.2 35.2 18.0 19.1 21.0 25.0 19.1 14.5 18.1 20.1 37.2 33.7 17.9 20.9 11.8 18.8 16.4 10.0 62.5 29.0 22.1 23.4 29.0 21.4 36.9 38.1 15.6 23.2 12.5 19.5 33.3 13.0 25.0 26.5 55.8 15.0 44.4 40.4 14.7 16.9 35.8 13.2 39.7 25.9 35.1 15.9 24.8 34.4 26.1 39.1 42.6 70.6 18.6 17.2 29.7 21.9 32.5 21.9 21.3 28.2 56.2 56.2 40.4 30.1 23.6 42.3 17.8 4.7 5.7 3.9 5.8 4.8 5.6 4.0 5.1 7.1 7.1 3.6 3.5 4.2 5.8 3.5 27.3 7.2 3.7 50.9 56.8 52.5 60.5 50.8 35.5 48.6 43.6 40.2 51.2 6.0 19.0 63.3 21.7 21.1 61.7 62.0 20.4 5.3 9.1 29.6 31.4 20.0 48.0 27.2 0.6 27.9 41.8 0.0 49.5 31.8 22.8 23.4 19.7 42.9 101.1 89.0 50.1 31.3 52.2 2.4 29.7 43.7 25.3 34.3 33.1 60.1 34.5 36.6 29.4 35.6 44.7 12.9 29.9 9.5 10.4 21.7 14.6 39.9 28.2 27.4 USF3 KIAA2018 ENSG00000176542 "Upstream transcription factor family member 3" Q68DE3 3 113648385-113696646 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029243, HPA029245" Uncertain Uncertain Nucleoplasm,Nucleoli,Centrosome NA NA "Nucleoplasm, Nucleoli" Centrosome "HPA029243: AB_10611114, HPA029245: AB_10600443" "unprognostic (2.80e-2)" "unprognostic (2.80e-1)" "unprognostic (4.21e-2)" "unprognostic (7.80e-2)" "unprognostic (2.25e-2)" "unprognostic (1.96e-2)" "unprognostic (3.53e-1)" "unprognostic (2.62e-2)" "unprognostic (2.93e-1)" "unprognostic (1.53e-2)" "unprognostic (8.74e-2)" "unprognostic (1.30e-1)" "prognostic favorable (1.74e-6)" "unprognostic (1.23e-1)" "unprognostic (1.97e-1)" "unprognostic (3.28e-1)" "unprognostic (5.55e-2)" 9.0 5.1 8.8 11.0 7.3 13.8 11.4 13.9 7.5 7.2 12.2 5.3 5.4 4.8 5.8 13.3 7.0 6.3 5.3 8.1 7.6 5.5 12.7 24.0 6.1 9.2 6.3 5.6 6.9 10.8 14.4 8.9 4.9 6.5 6.2 6.7 6.4 8.3 5.4 28.7 11.4 14.7 8.3 11.2 12.0 7.3 4.8 6.9 13.3 7.1 11.5 8.9 6.1 6.0 5.9 5.1 6.9 3.7 2.6 3.1 1.4 5.2 4.0 5.0 4.7 12.1 4.7 3.4 2.1 3.4 2.1 2.0 3.7 2.2 9.3 3.9 5.4 3.4 3.3 5.3 4.2 4.0 2.8 2.2 6.6 2.5 6.1 3.6 12.1 7.4 6.7 7.7 3.9 4.4 3.2 5.0 7.1 3.1 5.0 4.4 7.4 6.7 6.7 3.6 7.1 4.1 2.9 3.9 3.7 7.5 7.4 2.4 3.6 5.1 2.9 6.1 3.6 3.9 9.0 6.8 3.3 7.2 1.8 3.0 5.8 3.2 11.1 3.8 5.1 2.4 4.1 2.4 3.5 3.1 2.8 2.3 2.2 2.2 2.3 1.7 5.9 2.7 2.8 6.9 2.6 3.7 5.1 1.1 1.4 8.8 7.3 13.9 7.5 7.6 5.5 6.3 5.6 6.5 6.9 20.8 10.8 4.8 9.6 0.0 20.4 0.0 10.2 22.7 11.4 24.4 13.7 6.7 21.6 7.4 4.6 10.8 9.7 0.0 10.3 3.1 5.4 14.9 4.7 36.5 6.7 12.7 5.8 20.3 16.4 9.1 12.0 10.4 0.0 3.6 13.2 11.3 10.2 16.5 13.1 18.7 17.2 6.5 0.0 9.5 3.9 0.0 12.1 13.4 13.3 17.8 USP1 ENSG00000162607 "Ubiquitin specific peptidase 1" O94782 1 62436297-62451804 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 70.6" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 281.4;Spermatogonia: 214.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028387, HPA028440" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA028387: AB_2672578, HPA028440: AB_10603000" "unprognostic (1.22e-1)" "unprognostic (5.36e-2)" "unprognostic (1.78e-3)" "unprognostic (4.05e-3)" "unprognostic (2.57e-1)" "unprognostic (1.72e-2)" "prognostic unfavorable (5.81e-5)" "unprognostic (6.72e-2)" "unprognostic (1.11e-2)" "unprognostic (5.32e-2)" "unprognostic (3.33e-3)" "unprognostic (3.99e-2)" "unprognostic (2.76e-2)" "unprognostic (9.61e-3)" "unprognostic (5.70e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-1)" 11.6 9.0 11.3 17.2 10.7 29.3 15.9 20.6 14.2 19.2 13.3 7.8 8.0 10.8 15.1 12.0 15.6 13.8 8.9 9.0 11.5 9.6 11.8 9.3 11.7 19.2 14.2 9.6 26.7 12.7 14.8 18.4 13.6 10.9 14.8 13.9 7.6 12.7 13.5 11.7 12.3 13.3 15.8 15.5 18.1 11.6 31.6 11.8 70.6 15.0 13.3 20.1 16.5 16.5 14.7 11.8 23.4 12.4 15.5 16.3 9.2 22.3 6.6 27.8 15.0 6.2 7.5 15.4 21.5 14.7 26.8 29.3 11.1 10.9 40.4 15.6 12.0 24.0 13.0 22.7 14.8 37.5 20.2 16.4 33.2 22.9 11.6 6.8 35.5 16.8 4.0 9.7 24.2 18.3 7.3 12.6 27.5 24.0 35.3 18.8 10.0 36.3 13.7 24.4 13.4 13.7 34.5 47.1 25.0 10.0 16.7 28.7 16.1 24.3 19.9 23.5 19.4 11.4 21.7 8.7 20.7 22.5 30.2 30.1 14.0 19.5 46.4 14.0 28.4 18.5 17.4 9.5 23.4 12.6 9.6 16.3 14.7 15.0 12.7 11.4 10.7 14.3 11.9 16.9 15.5 12.4 11.8 13.6 9.2 11.3 10.7 20.6 14.2 11.5 9.6 14.2 9.6 10.9 11.8 44.7 25.6 45.4 30.6 55.3 44.0 29.7 20.4 56.2 43.3 15.7 21.6 30.6 16.6 26.4 117.0 37.9 12.9 0.0 29.7 56.2 38.1 45.1 26.6 15.8 26.9 33.4 8.1 23.4 28.2 52.6 46.3 31.1 25.3 53.3 29.2 47.5 22.4 7.0 38.5 13.5 78.0 51.8 47.7 281.4 214.8 56.2 27.6 46.5 30.4 28.8 USP10 "KIAA0190, UBPO" ENSG00000103194 "Ubiquitin specific peptidase 10" Q14694 16 84699978-84779922 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Autophagy, DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 105.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 6 "neutrophil: 105.5" "Lineage enriched" "Detected in all" 6 "granulocytes: 105.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006731, HPA006749" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA006731: AB_1080495, HPA006749: AB_1080492" "unprognostic (4.14e-2)" "unprognostic (2.28e-1)" "unprognostic (2.36e-2)" "unprognostic (4.85e-2)" "unprognostic (6.93e-2)" "unprognostic (1.77e-3)" "unprognostic (1.03e-3)" "unprognostic (2.91e-3)" "unprognostic (1.75e-1)" "unprognostic (3.84e-2)" "unprognostic (2.56e-2)" "unprognostic (1.82e-3)" "prognostic favorable (1.00e-4)" "unprognostic (5.91e-2)" "unprognostic (4.57e-2)" "unprognostic (8.57e-2)" "unprognostic (1.38e-1)" 13.9 18.8 16.0 24.2 19.0 13.4 14.4 24.4 20.4 15.9 18.1 15.6 8.4 16.1 20.2 10.4 19.7 18.2 12.0 16.4 19.3 15.1 16.4 20.7 13.7 18.8 19.7 17.4 18.5 17.1 35.8 15.0 23.5 16.2 15.0 15.6 17.9 15.3 17.8 47.0 17.0 17.5 20.2 16.3 16.0 15.0 15.5 16.2 20.4 17.6 15.7 20.9 19.7 15.8 7.2 10.4 105.5 8.6 7.7 17.3 10.0 13.9 19.3 18.8 23.3 6.9 11.8 25.4 13.8 14.6 23.4 12.9 27.2 12.2 24.2 16.0 14.4 11.7 16.0 26.1 21.9 31.2 9.8 13.7 13.9 9.1 18.0 9.2 20.6 8.4 7.4 17.0 24.4 28.3 13.9 17.9 16.2 37.9 5.3 16.2 29.2 21.3 10.0 22.6 15.6 13.1 27.8 10.3 11.5 14.7 11.4 17.6 10.4 33.0 10.7 9.3 17.2 24.7 13.2 13.1 16.3 13.0 8.2 13.1 8.9 12.3 61.4 10.5 13.3 16.6 2.5 8.6 1.6 5.7 7.0 6.8 7.2 17.3 6.3 10.4 6.7 9.9 6.0 105.5 7.7 6.3 3.5 6.1 10.0 16.0 19.0 24.4 20.4 19.3 15.1 19.7 17.4 16.2 16.2 50.6 41.3 27.5 36.9 45.7 24.1 56.0 25.5 124.5 62.6 26.2 27.5 85.2 26.6 26.4 61.2 28.2 27.5 23.3 21.5 65.0 33.0 35.8 53.5 33.4 27.3 19.1 27.7 27.0 34.9 79.4 21.9 31.0 23.6 27.9 26.5 20.1 22.1 17.5 21.2 35.6 48.5 25.8 38.2 32.5 29.0 43.3 50.9 25.4 33.2 36.5 USP11 UHX1 ENSG00000102226 "Ubiquitin specific peptidase 11" P51784 X 47232690-47248328 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 74.0" "Cell type enhanced" "Detected in all" 6 "Bipolar cells: 178.6;Horizontal cells: 131.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003103, HPA037536" Enhanced Supported Supported Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA003103: AB_10671088, HPA037536: AB_10672904" "unprognostic (1.60e-1)" "unprognostic (2.77e-3)" "unprognostic (5.84e-2)" "prognostic unfavorable (2.95e-4)" "unprognostic (3.08e-2)" "unprognostic (2.02e-1)" "unprognostic (6.11e-3)" "unprognostic (9.21e-2)" "unprognostic (3.18e-2)" "unprognostic (3.52e-1)" "unprognostic (3.29e-3)" "unprognostic (3.74e-2)" "prognostic favorable (4.13e-5)" "unprognostic (3.14e-2)" "unprognostic (9.23e-2)" "unprognostic (9.51e-2)" "unprognostic (7.11e-2)" 11.5 17.3 32.9 11.5 55.0 4.9 9.4 35.7 74.0 17.5 9.1 19.9 5.8 6.0 22.6 12.7 9.7 26.6 12.8 20.6 27.0 44.0 13.6 6.7 12.5 13.8 23.1 47.4 38.2 13.8 28.4 32.3 12.6 27.8 15.7 7.6 17.9 9.3 21.3 13.7 7.8 7.3 19.1 17.0 13.5 9.1 19.2 14.6 19.0 27.2 4.3 14.3 11.0 9.8 21.0 20.6 22.8 8.7 19.8 31.7 16.4 14.4 22.8 39.3 26.7 14.9 10.0 10.9 11.1 17.5 22.1 24.7 21.7 11.9 9.6 8.8 20.0 23.6 17.3 31.8 7.8 19.7 14.8 24.1 11.2 18.1 19.2 17.3 12.6 23.4 14.3 3.3 23.3 10.0 12.4 8.8 22.5 8.3 1.3 17.2 22.0 24.3 13.4 29.2 7.9 20.3 27.4 38.5 8.0 10.8 20.0 22.3 38.1 20.3 4.1 12.0 26.2 8.6 7.2 9.2 18.6 19.7 26.2 12.6 17.8 11.2 16.7 11.6 15.7 16.6 22.8 3.5 7.4 22.6 7.4 19.9 20.1 10.2 22.1 4.6 21.0 15.4 31.7 2.2 19.8 8.7 20.6 12.7 16.4 32.9 55.0 35.7 74.0 27.0 44.0 23.1 47.4 27.8 14.6 20.8 15.3 34.1 35.1 12.0 178.6 20.7 12.7 41.5 29.6 31.4 53.0 16.9 43.1 13.8 20.4 19.6 7.8 23.3 9.0 11.2 33.9 14.4 45.0 6.6 12.0 131.9 34.0 23.4 8.8 28.3 27.3 12.9 27.0 26.2 7.9 89.6 11.0 7.0 39.6 12.5 53.1 25.8 33.0 11.7 38.3 5.6 13.6 30.6 8.0 25.7 USP12 USP12L1 ENSG00000152484 "Ubiquitin specific peptidase 12" O75317 13 27066142-27171896 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007288, HPA059492" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA007288: AB_1080531, HPA059492: " "unprognostic (6.72e-3)" "unprognostic (2.63e-3)" "unprognostic (1.04e-1)" "unprognostic (2.34e-2)" "unprognostic (1.22e-1)" "unprognostic (5.85e-2)" "unprognostic (1.79e-1)" "unprognostic (3.39e-1)" "unprognostic (8.38e-2)" "unprognostic (8.77e-2)" "unprognostic (2.20e-1)" "unprognostic (3.06e-2)" "unprognostic (1.22e-2)" "unprognostic (1.40e-1)" "unprognostic (2.91e-1)" "unprognostic (6.77e-2)" "unprognostic (1.73e-1)" 15.7 10.4 18.3 23.3 17.8 46.0 15.6 16.6 18.3 12.1 30.6 16.1 8.8 13.0 15.3 11.6 23.5 9.5 14.5 11.3 19.3 15.9 18.3 27.9 19.9 19.6 20.5 7.5 12.0 13.4 10.7 16.2 14.8 12.4 17.5 19.1 10.1 8.9 9.5 9.8 17.3 33.0 43.8 18.5 16.5 14.7 11.0 13.1 8.4 12.0 6.6 18.5 42.8 24.2 4.6 3.0 5.3 2.1 2.3 3.6 1.2 12.1 7.6 14.6 7.6 9.8 12.6 5.2 17.1 12.1 9.5 7.1 13.8 19.1 17.3 8.6 13.5 23.1 7.5 9.5 9.9 20.4 27.9 8.2 26.7 9.9 9.7 12.4 15.4 18.8 7.8 14.6 10.7 12.4 12.1 21.9 12.0 8.9 8.4 19.7 7.1 9.4 20.6 10.5 15.6 13.5 10.8 18.7 4.1 18.8 8.6 16.2 9.8 14.7 12.4 13.8 19.1 5.8 15.0 25.8 10.0 9.6 21.3 15.5 6.5 7.2 12.3 16.8 9.2 11.1 0.0 1.2 5.3 1.5 1.3 2.5 3.2 2.4 2.0 1.6 4.6 1.6 1.7 1.2 2.3 2.1 3.0 3.6 1.2 18.3 17.8 16.6 15.5 19.3 15.9 20.5 7.5 12.4 13.1 26.8 25.1 15.1 22.9 81.5 21.6 22.6 10.2 16.0 10.3 22.7 37.3 12.2 24.9 11.8 16.7 31.9 32.8 46.7 14.0 5.6 31.0 29.2 12.7 22.2 12.6 27.0 20.1 17.2 15.8 8.2 7.2 23.3 37.1 44.1 23.6 10.9 19.7 25.8 6.0 15.7 29.9 32.3 45.3 2.5 8.9 69.1 9.2 13.8 20.4 30.3 USP13 IsoT-3 ENSG00000058056 "Ubiquitin specific peptidase 13" Q92995 3 179652755-179789401 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 34.8;skeletal muscle: 90.3" "Cell type enriched" "Detected in many" 6 "Cardiomyocytes: 182.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "MAIT T-cell: 15.4" "Lineage enriched" "Detected in many" 8 "T-cells: 15.4" "Cell line enhanced" "Detected in many" "HDLM-2: 36.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004827 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA004827: AB_1080497" "unprognostic (1.00e-2)" "unprognostic (2.09e-1)" "unprognostic (5.82e-2)" "unprognostic (7.14e-2)" "unprognostic (9.94e-2)" "unprognostic (3.96e-2)" "prognostic unfavorable (2.40e-5)" "unprognostic (1.76e-1)" "unprognostic (4.55e-2)" "unprognostic (7.79e-2)" "unprognostic (1.69e-3)" "unprognostic (2.22e-2)" "prognostic unfavorable (3.46e-6)" "unprognostic (4.93e-2)" "unprognostic (9.79e-2)" "unprognostic (3.38e-2)" "prognostic unfavorable (3.06e-4)" 6.4 7.5 2.0 2.3 2.8 0.8 3.5 2.9 4.1 2.7 2.1 4.6 1.5 0.7 3.2 3.8 2.6 2.5 2.5 34.8 2.0 2.3 2.3 3.4 6.0 2.5 2.1 2.1 7.2 3.0 3.3 9.8 1.9 3.0 3.0 1.8 3.1 3.3 2.1 90.3 1.8 1.7 3.7 2.5 1.6 1.6 5.6 1.3 1.7 5.5 17.1 3.2 2.6 1.9 2.0 1.9 0.0 0.4 0.0 15.4 0.7 12.5 5.4 10.2 7.8 4.6 6.4 4.9 7.4 8.5 10.9 9.2 7.9 4.4 15.5 8.3 8.9 12.3 0.9 11.4 4.5 13.0 36.6 4.9 4.1 8.1 7.4 3.3 11.4 0.0 6.9 1.6 8.5 10.8 5.3 8.7 6.1 2.0 20.0 9.0 8.2 6.9 2.1 7.9 1.1 4.9 11.9 10.1 12.7 7.4 3.5 5.8 7.5 7.1 9.5 4.3 3.0 16.4 8.2 9.4 13.2 10.5 11.3 28.4 9.7 8.1 31.7 6.1 7.7 12.2 0.0 0.2 0.0 1.3 0.4 15.4 2.0 1.3 2.9 1.5 0.6 1.0 1.0 0.0 0.0 0.4 1.9 0.6 0.7 2.0 2.8 2.9 4.1 2.0 2.3 2.1 2.1 3.0 1.3 8.9 31.0 4.3 1.7 2.3 12.7 182.3 5.1 2.7 9.1 1.8 5.9 8.7 13.3 1.0 2.1 9.7 0.3 0.0 3.7 1.6 7.1 3.4 2.3 6.8 3.7 15.9 9.2 27.6 3.1 2.0 8.6 4.7 13.5 0.0 1.6 6.3 1.6 5.8 8.9 2.7 9.7 12.9 5.3 5.1 2.1 1.4 4.2 3.2 3.8 1.6 USP16 Ubp-M ENSG00000156256 "Ubiquitin specific peptidase 16" Q9Y5T5 21 29024629-29054488 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 399.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021140 Supported Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021140: AB_1858668" "unprognostic (6.06e-2)" "unprognostic (3.14e-1)" "unprognostic (1.10e-2)" "unprognostic (1.47e-1)" "unprognostic (5.92e-2)" "unprognostic (5.79e-3)" "unprognostic (1.92e-1)" "unprognostic (8.99e-2)" "unprognostic (5.78e-2)" "unprognostic (7.40e-2)" "unprognostic (8.73e-2)" "unprognostic (8.65e-2)" "unprognostic (6.68e-2)" "unprognostic (2.84e-1)" "unprognostic (1.55e-1)" "unprognostic (2.84e-2)" "unprognostic (1.54e-1)" 25.4 21.7 24.4 27.4 24.2 20.4 22.8 32.4 23.1 24.2 24.3 13.5 23.6 20.4 22.6 28.2 27.1 19.4 17.0 23.8 23.8 22.6 28.4 34.0 16.8 20.7 25.8 19.5 27.3 23.6 31.6 41.6 45.9 25.3 26.0 22.3 13.3 20.6 28.8 35.8 16.1 33.2 26.2 28.6 29.1 20.8 20.1 25.3 37.6 28.4 25.6 25.5 30.8 17.1 30.9 23.5 21.2 20.5 19.9 26.2 10.1 22.0 8.8 14.1 12.6 10.0 16.5 13.3 21.6 14.4 15.0 14.3 11.0 14.4 22.5 6.5 20.7 22.9 10.1 17.4 15.7 19.6 21.6 18.5 30.1 10.7 12.2 14.9 29.5 16.7 14.1 16.6 19.5 18.1 11.1 14.3 12.9 24.7 39.9 17.3 10.1 18.1 10.8 15.0 18.0 11.5 12.2 34.8 25.8 12.3 16.0 15.3 16.3 14.0 22.4 18.9 10.0 15.4 20.2 14.4 17.6 21.8 16.1 22.1 34.1 46.8 23.7 18.3 21.4 17.4 21.2 16.2 20.9 25.4 16.1 19.8 26.4 23.9 22.8 14.9 30.9 26.2 24.8 15.5 19.9 20.5 23.5 24.5 10.1 24.4 24.2 32.4 23.1 23.8 22.6 25.8 19.5 25.3 25.3 80.4 84.0 98.9 106.9 50.8 161.8 74.6 53.5 112.4 87.6 50.6 84.4 70.3 112.7 61.8 399.0 40.7 72.4 23.3 103.3 66.4 62.2 82.7 136.5 77.6 53.4 68.3 79.3 46.1 54.6 89.6 81.1 59.7 59.1 95.6 64.7 103.3 77.6 75.8 81.7 60.8 186.0 58.2 71.0 80.0 64.3 56.2 135.5 69.2 70.2 111.6 USP20 KIAA1003 ENSG00000136878 "Ubiquitin specific peptidase 20" Q9Y2K6 9 129834698-129881838 "Enzymes, Predicted intracellular proteins" "Endocytosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "JURKAT: 42.3;K-562: 25.9;MOLT-4: 23.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006287, HPA007008" Uncertain Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA006287: AB_1080510, HPA007008: " "unprognostic (2.64e-2)" "prognostic favorable (8.01e-4)" "prognostic unfavorable (2.48e-4)" "prognostic favorable (4.01e-4)" "unprognostic (4.69e-1)" "unprognostic (1.89e-2)" "unprognostic (2.25e-1)" "unprognostic (2.55e-3)" "unprognostic (1.24e-1)" "unprognostic (7.89e-2)" "prognostic favorable (1.54e-7)" "unprognostic (2.09e-1)" "prognostic favorable (5.65e-5)" "unprognostic (1.76e-2)" "unprognostic (1.20e-1)" "unprognostic (1.19e-2)" "unprognostic (1.24e-2)" 7.8 13.2 10.5 15.2 14.6 24.4 8.5 23.0 19.6 13.2 12.1 12.7 10.2 9.7 13.3 6.2 9.3 11.6 12.5 8.8 10.5 13.7 8.0 7.3 9.1 19.6 9.6 16.1 16.8 12.9 11.5 19.0 8.0 11.9 14.9 6.1 10.8 13.7 17.2 10.2 14.0 11.8 20.0 8.8 14.6 10.2 14.0 8.8 51.5 19.3 4.2 15.3 15.6 10.0 3.8 2.4 4.8 1.7 9.0 10.7 5.4 2.5 2.5 4.4 6.0 5.8 5.0 6.3 4.1 3.5 3.2 2.2 2.1 2.8 3.5 3.6 4.0 3.6 6.5 2.6 3.0 1.3 19.0 3.5 6.5 6.8 1.4 4.1 6.1 4.8 4.4 4.4 4.2 3.1 5.6 3.4 42.3 25.9 4.4 1.9 6.8 23.8 14.5 3.5 5.4 6.0 4.0 5.0 5.9 2.5 2.8 1.0 4.9 4.8 6.2 3.9 2.7 6.4 8.5 5.0 3.5 1.6 4.7 2.7 4.3 6.3 2.4 7.0 8.0 3.3 1.0 1.7 4.8 8.6 1.4 9.3 3.7 8.8 8.3 2.4 3.8 10.4 8.9 2.8 9.0 1.3 2.1 10.7 5.4 10.5 14.6 23.0 19.6 10.5 13.7 9.6 16.1 11.9 8.8 8.9 8.6 3.2 2.3 2.5 7.9 5.9 2.5 4.0 2.3 1.8 3.9 5.1 3.3 2.2 1.1 2.4 4.0 0.0 3.4 2.1 3.8 3.0 1.1 5.6 3.0 9.5 8.1 7.4 2.1 2.8 5.8 3.1 3.3 3.6 4.6 5.8 2.3 3.7 4.6 2.2 5.9 0.0 6.2 12.2 4.4 1.8 5.1 11.3 5.1 1.4 USP21 "USP16, USP23" ENSG00000143258 "Ubiquitin specific peptidase 21" Q9UK80 1 161159450-161165723 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028397 Uncertain Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA028397: AB_10603227" "unprognostic (9.17e-2)" "unprognostic (1.44e-1)" "unprognostic (3.95e-2)" "prognostic unfavorable (7.05e-4)" "unprognostic (1.22e-2)" "unprognostic (1.26e-2)" "prognostic unfavorable (1.68e-4)" "unprognostic (5.35e-2)" "unprognostic (6.73e-2)" "unprognostic (2.76e-2)" "unprognostic (3.87e-3)" "unprognostic (1.31e-2)" "prognostic unfavorable (9.50e-6)" "unprognostic (2.45e-1)" "unprognostic (3.28e-1)" "unprognostic (2.13e-2)" "prognostic favorable (3.35e-5)" 11.8 16.4 22.1 12.8 21.2 15.3 19.1 23.6 24.8 18.1 16.1 25.5 14.0 15.5 19.7 14.6 18.3 33.3 14.1 13.7 20.9 12.1 15.4 10.6 14.0 16.7 26.4 14.1 28.3 19.0 24.4 17.2 15.2 20.5 18.1 13.1 17.1 19.0 25.3 19.4 23.5 15.4 15.1 17.0 18.7 16.0 17.0 22.9 16.0 24.5 9.6 15.6 17.9 19.2 14.1 12.0 18.3 11.1 13.4 17.2 10.7 7.4 12.9 16.9 16.3 13.5 11.3 10.4 5.5 9.0 15.2 11.9 11.8 14.7 9.8 9.5 6.8 9.5 12.9 10.9 10.7 8.4 18.6 18.4 11.6 18.6 9.2 9.8 10.3 8.7 9.5 14.4 10.4 15.1 17.2 10.7 21.7 17.2 13.6 9.7 13.7 18.2 16.2 15.8 14.6 16.4 17.3 5.6 16.4 8.9 8.9 15.4 19.9 10.3 10.9 8.3 13.2 23.9 16.7 6.3 10.9 9.8 7.6 9.4 27.6 21.3 14.5 10.0 8.9 9.8 13.0 11.1 18.3 14.9 7.1 17.2 12.8 13.8 15.4 12.0 14.1 16.0 14.6 9.6 13.4 7.7 12.0 13.3 10.7 22.1 21.2 23.6 24.8 20.9 12.1 26.4 14.1 20.5 22.9 0.0 3.0 1.7 1.5 1.3 3.9 2.2 10.2 10.7 3.4 1.8 5.9 3.6 1.7 1.4 0.6 2.8 2.0 0.0 2.0 2.1 2.4 2.0 2.3 1.7 1.9 0.0 5.2 6.2 7.6 0.4 4.6 1.7 1.7 0.0 4.1 3.0 1.7 2.9 3.9 1.8 4.4 6.5 1.9 3.6 2.7 1.3 2.6 2.5 3.7 1.4 USP24 KIAA1057 ENSG00000162402 "Ubiquitin specific peptidase 24" Q9UPU5 1 55066359-55215113 "Enzymes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 46.0" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 68.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026723, HPA028428, HPA067124" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA026723: AB_10599851, HPA028428: AB_10600991, HPA067124: AB_2685785" "unprognostic (2.28e-1)" "unprognostic (9.81e-3)" "unprognostic (4.70e-3)" "unprognostic (4.86e-3)" "unprognostic (9.31e-3)" "unprognostic (4.84e-3)" "prognostic unfavorable (1.34e-7)" "unprognostic (2.04e-1)" "unprognostic (6.93e-2)" "unprognostic (2.98e-1)" "unprognostic (5.08e-2)" "unprognostic (1.86e-1)" "unprognostic (8.12e-2)" "unprognostic (1.79e-1)" "unprognostic (6.42e-2)" "unprognostic (4.12e-2)" "unprognostic (1.64e-1)" 12.3 7.6 7.5 12.1 8.8 30.1 10.6 20.1 8.5 7.8 10.2 6.8 10.6 5.0 10.1 7.0 7.7 6.9 7.0 14.7 7.9 6.4 10.4 9.3 7.6 12.7 8.0 5.6 10.9 7.3 15.5 16.9 5.8 6.9 7.6 8.5 5.1 9.7 10.7 46.0 8.9 8.7 7.3 6.2 10.9 7.8 4.9 8.7 16.4 7.4 11.5 12.7 9.7 13.7 6.0 10.5 5.9 2.2 3.8 4.5 1.1 17.7 9.8 12.3 6.6 16.0 14.1 14.2 7.9 9.9 11.4 11.9 13.9 6.3 14.3 8.7 14.6 23.4 14.4 16.3 13.3 17.9 14.9 9.8 28.6 21.4 16.3 9.5 19.7 22.2 12.3 11.8 17.2 19.6 11.0 10.3 14.6 26.3 6.0 15.1 4.2 11.8 10.5 18.0 8.6 11.9 12.3 15.7 6.2 19.8 12.0 10.8 7.6 13.4 9.6 11.7 19.5 6.7 9.8 13.9 10.4 10.1 12.5 12.5 7.6 5.6 18.8 9.9 16.4 9.3 5.9 2.0 2.5 4.5 1.8 2.8 4.8 3.5 3.5 1.8 6.0 3.2 4.2 2.3 3.8 2.2 10.5 1.9 1.1 7.5 8.8 20.1 8.5 7.9 6.4 8.0 5.6 6.9 8.7 14.9 18.3 14.2 7.0 13.3 12.9 28.1 10.2 8.1 15.9 12.2 68.7 3.6 0.0 8.8 0.4 13.1 6.8 0.0 8.7 6.5 9.6 9.6 12.7 10.9 8.4 36.5 16.6 10.4 17.5 1.3 10.9 12.2 10.1 12.6 16.4 7.1 9.9 11.5 7.4 4.5 16.7 6.5 10.5 8.6 5.8 15.1 1.3 17.1 14.9 8.6 USP26 ENSG00000134588 "Ubiquitin specific peptidase 26" Q9BXU7 X 133024631-133097109 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "testis: 3.8" "Cell type enriched" "Detected in single" 14 "Spermatogonia: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "HPA000424, HPA027310" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA000424: , HPA027310: " "unprognostic (7.92e-4)" "unprognostic (3.59e-2)" "unprognostic (1.99e-2)" "unprognostic (2.08e-1)" 0.1 0.1 0.1 0.1 0.1 0.3 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.4 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.4 0.1 0.1 0.1 0.1 0.1 3.8 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.2 0.1 0.5 0.1 0.2 0.3 0.0 0.0 0.5 0.4 0.5 0.4 0.1 0.1 0.2 0.2 0.7 0.1 0.2 0.1 0.7 0.1 0.1 0.0 0.1 0.7 0.1 0.2 0.3 1.0 0.3 1.0 0.3 0.1 0.1 0.0 1.5 0.6 0.4 0.1 0.3 0.1 0.4 0.4 0.4 0.2 0.2 0.1 0.8 0.4 0.2 0.3 0.4 0.1 0.0 0.9 0.5 0.5 0.2 0.1 0.1 0.2 1.0 0.1 0.7 0.3 0.9 0.1 0.3 0.4 0.9 0.3 0.1 0.2 0.4 0.3 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.5 0.2 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.7 0.0 0.0 0.0 0.0 0.0 USP27X USP27 ENSG00000273820 "Ubiquitin specific peptidase 27, X-linked" A6NNY8 X 49879948-49882565 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 17.9;Ciliated cells: 24.1;Cytotrophoblasts: 34.3;Syncytiotrophoblasts: 21.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SuSa: 17.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077264 Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA077264: AB_2686831" "unprognostic (4.12e-2)" "unprognostic (9.58e-3)" "unprognostic (2.29e-1)" "unprognostic (4.66e-2)" "unprognostic (1.98e-1)" "unprognostic (1.74e-1)" "prognostic unfavorable (6.14e-4)" "unprognostic (3.10e-3)" "unprognostic (3.91e-2)" "unprognostic (1.31e-2)" "prognostic favorable (9.31e-4)" "unprognostic (5.37e-2)" "unprognostic (7.45e-3)" "unprognostic (1.19e-1)" "unprognostic (1.12e-1)" "unprognostic (2.01e-2)" "unprognostic (2.58e-1)" 1.8 3.3 1.8 5.9 2.9 0.3 7.7 1.7 7.4 3.9 5.9 4.8 2.2 1.1 12.7 4.1 3.1 4.7 3.8 3.9 2.2 3.5 3.5 6.1 1.9 1.3 3.2 8.8 3.2 4.1 0.8 15.5 2.8 4.1 1.7 4.1 5.2 3.9 7.5 2.6 4.7 3.9 1.3 2.0 1.9 3.8 1.9 2.8 3.2 3.6 2.2 3.7 3.1 1.7 1.0 0.7 0.7 0.3 1.3 0.4 1.8 4.7 5.5 6.3 5.2 4.3 4.6 2.1 3.4 2.4 2.0 8.5 2.1 1.2 2.0 5.4 7.9 3.0 7.8 5.2 3.5 2.4 3.7 2.0 1.4 7.7 3.5 0.6 4.3 6.0 3.6 3.4 3.4 5.9 3.3 5.5 3.9 2.0 3.8 4.5 2.9 1.7 6.0 3.5 3.3 3.1 4.8 0.4 3.9 1.8 1.4 4.1 4.0 3.8 4.9 17.9 4.4 1.4 2.5 2.8 5.4 4.8 0.8 1.9 0.5 0.8 3.2 1.7 3.0 0.7 0.4 0.1 0.6 0.4 0.8 0.6 0.5 0.3 1.0 1.7 0.8 0.6 0.7 0.3 0.7 0.4 1.3 0.4 17.9 13.3 0.0 4.1 2.6 9.7 2.3 0.0 24.1 13.6 0.0 0.0 34.3 5.0 1.1 0.0 3.1 0.7 0.0 0.6 2.0 1.8 2.5 2.3 1.7 3.4 4.8 4.1 3.1 0.3 0.0 2.0 1.1 0.0 1.0 1.2 10.2 1.2 0.0 3.2 2.6 2.0 6.5 1.7 0.0 1.4 1.9 21.9 1.3 1.7 1.7 USP28 KIAA1515 ENSG00000048028 "Ubiquitin specific peptidase 28" Q96RU2 11 113797874-113875570 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 40.1;skeletal muscle: 50.2" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 130.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SuSa: 42.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006778, HPA006779" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA006778: AB_1080520, HPA006779: AB_1080517" "unprognostic (2.54e-1)" "unprognostic (2.72e-1)" "unprognostic (2.99e-2)" "unprognostic (3.72e-2)" "unprognostic (5.51e-2)" "unprognostic (2.30e-1)" "unprognostic (9.73e-3)" "unprognostic (3.00e-1)" "unprognostic (2.04e-3)" "unprognostic (1.82e-3)" "unprognostic (3.17e-2)" "unprognostic (1.19e-1)" "unprognostic (5.11e-2)" "unprognostic (2.06e-2)" "unprognostic (9.03e-2)" "unprognostic (1.35e-3)" "unprognostic (5.03e-2)" 3.9 3.4 4.8 8.6 5.7 2.4 5.7 26.4 8.6 11.6 5.1 4.9 14.0 4.7 6.0 6.0 5.7 5.0 4.0 40.1 5.0 4.8 5.1 5.6 5.1 7.2 6.8 4.5 7.5 4.1 10.6 9.7 3.9 4.8 8.9 6.0 5.7 5.7 12.2 50.2 3.5 5.1 11.6 6.4 6.9 4.4 5.5 3.8 3.6 5.1 10.1 7.7 7.1 4.6 10.3 4.1 2.1 3.7 17.9 16.2 6.0 8.6 9.7 13.1 17.3 10.8 10.7 9.3 6.4 8.8 8.6 14.8 14.4 12.5 11.5 14.6 8.6 19.9 17.0 18.5 12.0 12.0 12.8 8.4 6.1 6.8 7.7 6.6 7.8 6.1 6.4 9.1 10.0 11.9 12.6 15.5 5.7 10.5 7.5 9.0 4.4 5.9 12.8 15.7 16.0 7.0 14.7 18.3 13.9 9.5 8.5 5.7 6.2 15.2 5.2 4.9 42.9 12.6 2.7 8.2 9.6 14.4 8.7 6.5 5.1 7.3 9.7 0.9 15.3 6.2 0.1 3.2 2.1 16.2 2.4 8.4 10.3 4.1 11.4 4.1 8.4 2.7 9.4 0.9 17.9 3.7 1.2 5.6 6.0 4.8 5.7 26.4 8.6 5.0 4.8 6.8 4.5 4.8 3.8 8.9 9.1 10.0 6.9 1.4 16.1 130.6 5.1 14.7 10.3 5.2 17.7 3.5 5.0 5.7 1.4 4.3 5.1 0.0 3.4 3.7 4.7 6.2 1.1 6.7 3.9 4.8 4.7 6.2 4.1 1.4 6.4 6.5 1.7 5.4 10.3 10.1 4.4 3.5 13.1 6.3 20.2 6.5 5.2 10.8 10.0 1.8 0.9 24.5 9.2 4.9 USP3 ENSG00000140455 "Ubiquitin specific peptidase 3" Q9Y6I4 15 63504511-63594640 "Enzymes, Predicted intracellular proteins" "Cell cycle, DNA damage, Ubl conjugation pathway" "Chromatin regulator, Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 33.4" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053275, HPA060513, HPA077975" Supported "Nucleoplasm,Midbody ring" "Intracellular and membrane" No No Nucleoplasm "Midbody ring" "HPA053275: AB_2682096, HPA060513: AB_2684299, HPA077975: AB_2732365" "unprognostic (4.63e-3)" "unprognostic (2.71e-1)" "unprognostic (7.88e-2)" "unprognostic (3.33e-2)" "unprognostic (2.16e-2)" "unprognostic (6.03e-2)" "unprognostic (6.26e-2)" "unprognostic (4.52e-2)" "unprognostic (1.62e-2)" "unprognostic (2.36e-1)" "unprognostic (3.54e-2)" "unprognostic (4.87e-2)" "unprognostic (1.17e-1)" "unprognostic (8.61e-2)" "unprognostic (2.78e-1)" "unprognostic (6.21e-2)" "prognostic favorable (1.38e-4)" 16.0 9.0 5.9 20.4 6.5 38.6 21.3 33.4 6.6 12.7 19.1 6.0 16.8 16.2 18.1 13.3 13.6 10.4 14.2 7.6 6.6 4.4 12.9 10.8 17.5 28.2 8.1 3.9 19.5 27.1 7.1 8.2 10.2 7.9 12.4 11.5 8.2 18.5 14.8 12.4 15.9 19.0 16.1 8.0 23.6 14.7 10.3 7.8 22.7 12.5 11.4 22.5 21.3 17.9 11.4 20.6 52.6 28.1 7.2 12.9 13.4 9.2 30.2 15.6 9.8 7.7 12.6 13.8 7.9 9.9 7.7 9.5 11.8 17.3 9.4 12.6 7.9 5.1 11.7 14.6 12.3 7.5 15.3 7.9 10.6 10.8 12.7 6.6 6.3 12.8 9.0 16.3 9.3 16.2 7.8 16.7 16.9 14.1 12.0 4.9 14.3 13.1 10.2 19.7 18.9 13.1 19.2 9.4 16.6 9.2 31.7 13.7 10.6 4.9 16.2 9.7 8.9 9.7 12.3 15.8 8.9 18.6 5.2 10.5 10.8 19.9 20.8 8.6 17.5 7.4 28.8 28.1 3.5 8.4 22.6 9.3 10.3 11.9 8.6 20.6 11.4 12.9 9.3 52.6 7.2 18.7 4.1 9.1 13.4 5.9 6.5 33.4 6.6 6.6 4.4 8.1 3.9 7.9 7.8 35.7 60.4 35.8 31.2 46.8 31.1 9.1 20.4 36.1 43.3 15.7 11.8 17.3 34.9 36.4 19.7 20.3 33.9 0.0 32.3 46.8 16.4 35.8 25.5 20.8 22.8 12.7 42.1 11.1 75.5 53.6 14.7 64.4 40.5 27.1 32.5 24.6 35.0 31.7 17.3 19.9 17.8 12.9 25.2 10.2 41.8 51.6 28.5 37.4 34.7 33.1 USP33 "KIAA1097, VDU1" ENSG00000077254 "Ubiquitin specific peptidase 33" Q8TEY7 1 77695987-77759852 "Enzymes, Predicted intracellular proteins" "Endocytosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005719 Uncertain Supported "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA005719: AB_10601708" "unprognostic (2.31e-3)" "unprognostic (2.73e-2)" "unprognostic (1.04e-2)" "unprognostic (2.36e-1)" "unprognostic (9.19e-3)" "unprognostic (1.88e-3)" "unprognostic (1.22e-2)" "unprognostic (6.06e-2)" "unprognostic (2.48e-1)" "unprognostic (2.25e-1)" "unprognostic (2.67e-1)" "unprognostic (3.59e-1)" "unprognostic (5.36e-3)" "unprognostic (4.89e-2)" "unprognostic (5.76e-2)" "unprognostic (2.19e-1)" "unprognostic (2.02e-2)" 30.8 27.1 28.1 18.8 32.1 24.6 28.6 55.3 37.5 21.6 20.4 20.6 18.5 20.2 23.3 23.0 17.8 19.2 21.7 17.0 30.7 30.6 26.0 20.3 21.0 20.7 26.0 25.4 25.3 17.0 28.8 23.4 34.6 38.7 24.6 21.0 21.4 19.5 19.8 16.3 19.4 23.8 19.8 21.4 22.3 19.5 19.9 21.6 27.8 25.1 12.9 20.3 21.0 20.0 15.7 12.2 33.2 18.4 12.3 17.8 10.6 16.1 7.4 25.6 17.7 36.9 32.3 22.0 17.7 16.9 21.6 24.3 9.8 14.0 12.1 16.8 17.2 35.5 12.8 18.6 12.1 26.6 11.1 14.5 42.7 18.1 8.5 23.0 14.5 10.8 23.7 9.5 20.9 15.4 20.9 19.2 11.1 16.6 10.6 16.2 6.2 13.1 14.5 24.7 12.6 14.7 12.6 27.0 8.5 20.4 16.6 21.5 16.6 12.4 16.5 24.7 22.8 9.2 15.8 16.1 20.0 14.2 20.1 16.7 8.7 11.0 11.8 15.1 17.2 10.1 33.2 15.4 20.0 15.1 15.0 15.3 13.4 14.7 15.2 11.5 15.7 17.8 15.6 20.9 12.3 18.4 12.2 13.2 10.6 28.1 32.1 55.3 37.5 30.7 30.6 26.0 25.4 38.7 21.6 41.7 36.3 21.6 16.5 15.2 50.9 31.5 20.4 36.1 25.0 33.2 55.0 21.0 8.3 16.9 2.8 26.4 26.8 0.0 13.4 15.9 21.2 23.9 22.0 18.1 16.5 58.8 34.1 28.8 33.6 3.6 33.1 22.3 21.9 19.8 26.0 34.5 15.7 28.6 30.1 19.2 40.3 19.4 17.5 36.1 26.3 14.3 10.0 27.5 22.9 20.0 USP34 "KIAA0570, KIAA0729" ENSG00000115464 "Ubiquitin specific peptidase 34" Q70CQ2 2 61187463-61470769 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 235.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025815, HPA070764" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA025815: AB_1858681, HPA070764: AB_2686308" "unprognostic (4.04e-2)" "unprognostic (8.21e-3)" "unprognostic (5.08e-2)" "unprognostic (3.14e-2)" "unprognostic (4.13e-2)" "unprognostic (1.43e-2)" "unprognostic (1.04e-1)" "unprognostic (2.66e-1)" "unprognostic (1.47e-1)" "unprognostic (2.90e-2)" "unprognostic (8.91e-2)" "unprognostic (4.62e-2)" "unprognostic (9.58e-2)" "unprognostic (1.66e-1)" "unprognostic (2.53e-1)" "unprognostic (6.34e-2)" "unprognostic (7.01e-2)" 17.2 19.6 31.8 37.2 25.6 24.8 28.3 77.1 35.5 22.5 22.7 14.4 31.1 11.4 22.2 44.5 18.6 17.5 20.0 16.9 30.5 24.0 20.5 21.5 29.7 34.2 22.0 21.2 24.7 17.2 33.5 40.3 13.4 22.0 22.7 21.5 21.2 16.9 45.2 27.0 31.6 21.0 22.7 20.8 24.8 19.3 26.4 25.3 21.7 23.2 13.9 33.5 19.1 16.7 6.0 5.8 3.4 4.6 5.2 7.5 2.3 16.8 12.1 15.7 16.3 29.9 20.1 13.2 10.4 14.7 9.3 8.9 16.9 6.5 40.0 11.1 22.4 9.9 9.3 12.4 13.7 17.4 14.3 9.8 24.2 11.7 27.2 25.2 17.9 15.4 21.9 17.8 17.0 25.4 22.8 19.6 11.4 16.5 13.0 20.7 15.8 11.8 26.1 10.6 17.2 9.6 12.7 19.2 10.7 27.5 20.7 13.0 13.9 16.4 12.2 17.9 21.0 6.4 13.0 17.5 14.8 19.7 8.7 13.6 15.1 7.4 42.0 13.9 16.7 12.6 3.4 2.0 2.8 7.5 2.2 6.7 5.1 5.1 5.5 1.8 6.0 5.8 7.5 3.4 5.2 4.6 5.8 4.5 2.3 31.8 25.6 77.1 35.5 30.5 24.0 22.0 21.2 22.0 25.3 59.6 60.6 35.3 50.1 54.3 132.9 41.8 56.0 33.5 59.1 31.4 235.6 26.6 8.3 35.4 108.3 51.2 38.6 0.0 29.1 19.8 45.2 63.1 31.2 36.3 19.7 101.7 46.7 23.4 40.3 105.2 52.6 41.4 38.8 30.7 32.2 62.5 38.7 38.4 62.9 18.3 185.3 25.8 46.7 97.9 106.7 53.6 44.6 40.8 31.2 57.6 USP35 KIAA1372 ENSG00000118369 "Ubiquitin specific peptidase 35" Q9P2H5 11 78188812-78214711 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 32.4" "Group enriched" "Detected in many" 4 "Early spermatids: 20.7;Late spermatids: 31.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "eosinophil: 3.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055213, HPA058592" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA055213: AB_2682740, HPA058592: AB_2683766" "unprognostic (6.69e-2)" "unprognostic (1.17e-2)" "unprognostic (1.69e-1)" "unprognostic (6.87e-3)" "unprognostic (3.38e-2)" "unprognostic (1.08e-2)" "unprognostic (2.00e-1)" "unprognostic (1.46e-1)" "unprognostic (3.57e-2)" "unprognostic (3.84e-3)" "unprognostic (1.03e-2)" "unprognostic (3.11e-2)" "unprognostic (1.29e-3)" "unprognostic (2.93e-1)" "unprognostic (1.31e-1)" "unprognostic (4.38e-2)" "unprognostic (1.49e-2)" 4.9 17.1 5.1 5.4 9.3 3.8 5.2 10.4 15.0 6.4 5.8 8.0 6.3 5.5 6.8 5.4 5.6 5.4 5.6 8.7 6.1 6.7 5.0 13.8 5.6 4.8 6.7 8.8 6.6 6.4 32.4 12.0 7.1 15.0 5.0 3.4 7.7 4.0 5.6 5.6 3.2 5.3 7.8 4.5 4.6 3.9 5.3 4.0 1.9 7.7 2.9 4.1 5.2 6.6 0.0 0.1 3.4 0.6 0.1 0.3 0.2 2.1 3.3 5.7 6.0 9.7 9.0 3.9 4.9 5.8 5.8 4.1 8.3 4.6 1.7 5.1 9.2 6.2 5.7 3.8 7.6 3.4 12.2 2.0 2.8 8.6 4.8 7.6 1.8 8.3 7.6 5.1 12.1 3.5 11.5 7.1 6.2 3.9 4.2 4.5 1.9 4.6 7.2 1.7 6.0 5.3 2.8 5.3 2.0 4.6 3.9 2.8 5.4 3.8 5.0 1.8 8.5 4.2 1.5 8.6 10.7 6.1 12.6 2.6 5.7 1.8 2.6 3.2 1.9 6.2 0.0 0.2 3.4 0.1 0.6 0.0 0.0 0.2 0.2 0.1 0.0 0.3 0.0 0.2 0.1 0.1 0.1 0.1 0.2 5.1 9.3 10.4 15.0 6.1 6.7 6.7 8.8 15.0 4.0 0.0 2.6 0.0 0.1 0.7 0.7 1.8 0.0 0.0 0.0 0.0 5.9 0.6 0.0 0.8 20.7 1.5 0.8 0.0 1.7 1.3 2.0 0.2 0.0 3.0 1.3 0.0 0.0 2.5 0.8 31.6 1.4 0.9 1.7 3.6 0.6 0.5 1.8 0.0 2.8 0.8 0.5 6.5 0.9 0.9 1.6 0.9 0.2 3.9 0.7 0.1 USP37 KIAA1594 ENSG00000135913 "Ubiquitin specific peptidase 37" Q86T82 2 218450251-218568361 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 117.3;Late spermatids: 116.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045160 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045160: AB_10795620" "unprognostic (7.00e-2)" "unprognostic (2.29e-1)" "unprognostic (8.83e-2)" "unprognostic (9.19e-4)" "unprognostic (1.83e-1)" "prognostic favorable (2.85e-4)" "unprognostic (2.18e-2)" "unprognostic (1.14e-1)" "unprognostic (9.66e-3)" "unprognostic (1.17e-1)" "unprognostic (3.78e-3)" "unprognostic (1.11e-1)" "unprognostic (3.82e-2)" "unprognostic (3.26e-1)" "unprognostic (2.87e-1)" "unprognostic (6.69e-2)" "unprognostic (6.41e-3)" 10.4 8.4 9.2 9.7 10.5 19.2 9.0 16.2 10.0 8.3 6.6 10.4 8.0 5.8 9.6 15.8 8.2 7.8 7.0 6.9 7.4 5.5 6.1 7.4 8.1 10.5 8.7 7.8 15.3 6.9 10.7 17.1 8.5 8.7 7.3 7.0 7.4 9.7 9.6 11.1 9.9 7.2 8.1 10.2 7.0 6.6 22.2 10.5 13.4 9.8 5.4 9.4 10.5 9.1 7.4 6.1 7.4 4.8 5.9 9.0 2.5 7.4 5.4 11.5 8.8 3.0 3.7 9.8 5.7 4.1 9.9 11.2 10.2 5.9 6.8 6.2 4.4 7.6 7.1 12.5 6.3 10.9 9.2 6.6 18.3 11.0 6.7 3.4 11.9 9.2 2.0 3.8 10.4 7.5 3.6 4.2 11.9 13.2 13.1 6.2 5.5 15.3 8.2 9.8 4.8 4.7 12.4 17.2 6.2 3.4 8.8 12.6 6.8 9.1 4.5 5.7 11.5 5.2 8.4 5.4 11.2 9.8 6.2 7.4 8.9 7.9 13.9 6.0 8.8 7.6 6.5 4.2 7.4 7.0 4.8 7.3 5.4 5.8 5.9 4.4 7.4 9.0 5.7 3.5 5.9 4.4 6.1 7.3 2.5 9.2 10.5 16.2 10.0 7.4 5.5 8.7 7.8 8.7 10.5 0.0 8.3 11.5 5.5 17.3 16.4 3.3 2.5 10.7 10.3 7.0 25.5 6.1 0.0 4.6 117.3 9.0 5.1 0.0 2.0 5.4 9.3 10.2 4.7 10.2 6.5 14.3 9.9 11.6 8.1 116.2 9.2 13.7 20.3 5.4 8.1 9.9 4.6 6.8 9.2 3.6 21.1 6.5 10.3 40.0 12.8 18.1 6.1 17.9 7.0 5.8 USP38 "HP43.8KD, KIAA1891" ENSG00000170185 "Ubiquitin specific peptidase 38" Q8NB14 4 143184917-143223830 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 45.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 35.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036990, HPA047948" Uncertain Approved Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA036990: AB_2675419, HPA047948: AB_2680220" "unprognostic (5.01e-2)" "unprognostic (2.45e-1)" "unprognostic (2.04e-3)" "unprognostic (2.99e-2)" "unprognostic (1.87e-1)" "unprognostic (2.61e-2)" "unprognostic (1.67e-1)" "unprognostic (7.49e-2)" "unprognostic (3.66e-2)" "unprognostic (3.97e-2)" "unprognostic (8.03e-2)" "unprognostic (7.72e-3)" "prognostic favorable (1.20e-4)" "unprognostic (3.15e-1)" "unprognostic (1.26e-1)" "unprognostic (1.29e-1)" "unprognostic (1.02e-1)" 7.7 7.8 6.6 6.6 6.5 19.1 8.3 7.4 7.8 7.9 12.1 8.6 8.8 8.8 8.3 7.1 8.6 7.1 7.6 12.5 6.6 5.3 9.3 15.2 12.7 11.1 10.3 5.1 6.3 8.8 10.0 6.2 11.4 5.9 6.6 6.6 7.1 7.2 7.0 45.3 8.9 13.2 6.5 10.8 10.6 7.4 7.5 8.2 22.6 8.6 10.2 8.4 7.8 8.8 6.3 8.1 12.5 5.7 12.3 9.9 5.0 4.8 4.5 4.0 6.9 5.3 5.3 3.0 7.7 7.5 7.2 6.1 13.1 7.2 6.0 5.5 6.5 4.6 3.8 9.5 7.7 5.9 14.6 6.1 5.5 5.4 2.8 7.3 11.1 5.5 6.4 7.1 7.3 5.9 5.1 7.1 6.9 11.9 18.9 4.7 7.7 14.5 2.1 3.6 9.8 8.9 9.5 6.0 5.7 4.6 5.6 8.2 7.4 6.0 10.5 6.7 3.1 6.4 4.2 8.4 6.6 5.4 5.7 8.0 21.1 35.7 10.9 6.7 8.5 5.5 12.5 5.4 11.7 7.5 5.7 9.6 6.3 6.6 6.5 8.1 5.7 6.7 5.7 5.4 12.3 5.7 3.5 9.9 5.0 6.6 6.5 7.4 7.7 6.6 5.3 10.3 5.1 5.9 8.2 20.8 13.7 10.5 16.5 47.6 7.5 15.1 7.6 13.4 14.8 0.0 11.8 10.9 1.7 7.5 27.8 12.0 18.4 0.0 6.6 5.8 9.7 16.1 3.5 32.7 9.2 7.9 29.4 17.8 14.5 15.4 6.4 12.2 11.8 1.8 19.9 13.6 8.5 11.5 8.9 14.2 8.2 12.9 15.1 9.5 5.1 51.7 22.3 13.4 14.5 38.1 USP39 "CGI-21, SAD1, SNRNP65" ENSG00000168883 "Ubiquitin specific peptidase 39" Q53GS9 2 85602856-85649282 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034823, HPA077350" Supported Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA034823: AB_10602488, HPA077350: " "unprognostic (1.10e-2)" "unprognostic (3.31e-3)" "unprognostic (1.83e-1)" "prognostic unfavorable (5.52e-4)" "unprognostic (8.46e-3)" "unprognostic (3.67e-2)" "prognostic unfavorable (2.84e-6)" "unprognostic (1.10e-2)" "unprognostic (1.69e-1)" "unprognostic (1.89e-1)" "unprognostic (5.17e-3)" "unprognostic (3.14e-2)" "prognostic unfavorable (4.05e-7)" "unprognostic (3.95e-3)" "unprognostic (2.25e-1)" "unprognostic (2.52e-2)" "unprognostic (2.52e-1)" 19.0 15.1 14.5 23.5 16.8 30.4 18.3 14.9 20.8 20.2 24.1 18.7 11.8 14.7 22.1 24.1 20.7 16.8 20.6 25.5 13.7 13.7 17.8 20.8 18.5 20.8 15.2 14.5 19.2 15.0 17.7 13.7 28.0 15.8 21.6 20.5 18.0 17.2 20.0 44.2 20.2 17.8 19.0 15.0 21.0 18.1 17.2 13.0 56.5 24.7 23.9 27.0 23.0 26.0 25.3 28.8 29.8 29.7 26.4 37.3 28.2 22.1 22.5 23.1 25.3 16.8 13.2 25.9 18.7 17.7 27.9 24.9 36.0 16.0 26.2 17.7 17.5 20.6 16.0 44.2 20.2 35.4 26.3 28.0 32.5 13.6 31.7 16.6 39.5 22.3 9.3 16.2 21.4 19.3 13.1 22.2 27.7 39.8 15.5 20.4 25.7 38.8 29.7 30.5 27.0 21.0 35.9 49.5 19.9 14.9 17.3 21.3 17.2 11.7 19.2 16.1 19.7 12.9 19.3 14.2 17.3 21.6 20.5 30.9 13.7 25.3 28.1 14.7 41.7 20.6 28.0 25.5 29.8 30.3 29.7 35.2 24.3 31.8 31.2 28.8 25.3 31.4 28.5 16.4 26.4 26.9 22.5 37.3 28.2 14.5 16.8 14.9 20.8 13.7 13.7 15.2 14.5 15.8 13.0 17.9 18.5 11.5 13.7 18.2 7.6 16.2 7.6 17.4 18.2 12.2 7.9 50.4 18.3 16.6 21.7 16.1 10.2 0.0 16.4 24.7 19.3 13.0 16.2 12.5 22.0 4.8 11.6 17.2 10.4 9.4 17.8 16.8 18.6 23.4 14.3 14.0 15.5 8.6 17.7 12.4 10.3 0.0 16.7 17.4 16.8 14.2 29.9 20.3 14.6 13.4 USP42 FLJ12697 ENSG00000106346 "Ubiquitin specific peptidase 42" Q9H9J4 7 6104884-6161564 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 70.7;Spermatocytes: 67.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064800 Approved Nucleoplasm NA NA Nucleoplasm "HPA064800: AB_2685355" "unprognostic (1.48e-2)" "unprognostic (1.47e-1)" "unprognostic (2.59e-1)" "unprognostic (1.69e-1)" "unprognostic (1.30e-2)" "unprognostic (1.53e-1)" "unprognostic (1.19e-2)" "unprognostic (3.32e-1)" "unprognostic (1.05e-1)" "unprognostic (2.82e-1)" "unprognostic (6.21e-3)" "unprognostic (2.47e-2)" "unprognostic (3.17e-3)" "unprognostic (3.14e-2)" "unprognostic (3.06e-2)" "unprognostic (2.19e-2)" "unprognostic (2.66e-1)" 6.7 5.6 5.7 5.7 9.5 19.8 7.2 14.1 10.6 8.5 7.4 10.4 5.5 8.1 14.1 7.0 6.9 8.1 6.5 5.4 5.8 6.0 7.4 7.1 7.3 6.5 6.7 4.9 10.6 11.7 10.5 10.9 8.2 6.2 7.4 6.5 8.9 6.6 6.3 7.4 9.2 9.2 8.7 9.9 7.8 6.7 25.2 8.1 14.3 7.7 6.2 8.3 7.6 6.9 1.9 2.2 3.3 2.4 1.9 4.3 0.8 8.4 6.3 11.4 11.1 6.6 5.0 7.8 4.6 5.9 5.4 5.4 4.4 4.5 10.1 3.0 5.7 8.0 7.9 9.5 5.0 5.9 2.4 7.4 4.6 5.4 4.5 5.6 10.8 5.3 5.9 6.0 5.8 7.5 5.0 6.6 8.5 17.8 6.8 3.6 7.5 6.5 12.1 12.9 4.4 4.8 12.4 8.9 6.9 5.1 4.5 8.8 15.5 5.8 12.2 3.6 10.9 5.6 5.6 5.5 4.9 18.1 6.1 5.4 6.1 5.1 8.8 4.1 6.6 9.5 2.3 1.1 3.3 2.1 2.4 3.0 1.9 2.6 1.3 1.1 1.1 1.7 4.3 1.4 1.9 1.2 2.2 1.8 0.8 5.7 9.5 14.1 10.6 5.8 6.0 6.7 4.9 6.2 8.1 11.9 6.5 11.5 16.3 35.9 18.1 6.9 0.0 10.7 6.8 1.8 21.6 7.3 0.0 9.4 70.7 12.2 12.5 0.0 8.9 6.5 8.5 16.7 9.2 7.8 7.2 20.6 10.3 14.7 7.0 32.5 13.3 11.5 10.1 6.4 14.6 11.3 10.2 7.0 12.0 4.2 17.9 12.9 11.3 67.4 32.6 36.3 22.4 12.1 11.3 13.5 USP45 MGC14793 ENSG00000123552 "Ubiquitin specific peptidase 45" Q70EL2 6 99432379-99521728 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease mutation, Leber congenital amaurosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029602, HPA029604" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA029602: AB_10600418, HPA029604: AB_10602283" "unprognostic (7.81e-3)" "unprognostic (3.10e-3)" "unprognostic (1.63e-2)" "unprognostic (6.62e-2)" "unprognostic (1.02e-2)" "unprognostic (1.92e-1)" "unprognostic (2.15e-2)" "unprognostic (1.01e-1)" "unprognostic (2.77e-2)" "unprognostic (8.65e-2)" "unprognostic (2.95e-3)" "unprognostic (1.10e-1)" "unprognostic (3.43e-3)" "unprognostic (1.13e-1)" "unprognostic (3.53e-1)" "unprognostic (1.43e-1)" "unprognostic (6.91e-2)" 9.8 9.1 8.5 10.2 12.2 7.2 9.0 28.4 11.6 9.0 9.7 8.6 8.9 13.7 15.7 9.6 10.0 8.1 11.9 11.5 7.7 8.5 12.2 9.0 7.1 12.7 9.8 8.0 10.7 9.6 10.2 21.7 9.6 15.0 9.9 13.1 7.9 9.8 8.4 14.6 11.8 12.4 10.8 10.6 9.9 8.9 5.7 9.4 7.1 10.7 10.4 9.5 8.8 15.0 8.6 5.1 3.7 2.5 2.6 6.2 1.4 4.2 3.0 6.0 8.5 11.2 10.6 6.4 7.4 8.3 7.7 11.1 6.3 4.8 11.3 5.5 7.4 9.1 5.8 9.2 7.3 10.7 8.9 8.8 11.0 6.0 4.9 8.6 10.2 6.3 11.3 5.9 6.9 11.9 8.2 11.4 10.3 26.5 11.3 7.3 3.9 3.2 9.8 9.7 6.6 6.5 4.8 4.5 6.3 10.8 5.0 8.5 7.0 5.3 6.9 5.4 7.9 3.7 5.0 11.5 4.2 5.4 6.2 11.2 4.8 4.4 20.7 7.3 9.7 7.5 3.7 2.0 0.6 4.9 1.3 6.2 7.4 4.2 5.6 3.5 8.6 3.0 2.9 0.5 2.6 2.5 5.1 3.5 1.4 8.5 12.2 28.4 11.6 7.7 8.5 9.8 8.0 15.0 9.4 3.0 4.3 4.4 6.8 2.1 7.9 7.1 7.6 12.0 3.4 3.5 17.7 5.3 5.0 3.9 10.8 5.3 5.8 0.0 2.3 5.9 3.8 5.6 2.3 3.8 3.5 9.5 2.4 8.0 4.1 5.9 12.0 3.9 3.3 13.6 2.3 5.6 4.3 2.9 8.1 13.4 7.6 0.0 6.2 1.8 5.5 2.5 6.2 5.1 6.0 6.5 USP48 "FLJ11328, FLJ20103, FLJ23054, FLJ23277, MGC14879, USP31" ENSG00000090686 "Ubiquitin specific peptidase 48" Q86UV5 1 21678298-21783606 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030045, HPA030046" Approved Supported Nucleoplasm,Mitochondria,Cytosol NA NA Nucleoplasm "Mitochondria, Cytosol" "HPA030045: AB_10670833, HPA030046: AB_10603325" "unprognostic (1.35e-1)" "unprognostic (3.72e-1)" "unprognostic (5.46e-3)" "unprognostic (2.21e-1)" "unprognostic (1.23e-1)" "unprognostic (7.00e-3)" "prognostic unfavorable (6.09e-8)" "unprognostic (1.04e-2)" "unprognostic (3.01e-3)" "unprognostic (9.30e-2)" "unprognostic (7.54e-2)" "unprognostic (4.45e-2)" "unprognostic (4.16e-3)" "unprognostic (2.03e-1)" "unprognostic (1.06e-1)" "unprognostic (5.70e-2)" "unprognostic (2.80e-2)" 20.1 38.8 18.6 28.9 30.9 30.9 22.1 48.2 27.5 19.9 18.4 25.6 15.4 17.6 21.3 17.6 19.0 17.4 20.5 17.8 16.9 15.8 15.5 18.3 18.3 26.2 26.6 22.5 27.0 19.8 24.6 35.4 23.1 26.8 21.6 22.0 22.1 24.5 16.3 17.0 23.9 22.2 22.2 19.7 29.1 26.2 15.8 23.6 25.8 23.9 14.0 29.0 19.8 21.0 13.7 10.5 33.7 9.6 5.6 11.2 5.6 14.9 7.1 16.8 12.1 14.6 18.0 16.6 18.8 12.8 12.7 16.8 6.5 15.3 16.8 12.7 17.0 9.9 13.8 20.6 15.2 19.3 16.3 14.1 35.9 26.5 11.8 13.0 18.0 19.2 14.6 13.1 12.8 14.3 17.4 37.2 12.8 28.2 47.5 15.5 7.4 14.9 23.4 10.5 15.3 12.8 21.0 16.9 19.6 14.5 12.6 20.5 12.8 17.7 16.3 42.5 23.5 8.3 21.8 26.4 13.7 11.2 16.7 10.9 38.2 27.1 16.7 13.2 22.3 20.0 33.7 9.6 16.7 6.4 4.6 7.6 13.7 9.5 9.5 10.5 12.8 11.2 7.0 8.9 5.6 5.0 7.7 10.1 5.6 18.6 30.9 48.2 27.5 16.9 15.8 26.6 22.5 26.8 23.6 50.6 38.5 34.3 22.6 19.7 74.8 58.2 22.9 32.1 20.5 19.2 58.9 51.8 21.6 25.0 51.8 24.5 18.7 70.0 17.5 50.1 30.9 20.6 47.5 21.2 26.0 47.7 20.8 28.3 22.2 33.0 32.2 24.7 55.6 47.7 26.9 29.1 20.0 17.5 48.4 16.5 69.2 32.3 25.0 42.9 48.2 22.5 27.2 35.5 30.2 17.1 USP5 IsoT ENSG00000111667 "Ubiquitin specific peptidase 5" P45974 12 6852128-6866632 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006756 Uncertain Approved Nucleoplasm,Cytosol NA NA 820000 "Nucleoplasm, Cytosol" "HPA006756: AB_1080534" "unprognostic (2.19e-1)" "unprognostic (5.83e-2)" "unprognostic (2.48e-1)" "unprognostic (2.57e-1)" "unprognostic (7.60e-2)" "unprognostic (2.21e-2)" "unprognostic (4.02e-2)" "unprognostic (3.93e-2)" "unprognostic (2.57e-1)" "unprognostic (4.71e-2)" "unprognostic (8.90e-3)" "unprognostic (4.69e-2)" "unprognostic (1.17e-2)" "unprognostic (2.65e-2)" "unprognostic (3.56e-1)" "unprognostic (3.23e-1)" "unprognostic (2.02e-3)" 18.6 28.7 23.1 17.8 32.6 13.6 12.9 24.6 50.9 15.9 21.5 26.8 13.8 17.6 22.3 12.8 27.7 19.1 14.7 22.4 23.9 28.6 14.9 24.8 14.4 18.6 23.6 33.2 14.4 13.2 29.7 19.6 21.7 36.8 19.5 16.1 11.6 14.1 22.7 41.2 33.5 18.1 25.3 23.6 14.1 15.9 30.9 18.7 22.8 19.2 20.4 19.9 21.3 16.0 10.8 18.6 5.3 16.6 10.8 17.1 16.6 25.6 40.1 27.0 30.5 18.4 17.0 34.5 27.9 21.4 33.4 24.4 37.9 25.5 31.0 14.7 29.0 26.5 22.7 29.6 27.7 21.4 58.2 25.1 28.4 32.3 20.6 14.3 25.6 30.0 17.1 16.1 28.9 20.0 22.4 28.5 12.5 24.4 12.5 27.5 28.1 38.5 12.8 52.6 26.2 17.0 30.3 35.2 21.5 19.1 25.0 14.9 30.1 19.0 29.0 12.1 35.1 11.6 21.1 27.6 28.3 34.3 21.5 34.7 15.0 34.6 47.3 31.5 16.4 27.5 2.3 12.3 5.3 17.1 16.6 16.1 10.8 15.2 14.4 18.6 10.0 14.6 14.8 0.9 10.8 14.7 13.6 12.9 16.6 23.1 32.6 24.6 50.9 23.9 28.6 23.6 33.2 36.8 18.7 8.9 12.5 13.0 9.5 10.3 18.1 8.1 17.8 4.0 5.7 21.0 56.9 38.0 10.0 25.9 8.7 7.9 17.7 0.0 17.8 24.3 16.4 7.4 14.9 19.7 24.7 38.1 16.0 9.2 12.1 15.5 21.3 9.6 15.1 47.7 14.7 13.8 16.9 17.8 31.8 14.7 14.5 32.3 9.7 24.5 23.8 13.6 44.2 14.1 22.7 5.6 USP7 HAUSP ENSG00000187555 "Ubiquitin specific peptidase 7" Q93009 16 8892094-8964514 "Enzymes, Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway" "Developmental protein, Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 217.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008108, HPA015641, CAB079904" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "CAB008108: AB_2233500, CAB079904: AB_2552261, HPA015641: AB_1858700" "unprognostic (6.73e-2)" "unprognostic (1.59e-1)" "unprognostic (3.36e-3)" "unprognostic (1.94e-2)" "unprognostic (9.64e-2)" "unprognostic (8.09e-2)" "unprognostic (4.69e-2)" "unprognostic (4.56e-2)" "unprognostic (4.81e-1)" "unprognostic (2.49e-1)" "unprognostic (2.35e-1)" "unprognostic (9.93e-2)" "prognostic favorable (8.56e-5)" "unprognostic (1.35e-1)" "unprognostic (1.07e-1)" "unprognostic (7.31e-2)" "unprognostic (2.69e-1)" 17.8 16.8 23.9 25.8 22.9 37.6 21.3 28.7 24.5 21.2 26.3 16.2 18.4 17.7 23.5 16.4 24.4 20.3 18.7 23.7 22.8 20.8 16.5 21.3 21.0 30.5 19.6 22.6 22.5 24.0 44.4 19.7 19.3 16.2 18.5 27.4 16.0 18.4 20.3 42.2 25.2 21.5 22.7 15.3 22.9 22.6 43.3 16.5 68.8 19.5 22.3 35.1 23.9 31.7 7.5 9.8 5.5 7.8 3.9 8.7 1.8 12.4 23.3 20.6 15.4 11.7 15.0 14.2 17.2 14.8 16.1 13.7 20.8 15.3 30.1 11.0 19.9 9.2 15.6 31.5 20.6 27.0 19.7 12.5 25.0 15.7 42.9 16.9 27.5 16.2 12.9 13.1 17.5 20.7 12.4 22.8 45.5 24.1 33.4 16.4 23.8 40.3 5.3 14.4 15.8 13.5 35.9 23.1 27.5 11.3 24.5 19.5 12.0 19.3 18.2 9.5 22.0 18.1 12.3 19.5 17.5 17.9 26.8 12.9 16.2 39.6 46.0 16.3 16.0 14.0 5.5 3.3 3.8 7.1 3.2 8.7 5.9 6.6 8.2 3.3 7.5 8.0 6.8 5.2 3.9 7.8 9.8 7.0 1.8 23.9 22.9 28.7 24.5 22.8 20.8 19.6 22.6 16.2 16.5 32.8 46.2 23.4 19.2 41.3 47.4 61.8 20.4 46.8 46.6 27.9 23.6 18.4 5.0 21.1 217.0 25.9 29.6 46.7 28.3 12.6 24.0 27.0 25.5 34.2 17.5 41.3 40.6 25.2 28.0 84.4 23.6 28.5 18.6 16.2 46.7 25.0 27.8 28.8 32.5 11.8 41.6 6.5 29.2 29.9 31.9 43.7 17.6 26.6 47.0 32.7 UTP11 "CGI-94, UTP11L" ENSG00000183520 "UTP11, small subunit processome component" Q9Y3A2 1 38009258-38024824 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 74.7" "Cell type enhanced" "Detected in many" 5 "Ductal cells: 54.9;Exocrine glandular cells: 58.5;Pancreatic endocrine cells: 60.3;Syncytiotrophoblasts: 65.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045830 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA045830: AB_10969917" "unprognostic (1.95e-1)" "unprognostic (2.23e-1)" "unprognostic (1.52e-1)" "unprognostic (3.18e-2)" "unprognostic (7.29e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (7.44e-8)" "unprognostic (3.51e-1)" "unprognostic (2.99e-2)" "unprognostic (1.66e-3)" "unprognostic (1.40e-1)" "unprognostic (9.65e-2)" "prognostic unfavorable (1.42e-8)" "unprognostic (1.39e-2)" "unprognostic (2.44e-2)" "unprognostic (1.11e-1)" "unprognostic (1.57e-1)" 11.3 12.4 9.1 9.6 8.4 9.3 9.7 7.5 11.3 10.6 12.1 6.0 6.9 7.3 11.4 9.1 13.8 9.8 8.6 11.5 12.9 9.5 9.1 13.1 7.4 8.6 9.3 8.7 10.7 11.5 6.6 10.2 11.4 11.2 12.9 8.7 6.7 10.0 8.8 74.7 9.4 7.6 19.7 10.9 10.2 10.4 9.3 5.7 10.5 8.1 26.1 10.6 22.6 10.9 12.9 18.7 9.6 22.5 21.9 17.7 12.3 15.0 9.1 16.0 15.6 12.0 16.4 14.6 17.1 16.3 23.2 21.4 13.4 18.9 25.2 16.1 13.8 11.4 13.2 18.1 15.0 29.1 18.9 16.6 29.3 12.3 11.7 16.2 29.2 19.3 15.1 9.7 25.6 22.4 14.5 18.5 19.3 33.5 13.7 26.2 10.7 22.6 30.2 38.9 16.9 12.2 20.1 34.2 23.4 15.2 14.7 21.2 17.6 15.0 13.0 27.5 17.6 11.8 18.0 13.6 15.9 19.2 17.3 32.5 13.1 25.6 21.3 21.3 32.1 19.5 8.4 18.9 9.6 16.9 20.5 17.7 10.5 13.5 14.0 18.7 12.9 12.4 15.0 5.7 21.9 22.5 18.0 15.6 12.3 9.1 8.4 7.5 11.3 12.9 9.5 9.3 8.7 11.2 5.7 32.8 35.8 0.0 0.0 0.0 0.0 0.0 0.0 46.8 38.7 24.4 0.0 47.4 33.2 54.9 0.0 0.0 0.0 0.0 58.5 41.6 0.0 0.0 23.3 0.0 47.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.0 33.3 0.0 0.0 60.3 0.0 0.0 36.3 0.0 0.0 0.0 0.0 0.0 0.0 65.1 0.0 0.0 0.0 UTP18 "CGI-48, WDR50" ENSG00000011260 "UTP18, small subunit processome component" Q9Y5J1 17 51260528-51297936 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 146.3;Late spermatids: 145.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052378 Approved Supported "Nucleoplasm,Nuclear membrane,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Nuclear membrane" "HPA052378: AB_2681805" "unprognostic (1.36e-2)" "unprognostic (1.00e-1)" "prognostic favorable (3.33e-4)" "unprognostic (2.62e-2)" "unprognostic (2.55e-2)" "unprognostic (5.99e-2)" "prognostic unfavorable (1.99e-4)" "unprognostic (2.47e-2)" "unprognostic (8.37e-3)" "unprognostic (1.10e-2)" "unprognostic (8.82e-2)" "unprognostic (2.75e-2)" "unprognostic (3.11e-3)" "unprognostic (9.51e-2)" "unprognostic (1.59e-1)" "unprognostic (8.72e-3)" "unprognostic (1.93e-2)" 15.6 16.1 14.4 18.0 20.5 26.9 20.2 23.3 20.9 15.0 13.6 14.5 12.4 13.6 13.0 13.4 17.7 14.0 11.1 8.9 14.2 13.9 17.1 16.9 14.0 22.9 17.0 20.5 19.4 18.1 17.3 19.4 28.3 16.1 13.1 15.0 12.8 14.9 11.9 19.1 25.7 13.0 10.2 14.4 22.0 13.5 42.5 16.9 21.6 19.1 15.6 25.3 15.2 17.9 26.1 26.4 12.4 22.9 17.4 28.1 24.9 26.5 26.4 16.8 15.4 11.1 16.7 43.9 14.7 12.2 25.8 24.9 16.5 14.9 33.7 21.1 10.9 27.6 14.5 27.3 15.7 38.5 22.0 35.6 35.4 16.0 28.7 15.2 37.4 17.4 10.6 12.2 21.9 17.8 13.1 15.4 16.8 28.7 15.5 19.4 16.4 33.5 25.5 24.1 37.9 28.0 30.5 38.3 26.4 18.8 17.7 18.8 23.8 17.1 20.4 33.4 21.9 25.1 19.1 13.4 26.6 22.3 21.9 30.5 30.1 55.4 39.0 16.5 26.1 19.0 6.8 22.9 12.4 20.5 21.6 24.9 26.1 25.8 24.7 26.4 24.4 28.1 26.2 4.0 17.4 21.1 16.6 25.7 24.9 14.4 20.5 23.3 20.9 14.2 13.9 17.0 20.5 16.1 16.9 14.9 25.5 32.0 48.3 53.3 16.3 3.9 17.8 48.2 22.7 14.0 13.7 61.4 33.2 24.4 146.3 25.4 10.5 0.0 40.8 58.4 26.5 24.1 31.1 16.6 54.8 9.5 15.4 8.6 38.6 145.5 24.7 35.4 21.9 38.7 19.4 20.6 29.1 17.8 20.8 29.8 10.3 12.9 16.5 115.2 106.7 46.0 66.6 27.7 22.5 46.3 UTRN "DMDL, DRP, DRP1" ENSG00000152818 Utrophin P46939 6 144285701-144853034 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 381.2;Early spermatids: 418.2;Late spermatids: 250.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HAP1: 58.4;HUVEC TERT2: 41.7;TIME: 53.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016348, HPA018894" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 6000000 "Nucleoplasm, Plasma membrane" "CAB016348: AB_628424, HPA018894: AB_10600839" "unprognostic (3.47e-2)" "unprognostic (2.82e-1)" "unprognostic (2.32e-1)" "unprognostic (6.87e-3)" "unprognostic (1.75e-1)" "unprognostic (3.30e-2)" "unprognostic (3.99e-3)" "unprognostic (2.44e-1)" "unprognostic (9.24e-2)" "unprognostic (1.29e-1)" "unprognostic (2.72e-1)" "unprognostic (7.10e-2)" "prognostic favorable (7.61e-5)" "unprognostic (6.32e-2)" "unprognostic (2.20e-1)" "unprognostic (1.66e-1)" "unprognostic (1.49e-2)" 34.5 14.1 11.6 34.5 23.5 22.9 25.4 3.1 11.3 32.6 15.3 6.8 21.9 7.7 28.8 21.5 17.7 21.4 15.8 13.8 9.2 12.8 15.5 11.8 35.2 30.9 12.7 8.8 22.7 23.8 53.1 13.0 21.1 16.0 23.4 15.2 17.3 18.4 24.8 11.7 16.7 14.8 19.8 16.6 45.8 13.3 45.0 8.5 27.4 32.4 20.0 25.7 20.7 23.4 11.7 15.0 10.6 48.0 10.3 12.6 3.7 6.9 5.9 10.5 13.6 18.3 16.8 6.3 10.3 10.1 8.4 12.3 22.5 2.6 2.2 9.1 23.1 9.9 4.1 58.4 8.7 12.1 23.3 6.7 8.3 6.4 13.3 7.2 9.2 0.1 9.7 1.8 12.4 6.5 7.9 41.7 6.6 0.5 6.1 11.8 4.6 7.3 4.0 4.2 4.3 6.3 6.6 19.0 0.2 9.7 0.2 13.4 0.2 16.1 2.2 6.4 16.8 8.9 12.5 53.6 8.1 10.1 4.1 9.8 4.7 6.3 0.3 4.9 5.6 13.2 9.8 12.3 6.6 12.6 36.3 9.0 7.4 8.0 10.2 5.1 11.7 7.0 7.3 10.6 10.3 48.0 15.0 6.4 3.7 11.6 23.5 3.1 11.3 9.2 12.8 12.7 8.8 16.0 8.5 381.2 100.6 59.6 24.2 26.2 6.0 51.2 35.7 125.8 185.4 29.6 0.0 73.5 0.0 20.7 418.2 142.7 5.3 0.0 27.6 3.8 38.2 40.0 27.8 12.1 19.7 57.2 30.0 68.2 90.1 250.3 22.2 56.1 37.1 8.2 14.2 29.3 24.9 10.5 31.5 4.9 3.4 142.3 109.3 5.7 4.6 39.6 108.1 64.0 20.4 18.4 UTY "KDM6AL, KDM6C" ENSG00000183878 "Ubiquitously transcribed tetratricopeptide repeat containing, Y-linked" O14607 Y 13248379-13480673 "Predicted intracellular proteins" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 37.7" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 60.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 14.9;U-266/84: 11.4;U-698: 14.9" "HPA000568, HPA001165" Supported Approved "Nucleoplasm,Nucleoli,Nucleoli rim" "Intracellular and membrane" NA NA Nucleoplasm "Nucleoli, Nucleoli rim" "HPA000568: AB_1858705, HPA001165: AB_1080541" "unprognostic (7.52e-2)" "unprognostic (6.60e-2)" "unprognostic (4.04e-6)" "unprognostic (6.47e-2)" "unprognostic (9.34e-2)" "unprognostic (2.00e-2)" "unprognostic (9.17e-2)" "unprognostic (1.53e-2)" "unprognostic (1.29e-1)" "unprognostic (1.41e-2)" "unprognostic (2.82e-1)" "unprognostic (2.67e-2)" "unprognostic (1.46e-2)" 5.3 5.1 3.0 15.4 10.3 9.0 5.1 6.1 11.0 0.4 8.4 18.0 18.4 4.3 0.4 16.5 7.2 0.4 6.5 4.7 3.5 3.4 5.0 6.9 11.9 19.0 3.3 0.0 0.5 15.1 0.4 6.3 5.9 13.0 14.0 10.6 16.8 10.9 16.1 9.3 7.4 10.1 18.6 4.8 17.4 5.7 6.7 0.0 37.7 6.3 10.3 22.0 7.2 0.0 6.1 4.8 6.6 3.8 9.9 6.7 1.3 0.0 1.8 0.0 0.0 0.0 0.0 6.6 3.3 5.7 3.7 5.7 0.0 0.0 9.0 0.0 3.8 0.0 0.0 0.0 0.0 5.3 4.9 0.0 14.9 0.1 0.0 4.9 0.0 0.0 6.0 5.9 0.0 0.0 0.0 0.0 3.1 0.0 0.0 4.1 0.0 5.1 0.1 0.0 0.0 0.0 0.0 2.4 4.0 4.1 6.1 3.7 0.0 0.0 0.0 10.7 6.8 0.0 3.2 4.3 6.6 0.0 0.0 2.3 10.2 11.4 14.9 0.6 0.0 0.0 1.8 2.8 5.8 4.7 3.4 6.7 5.0 4.6 3.6 3.0 6.1 6.5 4.7 6.6 9.9 3.8 4.8 5.3 1.3 3.0 10.3 6.1 11.0 3.5 3.4 3.3 0.0 13.0 0.0 14.9 22.3 25.2 17.2 10.1 30.4 5.2 2.5 10.7 13.6 17.4 60.9 8.5 0.0 2.9 0.3 7.7 1.0 0.0 0.0 2.7 7.6 12.2 15.1 0.0 2.4 35.0 1.7 8.6 13.3 0.9 10.0 15.3 8.5 10.8 0.0 18.3 2.5 0.0 11.0 1.3 38.6 0.0 6.2 1.8 5.9 13.4 11.1 21.3 0.0 16.0 UVSSA KIAA1530 ENSG00000163945 "UV stimulated scaffold protein A" "Q2YD98, Q8N1N5" 4 1347266-1395992 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050824, HPA053496" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA050824: AB_2681251, HPA053496: AB_2682170" "unprognostic (6.40e-3)" "unprognostic (4.91e-2)" "unprognostic (1.34e-1)" "unprognostic (1.13e-2)" "unprognostic (1.67e-1)" "unprognostic (3.85e-4)" "unprognostic (1.89e-1)" "unprognostic (4.80e-2)" "unprognostic (1.38e-1)" "unprognostic (4.88e-2)" "unprognostic (2.12e-3)" "unprognostic (3.92e-3)" "prognostic unfavorable (1.90e-4)" "unprognostic (2.76e-3)" "unprognostic (5.19e-2)" "unprognostic (1.02e-2)" "prognostic favorable (6.87e-4)" 6.5 7.1 5.7 8.0 10.8 11.8 8.1 7.2 7.1 6.1 7.6 10.6 10.9 9.7 10.0 11.4 6.8 10.7 5.5 4.8 8.0 3.4 5.8 6.3 9.4 7.6 7.8 4.3 9.5 13.4 6.7 19.0 9.4 7.0 6.7 5.6 9.6 11.1 6.7 8.7 19.6 8.7 7.2 8.4 9.9 8.9 22.2 7.6 7.1 11.5 3.1 7.3 9.3 7.0 1.5 2.4 3.6 2.1 8.2 1.6 1.5 4.3 6.8 6.3 6.6 9.8 9.7 5.9 3.9 3.0 3.1 2.5 4.6 7.3 2.6 7.5 3.3 7.5 4.6 3.6 4.6 2.6 4.5 2.2 6.4 8.7 7.0 2.6 3.9 8.5 2.9 8.8 3.3 3.8 3.7 5.1 6.1 6.5 8.9 3.8 3.1 6.3 9.1 6.7 2.6 6.1 5.7 3.1 3.8 2.7 5.9 4.8 6.3 2.7 3.5 4.7 5.9 9.1 2.2 10.8 11.9 3.0 4.5 6.4 15.8 9.0 5.8 9.0 4.9 7.3 0.2 1.8 1.7 1.6 1.1 1.0 1.2 1.3 1.5 2.4 1.5 1.3 0.9 3.6 8.2 2.1 1.4 0.6 1.5 5.7 10.8 7.2 7.1 8.0 3.4 7.8 4.3 7.0 7.6 6.0 25.8 3.7 4.3 4.8 13.8 3.1 7.6 21.4 9.1 15.7 39.3 2.6 3.3 6.5 3.9 5.3 8.8 0.0 7.4 2.5 4.8 4.7 8.1 9.0 5.7 28.6 5.8 6.2 5.9 5.1 4.9 8.5 5.0 6.4 8.0 12.9 7.5 5.7 3.5 3.6 28.3 0.0 4.7 22.1 8.3 5.4 3.1 5.9 5.5 3.1 UXT "ART-27, STAP1" ENSG00000126756 "Ubiquitously expressed prefoldin like chaperone" Q9UBK9 X 47651798-47659161 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Activator, Chaperone, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050499, HPA058400" Approved Supported "Nucleoplasm,Centriolar satellite" Yes No Nucleoplasm "Centriolar satellite" "HPA050499: AB_2681146, HPA058400: AB_2683706" "unprognostic (1.12e-1)" "unprognostic (3.85e-3)" "unprognostic (9.08e-2)" "unprognostic (2.09e-2)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "unprognostic (4.49e-2)" "unprognostic (1.24e-1)" "unprognostic (1.97e-1)" "unprognostic (2.31e-3)" "unprognostic (1.12e-2)" "unprognostic (1.17e-1)" "unprognostic (2.56e-2)" "unprognostic (1.44e-1)" "unprognostic (8.11e-2)" "unprognostic (8.64e-2)" "unprognostic (4.09e-3)" 30.9 37.4 21.7 33.7 23.6 54.4 38.9 20.0 27.3 26.7 31.9 24.8 33.5 23.2 26.8 39.8 30.1 32.4 31.3 47.3 20.9 16.5 34.7 66.8 24.9 46.1 23.6 24.9 50.5 54.1 21.4 29.6 39.0 26.0 30.0 31.1 19.5 46.5 30.5 42.1 36.2 29.1 21.1 27.6 37.1 31.9 24.7 22.6 50.4 37.0 33.2 41.6 24.5 32.5 58.2 60.2 26.2 35.8 36.0 73.5 52.0 45.8 50.9 21.7 28.8 49.7 60.0 38.2 29.8 43.6 51.1 48.5 43.7 43.8 52.6 21.7 42.4 47.3 37.3 30.8 40.7 36.4 34.3 61.1 26.5 58.0 43.1 57.9 58.3 52.1 42.1 52.2 43.0 46.3 35.6 41.1 45.4 28.9 50.9 43.2 50.5 39.8 81.3 31.1 42.0 58.1 35.5 44.0 72.3 41.1 33.8 20.6 27.0 33.1 36.0 46.0 41.5 42.3 54.1 30.0 35.8 39.0 49.2 32.6 40.2 35.4 47.2 45.6 64.9 36.1 18.7 35.8 26.2 40.2 35.5 54.1 58.2 57.7 43.2 47.4 56.7 73.5 60.2 23.0 36.0 32.4 60.2 52.9 52.0 21.7 23.6 20.0 27.3 20.9 16.5 23.6 24.9 26.0 22.6 68.5 66.8 281.0 227.2 190.8 23.2 91.3 173.3 104.4 77.3 92.5 15.7 159.9 266.9 141.0 57.0 149.5 224.3 70.0 277.6 166.5 144.8 211.1 151.2 220.1 215.1 9.5 179.6 164.5 216.2 146.7 194.8 227.9 187.3 293.1 261.4 59.3 182.8 282.8 184.2 337.2 20.1 142.3 173.2 63.7 82.2 178.2 178.7 244.2 308.1 250.0 VAMP5 ENSG00000168899 "Vesicle associated membrane protein 5" O95183 2 85584408-85593412 "Predicted membrane proteins" "Differentiation, Myogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Endothelial cells: 294.0;Ito cells: 443.2;Kupffer cells: 298.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 34.3;HUVEC TERT2: 64.1;LHCN-M2: 75.3;TIME: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035082 Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA035082: AB_10610564" "unprognostic (1.92e-1)" "unprognostic (3.09e-2)" "unprognostic (6.09e-2)" "unprognostic (1.13e-2)" "unprognostic (4.16e-2)" "unprognostic (1.25e-3)" "unprognostic (1.28e-2)" "unprognostic (5.29e-2)" "unprognostic (1.17e-2)" "unprognostic (3.49e-2)" "unprognostic (2.22e-1)" "unprognostic (7.59e-2)" "prognostic unfavorable (1.28e-5)" "unprognostic (9.61e-3)" "unprognostic (3.46e-2)" "unprognostic (1.71e-2)" "unprognostic (2.60e-1)" 26.2 25.8 12.6 18.9 14.1 11.7 27.5 4.3 9.2 17.9 22.1 8.5 9.2 7.6 18.9 27.2 24.3 18.3 18.8 37.0 11.0 10.9 18.5 31.2 28.8 32.1 16.8 9.6 19.6 6.3 3.2 7.2 24.4 17.7 29.0 6.9 16.0 7.7 13.0 70.9 9.5 17.0 25.5 14.1 33.3 12.3 13.7 8.1 18.0 17.5 19.8 13.0 21.8 25.8 10.2 13.8 27.5 80.4 14.3 39.4 39.3 0.1 0.0 0.4 0.0 16.3 28.6 0.4 17.3 27.5 17.0 18.8 6.8 2.6 0.0 0.4 29.9 9.2 0.2 0.0 0.4 7.6 24.5 0.5 0.3 0.4 9.5 34.3 0.7 0.1 19.8 1.7 7.1 0.2 25.1 64.1 10.9 0.0 0.0 75.3 2.4 10.6 2.3 0.0 4.7 0.1 15.9 0.0 0.4 0.4 0.6 0.0 0.6 0.1 4.9 0.1 0.4 0.5 0.8 43.8 0.4 1.2 1.3 0.0 0.0 0.5 0.4 20.0 0.9 11.6 8.2 38.1 27.5 31.7 80.4 29.8 9.7 24.1 23.5 12.8 10.2 18.5 22.3 11.8 14.3 64.4 13.8 39.4 39.3 12.6 14.1 4.3 9.2 11.0 10.9 16.8 9.6 17.7 8.1 17.9 30.0 50.0 38.6 54.0 0.8 75.5 81.5 29.4 37.5 41.8 0.0 16.6 24.9 28.6 1.2 294.0 58.6 0.0 43.2 6.9 187.6 42.9 43.8 141.5 73.6 3.2 12.1 443.2 298.8 4.7 178.4 77.9 261.5 100.0 11.0 11.5 39.6 48.9 155.2 64.7 0.5 58.2 94.7 4.8 3.2 39.5 18.1 106.6 7.6 32.9 VAMP8 EDB ENSG00000118640 "Vesicle associated membrane protein 8" Q9BV40 2 85561562-85582031 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 172.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 82.0;NB-4: 128.2;THP-1: 63.7;U-937: 85.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006882, HPA007215, CAB037132, CAB037147" Enhanced Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA 210000 "Golgi apparatus, Plasma membrane" Nucleoplasm "CAB037132: AB_1080547, CAB037147: AB_1080544, HPA006882: AB_1858716, HPA007215: " "unprognostic (1.00e-1)" "unprognostic (1.16e-1)" "unprognostic (7.46e-3)" "unprognostic (1.13e-1)" "unprognostic (7.33e-2)" "unprognostic (1.31e-1)" "unprognostic (1.76e-2)" "unprognostic (3.79e-3)" "unprognostic (3.83e-2)" "unprognostic (4.15e-1)" "unprognostic (2.74e-2)" "unprognostic (8.62e-2)" "unprognostic (1.57e-3)" "unprognostic (1.92e-2)" "unprognostic (2.16e-1)" "prognostic favorable (8.07e-9)" "prognostic favorable (1.59e-6)" 16.5 8.2 7.1 20.7 11.2 27.6 24.2 1.9 6.2 16.3 49.4 5.7 43.5 24.1 6.0 25.5 65.4 17.1 28.8 13.0 4.7 3.8 67.7 46.5 53.1 48.0 10.5 3.2 7.1 58.0 15.4 8.3 108.1 11.9 22.1 31.9 7.7 90.7 40.4 9.0 43.3 87.1 6.8 10.4 53.5 28.7 5.5 8.4 24.5 47.5 35.4 34.9 20.6 30.4 39.2 172.5 37.7 69.7 41.4 51.3 100.9 23.9 3.1 0.2 0.2 0.2 0.1 23.9 0.0 0.0 0.0 0.0 17.8 22.0 5.3 17.4 0.1 1.8 17.0 0.2 42.9 0.0 21.8 16.6 27.6 10.6 20.2 0.3 82.0 28.6 0.2 30.5 0.0 7.1 0.1 5.5 0.1 19.7 1.1 9.8 33.6 0.0 128.2 0.3 30.0 2.5 0.5 0.9 36.0 49.7 36.0 0.8 0.3 11.7 62.1 1.9 13.0 22.8 63.7 11.0 0.0 1.5 0.3 0.2 0.3 13.5 31.4 0.3 85.1 0.1 37.7 69.7 25.2 40.4 57.7 38.8 39.2 46.8 39.5 63.5 37.8 37.3 39.1 4.5 41.4 34.3 172.5 51.3 100.9 7.1 11.2 1.9 6.2 4.7 3.8 10.5 3.2 11.9 8.4 345.4 256.8 171.2 244.0 230.2 1.1 5.5 331.2 341.3 271.8 347.2 0.0 869.6 648.2 536.4 20.3 29.2 900.3 0.0 637.4 386.9 34.1 294.8 263.2 244.8 1050.6 0.0 124.1 155.3 836.3 34.0 8.6 660.7 334.0 762.0 322.8 2.4 674.2 501.5 7.1 797.0 1.6 45.3 25.8 28.4 6.4 288.3 734.1 248.2 230.6 528.7 VASN SLITL2 ENSG00000168140 Vasorin Q6EMK4 16 4371848-4383528 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Fibroblasts: 108.9;Peritubular cells: 57.3;Sertoli cells: 97.0;Smooth muscle cells: 96.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 12 "U-2197: 126.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011246, HPA016992" Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria "Secreted - unknown location" NA Yes 2400000000 Mitochondria "Nucleoplasm, Nucleoli" "HPA011246: AB_1858720, HPA016992: AB_2732418" "unprognostic (2.20e-1)" "unprognostic (2.75e-1)" "unprognostic (9.22e-2)" "prognostic unfavorable (6.24e-5)" "unprognostic (2.35e-3)" "unprognostic (8.91e-3)" "unprognostic (3.15e-3)" "unprognostic (5.92e-2)" "unprognostic (2.22e-1)" "unprognostic (1.24e-2)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (1.81e-1)" "unprognostic (8.82e-3)" "unprognostic (4.23e-2)" "unprognostic (4.95e-3)" "unprognostic (5.27e-2)" 22.4 10.2 4.9 7.7 6.7 3.8 28.6 1.6 6.5 19.9 5.1 5.6 6.4 5.1 14.3 13.6 16.2 9.9 10.2 12.9 4.4 1.8 21.6 14.1 17.2 5.2 2.7 2.9 21.0 9.8 1.7 5.9 30.2 4.8 12.9 2.0 33.6 7.9 13.1 7.0 16.0 4.0 9.4 3.6 7.9 6.5 14.7 3.5 0.0 15.2 5.5 8.2 16.6 19.0 0.3 0.2 0.4 0.0 0.0 0.2 0.0 0.3 0.5 0.0 0.0 2.8 3.2 1.2 5.3 5.2 1.6 2.7 0.3 0.6 0.0 1.9 3.5 0.2 0.0 0.0 0.1 0.2 1.2 0.1 0.1 1.5 1.6 10.2 0.0 0.0 3.3 0.0 4.0 0.1 2.7 0.0 0.0 0.2 0.0 0.2 1.8 0.0 0.4 0.3 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.1 0.9 2.5 4.2 0.0 0.2 0.9 0.2 0.0 4.9 1.3 126.7 0.6 0.0 0.0 0.0 1.5 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.9 6.7 1.6 6.5 4.4 1.8 2.7 2.9 4.8 3.5 6.0 12.5 0.9 6.0 8.5 0.0 12.9 35.7 1.4 3.4 22.7 0.0 3.0 6.6 10.3 1.0 3.3 0.2 0.0 2.6 6.4 108.9 7.4 3.5 12.9 2.8 0.0 0.0 4.9 0.3 1.8 46.3 1.2 13.5 0.0 0.4 16.3 17.4 0.0 57.3 12.5 0.7 97.0 96.8 0.5 5.1 6.6 8.4 1.8 0.2 3.3 VAX1 ENSG00000148704 "Ventral anterior homeobox 1" Q5SQQ9 10 117128521-117138301 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 21.8" "Cell type enhanced" "Detected in single" 27 "Cardiomyocytes: 1.1" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 21.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "A-431: 7.7;WM-115: 5.8" "Group enriched" "Detected in some" 6 "basal ganglia: 5.8;hypothalamus: 3.8;olfactory region: 1.8" "Low region specificity" "Detected in many" HPA028946 Uncertain Approved "Nucleoplasm,Nucleoli rim" Yes NA "Nucleoli rim" Nucleoplasm "HPA028946: AB_10602679" "unprognostic (1.08e-2)" "unprognostic (1.92e-2)" "unprognostic (1.46e-1)" "unprognostic (2.96e-2)" "unprognostic (5.77e-3)" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (5.72e-2)" "unprognostic (2.09e-1)" "unprognostic (2.99e-1)" 0.4 0.4 1.4 0.4 21.8 0.4 0.4 0.0 7.0 0.5 0.5 9.5 0.0 0.4 0.4 0.4 0.5 0.4 0.5 0.4 1.5 5.2 0.4 0.4 0.4 0.4 0.7 4.3 0.4 0.4 0.7 0.5 0.4 1.2 0.4 0.5 0.0 0.4 0.5 0.7 0.4 0.5 0.4 1.3 0.4 0.4 2.1 2.9 0.0 0.4 0.0 0.4 0.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.7 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 21.8 0.0 7.0 1.5 5.2 0.7 4.3 1.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 VCP "CDC48, IBMPFD, p97, TERA" ENSG00000165280 "Valosin containing protein" P55072 9 35056064-35073249 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Autophagy, DNA damage, DNA repair, Transport, Ubl conjugation pathway" Hydrolase "Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Syncytiotrophoblasts: 452.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005593, HPA012728, HPA012814" Supported Enhanced Nucleoplasm,Cytosol No No 110000000 "Nucleoplasm, Cytosol" "CAB005593: AB_2214638, HPA012728: AB_1858730, HPA012814: AB_1858729" "unprognostic (1.10e-1)" "unprognostic (2.66e-1)" "unprognostic (8.15e-2)" "prognostic favorable (7.30e-4)" "unprognostic (5.78e-2)" "unprognostic (1.87e-1)" "unprognostic (2.52e-3)" "unprognostic (1.13e-2)" "unprognostic (3.82e-2)" "unprognostic (1.81e-2)" "unprognostic (2.19e-2)" "unprognostic (3.24e-1)" "prognostic favorable (9.63e-7)" "unprognostic (1.83e-2)" "unprognostic (1.16e-1)" "unprognostic (3.93e-1)" "unprognostic (9.11e-2)" 33.7 43.6 19.6 30.3 21.8 30.8 31.4 19.4 31.0 32.2 25.7 22.7 32.9 22.2 30.5 34.0 40.0 24.7 33.8 69.6 20.0 23.4 30.1 63.4 27.6 42.7 23.1 21.1 25.0 34.9 44.5 29.0 46.3 26.3 33.4 26.5 21.2 30.7 34.1 80.4 29.2 26.3 29.2 23.0 37.8 28.9 25.6 18.2 43.3 32.1 42.2 35.7 31.5 26.5 25.9 29.4 43.4 30.6 23.0 32.1 34.4 36.0 41.2 28.4 15.3 34.3 24.2 21.7 33.6 38.1 50.3 37.2 27.5 14.9 28.6 29.5 41.7 44.2 17.4 42.3 40.1 43.6 30.7 24.5 19.9 39.0 37.6 26.7 22.3 26.6 27.6 27.0 43.6 19.5 21.1 54.4 13.1 20.6 20.8 40.2 25.4 21.8 53.7 37.0 18.7 39.4 19.4 22.1 17.7 39.3 25.8 15.5 19.5 20.3 23.0 10.2 36.9 18.5 15.9 44.5 20.2 26.1 17.9 29.5 10.6 22.4 24.5 33.1 16.1 25.8 43.4 24.5 31.9 24.7 27.2 23.8 25.9 23.6 24.8 29.4 21.1 17.7 18.5 28.4 23.0 30.6 18.9 32.1 34.4 19.6 21.8 19.4 31.0 20.0 23.4 23.1 21.1 26.3 18.2 74.5 72.0 80.5 100.9 68.5 80.1 178.9 43.3 71.0 68.2 52.4 111.9 240.5 63.0 177.8 24.1 121.1 90.3 23.3 162.4 147.5 81.6 98.2 61.1 102.4 116.5 69.9 80.8 122.8 57.9 36.5 77.6 66.7 72.6 234.4 63.9 87.7 195.1 56.3 81.7 89.3 82.6 135.8 82.4 127.7 117.9 79.3 452.1 76.6 57.1 105.3 VDR "NR1I1, PPP1R163" ENSG00000111424 "Vitamin D receptor" P11473 12 47841537-47943048 "Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 57.1;parathyroid gland: 45.8" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 101.9;Paneth cells: 43.0;Undifferentiated cells: 54.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "classical monocyte: 3.7;eosinophil: 2.1;intermediate monocyte: 7.0;myeloid DC: 5.7;neutrophil: 7.5;non-classical monocyte: 6.9" "Group enriched" "Detected in many" 8 "dendritic cells: 5.7;granulocytes: 7.5;monocytes: 7.0" "Cell line enhanced" "Detected in many" "HBEC3-KT: 23.0;HDLM-2: 32.4;U-937: 31.8" "Region enhanced" "Detected in single" "olfactory region: 2.5" "Not detected" "Not detected" "CAB004617, HPA047740, HPA072102" Supported "Nucleoplasm,Intermediate filaments,Cytosol" NA NA Nucleoplasm "Intermediate filaments, Cytosol" "CAB004617: AB_628040, HPA047740: AB_2680142, HPA072102: " "unprognostic (1.11e-2)" "unprognostic (5.49e-2)" "unprognostic (1.01e-1)" "unprognostic (7.59e-3)" "unprognostic (3.33e-3)" "unprognostic (2.74e-2)" "unprognostic (4.78e-2)" "unprognostic (1.69e-1)" "unprognostic (1.40e-1)" "unprognostic (1.62e-1)" "unprognostic (5.53e-3)" "unprognostic (6.72e-2)" "prognostic favorable (4.89e-6)" "unprognostic (1.46e-1)" "unprognostic (8.76e-2)" "unprognostic (3.28e-1)" "unprognostic (3.82e-2)" 3.0 9.2 0.2 10.0 0.3 2.5 7.8 0.3 0.6 3.5 40.9 0.4 4.1 21.2 1.2 7.7 10.2 1.1 10.7 1.5 0.5 0.3 13.0 0.6 8.3 3.8 0.5 0.1 1.3 6.5 45.8 11.7 4.4 0.6 2.1 12.6 0.4 4.9 2.8 5.3 15.2 57.1 1.2 1.5 3.1 2.6 1.5 0.2 2.0 1.9 9.4 8.2 4.0 5.2 0.7 5.7 7.5 7.0 0.2 0.8 1.2 5.5 0.9 0.0 0.0 4.8 7.0 0.1 6.8 3.5 5.8 5.0 4.0 4.7 1.4 7.4 4.6 4.1 10.4 0.2 23.0 2.7 32.4 1.7 2.4 1.3 0.3 3.5 4.9 7.8 9.4 10.8 6.4 10.5 9.2 0.4 0.5 0.7 1.5 2.6 3.7 0.1 2.4 0.0 13.8 7.5 0.1 0.0 3.5 5.2 5.5 2.6 0.1 5.8 16.7 2.1 0.0 18.8 2.7 0.4 11.1 2.9 3.2 3.8 0.9 0.0 1.2 3.4 31.8 2.8 0.2 3.7 2.1 0.0 7.0 0.1 0.7 0.3 0.0 5.7 0.1 0.1 0.0 7.5 0.2 6.9 0.6 0.8 1.2 0.2 0.3 0.3 0.6 0.5 0.3 0.5 0.1 0.6 0.2 11.9 15.3 1.9 8.2 32.1 0.4 1.2 0.0 9.4 11.4 7.0 0.0 0.1 6.6 3.7 0.1 0.8 101.9 0.0 9.4 0.1 7.8 3.9 6.9 0.4 3.6 0.0 20.8 0.0 6.6 0.0 0.0 18.7 8.5 6.4 30.0 0.2 14.7 43.0 0.4 17.5 0.2 0.0 2.8 0.7 0.3 35.5 0.2 3.2 54.4 8.4 VEPH1 "FLJ12604, KIAA1692" ENSG00000197415 "Ventricular zone expressed PH domain containing 1" Q14D04 3 157259742-157533619 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 38.1;pituitary gland: 70.3" "Cell type enhanced" "Detected in many" 18 "Alveolar cells type 1: 247.1;Alveolar cells type 2: 124.4;Early spermatids: 67.1;Late spermatids: 63.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "cerebellum: 2.2;pons and medulla: 5.5" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+: 24.5;hTERT-RPE1: 26.3;HUVEC TERT2: 65.1;TIME: 38.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA026645 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli, Cytosol" "HPA026645: AB_1858741" "unprognostic (4.35e-2)" "unprognostic (1.42e-2)" "unprognostic (2.44e-1)" "unprognostic (3.58e-1)" "unprognostic (5.17e-2)" "unprognostic (3.30e-3)" "unprognostic (2.87e-3)" "unprognostic (2.22e-1)" "unprognostic (3.52e-2)" "unprognostic (1.75e-3)" "unprognostic (3.57e-3)" "unprognostic (1.99e-2)" "prognostic favorable (7.75e-9)" "unprognostic (2.03e-1)" "unprognostic (2.57e-1)" "unprognostic (1.15e-4)" "unprognostic (7.49e-2)" 0.5 16.0 0.3 0.2 0.3 1.1 1.4 2.2 3.5 1.9 0.4 0.7 2.0 0.2 0.4 12.1 0.2 3.4 1.1 0.4 0.8 0.5 20.7 0.6 38.1 0.1 0.7 0.1 1.1 8.6 0.7 70.3 1.6 5.5 1.2 0.3 17.7 6.9 4.9 0.2 0.7 0.2 0.1 0.3 2.3 0.6 1.7 0.2 0.1 1.1 0.5 0.6 0.5 0.8 0.0 0.0 1.5 0.7 0.0 0.0 5.1 1.8 0.2 4.3 0.0 2.5 9.4 0.0 11.0 24.5 3.3 4.8 0.3 1.7 0.0 4.3 11.8 0.5 0.0 0.1 0.2 18.3 0.0 0.0 1.8 0.2 0.0 0.8 0.0 0.0 2.7 0.1 14.0 2.8 26.3 65.1 0.0 0.6 0.0 8.9 0.2 0.0 0.0 1.7 0.5 1.6 0.0 0.3 0.0 1.6 0.9 0.1 0.0 0.3 0.5 4.3 0.0 18.9 0.0 38.7 13.1 0.4 4.5 15.1 0.0 0.0 0.0 10.5 0.0 3.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.1 0.3 0.3 2.2 0.4 0.8 0.5 0.7 0.1 5.5 0.2 247.1 124.4 0.0 0.2 1.5 0.0 0.3 12.7 14.7 26.1 29.6 2.0 1.6 39.7 5.5 67.1 0.0 0.0 0.0 8.7 0.1 0.4 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 63.8 1.4 0.4 27.0 1.0 0.2 0.8 2.0 2.8 0.4 24.1 0.3 0.0 0.0 0.3 0.6 0.4 0.0 0.0 0.6 0.1 VEZF1 "DB1, ZNF161" ENSG00000136451 "Vascular endothelial zinc finger 1" Q14119 17 57971547-57988259 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027520, HPA048315" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA027520: AB_10602680, HPA048315: AB_2680353" "unprognostic (7.24e-2)" "unprognostic (3.18e-1)" "prognostic favorable (6.14e-5)" "unprognostic (2.12e-2)" "unprognostic (3.85e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (6.46e-4)" "unprognostic (2.71e-2)" "unprognostic (1.65e-1)" "unprognostic (4.72e-2)" "unprognostic (4.97e-2)" "unprognostic (5.15e-2)" "unprognostic (3.28e-3)" "unprognostic (1.45e-1)" "unprognostic (7.67e-2)" "unprognostic (8.67e-2)" "unprognostic (3.03e-2)" 18.3 26.6 21.2 18.6 29.2 38.6 27.9 24.0 24.2 27.4 31.2 32.4 21.4 15.9 34.0 16.9 21.1 32.4 20.3 24.1 23.6 14.5 23.8 13.4 23.6 21.2 32.2 16.4 28.7 22.6 19.8 26.1 21.2 24.6 26.2 19.2 22.6 23.5 26.1 51.7 13.5 21.2 29.7 21.6 20.6 22.4 16.5 37.2 39.8 31.3 19.6 15.6 29.7 36.4 13.9 17.5 26.2 26.0 25.3 18.2 11.9 19.3 22.0 42.3 14.7 10.9 15.5 14.7 16.1 23.4 20.3 18.5 10.5 20.6 10.0 27.5 17.9 18.8 11.2 16.9 18.4 27.7 28.0 13.2 18.5 17.4 12.4 13.8 16.2 16.6 11.0 23.1 13.1 25.0 28.5 19.6 13.7 13.8 14.0 20.6 7.4 26.2 8.8 14.5 17.3 25.8 20.1 33.1 7.7 12.5 18.5 17.6 33.1 15.7 7.2 23.6 18.5 41.2 16.7 19.2 28.8 29.3 17.8 26.1 14.6 11.5 15.4 20.0 14.4 36.6 21.6 13.8 26.2 17.0 17.1 17.5 12.0 14.0 18.2 16.5 13.9 17.8 15.8 24.1 25.3 26.0 17.5 13.1 11.9 21.2 29.2 24.0 24.2 23.6 14.5 32.2 16.4 24.6 37.2 77.4 48.7 19.9 33.3 32.2 65.0 85.3 40.8 66.9 51.2 24.4 62.8 14.1 21.6 30.9 18.8 40.5 18.7 0.0 31.8 14.2 34.8 46.0 54.4 17.8 19.0 31.8 47.0 34.4 37.2 28.5 33.4 41.5 40.5 19.8 30.2 41.2 25.1 21.0 26.2 23.7 61.8 51.8 39.1 37.7 21.3 18.3 16.6 23.0 23.5 32.0 VEZT DKFZP761C241 ENSG00000028203 "Vezatin, adherens junctions transmembrane protein" Q9HBM0 12 95217746-95302790 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004811, HPA017066" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA004811: AB_1080563, HPA017066: AB_1858742" "unprognostic (3.91e-1)" "unprognostic (6.34e-3)" "unprognostic (3.48e-2)" "unprognostic (1.64e-1)" "unprognostic (1.47e-1)" "unprognostic (1.31e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (2.28e-1)" "unprognostic (9.93e-2)" "unprognostic (4.18e-1)" "unprognostic (1.10e-3)" "unprognostic (3.37e-3)" "prognostic unfavorable (1.93e-5)" "prognostic unfavorable (3.68e-4)" "unprognostic (1.51e-1)" "unprognostic (4.06e-1)" "unprognostic (5.02e-2)" 12.3 21.4 15.4 14.3 17.2 5.1 14.6 28.3 27.2 12.9 14.4 9.1 19.0 9.5 17.1 15.9 15.6 11.5 12.1 14.7 11.8 9.5 12.1 10.4 13.8 9.6 11.0 14.0 13.3 12.6 15.7 20.4 19.6 11.4 15.8 10.6 10.3 10.9 13.9 42.7 16.1 11.0 16.2 12.5 7.2 10.7 7.2 12.2 13.6 29.8 14.5 10.0 15.7 12.2 5.2 4.4 1.1 3.5 2.4 5.0 1.2 10.3 9.6 13.3 7.2 10.2 7.3 5.1 7.6 9.6 6.1 9.7 3.5 4.9 13.4 5.0 6.6 3.3 5.4 9.5 6.7 11.4 9.0 5.3 5.1 2.5 3.6 5.5 10.1 3.0 9.2 11.7 5.7 16.5 14.2 12.8 6.6 3.0 5.3 5.5 2.8 8.7 4.8 6.7 3.3 9.8 7.9 6.3 4.3 17.7 7.5 9.0 7.8 7.3 11.1 3.5 12.4 13.7 1.7 10.2 5.5 2.1 2.4 4.2 5.2 7.8 11.4 2.1 3.7 2.8 0.5 3.1 1.1 3.6 3.5 4.7 5.2 5.0 2.1 4.4 3.6 2.4 2.0 0.3 2.4 0.9 1.8 3.5 1.2 15.4 17.2 28.3 18.8 11.8 9.5 11.0 14.0 11.4 12.2 65.5 43.0 27.5 49.9 69.0 66.8 41.6 33.1 29.4 47.8 31.4 80.5 32.2 8.3 45.1 8.5 39.8 29.7 0.0 39.7 17.6 29.0 46.9 28.8 32.6 18.8 58.8 36.9 40.5 28.3 8.3 30.2 23.7 35.4 20.8 26.8 23.0 54.7 29.1 31.1 18.9 146.1 6.5 34.3 27.3 17.9 63.2 92.6 20.3 20.7 66.0 VGLL1 "TDU, TONDU" ENSG00000102243 "Vestigial like family member 1" Q99990 X 136532152-136556807 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "placenta: 124.6" "Group enriched" "Detected in some" 11 "Cytotrophoblasts: 1053.7;Extravillous trophoblasts: 494.4;Syncytiotrophoblasts: 1495.8" "Cancer enhanced" "Detected in many" "urothelial cancer: 47.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 25.3;BEWO: 39.0;CAPAN-2: 14.2;RT4: 67.0;SK-BR-3: 65.8" "Low region specificity" "Detected in all" "HPA042403, HPA064616" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA042403: AB_2677980, HPA064616: AB_2685300" "unprognostic (1.38e-1)" "unprognostic (1.58e-1)" "unprognostic (3.09e-1)" "prognostic unfavorable (4.54e-4)" "unprognostic (5.16e-2)" "unprognostic (1.80e-1)" "unprognostic (4.28e-1)" "unprognostic (6.14e-3)" "unprognostic (1.92e-3)" "unprognostic (1.37e-2)" "unprognostic (5.53e-2)" "unprognostic (3.05e-1)" "unprognostic (1.46e-2)" "unprognostic (1.64e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 2.6 0.1 0.1 0.5 0.1 0.1 0.2 0.0 0.1 0.7 1.4 0.4 0.3 0.1 0.1 0.0 3.7 0.1 0.9 0.1 0.1 0.1 0.2 0.6 0.0 1.3 124.6 0.1 2.8 0.0 0.1 5.0 2.3 0.1 0.1 0.1 0.6 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.1 0.7 19.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.0 0.0 0.0 39.0 0.0 0.0 0.0 0.0 3.8 14.2 0.0 0.0 0.0 0.0 1.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 67.0 0.0 0.0 0.0 65.8 0.0 2.8 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 20.8 0.0 0.0 2.6 0.0 0.0 0.0 0.0 4.0 4.5 34.9 0.0 1053.7 0.0 1.3 0.0 0.0 0.0 0.0 0.2 494.4 0.0 2.2 1.1 0.0 93.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1495.8 0.0 0.0 9.8 VGLL4 KIAA0121 ENSG00000144560 "Vestigial like family member 4" Q14135 3 11556070-11771350 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038225, HPA038614" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" Yes No "Nucleoli fibrillar center" Nucleoplasm "HPA038225: AB_10674549, HPA038614: AB_2676115" "unprognostic (1.21e-2)" "unprognostic (4.68e-3)" "unprognostic (3.29e-1)" "unprognostic (1.49e-1)" "unprognostic (3.75e-1)" "unprognostic (6.13e-2)" "unprognostic (1.24e-2)" "unprognostic (2.73e-1)" "unprognostic (1.66e-1)" "unprognostic (4.35e-3)" "unprognostic (2.01e-2)" "unprognostic (1.86e-1)" "prognostic favorable (1.32e-5)" "unprognostic (1.04e-1)" "unprognostic (8.81e-2)" "unprognostic (9.42e-2)" "unprognostic (1.26e-1)" 22.3 29.3 26.6 20.7 25.1 10.5 28.2 18.0 23.8 32.3 18.6 22.8 17.8 18.9 35.6 23.3 23.6 36.0 28.9 20.7 23.3 13.2 22.5 10.6 20.4 15.2 22.4 14.9 65.4 18.4 27.2 19.6 19.9 19.7 21.8 14.7 28.8 28.7 23.5 13.8 24.2 18.6 24.7 28.2 15.8 18.6 25.4 23.3 30.0 37.5 21.3 19.9 23.4 30.3 5.6 5.3 16.2 5.8 6.3 11.3 5.8 10.3 7.0 20.1 6.1 25.5 13.8 37.7 6.9 14.3 6.1 6.0 5.9 10.3 14.1 16.0 10.9 10.7 7.0 9.2 11.5 4.3 8.5 14.0 15.1 7.0 9.8 19.9 11.8 10.0 17.2 24.0 8.3 10.7 36.0 22.8 15.0 5.4 2.4 9.4 8.9 14.0 13.6 12.4 15.3 12.4 18.1 13.6 18.4 14.0 15.0 8.8 25.4 7.9 8.5 17.7 13.8 8.3 11.7 12.0 16.6 8.1 10.8 17.4 3.8 10.9 30.9 18.3 20.2 32.1 16.2 4.4 1.0 11.3 2.5 7.3 5.6 6.2 9.2 5.3 4.0 8.5 8.9 2.6 6.3 5.8 4.5 3.1 5.8 26.6 25.1 18.0 23.8 23.3 13.2 22.4 14.9 19.7 23.3 29.8 14.4 15.2 51.3 57.4 41.2 2.8 43.3 53.5 31.8 41.8 139.4 60.4 53.0 61.8 12.4 50.4 28.1 23.3 31.6 68.9 55.2 68.7 13.9 13.0 28.2 69.9 33.3 55.9 17.0 12.4 67.9 13.8 42.2 25.2 29.4 89.9 45.9 42.1 85.2 21.3 50.6 32.3 46.2 10.2 27.7 66.6 37.4 18.8 36.0 58.0 VHL VHL1 ENSG00000134086 "Von Hippel-Lindau tumor suppressor" P40337 3 10141008-10152220 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes, Congenital erythrocytosis, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 54.7" "CAB005430, HPA031631, HPA031632" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB005430: AB_2241850, HPA031631: AB_2673968, HPA031632: AB_2673969" "prognostic unfavorable (9.02e-5)" "unprognostic (1.10e-1)" "unprognostic (4.46e-3)" "unprognostic (1.52e-1)" "unprognostic (1.10e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.32e-5)" "unprognostic (3.55e-1)" "unprognostic (3.03e-2)" "unprognostic (4.36e-2)" "unprognostic (5.82e-3)" "unprognostic (1.81e-2)" "unprognostic (2.51e-1)" "prognostic favorable (7.84e-4)" "unprognostic (1.46e-1)" "unprognostic (2.92e-2)" "unprognostic (1.28e-3)" 13.8 17.4 18.1 29.2 18.4 24.3 15.4 25.8 21.4 13.3 19.8 19.3 14.5 15.9 15.1 13.6 16.4 14.3 18.9 10.5 17.1 18.5 13.7 16.3 14.6 27.9 13.5 12.3 15.2 22.5 13.8 14.6 18.8 12.8 15.1 16.6 12.5 21.8 13.7 14.8 14.0 22.3 13.4 17.0 22.6 16.2 17.9 11.2 39.2 16.9 11.5 29.3 15.4 19.1 5.4 3.9 8.0 4.1 4.4 4.3 1.7 6.8 6.6 14.6 8.9 13.6 10.5 54.7 6.1 8.7 7.8 9.2 7.8 8.6 24.3 8.3 8.2 11.0 5.9 13.5 8.5 9.6 11.6 12.2 18.9 10.8 10.7 12.9 16.6 15.2 10.6 9.7 10.3 13.0 10.4 8.9 15.3 16.8 18.5 7.6 12.4 15.8 12.2 9.8 7.4 8.5 20.1 12.9 12.2 9.5 17.8 5.5 18.3 12.8 6.8 7.3 9.2 13.4 21.1 7.7 7.7 10.4 7.2 9.5 13.2 26.9 38.8 8.6 20.0 7.0 2.6 4.1 3.3 3.8 2.5 3.6 4.1 2.9 4.3 3.9 5.4 2.5 2.7 8.0 4.4 3.2 2.4 3.1 1.7 18.1 18.4 25.8 21.4 17.1 18.5 13.5 12.3 12.8 11.2 11.9 12.2 25.5 15.5 13.1 15.6 5.0 20.4 5.3 5.7 15.7 17.7 13.9 6.6 9.9 7.6 12.1 10.5 0.0 4.5 15.8 9.5 19.0 4.7 12.3 12.9 17.5 13.8 17.2 20.2 6.1 13.0 18.5 11.8 15.4 9.3 10.4 8.5 9.3 10.6 7.3 13.9 6.5 6.2 14.4 25.6 17.9 14.4 17.5 10.7 19.5 VILL ENSG00000136059 "Villin like" O15195 3 37988059-38007188 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 46.3;stomach 1: 52.5" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 130.9;Paneth cells: 94.7" "Cancer enhanced" "Detected in many" "pancreatic cancer: 22.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 13.2;OE19: 40.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA035675, HPA035676" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nucleoli fibrillar center" "HPA035675: AB_10671223, HPA035676: " "unprognostic (7.86e-3)" "unprognostic (7.37e-3)" "unprognostic (1.43e-1)" "unprognostic (2.03e-2)" "prognostic unfavorable (1.35e-4)" "prognostic favorable (1.75e-4)" "unprognostic (1.69e-1)" "unprognostic (1.44e-1)" "unprognostic (1.38e-1)" "unprognostic (2.18e-1)" "unprognostic (1.03e-2)" "unprognostic (2.95e-2)" "unprognostic (3.66e-3)" "unprognostic (5.55e-2)" "unprognostic (1.09e-1)" "unprognostic (1.15e-1)" "unprognostic (7.43e-3)" 2.7 2.1 7.1 12.3 7.2 6.3 3.4 4.7 5.3 5.3 28.0 1.7 3.9 33.2 6.2 3.2 3.8 4.1 21.8 3.3 5.3 4.1 2.8 0.6 7.0 7.3 2.9 4.6 3.9 2.2 0.6 3.4 3.6 2.9 8.5 14.8 4.5 3.8 4.8 1.0 5.1 46.3 3.8 3.4 6.3 52.5 3.5 3.5 12.1 4.5 3.1 9.6 15.0 3.8 5.4 4.6 0.1 3.9 4.0 9.2 4.8 4.2 0.0 0.1 0.2 1.5 1.2 0.4 1.2 1.0 1.2 1.2 3.2 13.2 2.0 1.9 0.8 0.0 1.0 0.9 0.1 0.2 0.4 0.0 3.7 0.0 0.3 1.9 3.9 5.1 1.8 1.2 1.2 0.0 0.0 2.4 8.5 3.7 1.2 1.4 0.0 6.2 4.4 0.1 40.5 0.0 2.4 0.0 1.0 0.4 5.1 0.0 0.1 0.0 0.3 0.9 0.0 0.3 6.4 1.4 0.5 0.2 1.6 0.0 0.7 1.5 0.6 0.3 5.6 2.6 0.0 3.9 0.0 8.7 2.4 9.2 4.4 5.8 4.9 2.6 5.4 7.4 5.4 0.1 4.0 1.6 4.6 6.8 4.8 7.1 7.2 4.7 5.3 5.3 4.1 2.9 4.6 2.9 3.5 8.9 9.0 0.5 5.1 2.1 0.8 1.5 10.2 12.0 14.8 0.0 0.0 2.4 0.0 2.1 4.9 3.7 130.9 0.0 15.4 2.8 3.7 5.4 8.1 0.0 2.0 1.6 9.2 3.1 1.0 14.5 3.4 2.7 1.7 1.8 40.6 26.2 22.9 94.7 2.5 1.4 0.4 0.0 3.8 4.5 2.4 1.3 0.8 10.0 38.0 23.8 VIRMA "DKFZP434I116, fSAP121, KIAA1429" ENSG00000164944 "Vir like m6A methyltransferase associated" Q69YN4 8 94487693-94553529 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 23.8;Club cells: 27.3;Cytotrophoblasts: 20.9;Extravillous trophoblasts: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031530 Approved Supported "Nucleoplasm,Nuclear bodies" No No "Nuclear bodies" Nucleoplasm "HPA031530: AB_10600818" "unprognostic (2.51e-2)" "unprognostic (7.41e-3)" "unprognostic (3.43e-1)" "unprognostic (3.83e-3)" "unprognostic (1.83e-1)" "unprognostic (7.83e-2)" "unprognostic (7.54e-3)" "unprognostic (1.98e-3)" "unprognostic (1.27e-1)" "unprognostic (2.77e-2)" "unprognostic (3.50e-3)" "unprognostic (1.74e-1)" "prognostic unfavorable (7.90e-4)" "unprognostic (2.48e-1)" "unprognostic (1.68e-1)" "unprognostic (3.82e-2)" "unprognostic (9.87e-2)" 25.0 16.5 14.6 19.1 16.9 30.9 23.4 20.9 16.9 21.5 16.0 16.6 17.4 10.7 20.4 13.7 16.5 18.9 12.6 13.9 12.9 11.7 15.0 16.3 14.1 17.6 13.8 14.3 23.3 21.7 25.2 23.8 19.0 15.5 15.4 16.0 12.2 15.2 15.6 16.2 14.5 15.4 23.3 17.8 16.7 19.1 21.2 14.7 30.8 18.0 18.5 19.3 22.2 15.2 8.2 6.0 12.3 14.3 10.5 13.3 6.3 21.0 13.5 14.6 8.0 18.0 23.9 9.4 14.7 15.1 16.1 16.5 9.4 17.9 22.9 14.0 19.2 12.6 13.8 19.5 17.9 23.7 20.2 10.7 27.4 11.2 9.2 13.2 13.5 9.8 18.3 7.3 19.3 18.6 16.4 20.2 15.2 27.9 14.4 16.1 12.4 26.1 7.5 9.4 21.6 10.3 15.6 13.3 12.7 10.4 14.7 11.5 15.9 11.6 2.9 12.8 15.0 16.9 10.9 19.9 14.8 8.8 12.6 13.5 11.4 14.2 27.4 14.6 17.9 14.1 12.3 5.6 9.8 8.4 7.4 13.3 8.2 9.3 11.2 6.0 6.7 11.5 9.8 7.1 10.5 14.3 3.8 7.8 6.3 14.6 16.9 20.9 16.9 12.9 11.7 13.8 14.3 15.5 14.7 23.8 15.5 0.0 0.0 0.0 0.0 0.0 0.0 16.0 27.3 7.0 0.0 20.9 6.6 13.2 0.0 0.0 0.0 0.0 10.6 20.0 0.0 0.0 4.7 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 8.2 0.0 0.0 12.4 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 VN1R1 "V1RL1, VNR19I1, ZVNH1, ZVNR1" ENSG00000178201 "Vomeronasal 1 receptor 1" Q9GZP7 19 57454790-57457142 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Pheromone response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 9.2" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 4.8;Cone photoreceptor cells: 2.0;Horizontal cells: 6.4;Rod photoreceptor cells: 3.3" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEK 293: 6.2;U-266/70: 5.6;U-266/84: 6.7" HPA062209 Uncertain Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA062209: " "unprognostic (7.11e-2)" "unprognostic (1.32e-1)" "unprognostic (2.52e-1)" "unprognostic (3.17e-2)" "unprognostic (1.61e-1)" "unprognostic (2.53e-1)" "unprognostic (1.51e-2)" "unprognostic (5.28e-2)" "unprognostic (1.01e-1)" "unprognostic (2.84e-2)" "unprognostic (1.65e-3)" "unprognostic (1.21e-2)" "unprognostic (5.41e-2)" "unprognostic (5.68e-2)" "unprognostic (2.73e-1)" "unprognostic (1.25e-2)" "unprognostic (4.59e-5)" 0.1 1.4 2.0 0.3 2.9 0.3 1.5 9.2 3.5 0.2 0.7 0.0 0.5 5.3 0.9 0.8 0.6 1.9 1.9 2.0 0.8 0.9 0.9 0.7 1.5 1.6 0.4 3.6 3.5 1.1 2.0 0.4 0.8 1.3 3.6 4.0 0.5 0.5 1.5 1.1 0.9 1.4 2.7 0.4 0.5 0.3 2.3 0.3 0.5 0.3 0.6 0.4 0.1 0.5 0.1 1.8 1.9 0.1 0.5 0.9 0.5 0.7 0.4 1.9 0.0 0.2 0.2 0.9 0.2 0.3 0.0 0.4 0.2 0.7 0.0 6.2 0.9 0.0 0.6 0.3 0.4 1.2 0.7 0.7 0.1 0.4 1.0 0.2 0.6 0.3 0.9 0.9 0.3 0.4 2.1 0.5 0.1 0.6 0.4 1.2 0.9 0.6 1.1 3.4 1.4 0.0 0.5 0.1 1.0 0.9 0.6 0.1 1.5 0.2 0.4 0.6 5.6 6.7 0.5 0.5 0.1 1.1 0.5 0.3 0.3 0.4 0.0 0.2 1.3 0.3 0.3 0.2 2.3 0.4 0.3 0.5 0.6 0.2 0.3 0.0 0.1 0.0 0.6 0.5 0.0 0.0 4.8 0.2 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.7 0.0 3.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 VPS13D "FLJ10619, KIAA0453" ENSG00000048707 "Vacuolar protein sorting 13 homolog D" Q5THJ4 1 12230032-12512047 "Predicted intracellular proteins" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Late spermatids: 141.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027332, HPA051621" Uncertain Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA027332: AB_2672223, HPA051621: AB_2681555" "unprognostic (2.97e-1)" "unprognostic (8.47e-2)" "unprognostic (2.89e-2)" "unprognostic (2.84e-2)" "unprognostic (9.74e-2)" "unprognostic (1.75e-2)" "unprognostic (1.66e-1)" "unprognostic (1.53e-3)" "unprognostic (3.33e-1)" "unprognostic (2.00e-2)" "unprognostic (1.57e-1)" "unprognostic (7.77e-2)" "prognostic favorable (7.42e-12)" "unprognostic (5.13e-1)" "unprognostic (1.72e-1)" "unprognostic (4.04e-2)" "unprognostic (8.31e-2)" 11.7 9.8 16.6 8.5 16.4 8.0 16.6 18.5 19.7 19.9 12.5 17.0 11.7 6.9 12.8 15.3 16.1 10.8 10.2 15.8 15.7 13.2 15.4 11.0 12.3 9.9 16.5 13.8 15.9 11.9 28.1 14.1 9.2 13.3 18.6 11.3 14.0 15.1 16.8 30.3 39.2 9.7 17.3 14.8 10.2 12.8 11.6 13.6 8.6 21.7 11.3 14.4 10.8 17.9 4.1 3.9 6.0 1.9 1.7 3.6 0.9 8.2 4.7 5.3 4.1 14.3 11.4 2.5 4.0 7.0 6.9 6.6 3.1 5.8 7.7 5.1 11.4 5.8 7.5 9.2 7.9 9.7 4.2 3.1 6.6 7.3 2.5 6.0 9.5 3.5 9.6 11.2 8.8 8.7 8.6 10.9 7.5 13.5 4.0 6.3 3.8 5.6 3.7 2.1 4.5 6.0 4.9 6.4 2.3 4.9 4.9 2.6 3.6 11.7 8.7 8.3 5.3 7.4 3.2 11.9 4.3 4.5 11.1 3.3 3.5 2.9 12.3 4.9 6.8 6.5 6.0 1.9 1.4 3.3 1.9 3.5 2.5 3.6 2.3 1.5 4.1 3.2 2.5 2.6 1.7 1.4 3.9 1.7 0.9 16.6 16.4 18.5 19.7 15.7 13.2 16.5 13.8 13.3 13.6 17.9 18.9 9.8 42.5 19.3 35.3 67.8 12.7 20.1 25.0 17.4 68.7 6.1 3.3 7.4 81.4 17.1 17.2 23.3 12.3 6.0 9.9 29.1 11.6 18.1 10.0 44.5 13.8 19.0 16.5 141.6 21.3 14.3 11.8 6.4 14.6 23.4 13.5 10.5 20.5 8.4 33.6 45.3 33.0 16.7 11.3 27.5 12.4 12.5 10.4 35.6 VPS33A ENSG00000139719 "VPS33A, CORVET/HOPS core subunit" Q96AX1 12 122229564-122266521 "Disease related genes, Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Disease mutation, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA038701 Approved Nucleoplasm NA NA Nucleoplasm "HPA038701: AB_10673473" "unprognostic (3.98e-2)" "unprognostic (2.90e-2)" "unprognostic (4.07e-2)" "unprognostic (4.61e-3)" "unprognostic (2.00e-1)" "unprognostic (2.14e-1)" "prognostic unfavorable (9.11e-5)" "unprognostic (2.17e-1)" "unprognostic (1.47e-1)" "unprognostic (2.40e-1)" "unprognostic (3.44e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (5.29e-4)" "unprognostic (4.63e-2)" "unprognostic (7.65e-2)" "prognostic favorable (2.41e-4)" "unprognostic (1.09e-2)" 10.4 15.2 13.4 13.6 17.3 12.6 12.7 17.3 19.9 9.6 13.7 14.2 10.5 11.7 11.7 16.8 10.5 12.8 10.4 9.5 13.6 14.4 12.6 12.5 10.8 14.9 13.7 16.8 12.9 11.4 14.7 19.3 17.3 16.8 10.8 11.7 13.0 11.5 14.5 17.1 14.3 11.8 13.6 13.4 16.6 11.2 16.3 9.9 16.1 10.4 9.1 15.8 11.3 11.6 11.6 11.7 21.3 13.7 13.1 17.4 9.6 7.9 10.6 10.9 4.3 8.4 6.5 12.6 7.3 8.0 12.8 8.1 17.3 4.0 8.9 6.2 4.9 9.0 6.8 19.5 7.7 11.1 11.9 10.5 9.1 7.3 15.0 10.8 12.3 9.9 7.2 6.5 9.0 7.3 10.6 8.3 9.8 20.4 4.6 8.3 9.0 5.9 12.7 15.7 6.5 11.4 10.4 10.0 10.5 5.4 8.4 7.9 12.1 15.3 4.6 14.1 11.7 19.7 8.3 5.4 5.8 9.2 10.9 6.7 14.4 31.1 13.9 9.2 8.0 7.9 21.3 11.2 17.9 11.8 12.2 10.6 11.6 13.4 12.5 11.7 9.2 9.6 11.1 9.5 13.1 13.7 7.4 17.4 9.6 13.4 17.3 17.3 19.9 13.6 14.4 13.7 16.8 16.8 9.9 8.9 3.8 8.5 4.0 2.9 15.7 5.9 5.1 13.4 3.4 7.0 9.8 18.5 3.3 12.0 15.9 4.5 7.0 0.0 10.9 17.9 3.5 2.2 13.9 7.7 18.2 3.2 17.2 8.6 8.1 9.7 7.5 11.0 3.3 22.6 6.9 12.1 12.1 7.4 10.6 9.5 15.1 19.4 5.2 34.2 29.0 2.6 18.1 12.9 7.3 1.7 VPS37C FLJ20847 ENSG00000167987 "VPS37C, ESCRT-I subunit" A5D8V6 11 61130256-61161617 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 6.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043348 Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA043348: AB_10794658" "unprognostic (1.97e-1)" "unprognostic (1.35e-1)" "unprognostic (2.50e-1)" "unprognostic (7.95e-3)" "unprognostic (3.38e-1)" "unprognostic (9.01e-2)" "prognostic unfavorable (5.85e-5)" "unprognostic (7.42e-2)" "unprognostic (1.14e-1)" "unprognostic (3.00e-1)" "unprognostic (3.41e-2)" "unprognostic (3.17e-2)" "prognostic favorable (2.37e-7)" "unprognostic (1.99e-1)" "unprognostic (1.08e-1)" "unprognostic (3.85e-1)" "unprognostic (7.05e-2)" 12.8 12.7 15.6 13.8 14.5 9.8 13.9 10.0 17.4 15.4 18.4 16.0 17.3 19.1 16.1 15.0 20.9 14.5 14.3 15.0 15.5 9.2 15.4 12.1 13.9 8.0 12.5 10.2 16.3 22.6 14.7 19.8 19.5 13.4 19.5 12.5 18.2 29.1 18.2 20.6 24.1 26.4 16.7 13.6 13.0 23.7 18.6 15.3 5.9 14.0 14.9 14.4 17.3 14.6 1.1 1.9 6.8 4.5 0.4 0.8 1.0 17.4 7.1 9.0 8.3 4.4 9.4 19.9 8.9 23.8 13.4 9.0 8.3 8.0 4.5 12.5 12.0 10.7 9.7 8.1 9.5 6.9 10.0 6.2 6.0 4.9 9.0 14.1 4.6 7.1 8.1 14.6 11.1 14.1 7.8 8.6 3.2 15.3 7.4 8.8 21.2 0.9 6.7 10.8 7.6 10.1 1.6 4.0 10.9 10.1 9.4 5.5 13.6 9.0 27.3 14.1 7.9 26.1 11.1 6.6 13.0 9.4 12.8 10.8 3.7 5.0 3.8 11.5 5.6 8.4 0.8 2.5 2.8 0.6 4.5 0.8 1.1 0.4 0.7 1.9 1.1 0.5 0.3 6.8 0.4 4.1 0.3 0.3 1.0 15.6 14.5 10.0 17.4 15.5 9.2 12.5 10.2 13.4 15.3 14.9 5.9 3.7 11.5 11.1 4.1 5.6 12.7 9.4 5.7 12.2 9.8 24.3 10.0 13.7 7.3 7.0 14.8 0.0 17.2 18.7 12.1 15.6 0.0 5.5 15.3 23.8 15.6 4.9 10.5 5.8 7.2 10.5 6.8 11.8 16.5 8.8 18.1 10.5 12.7 5.4 36.8 0.0 14.3 13.2 13.4 17.3 29.4 3.3 9.9 12.2 VPS54 "HCC8, PPP1R164" ENSG00000143952 "VPS54, GARP complex subunit" Q9P1Q0 2 63892146-64019072 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055894, HPA067981, HPA070582" Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA055894: AB_2682961, HPA067981: AB_2685938, HPA070582: AB_2686282" "unprognostic (1.35e-1)" "unprognostic (3.37e-2)" "unprognostic (6.47e-2)" "unprognostic (2.46e-1)" "unprognostic (3.37e-1)" "unprognostic (9.47e-3)" "prognostic unfavorable (2.47e-4)" "unprognostic (1.16e-1)" "unprognostic (4.62e-2)" "unprognostic (1.82e-1)" "prognostic favorable (2.03e-4)" "unprognostic (3.20e-1)" "unprognostic (8.38e-2)" "unprognostic (3.02e-2)" "unprognostic (1.36e-1)" "unprognostic (1.57e-1)" "unprognostic (4.91e-2)" 15.5 14.2 10.1 11.1 13.2 12.6 14.3 22.1 12.9 18.6 17.1 11.4 17.3 12.9 16.3 14.4 13.3 14.4 13.7 12.5 11.3 8.5 15.8 15.5 15.2 9.6 14.3 10.6 18.0 21.0 34.2 32.1 13.0 12.1 17.3 13.5 14.3 31.9 19.4 12.2 13.1 16.9 17.5 10.4 13.3 13.7 12.2 12.5 18.3 17.5 11.3 11.3 13.5 26.2 3.1 2.8 4.1 3.2 3.0 4.3 1.0 16.7 9.3 17.0 13.3 12.5 13.2 12.5 10.9 16.4 11.6 11.5 16.9 10.9 11.7 8.2 14.3 17.2 7.8 16.7 9.8 20.6 16.6 11.1 11.1 7.1 28.5 11.7 7.5 4.7 12.2 14.8 8.2 17.8 13.9 17.4 8.4 12.1 9.9 14.6 7.4 7.7 7.4 10.3 17.0 6.7 7.8 16.7 6.6 12.7 9.8 9.8 14.7 9.4 12.1 12.4 14.0 8.7 14.8 12.4 14.9 11.9 9.0 17.7 22.8 6.2 15.0 10.9 15.1 12.6 4.1 3.2 1.3 2.1 3.2 2.6 2.4 2.1 2.5 1.8 3.1 2.8 2.2 3.0 3.0 2.5 2.8 4.3 1.0 10.1 13.2 22.1 12.9 11.3 8.5 14.3 10.6 12.1 12.5 14.9 18.2 4.6 7.4 9.8 17.8 11.7 7.6 8.1 18.2 1.8 11.8 5.3 1.7 6.5 41.8 11.3 9.5 0.0 11.3 5.4 11.3 16.0 2.3 14.3 7.0 22.3 12.7 8.6 8.6 28.3 17.3 8.8 5.0 0.0 17.7 8.9 10.1 11.5 11.7 8.4 16.4 19.4 8.9 13.2 6.0 9.2 4.6 6.4 11.0 12.2 VPS9D1 "ATP-BL, C16orf7" ENSG00000075399 "VPS9 domain containing 1" Q9Y2B5 16 89707134-89720986 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 13 "neutrophil: 16.6" "Lineage enriched" "Detected in single" 27 "granulocytes: 16.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007847, HPA023620" Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA007847: AB_1845582, HPA023620: AB_1845583" "unprognostic (7.08e-2)" "unprognostic (8.63e-2)" "unprognostic (6.26e-3)" "unprognostic (1.63e-3)" "unprognostic (5.67e-2)" "unprognostic (2.29e-3)" "unprognostic (5.03e-2)" "unprognostic (8.72e-2)" "unprognostic (2.39e-1)" "unprognostic (1.03e-1)" "unprognostic (8.23e-3)" "unprognostic (1.37e-1)" "prognostic favorable (2.91e-5)" "unprognostic (4.06e-2)" "unprognostic (3.55e-1)" "unprognostic (2.25e-1)" "unprognostic (3.13e-3)" 8.6 15.4 16.1 19.2 17.9 14.2 5.3 22.7 30.6 6.7 7.1 13.3 8.8 16.6 7.1 7.2 17.0 7.0 9.3 11.0 17.2 16.3 11.7 15.0 8.2 10.4 12.6 24.1 6.4 12.2 16.5 17.6 6.8 17.6 7.9 4.9 10.2 15.3 8.4 12.8 12.6 13.0 6.2 9.3 15.7 10.3 13.5 10.6 1.7 9.3 7.5 7.7 8.5 7.6 0.2 0.2 16.6 0.6 0.1 0.4 0.1 4.6 6.9 7.7 8.3 7.8 7.7 6.5 8.5 8.8 7.3 3.6 6.0 10.2 4.7 5.5 9.2 4.1 10.6 0.6 4.8 2.1 4.2 11.8 3.3 6.0 7.2 6.0 1.9 8.2 8.4 4.4 8.8 2.0 11.9 5.0 4.4 8.4 2.9 4.8 20.7 3.5 7.4 2.9 3.6 8.0 8.8 6.4 2.9 5.8 7.3 6.5 6.9 10.8 4.1 8.6 2.5 18.3 8.2 7.9 9.7 12.1 7.8 5.1 13.4 4.2 4.1 14.0 5.1 8.0 1.2 0.6 0.3 0.2 0.4 0.0 0.2 0.1 0.1 0.2 0.2 0.4 0.2 16.6 0.1 0.2 0.0 0.2 0.1 16.1 17.9 22.7 30.6 17.2 16.3 12.6 24.1 17.6 10.6 6.0 6.1 4.1 1.8 1.8 12.3 7.2 2.5 1.4 5.7 8.7 9.8 2.6 6.6 4.4 10.5 2.2 9.8 0.0 6.7 1.9 4.1 1.4 4.6 9.6 4.3 7.9 10.4 8.6 9.4 16.4 5.8 6.4 3.3 1.0 4.1 6.6 4.9 3.6 5.6 4.9 11.9 0.0 4.3 8.6 4.3 3.3 2.5 3.1 6.3 1.7 VRK1 ENSG00000100749 "Vaccinia related kinase 1" Q99986 14 96797304-96931722 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 39.0" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 93.5;Spermatocytes: 141.1;Spermatogonia: 122.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000660, HPA017929" Enhanced Supported Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA000660: AB_1080579, HPA017929: AB_1858770" "unprognostic (1.03e-1)" "unprognostic (1.17e-2)" "unprognostic (1.84e-2)" "unprognostic (2.24e-3)" "unprognostic (5.42e-2)" "unprognostic (1.19e-2)" "prognostic unfavorable (4.15e-4)" "unprognostic (4.20e-2)" "unprognostic (2.11e-2)" "unprognostic (5.47e-2)" "unprognostic (5.14e-2)" "unprognostic (1.60e-1)" "unprognostic (2.53e-2)" "unprognostic (6.70e-2)" "unprognostic (4.56e-2)" "unprognostic (3.36e-2)" "unprognostic (1.58e-1)" 6.0 4.4 7.1 9.8 17.1 39.0 8.7 8.6 10.2 6.1 7.8 4.4 4.1 5.2 5.9 5.7 9.4 6.9 3.3 6.0 7.4 6.5 6.2 4.3 4.5 18.3 6.9 6.1 5.9 3.7 3.8 5.1 7.1 6.7 5.3 9.1 4.1 4.8 4.1 4.3 6.4 6.9 5.4 6.1 15.7 6.7 33.3 6.9 33.0 4.9 6.1 18.4 5.9 5.7 20.8 13.5 20.1 9.5 28.5 22.3 12.5 15.8 9.1 22.7 10.1 2.7 5.0 14.1 12.0 9.3 19.2 19.2 10.9 15.8 40.4 8.1 7.1 11.8 17.6 21.2 15.7 26.5 23.0 11.3 25.1 6.0 11.1 3.0 48.4 15.8 2.7 2.8 14.5 10.6 3.9 13.3 31.0 21.4 25.6 16.5 18.1 38.4 20.8 14.5 12.1 17.5 36.0 39.7 13.7 8.8 16.4 16.0 9.1 10.6 10.8 8.1 11.9 12.4 19.2 7.1 8.8 7.8 15.1 12.0 13.4 15.8 39.1 13.7 21.2 10.4 20.1 7.6 14.5 15.1 9.3 18.4 20.3 17.6 18.5 9.9 20.8 19.1 19.3 4.5 28.5 9.5 13.5 22.3 12.5 7.1 17.1 8.6 10.2 7.4 6.5 6.9 6.1 6.7 6.9 3.0 2.9 30.5 11.8 14.9 12.3 10.6 15.3 42.8 13.6 14.0 7.9 19.7 10.0 9.8 13.3 11.3 2.4 93.5 16.8 39.6 10.4 5.3 27.7 2.4 16.3 9.5 2.9 6.2 9.7 10.8 5.2 11.5 11.8 12.6 8.0 5.2 7.6 0.0 9.2 8.4 6.6 19.4 11.3 141.1 122.1 12.2 12.6 26.7 11.2 8.4 VRK3 ENSG00000105053 "Vaccinia related kinase 3" Q8IV63 19 49976467-50025946 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 77.2" "Group enriched" "Detected in all" 6 "Early spermatids: 469.4;Late spermatids: 1260.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056489 Approved Supported Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA056489: AB_2683150" "unprognostic (2.09e-1)" "unprognostic (3.14e-2)" "unprognostic (1.26e-1)" "unprognostic (4.94e-3)" "unprognostic (1.23e-1)" "unprognostic (2.22e-3)" "unprognostic (9.78e-2)" "unprognostic (3.47e-1)" "unprognostic (8.79e-2)" "unprognostic (2.48e-1)" "unprognostic (1.31e-2)" "unprognostic (1.43e-1)" "prognostic favorable (1.83e-4)" "unprognostic (9.38e-2)" "unprognostic (2.15e-1)" "unprognostic (1.06e-1)" "prognostic favorable (5.66e-4)" 9.7 11.9 9.2 9.4 12.7 10.7 8.3 12.0 14.1 8.9 13.4 11.9 9.3 13.4 15.7 10.8 8.4 18.0 12.2 7.4 9.3 11.1 16.7 16.2 8.5 13.4 10.4 9.9 11.2 11.5 7.1 11.8 10.7 9.8 9.4 11.7 14.2 14.3 8.5 11.8 7.7 17.3 7.5 11.0 12.8 10.9 77.2 9.1 24.7 14.1 6.0 12.9 9.9 8.0 24.5 19.7 47.3 20.9 33.5 30.1 18.1 16.0 16.7 12.3 13.2 16.3 15.1 12.8 11.6 13.9 17.3 19.1 8.9 18.0 19.4 8.3 11.2 12.1 12.0 11.4 9.9 14.0 16.9 23.4 15.1 10.1 15.4 12.3 18.8 26.6 13.5 14.9 10.0 10.6 15.5 14.2 21.3 18.3 29.0 12.4 6.8 25.4 12.7 6.6 28.6 14.4 20.5 12.9 24.8 14.7 17.0 13.8 6.7 11.4 14.0 12.6 11.4 12.9 20.1 10.7 17.7 10.3 7.1 9.0 18.8 23.9 10.2 14.2 11.7 12.1 37.0 17.8 32.4 23.8 18.8 19.1 24.5 21.7 22.7 19.7 21.9 22.1 20.4 47.3 33.5 20.9 18.8 30.1 18.1 9.2 12.7 12.0 14.1 9.3 11.1 10.4 9.9 9.8 9.1 6.0 29.4 27.3 13.1 6.0 34.9 7.1 20.4 56.2 26.1 14.0 135.5 38.6 26.6 25.3 469.4 15.8 62.6 23.3 28.7 31.8 13.8 24.2 17.4 37.6 29.7 30.2 21.4 25.2 25.0 1260.7 20.4 23.9 13.5 47.7 27.2 28.4 29.0 71.9 24.4 60.6 112.4 12.9 10.5 91.2 49.8 9.5 47.9 33.7 27.6 26.7 VRTN "C14orf115, FLJ10811, vertnin" ENSG00000133980 "Vertebrae development associated" Q9H8Y1 14 74303069-74360008 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 4.9;lymphoid tissue: 4.5;testis: 5.8" "Cell type enhanced" "Detected in single" 25 "Spermatocytes: 1.9" "Cancer enriched" "Detected in single" 40 "testis cancer: 15.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "NTERA-2: 33.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA001460 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA001460: AB_1078318" "unprognostic (1.20e-1)" "unprognostic (4.31e-2)" "unprognostic (1.37e-1)" "unprognostic (5.98e-2)" "unprognostic (1.35e-1)" "unprognostic (3.78e-2)" "unprognostic (1.66e-1)" "unprognostic (1.77e-1)" 0.1 0.1 0.1 2.2 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.6 0.0 4.9 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 4.5 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.6 0.0 0.1 0.2 0.2 5.8 0.0 0.0 0.1 0.0 1.9 0.1 0.1 0.8 1.2 1.4 0.5 0.8 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.5 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.4 0.5 0.3 0.3 0.2 0.3 0.2 0.5 0.2 0.8 0.3 0.4 1.4 0.8 0.5 1.2 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.9 0.0 0.0 0.0 0.0 0.0 VSIG10L ENSG00000186806 "V-set and immunoglobulin domain containing 10 like" Q86VR7 19 51331536-51342124 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 70.9;lymphoid tissue: 52.2;salivary gland: 72.9;tongue: 37.6" "Cell type enhanced" "Detected in many" 8 "Horizontal cells: 9.5;Melanocytes: 5.0;Sertoli cells: 6.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Hep G2: 5.9;OE19: 13.7;T-47d: 10.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA060453, HPA066745" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA060453: AB_2684280, HPA066745: AB_2685712" "unprognostic (1.70e-2)" "unprognostic (1.95e-2)" "unprognostic (1.30e-2)" "unprognostic (2.98e-3)" "unprognostic (1.08e-2)" "unprognostic (3.96e-2)" "prognostic unfavorable (8.75e-4)" "unprognostic (2.40e-3)" "unprognostic (2.78e-1)" "unprognostic (9.87e-2)" "unprognostic (2.62e-2)" "unprognostic (1.87e-1)" "unprognostic (2.90e-4)" "unprognostic (1.42e-2)" "unprognostic (8.51e-2)" "unprognostic (7.74e-2)" "unprognostic (5.19e-3)" 0.1 0.0 0.0 0.0 0.0 0.1 0.8 0.3 0.1 9.8 0.1 0.0 2.0 0.1 0.6 0.0 70.9 0.0 0.9 0.1 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 1.2 0.1 0.0 72.9 2.6 0.2 4.9 0.2 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 37.6 52.2 0.1 10.8 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.1 1.2 0.1 0.5 0.5 0.1 0.2 0.1 0.1 0.0 0.1 0.4 0.9 0.7 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.6 0.7 0.1 0.2 5.9 0.0 0.0 1.0 0.0 0.7 0.2 0.0 0.0 0.0 0.3 0.5 1.7 0.0 0.5 0.0 0.1 0.8 13.7 0.6 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.2 10.8 0.0 0.1 0.0 0.2 0.9 0.0 1.4 0.9 0.1 0.7 0.2 0.3 0.0 0.6 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.8 1.1 0.6 1.7 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.1 0.4 0.7 0.0 0.0 0.7 1.4 0.9 1.1 1.0 4.0 9.5 1.2 1.3 3.2 0.0 2.0 1.8 5.0 1.8 0.6 1.2 0.4 0.2 3.9 0.8 0.4 6.5 1.0 0.5 2.2 0.4 0.5 0.0 0.4 0.3 VSIG2 "CTH, CTXL" ENSG00000019102 "V-set and immunoglobulin domain containing 2" Q96IQ7 11 124747472-124752238 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 38.2;stomach 1: 105.5" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 296.5;Mucus-secreting cells: 283.0;Paneth cells: 482.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "OE19: 98.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA035919, HPA050147" Enhanced Approved Nucleoplasm NA NA 81000 Nucleoplasm "HPA035919: AB_10669981, HPA050147: AB_2681032" "unprognostic (1.64e-3)" "unprognostic (1.21e-1)" "unprognostic (1.10e-2)" "unprognostic (1.90e-1)" "unprognostic (2.00e-1)" "unprognostic (2.18e-3)" "unprognostic (2.16e-1)" "unprognostic (2.22e-2)" "unprognostic (3.47e-3)" "unprognostic (2.02e-1)" "unprognostic (6.01e-2)" "unprognostic (2.78e-2)" "unprognostic (2.99e-2)" "unprognostic (2.61e-1)" "unprognostic (1.95e-1)" "unprognostic (1.87e-1)" "unprognostic (1.36e-2)" 1.3 0.1 0.3 11.2 0.4 0.2 3.3 0.3 0.5 5.2 23.5 0.7 0.3 0.7 1.0 0.8 8.6 2.9 38.2 0.6 0.3 0.2 1.6 0.7 25.3 0.3 0.3 0.3 2.2 0.4 0.0 0.3 0.7 0.5 18.5 24.3 0.4 12.4 0.8 0.3 0.3 2.0 3.5 0.3 0.3 105.5 1.2 0.3 0.3 28.9 3.1 5.3 26.0 14.7 0.3 1.4 0.6 3.8 0.8 2.1 2.7 0.0 0.0 1.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 1.7 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 98.4 0.8 0.0 0.8 0.0 0.0 16.0 0.0 0.2 0.0 1.0 0.0 0.1 0.1 0.5 0.9 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.2 0.0 3.8 0.0 0.0 0.6 1.6 0.0 1.8 0.3 1.4 0.3 2.0 1.6 0.6 0.8 0.5 0.0 2.1 2.7 0.3 0.4 0.3 0.5 0.3 0.2 0.3 0.3 0.5 0.3 116.1 39.3 0.0 14.5 0.7 0.6 0.4 76.5 17.4 43.3 3.5 0.0 0.0 1.7 4.7 0.0 4.5 296.5 0.0 82.7 0.0 0.5 69.3 1.1 0.0 0.1 0.0 64.2 4.3 0.3 0.0 1.4 2.3 3.3 0.0 283.0 0.0 152.0 482.9 0.0 0.0 0.0 0.0 4.4 0.3 0.4 0.4 0.0 0.0 145.8 135.8 VSIR "B7-H5, B7H5, C10orf54, GI24, PD-1H, SISP1, VISTA" ENSG00000107738 "V-set immunoregulatory receptor" Q9H7M9 10 71747559-71773498 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 111.3" "Cell type enhanced" "Detected in many" 19 "Cytotrophoblasts: 279.2;Extravillous trophoblasts: 255.7;monocytes: 118.2;Syncytiotrophoblasts: 566.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 111.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 26.5;HaCaT: 20.2;HMC-1: 33.8;U-937: 29.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007968 Approved Nucleoplasm NA NA 360000 Nucleoplasm "HPA007968: AB_1845518" "unprognostic (1.19e-1)" "unprognostic (1.76e-3)" "unprognostic (1.64e-1)" "unprognostic (6.67e-2)" "unprognostic (9.29e-2)" "unprognostic (2.05e-2)" "unprognostic (1.88e-1)" "unprognostic (1.17e-1)" "unprognostic (1.68e-1)" "unprognostic (1.02e-2)" "unprognostic (6.82e-2)" "unprognostic (8.70e-2)" "unprognostic (2.57e-3)" "unprognostic (2.72e-1)" "prognostic unfavorable (6.93e-4)" "unprognostic (2.37e-3)" "unprognostic (3.29e-1)" 20.8 5.7 13.3 23.4 14.8 55.3 30.4 3.4 10.2 10.7 12.9 10.5 5.4 16.6 14.7 8.8 13.7 15.0 10.8 13.6 13.0 9.8 5.8 4.1 20.1 60.0 12.4 7.2 17.5 4.4 2.4 3.8 48.2 11.8 11.0 7.1 8.1 8.6 8.7 4.7 9.1 16.3 12.7 11.1 55.1 10.2 6.4 11.8 4.6 7.7 10.1 17.6 14.1 24.8 1.9 24.4 111.3 44.9 5.8 11.7 40.1 3.3 6.5 0.0 0.1 3.5 2.9 3.1 1.2 7.9 1.5 2.6 2.6 26.5 0.2 1.7 11.2 0.0 20.2 0.0 0.7 0.4 0.1 0.0 4.4 1.4 0.2 4.9 0.7 33.8 2.4 0.8 0.2 0.1 2.3 0.5 0.6 0.1 2.5 0.9 0.1 0.7 5.5 0.0 5.0 1.3 0.0 0.3 1.5 0.0 1.5 0.0 0.1 1.7 1.3 1.2 0.4 0.1 9.5 1.7 0.0 0.0 5.4 0.0 1.8 0.9 0.0 0.1 29.5 0.1 22.0 42.3 81.0 8.9 40.5 11.7 1.8 8.9 8.4 24.4 1.9 8.3 8.3 111.3 5.8 44.9 6.4 8.8 40.1 13.3 14.8 3.4 10.2 13.0 9.8 12.4 7.2 11.8 11.8 26.8 11.6 0.0 0.0 0.0 0.0 0.0 0.0 6.7 11.4 10.4 0.0 279.2 0.0 37.3 0.0 0.0 0.0 0.0 9.6 255.7 0.0 0.0 29.1 0.0 66.9 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 118.2 0.0 0.0 36.4 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 566.7 0.0 0.0 0.0 VSTM4 "C10orf72, FLJ31737" ENSG00000165633 "V-set and transmembrane domain containing 4" Q8IW00 10 49014245-49115509 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 81.0;Late spermatids: 104.4;Sertoli cells: 58.2" "Cancer enriched" "Detected in all" 5 "thyroid cancer: 22.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "K-562: 6.9;RH-30: 8.0;SH-SY5Y: 6.8;U-138 MG: 9.1;U-2197: 20.4;U-87 MG: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017279 Uncertain Approved Nucleoplasm,Vesicles "Secreted - unknown location" NA NA "Nucleoplasm, Vesicles" "HPA017279: AB_10959519" "unprognostic (8.46e-2)" "unprognostic (5.41e-1)" "unprognostic (1.89e-1)" "unprognostic (2.07e-1)" "unprognostic (1.80e-1)" "unprognostic (2.84e-2)" "unprognostic (1.20e-1)" "unprognostic (6.70e-2)" "unprognostic (1.93e-2)" "unprognostic (2.81e-2)" "unprognostic (3.03e-1)" "unprognostic (1.95e-2)" "unprognostic (2.56e-3)" "unprognostic (1.06e-2)" "unprognostic (1.62e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (4.25e-4)" 13.0 31.6 7.2 3.4 6.7 0.4 10.5 3.3 7.1 18.2 6.2 9.3 3.1 2.0 13.2 5.9 6.1 6.5 11.7 10.3 7.2 4.4 9.3 3.0 8.9 7.0 8.9 5.4 27.2 1.3 22.8 4.6 7.7 10.1 11.2 4.4 15.1 2.8 9.2 3.8 4.2 4.1 12.5 7.9 2.8 5.4 7.8 6.0 2.9 20.8 6.9 3.4 9.4 8.6 1.8 0.9 2.7 0.9 1.7 0.7 0.2 0.0 0.1 2.7 0.1 1.1 0.6 0.1 2.1 3.5 0.8 0.2 0.1 0.1 0.1 0.1 5.0 2.9 0.1 0.1 0.0 0.4 2.6 1.2 0.1 0.0 0.1 0.1 0.1 0.0 4.1 0.0 3.6 0.0 0.0 0.0 0.7 6.9 0.1 0.6 0.1 0.0 0.1 0.5 0.0 0.0 0.0 8.0 4.1 0.0 0.1 0.1 6.8 0.1 0.1 0.0 0.3 0.1 0.2 0.0 9.1 1.1 20.4 0.1 0.0 5.5 0.0 10.0 0.1 0.1 1.9 0.9 0.4 0.6 0.3 0.5 0.8 0.4 0.3 0.2 1.8 0.7 0.6 2.7 1.7 0.5 0.9 0.3 0.2 7.2 6.7 3.3 7.1 7.2 4.4 8.9 5.4 10.1 6.0 3.0 17.4 0.0 1.7 5.8 5.0 12.1 0.0 6.7 17.0 0.0 2.0 0.4 1.7 0.1 81.0 6.4 0.0 0.0 0.0 0.3 22.4 0.7 11.6 3.2 0.5 4.8 0.0 3.7 1.9 104.4 8.9 4.0 6.8 1.0 0.0 10.9 0.2 0.0 13.8 6.1 2.7 58.2 30.0 1.4 3.4 3.8 0.3 1.3 0.0 0.6 VTA1 "C6orf55, HSPC228, My012" ENSG00000009844 "Vesicle trafficking 1" Q9NP79 6 142147162-142224689 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030968, HPA030969" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA 22000 "Nucleoplasm, Vesicles, Cytosol" "HPA030968: AB_10602585, HPA030969: AB_2673679" "prognostic unfavorable (7.02e-4)" "unprognostic (1.84e-2)" "unprognostic (2.12e-3)" "unprognostic (1.17e-2)" "unprognostic (1.08e-2)" "unprognostic (2.56e-2)" "prognostic unfavorable (6.58e-6)" "unprognostic (2.83e-2)" "unprognostic (3.61e-1)" "unprognostic (5.18e-2)" "unprognostic (2.84e-2)" "unprognostic (1.16e-1)" "unprognostic (3.85e-2)" "unprognostic (1.66e-1)" "unprognostic (1.64e-1)" "unprognostic (1.96e-1)" "unprognostic (3.24e-1)" 18.8 19.5 20.5 15.5 28.2 17.2 20.6 25.0 39.3 17.2 22.0 18.5 9.6 24.2 16.0 17.1 31.4 17.9 14.9 21.2 19.8 20.3 24.9 29.9 13.5 19.3 20.1 20.7 15.3 15.6 16.3 21.7 30.5 30.7 16.8 26.3 11.2 19.4 13.5 48.6 20.9 32.7 17.0 24.0 20.8 14.6 12.9 18.2 33.6 18.0 24.3 24.0 18.4 19.7 29.0 30.9 58.6 38.1 30.9 30.1 36.1 18.4 15.9 26.0 39.8 23.0 25.3 18.0 42.0 25.1 38.5 36.8 26.9 14.5 30.2 28.4 37.6 29.3 23.7 27.6 28.6 53.4 20.4 24.3 32.7 17.1 32.1 17.0 50.7 19.0 20.9 33.6 38.4 24.9 20.7 24.6 23.6 30.3 15.2 32.1 27.0 32.9 26.4 19.5 23.9 18.3 30.3 20.9 18.4 29.6 20.6 27.3 21.2 23.6 18.2 21.1 22.7 19.7 34.6 17.8 17.4 24.2 29.0 30.1 15.0 25.9 34.4 11.4 28.4 26.4 58.6 31.0 49.5 23.5 38.1 30.1 29.0 26.8 27.4 30.9 26.6 29.8 29.9 19.1 30.9 37.4 19.0 25.7 36.1 20.5 28.2 25.0 39.3 19.8 20.3 20.1 20.7 30.7 18.2 20.8 16.9 15.6 15.3 22.3 9.1 37.0 10.2 40.2 25.0 15.7 0.0 28.5 14.9 26.8 2.2 15.7 29.3 0.0 24.4 30.4 20.0 13.7 11.6 22.7 24.3 11.1 20.7 8.0 20.8 2.1 10.9 15.6 8.5 18.0 24.5 21.3 24.7 17.5 11.7 24.5 10.8 6.5 8.2 20.6 25.7 27.0 26.5 16.2 23.7 15.3 VWA3B "DKFZp686F2227, MGC26733" ENSG00000168658 "Von Willebrand factor A domain containing 3B" Q502W6 2 98087116-98313299 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "fallopian tube: 24.4;testis: 51.9" "Cell type enhanced" "Detected in some" 26 "Ciliated cells: 178.0;Early spermatids: 410.6;Late spermatids: 741.4" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.0" "Group enriched" "Detected in many" 5 "amygdala: 1.0;basal ganglia: 1.7;hippocampal formation: 1.7;hypothalamus: 1.6;pons and medulla: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.0;U-138 MG: 1.7" "Low region specificity" "Detected in many" "HPA036700, HPA036701" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA036700: AB_2675261, HPA036701: AB_10673505" "unprognostic (2.36e-2)" "unprognostic (4.27e-2)" "unprognostic (1.23e-1)" "unprognostic (1.01e-3)" "unprognostic (5.16e-2)" "unprognostic (3.27e-1)" "unprognostic (1.33e-1)" "unprognostic (1.11e-1)" "unprognostic (1.74e-1)" "unprognostic (1.44e-2)" "unprognostic (4.53e-2)" "unprognostic (6.41e-2)" "unprognostic (2.63e-7)" "unprognostic (2.57e-1)" "unprognostic (5.04e-2)" "unprognostic (2.27e-1)" "unprognostic (4.96e-2)" 0.0 0.0 1.0 0.2 1.7 0.0 0.0 0.0 0.2 1.1 0.2 2.0 0.0 0.0 0.5 4.3 0.0 24.4 0.5 0.4 1.7 1.6 0.0 0.0 4.0 0.0 0.1 0.1 2.3 0.0 0.0 1.1 0.1 3.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 51.9 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.7 0.0 0.1 1.7 1.6 0.1 0.1 3.2 0.3 0.0 0.6 0.0 1.1 0.2 0.6 0.8 0.0 178.0 19.4 1.8 29.5 0.0 0.0 0.0 410.6 0.0 0.2 0.0 0.4 0.1 0.4 0.3 0.0 0.0 0.2 0.0 1.7 1.8 0.0 741.4 4.4 0.9 0.0 1.0 1.3 0.3 0.1 1.5 5.3 0.0 0.5 0.0 0.3 16.1 5.4 0.4 0.0 0.0 0.8 0.5 VWA5A "BCSC-1, LOH11CR2A" ENSG00000110002 "Von Willebrand factor A domain containing 5A" O00534 11 124115362-124147721 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 15 "granulocytes: 538.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 25.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 28.2;HEL: 20.3;HHSteC: 15.8;HUVEC TERT2: 18.7;RPTEC TERT1: 20.6" "Low region specificity" "Detected in all" "HPA037813, HPA037814, HPA061500" Uncertain Enhanced Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA037813: AB_10672727, HPA037814: AB_10672287, HPA061500: AB_2684542" "unprognostic (2.69e-1)" "unprognostic (1.75e-1)" "unprognostic (5.58e-2)" "unprognostic (6.48e-2)" "unprognostic (8.49e-3)" "unprognostic (2.48e-1)" "unprognostic (8.18e-2)" "unprognostic (4.88e-2)" "unprognostic (1.18e-1)" "unprognostic (5.15e-2)" "unprognostic (4.53e-2)" "unprognostic (2.38e-2)" "prognostic favorable (1.55e-5)" "unprognostic (4.54e-2)" "unprognostic (7.21e-2)" "unprognostic (2.16e-1)" "unprognostic (4.65e-1)" 14.8 20.2 13.8 7.5 13.4 1.6 16.0 2.3 9.3 15.5 23.9 7.5 10.0 16.7 16.6 17.0 12.6 9.9 19.9 6.5 14.1 24.6 16.0 4.3 19.4 6.8 12.5 6.6 9.6 15.3 5.5 34.2 25.9 15.2 22.5 28.4 10.3 31.2 13.2 3.0 17.9 24.0 13.6 15.0 6.0 17.8 6.3 7.6 3.9 13.7 7.1 9.8 14.9 11.8 4.5 4.8 25.6 5.3 4.3 7.5 3.6 0.0 0.2 3.6 0.2 3.9 3.6 1.3 0.5 0.2 0.3 0.1 0.2 28.2 0.0 3.5 0.6 4.9 0.1 0.7 6.4 0.0 9.6 0.0 20.3 5.1 0.6 15.8 0.2 9.5 10.7 0.7 0.6 2.1 1.4 18.7 2.7 1.1 3.5 1.1 0.1 0.4 0.3 5.7 0.0 0.7 0.0 12.6 0.1 20.6 0.2 3.2 0.3 0.5 0.2 1.0 8.7 2.5 0.9 0.5 0.1 2.7 0.1 0.0 1.3 1.1 0.0 11.7 0.4 0.2 25.6 4.8 0.5 2.9 3.3 0.7 4.5 3.2 1.7 4.8 2.3 4.1 2.6 0.3 4.3 5.3 2.6 7.5 3.6 13.8 13.4 2.3 9.3 14.1 24.6 12.5 6.6 15.2 7.6 8.9 36.5 0.8 11.6 15.2 2.9 2.4 7.6 25.4 14.8 31.4 2.0 7.8 8.3 19.7 32.8 3.6 25.8 0.0 25.0 2.1 7.8 8.4 538.2 2.4 29.2 30.2 14.5 1.8 5.6 3.6 2.6 6.0 5.0 2.8 22.5 12.0 20.8 17.3 0.4 11.5 1.1 0.0 3.8 0.2 2.3 10.9 1.6 4.9 22.5 14.0 VWA5B2 "DKFZp761K032, LOC90113" ENSG00000145198 "Von Willebrand factor A domain containing 5B2" Q8N398 3 184230429-184242329 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 35.9;brain: 10.1;pancreas: 11.0" "Cell type enriched" "Detected in some" 34 "Intestinal endocrine cells: 107.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SCLC-21H: 27.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036823, HPA036824, HPA061412" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA036823: AB_10672269, HPA036824: AB_2675334, HPA061412: AB_2684507" "unprognostic (3.92e-4)" "unprognostic (1.70e-1)" "unprognostic (1.69e-2)" "unprognostic (2.56e-3)" "unprognostic (3.37e-1)" "unprognostic (1.60e-1)" "unprognostic (1.70e-2)" "unprognostic (1.21e-1)" "unprognostic (3.80e-1)" "unprognostic (1.21e-1)" "unprognostic (4.32e-3)" "unprognostic (3.73e-2)" "unprognostic (1.12e-4)" "unprognostic (3.13e-1)" "unprognostic (3.65e-2)" "unprognostic (2.36e-1)" "unprognostic (1.83e-1)" 0.4 35.9 9.2 0.4 4.8 0.2 0.4 9.8 10.1 0.5 2.5 0.4 0.4 1.7 0.4 0.4 0.4 1.2 0.4 0.4 9.5 3.3 0.4 0.4 2.4 0.4 1.9 0.4 3.7 11.0 1.6 3.4 0.4 0.4 0.9 0.4 0.4 0.5 2.4 0.4 0.1 2.4 0.4 0.4 0.4 2.8 1.1 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 1.5 0.3 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.3 0.0 0.0 27.1 1.9 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 2.7 0.1 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 4.8 9.8 10.1 9.5 3.3 1.9 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 3.2 107.9 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.2 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 VWCE "FLJ32009, URG11, VWC1" ENSG00000167992 "Von Willebrand factor C and EGF domains" Q96DN2 11 61258286-61295424 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 19.8;ovary: 10.7" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 27.5;Hepatocytes: 14.0;Rod photoreceptor cells: 17.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 5.7;Hep G2: 19.3;HSkMC: 11.4;REH: 10.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA040401, HPA043921" Uncertain Supported Nucleoplasm,Vesicles,Cytosol "Secreted - unknown location" NA NA 1300000 Nucleoplasm "Vesicles, Cytosol" "HPA040401: AB_2676963, HPA043921: AB_2678731" "unprognostic (3.09e-2)" "unprognostic (1.10e-1)" "unprognostic (3.58e-2)" "unprognostic (1.15e-1)" "unprognostic (3.96e-3)" "unprognostic (9.27e-4)" "unprognostic (1.21e-2)" "unprognostic (4.01e-4)" "unprognostic (3.04e-2)" "unprognostic (3.42e-2)" "unprognostic (6.58e-4)" "unprognostic (7.20e-2)" "unprognostic (3.01e-1)" "unprognostic (1.25e-2)" "unprognostic (1.92e-1)" "unprognostic (2.34e-1)" "unprognostic (2.30e-1)" 2.9 1.1 0.9 0.6 1.3 2.3 3.1 0.7 1.3 2.8 1.0 1.4 3.4 0.5 1.4 2.9 1.5 5.7 1.4 1.0 1.3 1.2 0.6 19.8 0.8 0.3 0.4 1.1 10.7 0.1 0.5 0.5 9.1 0.3 1.8 0.6 1.3 1.7 1.0 1.9 0.9 1.1 1.2 0.2 0.9 0.3 1.8 0.5 6.5 0.8 1.0 1.0 1.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.2 1.1 0.4 0.2 1.8 0.0 0.3 5.7 0.0 0.3 0.0 0.4 0.1 0.0 2.0 0.0 0.1 0.4 0.0 0.5 0.0 19.3 1.1 0.0 0.1 11.4 0.5 0.5 0.0 0.1 1.8 2.6 0.2 0.3 0.3 0.1 4.2 0.0 1.6 0.0 0.0 10.9 0.1 0.0 0.1 0.1 0.4 0.9 0.0 0.1 0.6 2.0 0.7 0.0 0.5 0.2 0.3 0.5 0.1 0.2 0.4 0.9 0.8 0.2 0.2 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.3 0.7 1.3 1.3 1.2 0.4 1.1 0.3 0.5 3.0 1.7 0.0 1.5 1.5 3.2 0.7 0.0 5.3 2.3 0.0 27.5 0.9 0.0 0.1 0.4 2.2 0.0 0.0 0.4 2.2 1.4 0.4 3.5 14.0 1.1 0.0 1.7 3.1 4.0 0.0 6.4 2.2 1.7 1.8 0.0 3.2 0.0 0.0 1.8 0.3 17.1 0.0 0.5 0.9 3.0 1.9 3.7 0.5 0.1 0.7 VWDE FLJ14712 ENSG00000146530 "Von Willebrand factor D and EGF domains" Q8N2E2 7 12330885-12403941 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "pituitary gland: 29.5" "Cell type enhanced" "Detected in some" 14 "Basal glandular cells: 1.7;Cardiomyocytes: 4.7;Ciliated cells: 1.4;Glandular cells: 2.2;Urothelial cells: 1.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "K-562: 10.8;NTERA-2: 5.4;SCLC-21H: 8.7" "Low region specificity" "Detected in many" "HPA026619, HPA036044" Uncertain Approved Nucleoplasm,Cytosol "Secreted - unknown location" NA NA Cytosol Nucleoplasm "HPA026619: AB_2671920, HPA036044: AB_2674916" "unprognostic (6.39e-2)" "unprognostic (1.65e-3)" "unprognostic (5.36e-3)" "unprognostic (1.78e-4)" "unprognostic (1.39e-2)" "unprognostic (4.19e-3)" "unprognostic (2.38e-1)" "unprognostic (1.85e-1)" "unprognostic (1.78e-1)" "unprognostic (6.25e-2)" "unprognostic (1.68e-1)" "unprognostic (6.72e-2)" "unprognostic (1.84e-1)" "unprognostic (2.11e-3)" "unprognostic (1.58e-1)" "unprognostic (1.10e-1)" "unprognostic (2.73e-1)" 0.4 0.5 1.6 0.3 2.7 2.3 2.3 0.4 2.3 0.8 0.9 0.0 0.9 0.2 0.7 4.9 0.8 1.5 0.7 4.1 0.8 0.5 0.7 0.5 0.7 0.2 0.4 0.5 0.5 0.9 0.0 29.5 0.3 0.5 1.5 0.3 0.1 5.7 5.5 0.4 0.6 0.6 0.2 0.4 0.5 2.0 0.6 0.0 0.1 6.2 0.0 1.3 1.0 0.9 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.6 0.0 0.5 0.0 0.3 1.8 0.0 2.1 0.7 0.8 0.4 3.0 0.2 0.0 0.0 0.7 0.4 2.1 2.0 0.6 4.0 2.2 3.5 4.8 0.0 0.0 1.1 2.4 0.1 0.3 0.0 1.2 2.7 0.8 1.2 10.8 0.0 0.0 1.2 0.0 0.0 5.4 0.0 0.6 0.0 0.0 1.6 0.0 1.3 8.7 1.4 0.0 1.7 0.0 1.4 0.0 1.1 0.1 0.0 1.0 0.0 0.9 3.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.9 0.1 1.6 2.7 0.4 2.3 0.8 0.5 0.4 0.5 0.5 0.0 0.0 1.0 0.0 1.7 0.2 0.0 4.7 0.0 1.4 1.2 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.4 0.2 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.1 0.0 0.4 1.6 WAC "BM-016, FLJ31290, MGC10753, PRO1741, Wwp4" ENSG00000095787 "WW domain containing adaptor with coiled-coil" Q9BTA9 10 28532493-28623112 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036528, HPA042609, HPA074604" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA036528: AB_10670839, HPA042609: AB_2678076, HPA074604: " "unprognostic (1.04e-2)" "unprognostic (2.21e-1)" "unprognostic (1.78e-1)" "unprognostic (1.80e-1)" "unprognostic (4.53e-2)" "unprognostic (2.19e-2)" "prognostic unfavorable (9.27e-6)" "unprognostic (1.40e-1)" "unprognostic (1.44e-1)" "unprognostic (3.60e-1)" "unprognostic (2.07e-1)" "unprognostic (2.90e-1)" "unprognostic (1.82e-2)" "unprognostic (1.23e-1)" "unprognostic (3.13e-2)" "unprognostic (6.63e-2)" "unprognostic (1.36e-1)" 30.6 25.2 36.5 29.8 40.9 59.3 30.4 83.3 46.0 30.4 36.5 27.8 26.9 24.9 33.3 30.6 29.0 28.3 25.9 40.8 37.4 31.6 32.2 28.7 29.4 32.9 36.4 35.5 39.6 33.8 41.8 44.2 34.8 35.4 32.3 28.8 21.2 27.0 31.7 31.8 28.9 27.5 36.4 38.1 33.5 27.3 28.1 41.0 30.1 36.5 18.3 36.6 40.3 78.9 15.0 14.9 19.9 20.6 23.0 17.6 9.7 31.3 20.1 41.3 25.2 34.1 32.9 29.1 30.5 24.2 35.8 41.1 28.5 35.1 41.8 22.1 28.1 28.2 30.6 33.5 23.0 39.6 42.9 27.7 44.3 22.5 22.3 39.8 21.5 34.8 28.3 44.3 39.2 34.7 35.4 31.5 33.7 39.0 39.0 29.8 24.2 47.7 18.9 23.9 24.4 10.4 34.6 57.0 28.0 25.6 18.3 41.5 31.2 25.3 33.6 45.9 34.6 25.5 34.5 26.1 22.8 28.3 24.6 26.9 21.1 18.7 45.4 24.1 41.0 20.0 14.6 12.1 12.4 14.6 20.6 17.6 15.0 13.2 16.8 14.9 13.6 15.0 13.6 19.9 23.0 15.9 11.3 14.2 9.7 36.5 40.9 83.3 46.0 37.4 31.6 36.4 35.5 35.4 41.0 86.4 62.7 75.1 84.6 156.4 108.3 98.2 58.6 34.8 55.7 38.4 90.3 50.1 26.6 39.8 80.4 72.4 67.2 0.0 40.9 51.4 74.3 94.2 54.3 51.3 46.5 101.7 66.7 68.2 99.9 76.5 76.8 83.5 72.6 38.7 70.0 65.8 47.1 63.3 77.8 50.0 84.7 58.2 80.8 79.1 54.1 160.8 82.8 82.8 62.6 118.0 WAPL "FOE, KIAA0261, WAPAL" ENSG00000062650 "WAPL cohesin release factor" Q7Z5K2 10 86435256-86521815 "Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037874, HPA037875, HPA066141" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytokinetic bridge,Mitotic spindle,Centrosome,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytokinetic bridge, Mitotic spindle, Centrosome, Cytosol" "HPA037874: AB_10697086, HPA037875: AB_10672396, HPA066141: " "unprognostic (1.52e-1)" "unprognostic (1.09e-1)" "unprognostic (3.03e-2)" "unprognostic (2.91e-2)" "unprognostic (6.63e-2)" "unprognostic (3.51e-1)" "unprognostic (3.94e-2)" "unprognostic (1.37e-1)" "unprognostic (2.25e-1)" "unprognostic (5.78e-2)" "unprognostic (5.56e-2)" "unprognostic (7.61e-2)" "unprognostic (1.14e-1)" "unprognostic (1.88e-1)" "unprognostic (4.56e-1)" "unprognostic (1.42e-1)" "unprognostic (1.79e-1)" 15.3 15.4 16.0 15.5 16.9 19.8 15.6 23.6 15.0 13.4 14.0 12.1 6.8 12.5 16.0 8.7 20.4 12.6 11.2 13.3 15.3 8.2 14.5 23.1 17.5 19.3 14.8 11.5 14.8 13.6 18.1 18.2 19.0 13.4 13.9 13.1 9.4 14.9 10.6 34.4 20.4 16.0 16.0 16.4 18.2 13.5 28.1 16.4 39.2 15.9 9.4 22.4 15.1 15.9 5.2 6.2 14.3 8.7 3.9 7.7 3.1 20.2 9.5 16.7 22.0 13.3 14.2 14.7 17.8 22.0 15.2 16.6 20.6 17.9 30.8 12.1 15.9 13.4 19.1 18.9 15.3 23.4 20.0 12.4 18.6 15.2 22.6 15.2 37.6 21.5 11.1 17.9 19.4 32.7 17.3 16.9 18.0 19.5 18.6 17.3 17.3 23.4 14.1 14.8 12.7 9.6 16.7 13.5 12.2 13.1 18.0 6.5 12.6 15.7 10.6 19.3 17.3 23.2 20.1 16.2 14.6 17.4 12.8 23.3 18.3 25.4 32.6 13.4 26.9 10.3 14.3 4.7 9.4 4.7 5.3 7.0 5.2 6.3 6.5 6.2 4.8 7.2 5.7 7.3 3.9 8.7 4.7 7.7 3.1 16.0 16.9 23.6 15.0 15.3 8.2 14.8 11.5 13.4 16.4 77.4 51.5 21.9 40.4 0.0 47.2 0.0 12.7 25.4 38.7 15.7 19.6 36.2 18.3 52.5 61.6 29.2 15.6 70.0 46.0 25.0 22.4 50.1 23.3 41.2 35.6 52.4 17.5 28.8 48.6 27.3 29.7 49.5 0.0 56.9 31.7 45.3 46.8 37.1 30.4 26.7 127.3 64.7 0.0 125.1 82.8 0.0 63.6 38.9 32.2 54.7 WASHC4 "KIAA1033, SWIP" ENSG00000136051 "WASH complex subunit 4" Q2M389 12 105107324-105169134 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Collecting duct cells: 41.8;Hofbauer cells: 44.7;monocytes: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045666, HPA046737" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA045666: AB_2679411, HPA046737: AB_2679778" "unprognostic (2.68e-2)" "prognostic unfavorable (2.02e-4)" "unprognostic (4.85e-2)" "unprognostic (2.76e-1)" "unprognostic (1.10e-1)" "unprognostic (4.41e-1)" "unprognostic (9.79e-3)" "unprognostic (1.32e-2)" "unprognostic (3.14e-2)" "unprognostic (1.24e-2)" "unprognostic (1.81e-1)" "unprognostic (1.49e-2)" "unprognostic (2.96e-1)" "unprognostic (4.61e-2)" "unprognostic (1.87e-1)" "unprognostic (1.03e-1)" "unprognostic (3.86e-2)" 26.2 22.1 14.4 22.8 18.1 16.0 20.2 14.8 16.8 20.8 16.2 16.4 21.1 11.5 22.3 18.0 15.9 15.3 18.2 13.3 14.3 11.9 25.6 28.5 19.4 31.5 18.7 11.9 21.7 19.6 20.7 30.1 23.8 24.0 18.5 14.8 14.6 17.5 18.0 18.0 24.3 21.9 18.2 22.1 36.5 14.3 9.9 17.4 21.3 17.9 12.2 29.8 16.7 18.9 11.4 7.9 11.0 20.9 5.3 3.6 4.3 10.0 12.2 10.9 7.9 25.6 25.5 13.0 15.6 18.1 18.4 17.0 8.6 5.8 22.7 8.7 26.2 11.8 9.4 9.2 9.6 14.8 8.2 7.0 4.6 11.3 7.1 17.2 12.9 9.0 20.4 11.3 16.6 13.4 19.7 29.7 8.1 9.2 8.1 19.9 5.1 7.2 13.4 13.1 7.1 10.2 13.7 14.8 7.1 24.4 11.8 7.0 8.8 16.2 11.5 16.0 14.4 8.5 13.9 36.1 22.3 6.1 14.1 10.2 10.6 10.0 18.4 15.7 11.4 22.3 9.9 10.2 5.9 2.1 12.4 3.1 11.4 3.4 2.8 7.9 9.0 3.6 3.4 11.0 5.3 20.9 4.0 2.3 4.3 14.4 18.1 14.8 16.8 14.3 11.9 18.7 11.9 24.0 17.4 32.8 18.7 0.0 0.0 0.0 0.0 0.0 0.0 32.1 21.6 41.8 0.0 19.1 16.6 22.0 0.0 0.0 0.0 0.0 19.0 23.9 0.0 0.0 24.4 0.0 44.7 0.0 0.0 0.0 0.0 0.0 0.0 24.6 0.0 46.9 0.0 0.0 22.7 0.0 0.0 35.6 0.0 0.0 0.0 0.0 0.0 0.0 26.8 0.0 0.0 0.0 WASHC5 "KIAA0196, SPG8" ENSG00000164961 "WASH complex subunit 5" Q12768 8 125024260-125091840 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 17.5;Exocrine glandular cells: 14.9;Hofbauer cells: 18.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034216, CAB034219, HPA064649, HPA070916" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB034216: AB_2234159, CAB034219: AB_2130519, HPA064649: AB_2685312, HPA070916: AB_2686322" "unprognostic (1.98e-3)" "unprognostic (3.75e-2)" "unprognostic (8.40e-2)" "unprognostic (3.89e-3)" "unprognostic (2.98e-2)" "unprognostic (1.91e-1)" "prognostic unfavorable (6.74e-5)" "unprognostic (2.54e-2)" "unprognostic (3.54e-1)" "unprognostic (5.69e-2)" "unprognostic (9.10e-3)" "unprognostic (1.53e-1)" "unprognostic (9.39e-3)" "unprognostic (5.95e-2)" "unprognostic (2.17e-1)" "unprognostic (1.62e-1)" "unprognostic (2.33e-2)" 21.7 28.1 16.7 17.3 25.1 18.5 20.1 17.1 23.7 18.7 18.2 38.0 13.0 17.9 22.2 16.5 19.6 15.8 18.0 17.1 16.9 15.2 23.2 18.2 16.8 23.0 22.8 16.4 16.5 17.1 25.9 26.4 22.0 28.7 18.3 20.7 17.9 22.6 17.3 23.1 18.6 16.8 20.7 24.5 19.6 18.3 9.3 22.5 25.0 23.9 17.8 20.6 20.4 16.0 8.4 16.0 9.7 21.5 13.5 13.5 9.6 15.7 18.6 10.2 12.5 23.3 25.0 6.7 16.9 26.1 18.0 19.2 6.9 17.1 14.1 12.1 22.1 10.5 12.4 16.6 15.5 23.7 18.6 9.3 19.0 11.5 9.0 22.7 5.8 19.3 24.8 10.3 14.8 13.0 13.8 20.6 12.5 10.9 14.6 21.8 34.4 17.2 4.6 9.7 26.5 18.9 11.7 9.2 14.4 13.7 19.8 5.4 10.8 19.8 44.8 15.7 11.1 19.3 10.1 17.9 9.8 21.8 16.2 15.0 13.1 12.0 12.7 26.0 11.0 13.6 7.7 13.7 9.7 11.8 16.8 12.5 8.4 11.3 11.9 16.0 8.1 9.1 12.5 4.8 13.5 21.5 5.8 13.5 9.6 16.7 25.1 17.1 23.7 16.9 15.2 22.8 16.4 28.7 22.5 3.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 8.1 9.1 10.4 0.0 11.0 5.0 10.4 0.0 0.0 0.0 0.0 14.9 8.8 0.0 0.0 8.1 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 10.0 0.0 0.0 12.8 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 WBP11 "NPWBP, PPP1R165, SIPP1" ENSG00000084463 "WW domain binding protein 11" Q9Y2W2 12 14784579-14803540 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039710, HPA040037, HPA046403, HPA049126" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA039710: AB_2676638, HPA040037: AB_10796115, HPA046403: AB_2679654, HPA049126: AB_2680644" "unprognostic (4.40e-2)" "unprognostic (1.58e-1)" "unprognostic (4.16e-2)" "unprognostic (1.39e-2)" "unprognostic (1.55e-1)" "unprognostic (4.15e-2)" "prognostic unfavorable (9.40e-4)" "unprognostic (5.67e-3)" "unprognostic (3.30e-2)" "unprognostic (2.68e-1)" "unprognostic (9.69e-2)" "unprognostic (1.68e-1)" "unprognostic (2.96e-3)" "unprognostic (6.11e-2)" "unprognostic (3.07e-1)" "unprognostic (1.94e-1)" "unprognostic (4.09e-2)" 27.0 30.8 32.7 22.8 40.7 59.5 25.9 25.6 34.2 21.4 21.9 28.8 10.7 17.5 27.5 20.5 23.4 27.3 19.3 32.9 28.1 25.3 23.5 25.1 25.4 27.3 24.0 29.7 29.4 23.1 29.7 21.8 28.2 29.3 25.1 24.9 23.0 23.2 21.6 46.7 28.7 23.1 24.6 29.1 31.1 23.6 39.2 25.8 25.7 26.5 20.4 30.6 26.4 20.9 15.4 11.4 10.5 16.7 15.9 19.8 11.3 16.2 14.6 17.3 32.9 11.6 11.1 31.2 13.4 11.3 20.5 20.7 26.4 20.2 20.3 8.7 12.1 17.6 13.5 26.6 17.7 25.3 35.9 17.8 29.6 16.1 16.0 11.6 27.6 16.3 10.8 14.1 22.9 17.2 11.2 16.3 19.3 18.8 10.8 16.2 15.7 25.7 14.8 55.6 11.3 9.3 22.0 27.4 12.7 14.7 22.4 9.2 18.8 17.9 15.0 14.1 43.1 8.0 18.3 12.0 14.3 22.0 12.6 22.9 9.5 13.2 37.4 15.0 13.8 19.0 9.5 12.1 10.5 17.2 16.7 18.9 15.4 16.6 17.3 11.4 13.8 19.8 17.9 7.4 15.9 16.5 8.2 17.2 11.3 32.7 40.7 25.6 34.2 28.1 25.3 24.0 29.7 29.3 25.8 53.6 55.4 61.2 69.4 48.8 41.1 94.8 61.1 100.4 67.1 34.9 45.2 49.7 36.5 51.5 59.9 46.9 28.6 70.0 51.9 78.0 44.6 45.4 101.8 36.5 41.5 41.3 37.9 44.2 29.8 44.4 42.0 44.2 33.7 132.6 33.1 45.0 42.9 17.5 30.8 39.1 49.6 58.2 50.2 136.2 151.1 48.7 63.5 59.6 38.4 55.9 WBP1L "C10orf26, FLJ20154, OPAL1" ENSG00000166272 "WW domain binding protein 1 like" Q9NX94 10 102743970-102816267 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 77.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037635, HPA038371" Uncertain Approved Nucleoplasm,Microtubules NA NA Microtubules Nucleoplasm "HPA037635: AB_10672462, HPA038371: AB_2675980" "unprognostic (3.28e-2)" "unprognostic (6.46e-2)" "unprognostic (1.14e-2)" "prognostic favorable (4.03e-4)" "unprognostic (5.35e-3)" "unprognostic (2.73e-2)" "unprognostic (3.33e-2)" "unprognostic (1.25e-1)" "unprognostic (1.69e-1)" "unprognostic (2.43e-3)" "unprognostic (2.55e-1)" "unprognostic (1.34e-1)" "prognostic favorable (1.56e-6)" "unprognostic (2.34e-2)" "unprognostic (1.57e-1)" "unprognostic (4.88e-2)" "unprognostic (1.53e-1)" 23.8 23.0 11.5 12.9 13.7 2.3 14.2 9.5 14.2 19.0 14.5 12.2 13.3 9.0 18.9 14.9 13.1 18.9 15.3 23.6 11.9 8.9 11.6 21.3 13.3 11.5 14.9 8.0 23.6 9.3 12.5 13.5 14.1 17.5 15.2 9.2 20.2 21.8 14.9 77.3 20.1 12.3 16.3 15.0 12.5 15.0 11.0 10.1 23.2 26.1 35.5 11.1 17.6 11.4 6.1 8.2 14.7 16.7 12.4 8.7 8.9 10.1 13.2 7.3 12.3 24.3 19.8 14.9 10.4 28.3 10.4 13.1 9.0 15.9 8.8 14.1 16.0 8.4 11.3 5.3 9.0 7.9 8.8 5.6 17.8 6.0 6.4 15.8 8.5 21.2 21.3 16.2 13.3 10.3 23.9 20.2 10.7 8.6 11.1 17.7 13.3 10.3 9.5 5.5 7.8 6.5 20.7 19.2 5.6 9.2 10.1 1.7 7.0 5.7 5.8 11.7 13.7 23.7 9.5 15.0 10.0 10.4 11.3 9.2 20.6 10.8 6.5 14.2 16.5 4.4 6.6 11.8 14.7 8.7 13.7 6.9 6.1 7.4 8.4 8.2 6.0 6.8 7.2 14.4 12.4 16.7 5.2 7.5 8.9 11.5 13.7 9.5 14.2 11.9 8.9 14.9 8.0 17.5 10.1 20.8 21.3 12.6 8.9 7.2 5.5 12.1 15.3 20.1 17.0 12.2 0.0 27.0 1.7 13.1 1.9 18.4 17.0 0.0 22.1 12.1 18.9 19.8 38.0 44.0 23.3 12.7 8.7 23.9 39.9 1.0 12.0 16.5 10.1 18.0 15.7 8.3 18.1 11.5 18.4 9.2 3.7 19.4 19.6 5.0 6.1 10.3 33.4 8.7 10.9 8.9 WBP2 "GRAMD6, WBP-2" ENSG00000132471 "WW domain binding protein 2" Q969T9 17 75845699-75856507 "Disease related genes, Predicted intracellular proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065682, HPA068819" Approved Approved Nucleoplasm,Cytosol No No 870000 "Nucleoplasm, Cytosol" "HPA065682: AB_2685530, HPA068819: AB_2686042" "unprognostic (1.74e-1)" "unprognostic (1.71e-2)" "unprognostic (3.17e-2)" "unprognostic (2.85e-1)" "unprognostic (8.39e-2)" "unprognostic (7.12e-2)" "unprognostic (8.89e-2)" "unprognostic (3.09e-1)" "unprognostic (2.68e-3)" "unprognostic (1.58e-1)" "unprognostic (4.54e-3)" "unprognostic (6.18e-2)" "unprognostic (2.21e-1)" "unprognostic (5.86e-3)" "unprognostic (1.30e-1)" "unprognostic (2.13e-2)" "unprognostic (1.76e-1)" 37.4 50.4 59.5 22.8 79.8 29.9 22.6 62.5 119.3 24.3 20.4 75.2 15.0 27.0 22.9 19.7 25.7 36.6 26.4 51.6 58.7 56.4 32.0 48.7 31.9 22.3 62.1 56.2 41.8 35.7 36.8 24.5 23.0 110.8 32.2 17.2 40.3 55.5 33.6 47.1 28.2 25.9 23.0 55.6 30.5 27.4 28.5 44.3 10.6 26.8 15.7 21.5 24.5 18.3 14.9 11.1 63.5 25.5 11.2 15.1 16.8 25.5 29.8 11.2 13.3 23.1 23.1 14.8 8.3 26.2 19.2 23.9 14.8 26.2 13.3 21.3 11.8 61.1 15.4 11.7 25.1 17.7 9.8 22.6 24.5 18.1 24.0 47.7 10.1 41.9 25.6 24.0 22.7 31.9 33.9 37.2 20.6 16.4 40.3 15.4 26.1 20.8 20.8 9.5 18.1 19.8 14.3 22.5 24.7 27.9 15.9 18.9 29.5 14.5 25.3 40.4 21.4 34.1 25.3 21.3 19.6 17.3 19.0 13.1 37.3 26.7 9.9 55.0 9.4 13.9 42.8 16.7 56.0 11.6 20.5 12.9 14.9 13.0 11.7 11.1 12.0 12.6 10.3 63.5 11.2 25.5 8.6 15.1 16.8 59.5 79.8 62.5 119.3 58.7 56.4 62.1 56.2 110.8 44.3 77.4 66.5 53.1 106.6 54.1 107.3 69.8 50.9 25.4 33.0 50.6 70.7 59.5 137.6 109.6 243.3 60.2 61.9 23.3 166.3 55.9 37.9 110.3 63.7 57.0 115.5 106.5 32.2 41.7 53.9 234.4 55.0 64.6 57.3 124.4 36.0 83.7 108.2 69.1 50.5 60.3 104.3 25.8 37.3 33.5 25.6 69.9 154.5 55.4 22.9 81.3 WBP4 "FBP21, MGC117310" ENSG00000120688 "WW domain binding protein 4" O75554 13 41061274-41084006 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 76.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038965, HPA058738" Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" NA NA Nucleoplasm "Vesicles, Plasma membrane" "HPA038965: AB_10672836, HPA058738: AB_2683803" "unprognostic (2.56e-1)" "unprognostic (3.69e-3)" "unprognostic (1.75e-1)" "unprognostic (1.99e-2)" "unprognostic (9.30e-2)" "unprognostic (1.76e-3)" "unprognostic (1.54e-2)" "unprognostic (2.13e-2)" "unprognostic (1.34e-2)" "unprognostic (2.05e-2)" "unprognostic (3.71e-3)" "unprognostic (2.97e-1)" "unprognostic (2.66e-2)" "unprognostic (8.52e-2)" "unprognostic (7.65e-3)" "prognostic favorable (2.89e-4)" "unprognostic (2.52e-1)" 14.0 14.2 17.2 7.9 22.1 11.4 11.5 15.8 17.2 12.0 10.7 8.6 8.9 9.6 16.6 14.1 10.9 10.1 8.0 18.8 14.7 15.8 10.5 13.4 8.7 9.0 14.7 19.0 11.8 7.5 8.8 11.3 15.9 15.9 12.5 8.0 4.8 7.2 13.2 76.2 9.4 9.6 14.7 15.0 7.9 8.1 10.0 12.8 12.7 9.6 12.6 9.3 13.3 11.1 10.9 15.2 22.7 16.2 9.7 12.9 5.0 8.9 5.9 16.5 10.6 10.9 16.6 10.1 20.3 14.3 16.0 12.3 9.3 9.6 12.8 8.2 14.2 19.6 12.6 6.2 10.1 20.6 13.2 8.8 18.0 5.8 9.4 16.7 11.2 11.8 13.6 15.5 11.6 16.5 13.3 13.4 12.4 9.6 5.7 16.7 7.5 16.0 12.3 10.0 13.9 4.9 15.1 10.2 5.0 14.5 8.8 3.8 9.2 6.4 7.0 9.5 14.0 5.7 17.6 11.8 10.1 9.2 13.8 11.6 3.8 4.1 8.9 12.4 8.2 13.6 13.0 11.0 9.7 9.3 9.6 8.5 10.9 11.8 9.9 8.9 10.6 12.9 12.6 22.7 9.7 16.2 15.2 11.3 5.0 17.2 22.1 15.8 17.2 14.7 15.8 14.7 19.0 15.9 12.8 47.6 24.8 31.2 52.4 48.3 47.0 92.8 28.1 20.1 28.4 24.4 31.4 49.2 64.6 45.6 4.7 45.0 27.6 116.8 36.7 51.6 45.6 38.5 45.0 61.4 36.2 42.9 36.4 33.7 22.5 5.0 44.3 37.8 30.4 80.2 20.9 62.1 40.8 34.5 49.5 46.9 43.4 25.8 50.5 63.7 97.3 39.3 41.8 21.3 24.9 37.1 WDFY4 "C10orf64, Em:AC060234.3, FLJ45748, KIAA1607" ENSG00000128815 "WDFY family member 4" Q6ZS81 10 48684876-48982956 "Predicted intracellular proteins, Predicted membrane proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 19.7;lymphoid tissue: 31.2" "Cell type enhanced" "Detected in some" 10 "B-cells: 20.5;Early spermatids: 25.8;Hofbauer cells: 11.8;Kupffer cells: 11.7;Late spermatids: 11.6;Macrophages: 21.6;monocytes: 17.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "memory B-cell: 8.9;myeloid DC: 6.7;naive B-cell: 12.5;neutrophil: 6.2;plasmacytoid DC: 19.7" "Group enriched" "Detected in many" 7 "B-cells: 12.5;dendritic cells: 19.7;granulocytes: 6.2" "Cell line enhanced" "Detected in some" "Daudi: 30.0;HDLM-2: 27.5;HL-60: 10.5;THP-1: 9.3;U-698: 12.8;U-937: 12.4" "Low region specificity" "Detected in many" HPA040634 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040634: AB_10795491" "unprognostic (6.20e-2)" "unprognostic (6.60e-3)" "unprognostic (1.87e-1)" "unprognostic (3.31e-2)" "unprognostic (1.87e-1)" "unprognostic (9.38e-4)" "unprognostic (9.41e-2)" "unprognostic (3.89e-3)" "unprognostic (2.15e-2)" "unprognostic (3.74e-1)" "unprognostic (3.49e-2)" "unprognostic (9.64e-2)" "unprognostic (3.21e-1)" "unprognostic (1.34e-1)" "unprognostic (1.35e-2)" "unprognostic (1.97e-1)" "unprognostic (3.76e-2)" 2.7 1.5 3.6 31.2 5.4 8.6 1.5 0.9 2.7 1.2 1.6 5.2 0.0 1.1 1.2 1.5 1.5 1.5 2.6 1.4 3.1 1.9 1.7 1.2 9.4 20.8 5.3 0.6 1.1 1.1 0.2 1.1 0.8 3.7 1.2 1.5 1.2 5.7 0.4 0.9 2.0 10.2 1.3 7.3 19.1 1.6 1.5 4.4 4.1 1.6 0.9 26.6 3.0 1.2 12.5 19.7 6.2 1.7 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.5 0.0 3.2 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 12.4 0.0 0.0 1.7 0.0 0.0 1.6 0.0 8.9 0.0 0.1 6.7 12.5 0.0 0.0 6.2 0.0 0.8 19.7 0.0 0.6 3.6 5.4 0.9 2.7 3.1 1.9 5.3 0.6 3.7 4.4 0.0 0.6 20.5 0.0 0.3 0.0 1.1 0.0 0.0 1.2 1.8 0.0 0.1 1.7 0.0 25.8 0.3 0.0 0.0 0.0 0.1 0.9 0.0 5.7 0.0 11.8 0.0 0.0 0.0 11.7 11.6 0.3 21.6 1.7 17.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.6 0.6 0.3 0.2 0.0 0.0 0.0 WDHD1 "AND-1, CHTF4, CTF4" ENSG00000198554 "WD repeat and HMG-box DNA binding protein 1" O75717 14 54938950-55027105 "Predicted intracellular proteins, Predicted membrane proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.1" "Cell type enhanced" "Detected in many" 9 "Spermatocytes: 10.6;Spermatogonia: 20.5" "Cancer enhanced" "Detected in all" "testis cancer: 23.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000632, HPA001122" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA000632: , HPA001122: AB_1080589" "unprognostic (1.88e-1)" "unprognostic (1.21e-1)" "unprognostic (1.98e-2)" "unprognostic (2.25e-3)" "unprognostic (1.20e-1)" "unprognostic (6.85e-3)" "unprognostic (2.33e-4)" "unprognostic (5.52e-3)" "unprognostic (7.28e-3)" "unprognostic (8.05e-3)" "prognostic unfavorable (9.24e-4)" "unprognostic (5.11e-2)" "unprognostic (2.67e-4)" "unprognostic (8.31e-3)" "unprognostic (1.50e-1)" "unprognostic (3.49e-2)" "unprognostic (2.36e-2)" 5.0 2.8 6.3 6.6 7.5 10.8 3.8 7.2 4.6 3.7 4.9 2.7 0.6 3.2 4.2 2.9 7.0 4.0 2.3 2.3 3.2 2.3 2.8 2.1 2.9 8.9 3.3 2.5 4.1 2.0 3.0 1.9 6.0 4.4 2.1 7.3 2.6 3.0 2.2 2.0 4.5 3.6 4.6 2.8 4.6 2.8 8.8 3.5 21.1 2.1 6.4 11.2 3.6 4.3 4.8 1.8 4.3 0.9 4.3 4.6 1.6 16.0 10.4 20.6 9.0 2.0 4.9 12.0 15.6 6.7 12.6 15.5 6.9 10.8 18.4 8.0 4.4 9.1 13.7 30.6 9.0 26.6 12.3 5.3 12.1 10.1 6.6 0.8 22.8 9.3 2.5 1.6 15.6 6.1 3.0 8.2 12.0 15.1 9.3 12.1 8.9 21.4 4.5 16.3 8.6 10.8 20.1 29.6 7.1 3.6 10.8 12.0 8.4 16.6 4.2 5.4 15.7 11.3 4.6 5.3 16.1 19.1 11.7 13.2 2.8 5.7 24.6 7.3 11.3 12.6 4.3 0.8 1.4 2.3 0.6 3.2 3.0 2.7 3.3 1.4 4.8 3.3 4.6 1.2 4.3 0.9 1.8 3.9 1.6 6.3 7.5 7.2 4.6 3.2 2.3 3.3 2.5 4.4 3.5 0.0 1.3 2.9 1.5 3.4 2.1 1.5 0.0 4.0 5.7 3.5 0.0 5.8 0.0 1.8 0.5 1.0 0.5 0.0 0.9 8.0 3.1 0.5 0.0 0.8 3.4 3.2 0.0 1.3 1.6 0.8 0.0 2.0 1.7 1.8 2.5 1.5 1.0 0.0 2.8 1.9 3.3 0.0 3.3 10.6 20.5 2.0 2.2 0.0 3.1 0.9 WDR13 ENSG00000101940 "WD repeat domain 13" Q9H1Z4 X 48590042-48608867 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000913 Supported Supported "Nucleoplasm,Plasma membrane,Centriolar satellite" NA NA Nucleoplasm "Plasma membrane, Centriolar satellite" "HPA000913: AB_1858795" "unprognostic (5.03e-2)" "unprognostic (6.53e-3)" "unprognostic (3.65e-3)" "unprognostic (2.10e-3)" "unprognostic (3.50e-1)" "unprognostic (1.54e-3)" "unprognostic (3.54e-2)" "unprognostic (6.76e-2)" "unprognostic (2.40e-2)" "unprognostic (3.48e-1)" "unprognostic (1.58e-2)" "unprognostic (1.33e-1)" "unprognostic (2.82e-1)" "unprognostic (2.99e-1)" "unprognostic (1.66e-1)" "unprognostic (2.65e-1)" "unprognostic (4.32e-2)" 24.5 30.4 39.9 13.9 36.9 15.7 19.1 14.4 33.9 18.6 25.5 17.6 41.5 23.0 26.0 41.2 23.1 30.8 21.1 49.8 30.2 18.9 24.2 50.2 19.3 11.1 20.0 35.8 35.0 74.7 21.8 24.4 23.9 17.0 19.6 14.4 16.5 30.4 35.8 48.5 21.7 22.0 20.2 17.5 17.4 22.7 11.0 20.5 8.6 21.9 21.1 10.5 17.9 19.7 16.8 21.1 29.2 28.2 17.3 13.8 15.9 15.0 22.0 11.0 34.1 15.2 22.4 8.5 10.4 19.0 12.1 11.1 13.0 24.1 10.4 10.0 21.3 9.8 12.9 5.5 22.8 4.3 12.4 9.7 7.1 26.0 23.6 34.7 6.1 19.5 21.2 32.6 17.2 31.6 21.3 16.6 6.1 7.0 13.4 16.8 21.6 8.4 10.8 8.0 6.5 17.4 8.1 11.7 18.9 21.4 12.0 12.8 15.9 11.8 24.6 24.1 8.1 15.7 11.9 27.4 12.6 18.8 19.9 10.0 15.6 5.7 3.8 18.7 9.2 17.3 29.2 23.1 12.7 11.9 24.7 9.5 16.8 12.6 11.3 21.1 13.4 10.0 11.4 16.0 17.3 28.2 13.3 13.8 15.9 39.9 36.9 14.4 33.9 30.2 18.9 20.0 35.8 17.0 20.5 41.7 42.0 25.3 61.2 31.1 44.1 67.8 58.6 60.2 33.0 19.2 51.1 39.7 87.9 76.1 5.1 50.7 69.1 0.0 103.3 29.1 47.2 41.1 30.0 41.4 38.7 31.8 48.5 54.6 33.6 15.2 47.8 29.6 55.6 47.7 52.9 50.7 86.4 59.6 40.7 122.9 50.2 45.3 55.3 9.7 15.3 26.1 59.2 20.8 54.6 57.8 WDR18 Ipi3 ENSG00000065268 "WD repeat domain 18" Q9BV38 19 984271-998438 "Plasma proteins, Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 135.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050193, HPA050200" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA050193: AB_2681047, HPA050200: AB_2681049" "unprognostic (7.94e-2)" "unprognostic (3.08e-1)" "unprognostic (2.51e-1)" "unprognostic (2.13e-3)" "unprognostic (8.58e-2)" "unprognostic (2.03e-1)" "unprognostic (7.14e-2)" "unprognostic (4.88e-2)" "unprognostic (6.69e-2)" "unprognostic (2.70e-1)" "unprognostic (6.74e-3)" "unprognostic (1.43e-2)" "unprognostic (2.86e-2)" "unprognostic (1.60e-2)" "unprognostic (2.50e-1)" "unprognostic (3.07e-1)" "unprognostic (2.35e-1)" 13.1 16.5 13.4 16.7 14.5 14.0 11.1 24.0 20.5 10.9 14.3 14.4 12.2 16.9 11.4 17.4 18.8 11.5 11.7 14.9 12.0 11.6 17.9 23.4 11.0 18.7 12.4 8.2 16.1 32.2 10.5 14.6 15.1 10.3 14.4 6.8 14.3 19.5 15.1 28.7 16.9 15.5 10.6 9.8 14.0 17.0 15.2 9.2 22.7 13.1 20.9 16.8 11.0 10.8 22.9 40.7 6.2 28.1 18.4 21.3 22.3 18.9 18.6 5.9 9.9 5.7 5.2 23.0 8.5 5.1 10.9 8.2 20.7 6.7 22.4 10.1 13.0 1.2 15.6 16.1 18.6 4.3 11.7 24.9 10.8 11.2 25.6 13.3 23.3 10.3 6.8 9.9 6.5 15.4 5.5 9.8 11.1 23.9 8.9 4.0 20.0 17.3 32.9 33.0 13.7 11.8 32.6 13.4 35.0 6.9 12.1 21.9 20.4 8.1 7.0 8.3 4.3 16.4 14.1 9.5 12.0 14.4 23.5 13.4 28.2 24.0 10.9 10.4 14.6 12.7 4.0 27.4 6.2 19.7 28.1 19.2 19.9 19.9 21.1 40.7 22.9 20.0 18.2 1.2 18.4 22.1 25.5 21.3 22.3 13.4 14.5 24.0 20.5 12.0 11.6 12.4 8.2 10.3 9.2 8.9 15.4 24.7 23.5 17.2 26.2 11.3 10.2 17.4 12.5 29.6 21.6 78.7 59.7 51.0 27.4 16.3 19.1 0.0 47.1 135.7 17.5 21.9 16.1 36.8 40.6 25.4 31.0 23.4 19.8 25.5 14.4 17.7 15.1 63.1 28.4 30.2 40.9 21.0 15.2 108.1 20.6 12.9 18.9 34.1 29.9 17.8 50.2 23.6 44.1 23.7 WDR19 "DYF-2, FLJ23127, IFT144, KIAA1638, NPHP13, ORF26, Oseg6, Pwdmp" ENSG00000157796 "WD repeat domain 19" Q8NEZ3 4 39182404-39285810 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Ectodermal dysplasia, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 41.1" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 41.5;Spermatocytes: 30.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 25.4;ASC TERT1: 28.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039616, HPA058847" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA039616: AB_10796331, HPA058847: AB_2683834" "unprognostic (1.80e-1)" "unprognostic (9.32e-2)" "unprognostic (6.40e-2)" "unprognostic (5.69e-2)" "unprognostic (1.37e-1)" "unprognostic (1.26e-3)" "prognostic unfavorable (4.43e-4)" "unprognostic (1.06e-1)" "unprognostic (1.60e-1)" "unprognostic (9.63e-2)" "prognostic favorable (2.70e-4)" "prognostic unfavorable (8.58e-4)" "unprognostic (3.52e-2)" "unprognostic (2.40e-2)" "unprognostic (5.53e-2)" "unprognostic (1.82e-1)" "unprognostic (1.56e-2)" 8.5 7.6 8.1 4.8 12.9 3.4 9.2 21.0 14.5 13.2 7.8 5.7 7.8 1.9 15.5 11.2 5.4 20.9 8.6 5.1 11.7 4.1 8.6 7.0 8.6 4.4 6.0 11.0 19.0 6.6 10.1 41.1 6.3 14.6 8.1 4.3 6.9 7.6 8.2 3.1 6.0 5.7 9.5 9.7 4.3 8.0 12.7 7.3 6.8 17.1 3.8 5.0 9.9 8.9 3.9 1.1 1.5 2.0 2.3 2.4 0.8 3.2 2.3 5.5 6.6 25.4 28.5 2.5 4.3 9.7 4.5 6.0 1.4 3.7 5.3 2.1 4.1 9.7 1.9 5.4 2.8 5.0 0.3 3.9 1.0 4.4 2.7 7.9 5.2 1.4 17.3 6.1 6.0 3.8 12.5 5.4 5.4 4.7 5.3 5.4 1.1 3.5 3.6 1.8 1.9 2.6 4.3 5.6 2.4 3.7 1.3 6.1 5.6 4.2 1.4 2.8 6.9 2.8 1.9 3.9 4.4 3.0 9.7 4.2 3.9 3.6 3.7 6.6 1.5 2.0 0.7 1.2 0.9 1.7 2.0 1.3 3.4 2.1 2.4 1.1 3.9 2.1 2.1 1.5 2.3 1.7 0.7 1.4 0.8 8.1 12.9 21.0 14.5 11.7 4.1 6.0 11.0 14.6 7.3 11.9 5.7 3.2 4.9 4.2 7.6 3.8 2.5 41.5 12.5 17.4 9.8 1.0 0.0 4.5 3.0 4.5 0.0 0.0 3.1 2.0 5.6 3.1 2.3 10.6 2.7 23.8 2.4 4.3 1.9 2.6 15.3 2.9 1.7 1.0 2.2 7.3 2.9 0.0 17.7 3.4 22.5 0.0 3.8 30.3 10.2 4.1 1.1 1.0 1.0 1.8 WDR25 "C14orf67, MGC4645" ENSG00000176473 "WD repeat domain 25" Q64LD2 14 100376418-100530303 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Exocrine glandular cells: 29.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003113 Uncertain Approved Nucleoplasm "Secreted to blood" NA NA Nucleoplasm "HPA003113: AB_2215263" "unprognostic (5.31e-2)" "unprognostic (5.76e-3)" "unprognostic (2.28e-2)" "unprognostic (1.24e-1)" "unprognostic (1.11e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (7.36e-4)" "unprognostic (1.79e-2)" "unprognostic (6.62e-2)" "unprognostic (3.94e-3)" "unprognostic (2.44e-2)" "unprognostic (1.37e-2)" "prognostic favorable (3.89e-5)" "unprognostic (1.01e-2)" "unprognostic (1.73e-1)" "unprognostic (7.30e-2)" "unprognostic (7.51e-2)" 6.9 10.9 10.8 5.0 13.5 7.9 9.5 14.4 14.8 15.2 8.3 11.2 5.4 6.8 11.1 9.4 7.6 14.0 7.2 7.6 10.8 9.4 7.6 9.0 7.5 6.8 8.6 13.3 11.0 16.2 7.7 13.4 7.2 9.4 9.2 5.7 10.9 11.9 9.7 11.4 6.1 5.8 7.3 7.5 6.8 8.4 15.0 11.3 6.4 17.3 4.4 6.6 7.4 6.6 9.9 11.9 19.5 13.9 4.2 10.8 10.0 3.3 5.9 4.1 15.2 6.7 6.3 3.4 6.2 9.9 7.2 7.3 2.7 6.3 4.8 7.8 5.1 2.0 6.0 3.9 7.6 3.8 4.7 2.8 3.2 6.7 4.6 12.3 3.7 3.7 9.4 9.0 5.2 7.9 6.3 5.2 5.8 3.9 7.1 4.7 12.7 5.5 4.2 3.2 4.0 10.5 4.0 5.8 3.3 5.5 2.7 9.7 10.2 5.0 1.9 8.3 4.1 7.0 1.3 8.8 2.7 3.2 10.6 3.5 4.8 2.4 2.4 9.6 2.8 5.2 19.5 13.9 19.5 7.5 11.8 7.8 9.9 10.0 8.0 11.9 7.2 10.8 7.9 7.3 4.2 12.4 9.2 9.7 10.0 10.8 13.5 14.4 14.8 10.8 9.4 8.6 13.3 9.4 11.3 0.0 5.4 3.4 3.8 2.9 8.0 2.0 0.0 9.4 3.4 3.5 9.8 7.2 8.3 9.6 8.2 6.7 5.9 0.0 29.6 4.1 6.6 2.6 3.5 7.2 5.9 4.8 5.2 5.5 4.4 4.2 6.4 3.5 5.0 5.4 6.1 12.1 13.6 3.5 10.6 13.5 15.2 12.9 8.0 10.9 15.2 2.6 5.8 5.3 6.8 1.8 WDR26 "FLJ21016, GID7" ENSG00000162923 "WD repeat domain 26" Q9H7D7 1 224385143-224437033 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 63.9" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 178.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028538, HPA028539, HPA061094" Enhanced Enhanced Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "HPA028538: , HPA028539: AB_10669752, HPA061094: AB_2684427" "unprognostic (4.09e-3)" "unprognostic (1.29e-1)" "unprognostic (1.22e-1)" "unprognostic (1.31e-2)" "unprognostic (6.67e-2)" "unprognostic (2.27e-1)" "unprognostic (1.24e-1)" "unprognostic (1.64e-1)" "unprognostic (8.42e-2)" "unprognostic (6.32e-2)" "unprognostic (5.59e-2)" "unprognostic (4.18e-1)" "prognostic unfavorable (3.31e-6)" "unprognostic (8.40e-3)" "unprognostic (4.00e-1)" "unprognostic (2.17e-1)" "unprognostic (2.28e-1)" 8.2 7.2 6.7 6.7 6.7 18.5 7.2 8.2 7.3 7.8 7.0 6.7 6.7 4.0 6.8 9.3 13.0 5.9 7.0 7.5 6.7 5.0 6.7 9.3 9.0 7.2 6.7 6.7 7.0 6.9 9.2 6.7 8.7 6.7 7.0 6.7 6.7 7.2 6.7 15.2 9.9 6.7 7.1 6.7 10.2 6.3 63.9 6.7 6.7 7.0 6.7 7.4 6.7 8.3 1.5 2.1 8.3 3.9 2.7 2.7 1.3 11.9 6.2 19.3 8.9 25.8 29.4 13.9 17.6 28.8 16.1 15.2 9.8 13.6 14.2 17.7 28.3 6.2 10.9 11.3 15.1 26.5 11.1 12.9 9.8 8.1 9.2 28.1 10.2 17.2 27.3 21.9 17.0 16.1 26.7 26.8 8.7 12.9 14.7 21.1 6.6 10.5 9.9 18.6 12.4 7.2 9.7 20.2 11.2 19.6 12.1 7.0 17.9 20.0 27.1 21.5 21.1 31.1 16.8 28.1 13.8 6.3 12.9 21.1 15.7 7.5 9.7 15.7 7.3 17.0 4.1 1.9 3.3 2.7 2.4 1.5 1.5 1.9 2.1 1.8 1.4 1.4 2.1 8.3 2.7 3.9 2.1 1.6 1.3 6.7 6.7 8.2 6.7 6.7 5.0 6.7 6.7 6.7 6.7 98.3 43.8 19.4 25.3 99.0 23.8 42.4 45.9 41.5 50.0 33.2 29.5 23.4 5.0 19.2 178.7 37.6 21.6 0.0 20.3 11.8 51.5 39.3 46.2 31.0 44.5 36.5 34.0 44.2 119.9 79.7 34.2 49.8 43.9 12.6 40.3 16.9 26.6 25.9 26.5 17.0 22.9 19.4 41.9 36.4 24.6 107.0 57.1 31.6 23.8 59.3 WDR27 MGC43690 ENSG00000184465 "WD repeat domain 27" A2RRH5 6 169457212-169702048 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037497, HPA037498" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA037497: AB_10671503, HPA037498: AB_2675509" "unprognostic (2.10e-1)" "unprognostic (8.66e-3)" "unprognostic (1.32e-1)" "unprognostic (1.78e-2)" "unprognostic (8.59e-2)" "unprognostic (1.98e-3)" "unprognostic (3.81e-3)" "unprognostic (2.59e-2)" "unprognostic (1.83e-1)" "unprognostic (8.63e-2)" "unprognostic (2.43e-2)" "unprognostic (3.62e-2)" "prognostic unfavorable (1.78e-5)" "unprognostic (3.15e-2)" "unprognostic (2.19e-1)" "unprognostic (1.55e-1)" "unprognostic (4.30e-3)" 6.7 8.0 8.6 11.8 9.2 7.0 9.3 10.1 10.9 9.9 7.9 10.3 7.1 8.1 17.2 10.2 8.9 13.4 8.1 5.0 6.1 4.1 7.2 6.3 6.6 8.2 5.9 5.1 18.2 8.5 8.4 9.9 5.9 7.2 9.2 6.3 8.4 11.2 5.9 5.9 7.5 8.6 9.1 4.7 7.8 7.7 21.5 8.6 7.6 12.7 4.2 9.0 10.2 10.8 4.7 2.1 1.5 1.1 0.7 6.0 1.2 4.4 6.3 15.8 8.9 4.7 6.2 7.9 6.1 1.5 2.9 4.5 8.4 6.6 4.5 4.7 1.9 6.3 9.1 5.0 4.3 4.5 6.0 8.9 8.5 11.3 5.4 3.4 4.7 1.3 6.1 3.8 3.9 4.6 7.5 5.8 9.2 19.8 9.3 4.8 6.7 3.0 11.7 7.4 4.8 5.5 7.9 5.5 6.6 3.7 4.0 9.0 10.8 5.0 3.6 3.8 5.6 4.4 8.0 5.6 4.3 5.4 6.3 7.1 8.8 3.5 10.0 5.3 9.3 7.4 0.2 1.1 1.5 1.9 0.7 3.2 2.1 2.0 2.5 1.1 4.7 6.0 1.7 0.5 0.7 0.5 2.1 1.2 1.2 8.6 9.2 10.1 10.9 6.1 4.1 5.9 5.1 7.2 8.6 8.9 3.8 5.6 5.1 1.9 12.7 3.2 7.6 14.7 3.4 12.2 5.9 4.2 0.0 2.2 21.5 5.8 3.3 0.0 1.3 2.3 4.5 3.7 3.5 3.9 1.9 20.6 4.1 11.1 1.3 6.8 7.5 2.5 3.3 1.0 4.2 7.0 1.7 5.1 9.2 1.3 13.8 0.0 2.7 14.9 9.4 1.0 1.6 4.4 6.0 4.7 WDR3 "DIP2, FLJ12796, UTP12" ENSG00000065183 "WD repeat domain 3" Q9UNX4 1 117929720-117966542 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 60.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027509, HPA054354, HPA072915" Enhanced Nucleoplasm,Nucleoli No No Nucleoli Nucleoplasm "HPA027509: AB_10601808, HPA054354: AB_2682459, HPA072915: " "unprognostic (6.77e-2)" "unprognostic (4.53e-3)" "unprognostic (1.50e-1)" "unprognostic (2.46e-3)" "unprognostic (1.91e-2)" "unprognostic (3.57e-2)" "prognostic unfavorable (7.33e-5)" "unprognostic (1.29e-1)" "unprognostic (9.52e-2)" "unprognostic (6.04e-2)" "prognostic unfavorable (8.82e-4)" "unprognostic (8.90e-3)" "unprognostic (7.47e-2)" "unprognostic (5.29e-2)" "unprognostic (1.26e-1)" "unprognostic (1.93e-1)" "unprognostic (8.65e-2)" 12.5 13.5 7.7 10.6 10.7 3.3 12.2 8.4 9.7 10.5 7.7 6.8 9.7 7.3 12.6 6.5 13.3 10.5 4.6 8.7 7.1 6.4 8.5 14.8 7.3 15.5 6.9 6.2 12.1 21.4 16.3 14.8 8.4 8.3 8.4 10.8 6.6 9.8 8.1 25.4 10.5 6.8 11.7 6.2 8.5 9.3 14.9 6.9 15.2 11.1 9.5 15.2 10.2 9.1 8.7 11.9 0.5 6.6 7.9 12.4 6.3 15.2 9.7 9.7 14.8 10.6 8.7 11.2 10.7 7.0 12.5 11.0 10.2 5.1 18.1 14.7 7.9 8.0 10.3 24.1 12.3 19.9 14.9 12.5 17.0 10.4 8.2 8.7 31.8 9.0 8.5 8.9 15.8 24.0 7.4 11.9 12.8 20.7 8.9 10.9 8.8 15.1 7.3 35.0 13.4 15.6 14.5 33.7 13.8 6.2 10.2 15.0 13.7 12.2 15.1 17.3 14.1 6.0 13.3 10.5 9.4 15.0 17.1 23.9 13.1 15.3 28.4 13.8 20.6 24.2 0.1 6.0 0.5 8.8 6.1 11.4 8.7 8.0 10.3 11.9 7.9 12.4 11.3 0.5 7.9 6.6 6.6 10.7 6.3 7.7 10.7 8.4 9.7 7.1 6.4 6.9 6.2 8.3 6.9 8.9 11.0 9.2 10.8 18.5 9.6 14.0 5.1 25.4 33.0 7.0 5.9 9.2 8.3 8.4 28.6 11.7 2.7 0.0 11.8 7.5 9.5 8.9 15.1 25.5 7.2 14.3 3.5 11.6 6.3 34.2 11.5 7.4 10.1 2.8 5.1 6.5 10.6 3.5 11.0 6.0 6.4 12.9 14.6 25.9 60.1 19.6 4.2 5.7 9.4 7.7 WDR33 "FLJ11294, NET14, WDC146" ENSG00000136709 "WD repeat domain 33" Q9C0J8 2 127701022-127811187 "Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026897, HPA046527" Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA026897: AB_1858803, HPA046527: AB_2679686" "unprognostic (1.26e-1)" "unprognostic (7.22e-2)" "unprognostic (1.50e-1)" "unprognostic (1.79e-2)" "unprognostic (6.63e-2)" "unprognostic (8.32e-2)" "prognostic unfavorable (2.13e-4)" "unprognostic (1.01e-1)" "unprognostic (1.66e-2)" "unprognostic (8.13e-2)" "unprognostic (5.72e-3)" "unprognostic (1.61e-1)" "unprognostic (6.60e-2)" "unprognostic (3.64e-1)" "unprognostic (2.04e-1)" "unprognostic (9.85e-2)" "unprognostic (1.03e-2)" 19.8 19.2 18.1 22.5 22.5 18.8 21.7 51.4 24.3 20.9 19.8 22.0 22.8 18.2 32.2 19.0 20.6 18.6 17.9 16.8 17.7 16.5 22.3 32.3 18.5 25.0 19.4 14.5 29.2 21.8 26.4 41.8 20.9 22.0 21.9 19.5 24.4 25.3 17.4 22.0 27.8 21.3 21.0 22.2 28.1 18.0 24.5 20.8 39.5 25.2 16.6 30.5 21.5 22.4 24.4 21.6 26.7 18.3 25.9 26.3 14.4 18.5 10.5 18.4 14.9 10.9 11.4 19.1 17.0 13.6 18.0 17.1 24.4 14.3 23.6 18.9 11.2 16.6 15.2 20.7 14.4 23.7 21.6 12.4 22.7 13.4 26.0 12.3 27.3 17.0 11.1 15.3 17.2 14.7 12.9 15.3 21.4 18.8 21.2 12.6 11.7 28.3 20.0 22.3 12.1 12.0 19.9 18.6 18.7 10.3 24.2 17.2 13.4 15.2 14.1 12.0 18.1 10.9 16.0 14.2 14.2 20.8 15.8 14.5 20.7 31.6 45.0 11.6 10.9 13.2 21.2 16.7 26.7 21.5 18.3 21.9 24.4 21.9 20.6 21.6 23.0 23.3 22.1 11.4 25.9 18.2 15.8 26.3 14.4 18.1 22.5 51.4 24.3 17.7 16.5 19.4 14.5 22.0 20.8 32.8 38.9 53.6 65.1 97.7 50.6 43.7 50.9 26.8 25.0 34.9 60.9 70.6 39.7 41.7 25.0 53.7 27.8 46.7 39.3 76.0 51.5 42.9 63.5 58.0 43.8 57.2 37.8 42.4 42.9 17.6 46.6 47.4 72.6 84.8 34.6 30.4 34.6 31.7 47.4 42.1 55.4 45.3 50.9 89.8 72.4 101.3 92.5 69.8 38.3 50.3 WDR4 "TRM82, TRMT82" ENSG00000160193 "WD repeat domain 4" P57081 21 42843094-42879568 "Predicted intracellular proteins" "DNA damage, tRNA processing" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017381 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA017381: AB_1858807" "unprognostic (3.47e-2)" "unprognostic (2.15e-2)" "unprognostic (4.32e-2)" "unprognostic (2.13e-2)" "unprognostic (2.95e-2)" "unprognostic (1.89e-2)" "prognostic unfavorable (5.48e-7)" "unprognostic (2.85e-3)" "unprognostic (5.37e-2)" "unprognostic (2.27e-2)" "unprognostic (4.25e-1)" "unprognostic (4.78e-2)" "unprognostic (2.65e-2)" "unprognostic (1.74e-3)" "unprognostic (1.44e-1)" "unprognostic (1.74e-1)" "unprognostic (4.46e-2)" 9.1 9.3 8.4 14.2 8.4 12.1 7.5 9.3 11.1 7.6 7.2 6.7 6.5 10.7 12.5 5.1 17.4 8.2 8.1 6.1 8.3 4.9 7.3 12.2 7.8 18.2 8.9 8.4 9.7 22.0 6.9 8.4 8.9 8.5 7.0 7.0 6.8 11.8 8.4 13.1 10.2 7.5 7.4 6.6 11.7 7.3 10.9 9.6 10.1 9.3 11.3 17.0 8.5 11.1 7.5 9.1 0.2 8.8 4.4 5.5 4.4 14.6 20.6 5.5 7.8 3.3 3.6 13.4 8.5 3.1 7.2 4.7 20.6 7.6 24.5 5.0 6.0 10.5 8.1 19.1 10.8 5.1 7.8 18.2 24.6 21.5 17.3 5.9 15.1 6.1 2.0 4.7 9.8 7.2 2.6 9.4 8.8 29.6 9.1 6.3 12.2 15.5 8.6 13.8 11.0 20.2 17.1 3.3 24.2 5.4 9.0 13.1 8.4 8.9 13.3 4.2 1.9 8.7 11.7 6.9 11.2 7.4 5.1 17.0 12.5 8.7 19.8 5.4 24.1 13.1 0.0 5.4 0.2 3.5 8.8 4.7 7.5 4.7 4.3 9.1 7.2 4.8 4.9 0.0 4.4 5.0 4.4 5.5 4.4 8.4 8.4 9.3 11.1 8.3 4.9 8.9 8.4 8.5 9.6 0.0 4.5 6.0 7.4 7.6 3.4 2.0 0.0 1.4 1.2 0.0 2.0 14.1 0.0 6.4 2.9 4.9 3.3 0.0 5.7 17.8 3.8 5.6 10.3 6.4 11.5 3.2 5.2 3.7 1.8 2.5 2.6 4.8 6.8 1.8 3.6 2.4 6.8 0.0 2.8 5.7 4.0 6.5 6.2 9.7 9.1 9.5 9.6 3.8 7.0 8.8 WDR41 FLJ10904 ENSG00000164253 "WD repeat domain 41" Q9HAD4 5 77425970-77620611 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 146.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043124 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA043124: AB_10793990" "unprognostic (1.81e-1)" "unprognostic (9.42e-2)" "unprognostic (2.52e-3)" "unprognostic (9.69e-2)" "unprognostic (1.52e-1)" "unprognostic (4.56e-3)" "prognostic unfavorable (4.47e-4)" "unprognostic (1.28e-3)" "unprognostic (1.43e-1)" "unprognostic (1.68e-2)" "unprognostic (2.30e-3)" "unprognostic (1.49e-1)" "unprognostic (4.15e-3)" "unprognostic (6.11e-2)" "unprognostic (4.90e-1)" "unprognostic (1.85e-1)" "unprognostic (2.90e-3)" 16.2 12.8 18.8 13.1 21.7 17.3 16.2 19.5 23.3 15.1 12.6 17.7 9.4 9.4 13.3 13.3 20.6 17.5 12.2 16.9 18.8 17.5 15.8 14.8 14.0 13.9 21.4 20.0 9.4 21.3 14.4 15.8 11.4 28.9 12.0 13.8 11.5 13.7 12.0 19.7 12.8 11.2 19.2 23.3 12.5 11.5 26.6 19.8 8.1 23.1 12.9 16.6 13.5 13.6 8.9 24.8 24.0 18.1 15.8 5.7 7.3 6.8 11.8 16.6 24.2 17.3 24.8 13.0 21.8 23.6 10.3 19.2 10.7 11.5 20.8 10.1 20.6 17.8 8.9 12.4 29.8 11.1 25.0 14.2 8.3 13.8 9.2 26.5 17.5 20.7 15.7 38.4 11.7 25.5 11.4 16.5 11.8 8.2 22.7 16.8 14.7 9.2 11.3 6.1 6.9 4.7 22.2 22.7 14.6 11.3 5.8 9.7 11.9 18.6 11.7 18.1 20.8 11.7 22.0 14.4 14.0 11.4 7.6 15.9 20.7 16.8 37.2 19.2 7.9 23.3 11.4 14.0 24.0 5.7 16.3 5.5 8.9 3.4 5.1 24.8 5.4 2.3 4.2 6.8 15.8 18.1 11.1 2.6 7.3 18.8 21.7 19.5 23.3 18.8 17.5 21.4 20.0 28.9 19.8 35.7 10.5 11.5 21.9 10.6 34.7 14.7 12.7 20.1 9.1 17.4 19.6 7.4 31.5 19.8 146.0 11.7 3.5 0.0 18.1 22.6 22.6 18.9 15.1 11.1 24.0 22.3 5.8 8.0 22.7 78.8 8.9 25.0 16.9 8.2 7.6 12.9 15.9 5.8 7.8 14.0 16.3 6.5 18.7 46.9 43.9 12.4 5.3 17.3 10.3 21.6 WDR45B "WDR45L, WIPI3" ENSG00000141580 "WD repeat domain 45B" Q5MNZ6 17 82614562-82648553 "Predicted intracellular proteins" Autophagy "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 316.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017886 Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA017886: AB_1858810" "unprognostic (1.91e-1)" "unprognostic (7.77e-2)" "unprognostic (5.13e-2)" "unprognostic (3.78e-2)" "unprognostic (1.42e-1)" "unprognostic (3.88e-2)" "prognostic unfavorable (2.98e-5)" "unprognostic (1.23e-1)" "unprognostic (6.38e-2)" "unprognostic (1.22e-2)" "unprognostic (4.41e-2)" "unprognostic (1.07e-1)" "unprognostic (1.14e-2)" "unprognostic (9.93e-3)" "unprognostic (8.89e-2)" "unprognostic (4.27e-2)" "unprognostic (1.02e-1)" 25.4 31.0 37.1 17.2 39.0 38.7 38.9 30.3 38.1 27.4 23.5 35.3 19.9 21.8 25.6 24.9 39.9 32.7 29.5 29.4 36.6 29.2 26.6 22.9 23.5 26.6 38.2 28.5 32.8 35.6 29.9 24.2 19.6 39.2 26.6 21.2 18.8 32.6 23.8 20.9 28.4 25.0 29.3 53.3 19.3 29.5 47.7 39.1 6.8 26.5 23.3 23.5 23.3 24.8 10.0 15.6 22.1 19.3 8.9 12.6 11.9 29.2 20.1 17.0 15.5 15.7 14.6 20.2 21.9 24.7 35.9 30.8 24.0 15.6 8.4 13.7 19.5 22.9 16.3 16.3 18.6 33.1 5.3 32.4 17.1 11.5 18.6 20.7 13.5 13.1 15.8 19.6 19.1 18.0 15.5 28.9 11.3 12.7 7.9 20.0 18.8 9.6 9.2 21.7 23.5 26.8 10.5 30.7 8.6 19.4 29.3 22.1 32.6 21.6 22.2 25.6 20.8 26.4 10.3 19.7 37.3 29.3 26.2 39.0 20.4 8.7 12.4 24.3 13.6 27.3 16.5 19.3 22.1 12.3 19.2 12.6 10.0 9.7 10.4 15.6 9.9 8.7 7.9 16.2 8.9 14.8 8.0 7.6 11.9 37.1 39.0 30.3 38.1 36.6 29.2 38.2 28.5 39.2 39.1 29.8 45.5 39.3 40.6 53.1 35.0 17.3 63.7 66.9 76.2 40.1 11.8 45.7 74.6 105.9 126.0 49.0 65.0 0.0 119.7 62.3 43.4 67.1 71.6 61.8 40.3 42.9 45.5 45.4 49.5 316.4 52.9 44.0 54.0 54.1 58.5 56.9 135.0 52.0 45.3 50.9 30.8 32.3 51.5 70.5 153.1 63.2 90.4 39.5 52.5 79.5 WDR47 KIAA0893 ENSG00000085433 "WD repeat domain 47" O94967 1 108970214-109042113 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.6" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 83.1;Suprabasal keratinocytes: 91.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027287, HPA027289" Approved Approved "Nucleoplasm,Actin filaments" NA NA "Actin filaments" Nucleoplasm "HPA027287: AB_10599416, HPA027289: AB_10601862" "unprognostic (8.55e-2)" "unprognostic (3.36e-2)" "unprognostic (7.51e-2)" "unprognostic (2.44e-1)" "unprognostic (4.90e-1)" "prognostic favorable (9.86e-4)" "unprognostic (4.05e-3)" "unprognostic (2.83e-2)" "unprognostic (2.87e-1)" "unprognostic (3.67e-2)" "unprognostic (2.71e-2)" "unprognostic (1.93e-1)" "unprognostic (8.39e-3)" "unprognostic (7.90e-3)" "unprognostic (9.23e-2)" "unprognostic (2.73e-2)" "unprognostic (8.09e-2)" 7.1 7.2 17.7 5.1 24.0 10.1 6.4 19.9 42.6 8.0 5.6 9.5 3.4 3.7 9.4 5.8 13.7 8.4 7.1 7.5 20.1 20.6 7.5 3.6 6.7 5.0 14.8 21.0 7.6 5.6 10.4 4.4 6.3 24.8 7.3 5.4 5.8 4.7 7.2 14.2 20.3 4.1 9.8 12.7 5.3 5.6 19.9 11.3 5.5 6.1 4.8 7.0 6.8 6.3 3.5 5.6 18.8 5.0 2.2 4.6 2.0 10.8 3.3 6.3 8.0 12.6 11.1 3.4 12.4 7.6 8.3 9.3 3.2 1.6 4.9 6.7 11.8 6.1 12.2 9.0 5.4 10.9 9.0 5.0 4.1 7.3 3.6 7.2 6.3 6.1 6.8 9.1 12.9 6.3 10.1 9.8 5.8 2.4 6.9 14.1 6.4 6.1 5.0 2.7 3.5 6.6 8.7 16.2 2.7 13.8 9.4 11.3 10.2 10.8 5.8 8.6 7.1 2.7 6.5 16.7 11.1 5.1 19.3 10.1 4.4 3.6 4.0 12.9 6.3 16.4 11.4 4.7 5.8 3.2 5.0 2.8 2.0 2.9 3.4 5.1 3.5 2.6 2.2 18.8 2.2 4.5 5.6 4.6 2.0 17.7 24.0 19.9 32.4 20.1 20.6 14.8 21.0 24.8 11.3 11.9 9.2 1.9 4.3 83.1 15.1 17.6 12.7 18.7 10.3 7.0 43.2 2.1 5.0 2.7 24.9 11.7 2.4 0.0 0.8 1.6 6.1 2.2 2.3 1.7 3.9 11.1 2.9 4.9 5.6 30.9 7.8 8.6 23.6 5.4 1.0 12.6 3.3 0.0 14.2 4.8 31.5 6.5 17.6 25.7 26.2 91.2 4.1 4.3 1.7 3.3 WDR49 FLJ33620 ENSG00000174776 "WD repeat domain 49" Q8IV35 3 167478684-167653983 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 21.6;fallopian tube: 20.7" "Group enriched" "Detected in some" 5 "Ciliated cells: 50.9;Club cells: 18.2" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 5.6;myeloid DC: 4.1;plasmacytoid DC: 5.2" "Group enriched" "Detected in many" 24 "dendritic cells: 5.2;monocytes: 5.6" "Cell line enhanced" "Detected in some" "AF22: 3.4;NTERA-2: 3.8;THP-1: 17.1;U-937: 9.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA036225, HPA036226" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA036225: AB_10696652, HPA036226: AB_2675007" "unprognostic (1.68e-3)" "unprognostic (1.24e-3)" "unprognostic (2.48e-2)" "unprognostic (1.96e-1)" "unprognostic (5.67e-2)" "unprognostic (5.11e-3)" "unprognostic (1.66e-1)" "unprognostic (6.02e-2)" "unprognostic (9.28e-3)" "unprognostic (1.34e-1)" "unprognostic (4.60e-9)" "unprognostic (1.79e-4)" "unprognostic (3.50e-2)" "unprognostic (3.57e-2)" "unprognostic (2.07e-1)" 0.5 0.7 6.5 1.1 6.8 3.6 0.6 12.6 5.0 1.2 0.9 8.5 0.0 3.9 1.2 4.4 2.1 20.7 0.7 4.7 12.3 5.4 1.0 0.4 4.0 0.9 7.6 2.8 3.2 0.9 0.4 1.7 0.4 21.6 0.7 0.6 0.0 0.7 0.4 0.4 0.5 8.0 0.7 17.6 1.1 0.8 1.5 14.2 0.0 0.5 0.0 1.0 0.8 0.6 0.2 5.2 0.0 5.6 0.0 0.0 0.7 0.1 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 9.1 0.0 0.0 5.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.1 0.2 0.0 0.0 0.0 0.0 0.1 5.2 0.0 0.7 6.5 6.8 12.6 3.7 12.3 5.4 7.6 2.8 21.6 14.2 0.0 1.1 0.0 0.8 0.0 0.0 1.0 0.0 50.9 18.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.4 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 WDR5 "CFAP89, SWD3" ENSG00000196363 "WD repeat domain 5" P61964 9 134135365-134159968 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 127.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047182 Supported Nucleoplasm NA NA Nucleoplasm "HPA047182: AB_2679971" "unprognostic (9.28e-2)" "unprognostic (1.89e-2)" "unprognostic (1.52e-2)" "unprognostic (1.73e-1)" "unprognostic (1.72e-1)" "unprognostic (2.20e-1)" "unprognostic (1.05e-3)" "unprognostic (2.26e-3)" "unprognostic (1.22e-1)" "unprognostic (1.05e-1)" "unprognostic (4.31e-3)" "unprognostic (4.63e-2)" "unprognostic (7.06e-2)" "unprognostic (5.91e-3)" "unprognostic (1.47e-1)" "unprognostic (3.22e-2)" "unprognostic (2.88e-2)" 14.0 14.3 18.5 18.5 18.1 17.2 27.8 23.1 19.4 14.8 14.3 11.5 13.2 17.5 18.5 12.4 21.0 15.6 13.6 12.4 12.3 10.8 11.8 20.8 13.0 16.0 14.4 15.4 19.1 21.4 16.2 17.6 14.7 12.7 13.3 14.3 10.2 16.9 19.6 32.9 20.5 16.9 13.9 10.0 13.7 15.4 41.6 14.2 19.6 14.3 18.5 17.4 15.2 22.9 7.1 11.3 1.8 10.5 5.3 8.5 7.0 15.3 18.9 18.1 20.6 9.9 11.0 28.7 15.6 10.4 21.4 14.7 22.0 12.7 24.6 10.0 12.7 18.8 38.5 24.5 16.0 17.5 16.4 16.7 14.1 29.6 17.7 10.6 31.6 14.9 10.5 15.2 15.9 19.7 8.8 14.1 24.6 26.3 13.8 14.8 41.1 27.0 26.0 23.0 35.1 23.9 29.6 36.8 23.2 10.5 15.1 30.4 15.8 23.5 18.5 10.4 12.6 25.4 27.9 12.2 22.0 20.2 20.1 25.1 7.2 13.8 26.6 12.7 21.6 17.6 1.0 10.5 1.8 8.1 6.6 8.0 5.4 8.1 8.2 11.3 7.1 8.5 6.4 0.9 5.3 5.4 9.4 7.1 7.0 18.5 18.1 23.1 19.4 12.3 10.8 14.4 15.4 12.7 14.2 8.9 7.5 7.5 12.0 10.5 7.9 8.0 12.7 0.0 3.4 5.2 21.6 21.3 8.3 14.6 127.2 6.3 12.9 0.0 17.9 35.3 10.3 12.8 9.2 17.8 16.7 7.9 6.3 6.2 7.0 22.2 10.6 8.9 5.0 7.2 11.4 6.3 14.6 8.6 11.0 8.4 7.1 6.5 10.1 32.9 42.2 14.3 14.9 8.5 18.3 14.1 WDR55 "FLJ20195, FLJ21702" ENSG00000120314 "WD repeat domain 55" Q9H6Y2 5 140664676-140674124 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043470, HPA048143, HPA075133" Uncertain Enhanced Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA043470: AB_2678495, HPA048143: AB_2680282, HPA075133: " "prognostic unfavorable (1.51e-4)" "unprognostic (1.35e-1)" "unprognostic (7.77e-2)" "unprognostic (1.11e-1)" "unprognostic (1.44e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (8.88e-6)" "unprognostic (9.96e-2)" "unprognostic (2.78e-1)" "unprognostic (3.05e-1)" "unprognostic (4.00e-2)" "unprognostic (1.02e-2)" "unprognostic (1.19e-3)" "unprognostic (1.37e-1)" "unprognostic (2.14e-1)" "unprognostic (3.70e-1)" "unprognostic (2.51e-2)" 17.9 12.4 7.6 17.8 8.8 18.1 12.9 13.0 12.7 9.5 16.6 11.4 16.9 14.9 12.0 11.0 18.8 10.9 20.2 9.6 7.7 9.1 15.3 29.9 12.7 15.0 12.6 8.5 12.0 16.2 11.4 13.2 13.9 10.6 12.8 17.5 8.9 16.7 14.8 18.2 15.8 20.8 11.1 8.9 18.8 14.9 8.0 8.5 12.5 12.0 14.0 21.4 13.5 11.0 10.4 11.3 10.4 18.9 11.3 14.3 10.2 7.9 10.9 5.3 21.3 8.3 6.7 14.9 7.9 9.8 8.5 9.7 18.7 10.9 7.5 10.7 10.3 15.3 9.9 7.2 13.9 6.6 6.9 5.9 8.5 9.0 7.6 8.0 8.9 16.1 7.9 8.1 11.6 6.2 5.8 9.0 8.4 5.9 5.9 9.3 11.3 8.2 8.0 5.6 11.4 9.6 7.0 7.7 7.0 10.1 12.0 5.2 7.0 10.9 31.9 12.1 6.8 22.6 9.6 8.0 11.1 5.8 12.7 10.7 9.8 7.6 5.9 14.3 11.9 6.5 6.9 11.7 8.6 13.9 18.9 14.3 10.4 12.9 11.8 11.3 8.8 10.5 10.7 10.4 11.3 15.4 8.4 14.1 10.2 7.6 8.8 13.0 12.7 7.7 9.1 12.6 8.5 10.6 8.5 8.9 18.4 22.6 8.8 12.9 12.9 4.5 5.1 17.4 18.2 17.4 11.8 19.4 18.3 17.5 20.3 9.5 24.1 0.0 24.4 36.3 12.9 11.7 19.6 13.5 18.9 22.3 14.3 8.6 12.4 6.8 8.9 18.9 8.5 26.2 17.8 5.6 23.0 28.1 7.1 15.6 7.8 12.9 12.3 7.1 9.6 11.7 19.5 20.0 19.8 12.9 WDR61 REC14 ENSG00000140395 "WD repeat domain 61" Q9GZS3 15 78277835-78299794 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039932, HPA040065" Enhanced Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA039932: AB_10796336, HPA040065: AB_10793926" "unprognostic (1.08e-1)" "unprognostic (1.85e-2)" "unprognostic (8.91e-2)" "unprognostic (1.07e-1)" "unprognostic (2.09e-1)" "unprognostic (3.36e-1)" "unprognostic (2.44e-1)" "unprognostic (1.60e-1)" "unprognostic (3.05e-1)" "unprognostic (2.74e-3)" "unprognostic (4.21e-1)" "unprognostic (5.72e-2)" "prognostic favorable (2.03e-10)" "unprognostic (1.04e-1)" "unprognostic (3.13e-1)" "unprognostic (3.18e-1)" "unprognostic (1.09e-2)" 23.8 34.3 23.5 17.2 31.2 29.6 34.5 25.2 32.1 24.3 22.0 27.6 22.7 20.3 24.2 69.4 25.9 27.4 19.6 23.1 23.7 28.2 34.2 28.2 22.4 18.7 26.8 23.1 20.7 30.7 22.4 37.7 27.7 30.8 27.4 25.7 24.9 28.1 23.1 26.3 29.9 18.5 23.6 27.8 18.6 20.9 38.5 20.9 26.9 32.5 30.1 24.6 19.1 20.3 21.9 45.2 11.1 32.4 22.7 25.2 28.7 9.4 24.0 19.0 19.5 18.8 17.3 14.3 14.4 16.2 18.3 18.1 22.9 17.2 18.1 18.0 16.4 29.2 20.1 40.2 17.4 15.2 11.7 31.5 14.6 22.2 22.1 16.4 22.5 16.4 13.3 13.4 7.1 6.1 13.0 20.6 19.0 26.7 20.4 23.9 29.5 19.7 21.9 14.0 23.7 19.3 18.3 14.4 22.1 21.3 29.3 26.5 14.4 19.7 22.2 78.5 20.1 14.2 31.1 12.4 14.4 17.0 10.3 24.8 17.6 26.4 25.7 20.9 36.6 28.6 11.1 31.6 10.5 21.5 32.4 23.2 21.9 21.6 22.3 45.2 16.9 23.0 25.2 2.6 22.7 26.3 24.2 23.5 28.7 23.5 31.2 25.2 32.1 23.7 28.2 26.8 23.1 30.8 20.9 32.8 43.1 20.1 47.2 43.6 50.0 23.2 30.6 62.9 22.7 36.6 45.2 87.6 106.1 52.5 15.9 38.7 22.6 23.3 48.6 62.8 54.1 49.6 46.2 41.4 58.3 41.3 22.4 45.4 29.1 10.0 46.3 46.3 55.6 48.7 33.3 72.9 38.7 28.1 47.7 102.6 46.0 6.5 49.5 95.0 66.6 51.3 77.2 35.9 50.2 41.4 WDR7 "KIAA0541, TRAG" ENSG00000091157 "WD repeat domain 7" Q9Y4E6 18 56651343-57036606 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 29.5;Rod photoreceptor cells: 26.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042074, HPA051057" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042074: AB_2677833, HPA051057: AB_2732563" "unprognostic (1.03e-1)" "unprognostic (1.32e-2)" "unprognostic (1.65e-2)" "unprognostic (1.40e-1)" "unprognostic (3.71e-2)" "unprognostic (3.66e-2)" "unprognostic (1.97e-1)" "unprognostic (3.58e-1)" "unprognostic (7.70e-2)" "unprognostic (9.21e-2)" "unprognostic (2.00e-2)" "unprognostic (5.05e-2)" "prognostic favorable (1.13e-5)" "unprognostic (4.80e-2)" "unprognostic (4.52e-3)" "unprognostic (7.76e-2)" "unprognostic (2.23e-2)" 8.0 11.3 14.2 7.9 21.2 9.1 6.8 16.7 34.0 7.5 7.7 11.9 6.1 6.0 7.1 8.1 6.6 6.4 7.7 8.8 17.3 17.9 7.9 10.4 7.2 9.5 14.4 16.4 6.6 6.2 15.6 19.0 6.9 21.1 11.1 7.4 7.9 6.1 8.8 10.5 5.7 6.1 8.3 12.5 8.3 6.9 6.2 12.1 13.2 13.1 4.0 8.2 7.4 6.3 4.5 6.3 9.2 8.7 7.4 9.0 3.2 3.9 6.6 7.6 4.2 12.0 7.0 1.9 7.8 6.7 6.5 7.7 2.6 2.5 10.9 3.1 7.0 5.5 4.2 7.6 6.1 8.1 12.6 4.6 10.3 5.4 2.4 7.2 15.4 13.1 5.9 5.1 8.6 5.8 5.4 8.0 5.2 4.9 15.1 8.0 3.8 10.6 4.6 3.2 2.0 4.4 4.8 5.8 5.3 4.9 7.1 9.9 4.9 5.6 2.7 3.6 6.7 4.2 4.4 7.0 9.3 4.7 2.8 4.2 15.2 11.3 11.9 7.6 7.8 6.2 7.2 5.0 9.2 6.6 7.6 8.2 4.4 7.5 6.7 6.3 4.5 7.9 7.2 4.6 7.4 8.7 3.0 9.0 3.2 14.2 21.2 16.7 23.7 17.3 17.9 14.4 16.4 21.1 12.1 3.0 4.5 3.7 1.4 2.6 22.0 11.0 7.6 5.3 10.3 0.0 29.5 1.6 3.3 2.6 13.5 6.7 3.6 0.0 3.1 1.0 3.0 3.7 10.4 6.2 5.2 25.4 8.1 8.6 19.1 4.3 5.2 6.4 0.0 4.6 2.7 7.4 2.7 2.9 7.8 3.1 26.3 6.5 3.8 1.9 1.5 2.0 0.6 4.3 3.5 1.4 WDR74 FLJ10439 ENSG00000133316 "WD repeat domain 74" Q6RFH5 11 62832342-62841809 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 77.4" "Group enriched" "Detected in many" 4 "Club cells: 168.4;Early spermatids: 612.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037795, HPA038419" Uncertain Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA037795: AB_10671380, HPA038419: AB_2676006" "unprognostic (5.52e-2)" "unprognostic (3.10e-1)" "unprognostic (1.06e-1)" "unprognostic (1.17e-2)" "unprognostic (4.35e-2)" "unprognostic (3.47e-2)" "unprognostic (3.97e-3)" "unprognostic (6.58e-2)" "unprognostic (1.67e-2)" "unprognostic (1.62e-2)" "unprognostic (2.46e-2)" "unprognostic (8.20e-3)" "unprognostic (1.29e-3)" "unprognostic (2.77e-2)" "unprognostic (6.82e-2)" "unprognostic (1.29e-1)" "unprognostic (1.35e-1)" 14.2 13.2 12.6 19.7 13.8 77.4 14.2 14.6 21.5 12.5 12.5 10.9 8.7 10.8 14.1 10.2 16.1 15.1 12.8 12.6 12.2 11.9 15.5 19.7 10.0 18.1 15.4 16.5 17.4 20.6 9.4 8.0 11.9 13.6 12.5 11.2 8.0 16.5 9.8 42.1 19.8 10.6 11.5 9.5 18.0 13.4 23.5 16.6 16.0 20.0 19.1 16.0 12.4 14.0 39.1 44.8 15.9 34.8 26.8 16.7 11.9 16.4 19.8 7.7 12.8 6.4 8.8 24.0 9.2 10.0 20.1 13.4 28.9 20.2 28.9 26.3 7.6 16.2 22.0 23.7 18.4 15.8 18.4 17.5 14.6 21.8 25.0 18.8 28.9 9.6 8.5 20.7 12.8 42.6 6.6 9.8 21.1 31.8 8.6 9.1 31.6 27.6 46.0 31.5 18.9 26.3 28.2 13.3 50.4 14.2 9.4 17.2 19.4 10.7 22.0 29.7 7.8 15.5 22.4 7.0 11.8 14.2 26.3 23.1 21.4 29.7 35.1 13.0 17.7 15.3 8.7 34.8 3.2 11.7 16.9 14.7 18.6 12.1 11.0 29.2 39.1 16.7 14.8 15.9 26.8 11.3 44.8 13.7 11.9 12.6 13.8 14.6 21.5 12.2 11.9 15.4 16.5 13.6 16.6 35.7 64.8 46.3 33.6 92.8 13.9 1.4 33.1 44.2 168.4 15.7 15.7 47.5 36.5 39.1 612.8 32.3 22.2 0.0 34.8 40.2 35.6 20.1 41.7 28.4 34.0 3.2 39.4 17.8 30.3 74.1 30.5 38.9 28.7 18.0 28.7 13.4 36.2 26.6 20.1 37.0 11.0 19.4 37.3 14.7 27.4 95.5 29.1 57.9 38.1 31.5 WDR75 "FLJ12519, NET16, UTP17" ENSG00000115368 "WD repeat domain 75" Q8IWA0 2 189441433-189475565 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038199 Approved Nucleoplasm NA NA Nucleoplasm "HPA038199: AB_10674548" "unprognostic (1.23e-1)" "unprognostic (7.34e-2)" "unprognostic (3.31e-1)" "unprognostic (1.54e-1)" "unprognostic (4.22e-2)" "unprognostic (1.29e-2)" "prognostic unfavorable (6.50e-8)" "unprognostic (1.49e-1)" "unprognostic (2.46e-3)" "unprognostic (1.93e-2)" "unprognostic (3.25e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (3.15e-11)" "unprognostic (1.34e-1)" "unprognostic (7.56e-2)" "unprognostic (1.10e-1)" "unprognostic (1.38e-2)" 24.8 23.8 15.4 20.7 20.4 17.7 25.5 25.5 25.6 26.8 16.4 16.1 18.4 15.1 25.5 27.3 20.1 21.7 15.6 14.9 16.5 17.0 21.6 18.5 13.7 25.2 20.0 17.5 28.9 22.4 19.0 21.7 17.5 20.7 18.5 19.5 13.9 15.4 14.5 16.7 22.6 17.4 20.9 23.6 24.1 17.6 18.2 24.2 28.9 15.5 25.3 24.0 24.8 19.2 8.1 9.9 3.3 7.8 7.8 13.7 5.6 13.2 12.8 16.2 20.3 17.8 18.9 20.2 28.3 12.5 31.0 24.1 27.0 14.5 29.2 16.0 8.5 12.2 18.9 31.0 18.3 30.5 19.2 14.5 39.0 23.4 19.9 16.8 42.1 19.1 15.6 15.4 22.2 31.2 13.0 20.3 16.2 37.9 16.6 20.5 14.3 19.5 28.1 39.2 15.2 35.3 18.5 26.5 22.8 15.1 16.6 15.9 16.2 18.0 16.2 14.1 27.8 15.0 17.7 19.3 18.3 20.3 14.2 20.5 18.4 29.5 35.7 13.1 19.2 15.5 1.3 5.2 3.3 8.0 7.8 13.7 8.1 8.2 10.5 9.9 6.8 10.8 9.5 0.0 7.8 5.0 5.4 10.4 5.6 15.4 20.4 25.5 25.6 16.5 17.0 20.0 17.5 20.7 24.2 26.8 13.1 8.1 18.3 15.0 6.0 15.4 2.5 10.7 7.9 1.8 7.9 16.5 10.0 12.6 1.4 13.1 5.1 0.0 14.5 13.3 11.8 6.5 4.7 7.8 9.4 15.9 8.6 9.8 30.6 2.1 16.7 8.6 13.5 4.6 10.6 4.4 13.8 8.6 14.9 11.0 8.8 19.4 15.5 28.4 27.9 9.8 14.4 13.1 10.4 14.7 WDR77 "MEP50, p44" ENSG00000116455 "WD repeat domain 77" Q9BQA1 1 111439890-111449376 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 68.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026437, HPA026448, HPA027271" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA026437: AB_10600199, HPA026448: AB_10600993, HPA027271: AB_10602004" "unprognostic (1.84e-1)" "unprognostic (7.01e-2)" "unprognostic (6.26e-3)" "unprognostic (1.19e-3)" "unprognostic (1.12e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (2.06e-6)" "unprognostic (5.14e-1)" "unprognostic (3.88e-3)" "prognostic favorable (7.88e-4)" "unprognostic (6.16e-2)" "unprognostic (1.72e-3)" "unprognostic (1.63e-2)" "unprognostic (8.13e-2)" "unprognostic (1.92e-1)" "unprognostic (6.17e-2)" "unprognostic (1.23e-2)" 11.2 16.5 10.0 17.3 16.2 5.9 9.7 8.5 18.1 9.8 10.9 14.3 5.7 9.5 13.9 15.7 19.0 68.6 15.7 16.6 9.9 10.8 13.6 19.2 9.9 16.8 12.1 9.6 14.6 14.0 15.1 11.7 12.1 15.8 12.6 16.6 10.3 16.4 13.4 27.2 8.9 11.1 13.0 7.9 16.5 14.5 12.9 9.3 19.3 9.9 23.2 22.7 19.1 11.0 24.9 25.7 6.2 17.7 26.7 16.1 11.9 20.7 18.2 17.4 14.3 10.5 6.1 24.2 15.7 8.4 24.1 15.9 26.7 7.8 35.4 15.4 13.3 15.6 15.1 31.4 30.1 29.2 14.0 24.6 21.1 21.3 38.4 11.8 21.6 36.1 7.5 21.6 23.6 15.2 6.4 16.0 15.8 28.1 9.4 23.2 26.2 27.7 11.3 34.2 19.5 30.5 27.7 27.4 13.5 21.4 36.8 14.4 10.5 13.8 17.4 12.5 23.3 14.0 14.9 11.6 13.4 26.9 25.9 33.3 7.8 9.8 31.8 16.9 24.3 39.1 6.2 11.6 2.9 13.9 17.7 15.5 24.9 15.1 15.5 25.7 21.6 16.1 15.0 1.7 26.7 15.5 16.1 12.5 11.9 10.0 16.2 8.5 18.1 9.9 10.8 12.1 9.6 15.8 9.3 11.9 10.7 30.3 21.0 18.4 11.9 21.5 12.7 37.5 9.1 17.4 23.6 49.7 21.6 29.8 2.7 9.8 7.4 0.0 11.8 45.7 9.9 13.5 15.1 13.4 41.0 7.9 15.1 8.0 19.6 2.7 6.9 17.8 5.0 10.8 16.5 8.4 20.0 7.0 8.5 24.4 9.2 12.9 13.1 12.3 22.6 16.2 38.1 17.5 21.3 22.3 WDR81 "CAMRQ2, FLJ33817, PPP1R166, SORF-2" ENSG00000167716 "WD repeat domain 81" Q562E7 17 1716523-1738599 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 20.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023044, HPA063703" Uncertain Approved Nucleoplasm,Vesicles,Cytosol "Intracellular and membrane" NA NA Nucleoplasm "Vesicles, Cytosol" "HPA023044: AB_1858822, HPA063703: " "unprognostic (1.00e-1)" "unprognostic (4.67e-2)" "unprognostic (6.63e-2)" "unprognostic (4.90e-3)" "unprognostic (6.10e-2)" "unprognostic (7.75e-3)" "unprognostic (2.01e-1)" "unprognostic (2.09e-1)" "unprognostic (3.06e-2)" "unprognostic (1.60e-2)" "prognostic favorable (3.30e-4)" "unprognostic (3.26e-1)" "unprognostic (8.72e-2)" "unprognostic (2.25e-1)" "unprognostic (8.43e-2)" "unprognostic (7.99e-2)" "unprognostic (3.90e-2)" 12.7 12.2 8.9 12.1 8.4 10.7 22.9 7.0 11.7 12.6 9.1 10.5 26.4 11.3 14.9 11.6 7.4 12.8 9.3 9.0 8.4 4.3 9.6 22.7 17.2 21.4 9.2 4.4 18.5 8.3 3.5 9.9 8.9 8.5 11.9 4.6 10.6 10.1 21.8 13.1 16.7 12.7 11.6 5.0 19.0 8.4 6.3 8.2 17.3 8.1 5.2 10.3 11.6 16.2 2.8 6.9 5.1 5.0 4.2 3.0 1.9 0.5 10.8 1.5 7.3 10.5 5.8 8.0 0.6 0.1 0.4 0.0 1.4 4.0 4.2 5.8 4.3 5.6 10.2 5.3 7.2 0.3 7.9 11.3 0.1 7.4 4.9 18.0 3.4 6.6 14.5 7.4 5.2 3.2 2.1 4.0 3.4 0.3 5.4 6.0 5.2 1.1 5.8 3.4 3.2 7.6 5.5 2.5 5.6 3.0 1.5 2.1 4.6 3.9 3.3 12.6 0.1 4.9 5.0 6.0 4.2 5.0 6.7 5.5 0.4 0.9 2.4 6.5 5.5 2.9 0.0 3.1 5.1 2.6 5.0 3.0 2.8 2.7 2.6 3.8 2.3 1.8 2.4 0.6 4.2 4.3 6.9 2.4 1.9 8.9 8.4 7.0 11.7 8.4 4.3 9.2 4.4 8.5 8.2 11.9 9.3 4.7 2.5 2.3 4.7 2.6 5.1 4.0 3.4 0.0 3.9 2.1 1.7 2.5 0.5 2.9 5.9 0.0 3.8 1.7 3.1 2.4 4.6 20.9 20.3 4.8 1.2 5.5 17.2 0.4 15.3 9.1 0.0 5.4 4.0 2.8 4.7 3.4 14.2 11.1 1.7 19.4 2.0 0.5 1.5 1.5 1.9 2.9 3.5 1.3 WDR83 MORG1 ENSG00000123154 "WD repeat domain 83" Q9BRX9 19 12666800-12675832 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042629, HPA042838" Uncertain Approved Nucleoplasm,Vesicles,Centrosome NA NA Vesicles "Nucleoplasm, Centrosome" "HPA042629: AB_10794763, HPA042838: AB_10794173" "unprognostic (1.12e-2)" "unprognostic (3.15e-3)" "unprognostic (1.43e-3)" "unprognostic (1.34e-2)" "unprognostic (1.36e-1)" "unprognostic (1.35e-2)" "unprognostic (2.64e-1)" "unprognostic (3.60e-3)" "unprognostic (2.52e-1)" "unprognostic (1.56e-2)" "prognostic favorable (5.44e-4)" "unprognostic (1.30e-2)" "unprognostic (4.07e-2)" "unprognostic (2.85e-2)" "unprognostic (1.18e-1)" "unprognostic (2.37e-1)" "prognostic favorable (3.12e-4)" 6.4 7.8 10.2 6.2 9.1 8.8 6.5 17.2 14.5 7.1 5.2 9.1 2.3 4.9 5.8 6.1 5.9 11.3 5.2 9.2 8.5 8.9 8.1 5.9 6.0 8.3 12.4 11.6 9.2 11.6 9.4 6.7 4.9 9.1 6.9 2.6 7.7 14.6 6.9 4.6 11.3 6.3 3.8 7.0 7.4 7.1 9.2 10.6 11.7 9.2 2.6 5.8 6.0 5.7 8.8 19.4 5.4 11.1 17.6 11.3 8.6 4.9 8.3 4.7 6.5 9.3 3.5 3.8 4.7 4.4 5.7 6.0 9.6 4.3 7.5 6.9 4.2 3.2 5.6 5.5 7.3 1.0 7.6 12.2 5.9 5.5 6.0 7.4 8.2 7.0 6.4 5.9 4.6 3.8 3.8 5.7 16.3 5.2 0.8 2.6 18.8 11.9 6.7 3.8 5.8 14.4 8.5 6.1 7.0 5.4 5.9 9.9 6.6 5.1 7.0 4.1 2.7 3.9 8.1 3.1 6.4 2.0 5.1 4.9 19.1 12.8 3.3 10.0 6.3 4.1 4.5 11.1 4.6 9.2 9.6 10.7 8.1 8.9 8.6 11.1 8.8 8.7 11.3 5.4 17.6 4.7 19.4 9.8 8.6 10.2 9.1 17.2 14.5 8.5 8.9 12.4 11.6 9.1 10.6 0.0 15.6 12.6 11.4 13.7 20.5 4.2 12.7 10.7 7.9 17.4 11.8 11.1 14.9 13.6 13.8 10.5 9.3 0.0 15.2 11.6 11.0 13.4 13.9 7.2 11.5 19.1 9.2 9.2 11.6 43.7 14.7 14.8 15.1 18.0 6.7 15.0 11.1 5.9 17.0 22.6 20.4 19.4 13.2 25.0 16.9 14.1 7.6 16.2 8.1 12.2 WDR88 PQWD ENSG00000166359 "WD repeat domain 88" Q6ZMY6 19 33132090-33175795 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 25.2" "Group enriched" "Detected in some" 15 "Early spermatids: 24.8;Late spermatids: 9.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "JURKAT: 6.4" "Not detected" "Not detected" "HPA041916, HPA050336" Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA041916: AB_10804121, HPA050336: AB_2681093" "unprognostic (1.02e-1)" "unprognostic (9.40e-2)" "unprognostic (3.12e-1)" "unprognostic (1.33e-4)" "unprognostic (5.14e-2)" "unprognostic (7.98e-2)" "unprognostic (8.44e-2)" "unprognostic (2.01e-1)" "unprognostic (6.62e-2)" "unprognostic (1.60e-1)" "unprognostic (1.06e-4)" "unprognostic (3.40e-1)" "unprognostic (1.87e-2)" "unprognostic (2.28e-1)" "unprognostic (1.63e-1)" "unprognostic (2.43e-2)" "unprognostic (6.67e-2)" 0.3 0.5 0.4 1.1 0.6 1.0 0.3 0.7 1.4 0.3 0.3 0.3 0.3 0.7 0.3 0.3 0.7 0.2 0.6 1.2 0.4 0.4 0.3 0.3 0.3 1.6 0.3 0.3 1.0 1.0 0.0 0.5 0.3 0.3 0.3 0.0 0.3 1.1 0.3 0.3 0.9 0.9 0.3 0.3 0.6 0.3 25.2 0.3 0.3 1.4 0.3 0.3 0.3 0.3 1.2 0.6 0.6 1.3 2.9 1.4 0.3 1.0 2.2 1.5 2.7 0.8 0.0 2.0 0.8 0.0 0.2 0.0 1.1 2.2 2.7 1.4 0.0 1.6 0.8 0.0 0.3 0.0 5.5 0.8 2.5 1.7 0.5 0.0 1.9 2.2 0.0 0.0 0.0 0.0 0.6 0.0 6.4 1.7 2.8 0.0 3.2 1.1 1.2 1.1 0.9 0.9 2.1 0.8 0.5 0.0 1.3 3.9 3.9 2.7 1.2 0.6 1.9 3.4 2.0 1.5 0.7 2.1 1.2 0.4 2.6 1.8 1.5 0.4 4.2 1.1 0.0 0.4 0.4 1.4 1.3 1.3 0.0 1.2 1.0 0.3 1.2 0.8 0.7 0.6 2.9 0.6 0.6 0.2 0.3 0.4 0.6 0.7 0.8 0.4 0.4 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.0 0.0 0.0 0.0 WDR92 "FLJ31741, Monad" ENSG00000243667 "WD repeat domain 92" Q96MX6 2 68122936-68157560 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 48.2;Cone photoreceptor cells: 45.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035335, HPA035336" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA035335: AB_10959456, HPA035336: AB_10964348" "unprognostic (3.55e-2)" "unprognostic (3.42e-3)" "unprognostic (6.80e-2)" "unprognostic (1.69e-2)" "unprognostic (1.31e-1)" "unprognostic (3.20e-2)" "unprognostic (3.76e-3)" "unprognostic (2.51e-2)" "unprognostic (1.34e-1)" "unprognostic (2.01e-1)" "unprognostic (4.91e-2)" "unprognostic (3.61e-1)" "unprognostic (3.56e-3)" "unprognostic (9.86e-2)" "unprognostic (7.23e-2)" "unprognostic (4.07e-1)" "unprognostic (3.15e-2)" 9.5 12.4 16.6 12.8 26.5 5.2 12.3 19.8 17.3 9.2 10.0 12.3 6.5 9.2 11.1 23.7 10.5 16.2 7.8 12.7 12.2 10.7 8.7 9.8 8.3 12.9 8.7 7.9 11.3 13.5 15.8 17.1 8.2 15.0 12.2 11.9 10.9 10.8 12.4 15.4 14.9 8.6 16.2 9.5 11.1 9.2 12.8 12.3 10.2 12.9 12.2 12.1 10.1 10.2 8.8 7.9 1.9 4.1 9.0 8.5 4.8 14.4 10.3 11.6 11.9 13.3 13.9 10.4 13.2 9.1 11.3 11.8 8.0 12.3 17.9 4.7 9.0 15.9 14.7 12.0 8.1 14.5 11.8 14.5 17.2 12.7 8.0 6.7 19.1 5.2 8.7 10.5 9.4 8.2 12.2 11.0 14.1 13.0 10.8 12.6 9.1 12.5 16.7 12.2 13.4 12.3 14.9 16.0 13.9 11.3 8.2 12.9 10.9 8.6 15.2 11.4 12.1 11.8 12.0 13.7 18.0 8.1 11.5 11.4 7.6 11.1 11.7 18.8 18.8 9.2 0.7 3.9 1.9 5.7 4.1 7.7 8.8 6.1 6.3 4.6 8.5 8.0 8.5 1.6 9.0 2.7 7.9 5.9 4.8 16.6 26.5 19.8 17.3 12.2 10.7 8.7 7.9 15.0 12.3 3.0 7.5 12.4 4.4 3.1 22.3 3.1 0.0 48.2 13.6 5.2 45.2 11.9 1.7 6.6 4.7 5.8 1.0 23.3 5.7 7.3 5.3 2.5 12.7 5.0 6.2 11.1 0.0 3.7 1.6 2.2 7.2 4.0 1.7 5.4 3.0 10.1 5.1 3.5 8.9 6.3 21.5 6.5 4.1 27.1 14.3 3.6 4.2 4.1 7.3 1.7 WDSUB1 "FLJ36175, UBOX6, WDSAM1" ENSG00000196151 "WD repeat, sterile alpha motif and U-box domain containing 1" Q8N9V3 2 159235793-159286799 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036840, HPA058172" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA036840: AB_10670926, HPA058172: AB_2683628" "unprognostic (1.37e-2)" "prognostic favorable (3.35e-4)" "unprognostic (2.56e-1)" "unprognostic (7.33e-3)" "unprognostic (3.44e-2)" "unprognostic (9.65e-2)" "prognostic unfavorable (2.67e-4)" "unprognostic (2.76e-3)" "unprognostic (4.90e-3)" "unprognostic (1.10e-1)" "unprognostic (1.07e-2)" "unprognostic (6.75e-2)" "unprognostic (3.46e-3)" "unprognostic (8.49e-2)" "unprognostic (1.72e-1)" "unprognostic (1.00e-2)" "unprognostic (2.87e-2)" 10.3 14.2 9.7 6.6 12.7 10.9 14.8 18.9 14.0 10.3 8.5 8.9 10.6 5.8 9.8 22.1 11.1 11.8 9.9 11.5 9.7 10.6 27.7 8.2 10.7 16.1 11.5 7.0 16.4 15.5 19.4 23.8 15.7 9.2 11.3 9.2 16.0 11.8 8.7 7.7 8.2 7.7 9.9 9.5 10.5 9.0 7.7 10.2 8.5 22.2 6.1 9.2 10.0 15.0 9.8 10.3 2.8 9.3 16.2 13.0 6.2 6.1 4.6 4.2 6.6 7.6 8.8 14.2 4.8 9.5 8.8 15.5 9.9 10.0 8.2 5.1 7.2 15.1 3.7 11.7 4.4 12.4 3.2 9.7 8.4 5.3 10.0 9.3 7.1 11.7 5.1 16.4 10.8 8.9 16.9 7.2 10.9 11.1 6.2 8.3 6.3 5.1 13.2 5.7 10.4 9.9 8.0 6.2 4.4 10.1 8.9 7.8 5.1 5.0 6.5 11.2 20.4 5.0 12.6 3.0 6.3 4.6 8.8 4.6 3.2 5.3 7.6 11.1 8.9 3.9 2.7 9.3 2.8 13.0 7.0 9.8 9.8 5.2 8.1 10.3 8.9 6.3 7.4 0.6 16.2 6.3 9.7 2.6 6.2 9.7 12.7 18.9 14.0 9.7 10.6 11.5 7.0 9.2 10.2 11.9 5.0 6.7 7.4 4.7 6.4 10.7 10.2 17.4 9.1 19.2 2.0 20.1 29.9 7.2 3.0 6.6 5.1 0.0 3.1 7.7 8.8 6.6 11.5 1.7 15.4 4.8 5.2 6.2 13.9 2.1 11.8 9.5 5.0 3.6 5.5 6.0 4.7 9.0 10.6 17.4 8.9 0.0 7.1 10.5 20.2 5.5 19.2 10.1 7.0 5.1 WDYHV1 "C8orf32, FLJ10204" ENSG00000156795 "WDYHV motif containing 1" Q96HA8 8 123416725-123467230 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 39.8" "Low region specificity" "Detected in all" "HPA024823, HPA053680" Approved Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA024823: AB_1845773, HPA053680: AB_2682228" "unprognostic (9.97e-2)" "unprognostic (4.82e-2)" "unprognostic (3.48e-1)" "prognostic unfavorable (4.93e-5)" "unprognostic (1.69e-1)" "unprognostic (5.00e-2)" "prognostic unfavorable (3.47e-4)" "unprognostic (1.93e-2)" "unprognostic (1.20e-1)" "unprognostic (1.90e-1)" "unprognostic (1.19e-1)" "unprognostic (5.79e-2)" "unprognostic (2.81e-2)" "unprognostic (1.26e-1)" "unprognostic (5.39e-2)" "unprognostic (7.46e-2)" "unprognostic (2.37e-1)" 10.5 15.5 13.2 7.9 13.6 6.3 17.2 14.3 16.8 14.5 9.9 13.9 10.7 5.8 11.2 12.0 10.2 9.8 8.8 24.8 12.8 19.8 13.6 9.1 8.6 11.4 17.0 10.8 20.4 21.3 9.0 12.8 8.2 16.2 13.5 9.5 9.7 8.3 12.5 19.2 9.8 5.4 13.0 17.0 7.9 10.0 17.5 15.6 5.3 14.4 9.1 11.3 10.1 9.1 5.9 7.2 8.7 7.5 13.1 9.2 5.5 9.1 10.8 12.7 6.7 5.5 12.6 5.7 7.6 6.7 7.2 9.2 6.4 6.1 7.3 6.9 5.3 10.2 5.3 8.1 8.8 9.7 17.2 7.1 7.9 5.2 8.7 7.7 3.0 3.4 8.5 5.4 9.6 11.8 9.3 7.2 13.8 5.9 10.1 10.6 28.5 8.8 6.2 5.1 21.2 7.4 5.1 8.0 5.8 9.6 8.1 6.5 14.1 7.8 39.8 12.1 14.3 6.6 3.3 3.9 9.6 15.1 7.1 9.2 7.6 15.4 9.0 7.8 4.6 6.0 8.7 6.3 2.5 7.8 7.5 8.4 5.2 8.4 7.3 7.2 5.9 6.5 7.4 1.8 13.1 4.0 4.6 9.2 5.5 13.2 13.6 14.3 16.8 12.8 19.8 17.0 10.8 16.2 15.6 3.0 6.7 12.0 8.7 6.6 5.4 16.2 7.6 1.4 5.7 14.0 2.0 10.4 33.2 10.5 7.6 8.2 3.3 0.0 13.2 18.4 7.7 13.3 8.1 4.2 12.0 4.8 0.0 10.4 9.5 11.5 8.1 7.2 10.1 9.0 6.2 6.0 10.4 9.1 11.0 11.2 7.2 12.9 11.3 20.6 28.7 7.9 8.4 4.3 8.8 8.7 WEE2 FLJ16107 ENSG00000214102 "WEE1 homolog 2" P0C1S8 7 141708353-141731271 "Enzymes, Predicted intracellular proteins" Meiosis "Kinase, Transferase, Tyrosine-protein kinase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 21 "Distal tubular cells: 1.7;Proximal tubular cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "CACO-2: 8.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA027418, HPA054280" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA027418: AB_10603144, HPA054280: " "unprognostic (6.35e-2)" "unprognostic (1.47e-1)" "unprognostic (1.89e-1)" "unprognostic (3.18e-1)" "unprognostic (2.33e-1)" "unprognostic (4.00e-2)" "unprognostic (2.90e-1)" "unprognostic (1.97e-2)" "unprognostic (3.23e-2)" "unprognostic (3.02e-2)" "unprognostic (2.61e-1)" "unprognostic (1.76e-2)" "unprognostic (1.73e-1)" "unprognostic (3.25e-2)" "unprognostic (2.66e-1)" "unprognostic (6.07e-2)" "unprognostic (2.88e-3)" 0.6 0.1 0.5 0.3 1.0 0.0 0.4 0.8 0.6 0.6 0.1 0.0 0.7 0.0 1.3 0.7 1.6 1.3 0.5 0.6 1.3 0.1 0.3 1.6 0.6 1.2 1.1 0.0 1.0 0.0 0.3 0.0 0.9 0.0 0.7 2.8 0.4 0.0 0.8 0.4 0.8 1.3 2.0 0.0 0.5 0.3 0.2 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 1.4 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 8.2 0.4 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 1.4 0.1 0.1 0.0 0.3 1.0 0.3 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.3 0.5 1.6 1.2 0.0 0.0 0.2 0.1 0.0 0.9 0.0 0.0 0.2 0.1 1.7 1.1 0.5 0.0 0.4 0.7 0.0 0.0 0.0 0.4 0.0 0.1 0.2 0.4 0.6 0.0 0.1 0.1 0.6 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 WIPF2 "WICH, WIRE" ENSG00000171475 "WAS/WASL interacting protein family member 2" Q8TF74 17 40219304-40284136 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 48.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024000, HPA024001, HPA024467" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA024000: AB_1858840, HPA024001: AB_1858841, HPA024467: AB_1858842" "unprognostic (1.90e-1)" "unprognostic (1.02e-1)" "unprognostic (2.59e-1)" "unprognostic (6.07e-2)" "unprognostic (2.63e-2)" "unprognostic (1.83e-1)" "unprognostic (5.18e-3)" "unprognostic (1.92e-1)" "unprognostic (2.05e-1)" "unprognostic (8.51e-3)" "unprognostic (2.05e-2)" "unprognostic (4.34e-2)" "unprognostic (1.32e-3)" "unprognostic (4.12e-1)" "unprognostic (7.51e-2)" "unprognostic (5.28e-2)" "unprognostic (9.23e-2)" 13.0 9.4 21.0 11.5 21.6 18.8 10.7 23.0 27.4 12.8 17.3 15.8 11.1 14.8 13.2 11.7 18.9 11.9 12.4 7.9 22.3 16.8 15.6 9.4 15.4 9.5 16.7 18.5 10.3 13.7 19.3 10.6 14.5 16.1 11.0 17.1 9.4 12.2 13.4 7.6 18.8 16.2 15.0 13.8 14.1 15.8 9.5 17.7 8.3 11.2 8.1 13.3 12.4 20.4 4.3 4.1 11.4 3.2 3.8 5.3 1.5 11.3 17.2 7.5 7.0 7.9 8.3 7.4 10.0 7.0 9.1 9.7 8.4 9.7 6.5 11.3 11.8 11.3 19.2 6.3 7.5 12.4 11.5 7.7 7.0 8.5 10.0 8.0 9.1 8.0 6.6 9.7 9.6 10.8 9.8 8.8 7.0 6.6 6.0 8.7 6.4 9.0 4.6 4.5 8.2 5.4 5.8 9.0 6.4 9.7 17.7 9.2 6.5 17.9 48.6 6.5 13.4 16.5 5.7 12.7 6.2 9.4 11.8 11.2 6.9 10.4 6.8 13.7 4.9 9.2 6.8 3.2 3.5 5.3 2.9 4.6 4.3 3.2 3.4 2.4 3.7 3.7 3.3 11.4 3.8 3.2 4.1 3.8 1.5 21.0 21.6 23.0 27.4 22.3 16.8 16.7 18.5 16.1 17.7 62.5 30.4 19.3 28.3 38.2 34.5 10.4 40.8 17.4 17.0 43.6 43.2 41.5 11.6 25.9 2.1 31.3 67.0 0.0 31.5 23.9 26.2 34.4 38.0 20.9 26.2 39.7 45.4 40.5 36.8 2.5 18.7 21.8 15.1 19.8 27.8 24.3 38.9 54.5 24.4 21.7 17.3 38.8 24.7 17.3 35.4 60.3 56.3 25.4 30.7 64.6 WIPI1 "ATG18, ATG18A, FLJ10055, WIPI49" ENSG00000070540 "WD repeat domain, phosphoinositide interacting 1" Q5MNZ9 17 68420948-68457513 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Extravillous trophoblasts: 132.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 25.0;eosinophil: 53.0" "Lineage enriched" "Detected in all" 9 "granulocytes: 53.0" "Cell line enhanced" "Detected in many" "ASC diff: 52.6;ASC TERT1: 40.2;HHSteC: 50.7;HSkMC: 42.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007493, CAB037230" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB037230: AB_1841265, HPA007493: AB_1848642" "unprognostic (2.83e-2)" "unprognostic (7.85e-2)" "unprognostic (1.05e-3)" "unprognostic (1.31e-1)" "unprognostic (1.42e-1)" "unprognostic (3.03e-2)" "unprognostic (3.97e-3)" "unprognostic (1.78e-2)" "prognostic favorable (3.11e-4)" "unprognostic (2.86e-1)" "unprognostic (1.79e-1)" "unprognostic (3.06e-1)" "unprognostic (6.32e-3)" "unprognostic (6.56e-2)" "unprognostic (4.99e-2)" "unprognostic (1.78e-1)" "unprognostic (1.89e-3)" 18.4 11.0 6.0 6.5 10.0 10.5 19.6 7.6 9.6 16.1 15.9 7.8 39.7 5.7 9.0 12.9 8.1 6.7 10.7 34.8 5.3 3.7 20.2 11.5 14.4 12.2 8.5 5.3 6.9 23.9 10.0 10.2 33.5 9.4 8.4 17.9 11.5 30.2 19.3 49.3 11.8 7.7 10.0 7.5 8.9 14.5 4.6 6.5 1.6 10.0 25.2 9.8 10.3 10.3 1.1 2.2 53.0 5.7 2.5 3.1 3.3 1.0 2.2 1.9 2.8 52.6 40.2 10.7 7.7 36.8 3.1 10.0 1.6 1.6 0.5 3.5 16.5 11.0 0.8 0.7 4.9 5.5 0.9 0.9 7.6 0.7 9.4 50.7 0.5 11.0 42.3 9.1 12.3 16.8 10.3 13.9 1.1 0.4 19.2 9.3 6.5 0.1 1.5 0.4 2.8 3.2 0.1 6.7 7.4 4.7 3.7 0.5 2.6 1.7 24.1 39.1 10.7 12.4 2.1 13.2 15.3 2.2 7.0 1.9 16.8 19.0 2.2 23.1 3.6 6.8 25.0 4.6 53.0 3.1 5.5 1.4 1.1 0.8 3.0 2.2 0.4 0.0 1.5 9.7 2.5 5.7 1.5 0.6 3.3 6.0 10.0 7.6 9.6 5.3 3.7 8.5 5.3 9.4 6.5 8.9 11.5 11.1 11.2 6.9 11.0 6.7 25.5 53.5 33.0 15.7 2.0 35.8 26.6 25.2 5.6 10.8 13.4 70.0 49.5 132.1 43.1 46.3 6.9 10.6 31.2 9.5 11.5 41.1 15.3 3.6 42.8 14.5 40.5 47.7 56.7 12.4 33.5 11.5 39.6 54.2 12.4 25.8 15.5 4.4 4.5 5.9 104.6 17.5 25.7 23.5 WIPI2 "ATG18B, ATG21, CGI-50, DKFZP434J154, DKFZp686P02188, FLJ12979, FLJ14217, FLJ42984" ENSG00000157954 "WD repeat domain, phosphoinositide interacting 2" Q9Y4P8 7 5190188-5233826 "Predicted intracellular proteins" Autophagy "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019852, HPA021488" Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA019852: AB_1846589, HPA021488: AB_1846591" "unprognostic (5.79e-2)" "unprognostic (1.47e-1)" "unprognostic (2.57e-2)" "prognostic unfavorable (7.69e-5)" "unprognostic (1.96e-3)" "unprognostic (9.27e-3)" "unprognostic (4.60e-3)" "unprognostic (4.96e-2)" "unprognostic (6.60e-2)" "unprognostic (4.23e-1)" "prognostic favorable (9.78e-4)" "unprognostic (1.20e-1)" "prognostic favorable (2.05e-6)" "unprognostic (2.61e-2)" "unprognostic (1.37e-1)" "unprognostic (7.41e-2)" "unprognostic (6.98e-2)" 24.5 23.6 33.9 17.8 34.7 32.7 21.9 30.6 47.4 20.6 21.7 27.8 17.4 20.3 24.4 23.1 25.4 25.3 20.5 30.5 27.9 27.2 23.5 27.5 21.9 22.3 26.0 31.2 25.0 30.8 28.7 23.2 27.0 26.1 25.0 17.2 25.0 34.7 25.5 28.3 31.8 18.2 22.9 25.6 22.0 23.0 49.3 26.0 26.6 24.1 15.9 23.4 22.9 20.5 6.1 6.9 13.0 6.3 2.6 9.2 2.2 27.2 17.4 17.1 29.1 26.3 27.6 26.3 24.3 28.0 26.0 27.5 16.9 25.4 19.5 18.7 30.4 32.4 20.0 17.2 19.8 20.3 10.0 26.7 13.3 17.6 18.6 26.0 20.8 14.6 29.0 23.9 29.5 16.4 26.0 36.1 26.8 37.6 17.7 23.5 28.3 15.8 36.1 35.5 14.6 25.6 26.1 24.4 32.0 17.1 13.3 21.3 32.1 17.8 30.7 21.1 29.9 18.8 39.8 28.6 16.6 35.0 27.7 18.1 31.8 29.6 22.2 27.1 24.2 24.5 0.3 4.9 13.0 5.1 6.3 3.1 5.6 6.7 9.1 4.5 6.1 8.5 5.4 9.9 2.6 4.2 6.9 9.2 2.2 33.9 34.7 30.6 47.4 27.9 27.2 26.0 31.2 26.1 26.0 35.7 26.9 47.2 36.3 48.8 67.7 25.4 25.5 21.4 17.0 17.4 58.9 79.1 61.3 36.3 146.8 28.9 32.1 46.7 36.2 84.9 33.8 70.9 31.1 55.0 59.9 44.5 37.9 47.9 51.5 127.3 39.4 39.2 42.2 65.9 47.0 87.1 45.2 38.5 52.6 60.3 50.4 51.8 32.0 181.0 130.5 62.0 126.1 42.4 42.2 42.4 WIZ ZNF803 ENSG00000011451 "Widely interspaced zinc finger motifs" O95785 19 15419980-15449951 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022923, HPA023774" Supported Enhanced Nucleoplasm,Midbody Yes No Nucleoplasm Midbody "HPA022923: AB_1858845, HPA023774: AB_2671308" "unprognostic (3.50e-2)" "unprognostic (3.91e-2)" "unprognostic (1.21e-2)" "prognostic unfavorable (5.12e-5)" "unprognostic (1.05e-1)" "unprognostic (4.96e-3)" "unprognostic (9.73e-3)" "unprognostic (3.00e-1)" "unprognostic (2.24e-2)" "unprognostic (4.69e-2)" "unprognostic (7.46e-2)" "unprognostic (5.47e-2)" "unprognostic (2.65e-1)" "unprognostic (4.27e-2)" "unprognostic (1.11e-1)" "unprognostic (2.31e-2)" "unprognostic (2.11e-1)" 28.0 17.5 27.6 18.3 21.6 13.6 20.9 15.8 24.4 17.5 17.3 12.8 18.0 18.2 25.2 12.0 16.3 16.3 15.3 17.3 23.0 11.4 13.8 18.4 13.5 17.5 14.1 19.0 21.6 26.9 14.3 10.9 13.7 13.7 17.4 7.7 12.4 21.9 23.1 24.4 21.5 16.8 16.5 11.9 18.0 15.6 40.9 15.8 18.6 13.3 14.6 12.1 19.3 21.4 2.0 1.5 0.7 3.6 2.5 1.2 0.5 13.5 9.3 13.4 17.0 19.3 7.9 10.9 14.2 7.0 11.9 8.2 8.2 25.5 11.3 23.5 12.9 7.2 11.6 7.3 10.0 2.9 8.8 12.5 8.2 7.2 6.4 12.3 9.4 12.3 14.0 13.2 8.6 9.4 7.4 10.7 8.9 12.8 9.7 8.0 27.6 17.1 8.7 18.1 13.3 22.2 16.0 6.1 11.4 7.7 10.6 18.3 23.3 12.5 11.4 9.2 4.8 12.5 8.9 17.2 27.3 10.8 21.4 18.1 14.4 8.6 12.2 11.4 11.4 18.4 0.0 1.4 0.0 1.2 1.2 1.0 0.5 0.8 1.2 1.0 2.0 1.0 1.0 0.7 2.5 3.6 1.5 0.8 0.5 27.6 21.6 15.8 24.4 23.0 11.4 14.1 19.0 13.7 15.8 11.9 5.8 8.5 5.5 14.1 8.8 9.1 12.7 0.0 3.4 12.2 0.0 6.1 3.3 12.3 6.3 13.5 5.0 0.0 17.1 8.3 9.9 8.6 1.1 13.2 6.7 6.4 6.4 13.5 10.2 6.4 14.7 7.1 6.8 5.4 9.5 7.1 16.5 0.0 18.0 4.7 7.5 12.9 10.8 27.2 26.0 17.8 6.2 4.4 10.5 11.8 WNT2B "WNT13, XWNT2" ENSG00000134245 "Wnt family member 2B" Q93097 1 112466541-112530165 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 66.7" "Group enriched" "Detected in many" 4 "Leydig cells: 74.2;Peritubular cells: 185.6" "Cancer enhanced" "Detected in many" "testis cancer: 4.4" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 6.8;HSkMC: 13.0;SuSa: 5.3;TIME: 5.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047274, HPA066368" Approved Nucleoplasm,Vesicles "Secreted to extracellular matrix" NA NA Vesicles Nucleoplasm "HPA047274: AB_2732539, HPA066368: AB_2685664" "unprognostic (2.08e-3)" "unprognostic (2.06e-3)" "unprognostic (2.94e-2)" "unprognostic (1.25e-1)" "unprognostic (1.77e-1)" "unprognostic (1.49e-1)" "unprognostic (9.42e-2)" "unprognostic (4.90e-3)" "unprognostic (1.15e-1)" "unprognostic (2.37e-1)" "unprognostic (5.94e-2)" "unprognostic (1.13e-1)" "unprognostic (5.65e-4)" "unprognostic (5.41e-2)" "unprognostic (7.64e-2)" "unprognostic (4.80e-2)" "unprognostic (2.49e-2)" 3.4 1.9 1.7 3.4 4.6 0.2 2.1 2.6 2.9 9.2 12.0 0.8 3.7 3.9 7.5 5.4 7.6 4.4 8.0 3.6 1.6 1.7 1.8 0.5 5.2 0.9 2.0 2.4 28.7 2.0 1.2 1.9 6.0 1.5 7.3 6.8 66.7 1.7 18.3 1.3 13.4 9.1 12.9 3.0 1.2 4.4 16.2 0.8 0.5 1.4 5.6 1.9 10.3 8.5 2.3 1.2 1.7 0.7 0.8 1.2 0.1 0.7 0.4 3.4 0.8 3.4 6.8 0.6 1.4 1.5 0.4 0.6 0.3 0.7 1.8 0.3 1.6 0.4 2.1 1.1 0.5 0.3 0.1 0.7 0.2 1.1 0.5 2.9 0.2 0.8 13.0 1.2 0.6 0.2 1.9 1.7 0.5 0.2 0.3 0.4 0.5 0.1 0.2 0.6 0.1 0.5 0.1 0.5 0.0 2.4 0.4 0.5 0.5 1.3 0.2 1.1 5.3 0.1 0.4 5.2 0.5 2.0 1.3 0.4 0.2 0.1 0.0 1.4 0.2 1.3 0.9 0.7 1.0 0.9 0.3 0.8 1.4 1.2 1.0 0.3 2.3 0.4 0.7 1.7 0.8 0.5 1.2 0.4 0.1 1.7 4.6 2.6 2.9 1.6 1.7 2.0 2.4 1.5 0.8 11.9 3.5 0.5 1.6 9.0 13.0 3.9 2.5 4.0 2.3 1.8 25.5 1.6 0.0 0.7 3.5 8.4 2.3 0.0 1.2 0.7 7.8 1.5 2.3 0.0 1.0 4.8 8.1 4.9 1.6 2.8 74.2 5.7 3.3 1.8 1.7 8.2 1.6 4.2 185.6 0.6 30.4 0.0 2.8 4.2 4.2 12.2 1.6 1.9 1.5 2.0 WRAP53 "FLJ10385, TCAB1, WDR79" ENSG00000141499 "WD repeat containing antisense to TP53" Q9BUR4 17 7686071-7703502 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" "Chaperone, RNA-binding" "Disease mutation, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 32.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023026, HPA028130, HPA029928" Enhanced Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA023026: AB_10963931, HPA028130: AB_10961728, HPA029928: AB_2673257" "unprognostic (1.45e-1)" "unprognostic (3.50e-3)" "unprognostic (6.81e-2)" "unprognostic (2.53e-3)" "unprognostic (3.86e-1)" "unprognostic (2.10e-1)" "prognostic unfavorable (4.70e-4)" "unprognostic (8.69e-2)" "unprognostic (3.29e-1)" "unprognostic (1.41e-1)" "prognostic favorable (8.26e-4)" "unprognostic (2.68e-2)" "unprognostic (5.67e-2)" "unprognostic (7.23e-2)" "unprognostic (2.47e-1)" "unprognostic (2.93e-2)" "unprognostic (4.04e-1)" 6.9 6.9 8.1 10.3 8.0 13.3 6.8 11.8 10.7 7.4 7.2 10.6 6.8 6.8 8.4 8.4 7.9 25.6 7.7 6.8 7.5 6.6 9.4 6.6 8.7 12.7 7.9 5.8 7.8 12.0 6.1 7.6 8.1 7.8 5.3 7.3 7.8 6.6 6.6 9.8 8.1 7.7 7.8 5.4 12.5 7.2 11.4 8.3 22.8 7.6 6.6 12.8 7.5 6.2 4.7 6.6 20.0 5.8 4.2 8.5 3.5 11.2 21.1 15.2 15.2 4.6 4.3 8.9 7.3 7.8 24.0 22.4 12.2 7.0 13.5 7.7 6.5 10.6 12.5 17.4 12.9 18.5 8.1 22.6 6.2 14.0 10.2 4.1 4.8 8.1 3.4 5.0 21.1 4.8 3.6 15.5 16.2 5.9 4.4 9.5 10.2 13.8 11.6 8.1 8.9 10.6 18.3 10.0 7.9 8.8 4.0 7.0 10.6 11.5 6.2 6.1 7.9 8.4 5.1 5.4 9.5 10.1 0.0 18.8 3.5 8.9 7.1 8.6 8.2 11.6 20.0 5.2 4.6 5.4 5.8 6.3 3.3 4.2 6.0 4.7 4.7 3.8 4.4 2.7 4.2 2.3 6.6 8.5 3.5 8.1 8.0 11.8 10.7 7.5 6.6 7.9 5.8 7.8 8.3 3.0 4.3 9.3 4.9 3.4 4.6 2.3 2.5 32.1 3.4 10.4 5.9 9.2 3.3 8.2 2.6 4.0 3.4 0.0 8.8 14.2 3.8 1.7 1.1 4.9 6.8 1.6 2.9 3.1 7.0 1.3 2.3 4.4 3.3 9.0 5.2 6.3 5.5 3.5 2.1 5.6 6.2 0.0 4.7 13.3 6.7 4.0 3.4 5.3 6.3 3.1 WRNIP1 "bA420G6.2, FLJ22526, WHIP" ENSG00000124535 "Werner helicase interacting protein 1" Q96S55 6 2765414-2786952 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031752, HPA031753" Enhanced Approved Nucleoplasm No No Nucleoplasm "HPA031752: AB_10603004, HPA031753: AB_2674028" "unprognostic (5.52e-2)" "unprognostic (5.95e-2)" "unprognostic (6.83e-3)" "unprognostic (8.35e-3)" "unprognostic (7.66e-2)" "unprognostic (7.10e-2)" "unprognostic (5.63e-3)" "unprognostic (3.40e-2)" "unprognostic (1.39e-2)" "unprognostic (1.73e-2)" "unprognostic (1.81e-1)" "unprognostic (6.29e-2)" "unprognostic (2.28e-1)" "unprognostic (2.37e-1)" "unprognostic (2.61e-2)" "unprognostic (1.85e-1)" "unprognostic (2.29e-1)" 15.4 23.1 29.9 19.8 32.1 31.2 22.4 42.5 33.5 22.2 21.9 23.3 25.7 17.7 19.8 29.7 32.8 28.0 24.7 28.8 30.9 30.1 23.3 25.8 21.2 23.4 27.4 26.2 23.2 37.4 39.2 31.2 32.3 21.3 22.5 22.6 23.9 34.6 22.0 29.0 27.8 19.6 18.5 20.2 20.7 19.3 24.6 24.2 34.1 31.6 36.0 25.3 18.8 29.2 3.4 4.2 9.1 2.8 3.7 6.5 2.3 31.5 15.9 16.2 26.5 17.2 14.9 21.6 14.5 20.4 26.8 26.7 25.1 14.8 28.4 39.7 18.7 29.1 24.6 26.5 29.2 26.2 28.3 29.1 29.7 18.1 39.2 19.6 18.6 20.6 15.1 23.9 24.6 26.8 18.7 33.9 27.0 22.6 10.3 19.5 30.9 27.5 33.8 13.9 21.8 19.8 22.0 23.7 28.8 28.4 19.5 49.0 14.0 17.2 17.5 33.8 26.7 22.5 21.0 18.4 20.1 15.2 17.4 35.1 13.3 23.1 22.1 7.9 20.3 27.2 9.1 2.6 3.4 6.5 2.8 2.1 3.4 4.7 4.8 2.1 2.4 5.5 5.2 1.1 3.7 1.4 4.2 6.5 2.3 29.9 32.1 42.5 33.5 30.9 30.1 27.4 26.2 21.3 24.2 17.9 10.5 3.7 10.8 28.8 23.9 17.3 35.7 21.4 7.9 10.4 7.9 26.5 3.3 12.6 42.1 18.0 18.7 0.0 11.8 20.2 14.8 14.5 9.2 21.9 11.1 7.9 38.2 30.1 13.8 11.0 20.8 12.7 20.3 7.2 24.1 18.0 15.9 11.5 20.8 11.3 16.5 6.5 11.8 21.4 24.7 28.1 21.3 4.5 23.0 13.2 WSCD1 KIAA0523 ENSG00000179314 "WSC domain containing 1" Q658N2 17 6057807-6124427 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.7;lymphoid tissue: 16.7" "Group enriched" "Detected in many" 6 "Early spermatids: 70.9;Enterocytes: 18.3;Late spermatids: 67.5" "Group enriched" "Detected in many" 7 "glioma: 18.8;renal cancer: 4.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 21.9;HUVEC TERT2: 13.4;OE19: 13.9;PC-3: 13.5;RH-30: 27.7;SCLC-21H: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015919 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA Nucleoplasm "Golgi apparatus" "HPA015919: AB_2216211" "unprognostic (1.50e-1)" "unprognostic (7.10e-2)" "unprognostic (5.32e-2)" "unprognostic (1.15e-2)" "unprognostic (2.61e-1)" "unprognostic (4.18e-2)" "unprognostic (4.53e-2)" "unprognostic (1.61e-1)" "unprognostic (3.59e-2)" "unprognostic (1.69e-1)" "unprognostic (3.46e-4)" "unprognostic (2.08e-1)" "unprognostic (1.18e-2)" "unprognostic (4.13e-2)" "unprognostic (1.67e-1)" "unprognostic (1.19e-1)" "unprognostic (1.62e-2)" 3.9 2.6 11.2 1.6 7.3 0.4 1.3 17.1 24.7 1.5 8.7 11.2 0.0 4.7 1.5 1.4 1.2 1.7 1.6 3.8 10.5 9.7 6.2 1.1 1.8 1.9 11.9 5.3 0.8 2.4 2.3 2.7 6.5 8.5 1.2 5.4 1.1 1.8 1.3 13.3 2.0 5.7 2.1 12.2 16.7 1.4 12.9 10.5 0.6 1.3 0.0 1.6 1.0 2.3 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 3.1 21.9 1.7 0.1 0.0 1.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 5.4 0.1 0.0 0.0 7.4 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 13.4 0.0 0.0 0.5 0.6 0.4 0.0 0.0 7.3 13.9 13.5 0.0 27.7 0.8 4.6 1.1 8.5 0.0 0.1 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 11.2 7.3 17.1 7.3 10.5 9.7 11.9 5.3 8.5 10.5 0.0 0.0 0.0 0.0 0.3 5.6 2.8 0.0 0.0 0.0 1.8 0.0 0.7 1.7 0.3 70.9 3.0 18.3 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.9 1.6 0.0 8.0 0.3 67.5 0.6 0.0 1.7 0.0 2.8 9.1 0.3 5.7 0.0 1.2 2.8 0.0 1.4 0.5 2.8 0.5 0.0 0.0 5.6 0.1 WSCD2 KIAA0789 ENSG00000075035 "WSC domain containing 2" Q2TBF2 12 108129471-108250537 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.0;seminal vesicle: 18.2;thyroid gland: 21.8" "Group enriched" "Detected in some" 10 "Bipolar cells: 35.7;Horizontal cells: 20.6" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.6" "Region enhanced" "Detected in all" "cerebellum: 44.0" "Cell type enhanced" "Detected in single" "T-reg: 2.5" "Lineage enhanced" "Detected in single" "T-cells: 2.5" "Cell line enriched" "Detected in some" 21 "RT4: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013346, HPA048133" Approved Uncertain Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA013346: AB_1858865, HPA048133: AB_2797236" "unprognostic (1.50e-1)" "unprognostic (1.64e-3)" "unprognostic (1.50e-2)" "unprognostic (4.27e-3)" "unprognostic (1.68e-1)" "unprognostic (3.43e-1)" "unprognostic (1.80e-2)" "unprognostic (3.43e-3)" "unprognostic (3.03e-2)" "unprognostic (3.05e-1)" "unprognostic (3.15e-1)" "unprognostic (7.43e-2)" "unprognostic (5.99e-2)" "unprognostic (3.73e-2)" "unprognostic (2.11e-1)" "unprognostic (2.32e-3)" "unprognostic (7.62e-3)" 1.4 1.2 6.5 0.5 12.5 0.4 1.0 44.0 15.2 5.4 1.7 1.6 0.0 0.7 6.9 3.0 3.8 2.0 0.5 0.5 10.0 3.0 1.3 0.4 0.8 0.5 1.3 6.0 0.6 2.1 0.4 0.9 0.6 1.9 6.0 0.7 9.9 0.5 18.2 0.5 0.6 0.9 9.2 1.5 0.5 2.0 0.6 2.0 0.0 21.8 0.2 0.5 3.0 0.9 0.8 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 27.5 0.4 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 6.5 12.5 44.0 15.2 10.0 3.0 1.3 6.0 1.9 2.0 0.0 0.0 0.5 0.0 0.1 35.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 20.6 0.0 1.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.9 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 WT1 "AWT1, GUD, NPHS4, WAGR, WIT-2" ENSG00000184937 "Wilms tumor 1" P19544 11 32387775-32435630 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 69.0;fallopian tube: 34.5;ovary: 53.4" "Cell type enhanced" "Detected in some" 18 "Collecting duct cells: 19.2;Late spermatids: 5.9;Leydig cells: 7.8;Sertoli cells: 6.5" "Cancer enriched" "Detected in many" 14 "ovarian cancer: 55.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 13.5;HMC-1: 17.4;K-562: 12.2;NB-4: 32.6;THP-1: 15.6" "Region enhanced" "Detected in single" "pons and medulla: 0.5" "Not detected" "Not detected" "CAB000327, HPA035717, HPA053848" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB000327: AB_2304486, HPA035717: AB_2674748, HPA053848: AB_2682279" "unprognostic (3.09e-3)" "unprognostic (9.97e-4)" "unprognostic (3.32e-1)" "unprognostic (8.24e-3)" "unprognostic (5.20e-2)" "unprognostic (1.98e-3)" "unprognostic (2.94e-2)" "unprognostic (1.59e-2)" "unprognostic (1.23e-2)" "unprognostic (4.15e-2)" "unprognostic (1.86e-2)" "unprognostic (1.36e-1)" "unprognostic (1.31e-10)" "unprognostic (2.65e-3)" "unprognostic (1.87e-1)" "unprognostic (1.96e-3)" "unprognostic (1.30e-2)" 10.3 0.0 0.2 1.8 0.6 0.0 0.2 0.2 0.5 20.3 1.5 0.2 3.7 0.0 69.0 9.3 0.4 34.5 0.8 2.1 0.9 0.0 5.3 0.2 0.8 0.5 0.2 0.2 53.4 0.2 0.0 0.2 6.9 0.3 0.9 0.0 0.2 0.2 4.2 0.2 0.0 0.4 23.7 0.2 14.6 0.0 24.5 0.2 0.2 0.3 0.2 0.2 1.3 4.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.1 0.1 0.0 0.0 0.0 6.3 0.0 0.0 0.0 4.7 13.5 0.0 1.2 3.8 9.0 17.4 0.0 0.0 2.8 0.0 0.0 0.0 2.8 12.2 0.1 2.7 0.0 7.9 32.6 0.7 0.0 3.8 1.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 1.8 15.6 0.1 0.0 2.4 0.0 0.3 0.0 0.0 0.0 0.1 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.6 0.2 0.5 0.9 0.0 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 19.2 0.0 0.9 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.3 0.0 0.0 2.5 0.0 5.9 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.2 0.0 6.5 0.0 1.9 0.9 0.0 0.7 0.0 0.0 0.1 WWTR1 "DKFZp586I1419, TAZ" ENSG00000018408 "WW domain containing transcription regulator 1" Q9GZV5 3 149517235-149736714 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 158.0;Endothelial cells: 172.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.6;memory CD8 T-cell: 2.8" "Lineage enriched" "Detected in single" 4 "T-cells: 2.8" "Cell line enhanced" "Detected in many" "EFO-21: 60.9;SK-MEL-30: 42.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007415, CAB017483, CAB068248" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "CAB017483: AB_2216639, CAB068248: AB_2665648, HPA007415: AB_1080602" "unprognostic (1.85e-2)" "unprognostic (2.24e-2)" "unprognostic (3.41e-3)" "unprognostic (1.33e-2)" "unprognostic (7.94e-2)" "unprognostic (1.37e-1)" "unprognostic (2.41e-2)" "unprognostic (2.22e-1)" "unprognostic (1.74e-2)" "unprognostic (2.34e-1)" "unprognostic (1.63e-2)" "unprognostic (3.32e-1)" "unprognostic (1.17e-3)" "unprognostic (2.76e-2)" "unprognostic (2.53e-1)" "unprognostic (3.98e-2)" "unprognostic (1.01e-3)" 25.1 9.9 9.3 16.0 18.6 0.2 20.4 7.7 10.5 27.2 38.5 18.4 15.0 5.6 27.2 17.6 41.2 16.4 25.8 20.6 14.7 9.0 31.0 13.1 29.8 6.2 15.2 5.6 30.9 21.7 10.4 8.5 29.0 20.7 34.6 9.1 29.4 15.8 22.4 12.1 13.4 11.7 81.5 25.8 13.8 20.8 12.0 16.4 0.7 18.2 13.2 7.1 68.4 31.0 0.2 0.1 0.6 0.1 0.1 2.8 0.4 16.8 20.0 10.6 14.2 12.7 22.7 11.2 9.8 14.4 4.4 4.7 11.2 14.3 0.0 60.9 11.0 13.6 10.0 6.9 7.1 4.4 4.7 5.3 0.0 5.2 9.3 7.2 0.0 0.0 12.0 1.8 15.4 6.8 17.0 34.5 0.0 0.0 0.0 15.3 2.2 0.0 0.0 2.4 0.0 25.3 0.0 14.3 0.1 37.8 2.5 0.0 0.1 6.5 4.6 42.0 8.3 7.8 0.3 28.0 8.7 4.2 7.0 19.1 0.2 0.1 0.2 18.7 0.0 22.2 0.4 0.1 0.1 2.6 0.0 0.0 0.0 0.3 2.8 0.0 0.2 0.1 1.3 0.6 0.1 0.0 0.1 1.9 0.4 9.3 18.6 7.7 10.5 14.7 9.0 15.2 5.6 20.7 16.4 59.6 79.0 0.0 158.0 45.9 2.0 42.0 147.7 60.2 128.5 47.1 3.9 10.5 6.6 55.4 14.8 172.1 0.7 0.0 23.5 70.1 58.9 72.2 7.0 20.3 3.7 0.0 0.0 92.7 6.4 3.6 53.5 8.0 28.7 3.6 0.0 10.4 31.6 0.0 118.8 48.8 2.0 58.2 48.4 1.7 0.7 31.0 12.4 5.3 0.0 80.1 XAB2 "HCNP, HCRN, NTC90, SYF1" ENSG00000076924 "XPA binding protein 2" Q9HCS7 19 7619525-7629565 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, mRNA processing, mRNA splicing, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048751 Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA048751: AB_2680512" "unprognostic (1.13e-1)" "prognostic favorable (4.04e-4)" "unprognostic (1.99e-3)" "prognostic favorable (4.96e-4)" "unprognostic (1.35e-1)" "unprognostic (4.98e-3)" "unprognostic (4.95e-2)" "unprognostic (4.56e-3)" "unprognostic (1.40e-1)" "unprognostic (2.10e-1)" "prognostic favorable (7.47e-4)" "unprognostic (2.69e-1)" "unprognostic (7.43e-3)" "unprognostic (3.88e-2)" "unprognostic (1.61e-1)" "unprognostic (1.51e-1)" "unprognostic (1.80e-3)" 13.5 18.4 12.2 13.3 17.8 35.7 17.8 22.9 22.6 16.3 12.1 19.2 12.1 16.3 15.5 12.1 17.8 18.9 12.7 17.5 11.9 10.3 20.1 24.6 13.0 17.0 16.8 11.4 29.6 34.3 11.9 12.2 14.6 13.3 15.2 5.3 13.6 28.7 18.1 18.0 19.5 13.8 13.7 13.4 18.8 22.8 30.2 15.8 24.8 21.4 13.2 15.9 18.6 15.6 15.2 9.0 9.9 14.1 8.9 16.7 13.8 15.5 14.3 8.7 11.3 9.2 6.9 17.0 9.2 10.8 16.3 16.6 18.4 10.3 10.5 18.2 8.5 11.9 13.8 12.3 13.3 4.2 18.5 15.8 14.0 12.1 16.1 11.9 18.5 12.7 12.1 11.1 11.5 8.3 8.8 9.9 22.8 12.5 28.2 5.0 17.3 17.3 28.9 19.7 9.8 28.3 19.4 11.0 18.4 6.5 12.3 12.4 14.2 10.4 10.2 9.0 6.0 13.0 16.5 9.7 7.5 12.3 16.9 15.4 48.6 28.6 15.3 12.8 15.8 11.1 8.3 12.2 9.9 14.8 11.6 13.6 12.3 13.8 11.0 9.0 15.2 16.7 12.6 7.3 8.9 14.1 7.8 15.8 13.8 12.2 17.8 22.9 22.6 11.9 10.3 16.8 11.4 13.3 15.8 0.0 2.6 13.7 12.3 17.4 13.6 0.8 22.9 0.0 3.4 45.4 11.8 36.8 29.9 16.2 26.4 13.5 25.0 0.0 30.1 23.1 15.3 13.9 19.6 36.5 17.5 3.2 17.9 14.7 16.5 13.5 26.2 9.3 25.3 31.5 17.7 13.8 14.4 14.4 20.5 74.5 11.3 38.8 18.8 34.6 47.5 15.6 55.2 20.3 16.2 12.7 XAF1 "BIRC4BP, HSXIAPAF1, XIAPAF1" ENSG00000132530 "XIAP associated factor 1" Q6GPH4 17 6755447-6775647 "Predicted intracellular proteins" Apoptosis "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 56.6;Club cells: 50.0;granulocytes: 46.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 33.1;BJ hTERT+ SV40 Large T+ RasG12V: 34.2;HHSteC: 15.2" HPA057302 Approved Supported "Nucleoplasm,Mitochondria,Rods & Rings" Yes NA Mitochondria "Nucleoplasm, Rods & Rings" "HPA057302: AB_2683405" "unprognostic (6.28e-2)" "unprognostic (1.71e-1)" "unprognostic (8.62e-3)" "unprognostic (1.28e-2)" "unprognostic (3.81e-1)" "unprognostic (1.11e-2)" "unprognostic (5.09e-3)" "unprognostic (4.89e-2)" "unprognostic (1.39e-1)" "unprognostic (8.08e-3)" "unprognostic (3.34e-3)" "unprognostic (1.79e-1)" "prognostic unfavorable (2.73e-7)" "unprognostic (2.33e-1)" "unprognostic (1.74e-2)" "unprognostic (2.31e-1)" "unprognostic (6.15e-3)" 32.8 7.5 12.2 27.0 13.2 17.5 14.4 4.3 14.0 12.8 10.5 8.9 11.4 15.3 15.6 22.4 11.8 12.0 20.1 13.1 10.7 7.9 19.1 37.9 25.1 15.8 11.0 9.6 34.6 2.7 2.2 8.6 15.2 16.4 13.2 10.1 9.9 26.4 9.0 9.1 10.7 14.4 14.7 10.8 35.0 14.0 5.4 11.0 17.3 10.5 9.2 11.3 12.0 13.4 4.3 7.7 13.1 11.6 7.7 8.5 5.3 2.0 0.1 0.2 0.5 2.8 6.3 0.2 2.5 10.4 33.1 34.2 0.2 3.0 0.5 0.8 3.8 11.9 1.2 0.0 0.5 3.8 4.5 0.1 0.7 0.3 0.4 15.2 0.4 3.1 2.9 0.0 4.4 0.1 0.1 2.7 9.6 0.2 10.8 1.0 0.1 2.2 8.8 0.2 0.1 0.8 4.3 0.1 0.2 0.0 1.9 0.2 0.2 1.2 0.2 5.5 0.2 0.3 12.1 0.3 0.4 0.3 0.9 0.2 1.6 0.5 0.2 0.9 7.2 0.8 13.1 8.8 4.2 7.5 11.6 5.7 3.3 5.9 5.2 7.7 4.3 4.0 4.1 10.6 7.7 10.7 0.8 8.5 5.3 12.2 13.2 4.3 14.0 10.7 7.9 11.0 9.6 16.4 11.0 56.6 31.7 5.4 5.3 4.6 0.2 1.6 12.7 36.1 50.0 0.0 0.0 0.1 0.0 1.1 3.1 24.8 8.1 23.3 1.7 3.5 8.7 2.7 46.3 13.6 15.0 0.0 1.7 28.8 16.4 0.6 33.6 22.5 5.0 3.6 8.4 1.0 6.2 0.0 25.8 0.2 0.3 19.4 3.9 0.3 0.6 2.4 0.3 13.8 6.6 5.4 XAGE1A "CT12.1a, GAGED2, XAGE-1, XAGE1" ENSG00000204379 "X antigen family member 1A" Q9HD64 X 52495676-52500812 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 28.7" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 9.3;Spermatogonia: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 74.6;NB-4: 72.7;THP-1: 74.6;U-2 OS: 54.5;U-266/70: 35.5;U-266/84: 96.5;U-937: 59.9" HPA046363 Approved Nucleoplasm NA NA Nucleoplasm "HPA046363: " 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 74.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 72.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.5 0.0 0.1 0.2 0.0 5.1 74.6 0.0 0.0 54.5 0.0 10.4 35.5 96.5 0.1 0.0 59.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 XAGE1B CT12.1b ENSG00000204382 "X antigen family member 1B" Q9HD64 X 52512077-52520803 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 28.8" "Cell type enhanced" "Detected in single" 28 "Spermatogonia: 1.9" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 19 "plasmacytoid DC: 4.7" "Lineage enriched" "Detected in single" 19 "dendritic cells: 4.7" "Cell line enhanced" "Detected in some" "HMC-1: 78.4;NB-4: 76.2;THP-1: 74.1;U-2 OS: 56.8;U-266/70: 35.7;U-266/84: 97.4;U-937: 60.9" HPA046363 Approved Nucleoplasm NA NA Nucleoplasm "HPA046363: " 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 28.8 0.0 0.3 0.0 0.0 0.0 4.7 0.0 0.2 0.0 0.0 0.0 0.3 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 78.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.1 76.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.6 0.0 0.2 0.3 0.0 5.3 74.1 0.0 0.0 56.8 0.0 10.5 35.7 97.4 0.1 0.0 60.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.9 0.0 0.0 0.0 0.0 0.0 XAGE5 "CT12.5, GAGED5, XAGE-5" ENSG00000171405 "X antigen family member 5" Q8WWM1 X 52812204-52818301 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 6 "testis: 5.1" "Cell type enriched" "Detected in some" 6 "Spermatogonia: 9.6" "Cancer enhanced" "Detected in single" "liver cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 34 "U-2 OS: 22.7" "HPA052507, HPA055941" Uncertain Approved Nucleoplasm,Vesicles No No "Nucleoplasm, Vesicles" "HPA052507: AB_2681855, HPA055941: AB_2682978" "unprognostic (1.89e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.7 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 9.6 0.0 1.6 0.0 0.0 0.0 XDH "XO, XOR" ENSG00000158125 "Xanthine dehydrogenase" P47989 2 31334321-31414715 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 78.6;liver: 32.5" "Group enriched" "Detected in many" 5 "Enterocytes: 95.3;Hepatocytes: 35.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 6.2;HBEC3-KT: 15.3;hTERT-HME1: 24.5;U-251 MG: 6.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA062641, HPA069323" Supported Uncertain Nucleoplasm,Nucleoli "Intracellular and membrane" No No Nucleoplasm Nucleoli "HPA062641: AB_2684816, HPA069323: AB_2686121" "unprognostic (8.58e-2)" "unprognostic (4.07e-2)" "unprognostic (1.34e-2)" "unprognostic (1.79e-1)" "unprognostic (2.08e-2)" "unprognostic (7.06e-2)" "unprognostic (4.38e-3)" "unprognostic (7.48e-3)" "unprognostic (3.55e-1)" "unprognostic (3.60e-2)" "unprognostic (3.95e-3)" "unprognostic (3.51e-2)" "unprognostic (1.24e-6)" "unprognostic (2.25e-1)" "unprognostic (5.25e-2)" "unprognostic (2.54e-1)" "prognostic favorable (8.73e-6)" 0.2 0.2 0.2 2.4 0.2 0.0 17.8 0.2 0.2 2.6 17.9 0.1 0.0 20.1 0.3 6.3 9.3 0.2 1.8 0.2 0.1 0.2 0.4 32.5 0.2 0.0 0.2 0.0 0.2 0.4 0.0 1.5 3.7 0.1 1.2 4.2 0.1 20.9 0.0 0.7 1.0 78.6 0.1 0.2 0.2 1.3 0.2 0.0 0.2 0.3 2.4 6.1 1.8 1.1 0.7 0.3 1.0 0.6 0.7 0.5 0.0 1.5 0.3 0.0 0.0 0.0 0.1 0.1 6.2 3.6 0.7 1.1 0.2 1.7 0.0 1.2 0.2 0.6 3.2 0.0 15.3 0.8 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.4 0.9 24.5 0.3 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.3 0.9 0.1 0.0 1.1 3.3 4.5 3.9 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 3.0 1.9 0.1 6.7 2.0 0.1 0.0 0.2 0.0 0.0 0.5 0.6 0.2 0.2 0.2 0.4 0.1 0.3 0.3 0.0 0.7 0.2 0.5 1.0 0.7 0.2 0.3 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.0 0.1 0.0 0.0 3.7 0.0 2.6 0.5 0.3 0.3 2.5 0.0 2.3 0.0 0.0 0.1 0.0 2.4 0.2 0.0 95.3 0.0 7.2 0.5 0.0 0.5 0.0 35.8 0.0 0.0 11.3 1.8 1.6 0.0 0.0 0.0 0.0 0.0 5.2 0.1 8.8 7.0 0.0 0.0 0.5 0.0 0.2 0.0 0.1 0.1 0.3 0.0 12.8 14.2 XIAP "API3, BIRC4, hILP" ENSG00000101966 "X-linked inhibitor of apoptosis" P98170 X 123859724-123913979 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway, Wnt signaling pathway" "Protease inhibitor, Thiol protease inhibitor, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB009203, HPA042428" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB009203: AB_2257167, HPA042428: AB_2677993" "prognostic unfavorable (9.21e-4)" "unprognostic (8.43e-2)" "unprognostic (1.50e-2)" "unprognostic (2.14e-1)" "unprognostic (1.40e-1)" "unprognostic (9.41e-2)" "unprognostic (1.95e-2)" "unprognostic (8.51e-2)" "unprognostic (9.17e-2)" "unprognostic (3.90e-2)" "unprognostic (7.50e-2)" "unprognostic (4.41e-2)" "unprognostic (3.15e-3)" "unprognostic (8.21e-3)" "unprognostic (2.26e-1)" "unprognostic (4.99e-2)" "unprognostic (4.65e-2)" 17.4 14.4 20.0 18.1 20.2 12.0 15.9 21.3 18.9 17.2 19.4 14.5 22.9 16.1 17.4 17.0 18.9 12.6 14.7 15.7 18.9 22.1 19.8 19.4 16.5 15.5 18.8 14.6 13.9 19.7 36.6 26.1 18.2 15.9 15.6 16.8 16.9 14.6 22.9 21.5 14.2 23.4 17.0 19.0 15.8 16.2 7.0 12.3 13.9 24.3 11.4 14.0 15.4 20.5 5.7 4.3 11.1 3.9 3.3 5.5 1.9 11.7 10.0 7.9 6.8 9.4 12.1 10.3 12.8 9.5 7.0 6.0 4.5 13.8 11.0 19.0 10.9 13.3 4.4 11.7 8.0 12.9 11.4 6.4 7.4 8.4 6.8 11.9 13.4 15.4 8.3 12.5 11.6 15.0 8.1 9.6 8.3 11.7 12.7 13.5 12.2 7.5 6.5 6.5 11.7 7.9 8.0 9.2 11.6 10.5 17.1 5.4 7.9 17.5 10.1 10.3 7.3 6.2 6.6 11.9 0.4 4.8 21.0 14.2 10.7 10.7 12.2 14.4 9.6 8.8 11.1 2.6 3.5 5.0 2.3 4.7 4.6 3.8 5.5 1.4 5.7 4.4 3.0 8.2 3.3 3.9 4.3 2.5 1.9 20.0 20.2 21.3 18.9 18.9 22.1 18.8 14.6 15.9 12.3 74.5 82.4 26.9 28.9 23.7 71.7 36.7 56.0 46.8 63.7 50.6 90.3 15.7 23.2 32.6 2.2 45.7 74.1 0.0 46.9 25.4 27.8 42.3 57.9 73.4 26.6 71.5 45.5 66.3 41.2 1.5 39.4 43.8 8.5 27.9 52.4 42.8 52.8 48.9 48.4 48.2 129.5 64.7 27.8 10.4 19.9 31.0 31.8 33.1 39.8 58.3 XIRP1 "CMYA1, DKFZp451D042, Xin" ENSG00000168334 "Xin actin binding repeat containing 1" Q702N8 3 39183210-39192596 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "heart muscle: 95.0;skeletal muscle: 219.0" "Cell type enriched" "Detected in single" 1478 "Cardiomyocytes: 827.4" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 9.3;LHCN-M2: 2.3;RH-30: 6.2;SuSa: 1.9" "HPA016750, HPA018458, CAB026391" Enhanced Approved "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" Nucleoplasm "CAB026391: , HPA016750: AB_1858884, HPA018458: AB_1858885" "unprognostic (2.19e-1)" "unprognostic (6.40e-2)" "unprognostic (1.13e-1)" "unprognostic (9.75e-2)" "unprognostic (2.76e-1)" "unprognostic (2.43e-2)" "unprognostic (4.94e-2)" "unprognostic (2.66e-3)" "unprognostic (1.66e-3)" "unprognostic (1.46e-1)" "unprognostic (5.30e-2)" "unprognostic (6.26e-2)" "unprognostic (1.02e-5)" "unprognostic (2.08e-2)" "unprognostic (2.78e-2)" "unprognostic (6.86e-4)" "unprognostic (4.12e-2)" 1.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 1.7 1.9 0.0 0.4 95.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.2 0.3 1.1 0.0 0.0 1.3 0.0 219.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 4.9 18.2 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 1.1 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 827.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 XIRP2 CMYA3 ENSG00000163092 "Xin actin binding repeat containing 2" A4UGR9 2 166888487-167259753 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 292.8" "Cell type enriched" "Detected in some" 66 "Cardiomyocytes: 1858.5" "Cancer enriched" "Detected in some" 5 "head and neck cancer: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.3;HEL: 1.5;HUVEC TERT2: 8.7;U-2197: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA034813, HPA074599" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA034813: AB_10602588, HPA074599: " "unprognostic (5.27e-4)" "unprognostic (5.96e-3)" "unprognostic (7.42e-2)" "unprognostic (2.42e-1)" "unprognostic (1.74e-1)" "unprognostic (2.56e-1)" 7.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 3.3 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 4.3 0.0 292.8 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 2.3 51.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 1.5 0.0 0.2 0.2 0.0 0.0 0.9 0.0 0.2 0.7 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1858.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 XK "Kx, NA, NAC, X1k, XKR1" ENSG00000047597 "X-linked Kx blood group" P51811 X 37685756-37732130 "Blood group antigen proteins, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Blood group antigen" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 23.6" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 21.1;Erythroid cells: 23.3;Mucus-secreting cells: 12.1;Undifferentiated cells: 10.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 40 "basophil: 9.4;eosinophil: 6.8" "Lineage enriched" "Detected in single" 94 "granulocytes: 9.4" "Cell line enhanced" "Detected in many" "HEL: 25.2;HL-60: 13.0;K-562: 16.2;NB-4: 11.9;RPMI-8226: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019036 Approved Approved Nucleoplasm,Vesicles,Mitochondria No No Mitochondria "Nucleoplasm, Vesicles" "HPA019036: AB_1846286" "unprognostic (2.37e-2)" "unprognostic (7.13e-3)" "unprognostic (5.03e-2)" "unprognostic (1.00e-2)" "unprognostic (7.97e-2)" "unprognostic (4.56e-1)" "unprognostic (3.59e-2)" "unprognostic (4.00e-2)" "unprognostic (4.77e-3)" "unprognostic (5.07e-2)" "unprognostic (6.63e-2)" "unprognostic (5.90e-2)" "unprognostic (4.44e-8)" "unprognostic (1.74e-1)" "unprognostic (4.75e-2)" "unprognostic (1.06e-1)" "unprognostic (1.43e-1)" 0.6 2.9 4.9 3.0 5.1 14.0 1.1 10.2 8.3 1.8 16.5 1.2 0.0 12.9 1.2 0.8 2.7 4.8 2.0 8.1 4.7 6.6 1.4 2.1 1.5 0.7 3.0 5.9 1.2 7.9 2.2 3.8 1.4 4.4 2.1 13.8 1.0 8.6 1.5 5.9 1.2 23.6 3.2 1.6 1.2 13.3 3.5 0.2 0.1 1.4 5.9 0.8 2.9 2.5 0.0 0.0 9.4 0.0 0.0 0.0 0.7 9.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 8.4 0.1 0.0 0.4 1.6 8.9 0.0 0.0 0.0 2.4 25.2 1.4 0.0 0.0 13.0 2.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 16.2 6.4 0.1 0.9 0.1 11.9 3.2 0.4 3.2 0.0 0.0 11.4 0.0 0.6 2.4 0.0 0.4 0.8 0.0 0.5 1.2 3.2 0.0 0.0 0.4 0.0 1.4 5.5 9.1 0.0 0.1 6.9 0.0 9.4 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 4.9 5.1 10.2 8.3 4.7 6.6 3.0 5.9 4.4 0.2 0.0 0.6 0.0 0.2 0.3 0.5 5.9 0.0 1.4 0.0 0.0 5.9 0.1 0.0 0.0 0.9 0.0 21.1 23.3 2.6 0.1 0.0 1.1 0.0 0.8 0.1 3.2 5.8 0.0 0.0 0.2 0.0 0.0 1.7 0.0 12.1 0.0 1.2 8.6 0.7 0.0 0.9 0.0 1.7 4.6 4.3 1.0 0.0 0.0 10.8 0.4 XPA "XP1, XPAC" ENSG00000136936 "XPA, DNA damage recognition and repair factor" P23025 9 97674909-97697357 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Cancer-related genes, Disease mutation, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000155, HPA056856" Supported Approved "Nucleoplasm,Cytokinetic bridge" Yes No Nucleoplasm "Cytokinetic bridge" "CAB000155: , HPA056856: AB_2683258" "unprognostic (8.76e-2)" "unprognostic (1.05e-3)" "unprognostic (1.60e-1)" "unprognostic (2.30e-2)" "unprognostic (4.17e-1)" "unprognostic (1.84e-1)" "unprognostic (5.26e-2)" "unprognostic (2.38e-1)" "unprognostic (3.90e-2)" "unprognostic (1.28e-1)" "unprognostic (1.97e-3)" "unprognostic (9.55e-3)" "prognostic favorable (4.28e-5)" "unprognostic (2.19e-2)" "unprognostic (1.56e-1)" "unprognostic (3.03e-2)" "unprognostic (1.17e-1)" 18.7 17.5 20.1 17.1 21.0 10.6 17.4 26.8 20.8 20.3 25.2 17.2 11.7 20.6 25.5 15.4 18.9 15.0 19.5 12.9 17.2 15.3 24.9 24.2 14.8 16.7 18.6 17.5 17.2 14.5 23.0 23.1 12.8 17.7 20.3 13.6 16.4 16.1 21.7 43.3 16.3 22.2 27.5 17.1 16.2 25.1 6.4 15.8 15.7 31.5 11.9 21.6 22.0 16.4 22.2 23.4 12.7 15.8 19.7 21.6 11.3 23.0 5.4 8.1 10.0 9.9 9.7 5.6 6.3 10.0 11.5 7.8 14.1 19.4 13.0 6.1 6.9 7.7 11.6 6.4 7.6 9.8 8.9 12.9 10.2 11.8 7.8 10.8 12.1 12.4 8.4 8.2 5.3 5.5 7.8 12.8 10.8 14.1 10.2 6.3 7.2 15.7 14.6 5.5 22.0 9.0 16.0 17.3 11.0 18.3 9.0 11.4 11.5 9.0 6.9 8.1 6.4 10.1 7.3 8.0 4.0 10.1 15.9 13.6 18.1 14.5 8.2 10.0 8.7 7.9 6.0 13.3 12.7 16.2 13.1 18.7 19.5 17.7 15.6 13.5 22.2 21.6 18.6 1.5 19.7 15.8 23.4 18.3 11.3 20.1 21.0 26.8 20.8 17.2 15.3 18.6 17.5 17.7 15.8 23.8 31.5 27.5 17.4 15.3 99.5 29.1 50.9 34.8 40.9 21.0 76.6 27.4 102.8 31.2 1.2 29.2 16.9 0.0 33.5 8.3 24.2 16.3 29.0 40.6 30.4 79.4 21.5 17.8 17.5 2.6 40.9 29.8 13.5 49.5 21.3 71.6 24.5 21.0 44.6 38.3 99.8 32.3 31.9 12.8 16.4 16.4 11.7 25.3 26.3 20.2 XPC "RAD4, XPCC" ENSG00000154767 "XPC complex subunit, DNA damage recognition and repair factor" Q01831 3 14145147-14178783 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease mutation, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009932, HPA035707, HPA069673" Supported Enhanced "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "CAB009932: AB_2241587, HPA035707: AB_2674743, HPA069673: AB_2686167" "unprognostic (7.46e-2)" "unprognostic (2.52e-2)" "unprognostic (4.50e-2)" "unprognostic (3.01e-1)" "unprognostic (6.63e-2)" "unprognostic (2.54e-2)" "unprognostic (1.97e-1)" "unprognostic (5.65e-2)" "unprognostic (1.50e-1)" "unprognostic (7.13e-3)" "unprognostic (4.39e-2)" "unprognostic (2.07e-1)" "prognostic favorable (4.14e-7)" "unprognostic (1.59e-1)" "unprognostic (7.88e-2)" "unprognostic (7.62e-2)" "prognostic favorable (2.46e-4)" 20.2 17.1 14.2 24.0 30.2 8.4 21.4 16.1 19.3 22.3 18.9 20.8 27.5 18.0 24.6 18.3 16.9 24.9 25.1 12.4 16.2 14.4 24.6 23.4 19.9 21.1 33.4 15.2 35.0 20.9 35.4 26.7 28.0 22.1 20.9 15.9 16.7 17.6 30.3 22.4 30.5 23.6 17.7 22.6 23.3 15.9 12.9 30.6 18.5 25.7 12.4 20.8 22.4 22.3 10.9 7.0 34.6 8.8 8.8 12.2 6.1 4.5 11.6 13.1 8.4 19.7 13.6 44.5 11.3 32.3 10.9 8.5 4.2 5.4 15.1 5.0 13.7 5.1 5.7 8.6 18.0 9.0 6.1 7.4 8.0 12.3 7.8 17.5 6.0 15.3 19.3 21.4 14.5 29.1 12.8 12.9 6.9 11.0 8.2 12.1 9.5 4.9 5.7 7.8 7.4 7.9 6.3 5.9 12.1 13.8 13.5 2.8 10.2 12.3 10.2 8.1 21.5 10.7 4.9 20.2 4.2 11.5 6.4 5.2 18.9 13.7 8.9 10.1 7.0 15.2 12.0 8.2 9.4 9.8 6.3 9.6 10.7 11.2 9.6 7.0 10.9 12.2 8.7 34.6 8.8 8.8 6.7 9.2 6.1 14.2 30.2 16.1 19.3 16.2 14.4 33.4 15.2 22.1 30.6 56.6 54.6 22.2 18.7 12.2 33.8 11.2 33.1 84.3 73.9 15.7 37.3 34.0 29.9 16.3 1.9 24.9 12.3 46.7 16.9 17.1 16.4 15.5 44.1 30.4 16.2 25.4 15.6 22.1 24.3 1.8 28.4 28.4 8.5 38.7 12.2 29.9 15.2 14.8 26.5 34.1 50.6 25.8 18.0 22.7 57.3 9.7 26.8 34.6 13.3 8.7 XPO1 "CRM1, emb" ENSG00000082898 "Exportin 1" O14980 2 61477849-61538626 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Transport" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010184, HPA042933" Supported Enhanced "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" NA NA 170000 "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "CAB010184: AB_2215817, HPA042933: AB_2678229" "unprognostic (7.34e-2)" "unprognostic (7.04e-2)" "unprognostic (6.37e-2)" "unprognostic (1.67e-2)" "unprognostic (5.61e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.84e-5)" "unprognostic (1.84e-1)" "unprognostic (1.99e-3)" "unprognostic (4.43e-1)" "unprognostic (3.53e-3)" "unprognostic (4.90e-2)" "prognostic unfavorable (3.74e-4)" "unprognostic (5.69e-2)" "unprognostic (2.08e-1)" "unprognostic (2.43e-1)" "unprognostic (5.55e-2)" 20.7 27.9 36.1 28.1 39.6 21.6 35.1 41.5 36.3 28.2 23.2 19.5 26.0 16.5 35.7 35.3 26.1 36.0 20.3 20.1 33.0 19.2 19.5 22.2 22.0 34.5 42.0 19.5 45.0 34.6 33.4 27.6 30.8 33.6 25.8 24.5 18.0 20.2 29.9 34.9 29.8 25.0 28.4 32.1 24.5 21.9 32.1 39.3 51.1 28.2 16.4 35.7 26.0 57.8 6.1 5.4 12.6 5.1 6.2 5.1 2.5 39.4 35.3 47.9 35.9 21.7 29.2 35.3 43.7 28.2 46.0 39.4 46.9 29.7 57.9 30.6 29.9 46.8 33.5 73.0 30.3 67.7 35.3 26.9 57.0 36.3 29.3 15.7 57.4 39.0 16.4 22.7 36.3 39.6 34.9 37.5 29.2 65.7 33.8 42.3 20.8 47.7 25.2 55.7 47.2 27.1 42.8 54.7 35.2 20.9 30.0 38.3 20.4 42.5 35.9 21.3 50.4 29.4 28.4 25.0 43.2 49.1 35.1 42.9 27.5 45.3 84.0 26.8 49.3 38.9 12.6 5.1 5.8 5.1 5.0 4.7 4.3 3.6 4.5 3.9 6.1 4.3 3.7 12.4 6.2 3.2 5.4 3.2 2.5 36.1 39.6 41.5 36.3 33.0 19.2 42.0 19.5 33.6 39.3 38.7 36.3 31.8 27.6 46.2 69.7 57.0 43.3 46.8 28.4 29.6 90.3 46.3 11.6 24.4 3.2 40.7 19.3 70.0 22.5 42.3 40.9 34.4 40.5 48.0 49.4 68.3 43.4 42.4 46.3 8.0 31.1 53.2 35.4 49.5 31.2 34.0 26.3 17.5 29.0 20.8 102.5 19.4 43.7 64.6 88.2 49.7 25.2 42.9 37.6 38.3 XPO4 "FLJ13046, KIAA1721" ENSG00000132953 "Exportin 4" Q9C0E2 13 20777329-20903048 "Plasma proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 47.3" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 60.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053768 Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA053768: AB_2682254" "unprognostic (2.24e-1)" "unprognostic (1.20e-2)" "unprognostic (3.79e-2)" "prognostic unfavorable (8.25e-4)" "unprognostic (2.04e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (4.63e-4)" "unprognostic (1.67e-1)" "unprognostic (7.24e-3)" "unprognostic (9.50e-3)" "unprognostic (2.99e-1)" "unprognostic (1.67e-2)" "unprognostic (1.00e-2)" "unprognostic (9.82e-2)" "unprognostic (1.16e-1)" "unprognostic (3.23e-2)" "unprognostic (2.42e-1)" 8.9 6.6 4.9 6.9 9.6 10.9 7.9 13.6 11.1 7.5 6.7 11.6 7.9 5.0 11.4 5.9 7.5 7.3 4.9 12.8 6.1 5.3 6.9 6.1 7.7 8.6 8.0 5.3 9.0 7.8 8.1 12.9 6.8 10.2 7.3 7.6 10.7 7.4 7.4 47.3 8.2 7.2 8.2 8.3 8.6 6.7 7.9 8.0 14.3 8.4 6.3 12.3 7.8 7.3 3.1 2.7 3.1 6.0 3.1 4.0 1.2 6.7 5.1 8.4 8.0 4.1 7.2 8.7 7.7 5.7 9.1 7.6 10.4 8.5 14.9 4.2 7.4 6.9 11.1 19.4 10.4 17.1 10.1 5.5 23.6 6.4 6.9 6.2 20.6 7.7 7.0 6.6 9.2 17.6 5.3 11.0 8.6 11.1 4.9 8.6 5.5 9.8 9.1 9.5 14.3 4.8 11.0 13.9 6.2 6.3 8.2 9.6 6.6 6.6 9.7 7.9 8.9 5.7 11.3 9.0 6.5 5.1 7.9 10.9 3.3 4.8 12.4 3.2 13.3 9.6 3.1 2.0 2.1 3.4 2.3 4.0 3.1 2.9 2.9 2.7 2.6 3.6 3.5 0.0 3.1 6.0 2.0 2.7 1.2 4.9 9.6 13.6 11.1 6.1 5.3 8.0 5.3 10.2 8.0 11.9 15.1 10.4 7.2 7.3 14.3 19.9 10.2 2.7 0.0 8.7 60.9 6.9 0.0 4.9 8.1 7.1 3.5 0.0 3.6 6.4 7.7 6.1 15.0 9.6 9.1 9.5 1.2 13.5 7.9 6.1 16.1 8.0 11.8 6.4 6.8 6.4 4.3 3.5 7.8 3.4 21.0 32.3 9.3 10.9 17.2 9.8 10.8 11.5 8.5 8.7 XPO5 KIAA1291 ENSG00000124571 "Exportin 5" Q9HAV4 6 43522330-43576075 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, RNA-mediated gene silencing, Transport" "RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 27.2;Spermatogonia: 26.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012357, HPA018402, HPA023959, HPA029909" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB012357: , HPA018402: AB_1848330, HPA023959: AB_1848331, HPA029909: AB_10611245" "unprognostic (6.98e-2)" "unprognostic (4.34e-2)" "unprognostic (5.13e-2)" "prognostic unfavorable (4.94e-7)" "unprognostic (6.16e-2)" "unprognostic (2.43e-2)" "prognostic unfavorable (3.98e-8)" "unprognostic (4.78e-1)" "unprognostic (4.72e-3)" "unprognostic (1.72e-1)" "unprognostic (4.86e-2)" "unprognostic (1.49e-1)" "unprognostic (1.07e-2)" "unprognostic (1.97e-1)" "unprognostic (1.45e-1)" "unprognostic (9.48e-2)" "unprognostic (5.66e-3)" 11.5 12.2 9.5 10.8 14.0 9.0 10.8 14.6 15.4 9.6 8.8 11.5 8.3 7.8 12.0 12.0 16.7 9.8 7.5 8.9 8.0 7.3 10.0 13.1 9.4 10.0 9.5 8.0 11.9 19.7 17.7 16.1 9.5 9.4 10.5 11.5 9.7 12.9 10.6 14.9 15.3 8.6 12.3 8.0 9.9 11.2 42.3 9.7 18.3 16.7 8.5 13.7 10.5 10.4 3.7 5.9 3.6 11.7 8.4 6.8 4.4 15.6 9.4 15.7 31.6 8.2 6.9 14.6 8.2 5.8 16.2 11.8 25.8 5.5 21.3 10.7 7.8 15.3 13.5 26.1 11.9 18.3 15.4 20.7 20.6 11.3 18.7 11.8 22.7 11.0 5.0 12.4 17.0 26.6 5.8 11.5 15.3 44.1 16.8 10.9 19.2 17.1 11.3 16.8 43.1 9.6 18.7 16.7 15.9 9.3 12.3 32.5 13.4 11.4 10.5 14.6 14.4 12.1 18.3 9.6 12.0 14.3 11.4 17.2 10.7 11.7 41.9 4.3 19.9 12.8 0.0 5.0 3.6 6.3 6.4 5.8 3.7 5.6 6.8 5.9 3.4 4.5 5.9 0.5 8.4 11.7 1.8 5.5 4.4 9.5 14.0 14.6 15.4 8.0 7.3 9.5 8.0 9.4 9.7 6.0 3.5 3.0 4.4 7.9 10.8 5.4 2.5 5.3 1.2 10.4 7.9 4.2 1.7 6.5 9.2 4.5 3.3 0.0 6.6 5.6 6.4 6.0 11.5 4.0 5.5 20.6 13.8 1.8 6.5 10.2 3.7 4.0 1.7 2.8 6.6 4.1 6.4 0.0 7.8 4.2 13.7 0.0 4.4 27.2 26.3 6.1 3.7 3.2 6.4 5.2 XPO6 "FLJ22519, KIAA0370, RANBP20" ENSG00000169180 "Exportin 6" Q96QU8 16 28097979-28211920 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 7 "neutrophil: 56.4" "Lineage enriched" "Detected in all" 9 "granulocytes: 56.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038246 Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" No No "Nucleoplasm, Nucleoli" "Plasma membrane, Cytosol" "HPA038246: AB_10674550" "unprognostic (1.17e-1)" "unprognostic (5.43e-2)" "unprognostic (1.07e-1)" "unprognostic (3.76e-1)" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (3.68e-4)" "unprognostic (2.22e-1)" "unprognostic (1.41e-1)" "unprognostic (1.31e-2)" "unprognostic (4.48e-1)" "unprognostic (1.40e-1)" "unprognostic (1.01e-3)" "unprognostic (2.10e-1)" "unprognostic (5.36e-2)" "unprognostic (8.50e-2)" "prognostic unfavorable (8.80e-4)" 18.4 14.1 24.3 32.0 25.0 47.9 17.7 16.0 30.6 12.4 17.7 30.4 9.9 13.4 13.5 12.0 16.8 14.1 14.9 9.6 27.5 23.9 13.3 19.1 20.6 54.6 25.6 16.9 15.3 13.2 22.0 18.0 25.9 21.7 14.1 17.0 16.3 19.4 13.1 8.3 18.8 18.3 16.3 23.8 50.4 14.8 28.9 19.8 37.1 18.0 7.8 31.8 17.2 13.2 5.2 2.6 56.4 4.4 2.7 6.5 2.0 28.5 20.5 18.1 19.4 12.6 20.0 20.8 35.4 32.0 41.4 42.0 28.7 20.5 20.3 30.5 32.1 21.1 18.7 42.9 27.1 50.4 45.7 26.6 22.2 28.9 32.0 29.7 31.0 25.0 15.7 20.2 36.8 36.5 17.8 23.8 20.7 40.4 10.3 28.0 32.0 37.2 36.9 30.6 13.9 19.6 34.9 21.5 33.6 15.4 14.6 35.3 19.2 17.5 29.2 15.5 21.0 21.0 20.5 25.1 35.0 23.5 29.8 29.4 24.0 30.3 30.1 26.7 32.3 29.5 4.7 2.7 8.4 4.1 3.0 4.4 5.2 4.7 4.4 2.0 3.9 5.2 6.5 56.4 2.7 4.4 2.6 3.8 2.0 24.3 25.0 16.0 30.6 27.5 23.9 25.6 16.9 21.7 19.8 8.9 13.9 21.7 8.2 16.6 23.8 6.6 2.5 9.4 10.3 22.7 29.5 9.8 6.6 13.3 27.6 10.6 14.7 0.0 16.4 13.9 12.4 15.6 2.3 14.0 19.9 20.6 22.7 8.6 23.4 30.6 10.0 14.7 6.8 27.1 21.5 8.3 18.1 14.0 8.1 5.0 26.3 6.5 11.3 29.5 29.2 18.6 7.0 20.8 17.0 12.6 XPOT XPO3 ENSG00000184575 "Exportin for tRNA" O43592 12 64404350-64451127 "Predicted intracellular proteins, Transporters" Transport "RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Muller glia cells: 71.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048067, HPA057602" Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA048067: AB_2680246, HPA057602: AB_2683481" "unprognostic (4.53e-3)" "unprognostic (7.20e-2)" "unprognostic (1.38e-1)" "unprognostic (3.78e-3)" "unprognostic (1.01e-2)" "unprognostic (3.14e-1)" "prognostic unfavorable (1.81e-7)" "unprognostic (1.50e-2)" "unprognostic (2.22e-2)" "unprognostic (1.50e-1)" "unprognostic (2.16e-2)" "unprognostic (8.87e-2)" "prognostic unfavorable (2.41e-12)" "unprognostic (2.72e-1)" "unprognostic (3.68e-1)" "unprognostic (5.20e-2)" "prognostic unfavorable (5.79e-4)" 19.3 19.4 20.7 19.3 22.8 26.9 29.9 17.9 21.7 16.9 12.4 18.7 13.2 10.5 16.1 19.8 21.3 12.5 12.6 12.7 19.0 19.4 14.7 35.7 18.3 18.9 22.4 15.5 17.3 30.1 21.4 18.5 18.6 23.5 15.3 14.7 15.8 21.3 13.7 15.6 17.3 11.6 16.7 21.7 14.5 14.7 17.9 21.3 18.2 48.7 14.1 21.4 15.8 27.8 7.9 10.2 10.1 7.5 11.1 14.7 6.5 17.8 12.4 12.6 15.8 19.0 20.3 23.1 23.9 20.1 16.1 14.7 12.3 6.1 36.3 17.1 30.1 17.2 13.5 23.9 18.4 23.4 22.6 12.6 20.2 11.6 10.7 33.7 37.1 18.3 14.4 47.5 17.9 55.3 20.9 14.2 27.2 33.5 72.9 17.0 21.9 20.4 14.7 24.0 12.6 22.2 16.3 15.2 27.1 8.8 10.5 14.1 16.5 14.0 16.1 34.6 12.8 28.6 37.0 14.9 12.7 12.8 18.2 18.7 45.9 35.2 28.1 28.1 29.0 20.4 5.8 7.5 10.1 10.9 7.5 14.7 7.9 12.4 11.3 10.2 5.3 11.4 9.6 2.3 11.1 6.7 3.5 10.3 6.5 20.7 22.8 17.9 21.2 19.0 19.4 22.4 15.5 23.5 21.3 11.9 7.8 10.7 12.2 17.4 16.4 9.8 12.7 5.3 11.4 14.0 11.8 21.2 14.9 8.8 3.3 16.7 5.4 23.3 11.0 17.4 18.5 18.0 24.3 28.2 12.9 12.7 10.9 24.5 21.3 4.1 18.7 12.1 20.3 3.6 10.9 71.1 13.5 3.5 19.1 11.3 21.2 12.9 19.6 11.8 12.7 19.6 14.2 15.0 12.7 12.8 XRCC1 RCC ENSG00000073050 "X-ray repair cross complementing 1" P18887 19 43543040-43580473 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Cancer-related genes, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ciliated cells: 48.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005427, HPA006717" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB005427: AB_2215661, HPA006717: AB_1858896" "unprognostic (1.10e-2)" "unprognostic (3.51e-3)" "unprognostic (4.59e-1)" "unprognostic (2.81e-2)" "unprognostic (4.08e-1)" "unprognostic (2.68e-2)" "prognostic unfavorable (7.33e-5)" "unprognostic (5.07e-2)" "unprognostic (3.12e-1)" "unprognostic (7.51e-2)" "unprognostic (3.00e-2)" "unprognostic (9.54e-2)" "unprognostic (1.07e-1)" "unprognostic (2.28e-1)" "unprognostic (9.34e-3)" "unprognostic (2.20e-2)" "unprognostic (5.69e-2)" 16.6 17.5 20.8 18.7 22.4 22.4 16.9 23.6 22.7 20.3 17.4 19.2 18.0 13.6 23.8 18.9 20.2 24.9 16.9 15.7 16.5 16.3 16.3 10.4 16.3 22.8 15.8 21.1 34.2 22.1 19.4 32.0 19.7 15.7 16.7 12.6 21.8 16.4 19.2 18.8 20.4 14.2 18.8 15.3 19.5 17.2 25.0 17.9 38.9 21.5 12.0 21.6 18.1 17.2 14.2 13.6 20.3 14.2 10.6 17.7 12.9 25.6 21.1 25.0 22.3 12.2 11.5 13.3 14.4 16.3 19.0 20.8 13.2 18.7 19.3 18.3 12.7 18.8 13.3 14.9 16.5 11.3 21.3 15.4 24.7 20.6 15.3 12.3 13.9 21.5 13.3 11.4 24.0 12.1 23.2 17.1 22.9 15.5 19.7 16.8 21.2 28.7 25.1 7.8 20.0 9.3 24.2 15.6 11.1 16.2 20.5 20.7 13.1 17.9 17.5 8.6 13.5 16.5 34.1 9.6 25.2 19.7 7.5 17.9 21.7 20.9 14.2 20.4 12.6 27.3 20.3 14.2 16.8 12.9 13.4 14.6 14.2 16.1 17.7 13.6 12.6 14.0 12.8 16.3 10.6 8.3 10.5 16.2 12.9 20.8 22.4 23.6 22.7 16.5 16.3 15.8 21.1 15.7 17.9 14.9 9.8 9.7 6.8 5.5 11.0 7.4 2.5 48.2 11.4 7.0 5.9 25.8 16.6 12.7 22.1 9.0 7.3 0.0 10.1 16.2 11.7 4.1 19.6 4.9 18.6 4.8 13.1 9.2 19.5 13.6 9.5 11.8 13.5 14.4 13.0 7.3 11.2 8.6 12.0 11.8 11.3 6.5 8.3 19.0 12.9 6.1 16.7 17.5 13.3 2.4 XRCC2 FANCU ENSG00000196584 "X-ray repair cross complementing 2" O43543 7 152644779-152676165 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Fanconi anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 12.7;testis: 11.7" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 19.4;Spermatocytes: 22.4;Spermatogonia: 24.3;Syncytiotrophoblasts: 10.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065153 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA065153: AB_2685422" "unprognostic (9.31e-3)" "unprognostic (8.25e-2)" "unprognostic (1.62e-1)" "unprognostic (5.53e-3)" "unprognostic (9.10e-2)" "unprognostic (2.52e-2)" "unprognostic (3.36e-5)" "unprognostic (9.98e-3)" "unprognostic (5.82e-3)" "unprognostic (4.04e-3)" "unprognostic (1.06e-3)" "unprognostic (2.43e-2)" "unprognostic (1.55e-15)" "unprognostic (4.52e-3)" "unprognostic (3.01e-1)" "unprognostic (5.14e-1)" "unprognostic (1.73e-2)" 1.3 1.3 3.4 4.5 2.0 5.4 2.4 4.4 2.6 1.6 1.5 2.5 0.6 1.1 1.9 2.2 2.6 1.3 0.6 2.5 3.3 1.1 1.1 1.3 1.4 3.0 1.9 1.9 2.0 1.2 0.4 1.3 7.2 2.7 1.5 2.9 0.6 1.5 1.3 1.1 1.6 1.9 1.3 1.8 1.8 1.5 11.7 2.2 12.7 1.2 1.1 3.6 1.3 1.6 1.8 1.0 3.1 1.1 1.1 1.6 0.6 7.5 4.5 6.7 7.3 0.8 0.7 7.7 5.4 2.0 4.7 4.7 5.7 6.6 10.7 4.2 2.1 7.4 5.5 5.4 4.4 8.7 5.1 5.6 7.7 6.1 3.1 0.3 11.5 3.8 0.5 0.4 7.7 2.0 1.0 1.6 6.4 15.9 9.2 2.7 5.2 10.6 2.7 8.8 4.5 4.1 8.5 9.0 6.0 1.4 5.0 6.4 6.1 6.1 2.7 1.1 4.5 2.2 2.5 3.2 6.3 2.8 5.9 10.0 3.3 6.5 9.4 3.3 6.2 8.2 2.0 0.9 1.5 1.6 0.6 1.1 1.3 1.3 1.1 0.3 1.8 1.6 0.8 3.1 1.1 1.1 1.0 1.5 0.6 3.4 2.0 4.4 2.6 3.3 1.1 1.9 1.9 2.7 2.2 0.0 1.4 1.5 0.9 1.1 4.8 0.6 0.0 0.0 2.3 1.8 0.0 7.1 0.0 0.6 6.1 0.6 0.0 0.0 0.2 19.4 1.9 0.5 0.0 0.0 2.1 0.0 0.0 1.8 1.2 3.6 0.9 0.4 0.0 1.0 1.4 2.0 0.3 0.0 1.1 0.1 2.0 0.0 0.5 22.4 24.3 1.3 10.5 0.5 1.5 0.8 XRCC3 ENSG00000126215 "X-ray repair cross complementing 3" O43542 14 103697609-103715504 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 30.3" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 6.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062422, HPA068953" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA062422: AB_2684757, HPA068953: AB_2686062" "unprognostic (2.52e-2)" "unprognostic (1.81e-3)" "unprognostic (6.75e-2)" "unprognostic (4.01e-2)" "unprognostic (4.29e-1)" "unprognostic (1.83e-1)" "unprognostic (2.53e-4)" "unprognostic (2.93e-2)" "unprognostic (4.67e-2)" "unprognostic (1.58e-2)" "unprognostic (4.46e-2)" "unprognostic (2.53e-2)" "unprognostic (3.52e-7)" "unprognostic (1.27e-1)" "unprognostic (1.57e-1)" "unprognostic (8.84e-2)" "unprognostic (3.72e-2)" 5.4 3.3 8.1 15.1 7.3 22.0 5.4 11.3 8.0 5.5 5.8 6.5 4.6 5.4 6.4 5.1 8.5 6.1 5.3 4.4 6.9 2.6 4.1 3.8 6.0 11.1 7.3 5.4 7.0 7.8 2.1 4.4 5.6 6.8 7.7 6.2 5.3 11.1 2.9 8.9 30.3 7.0 2.3 5.3 13.5 6.8 10.1 5.0 17.6 5.6 6.7 14.2 5.3 9.0 4.5 2.0 3.0 3.3 2.5 3.9 3.6 12.7 23.3 12.8 15.9 1.1 3.3 23.3 14.1 4.7 20.0 21.6 12.9 20.5 20.3 12.2 2.9 15.9 20.4 14.0 21.0 12.3 12.5 14.5 19.8 11.4 11.9 2.0 17.7 12.9 2.5 2.1 17.6 11.2 4.2 8.1 20.7 12.2 12.5 10.3 27.8 30.7 14.0 11.0 18.7 16.6 25.0 18.5 8.0 4.4 17.6 12.7 10.5 16.6 9.0 5.8 7.4 14.2 13.9 7.0 10.4 12.2 33.0 15.4 10.7 9.7 25.2 6.5 14.7 15.9 2.6 1.6 3.0 3.8 3.3 3.9 4.5 3.3 3.2 2.0 4.0 3.3 2.2 1.2 2.5 2.5 1.4 2.5 3.6 8.1 7.3 11.3 8.0 6.9 2.6 7.3 5.4 6.8 5.0 0.0 0.0 1.9 2.1 1.3 1.5 0.2 2.5 1.4 3.4 0.0 2.0 6.8 1.7 1.4 0.4 0.9 2.0 0.0 1.6 4.5 0.4 1.4 0.0 0.4 3.8 3.2 1.2 0.0 0.0 1.5 0.3 1.5 0.0 1.8 5.0 1.3 1.4 3.5 1.1 0.0 2.1 0.0 0.9 3.4 5.7 1.1 2.6 0.0 5.0 0.7 XRCC4 ENSG00000152422 "X-ray repair cross complementing 4" Q13426 5 83077498-83353787 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Pancreatic endocrine cells: 43.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 37.1" "Low region specificity" "Detected in all" "HPA006801, HPA051538" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006801: AB_1858899, HPA051538: AB_2681526" "prognostic unfavorable (1.80e-5)" "unprognostic (3.05e-2)" "unprognostic (5.12e-2)" "unprognostic (3.91e-3)" "unprognostic (1.55e-1)" "unprognostic (1.69e-1)" "unprognostic (1.44e-3)" "unprognostic (2.23e-2)" "unprognostic (2.19e-2)" "unprognostic (5.77e-2)" "unprognostic (2.38e-2)" "unprognostic (8.24e-2)" "unprognostic (4.46e-2)" "unprognostic (1.79e-1)" "unprognostic (1.97e-1)" "unprognostic (2.34e-1)" "unprognostic (6.91e-2)" 8.8 9.4 8.1 12.9 10.1 5.9 9.4 4.8 10.2 5.3 9.1 7.2 5.4 11.4 8.3 7.7 10.1 6.2 8.1 13.0 8.5 6.6 12.2 8.1 7.6 11.7 8.7 5.8 5.8 4.9 4.0 9.5 11.3 11.5 6.3 8.8 3.7 7.2 7.1 5.3 5.7 15.4 5.9 9.5 14.6 6.4 12.5 8.8 20.6 7.4 9.7 12.9 8.7 5.8 7.4 10.3 12.3 19.1 11.5 7.0 6.8 8.6 6.9 8.4 7.5 4.8 7.0 8.0 8.3 6.9 9.2 10.8 5.8 12.9 12.4 6.2 6.6 13.2 7.6 5.6 18.8 15.2 5.7 7.0 6.4 5.2 7.3 3.2 7.1 10.4 4.8 8.6 11.9 6.7 9.4 7.3 8.2 4.6 5.8 10.5 7.0 13.0 9.2 4.7 5.3 10.2 10.9 37.1 12.4 8.5 4.0 5.5 7.1 5.2 3.9 10.5 7.4 7.9 11.6 4.5 5.0 10.7 5.3 11.0 4.7 6.9 15.3 9.0 12.9 8.0 12.1 13.5 9.2 4.7 19.1 4.9 7.4 5.2 5.2 10.3 6.3 7.0 5.6 12.3 11.5 17.8 7.6 5.6 6.8 8.1 10.1 4.8 10.2 8.5 6.6 8.7 5.8 11.5 8.8 14.9 5.6 12.8 11.2 4.7 4.3 12.3 5.1 10.7 12.5 5.2 0.0 15.8 13.3 15.0 7.8 7.5 6.8 0.0 24.8 33.3 10.1 4.9 10.4 4.9 17.2 1.6 0.0 11.6 20.2 3.6 7.2 25.5 8.5 14.4 6.9 7.5 43.1 4.9 6.7 16.5 3.8 0.0 7.2 24.9 25.3 3.9 10.0 10.9 5.2 8.4 XRCC5 "KARP-1, KU80, Ku86, KUB2" ENSG00000079246 "X-ray repair cross complementing 5" P13010 2 216107464-216206303 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004468, HPA025813, HPA064685" Supported Enhanced Nucleoplasm NA NA 140000 Nucleoplasm "CAB004468: AB_672929, HPA025813: AB_1858901, HPA064685: AB_2685322" "unprognostic (4.23e-2)" "unprognostic (1.75e-1)" "unprognostic (9.07e-3)" "unprognostic (3.44e-3)" "unprognostic (2.44e-2)" "unprognostic (7.00e-2)" "prognostic unfavorable (2.10e-7)" "unprognostic (4.42e-3)" "unprognostic (1.38e-1)" "unprognostic (1.06e-1)" "unprognostic (3.38e-3)" "unprognostic (1.96e-1)" "unprognostic (1.08e-1)" "unprognostic (2.30e-1)" "unprognostic (2.88e-2)" "unprognostic (3.58e-2)" "unprognostic (6.01e-2)" 53.7 47.6 35.2 47.0 56.8 47.0 56.6 47.0 59.7 51.2 44.3 45.2 39.5 39.5 62.9 43.8 61.1 51.7 41.2 43.7 38.6 36.4 62.4 67.1 43.8 56.2 41.8 45.2 58.7 46.7 63.0 56.1 54.3 58.3 46.0 53.5 36.1 49.4 47.9 65.0 54.7 46.5 49.7 44.2 60.5 47.9 36.9 38.0 112.4 64.2 55.6 65.5 56.5 47.7 38.6 51.5 60.9 61.3 50.4 54.0 82.3 38.8 33.0 74.1 39.6 32.9 37.8 44.8 46.3 47.9 53.5 57.7 70.8 38.7 37.6 37.8 40.4 46.9 34.8 72.8 56.1 82.6 35.8 50.1 81.6 52.2 66.1 40.9 72.6 40.0 34.4 30.0 62.8 27.5 38.3 63.1 46.5 51.5 34.4 69.7 37.4 81.1 36.7 86.1 39.4 29.5 71.4 65.5 31.1 57.6 44.3 65.0 54.8 37.2 27.6 33.3 78.1 33.9 54.5 45.4 50.4 42.4 32.9 52.3 41.7 50.5 84.0 39.2 57.0 49.4 60.9 51.5 51.8 50.2 54.0 54.0 38.6 49.1 50.9 51.5 37.5 49.9 49.8 59.4 50.4 61.3 31.4 49.3 82.3 35.2 56.8 47.0 59.7 38.6 36.4 41.8 45.2 58.3 38.0 98.3 108.3 82.7 152.6 101.0 129.3 138.8 101.9 165.9 152.4 96.0 43.2 176.4 82.9 239.3 65.8 131.5 70.4 70.0 206.2 196.4 122.7 101.3 140.1 177.3 138.8 84.2 128.0 77.3 91.0 17.1 94.0 132.7 65.8 380.5 79.8 130.6 194.7 63.1 121.6 110.9 102.9 109.9 137.9 221.2 164.2 105.1 138.4 124.6 99.6 138.1 XRCC6 "D22S671, D22S731, G22P1, KU70, ML8" ENSG00000196419 "X-ray repair cross complementing 6" P12956 22 41621119-41664048 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Helicase, Hydrolase, Lyase, Multifunctional enzyme" "Cancer-related genes, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004254, HPA047549, HPA062226" Enhanced Enhanced Nucleoplasm No No 24000 Nucleoplasm "CAB004254: AB_628453, HPA047549: AB_2680085, HPA062226: AB_2684716" "unprognostic (5.55e-2)" "unprognostic (2.39e-2)" "unprognostic (1.82e-3)" "unprognostic (2.39e-1)" "unprognostic (2.47e-2)" "unprognostic (9.17e-2)" "unprognostic (1.16e-3)" "unprognostic (2.32e-2)" "unprognostic (2.21e-1)" "unprognostic (2.11e-1)" "unprognostic (1.89e-2)" "unprognostic (1.33e-1)" "unprognostic (2.06e-3)" "unprognostic (1.22e-1)" "unprognostic (2.28e-1)" "unprognostic (4.77e-2)" "unprognostic (7.95e-2)" 49.2 67.9 44.4 47.8 54.3 62.3 49.7 44.5 57.5 51.2 51.3 39.5 44.1 44.7 59.9 41.0 68.6 52.4 35.2 63.0 59.3 39.2 50.1 61.6 48.1 66.9 37.2 50.6 61.5 44.0 48.4 53.1 63.5 51.5 46.1 56.4 39.7 59.2 52.1 100.9 58.6 46.9 58.2 68.4 54.4 50.8 113.6 34.2 83.8 49.5 59.2 70.9 51.4 50.1 51.9 63.7 42.7 57.0 46.6 62.6 96.7 62.2 45.0 62.6 54.5 38.2 34.1 49.4 45.4 54.7 95.6 78.9 66.0 39.5 100.5 38.2 55.1 43.0 46.9 86.5 56.9 96.4 55.9 108.6 53.9 55.1 65.4 34.6 127.2 62.4 30.8 39.3 59.7 32.9 38.4 59.4 43.8 52.6 42.7 61.5 68.6 66.1 47.5 57.5 132.4 53.3 75.7 65.9 79.8 54.0 46.7 29.2 20.9 73.9 39.4 52.4 49.3 45.3 51.5 41.9 47.8 66.5 42.0 59.6 42.4 74.0 102.5 44.8 50.5 56.4 24.5 50.1 42.7 51.1 57.0 53.5 51.9 56.8 55.8 63.7 48.2 62.6 55.8 13.5 46.6 55.5 37.7 61.8 96.7 44.4 54.3 44.5 57.5 59.3 39.2 37.2 50.6 51.5 34.2 89.3 116.9 114.6 165.5 110.1 101.4 76.4 96.8 104.4 113.7 78.5 58.9 380.2 140.9 149.3 68.8 107.6 88.2 46.7 159.8 266.0 133.6 98.3 115.6 92.4 150.7 82.6 94.6 71.8 90.4 42.8 117.3 120.1 84.4 217.4 92.7 138.2 128.0 107.8 119.2 113.5 75.0 161.7 129.7 482.0 292.1 89.3 302.9 130.7 133.6 112.7 XRN2 ENSG00000088930 "5'-3' exoribonuclease 2" Q9H0D6 20 21303304-21389827 "Predicted intracellular proteins" "mRNA processing, Transcription, Transcription regulation, Transcription termination" "DNA-binding, Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047118, HPA050485" Supported Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA047118: AB_2679941, HPA050485: AB_2681141" "unprognostic (9.38e-2)" "unprognostic (4.70e-2)" "unprognostic (2.07e-2)" "unprognostic (3.09e-2)" "unprognostic (1.34e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (3.54e-5)" "unprognostic (7.26e-2)" "unprognostic (1.05e-1)" "unprognostic (1.94e-1)" "unprognostic (1.09e-2)" "unprognostic (1.40e-1)" "unprognostic (1.99e-3)" "unprognostic (1.22e-1)" "unprognostic (1.97e-1)" "unprognostic (1.63e-2)" "unprognostic (1.31e-1)" 42.9 35.1 12.5 24.5 17.7 38.3 30.4 18.0 16.4 26.8 22.8 18.6 23.3 14.4 38.6 25.2 22.1 30.6 21.8 19.3 13.7 10.3 31.4 35.3 27.5 33.4 17.4 12.1 32.1 26.4 30.0 35.3 26.5 15.9 25.7 20.1 19.1 27.6 25.0 36.8 23.0 21.6 24.1 18.6 40.9 23.2 27.4 18.3 41.1 31.3 20.4 30.6 33.1 21.7 16.0 30.6 35.0 33.9 21.7 24.6 23.8 27.4 32.7 36.1 27.6 27.0 33.3 35.8 25.3 33.1 33.8 39.5 21.8 31.6 27.1 15.1 26.5 46.1 32.7 40.6 42.6 43.5 12.2 20.5 35.0 12.3 41.1 23.8 31.4 30.5 31.5 21.6 37.2 32.7 30.2 29.0 26.1 28.0 23.3 31.3 21.5 46.2 20.8 28.1 26.8 22.1 34.0 61.4 23.1 28.8 29.2 28.0 36.4 29.5 36.4 27.1 29.2 20.4 37.5 26.7 34.0 25.5 7.7 31.9 20.6 26.4 29.1 13.1 14.7 25.6 15.1 33.9 23.8 18.6 27.2 24.6 16.0 20.4 20.2 30.6 15.1 21.8 21.0 35.0 21.7 32.7 13.2 24.0 23.8 12.5 17.7 18.0 16.4 13.7 10.3 17.4 12.1 15.9 18.3 56.6 105.5 63.6 78.1 56.4 39.0 48.7 53.5 108.4 109.2 38.4 39.3 93.9 23.2 104.4 113.2 77.5 32.5 0.0 104.1 85.7 61.2 59.6 79.9 61.8 93.6 47.7 57.1 43.0 136.4 16.3 53.5 87.6 57.3 76.7 45.4 69.3 88.3 45.9 52.3 62.6 44.7 58.2 72.1 99.1 113.5 58.7 88.0 62.3 54.7 73.2 XRRA1 FLJ00225 ENSG00000166435 "X-ray radiation resistance associated 1" Q6P2D8 11 74807739-74949200 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 131.6;Spermatocytes: 100.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 27.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039263 Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA039263: AB_2676419" "unprognostic (3.58e-1)" "unprognostic (1.04e-2)" "unprognostic (1.24e-1)" "unprognostic (3.11e-2)" "unprognostic (7.33e-2)" "unprognostic (1.20e-1)" "unprognostic (2.69e-1)" "unprognostic (1.71e-1)" "unprognostic (3.31e-1)" "unprognostic (1.23e-1)" "unprognostic (3.04e-1)" "unprognostic (1.62e-1)" "unprognostic (5.94e-3)" "unprognostic (2.13e-1)" "unprognostic (3.31e-2)" "unprognostic (2.06e-1)" "unprognostic (2.27e-1)" 7.1 7.9 6.2 19.5 8.6 3.7 10.7 5.7 7.5 8.6 7.3 7.6 22.9 5.8 9.0 13.5 6.6 9.6 8.7 9.5 7.9 5.9 6.9 8.1 9.5 4.1 5.7 7.0 9.3 22.7 11.9 8.1 5.3 10.8 10.5 5.6 7.4 13.1 16.8 15.7 5.8 5.9 10.1 13.7 7.2 6.4 35.0 6.1 5.6 14.3 4.1 5.8 6.3 7.4 3.5 3.4 6.2 5.2 2.0 8.5 3.0 3.9 2.3 0.5 3.7 5.9 3.9 1.6 1.7 1.9 1.0 1.0 1.2 2.1 1.6 6.4 1.9 8.5 3.2 4.6 2.3 2.2 6.4 0.4 1.4 1.3 2.2 1.7 0.8 0.7 3.7 2.6 4.2 27.9 8.1 2.0 5.4 3.6 3.8 4.9 1.4 1.4 2.0 1.3 4.8 2.0 0.7 3.0 1.2 0.8 3.0 3.6 3.0 8.0 3.4 10.7 1.9 2.1 4.1 1.3 6.0 3.9 4.4 1.6 5.4 4.7 4.4 1.4 0.8 2.0 2.9 4.3 3.8 6.3 5.2 6.6 3.5 4.6 4.7 3.4 3.5 4.6 4.5 6.2 2.0 3.2 2.5 8.5 3.0 6.2 8.6 5.7 7.5 7.9 5.9 5.7 7.0 10.8 6.1 8.9 9.1 42.7 9.6 9.7 52.4 5.5 7.6 14.7 11.4 21.0 131.6 10.3 13.3 6.9 31.4 11.9 13.5 0.0 7.0 8.3 11.6 7.7 11.5 10.2 6.9 46.1 11.6 17.8 10.4 63.5 27.6 7.4 27.0 9.0 13.3 27.7 5.6 14.4 28.7 13.9 79.0 25.8 8.4 100.4 34.9 6.6 9.2 37.0 16.9 5.8 YAF2 ENSG00000015153 "YY1 associated factor 2" Q8IY57 12 42157104-42238349 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 8 "Cardiomyocytes: 1091.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 45.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026867 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA026867: AB_1858911" "unprognostic (1.41e-1)" "unprognostic (2.24e-1)" "unprognostic (9.30e-2)" "unprognostic (3.06e-1)" "unprognostic (2.06e-2)" "unprognostic (4.12e-1)" "unprognostic (7.10e-3)" "unprognostic (2.70e-1)" "unprognostic (2.86e-3)" "unprognostic (2.44e-2)" "unprognostic (3.58e-2)" "unprognostic (5.57e-2)" "unprognostic (4.57e-2)" "unprognostic (3.42e-1)" "unprognostic (2.33e-1)" "unprognostic (5.76e-2)" "unprognostic (1.20e-2)" 11.2 11.4 15.6 7.6 14.2 9.7 10.0 16.3 19.7 11.0 7.9 8.4 6.9 7.2 10.9 11.1 8.5 7.8 10.1 39.4 12.9 13.3 10.5 19.2 8.4 12.4 13.2 11.3 11.0 7.6 7.4 14.6 10.2 14.5 9.3 8.3 8.1 7.1 10.0 43.9 6.5 8.9 11.6 10.8 11.3 7.0 7.8 9.1 12.7 11.9 8.3 10.5 11.2 9.1 13.6 10.8 32.6 9.8 14.2 14.1 5.2 7.0 5.3 8.2 6.0 10.4 9.5 4.7 9.1 9.3 8.7 8.0 7.4 5.5 4.5 7.6 8.3 3.4 5.5 8.0 5.9 11.9 10.6 8.8 9.7 2.9 3.8 6.2 9.1 6.1 6.7 8.6 6.7 13.7 8.6 8.6 4.7 9.5 10.2 10.8 3.4 9.8 12.1 1.8 8.2 5.8 6.8 9.5 6.4 10.8 4.7 5.9 8.3 7.6 9.3 7.9 3.9 6.0 7.4 8.1 7.8 6.1 8.9 4.7 9.4 11.9 14.8 8.2 45.4 2.9 17.9 9.3 15.1 10.9 9.8 11.1 11.2 10.3 12.4 6.9 13.6 8.3 8.6 32.6 14.2 8.9 10.8 14.1 5.2 15.6 14.2 16.3 16.7 12.9 13.3 13.2 11.3 14.5 9.1 20.8 12.0 51.1 37.6 51.6 71.2 1091.6 33.1 21.4 30.7 19.2 80.5 35.9 53.0 28.7 25.4 49.0 20.6 23.3 39.3 18.5 47.4 31.2 70.3 92.4 24.5 136.7 37.3 53.4 36.4 11.8 53.8 38.8 40.5 40.5 25.8 71.4 31.6 23.0 72.2 37.2 98.7 103.5 54.7 30.7 29.6 44.7 37.9 58.6 23.0 27.3 YAP1 YAP65 ENSG00000137693 "Yes associated protein 1" P46937 11 102110461-102233423 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009370, HPA038885, CAB069915, HPA070359" Enhanced Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "CAB009370: AB_2273277, CAB069915: AB_922796, HPA038885: AB_2676255, HPA070359: AB_2732154" "unprognostic (9.56e-2)" "unprognostic (6.75e-2)" "unprognostic (2.08e-1)" "unprognostic (3.03e-1)" "unprognostic (1.35e-1)" "unprognostic (3.16e-1)" "unprognostic (1.95e-1)" "unprognostic (1.28e-1)" "unprognostic (2.66e-3)" "unprognostic (3.73e-1)" "prognostic unfavorable (2.03e-4)" "unprognostic (9.26e-2)" "unprognostic (4.80e-2)" "unprognostic (8.38e-2)" "unprognostic (1.77e-1)" "unprognostic (1.04e-1)" "unprognostic (1.29e-2)" 27.1 15.8 11.6 12.1 10.0 0.0 34.9 7.0 9.5 37.5 21.3 7.0 40.1 9.8 51.7 33.3 36.9 25.5 34.6 18.8 12.5 6.0 17.3 32.1 26.2 7.6 9.3 6.1 41.1 8.9 18.9 6.4 34.0 15.0 34.8 11.4 21.7 22.2 35.2 27.8 23.4 15.1 58.2 17.2 7.6 18.2 15.6 9.7 2.6 34.0 25.7 12.6 42.3 41.1 0.1 0.0 0.0 0.0 0.0 0.3 0.2 11.7 11.0 30.7 15.0 33.6 32.1 25.7 27.7 31.7 27.0 22.3 27.4 28.6 0.0 22.9 36.2 20.1 20.8 15.2 39.5 28.7 3.4 5.4 0.0 15.0 18.6 25.7 0.0 0.5 25.6 26.0 29.6 48.3 30.2 8.4 1.4 0.0 0.0 30.5 5.6 0.5 0.0 14.5 28.3 10.5 0.0 17.3 0.0 19.9 21.0 0.1 1.0 32.6 12.3 9.2 29.4 22.2 0.1 9.2 38.5 15.1 19.3 11.6 0.0 0.0 0.1 11.2 0.0 27.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 11.6 10.0 7.0 9.5 12.5 6.0 9.3 6.1 15.0 9.7 32.8 51.8 1.7 40.6 101.0 0.3 34.4 76.5 24.1 35.2 87.2 0.0 79.0 10.0 28.8 3.9 26.3 16.2 0.0 15.8 14.7 61.4 50.8 0.0 36.0 9.2 0.0 7.0 24.5 1.3 2.7 35.1 2.3 42.2 1.8 13.7 26.2 23.1 20.9 38.2 20.0 1.0 38.8 48.4 2.7 0.9 107.6 51.5 0.0 24.7 55.2 YBEY C21orf57 ENSG00000182362 "YbeY metallopeptidase (putative)" P58557 21 46286337-46297751 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 58.3" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 253.1;Late spermatids: 197.2;Spermatocytes: 177.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016593, HPA018162" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA016593: AB_1845698, HPA018162: AB_1845699" "prognostic favorable (5.54e-4)" "unprognostic (1.05e-1)" "unprognostic (2.43e-2)" "unprognostic (7.24e-3)" "unprognostic (4.81e-1)" "unprognostic (2.78e-2)" "unprognostic (7.99e-2)" "unprognostic (1.95e-1)" "unprognostic (1.72e-1)" "unprognostic (8.87e-2)" "unprognostic (1.66e-3)" "unprognostic (2.95e-1)" "unprognostic (1.51e-2)" "unprognostic (7.50e-2)" "unprognostic (7.48e-2)" "unprognostic (1.94e-1)" "unprognostic (3.64e-3)" 7.0 8.3 9.5 8.9 10.3 4.1 10.9 8.9 12.1 7.6 11.1 11.6 10.1 8.9 6.6 12.0 5.9 8.2 6.8 8.1 9.0 9.1 8.8 11.0 10.1 10.9 11.4 10.5 8.2 11.3 10.1 10.0 4.7 9.2 10.4 9.7 7.3 10.5 9.6 11.5 9.4 12.4 6.3 13.6 7.0 6.8 58.3 8.5 6.8 7.5 12.7 10.6 6.3 6.4 21.8 16.0 14.8 7.8 12.7 16.8 6.8 10.1 8.9 7.6 9.2 5.8 22.4 7.4 6.9 10.4 6.9 8.4 4.7 1.7 12.9 6.1 7.1 3.6 3.3 3.2 3.2 6.3 12.2 12.8 3.7 5.8 1.8 16.8 4.1 0.4 15.4 13.9 5.4 11.3 9.0 4.4 6.4 8.8 15.5 8.0 8.6 8.1 5.4 22.3 3.8 9.3 17.2 3.6 24.7 14.0 4.7 5.6 9.9 9.4 4.3 18.6 2.6 2.2 3.7 5.4 6.6 2.4 5.3 4.5 19.4 34.3 22.2 12.0 4.6 4.0 14.8 6.1 4.6 9.6 6.8 9.3 21.8 11.6 11.7 6.9 15.5 11.4 13.0 2.1 12.7 7.8 16.0 16.8 6.8 9.5 10.3 8.9 12.1 9.0 9.1 11.4 10.5 9.2 8.5 3.0 6.1 22.7 30.1 41.1 13.0 19.0 15.3 10.7 13.6 17.4 7.9 14.0 54.7 31.5 253.1 18.0 46.6 0.0 67.1 20.6 27.3 31.8 11.5 43.2 21.8 15.9 30.8 22.1 27.5 197.2 37.7 32.3 37.1 17.2 53.4 14.0 43.0 49.1 23.0 56.4 21.1 6.5 27.0 177.3 30.9 52.9 8.0 22.4 53.3 31.2 YDJC ENSG00000161179 "YdjC chitooligosaccharide deacetylase homolog" A8MPS7 22 21628089-21630064 "Predicted intracellular proteins" "Carbohydrate metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 39.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061005 Approved Nucleoplasm NA NA Nucleoplasm "HPA061005: AB_2684412" "unprognostic (5.34e-2)" "unprognostic (2.30e-1)" "unprognostic (3.96e-1)" "unprognostic (2.29e-1)" "unprognostic (2.31e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (9.84e-4)" "unprognostic (9.35e-2)" "unprognostic (7.08e-2)" "unprognostic (8.09e-3)" "unprognostic (1.24e-1)" "unprognostic (9.86e-2)" "unprognostic (4.90e-3)" "unprognostic (1.07e-1)" "unprognostic (2.25e-1)" "unprognostic (9.60e-2)" "prognostic favorable (8.98e-5)" 5.0 6.5 8.1 12.4 6.9 4.0 4.9 5.8 12.3 9.4 9.8 6.0 6.9 10.3 5.4 5.8 9.4 8.3 7.0 3.5 8.6 5.7 12.4 10.2 5.3 13.3 5.9 3.8 7.9 19.2 9.2 4.4 7.3 5.8 7.1 6.2 4.3 8.2 6.1 4.6 8.1 11.8 4.5 5.9 10.2 7.4 4.2 3.8 10.3 14.6 7.5 13.8 7.1 5.5 20.4 18.1 11.6 15.4 21.4 16.0 11.7 3.8 0.9 0.1 0.3 1.2 0.9 4.4 1.7 1.0 1.0 1.7 0.3 1.5 3.8 6.4 0.0 1.0 3.4 1.2 2.9 1.6 3.3 13.0 5.4 0.7 4.7 1.6 9.6 4.1 1.4 5.9 0.8 7.5 1.1 2.9 5.8 39.8 0.7 0.7 4.0 3.5 13.6 1.5 11.0 7.3 2.4 0.0 3.8 7.1 2.0 5.1 3.2 1.6 2.5 3.5 0.0 3.4 4.6 2.4 0.4 4.8 1.0 2.2 7.4 4.2 3.5 0.4 2.9 0.8 7.6 15.4 11.6 11.1 13.6 11.2 18.1 15.8 12.1 18.1 20.4 13.8 12.6 5.6 21.4 9.7 12.3 16.0 11.7 8.1 6.9 5.8 12.3 8.6 5.7 5.9 3.8 5.8 3.8 6.0 8.0 46.3 34.3 22.1 4.4 3.2 17.8 4.0 3.4 41.8 0.0 36.6 33.2 53.1 17.0 14.7 35.8 0.0 37.1 56.3 10.3 33.7 11.5 13.0 26.8 3.2 15.5 3.7 14.1 3.2 9.8 24.8 13.5 70.3 27.8 5.3 44.3 33.4 6.3 52.1 4.7 19.4 8.2 13.0 32.4 19.8 19.3 33.0 35.4 36.1 YEATS2 "FLJ10201, FLJ12841, FLJ13308, KIAA1197" ENSG00000163872 "YEATS domain containing 2" Q9ULM3 3 183697818-183812625 "Predicted intracellular proteins" Epilepsy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 32.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045891 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA045891: AB_10961271" "unprognostic (1.57e-2)" "unprognostic (1.10e-1)" "unprognostic (3.56e-2)" "unprognostic (3.40e-3)" "unprognostic (1.14e-1)" "unprognostic (7.49e-2)" "prognostic unfavorable (4.82e-6)" "unprognostic (2.44e-1)" "unprognostic (3.91e-2)" "unprognostic (1.32e-1)" "unprognostic (8.33e-3)" "unprognostic (1.65e-3)" "prognostic unfavorable (6.90e-9)" "unprognostic (1.66e-1)" "unprognostic (1.53e-1)" "unprognostic (1.21e-1)" "unprognostic (2.08e-2)" 11.1 8.5 17.9 18.9 21.0 20.4 13.1 27.2 22.7 13.7 12.8 17.9 4.9 9.0 16.0 8.5 13.1 17.5 10.9 10.7 15.5 14.9 10.5 5.9 16.1 19.1 14.1 17.8 25.8 8.9 18.1 20.2 17.9 14.9 14.2 11.6 12.8 12.5 12.9 8.4 13.6 10.7 19.6 16.2 13.6 9.8 13.0 15.0 21.7 16.2 5.1 18.5 15.0 14.3 2.6 2.8 10.5 8.0 1.5 2.7 2.3 18.9 5.7 16.9 7.5 8.3 12.3 18.8 11.3 8.8 16.9 19.9 14.0 6.9 17.4 21.0 9.9 26.2 12.2 16.4 10.9 17.3 14.2 9.7 17.6 6.2 6.8 12.8 13.0 10.2 8.4 8.5 12.1 14.7 16.9 17.1 18.1 6.9 14.7 12.6 5.1 18.8 10.1 15.2 6.9 11.4 26.8 15.9 20.9 6.8 8.4 16.4 11.7 8.4 28.8 14.9 14.9 14.2 9.0 14.4 15.6 11.4 7.8 12.6 14.1 11.0 29.6 12.1 13.1 11.0 0.1 6.0 1.6 2.7 2.5 1.9 2.6 2.3 1.9 2.0 1.8 1.9 2.1 10.5 1.5 8.0 2.8 0.9 2.3 17.9 21.0 27.2 22.7 15.5 14.9 14.1 17.8 14.9 15.0 32.8 2.9 7.6 2.7 1.8 18.1 8.7 2.5 9.4 5.7 5.2 9.8 3.9 0.0 5.5 1.9 9.5 4.0 0.0 3.5 7.5 4.3 4.8 6.9 2.1 6.0 12.7 8.2 8.0 8.4 2.1 9.2 5.8 1.7 2.8 5.8 6.1 6.9 0.0 8.9 0.8 16.5 0.0 4.1 1.9 14.3 3.0 1.7 3.2 4.3 2.1 YEATS4 "GAS41, NuBI-1, YAF9" ENSG00000127337 "YEATS domain containing 4" O95619 12 69359703-69390796 "Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "Spermatocytes: 352.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072532 Approved "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA072532: AB_2686530" "unprognostic (7.23e-2)" "unprognostic (8.50e-3)" "unprognostic (2.05e-3)" "unprognostic (8.07e-3)" "unprognostic (1.64e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (3.52e-6)" "unprognostic (1.77e-2)" "unprognostic (3.03e-3)" "unprognostic (1.80e-2)" "unprognostic (6.15e-2)" "unprognostic (2.13e-1)" "unprognostic (7.19e-2)" "unprognostic (8.47e-2)" "unprognostic (2.04e-1)" "unprognostic (1.96e-1)" "unprognostic (1.78e-1)" 10.0 13.4 10.7 12.9 11.7 33.1 15.6 21.2 16.0 9.4 10.3 8.2 5.6 11.4 10.6 13.6 12.7 10.8 7.3 10.2 10.2 11.4 13.0 12.6 8.8 17.6 13.8 8.1 10.7 19.2 6.0 14.7 9.2 11.5 9.6 12.1 12.1 12.1 9.0 12.5 9.5 11.2 9.7 11.7 12.1 10.3 51.6 10.9 22.6 12.2 13.4 16.7 10.1 9.8 13.5 10.7 14.7 15.1 12.8 23.1 13.0 17.3 8.9 17.5 10.8 4.1 6.6 14.1 10.5 11.3 18.7 15.6 10.3 5.2 35.4 10.3 5.7 9.5 13.5 13.9 10.7 18.4 17.3 15.2 20.3 7.1 12.5 5.7 29.4 18.0 4.8 13.7 9.9 14.8 9.5 10.6 29.4 17.1 43.3 9.1 8.7 41.3 32.2 24.5 11.7 12.3 22.0 16.5 17.2 10.4 15.8 19.5 13.3 10.9 10.6 17.1 11.5 20.3 17.4 6.2 7.7 7.8 21.3 12.8 11.5 14.0 38.6 8.3 14.1 13.4 5.2 7.8 14.7 13.5 11.0 15.1 13.2 18.9 14.1 10.7 13.5 23.1 19.5 4.0 12.8 15.1 8.9 18.3 13.0 10.7 11.7 21.2 16.0 10.2 11.4 13.8 8.1 11.5 10.9 6.0 19.6 31.4 31.2 26.4 23.3 22.2 15.3 24.1 25.0 10.4 11.8 38.5 39.7 23.6 5.4 14.6 15.1 46.7 33.9 48.2 16.2 30.4 18.5 16.6 33.0 17.5 16.9 9.8 10.0 12.0 17.3 24.0 11.8 56.9 25.2 21.7 26.2 17.5 22.6 28.7 21.9 19.4 14.6 352.0 74.5 28.0 19.7 33.1 35.3 31.0 YIPF1 "DJ167A19.1, FinGER1" ENSG00000058799 "Yip1 domain family member 1" Q9Y548 1 53851719-53889834 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 108.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014716, HPA073931" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA014716: AB_1847686, HPA073931: " "unprognostic (4.94e-2)" "unprognostic (4.50e-1)" "unprognostic (6.37e-2)" "unprognostic (2.06e-2)" "unprognostic (3.93e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (1.34e-4)" "unprognostic (1.96e-1)" "unprognostic (6.64e-2)" "unprognostic (2.34e-1)" "unprognostic (1.49e-1)" "unprognostic (2.76e-1)" "unprognostic (1.24e-2)" "unprognostic (7.75e-3)" "unprognostic (2.38e-1)" "unprognostic (5.39e-3)" "unprognostic (6.35e-1)" 10.1 15.6 12.8 9.1 13.9 8.0 18.2 6.9 12.8 11.2 12.1 8.8 11.5 11.0 6.6 12.2 14.0 10.2 10.8 13.4 10.6 12.1 16.1 31.8 11.9 14.1 12.4 9.1 11.8 13.7 7.2 15.5 15.4 14.4 17.8 14.4 10.2 17.1 14.3 18.7 13.9 10.6 9.4 10.6 13.3 13.0 10.8 11.1 10.3 33.5 9.8 15.7 12.9 16.2 8.1 11.4 26.7 14.5 6.9 16.0 10.2 6.9 4.2 6.7 4.7 7.9 8.9 6.0 5.0 7.9 9.3 12.2 4.8 2.1 2.3 8.5 6.0 14.3 8.3 8.8 11.1 9.6 17.6 7.0 5.8 4.7 7.2 10.9 6.4 5.5 8.9 10.5 7.4 9.0 7.9 10.0 8.7 6.0 6.7 9.0 5.9 6.5 9.3 4.9 8.2 7.0 4.1 6.3 9.9 7.9 3.6 3.0 3.8 4.7 9.0 23.0 22.1 13.9 7.2 4.5 3.8 3.9 6.7 4.3 13.5 15.4 4.3 5.8 5.3 3.3 12.5 12.5 13.2 8.5 11.3 8.0 8.1 7.3 8.5 11.4 7.7 7.1 6.7 26.7 6.9 14.5 7.8 16.0 10.2 12.8 13.9 6.9 12.8 10.6 12.1 12.4 9.1 14.4 11.1 6.0 13.0 10.7 15.1 7.6 6.5 8.5 28.1 14.7 15.9 8.7 0.0 65.7 10.0 23.6 22.9 8.7 11.7 0.0 28.3 23.0 8.3 37.4 9.2 17.4 34.5 9.5 9.2 13.5 19.9 41.4 5.5 15.8 10.1 16.2 23.0 16.2 25.6 12.9 8.9 13.5 5.4 0.0 6.2 12.7 18.3 9.5 108.4 13.8 9.5 22.0 YIPF3 "C6orf109, dJ337H4.3, DKFZp566C243, FinGER3, KLIP1" ENSG00000137207 "Yip1 domain family member 3" Q9GZM5 6 43511827-43516990 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 99.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014859, HPA063699" Supported Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA014859: AB_1845729, HPA063699: AB_2685095" "unprognostic (2.82e-2)" "unprognostic (1.29e-1)" "unprognostic (2.29e-2)" "unprognostic (4.71e-2)" "unprognostic (1.74e-1)" "unprognostic (2.05e-1)" "unprognostic (2.15e-3)" "unprognostic (3.77e-1)" "unprognostic (1.33e-1)" "unprognostic (1.70e-3)" "unprognostic (1.70e-2)" "unprognostic (1.12e-1)" "unprognostic (1.40e-1)" "unprognostic (1.94e-2)" "unprognostic (3.55e-1)" "unprognostic (1.21e-1)" "unprognostic (1.10e-1)" 26.8 51.0 26.1 20.3 36.8 19.3 28.1 24.2 48.9 33.5 30.4 38.1 40.3 31.9 31.2 50.5 31.9 34.4 39.9 30.9 26.2 25.5 44.2 62.0 30.0 21.1 26.1 21.4 34.0 73.7 47.0 38.9 59.3 29.7 36.0 29.9 36.8 75.4 31.8 30.6 26.9 38.4 27.4 28.1 28.0 38.8 27.8 22.6 27.9 51.2 31.3 32.9 32.8 26.5 11.7 18.5 74.3 19.7 14.6 18.3 16.0 19.0 13.4 19.8 38.3 44.6 36.1 11.9 23.0 35.7 19.1 24.2 16.0 13.9 7.8 18.4 42.2 16.5 19.2 14.5 22.4 12.1 14.3 20.8 12.2 19.8 30.4 34.6 12.9 18.4 36.0 29.3 16.2 16.1 32.5 28.7 13.3 13.2 18.1 22.7 29.2 9.8 16.5 10.2 99.8 14.9 8.7 9.1 20.6 34.0 20.3 16.0 22.9 10.4 13.9 24.3 15.7 22.9 27.2 27.3 21.7 11.4 11.9 15.8 21.3 17.1 15.5 15.4 11.2 14.6 26.2 19.7 28.3 15.3 18.5 13.3 11.7 13.8 13.5 18.5 11.7 11.3 12.6 74.3 14.6 18.4 17.0 18.3 16.0 26.1 36.8 24.2 48.9 26.2 25.5 26.1 21.4 29.7 22.6 32.8 25.2 38.7 57.7 36.1 56.4 26.7 56.0 32.1 39.8 52.4 35.3 167.5 41.4 124.0 24.9 56.8 99.6 23.3 88.8 180.7 66.2 64.5 40.3 62.3 87.8 55.6 102.8 65.7 41.3 59.8 64.7 40.3 62.4 92.8 108.3 110.5 105.8 94.7 62.9 58.6 49.3 32.3 47.5 38.7 38.1 31.0 220.8 42.4 69.7 72.1 YIPF5 "FinGER5, SMAP-5" ENSG00000145817 "Yip1 domain family member 5" Q969M3 5 144158159-144170714 "Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "TIME: 64.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042338, HPA073622" Supported Supported "Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Vesicles" NA NA "Endoplasmic reticulum, Golgi apparatus, Vesicles" Nucleoplasm "HPA042338: AB_2677953, HPA073622: AB_2686618" "prognostic unfavorable (7.83e-5)" "unprognostic (1.13e-3)" "unprognostic (1.95e-2)" "unprognostic (8.35e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.12e-5)" "prognostic unfavorable (3.26e-5)" "unprognostic (2.89e-2)" "unprognostic (1.99e-1)" "unprognostic (3.64e-2)" "unprognostic (1.20e-3)" "unprognostic (4.79e-2)" "unprognostic (8.79e-2)" "unprognostic (1.69e-1)" "unprognostic (1.24e-2)" "unprognostic (5.11e-2)" "unprognostic (6.49e-2)" 26.6 26.6 18.4 14.7 21.2 15.8 22.5 19.2 22.6 23.9 22.2 17.2 22.5 26.5 25.7 22.0 27.2 18.9 19.0 18.3 15.1 18.5 23.0 27.8 20.4 21.0 16.2 20.5 19.6 41.7 21.5 45.3 37.1 21.8 16.8 23.4 18.9 32.7 18.3 11.9 24.5 30.5 25.2 19.7 18.8 23.8 20.7 16.2 14.0 20.2 21.2 20.1 24.1 19.9 22.3 27.2 28.8 28.1 23.7 36.7 23.4 11.5 7.7 10.1 8.0 24.2 26.2 9.2 39.5 26.9 17.8 28.8 12.3 12.2 6.3 19.1 42.8 20.5 10.7 9.6 19.4 24.1 8.8 8.3 4.7 13.5 12.5 19.6 10.4 7.8 19.8 18.2 15.9 13.1 30.8 16.9 7.0 4.9 10.7 24.0 6.0 5.1 5.9 6.5 7.4 8.5 5.4 15.0 10.5 11.1 10.3 6.9 8.5 13.7 7.4 17.5 10.7 15.3 6.9 64.9 21.0 10.2 20.3 15.5 9.7 16.1 8.0 20.1 10.0 15.3 25.6 21.0 28.8 30.3 28.1 34.3 22.3 31.0 33.6 25.0 21.5 32.8 30.8 15.6 23.7 25.4 27.2 36.7 23.4 18.4 21.2 19.2 22.6 15.1 18.5 16.2 20.5 21.8 16.2 35.7 24.3 40.2 21.0 26.2 39.5 19.3 22.9 49.5 26.1 19.2 31.4 48.9 26.6 36.5 8.3 38.7 36.0 46.7 60.0 68.2 45.1 27.2 35.8 30.5 33.0 31.8 14.3 33.2 27.9 5.3 32.8 24.3 28.7 34.3 44.6 54.8 46.2 31.9 31.8 30.4 43.2 38.8 28.8 78.4 48.5 22.7 56.4 34.5 25.2 18.5 YLPM1 "C14orf170, PPP1R169, ZAP" ENSG00000119596 "YLP motif containing 1" P49750 14 74763366-74859435 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048070, HPA061123" Uncertain Supported "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA048070: AB_2680247, HPA061123: AB_2684435" "unprognostic (2.17e-1)" "unprognostic (3.32e-2)" "unprognostic (3.95e-1)" "unprognostic (2.98e-1)" "unprognostic (3.79e-2)" "unprognostic (7.64e-2)" "unprognostic (3.22e-3)" "unprognostic (8.74e-2)" "unprognostic (3.60e-2)" "unprognostic (2.56e-1)" "unprognostic (7.83e-3)" "unprognostic (6.63e-2)" "prognostic favorable (6.08e-7)" "unprognostic (1.09e-2)" "unprognostic (2.41e-1)" "unprognostic (1.87e-1)" "unprognostic (1.60e-1)" 17.2 19.0 28.9 21.7 33.4 26.1 21.0 51.4 32.6 18.6 15.4 24.9 18.8 13.1 23.8 20.6 17.4 20.6 15.9 15.8 24.2 18.2 15.7 14.0 16.4 20.8 24.1 24.8 31.3 21.0 30.9 30.5 19.8 22.5 20.0 17.2 18.8 20.6 22.8 20.7 23.0 16.5 17.7 21.2 18.9 16.2 28.8 27.6 24.7 22.5 8.7 20.6 22.4 18.7 5.5 7.8 3.3 3.9 5.4 4.6 3.0 19.2 21.4 23.5 4.5 16.9 16.5 12.7 13.4 13.7 13.6 13.7 18.8 13.9 28.9 10.0 15.1 9.7 17.5 20.3 13.9 21.6 17.4 11.7 20.9 13.6 12.8 9.1 15.9 16.0 14.4 9.3 15.3 11.6 16.1 18.5 16.1 16.5 13.8 16.7 19.8 18.3 12.9 14.0 11.9 18.0 27.7 23.4 10.1 10.8 27.8 17.2 16.9 21.5 13.3 5.1 15.7 15.9 10.6 27.7 16.5 21.1 11.8 16.8 16.9 16.3 31.9 14.3 11.7 12.3 0.7 3.4 3.3 3.8 3.9 4.2 4.4 3.2 3.2 3.1 5.5 4.6 4.6 2.7 5.4 3.1 7.8 2.7 3.0 28.9 33.4 51.4 32.6 24.2 18.2 24.1 24.8 22.5 27.6 23.8 29.3 17.9 9.5 17.6 43.2 36.4 17.8 38.8 30.7 8.7 39.3 17.3 1.7 12.8 28.4 22.5 12.1 0.0 13.5 12.1 17.6 15.9 16.3 16.0 16.1 49.3 19.7 20.3 19.1 12.5 31.4 16.6 5.0 15.4 17.9 27.2 14.2 10.5 45.6 11.8 28.3 19.4 15.1 59.1 47.3 20.5 13.2 17.0 19.4 10.5 YOD1 "DKFZp451J1719, DUBA8, OTUD2" ENSG00000180667 "YOD1 deubiquitinase" Q5VVQ6 1 207043849-207052980 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway, Unfolded protein response" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 44.7" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 69.8;Urothelial cells: 62.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 40.3;K-562: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028400, HPA028439" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 40000 "Nucleoplasm, Plasma membrane, Cytosol" "HPA028400: AB_10599854, HPA028439: AB_10600994" "unprognostic (3.69e-2)" "unprognostic (8.72e-2)" "unprognostic (1.17e-1)" "unprognostic (2.39e-1)" "unprognostic (2.03e-2)" "unprognostic (3.28e-2)" "unprognostic (9.87e-3)" "unprognostic (9.38e-2)" "unprognostic (2.31e-3)" "unprognostic (8.96e-2)" "unprognostic (1.47e-3)" "unprognostic (1.03e-2)" "unprognostic (6.07e-2)" "unprognostic (6.86e-2)" "unprognostic (2.83e-1)" "unprognostic (1.79e-2)" "unprognostic (3.62e-1)" 4.5 4.6 4.0 4.0 5.3 44.7 6.6 4.8 7.5 6.1 3.9 7.6 2.6 4.1 4.0 3.1 24.5 3.7 3.5 5.0 4.0 2.2 4.5 5.2 9.4 4.2 7.1 4.4 3.5 3.6 2.5 5.1 6.3 5.1 3.4 4.0 3.4 9.7 3.0 6.5 14.9 4.8 2.7 8.5 5.2 8.4 5.6 6.9 14.3 5.8 10.0 8.2 5.8 12.3 0.5 1.3 3.9 1.5 1.2 1.8 0.9 5.4 2.9 4.6 2.7 1.6 2.1 9.0 3.6 2.8 2.7 2.8 5.5 5.6 2.8 1.5 2.2 1.3 6.0 0.0 4.4 3.1 2.3 4.9 40.3 11.9 2.6 1.5 5.2 14.2 1.5 3.4 2.2 8.6 3.2 2.4 5.9 28.0 0.0 2.3 0.0 4.6 2.9 4.4 2.2 6.5 2.3 0.2 2.1 2.7 6.1 2.4 5.3 5.9 6.9 7.7 4.2 2.4 3.7 1.1 2.4 6.2 1.9 4.7 4.6 0.2 4.2 2.8 0.0 1.6 3.9 1.2 2.0 1.1 1.5 1.5 0.4 1.7 0.9 1.3 0.5 1.4 1.8 2.9 1.2 1.0 0.7 0.8 0.9 4.0 5.3 4.8 7.5 4.0 2.2 7.1 4.4 5.1 6.9 38.7 9.8 0.8 21.4 28.0 7.8 5.3 5.1 13.4 5.7 1.8 3.9 2.3 1.7 3.8 28.6 3.5 9.8 46.7 9.3 2.7 5.7 29.8 8.1 5.4 2.4 11.1 8.5 3.7 8.5 69.8 1.4 6.4 13.5 1.8 3.5 4.2 15.5 4.9 2.1 5.4 16.2 6.5 3.1 8.8 4.1 35.1 1.5 7.5 5.4 62.9 YPEL5 CGI-127 ENSG00000119801 "Yippee like 5" P62699 2 30146941-30160533 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 164.9" "Cell type enhanced" "Detected in all" 4 "monocytes: 480.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042809 Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA042809: AB_2678179" "unprognostic (7.22e-3)" "unprognostic (6.50e-3)" "unprognostic (9.16e-2)" "unprognostic (5.47e-2)" "unprognostic (4.88e-2)" "unprognostic (1.83e-2)" "unprognostic (3.60e-2)" "unprognostic (3.39e-2)" "unprognostic (1.95e-1)" "unprognostic (5.73e-2)" "unprognostic (2.26e-1)" "unprognostic (1.23e-1)" "unprognostic (1.52e-3)" "unprognostic (1.16e-2)" "unprognostic (7.35e-2)" "unprognostic (1.08e-1)" "unprognostic (4.67e-3)" 29.6 32.5 39.0 20.1 38.2 164.9 32.9 34.2 52.9 31.2 34.6 20.7 38.2 19.4 28.7 40.9 35.1 25.6 30.8 26.1 38.1 39.5 40.5 29.8 31.9 30.5 35.3 32.5 30.0 23.4 24.6 26.0 48.1 36.4 33.8 22.2 33.1 28.7 47.6 27.7 26.1 29.1 36.8 30.6 29.6 27.2 31.4 18.3 34.2 39.0 20.6 28.2 40.1 25.2 21.3 35.0 72.4 31.9 12.5 21.6 30.9 9.9 5.5 12.0 5.9 34.1 33.1 10.2 14.1 43.7 8.2 12.7 4.5 10.3 5.9 9.6 28.4 19.0 5.4 2.7 14.4 11.6 26.1 5.4 3.1 2.5 7.2 29.1 1.0 7.2 34.1 29.4 15.5 20.0 35.6 15.5 3.9 4.3 10.5 22.1 5.2 3.2 7.2 6.7 11.5 6.5 1.9 16.3 5.6 27.5 19.4 4.8 14.9 7.2 6.9 17.5 23.0 7.7 5.8 20.3 22.3 8.6 6.1 3.9 25.1 9.8 7.9 15.9 2.8 9.0 41.7 19.6 43.1 13.6 21.8 13.5 21.3 16.6 15.9 18.2 17.4 16.0 14.1 72.4 12.5 31.9 35.0 21.6 30.9 39.0 38.2 34.2 52.9 38.1 39.5 35.3 32.5 36.4 18.3 77.4 75.1 107.8 142.4 118.9 71.0 67.4 35.7 57.6 64.8 96.0 45.2 147.4 117.7 76.8 214.0 63.9 69.5 116.8 69.5 110.5 88.3 121.7 81.7 36.8 91.0 60.4 200.3 49.1 87.4 400.6 53.5 101.5 161.9 480.7 69.6 83.5 86.2 73.7 77.8 97.1 49.3 51.8 103.9 99.6 72.4 124.6 341.2 117.6 43.7 247.9 YTHDC1 "KIAA1966, YT521, YT521-B" ENSG00000083896 "YTH domain containing 1" Q96MU7 4 68310387-68350089 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036462 Supported Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA036462: AB_10669793" "unprognostic (1.02e-1)" "unprognostic (8.44e-3)" "unprognostic (5.74e-3)" "unprognostic (1.35e-1)" "unprognostic (7.59e-2)" "unprognostic (1.33e-3)" "unprognostic (1.52e-3)" "unprognostic (8.28e-2)" "unprognostic (1.38e-1)" "unprognostic (1.09e-1)" "unprognostic (2.35e-2)" "unprognostic (1.41e-2)" "unprognostic (6.64e-3)" "unprognostic (1.63e-2)" "unprognostic (1.70e-1)" "unprognostic (4.05e-1)" "prognostic favorable (7.29e-5)" 22.1 16.6 25.1 28.8 33.2 101.8 24.3 38.4 25.8 30.3 20.8 24.4 24.0 16.7 29.2 25.1 25.4 20.2 17.6 18.5 23.5 19.6 19.8 19.5 21.1 26.8 26.1 23.4 39.7 24.2 27.6 32.4 33.2 22.8 25.2 21.3 13.8 22.7 30.2 32.9 26.1 21.2 27.6 25.4 23.6 20.6 17.7 35.1 30.2 23.8 20.2 26.7 34.8 30.3 18.0 15.1 41.6 9.3 7.5 11.1 3.2 17.6 10.6 21.7 13.0 13.1 11.4 18.0 19.5 12.3 12.2 12.9 13.1 16.3 29.0 16.0 9.9 9.9 13.4 20.3 17.1 19.9 21.4 12.3 22.1 15.2 14.5 13.4 23.3 17.1 10.8 18.6 10.9 26.2 15.7 13.2 14.1 20.8 17.1 17.8 13.5 27.1 21.0 16.3 17.3 10.5 23.8 24.6 12.9 19.1 20.5 18.9 14.8 17.0 18.4 14.1 21.2 14.4 16.3 13.9 14.1 14.9 9.7 12.8 17.8 11.9 30.3 9.5 15.2 12.9 20.2 8.3 14.7 9.9 5.0 7.7 12.7 8.0 7.9 4.6 18.0 11.1 9.2 41.6 7.5 9.3 15.1 7.3 3.2 25.1 33.2 38.4 25.8 23.5 19.6 26.1 23.4 22.8 35.1 104.2 120.5 72.4 101.3 106.6 102.8 78.1 73.9 139.2 159.3 69.8 66.8 58.2 44.7 60.9 61.3 76.3 40.0 23.3 49.7 94.0 62.9 98.5 88.2 72.1 37.8 85.8 82.2 47.9 51.2 14.3 69.0 70.8 60.8 45.1 60.5 91.4 65.5 48.7 63.6 32.1 131.7 51.8 97.3 131.7 89.6 117.6 99.5 74.8 54.4 85.9 YTHDC2 "DKFZp564A186, FLJ10053, FLJ2194" ENSG00000047188 "YTH domain containing 2" Q9H6S0 5 113513683-113595285 "Enzymes, Predicted intracellular proteins" "Differentiation, Meiosis, Oogenesis, Spermatogenesis" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 92.8;Spermatocytes: 97.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037364, HPA072678" Approved Approved "Nucleoplasm,Nuclear bodies,Cytoplasmic bodies" NA NA Nucleoplasm "Nuclear bodies, Cytoplasmic bodies" "HPA037364: AB_10672788, HPA072678: AB_2686548" "unprognostic (2.09e-1)" "unprognostic (2.10e-1)" "prognostic favorable (1.82e-5)" "unprognostic (4.33e-3)" "unprognostic (1.45e-1)" "unprognostic (6.48e-3)" "unprognostic (1.96e-1)" "unprognostic (7.82e-3)" "unprognostic (3.55e-2)" "unprognostic (8.56e-3)" "unprognostic (4.61e-2)" "unprognostic (2.03e-1)" "unprognostic (4.15e-2)" "unprognostic (3.05e-1)" "unprognostic (9.96e-2)" "unprognostic (1.08e-2)" "unprognostic (2.56e-2)" 15.2 16.3 12.4 18.5 16.8 12.8 15.3 25.2 26.1 16.5 12.7 11.7 9.0 13.6 17.7 14.6 16.1 14.2 12.2 13.0 10.4 10.5 14.3 18.3 12.4 18.7 12.8 10.2 19.9 14.7 35.5 26.2 10.3 18.6 12.8 15.3 14.9 15.5 13.3 18.5 16.5 16.5 13.2 13.7 19.3 13.4 20.5 13.3 19.7 16.2 15.4 18.4 14.7 14.8 9.5 5.5 4.2 4.9 5.7 5.7 1.7 11.1 10.1 13.1 22.2 7.3 9.7 14.4 8.7 9.6 11.1 17.4 7.0 6.3 20.4 6.2 7.2 14.3 10.9 15.8 19.4 14.6 8.8 14.3 11.1 18.1 9.5 10.8 8.8 9.8 7.9 7.5 7.0 12.8 10.5 15.4 9.3 10.8 9.4 9.8 3.7 12.2 6.3 6.1 3.3 6.7 5.2 11.4 15.8 9.3 14.8 10.5 8.8 11.6 8.5 8.9 8.6 12.0 8.0 13.4 17.1 6.0 8.8 11.7 9.7 12.1 12.8 9.8 10.1 7.2 0.0 4.3 4.2 4.5 2.8 5.3 9.5 5.3 4.8 3.6 8.1 5.7 4.7 1.8 5.7 4.9 5.5 3.7 1.7 12.4 16.8 25.2 26.1 10.4 10.5 12.8 10.2 18.6 13.3 26.8 29.1 18.2 17.4 11.7 58.8 17.3 12.7 28.1 30.7 12.2 78.5 11.1 0.0 15.3 22.0 18.5 11.2 23.3 16.5 8.1 14.7 12.8 11.6 19.7 14.4 49.3 6.9 20.9 27.6 37.6 18.4 18.8 11.8 17.2 13.0 25.3 13.7 7.0 13.8 15.2 92.8 25.8 19.4 97.9 24.0 12.5 15.1 21.2 13.6 15.2 YWHAB YWHAA ENSG00000166913 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta" P31946 20 44885676-44908532 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003759, HPA007925, HPA011212, HPA061603" Enhanced Supported "Nucleoplasm,Nucleoli rim,Cytosol" NA NA 210000000 Cytosol "Nucleoplasm, Nucleoli rim" "CAB003759: AB_289588, HPA007925: AB_1844340, HPA011212: AB_1844334, HPA061603: " "prognostic unfavorable (9.18e-4)" "unprognostic (1.48e-1)" "unprognostic (9.06e-2)" "prognostic unfavorable (5.46e-4)" "unprognostic (3.80e-1)" "prognostic unfavorable (6.14e-4)" "prognostic unfavorable (1.91e-6)" "prognostic unfavorable (6.01e-4)" "unprognostic (8.92e-2)" "unprognostic (2.01e-1)" "unprognostic (1.53e-2)" "unprognostic (2.35e-1)" "prognostic favorable (2.52e-5)" "unprognostic (6.72e-2)" "unprognostic (2.40e-1)" "unprognostic (6.60e-3)" "unprognostic (8.59e-2)" 39.3 38.6 65.5 39.4 79.2 28.6 33.0 60.1 87.9 34.0 47.5 27.7 28.7 37.9 35.2 26.4 48.1 30.2 29.6 40.3 68.7 63.4 47.3 36.5 37.4 46.8 49.8 76.2 25.8 18.9 41.1 18.4 36.7 50.1 31.4 53.4 22.9 30.7 43.2 28.3 38.4 39.3 43.3 38.4 53.7 36.7 16.8 33.6 48.2 36.1 31.8 60.2 41.2 34.9 30.9 41.9 37.3 58.4 26.8 43.5 26.6 52.4 39.8 32.1 30.7 53.4 47.3 43.5 47.8 46.6 58.9 51.7 82.8 59.4 56.0 50.1 63.1 64.1 55.9 45.2 88.8 70.5 21.4 27.6 41.7 35.0 49.1 35.4 67.5 40.4 36.9 66.5 46.1 59.6 40.4 58.9 34.5 44.9 27.1 60.4 62.0 52.7 55.6 30.3 60.2 61.9 41.4 46.5 43.5 63.1 58.7 34.3 36.6 81.0 86.6 55.7 39.1 63.0 65.0 66.8 91.6 47.0 51.6 48.6 18.1 33.0 51.4 66.9 45.2 46.5 34.8 40.1 34.4 29.7 52.2 30.2 30.9 37.7 36.3 41.9 28.6 30.8 36.6 37.3 26.8 58.4 26.5 43.5 26.6 65.5 79.2 60.1 87.9 68.7 63.4 49.8 76.2 50.1 33.6 235.2 267.7 257.8 195.0 245.8 236.2 168.2 214.0 242.2 213.9 235.5 47.1 316.7 195.6 394.2 12.6 314.4 343.6 0.0 427.4 513.3 214.8 235.2 219.7 140.9 363.9 276.5 286.2 292.8 365.8 16.1 174.9 402.5 210.9 466.1 277.5 222.2 471.9 382.0 197.7 259.3 98.3 226.4 208.3 50.5 174.0 284.4 444.3 286.3 279.8 359.2 YWHAE FLJ45465 ENSG00000108953 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon" P62258 17 1344272-1400378 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008445, CAB016200, CAB021109, CAB047350, HPA061603" Approved Supported "Nucleoplasm,Nucleoli rim,Cytosol" NA NA 160000000 Cytosol "Nucleoplasm, Nucleoli rim" "CAB016200: AB_626619, CAB021109: AB_10060396, CAB047350: , HPA008445: AB_1844336, HPA061603: " "unprognostic (1.29e-1)" "unprognostic (1.50e-1)" "unprognostic (3.99e-2)" "prognostic favorable (6.48e-6)" "unprognostic (1.59e-1)" "unprognostic (2.91e-2)" "unprognostic (2.73e-2)" "unprognostic (4.77e-3)" "unprognostic (4.53e-2)" "unprognostic (5.14e-2)" "unprognostic (1.59e-1)" "unprognostic (2.73e-1)" "unprognostic (1.92e-3)" "unprognostic (8.33e-2)" "unprognostic (2.57e-1)" "unprognostic (3.24e-2)" "unprognostic (8.94e-2)" 55.2 54.3 107.5 35.3 87.1 32.7 37.3 71.5 118.4 28.4 40.2 60.9 23.8 40.2 35.9 54.1 43.1 44.2 23.4 57.7 92.3 81.9 64.5 50.9 32.8 25.4 94.1 77.9 40.2 40.2 41.0 37.9 45.1 73.7 35.0 42.5 27.9 42.4 27.7 135.9 36.8 36.2 32.2 101.1 26.2 38.5 46.0 53.6 30.9 47.5 36.5 37.2 31.6 32.1 19.2 41.5 17.2 36.2 15.0 23.3 31.5 79.3 59.3 71.9 60.4 31.8 36.8 69.1 51.3 30.3 45.8 35.6 106.0 32.6 53.9 60.4 42.5 36.3 55.2 60.9 51.9 65.1 37.2 113.5 37.6 49.5 45.3 38.0 36.0 38.6 33.3 38.3 45.9 70.4 41.5 55.1 39.3 43.1 39.0 58.9 38.6 47.6 28.7 65.9 49.5 38.5 57.9 34.0 38.2 46.6 46.0 40.1 60.8 61.8 25.3 40.2 42.5 48.1 33.3 52.1 44.5 37.9 56.2 90.6 24.5 45.2 45.2 53.4 43.1 64.3 17.2 31.8 8.6 12.4 36.2 15.6 19.2 18.7 13.9 41.5 16.1 17.0 14.3 10.8 15.0 30.9 28.8 23.3 31.5 107.5 87.1 71.5 90.2 92.3 81.9 94.1 77.9 73.7 53.6 276.9 161.5 157.1 381.2 509.9 135.0 437.9 257.4 539.4 243.4 352.4 47.1 418.8 631.6 405.9 192.2 338.4 245.3 70.0 366.4 587.8 367.2 359.0 204.6 255.7 335.2 104.9 338.5 239.4 235.4 296.2 260.1 221.5 403.2 401.2 274.5 253.1 384.5 266.5 277.2 497.3 121.5 239.3 263.7 441.4 573.9 512.8 434.5 126.4 277.6 415.5 YWHAG PPP1R170 ENSG00000170027 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma" P61981 7 76326794-76359031 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 117.8;skeletal muscle: 91.8" "Cell type enhanced" "Detected in all" 5 "Basal keratinocytes: 363.1;Suprabasal keratinocytes: 371.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013274, CAB018389, HPA026918, HPA061603" Approved Approved Supported "Nucleoplasm,Nucleoli rim,Cytosol" NA NA 160000000 Cytosol "Nucleoplasm, Nucleoli rim" "CAB013274: , CAB018389: AB_2217962, HPA026918: AB_10610566, HPA061603: " "unprognostic (3.71e-2)" "prognostic unfavorable (4.53e-4)" "unprognostic (3.88e-2)" "unprognostic (1.25e-2)" "unprognostic (6.28e-3)" "unprognostic (2.40e-3)" "unprognostic (8.98e-3)" "prognostic unfavorable (5.34e-4)" "unprognostic (1.63e-1)" "unprognostic (1.64e-1)" "prognostic unfavorable (7.44e-4)" "unprognostic (3.03e-2)" "prognostic unfavorable (4.01e-4)" "unprognostic (9.31e-2)" "unprognostic (1.51e-1)" "unprognostic (2.45e-2)" "unprognostic (1.70e-1)" 52.4 31.2 46.3 17.7 54.6 7.3 17.2 36.2 117.8 13.4 14.2 13.3 4.6 14.4 15.0 7.0 18.6 9.0 17.0 33.1 50.2 56.2 15.9 22.0 12.9 12.1 45.9 49.8 13.3 18.0 14.8 7.8 16.6 74.6 14.7 14.0 8.6 10.0 13.3 91.8 11.7 12.5 20.2 22.8 12.7 11.2 8.9 13.5 6.8 8.8 13.8 14.3 14.7 13.2 3.1 5.9 3.2 5.0 1.1 3.3 1.7 37.4 47.2 41.7 53.0 42.8 24.7 18.9 43.6 21.6 27.1 29.4 29.6 40.4 52.9 15.0 38.7 45.1 35.1 52.3 48.1 38.1 35.8 22.8 50.1 32.3 32.8 39.1 61.1 49.0 27.1 46.2 31.6 65.5 28.8 42.9 28.8 68.7 59.9 40.3 35.3 43.6 45.2 46.3 30.3 33.1 51.1 42.3 58.4 42.4 25.6 22.4 62.3 48.3 62.0 30.8 56.2 43.1 37.0 45.3 52.9 30.7 46.9 58.2 19.9 37.2 81.5 47.5 57.8 56.3 3.2 5.0 1.1 2.1 4.6 3.3 3.1 2.4 2.6 5.2 1.8 1.8 2.0 1.1 1.1 3.8 5.9 2.0 1.7 46.3 54.6 36.2 88.9 50.2 56.2 45.9 49.8 74.6 13.5 29.8 23.7 44.7 105.7 363.1 100.2 200.1 43.3 22.7 45.5 36.6 11.8 29.7 31.5 43.8 87.4 64.2 34.1 46.7 32.8 61.5 84.6 106.7 66.8 81.5 75.7 117.6 81.9 48.5 90.6 18.9 42.8 83.5 89.4 41.5 31.5 23.8 60.8 28.8 40.7 41.0 26.9 32.3 122.6 10.3 16.7 371.9 56.2 18.7 33.8 146.6 YWHAQ "14-3-3, HS1" ENSG00000134308 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta" P27348 2 9583972-9631014 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007925, CAB010286, HPA061603" Approved Supported "Nucleoplasm,Nucleoli rim,Cytosol" NA NA 120000000 Cytosol "Nucleoplasm, Nucleoli rim" "CAB010286: AB_2218221, HPA007925: AB_1844340, HPA061603: " "unprognostic (2.65e-2)" "unprognostic (3.99e-2)" "unprognostic (2.78e-2)" "prognostic unfavorable (8.20e-4)" "unprognostic (1.53e-1)" "unprognostic (5.78e-3)" "prognostic unfavorable (9.83e-6)" "unprognostic (4.90e-3)" "unprognostic (2.98e-2)" "unprognostic (5.51e-2)" "unprognostic (6.18e-2)" "unprognostic (1.45e-1)" "unprognostic (2.95e-2)" "unprognostic (6.74e-2)" "unprognostic (9.75e-2)" "unprognostic (1.63e-1)" "unprognostic (4.39e-3)" 40.5 47.3 77.8 32.1 60.8 48.0 50.8 88.5 82.5 52.2 44.0 82.5 25.0 37.9 60.5 48.2 57.6 45.3 40.0 68.5 73.7 76.2 45.9 37.2 35.0 38.2 74.3 54.8 55.9 64.4 39.2 39.0 39.3 69.8 54.2 44.1 31.2 38.9 48.8 17.6 33.3 36.5 57.9 72.2 29.8 36.9 44.3 63.5 58.8 45.4 56.7 43.3 47.7 46.3 31.5 30.9 24.8 28.9 51.4 58.4 60.9 43.6 65.8 59.7 57.5 47.0 65.1 56.1 59.9 59.1 63.0 52.9 49.4 38.4 56.5 31.3 85.8 65.8 41.1 66.2 65.3 81.4 139.0 53.8 52.8 42.9 52.8 35.9 50.8 32.0 43.9 38.5 68.7 44.9 57.7 70.6 40.7 51.8 34.1 77.3 30.3 89.9 51.9 101.2 49.2 75.8 65.8 77.4 69.1 69.4 39.1 56.8 96.2 54.5 56.6 43.3 52.3 35.2 26.2 64.3 79.2 56.1 68.5 91.3 34.9 47.7 74.5 67.7 53.1 65.6 17.1 22.2 24.8 47.8 28.9 58.4 31.5 45.1 50.8 30.9 28.8 24.7 39.9 6.8 51.4 27.2 15.7 43.1 60.9 77.8 60.8 88.5 69.0 73.7 76.2 74.3 54.8 69.8 63.5 47.6 54.2 118.7 293.0 281.3 203.3 78.7 73.9 77.6 76.2 129.1 25.5 223.0 353.1 336.2 171.2 152.5 136.5 93.5 248.0 498.0 248.0 243.9 124.5 87.6 192.8 540.3 179.5 67.5 94.8 285.3 161.1 114.1 280.0 283.1 112.7 196.5 233.6 132.5 235.5 197.6 82.9 194.1 334.9 246.8 203.3 310.7 199.5 181.1 168.3 364.8 YWHAZ "14-3-3-zeta, KCIP-1, YWHAD" ENSG00000164924 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta" P63104 8 100916525-100953388 "Plasma proteins, Predicted intracellular proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 1590.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB005065, HPA061603" Approved Approved "Nucleoplasm,Nucleoli rim,Cytosol" NA NA 760000000 Cytosol "Nucleoplasm, Nucleoli rim" "CAB005065: AB_2218378, HPA061603: " "unprognostic (4.70e-3)" "unprognostic (7.38e-3)" "unprognostic (8.09e-2)" "prognostic unfavorable (3.91e-4)" "unprognostic (1.83e-3)" "unprognostic (2.00e-2)" "prognostic unfavorable (2.28e-5)" "prognostic unfavorable (3.93e-4)" "unprognostic (1.65e-1)" "unprognostic (3.72e-1)" "prognostic unfavorable (1.20e-5)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.03e-6)" "unprognostic (1.02e-1)" "unprognostic (1.69e-1)" "unprognostic (1.20e-1)" "unprognostic (1.49e-1)" 54.6 40.9 89.9 51.8 104.6 70.8 39.6 55.8 117.7 52.4 69.6 38.7 25.3 47.4 43.5 37.6 141.8 38.3 51.9 29.1 81.7 67.0 44.1 32.9 40.7 60.0 50.1 66.7 46.4 27.5 37.8 25.2 69.0 78.2 42.5 70.3 31.7 55.2 47.2 19.7 63.0 71.4 53.5 43.8 56.3 51.5 34.1 31.5 89.4 46.0 74.9 83.2 53.6 70.2 58.6 57.2 129.4 77.9 57.0 78.4 104.9 135.5 66.0 125.8 36.1 31.3 39.8 62.4 63.7 82.9 86.3 84.1 45.9 89.0 60.9 69.1 101.2 71.9 59.0 79.1 90.8 131.5 53.9 31.2 57.5 49.9 29.7 41.2 24.0 66.0 36.9 123.8 71.3 113.7 73.1 77.5 43.6 65.4 59.8 73.7 49.2 99.1 42.6 42.5 171.2 69.1 42.2 36.6 41.9 83.0 76.6 70.5 50.3 48.4 48.1 100.9 93.7 69.7 28.4 63.0 43.8 64.3 52.7 57.1 38.1 45.2 74.8 72.4 45.4 179.2 129.4 45.0 81.2 69.1 66.5 70.3 58.6 59.0 66.5 57.2 48.0 44.8 56.4 74.6 57.0 77.9 35.4 78.4 104.9 89.9 104.6 55.8 117.7 81.7 67.0 50.1 66.7 78.2 31.5 232.3 218.0 255.7 330.0 894.5 96.7 77.9 206.4 306.5 335.5 249.5 84.4 219.2 102.8 385.1 1094.8 171.9 335.2 46.7 365.6 441.5 215.1 349.2 432.9 89.1 253.4 127.1 254.5 172.5 286.2 1590.1 116.2 345.3 371.2 266.9 443.9 100.4 544.8 334.6 138.3 122.2 86.4 129.4 256.3 148.6 68.6 1035.6 342.0 343.9 282.9 758.7 YY1 "DELTA, INO80S, NF-E1, UCRBP, YIN-YANG-1" ENSG00000100811 "YY1 transcription factor" P25490 14 100238298-100282792 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, DNA damage, DNA recombination, DNA repair, Spermatogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001119, CAB009392" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" NA NA Nucleoplasm "Nucleoli fibrillar center, Vesicles" "CAB009392: AB_2218501, HPA001119: AB_1858930" "unprognostic (7.67e-2)" "unprognostic (8.08e-2)" "unprognostic (2.57e-2)" "prognostic unfavorable (6.13e-4)" "unprognostic (6.75e-3)" "unprognostic (8.31e-3)" "prognostic unfavorable (3.44e-4)" "unprognostic (1.09e-1)" "unprognostic (4.26e-2)" "unprognostic (7.68e-3)" "unprognostic (1.40e-1)" "unprognostic (1.51e-1)" "unprognostic (3.72e-2)" "unprognostic (4.36e-2)" "unprognostic (1.66e-1)" "unprognostic (2.30e-1)" "unprognostic (4.30e-1)" 32.7 28.8 26.3 27.0 25.8 45.3 33.8 33.6 26.4 28.1 37.6 24.9 34.6 26.4 29.5 33.7 34.1 24.4 27.4 38.3 27.6 21.9 31.4 42.8 31.8 30.6 26.5 21.1 26.9 27.7 32.5 23.6 35.2 24.1 29.3 28.2 21.5 25.6 23.1 39.9 27.2 31.0 25.9 26.5 30.6 25.3 22.6 25.8 60.2 40.9 23.3 35.2 29.7 47.0 8.2 6.3 14.2 7.0 12.0 9.0 3.0 23.8 12.6 25.9 20.6 20.7 25.9 28.2 23.7 21.4 25.8 26.1 15.2 40.1 36.5 33.8 20.7 15.6 25.0 28.2 24.4 35.2 28.4 22.8 33.9 14.7 19.5 19.2 40.5 29.7 15.7 29.3 17.8 24.5 23.6 24.5 26.9 26.3 25.5 24.4 29.6 44.1 22.1 27.1 38.6 21.7 36.0 36.1 19.8 28.9 23.7 27.6 20.6 31.6 22.9 32.1 23.6 35.1 37.2 22.3 16.0 20.1 39.0 20.7 26.8 27.2 50.6 22.3 26.3 20.8 5.1 7.0 14.2 5.5 5.9 7.0 6.3 7.6 7.7 6.1 8.2 7.1 6.8 12.2 12.0 4.5 6.3 9.0 3.0 26.3 25.8 33.6 26.4 27.6 21.9 26.5 21.1 24.1 25.8 50.6 53.8 77.0 90.1 211.3 79.2 72.5 61.1 36.1 38.7 64.6 76.6 101.0 61.3 59.0 8.2 94.0 85.8 23.3 70.8 103.7 89.5 134.5 70.4 100.7 71.3 120.8 105.6 87.2 94.9 11.0 87.8 94.4 72.6 45.1 80.2 80.6 70.0 88.8 94.7 71.8 75.3 90.5 110.2 79.0 66.8 212.4 146.8 81.6 102.0 131.5 Z82206.1 ENSG00000225528 22 39960397-39964718 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 14 "blood: 8.1;bone marrow: 4.1;lymphoid tissue: 2.3" "Group enriched" "Detected in some" 5 "Distal tubular cells: 6.6;granulocytes: 3.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 4.0;JURKAT: 3.2;K-562: 16.1;MOLT-4: 2.7" HPA047397 Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies" Yes NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Nuclear bodies" "HPA047397: AB_2680029" "unprognostic (8.48e-4)" "unprognostic (2.95e-6)" "unprognostic (3.67e-1)" "unprognostic (5.90e-2)" "unprognostic (4.27e-1)" "unprognostic (6.95e-3)" "unprognostic (3.74e-1)" "unprognostic (5.41e-4)" "unprognostic (2.33e-1)" "unprognostic (2.13e-2)" "unprognostic (1.18e-3)" "unprognostic (8.77e-2)" "unprognostic (6.53e-5)" "unprognostic (1.89e-1)" "unprognostic (1.70e-1)" "unprognostic (1.11e-1)" "unprognostic (6.58e-3)" 0.0 0.0 0.5 4.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.0 0.1 0.0 0.0 1.1 0.3 3.6 3.0 5.7 2.2 2.2 8.1 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 16.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 1.8 4.4 5.2 2.2 4.5 3.6 6.5 5.7 2.7 3.2 6.7 8.1 4.3 2.2 1.9 3.0 4.2 7.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZADH2 MGC45594 ENSG00000180011 "Zinc binding alcohol dehydrogenase domain containing 2" Q8N4Q0 18 75195108-75209348 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021468, HPA053646" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Vesicles "Nucleoplasm, Golgi apparatus" "HPA021468: AB_1858932, HPA053646: AB_2682216" "unprognostic (3.22e-2)" "unprognostic (1.03e-2)" "unprognostic (7.14e-2)" "unprognostic (1.13e-1)" "unprognostic (4.79e-1)" "unprognostic (5.11e-3)" "unprognostic (1.15e-1)" "unprognostic (1.49e-1)" "unprognostic (3.62e-3)" "unprognostic (1.42e-1)" "unprognostic (3.05e-2)" "unprognostic (1.48e-1)" "prognostic favorable (1.02e-6)" "unprognostic (3.41e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (1.94e-4)" "unprognostic (2.23e-1)" 14.1 12.1 15.6 12.5 22.5 12.7 28.1 19.1 24.1 15.5 18.9 10.8 13.6 13.7 12.8 19.0 18.1 13.5 15.7 24.4 17.4 11.3 18.0 23.4 13.3 12.7 12.9 18.4 19.6 19.5 22.4 20.5 26.2 19.3 13.8 21.4 13.5 16.3 14.1 34.5 15.8 24.0 16.9 12.1 15.0 15.5 7.1 11.2 11.2 20.7 15.5 14.5 17.4 15.5 2.7 3.3 12.1 5.2 2.5 4.8 2.3 9.4 6.3 6.7 13.8 10.5 13.6 7.4 17.2 20.0 6.8 8.5 3.8 13.5 6.6 2.8 17.0 8.0 12.9 8.3 14.5 4.8 41.3 12.2 14.9 13.9 7.5 7.5 25.1 15.2 15.0 14.6 5.4 12.5 12.6 13.9 15.8 8.0 24.5 12.9 11.1 6.3 12.4 1.7 9.2 14.4 13.5 10.8 21.9 13.2 16.1 12.5 10.3 9.5 9.8 10.9 5.0 9.8 12.5 12.3 13.4 10.2 4.2 5.4 4.0 17.4 4.5 8.8 21.8 10.7 1.9 5.0 12.1 4.8 4.2 3.8 2.7 4.1 4.5 3.3 2.5 2.3 3.5 2.7 2.5 5.2 2.5 4.4 2.3 15.6 22.5 19.1 24.1 17.4 11.3 12.9 18.4 19.3 11.2 32.8 14.1 10.4 16.0 8.7 56.1 45.6 17.8 5.3 10.3 26.2 5.9 8.2 16.6 10.1 0.4 23.3 27.4 0.0 18.6 5.9 16.9 16.0 6.9 20.7 14.3 23.8 22.5 19.6 18.6 1.1 33.9 14.8 11.8 14.4 25.7 20.9 12.7 21.0 59.4 14.6 39.1 19.4 9.8 0.3 6.3 9.7 5.6 10.0 27.0 18.3 ZBED1 "ALTE, DREF, hDREF, KIAA0785, TRAMP" ENSG00000214717 "Zinc finger BED-type containing 1" O96006 X 2486414-2500967 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 63.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 43.3" "Low region specificity" "Detected in all" HPA077591 Approved Approved "Nucleoplasm,Nuclear membrane,Centrosome" NA NA "Nucleoplasm, Centrosome" "Nuclear membrane" "HPA077591: AB_2686847" "unprognostic (7.66e-3)" "unprognostic (3.79e-2)" "unprognostic (2.39e-2)" "unprognostic (4.92e-3)" "unprognostic (4.86e-2)" "unprognostic (1.50e-2)" "unprognostic (1.62e-1)" "unprognostic (1.19e-1)" "unprognostic (1.21e-1)" "unprognostic (1.22e-2)" "unprognostic (1.53e-1)" "unprognostic (1.53e-1)" "prognostic unfavorable (3.13e-4)" "unprognostic (3.81e-2)" "unprognostic (2.12e-1)" "unprognostic (3.95e-2)" "unprognostic (3.27e-1)" 8.5 10.5 24.8 6.0 30.7 3.1 63.7 24.8 29.0 36.8 8.1 1.7 1.7 10.6 28.9 2.8 6.1 6.4 7.1 43.4 27.3 7.2 39.6 13.6 5.9 6.0 25.1 19.6 28.7 10.4 6.8 27.8 37.5 32.5 6.8 6.4 1.7 7.7 6.3 29.5 9.5 11.2 5.1 30.4 7.9 6.6 3.4 27.1 1.7 5.4 1.7 4.8 5.8 31.4 12.7 13.7 13.0 12.4 5.4 11.5 10.2 5.2 13.1 9.6 10.5 6.1 6.5 43.3 7.4 8.2 4.4 5.1 16.7 4.6 10.4 8.6 9.9 12.1 2.5 9.1 7.7 3.3 12.2 12.2 7.7 11.2 14.2 8.0 4.7 16.2 9.6 6.1 4.6 3.5 6.6 10.4 7.1 9.8 3.4 8.5 3.7 7.9 3.8 23.5 3.4 7.8 6.4 9.4 4.9 7.4 10.2 11.4 11.2 6.3 17.1 11.8 11.2 4.7 10.2 14.2 9.5 5.0 5.2 8.1 4.2 0.0 17.2 3.8 6.8 5.3 1.8 11.6 9.7 11.5 12.4 10.3 9.4 6.8 6.5 13.7 12.7 6.6 5.4 13.0 5.4 9.3 10.1 6.6 10.2 24.8 30.7 24.8 29.0 27.3 7.2 25.1 19.6 32.5 27.1 11.9 9.4 11.5 14.3 13.5 56.5 22.9 48.4 14.7 7.9 24.4 13.7 13.2 10.0 21.0 0.2 17.9 19.8 0.0 20.2 15.4 16.9 18.3 14.9 33.1 15.5 9.5 14.9 13.5 11.8 0.8 18.4 17.7 8.5 19.0 19.5 19.9 20.8 17.3 21.5 15.8 22.4 6.5 14.4 0.0 3.2 9.8 31.8 12.5 21.9 11.5 ZBED3 MGC15435 ENSG00000132846 "Zinc finger BED-type containing 3" Q96IU2 5 77072072-77087323 "Predicted intracellular proteins, Transcription factors" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 24.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 18.9;JURKAT: 19.6;MOLT-4: 17.8" "Low region specificity" "Detected in all" HPA055995 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA055995: AB_2683000" "unprognostic (3.23e-2)" "unprognostic (1.17e-1)" "unprognostic (2.24e-2)" "unprognostic (1.22e-1)" "unprognostic (3.78e-2)" "unprognostic (4.02e-2)" "unprognostic (2.97e-1)" "unprognostic (1.45e-2)" "unprognostic (6.96e-3)" "unprognostic (1.82e-2)" "unprognostic (8.64e-3)" "unprognostic (3.63e-1)" "prognostic favorable (1.68e-4)" "unprognostic (2.08e-1)" "unprognostic (1.92e-1)" "unprognostic (5.41e-2)" "unprognostic (1.08e-1)" 14.4 5.2 8.0 3.0 16.6 3.4 13.0 6.7 10.8 10.5 6.9 20.5 6.4 5.7 15.8 12.7 3.8 10.6 5.3 6.5 9.5 6.2 18.0 16.2 7.3 3.3 22.7 7.2 12.2 10.9 13.9 9.0 3.6 9.5 7.8 6.5 8.3 8.3 10.3 3.7 3.9 5.0 13.0 10.5 5.0 8.7 4.0 13.7 5.2 16.4 1.6 2.8 5.4 5.8 0.2 1.8 0.3 1.1 0.1 0.8 0.2 3.2 2.6 3.4 18.9 14.5 1.0 0.2 1.1 3.2 1.7 4.5 5.6 1.5 0.0 7.1 2.1 0.7 0.4 1.8 1.1 1.5 1.0 3.5 2.5 5.7 6.4 8.6 3.3 1.0 16.2 4.4 0.8 3.3 2.7 5.3 19.6 0.0 7.0 1.0 3.2 17.8 0.5 2.3 0.8 1.6 7.5 6.6 1.0 7.8 1.2 3.8 8.0 3.8 3.2 5.4 1.4 4.8 2.4 2.1 1.5 2.9 3.3 4.4 5.1 4.8 7.3 2.3 6.5 3.4 0.0 1.1 0.3 0.4 0.4 0.4 0.1 0.3 0.5 0.9 0.2 0.8 0.8 0.3 0.1 0.1 1.8 0.0 0.2 8.0 16.6 6.7 10.8 9.5 6.2 22.7 7.2 9.5 13.7 0.0 3.2 3.0 3.4 1.1 8.3 9.6 10.2 0.0 3.4 12.2 11.8 1.3 14.9 4.1 3.4 9.0 2.0 0.0 5.1 0.2 4.8 4.4 1.1 24.6 8.2 3.2 15.5 9.2 10.2 1.5 16.4 4.6 6.8 0.0 5.1 13.8 3.7 3.5 10.6 16.5 14.4 0.0 3.3 1.4 3.3 1.3 0.2 0.0 6.4 1.4 ZBED4 KIAA0637 ENSG00000100426 "Zinc finger BED-type containing 4" O75132 22 49853842-49890078 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045341 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA045341: AB_2679295" "unprognostic (3.82e-2)" "unprognostic (6.39e-2)" "unprognostic (7.22e-3)" "unprognostic (4.43e-2)" "unprognostic (7.90e-2)" "unprognostic (2.42e-1)" "unprognostic (2.48e-3)" "unprognostic (1.23e-1)" "unprognostic (1.24e-1)" "unprognostic (8.74e-3)" "unprognostic (9.44e-2)" "unprognostic (2.43e-2)" "unprognostic (1.27e-1)" "unprognostic (1.07e-1)" "unprognostic (2.18e-1)" "unprognostic (2.53e-2)" "unprognostic (5.20e-2)" 5.5 4.6 5.9 11.3 7.5 15.0 7.3 11.7 7.5 5.8 9.1 8.9 2.8 8.5 6.7 6.4 11.5 6.0 7.1 4.8 5.1 4.7 7.2 8.0 8.0 11.4 5.4 3.8 6.8 16.5 5.6 6.4 6.6 4.9 6.1 8.0 5.8 11.1 3.7 8.5 8.0 8.5 5.2 6.5 9.5 7.2 8.8 5.3 29.7 6.2 5.4 10.9 6.9 5.9 1.6 2.5 1.6 1.4 6.7 4.1 1.5 9.3 8.3 15.9 12.7 4.9 5.4 9.9 5.5 4.6 6.1 5.6 8.5 4.2 18.4 3.9 5.8 6.4 10.7 11.2 7.1 6.6 7.2 13.7 10.5 8.4 8.0 7.2 22.3 15.2 5.1 10.8 6.6 10.2 6.1 8.1 18.0 11.2 8.8 7.2 7.4 18.4 10.6 8.7 8.1 5.9 22.2 14.5 11.1 6.5 9.4 8.5 16.8 5.4 16.2 11.0 10.4 7.6 12.8 9.3 8.4 13.3 4.9 7.7 8.9 5.5 16.8 5.0 10.0 9.8 0.7 0.9 1.6 2.2 1.4 4.1 1.6 2.2 2.3 2.4 1.1 2.7 2.1 0.6 6.7 1.4 2.5 1.6 1.5 5.9 7.5 11.7 7.5 5.1 4.7 5.4 3.8 4.9 5.3 0.0 6.2 8.3 4.1 4.5 8.2 6.5 7.6 2.7 10.3 5.2 13.7 3.2 3.3 8.2 4.2 5.0 5.2 0.0 6.1 5.3 4.3 7.4 0.0 5.4 6.0 12.7 12.1 7.4 9.1 3.6 2.8 4.8 0.0 2.8 9.6 2.3 10.3 7.0 3.9 2.1 9.3 6.5 5.0 3.2 5.3 3.3 2.7 7.5 9.3 5.7 ZBED5 Buster1 ENSG00000236287 "Zinc finger BED-type containing 5" Q49AG3 11 10812074-10858796 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048472, HPA050994" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli fibrillar center" "HPA048472: AB_2680408, HPA050994: AB_2681300" "unprognostic (7.74e-2)" "unprognostic (1.36e-1)" "unprognostic (2.37e-1)" "unprognostic (4.72e-2)" "unprognostic (3.40e-1)" "unprognostic (9.05e-2)" "prognostic unfavorable (2.19e-5)" "unprognostic (5.69e-2)" "unprognostic (4.61e-2)" "unprognostic (2.23e-2)" "unprognostic (2.25e-2)" "unprognostic (3.27e-2)" "unprognostic (8.77e-3)" "unprognostic (1.47e-2)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "prognostic favorable (3.87e-4)" 21.6 18.5 20.4 32.6 21.6 21.5 27.5 43.2 30.2 35.6 24.7 22.0 17.2 18.4 34.7 27.6 22.5 30.8 19.8 32.7 21.3 13.1 24.0 13.0 24.5 38.1 24.0 23.4 40.2 24.4 42.0 44.6 20.9 27.1 30.1 22.7 16.3 24.9 19.1 32.6 36.8 29.4 22.4 30.5 35.6 22.2 17.2 25.3 45.0 34.9 17.7 32.3 30.0 26.4 18.4 12.4 5.8 8.4 13.4 14.5 6.2 20.1 16.3 28.5 18.5 15.5 24.4 14.7 16.5 17.2 11.4 11.2 11.6 44.0 22.4 12.5 12.2 15.6 25.0 17.7 17.2 15.4 21.5 16.0 5.7 34.2 7.1 12.8 18.3 7.7 16.4 25.2 8.5 18.9 20.1 14.0 11.2 15.0 25.4 16.2 10.2 17.8 19.9 15.4 14.8 21.7 27.1 15.8 11.8 13.3 28.4 14.1 25.1 17.1 22.1 13.1 16.9 20.9 10.3 13.8 24.4 17.6 16.2 11.5 12.5 15.4 17.6 21.1 13.0 18.5 0.7 6.7 5.8 9.3 7.3 12.0 16.7 11.1 11.7 9.6 18.4 14.5 14.0 5.6 13.4 8.4 12.4 9.4 6.2 20.4 21.6 43.2 30.2 21.3 13.1 24.0 23.4 27.1 25.3 53.6 24.1 23.3 40.9 30.8 31.1 31.9 17.8 56.2 47.8 21.0 27.5 14.5 19.9 19.1 5.8 16.5 10.2 0.0 14.1 8.6 17.9 19.1 8.1 5.7 10.6 27.0 26.6 23.9 15.9 4.9 25.3 17.7 15.1 11.8 15.8 20.1 15.4 17.5 25.8 12.4 32.3 19.4 24.0 41.8 17.0 31.1 10.4 17.3 16.0 21.0 ZBED6 ENSG00000257315 "Zinc finger BED-type containing 6" P86452 1 203795714-203854999 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA026439, HPA028490, HPA028526, HPA068807" Approved Approved "Nucleoplasm,Centriolar satellite" NA NA Nucleoplasm "Centriolar satellite" "HPA026439: AB_10599829, HPA028490: AB_10601447, HPA028526: AB_10611533, HPA068807: AB_2686040" "unprognostic (1.79e-1)" "unprognostic (4.96e-3)" "unprognostic (4.81e-2)" "unprognostic (2.73e-1)" "unprognostic (6.94e-2)" "unprognostic (3.37e-2)" "unprognostic (1.03e-1)" "unprognostic (1.72e-1)" "unprognostic (1.24e-2)" "unprognostic (2.28e-3)" "unprognostic (7.54e-3)" "unprognostic (1.56e-1)" "unprognostic (4.11e-2)" "unprognostic (1.47e-1)" "unprognostic (2.59e-1)" "unprognostic (4.15e-3)" "unprognostic (1.47e-2)" 9.1 10.1 7.8 4.9 6.3 4.3 21.8 13.3 7.3 12.1 8.4 6.8 6.2 8.4 12.2 4.7 8.7 7.4 8.1 6.8 8.6 2.4 8.3 9.9 8.9 6.7 9.6 4.1 12.0 10.0 10.1 18.9 13.3 7.7 7.6 5.4 4.0 11.0 7.4 11.7 10.6 10.8 6.3 8.5 8.8 7.6 18.6 7.6 9.7 11.9 5.5 6.9 9.0 19.8 0.7 1.5 0.4 0.5 1.8 0.8 0.1 3.8 5.3 8.6 4.0 10.7 19.2 3.9 4.6 13.9 4.4 5.6 1.2 4.1 2.8 1.1 10.4 2.2 5.4 2.8 5.1 7.8 6.0 2.1 5.6 5.2 1.4 4.9 3.4 3.5 9.8 3.4 5.1 5.5 9.9 13.6 3.3 5.9 10.0 9.8 2.4 2.8 3.3 2.2 2.1 2.3 1.8 7.2 2.5 3.9 5.3 1.8 9.9 6.1 9.1 2.4 9.6 10.5 5.1 15.9 7.7 6.2 3.0 3.3 4.0 1.4 1.0 7.2 2.3 6.3 0.0 0.5 0.2 0.8 0.2 0.1 0.7 0.3 0.6 0.4 0.2 0.1 0.6 0.4 1.8 0.2 1.5 0.3 0.1 7.8 6.3 13.3 7.3 8.6 2.4 9.6 4.1 7.7 7.6 8.9 4.6 4.8 31.2 14.2 18.0 1.7 7.6 13.4 17.0 0.0 29.5 12.1 0.0 0.1 0.8 11.5 20.6 0.0 0.0 11.2 15.3 35.0 33.4 3.8 5.4 11.1 17.7 7.4 5.0 0.8 18.4 9.8 13.5 0.0 5.4 18.8 0.1 14.4 14.2 0.0 18.7 25.8 18.6 5.6 5.4 14.9 29.2 15.2 10.6 38.3 ZBED8 "Buster3, C5orf54" ENSG00000221886 "Zinc finger BED-type containing 8" Q8IZ13 5 160393148-160400097 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 9.4;Sertoli cells: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045445, HPA055817" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA045445: AB_10959608, HPA055817: AB_2682933" "unprognostic (1.51e-1)" "unprognostic (2.06e-1)" "unprognostic (1.20e-1)" "unprognostic (8.40e-2)" "unprognostic (7.04e-3)" "unprognostic (7.50e-2)" "unprognostic (1.47e-5)" "unprognostic (6.52e-2)" "unprognostic (1.05e-2)" "unprognostic (5.65e-2)" "prognostic favorable (3.72e-4)" "unprognostic (1.16e-1)" "unprognostic (7.44e-2)" "unprognostic (9.74e-2)" "unprognostic (9.25e-2)" "unprognostic (2.50e-1)" "unprognostic (9.96e-3)" 3.6 8.1 10.4 1.9 12.4 0.6 6.7 20.1 8.8 11.1 6.3 9.9 5.2 2.9 10.5 13.5 3.8 9.4 4.4 6.8 7.9 6.6 6.7 2.5 4.2 2.5 14.2 6.4 18.8 4.4 6.3 21.7 7.6 9.7 8.3 3.5 5.6 7.9 10.3 4.1 4.8 2.8 8.2 9.5 3.6 4.6 7.0 12.5 2.1 9.5 1.5 3.1 5.5 9.0 0.8 2.9 1.1 3.1 3.3 2.4 1.6 5.5 4.4 10.9 9.5 8.7 6.4 4.5 4.8 4.5 5.9 8.9 3.9 4.4 4.6 9.2 1.6 13.9 6.0 6.2 2.8 7.9 4.7 6.2 2.9 6.4 5.0 3.3 1.9 3.7 2.5 5.9 4.3 2.9 5.4 3.0 3.9 2.0 4.4 6.2 2.2 1.7 3.1 2.6 2.3 4.7 2.3 12.6 3.0 2.7 1.6 11.2 3.8 6.3 1.8 5.2 4.5 4.2 1.9 2.1 8.8 5.9 2.7 3.9 4.0 6.8 1.1 6.3 2.8 8.6 0.0 2.4 1.1 2.4 1.9 1.4 0.8 2.2 1.7 2.9 0.6 1.7 1.3 0.3 3.3 3.1 2.6 0.0 1.6 10.4 12.4 20.1 8.8 7.9 6.6 14.2 6.4 9.7 12.5 0.0 0.3 0.0 0.7 0.0 4.6 2.4 0.0 9.4 1.2 1.8 2.0 3.5 1.7 1.1 0.8 1.5 0.0 0.0 0.4 1.2 0.9 0.8 0.0 0.0 1.2 3.2 0.0 0.6 1.2 0.0 6.1 0.0 0.0 1.8 0.6 5.8 0.7 0.0 5.3 1.0 3.9 12.9 0.5 1.6 4.9 0.0 1.1 0.0 0.6 0.3 ZBED9 "Buster4, FLJ31087, KIAA1925, SCAND3, ZFP38-L, ZNF305P2, ZNF452" ENSG00000232040 "Zinc finger BED-type containing 9" Q6R2W3 6 28570535-28616212 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 13.2;testis: 17.6" "Group enriched" "Detected in many" 4 "Early spermatids: 17.9;Spermatocytes: 27.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 7.8;hTCEpi: 7.1;K-562: 12.5;U-266/84: 6.0" HPA007246 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA Nucleoli "Nucleoplasm, Golgi apparatus" "HPA007246: AB_1080727" "unprognostic (1.01e-1)" "unprognostic (5.16e-5)" "unprognostic (1.88e-1)" "unprognostic (1.27e-4)" "unprognostic (3.96e-2)" "unprognostic (9.46e-3)" "unprognostic (3.40e-1)" "unprognostic (2.73e-2)" "unprognostic (4.24e-2)" "unprognostic (2.34e-3)" "unprognostic (8.21e-3)" "unprognostic (4.31e-1)" "unprognostic (2.42e-2)" "unprognostic (1.14e-2)" "unprognostic (7.66e-3)" "unprognostic (3.92e-2)" "unprognostic (1.59e-1)" 0.8 1.8 2.6 0.4 7.2 0.4 2.3 9.5 4.7 2.3 1.1 0.3 9.3 0.7 1.6 7.5 1.0 3.1 0.7 1.2 2.4 2.3 2.3 3.2 1.9 0.5 1.3 2.9 4.1 3.4 3.2 6.9 3.0 3.5 3.4 1.5 0.8 2.4 13.2 0.5 0.7 0.8 1.1 0.8 0.6 1.0 17.6 0.7 0.0 4.1 0.0 0.6 1.4 1.2 0.5 0.7 1.1 0.7 0.4 1.4 0.2 1.8 1.8 1.9 0.0 0.0 0.0 2.3 0.4 0.0 0.4 1.2 0.0 1.2 0.0 7.8 0.1 3.8 1.0 0.0 2.1 0.4 0.0 5.2 0.5 1.2 1.8 1.3 0.0 0.0 1.1 7.1 0.1 3.5 1.1 0.0 0.0 12.5 0.0 0.1 1.4 0.0 0.1 1.8 0.0 0.9 0.7 0.8 0.1 2.0 2.2 2.0 4.9 0.0 2.0 0.0 2.8 0.0 0.6 0.0 0.0 2.2 0.0 1.2 0.0 6.0 0.0 0.0 0.0 0.0 0.6 0.3 0.3 0.3 0.4 0.1 0.2 0.4 0.4 0.2 0.5 1.4 1.0 1.1 0.4 0.7 0.7 0.1 0.2 2.6 7.2 9.5 4.7 2.4 2.3 1.3 2.9 3.5 0.7 0.0 2.7 0.0 0.8 0.0 1.6 1.6 5.1 1.4 1.2 0.0 2.0 2.0 1.7 1.7 17.9 0.0 0.4 0.0 1.2 1.1 0.4 1.1 0.0 1.6 0.3 0.0 1.2 0.0 0.0 3.2 2.3 0.0 0.0 0.0 1.4 1.1 0.6 0.0 0.0 0.7 1.1 0.0 0.0 27.7 2.9 0.0 0.8 0.0 0.9 0.6 ZBTB1 "KIAA0997, ZNF909" ENSG00000126804 "Zinc finger and BTB domain containing 1" Q9Y2K1 14 64503712-64533690 "Predicted intracellular proteins, Transcription factors" "Differentiation, DNA damage, DNA repair, Immunity, Innate immunity, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 74.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050516, HPA054552, HPA075151" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA050516: AB_2681153, HPA054552: , HPA075151: " "unprognostic (4.09e-1)" "unprognostic (3.68e-1)" "unprognostic (1.08e-1)" "unprognostic (9.51e-2)" "unprognostic (1.28e-1)" "prognostic favorable (4.92e-4)" "unprognostic (1.11e-3)" "unprognostic (9.43e-2)" "unprognostic (6.64e-2)" "unprognostic (2.00e-1)" "unprognostic (9.65e-2)" "unprognostic (6.63e-2)" "unprognostic (3.34e-2)" "unprognostic (6.26e-2)" "unprognostic (2.23e-1)" "unprognostic (2.58e-1)" "unprognostic (3.27e-2)" 19.5 13.0 15.4 19.2 17.9 47.2 34.4 15.6 23.5 15.3 14.6 9.0 13.7 10.8 15.3 18.4 13.6 16.3 14.0 15.0 18.0 11.3 15.8 14.1 20.2 27.1 24.6 9.3 16.4 17.8 19.1 19.2 16.7 15.7 19.6 14.8 10.2 16.4 17.8 18.4 22.2 18.4 16.2 22.3 26.2 14.9 7.2 20.3 39.0 18.9 11.6 22.4 16.0 25.4 12.1 10.9 25.6 13.4 15.1 18.8 11.3 24.6 8.3 18.7 11.6 19.4 23.5 19.2 10.7 16.1 10.2 13.0 8.0 17.6 23.8 10.8 15.2 8.0 17.5 9.0 10.7 14.0 35.1 6.1 11.6 15.2 6.7 12.2 9.6 17.0 30.1 18.8 7.0 10.6 22.5 11.7 15.4 5.7 16.4 18.8 18.8 16.5 9.7 7.8 12.8 12.5 14.9 11.5 9.1 17.8 30.1 13.1 10.5 17.6 13.3 14.3 18.9 12.8 12.4 15.5 17.1 11.6 8.1 7.4 20.6 8.8 26.7 17.2 9.2 11.1 25.6 10.4 16.6 15.1 9.9 17.3 12.1 13.5 16.7 10.9 11.3 14.0 16.8 8.0 15.1 13.4 6.9 18.8 11.3 15.4 17.9 15.6 23.5 18.0 11.3 24.6 9.3 15.7 20.3 14.9 10.1 27.6 14.0 28.2 10.6 11.2 5.1 18.7 13.6 8.7 11.8 6.5 8.3 11.2 74.1 18.8 6.5 23.3 7.5 11.5 26.8 12.8 27.7 6.8 14.0 6.4 21.2 12.9 20.8 26.6 14.7 28.1 28.7 6.4 12.0 8.7 13.0 9.5 17.3 4.4 8.2 6.5 31.2 2.3 4.3 21.1 6.5 20.0 10.0 18.0 ZBTB10 "FLJ12752, RINZF" ENSG00000205189 "Zinc finger and BTB domain containing 10" Q96DT7 8 80485619-80526265 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 28.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021554, HPA050569" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021554: AB_1858937, HPA050569: AB_2681179" "unprognostic (7.97e-2)" "unprognostic (3.53e-1)" "unprognostic (2.26e-1)" "unprognostic (6.67e-2)" "unprognostic (9.28e-2)" "unprognostic (8.97e-3)" "unprognostic (1.29e-2)" "unprognostic (1.87e-1)" "unprognostic (1.13e-1)" "unprognostic (4.86e-1)" "unprognostic (3.66e-2)" "unprognostic (2.15e-1)" "prognostic favorable (3.52e-4)" "unprognostic (4.65e-3)" "unprognostic (2.40e-1)" "unprognostic (7.15e-2)" "unprognostic (2.63e-2)" 12.4 8.2 6.3 8.4 6.8 21.3 14.1 13.5 8.0 11.3 6.9 6.1 8.6 2.0 14.5 9.1 5.7 12.2 7.4 9.0 5.6 5.3 10.7 18.4 11.5 9.7 7.5 3.3 18.8 16.2 9.4 7.2 22.8 6.4 17.6 8.0 7.9 8.7 6.8 17.3 3.8 4.3 14.0 7.6 6.6 6.6 12.1 6.3 14.6 10.3 7.5 4.1 19.2 13.4 2.1 3.6 0.6 0.8 2.0 1.5 0.2 0.0 2.4 12.5 6.3 5.5 4.2 16.9 2.2 0.0 1.8 1.8 5.2 1.9 7.1 6.5 3.4 5.4 0.6 9.7 3.0 2.1 0.0 15.9 3.7 1.6 4.1 3.2 1.3 1.7 4.0 2.9 2.2 6.3 1.5 4.5 6.1 3.3 14.1 1.5 3.8 7.0 3.2 3.1 0.7 3.8 8.2 6.8 2.4 5.2 7.1 7.3 8.6 2.9 28.6 8.4 14.9 5.4 5.1 5.7 4.3 8.1 0.0 2.0 4.2 2.0 8.1 1.6 0.0 5.3 0.6 0.2 0.0 0.8 0.3 0.9 1.1 0.7 0.9 0.7 2.1 1.5 1.4 0.0 2.0 0.8 3.6 0.0 0.2 6.3 6.8 13.5 5.5 5.6 5.3 7.5 3.3 6.4 6.3 23.8 14.2 14.3 11.0 25.2 12.9 29.0 17.8 22.7 14.8 12.2 15.7 30.3 3.3 11.0 53.3 23.8 20.6 0.0 6.0 31.5 26.2 72.3 9.2 28.4 11.2 30.2 58.0 12.9 14.8 24.7 17.8 11.5 47.2 15.4 32.3 19.3 8.4 5.8 19.8 11.1 8.2 25.8 36.5 14.4 10.6 11.0 88.0 17.9 29.2 10.7 ZBTB11 "ZNF-U69274, ZNF913" ENSG00000066422 "Zinc finger and BTB domain containing 11" O95625 3 101648889-101677495 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015328, HPA024138" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA015328: AB_1858938, HPA024138: AB_1858939" "unprognostic (3.25e-3)" "unprognostic (9.62e-2)" "unprognostic (4.92e-2)" "prognostic unfavorable (7.49e-4)" "unprognostic (2.86e-2)" "unprognostic (7.04e-2)" "unprognostic (1.17e-3)" "unprognostic (4.77e-1)" "unprognostic (6.65e-3)" "unprognostic (1.75e-1)" "unprognostic (1.41e-1)" "unprognostic (1.45e-2)" "unprognostic (5.64e-2)" "unprognostic (2.91e-1)" "unprognostic (1.89e-1)" "unprognostic (5.90e-2)" "unprognostic (2.09e-1)" 11.6 11.0 14.8 14.8 16.5 44.0 13.7 21.9 16.0 14.1 11.9 8.5 8.4 11.4 13.6 10.4 14.1 10.9 10.5 9.1 12.3 12.4 10.5 12.9 14.2 16.6 11.2 12.9 15.0 16.4 19.1 14.3 14.2 14.3 13.0 10.8 7.1 15.2 13.2 16.2 16.6 12.7 12.3 13.5 16.6 11.7 13.7 13.6 28.7 13.6 10.2 16.4 14.4 22.3 6.8 8.0 9.6 11.6 5.2 9.0 4.6 9.8 11.0 7.3 9.7 11.4 11.2 12.8 9.7 9.4 8.8 9.7 9.9 6.8 11.9 7.9 7.2 8.1 12.2 10.8 10.8 15.8 12.4 7.7 26.5 10.2 9.1 8.8 18.6 9.7 9.0 14.0 8.1 18.9 8.0 8.6 13.8 15.1 14.6 9.4 12.0 16.3 8.3 6.9 10.4 16.3 13.4 11.4 14.4 8.2 11.7 21.4 7.9 12.5 10.3 12.8 4.8 13.1 10.2 9.8 13.6 10.1 5.6 9.6 16.8 13.9 22.3 8.5 12.3 9.6 9.6 6.3 7.0 6.8 8.2 9.0 5.4 5.8 7.5 8.0 6.8 6.8 5.6 4.3 5.2 11.6 4.8 6.3 4.6 14.8 16.5 21.9 16.0 12.3 12.4 11.2 12.9 14.3 13.6 29.8 14.4 13.7 18.0 41.2 12.0 10.8 12.7 24.1 26.1 1.8 31.4 8.2 0.0 5.5 2.6 16.7 9.1 0.0 4.8 6.6 21.6 14.6 8.1 8.9 6.8 20.6 19.4 15.4 25.9 2.3 7.8 20.4 18.6 8.2 10.2 11.7 6.7 3.5 13.4 4.8 22.8 6.5 16.2 16.1 19.3 42.9 14.1 22.4 9.5 20.4 ZBTB12 "C6orf46, D6S59E, G10, NG35" ENSG00000204366 "Zinc finger and BTB domain containing 12" Q9Y330 6 31899607-31901992 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 20 "Cardiomyocytes: 3.9;Horizontal cells: 3.2;Rod photoreceptor cells: 1.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047161, HPA070639" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA047161: AB_2679962, HPA070639: " "unprognostic (2.05e-1)" "unprognostic (3.15e-2)" "unprognostic (3.77e-1)" "unprognostic (2.93e-1)" "unprognostic (1.24e-1)" "unprognostic (8.92e-2)" "unprognostic (1.26e-3)" "unprognostic (1.55e-1)" "unprognostic (5.22e-2)" "unprognostic (8.16e-2)" "unprognostic (2.58e-1)" "unprognostic (5.41e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (1.87e-1)" "unprognostic (2.11e-1)" "unprognostic (6.39e-2)" "unprognostic (8.98e-3)" 2.2 3.2 5.0 3.4 4.6 1.8 3.0 4.5 5.5 5.3 2.7 7.4 5.7 4.8 5.7 2.3 2.9 5.3 2.6 2.8 5.5 3.6 1.6 1.4 2.2 2.5 8.6 2.9 7.4 2.2 2.5 2.1 2.3 4.0 6.5 1.2 3.2 4.5 2.4 3.3 1.8 3.7 7.3 4.7 3.2 3.3 2.4 9.9 3.5 6.5 1.8 1.6 4.4 6.7 0.2 0.0 0.3 0.0 0.0 0.2 0.0 0.0 2.7 6.2 5.4 1.2 1.4 0.5 1.1 1.1 2.2 1.6 2.1 2.9 2.7 2.6 1.3 4.3 0.7 3.1 2.1 0.9 7.1 8.5 2.3 0.0 4.2 2.2 8.8 4.2 1.2 0.8 0.9 1.7 3.1 0.1 3.1 2.6 1.6 1.3 2.8 4.5 6.3 6.4 1.5 1.0 9.9 1.3 0.0 1.3 1.6 3.4 11.4 1.1 0.6 3.1 1.5 0.0 2.7 0.9 3.4 1.1 1.5 0.1 2.3 8.3 2.8 1.5 0.9 3.5 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.0 4.6 4.5 5.1 5.5 3.6 8.6 2.9 4.0 9.9 0.0 0.0 0.0 0.0 0.0 0.8 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 ZBTB14 "ZFP161, ZNF478" ENSG00000198081 "Zinc finger and BTB domain containing 14" O43829 18 5289019-5297053 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050758, HPA070819" Uncertain Supported Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "HPA050758: AB_2681226, HPA070819: AB_2686316" "unprognostic (5.28e-2)" "unprognostic (4.37e-2)" "unprognostic (4.25e-2)" "unprognostic (2.66e-1)" "unprognostic (1.27e-1)" "unprognostic (1.85e-2)" "unprognostic (2.95e-2)" "unprognostic (8.64e-2)" "unprognostic (1.19e-3)" "unprognostic (4.72e-3)" "unprognostic (3.25e-2)" "unprognostic (1.49e-1)" "unprognostic (3.70e-2)" "unprognostic (2.03e-1)" "unprognostic (2.53e-1)" "unprognostic (3.73e-1)" "unprognostic (2.90e-2)" 11.2 9.1 13.1 11.6 13.4 6.8 10.8 24.3 12.8 8.7 8.7 10.7 10.8 7.2 12.5 14.9 10.8 9.3 10.3 7.1 13.1 10.2 9.8 11.3 11.0 19.5 14.5 7.6 14.2 12.1 12.8 8.7 8.5 7.3 9.8 8.7 10.3 9.8 11.1 6.9 11.8 12.7 7.5 16.4 17.4 9.8 10.8 8.2 30.8 15.9 7.0 18.1 11.2 11.8 10.1 8.6 14.3 8.2 7.5 13.4 7.6 7.1 9.5 12.5 9.2 9.4 12.4 8.3 7.1 10.6 10.1 8.9 9.1 9.4 25.1 6.3 8.6 11.6 6.7 9.1 10.7 10.2 4.9 4.9 9.9 8.7 8.3 6.6 12.4 12.0 9.9 9.1 7.0 6.6 10.9 15.6 18.2 6.3 8.3 10.2 7.8 18.6 8.3 11.0 8.9 4.9 11.1 8.0 7.2 8.5 8.8 11.1 10.9 10.9 7.2 11.5 13.0 8.6 14.3 8.7 13.1 10.9 10.1 10.6 5.3 5.3 15.5 13.8 10.7 11.5 10.9 5.7 14.3 9.9 8.2 9.9 8.3 12.7 11.4 8.6 10.1 13.4 12.7 1.3 7.5 7.3 6.5 7.9 7.6 13.1 13.4 24.3 12.8 13.1 10.2 14.5 7.6 7.3 8.2 6.0 4.1 11.1 1.3 2.2 6.5 2.8 2.5 1.4 1.2 5.2 0.0 4.0 5.0 4.2 0.8 6.3 4.0 0.0 2.9 4.9 4.5 2.5 16.1 5.7 6.2 4.8 1.2 9.2 5.9 1.7 5.5 5.2 1.7 4.6 5.1 8.2 3.2 4.2 5.3 4.0 5.8 0.0 4.1 0.7 11.7 2.6 1.8 4.4 4.4 0.6 ZBTB2 "bA351K16.2, KIAA1483, ZNF437" ENSG00000181472 "Zinc finger and BTB domain containing 2" Q8N680 6 151364117-151391548 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023136, HPA023137, HPA023458, HPA023487" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA023136: AB_1858941, HPA023137: AB_1858942, HPA023458: AB_1858944, HPA023487: AB_1858945" "unprognostic (1.13e-2)" "unprognostic (8.14e-2)" "unprognostic (1.93e-1)" "unprognostic (2.42e-2)" "unprognostic (8.36e-3)" "unprognostic (1.08e-1)" "prognostic unfavorable (1.21e-5)" "unprognostic (6.36e-2)" "unprognostic (2.21e-2)" "unprognostic (1.18e-1)" "unprognostic (1.72e-2)" "unprognostic (8.27e-2)" "prognostic unfavorable (9.36e-6)" "unprognostic (1.45e-1)" "unprognostic (1.05e-1)" "unprognostic (2.44e-3)" "unprognostic (7.73e-2)" 11.1 7.7 10.3 10.6 8.6 14.4 13.3 11.7 10.7 9.3 10.3 8.2 9.2 7.9 11.1 8.1 8.5 10.7 11.5 8.4 8.4 6.6 7.7 9.9 13.1 14.4 11.0 6.8 17.4 14.4 8.6 5.3 9.2 10.3 8.7 9.9 6.9 11.1 12.3 14.0 8.6 10.6 14.6 9.6 12.0 9.4 7.7 11.1 27.7 32.2 8.0 13.0 11.2 13.9 5.7 6.6 15.1 10.7 7.8 14.1 6.3 8.8 6.4 9.9 7.4 10.6 11.2 10.6 14.1 20.3 17.8 17.0 12.4 7.3 22.8 7.9 14.1 18.0 10.6 15.8 17.1 22.3 10.3 11.8 10.2 7.7 18.7 15.8 27.6 12.7 11.8 10.3 16.3 20.0 10.2 10.4 10.8 18.6 13.4 12.5 19.8 14.9 12.9 12.0 11.0 9.8 14.3 9.3 9.1 13.5 13.5 11.0 7.7 11.1 14.6 11.0 10.4 9.8 16.6 8.5 15.1 16.4 6.9 18.6 17.9 18.6 25.5 6.2 15.1 10.7 13.6 6.0 15.1 11.3 6.6 14.1 5.7 10.3 13.4 6.6 4.4 8.7 10.5 6.9 7.8 10.7 2.7 8.3 6.3 10.3 8.6 11.7 10.7 8.4 6.6 11.0 6.8 10.3 11.1 8.9 5.8 5.9 7.3 14.0 2.9 7.6 5.1 8.1 11.4 0.0 0.0 5.2 11.6 4.2 7.2 8.7 4.6 0.0 2.5 16.2 8.2 12.0 9.2 2.4 6.6 1.6 8.6 4.3 7.6 8.9 8.1 9.4 10.1 1.0 6.6 2.9 3.9 0.0 3.9 4.1 1.8 6.5 14.2 3.2 6.8 15.9 10.4 14.9 6.4 8.2 ZBTB20 "DKFZp566F123, DPZF, ODA-8S, ZNF288" ENSG00000181722 "Zinc finger and BTB domain containing 20" Q9HC78 3 114314501-115147271 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 44.6" "Cell type enhanced" "Detected in many" 5 "Collecting duct cells: 279.2;Early spermatids: 317.2" "Cancer enhanced" "Detected in some" "stomach cancer: 1.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 7.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015551, HPA016815" Approved Enhanced "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA015551: AB_2669217, HPA016815: AB_1858947" "unprognostic (1.79e-1)" "unprognostic (1.50e-2)" "unprognostic (5.51e-2)" "unprognostic (2.33e-3)" "unprognostic (5.72e-3)" "unprognostic (3.31e-2)" "unprognostic (1.74e-1)" "unprognostic (2.39e-1)" "unprognostic (1.13e-1)" "unprognostic (2.68e-1)" "unprognostic (7.51e-2)" "unprognostic (1.28e-1)" "unprognostic (1.47e-3)" "unprognostic (6.94e-2)" "unprognostic (1.41e-1)" "unprognostic (7.83e-3)" "unprognostic (1.81e-1)" 10.7 7.3 6.3 2.9 12.3 4.0 6.2 17.3 9.3 7.2 4.2 10.8 5.3 1.7 6.6 17.4 3.5 4.9 4.3 6.1 9.7 5.2 9.8 9.8 4.4 3.3 14.9 3.7 12.7 5.9 5.3 26.1 2.2 11.5 10.0 2.7 7.9 5.4 9.2 12.1 4.4 4.0 7.5 19.2 4.4 3.9 44.6 14.2 2.1 9.1 8.1 3.3 5.2 5.0 18.2 4.3 7.8 3.6 4.1 7.7 2.7 2.3 4.4 1.7 4.2 6.3 2.8 0.0 1.8 3.9 1.1 0.9 2.5 0.8 0.6 6.1 4.6 1.5 0.1 6.1 1.0 1.1 0.5 0.1 0.6 2.1 1.9 1.5 0.3 0.0 2.7 0.3 2.5 0.8 3.9 1.3 0.5 0.1 1.0 6.4 0.0 0.3 0.2 0.4 0.0 0.2 0.2 5.1 0.0 4.3 0.0 0.4 1.0 0.8 0.0 1.3 0.2 0.0 0.5 7.2 1.6 5.5 0.3 2.7 1.6 0.0 0.3 2.6 0.4 2.0 7.8 1.4 5.1 6.1 2.0 4.2 18.2 6.0 5.6 1.6 10.7 7.7 6.6 3.1 4.1 3.6 4.3 2.8 2.7 6.3 12.3 17.3 9.3 9.7 5.2 14.9 3.7 11.5 14.2 148.9 92.8 51.6 33.4 22.9 70.0 42.8 101.9 45.5 35.2 279.2 56.9 0.2 41.4 165.4 317.2 68.7 13.9 0.0 71.6 0.5 90.0 35.5 79.6 95.2 3.8 76.3 30.5 49.7 16.5 71.3 97.8 22.0 30.4 34.3 15.3 183.7 101.7 11.4 113.5 147.9 113.2 84.1 55.2 6.6 4.3 16.2 0.5 36.3 16.6 21.7 ZBTB21 "KIAA1227, ZNF295" ENSG00000173276 "Zinc finger and BTB domain containing 21" Q9ULJ3 21 41986831-42010387 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Basal keratinocytes: 53.2;Suprabasal keratinocytes: 55.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 32.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024655, HPA031757, HPA031758" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA024655: AB_1859171, HPA031757: AB_2674031, HPA031758: AB_2674032" "unprognostic (1.16e-2)" "unprognostic (3.51e-2)" "unprognostic (8.79e-2)" "unprognostic (1.79e-1)" "unprognostic (5.88e-2)" "unprognostic (4.61e-2)" "unprognostic (6.03e-3)" "unprognostic (2.19e-2)" "unprognostic (2.67e-1)" "unprognostic (6.21e-3)" "unprognostic (2.67e-2)" "unprognostic (4.59e-2)" "unprognostic (1.35e-3)" "unprognostic (1.81e-2)" "unprognostic (3.45e-1)" "unprognostic (1.63e-3)" "unprognostic (4.02e-1)" 13.1 41.0 11.0 6.8 12.9 39.2 11.8 11.5 14.4 10.3 7.5 8.3 7.4 4.9 15.4 9.2 8.0 11.4 13.8 9.4 9.6 7.3 8.0 19.6 10.3 5.8 8.3 6.2 19.6 10.7 20.9 11.7 18.3 8.8 9.6 6.2 6.8 8.5 8.6 5.3 13.8 7.6 9.9 8.9 8.7 8.9 13.1 10.4 10.1 12.1 6.4 7.1 10.7 14.5 4.9 5.0 5.0 6.2 1.3 5.9 2.4 6.5 5.2 5.1 5.8 7.3 5.7 5.0 6.1 8.8 5.9 9.0 6.2 3.3 11.7 2.8 6.1 10.6 5.0 7.5 4.3 9.6 6.1 7.4 1.3 5.3 3.7 5.6 4.5 2.8 3.2 9.3 8.2 10.8 2.6 3.3 6.4 7.6 20.4 4.1 9.6 12.2 2.2 5.1 4.8 6.5 5.2 5.8 13.6 2.6 5.3 7.3 4.3 8.5 12.8 5.9 2.7 4.5 2.1 3.7 8.7 4.9 6.0 6.0 32.6 28.5 11.0 11.4 7.6 5.6 0.2 4.9 2.4 3.7 6.0 4.2 4.9 4.0 2.9 5.0 4.5 5.9 4.3 5.0 1.3 6.2 4.3 2.6 2.4 11.0 12.9 11.5 14.4 9.6 7.3 8.3 6.2 8.8 10.4 6.0 37.9 18.5 32.4 53.2 12.5 3.7 2.5 16.0 15.9 7.0 2.0 5.7 10.0 4.7 11.1 17.4 4.9 0.0 4.3 4.2 27.2 23.1 16.1 17.8 5.5 30.2 4.1 9.2 7.6 4.1 3.7 12.2 33.7 5.4 8.7 9.4 3.7 6.0 9.9 4.4 13.6 6.5 19.6 15.2 11.1 55.3 8.1 10.7 5.1 16.2 ZBTB22 "BING1, fru, fruitless, ZBTB22A, ZNF297, ZNF297A" ENSG00000236104 "Zinc finger and BTB domain containing 22" O15209 6 33314406-33317942 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043848 Approved Nucleoplasm No No Nucleoplasm "HPA043848: AB_10961146" "unprognostic (1.32e-1)" "unprognostic (2.87e-1)" "unprognostic (3.00e-1)" "unprognostic (1.11e-1)" "unprognostic (1.38e-1)" "unprognostic (2.82e-1)" "unprognostic (1.31e-1)" "unprognostic (1.55e-2)" "unprognostic (2.06e-1)" "unprognostic (6.88e-2)" "unprognostic (4.98e-2)" "unprognostic (1.81e-1)" "unprognostic (6.54e-3)" "unprognostic (1.67e-2)" "unprognostic (2.86e-1)" "unprognostic (1.66e-2)" "unprognostic (9.32e-3)" 7.0 15.4 9.5 5.7 11.0 4.9 8.3 9.0 18.1 11.0 8.0 9.4 6.4 12.0 12.5 20.9 11.6 9.9 11.0 10.1 11.6 7.2 8.8 6.8 10.6 12.4 7.4 14.9 14.8 20.3 37.6 8.2 15.9 8.7 9.2 9.7 8.8 8.8 11.3 7.8 13.1 10.1 11.0 7.7 10.7 8.5 7.5 6.4 7.2 14.9 3.0 8.9 9.9 9.7 1.8 1.8 3.3 1.7 0.6 3.2 0.8 0.2 0.3 7.2 3.7 7.2 3.8 4.3 5.4 8.8 7.2 6.3 0.1 3.3 2.0 4.1 11.7 9.5 0.5 0.3 3.9 4.5 7.3 4.4 6.3 5.6 2.4 0.0 2.0 3.0 12.7 12.9 0.2 3.3 8.4 0.6 5.3 1.3 8.2 3.1 4.6 3.7 6.5 0.0 0.3 1.5 0.4 0.0 4.5 5.3 0.3 7.9 0.4 0.6 0.3 3.3 4.5 0.6 0.3 10.4 3.5 4.8 0.1 0.1 3.5 3.8 2.2 5.7 1.9 5.0 2.0 0.8 3.3 1.3 1.7 0.4 1.8 1.6 1.0 1.1 1.6 3.2 0.8 1.5 0.6 0.7 1.8 0.4 0.8 9.5 11.0 9.0 18.1 11.6 7.2 7.4 14.9 8.7 6.4 0.0 5.3 3.7 13.4 5.7 18.8 3.8 2.5 0.0 2.3 7.0 7.9 5.7 19.9 9.1 0.9 6.7 5.4 0.0 6.3 3.7 6.2 8.5 3.5 1.6 4.7 19.1 7.5 5.5 5.4 1.1 8.6 4.6 1.7 16.2 7.8 14.7 5.6 7.0 6.0 6.2 17.6 12.9 5.0 1.4 1.3 6.5 8.5 6.9 5.9 11.6 ZBTB24 "BIF1, KIAA0441, PATZ2, ZNF450" ENSG00000112365 "Zinc finger and BTB domain containing 24" O43167 6 109462594-109483237 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Rod photoreceptor cells: 63.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017872, HPA049003" Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Centrosome" Yes No Nucleoplasm "Cytokinetic bridge, Centrosome" "HPA017872: AB_2669673, HPA049003: AB_2680596" "unprognostic (8.15e-2)" "unprognostic (1.56e-1)" "unprognostic (1.03e-1)" "unprognostic (1.41e-1)" "unprognostic (4.80e-2)" "unprognostic (1.98e-2)" "prognostic unfavorable (3.15e-4)" "unprognostic (4.53e-2)" "unprognostic (5.09e-2)" "unprognostic (3.31e-2)" "unprognostic (1.22e-3)" "unprognostic (1.37e-1)" "unprognostic (1.75e-3)" "unprognostic (1.26e-1)" "unprognostic (2.69e-1)" "unprognostic (2.60e-1)" "unprognostic (6.77e-2)" 9.6 7.1 6.6 13.8 13.7 16.6 10.1 12.7 11.5 9.5 7.5 11.4 6.8 7.6 9.8 7.5 8.4 8.4 6.4 5.5 7.0 6.8 9.1 6.6 8.5 16.9 11.5 8.8 8.3 8.2 19.1 10.0 12.4 8.8 8.8 8.5 9.6 9.8 9.1 9.7 12.2 11.1 8.5 7.7 13.7 8.6 9.0 12.1 17.4 10.8 5.2 17.1 10.0 10.2 5.7 2.2 1.7 1.5 2.4 5.3 1.0 3.9 4.1 3.8 9.4 6.1 6.2 6.2 4.5 6.3 5.8 6.6 5.7 3.1 16.9 5.9 5.7 6.9 5.2 9.5 7.1 8.7 10.4 9.3 13.7 5.5 4.3 4.5 11.1 7.0 6.2 5.9 5.8 10.1 4.0 4.7 8.0 11.4 9.5 5.9 6.8 15.8 7.5 9.3 4.0 4.6 10.0 5.3 7.0 7.1 6.8 6.4 5.6 5.8 6.2 14.4 5.5 4.3 12.1 4.6 4.7 4.7 3.9 9.8 4.6 3.6 17.3 6.1 8.8 7.8 0.1 1.2 1.7 1.5 1.1 0.9 5.7 3.0 1.8 1.4 5.6 3.9 2.2 0.8 2.4 1.5 2.2 5.3 1.0 6.6 13.7 12.7 11.5 7.0 6.8 11.5 8.8 8.8 12.1 11.9 7.8 15.9 6.2 9.0 17.3 3.3 7.6 8.1 5.7 3.5 29.5 7.0 3.3 6.8 1.3 4.5 5.5 0.0 7.9 9.4 7.3 5.9 9.2 5.0 6.9 9.5 9.2 3.1 12.6 1.1 6.6 8.9 8.5 22.6 11.1 8.1 5.5 3.5 6.0 6.1 63.1 0.0 4.2 4.6 29.8 8.4 6.5 14.9 7.8 5.8 ZBTB25 "C14orf51, KUP, ZNF46" ENSG00000089775 "Zinc finger and BTB domain containing 25" P24278 14 64449106-64505213 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 44.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054699 Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA054699: AB_2682579" "unprognostic (1.13e-2)" "unprognostic (1.86e-1)" "unprognostic (1.16e-1)" "unprognostic (1.64e-2)" "unprognostic (1.82e-2)" "unprognostic (1.11e-3)" "unprognostic (5.32e-3)" "unprognostic (4.21e-2)" "unprognostic (2.26e-1)" "unprognostic (7.33e-2)" "unprognostic (1.70e-3)" "unprognostic (2.48e-1)" "prognostic unfavorable (3.56e-6)" "unprognostic (3.29e-2)" "unprognostic (1.05e-1)" "unprognostic (4.62e-2)" "unprognostic (1.04e-1)" 12.1 12.0 16.5 18.4 19.2 14.6 18.1 17.1 15.2 12.3 12.6 13.9 7.7 8.1 13.3 18.8 8.3 14.6 11.9 20.0 13.0 10.8 10.1 12.4 12.5 28.0 15.4 12.9 16.3 12.9 18.1 18.6 9.5 14.7 12.9 11.3 13.2 9.0 12.8 19.2 15.9 14.1 13.2 18.5 17.0 11.1 11.5 18.1 31.8 19.2 7.8 22.7 20.0 14.0 6.4 2.9 2.8 2.4 6.3 11.5 6.3 15.1 6.7 4.5 4.5 6.5 8.1 8.8 2.6 4.7 4.3 5.7 3.2 10.6 11.3 3.1 4.3 5.5 14.0 4.4 4.4 5.3 11.7 1.4 2.6 10.0 1.4 7.4 1.8 6.0 10.3 4.3 4.3 8.5 9.3 3.9 10.9 1.5 18.7 5.1 6.5 6.4 2.7 2.3 5.4 7.0 4.9 4.8 4.8 5.0 7.2 4.3 4.7 5.6 4.3 3.5 4.3 5.4 1.4 4.2 6.0 9.1 2.8 4.0 16.5 3.8 5.2 8.9 2.3 4.4 2.8 2.4 1.5 6.9 1.6 9.0 6.4 9.7 6.6 1.6 4.3 11.5 11.2 2.6 6.3 1.3 2.9 8.3 6.3 16.5 19.2 17.1 15.2 13.0 10.8 15.4 12.9 14.7 18.1 6.0 8.8 17.7 6.8 7.0 17.8 16.1 7.6 13.4 5.7 7.0 17.7 6.4 8.3 6.5 44.5 7.7 1.8 0.0 5.7 8.0 5.6 6.6 5.8 8.9 9.5 7.9 3.4 7.4 8.2 36.7 12.4 11.3 16.9 4.6 2.7 8.6 6.0 3.2 10.3 5.8 21.2 0.0 7.2 10.7 11.7 7.3 3.3 24.9 3.9 4.7 ZBTB33 "kaiso, WUGSC:H_DJ525N14.1, ZNF-kaiso, ZNF348" ENSG00000177485 "Zinc finger and BTB domain containing 33" Q86T24 X 120250752-120258398 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000755, CAB001980, HPA005732" Approved Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "CAB001980: , HPA000755: AB_1079167, HPA005732: AB_1079166" "unprognostic (9.14e-3)" "unprognostic (1.45e-2)" "unprognostic (1.17e-1)" "unprognostic (1.01e-2)" "unprognostic (2.47e-2)" "unprognostic (6.13e-2)" "unprognostic (1.72e-2)" "unprognostic (1.94e-1)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" "unprognostic (1.25e-1)" "unprognostic (4.51e-2)" "unprognostic (5.08e-3)" "unprognostic (1.68e-1)" "unprognostic (1.12e-1)" "unprognostic (6.44e-2)" "unprognostic (2.59e-2)" 15.4 10.4 12.8 9.3 15.5 20.2 18.0 16.3 13.9 9.6 8.5 11.6 9.1 9.1 7.7 11.5 14.9 10.0 9.0 6.0 12.6 15.0 8.0 22.5 10.7 14.0 13.4 11.6 12.2 11.6 17.7 15.5 10.2 16.7 10.5 7.9 6.2 15.0 10.0 9.5 21.6 10.2 6.0 18.6 12.7 9.9 6.9 14.8 29.3 17.4 5.3 14.6 10.3 9.7 3.4 8.9 14.2 8.9 5.1 7.2 5.2 9.3 10.4 14.2 12.9 11.2 12.8 16.7 7.2 9.7 8.5 10.5 6.3 8.2 13.7 13.8 7.3 11.3 14.4 22.4 11.4 10.8 15.1 16.1 14.3 15.8 8.5 8.5 14.2 16.3 9.1 13.9 8.6 12.8 12.1 14.4 13.8 9.2 16.0 10.4 11.2 13.3 9.3 17.3 14.0 11.3 15.1 10.8 21.8 8.6 16.7 26.0 11.0 15.3 15.1 17.0 11.1 8.1 20.1 14.1 6.8 5.0 10.1 12.8 9.0 9.1 17.4 9.5 20.4 8.4 14.2 6.1 7.7 4.4 8.9 7.2 3.4 5.6 5.5 8.9 3.3 7.1 4.8 1.2 5.1 5.6 8.5 4.9 5.2 12.8 15.5 16.3 13.9 12.6 15.0 13.4 11.6 16.7 14.8 14.9 6.5 4.2 6.8 11.3 4.3 4.5 10.2 12.0 15.9 1.8 0.0 6.6 1.7 4.9 0.1 6.9 4.6 23.3 5.8 6.9 5.4 6.9 0.0 16.6 6.8 3.2 8.1 8.0 9.9 0.0 4.0 9.8 3.3 10.0 7.8 6.5 6.4 5.7 2.5 2.8 1.4 6.5 3.1 2.9 11.7 11.4 7.8 9.6 6.5 10.1 ZBTB34 "KIAA1993, MGC24652, ZNF918" ENSG00000177125 "Zinc finger and BTB domain containing 34" Q8NCN2 9 126860665-126885878 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023893 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA023893: AB_2219180" "unprognostic (2.96e-2)" "unprognostic (1.83e-1)" "unprognostic (2.72e-3)" "unprognostic (6.59e-3)" "unprognostic (8.08e-2)" "unprognostic (1.07e-1)" "unprognostic (2.56e-4)" "unprognostic (1.62e-1)" "unprognostic (2.96e-2)" "unprognostic (5.15e-2)" "unprognostic (9.32e-3)" "unprognostic (3.94e-2)" "unprognostic (2.55e-2)" "unprognostic (3.23e-2)" "unprognostic (9.71e-2)" "unprognostic (3.69e-2)" "unprognostic (2.01e-2)" 9.4 5.0 9.7 7.1 12.0 21.8 6.7 15.6 13.2 5.8 6.1 9.0 4.7 5.2 9.4 5.8 6.0 6.4 6.9 5.3 10.0 5.2 6.1 5.4 9.8 8.9 12.2 6.5 6.7 6.3 7.9 7.0 11.4 11.5 5.9 5.3 8.9 7.3 5.8 6.1 7.5 6.8 5.6 10.2 10.6 6.6 5.2 10.3 8.9 7.2 2.2 7.7 6.4 10.8 0.7 1.0 4.5 1.0 1.2 0.8 0.4 2.5 3.4 10.2 4.2 8.0 8.0 14.1 3.1 4.6 3.7 4.1 8.2 4.8 4.9 3.4 3.3 3.4 7.9 12.2 3.1 3.7 5.1 5.1 5.6 9.1 4.3 5.6 7.6 9.3 7.0 5.0 4.3 5.0 4.8 4.9 8.7 11.8 3.9 3.5 3.6 4.9 6.4 8.8 4.9 2.6 9.3 11.7 5.0 4.8 3.8 3.2 11.0 4.1 3.7 5.6 9.6 3.6 11.5 5.1 3.4 6.3 4.8 3.4 7.0 8.1 4.2 3.1 6.4 3.2 2.3 1.0 3.0 0.8 0.4 0.8 0.6 0.3 0.3 0.8 0.7 0.8 0.4 4.5 1.2 0.6 1.0 0.1 0.4 9.7 12.0 15.6 13.2 10.0 5.2 12.2 6.5 11.5 10.3 3.0 5.8 0.0 2.3 4.7 6.2 2.0 0.0 1.4 3.4 1.8 5.9 3.3 1.7 2.3 6.3 4.5 3.3 0.0 1.4 2.4 4.9 3.8 0.0 3.4 6.5 7.9 1.7 4.9 11.3 15.3 6.4 6.9 5.0 1.8 3.8 1.9 2.6 4.8 0.7 1.9 11.9 0.0 4.2 4.2 2.5 7.2 2.7 1.5 2.3 4.6 ZBTB37 "MGC2629, ZNF908" ENSG00000185278 "Zinc finger and BTB domain containing 37" Q5TC79 1 173868082-173903549 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 49.0;Rod photoreceptor cells: 67.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023438 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA023438: AB_1858954" "unprognostic (1.18e-1)" "unprognostic (2.55e-1)" "unprognostic (1.03e-2)" "unprognostic (2.51e-1)" "unprognostic (5.46e-2)" "unprognostic (2.66e-4)" "unprognostic (2.93e-1)" "unprognostic (1.57e-2)" "unprognostic (9.86e-2)" "unprognostic (2.41e-1)" "unprognostic (3.72e-2)" "unprognostic (9.53e-2)" "unprognostic (7.05e-3)" "unprognostic (1.44e-1)" "unprognostic (1.38e-1)" "unprognostic (4.03e-3)" "unprognostic (1.96e-2)" 6.4 4.0 6.9 6.5 9.8 11.1 5.8 6.4 7.9 5.3 4.0 11.2 3.7 4.0 9.1 5.5 3.4 4.6 4.7 5.6 7.2 3.7 5.3 4.8 6.0 7.7 9.9 5.2 7.6 4.5 6.8 9.2 4.7 7.8 5.3 3.9 10.6 4.6 4.9 4.0 7.0 5.2 6.8 9.5 7.9 5.1 18.4 8.8 7.7 6.1 2.8 6.3 4.8 5.5 1.8 2.4 6.0 1.0 2.3 2.8 0.8 2.4 3.7 5.6 2.4 3.5 2.8 6.2 2.2 1.6 4.0 2.9 4.6 3.1 6.6 4.7 3.4 2.1 3.1 4.8 2.4 3.4 3.7 3.0 9.1 3.9 2.2 2.1 5.3 5.8 2.5 1.7 6.0 4.0 2.5 2.0 4.7 8.0 4.4 4.2 1.8 3.6 1.4 5.4 1.8 0.9 2.4 5.0 2.2 2.2 6.1 4.2 5.3 3.1 4.3 4.4 6.2 6.2 5.6 3.6 5.3 5.7 2.6 3.5 8.0 5.9 10.6 3.5 3.0 3.2 0.4 1.0 3.4 2.8 1.0 1.2 0.7 1.3 2.0 0.6 1.8 0.7 1.8 6.0 2.3 1.0 2.4 1.0 0.8 6.9 9.8 6.4 7.9 7.2 3.7 9.9 5.2 7.8 8.8 6.0 4.6 11.9 3.1 2.6 26.9 8.4 12.7 9.4 2.3 10.4 31.4 6.8 6.6 2.8 40.4 5.2 3.9 0.0 3.3 3.4 4.3 4.2 2.3 4.3 4.2 17.5 3.4 13.5 15.1 49.0 8.1 7.6 10.1 2.8 3.6 11.9 2.5 3.5 12.4 4.4 67.3 6.5 6.2 17.6 13.3 5.1 7.7 12.9 3.3 2.7 ZBTB38 "CIBZ, FLJ35036, PPP1R171, ZNF921" ENSG00000177311 "Zinc finger and BTB domain containing 38" Q8NAP3 3 141324213-141449792 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 52.0;RPMI-8226: 75.3;U-266/70: 51.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014865, HPA059378" Enhanced Nucleoplasm No No Nucleoplasm "HPA014865: AB_2732412, HPA059378: AB_2683998" "unprognostic (1.78e-1)" "unprognostic (3.18e-1)" "unprognostic (2.97e-3)" "unprognostic (1.93e-1)" "unprognostic (2.78e-1)" "unprognostic (2.84e-2)" "unprognostic (4.01e-2)" "unprognostic (7.99e-2)" "unprognostic (8.45e-2)" "unprognostic (1.38e-1)" "unprognostic (2.01e-3)" "unprognostic (4.53e-1)" "unprognostic (5.07e-3)" "unprognostic (1.04e-1)" "unprognostic (1.83e-1)" "unprognostic (1.29e-2)" "unprognostic (1.04e-1)" 18.4 27.6 19.6 16.3 26.5 5.4 20.2 50.9 30.1 28.0 23.2 11.6 15.5 14.9 36.1 11.1 14.4 20.1 25.4 21.7 16.3 12.5 18.8 13.2 20.1 16.7 17.6 21.0 21.3 17.3 43.5 21.8 19.9 18.3 19.7 21.9 13.4 22.8 21.3 56.7 11.1 20.4 30.1 18.7 11.8 17.1 17.4 20.1 2.6 20.3 9.4 19.5 25.7 24.5 11.4 5.1 13.6 5.3 14.8 17.8 6.7 10.7 16.0 1.9 3.8 17.2 16.3 2.5 17.4 21.0 16.9 24.7 8.3 6.3 0.3 7.2 15.1 13.2 3.1 2.1 14.7 38.7 10.4 3.0 3.0 15.3 4.8 19.3 0.2 4.5 12.2 8.7 17.9 36.4 27.7 12.9 0.3 3.2 52.0 19.1 1.1 0.2 0.6 1.9 3.0 2.0 0.2 5.5 75.3 10.9 6.7 0.7 2.7 25.5 2.5 9.2 3.4 5.2 2.7 31.0 13.8 3.5 26.8 8.1 51.9 30.2 3.8 23.7 0.3 7.6 13.6 3.4 9.4 17.8 5.3 13.3 11.4 11.7 17.7 5.1 5.1 9.1 14.7 4.0 14.8 4.2 2.5 15.3 6.7 19.6 26.5 50.9 30.1 16.3 12.5 17.6 21.0 18.3 20.1 71.5 54.7 23.8 31.7 18.1 86.6 104.9 66.2 48.2 69.4 55.8 70.7 27.6 24.9 35.6 201.9 74.9 41.3 0.0 27.8 12.6 45.6 45.5 64.9 27.0 27.6 133.5 34.5 48.5 19.7 97.7 65.3 39.9 37.1 95.6 43.1 55.0 48.7 28.8 96.9 39.2 66.4 116.4 91.0 7.2 10.0 16.3 104.5 67.8 69.1 34.1 ZBTB4 "KAISO-L1, KIAA1538, ZNF903" ENSG00000174282 "Zinc finger and BTB domain containing 4" Q9P1Z0 17 7459366-7484263 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008980, HPA064763" Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No "Nuclear bodies" "Nucleoplasm, Cytosol" "CAB008980: , HPA064763: AB_2685347" "unprognostic (2.23e-1)" "unprognostic (3.95e-1)" "unprognostic (7.17e-2)" "unprognostic (2.92e-2)" "unprognostic (5.32e-2)" "unprognostic (7.62e-3)" "unprognostic (2.43e-1)" "unprognostic (1.67e-2)" "unprognostic (1.28e-1)" "unprognostic (1.63e-3)" "prognostic favorable (2.53e-4)" "unprognostic (1.73e-1)" "prognostic favorable (1.65e-9)" "unprognostic (1.10e-1)" "unprognostic (4.86e-2)" "unprognostic (1.88e-1)" "unprognostic (6.04e-3)" 20.1 23.5 20.1 10.9 22.7 4.7 20.6 27.9 38.3 26.3 21.8 19.8 13.7 9.2 22.8 22.7 16.6 22.5 15.1 22.3 19.6 18.3 15.6 6.3 21.4 10.7 21.0 19.4 35.1 16.3 70.1 15.4 14.6 25.8 22.3 9.9 26.2 19.9 30.0 21.4 14.8 11.3 22.3 20.2 18.7 14.2 10.6 14.7 8.2 23.9 9.5 12.7 23.4 24.7 1.8 1.3 1.4 4.6 2.0 3.5 1.5 6.3 8.7 2.2 4.2 23.5 12.2 4.0 8.9 12.9 8.1 8.1 2.9 3.1 0.6 7.1 16.9 5.9 10.1 2.2 12.5 5.9 10.1 3.8 3.2 7.1 2.0 6.6 0.6 7.6 8.5 13.1 7.8 10.0 19.1 7.0 2.4 1.0 2.1 8.9 4.2 2.2 1.3 0.9 2.6 4.2 4.0 3.8 0.9 9.9 5.4 1.3 3.3 3.9 2.8 4.1 4.1 5.2 1.4 9.7 9.1 3.6 8.6 7.3 3.8 2.6 0.4 9.8 2.0 4.7 1.1 0.9 1.4 3.2 1.4 3.5 1.6 2.6 2.6 0.7 1.8 3.4 3.1 0.6 2.0 4.6 1.3 1.3 1.5 20.1 22.7 27.9 38.3 19.6 18.3 21.0 19.4 25.8 14.7 47.6 49.8 8.2 16.6 27.2 75.9 76.7 22.9 17.4 19.4 19.2 64.8 8.5 3.3 13.6 34.6 26.1 5.4 0.0 12.4 1.9 17.3 18.9 12.8 7.8 11.9 69.9 16.7 22.1 26.3 41.2 48.1 17.7 16.9 5.4 10.3 24.7 16.4 7.0 65.7 8.9 38.5 32.3 30.9 5.4 4.1 20.6 4.3 20.1 7.6 11.1 ZBTB40 "KIAA0478, ZNF923" ENSG00000184677 "Zinc finger and BTB domain containing 40" Q9NUA8 1 22451851-22531157 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 29.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042386 Approved Nucleoplasm NA NA Nucleoplasm "HPA042386: AB_10794649" "unprognostic (2.78e-1)" "unprognostic (3.39e-1)" "unprognostic (2.29e-1)" "unprognostic (5.17e-2)" "unprognostic (6.91e-2)" "prognostic favorable (2.01e-4)" "prognostic unfavorable (7.78e-8)" "unprognostic (8.11e-2)" "unprognostic (1.64e-2)" "unprognostic (2.44e-2)" "prognostic favorable (4.12e-5)" "unprognostic (1.52e-1)" "unprognostic (6.74e-2)" "unprognostic (1.98e-2)" "unprognostic (9.51e-2)" "unprognostic (6.66e-2)" "unprognostic (3.34e-2)" 14.1 21.0 8.3 13.5 12.3 11.2 10.8 18.0 12.6 13.9 11.7 14.1 10.9 10.6 21.5 10.5 8.8 13.1 11.9 8.4 9.6 6.4 11.7 8.2 11.5 17.8 12.9 7.3 15.3 15.5 19.0 31.6 8.5 11.6 13.6 11.6 13.5 14.6 10.6 12.7 11.5 18.1 14.4 12.8 23.2 12.5 9.2 13.0 16.6 14.4 6.8 19.5 12.9 14.8 2.5 1.7 1.6 2.1 7.6 3.0 0.8 7.0 8.0 13.3 14.0 10.0 8.4 12.0 6.1 6.7 9.4 10.3 7.2 8.7 8.2 7.3 7.3 7.7 9.1 13.5 6.5 11.3 10.8 11.3 17.4 15.2 8.5 8.7 10.2 16.9 7.0 9.7 12.5 9.6 7.4 8.1 11.7 18.5 0.1 7.7 5.2 6.9 13.0 8.0 5.9 6.7 11.8 10.4 9.3 4.7 7.6 11.2 9.2 11.5 8.5 4.9 8.6 16.1 8.7 9.9 11.6 9.6 11.9 6.0 5.7 7.5 8.4 7.0 12.8 8.3 1.6 1.0 0.6 2.4 2.1 3.0 1.8 1.9 2.0 1.7 2.5 1.9 2.3 0.4 7.6 1.0 1.1 2.7 0.8 8.3 12.3 18.0 12.6 9.6 6.4 12.9 7.3 11.6 13.0 11.9 14.7 11.3 3.1 5.0 13.1 11.0 10.2 6.7 15.9 1.8 29.5 4.2 1.7 4.9 3.6 6.3 3.4 0.0 6.4 3.7 4.7 4.3 15.1 2.9 4.1 11.1 15.5 4.9 4.5 4.7 5.5 4.5 13.5 0.0 5.2 8.2 5.8 7.0 6.3 1.9 23.1 12.9 5.2 5.9 8.5 3.6 2.4 5.1 5.1 2.4 ZBTB41 "DKFZp686C06120, FLJ36199, FRBZ1, ZNF924" ENSG00000177888 "Zinc finger and BTB domain containing 41" Q5SVQ8 1 197153680-197200542 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034841, HPA034842" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" Nucleoplasm "HPA034841: AB_2674355, HPA034842: AB_10669995" "unprognostic (2.36e-1)" "unprognostic (5.58e-3)" "unprognostic (8.01e-3)" "unprognostic (6.07e-2)" "unprognostic (4.14e-2)" "unprognostic (3.83e-2)" "prognostic unfavorable (5.86e-4)" "unprognostic (1.43e-1)" "unprognostic (1.81e-2)" "unprognostic (2.81e-1)" "unprognostic (7.51e-3)" "unprognostic (2.17e-2)" "unprognostic (2.48e-2)" "unprognostic (1.80e-1)" "unprognostic (1.38e-1)" "unprognostic (2.98e-2)" "unprognostic (1.58e-1)" 2.6 3.8 4.1 1.8 4.0 0.2 5.9 10.8 5.0 4.5 2.2 2.1 3.2 3.8 2.4 2.8 3.2 2.3 4.0 4.7 4.3 3.3 2.3 2.4 4.2 5.9 2.9 5.6 3.8 2.2 3.3 2.5 2.9 2.6 3.3 2.4 1.8 2.2 4.8 3.0 3.2 2.6 6.4 2.2 3.1 2.1 1.5 1.4 1.7 0.7 1.8 2.2 0.7 7.3 4.1 5.5 4.4 8.8 13.3 4.4 4.4 7.3 4.7 4.5 2.6 6.2 2.7 6.5 10.1 2.8 6.1 3.8 3.9 7.5 2.4 2.3 2.2 5.6 2.4 7.8 4.3 2.2 5.4 10.2 4.7 8.2 9.6 3.2 3.1 5.1 3.3 12.0 3.6 3.2 2.4 2.1 5.1 1.5 2.2 7.7 4.8 5.8 4.2 7.9 7.0 8.0 14.1 8.4 4.2 10.7 3.3 5.2 9.3 5.4 7.3 5.8 3.8 1.9 2.9 4.4 1.6 12.9 1.7 0.7 0.4 1.2 0.4 2.2 1.5 1.6 1.6 1.4 1.4 2.2 2.0 0.0 1.8 0.6 0.7 1.0 0.7 17.9 6.2 7.2 4.6 6.6 13.6 12.8 7.6 10.7 10.3 15.7 2.0 3.3 1.7 6.1 2.9 5.5 3.8 0.0 4.9 3.2 6.1 8.3 1.1 8.3 3.7 23.8 12.6 8.0 7.9 2.7 14.4 4.6 11.8 6.4 6.5 30.0 6.0 0.0 11.3 9.1 8.1 6.5 6.1 6.5 4.5 8.8 2.9 4.5 7.6 5.2 ZBTB42 ZNF925 ENSG00000179627 "Zinc finger and BTB domain containing 42" B2RXF5 14 104800596-104804712 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 25.8" "Cell type enhanced" "Detected in many" 4 "Club cells: 11.4;Exocrine glandular cells: 11.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 8 "eosinophil: 8.4" "Lineage enriched" "Detected in single" 8 "granulocytes: 8.4" "Cell line enhanced" "Detected in many" "HDLM-2: 13.5;MCF7: 22.8;T-47d: 18.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA066961 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA066961: AB_2685756" "unprognostic (1.23e-1)" "unprognostic (1.84e-1)" "unprognostic (8.68e-2)" "unprognostic (1.59e-1)" "unprognostic (6.99e-2)" "unprognostic (6.67e-2)" "unprognostic (6.17e-3)" "unprognostic (2.56e-1)" "unprognostic (4.35e-1)" "unprognostic (2.70e-2)" "unprognostic (1.63e-1)" "unprognostic (3.42e-1)" "prognostic favorable (2.30e-9)" "unprognostic (1.34e-1)" "unprognostic (2.75e-1)" "unprognostic (1.58e-3)" "unprognostic (5.45e-2)" 4.8 4.1 1.1 2.4 1.3 0.1 3.8 0.7 1.2 4.5 4.7 0.9 7.7 3.9 2.6 6.2 5.4 5.6 10.1 4.1 0.8 0.6 4.8 9.9 9.0 4.6 1.2 0.6 5.1 25.8 2.0 1.7 2.4 1.7 7.5 2.1 3.2 10.6 7.3 6.9 2.8 5.2 1.5 1.3 2.9 6.6 2.4 0.3 3.7 6.7 4.5 4.8 3.1 2.3 0.8 0.7 8.4 0.3 0.2 0.9 0.3 0.9 3.0 0.9 3.7 0.7 0.8 3.9 1.3 1.4 2.4 2.2 1.9 3.6 0.3 2.7 1.3 1.6 4.1 0.8 1.3 0.4 13.5 0.9 1.2 1.6 2.2 1.2 0.3 7.4 1.5 1.5 0.9 0.5 1.7 1.0 2.7 2.0 2.0 0.4 22.8 2.4 1.9 0.6 6.1 2.9 3.5 0.2 1.8 1.8 5.9 4.2 1.8 1.0 5.6 2.4 0.9 18.9 1.4 1.7 0.9 2.2 0.2 0.4 2.3 1.2 0.2 3.1 1.3 2.0 0.0 0.3 8.4 0.5 0.1 0.9 0.8 0.7 0.1 0.1 0.6 0.5 0.8 0.1 0.2 0.1 0.7 0.6 0.3 1.1 1.3 0.7 1.2 0.8 0.6 1.2 0.6 1.7 0.3 3.0 9.4 0.0 4.0 0.3 0.4 3.8 10.2 1.4 11.4 0.0 0.0 0.9 3.3 3.6 1.9 1.6 3.1 0.0 11.3 1.4 0.6 5.6 0.0 6.4 0.9 0.0 5.2 1.8 3.7 0.0 0.6 1.0 1.7 0.0 7.3 2.6 7.2 2.9 0.4 3.5 0.3 0.0 1.4 0.6 3.6 0.1 0.7 0.0 3.3 4.0 ZBTB43 "FLJ22470, KIAA0414, ZBTB22B, ZNF-X, ZNF297B" ENSG00000169155 "Zinc finger and BTB domain containing 43" O43298 9 126805006-126838210 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 51.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016825 Enhanced Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA016825: AB_1858959" "unprognostic (1.18e-1)" "unprognostic (2.66e-1)" "unprognostic (7.02e-2)" "unprognostic (9.11e-2)" "unprognostic (5.69e-2)" "unprognostic (3.41e-1)" "unprognostic (1.20e-1)" "unprognostic (1.27e-2)" "unprognostic (6.87e-2)" "unprognostic (3.72e-2)" "unprognostic (5.14e-1)" "unprognostic (5.41e-3)" "prognostic favorable (8.73e-4)" "unprognostic (6.76e-2)" "unprognostic (5.96e-2)" "unprognostic (1.11e-1)" "unprognostic (7.13e-2)" 6.6 6.2 7.8 4.9 12.1 51.7 6.6 10.6 13.6 5.8 5.6 9.5 3.0 5.6 6.6 5.2 10.3 5.3 5.9 9.5 7.9 5.7 5.1 9.0 9.3 6.0 8.6 7.1 7.1 5.9 9.6 9.3 8.2 8.1 5.1 6.6 7.5 7.4 4.4 34.7 14.6 6.7 6.0 8.5 5.7 7.4 15.7 9.3 5.3 6.2 7.1 10.1 5.5 7.0 6.1 5.2 10.6 6.3 9.0 10.7 4.3 4.6 3.6 6.5 6.0 5.6 7.9 6.8 6.6 6.1 4.9 4.4 8.7 3.2 6.5 3.1 6.2 9.9 13.5 5.8 6.1 6.1 6.1 3.8 4.5 10.6 3.7 7.5 6.2 8.5 9.6 15.5 7.9 19.9 4.7 3.7 5.4 7.7 15.1 7.2 5.0 5.4 4.0 5.9 5.0 6.2 4.7 21.1 5.2 5.4 5.4 5.8 5.4 6.7 6.4 5.8 6.2 5.9 4.0 3.5 5.9 5.7 6.6 5.3 16.2 11.5 2.5 7.4 5.3 4.8 10.6 6.3 5.3 10.7 6.3 10.2 6.1 5.8 6.2 5.2 5.1 6.4 7.3 3.5 9.0 4.8 2.8 8.2 4.3 7.8 12.1 10.6 13.6 7.9 5.7 8.6 7.1 8.1 9.3 32.8 40.1 29.9 62.2 75.4 37.7 33.5 22.9 20.1 46.6 26.2 102.1 15.5 1.7 27.3 73.1 17.3 40.0 0.0 16.1 10.4 25.7 47.1 30.1 22.9 13.6 25.4 10.9 17.2 14.6 30.4 16.4 26.4 23.6 11.8 16.6 33.0 31.3 14.2 13.4 5.8 56.4 12.9 25.9 42.1 61.8 102.6 43.5 20.1 18.1 123.4 ZBTB44 "BTBD15, HSPC063, ZNF851" ENSG00000196323 "Zinc finger and BTB domain containing 44" Q8NCP5 11 130226677-130314686 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052589 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA052589: AB_2681874" "unprognostic (4.04e-2)" "unprognostic (1.33e-1)" "unprognostic (8.03e-2)" "unprognostic (7.60e-2)" "unprognostic (4.13e-2)" "unprognostic (5.63e-2)" "unprognostic (2.19e-1)" "unprognostic (2.47e-2)" "unprognostic (1.93e-2)" "unprognostic (3.56e-2)" "unprognostic (1.38e-3)" "unprognostic (3.34e-1)" "unprognostic (8.45e-3)" "unprognostic (6.39e-2)" "unprognostic (2.19e-1)" "unprognostic (1.43e-1)" "unprognostic (1.78e-2)" 14.6 14.1 27.8 10.6 22.3 10.6 21.2 42.4 29.0 13.5 12.1 11.8 22.0 9.2 13.1 18.4 13.7 15.4 9.6 13.6 25.4 9.4 27.4 14.7 15.2 15.3 17.4 17.4 18.4 13.7 24.2 14.7 12.9 16.9 12.5 10.6 8.5 16.7 19.2 38.8 15.6 12.4 10.2 11.8 14.1 11.8 34.2 21.8 28.2 14.6 8.4 16.3 16.5 28.6 3.5 4.1 5.8 2.2 3.7 5.8 1.1 6.7 4.5 6.8 6.5 9.7 9.3 7.7 4.3 6.7 3.5 4.5 7.4 21.0 22.6 21.4 6.6 9.6 7.2 9.5 8.3 6.1 18.2 5.8 32.3 5.1 4.7 5.5 17.0 24.9 6.0 9.6 6.2 13.6 8.1 5.5 12.2 9.6 33.4 4.2 4.8 15.1 11.0 6.2 9.9 7.5 10.5 6.1 7.6 10.0 5.9 14.3 6.2 12.7 7.9 3.2 6.6 15.1 12.8 6.3 7.9 7.0 3.9 4.6 6.2 9.0 19.3 2.0 21.1 6.6 2.2 1.8 2.3 5.8 2.2 3.7 3.0 3.4 3.4 2.1 3.5 2.8 3.3 5.8 3.7 1.6 4.1 3.9 1.1 27.8 22.3 42.4 29.0 25.4 9.4 17.4 17.4 16.9 21.8 23.8 29.6 39.5 29.4 64.1 42.4 36.1 45.9 17.4 20.5 73.3 55.0 26.8 16.6 19.9 44.5 29.3 14.8 46.7 17.7 14.9 37.6 40.5 10.3 39.9 13.2 19.1 18.6 38.1 33.7 39.7 68.1 24.4 21.9 6.4 27.5 21.6 20.9 11.5 74.3 67.0 37.1 38.8 25.8 78.2 59.9 71.8 22.4 39.5 34.6 33.9 ZBTB46 "BTBD4, BZEL, FLJ13502, RINZF, ZNF340" ENSG00000130584 "Zinc finger and BTB domain containing 46" Q86UZ6 20 63743666-63831244 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 17.7;Ito cells: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "myeloid DC: 3.4" "Lineage enriched" "Detected in single" 5 "dendritic cells: 3.4" "Cell line enhanced" "Detected in many" "NB-4: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013997 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA013997: AB_1858961" "unprognostic (1.11e-1)" "unprognostic (1.96e-3)" "unprognostic (1.30e-4)" "unprognostic (3.13e-2)" "unprognostic (1.36e-1)" "unprognostic (2.46e-2)" "unprognostic (9.33e-2)" "unprognostic (9.87e-2)" "unprognostic (1.92e-1)" "unprognostic (1.38e-1)" "prognostic favorable (2.17e-4)" "unprognostic (3.87e-1)" "unprognostic (1.00e-1)" "unprognostic (3.54e-1)" "unprognostic (4.07e-2)" "unprognostic (6.70e-2)" "unprognostic (2.12e-1)" 9.2 4.6 6.3 3.8 4.3 2.3 6.0 24.2 6.1 8.1 1.9 2.6 3.2 2.2 9.9 8.0 2.3 6.7 4.4 10.1 4.3 3.8 7.3 3.6 6.4 5.7 4.3 3.0 12.4 6.2 3.4 8.8 7.1 5.3 3.8 1.3 9.4 5.1 6.6 7.3 2.9 3.0 3.3 2.5 14.8 2.4 3.5 2.7 1.8 8.5 4.4 2.0 4.0 10.7 0.2 3.4 0.3 0.6 0.7 0.7 0.2 2.5 2.5 8.6 2.8 0.4 0.9 4.7 1.2 2.9 0.5 0.3 5.9 6.7 0.4 9.1 0.1 3.2 2.5 0.5 0.1 0.4 0.9 2.3 0.5 2.5 5.4 2.0 0.8 1.5 0.5 0.1 0.1 0.0 1.3 0.8 0.3 3.2 0.8 1.6 6.2 0.4 11.8 1.5 3.3 5.4 3.2 4.2 3.6 0.5 1.7 8.6 2.6 2.1 5.2 0.8 4.9 6.4 8.1 0.7 7.3 4.1 3.5 1.4 1.8 4.9 0.8 1.3 1.7 1.3 0.0 0.4 0.2 0.6 0.6 0.3 0.2 0.4 0.6 3.4 0.0 0.4 0.4 0.3 0.7 0.2 0.1 0.7 0.2 6.3 4.3 24.2 6.1 4.3 3.8 4.3 3.0 5.3 2.7 0.0 0.6 0.0 1.1 0.3 4.2 9.0 2.5 0.0 2.3 1.8 17.7 3.5 0.0 1.4 0.4 7.5 0.0 0.0 0.5 0.7 2.5 1.9 2.3 0.0 2.6 1.6 1.2 33.2 5.4 0.9 7.5 2.5 1.7 2.8 0.0 3.8 1.8 0.0 8.1 1.1 9.0 0.0 1.8 0.5 1.7 0.4 3.1 0.0 0.1 1.6 ZBTB47 "DKFZp434N0615, KIAA1190, ZNF651" ENSG00000114853 "Zinc finger and BTB domain containing 47" Q9UFB7 3 42653684-42665854 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 28.1;skeletal muscle: 33.1" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 7.9;Early spermatids: 9.9;Melanocytes: 8.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 33.9;fHDF/TERT166: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074057 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA074057: AB_2686657" "unprognostic (1.03e-1)" "unprognostic (1.15e-2)" "unprognostic (8.23e-2)" "unprognostic (3.99e-3)" "unprognostic (3.74e-2)" "unprognostic (1.95e-2)" "unprognostic (2.07e-1)" "unprognostic (1.23e-1)" "unprognostic (2.74e-1)" "unprognostic (2.00e-2)" "unprognostic (4.86e-2)" "unprognostic (8.99e-2)" "prognostic favorable (7.96e-5)" "unprognostic (5.77e-2)" "unprognostic (1.26e-1)" "unprognostic (4.57e-2)" "unprognostic (7.10e-2)" 5.8 3.3 11.4 3.1 18.0 0.5 2.8 3.3 11.3 4.8 4.4 15.7 0.7 1.1 5.4 1.5 4.4 3.1 4.4 28.1 16.1 4.7 1.2 2.0 2.6 2.1 8.6 9.1 5.0 4.5 2.7 3.0 2.1 6.3 4.8 1.0 2.9 7.6 6.2 33.1 2.8 1.4 5.8 12.8 1.7 3.0 3.1 16.7 0.7 5.2 4.2 1.6 3.7 3.3 0.0 0.9 2.8 1.6 0.3 0.3 0.4 3.6 3.3 2.0 1.3 33.9 13.2 0.7 8.8 7.6 3.9 2.8 0.7 1.5 0.0 3.6 18.0 1.4 0.9 0.5 3.4 0.8 0.0 4.4 2.2 9.5 0.8 10.4 0.0 3.0 14.1 6.2 4.9 4.3 10.0 4.2 0.0 2.0 2.6 7.7 0.9 0.1 0.3 1.1 0.1 2.2 2.7 3.9 1.0 2.1 0.8 2.3 3.8 4.1 0.7 3.3 0.9 4.6 4.8 9.5 8.1 4.7 7.8 3.5 0.1 0.0 0.0 7.4 2.6 2.4 0.0 1.6 0.1 0.3 1.1 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 2.8 0.3 0.9 0.0 0.0 0.4 11.4 18.0 3.3 9.3 16.1 4.7 8.6 9.1 6.3 16.7 0.0 0.6 0.0 1.2 3.5 4.8 7.9 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.6 9.9 1.5 0.0 0.0 1.1 0.1 3.0 1.1 4.6 0.5 1.2 0.0 0.0 1.8 1.8 1.4 3.1 1.3 8.5 1.0 0.0 6.6 0.7 0.2 2.8 0.6 1.7 0.0 5.6 0.0 0.2 2.8 0.1 0.0 0.0 1.0 ZBTB48 "HKR3, TZAP, ZNF855" ENSG00000204859 "Zinc finger and BTB domain containing 48" P10074 1 6580001-6589280 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030417 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030417: AB_10603145" "unprognostic (6.66e-2)" "prognostic favorable (1.04e-4)" "unprognostic (7.15e-3)" "unprognostic (9.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.92e-2)" "unprognostic (2.71e-1)" "unprognostic (8.15e-3)" "unprognostic (6.43e-2)" "unprognostic (1.70e-1)" "prognostic favorable (5.19e-6)" "unprognostic (7.73e-2)" "unprognostic (1.82e-2)" "unprognostic (1.23e-1)" "unprognostic (2.77e-2)" "unprognostic (2.84e-1)" "unprognostic (1.91e-3)" 10.8 12.0 9.6 15.1 12.6 13.3 12.3 11.1 16.3 13.5 12.2 12.7 21.4 11.7 13.2 15.1 12.7 14.2 17.6 9.6 8.9 7.5 12.9 21.6 14.3 17.1 7.0 11.3 19.9 15.8 17.1 14.0 10.7 11.4 17.2 13.2 16.9 12.6 11.7 10.9 14.4 17.2 11.3 8.8 17.1 12.9 28.2 10.3 19.9 18.4 7.4 15.9 13.0 14.4 7.5 7.8 26.7 6.8 6.6 6.4 5.3 3.9 4.8 7.6 11.1 8.5 6.6 3.9 4.0 4.8 7.7 8.4 4.9 9.1 13.1 7.2 3.5 5.3 7.4 11.5 8.0 6.2 13.3 10.9 10.6 13.9 4.8 10.1 17.0 28.8 6.6 6.2 7.5 12.1 10.4 5.6 10.0 10.4 8.6 5.7 7.6 8.3 12.2 5.7 7.7 8.3 9.5 7.1 14.4 6.9 3.7 14.9 6.9 6.0 13.8 9.2 8.3 7.9 13.7 6.3 5.3 3.5 5.7 5.0 9.4 8.1 20.3 4.9 13.7 3.0 10.9 6.8 26.7 6.0 4.2 6.0 6.5 4.7 5.7 7.8 7.5 6.4 5.5 10.0 6.6 6.6 5.0 3.8 5.3 9.6 12.6 11.1 16.3 8.9 7.5 7.0 11.3 11.4 10.3 3.0 10.5 6.7 8.5 4.1 7.1 4.5 12.7 13.4 7.9 10.4 5.9 5.1 10.0 4.1 36.3 4.7 15.8 0.0 3.2 4.1 5.8 5.2 26.5 11.6 9.6 9.5 14.9 4.3 6.2 14.2 8.1 9.8 5.0 10.0 12.7 10.4 2.7 14.0 5.3 10.5 7.4 19.4 5.2 17.7 10.4 4.8 4.2 10.1 9.5 5.8 ZBTB49 "FLJ38559, ZNF509" ENSG00000168826 "Zinc finger and BTB domain containing 49" Q6ZSB9 4 4290251-4321786 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 9.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024450 Approved Approved Nucleoplasm,Microtubules,Cytosol NA NA Nucleoplasm "Microtubules, Cytosol" "HPA024450: AB_1859311" "unprognostic (4.30e-2)" "unprognostic (5.30e-3)" "unprognostic (1.30e-1)" "unprognostic (2.49e-2)" "unprognostic (2.54e-1)" "prognostic favorable (5.24e-4)" "unprognostic (3.56e-2)" "unprognostic (2.77e-2)" "unprognostic (4.74e-2)" "unprognostic (1.11e-1)" "prognostic favorable (1.76e-4)" "unprognostic (5.54e-3)" "unprognostic (1.66e-1)" "unprognostic (1.45e-1)" "unprognostic (9.09e-2)" "unprognostic (1.98e-1)" "prognostic favorable (2.88e-5)" 7.3 5.4 5.0 6.0 9.0 11.8 6.8 9.2 8.7 7.2 6.2 9.9 3.4 4.5 9.5 7.0 5.6 6.3 5.3 6.2 6.1 5.1 4.7 5.9 6.5 7.5 6.8 5.3 10.6 7.7 6.0 13.3 5.6 8.9 7.9 4.4 7.1 10.0 6.5 10.1 4.8 6.3 6.5 6.1 9.2 6.0 10.3 6.7 6.7 8.1 5.0 8.5 7.8 5.8 2.9 1.9 12.1 2.7 3.2 6.4 1.8 2.0 3.4 4.3 7.2 5.8 6.1 5.1 2.6 5.1 5.7 4.4 3.0 4.0 7.4 2.7 2.8 7.0 3.6 7.5 4.3 5.9 2.4 2.9 8.6 2.3 4.2 4.9 5.2 3.2 3.9 3.6 5.2 3.4 3.2 5.7 8.0 4.4 4.0 5.3 3.4 10.2 10.2 7.3 3.0 4.6 6.1 5.6 4.6 2.2 3.7 5.2 5.0 5.7 2.2 5.7 6.0 3.1 5.1 5.5 5.1 2.3 3.4 5.5 4.9 4.8 6.3 3.7 4.4 5.0 3.7 2.6 12.1 6.4 2.7 5.0 2.2 3.6 6.0 1.9 2.9 4.1 4.7 6.2 3.2 2.2 0.4 3.2 1.8 5.0 9.0 9.2 8.7 6.1 5.1 6.8 5.3 8.9 6.7 0.0 1.4 2.7 1.6 2.3 2.4 1.6 0.0 1.4 2.3 1.8 3.9 1.6 0.0 1.8 1.5 2.2 0.9 0.0 2.2 1.2 2.0 1.5 1.1 1.5 1.6 1.6 1.2 3.7 2.6 0.0 1.4 2.1 3.3 3.6 1.7 1.7 1.0 2.9 2.1 0.8 7.8 0.0 1.1 9.5 5.3 2.3 1.3 2.9 1.3 1.0 ZBTB5 KIAA0354 ENSG00000168795 "Zinc finger and BTB domain containing 5" O15062 9 37438114-37465399 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021521 Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Nucleoplasm, Nuclear bodies" "Golgi apparatus" "HPA021521: AB_2670736" "unprognostic (2.36e-2)" "unprognostic (2.78e-2)" "unprognostic (5.22e-2)" "unprognostic (6.35e-2)" "unprognostic (1.55e-2)" "unprognostic (2.08e-2)" "unprognostic (4.96e-3)" "unprognostic (5.81e-2)" "unprognostic (3.95e-2)" "unprognostic (1.43e-1)" "unprognostic (4.72e-2)" "unprognostic (2.12e-2)" "unprognostic (1.27e-3)" "unprognostic (5.73e-3)" "unprognostic (2.30e-1)" "unprognostic (2.77e-3)" "unprognostic (1.80e-1)" 7.9 9.2 6.7 10.8 9.5 16.0 10.6 12.8 11.2 10.6 10.0 15.9 7.0 8.7 11.8 11.5 24.6 8.8 7.7 8.4 8.7 5.9 11.0 17.2 11.3 11.7 14.0 6.9 12.5 12.4 11.4 7.9 11.8 9.9 11.3 8.4 9.8 11.9 16.5 7.4 16.6 11.1 7.6 10.4 10.8 10.1 20.4 11.7 15.2 14.8 7.8 17.8 9.5 12.7 2.7 2.6 0.4 1.2 1.1 3.2 1.2 6.6 7.7 19.9 12.3 5.1 3.6 8.5 5.5 4.3 6.8 5.6 5.7 4.9 13.6 6.0 4.1 5.0 8.1 12.9 4.6 5.2 10.0 6.7 5.0 19.8 6.6 5.0 6.1 4.4 3.5 11.6 3.4 7.2 7.7 7.5 10.9 11.7 11.6 5.0 4.2 12.8 4.5 5.0 7.2 3.9 11.7 9.6 5.1 6.5 6.0 9.2 16.5 5.4 8.7 4.2 10.5 13.9 6.0 5.1 4.8 13.3 2.8 5.2 6.2 6.8 11.9 4.4 5.3 5.0 0.4 1.2 0.2 2.2 0.9 2.6 2.7 1.9 1.9 2.6 2.7 2.9 3.2 0.1 1.1 0.1 0.8 1.5 1.2 6.7 9.5 12.8 11.2 8.7 5.9 14.0 6.9 9.9 11.7 14.9 6.2 4.2 6.7 12.7 1.8 3.1 5.1 4.0 11.4 1.8 5.9 3.1 0.0 3.4 1.8 3.3 3.3 0.0 2.8 1.9 4.3 8.9 1.1 7.4 2.1 12.7 8.1 5.5 2.8 3.3 3.7 1.8 3.3 2.8 4.5 3.9 3.3 3.5 3.5 2.6 4.8 0.0 5.1 7.5 7.2 15.8 4.8 1.9 4.5 6.5 ZBTB6 "ZID, ZNF482" ENSG00000186130 "Zinc finger and BTB domain containing 6" Q15916 9 122908056-122913330 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054111, HPA076894" Approved Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA054111: AB_2682384, HPA076894: AB_2686818" "unprognostic (9.74e-3)" "unprognostic (8.40e-2)" "unprognostic (1.45e-2)" "unprognostic (7.84e-2)" "prognostic favorable (2.06e-5)" "unprognostic (1.81e-1)" "unprognostic (2.39e-3)" "unprognostic (1.13e-1)" "unprognostic (1.06e-1)" "unprognostic (6.11e-2)" "unprognostic (1.33e-1)" "unprognostic (7.20e-2)" "prognostic favorable (5.08e-4)" "unprognostic (4.31e-2)" "unprognostic (1.53e-1)" "unprognostic (2.67e-1)" "unprognostic (1.92e-2)" 11.9 10.4 10.7 11.8 12.2 5.2 12.9 17.7 13.2 13.7 9.4 9.0 10.7 10.4 12.6 8.2 11.6 9.4 7.3 9.7 10.2 9.4 11.0 9.2 12.4 26.2 15.6 10.3 13.8 10.0 11.6 14.0 14.1 10.5 10.2 9.0 6.3 9.9 11.4 14.0 10.0 15.0 10.0 13.2 14.0 9.7 9.5 14.4 22.7 13.8 10.1 16.0 11.1 9.3 2.1 2.3 11.8 3.9 3.8 4.0 2.4 4.1 4.8 7.9 7.2 8.4 8.1 8.0 7.0 8.6 7.0 6.3 5.0 5.3 6.6 4.4 6.3 6.3 19.0 8.2 8.6 8.8 9.3 6.5 7.0 10.4 4.6 8.3 9.2 12.7 6.6 13.1 6.4 10.7 8.7 6.4 8.4 7.3 8.2 10.1 7.7 9.3 6.2 9.9 12.3 8.3 5.0 21.7 9.2 7.4 6.8 10.0 12.9 10.8 10.6 6.6 8.7 13.3 6.1 6.5 7.7 6.0 7.8 8.0 14.4 17.2 1.8 9.0 6.3 7.8 11.8 2.3 3.3 2.0 2.5 2.7 2.1 2.8 1.9 2.3 1.7 4.0 3.5 3.0 3.8 3.9 1.3 2.9 2.4 10.7 12.2 17.7 12.1 10.2 9.4 15.6 10.3 10.5 14.4 6.0 2.2 0.0 2.7 1.9 7.3 2.8 7.6 4.0 9.1 1.8 9.8 1.7 0.0 2.1 7.6 2.9 2.6 0.0 2.1 1.0 2.5 3.2 7.0 2.4 2.1 6.4 2.9 7.4 9.2 3.2 2.8 5.4 1.7 1.8 4.2 7.4 2.6 3.4 7.4 3.3 9.1 6.5 2.5 5.2 3.0 2.4 1.6 5.1 3.3 2.7 ZBTB7A "DKFZp547O146, FBI-1, LRF, pokemon, ZBTB7, ZNF857A" ENSG00000178951 "Zinc finger and BTB domain containing 7A" O95365 19 4044364-4066945 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037214, CAB037285, HPA046387" Supported Approved Nucleoplasm NA NA Nucleoplasm "CAB037214: AB_609875, CAB037285: AB_609874, HPA046387: AB_2679648" "unprognostic (8.88e-2)" "unprognostic (1.21e-1)" "unprognostic (3.02e-1)" "prognostic favorable (6.50e-6)" "unprognostic (7.54e-2)" "unprognostic (3.65e-3)" "unprognostic (3.71e-2)" "unprognostic (1.12e-1)" "unprognostic (1.56e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (2.99e-4)" "unprognostic (3.75e-1)" "prognostic favorable (1.34e-6)" "prognostic favorable (1.79e-4)" "unprognostic (2.01e-1)" "unprognostic (4.25e-1)" "unprognostic (1.36e-2)" 19.6 13.6 18.1 14.3 19.5 17.5 13.6 26.3 26.6 15.2 23.3 14.3 16.0 27.1 16.7 10.6 29.8 12.6 21.1 11.1 20.6 10.4 11.6 12.2 13.7 14.2 13.2 11.6 12.0 12.1 16.2 11.4 12.9 16.8 14.2 11.6 12.4 16.3 14.0 32.0 21.9 22.7 14.2 10.2 19.5 29.2 5.6 13.2 12.4 10.6 15.8 20.5 17.7 16.0 2.9 2.2 4.9 3.7 2.8 2.2 0.5 17.5 8.7 1.5 5.5 12.4 12.8 6.1 12.7 8.0 3.7 3.9 3.1 7.8 8.2 8.5 9.7 5.1 15.6 2.0 6.4 3.3 15.1 8.6 4.9 6.2 4.2 8.4 7.1 17.4 7.0 10.7 5.2 5.2 7.8 4.2 3.9 9.3 7.7 4.2 12.3 8.4 4.9 3.8 8.3 11.0 6.3 4.6 8.2 5.9 7.7 6.7 5.1 7.9 18.0 7.7 1.4 10.1 12.2 12.6 14.0 6.5 18.7 16.4 15.5 6.6 4.7 17.6 7.3 8.9 1.6 2.8 0.8 2.2 3.7 1.8 2.9 1.3 1.7 0.8 1.9 1.0 2.0 4.9 2.8 2.9 2.2 0.9 0.5 18.1 19.5 26.3 26.6 20.6 10.4 13.2 11.6 16.8 13.2 38.7 38.6 34.0 57.5 78.6 100.0 23.6 79.0 18.7 21.6 40.1 51.1 18.0 23.2 18.6 4.0 41.1 124.6 23.3 17.5 8.9 23.5 73.0 25.5 59.6 21.6 151.0 46.0 63.8 54.1 4.4 40.9 49.9 35.4 16.2 105.5 27.3 24.2 77.7 46.3 15.9 69.0 32.3 43.4 3.8 1.7 99.5 45.0 54.2 87.3 93.1 ZBTB7B "c-Krox, hcKrox, ZBTB15, ZFP67, ZNF857B" ENSG00000160685 "Zinc finger and BTB domain containing 7B" O15156 1 155002630-155018522 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 54.0" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 141.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006811, HPA025820" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006811: AB_1859046, HPA025820: AB_1859045" "unprognostic (5.13e-2)" "unprognostic (2.83e-1)" "unprognostic (1.45e-1)" "unprognostic (4.36e-2)" "unprognostic (2.43e-1)" "unprognostic (4.95e-3)" "unprognostic (9.55e-2)" "unprognostic (1.41e-1)" "unprognostic (3.72e-1)" "unprognostic (2.56e-1)" "unprognostic (2.65e-2)" "unprognostic (1.46e-2)" "unprognostic (5.35e-2)" "unprognostic (1.11e-2)" "unprognostic (1.82e-1)" "unprognostic (1.61e-1)" "unprognostic (1.53e-2)" 9.4 11.1 3.0 8.8 4.7 11.6 11.1 4.0 4.9 9.5 33.7 11.3 22.3 27.3 5.4 4.5 29.1 5.9 13.2 6.4 4.3 2.1 9.3 19.1 10.5 6.3 8.0 4.3 6.2 18.2 5.1 6.4 11.3 5.9 9.9 8.1 9.6 19.1 18.6 11.8 33.3 54.0 5.4 5.6 10.3 11.2 3.8 7.3 1.8 14.3 11.2 16.0 8.6 12.4 2.0 2.3 5.7 3.4 1.5 2.5 4.3 7.5 13.5 1.2 4.1 6.2 3.5 16.6 5.2 6.2 5.5 6.4 9.0 11.0 3.3 9.4 5.8 4.3 11.5 3.8 7.3 1.1 18.0 4.3 5.5 22.5 6.0 9.1 4.2 15.2 4.6 26.2 7.5 9.3 7.4 4.3 0.5 7.8 15.3 3.1 14.3 0.1 9.4 4.1 12.1 11.2 3.1 0.9 20.7 8.2 7.9 7.7 7.9 10.0 26.8 4.2 5.3 16.7 14.1 3.6 3.6 6.3 7.0 4.3 18.2 11.1 3.5 8.3 14.0 4.0 0.9 3.2 2.9 1.5 3.4 0.5 1.6 2.0 0.9 2.3 2.0 1.7 0.5 5.7 1.5 2.9 0.2 2.5 4.3 3.0 4.7 4.0 4.9 4.3 2.1 8.0 4.3 5.9 7.3 8.9 0.0 4.7 8.4 31.3 14.0 1.4 20.4 0.0 1.2 5.2 2.0 9.2 10.0 11.9 2.2 4.1 141.0 0.0 13.0 12.8 5.6 21.8 5.7 23.7 12.7 15.9 6.4 4.9 30.8 5.6 8.3 16.2 15.1 6.4 27.3 5.1 14.5 48.0 6.7 8.9 9.8 0.0 6.3 0.4 1.2 46.9 23.0 7.4 33.0 16.9 ZBTB9 "MGC23166, ZNF919" ENSG00000213588 "Zinc finger and BTB domain containing 9" Q96C00 6 33453970-33457548 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 12 "Basal keratinocytes: 3.9;Intestinal endocrine cells: 1.7;Melanocytes: 1.7;Suprabasal keratinocytes: 3.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 10.3;GAMG: 15.7;U-698: 11.6" "Low region specificity" "Detected in all" "HPA036767, HPA058171" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA036767: AB_10696787, HPA058171: " "unprognostic (1.79e-2)" "unprognostic (1.46e-1)" "unprognostic (6.86e-2)" "unprognostic (2.89e-1)" "unprognostic (2.18e-1)" "unprognostic (9.16e-2)" "unprognostic (1.85e-4)" "unprognostic (4.20e-1)" "unprognostic (2.73e-1)" "unprognostic (2.13e-1)" "unprognostic (1.70e-2)" "unprognostic (4.10e-1)" "unprognostic (2.17e-1)" "unprognostic (1.67e-1)" "unprognostic (1.71e-1)" "unprognostic (2.47e-1)" "unprognostic (2.95e-1)" 4.5 7.1 5.5 5.4 5.9 4.4 3.3 4.9 7.4 5.4 4.4 6.4 2.4 6.6 4.5 8.7 5.4 4.8 4.2 4.4 5.9 5.1 7.7 5.4 3.7 6.6 4.4 4.5 10.6 11.3 8.5 17.3 4.5 4.2 5.9 7.1 4.6 6.3 3.9 5.7 5.0 3.9 3.8 3.5 5.4 3.7 12.7 3.8 9.7 6.8 4.0 13.7 7.8 4.3 0.8 2.6 8.5 2.2 1.9 4.3 1.0 0.1 0.1 4.6 0.7 2.3 0.1 10.3 0.1 0.2 0.0 0.0 1.6 0.0 1.6 1.5 0.1 15.7 0.0 4.4 1.8 0.6 1.8 0.0 6.1 0.0 0.0 0.0 2.3 6.0 0.2 0.2 2.7 2.7 0.0 0.0 0.3 2.5 0.5 2.0 0.5 0.4 0.0 2.9 0.2 0.4 3.0 2.8 2.0 2.4 2.1 0.5 0.3 3.0 0.1 1.0 0.2 0.5 0.4 1.5 0.3 0.1 0.9 1.1 0.0 1.7 11.6 0.2 1.9 0.0 8.5 1.5 0.5 3.9 1.5 1.9 0.3 1.9 4.3 2.6 0.8 3.6 3.2 1.4 1.9 2.2 0.3 3.2 1.0 5.5 5.9 4.9 7.4 5.9 5.1 4.4 4.5 4.2 3.8 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.2 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.8 0.0 0.0 1.7 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 3.1 0.0 0.0 0.7 0.0 ZC3H12A "FLJ23231, MCPIP1" ENSG00000163874 "Zinc finger CCCH-type containing 12A" Q5D1E8 1 37474552-37484379 "Disease related genes, Predicted intracellular proteins" "Angiogenesis, Antiviral defense, Apoptosis, Differentiation, DNA damage, Host-virus interaction, Immunity, Inflammatory response, Neurogenesis, Stress response, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 58.7;tongue: 56.9" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 174.0;Suprabasal keratinocytes: 196.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 24.3;RT4: 30.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA032052, HPA032053" Uncertain Supported "Nucleoplasm,Cytoplasmic bodies" No No "Cytoplasmic bodies" Nucleoplasm "HPA032052: AB_10603241, HPA032053: AB_2674128" "unprognostic (2.35e-2)" "unprognostic (6.09e-3)" "unprognostic (1.51e-2)" "prognostic favorable (9.67e-4)" "unprognostic (1.01e-1)" "unprognostic (1.88e-1)" "unprognostic (9.03e-2)" "unprognostic (4.66e-3)" "unprognostic (1.05e-1)" "unprognostic (9.69e-3)" "unprognostic (9.01e-2)" "unprognostic (1.82e-2)" "prognostic unfavorable (5.95e-5)" "unprognostic (5.17e-2)" "unprognostic (4.69e-2)" "unprognostic (1.68e-1)" "unprognostic (3.77e-2)" 11.7 8.4 0.8 15.0 2.9 58.7 8.2 1.3 1.3 6.4 13.3 2.9 5.6 7.0 5.0 6.9 25.2 8.1 22.6 6.3 2.1 0.7 6.7 10.7 21.0 11.3 1.8 0.7 7.1 6.8 1.0 4.6 8.1 3.8 16.1 4.2 3.0 10.9 6.3 11.8 23.1 14.1 8.5 2.6 10.9 11.0 3.4 1.1 8.3 4.0 56.9 34.8 17.0 22.2 6.1 2.6 8.9 2.1 5.5 5.5 2.3 3.7 2.7 0.3 1.7 1.4 2.0 3.1 2.7 24.3 1.7 2.3 3.0 8.5 4.2 11.6 2.6 19.2 8.2 1.1 17.5 1.0 8.5 1.6 1.1 8.9 4.7 2.0 2.2 1.8 4.4 9.0 15.2 2.7 4.0 1.9 2.2 2.1 7.0 1.6 4.5 1.7 3.9 2.1 5.0 2.4 2.5 1.1 2.5 4.4 30.1 0.8 0.5 5.4 8.6 0.6 2.8 3.0 2.5 2.0 5.2 2.9 3.8 4.1 5.6 2.0 3.1 11.9 4.6 1.0 1.8 2.1 5.8 5.4 2.1 5.5 5.2 2.2 3.3 2.6 6.1 1.3 2.5 8.9 5.5 1.9 2.5 2.8 2.3 0.8 2.9 1.3 1.3 2.1 0.7 1.8 0.7 3.8 1.1 14.9 39.3 19.1 112.5 174.0 0.0 3.9 38.2 8.1 21.6 10.4 0.0 3.1 0.0 64.4 17.4 11.7 60.6 0.0 65.3 7.5 22.6 104.0 42.6 11.6 9.3 0.0 61.3 1.8 10.8 2.4 0.9 50.4 45.5 20.8 50.6 0.8 44.4 38.4 1.1 0.3 4.3 6.5 45.7 1.4 0.9 196.9 9.8 17.3 33.3 73.7 ZC3H12D "C6orf95, dJ281H8.1, MCPIP4" ENSG00000178199 "Zinc finger CCCH-type containing 12D" A2A288 6 149446795-149485061 "Disease related genes, Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 38.1" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 5.4;Kupffer cells: 10.8;T-cells: 5.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "HDLM-2: 27.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA036897 Uncertain Supported "Nucleoplasm,Cytoplasmic bodies" NA NA "Nucleoplasm, Cytoplasmic bodies" "HPA036897: AB_10672104" "unprognostic (2.89e-2)" "unprognostic (3.91e-4)" "unprognostic (1.68e-2)" "unprognostic (1.88e-2)" "unprognostic (3.12e-1)" "unprognostic (2.47e-6)" "unprognostic (2.20e-2)" "unprognostic (2.50e-3)" "unprognostic (1.34e-1)" "unprognostic (3.30e-2)" "unprognostic (2.33e-2)" "unprognostic (1.86e-1)" "unprognostic (1.28e-4)" "unprognostic (1.21e-2)" "unprognostic (9.24e-3)" "unprognostic (6.99e-2)" "unprognostic (5.52e-2)" 3.3 0.8 0.5 33.4 1.0 3.4 1.2 0.7 0.6 0.8 3.0 0.1 1.0 3.0 0.6 1.2 0.8 0.8 0.9 0.6 0.5 0.7 1.3 0.8 2.0 10.6 0.5 0.0 0.4 0.7 0.0 0.6 0.8 0.5 0.7 1.5 0.9 2.0 0.2 0.4 1.1 7.7 0.4 0.7 9.5 0.7 0.7 0.4 4.8 0.9 1.6 38.1 1.7 0.6 3.2 1.7 1.3 2.7 0.7 7.2 1.5 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.1 6.4 0.1 0.0 0.2 0.2 0.0 0.0 0.1 27.0 0.2 0.2 0.8 2.2 0.0 2.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.1 0.0 2.0 0.0 0.0 0.0 5.6 0.0 0.7 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 3.6 0.0 0.2 0.1 0.1 0.1 0.1 0.2 2.3 0.3 2.1 0.1 1.3 1.8 0.4 0.3 1.0 0.5 3.1 3.2 1.5 1.7 3.2 2.0 0.5 1.3 0.7 2.7 1.0 7.2 1.5 0.5 1.0 0.7 0.6 0.5 0.7 0.5 0.0 0.5 0.4 3.0 3.8 3.2 0.5 0.3 0.6 1.1 2.5 0.0 1.2 0.0 3.9 0.0 1.7 0.0 0.3 1.1 5.4 0.0 0.3 0.0 0.6 0.3 0.0 0.0 3.2 0.0 0.0 2.5 10.8 0.2 0.0 3.6 1.7 0.0 1.5 0.8 0.2 0.0 0.0 1.4 0.6 0.0 0.3 0.1 0.4 1.3 0.0 5.7 2.1 0.3 ZC3H3 "KIAA0150, ZC3HDC3" ENSG00000014164 "Zinc finger CCCH-type containing 3" Q8IXZ2 8 143437655-143541453 "Predicted intracellular proteins" "mRNA transport, Transport" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023658, HPA050577" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA023658: AB_1858973, HPA050577: " "unprognostic (1.15e-1)" "unprognostic (7.74e-2)" "unprognostic (1.87e-2)" "unprognostic (6.77e-2)" "unprognostic (1.33e-1)" "unprognostic (2.66e-1)" "prognostic unfavorable (4.06e-4)" "unprognostic (2.18e-3)" "unprognostic (2.12e-1)" "unprognostic (1.30e-2)" "unprognostic (3.69e-1)" "unprognostic (3.32e-1)" "prognostic unfavorable (4.38e-7)" "unprognostic (3.59e-2)" "unprognostic (1.33e-1)" "unprognostic (5.67e-2)" "unprognostic (2.18e-1)" 11.9 7.9 9.9 10.1 11.1 28.0 9.1 17.3 16.6 6.3 7.5 11.9 9.8 20.8 9.4 4.4 9.2 7.6 7.1 6.0 7.9 4.5 12.6 26.9 9.3 8.5 7.3 8.7 8.6 10.1 5.7 6.4 8.8 8.5 7.9 3.6 9.1 12.0 7.7 15.1 10.9 16.5 10.0 5.0 13.4 11.8 23.2 7.4 13.8 9.4 7.0 9.1 8.0 7.7 5.2 5.3 13.4 8.1 2.9 9.2 6.7 7.6 11.4 3.6 8.6 2.2 2.6 10.1 4.4 3.2 5.7 4.7 6.1 7.1 5.5 8.1 3.6 3.1 8.8 2.9 4.6 1.2 11.9 10.2 7.0 6.9 9.6 5.5 3.4 6.2 5.9 4.3 4.7 3.3 2.6 4.1 5.4 11.5 10.2 2.3 19.9 16.2 6.5 6.6 6.3 18.6 9.4 2.9 17.2 4.0 4.7 9.3 6.1 8.7 7.6 4.7 2.0 12.2 6.4 5.6 5.0 15.3 10.9 7.6 9.3 6.2 4.7 6.5 8.2 5.4 9.1 6.3 8.6 6.2 8.1 7.3 5.2 7.1 7.5 5.3 4.7 9.2 7.3 13.4 2.9 5.0 4.5 5.1 6.7 9.9 11.1 17.3 16.6 7.9 4.5 7.3 8.7 8.5 7.4 0.0 2.9 5.6 3.1 6.3 6.7 1.2 0.0 0.0 1.2 5.2 7.9 6.8 1.7 5.6 4.9 3.6 12.7 0.0 6.4 7.5 5.6 3.5 5.7 12.2 7.3 4.8 10.3 2.5 7.3 5.8 4.9 8.1 3.3 8.2 7.9 5.6 5.9 0.0 5.3 8.8 7.0 12.9 2.1 12.7 14.0 7.5 10.3 5.1 7.4 4.8 ZC3H4 "C19orf7, KIAA1064" ENSG00000130749 "Zinc finger CCCH-type containing 4" Q9UPT8 19 47064187-47113752 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040934, HPA041068" Supported Enhanced Nucleoplasm,Cytosol NA NA 8500 Nucleoplasm Cytosol "HPA040934: AB_10795495, HPA041068: AB_10796567" "unprognostic (8.02e-3)" "unprognostic (3.68e-3)" "unprognostic (3.11e-2)" "unprognostic (1.91e-1)" "unprognostic (3.17e-1)" "unprognostic (7.04e-3)" "unprognostic (9.37e-2)" "unprognostic (1.28e-1)" "unprognostic (3.03e-1)" "unprognostic (2.93e-1)" "unprognostic (1.68e-2)" "unprognostic (1.53e-1)" "unprognostic (9.14e-2)" "unprognostic (3.00e-3)" "unprognostic (1.19e-1)" "unprognostic (5.90e-2)" "prognostic favorable (2.23e-4)" 12.0 8.2 8.6 14.5 16.9 8.5 18.2 25.6 13.9 8.9 9.6 14.7 9.8 11.5 12.8 6.0 11.8 10.4 6.5 8.2 9.3 7.6 9.2 10.9 19.9 14.1 16.5 5.2 14.6 12.5 10.4 45.4 15.4 13.9 9.7 7.2 10.8 11.8 10.4 14.1 13.5 11.5 8.5 26.0 16.0 11.5 14.5 12.4 17.5 10.5 9.3 11.5 10.3 24.0 5.2 6.8 6.2 3.7 5.2 5.6 1.2 8.8 13.8 8.6 12.2 4.8 3.0 8.8 7.1 4.0 6.7 4.5 9.8 9.9 18.7 5.3 4.8 4.1 15.4 3.8 10.1 4.3 11.5 6.1 13.3 8.4 7.4 4.2 12.6 14.2 5.1 2.8 6.2 4.9 3.6 5.4 11.6 12.8 7.1 4.3 15.4 14.2 21.3 12.8 6.0 4.7 22.4 7.4 8.4 5.0 14.5 10.5 14.9 10.8 9.1 5.3 4.4 9.5 10.2 9.5 9.1 8.9 5.8 9.9 9.3 7.5 16.7 7.1 10.3 12.9 4.6 2.2 3.2 5.5 3.7 5.6 5.2 4.9 5.5 2.9 5.1 4.3 4.8 6.2 5.2 3.5 6.8 3.1 1.2 8.6 16.9 25.6 13.9 9.3 7.6 16.5 5.2 13.9 12.4 3.0 13.3 13.6 5.5 19.8 24.1 11.2 25.5 12.0 12.5 19.2 13.7 5.7 8.3 9.9 11.9 13.0 15.8 23.3 10.1 5.8 13.5 7.5 11.6 11.9 10.9 15.9 18.4 17.2 27.8 5.4 15.5 14.8 6.8 13.6 20.6 17.4 10.3 16.7 9.2 7.0 23.0 6.5 10.2 13.0 9.2 19.6 7.2 14.4 14.9 6.7 ZC3H6 "FLJ41410, FLJ45877, KIAA2035, ZC3HDC6" ENSG00000188177 "Zinc finger CCCH-type containing 6" P61129 2 112275594-112340063 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 108.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036019, HPA036020, HPA076065" Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA036019: AB_10673228, HPA036020: AB_2674904, HPA076065: AB_2732300" "unprognostic (1.05e-2)" "unprognostic (3.01e-1)" "unprognostic (2.77e-2)" "unprognostic (1.48e-1)" "unprognostic (1.17e-1)" "unprognostic (1.40e-3)" "unprognostic (1.83e-1)" "unprognostic (3.99e-3)" "unprognostic (3.30e-1)" "unprognostic (1.37e-1)" "unprognostic (2.43e-2)" "unprognostic (1.68e-1)" "unprognostic (4.41e-2)" "unprognostic (6.42e-3)" "unprognostic (1.40e-1)" "unprognostic (1.17e-1)" "unprognostic (6.45e-2)" 10.9 8.8 8.1 6.2 18.9 5.8 11.2 16.6 14.3 10.9 8.1 11.4 7.7 5.3 9.1 11.9 6.7 10.3 6.5 9.4 8.9 7.4 7.6 6.4 7.4 8.9 15.6 10.5 20.5 7.1 13.8 18.3 7.0 11.1 9.8 6.2 8.6 8.2 8.0 16.4 14.3 7.5 10.5 11.5 10.0 6.9 9.4 13.1 12.4 12.5 5.2 8.6 13.4 8.6 5.5 2.9 3.9 3.4 1.8 4.5 1.1 1.7 0.8 4.0 3.7 3.5 7.0 1.2 2.0 3.1 1.2 2.6 0.4 2.4 2.9 1.5 1.1 3.4 1.1 1.2 0.5 1.7 3.2 0.4 0.5 0.9 0.1 3.3 0.9 0.8 2.7 5.4 1.4 9.2 5.7 1.9 3.6 0.7 4.9 2.8 1.6 1.7 1.2 2.5 1.1 0.9 1.1 0.2 2.5 1.7 0.3 2.8 3.9 1.9 1.1 2.0 2.2 1.2 1.1 3.0 2.0 0.3 2.2 0.9 5.2 1.5 2.5 3.7 1.9 4.9 1.5 1.8 2.3 2.9 1.3 3.2 3.7 3.9 3.0 1.6 5.5 4.5 3.7 3.9 1.8 3.4 2.9 3.2 1.1 8.1 18.9 16.6 14.3 8.9 7.4 15.6 10.5 11.1 13.1 35.7 23.5 7.8 27.2 15.3 64.1 63.7 17.8 37.5 26.1 21.0 51.1 17.6 24.9 10.4 9.8 27.8 9.0 0.0 13.1 6.2 18.3 24.3 25.5 15.8 10.9 108.1 15.5 23.4 15.2 11.0 42.8 13.5 5.0 16.2 13.3 47.9 11.9 9.1 33.9 18.3 82.7 32.3 26.8 70.4 48.8 16.2 6.6 22.4 14.0 17.2 ZC3H8 "Fliz1, ZC3HDC8" ENSG00000144161 "Zinc finger CCCH-type containing 8" Q8N5P1 2 112211525-112255136 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034803, HPA034804" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA034803: AB_2674338, HPA034804: AB_10670284" "unprognostic (2.45e-1)" "unprognostic (1.64e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.12e-6)" "unprognostic (4.93e-2)" "unprognostic (1.01e-1)" "unprognostic (4.29e-3)" "unprognostic (8.76e-2)" "unprognostic (1.20e-2)" "unprognostic (5.04e-2)" "unprognostic (7.22e-2)" "unprognostic (2.89e-2)" "prognostic unfavorable (1.89e-4)" "unprognostic (2.74e-2)" "unprognostic (3.49e-2)" "unprognostic (8.02e-3)" "unprognostic (4.88e-3)" 6.5 7.9 13.0 9.0 15.9 9.1 13.6 18.2 19.6 7.5 7.7 7.2 9.1 8.8 8.4 7.5 16.1 8.8 4.5 13.7 11.1 8.6 9.2 9.8 5.0 12.8 11.6 12.6 10.3 15.4 15.2 35.7 6.2 13.6 9.8 10.4 5.2 11.3 11.7 33.1 12.5 8.3 7.6 13.7 11.7 7.8 14.1 13.8 12.6 12.2 12.8 13.8 9.0 12.4 7.2 4.7 2.4 2.8 8.7 10.6 2.9 11.8 5.8 7.4 7.6 4.2 4.6 11.7 3.8 3.2 5.3 4.5 13.9 4.6 24.8 7.0 2.6 7.5 7.2 10.8 7.6 7.2 8.7 4.9 16.4 6.4 7.0 6.7 15.2 7.6 5.7 15.3 10.4 16.2 3.9 4.0 15.1 20.9 6.9 4.1 7.8 16.4 13.8 6.9 12.6 16.4 11.5 12.7 10.1 4.9 5.3 11.2 8.7 7.1 7.7 16.0 6.8 6.1 8.2 5.3 7.0 9.0 4.9 9.5 12.4 14.8 24.4 5.0 12.8 2.7 2.4 2.8 0.9 5.1 2.3 10.6 6.4 5.1 5.3 2.9 7.2 8.8 7.5 1.5 8.7 2.7 4.7 5.1 2.9 13.0 15.9 18.2 19.6 11.1 8.6 11.6 12.6 13.6 13.8 8.9 14.6 28.4 15.7 11.2 45.9 34.3 10.2 18.7 30.7 7.0 39.3 15.2 23.2 12.4 23.9 13.4 10.6 0.0 16.0 12.8 10.8 12.6 33.6 7.8 10.0 36.5 14.3 13.5 13.3 27.2 20.4 12.4 1.7 4.6 20.0 17.8 16.0 10.5 19.1 15.3 46.6 12.9 12.7 52.3 34.2 15.6 11.9 21.8 22.1 10.8 ZC3HC1 NIPA ENSG00000091732 "Zinc finger C3HC-type containing 1" Q86WB0 7 130018286-130051451 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 31.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019089, HPA024023" Enhanced Supported "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA019089: AB_1858976, HPA024023: AB_1858977" "unprognostic (7.14e-3)" "unprognostic (4.07e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (3.36e-4)" "unprognostic (1.89e-1)" "unprognostic (3.39e-2)" "prognostic unfavorable (1.02e-6)" "unprognostic (2.11e-1)" "unprognostic (1.11e-3)" "unprognostic (1.48e-1)" "unprognostic (1.12e-2)" "unprognostic (2.91e-1)" "unprognostic (1.10e-3)" "unprognostic (2.33e-1)" "unprognostic (5.11e-2)" "unprognostic (2.60e-2)" "unprognostic (1.53e-1)" 11.0 13.8 8.1 10.0 10.3 4.9 14.2 9.5 12.6 9.5 9.2 9.9 5.9 6.0 14.5 11.0 7.9 9.4 7.5 16.3 8.2 8.9 13.2 14.8 6.9 13.6 7.3 8.4 10.7 10.6 10.5 9.6 10.0 10.5 9.0 8.4 9.6 10.5 8.4 33.0 7.1 7.8 12.9 5.5 13.7 9.0 24.6 6.6 15.4 8.3 11.9 11.5 8.5 9.6 23.1 20.2 17.4 17.7 17.4 23.8 15.8 7.0 12.0 14.9 16.8 8.5 7.8 10.3 9.2 11.0 17.4 18.1 14.1 12.1 16.3 6.7 11.7 23.8 6.5 19.5 13.9 17.2 10.6 16.7 11.3 10.9 13.7 13.7 13.0 11.6 9.4 10.5 18.1 11.8 9.9 19.0 14.0 33.9 5.7 17.6 12.4 15.3 25.1 30.4 12.4 13.7 14.5 11.5 14.2 17.6 4.8 9.6 17.2 13.3 19.3 14.7 22.3 8.4 13.8 8.7 11.9 5.8 10.4 15.4 11.1 16.7 21.2 18.8 16.7 20.2 17.4 16.2 14.5 17.0 17.7 19.5 23.1 18.2 18.2 20.2 20.6 23.8 18.8 1.3 17.4 16.3 11.9 18.5 15.8 8.1 10.3 9.5 12.6 8.2 8.9 7.3 8.4 10.5 6.6 6.0 2.9 5.1 4.3 1.3 5.8 12.1 7.6 10.7 3.4 7.0 0.0 16.1 14.9 10.7 2.6 6.5 2.1 0.0 8.4 13.7 4.8 2.2 4.6 8.5 7.8 6.4 3.5 11.6 3.2 4.3 8.1 4.1 1.7 15.4 4.1 7.2 7.8 7.0 6.0 17.0 5.6 0.0 5.1 31.6 18.8 1.5 6.2 5.7 4.2 1.4 ZCCHC10 FLJ20094 ENSG00000155329 "Zinc finger CCHC-type containing 10" Q8TBK6 5 132996985-133026604 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038944 Approved Approved "Nucleoplasm,Nucleoli rim" NA NA "Nucleoli rim" Nucleoplasm "HPA038944: AB_10673601" "unprognostic (1.09e-1)" "unprognostic (3.08e-2)" "unprognostic (1.03e-2)" "unprognostic (2.30e-2)" "unprognostic (4.77e-1)" "unprognostic (1.90e-3)" "unprognostic (1.23e-3)" "unprognostic (8.80e-2)" "unprognostic (1.89e-3)" "unprognostic (1.69e-1)" "unprognostic (2.03e-1)" "unprognostic (8.30e-3)" "unprognostic (1.36e-2)" "unprognostic (1.27e-1)" "unprognostic (8.85e-2)" "unprognostic (1.62e-1)" "unprognostic (8.89e-3)" 18.6 17.3 14.5 18.2 14.1 30.6 16.4 18.1 20.6 17.4 24.1 10.5 15.4 18.3 18.7 15.4 26.9 14.9 14.2 17.3 13.7 12.4 19.6 23.5 21.0 26.0 11.9 15.2 17.3 17.7 9.8 27.4 23.0 15.3 16.1 22.1 10.0 17.9 16.8 31.5 14.0 21.7 14.0 17.5 23.6 17.8 20.3 14.1 25.6 13.9 22.4 26.5 17.8 17.3 48.1 27.2 16.5 28.0 22.9 27.7 18.8 11.9 12.4 16.5 13.6 8.3 7.5 21.6 12.6 9.8 16.1 18.7 31.4 14.8 33.2 19.3 8.4 12.7 15.1 20.1 16.1 17.5 19.5 26.7 19.3 15.3 23.2 12.3 16.5 22.5 6.8 18.5 9.8 16.0 8.8 15.9 16.5 20.8 18.4 12.2 15.6 25.7 19.2 17.9 12.7 13.1 23.1 19.5 14.4 14.8 17.2 13.0 10.9 20.1 8.2 23.2 23.4 18.2 21.5 16.1 13.8 16.4 9.0 18.1 15.6 24.7 46.6 11.3 29.6 16.2 16.5 28.0 16.4 19.7 25.3 20.6 39.7 24.1 23.5 27.2 48.1 21.2 21.8 14.6 22.9 25.3 24.0 27.7 18.8 14.5 14.1 18.1 20.6 13.7 12.4 11.9 15.2 15.3 14.1 26.8 38.6 82.1 33.1 29.7 26.0 45.6 61.1 30.8 35.2 12.2 7.9 43.8 28.2 33.8 5.0 32.1 53.0 0.0 58.5 44.4 38.5 26.8 32.3 53.9 41.1 27.0 36.4 38.1 58.5 5.0 22.7 44.8 33.7 38.7 50.6 17.3 47.2 73.7 28.0 70.8 25.2 12.9 34.4 62.4 63.2 33.1 51.5 45.7 45.4 45.6 ZCCHC2 "C18orf49, FLJ20222, FLJ20281, KIAA1744" ENSG00000141664 "Zinc finger CCHC-type containing 2" Q9C0B9 18 62523007-62587709 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "salivary gland: 99.1" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 114.5;Late spermatids: 110.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040943 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" Nucleoplasm "HPA040943: AB_10795496" "unprognostic (9.32e-2)" "unprognostic (1.68e-1)" "unprognostic (1.17e-1)" "unprognostic (2.84e-3)" "unprognostic (1.40e-1)" "unprognostic (4.07e-2)" "unprognostic (4.79e-2)" "unprognostic (2.60e-1)" "unprognostic (1.93e-1)" "unprognostic (8.25e-2)" "unprognostic (2.32e-2)" "unprognostic (1.30e-1)" "unprognostic (5.12e-2)" "unprognostic (2.45e-1)" "unprognostic (3.72e-2)" "unprognostic (1.46e-1)" "unprognostic (1.29e-1)" 12.6 5.0 6.8 7.0 7.5 22.8 16.0 8.0 6.8 7.5 8.5 6.0 5.3 6.8 6.9 7.1 6.5 7.4 9.0 8.5 5.3 5.7 5.8 23.0 10.1 7.6 8.1 5.7 8.8 6.3 7.8 8.5 8.2 5.5 8.1 5.8 4.5 99.1 5.9 16.8 11.3 7.5 7.6 5.6 8.9 6.5 13.4 8.9 10.8 7.8 4.3 6.4 11.0 19.3 1.6 1.0 4.9 1.6 0.6 2.0 0.4 6.0 5.2 4.5 8.9 13.8 5.9 8.6 3.4 5.2 8.3 8.3 2.8 3.7 17.0 4.6 5.7 6.8 10.2 14.5 7.6 3.4 11.7 6.8 4.4 12.1 19.0 4.7 8.5 6.5 5.8 9.9 5.2 9.8 6.0 15.5 7.7 4.7 5.7 2.7 4.9 5.5 3.6 2.9 4.4 5.2 7.4 4.8 0.1 5.7 6.1 5.7 3.5 5.8 13.1 5.1 8.5 4.6 6.8 6.6 8.1 5.6 3.2 4.9 2.2 4.3 7.3 6.1 3.6 3.0 0.0 1.0 2.4 1.7 1.6 1.2 0.5 1.1 1.5 0.3 1.6 2.0 1.3 4.9 0.6 0.3 1.0 1.2 0.4 6.8 7.5 8.0 6.8 5.3 5.7 8.1 5.7 5.5 8.9 23.8 19.7 4.2 13.1 23.7 27.6 18.8 15.3 9.4 14.8 15.7 51.1 6.3 3.3 5.4 114.5 20.9 7.7 0.0 5.3 10.1 7.6 13.8 2.3 28.0 12.5 41.3 12.1 17.8 39.8 110.8 7.5 21.1 6.8 4.6 13.2 9.2 4.8 10.5 7.4 4.3 19.1 6.5 15.3 11.5 6.6 16.2 5.7 7.5 10.3 10.5 ZCCHC24 "C10orf56, FLJ90798, Z3CXXC8" ENSG00000165424 "Zinc finger CCHC-type containing 24" Q8N2G6 10 79382325-79445627 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 56.8" "Cell type enhanced" "Detected in many" 7 "Fibroblasts: 40.7;Hepatocytes: 44.7;Ito cells: 57.1;Leydig cells: 63.6;Peritubular cells: 61.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 43.5;ASC TERT1: 37.4;BJ hTERT+: 28.5;HSkMC: 38.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038348 Approved Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA038348: AB_10669538" "unprognostic (3.47e-3)" "unprognostic (8.70e-3)" "unprognostic (3.35e-1)" "unprognostic (1.67e-1)" "unprognostic (1.23e-1)" "unprognostic (7.28e-2)" "unprognostic (2.17e-2)" "unprognostic (2.25e-2)" "unprognostic (2.62e-1)" "prognostic unfavorable (3.76e-4)" "unprognostic (4.77e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (5.35e-6)" "unprognostic (1.84e-2)" "unprognostic (5.52e-2)" "unprognostic (2.85e-2)" "unprognostic (2.95e-3)" 27.9 9.0 30.9 9.5 54.4 1.8 9.8 11.1 36.0 22.9 19.8 56.8 4.2 4.6 18.0 6.9 10.3 15.5 16.8 19.1 30.6 19.7 3.5 13.5 10.2 4.8 56.7 23.5 20.1 4.0 3.9 3.0 11.4 36.2 14.5 6.8 4.5 6.2 20.7 34.8 5.0 5.4 25.6 36.8 7.0 9.0 6.6 51.9 0.0 6.0 2.5 3.2 14.9 7.3 0.0 3.4 0.6 2.4 0.7 0.9 0.5 0.9 0.9 3.2 2.8 43.5 37.4 0.8 7.5 28.5 4.5 5.2 0.8 0.0 0.0 4.1 15.1 1.5 0.0 0.5 0.1 3.8 1.8 2.0 0.4 2.3 0.9 11.3 1.1 0.6 38.8 0.4 4.0 1.1 13.3 0.9 0.2 1.4 1.6 3.8 0.3 0.0 4.4 0.7 0.2 9.3 0.2 3.8 0.6 0.5 1.2 0.1 4.0 2.3 0.3 9.4 3.2 1.1 2.1 0.6 4.3 4.0 11.7 2.5 2.9 1.9 0.0 8.8 1.4 15.3 0.0 2.4 0.6 0.9 1.1 0.2 0.0 0.0 0.3 1.6 0.0 0.0 0.2 0.6 0.7 0.1 3.4 0.4 0.5 30.9 54.4 11.1 36.0 30.6 19.7 56.7 23.5 36.2 51.9 0.0 1.6 0.0 1.5 6.8 0.0 16.5 7.6 1.4 1.2 0.0 0.0 0.6 0.0 0.8 1.7 17.0 0.0 0.0 0.7 0.8 40.7 3.6 1.1 44.7 8.5 0.0 0.0 57.1 15.9 3.7 63.6 6.8 15.1 1.0 0.4 16.4 0.7 0.0 61.5 1.4 0.7 12.9 21.2 0.7 1.0 4.0 1.3 4.3 0.0 1.1 ZCCHC6 "FLJ13409, KIAA1711, PAPD6, TUT7" ENSG00000083223 "Zinc finger CCHC-type containing 6" Q5VYS8 9 86287733-86354454 "Enzymes, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 42.1" "Group enriched" "Detected in all" 5 "granulocytes: 42.1;monocytes: 15.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020615, HPA020620" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA020615: AB_1858983, HPA020620: AB_1858984" "unprognostic (1.10e-1)" "unprognostic (1.36e-1)" "unprognostic (1.64e-1)" "unprognostic (1.26e-2)" "unprognostic (3.66e-1)" "unprognostic (1.39e-1)" "unprognostic (4.11e-2)" "unprognostic (2.49e-2)" "unprognostic (4.43e-2)" "unprognostic (6.51e-2)" "unprognostic (1.91e-2)" "unprognostic (3.07e-1)" "unprognostic (5.79e-3)" "unprognostic (1.59e-2)" "unprognostic (1.13e-1)" "unprognostic (4.14e-2)" "unprognostic (1.40e-1)" 11.2 9.3 7.7 22.6 11.2 17.0 17.3 9.7 13.7 10.8 13.5 5.6 12.8 9.4 8.6 8.1 23.1 8.3 10.3 10.1 9.4 5.2 7.4 33.1 16.3 19.5 9.8 5.1 9.0 12.9 9.2 18.6 33.3 9.0 19.3 10.8 4.5 14.0 13.6 12.5 30.9 15.6 9.7 13.6 22.2 11.7 10.3 10.7 23.3 8.7 15.2 16.9 13.7 14.3 4.4 4.3 42.1 15.7 4.5 5.7 2.9 9.9 10.8 6.4 9.3 16.5 25.1 7.9 13.6 13.3 6.0 7.0 4.9 8.9 14.2 12.4 9.0 6.2 17.6 7.6 7.7 9.0 16.6 4.1 10.2 11.5 9.1 14.0 11.6 14.9 16.6 16.1 9.6 11.4 9.5 10.1 7.9 9.6 15.4 16.8 10.7 9.7 7.0 5.2 17.2 7.3 4.9 11.2 6.5 10.7 19.6 4.7 3.7 8.3 11.0 4.7 8.2 4.1 5.3 15.5 5.8 7.0 10.2 9.3 17.8 13.9 10.6 13.8 7.0 7.6 11.5 7.1 7.1 5.7 9.1 4.9 4.4 3.2 4.1 4.3 4.4 3.7 4.0 42.1 4.5 15.7 2.0 3.0 2.9 7.7 11.2 9.7 13.7 9.4 5.2 9.8 5.1 9.0 10.7 59.6 30.7 5.3 28.7 28.0 13.1 0.0 12.7 26.8 37.5 0.0 17.7 18.4 0.0 0.0 77.5 14.4 23.4 0.0 0.0 14.3 9.9 42.1 45.1 45.3 20.1 17.5 16.0 17.2 62.4 17.6 15.8 40.3 30.4 0.0 18.3 11.4 0.0 20.7 12.4 0.0 14.9 12.9 10.3 19.8 7.8 35.4 77.3 27.7 17.7 54.5 ZCCHC8 DKFZp434E2220 ENSG00000033030 "Zinc finger CCHC-type containing 8" Q6NZY4 12 122471600-122501073 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Cone photoreceptor cells: 117.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037483, HPA037484" Supported Enhanced Nucleoplasm NA NA 130000 Nucleoplasm "HPA037483: AB_10671502, HPA037484: AB_10672485" "unprognostic (1.96e-3)" "unprognostic (8.48e-2)" "unprognostic (5.55e-2)" "unprognostic (5.24e-2)" "unprognostic (2.44e-1)" "unprognostic (6.30e-3)" "unprognostic (1.33e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (7.40e-4)" "unprognostic (1.03e-1)" "unprognostic (6.95e-2)" "unprognostic (4.78e-2)" "prognostic unfavorable (5.36e-4)" "unprognostic (8.86e-2)" "unprognostic (2.88e-1)" "unprognostic (2.55e-2)" "unprognostic (1.48e-2)" 13.6 11.9 12.8 15.0 14.2 44.3 13.9 25.5 17.6 15.8 11.7 9.6 19.3 11.1 16.0 10.9 14.3 13.7 9.5 9.0 11.7 6.3 10.6 14.0 11.9 12.2 12.4 7.2 17.3 16.4 14.2 21.8 13.2 9.9 13.3 10.9 10.4 13.6 15.1 21.7 14.9 13.9 14.0 12.8 14.5 13.8 14.5 14.4 19.5 15.8 10.5 17.3 14.6 13.3 10.5 6.8 9.0 8.8 10.0 12.5 5.4 11.6 11.5 17.1 17.6 7.5 10.4 21.8 14.0 9.6 18.8 14.5 10.9 10.1 21.4 9.5 6.0 10.2 14.4 19.1 8.9 16.0 17.3 11.0 13.2 12.7 9.7 18.1 22.7 14.3 8.3 13.5 11.8 16.3 15.5 10.0 20.3 19.1 12.9 9.1 7.5 16.2 17.5 15.4 8.7 13.1 17.9 14.1 16.7 9.1 6.7 12.0 12.9 16.5 8.6 19.0 17.6 15.7 17.2 10.1 11.8 11.6 10.3 14.0 13.8 8.0 28.4 6.2 14.1 6.8 9.0 7.2 4.7 8.9 8.6 8.9 10.5 9.9 10.6 6.8 9.4 11.0 9.0 5.7 10.0 8.8 6.6 12.5 5.4 12.8 14.2 25.5 17.6 11.7 6.3 12.4 7.2 9.9 14.4 29.8 16.9 24.1 26.0 18.2 28.5 8.1 20.4 18.7 37.5 8.7 117.8 14.9 1.7 9.8 63.3 15.8 12.7 23.3 8.3 14.2 15.5 18.3 18.5 13.4 11.2 14.3 18.8 10.4 12.3 37.2 13.8 18.1 15.1 17.2 14.0 16.4 12.1 11.5 13.8 5.7 66.5 6.5 17.5 31.1 11.9 22.5 27.0 17.0 14.0 19.2 ZCCHC9 "DKFZp761J139, PPP1R41" ENSG00000131732 "Zinc finger CCHC-type containing 9" Q8N567 5 81301590-81313297 "Predicted intracellular proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038404 Uncertain Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA038404: AB_10672744" "unprognostic (1.55e-1)" "unprognostic (2.27e-1)" "unprognostic (1.31e-2)" "unprognostic (1.43e-2)" "unprognostic (1.57e-2)" "unprognostic (1.71e-2)" "unprognostic (6.29e-2)" "unprognostic (4.91e-2)" "unprognostic (1.10e-1)" "unprognostic (3.31e-1)" "unprognostic (3.58e-2)" "unprognostic (2.68e-2)" "unprognostic (5.20e-3)" "unprognostic (1.60e-1)" "unprognostic (2.05e-1)" "unprognostic (1.29e-1)" "unprognostic (1.06e-1)" 14.4 12.9 11.7 16.1 10.5 8.9 15.2 14.3 11.5 21.1 19.7 7.4 14.5 13.9 18.4 16.4 21.4 13.9 14.3 11.9 10.0 10.7 23.0 36.3 10.7 16.2 11.1 10.1 19.6 13.8 10.9 22.6 23.0 10.4 23.1 14.6 13.6 12.2 18.1 14.4 15.2 27.7 22.5 12.2 18.0 14.5 14.8 10.0 17.9 19.6 19.1 16.4 26.8 23.5 14.9 17.5 12.8 16.2 11.6 19.1 7.3 10.3 7.3 18.1 9.5 15.7 14.9 24.4 15.6 18.6 12.1 16.9 16.1 14.3 9.6 6.5 7.8 20.9 7.7 14.3 14.3 19.3 21.5 13.5 9.9 8.2 18.9 18.5 12.5 8.2 11.5 12.5 10.3 25.8 9.4 10.1 10.6 16.5 9.4 12.4 14.1 20.7 18.9 13.1 5.8 9.4 12.4 23.3 14.1 9.4 10.4 8.8 8.4 12.4 7.5 55.7 13.7 9.3 20.3 6.9 7.6 9.3 13.5 17.0 13.5 13.9 14.7 13.4 18.3 16.2 12.8 12.3 11.9 12.8 16.2 16.3 14.9 17.2 15.5 14.8 13.2 16.7 17.1 12.0 11.6 14.0 17.5 19.1 7.3 11.7 10.5 14.3 11.5 10.0 10.7 11.1 10.1 10.4 10.0 8.9 15.2 18.2 10.8 8.0 16.3 10.0 38.2 34.8 18.2 29.6 13.7 24.6 26.6 18.8 41.9 12.3 15.4 0.0 17.9 44.7 16.4 11.3 12.7 47.4 31.3 25.4 7.5 32.5 16.7 12.8 30.2 22.3 3.3 32.5 18.1 18.2 22.3 18.7 27.3 37.0 28.3 19.4 24.8 64.6 31.5 8.2 19.2 17.5 18.1 11.4 ZDBF2 "FLJ45338, KIAA1571, Slx9" ENSG00000204186 "Zinc finger DBF-type containing 2" Q9HCK1 2 206274663-206314428 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.9" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 24.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SuSa: 13.4" "Low region specificity" "Detected in many" "HPA039121, HPA050311" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039121: AB_2676357, HPA050311: AB_2681081" "unprognostic (8.32e-2)" "unprognostic (1.66e-1)" "unprognostic (2.75e-2)" "unprognostic (2.86e-2)" "unprognostic (3.27e-2)" "unprognostic (4.52e-2)" "unprognostic (2.01e-1)" "unprognostic (2.98e-1)" "unprognostic (7.73e-3)" "unprognostic (7.59e-2)" "unprognostic (4.41e-2)" "unprognostic (3.80e-2)" "unprognostic (2.01e-1)" "unprognostic (9.59e-2)" "unprognostic (3.08e-1)" "unprognostic (3.09e-1)" "unprognostic (1.40e-1)" 4.4 12.0 8.6 3.5 26.9 2.2 4.2 14.7 12.7 5.4 3.7 2.1 5.1 2.0 7.2 6.1 3.1 5.1 4.4 4.5 8.9 8.3 4.9 3.6 3.2 3.8 3.7 10.8 14.8 8.3 5.6 20.9 7.5 9.0 4.7 2.6 3.8 3.7 5.3 5.4 3.9 3.0 5.1 4.0 4.2 3.4 5.4 3.1 2.5 6.5 2.9 3.3 3.7 3.5 0.7 0.5 0.3 0.0 0.3 1.4 0.2 1.7 0.3 6.0 1.1 2.0 1.8 8.4 1.7 2.0 0.8 1.2 0.9 1.4 0.0 0.8 2.1 3.5 0.4 3.8 1.3 1.6 2.1 3.6 0.0 3.4 0.2 2.6 1.8 3.8 1.8 2.1 1.5 3.6 6.1 2.2 1.4 0.3 2.3 2.6 0.3 0.4 0.0 8.1 0.1 1.7 0.0 6.2 0.0 1.0 0.9 3.1 7.5 3.0 0.0 2.4 13.4 0.2 0.0 3.3 0.7 2.9 0.7 1.3 5.4 1.3 0.3 4.2 0.0 2.0 0.3 0.0 0.0 0.3 0.0 0.9 0.5 1.0 0.6 0.0 0.7 1.1 0.7 0.0 0.3 0.0 0.5 1.4 0.2 8.6 26.9 14.7 12.7 8.9 8.3 3.7 10.8 9.0 3.1 3.0 3.8 0.5 1.6 3.5 24.3 7.6 2.5 13.4 5.7 10.4 13.7 3.9 0.0 2.3 2.8 3.6 0.7 0.0 1.9 5.9 4.8 3.0 12.7 2.0 0.4 7.9 7.5 3.7 0.3 4.2 4.0 0.0 1.7 0.0 1.1 9.7 1.7 0.0 4.9 1.7 16.8 0.0 13.7 4.7 8.0 2.9 7.6 1.3 0.4 0.9 ZDHHC12 "FLJ14524, ZNF400" ENSG00000160446 "Zinc finger DHHC-type containing 12" Q96GR4 9 128720869-128724127 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 77.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 54.8" "Low region specificity" "Detected in all" HPA059339 Uncertain Approved "Nucleoplasm,Intermediate filaments" No No Nucleoplasm "Intermediate filaments" "HPA059339: AB_2683985" "unprognostic (2.05e-1)" "unprognostic (5.81e-2)" "unprognostic (2.54e-1)" "unprognostic (1.53e-3)" "unprognostic (5.34e-3)" "unprognostic (3.11e-2)" "unprognostic (1.50e-3)" "unprognostic (6.56e-3)" "unprognostic (1.02e-1)" "unprognostic (6.42e-2)" "unprognostic (9.97e-2)" "unprognostic (9.41e-2)" "unprognostic (1.09e-2)" "unprognostic (8.82e-3)" "unprognostic (2.18e-1)" "unprognostic (1.95e-2)" "unprognostic (3.23e-1)" 7.3 10.9 3.9 15.3 4.5 21.8 11.2 2.5 6.5 7.5 21.2 6.8 19.3 16.2 5.9 8.3 27.2 6.9 21.5 9.2 3.5 3.1 20.6 23.6 14.2 28.0 3.8 3.8 5.0 40.5 4.3 5.0 24.7 4.8 11.1 8.4 7.7 26.3 13.3 7.5 16.8 33.0 5.4 5.8 14.9 18.7 9.2 2.7 23.6 10.3 16.4 24.4 10.1 11.7 22.2 50.6 77.4 28.7 17.4 26.1 18.8 14.2 39.0 1.6 8.4 5.1 3.5 16.4 9.2 8.2 10.1 6.8 31.9 16.5 9.9 8.6 6.9 17.6 37.7 3.5 18.2 1.0 18.2 9.4 5.2 29.7 14.0 10.4 8.7 24.2 5.6 12.6 8.2 3.1 4.8 7.4 18.8 5.2 25.3 1.9 54.8 11.9 17.5 7.2 31.7 32.3 5.4 5.9 28.5 7.7 13.4 11.6 8.4 12.5 17.3 4.9 2.7 26.7 9.3 7.4 0.0 10.5 7.1 12.3 16.4 28.9 4.4 16.8 10.1 11.1 39.2 26.5 77.4 23.5 24.7 20.3 20.3 21.8 22.5 21.0 22.2 22.7 20.6 56.8 17.4 28.7 50.6 26.1 18.8 3.9 4.5 2.5 6.5 3.5 3.1 3.8 3.8 4.8 2.7 14.9 8.1 54.1 42.0 14.3 0.9 9.6 79.0 4.0 11.4 43.6 0.0 147.4 11.6 94.7 58.6 14.7 157.1 70.0 176.4 191.0 11.1 49.6 18.4 48.9 121.4 0.0 49.2 28.3 52.9 22.4 8.9 39.8 40.5 159.7 93.7 14.5 109.4 171.9 6.7 32.7 1.7 6.5 9.5 23.1 17.5 24.6 112.1 48.4 94.2 52.6 ZDHHC16 APH2 ENSG00000171307 "Zinc finger DHHC-type containing 16" Q969W1 10 97446131-97457370 "Enzymes, Predicted membrane proteins" "Apoptosis, DNA damage" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039893, HPA040214" Uncertain Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA039893: AB_10794757, HPA040214: AB_2676886" "unprognostic (4.44e-2)" "unprognostic (3.14e-2)" "unprognostic (3.34e-1)" "unprognostic (1.20e-2)" "unprognostic (8.75e-2)" "unprognostic (8.35e-3)" "unprognostic (1.27e-2)" "unprognostic (3.62e-2)" "unprognostic (5.49e-2)" "unprognostic (1.57e-1)" "unprognostic (2.31e-1)" "unprognostic (6.34e-2)" "unprognostic (1.93e-3)" "unprognostic (1.34e-1)" "unprognostic (1.07e-1)" "unprognostic (1.28e-2)" "unprognostic (2.48e-1)" 12.0 13.7 15.9 10.8 17.3 6.4 17.9 17.6 24.6 17.1 17.9 15.6 18.1 15.1 15.5 21.2 17.6 11.5 14.4 18.1 13.2 11.0 23.3 37.4 20.8 11.1 10.9 13.0 15.1 22.5 21.8 15.4 30.7 10.5 16.0 18.9 18.1 28.5 14.1 20.7 14.0 15.7 17.6 8.5 13.2 19.4 16.4 10.8 14.7 19.6 15.4 16.1 15.1 20.0 9.3 14.2 9.4 10.4 13.0 12.0 5.8 21.7 25.5 17.0 21.0 27.3 18.7 17.8 23.9 31.9 27.6 26.5 19.8 19.5 19.2 27.6 34.9 24.2 25.6 21.4 33.8 24.7 19.0 24.8 12.2 17.9 18.8 21.9 14.4 17.9 20.9 22.4 32.3 23.3 30.0 28.3 17.8 9.7 14.6 35.0 20.7 21.8 19.8 13.9 19.8 22.2 15.0 17.3 17.6 23.4 10.1 8.3 11.8 14.6 15.1 12.9 17.7 19.9 14.2 17.3 17.4 16.2 11.2 27.9 14.0 22.6 11.8 20.1 22.5 9.1 0.3 9.8 9.4 7.0 10.4 8.0 8.2 12.0 11.1 14.2 9.3 9.9 9.8 0.5 13.0 10.4 10.9 9.4 5.8 15.9 17.3 17.6 24.6 13.2 11.0 10.9 13.0 10.5 10.8 17.9 17.2 14.5 15.7 4.6 15.1 9.7 15.3 6.7 27.3 12.2 3.9 35.3 21.6 31.3 20.3 9.2 12.9 0.0 28.4 55.1 10.0 16.3 6.9 15.8 21.8 12.7 6.9 8.0 7.3 5.7 8.1 7.5 3.3 24.4 16.7 10.4 30.7 10.5 3.5 17.8 10.6 6.5 4.9 16.1 12.7 3.8 31.7 7.5 17.9 14.1 ZDHHC23 MGC42530 ENSG00000184307 "Zinc finger DHHC-type containing 23" Q8IYP9 3 113947901-113965401 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 25.8" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 20.4;Late spermatids: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 2.7;naive B-cell: 1.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016808 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA016808: AB_1859002" "unprognostic (2.10e-3)" "unprognostic (2.86e-1)" "unprognostic (4.48e-3)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.49e-1)" "unprognostic (3.98e-3)" "unprognostic (1.37e-2)" "unprognostic (2.48e-1)" "unprognostic (3.19e-1)" "unprognostic (6.63e-2)" "unprognostic (1.86e-1)" "unprognostic (2.78e-2)" "prognostic favorable (1.48e-7)" "unprognostic (2.58e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (5.90e-4)" "unprognostic (3.29e-3)" 1.0 0.8 6.3 2.1 5.9 0.4 1.9 2.7 10.4 1.4 7.7 0.9 2.2 6.0 1.5 1.6 1.7 2.1 1.8 1.3 8.9 1.9 4.7 3.2 2.4 2.7 0.9 4.7 1.1 4.4 8.2 3.5 0.4 1.4 1.8 9.9 1.2 4.9 1.4 1.2 2.9 5.4 0.7 0.9 1.9 5.0 25.8 0.6 0.8 5.5 0.9 2.8 1.7 1.5 2.7 1.1 0.5 0.0 0.0 0.5 0.1 13.1 3.3 0.4 7.8 1.2 0.2 11.5 5.2 1.6 1.0 1.6 5.4 8.9 6.1 4.6 3.0 8.6 8.7 10.0 1.4 1.7 3.6 4.6 5.6 4.8 3.3 0.4 6.2 5.2 0.2 1.7 0.2 0.6 1.2 0.8 6.5 0.0 3.6 0.1 7.6 5.1 0.4 2.4 13.6 3.7 0.9 4.5 5.0 5.6 6.5 13.7 3.5 4.0 13.5 2.6 3.2 8.1 2.1 0.2 3.8 7.6 0.8 2.3 4.0 5.2 9.8 3.2 4.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.5 0.1 0.0 1.7 0.1 0.0 0.5 0.0 0.0 1.1 0.1 0.1 6.3 5.9 2.7 10.4 8.9 1.9 0.9 4.7 1.4 0.6 0.0 1.0 5.9 1.6 2.7 1.8 1.2 10.2 5.3 2.3 15.7 7.9 0.6 0.0 2.1 20.4 1.4 15.7 0.0 1.6 1.2 0.6 3.5 0.0 5.4 0.4 0.0 13.3 1.8 0.3 26.8 1.1 1.2 3.3 1.0 12.2 3.8 0.7 9.5 0.0 3.4 0.7 0.0 0.3 11.6 1.9 2.4 0.2 0.0 11.4 1.7 ZDHHC5 "DHHC5, KIAA1748, ZNF375" ENSG00000156599 "Zinc finger DHHC-type containing 5" Q9C0B5 11 57667747-57701187 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014670 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA014670: AB_2257442" "unprognostic (1.34e-1)" "unprognostic (3.47e-2)" "unprognostic (2.51e-1)" "unprognostic (2.29e-1)" "unprognostic (5.32e-2)" "unprognostic (1.70e-2)" "unprognostic (9.82e-3)" "unprognostic (1.74e-3)" "unprognostic (4.36e-2)" "unprognostic (9.78e-2)" "prognostic unfavorable (6.74e-5)" "unprognostic (1.76e-1)" "unprognostic (4.72e-3)" "unprognostic (2.16e-1)" "unprognostic (6.80e-2)" "unprognostic (2.06e-2)" "unprognostic (1.74e-3)" 19.6 18.2 6.9 14.2 16.1 13.0 17.3 12.4 19.2 20.0 18.7 14.1 20.9 14.6 19.8 15.9 45.8 16.0 19.1 18.2 8.2 8.1 27.8 24.8 18.7 18.0 8.5 8.2 16.2 21.3 31.4 13.9 31.4 12.8 15.5 18.2 19.1 29.3 18.4 31.3 33.2 25.9 15.2 8.7 21.5 16.3 35.7 7.8 26.4 25.5 23.9 39.1 23.3 26.0 9.4 13.4 15.5 11.3 6.9 13.1 9.0 28.4 31.6 12.4 12.6 27.5 21.2 23.4 26.8 32.1 22.4 16.8 19.1 35.1 19.2 34.8 31.6 19.3 40.3 19.3 31.7 20.0 23.6 8.7 16.3 14.5 17.0 30.8 30.5 27.7 29.8 28.7 33.1 33.7 18.6 25.2 16.2 21.4 24.3 28.3 17.1 17.1 8.5 15.0 21.1 19.0 17.1 25.1 23.7 25.6 42.2 9.0 11.5 24.9 28.2 26.1 17.5 30.2 17.5 29.5 29.1 15.1 30.5 18.6 17.7 21.9 16.5 21.6 15.8 25.2 15.5 8.1 9.8 11.1 10.1 13.1 9.0 10.9 9.4 8.0 9.4 11.0 11.1 10.2 6.9 11.3 13.4 9.8 9.0 6.9 16.1 12.4 19.2 8.2 8.1 8.5 8.2 12.8 7.8 14.9 10.9 5.3 10.2 14.3 17.5 18.1 12.7 14.7 20.5 12.2 35.3 8.5 3.3 13.1 15.8 11.7 31.9 0.0 15.7 8.4 8.5 14.0 19.6 13.2 11.0 12.7 11.1 13.5 16.1 6.8 10.9 12.0 1.7 9.0 16.2 9.6 19.0 19.3 7.1 10.2 45.0 0.0 9.2 6.5 6.6 17.3 15.6 8.7 15.8 15.9 ZDHHC8 "KIAA1292, ZNF378" ENSG00000099904 "Zinc finger DHHC-type containing 8" Q9ULC8 22 20129456-20148007 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003422 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA003422: AB_1080640" "unprognostic (1.00e-2)" "prognostic unfavorable (9.68e-4)" "unprognostic (3.36e-1)" "unprognostic (1.36e-1)" "unprognostic (2.49e-1)" "unprognostic (8.02e-2)" "unprognostic (5.14e-2)" "unprognostic (1.03e-2)" "unprognostic (2.43e-1)" "unprognostic (1.43e-3)" "unprognostic (9.34e-3)" "unprognostic (3.20e-1)" "prognostic unfavorable (4.04e-4)" "unprognostic (1.11e-1)" "unprognostic (1.02e-1)" "unprognostic (9.88e-2)" "unprognostic (9.57e-2)" 20.7 19.2 25.7 16.9 23.0 9.2 23.4 24.4 35.3 14.3 9.9 14.0 17.3 11.6 16.0 10.9 13.9 13.6 14.4 16.0 18.7 10.6 15.2 16.5 14.6 15.4 17.7 17.6 18.0 23.9 17.4 21.0 16.4 19.0 13.4 7.0 17.5 20.4 16.6 20.5 22.2 11.2 13.0 10.4 19.8 15.9 8.4 18.6 8.9 18.5 7.9 11.1 12.9 14.5 2.0 4.1 4.0 1.5 1.3 2.5 0.5 11.5 7.4 11.8 15.5 17.3 10.4 10.6 21.8 14.9 14.8 13.3 3.8 6.0 0.0 9.0 18.1 8.0 15.9 6.2 16.7 7.3 16.6 23.7 5.6 19.4 8.8 14.3 0.0 7.9 18.1 11.3 11.4 9.6 9.1 16.5 8.3 38.6 9.1 13.1 5.6 6.8 15.1 6.0 5.1 11.7 14.6 10.3 4.1 6.4 14.1 19.0 9.6 8.8 4.3 10.4 5.6 0.3 7.9 18.9 33.7 24.7 18.9 9.7 13.2 4.3 4.4 9.9 7.3 9.9 4.0 1.2 0.3 2.5 1.5 1.3 0.8 0.7 1.2 0.4 2.0 1.3 1.8 0.0 1.3 0.8 4.1 2.0 0.5 25.7 23.0 24.4 35.3 18.7 10.6 17.7 17.6 19.0 18.6 3.0 1.9 2.7 3.4 8.0 11.5 6.8 5.1 0.0 3.4 10.4 13.7 3.1 1.7 4.5 0.5 9.0 2.4 0.0 3.8 6.1 8.0 4.0 5.7 7.8 4.2 12.7 4.1 11.6 4.9 1.3 10.0 5.0 5.0 2.8 5.5 8.3 6.2 4.3 13.8 1.9 11.0 6.5 5.5 0.3 2.3 8.5 2.9 2.5 4.8 2.7 ZEB1 "AREB6, BZP, FECD6, NIL-2-A, PPCD3, TCF8, ZEB, Zfhep, Zfhx1a" ENSG00000148516 "Zinc finger E-box binding homeobox 1" P37275 10 31318495-31529814 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 99.5;Early spermatids: 98.1;Endothelial cells: 105.0;Late spermatids: 111.0;Peritubular cells: 95.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 47.1;RH-30: 27.8;TIME: 36.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027524, CAB058686, CAB079943" Enhanced Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "CAB058686: AB_2665569, CAB079943: , HPA027524: AB_1844977" "unprognostic (1.54e-1)" "unprognostic (3.08e-1)" "unprognostic (3.42e-2)" "unprognostic (1.04e-1)" "unprognostic (4.85e-2)" "unprognostic (7.40e-2)" "unprognostic (1.34e-2)" "unprognostic (5.59e-2)" "unprognostic (1.30e-1)" "unprognostic (2.96e-2)" "unprognostic (3.48e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (7.34e-6)" "unprognostic (5.59e-3)" "unprognostic (1.19e-1)" "unprognostic (1.62e-2)" "unprognostic (1.66e-2)" 18.8 7.4 14.4 13.9 14.4 6.1 11.4 15.5 24.1 31.3 31.2 7.1 8.0 4.9 32.9 14.1 17.3 12.0 16.0 27.9 12.9 14.7 5.9 8.1 12.5 7.0 13.7 11.9 11.5 3.4 2.7 9.3 13.3 13.1 20.4 11.0 4.8 5.9 24.2 36.2 5.1 8.3 40.4 20.4 6.6 14.8 7.3 14.9 22.6 8.3 18.7 8.0 53.1 20.7 5.4 3.8 11.5 0.0 7.2 10.2 2.2 0.0 6.1 15.4 15.0 21.6 47.1 0.0 13.4 18.7 2.5 4.9 0.0 0.0 4.3 6.4 16.2 3.6 0.0 6.5 0.0 4.6 8.2 3.2 0.0 3.6 2.7 18.0 3.4 0.1 21.8 0.0 8.0 8.1 8.2 23.7 3.6 3.0 5.7 16.7 0.0 11.9 1.8 0.9 0.0 3.1 4.3 27.8 1.7 4.4 0.0 0.4 5.7 4.6 0.0 0.0 3.0 0.0 2.3 36.2 15.2 3.6 3.4 6.4 2.8 2.3 5.1 4.3 0.0 1.7 5.1 0.0 6.6 3.6 0.0 4.8 5.4 4.5 2.3 1.5 4.7 10.2 4.5 11.5 7.2 0.0 3.8 5.8 2.2 14.4 14.4 15.5 11.9 12.9 14.7 13.7 11.9 13.1 14.9 0.0 11.4 18.0 2.5 10.0 38.8 99.5 2.5 1.4 5.7 1.8 43.2 0.2 0.0 1.8 98.1 105.0 0.0 0.0 2.2 0.4 37.0 2.6 1.1 11.3 1.2 9.5 0.0 44.8 5.3 111.0 28.4 5.0 25.3 17.2 0.0 3.1 1.9 0.0 95.8 1.4 39.7 77.6 47.8 16.3 15.3 7.5 0.6 14.9 0.0 3.7 ZEB2 "KIAA0569, SIP-1, SIP1, ZFHX1B" ENSG00000169554 "Zinc finger E-box binding homeobox 2" O60315 2 144364364-144524583 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation, Epilepsy, Hirschsprung disease, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 76.6" "Cell type enhanced" "Detected in many" 10 "Horizontal cells: 626.1;Kupffer cells: 357.2;Macrophages: 271.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 39.1;THP-1: 46.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003456 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA003456: AB_10603840" "unprognostic (1.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.12e-1)" "unprognostic (2.42e-1)" "unprognostic (4.12e-1)" "unprognostic (4.17e-2)" "unprognostic (3.69e-1)" "unprognostic (3.77e-2)" "unprognostic (5.83e-2)" "unprognostic (7.90e-2)" "unprognostic (1.33e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (6.04e-5)" "unprognostic (1.11e-2)" "unprognostic (1.73e-2)" "unprognostic (7.45e-2)" "unprognostic (1.32e-2)" 30.2 23.7 48.0 27.8 42.4 55.5 16.6 6.7 36.6 29.4 12.3 72.9 3.4 11.3 15.6 11.1 14.4 11.1 22.6 22.5 52.5 28.8 9.9 11.6 20.7 19.6 54.4 26.4 37.5 3.6 5.0 3.1 31.5 37.6 10.9 16.3 15.7 5.7 12.5 9.6 7.7 12.8 17.2 76.6 32.6 9.3 8.2 38.7 1.9 8.3 7.5 12.4 21.5 14.8 5.0 12.7 9.7 21.6 3.6 10.7 7.4 0.4 0.5 22.5 0.0 26.9 13.7 0.0 9.2 9.4 10.4 10.1 0.0 0.2 1.7 0.0 10.0 2.8 0.1 3.8 0.0 13.0 9.6 2.6 39.1 1.6 0.0 6.1 6.7 31.1 11.2 0.2 12.9 6.2 8.8 7.8 0.0 10.9 1.1 12.2 0.0 0.0 20.5 3.2 0.0 0.5 11.5 15.5 0.0 0.1 0.2 0.2 5.9 1.1 0.0 24.3 7.5 0.0 46.5 12.1 12.0 0.2 23.3 2.9 12.7 0.0 1.9 17.9 20.2 32.2 9.7 21.6 5.7 10.7 20.8 1.0 4.4 1.4 5.3 12.7 5.0 1.1 4.0 7.5 3.6 19.5 10.2 0.3 7.4 48.0 42.4 6.7 35.6 52.5 28.8 54.4 26.4 37.6 38.7 6.0 25.8 45.8 1.2 22.0 178.1 50.1 2.5 6.7 18.2 5.2 3.9 1.3 1.7 0.6 2.0 23.8 0.0 23.3 0.7 1.6 146.0 1.5 150.5 2.1 126.8 626.1 0.0 81.0 357.2 4.0 111.7 271.2 97.8 46.9 0.0 84.2 0.2 0.0 62.6 7.3 8.6 181.1 167.0 2.3 7.0 17.1 3.9 99.2 0.0 2.0 ZFAND2B AIRAPL ENSG00000158552 "Zinc finger AN1-type containing 2B" Q8WV99 2 219195237-219209651 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 133.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035159, HPA035160" Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Cytosol" "HPA035159: AB_2674499, HPA035160: AB_10670697" "unprognostic (3.71e-1)" "unprognostic (5.49e-3)" "unprognostic (2.77e-3)" "unprognostic (2.59e-1)" "unprognostic (2.97e-1)" "unprognostic (6.85e-3)" "unprognostic (1.40e-2)" "unprognostic (2.27e-1)" "unprognostic (7.36e-2)" "unprognostic (1.20e-1)" "prognostic favorable (9.38e-4)" "unprognostic (2.05e-2)" "unprognostic (1.44e-1)" "unprognostic (1.69e-3)" "unprognostic (1.32e-1)" "unprognostic (6.21e-2)" "unprognostic (7.02e-2)" 13.4 12.9 16.4 14.6 16.9 23.8 13.5 22.3 24.6 14.8 30.0 20.2 15.9 30.5 15.3 14.2 22.2 13.1 22.2 11.6 16.2 13.3 20.0 28.5 15.2 27.3 18.8 17.9 14.1 29.1 18.6 18.0 22.2 15.6 14.7 18.5 11.3 17.3 14.2 15.9 23.4 34.7 24.5 17.5 22.6 21.8 9.5 13.9 23.0 30.0 12.9 19.3 14.7 16.6 29.1 20.5 36.6 27.8 30.7 32.5 25.4 10.6 7.3 8.3 11.7 8.9 9.4 11.6 10.8 12.7 15.6 15.5 16.3 9.1 8.6 11.5 18.4 12.7 7.4 7.7 13.7 12.5 13.3 12.0 19.8 12.0 14.1 18.2 10.5 22.9 7.7 30.2 15.3 36.6 8.8 10.4 19.1 11.5 24.6 15.2 18.4 17.3 22.1 4.3 14.8 8.4 10.8 5.0 14.8 14.7 9.0 18.2 8.2 5.2 8.8 12.0 9.8 7.5 22.3 11.0 15.7 14.8 18.1 15.3 10.2 3.3 15.5 15.4 20.8 12.2 17.7 21.7 28.6 32.1 27.8 28.0 25.4 29.3 31.3 16.4 29.1 26.7 32.5 36.6 30.7 21.9 20.5 30.2 25.4 16.4 16.9 22.3 24.6 16.2 13.3 18.8 17.9 15.6 13.9 20.8 26.3 36.4 21.1 24.2 13.5 11.1 25.5 8.1 9.1 19.2 13.7 22.5 48.0 34.1 3.4 27.0 133.2 0.0 57.4 20.0 23.7 23.5 32.3 35.5 29.9 7.9 38.6 14.7 29.1 5.5 29.7 26.7 33.7 13.6 57.3 20.9 46.6 94.7 28.0 57.5 14.9 25.8 33.0 5.7 13.0 31.6 42.9 46.7 47.7 24.8 ZFAND3 "FLJ13222, TEX27" ENSG00000156639 "Zinc finger AN1-type containing 3" Q9H8U3 6 37819499-38154624 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 23 "Early spermatids: 795.9;Late spermatids: 2445.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016755 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA016755: AB_1859011" "unprognostic (3.32e-1)" "unprognostic (3.04e-2)" "unprognostic (1.36e-1)" "unprognostic (2.89e-2)" "unprognostic (1.60e-1)" "unprognostic (1.14e-1)" "unprognostic (9.24e-2)" "unprognostic (1.37e-1)" "unprognostic (1.07e-1)" "unprognostic (1.36e-2)" "unprognostic (9.30e-2)" "unprognostic (1.48e-2)" "unprognostic (9.60e-3)" "unprognostic (1.01e-1)" "unprognostic (2.94e-1)" "unprognostic (7.41e-2)" "unprognostic (4.33e-1)" 26.7 27.5 31.0 26.0 31.1 23.9 37.6 26.2 31.4 28.6 27.0 26.6 26.0 24.5 25.9 31.2 22.2 21.4 33.5 30.5 29.9 24.1 31.6 35.6 24.8 26.1 30.4 22.2 23.9 26.1 33.9 31.6 31.4 24.2 23.7 20.2 24.3 20.3 31.0 77.9 19.4 26.9 35.4 33.4 21.9 25.1 60.5 27.3 26.4 32.1 19.7 19.3 30.7 34.0 3.0 4.4 9.2 2.8 2.9 2.6 1.4 17.2 10.7 37.0 26.2 22.4 23.3 12.8 28.9 33.7 26.1 27.9 21.0 10.2 7.2 22.2 30.7 30.6 11.9 14.1 21.3 35.9 27.4 9.0 21.7 5.6 20.0 52.6 9.0 19.0 29.3 28.1 27.5 46.8 32.1 22.5 17.1 10.3 15.3 19.7 14.9 14.1 7.6 11.0 25.6 11.2 14.9 14.9 8.7 24.7 29.5 23.0 20.2 16.2 14.2 49.7 31.4 21.8 19.1 24.5 27.5 20.9 14.7 18.0 14.9 13.5 21.8 10.3 14.3 28.3 0.7 2.7 8.8 2.6 2.8 1.8 1.9 1.9 2.0 1.3 3.0 1.7 2.6 9.2 2.9 2.1 4.4 2.4 1.4 31.0 31.1 26.2 31.4 29.9 24.1 30.4 22.2 24.2 27.3 20.8 8.6 15.7 25.6 24.3 24.2 20.2 20.4 6.7 3.4 45.4 21.6 27.7 63.0 22.6 795.9 23.8 49.2 23.3 25.1 25.5 23.1 42.8 4.7 43.1 29.1 28.6 15.5 24.5 37.3 2445.8 35.9 24.9 13.5 20.8 27.9 32.1 31.8 24.1 51.9 29.5 21.8 32.3 24.0 65.7 37.2 26.3 72.0 21.8 17.2 47.7 ZFAND5 "ZA20D2, ZFAND5A, ZNF216" ENSG00000107372 "Zinc finger AN1-type containing 5" O76080 9 72351425-72365235 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 207.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 83.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018129, HPA077824" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA018129: AB_1859012, HPA077824: " "unprognostic (1.97e-1)" "unprognostic (5.79e-2)" "unprognostic (1.91e-1)" "prognostic favorable (4.43e-4)" "unprognostic (1.53e-1)" "unprognostic (2.24e-1)" "unprognostic (3.39e-3)" "unprognostic (3.81e-2)" "unprognostic (2.12e-1)" "unprognostic (1.39e-1)" "unprognostic (3.34e-1)" "unprognostic (2.47e-1)" "unprognostic (3.90e-2)" "unprognostic (6.85e-2)" "unprognostic (3.92e-2)" "unprognostic (3.86e-2)" "unprognostic (7.03e-2)" 82.5 57.6 26.9 15.5 35.2 36.6 57.1 31.7 34.3 28.6 23.1 20.3 31.4 10.8 25.7 35.5 29.0 27.4 28.7 33.0 24.3 22.6 32.6 56.5 31.6 23.6 24.3 21.1 59.3 20.9 17.0 45.4 22.4 25.1 24.0 15.1 22.4 17.2 52.7 207.5 17.6 15.8 28.4 25.9 24.1 23.2 26.7 21.7 14.6 23.1 29.5 16.5 39.2 29.3 7.0 13.6 15.4 32.1 8.6 6.8 7.8 22.2 22.8 26.9 11.9 34.8 16.6 20.3 26.3 36.7 14.2 11.1 2.8 21.0 12.4 16.0 41.2 20.1 24.9 62.0 10.3 21.3 83.9 9.6 9.8 13.1 13.9 25.7 14.0 14.6 21.7 19.1 14.8 16.6 33.1 25.1 12.0 9.4 16.4 16.6 5.9 18.3 8.0 34.7 20.9 15.9 14.3 14.0 13.1 46.2 21.6 19.7 17.6 16.6 18.3 21.5 29.2 8.1 12.3 19.1 11.8 14.6 20.8 18.0 23.7 20.6 6.5 15.9 9.6 29.2 15.1 13.6 15.4 5.2 21.6 5.7 7.0 6.8 6.6 13.6 6.2 6.3 5.6 12.2 8.6 32.1 2.9 4.8 7.8 26.9 35.2 31.7 34.3 24.3 22.6 24.3 21.1 25.1 21.7 163.8 158.6 37.3 496.3 301.3 88.2 288.5 91.7 88.3 127.4 125.6 70.7 117.4 126.0 118.6 62.4 115.1 102.1 46.7 122.4 145.8 149.1 300.6 109.4 271.5 176.8 38.1 131.1 95.2 243.2 35.2 109.6 177.8 197.4 297.6 71.5 51.7 193.5 79.3 87.7 95.7 65.3 84.1 204.0 123.7 99.9 254.7 189.3 64.8 81.2 398.4 ZFAND6 "AWP1, ZA20D3, ZFAND5B" ENSG00000086666 "Zinc finger AN1-type containing 6" Q6FIF0 15 80059568-80138393 "Predicted intracellular proteins" "Apoptosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034845, HPA052746, HPA077824" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA034845: AB_10671234, HPA052746: , HPA077824: " "unprognostic (2.04e-1)" "unprognostic (2.25e-2)" "unprognostic (3.26e-1)" "unprognostic (2.31e-1)" "unprognostic (1.29e-1)" "unprognostic (3.70e-2)" "unprognostic (4.26e-2)" "unprognostic (1.03e-1)" "unprognostic (4.91e-2)" "unprognostic (1.22e-1)" "unprognostic (1.74e-2)" "unprognostic (6.48e-3)" "unprognostic (4.90e-3)" "unprognostic (1.22e-1)" "unprognostic (1.45e-1)" "unprognostic (1.55e-1)" "prognostic favorable (8.20e-4)" 34.3 33.9 22.8 28.5 20.9 26.3 39.7 23.7 20.1 22.2 26.0 16.1 21.3 20.5 28.7 33.3 30.9 21.6 21.7 33.9 23.0 22.2 33.0 55.0 27.1 34.2 22.3 17.2 22.8 22.3 22.9 27.1 33.6 21.2 24.1 23.7 23.9 23.5 20.7 55.2 19.8 33.7 33.1 29.0 34.4 22.1 56.0 21.9 25.0 47.2 28.7 30.1 27.5 19.5 44.9 20.2 79.2 31.1 15.5 21.0 23.6 20.3 42.3 31.5 18.0 32.5 25.9 30.0 24.3 33.9 21.3 29.2 14.8 35.7 22.6 31.6 24.8 20.8 16.7 33.4 24.3 22.8 13.7 28.9 54.1 20.2 20.9 38.1 19.2 35.8 22.9 31.9 23.5 32.0 29.4 31.9 19.7 21.5 17.9 23.2 21.5 15.1 19.1 19.7 18.3 14.3 12.5 27.9 51.5 52.8 34.2 6.5 18.7 20.9 24.3 61.4 40.9 23.9 27.9 29.4 22.4 18.3 14.4 23.5 24.0 47.0 26.5 23.3 33.4 15.6 79.2 17.6 54.6 19.7 22.8 17.1 44.9 18.0 18.9 20.2 29.6 19.0 21.0 42.7 15.5 31.1 17.5 17.2 23.6 22.8 20.9 23.7 20.1 23.0 22.2 22.3 17.2 21.2 21.9 50.6 65.5 114.2 120.6 132.8 41.4 77.8 94.3 120.5 39.8 71.5 39.3 106.7 169.1 90.4 449.7 71.9 71.9 93.5 86.9 109.2 74.4 154.0 101.7 120.4 124.0 30.2 79.3 74.3 105.4 383.1 49.2 110.5 118.1 216.4 74.2 71.0 95.0 87.7 59.1 180.4 74.0 90.5 76.2 235.8 150.3 148.0 328.5 96.4 55.7 161.1 ZFAT "KIAA1485, ZFAT1, ZNF406" ENSG00000066827 "Zinc finger and AT-hook domain containing" Q9P243 8 134477788-134713049 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 68.8" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 57.3;Early spermatids: 44.4;Late spermatids: 36.0;Syncytiotrophoblasts: 106.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "plasmacytoid DC: 22.1" "Lineage enriched" "Detected in single" 25 "dendritic cells: 22.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020989, HPA063592" Enhanced Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA020989: AB_2670552, HPA063592: AB_2685051" "unprognostic (2.00e-1)" "unprognostic (1.45e-1)" "unprognostic (4.62e-3)" "unprognostic (5.91e-3)" "unprognostic (2.45e-1)" "unprognostic (5.12e-2)" "unprognostic (1.31e-4)" "unprognostic (6.27e-2)" "unprognostic (2.68e-2)" "unprognostic (1.28e-1)" "unprognostic (2.43e-2)" "unprognostic (1.13e-1)" "unprognostic (1.90e-2)" "unprognostic (1.80e-1)" "unprognostic (2.24e-1)" "unprognostic (7.08e-3)" "unprognostic (1.33e-1)" 4.5 2.9 4.2 3.5 4.2 1.7 5.0 6.8 4.5 3.0 7.8 2.6 2.8 3.2 5.0 3.1 4.2 3.3 2.4 3.8 3.0 1.7 12.4 2.8 4.1 4.5 2.5 2.8 3.3 3.3 3.7 4.6 68.8 2.9 3.9 2.6 4.3 3.7 4.2 8.5 3.4 3.8 3.9 2.0 4.4 3.6 3.5 3.0 4.8 3.3 2.8 4.0 6.0 5.3 0.6 22.1 0.8 0.5 0.0 0.5 0.5 5.7 9.0 3.3 4.1 6.4 6.4 2.8 6.2 5.5 5.8 5.8 6.2 7.2 6.4 5.5 6.4 3.4 4.4 6.6 7.8 7.4 5.4 8.8 12.0 9.2 4.6 5.0 6.7 5.9 5.4 4.0 6.4 8.2 5.2 7.0 2.4 4.5 12.0 4.8 7.4 6.9 0.8 4.6 5.8 5.9 4.3 4.3 2.7 5.4 8.6 3.7 3.1 6.4 4.9 5.2 3.9 4.1 6.4 7.6 3.4 5.0 4.8 7.0 4.4 5.8 6.4 4.3 5.0 6.4 0.7 0.3 0.8 0.3 0.5 0.3 0.6 0.2 0.5 0.3 0.6 0.4 0.2 0.7 0.0 0.3 22.1 0.1 0.5 4.2 4.2 6.8 4.5 3.0 1.7 2.5 2.8 2.9 3.0 3.0 3.5 6.0 1.2 1.3 3.6 1.6 0.0 0.0 3.4 1.8 3.9 57.3 0.0 2.0 44.4 1.1 1.1 0.0 1.3 13.9 2.4 1.2 2.3 1.0 7.1 1.6 0.0 0.6 2.4 36.0 3.1 2.0 8.5 3.6 1.3 2.6 2.9 0.0 2.5 9.2 5.9 0.0 1.6 2.9 5.5 1.5 106.0 1.3 1.1 1.1 ZFC3H1 "CCDC131, CSRC2, KIAA0546, MGC23401, PSRC2" ENSG00000133858 "Zinc finger C3H1-type containing" O60293 12 71609472-71667725 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007072, HPA007151" Enhanced Approved "Nucleoplasm,Intermediate filaments" NA NA Nucleoplasm "Intermediate filaments" "HPA007072: AB_1846134, HPA007151: AB_1846133" "unprognostic (3.90e-3)" "unprognostic (3.69e-1)" "unprognostic (2.78e-1)" "unprognostic (2.15e-2)" "unprognostic (9.44e-2)" "unprognostic (6.14e-2)" "prognostic unfavorable (3.63e-4)" "unprognostic (1.00e-1)" "unprognostic (1.15e-1)" "unprognostic (6.56e-2)" "unprognostic (3.80e-2)" "unprognostic (2.53e-3)" "prognostic unfavorable (1.48e-5)" "unprognostic (1.46e-1)" "unprognostic (1.31e-1)" "unprognostic (1.85e-1)" "unprognostic (4.07e-3)" 12.1 12.8 17.6 19.1 17.4 22.7 12.9 35.3 23.8 15.4 16.9 6.7 14.6 8.0 13.7 17.3 15.1 12.8 12.7 12.1 14.6 7.7 10.7 8.0 16.4 19.1 14.8 12.3 17.1 11.6 17.6 17.6 14.6 14.9 12.6 13.2 6.7 12.0 14.2 11.6 12.2 15.2 12.4 14.7 15.9 13.5 17.5 17.6 16.8 13.5 8.4 17.1 15.7 20.8 14.8 12.7 29.7 10.3 4.2 7.2 1.1 10.4 10.6 7.7 5.3 10.7 19.1 4.6 8.2 13.2 13.0 12.9 9.8 5.8 13.5 4.7 10.1 5.3 11.3 10.9 4.8 17.3 13.7 8.0 13.2 16.4 4.5 6.0 14.4 6.5 10.6 10.4 9.1 3.9 16.7 13.0 11.1 12.2 6.0 11.9 3.2 10.1 5.0 7.7 4.9 6.1 8.8 9.4 10.4 9.8 7.7 5.3 4.8 8.3 5.3 5.4 8.7 14.2 9.5 9.8 7.3 5.0 4.2 4.1 10.4 6.3 10.5 8.5 10.1 5.1 20.7 10.3 12.1 7.2 4.8 5.5 9.2 6.2 4.6 3.9 14.8 5.8 4.9 29.7 4.2 8.7 12.7 4.9 1.1 17.6 17.4 35.3 23.8 14.6 7.7 14.8 12.3 14.9 17.6 32.8 23.8 26.2 48.6 42.6 31.6 15.1 5.1 21.4 34.2 14.0 21.6 11.9 1.7 17.8 75.9 28.7 28.5 0.0 14.5 12.8 33.8 39.6 47.4 9.8 15.6 55.6 20.1 20.9 18.0 52.4 29.7 35.1 10.1 27.1 23.4 18.9 21.4 35.1 21.5 5.8 31.7 25.8 25.5 29.6 25.8 35.8 9.6 24.9 21.5 64.9 ZFHX2 "KIAA1056, KIAA1762, ZFH-5, ZNF409" ENSG00000136367 "Zinc finger homeobox 2" Q9C0A1 14 23520855-23556192 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.5;testis: 17.9" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 30.6;Late spermatids: 13.8;Spermatocytes: 19.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 8.1;SuSa: 6.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000720, HPA005146" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" Yes No "Nucleoli fibrillar center" Nucleoplasm "HPA000720: AB_10603462, HPA005146: AB_1859250" "unprognostic (7.54e-3)" "unprognostic (2.01e-1)" "unprognostic (1.53e-1)" "unprognostic (2.53e-1)" "unprognostic (2.61e-1)" "unprognostic (6.12e-3)" "unprognostic (1.40e-1)" "unprognostic (5.40e-2)" "unprognostic (3.94e-2)" "unprognostic (3.71e-2)" "unprognostic (5.08e-4)" "unprognostic (2.39e-1)" "unprognostic (5.33e-3)" "unprognostic (3.75e-1)" "unprognostic (7.35e-2)" "unprognostic (1.76e-1)" "unprognostic (1.90e-2)" 1.7 2.6 5.1 1.9 5.8 0.9 1.7 15.5 12.4 1.7 1.6 3.9 1.2 1.1 1.9 2.0 1.2 6.6 1.9 1.2 6.8 4.9 3.0 1.1 2.1 1.5 4.5 6.3 2.0 1.9 7.4 8.1 1.2 5.4 2.0 1.2 1.6 1.8 4.0 2.3 2.1 1.2 2.4 3.2 1.1 1.8 17.9 6.1 0.0 2.1 0.0 1.4 1.8 0.7 0.3 0.5 2.3 0.4 0.0 0.9 0.0 0.2 5.1 4.1 8.1 2.8 0.4 0.3 1.1 0.4 0.6 2.1 0.5 0.4 0.3 0.5 0.1 0.5 0.1 2.1 0.3 0.9 3.6 1.3 4.1 0.0 1.0 0.4 0.7 3.0 0.6 0.1 0.8 0.3 2.2 0.5 3.6 0.6 0.7 0.1 1.4 0.5 0.5 5.0 0.6 1.2 2.2 0.1 0.0 2.2 1.9 4.5 2.9 0.7 1.1 0.3 6.6 1.7 1.0 0.1 0.0 2.1 1.3 0.5 0.5 1.6 0.2 0.1 0.3 0.2 0.0 0.4 0.0 0.1 0.3 0.9 0.0 0.0 0.2 0.5 0.3 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 5.1 5.8 15.5 12.4 6.8 4.9 4.5 6.3 5.4 6.1 0.0 0.6 0.0 0.4 0.1 9.0 2.0 0.0 6.7 3.4 1.8 0.0 0.2 1.7 2.8 30.6 0.6 0.0 0.0 2.1 0.0 0.8 1.2 0.0 0.0 0.8 7.9 6.4 0.6 0.6 13.8 0.6 0.7 0.0 1.8 0.7 3.9 1.3 0.0 0.4 1.0 3.2 0.0 0.2 19.2 1.1 0.0 0.2 0.0 0.6 0.1 ZFHX3 "ATBF1, ZNF927" ENSG00000140836 "Zinc finger homeobox 3" Q15911 16 72782885-73891871 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Myogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Smooth muscle cells: 198.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059353 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA059353: AB_2683987" "prognostic unfavorable (1.55e-4)" "unprognostic (3.57e-2)" "unprognostic (1.68e-1)" "unprognostic (2.03e-2)" "unprognostic (2.81e-2)" "unprognostic (3.12e-1)" "unprognostic (4.24e-2)" "unprognostic (6.36e-2)" "unprognostic (9.94e-3)" "unprognostic (2.85e-1)" "unprognostic (1.06e-1)" "unprognostic (4.16e-2)" "prognostic favorable (1.37e-5)" "unprognostic (6.76e-2)" "unprognostic (1.10e-1)" "unprognostic (2.11e-1)" "unprognostic (2.15e-2)" 7.9 6.0 2.5 2.3 4.6 1.1 11.3 1.5 4.1 7.5 7.7 5.4 14.5 2.0 7.4 7.3 4.5 4.9 18.2 4.9 4.3 4.8 4.4 6.5 6.1 1.4 4.0 2.6 4.4 5.7 23.8 6.3 8.1 5.5 12.0 3.5 10.5 5.0 19.5 16.9 3.6 3.6 15.5 9.7 3.9 5.0 2.3 5.2 0.5 10.8 4.0 1.0 16.7 14.7 0.8 1.0 0.2 1.6 2.5 0.1 0.2 4.4 7.9 12.9 10.7 4.8 6.1 13.3 3.4 3.7 2.2 2.5 9.0 2.5 1.9 6.0 6.4 3.0 3.1 8.1 4.0 3.0 7.8 2.0 0.3 10.8 12.8 4.4 1.3 3.2 2.2 2.4 6.4 5.8 2.0 4.1 0.9 0.9 0.5 5.4 9.2 0.4 2.6 2.3 2.3 1.3 5.9 3.5 0.6 3.5 7.5 9.6 3.4 6.0 1.9 4.3 6.2 2.6 0.6 8.8 5.4 6.4 5.7 4.5 4.9 1.6 1.4 2.6 1.2 4.1 0.2 1.6 0.2 0.1 0.9 0.1 0.5 0.0 0.0 0.7 0.8 0.0 0.1 0.2 2.5 1.1 1.0 0.1 0.2 2.5 4.6 1.5 4.1 4.3 4.8 4.0 2.6 5.5 5.2 65.5 26.1 8.1 52.4 15.0 87.0 16.5 43.3 32.1 48.9 45.4 21.6 35.9 5.0 23.2 1.9 28.2 6.0 0.0 20.2 18.1 50.1 96.3 20.7 30.0 55.1 22.3 25.8 42.4 67.6 1.3 9.8 55.4 20.3 24.4 18.0 18.0 20.8 21.0 18.7 6.1 31.2 122.9 198.8 3.4 17.7 15.1 51.9 3.2 29.3 41.2 ZFHX4 "FLJ20980, ZFH4" ENSG00000091656 "Zinc finger homeobox 4" Q86UP3 8 76681219-76867285 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 29.1" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 75.7;Cholangiocytes: 48.4;Early spermatids: 49.4;Hepatocytes: 24.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HSkMC: 13.1;TIME: 28.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023837 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA023837: AB_1859013" "unprognostic (2.00e-1)" "unprognostic (8.19e-2)" "unprognostic (2.63e-3)" "unprognostic (6.14e-8)" "unprognostic (3.81e-1)" "unprognostic (1.17e-1)" "unprognostic (7.61e-2)" "unprognostic (2.61e-2)" "unprognostic (3.79e-2)" "unprognostic (9.15e-4)" "unprognostic (3.18e-2)" "unprognostic (1.17e-3)" "unprognostic (6.20e-7)" "unprognostic (3.50e-3)" "unprognostic (2.51e-1)" "unprognostic (4.50e-4)" "unprognostic (5.89e-4)" 4.9 8.8 6.2 2.1 10.7 0.8 5.8 1.4 8.5 6.3 5.1 7.7 14.1 1.0 2.2 8.9 1.7 2.0 2.9 1.5 7.2 4.3 1.6 7.3 1.1 1.5 8.3 4.3 5.5 1.5 1.2 13.7 1.1 5.9 3.2 2.0 8.0 1.6 29.1 6.5 1.4 1.3 11.8 11.6 1.2 2.0 15.6 9.8 0.0 1.2 2.4 1.0 7.8 5.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.3 2.5 0.0 4.9 6.4 0.0 2.1 3.0 2.4 2.6 0.0 0.0 0.0 4.0 3.5 1.2 0.2 4.9 0.6 4.5 0.0 7.2 0.1 0.0 0.0 1.3 0.0 0.3 13.1 0.2 6.4 2.6 4.5 0.4 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.4 0.2 4.2 0.0 4.4 0.0 3.9 0.0 0.0 4.6 0.0 0.5 0.0 0.0 0.6 0.0 28.6 2.5 3.8 7.2 4.8 7.4 0.7 0.0 1.1 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 10.7 1.4 8.5 7.2 4.3 8.3 4.3 5.9 9.8 0.0 1.0 0.0 0.0 0.5 75.7 3.2 48.4 0.0 0.0 5.2 2.0 0.0 0.0 0.0 49.4 0.9 0.0 0.0 0.0 0.0 4.7 0.2 0.0 24.6 0.3 4.8 0.0 1.8 0.3 17.6 12.7 1.1 0.0 0.0 0.0 19.8 0.0 0.0 20.1 0.0 5.3 0.0 1.6 8.6 1.5 1.0 0.0 0.0 0.0 0.6 ZFP1 "FLJ34243, ZNF475" ENSG00000184517 "ZFP1 zinc finger protein" Q6P2D0 16 75148492-75172236 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 17.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 23.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044916, HPA062910" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA044916: AB_2679144, HPA062910: AB_2684902" "unprognostic (1.39e-2)" "unprognostic (1.84e-1)" "unprognostic (1.36e-2)" "unprognostic (1.38e-1)" "prognostic favorable (4.24e-5)" "unprognostic (1.36e-2)" "unprognostic (4.34e-2)" "unprognostic (2.99e-1)" "unprognostic (1.50e-1)" "unprognostic (4.43e-2)" "unprognostic (1.20e-1)" "unprognostic (1.13e-2)" "unprognostic (1.24e-3)" "prognostic unfavorable (9.80e-4)" "unprognostic (5.55e-1)" "unprognostic (6.64e-2)" "unprognostic (2.08e-1)" 6.0 5.9 13.7 4.6 14.8 4.1 7.4 14.8 19.0 8.6 6.6 8.9 5.9 4.2 9.1 5.6 5.2 7.1 6.6 7.1 12.8 9.9 7.8 23.2 6.1 6.7 10.2 10.0 11.4 4.9 11.9 7.1 7.1 12.8 6.7 5.0 5.0 3.6 7.8 7.4 4.8 4.0 9.5 10.7 5.1 4.5 7.6 9.4 18.1 11.6 3.7 7.4 6.8 5.0 3.6 1.9 3.0 3.2 4.4 4.7 2.2 2.5 5.3 7.4 6.8 4.2 5.7 3.0 3.1 3.6 7.0 8.4 4.3 1.9 10.7 3.5 2.5 2.7 3.3 6.8 4.5 7.8 5.6 4.3 3.8 2.0 3.1 3.8 3.7 12.5 3.9 4.4 4.9 6.5 7.0 4.5 10.1 4.6 2.3 5.0 9.7 13.0 3.5 2.4 2.0 2.1 12.2 3.3 3.4 2.9 2.1 7.7 6.0 7.8 2.2 2.8 2.0 5.0 3.0 3.1 6.4 6.7 2.9 3.4 9.5 9.0 23.9 3.0 5.2 4.7 3.0 1.7 0.7 4.3 3.2 4.6 3.4 2.9 4.7 1.9 3.6 3.9 4.1 0.1 4.4 1.4 0.8 4.4 2.2 13.7 14.8 14.8 19.0 12.8 9.9 10.2 10.0 12.8 9.4 6.0 3.7 2.4 2.0 4.7 4.6 3.1 2.5 2.7 2.3 1.8 0.0 2.3 1.7 2.9 3.5 3.9 0.4 0.0 1.9 2.1 4.7 1.4 1.1 10.6 1.8 12.7 6.9 2.5 4.6 4.3 3.1 1.6 1.7 2.8 0.9 6.5 1.6 0.0 3.9 3.4 2.9 0.0 6.1 17.0 8.2 5.1 3.4 4.5 1.7 2.0 ZFP28 "KIAA1431, mkr5" ENSG00000196867 "ZFP28 zinc finger protein" Q8NHY6 19 56538948-56556810 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028879 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA028879: AB_10603841" "unprognostic (5.02e-3)" "unprognostic (3.67e-3)" "unprognostic (1.78e-1)" "unprognostic (1.90e-1)" "unprognostic (1.89e-1)" "unprognostic (4.24e-3)" "unprognostic (1.73e-1)" "unprognostic (7.00e-2)" "unprognostic (4.26e-3)" "unprognostic (3.16e-2)" "unprognostic (3.32e-4)" "unprognostic (1.15e-3)" "unprognostic (2.36e-5)" "unprognostic (6.77e-3)" "unprognostic (1.53e-1)" "unprognostic (1.07e-1)" "unprognostic (1.34e-1)" 3.1 3.6 4.9 1.4 4.1 0.4 3.7 6.1 7.0 3.4 2.5 1.1 5.6 4.2 2.3 3.1 3.2 3.6 5.4 5.7 3.1 0.1 3.5 1.6 5.0 10.1 2.5 6.1 4.0 2.9 4.3 1.6 2.3 4.0 1.9 2.7 1.2 4.4 5.5 2.8 2.1 5.1 4.0 1.8 2.8 2.5 3.1 1.5 3.9 0.5 2.4 3.7 0.9 0.0 1.7 7.9 2.4 2.7 2.6 4.1 5.1 4.9 4.1 6.8 0.0 1.1 0.0 2.6 6.1 8.0 0.2 3.8 1.7 6.3 0.0 6.6 5.2 0.2 0.0 7.6 0.2 6.0 7.1 2.2 6.2 0.1 8.2 0.8 2.8 1.0 0.1 5.3 0.0 2.6 0.9 3.6 0.0 1.7 4.0 10.2 0.0 5.5 3.3 0.0 7.2 0.0 0.3 1.2 7.5 3.0 5.2 1.9 3.8 4.2 0.4 6.2 0.1 0.2 0.4 0.1 0.1 0.4 0.0 0.5 3.9 0.5 0.3 2.6 1.9 2.6 1.8 1.1 3.1 2.1 1.6 0.5 2.4 0.4 1.5 3.7 0.9 8.9 2.2 0.0 2.2 5.0 7.8 3.9 0.0 2.7 2.3 5.2 3.9 0.8 6.6 2.4 2.4 3.7 0.2 0.0 0.7 0.6 2.4 2.3 3.5 0.4 0.7 9.5 2.4 2.5 0.0 1.4 3.7 1.3 5.0 1.8 0.3 5.6 1.0 1.5 4.6 2.3 5.4 0.0 4.1 3.8 5.3 3.3 0.6 1.0 0.9 1.3 ZFP3 "FLJ30726, ZNF752" ENSG00000180787 "ZFP3 zinc finger protein" Q96NJ6 17 5078248-5096374 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 13.4;Cone photoreceptor cells: 7.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 7.5;SH-SY5Y: 7.7;SiHa: 7.0" "Low region specificity" "Detected in all" "HPA053085, HPA057290" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA053085: AB_2682039, HPA057290: AB_2683400" "unprognostic (3.71e-2)" "prognostic favorable (5.68e-4)" "unprognostic (1.45e-1)" "unprognostic (4.88e-2)" "unprognostic (1.55e-1)" "unprognostic (4.32e-4)" "unprognostic (3.05e-1)" "prognostic favorable (1.38e-4)" "unprognostic (5.42e-2)" "unprognostic (3.33e-1)" "prognostic favorable (1.07e-4)" "unprognostic (4.89e-2)" "prognostic favorable (7.69e-7)" "unprognostic (8.30e-2)" "unprognostic (1.16e-1)" "unprognostic (6.32e-2)" "unprognostic (3.29e-3)" 4.9 6.3 11.0 10.0 10.4 1.9 8.9 19.6 14.7 6.8 8.9 11.9 9.6 13.0 6.9 6.9 6.7 11.2 6.3 12.4 9.8 7.6 10.2 3.3 7.3 9.2 7.9 8.3 9.9 11.3 16.6 10.8 5.2 11.4 7.9 10.9 7.4 10.7 15.4 33.3 6.7 11.3 6.3 8.5 10.2 8.3 9.9 11.8 10.6 11.1 3.5 11.2 6.6 5.7 5.4 1.4 1.4 2.2 1.9 4.3 1.6 0.0 1.3 0.3 0.0 1.2 0.6 0.0 2.8 0.0 2.2 2.5 5.6 2.6 0.0 4.0 2.8 1.0 5.7 0.0 0.0 1.2 0.0 0.1 0.2 2.1 0.0 3.9 0.0 7.5 2.0 0.0 1.5 0.0 0.0 0.7 0.2 0.0 0.1 0.4 0.0 0.1 0.2 0.3 4.0 0.6 0.0 0.8 1.8 3.5 3.4 3.6 7.7 7.0 5.8 3.6 1.3 3.5 5.5 0.0 0.0 1.2 2.0 4.0 0.1 0.2 0.0 0.0 0.0 3.2 0.0 2.0 1.4 2.8 2.2 1.7 2.1 1.6 2.5 1.4 5.4 4.3 3.0 0.2 1.9 1.9 0.9 1.6 1.6 11.0 10.4 19.6 14.7 9.8 7.6 7.9 8.3 11.4 11.8 0.0 3.4 0.0 0.4 0.2 3.9 6.3 0.0 13.4 2.3 1.8 7.9 1.0 0.0 1.3 0.4 1.6 2.1 0.0 1.0 0.3 0.9 0.4 1.1 0.0 1.4 3.2 0.0 5.5 1.2 0.0 1.4 1.2 0.0 0.0 1.7 3.2 0.4 0.0 1.1 1.1 6.0 0.0 0.5 6.6 4.3 0.1 0.7 0.0 2.5 0.4 ZFP37 ZNF906 ENSG00000136866 "ZFP37 zinc finger protein" Q9Y6Q3 9 113038380-113056759 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049112 Uncertain Approved Nucleoplasm,Vesicles Yes No "Nucleoplasm, Vesicles" "HPA049112: AB_2680637" "unprognostic (3.18e-1)" "unprognostic (9.57e-2)" "unprognostic (5.62e-2)" "unprognostic (3.54e-3)" "prognostic favorable (1.96e-4)" "unprognostic (7.84e-2)" "unprognostic (8.09e-2)" "unprognostic (2.70e-3)" "unprognostic (1.47e-1)" "unprognostic (2.53e-2)" "unprognostic (2.51e-2)" "unprognostic (1.38e-3)" "unprognostic (4.22e-2)" "unprognostic (9.46e-2)" "unprognostic (3.67e-1)" "unprognostic (4.86e-1)" "unprognostic (2.07e-1)" 3.8 4.4 4.9 3.1 19.2 0.9 6.7 10.9 9.9 6.5 3.6 5.3 4.0 2.1 10.5 5.8 3.2 6.3 3.5 3.7 10.5 5.6 5.8 1.7 3.2 2.8 6.7 10.6 17.0 3.2 4.3 8.5 3.2 10.7 6.3 2.9 2.8 3.2 4.8 3.2 3.2 2.5 6.2 9.1 4.7 3.0 5.1 5.9 0.4 6.9 2.4 3.2 4.3 5.6 2.3 0.9 0.2 0.4 1.3 5.6 0.7 0.6 1.8 7.7 6.4 4.3 8.3 3.9 2.4 3.6 2.7 2.3 0.0 1.8 4.3 1.9 2.5 3.5 1.6 0.0 0.9 4.2 5.3 0.9 0.2 3.8 2.0 2.3 0.0 0.9 2.3 0.8 3.2 6.3 6.6 1.5 0.0 0.4 3.8 5.6 0.0 0.0 0.0 7.9 4.6 0.0 0.0 10.7 0.6 2.0 0.0 6.6 6.2 7.5 1.6 1.4 4.0 6.3 0.0 0.6 6.3 2.8 7.3 3.6 1.5 2.9 0.0 4.8 0.1 3.8 0.2 0.1 0.1 2.5 0.4 1.9 2.3 2.2 2.2 0.9 1.1 1.8 2.5 0.2 1.3 0.0 0.1 5.6 0.7 4.9 19.2 10.9 9.9 10.5 5.6 6.7 10.6 10.7 5.9 0.0 0.3 0.0 0.8 0.2 10.6 2.0 0.0 0.0 0.0 0.0 5.9 0.7 3.3 1.2 0.6 2.2 0.0 0.0 0.8 1.3 2.1 0.4 5.7 1.1 0.4 6.4 1.2 1.3 0.0 0.0 2.0 0.4 0.0 0.0 0.1 3.1 0.2 0.2 2.1 2.2 5.2 6.5 1.5 5.6 4.1 0.0 0.1 0.5 0.1 0.4 ZFP41 "FLJ00028, FLJ38705, ZNF753" ENSG00000181638 "ZFP41 zinc finger protein" 8 143246821-143262705 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 7.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA047232, HPA056268" Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Plasma membrane" "HPA047232: , HPA056268: AB_2683082" "unprognostic (9.16e-2)" "unprognostic (1.49e-1)" "unprognostic (1.07e-1)" "unprognostic (1.47e-2)" "unprognostic (1.10e-1)" "unprognostic (1.45e-2)" "prognostic unfavorable (3.46e-5)" "unprognostic (4.92e-2)" "unprognostic (7.18e-2)" "unprognostic (3.53e-2)" "unprognostic (4.16e-3)" "unprognostic (2.98e-1)" "unprognostic (1.55e-2)" "unprognostic (6.89e-2)" "unprognostic (1.59e-1)" "unprognostic (3.44e-2)" "unprognostic (3.20e-1)" 7.8 6.6 10.3 6.5 9.0 4.1 5.6 12.6 13.7 8.0 8.8 10.7 6.5 9.4 12.5 6.8 5.7 9.2 5.6 6.3 10.8 14.3 6.5 5.8 6.3 6.7 10.7 7.4 13.1 9.1 11.4 10.2 3.5 9.6 7.7 4.5 8.9 12.6 9.1 8.1 12.1 9.1 7.3 7.4 8.5 7.2 10.6 8.6 4.6 8.0 4.6 6.7 6.7 10.0 0.9 3.7 0.1 0.9 0.7 2.2 0.8 7.1 11.4 5.0 6.6 5.8 4.5 5.9 4.3 2.4 8.5 5.8 5.6 6.0 4.0 6.5 5.6 8.7 5.9 5.4 5.7 4.2 6.3 6.6 5.0 5.5 4.4 8.1 2.0 3.1 4.7 8.1 5.5 8.1 5.9 4.0 2.9 10.6 3.9 4.0 12.8 5.3 2.2 7.4 8.8 11.3 2.8 4.1 1.4 3.7 6.5 6.3 8.7 12.2 3.4 6.4 4.5 8.5 3.9 4.2 6.5 11.6 5.0 6.9 6.3 4.8 1.9 5.7 4.8 8.4 0.0 0.6 0.1 1.3 0.9 2.2 0.4 1.1 0.9 0.5 0.9 1.9 1.2 0.0 0.7 0.1 3.7 0.9 0.8 10.3 9.0 12.6 13.7 10.8 14.3 10.7 7.4 9.6 8.6 0.0 1.3 1.3 0.6 1.0 1.4 2.8 2.5 4.0 1.2 3.5 5.9 0.2 1.7 1.6 1.3 0.7 2.7 0.0 0.8 0.9 1.1 0.4 0.0 3.9 1.0 6.4 2.9 1.8 2.2 1.4 1.1 0.9 1.7 0.0 3.2 2.7 1.2 4.3 2.1 1.1 2.2 0.0 1.1 7.7 3.4 0.3 0.2 0.0 2.9 0.3 ZFP62 "FLJ34231, ZET, ZNF755" ENSG00000196670 "ZFP62 zinc finger protein" Q8NB50 5 180847611-180861285 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048629 Approved Approved "Nucleoplasm,Actin filaments" NA NA "Nucleoplasm, Actin filaments" "HPA048629: AB_2680467" "unprognostic (2.77e-2)" "unprognostic (1.77e-1)" "unprognostic (9.18e-2)" "unprognostic (1.04e-1)" "unprognostic (1.08e-1)" "unprognostic (1.98e-1)" "unprognostic (1.89e-2)" "unprognostic (9.49e-2)" "unprognostic (7.11e-3)" "unprognostic (7.29e-2)" "unprognostic (3.44e-2)" "unprognostic (1.05e-2)" "unprognostic (2.14e-1)" "unprognostic (4.34e-2)" "unprognostic (1.97e-1)" "unprognostic (4.33e-2)" "unprognostic (2.29e-3)" 10.9 8.6 17.2 16.0 20.2 4.0 14.4 19.9 16.5 14.3 14.5 11.9 15.1 13.7 15.6 16.4 15.1 16.8 13.2 9.7 17.6 9.5 11.9 8.3 10.4 17.7 18.3 12.8 22.5 15.2 18.9 16.3 10.1 16.4 15.1 18.4 10.1 15.6 18.5 14.5 16.0 15.5 18.8 15.7 13.4 16.3 8.8 22.1 26.9 25.4 10.5 20.0 16.0 14.8 7.0 3.8 7.7 4.9 4.8 10.3 4.2 7.9 5.9 12.8 16.5 9.4 8.4 15.8 8.1 6.2 6.8 9.4 14.4 19.9 19.6 13.1 3.7 7.8 11.9 6.1 14.5 10.2 33.4 11.3 11.0 15.9 4.8 6.4 10.0 6.6 6.5 11.6 6.9 11.9 10.4 6.0 11.7 9.1 10.8 9.2 18.7 14.4 5.5 9.0 7.2 14.4 12.8 13.1 10.9 5.6 14.4 16.9 11.8 11.9 9.0 8.8 9.4 13.8 9.0 8.6 10.4 9.1 5.0 8.2 11.4 13.0 9.8 8.6 13.5 8.1 7.7 3.2 3.9 4.0 4.3 7.8 6.9 5.5 5.8 3.4 7.0 10.3 8.6 1.5 4.8 4.9 3.8 5.6 4.2 17.2 20.2 19.9 16.5 17.6 9.5 18.3 12.8 16.4 22.1 8.9 11.2 13.8 7.6 6.4 8.3 8.1 5.1 4.0 5.7 0.0 2.0 5.5 13.3 8.5 17.8 8.4 10.9 23.3 14.2 5.8 3.7 6.8 8.1 4.3 5.6 1.6 9.9 9.8 7.9 25.0 15.8 3.3 5.0 6.4 15.8 10.0 12.1 3.5 11.0 7.7 13.3 12.9 6.1 24.7 13.6 4.1 4.7 8.5 15.7 7.4 ZFP64 "dJ548G19.1, dJ831D17.1, FLJ10734, FLJ12628, ZNF338" ENSG00000020256 "ZFP64 zinc finger protein" "Q9NPA5, Q9NTW7" 20 52051663-52204308 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035112, HPA058387" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA035112: AB_10672859, HPA058387: AB_2683702" "unprognostic (3.86e-2)" "unprognostic (8.84e-2)" "unprognostic (2.34e-1)" "unprognostic (4.61e-3)" "unprognostic (9.22e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (9.86e-7)" "unprognostic (4.68e-2)" "unprognostic (5.49e-2)" "unprognostic (3.35e-1)" "unprognostic (1.66e-1)" "unprognostic (1.03e-1)" "unprognostic (1.35e-3)" "unprognostic (2.22e-2)" "unprognostic (2.30e-1)" "unprognostic (2.29e-1)" "unprognostic (1.38e-2)" 9.4 12.1 11.5 10.6 14.5 9.7 10.1 11.6 18.7 12.7 13.2 14.5 12.6 13.3 14.4 9.7 16.3 13.9 15.0 9.4 10.5 10.3 10.9 11.8 9.1 12.1 10.2 11.9 16.7 10.9 14.8 11.5 8.8 11.6 16.5 11.5 15.1 13.7 12.3 9.4 22.3 13.0 11.0 11.1 11.6 11.9 12.8 9.2 22.9 14.3 12.5 16.7 13.6 13.6 8.6 6.7 12.4 6.6 7.8 7.8 4.3 19.7 11.1 8.6 20.6 4.4 8.0 12.4 6.7 10.1 15.0 12.7 10.5 8.2 8.7 13.6 12.2 12.6 26.8 7.0 15.2 9.4 3.6 21.7 5.2 19.9 11.3 12.1 5.9 3.9 7.0 23.3 7.6 8.8 7.8 10.3 9.5 6.2 11.5 3.8 8.3 8.0 5.0 8.6 10.9 8.5 8.9 4.5 8.7 7.1 8.0 8.9 10.4 13.2 16.7 12.8 7.5 11.2 7.1 6.7 10.6 15.8 11.6 4.3 12.3 11.1 7.1 10.3 5.9 7.1 7.4 5.4 12.4 7.8 3.1 5.7 8.6 5.9 6.1 6.7 6.0 6.8 6.4 3.2 7.8 6.6 6.5 5.3 4.3 11.5 14.5 11.6 18.7 10.5 10.3 10.2 11.9 11.6 9.2 3.0 3.5 2.2 4.3 7.7 5.0 3.9 0.0 4.0 1.2 0.0 2.0 3.7 6.6 6.9 4.9 3.5 4.4 0.0 5.0 7.1 4.3 3.1 6.9 5.0 3.5 1.6 6.4 11.1 3.8 8.0 6.1 2.2 3.3 1.8 10.2 2.3 4.7 3.5 6.7 3.8 4.8 6.5 5.1 9.1 2.1 11.7 1.0 4.4 8.4 2.5 ZFP69 "FLJ16030, ZFP69A, ZKSCAN23A, ZNF642, ZSCAN54A" ENSG00000187815 "ZFP69 zinc finger protein" Q49AA0 1 40477215-40496343 "Predicted intracellular proteins, Transcription factors" "Lipid metabolism, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 6.0;Early spermatids: 5.9;Spermatogonia: 4.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 4.8" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 5 "THP-1: 36.3" "Low region specificity" "Detected in many" "HPA027808, HPA054942" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA027808: AB_10601031, HPA054942: AB_2682644" "unprognostic (1.07e-2)" "unprognostic (6.00e-2)" "unprognostic (7.58e-3)" "unprognostic (4.15e-2)" "unprognostic (1.52e-1)" "prognostic favorable (9.31e-4)" "unprognostic (7.21e-3)" "unprognostic (1.72e-1)" "unprognostic (8.40e-3)" "unprognostic (6.34e-3)" "unprognostic (2.31e-1)" "unprognostic (4.46e-2)" "prognostic unfavorable (5.00e-6)" "unprognostic (1.05e-1)" "unprognostic (3.14e-2)" "unprognostic (5.98e-2)" "unprognostic (2.81e-1)" 5.1 3.4 8.3 5.8 8.5 4.1 5.1 6.8 5.8 4.7 5.3 7.5 5.1 4.4 5.6 5.6 4.4 5.2 8.9 7.3 6.7 5.6 3.7 4.7 5.6 6.3 9.0 2.4 6.8 6.7 8.1 3.1 5.3 8.6 5.6 4.9 3.9 4.9 6.0 1.2 6.7 4.9 9.7 8.7 6.9 4.8 8.4 8.4 9.4 5.2 2.9 6.8 6.1 14.3 1.1 0.6 0.1 0.5 4.8 2.0 0.6 3.3 0.0 2.0 2.6 2.5 2.6 3.4 1.8 2.1 2.8 3.3 1.8 2.6 6.0 2.4 2.9 3.7 2.7 3.8 1.6 3.3 5.4 2.6 4.4 3.0 2.9 2.0 0.1 4.8 2.6 4.0 1.9 2.9 0.9 1.6 0.1 2.5 0.0 1.6 1.7 4.5 5.6 3.8 0.3 0.0 2.5 7.1 2.8 1.5 2.5 2.6 4.2 3.1 2.9 5.1 3.2 0.0 36.3 0.7 1.3 2.6 3.6 0.2 0.1 4.6 3.8 2.4 0.9 3.5 0.0 0.5 0.1 1.6 0.2 2.0 1.1 1.2 1.9 0.6 0.6 0.6 2.0 0.1 4.8 0.4 0.0 0.6 0.6 8.3 8.5 6.8 5.8 6.7 5.6 9.0 2.4 8.6 8.4 6.0 0.0 0.9 0.3 0.9 1.3 1.2 0.0 1.4 0.0 0.0 0.0 1.0 1.7 1.3 5.9 1.8 0.3 0.0 1.2 1.2 0.7 0.2 0.0 0.9 1.1 0.0 0.0 0.6 1.5 2.5 1.1 1.4 1.7 1.8 1.4 1.6 0.8 0.0 1.8 0.5 0.8 0.0 0.5 2.7 4.6 0.4 0.2 0.7 1.4 0.1 ZFP69B "FLJ34293, ZKSCAN23B, ZNF643, ZSCAN54B" ENSG00000187801 "ZFP69 zinc finger protein B" Q9UJL9 1 40450102-40463718 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.8" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 2.9;Spermatogonia: 5.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA044289 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044289: AB_10962717" "unprognostic (2.01e-2)" "unprognostic (2.38e-2)" "unprognostic (1.17e-2)" "unprognostic (1.73e-2)" "unprognostic (1.58e-1)" "unprognostic (1.36e-2)" "unprognostic (6.44e-9)" "unprognostic (2.05e-1)" "unprognostic (7.10e-2)" "unprognostic (1.02e-2)" "unprognostic (6.85e-2)" "unprognostic (1.35e-1)" "unprognostic (3.23e-5)" "unprognostic (1.64e-1)" "unprognostic (8.05e-2)" "unprognostic (7.88e-2)" "unprognostic (1.89e-1)" 1.6 1.7 7.8 4.6 11.1 1.1 2.8 8.2 12.8 3.1 2.5 1.8 0.1 2.6 4.3 2.4 2.2 1.6 3.3 1.8 6.3 4.9 1.6 2.4 1.6 3.7 3.6 5.8 2.0 3.5 3.2 3.6 1.1 4.7 2.0 3.1 1.2 1.9 1.8 1.2 1.4 1.8 3.0 3.2 2.3 2.5 4.0 3.8 5.0 2.7 0.9 5.5 3.8 1.7 2.1 1.2 0.9 2.1 1.3 4.1 1.0 3.3 1.3 5.7 14.0 2.1 5.7 1.6 3.2 3.1 1.5 2.8 1.6 2.2 6.3 3.2 2.8 2.9 1.2 2.9 2.8 3.3 5.5 1.2 2.6 3.2 4.8 1.5 0.4 4.2 1.3 4.7 5.2 6.9 1.5 2.0 8.5 6.8 6.4 4.4 2.3 8.5 0.6 7.7 1.2 1.4 4.8 5.6 3.0 2.9 3.3 7.7 8.0 5.1 4.4 2.2 3.4 2.3 7.4 4.3 4.8 10.1 4.4 4.6 9.8 9.3 13.8 6.3 0.9 4.9 0.0 0.3 0.9 2.6 2.1 3.5 2.0 1.8 1.4 1.2 2.1 3.4 3.0 0.2 1.3 0.7 0.5 4.1 1.0 7.8 11.1 8.2 12.8 6.3 4.9 3.6 5.8 4.7 3.8 0.0 0.0 0.0 0.6 0.2 2.9 0.4 0.0 0.0 0.0 1.8 0.0 0.4 0.0 1.0 0.0 0.3 0.0 0.0 0.2 1.3 0.4 0.2 0.0 0.0 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.8 0.9 0.0 0.4 0.0 1.7 0.0 0.3 1.5 5.9 0.1 0.0 0.8 0.1 0.3 ZFP82 "KIAA1948, MGC45380, ZNF545" ENSG00000181007 "ZFP82 zinc finger protein" Q8N141 19 36383120-36418656 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 21.6;Horizontal cells: 31.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051669, HPA060470" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear membrane" "HPA051669: AB_2732568, HPA060470: AB_2684290" "unprognostic (1.52e-1)" "unprognostic (2.38e-2)" "unprognostic (6.03e-2)" "unprognostic (4.14e-4)" "unprognostic (9.63e-2)" "unprognostic (9.17e-4)" "unprognostic (1.91e-2)" "unprognostic (2.01e-1)" "unprognostic (9.72e-2)" "unprognostic (1.55e-2)" "unprognostic (2.61e-3)" "unprognostic (4.91e-1)" "unprognostic (3.69e-2)" "unprognostic (6.00e-2)" "unprognostic (3.21e-2)" "unprognostic (3.81e-2)" "unprognostic (3.05e-1)" 4.3 5.0 9.8 8.8 9.3 1.5 8.7 15.0 13.9 9.9 5.2 5.3 2.4 2.4 9.1 12.4 2.7 9.0 5.4 7.3 8.5 9.7 5.5 1.8 4.9 7.8 8.3 6.3 13.8 2.7 8.0 10.1 7.0 8.3 7.4 3.3 3.6 4.1 6.8 2.1 2.2 3.6 7.8 6.8 6.3 3.1 6.4 8.7 9.3 10.8 1.6 8.6 5.8 6.9 9.6 3.1 1.1 1.1 4.7 9.2 2.9 0.0 2.6 8.4 8.8 2.9 3.7 2.8 3.4 4.3 7.0 9.0 1.6 1.2 7.4 5.8 4.1 5.8 0.2 0.0 0.9 8.8 6.9 4.2 6.6 1.9 2.1 6.7 0.0 5.8 5.7 1.3 5.0 1.5 0.0 3.2 9.2 0.0 0.0 6.8 0.0 11.4 0.0 7.8 0.0 1.5 9.6 5.7 2.2 3.4 4.2 0.1 8.7 0.0 0.5 5.4 8.4 1.6 5.1 0.4 2.5 4.4 4.4 5.7 5.0 3.4 11.3 0.0 0.0 5.4 0.0 0.9 1.1 6.0 1.1 6.0 9.6 5.9 6.8 2.7 9.0 9.2 8.1 0.1 4.7 1.1 3.1 3.6 2.9 9.8 9.3 15.0 13.9 8.5 9.7 8.3 6.3 8.3 8.7 0.0 8.3 1.9 2.5 0.9 19.2 3.5 2.5 8.1 3.4 5.2 21.6 6.8 8.3 4.5 4.8 4.2 0.0 0.0 1.2 5.4 4.5 1.7 5.8 0.5 3.7 31.8 2.9 2.5 1.9 1.3 5.5 3.5 5.0 1.0 0.3 9.4 1.4 0.0 7.1 4.5 10.4 19.4 4.2 10.8 6.3 0.5 1.1 4.9 1.0 0.9 ZFP91 "PZF, ZNF757" ENSG00000186660 "ZFP91 zinc finger protein" Q96JP5 11 58579111-58621042 "Enzymes, Predicted intracellular proteins, Transcription factors" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 181.7;Late spermatids: 146.8;Spermatocytes: 142.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA024037, CAB025417, HPA065325" Approved Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "CAB025417: , HPA024037: AB_1859051, HPA065325: AB_2685468" "unprognostic (6.10e-2)" "unprognostic (5.01e-2)" "unprognostic (3.33e-3)" "unprognostic (9.19e-2)" "unprognostic (1.24e-1)" "unprognostic (2.33e-1)" "unprognostic (2.33e-2)" "unprognostic (3.37e-2)" "unprognostic (1.06e-1)" "unprognostic (2.36e-2)" "prognostic unfavorable (3.74e-6)" "unprognostic (3.16e-1)" "unprognostic (1.75e-3)" "unprognostic (3.12e-2)" "unprognostic (2.61e-1)" "unprognostic (2.23e-1)" "unprognostic (2.00e-3)" 17.1 14.7 20.1 13.6 25.6 32.0 14.9 24.4 21.7 15.3 18.1 23.2 15.8 16.2 16.3 11.8 16.3 13.6 13.8 26.5 20.3 15.4 16.3 19.4 15.0 14.4 20.8 18.1 14.9 14.3 26.7 17.0 14.2 19.7 13.1 21.9 11.2 14.5 15.5 33.8 17.5 19.6 16.9 21.6 15.0 13.9 71.0 19.4 15.7 16.8 14.6 15.9 17.8 21.4 4.6 7.0 5.4 5.0 3.7 5.4 2.8 24.8 14.3 16.8 17.0 16.1 19.5 9.2 20.6 38.7 23.8 20.4 7.8 26.3 29.8 20.4 25.9 23.8 22.2 17.0 21.8 31.4 15.8 9.6 19.6 14.5 8.4 18.3 24.7 32.4 17.0 21.5 33.5 39.3 19.8 23.6 20.2 19.4 28.3 30.6 8.3 21.3 13.7 8.8 14.4 13.9 16.6 28.4 19.7 17.5 24.0 18.0 14.4 26.2 24.1 33.5 9.5 26.9 18.6 26.4 30.2 20.8 45.3 22.8 16.4 12.1 24.7 26.6 13.9 30.7 3.9 5.0 3.5 5.4 4.5 3.0 4.5 3.3 3.3 4.9 4.6 3.6 4.6 5.4 3.7 4.2 7.0 2.6 2.8 20.1 25.6 24.4 21.7 20.3 15.4 20.8 18.1 19.7 19.4 23.8 34.8 33.2 21.5 53.3 28.8 39.5 48.4 25.4 21.6 17.4 15.7 10.3 11.6 19.8 181.7 27.0 27.7 46.7 27.1 10.5 32.9 25.9 48.6 41.4 14.5 33.4 24.2 25.8 36.8 146.8 28.4 27.0 21.9 20.8 30.4 19.8 24.5 11.5 25.5 19.1 19.0 19.4 20.6 142.7 40.2 58.2 11.6 21.8 37.2 34.3 ZFPM1 "FOG, FOG1, ZC2HC11A, ZNF89A" ENSG00000179588 "Zinc finger protein, FOG family member 1" Q8IX07 16 88453317-88537016 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "gallbladder: 30.4" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 19.6;Cone photoreceptor cells: 27.5;Horizontal cells: 33.4;Muller glia cells: 36.6" "Cancer enhanced" "Detected in all" "stomach cancer: 12.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 14.5;K-562: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046603 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA046603: AB_2679718" "unprognostic (1.29e-1)" "unprognostic (2.42e-1)" "unprognostic (3.08e-2)" "unprognostic (3.32e-2)" "unprognostic (1.13e-1)" "unprognostic (9.21e-2)" "unprognostic (1.24e-1)" "unprognostic (7.13e-3)" "unprognostic (1.02e-1)" "unprognostic (1.55e-2)" "unprognostic (5.58e-2)" "unprognostic (3.05e-2)" "unprognostic (2.49e-4)" "unprognostic (1.99e-2)" "unprognostic (3.32e-1)" "unprognostic (4.89e-2)" "prognostic favorable (4.24e-4)" 4.3 3.7 3.7 7.9 2.9 12.0 2.2 6.8 3.3 2.9 11.2 1.6 4.7 18.5 3.8 4.5 2.8 3.7 30.4 4.7 3.9 3.0 2.7 15.2 5.4 5.5 2.7 1.9 7.3 24.5 1.5 5.6 1.8 2.1 7.0 1.7 7.7 6.9 7.3 2.2 3.8 15.4 1.5 2.1 12.7 21.5 12.7 0.8 15.7 3.8 1.4 9.4 4.8 2.2 0.3 0.6 1.5 0.3 0.6 1.3 0.3 1.1 2.9 2.2 4.5 0.4 0.1 9.3 3.1 0.4 1.0 0.3 9.2 1.1 4.5 2.4 0.4 1.1 7.2 0.1 2.5 0.2 3.4 1.9 14.5 5.7 8.0 1.7 0.8 4.9 1.0 1.7 1.1 0.4 1.1 1.0 1.2 21.5 0.3 0.8 5.5 5.1 5.2 1.5 7.0 2.5 1.5 1.0 2.1 1.0 3.6 6.0 10.1 3.8 0.2 3.0 1.2 2.4 2.4 3.6 3.9 2.5 1.7 0.6 1.1 0.7 0.4 1.1 1.7 3.7 0.0 0.1 1.5 0.9 0.2 0.2 0.1 0.4 1.3 0.2 0.3 0.3 0.5 0.9 0.6 0.3 0.6 0.1 0.3 3.7 2.9 6.8 3.3 3.9 3.0 2.7 1.9 2.1 0.8 3.0 2.1 0.5 4.4 0.8 19.6 11.8 7.6 0.0 0.0 1.8 27.5 0.3 1.7 1.2 0.5 1.9 5.1 0.0 4.3 0.1 2.1 2.3 0.0 5.9 0.8 33.4 5.8 4.9 4.8 0.7 0.9 0.9 1.7 0.0 6.7 36.6 2.9 4.5 1.4 1.1 17.4 0.0 1.9 0.3 0.4 1.3 0.2 0.0 4.1 1.8 ZFPM2 "FOG2, hFOG-2, ZC2HC11B, ZNF89B" ENSG00000169946 "Zinc finger protein, FOG family member 2" Q8WW38 8 104590733-105804532 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Gonadal differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.0;ovary: 37.8" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 18.3;Early spermatids: 43.3;Late spermatids: 22.7;Leydig cells: 22.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 67.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.4;ASC diff: 5.6;BJ hTERT+: 13.9;HHSteC: 10.1;hTEC/SVTERT24-B: 5.7;HUVEC TERT2: 10.6;K-562: 5.7;TIME: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004094 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA004094: AB_1859058" "unprognostic (4.48e-2)" "unprognostic (3.24e-2)" "unprognostic (7.77e-3)" "unprognostic (1.36e-2)" "unprognostic (3.51e-1)" "unprognostic (1.53e-1)" "unprognostic (8.37e-2)" "unprognostic (8.35e-3)" "unprognostic (1.97e-2)" "unprognostic (1.04e-1)" "unprognostic (1.97e-1)" "unprognostic (5.74e-2)" "unprognostic (1.69e-6)" "unprognostic (4.10e-3)" "unprognostic (5.41e-2)" "unprognostic (1.63e-4)" "unprognostic (2.61e-2)" 10.7 3.8 7.9 3.9 2.7 0.6 15.4 67.0 8.2 8.4 4.2 0.7 2.0 1.1 16.6 7.3 5.5 14.2 6.8 11.2 14.8 3.5 1.8 3.5 5.6 8.2 3.4 4.9 37.8 1.4 1.2 2.5 5.0 9.3 3.3 2.9 0.9 1.5 2.9 23.3 2.0 2.3 19.8 3.5 3.5 3.5 4.9 2.0 0.0 8.0 6.5 2.1 7.6 9.9 0.1 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 6.4 0.0 5.6 1.8 0.0 0.5 13.9 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 5.0 1.6 0.0 0.0 10.1 0.0 0.0 0.6 0.0 5.7 0.0 1.9 10.6 0.0 5.7 0.0 1.4 0.0 1.4 0.0 0.2 0.1 1.5 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.5 4.4 0.0 6.4 0.3 0.9 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 2.7 67.0 8.2 14.8 3.5 3.4 4.9 9.3 2.0 0.0 1.1 0.0 0.2 3.2 0.6 18.3 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 43.3 6.2 0.0 0.0 0.0 0.1 8.7 0.4 0.0 0.0 0.3 7.9 0.0 8.6 0.0 22.7 22.2 0.0 1.7 1.0 0.0 0.0 0.1 0.0 12.7 0.0 0.6 6.5 3.1 0.7 1.4 2.5 0.3 0.0 0.0 0.3 ZFR "SPG71, ZFR1" ENSG00000056097 "Zinc finger RNA binding protein" Q96KR1 5 32354350-32444761 "Predicted intracellular proteins" "Developmental protein, DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016666 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA016666: AB_1859060" "unprognostic (7.45e-3)" "unprognostic (8.46e-2)" "unprognostic (4.07e-3)" "unprognostic (4.92e-2)" "unprognostic (1.14e-1)" "unprognostic (1.76e-2)" "prognostic unfavorable (4.75e-4)" "unprognostic (1.38e-1)" "unprognostic (1.47e-2)" "unprognostic (6.42e-2)" "unprognostic (1.58e-1)" "unprognostic (3.66e-2)" "unprognostic (1.16e-1)" "unprognostic (1.47e-2)" "unprognostic (5.46e-2)" "unprognostic (1.16e-1)" "unprognostic (2.07e-1)" 22.5 24.2 36.0 16.9 42.8 21.7 22.1 37.3 40.7 23.6 19.4 29.9 11.7 15.0 23.9 18.7 21.8 23.9 19.6 27.6 36.2 27.6 25.1 20.2 15.8 19.8 32.1 28.3 33.5 21.2 33.0 26.5 28.7 29.4 22.6 19.0 16.1 21.1 21.9 37.4 15.1 20.3 22.9 36.3 17.4 16.9 23.6 38.6 20.0 28.6 11.3 20.7 24.1 23.5 14.6 14.2 23.4 20.0 18.7 15.9 10.5 16.1 24.1 28.3 17.6 31.3 23.0 24.8 25.0 21.2 26.6 19.1 24.0 14.4 23.8 16.4 24.4 34.8 12.7 36.7 17.7 37.5 22.4 20.6 29.1 26.0 23.5 27.5 29.8 24.0 21.8 22.3 28.1 51.7 24.2 20.0 11.8 29.1 20.1 27.1 12.2 26.0 12.6 20.8 17.1 18.1 21.3 38.1 13.0 19.9 26.7 15.8 16.7 37.2 21.7 22.3 20.9 13.5 36.9 22.5 26.5 24.8 19.4 20.8 10.0 17.6 26.9 19.5 24.1 32.0 23.4 12.7 15.7 13.8 20.0 15.9 14.6 13.3 14.0 14.2 11.6 12.9 12.9 8.2 18.7 19.2 7.7 12.2 10.5 36.0 42.8 37.3 35.7 36.2 27.6 32.1 28.3 29.4 38.6 47.6 46.0 30.2 44.4 23.1 60.3 96.3 38.2 68.3 79.6 29.6 21.6 33.4 41.4 44.6 35.2 42.5 25.7 0.0 31.4 27.3 40.7 54.7 73.0 33.5 28.7 73.1 37.9 35.6 32.1 25.8 49.2 33.2 28.7 49.5 24.0 69.5 39.3 40.1 57.3 32.7 51.9 38.8 44.8 101.1 71.8 21.5 46.5 37.3 30.0 46.1 ZFR2 KIAA1086 ENSG00000105278 "Zinc finger RNA binding protein 2" Q9UPR6 19 3804024-3869032 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.0;pituitary gland: 19.8;testis: 20.3" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 29.9;Cone photoreceptor cells: 25.5;Early spermatids: 21.1;Horizontal cells: 30.2;Rod photoreceptor cells: 35.3;Spermatocytes: 26.9" "Cancer enhanced" "Detected in some" "cervical cancer: 2.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 12 "HMC-1: 17.8;NTERA-2: 30.6;SiHa: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043275, HPA055678" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA043275: , HPA055678: AB_2682883" "unprognostic (1.74e-3)" "unprognostic (2.32e-3)" "unprognostic (4.05e-3)" "unprognostic (1.51e-2)" "unprognostic (6.60e-3)" "unprognostic (5.47e-4)" "unprognostic (9.12e-2)" "unprognostic (3.87e-2)" "unprognostic (1.18e-2)" "unprognostic (4.92e-2)" "unprognostic (1.97e-3)" "unprognostic (4.29e-2)" "unprognostic (3.58e-1)" "unprognostic (3.58e-1)" "unprognostic (5.81e-2)" "unprognostic (9.20e-2)" "unprognostic (2.18e-2)" 1.0 6.8 13.0 1.2 17.0 1.3 1.3 2.2 16.9 1.5 0.9 1.9 0.0 0.9 0.9 0.8 0.8 2.4 1.2 1.1 7.6 12.2 0.9 0.9 1.4 1.1 4.9 10.9 1.0 1.7 0.8 19.8 0.8 7.4 1.3 1.0 5.7 1.2 1.1 0.9 1.2 1.4 0.8 3.9 1.3 1.3 20.3 2.3 0.0 1.2 0.0 1.4 0.8 0.2 0.9 0.2 1.5 0.2 1.7 4.5 1.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.2 0.7 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 30.6 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.1 0.6 9.0 0.0 0.5 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 1.5 0.2 0.2 3.4 0.0 4.5 0.2 2.6 1.9 0.0 0.9 3.9 3.4 0.5 1.7 0.0 0.2 0.8 1.4 13.0 17.0 2.2 15.0 7.6 12.2 4.9 10.9 7.4 2.3 0.0 0.6 0.0 0.5 0.9 29.9 1.1 0.0 2.7 0.0 0.0 25.5 0.0 0.0 0.3 21.1 0.5 0.0 0.0 0.2 0.1 0.2 0.4 1.1 0.0 0.1 30.2 0.0 0.0 0.0 7.5 0.9 0.0 1.7 0.0 0.0 4.0 0.3 0.0 0.0 0.2 35.3 0.0 0.3 26.9 14.1 0.1 0.0 2.2 0.0 0.4 ZFX ZNF926 ENSG00000005889 "Zinc finger protein, X-linked" P17010 X 24149173-24216255 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA001748, HPA003877, HPA071863" Supported Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA001748: AB_1080650, HPA003877: AB_1080648, HPA071863: AB_2686463" "unprognostic (2.60e-1)" "unprognostic (1.09e-1)" "unprognostic (7.99e-2)" "unprognostic (4.64e-2)" "unprognostic (1.66e-1)" "unprognostic (2.78e-1)" "unprognostic (1.81e-2)" "unprognostic (1.56e-1)" "unprognostic (2.77e-2)" "unprognostic (1.90e-1)" "unprognostic (6.84e-2)" "unprognostic (1.47e-1)" "unprognostic (9.22e-3)" "unprognostic (2.39e-1)" "unprognostic (4.27e-2)" "unprognostic (1.93e-1)" "unprognostic (5.95e-2)" 20.3 8.8 10.8 8.2 11.7 25.9 23.5 22.1 12.6 18.5 12.2 7.2 8.4 6.6 18.5 11.0 10.6 15.8 7.2 17.8 10.1 6.6 16.6 11.3 9.7 12.7 13.1 9.6 20.2 11.8 20.2 17.9 23.2 10.4 16.4 6.5 7.0 9.4 13.1 24.1 8.9 11.8 15.7 11.3 12.4 10.1 5.4 14.7 16.4 13.9 8.9 10.6 12.5 25.3 11.9 9.6 16.6 10.3 9.9 10.7 7.0 8.0 10.9 11.3 13.1 15.3 10.7 5.9 7.6 7.2 8.8 9.2 6.7 6.0 9.3 10.3 11.7 19.3 10.3 12.9 14.1 11.8 9.0 16.0 8.2 33.8 3.9 6.4 10.8 14.5 9.3 4.5 17.1 22.3 9.5 11.0 5.6 9.7 10.1 6.3 4.4 7.7 8.0 6.5 3.5 8.4 10.6 9.0 8.1 5.2 13.0 6.0 9.0 23.0 9.2 7.4 7.8 5.8 5.7 10.8 7.8 4.6 10.8 5.3 5.7 7.5 9.3 6.1 4.6 9.0 11.2 8.7 13.5 10.6 10.3 10.7 8.4 9.9 10.6 9.6 11.9 9.9 9.4 16.6 9.9 9.4 6.9 5.7 7.0 10.8 11.7 22.1 12.6 10.1 6.6 13.1 9.6 10.4 14.7 17.9 11.8 18.4 16.0 19.6 19.3 13.7 22.9 16.0 22.7 7.0 19.6 46.1 5.0 13.6 1.5 25.5 11.9 23.3 13.8 10.2 28.3 17.9 27.6 20.7 15.1 14.3 19.7 27.6 25.3 3.1 33.1 20.1 28.7 19.8 15.1 15.6 11.6 14.2 33.6 9.4 19.1 32.3 26.9 9.3 25.2 18.2 17.3 22.5 15.1 15.4 ZFY ZNF911 ENSG00000067646 "Zinc finger protein, Y-linked" P08048 Y 2935281-2982506 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Late spermatids: 59.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA001748, HPA071863" Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA001748: AB_1080650, HPA071863: AB_2686463" "unprognostic (1.07e-1)" "unprognostic (7.43e-2)" "prognostic favorable (3.58e-5)" "unprognostic (1.07e-1)" "unprognostic (7.52e-2)" "unprognostic (2.75e-2)" "unprognostic (2.94e-2)" "unprognostic (1.04e-1)" "unprognostic (8.32e-2)" "unprognostic (1.20e-2)" "unprognostic (1.91e-1)" "unprognostic (2.54e-2)" 4.1 2.9 2.8 6.8 4.3 9.6 3.4 6.8 5.3 0.0 5.4 2.8 14.1 3.2 0.0 9.1 7.2 0.0 7.0 6.1 3.0 3.0 2.7 13.1 10.1 10.9 2.6 0.0 0.0 10.0 0.1 3.3 5.8 4.5 10.6 8.0 3.5 15.8 10.2 7.0 2.9 6.3 5.8 3.3 9.1 4.7 10.5 0.0 12.6 7.2 5.7 5.8 6.1 0.0 5.8 5.9 4.7 4.7 6.2 7.0 2.7 0.0 3.6 0.0 0.0 0.0 0.0 6.5 9.1 8.8 7.8 7.6 0.0 0.0 7.0 0.0 9.5 0.0 0.0 0.0 0.0 10.5 10.5 0.0 12.9 0.1 4.6 6.9 0.0 0.0 7.6 6.2 0.0 0.0 0.0 0.0 1.8 0.0 0.0 8.8 0.0 5.3 0.0 2.9 0.0 0.0 0.0 5.7 2.7 5.3 11.9 6.2 0.0 0.0 0.0 9.1 4.3 0.0 4.2 7.9 7.6 0.0 0.0 4.6 4.9 0.0 11.8 1.0 0.0 0.0 0.0 4.7 4.7 5.0 3.9 7.0 4.3 5.5 2.8 5.9 5.8 6.3 3.0 3.2 6.2 3.3 4.3 3.1 2.7 2.8 4.3 6.8 5.3 3.0 3.0 2.6 0.0 4.5 0.0 8.9 8.0 16.9 9.6 9.8 11.8 5.9 5.1 8.1 13.6 1.8 7.9 4.4 0.0 2.7 28.3 7.3 0.0 0.0 0.0 1.2 7.8 7.9 6.9 0.5 2.6 12.7 1.7 8.0 5.0 59.3 9.2 8.5 3.3 3.6 0.0 11.2 2.1 0.0 10.3 2.9 7.8 12.9 7.6 19.0 3.8 8.3 3.1 11.4 0.0 10.5 ZFYVE27 "FLJ32919, SPG33" ENSG00000155256 "Zinc finger FYVE-type containing 27" Q5T4F4 10 97737121-97760907 "Disease related genes, Predicted membrane proteins" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037523, HPA069876" Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA037523: AB_10672351, HPA069876: AB_2686218" "unprognostic (2.21e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (6.91e-4)" "unprognostic (3.12e-1)" "unprognostic (3.42e-2)" "unprognostic (9.76e-2)" "unprognostic (1.22e-1)" "unprognostic (2.30e-2)" "unprognostic (2.48e-2)" "unprognostic (7.15e-2)" "unprognostic (2.05e-3)" "unprognostic (5.24e-2)" "unprognostic (3.38e-3)" "prognostic favorable (7.54e-4)" "unprognostic (4.18e-2)" "unprognostic (1.26e-2)" "prognostic favorable (7.80e-4)" 10.1 22.6 16.1 12.7 20.8 20.7 11.8 28.6 33.0 10.3 17.4 15.7 17.4 25.6 11.6 25.4 9.8 17.9 14.1 12.8 17.6 20.7 15.5 18.2 11.3 15.2 15.1 23.4 17.1 15.4 19.6 24.3 14.3 17.6 13.3 17.5 25.6 14.0 11.8 7.9 17.1 24.0 9.4 14.7 18.1 14.9 14.2 13.3 12.2 13.1 5.5 14.7 8.5 10.4 11.2 8.5 13.4 12.6 9.0 15.2 11.7 10.4 12.9 7.8 17.2 8.9 6.2 10.6 10.7 11.3 12.5 12.3 11.4 21.8 16.2 12.3 7.7 16.1 23.5 11.3 10.4 6.7 16.7 11.3 7.6 12.7 10.6 11.4 12.2 15.4 10.1 12.6 12.3 9.5 20.2 7.0 13.7 11.4 11.0 9.3 8.1 9.8 23.3 6.3 9.1 10.0 11.4 7.8 7.6 12.0 6.5 6.3 12.2 7.2 6.1 27.8 7.4 13.3 12.2 7.4 6.3 7.5 9.6 20.3 12.8 10.7 8.5 15.8 15.8 7.2 7.1 8.4 13.4 15.2 9.1 13.1 10.9 10.5 12.0 8.0 11.2 12.1 12.9 12.1 9.0 12.6 8.5 13.4 11.7 16.1 20.8 28.6 33.0 17.6 20.7 15.1 23.4 17.6 13.3 3.0 10.7 11.5 10.1 7.2 28.2 7.7 15.3 6.7 3.4 14.0 55.0 6.5 6.6 13.2 4.6 9.5 29.9 0.0 13.9 5.2 6.2 10.4 13.9 9.6 7.3 35.0 19.4 6.2 8.6 1.3 8.9 8.4 10.1 11.8 12.3 15.2 11.2 22.8 8.5 7.0 41.6 19.4 7.8 6.6 7.7 4.8 11.3 15.0 12.0 14.8 ZFYVE28 KIAA1643 ENSG00000159733 "Zinc finger FYVE-type containing 28" Q9HCC9 4 2269582-2418663 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 63.6" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 28.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 63.6" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 11.2;NB-4: 12.1;U-266/70: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038175, HPA057587" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA038175: AB_10697244, HPA057587: AB_2683477" "unprognostic (1.59e-1)" "unprognostic (4.60e-2)" "unprognostic (7.68e-2)" "unprognostic (3.08e-3)" "unprognostic (9.89e-3)" "unprognostic (3.79e-2)" "unprognostic (3.17e-1)" "unprognostic (1.31e-1)" "unprognostic (1.66e-1)" "unprognostic (4.78e-3)" "unprognostic (2.56e-2)" "unprognostic (3.64e-2)" "prognostic favorable (1.35e-6)" "unprognostic (6.05e-2)" "unprognostic (5.27e-2)" "unprognostic (2.97e-1)" "unprognostic (2.41e-2)" 4.5 8.6 7.7 5.1 15.8 3.1 3.7 63.6 15.1 3.7 7.4 4.6 1.8 10.4 4.1 3.1 3.4 4.3 5.9 2.4 7.1 5.5 5.7 4.2 4.4 6.1 7.9 8.0 3.4 7.3 7.9 7.5 1.8 9.9 2.9 5.1 5.8 9.5 5.4 4.3 5.7 11.9 2.8 9.4 7.0 7.5 7.9 6.7 1.2 5.3 3.1 4.0 4.5 3.2 3.1 0.7 0.9 0.4 0.3 4.4 1.3 0.8 1.0 0.2 3.7 2.2 0.7 0.1 1.8 3.1 1.0 0.3 0.1 6.7 0.0 1.9 3.2 2.6 3.8 1.2 0.3 0.6 9.7 1.3 0.2 4.3 0.3 4.4 0.7 11.2 3.0 0.6 1.1 0.1 7.0 3.1 1.0 1.8 8.2 0.9 2.2 0.1 12.1 0.1 2.0 8.2 0.0 0.0 3.9 1.5 0.5 5.8 0.4 1.8 0.1 1.0 0.1 2.5 0.3 0.5 1.8 0.0 5.5 0.1 12.8 9.3 0.2 5.4 2.3 1.8 0.9 0.4 0.1 4.4 0.0 1.9 0.9 2.3 3.2 0.7 3.1 3.2 3.2 0.1 0.3 0.3 0.2 4.0 1.3 7.7 15.8 63.6 15.1 7.1 5.5 7.9 8.0 9.9 6.7 0.0 1.7 0.0 3.2 5.3 10.7 3.3 5.1 1.4 3.4 10.4 17.7 0.3 6.6 2.7 28.4 4.5 16.9 0.0 2.0 0.2 1.9 1.5 9.2 4.9 1.8 7.9 2.4 5.5 1.9 5.8 1.4 7.1 6.8 4.6 5.9 1.4 2.1 9.0 2.1 3.1 16.3 0.0 2.8 2.1 9.0 4.3 0.2 21.0 5.2 4.1 ZG16B "HRPE773, JCLN2, PRO1567" ENSG00000162078 "Zymogen granule protein 16B" Q96DA0 16 2830169-2839585 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "salivary gland: 1069.4" "Cell type enhanced" "Detected in many" 14 "Basal glandular cells: 160.9;Glandular cells: 457.9;Mucus-secreting cells: 224.9;Urothelial cells: 223.9" "Cancer enhanced" "Detected in many" "prostate cancer: 47.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "classical monocyte: 6.7;intermediate monocyte: 11.4;non-classical monocyte: 7.3" "Lineage enriched" "Detected in many" 7 "monocytes: 11.4" "Cell line enhanced" "Detected in some" "MCF7: 15.2;OE19: 32.4;SK-BR-3: 14.0;T-47d: 12.8" "HPA041125, HPA053549" Enhanced Approved Nucleoplasm,Vesicles "Secreted to digestive system" NA NA 1200000 Vesicles Nucleoplasm "HPA041125: AB_10794264, HPA053549: AB_2682184" "unprognostic (5.29e-2)" "unprognostic (2.71e-1)" "unprognostic (4.37e-2)" "prognostic favorable (3.48e-6)" "unprognostic (1.39e-3)" "unprognostic (1.94e-2)" "unprognostic (2.34e-3)" "unprognostic (4.13e-2)" "unprognostic (1.01e-1)" "unprognostic (3.45e-3)" "unprognostic (1.37e-1)" "unprognostic (1.47e-2)" "unprognostic (1.67e-1)" "unprognostic (1.17e-1)" "unprognostic (2.17e-1)" "unprognostic (1.04e-1)" "unprognostic (8.33e-2)" 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.1 0.0 0.7 0.2 0.0 0.2 0.1 0.1 0.1 0.5 0.0 1.4 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 1.0 0.6 0.0 0.0 0.0 1.6 0.3 0.0 1069.4 0.2 0.1 0.8 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 78.5 3.7 0.2 0.2 0.0 1.1 1.7 11.4 1.1 0.4 1.7 0.0 0.6 0.0 0.0 0.2 1.1 0.1 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.1 0.0 0.1 1.2 0.0 2.5 0.0 0.0 0.0 5.0 1.4 1.3 1.0 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.0 0.1 2.1 0.1 15.2 0.0 0.2 0.1 32.4 2.9 0.0 0.0 4.8 0.1 3.6 0.0 0.0 0.0 14.0 0.0 0.1 12.8 0.0 1.8 0.0 0.3 1.1 0.0 0.0 0.2 0.2 0.2 3.7 0.1 1.7 6.7 0.0 0.0 11.4 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.5 1.1 7.3 0.0 0.4 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 160.9 8.0 0.0 0.0 89.2 1.4 5.7 1.8 0.0 0.0 0.0 3.6 5.3 0.1 36.1 0.0 25.2 2.7 0.8 457.9 5.7 0.0 13.1 0.0 55.9 0.6 2.9 3.1 0.0 2.6 79.2 1.8 224.9 0.0 30.0 80.9 0.0 0.0 0.0 0.0 0.3 1.0 0.1 21.0 0.2 0.0 68.0 223.9 ZGLP1 "GATAD3, GLP-1, GLP1" ENSG00000220201 "Zinc finger, GATA-like protein 1" P0C6A0 19 10304803-10309880 "Predicted intracellular proteins, Transcription factors" "Differentiation, Oogenesis, Spermatogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Hofbauer cells: 12.3;Kupffer cells: 16.8;Macrophages: 7.8;Spermatogonia: 16.8" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "NB-4: 26.6;U-937: 6.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA049855 Uncertain Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA049855: AB_2680916" "unprognostic (1.73e-2)" "unprognostic (3.43e-3)" "unprognostic (1.42e-3)" "unprognostic (1.87e-2)" "unprognostic (1.90e-1)" "unprognostic (1.46e-4)" "unprognostic (1.18e-1)" "unprognostic (1.34e-2)" "unprognostic (3.04e-2)" "unprognostic (3.10e-2)" "unprognostic (1.10e-4)" "unprognostic (2.82e-2)" "unprognostic (6.57e-7)" "unprognostic (6.86e-2)" "unprognostic (6.21e-2)" "unprognostic (1.57e-1)" "unprognostic (2.57e-4)" 0.5 0.9 2.5 2.0 6.5 0.9 1.0 8.0 5.4 1.4 0.9 2.2 2.1 0.7 0.6 2.6 1.8 0.6 2.9 3.4 2.4 3.0 1.0 3.6 1.0 3.9 3.1 1.9 4.8 2.0 3.4 0.3 5.1 2.5 1.4 4.8 1.6 0.2 0.9 2.6 1.4 3.7 5.3 1.4 1.2 0.9 0.3 0.3 0.1 0.3 0.0 1.0 0.1 0.4 1.0 1.4 0.5 0.9 0.4 3.6 0.8 0.2 0.7 1.5 1.0 0.3 1.5 0.8 0.2 0.6 1.5 1.0 0.3 0.2 1.3 4.6 1.4 1.3 0.5 0.6 0.0 0.4 0.8 2.1 0.7 0.4 0.6 0.2 1.2 1.4 1.0 0.9 1.6 0.1 26.6 2.2 0.3 1.7 1.5 0.7 0.7 0.6 0.6 1.2 1.4 0.3 0.3 1.2 0.4 2.1 0.4 0.5 2.1 2.4 2.0 0.2 5.2 6.1 0.6 0.4 6.7 0.9 0.0 0.3 0.0 1.0 0.1 0.6 0.0 0.1 0.1 0.2 0.3 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.1 0.0 2.6 0.9 0.4 0.8 1.4 0.4 0.0 1.4 1.2 1.8 0.0 0.4 0.0 0.4 0.4 0.8 0.4 0.0 0.0 0.3 0.6 0.8 0.0 1.0 12.3 6.4 0.0 0.6 16.8 0.6 0.9 7.8 3.3 1.8 0.2 1.1 0.3 0.8 0.7 0.3 1.3 0.0 0.4 1.8 16.8 0.6 0.1 0.0 1.1 0.0 ZGPAT "dJ583P15.3, FLJ14972, GPATC6, GPATCH6, KIAA1847, MGC44880, ZC3H9, ZC3HDC9, ZIP" ENSG00000197114 "Zinc finger CCCH-type and G-patch domain containing" Q8N5A5 20 63707465-63736142 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 56.1" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 4.3;Club cells: 2.3;granulocytes: 2.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056705 Supported "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA056705: AB_2683213" "unprognostic (4.50e-2)" "unprognostic (2.74e-1)" "unprognostic (5.30e-2)" "unprognostic (4.42e-2)" "unprognostic (8.58e-2)" "prognostic favorable (6.17e-5)" "unprognostic (1.06e-1)" "unprognostic (6.97e-2)" "unprognostic (2.52e-1)" "unprognostic (1.54e-1)" "unprognostic (9.31e-3)" "unprognostic (1.60e-2)" "unprognostic (3.43e-3)" "unprognostic (1.37e-1)" "unprognostic (4.11e-2)" "unprognostic (1.24e-1)" "unprognostic (9.86e-3)" 9.3 9.8 9.6 13.6 14.5 14.5 8.0 20.2 13.2 7.6 8.9 12.0 10.8 11.1 12.9 6.1 9.1 8.1 11.2 8.8 10.3 7.1 11.7 56.1 7.2 11.0 16.9 10.7 7.3 12.6 8.3 10.8 9.0 14.2 8.3 3.9 8.0 14.0 8.8 9.2 10.5 10.8 9.4 8.5 11.7 10.3 14.9 15.0 11.3 8.0 5.8 13.5 8.3 9.2 15.6 21.7 19.2 16.4 20.2 23.8 13.0 8.6 11.1 4.4 7.0 3.6 2.5 10.1 9.0 6.0 14.3 6.0 23.8 11.9 9.0 17.2 5.0 13.8 15.8 2.9 10.6 1.8 6.0 7.7 8.4 9.7 24.3 7.1 5.2 14.9 6.4 9.0 5.8 2.3 3.8 7.7 10.9 9.2 8.5 4.7 8.6 12.9 12.5 7.1 12.8 14.0 13.6 3.3 9.1 7.9 8.0 8.3 10.4 12.8 14.5 8.0 2.3 9.9 14.8 8.7 22.3 7.9 8.4 11.4 8.4 13.2 12.3 14.0 5.2 9.9 6.6 16.0 19.2 23.8 16.4 23.1 15.6 20.4 21.5 15.1 14.5 20.3 20.5 17.0 20.2 13.2 21.7 19.8 13.0 9.6 14.5 20.2 13.2 10.3 7.1 16.9 10.7 14.2 15.0 3.0 4.3 0.0 0.0 0.0 0.9 0.2 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.1 0.0 0.2 0.2 0.2 0.0 2.3 1.6 0.2 0.0 1.7 0.6 1.8 0.0 0.0 0.4 1.7 0.0 0.0 0.3 0.3 0.0 0.0 0.4 1.0 0.0 0.3 0.0 0.1 0.3 0.2 0.0 0.0 0.1 ZHX1 ENSG00000165156 "Zinc fingers and homeoboxes 1" Q9UKY1 8 123248451-123275541 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Horizontal cells: 138.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055357 Supported Nucleoplasm No No Nucleoplasm "HPA055357: AB_2682793" "unprognostic (4.36e-3)" "unprognostic (6.73e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (6.09e-4)" "unprognostic (8.73e-3)" "unprognostic (5.61e-2)" "unprognostic (9.22e-2)" "unprognostic (1.51e-1)" "unprognostic (2.01e-1)" "unprognostic (6.00e-2)" "unprognostic (7.97e-2)" "unprognostic (1.44e-1)" "unprognostic (2.07e-2)" "unprognostic (6.63e-2)" "unprognostic (1.51e-1)" "unprognostic (1.30e-2)" "unprognostic (1.76e-2)" 21.1 12.6 23.9 9.4 23.1 9.4 16.8 21.8 22.5 18.8 13.9 13.3 19.0 14.8 14.7 14.3 30.7 15.7 12.5 12.3 23.6 18.7 19.0 31.0 11.6 9.3 20.3 16.2 18.1 13.9 28.6 25.2 11.6 18.8 17.3 12.3 10.6 15.6 18.8 14.4 21.8 19.9 16.8 23.8 14.1 11.8 8.0 24.4 13.1 31.2 10.7 11.8 16.4 24.3 4.4 5.8 4.0 14.5 7.5 6.3 3.3 10.1 4.6 6.4 7.5 12.4 10.4 4.1 12.3 6.9 9.2 10.7 8.1 4.4 15.4 16.6 14.9 4.1 7.0 18.1 11.4 11.7 30.5 9.3 24.9 10.7 4.8 8.4 9.1 12.1 7.8 12.9 12.5 10.7 7.9 7.1 7.4 29.1 12.3 13.6 30.8 20.9 4.0 1.7 21.4 9.8 10.8 5.8 11.0 8.1 23.3 31.1 11.6 14.1 40.0 4.8 3.9 16.3 10.5 6.7 14.7 19.4 11.7 8.2 11.5 31.6 17.4 9.9 17.1 4.0 1.7 4.3 4.0 4.9 7.6 6.0 4.1 6.1 4.3 5.8 4.4 5.9 6.1 1.5 7.5 14.5 3.3 6.3 3.3 23.9 23.1 21.8 22.5 23.6 18.7 20.3 16.2 18.8 24.4 23.8 21.7 12.3 21.5 33.0 40.1 27.9 22.9 21.4 30.7 19.2 45.2 8.4 26.6 14.5 8.8 27.5 25.3 23.3 19.3 5.3 27.2 19.1 27.7 58.6 13.1 138.2 41.6 22.1 21.6 14.7 43.1 17.9 25.3 12.6 24.2 40.4 14.6 30.6 60.5 28.8 31.1 38.8 27.2 26.2 22.2 54.6 8.0 17.3 20.2 21.3 ZHX1-C8orf76 ENSG00000259305 "ZHX1-C8orf76 readthrough" Q96EF9 8 123226189-123274284 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 9.5;Urothelial cells: 6.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 24.3" HPA023708 Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA023708: AB_1845785" "unprognostic (1.06e-1)" "unprognostic (2.11e-1)" "unprognostic (1.37e-2)" "unprognostic (1.83e-3)" "unprognostic (1.13e-1)" "unprognostic (1.16e-1)" "unprognostic (2.49e-3)" "unprognostic (7.10e-2)" "unprognostic (1.91e-2)" "unprognostic (9.34e-3)" "unprognostic (2.29e-1)" "unprognostic (3.09e-2)" "unprognostic (5.64e-11)" "unprognostic (1.79e-1)" "unprognostic (2.09e-1)" "unprognostic (1.98e-1)" "unprognostic (1.06e-2)" 8.6 7.4 11.4 5.0 11.0 25.9 8.7 10.3 10.7 8.5 6.2 5.9 8.9 8.1 7.3 8.1 10.4 5.9 5.4 8.7 11.2 5.0 7.1 9.7 9.7 8.7 9.6 7.4 8.7 6.8 7.1 12.7 7.1 8.8 8.7 9.9 4.5 9.0 8.7 11.9 9.9 9.3 7.7 11.4 10.5 6.6 5.1 11.7 5.8 10.5 4.6 10.2 7.5 11.6 5.5 4.6 8.0 8.3 4.8 8.5 3.3 3.0 3.9 2.9 2.0 1.8 2.0 2.1 1.3 1.4 3.4 2.6 3.2 2.4 1.8 1.2 2.3 2.0 2.1 3.3 1.8 5.1 2.9 6.7 5.3 2.7 3.8 1.9 1.1 3.0 2.7 2.7 2.8 1.7 1.5 3.9 5.6 4.4 2.6 3.0 9.5 4.4 3.5 0.7 6.2 4.4 3.5 1.9 2.5 2.4 3.1 4.5 3.3 2.8 24.3 1.4 1.7 3.6 1.0 0.3 1.5 2.7 2.3 3.2 3.7 4.5 3.9 2.0 2.9 1.0 3.1 5.7 8.0 4.1 8.3 3.7 5.5 5.3 3.5 4.6 4.6 4.4 3.6 1.8 4.8 5.9 4.0 8.5 3.3 11.4 11.0 10.3 10.7 11.2 5.0 9.6 7.4 8.8 11.7 0.0 1.4 0.5 3.5 0.0 0.4 0.8 2.5 2.7 1.2 3.5 0.0 1.6 1.7 1.6 0.7 1.5 1.1 0.0 1.6 2.0 0.1 2.4 0.0 0.9 2.5 9.5 2.9 1.3 0.6 0.9 0.9 1.2 0.0 1.8 1.3 0.8 1.7 0.0 1.1 1.2 1.1 0.0 0.9 2.5 2.2 0.0 0.8 0.7 1.0 6.0 ZHX2 KIAA0854 ENSG00000178764 "Zinc fingers and homeoboxes 2" Q9Y6X8 8 122781394-122974512 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 24.1;REH: 25.8;U-698: 24.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006769, HPA006996" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006769: AB_10669919, HPA006996: AB_10670555" "unprognostic (8.28e-2)" "unprognostic (3.80e-3)" "unprognostic (6.48e-2)" "unprognostic (6.90e-2)" "unprognostic (8.19e-3)" "unprognostic (3.61e-2)" "unprognostic (2.03e-2)" "unprognostic (2.68e-2)" "unprognostic (1.35e-1)" "unprognostic (4.80e-2)" "unprognostic (2.25e-1)" "unprognostic (1.36e-1)" "unprognostic (7.29e-2)" "unprognostic (2.03e-2)" "unprognostic (1.70e-1)" "unprognostic (7.61e-3)" "unprognostic (3.04e-1)" 11.3 12.4 14.6 26.2 14.8 7.1 12.7 11.1 16.2 15.1 8.2 22.2 9.8 6.0 15.8 10.6 10.8 17.7 13.9 16.3 16.0 9.8 9.7 15.9 13.2 26.8 19.3 10.3 31.5 20.3 10.1 13.5 7.1 12.4 16.9 7.7 12.7 13.4 15.2 31.1 9.3 11.7 13.6 14.3 15.9 8.3 5.2 20.0 17.9 15.3 10.9 24.7 17.7 11.3 12.2 5.4 9.6 1.9 6.9 7.5 3.2 2.6 1.3 7.7 1.5 3.8 1.2 0.0 1.6 5.1 1.8 2.4 0.3 8.9 24.1 6.7 5.3 1.4 2.2 5.1 3.1 2.0 10.8 3.4 11.2 1.7 8.5 4.1 2.7 3.5 3.3 3.7 1.7 9.1 8.7 2.0 4.4 0.4 8.5 2.1 7.6 2.5 2.4 4.2 1.4 1.8 25.8 4.2 1.9 8.5 6.8 3.3 1.9 6.5 19.2 3.2 5.4 3.3 6.0 3.5 1.4 3.7 1.7 3.4 2.2 0.0 24.7 1.4 2.1 2.3 9.6 1.0 5.2 6.9 1.3 7.2 12.2 5.0 6.7 1.2 11.0 7.5 5.9 5.1 6.9 1.9 5.4 5.1 3.2 14.6 14.8 11.1 12.8 16.0 9.8 19.3 10.3 12.4 20.0 6.0 2.9 16.4 4.3 4.8 2.4 8.9 12.7 2.7 1.2 8.7 0.0 0.4 3.3 9.4 7.5 6.7 3.1 0.0 5.5 0.2 7.8 11.8 8.1 9.9 1.7 4.8 4.1 7.4 5.4 1.9 9.8 2.5 10.1 5.4 4.8 12.8 7.0 3.5 18.4 3.7 0.7 0.0 18.1 0.5 0.1 7.8 1.1 15.2 3.4 7.8 ZHX3 "KIAA0395, TIX1" ENSG00000174306 "Zinc fingers and homeoboxes 3" Q9H4I2 20 41178448-41317672 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 77.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046498 Supported Nucleoplasm NA NA Nucleoplasm "HPA046498: AB_2679676" "unprognostic (6.26e-2)" "unprognostic (1.41e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (3.40e-2)" "unprognostic (4.50e-2)" "unprognostic (2.29e-1)" "unprognostic (3.88e-1)" "unprognostic (3.42e-1)" "unprognostic (7.25e-3)" "unprognostic (1.50e-2)" "unprognostic (1.06e-1)" "prognostic favorable (2.53e-5)" "unprognostic (3.06e-1)" "unprognostic (2.74e-1)" "prognostic unfavorable (7.52e-4)" "prognostic unfavorable (1.84e-5)" 15.7 18.6 19.8 7.9 24.7 4.1 19.3 26.8 27.6 13.7 13.9 18.2 7.0 10.6 13.1 7.8 16.8 12.1 10.6 12.8 21.1 13.9 33.2 13.2 11.3 8.0 17.0 16.9 20.4 14.4 22.7 10.5 6.4 15.8 11.1 10.3 13.7 6.1 15.6 29.7 11.4 10.5 20.1 17.7 5.1 13.1 26.6 20.3 4.4 23.2 7.8 6.1 15.7 17.4 3.1 0.9 1.6 0.9 2.3 1.8 0.5 9.4 2.7 2.9 6.1 23.6 25.4 3.3 13.3 15.3 12.4 8.4 4.8 1.2 6.6 6.5 24.9 3.3 3.0 3.4 16.8 13.3 1.8 3.0 2.7 3.7 3.6 9.7 3.1 3.5 15.5 8.2 9.3 12.1 8.4 5.3 5.0 2.5 4.6 16.6 18.9 4.9 1.8 1.2 4.4 10.0 2.4 8.1 2.6 17.0 2.8 10.1 3.6 8.8 5.2 3.2 2.6 5.0 4.4 8.5 31.1 4.7 10.9 6.5 5.3 3.2 2.9 12.8 4.7 4.9 0.3 0.7 1.6 1.2 0.4 1.7 2.4 0.9 0.8 0.9 3.1 1.8 1.7 0.5 2.3 0.9 0.6 1.1 0.5 19.8 24.7 26.8 21.9 21.1 13.9 17.0 16.9 15.8 20.3 17.9 13.1 5.2 3.0 2.6 16.1 10.1 15.3 2.7 6.8 21.0 3.9 0.5 10.0 3.6 77.4 7.3 6.6 0.0 2.2 2.5 8.7 2.0 1.1 25.9 2.5 38.1 14.3 15.4 4.3 27.7 17.3 3.3 1.7 1.0 4.4 29.4 3.4 0.0 23.0 17.4 6.9 25.8 7.2 9.8 4.4 3.1 0.3 0.9 3.8 1.8 ZIC1 "ZIC, ZNF201" ENSG00000152977 "Zic family member 1" Q15915 3 147393422-147510293 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "brain: 124.7" "Cell type enhanced" "Detected in some" 14 "Hepatocytes: 4.4;Leydig cells: 1.4;Muller glia cells: 4.2;Peritubular cells: 1.4;Rod photoreceptor cells: 1.5" "Cancer enhanced" "Detected in many" "glioma: 9.5" "Region enriched" "Detected in all" 8 "cerebellum: 124.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "AF22: 62.2" "Region enhanced" "Detected in many" "cerebellum: 232.6" "Region enriched" "Detected in many" 9 "cerebellum: 491.0" HPA004098 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA004098: AB_1859065" "unprognostic (1.33e-2)" "unprognostic (1.82e-1)" "unprognostic (4.01e-2)" "unprognostic (2.36e-1)" "unprognostic (9.32e-2)" "unprognostic (1.52e-2)" "unprognostic (1.68e-2)" "unprognostic (2.19e-1)" "unprognostic (5.01e-1)" "unprognostic (2.61e-7)" "unprognostic (2.95e-3)" "unprognostic (1.67e-2)" "unprognostic (3.01e-1)" 0.7 0.6 1.5 0.5 8.6 0.5 0.8 124.7 25.5 0.5 0.7 12.3 0.0 0.9 0.6 3.8 1.0 0.5 0.8 0.5 6.2 5.2 0.5 7.3 0.7 0.7 5.2 8.0 0.9 0.5 0.6 0.6 0.5 15.3 0.5 0.7 3.0 0.5 0.6 7.4 4.1 1.9 0.5 10.0 0.5 0.5 1.0 4.5 0.0 0.5 0.0 0.5 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 62.2 0.0 6.5 7.2 3.5 4.0 4.8 4.3 3.6 0.0 0.0 0.0 3.2 0.3 3.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.1 0.0 0.2 0.0 0.0 1.0 0.0 3.8 15.0 0.0 0.0 0.1 0.3 0.0 0.0 6.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 3.6 0.0 0.0 0.0 0.0 6.5 0.0 10.1 3.8 0.0 0.0 0.0 4.8 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 8.6 124.7 5.2 6.2 5.2 5.2 8.0 15.3 4.5 0.0 0.0 0.0 0.0 0.1 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 4.2 0.0 0.0 1.4 0.0 1.5 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 ZIC3 "HTX, HTX1, ZNF203" ENSG00000156925 "Zic family member 3" O60481 X 137566142-137577691 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Heterotaxy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "brain: 50.6" "Cell type enhanced" "Detected in some" 27 "Muller glia cells: 7.1;Rod photoreceptor cells: 1.1;Spermatocytes: 1.4;Spermatogonia: 2.7" "Cancer enriched" "Detected in single" 14 "testis cancer: 5.0" "Region enriched" "Detected in all" 8 "cerebellum: 50.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 35 "AF22: 24.0;NTERA-2: 26.7;SuSa: 16.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA052936, HPA069523" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA052936: AB_2681993, HPA069523: AB_2732136" "unprognostic (3.55e-5)" "unprognostic (3.82e-1)" "unprognostic (1.95e-1)" "unprognostic (3.31e-1)" 0.3 0.2 1.4 0.4 2.5 1.1 0.4 50.6 5.8 0.3 0.4 2.7 0.0 0.5 0.5 0.2 0.3 0.3 0.4 0.3 1.9 2.2 0.3 0.3 0.4 0.4 2.4 1.2 0.4 0.5 0.4 1.1 0.4 6.1 0.5 0.3 3.9 0.7 0.3 0.5 0.8 0.5 0.2 1.9 0.5 0.4 3.9 2.2 0.0 0.5 0.0 0.4 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 26.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 16.2 0.3 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 2.5 50.6 2.6 1.9 2.2 2.4 1.2 6.1 2.2 0.0 0.0 0.0 0.0 0.1 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.4 2.7 0.0 0.0 0.0 0.0 0.0 ZIC4 ENSG00000174963 "Zic family member 4" Q8N9L1 3 147386046-147406860 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 52.2" "Group enriched" "Detected in some" 5 "Collecting duct cells: 1.8;Early spermatids: 2.8;Late spermatids: 6.7;Muller glia cells: 4.2" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 18 "cerebellum: 52.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 18.7;ASC diff: 5.3;BEWO: 4.0;MCF7: 5.3;SH-SY5Y: 5.6;U-2197: 4.4" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 118.4" HPA030194 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030194: AB_2673367" "unprognostic (1.12e-1)" "unprognostic (9.95e-2)" "unprognostic (5.59e-3)" "unprognostic (1.02e-1)" "unprognostic (6.83e-2)" "unprognostic (1.10e-1)" "unprognostic (2.20e-1)" "unprognostic (9.13e-2)" "unprognostic (1.10e-10)" "unprognostic (3.50e-2)" "unprognostic (8.69e-2)" 0.2 0.0 0.2 0.0 0.4 0.0 0.0 52.2 7.9 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.8 0.0 0.5 0.0 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 1.0 0.0 0.0 3.7 3.5 0.5 0.0 1.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 18.7 0.0 5.3 2.2 4.0 1.9 0.4 0.2 0.5 0.0 0.0 0.0 2.4 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.0 0.4 5.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 5.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.4 0.0 4.4 2.0 0.0 0.0 0.0 1.8 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 52.2 0.4 0.3 0.8 0.3 0.4 2.9 0.3 0.0 0.0 0.0 0.0 0.1 0.6 0.8 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 ZIC5 ENSG00000139800 "Zic family member 5" Q96T25 13 99962964-99971909 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 48.9" "Cell type enhanced" "Detected in some" 29 "Muller glia cells: 1.7;Rod photoreceptor cells: 1.3;Spermatocytes: 5.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 24 "cerebellum: 48.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 11.2;HEK 293: 6.4;NTERA-2: 7.6;SCLC-21H: 43.8" "Group enriched" "Detected in many" 5 "basal ganglia: 19.3;cerebellum: 20.7;thalamus: 5.7" "Region enriched" "Detected in all" 6 "cerebellum: 53.2" HPA074045 Uncertain Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA074045: " "unprognostic (2.78e-5)" "unprognostic (1.71e-2)" "unprognostic (2.44e-2)" "unprognostic (2.29e-3)" "unprognostic (1.07e-1)" "unprognostic (1.30e-1)" "unprognostic (4.38e-4)" "unprognostic (2.13e-2)" "unprognostic (1.02e-1)" "unprognostic (5.01e-2)" "unprognostic (1.06e-2)" "unprognostic (3.87e-2)" "unprognostic (1.13e-1)" "unprognostic (3.12e-2)" "unprognostic (4.94e-2)" 0.1 0.0 1.2 0.0 0.5 0.0 0.1 48.9 4.2 0.0 0.2 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.5 0.5 0.1 0.1 0.1 0.1 0.4 0.3 0.0 0.0 0.1 0.0 0.0 2.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.8 0.1 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 11.2 0.9 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.5 1.0 0.0 1.6 0.0 0.5 0.0 2.2 0.0 0.0 1.9 6.4 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.4 1.5 0.0 0.0 0.8 0.0 0.8 7.6 0.0 0.1 0.9 0.4 0.0 0.0 0.0 43.8 0.0 1.2 1.0 0.0 0.8 0.0 1.4 0.0 0.6 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.5 48.9 1.3 1.5 0.5 0.4 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.3 0.0 0.0 5.7 0.4 0.0 0.0 0.0 0.0 0.0 ZKSCAN1 "KOX18, PHZ-37, ZNF139, ZNF36, ZSCAN33" ENSG00000106261 "Zinc finger with KRAB and SCAN domains 1" P17029 7 100015572-100041689 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Intestinal endocrine cells: 212.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006672 Uncertain Approved "Nucleoplasm,Nuclear bodies,Mitochondria" Yes No "Nuclear bodies" "Nucleoplasm, Mitochondria" "HPA006672: AB_1080707" "unprognostic (2.58e-1)" "unprognostic (1.59e-2)" "unprognostic (3.57e-2)" "unprognostic (4.62e-2)" "unprognostic (1.94e-1)" "unprognostic (2.24e-2)" "unprognostic (1.47e-2)" "unprognostic (4.76e-3)" "unprognostic (3.24e-2)" "unprognostic (1.86e-2)" "unprognostic (6.34e-3)" "unprognostic (8.59e-2)" "unprognostic (1.27e-3)" "unprognostic (7.75e-2)" "unprognostic (1.49e-1)" "unprognostic (1.70e-1)" "unprognostic (9.09e-3)" 11.7 19.5 16.1 12.1 23.9 8.1 23.6 15.0 23.9 16.8 21.2 38.9 16.3 18.1 16.2 18.3 19.8 23.0 25.1 10.8 18.8 15.2 14.2 47.6 11.7 12.2 26.1 27.3 20.6 26.7 18.3 14.3 11.1 27.6 24.3 24.3 14.7 25.0 19.4 11.9 32.5 16.5 14.3 23.6 13.5 33.0 16.4 23.1 17.3 12.5 11.4 12.1 14.4 17.5 6.1 7.3 13.3 10.0 11.7 7.5 4.5 9.2 6.8 18.1 19.8 18.7 22.8 6.8 10.4 12.7 6.2 6.3 4.1 8.8 10.5 13.3 11.6 11.0 7.7 10.4 9.0 12.0 10.1 6.4 8.5 8.3 10.6 10.6 16.1 10.2 15.3 14.4 8.4 28.3 17.0 13.7 12.5 19.5 9.2 12.3 12.3 15.3 9.6 7.3 17.4 8.6 9.1 9.2 9.4 10.5 14.6 21.1 25.2 16.2 21.3 18.3 10.8 10.8 10.8 20.6 13.7 13.4 15.9 10.5 10.7 18.5 10.9 9.3 11.6 17.9 13.3 4.7 5.0 6.8 4.0 6.7 5.1 5.4 6.7 7.3 6.1 7.5 5.3 5.3 11.7 10.0 5.2 4.3 4.5 16.1 23.9 15.0 23.9 18.8 15.2 26.1 27.3 27.6 23.1 23.8 39.4 30.6 38.6 13.4 91.6 37.3 142.7 161.9 56.9 43.6 141.4 32.1 13.3 46.0 35.7 43.9 59.0 0.0 38.3 12.7 32.9 84.1 33.6 124.6 17.1 84.2 212.3 35.6 28.8 14.6 47.5 27.1 38.8 27.9 82.8 74.9 41.8 84.2 50.2 23.0 68.3 19.4 22.2 28.9 14.6 18.7 55.2 18.7 98.9 47.9 ZKSCAN2 "FLJ23199, ZNF694, ZSCAN34" ENSG00000155592 "Zinc finger with KRAB and SCAN domains 2" Q63HK3 16 25236001-25257931 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 14.9;Cone photoreceptor cells: 13.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049141 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA Nucleoplasm "Nucleoli fibrillar center, Golgi apparatus" "HPA049141: AB_2680652" "unprognostic (2.71e-1)" "unprognostic (4.99e-2)" "unprognostic (2.47e-1)" "unprognostic (6.57e-2)" "unprognostic (3.03e-1)" "unprognostic (1.65e-1)" "unprognostic (1.26e-1)" "unprognostic (5.14e-2)" "unprognostic (1.01e-1)" "unprognostic (9.14e-2)" "unprognostic (8.28e-4)" "unprognostic (2.63e-1)" "prognostic favorable (1.70e-6)" "unprognostic (2.33e-1)" "unprognostic (2.29e-1)" "unprognostic (1.97e-1)" "unprognostic (4.03e-2)" 3.4 4.0 5.9 2.6 5.8 4.5 4.8 6.2 7.6 6.1 3.7 7.3 3.5 2.0 6.4 4.4 2.2 4.9 2.9 5.0 5.3 6.5 4.4 4.5 3.4 5.6 5.2 5.1 10.5 3.3 11.8 8.0 4.7 5.4 4.7 3.0 5.5 4.0 5.0 7.5 2.0 3.0 5.2 5.1 3.3 3.1 12.7 4.6 6.7 5.8 4.4 3.2 4.1 3.0 0.7 1.6 0.9 0.6 2.0 1.4 0.5 2.3 2.3 10.6 6.6 4.3 4.1 4.3 2.6 3.9 3.8 3.7 6.0 1.7 7.6 2.8 2.9 4.2 1.7 7.0 3.4 4.6 4.2 4.8 4.5 4.2 9.2 5.7 3.6 2.4 5.4 4.2 3.6 6.1 4.1 3.0 5.6 8.1 3.8 3.6 2.4 8.9 3.9 5.8 0.8 2.2 10.6 7.8 1.6 3.1 3.3 8.4 8.4 3.2 2.8 2.8 5.3 3.4 5.9 2.9 6.2 4.1 2.4 4.0 5.2 4.2 9.2 2.1 2.9 3.7 0.0 0.6 0.9 0.7 0.4 1.0 0.5 1.1 0.8 0.8 0.7 1.1 1.4 0.0 2.0 0.5 1.6 0.2 0.5 5.9 5.8 6.2 7.6 5.3 6.5 5.2 5.1 5.4 4.6 14.9 2.9 1.5 2.2 0.7 6.8 2.8 0.0 1.4 0.0 1.8 13.7 3.0 0.0 1.3 3.2 2.2 0.9 0.0 0.8 1.7 1.9 1.9 1.1 2.6 1.3 6.4 4.7 0.6 1.5 1.3 4.6 0.8 1.7 1.0 1.5 3.7 1.9 0.0 3.5 1.1 8.8 0.0 1.4 9.8 7.9 0.5 3.4 0.8 1.3 1.3 ZKSCAN3 "ZF47, Zfp47, ZNF306, ZNF309, ZSCAN35" ENSG00000189298 "Zinc finger with KRAB and SCAN domains 3" Q9BRR0 6 28349914-28369177 "Predicted intracellular proteins, Transcription factors" "Autophagy, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 7.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA009637, HPA060116" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA009637: AB_2668244, HPA060116: AB_2732641" "unprognostic (2.71e-2)" "unprognostic (1.94e-1)" "unprognostic (8.12e-2)" "unprognostic (2.67e-1)" "prognostic favorable (4.93e-4)" "unprognostic (6.42e-2)" "unprognostic (4.63e-3)" "unprognostic (2.50e-2)" "unprognostic (8.65e-2)" "unprognostic (4.37e-3)" "unprognostic (7.09e-3)" "unprognostic (1.29e-1)" "unprognostic (8.20e-2)" "unprognostic (2.73e-1)" "unprognostic (2.00e-1)" "unprognostic (2.41e-2)" "unprognostic (3.10e-3)" 6.7 8.7 5.8 10.3 9.0 2.4 8.8 11.8 10.3 9.3 9.3 12.3 7.2 4.9 11.2 10.5 6.4 8.6 7.5 6.0 6.3 4.9 7.6 7.2 6.8 6.6 7.1 8.9 12.9 7.3 14.4 13.5 8.7 10.6 9.6 8.8 8.7 7.6 10.2 5.1 8.2 7.2 10.5 9.0 9.3 8.8 7.1 8.1 14.9 9.7 3.8 8.3 9.3 8.4 4.8 4.2 9.6 4.0 3.1 4.9 2.1 3.1 1.9 7.5 13.4 6.8 4.8 2.8 2.8 3.1 4.8 6.4 2.5 1.8 4.9 6.6 3.0 5.2 4.3 8.2 3.7 4.9 4.5 3.4 6.4 4.9 4.1 4.8 6.3 2.1 4.3 3.3 5.3 4.5 5.7 7.6 6.3 16.1 3.2 5.7 1.0 3.2 6.1 3.4 1.8 2.0 9.1 5.8 7.0 5.0 2.3 6.0 6.7 5.0 2.7 4.5 10.3 3.8 6.4 4.5 5.1 3.3 3.3 3.5 4.2 6.3 4.5 1.7 8.4 3.4 3.0 2.4 9.6 4.8 4.0 4.9 4.7 3.2 3.7 3.2 4.8 3.0 4.9 3.1 3.1 2.4 4.2 4.2 2.1 5.8 9.0 11.8 10.3 6.3 4.9 7.1 8.9 10.6 8.1 0.0 4.3 0.0 0.4 0.5 1.1 1.6 0.0 4.0 0.0 3.5 7.9 2.2 0.0 1.1 0.6 2.1 1.0 0.0 0.9 1.7 1.0 0.5 2.3 1.5 1.7 0.0 0.0 4.9 4.3 1.5 2.6 1.0 0.0 2.8 2.2 2.2 1.9 0.0 1.4 1.4 1.9 0.0 0.9 0.7 1.1 0.3 0.8 1.9 2.3 0.3 ZKSCAN4 "FLJ32136, P1P373C6, p373c6.1, ZNF307, ZNF427, ZSCAN36" ENSG00000187626 "Zinc finger with KRAB and SCAN domains 4" Q969J2 6 28244623-28252224 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Kupffer cells: 9.4;Spermatocytes: 17.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA009637 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA009637: AB_2668244" "unprognostic (4.29e-2)" "unprognostic (2.88e-1)" "unprognostic (1.04e-1)" "unprognostic (5.01e-2)" "unprognostic (4.23e-3)" "unprognostic (3.77e-2)" "prognostic unfavorable (1.90e-6)" "prognostic favorable (5.04e-4)" "unprognostic (8.73e-3)" "unprognostic (1.80e-2)" "unprognostic (7.20e-2)" "unprognostic (5.13e-2)" "unprognostic (2.13e-2)" "unprognostic (1.62e-1)" "unprognostic (6.07e-2)" "unprognostic (9.70e-2)" "unprognostic (7.36e-3)" 5.9 6.1 5.8 5.2 8.9 2.7 7.5 13.2 8.3 6.5 5.7 7.5 6.8 6.3 8.5 6.9 5.7 6.7 5.3 4.1 5.6 4.2 5.8 6.0 5.2 10.4 4.9 5.3 8.4 9.4 7.2 7.3 7.3 5.7 6.0 6.7 6.2 6.5 6.9 3.5 6.4 7.1 5.2 6.8 16.1 5.3 15.8 7.3 16.1 5.5 2.4 10.4 6.7 6.4 5.9 12.8 9.3 5.9 6.8 9.1 4.4 3.4 2.6 6.3 9.3 7.4 7.2 6.6 4.2 6.7 6.6 6.6 3.8 3.0 8.4 8.0 5.1 4.1 3.9 6.7 5.7 6.6 3.9 6.2 7.2 5.4 5.2 5.2 13.9 6.1 8.3 6.7 5.9 5.5 7.5 6.5 7.3 7.2 1.8 5.1 3.6 8.1 14.1 4.9 1.5 4.8 7.8 8.5 5.2 3.5 2.6 8.6 7.1 3.6 4.2 7.1 6.7 4.0 6.1 4.3 6.7 4.0 3.6 4.3 5.5 5.2 4.0 2.1 13.5 4.1 9.3 5.7 5.9 6.1 4.7 7.0 5.9 6.0 5.9 9.9 5.1 9.1 8.1 7.4 6.8 5.9 12.8 5.4 4.4 5.8 8.9 13.2 8.3 5.6 4.2 4.9 5.3 5.7 7.3 0.0 0.3 2.0 0.2 0.3 1.3 1.2 2.5 0.0 3.4 1.8 2.0 2.9 0.0 2.4 5.2 1.1 1.5 0.0 1.8 2.3 1.4 0.3 2.3 0.9 4.0 1.6 3.4 4.3 9.4 5.6 2.6 2.3 1.7 1.8 1.3 2.0 1.6 3.1 3.5 1.4 1.8 0.0 0.9 17.1 1.9 0.3 0.9 2.2 2.8 0.3 ZKSCAN8 "LD5-1, ZNF192, ZSCAN40" ENSG00000198315 "Zinc finger with KRAB and SCAN domains 8" Q15776 6 28141910-28159472 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003483 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003483: AB_1080686" "unprognostic (2.02e-1)" "unprognostic (1.45e-1)" "unprognostic (3.94e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (2.75e-3)" "unprognostic (4.19e-2)" "unprognostic (2.24e-3)" "unprognostic (5.34e-2)" "unprognostic (9.80e-3)" "unprognostic (4.68e-3)" "unprognostic (2.63e-2)" "unprognostic (2.29e-1)" "unprognostic (1.22e-2)" "unprognostic (4.30e-2)" "unprognostic (1.66e-1)" "unprognostic (1.28e-1)" "unprognostic (6.33e-3)" 16.5 12.1 13.4 10.3 15.6 17.7 16.1 27.7 16.5 17.7 16.3 20.8 12.5 9.2 21.8 19.9 10.0 17.2 11.0 10.7 13.5 9.3 11.2 10.9 14.1 13.9 18.4 13.3 25.0 15.4 21.9 22.6 12.8 14.0 15.1 11.9 17.2 13.9 17.2 12.0 11.5 15.9 18.3 18.2 14.4 14.1 12.8 18.2 18.1 17.1 8.8 14.5 16.7 12.4 3.8 1.9 4.1 4.2 3.0 3.1 1.3 5.8 3.7 18.1 17.9 11.6 10.9 5.7 6.7 12.1 8.5 10.9 4.1 3.5 12.9 10.9 6.4 7.4 5.1 11.5 4.4 12.7 6.9 9.8 11.7 7.1 9.5 10.7 14.3 8.8 11.4 7.6 8.9 13.6 15.2 8.8 11.5 17.9 4.9 9.1 3.0 10.0 12.7 6.8 1.5 4.2 10.7 11.4 10.2 6.3 7.2 13.7 17.3 7.8 3.7 8.5 10.8 4.2 8.1 7.3 13.0 7.5 4.3 8.8 12.0 8.5 10.7 3.7 10.1 6.9 4.1 1.3 1.3 2.7 3.3 3.1 1.5 1.7 1.2 1.0 3.8 2.8 2.3 0.5 3.0 4.2 1.9 1.6 1.3 13.4 15.6 27.7 16.5 13.5 9.3 18.4 13.3 14.0 18.2 3.0 9.4 0.9 2.0 4.2 8.8 6.9 10.2 5.3 5.7 7.0 5.9 3.3 0.0 2.5 2.9 7.0 1.7 0.0 2.5 1.7 5.4 3.9 4.7 7.8 3.6 6.4 6.9 7.4 9.1 3.4 8.3 4.7 1.7 2.8 4.9 7.5 2.4 0.0 8.5 1.4 8.1 0.0 7.2 10.8 5.7 2.5 1.9 6.9 3.9 2.0 ZMAT1 KIAA1789 ENSG00000166432 "Zinc finger matrin-type 1" Q5H9K5 X 101882288-101932031 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "epididymis: 38.7" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 54.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 12.6;U-266/70: 6.3" "Low region specificity" "Detected in all" HPA012827 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA012827: AB_1859070" "unprognostic (9.30e-2)" "unprognostic (4.13e-2)" "unprognostic (2.51e-2)" "unprognostic (2.80e-1)" "unprognostic (1.08e-1)" "unprognostic (1.08e-5)" "unprognostic (1.20e-3)" "unprognostic (2.22e-2)" "unprognostic (3.70e-2)" "unprognostic (6.09e-2)" "prognostic favorable (1.72e-5)" "unprognostic (6.33e-3)" "unprognostic (1.72e-2)" "unprognostic (3.05e-1)" "unprognostic (5.28e-2)" "unprognostic (2.21e-1)" "unprognostic (1.38e-2)" 6.1 13.0 11.4 9.9 12.4 10.0 9.9 7.1 12.8 5.0 4.9 16.5 7.0 4.0 7.4 38.7 3.0 7.3 7.2 7.6 11.1 9.6 9.6 6.5 10.8 10.9 10.2 11.4 11.9 7.3 14.5 31.4 2.3 9.2 9.3 3.4 13.6 7.9 14.2 5.1 4.3 5.4 8.3 12.0 10.7 4.1 5.9 11.3 7.0 18.8 3.2 7.5 3.3 3.7 3.7 3.2 2.6 1.1 0.6 1.6 0.6 0.4 0.0 1.5 1.5 0.0 0.0 0.2 0.6 0.1 0.0 0.7 0.0 1.8 2.7 0.2 0.0 0.4 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.4 0.8 0.0 0.0 0.0 0.3 0.3 1.1 2.8 0.0 12.6 1.0 0.0 0.1 0.2 1.9 0.0 0.2 2.1 0.0 0.1 3.4 0.0 0.6 1.7 1.0 0.0 0.1 1.7 2.2 3.1 3.1 0.9 0.0 0.0 0.1 6.3 0.4 0.0 0.6 3.0 0.9 2.6 1.1 1.7 0.9 0.4 1.6 2.0 1.3 1.4 0.2 3.7 1.6 1.4 0.8 0.6 0.7 3.2 0.6 0.6 11.4 12.4 7.1 12.8 11.1 9.6 10.2 11.4 9.2 11.3 14.9 34.0 4.5 5.8 3.7 34.3 22.7 5.1 22.7 26.1 14.0 41.2 0.0 3.3 3.2 8.5 10.8 1.1 23.3 2.5 0.0 5.4 9.2 15.1 9.0 3.1 15.9 9.9 12.3 6.1 7.5 1.7 9.3 6.8 8.2 2.9 38.4 1.6 1.4 1.1 3.7 54.5 0.0 8.6 10.3 9.7 2.5 0.1 8.7 2.1 4.1 ZMAT2 "FLJ31121, hSNU23, Snu23" ENSG00000146007 "Zinc finger matrin-type 2" Q96NC0 5 140698680-140706676 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036518 Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA036518: AB_10671960" "unprognostic (4.00e-1)" "unprognostic (2.43e-3)" "prognostic favorable (7.96e-4)" "unprognostic (2.31e-1)" "unprognostic (2.32e-1)" "unprognostic (1.60e-3)" "unprognostic (1.25e-3)" "unprognostic (2.16e-1)" "unprognostic (2.35e-1)" "unprognostic (3.38e-3)" "unprognostic (6.01e-2)" "unprognostic (8.27e-2)" "unprognostic (4.60e-3)" "unprognostic (2.54e-1)" "unprognostic (2.72e-2)" "unprognostic (2.91e-3)" "unprognostic (2.84e-2)" 25.3 25.1 36.7 19.9 50.4 32.1 31.9 31.2 52.4 23.6 26.7 16.0 24.9 17.7 27.7 29.1 29.7 27.1 17.6 18.1 60.2 27.6 31.2 29.4 21.3 25.3 28.4 53.8 26.5 17.6 36.5 21.9 24.1 33.6 22.7 30.0 13.9 24.6 26.5 102.9 25.1 19.9 25.2 36.1 26.2 24.7 15.2 19.8 24.4 23.7 29.8 33.9 20.9 30.7 12.3 11.8 42.5 15.1 11.2 17.1 11.5 22.3 37.6 24.5 41.7 40.2 27.0 33.0 23.4 25.6 32.5 35.6 57.6 37.4 25.2 37.9 40.0 36.5 21.5 34.6 46.7 41.4 27.5 30.8 20.4 45.5 40.0 25.5 47.5 27.1 31.0 36.0 33.5 39.2 32.5 27.4 40.6 22.7 28.1 29.9 34.3 38.4 33.4 18.2 15.8 24.2 26.9 28.9 27.4 28.5 32.8 29.1 22.3 32.9 33.1 34.3 36.3 45.3 41.8 22.7 28.6 15.4 14.8 35.7 18.4 37.3 28.5 30.5 33.2 21.7 20.9 15.1 23.6 13.4 12.3 17.1 12.3 14.8 13.7 10.9 12.0 14.0 14.7 42.5 11.2 12.0 11.8 13.9 11.5 36.7 50.4 31.2 52.4 60.2 27.6 28.4 53.8 33.6 19.8 47.6 66.5 76.7 61.0 50.5 28.3 71.2 79.0 100.4 79.6 66.3 5.9 109.7 99.5 67.5 6.5 62.6 68.8 163.5 58.5 105.3 53.9 57.5 77.7 83.2 72.9 15.9 66.0 46.6 91.4 9.8 52.3 72.0 55.6 129.0 47.6 71.0 61.9 73.7 54.5 126.4 18.0 51.8 51.5 36.1 75.4 55.3 173.5 79.8 53.0 81.0 ZMAT3 "FLJ12296, MGC10613, PAG608, WIG-1, WIG1" ENSG00000172667 "Zinc finger matrin-type 3" Q9HA38 3 179017223-179072279 "Predicted intracellular proteins" "Apoptosis, DNA damage, Growth regulation, Protein transport, Translocation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 150.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 28.8;LHCN-M2: 31.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027569, HPA028671, HPA054356" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA027569: AB_2732438, HPA028671: AB_2672725, HPA054356: AB_2682460" "unprognostic (3.53e-3)" "unprognostic (1.76e-1)" "unprognostic (1.56e-1)" "unprognostic (1.46e-1)" "unprognostic (1.46e-1)" "unprognostic (1.88e-1)" "unprognostic (4.81e-2)" "unprognostic (3.57e-2)" "unprognostic (1.45e-1)" "unprognostic (4.37e-2)" "unprognostic (6.88e-2)" "unprognostic (1.60e-1)" "unprognostic (1.85e-2)" "unprognostic (7.09e-2)" "unprognostic (2.51e-1)" "unprognostic (3.91e-2)" "unprognostic (1.46e-2)" 7.1 11.9 18.8 7.1 19.7 4.4 8.3 7.5 27.3 9.1 8.4 9.6 4.4 4.9 8.5 8.6 10.0 8.2 12.6 8.6 15.8 17.1 9.1 16.2 8.2 9.2 16.9 13.3 7.0 7.3 15.7 10.1 7.8 17.4 8.6 12.6 7.1 7.6 11.5 5.5 8.4 5.4 15.5 14.4 9.2 7.2 4.6 9.4 15.7 10.6 3.2 8.6 9.4 6.7 3.6 1.8 3.9 3.3 4.0 5.8 1.3 2.0 1.4 4.5 2.6 21.7 24.8 10.4 8.0 12.4 1.2 1.5 1.8 1.2 8.5 4.1 13.1 1.8 1.9 1.5 8.8 2.7 6.1 2.4 3.5 2.8 5.7 17.3 3.9 5.6 28.8 16.6 2.9 5.8 19.1 17.1 2.4 1.9 1.0 31.8 2.0 3.3 0.7 2.0 2.8 1.1 3.6 4.1 1.8 6.9 4.0 0.9 4.7 2.5 2.3 2.7 8.8 2.8 1.7 19.1 18.4 6.8 3.1 3.7 1.0 0.9 3.5 11.0 0.5 12.5 3.4 1.8 3.9 4.8 1.3 2.7 2.3 3.5 3.9 1.7 3.6 5.8 4.2 2.3 4.0 3.3 1.8 2.5 1.3 18.8 19.7 7.5 22.3 15.8 17.1 16.9 13.3 17.4 9.4 50.6 150.5 11.0 9.5 35.1 19.2 17.1 33.1 33.5 54.6 33.2 23.6 6.8 6.6 13.0 0.7 12.3 11.6 0.0 18.0 2.5 17.4 17.4 37.1 30.0 15.3 58.8 20.1 19.0 40.6 1.5 18.7 15.1 49.0 47.7 10.0 11.8 21.3 12.9 27.3 14.6 10.8 38.8 27.2 7.1 12.8 32.0 3.7 20.8 8.3 9.2 ZMAT4 FLJ13842 ENSG00000165061 "Zinc finger matrin-type 4" Q9H898 8 40530590-40897833 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 11.5;brain: 21.6;thyroid gland: 29.1" "Group enriched" "Detected in some" 5 "Early spermatids: 18.2;Late spermatids: 39.7" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.9" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 115 "NK-cell: 11.5" "Lineage enriched" "Detected in single" 115 "NK-cells: 11.5" "Group enriched" "Detected in some" 5 "AF22: 21.1;U-2197: 13.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA069813, HPA071585" Enhanced Approved Nucleoplasm,Nucleoli No NA "Nucleoplasm, Nucleoli" "HPA069813: AB_2686206, HPA071585: AB_2686423" "unprognostic (1.25e-2)" "unprognostic (9.29e-2)" "unprognostic (2.80e-1)" "unprognostic (2.83e-3)" "unprognostic (1.00e-1)" "unprognostic (1.42e-1)" "unprognostic (1.07e-1)" "unprognostic (9.73e-2)" "unprognostic (1.24e-1)" "unprognostic (2.02e-2)" "unprognostic (4.46e-4)" "unprognostic (5.44e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (3.51e-4)" "unprognostic (4.79e-3)" 0.8 2.0 4.4 0.9 15.3 0.8 0.9 0.6 20.4 3.3 1.0 0.9 0.0 0.7 1.4 1.0 0.7 0.9 1.0 1.5 6.1 4.0 1.2 0.7 0.8 0.9 3.3 7.8 1.6 0.7 0.7 5.3 1.0 21.6 1.6 1.2 1.4 0.8 1.5 0.7 0.7 0.8 0.8 1.0 1.3 1.0 2.9 3.9 0.0 29.1 0.0 0.9 0.8 0.2 0.0 0.0 0.0 0.0 11.5 0.0 0.1 0.0 1.2 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.2 0.0 0.0 0.2 0.0 0.0 1.2 0.3 0.0 0.0 0.0 1.8 3.4 0.0 0.0 0.0 0.6 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.1 4.4 15.3 0.6 20.4 6.1 4.0 3.3 7.8 21.6 3.9 0.0 0.0 0.0 0.2 0.0 6.0 0.4 2.5 0.0 0.0 0.0 5.9 0.0 1.7 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 39.7 2.6 0.0 0.0 0.0 0.0 1.2 0.0 0.0 2.1 0.0 1.4 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 ZMAT5 "SNRNP20, ZC3H19" ENSG00000100319 "Zinc finger matrin-type 5" Q9UDW3 22 29730956-29767011 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004858 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA004858: AB_1080657" "unprognostic (2.14e-1)" "unprognostic (8.03e-3)" "unprognostic (1.23e-1)" "unprognostic (1.19e-2)" "unprognostic (1.02e-1)" "unprognostic (5.47e-3)" "unprognostic (6.04e-3)" "unprognostic (5.69e-2)" "unprognostic (5.75e-2)" "unprognostic (3.71e-2)" "unprognostic (2.04e-1)" "unprognostic (2.15e-2)" "unprognostic (1.03e-1)" "unprognostic (1.52e-1)" "unprognostic (2.65e-1)" "unprognostic (2.62e-1)" "unprognostic (4.10e-2)" 10.6 20.3 18.7 10.6 21.5 13.4 11.9 11.8 20.2 13.2 12.2 16.4 24.9 12.9 13.8 22.2 15.5 22.4 11.1 20.4 16.7 14.4 14.7 18.4 14.0 13.9 17.1 16.9 16.5 20.9 18.4 8.5 8.9 16.7 14.0 7.9 13.5 19.2 19.2 34.2 13.0 10.8 14.7 17.0 15.0 13.8 13.3 15.0 16.0 21.3 11.9 12.5 13.2 12.2 26.8 34.1 42.2 41.8 26.0 26.8 28.3 10.1 12.9 11.4 21.9 14.3 16.0 5.2 11.1 14.0 16.9 20.8 11.0 6.4 6.9 11.3 11.8 13.0 9.5 9.7 11.6 11.3 22.2 21.1 26.6 6.5 20.4 26.8 12.1 8.8 13.9 17.9 21.6 13.2 14.4 17.8 11.0 6.9 15.3 14.0 15.0 17.3 12.7 4.2 19.8 15.1 21.0 20.3 18.4 13.4 6.2 8.9 16.4 10.5 13.2 15.6 6.7 19.8 17.1 11.3 23.3 11.7 15.6 16.5 14.2 11.3 11.4 17.8 14.7 16.3 20.7 39.9 42.2 22.8 41.8 22.8 26.8 23.8 23.6 34.1 24.4 20.9 24.6 32.4 26.0 40.7 26.4 26.8 28.3 18.7 21.5 11.8 20.2 16.7 14.4 17.1 16.9 16.7 15.0 14.9 21.0 14.0 18.0 8.5 11.8 1.2 17.8 14.7 10.3 14.0 17.7 19.0 28.2 29.5 0.6 11.9 18.2 23.3 23.7 15.0 17.5 10.8 33.4 11.5 39.9 4.8 13.8 12.3 23.0 1.5 14.7 22.5 11.8 34.3 16.9 24.6 26.5 17.3 20.5 30.5 16.7 32.3 19.6 8.6 23.8 10.3 11.8 23.5 13.6 16.0 ZMIZ1 "FLJ13541, hZIMP10, KIAA1224, MIZ, RAI17, RP11-519K18.1, Zimp10" ENSG00000108175 "Zinc finger MIZ-type containing 1" Q9ULJ6 10 79069035-79316528 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 174.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 54.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045144, HPA071156" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA045144: AB_10962360, HPA071156: " "unprognostic (4.09e-3)" "unprognostic (1.72e-1)" "unprognostic (2.63e-1)" "unprognostic (5.59e-2)" "unprognostic (2.02e-1)" "unprognostic (2.86e-2)" "unprognostic (3.64e-3)" "unprognostic (1.06e-1)" "unprognostic (9.96e-2)" "unprognostic (1.16e-1)" "unprognostic (3.13e-2)" "unprognostic (7.90e-2)" "prognostic favorable (3.64e-7)" "unprognostic (2.42e-1)" "unprognostic (1.18e-1)" "unprognostic (8.22e-2)" "unprognostic (1.34e-2)" 24.7 21.1 15.9 15.8 18.9 20.0 24.1 43.7 35.7 41.5 21.3 23.8 26.0 16.5 42.4 18.0 28.1 22.2 35.5 25.1 19.0 17.1 17.4 13.9 23.5 13.7 22.2 15.7 44.3 20.2 14.6 12.7 18.7 22.1 21.9 13.0 33.3 24.6 26.9 38.0 24.5 21.2 25.6 16.4 36.2 21.4 8.4 21.5 16.0 33.3 22.4 16.5 25.6 30.1 1.0 4.6 5.7 6.1 5.4 2.3 1.8 7.1 9.0 17.1 7.3 17.8 5.1 5.9 6.9 12.4 4.9 2.8 2.6 3.3 3.7 5.6 16.1 12.8 10.1 2.8 5.1 2.6 7.9 1.5 13.1 3.4 7.7 12.6 7.2 27.7 6.7 5.7 7.0 5.0 31.1 7.8 3.1 5.0 19.6 4.1 13.6 7.2 11.3 5.0 4.1 13.7 32.2 3.2 3.6 3.6 6.0 17.9 26.1 4.5 54.9 14.2 6.4 17.5 7.0 10.9 18.6 7.5 9.3 8.7 3.6 6.3 0.0 24.4 12.9 3.5 1.8 3.7 2.7 2.3 6.1 1.6 1.0 1.6 1.2 4.6 0.4 0.6 1.2 5.7 5.4 5.1 4.5 1.6 1.8 15.9 18.9 43.7 19.1 19.0 17.1 22.2 15.7 22.1 21.5 35.7 24.2 15.7 8.0 20.3 45.8 47.8 22.9 18.7 18.2 15.7 0.0 6.1 6.6 17.8 40.8 38.3 20.5 0.0 21.1 4.7 23.1 10.7 48.6 8.6 34.9 60.4 13.3 62.0 35.9 174.4 26.2 39.9 23.6 13.6 15.9 13.3 18.0 20.1 22.3 7.3 3.4 19.4 18.9 1.7 2.3 20.7 3.0 8.5 13.6 10.7 ZMIZ2 "DKFZp761I2123, hZIMP7, KIAA1886, NET27, ZIMP7" ENSG00000122515 "Zinc finger MIZ-type containing 2" Q8NF64 7 44748581-44769881 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 62.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040716 Supported Supported Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA040716: AB_10805826" "unprognostic (2.28e-2)" "unprognostic (1.89e-1)" "unprognostic (1.44e-2)" "unprognostic (2.21e-2)" "unprognostic (9.46e-3)" "unprognostic (1.01e-3)" "prognostic unfavorable (6.82e-5)" "unprognostic (2.47e-1)" "unprognostic (2.36e-1)" "unprognostic (2.73e-1)" "unprognostic (5.89e-2)" "unprognostic (4.58e-2)" "unprognostic (1.05e-1)" "unprognostic (1.80e-1)" "unprognostic (1.66e-1)" "unprognostic (1.15e-1)" "unprognostic (3.15e-3)" 14.3 16.0 31.7 24.5 31.5 19.8 13.3 24.0 43.2 12.7 15.2 22.9 17.5 23.8 16.4 16.8 16.8 17.3 17.3 15.9 28.2 15.4 19.0 10.1 18.3 24.0 17.0 27.2 17.9 32.3 19.8 23.0 11.0 17.0 16.4 12.5 16.5 32.5 23.0 18.7 31.1 22.2 17.9 16.5 28.8 21.3 20.8 17.5 16.7 25.1 14.0 19.1 15.5 13.2 4.9 4.1 1.0 2.4 3.4 2.5 0.9 14.4 16.6 7.8 15.0 5.3 3.5 8.2 7.4 7.1 6.4 7.7 9.4 22.7 9.9 11.7 7.7 15.9 19.8 4.8 8.4 3.8 23.5 9.2 4.0 15.6 7.4 10.9 5.7 8.9 5.4 5.2 10.0 6.6 5.7 11.8 10.8 11.7 22.6 9.3 13.8 12.7 15.9 14.7 11.0 16.2 15.9 4.3 12.9 7.5 11.1 27.7 18.3 10.0 19.6 4.5 7.7 18.6 8.9 17.5 6.1 13.4 16.4 17.0 33.3 10.5 7.7 11.8 10.2 24.9 1.0 1.6 0.7 2.5 2.4 1.6 2.7 1.2 1.8 1.6 4.9 0.8 0.9 0.7 3.4 1.2 4.1 1.1 0.9 31.7 31.5 24.0 43.2 28.2 15.4 17.0 27.2 17.0 17.5 11.9 19.2 10.7 3.8 9.0 10.7 14.5 2.5 8.1 11.4 22.7 13.7 6.7 1.7 15.0 24.7 12.3 15.8 0.0 13.5 2.1 9.7 8.2 13.9 14.5 9.7 11.1 19.1 15.4 17.9 62.4 12.4 14.8 13.5 32.5 17.7 4.9 20.5 14.0 17.0 6.9 6.9 6.5 9.8 4.5 5.3 16.2 6.1 9.6 20.0 8.4 ZMYM2 "FIM, MYM, RAMP, ZNF198" ENSG00000121741 "Zinc finger MYM-type containing 2" Q9UBW7 13 19958670-20091829 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031765 Approved Approved "Nucleoplasm,Endoplasmic reticulum" NA NA "Nucleoplasm, Endoplasmic reticulum" "HPA031765: AB_10601927" "unprognostic (2.96e-1)" "unprognostic (3.42e-3)" "unprognostic (1.85e-1)" "unprognostic (1.69e-1)" "unprognostic (7.71e-2)" "unprognostic (2.33e-1)" "unprognostic (2.66e-3)" "unprognostic (1.16e-1)" "unprognostic (6.78e-2)" "unprognostic (5.88e-2)" "unprognostic (4.60e-2)" "unprognostic (2.80e-2)" "unprognostic (6.65e-3)" "unprognostic (2.05e-1)" "unprognostic (8.74e-2)" "unprognostic (1.06e-1)" "prognostic favorable (6.07e-4)" 15.0 17.3 15.9 18.1 23.3 22.2 16.1 23.9 26.8 18.3 16.8 14.0 13.7 13.3 20.0 14.0 18.5 16.1 15.7 17.1 14.4 12.0 17.3 13.7 15.4 14.2 12.9 20.2 21.7 16.2 17.1 32.1 14.0 23.2 19.4 13.8 13.8 18.2 17.6 19.7 18.3 14.5 15.3 16.2 16.3 16.0 44.5 16.5 38.0 24.3 10.4 19.7 19.5 17.2 5.5 6.3 7.4 5.9 5.4 7.9 3.5 6.4 5.8 22.3 9.6 9.9 10.6 10.6 6.7 10.8 8.7 10.4 8.9 13.3 15.4 6.2 9.4 8.3 10.3 16.4 7.2 11.8 6.1 4.6 27.2 8.7 4.4 9.9 22.9 8.3 10.5 13.5 6.9 7.1 13.8 14.7 15.9 10.3 11.0 11.9 9.1 22.1 6.5 20.6 19.5 3.6 24.7 24.3 7.2 6.7 9.4 26.1 26.0 13.0 9.3 12.2 15.7 12.3 16.4 8.6 4.3 6.9 5.2 3.5 8.7 6.8 15.9 3.7 5.4 10.3 0.2 5.2 4.0 5.5 5.9 6.7 5.5 7.5 5.6 6.1 4.5 7.9 6.9 7.4 5.4 4.9 6.3 5.4 3.5 15.9 23.3 23.9 26.8 14.4 12.0 12.9 20.2 23.2 16.5 41.7 35.3 47.7 40.3 48.9 111.9 33.0 28.1 36.1 46.6 48.8 106.0 13.1 5.0 20.1 90.8 35.1 23.6 0.0 15.4 10.5 38.8 45.9 45.1 28.4 19.1 68.3 53.6 43.6 57.0 140.1 51.8 45.1 32.1 20.8 31.0 48.9 25.9 31.6 38.5 13.7 112.6 32.3 39.3 94.3 48.9 39.0 9.5 45.9 27.6 70.2 ZMYM3 "DXS6673E, KIAA0385, MYM, ZNF198L2, ZNF261" ENSG00000147130 "Zinc finger MYM-type containing 3" Q14202 X 71239624-71255146 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 29.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003211, HPA075255" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA003211: AB_1080661, HPA075255: AB_2732287" "unprognostic (2.17e-1)" "unprognostic (1.73e-1)" "unprognostic (1.31e-1)" "unprognostic (7.69e-3)" "unprognostic (2.03e-1)" "unprognostic (1.68e-1)" "prognostic unfavorable (5.18e-4)" "unprognostic (5.03e-2)" "unprognostic (9.10e-2)" "unprognostic (2.33e-2)" "unprognostic (4.07e-2)" "unprognostic (1.17e-1)" "unprognostic (2.93e-1)" "unprognostic (2.73e-1)" "unprognostic (5.50e-2)" "unprognostic (4.42e-2)" "unprognostic (1.30e-3)" 7.3 23.7 22.5 7.9 20.6 6.2 7.9 16.6 22.7 10.8 10.4 13.6 10.3 7.0 14.0 19.2 8.0 19.8 11.3 9.3 19.5 14.6 10.6 9.6 10.8 10.9 16.8 20.6 36.8 8.2 15.3 14.4 7.8 14.0 14.3 8.0 10.5 11.2 18.0 9.5 11.1 8.8 14.8 14.1 12.1 9.0 15.9 17.3 13.9 12.6 6.4 10.4 11.9 10.0 9.4 13.5 6.8 7.3 6.0 6.8 5.0 7.1 13.1 31.8 16.8 9.3 9.4 8.1 6.6 9.9 14.3 13.5 14.4 10.8 18.0 16.5 11.8 13.0 6.7 27.1 10.0 10.9 6.0 14.5 15.7 11.6 12.8 4.3 14.6 9.8 11.0 5.8 10.4 6.5 25.6 12.0 14.6 18.0 10.0 10.5 11.8 17.5 18.7 31.6 8.8 11.5 22.0 9.7 13.3 10.6 8.7 15.2 10.5 11.2 7.0 6.5 24.2 10.3 9.6 9.2 7.1 13.2 10.3 5.9 9.1 5.4 15.4 8.6 20.0 7.8 6.8 7.3 5.6 6.1 6.3 6.8 9.4 6.8 5.6 6.4 9.0 6.0 5.9 0.5 6.0 5.1 13.5 6.3 5.0 22.5 20.6 16.6 22.7 19.5 14.6 16.8 20.6 14.0 17.3 11.9 11.0 1.7 2.2 3.4 12.7 7.3 7.6 2.7 15.9 29.6 9.8 6.9 1.7 5.6 1.0 7.2 3.9 0.0 7.7 5.0 5.1 1.7 2.3 13.1 8.3 12.7 4.6 5.5 11.1 3.1 12.7 6.3 3.3 12.6 8.2 11.6 6.5 10.2 21.9 11.8 7.1 6.5 4.4 1.4 3.6 3.3 3.5 4.3 8.2 1.3 ZMYM4 "KIAA0425, MYM, ZNF198L3, ZNF262" ENSG00000146463 "Zinc finger MYM-type containing 4" Q5VZL5 1 35268967-35422058 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051301, HPA054802" Approved Approved Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "HPA051301: AB_2681431, HPA054802: AB_2682605" "unprognostic (8.95e-2)" "unprognostic (6.80e-2)" "unprognostic (1.51e-2)" "unprognostic (1.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (9.75e-9)" "unprognostic (9.76e-2)" "unprognostic (4.35e-3)" "unprognostic (4.44e-2)" "unprognostic (6.70e-2)" "unprognostic (4.98e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (1.18e-1)" "unprognostic (2.04e-1)" "unprognostic (9.18e-2)" "unprognostic (2.21e-1)" 16.6 15.9 17.9 17.3 22.1 13.6 19.7 28.1 24.7 22.0 14.8 17.1 18.3 10.2 19.8 18.2 15.0 17.9 15.7 13.1 17.6 19.0 15.8 14.4 14.1 15.0 15.8 14.6 27.0 15.7 26.1 22.6 19.6 22.2 21.0 13.6 18.2 18.0 26.8 15.9 12.9 12.5 16.6 15.2 16.0 15.4 36.3 13.6 26.7 21.6 13.0 18.8 17.2 14.7 4.2 9.8 3.5 8.2 9.6 4.4 2.5 12.8 10.4 32.1 16.2 9.4 20.4 11.8 15.3 23.1 18.7 24.4 11.2 12.9 23.9 9.4 19.1 9.1 8.3 22.2 11.3 27.0 13.5 15.4 29.2 12.2 9.5 17.0 25.0 13.2 15.4 10.1 18.1 17.2 15.6 20.7 13.3 31.8 6.6 22.6 7.7 21.1 13.9 26.7 6.7 10.0 23.7 20.6 11.6 13.4 17.0 18.5 18.0 18.4 13.5 20.9 21.1 10.9 19.0 24.9 17.4 18.1 7.6 16.4 7.2 13.4 18.4 12.6 19.1 16.6 2.4 5.0 3.5 4.3 7.1 4.4 4.2 4.2 3.8 4.8 3.7 4.1 3.9 1.0 9.6 8.2 9.8 3.1 2.5 17.9 22.1 28.1 24.7 17.6 19.0 15.8 14.6 22.2 13.6 11.9 15.0 11.0 16.2 10.2 27.2 29.5 35.7 22.7 22.7 26.2 29.5 12.4 5.0 19.4 48.6 21.1 5.3 0.0 20.5 10.2 15.8 19.3 13.9 16.1 11.2 22.3 21.5 17.2 18.4 69.6 24.5 13.7 5.0 13.6 13.8 20.1 18.6 9.0 21.5 9.1 33.8 19.4 15.5 22.9 10.4 9.9 11.8 11.7 12.2 24.5 ZMYM5 "MYM, ZNF198L1, ZNF237" ENSG00000132950 "Zinc finger MYM-type containing 5" Q9UJ78 13 19823482-19863636 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA015544, HPA020879" Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA015544: , HPA020879: AB_2670524" "unprognostic (4.14e-1)" "unprognostic (3.05e-2)" "unprognostic (1.63e-2)" "unprognostic (1.36e-1)" "unprognostic (4.94e-2)" "unprognostic (9.35e-2)" "unprognostic (1.07e-2)" "unprognostic (2.70e-2)" "unprognostic (3.79e-2)" "unprognostic (1.31e-2)" "unprognostic (1.73e-1)" "unprognostic (1.51e-1)" "unprognostic (4.37e-2)" "unprognostic (2.11e-1)" "unprognostic (2.49e-1)" "unprognostic (1.12e-1)" "unprognostic (7.16e-2)" 10.2 10.6 7.4 10.5 8.6 11.4 10.7 18.2 11.9 9.7 8.5 6.0 6.2 6.9 9.3 10.6 12.4 8.5 10.9 9.0 8.5 5.6 7.6 7.8 8.9 10.6 13.7 5.5 11.0 8.2 6.4 18.6 8.1 9.2 9.7 7.5 7.6 9.5 9.4 9.5 8.7 10.7 9.7 13.2 9.6 8.1 25.2 10.6 22.1 10.8 7.5 12.3 10.9 10.9 12.8 9.9 15.6 8.7 9.3 13.1 5.4 6.6 3.4 8.2 6.3 5.8 9.2 2.9 6.5 10.0 10.3 8.7 8.3 13.2 9.2 6.8 9.3 12.9 6.3 5.9 7.5 12.1 7.3 4.7 17.1 6.2 5.7 17.8 12.6 9.3 11.2 9.2 5.6 10.7 11.0 10.6 6.1 6.9 8.0 9.8 16.4 9.2 12.6 4.3 8.8 5.3 10.3 10.2 3.6 8.8 7.4 7.4 7.1 8.0 6.9 20.9 8.9 10.3 10.8 8.4 5.7 4.2 7.6 4.5 13.1 5.7 13.7 5.6 5.4 9.1 15.6 7.0 9.9 11.7 6.3 12.4 12.8 13.1 11.2 7.0 11.1 10.4 11.1 13.7 9.3 8.7 9.9 10.5 5.4 7.4 8.6 18.2 11.9 8.5 5.6 13.7 5.5 9.2 10.6 26.8 12.9 4.8 15.6 21.6 30.4 12.6 20.4 8.1 15.9 10.4 17.7 15.2 6.6 13.9 11.9 15.5 9.6 23.3 9.2 8.4 17.8 15.9 32.4 7.3 9.9 27.0 26.5 16.0 14.9 16.7 21.0 16.5 20.3 11.8 10.2 15.2 11.9 11.5 17.3 8.4 27.9 32.3 22.6 66.1 52.8 19.1 7.0 28.7 9.3 27.5 ZMYM6 "Buster2, MYM, ZBED7, ZNF198L4, ZNF258" ENSG00000163867 "Zinc finger MYM-type containing 6" O95789 1 34986165-35031968 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA011004, HPA071865" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA011004: AB_1859075, HPA071865: AB_2686464" "prognostic favorable (1.30e-5)" "unprognostic (1.31e-1)" "unprognostic (2.16e-2)" "unprognostic (1.98e-1)" "unprognostic (3.06e-2)" "unprognostic (3.92e-2)" "unprognostic (2.11e-6)" "unprognostic (1.77e-3)" "unprognostic (4.83e-3)" "unprognostic (3.65e-1)" "unprognostic (5.27e-2)" "unprognostic (1.70e-2)" "unprognostic (9.29e-2)" "unprognostic (7.15e-2)" "unprognostic (2.28e-1)" "unprognostic (1.72e-1)" "unprognostic (4.84e-3)" 12.8 14.7 9.4 13.3 15.9 21.3 11.6 16.3 16.0 10.7 10.9 14.6 9.8 11.0 13.3 13.6 12.8 11.7 10.7 10.8 8.6 8.3 11.7 9.7 12.2 14.9 13.8 10.2 15.9 11.5 13.7 33.7 7.9 17.0 11.0 12.9 12.5 12.9 11.0 8.0 13.6 15.3 11.9 16.7 20.1 11.6 14.9 10.1 16.2 15.4 8.4 14.7 12.5 11.2 10.1 12.3 9.0 9.3 6.5 9.3 4.3 9.3 5.1 9.4 8.9 10.7 13.5 5.8 7.8 11.7 9.5 10.3 4.0 10.3 13.0 8.4 11.5 6.4 9.2 10.4 8.3 11.6 8.9 6.1 11.4 7.4 5.4 9.4 15.8 13.4 11.3 11.9 10.4 8.7 7.2 10.5 10.3 17.5 14.2 9.4 3.1 7.3 10.7 9.4 5.3 8.3 10.3 12.4 7.3 7.8 7.3 9.8 9.1 9.1 8.6 10.7 9.7 5.7 8.8 10.7 11.8 8.7 12.4 11.5 8.8 13.4 9.5 12.0 15.2 9.4 4.6 9.3 9.0 9.3 7.5 8.1 8.1 6.4 5.3 8.3 10.1 9.1 6.1 4.9 6.5 9.1 12.3 6.8 4.3 9.4 15.9 16.3 16.0 8.6 8.3 13.8 10.2 17.0 10.1 11.9 13.9 8.8 4.6 5.4 12.2 13.7 10.2 6.7 6.8 15.7 19.6 3.1 5.0 5.1 1.3 5.2 7.3 0.0 4.7 2.8 5.4 3.5 9.3 6.8 6.8 12.7 3.5 6.7 21.1 1.1 7.8 15.2 1.7 11.8 7.1 7.7 4.7 6.8 10.6 5.8 18.2 12.9 8.2 13.4 17.7 5.6 4.5 6.9 7.9 5.4 ZMYND11 BS69 ENSG00000015171 "Zinc finger MYND-type containing 11" Q15326 10 134465-254637 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015816 Supported Nucleoplasm NA NA Nucleoplasm "HPA015816: AB_1845427" "unprognostic (1.96e-1)" "unprognostic (1.66e-1)" "unprognostic (3.00e-1)" "unprognostic (1.12e-1)" "unprognostic (9.12e-2)" "unprognostic (2.33e-2)" "unprognostic (5.49e-2)" "unprognostic (1.52e-2)" "unprognostic (1.80e-2)" "unprognostic (3.73e-2)" "unprognostic (4.47e-3)" "unprognostic (6.35e-2)" "prognostic favorable (4.76e-7)" "unprognostic (1.25e-1)" "unprognostic (2.40e-1)" "unprognostic (9.04e-2)" "unprognostic (1.42e-1)" 19.9 19.6 35.7 12.8 35.0 5.1 23.9 38.0 32.5 26.4 26.9 27.3 18.5 15.4 28.8 24.8 23.0 21.8 18.5 28.7 34.1 27.7 26.9 17.8 19.7 12.0 33.3 26.2 30.0 24.2 63.6 24.0 17.6 27.5 28.0 17.9 17.0 21.6 30.2 29.1 16.2 15.4 49.2 38.0 15.5 19.5 15.9 28.9 7.1 46.0 13.4 12.4 31.3 29.6 4.4 4.0 16.2 2.8 12.3 10.7 4.3 23.8 25.4 20.7 16.5 23.4 22.8 12.5 24.4 14.2 17.3 16.3 15.2 24.0 0.0 7.8 30.5 5.5 14.4 11.3 17.5 22.2 9.4 9.2 26.2 13.8 16.3 25.5 7.1 14.8 15.8 22.8 16.8 15.6 22.3 21.4 12.6 7.0 17.4 28.5 29.2 11.0 9.6 6.5 25.8 4.4 10.5 13.4 12.5 21.9 28.1 9.2 17.0 27.0 32.1 12.6 12.2 28.9 13.8 27.7 17.4 6.1 34.0 18.4 14.0 17.7 1.7 17.3 13.4 11.6 9.8 2.0 16.2 10.7 2.8 9.5 4.4 7.7 10.7 3.1 3.0 8.3 8.3 0.9 12.3 1.2 4.0 7.2 4.3 35.7 35.0 38.0 31.4 34.1 27.7 33.3 26.2 27.5 28.9 56.6 41.4 13.5 22.3 23.0 34.4 88.2 28.1 30.8 43.3 31.4 11.8 12.6 43.1 24.9 22.3 40.7 12.7 0.0 27.4 5.0 32.9 37.2 44.0 24.9 12.0 19.1 24.9 27.0 21.8 20.1 36.2 14.0 23.6 9.0 27.6 64.0 24.4 10.5 52.6 34.6 19.8 12.9 40.1 22.4 25.8 24.3 10.4 17.9 17.9 21.6 ZMYND8 "PRKCBP1, RACK7" ENSG00000101040 "Zinc finger MYND-type containing 8" Q9ULU4 20 47209214-47356889 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cone photoreceptor cells: 151.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020949 Approved Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA020949: AB_1857223" "prognostic unfavorable (2.56e-4)" "unprognostic (5.09e-2)" "unprognostic (5.84e-2)" "unprognostic (3.30e-1)" "unprognostic (2.12e-1)" "unprognostic (1.67e-1)" "prognostic unfavorable (2.62e-4)" "unprognostic (2.10e-1)" "unprognostic (2.60e-1)" "unprognostic (1.50e-1)" "unprognostic (8.64e-2)" "unprognostic (3.62e-1)" "prognostic unfavorable (7.06e-5)" "unprognostic (3.59e-2)" "unprognostic (7.50e-2)" "unprognostic (2.53e-1)" "unprognostic (1.47e-3)" 11.9 30.2 22.0 18.3 26.9 24.1 16.1 33.2 30.5 12.1 15.0 18.1 24.1 11.8 11.2 37.4 15.2 17.7 13.4 10.0 21.0 18.1 12.3 9.5 11.9 13.3 28.7 17.8 15.5 13.1 17.0 43.2 12.6 23.0 10.7 16.0 14.8 14.6 17.0 15.9 17.8 15.0 9.6 17.4 16.8 20.9 13.7 30.0 25.5 12.1 6.2 17.8 17.5 12.6 15.3 12.6 19.3 5.9 12.4 9.4 3.0 8.1 5.1 27.9 11.2 4.8 6.7 18.3 6.5 5.4 6.9 7.1 32.1 7.9 7.8 10.7 4.9 8.4 5.7 12.0 29.0 10.4 3.3 4.5 32.7 1.8 28.3 17.5 3.4 17.3 6.6 13.4 7.6 29.4 12.6 18.5 2.8 26.3 5.4 12.5 9.5 1.2 13.4 26.4 6.0 7.4 16.5 4.6 6.7 9.3 14.9 11.7 4.4 3.1 9.9 13.3 22.8 5.2 6.7 43.3 7.4 5.2 7.2 6.0 3.8 7.1 7.1 25.2 5.5 24.4 19.3 5.9 7.6 7.0 5.6 6.9 11.1 7.0 7.1 3.5 15.3 9.4 9.3 15.4 12.4 4.8 12.6 6.7 3.0 22.0 26.9 33.2 30.5 21.0 18.1 28.7 17.8 23.0 30.0 41.7 63.3 14.9 25.6 7.8 102.2 20.6 35.7 92.3 75.1 85.5 151.2 21.5 13.3 25.2 13.5 34.3 43.4 70.0 24.8 35.2 26.0 18.1 30.2 13.1 18.8 81.0 54.1 34.4 37.6 17.0 25.6 18.4 10.1 19.0 47.7 29.6 39.0 37.9 25.1 10.5 45.8 32.3 14.7 7.2 23.8 7.3 55.6 15.2 28.6 22.7 ZNF10 KOX1 ENSG00000256223 "Zinc finger protein 10" P21506 12 133130575-133159465 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 57.6" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 29.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA003204 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA003204: AB_1080663" "unprognostic (1.55e-2)" "unprognostic (2.77e-3)" "unprognostic (4.32e-2)" "unprognostic (1.35e-1)" "unprognostic (6.48e-2)" "unprognostic (2.67e-3)" "unprognostic (1.87e-1)" "unprognostic (6.39e-3)" "unprognostic (4.02e-3)" "unprognostic (2.13e-1)" "unprognostic (3.35e-3)" "unprognostic (2.50e-2)" "unprognostic (3.94e-2)" "unprognostic (3.41e-1)" "unprognostic (1.52e-1)" "unprognostic (4.36e-2)" "unprognostic (5.13e-3)" 4.8 12.7 5.7 4.9 11.5 6.3 10.5 13.0 9.9 9.3 7.9 7.8 14.4 3.0 12.7 20.7 5.1 10.2 9.9 6.7 5.0 5.6 7.3 7.6 6.4 4.4 8.5 6.4 18.2 10.3 22.6 57.6 4.2 8.3 12.2 5.4 8.8 6.2 16.4 5.1 7.2 5.6 12.3 8.8 5.0 8.2 12.1 7.9 6.8 17.3 5.1 5.6 8.1 7.2 4.4 4.4 1.8 0.7 8.6 8.8 2.4 3.1 2.0 10.0 0.0 11.3 4.7 6.1 4.1 3.7 5.1 3.5 3.6 2.2 0.0 5.7 4.1 2.8 1.6 6.4 3.4 3.7 0.0 5.9 7.4 9.4 3.7 3.4 4.5 2.5 4.9 3.2 5.5 6.1 7.6 4.1 5.8 5.3 0.0 6.0 1.1 10.8 9.5 10.3 2.0 4.1 8.9 6.4 5.0 3.9 7.3 10.2 6.4 8.1 1.1 3.4 4.8 6.3 4.4 4.0 3.7 3.4 3.5 3.4 0.2 0.0 11.8 1.2 1.6 3.4 1.1 0.6 1.8 4.0 0.7 4.5 4.2 4.6 5.5 1.7 4.4 8.8 4.4 0.7 8.6 0.5 4.4 1.2 2.4 5.7 11.5 13.0 9.9 5.0 5.6 8.5 6.4 8.3 7.9 0.0 7.0 3.7 4.2 3.4 16.5 6.7 2.5 1.4 9.1 0.0 29.5 3.5 1.7 1.7 11.6 2.3 1.7 0.0 1.2 1.7 3.1 4.1 10.4 3.8 2.1 4.8 12.1 1.3 3.1 4.7 2.6 2.8 3.3 1.8 3.0 6.1 0.9 2.3 6.3 1.7 16.3 0.0 11.3 13.7 13.8 3.3 3.2 4.4 3.0 1.4 ZNF106 "SH3BP3, ZFP106, ZNF474" ENSG00000103994 "Zinc finger protein 106" Q9H2Y7 15 42412823-42491123 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 64.8;skeletal muscle: 111.1" "Cell type enriched" "Detected in all" 9 "Cardiomyocytes: 1626.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 48.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054267 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA054267: AB_2682431" "unprognostic (2.15e-2)" "unprognostic (3.31e-1)" "unprognostic (7.10e-2)" "unprognostic (2.61e-2)" "unprognostic (4.01e-2)" "unprognostic (1.34e-1)" "unprognostic (9.32e-2)" "unprognostic (2.49e-1)" "unprognostic (3.96e-1)" "unprognostic (1.33e-2)" "unprognostic (2.27e-1)" "unprognostic (2.07e-1)" "unprognostic (1.76e-3)" "unprognostic (8.71e-2)" "unprognostic (1.78e-1)" "unprognostic (4.36e-1)" "unprognostic (4.09e-3)" 14.9 5.4 8.8 6.6 10.4 9.0 10.3 6.3 9.1 7.1 7.8 4.5 4.5 3.9 7.4 6.3 12.7 5.4 6.1 64.8 9.2 6.3 6.4 3.7 7.8 6.0 7.6 6.4 6.6 4.4 8.4 7.1 5.0 11.9 7.8 5.6 11.3 6.0 5.7 111.1 4.3 5.9 10.9 8.0 6.3 6.0 5.7 7.2 3.4 5.7 46.9 6.8 7.0 17.7 8.3 10.8 48.5 19.6 3.9 5.1 4.5 14.4 8.4 14.7 16.2 37.2 32.8 9.0 11.8 11.2 10.3 11.0 19.7 4.2 9.7 10.5 14.4 11.8 16.6 15.2 12.0 15.8 15.7 7.3 18.6 19.6 7.0 10.7 22.2 11.1 24.7 8.1 15.7 17.5 9.2 16.5 12.2 22.0 1.3 16.7 5.7 8.5 5.4 6.2 11.4 8.6 8.1 26.7 5.3 5.4 16.3 9.4 5.0 23.8 11.2 13.2 12.0 10.3 14.5 24.9 11.1 17.1 14.7 17.2 8.1 15.6 36.4 9.9 17.8 19.2 19.9 19.6 7.6 5.1 15.9 4.5 6.7 4.2 4.2 10.5 8.3 3.8 3.4 48.5 3.9 18.5 10.8 3.8 4.5 8.8 10.4 6.3 9.1 9.2 6.3 7.6 6.4 11.9 7.2 125.0 90.2 37.8 49.6 34.2 58.0 1626.8 56.0 188.7 61.4 27.9 90.3 31.5 34.9 37.0 133.3 49.8 30.9 23.3 36.8 30.7 62.9 79.6 42.8 32.7 46.8 33.4 38.7 57.1 104.1 80.0 34.8 64.4 62.4 28.9 28.5 43.3 51.2 23.0 87.0 34.8 75.4 45.3 46.4 55.4 37.4 26.1 25.6 29.4 33.7 64.4 ZNF114 MGC17986 ENSG00000178150 "Zinc finger protein 114" Q8NC26 19 48270102-48287608 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 11.5" "Cell type enhanced" "Detected in many" 12 "Club cells: 4.5;Syncytiotrophoblasts: 12.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 17.0;Hep G2: 19.9;NTERA-2: 10.3;REH: 10.5" "HPA025019, HPA029553" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA025019: AB_1859080, HPA029553: AB_10603005" "unprognostic (1.82e-1)" "unprognostic (1.88e-1)" "unprognostic (5.41e-2)" "unprognostic (2.33e-3)" "unprognostic (1.56e-1)" "prognostic unfavorable (3.29e-4)" "unprognostic (2.67e-1)" "unprognostic (3.35e-2)" "unprognostic (1.12e-1)" "unprognostic (2.49e-1)" "unprognostic (4.56e-3)" "unprognostic (5.21e-2)" "unprognostic (1.13e-7)" "unprognostic (9.74e-2)" "unprognostic (2.78e-1)" "unprognostic (9.15e-2)" "unprognostic (1.63e-1)" 1.5 1.0 3.7 2.2 2.7 2.1 1.2 1.2 3.3 2.3 0.6 2.1 1.0 0.9 2.4 2.4 1.3 1.9 1.5 1.7 3.7 4.6 1.6 0.5 1.4 1.9 2.6 0.8 1.2 5.3 4.2 1.6 7.5 2.1 3.1 0.4 2.5 3.7 1.3 3.7 3.7 0.7 1.4 3.5 1.6 0.7 1.6 1.7 1.0 11.5 0.5 1.1 1.3 5.7 2.6 3.5 5.4 0.7 2.0 0.6 0.4 2.7 4.3 5.2 0.5 0.3 0.0 17.0 0.5 0.0 1.6 2.1 1.5 4.3 0.1 5.0 0.3 1.9 5.6 7.1 0.3 1.8 0.1 0.4 0.6 1.3 19.9 1.6 2.7 0.5 0.3 0.5 0.8 0.1 0.5 0.3 0.7 0.7 0.4 0.3 8.1 0.2 8.4 10.3 7.4 0.9 10.5 0.0 0.3 0.2 2.3 2.1 2.4 2.8 0.0 3.0 3.3 1.1 5.0 0.7 0.8 1.8 1.5 0.5 0.4 0.1 0.1 0.2 1.5 0.8 3.3 0.7 0.9 0.5 0.6 0.3 0.9 0.6 0.4 1.7 2.6 0.5 0.4 5.4 2.0 0.7 3.5 0.2 0.4 3.7 2.7 1.2 3.3 3.7 4.6 2.6 0.8 2.1 1.7 3.0 2.6 0.0 0.8 0.3 1.2 0.4 0.0 1.4 4.5 0.0 0.0 1.9 1.7 0.1 2.1 1.1 0.0 0.0 0.5 2.1 0.8 0.7 0.0 0.4 1.4 0.0 0.0 1.8 0.8 0.0 1.1 1.1 0.0 0.0 0.0 1.3 0.4 0.0 0.7 0.0 0.6 0.0 0.8 0.5 2.7 0.1 12.8 0.0 0.0 1.0 ZNF12 "GIOT-3, KOX3, ZNF325" ENSG00000164631 "Zinc finger protein 12" P17014 7 6688433-6706923 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063402 Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA063402: AB_2685005" "unprognostic (2.68e-1)" "unprognostic (6.97e-3)" "unprognostic (9.52e-2)" "unprognostic (1.84e-1)" "unprognostic (8.32e-2)" "unprognostic (1.74e-1)" "unprognostic (3.06e-3)" "unprognostic (1.41e-1)" "unprognostic (6.67e-2)" "unprognostic (2.89e-3)" "unprognostic (5.52e-2)" "unprognostic (7.76e-2)" "unprognostic (1.08e-1)" "unprognostic (1.87e-1)" "unprognostic (2.10e-2)" "unprognostic (4.36e-2)" "unprognostic (8.46e-3)" 16.7 12.1 12.1 15.6 11.7 8.8 17.0 25.4 13.5 18.9 17.7 9.2 16.0 12.2 17.4 17.9 15.1 15.1 11.9 12.6 10.1 9.7 15.6 13.8 12.2 15.1 10.3 12.8 19.6 13.2 25.2 20.0 20.3 10.3 23.9 13.2 8.6 14.7 16.1 9.5 13.8 18.6 12.5 16.1 18.6 12.9 7.5 13.9 21.1 21.9 7.9 16.0 21.9 29.3 2.1 1.9 9.4 0.9 1.9 3.5 0.4 12.0 5.7 11.4 14.3 11.7 12.0 11.0 7.6 13.8 9.8 10.3 7.8 7.0 9.2 5.3 9.4 22.1 14.5 9.4 7.4 15.0 3.5 7.1 9.2 8.6 7.7 11.0 14.6 10.0 13.1 16.6 7.0 11.4 14.6 7.1 7.4 14.6 8.5 12.9 9.5 5.6 13.5 13.8 3.8 8.8 7.4 16.4 5.6 8.0 12.0 10.5 18.6 8.8 16.1 9.2 15.0 10.2 16.7 7.0 11.1 14.0 8.8 10.0 8.1 5.2 9.4 9.0 9.9 14.6 9.4 0.9 1.1 2.5 0.7 3.5 2.0 2.1 2.8 0.9 2.1 2.7 3.4 0.9 1.9 0.8 1.9 1.7 0.4 12.1 11.7 25.4 13.5 10.1 9.7 10.3 12.8 10.3 13.9 8.9 9.9 13.7 14.1 23.9 26.7 16.2 12.7 9.4 10.3 3.5 15.7 9.8 1.7 7.7 0.4 15.5 6.8 23.3 5.7 7.5 14.2 10.8 11.5 9.0 8.4 35.0 7.5 16.0 11.5 0.8 20.8 7.2 5.0 5.4 11.1 19.5 7.5 7.0 21.2 5.7 19.8 25.8 14.4 12.3 6.0 19.6 7.2 6.4 11.5 14.9 ZNF121 "D19S204, ZHC32, ZNF20" ENSG00000197961 "Zinc finger protein 121" P58317 19 9560353-9584533 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA054961 Uncertain Approved Nucleoplasm,Nucleoli,Centrosome NA NA "Nucleoplasm, Centrosome" Nucleoli "HPA054961: AB_2682651" "unprognostic (3.06e-1)" "unprognostic (9.38e-3)" "unprognostic (9.51e-2)" "unprognostic (7.49e-2)" "unprognostic (3.07e-2)" "unprognostic (3.91e-3)" "unprognostic (3.68e-2)" "unprognostic (1.76e-1)" "unprognostic (6.80e-3)" "prognostic favorable (6.59e-5)" "unprognostic (9.36e-2)" "unprognostic (1.76e-3)" "prognostic unfavorable (1.01e-4)" "unprognostic (8.75e-3)" "unprognostic (2.83e-1)" "unprognostic (1.06e-1)" "prognostic favorable (5.75e-5)" 13.8 8.9 10.4 11.0 12.3 21.0 14.0 16.1 11.8 10.6 8.9 6.2 12.5 6.7 9.4 10.0 16.5 12.4 7.6 10.3 10.3 5.0 9.2 13.2 14.6 13.0 13.6 6.3 13.8 12.5 22.3 20.2 8.3 11.0 11.8 10.6 5.3 14.1 13.7 9.4 18.6 12.3 12.3 14.8 12.4 11.1 6.2 13.0 12.2 11.3 10.4 12.1 15.8 12.7 6.0 4.6 2.9 4.5 7.1 6.8 1.8 7.7 5.0 6.0 12.5 2.8 3.3 9.3 2.7 2.4 4.0 5.0 8.7 3.4 8.8 7.7 2.1 2.2 7.7 12.2 7.1 5.7 4.2 19.8 27.5 12.3 7.7 3.5 13.6 13.8 4.5 6.3 4.0 10.5 3.6 2.9 9.7 9.8 15.0 2.9 6.5 10.1 31.3 14.8 3.1 8.7 6.5 8.2 6.1 3.9 33.0 10.7 5.4 5.3 5.2 3.1 12.5 4.3 4.4 4.2 12.8 7.2 4.4 6.9 16.0 8.7 10.4 3.5 8.0 4.4 2.9 3.6 2.1 5.5 4.4 6.8 4.0 4.9 5.1 4.1 6.0 6.1 6.8 2.8 7.1 4.5 4.6 4.3 1.8 10.4 12.3 16.1 11.8 10.3 5.0 13.6 6.3 11.0 13.0 6.0 8.0 14.1 29.6 20.0 6.5 9.7 7.6 10.7 17.0 8.7 11.8 10.7 6.6 9.0 1.1 7.1 3.3 23.3 4.7 9.4 7.3 18.2 14.0 9.6 4.6 6.4 13.1 9.2 8.9 0.4 5.8 9.2 8.5 1.8 9.2 2.5 9.4 3.5 7.8 4.2 7.0 6.5 6.6 5.4 11.3 27.7 8.8 13.8 12.3 32.8 ZNF124 "HZF-16, HZF16" ENSG00000196418 "Zinc finger protein 124" Q15973 1 247121975-247172016 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 14.7;salivary gland: 23.4" "Group enriched" "Detected in many" 31 "Early spermatids: 319.1;Late spermatids: 835.8" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA031127 Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA031127: AB_10602685" "unprognostic (3.97e-1)" "unprognostic (3.50e-1)" "unprognostic (2.14e-1)" "unprognostic (2.43e-1)" "unprognostic (2.01e-2)" "unprognostic (2.23e-2)" "unprognostic (4.54e-3)" "unprognostic (1.42e-3)" "unprognostic (1.66e-3)" "unprognostic (8.23e-2)" "unprognostic (8.08e-2)" "unprognostic (3.35e-2)" "unprognostic (5.40e-2)" "unprognostic (3.38e-2)" "unprognostic (3.03e-1)" "unprognostic (2.41e-1)" "prognostic favorable (1.03e-4)" 1.9 1.1 1.2 1.9 1.0 2.8 2.1 1.9 1.4 1.6 3.9 3.5 4.1 2.3 1.7 1.7 1.8 1.5 1.5 1.7 3.4 1.9 2.8 3.0 1.8 3.1 3.9 0.5 0.8 2.2 2.3 4.0 23.4 1.2 1.1 2.2 4.2 1.8 2.1 5.2 2.6 2.8 2.4 3.4 3.1 1.8 10.6 12.6 10.0 14.7 9.9 12.3 6.3 3.6 2.8 7.9 10.4 3.0 1.9 19.9 3.8 2.3 4.0 4.1 4.2 3.3 7.4 4.5 3.0 2.7 4.0 9.4 3.0 5.7 0.4 2.6 6.5 3.3 8.9 2.9 11.6 7.5 2.3 2.4 3.9 3.8 1.9 5.7 8.7 9.1 5.2 5.0 3.2 11.9 7.5 20.5 7.1 6.5 12.6 6.4 5.2 3.8 11.0 12.4 12.6 5.6 4.4 3.8 9.9 3.2 18.6 6.5 3.0 4.5 3.3 6.8 4.5 5.5 10.9 1.2 11.9 6.3 6.2 8.8 10.0 7.0 9.9 10.1 10.6 9.1 8.5 12.6 6.7 12.3 11.8 2.0 9.9 14.7 9.9 6.7 6.3 14.9 9.9 3.7 3.6 3.2 3.3 4.4 5.1 4.0 7.9 3.5 3.9 3.1 1.7 4.3 319.1 8.8 6.6 0.0 4.3 5.7 2.7 4.0 10.5 0.8 7.2 0.0 7.5 2.5 18.7 835.8 11.2 14.2 6.8 5.4 5.6 2.1 3.7 10.7 11.3 4.9 5.2 6.5 3.3 7.4 12.8 1.4 1.1 4.3 8.0 5.7 ZNF131 "pHZ-10, ZBTB35" ENSG00000172262 "Zinc finger protein 131" P52739 5 43065176-43192021 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007023, HPA027748, HPA074630" Approved Enhanced "Nucleoplasm,Intermediate filaments" No No Nucleoplasm "Intermediate filaments" "HPA007023: AB_2667726, HPA027748: AB_2672374, HPA074630: AB_2686705" "unprognostic (1.23e-1)" "unprognostic (8.24e-2)" "unprognostic (4.70e-2)" "unprognostic (7.97e-2)" "unprognostic (8.84e-2)" "unprognostic (7.18e-2)" "prognostic unfavorable (1.56e-4)" "unprognostic (2.52e-1)" "unprognostic (2.98e-3)" "unprognostic (1.94e-2)" "unprognostic (5.83e-2)" "unprognostic (8.07e-2)" "unprognostic (2.09e-2)" "unprognostic (1.47e-2)" "unprognostic (2.76e-1)" "unprognostic (3.11e-3)" "unprognostic (1.46e-2)" 16.0 14.3 15.0 18.6 16.7 24.3 20.3 24.8 18.5 18.9 13.0 10.6 10.3 10.0 19.3 10.3 15.3 13.4 13.3 10.8 15.1 13.0 12.3 14.8 12.6 21.6 12.8 14.6 21.6 16.1 13.9 17.3 20.0 14.2 13.9 13.8 8.1 11.9 16.0 16.5 18.2 12.9 16.5 11.9 16.1 12.5 31.0 13.0 27.2 15.5 15.3 17.2 15.5 18.0 13.0 8.9 7.9 7.1 11.7 18.3 7.4 10.5 6.5 14.2 18.8 13.5 9.3 12.0 14.0 11.5 14.0 11.9 10.1 9.5 21.4 11.5 9.4 13.1 7.6 16.7 8.9 19.9 10.4 14.8 13.2 37.4 7.5 12.4 22.8 10.8 8.4 17.0 10.3 16.9 10.0 10.6 16.8 16.8 23.0 15.9 10.3 22.3 28.8 9.4 9.9 10.8 14.8 21.6 16.7 11.8 10.4 8.8 12.9 35.9 17.4 18.0 10.0 9.7 21.8 7.9 17.7 16.4 9.0 13.1 9.3 13.1 24.5 9.3 30.1 11.7 7.9 6.1 4.1 15.0 7.1 15.3 10.1 14.9 14.5 8.9 13.0 18.3 14.6 3.1 11.7 4.8 8.5 10.8 7.4 15.0 16.7 24.8 18.5 15.1 13.0 12.8 14.6 14.2 13.0 20.8 18.7 38.9 47.9 44.1 49.5 17.3 15.3 17.4 18.2 8.7 49.1 22.3 26.6 12.1 29.7 27.5 27.7 0.0 10.3 21.3 29.8 30.2 23.1 10.9 14.4 36.5 30.0 23.9 22.5 12.8 19.0 31.2 20.3 22.6 19.5 24.0 13.8 24.6 19.8 9.8 60.6 25.8 37.3 81.7 71.0 57.2 21.3 41.7 27.6 33.9 ZNF133 "pHZ-13, pHZ-66, ZNF150" ENSG00000125846 "Zinc finger protein 133" P52736 20 18288283-18316996 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 18.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001493 Supported Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA001493: AB_1080666" "unprognostic (9.09e-3)" "unprognostic (3.24e-1)" "unprognostic (8.27e-3)" "unprognostic (6.82e-2)" "unprognostic (2.20e-2)" "unprognostic (1.54e-2)" "prognostic unfavorable (4.46e-6)" "unprognostic (6.01e-3)" "unprognostic (8.60e-2)" "unprognostic (4.17e-1)" "unprognostic (1.04e-3)" "unprognostic (7.36e-2)" "prognostic unfavorable (2.20e-5)" "unprognostic (5.86e-2)" "unprognostic (1.37e-1)" "unprognostic (1.62e-1)" "unprognostic (1.52e-1)" 10.0 10.1 12.4 11.4 15.9 5.6 20.8 25.4 18.4 13.9 11.6 14.4 12.6 7.7 18.2 24.9 13.2 14.2 11.2 10.6 12.0 12.0 12.1 9.6 10.6 7.4 10.3 12.1 19.5 12.5 17.9 24.7 12.5 14.1 14.9 10.2 9.2 13.6 13.9 17.2 22.2 8.1 15.7 12.1 12.5 9.9 8.9 13.2 7.1 14.7 9.3 9.5 10.0 12.1 5.4 5.4 3.4 4.5 10.7 8.7 3.5 7.0 7.7 6.1 8.7 14.9 10.4 13.0 6.6 9.8 8.5 12.3 6.1 8.3 1.8 4.0 7.8 9.7 15.4 5.8 17.3 8.0 2.0 4.0 4.8 6.6 13.6 11.3 4.0 0.7 10.1 11.9 7.1 20.8 11.6 8.1 8.0 5.6 2.1 7.3 7.0 5.0 6.7 5.0 8.4 7.7 4.4 8.4 4.5 8.3 4.8 8.6 8.8 5.1 13.9 9.5 8.9 5.3 11.1 5.7 9.0 4.3 6.3 6.5 6.7 6.7 0.6 2.7 2.7 5.1 1.2 4.3 3.4 8.7 3.0 5.8 4.7 7.4 5.9 5.4 5.4 5.8 6.8 1.5 10.7 4.5 2.8 5.5 3.5 12.4 15.9 25.4 18.4 12.0 12.0 10.3 12.1 14.1 13.2 6.0 11.6 3.2 2.4 1.9 7.1 5.9 2.5 4.0 3.4 1.8 3.9 3.5 3.3 3.9 11.4 3.6 1.5 0.0 2.0 2.7 4.2 2.1 6.9 3.4 3.8 3.2 1.2 4.9 1.9 18.8 7.2 2.1 0.0 1.0 3.9 3.1 3.3 0.0 4.2 2.7 5.2 0.0 3.0 5.4 1.7 2.8 1.9 0.5 3.3 2.3 ZNF134 pHZ-15 ENSG00000213762 "Zinc finger protein 134" P52741 19 57614233-57624723 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA009064 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA009064: AB_1080668" "unprognostic (3.60e-2)" "prognostic unfavorable (1.03e-4)" "unprognostic (1.88e-1)" "unprognostic (4.29e-2)" "unprognostic (9.62e-2)" "prognostic unfavorable (5.21e-4)" "unprognostic (6.34e-2)" "unprognostic (1.35e-1)" "unprognostic (4.34e-2)" "unprognostic (1.48e-1)" "unprognostic (3.39e-2)" "unprognostic (1.17e-2)" "prognostic favorable (2.61e-4)" "unprognostic (1.56e-2)" "unprognostic (3.40e-1)" "unprognostic (2.52e-2)" "unprognostic (1.34e-1)" 10.8 12.6 12.7 9.4 17.7 18.9 13.7 26.2 14.6 11.3 12.4 10.6 10.9 6.4 13.9 11.6 11.5 12.2 9.5 11.5 11.3 9.3 10.6 8.8 10.6 12.2 10.9 13.4 14.5 8.7 24.4 18.9 14.1 13.7 13.8 8.5 12.1 12.1 16.0 13.5 15.3 10.8 14.6 10.0 13.1 10.8 14.2 9.9 17.1 15.3 8.4 14.9 15.9 9.7 10.2 5.1 8.0 4.6 12.9 9.8 5.8 1.6 4.4 10.6 5.7 4.7 6.5 5.4 5.0 7.5 6.7 3.4 1.4 1.9 3.3 3.2 5.6 5.1 1.4 4.8 8.4 11.6 0.0 22.4 10.4 4.4 4.1 7.0 6.8 7.8 8.6 8.4 5.1 11.5 8.9 4.5 5.5 1.3 3.9 10.0 2.4 13.5 2.9 14.8 1.0 9.5 8.0 15.6 5.2 5.0 14.3 8.5 10.0 7.5 3.3 4.9 12.2 4.6 5.5 5.8 10.1 4.4 2.3 6.0 10.5 13.9 4.9 5.3 1.2 6.6 1.9 4.6 8.0 7.3 3.3 9.8 10.2 7.7 7.9 5.1 9.5 9.0 9.0 3.8 12.9 3.5 3.8 4.7 5.8 12.7 17.7 26.2 14.6 11.3 9.3 10.9 13.4 13.7 9.9 8.9 2.6 11.2 10.5 4.7 8.3 9.3 10.2 5.3 5.7 3.5 11.8 7.8 6.6 7.2 0.5 6.4 1.2 0.0 3.2 3.3 5.0 8.1 5.8 4.3 4.6 7.9 1.2 5.5 4.1 0.9 6.6 4.7 3.3 7.2 4.8 9.1 3.0 3.5 13.8 4.0 10.4 6.5 7.2 0.9 14.3 6.8 13.6 9.6 3.8 12.6 ZNF14 "GIOT-4, KOX6" ENSG00000105708 "Zinc finger protein 14" P17017 19 19710471-19733097 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA049863 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA049863: AB_2680921" "unprognostic (1.04e-1)" "unprognostic (9.86e-2)" "unprognostic (6.22e-2)" "unprognostic (1.61e-2)" "unprognostic (6.08e-3)" "unprognostic (1.04e-2)" "unprognostic (1.06e-1)" "prognostic favorable (7.96e-4)" "unprognostic (1.84e-3)" "unprognostic (1.04e-2)" "unprognostic (5.51e-3)" "unprognostic (1.55e-2)" "prognostic favorable (8.09e-6)" "unprognostic (1.83e-2)" "unprognostic (1.61e-1)" "unprognostic (5.17e-2)" "unprognostic (9.05e-3)" 7.4 5.3 7.9 8.7 10.5 11.9 12.8 23.3 10.3 11.3 7.0 8.1 6.6 3.9 9.4 9.6 5.7 9.3 6.0 6.6 8.1 7.6 8.4 1.7 4.9 10.5 12.2 6.0 15.7 7.5 12.7 10.7 8.8 9.4 12.3 5.1 6.5 7.1 9.9 3.4 7.2 7.2 8.9 9.0 9.4 7.0 6.2 10.7 7.1 13.8 3.1 10.9 9.8 7.7 10.3 3.0 11.4 3.6 6.5 18.4 6.3 3.5 3.6 6.1 7.9 4.1 4.5 7.3 3.7 5.1 5.5 6.0 3.4 2.8 9.5 6.2 3.9 3.1 3.6 6.3 3.7 6.9 2.3 7.3 4.5 2.7 4.5 5.0 0.1 6.9 4.5 3.9 3.8 3.3 7.3 3.4 4.7 5.2 4.5 5.4 5.9 8.0 5.1 7.9 6.7 10.4 4.2 9.9 4.6 3.9 7.2 6.1 4.4 0.1 4.3 5.8 5.4 6.0 9.2 2.1 4.8 1.3 5.6 4.8 3.6 4.2 8.4 0.3 5.0 2.8 11.4 1.8 6.1 9.6 3.1 15.1 10.3 13.1 12.0 2.6 8.2 18.4 14.5 4.1 6.5 3.6 3.0 8.4 6.3 7.9 10.5 23.3 10.3 8.1 7.6 12.2 6.0 9.4 10.7 0.0 3.0 1.5 3.8 2.2 4.5 1.9 0.0 4.0 1.2 3.5 0.0 2.6 3.3 1.3 0.5 2.3 0.3 0.0 1.2 1.5 2.8 1.8 1.1 0.0 1.5 6.4 2.9 1.3 0.6 0.5 1.7 2.4 3.3 0.0 1.6 3.5 1.0 0.9 3.5 2.2 5.6 6.5 2.1 3.2 3.0 1.3 1.8 5.3 1.5 2.0 ZNF140 pHZ-39 ENSG00000196387 "Zinc finger protein 140" P52738 12 133079838-133107544 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003655, HPA048332" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA003655: , HPA048332: AB_2680362" "unprognostic (1.88e-1)" "unprognostic (3.23e-1)" "unprognostic (3.17e-1)" "unprognostic (7.00e-2)" "unprognostic (2.90e-2)" "unprognostic (3.95e-1)" "unprognostic (2.02e-1)" "unprognostic (2.23e-2)" "unprognostic (2.24e-3)" "unprognostic (2.35e-1)" "unprognostic (1.21e-2)" "unprognostic (5.76e-3)" "unprognostic (7.67e-2)" "unprognostic (8.23e-2)" "unprognostic (8.08e-2)" "unprognostic (1.96e-2)" "unprognostic (9.13e-3)" 13.0 12.5 8.8 8.3 11.8 5.4 14.7 15.5 12.7 14.4 9.4 11.1 12.7 11.5 16.6 13.9 10.7 13.8 10.6 10.4 11.0 8.2 11.4 10.9 9.0 14.0 12.2 10.0 18.1 14.4 9.6 23.5 9.9 9.2 14.4 7.4 9.4 12.9 12.5 9.6 13.5 9.6 15.5 8.8 10.0 10.3 10.2 10.2 15.0 17.6 9.3 13.4 10.8 11.6 13.7 9.4 14.9 8.7 14.2 18.8 8.0 4.4 3.7 7.8 0.2 4.8 8.2 8.3 4.2 2.3 2.9 3.0 2.5 2.1 1.8 7.1 4.8 3.7 4.0 4.1 3.0 3.6 0.2 5.1 5.1 4.7 4.0 8.6 4.5 9.4 9.0 7.6 5.1 13.4 9.2 5.7 7.2 2.5 2.2 7.1 6.2 9.4 10.0 7.8 2.1 2.6 7.3 1.0 4.8 5.4 8.0 7.1 10.1 8.2 4.9 4.9 4.3 7.7 8.2 8.3 0.7 5.2 4.1 2.6 2.3 0.0 4.0 0.8 4.9 4.5 10.2 5.5 14.9 10.8 8.7 14.8 13.7 12.5 12.5 9.4 10.8 18.8 14.0 9.8 14.2 5.3 4.9 13.8 8.0 8.8 11.8 15.5 12.7 11.0 8.2 12.2 10.0 9.2 10.2 0.0 16.0 5.6 10.1 6.4 7.1 6.1 2.5 10.7 19.4 0.0 9.8 7.2 11.6 8.3 9.2 6.4 4.7 0.0 5.2 6.2 7.4 7.7 7.0 3.9 5.0 6.4 13.2 9.2 5.4 3.6 8.3 5.6 8.5 2.8 6.3 8.3 5.8 8.5 7.8 7.9 6.7 0.0 6.6 18.8 11.3 5.3 12.5 9.6 5.9 8.4 ZNF142 "KIAA0236, pHZ-49" ENSG00000115568 "Zinc finger protein 142" P52746 2 218637916-218659655 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049594 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA049594: AB_2680829" "unprognostic (2.17e-1)" "unprognostic (4.43e-1)" "unprognostic (8.20e-3)" "unprognostic (9.08e-2)" "unprognostic (3.54e-1)" "unprognostic (3.87e-2)" "prognostic unfavorable (1.35e-5)" "unprognostic (2.94e-1)" "unprognostic (1.01e-1)" "unprognostic (2.20e-2)" "unprognostic (9.63e-3)" "unprognostic (4.77e-2)" "unprognostic (1.83e-2)" "unprognostic (6.31e-2)" "unprognostic (3.77e-2)" "unprognostic (2.30e-2)" "unprognostic (7.05e-2)" 10.4 10.4 16.7 13.6 18.2 23.6 10.9 22.8 21.0 11.8 12.5 18.2 8.4 8.2 14.4 7.7 13.6 12.6 12.3 12.5 17.0 11.7 11.2 7.7 11.3 15.0 14.3 15.0 12.9 14.7 19.8 15.5 9.0 12.5 12.7 10.0 10.2 11.7 15.5 18.7 18.7 12.2 14.4 12.6 14.4 12.7 12.3 15.7 16.3 13.2 7.9 14.3 14.9 11.7 4.4 3.5 3.1 3.1 1.7 4.5 2.0 6.0 10.5 8.4 11.5 7.8 6.6 9.1 7.2 4.2 10.0 7.2 20.3 4.8 8.7 6.7 6.2 8.6 11.4 16.7 9.8 6.6 10.7 14.3 11.2 20.7 10.8 5.0 15.8 11.9 4.5 9.0 12.0 10.7 5.0 8.0 9.8 17.9 16.7 5.5 14.1 12.0 8.9 10.8 3.3 9.7 18.3 4.5 8.4 6.0 12.3 14.0 10.6 5.3 11.9 4.0 8.4 6.6 5.5 9.1 10.6 11.0 7.5 10.5 10.4 6.1 14.8 6.1 7.4 9.9 2.3 3.1 3.1 4.5 0.7 2.3 4.4 3.2 2.4 2.7 2.2 4.0 2.4 1.9 1.7 0.5 3.5 4.0 2.0 16.7 18.2 22.8 21.0 17.0 11.7 14.3 15.0 12.5 15.7 3.0 0.3 2.2 1.7 5.3 2.6 4.8 2.5 0.0 2.3 3.5 5.9 1.8 0.0 2.4 1.5 1.9 3.0 0.0 3.2 1.8 2.0 2.1 1.1 2.9 2.5 1.6 0.0 4.3 5.1 3.1 3.4 2.9 3.3 1.8 2.7 2.0 3.8 2.6 3.5 1.7 3.2 6.5 0.8 4.8 4.9 5.4 0.9 4.4 3.2 2.0 ZNF143 "pHZ-1, SBF, STAF" ENSG00000166478 "Zinc finger protein 143" P52747 11 9460319-9528524 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Sertoli cells: 58.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003263, HPA003264, HPA074818" Supported Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Nuclear bodies, Golgi apparatus, Vesicles" "HPA003263: AB_1080672, HPA003264: , HPA074818: AB_2686715" "unprognostic (2.30e-2)" "unprognostic (2.12e-2)" "unprognostic (5.51e-2)" "unprognostic (9.72e-2)" "unprognostic (5.09e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (1.76e-5)" "unprognostic (4.87e-3)" "unprognostic (2.57e-3)" "unprognostic (9.56e-2)" "unprognostic (1.26e-3)" "unprognostic (1.06e-1)" "prognostic unfavorable (6.78e-4)" "unprognostic (1.20e-3)" "unprognostic (1.92e-2)" "unprognostic (1.06e-2)" "unprognostic (7.55e-2)" 22.7 9.8 11.6 13.6 11.7 20.9 16.4 25.4 11.8 16.8 14.7 11.0 12.8 11.8 20.8 19.5 14.7 13.4 10.7 13.2 11.9 10.8 11.9 12.1 14.0 18.0 12.6 8.7 18.8 10.7 10.3 24.0 15.7 11.4 17.4 12.9 11.7 14.9 13.0 27.0 12.8 13.5 16.1 15.2 18.7 11.6 20.4 13.8 27.4 18.8 10.4 17.3 25.0 21.8 13.0 12.0 31.2 15.6 10.2 17.0 10.5 15.2 14.9 18.8 12.2 15.3 14.3 16.9 16.9 13.8 13.1 14.4 20.8 19.1 15.1 7.9 13.7 11.2 17.5 18.1 13.5 19.8 15.1 21.9 14.3 21.9 14.4 12.6 19.8 14.4 12.5 16.2 17.8 15.7 17.1 13.0 14.0 15.4 18.6 14.3 13.2 18.1 8.1 20.9 17.7 15.7 16.5 17.0 9.3 11.6 18.8 12.9 12.6 18.8 12.8 11.1 17.3 11.8 11.1 12.5 17.4 12.4 12.1 15.0 9.2 15.7 25.9 11.1 11.3 9.9 20.6 14.2 31.2 17.0 13.9 15.3 13.0 15.2 13.8 12.0 11.2 14.2 12.2 25.7 10.2 15.6 5.8 16.6 10.5 11.6 11.7 25.4 11.8 11.9 10.8 12.6 8.7 11.4 13.8 6.0 15.5 5.7 33.1 23.7 6.6 14.0 5.1 13.4 7.9 5.2 7.9 8.5 3.3 11.2 13.0 11.3 5.1 0.0 10.1 13.6 10.5 16.9 13.9 8.5 8.8 4.8 6.3 4.9 7.1 7.8 10.9 14.1 10.1 9.0 6.0 14.3 11.6 7.4 6.3 5.3 13.5 58.2 16.0 42.3 21.7 20.6 15.3 15.7 6.6 28.8 ZNF148 "BERF-1, BFCOL1, HT-BETA, pHZ-52, ZBP-89, ZFP148" ENSG00000163848 "Zinc finger protein 148" Q9UQR1 3 125225561-125375354 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001656, CAB017486" Supported Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "CAB017486: AB_794260, HPA001656: AB_1079995" "unprognostic (2.40e-1)" "unprognostic (1.12e-2)" "unprognostic (5.03e-2)" "unprognostic (3.94e-2)" "unprognostic (5.94e-3)" "unprognostic (5.66e-2)" "unprognostic (1.24e-2)" "unprognostic (2.36e-1)" "unprognostic (1.69e-2)" "unprognostic (1.33e-2)" "prognostic unfavorable (2.88e-4)" "unprognostic (6.36e-2)" "unprognostic (7.97e-3)" "unprognostic (1.71e-1)" "unprognostic (2.84e-1)" "unprognostic (3.63e-2)" "unprognostic (2.72e-1)" 10.5 9.2 12.5 13.4 17.4 5.3 9.4 18.4 17.7 10.7 8.9 4.1 3.3 5.7 11.2 8.3 8.9 10.2 8.6 11.7 11.2 7.2 10.6 9.0 8.8 8.8 11.9 11.8 14.5 7.7 15.7 18.2 7.6 10.5 9.1 9.2 6.7 10.3 12.2 12.2 7.6 8.0 11.0 7.6 8.6 7.4 9.5 10.9 25.4 24.4 3.2 10.8 10.7 9.8 13.9 7.3 29.7 12.1 18.8 17.3 10.2 18.4 12.2 13.3 11.8 11.9 12.9 10.1 16.8 19.7 18.9 18.1 11.5 10.3 14.9 11.8 24.8 15.3 15.1 14.5 12.7 27.0 6.6 5.5 18.3 14.7 5.9 8.8 12.5 18.5 10.4 13.3 17.7 18.8 12.5 12.9 10.9 8.9 12.7 13.9 14.4 15.5 4.6 8.5 12.5 10.5 11.2 14.6 8.3 10.8 20.6 11.5 9.7 22.4 11.4 18.7 7.7 14.2 12.6 16.6 14.4 15.5 18.0 10.7 11.1 12.6 22.6 10.8 8.0 13.2 2.5 8.7 17.4 13.4 8.4 13.8 13.8 11.8 12.5 7.3 13.9 17.3 13.5 29.7 18.8 12.1 6.5 10.8 10.2 12.5 17.4 18.4 17.7 11.2 7.2 11.9 11.8 10.5 10.9 86.4 32.9 27.3 25.1 31.6 67.0 66.1 28.1 24.1 43.3 31.4 37.3 23.6 21.6 32.2 73.6 43.1 22.7 46.7 32.7 20.8 30.5 30.4 48.6 37.5 26.6 71.5 46.0 36.8 37.3 83.4 44.5 32.2 16.9 28.9 37.1 41.2 29.0 17.5 55.5 36.0 37.8 32.3 38.1 18.2 18.1 33.5 26.4 45.9 33.3 32.5 ZNF154 pHZ-92 ENSG00000179909 "Zinc finger protein 154" Q13106 19 57697367-57709194 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 7.6;Cone photoreceptor cells: 7.9;granulocytes: 10.4;Horizontal cells: 7.9;Rod photoreceptor cells: 10.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 8.1;HSkMC: 4.6;MOLT-4: 6.5;NTERA-2: 4.5;SuSa: 10.0" HPA076284 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA076284: " "unprognostic (3.32e-2)" "unprognostic (3.43e-1)" "unprognostic (1.26e-2)" "unprognostic (1.33e-1)" "unprognostic (5.81e-2)" "unprognostic (5.17e-3)" "unprognostic (2.25e-1)" "unprognostic (1.41e-2)" "unprognostic (1.27e-3)" "unprognostic (1.57e-1)" "unprognostic (5.45e-2)" "unprognostic (2.02e-1)" "unprognostic (1.20e-3)" "unprognostic (9.39e-2)" "unprognostic (3.35e-1)" "unprognostic (8.38e-3)" "unprognostic (1.11e-1)" 2.8 5.9 7.9 5.7 10.2 2.5 4.3 17.9 9.3 3.1 5.7 2.6 9.9 2.2 2.8 3.6 4.4 3.1 4.1 5.6 7.8 3.1 3.8 1.8 3.6 8.8 2.2 6.4 3.4 3.4 11.9 11.5 6.0 5.1 4.5 2.8 7.3 5.0 12.6 3.1 2.0 5.4 5.6 3.6 8.4 3.2 2.3 3.9 11.4 10.5 0.6 8.3 6.6 2.1 3.1 1.5 5.1 0.3 2.7 3.2 0.8 0.2 0.3 8.1 0.3 0.0 0.0 0.5 1.2 0.0 0.0 0.1 0.2 0.4 0.4 0.2 2.0 0.3 0.2 0.0 0.0 0.2 0.2 0.6 0.3 1.1 0.2 2.9 0.4 0.8 4.6 0.0 0.5 0.0 2.8 0.1 0.4 0.3 0.6 1.8 0.1 6.5 0.3 4.5 0.3 0.2 0.3 0.8 0.2 0.1 1.1 0.5 0.3 0.3 0.3 0.1 10.0 0.4 0.5 0.2 0.2 0.5 0.2 0.3 0.8 0.3 0.4 0.1 0.3 0.2 1.8 0.3 5.1 1.1 0.1 3.2 1.3 0.6 1.5 0.3 3.1 1.0 1.4 1.9 2.7 0.2 1.5 0.1 0.8 7.9 10.2 17.9 9.3 7.8 3.1 2.2 6.4 5.1 3.9 0.0 3.4 2.2 1.1 0.3 7.6 3.1 0.0 1.4 0.0 1.8 7.9 0.2 0.0 1.7 0.0 1.6 0.0 0.0 0.2 0.1 1.4 1.7 10.4 0.2 1.3 7.9 0.0 1.8 0.0 0.0 0.3 1.1 0.0 1.0 0.0 3.2 0.1 0.0 1.4 0.0 10.1 0.0 0.4 0.4 0.9 0.4 0.2 3.1 0.0 1.5 ZNF155 pHZ-96 ENSG00000204920 "Zinc finger protein 155" Q12901 19 43967862-43998325 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 6.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA003220 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA003220: AB_1080675" "unprognostic (2.71e-2)" "unprognostic (9.30e-2)" "unprognostic (2.95e-1)" "unprognostic (1.99e-1)" "unprognostic (7.98e-3)" "unprognostic (4.36e-2)" "unprognostic (2.98e-1)" "unprognostic (1.90e-1)" "unprognostic (3.39e-2)" "unprognostic (1.62e-1)" "unprognostic (1.08e-2)" "unprognostic (2.58e-2)" "unprognostic (2.04e-2)" "unprognostic (3.04e-1)" "unprognostic (1.61e-1)" "unprognostic (1.04e-1)" "unprognostic (6.57e-2)" 9.9 9.7 6.1 5.2 9.4 4.2 9.4 16.0 11.1 10.1 7.6 11.7 9.6 5.4 12.8 12.0 7.0 7.7 6.2 9.7 7.2 7.5 8.9 10.6 7.4 8.0 6.8 5.4 10.6 5.7 15.8 13.0 7.1 9.4 9.9 8.0 7.7 10.0 8.1 6.2 8.8 10.8 10.1 9.4 11.5 8.3 5.2 7.4 10.1 13.3 8.5 8.9 13.1 6.4 6.2 5.1 11.8 3.5 6.4 9.3 4.9 4.5 3.8 9.7 8.8 5.4 6.2 2.8 3.7 3.5 2.7 3.8 2.5 2.3 0.0 4.8 5.8 3.7 3.5 3.2 8.0 4.4 5.0 8.0 9.5 8.1 2.7 5.5 3.0 5.6 8.8 6.4 5.4 8.0 7.8 6.1 0.2 0.1 0.1 7.1 4.0 4.3 3.5 5.9 1.9 3.4 0.0 10.3 3.4 7.1 14.8 6.5 8.7 9.2 0.5 3.6 8.8 6.2 8.4 4.5 5.9 8.7 3.8 5.4 10.8 7.7 0.0 5.0 0.7 5.4 10.3 3.4 11.8 8.5 3.5 8.4 5.3 6.1 9.3 5.1 6.2 7.4 6.8 3.0 6.4 2.7 3.0 5.2 4.9 6.1 9.4 16.0 11.1 7.2 7.5 6.8 5.4 9.4 7.4 0.0 2.2 0.0 1.1 1.3 4.2 0.4 0.0 0.0 1.2 0.0 0.0 1.5 1.7 1.5 0.3 1.7 1.6 0.0 1.3 0.4 1.5 0.9 1.1 1.3 1.5 6.4 0.0 2.5 0.3 0.5 2.6 1.1 1.7 1.0 1.3 3.8 0.9 0.0 5.3 1.8 2.8 0.0 1.9 0.9 1.0 1.1 0.9 1.8 1.3 1.0 ZNF16 KOX9 ENSG00000170631 "Zinc finger protein 16" P17020 8 144930358-144950888 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Cell division, Transcription, Transcription regulation" "Activator, DNA-binding, Mitogen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035782, HPA061835" Uncertain Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA035782: AB_10603243, HPA061835: AB_2684621" "unprognostic (4.11e-2)" "unprognostic (1.51e-2)" "unprognostic (6.87e-2)" "unprognostic (2.45e-1)" "unprognostic (2.69e-1)" "prognostic favorable (2.39e-4)" "unprognostic (7.53e-3)" "unprognostic (1.10e-1)" "unprognostic (1.24e-1)" "unprognostic (8.50e-2)" "unprognostic (1.45e-1)" "unprognostic (2.21e-1)" "unprognostic (8.59e-2)" "unprognostic (1.70e-2)" "unprognostic (2.96e-1)" "unprognostic (9.75e-2)" "unprognostic (4.17e-3)" 8.1 6.0 8.9 7.1 9.0 3.4 9.7 8.1 10.1 9.7 10.1 7.8 7.1 7.2 13.8 11.1 9.4 11.2 13.3 6.5 7.5 4.9 8.5 5.9 5.7 5.0 6.4 7.5 17.4 12.1 15.9 7.0 6.0 6.5 8.9 7.3 7.7 7.4 9.2 12.4 14.0 10.8 10.3 4.9 6.4 7.7 10.9 5.3 6.7 10.8 5.3 6.8 9.1 10.1 5.6 6.4 3.5 4.0 12.2 7.8 4.1 4.9 4.4 8.7 4.8 7.5 10.5 6.3 4.5 10.0 9.1 8.3 3.3 5.1 7.9 6.0 5.8 4.9 4.0 6.1 10.0 8.3 3.3 5.1 9.0 4.9 4.9 12.5 3.3 5.3 12.8 10.1 5.8 15.3 9.1 5.0 6.0 6.1 5.3 7.2 6.7 6.5 3.3 5.4 7.6 10.0 8.2 5.1 5.0 7.7 7.5 7.3 5.4 9.5 5.8 7.7 7.0 10.8 6.1 5.3 4.1 8.8 4.8 5.0 3.9 3.2 7.2 4.8 4.5 6.5 3.5 4.0 2.7 6.9 3.7 7.8 4.1 5.5 6.3 6.4 5.6 5.6 5.1 0.5 12.2 3.7 3.5 7.2 4.1 8.9 9.0 8.1 10.1 7.5 4.9 6.4 7.5 6.5 5.3 3.0 4.1 0.0 5.7 2.4 10.8 3.6 7.6 2.7 0.0 8.7 11.8 4.6 1.7 5.6 8.1 3.1 4.5 0.0 3.8 2.9 3.8 3.2 6.9 3.4 3.1 6.4 4.1 6.2 3.2 1.9 5.8 2.6 1.7 4.6 4.7 6.0 3.5 3.5 6.0 3.6 23.7 0.0 2.0 14.0 12.4 4.0 4.6 5.3 4.9 4.7 ZNF169 MGC51961 ENSG00000175787 "Zinc finger protein 169" Q14929 9 94259311-94301454 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041769, HPA061185" Uncertain Approved "Nucleoplasm,Nuclear speckles,Vesicles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" "Vesicles, Cytosol" "HPA041769: AB_2677662, HPA061185: " "unprognostic (1.07e-1)" "unprognostic (2.29e-1)" "unprognostic (1.03e-1)" "unprognostic (3.39e-1)" "unprognostic (3.27e-2)" "unprognostic (9.08e-3)" "unprognostic (1.18e-3)" "unprognostic (7.33e-2)" "unprognostic (2.27e-1)" "unprognostic (7.45e-2)" "unprognostic (6.79e-2)" "unprognostic (1.69e-2)" "unprognostic (1.49e-4)" "unprognostic (6.32e-2)" "unprognostic (1.15e-1)" "unprognostic (1.69e-1)" "unprognostic (2.15e-4)" 4.5 4.2 6.5 8.5 10.9 5.9 7.8 12.7 13.5 7.4 6.7 8.3 4.4 5.6 7.7 8.7 4.1 7.5 5.7 4.6 8.6 5.7 5.5 3.2 5.0 11.0 9.8 8.5 9.4 5.2 5.9 4.9 4.3 8.2 6.6 11.1 5.8 7.2 5.6 8.6 10.0 8.6 6.6 7.1 10.6 8.1 4.3 9.5 10.5 8.0 5.0 10.0 6.9 6.5 9.5 4.5 6.1 6.9 6.7 9.1 3.4 3.9 3.5 3.9 6.9 1.9 4.9 4.4 1.4 2.7 3.0 3.2 2.3 6.0 9.5 1.9 2.3 3.3 7.9 8.0 3.6 4.1 5.5 8.6 6.7 7.9 4.4 2.8 10.1 6.9 4.2 4.0 2.6 4.2 3.9 3.8 9.3 6.0 3.0 3.9 3.8 4.7 5.6 6.4 8.3 4.3 4.1 2.8 3.1 2.7 3.6 4.1 4.9 2.7 4.8 2.0 4.1 3.1 4.4 4.1 2.9 3.6 3.5 3.0 5.2 1.9 2.0 2.6 6.7 2.7 3.2 6.5 6.1 5.5 6.9 6.9 6.3 6.2 3.9 4.5 9.5 6.7 9.1 5.6 6.7 5.0 4.2 6.5 3.4 6.5 10.9 12.7 13.5 8.6 5.7 9.8 8.5 8.2 9.5 3.0 0.3 2.7 1.7 0.2 5.0 0.8 0.0 2.7 3.4 1.8 3.9 0.4 0.0 0.9 0.9 2.2 2.4 0.0 0.7 0.6 0.9 1.6 0.0 1.0 0.7 4.8 1.2 1.3 4.4 0.6 5.5 2.3 0.0 1.8 2.5 2.8 1.0 2.5 3.2 0.3 4.4 0.0 1.1 4.8 2.2 0.4 0.3 3.9 1.5 1.8 ZNF174 ZSCAN8 ENSG00000103343 "Zinc finger protein 174" Q15697 16 3401235-3409370 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009656 Approved Supported "Nucleoplasm,Actin filaments,Cytosol" NA NA Nucleoplasm "Actin filaments, Cytosol" "HPA009656: AB_1080679" "unprognostic (4.33e-2)" "unprognostic (6.81e-3)" "unprognostic (2.08e-1)" "unprognostic (7.68e-2)" "unprognostic (1.94e-3)" "unprognostic (5.19e-2)" "unprognostic (2.03e-3)" "unprognostic (6.39e-3)" "unprognostic (2.41e-1)" "unprognostic (4.25e-3)" "unprognostic (2.06e-3)" "unprognostic (4.35e-2)" "unprognostic (6.28e-2)" "unprognostic (1.02e-1)" "unprognostic (7.68e-2)" "unprognostic (2.55e-1)" "unprognostic (1.83e-1)" 10.0 11.6 11.1 9.0 16.0 5.7 12.8 15.8 24.3 13.0 14.8 18.1 9.4 9.6 16.8 18.8 11.0 17.7 13.4 15.3 11.8 12.0 11.1 9.9 8.7 11.6 15.1 10.5 21.0 9.1 28.5 15.2 8.2 15.7 14.7 11.7 16.1 12.2 18.2 14.1 11.4 9.7 16.8 13.3 11.9 10.5 13.5 15.7 18.8 12.2 9.1 12.8 14.8 10.8 9.5 6.9 23.1 6.4 6.8 11.5 6.7 6.3 10.5 12.1 13.6 14.7 10.6 8.3 6.0 14.8 13.0 11.9 8.3 11.1 22.0 9.5 10.5 11.8 9.2 11.2 10.0 12.3 13.9 11.5 11.3 9.9 10.0 10.6 12.9 13.7 12.7 11.8 11.0 11.0 12.6 11.0 15.4 17.9 9.9 13.3 10.6 12.8 10.8 13.2 9.4 13.0 18.4 13.6 17.3 9.5 3.2 11.4 8.8 11.7 13.0 10.0 12.0 12.7 14.4 8.8 9.7 10.6 7.8 7.8 12.3 13.3 17.3 5.2 8.1 9.1 13.1 5.7 23.1 9.1 6.4 8.7 9.5 9.4 10.2 6.9 7.1 11.5 8.5 6.8 6.8 4.2 3.6 8.8 6.7 11.1 16.0 15.8 24.3 11.8 12.0 15.1 10.5 15.7 15.7 3.0 1.3 1.4 1.4 1.6 6.9 4.4 7.6 1.4 1.2 0.0 5.9 5.3 3.3 4.4 4.3 3.8 3.3 0.0 3.7 3.5 2.8 1.7 1.1 3.2 3.8 3.2 3.5 2.5 1.8 3.1 8.1 1.3 3.3 1.8 2.0 7.4 3.6 3.2 9.2 3.7 8.1 0.0 1.5 11.8 9.5 1.6 2.4 3.8 3.4 0.6 ZNF175 OTK18 ENSG00000105497 "Zinc finger protein 175" Q9Y473 19 51571298-51592508 "Predicted intracellular proteins, Transcription factors" "Antiviral defense, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 15.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 25.5;RT4: 23.2;TIME: 23.4" "Low region specificity" "Detected in all" HPA002717 Uncertain Supported "Nucleoplasm,Intermediate filaments,Cytosol" NA NA Cytosol "Nucleoplasm, Intermediate filaments" "HPA002717: AB_1080681" "unprognostic (9.41e-2)" "unprognostic (1.43e-1)" "unprognostic (2.44e-1)" "unprognostic (1.59e-1)" "unprognostic (1.46e-1)" "unprognostic (9.50e-3)" "unprognostic (2.44e-1)" "unprognostic (1.84e-1)" "unprognostic (7.33e-3)" "unprognostic (9.94e-2)" "unprognostic (6.33e-3)" "unprognostic (6.20e-2)" "unprognostic (1.35e-3)" "unprognostic (1.50e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (6.64e-4)" "unprognostic (3.50e-3)" 6.1 6.7 11.2 6.1 12.6 4.7 8.4 26.2 16.0 7.7 6.5 7.1 9.4 8.4 9.2 8.5 5.5 7.6 4.9 6.6 12.7 7.4 7.3 6.4 8.0 8.7 11.1 10.3 14.5 7.3 19.8 10.9 12.1 11.4 7.6 6.1 6.4 9.1 9.5 6.4 5.5 7.9 8.1 8.8 9.7 6.7 15.0 11.7 9.2 10.8 5.0 9.2 8.7 11.9 2.1 4.6 0.6 1.3 0.9 2.2 0.7 1.8 3.2 3.3 3.4 3.5 4.8 0.0 4.1 5.3 3.9 4.7 3.3 2.8 3.3 2.4 4.1 2.4 3.1 3.5 2.8 7.0 0.0 5.2 25.5 5.0 1.1 3.0 4.2 16.4 1.9 2.7 7.9 3.9 19.8 6.2 3.3 8.5 3.5 4.2 0.0 4.5 3.2 1.8 2.2 3.3 0.0 4.2 1.6 2.1 23.2 4.1 3.0 3.9 1.3 2.5 2.7 1.0 3.5 23.4 6.0 2.7 1.4 4.0 4.6 8.4 3.4 16.6 2.5 3.0 0.1 1.3 0.0 1.7 0.5 1.8 1.9 1.6 1.4 1.4 2.1 2.2 1.7 0.6 0.9 0.3 4.6 0.3 0.7 11.2 12.6 26.2 16.0 12.7 7.4 11.1 10.3 11.4 11.7 6.0 4.8 2.4 1.5 1.0 6.1 3.1 2.5 5.3 7.9 5.2 2.0 6.3 1.7 1.6 9.5 2.9 2.0 0.0 1.4 1.2 2.6 1.6 13.9 2.1 2.7 15.9 1.7 5.5 6.6 7.0 3.1 2.0 3.3 1.8 1.2 2.3 4.5 0.0 2.5 1.4 7.4 0.0 2.1 5.8 4.1 1.3 10.1 1.8 2.1 0.7 ZNF18 "HDSG1, KOX11, Zfp535, ZKSCAN6, ZNF535, ZSCAN38" ENSG00000154957 "Zinc finger protein 18" P17022 17 11977439-11997510 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 23.1;Late spermatids: 19.5;Spermatocytes: 11.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SuSa: 30.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006144 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" "Plasma membrane, Cytosol" "HPA006144: AB_1080683" "unprognostic (2.99e-3)" "prognostic favorable (6.32e-4)" "unprognostic (2.32e-1)" "unprognostic (2.50e-2)" "unprognostic (4.91e-2)" "unprognostic (2.72e-3)" "unprognostic (2.28e-2)" "unprognostic (5.93e-3)" "unprognostic (1.25e-1)" "unprognostic (2.93e-2)" "prognostic favorable (5.12e-6)" "unprognostic (2.28e-1)" "prognostic unfavorable (3.06e-6)" "unprognostic (1.52e-2)" "unprognostic (9.31e-2)" "unprognostic (3.34e-2)" "unprognostic (3.53e-3)" 8.3 6.8 8.2 7.0 13.9 15.7 9.6 9.4 15.5 8.5 7.2 13.2 3.5 6.4 14.1 9.5 8.8 7.5 7.2 7.3 9.0 8.7 6.5 13.2 6.2 10.5 9.9 9.8 10.4 7.8 8.4 11.8 5.1 14.5 9.8 9.2 12.5 9.0 7.1 8.2 12.8 8.2 7.8 10.8 12.3 6.2 15.5 9.2 15.6 8.4 14.3 10.2 7.7 7.6 9.1 8.8 19.6 7.6 7.0 11.2 5.6 2.2 4.7 5.0 7.4 9.4 8.4 2.6 3.3 5.8 4.3 4.6 2.1 3.9 7.7 4.9 3.5 3.7 4.7 4.1 5.1 4.7 5.8 3.5 4.5 4.8 3.0 6.7 2.6 6.1 6.9 8.4 3.2 6.0 4.9 6.5 9.1 2.6 3.6 5.8 2.3 8.4 5.1 3.7 8.2 2.1 7.0 5.0 3.4 6.2 2.7 1.9 4.2 5.6 2.7 4.3 30.3 3.9 2.4 5.0 5.1 2.5 2.3 2.4 4.0 2.9 3.8 5.9 5.9 6.0 10.6 5.9 6.6 11.0 5.8 10.2 9.1 10.2 10.3 5.8 8.2 11.0 11.2 19.6 7.0 7.6 8.8 10.6 5.6 8.2 13.9 9.4 15.5 9.0 8.7 9.9 9.8 14.5 9.2 0.0 1.3 0.5 1.1 1.8 1.8 1.2 2.5 1.4 0.0 1.8 2.0 2.0 1.7 2.4 23.1 1.4 2.9 0.0 0.8 1.8 2.4 1.0 2.3 3.2 3.6 1.6 1.2 1.3 2.1 19.5 3.1 1.9 1.7 2.8 3.6 1.8 2.1 3.4 3.2 2.5 1.1 0.0 2.2 11.2 3.2 1.9 1.3 4.4 3.1 1.0 ZNF180 HHZ168 ENSG00000167384 "Zinc finger protein 180" Q9UJW8 19 44474428-44500524 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028979, HPA028980" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA028979: AB_10600328, HPA028980: AB_10611524" "unprognostic (2.25e-1)" "unprognostic (5.53e-2)" "unprognostic (8.34e-3)" "unprognostic (1.37e-2)" "unprognostic (1.82e-1)" "unprognostic (7.13e-3)" "unprognostic (1.73e-1)" "unprognostic (2.16e-2)" "unprognostic (4.09e-3)" "unprognostic (1.33e-1)" "unprognostic (1.65e-2)" "unprognostic (1.71e-1)" "unprognostic (2.37e-2)" "unprognostic (6.49e-2)" "unprognostic (2.21e-1)" "unprognostic (2.02e-2)" "unprognostic (3.38e-3)" 8.2 8.6 7.3 10.0 9.1 6.7 10.5 13.4 8.7 10.3 7.7 7.1 10.4 8.8 11.1 6.3 7.5 9.7 8.0 5.9 6.8 5.6 9.4 9.5 7.0 10.7 6.9 5.1 11.9 8.0 16.4 13.7 7.5 8.7 12.3 8.7 6.7 7.4 11.6 6.0 8.8 10.7 7.7 6.6 12.8 7.7 8.1 8.3 17.7 11.2 7.2 8.6 8.2 8.7 6.0 3.8 6.5 3.4 3.6 9.6 3.0 8.3 2.4 10.3 7.1 2.2 4.2 6.9 4.2 4.4 6.8 8.3 4.5 1.6 1.1 5.3 5.9 6.1 2.2 5.9 10.1 8.6 8.5 4.4 10.2 2.7 3.0 2.2 12.6 6.1 4.5 3.9 4.7 5.7 6.8 5.0 4.0 5.0 7.1 5.4 1.6 6.4 4.2 6.2 7.3 4.7 4.5 5.3 5.5 6.9 15.0 8.7 6.8 8.1 7.3 4.5 6.7 4.4 10.5 4.0 12.4 5.5 1.4 6.8 1.9 5.7 3.8 4.1 5.5 6.2 5.8 3.4 6.5 3.5 2.4 4.6 5.4 4.5 5.5 3.8 6.0 5.8 5.4 2.9 3.6 2.7 1.8 9.6 3.0 7.3 9.1 13.4 8.7 6.8 5.6 6.9 5.1 8.7 8.3 6.0 1.0 0.9 1.6 2.3 6.4 4.1 0.0 5.3 4.5 1.8 3.9 4.5 6.6 3.2 4.8 2.1 2.1 23.3 3.7 2.8 2.4 2.0 1.1 2.9 2.8 1.6 4.1 7.4 3.8 0.9 2.6 2.2 5.0 2.8 4.5 5.6 3.2 5.7 4.2 2.9 4.6 6.5 3.1 2.4 5.3 1.1 2.6 5.7 4.3 1.4 ZNF181 "HHZ181, MGC44316" ENSG00000197841 "Zinc finger protein 181" Q2M3W8 19 34734155-34745378 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA043701, HPA062305" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA043701: AB_10960859, HPA062305: AB_2684743" "unprognostic (2.00e-1)" "unprognostic (1.01e-1)" "unprognostic (1.16e-1)" "unprognostic (1.06e-4)" "unprognostic (1.06e-1)" "unprognostic (4.83e-3)" "unprognostic (5.60e-2)" "unprognostic (2.28e-2)" "prognostic unfavorable (2.60e-4)" "unprognostic (1.01e-1)" "prognostic favorable (1.05e-4)" "unprognostic (1.06e-1)" "unprognostic (6.52e-2)" "unprognostic (2.60e-1)" "unprognostic (1.13e-1)" "unprognostic (9.34e-2)" "prognostic favorable (5.45e-4)" 8.5 12.1 13.4 7.2 14.2 3.9 13.0 20.8 15.1 11.1 12.0 9.4 12.7 11.7 11.6 8.1 8.3 11.4 8.9 17.0 12.4 10.1 11.2 17.2 9.7 8.3 17.4 11.2 22.8 15.7 16.3 19.3 6.7 13.7 12.2 8.9 6.9 9.3 13.9 25.5 5.7 13.6 10.6 14.6 11.2 9.8 8.3 15.8 11.0 13.1 10.1 10.7 11.8 9.3 12.0 5.8 5.4 12.1 8.4 16.1 5.6 3.6 6.1 7.4 9.6 12.0 9.3 2.2 4.4 8.0 5.0 5.8 4.2 3.9 5.8 12.8 7.0 6.7 3.5 5.0 5.0 3.8 12.0 5.1 10.9 7.5 5.9 14.2 6.4 3.8 7.4 8.1 3.5 6.9 12.3 4.7 12.6 8.7 0.2 9.8 2.6 12.4 4.3 4.7 8.4 5.0 8.5 9.0 7.3 6.8 4.4 5.0 9.4 9.9 2.7 10.0 6.3 5.7 10.0 6.6 12.8 6.4 3.1 4.8 9.0 13.1 4.8 5.1 1.6 6.4 2.6 3.6 5.4 7.5 5.0 7.7 7.5 10.2 10.2 5.1 12.0 16.1 11.4 0.7 8.4 12.1 5.8 6.2 5.6 13.4 14.2 20.8 15.1 12.4 10.1 17.4 11.2 13.7 15.8 14.9 4.0 0.5 3.6 1.4 15.3 38.2 0.0 24.1 13.6 5.2 3.9 2.6 14.9 4.6 1.7 6.0 4.7 0.0 4.4 0.9 3.9 2.4 2.3 6.7 3.2 12.7 4.1 6.7 4.7 1.8 8.6 5.0 5.0 1.8 6.6 13.2 2.4 5.7 11.3 6.7 13.1 0.0 6.6 12.7 9.6 0.6 0.9 5.7 4.7 0.9 ZNF182 "HHZ150, KOX14, Zfp182, ZNF21" ENSG00000147118 "Zinc finger protein 182" P17025 X 47974851-48003978 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 11.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059574 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA059574: AB_2684068" "unprognostic (1.86e-1)" "unprognostic (9.55e-2)" "unprognostic (1.13e-1)" "unprognostic (1.25e-1)" "unprognostic (4.45e-2)" "unprognostic (2.51e-3)" "prognostic unfavorable (3.73e-4)" "unprognostic (1.88e-3)" "unprognostic (6.88e-2)" "unprognostic (8.81e-2)" "unprognostic (3.53e-3)" "unprognostic (2.42e-2)" "prognostic unfavorable (2.42e-5)" "unprognostic (1.01e-1)" "unprognostic (9.49e-2)" "unprognostic (8.59e-2)" "prognostic favorable (1.55e-7)" 6.8 6.9 10.2 7.3 15.2 8.7 8.8 22.1 12.9 8.3 6.5 7.1 5.4 5.7 8.1 9.7 4.7 7.6 6.5 5.0 9.1 6.4 7.7 7.3 7.0 11.9 10.2 7.1 9.9 9.4 11.0 16.9 6.7 9.9 8.4 7.1 4.7 6.1 7.7 4.2 7.3 7.9 6.1 7.7 12.6 7.3 5.8 12.9 16.1 13.2 3.5 12.1 7.0 8.7 7.9 4.3 7.4 8.5 4.9 9.0 4.4 3.6 4.8 6.2 5.9 3.5 4.0 2.4 4.7 5.6 6.9 8.3 3.7 4.9 9.4 3.5 3.0 6.4 4.5 10.1 2.7 8.4 6.6 5.9 4.7 6.2 4.8 4.4 8.7 7.7 3.4 5.8 5.8 7.0 8.2 4.1 9.3 4.0 7.0 6.3 2.7 6.7 15.6 9.7 2.4 5.7 5.7 11.6 10.3 6.0 2.5 5.7 7.8 7.6 2.5 4.4 14.1 6.2 7.6 4.1 5.5 6.0 7.8 3.9 9.3 7.6 7.3 3.8 7.4 3.6 3.1 3.4 7.0 6.2 3.4 7.0 7.9 5.6 5.7 4.3 5.6 9.0 7.5 7.4 4.9 8.5 3.2 5.2 4.4 10.2 15.2 22.1 12.9 9.1 6.4 10.2 7.1 9.9 12.9 11.9 6.5 3.7 0.7 0.2 6.3 2.7 2.5 4.0 2.3 1.8 2.0 1.8 0.0 2.3 0.3 1.4 0.7 0.0 1.6 1.1 1.4 1.0 0.0 2.1 1.4 1.6 7.5 4.9 4.6 0.0 2.3 3.3 3.3 3.6 4.4 3.8 2.5 1.4 1.8 1.9 2.7 0.0 1.3 3.0 2.0 1.0 0.7 2.5 2.3 0.9 ZNF184 ENSG00000096654 "Zinc finger protein 184" Q99676 6 27450743-27473118 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003226, HPA064793" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA003226: AB_2218705, HPA064793: AB_2732722" "unprognostic (8.86e-2)" "unprognostic (5.55e-2)" "unprognostic (2.27e-3)" "unprognostic (1.70e-1)" "unprognostic (4.99e-3)" "unprognostic (6.04e-2)" "unprognostic (1.99e-2)" "unprognostic (1.74e-2)" "unprognostic (1.17e-2)" "prognostic favorable (4.41e-5)" "unprognostic (2.59e-1)" "unprognostic (5.64e-2)" "unprognostic (2.77e-2)" "unprognostic (1.30e-1)" "unprognostic (1.05e-1)" "unprognostic (2.31e-2)" "unprognostic (5.79e-3)" 5.8 5.3 9.9 6.0 12.5 11.3 8.5 10.8 23.4 10.2 6.7 8.6 3.4 5.1 8.5 6.6 6.4 7.1 6.2 4.7 11.8 6.0 10.7 5.2 6.1 8.7 11.5 14.1 9.9 6.0 11.7 9.2 4.5 8.7 7.0 7.1 3.4 7.0 7.1 6.4 8.7 6.0 6.9 10.9 7.4 6.5 13.3 9.9 14.1 8.9 3.7 9.7 7.7 6.8 7.7 4.2 8.1 3.8 7.2 12.0 4.1 4.2 1.3 7.4 13.3 5.3 4.0 2.4 4.1 5.6 4.9 7.5 2.4 2.5 7.7 7.1 2.7 3.3 2.6 6.5 2.6 7.1 7.4 4.0 9.2 4.8 3.3 2.8 10.9 6.6 2.9 4.1 3.5 3.7 5.8 5.2 11.9 7.0 14.3 8.0 2.1 17.5 9.3 4.3 2.3 3.0 23.1 10.3 11.4 3.4 3.9 12.6 6.1 4.7 4.1 6.1 3.8 4.7 9.5 3.5 7.5 4.9 3.3 4.7 6.6 11.0 14.5 1.6 12.8 7.3 2.2 2.8 8.1 8.9 3.8 12.0 7.7 9.4 8.5 4.2 6.6 7.1 9.0 1.5 7.2 2.9 2.6 10.5 4.1 9.9 12.5 10.8 23.4 11.8 6.0 11.5 14.1 8.7 9.9 6.0 7.2 4.5 3.0 3.7 2.1 3.3 2.5 8.1 7.9 1.8 2.0 3.5 6.6 2.0 23.7 4.2 1.3 0.0 2.6 2.5 3.1 3.8 4.7 1.6 2.5 9.5 6.8 3.1 3.5 9.2 3.1 3.1 1.7 1.8 5.0 2.7 2.2 2.8 3.5 3.1 4.1 0.0 5.6 11.2 5.7 3.9 2.4 6.9 3.7 4.2 ZNF195 ENSG00000005801 "Zinc finger protein 195" O14628 11 3339261-3379222 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA030605 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030605: AB_10602686" "unprognostic (2.30e-2)" "unprognostic (5.26e-2)" "unprognostic (1.74e-1)" "unprognostic (1.67e-1)" "unprognostic (5.40e-2)" "unprognostic (4.02e-2)" "prognostic unfavorable (3.53e-5)" "unprognostic (3.10e-2)" "unprognostic (1.39e-2)" "unprognostic (5.94e-2)" "unprognostic (3.14e-1)" "prognostic unfavorable (4.24e-4)" "prognostic unfavorable (7.89e-5)" "unprognostic (1.25e-1)" "unprognostic (1.57e-1)" "unprognostic (1.54e-2)" "prognostic favorable (4.79e-7)" 12.2 11.3 14.0 13.2 18.8 15.0 20.9 28.0 22.7 13.4 15.4 19.6 10.8 13.5 13.4 25.3 10.8 12.6 11.1 9.6 15.2 16.9 16.4 14.6 12.7 16.5 16.9 10.5 10.6 16.0 8.8 20.8 9.9 22.5 16.4 19.4 9.3 13.2 9.7 13.0 13.5 14.0 11.3 15.4 19.5 13.3 6.9 20.0 25.8 15.9 8.6 15.9 13.1 12.9 13.6 12.2 9.9 9.2 13.0 19.1 8.2 8.1 8.8 15.2 18.4 5.3 6.7 22.3 8.3 7.1 8.9 11.1 9.3 15.1 13.2 5.2 5.4 12.3 11.3 16.9 10.1 12.9 6.4 14.1 9.8 8.7 9.3 6.9 16.1 14.7 8.5 9.8 7.4 12.5 6.3 11.1 17.3 17.1 8.6 9.7 6.5 19.1 12.8 35.4 9.1 9.0 16.8 9.4 6.7 14.0 19.1 25.5 25.3 9.1 11.5 7.6 14.4 5.6 14.5 7.8 4.2 8.1 7.6 7.3 7.9 11.0 20.9 4.3 11.9 7.4 1.9 8.4 9.9 12.0 9.2 15.2 13.6 14.8 14.6 12.2 12.7 14.0 15.6 1.4 13.0 7.7 10.7 19.1 8.2 14.0 18.8 28.0 22.7 15.2 16.9 16.9 10.5 22.5 20.0 14.9 21.6 16.5 15.0 10.8 14.9 15.5 10.2 21.4 21.6 7.0 9.8 8.4 8.3 20.8 2.4 11.1 8.5 0.0 16.3 9.2 6.2 6.5 5.8 6.7 9.6 17.5 19.5 9.2 11.4 0.0 5.5 8.5 6.8 7.2 13.1 17.0 22.6 11.5 5.3 9.1 12.8 0.0 7.5 10.0 8.7 5.9 3.3 12.8 14.5 15.4 ZNF197 "D3S1363E, P18, ZKSCAN9, ZNF166, ZSCAN41" ENSG00000186448 "Zinc finger protein 197" O14709 3 44584888-44648471 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 8.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA054567 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA054567: AB_2682527" "unprognostic (1.06e-1)" "unprognostic (6.35e-2)" "unprognostic (6.10e-2)" "unprognostic (1.09e-1)" "unprognostic (5.49e-2)" "unprognostic (1.68e-2)" "unprognostic (1.13e-1)" "unprognostic (2.23e-2)" "unprognostic (7.49e-2)" "unprognostic (2.01e-1)" "unprognostic (1.61e-1)" "prognostic unfavorable (6.78e-4)" "unprognostic (1.49e-2)" "unprognostic (3.14e-1)" "unprognostic (7.83e-2)" "unprognostic (1.23e-1)" "unprognostic (2.85e-2)" 9.9 9.9 14.0 12.4 16.1 4.2 12.7 23.7 15.4 13.5 10.9 8.6 18.3 8.9 13.6 13.4 8.3 11.0 9.2 9.8 13.2 12.4 10.2 12.8 9.4 9.7 15.0 14.0 18.4 10.2 17.8 23.5 11.1 16.0 13.7 11.1 9.2 9.0 19.8 18.2 10.8 8.8 17.6 18.3 10.1 9.2 10.1 16.2 11.8 15.9 8.9 9.6 12.0 15.7 2.7 3.2 0.9 8.4 2.5 1.7 0.7 3.0 1.4 14.0 4.5 7.9 8.6 0.4 6.2 7.9 5.4 5.8 3.0 2.6 3.0 3.7 5.2 3.1 2.1 7.1 5.4 6.1 0.7 1.7 12.7 5.3 2.1 7.6 10.2 3.3 9.1 8.1 5.8 9.8 7.9 3.8 4.4 7.9 5.0 8.7 0.7 5.8 6.7 9.2 3.3 4.4 1.9 10.1 3.7 5.7 3.7 6.0 10.1 5.8 2.7 8.4 7.9 7.8 8.8 4.4 6.0 4.3 8.4 5.1 6.5 7.5 2.0 4.7 3.1 5.9 0.6 1.4 0.9 1.5 0.6 1.5 1.1 1.4 1.4 1.9 2.7 1.7 1.0 0.9 2.5 8.4 3.2 1.5 0.7 14.0 16.1 23.7 14.7 13.2 12.4 15.0 14.0 16.0 16.2 14.9 5.4 3.7 4.2 2.3 11.8 10.1 2.5 5.3 14.8 0.0 7.9 1.0 1.7 6.4 11.8 4.5 4.5 0.0 7.7 0.5 4.3 4.0 3.5 6.7 4.0 15.9 5.8 5.5 3.5 2.2 5.2 3.6 5.0 7.2 6.5 12.2 5.8 7.0 4.9 3.7 8.9 6.5 4.2 10.8 5.3 3.0 0.3 5.2 5.0 2.6 ZNF2 "A1-5, Zfp661, ZNF661" ENSG00000275111 "Zinc finger protein 2" Q9BSG1 2 95165432-95184317 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041358 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA041358: AB_10795539" "unprognostic (1.18e-1)" "unprognostic (6.41e-3)" "unprognostic (5.81e-2)" "unprognostic (9.29e-2)" "unprognostic (4.47e-2)" "unprognostic (6.03e-2)" "unprognostic (1.13e-3)" "prognostic favorable (4.69e-5)" "unprognostic (1.47e-2)" "unprognostic (1.78e-1)" "unprognostic (2.37e-2)" "unprognostic (2.63e-2)" "unprognostic (2.66e-3)" "unprognostic (2.57e-2)" "unprognostic (6.78e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-2)" 5.1 4.1 5.2 3.2 6.3 0.7 4.0 6.4 6.1 5.3 2.6 6.4 2.5 3.3 5.4 5.7 3.5 4.8 2.3 4.6 5.1 4.2 2.7 3.5 4.3 5.3 5.0 6.5 2.8 6.5 7.1 3.1 5.2 4.8 2.5 4.9 3.7 5.5 4.2 4.7 2.2 4.1 6.1 4.3 3.5 4.3 5.9 4.3 5.0 4.5 5.0 4.3 4.0 7.2 5.0 15.1 6.2 4.2 8.6 4.5 5.4 5.2 6.5 10.8 9.7 7.6 4.2 6.1 8.0 8.4 11.0 5.6 3.7 3.5 4.3 5.7 5.9 4.5 6.9 4.6 8.8 7.6 5.9 8.0 4.3 7.0 7.9 4.1 5.2 6.5 6.5 7.6 11.9 9.3 7.2 6.6 5.3 2.9 8.6 4.9 5.9 5.7 2.8 4.8 7.2 5.7 11.2 4.5 4.8 3.2 5.5 7.5 5.7 8.2 6.9 5.7 5.1 6.3 5.8 10.1 5.9 8.0 5.1 5.0 4.3 4.3 6.8 5.4 7.7 5.9 4.4 15.1 8.6 6.2 6.2 7.2 7.0 7.5 5.0 6.9 8.5 8.6 3.6 4.2 4.7 4.1 7.6 4.5 0.0 1.7 0.5 0.6 0.9 2.8 2.4 2.5 4.0 2.3 1.8 0.0 1.3 5.0 1.5 1.6 1.6 0.7 0.0 1.6 1.1 1.2 0.7 1.1 1.6 2.2 1.6 0.0 1.3 3.2 0.4 2.0 1.7 0.0 0.0 0.7 3.6 0.8 0.0 2.8 2.2 2.9 6.5 1.9 4.2 6.8 1.0 1.4 2.1 1.2 0.6 ZNF20 KOX13 ENSG00000132010 "Zinc finger protein 20" P17024 19 12092843-12140407 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Ciliated cells: 32.1;Early spermatids: 34.4;Late spermatids: 39.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 18.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA020887 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA020887: AB_2218842" "unprognostic (1.77e-2)" "unprognostic (1.06e-2)" "unprognostic (1.69e-2)" "unprognostic (1.20e-3)" "unprognostic (4.00e-2)" "unprognostic (1.08e-4)" "unprognostic (1.69e-1)" "unprognostic (2.14e-2)" "unprognostic (1.57e-3)" "unprognostic (1.04e-1)" "unprognostic (4.40e-2)" "unprognostic (7.01e-2)" "unprognostic (9.23e-2)" "unprognostic (1.21e-1)" "unprognostic (1.50e-2)" "unprognostic (1.15e-2)" "unprognostic (1.21e-3)" 3.3 4.0 2.7 3.5 4.0 4.9 6.3 3.5 3.7 7.3 4.4 2.3 9.5 1.8 6.3 7.8 4.5 10.3 2.7 2.5 3.0 2.8 5.6 2.6 3.6 4.3 2.8 1.3 6.6 6.1 4.0 9.5 3.8 4.0 9.1 4.4 2.7 4.6 4.0 1.9 6.2 7.5 3.9 2.9 6.0 4.4 14.8 3.8 8.9 9.3 3.9 3.9 5.3 4.5 2.3 2.2 18.5 2.2 6.0 3.3 1.0 3.3 0.1 4.6 9.6 2.1 3.5 3.6 3.0 5.3 2.7 3.8 1.0 1.9 3.2 3.4 3.4 4.0 2.1 2.5 2.1 2.8 2.6 0.7 1.3 3.5 1.6 1.2 0.1 3.0 3.0 4.6 1.1 1.6 3.1 1.6 6.5 2.0 0.5 5.7 1.3 4.1 3.6 7.8 1.6 2.6 3.1 2.6 1.7 3.4 7.3 2.0 4.6 2.7 1.9 3.9 4.7 3.6 5.2 0.0 6.5 2.2 6.3 2.0 5.3 2.9 3.1 0.4 0.0 2.5 9.7 2.2 5.1 1.5 1.1 1.5 1.5 1.3 1.5 1.2 2.3 1.4 1.2 18.5 6.0 2.0 2.2 3.3 1.0 2.7 4.0 3.5 3.7 3.0 2.8 2.8 1.3 4.0 3.8 0.0 0.0 0.0 0.7 0.1 0.5 0.7 2.5 32.1 0.0 1.8 2.0 0.8 1.7 2.0 34.4 0.1 2.3 0.0 2.1 1.0 0.4 1.7 2.3 2.1 1.3 0.0 4.1 0.0 1.0 39.3 0.6 0.2 0.0 1.8 1.3 0.5 1.9 2.5 0.0 1.9 1.3 0.0 0.4 7.6 1.7 0.5 0.9 0.0 1.2 1.4 ZNF205 "Zfp13, ZNF210" ENSG00000122386 "Zinc finger protein 205" O95201 16 3112560-3120517 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001791 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA001791: AB_1080688" "unprognostic (8.46e-2)" "unprognostic (1.57e-1)" "unprognostic (1.94e-2)" "unprognostic (5.72e-2)" "unprognostic (3.51e-1)" "unprognostic (2.28e-2)" "unprognostic (1.98e-3)" "unprognostic (4.14e-2)" "unprognostic (1.02e-1)" "unprognostic (6.71e-2)" "unprognostic (7.26e-2)" "unprognostic (6.17e-2)" "unprognostic (4.15e-2)" "unprognostic (3.46e-2)" "unprognostic (8.41e-2)" "unprognostic (9.43e-2)" "unprognostic (9.19e-3)" 10.7 10.6 11.4 7.0 13.6 3.5 9.8 16.4 16.8 11.8 11.1 14.2 17.2 13.9 13.0 9.3 10.6 14.2 14.9 12.9 11.5 10.1 13.6 12.4 10.3 5.3 13.0 12.1 17.2 18.3 16.5 10.9 11.0 12.0 12.9 6.1 10.2 15.4 14.8 30.6 19.0 11.1 9.7 9.0 9.0 11.5 5.6 14.3 1.4 14.4 9.0 4.6 8.2 12.4 0.6 0.3 1.5 0.5 2.7 2.4 0.6 7.6 9.2 8.8 14.1 3.5 4.7 12.1 6.4 6.7 8.4 10.4 4.9 7.3 0.3 8.4 4.0 5.4 11.9 7.7 6.6 4.0 2.0 15.5 3.2 12.8 6.2 7.9 0.4 1.8 5.1 10.4 8.0 5.5 8.7 9.6 0.2 6.8 5.8 4.2 12.9 0.1 0.3 9.3 5.0 7.6 0.4 11.1 6.9 4.9 4.3 12.5 10.9 6.6 14.3 9.3 4.8 10.1 2.8 5.5 8.5 9.8 8.2 9.0 0.1 5.8 0.3 3.7 0.4 7.1 0.0 0.5 1.5 2.1 0.4 1.8 0.4 0.7 1.9 0.3 0.6 1.8 2.4 0.2 2.7 0.0 0.2 1.1 0.6 11.4 13.6 16.4 16.8 11.5 10.1 13.0 12.1 12.0 14.3 0.0 0.0 2.4 3.8 5.0 7.3 1.1 10.2 0.0 0.0 5.2 3.9 7.8 5.0 10.5 0.7 5.6 15.6 0.0 11.8 12.1 5.6 2.9 4.6 8.3 7.6 6.4 9.9 7.4 4.6 0.9 15.8 2.5 5.0 5.4 13.2 8.5 11.9 7.0 18.4 12.2 8.2 25.8 5.8 1.7 1.1 4.8 4.0 0.0 12.0 1.6 ZNF207 ENSG00000010244 "Zinc finger protein 207" O43670 17 32350117-32381886 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017013, HPA063908" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA017013: AB_1859124, HPA063908: AB_2685149" "unprognostic (8.40e-3)" "unprognostic (1.84e-1)" "prognostic favorable (2.81e-4)" "unprognostic (7.57e-2)" "unprognostic (2.44e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (7.30e-8)" "unprognostic (2.68e-1)" "unprognostic (4.75e-3)" "unprognostic (8.53e-2)" "unprognostic (5.18e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (4.17e-8)" "unprognostic (1.28e-2)" "unprognostic (2.06e-1)" "unprognostic (1.25e-1)" "unprognostic (1.04e-1)" 41.0 36.7 29.7 42.6 29.9 101.0 37.1 51.0 35.2 40.1 33.2 39.1 31.0 26.9 44.3 37.5 61.0 35.4 29.5 32.5 25.8 24.4 33.3 33.7 40.3 45.6 35.4 25.5 43.9 31.3 38.4 53.1 52.5 28.4 32.5 41.3 37.7 42.1 31.4 42.4 39.7 34.9 39.0 41.4 41.8 34.7 32.7 33.8 74.9 35.6 46.5 60.4 42.0 43.1 28.3 45.7 39.6 39.1 36.9 38.8 35.6 37.8 46.6 50.5 28.4 27.1 29.3 40.5 38.0 53.6 54.1 48.7 44.3 36.3 52.2 29.4 46.6 42.0 39.2 65.1 46.0 61.2 26.8 43.6 53.5 42.7 45.5 28.4 67.7 49.2 33.8 27.7 37.9 21.2 30.5 49.9 26.6 54.2 40.3 51.8 34.6 54.1 31.8 43.5 36.3 26.6 48.7 45.3 48.7 44.6 74.1 35.4 39.5 35.7 26.3 33.5 45.2 47.5 40.3 35.2 30.6 36.4 31.0 51.3 34.5 51.1 83.4 26.1 32.2 47.3 39.6 34.2 34.3 33.0 38.4 34.1 28.3 30.4 30.3 45.7 22.1 25.7 29.3 17.7 36.9 39.1 21.6 38.8 35.6 29.7 29.9 51.0 35.2 25.8 24.4 35.4 25.5 28.4 33.8 74.5 102.5 74.9 153.6 132.7 131.5 29.5 58.6 99.0 149.0 61.1 212.1 105.3 46.4 78.7 38.1 90.4 96.3 46.7 92.1 139.6 97.2 143.7 71.8 51.6 86.8 95.3 111.3 88.4 95.4 18.3 99.2 106.7 52.3 121.8 73.1 61.6 105.4 86.5 91.9 39.8 151.1 122.9 93.9 117.2 108.3 129.7 149.4 101.5 89.7 220.0 ZNF212 C2H2-150 ENSG00000170260 "Zinc finger protein 212" Q9UDV6 7 149239651-149255609 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049807, HPA054178" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA049807: AB_2680891, HPA054178: AB_2682406" "unprognostic (1.07e-2)" "unprognostic (6.31e-2)" "unprognostic (6.77e-3)" "unprognostic (3.66e-3)" "unprognostic (6.48e-2)" "unprognostic (2.79e-3)" "unprognostic (5.55e-3)" "unprognostic (8.75e-3)" "unprognostic (1.37e-3)" "unprognostic (1.15e-1)" "unprognostic (4.32e-3)" "unprognostic (2.46e-1)" "unprognostic (2.30e-1)" "unprognostic (4.75e-2)" "unprognostic (2.99e-1)" "unprognostic (1.60e-2)" "unprognostic (1.59e-1)" 7.3 10.9 8.0 11.7 8.8 16.3 11.2 12.0 13.0 13.0 12.4 11.5 13.1 14.2 14.4 12.6 19.1 11.4 11.9 6.6 9.3 6.7 9.4 12.8 7.4 11.0 7.0 11.8 13.7 10.8 13.0 10.4 19.5 10.5 12.2 7.7 10.9 16.7 12.8 9.7 16.5 13.0 8.1 7.3 15.0 9.1 20.5 7.8 21.8 11.2 6.7 12.9 9.6 15.8 5.8 5.7 9.4 4.5 10.5 9.1 2.7 8.3 8.3 10.2 12.8 7.2 5.9 11.3 5.1 7.7 9.2 9.3 7.0 10.7 11.0 7.9 5.0 7.4 7.7 7.5 8.3 7.6 8.4 13.4 6.0 5.9 5.8 5.5 9.9 7.5 6.7 9.6 6.3 6.7 5.7 5.4 13.6 11.0 8.5 5.3 11.9 17.8 20.3 13.4 6.6 10.0 12.2 7.0 11.9 5.7 7.0 10.3 16.8 7.7 7.6 7.4 6.4 4.5 10.6 4.5 9.3 2.6 11.8 9.2 19.7 8.6 9.9 12.2 9.0 8.4 0.0 4.5 9.4 7.0 3.8 6.8 5.7 5.2 5.8 5.7 5.8 9.1 7.5 2.6 10.5 4.4 5.0 7.5 2.7 8.0 8.8 12.0 13.0 9.3 6.7 7.0 11.8 10.5 7.8 6.0 3.5 5.9 2.6 8.7 6.7 2.4 5.1 4.0 0.0 0.0 3.9 8.1 3.3 4.7 1.5 3.8 6.6 0.0 3.4 8.1 2.8 3.7 2.3 5.9 3.6 9.5 6.4 3.1 4.0 0.0 5.8 2.9 1.7 6.4 6.0 5.8 4.1 0.0 5.6 2.4 8.5 12.9 1.7 13.4 18.6 7.5 12.6 6.5 6.3 3.3 ZNF213 "CR53, ZKSCAN21, ZSCAN53" ENSG00000085644 "Zinc finger protein 213" O14771 16 3129777-3142805 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 18.5;Late spermatids: 41.1;Sertoli cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035000, HPA056750" Uncertain Approved "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" NA NA "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "HPA035000: AB_10669997, HPA056750: AB_2683225" "unprognostic (1.94e-1)" "unprognostic (1.62e-2)" "unprognostic (3.25e-1)" "unprognostic (1.87e-2)" "unprognostic (1.31e-2)" "unprognostic (4.05e-3)" "prognostic unfavorable (6.74e-4)" "unprognostic (4.72e-2)" "unprognostic (1.25e-1)" "unprognostic (2.31e-1)" "unprognostic (1.66e-1)" "unprognostic (2.90e-1)" "unprognostic (4.73e-1)" "unprognostic (7.67e-2)" "unprognostic (2.02e-1)" "unprognostic (3.33e-1)" "unprognostic (1.57e-1)" 5.7 8.2 9.0 6.0 10.3 6.0 5.7 10.8 16.7 5.0 6.2 14.6 4.7 9.3 7.5 5.1 8.4 6.8 6.0 9.1 9.5 7.7 4.4 2.4 6.3 8.8 7.1 9.3 10.3 12.1 8.7 7.3 4.1 9.1 6.5 2.5 6.8 17.4 5.9 11.1 16.9 11.2 6.8 7.6 7.5 6.9 20.1 8.0 7.5 9.2 4.7 5.4 7.1 5.8 4.8 3.2 3.5 2.5 4.0 4.7 1.8 3.4 10.7 4.8 11.3 4.6 3.9 5.9 6.2 2.5 3.3 3.9 3.4 7.0 4.1 6.1 4.0 4.8 8.3 2.2 6.9 1.3 8.6 8.3 2.9 11.8 6.6 8.9 7.0 7.7 3.7 8.6 4.6 1.7 2.5 2.5 8.1 7.4 9.2 2.1 14.6 6.6 8.7 8.2 3.6 8.2 8.9 5.6 7.5 2.6 2.3 9.9 8.5 9.4 5.6 4.4 3.2 7.4 12.2 6.1 6.7 6.2 7.6 4.3 5.2 4.8 6.3 2.7 9.3 5.1 0.0 1.6 3.4 3.7 2.5 3.2 2.7 3.6 2.4 1.6 4.8 4.7 3.4 3.5 4.0 1.9 3.2 2.0 1.8 9.0 10.3 10.8 16.7 9.5 7.7 7.1 9.3 9.1 8.0 0.0 0.6 1.7 1.3 1.6 5.9 3.3 2.5 1.4 1.2 0.0 2.0 1.4 1.7 3.5 18.5 2.2 8.5 0.0 4.3 1.6 2.5 1.7 4.6 1.0 2.8 7.9 2.4 2.5 4.1 41.1 6.1 2.3 0.0 3.6 5.3 4.6 4.9 3.5 6.7 2.3 5.2 19.4 4.4 8.9 3.8 1.8 1.1 0.0 5.2 1.3 ZNF215 "ZKSCAN11, ZSCAN43" ENSG00000149054 "Zinc finger protein 215" Q9UL58 11 6926404-7001004 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 11.6" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 7.0;Cone photoreceptor cells: 5.9;Spermatogonia: 7.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 18.1" "Low region specificity" "Detected in all" "HPA047243, HPA051010" Enhanced Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA047243: , HPA051010: AB_2681308" "unprognostic (2.18e-2)" "unprognostic (1.52e-1)" "unprognostic (2.29e-2)" "unprognostic (1.08e-1)" "unprognostic (8.18e-2)" "unprognostic (4.76e-2)" "unprognostic (1.01e-4)" "unprognostic (2.02e-1)" "unprognostic (1.50e-2)" "unprognostic (1.05e-1)" "unprognostic (3.44e-1)" "unprognostic (1.45e-2)" "unprognostic (9.01e-3)" "unprognostic (4.29e-3)" "unprognostic (7.89e-2)" "unprognostic (1.21e-1)" "unprognostic (1.90e-1)" 1.2 1.4 1.5 9.0 1.8 1.4 2.7 0.7 4.0 1.9 4.2 0.3 0.9 4.6 2.3 5.2 2.8 1.4 1.1 1.4 1.2 2.2 2.9 1.6 1.5 6.7 0.7 1.4 1.9 10.4 0.0 0.8 0.7 1.9 2.7 5.5 1.2 4.2 2.0 0.9 1.6 5.5 0.9 1.1 4.8 1.6 6.1 0.0 6.5 2.7 2.1 11.6 3.3 2.2 2.5 2.9 4.0 1.8 1.5 1.4 0.8 2.6 1.2 1.8 0.6 1.3 1.6 5.8 6.2 5.3 3.2 6.4 0.2 0.1 8.7 2.0 3.3 4.1 3.1 5.1 6.1 6.1 0.0 7.0 0.1 0.8 0.1 1.3 5.3 0.4 2.8 2.9 0.1 6.7 1.6 5.1 0.1 10.2 3.0 1.3 0.1 0.2 0.2 8.5 0.0 1.7 0.2 0.1 1.0 0.2 4.8 0.1 0.2 0.0 2.2 0.2 4.5 0.2 2.2 2.4 2.0 5.8 2.4 0.1 0.4 0.1 18.1 4.6 0.3 1.8 4.0 1.8 0.6 0.8 1.0 0.3 2.5 0.6 1.4 1.7 2.5 1.4 0.8 2.7 1.5 0.5 2.9 0.7 0.8 1.5 1.8 0.7 4.0 1.2 2.2 0.7 1.4 1.9 0.0 0.0 0.0 2.2 1.3 0.3 0.5 0.2 0.0 0.0 1.2 7.0 5.9 0.3 1.7 0.1 0.2 0.0 1.3 0.0 1.5 2.2 0.5 0.4 1.1 1.0 0.4 3.2 1.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 2.6 0.2 0.4 0.0 0.0 0.8 0.0 0.0 0.9 1.5 7.5 0.3 0.0 0.0 2.5 0.6 ZNF219 ENSG00000165804 "Zinc finger protein 219" Q9P2Y4 14 21090046-21104722 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030761, HPA056168" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA030761: AB_2673598, HPA056168: AB_2683052" "unprognostic (9.82e-3)" "unprognostic (4.50e-3)" "unprognostic (3.35e-1)" "unprognostic (1.11e-3)" "unprognostic (4.49e-2)" "unprognostic (1.96e-1)" "unprognostic (2.54e-1)" "unprognostic (6.79e-2)" "unprognostic (2.62e-2)" "unprognostic (1.70e-1)" "unprognostic (6.02e-2)" "unprognostic (1.30e-1)" "unprognostic (1.80e-3)" "unprognostic (6.28e-2)" "unprognostic (1.92e-1)" "unprognostic (2.56e-2)" "unprognostic (2.35e-2)" 20.9 26.9 11.6 7.9 7.8 4.5 50.2 22.3 12.7 18.1 26.7 5.0 31.7 23.8 15.9 13.6 20.3 10.1 20.1 22.6 10.4 9.4 12.1 10.5 16.7 10.8 13.2 4.8 18.8 13.2 16.1 8.9 7.4 13.1 14.1 11.8 11.3 22.5 27.4 16.4 38.8 26.7 22.6 4.3 5.8 12.1 8.0 4.8 15.3 11.8 20.0 7.3 20.8 17.4 0.5 2.1 2.8 0.4 0.7 1.3 0.2 3.4 11.8 15.2 22.2 2.1 2.0 21.8 4.4 6.7 2.2 3.5 6.8 7.9 5.2 3.3 1.6 2.5 26.1 4.8 13.9 1.5 10.6 5.1 3.1 16.8 14.2 1.3 0.6 4.9 3.0 11.8 3.6 6.7 3.0 2.7 4.9 2.9 1.6 1.2 9.6 6.9 4.9 21.5 6.7 2.5 14.6 2.5 1.3 1.7 19.4 17.4 15.6 6.0 3.5 3.2 3.3 4.3 1.8 0.5 2.7 12.3 6.7 1.7 2.8 1.7 1.1 1.7 2.6 5.3 0.0 0.4 0.1 1.3 0.1 0.1 0.2 0.3 0.6 0.2 0.5 0.6 0.5 2.8 0.7 0.0 2.1 0.1 0.2 11.6 7.8 22.3 11.8 10.4 9.4 13.2 4.8 13.1 4.8 3.0 12.5 1.4 11.5 13.2 34.2 6.5 10.2 2.7 1.2 3.5 25.5 8.0 1.7 7.4 9.9 5.3 22.0 0.0 9.6 0.8 6.6 6.8 14.9 7.8 6.8 11.1 7.5 6.7 9.1 2.9 9.2 5.3 8.5 0.0 15.4 25.4 7.5 5.8 11.7 6.8 24.9 12.9 11.3 2.6 3.1 13.7 10.4 4.3 25.2 12.0 ZNF22 "HKR-T1, KOX15, Zfp422, ZNF422" ENSG00000165512 "Zinc finger protein 22" P17026 10 45000475-45005326 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA016736, HPA054893" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA016736: AB_1859133, HPA054893: AB_2682632" "unprognostic (2.87e-2)" "unprognostic (1.10e-1)" "unprognostic (2.65e-1)" "unprognostic (5.77e-2)" "unprognostic (3.50e-3)" "unprognostic (3.42e-2)" "unprognostic (4.77e-2)" "unprognostic (2.01e-1)" "unprognostic (1.01e-3)" "unprognostic (9.31e-3)" "unprognostic (2.94e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (1.11e-5)" "prognostic unfavorable (8.06e-4)" "unprognostic (1.39e-1)" "unprognostic (9.96e-2)" "unprognostic (4.58e-2)" 28.5 7.9 15.3 14.5 14.0 12.4 38.6 13.5 13.7 15.7 12.1 9.9 14.7 10.8 18.0 14.0 11.4 15.1 10.5 14.7 14.2 13.0 17.0 22.8 14.1 19.9 14.9 10.2 21.6 29.2 5.5 11.1 22.6 13.6 18.1 12.5 10.2 12.9 11.9 14.0 6.2 13.1 13.9 15.6 17.8 12.4 9.0 14.5 40.1 25.4 11.7 19.1 12.2 12.1 19.8 24.7 13.4 10.9 25.2 25.2 13.6 11.5 1.8 16.2 10.0 8.6 6.2 0.1 5.4 11.1 13.9 15.1 6.4 9.7 11.9 8.9 8.0 3.1 1.9 15.5 5.7 19.8 7.4 0.2 12.4 3.0 0.0 18.0 24.0 4.3 11.0 8.4 5.7 0.2 0.1 21.9 32.6 16.2 21.6 10.9 0.3 44.6 36.3 9.7 6.6 3.2 32.9 22.5 16.8 10.8 9.7 15.7 13.5 4.9 9.9 8.0 15.5 2.1 24.1 12.1 10.2 18.8 7.1 18.1 12.4 12.1 11.4 6.5 0.9 10.8 8.0 10.9 13.4 21.0 10.3 25.2 16.0 13.7 21.6 14.3 19.8 18.9 23.1 1.1 25.2 6.5 24.7 7.7 13.6 15.3 14.0 13.5 13.7 14.2 13.0 14.9 10.2 13.6 14.5 26.8 20.6 39.5 55.7 17.1 32.7 8.9 53.5 41.5 30.7 31.4 9.8 60.0 48.0 50.3 2.7 58.3 4.5 46.7 37.4 50.1 50.3 45.8 31.3 47.9 42.0 36.5 38.4 77.3 24.7 2.4 41.1 26.9 18.6 74.9 34.1 47.6 36.1 10.5 48.1 37.2 30.4 32.3 36.2 37.5 34.5 11.5 44.5 30.5 34.2 25.9 ZNF222 ENSG00000159885 "Zinc finger protein 222" Q9UK12 19 44025342-44033112 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "Early spermatids: 43.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA004086 Approved Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA004086: AB_2273259" "unprognostic (1.91e-3)" "unprognostic (3.41e-2)" "unprognostic (8.08e-2)" "unprognostic (1.02e-1)" "unprognostic (3.81e-2)" "unprognostic (7.45e-2)" "unprognostic (1.75e-3)" "unprognostic (6.75e-2)" "unprognostic (1.58e-2)" "unprognostic (7.58e-2)" "prognostic favorable (5.56e-7)" "unprognostic (2.19e-3)" "unprognostic (1.36e-1)" "unprognostic (2.44e-1)" "unprognostic (8.42e-2)" "unprognostic (2.05e-2)" "unprognostic (1.16e-3)" 4.8 7.7 8.1 5.1 9.1 8.0 8.3 18.3 12.6 6.2 4.4 7.5 5.3 2.9 5.1 7.3 3.5 5.5 6.4 7.5 11.5 8.2 5.9 5.1 5.7 7.2 8.8 7.8 8.9 5.4 6.6 12.7 5.4 10.7 6.6 5.0 5.7 6.9 6.4 3.7 4.5 5.0 6.0 9.3 8.8 5.5 15.4 11.1 10.3 7.6 5.0 7.3 8.5 6.6 7.6 4.0 8.9 3.6 6.1 9.7 4.0 3.9 4.6 7.9 7.1 6.1 6.2 0.4 4.2 7.6 5.0 7.8 2.4 2.6 1.4 6.6 4.7 6.0 1.3 5.4 4.0 6.3 5.8 5.9 6.5 5.8 3.8 7.6 0.2 5.9 4.7 5.5 4.1 7.1 8.0 4.6 5.8 1.2 2.8 6.2 0.5 4.4 2.6 4.7 1.8 2.3 0.1 8.4 2.1 4.2 12.4 4.2 9.7 6.9 1.3 5.7 7.2 1.7 6.3 3.4 5.5 5.3 3.2 5.2 11.3 9.2 0.1 2.9 0.1 6.1 8.9 3.6 7.0 9.2 2.3 7.7 7.4 8.7 8.9 3.6 7.6 9.7 7.3 7.5 6.1 2.8 4.0 6.0 4.0 8.1 9.1 18.3 12.6 11.5 8.2 8.8 7.8 10.7 11.1 0.0 1.0 0.0 1.7 2.3 4.9 1.9 0.0 0.0 1.2 5.2 0.0 1.8 6.6 2.3 43.5 1.8 0.7 0.0 1.1 0.9 2.1 1.0 4.6 1.0 2.0 6.4 2.9 1.3 1.2 1.5 1.7 1.2 1.7 1.0 1.7 6.5 0.8 0.0 2.1 1.2 2.6 0.0 2.7 5.1 1.2 1.5 0.9 4.1 1.2 0.6 ZNF223 ENSG00000178386 "Zinc finger protein 223" Q9UK11 19 44051367-44067991 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 21.6" "HPA067823, HPA079175" Approved Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA067823: AB_2685906, HPA079175: " "unprognostic (6.15e-2)" "unprognostic (1.06e-1)" "unprognostic (1.27e-1)" "unprognostic (1.63e-1)" "unprognostic (1.02e-2)" "unprognostic (2.42e-1)" "unprognostic (8.36e-2)" "unprognostic (1.29e-2)" "unprognostic (1.86e-3)" "unprognostic (1.04e-1)" "unprognostic (1.20e-2)" "unprognostic (1.85e-1)" "unprognostic (6.32e-2)" "unprognostic (4.33e-1)" "unprognostic (4.95e-2)" "unprognostic (3.67e-1)" "unprognostic (2.58e-4)" 6.5 8.0 6.6 5.9 14.7 3.2 10.1 19.8 17.3 7.6 8.0 9.6 6.0 7.1 7.7 11.3 6.5 7.5 9.5 8.8 9.4 8.5 7.5 4.7 7.0 6.0 6.7 7.4 7.7 6.2 10.8 9.8 9.7 15.3 12.3 10.7 7.1 7.7 9.4 3.5 8.8 9.2 7.8 5.7 8.6 8.8 6.2 7.9 6.7 11.7 4.6 7.6 9.0 6.2 4.4 7.7 11.6 7.1 6.6 9.3 2.6 2.5 1.4 5.5 1.3 3.6 4.6 0.1 3.9 4.3 3.5 5.1 2.6 4.3 0.0 3.7 3.0 2.1 2.5 0.0 4.4 3.8 0.0 4.1 5.1 3.9 3.5 2.7 0.2 0.1 4.5 3.5 3.0 2.9 5.0 3.9 0.1 0.2 0.0 3.9 2.0 0.0 1.8 4.1 1.7 1.9 0.0 2.2 1.2 4.2 21.6 3.4 8.1 6.8 0.9 2.7 7.4 3.9 4.7 3.9 3.3 3.2 1.8 1.4 2.6 4.4 0.0 1.4 0.0 3.2 11.6 5.8 8.7 2.8 7.1 4.3 3.6 4.7 2.4 6.4 4.4 9.3 4.0 0.5 6.6 2.9 7.7 4.0 2.6 6.6 14.7 19.8 17.3 9.4 8.5 6.7 7.4 15.3 7.9 0.0 0.6 0.0 0.5 0.0 2.9 0.8 2.5 1.4 0.0 1.8 2.0 1.6 3.3 1.9 2.7 2.1 0.7 0.0 0.4 0.4 0.2 0.5 0.0 0.6 1.4 3.2 0.0 2.5 1.6 0.8 1.4 1.2 0.0 1.0 2.4 1.5 1.1 0.0 1.8 1.0 1.2 0.0 0.0 1.9 1.9 0.0 0.8 0.0 2.1 0.7 ZNF224 "BMZF-2, KOX22, ZNF255, ZNF27" ENSG00000267680 "Zinc finger protein 224" Q9NZL3 19 44094339-44109886 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA054045 Approved Supported "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "HPA054045: AB_2682354" "unprognostic (1.01e-3)" "unprognostic (4.94e-2)" "unprognostic (2.23e-1)" "unprognostic (3.40e-3)" "unprognostic (8.47e-2)" "unprognostic (4.25e-4)" "unprognostic (9.61e-2)" "unprognostic (6.35e-3)" "unprognostic (3.61e-2)" "unprognostic (2.31e-1)" "unprognostic (1.81e-3)" "unprognostic (2.64e-2)" "prognostic unfavorable (5.32e-4)" "unprognostic (1.68e-1)" "unprognostic (1.67e-1)" "unprognostic (1.16e-1)" "prognostic favorable (1.53e-7)" 13.5 13.3 12.4 13.6 17.7 6.9 14.4 29.2 20.2 13.6 11.0 10.8 17.7 14.8 14.9 20.3 10.0 13.5 11.6 9.0 16.4 7.8 12.7 13.3 14.6 17.1 20.3 11.0 18.6 13.1 16.6 25.0 12.1 15.4 15.0 18.1 11.6 13.8 13.9 6.6 20.2 19.4 15.0 12.3 23.6 13.1 5.4 15.8 14.9 18.0 8.7 18.3 12.1 11.3 11.6 6.5 25.0 8.1 10.0 14.5 6.7 6.1 10.2 11.0 9.0 10.9 11.5 9.0 7.7 11.5 5.4 12.4 5.0 4.9 7.4 8.6 10.1 4.1 6.9 6.0 6.6 7.2 7.5 12.2 14.1 16.9 5.2 5.8 10.1 16.6 14.2 12.0 6.6 9.9 17.1 9.6 7.4 4.3 9.0 8.9 1.6 8.9 12.3 4.7 3.3 7.1 5.3 11.9 4.5 8.1 19.6 5.6 12.9 10.6 4.6 3.5 11.4 4.5 13.3 10.0 11.9 7.7 5.3 5.4 12.1 11.3 4.2 6.4 7.9 5.5 25.0 6.1 14.1 13.3 4.1 14.5 11.2 11.2 13.1 6.5 11.6 14.1 10.9 4.5 10.0 8.1 5.8 12.5 6.7 12.4 17.7 29.2 20.2 16.4 7.8 20.3 11.0 15.4 15.8 20.8 13.4 27.2 6.3 4.9 25.7 4.0 22.9 5.3 7.9 24.4 17.7 10.3 1.7 6.4 11.3 9.5 18.0 0.0 4.6 6.2 10.0 8.4 20.7 5.3 6.6 25.4 9.2 12.9 8.8 2.9 15.0 11.5 5.0 19.0 8.8 17.8 6.3 17.5 13.1 1.4 21.3 12.9 6.4 3.7 3.7 5.9 6.9 29.4 8.5 8.0 ZNF225 ENSG00000256294 "Zinc finger protein 225" Q9UK10 19 44112181-44134816 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 6.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 18.9" HPA073778 Approved Nucleoplasm NA NA Nucleoplasm "HPA073778: AB_2686634" "unprognostic (1.52e-1)" "unprognostic (8.99e-2)" "unprognostic (1.36e-1)" "unprognostic (1.65e-1)" "unprognostic (1.45e-2)" "unprognostic (1.59e-2)" "unprognostic (9.03e-2)" "unprognostic (7.54e-2)" "unprognostic (1.26e-2)" "unprognostic (6.82e-2)" "unprognostic (7.18e-3)" "unprognostic (5.67e-2)" "unprognostic (7.54e-2)" "unprognostic (1.84e-1)" "unprognostic (6.60e-2)" "unprognostic (5.90e-2)" "unprognostic (3.17e-4)" 6.0 8.3 8.7 4.9 8.5 4.1 16.0 15.8 8.8 8.4 5.6 10.8 9.9 4.7 7.9 5.1 5.8 6.4 5.5 5.9 7.6 5.1 6.0 6.3 5.3 7.3 10.2 6.0 10.3 6.2 7.9 11.0 6.2 8.7 6.9 4.8 7.4 6.2 7.1 4.6 6.0 6.1 6.5 7.3 8.2 5.5 21.4 9.9 11.8 7.8 2.0 7.1 6.5 6.0 6.7 6.4 11.4 6.7 6.0 7.6 3.3 2.6 4.3 5.6 6.5 8.5 7.6 1.3 4.3 6.6 5.1 6.7 2.6 1.6 1.1 3.3 4.7 3.0 2.3 5.1 3.2 4.6 2.6 4.9 7.7 5.5 2.4 4.9 4.7 7.4 7.1 3.9 4.6 7.5 8.8 5.0 3.5 2.2 1.4 4.4 0.8 3.4 3.4 5.1 1.9 4.4 2.9 7.8 2.5 5.1 5.3 3.4 5.9 7.8 18.9 2.2 6.0 2.1 8.1 5.0 4.8 5.0 2.3 2.9 6.2 3.7 0.8 2.3 2.8 4.2 11.4 4.7 7.4 5.3 6.7 5.2 5.0 4.1 4.0 6.4 6.7 7.6 5.5 1.2 6.0 2.7 2.8 5.3 3.3 8.7 8.5 15.8 8.8 7.6 5.1 10.2 6.0 8.7 9.9 0.0 1.7 0.8 0.6 0.2 4.2 1.2 0.0 2.7 2.3 1.8 0.0 1.7 3.3 1.1 4.8 1.6 0.7 0.0 1.2 0.9 1.4 0.3 0.0 1.6 1.3 6.4 1.2 3.1 4.4 1.9 2.6 1.1 0.0 0.0 0.6 3.2 1.1 2.0 1.8 0.8 3.7 0.0 0.5 3.9 2.0 0.4 0.2 2.2 1.0 0.3 ZNF232 ZSCAN11 ENSG00000167840 "Zinc finger protein 232" Q9UNY5 17 5105541-5123116 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027309, HPA028611" Uncertain Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA027309: AB_10603464, HPA028611: AB_2672700" "unprognostic (4.20e-2)" "unprognostic (2.06e-3)" "unprognostic (3.69e-1)" "unprognostic (5.59e-3)" "unprognostic (5.21e-2)" "unprognostic (5.90e-3)" "prognostic unfavorable (4.66e-4)" "unprognostic (3.12e-2)" "unprognostic (5.46e-3)" "unprognostic (2.49e-2)" "prognostic favorable (6.55e-4)" "unprognostic (3.28e-2)" "unprognostic (3.49e-3)" "unprognostic (2.22e-2)" "unprognostic (2.28e-1)" "unprognostic (1.11e-1)" "unprognostic (8.61e-3)" 6.7 5.2 6.5 6.7 9.5 2.0 7.4 14.3 11.1 6.6 8.2 11.1 7.8 4.5 8.9 10.1 5.5 9.9 5.5 5.9 7.3 5.4 6.6 6.3 6.3 7.0 9.8 5.7 14.3 10.0 3.8 8.7 6.2 8.7 7.6 5.9 6.5 8.8 6.4 7.7 5.5 6.3 8.5 6.2 6.9 7.2 7.5 10.7 6.4 8.0 5.4 6.1 6.3 6.2 11.8 7.4 1.9 2.1 5.4 7.8 3.9 5.4 4.1 6.8 6.9 2.4 1.0 3.7 2.7 1.4 2.7 3.7 6.4 1.3 11.0 3.3 0.9 3.9 3.8 4.7 2.7 1.6 4.3 7.2 1.9 9.5 5.7 3.5 0.0 3.4 2.0 3.0 2.8 2.5 1.9 1.9 13.3 9.2 4.1 3.2 2.6 9.3 3.8 13.3 4.7 4.5 8.0 4.3 7.4 2.2 0.8 7.1 4.6 5.3 2.1 4.3 5.4 1.1 2.7 3.1 2.7 4.6 2.1 5.2 5.5 8.6 2.8 6.9 0.3 4.4 1.4 2.1 1.9 4.7 1.9 5.5 11.8 5.2 6.2 4.0 11.0 7.8 7.2 0.1 5.4 1.2 7.4 4.2 3.9 6.5 9.5 14.3 11.1 7.3 5.4 9.8 5.7 8.7 10.7 0.0 1.6 2.2 3.1 3.8 5.0 5.0 0.0 5.3 4.5 5.2 0.0 3.2 3.3 5.3 6.0 4.0 2.1 0.0 3.5 4.0 2.4 2.0 0.0 3.2 5.1 0.0 1.2 3.1 2.7 4.8 3.4 1.8 0.0 1.0 2.7 3.8 3.5 5.8 4.9 2.6 2.8 0.0 4.1 12.1 10.9 4.1 1.7 1.5 3.3 1.6 ZNF233 FLJ38032 ENSG00000159915 "Zinc finger protein 233" A6NK53 19 44259880-44275317 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 25.2" "Cell type enhanced" "Detected in some" 20 "Early spermatids: 23.3;Spermatocytes: 8.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 10.7;U-266/84: 10.0" HPA020975 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA020975: AB_1859145" "unprognostic (2.26e-1)" "unprognostic (1.53e-1)" "unprognostic (1.05e-1)" "unprognostic (4.78e-1)" "unprognostic (1.60e-1)" "unprognostic (3.72e-2)" "unprognostic (7.37e-3)" "unprognostic (2.77e-2)" "unprognostic (9.07e-3)" "unprognostic (1.48e-1)" "unprognostic (4.20e-3)" "unprognostic (1.65e-1)" "unprognostic (6.28e-3)" "unprognostic (6.88e-2)" "unprognostic (3.47e-2)" "unprognostic (2.71e-4)" "unprognostic (1.55e-1)" 0.6 2.3 4.4 2.1 6.3 3.9 2.5 10.9 8.5 1.3 4.3 0.8 0.2 1.9 0.9 2.8 1.4 2.2 1.8 4.8 4.1 5.0 2.1 0.8 1.2 2.3 3.3 6.1 1.2 1.6 3.1 11.2 2.2 6.2 4.8 2.2 2.1 1.6 2.3 2.5 3.8 1.8 1.6 3.4 2.2 2.1 25.2 2.4 3.3 3.5 2.7 1.0 1.6 0.8 4.7 3.9 3.3 1.2 3.4 2.2 0.5 0.7 2.7 3.1 3.1 3.2 0.6 1.3 1.2 0.8 1.0 1.8 2.8 3.3 1.2 2.9 0.8 1.5 1.3 0.1 0.7 1.1 0.6 3.8 1.9 3.5 2.9 2.2 1.3 1.3 0.7 0.5 0.7 1.9 4.3 1.3 1.4 1.3 5.9 0.2 1.6 1.0 1.0 3.2 0.6 0.8 2.0 0.4 2.4 0.7 2.4 4.3 6.4 1.2 0.8 2.1 5.7 5.1 1.5 0.8 1.3 0.8 0.9 0.8 10.7 10.0 2.2 4.4 1.3 1.4 3.3 1.0 0.9 1.6 1.1 1.5 2.7 1.4 1.1 0.5 4.7 2.0 2.2 2.4 3.4 1.2 3.9 2.1 0.5 4.4 6.3 10.9 8.5 4.1 5.0 3.3 6.1 6.2 2.4 0.0 0.3 0.0 0.1 0.0 3.7 4.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 23.3 0.0 0.4 0.0 0.0 0.1 0.5 0.4 0.0 0.0 0.5 0.0 1.2 0.0 0.0 4.5 0.6 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.7 0.0 4.2 0.0 0.1 8.7 1.9 0.0 0.0 0.0 0.3 0.0 ZNF235 "ANF270, HZF6, ZFP93, ZNF270" ENSG00000159917 "Zinc finger protein 235" Q14590 19 44228729-44305046 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 5.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045582 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA045582: AB_10963792" "unprognostic (2.11e-2)" "unprognostic (1.67e-1)" "unprognostic (1.11e-2)" "unprognostic (9.91e-3)" "unprognostic (2.04e-2)" "unprognostic (1.23e-4)" "unprognostic (4.00e-2)" "unprognostic (1.64e-1)" "unprognostic (1.49e-2)" "unprognostic (3.37e-1)" "unprognostic (1.46e-5)" "unprognostic (1.20e-2)" "unprognostic (1.36e-1)" "unprognostic (2.87e-1)" "unprognostic (1.10e-2)" "unprognostic (2.65e-3)" "unprognostic (3.38e-2)" 5.6 4.8 8.1 6.6 10.4 1.8 8.1 13.9 10.3 6.1 7.7 10.7 10.1 5.0 13.2 6.5 5.2 7.1 4.9 6.9 7.8 7.5 6.7 5.5 6.6 7.4 8.5 4.1 8.1 6.2 10.1 9.0 7.3 9.4 7.7 6.0 6.9 5.8 8.2 6.5 4.4 6.4 6.9 7.1 8.2 5.3 6.8 8.5 10.7 9.1 2.9 9.3 6.2 5.9 10.9 8.3 14.5 3.7 5.6 7.5 2.4 2.0 3.2 6.4 6.4 4.8 2.9 2.4 1.2 3.8 2.3 2.8 2.0 3.5 3.4 3.2 2.4 3.6 1.7 5.6 2.6 2.8 0.0 6.9 7.3 4.9 2.9 3.9 4.1 4.4 2.9 3.5 2.6 3.1 4.0 3.8 6.3 1.7 0.0 2.5 1.6 6.7 0.8 7.6 3.5 2.0 3.3 6.1 2.9 4.6 5.0 4.6 13.0 3.4 4.1 3.0 6.7 3.2 5.0 4.4 2.1 3.0 0.6 1.4 7.8 7.8 2.4 1.8 1.1 3.4 14.5 3.7 3.6 6.8 3.0 4.7 6.9 5.1 5.8 2.7 10.9 7.5 6.5 2.0 5.6 2.9 8.3 3.7 2.4 8.1 10.4 13.9 10.3 7.8 7.5 8.5 4.1 9.4 8.5 0.0 0.0 2.7 0.6 0.5 1.7 1.9 2.5 0.0 0.0 0.0 5.9 1.2 0.0 0.9 0.9 1.4 1.1 0.0 0.0 0.4 0.7 0.8 2.3 0.9 1.2 1.6 0.0 2.5 1.8 0.0 0.6 1.3 1.7 0.0 0.7 1.2 0.4 2.8 3.2 0.4 1.6 0.0 1.9 2.6 4.8 0.5 1.3 3.9 1.0 0.1 ZNF236 ENSG00000130856 "Zinc finger protein 236" Q9UL36 18 76822607-76970727 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008600 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cell Junctions" Cytosol "HPA008600: AB_1080696" "unprognostic (1.38e-1)" "unprognostic (7.24e-2)" "unprognostic (3.13e-1)" "unprognostic (1.99e-1)" "unprognostic (1.20e-1)" "unprognostic (9.88e-3)" "unprognostic (5.51e-2)" "unprognostic (1.77e-1)" "unprognostic (2.83e-3)" "unprognostic (2.43e-1)" "unprognostic (2.77e-1)" "unprognostic (1.34e-1)" "unprognostic (2.95e-2)" "unprognostic (9.40e-2)" "unprognostic (1.74e-1)" "unprognostic (1.37e-1)" "unprognostic (1.37e-1)" 5.7 5.2 7.0 9.1 11.2 10.8 10.0 15.3 11.0 7.2 5.8 7.3 6.7 5.0 7.6 7.1 5.6 7.6 6.3 5.1 8.3 5.7 4.7 4.3 6.4 6.2 8.3 3.5 11.3 7.1 12.2 8.9 5.6 7.3 6.2 4.1 5.4 6.6 12.6 5.7 9.9 5.5 5.8 6.5 5.5 5.8 16.6 10.6 10.4 6.5 1.9 10.0 6.2 12.7 9.0 4.6 5.9 3.4 3.0 5.4 1.2 4.2 5.7 8.0 5.9 6.2 6.0 3.6 3.3 4.6 5.3 4.2 4.0 4.0 6.0 1.6 4.3 5.6 7.8 5.5 4.6 4.4 6.4 5.6 5.7 6.6 4.7 3.8 9.1 6.6 5.9 5.1 5.0 7.7 5.7 5.3 9.6 5.4 5.1 5.3 4.0 11.2 5.1 4.4 1.3 4.5 7.1 8.3 4.0 3.9 6.7 4.6 4.8 5.9 3.6 4.1 3.9 4.3 6.4 5.4 9.1 3.7 2.4 4.9 3.5 4.7 7.8 6.0 5.0 6.8 1.1 3.4 5.9 5.4 2.9 5.2 9.0 4.0 3.7 2.2 8.1 4.6 4.8 3.7 3.0 2.7 4.6 3.9 1.2 7.0 11.2 15.3 11.0 8.3 5.7 8.3 3.5 7.3 10.6 8.9 6.4 3.7 7.4 6.4 14.6 6.9 10.2 14.7 6.8 7.0 9.8 6.9 1.7 4.3 6.0 7.5 4.3 23.3 3.4 6.0 7.7 6.0 1.1 5.7 5.3 23.8 5.8 7.4 8.7 3.3 9.8 5.3 6.8 5.4 4.7 10.8 3.9 2.9 6.7 2.2 14.3 6.5 8.2 27.0 18.5 7.3 5.0 5.1 5.2 5.8 ZNF239 "HOK-2, MOK2" ENSG00000196793 "Zinc finger protein 239" Q16600 10 43556344-43574618 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 26.8;Late spermatids: 9.8;Spermatogonia: 7.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 13 "B-cells: 4.2;T-cells: 8.8" "Cell line enhanced" "Detected in many" "NTERA-2: 18.1;T-47d: 14.1" "Low region specificity" "Detected in all" "HPA030843, HPA046679" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA030843: AB_2673632, HPA046679: AB_10960498" "unprognostic (1.74e-2)" "unprognostic (1.59e-1)" "unprognostic (1.40e-1)" "unprognostic (1.45e-3)" "unprognostic (4.05e-2)" "unprognostic (3.08e-1)" "unprognostic (1.05e-7)" "unprognostic (2.98e-1)" "unprognostic (1.84e-1)" "unprognostic (5.90e-3)" "unprognostic (4.13e-2)" "unprognostic (5.59e-3)" "prognostic unfavorable (4.70e-7)" "unprognostic (2.62e-2)" "unprognostic (3.64e-1)" "unprognostic (1.60e-1)" "unprognostic (1.34e-1)" 5.0 5.0 8.8 5.6 9.3 0.9 10.4 5.7 8.2 6.8 5.3 5.2 2.1 2.9 8.8 4.5 2.5 8.7 3.5 4.1 6.5 5.1 4.6 2.6 2.7 5.3 5.3 8.5 8.1 8.7 9.9 8.6 2.0 7.2 10.6 5.8 1.7 6.2 9.4 4.9 1.3 3.3 9.8 3.7 2.7 4.7 14.5 6.8 1.6 6.5 1.4 5.1 6.1 10.4 4.2 0.1 0.0 0.0 0.5 8.8 1.9 0.0 3.1 3.7 3.6 5.2 3.9 0.0 6.6 0.7 7.9 7.0 8.0 7.2 0.0 2.5 3.5 3.0 0.2 0.0 0.3 10.1 0.1 5.3 0.0 5.3 0.0 4.1 0.0 2.4 4.3 0.1 6.2 0.0 2.4 0.2 0.0 10.3 0.0 6.5 3.4 1.0 1.0 18.1 3.4 3.6 0.0 0.0 0.2 6.6 2.8 7.0 9.5 2.9 0.1 0.4 5.4 14.1 4.4 0.8 0.0 8.1 0.2 8.3 0.9 6.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 2.1 0.0 5.0 3.6 4.8 3.2 0.1 4.2 8.8 5.2 0.0 0.5 0.0 0.0 2.5 1.9 8.8 9.3 5.7 8.2 6.5 5.1 5.3 8.5 7.2 6.8 0.0 0.3 0.0 1.4 0.0 3.1 0.4 0.0 0.0 2.3 3.5 0.0 0.1 1.7 1.7 26.8 0.1 0.0 0.0 0.3 1.1 0.7 0.8 0.0 0.2 0.3 0.0 0.0 0.6 0.0 9.8 0.3 0.0 0.0 1.0 0.6 1.2 1.2 0.0 1.4 1.4 0.6 0.0 1.0 5.7 7.5 0.0 0.1 0.0 1.2 0.1 ZNF24 "KOX17, Zfp191, ZNF191, ZSCAN3" ENSG00000172466 "Zinc finger protein 24" P17028 18 35332212-35345482 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024062, CAB025642" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB025642: , HPA024062: AB_1859150" "unprognostic (1.19e-1)" "unprognostic (3.25e-1)" "unprognostic (1.16e-3)" "unprognostic (2.42e-2)" "unprognostic (2.09e-1)" "unprognostic (1.49e-2)" "unprognostic (3.12e-2)" "unprognostic (2.79e-2)" "unprognostic (6.01e-2)" "unprognostic (7.69e-2)" "unprognostic (5.68e-2)" "unprognostic (2.44e-2)" "prognostic favorable (1.44e-4)" "unprognostic (5.25e-2)" "unprognostic (1.74e-2)" "unprognostic (9.27e-2)" "unprognostic (5.30e-3)" 17.2 19.5 26.9 17.7 39.8 17.9 30.5 33.5 33.3 19.7 17.8 31.9 15.5 16.9 20.6 19.7 16.3 16.7 15.4 17.0 28.3 20.0 20.8 25.7 18.9 22.2 44.8 21.5 23.2 21.6 31.4 32.6 19.6 28.4 22.5 18.5 14.5 20.1 16.6 26.8 13.7 18.8 18.1 37.3 20.4 20.6 16.1 42.8 27.4 28.6 14.5 21.5 18.0 15.1 23.7 21.8 31.0 20.3 15.5 19.1 10.9 8.6 8.8 28.2 14.7 12.0 13.0 7.9 11.9 13.5 14.8 17.1 5.6 7.2 19.9 13.5 9.9 11.9 16.2 20.7 11.2 25.6 18.0 11.3 14.2 17.6 12.0 12.6 29.9 23.0 10.9 19.4 13.2 14.4 17.1 14.0 12.6 21.4 12.9 15.3 10.3 22.7 12.8 14.6 5.8 6.0 17.1 18.3 15.8 14.9 20.2 24.1 20.7 14.6 13.7 25.5 15.3 12.8 22.9 11.8 21.4 9.6 5.0 11.8 32.9 26.4 20.3 11.9 12.3 19.4 18.6 15.6 17.6 19.0 14.9 18.6 23.1 19.1 16.2 14.2 23.7 18.7 17.1 31.0 15.5 20.3 21.8 14.1 10.9 26.9 39.8 33.5 33.3 28.3 20.0 44.8 21.5 28.4 42.8 53.6 50.0 42.5 56.3 29.2 56.6 41.7 35.7 62.9 64.8 24.4 41.2 34.7 23.2 38.6 86.9 37.9 27.3 0.0 36.0 25.2 35.1 59.8 41.7 43.2 30.2 74.7 53.4 40.5 31.6 19.7 50.3 37.6 21.9 30.7 37.6 91.6 37.1 37.1 47.0 28.5 80.2 45.3 29.9 45.6 53.9 28.4 59.2 44.5 29.2 61.8 ZNF248 bA162G10.3 ENSG00000198105 "Zinc finger protein 248" Q8NDW4 10 37776526-37858106 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 46.4;Cone photoreceptor cells: 45.2;Horizontal cells: 39.7;Rod photoreceptor cells: 40.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018237, HPA018287, HPA018455" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA018237: AB_2669815, HPA018287: AB_2669829, HPA018455: AB_2669869" "unprognostic (6.25e-3)" "unprognostic (1.16e-2)" "unprognostic (3.75e-2)" "unprognostic (3.15e-2)" "unprognostic (3.20e-2)" "unprognostic (6.51e-3)" "unprognostic (2.50e-4)" "prognostic favorable (1.04e-4)" "unprognostic (6.37e-3)" "unprognostic (2.05e-2)" "prognostic favorable (1.22e-4)" "prognostic unfavorable (6.71e-4)" "prognostic unfavorable (2.25e-4)" "unprognostic (2.70e-1)" "unprognostic (1.62e-1)" "unprognostic (9.51e-2)" "unprognostic (8.68e-3)" 5.1 7.7 11.0 6.4 18.3 0.7 8.2 29.8 16.2 11.7 14.0 9.5 11.4 5.7 16.1 15.5 6.1 12.6 7.0 8.0 11.5 10.3 6.3 4.9 6.4 6.3 11.2 12.7 14.1 5.8 17.7 23.8 6.7 11.4 13.5 9.6 8.4 7.4 18.1 7.9 7.4 6.8 12.3 7.7 7.4 6.7 7.0 13.3 3.1 14.2 4.6 6.7 8.0 8.9 6.7 3.8 1.4 1.8 4.0 8.9 3.0 5.4 4.6 1.0 12.9 9.3 7.9 5.7 5.6 2.9 5.8 6.3 5.6 6.9 7.2 4.9 3.9 4.4 6.9 7.4 4.0 5.1 12.5 8.2 8.9 9.5 6.8 4.7 7.3 6.1 3.2 7.6 3.0 2.5 11.7 5.3 7.9 3.8 5.2 8.5 2.6 7.4 4.8 3.9 3.6 24.9 6.9 13.1 5.1 7.2 2.7 5.4 10.4 4.8 2.7 3.2 8.4 7.1 2.1 5.2 5.3 5.7 4.2 3.4 8.2 8.6 6.0 7.1 9.8 2.5 1.1 1.8 1.4 5.7 1.2 6.2 5.8 5.1 4.8 3.8 6.7 8.9 7.6 0.2 4.0 1.6 3.5 2.6 3.0 11.0 18.3 29.8 16.2 11.5 10.3 11.2 12.7 11.4 13.3 11.9 11.8 6.6 7.0 1.8 46.4 19.3 10.2 6.7 9.1 5.2 45.2 5.0 6.6 3.3 0.6 5.6 4.0 0.0 1.4 2.6 8.5 4.5 4.7 3.9 3.7 39.7 5.2 5.5 1.3 1.5 9.2 2.8 1.7 3.6 4.0 22.6 3.4 3.6 11.3 3.3 40.3 0.0 10.3 8.4 10.8 2.4 2.2 3.3 4.9 3.7 ZNF25 "FLJ31890, KOX19, Zfp9" ENSG00000175395 "Zinc finger protein 25" P17030 10 37949572-37976633 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 26.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030190 Uncertain Approved "Nucleoplasm,Golgi apparatus" No No "Nucleoplasm, Golgi apparatus" "HPA030190: AB_10602687" "unprognostic (9.42e-2)" "unprognostic (6.18e-2)" "unprognostic (5.64e-2)" "unprognostic (2.93e-1)" "unprognostic (4.67e-2)" "unprognostic (1.44e-2)" "unprognostic (2.64e-2)" "unprognostic (3.85e-3)" "unprognostic (1.15e-1)" "unprognostic (5.32e-2)" "unprognostic (1.40e-3)" "unprognostic (1.45e-1)" "unprognostic (2.01e-3)" "unprognostic (1.21e-2)" "unprognostic (1.29e-1)" "unprognostic (9.30e-3)" "unprognostic (2.61e-1)" 9.7 12.1 17.0 4.0 21.7 2.7 8.7 23.2 27.6 10.9 8.1 7.3 3.4 2.7 11.3 7.5 6.5 7.3 7.1 11.1 13.3 16.7 6.8 3.5 6.9 4.9 12.7 23.7 13.1 4.0 7.1 10.7 5.4 16.0 8.9 5.4 5.1 4.5 11.0 22.9 5.1 3.7 11.6 9.5 7.1 4.4 5.2 11.6 1.2 6.3 5.7 4.9 8.4 5.4 2.3 3.4 6.0 8.5 1.8 3.7 2.2 1.6 3.0 3.3 6.7 12.5 9.6 0.6 3.6 4.9 2.8 4.3 0.5 2.3 3.0 1.0 6.3 1.1 0.4 0.9 1.5 4.6 7.0 1.6 4.8 0.0 1.0 7.9 3.2 3.1 6.8 6.6 3.1 3.6 11.3 4.8 3.9 0.4 2.3 6.8 0.9 1.0 2.4 0.6 0.5 2.2 1.1 3.7 0.6 3.4 0.6 1.2 7.7 1.2 0.2 4.5 1.3 2.9 5.1 6.9 4.4 0.8 7.1 2.2 2.9 1.3 1.2 8.4 6.2 2.9 2.3 2.8 6.0 3.1 4.7 3.4 2.0 2.7 2.6 3.4 2.3 3.7 3.0 0.5 1.8 8.5 0.5 2.2 2.2 17.0 21.7 23.2 27.6 13.3 16.7 12.7 23.7 16.0 11.6 3.0 2.7 3.4 2.0 3.1 17.7 20.4 5.1 12.0 3.4 7.0 5.9 1.0 1.7 1.7 26.3 5.8 0.8 0.0 2.1 0.4 8.5 2.0 8.1 2.9 5.1 15.9 0.0 10.4 10.2 20.4 11.2 10.1 3.3 5.4 1.1 12.8 1.6 0.0 15.2 3.0 7.1 0.0 13.3 3.2 7.2 3.4 0.2 4.5 0.7 0.7 ZNF251 ENSG00000198169 "Zinc finger protein 251" Q9BRH9 8 144720907-144756417 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018290 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA018290: AB_1859153" "unprognostic (1.16e-3)" "unprognostic (1.50e-1)" "unprognostic (1.47e-1)" "unprognostic (1.77e-1)" "unprognostic (6.87e-2)" "unprognostic (1.20e-1)" "unprognostic (4.26e-3)" "unprognostic (3.04e-2)" "unprognostic (2.53e-1)" "unprognostic (2.30e-1)" "unprognostic (5.75e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (1.42e-9)" "unprognostic (5.29e-2)" "unprognostic (1.60e-1)" "unprognostic (1.77e-1)" "unprognostic (2.33e-3)" 10.1 6.7 14.1 8.6 11.8 4.0 10.5 26.0 12.5 13.1 9.9 12.0 8.5 8.7 14.3 25.9 6.4 11.3 11.2 7.9 10.2 9.2 9.8 6.6 8.4 10.8 10.5 9.6 13.8 9.0 17.6 15.1 10.2 10.0 11.8 12.0 9.8 12.0 14.2 11.5 8.8 9.6 11.1 8.7 11.4 10.8 12.0 12.8 9.9 19.6 6.1 10.0 9.5 10.4 2.6 2.4 2.3 0.9 2.7 3.7 1.5 5.0 1.9 11.3 4.2 5.5 8.7 1.2 6.7 3.9 3.6 7.0 1.1 5.2 5.8 4.8 5.4 3.0 7.7 3.4 3.7 7.0 3.5 3.3 6.2 16.1 1.3 4.7 1.0 3.4 7.7 4.7 2.7 3.6 11.5 3.1 9.6 4.3 1.7 2.5 0.3 5.7 0.6 4.8 1.8 0.0 8.3 1.6 2.5 1.0 2.2 5.6 4.4 5.7 1.8 4.5 6.3 4.2 1.9 1.7 5.0 10.6 6.5 4.6 3.9 1.0 6.5 4.3 2.0 2.6 0.0 0.2 2.3 1.8 0.6 3.3 1.4 2.8 3.0 2.4 2.6 3.7 1.2 0.1 2.7 0.9 1.4 2.5 1.5 14.1 11.8 26.0 12.5 10.2 9.2 10.5 9.6 10.0 12.8 0.0 4.0 0.5 3.3 1.9 4.9 2.9 2.5 8.1 14.8 1.8 5.9 1.6 5.0 1.4 14.3 5.7 1.3 0.0 1.4 1.1 2.7 3.2 1.1 1.0 1.3 4.8 1.2 0.6 3.8 5.8 7.2 2.6 1.7 3.6 2.1 3.1 1.6 1.5 4.2 2.4 5.7 12.9 2.1 8.7 11.1 2.8 1.1 3.5 1.7 1.7 ZNF256 BMZF-3 ENSG00000152454 "Zinc finger protein 256" Q9Y2P7 19 57940833-57947675 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 8.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 23.8" HPA055390 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA055390: AB_2682803" "unprognostic (2.47e-2)" "unprognostic (3.43e-2)" "unprognostic (5.20e-2)" "unprognostic (1.27e-1)" "unprognostic (2.95e-2)" "unprognostic (1.42e-1)" "unprognostic (3.03e-1)" "unprognostic (3.38e-1)" "unprognostic (3.49e-3)" "unprognostic (2.32e-2)" "unprognostic (4.73e-3)" "unprognostic (2.83e-2)" "unprognostic (6.39e-3)" "unprognostic (6.67e-2)" "unprognostic (1.46e-1)" "unprognostic (1.27e-1)" "unprognostic (3.28e-3)" 7.4 5.1 8.4 6.7 12.2 16.6 11.0 22.7 11.3 5.9 6.6 7.2 5.8 4.4 8.2 8.8 6.1 8.8 5.4 11.2 7.4 4.1 6.1 3.7 6.8 8.8 7.9 8.3 11.2 4.6 8.7 9.8 8.7 7.4 7.9 5.8 8.6 7.0 8.4 9.4 13.5 7.3 7.6 5.7 9.5 5.4 8.4 7.4 7.1 8.8 4.9 9.8 7.0 6.0 7.5 5.4 1.7 4.5 4.6 8.9 3.0 2.7 0.9 7.0 7.1 1.5 2.5 6.1 2.3 2.5 3.8 2.6 0.5 1.6 0.0 2.2 3.1 6.0 0.3 1.6 5.4 6.3 0.0 23.8 6.7 0.0 1.8 2.8 0.0 5.6 4.9 1.5 2.8 0.0 4.0 2.3 6.6 0.5 0.0 4.0 0.6 9.2 0.0 8.5 0.2 6.0 3.0 8.8 4.2 2.8 12.1 3.6 5.2 0.0 2.2 1.7 9.1 5.3 2.2 0.9 7.9 4.8 0.0 4.7 3.3 3.2 12.2 0.2 0.0 3.4 1.7 1.3 1.6 4.5 4.5 8.2 6.6 7.8 6.9 5.4 7.5 7.7 8.9 0.6 4.6 4.0 2.6 6.2 3.0 8.4 12.2 22.7 11.3 7.4 4.1 7.9 8.3 7.4 7.4 0.0 0.0 2.0 4.4 2.4 4.0 2.5 2.5 5.3 0.0 1.8 0.0 2.9 3.3 2.7 0.2 2.8 0.5 0.0 0.7 1.4 1.6 2.1 0.0 0.6 1.1 1.6 1.2 0.6 0.6 0.0 1.7 0.3 0.0 2.8 0.9 4.0 0.7 0.0 0.4 0.7 6.8 0.0 1.4 1.6 8.1 3.0 2.2 3.3 1.2 3.4 ZNF260 "ozrf1, Zfp260" ENSG00000254004 "Zinc finger protein 260" Q3ZCT1 19 36510695-36528660 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028806 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA028806: AB_10795285" "unprognostic (1.34e-1)" "unprognostic (6.31e-2)" "unprognostic (8.35e-3)" "unprognostic (1.11e-3)" "unprognostic (3.55e-2)" "unprognostic (1.29e-3)" "unprognostic (7.83e-3)" "unprognostic (3.91e-1)" "unprognostic (1.13e-2)" "unprognostic (8.36e-2)" "unprognostic (1.06e-1)" "unprognostic (1.81e-2)" "prognostic favorable (1.44e-4)" "unprognostic (7.73e-2)" "unprognostic (2.17e-1)" "unprognostic (1.06e-1)" "unprognostic (7.89e-3)" 8.4 9.4 10.3 7.6 16.8 2.3 12.0 18.4 14.1 10.8 7.0 6.2 9.4 6.2 11.2 7.9 8.0 8.4 8.2 7.5 11.2 9.5 11.6 8.5 7.3 12.4 17.1 9.1 13.4 6.6 20.4 19.5 10.9 11.9 10.3 7.1 5.9 8.8 7.6 4.8 10.0 7.7 8.1 20.6 8.3 8.1 4.5 15.4 17.3 14.7 5.5 9.7 10.7 8.4 5.9 3.2 6.8 3.5 4.1 7.2 3.0 7.9 8.1 18.8 14.1 5.8 8.9 8.2 7.0 7.5 6.5 8.3 3.6 4.5 5.2 11.5 5.6 4.9 3.0 9.4 4.3 10.0 6.9 4.1 7.8 6.2 4.1 8.1 3.9 6.5 8.0 7.2 6.7 10.3 9.3 8.6 7.9 6.1 5.8 12.8 4.3 14.4 2.5 11.9 4.9 3.5 9.6 11.6 3.9 7.2 14.3 13.6 14.9 15.5 8.3 5.7 12.1 7.0 7.4 7.4 11.3 11.8 6.6 6.2 7.5 14.3 12.3 0.3 4.1 15.2 6.8 2.8 3.0 4.0 2.5 4.2 5.1 5.3 3.2 3.2 5.9 7.2 5.5 1.6 4.1 3.5 2.2 4.6 3.0 10.3 16.8 18.4 14.1 11.2 9.5 17.1 9.1 11.9 15.4 8.9 3.8 4.4 7.3 9.2 7.6 7.5 0.0 5.3 12.5 0.0 7.9 5.5 5.0 7.1 7.4 6.7 2.5 0.0 3.9 5.7 6.1 7.0 8.1 3.0 4.1 20.6 11.5 9.8 3.3 3.1 5.5 4.9 1.7 7.2 6.6 7.5 5.2 2.9 7.8 6.7 7.4 6.5 4.8 5.6 3.7 11.4 3.4 6.9 5.0 10.8 ZNF263 "FPM315, ZKSCAN12, ZSCAN44" ENSG00000006194 "Zinc finger protein 263" O14978 16 3263800-3301401 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 41.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035085, HPA035086" Approved Supported "Nucleoplasm,Mitotic spindle,Cytosol" Yes No Cytosol "Nucleoplasm, Mitotic spindle" "HPA035085: AB_10671099, HPA035086: AB_10603244" "unprognostic (2.06e-1)" "unprognostic (2.97e-2)" "unprognostic (2.57e-1)" "unprognostic (1.31e-1)" "unprognostic (3.33e-1)" "unprognostic (2.25e-1)" "unprognostic (6.42e-2)" "unprognostic (7.00e-2)" "unprognostic (1.04e-1)" "unprognostic (1.68e-1)" "unprognostic (6.39e-2)" "unprognostic (2.30e-3)" "unprognostic (2.98e-3)" "unprognostic (5.10e-2)" "unprognostic (1.34e-1)" "unprognostic (3.16e-2)" "unprognostic (2.66e-1)" 28.3 17.8 21.5 16.9 25.7 15.0 23.3 26.4 23.5 21.9 19.2 18.1 14.0 13.8 30.4 23.4 15.4 24.2 17.6 14.6 15.7 14.2 16.9 17.1 18.5 20.4 20.3 18.1 30.7 23.0 36.4 24.8 20.1 16.8 21.8 16.8 20.2 19.5 21.1 15.8 22.7 18.2 18.6 14.0 23.6 20.5 17.3 16.5 18.9 20.1 14.5 28.8 20.2 27.6 6.6 5.5 9.6 5.0 6.7 9.2 3.3 8.6 11.2 13.4 19.4 10.7 14.1 17.4 11.9 18.3 14.3 15.6 12.2 13.6 31.9 12.4 15.3 13.3 11.0 18.2 12.1 14.4 17.5 18.2 14.5 15.0 11.7 12.5 21.4 17.8 16.2 25.4 13.0 19.2 16.1 12.2 20.6 16.3 21.7 11.7 11.9 19.7 16.5 24.9 10.2 9.6 32.1 13.6 25.1 10.0 8.7 19.4 20.3 13.0 14.1 14.5 16.3 15.6 25.6 12.6 15.2 14.6 11.2 11.1 23.3 24.7 38.5 5.9 10.8 10.7 2.1 3.9 9.6 6.0 4.2 6.9 4.5 7.3 8.0 5.5 6.6 9.2 6.8 5.0 6.7 5.0 4.6 4.9 3.3 21.5 25.7 26.4 23.5 15.7 14.2 20.3 18.1 16.8 16.5 0.0 14.4 9.1 14.5 15.5 10.2 3.6 12.7 4.0 4.5 1.8 0.0 9.7 6.6 8.9 41.6 11.1 6.0 0.0 8.6 8.9 10.8 11.4 6.9 5.8 8.0 3.2 12.7 5.5 8.9 26.2 7.5 8.0 15.1 8.2 9.2 10.1 8.2 3.5 7.4 5.0 9.0 12.9 18.6 11.4 10.4 18.1 9.3 10.0 11.7 11.9 ZNF264 KIAA0412 ENSG00000083844 "Zinc finger protein 264" O43296 19 57191500-57222846 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046330 Approved Nucleoplasm NA NA Nucleoplasm "HPA046330: " "unprognostic (2.19e-1)" "unprognostic (2.33e-1)" "unprognostic (9.26e-2)" "unprognostic (1.08e-3)" "unprognostic (3.60e-1)" "unprognostic (1.25e-2)" "unprognostic (1.23e-1)" "unprognostic (2.75e-1)" "unprognostic (9.92e-2)" "unprognostic (2.70e-1)" "unprognostic (2.19e-3)" "unprognostic (5.96e-2)" "unprognostic (2.16e-2)" "unprognostic (4.39e-2)" "unprognostic (2.04e-1)" "unprognostic (3.36e-1)" "unprognostic (1.65e-2)" 10.4 10.7 8.1 10.2 12.4 12.1 14.5 15.0 11.2 12.2 8.2 10.9 17.6 8.0 13.2 10.1 11.3 12.2 8.9 7.2 8.3 5.2 10.5 11.6 14.2 13.5 12.4 10.2 15.6 21.2 14.7 13.7 11.3 10.0 10.5 8.0 9.6 12.8 13.5 8.3 11.6 12.9 10.6 9.0 17.3 13.4 15.9 11.1 16.3 13.1 10.4 11.6 11.3 10.6 6.6 3.3 7.1 2.8 4.1 6.6 2.0 7.1 5.1 5.9 4.6 4.2 5.9 2.4 4.2 6.6 5.8 10.5 3.5 5.8 2.3 2.9 5.9 4.8 7.7 0.0 5.8 8.4 0.1 21.1 9.6 8.0 2.7 5.0 1.8 9.1 6.1 3.2 7.2 16.8 4.9 5.5 5.7 0.1 0.2 5.2 0.0 7.9 2.4 3.8 2.0 12.9 2.9 7.5 7.7 4.7 10.0 6.6 4.4 8.5 2.6 3.3 5.2 4.7 4.6 8.1 7.7 6.7 2.3 6.0 10.4 12.3 7.3 5.9 0.1 3.2 1.5 1.8 7.1 3.6 2.7 2.5 6.6 5.1 3.5 2.3 3.8 6.6 6.3 1.7 4.1 2.8 3.3 3.6 2.0 8.1 12.4 15.0 11.2 8.3 5.2 12.4 10.2 10.0 11.1 14.9 20.2 17.9 9.2 1.3 20.1 7.4 30.6 8.1 12.5 15.7 29.5 5.8 6.6 10.0 20.8 12.5 8.8 0.0 13.5 7.4 4.7 13.1 8.1 11.9 11.3 30.2 15.5 26.4 17.2 14.4 9.2 7.2 0.0 8.2 12.0 11.1 12.0 2.9 14.9 9.2 19.8 25.8 5.9 18.1 16.2 1.1 4.1 14.0 9.9 13.7 ZNF266 HZF1 ENSG00000174652 "Zinc finger protein 266" Q14584 19 9412598-9435578 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 46.5" "HPA026836, HPA054110" Uncertain Supported "Nucleoplasm,Vesicles,Rods & Rings" NA NA Vesicles "Nucleoplasm, Rods & Rings" "HPA026836: AB_2672018, HPA054110: AB_2682383" "unprognostic (2.50e-2)" "prognostic favorable (1.41e-4)" "unprognostic (2.27e-2)" "unprognostic (1.04e-1)" "unprognostic (7.60e-2)" "prognostic favorable (3.94e-6)" "unprognostic (1.72e-2)" "prognostic favorable (4.47e-4)" "unprognostic (4.59e-2)" "unprognostic (9.00e-3)" "prognostic favorable (3.03e-5)" "unprognostic (2.92e-3)" "prognostic unfavorable (1.82e-4)" "unprognostic (7.76e-2)" "unprognostic (1.08e-1)" "unprognostic (3.56e-2)" "prognostic favorable (9.15e-5)" 14.7 12.1 11.0 21.5 12.5 12.8 17.6 19.0 10.0 21.8 15.7 13.1 9.6 8.6 17.2 55.8 12.7 14.6 12.8 11.7 8.2 5.4 10.9 10.4 15.8 21.0 14.5 4.9 18.9 11.2 12.5 19.8 13.0 11.4 23.8 15.7 14.4 14.4 13.5 9.3 19.1 20.8 17.0 10.9 31.3 13.5 13.0 11.4 34.6 20.8 7.3 23.4 14.4 14.2 6.9 3.8 5.6 5.5 12.6 13.0 5.1 10.8 2.8 8.1 15.3 5.8 11.3 6.5 12.0 10.2 9.9 16.6 5.8 4.7 12.1 7.7 5.9 3.7 4.1 10.2 6.4 11.9 3.4 16.8 16.6 14.8 8.5 5.2 9.5 10.2 10.7 8.8 5.4 8.3 9.9 8.0 14.5 8.6 0.1 9.2 1.0 13.8 46.5 8.4 4.9 9.1 6.2 8.4 8.4 7.8 13.5 6.9 10.8 5.5 6.5 6.7 8.4 4.8 7.3 7.2 9.3 3.6 14.0 6.1 19.8 26.3 14.4 2.9 9.1 7.0 4.8 4.1 5.6 13.0 4.8 8.5 6.0 7.2 9.2 3.3 6.9 10.6 10.2 3.6 12.6 5.5 3.8 8.7 5.1 11.0 12.5 19.0 10.0 8.2 5.4 14.5 4.9 11.4 11.4 0.0 11.0 14.5 6.3 3.5 8.1 5.0 2.5 4.0 7.9 3.5 11.8 3.8 3.3 4.8 0.7 5.2 6.2 23.3 3.2 2.7 4.7 6.2 11.5 2.5 4.2 7.9 9.1 12.3 11.7 1.4 5.8 7.9 5.0 8.2 6.4 4.3 3.4 5.1 4.2 1.1 9.3 6.5 5.6 3.5 7.8 4.1 3.9 14.1 6.3 5.4 ZNF267 HZF2 ENSG00000185947 "Zinc finger protein 267" Q14586 16 31873758-31917357 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "monocytes: 94.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003866 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA003866: AB_1080698" "unprognostic (2.73e-2)" "unprognostic (4.24e-2)" "unprognostic (1.61e-1)" "unprognostic (1.05e-1)" "unprognostic (4.84e-2)" "unprognostic (6.24e-2)" "unprognostic (5.60e-3)" "unprognostic (8.64e-2)" "unprognostic (6.73e-2)" "unprognostic (1.31e-1)" "unprognostic (3.60e-2)" "unprognostic (2.75e-2)" "prognostic unfavorable (1.58e-6)" "unprognostic (2.34e-1)" "unprognostic (3.34e-2)" "unprognostic (3.95e-1)" "unprognostic (8.21e-2)" 19.3 5.1 5.4 21.3 7.2 23.8 9.9 8.2 7.5 10.7 9.8 3.9 1.3 7.3 7.3 7.8 14.6 6.4 10.6 6.6 5.4 5.3 9.2 6.8 21.7 20.4 7.0 5.1 8.2 6.1 7.5 7.1 10.5 7.7 8.6 7.7 3.4 10.3 4.3 10.8 5.7 11.2 6.3 11.1 31.1 6.8 9.6 8.0 20.0 7.9 11.0 18.4 12.3 8.7 9.6 8.3 34.8 11.5 6.9 8.9 5.0 5.1 5.3 5.5 4.3 3.9 4.7 16.7 4.3 7.1 6.0 9.1 10.5 8.3 9.0 7.8 3.4 5.9 6.7 8.8 6.8 11.5 13.8 7.4 9.4 3.3 9.5 3.6 10.0 22.3 6.5 4.7 8.4 6.2 4.3 8.4 7.2 15.1 22.3 8.1 7.1 6.8 6.7 5.1 4.0 3.3 6.8 15.4 8.1 6.8 23.0 1.8 2.7 6.6 5.8 6.1 10.0 3.5 14.2 10.2 5.9 5.2 5.1 7.1 12.7 6.9 9.5 7.7 8.3 3.5 13.8 10.8 14.4 5.8 10.8 8.5 9.6 7.7 5.8 8.3 6.8 6.0 7.2 34.8 6.9 11.5 4.9 8.9 5.0 5.4 7.2 8.2 7.5 5.4 5.3 7.0 5.1 7.7 8.0 8.9 10.1 20.4 34.3 28.3 4.3 5.2 5.1 20.1 11.4 3.5 0.0 12.4 6.6 15.6 9.8 23.3 4.6 0.0 17.4 8.6 20.6 27.4 59.9 2.0 19.4 11.1 7.5 9.2 23.5 5.2 5.5 52.4 13.5 94.6 4.9 3.1 30.8 5.8 3.2 10.0 3.9 0.0 13.7 15.8 29.5 22.3 7.0 23.0 3.8 46.4 ZNF273 HZF9 ENSG00000198039 "Zinc finger protein 273" Q14593 7 64870172-64930966 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Ciliated cells: 95.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA077549 Approved Nucleoplasm NA NA Nucleoplasm "HPA077549: AB_2732352" "unprognostic (7.01e-2)" "unprognostic (3.10e-1)" "unprognostic (1.80e-2)" "unprognostic (5.87e-4)" "unprognostic (1.83e-1)" "unprognostic (2.31e-1)" "unprognostic (1.97e-2)" "unprognostic (1.65e-2)" "unprognostic (2.02e-5)" "unprognostic (2.54e-1)" "unprognostic (5.76e-2)" "unprognostic (1.33e-1)" "unprognostic (3.43e-2)" "unprognostic (1.04e-2)" "unprognostic (3.14e-1)" "unprognostic (9.48e-2)" "unprognostic (1.85e-2)" 2.8 1.5 1.9 1.7 4.1 5.5 4.8 8.6 3.7 3.5 1.5 2.1 1.0 1.4 2.6 0.7 2.9 3.4 0.9 1.7 2.7 1.6 1.7 1.8 1.8 5.0 4.4 2.6 3.7 1.7 0.9 2.8 2.1 5.2 1.9 1.9 0.0 1.8 1.7 1.9 12.1 1.6 1.4 2.6 3.8 1.7 9.2 5.1 11.5 5.8 4.2 3.5 2.2 1.8 3.2 1.8 5.0 0.7 0.7 2.5 1.0 2.2 1.6 3.6 5.2 0.5 1.2 3.0 1.0 0.7 1.5 2.8 2.5 2.0 5.9 3.2 0.4 2.8 0.7 7.2 1.4 1.2 2.9 2.6 3.1 0.9 0.8 0.2 3.1 2.1 0.8 0.9 2.5 2.4 1.1 1.4 8.8 8.3 2.2 1.8 2.0 6.5 3.1 7.1 1.2 2.5 6.9 5.6 3.5 0.8 1.3 3.3 3.4 2.8 1.4 1.6 7.3 2.6 4.2 0.7 1.8 1.9 1.3 2.1 2.2 2.9 8.7 0.5 3.0 1.3 5.0 0.6 3.1 1.0 0.7 1.9 3.2 2.1 1.4 1.7 2.4 1.7 2.5 1.0 0.7 0.5 1.8 2.2 1.0 1.9 4.1 8.6 3.7 2.7 1.6 4.4 2.6 5.2 5.1 3.0 2.9 8.7 5.1 22.1 5.3 3.7 2.5 95.0 13.6 1.8 0.0 5.2 6.6 2.6 20.2 8.0 0.3 23.3 2.5 10.4 7.5 3.1 3.5 0.8 3.1 4.8 0.0 6.7 4.3 8.2 5.8 3.7 5.0 3.6 1.7 2.9 2.6 5.8 3.2 1.1 2.6 0.0 3.3 16.7 7.9 16.6 2.4 7.2 3.3 2.5 ZNF274 "ZKSCAN19, ZSCAN51" ENSG00000171606 "Zinc finger protein 274" Q96GC6 19 58183029-58213562 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 60.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 39.1" "Low region specificity" "Detected in all" HPA028880 Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA028880: AB_10601929" "unprognostic (2.38e-3)" "unprognostic (1.35e-1)" "unprognostic (1.95e-1)" "unprognostic (3.84e-1)" "prognostic favorable (6.16e-4)" "unprognostic (2.73e-2)" "unprognostic (1.56e-2)" "unprognostic (1.34e-1)" "unprognostic (6.57e-2)" "unprognostic (2.19e-1)" "unprognostic (5.61e-2)" "prognostic unfavorable (1.75e-4)" "unprognostic (2.91e-2)" "unprognostic (5.15e-2)" "unprognostic (3.47e-2)" "unprognostic (8.85e-2)" "unprognostic (2.58e-3)" 9.9 7.6 5.9 8.8 7.0 8.8 15.4 16.6 6.7 7.5 9.9 11.7 14.0 6.3 10.0 12.2 11.7 9.8 14.7 12.0 5.9 4.8 7.3 14.0 12.0 12.8 12.5 5.5 16.8 8.9 20.3 10.9 7.6 9.5 10.4 5.8 14.5 8.6 11.0 11.2 11.4 10.6 10.6 8.7 10.7 8.3 19.3 7.9 6.1 15.3 8.6 10.9 11.2 12.8 16.3 6.7 23.0 8.0 14.0 18.1 8.8 9.0 6.4 10.7 4.4 6.8 10.1 10.4 7.5 4.1 8.2 7.4 3.7 6.7 3.1 4.9 4.6 8.8 2.6 5.0 10.5 11.4 6.4 39.1 14.6 6.3 6.0 11.1 10.4 24.2 8.0 13.5 10.1 19.5 8.5 6.5 5.0 10.9 14.1 6.1 5.9 5.6 9.3 10.2 5.3 6.3 12.7 2.7 13.4 6.2 3.8 7.0 3.1 10.0 4.4 8.4 8.5 10.6 19.7 6.2 4.5 6.7 5.1 8.4 6.4 6.8 10.3 2.0 11.5 9.3 13.7 4.7 23.0 9.3 5.1 14.3 13.8 12.2 13.2 6.7 16.3 18.1 13.0 17.3 14.0 8.0 3.1 15.3 8.8 5.9 7.0 16.6 6.7 5.9 4.8 12.5 5.5 9.5 7.9 14.9 18.7 18.2 36.1 9.3 30.1 14.3 12.7 10.7 10.3 17.4 41.2 9.0 1.7 10.9 14.5 11.3 11.9 0.0 4.9 9.9 6.6 25.3 28.8 6.8 6.8 19.1 6.3 4.3 10.2 8.1 11.2 13.4 6.8 10.0 8.8 20.1 9.3 17.5 11.3 9.0 60.4 19.4 11.8 17.9 12.8 10.7 14.0 25.3 7.6 21.2 ZNF276 "CENP-Z, CENPZ, MGC45417, ZADT, ZFP276, ZNF477" ENSG00000158805 "Zinc finger protein 276" Q8N554 16 89720400-89740903 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021309, HPA022255" Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nucleoli, Plasma membrane" "HPA021309: AB_1859024, HPA022255: AB_1859025" "unprognostic (1.45e-2)" "unprognostic (7.05e-2)" "unprognostic (1.17e-2)" "unprognostic (8.25e-3)" "unprognostic (1.17e-1)" "unprognostic (2.95e-3)" "unprognostic (1.27e-1)" "unprognostic (3.70e-2)" "unprognostic (1.92e-1)" "unprognostic (7.85e-2)" "unprognostic (1.59e-2)" "unprognostic (1.36e-3)" "prognostic unfavorable (3.37e-4)" "unprognostic (2.65e-2)" "unprognostic (4.14e-1)" "unprognostic (1.26e-1)" "unprognostic (1.62e-3)" 9.7 9.8 9.0 18.6 13.1 25.5 7.9 20.2 12.3 10.8 11.1 30.6 9.4 16.0 9.0 8.4 14.5 11.4 9.5 6.7 9.8 7.3 8.4 10.1 9.6 21.7 21.3 11.2 13.5 10.9 11.0 11.6 7.4 12.6 10.2 8.8 8.1 11.3 11.4 11.4 18.5 15.3 6.8 9.9 22.2 12.2 6.4 18.4 11.1 10.1 8.1 15.1 9.5 10.3 2.9 2.0 4.5 1.9 5.0 10.1 2.4 5.0 4.3 3.5 9.1 2.8 3.9 6.1 3.5 2.1 3.2 1.2 5.5 5.4 6.7 4.4 3.7 1.6 9.4 4.4 3.9 2.4 4.1 23.5 6.0 8.0 2.1 5.5 5.8 7.9 5.4 5.2 4.3 3.6 3.2 4.9 6.0 11.0 5.7 1.5 7.1 7.3 13.3 2.6 5.0 9.6 11.8 3.8 4.5 4.0 3.0 9.5 8.0 7.6 6.9 4.2 2.2 9.3 8.4 5.5 5.4 7.3 4.2 3.0 20.8 6.7 3.5 4.3 9.7 5.3 4.3 1.7 2.8 10.1 1.9 4.8 2.0 5.5 7.6 1.8 2.9 5.6 7.2 4.5 5.0 1.2 2.0 4.0 2.4 9.0 13.1 20.2 11.3 9.8 7.3 21.3 11.2 12.6 18.4 8.9 14.1 17.5 7.4 10.2 13.9 2.0 5.1 4.0 10.3 10.4 19.6 4.0 1.7 7.1 1.6 10.0 16.3 0.0 5.8 3.4 6.9 7.2 11.6 9.8 8.0 6.4 6.9 20.3 10.5 1.3 10.6 15.3 8.5 5.4 11.8 12.3 6.8 11.5 9.9 2.4 23.5 12.9 5.6 15.1 10.6 14.1 3.3 34.9 14.0 8.9 ZNF277 "NRIF4, ZNF277P" ENSG00000198839 "Zinc finger protein 277" Q9NRM2 7 112206588-112343096 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027307 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA027307: AB_1859164" "unprognostic (2.04e-1)" "unprognostic (1.43e-1)" "unprognostic (1.07e-1)" "unprognostic (3.95e-2)" "unprognostic (7.76e-2)" "unprognostic (3.17e-2)" "unprognostic (1.43e-1)" "unprognostic (4.18e-2)" "unprognostic (4.60e-2)" "unprognostic (7.61e-2)" "unprognostic (1.88e-2)" "unprognostic (2.85e-1)" "prognostic favorable (9.47e-4)" "unprognostic (1.05e-1)" "unprognostic (2.64e-2)" "unprognostic (2.46e-1)" "unprognostic (1.06e-1)" 15.2 14.8 11.2 12.9 16.2 10.9 20.1 9.3 13.8 13.6 13.9 8.4 8.8 13.7 14.7 8.8 18.4 12.6 14.3 14.4 11.8 9.1 22.7 30.0 19.2 14.3 11.3 11.9 15.4 23.5 13.5 16.4 8.1 11.6 17.1 14.2 5.5 14.9 12.9 12.7 17.7 13.4 15.9 16.1 13.7 14.6 10.2 14.1 23.9 22.4 11.1 15.6 26.6 13.6 13.3 10.4 9.5 14.3 12.4 17.2 9.1 5.9 6.2 8.3 10.3 13.7 38.1 6.4 5.8 12.8 4.9 10.4 5.7 9.3 13.3 11.6 6.2 11.1 5.0 5.2 10.1 11.6 7.0 8.0 5.4 6.1 12.6 13.4 10.3 7.9 21.9 18.1 9.4 12.4 19.8 16.9 14.7 9.5 14.2 9.2 9.6 14.4 20.1 4.9 7.9 6.4 8.0 9.8 13.8 14.4 6.8 6.3 12.7 7.1 13.7 14.1 13.3 5.5 11.0 10.4 6.8 4.1 17.7 5.5 10.4 8.4 13.2 5.8 10.2 7.6 7.1 11.6 9.5 11.2 14.3 15.9 13.3 15.2 17.2 10.4 11.2 16.3 13.5 9.3 12.4 11.6 10.1 17.0 9.1 11.2 16.2 9.3 13.8 11.8 9.1 11.3 11.9 11.6 14.1 35.7 18.2 13.7 16.1 18.3 10.0 11.8 22.9 10.7 18.2 5.2 2.0 10.4 23.2 20.2 37.5 16.5 11.8 0.0 27.0 13.8 12.7 16.7 7.0 17.3 19.2 30.2 17.7 10.4 39.5 4.4 15.8 26.3 11.8 36.9 21.0 5.8 24.3 21.0 23.7 25.9 11.4 19.4 13.3 20.6 7.8 21.2 11.6 28.4 22.1 18.1 ZNF280A "3'OY11.1, SUHW1, ZNF280, ZNF636" ENSG00000169548 "Zinc finger protein 280A" P59817 22 22513736-22520270 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 5.6;epididymis: 5.6;retina: 2.2" "Cell type enhanced" "Detected in some" 30 "Melanocytes: 1.7;Syncytiotrophoblasts: 4.2" "Cancer enhanced" "Detected in some" "melanoma: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.1;EFO-21: 1.9;K-562: 13.0;SK-MEL-30: 3.5" "Not detected" "Not detected" HPA044475 Approved Nucleoplasm NA NA Nucleoplasm "HPA044475: AB_10960420" "unprognostic (7.53e-2)" "unprognostic (3.76e-2)" "unprognostic (1.26e-1)" "unprognostic (2.56e-2)" "unprognostic (3.14e-1)" "unprognostic (1.78e-2)" "unprognostic (3.29e-1)" "unprognostic (4.65e-3)" "unprognostic (1.58e-1)" "unprognostic (1.29e-1)" 0.0 5.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.4 0.0 0.0 0.1 5.6 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.5 0.0 1.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.2 0.0 1.0 0.0 0.1 1.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.8 0.0 13.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.5 0.3 0.5 0.2 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 4.2 0.0 0.0 0.0 ZNF280B "5'OY11.1, SUHW2, ZNF279, ZNF632" ENSG00000275004 "Zinc finger protein 280B" Q86YH2 22 22484421-22509154 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 12.4;testis: 19.2" "Group enriched" "Detected in many" 14 "Early spermatids: 147.7;Late spermatids: 74.6;Spermatocytes: 65.0;Spermatogonia: 149.7" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 13.1;U-2 OS: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059519 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA059519: AB_2684050" "unprognostic (7.32e-2)" "unprognostic (2.99e-2)" "unprognostic (1.12e-1)" "unprognostic (2.00e-1)" "unprognostic (2.09e-2)" "unprognostic (1.00e-1)" "unprognostic (2.65e-1)" "unprognostic (2.08e-2)" "unprognostic (2.03e-1)" "unprognostic (1.14e-2)" "unprognostic (2.85e-3)" "unprognostic (1.10e-1)" "unprognostic (5.42e-2)" "unprognostic (3.34e-2)" "unprognostic (4.80e-1)" "unprognostic (2.44e-2)" "unprognostic (5.34e-2)" 0.3 2.1 4.3 0.9 5.5 0.6 0.5 3.9 6.8 0.7 0.5 1.6 0.0 0.4 1.5 1.3 0.5 1.2 0.6 0.8 1.8 0.5 0.3 0.5 1.2 1.7 3.2 2.5 0.7 2.0 5.6 0.5 6.6 1.3 0.7 3.5 0.5 1.4 0.8 0.6 0.6 1.1 2.2 1.1 0.6 19.2 1.2 0.0 2.3 0.0 1.2 0.6 0.0 3.3 3.1 12.4 6.4 6.8 5.4 2.0 0.0 1.9 2.2 0.0 0.0 0.0 2.9 0.4 0.0 0.0 0.0 1.1 0.8 2.0 2.1 0.0 1.8 0.0 1.8 0.3 0.0 0.0 3.5 2.3 0.4 2.7 1.6 1.6 3.0 0.9 0.0 1.8 0.0 0.3 1.9 2.2 13.1 0.8 0.7 0.0 2.0 1.1 1.6 0.9 0.4 1.7 0.0 0.2 0.6 0.0 1.2 1.6 0.0 0.0 0.7 2.0 0.0 1.4 0.8 3.3 6.9 0.7 0.0 1.2 1.2 1.2 2.0 1.5 0.1 12.4 2.3 3.8 2.9 3.3 5.4 3.1 3.6 3.1 2.0 3.3 4.5 4.9 5.9 6.8 6.4 3.1 3.5 2.0 0.0 1.1 2.7 0.5 0.1 6.6 1.2 5.1 0.0 1.2 0.0 3.9 0.1 0.0 1.9 147.7 0.3 0.0 0.0 3.0 0.2 0.5 0.6 0.0 0.0 2.4 4.8 2.9 2.5 0.6 74.6 2.3 0.4 5.0 2.8 0.9 6.0 2.1 0.0 6.7 2.9 7.9 6.5 0.3 65.0 149.7 0.0 0.2 0.5 1.2 0.0 ZNF280C "FLJ20095, SUHW3, ZNF633" ENSG00000056277 "Zinc finger protein 280C" Q8ND82 X 130202711-130268899 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Spermatocytes: 11.4;Spermatogonia: 35.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051494, HPA055788" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA051494: AB_2681506, HPA055788: AB_2682921" "unprognostic (2.97e-1)" "unprognostic (2.02e-1)" "unprognostic (3.97e-1)" "unprognostic (5.69e-3)" "unprognostic (2.98e-2)" "unprognostic (8.52e-2)" "unprognostic (1.16e-6)" "unprognostic (1.96e-2)" "unprognostic (3.33e-2)" "unprognostic (9.77e-2)" "unprognostic (1.06e-2)" "unprognostic (3.69e-2)" "unprognostic (3.27e-8)" "unprognostic (1.71e-1)" "unprognostic (1.77e-2)" "unprognostic (3.66e-2)" "unprognostic (6.85e-2)" 5.4 4.5 3.9 7.1 6.8 6.2 4.9 5.6 6.8 7.6 4.4 5.4 2.9 3.7 10.6 13.3 4.6 5.0 5.1 3.3 3.8 4.2 4.0 4.1 4.1 5.7 4.2 4.2 6.8 4.6 4.9 12.5 4.8 5.8 5.5 4.0 5.1 4.1 3.8 4.5 4.5 4.4 5.0 5.8 6.0 3.8 21.5 2.8 8.2 4.9 3.6 6.8 4.9 5.4 4.0 2.3 2.7 2.9 4.5 4.9 1.1 3.4 4.4 11.8 10.5 3.5 4.9 4.4 3.3 4.4 3.6 5.4 2.7 5.6 8.3 13.3 2.4 7.0 3.4 8.1 2.6 6.3 7.2 2.3 3.6 3.4 2.0 2.8 11.5 3.3 3.6 1.2 5.0 5.3 3.5 4.0 5.4 1.7 5.1 4.1 4.4 6.2 4.7 6.8 5.2 3.7 8.7 4.0 3.2 3.7 5.6 5.7 7.9 3.2 1.9 3.8 5.0 2.1 4.0 4.0 3.9 3.3 6.4 8.6 2.1 1.3 4.7 3.6 10.5 3.6 2.7 1.4 1.5 3.0 2.2 4.9 4.0 3.8 3.5 1.9 3.2 2.7 3.7 0.8 4.5 2.9 2.3 4.8 1.1 3.9 6.8 5.6 6.8 3.8 4.2 4.2 4.2 5.8 2.8 3.0 2.2 3.7 1.9 0.8 2.6 1.0 0.0 4.0 1.2 1.8 2.0 1.6 0.0 1.1 0.2 1.8 1.1 0.0 1.6 1.5 1.7 1.3 0.0 2.1 1.4 4.8 4.6 3.1 1.9 0.0 3.1 1.7 0.0 4.6 0.7 0.8 1.0 1.9 2.8 1.9 2.9 6.5 1.5 11.4 35.1 1.4 0.7 1.5 1.9 2.0 ZNF280D "FLJ20086, SUHW4, ZNF634" ENSG00000137871 "Zinc finger protein 280D" Q6N043 15 56630181-56734086 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA030233 Approved Approved "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus, Centrosome" "HPA030233: AB_10602590" "unprognostic (1.57e-1)" "unprognostic (2.17e-1)" "unprognostic (3.55e-2)" "unprognostic (1.47e-2)" "unprognostic (1.64e-2)" "unprognostic (1.70e-2)" "unprognostic (3.08e-1)" "unprognostic (3.77e-2)" "unprognostic (6.15e-2)" "unprognostic (3.63e-1)" "unprognostic (7.33e-2)" "unprognostic (1.33e-1)" "unprognostic (1.11e-2)" "unprognostic (1.98e-1)" "unprognostic (9.75e-2)" "unprognostic (2.19e-1)" "unprognostic (7.72e-2)" 16.5 15.7 10.5 9.2 13.3 22.8 16.5 23.0 18.8 21.1 14.3 14.2 12.6 8.1 21.2 9.0 12.0 18.2 9.9 11.4 10.3 7.0 11.0 14.0 11.4 9.8 11.3 14.9 27.2 16.9 14.4 28.0 12.2 16.9 18.1 12.4 8.5 18.8 11.7 22.0 9.8 11.2 24.8 16.3 11.1 14.6 8.4 14.5 46.3 13.6 8.4 10.0 23.6 19.6 6.1 5.9 10.0 4.1 3.0 4.3 1.8 8.6 4.9 9.1 13.9 9.2 12.9 6.7 13.4 9.5 5.6 6.4 3.4 9.0 14.6 5.6 9.4 5.3 6.4 4.5 3.5 6.7 7.4 2.7 1.5 8.1 5.3 9.2 13.1 4.4 8.4 4.9 3.8 5.4 13.7 12.2 15.2 7.6 17.0 8.5 6.1 8.7 1.5 0.0 10.2 4.0 2.8 15.0 10.4 6.5 10.1 7.3 13.4 11.2 6.9 4.3 0.5 7.6 12.2 10.7 8.2 12.4 7.5 10.7 8.9 13.4 0.0 9.2 19.5 8.8 10.0 4.1 5.4 3.6 3.7 3.6 6.1 3.4 3.1 5.9 5.5 3.5 4.3 0.6 3.0 3.2 5.9 3.0 1.8 10.5 13.3 23.0 18.8 10.3 7.0 11.3 14.9 16.9 14.5 8.9 17.6 17.1 16.1 9.8 79.9 32.7 15.3 9.4 13.6 3.5 78.5 18.6 6.6 10.3 12.9 31.2 14.9 0.0 12.2 17.5 22.1 18.3 17.3 26.7 30.7 65.2 31.0 31.9 32.7 32.5 30.8 15.5 15.1 10.0 22.7 21.1 10.9 3.5 19.8 11.5 78.5 6.5 18.4 45.7 26.2 12.2 11.1 18.8 19.7 11.6 ZNF281 ZBP-99 ENSG00000162702 "Zinc finger protein 281" Q9Y2X9 1 200404940-200410056 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051228 Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA051228: AB_2681396" "unprognostic (3.13e-1)" "prognostic unfavorable (1.16e-4)" "unprognostic (1.50e-1)" "unprognostic (8.99e-3)" "unprognostic (1.23e-1)" "unprognostic (5.48e-2)" "unprognostic (1.65e-1)" "unprognostic (1.92e-2)" "unprognostic (3.71e-3)" "unprognostic (8.30e-2)" "unprognostic (3.69e-2)" "unprognostic (5.99e-2)" "prognostic unfavorable (2.60e-5)" "unprognostic (1.26e-2)" "unprognostic (4.86e-1)" "unprognostic (6.19e-2)" "unprognostic (1.83e-1)" 8.4 5.7 8.8 11.4 18.3 31.2 8.8 22.4 13.1 8.5 7.9 9.1 4.0 6.2 8.8 4.6 4.6 6.8 11.3 5.2 10.5 9.2 8.1 22.9 9.1 11.4 17.3 8.1 6.7 7.6 7.0 8.7 10.3 12.0 6.1 5.0 4.1 6.4 5.1 7.8 3.1 7.3 9.8 11.2 11.4 7.5 10.0 19.9 19.9 5.9 4.8 12.3 8.8 10.2 7.1 5.3 24.5 5.4 4.7 9.3 2.2 11.0 10.8 15.1 7.0 6.0 8.3 13.2 11.6 18.3 11.7 11.1 10.6 8.7 15.9 6.9 13.2 13.7 7.5 16.2 10.8 14.0 17.1 9.9 12.7 8.2 10.9 6.6 11.6 7.3 8.0 12.1 12.6 13.8 14.9 10.5 8.7 18.3 2.6 11.8 5.2 11.9 7.3 35.1 3.4 9.8 11.3 10.5 9.5 12.0 5.6 5.3 14.1 11.5 7.7 10.1 24.8 15.4 8.5 14.2 21.9 16.4 5.0 12.3 9.9 9.6 20.4 11.6 9.2 11.6 8.4 5.1 18.4 6.6 5.4 6.7 7.1 5.7 6.9 5.1 6.5 9.3 8.1 24.5 4.7 4.9 5.3 6.7 2.2 8.8 18.3 22.4 13.1 10.5 9.2 17.3 8.1 12.0 19.9 59.6 29.3 27.2 21.7 42.7 47.6 12.9 30.6 17.4 23.9 26.2 27.5 11.5 11.6 18.9 2.1 26.6 10.7 23.3 9.2 25.2 20.8 19.3 5.8 62.2 18.0 17.5 25.7 28.3 42.5 0.9 9.2 21.8 21.9 16.2 10.4 17.4 14.8 13.1 7.4 15.8 32.4 12.9 20.8 46.8 38.7 19.8 10.3 27.4 10.6 13.6 ZNF282 HUB1 ENSG00000170265 "Zinc finger protein 282" Q9UDV7 7 149195485-149226248 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024374 Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA024374: AB_1851322" "unprognostic (1.79e-1)" "unprognostic (6.97e-2)" "unprognostic (1.19e-3)" "unprognostic (5.23e-3)" "unprognostic (3.11e-2)" "unprognostic (3.70e-2)" "prognostic unfavorable (3.03e-5)" "unprognostic (1.32e-1)" "unprognostic (3.33e-2)" "unprognostic (2.73e-1)" "unprognostic (3.34e-2)" "unprognostic (1.56e-2)" "unprognostic (2.13e-1)" "unprognostic (1.63e-3)" "unprognostic (7.88e-2)" "unprognostic (1.54e-1)" "unprognostic (2.03e-2)" 13.6 11.7 12.6 12.7 11.5 17.5 13.1 20.7 18.1 19.1 16.1 16.6 16.8 17.7 17.9 14.1 17.9 17.2 18.1 12.5 10.2 8.4 12.4 14.4 12.3 11.2 10.8 11.8 18.5 26.6 12.2 12.3 24.9 10.8 21.4 7.8 13.3 17.8 15.8 20.7 19.5 14.5 15.1 8.9 15.2 14.6 6.4 12.9 14.2 14.1 16.3 12.7 17.0 13.8 3.9 2.4 3.5 1.8 1.8 3.4 1.0 11.6 11.5 6.8 16.3 6.0 7.1 10.0 10.6 7.8 9.4 9.4 10.5 12.8 11.7 16.1 6.6 8.3 12.9 8.0 10.1 3.6 17.6 28.2 9.8 7.5 8.9 8.9 12.3 11.1 8.1 13.8 9.0 9.9 7.1 9.7 7.9 18.8 9.2 5.0 13.7 25.9 18.3 22.0 6.7 14.5 16.9 6.6 16.3 5.1 11.2 15.5 14.8 11.8 14.2 9.7 3.8 9.1 12.0 12.1 13.5 3.0 16.1 15.4 13.3 7.9 8.7 11.2 10.7 11.5 0.0 1.8 3.5 2.1 1.5 2.3 0.9 2.7 2.1 1.0 3.9 1.4 1.8 1.8 1.8 1.7 2.4 3.4 1.0 12.6 11.5 20.7 18.1 10.2 8.4 10.8 11.8 10.8 12.9 3.0 5.0 1.9 2.4 6.4 10.9 4.0 7.6 0.0 2.3 1.8 3.9 9.2 0.0 4.4 25.4 4.5 8.3 0.0 3.7 4.7 4.7 4.3 5.7 7.5 5.3 14.3 12.6 6.2 4.5 21.6 5.8 2.5 1.7 3.6 10.2 5.4 5.3 9.5 5.3 3.2 7.0 12.9 3.8 1.1 1.2 5.6 4.2 1.5 9.3 3.3 ZNF283 ENSG00000167637 "Zinc finger protein 283" Q8N7M2 19 43827292-43852017 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 19.7;Cone photoreceptor cells: 21.6;Rod photoreceptor cells: 34.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2 OS: 22.6" "Low region specificity" "Detected in all" HPA072977 Approved Nucleoplasm NA NA Nucleoplasm "HPA072977: AB_2686563" "unprognostic (1.01e-1)" "unprognostic (1.19e-1)" "unprognostic (3.05e-2)" "unprognostic (1.54e-1)" "unprognostic (5.42e-2)" "unprognostic (1.05e-3)" "unprognostic (6.49e-2)" "unprognostic (8.47e-2)" "unprognostic (3.08e-2)" "unprognostic (3.84e-1)" "unprognostic (1.16e-2)" "unprognostic (8.18e-3)" "unprognostic (4.93e-2)" "unprognostic (1.92e-1)" "unprognostic (6.88e-2)" "unprognostic (1.26e-1)" "unprognostic (4.63e-2)" 5.4 6.5 9.1 4.5 12.3 2.6 10.6 18.7 12.7 6.7 6.4 9.1 6.7 6.5 11.5 9.2 7.1 9.0 6.4 10.9 11.8 8.2 6.6 4.6 5.2 6.4 14.7 11.9 11.3 5.8 12.1 17.6 6.6 11.1 9.2 8.5 6.9 7.4 6.4 6.0 8.9 6.9 7.6 15.0 7.2 7.8 3.6 15.7 6.4 10.5 5.1 6.5 6.5 7.6 5.3 4.6 11.9 4.2 7.0 5.1 2.2 6.6 4.8 4.8 9.3 4.5 8.1 4.2 3.8 4.9 4.5 6.4 3.9 3.3 0.1 2.9 6.3 5.6 6.1 6.2 4.8 7.3 1.6 7.8 5.7 8.2 2.8 3.2 3.3 4.2 6.1 6.2 5.6 6.9 5.9 3.8 2.0 6.4 1.8 5.9 3.2 1.8 2.8 4.5 3.3 2.9 0.0 3.5 1.6 3.9 8.8 5.6 7.9 7.6 5.2 3.3 4.7 2.8 6.0 4.1 6.7 22.6 3.5 4.7 5.0 4.8 0.4 2.9 0.4 4.6 6.7 4.2 3.9 4.3 3.1 5.0 4.5 4.2 2.7 3.0 5.3 5.1 3.5 11.9 7.0 2.9 4.6 4.3 2.2 9.1 12.3 18.7 12.7 11.8 8.2 14.7 11.9 11.1 15.7 8.9 19.7 0.8 2.1 2.2 10.3 4.5 2.5 4.0 10.3 0.0 21.6 2.5 6.6 2.4 1.1 2.8 2.4 0.0 1.6 1.7 2.8 1.7 3.5 1.0 2.1 6.4 5.8 6.2 2.2 0.0 2.3 2.8 1.7 3.6 3.3 3.6 2.0 3.4 3.2 1.1 34.1 0.0 3.3 1.5 4.1 1.4 2.4 1.3 4.0 2.2 ZNF292 "bA393I2.3, KIAA0530, ZFP292, Zn-15, Zn-16" ENSG00000188994 "Zinc finger protein 292" O60281 6 87152833-87264196 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032154, HPA050618" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA032154: AB_10601930, HPA050618: AB_2681190" "unprognostic (6.26e-2)" "unprognostic (1.32e-2)" "unprognostic (2.97e-1)" "unprognostic (3.66e-2)" "unprognostic (1.02e-2)" "unprognostic (2.07e-2)" "unprognostic (2.08e-3)" "unprognostic (2.28e-2)" "unprognostic (2.81e-2)" "unprognostic (4.03e-2)" "unprognostic (8.43e-2)" "unprognostic (7.46e-2)" "unprognostic (9.06e-2)" "unprognostic (2.80e-1)" "unprognostic (1.22e-1)" "unprognostic (2.02e-1)" "unprognostic (7.36e-2)" 11.8 10.2 15.2 16.7 16.8 31.1 14.5 31.1 19.7 15.0 13.9 10.3 11.4 11.2 16.4 15.1 11.1 11.1 9.8 11.6 13.6 9.0 9.8 10.8 9.7 14.8 18.2 9.8 20.6 12.5 14.6 20.7 12.3 15.3 14.0 10.2 12.0 15.0 11.2 9.3 14.0 15.7 12.3 18.6 12.2 11.6 8.7 19.6 25.6 14.1 5.7 16.5 22.6 22.9 16.7 10.4 35.8 7.6 4.3 8.3 3.0 6.3 3.8 12.8 11.2 7.3 6.7 13.3 4.9 6.4 5.9 8.2 6.4 4.5 9.8 7.3 6.5 8.4 6.6 7.9 7.5 12.9 22.2 6.0 13.2 4.9 5.1 5.5 10.6 6.0 6.6 7.4 5.8 7.6 9.5 5.4 10.6 9.6 15.1 6.4 3.5 6.1 9.5 6.4 2.2 3.5 12.9 12.7 3.7 5.2 13.8 9.6 13.5 6.3 4.2 4.8 7.7 4.2 12.8 6.1 7.9 5.5 5.8 7.8 14.0 9.1 6.7 8.7 9.2 5.7 18.0 7.6 7.9 6.9 2.2 6.5 16.6 7.4 7.5 3.2 16.7 8.3 7.1 35.8 4.3 2.3 10.4 7.1 3.0 15.2 16.8 31.1 19.7 13.6 9.0 18.2 9.8 15.3 19.6 56.6 56.6 44.4 25.9 58.7 160.5 61.0 40.8 32.1 48.9 24.4 115.8 19.3 8.3 84.7 16.4 40.7 47.6 0.0 33.2 25.7 35.7 37.4 27.8 15.3 23.3 176.4 45.4 36.2 26.5 6.4 55.5 39.5 30.4 44.1 44.3 74.5 51.7 42.1 62.2 11.6 93.9 32.3 37.3 48.7 29.8 44.9 177.1 57.3 40.7 34.6 ZNF296 ZNF342 ENSG00000170684 "Zinc finger protein 296" Q8WUU4 19 45071500-45076588 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 29.8;lymphoid tissue: 26.2" "Cell type enhanced" "Detected in many" 7 "monocytes: 36.9;Paneth cells: 28.6;Undifferentiated cells: 23.5" "Cancer enhanced" "Detected in all" "testis cancer: 19.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 16.6;SK-BR-3: 11.2;U-698: 19.4" "Low region specificity" "Detected in many" "HPA046940, HPA049576" Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA046940: AB_2679871, HPA049576: AB_2680821" "unprognostic (1.32e-1)" "unprognostic (5.37e-3)" "unprognostic (1.18e-1)" "unprognostic (7.71e-2)" "unprognostic (1.46e-1)" "prognostic favorable (5.24e-4)" "unprognostic (3.83e-3)" "unprognostic (1.67e-2)" "unprognostic (9.70e-2)" "unprognostic (9.55e-2)" "unprognostic (3.20e-3)" "unprognostic (1.12e-1)" "unprognostic (2.67e-5)" "unprognostic (7.14e-3)" "unprognostic (1.52e-1)" "unprognostic (1.74e-1)" "unprognostic (1.39e-3)" 1.4 0.8 2.4 22.8 3.4 10.5 7.3 6.6 1.4 3.0 7.1 0.4 3.2 6.4 1.0 1.2 11.3 1.4 4.0 1.4 2.0 1.7 1.4 1.0 3.4 15.9 1.1 0.1 0.6 2.7 0.3 3.5 0.7 0.8 2.4 1.0 0.8 13.8 3.4 0.8 6.2 10.1 0.6 1.3 16.9 5.5 2.6 0.6 4.3 1.7 9.5 26.2 2.0 2.7 29.8 26.7 14.7 6.2 14.7 3.5 2.6 3.0 2.1 0.0 0.4 0.0 0.2 1.8 0.5 0.0 0.2 0.2 3.5 1.2 16.6 1.9 0.1 0.0 5.8 0.8 1.3 0.0 3.5 4.4 4.8 0.9 3.4 0.9 2.7 5.1 0.7 0.6 0.7 0.0 0.1 0.5 0.3 3.5 5.9 0.0 4.6 0.2 4.6 1.9 2.0 4.4 9.3 0.0 10.0 0.4 1.1 3.1 0.3 2.1 11.2 0.1 0.3 2.4 5.5 1.1 0.0 1.7 0.1 0.0 6.1 6.1 19.4 0.1 3.5 0.1 14.7 3.6 5.7 3.0 6.2 3.5 29.8 1.6 3.3 8.8 22.4 0.7 1.7 1.8 14.7 5.8 26.7 1.4 2.6 2.4 3.4 6.6 1.4 2.0 1.7 1.1 0.1 0.8 0.6 0.0 1.1 18.6 12.1 10.8 0.9 0.9 0.0 2.7 1.2 3.5 3.9 0.3 0.0 1.9 0.4 0.0 13.3 0.0 0.8 1.9 1.7 2.8 9.2 0.0 3.0 0.0 5.1 1.3 3.0 0.0 0.0 4.1 3.3 36.9 19.9 0.5 1.0 28.6 1.1 0.3 1.6 0.0 2.0 0.9 10.9 8.8 0.7 10.2 23.5 5.7 ZNF3 "A8-51, FLJ20216, HF.12, KOX25, PP838, Zfp113" ENSG00000166526 "Zinc finger protein 3" P17036 7 100064033-100082548 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003719 Supported Supported Approved Nucleoplasm No No Nucleoplasm "HPA003719: AB_1080701" "unprognostic (5.92e-2)" "unprognostic (3.82e-2)" "unprognostic (1.00e-1)" "unprognostic (1.01e-1)" "unprognostic (3.19e-2)" "unprognostic (2.76e-2)" "unprognostic (1.10e-1)" "prognostic favorable (5.73e-4)" "prognostic unfavorable (1.59e-4)" "unprognostic (2.65e-1)" "unprognostic (2.50e-3)" "unprognostic (7.54e-2)" "unprognostic (3.71e-2)" "unprognostic (8.22e-3)" "unprognostic (1.24e-1)" "unprognostic (3.41e-2)" "prognostic favorable (2.20e-4)" 16.1 12.8 12.8 9.8 16.8 20.7 19.2 18.3 22.6 18.6 16.4 39.5 16.6 19.3 23.9 20.5 15.2 33.9 11.6 11.5 14.8 11.2 15.0 19.3 11.7 11.1 20.8 11.1 22.5 18.9 17.9 17.8 13.3 21.1 15.6 17.8 19.7 16.4 16.3 18.9 15.4 22.1 14.6 18.0 15.6 16.0 11.8 21.9 21.4 17.6 11.1 16.6 16.7 15.5 16.2 11.2 17.9 12.2 17.3 17.2 9.4 6.2 7.0 19.3 27.6 9.8 7.7 11.3 8.0 9.1 12.2 10.4 8.7 9.4 9.0 14.6 7.6 9.9 8.5 14.2 8.7 10.0 9.9 12.0 7.3 9.1 11.9 11.6 13.0 6.9 9.5 10.9 8.1 19.1 13.5 10.8 13.4 20.3 14.3 11.0 16.8 30.5 13.1 26.6 11.3 12.8 13.1 15.6 22.3 10.9 12.4 21.7 30.2 9.3 27.9 12.4 19.1 8.2 13.2 8.3 15.2 10.9 10.8 10.3 19.2 21.7 17.9 7.7 11.7 14.2 12.3 9.8 17.9 14.2 9.6 17.2 13.3 12.5 14.9 9.9 16.2 14.2 15.5 4.1 17.3 12.2 11.2 11.5 9.4 12.8 16.8 18.3 22.6 14.8 11.2 20.8 11.1 21.1 21.9 11.9 35.9 12.2 8.4 6.8 16.1 9.8 25.5 38.8 14.8 3.5 15.7 10.4 6.6 16.8 1.1 14.6 19.7 0.0 9.6 5.9 8.5 10.1 15.0 12.4 5.7 17.5 25.2 10.4 12.0 1.1 14.1 6.0 3.3 11.8 17.4 20.5 13.3 17.5 14.2 10.6 18.3 6.5 7.3 10.3 17.4 7.9 8.7 11.8 15.8 7.4 ZNF30 "DKFZp686N19164, FLJ20562, KOX28" ENSG00000168661 "Zinc finger protein 30" P17039 19 34926903-34945170 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.4" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 12.7;Rod photoreceptor cells: 10.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA030400 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030400: AB_10603245" "unprognostic (3.04e-1)" "unprognostic (9.77e-2)" "unprognostic (9.69e-2)" "unprognostic (3.38e-1)" "unprognostic (8.39e-2)" "unprognostic (1.49e-2)" "unprognostic (5.10e-3)" "unprognostic (4.97e-2)" "unprognostic (1.58e-2)" "unprognostic (3.42e-1)" "prognostic favorable (1.16e-4)" "unprognostic (5.84e-2)" "unprognostic (4.40e-2)" "unprognostic (2.21e-1)" "unprognostic (1.44e-1)" "unprognostic (4.07e-2)" "unprognostic (2.86e-2)" 3.4 5.2 11.1 2.6 10.9 0.7 5.9 21.4 11.6 5.3 3.9 5.0 2.9 4.2 4.5 3.4 3.4 7.0 2.6 5.0 7.0 5.4 4.6 6.5 6.0 5.1 10.0 6.5 5.6 6.9 6.4 7.7 3.3 6.6 5.8 4.5 5.8 4.6 5.2 5.3 5.6 3.9 5.1 7.2 5.4 4.8 3.9 8.3 2.4 4.4 2.0 5.1 3.8 4.0 3.4 1.3 2.8 0.4 6.9 7.2 1.8 3.6 8.2 3.5 8.8 6.3 4.0 0.1 3.6 2.6 3.3 3.7 5.8 1.2 0.0 4.8 2.3 1.2 2.3 10.1 5.1 4.2 0.0 4.8 2.7 4.4 4.4 3.2 3.6 2.5 3.5 4.6 3.3 4.4 1.4 5.2 7.2 8.7 0.0 5.3 2.7 2.6 1.6 4.9 8.9 4.3 3.4 2.7 0.9 2.5 3.2 4.6 6.6 0.0 0.1 3.4 3.8 3.3 1.0 3.7 7.0 3.7 2.5 4.8 2.4 11.5 1.0 1.4 0.0 4.0 2.8 0.1 0.1 4.8 0.4 4.7 3.4 3.8 2.2 1.3 2.1 7.2 7.2 0.0 6.9 0.0 1.2 3.4 1.8 11.1 10.9 21.4 11.6 7.0 5.4 10.0 6.5 6.6 8.3 0.0 0.6 0.0 0.2 0.3 5.3 2.8 0.0 4.0 0.0 1.8 5.9 0.1 3.3 0.9 0.2 3.5 0.0 0.0 1.2 0.5 0.6 0.3 5.7 1.0 0.7 12.7 1.2 5.5 1.8 0.4 2.0 0.1 1.7 0.0 1.4 3.5 1.0 0.0 2.1 1.3 10.0 0.0 1.0 2.6 2.4 0.1 0.0 1.7 1.3 0.3 ZNF300 ENSG00000145908 "Zinc finger protein 300" Q96RE9 5 150894392-150904983 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 7.0;Spermatocytes: 6.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 3.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 17.2;HeLa: 18.9" "HPA028975, HPA051777" Uncertain Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies" NA NA Nucleoplasm "Nucleoli, Nucleoli rim, Nuclear bodies" "HPA028975: AB_2672851, HPA051777: AB_2681606" "unprognostic (5.06e-2)" "unprognostic (1.05e-2)" "unprognostic (8.41e-2)" "unprognostic (2.31e-1)" "unprognostic (7.61e-2)" "unprognostic (1.13e-2)" "unprognostic (1.15e-1)" "unprognostic (6.23e-3)" "unprognostic (4.21e-2)" "unprognostic (3.23e-1)" "unprognostic (8.62e-2)" "unprognostic (6.85e-3)" "prognostic unfavorable (3.21e-6)" "unprognostic (3.62e-3)" "unprognostic (2.99e-1)" "unprognostic (3.46e-1)" "unprognostic (1.50e-2)" 4.5 1.3 4.8 4.0 12.0 3.6 7.2 12.5 6.4 7.4 4.3 5.4 4.1 4.1 11.7 5.3 7.5 5.4 5.4 4.0 7.5 3.2 7.3 1.5 3.0 4.4 8.2 2.4 16.6 7.3 1.0 7.3 2.4 7.4 7.0 4.4 3.6 3.8 3.9 1.5 6.9 5.8 6.4 9.2 5.1 7.1 14.9 9.1 1.5 9.3 2.7 4.4 5.5 6.2 3.8 1.2 1.1 1.5 1.7 1.0 0.8 1.2 2.8 17.2 0.0 1.5 3.6 0.0 4.2 3.3 3.7 5.4 1.4 2.1 0.0 3.7 3.5 11.2 2.5 0.0 9.7 5.8 0.0 5.6 0.0 18.9 2.2 3.1 0.1 0.0 5.5 3.0 7.7 9.1 5.3 6.3 0.1 0.0 9.2 3.7 0.0 0.0 0.8 16.5 0.0 0.0 0.0 2.5 4.9 2.7 3.1 9.7 16.1 9.9 8.6 5.7 10.9 5.7 0.0 2.7 5.0 2.1 3.6 7.6 0.3 0.1 0.0 0.5 0.1 10.3 0.0 0.6 1.1 0.7 1.5 0.1 0.9 1.0 0.0 1.2 3.8 0.7 0.4 0.2 1.7 0.1 0.1 0.0 0.8 4.8 12.0 12.5 6.4 7.5 3.2 8.2 2.4 7.4 9.1 0.0 0.3 0.0 2.5 1.3 3.6 0.4 0.0 0.0 2.3 7.0 0.0 0.7 1.7 2.1 1.3 2.1 0.4 0.0 1.4 1.9 3.0 2.0 0.0 0.2 0.4 0.0 2.9 0.6 0.6 0.5 2.3 0.7 0.0 1.8 0.7 3.9 1.4 0.0 1.1 1.1 4.6 6.5 1.7 6.6 3.8 1.9 0.7 1.3 1.2 2.6 ZNF317 ENSG00000130803 "Zinc finger protein 317" Q96PQ6 19 9140380-9163424 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042075, HPA048625" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA042075: AB_10796471, HPA048625: AB_2680464" "unprognostic (3.81e-1)" "unprognostic (3.11e-2)" "unprognostic (3.90e-1)" "unprognostic (1.63e-1)" "unprognostic (2.98e-2)" "unprognostic (6.07e-3)" "unprognostic (7.70e-2)" "unprognostic (6.17e-2)" "unprognostic (3.89e-2)" "unprognostic (1.72e-2)" "unprognostic (1.18e-1)" "unprognostic (1.14e-1)" "unprognostic (1.67e-3)" "unprognostic (1.30e-3)" "unprognostic (2.30e-1)" "unprognostic (3.36e-1)" "unprognostic (2.42e-3)" 14.6 17.2 18.4 22.8 19.4 36.1 30.3 22.0 24.1 15.6 17.2 22.1 12.4 17.9 19.4 19.5 17.8 17.2 16.9 13.1 18.3 16.1 17.5 20.5 17.1 22.2 19.7 15.2 18.8 21.5 22.0 19.9 14.5 14.6 18.2 17.1 17.9 15.3 18.5 14.3 22.0 17.8 16.9 17.0 25.7 18.0 8.7 19.4 27.0 17.0 11.2 23.4 16.2 15.5 19.0 14.4 14.5 15.0 21.7 20.9 12.9 8.6 7.4 8.1 10.8 8.1 7.9 7.0 7.3 11.4 10.0 12.2 8.3 4.6 14.7 9.4 7.5 11.9 8.8 13.2 12.3 13.1 12.1 17.8 12.8 6.7 9.2 11.1 13.5 13.4 9.4 16.8 11.4 19.9 8.7 8.7 13.2 12.0 17.1 10.0 7.2 17.0 43.6 15.1 9.2 15.9 12.1 10.2 11.8 8.7 14.7 14.0 9.6 10.1 9.0 11.3 7.3 6.7 14.4 7.7 7.1 6.5 16.1 9.6 21.6 20.6 16.7 6.9 12.0 9.1 13.9 14.1 14.5 13.6 15.0 20.9 19.0 17.9 15.4 14.4 16.0 17.1 18.5 8.8 21.7 11.9 13.2 20.8 12.9 18.4 19.4 22.0 24.1 18.3 16.1 19.7 15.2 14.6 19.4 8.9 12.0 9.8 6.8 6.5 6.5 5.9 12.7 12.0 12.5 5.2 5.9 4.4 3.3 4.6 0.6 7.1 5.7 0.0 5.5 4.3 5.2 7.0 12.8 9.8 7.0 7.9 6.9 5.5 12.7 1.3 3.4 9.5 5.0 3.6 7.2 4.0 6.8 3.5 3.5 7.7 4.8 0.0 5.2 2.1 1.1 5.6 9.2 13.8 9.2 8.9 ZNF318 "HRIHFB2436, ZFP318" ENSG00000171467 "Zinc finger protein 318" Q5VUA4 6 43307134-43369478 "Predicted intracellular proteins" "Meiosis, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 78.2;Spermatogonia: 41.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "naive B-cell: 6.3" "Lineage enriched" "Detected in many" 4 "B-cells: 6.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027022, HPA027031" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA027022: AB_1859189, HPA027031: AB_1859190" "unprognostic (1.64e-1)" "unprognostic (3.80e-1)" "unprognostic (1.13e-1)" "unprognostic (4.11e-3)" "unprognostic (1.97e-2)" "unprognostic (3.02e-2)" "unprognostic (2.53e-3)" "unprognostic (1.93e-1)" "unprognostic (1.80e-2)" "unprognostic (3.37e-2)" "unprognostic (8.24e-2)" "unprognostic (3.47e-1)" "unprognostic (4.61e-3)" "unprognostic (3.61e-1)" "unprognostic (3.00e-1)" "unprognostic (2.82e-1)" "unprognostic (1.54e-2)" 8.3 7.1 14.2 15.3 13.7 9.9 12.2 24.7 17.7 12.5 8.9 10.4 9.2 7.1 12.7 11.1 7.0 9.0 7.1 7.6 12.8 6.3 7.3 8.3 9.2 23.6 15.4 9.4 13.2 8.6 14.6 8.0 7.9 11.4 10.2 8.2 7.9 7.9 8.6 8.6 11.7 10.0 9.2 9.0 14.6 6.8 39.2 16.8 10.0 13.7 4.7 23.6 9.8 10.9 6.3 0.9 0.4 0.7 0.7 1.4 0.5 15.4 3.9 11.3 18.8 10.0 9.0 5.6 6.7 8.9 8.2 7.1 4.1 2.0 24.6 3.8 8.9 9.6 7.0 12.6 5.9 10.7 6.4 6.4 6.8 5.0 6.5 5.0 12.1 5.5 5.7 6.3 6.9 6.1 6.9 6.3 7.0 9.1 12.3 8.6 5.5 3.6 7.7 5.1 26.2 3.7 4.5 11.0 3.9 4.5 3.7 10.4 6.4 5.2 4.6 5.5 9.2 5.7 16.9 6.3 11.5 5.7 7.7 6.6 7.3 5.9 17.6 3.6 9.3 6.4 0.0 0.7 0.0 1.4 0.5 0.4 1.4 1.2 0.9 0.9 6.3 0.9 1.0 0.4 0.7 0.4 0.7 1.2 0.5 14.2 13.7 24.7 17.7 12.8 6.3 15.4 9.4 11.4 16.8 8.9 12.6 7.3 4.2 8.7 15.4 7.7 12.7 6.7 7.9 8.7 7.9 4.9 3.3 4.1 21.1 4.7 5.7 0.0 4.0 3.8 6.4 3.2 5.8 16.8 5.5 23.8 5.2 14.1 10.8 12.9 5.8 6.6 3.3 4.6 4.9 10.2 4.2 9.1 9.2 3.4 12.1 25.8 3.9 78.2 41.7 4.4 1.5 5.0 8.5 1.3 ZNF319 "KIAA1388, Zfp319" ENSG00000166188 "Zinc finger protein 319" Q9P2F9 16 57994668-58000453 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 9.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052584 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA052584: AB_2681873" "unprognostic (1.39e-2)" "unprognostic (1.81e-2)" "unprognostic (1.66e-1)" "unprognostic (3.83e-2)" "unprognostic (3.82e-1)" "unprognostic (2.13e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (7.63e-2)" "unprognostic (1.15e-1)" "unprognostic (4.87e-2)" "prognostic favorable (5.87e-5)" "unprognostic (8.69e-2)" "unprognostic (3.72e-3)" "unprognostic (4.49e-1)" "unprognostic (1.82e-1)" "unprognostic (3.53e-2)" "unprognostic (5.80e-2)" 8.0 8.4 7.6 7.5 7.7 21.3 7.1 11.2 15.0 11.0 8.0 10.6 5.1 6.7 12.0 8.0 6.1 9.7 10.6 6.7 7.3 8.2 7.8 5.7 8.5 10.4 7.1 6.2 13.7 10.6 17.1 7.0 9.4 9.4 8.7 4.3 11.2 8.6 10.8 8.9 6.9 6.6 8.8 6.4 13.9 6.5 6.1 6.0 16.9 19.8 5.6 10.2 11.2 6.2 1.6 2.9 7.4 2.6 1.8 5.3 2.5 4.9 13.5 6.7 9.0 6.2 7.6 5.6 7.1 7.0 6.9 3.4 5.3 2.9 8.4 13.0 6.8 5.6 5.5 5.5 7.6 4.2 3.6 5.3 3.1 5.8 6.3 12.3 4.0 10.7 11.1 9.0 5.5 12.0 6.6 4.3 6.2 6.6 1.4 5.7 4.3 7.7 6.9 3.7 2.4 13.5 13.7 4.5 8.3 4.5 12.8 4.8 5.1 11.8 4.4 4.5 4.8 1.6 6.0 8.4 5.4 3.2 2.7 5.4 7.6 3.2 6.5 4.0 4.2 5.8 0.0 2.6 7.4 5.3 1.9 3.6 1.6 2.8 3.7 2.9 1.6 1.9 3.0 4.8 1.8 1.5 1.1 2.3 2.5 7.6 7.7 11.2 15.0 7.3 8.2 7.1 6.2 9.4 6.0 3.0 4.3 0.0 0.5 0.8 2.0 5.1 5.1 4.0 1.2 0.0 0.0 1.4 3.3 2.1 0.2 1.6 1.0 0.0 2.5 0.9 1.6 0.6 1.1 1.6 1.9 0.0 4.7 4.9 9.1 0.0 2.8 1.2 0.0 1.0 1.4 2.8 2.7 0.0 3.2 1.0 2.9 0.0 1.0 1.9 0.7 1.1 0.2 2.5 1.3 0.0 ZNF32 KOX30 ENSG00000169740 "Zinc finger protein 32" P17041 10 43643859-43648856 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 89.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039148 Approved "Nucleoplasm,Nuclear bodies" Yes No "Nuclear bodies" Nucleoplasm "HPA039148: AB_2676365" "unprognostic (1.05e-2)" "unprognostic (2.04e-3)" "unprognostic (1.15e-3)" "unprognostic (9.76e-2)" "unprognostic (1.04e-2)" "unprognostic (5.26e-2)" "prognostic unfavorable (7.08e-4)" "unprognostic (7.39e-2)" "unprognostic (9.94e-3)" "unprognostic (2.90e-3)" "prognostic favorable (3.02e-4)" "unprognostic (1.39e-1)" "unprognostic (5.73e-3)" "unprognostic (6.66e-2)" "unprognostic (4.57e-2)" "unprognostic (2.89e-1)" "unprognostic (1.15e-1)" 14.4 16.2 24.4 12.4 23.6 4.4 29.2 21.1 20.1 20.2 20.4 19.0 18.0 7.9 21.9 37.7 12.6 20.7 14.7 26.1 22.2 20.8 22.1 17.7 13.7 12.2 27.7 17.7 28.7 26.0 18.7 20.3 10.3 22.5 22.5 15.1 14.7 18.5 25.4 45.7 14.4 11.0 23.4 19.8 14.2 14.5 8.6 25.8 15.4 25.8 14.5 15.4 17.9 25.4 14.2 11.2 8.5 6.9 23.0 21.7 10.3 9.6 8.6 13.0 19.6 24.0 25.9 4.2 8.6 26.2 16.2 14.7 5.8 4.9 0.0 15.3 18.4 7.6 5.7 8.3 8.4 11.9 10.5 9.1 2.5 5.4 6.6 22.5 0.2 7.9 26.5 19.4 10.0 12.1 15.6 12.2 34.5 7.4 0.0 20.3 8.8 9.5 8.8 10.1 9.8 4.5 14.8 14.6 2.2 16.2 3.8 16.7 14.8 7.1 5.3 13.5 15.0 19.6 9.0 5.2 9.1 11.0 6.6 2.1 5.8 15.1 0.0 3.2 6.2 8.4 4.1 6.9 8.5 19.3 6.1 19.1 13.3 15.5 21.4 11.2 14.2 20.0 21.7 0.6 23.0 5.4 9.5 10.8 10.3 24.4 23.6 21.1 20.1 22.2 20.8 27.7 17.7 22.5 25.8 8.9 14.7 20.1 21.3 9.7 22.4 10.9 15.3 13.4 11.4 17.4 7.9 14.8 89.5 34.7 1.8 18.7 6.1 0.0 41.6 15.5 19.7 29.1 29.0 22.5 26.1 15.9 26.7 17.2 15.9 0.4 39.1 14.8 16.9 12.6 17.5 29.0 29.6 14.0 51.2 43.0 19.9 32.3 22.7 11.2 13.0 13.4 5.6 23.0 18.1 13.6 ZNF320 "DKFZp686G16228, ZFPL" ENSG00000182986 "Zinc finger protein 320" A2RRD8 19 52863790-52897693 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cholangiocytes: 17.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 24.5;U-266/84: 20.2" "HPA043696, HPA062474" Uncertain Uncertain "Nucleoplasm,Cytoplasmic bodies" NA NA Nucleoplasm "Cytoplasmic bodies" "HPA043696: AB_10793951, HPA062474: AB_2732685" "unprognostic (3.33e-2)" "unprognostic (4.43e-2)" "unprognostic (2.55e-2)" "unprognostic (2.25e-1)" "unprognostic (2.92e-2)" "unprognostic (7.12e-2)" "unprognostic (1.47e-4)" "unprognostic (8.90e-2)" "unprognostic (3.71e-3)" "unprognostic (2.75e-3)" "unprognostic (2.50e-1)" "unprognostic (2.01e-3)" "unprognostic (6.41e-3)" "unprognostic (1.32e-1)" "unprognostic (2.76e-1)" "unprognostic (7.65e-2)" "unprognostic (2.61e-3)" 6.3 8.6 10.5 8.7 11.7 8.3 9.9 15.5 12.2 10.8 9.9 9.4 27.7 7.1 13.8 12.7 7.0 11.3 9.5 9.8 9.0 7.0 11.8 2.5 7.1 6.8 9.1 10.1 15.5 10.3 17.7 15.7 15.7 10.9 12.1 10.9 9.7 9.7 23.8 7.4 13.1 7.8 8.6 11.4 9.8 8.7 6.3 12.6 8.9 13.0 5.3 6.8 19.4 11.0 5.0 3.7 5.9 3.4 10.1 5.1 2.6 3.5 0.3 4.7 10.8 0.7 1.7 8.1 1.8 1.7 3.0 3.9 1.4 1.3 3.2 3.2 2.1 1.5 1.8 0.0 0.6 1.4 0.0 1.2 4.0 4.9 0.0 2.1 0.4 4.2 2.6 1.7 3.8 0.4 1.2 2.0 2.1 3.5 0.5 2.4 0.0 3.6 3.6 5.5 0.1 3.3 4.2 6.0 4.3 1.7 24.5 4.1 8.5 0.1 2.8 1.7 4.8 3.0 0.0 2.2 1.6 3.5 0.8 3.5 6.3 20.2 2.8 0.2 0.1 2.3 3.1 3.3 2.6 3.9 3.4 3.5 3.2 2.6 2.9 2.6 5.0 4.7 5.1 5.9 10.1 2.6 3.7 2.5 2.6 10.5 11.7 15.5 12.2 9.0 7.0 9.1 10.1 10.9 12.6 3.0 1.7 2.2 5.4 1.6 7.2 10.0 17.8 1.4 4.5 1.8 9.8 8.1 0.0 0.2 3.8 5.0 5.1 0.0 0.0 5.5 4.3 6.8 1.1 0.8 3.6 15.9 10.3 5.5 1.9 2.1 4.0 1.5 3.3 0.0 9.4 5.6 0.1 3.5 2.5 0.2 12.6 0.0 2.7 3.4 5.3 3.8 6.4 0.7 4.3 6.7 ZNF322 "bA457M11.2, bA457M11.3, HCG12, ZNF322A, ZNF388, ZNF489" ENSG00000181315 "Zinc finger protein 322" Q6U7Q0 6 26634383-26659752 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043161, HPA046692" Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA043161: AB_2678346, HPA046692: AB_2679755" "unprognostic (1.01e-2)" "unprognostic (2.81e-1)" "unprognostic (5.20e-2)" "unprognostic (3.39e-3)" "prognostic favorable (1.28e-4)" "unprognostic (1.21e-1)" "unprognostic (9.35e-2)" "prognostic favorable (8.57e-4)" "unprognostic (5.24e-2)" "unprognostic (3.52e-2)" "unprognostic (2.53e-1)" "unprognostic (2.50e-1)" "unprognostic (1.73e-1)" "unprognostic (1.08e-1)" "unprognostic (3.55e-1)" "unprognostic (3.24e-2)" "unprognostic (5.71e-2)" 8.8 9.7 7.7 5.4 10.9 0.4 10.1 10.6 15.4 13.1 8.6 7.9 9.5 6.9 12.7 10.8 6.8 9.2 11.5 13.3 8.4 6.9 9.5 7.0 7.9 6.7 8.8 7.0 14.8 6.9 15.0 18.0 8.6 11.8 12.3 8.6 8.6 8.2 15.5 7.7 5.0 7.9 9.7 10.7 8.7 7.6 8.2 12.5 4.3 13.6 6.7 7.2 11.8 8.4 11.2 7.9 10.5 11.2 17.6 11.4 4.9 5.8 4.4 17.5 20.1 11.5 15.4 6.3 7.8 10.4 10.9 13.2 8.6 3.6 7.1 18.9 6.8 13.7 7.4 13.0 5.1 13.7 10.9 11.8 12.5 5.8 8.4 13.1 0.0 11.4 9.4 18.0 7.2 8.2 13.7 9.4 8.8 14.3 7.6 12.0 3.3 8.8 10.5 5.1 5.4 5.4 9.8 12.4 10.1 6.7 9.3 14.2 15.0 9.3 8.8 16.4 8.9 8.2 8.1 9.3 18.2 7.3 7.4 7.9 8.0 16.0 6.8 3.9 2.0 18.3 3.3 8.7 10.5 11.4 7.4 8.3 11.2 5.8 7.4 7.0 10.5 6.8 9.9 8.3 17.6 11.2 7.9 4.4 4.9 7.7 10.9 10.6 15.4 8.4 6.9 8.8 7.0 11.8 12.5 6.0 8.0 16.7 14.7 3.5 32.6 4.8 10.2 10.7 15.9 8.7 7.9 10.4 29.9 14.8 2.6 13.5 8.7 0.0 8.9 9.8 12.8 21.0 12.7 6.0 11.3 44.5 18.9 14.1 6.5 2.5 27.9 10.4 8.5 8.2 12.9 25.0 13.2 11.8 24.8 11.1 12.6 32.3 14.6 17.0 10.2 5.6 8.0 8.5 9.4 21.0 ZNF324 "ZF5128, ZNF324A" ENSG00000083812 "Zinc finger protein 324" O75467 19 58467045-58475436 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 35.6;Horizontal cells: 31.8;Rod photoreceptor cells: 57.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 35.6" HPA039774 Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" No No "Nucleoplasm, Nuclear membrane, Cytosol" "HPA039774: AB_10673149" "unprognostic (8.60e-2)" "unprognostic (7.42e-3)" "unprognostic (1.07e-1)" "unprognostic (1.21e-1)" "unprognostic (5.12e-3)" "unprognostic (3.69e-3)" "unprognostic (2.36e-2)" "unprognostic (5.09e-3)" "unprognostic (2.84e-1)" "unprognostic (1.57e-1)" "prognostic favorable (4.74e-5)" "unprognostic (6.39e-2)" "prognostic favorable (1.34e-7)" "unprognostic (1.19e-1)" "unprognostic (8.27e-2)" "prognostic unfavorable (6.99e-4)" "unprognostic (3.56e-1)" 7.7 8.0 8.9 11.5 10.8 12.6 7.4 15.8 14.0 9.8 8.8 11.9 10.2 8.5 12.0 9.1 12.7 10.5 9.2 7.6 9.9 9.3 6.5 10.5 7.7 10.5 10.4 11.5 14.6 15.0 10.2 12.7 7.1 7.1 10.6 6.0 7.2 11.2 13.3 5.8 11.9 7.3 8.2 9.3 8.3 8.6 8.0 9.7 16.8 11.9 8.1 10.7 9.3 7.2 6.4 6.4 13.1 5.0 6.0 11.8 3.4 4.1 5.2 3.6 5.4 4.1 3.6 3.9 3.3 4.2 3.4 3.1 4.6 2.1 6.5 3.2 2.8 4.9 5.3 4.6 4.6 1.6 5.6 35.6 4.5 4.0 2.2 3.3 7.5 5.3 2.7 5.8 4.8 2.2 3.9 2.4 5.6 6.3 4.2 3.7 3.3 6.7 4.1 2.8 4.4 7.9 7.2 4.5 4.1 2.4 8.3 7.3 5.7 3.7 6.0 2.6 2.9 3.0 5.5 4.2 10.3 2.3 3.6 5.7 6.2 6.2 3.3 5.2 3.6 3.2 2.3 4.7 7.2 9.5 5.0 10.7 5.3 7.6 10.5 3.2 6.4 11.8 8.9 13.1 6.0 3.9 6.4 7.2 3.4 8.9 10.8 15.8 14.0 9.9 9.3 10.4 11.5 7.1 9.7 0.0 1.7 5.1 4.5 8.0 35.6 5.6 2.5 2.7 3.4 0.0 23.6 4.1 0.0 4.0 0.9 4.2 9.2 0.0 3.6 3.2 4.6 5.2 1.1 2.9 2.5 31.8 7.5 5.5 1.8 0.7 11.8 3.6 3.3 1.8 5.0 16.4 3.2 7.4 13.8 1.4 57.5 6.5 7.8 10.7 13.8 11.7 5.6 8.7 5.6 4.1 ZNF326 "FLJ20403, ZAN75, Zfp326, ZIRD" ENSG00000162664 "Zinc finger protein 326" Q5BKZ1 1 89995112-90035531 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Bipolar cells: 134.9;Cone photoreceptor cells: 351.5;Rod photoreceptor cells: 448.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028450, HPA028461, HPA028466" Supported Enhanced "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "HPA028450: AB_2672616, HPA028461: AB_10601777, HPA028466: AB_10601677" "prognostic favorable (9.46e-4)" "unprognostic (2.45e-1)" "unprognostic (7.25e-3)" "unprognostic (1.09e-1)" "unprognostic (5.28e-3)" "unprognostic (1.67e-2)" "unprognostic (8.61e-3)" "unprognostic (1.70e-2)" "unprognostic (1.58e-1)" "unprognostic (3.17e-2)" "unprognostic (3.66e-2)" "unprognostic (1.33e-2)" "unprognostic (2.62e-2)" "unprognostic (8.59e-2)" "unprognostic (1.33e-1)" "unprognostic (2.29e-1)" "prognostic favorable (2.84e-4)" 12.7 13.4 18.4 12.7 27.8 45.2 17.7 20.2 18.5 11.8 14.1 23.2 16.3 18.5 18.3 17.1 17.5 11.9 13.9 12.5 19.2 15.2 13.4 15.2 11.5 15.3 26.1 14.1 21.8 20.2 14.4 18.0 14.5 22.8 13.3 20.7 23.9 15.7 9.4 19.2 14.5 18.9 17.8 31.3 11.0 14.6 10.6 27.8 17.3 14.1 10.5 15.1 11.9 17.2 6.8 8.4 3.6 6.1 7.8 4.3 2.2 17.2 15.8 24.6 11.7 11.0 5.2 26.0 17.5 6.8 14.5 9.1 14.6 12.6 21.6 12.5 9.0 16.0 15.6 25.6 11.4 20.0 12.6 12.3 19.5 15.4 13.3 3.7 22.9 9.6 4.6 5.4 14.4 9.2 10.2 8.4 10.1 26.0 9.4 11.7 8.2 23.6 13.0 23.1 14.6 18.0 16.8 24.9 5.8 12.0 19.4 21.6 14.0 20.1 18.7 8.5 18.2 10.3 6.0 11.4 17.1 17.2 14.4 17.3 8.0 7.9 21.6 4.1 18.1 10.9 2.1 5.1 3.6 4.0 6.1 3.2 4.2 3.2 3.4 4.0 6.8 3.2 4.3 2.5 7.8 4.6 8.4 2.8 2.2 18.4 27.8 20.2 18.5 19.2 15.2 26.1 14.1 22.8 27.8 20.8 44.0 32.0 53.5 57.9 134.9 34.4 15.3 45.5 44.3 22.7 351.5 36.5 16.6 45.3 3.4 38.7 63.7 0.0 48.0 73.0 29.8 46.9 48.7 28.0 22.6 65.2 67.4 24.5 16.4 4.2 40.0 32.7 37.1 46.9 33.4 49.5 37.7 66.6 31.8 14.7 448.1 25.8 38.7 58.0 40.9 39.5 41.3 22.4 36.2 68.1 ZNF329 FLJ12586 ENSG00000181894 "Zinc finger protein 329" Q86UD4 19 58126252-58155110 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 11.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044373, HPA077958" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA044373: AB_10966569, HPA077958: " "unprognostic (3.24e-1)" "unprognostic (1.36e-1)" "unprognostic (2.36e-1)" "unprognostic (6.01e-2)" "unprognostic (2.58e-1)" "unprognostic (6.53e-3)" "unprognostic (1.27e-2)" "unprognostic (1.28e-1)" "unprognostic (1.80e-2)" "unprognostic (1.29e-2)" "unprognostic (1.49e-2)" "unprognostic (2.19e-3)" "prognostic favorable (8.58e-9)" "unprognostic (9.23e-2)" "unprognostic (1.37e-2)" "unprognostic (1.78e-2)" "unprognostic (2.52e-1)" 7.1 7.2 9.2 5.2 11.7 10.3 11.7 15.9 14.7 10.8 6.9 8.1 5.7 3.5 10.6 10.7 5.6 10.5 7.0 6.7 9.2 10.0 11.8 8.0 6.9 6.8 8.5 6.7 11.2 5.4 20.4 10.7 7.9 10.6 10.1 6.1 9.7 7.1 9.1 2.7 7.2 5.9 9.6 6.5 8.2 6.1 23.7 7.6 8.6 11.3 3.5 8.0 8.7 15.1 8.0 5.0 6.4 1.7 5.3 7.6 2.2 3.2 1.7 7.7 13.3 6.2 6.4 0.1 4.2 8.9 4.6 3.5 1.4 2.5 2.0 2.3 7.5 2.8 1.1 1.3 5.8 5.7 1.5 10.3 6.6 2.3 2.4 6.0 3.9 6.4 6.6 6.2 4.5 9.3 7.4 6.0 4.7 1.6 8.8 6.6 1.1 6.8 2.4 5.8 1.7 5.6 3.7 7.6 2.0 4.9 6.6 5.1 4.8 6.7 0.8 3.3 10.4 7.7 2.2 3.6 12.1 3.3 1.1 0.0 5.2 15.4 4.9 2.6 0.1 6.9 4.8 1.6 6.4 2.5 1.7 4.4 5.8 4.8 4.3 2.1 8.0 7.6 4.6 4.9 5.3 1.1 5.0 2.1 2.2 9.2 11.7 15.9 14.7 9.2 10.0 8.5 6.7 10.6 7.6 3.0 0.3 0.0 2.1 1.4 11.9 4.0 7.6 1.4 3.4 3.5 5.9 1.9 1.7 2.0 1.1 3.8 0.5 0.0 1.4 1.1 1.8 1.5 2.3 3.4 1.3 7.9 2.4 3.7 1.3 1.3 2.6 1.7 0.0 0.0 1.6 5.6 0.9 0.2 1.4 1.7 7.5 0.0 1.9 5.8 6.1 1.4 1.3 4.4 1.4 1.4 ZNF331 "RITA, ZNF361, ZNF463" ENSG00000130844 "Zinc finger protein 331" Q9NQX6 19 53520981-53580269 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 66.4;ovary: 86.4" "Cell type enhanced" "Detected in many" 7 "granulocytes: 234.6;Smooth muscle cells: 196.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 36.4;RT4: 27.8" "Low region specificity" "Detected in all" HPA063157 Approved Nucleoplasm NA NA Nucleoplasm "HPA063157: AB_2684951" "unprognostic (2.19e-1)" "unprognostic (1.79e-1)" "unprognostic (5.18e-2)" "unprognostic (1.55e-2)" "unprognostic (4.24e-1)" "unprognostic (8.16e-2)" "unprognostic (7.62e-3)" "unprognostic (3.25e-2)" "unprognostic (1.84e-2)" "unprognostic (4.40e-2)" "unprognostic (5.68e-3)" "unprognostic (2.69e-1)" "unprognostic (4.73e-2)" "prognostic unfavorable (4.79e-4)" "unprognostic (2.08e-1)" "prognostic unfavorable (7.43e-4)" "unprognostic (6.74e-2)" 19.1 66.4 6.8 9.0 8.2 18.6 10.5 11.4 9.5 9.4 5.3 8.4 8.9 2.1 9.5 11.6 4.9 19.5 23.8 15.5 5.1 7.7 6.6 6.1 15.6 4.0 6.8 5.5 86.4 9.9 11.3 29.0 23.3 7.2 10.2 4.2 9.9 4.7 31.5 6.3 5.2 4.8 8.5 9.1 4.5 6.3 8.1 6.0 3.8 7.8 4.4 4.8 25.7 9.2 8.1 4.1 6.5 7.4 4.6 14.7 5.2 0.1 5.1 10.3 11.8 8.0 5.9 17.2 7.3 6.5 5.6 10.2 5.5 2.6 4.1 1.9 4.3 2.6 3.0 7.4 5.5 10.0 0.0 36.4 5.1 8.7 3.3 5.8 3.2 7.2 5.9 3.6 6.2 3.0 3.1 2.5 6.4 0.2 1.6 5.5 3.6 7.2 6.8 4.6 0.1 7.6 8.9 6.5 4.2 3.3 27.8 7.3 7.4 3.4 9.7 2.4 21.4 1.7 2.9 2.6 7.9 7.0 4.6 4.8 20.3 13.2 7.7 0.1 0.4 6.1 0.5 4.9 6.5 8.7 3.8 13.4 8.1 9.4 8.8 3.6 8.1 14.7 9.7 0.7 4.6 7.4 4.1 9.4 5.2 6.8 8.2 11.4 9.5 5.1 7.7 6.8 5.5 7.2 6.0 17.9 70.7 15.9 15.3 39.8 52.9 16.5 7.6 17.4 20.5 73.3 27.5 32.9 8.3 2.9 128.2 19.9 2.1 0.0 3.6 30.4 36.8 11.9 234.6 3.9 60.1 28.6 22.5 14.7 33.7 61.5 22.5 79.8 43.9 3.6 5.1 25.1 2.3 3.5 18.4 3.7 35.8 0.0 196.7 34.4 19.8 44.3 37.2 74.7 3.2 9.4 ZNF333 KIAA1806 ENSG00000160961 "Zinc finger protein 333" Q96JL9 19 14689801-14733746 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043973, HPA054680" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA043973: AB_10961277, HPA054680: AB_2682571" "unprognostic (8.16e-2)" "unprognostic (2.80e-4)" "unprognostic (5.21e-2)" "unprognostic (2.83e-1)" "unprognostic (1.21e-2)" "unprognostic (1.45e-3)" "unprognostic (2.98e-2)" "unprognostic (2.17e-3)" "unprognostic (2.12e-2)" "unprognostic (1.46e-1)" "unprognostic (4.87e-3)" "unprognostic (3.46e-2)" "unprognostic (1.32e-5)" "unprognostic (4.09e-2)" "unprognostic (1.45e-1)" "unprognostic (2.62e-1)" "unprognostic (7.06e-3)" 10.7 8.1 8.8 7.8 11.3 12.2 9.4 16.2 12.1 11.4 9.9 14.3 7.0 4.5 16.5 11.0 5.3 10.8 6.6 6.3 8.6 6.9 5.8 4.9 8.7 7.3 16.8 9.8 15.3 9.1 8.2 7.5 7.4 10.3 8.8 5.9 10.3 5.7 8.5 14.5 7.7 6.5 11.6 9.6 13.0 6.7 8.8 12.8 6.7 6.9 4.3 6.6 9.5 8.8 2.7 4.9 7.9 5.0 13.5 5.4 2.4 1.5 0.9 5.8 7.8 8.4 7.9 2.2 3.5 4.9 3.1 4.5 0.4 1.4 2.4 4.0 4.6 1.0 1.5 2.0 1.4 4.6 5.6 1.5 9.9 2.1 2.4 6.9 4.0 5.7 7.3 3.9 2.9 8.2 4.3 4.5 3.0 2.0 4.8 3.9 0.8 2.6 9.5 2.3 3.3 1.8 3.7 3.3 2.3 3.0 2.1 3.2 6.2 3.2 0.4 5.7 2.5 1.5 6.7 7.2 5.3 2.4 8.5 3.7 2.3 1.0 2.5 5.5 6.9 6.2 7.9 4.0 6.0 4.0 5.0 5.4 2.6 3.6 3.0 4.9 2.7 4.1 3.6 7.0 13.5 4.3 2.4 3.0 2.4 8.8 11.3 16.2 12.1 8.6 6.9 16.8 9.8 10.3 12.8 6.0 8.3 1.7 5.0 2.7 12.5 2.7 0.0 4.0 2.3 3.5 3.9 2.5 1.7 2.2 4.6 6.5 1.1 0.0 2.6 2.1 5.9 3.7 16.1 1.8 4.4 7.9 2.4 6.7 9.9 2.5 9.2 6.5 1.7 4.6 1.0 5.2 2.1 2.5 8.5 1.3 17.7 12.9 6.2 10.8 6.8 2.4 1.1 4.9 2.2 3.1 ZNF334 bA179N14.1 ENSG00000198185 "Zinc finger protein 334" Q9HCZ1 20 46499630-46513559 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ciliated cells: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "NK-cell: 2.7;plasmacytoid DC: 3.6" "Group enriched" "Detected in many" 5 "dendritic cells: 3.6;NK-cells: 2.7" "Cell line enhanced" "Detected in many" "AF22: 12.1;BEWO: 15.2;NTERA-2: 8.1;SCLC-21H: 10.1;SuSa: 18.1" "Low region specificity" "Detected in all" HPA050022 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA050022: AB_2680994" "unprognostic (3.04e-2)" "unprognostic (1.28e-2)" "unprognostic (3.68e-1)" "unprognostic (2.74e-4)" "unprognostic (9.08e-2)" "unprognostic (5.26e-2)" "unprognostic (1.15e-2)" "unprognostic (2.49e-1)" "unprognostic (3.67e-2)" "unprognostic (3.62e-2)" "unprognostic (8.25e-2)" "unprognostic (8.12e-2)" "unprognostic (4.14e-2)" "unprognostic (5.55e-3)" "unprognostic (1.88e-1)" "unprognostic (2.92e-2)" "unprognostic (1.71e-3)" 3.1 7.3 11.1 2.2 14.3 1.9 9.5 18.2 12.0 6.4 2.6 8.1 11.5 2.9 9.2 13.4 2.4 12.1 5.8 2.1 9.8 7.8 6.8 4.1 4.7 2.1 5.8 6.9 22.5 7.5 2.9 20.4 7.0 11.5 12.8 3.5 7.0 6.8 10.0 1.5 3.0 3.8 4.9 7.6 3.1 7.0 8.3 8.8 2.7 10.8 1.7 1.8 5.2 4.5 0.4 3.6 0.2 0.5 2.7 0.1 0.1 0.0 0.0 12.1 0.0 0.8 0.1 15.2 1.0 0.1 0.9 0.1 0.0 3.1 0.0 0.0 0.3 3.7 0.0 0.0 0.2 0.4 0.0 2.5 3.8 0.1 4.3 3.3 0.0 0.0 3.9 0.0 1.0 0.0 0.5 0.1 0.1 2.5 0.0 0.1 0.0 0.0 6.8 8.1 2.0 1.0 0.0 0.0 0.0 3.3 2.9 10.1 5.7 0.0 0.3 0.2 18.1 0.0 3.4 0.0 0.1 5.5 0.1 0.0 0.9 4.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.4 0.1 0.0 0.2 0.2 0.1 0.0 0.1 2.7 0.0 3.6 0.0 0.1 11.1 14.3 18.2 12.0 9.8 7.8 5.8 6.9 11.5 8.8 8.9 5.0 0.0 3.4 0.1 11.8 1.4 2.5 13.4 9.1 3.5 2.0 3.6 5.0 3.8 0.4 1.1 0.0 0.0 1.1 3.1 2.0 2.2 2.3 1.0 1.4 9.5 0.0 3.7 0.0 1.3 2.6 0.0 0.0 0.0 1.3 11.0 1.9 0.0 1.8 2.8 11.0 0.0 1.6 5.1 7.7 0.0 0.8 0.0 1.6 1.4 ZNF335 "bA465L10.2, NIF-1" ENSG00000198026 "Zinc finger protein 335" Q9H4Z2 20 45948653-45972172 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063999, HPA071230" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063999: AB_2685170, HPA071230: AB_2686369" "unprognostic (1.50e-1)" "unprognostic (8.05e-2)" "unprognostic (8.29e-3)" "unprognostic (7.85e-2)" "unprognostic (1.35e-2)" "prognostic favorable (4.48e-4)" "prognostic unfavorable (1.59e-4)" "unprognostic (2.74e-2)" "unprognostic (1.01e-1)" "unprognostic (7.91e-2)" "unprognostic (1.30e-3)" "prognostic unfavorable (7.04e-4)" "prognostic unfavorable (2.77e-5)" "unprognostic (4.10e-1)" "unprognostic (1.94e-1)" "unprognostic (2.44e-1)" "unprognostic (2.88e-3)" 10.5 8.3 12.0 12.2 13.6 28.8 10.7 17.9 15.7 10.5 10.3 9.7 4.0 11.5 14.2 5.2 11.2 12.3 8.2 7.0 10.7 5.0 8.6 7.8 10.4 15.0 8.1 11.6 15.2 10.5 13.2 10.4 13.7 8.2 10.7 6.7 8.4 12.0 9.2 12.3 22.9 13.5 7.9 7.6 13.9 10.6 16.5 10.1 19.4 14.9 8.8 12.0 11.4 9.5 3.7 3.6 5.0 4.5 8.9 7.3 3.5 9.1 9.3 8.3 9.0 4.4 5.6 17.7 8.2 5.7 8.2 5.9 20.1 10.3 11.0 12.2 8.0 7.5 13.2 8.0 12.3 3.7 7.5 10.9 9.1 13.6 10.6 6.9 11.8 15.6 9.0 10.5 10.7 7.7 5.9 7.0 11.6 8.6 14.8 5.6 18.6 13.9 11.5 5.7 6.2 15.4 11.5 5.5 9.2 7.2 14.4 8.4 7.4 12.2 17.2 8.6 5.2 13.0 9.8 7.3 17.7 7.7 11.2 11.1 17.3 8.8 11.4 14.3 7.4 9.7 2.4 3.5 5.0 7.3 4.5 3.7 3.3 3.6 4.9 3.6 3.7 3.1 3.4 3.6 8.9 3.6 2.5 3.6 3.5 12.0 13.6 17.9 15.7 10.7 5.0 8.1 11.6 8.2 10.1 11.9 15.9 11.8 11.4 16.7 17.4 2.8 2.5 1.4 4.5 1.8 25.5 7.2 0.0 3.9 22.2 8.3 13.7 0.0 5.1 7.0 7.8 9.9 6.9 5.7 5.3 12.7 20.6 7.4 6.4 17.7 6.9 10.2 8.5 2.8 9.2 5.8 6.6 10.5 4.9 1.9 11.1 0.0 8.6 3.7 8.3 19.6 10.0 16.2 9.1 11.4 ZNF34 KOX32 ENSG00000196378 "Zinc finger protein 34" Q8IZ26 8 144773114-144787345 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA053925, HPA060755, HPA066805" Uncertain Enhanced Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA053925: AB_2682311, HPA060755: AB_2684354, HPA066805: AB_2685725" "unprognostic (2.54e-1)" "unprognostic (3.50e-1)" "unprognostic (5.01e-2)" "unprognostic (7.60e-2)" "unprognostic (1.98e-1)" "unprognostic (1.67e-2)" "unprognostic (3.26e-2)" "unprognostic (3.54e-2)" "unprognostic (2.85e-2)" "unprognostic (1.40e-2)" "unprognostic (9.84e-3)" "unprognostic (1.46e-1)" "unprognostic (3.46e-3)" "unprognostic (5.80e-2)" "unprognostic (2.09e-3)" "unprognostic (1.56e-1)" "unprognostic (1.30e-1)" 9.0 5.7 12.3 4.1 11.5 4.6 8.6 28.5 14.4 10.0 9.4 12.6 7.8 3.6 10.0 8.0 6.3 10.4 6.6 7.5 13.4 7.8 6.4 6.5 7.5 5.8 17.2 13.8 17.0 7.8 12.5 11.5 7.6 12.2 8.7 6.0 8.3 5.6 12.7 5.9 8.0 5.4 10.7 11.8 6.0 5.9 7.1 16.0 4.1 11.1 1.8 4.7 8.7 7.8 7.2 10.4 12.7 15.2 5.5 8.5 5.0 3.0 5.3 8.9 6.6 7.6 7.4 2.4 2.9 6.2 7.3 6.1 1.2 5.1 5.0 5.5 7.3 4.2 3.1 5.1 5.8 5.5 4.9 4.3 9.6 8.2 4.0 6.9 2.5 5.0 7.9 6.8 5.8 11.9 7.5 4.9 3.2 6.4 4.1 6.3 7.8 5.5 3.9 6.4 7.1 5.6 5.0 3.6 6.0 4.1 3.1 8.4 6.3 6.7 4.7 4.5 5.9 5.3 3.2 3.5 6.7 5.9 5.6 5.6 5.1 1.7 5.7 4.9 4.1 8.0 8.1 7.0 12.7 7.4 6.4 6.5 6.8 6.9 8.5 10.4 7.2 4.9 7.4 1.0 5.5 15.2 4.9 5.4 5.0 12.3 11.5 28.5 14.4 13.4 7.8 17.2 13.8 12.2 16.0 6.0 3.2 0.9 1.5 3.3 7.1 2.0 0.0 1.4 4.5 0.0 0.0 2.2 5.0 2.7 6.0 4.9 1.3 0.0 1.2 2.1 3.3 1.5 4.7 2.4 1.6 12.7 0.0 3.7 1.9 5.5 6.6 3.1 3.3 12.6 1.9 5.4 1.2 1.9 4.6 1.4 8.7 6.5 4.7 9.3 6.3 4.3 1.9 4.1 2.3 0.7 ZNF341 dJ553F4.3 ENSG00000131061 "Zinc finger protein 341" Q9BYN7 20 33731657-33792269 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Club cells: 6.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023240, HPA024607, HPA067108" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" Yes No "Nucleoplasm, Vesicles" "Nuclear bodies" "HPA023240: AB_1859207, HPA024607: AB_1859208, HPA067108: AB_2685780" "unprognostic (1.74e-1)" "unprognostic (2.18e-1)" "unprognostic (3.73e-1)" "unprognostic (2.10e-1)" "unprognostic (9.31e-2)" "prognostic favorable (3.93e-4)" "prognostic unfavorable (1.87e-4)" "unprognostic (2.44e-1)" "unprognostic (1.70e-1)" "unprognostic (1.80e-1)" "unprognostic (7.38e-2)" "unprognostic (9.31e-2)" "unprognostic (8.17e-5)" "unprognostic (4.84e-2)" "unprognostic (2.90e-1)" "unprognostic (8.67e-3)" "unprognostic (3.68e-2)" 4.5 4.3 7.3 6.9 10.4 7.7 5.1 10.4 9.1 6.5 4.9 7.2 2.1 5.8 6.5 3.5 6.7 5.4 5.2 4.5 6.8 3.1 3.1 3.6 4.7 5.5 8.8 6.3 5.5 5.4 4.0 5.2 5.4 4.9 4.9 4.9 3.7 5.7 6.9 7.2 8.2 5.0 4.9 4.2 5.8 4.5 7.4 6.9 4.9 4.9 2.9 4.7 6.5 5.5 2.6 1.5 5.9 2.4 2.2 2.4 1.4 1.8 8.3 3.0 4.0 3.0 2.1 11.2 2.8 1.7 2.7 1.3 6.2 5.3 3.8 3.8 2.0 3.0 3.6 2.8 4.9 0.9 3.7 2.8 4.3 3.4 2.9 1.1 2.4 4.7 2.1 3.0 2.1 1.2 2.3 2.7 4.5 2.2 1.6 2.4 3.8 2.2 1.0 2.6 3.5 4.2 2.6 1.3 1.8 1.5 6.4 2.1 1.9 8.2 5.5 1.0 2.4 6.3 2.2 2.1 3.5 1.2 0.9 2.2 1.2 1.6 2.9 4.3 1.6 2.7 3.5 1.9 5.9 1.9 2.4 1.6 2.6 1.2 1.3 1.5 2.5 1.1 2.4 3.8 2.2 1.5 1.1 1.0 1.4 7.3 10.4 10.4 9.1 6.8 3.1 8.8 6.3 4.9 6.9 3.0 6.1 4.7 1.0 0.3 2.3 2.0 2.5 5.3 6.8 1.8 2.0 2.2 0.0 1.5 0.5 0.7 4.2 0.0 1.2 2.6 1.3 1.9 2.3 0.8 1.2 1.6 1.2 1.3 2.2 0.0 0.6 2.5 0.0 0.0 2.1 0.2 1.6 0.8 0.4 0.3 2.1 0.0 0.6 1.1 2.2 0.9 1.7 0.0 1.3 1.8 ZNF343 MGC10715 ENSG00000088876 "Zinc finger protein 343" Q6P1L6 20 2481817-2524702 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 7.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA030587, HPA052438" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA030587: AB_10603246, HPA052438: AB_2681833" "unprognostic (5.77e-2)" "unprognostic (1.31e-1)" "unprognostic (1.66e-1)" "unprognostic (6.75e-3)" "unprognostic (3.83e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.38e-6)" "unprognostic (9.26e-2)" "unprognostic (3.03e-2)" "unprognostic (2.06e-1)" "unprognostic (4.88e-1)" "unprognostic (5.60e-2)" "prognostic unfavorable (4.53e-5)" "unprognostic (1.65e-1)" "unprognostic (3.71e-1)" "unprognostic (3.41e-2)" "unprognostic (9.53e-2)" 11.6 8.6 10.4 8.0 11.9 3.9 12.4 20.6 15.0 10.6 12.3 10.7 8.5 5.1 13.9 18.0 8.9 10.6 8.1 7.8 10.0 7.1 9.3 8.0 9.4 9.9 9.1 7.6 12.7 12.8 17.2 10.9 9.4 10.4 10.2 10.1 9.0 8.7 10.4 13.8 11.3 7.5 13.0 9.1 8.2 8.9 7.5 9.5 5.4 11.4 6.6 9.8 11.3 12.9 8.9 5.3 4.5 3.9 1.8 7.6 3.0 9.6 10.4 7.0 7.7 8.1 8.4 2.5 6.7 7.6 8.4 8.7 5.4 5.7 12.4 2.6 6.8 9.6 9.2 10.8 12.3 10.9 3.3 5.3 8.0 4.6 10.7 7.3 4.8 3.0 7.6 12.4 10.1 16.3 8.8 8.2 9.7 10.4 6.3 7.9 3.4 10.3 3.2 7.1 8.4 11.1 8.5 9.5 7.4 4.2 2.6 8.2 13.1 8.5 14.0 8.0 6.0 4.9 4.1 5.3 11.6 5.3 8.4 7.7 12.9 20.6 6.4 3.1 6.6 6.7 0.6 3.9 4.5 5.1 3.8 5.4 7.0 6.3 4.4 3.9 8.9 5.8 7.6 3.3 1.8 3.4 5.3 5.7 3.0 10.4 11.9 20.6 15.0 10.0 7.1 9.1 7.6 10.4 9.5 3.0 1.0 2.4 1.3 1.8 4.5 1.6 0.0 1.4 3.4 1.8 0.0 2.0 1.7 1.9 0.6 2.1 1.1 0.0 0.8 1.1 2.1 1.2 1.1 2.4 1.2 7.9 2.9 1.8 1.0 0.0 3.7 1.2 1.7 1.0 2.0 2.7 1.9 0.0 2.8 2.5 2.9 0.0 3.1 3.9 3.3 1.9 0.7 1.5 1.8 1.3 ZNF346 "JAZ, Zfp346" ENSG00000113761 "Zinc finger protein 346" Q9UL40 5 177022696-177081189 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018485 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA018485: AB_1859213" "unprognostic (1.89e-1)" "unprognostic (4.25e-2)" "unprognostic (5.71e-3)" "prognostic unfavorable (9.54e-5)" "unprognostic (9.85e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (1.88e-7)" "unprognostic (2.69e-2)" "unprognostic (1.45e-2)" "unprognostic (2.13e-1)" "prognostic favorable (1.20e-4)" "unprognostic (5.11e-2)" "unprognostic (7.86e-2)" "unprognostic (8.60e-2)" "unprognostic (1.61e-1)" "unprognostic (2.36e-2)" "unprognostic (1.44e-2)" 9.0 12.1 17.0 14.8 21.3 10.6 12.4 26.8 21.6 13.2 10.7 15.2 11.2 9.1 17.4 16.0 13.8 16.9 10.0 11.4 14.7 14.3 11.5 10.1 8.9 13.2 10.9 19.3 27.0 12.5 16.1 19.0 10.0 13.6 13.0 10.7 14.7 11.1 15.1 16.7 14.7 9.2 18.0 10.5 13.1 9.7 16.8 12.5 15.8 19.6 9.1 17.4 10.8 12.1 7.3 4.0 5.9 3.7 17.0 8.5 4.5 4.2 7.2 12.8 17.5 6.7 6.9 10.3 7.3 7.9 12.3 13.6 9.8 6.6 11.0 8.3 7.5 10.6 5.9 12.4 11.7 11.9 33.8 10.1 7.5 9.0 8.6 8.0 12.4 7.1 6.8 7.1 11.8 8.6 7.4 13.8 13.1 8.9 7.1 5.7 13.7 16.4 6.2 5.7 5.5 12.9 17.6 8.9 5.1 8.5 5.1 16.3 7.0 9.5 6.9 6.0 6.6 9.6 6.7 7.8 9.9 7.7 6.6 8.0 6.3 6.9 12.9 4.0 10.6 8.1 0.3 3.7 5.9 8.5 3.5 5.4 5.1 5.9 5.5 4.0 7.3 7.5 7.5 3.9 17.0 3.5 3.6 5.6 4.5 17.0 21.3 26.8 21.6 14.7 14.3 10.9 19.3 13.6 12.5 0.0 5.9 6.1 2.8 2.6 11.8 3.4 7.6 0.0 3.4 5.2 5.9 7.9 8.3 5.2 2.1 6.3 2.8 0.0 5.0 4.6 3.9 1.0 2.3 3.2 4.9 7.9 4.6 3.7 2.7 4.0 4.6 2.2 3.3 3.6 3.2 8.4 3.4 2.6 6.0 3.6 6.1 0.0 4.2 10.8 10.2 4.3 2.7 5.2 2.8 1.6 ZNF35 "HF.10, HF10, Zfp105" ENSG00000169981 "Zinc finger protein 35" P13682 3 44648727-44660791 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 15.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051859, HPA054738" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA051859: AB_2681642, HPA054738: AB_2682588" "unprognostic (1.54e-1)" "unprognostic (1.81e-1)" "unprognostic (1.77e-2)" "unprognostic (1.41e-1)" "unprognostic (8.91e-3)" "unprognostic (9.91e-2)" "unprognostic (6.68e-2)" "unprognostic (1.48e-1)" "unprognostic (2.01e-2)" "unprognostic (4.54e-2)" "unprognostic (1.47e-2)" "unprognostic (1.69e-2)" "unprognostic (9.08e-3)" "unprognostic (1.23e-1)" "unprognostic (8.64e-2)" "unprognostic (1.60e-3)" "unprognostic (3.30e-1)" 8.8 5.9 8.3 6.2 10.4 6.2 8.2 8.7 11.5 8.1 8.3 8.4 7.2 5.2 10.8 11.0 8.8 6.4 6.8 7.9 7.3 6.3 10.2 4.5 7.1 5.3 8.2 7.0 6.4 6.3 8.4 15.3 5.9 10.8 8.7 6.6 7.7 7.2 8.8 8.1 7.9 7.6 12.0 8.5 11.9 7.4 17.7 7.5 3.9 7.9 8.4 8.8 8.3 7.0 4.0 3.9 1.5 4.0 4.6 2.4 1.9 3.1 2.4 6.3 8.0 4.1 3.3 1.2 3.8 5.4 6.8 6.5 4.2 1.4 2.7 1.7 5.3 3.0 2.3 0.3 5.5 7.1 0.0 2.2 9.0 4.4 0.2 3.8 8.9 6.9 3.4 4.3 6.1 5.5 3.3 5.4 0.1 6.0 2.6 7.4 2.0 0.2 2.9 13.9 2.3 6.7 0.1 6.7 4.7 3.6 8.9 3.5 9.0 4.9 3.0 0.8 5.4 8.0 5.6 5.5 7.3 5.3 3.9 7.6 7.2 11.0 1.5 6.2 4.4 5.6 0.0 3.8 1.5 2.2 4.0 1.4 3.6 0.6 2.4 3.9 4.0 1.1 1.2 0.2 4.6 3.7 1.6 0.2 1.9 8.3 10.4 8.7 11.5 7.3 6.3 8.2 7.0 10.8 7.5 6.0 8.3 6.1 3.3 2.5 4.5 2.8 5.1 5.3 3.4 1.8 0.0 0.2 1.7 6.5 8.0 4.9 1.6 0.0 7.6 0.1 2.6 2.8 0.0 0.4 3.3 6.4 2.4 4.3 4.0 4.9 1.1 3.8 1.7 3.6 1.5 4.3 7.5 2.0 4.2 2.4 6.2 0.0 3.1 15.4 9.6 2.5 0.3 2.2 2.3 3.0 ZNF350 "ZBRK1, ZFQR" ENSG00000256683 "Zinc finger protein 350" Q9GZX5 19 51964343-51986856 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "prostate cancer: 16.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA001521 Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA001521: AB_1080705" "unprognostic (7.26e-3)" "unprognostic (4.02e-2)" "unprognostic (2.51e-2)" "unprognostic (5.84e-2)" "unprognostic (1.03e-2)" "unprognostic (4.17e-2)" "unprognostic (7.08e-2)" "unprognostic (6.64e-2)" "unprognostic (2.08e-2)" "unprognostic (1.30e-1)" "unprognostic (1.76e-1)" "unprognostic (3.25e-3)" "unprognostic (6.64e-3)" "unprognostic (1.19e-2)" "unprognostic (3.16e-1)" "unprognostic (8.30e-2)" "prognostic favorable (2.54e-4)" 10.5 6.5 10.1 5.9 14.4 25.6 16.3 19.9 10.2 8.8 8.3 9.2 7.1 6.4 9.8 10.3 8.0 7.5 6.3 8.4 13.4 6.5 9.0 6.3 7.5 10.1 14.8 10.9 10.6 6.9 9.0 14.2 10.4 10.0 32.1 10.7 6.3 8.3 8.0 10.3 9.5 12.9 7.9 14.9 11.4 8.5 8.1 14.0 13.6 12.5 6.7 10.1 11.6 7.6 10.1 8.4 29.8 9.0 13.0 12.0 4.9 0.7 4.4 5.6 6.5 7.6 6.7 1.1 4.7 6.2 4.6 9.4 0.0 3.3 1.9 3.6 5.1 8.8 5.5 5.0 6.5 6.4 0.0 10.0 7.9 6.7 3.9 6.4 2.0 10.1 10.3 9.7 6.1 7.0 9.3 5.4 3.3 2.1 0.1 5.7 2.6 7.9 9.3 3.5 0.4 6.5 3.8 8.3 6.3 7.4 11.4 4.6 6.2 0.0 5.7 4.5 8.1 9.5 7.3 5.5 5.0 3.7 3.0 4.5 1.6 2.5 2.6 1.0 0.1 5.4 29.8 7.1 15.6 10.6 7.8 10.8 10.1 10.2 10.2 8.4 10.0 12.0 9.5 19.4 13.0 9.0 5.5 8.1 4.9 10.1 14.4 19.9 10.2 13.4 6.5 14.8 10.9 10.0 14.0 0.0 5.3 6.7 9.8 5.3 9.2 6.2 2.5 8.1 11.4 8.7 11.8 9.9 6.6 5.8 8.8 6.8 5.1 0.0 4.6 8.5 6.6 15.3 11.5 2.4 7.3 6.4 7.0 6.2 9.7 1.5 10.3 11.4 11.8 9.0 6.3 7.0 4.9 5.3 5.6 4.1 12.1 0.0 8.9 7.9 5.3 6.0 19.3 17.5 4.5 11.1 ZNF354A "EZNF, HKL1, KID-1, KID1, TCF17" ENSG00000169131 "Zinc finger protein 354A" O60765 5 178694605-178730702 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 29.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052043 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA052043: AB_2681706" "unprognostic (2.79e-1)" "unprognostic (3.44e-2)" "unprognostic (7.06e-3)" "unprognostic (1.78e-3)" "unprognostic (1.38e-1)" "unprognostic (1.32e-1)" "unprognostic (3.25e-2)" "unprognostic (1.41e-1)" "unprognostic (7.66e-3)" "prognostic favorable (8.28e-4)" "unprognostic (4.06e-2)" "unprognostic (4.55e-2)" "prognostic unfavorable (3.45e-6)" "unprognostic (8.71e-2)" "unprognostic (4.13e-1)" "unprognostic (1.13e-1)" "unprognostic (1.07e-2)" 14.0 7.0 13.0 12.1 13.6 14.2 14.2 13.3 14.4 12.6 15.0 6.7 11.4 7.1 13.7 13.3 10.4 11.7 9.8 14.5 13.2 9.3 18.0 6.2 10.8 12.7 16.7 16.1 10.9 15.0 11.7 14.1 14.0 13.4 13.3 10.0 7.1 8.8 15.1 11.9 12.3 10.6 13.6 12.9 17.1 10.4 14.0 14.4 13.1 15.1 8.6 14.2 17.0 25.1 5.7 5.3 15.0 5.8 6.0 6.4 3.6 4.3 3.4 7.1 18.8 12.4 10.1 29.4 5.0 6.7 7.0 7.5 5.0 7.3 5.8 6.6 4.5 12.9 8.6 2.6 21.3 10.8 7.7 8.1 1.7 4.2 0.6 9.4 0.0 4.9 7.9 13.7 6.1 12.5 9.0 6.6 7.9 1.4 0.0 10.1 8.7 8.7 5.8 6.2 4.0 8.8 6.5 1.2 3.6 6.5 4.4 7.8 8.5 6.3 7.2 9.7 9.8 5.9 8.5 5.1 7.9 5.2 4.5 4.2 1.9 4.0 3.6 0.2 1.3 9.9 4.4 5.8 14.5 5.1 3.8 6.4 5.7 4.6 5.7 5.3 3.6 5.3 3.8 15.0 6.0 3.9 1.9 4.1 3.6 13.0 13.6 13.3 14.4 13.2 9.3 16.7 16.1 13.4 14.4 11.9 6.1 3.2 10.0 4.4 8.9 5.5 0.0 12.0 10.3 7.0 13.7 10.6 11.6 9.8 9.2 8.0 2.1 0.0 6.6 10.6 6.1 5.3 5.8 0.8 8.0 6.4 4.6 6.2 8.2 3.2 6.4 7.8 10.1 3.6 2.2 7.4 6.7 0.0 9.9 13.5 9.7 6.5 9.2 22.3 9.8 4.8 10.2 10.9 4.3 6.9 ZNF354B "FLJ25008, KID2" ENSG00000178338 "Zinc finger protein 354B" Q96LW1 5 178859953-178888122 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 28.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029056 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA029056: AB_10603006" "unprognostic (2.15e-1)" "unprognostic (2.45e-2)" "unprognostic (1.73e-1)" "unprognostic (4.19e-2)" "unprognostic (5.24e-1)" "prognostic favorable (9.52e-4)" "unprognostic (2.88e-4)" "unprognostic (6.72e-2)" "unprognostic (1.26e-3)" "unprognostic (1.11e-3)" "unprognostic (6.22e-2)" "unprognostic (1.80e-2)" "prognostic unfavorable (1.30e-5)" "unprognostic (2.25e-1)" "unprognostic (5.51e-2)" "unprognostic (2.32e-2)" "unprognostic (3.15e-3)" 14.2 8.8 13.1 9.4 15.3 5.4 15.0 22.8 13.3 14.5 11.7 8.1 9.3 8.9 14.2 10.0 8.6 10.7 9.2 7.3 13.7 5.6 10.0 7.4 9.8 10.3 15.8 7.7 13.0 13.0 15.8 20.4 28.6 11.2 13.3 8.1 4.7 10.7 11.7 12.9 10.7 9.8 9.7 11.6 12.4 10.1 7.3 16.3 12.8 15.5 8.3 9.5 11.6 11.9 8.1 3.8 2.6 3.3 2.2 5.9 1.6 4.4 3.5 6.6 14.9 6.5 6.4 16.8 5.5 5.1 5.4 6.3 4.4 8.0 0.0 6.1 4.9 7.5 9.2 8.3 9.2 6.7 0.0 6.8 5.1 11.6 3.2 5.6 0.1 3.6 5.8 5.7 4.4 6.9 8.3 4.8 7.8 4.2 0.0 5.8 4.9 8.1 11.6 3.5 2.1 4.7 7.8 3.6 4.9 4.7 5.4 7.4 7.7 6.7 6.0 4.3 6.7 5.3 8.9 5.6 9.6 8.7 3.4 4.1 3.3 4.7 0.2 0.6 0.0 5.0 2.6 3.3 1.3 5.9 1.9 5.4 4.8 4.2 3.3 2.8 8.1 5.1 5.1 0.9 2.2 2.2 3.8 3.5 1.6 13.1 15.3 22.8 13.3 13.7 5.6 15.8 7.7 11.2 16.3 8.9 4.5 0.0 6.0 4.0 6.2 6.9 5.1 8.1 9.1 7.0 7.9 15.2 0.0 3.9 0.4 9.0 1.1 0.0 1.9 5.0 3.8 4.3 0.0 1.9 4.3 11.1 0.0 7.4 3.4 0.0 4.6 5.4 0.0 1.0 2.4 4.3 2.0 0.0 4.9 1.5 6.2 0.0 5.6 6.9 10.9 4.6 28.9 4.4 1.9 2.8 ZNF354C KID3 ENSG00000177932 "Zinc finger protein 354C" Q86Y25 5 179060415-179083537 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 10.1;Horizontal cells: 15.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030904, HPA068570" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA030904: AB_10603842, HPA068570: " "unprognostic (1.55e-1)" "unprognostic (1.78e-1)" "unprognostic (1.82e-1)" "unprognostic (6.56e-4)" "unprognostic (4.76e-1)" "unprognostic (2.40e-3)" "unprognostic (2.61e-2)" "unprognostic (2.83e-2)" "unprognostic (1.01e-3)" "unprognostic (1.58e-1)" "unprognostic (1.11e-1)" "unprognostic (5.57e-2)" "unprognostic (1.62e-1)" "unprognostic (2.46e-2)" "unprognostic (1.61e-1)" "unprognostic (4.00e-2)" "unprognostic (2.83e-1)" 6.4 4.9 6.6 4.6 7.9 1.2 8.2 12.9 8.9 9.3 7.4 7.7 6.5 2.6 10.6 4.1 5.6 7.8 5.4 5.6 7.7 3.4 4.6 3.0 6.6 6.5 9.4 5.3 15.0 5.3 3.4 3.5 6.5 6.7 9.0 3.5 5.7 4.3 7.3 5.5 4.1 5.1 8.8 5.7 6.4 5.3 4.5 9.3 5.5 9.8 3.1 6.8 6.5 10.5 1.3 0.9 0.8 2.0 1.5 3.3 1.5 0.8 1.2 9.7 15.6 5.1 8.3 0.0 4.4 3.8 4.8 5.6 0.0 1.9 0.0 5.3 4.7 8.2 3.0 0.0 1.5 9.3 0.0 0.1 0.0 0.4 0.0 4.9 0.0 2.2 6.2 1.4 4.8 0.0 1.5 2.3 0.0 0.1 0.0 5.7 0.5 8.9 0.0 6.9 0.7 0.0 0.0 0.0 0.0 1.8 0.4 6.0 10.1 6.9 0.1 4.6 4.4 4.1 3.6 2.9 0.0 6.5 4.2 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.8 0.5 0.5 2.2 0.9 2.2 1.3 2.9 2.0 0.9 1.3 3.3 2.8 0.0 1.5 2.0 0.1 1.7 1.5 6.6 7.9 12.9 8.4 7.7 3.4 9.4 5.3 6.7 9.3 3.0 1.9 0.0 0.7 0.8 10.1 5.3 2.5 1.4 3.4 0.0 0.0 1.8 0.0 0.9 0.4 2.4 0.0 0.0 0.8 1.0 2.6 0.5 1.1 0.5 1.3 15.9 0.0 6.2 0.6 0.0 2.8 2.0 1.7 0.0 0.4 5.6 0.6 0.0 5.3 0.5 5.1 6.5 1.9 2.5 1.0 0.6 0.5 0.5 0.4 0.1 ZNF358 "FLJ10390, ZFEND" ENSG00000198816 "Zinc finger protein 358" Q9NW07 19 7515292-7521026 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 103.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030887, HPA063624" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA030887: AB_10602688, HPA063624: AB_2685064" "unprognostic (1.32e-2)" "unprognostic (3.40e-1)" "unprognostic (1.34e-2)" "unprognostic (1.59e-2)" "unprognostic (9.89e-3)" "unprognostic (7.82e-2)" "unprognostic (7.40e-2)" "unprognostic (3.54e-1)" "unprognostic (1.30e-1)" "unprognostic (6.52e-2)" "prognostic favorable (2.50e-4)" "unprognostic (4.30e-1)" "unprognostic (4.48e-1)" "unprognostic (4.11e-2)" "unprognostic (2.00e-1)" "unprognostic (9.72e-2)" "unprognostic (3.60e-2)" 23.7 21.1 33.6 7.9 26.1 2.1 31.6 21.4 54.7 30.1 26.1 20.2 17.5 19.2 22.4 19.5 18.0 27.9 20.9 36.4 29.1 22.5 17.4 17.9 14.4 6.8 24.9 20.2 46.1 25.0 21.1 17.7 12.2 15.0 23.1 12.6 19.1 32.3 30.8 95.9 11.7 18.0 24.9 16.8 13.8 18.3 8.5 18.3 4.4 27.3 13.5 7.7 24.7 24.3 2.6 1.4 4.6 1.8 0.7 2.4 0.7 10.3 7.0 13.2 21.0 28.4 31.6 11.3 3.9 25.7 18.0 15.9 3.0 7.4 0.0 15.3 21.0 2.8 4.1 5.4 10.0 5.8 0.0 11.6 2.0 8.6 4.2 31.2 0.3 0.1 27.5 19.0 8.5 7.4 27.0 18.8 0.0 5.2 0.0 15.8 5.1 0.0 7.5 13.5 4.3 12.4 11.5 7.1 1.1 9.4 4.5 14.7 29.3 4.9 4.1 14.1 8.9 3.1 5.5 8.8 11.6 8.5 17.2 5.9 14.1 7.6 0.0 10.7 0.0 16.0 4.6 1.7 1.1 1.8 1.8 1.3 0.4 0.6 1.0 0.9 2.6 1.4 2.4 0.0 0.7 0.4 1.4 0.0 0.7 33.6 26.1 21.4 54.7 29.1 22.5 24.9 20.2 15.0 18.3 8.9 12.0 3.0 9.8 6.9 20.2 103.8 12.7 1.4 3.4 15.7 13.7 2.5 5.0 11.1 4.1 17.6 35.9 0.0 14.4 4.4 16.5 10.0 14.9 38.9 8.8 47.7 35.1 29.4 15.9 4.7 35.1 7.1 5.0 2.8 27.3 32.3 15.6 17.5 35.0 24.2 15.2 12.9 19.8 0.5 0.7 3.1 2.5 3.9 19.2 10.4 ZNF362 "FLJ25476, lin-29, RN" ENSG00000160094 "Zinc finger protein 362" Q5T0B9 1 33256545-33300719 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059239 Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA059239: AB_2683955" "unprognostic (8.31e-3)" "unprognostic (2.61e-1)" "unprognostic (2.23e-2)" "unprognostic (6.90e-3)" "unprognostic (1.08e-1)" "unprognostic (2.34e-2)" "unprognostic (4.02e-3)" "unprognostic (2.02e-2)" "unprognostic (7.74e-2)" "unprognostic (1.82e-1)" "unprognostic (9.25e-2)" "unprognostic (1.52e-1)" "unprognostic (1.93e-1)" "unprognostic (1.30e-1)" "unprognostic (2.67e-1)" "unprognostic (5.83e-2)" "unprognostic (2.66e-1)" 21.6 14.0 18.1 12.0 17.2 8.9 21.7 24.5 30.5 18.6 17.3 13.8 9.6 11.0 23.7 23.8 14.2 20.1 20.7 28.0 15.4 13.8 16.8 8.8 18.7 26.3 12.8 15.6 23.3 19.9 16.4 19.1 17.9 12.3 20.4 8.8 27.4 22.8 21.7 26.1 23.5 11.6 28.1 13.1 22.6 14.0 8.5 10.3 17.9 17.4 14.1 15.3 20.1 15.4 6.0 8.3 6.0 4.6 4.2 4.7 2.5 3.3 5.4 23.7 9.4 6.3 4.4 15.6 4.7 5.5 5.8 6.2 5.6 11.4 1.7 10.3 5.9 1.8 11.3 5.5 2.6 2.4 10.0 5.0 8.5 3.3 6.8 5.6 4.0 6.9 9.4 6.6 2.5 2.2 5.9 7.9 11.3 0.9 2.9 4.4 8.1 13.0 6.7 14.1 2.0 5.1 21.3 5.6 0.7 4.6 5.4 8.4 25.4 13.3 4.2 20.9 10.6 4.1 10.4 11.4 3.5 4.8 8.3 3.1 8.9 8.2 1.8 2.8 3.6 10.4 3.8 4.6 6.0 4.7 4.1 3.4 3.0 3.5 4.1 3.3 6.0 3.1 2.9 3.5 4.2 4.5 8.3 2.6 2.5 18.1 17.2 24.5 30.5 15.4 13.8 12.8 15.6 12.3 10.3 8.9 11.3 1.9 4.0 9.0 12.3 19.4 7.6 1.4 9.1 10.4 0.0 9.4 1.7 5.5 0.9 10.5 3.1 0.0 6.5 5.7 9.7 2.2 9.3 6.6 8.7 7.9 1.7 19.6 14.5 5.4 12.7 6.1 8.5 1.0 4.0 7.7 3.7 8.5 20.1 9.9 4.5 6.5 11.3 0.9 2.5 8.3 3.0 4.9 6.9 1.3 ZNF367 FLJ33970 ENSG00000165244 "Zinc finger protein 367" Q7RTV3 9 96385941-96418329 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 23.8;lymphoid tissue: 21.5" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 8.9;Sertoli cells: 6.5;Spermatocytes: 7.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Lineage enriched" "Detected in single" 7 "T-cells: 1.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015319, HPA015785" Uncertain Supported Nucleoplasm NA Yes Nucleoplasm "HPA015319: AB_2669185, HPA015785: AB_2217750" "unprognostic (5.91e-2)" "unprognostic (2.78e-3)" "unprognostic (2.17e-2)" "unprognostic (1.11e-2)" "unprognostic (2.36e-1)" "unprognostic (4.57e-3)" "unprognostic (7.76e-3)" "unprognostic (1.60e-3)" "unprognostic (4.35e-2)" "unprognostic (3.01e-1)" "unprognostic (3.78e-3)" "unprognostic (2.71e-2)" "unprognostic (4.88e-3)" "unprognostic (3.23e-3)" "unprognostic (1.72e-1)" "prognostic favorable (2.34e-4)" "unprognostic (2.28e-1)" 2.7 1.2 2.1 8.9 4.6 23.8 4.4 2.9 3.9 2.2 4.9 2.9 1.7 3.2 1.3 2.1 4.5 1.3 3.0 4.6 2.5 2.1 3.3 12.0 2.6 4.7 4.4 2.0 2.2 1.8 3.9 0.6 3.7 3.8 1.4 3.8 2.1 3.2 0.6 3.9 3.9 3.2 2.6 4.3 3.4 2.4 9.6 4.3 21.5 1.3 6.5 5.0 2.1 2.5 0.1 0.2 0.1 0.2 0.1 1.8 0.7 13.3 5.5 5.4 4.9 2.1 3.0 7.4 18.7 11.1 9.3 11.2 3.4 9.5 10.2 8.0 8.9 7.0 16.5 6.3 6.8 11.1 11.1 5.5 7.4 10.6 2.8 0.0 10.3 9.1 0.5 0.4 7.5 3.8 2.0 3.4 7.2 6.7 24.9 11.9 8.9 15.8 8.5 3.7 14.8 9.1 8.0 27.6 6.2 2.7 9.0 9.6 6.7 8.2 9.9 5.7 4.6 5.2 9.2 3.0 15.4 8.8 14.1 14.1 9.7 16.4 4.2 9.3 9.1 12.9 0.0 0.0 0.1 1.2 0.0 0.8 0.0 0.8 1.2 0.2 0.1 1.1 1.3 0.0 0.1 0.2 0.1 1.8 0.7 2.1 4.6 2.9 3.9 2.5 2.1 4.4 2.0 3.8 4.3 0.0 0.0 2.2 1.0 8.9 0.6 2.2 0.0 0.0 1.2 0.0 0.0 1.6 0.0 0.4 0.6 0.6 0.6 0.0 1.0 3.5 1.7 0.4 0.0 3.9 1.7 0.0 0.0 1.3 2.5 0.6 0.6 1.5 3.3 0.0 1.9 0.5 0.5 0.0 0.7 2.2 1.5 6.5 2.5 7.2 1.4 5.6 0.7 2.5 2.5 0.1 ZNF383 FLJ35863 ENSG00000188283 "Zinc finger protein 383" Q8NA42 19 37217926-37248738 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063945 Approved Supported "Nucleoplasm,Nuclear membrane" No No "Nucleoplasm, Nuclear membrane" "HPA063945: AB_2685158" "unprognostic (1.92e-1)" "unprognostic (1.35e-1)" "unprognostic (1.39e-1)" "unprognostic (1.26e-2)" "unprognostic (3.72e-3)" "unprognostic (1.20e-3)" "unprognostic (1.85e-1)" "unprognostic (6.27e-3)" "unprognostic (1.66e-2)" "unprognostic (1.27e-1)" "prognostic favorable (9.97e-4)" "unprognostic (7.40e-2)" "unprognostic (5.44e-2)" "unprognostic (4.34e-2)" "unprognostic (1.74e-1)" "unprognostic (2.01e-3)" "prognostic favorable (3.71e-4)" 9.1 7.5 9.3 10.4 12.1 6.9 10.7 20.4 10.8 9.1 8.2 12.6 10.4 7.5 11.6 7.8 8.9 8.2 6.1 9.6 8.7 6.9 9.3 7.4 7.2 11.3 14.2 6.5 12.9 9.2 9.4 11.0 6.5 11.8 9.6 7.4 8.7 8.5 8.7 14.0 11.8 9.5 10.8 13.7 10.8 8.4 10.5 12.1 13.2 11.4 5.7 11.9 10.2 9.4 11.4 4.0 6.3 5.4 5.7 11.6 4.8 3.8 8.7 6.1 9.2 7.6 7.8 4.0 5.2 7.2 5.3 8.0 4.0 4.6 5.2 8.0 5.0 4.9 3.8 5.0 7.0 7.8 7.2 5.4 7.8 6.5 3.2 8.5 9.0 8.6 10.0 6.0 5.1 10.0 6.9 4.8 7.4 4.0 2.7 6.8 1.6 7.7 4.1 5.4 7.5 3.0 5.6 10.9 4.6 4.6 10.8 7.3 5.4 8.4 5.0 7.3 8.2 5.9 5.3 3.0 7.0 4.7 4.8 5.0 8.5 8.0 10.0 1.0 4.3 6.3 3.6 4.1 6.3 7.6 4.7 10.7 9.8 7.2 9.2 4.0 11.4 11.6 9.1 5.0 5.7 5.4 3.8 7.0 4.8 9.3 12.1 20.4 10.8 8.7 6.9 14.2 6.5 11.8 12.1 3.0 4.1 6.5 3.7 2.4 8.3 11.7 2.5 2.7 2.3 1.8 13.7 3.4 1.7 3.0 7.3 4.2 4.1 0.0 3.1 3.6 2.9 3.9 5.7 2.1 3.1 14.3 2.4 6.2 5.0 2.5 6.1 4.8 8.5 4.6 4.5 7.3 2.6 3.5 7.1 3.7 9.5 12.9 5.1 4.8 5.3 2.9 4.1 7.2 5.0 3.3 ZNF384 "CAGH1A, CIZ, NMP4, NP, TNRC1" ENSG00000126746 "Zinc finger protein 384" Q8TF68 12 6666477-6689572 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004051 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA004051: AB_1859228" "unprognostic (1.90e-1)" "unprognostic (5.11e-3)" "unprognostic (1.76e-1)" "unprognostic (6.16e-2)" "unprognostic (1.79e-1)" "unprognostic (3.04e-2)" "unprognostic (1.87e-2)" "unprognostic (9.94e-2)" "unprognostic (1.35e-2)" "unprognostic (2.57e-2)" "unprognostic (3.51e-2)" "unprognostic (4.25e-1)" "unprognostic (1.24e-2)" "unprognostic (1.01e-1)" "unprognostic (2.22e-1)" "unprognostic (2.06e-1)" "unprognostic (8.13e-2)" 20.5 22.8 18.9 30.9 19.9 33.4 22.1 36.1 23.0 23.2 23.3 19.5 16.8 22.1 29.8 17.6 21.1 24.2 25.3 16.1 16.0 10.8 20.7 19.9 19.7 21.9 19.7 17.7 31.3 25.8 25.8 20.5 23.9 14.8 22.7 21.4 18.6 22.4 20.6 22.7 24.1 29.4 24.8 14.2 33.6 21.3 20.5 18.7 39.7 27.0 17.5 29.7 25.2 28.9 10.2 11.1 14.2 13.3 15.6 17.3 7.3 10.5 20.3 25.0 16.7 17.7 12.6 33.6 15.3 14.3 14.9 15.9 22.2 22.7 25.0 5.8 17.2 21.6 14.3 18.4 14.1 17.0 45.1 16.7 28.6 26.9 11.5 12.5 27.1 21.2 13.8 13.7 18.3 28.6 28.1 12.8 17.7 14.9 8.7 16.2 16.4 24.4 17.5 48.4 19.3 8.9 24.3 26.8 9.6 13.2 28.5 7.8 25.3 15.9 21.3 13.7 44.0 5.6 22.5 15.9 16.4 22.9 12.8 18.0 12.1 11.4 45.6 16.1 9.8 18.5 3.3 8.0 14.2 17.3 9.7 13.8 10.2 11.0 13.6 11.1 8.8 10.8 12.1 14.2 15.6 13.3 7.4 13.2 7.3 18.9 19.9 36.1 23.0 16.0 10.8 19.7 17.7 14.8 18.7 0.0 8.3 8.0 2.9 7.0 4.7 2.3 12.7 4.0 3.4 1.8 9.8 5.8 0.0 3.8 3.4 5.8 9.7 0.0 4.3 4.4 6.1 4.4 5.7 5.8 6.1 0.0 3.5 9.2 14.1 1.8 7.8 7.2 5.0 6.4 13.6 6.0 5.7 14.1 8.1 3.1 7.6 0.0 3.4 6.7 6.3 8.5 6.1 10.2 11.2 3.8 ZNF385A "DKFZp586G1122, Hzf, ZFP385, ZNF385" ENSG00000161642 "Zinc finger protein 385A" Q96PM9 12 54369133-54391298 "Predicted intracellular proteins" "DNA damage, Transcription, Transcription regulation, Translation regulation" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 81.6" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 219.7;Cone photoreceptor cells: 161.0;Horizontal cells: 136.7;Rod photoreceptor cells: 153.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "classical monocyte: 15.3;intermediate monocyte: 16.8;myeloid DC: 16.6;non-classical monocyte: 11.9" "Group enriched" "Detected in many" 10 "dendritic cells: 16.6;monocytes: 16.8" "Cell line enhanced" "Detected in many" "HaCaT: 29.4;HBEC3-KT: 28.0;HEL: 35.2;hTCEpi: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039799 Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA039799: AB_10795117" "unprognostic (8.56e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (5.20e-4)" "unprognostic (6.70e-2)" "unprognostic (1.07e-2)" "unprognostic (1.79e-3)" "unprognostic (2.30e-2)" "unprognostic (1.21e-1)" "unprognostic (2.75e-1)" "unprognostic (1.30e-1)" "unprognostic (1.42e-1)" "unprognostic (2.12e-1)" "prognostic unfavorable (9.75e-5)" "unprognostic (1.00e-1)" "unprognostic (3.68e-2)" "unprognostic (2.43e-1)" "unprognostic (6.07e-3)" 23.7 4.3 23.6 16.3 27.3 16.8 7.9 13.2 32.5 7.9 5.7 12.8 2.3 4.8 3.2 10.7 28.1 6.2 8.9 4.3 18.4 22.6 2.3 3.8 11.6 8.9 31.8 15.4 2.0 2.0 13.8 8.5 12.6 19.4 10.3 5.4 35.5 8.9 10.1 5.9 81.6 5.7 8.7 16.4 13.9 4.4 2.1 16.1 5.5 18.1 21.9 21.9 25.8 14.9 0.8 16.6 1.6 16.8 0.0 0.2 6.6 0.8 3.4 5.3 6.6 6.1 4.1 14.6 0.6 2.6 2.8 2.4 7.0 2.6 1.9 2.4 1.4 2.2 29.4 2.0 28.0 0.9 1.8 2.8 35.2 2.3 1.3 2.7 0.5 24.7 3.6 31.6 3.1 7.9 6.8 1.7 4.9 16.9 0.1 1.2 15.6 1.7 5.0 3.0 3.3 2.7 6.2 0.4 6.9 2.1 23.0 2.3 10.6 0.2 19.9 1.4 6.4 23.5 14.7 1.7 1.5 3.5 1.7 1.7 0.5 0.1 1.6 6.3 1.6 3.8 1.6 15.3 0.0 0.0 16.8 0.0 0.6 0.0 0.0 16.6 0.8 0.0 0.2 1.2 0.0 11.9 1.6 0.0 6.6 23.6 27.3 13.2 32.5 18.4 22.6 31.8 15.4 19.4 16.1 0.0 0.0 5.0 20.2 32.2 219.7 3.1 2.5 2.7 2.3 8.7 161.0 56.0 8.3 3.5 0.4 2.9 0.0 0.0 0.5 5.3 14.9 11.9 1.1 1.0 53.9 136.7 4.6 2.5 63.8 0.0 13.8 52.2 8.5 19.0 0.0 74.9 2.2 0.0 8.5 2.1 153.5 0.0 4.7 2.2 2.5 57.7 91.1 1.3 0.0 27.3 ZNF394 "FLJ12298, ZKSCAN14, ZSCAN46" ENSG00000160908 "Zinc finger protein 394" Q53GI3 7 99486519-99500324 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 77.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051421, HPA054639" Uncertain Enhanced Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA051421: AB_2681479, HPA054639: AB_2682553" "prognostic favorable (3.56e-4)" "unprognostic (1.62e-1)" "unprognostic (2.83e-3)" "unprognostic (2.60e-1)" "unprognostic (2.09e-2)" "unprognostic (1.53e-1)" "unprognostic (2.54e-1)" "prognostic favorable (2.11e-4)" "unprognostic (3.62e-2)" "unprognostic (4.14e-1)" "unprognostic (6.28e-2)" "unprognostic (2.45e-1)" "unprognostic (1.59e-1)" "unprognostic (4.70e-2)" "unprognostic (7.47e-2)" "unprognostic (3.42e-1)" "prognostic favorable (1.09e-4)" 11.3 8.3 10.0 11.5 11.8 77.5 12.2 16.4 13.2 10.8 10.9 11.7 8.8 10.7 11.0 7.7 12.2 11.2 9.3 10.4 7.9 6.2 9.4 9.5 12.6 12.2 11.2 6.6 14.3 12.0 7.9 16.2 8.4 9.7 13.0 9.1 10.1 10.1 9.0 14.8 13.6 13.5 9.1 9.1 19.1 10.9 9.5 11.0 15.6 11.4 8.8 17.5 11.9 11.6 17.6 22.3 31.6 17.0 24.3 29.3 17.0 7.8 7.8 5.3 11.1 8.2 5.6 10.5 6.7 8.9 7.8 7.6 8.2 8.7 9.4 9.7 6.9 11.0 7.6 7.1 8.5 7.7 6.8 9.4 9.2 9.3 9.0 6.6 13.1 16.1 7.4 7.4 7.6 8.1 5.8 8.9 8.4 13.2 18.7 7.1 14.7 13.5 21.5 11.8 9.8 9.4 7.7 5.8 16.3 8.4 11.2 6.3 13.1 7.8 19.0 12.6 13.5 4.9 16.3 9.3 9.5 9.5 13.6 8.3 15.4 16.1 15.2 6.7 13.3 9.9 31.6 14.3 24.1 23.1 17.0 24.2 17.6 23.6 25.0 15.6 17.2 29.3 23.1 26.3 24.3 16.7 22.3 25.2 17.0 10.0 11.8 16.4 13.2 7.9 6.2 11.2 6.6 9.7 11.0 14.9 22.4 32.0 29.5 31.6 8.1 7.0 2.5 20.1 11.4 10.4 11.8 13.3 14.9 13.3 5.6 16.9 25.5 0.0 12.4 14.8 17.4 23.7 57.7 10.5 16.3 14.3 20.0 12.9 22.1 1.1 14.4 20.8 27.0 15.4 14.7 12.4 14.1 18.6 12.7 9.5 10.6 12.9 17.0 42.5 30.3 31.0 24.8 44.5 15.8 52.9 ZNF395 "DKFZp434K1210, HDBP2, PBF, PRF-1" ENSG00000186918 "Zinc finger protein 395" Q9H8N7 8 28345585-28402701 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 49.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049382, HPA076275" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA049382: , HPA076275: " "unprognostic (1.28e-1)" "unprognostic (3.02e-1)" "unprognostic (1.95e-2)" "unprognostic (2.01e-1)" "unprognostic (1.61e-2)" "unprognostic (4.51e-2)" "prognostic unfavorable (1.66e-4)" "unprognostic (9.35e-3)" "unprognostic (8.90e-2)" "unprognostic (2.15e-2)" "unprognostic (7.08e-2)" "unprognostic (2.25e-2)" "prognostic unfavorable (5.71e-5)" "unprognostic (1.35e-1)" "unprognostic (1.32e-1)" "unprognostic (2.46e-2)" "unprognostic (7.42e-2)" 17.4 10.7 10.0 13.3 10.9 18.6 19.0 7.4 10.1 16.8 22.5 9.7 13.4 12.1 12.0 11.9 27.2 16.9 14.1 15.0 10.4 5.4 13.1 19.5 11.3 18.0 9.0 6.8 33.8 27.8 9.8 9.5 19.6 7.6 22.1 8.3 13.7 21.7 11.1 13.8 23.2 16.3 13.8 8.8 11.9 14.2 12.3 10.8 9.6 18.2 10.2 25.3 27.5 27.6 13.7 6.4 10.6 4.2 3.3 7.2 2.1 49.8 7.1 6.9 18.8 5.2 7.6 19.7 6.1 10.8 4.9 11.8 11.3 8.8 23.8 21.2 9.5 11.5 10.8 6.1 15.0 9.7 3.9 4.8 5.9 1.5 2.3 5.4 2.4 2.5 13.3 20.7 0.9 12.9 14.2 2.6 8.1 6.1 5.3 6.8 8.5 11.2 7.7 10.7 12.2 8.4 11.0 7.4 7.9 11.5 9.9 18.9 19.6 1.5 3.8 9.8 6.2 7.5 5.9 0.7 10.5 12.8 5.6 2.5 6.5 3.3 15.6 27.7 4.9 9.2 6.7 4.2 10.6 4.8 0.8 4.6 10.0 5.6 5.6 1.6 13.7 7.2 4.9 1.8 3.3 0.6 6.4 2.1 2.1 10.0 10.9 7.4 10.1 10.4 5.4 9.0 6.8 7.6 10.8 29.8 20.7 18.5 16.7 14.9 9.0 9.3 2.5 13.4 18.2 8.7 13.7 12.7 3.3 15.9 0.6 11.7 16.0 0.0 20.7 16.9 18.0 13.9 10.5 26.8 5.1 6.4 26.2 22.1 13.8 0.6 23.0 4.7 10.1 0.0 22.3 17.3 27.8 0.0 17.0 6.7 9.7 25.8 10.3 0.5 2.1 10.0 5.3 8.3 29.2 8.1 ZNF398 "KIAA1339, P51, P71, ZER6" ENSG00000197024 "Zinc finger protein 398" Q8TD17 7 149126416-149182802 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NTERA-2: 36.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071533 Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA071533: AB_2686412" "unprognostic (4.11e-1)" "unprognostic (8.56e-2)" "unprognostic (3.90e-2)" "unprognostic (1.47e-1)" "unprognostic (1.21e-1)" "unprognostic (6.65e-3)" "unprognostic (2.94e-3)" "unprognostic (2.27e-2)" "unprognostic (3.64e-3)" "unprognostic (1.43e-1)" "unprognostic (7.52e-2)" "unprognostic (2.75e-2)" "unprognostic (1.45e-1)" "unprognostic (3.97e-2)" "unprognostic (9.27e-2)" "unprognostic (9.17e-2)" "unprognostic (1.89e-1)" 8.9 8.1 12.7 10.2 12.5 15.6 10.6 25.9 16.0 11.7 10.7 10.2 10.5 8.8 9.8 10.2 14.3 10.4 8.6 9.3 10.9 9.0 9.3 10.7 9.2 10.0 10.7 11.4 11.1 13.4 14.7 20.9 8.6 9.8 12.7 8.6 8.5 11.2 12.5 10.0 17.2 9.5 9.7 9.8 12.6 11.1 18.1 12.6 13.0 8.7 7.4 12.3 9.9 11.1 2.9 1.6 6.1 2.0 1.9 3.8 1.2 7.6 6.4 5.0 9.7 7.5 5.3 6.4 4.7 6.0 5.4 5.9 5.4 3.6 8.9 5.4 7.8 4.8 6.4 8.6 5.9 3.8 5.9 11.9 5.9 5.1 3.5 5.2 6.6 6.2 6.0 8.7 5.8 6.2 3.9 3.6 3.6 9.1 3.2 5.7 9.6 9.8 6.8 36.0 6.4 6.8 7.7 5.7 6.7 4.0 12.8 7.5 8.3 6.5 8.0 3.9 5.6 5.0 7.4 4.8 5.5 1.6 9.8 5.8 10.3 4.9 6.9 7.5 5.5 5.3 5.1 1.6 6.1 3.1 2.0 3.7 2.9 2.1 3.4 1.5 2.5 3.3 3.8 3.1 1.9 1.7 1.6 3.0 1.2 12.7 12.5 25.9 16.0 10.9 9.0 10.7 11.4 9.8 12.6 6.0 2.9 3.7 3.5 6.9 7.4 5.8 0.0 2.7 4.5 5.2 5.9 3.1 0.0 3.6 19.4 4.5 3.3 0.0 2.5 4.0 4.7 4.5 4.6 2.8 3.2 3.2 1.7 4.9 4.7 19.2 6.6 3.4 8.5 2.8 3.3 5.3 4.4 2.6 8.5 2.4 9.7 0.0 2.5 16.6 7.9 7.4 2.6 1.8 3.3 8.1 ZNF407 "FLJ13839, FLJ20307, KIAA1703" ENSG00000215421 "Zinc finger protein 407" Q9C0G0 18 74597870-75065671 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028255, HPA041673" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA028255: AB_10603466, HPA041673: AB_2677610" "unprognostic (3.96e-1)" "unprognostic (1.95e-1)" "unprognostic (2.48e-1)" "unprognostic (8.62e-2)" "unprognostic (4.61e-2)" "unprognostic (2.09e-2)" "unprognostic (1.76e-2)" "unprognostic (4.31e-1)" "unprognostic (1.19e-3)" "unprognostic (4.04e-4)" "unprognostic (3.47e-2)" "unprognostic (2.22e-1)" "prognostic favorable (9.79e-5)" "unprognostic (8.87e-2)" "unprognostic (3.07e-1)" "unprognostic (1.24e-1)" "unprognostic (3.11e-2)" 7.7 6.3 8.5 11.7 11.4 12.0 7.6 15.5 10.5 11.8 9.4 5.3 5.8 5.8 11.7 5.2 7.3 9.4 5.5 8.1 7.3 5.2 6.6 6.0 7.4 7.9 7.8 5.7 12.8 6.0 14.9 13.2 10.8 9.0 7.6 6.0 5.9 8.4 7.7 13.3 7.7 10.3 8.7 7.5 11.2 7.5 10.0 7.7 18.1 9.4 8.2 7.6 9.9 9.2 2.4 3.6 6.0 2.6 3.0 3.1 0.9 4.6 4.9 5.6 5.1 4.1 6.1 4.0 6.2 5.5 4.6 5.0 2.0 2.7 6.7 1.9 8.7 3.1 5.5 5.2 6.8 6.9 11.1 3.2 8.6 6.6 3.8 3.7 13.0 7.6 5.5 3.1 7.4 6.5 4.4 6.9 4.8 4.9 10.0 7.0 3.7 6.3 1.8 3.2 1.7 4.4 6.5 7.2 5.3 3.3 8.8 5.3 5.0 5.8 3.7 4.4 4.2 4.2 5.6 9.6 10.5 4.4 2.9 4.9 3.5 7.2 7.1 3.8 5.6 6.2 4.0 1.9 2.3 3.1 2.6 2.9 2.1 2.3 1.7 0.7 2.4 2.6 3.1 6.0 3.0 1.6 3.6 0.6 0.9 8.5 11.4 15.5 10.5 7.3 5.2 7.8 5.7 9.0 7.7 6.0 4.6 6.1 4.7 2.9 10.7 16.5 5.1 8.1 5.7 5.2 5.9 3.4 0.0 3.8 3.2 5.8 5.4 0.0 2.5 2.3 3.8 4.2 1.1 5.1 2.7 4.8 4.1 2.5 5.6 2.2 4.9 4.4 5.0 2.8 4.9 8.1 3.4 3.7 4.2 1.9 13.7 6.5 3.3 9.6 12.2 3.6 4.3 5.1 3.3 3.8 ZNF41 "MGC8941, MRX89" ENSG00000147124 "Zinc finger protein 41" P51814 X 47445879-47482946 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ito cells: 5.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069102 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA069102: AB_2686086" "unprognostic (9.63e-2)" "unprognostic (1.94e-1)" "unprognostic (3.12e-2)" "unprognostic (5.72e-2)" "unprognostic (6.87e-2)" "prognostic favorable (8.32e-4)" "unprognostic (3.72e-1)" "unprognostic (5.66e-2)" "unprognostic (6.01e-2)" "unprognostic (3.17e-2)" "unprognostic (1.51e-1)" "unprognostic (4.23e-2)" "prognostic favorable (6.95e-4)" "unprognostic (1.95e-1)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "unprognostic (1.92e-3)" 8.8 8.0 8.5 11.8 12.2 2.4 10.2 15.2 12.1 10.6 9.5 8.4 8.6 6.8 8.6 9.4 8.3 7.2 9.8 15.2 8.9 7.9 8.8 8.8 8.8 9.4 8.9 8.6 8.8 10.1 20.0 13.8 7.9 9.3 9.3 11.5 7.1 11.0 8.4 26.7 7.6 9.1 9.8 7.9 10.7 8.5 4.3 11.1 12.8 11.5 9.2 11.5 9.7 8.5 6.9 6.5 4.8 6.2 5.6 7.9 4.0 6.0 6.6 5.5 14.0 6.8 7.6 3.8 8.3 7.0 7.2 8.3 3.7 6.6 8.7 4.6 10.9 9.3 9.5 12.4 5.7 9.1 13.7 4.7 2.1 9.2 2.3 4.7 8.6 7.8 5.5 7.3 8.2 10.8 6.5 6.6 7.3 6.2 9.5 9.0 9.0 8.9 4.7 9.3 5.5 10.4 8.3 7.2 8.9 5.5 10.3 7.6 7.8 12.2 9.6 4.8 6.8 10.0 4.8 9.8 7.7 6.0 15.5 5.9 6.9 9.3 9.4 6.6 17.3 8.2 1.4 4.7 4.8 6.5 6.2 7.9 4.9 5.9 7.2 6.5 6.9 6.7 6.1 1.1 5.6 3.0 4.3 4.8 4.0 8.5 12.2 15.2 12.1 8.9 7.9 8.9 8.6 9.3 11.1 3.0 3.8 0.0 1.9 0.6 3.4 3.6 0.0 2.7 1.2 0.0 0.0 0.2 1.7 1.2 0.0 2.1 1.7 0.0 1.2 0.6 1.0 1.2 1.1 1.6 0.9 0.0 0.0 5.5 1.2 0.0 0.9 2.0 1.7 0.0 1.6 1.6 1.4 3.4 0.7 0.7 3.3 0.0 1.2 1.1 1.5 0.1 0.7 0.8 1.7 1.7 ZNF414 "MGC15716, Zfp414" ENSG00000133250 "Zinc finger protein 414" Q96IQ9 19 8509678-8514164 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 59.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053769 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA053769: AB_2682255" "unprognostic (7.74e-2)" "unprognostic (2.52e-2)" "unprognostic (6.26e-3)" "prognostic favorable (4.17e-4)" "unprognostic (1.45e-1)" "prognostic favorable (1.67e-6)" "unprognostic (1.21e-1)" "unprognostic (2.32e-1)" "unprognostic (6.42e-2)" "unprognostic (7.29e-2)" "prognostic favorable (4.59e-4)" "unprognostic (1.08e-1)" "unprognostic (2.07e-2)" "unprognostic (3.84e-1)" "unprognostic (1.94e-1)" "unprognostic (1.91e-1)" "prognostic favorable (8.71e-4)" 16.6 16.2 14.3 13.6 22.7 20.8 10.6 17.6 28.6 13.2 10.9 22.4 5.6 21.4 16.6 10.0 11.6 11.6 9.7 9.9 14.1 11.4 12.0 13.1 10.7 15.8 15.5 14.8 16.7 13.7 9.2 15.3 14.0 17.3 15.8 4.6 13.4 20.5 14.1 23.6 25.5 16.6 7.7 12.5 22.8 19.1 13.6 20.3 19.9 15.7 6.1 13.5 11.8 12.3 3.0 3.4 5.4 2.1 2.5 2.7 1.2 5.4 4.7 2.6 4.2 0.7 1.7 5.8 4.1 1.6 2.7 2.5 4.2 2.7 7.6 12.2 1.3 2.0 7.7 0.8 3.4 0.4 6.8 19.1 4.8 4.4 4.9 3.8 4.1 6.5 3.1 2.5 2.2 0.9 1.5 1.1 4.8 6.3 11.2 1.7 6.8 9.3 24.2 7.7 1.4 13.5 10.9 1.3 7.6 1.9 4.5 9.0 14.0 4.6 3.5 3.7 0.5 6.7 4.8 4.3 8.1 4.1 11.7 5.4 16.4 6.8 5.9 6.5 3.5 4.3 3.0 1.6 0.8 1.8 1.4 1.0 2.5 2.7 2.7 1.6 3.0 2.6 2.6 5.4 2.5 2.1 3.4 1.4 1.2 14.3 22.7 17.6 28.6 14.1 11.4 15.5 14.8 17.3 20.3 0.0 0.6 4.9 12.9 10.5 17.5 1.7 7.6 0.0 0.0 3.5 9.8 23.8 13.3 3.0 21.5 6.7 11.9 0.0 4.7 18.3 12.7 8.8 4.6 9.7 11.4 11.1 21.4 11.1 9.1 59.9 19.0 9.6 8.5 5.4 12.8 17.9 3.8 11.5 15.2 13.5 18.9 12.9 7.8 24.4 30.2 10.7 26.3 10.5 11.7 8.1 ZNF417 MGC34079 ENSG00000173480 "Zinc finger protein 417" Q8TAU3 19 57900296-57916610 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Club cells: 7.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 34.1" "HPA042125, HPA043288, HPA056213" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA042125: AB_2677862, HPA043288: AB_2678410, HPA056213: AB_2683069" "unprognostic (2.48e-1)" "unprognostic (2.55e-1)" "unprognostic (1.28e-1)" "unprognostic (3.74e-2)" "unprognostic (8.93e-2)" "unprognostic (1.63e-2)" "unprognostic (1.85e-1)" "unprognostic (5.76e-2)" "unprognostic (2.59e-3)" "unprognostic (2.34e-1)" "unprognostic (7.65e-3)" "unprognostic (5.33e-2)" "unprognostic (7.63e-2)" "unprognostic (1.01e-1)" "unprognostic (1.93e-2)" "unprognostic (8.75e-2)" "prognostic favorable (3.48e-4)" 7.4 8.8 12.3 11.8 11.8 10.2 16.6 18.5 12.8 15.1 10.1 11.8 16.8 7.0 10.7 38.9 7.9 10.3 11.4 9.5 11.7 10.4 9.4 11.0 9.1 12.8 13.3 12.3 12.7 9.4 14.2 23.8 10.8 10.2 12.7 10.5 12.3 14.2 13.9 6.2 21.5 13.1 10.3 10.1 12.7 10.7 8.0 13.4 14.9 16.1 5.6 16.3 9.1 9.8 6.8 5.8 9.7 3.8 3.6 7.6 2.7 4.1 6.2 10.2 7.0 10.3 9.9 8.7 5.1 7.5 4.8 4.0 6.7 2.4 8.6 2.8 7.5 3.7 2.8 6.4 6.9 13.5 1.6 34.1 9.2 14.2 6.3 7.0 8.5 10.0 7.2 7.2 4.7 6.3 9.1 6.1 7.1 2.8 0.5 9.9 3.9 9.2 4.1 5.9 2.8 6.4 7.2 12.3 6.2 4.8 18.7 9.5 6.2 6.8 4.6 1.6 11.1 4.9 7.1 4.1 12.2 5.3 2.7 5.1 9.6 15.2 7.3 5.1 3.4 5.7 9.7 3.6 7.9 5.0 3.8 5.9 5.1 5.7 4.9 2.8 6.8 7.6 5.5 6.3 3.6 2.8 5.8 4.4 2.7 12.3 11.8 18.5 12.8 11.7 10.4 13.3 12.3 10.2 13.4 6.0 0.6 0.5 1.0 0.7 4.2 2.4 2.5 2.7 7.9 0.0 0.0 0.8 0.0 0.9 0.4 2.2 0.9 0.0 1.2 0.7 0.8 1.4 4.6 1.7 0.9 1.6 5.8 3.1 1.6 0.0 2.3 1.5 0.0 0.0 1.6 1.1 0.4 0.0 1.4 1.1 3.6 6.5 0.9 1.2 2.1 1.1 0.7 0.0 1.7 1.3 ZNF418 "FLJ31551, KIAA1956" ENSG00000196724 "Zinc finger protein 418" Q8TF45 19 57921884-57935393 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 7.7;Ciliated cells: 8.1;Sertoli cells: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 13.2;SuSa: 9.5;T-47d: 8.2" "HPA043800, HPA053762, HPA072145" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: " "unprognostic (4.41e-2)" "unprognostic (3.20e-1)" "unprognostic (1.91e-1)" "unprognostic (4.27e-1)" "unprognostic (2.21e-2)" "unprognostic (1.44e-2)" "unprognostic (1.62e-1)" "unprognostic (2.20e-1)" "unprognostic (2.96e-3)" "unprognostic (1.14e-1)" "unprognostic (6.92e-3)" "prognostic unfavorable (1.72e-4)" "unprognostic (1.63e-2)" "unprognostic (4.77e-2)" "unprognostic (1.66e-1)" "unprognostic (1.29e-1)" "unprognostic (1.36e-3)" 3.0 4.5 9.4 4.2 13.4 2.7 9.3 25.8 11.8 4.4 6.0 16.0 9.4 1.6 6.4 8.6 3.1 7.5 5.5 13.2 9.8 6.3 5.7 3.2 5.4 7.5 14.5 10.2 10.3 6.9 14.8 10.0 8.7 9.9 7.7 2.5 5.8 5.0 9.2 4.6 13.7 3.6 6.5 9.7 7.4 5.3 8.2 11.9 3.5 9.9 1.0 6.8 5.8 4.3 8.5 2.9 1.9 2.1 5.9 3.0 1.1 0.4 2.0 13.2 4.2 2.1 4.5 1.5 3.7 1.3 3.0 0.2 0.3 1.4 0.5 2.7 2.3 4.0 1.2 0.0 3.3 3.6 0.3 1.1 0.2 0.9 0.2 1.2 0.4 2.7 3.7 1.0 3.7 0.0 0.0 0.6 1.1 1.0 0.9 2.5 0.5 0.7 0.5 6.8 0.1 0.5 0.5 1.0 4.4 2.6 1.6 0.2 0.6 0.1 2.4 0.1 9.5 8.2 1.4 0.0 0.8 0.6 0.5 0.7 2.2 5.2 3.3 0.4 1.5 2.6 1.9 0.8 0.7 0.3 2.1 0.8 5.0 1.8 1.2 1.7 8.5 3.0 0.8 1.1 5.9 0.7 2.9 0.0 1.1 9.4 13.4 25.8 11.8 9.8 6.3 14.5 10.2 9.9 11.9 0.0 1.1 0.5 0.8 0.3 3.9 7.7 2.5 8.1 1.2 0.0 3.9 1.0 1.7 1.1 0.1 1.6 0.0 0.0 0.5 0.5 0.9 1.1 5.7 0.5 0.7 3.2 0.0 1.8 0.0 0.2 0.3 0.0 0.0 0.0 0.0 4.0 0.2 0.0 1.4 0.7 5.4 12.9 0.9 1.0 6.4 0.4 0.7 0.5 0.0 0.7 ZNF419 "ZAPHIR, ZNF419A" ENSG00000105136 "Zinc finger protein 419" Q96HQ0 19 57487711-57496097 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 24.5" "HPA003152, HPA003274" Uncertain Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA003152: AB_1080716, HPA003274: AB_1080714" "unprognostic (3.50e-2)" "unprognostic (1.40e-5)" "unprognostic (1.12e-1)" "unprognostic (2.63e-2)" "unprognostic (2.55e-2)" "unprognostic (8.26e-2)" "unprognostic (2.93e-2)" "unprognostic (1.21e-2)" "unprognostic (3.18e-1)" "unprognostic (1.33e-1)" "unprognostic (8.55e-5)" "prognostic unfavorable (6.47e-4)" "unprognostic (1.20e-1)" "unprognostic (2.42e-1)" "unprognostic (1.55e-1)" "unprognostic (1.28e-1)" "prognostic favorable (2.53e-5)" 7.1 10.3 11.0 8.9 12.4 4.4 11.9 20.4 14.3 8.6 7.1 8.4 8.7 6.4 7.6 17.0 5.7 11.0 6.5 8.0 10.9 9.4 9.4 8.4 10.0 11.2 11.4 11.7 13.4 6.0 17.4 17.3 10.2 12.4 10.6 6.4 7.0 9.1 11.6 17.4 12.0 7.1 7.1 10.2 12.7 7.4 7.2 12.1 8.4 14.1 4.8 14.2 6.6 5.6 12.4 4.1 5.4 3.2 8.7 13.3 4.5 3.7 3.8 7.5 7.8 3.6 5.6 6.4 4.6 6.5 4.3 24.5 2.7 2.3 1.3 3.6 3.3 3.8 1.1 3.3 9.3 6.2 0.3 16.8 5.8 5.9 2.9 12.6 4.6 4.4 7.8 14.2 4.2 10.6 8.9 4.7 5.9 0.6 0.9 5.6 0.6 7.3 4.8 5.1 0.4 5.5 6.9 7.4 5.1 4.6 8.1 6.1 7.1 4.4 4.3 4.4 7.0 3.8 6.9 4.7 5.1 5.6 1.8 4.1 10.8 12.2 3.3 4.0 2.5 4.2 3.8 2.5 5.4 5.3 3.2 8.5 12.4 8.5 6.6 4.1 12.1 13.3 7.7 3.2 8.7 2.4 3.0 5.4 4.5 11.0 12.4 20.4 14.3 10.9 9.4 11.4 11.7 12.4 12.1 0.0 7.7 11.5 4.7 3.7 8.2 3.9 2.5 0.0 3.4 7.0 5.9 4.3 0.0 5.2 0.2 3.6 1.3 0.0 1.6 2.1 2.3 6.3 4.6 4.2 2.8 9.5 1.2 7.4 3.1 0.4 1.7 1.8 5.0 5.4 2.3 5.8 1.9 0.9 5.3 1.7 9.5 6.5 2.4 1.4 7.9 3.3 7.0 7.5 1.2 4.3 ZNF420 FLJ32191 ENSG00000197050 "Zinc finger protein 420" Q8TAQ5 19 37007857-37130314 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA059675 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA059675: AB_2684101" "unprognostic (1.00e-2)" "unprognostic (5.00e-2)" "unprognostic (2.30e-2)" "unprognostic (5.40e-3)" "prognostic favorable (3.57e-5)" "unprognostic (7.94e-2)" "unprognostic (8.66e-2)" "unprognostic (1.39e-1)" "unprognostic (7.14e-3)" "unprognostic (1.64e-1)" "unprognostic (5.24e-2)" "unprognostic (7.59e-2)" "prognostic favorable (1.83e-4)" "unprognostic (2.42e-1)" "unprognostic (7.23e-2)" "unprognostic (7.35e-3)" "unprognostic (1.63e-2)" 6.0 7.4 9.3 6.6 12.6 2.2 9.7 21.2 12.1 9.2 6.6 6.1 5.8 4.2 8.6 6.9 5.8 9.7 4.9 5.7 10.6 7.9 7.4 5.5 4.7 7.6 12.5 7.7 14.8 5.3 12.5 16.0 5.6 10.0 7.6 4.5 4.6 5.6 7.3 8.4 6.2 4.9 9.7 8.7 7.0 5.3 15.5 10.6 9.3 12.3 3.1 7.9 5.8 8.6 10.7 4.8 5.8 3.4 11.1 11.8 5.1 0.0 7.0 6.5 6.8 6.0 3.9 3.6 4.1 4.3 4.9 7.5 1.4 1.4 3.3 8.7 2.8 3.1 1.2 6.4 2.1 5.6 10.8 5.3 7.3 4.2 2.7 6.2 5.9 3.3 4.0 4.7 5.0 3.5 5.5 2.7 5.6 4.1 0.3 5.5 2.3 10.2 2.3 7.4 2.6 4.1 5.8 13.6 7.0 2.7 4.4 9.2 10.5 6.2 2.5 3.3 4.9 4.1 5.2 3.0 5.0 7.9 4.6 4.9 10.1 12.6 8.1 0.0 1.2 4.4 1.8 2.5 5.8 9.0 3.4 9.7 8.7 10.1 9.4 4.8 10.7 10.5 11.3 0.4 11.1 3.3 2.5 11.8 5.1 9.3 12.6 21.2 12.1 10.6 7.9 12.5 7.7 10.0 10.6 11.9 11.3 1.7 2.4 8.9 20.3 4.8 2.5 9.4 7.9 3.5 0.0 7.5 6.6 3.2 25.4 5.6 1.4 0.0 1.1 3.5 4.5 3.4 12.7 3.8 3.6 15.9 5.8 8.6 3.8 24.2 8.9 2.2 6.8 1.8 2.7 6.0 1.7 3.5 8.9 3.7 8.8 25.8 6.1 14.0 7.0 7.5 3.3 7.9 4.0 1.8 ZNF423 "Ebfaz, JBTS19, KIAA0760, NPHP14, OAZ, Roaz, Zfp104" ENSG00000102935 "Zinc finger protein 423" Q2M1K9 16 49487524-49857919 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Ciliopathy, Disease mutation, Joubert syndrome, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Late spermatids: 47.7;Leydig cells: 25.6;Peritubular cells: 51.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "NK-cell: 1.6" "Lineage enriched" "Detected in single" 5 "NK-cells: 1.6" "Cell line enhanced" "Detected in some" "AF22: 24.7;NTERA-2: 12.6;REH: 10.7;SCLC-21H: 13.4;SH-SY5Y: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015258, HPA065820" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA015258: , HPA065820: AB_2685563" "unprognostic (2.81e-1)" "unprognostic (1.18e-1)" "unprognostic (1.19e-1)" "unprognostic (2.68e-1)" "unprognostic (2.86e-1)" "unprognostic (8.65e-3)" "unprognostic (3.37e-2)" "unprognostic (4.84e-2)" "unprognostic (1.14e-1)" "unprognostic (2.77e-1)" "unprognostic (9.13e-2)" "unprognostic (8.97e-2)" "unprognostic (1.22e-1)" "unprognostic (6.64e-3)" "unprognostic (8.25e-2)" "unprognostic (2.92e-2)" "unprognostic (5.84e-2)" 10.8 4.1 10.3 3.0 8.8 0.9 7.3 9.1 9.0 14.3 4.8 7.7 6.8 2.2 10.0 9.4 6.7 14.0 9.3 9.1 8.8 9.5 1.9 1.5 6.7 3.7 8.6 7.2 13.6 4.2 5.3 4.7 5.8 7.5 12.2 4.0 14.5 4.0 13.8 28.7 2.4 3.3 9.3 5.6 2.2 2.6 7.1 7.7 0.0 4.9 11.0 2.2 5.3 7.1 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 24.7 1.3 2.0 0.3 3.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.5 0.0 0.0 0.7 0.2 0.0 1.6 0.0 0.1 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.8 0.2 12.6 0.0 0.0 10.7 0.0 0.0 0.0 0.7 13.4 40.1 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.4 7.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 10.3 8.8 9.1 8.8 8.8 9.5 8.6 7.2 7.5 7.7 0.0 0.0 0.0 0.2 2.4 8.0 2.8 0.0 0.0 0.0 0.0 0.0 0.5 1.7 0.2 14.5 9.1 0.4 0.0 0.2 0.6 10.8 0.1 0.0 0.8 0.6 0.0 0.0 12.9 0.3 47.7 25.6 0.2 1.7 0.0 1.3 7.5 0.2 0.0 51.2 0.0 1.0 0.0 6.4 0.5 0.6 1.5 0.2 0.0 0.4 0.0 ZNF425 ENSG00000204947 "Zinc finger protein 425" Q6IV72 7 149102784-149126346 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 5.0;Horizontal cells: 6.4;Peritubular cells: 4.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA020087 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA020087: AB_2670358" "unprognostic (4.27e-1)" "unprognostic (1.28e-1)" "unprognostic (7.40e-4)" "unprognostic (9.97e-2)" "unprognostic (1.19e-1)" "unprognostic (1.35e-2)" "unprognostic (8.18e-2)" "unprognostic (2.63e-2)" "unprognostic (1.25e-2)" "unprognostic (2.14e-1)" "unprognostic (8.21e-4)" "unprognostic (3.09e-1)" "unprognostic (1.25e-4)" "unprognostic (3.04e-2)" "unprognostic (2.32e-1)" "unprognostic (5.19e-3)" "unprognostic (1.58e-2)" 1.5 3.1 7.2 3.7 7.4 1.4 4.0 7.7 9.6 4.9 3.7 10.8 2.1 2.3 5.2 5.2 4.8 5.5 4.1 2.0 7.9 5.3 4.3 2.4 2.3 1.9 6.2 9.3 9.0 3.4 8.2 3.0 1.6 7.8 4.6 1.8 4.7 3.8 5.5 7.5 5.6 1.9 5.6 4.8 2.2 3.3 3.1 6.2 3.3 4.6 1.6 2.6 3.8 3.0 4.3 4.5 4.3 1.5 6.1 5.4 1.6 1.9 2.5 5.2 4.4 7.8 2.3 3.0 2.8 4.8 1.5 1.8 0.7 2.6 2.2 4.1 2.2 2.1 2.7 0.9 1.4 0.7 1.6 2.0 2.6 3.1 1.2 4.4 1.3 1.2 4.6 2.4 1.5 2.9 4.4 0.8 3.5 2.0 2.3 5.3 9.0 3.4 4.0 12.2 2.8 4.7 3.7 2.7 1.3 3.4 2.7 2.3 4.3 2.8 3.5 6.5 3.5 2.3 3.8 0.9 3.5 0.5 3.9 0.8 4.5 2.8 1.8 2.9 0.8 2.9 4.3 1.4 2.8 3.9 1.5 5.3 3.0 3.3 2.8 1.3 4.3 4.9 5.4 3.5 6.1 0.9 4.5 3.9 1.6 7.2 7.4 7.7 9.6 7.9 5.3 6.2 9.3 7.8 6.2 0.0 1.3 0.0 0.7 0.2 3.1 1.4 0.0 2.7 1.2 3.5 0.0 0.7 5.0 1.3 0.6 0.3 0.5 0.0 0.4 0.6 0.6 0.8 0.0 0.6 0.4 6.4 1.2 0.0 0.0 0.0 4.0 0.0 0.0 2.8 0.9 4.3 0.6 0.0 4.9 0.8 1.1 0.0 1.2 2.3 3.6 0.3 0.8 0.0 0.6 0.4 ZNF426 MGC2663 ENSG00000130818 "Zinc finger protein 426" Q9BUY5 19 9523224-9538645 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029342 Approved Approved Nucleoplasm Yes No Nucleoplasm "HPA029342: AB_10603007" "unprognostic (3.64e-1)" "unprognostic (1.52e-1)" "unprognostic (1.31e-1)" "unprognostic (1.65e-2)" "unprognostic (6.62e-2)" "prognostic favorable (3.74e-4)" "unprognostic (4.34e-2)" "unprognostic (1.77e-2)" "unprognostic (4.75e-3)" "unprognostic (1.05e-3)" "unprognostic (8.89e-3)" "unprognostic (7.41e-3)" "prognostic favorable (2.57e-6)" "unprognostic (1.05e-1)" "unprognostic (3.17e-2)" "unprognostic (2.49e-1)" "prognostic favorable (1.81e-4)" 8.0 7.0 6.5 5.0 8.9 6.7 9.3 13.5 8.8 10.9 7.8 7.5 7.2 3.9 10.3 7.2 28.2 8.5 5.9 7.1 8.0 4.5 6.6 3.1 6.8 7.2 6.4 5.4 12.8 5.8 9.1 7.9 7.3 7.0 8.4 5.4 7.8 8.8 7.7 6.7 6.6 5.6 10.5 8.0 5.9 6.7 7.9 7.3 9.9 9.1 6.7 7.4 11.1 11.9 8.8 4.4 9.8 6.7 8.7 12.7 3.9 4.4 1.5 9.2 9.7 6.2 8.2 5.2 5.8 8.7 7.7 9.5 2.0 2.1 4.5 4.7 5.6 5.4 3.8 9.5 6.7 11.7 2.1 7.3 18.7 7.6 3.4 5.6 0.6 6.1 10.4 5.9 8.6 12.4 8.5 8.3 7.9 7.4 0.5 7.4 0.4 10.7 9.1 11.5 1.0 3.6 5.8 11.4 4.7 4.3 11.7 5.2 7.0 9.7 3.5 7.9 8.3 4.8 4.4 6.7 11.0 6.4 4.8 6.1 5.3 7.4 3.9 1.6 0.3 7.8 9.8 3.9 6.9 11.2 5.6 9.9 8.6 8.7 10.9 4.4 8.8 12.7 11.9 8.3 8.7 6.7 4.1 8.1 3.9 6.5 8.9 13.5 8.8 8.0 4.5 6.4 5.4 7.0 7.3 26.8 34.0 5.4 13.4 3.1 22.8 8.7 2.5 24.1 19.4 7.0 19.6 10.8 18.3 9.4 24.1 12.7 3.2 23.3 3.5 8.2 7.7 12.5 26.7 2.5 6.6 35.0 3.5 12.3 7.6 4.9 15.8 7.4 3.3 10.0 5.9 22.7 5.7 3.5 20.8 5.0 18.2 6.5 8.8 12.5 9.8 2.5 11.9 12.5 6.9 16.1 ZNF429 ENSG00000197013 "Zinc finger protein 429" Q86V71 19 21496682-21556270 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA004139 Approved Nucleoplasm NA NA Nucleoplasm "HPA004139: AB_2667147" "unprognostic (1.06e-1)" "unprognostic (1.88e-1)" "unprognostic (2.77e-1)" "unprognostic (1.75e-2)" "unprognostic (1.45e-2)" "unprognostic (3.13e-1)" "unprognostic (3.39e-2)" "unprognostic (1.95e-2)" "unprognostic (2.19e-1)" "prognostic favorable (1.96e-8)" "prognostic favorable (7.30e-4)" "unprognostic (5.85e-2)" "unprognostic (1.08e-2)" "unprognostic (2.91e-2)" "unprognostic (2.94e-2)" "unprognostic (2.19e-1)" "unprognostic (1.48e-1)" 6.3 14.3 12.0 4.8 13.1 4.3 11.2 15.3 14.2 10.2 6.7 12.3 10.3 5.4 7.5 12.4 6.2 10.8 5.6 4.9 9.6 7.6 11.3 11.1 6.4 9.0 12.6 8.6 14.3 14.3 17.7 24.1 7.4 12.3 8.7 8.9 8.4 9.3 8.2 5.2 11.0 6.2 5.7 9.1 10.6 8.4 11.3 12.9 7.5 16.6 5.1 7.5 7.8 7.5 7.2 2.7 10.4 2.4 9.2 9.5 2.8 0.3 0.9 5.2 6.1 3.6 3.7 4.7 2.7 2.0 3.8 5.8 0.6 3.3 4.4 7.6 1.8 3.3 1.4 3.0 1.2 7.5 1.3 3.6 0.8 0.7 1.6 1.9 4.6 1.8 3.3 1.8 2.3 0.7 3.5 0.2 7.0 7.2 0.9 5.9 3.2 11.0 2.9 5.3 0.1 1.7 5.0 2.9 1.8 4.2 5.2 8.6 3.5 0.2 0.2 1.8 10.8 6.1 2.9 0.6 0.5 1.1 4.3 2.0 0.7 3.6 5.9 0.3 0.4 1.7 10.0 1.8 8.4 4.9 2.2 5.3 7.2 6.8 6.5 1.6 6.4 9.5 8.6 10.4 9.2 2.4 2.7 4.1 2.8 12.0 13.1 15.3 14.2 9.6 7.6 12.6 8.6 12.3 12.9 26.8 9.9 1.5 5.8 2.5 13.6 4.8 5.1 17.4 14.8 7.0 5.9 7.7 18.3 6.3 27.6 5.0 4.0 0.0 4.4 6.1 5.8 5.1 3.5 5.4 3.0 3.2 6.4 6.7 2.1 3.9 10.6 4.3 5.0 1.8 5.6 10.0 5.0 6.2 5.6 10.6 7.6 19.4 5.1 14.2 16.8 1.8 5.7 10.2 5.8 3.1 ZNF432 KIAA0798 ENSG00000256087 "Zinc finger protein 432" O94892 19 52031379-52095738 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 25.4;Rod photoreceptor cells: 29.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA052082, HPA060274, HPA065606" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA052082: AB_2681719, HPA060274: AB_2684238, HPA065606: AB_2685518" "unprognostic (1.62e-1)" "unprognostic (2.34e-1)" "unprognostic (1.92e-1)" "unprognostic (7.04e-3)" "unprognostic (1.08e-2)" "unprognostic (2.41e-3)" "unprognostic (3.19e-2)" "unprognostic (2.56e-1)" "unprognostic (6.92e-2)" "unprognostic (1.83e-1)" "unprognostic (3.14e-2)" "unprognostic (5.49e-3)" "prognostic unfavorable (6.47e-4)" "unprognostic (1.90e-1)" "unprognostic (2.04e-1)" "unprognostic (1.90e-1)" "prognostic favorable (4.11e-5)" 8.6 9.8 8.4 5.9 12.5 9.4 9.6 11.0 9.1 14.3 5.9 4.5 6.4 6.4 8.3 12.8 7.2 7.9 5.2 7.0 9.8 5.9 10.1 4.3 6.0 5.6 7.8 7.3 10.8 19.0 8.5 15.5 6.3 8.8 17.4 6.2 7.3 7.5 6.9 4.2 9.7 8.6 6.4 10.8 8.3 6.9 9.3 11.2 8.9 14.0 4.2 5.6 8.2 7.2 5.6 3.0 4.1 4.1 2.5 5.7 2.9 4.3 3.6 9.0 13.2 5.5 6.8 3.0 4.9 4.2 3.8 6.3 2.9 2.6 3.2 1.7 5.6 4.2 3.2 4.5 5.1 6.5 3.1 11.3 8.8 8.2 5.4 2.6 0.0 8.2 7.4 3.6 5.3 7.6 7.2 5.1 3.6 2.6 13.2 7.0 2.3 8.8 5.1 3.3 2.2 5.7 4.4 8.9 4.8 5.4 19.5 5.2 4.9 7.7 4.2 2.6 6.2 4.0 3.9 6.5 3.6 5.1 3.6 5.0 6.6 9.0 6.9 6.8 0.8 6.0 2.7 3.6 4.1 5.1 4.1 3.6 5.6 3.1 3.4 3.0 4.9 5.7 4.0 3.8 2.5 2.1 2.3 3.7 2.9 8.4 12.5 11.0 9.1 9.8 5.9 7.8 7.3 8.8 11.2 14.9 10.6 2.4 2.9 1.8 9.5 5.2 2.5 13.4 18.2 8.7 15.7 2.1 3.3 2.7 12.2 4.1 2.1 0.0 1.4 5.1 3.7 3.8 11.6 0.8 2.0 25.4 9.8 4.3 4.6 9.0 3.4 2.5 3.3 2.8 4.6 6.2 1.4 5.1 4.2 2.2 29.8 6.5 3.3 8.0 7.5 1.9 4.1 3.2 3.0 2.1 ZNF436 "KIAA1710, Zfp46" ENSG00000125945 "Zinc finger protein 436" Q9C0F3 1 23359448-23369442 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 15.2;HSkMC: 27.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043817 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043817: AB_10794774" "unprognostic (1.50e-1)" "unprognostic (2.91e-1)" "unprognostic (1.44e-1)" "unprognostic (1.93e-1)" "unprognostic (8.10e-2)" "unprognostic (2.12e-2)" "unprognostic (1.10e-1)" "unprognostic (1.20e-1)" "unprognostic (1.86e-1)" "unprognostic (1.09e-2)" "unprognostic (1.76e-1)" "unprognostic (1.92e-1)" "unprognostic (9.51e-3)" "unprognostic (5.04e-2)" "unprognostic (3.22e-1)" "unprognostic (1.06e-1)" "unprognostic (7.75e-3)" 14.5 18.6 10.1 4.7 13.0 2.9 12.9 13.6 15.8 10.7 8.7 11.8 8.6 6.3 15.1 17.5 18.4 10.2 11.2 11.7 9.9 6.1 6.7 4.3 7.8 5.6 12.9 9.6 20.3 8.1 11.6 6.5 8.5 11.3 12.1 6.9 6.3 16.9 13.4 7.2 15.6 6.1 12.7 12.6 8.0 6.8 10.4 10.0 5.7 12.3 9.7 8.0 12.5 11.2 1.6 2.8 1.6 2.1 6.6 2.3 1.6 2.8 1.8 6.5 3.4 7.3 15.2 3.1 2.5 3.5 3.3 3.9 1.0 2.4 1.9 2.9 3.6 2.1 3.5 11.6 4.3 3.6 2.3 2.5 2.0 3.7 1.6 2.9 0.8 1.4 27.7 6.3 2.8 3.3 6.0 4.7 2.3 2.4 1.4 3.5 1.3 2.1 1.6 0.2 1.3 2.8 2.8 2.7 1.8 2.7 7.2 3.0 3.7 7.1 3.6 2.8 2.3 2.0 1.0 3.7 2.8 2.1 2.2 1.4 2.1 2.6 1.6 2.2 1.7 2.2 0.0 1.8 1.6 2.0 2.1 2.0 1.3 1.4 2.1 2.8 1.6 2.3 2.0 1.3 6.6 2.0 0.4 2.2 1.6 10.1 13.0 13.6 15.8 9.9 6.1 12.9 9.6 11.3 10.0 0.0 0.3 0.8 1.0 4.6 3.6 4.8 2.5 2.7 0.0 5.2 5.9 2.9 0.0 2.7 0.9 8.7 2.7 0.0 4.3 1.5 4.6 3.4 0.0 3.0 1.8 9.5 3.5 1.8 2.6 1.1 9.2 0.7 5.0 6.4 3.9 11.8 3.9 5.8 11.0 2.1 2.1 0.0 2.0 4.7 6.0 8.4 2.4 1.0 2.9 1.1 ZNF438 bA330O11.1 ENSG00000183621 "Zinc finger protein 438" Q7Z4V0 10 30820207-31031937 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 14.5;HUVEC TERT2: 14.6;U-937: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039843 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039843: AB_10795159" "unprognostic (1.69e-1)" "unprognostic (9.49e-3)" "unprognostic (3.72e-2)" "unprognostic (9.21e-2)" "unprognostic (4.75e-2)" "unprognostic (1.22e-2)" "unprognostic (3.98e-3)" "unprognostic (1.30e-1)" "unprognostic (4.65e-1)" "unprognostic (2.33e-1)" "unprognostic (2.11e-2)" "unprognostic (4.85e-2)" "unprognostic (1.08e-2)" "unprognostic (9.96e-2)" "unprognostic (1.52e-1)" "unprognostic (8.52e-3)" "unprognostic (9.50e-2)" 21.8 5.8 9.8 10.0 10.2 7.9 9.7 11.8 9.9 10.6 12.9 13.0 2.6 6.2 22.6 11.3 8.3 10.2 9.2 13.8 9.3 6.2 6.2 8.6 12.0 7.1 10.1 6.6 10.2 4.5 6.6 17.3 6.4 9.6 9.0 6.9 7.7 9.5 9.6 29.1 8.9 7.6 14.3 8.6 13.6 8.3 10.1 11.9 7.7 15.8 8.7 5.2 10.5 12.1 3.1 3.1 14.1 7.8 3.8 3.9 3.5 2.8 2.8 2.4 2.1 14.5 10.1 1.4 2.2 3.2 3.5 4.4 0.1 3.4 3.8 2.6 3.9 3.3 0.7 1.2 1.7 5.0 8.7 0.9 1.6 1.6 0.1 8.1 1.3 1.8 4.8 2.9 5.0 2.9 3.2 14.6 4.5 3.2 2.7 4.8 2.0 4.3 7.3 0.2 2.0 1.2 1.9 3.5 2.2 5.0 0.7 1.8 2.0 1.1 0.4 1.5 1.7 1.1 12.3 6.1 1.6 2.7 4.7 2.7 0.6 1.0 0.0 3.2 19.2 1.1 1.4 7.8 3.3 2.3 7.4 1.7 1.2 1.8 3.0 2.4 3.1 3.6 2.0 14.1 3.8 4.4 3.1 3.9 3.5 9.8 10.2 11.8 9.9 9.3 6.2 10.1 6.6 9.6 11.9 3.0 3.7 0.5 1.9 0.9 5.4 10.1 2.5 5.3 5.7 3.5 5.9 2.7 6.6 3.0 9.5 3.7 2.0 0.0 3.8 4.0 3.1 1.0 11.6 1.0 7.0 3.2 0.0 6.2 11.7 5.7 3.7 9.1 0.0 3.6 2.5 1.8 3.2 0.0 7.8 2.7 5.0 6.5 5.1 6.4 6.4 2.0 1.4 1.8 2.3 2.0 ZNF439 DKFZp571K0837 ENSG00000171291 "Zinc finger protein 439" Q8NDP4 19 11848726-11883750 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 49.1;Rod photoreceptor cells: 47.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 15.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 12.9;U-138 MG: 13.8" HPA047845 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA047845: AB_2680178" "unprognostic (1.56e-1)" "unprognostic (2.56e-3)" "unprognostic (4.83e-2)" "unprognostic (3.55e-3)" "unprognostic (2.93e-2)" "unprognostic (1.19e-3)" "unprognostic (8.26e-3)" "unprognostic (7.54e-2)" "unprognostic (1.14e-1)" "unprognostic (5.17e-2)" "unprognostic (9.66e-4)" "unprognostic (1.00e-1)" "unprognostic (8.68e-2)" "unprognostic (2.40e-1)" "unprognostic (8.19e-2)" "unprognostic (4.94e-2)" "unprognostic (1.29e-2)" 3.4 4.7 11.0 8.6 13.2 6.2 9.9 19.7 10.7 6.2 6.0 9.2 6.6 2.3 7.4 9.0 4.3 5.2 4.4 5.5 8.8 5.3 8.0 1.9 6.7 11.2 15.7 10.5 11.4 6.1 27.3 16.8 8.8 11.8 8.2 6.8 5.8 7.0 8.1 1.8 13.1 10.0 4.9 9.7 12.4 5.1 8.5 12.8 13.7 10.0 2.3 12.4 9.0 8.1 8.6 2.5 15.9 2.8 1.9 5.3 1.9 0.1 0.0 3.6 10.6 0.3 0.3 0.0 4.5 1.6 5.4 3.7 2.5 0.2 3.8 1.9 2.4 1.6 0.1 0.0 0.3 6.4 0.0 0.1 3.7 0.0 1.5 1.1 0.0 3.7 1.1 0.3 1.1 0.0 2.4 0.0 3.6 0.7 0.0 0.3 0.3 5.1 12.9 4.5 0.0 1.0 6.1 1.0 0.0 4.0 2.2 6.6 7.1 0.0 0.1 4.6 4.0 2.8 8.4 0.0 13.8 1.3 1.2 2.6 5.3 8.2 8.6 0.2 0.0 3.7 15.9 0.5 4.8 1.7 1.4 2.1 8.6 2.8 1.7 2.5 7.6 5.3 2.9 1.5 1.9 2.8 2.4 1.1 1.9 11.0 13.2 19.7 10.7 8.8 5.3 15.7 10.5 11.8 12.8 3.0 7.2 15.7 1.8 0.5 27.0 3.1 12.7 6.7 10.3 0.0 49.1 24.1 3.3 6.9 3.6 4.7 4.1 0.0 1.6 17.8 3.1 2.5 28.9 0.0 3.5 15.9 5.8 7.4 1.6 2.8 4.0 3.1 5.0 1.0 2.4 12.5 2.5 3.2 7.4 1.9 47.8 12.9 3.8 15.6 6.6 1.6 11.3 8.5 2.1 1.4 ZNF44 "KOX7, ZNF504, ZNF55, ZNF58" ENSG00000197857 "Zinc finger protein 44" P15621 19 12224686-12294887 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 81.2;Early spermatids: 95.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA003146 Supported Approved Nucleoplasm,Microtubules,Cytosol NA NA Nucleoplasm "Microtubules, Cytosol" "HPA003146: AB_1080723" "unprognostic (1.51e-1)" "unprognostic (2.47e-3)" "unprognostic (7.07e-2)" "unprognostic (4.60e-2)" "unprognostic (9.63e-2)" "prognostic favorable (8.74e-4)" "unprognostic (8.39e-2)" "prognostic favorable (7.54e-4)" "unprognostic (5.65e-3)" "unprognostic (9.17e-2)" "unprognostic (1.75e-3)" "unprognostic (3.56e-3)" "unprognostic (7.30e-3)" "unprognostic (2.75e-1)" "unprognostic (2.09e-1)" "unprognostic (5.69e-2)" "prognostic favorable (9.21e-6)" 10.5 8.4 9.6 7.3 13.1 20.2 13.6 19.3 9.8 9.8 11.6 7.9 20.8 8.2 9.6 13.2 10.3 9.5 8.1 7.0 8.5 4.6 11.7 15.2 9.6 9.6 12.2 6.9 15.9 11.1 8.7 12.1 7.0 9.4 11.1 13.0 9.1 9.2 18.1 17.3 15.4 11.1 14.1 11.6 13.9 9.6 13.8 12.8 6.5 11.3 6.5 10.5 10.7 10.8 4.7 3.1 15.1 3.0 11.5 9.5 3.5 3.6 1.0 2.8 4.9 2.8 2.8 12.0 5.2 2.3 8.3 7.4 4.9 2.0 3.6 6.5 4.9 2.4 3.8 3.5 3.6 7.2 0.0 3.3 3.4 4.8 12.9 3.8 0.0 9.3 2.9 5.7 5.1 6.6 3.4 3.2 4.4 2.2 0.7 5.2 3.7 5.2 6.0 2.7 3.6 6.2 3.6 6.2 4.4 5.0 8.6 3.1 3.7 6.6 2.6 1.6 7.8 5.5 5.8 3.7 10.0 2.7 9.7 4.5 7.7 9.7 3.5 0.2 3.1 2.9 9.8 1.6 15.1 8.0 3.0 9.4 4.7 8.6 8.6 1.4 3.2 9.5 9.2 5.3 11.5 3.0 3.1 5.7 3.5 9.6 13.1 19.3 9.8 8.5 4.6 12.2 6.9 9.4 12.8 26.8 14.5 9.3 5.4 8.0 16.5 15.1 22.9 32.1 17.0 61.1 35.3 14.0 81.2 8.3 95.8 7.1 14.2 0.0 8.0 6.3 8.0 6.5 23.1 11.1 7.2 15.9 15.0 14.1 7.9 23.8 13.0 10.8 10.1 3.6 11.5 10.6 7.3 11.5 5.6 9.1 35.3 19.4 9.8 17.6 17.9 10.2 7.2 19.2 11.8 8.6 ZNF440 FLJ37933 ENSG00000171295 "Zinc finger protein 440" Q8IYI8 19 11814284-11835201 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 83.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 12.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 20.1" HPA047845 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA047845: AB_2680178" "unprognostic (2.48e-1)" "unprognostic (8.96e-3)" "unprognostic (1.34e-1)" "unprognostic (4.40e-2)" "unprognostic (2.45e-3)" "unprognostic (1.24e-3)" "unprognostic (1.03e-1)" "unprognostic (3.13e-2)" "unprognostic (9.05e-2)" "unprognostic (4.64e-3)" "unprognostic (1.33e-1)" "prognostic unfavorable (3.57e-4)" "prognostic favorable (1.18e-4)" "unprognostic (9.81e-3)" "unprognostic (2.22e-1)" "unprognostic (3.80e-2)" "prognostic favorable (9.88e-4)" 8.5 6.3 5.2 6.4 7.7 7.8 9.5 12.7 9.1 10.1 13.0 4.5 9.2 7.5 11.0 8.6 15.2 19.6 6.0 4.9 10.4 4.4 9.1 5.8 10.7 5.9 5.2 5.7 10.7 8.5 19.2 9.5 21.2 11.1 12.4 15.2 5.4 11.0 10.6 5.4 20.4 11.7 6.0 7.9 7.2 11.4 9.0 6.1 6.6 8.7 9.2 7.0 19.1 10.7 1.8 2.4 12.1 3.6 3.8 2.4 1.0 5.1 0.0 5.9 7.2 4.5 4.0 15.6 3.7 3.0 4.4 3.9 5.5 4.5 2.9 3.6 3.3 2.2 6.5 3.0 7.0 6.2 0.2 2.0 4.1 3.3 4.4 2.2 0.0 9.4 2.3 4.8 2.8 0.8 3.1 2.5 4.0 15.2 0.3 5.1 2.2 3.6 5.3 4.5 1.8 4.7 3.0 7.7 1.2 3.2 20.1 3.4 2.7 5.7 2.4 4.1 6.6 10.3 7.9 2.6 10.2 2.1 7.4 3.2 5.5 3.9 3.9 4.8 2.6 3.7 12.1 1.9 2.4 1.7 1.2 2.0 1.4 2.1 1.9 2.4 1.8 1.5 2.4 3.6 3.8 3.6 1.5 2.4 1.0 5.2 7.7 12.7 9.1 10.4 4.4 5.2 5.7 11.1 6.1 14.9 6.4 0.9 9.2 2.6 5.3 2.5 2.5 83.0 20.5 8.7 33.4 23.6 3.3 3.1 16.5 3.6 15.4 0.0 3.2 15.6 2.3 6.2 10.4 1.1 3.9 6.4 6.4 4.3 4.4 3.6 2.6 3.3 3.3 1.0 9.5 2.2 4.2 12.4 1.8 1.3 12.4 0.0 3.8 9.3 2.5 4.3 24.9 4.9 11.5 8.4 ZNF443 ZK1 ENSG00000180855 "Zinc finger protein 443" Q9Y2A4 19 12429707-12441112 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 13.9" "HPA003150, HPA018683" Approved Approved "Nucleoplasm,Centriolar satellite" NA NA Nucleoplasm "Centriolar satellite" "HPA003150: AB_1080725, HPA018683: AB_2669920" "unprognostic (5.64e-3)" "unprognostic (1.51e-2)" "unprognostic (7.98e-2)" "unprognostic (1.45e-2)" "unprognostic (1.92e-1)" "unprognostic (7.38e-3)" "unprognostic (3.42e-1)" "unprognostic (1.64e-3)" "unprognostic (1.28e-3)" "unprognostic (1.05e-2)" "unprognostic (7.10e-2)" "unprognostic (2.92e-2)" "prognostic favorable (2.74e-7)" "unprognostic (3.85e-3)" "unprognostic (2.16e-1)" "unprognostic (2.19e-2)" "prognostic favorable (3.91e-4)" 5.5 3.4 5.5 9.5 6.9 1.0 8.5 13.6 5.9 7.6 7.2 2.0 21.4 4.0 6.6 6.3 4.9 5.2 4.2 3.3 4.3 4.5 10.6 5.8 4.7 3.2 4.2 3.0 4.9 5.9 9.3 4.1 6.3 5.0 7.0 6.7 1.9 5.7 12.9 1.9 7.3 8.9 3.6 5.9 3.6 4.7 3.4 4.1 16.9 4.8 3.7 4.3 7.9 9.6 4.0 2.2 4.8 1.2 3.1 7.1 2.0 3.3 1.4 6.0 5.3 1.8 1.5 8.2 2.5 1.8 3.3 3.1 3.2 0.9 3.9 4.4 1.9 1.3 2.0 3.8 2.4 2.8 0.0 2.1 1.6 1.9 7.4 0.4 3.7 4.6 1.4 1.5 1.6 0.7 2.2 1.9 5.0 2.7 0.0 3.6 4.0 13.9 5.1 5.1 3.3 5.2 1.6 6.2 4.7 4.0 12.4 2.8 4.7 4.0 2.2 0.6 3.4 0.1 4.7 1.2 6.6 2.7 3.7 2.3 2.5 3.6 2.5 0.9 3.8 1.4 4.8 1.2 1.6 2.1 0.6 7.1 4.0 4.5 4.3 2.2 3.2 4.0 2.7 0.7 3.1 0.3 1.1 3.3 2.0 5.5 6.9 13.6 5.9 4.3 4.5 4.2 3.0 5.0 4.1 0.0 0.3 2.2 1.2 0.9 1.5 1.6 2.5 2.7 1.2 0.0 3.9 6.5 1.7 2.6 4.1 1.6 1.5 0.0 1.0 0.9 1.1 0.5 0.0 1.6 1.1 1.6 2.9 1.3 1.9 1.3 0.6 0.7 0.0 0.0 2.3 2.5 1.0 1.7 2.1 1.7 2.2 0.0 1.4 1.2 4.9 2.3 1.4 3.2 2.6 0.6 ZNF444 "EZF2, FLJ11137, ZSCAN17" ENSG00000167685 "Zinc finger protein 444" Q8N0Y2 19 56132599-56160893 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 51.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056895, HPA065203" Approved Enhanced Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA056895: AB_2683267, HPA065203: AB_2685431" "unprognostic (1.58e-1)" "unprognostic (3.34e-1)" "unprognostic (5.00e-2)" "unprognostic (1.23e-2)" "unprognostic (1.26e-1)" "unprognostic (4.57e-2)" "unprognostic (1.32e-2)" "unprognostic (2.01e-2)" "unprognostic (1.56e-1)" "unprognostic (7.29e-2)" "unprognostic (1.35e-3)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.61e-4)" "unprognostic (4.70e-2)" "unprognostic (1.32e-1)" "unprognostic (1.32e-1)" "prognostic favorable (1.87e-4)" 9.4 13.4 15.0 7.1 21.0 3.7 8.3 14.9 20.1 9.0 14.8 12.8 14.3 13.6 10.5 9.9 6.6 11.9 11.2 10.5 13.5 13.3 9.9 37.4 10.9 6.1 12.3 11.0 12.5 25.3 8.5 12.2 12.5 8.0 14.3 5.3 10.4 14.1 25.6 17.2 11.5 11.3 7.5 10.3 8.6 17.2 9.2 10.4 28.1 16.6 2.8 8.2 10.4 6.8 4.3 3.5 3.5 1.7 3.7 7.1 1.8 4.7 9.1 8.4 7.3 3.6 3.7 5.5 6.1 4.0 5.2 5.7 10.0 5.4 8.4 5.4 3.5 2.6 4.4 5.2 4.1 2.2 7.3 51.5 8.2 6.1 18.0 5.9 3.6 7.7 4.3 3.8 4.2 3.3 7.9 4.6 10.5 10.6 3.7 3.6 6.2 11.8 10.3 9.1 9.5 16.7 13.8 5.4 4.4 5.7 4.4 9.0 12.4 3.1 10.3 4.5 4.8 10.2 6.7 6.0 9.4 8.1 2.0 6.6 9.1 7.7 6.3 5.9 5.0 6.1 3.1 1.7 3.5 4.1 1.4 4.5 2.0 6.9 6.9 2.1 4.3 7.1 4.6 0.2 3.7 1.0 3.5 4.2 1.8 15.0 21.0 14.9 20.1 13.5 13.3 12.3 11.0 8.0 10.4 3.0 14.9 10.2 14.2 2.7 16.7 11.4 33.1 13.4 9.1 10.4 7.9 16.2 8.3 23.1 26.9 15.8 12.8 0.0 19.3 7.9 9.2 13.8 10.3 34.7 9.4 19.1 28.2 19.6 5.3 28.6 11.2 3.9 15.1 19.8 24.4 16.6 21.0 10.5 11.3 18.8 13.6 25.8 13.2 10.4 19.8 4.5 10.4 13.1 19.3 8.9 ZNF445 "ZKSCAN15, ZNF168, ZSCAN47" ENSG00000185219 "Zinc finger protein 445" P59923 3 44431720-44477670 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 34.4;Cone photoreceptor cells: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006678 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA Nucleoplasm "Mitochondria, Cytosol" "HPA006678: AB_10603329" "unprognostic (7.72e-2)" "unprognostic (2.55e-1)" "unprognostic (1.12e-2)" "unprognostic (1.42e-1)" "unprognostic (7.14e-2)" "unprognostic (1.67e-2)" "unprognostic (1.79e-2)" "unprognostic (2.72e-2)" "unprognostic (1.60e-2)" "unprognostic (1.62e-1)" "unprognostic (1.03e-2)" "unprognostic (4.55e-2)" "unprognostic (3.11e-3)" "unprognostic (1.76e-1)" "unprognostic (2.48e-1)" "unprognostic (4.40e-3)" "unprognostic (1.05e-1)" 6.8 6.4 8.3 6.4 10.9 4.5 7.5 16.5 10.9 8.6 7.1 11.7 8.0 5.1 13.6 7.7 5.2 8.3 6.1 6.3 7.7 7.0 6.3 7.5 6.7 6.6 11.3 10.5 13.0 7.6 16.1 13.9 7.1 7.9 8.6 6.6 9.9 8.1 8.2 11.2 8.2 5.7 12.3 6.6 7.0 7.3 6.5 8.9 14.2 6.9 4.8 8.1 6.7 8.2 1.1 1.1 4.1 2.5 1.9 1.5 0.5 2.5 2.9 9.1 7.1 5.1 5.2 4.1 3.5 2.9 5.3 5.3 4.4 2.3 4.5 2.2 3.6 3.4 2.1 6.1 2.4 6.4 4.9 2.3 8.3 5.9 4.3 3.2 10.5 7.0 3.6 3.0 5.9 3.8 4.5 3.7 6.4 6.4 3.4 4.2 1.7 10.0 7.1 6.2 1.6 2.7 4.5 5.7 2.2 2.9 5.3 4.5 5.6 5.4 2.8 1.4 7.1 5.2 4.6 4.4 7.5 6.7 4.6 4.4 2.7 2.0 3.8 2.8 5.3 4.5 2.7 1.3 2.3 1.2 0.8 1.1 0.7 0.9 0.9 0.9 1.1 1.5 1.1 4.1 1.9 2.5 1.1 0.4 0.5 8.3 10.9 16.5 10.9 7.7 7.0 11.3 10.5 7.9 8.9 11.9 16.7 7.3 4.1 3.7 34.4 7.8 2.5 12.0 10.3 10.4 35.3 3.3 1.7 4.4 1.9 6.8 2.6 0.0 7.3 1.5 6.1 5.2 10.5 8.5 4.7 27.0 6.9 10.4 14.0 1.6 8.6 7.7 0.0 1.0 6.5 13.4 4.4 3.5 9.2 2.3 30.0 12.9 6.1 5.7 6.1 2.3 1.1 5.7 6.9 3.4 ZNF449 "FLJ23614, ZSCAN19" ENSG00000173275 "Zinc finger protein 449" Q6P9G9 X 135344796-135363152 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 9.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018079 Uncertain Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Nucleoplasm, Cytosol" "HPA018079: AB_1859277" "unprognostic (5.51e-3)" "unprognostic (1.64e-1)" "unprognostic (6.94e-2)" "unprognostic (2.74e-1)" "unprognostic (1.30e-1)" "unprognostic (2.20e-1)" "unprognostic (3.74e-2)" "unprognostic (1.42e-2)" "unprognostic (1.66e-2)" "unprognostic (4.86e-2)" "unprognostic (2.69e-1)" "unprognostic (5.31e-2)" "unprognostic (1.34e-3)" "unprognostic (1.28e-1)" "unprognostic (2.54e-1)" "unprognostic (9.61e-2)" "unprognostic (4.22e-2)" 13.7 15.8 5.3 6.7 10.4 1.9 11.6 7.5 10.8 10.1 7.2 6.0 4.8 5.0 14.0 10.9 7.5 6.0 8.6 8.3 5.0 6.1 6.1 5.0 7.3 5.8 6.3 9.6 9.7 16.1 12.5 9.8 11.0 12.2 9.6 5.5 6.6 8.6 7.5 7.6 5.8 5.3 12.4 5.0 9.5 7.6 4.8 4.7 5.3 10.6 4.6 6.4 12.1 8.9 1.5 2.6 3.6 6.6 5.6 5.7 2.2 2.9 4.3 8.7 7.1 7.9 15.9 4.3 5.7 4.4 3.7 9.0 1.4 4.0 1.8 7.4 4.5 5.0 3.4 6.1 2.5 5.9 2.5 5.1 2.4 4.1 2.1 6.0 1.9 3.7 6.1 7.7 3.1 9.2 5.2 6.9 4.7 2.3 2.1 10.4 1.7 2.4 2.2 3.0 2.9 4.7 2.0 5.9 2.7 5.5 1.7 2.1 5.2 1.4 4.2 4.3 5.8 3.1 2.1 6.8 8.5 3.1 5.7 5.0 1.6 2.0 1.4 3.3 3.3 5.5 1.7 2.7 3.6 3.0 3.4 5.7 1.5 2.7 4.1 2.6 1.1 2.6 2.6 0.6 5.6 6.6 1.5 2.4 2.2 5.3 10.4 7.5 10.8 5.0 6.1 6.3 9.6 12.2 4.7 0.0 2.1 0.5 0.8 0.8 6.6 8.1 0.0 2.7 1.2 1.8 0.0 1.9 0.0 1.4 0.2 3.6 0.4 0.0 0.6 1.7 2.5 1.0 1.1 0.5 3.3 9.5 2.9 8.0 2.2 0.0 4.9 2.2 3.3 5.4 1.1 4.4 1.2 0.8 3.9 0.3 2.9 0.0 1.3 1.0 2.2 1.9 1.0 1.8 0.6 0.3 ZNF45 ZNF13 ENSG00000124459 "Zinc finger protein 45" Q02386 19 43912629-43935278 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Sertoli cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038611, HPA075124" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA038611: AB_10669544, HPA075124: AB_2686735" "unprognostic (1.67e-2)" "unprognostic (4.84e-1)" "unprognostic (1.07e-2)" "unprognostic (1.84e-3)" "unprognostic (1.23e-1)" "unprognostic (9.31e-2)" "unprognostic (5.34e-2)" "unprognostic (1.04e-1)" "unprognostic (1.60e-3)" "unprognostic (1.91e-1)" "unprognostic (7.68e-3)" "unprognostic (5.17e-3)" "unprognostic (5.17e-3)" "unprognostic (1.67e-1)" "unprognostic (1.66e-1)" "unprognostic (4.43e-2)" "unprognostic (5.82e-2)" 11.8 12.0 7.5 7.8 9.0 8.2 10.9 17.9 10.0 12.9 9.3 12.2 7.2 8.4 12.1 8.8 8.2 10.5 8.0 7.3 11.3 7.2 9.8 8.7 8.9 10.9 9.7 5.4 14.4 7.7 18.3 13.7 8.9 10.3 11.4 9.5 11.1 9.9 16.8 8.8 8.8 9.8 10.0 7.4 14.8 8.5 6.1 11.4 22.1 14.9 6.6 11.5 10.7 8.8 8.4 6.6 7.4 5.7 8.4 11.9 5.4 6.2 8.4 12.1 10.8 5.9 5.2 4.2 8.2 9.0 8.6 13.2 4.1 2.6 9.1 5.1 5.1 6.7 3.6 9.1 6.0 10.9 7.7 9.7 13.6 7.2 3.6 5.5 13.3 9.2 5.2 6.0 6.3 5.6 8.6 6.8 3.2 4.2 3.7 9.2 2.9 7.8 3.4 14.2 5.9 3.6 6.5 12.0 3.3 5.3 14.0 8.3 13.7 11.5 4.7 3.9 8.1 4.9 8.8 7.1 9.6 14.1 4.0 7.4 15.2 24.5 10.2 4.1 5.2 11.1 3.8 5.0 7.4 8.0 4.6 11.9 8.4 7.7 8.4 6.6 6.3 10.8 7.3 1.5 8.4 5.7 4.4 8.1 5.4 7.5 9.0 17.9 10.0 11.3 7.2 9.7 5.4 10.3 11.4 3.0 1.7 5.2 0.8 1.3 1.3 2.0 0.0 5.3 4.5 0.0 5.9 1.7 0.0 2.3 0.1 1.5 2.0 0.0 1.4 0.9 1.5 1.9 0.0 1.8 2.4 3.2 2.4 1.3 2.2 0.2 1.7 2.3 1.7 1.0 3.4 1.3 1.1 0.0 4.6 1.6 1.9 19.4 0.9 0.9 1.7 1.4 1.0 2.5 2.2 1.2 ZNF451 "COASTER, dJ417I1.1, KIAA0576, KIAA1702" ENSG00000112200 "Zinc finger protein 451" Q9Y4E5 6 57086844-57170307 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 214.0;Late spermatids: 315.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028838 Approved Nucleoplasm NA NA Nucleoplasm "HPA028838: AB_10603330" "unprognostic (5.95e-2)" "unprognostic (1.28e-1)" "unprognostic (1.26e-1)" "unprognostic (1.81e-1)" "unprognostic (9.00e-3)" "unprognostic (1.06e-2)" "unprognostic (1.02e-1)" "unprognostic (6.87e-3)" "unprognostic (1.38e-2)" "unprognostic (1.27e-3)" "unprognostic (9.09e-2)" "unprognostic (6.42e-2)" "unprognostic (1.11e-3)" "unprognostic (2.11e-1)" "unprognostic (2.50e-1)" "unprognostic (2.13e-3)" "unprognostic (6.17e-2)" 13.2 17.8 14.2 10.8 30.9 61.8 14.4 23.3 21.2 13.8 12.8 15.5 11.6 8.8 14.9 16.1 11.7 12.0 11.2 11.2 15.4 13.0 11.9 13.3 13.5 15.2 20.5 13.9 14.3 11.9 14.5 27.6 18.0 20.3 14.9 10.8 8.8 11.3 11.8 11.2 12.3 12.0 18.9 21.1 15.5 12.9 27.5 21.0 16.5 16.6 7.8 14.1 14.9 12.9 14.2 14.2 19.3 10.0 7.7 12.3 6.8 9.3 5.1 12.9 7.9 12.3 15.9 12.4 10.4 13.1 12.7 13.8 11.7 4.7 10.3 6.9 11.5 15.1 8.9 12.6 11.6 20.6 8.3 8.9 26.7 9.3 10.8 9.4 14.8 11.6 11.2 11.8 14.0 17.7 9.4 12.4 14.8 35.6 10.0 10.8 6.8 18.5 12.8 7.0 7.2 5.7 12.7 16.5 9.6 8.4 16.1 15.3 10.3 11.3 7.5 12.3 15.9 9.0 14.3 8.1 12.8 13.2 16.4 12.1 9.7 16.2 21.0 11.2 18.4 6.3 19.3 10.0 9.7 10.8 8.3 10.6 9.6 9.3 6.4 10.6 14.2 12.3 9.4 5.0 7.7 8.5 14.2 7.2 6.8 14.2 30.9 23.3 21.2 15.4 13.0 20.5 13.9 20.3 21.0 23.8 28.0 21.7 12.6 50.0 55.6 22.7 28.1 36.1 25.0 29.6 70.7 34.1 8.3 12.4 214.0 28.6 18.6 116.8 11.9 26.4 47.4 21.6 40.6 25.6 15.7 46.1 35.3 49.7 29.7 315.8 34.8 30.7 32.1 10.0 21.2 32.3 15.3 11.5 38.9 11.0 66.7 6.5 38.5 46.0 30.2 37.4 11.0 24.9 21.0 14.7 ZNF460 "HZF8, ZNF272" ENSG00000197714 "Zinc finger protein 460" Q14592 19 57280051-57293569 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 7.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 17.3" "HPA053004, HPA066506" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA053004: AB_2682012, HPA066506: AB_2685681" "unprognostic (2.57e-1)" "unprognostic (1.72e-1)" "unprognostic (1.28e-2)" "unprognostic (3.65e-2)" "unprognostic (1.58e-2)" "unprognostic (3.20e-1)" "unprognostic (8.04e-2)" "unprognostic (2.52e-1)" "unprognostic (2.19e-1)" "unprognostic (2.86e-1)" "unprognostic (2.89e-2)" "unprognostic (1.68e-1)" "unprognostic (1.32e-1)" "unprognostic (2.12e-1)" "unprognostic (1.62e-1)" "unprognostic (2.08e-2)" "unprognostic (4.10e-2)" 9.5 23.2 7.7 6.2 12.0 24.7 9.2 9.4 10.1 6.8 5.6 12.7 7.5 3.6 6.5 5.4 7.7 5.7 6.5 8.7 7.4 5.0 7.0 8.5 7.9 5.5 14.6 7.0 13.2 6.5 10.3 13.0 8.0 8.6 7.0 4.8 6.4 8.3 7.3 8.7 9.6 5.1 7.4 10.8 7.8 5.9 9.6 10.7 5.9 8.3 6.7 8.6 5.9 7.5 5.4 0.4 3.4 2.8 2.0 3.6 1.6 1.6 2.4 1.9 2.7 2.0 1.7 5.0 1.1 1.5 1.2 3.7 3.0 0.9 2.3 1.1 1.3 1.1 1.1 2.6 1.3 2.1 1.8 5.0 2.3 1.8 1.5 2.2 3.9 2.6 0.9 2.3 3.2 3.7 1.0 0.8 2.6 2.2 17.3 1.4 1.2 2.4 0.6 2.7 1.2 2.4 1.7 2.7 1.1 0.8 3.1 2.5 1.3 2.7 1.4 1.6 1.3 1.2 2.7 1.1 3.7 4.3 0.5 2.1 7.5 3.2 4.0 1.3 1.5 1.1 0.0 1.2 2.6 2.2 2.8 2.3 2.3 1.7 1.2 0.4 5.4 3.6 1.5 3.4 2.0 1.9 0.2 2.7 1.6 7.7 12.0 9.4 10.1 7.4 5.0 14.6 7.0 8.6 10.7 3.0 1.0 1.7 2.8 2.7 3.9 4.2 0.0 2.7 2.3 0.0 0.0 1.2 0.0 1.2 2.2 2.7 0.4 0.0 0.3 1.7 1.7 2.8 0.0 1.5 0.9 7.9 0.0 7.4 3.0 0.0 1.7 1.8 1.7 3.6 0.6 2.9 1.6 0.0 1.4 0.8 3.2 0.0 5.7 2.8 1.2 2.0 2.2 1.3 0.8 3.4 ZNF461 "GIOT-1, MGC33911" ENSG00000197808 "Zinc finger protein 461" Q8TAF7 19 36637192-36666853 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 26.8;Alveolar cells type 2: 31.6;Club cells: 21.6;granulocytes: 31.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021139 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA021139: AB_10961418" "unprognostic (8.37e-3)" "unprognostic (2.23e-1)" "unprognostic (1.74e-1)" "prognostic unfavorable (3.64e-4)" "unprognostic (2.08e-2)" "unprognostic (6.32e-2)" "unprognostic (5.60e-2)" "unprognostic (1.57e-1)" "unprognostic (1.79e-3)" "unprognostic (2.11e-1)" "unprognostic (7.01e-3)" "unprognostic (2.43e-2)" "unprognostic (1.51e-1)" "unprognostic (4.21e-2)" "unprognostic (4.54e-2)" "unprognostic (5.86e-2)" "unprognostic (5.11e-3)" 6.0 8.7 8.1 5.6 12.3 6.3 7.2 13.5 12.0 7.1 5.9 8.5 4.7 1.5 10.2 7.1 5.2 7.6 5.8 5.0 6.9 7.5 6.8 5.1 5.4 6.9 7.0 8.6 10.8 4.0 7.9 12.1 8.7 8.7 6.7 4.7 5.7 4.8 6.3 4.1 5.9 5.4 8.5 7.4 7.9 5.4 8.1 9.2 5.9 10.6 3.1 7.6 6.2 7.3 3.3 2.3 1.0 2.3 2.2 6.2 1.6 2.9 5.3 4.0 5.1 2.8 6.3 2.5 3.1 3.5 4.9 6.8 0.9 1.3 0.4 6.7 4.4 4.8 0.5 2.8 3.4 5.3 5.4 4.0 4.6 0.7 2.0 4.5 3.9 5.6 3.9 6.2 1.6 4.4 5.8 3.0 2.5 0.2 0.4 4.9 3.1 6.1 1.0 2.3 0.4 2.0 0.4 3.9 0.9 1.5 6.7 4.7 6.7 0.3 2.3 4.2 4.3 2.5 1.5 3.0 3.0 3.8 1.9 3.8 8.8 13.0 1.6 0.0 0.8 3.8 0.0 0.8 1.0 2.5 2.3 3.1 2.8 4.1 6.2 2.3 3.3 3.1 2.2 0.1 2.2 0.4 0.7 3.5 1.6 8.1 12.3 13.5 12.0 6.9 7.5 7.0 8.6 8.7 9.2 26.8 31.6 1.3 1.7 3.0 5.5 1.6 5.1 14.7 21.6 3.5 0.0 2.4 1.7 1.2 17.7 3.4 0.2 0.0 0.8 2.4 3.0 1.7 31.3 1.0 1.5 3.2 2.9 4.3 2.2 4.1 0.9 1.9 0.0 0.0 1.0 1.9 0.7 0.0 1.8 1.5 3.2 0.0 3.1 7.7 4.2 3.0 2.4 4.3 1.2 1.5 ZNF462 "DKFZP762N2316, KIAA1803, Zfp462" ENSG00000148143 "Zinc finger protein 462" Q96JM2 9 106863097-107013634 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022283 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA022283: AB_2220602" "unprognostic (4.22e-2)" "unprognostic (3.89e-2)" "unprognostic (2.60e-2)" "unprognostic (1.25e-2)" "unprognostic (1.99e-1)" "unprognostic (2.28e-1)" "unprognostic (2.04e-2)" "unprognostic (2.01e-1)" "unprognostic (3.62e-2)" "unprognostic (1.84e-2)" "unprognostic (2.16e-1)" "unprognostic (6.04e-2)" "prognostic favorable (6.19e-4)" "unprognostic (2.96e-2)" "unprognostic (1.68e-1)" "unprognostic (9.00e-2)" "unprognostic (1.33e-2)" 4.8 11.9 10.4 5.0 11.0 0.8 6.4 25.4 9.5 10.4 6.5 13.2 7.7 2.3 13.3 5.1 10.7 9.1 6.0 8.6 10.6 6.6 5.6 2.9 5.3 1.8 8.1 7.8 11.5 2.1 18.1 10.0 5.6 10.0 11.4 6.4 8.1 12.6 11.9 22.1 11.2 3.3 10.8 9.7 4.8 3.3 9.1 9.8 1.5 11.7 5.4 2.5 5.6 9.3 0.4 0.5 1.1 0.6 1.8 1.7 0.3 3.2 7.6 15.2 10.4 5.1 3.8 2.2 2.0 2.9 2.0 2.2 9.3 3.3 0.0 5.7 2.1 9.3 5.1 9.8 9.0 2.5 0.1 1.3 0.0 2.5 0.0 2.0 1.6 0.3 3.5 4.1 4.5 12.5 5.4 1.0 4.0 0.0 4.2 5.5 5.7 1.8 0.1 11.6 0.0 7.4 0.0 10.2 0.2 5.8 2.8 7.0 8.0 3.8 0.1 3.3 10.1 7.8 0.0 1.0 2.6 9.0 5.9 6.3 0.0 0.1 0.1 4.3 0.2 9.3 1.1 0.2 0.3 0.7 0.4 1.2 0.3 0.7 0.3 0.3 0.4 1.7 0.5 0.7 1.8 0.6 0.5 0.3 0.3 10.4 11.0 25.4 7.7 10.6 6.6 8.1 7.8 10.0 9.8 20.8 23.2 1.3 10.3 29.9 56.8 21.4 20.4 13.4 12.5 7.0 29.5 9.6 5.0 6.7 52.2 23.3 6.3 0.0 2.3 4.1 10.4 13.6 16.2 0.0 1.6 17.5 16.1 39.3 1.0 10.4 13.6 1.3 11.8 3.6 19.9 20.3 4.8 0.0 25.5 14.7 38.6 25.8 19.8 1.2 12.8 10.0 2.6 0.0 16.8 6.4 ZNF468 ENSG00000204604 "Zinc finger protein 468" "A2RRD8, Q5VIY5" 19 52838008-52890375 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 65.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 46.9" "HPA043696, HPA062474" Uncertain Uncertain "Nucleoplasm,Cytoplasmic bodies" NA NA Nucleoplasm "Cytoplasmic bodies" "HPA043696: AB_10793951, HPA062474: AB_2732685" "prognostic unfavorable (6.87e-4)" "unprognostic (2.16e-1)" "unprognostic (1.00e-2)" "unprognostic (1.31e-1)" "unprognostic (1.46e-2)" "unprognostic (2.24e-1)" "unprognostic (1.42e-2)" "unprognostic (9.93e-2)" "unprognostic (1.38e-2)" "unprognostic (2.55e-1)" "unprognostic (2.09e-1)" "unprognostic (1.25e-2)" "prognostic favorable (3.94e-7)" "unprognostic (1.04e-1)" "unprognostic (2.95e-2)" "unprognostic (1.41e-1)" "unprognostic (5.59e-2)" 6.6 7.6 6.6 3.5 5.1 5.2 6.9 8.4 5.1 6.2 6.2 4.3 11.0 3.2 4.7 6.4 6.3 6.3 8.0 4.6 4.2 2.9 8.2 3.4 4.9 9.8 4.2 2.8 4.8 10.0 8.8 5.5 65.5 5.2 7.9 7.2 3.1 7.0 5.8 3.7 4.6 10.8 6.2 3.9 5.1 7.1 3.4 3.3 12.0 10.4 1.9 5.5 8.0 5.4 8.8 7.0 11.5 10.3 19.1 12.5 8.6 6.2 0.8 5.7 10.0 6.1 4.5 16.7 5.0 6.3 6.5 9.7 6.2 3.9 9.6 5.1 5.3 7.7 3.3 3.9 5.1 8.6 0.0 5.8 7.3 6.4 2.6 12.4 0.4 9.4 7.2 6.1 8.0 6.6 3.6 5.4 5.3 7.2 0.4 5.7 1.4 9.1 5.9 7.0 4.5 6.1 5.5 8.2 6.4 8.8 46.9 5.9 8.7 6.3 5.7 1.5 12.6 7.5 5.7 4.4 2.2 5.7 3.0 7.3 3.9 13.9 8.6 0.5 0.8 8.0 8.3 6.1 11.5 12.3 10.3 12.5 8.1 8.0 9.8 7.0 8.8 10.0 9.2 6.3 19.1 8.0 5.3 9.3 8.6 6.6 5.1 8.4 5.1 4.2 2.9 4.2 2.8 5.2 3.3 3.0 3.7 4.5 4.7 3.0 1.0 3.3 7.6 0.0 5.7 8.7 0.0 6.4 14.9 6.1 2.4 3.1 5.3 0.0 8.3 10.7 2.5 8.9 17.3 2.6 5.4 0.0 8.2 3.1 10.0 0.4 0.9 3.5 1.7 3.6 12.2 0.8 7.5 7.0 2.5 5.4 0.2 0.0 2.7 0.5 4.0 4.6 20.1 6.9 6.9 9.7 ZNF470 "CZF-1, FLJ26175" ENSG00000197016 "Zinc finger protein 470" Q6ECI4 19 56567511-56588911 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 11.1;Spermatogonia: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 13.3" "Low region specificity" "Detected in all" HPA029000 Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA029000: AB_10603843" "unprognostic (1.40e-2)" "unprognostic (5.51e-2)" "unprognostic (5.91e-2)" "unprognostic (9.21e-4)" "unprognostic (3.46e-2)" "unprognostic (1.40e-2)" "unprognostic (7.11e-2)" "unprognostic (4.58e-2)" "unprognostic (6.91e-3)" "unprognostic (2.39e-2)" "unprognostic (3.45e-3)" "unprognostic (3.33e-3)" "unprognostic (3.89e-2)" "unprognostic (2.82e-2)" "unprognostic (4.68e-1)" "unprognostic (2.76e-3)" "unprognostic (2.88e-3)" 4.6 6.5 11.7 2.9 10.6 1.4 5.3 12.7 12.1 6.3 4.8 5.5 1.3 2.8 5.7 8.8 4.3 5.8 5.1 5.4 12.4 11.7 6.7 8.6 5.1 3.6 11.8 9.4 7.2 4.5 9.3 7.2 4.6 9.8 7.0 3.4 5.8 3.8 6.9 3.0 5.1 3.1 5.4 11.6 4.4 3.6 8.3 9.9 3.6 6.8 1.2 4.6 4.6 5.2 3.2 2.0 2.9 1.0 2.3 4.4 0.9 0.0 1.7 6.5 2.8 3.6 3.3 5.5 3.1 1.2 2.3 4.5 0.4 1.5 0.0 2.0 3.3 4.1 0.1 2.7 1.4 2.6 0.0 13.3 5.7 0.1 0.4 3.1 1.2 6.7 3.9 2.0 2.6 0.8 2.6 1.5 0.3 0.1 0.1 3.5 0.1 1.2 2.0 5.5 0.0 0.7 0.2 4.7 0.9 2.7 4.0 2.5 6.3 0.1 0.5 0.9 4.5 2.1 3.5 1.1 0.2 2.7 2.2 4.2 2.1 2.8 0.2 0.0 3.5 1.0 1.3 0.8 2.9 2.2 0.6 4.4 2.5 1.9 1.3 1.4 3.2 3.0 3.0 2.2 2.3 1.0 2.0 1.5 0.9 11.7 10.6 12.7 12.1 12.4 11.7 11.8 9.4 9.8 9.9 3.0 2.2 0.0 1.4 0.9 8.5 6.3 5.1 1.4 2.3 0.0 9.8 0.9 1.7 2.1 1.0 1.6 0.9 0.0 0.6 0.8 1.8 1.4 6.9 1.7 1.1 11.1 0.0 0.6 0.6 1.0 2.0 2.6 1.7 1.8 0.7 4.0 1.0 0.8 2.8 2.2 6.2 6.5 1.9 3.9 10.6 0.5 0.2 0.0 1.8 0.8 ZNF471 "KIAA1396, Z1971" ENSG00000196263 "Zinc finger protein 471" Q9BX82 19 56507843-56530221 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 17.3;Ciliated cells: 17.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 9.5;hTERT-RPE1: 13.8;SuSa: 10.4" "Low region specificity" "Detected in all" HPA066695 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA066695: AB_2685704" "unprognostic (2.89e-2)" "unprognostic (2.79e-4)" "unprognostic (1.58e-1)" "unprognostic (2.90e-2)" "unprognostic (2.22e-1)" "unprognostic (2.42e-3)" "unprognostic (1.45e-1)" "unprognostic (8.44e-2)" "unprognostic (1.01e-2)" "unprognostic (4.14e-2)" "unprognostic (4.47e-4)" "unprognostic (9.36e-2)" "prognostic favorable (2.37e-4)" "unprognostic (3.84e-3)" "unprognostic (1.08e-1)" "unprognostic (7.89e-2)" "unprognostic (3.44e-3)" 5.8 7.2 18.5 4.1 18.5 3.0 7.8 23.1 19.3 7.8 8.2 11.2 5.9 2.1 14.2 17.8 5.4 9.8 7.4 5.8 17.4 7.5 5.5 2.6 6.2 3.2 12.2 13.3 24.7 3.9 16.3 10.9 6.6 15.1 9.3 5.1 4.6 6.5 8.5 4.9 10.1 3.2 10.4 11.5 4.6 4.5 8.7 21.3 1.6 10.6 3.1 2.2 6.7 9.9 3.1 1.6 5.4 1.3 3.0 2.1 0.3 0.5 0.5 5.4 0.8 4.5 5.1 0.6 4.9 1.8 2.2 2.0 0.8 0.8 0.8 3.3 5.2 4.4 0.5 0.7 0.4 2.2 1.1 2.0 3.9 1.3 0.6 4.4 1.1 3.5 9.5 1.8 2.9 0.2 13.8 0.2 0.6 1.2 1.7 2.5 0.6 0.5 0.7 1.4 0.4 2.1 0.6 3.5 0.5 3.9 4.1 0.9 3.2 0.5 0.2 0.2 10.4 0.7 0.8 0.8 8.4 3.7 0.9 3.7 1.3 1.2 0.5 0.7 0.6 0.6 3.9 1.3 0.9 1.9 1.0 1.5 1.2 1.7 1.2 0.7 3.1 1.7 2.1 5.4 3.0 1.0 1.6 1.0 0.3 18.5 18.5 23.1 19.3 17.4 7.5 12.2 13.3 15.1 21.3 17.9 17.3 0.0 2.3 0.6 9.8 9.3 2.5 17.4 12.5 5.2 5.9 1.0 3.3 1.3 5.3 6.7 0.9 0.0 0.8 0.3 2.6 2.8 2.3 0.8 0.4 6.4 1.2 6.2 0.6 2.5 4.6 1.9 1.7 1.0 0.7 11.3 0.7 0.0 6.7 1.1 9.1 6.5 3.1 7.1 7.5 0.5 0.7 0.0 1.0 1.4 ZNF473 "DKFZP434N043, HZFP100, KIAA1141" ENSG00000142528 "Zinc finger protein 473" Q8WTR7 19 50025714-50053414 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 38.6" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 63.5;Spermatocytes: 38.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA004191, HPA073309" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA004191: AB_2667168, HPA073309: AB_2686594" "unprognostic (7.47e-3)" "unprognostic (3.57e-2)" "unprognostic (2.47e-1)" "unprognostic (3.40e-1)" "unprognostic (4.27e-1)" "unprognostic (8.00e-3)" "prognostic unfavorable (3.72e-4)" "unprognostic (1.31e-3)" "unprognostic (6.44e-3)" "unprognostic (1.42e-1)" "unprognostic (1.70e-2)" "unprognostic (3.22e-3)" "unprognostic (8.49e-2)" "unprognostic (1.60e-1)" "unprognostic (3.93e-2)" "unprognostic (7.76e-2)" "unprognostic (1.08e-1)" 3.8 3.7 4.4 3.8 6.5 3.8 4.8 9.7 5.8 4.1 3.7 4.6 3.7 2.9 5.9 4.4 3.8 10.1 3.4 3.0 5.1 4.3 3.8 4.1 4.0 3.7 5.9 3.2 4.8 4.8 4.0 7.7 3.1 7.3 5.1 3.3 2.7 3.4 5.6 4.9 3.8 3.0 5.1 5.0 6.4 3.3 38.6 7.7 2.6 5.2 3.3 4.5 3.7 18.6 12.4 5.6 5.0 7.9 2.4 11.6 4.6 9.4 6.4 10.1 8.4 3.8 4.7 5.7 8.9 5.2 12.7 11.9 12.3 6.3 14.4 3.4 5.1 4.7 7.1 12.7 5.9 16.3 10.3 12.0 14.8 5.6 5.7 4.7 10.6 8.8 4.8 11.0 13.3 17.6 5.2 4.2 8.7 20.9 13.2 6.4 4.1 8.1 5.0 7.1 14.7 9.9 10.4 14.0 6.3 4.2 10.4 8.3 9.4 12.6 6.9 6.2 7.0 6.2 9.8 2.0 17.7 9.0 3.4 8.9 6.1 14.4 12.3 4.2 8.4 14.3 2.2 5.5 2.9 7.2 7.9 7.3 12.4 7.2 8.8 5.4 10.2 9.2 11.6 5.0 2.4 3.5 5.6 3.9 4.6 4.4 6.5 9.7 5.8 5.1 4.3 5.9 3.2 7.3 7.7 0.0 1.7 2.7 2.3 4.0 0.7 2.1 0.0 13.4 1.2 0.0 0.0 2.0 3.3 2.1 63.5 2.8 1.7 0.0 2.8 2.5 2.4 2.8 0.0 1.0 1.9 0.0 1.7 8.6 2.1 16.0 3.4 1.6 1.7 2.8 2.7 1.7 3.2 2.0 3.5 1.5 3.7 12.9 2.9 38.6 20.2 4.1 1.6 3.2 1.8 1.4 ZNF480 MGC32104 ENSG00000198464 "Zinc finger protein 480" Q8WV37 19 52297177-52325922 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA042218 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042218: AB_10794791" "unprognostic (1.50e-2)" "unprognostic (1.43e-1)" "unprognostic (1.56e-1)" "unprognostic (1.35e-1)" "unprognostic (3.01e-2)" "unprognostic (5.22e-2)" "unprognostic (2.01e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.65e-4)" "unprognostic (4.22e-2)" "unprognostic (7.81e-3)" "unprognostic (4.97e-2)" "prognostic favorable (2.03e-4)" "unprognostic (3.05e-1)" "unprognostic (1.11e-2)" "unprognostic (2.54e-1)" "unprognostic (1.82e-3)" 9.8 8.4 8.2 7.9 15.4 7.0 7.1 13.6 12.5 6.5 8.3 4.8 3.4 7.9 6.2 2.4 8.5 4.5 4.7 17.9 8.7 3.2 10.9 7.5 8.4 9.8 13.1 4.1 6.0 3.8 5.6 10.7 6.2 12.5 5.9 8.6 4.9 8.4 5.5 12.9 8.0 9.3 5.1 8.7 15.0 8.0 3.3 12.6 10.8 8.4 7.9 12.3 8.7 8.2 16.6 17.0 9.4 9.1 14.6 15.0 5.9 3.2 13.4 8.8 10.2 10.4 9.8 7.0 8.6 12.7 6.2 7.3 6.0 4.8 16.7 5.4 7.1 11.4 7.2 9.4 8.7 9.0 0.1 15.8 17.0 6.7 5.7 10.0 24.0 13.9 8.9 11.2 8.5 10.1 13.0 8.9 14.6 12.2 6.0 13.8 5.4 21.9 4.9 6.8 10.9 11.0 11.3 9.3 13.8 8.9 23.9 8.6 7.2 12.5 9.1 3.5 18.9 7.5 17.7 15.2 6.2 7.8 3.5 13.3 13.7 25.3 34.6 2.7 13.2 10.9 7.7 8.5 9.4 12.0 8.2 13.7 16.6 12.0 13.9 10.4 16.5 11.5 15.0 3.6 14.6 9.1 17.0 13.4 5.9 8.2 15.4 13.6 12.5 8.7 3.2 13.1 4.1 12.5 12.6 32.8 10.2 16.1 11.4 4.8 4.0 37.0 10.2 20.1 14.8 3.5 2.0 7.5 14.9 15.0 1.5 18.5 10.3 23.3 24.0 12.9 7.1 10.7 11.6 13.5 15.1 6.4 12.1 14.7 14.0 2.1 8.3 16.7 6.8 19.8 17.3 4.1 29.6 8.6 7.8 20.7 6.6 0.0 9.2 1.8 5.6 7.3 12.4 23.5 16.1 18.3 ZNF484 "BA526D8.4, FLJ33884" ENSG00000127081 "Zinc finger protein 484" Q5JVG2 9 92845031-92878038 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.0" "Cell type enhanced" "Detected in some" 7 "Ciliated cells: 6.7;Club cells: 7.9;Horizontal cells: 4.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA028973 Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA028973: AB_10610703" "unprognostic (5.52e-2)" "unprognostic (3.05e-2)" "unprognostic (1.72e-1)" "unprognostic (6.05e-2)" "unprognostic (5.69e-2)" "unprognostic (3.86e-1)" "unprognostic (6.45e-2)" "unprognostic (1.91e-1)" "unprognostic (6.04e-2)" "unprognostic (9.84e-2)" "unprognostic (3.12e-1)" "unprognostic (1.91e-2)" "unprognostic (4.03e-2)" "unprognostic (3.74e-1)" "unprognostic (4.77e-1)" "unprognostic (6.49e-2)" "unprognostic (1.51e-1)" 6.5 6.6 9.9 5.4 14.6 10.1 6.5 33.0 13.9 7.7 4.8 7.8 4.7 3.7 7.0 5.3 4.2 6.2 4.7 4.9 11.7 7.0 7.3 5.2 5.8 6.6 12.5 7.1 9.1 4.5 12.1 14.0 7.9 12.6 7.0 5.2 4.6 5.0 6.3 3.7 4.2 5.0 6.2 17.1 7.7 6.0 4.8 13.5 2.8 9.0 1.9 7.9 7.3 5.8 5.6 2.5 5.3 3.5 4.5 7.4 3.0 4.1 5.1 6.7 4.3 3.5 4.3 0.0 3.4 5.5 6.1 6.7 1.6 3.2 3.6 3.0 2.7 4.3 6.8 4.9 5.1 6.5 5.8 2.1 3.1 4.1 3.3 5.4 2.5 5.6 4.8 3.9 6.7 7.1 4.5 5.3 4.0 3.3 14.6 6.5 4.2 3.7 1.2 5.6 4.7 2.5 3.1 8.2 2.6 3.2 4.8 4.7 4.2 6.0 1.7 3.4 5.3 0.4 2.0 5.7 5.5 5.3 2.8 2.4 5.5 2.7 2.1 3.6 2.1 4.3 1.4 2.5 5.3 5.3 3.5 6.5 3.7 5.4 4.4 2.2 5.6 7.4 6.7 1.4 4.5 3.1 2.5 4.4 3.0 9.9 14.6 33.0 13.9 11.7 7.0 12.5 7.1 12.6 13.5 0.0 1.0 0.0 0.5 0.1 4.2 1.7 0.0 6.7 7.9 1.8 0.0 0.9 1.7 1.1 0.5 0.9 0.8 0.0 0.4 0.9 0.7 0.4 2.3 0.2 0.7 4.8 0.0 0.0 0.8 0.0 0.6 0.2 0.0 0.0 0.9 3.1 0.7 0.9 1.4 1.3 3.5 0.0 1.0 0.5 0.8 0.1 0.6 1.3 0.5 0.5 ZNF487 "KRBO1, ZNF487P" ENSG00000243660 "Zinc finger protein 487" B1APH4 10 43436841-43483179 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 32.1" "Group enriched" "Detected in many" 7 "Ciliated cells: 78.9;Early spermatids: 155.2;Late spermatids: 196.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA037820 Approved "Nucleoplasm,Nuclear membrane,Cytosol" Yes No "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA037820: AB_10697083" "unprognostic (1.97e-1)" "unprognostic (1.69e-3)" "unprognostic (1.49e-1)" "unprognostic (3.42e-3)" "unprognostic (7.40e-2)" "unprognostic (1.42e-2)" "unprognostic (7.10e-2)" "unprognostic (4.84e-1)" "unprognostic (4.00e-2)" "unprognostic (1.05e-2)" "unprognostic (6.97e-4)" "unprognostic (5.85e-2)" "unprognostic (3.97e-4)" "unprognostic (2.91e-1)" "unprognostic (4.42e-2)" "unprognostic (2.52e-2)" "unprognostic (5.92e-2)" 4.1 2.7 4.8 2.7 5.3 5.1 3.9 11.1 9.1 4.6 3.5 3.3 2.2 3.3 5.1 3.1 2.8 7.9 4.9 3.2 6.6 5.0 3.3 3.1 4.0 2.9 5.6 7.4 6.1 2.3 3.7 6.9 2.6 11.2 3.3 2.7 4.0 2.5 4.0 1.7 3.3 3.5 4.2 8.1 3.1 3.0 32.1 6.4 4.3 4.4 2.0 2.9 4.3 3.4 3.2 5.1 13.9 3.9 3.5 4.7 2.6 2.4 2.3 2.8 3.0 3.6 7.2 0.7 4.0 6.9 3.7 4.0 3.6 6.6 6.1 0.7 4.7 3.7 3.9 0.9 1.5 4.6 0.6 1.5 1.9 0.5 2.0 4.4 1.9 2.8 7.1 3.3 6.0 4.5 7.5 1.3 1.3 1.0 1.2 2.7 4.1 3.9 1.6 0.8 1.3 2.5 2.0 1.0 2.4 8.2 2.6 2.8 1.9 3.4 2.0 2.2 1.8 3.1 2.3 2.0 3.4 2.4 1.9 1.1 0.5 1.6 6.7 8.2 2.7 1.3 2.5 3.9 5.8 4.7 2.8 4.0 2.8 3.5 4.3 5.1 3.2 3.0 3.6 13.9 3.5 1.5 3.9 1.8 2.6 4.8 5.3 11.1 9.1 6.6 5.0 5.6 7.4 11.2 6.4 20.8 3.7 7.2 5.4 1.5 4.9 3.1 5.1 78.9 9.1 5.2 7.9 1.4 10.0 3.7 155.2 4.9 5.2 0.0 1.8 3.3 4.0 5.1 0.0 2.4 3.0 6.4 7.5 3.7 5.7 196.9 4.4 5.6 1.7 2.8 4.6 8.0 1.7 3.7 6.3 9.1 17.1 0.0 3.6 6.7 7.6 2.5 1.4 5.0 3.0 5.5 ZNF488 FLJ32104 ENSG00000265763 "Zinc finger protein 488" Q96MN9 10 47365496-47384273 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 29.7;intestine: 25.8" "Cell type enriched" "Detected in some" 5 "Syncytiotrophoblasts: 30.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 23.7;HDLM-2: 34.3;RT4: 19.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035957, HPA035958" Supported Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Nucleoplasm, Cytosol" "HPA035957: AB_10672234, HPA035958: AB_2674887" "unprognostic (3.29e-2)" "unprognostic (1.05e-2)" "unprognostic (7.87e-2)" "unprognostic (1.49e-4)" "unprognostic (1.16e-1)" "unprognostic (8.85e-2)" "unprognostic (1.60e-3)" "unprognostic (2.13e-2)" "unprognostic (3.11e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (4.02e-7)" "unprognostic (3.60e-1)" "unprognostic (6.62e-5)" "unprognostic (2.76e-1)" "unprognostic (4.47e-1)" "unprognostic (8.10e-2)" "unprognostic (3.18e-2)" 0.4 0.4 5.7 0.4 18.5 0.3 1.2 2.9 14.2 0.5 3.2 17.0 0.0 25.8 0.5 2.3 0.9 0.5 0.6 0.4 15.1 1.1 0.3 0.5 0.3 19.8 6.0 0.7 0.3 0.3 0.0 4.1 21.4 0.6 1.1 0.0 0.6 0.4 0.3 2.2 12.5 0.4 29.7 0.3 0.6 1.2 12.8 0.0 0.3 0.0 0.9 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.4 6.8 1.2 0.3 0.0 0.0 0.1 0.2 0.3 0.4 0.4 2.7 6.4 0.1 0.4 0.0 2.7 23.7 0.6 2.6 0.3 34.3 0.7 0.1 0.7 0.2 0.0 0.0 0.3 0.0 6.2 0.2 0.6 0.1 0.0 1.3 0.0 0.0 0.0 0.1 0.2 0.1 1.8 5.1 0.6 0.0 3.0 0.0 0.1 19.1 5.7 1.0 1.6 0.2 0.0 2.7 0.5 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.8 0.3 0.0 0.0 0.0 0.0 0.0 5.6 5.0 0.3 0.0 0.0 1.0 0.0 0.2 0.3 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.1 30.2 0.0 0.8 0.3 ZNF497 FLJ44773 ENSG00000174586 "Zinc finger protein 497" Q6ZNH5 19 58354357-58362848 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 1: 6.0;Ciliated cells: 5.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 17.5" HPA047872 Uncertain Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA047872: AB_2680196" "unprognostic (8.24e-2)" "unprognostic (1.12e-1)" "unprognostic (2.17e-1)" "unprognostic (1.09e-3)" "unprognostic (1.02e-1)" "unprognostic (1.42e-2)" "unprognostic (2.30e-2)" "unprognostic (8.53e-2)" "unprognostic (9.45e-2)" "unprognostic (9.29e-2)" "unprognostic (4.16e-3)" "unprognostic (7.03e-3)" "unprognostic (1.25e-1)" "unprognostic (1.07e-1)" "unprognostic (4.58e-2)" "unprognostic (7.28e-2)" "unprognostic (1.24e-1)" 0.8 2.3 3.3 2.8 5.5 2.3 5.0 7.5 6.2 3.3 1.7 3.1 3.0 2.0 4.1 3.7 3.6 9.1 3.1 2.0 7.2 3.3 3.7 5.0 3.2 3.8 2.0 4.5 4.5 6.0 3.8 5.9 1.8 5.8 3.2 1.2 1.4 7.7 1.9 0.8 4.6 3.1 0.6 3.5 3.6 2.8 2.3 0.6 2.5 4.9 2.0 1.5 1.4 2.1 4.7 4.8 2.3 2.8 2.1 4.8 1.9 1.7 5.9 5.3 5.1 0.2 0.1 7.1 3.2 0.0 0.0 0.0 0.4 1.9 3.4 1.7 0.0 3.0 0.8 0.6 0.4 0.0 3.6 17.5 3.1 1.6 1.0 0.3 1.2 8.2 0.4 0.8 0.1 0.6 5.9 0.0 8.6 2.5 0.5 0.1 6.0 4.3 4.4 3.3 1.4 1.8 10.7 3.9 1.8 0.5 1.4 4.1 5.9 1.7 5.2 2.9 2.8 7.1 3.5 0.5 5.9 3.1 0.5 1.0 7.7 9.1 3.0 1.6 3.5 3.2 2.3 2.8 0.9 2.4 1.1 2.6 3.8 2.8 2.9 2.7 4.7 2.9 4.8 1.0 2.1 0.9 4.8 3.1 1.9 3.3 5.5 7.5 4.2 7.2 3.3 2.0 4.5 5.8 0.6 6.0 0.3 0.0 0.4 0.2 1.4 0.6 0.0 5.3 1.2 0.0 0.0 1.7 1.7 1.1 1.0 0.3 0.4 0.0 0.2 0.4 0.2 0.2 0.0 1.5 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.1 1.1 0.4 0.3 0.0 0.7 1.5 0.0 0.0 0.0 1.1 0.3 0.2 0.0 1.2 0.0 ZNF500 "KIAA0557, ZKSCAN18, ZSCAN50" ENSG00000103199 "Zinc finger protein 500" O60304 16 4748239-4767624 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA035498, HPA057963" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA035498: AB_10602356, HPA057963: AB_2683565" "unprognostic (3.83e-2)" "unprognostic (5.50e-2)" "unprognostic (2.57e-1)" "unprognostic (1.06e-1)" "unprognostic (3.17e-1)" "unprognostic (3.61e-3)" "unprognostic (8.72e-3)" "unprognostic (7.77e-3)" "unprognostic (1.45e-2)" "unprognostic (1.28e-2)" "unprognostic (8.04e-3)" "unprognostic (4.07e-2)" "unprognostic (1.10e-2)" "prognostic favorable (3.41e-4)" "unprognostic (8.98e-2)" "unprognostic (6.89e-2)" "unprognostic (3.19e-2)" 8.1 6.4 10.2 9.4 7.5 5.9 8.1 13.8 11.4 10.3 8.0 11.7 11.5 8.4 12.2 10.9 6.2 8.9 10.4 6.0 6.2 5.1 6.0 5.2 7.2 12.5 6.6 9.4 13.9 8.5 9.1 8.0 6.7 6.6 9.3 5.3 10.6 11.3 14.9 7.5 8.5 7.5 7.5 5.4 11.4 7.7 7.2 8.4 9.9 9.2 7.1 8.3 9.2 8.4 5.3 6.5 3.4 2.5 3.0 4.9 2.1 2.0 8.4 2.8 7.3 3.3 3.0 12.8 6.1 6.8 7.6 5.2 3.7 4.0 4.4 5.3 3.3 2.8 4.7 5.8 3.2 5.6 3.2 8.8 3.6 10.6 5.0 4.7 2.5 4.0 3.5 7.8 3.4 6.5 7.5 4.3 5.6 5.3 7.0 3.0 4.6 5.2 4.4 3.6 1.6 3.0 9.3 6.7 8.7 2.5 2.4 10.4 6.8 5.2 7.9 2.3 2.0 5.1 4.1 4.8 7.2 5.5 8.0 2.9 6.7 4.5 3.9 2.2 2.1 4.5 2.3 2.5 3.4 3.9 2.4 3.3 4.9 2.5 3.0 1.4 5.3 4.2 4.9 2.9 3.0 1.7 6.5 3.9 2.1 10.2 7.5 13.8 11.4 6.2 5.1 6.6 9.4 6.6 8.4 11.9 2.4 8.9 2.6 2.2 16.8 4.8 2.5 5.3 2.3 7.0 23.6 4.9 1.7 3.8 6.8 4.9 4.9 0.0 2.7 3.8 3.6 4.3 6.9 4.0 2.7 17.5 8.1 9.2 3.3 1.3 10.6 3.1 1.7 9.0 4.9 12.1 2.9 0.0 10.6 2.2 20.5 0.0 4.1 12.6 8.3 1.9 3.8 5.7 5.2 1.6 ZNF503 "FLJ45745, MGC2555, Nlz2" ENSG00000165655 "Zinc finger protein 503" Q96F45 10 75397830-75401906 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Smooth muscle cells: 105.0" "Cancer enhanced" "Detected in all" "ovarian cancer: 62.9" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 1.6;myeloid DC: 1.4" "Group enriched" "Detected in many" 16 "dendritic cells: 1.4;monocytes: 1.6" "Cell line enhanced" "Detected in many" "HEK 293: 39.0;PC-3: 50.6;U-87 MG: 15.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA026848 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA026848: AB_10610704" "unprognostic (1.18e-1)" "unprognostic (8.56e-2)" "unprognostic (8.63e-3)" "unprognostic (7.41e-2)" "unprognostic (2.82e-1)" "unprognostic (3.57e-2)" "unprognostic (9.63e-2)" "unprognostic (7.42e-2)" "unprognostic (3.42e-2)" "unprognostic (3.22e-1)" "unprognostic (6.53e-2)" "prognostic unfavorable (3.50e-4)" "prognostic favorable (1.97e-4)" "unprognostic (1.53e-1)" "unprognostic (8.28e-2)" "unprognostic (2.05e-1)" "unprognostic (1.59e-1)" 9.4 23.1 2.3 6.2 7.2 2.2 14.1 0.8 4.7 47.8 10.2 3.0 20.8 9.0 28.1 15.1 27.8 14.1 15.3 5.8 3.4 3.0 22.1 5.7 16.5 2.6 4.8 1.5 38.1 19.4 4.0 3.0 4.8 7.5 21.3 2.5 18.5 6.4 50.7 2.9 3.2 6.6 10.1 8.0 7.6 9.4 7.3 2.9 0.5 7.7 8.5 3.7 14.4 25.0 0.0 1.4 0.0 1.6 0.0 0.0 0.1 1.7 1.6 0.3 2.1 3.7 2.5 0.5 1.6 0.9 0.6 0.6 2.5 6.9 0.0 4.6 1.5 0.3 3.1 0.2 1.6 0.4 0.0 39.0 0.0 4.2 8.1 2.9 2.0 4.4 6.7 1.6 1.2 0.7 5.7 0.1 0.2 0.0 0.0 0.9 0.8 0.0 6.1 0.0 1.2 50.6 0.0 1.9 0.0 0.9 1.3 1.4 1.8 2.8 0.2 8.4 0.3 0.3 1.4 1.3 5.1 5.8 10.5 4.2 0.0 0.0 0.0 15.7 9.0 4.0 0.0 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 2.3 7.2 0.8 3.6 3.4 3.0 4.8 1.5 7.5 2.9 35.7 12.3 2.2 37.9 24.2 18.3 13.2 7.6 0.0 9.1 38.4 19.6 0.5 49.7 39.4 0.0 21.8 0.8 23.3 30.0 0.4 30.7 20.3 5.8 8.9 12.0 6.4 3.5 39.9 27.3 1.1 55.3 16.3 23.6 5.4 6.1 5.6 32.4 0.0 46.3 28.3 21.2 38.8 105.0 0.2 2.4 12.2 0.2 0.0 7.2 12.7 ZNF510 KIAA0972 ENSG00000081386 "Zinc finger protein 510" Q9Y2H8 9 96755865-96778129 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049139 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA049139: AB_2680651" "unprognostic (2.70e-2)" "unprognostic (3.44e-1)" "unprognostic (1.07e-1)" "unprognostic (6.92e-2)" "unprognostic (2.01e-2)" "unprognostic (1.43e-2)" "unprognostic (3.78e-1)" "unprognostic (1.21e-2)" "unprognostic (8.50e-3)" "unprognostic (3.90e-2)" "unprognostic (1.06e-1)" "unprognostic (4.34e-2)" "prognostic favorable (5.94e-4)" "unprognostic (1.02e-2)" "unprognostic (1.17e-1)" "unprognostic (5.17e-2)" "unprognostic (2.18e-2)" 9.1 9.2 10.9 6.5 15.7 5.7 12.7 23.0 13.9 14.4 8.8 6.3 11.6 4.6 11.5 8.1 7.9 10.7 6.5 7.4 11.5 10.3 8.9 8.5 8.4 11.4 8.6 12.3 14.9 10.7 13.5 19.8 6.9 10.1 12.6 9.3 5.2 7.5 11.2 9.2 6.2 6.8 11.3 9.2 10.1 6.8 8.2 9.1 14.9 11.2 4.3 13.3 13.9 10.7 5.9 1.3 3.8 2.9 6.4 7.7 2.1 5.1 5.2 11.5 8.5 9.8 9.2 5.9 5.8 11.4 9.7 8.6 4.9 3.8 6.7 3.1 6.1 9.5 11.2 3.3 5.4 8.7 10.7 5.5 9.4 9.7 2.5 5.8 3.6 6.2 7.9 7.2 8.3 10.4 9.1 9.3 12.9 9.6 6.5 9.4 4.6 10.4 4.8 8.1 7.5 5.3 6.8 18.8 3.3 5.1 4.9 11.9 9.5 11.2 5.2 5.7 8.4 3.8 6.8 8.2 6.2 5.9 7.0 6.7 11.4 12.0 4.9 3.5 2.5 6.2 2.3 1.2 3.8 3.8 1.9 7.7 3.6 5.0 3.0 1.0 5.9 5.7 5.2 0.4 6.4 2.9 1.3 7.1 2.1 10.9 15.7 23.0 13.9 11.5 10.3 8.6 12.3 10.1 9.1 3.0 2.7 2.0 1.4 1.4 10.5 4.4 0.0 4.0 3.4 3.5 2.0 2.0 1.7 1.9 5.0 2.7 1.0 0.0 2.3 1.2 1.7 1.4 1.1 1.0 1.7 15.9 1.2 5.5 3.4 5.6 5.5 2.2 5.0 1.0 1.8 3.8 1.3 1.7 3.9 1.5 7.0 6.5 1.4 3.2 4.9 1.3 0.7 3.2 1.4 1.0 ZNF511 MGC30006 ENSG00000198546 "Zinc finger protein 511" Q8NB15 10 133308475-133313162 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA035360 Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" "Intracellular and membrane" NA NA "Nuclear bodies" "Nucleoplasm, Vesicles" "HPA035360: AB_10601931" "unprognostic (3.35e-2)" "unprognostic (2.19e-1)" "unprognostic (1.91e-1)" "unprognostic (8.84e-2)" "unprognostic (1.31e-1)" "unprognostic (1.16e-1)" "unprognostic (3.04e-1)" "unprognostic (1.68e-2)" "unprognostic (2.75e-1)" "unprognostic (1.64e-2)" "unprognostic (1.40e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.94e-2)" "unprognostic (3.91e-2)" "unprognostic (2.55e-1)" "unprognostic (4.52e-2)" 11.4 11.2 10.1 13.2 10.3 14.8 20.5 16.9 11.0 12.0 18.3 8.7 17.1 8.2 16.8 13.2 13.1 15.4 11.7 20.6 9.4 7.7 13.8 21.2 11.4 16.4 9.6 8.7 21.2 30.1 9.9 13.6 9.7 8.2 17.4 10.9 11.4 17.3 13.6 25.9 9.3 19.1 15.5 8.8 12.7 12.1 21.3 10.8 12.3 16.0 23.2 11.9 12.2 16.8 21.5 19.3 21.6 18.9 12.8 15.6 15.3 11.2 13.0 7.3 9.0 7.6 6.4 6.9 6.4 10.6 15.4 13.0 21.3 11.6 14.1 5.3 7.2 9.4 10.3 11.5 9.9 6.0 9.6 32.7 7.3 5.8 10.8 6.1 13.2 10.6 6.3 5.4 11.7 5.5 8.6 6.9 5.6 11.4 3.9 5.3 18.4 3.8 16.9 7.9 9.2 24.2 6.3 9.5 2.9 7.8 4.1 4.3 6.9 5.3 5.9 7.6 4.3 5.0 7.5 6.7 6.4 6.3 5.5 15.3 5.0 7.6 16.3 7.6 6.3 2.5 10.6 18.9 21.6 14.3 14.9 11.8 21.5 12.5 15.6 18.9 14.7 14.4 13.5 2.9 12.8 14.7 19.3 10.4 15.3 10.1 10.3 16.9 11.0 9.4 7.7 9.6 8.7 8.2 10.8 14.9 12.6 26.7 38.9 26.3 19.5 20.6 22.9 17.4 13.6 21.0 7.9 51.6 59.7 31.3 18.3 19.9 31.6 0.0 35.6 53.1 31.6 36.6 77.2 44.5 43.0 20.6 51.3 13.5 23.5 4.5 38.6 44.9 15.1 70.3 85.0 25.5 31.4 45.6 28.7 56.4 18.9 25.8 29.9 56.3 46.2 31.5 23.6 29.9 64.1 35.3 ZNF511-PRAP1 ENSG00000283496 "ZNF511-PRAP1 readthrough" 10 133309410-133352529 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 31.6;liver: 23.8" "Cell type enriched" "Detected in single" 12 "Club cells: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 16.1;OE19: 11.5" "HPA035360, HPA038713, HPA052451" Supported Uncertain "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Nuclear bodies" "Nucleoplasm, Vesicles" "HPA035360: AB_10601931, HPA038713: AB_10673117, HPA052451: AB_2681839" 2.1 1.6 1.1 5.0 1.7 1.2 6.2 3.0 2.7 3.1 11.9 1.9 4.9 31.6 3.9 3.5 3.5 1.3 3.0 4.8 1.8 13.7 23.8 2.1 4.7 2.2 1.9 4.9 9.7 0.9 2.1 1.5 1.7 5.1 7.6 2.9 5.0 3.0 5.8 1.3 28.1 4.4 0.8 3.0 3.4 6.5 2.7 3.2 4.6 7.1 3.0 2.0 4.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.2 3.1 5.0 0.0 0.0 6.7 0.0 1.4 0.0 0.0 6.7 2.1 0.0 3.2 1.7 0.2 0.1 0.8 0.0 2.1 0.3 0.0 0.9 0.0 16.1 0.0 1.2 1.8 0.0 0.0 1.5 4.8 0.0 0.0 0.6 0.3 6.1 0.0 0.0 3.2 5.2 0.3 11.5 0.0 0.9 1.2 2.9 0.2 0.3 0.5 5.4 0.3 2.7 2.3 3.3 0.0 0.5 0.0 0.0 3.0 2.5 0.1 1.5 0.0 0.8 0.3 1.1 0.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF512 KIAA1805 ENSG00000243943 "Zinc finger protein 512" Q96ME7 2 27582969-27623215 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031430 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA031430: AB_10603844" "prognostic favorable (9.79e-4)" "unprognostic (4.19e-2)" "unprognostic (1.87e-2)" "prognostic unfavorable (5.10e-4)" "unprognostic (1.33e-1)" "unprognostic (3.07e-2)" "unprognostic (7.75e-3)" "prognostic favorable (5.08e-9)" "unprognostic (6.08e-2)" "unprognostic (2.33e-1)" "prognostic favorable (5.19e-4)" "unprognostic (1.10e-2)" "unprognostic (8.09e-3)" "unprognostic (4.44e-2)" "unprognostic (1.85e-1)" "unprognostic (5.66e-2)" "unprognostic (5.60e-3)" 11.0 12.8 12.0 13.3 19.9 5.2 15.6 18.5 22.4 18.1 14.8 20.4 12.1 7.4 23.7 14.7 9.9 20.8 12.3 12.0 11.0 14.3 12.1 6.7 12.9 14.5 12.1 15.4 33.7 8.1 28.0 27.6 12.1 18.8 17.8 11.7 18.7 11.3 19.1 7.2 6.8 12.5 17.4 14.2 15.0 11.0 12.0 11.6 21.3 19.6 6.6 15.8 17.2 14.0 9.6 6.3 14.6 5.2 17.0 14.6 8.5 11.6 10.3 21.4 9.5 10.6 12.1 0.0 5.8 8.2 11.0 13.0 7.9 7.4 10.2 6.5 6.6 9.1 4.0 18.9 5.4 11.7 9.4 15.2 21.3 8.4 12.0 8.2 13.8 9.7 11.0 6.0 8.5 2.5 8.8 17.4 17.9 18.4 7.5 16.1 1.4 1.4 10.6 14.8 7.7 0.0 23.2 30.2 8.8 7.8 3.2 21.0 20.9 5.5 3.5 16.2 10.7 4.3 8.0 14.3 3.9 9.4 3.9 7.5 7.6 5.3 17.6 5.8 17.3 7.9 14.6 4.2 7.3 8.7 5.2 11.7 9.6 10.9 12.4 6.3 8.0 14.6 12.2 1.2 17.0 4.1 4.5 7.5 8.5 12.0 19.9 18.5 22.4 11.0 14.3 12.1 15.4 18.8 11.6 8.9 13.9 9.3 8.3 3.4 20.9 14.5 7.6 9.4 9.1 17.4 15.7 1.4 8.3 5.9 8.4 10.5 1.8 0.0 1.6 0.9 8.0 7.3 5.8 3.9 4.5 17.5 8.6 11.6 6.0 5.4 13.8 5.5 1.7 4.6 5.5 16.6 3.2 0.0 16.3 2.9 13.9 19.4 11.7 8.9 7.9 2.6 1.0 8.2 4.9 6.7 ZNF512B "GM632, MGC149845, MGC149846" ENSG00000196700 "Zinc finger protein 512B" Q96KM6 20 63956702-63969865 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 20.1;Cone photoreceptor cells: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006688, HPA008731" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006688: AB_10963053, HPA008731: " "unprognostic (7.00e-2)" "unprognostic (1.03e-1)" "unprognostic (2.40e-3)" "unprognostic (7.19e-3)" "unprognostic (2.33e-1)" "unprognostic (1.84e-1)" "unprognostic (5.30e-3)" "unprognostic (2.38e-2)" "unprognostic (3.04e-1)" "unprognostic (1.13e-1)" "unprognostic (6.99e-3)" "unprognostic (5.03e-3)" "unprognostic (2.12e-1)" "unprognostic (7.72e-2)" "unprognostic (5.52e-2)" "unprognostic (1.95e-3)" "unprognostic (3.72e-2)" 7.5 8.2 11.0 6.3 13.3 6.2 5.6 14.3 16.7 7.4 3.6 9.9 6.1 5.3 9.3 9.0 10.1 8.5 7.5 8.3 11.0 8.5 9.6 18.5 7.1 7.0 8.8 10.5 11.3 14.4 13.6 10.3 10.4 8.4 8.5 1.7 9.9 15.5 10.5 11.2 14.3 5.8 7.8 6.4 9.3 8.5 8.8 6.5 6.2 10.7 5.8 8.8 6.2 6.7 0.6 0.4 0.0 0.1 1.4 1.1 0.3 5.4 9.2 10.4 11.0 4.6 3.4 9.5 7.9 6.2 23.8 7.8 17.9 9.2 3.6 19.4 6.8 4.4 7.0 7.8 11.7 5.7 5.8 11.2 8.8 12.9 17.0 7.4 4.7 10.6 7.2 9.7 8.2 4.7 6.3 7.3 16.2 12.2 5.5 4.7 13.0 23.0 10.3 7.2 7.0 12.1 10.6 0.9 10.7 4.3 9.2 15.2 8.9 6.5 10.8 5.2 5.2 22.7 11.5 10.2 22.9 3.5 5.7 6.7 13.2 6.3 10.0 8.2 0.0 9.7 0.0 0.1 0.0 1.1 0.0 0.1 0.1 1.0 0.1 0.4 0.6 1.1 1.0 0.0 1.4 0.0 0.4 0.0 0.3 11.0 13.3 14.3 16.7 11.0 8.5 8.8 10.5 8.4 6.5 3.0 6.4 3.2 2.9 4.7 20.1 1.7 7.6 1.4 5.7 1.8 21.6 6.2 1.7 3.2 0.1 3.0 0.3 0.0 5.2 2.6 4.5 2.5 0.0 15.3 3.2 12.7 5.8 8.6 1.3 1.0 6.1 0.7 5.0 1.8 0.5 8.0 2.8 0.0 6.3 4.1 10.5 0.0 3.4 3.0 4.8 6.0 4.2 2.9 1.3 2.4 ZNF514 FLJ14457 ENSG00000144026 "Zinc finger protein 514" Q96K75 2 95147330-95165413 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028974 Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA028974: AB_10603845" "unprognostic (8.79e-2)" "unprognostic (1.41e-1)" "unprognostic (1.23e-1)" "unprognostic (1.33e-2)" "unprognostic (1.42e-1)" "unprognostic (5.99e-2)" "unprognostic (1.11e-2)" "unprognostic (1.80e-2)" "unprognostic (4.68e-2)" "unprognostic (1.42e-2)" "unprognostic (1.73e-1)" "unprognostic (5.17e-2)" "unprognostic (1.80e-3)" "unprognostic (4.33e-2)" "unprognostic (1.91e-1)" "unprognostic (1.00e-1)" "unprognostic (1.79e-2)" 7.1 7.6 7.8 5.1 16.4 1.7 12.7 14.9 12.9 10.4 10.5 15.7 12.0 9.4 15.0 27.1 8.1 11.5 6.7 8.4 14.2 8.4 9.8 5.0 8.4 7.0 17.0 9.9 20.6 9.6 12.5 23.5 7.9 11.5 12.1 9.6 10.1 11.5 11.6 12.0 11.6 9.4 10.6 12.5 8.9 10.0 19.8 18.0 14.0 15.2 10.3 7.8 8.9 10.9 7.7 5.2 10.4 5.3 6.4 11.3 5.5 13.4 4.7 12.5 8.4 9.4 12.6 9.7 5.3 5.7 8.6 9.2 7.0 5.0 2.1 2.7 5.7 14.3 8.2 6.6 4.9 9.8 4.4 8.8 2.5 6.3 5.7 4.0 1.4 6.8 7.7 15.1 5.4 3.8 13.5 4.2 7.6 6.9 2.4 6.7 6.4 3.6 6.8 4.2 4.4 4.7 6.5 4.4 4.7 5.8 5.7 11.7 8.5 5.6 2.7 5.7 19.1 5.2 5.0 4.4 6.2 8.5 2.0 4.3 7.1 5.2 3.5 6.8 2.8 4.1 10.4 5.3 9.9 5.1 2.6 6.1 7.3 6.8 4.8 5.2 7.7 11.3 9.2 1.5 6.4 3.0 4.1 7.1 5.5 7.8 16.4 14.9 12.9 14.2 8.4 17.0 9.9 11.5 18.0 8.9 6.4 7.8 7.3 4.9 14.3 11.4 17.8 8.1 4.5 0.0 17.7 5.3 23.2 5.3 34.4 8.3 5.3 0.0 4.5 3.0 5.6 9.3 1.1 6.4 6.8 14.3 9.2 7.4 3.5 34.3 9.8 3.8 6.8 3.6 10.1 11.8 4.6 3.5 7.1 15.0 34.1 6.5 4.1 12.2 10.6 5.5 3.1 6.9 6.8 9.5 ZNF516 "HsT287, KIAA0222" ENSG00000101493 "Zinc finger protein 516" Q92618 18 76358190-76495190 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 69.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 12.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 12.2" "Cell line enhanced" "Detected in many" "THP-1: 21.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015792 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA015792: AB_1859314" "prognostic favorable (7.09e-4)" "unprognostic (7.28e-2)" "unprognostic (4.51e-1)" "unprognostic (1.22e-3)" "unprognostic (3.33e-1)" "unprognostic (1.93e-1)" "prognostic unfavorable (2.79e-4)" "unprognostic (2.63e-3)" "unprognostic (3.14e-1)" "unprognostic (3.29e-2)" "prognostic favorable (7.96e-4)" "unprognostic (5.87e-2)" "prognostic favorable (1.21e-4)" "unprognostic (1.27e-1)" "unprognostic (1.10e-1)" "unprognostic (1.71e-1)" "unprognostic (2.02e-1)" 4.2 5.4 8.3 5.7 9.9 15.1 4.7 2.0 4.8 20.8 5.9 4.5 18.6 4.1 25.2 8.0 6.3 15.8 3.9 3.5 5.1 2.9 3.4 5.1 5.0 4.2 4.7 3.9 17.0 4.6 8.7 10.8 2.6 6.4 7.3 1.8 13.1 6.4 13.3 8.6 6.3 4.1 9.1 3.3 6.3 4.5 18.6 4.6 3.0 4.8 4.0 4.9 8.0 10.9 0.4 1.6 12.2 2.2 1.0 0.6 0.4 1.5 1.7 12.4 16.3 3.7 5.5 1.5 9.4 7.9 2.0 3.8 3.5 5.7 8.1 2.0 10.0 5.1 3.3 6.8 9.0 1.4 0.0 5.3 0.7 0.0 7.6 9.1 5.3 5.4 10.4 4.1 4.3 4.5 2.8 2.3 3.4 0.0 0.0 2.0 3.2 0.1 9.5 6.2 1.0 0.4 3.5 1.3 4.1 3.2 7.0 12.5 7.7 0.1 0.0 10.1 5.2 2.0 21.7 1.5 4.7 8.2 0.1 0.9 0.0 0.2 6.2 2.8 3.7 12.0 2.7 2.2 3.0 0.1 1.5 0.6 0.1 0.2 0.1 1.6 0.4 0.6 0.3 12.2 1.0 1.6 1.0 0.0 0.4 8.3 9.9 2.0 4.8 5.1 2.9 4.7 3.9 6.4 4.6 8.9 8.5 3.9 14.0 17.3 14.8 7.6 7.6 9.4 2.3 1.8 29.5 0.2 3.3 4.9 69.3 9.0 5.2 0.0 2.5 0.3 10.2 10.7 1.1 11.3 7.1 3.2 12.1 8.0 20.3 27.6 28.1 14.9 11.8 8.2 5.4 6.5 4.5 5.3 32.9 4.4 29.5 12.9 17.3 3.4 33.4 17.7 0.5 2.9 3.5 17.5 ZNF517 ENSG00000197363 "Zinc finger protein 517" Q6ZMY9 8 144798876-144811169 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 7.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 14.0" HPA055337 Approved Nucleoplasm NA NA Nucleoplasm "HPA055337: AB_2682788" "unprognostic (9.54e-3)" "unprognostic (4.72e-2)" "unprognostic (3.20e-2)" "unprognostic (3.06e-2)" "unprognostic (1.81e-1)" "unprognostic (1.55e-2)" "unprognostic (2.22e-2)" "unprognostic (3.13e-1)" "unprognostic (4.83e-2)" "unprognostic (9.64e-2)" "prognostic favorable (1.66e-4)" "unprognostic (1.83e-1)" "unprognostic (4.23e-2)" "unprognostic (2.75e-1)" "unprognostic (2.40e-1)" "unprognostic (1.38e-1)" "unprognostic (9.57e-2)" 2.9 6.5 5.3 3.1 4.5 1.5 8.5 7.3 8.6 3.3 3.0 2.7 5.3 3.6 5.6 3.1 3.2 4.1 3.2 5.8 6.8 3.2 3.9 3.2 4.6 6.5 5.6 6.1 7.5 3.8 4.5 3.9 4.4 4.2 3.7 0.5 5.4 6.9 1.9 9.6 10.5 4.5 1.4 4.1 4.3 3.6 3.6 4.4 3.0 4.1 1.4 1.4 4.1 2.8 4.1 1.1 0.5 2.4 1.4 2.2 1.2 2.1 3.9 6.6 6.4 1.0 2.0 3.4 1.9 0.5 0.4 0.3 1.3 2.3 1.2 4.6 0.6 2.8 2.1 0.3 0.7 0.9 4.6 1.7 2.7 2.1 14.0 2.5 0.6 2.8 1.4 1.7 0.3 1.3 3.7 1.5 3.4 3.1 1.8 1.1 3.4 2.7 1.6 4.6 4.2 4.4 3.9 2.0 0.9 0.6 2.6 2.9 8.4 5.3 2.1 2.0 3.4 5.4 2.4 1.8 4.4 6.9 2.3 1.9 3.0 0.5 0.8 4.8 1.1 3.6 0.4 1.2 0.0 1.8 2.4 1.5 4.1 1.7 1.2 1.1 0.7 1.4 1.2 0.5 1.4 1.4 0.5 2.2 1.2 5.3 4.5 7.3 8.6 6.8 3.2 5.6 6.1 4.2 4.4 0.0 0.3 0.0 5.0 0.5 3.6 2.8 5.1 0.0 1.2 0.0 7.9 0.6 1.7 0.8 1.2 1.1 1.0 0.0 0.4 0.5 0.8 1.2 0.0 1.7 1.3 3.2 1.2 3.1 1.6 0.0 0.9 1.3 0.0 0.0 1.0 2.3 0.7 0.0 1.1 2.2 3.7 0.0 1.4 3.0 2.6 1.0 0.3 1.0 0.8 4.4 ZNF518A "KIAA0335, ZNF518" ENSG00000177853 "Zinc finger protein 518A" Q6AHZ1 10 96129715-96205288 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029049 Approved Nucleoplasm Yes No Nucleoplasm "HPA029049: AB_2672885" "unprognostic (1.48e-1)" "unprognostic (5.24e-2)" "unprognostic (1.70e-2)" "unprognostic (4.66e-2)" "unprognostic (7.61e-2)" "unprognostic (3.38e-3)" "unprognostic (1.21e-1)" "unprognostic (1.07e-1)" "unprognostic (2.73e-2)" "unprognostic (6.02e-1)" "unprognostic (2.97e-1)" "unprognostic (1.09e-3)" "unprognostic (8.38e-3)" "unprognostic (1.43e-1)" "unprognostic (3.06e-1)" "unprognostic (3.09e-2)" "unprognostic (1.16e-3)" 3.5 2.8 4.8 4.6 5.9 6.1 6.9 7.1 5.6 5.7 6.4 6.5 5.9 4.4 6.0 7.7 3.8 4.0 4.4 2.8 4.1 6.1 4.0 4.2 4.9 8.1 4.5 7.3 4.8 5.0 15.1 5.8 7.7 5.6 6.6 4.6 3.4 4.2 2.2 5.3 8.7 5.6 7.1 5.0 6.1 15.0 5.5 12.2 7.3 3.9 5.4 4.0 4.2 4.4 4.8 11.0 7.9 3.9 5.6 2.3 2.8 6.4 7.2 0.0 3.7 4.2 8.7 3.0 1.7 3.3 3.4 6.0 6.9 10.4 2.9 1.9 4.7 4.1 8.2 2.9 3.0 4.8 4.4 15.6 2.2 9.8 3.2 16.9 9.5 2.7 7.1 3.4 5.6 2.4 3.9 12.3 13.3 7.0 3.2 2.8 9.9 10.3 11.1 3.1 0.4 11.2 8.2 4.2 3.9 5.8 2.1 5.1 4.2 4.0 3.1 12.5 4.8 10.8 2.5 1.6 6.1 2.1 3.2 6.5 16.4 6.1 1.1 13.0 1.6 11.0 4.5 5.4 3.2 4.8 5.1 4.4 3.9 3.2 2.8 4.1 5.6 3.8 4.5 3.9 7.9 4.8 4.0 2.3 53.6 26.2 21.5 15.3 0.0 58.9 23.0 20.4 18.7 27.3 38.4 41.2 35.7 16.6 19.5 13.8 17.3 38.1 0.0 22.4 24.4 8.2 20.6 9.2 25.2 24.3 71.5 58.8 36.2 28.9 11.8 32.5 31.3 0.0 13.6 31.2 37.1 25.4 45.6 23.7 14.8 61.0 19.4 12.2 64.6 88.8 0.0 36.6 27.7 30.2 15.4 ZNF518B KIAA1729 ENSG00000178163 "Zinc finger protein 518B" Q9C0D4 4 10439874-10457410 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031215, HPA031216" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA031215: AB_10600200, HPA031216: AB_10601449" "unprognostic (2.69e-1)" "unprognostic (1.68e-1)" "unprognostic (2.89e-1)" "unprognostic (7.74e-3)" "unprognostic (2.11e-1)" "unprognostic (7.99e-2)" "unprognostic (1.01e-1)" "unprognostic (4.91e-2)" "unprognostic (3.39e-2)" "unprognostic (3.07e-1)" "unprognostic (2.24e-1)" "unprognostic (5.14e-2)" "unprognostic (1.90e-1)" "unprognostic (1.27e-1)" "unprognostic (5.44e-2)" "unprognostic (1.02e-1)" "unprognostic (1.89e-3)" 11.2 9.6 9.4 10.5 12.2 6.1 12.9 16.0 13.2 11.4 10.3 6.0 9.6 6.4 10.4 11.4 7.7 8.3 7.8 11.0 9.3 9.9 6.2 4.2 7.5 12.6 7.5 7.6 15.8 5.7 10.5 12.7 13.1 8.3 12.7 5.4 9.3 12.1 13.5 12.1 6.5 11.4 10.0 6.4 11.1 7.9 15.1 4.7 19.5 14.1 7.3 14.8 10.7 11.5 9.5 4.5 11.8 5.3 6.8 4.8 2.3 4.9 3.4 13.2 3.8 1.7 2.6 0.0 5.8 1.4 3.6 4.3 0.0 0.0 0.0 5.9 8.4 10.2 0.1 3.0 6.4 8.0 0.0 5.5 16.0 0.0 0.0 7.7 0.0 7.1 7.5 3.8 5.7 0.0 7.4 12.2 12.0 17.2 0.0 2.9 0.0 10.8 0.4 12.8 2.5 7.7 9.3 5.6 1.8 0.1 7.0 9.9 2.9 2.7 0.0 1.8 11.0 2.1 4.3 9.2 0.0 12.1 0.0 5.4 6.8 5.0 9.4 0.7 0.9 0.7 2.8 2.5 11.8 2.9 2.6 3.8 9.5 4.6 3.3 4.5 5.2 4.8 4.4 6.5 6.8 5.3 1.5 3.4 2.3 9.4 12.2 16.0 13.2 9.3 9.9 7.5 7.6 8.3 4.7 3.0 4.6 4.2 17.0 14.2 9.2 23.8 5.1 5.3 10.3 0.0 9.8 7.9 3.3 2.4 10.3 12.6 4.2 0.0 3.3 7.4 6.7 17.5 16.1 1.6 7.7 11.1 1.2 9.2 8.2 15.2 15.0 5.0 1.7 4.6 2.7 8.3 1.9 2.9 20.1 1.0 10.6 0.0 6.2 12.3 8.3 12.4 7.7 5.7 3.0 15.8 ZNF521 "EHZF, Evi3" ENSG00000198795 "Zinc finger protein 521" Q96K83 18 25061926-25352190 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 69.1" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 27.9;Endothelial cells: 22.4;Horizontal cells: 14.3;Ito cells: 14.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 6 "cerebellum: 69.1" "Group enriched" "Detected in some" 5 "basophil: 8.8;plasmacytoid DC: 9.8" "Group enriched" "Detected in many" 5 "dendritic cells: 9.8;granulocytes: 8.8" "Cell line enhanced" "Detected in many" "AF22: 32.0;fHDF/TERT166: 15.0;HUVEC TERT2: 21.9;THP-1: 17.8" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 105.4" "HPA023056, HPA023849" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA023056: AB_1859315, HPA023849: AB_1859316" "unprognostic (8.80e-3)" "unprognostic (9.68e-2)" "unprognostic (2.05e-1)" "unprognostic (3.40e-2)" "unprognostic (5.43e-2)" "unprognostic (3.73e-3)" "unprognostic (1.52e-3)" "unprognostic (6.17e-2)" "unprognostic (1.72e-1)" "unprognostic (1.57e-1)" "unprognostic (8.18e-2)" "unprognostic (1.83e-1)" "unprognostic (1.19e-3)" "unprognostic (1.16e-3)" "unprognostic (2.43e-1)" "unprognostic (2.52e-3)" "unprognostic (7.82e-4)" 9.2 11.3 5.2 2.8 7.0 1.9 9.1 69.1 11.5 11.0 3.4 9.1 4.7 1.7 19.8 5.9 3.8 9.0 10.0 7.0 5.8 5.1 3.1 1.2 6.4 4.0 8.4 2.8 20.5 1.4 1.4 16.8 8.0 12.2 4.4 3.5 6.7 8.7 3.0 3.8 4.6 3.2 13.3 12.2 18.5 2.4 3.4 8.9 0.5 5.3 6.9 2.6 7.4 5.4 0.0 9.8 8.8 0.1 1.7 0.0 0.1 0.0 0.0 32.0 0.0 5.1 9.0 0.1 4.6 6.7 1.6 1.0 0.0 0.0 0.0 0.0 15.0 0.0 0.1 0.0 0.0 1.3 0.0 1.9 6.3 0.3 0.2 0.9 0.0 9.6 11.1 0.0 0.1 0.0 0.0 21.9 7.6 0.1 0.0 2.8 0.0 4.1 0.0 2.2 0.0 0.0 0.0 7.2 0.5 0.0 0.0 4.1 2.6 0.4 0.0 0.0 3.0 0.0 17.8 12.4 12.7 1.0 3.7 0.7 0.0 0.0 0.1 4.8 0.0 10.4 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 9.8 0.0 0.1 5.2 7.0 69.1 4.3 5.8 5.1 8.4 2.8 12.2 8.9 0.0 4.8 0.0 0.1 3.3 27.9 9.1 0.0 2.7 1.2 0.0 2.0 0.0 0.0 0.0 1.6 22.4 0.0 0.0 0.0 0.0 7.2 0.2 12.7 0.0 0.1 14.3 1.2 14.1 1.6 3.6 9.2 0.9 13.5 0.0 0.0 0.7 0.0 0.0 7.4 3.1 2.7 0.0 3.3 0.1 1.5 3.9 0.1 0.0 0.0 0.1 ZNF524 MGC23143 ENSG00000171443 "Zinc finger protein 524" Q96C55 19 55600022-55603138 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050981 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA050981: AB_2681298" "unprognostic (6.69e-2)" "unprognostic (1.23e-2)" "unprognostic (5.70e-2)" "unprognostic (4.27e-3)" "unprognostic (2.88e-2)" "unprognostic (3.63e-2)" "unprognostic (1.30e-2)" "unprognostic (5.13e-2)" "unprognostic (2.99e-1)" "unprognostic (2.02e-1)" "unprognostic (1.35e-1)" "unprognostic (2.13e-1)" "unprognostic (8.26e-2)" "unprognostic (1.02e-2)" "unprognostic (3.84e-1)" "unprognostic (1.59e-2)" "prognostic favorable (4.98e-8)" 10.4 7.9 7.9 9.9 8.2 9.4 36.6 6.9 10.3 7.1 10.9 5.5 15.8 15.8 7.9 13.6 12.8 8.7 16.2 9.6 7.5 4.4 8.4 10.8 10.5 14.1 12.2 4.8 7.1 31.4 5.4 7.8 5.4 7.5 10.6 4.5 4.5 22.9 13.8 32.1 13.8 12.3 6.4 8.1 11.8 13.3 4.0 9.5 7.9 12.9 12.1 5.9 8.4 16.5 13.2 16.5 16.4 21.2 10.1 19.1 12.4 8.7 8.8 1.3 6.1 4.0 8.5 10.0 5.7 3.4 3.7 3.7 2.6 10.2 4.5 3.3 3.2 2.1 7.1 0.8 4.3 0.5 13.2 22.3 5.4 4.9 4.6 10.0 3.4 7.0 7.0 10.3 3.0 3.1 3.8 6.8 5.8 5.0 9.2 1.9 5.1 3.4 7.5 1.5 8.5 10.0 4.5 3.1 13.3 4.7 5.0 6.2 3.9 5.6 8.1 6.3 1.1 3.8 11.6 5.8 3.1 5.4 6.0 7.4 4.0 4.7 2.1 8.6 9.0 4.2 11.5 21.2 16.4 12.7 18.3 11.7 11.6 13.2 12.2 16.5 13.2 15.8 8.6 13.4 10.1 12.1 5.1 19.1 12.4 7.9 8.2 6.9 10.3 7.5 4.4 12.2 4.8 7.5 9.5 6.0 13.1 16.6 18.3 22.3 9.0 9.6 15.3 5.3 5.7 7.0 5.9 18.6 14.9 22.8 2.1 23.4 69.5 0.0 45.9 15.9 12.5 14.5 10.3 20.3 34.9 6.4 22.4 33.7 61.7 3.6 16.7 26.7 28.7 19.0 48.1 7.2 32.4 49.5 20.5 25.8 6.4 19.4 15.1 0.9 4.1 31.1 21.4 30.8 43.9 16.6 ZNF526 "KIAA1951, MGC4267" ENSG00000167625 "Zinc finger protein 526" Q8TF50 19 42220271-42228201 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 41.9;Club cells: 28.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023070, HPA056609" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus, Vesicles" "HPA023070: AB_2671057, HPA056609: AB_2683189" "unprognostic (2.04e-1)" "unprognostic (3.15e-1)" "unprognostic (2.42e-1)" "unprognostic (3.95e-3)" "unprognostic (1.46e-1)" "unprognostic (5.86e-2)" "unprognostic (9.09e-3)" "unprognostic (1.79e-1)" "unprognostic (8.84e-2)" "unprognostic (8.62e-3)" "unprognostic (1.28e-2)" "unprognostic (2.14e-1)" "unprognostic (1.59e-1)" "unprognostic (1.98e-1)" "unprognostic (1.35e-1)" "unprognostic (2.81e-1)" "unprognostic (2.30e-1)" 10.1 7.0 5.9 12.3 9.1 8.5 8.5 14.5 10.0 10.6 8.5 8.6 9.2 8.3 12.2 6.4 8.4 9.3 5.0 6.8 7.5 4.3 7.0 7.6 7.3 9.1 8.7 6.6 12.0 9.0 10.1 11.7 8.6 6.2 9.9 5.6 7.5 11.1 9.1 11.7 13.0 10.1 6.3 4.6 9.1 7.9 11.6 8.1 13.8 7.6 6.1 11.5 9.0 10.3 6.9 6.1 2.5 7.1 4.5 10.7 4.3 7.1 23.3 6.9 6.1 7.9 7.6 6.0 8.4 7.8 8.9 9.8 12.2 5.2 11.7 6.1 8.9 4.0 5.3 7.3 9.1 5.6 6.9 8.7 11.7 10.9 11.7 7.3 7.4 7.6 7.5 7.4 8.9 9.3 5.5 5.5 6.3 11.1 7.4 5.6 10.0 7.4 4.8 4.5 6.3 8.4 8.7 8.4 5.2 4.0 13.1 7.0 6.2 9.6 9.7 7.0 5.5 3.9 13.3 7.4 11.0 7.6 4.6 10.5 9.0 5.3 8.1 7.3 7.3 9.1 2.5 5.1 1.9 7.0 5.4 10.7 6.9 5.5 6.3 4.2 6.7 6.7 8.3 1.2 4.5 7.1 6.1 5.4 4.3 5.9 9.1 14.5 10.0 7.5 4.3 8.7 6.6 6.2 8.1 20.8 41.9 6.4 4.0 4.8 7.6 2.0 0.0 14.7 28.4 3.5 13.7 6.4 3.3 3.3 4.6 4.7 4.7 0.0 2.4 7.0 4.1 2.5 23.3 3.2 3.9 6.4 13.2 4.3 4.7 5.5 6.6 4.6 0.0 4.6 5.0 3.3 2.6 3.5 2.8 2.4 8.7 0.0 4.2 5.8 9.8 4.4 8.6 5.0 4.9 2.1 ZNF529 KIAA1615 ENSG00000186020 "Zinc finger protein 529" Q6P280 19 36534774-36605276 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Horizontal cells: 71.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA031311 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA031311: AB_10604158" "unprognostic (2.19e-2)" "unprognostic (4.89e-2)" "unprognostic (8.51e-2)" "unprognostic (7.94e-2)" "unprognostic (1.83e-3)" "unprognostic (2.61e-3)" "unprognostic (8.67e-2)" "unprognostic (1.30e-2)" "unprognostic (3.84e-3)" "unprognostic (7.10e-2)" "unprognostic (1.05e-3)" "unprognostic (6.61e-3)" "unprognostic (3.37e-2)" "unprognostic (1.45e-2)" "unprognostic (1.00e-1)" "unprognostic (9.64e-2)" "prognostic favorable (1.39e-5)" 9.0 11.8 13.8 11.6 22.4 15.9 12.4 22.6 18.3 9.5 7.6 16.0 8.1 6.5 14.4 12.7 6.2 13.3 8.5 11.7 13.4 12.2 7.1 8.1 9.2 13.4 20.4 16.5 15.5 6.1 17.0 17.2 10.3 16.0 10.5 7.1 9.0 6.9 8.1 8.5 13.7 8.0 10.2 16.9 11.4 7.1 16.7 18.4 15.3 12.2 3.7 12.4 7.4 8.6 5.3 2.7 6.3 2.1 3.9 6.3 2.4 3.7 7.6 10.6 12.3 6.3 7.7 4.8 5.7 3.5 3.7 7.9 3.8 2.9 9.1 7.7 5.2 4.0 1.7 8.6 3.4 6.5 13.0 9.4 11.8 5.1 2.6 7.3 8.9 7.1 8.6 5.6 4.6 7.6 6.2 3.0 7.4 5.2 0.7 7.6 1.2 9.5 3.4 7.6 0.1 2.9 2.8 7.6 4.9 3.4 8.4 5.3 10.6 7.5 3.1 2.8 5.0 3.6 6.5 5.6 8.0 5.2 5.1 6.9 12.6 6.3 8.9 0.2 3.0 5.2 6.3 2.1 2.6 4.4 1.4 6.3 5.3 5.0 4.9 2.2 4.9 5.7 4.5 1.0 3.9 1.4 2.7 5.6 2.4 13.8 22.4 22.6 18.3 13.4 12.2 20.4 16.5 16.0 18.4 3.0 3.5 6.5 4.7 8.8 19.0 14.3 2.5 5.3 6.8 7.0 23.6 2.9 5.0 3.0 3.4 6.8 1.4 23.3 1.4 2.5 6.2 5.9 2.3 6.8 3.3 71.5 2.9 5.5 2.6 1.4 6.1 5.3 5.0 0.0 3.2 8.2 1.9 2.9 6.3 3.4 22.6 0.0 7.5 14.9 10.5 8.0 2.7 10.0 2.5 5.5 ZNF532 FLJ10697 ENSG00000074657 "Zinc finger protein 532" Q9HCE3 18 58862600-58986480 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Glandular cells: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 6.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 40.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015322 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA015322: AB_2304947" "unprognostic (3.43e-1)" "unprognostic (4.36e-2)" "unprognostic (1.41e-3)" "prognostic unfavorable (6.46e-5)" "unprognostic (4.24e-1)" "unprognostic (5.84e-2)" "unprognostic (1.50e-3)" "unprognostic (7.40e-2)" "unprognostic (5.33e-2)" "unprognostic (1.42e-1)" "unprognostic (2.09e-3)" "unprognostic (1.90e-1)" "unprognostic (7.60e-3)" "unprognostic (1.06e-2)" "unprognostic (1.85e-1)" "unprognostic (5.53e-2)" "prognostic unfavorable (5.76e-4)" 12.3 7.0 14.3 8.0 17.1 0.6 11.4 44.6 22.5 17.5 12.3 23.7 11.6 3.7 35.5 11.2 12.3 15.0 13.1 18.6 14.7 11.9 7.2 2.3 10.4 7.8 14.2 13.4 29.6 4.2 14.5 18.2 13.7 15.0 27.1 7.2 14.5 7.8 19.6 29.5 8.8 6.1 22.5 18.9 8.5 7.1 12.5 17.2 2.5 13.6 7.0 8.9 13.0 19.8 6.7 1.4 0.0 2.2 0.4 1.0 0.7 6.9 9.8 40.7 21.4 6.7 15.0 2.0 12.9 12.0 8.8 8.0 3.4 7.6 8.5 9.9 15.7 4.6 11.5 0.3 9.4 8.8 6.3 8.5 0.0 14.7 0.2 8.9 0.0 0.0 11.6 18.4 9.2 16.9 12.2 9.9 0.0 0.1 10.7 10.4 0.0 0.0 0.1 21.5 0.3 6.3 0.2 10.5 1.4 6.1 0.9 9.2 24.5 8.4 0.9 14.2 29.0 10.3 5.7 7.3 24.0 17.9 0.1 10.1 0.1 7.1 2.3 8.6 0.0 18.4 0.0 0.4 0.0 1.0 2.2 0.3 6.7 0.5 0.5 1.4 3.6 0.1 0.3 0.0 0.4 0.3 0.2 0.0 0.7 14.3 17.1 44.6 21.4 14.7 11.9 14.2 13.4 15.0 17.2 11.9 9.8 8.2 10.0 9.4 31.7 13.7 10.2 9.4 10.3 1.8 25.5 1.7 0.0 4.5 3.4 21.0 0.0 0.0 0.4 1.7 15.8 38.3 0.0 0.0 3.8 33.4 4.1 17.8 8.8 2.8 10.6 10.9 8.5 3.6 0.0 23.3 3.8 0.3 17.0 1.4 8.5 12.9 15.6 2.3 21.3 8.2 2.9 2.5 0.3 10.3 ZNF536 KIAA0390 ENSG00000198597 "Zinc finger protein 536" O15090 19 30228290-30713538 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 44.5" "Group enriched" "Detected in some" 5 "Bipolar cells: 29.2;Horizontal cells: 66.7;Muller glia cells: 58.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 4.0;HAP1: 8.9;SH-SY5Y: 24.4;U-937: 5.9;WM-115: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077341 Approved "Nucleoplasm,Cell Junctions" NA NA "Nucleoplasm, Cell Junctions" "HPA077341: AB_2732340" "unprognostic (1.98e-1)" "unprognostic (4.11e-1)" "unprognostic (1.92e-2)" "unprognostic (1.70e-2)" "unprognostic (2.09e-1)" "unprognostic (1.03e-1)" "unprognostic (4.70e-2)" "unprognostic (4.68e-1)" "unprognostic (5.50e-2)" "unprognostic (1.74e-2)" "unprognostic (1.25e-2)" "unprognostic (4.46e-4)" "unprognostic (1.58e-1)" "unprognostic (2.01e-2)" "unprognostic (1.55e-2)" "unprognostic (3.45e-1)" 1.1 6.0 9.9 2.0 21.0 0.6 0.8 14.3 24.1 4.2 4.0 44.5 0.0 2.7 1.7 1.3 6.9 1.0 1.3 2.9 13.3 7.7 0.8 0.7 1.0 0.7 20.9 9.6 0.9 0.9 0.7 3.4 0.7 18.3 3.7 4.1 4.8 1.6 2.4 1.4 1.2 4.2 1.2 23.1 1.5 2.1 5.0 18.4 0.0 6.9 0.0 0.7 2.9 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 8.9 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 24.4 0.0 0.0 1.6 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 5.9 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 9.9 21.0 14.3 15.1 13.3 7.7 20.9 9.6 18.3 18.4 0.0 0.0 0.0 0.1 0.3 29.2 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.5 66.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.4 0.0 0.0 0.0 0.0 9.5 0.0 1.9 0.3 0.4 0.3 0.0 0.0 0.0 0.1 ZNF540 DKFZp547B0714 ENSG00000171817 "Zinc finger protein 540" Q8NDQ6 19 37551406-37614097 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 30.7" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 23.5;Early spermatids: 14.0;Horizontal cells: 17.5;Rod photoreceptor cells: 19.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 6.8" HPA003444 Supported Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA003444: AB_1080732" "unprognostic (2.51e-2)" "unprognostic (2.30e-4)" "unprognostic (4.92e-2)" "unprognostic (1.12e-1)" "unprognostic (2.80e-4)" "unprognostic (4.24e-4)" "unprognostic (3.44e-3)" "unprognostic (8.88e-4)" "unprognostic (2.65e-1)" "unprognostic (3.17e-1)" "unprognostic (3.38e-5)" "unprognostic (1.50e-1)" "unprognostic (1.09e-6)" "unprognostic (2.74e-1)" "unprognostic (4.75e-2)" "unprognostic (8.08e-2)" "unprognostic (8.33e-5)" 2.8 9.3 8.6 3.9 29.9 1.2 6.0 23.7 16.7 5.8 4.4 5.0 5.3 3.9 6.0 9.4 3.0 4.2 3.6 9.1 8.6 12.1 6.3 2.6 5.0 6.3 9.0 9.1 13.8 3.8 13.3 30.7 2.3 11.0 7.1 3.6 9.0 6.1 8.9 2.9 6.0 4.5 3.8 7.9 6.3 4.6 11.5 9.5 2.7 14.4 3.1 6.0 3.4 4.0 3.1 0.3 1.2 0.1 3.0 7.1 1.8 0.4 0.0 2.6 2.6 6.8 4.1 0.2 0.9 0.9 1.1 2.1 0.2 0.0 1.2 0.3 2.4 0.6 1.0 1.8 0.9 0.9 3.7 2.6 0.9 1.2 0.0 1.8 1.2 2.0 1.8 2.4 0.7 0.0 0.5 0.1 5.1 0.4 0.0 1.6 0.1 1.7 0.7 0.9 0.3 0.5 1.4 1.6 0.8 0.6 0.4 2.7 3.0 1.0 0.3 0.3 1.9 1.3 0.7 0.0 1.0 3.1 1.2 0.9 3.6 2.0 2.5 0.0 0.4 0.6 0.0 0.0 1.2 3.9 0.1 3.9 2.9 4.1 4.4 0.1 3.1 6.8 7.1 0.2 3.0 0.0 0.3 4.2 1.8 8.6 29.9 23.7 16.7 8.6 12.1 9.0 9.1 11.0 9.5 3.0 1.6 0.8 1.1 1.4 23.5 8.7 0.0 0.0 2.3 1.8 5.9 0.2 6.6 0.1 14.0 0.9 0.4 0.0 0.4 0.3 0.9 0.4 3.5 0.8 0.7 17.5 0.0 2.5 0.3 4.3 2.3 0.9 3.3 0.0 0.0 5.2 0.3 0.0 5.3 2.1 19.7 6.5 3.3 4.4 2.7 1.1 0.1 3.5 0.2 0.0 ZNF541 DKFZp434I1930 ENSG00000118156 "Zinc finger protein 541" Q9H0D2 19 47520685-47555856 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 17.7" "Group enriched" "Detected in some" 8 "Early spermatids: 18.8;Late spermatids: 8.5;Proximal tubular cells: 10.3;Spermatocytes: 28.8;Spermatogonia: 9.8" "Cancer enhanced" "Detected in some" "cervical cancer: 2.7" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.3" "Lineage enriched" "Detected in single" 23 "T-cells: 2.3" "Group enriched" "Detected in some" 5 "HEL: 3.1;SiHa: 10.2;U-87 MG: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA058541, HPA076453" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA058541: AB_2683748, HPA076453: AB_2732310" "unprognostic (4.49e-2)" "prognostic favorable (2.94e-4)" "unprognostic (8.33e-2)" "unprognostic (3.09e-1)" "unprognostic (2.74e-1)" "unprognostic (5.92e-5)" "unprognostic (7.98e-2)" "unprognostic (5.19e-3)" "unprognostic (1.38e-1)" "unprognostic (1.98e-1)" "unprognostic (1.04e-2)" "unprognostic (7.52e-2)" "unprognostic (3.09e-2)" "unprognostic (5.20e-2)" "unprognostic (2.14e-1)" "unprognostic (1.01e-1)" "unprognostic (1.59e-2)" 1.2 2.6 0.1 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.9 0.0 0.1 0.1 0.0 2.2 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.0 0.5 0.0 17.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.1 0.0 0.5 0.2 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 1.0 0.3 0.0 0.2 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 1.5 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.0 18.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 8.5 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.3 0.8 0.0 0.0 28.8 9.8 0.1 0.0 0.0 0.0 0.0 ZNF543 DKFZp434H055 ENSG00000178229 "Zinc finger protein 543" Q08ER8 19 57320509-57330776 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 12.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA046330 Approved Nucleoplasm NA NA Nucleoplasm "HPA046330: " "unprognostic (9.20e-2)" "unprognostic (8.89e-2)" "unprognostic (2.60e-2)" "unprognostic (1.51e-1)" "unprognostic (1.45e-1)" "unprognostic (4.71e-1)" "unprognostic (2.45e-2)" "unprognostic (9.86e-2)" "unprognostic (1.01e-1)" "unprognostic (6.55e-2)" "unprognostic (2.44e-2)" "unprognostic (7.47e-2)" "prognostic favorable (2.03e-5)" "unprognostic (1.94e-1)" "unprognostic (1.10e-1)" "unprognostic (2.05e-1)" "unprognostic (2.84e-2)" 6.2 6.0 6.6 4.0 10.1 5.0 8.0 18.1 10.3 5.7 5.3 7.4 7.1 2.3 6.5 5.4 7.7 6.9 4.7 5.2 7.0 4.0 5.1 3.9 5.1 6.5 8.4 5.8 14.8 5.7 10.0 10.8 8.1 7.2 6.4 3.5 7.5 6.8 7.3 6.7 8.9 4.8 6.2 7.7 7.2 4.9 11.0 8.0 15.8 7.9 2.4 8.0 6.5 5.1 6.4 3.6 7.3 3.5 5.2 5.6 3.5 3.3 4.5 4.2 6.6 3.7 3.3 5.1 2.0 3.6 3.8 6.8 1.4 2.0 5.4 2.8 2.7 2.5 1.9 3.6 3.7 5.0 2.4 9.7 5.2 4.7 4.1 4.1 5.0 3.5 3.6 3.9 3.0 6.3 3.2 2.9 6.3 2.8 1.0 2.8 0.4 5.8 1.6 3.8 0.3 3.5 5.5 6.4 5.7 2.5 8.2 7.8 5.5 5.7 2.3 3.9 3.9 2.8 4.7 2.8 5.6 4.0 1.1 3.7 8.1 5.3 6.2 2.7 2.3 2.9 2.2 3.4 7.3 3.8 3.2 4.9 6.0 4.1 5.6 3.6 6.4 5.0 4.9 3.6 5.2 3.5 2.4 2.1 3.5 6.6 10.1 18.1 10.3 7.0 4.0 8.4 5.8 7.2 8.0 3.0 0.3 0.5 1.1 2.4 4.2 1.4 2.5 0.0 2.3 0.0 5.9 2.4 5.0 1.4 12.4 2.9 0.2 0.0 0.4 1.2 0.9 1.6 2.3 1.0 1.3 6.4 0.0 1.3 0.6 8.6 1.4 2.0 1.7 0.0 1.3 3.9 0.2 0.0 2.1 0.6 4.9 6.5 1.4 2.3 1.9 2.3 1.8 1.8 1.1 1.3 ZNF544 AF020591 ENSG00000198131 "Zinc finger protein 544" Q6NX49 19 58228594-58277495 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 52.3" "Low region specificity" "Detected in all" HPA002732 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA002732: AB_1080735" "unprognostic (5.28e-2)" "unprognostic (9.71e-2)" "unprognostic (3.28e-1)" "unprognostic (1.24e-2)" "unprognostic (4.32e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (1.04e-5)" "unprognostic (3.61e-3)" "prognostic unfavorable (3.65e-5)" "unprognostic (4.94e-2)" "unprognostic (2.31e-2)" "unprognostic (8.87e-2)" "unprognostic (1.42e-2)" "unprognostic (3.68e-1)" "unprognostic (1.20e-1)" "unprognostic (1.54e-1)" "unprognostic (2.49e-1)" 7.0 10.2 14.0 12.7 12.9 6.8 12.8 20.6 14.4 11.7 8.0 10.7 5.4 4.3 18.3 31.2 10.8 20.1 9.4 13.9 12.0 12.2 10.2 7.3 7.2 9.7 12.6 13.7 12.6 12.1 22.8 19.1 9.9 11.1 10.1 8.5 16.2 8.7 9.6 3.7 11.7 7.4 10.4 13.0 10.2 8.8 19.6 12.0 13.9 16.5 8.9 12.0 10.4 7.9 11.7 8.4 12.5 3.8 14.4 11.1 5.4 15.5 6.1 4.2 4.7 4.5 7.7 10.3 7.4 3.4 14.1 9.9 5.3 6.8 20.7 3.6 8.8 0.0 5.3 5.1 16.3 19.8 9.6 52.3 15.8 12.2 2.5 12.5 9.5 12.7 5.3 24.2 9.6 26.8 13.5 12.4 0.1 8.9 0.0 8.2 4.9 19.9 6.6 9.7 3.3 2.9 6.9 4.7 16.0 9.6 24.5 23.0 0.0 8.9 4.5 3.2 7.7 6.5 6.9 10.4 2.6 9.2 2.7 8.4 18.1 35.3 0.0 0.0 0.0 6.4 2.3 2.3 12.5 7.6 3.8 7.0 9.3 6.8 9.6 5.3 11.7 8.3 11.1 2.8 14.4 0.9 8.4 5.5 5.4 14.0 12.9 20.6 14.4 12.0 12.2 12.6 13.7 11.1 12.0 6.0 9.9 20.6 9.3 5.3 24.8 10.6 17.8 16.0 20.5 7.0 43.2 13.7 16.6 6.3 33.3 7.2 4.7 0.0 3.8 8.6 5.8 10.4 10.4 6.6 11.2 20.6 11.1 7.4 4.6 46.6 5.2 5.1 8.5 1.8 5.7 18.3 6.7 0.0 3.5 6.8 35.7 19.4 5.1 46.0 26.2 6.8 9.8 12.2 7.6 10.1 ZNF546 "MGC43537, ZNF49" ENSG00000187187 "Zinc finger protein 546" Q86UE3 19 39984134-40021041 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 25.9;Spermatocytes: 50.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA030838 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030838: AB_10603332" "unprognostic (4.38e-6)" "unprognostic (3.29e-1)" "unprognostic (1.80e-1)" "unprognostic (1.69e-2)" "unprognostic (6.10e-2)" "unprognostic (7.18e-4)" "unprognostic (1.05e-1)" "unprognostic (1.73e-2)" "unprognostic (8.20e-3)" "unprognostic (4.99e-2)" "unprognostic (2.03e-3)" "unprognostic (2.70e-1)" "unprognostic (5.69e-3)" "unprognostic (2.23e-1)" "unprognostic (6.46e-2)" "unprognostic (2.28e-1)" "unprognostic (2.58e-5)" 4.1 5.1 5.0 3.7 7.1 2.5 4.7 7.9 6.6 4.2 3.6 7.6 7.3 2.0 6.3 3.8 2.8 5.7 2.9 4.9 4.7 3.8 4.8 5.5 3.2 3.8 7.9 4.4 7.3 3.7 6.5 8.5 3.1 6.8 4.6 2.7 5.2 2.9 6.1 5.6 3.8 3.4 5.3 8.3 5.4 3.1 20.8 7.9 6.6 6.0 2.8 4.4 3.6 3.3 2.7 2.8 2.6 2.4 2.5 4.7 1.2 0.2 4.6 2.0 2.6 4.7 3.4 0.3 1.8 2.8 2.2 3.0 0.2 0.6 2.5 2.1 1.6 1.2 0.2 1.0 0.3 3.3 2.6 3.3 3.2 3.2 1.7 2.5 3.2 2.2 2.7 2.0 1.3 3.5 2.8 2.8 4.5 4.0 6.1 2.3 0.6 1.5 0.7 0.7 0.3 0.6 1.8 1.7 1.2 1.1 0.4 1.4 1.5 1.0 0.2 1.8 2.7 0.9 1.4 1.1 0.7 1.5 0.3 1.4 4.6 4.4 0.5 1.7 1.3 1.4 1.6 1.5 2.6 3.7 2.4 2.5 2.7 2.4 2.2 2.8 2.4 4.7 4.1 1.1 2.5 1.2 0.7 3.0 1.2 5.0 7.1 7.9 6.6 4.7 3.8 7.9 4.4 6.8 7.9 0.0 5.8 1.9 0.7 0.5 8.2 5.1 2.5 5.3 1.2 3.5 11.8 1.0 1.7 1.0 25.9 2.9 0.3 0.0 0.4 0.1 1.3 0.7 0.0 2.9 1.6 1.6 0.0 5.5 2.1 4.8 4.0 1.8 0.0 0.0 0.0 5.6 0.5 0.0 3.9 3.1 9.1 0.0 1.2 50.8 2.6 0.0 0.2 1.3 0.8 0.6 ZNF548 FLJ32932 ENSG00000188785 "Zinc finger protein 548" Q8NEK5 19 57389850-57402992 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 33.1" HPA066042 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA066042: AB_2685602" "prognostic favorable (7.85e-4)" "unprognostic (4.61e-2)" "unprognostic (5.53e-2)" "unprognostic (8.52e-2)" "unprognostic (1.28e-1)" "unprognostic (4.05e-3)" "unprognostic (1.61e-2)" "unprognostic (6.77e-2)" "unprognostic (3.01e-2)" "unprognostic (1.59e-2)" "unprognostic (4.66e-2)" "unprognostic (2.50e-2)" "unprognostic (1.33e-1)" "unprognostic (3.85e-1)" "unprognostic (1.55e-1)" "unprognostic (3.86e-3)" "unprognostic (5.85e-2)" 18.6 9.2 11.0 17.0 18.1 26.8 17.5 27.5 16.3 9.7 13.1 13.2 7.4 7.5 14.3 12.7 11.0 14.3 13.4 16.0 9.2 7.0 9.6 9.5 16.1 24.0 12.9 10.7 18.6 8.1 14.5 14.0 10.6 11.5 13.1 10.3 14.1 10.5 10.1 13.5 12.8 19.6 16.1 9.1 23.6 10.6 9.8 10.4 13.5 14.6 9.8 20.4 12.2 11.5 10.2 4.9 3.4 3.3 7.3 9.7 3.8 5.6 5.1 10.1 7.1 5.3 5.8 1.9 4.5 7.0 6.9 13.2 1.1 14.4 5.6 2.9 4.5 4.5 2.3 4.1 5.2 7.6 2.8 13.3 5.9 33.1 6.5 4.2 6.5 12.0 6.7 7.3 6.7 10.4 6.6 3.5 11.6 0.3 0.0 6.0 1.5 10.2 2.2 2.7 0.2 5.7 11.7 10.9 8.0 3.9 10.1 6.0 7.2 6.2 2.6 3.2 8.8 5.9 5.6 5.4 8.1 7.6 2.7 7.3 13.9 9.2 8.4 5.7 3.4 8.1 2.2 2.4 3.4 6.8 2.6 9.7 6.6 6.3 8.4 4.9 10.2 9.1 9.5 2.1 7.3 3.3 4.1 9.3 3.8 11.0 18.1 27.5 16.3 9.2 7.0 12.9 10.7 11.5 10.4 3.0 7.0 7.2 4.9 6.0 4.6 4.5 10.2 5.3 3.4 7.0 5.9 3.6 3.3 3.6 7.4 9.0 2.1 0.0 2.1 2.3 4.4 3.1 9.2 6.4 3.6 1.6 5.8 10.4 4.1 3.4 5.2 2.8 0.0 2.8 3.4 5.7 2.5 0.0 3.9 2.4 9.1 0.0 8.1 11.6 5.7 5.0 3.7 7.5 2.1 1.7 ZNF549 FLJ34917 ENSG00000121406 "Zinc finger protein 549" Q6P9A3 19 57527325-57557542 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 13.7;Rod photoreceptor cells: 14.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 13.4" "Group enriched" "Detected in all" 4 "B-cells: 4.7;NK-cells: 13.4;T-cells: 5.8" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 16.5" HPA039511 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039511: AB_10671998" "unprognostic (6.27e-2)" "unprognostic (9.03e-3)" "unprognostic (2.02e-2)" "unprognostic (1.20e-2)" "unprognostic (4.28e-2)" "unprognostic (2.80e-1)" "unprognostic (2.35e-1)" "unprognostic (1.34e-1)" "unprognostic (2.14e-1)" "unprognostic (7.07e-2)" "unprognostic (4.01e-4)" "unprognostic (4.03e-3)" "unprognostic (2.51e-8)" "unprognostic (2.88e-2)" "unprognostic (9.92e-2)" "unprognostic (9.89e-3)" "unprognostic (9.11e-3)" 4.7 6.2 7.3 11.8 11.0 5.9 9.3 18.8 10.3 5.2 5.8 8.0 4.0 3.6 7.2 7.7 3.9 8.0 6.9 5.4 9.0 6.2 5.6 2.6 7.6 8.8 9.5 7.0 11.2 4.5 12.5 13.8 6.9 7.0 8.3 4.4 6.5 5.6 6.7 5.4 7.3 6.1 7.3 10.6 9.9 5.2 7.2 8.5 11.2 9.1 3.0 9.7 6.5 11.6 4.7 1.8 1.8 1.2 13.4 5.8 2.1 1.4 1.8 7.4 6.1 2.2 1.8 1.8 3.4 4.2 3.4 16.5 1.9 1.3 2.0 2.5 3.1 4.2 0.8 2.3 5.0 5.6 0.2 13.6 9.2 1.4 2.8 3.2 7.6 6.5 3.3 3.9 3.4 4.8 4.9 2.1 5.3 0.1 0.3 6.1 0.8 8.5 3.2 6.3 0.2 4.9 6.1 6.1 4.1 1.3 3.5 3.0 5.3 0.1 0.5 4.0 6.6 4.1 6.0 1.8 6.5 4.5 0.3 5.0 3.5 10.1 6.4 1.1 2.6 5.9 0.7 1.0 1.8 3.0 0.8 4.1 2.7 4.1 4.6 1.8 4.7 5.8 3.7 0.8 13.4 1.2 1.6 2.4 2.1 7.3 11.0 18.8 10.3 9.0 6.2 9.5 7.0 7.0 8.5 0.0 3.2 2.7 1.0 1.4 8.6 2.7 5.1 8.1 0.0 1.8 13.7 1.4 3.3 1.2 0.4 2.9 0.4 0.0 0.6 0.7 2.1 1.4 5.8 0.6 1.3 7.9 3.5 4.9 1.6 0.0 2.8 1.1 5.0 0.0 0.3 4.1 0.6 1.5 2.1 0.6 14.6 6.5 1.4 0.7 3.8 1.4 0.9 2.9 0.8 0.9 ZNF551 DKFZp686H1038 ENSG00000204519 "Zinc finger protein 551" Q7Z340 19 57681969-57717301 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 21.4" "Low region specificity" "Detected in all" HPA038187 Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA038187: AB_2675884" "unprognostic (1.96e-1)" "unprognostic (3.02e-2)" "unprognostic (2.78e-1)" "unprognostic (1.04e-1)" "unprognostic (6.24e-3)" "unprognostic (1.30e-1)" "unprognostic (1.52e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (7.68e-5)" "unprognostic (2.92e-1)" "unprognostic (5.89e-2)" "unprognostic (4.83e-3)" "prognostic favorable (1.32e-4)" "unprognostic (4.70e-2)" "unprognostic (2.73e-1)" "unprognostic (1.26e-2)" "unprognostic (1.54e-1)" 6.6 5.6 4.4 8.3 6.9 12.8 7.9 17.3 5.2 5.2 5.1 6.8 8.6 4.2 6.3 5.9 5.3 5.9 6.1 4.9 4.9 4.6 5.1 3.2 3.8 10.8 3.8 3.3 6.8 10.7 6.1 11.3 5.3 4.9 6.0 5.1 6.4 6.0 5.8 8.8 7.3 5.6 6.8 4.0 8.2 5.1 18.1 5.7 13.0 11.1 5.2 10.3 6.4 6.0 6.6 4.7 2.1 3.1 4.7 8.1 3.8 2.6 5.9 7.3 5.3 1.4 1.7 7.8 3.2 2.3 4.5 2.1 5.0 2.6 4.8 2.1 2.4 3.3 3.0 4.9 7.3 7.1 0.0 21.4 8.5 0.2 2.2 1.3 6.0 7.8 3.0 2.8 4.6 4.2 2.6 1.8 5.1 5.8 0.0 4.0 2.5 12.3 2.4 15.4 5.1 9.6 7.8 12.7 6.4 1.8 15.4 7.1 5.9 4.8 3.1 2.5 7.3 3.9 7.9 2.2 5.2 5.4 1.7 6.0 5.3 11.3 11.0 1.0 3.0 4.9 1.9 2.1 2.1 3.3 3.1 6.2 6.6 4.9 5.2 4.7 5.5 8.1 7.3 1.1 4.7 1.6 3.8 3.9 3.8 4.4 6.9 17.3 5.2 4.9 4.6 3.8 3.3 4.9 5.7 6.0 3.8 2.2 5.2 4.6 7.5 1.2 2.5 6.7 9.1 1.8 7.9 3.4 1.7 2.7 9.6 2.0 1.6 0.0 0.9 2.4 1.9 2.9 1.1 1.7 2.3 3.2 2.4 2.5 2.4 2.7 3.1 2.1 1.7 0.0 3.3 4.0 1.4 0.0 4.6 0.6 14.6 0.0 1.3 7.0 14.0 6.1 2.4 3.3 4.1 7.9 ZNF552 FLJ21603 ENSG00000178935 "Zinc finger protein 552" Q9H707 19 57803841-57814913 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "breast cancer: 23.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 20.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 20.5" "Cell line enhanced" "Detected in many" "RT4: 23.0;T-47d: 37.1" "HPA043800, HPA053762, HPA072145" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: " "prognostic favorable (4.57e-4)" "unprognostic (2.09e-1)" "prognostic favorable (2.66e-4)" "unprognostic (9.03e-2)" "unprognostic (9.89e-2)" "prognostic favorable (9.96e-4)" "unprognostic (3.03e-2)" "unprognostic (1.29e-3)" "unprognostic (3.36e-3)" "unprognostic (6.72e-2)" "unprognostic (1.93e-1)" "unprognostic (1.18e-1)" "unprognostic (2.24e-3)" "unprognostic (2.41e-2)" "unprognostic (9.01e-2)" "unprognostic (3.09e-1)" "unprognostic (2.04e-3)" 2.9 3.3 3.4 14.7 2.8 5.9 22.2 5.4 3.8 8.4 10.1 4.6 6.5 5.6 8.4 6.0 7.1 4.5 7.8 4.0 2.8 2.2 12.3 5.5 5.7 8.0 3.8 1.2 4.8 5.9 3.8 5.7 11.9 4.7 12.9 10.0 5.2 22.4 14.7 7.2 7.7 10.2 4.3 3.0 6.5 14.2 3.5 2.7 6.7 3.9 2.6 6.3 28.7 11.1 3.4 1.8 20.5 2.7 1.9 3.7 1.8 3.0 1.9 2.2 3.8 1.7 1.0 16.3 1.1 1.5 2.6 1.6 5.1 4.9 4.3 2.1 2.2 0.6 2.9 4.5 3.3 3.5 1.8 8.6 1.5 4.2 3.8 4.1 4.7 2.2 2.0 6.0 1.8 2.0 1.5 3.3 4.6 3.0 1.4 1.6 2.7 2.0 1.3 3.4 3.7 4.1 4.0 2.7 4.4 7.4 23.0 2.7 2.1 5.5 12.3 2.6 6.3 37.1 2.0 2.5 2.3 2.4 1.4 2.0 6.2 4.1 3.5 1.8 3.5 1.3 1.2 2.7 5.5 2.2 2.5 2.1 2.8 2.9 3.5 1.3 3.4 3.7 3.2 20.5 1.9 1.0 1.8 2.2 1.8 3.4 2.8 5.4 3.8 2.8 2.2 3.8 1.2 4.7 2.7 11.9 1.9 5.9 15.6 2.3 5.1 1.3 17.8 22.7 10.3 19.2 2.0 16.8 21.6 5.6 3.3 2.3 9.7 0.0 1.6 5.8 2.7 9.4 8.1 3.4 4.3 3.2 8.1 5.5 2.2 0.9 2.6 3.2 1.7 1.0 9.3 2.0 2.6 9.1 2.1 3.6 13.3 6.5 2.1 2.7 4.1 2.4 17.8 5.7 7.8 11.2 ZNF554 FLJ34817 ENSG00000172006 "Zinc finger protein 554" Q86TJ5 19 2819874-2835773 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 15.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA060247, HPA063358" Uncertain Enhanced Nucleoplasm,Nucleoli No No Nucleoplasm Nucleoli "HPA060247: AB_2684230, HPA063358: AB_2684995" "unprognostic (3.81e-1)" "unprognostic (1.89e-3)" "unprognostic (1.84e-1)" "unprognostic (3.58e-3)" "unprognostic (5.05e-2)" "unprognostic (7.36e-5)" "unprognostic (1.65e-1)" "prognostic favorable (9.31e-4)" "unprognostic (1.82e-1)" "unprognostic (3.37e-3)" "prognostic favorable (4.69e-4)" "unprognostic (1.57e-1)" "prognostic favorable (1.99e-5)" "unprognostic (1.75e-1)" "unprognostic (9.91e-3)" "unprognostic (1.79e-2)" "prognostic favorable (5.00e-4)" 4.1 4.4 7.9 2.0 9.1 1.9 5.1 12.2 14.1 6.0 4.6 7.7 5.6 6.1 6.8 4.5 4.0 6.4 5.6 7.3 8.2 8.4 6.6 8.6 5.0 3.9 6.2 6.9 8.2 5.0 9.8 8.4 25.9 6.0 5.7 4.3 7.7 7.6 5.4 8.9 7.4 4.7 5.6 4.2 3.7 4.2 4.0 6.5 5.1 7.9 4.7 6.0 4.5 4.1 2.3 3.6 0.6 0.6 1.8 1.8 0.7 3.7 0.1 3.3 3.6 2.3 3.0 4.2 2.4 2.6 5.0 2.3 0.3 1.0 3.5 2.3 1.9 3.8 1.8 0.3 1.9 0.7 0.0 1.7 1.0 1.2 1.5 1.8 0.5 0.8 2.4 4.4 1.4 2.0 3.0 0.4 4.4 3.6 2.0 1.6 0.7 1.7 0.4 1.6 1.2 1.1 1.9 2.2 0.9 3.2 3.0 3.0 5.4 2.7 0.5 4.0 4.2 1.4 1.8 0.0 0.4 1.0 1.4 0.9 6.6 7.3 0.7 1.9 1.7 1.0 0.2 0.3 0.6 0.4 0.1 1.5 0.8 0.7 0.9 0.0 2.3 1.8 0.3 0.2 1.8 0.6 3.6 0.3 0.7 7.9 9.1 12.2 11.2 8.2 8.4 6.2 6.9 6.0 6.5 11.9 15.1 0.9 2.6 1.1 4.1 2.8 2.5 8.1 6.8 0.0 7.9 1.9 3.3 2.0 0.4 2.5 3.8 0.0 1.2 1.0 2.0 2.5 0.0 1.9 1.3 3.2 3.5 2.5 1.0 0.2 2.8 2.0 0.0 1.0 1.7 4.6 1.7 0.0 2.5 2.1 4.7 0.0 1.5 4.4 10.4 1.3 7.3 4.5 2.2 1.5 ZNF556 FLJ11637 ENSG00000172000 "Zinc finger protein 556" Q9HAH1 19 2867335-2883445 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 14.6;brain: 22.3;ovary: 11.3" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 12.2;Ciliated cells: 8.1;Club cells: 9.1;granulocytes: 7.0" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 16 "cerebellum: 22.3" "Cell type enriched" "Detected in some" 11 "plasmacytoid DC: 14.6" "Lineage enriched" "Detected in many" 11 "dendritic cells: 14.6" "Cell line enhanced" "Detected in some" "CACO-2: 7.2;HBEC3-KT: 7.7;Hep G2: 12.1;RH-30: 18.0;THP-1: 6.5" HPA060593 Approved Nucleoplasm NA NA Nucleoplasm "HPA060593: AB_2684328" "unprognostic (1.36e-1)" "unprognostic (9.07e-2)" "unprognostic (2.70e-3)" "unprognostic (1.01e-1)" "unprognostic (1.58e-1)" "unprognostic (1.98e-2)" "unprognostic (3.12e-3)" "unprognostic (3.23e-1)" "unprognostic (4.81e-1)" "unprognostic (2.17e-1)" "unprognostic (6.14e-4)" "unprognostic (2.85e-1)" "unprognostic (2.61e-2)" "unprognostic (1.51e-1)" "unprognostic (1.51e-1)" "unprognostic (5.26e-3)" "unprognostic (5.54e-3)" 0.3 0.2 0.5 0.3 0.5 1.0 0.5 22.3 0.5 0.7 0.3 0.0 1.7 0.1 1.6 0.7 3.1 4.2 0.8 0.2 0.4 0.3 2.6 0.1 0.4 0.3 0.4 0.1 11.3 2.6 0.4 1.6 0.8 1.3 0.4 0.1 0.1 1.0 0.1 4.5 0.7 0.2 0.3 0.5 0.3 0.3 3.5 0.0 0.6 0.2 8.7 0.9 0.2 0.2 0.4 14.6 1.2 0.2 0.6 0.2 0.1 1.9 0.3 0.0 3.2 0.0 0.0 3.1 0.0 0.0 0.0 0.0 7.2 0.1 2.4 1.2 0.1 0.0 0.1 0.0 7.7 0.0 0.1 0.0 0.1 3.2 12.1 0.1 0.2 3.8 0.6 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 2.3 0.0 0.0 0.2 0.0 0.1 0.1 0.0 18.0 1.5 0.0 0.3 0.1 2.9 0.0 0.3 0.0 0.1 3.7 6.5 0.0 0.1 0.1 4.7 0.1 2.1 3.9 0.1 0.2 0.1 0.1 1.2 0.2 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.4 0.2 0.2 1.2 0.6 0.1 14.6 0.1 0.1 0.5 0.5 22.3 0.5 0.4 0.3 0.4 0.1 1.3 0.0 3.0 12.2 0.0 2.3 0.3 2.2 0.4 0.0 8.1 9.1 3.5 2.0 0.4 0.0 0.1 1.6 0.1 0.0 0.0 0.0 0.2 0.5 1.5 7.0 0.0 0.2 3.2 0.0 1.3 1.2 0.0 0.6 1.4 0.0 0.0 0.0 0.8 0.1 0.0 0.4 0.6 4.6 0.0 0.5 5.6 4.7 0.1 0.2 0.8 0.0 1.6 ZNF557 MGC4054 ENSG00000130544 "Zinc finger protein 557" Q8N988 19 7069444-7087968 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA003151, HPA029291" Uncertain Approved "Nucleoplasm,Intermediate filaments,Cytosol" No No "Nucleoplasm, Intermediate filaments" Cytosol "HPA003151: AB_1859344, HPA029291: AB_10602357" "unprognostic (1.05e-1)" "unprognostic (2.96e-3)" "unprognostic (5.29e-2)" "prognostic favorable (5.70e-4)" "unprognostic (2.56e-2)" "prognostic favorable (3.67e-6)" "unprognostic (1.32e-1)" "prognostic favorable (2.62e-4)" "unprognostic (2.51e-2)" "unprognostic (2.51e-2)" "prognostic favorable (1.51e-4)" "unprognostic (2.28e-1)" "unprognostic (2.24e-2)" "unprognostic (1.52e-3)" "unprognostic (4.71e-2)" "unprognostic (6.18e-2)" "unprognostic (2.81e-3)" 6.8 9.2 7.2 8.1 9.4 13.1 8.5 12.4 9.9 7.0 6.5 11.1 7.2 5.1 9.5 7.7 8.7 8.5 6.0 5.5 5.9 5.6 6.9 10.3 6.8 9.7 7.6 8.1 9.8 9.0 7.0 12.9 6.7 9.2 7.5 6.4 7.2 9.2 10.5 5.3 7.2 7.6 7.6 6.7 11.7 8.0 8.4 9.8 21.7 9.0 4.0 11.3 7.0 7.1 10.7 11.1 9.3 6.7 13.7 11.5 4.0 3.6 4.4 4.1 8.4 6.3 4.7 3.4 3.9 5.0 5.1 6.9 5.1 2.5 7.1 6.9 4.8 3.6 5.0 8.0 5.1 4.8 9.1 4.9 10.2 7.9 2.7 4.5 10.3 10.9 6.2 6.0 5.6 7.6 4.5 4.7 6.6 4.2 12.8 7.5 5.3 7.9 3.1 3.9 3.9 6.2 5.6 6.1 4.2 3.2 9.5 4.8 5.9 5.8 4.3 4.4 3.9 3.5 6.3 7.0 4.4 3.3 8.6 4.1 12.2 9.3 6.8 4.9 5.5 3.5 9.3 6.7 8.6 9.5 5.5 10.6 7.6 10.3 8.6 7.2 10.7 11.5 9.6 7.4 13.7 5.2 11.1 9.3 4.0 7.2 9.4 12.4 9.9 5.9 5.6 7.6 8.1 9.2 9.8 3.0 4.1 8.8 5.9 1.3 8.3 4.5 2.5 5.3 7.9 7.0 0.0 5.2 13.3 6.0 0.8 5.3 4.5 23.3 5.4 3.8 4.0 5.1 8.1 4.0 5.3 15.9 5.2 7.4 7.3 0.0 4.0 6.4 0.0 4.6 6.6 5.2 5.0 3.7 5.3 6.7 6.4 0.0 4.8 15.9 16.4 1.1 4.8 6.4 5.1 6.4 ZNF559 MGC13105 ENSG00000188321 "Zinc finger protein 559" Q9BR84 19 9323772-9351162 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 34.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA059632, HPA065485" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA059632: AB_2684089, HPA065485: AB_2685497" "unprognostic (1.35e-3)" "unprognostic (1.98e-1)" "unprognostic (4.75e-2)" "unprognostic (1.01e-1)" "unprognostic (2.36e-2)" "unprognostic (3.24e-2)" "unprognostic (1.06e-1)" "unprognostic (1.38e-1)" "unprognostic (2.64e-3)" "prognostic favorable (6.99e-4)" "unprognostic (7.28e-3)" "unprognostic (4.04e-2)" "unprognostic (8.48e-2)" "unprognostic (2.21e-2)" "unprognostic (6.20e-2)" "unprognostic (2.24e-1)" "unprognostic (1.75e-3)" 9.3 11.1 17.7 8.4 16.2 2.7 14.1 39.5 16.1 13.6 10.4 17.2 11.4 5.1 18.8 18.8 5.9 17.3 8.2 11.9 14.2 8.2 11.2 7.5 10.4 11.8 17.6 15.5 24.0 7.6 22.1 29.2 9.8 16.2 13.6 9.3 11.2 8.3 11.4 3.3 8.7 9.8 16.3 16.2 14.9 8.8 13.7 19.8 10.7 14.0 3.4 10.3 10.2 11.3 12.5 5.3 18.9 4.3 14.2 15.8 6.2 8.7 4.7 9.3 11.3 5.5 5.0 2.4 5.3 11.0 8.0 6.8 2.3 1.0 7.1 6.3 7.7 10.9 3.1 5.6 5.0 10.2 11.4 7.5 9.6 7.8 3.1 9.8 8.4 10.6 10.5 9.1 9.0 11.2 6.8 6.7 10.7 7.0 25.2 5.0 0.0 11.4 26.6 15.1 1.5 7.8 5.6 11.3 9.6 4.9 12.3 10.5 8.8 10.4 1.7 12.5 14.2 7.5 6.4 5.6 14.7 3.3 12.0 8.0 2.0 0.0 6.9 2.6 5.3 9.2 18.9 3.4 7.5 9.1 3.2 12.0 11.9 9.6 9.6 5.3 12.5 15.8 12.7 1.9 14.2 4.3 4.4 8.4 6.2 17.7 16.2 39.5 16.1 14.2 8.2 17.6 15.5 16.2 19.8 3.0 3.5 6.2 5.8 3.4 26.6 7.1 10.2 6.7 3.4 3.5 25.5 5.9 1.7 5.9 7.0 10.5 1.7 0.0 2.7 3.8 8.9 4.1 2.3 2.1 4.2 25.4 2.9 12.3 3.8 1.8 11.8 5.7 3.3 5.4 3.7 25.1 2.8 2.9 12.7 2.4 27.1 6.5 11.3 15.7 34.5 2.6 2.4 10.1 3.8 2.2 ZNF560 FLJ31986 ENSG00000198028 "Zinc finger protein 560" Q96MR9 19 9466507-9498607 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "testis: 21.1" "Cell type enriched" "Detected in some" 4 "Early spermatids: 48.7" "Cancer enriched" "Detected in some" 7 "testis cancer: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HEL: 17.9;HMC-1: 4.4;NTERA-2: 17.8;SuSa: 8.8" "HPA045439, HPA074438" Enhanced "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA045439: AB_2732520, HPA074438: " "unprognostic (4.43e-3)" "unprognostic (8.91e-2)" "unprognostic (9.85e-3)" "unprognostic (2.43e-2)" "unprognostic (1.17e-1)" "unprognostic (3.29e-1)" "unprognostic (1.04e-1)" "unprognostic (1.39e-1)" "unprognostic (6.57e-3)" "unprognostic (6.33e-5)" "unprognostic (5.60e-2)" "unprognostic (2.32e-1)" "unprognostic (9.15e-3)" "unprognostic (1.65e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.4 2.6 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 21.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.8 2.4 0.0 1.4 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.0 1.0 17.9 0.0 0.0 1.3 0.0 4.4 2.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.6 0.0 0.1 0.0 0.0 0.0 0.0 11.3 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 6.0 8.3 0.0 0.0 0.0 0.0 0.0 ZNF561 MGC45408 ENSG00000171469 "Zinc finger protein 561" Q8N587 19 9604680-9621399 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA055332, HPA062397" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA055332: AB_2682786, HPA062397: AB_2684751" "unprognostic (6.68e-2)" "unprognostic (1.26e-1)" "unprognostic (6.86e-3)" "unprognostic (3.43e-2)" "unprognostic (1.18e-2)" "unprognostic (3.63e-3)" "unprognostic (9.92e-2)" "unprognostic (2.53e-2)" "unprognostic (9.54e-2)" "prognostic favorable (1.31e-4)" "unprognostic (9.21e-2)" "unprognostic (3.34e-2)" "prognostic favorable (1.16e-4)" "unprognostic (1.99e-1)" "unprognostic (2.13e-1)" "unprognostic (3.27e-3)" "unprognostic (2.85e-3)" 11.7 11.7 7.5 9.1 8.8 7.7 14.6 11.2 8.2 14.5 11.5 10.4 21.9 6.6 18.6 14.9 21.5 16.3 11.1 9.1 7.0 6.4 11.3 10.7 10.8 13.4 9.6 6.2 18.1 16.9 13.1 18.3 8.8 7.4 19.2 11.4 9.6 13.3 15.9 10.3 15.7 10.6 22.2 8.5 10.4 11.6 7.7 11.7 16.4 20.6 11.7 12.2 26.1 14.3 7.2 6.6 9.3 8.5 2.7 10.9 5.7 7.6 3.0 17.0 13.3 14.8 17.6 15.3 10.0 13.4 12.5 14.2 5.6 3.4 6.8 7.4 9.9 7.3 4.3 11.4 19.2 13.1 9.5 12.1 8.6 6.4 9.7 8.6 11.3 8.7 11.3 30.3 9.3 12.2 20.0 15.7 5.0 9.9 9.2 15.6 3.6 4.8 11.9 14.1 6.4 9.6 5.7 8.5 7.4 11.4 28.1 10.9 11.0 0.2 6.2 7.8 17.3 7.9 7.5 4.9 13.6 4.7 9.6 9.7 11.2 15.7 9.4 6.7 2.9 9.1 5.0 8.5 9.3 8.5 8.2 10.9 4.8 6.6 7.6 6.6 7.2 9.6 7.2 5.5 2.7 4.2 5.9 6.3 5.7 7.5 8.8 11.2 8.2 7.0 6.4 9.6 6.2 7.4 11.7 0.0 6.5 5.1 21.6 12.2 9.2 9.0 7.6 28.1 9.1 14.0 5.9 6.9 3.3 10.1 5.2 7.1 6.9 0.0 5.7 6.5 5.6 10.8 7.0 6.4 9.6 9.5 10.9 10.4 10.3 5.2 10.6 7.0 3.3 5.4 6.7 6.0 7.4 7.0 12.4 6.8 11.0 6.5 5.6 7.2 9.8 19.6 5.4 7.5 6.8 25.5 ZNF562 FLJ20079 ENSG00000171466 "Zinc finger protein 562" Q6V9R5 19 9641808-9675086 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 68.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA055332, HPA062397" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA055332: AB_2682786, HPA062397: AB_2684751" "unprognostic (2.14e-2)" "unprognostic (1.61e-1)" "unprognostic (2.85e-3)" "unprognostic (1.62e-1)" "unprognostic (2.02e-2)" "prognostic favorable (4.17e-4)" "unprognostic (4.44e-2)" "unprognostic (2.14e-1)" "unprognostic (7.88e-2)" "unprognostic (2.96e-3)" "unprognostic (1.81e-1)" "unprognostic (4.07e-2)" "unprognostic (1.81e-2)" "unprognostic (1.62e-3)" "unprognostic (9.44e-2)" "unprognostic (3.82e-2)" "unprognostic (1.13e-3)" 12.3 11.2 13.9 11.3 15.8 11.6 21.4 20.5 15.2 11.8 15.0 13.5 20.9 9.8 14.6 10.9 26.1 12.0 12.1 11.4 13.4 10.9 11.1 12.2 12.9 10.2 14.9 11.9 13.7 15.5 13.8 22.6 11.1 14.3 13.1 15.0 9.0 15.7 23.4 7.0 12.9 10.6 15.1 16.1 14.0 11.5 6.3 16.8 10.9 11.8 9.4 13.3 16.6 14.5 6.4 8.5 5.5 9.6 6.5 7.9 2.6 8.3 6.6 9.7 17.8 5.8 4.7 0.5 7.9 6.1 8.8 9.1 4.9 4.6 7.5 8.2 6.3 7.5 6.4 11.7 9.7 11.6 8.8 9.2 27.6 6.7 5.1 5.8 10.1 20.6 8.3 7.2 11.1 18.5 5.5 9.3 6.8 13.3 13.4 8.3 4.2 10.0 3.0 12.4 5.5 4.7 3.9 10.6 3.9 4.1 22.2 10.6 6.9 12.8 5.2 6.3 7.9 7.5 8.5 8.7 16.5 5.6 7.5 10.6 11.8 25.9 12.7 2.3 0.6 8.1 4.1 6.2 5.5 7.0 9.6 7.9 6.3 5.6 4.3 8.5 6.4 5.8 7.1 2.4 6.5 9.2 5.1 4.0 2.6 13.9 15.8 20.5 15.2 13.4 10.9 14.9 11.9 14.3 16.8 8.9 21.0 11.3 31.2 5.7 30.2 7.8 22.9 6.7 18.2 24.4 68.7 13.3 16.6 17.2 6.0 12.4 22.9 0.0 7.6 13.8 12.1 31.0 12.7 12.1 10.8 27.0 23.0 16.5 26.6 11.0 11.2 14.8 6.8 11.8 14.8 13.2 18.0 17.3 12.7 6.8 28.1 0.0 9.2 14.2 11.4 8.8 16.2 12.8 15.2 55.8 ZNF565 FLJ36991 ENSG00000196357 "Zinc finger protein 565" Q8N9K5 19 36182060-36246257 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 18.7;Late spermatids: 12.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA044123 Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA044123: AB_10794395" "unprognostic (1.51e-1)" "unprognostic (3.77e-2)" "unprognostic (6.80e-2)" "unprognostic (7.46e-3)" "unprognostic (6.08e-3)" "unprognostic (7.97e-3)" "unprognostic (2.10e-1)" "unprognostic (1.01e-2)" "unprognostic (1.90e-2)" "unprognostic (5.73e-2)" "unprognostic (1.03e-2)" "unprognostic (1.49e-3)" "unprognostic (3.67e-3)" "unprognostic (1.22e-1)" "unprognostic (3.35e-2)" "unprognostic (1.55e-3)" "unprognostic (1.93e-4)" 5.9 5.7 12.1 4.2 11.6 7.1 7.1 10.4 12.8 5.7 5.2 16.8 4.8 4.4 7.1 6.5 5.2 6.7 4.8 5.3 8.0 7.7 5.5 6.2 4.6 4.4 17.3 10.1 11.1 5.7 4.9 7.5 4.6 12.1 7.0 5.8 4.1 8.0 5.6 7.8 6.6 4.1 6.2 17.3 4.5 6.1 13.5 14.9 2.3 6.8 3.5 5.7 6.6 8.4 2.1 3.6 13.8 3.7 3.1 4.5 2.3 3.8 5.5 6.6 4.6 10.4 6.9 1.8 3.8 6.3 4.6 7.9 3.2 3.4 2.9 5.0 4.9 2.2 2.3 3.3 2.8 7.3 5.0 1.5 5.3 4.8 4.2 4.4 3.5 3.7 8.1 8.0 3.0 8.0 4.9 5.5 3.4 3.5 3.6 5.6 4.9 4.2 0.9 2.6 8.4 2.6 3.6 3.9 2.9 4.6 5.2 5.3 5.5 3.1 3.6 3.5 4.2 2.5 3.8 4.5 6.6 3.8 4.8 5.5 1.1 1.8 1.9 6.3 2.9 3.2 13.8 3.1 4.8 3.5 3.2 3.8 2.1 4.0 3.4 3.6 2.1 4.5 3.5 1.5 3.1 3.7 1.9 2.0 2.3 12.1 11.6 10.4 12.8 8.0 7.7 17.3 10.1 12.1 14.9 3.0 0.6 0.0 5.2 1.9 3.6 2.5 0.0 4.0 0.0 1.8 5.9 1.1 0.0 2.5 18.7 3.0 0.9 0.0 2.6 1.6 2.5 3.3 0.0 0.8 1.4 1.6 1.2 1.3 2.4 12.4 4.9 1.7 0.0 1.0 1.0 2.4 2.4 0.0 2.5 1.0 4.6 6.5 2.3 10.9 7.3 1.3 1.7 2.2 1.5 3.7 ZNF566 "FLJ14779, MGC12515" ENSG00000186017 "Zinc finger protein 566" Q969W8 19 36445119-36489902 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 33.4;Horizontal cells: 30.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023456 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA023456: AB_2221143" "unprognostic (1.68e-1)" "unprognostic (6.34e-2)" "unprognostic (7.77e-2)" "prognostic unfavorable (1.86e-4)" "unprognostic (3.89e-3)" "unprognostic (5.71e-4)" "unprognostic (1.74e-1)" "unprognostic (3.21e-2)" "unprognostic (1.92e-2)" "unprognostic (7.56e-2)" "unprognostic (8.19e-4)" "unprognostic (7.51e-2)" "unprognostic (1.20e-1)" "unprognostic (1.20e-1)" "unprognostic (9.48e-2)" "unprognostic (3.00e-1)" "unprognostic (5.47e-3)" 8.2 8.2 10.4 7.2 11.4 5.9 9.0 22.7 14.2 8.7 7.0 9.4 5.8 6.7 12.1 10.3 6.1 9.7 6.2 8.1 10.9 11.7 8.8 8.4 7.9 9.1 11.6 11.8 14.3 6.3 10.4 14.0 5.5 12.7 8.1 5.9 11.6 6.3 7.2 7.3 8.5 6.4 9.1 10.7 7.6 6.0 5.1 13.8 5.1 10.3 5.3 8.9 8.4 6.1 8.1 2.8 5.6 1.6 4.6 8.6 3.2 3.6 8.7 10.1 11.1 7.6 7.7 7.0 7.0 6.0 8.9 9.4 3.6 1.5 6.8 7.7 4.5 4.0 2.5 9.0 2.5 10.2 11.0 6.9 6.9 6.0 3.1 5.6 7.4 8.3 6.6 3.7 4.7 7.5 4.2 3.4 7.2 10.0 0.2 6.0 5.7 9.5 3.8 12.1 6.3 3.8 6.3 8.0 4.6 2.7 7.0 9.4 14.3 8.4 4.9 6.7 5.0 4.3 10.1 3.8 7.7 10.6 3.3 6.7 2.9 7.7 9.4 0.4 4.9 10.1 5.6 1.5 1.9 5.3 1.4 8.6 8.1 6.5 6.5 2.8 6.1 7.9 8.0 1.4 4.6 1.6 2.0 6.7 3.2 10.4 11.4 22.7 14.2 10.9 11.7 11.6 11.8 12.7 13.8 8.9 7.7 3.7 3.7 3.0 20.8 8.7 5.1 4.0 10.3 5.2 33.4 5.6 10.0 4.0 1.7 7.1 2.3 0.0 2.2 2.9 7.6 4.4 2.3 4.7 3.7 30.2 2.9 9.2 2.8 0.4 7.8 4.3 10.1 1.0 4.3 7.5 1.9 5.9 13.8 5.4 20.7 19.4 8.5 6.5 4.2 2.9 1.6 9.5 4.6 2.6 ZNF567 MGC45586 ENSG00000189042 "Zinc finger protein 567" Q8N184 19 36687612-36727701 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 64.6;Late spermatids: 69.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023937 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA023937: AB_1859351" "unprognostic (4.39e-3)" "unprognostic (2.26e-1)" "unprognostic (1.76e-1)" "unprognostic (1.03e-2)" "unprognostic (2.36e-2)" "unprognostic (6.57e-2)" "unprognostic (2.40e-2)" "unprognostic (1.14e-1)" "unprognostic (2.93e-3)" "unprognostic (1.54e-1)" "unprognostic (9.93e-2)" "unprognostic (1.80e-2)" "unprognostic (1.04e-1)" "unprognostic (1.18e-1)" "unprognostic (2.58e-1)" "unprognostic (7.24e-2)" "unprognostic (9.03e-2)" 5.9 7.0 6.3 6.7 6.9 5.0 10.2 12.2 10.2 8.0 6.3 4.7 6.6 3.8 9.2 7.5 7.8 7.0 5.5 5.3 7.7 6.0 6.0 7.7 5.8 8.6 7.1 2.3 8.4 4.9 10.4 15.8 13.0 8.0 9.3 5.0 5.1 7.3 12.1 7.4 5.6 5.5 9.7 9.1 7.2 5.5 14.2 9.6 9.0 8.3 3.3 8.2 6.6 7.5 8.8 3.9 7.0 2.3 7.9 8.2 3.0 6.8 5.3 9.8 8.7 5.7 5.6 9.4 5.0 7.8 5.7 9.3 3.0 2.4 4.3 6.1 4.5 4.3 1.8 9.0 5.2 7.9 8.4 4.7 8.1 5.9 2.9 5.2 10.2 6.3 8.7 6.3 5.4 10.6 7.5 6.6 8.8 3.2 2.3 6.8 4.2 13.2 3.9 9.4 4.6 4.3 6.5 13.5 6.1 3.7 10.5 7.4 7.9 9.3 4.7 5.0 11.6 5.9 7.0 4.1 7.6 7.7 3.8 5.6 8.8 7.3 14.3 0.0 4.1 6.6 5.7 2.3 7.0 7.7 2.0 6.3 7.3 8.2 7.1 3.9 8.8 8.2 8.2 1.3 7.9 2.0 2.7 6.6 3.0 6.3 6.9 12.2 10.2 7.7 6.0 7.1 2.3 8.0 9.6 6.0 5.8 9.4 9.2 10.4 7.7 5.3 2.5 2.7 7.9 8.7 9.8 13.1 3.3 7.5 64.6 8.9 3.2 0.0 4.4 11.7 5.8 10.4 17.3 6.6 6.3 11.1 4.1 12.3 4.7 69.6 9.2 3.8 6.8 7.2 4.8 8.1 4.2 7.0 14.2 5.6 5.7 6.5 9.2 35.8 10.4 15.4 23.0 11.8 4.1 10.3 ZNF568 DKFZp686B0797 ENSG00000198453 "Zinc finger protein 568" Q3ZCX4 19 36916329-36998700 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 38.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024541, HPA052061" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA024541: , HPA052061: AB_2681713" "unprognostic (3.62e-2)" "unprognostic (2.73e-1)" "unprognostic (9.97e-2)" "unprognostic (1.99e-3)" "unprognostic (5.07e-2)" "unprognostic (2.81e-2)" "unprognostic (8.64e-2)" "unprognostic (2.65e-2)" "unprognostic (5.83e-5)" "unprognostic (1.75e-1)" "unprognostic (1.76e-2)" "unprognostic (1.16e-1)" "unprognostic (2.05e-5)" "unprognostic (2.03e-2)" "unprognostic (1.81e-1)" "unprognostic (5.06e-3)" "unprognostic (9.98e-3)" 6.9 11.3 11.8 5.6 14.7 5.9 9.2 30.4 13.4 11.3 7.3 10.5 6.3 4.5 12.3 8.1 5.9 10.3 5.6 8.9 11.5 13.0 7.8 5.5 6.9 6.5 15.0 9.8 16.3 6.8 14.4 24.6 8.4 13.7 8.5 5.0 8.1 8.6 9.0 8.5 6.8 5.2 10.6 13.0 9.3 7.0 9.5 16.3 6.4 13.2 7.6 7.0 7.6 7.3 8.7 3.0 12.8 2.3 7.1 10.1 3.1 0.2 4.5 7.4 2.4 6.9 7.7 2.3 6.2 6.2 5.2 7.1 0.2 2.6 0.3 7.4 7.7 3.8 1.2 0.1 3.6 5.4 1.0 5.3 2.3 0.6 0.8 8.8 0.2 5.9 10.0 4.3 5.2 0.1 6.5 2.7 3.3 0.4 0.9 7.6 0.3 1.6 1.2 6.0 0.0 0.3 0.6 5.4 2.4 4.9 9.8 7.3 9.4 0.3 0.2 5.5 7.5 6.0 1.0 5.2 3.6 10.2 5.8 4.2 8.7 10.6 5.4 0.2 0.2 11.3 12.8 1.9 6.5 8.4 1.5 7.6 8.7 7.9 7.0 3.0 7.6 10.1 8.0 1.6 7.1 2.3 2.9 6.7 3.1 11.8 14.7 30.4 13.4 11.5 13.0 15.0 9.8 13.7 16.3 3.0 6.5 2.2 2.8 4.5 17.6 5.0 5.1 6.7 2.3 8.7 13.7 4.3 3.3 6.1 21.7 6.0 0.4 0.0 3.3 3.3 6.4 3.4 16.1 1.0 3.0 38.1 0.0 4.9 1.0 14.8 6.1 3.5 1.7 3.6 1.1 8.1 2.2 0.0 9.2 4.0 16.4 6.5 5.7 9.9 12.4 3.6 2.4 6.7 1.2 2.4 ZNF569 "FLJ32053, ZAP1" ENSG00000196437 "Zinc finger protein 569" Q5MCW4 19 37411155-37469275 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Cone photoreceptor cells: 29.5;Early spermatids: 102.9;Rod photoreceptor cells: 31.0;Spermatocytes: 35.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA052994 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus, Vesicles" "HPA052994: AB_2682007" "unprognostic (1.40e-1)" "unprognostic (3.37e-1)" "unprognostic (4.95e-2)" "unprognostic (2.18e-2)" "unprognostic (5.44e-2)" "unprognostic (4.79e-2)" "unprognostic (2.95e-2)" "unprognostic (4.00e-1)" "unprognostic (5.08e-2)" "unprognostic (6.50e-3)" "unprognostic (4.01e-3)" "unprognostic (9.41e-2)" "unprognostic (9.70e-2)" "unprognostic (3.04e-2)" "unprognostic (5.77e-2)" "unprognostic (1.91e-2)" "unprognostic (1.37e-1)" 5.8 7.8 10.9 6.1 11.1 7.7 6.6 20.9 10.6 6.9 5.0 6.4 3.8 3.2 7.2 9.5 4.4 6.5 4.5 7.7 8.0 11.2 6.9 6.0 4.6 7.2 8.6 8.7 10.9 3.7 8.8 18.5 5.5 10.6 6.6 3.5 5.2 4.5 5.6 7.2 6.5 4.1 6.3 10.2 6.2 4.2 20.1 11.3 9.6 10.5 3.8 5.9 6.4 4.7 7.2 3.2 7.1 4.0 6.2 11.3 3.2 2.8 5.8 6.7 11.0 5.5 4.9 3.3 5.2 3.1 5.7 6.1 1.9 1.2 3.3 7.6 3.8 5.6 1.0 7.4 2.0 6.0 7.6 4.4 8.6 1.4 3.2 3.3 1.6 3.6 3.4 1.3 5.7 0.1 5.5 4.5 10.7 2.8 0.6 8.0 1.7 10.9 3.7 7.8 0.2 4.1 7.1 8.4 3.5 4.0 2.8 5.7 8.9 0.2 1.3 2.9 6.8 4.9 6.9 4.4 4.4 9.1 3.4 8.3 9.5 16.0 13.1 0.3 3.6 7.0 4.9 2.6 7.1 8.7 3.3 7.7 6.1 7.8 8.1 2.8 7.2 11.3 8.9 2.7 6.2 4.0 3.2 7.8 3.2 10.9 11.1 20.9 10.6 8.0 11.2 8.6 8.7 10.6 11.3 0.0 1.7 0.0 1.9 1.4 15.7 13.7 0.0 6.7 7.9 1.8 29.5 2.7 1.7 1.5 102.9 3.8 0.5 0.0 1.7 3.0 3.4 1.0 2.3 1.7 2.4 3.2 0.0 3.7 2.2 27.5 4.4 4.1 0.0 3.6 0.3 7.5 1.2 0.0 7.1 4.2 31.0 0.0 4.4 35.4 11.9 1.8 0.7 7.9 0.8 1.0 ZNF570 FLJ30791 ENSG00000171827 "Zinc finger protein 570" Q96NI8 19 37467585-37488652 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 40.9;Horizontal cells: 30.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028881 Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA028881: AB_10603938" "unprognostic (2.93e-2)" "unprognostic (1.55e-1)" "unprognostic (3.71e-2)" "unprognostic (1.24e-1)" "unprognostic (1.70e-2)" "unprognostic (1.28e-2)" "unprognostic (3.32e-2)" "unprognostic (1.23e-1)" "unprognostic (2.01e-2)" "unprognostic (1.12e-1)" "unprognostic (6.54e-2)" "unprognostic (4.59e-2)" "prognostic favorable (4.06e-5)" "unprognostic (5.30e-2)" "unprognostic (2.85e-2)" "unprognostic (3.12e-2)" "unprognostic (2.20e-3)" 7.4 5.8 7.6 3.7 8.8 4.3 6.7 8.2 9.8 6.1 4.7 6.7 3.0 4.4 7.1 4.9 5.2 4.9 5.0 5.4 6.6 5.7 6.7 4.0 4.6 5.6 9.3 6.2 8.3 4.5 13.6 8.0 4.8 8.3 6.8 2.9 4.5 5.0 5.3 4.9 4.1 4.0 5.4 9.0 6.9 4.7 14.7 10.0 7.2 7.5 4.9 5.4 5.7 7.8 3.7 2.0 3.9 3.3 4.7 5.6 2.3 1.9 2.7 3.7 10.9 5.0 6.3 1.8 3.9 2.0 3.7 5.0 0.0 0.8 0.5 5.2 2.8 2.2 0.4 3.1 2.4 4.5 2.2 2.2 2.5 0.3 1.2 3.4 0.2 5.5 5.3 2.2 2.5 0.1 3.4 3.6 4.4 0.4 0.2 3.8 0.8 6.1 1.9 2.4 0.1 1.1 1.1 3.8 2.0 3.0 3.1 3.4 7.0 0.0 0.1 1.2 4.8 2.2 2.8 1.8 1.5 2.8 2.4 2.7 6.1 5.3 2.8 0.0 0.3 2.9 1.4 1.9 2.3 3.6 3.3 2.9 3.6 5.6 2.4 1.9 3.7 5.0 5.0 3.9 4.7 1.4 2.0 3.4 2.3 7.6 8.8 8.2 9.8 6.6 5.7 9.3 6.2 8.3 10.0 6.0 0.3 2.2 1.7 1.4 5.9 10.9 5.1 5.3 4.5 1.8 9.8 2.1 8.3 4.6 40.9 4.3 1.0 0.0 3.3 6.2 3.0 1.7 5.8 2.1 2.8 30.2 5.8 5.5 3.2 5.4 4.6 2.5 5.0 1.8 1.5 6.2 2.7 0.0 9.2 3.5 6.6 0.0 3.6 10.2 7.2 0.4 1.1 4.3 2.1 0.9 ZNF571 HSPC059 ENSG00000180479 "Zinc finger protein 571" Q7Z3V5 19 37554782-37594790 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 61.8" "Cell type enhanced" "Detected in many" 4 "granulocytes: 15.0;Rod photoreceptor cells: 16.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA054762 Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA054762: " "unprognostic (1.16e-1)" "unprognostic (3.01e-2)" "unprognostic (3.92e-2)" "unprognostic (1.19e-1)" "unprognostic (5.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.19e-1)" "unprognostic (9.03e-4)" "unprognostic (5.77e-2)" "unprognostic (9.82e-2)" "unprognostic (1.22e-3)" "unprognostic (3.90e-2)" "unprognostic (2.14e-2)" "unprognostic (8.93e-2)" "unprognostic (2.62e-1)" "unprognostic (4.89e-2)" "unprognostic (2.71e-4)" 6.5 6.7 8.6 3.2 12.9 6.1 12.5 12.5 12.8 5.9 4.2 9.8 4.4 2.3 6.7 8.7 3.9 6.0 4.5 4.2 10.4 7.2 6.4 4.2 4.1 4.4 15.3 9.4 8.5 3.8 11.5 12.2 4.8 13.4 7.1 3.4 5.1 3.6 4.5 3.5 7.1 3.7 7.7 14.3 4.8 3.5 8.5 15.8 3.7 61.8 3.3 5.0 6.6 5.3 9.4 4.1 4.9 1.3 3.7 8.4 3.2 1.8 1.0 6.3 9.1 4.7 4.8 2.0 2.7 4.4 6.6 8.2 1.9 1.7 9.6 8.6 2.8 4.6 2.4 2.0 2.9 11.0 2.1 7.9 5.1 2.7 1.1 5.4 1.9 5.8 2.6 5.3 6.3 5.8 4.7 1.3 8.7 2.4 0.8 5.3 1.7 9.6 2.1 15.8 2.9 3.5 4.8 3.0 5.1 9.1 11.6 13.6 9.5 6.4 2.1 3.2 13.2 9.7 1.3 0.8 3.0 3.9 3.3 6.9 7.7 15.8 13.2 0.5 0.8 6.6 1.8 0.8 4.9 6.7 1.3 6.1 8.7 6.3 6.5 2.7 9.4 7.8 8.4 1.5 3.7 1.2 4.1 4.2 3.2 8.6 12.9 12.5 12.8 10.4 7.2 15.3 9.4 13.4 15.8 0.0 1.3 4.5 1.1 1.5 9.3 1.1 2.5 4.0 5.7 5.2 9.8 1.8 3.3 1.7 10.5 2.5 0.8 0.0 1.4 1.3 2.3 1.7 15.0 0.8 1.4 12.7 1.2 2.5 1.3 2.5 4.0 1.3 5.0 0.0 2.1 4.5 0.8 0.0 2.5 2.6 16.6 12.9 1.7 7.2 5.7 2.3 1.0 6.2 1.3 0.5 ZNF574 FLJ22059 ENSG00000105732 "Zinc finger protein 574" Q6ZN55 19 42068477-42081549 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 29.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023196, HPA057274" Approved Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA023196: AB_2671105, HPA057274: AB_2683392" "unprognostic (3.90e-1)" "unprognostic (3.68e-2)" "unprognostic (3.39e-2)" "unprognostic (7.84e-2)" "unprognostic (1.66e-1)" "unprognostic (2.11e-2)" "unprognostic (9.49e-2)" "unprognostic (2.84e-2)" "unprognostic (5.24e-2)" "unprognostic (1.55e-3)" "unprognostic (6.36e-3)" "unprognostic (2.11e-1)" "unprognostic (2.10e-2)" "unprognostic (6.48e-2)" "unprognostic (3.51e-2)" "unprognostic (2.97e-1)" "unprognostic (1.09e-3)" 11.1 6.8 7.9 6.6 10.2 14.9 9.7 15.6 17.8 11.2 10.2 12.5 4.6 10.2 13.0 4.5 12.2 12.4 8.0 8.0 8.0 6.8 6.8 8.4 8.6 9.0 11.7 8.5 15.4 12.1 8.7 8.3 8.8 8.4 10.8 4.5 10.8 12.1 11.1 10.4 14.3 8.6 10.3 5.6 10.8 8.7 28.5 12.3 15.6 10.2 9.1 12.4 10.6 9.3 18.7 12.5 15.6 10.5 10.1 18.9 11.6 10.3 28.6 6.4 8.2 5.8 5.9 6.9 7.8 6.8 10.3 9.8 11.2 7.0 15.0 7.0 6.2 5.3 6.3 7.3 9.8 3.8 7.9 12.3 14.2 6.9 9.5 6.4 8.8 9.8 6.9 9.8 9.3 7.9 6.1 5.5 8.3 11.7 9.5 7.0 21.1 10.3 7.3 11.5 9.0 11.4 14.2 6.2 6.4 5.0 13.7 10.8 9.2 8.0 17.0 5.1 4.3 8.0 13.9 6.7 13.9 11.0 4.1 11.5 10.4 6.3 10.9 7.8 8.2 7.9 11.1 10.4 15.6 17.5 7.9 18.7 18.7 13.1 18.9 12.5 14.8 13.8 12.8 13.3 10.1 10.5 11.0 10.1 11.6 7.9 10.2 15.6 17.8 8.0 6.8 11.7 8.5 8.4 12.3 0.0 3.5 1.9 14.4 26.1 6.7 3.5 0.0 2.7 3.4 1.8 2.0 6.5 1.7 5.8 17.4 5.8 5.1 0.0 4.5 5.5 8.0 8.8 12.7 2.5 4.3 3.2 3.4 8.0 1.0 11.6 5.2 3.3 8.5 10.0 7.3 3.8 4.4 6.6 8.1 3.7 9.2 6.5 8.9 29.4 18.1 19.8 4.0 6.4 7.5 10.2 ZNF575 FLJ32567 ENSG00000176472 "Zinc finger protein 575" Q86XF7 19 43525497-43536130 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 6.0;Paneth cells: 5.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MOLT-4: 11.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051865 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA051865: AB_2681643" "unprognostic (1.77e-3)" "unprognostic (2.73e-2)" "unprognostic (1.07e-1)" "unprognostic (1.98e-1)" "unprognostic (8.56e-2)" "unprognostic (6.53e-4)" "unprognostic (1.23e-1)" "unprognostic (2.37e-1)" "unprognostic (2.36e-2)" "unprognostic (2.21e-1)" "unprognostic (3.87e-5)" "unprognostic (1.10e-1)" "unprognostic (4.64e-2)" "unprognostic (2.22e-1)" "unprognostic (2.17e-1)" "unprognostic (7.83e-2)" "unprognostic (2.75e-1)" 8.8 3.9 10.5 3.8 10.0 2.5 3.2 12.3 13.5 4.9 13.8 6.8 2.9 5.6 4.7 4.0 2.4 3.6 4.6 3.6 6.6 4.2 3.9 3.2 3.6 3.9 5.4 6.2 6.3 2.3 3.0 5.2 2.0 6.7 5.5 7.1 5.1 5.0 4.1 12.9 4.8 6.4 3.4 6.0 5.8 4.7 1.9 6.5 2.4 3.3 2.3 4.2 3.5 3.7 3.0 1.9 0.8 0.9 7.0 4.4 1.3 2.9 2.6 0.6 0.8 4.0 3.4 0.2 1.9 1.3 0.7 1.0 0.6 1.1 0.6 1.3 1.4 0.3 1.6 0.1 0.3 0.3 4.2 0.5 2.2 0.9 0.5 0.9 0.9 2.7 1.9 1.2 1.0 0.2 2.1 0.6 4.2 0.9 4.1 1.2 1.9 11.7 0.3 0.2 2.1 1.4 6.4 0.0 1.5 0.7 1.7 0.6 1.0 1.5 2.0 1.9 0.5 0.5 1.1 2.0 3.7 2.5 0.8 1.4 2.2 3.2 1.8 2.3 2.7 3.9 0.1 0.9 0.6 3.0 0.5 1.2 1.5 2.8 2.9 1.3 3.0 4.4 3.2 0.8 7.0 0.3 1.9 2.3 1.3 10.5 10.0 12.3 13.5 6.6 4.2 5.4 6.2 6.7 6.5 6.0 0.6 0.0 0.5 0.1 1.1 1.5 0.0 0.0 1.2 0.0 3.9 1.0 3.3 0.4 0.0 1.0 2.6 0.0 0.6 0.7 1.9 0.4 0.0 2.0 1.4 0.0 1.2 2.5 1.0 0.0 2.3 1.7 1.7 0.0 2.0 0.3 0.1 5.3 3.2 1.9 0.0 0.0 2.4 0.1 0.9 1.5 0.2 1.0 2.3 0.3 ZNF576 MGC2508 ENSG00000124444 "Zinc finger protein 576" Q9H609 19 43596392-43601157 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 70.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050064 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA050064: AB_2681003" "unprognostic (1.28e-2)" "unprognostic (8.69e-3)" "unprognostic (1.12e-1)" "unprognostic (1.84e-3)" "unprognostic (2.82e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.60e-1)" "unprognostic (7.42e-3)" "unprognostic (2.42e-2)" "unprognostic (6.65e-3)" "unprognostic (8.66e-2)" "unprognostic (1.76e-3)" "unprognostic (2.58e-2)" "unprognostic (1.40e-1)" "unprognostic (3.02e-1)" "unprognostic (1.34e-3)" 11.8 14.4 14.5 11.4 18.7 5.2 11.3 28.0 19.4 11.2 11.5 15.3 11.4 16.0 12.7 9.0 15.0 14.2 13.4 16.0 13.3 13.7 12.1 23.5 8.7 12.5 15.7 16.8 17.9 14.7 11.4 16.4 10.2 16.5 16.9 8.5 9.5 17.7 12.9 21.0 11.3 15.1 9.8 13.4 10.3 11.9 13.2 13.3 13.3 13.9 8.4 10.2 16.1 10.5 22.3 22.2 13.9 13.6 15.7 17.7 10.3 15.7 18.4 6.8 8.7 9.2 8.2 6.2 13.2 8.8 13.3 14.9 9.0 12.1 10.4 15.0 9.9 7.8 6.4 9.8 9.3 3.6 11.2 16.7 7.6 12.8 11.1 7.6 10.2 14.3 7.0 11.8 11.6 4.7 6.7 9.4 9.2 9.5 13.5 10.1 15.6 14.2 4.6 4.8 13.2 15.7 12.0 6.1 10.2 7.9 14.2 12.7 8.0 8.7 17.6 6.7 5.2 8.2 11.8 9.8 17.9 9.9 7.9 19.2 7.1 8.0 7.1 15.4 11.9 15.3 9.3 13.6 13.9 15.9 12.6 14.3 22.3 16.0 13.5 13.9 16.7 17.7 14.0 7.3 15.7 12.5 22.2 15.9 10.3 14.5 18.7 28.0 19.4 13.3 13.7 15.7 16.8 16.5 13.3 6.0 5.3 15.6 7.4 9.4 23.0 10.4 10.2 6.7 7.9 14.0 29.5 12.5 18.3 15.8 29.8 10.5 16.5 0.0 16.6 17.4 10.4 14.8 9.2 17.0 13.7 22.3 10.9 15.4 5.9 70.7 12.4 7.8 18.6 12.6 10.9 22.7 16.0 11.5 14.5 24.5 31.2 6.5 9.2 28.6 15.8 10.8 4.8 11.5 12.8 9.8 ZNF577 MGC4400 ENSG00000161551 "Zinc finger protein 577" Q9BSK1 19 51804816-51890950 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 33.2;Early spermatids: 47.8;Late spermatids: 35.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041499, HPA046761" Uncertain Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA041499: AB_2677516, HPA046761: AB_2679791" "unprognostic (1.17e-1)" "unprognostic (2.71e-1)" "unprognostic (5.69e-2)" "unprognostic (4.17e-1)" "unprognostic (8.21e-2)" "unprognostic (1.45e-3)" "unprognostic (1.48e-1)" "unprognostic (1.64e-2)" "unprognostic (3.01e-3)" "unprognostic (1.18e-1)" "unprognostic (1.04e-1)" "unprognostic (6.51e-3)" "unprognostic (2.81e-3)" "unprognostic (2.72e-2)" "unprognostic (2.70e-1)" "unprognostic (7.02e-2)" "prognostic favorable (2.03e-4)" 7.9 6.8 13.4 5.8 15.5 4.2 13.9 14.6 12.1 10.2 10.9 9.9 15.5 5.1 12.3 11.1 6.3 10.0 8.9 8.0 14.8 5.6 11.0 5.5 6.8 5.6 7.6 8.7 27.2 7.1 17.4 7.5 10.1 9.9 17.4 7.6 17.2 12.9 16.1 9.4 22.3 8.1 14.4 11.0 10.1 7.1 22.5 14.9 3.8 16.3 5.2 6.3 8.8 10.2 9.4 3.2 7.1 4.0 4.6 4.6 1.8 1.2 0.1 6.6 8.1 11.4 12.4 0.0 7.7 2.9 3.0 6.1 0.8 1.0 1.3 0.8 3.5 4.4 2.1 2.6 1.6 1.6 0.0 7.6 12.7 0.1 1.1 8.8 2.8 4.3 9.6 5.0 4.4 1.3 9.5 1.5 0.0 2.7 0.0 3.8 0.0 7.8 3.6 7.6 0.0 0.2 3.4 3.3 2.3 4.9 2.9 2.7 1.4 1.9 0.9 6.5 7.0 1.3 3.1 1.0 5.5 7.7 1.6 2.7 5.4 0.0 1.7 1.5 0.5 8.9 7.1 2.6 5.7 1.7 4.0 4.6 9.4 3.0 3.6 2.8 5.1 3.8 2.4 1.2 4.6 3.0 3.2 1.4 1.8 13.4 15.5 14.6 12.1 14.8 5.6 7.6 8.7 9.9 14.9 0.0 1.6 6.7 3.0 3.9 11.1 7.8 5.1 1.4 1.2 17.4 9.8 6.0 33.2 3.1 47.8 6.0 2.7 0.0 1.0 4.5 5.5 6.1 4.7 1.5 4.7 6.4 2.9 4.3 2.4 35.6 7.5 5.1 0.0 5.4 5.0 14.0 1.2 0.0 12.0 4.2 9.3 0.0 6.6 10.7 14.4 4.5 3.8 2.5 4.2 2.1 ZNF579 FLJ35453 ENSG00000218891 "Zinc finger protein 579" Q8NAF0 19 55576770-55580845 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEK 293: 28.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA062812 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA062812: AB_2684873" "unprognostic (1.76e-2)" "unprognostic (1.43e-2)" "unprognostic (4.09e-2)" "unprognostic (9.08e-2)" "unprognostic (2.87e-1)" "unprognostic (5.95e-2)" "unprognostic (4.79e-2)" "unprognostic (2.87e-2)" "unprognostic (5.39e-2)" "unprognostic (1.71e-1)" "unprognostic (5.85e-3)" "unprognostic (1.68e-2)" "prognostic unfavorable (1.00e-5)" "unprognostic (5.27e-2)" "unprognostic (3.46e-1)" "unprognostic (1.57e-1)" "unprognostic (4.08e-3)" 9.6 7.0 9.0 5.9 11.2 7.5 8.8 27.5 19.5 10.3 8.5 13.4 10.9 8.3 12.6 13.7 8.2 13.6 14.5 10.2 7.8 8.9 11.3 8.6 10.4 8.2 8.0 6.3 13.4 12.4 6.8 10.3 5.2 9.7 10.4 5.3 10.6 9.8 10.6 33.0 11.8 6.5 8.2 7.1 8.2 17.6 5.7 7.6 8.5 14.6 8.3 6.6 10.9 9.8 1.9 1.8 0.9 1.7 0.6 1.3 0.2 5.1 10.4 5.7 5.8 9.4 6.5 7.3 10.2 2.7 5.6 6.1 3.5 6.3 8.5 4.1 6.0 1.9 5.0 3.3 5.5 5.8 1.5 28.6 5.1 17.8 6.4 9.6 3.2 4.5 16.3 6.3 4.3 4.5 12.7 3.1 3.2 10.2 2.9 11.0 6.6 4.4 4.2 5.1 2.7 16.5 8.0 5.3 3.4 7.5 9.6 6.9 10.1 6.8 5.3 4.8 11.5 2.7 4.3 6.9 7.4 7.2 2.3 6.1 7.7 6.4 4.6 3.9 5.0 3.6 0.5 1.7 0.2 0.8 0.6 0.4 0.4 0.3 0.9 1.8 1.9 1.3 0.5 0.9 0.6 0.5 1.8 0.8 0.2 9.0 11.2 27.5 19.5 7.8 8.9 8.0 6.3 9.7 7.6 3.0 7.0 3.4 6.4 3.0 11.2 4.2 17.8 2.7 1.2 5.2 11.8 0.7 3.3 4.3 0.0 5.6 2.3 0.0 4.1 0.7 3.1 7.3 4.6 5.5 4.5 14.3 10.9 12.3 4.1 0.0 7.8 3.0 3.3 1.0 6.9 14.8 5.3 0.0 11.7 9.1 7.4 12.9 3.3 0.3 0.9 2.9 0.3 1.3 5.3 7.8 ZNF580 ENSG00000213015 "Zinc finger protein 580" Q9UK33 19 55635016-55643469 "Predicted intracellular proteins, Transcription factors" "Chemotaxis, Inflammatory response, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "HEK 293: 78.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054058 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA054058: AB_2682360" "unprognostic (1.36e-2)" "unprognostic (5.13e-3)" "unprognostic (2.47e-3)" "unprognostic (3.80e-2)" "unprognostic (1.72e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (5.63e-4)" "unprognostic (3.54e-2)" "unprognostic (3.07e-1)" "unprognostic (6.21e-2)" "prognostic favorable (2.36e-5)" "unprognostic (1.47e-1)" "prognostic unfavorable (5.79e-6)" "unprognostic (1.43e-1)" "unprognostic (2.29e-1)" "unprognostic (3.36e-1)" "unprognostic (3.46e-3)" 32.8 23.6 24.5 25.5 23.4 17.2 19.1 28.7 28.2 23.4 25.2 23.1 36.4 19.8 32.2 39.5 18.2 25.8 25.5 17.2 23.1 21.7 23.3 8.7 17.1 24.2 19.1 22.0 33.0 24.1 37.8 38.2 13.7 19.9 31.3 16.2 23.0 31.7 34.2 20.9 19.4 20.0 32.4 17.3 30.1 24.9 10.7 20.9 23.0 35.4 10.8 21.6 25.8 21.1 12.8 4.1 10.5 9.2 2.9 3.3 1.5 4.7 8.9 8.2 5.3 9.1 5.1 3.2 6.4 7.6 10.0 12.5 1.5 4.6 3.4 1.8 9.3 2.2 3.9 5.4 5.8 7.8 10.9 78.3 6.4 8.4 4.2 12.1 3.1 14.6 11.0 6.2 4.8 9.3 13.3 6.9 8.8 6.3 9.6 8.3 1.5 14.1 4.6 4.2 3.1 11.5 12.8 2.9 14.2 11.3 5.6 9.1 11.2 4.5 4.5 5.8 4.6 3.8 3.3 8.6 5.5 8.3 3.7 3.5 19.4 5.2 8.5 3.0 4.9 5.2 4.4 3.4 10.5 1.2 4.8 1.3 8.2 2.7 2.7 3.6 12.8 3.3 2.8 6.2 2.9 9.2 4.1 2.1 1.5 24.5 23.4 28.7 28.2 23.1 21.7 19.1 22.0 19.9 20.9 8.9 8.9 35.7 31.8 16.6 31.0 8.9 33.1 1.4 5.7 54.1 3.9 23.6 64.6 36.4 2.7 31.8 25.8 0.0 48.6 17.3 31.7 34.7 19.5 9.5 22.2 19.1 64.7 40.5 25.4 4.3 55.0 28.0 37.1 45.9 23.8 26.9 38.3 28.1 66.4 55.9 16.6 38.8 37.1 7.9 12.1 14.8 15.9 20.2 26.9 27.6 ZNF582 FLJ30927 ENSG00000018869 "Zinc finger protein 582" Q96NG8 19 56375846-56393545 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 11.6;Sertoli cells: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 24.3" "Low region specificity" "Detected in all" HPA028858 Uncertain Approved Nucleoplasm,Cytosol No No Cytosol Nucleoplasm "HPA028858: AB_10603247" "unprognostic (1.19e-3)" "unprognostic (9.86e-4)" "unprognostic (3.88e-1)" "unprognostic (3.46e-2)" "unprognostic (4.08e-3)" "unprognostic (1.04e-2)" "unprognostic (2.12e-2)" "unprognostic (6.05e-2)" "unprognostic (3.10e-2)" "unprognostic (4.12e-2)" "unprognostic (1.67e-3)" "unprognostic (5.80e-2)" "unprognostic (2.02e-7)" "unprognostic (3.50e-2)" "unprognostic (4.92e-2)" "unprognostic (8.54e-2)" "unprognostic (5.00e-3)" 4.8 8.7 7.7 4.7 8.9 2.7 6.3 9.4 9.0 4.7 4.9 7.8 3.6 2.3 7.9 13.5 4.8 6.1 6.4 8.0 8.2 7.1 5.9 4.8 5.2 8.0 9.6 3.9 10.2 4.0 7.5 11.4 5.4 8.9 8.4 2.7 4.4 4.1 5.5 3.5 5.6 3.3 5.5 7.7 7.2 3.4 8.9 13.1 7.8 13.8 2.2 3.7 5.4 5.9 5.9 3.4 5.9 3.3 11.0 6.5 2.8 0.0 1.1 6.1 1.2 1.5 1.6 0.0 2.4 2.6 1.6 1.3 0.0 0.3 0.0 1.6 1.4 3.5 0.0 0.8 0.3 1.3 0.0 24.3 5.8 0.0 0.4 2.6 1.6 4.7 5.4 1.3 1.0 0.0 1.5 1.0 0.6 1.3 0.0 1.0 0.0 3.4 3.7 3.3 0.0 0.0 1.6 2.1 2.1 1.3 3.3 0.0 3.9 0.0 0.8 0.0 4.7 2.7 3.2 1.0 3.2 6.4 0.8 3.3 5.2 5.6 3.7 0.2 0.4 1.8 4.3 2.2 5.9 4.4 3.3 6.5 5.9 5.2 4.4 3.3 4.3 3.8 4.8 0.5 11.0 2.4 3.4 1.6 2.8 7.7 8.9 9.4 9.0 8.2 7.1 9.6 3.9 8.9 13.1 0.0 0.0 5.2 2.1 1.1 3.3 2.7 0.0 1.4 1.2 7.0 2.0 2.1 11.6 2.4 0.7 5.3 0.0 0.0 0.6 0.6 2.6 3.3 8.1 2.1 2.5 1.6 0.0 1.8 1.0 0.4 2.0 2.9 3.3 1.8 0.6 8.0 1.0 0.0 3.9 3.3 5.7 12.9 2.1 1.8 5.7 0.9 3.0 2.5 0.6 1.7 ZNF585B "FLJ14928, SZFP41" ENSG00000245680 "Zinc finger protein 585B" Q52M93 19 37181579-37218153 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA075556 Approved "Nucleoplasm,Cytoplasmic bodies" NA NA "Nucleoplasm, Cytoplasmic bodies" "HPA075556: AB_2686757" "unprognostic (9.53e-3)" "unprognostic (2.51e-1)" "unprognostic (1.22e-1)" "unprognostic (1.30e-2)" "unprognostic (9.52e-2)" "unprognostic (2.04e-1)" "unprognostic (8.48e-2)" "unprognostic (2.13e-1)" "unprognostic (3.11e-2)" "unprognostic (5.01e-2)" "unprognostic (3.56e-2)" "unprognostic (2.58e-1)" "unprognostic (3.26e-2)" "unprognostic (4.59e-2)" "unprognostic (2.79e-1)" "unprognostic (6.41e-2)" "unprognostic (4.18e-3)" 6.6 8.3 11.2 5.8 13.4 2.6 9.3 17.9 12.9 10.0 8.1 8.7 11.4 5.6 11.6 15.2 5.8 8.8 7.5 7.2 9.8 10.0 8.7 5.2 6.2 7.3 14.1 9.8 15.0 6.2 23.4 22.6 8.0 10.1 8.9 7.2 8.3 6.3 11.6 5.0 6.3 7.2 10.1 12.3 9.7 7.6 9.2 12.4 9.5 13.1 5.6 9.1 9.3 7.2 6.5 1.9 3.7 4.2 2.9 7.1 2.9 2.4 4.2 3.8 7.5 6.3 9.9 2.1 3.2 5.2 5.9 8.9 2.3 3.1 0.1 6.9 4.2 4.2 0.7 0.1 5.0 7.4 4.9 1.9 3.2 5.5 1.2 6.1 0.3 6.8 7.7 3.0 6.7 3.5 4.7 2.4 0.4 0.0 0.2 3.5 1.5 5.6 2.1 4.2 1.2 1.2 0.2 2.1 0.1 3.2 10.0 6.7 4.3 0.0 0.3 1.5 5.1 2.9 3.5 2.0 0.6 1.4 5.0 3.8 5.7 7.5 6.9 0.3 0.1 6.5 3.3 1.6 3.7 5.0 3.1 6.3 6.5 3.6 4.4 1.9 4.9 5.2 7.1 2.5 2.9 4.2 1.7 3.5 2.9 11.2 13.4 17.9 12.9 9.8 10.0 14.1 9.8 10.1 12.4 6.0 6.4 1.4 1.6 1.4 6.1 5.0 7.6 8.1 12.5 12.2 2.0 2.3 1.7 2.5 13.5 3.3 2.8 0.0 1.7 2.1 2.6 1.9 6.9 1.7 3.0 3.2 0.0 2.5 3.3 5.9 3.7 2.2 1.7 1.0 3.3 3.7 2.0 2.0 6.3 3.0 3.9 0.0 3.3 4.1 4.3 1.4 2.6 3.2 2.5 2.1 ZNF587 "FLJ14710, FLJ20813, UBF-fl, ZF6" ENSG00000198466 "Zinc finger protein 587" Q96SQ5 19 57849857-57865112 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 29.4" "HPA042125, HPA043288, HPA056213" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA042125: AB_2677862, HPA043288: AB_2678410, HPA056213: AB_2683069" "unprognostic (1.61e-2)" "unprognostic (5.39e-2)" "unprognostic (3.92e-2)" "unprognostic (1.91e-1)" "unprognostic (2.42e-1)" "unprognostic (2.12e-2)" "unprognostic (6.81e-2)" "unprognostic (3.53e-1)" "unprognostic (6.60e-3)" "unprognostic (1.43e-1)" "unprognostic (2.29e-1)" "unprognostic (6.84e-3)" "prognostic unfavorable (7.98e-4)" "unprognostic (1.59e-1)" "unprognostic (2.11e-1)" "unprognostic (7.30e-2)" "unprognostic (3.68e-3)" 7.4 6.3 11.8 17.8 11.2 9.4 13.5 11.0 10.5 7.7 20.0 10.1 16.7 11.6 9.4 13.0 7.8 7.7 13.4 7.5 7.6 6.6 9.0 7.5 7.7 7.5 11.2 9.5 10.0 11.2 8.9 14.7 10.7 7.8 12.4 18.8 7.5 15.0 9.3 7.7 8.2 25.1 7.6 6.8 8.1 13.2 5.1 9.5 17.0 10.5 2.6 13.1 9.2 9.0 3.6 2.0 6.0 2.0 1.7 2.4 1.0 5.5 6.7 5.9 5.0 5.7 7.9 7.6 5.6 6.7 7.9 6.6 8.7 4.1 6.0 2.9 5.2 3.3 4.2 9.9 8.5 15.1 3.7 20.9 9.0 17.4 5.4 3.7 9.0 7.4 7.7 3.7 8.4 7.7 7.2 8.4 5.9 9.2 5.1 5.6 2.6 5.4 2.8 2.5 2.1 6.0 5.3 5.9 3.2 5.0 29.4 8.2 4.2 7.6 5.7 2.3 7.9 5.8 4.9 4.4 7.6 4.6 2.4 7.0 10.2 7.4 5.7 3.7 4.1 4.3 6.0 1.8 1.9 1.8 1.6 2.1 1.9 1.9 1.6 1.3 3.6 2.1 2.4 5.1 1.7 2.0 2.0 1.7 1.0 11.8 11.2 11.0 10.5 7.6 6.6 11.2 9.5 7.8 9.5 3.0 5.0 6.0 10.8 8.1 19.4 6.9 25.5 13.4 6.8 7.0 29.5 9.3 10.0 7.9 7.4 6.0 12.0 0.0 3.1 9.3 8.4 12.6 12.7 6.6 5.6 19.1 22.4 11.6 5.1 1.0 4.4 5.5 0.0 3.6 19.3 8.4 6.0 14.4 8.5 6.1 23.9 0.0 5.1 3.7 7.6 5.8 8.5 6.9 14.1 13.3 ZNF587B ENSG00000269343 "Zinc finger protein 587B" E7ETH6 19 57819741-57846238 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 29.1" "HPA043800, HPA053762, HPA072145" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: " "unprognostic (4.13e-3)" "unprognostic (1.43e-1)" "unprognostic (1.36e-1)" "unprognostic (5.52e-2)" "unprognostic (2.19e-1)" "unprognostic (5.69e-2)" "unprognostic (3.22e-3)" "unprognostic (3.80e-2)" "prognostic unfavorable (1.37e-4)" "unprognostic (5.47e-2)" "unprognostic (2.47e-2)" "prognostic unfavorable (1.33e-4)" "unprognostic (1.16e-1)" "unprognostic (3.57e-2)" "unprognostic (2.94e-1)" "unprognostic (7.48e-2)" "unprognostic (8.70e-2)" 7.6 7.1 5.0 15.0 7.9 19.4 14.1 8.9 6.5 7.8 10.4 6.6 12.4 12.6 13.6 10.7 9.4 9.1 10.7 6.4 5.4 3.3 8.9 14.6 9.3 10.9 6.2 5.5 10.9 17.2 13.3 14.5 8.2 5.7 10.1 11.5 7.6 19.5 16.7 12.7 14.5 12.6 10.2 3.7 15.5 10.3 11.8 7.4 8.0 10.2 7.1 13.1 10.8 7.0 4.5 3.7 5.0 5.3 3.2 6.3 4.5 4.8 13.0 5.8 12.0 1.4 1.5 6.2 3.6 3.1 4.4 2.6 7.8 7.3 9.9 2.1 5.4 2.0 3.8 5.0 13.2 10.0 1.6 11.6 7.0 10.6 8.4 5.1 12.3 7.1 5.0 2.7 5.8 6.2 1.1 3.4 6.9 8.1 4.8 2.5 5.3 5.7 2.1 14.7 4.9 6.0 4.8 5.1 4.5 5.3 29.1 3.4 5.5 4.0 5.9 3.4 9.5 7.8 5.2 4.6 5.1 5.8 1.0 5.5 6.4 5.1 7.8 4.2 3.8 5.6 5.0 5.3 2.5 3.9 5.3 4.8 4.5 4.4 4.9 3.2 4.4 6.3 5.3 2.4 3.2 2.9 3.7 3.0 4.5 5.0 7.9 8.9 6.5 5.4 3.3 6.2 5.5 5.7 7.4 6.0 1.0 4.2 2.9 2.9 3.6 2.8 5.1 2.7 7.9 0.0 0.0 2.9 1.7 3.2 3.6 2.8 1.1 0.0 1.7 2.7 1.0 2.6 0.0 2.4 1.2 3.2 4.1 5.5 2.1 1.0 0.6 3.2 1.7 0.0 3.3 0.8 1.7 0.0 0.7 2.5 3.2 6.5 0.5 3.8 4.7 3.3 2.1 1.5 2.8 2.6 ZNF589 SZF1 ENSG00000164048 "Zinc finger protein 589" Q86UQ0 3 48241100-48299253 "Predicted intracellular proteins, Transcription factors" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 15.2;Cone photoreceptor cells: 19.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HAP1: 23.4;NTERA-2: 37.1" HPA003145 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA003145: AB_1080738" "unprognostic (2.49e-3)" "prognostic favorable (2.50e-4)" "unprognostic (9.14e-2)" "unprognostic (7.34e-3)" "unprognostic (1.18e-1)" "prognostic favorable (1.71e-4)" "unprognostic (3.01e-5)" "prognostic favorable (6.45e-5)" "unprognostic (2.64e-2)" "unprognostic (9.67e-2)" "prognostic favorable (1.21e-4)" "unprognostic (8.02e-2)" "unprognostic (1.46e-1)" "unprognostic (1.32e-2)" "unprognostic (3.45e-2)" "unprognostic (9.57e-3)" "unprognostic (2.19e-2)" 6.6 9.8 15.5 10.2 17.0 5.2 7.4 42.8 16.2 7.7 7.2 10.4 7.6 4.5 8.4 22.6 9.4 8.3 5.4 6.0 13.5 6.6 6.3 3.5 9.0 12.9 18.2 7.9 16.1 6.4 9.9 16.3 3.5 14.0 20.8 7.5 10.7 9.6 18.1 6.4 11.0 14.4 9.2 13.9 22.8 7.0 5.8 14.9 5.7 18.8 3.3 13.0 7.2 9.6 4.0 13.3 1.8 3.1 1.3 5.1 2.2 2.3 1.6 6.8 5.6 8.8 4.7 8.6 2.1 1.8 2.8 3.6 3.5 3.2 9.2 1.8 2.5 2.1 2.0 23.4 5.8 2.1 5.8 5.4 10.9 6.6 2.7 1.6 2.4 3.0 1.5 3.9 3.2 2.3 2.9 4.8 7.2 7.7 2.1 1.5 2.2 3.4 2.0 37.1 2.0 3.6 1.6 2.5 3.4 2.0 2.3 2.3 4.9 1.7 2.0 6.9 10.6 2.9 3.9 7.6 1.6 3.2 3.6 1.4 4.8 5.9 7.5 1.7 6.7 4.8 1.1 2.8 1.8 3.8 2.4 4.4 4.0 4.4 4.9 2.8 2.7 5.1 4.9 1.5 1.3 3.1 13.3 3.8 2.2 15.5 17.0 42.8 16.2 13.5 6.6 18.2 7.9 14.0 14.9 0.0 4.8 0.8 1.0 1.0 15.2 3.0 0.0 2.7 3.4 8.7 19.6 1.9 3.3 1.2 1.3 2.1 1.3 0.0 0.9 0.9 1.8 0.8 0.0 1.0 3.1 1.6 1.7 1.8 3.7 1.5 2.0 4.6 1.7 0.0 2.3 4.8 0.7 1.4 4.2 1.4 11.0 6.5 1.9 0.6 2.7 1.1 0.0 2.5 2.3 0.7 ZNF592 "CAMOS, KIAA0211, SCAR5" ENSG00000166716 "Zinc finger protein 592" Q92610 15 84748635-84806432 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020332, HPA021600" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA020332: AB_1859365, HPA021600: AB_1859364" "unprognostic (2.83e-1)" "unprognostic (1.90e-1)" "unprognostic (2.48e-2)" "unprognostic (2.35e-2)" "unprognostic (1.15e-1)" "unprognostic (7.63e-2)" "unprognostic (4.15e-1)" "unprognostic (2.26e-1)" "unprognostic (1.13e-1)" "unprognostic (5.04e-1)" "unprognostic (7.98e-2)" "unprognostic (2.84e-1)" "unprognostic (4.80e-3)" "unprognostic (3.64e-1)" "unprognostic (6.62e-2)" "unprognostic (3.90e-1)" "unprognostic (2.62e-1)" 16.8 15.0 19.0 19.8 20.0 20.5 22.5 20.4 20.6 17.3 16.4 22.7 16.6 17.0 21.5 17.8 12.9 19.0 14.7 16.4 18.6 13.4 15.7 17.5 15.8 21.0 22.5 12.0 26.9 23.5 23.3 18.4 13.0 16.8 15.2 15.9 16.1 14.9 15.8 31.3 21.2 17.9 17.7 19.1 20.0 13.8 17.8 21.0 23.9 16.7 15.9 19.7 14.7 21.3 3.7 3.4 6.6 3.5 2.3 3.3 1.7 7.1 12.1 11.3 6.3 12.6 8.5 12.4 5.0 7.2 8.4 6.7 11.5 8.5 10.4 6.5 11.3 7.2 13.2 17.3 7.2 5.9 8.3 10.3 12.0 12.0 10.1 7.7 9.7 9.6 9.2 10.2 6.5 10.8 10.0 7.2 7.3 11.8 6.6 8.7 11.0 6.5 11.9 10.2 6.8 4.8 9.6 10.1 9.1 8.8 14.6 10.2 11.1 11.5 10.4 8.2 16.4 5.8 20.8 10.2 12.5 7.3 6.9 9.5 7.6 8.0 11.3 7.9 14.5 7.2 0.0 3.1 2.2 3.3 3.5 1.3 3.7 2.1 3.1 3.4 3.7 2.8 2.4 6.6 2.3 3.2 2.7 1.8 1.7 19.0 20.0 20.4 20.6 18.6 13.4 22.5 12.0 16.8 21.0 8.9 13.8 6.2 3.9 7.4 8.9 4.6 7.6 2.7 5.7 3.5 7.9 4.4 0.0 6.6 6.6 7.1 13.7 0.0 6.9 6.2 7.7 4.8 3.5 13.7 9.8 3.2 7.5 12.3 13.6 7.6 4.4 8.8 6.8 8.2 9.1 4.4 8.3 10.8 9.2 5.4 8.2 6.5 5.1 10.5 10.4 6.1 4.0 6.9 9.2 4.1 ZNF593 ZT86 ENSG00000142684 "Zinc finger protein 593" O00488 1 26169871-26170873 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 59.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054363, HPA059387" Supported Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA054363: AB_2682462, HPA059387: AB_2684001" "unprognostic (1.23e-2)" "unprognostic (8.97e-2)" "unprognostic (7.13e-2)" "unprognostic (7.42e-2)" "unprognostic (9.37e-2)" "unprognostic (5.92e-2)" "unprognostic (1.63e-2)" "unprognostic (8.96e-2)" "unprognostic (5.06e-1)" "unprognostic (1.76e-2)" "unprognostic (1.78e-1)" "unprognostic (1.08e-1)" "unprognostic (4.46e-2)" "unprognostic (1.49e-1)" "unprognostic (1.19e-1)" "unprognostic (1.66e-1)" "unprognostic (4.79e-2)" 11.7 11.5 9.4 10.7 9.4 15.7 18.3 7.2 12.1 9.0 11.7 7.0 12.1 11.4 8.7 9.0 10.9 8.4 11.3 14.5 8.9 10.0 13.5 30.8 7.7 16.8 10.0 7.0 11.6 36.2 9.7 9.3 12.7 10.9 10.4 5.8 5.9 15.9 12.0 59.3 9.8 11.0 6.5 7.3 13.0 15.2 9.3 8.3 5.4 15.1 17.2 9.2 10.6 10.1 23.5 26.8 0.7 25.0 16.1 21.7 14.1 20.1 11.1 3.8 13.4 3.7 4.9 20.2 9.0 4.6 10.5 10.1 17.0 12.2 23.6 16.6 5.6 8.4 13.2 12.9 11.7 3.8 14.1 41.4 16.0 9.1 25.7 16.1 22.1 14.1 8.8 11.5 11.6 12.2 4.4 8.8 5.8 24.0 9.1 6.2 15.4 9.0 41.1 15.1 19.5 39.5 11.3 6.7 23.8 7.5 8.9 10.1 11.0 10.9 27.4 34.2 3.3 11.3 12.5 9.1 10.1 11.9 21.1 16.8 18.0 18.2 25.5 11.8 45.9 12.9 0.1 15.7 0.2 14.2 25.0 13.3 23.5 20.1 14.0 21.7 22.7 15.0 14.3 0.7 16.1 25.0 26.8 21.7 14.1 9.4 9.4 7.2 12.1 8.9 10.0 10.0 7.0 10.9 8.3 11.9 63.0 48.3 137.4 152.1 16.6 5.9 58.6 21.4 40.9 57.6 2.0 93.3 87.9 89.4 5.0 36.0 55.3 23.3 126.2 135.2 54.6 99.4 51.7 184.5 69.6 3.2 105.3 38.6 55.7 10.0 30.0 42.5 47.2 47.7 71.1 18.5 122.6 60.4 21.9 148.8 11.7 12.9 55.6 33.0 56.3 147.0 186.2 28.8 68.1 152.9 ZNF594 KIAA1871 ENSG00000180626 "Zinc finger protein 594" Q96JF6 17 5179536-5191883 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 14.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA060283, HPA067178, HPA069360, HPA074493, HPA077596" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA060283: AB_2732645, HPA067178: AB_2685796, HPA069360: AB_2732131, HPA074493: , HPA077596: " "unprognostic (6.67e-2)" "unprognostic (1.07e-2)" "unprognostic (6.93e-2)" "unprognostic (7.92e-3)" "unprognostic (1.11e-1)" "unprognostic (8.24e-3)" "unprognostic (3.36e-2)" "unprognostic (1.32e-1)" "unprognostic (6.67e-2)" "unprognostic (1.86e-1)" "unprognostic (1.33e-5)" "unprognostic (4.09e-3)" "unprognostic (1.08e-1)" "unprognostic (1.08e-1)" "unprognostic (4.99e-1)" "unprognostic (5.21e-2)" "unprognostic (6.59e-2)" 4.0 6.2 11.8 8.4 11.2 1.3 8.8 13.8 13.4 7.5 6.3 8.0 5.3 3.1 9.3 8.4 4.2 8.3 4.2 4.9 8.9 5.9 6.7 3.8 4.1 10.1 13.6 6.6 19.8 6.0 15.3 15.9 5.8 9.2 9.6 5.1 6.0 6.5 10.2 6.7 3.8 6.8 6.0 8.3 8.4 5.2 7.8 11.1 11.9 10.2 2.1 10.2 6.6 5.6 5.9 4.5 1.1 1.0 2.4 5.2 1.0 5.5 2.5 10.7 8.3 1.7 1.9 8.9 3.8 1.9 6.8 6.5 7.0 2.0 12.6 6.0 3.0 5.0 6.2 6.8 0.2 8.7 6.7 6.9 4.1 8.8 3.5 2.4 0.0 4.1 1.4 1.1 4.0 0.0 1.8 0.7 7.5 1.6 3.2 2.3 5.3 3.4 1.7 4.8 0.9 3.4 7.3 9.0 1.7 1.9 1.5 6.3 8.4 2.9 1.5 5.7 4.9 3.4 3.0 0.1 0.1 3.8 3.4 2.7 2.1 4.1 3.0 0.6 0.0 4.1 0.4 0.8 1.1 3.2 1.0 2.3 3.5 3.3 2.9 1.0 5.9 5.2 3.4 0.4 2.4 0.9 4.5 4.4 1.0 11.8 11.2 13.8 13.4 8.9 5.9 13.6 6.6 9.2 11.1 6.0 3.8 1.4 1.2 1.0 9.4 4.2 7.6 6.7 4.5 5.2 5.9 1.0 6.6 1.3 0.6 1.0 0.0 0.0 1.0 0.6 0.9 0.8 3.5 0.8 0.8 14.3 1.2 3.7 2.2 2.6 3.1 0.0 0.0 1.8 0.9 8.2 0.7 1.1 2.5 0.6 9.8 0.0 1.0 2.3 3.8 0.3 0.2 0.8 1.2 0.4 ZNF597 "FLJ33071, HIT-4" ENSG00000167981 "Zinc finger protein 597" Q96LX8 16 3432422-3443542 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 23.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 11.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 11.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001556 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA001556: AB_1080740" "unprognostic (1.98e-1)" "unprognostic (8.07e-2)" "unprognostic (1.03e-1)" "unprognostic (9.15e-3)" "unprognostic (2.88e-1)" "unprognostic (6.16e-2)" "unprognostic (1.84e-2)" "unprognostic (5.56e-2)" "unprognostic (3.70e-2)" "unprognostic (2.84e-2)" "unprognostic (1.34e-1)" "unprognostic (8.75e-3)" "unprognostic (4.73e-2)" "unprognostic (7.26e-2)" "unprognostic (4.58e-1)" "unprognostic (2.89e-1)" "unprognostic (5.99e-3)" 6.7 6.7 4.5 4.6 8.5 5.0 5.9 5.2 8.7 4.7 4.2 7.3 2.4 3.8 5.6 6.8 4.0 5.9 6.0 5.4 4.8 4.4 5.2 5.4 7.4 6.1 4.5 4.5 7.2 5.2 4.5 7.7 7.9 8.9 4.8 3.2 5.8 4.6 4.9 3.6 4.4 5.1 4.1 4.6 5.4 4.8 13.2 5.4 5.4 6.4 2.6 5.6 5.7 4.6 1.4 1.1 11.3 2.2 0.9 2.2 0.8 0.0 1.8 2.3 5.4 1.7 2.6 8.7 2.6 3.2 2.5 3.2 0.0 3.3 4.4 2.5 2.9 1.9 1.4 5.1 2.3 3.3 2.6 2.0 7.5 4.8 3.1 2.5 4.4 4.5 3.3 3.7 2.8 3.2 2.5 6.8 2.4 1.6 2.9 2.9 1.4 3.1 4.7 7.3 1.9 0.0 2.0 6.7 3.0 2.1 7.1 2.9 4.1 5.1 2.7 1.9 6.4 2.3 6.7 4.4 4.2 2.2 0.0 2.5 3.8 4.0 0.5 0.0 2.6 2.5 3.8 1.1 11.3 1.3 2.2 2.2 1.4 1.0 1.1 1.1 1.1 1.9 1.4 0.3 0.9 1.0 0.5 1.6 0.8 4.5 8.5 5.2 8.7 4.8 4.4 4.5 4.5 8.9 5.4 23.8 1.6 2.7 1.6 0.1 1.9 1.4 0.0 1.4 9.1 1.8 0.0 1.0 0.0 0.9 3.8 2.2 0.7 0.0 0.9 1.6 1.0 2.1 3.5 1.0 1.0 0.0 2.4 3.1 1.5 3.3 1.1 0.9 0.0 2.8 1.6 1.5 1.6 0.0 2.1 1.2 3.2 6.5 1.0 4.2 6.9 0.4 1.3 0.7 2.3 1.8 ZNF599 FLJ30663 ENSG00000153896 "Zinc finger protein 599" Q96NL3 19 34758076-34773229 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 28.2;Early spermatids: 64.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014701 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA014701: AB_1859371" "unprognostic (3.52e-3)" "unprognostic (1.42e-3)" "unprognostic (1.99e-2)" "unprognostic (9.35e-3)" "unprognostic (9.20e-2)" "unprognostic (5.16e-3)" "unprognostic (3.95e-3)" "unprognostic (1.72e-2)" "unprognostic (1.70e-2)" "unprognostic (7.35e-3)" "unprognostic (1.77e-3)" "unprognostic (5.03e-2)" "unprognostic (4.42e-2)" "unprognostic (1.16e-1)" "unprognostic (1.00e-1)" "unprognostic (2.71e-2)" "unprognostic (8.12e-3)" 5.9 8.1 10.0 5.2 12.5 2.4 8.5 16.8 8.0 10.1 6.5 11.7 5.8 4.5 12.2 21.4 4.4 14.1 6.5 5.8 10.3 6.8 9.7 4.9 6.0 5.7 10.5 5.7 11.4 5.7 14.3 13.2 6.0 8.1 10.4 5.5 11.6 7.4 9.5 5.5 8.0 5.4 7.1 8.1 6.5 5.9 19.9 11.2 10.4 13.2 6.0 6.2 6.4 7.2 4.3 3.8 6.4 4.8 5.7 6.7 2.9 5.2 2.6 5.9 5.4 6.5 8.7 3.2 1.9 5.4 4.8 5.7 2.3 3.6 0.6 5.6 3.7 4.4 2.7 3.8 2.5 6.0 0.6 4.8 4.1 5.4 6.5 5.0 0.9 4.6 7.8 3.6 2.2 2.3 8.9 5.5 9.9 6.8 0.5 7.5 2.1 10.1 4.2 2.5 7.2 0.2 5.5 5.5 3.3 6.0 1.2 7.0 9.9 6.5 1.2 3.8 4.5 3.4 0.5 2.9 4.8 5.4 3.6 2.0 6.1 6.6 0.5 2.9 0.1 4.5 3.1 1.1 6.4 6.1 2.5 4.0 2.0 6.5 3.5 1.7 4.3 6.7 5.9 0.6 5.7 4.8 3.8 4.9 2.9 10.0 12.5 16.8 8.0 10.3 6.8 10.5 5.7 8.1 11.2 0.0 3.0 0.8 5.4 2.7 3.1 3.7 2.5 22.7 10.3 17.4 2.0 6.8 28.2 3.7 64.0 4.9 1.6 0.0 2.0 3.8 6.0 6.5 0.0 2.5 3.2 0.0 1.2 6.2 1.5 24.3 9.5 1.3 5.0 1.0 3.1 11.2 2.5 0.0 4.6 11.5 2.4 6.5 4.4 22.1 5.5 1.4 1.6 4.3 3.4 4.7 ZNF605 ENSG00000196458 "Zinc finger protein 605" Q86T29 12 132918308-132956306 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA061970, HPA062655" Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA061970: AB_2684649, HPA062655: AB_2684820" "unprognostic (2.38e-1)" "unprognostic (2.58e-1)" "unprognostic (3.44e-2)" "unprognostic (2.98e-2)" "unprognostic (6.38e-2)" "unprognostic (3.83e-2)" "unprognostic (1.16e-6)" "unprognostic (3.62e-1)" "unprognostic (1.15e-1)" "unprognostic (4.03e-1)" "unprognostic (2.13e-2)" "unprognostic (1.10e-2)" "unprognostic (2.89e-1)" "unprognostic (6.58e-2)" "unprognostic (1.10e-1)" "unprognostic (7.53e-2)" "unprognostic (9.06e-3)" 5.5 8.2 10.9 7.6 9.9 3.2 12.2 19.0 12.8 10.1 8.3 8.4 9.5 6.7 10.2 13.1 7.3 9.3 6.6 9.9 10.8 7.9 9.9 8.1 7.6 8.0 7.8 8.2 13.3 8.2 16.9 12.9 10.2 8.1 10.7 6.9 9.9 8.8 9.6 14.6 11.5 8.3 8.2 7.4 7.4 8.7 4.8 9.1 8.5 15.5 6.1 7.5 8.5 9.9 2.6 1.4 1.9 1.2 1.7 3.0 0.8 4.5 3.7 9.6 9.1 5.3 10.9 7.2 6.3 3.6 2.9 2.1 0.6 0.6 1.9 3.4 5.4 3.6 2.5 4.2 1.6 3.6 1.6 7.1 8.7 2.9 2.9 4.0 3.6 9.7 7.0 7.0 2.0 4.5 9.0 2.2 4.6 1.3 0.1 7.3 1.3 4.8 5.1 7.4 1.3 5.1 4.4 6.3 1.3 5.0 7.9 6.2 7.1 2.8 1.7 4.3 5.9 10.4 10.6 4.3 3.7 5.9 5.4 2.5 0.0 0.0 1.6 0.1 3.1 2.1 1.6 1.2 1.3 1.6 0.8 0.9 2.6 1.4 1.7 0.9 2.2 3.0 1.9 1.9 1.7 0.9 1.4 0.4 0.8 10.9 9.9 19.0 12.8 10.8 7.9 7.8 8.2 8.1 9.1 17.9 36.9 2.7 8.2 3.1 33.5 19.9 20.4 21.4 39.8 8.7 27.5 5.6 8.3 5.7 1.5 8.3 4.5 0.0 3.0 3.1 7.6 7.4 9.3 4.3 3.2 38.1 5.8 13.5 6.5 1.3 14.7 3.8 0.0 4.6 9.8 19.8 6.8 0.0 12.7 4.2 36.9 12.9 6.2 5.4 7.3 4.0 4.7 5.0 7.3 6.5 ZNF606 "FLJ14260, KIAA1852, ZNF328" ENSG00000166704 "Zinc finger protein 606" Q8WXB4 19 57977053-58003349 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 29.4;Cone photoreceptor cells: 23.6;Rod photoreceptor cells: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 20.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041712, HPA043584" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA041712: AB_10960410, HPA043584: AB_2678565" "unprognostic (1.05e-2)" "unprognostic (1.05e-1)" "unprognostic (4.09e-2)" "unprognostic (3.76e-2)" "unprognostic (4.92e-2)" "unprognostic (6.21e-2)" "unprognostic (1.10e-1)" "unprognostic (6.83e-2)" "unprognostic (3.48e-3)" "unprognostic (4.26e-2)" "unprognostic (1.29e-3)" "unprognostic (4.09e-2)" "unprognostic (1.03e-1)" "unprognostic (5.00e-2)" "unprognostic (3.21e-2)" "unprognostic (4.01e-2)" "prognostic favorable (4.75e-6)" 6.9 7.1 13.0 7.1 12.8 5.5 12.8 18.2 11.6 9.6 7.8 12.8 11.3 8.6 11.1 14.6 6.6 14.0 9.8 6.7 15.0 6.9 9.0 6.9 7.7 11.2 16.9 8.2 14.6 8.3 18.9 18.1 6.7 12.3 12.4 7.2 10.2 11.1 10.0 9.9 11.0 10.3 9.2 10.8 12.9 10.0 8.9 11.7 20.1 17.8 6.3 9.8 9.2 7.7 9.8 7.9 9.1 3.0 6.3 8.5 2.4 1.4 2.6 11.3 9.5 3.4 4.8 8.2 3.4 1.2 3.4 2.1 3.3 4.0 2.2 2.7 2.3 3.7 3.4 1.4 3.3 4.6 0.0 20.2 5.5 0.9 3.1 2.7 0.0 4.5 5.7 1.7 2.9 1.7 5.3 2.4 6.6 2.8 0.1 4.3 1.3 7.3 1.3 6.9 1.7 4.9 8.2 4.2 3.2 3.6 6.9 10.6 7.1 6.1 0.2 2.5 5.7 5.5 5.2 2.8 2.7 4.0 1.1 1.1 6.7 7.2 1.6 0.2 0.6 3.5 9.1 3.0 7.4 3.0 2.4 4.1 8.3 4.8 3.4 2.6 9.8 8.5 4.7 7.8 6.3 2.6 7.9 3.2 2.4 13.0 12.8 18.2 11.6 15.0 6.9 16.9 8.2 12.3 11.7 6.0 5.6 2.7 2.9 0.9 13.6 5.7 0.0 29.4 5.7 12.2 23.6 2.9 3.3 2.6 2.0 4.3 2.0 0.0 1.4 0.8 1.9 4.0 4.7 1.6 1.7 11.1 0.0 6.2 0.8 0.0 7.5 2.0 0.0 1.0 2.6 8.4 1.7 3.1 3.2 1.8 25.5 6.5 2.3 5.9 10.2 1.8 2.9 3.5 2.3 3.0 ZNF607 "FLJ14802, MGC13071" ENSG00000198182 "Zinc finger protein 607" Q96SK3 19 37696363-37719790 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 25.9;Late spermatids: 20.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA049465, HPA055018" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA049465: AB_2680778, HPA055018: AB_2682674" "unprognostic (6.70e-2)" "unprognostic (8.00e-2)" "unprognostic (1.77e-3)" "unprognostic (2.69e-3)" "unprognostic (1.58e-1)" "unprognostic (9.23e-2)" "unprognostic (9.86e-3)" "unprognostic (2.15e-1)" "unprognostic (4.86e-2)" "unprognostic (1.95e-1)" "unprognostic (1.80e-3)" "unprognostic (1.68e-1)" "unprognostic (6.43e-3)" "unprognostic (3.86e-1)" "unprognostic (4.30e-2)" "unprognostic (5.03e-2)" "prognostic favorable (5.23e-5)" 3.1 5.4 8.1 4.2 9.0 1.4 7.7 14.9 9.4 5.9 4.9 9.8 4.6 3.9 9.0 8.0 5.6 10.8 4.2 5.6 7.0 6.6 5.9 1.6 4.7 5.6 12.3 7.2 12.2 5.0 14.0 12.3 6.1 9.3 7.2 4.9 6.7 4.4 6.2 4.4 7.9 4.6 8.4 11.3 5.5 5.5 13.9 8.7 7.3 9.1 2.4 7.2 5.5 6.0 5.7 3.0 2.8 0.4 3.8 5.3 1.5 5.1 5.3 8.4 8.8 4.6 5.3 5.9 3.7 3.7 3.5 6.3 8.1 2.9 7.2 5.6 4.0 4.6 2.6 8.2 2.8 5.3 3.6 8.4 3.5 4.5 4.4 3.7 0.1 2.2 3.5 5.6 4.2 4.0 5.1 1.8 4.8 7.3 0.0 3.8 4.4 7.0 3.9 9.9 3.6 2.2 3.4 13.0 1.9 3.7 6.7 2.4 7.6 0.2 2.2 0.7 6.4 5.9 0.6 0.4 2.6 1.8 3.0 4.3 7.3 7.9 10.2 0.1 0.0 3.3 0.0 0.4 2.8 2.7 0.3 1.7 5.7 4.2 5.3 1.5 4.2 3.6 4.4 0.0 3.8 0.4 3.0 1.5 1.5 8.1 9.0 14.9 9.4 7.0 6.6 12.3 7.2 9.3 8.7 3.0 0.3 0.0 0.7 1.1 2.5 3.0 0.0 8.1 2.3 1.8 2.0 1.9 0.0 1.5 25.9 1.4 0.7 0.0 1.1 2.1 0.9 0.9 0.0 0.4 1.2 1.6 0.0 1.3 0.0 20.8 0.9 1.0 3.3 1.0 1.7 2.0 0.7 0.0 1.8 1.0 1.3 0.0 1.3 2.9 5.3 1.0 0.7 1.3 1.2 0.7 ZNF608 "DKFZp434M098, KIAA1281, NY-REN-36" ENSG00000168916 "Zinc finger protein 608" Q9ULD9 5 124636913-124748807 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Club cells: 60.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.2;naive B-cell: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 25.1;AN3-CA: 16.0;REH: 43.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005545, HPA076984" Approved Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA005545: AB_1080742, HPA076984: " "unprognostic (3.82e-2)" "unprognostic (2.50e-2)" "unprognostic (1.92e-1)" "prognostic unfavorable (5.47e-4)" "unprognostic (3.75e-1)" "unprognostic (2.26e-1)" "unprognostic (3.04e-2)" "unprognostic (5.02e-2)" "unprognostic (7.52e-2)" "unprognostic (5.24e-2)" "unprognostic (3.67e-1)" "unprognostic (2.69e-2)" "prognostic unfavorable (1.28e-5)" "unprognostic (6.36e-2)" "unprognostic (2.80e-1)" "unprognostic (3.02e-1)" "unprognostic (9.56e-2)" 8.5 14.7 17.0 7.5 17.2 2.0 10.1 25.5 16.5 11.5 10.4 28.3 2.8 15.7 7.5 7.1 5.4 13.6 10.1 12.5 19.7 8.8 8.2 3.9 15.3 10.8 21.8 10.7 9.6 12.0 9.1 11.6 4.5 18.0 8.5 10.7 14.1 8.3 7.1 8.9 4.8 9.1 6.4 22.9 3.9 9.8 13.0 24.5 4.6 13.4 3.3 11.0 6.6 6.6 3.1 1.1 5.2 0.0 0.0 0.0 0.0 0.1 0.4 25.1 16.0 3.7 6.1 0.0 0.0 0.6 0.1 1.5 2.6 7.5 8.2 8.4 0.0 4.0 0.3 1.7 1.5 0.1 0.0 4.0 0.0 0.0 0.1 5.8 0.0 0.7 6.1 4.5 0.7 0.7 3.8 5.3 0.0 0.8 0.1 1.3 0.0 0.0 0.0 10.6 0.2 0.3 43.6 2.2 0.0 3.6 0.3 3.8 13.2 0.0 0.3 5.6 14.9 1.4 0.7 1.4 5.1 9.8 0.1 1.5 4.0 3.9 14.8 1.3 0.2 7.2 5.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 3.1 0.0 0.0 0.9 0.0 0.0 1.1 0.0 0.0 17.0 17.2 25.5 14.3 19.7 8.8 21.8 10.7 18.0 24.5 29.8 27.0 3.7 10.9 1.1 34.0 19.7 10.2 20.1 60.3 14.0 37.3 0.6 3.3 12.1 10.4 13.7 9.3 0.0 7.7 3.3 4.7 3.1 0.0 0.9 0.6 39.7 38.4 11.6 0.3 5.7 2.0 1.2 6.8 3.6 5.3 38.4 5.6 7.6 1.4 5.7 37.0 0.0 1.6 12.0 5.8 0.6 0.3 0.0 7.0 1.6 ZNF609 KIAA0295 ENSG00000180357 "Zinc finger protein 609" O15014 15 64460742-64686068 "Predicted intracellular proteins" "Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 133.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040742, HPA040832" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040742: AB_10963581, HPA040832: AB_10960400" "unprognostic (2.09e-1)" "unprognostic (1.17e-1)" "unprognostic (1.71e-1)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "unprognostic (2.48e-1)" "unprognostic (1.36e-1)" "unprognostic (1.47e-1)" "unprognostic (2.61e-1)" "unprognostic (3.11e-2)" "unprognostic (5.02e-2)" "unprognostic (7.21e-2)" "unprognostic (9.51e-2)" "unprognostic (2.17e-1)" "unprognostic (1.22e-1)" "unprognostic (1.37e-2)" "unprognostic (2.28e-1)" 11.1 11.2 14.5 14.5 12.6 7.3 11.4 17.1 15.1 17.9 14.2 16.2 19.1 12.1 18.7 8.4 10.2 15.7 14.0 10.9 12.3 10.4 9.1 10.2 13.9 11.3 10.9 11.0 29.9 11.6 18.1 11.6 16.3 10.9 15.2 11.4 14.6 12.6 22.8 9.2 11.9 11.2 16.1 12.7 12.9 11.4 28.9 13.6 21.4 12.4 4.5 12.1 15.6 28.4 1.2 2.8 3.2 1.7 4.0 3.0 0.5 6.1 15.6 16.9 6.4 6.5 8.3 5.8 8.1 10.8 10.2 10.3 9.6 9.8 10.6 6.8 9.5 13.9 13.2 24.7 11.1 10.7 12.3 5.3 19.4 9.0 4.7 12.0 11.1 13.0 8.4 10.2 10.6 21.0 14.8 18.8 9.1 30.4 6.9 8.3 5.6 8.6 4.7 12.8 8.3 4.4 7.9 15.4 5.5 7.4 11.1 13.7 10.5 11.0 12.6 7.5 16.9 6.2 7.8 18.7 9.5 15.2 4.9 10.0 7.7 8.7 9.6 5.9 12.2 7.7 3.2 1.7 1.9 2.3 0.7 1.6 0.7 1.3 1.6 0.6 1.2 3.0 3.0 2.1 4.0 0.8 2.8 0.8 0.5 14.5 12.6 17.1 15.1 12.3 10.4 10.9 11.0 10.9 13.6 11.9 20.1 6.1 13.9 16.0 28.1 18.3 17.8 30.8 25.0 17.4 133.5 12.7 3.3 12.3 17.2 14.4 9.9 0.0 12.8 11.9 12.1 18.2 9.3 11.6 8.7 42.9 17.9 17.8 23.1 9.6 16.7 11.6 13.5 9.0 10.8 19.5 11.6 11.5 13.1 3.1 56.5 19.4 9.2 31.7 14.0 15.2 26.1 13.3 10.5 15.6 ZNF610 FLJ36040 ENSG00000167554 "Zinc finger protein 610" Q8N9Z0 19 52336245-52367778 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Early spermatids: 28.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 11.7" "HPA055771, HPA078134" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA055771: AB_2682914, HPA078134: AB_2732372" "unprognostic (1.13e-1)" "unprognostic (5.48e-3)" "unprognostic (1.52e-1)" "unprognostic (8.75e-2)" "unprognostic (3.65e-2)" "unprognostic (1.27e-1)" "unprognostic (3.34e-1)" "unprognostic (2.84e-1)" "unprognostic (1.83e-1)" "prognostic favorable (3.38e-4)" "unprognostic (5.54e-2)" "unprognostic (1.14e-2)" "prognostic favorable (1.05e-7)" "unprognostic (2.46e-2)" "unprognostic (1.11e-2)" "unprognostic (1.88e-2)" "unprognostic (5.73e-3)" 2.3 4.8 7.9 2.1 11.9 0.8 5.5 11.0 9.7 5.5 3.0 6.9 3.3 1.5 5.1 11.7 2.1 7.4 4.3 4.2 7.6 7.7 5.9 1.0 3.3 2.6 7.5 7.2 14.3 2.9 7.5 6.8 4.5 10.0 7.6 2.9 5.7 2.2 4.1 1.9 1.6 1.8 4.4 8.5 4.1 2.7 18.1 7.3 3.6 7.7 0.2 2.1 3.6 2.4 3.6 1.5 4.0 0.5 2.5 4.8 1.6 0.2 0.0 6.0 4.9 4.0 3.4 4.6 1.8 3.3 1.1 3.3 0.0 0.4 0.4 3.7 0.8 7.4 0.2 0.0 0.0 2.8 0.1 2.9 0.1 0.3 0.2 4.8 0.0 1.5 4.6 0.1 1.2 0.2 2.9 3.4 3.3 0.3 0.2 5.4 1.2 3.1 0.9 5.7 0.0 0.4 2.2 4.5 0.6 2.1 4.3 7.5 4.3 0.1 0.4 1.8 8.9 3.6 2.6 2.7 0.3 2.0 0.1 2.3 0.2 11.7 0.0 0.0 0.1 2.3 4.0 0.5 1.1 2.9 0.1 4.4 2.5 2.4 2.3 1.4 3.6 4.8 2.0 1.4 2.5 0.1 1.5 3.2 1.6 7.9 11.9 11.0 9.7 7.6 7.7 7.5 7.2 10.0 7.3 0.0 0.3 0.0 0.8 0.0 2.9 2.6 2.5 2.7 3.4 3.5 3.9 1.2 5.0 1.6 28.1 1.1 0.0 0.0 0.0 1.4 0.8 0.9 2.3 0.0 0.5 0.0 0.0 0.6 0.8 7.0 0.9 0.0 1.7 0.0 0.0 3.8 0.2 0.0 1.1 0.6 2.4 6.5 0.4 5.0 2.3 0.3 0.6 0.0 0.4 0.3 ZNF613 FLJ13590 ENSG00000176024 "Zinc finger protein 613" Q6PF04 19 51927147-51948759 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 25.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026833 Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA026833: AB_1859377" "unprognostic (1.10e-1)" "unprognostic (2.57e-1)" "unprognostic (9.27e-2)" "unprognostic (2.84e-1)" "unprognostic (9.31e-3)" "unprognostic (1.79e-1)" "unprognostic (2.25e-2)" "unprognostic (1.08e-1)" "unprognostic (1.33e-2)" "unprognostic (1.91e-1)" "unprognostic (2.73e-1)" "unprognostic (5.30e-2)" "unprognostic (5.30e-3)" "unprognostic (1.12e-1)" "unprognostic (1.79e-1)" "unprognostic (4.78e-3)" "prognostic favorable (1.92e-6)" 4.7 5.3 7.1 3.9 7.4 1.6 9.5 14.2 7.4 5.3 6.5 5.2 1.9 2.8 5.5 5.3 4.7 4.3 3.7 4.3 9.7 4.7 8.7 4.0 4.9 6.3 7.2 4.9 6.5 3.4 7.4 7.0 8.2 8.8 25.4 6.7 5.4 4.5 5.6 3.9 4.5 4.9 5.8 7.5 6.7 4.2 3.5 7.0 9.0 7.3 2.6 5.2 5.8 4.1 10.1 9.6 14.1 11.3 9.5 14.3 7.0 3.1 4.1 6.8 6.8 5.9 6.8 1.7 5.2 8.4 7.0 9.1 1.3 3.7 2.6 2.8 6.5 6.2 3.5 6.6 6.5 7.6 0.1 8.6 5.5 2.9 3.9 6.1 0.3 7.8 5.0 7.5 6.6 5.4 8.6 7.5 6.5 2.5 0.0 7.0 0.5 9.1 4.0 4.9 1.3 5.9 5.0 7.3 2.8 6.8 10.7 4.6 4.5 8.5 6.2 5.0 11.2 6.5 6.7 4.8 3.1 5.8 2.3 5.6 6.0 0.0 5.1 0.2 0.0 9.2 7.7 7.4 14.1 10.4 7.5 9.3 7.6 11.1 12.1 9.6 10.1 11.2 14.3 7.6 9.5 11.3 4.8 10.0 7.0 7.1 7.4 14.2 7.4 9.7 4.7 7.2 4.9 8.8 7.0 3.0 1.6 0.0 0.5 0.5 2.1 3.1 2.5 0.0 3.4 3.5 0.0 4.9 3.3 2.1 2.0 2.4 1.0 0.0 1.9 1.5 0.9 1.1 1.1 1.5 2.6 0.0 1.2 1.8 1.8 0.4 1.1 1.1 0.0 3.6 2.9 2.2 1.7 2.8 1.4 1.4 4.2 0.0 0.5 1.6 1.1 0.5 5.9 0.9 1.7 0.5 ZNF614 FLJ21941 ENSG00000142556 "Zinc finger protein 614" Q8N883 19 52012765-52030240 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 37.9;Late spermatids: 32.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021197 Uncertain Approved Nucleoplasm,Vesicles,Cytosol No No Nucleoplasm "Vesicles, Cytosol" "HPA021197: AB_1859380" "unprognostic (1.30e-1)" "unprognostic (2.37e-2)" "unprognostic (3.24e-2)" "unprognostic (1.30e-1)" "unprognostic (7.67e-3)" "unprognostic (2.68e-1)" "unprognostic (4.74e-3)" "unprognostic (5.07e-3)" "unprognostic (1.09e-1)" "unprognostic (1.32e-1)" "unprognostic (1.60e-1)" "unprognostic (1.74e-2)" "unprognostic (1.66e-2)" "unprognostic (3.06e-2)" "unprognostic (1.57e-1)" "unprognostic (2.30e-1)" "unprognostic (7.15e-3)" 7.7 7.1 9.9 5.6 9.4 10.1 10.1 15.6 12.5 9.2 7.3 6.6 5.8 4.5 9.5 7.3 6.3 8.8 6.0 7.0 7.9 8.5 6.9 4.7 6.3 8.2 9.3 7.1 14.0 5.1 6.5 13.7 14.2 9.7 16.4 5.5 5.5 5.4 8.9 11.1 7.6 6.3 8.9 13.5 9.7 5.8 13.8 10.7 18.2 14.3 5.1 7.5 8.5 9.6 6.0 5.5 4.3 5.9 9.6 8.1 3.2 3.8 2.9 7.4 9.5 5.2 5.9 1.0 5.2 3.7 4.9 5.9 3.7 2.2 9.7 2.9 4.4 4.5 1.7 10.8 6.9 7.2 2.6 15.5 14.6 5.2 7.3 4.3 3.0 7.4 4.5 3.8 4.9 6.9 4.9 5.6 8.6 7.7 2.2 6.4 1.5 12.5 6.0 8.4 0.6 5.2 8.3 14.1 8.0 5.0 9.8 9.9 5.9 3.1 3.9 3.2 9.5 5.2 7.7 5.7 4.8 6.6 2.7 6.2 4.4 6.8 14.9 4.6 4.2 6.3 4.3 4.3 3.0 6.5 5.9 7.8 6.0 5.7 6.1 5.5 6.0 8.1 5.3 3.3 9.6 4.5 3.1 5.9 3.2 9.9 9.4 15.6 12.5 7.9 8.5 9.3 7.1 9.7 10.7 0.0 2.1 0.9 3.8 2.9 5.5 5.3 2.5 0.0 6.8 5.2 3.9 4.6 0.0 2.4 37.9 4.4 1.6 0.0 0.8 4.7 3.7 3.9 6.9 1.5 2.1 15.9 5.2 5.5 6.4 32.8 3.7 2.2 1.7 1.0 2.0 4.1 1.0 0.0 6.7 1.8 5.1 0.0 6.4 2.2 4.7 2.4 12.0 2.5 2.2 4.4 ZNF618 "KIAA1952, NEDD10" ENSG00000157657 "Zinc finger protein 618" Q5T7W0 9 113876282-114056591 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 55.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 20.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023116, HPA061732" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA023116: AB_10964204, HPA061732: AB_2684596" "unprognostic (1.92e-1)" "unprognostic (3.22e-2)" "unprognostic (2.29e-2)" "unprognostic (4.17e-3)" "prognostic unfavorable (6.34e-4)" "unprognostic (3.07e-1)" "unprognostic (1.04e-1)" "unprognostic (3.61e-1)" "unprognostic (6.43e-2)" "unprognostic (2.38e-2)" "unprognostic (1.56e-2)" "unprognostic (8.24e-2)" "prognostic favorable (5.22e-7)" "unprognostic (4.57e-2)" "unprognostic (2.79e-1)" "unprognostic (1.04e-1)" "unprognostic (3.51e-2)" 5.2 7.5 5.0 8.1 5.2 3.4 6.1 19.2 5.0 9.3 3.6 5.4 4.0 3.3 11.5 7.3 3.5 8.4 12.1 3.1 4.3 3.8 13.3 8.2 5.2 3.0 2.8 3.3 15.0 13.3 15.8 11.6 3.2 4.8 5.9 2.5 14.5 6.0 4.8 3.1 3.4 2.6 6.9 2.7 5.4 6.4 5.6 2.4 5.6 10.9 2.6 3.0 4.3 6.6 1.3 4.3 4.0 0.9 2.8 0.9 0.9 4.4 13.6 20.4 8.9 4.9 5.8 1.0 2.9 4.8 5.9 5.2 0.1 3.2 2.4 2.8 5.0 1.6 0.1 10.2 5.0 2.3 0.0 4.0 0.0 1.0 0.0 3.7 2.6 4.6 5.6 2.0 6.2 1.4 5.4 14.8 0.3 0.0 0.0 2.6 7.2 0.1 3.3 10.1 0.3 3.0 18.8 11.9 0.0 6.3 4.9 6.3 15.0 8.3 5.3 5.4 6.1 0.4 5.3 12.0 7.9 6.3 4.4 3.5 0.0 0.0 0.0 0.6 4.0 5.5 4.0 0.9 0.6 0.9 0.5 0.3 0.0 0.1 0.8 3.4 1.3 0.7 0.5 0.0 2.8 0.7 4.3 0.0 0.9 5.0 5.2 19.2 5.0 4.3 3.8 2.8 3.3 4.8 2.4 3.0 10.4 0.8 4.7 1.8 14.0 2.4 28.1 2.7 4.5 10.4 3.9 0.2 6.6 11.5 5.1 3.0 0.0 0.0 7.0 0.2 5.8 2.0 20.7 7.8 3.6 55.6 2.4 12.3 3.3 3.3 14.1 6.0 0.0 18.0 1.4 9.1 9.6 1.9 14.5 8.4 1.1 25.8 11.3 0.1 13.2 3.1 0.2 2.2 2.3 1.6 ZNF619 FLJ90764 ENSG00000177873 "Zinc finger protein 619" Q8N2I2 3 40477113-40490236 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 3.8;Collecting duct cells: 3.5;Rod photoreceptor cells: 3.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045094 Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA Nucleoplasm "Intermediate filaments" "HPA045094: AB_10959900" "unprognostic (7.16e-2)" "unprognostic (5.94e-1)" "unprognostic (8.38e-3)" "unprognostic (5.42e-2)" "unprognostic (8.16e-3)" "unprognostic (1.32e-2)" "unprognostic (5.59e-2)" "unprognostic (1.85e-1)" "unprognostic (5.46e-2)" "unprognostic (2.65e-1)" "unprognostic (7.99e-2)" "unprognostic (6.15e-3)" "unprognostic (8.28e-6)" "unprognostic (1.94e-1)" "unprognostic (1.69e-1)" "unprognostic (6.56e-2)" "unprognostic (1.38e-2)" 8.8 7.6 6.3 9.2 9.5 9.0 9.2 7.9 8.7 7.0 6.7 13.3 8.4 7.3 9.3 6.6 6.4 8.4 8.9 6.9 7.8 5.8 7.1 8.1 9.6 18.0 12.7 9.2 9.4 12.3 14.0 6.6 6.3 7.3 7.0 8.2 9.7 8.6 10.4 8.5 7.3 7.5 7.6 9.6 9.0 7.3 3.8 9.3 6.0 10.2 5.0 9.4 8.0 6.8 4.1 4.5 5.1 4.5 5.2 5.1 2.7 2.7 4.0 4.7 4.1 6.9 7.2 1.7 3.6 4.5 7.0 7.0 1.2 3.9 0.3 2.3 3.4 3.2 3.0 4.3 7.5 7.6 4.8 1.6 8.3 3.2 1.9 7.2 5.8 7.5 5.8 5.6 7.1 10.5 6.2 6.5 0.3 5.5 3.9 4.3 3.4 0.1 2.6 2.5 3.4 3.6 1.6 4.8 4.5 2.9 6.3 3.0 3.1 4.1 6.0 3.2 4.4 4.8 3.9 4.9 5.1 4.0 2.8 4.1 2.2 2.8 0.3 3.1 3.6 5.4 2.8 3.2 5.1 3.0 4.5 3.3 3.3 3.0 3.8 4.5 4.1 3.1 3.9 3.8 5.2 4.3 2.8 5.1 2.7 6.3 9.5 7.9 8.7 7.8 5.8 12.7 9.2 7.3 9.3 0.0 0.6 0.0 0.7 0.2 3.8 0.8 0.0 1.4 0.0 3.5 2.0 1.2 0.0 1.1 0.0 1.1 1.0 0.0 1.3 0.8 0.6 0.5 0.0 0.5 1.0 0.0 0.0 1.8 1.0 0.0 1.1 0.2 0.0 1.0 0.7 2.9 0.6 0.0 0.4 1.3 3.7 0.0 0.5 1.0 1.3 0.1 0.3 0.0 1.0 0.6 ZNF622 "MGC17552, MGC2485, ZPR9" ENSG00000173545 "Zinc finger protein 622" Q969S3 5 16451519-16465792 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036514, HPA036515" Uncertain Supported "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "Nucleoplasm, Nucleoli" "HPA036514: AB_2675167, HPA036515: AB_10672224" "unprognostic (6.29e-2)" "unprognostic (1.32e-1)" "unprognostic (1.60e-1)" "unprognostic (1.00e-2)" "unprognostic (6.53e-2)" "unprognostic (8.24e-3)" "unprognostic (4.71e-3)" "unprognostic (1.06e-1)" "unprognostic (1.71e-1)" "unprognostic (3.14e-2)" "unprognostic (1.62e-1)" "unprognostic (8.69e-2)" "unprognostic (5.93e-2)" "unprognostic (2.19e-1)" "unprognostic (7.42e-2)" "unprognostic (1.21e-1)" "unprognostic (2.78e-1)" 14.3 10.8 18.3 12.1 19.4 28.8 14.8 20.5 20.3 12.6 19.5 14.5 9.5 15.5 14.4 16.9 13.6 13.2 12.3 38.6 13.8 14.6 14.8 18.8 12.8 14.5 16.8 15.5 15.1 45.9 12.5 15.0 16.0 17.2 13.1 19.8 10.9 17.5 12.8 29.0 18.6 19.6 12.6 12.8 12.4 15.9 14.1 17.3 14.0 16.7 11.9 15.4 13.7 14.9 50.4 45.6 55.4 45.9 39.1 56.9 47.2 11.0 24.3 7.6 15.7 18.7 16.0 27.7 20.0 15.2 16.3 20.9 28.8 10.3 13.0 27.1 15.8 22.0 14.7 12.2 15.6 13.2 17.5 16.6 11.9 43.1 20.6 26.9 23.0 14.3 24.6 19.8 15.2 14.4 12.7 11.4 7.8 16.0 12.9 17.9 18.7 12.0 22.5 13.4 10.5 24.1 9.5 9.3 11.1 15.1 16.7 10.6 11.9 27.9 21.0 32.4 13.9 11.6 17.9 15.5 18.3 13.9 17.7 12.6 18.7 16.7 18.2 15.9 20.0 12.7 45.2 41.6 52.9 49.1 43.4 51.2 50.4 49.5 53.7 45.6 47.0 56.9 47.7 55.4 39.1 45.9 37.0 50.1 47.2 18.3 19.4 20.5 20.3 13.8 14.6 16.8 15.5 17.2 17.3 20.8 24.5 31.7 36.6 53.9 21.6 68.8 12.7 22.7 19.4 14.0 9.8 53.3 23.2 49.8 98.2 21.5 74.9 0.0 58.2 46.3 35.5 23.5 50.8 21.9 45.1 15.9 94.5 9.8 15.4 46.0 16.7 31.7 32.1 49.5 33.2 20.1 47.9 129.6 18.7 30.7 15.9 19.4 31.6 40.3 26.2 37.8 34.0 30.9 34.7 29.6 ZNF623 KIAA0628 ENSG00000183309 "Zinc finger protein 623" O75123 8 143636013-143656418 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 13.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SiHa: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044372 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA044372: AB_10966790" "unprognostic (1.06e-3)" "unprognostic (1.38e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (2.94e-4)" "unprognostic (1.44e-1)" "unprognostic (8.67e-2)" "unprognostic (4.00e-3)" "unprognostic (6.95e-2)" "unprognostic (2.71e-1)" "unprognostic (1.55e-1)" "unprognostic (1.66e-1)" "unprognostic (2.25e-1)" "unprognostic (1.36e-1)" "unprognostic (2.08e-1)" "unprognostic (1.82e-1)" "unprognostic (5.21e-2)" "unprognostic (8.03e-2)" 9.4 8.7 10.4 10.2 14.1 5.3 11.3 18.2 16.7 14.5 10.7 12.2 10.3 12.1 15.0 11.2 10.3 10.8 10.5 10.0 9.6 9.1 8.1 8.6 10.1 10.9 8.8 14.5 17.7 10.4 9.5 9.9 8.6 11.9 12.4 9.8 8.5 12.0 8.5 11.7 14.0 12.0 12.0 8.3 10.7 8.6 11.2 10.2 12.3 12.6 6.5 11.4 11.7 12.5 2.9 1.3 13.5 3.6 2.0 3.3 1.1 3.3 4.8 3.8 6.1 4.1 6.7 3.5 1.9 3.8 4.1 0.7 3.0 6.0 1.3 2.7 7.1 7.0 2.3 5.8 1.9 3.7 5.5 2.2 7.9 7.7 1.7 3.4 1.3 2.2 3.6 4.6 2.2 10.9 5.5 3.5 7.3 7.7 5.4 4.8 8.9 7.8 2.0 4.5 6.4 17.5 4.5 1.9 8.4 3.1 2.9 5.9 7.5 19.3 4.2 5.2 6.2 6.6 5.0 1.0 7.4 1.2 1.1 2.0 1.5 1.7 4.5 3.4 2.3 4.3 13.5 1.0 3.5 2.6 1.3 1.4 2.7 1.7 1.3 1.3 2.9 3.3 2.5 1.8 2.0 3.6 1.2 1.8 1.1 10.4 14.1 18.2 16.7 9.6 9.1 8.8 14.5 11.9 10.2 6.0 4.6 5.4 3.1 1.4 5.7 9.3 10.2 1.4 1.2 7.0 5.9 5.0 3.3 5.4 3.0 4.5 4.3 0.0 3.2 4.9 3.1 3.1 1.1 5.1 4.8 14.3 5.2 7.4 8.7 2.8 7.8 2.8 3.3 7.2 5.0 7.4 3.9 0.0 13.1 3.7 6.8 19.4 2.0 5.9 12.2 2.3 4.0 4.4 5.0 1.6 ZNF625 ENSG00000257591 "Zinc finger protein 625" Q96I27 19 12142090-12156729 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 9.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA074014 Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA074014: AB_2686652" "unprognostic (7.88e-3)" "unprognostic (6.74e-2)" "unprognostic (9.56e-2)" "unprognostic (8.75e-2)" "unprognostic (7.21e-3)" "unprognostic (6.11e-3)" "unprognostic (4.72e-2)" "unprognostic (3.31e-2)" "unprognostic (6.23e-2)" "unprognostic (2.73e-1)" "unprognostic (5.49e-2)" "unprognostic (3.70e-2)" "unprognostic (8.29e-2)" "unprognostic (4.41e-2)" "unprognostic (1.50e-1)" "unprognostic (6.98e-2)" "unprognostic (1.62e-1)" 4.9 5.2 6.7 3.4 5.4 3.8 8.5 11.2 8.3 7.2 5.1 5.6 7.5 2.8 8.3 10.6 4.7 6.0 4.7 3.7 6.0 8.8 6.0 2.8 4.8 5.2 6.6 5.5 13.1 5.4 6.9 9.4 6.4 6.4 7.3 3.5 7.5 4.0 7.1 2.0 7.3 3.3 6.6 4.7 5.8 3.8 4.6 2.9 1.0 8.7 3.2 3.9 7.3 7.2 1.4 0.4 1.3 0.5 2.9 2.1 0.7 0.7 0.0 6.5 10.8 2.8 2.0 1.1 2.7 3.5 4.0 4.4 0.1 0.2 0.0 5.0 2.1 3.0 0.6 0.0 3.5 3.8 0.0 2.0 2.9 0.0 2.9 1.3 0.2 4.1 1.7 1.4 3.3 2.1 2.8 3.1 0.2 0.0 0.0 6.0 2.1 0.1 1.3 7.8 0.0 3.9 0.2 5.8 0.0 3.4 8.7 4.4 3.0 0.0 0.1 2.2 8.3 4.7 0.2 2.4 9.3 4.2 6.9 3.6 7.1 5.6 0.0 2.2 0.0 3.3 0.7 0.4 0.2 0.7 0.5 0.9 0.5 1.0 1.2 0.4 1.4 1.5 1.2 1.3 2.9 0.1 0.3 2.1 0.7 6.7 5.4 11.2 6.8 6.0 8.8 6.6 5.5 6.4 2.9 3.0 1.0 0.0 0.5 0.3 5.4 0.0 5.1 4.0 0.0 1.8 9.8 3.6 3.3 2.8 0.1 1.5 0.0 0.0 2.7 3.1 1.9 0.5 0.0 0.6 1.2 4.8 1.2 6.2 4.5 1.3 0.6 1.0 0.0 2.8 0.3 4.4 3.1 1.7 1.4 2.1 8.7 0.0 2.3 1.9 8.3 0.6 1.0 0.0 1.2 0.3 ZNF626 ENSG00000188171 "Zinc finger protein 626" Q68DY1 19 20620061-20661596 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 13.8" HPA045631 Uncertain Approved "Nucleoplasm,Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" Nucleoplasm "HPA045631: AB_2679397" "unprognostic (1.75e-1)" "unprognostic (4.38e-2)" "unprognostic (3.58e-2)" "unprognostic (1.04e-1)" "unprognostic (2.53e-2)" "unprognostic (2.18e-2)" "unprognostic (6.24e-2)" "unprognostic (2.95e-2)" "unprognostic (1.23e-2)" "unprognostic (6.51e-3)" "unprognostic (1.92e-1)" "unprognostic (2.49e-1)" "unprognostic (5.10e-2)" "unprognostic (1.73e-2)" "unprognostic (1.05e-1)" "unprognostic (2.12e-2)" "unprognostic (2.31e-1)" 8.1 13.9 10.2 6.0 15.6 4.1 18.5 15.2 14.8 11.2 8.3 12.0 21.6 2.4 13.0 9.5 8.0 14.0 10.7 10.8 10.1 10.1 12.7 6.5 7.2 12.4 10.9 11.1 29.2 9.6 36.3 14.8 8.3 11.0 12.8 4.4 13.6 8.9 23.9 7.3 10.8 6.0 11.9 12.1 7.8 9.1 5.8 11.9 13.6 26.9 4.9 10.7 21.3 9.7 11.4 4.2 11.6 4.3 9.1 8.6 4.2 0.1 0.0 4.3 0.7 5.3 6.9 0.5 4.9 0.5 7.0 6.2 0.2 0.2 0.7 2.6 6.0 8.1 0.8 0.0 0.2 8.9 0.0 0.2 0.0 0.1 1.7 9.4 0.1 0.1 12.9 2.2 4.1 2.2 0.2 3.3 0.2 3.0 0.5 7.3 0.1 0.8 1.1 9.3 0.0 2.2 4.3 3.2 1.6 7.0 5.3 1.5 8.3 0.2 0.5 4.4 8.7 10.3 0.4 0.0 3.2 0.2 12.7 0.5 6.9 13.8 6.2 0.1 0.1 0.5 0.8 1.1 6.0 7.6 1.0 7.3 7.9 8.0 8.6 3.2 11.4 7.7 6.6 11.6 9.1 4.3 4.2 3.7 4.2 10.2 15.6 15.2 14.8 10.1 10.1 10.9 11.1 11.0 11.9 3.0 8.0 18.2 11.4 8.4 11.1 9.0 10.2 12.0 4.5 26.2 9.8 14.9 26.6 6.8 0.8 9.0 0.0 0.0 8.4 19.4 10.3 16.3 6.9 6.4 9.3 12.7 2.4 19.0 3.1 1.5 17.3 6.3 5.0 3.6 0.7 14.2 7.6 0.0 14.5 21.3 7.9 12.9 9.2 7.2 15.8 11.0 36.3 10.1 0.1 13.4 ZNF627 FLJ90365 ENSG00000198551 "Zinc finger protein 627" Q7L945 19 11559374-11619135 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA049770, HPA073463" Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA049770: AB_2680871, HPA073463: AB_2686606" "unprognostic (1.81e-1)" "unprognostic (9.89e-2)" "unprognostic (1.64e-2)" "unprognostic (3.14e-2)" "unprognostic (7.89e-3)" "prognostic favorable (8.12e-4)" "unprognostic (2.81e-1)" "unprognostic (1.00e-1)" "unprognostic (1.83e-3)" "unprognostic (3.17e-2)" "unprognostic (2.03e-1)" "unprognostic (1.67e-2)" "prognostic favorable (6.93e-7)" "unprognostic (2.10e-1)" "unprognostic (1.00e-1)" "unprognostic (3.91e-1)" "unprognostic (6.39e-3)" 10.3 8.4 9.9 10.1 11.1 10.5 17.5 15.6 12.8 13.8 9.2 11.1 15.4 8.1 16.7 14.6 7.9 19.4 10.1 8.4 9.2 10.0 15.4 11.0 9.6 10.3 12.3 10.0 20.9 19.7 9.3 17.8 9.8 10.3 13.4 11.0 12.5 11.6 14.8 7.7 10.1 8.5 14.1 9.6 9.9 9.2 12.1 11.8 17.4 19.9 7.8 11.3 11.9 13.8 10.2 8.0 13.4 5.6 7.9 8.9 4.8 4.7 3.9 12.8 15.7 5.8 6.1 7.2 7.0 8.3 8.0 8.2 3.2 3.3 3.5 7.1 5.5 4.1 4.3 5.1 6.9 9.1 6.3 2.3 9.9 2.5 6.2 10.9 5.6 5.7 7.3 9.9 5.5 12.2 12.5 8.8 9.0 9.3 5.1 10.6 9.8 9.0 5.6 9.4 3.2 8.6 10.0 9.6 4.8 9.1 7.5 17.7 12.8 9.2 5.2 9.8 11.4 9.1 15.9 7.8 8.7 4.0 4.9 4.9 7.2 7.0 3.9 4.0 9.3 7.1 13.4 4.9 7.8 5.4 5.6 6.4 10.2 6.6 6.6 8.0 6.9 8.9 7.9 2.6 7.9 5.3 3.1 3.6 4.8 9.9 11.1 15.6 12.8 9.2 10.0 12.3 10.0 10.3 11.8 11.9 5.1 11.9 3.2 1.1 4.7 11.5 10.2 9.4 1.2 8.7 3.9 4.3 14.9 4.7 6.0 3.2 3.2 0.0 2.1 3.5 3.3 4.2 1.1 5.3 2.8 6.4 5.1 4.3 5.7 2.4 4.9 2.1 0.0 3.6 3.8 5.5 4.0 3.5 4.9 6.0 5.6 0.0 4.1 14.4 3.9 2.4 3.9 3.2 3.7 2.6 ZNF628 "ZEC, Zfp628" ENSG00000197483 "Zinc finger protein 628" Q5EBL2 19 55476332-55484487 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 25.5;Late spermatids: 72.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044451 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA044451: AB_10962507" "unprognostic (8.70e-2)" "unprognostic (5.08e-1)" "unprognostic (8.30e-2)" "unprognostic (1.81e-1)" "unprognostic (4.65e-2)" "unprognostic (2.35e-2)" "unprognostic (2.13e-2)" "unprognostic (5.19e-2)" "unprognostic (3.10e-1)" "unprognostic (7.15e-2)" "unprognostic (4.58e-3)" "unprognostic (3.23e-2)" "unprognostic (1.06e-1)" "unprognostic (1.42e-1)" "unprognostic (2.66e-1)" "unprognostic (3.49e-2)" "unprognostic (4.88e-3)" 6.8 4.7 3.6 6.0 5.0 9.8 5.0 4.1 10.5 5.5 5.8 5.2 5.6 8.4 6.9 4.7 5.0 5.7 4.8 4.3 2.4 2.4 5.4 10.0 5.5 5.4 1.9 4.9 7.6 6.8 2.8 5.9 6.9 4.6 6.2 2.0 5.4 5.7 5.0 15.0 7.3 7.0 4.9 2.0 7.2 8.0 20.8 2.1 12.1 5.0 5.0 7.5 6.2 4.4 0.6 1.0 0.5 2.3 0.4 1.0 0.3 6.7 4.2 1.0 2.9 0.5 1.3 8.2 4.7 0.9 1.7 1.3 2.6 2.9 6.3 4.6 0.8 1.3 3.9 0.5 2.8 0.2 6.5 15.9 4.4 3.8 2.3 1.8 3.4 11.4 1.0 1.8 1.2 0.7 0.8 1.2 3.8 6.5 3.4 0.6 4.5 4.9 2.3 4.5 1.9 8.4 9.2 1.6 6.0 1.4 4.2 5.2 5.7 3.5 4.0 5.9 0.3 4.0 5.3 2.9 3.0 4.5 3.0 4.8 8.0 6.9 4.9 3.9 2.5 2.9 0.0 0.7 0.5 0.7 0.2 0.5 0.6 1.0 0.6 0.7 0.2 0.3 0.4 0.5 0.4 2.3 1.0 0.0 0.3 3.6 5.0 4.1 10.5 2.4 2.4 1.9 4.9 4.6 2.1 0.0 1.4 5.9 6.4 4.4 4.5 2.0 2.5 0.0 0.0 3.5 3.9 2.9 8.3 2.3 25.5 2.1 5.5 0.0 3.1 2.6 2.8 3.5 13.8 2.6 2.8 4.8 6.9 2.5 1.8 72.4 5.2 2.9 3.3 0.0 4.5 3.8 4.1 5.1 4.2 2.8 2.7 12.9 3.2 4.2 3.6 4.0 4.6 3.8 4.2 4.3 ZNF629 "KIAA0326, ZNF65" ENSG00000102870 "Zinc finger protein 629" Q9UEG4 16 30778449-30787202 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 24.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019550, HPA056051" Uncertain Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA019550: AB_1859386, HPA056051: AB_2683020" "unprognostic (1.03e-2)" "unprognostic (2.15e-2)" "unprognostic (1.24e-1)" "unprognostic (2.67e-1)" "unprognostic (3.17e-1)" "unprognostic (6.38e-2)" "unprognostic (6.14e-2)" "unprognostic (2.98e-2)" "unprognostic (3.15e-1)" "unprognostic (6.24e-2)" "unprognostic (4.87e-3)" "unprognostic (2.66e-2)" "prognostic favorable (4.57e-10)" "unprognostic (8.41e-2)" "unprognostic (1.96e-1)" "unprognostic (5.71e-2)" "unprognostic (9.70e-2)" 8.6 12.8 8.4 5.2 12.7 6.3 9.4 15.1 21.1 11.3 9.8 16.4 8.2 9.4 13.6 8.4 7.4 11.9 9.2 19.5 9.0 7.7 10.9 8.2 9.0 3.4 9.4 7.9 15.6 8.9 30.2 9.1 6.5 12.2 9.6 8.1 14.8 10.4 11.5 14.0 12.0 10.3 11.9 7.6 6.7 10.5 6.4 8.9 11.8 9.9 10.2 6.7 11.2 7.4 0.3 2.9 0.8 1.6 1.4 1.3 0.7 6.2 10.3 16.1 12.4 7.9 7.4 2.4 7.1 10.4 11.2 9.5 6.3 5.8 1.1 6.9 11.5 3.5 7.5 7.8 9.4 7.5 0.2 11.7 8.8 9.1 6.5 8.5 3.1 5.4 12.2 7.1 6.9 5.8 8.8 5.9 0.5 12.8 0.2 9.7 13.4 4.6 4.1 8.4 3.0 4.3 15.6 12.4 0.5 9.4 10.4 15.3 17.1 6.9 13.0 1.7 5.5 9.7 11.3 7.1 10.6 6.9 7.1 5.3 0.2 0.0 0.3 6.9 7.8 3.5 0.0 1.6 0.8 0.3 0.2 0.5 0.2 0.3 0.2 1.3 0.3 1.3 1.0 0.1 1.4 0.4 2.9 0.0 0.7 8.4 12.7 15.1 21.1 9.0 7.7 9.4 7.9 12.2 8.9 17.9 10.3 2.0 2.8 1.6 16.3 24.6 5.1 6.7 7.9 8.7 3.9 1.0 1.7 7.0 1.1 6.8 4.3 0.0 6.9 0.3 3.3 3.0 2.3 3.8 3.7 15.9 11.1 6.7 4.1 2.4 8.6 2.5 1.7 10.8 6.2 11.3 9.0 3.5 4.2 3.3 11.1 0.0 3.4 2.6 1.7 1.6 0.5 0.0 9.5 3.4 ZNF630 "BC037316, dJ54B20.2, FLJ20573, MGC138344" ENSG00000221994 "Zinc finger protein 630" Q2M218 X 47983356-48071658 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 9 "Intestinal endocrine cells: 4.1;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001053, HPA068130" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA001053: AB_2666183, HPA068130: AB_2685961" "unprognostic (1.03e-1)" "unprognostic (2.73e-1)" "unprognostic (1.42e-1)" "unprognostic (1.65e-1)" "unprognostic (8.09e-2)" "unprognostic (5.86e-3)" "unprognostic (5.83e-2)" "unprognostic (9.06e-3)" "unprognostic (8.68e-2)" "unprognostic (5.83e-2)" "unprognostic (2.14e-2)" "unprognostic (7.92e-2)" "unprognostic (6.07e-3)" "unprognostic (5.92e-2)" "unprognostic (1.31e-1)" "unprognostic (3.27e-1)" "unprognostic (7.51e-5)" 4.0 5.2 5.3 6.4 9.0 2.1 6.7 8.8 8.5 7.0 5.4 5.9 11.3 3.5 6.3 7.5 5.0 4.8 5.8 5.9 6.0 4.6 5.2 3.0 5.0 5.4 12.3 5.8 11.2 8.3 11.9 10.1 4.9 8.8 8.4 6.2 6.4 6.1 6.9 2.3 4.0 4.2 7.5 7.3 4.8 6.8 1.8 10.1 1.0 9.3 1.5 3.6 8.4 13.7 2.6 3.8 5.8 1.9 1.5 2.8 2.0 1.4 1.1 0.3 0.0 0.1 0.1 0.0 1.9 0.6 1.0 0.9 3.3 5.4 0.1 1.0 2.0 2.3 2.3 0.0 1.0 1.3 0.0 0.0 0.0 1.4 0.0 1.4 0.0 0.0 1.3 5.6 3.2 0.0 3.9 1.0 0.0 0.0 5.4 3.6 5.7 0.0 0.0 2.1 4.8 1.6 0.7 1.2 0.0 2.5 3.0 3.2 2.6 7.0 4.8 2.1 5.0 5.7 1.3 1.2 0.0 2.5 2.5 0.0 0.0 4.7 0.0 0.0 0.1 4.5 5.8 1.9 4.8 2.2 1.0 2.4 2.6 2.0 2.0 3.8 1.8 2.5 2.8 2.1 1.5 0.6 0.9 1.1 2.0 5.3 9.0 8.8 8.5 6.0 4.6 12.3 5.8 8.8 10.1 0.0 0.0 0.0 1.0 0.1 2.1 1.0 0.0 0.0 0.0 1.8 0.0 0.1 1.7 1.2 0.0 0.6 0.7 0.0 1.0 0.7 0.6 0.9 0.0 0.0 0.8 0.0 4.1 2.5 0.0 0.0 0.3 0.0 0.0 1.0 1.4 1.1 0.8 0.0 0.4 0.6 0.9 6.5 1.0 0.1 0.5 0.3 0.2 0.8 1.0 0.7 ZNF638 "MGC26130, NP220, ZFML, Zfp638" ENSG00000075292 "Zinc finger protein 638" Q14966 2 71276561-71435069 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036784, HPA057395" Supported Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA036784: AB_10672478, HPA057395: AB_2683426" "unprognostic (2.58e-2)" "unprognostic (3.15e-1)" "unprognostic (7.57e-2)" "unprognostic (1.26e-3)" "unprognostic (2.18e-2)" "unprognostic (1.29e-1)" "unprognostic (1.35e-2)" "unprognostic (5.68e-3)" "unprognostic (2.31e-2)" "unprognostic (1.11e-1)" "unprognostic (1.69e-1)" "unprognostic (1.32e-1)" "unprognostic (2.66e-3)" "unprognostic (3.28e-1)" "unprognostic (7.68e-2)" "unprognostic (1.93e-2)" "prognostic favorable (8.73e-5)" 20.7 19.1 22.4 14.9 26.0 18.7 19.8 51.3 25.5 19.8 19.7 23.4 13.0 11.3 26.0 14.8 17.3 20.1 14.3 16.0 20.1 11.9 18.7 22.9 16.4 16.9 25.4 19.9 31.1 15.4 28.9 46.7 16.9 23.9 17.2 14.7 14.1 20.6 15.5 33.2 16.9 15.8 18.4 22.7 16.0 17.3 21.0 29.7 26.0 22.5 11.2 16.1 26.6 17.8 14.8 10.2 32.4 12.8 11.8 14.1 6.0 14.8 21.5 33.1 15.4 19.5 21.4 25.5 17.0 19.8 14.5 13.1 20.5 14.6 24.5 15.9 15.5 22.7 12.6 30.7 17.5 21.2 24.9 17.1 32.2 23.5 18.6 16.9 29.4 21.9 13.6 17.1 15.6 29.1 20.8 22.3 16.6 32.2 14.5 21.1 14.9 20.7 21.7 28.6 22.4 13.8 17.7 50.1 17.1 15.5 22.8 25.5 16.8 21.0 14.8 21.5 34.5 13.8 18.2 22.8 18.0 26.3 13.3 17.1 11.9 18.3 24.3 15.1 19.3 19.5 32.4 10.1 18.7 11.4 9.5 10.6 14.5 10.6 10.4 7.9 14.8 14.1 10.3 17.1 11.8 12.8 10.2 8.9 6.0 22.4 26.0 51.3 25.5 20.1 11.9 25.4 19.9 23.9 29.7 62.5 96.8 21.9 49.0 28.2 107.5 95.4 33.1 95.0 67.1 38.4 115.8 33.4 16.6 33.6 9.1 50.4 34.1 0.0 35.4 23.2 45.8 52.3 76.3 39.4 28.2 63.5 36.9 35.0 35.3 11.0 69.6 45.7 21.9 49.5 31.9 69.1 35.4 26.0 60.1 17.0 107.8 32.3 40.0 110.7 64.1 26.5 42.0 42.7 33.6 45.0 ZNF639 "ANC-2H01, ZASC1" ENSG00000121864 "Zinc finger protein 639" Q9UID6 3 179322991-179338583 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049023, HPA052163" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA049023: AB_2680603, HPA052163: AB_2681747" "unprognostic (5.64e-2)" "unprognostic (6.16e-2)" "unprognostic (8.15e-2)" "unprognostic (1.33e-2)" "prognostic favorable (5.45e-5)" "unprognostic (1.06e-1)" "prognostic unfavorable (2.13e-4)" "unprognostic (7.74e-2)" "unprognostic (1.05e-2)" "unprognostic (2.16e-3)" "unprognostic (4.70e-3)" "unprognostic (4.58e-2)" "unprognostic (2.48e-2)" "unprognostic (1.59e-1)" "unprognostic (7.82e-2)" "unprognostic (1.33e-2)" "unprognostic (1.56e-1)" 19.4 17.2 18.4 12.4 18.0 36.7 28.5 25.4 25.8 24.0 23.7 18.3 15.9 12.7 24.6 20.0 18.8 21.7 14.8 22.1 17.7 15.8 18.8 19.2 17.3 27.5 17.0 17.0 25.6 21.4 31.1 25.2 16.3 19.4 23.6 16.9 19.5 19.6 21.5 23.5 12.3 16.7 23.4 17.2 23.1 17.4 13.3 19.1 25.9 36.4 15.3 17.5 25.1 22.8 4.0 1.7 4.6 2.3 4.5 5.7 1.6 25.6 6.1 11.9 14.6 10.8 13.3 11.7 12.3 18.7 20.5 18.6 10.1 10.4 30.0 18.7 15.2 25.0 9.8 18.3 16.5 25.9 27.4 13.9 30.5 8.9 10.1 18.9 24.1 11.5 10.6 17.5 10.5 24.7 15.4 13.9 20.2 18.5 16.3 16.1 13.1 24.9 10.7 19.8 18.4 14.1 24.0 12.3 36.0 12.7 10.6 21.9 13.2 12.3 13.7 15.9 10.5 34.9 19.1 11.3 14.0 14.7 11.0 31.3 6.5 5.8 56.1 10.3 18.7 9.6 4.6 2.3 2.2 3.5 1.5 3.2 4.0 5.7 5.6 1.7 3.6 4.9 4.7 1.6 4.5 0.9 0.8 4.6 1.6 18.4 18.0 25.4 25.8 17.7 15.8 17.0 17.0 19.4 19.1 17.9 13.2 12.1 24.6 18.5 20.3 16.8 7.6 6.7 10.3 14.0 51.1 12.4 28.2 10.4 16.8 19.4 7.4 0.0 8.5 9.5 17.9 24.8 9.3 14.1 8.6 15.9 18.0 20.9 14.2 6.6 22.7 13.0 13.5 12.6 16.3 17.5 8.8 7.0 22.6 17.0 41.5 25.8 17.5 24.5 20.2 15.3 2.9 10.9 11.3 20.3 ZNF641 FLJ31295 ENSG00000167528 "Zinc finger protein 641" Q96N77 12 48337180-48351414 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035189 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA035189: AB_10603333" "unprognostic (1.79e-1)" "unprognostic (1.85e-1)" "unprognostic (2.70e-2)" "unprognostic (9.82e-3)" "unprognostic (3.71e-2)" "unprognostic (1.08e-2)" "unprognostic (1.90e-2)" "unprognostic (1.35e-3)" "unprognostic (7.82e-3)" "prognostic favorable (3.91e-4)" "prognostic favorable (8.30e-5)" "unprognostic (3.67e-1)" "unprognostic (2.68e-2)" "unprognostic (7.61e-2)" "unprognostic (1.51e-1)" "unprognostic (5.76e-2)" "unprognostic (7.85e-3)" 10.6 28.6 11.9 11.1 10.8 6.4 10.4 11.3 17.1 14.6 9.2 11.8 7.3 10.1 15.3 10.9 7.8 12.5 13.0 11.4 13.1 8.7 10.9 10.4 13.9 12.4 9.5 17.9 25.6 16.0 17.2 12.2 15.2 13.6 11.0 9.1 11.8 9.7 11.5 22.5 6.2 9.3 19.2 12.6 14.8 10.1 12.1 9.5 14.6 15.6 8.1 13.6 12.7 12.5 1.2 4.7 9.7 5.0 6.4 4.3 2.9 3.1 4.0 8.1 13.8 7.3 2.0 5.8 7.1 5.1 3.8 2.5 9.1 8.0 5.4 10.5 6.7 7.1 4.8 2.9 4.9 1.3 13.8 5.1 9.7 7.3 2.2 7.6 11.5 13.6 3.1 7.2 2.8 6.0 6.5 3.6 8.0 9.3 5.6 3.6 3.5 4.5 4.0 1.7 3.1 2.2 3.0 8.1 4.2 6.3 14.3 3.3 5.0 8.7 3.7 5.1 7.1 8.8 11.7 1.5 4.2 7.1 4.6 3.5 6.6 5.9 4.4 2.7 12.3 4.4 1.9 4.1 8.6 4.3 3.9 2.6 0.7 2.5 4.0 4.7 1.2 2.3 4.0 9.7 6.4 5.0 1.9 1.3 2.9 11.9 10.8 11.3 17.1 13.1 8.7 9.5 17.9 13.6 9.5 6.0 17.3 7.4 12.9 2.7 12.1 7.7 12.7 6.7 6.8 7.0 9.8 1.1 6.6 7.1 1.3 9.6 3.9 0.0 8.8 0.7 6.7 4.7 3.5 6.4 6.8 17.5 5.2 18.4 16.2 1.9 14.4 13.6 0.0 2.8 1.8 15.3 6.8 0.0 22.6 3.7 16.8 19.4 9.8 5.9 5.3 1.9 0.5 12.8 2.4 5.4 ZNF646 KIAA0296 ENSG00000167395 "Zinc finger protein 646" O15015 16 31074422-31084196 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 19.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 19.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042364, HPA066468" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA042364: AB_10794796, HPA066468: AB_2732746" "unprognostic (1.61e-2)" "unprognostic (2.18e-1)" "unprognostic (8.08e-2)" "unprognostic (1.18e-2)" "unprognostic (4.66e-1)" "unprognostic (6.20e-3)" "prognostic unfavorable (1.28e-6)" "unprognostic (3.23e-2)" "unprognostic (4.21e-2)" "unprognostic (6.96e-2)" "unprognostic (1.16e-2)" "unprognostic (9.83e-2)" "unprognostic (2.07e-2)" "unprognostic (2.65e-1)" "unprognostic (1.93e-1)" "unprognostic (1.07e-1)" "unprognostic (2.16e-1)" 9.8 6.4 5.9 10.4 7.6 13.4 7.3 12.2 7.8 10.2 6.8 10.4 8.2 10.6 9.8 6.8 7.5 8.6 7.6 5.9 6.8 5.5 6.9 6.1 13.5 11.3 10.6 5.6 10.3 8.2 10.1 9.4 8.0 7.2 7.9 4.9 5.8 9.8 14.2 12.4 10.6 9.6 6.5 7.4 12.9 9.1 36.1 9.2 24.7 7.7 5.2 11.5 7.8 10.8 4.0 5.2 19.8 3.7 3.4 4.3 1.5 6.1 12.9 8.5 6.6 6.1 4.8 11.2 6.8 7.2 8.2 7.6 9.4 5.9 12.0 10.9 5.7 5.4 8.3 7.0 7.4 3.2 13.8 6.6 8.9 11.4 7.8 6.3 11.4 13.9 6.1 6.8 8.8 5.0 6.4 4.9 10.3 14.1 7.1 6.2 9.8 12.6 7.8 11.4 2.8 6.7 20.4 16.6 12.1 2.6 5.9 12.3 12.4 7.8 8.3 4.1 3.9 6.9 10.0 9.8 10.4 5.9 6.9 6.3 11.9 10.9 12.2 9.4 12.4 8.1 5.9 3.7 9.4 4.3 3.3 2.2 3.3 2.0 1.7 3.5 4.0 2.2 2.5 19.8 3.4 2.1 5.2 2.0 1.5 5.9 7.6 12.2 7.8 6.8 5.5 10.6 5.6 7.2 9.2 3.0 2.2 2.4 0.9 3.0 3.0 1.2 2.5 1.4 1.2 1.8 3.9 1.5 1.7 3.8 19.8 2.9 5.2 0.0 2.9 1.7 2.1 2.2 1.1 1.5 4.1 1.6 5.8 0.6 2.4 2.7 2.6 4.4 0.0 3.6 3.7 3.7 3.6 5.8 4.2 1.9 1.0 0.0 1.1 10.4 6.7 3.4 2.1 2.2 3.5 2.0 ZNF652 KIAA0924 ENSG00000198740 "Zinc finger protein 652" Q9Y2D9 17 49289206-49362473 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044408 Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA044408: AB_2678932" "unprognostic (1.33e-2)" "unprognostic (5.54e-2)" "unprognostic (1.15e-1)" "prognostic favorable (1.35e-4)" "unprognostic (1.12e-1)" "unprognostic (1.13e-1)" "unprognostic (1.38e-1)" "unprognostic (7.31e-3)" "unprognostic (2.34e-1)" "unprognostic (4.52e-2)" "unprognostic (1.13e-2)" "unprognostic (2.75e-1)" "unprognostic (4.09e-3)" "unprognostic (1.07e-1)" "unprognostic (1.66e-1)" "unprognostic (3.90e-2)" "unprognostic (1.30e-2)" 6.4 6.2 8.5 6.3 23.7 9.7 16.0 8.4 14.5 7.0 8.5 17.1 8.2 5.2 6.8 4.6 5.6 5.5 6.4 5.4 9.6 5.6 5.9 8.0 7.3 6.1 28.3 6.5 7.6 7.4 10.0 7.6 6.5 13.0 6.8 6.4 6.0 12.6 8.2 19.9 11.0 7.0 7.9 15.6 8.6 7.8 9.9 23.4 5.1 8.2 1.5 6.6 8.0 6.7 2.7 2.3 6.2 2.1 1.4 1.8 0.6 4.8 4.0 3.4 4.6 3.4 2.3 4.7 1.9 3.2 2.6 2.7 7.0 3.1 10.5 5.8 3.9 1.7 3.3 3.8 3.9 4.0 4.3 3.1 4.3 5.6 3.9 1.6 3.7 6.4 2.8 2.2 2.2 3.8 1.6 2.6 5.7 3.7 9.8 2.1 6.4 5.1 1.1 3.9 2.3 2.8 4.0 8.4 4.3 1.9 7.1 7.1 4.6 3.5 3.4 4.2 5.2 7.3 4.2 4.5 7.2 6.3 3.2 2.9 11.2 9.0 8.2 3.7 2.6 2.7 3.0 1.6 2.4 1.5 0.8 1.8 1.3 1.1 1.5 1.2 2.7 1.0 1.1 6.2 1.4 2.1 2.3 0.6 0.6 8.5 23.7 8.4 14.5 9.6 5.6 28.3 6.5 13.0 23.4 17.9 13.7 32.2 11.8 14.5 48.4 14.2 28.1 18.7 15.9 27.9 60.9 18.4 11.6 14.9 15.4 19.7 13.4 23.3 17.0 14.6 17.3 19.8 4.7 36.8 11.4 41.3 11.6 25.8 30.8 10.9 44.8 15.0 25.3 6.4 23.9 31.2 15.3 21.0 41.8 12.4 48.2 0.0 19.8 50.7 30.3 21.2 11.2 29.4 20.8 9.7 ZNF653 Zip67 ENSG00000161914 "Zinc finger protein 653" Q96CK0 19 11483427-11505923 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 11.5;Late spermatids: 19.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 2.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023631, HPA023635" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA023631: AB_2671269, HPA023635: AB_10603940" "unprognostic (1.21e-1)" "unprognostic (5.23e-2)" "prognostic unfavorable (8.37e-4)" "prognostic favorable (4.15e-4)" "unprognostic (9.75e-2)" "unprognostic (1.67e-3)" "unprognostic (1.11e-1)" "unprognostic (2.46e-1)" "unprognostic (1.14e-1)" "unprognostic (1.14e-3)" "unprognostic (1.29e-3)" "unprognostic (1.12e-1)" "unprognostic (7.91e-3)" "unprognostic (1.43e-2)" "unprognostic (3.09e-2)" "unprognostic (3.15e-1)" "prognostic favorable (8.74e-4)" 5.5 8.5 7.5 6.3 9.0 3.8 4.7 19.1 9.6 4.4 5.1 3.5 3.1 3.9 4.3 2.0 4.2 5.3 5.0 4.2 8.5 7.3 4.9 5.6 3.3 4.7 5.0 3.5 5.7 7.9 6.6 5.1 4.0 5.1 5.3 2.4 2.4 5.3 4.1 4.2 8.4 5.7 4.7 3.8 4.1 3.9 13.2 5.7 7.2 6.6 5.7 6.8 6.9 17.2 0.5 1.0 0.5 0.1 0.1 2.4 0.1 9.9 8.2 6.4 5.5 1.7 1.3 4.6 3.8 3.2 5.5 5.1 5.7 4.4 6.9 4.8 4.2 5.9 4.5 4.9 3.8 2.8 7.2 6.3 4.5 6.1 6.6 1.8 5.8 7.7 3.9 4.9 5.2 4.2 5.3 4.2 6.1 6.3 10.5 3.2 14.1 8.0 13.5 6.9 5.6 6.3 7.0 4.2 8.9 6.1 8.4 7.3 10.8 2.5 4.3 4.8 3.0 4.3 3.9 5.2 8.0 5.2 8.8 9.0 13.6 20.3 4.8 7.0 8.0 4.5 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.1 0.0 0.5 0.2 0.0 0.5 0.1 0.0 1.0 2.4 0.1 7.5 9.0 19.1 9.6 8.5 7.3 5.0 3.5 5.1 5.7 0.0 0.0 4.7 3.3 2.9 4.1 1.6 0.0 0.0 0.0 1.8 5.9 1.0 0.0 4.1 11.5 1.1 3.1 0.0 4.5 1.0 1.3 2.2 4.6 2.8 0.9 1.6 4.6 3.1 1.9 19.8 1.7 0.6 0.0 4.6 3.3 4.5 3.9 0.0 2.1 2.4 3.7 0.0 1.4 7.1 2.7 2.4 1.4 1.9 2.2 2.0 ZNF654 "FLJ10997, FLJ21142" ENSG00000175105 "Zinc finger protein 654" Q8IZM8 3 88059274-88144665 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 35.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036172, HPA036173, HPA049262, HPA077939" Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA Microtubules "Nucleoplasm, Cytokinetic bridge, Mitotic spindle" "HPA036172: AB_10672081, HPA036173: AB_2674987, HPA049262: , HPA077939: AB_2732364" "unprognostic (2.54e-2)" "unprognostic (2.28e-1)" "unprognostic (6.89e-3)" "unprognostic (2.54e-1)" "unprognostic (1.48e-1)" "unprognostic (3.29e-2)" "unprognostic (5.74e-2)" "unprognostic (3.45e-2)" "unprognostic (7.65e-2)" "unprognostic (2.02e-1)" "unprognostic (5.72e-3)" "prognostic unfavorable (9.97e-6)" "unprognostic (1.29e-2)" "unprognostic (2.92e-1)" "unprognostic (1.73e-1)" "unprognostic (2.15e-2)" "unprognostic (2.50e-2)" 18.2 8.9 10.9 13.2 11.6 15.1 12.6 18.6 13.3 13.5 11.8 9.8 13.5 9.7 14.0 12.1 14.4 9.5 10.8 10.4 11.3 8.5 11.0 15.4 11.8 12.3 13.9 10.3 14.7 9.5 12.8 21.8 11.9 11.1 12.8 9.8 10.7 12.5 10.2 13.9 14.9 13.4 13.1 15.8 10.1 10.0 12.3 14.8 22.2 13.4 9.4 12.0 16.6 14.6 2.6 2.3 10.0 2.0 6.5 4.0 1.7 4.7 2.0 3.4 4.8 7.6 6.3 3.1 6.3 5.7 4.2 6.0 3.0 2.9 7.5 4.3 5.4 3.0 3.2 3.7 5.8 8.5 4.6 2.0 4.7 2.7 2.2 5.7 5.3 5.3 6.2 5.8 4.7 5.6 9.0 5.7 4.4 3.1 6.2 9.5 3.6 5.3 4.9 1.8 3.9 3.2 3.7 2.3 3.6 4.1 6.2 2.6 2.3 4.5 3.7 11.9 4.6 5.0 4.2 6.4 9.4 6.2 35.2 4.5 7.0 4.8 5.3 7.6 5.1 6.0 10.0 1.9 2.7 2.9 2.0 3.3 1.8 3.2 4.0 2.3 2.6 3.9 2.6 2.7 6.5 1.4 1.1 2.2 1.7 10.9 11.6 18.6 13.3 11.3 8.5 13.9 10.3 11.1 14.8 8.9 13.3 6.9 8.9 19.9 12.3 10.9 7.6 9.4 11.4 5.2 11.8 3.7 1.7 5.6 0.8 11.3 8.7 0.0 4.5 2.9 14.1 9.3 15.1 11.3 5.3 15.9 5.1 9.2 11.7 1.1 6.9 13.3 8.5 1.8 9.2 9.5 7.0 7.0 11.7 4.8 13.3 6.5 6.2 10.4 7.9 16.3 6.9 11.7 7.1 11.5 ZNF655 "VIK, VIK-1" ENSG00000197343 "Zinc finger protein 655" Q8N720 7 99558406-99576453 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029534, HPA050750" Uncertain Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA029534: AB_10603008, HPA050750: AB_2681225" "prognostic favorable (7.12e-4)" "unprognostic (3.03e-2)" "unprognostic (9.62e-2)" "unprognostic (5.00e-1)" "unprognostic (1.51e-1)" "unprognostic (5.42e-2)" "unprognostic (3.31e-2)" "unprognostic (3.93e-3)" "prognostic unfavorable (7.24e-4)" "unprognostic (2.01e-1)" "unprognostic (1.49e-2)" "unprognostic (1.18e-1)" "unprognostic (1.42e-2)" "unprognostic (2.16e-1)" "unprognostic (2.11e-1)" "unprognostic (1.62e-2)" "unprognostic (1.12e-1)" 14.6 19.0 17.4 24.1 20.7 10.3 16.9 31.1 20.3 18.8 20.2 19.7 18.0 22.2 15.3 19.0 39.2 15.6 15.1 11.3 14.7 14.4 19.1 21.2 19.9 23.8 21.3 16.1 19.4 30.8 13.9 25.0 21.1 20.4 16.9 16.8 14.1 25.5 19.0 18.2 25.5 19.7 19.8 21.3 22.2 24.1 11.1 19.4 27.8 16.0 14.3 23.1 21.4 20.7 15.0 17.5 44.7 22.2 14.7 25.7 21.4 16.2 15.8 5.8 8.6 6.6 9.9 5.0 9.8 18.5 17.0 16.3 8.7 16.0 11.4 0.1 13.7 22.6 10.3 6.8 11.9 17.2 13.7 9.9 7.9 6.7 11.0 10.1 14.4 15.3 8.5 14.5 15.7 22.2 8.2 7.4 9.7 21.0 15.8 10.6 0.0 20.1 13.2 6.8 0.0 0.0 7.2 5.4 22.4 11.2 17.9 6.7 12.4 9.3 0.3 9.8 9.6 5.3 8.6 5.2 9.5 25.1 15.6 17.6 18.6 27.1 24.8 9.7 7.3 15.3 44.7 18.8 31.2 22.3 19.9 20.5 15.0 20.5 25.6 17.5 13.3 16.5 20.7 21.9 14.7 22.2 10.1 25.7 21.4 17.4 20.7 31.1 20.3 14.7 14.4 21.3 16.1 20.4 19.4 89.3 73.3 45.4 33.6 39.8 46.9 31.5 33.1 26.8 48.9 22.7 39.3 24.8 28.2 24.8 7.8 13.4 38.0 0.0 31.4 35.4 23.7 39.5 17.4 20.8 32.5 47.7 39.9 19.0 58.3 7.1 23.6 52.1 21.9 33.3 34.0 23.0 36.8 49.1 23.7 33.4 45.2 12.9 24.1 30.2 25.1 42.8 61.6 48.4 25.9 52.5 ZNF658 "DKFZp572C163, FLJ32813, MGC35232" ENSG00000274349 "Zinc finger protein 658" Q5TYW1 9 66856426-66932141 "Predicted intracellular proteins, Transcription factors" "Ribosome biogenesis, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "blood: 20.9" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 12.0;Distal tubular cells: 13.3;Horizontal cells: 9.5" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in some" 11 "neutrophil: 20.9" "Lineage enriched" "Detected in many" 11 "granulocytes: 20.9" "Low cell line specificity" "Detected in many" "HPA047730, HPA048668" Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA047730: AB_2680136, HPA048668: AB_2680487" "unprognostic (9.54e-2)" "unprognostic (1.60e-1)" "unprognostic (9.06e-3)" "unprognostic (1.97e-1)" "unprognostic (1.02e-1)" "unprognostic (3.32e-2)" "unprognostic (1.45e-1)" "unprognostic (1.38e-2)" "unprognostic (1.35e-1)" "unprognostic (1.40e-1)" "unprognostic (2.75e-3)" "unprognostic (8.04e-2)" "unprognostic (1.18e-4)" "unprognostic (2.68e-2)" "unprognostic (6.99e-2)" "unprognostic (1.06e-2)" "unprognostic (1.71e-1)" 0.5 0.8 0.1 0.0 2.8 1.4 1.6 0.6 0.3 1.5 0.8 1.4 1.8 0.1 1.8 1.5 0.5 0.9 0.5 3.5 1.1 2.4 0.1 1.8 0.7 1.6 1.4 1.9 4.5 0.0 0.9 1.1 0.6 1.2 2.1 0.9 0.9 1.3 0.4 20.9 0.5 1.8 1.4 0.1 2.8 4.8 4.7 8.8 4.8 5.8 3.6 2.2 4.1 3.1 3.4 0.4 2.2 6.4 2.5 2.1 3.3 7.6 3.7 4.4 3.3 0.2 2.3 1.0 4.0 1.0 5.3 4.0 2.4 4.5 9.8 3.0 4.4 6.4 6.0 4.3 1.3 1.3 3.9 1.6 3.2 2.0 4.0 2.0 8.2 0.3 7.5 2.3 3.3 7.3 6.8 4.1 3.5 1.9 3.4 5.1 2.7 10.3 1.3 4.0 5.1 3.5 2.7 0.8 3.7 1.6 1.8 1.4 4.2 0.5 0.5 1.5 0.6 0.4 0.1 0.6 0.9 0.8 0.2 1.3 1.4 0.7 20.9 1.8 0.4 0.4 0.5 0.1 3.0 2.7 0.5 1.0 0.8 6.4 3.2 0.0 12.0 3.4 0.0 0.0 2.3 13.3 0.9 0.6 0.7 0.9 0.0 0.6 0.7 0.9 0.7 1.1 2.4 1.6 9.5 0.0 0.6 1.3 0.9 2.8 0.1 0.0 0.0 1.8 4.9 0.8 0.0 4.9 4.8 3.9 0.0 0.5 2.6 2.0 1.8 0.8 0.0 1.2 0.9 ZNF664 "DKFZp761B128, ZFOC1, ZNF176" ENSG00000179195 "Zinc finger protein 664" Q8N3J9 12 123971845-124015439 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 134.6;Late spermatids: 216.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047846 Approved Nucleoplasm NA NA Nucleoplasm "HPA047846: AB_2680179" "unprognostic (4.16e-2)" "unprognostic (1.32e-1)" "unprognostic (5.75e-3)" "unprognostic (1.90e-2)" "unprognostic (8.12e-2)" "unprognostic (3.79e-1)" "unprognostic (2.49e-3)" "unprognostic (3.16e-2)" "unprognostic (1.38e-1)" "unprognostic (1.76e-1)" "unprognostic (2.21e-1)" "unprognostic (1.49e-1)" "unprognostic (1.16e-3)" "unprognostic (7.13e-2)" "unprognostic (1.24e-1)" "unprognostic (1.85e-2)" "unprognostic (1.85e-2)" 22.9 15.0 38.3 11.3 34.5 5.3 29.4 26.9 24.8 23.0 25.5 34.2 26.0 36.6 18.9 35.3 14.4 27.3 16.1 22.4 39.2 30.7 29.3 21.0 20.6 10.4 46.7 20.1 15.2 28.2 72.1 33.4 17.0 28.7 21.1 28.3 22.2 31.2 21.1 21.3 8.9 39.8 14.6 61.8 11.1 20.1 12.0 30.0 10.1 43.9 11.0 13.2 15.3 17.5 2.4 1.0 0.5 0.6 1.7 4.3 1.7 25.0 17.6 28.2 29.4 22.2 16.9 24.0 14.7 20.0 15.3 12.6 21.8 13.8 24.7 18.0 19.9 11.0 22.1 40.3 18.1 28.4 20.8 29.1 38.4 23.0 18.4 26.7 23.1 21.2 10.7 40.6 15.9 26.2 36.1 24.3 24.3 23.4 10.5 13.6 19.2 22.8 10.6 26.4 24.8 38.3 19.9 27.5 14.9 33.2 41.4 58.6 42.5 25.3 27.1 24.8 24.6 48.3 12.3 15.8 13.3 21.6 18.7 15.2 14.5 18.0 19.5 23.1 16.3 20.4 0.2 0.6 0.5 2.8 0.3 4.3 1.9 2.2 2.4 1.0 2.4 2.7 2.2 0.3 1.7 0.0 0.8 3.8 1.7 38.3 34.5 26.9 24.8 39.2 30.7 46.7 20.1 28.7 30.0 23.8 40.2 18.0 12.5 11.2 23.4 54.0 33.1 56.2 40.9 19.2 19.6 7.7 24.9 30.5 134.6 18.0 68.9 0.0 27.3 7.3 27.4 34.5 12.7 38.4 10.7 30.2 42.1 17.2 14.3 216.3 21.6 7.0 20.3 3.6 59.6 29.4 34.9 45.6 16.3 22.7 30.2 19.4 18.6 21.1 25.1 7.8 8.4 10.1 48.2 15.8 ZNF667 FLJ14011 ENSG00000198046 "Zinc finger protein 667" Q5HYK9 19 56439325-56478065 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 27.9;Cone photoreceptor cells: 23.6;Horizontal cells: 30.2;Rod photoreceptor cells: 28.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 6.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 10.1;hTERT-RPE1: 15.1;U-138 MG: 12.7" "Low region specificity" "Detected in all" "HPA030731, HPA046673" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA030731: AB_2673584, HPA046673: AB_2679746" "unprognostic (6.10e-2)" "unprognostic (7.87e-3)" "unprognostic (2.91e-2)" "unprognostic (4.81e-2)" "unprognostic (6.38e-2)" "unprognostic (2.26e-3)" "unprognostic (8.55e-2)" "unprognostic (5.37e-2)" "unprognostic (1.05e-1)" "unprognostic (5.67e-2)" "unprognostic (3.77e-4)" "unprognostic (1.22e-1)" "unprognostic (4.09e-2)" "unprognostic (8.34e-3)" "unprognostic (3.54e-2)" "unprognostic (7.62e-2)" "unprognostic (1.55e-2)" 2.4 7.7 8.0 1.7 18.2 6.2 6.8 12.1 16.1 4.7 2.6 5.3 1.8 1.6 6.4 11.6 2.4 6.3 4.3 4.0 10.2 9.9 4.1 1.3 2.1 2.4 6.5 8.3 11.1 3.5 6.1 18.9 3.0 9.7 5.6 0.9 3.2 4.5 4.5 2.0 2.9 1.1 5.6 6.6 2.4 1.8 5.9 5.3 2.9 12.6 0.6 1.8 3.7 4.2 6.2 2.2 0.4 0.0 4.5 3.7 0.6 0.1 0.2 8.7 0.1 0.0 0.0 0.2 3.7 2.8 3.4 2.7 0.2 0.1 0.4 5.2 1.3 5.2 0.1 0.0 0.1 5.2 0.0 1.9 10.1 0.1 0.2 2.7 5.9 4.6 5.6 0.1 0.7 0.0 15.1 0.0 0.3 0.0 0.3 2.6 0.2 0.1 0.2 6.3 0.1 1.7 0.0 3.3 7.0 3.4 0.5 0.2 5.1 0.2 0.1 0.0 8.1 2.4 0.0 0.0 12.7 3.4 0.2 6.5 0.2 5.4 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 1.2 0.4 0.3 0.3 6.2 1.5 3.7 0.4 4.5 0.0 2.2 0.0 0.6 8.0 18.2 12.1 14.4 10.2 9.9 6.5 8.3 9.7 5.3 0.0 0.0 0.0 5.6 3.0 27.9 4.5 0.0 5.3 4.5 5.2 23.6 0.1 0.0 2.7 2.1 3.6 0.0 0.0 0.2 0.0 5.3 3.6 9.2 0.0 0.2 30.2 1.2 1.8 0.0 1.6 4.9 0.6 3.3 0.0 0.0 9.3 0.5 0.0 6.7 1.2 28.2 0.0 3.0 7.7 14.4 3.6 0.1 0.0 0.0 2.5 ZNF668 FLJ13479 ENSG00000167394 "Zinc finger protein 668" Q96K58 16 31060843-31074320 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 31.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043048 Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA043048: AB_10962503" "unprognostic (2.71e-2)" "unprognostic (4.95e-2)" "unprognostic (6.42e-2)" "unprognostic (1.48e-1)" "unprognostic (3.27e-1)" "unprognostic (7.20e-3)" "unprognostic (6.73e-5)" "unprognostic (4.03e-2)" "unprognostic (1.37e-1)" "unprognostic (1.84e-1)" "unprognostic (7.71e-3)" "prognostic unfavorable (6.24e-4)" "unprognostic (1.72e-3)" "unprognostic (2.00e-1)" "unprognostic (2.23e-1)" "unprognostic (4.83e-3)" "unprognostic (7.25e-2)" 7.1 8.2 8.2 8.9 10.0 18.5 5.9 11.1 15.4 8.3 10.2 6.6 5.1 11.8 9.4 5.6 8.0 6.1 9.6 5.1 8.6 7.4 5.9 6.9 7.3 8.6 7.6 5.2 5.7 10.6 4.6 6.7 10.1 9.2 8.1 4.2 4.9 7.2 7.6 12.6 9.0 10.3 9.5 6.5 8.6 8.8 10.0 6.1 16.9 5.4 8.8 7.5 6.6 6.5 5.6 7.3 8.6 4.8 8.4 13.9 5.4 3.6 12.6 2.8 7.0 3.0 3.1 9.7 10.4 7.6 5.2 4.4 5.7 5.1 5.9 8.4 6.1 3.3 6.7 1.9 5.6 1.3 7.5 8.2 3.6 7.8 9.1 3.7 5.7 9.1 3.8 2.3 9.0 1.8 1.7 3.8 6.5 6.8 3.7 9.5 12.4 12.0 12.3 10.1 2.6 10.7 16.0 21.3 8.6 2.8 8.1 9.9 11.7 6.6 9.3 3.2 1.1 7.1 8.3 6.4 13.1 5.4 9.9 4.5 6.2 10.2 8.3 8.7 6.0 8.4 7.6 4.8 8.6 13.9 4.7 9.2 5.6 4.1 8.4 7.3 4.4 4.5 5.6 1.7 8.4 3.8 3.9 4.3 5.4 8.2 10.0 11.1 15.4 8.6 7.4 7.6 5.2 9.2 6.1 0.0 5.1 2.2 2.6 7.4 2.9 0.5 5.1 1.4 2.3 0.0 0.0 5.4 6.6 8.2 31.1 3.1 6.3 0.0 4.1 9.5 6.0 2.2 4.6 1.8 6.0 11.1 4.6 3.7 3.2 12.7 5.8 4.4 3.3 4.6 3.8 4.8 6.4 4.2 14.2 4.7 1.9 0.0 2.5 2.9 13.3 7.8 5.8 6.4 4.7 1.7 ZNF670 MGC12466 ENSG00000277462 "Zinc finger protein 670" Q9BS34 1 247036784-247078755 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 21.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA003142 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003142: AB_1859404" "unprognostic (2.11e-1)" "unprognostic (8.04e-3)" "unprognostic (2.05e-3)" "unprognostic (9.98e-2)" "unprognostic (1.27e-1)" "unprognostic (3.76e-1)" "unprognostic (1.26e-2)" "unprognostic (1.50e-2)" "unprognostic (1.63e-2)" "unprognostic (3.23e-2)" "unprognostic (9.88e-2)" "unprognostic (5.21e-3)" "unprognostic (2.19e-2)" "unprognostic (1.23e-1)" "unprognostic (2.46e-1)" "unprognostic (1.95e-1)" "unprognostic (1.39e-2)" 3.5 2.2 3.1 2.9 5.5 0.7 6.2 12.0 6.1 4.1 2.6 3.2 0.0 2.8 5.7 3.4 1.9 3.7 3.8 2.5 4.5 3.9 3.0 4.0 3.4 1.8 1.3 5.5 2.8 3.1 1.3 1.4 4.0 3.4 3.5 2.5 1.9 3.1 1.6 2.6 2.4 4.3 2.9 3.1 3.3 4.8 2.7 5.4 3.7 3.0 4.7 4.2 1.0 6.6 4.1 1.7 2.3 2.8 6.5 2.3 3.8 2.7 7.8 9.6 2.0 3.4 18.1 4.9 3.3 5.9 5.9 3.2 4.1 6.2 8.2 3.0 3.2 3.2 8.6 3.8 11.2 4.6 1.1 5.5 1.8 4.9 1.7 6.8 3.4 1.9 4.0 3.8 7.4 0.9 3.8 4.9 7.9 2.7 5.9 1.5 8.0 3.3 14.5 8.6 4.9 8.3 9.7 5.8 3.5 8.4 9.0 8.2 6.9 2.7 3.8 4.6 2.8 14.3 2.4 3.6 4.1 2.6 5.4 5.2 9.9 12.7 1.3 4.9 4.5 0.0 2.0 1.7 4.4 2.3 2.3 6.6 4.1 4.6 4.1 5.9 6.5 4.9 0.2 2.8 1.4 2.3 3.0 2.3 3.0 1.7 0.0 8.6 21.5 4.3 0.6 7.6 6.7 4.5 5.2 0.0 2.2 5.0 4.6 5.2 4.4 0.4 0.0 2.5 6.7 2.3 3.8 0.0 2.8 2.1 6.4 0.0 4.9 1.9 1.0 1.7 1.6 6.8 2.8 2.7 2.0 2.7 1.5 1.4 2.8 1.4 0.0 4.4 1.6 3.3 9.8 0.7 0.0 1.1 3.7 ZNF671 FLJ23506 ENSG00000083814 "Zinc finger protein 671" Q8TAW3 19 57719751-57727624 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 7.8;Rod photoreceptor cells: 6.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 10.4" "Low region specificity" "Detected in all" "HPA046099, HPA056043" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA046099: AB_10962484, HPA056043: " "prognostic favorable (2.20e-4)" "unprognostic (4.16e-3)" "unprognostic (6.02e-2)" "unprognostic (5.91e-3)" "unprognostic (8.76e-2)" "unprognostic (3.97e-3)" "unprognostic (6.12e-2)" "unprognostic (5.56e-3)" "unprognostic (8.26e-3)" "unprognostic (2.04e-1)" "prognostic favorable (3.57e-4)" "unprognostic (2.14e-1)" "unprognostic (1.92e-3)" "unprognostic (1.71e-1)" "unprognostic (2.49e-1)" "unprognostic (2.02e-1)" "unprognostic (4.22e-1)" 3.3 7.9 9.1 6.3 10.1 5.6 6.6 28.5 10.4 5.4 6.7 4.5 4.5 2.7 3.3 8.4 3.2 6.9 4.2 8.1 9.0 6.7 6.2 3.3 5.6 13.2 8.0 7.5 5.4 4.1 16.1 11.3 5.9 7.9 6.6 3.7 7.8 4.5 9.4 10.3 3.2 7.1 6.6 9.0 15.1 3.8 7.1 8.9 15.6 10.4 1.1 12.1 6.2 2.5 22.2 11.0 13.7 10.0 13.9 19.4 10.9 0.1 0.2 2.4 0.0 0.4 0.1 0.0 2.7 1.6 5.4 1.9 0.3 0.4 5.5 0.9 3.9 1.7 0.1 2.0 2.2 6.3 6.0 3.9 0.1 0.9 0.0 4.7 0.0 8.1 7.0 1.6 3.4 1.8 6.2 0.8 5.9 0.8 2.7 4.7 0.1 10.4 0.1 3.5 0.0 5.6 4.1 7.5 3.3 2.0 0.2 0.2 0.0 0.0 0.1 3.6 6.3 1.6 7.7 0.0 0.6 2.9 0.0 2.0 4.9 0.1 3.0 0.6 1.3 1.8 12.1 7.6 13.7 6.4 7.0 16.7 17.2 13.3 11.0 11.0 22.2 19.4 15.5 5.6 13.9 10.0 10.0 13.1 10.9 9.1 10.1 28.5 10.4 9.0 6.7 8.0 7.5 7.9 8.9 0.0 1.1 0.9 0.6 0.6 5.3 4.8 2.5 0.0 1.2 3.5 0.0 1.8 1.7 2.6 0.1 1.0 0.0 0.0 0.0 0.9 1.0 0.5 2.3 1.0 3.3 6.4 0.0 1.3 1.6 0.4 0.0 1.6 1.7 1.8 0.0 7.8 0.5 0.0 0.4 1.3 6.8 0.0 0.4 5.6 4.5 0.4 0.7 4.3 0.3 0.1 ZNF672 FLJ22301 ENSG00000171161 "Zinc finger protein 672" Q499Z4 1 248838210-248849517 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055779, HPA062506" Approved Enhanced Nucleoplasm Yes Yes Nucleoplasm "HPA055779: AB_2682917, HPA062506: AB_2684786" "unprognostic (1.64e-2)" "unprognostic (3.45e-2)" "unprognostic (8.96e-2)" "unprognostic (2.92e-2)" "unprognostic (2.50e-1)" "unprognostic (9.54e-3)" "unprognostic (7.42e-3)" "unprognostic (1.08e-2)" "unprognostic (2.50e-1)" "unprognostic (2.40e-2)" "prognostic favorable (7.51e-4)" "unprognostic (9.03e-2)" "unprognostic (1.16e-2)" "unprognostic (1.99e-2)" "unprognostic (2.69e-1)" "unprognostic (8.35e-3)" "prognostic favorable (1.79e-5)" 11.3 12.5 11.1 16.4 13.6 15.1 12.1 18.6 15.3 10.2 13.0 17.3 15.0 13.8 12.1 10.7 15.9 11.3 13.3 20.1 11.4 10.2 14.8 27.5 13.6 16.7 14.1 7.5 12.0 14.1 20.4 14.1 16.1 12.4 18.7 11.1 15.1 24.1 14.8 46.6 13.3 16.8 11.3 11.2 16.0 12.7 12.4 14.5 28.1 21.7 21.0 17.3 14.5 10.4 14.5 20.8 9.6 13.4 10.5 8.0 10.3 10.2 11.7 9.6 10.7 5.4 3.8 18.1 9.8 5.3 6.9 7.6 6.4 10.8 11.6 10.1 6.4 5.4 10.1 5.2 7.2 4.6 16.8 2.9 17.7 10.8 8.6 7.0 7.7 13.7 4.2 6.0 9.2 6.6 5.7 6.5 8.0 21.5 9.7 4.9 7.4 13.6 7.7 11.0 11.8 19.9 25.7 9.1 9.1 7.2 8.5 14.1 12.4 8.7 13.3 8.6 6.0 7.7 15.8 5.5 9.8 5.8 6.5 19.8 29.1 10.9 6.8 9.1 13.6 8.0 7.6 13.3 9.6 8.0 13.4 6.7 10.8 5.7 7.9 20.8 14.5 6.3 5.6 8.1 10.5 12.4 11.7 6.5 10.3 11.1 13.6 18.6 15.3 11.4 10.2 14.1 7.5 12.4 14.5 3.0 17.5 21.4 22.4 11.6 21.0 16.9 7.6 5.3 4.5 15.7 11.8 28.2 18.3 16.4 6.2 12.1 18.8 0.0 9.4 16.4 10.8 20.5 28.7 14.8 15.4 9.5 17.3 5.5 15.2 8.9 5.2 14.1 11.8 12.6 16.6 19.2 12.1 17.3 5.3 13.5 30.2 6.5 9.9 22.9 13.6 12.8 59.6 13.8 15.2 19.9 ZNF674 "MRX92, ZNF673B" ENSG00000251192 "Zinc finger protein 674" Q2M3X9 X 46497727-46545457 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 8.9;Horizontal cells: 12.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031026, HPA065295" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA031026: AB_10602690, HPA065295: AB_2685456" "unprognostic (6.11e-4)" "unprognostic (1.97e-2)" "unprognostic (2.16e-1)" "unprognostic (9.30e-2)" "unprognostic (1.54e-2)" "unprognostic (3.39e-2)" "unprognostic (6.41e-5)" "unprognostic (2.74e-4)" "unprognostic (5.68e-2)" "unprognostic (2.43e-2)" "unprognostic (2.23e-3)" "unprognostic (1.02e-1)" "unprognostic (1.12e-1)" "unprognostic (1.31e-1)" "unprognostic (2.00e-1)" "unprognostic (3.25e-4)" "unprognostic (8.45e-4)" 6.7 5.1 5.7 4.0 10.1 3.8 5.5 12.6 9.8 4.7 4.5 6.8 1.9 4.2 6.3 6.5 4.1 3.7 4.9 4.9 5.7 6.3 5.6 8.1 4.3 5.1 6.4 5.8 7.2 7.4 4.8 11.2 4.5 9.6 8.2 5.1 6.8 4.5 5.7 5.0 5.4 4.6 6.9 6.8 5.8 3.9 3.7 7.0 6.0 6.9 1.8 4.6 4.5 5.1 2.3 2.5 5.8 3.5 1.9 2.7 2.1 2.6 3.4 3.4 4.2 3.1 3.1 3.3 2.8 3.9 3.7 3.9 2.2 2.2 2.9 1.8 4.8 6.6 2.5 4.5 3.4 4.1 2.4 2.9 1.3 3.6 1.9 4.1 3.1 5.3 2.9 5.5 2.7 8.9 3.8 2.9 5.0 1.5 4.4 3.3 1.7 3.1 1.4 5.4 0.8 3.2 1.5 5.7 3.3 2.5 1.1 1.3 2.9 4.3 1.4 8.9 9.8 3.6 2.2 2.5 4.7 5.4 2.9 2.6 5.1 4.5 1.3 2.0 1.6 4.7 2.5 2.2 2.9 1.9 3.5 2.0 2.3 2.7 1.5 2.1 1.4 2.2 2.3 5.8 1.9 0.8 2.5 2.2 2.1 5.7 10.1 12.6 9.8 5.7 6.3 6.4 5.8 9.6 7.0 8.9 2.6 0.5 2.8 1.6 7.3 3.3 0.0 4.0 4.5 1.8 0.0 0.7 0.0 0.7 0.0 1.9 0.9 0.0 0.4 0.6 1.1 2.3 2.3 1.8 0.9 12.7 0.0 2.5 2.1 0.0 0.3 1.1 0.0 1.0 0.9 2.9 1.3 0.9 1.8 0.6 5.4 0.0 1.2 0.7 3.2 1.5 0.3 1.7 0.7 1.7 ZNF677 MGC48625 ENSG00000197928 "Zinc finger protein 677" Q86XU0 19 53235381-53254898 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 40.5" "Group enriched" "Detected in many" 11 "Early spermatids: 557.4;Late spermatids: 339.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 19.6;SuSa: 17.4" HPA023106 Approved Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA023106: AB_1859409" "unprognostic (2.06e-2)" "unprognostic (1.52e-1)" "unprognostic (2.88e-2)" "unprognostic (1.32e-1)" "unprognostic (2.34e-2)" "unprognostic (2.02e-3)" "unprognostic (7.73e-2)" "unprognostic (4.07e-3)" "unprognostic (7.87e-3)" "unprognostic (8.16e-2)" "unprognostic (2.52e-1)" "unprognostic (3.12e-2)" "unprognostic (8.70e-8)" "unprognostic (6.57e-3)" "unprognostic (7.85e-2)" "unprognostic (1.76e-1)" "unprognostic (3.17e-2)" 9.1 7.3 5.9 4.3 8.3 4.2 9.3 13.0 7.3 7.4 7.0 13.9 1.3 2.9 12.3 5.7 4.6 9.7 6.2 9.4 5.3 4.3 6.3 2.3 6.8 7.3 9.9 4.8 14.3 4.4 9.1 9.9 7.5 6.6 8.9 3.4 7.6 7.4 6.2 3.9 7.5 3.9 8.1 10.5 7.0 5.7 40.5 8.7 6.7 10.1 5.2 5.0 8.2 6.6 17.4 14.5 10.1 2.8 10.3 15.4 4.1 0.2 0.2 11.4 0.4 3.9 6.0 2.0 7.4 5.6 7.7 7.0 0.0 0.4 0.1 5.6 6.4 9.7 0.7 0.0 5.8 2.3 0.2 4.1 0.3 0.5 0.2 9.6 0.1 7.6 10.3 0.0 7.4 0.1 0.2 3.4 0.1 0.1 0.5 5.2 0.2 6.2 0.2 19.6 0.1 2.6 0.1 0.0 0.2 2.2 3.0 0.2 10.8 0.2 2.8 0.1 17.4 0.4 0.3 2.1 12.1 0.2 0.2 4.9 0.3 0.1 0.2 0.2 0.3 0.1 10.1 2.2 6.4 5.1 2.8 7.3 9.6 7.2 5.6 6.1 17.4 15.4 10.0 2.6 10.3 1.8 14.5 4.5 4.1 5.9 8.3 13.0 7.0 5.3 4.3 9.9 4.8 6.6 8.7 23.8 3.2 10.7 23.0 10.2 23.9 15.9 15.3 9.4 17.0 19.2 13.7 10.7 29.9 13.8 557.4 22.4 0.7 23.3 6.0 17.2 15.5 23.9 13.9 0.4 6.7 27.0 0.0 22.7 4.0 339.6 25.3 10.3 13.5 9.0 2.4 20.1 6.5 0.0 16.3 2.2 19.1 19.4 17.6 39.3 35.1 12.8 9.8 10.4 1.9 22.1 ZNF680 FLJ90430 ENSG00000173041 "Zinc finger protein 680" Q8NEM1 7 64519884-64563106 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 37.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA003173 Approved Nucleoplasm NA NA Nucleoplasm "HPA003173: AB_1080744" "unprognostic (1.65e-1)" "unprognostic (3.21e-2)" "unprognostic (6.88e-2)" "unprognostic (7.41e-2)" "unprognostic (1.52e-3)" "unprognostic (3.62e-2)" "unprognostic (1.79e-1)" "unprognostic (2.07e-1)" "unprognostic (1.07e-2)" "unprognostic (1.20e-1)" "unprognostic (2.46e-1)" "unprognostic (5.72e-2)" "unprognostic (1.35e-1)" "unprognostic (8.66e-2)" "unprognostic (2.21e-1)" "unprognostic (2.26e-1)" "unprognostic (8.05e-3)" 6.4 15.8 18.7 4.2 24.4 2.6 15.4 37.0 23.7 7.7 4.4 7.1 3.3 3.4 5.9 7.0 4.4 6.2 6.2 12.1 20.0 10.8 9.8 21.6 5.7 6.9 23.4 14.6 13.1 5.8 4.0 10.0 5.3 19.9 12.0 6.2 3.9 5.4 6.8 11.6 6.6 3.9 7.1 25.9 7.3 7.0 4.7 24.4 5.4 28.5 6.6 6.0 6.8 5.2 4.3 1.7 4.2 1.3 8.3 4.4 1.7 3.7 2.2 8.8 10.6 4.4 5.0 5.6 3.1 2.5 5.6 7.0 3.0 7.3 7.1 7.6 2.9 6.3 2.6 7.2 3.3 9.1 1.3 5.1 5.4 4.3 2.7 1.9 7.1 4.9 3.3 4.0 4.9 5.5 7.0 5.2 10.1 9.7 0.0 7.6 2.9 11.0 11.5 10.4 3.3 2.7 8.7 9.0 21.4 7.7 12.2 7.2 9.7 9.2 8.7 3.2 17.4 8.8 3.1 2.8 6.8 3.4 3.2 5.2 6.3 8.1 20.2 0.3 6.6 5.9 4.2 1.0 1.1 3.0 1.3 2.5 4.3 4.1 3.5 1.7 3.4 4.4 4.0 0.5 8.3 1.1 1.4 1.2 1.7 18.7 24.4 37.0 23.7 20.0 10.8 23.4 14.6 19.9 24.4 11.9 3.2 9.9 9.2 3.8 11.2 11.6 20.4 2.7 12.5 24.4 3.9 10.0 8.3 7.5 0.8 8.7 2.2 0.0 8.0 8.8 9.1 11.1 6.9 17.4 4.4 1.6 0.0 26.4 12.4 1.3 25.6 5.6 6.8 8.2 4.3 22.8 5.2 3.5 20.8 5.6 9.0 19.4 6.9 11.1 15.1 4.5 5.9 10.2 4.5 8.1 ZNF684 MGC27466 ENSG00000117010 "Zinc finger protein 684" Q5T5D7 1 40531561-40548169 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 28.0" "Low region specificity" "Detected in all" HPA059153 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA059153: AB_2683932" "unprognostic (4.56e-2)" "unprognostic (1.41e-1)" "unprognostic (1.01e-4)" "unprognostic (2.29e-2)" "unprognostic (2.96e-2)" "unprognostic (3.67e-4)" "unprognostic (8.49e-2)" "unprognostic (2.26e-3)" "unprognostic (2.10e-2)" "unprognostic (7.00e-2)" "unprognostic (4.14e-3)" "unprognostic (3.96e-2)" "prognostic favorable (4.89e-10)" "unprognostic (4.76e-3)" "unprognostic (7.11e-2)" "unprognostic (5.98e-2)" "unprognostic (1.52e-2)" 3.6 6.4 4.1 2.9 8.9 8.2 4.2 5.8 7.4 3.6 3.8 2.3 5.4 3.2 3.6 4.3 3.2 3.1 3.4 10.6 4.4 3.3 18.3 20.8 3.4 4.4 9.8 3.6 3.8 5.4 2.5 4.6 2.1 5.4 5.1 4.8 1.6 3.5 4.1 4.4 4.1 3.4 3.2 5.9 5.1 4.2 4.3 7.8 6.4 5.6 4.1 3.5 3.1 2.7 6.0 3.9 7.0 7.7 3.5 5.9 2.4 2.2 0.7 2.8 3.8 2.6 3.8 1.7 2.0 2.0 2.4 4.1 1.4 2.9 3.8 1.7 1.3 1.6 2.7 2.8 2.0 3.8 3.3 4.7 4.1 2.6 3.6 1.3 4.4 4.5 2.5 0.8 2.9 1.1 1.4 3.7 3.0 2.1 5.7 3.4 0.6 6.4 5.1 6.8 0.9 2.3 3.0 8.4 2.6 3.6 1.9 2.1 3.6 3.7 3.7 4.1 3.6 1.6 28.0 2.1 2.5 5.2 2.4 3.9 4.8 3.4 4.4 2.2 4.7 3.8 7.0 4.0 1.9 5.9 7.7 3.2 6.0 4.2 3.6 2.4 3.5 2.8 5.5 2.3 3.5 4.1 3.9 4.7 2.4 4.1 8.9 5.8 7.4 4.4 3.3 9.8 3.6 5.4 7.8 6.0 2.7 3.7 1.7 2.1 3.0 9.9 2.5 5.3 3.4 7.0 0.0 1.0 14.9 4.4 1.8 3.5 1.3 0.0 12.9 2.1 2.8 1.0 2.3 14.5 4.2 3.2 1.2 4.3 4.3 2.6 2.3 4.3 8.5 7.2 1.7 3.5 4.9 2.0 2.8 12.4 2.3 0.0 4.7 6.1 3.2 1.1 0.0 4.8 3.8 0.9 ZNF687 KIAA1441 ENSG00000143373 "Zinc finger protein 687" Q8N1G0 1 151281618-151292180 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 13.1;neutrophil: 9.6" "Group enriched" "Detected in many" 6 "granulocytes: 13.1;monocytes: 4.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021193, HPA023948" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021193: AB_1859415, HPA023948: AB_2671380" "unprognostic (2.23e-1)" "unprognostic (3.25e-1)" "unprognostic (2.93e-2)" "unprognostic (9.64e-3)" "unprognostic (2.44e-2)" "unprognostic (7.82e-2)" "unprognostic (2.62e-2)" "unprognostic (1.56e-1)" "unprognostic (1.39e-1)" "unprognostic (9.91e-2)" "unprognostic (8.69e-3)" "unprognostic (2.10e-1)" "unprognostic (5.82e-3)" "unprognostic (1.36e-1)" "unprognostic (1.41e-1)" "unprognostic (8.54e-2)" "unprognostic (7.99e-2)" 9.8 13.6 9.9 10.7 11.4 36.1 10.6 16.1 21.0 13.6 17.3 17.1 10.9 11.7 13.5 12.9 12.9 13.2 12.8 10.0 9.2 9.7 13.0 14.4 10.2 14.8 9.4 10.7 16.6 21.4 23.0 16.4 13.5 10.6 13.3 8.1 17.6 16.2 13.3 12.5 14.1 15.2 11.4 9.6 17.9 12.5 22.5 9.8 19.6 14.0 8.3 15.4 13.9 9.9 1.3 0.9 13.1 4.1 0.5 0.9 1.0 9.4 14.3 13.2 8.0 7.4 6.3 18.3 5.3 8.4 8.9 8.9 11.2 12.4 8.1 13.1 7.7 9.6 14.7 11.5 9.8 4.0 12.0 12.6 7.7 11.5 12.7 8.2 8.7 11.3 9.9 10.0 7.4 7.9 7.9 5.9 9.1 12.0 14.4 4.9 28.1 12.2 10.5 17.9 12.2 10.8 10.9 10.8 14.7 7.4 13.9 12.3 19.6 13.2 15.6 12.7 12.9 20.6 19.0 5.7 7.1 8.3 9.2 7.6 18.0 15.1 19.8 9.1 5.9 9.0 0.4 1.8 13.1 0.6 2.2 0.7 1.1 0.6 0.6 0.9 1.3 0.8 0.9 9.6 0.5 4.1 0.8 0.4 1.0 9.9 11.4 16.1 21.0 9.2 9.7 9.4 10.7 10.6 9.8 3.0 5.8 1.9 3.0 4.1 6.4 1.2 7.6 1.4 1.2 1.8 9.8 5.7 3.3 5.1 1.6 2.5 5.9 0.0 5.1 4.2 4.1 3.5 0.0 4.0 4.5 7.9 2.4 4.3 3.8 2.1 5.8 4.3 0.0 5.4 6.5 6.1 6.4 2.9 6.7 3.3 10.6 12.9 2.2 8.6 8.6 3.0 7.9 3.3 7.5 4.1 ZNF688 ENSG00000229809 "Zinc finger protein 688" P0C7X2 16 30569346-30572734 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Early spermatids: 132.4;Late spermatids: 434.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048922 Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA Nucleoplasm "Plasma membrane, Cell Junctions" "HPA048922: AB_2680557" "prognostic favorable (5.90e-4)" "prognostic favorable (7.74e-4)" "unprognostic (1.68e-1)" "prognostic favorable (4.58e-5)" "unprognostic (1.37e-1)" "unprognostic (1.76e-2)" "unprognostic (4.01e-1)" "prognostic favorable (3.24e-4)" "unprognostic (1.11e-1)" "unprognostic (3.26e-2)" "prognostic favorable (6.61e-4)" "unprognostic (7.75e-2)" "unprognostic (5.14e-2)" "unprognostic (7.08e-2)" "unprognostic (2.48e-1)" "unprognostic (4.12e-2)" "unprognostic (4.03e-2)" 10.7 11.9 14.2 11.8 11.8 13.7 8.0 13.8 16.7 8.8 15.3 15.5 12.1 20.5 11.5 9.6 12.0 13.5 14.5 17.2 13.1 10.6 11.2 12.4 10.3 19.9 12.1 11.5 12.9 14.7 8.4 14.0 7.8 11.2 11.8 9.0 11.0 13.8 10.1 32.5 9.5 14.4 14.2 11.0 13.9 13.0 24.6 8.3 21.6 13.7 8.3 10.0 10.4 13.3 6.1 5.4 12.6 5.4 15.1 6.8 2.8 7.8 5.9 6.0 6.3 11.4 2.9 2.5 4.5 6.2 3.8 3.0 1.8 11.9 4.1 9.1 5.6 5.2 5.8 1.7 2.8 4.1 12.2 3.6 2.8 2.3 1.4 3.0 3.9 12.7 5.9 6.3 4.0 4.9 6.5 3.8 5.6 2.9 9.6 4.2 4.7 11.1 4.3 2.2 7.7 1.9 9.5 2.4 6.2 6.6 2.5 8.6 9.6 1.6 11.8 9.9 1.8 12.9 6.5 2.9 3.3 3.6 3.8 3.5 13.8 9.6 4.4 10.1 3.4 5.6 12.6 3.9 8.3 4.8 3.9 5.8 5.5 5.6 5.4 3.9 6.1 4.8 4.4 6.0 15.1 5.4 5.4 6.8 2.8 14.2 11.8 13.8 16.7 13.1 10.6 12.1 11.5 11.2 8.3 6.0 1.9 17.1 10.5 5.7 19.5 8.5 17.8 20.1 6.8 15.7 17.7 6.3 41.4 19.2 132.4 11.1 34.5 0.0 27.4 7.9 13.1 9.8 4.7 18.7 21.4 20.6 19.5 14.1 22.9 434.2 18.4 15.6 16.9 28.9 25.1 28.0 19.6 32.3 18.7 38.4 25.5 6.5 12.5 25.3 7.9 6.1 3.9 20.3 22.1 5.7 ZNF689 FLJ90415 ENSG00000156853 "Zinc finger protein 689" Q96CS4 16 30602558-30624012 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 39.7;Late spermatids: 41.2;Spermatocytes: 48.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054095, HPA055385" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" No No "Nucleoplasm, Nucleoli fibrillar center" "HPA054095: AB_2682377, HPA055385: AB_2682801" "unprognostic (5.62e-2)" "unprognostic (2.36e-2)" "unprognostic (2.77e-3)" "unprognostic (2.73e-2)" "unprognostic (7.73e-2)" "unprognostic (3.74e-2)" "unprognostic (1.57e-1)" "unprognostic (8.38e-2)" "unprognostic (5.83e-3)" "unprognostic (2.26e-1)" "prognostic favorable (9.89e-4)" "unprognostic (3.21e-1)" "unprognostic (1.58e-3)" "unprognostic (3.93e-2)" "unprognostic (5.23e-1)" "unprognostic (1.84e-1)" "unprognostic (3.69e-2)" 5.9 5.7 5.6 4.7 7.5 7.8 15.0 7.5 10.7 7.4 6.2 8.6 5.4 6.7 8.5 4.1 3.7 6.4 6.1 5.2 4.7 4.5 5.2 6.3 4.9 5.2 8.0 4.9 8.0 7.2 11.8 7.7 4.6 4.8 6.1 4.6 7.7 4.8 7.1 6.7 3.8 6.7 6.0 4.8 7.3 5.7 28.2 8.2 11.4 6.7 4.3 6.5 6.8 4.6 4.4 9.6 2.7 10.5 9.3 6.0 4.4 3.5 6.3 8.8 9.2 3.8 3.8 4.4 4.4 6.4 7.2 7.0 7.4 2.8 10.2 6.9 3.8 5.2 2.7 11.0 4.8 5.8 8.3 18.7 8.6 5.5 11.3 4.0 8.4 6.6 3.6 4.6 4.9 4.9 3.9 5.0 9.4 10.1 5.9 4.6 5.3 15.5 8.0 10.0 2.8 6.5 19.6 8.5 9.1 3.0 3.5 11.1 6.7 3.2 5.8 5.0 4.6 6.1 7.4 3.9 9.4 4.0 4.5 6.0 10.9 12.5 12.3 3.4 9.3 9.0 0.2 6.8 2.7 5.9 10.0 4.3 4.4 5.0 6.0 9.6 3.7 4.5 4.2 0.4 9.3 10.5 3.6 4.7 4.4 5.6 7.5 7.5 10.7 4.7 4.5 8.0 4.9 4.8 8.2 3.0 1.3 10.9 4.5 1.4 7.9 3.9 10.2 1.4 0.0 1.8 5.9 3.5 0.0 5.4 39.7 6.7 6.1 0.0 5.9 3.0 4.5 4.5 13.9 5.0 4.3 9.5 5.8 5.5 3.5 41.2 7.5 4.4 0.0 1.8 5.5 5.2 4.7 3.5 9.9 3.5 5.9 0.0 4.5 48.6 7.7 0.9 0.7 5.0 6.0 2.3 ZNF69 Cos5 ENSG00000198429 "Zinc finger protein 69" Q9UC07 19 11887784-11914329 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cholangiocytes: 15.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 11.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 13.1" HPA047845 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA047845: AB_2680178" "unprognostic (1.08e-1)" "unprognostic (4.58e-2)" "unprognostic (1.80e-1)" "prognostic favorable (1.55e-4)" "unprognostic (2.45e-2)" "unprognostic (1.21e-2)" "unprognostic (3.47e-2)" "unprognostic (1.37e-2)" "unprognostic (3.08e-3)" "unprognostic (3.97e-2)" "unprognostic (2.09e-1)" "unprognostic (4.83e-3)" "unprognostic (4.12e-2)" "unprognostic (2.54e-1)" "unprognostic (1.26e-1)" "unprognostic (7.97e-2)" "unprognostic (1.93e-2)" 3.8 7.7 4.3 10.6 4.9 3.5 14.3 6.7 5.4 7.9 10.9 3.5 5.4 3.4 6.3 4.6 2.9 8.3 7.8 7.1 6.1 3.6 14.0 11.8 7.1 7.1 4.5 1.6 11.1 11.0 22.7 4.9 4.5 7.1 7.4 11.6 5.7 5.9 4.1 2.5 2.1 5.2 12.1 6.3 4.2 12.7 11.1 4.8 9.4 6.3 1.9 3.0 7.8 13.8 1.0 2.4 11.0 2.3 3.3 4.8 2.0 5.0 0.2 13.1 7.3 1.4 0.1 4.5 7.6 5.3 4.2 5.2 3.4 2.0 3.2 4.5 4.4 3.2 0.1 0.0 2.9 4.3 0.0 0.1 1.5 0.1 7.5 1.1 0.0 3.1 2.1 0.0 1.5 0.1 2.1 0.1 4.6 0.0 0.2 8.7 0.0 3.9 0.6 8.1 0.4 0.0 0.1 3.0 0.1 9.6 3.4 1.2 3.6 0.0 0.2 1.9 6.7 6.7 2.0 0.3 3.4 2.2 3.4 4.2 3.5 3.2 0.0 0.1 0.0 10.6 11.0 2.1 1.5 2.6 2.3 2.5 1.0 1.8 1.1 2.4 0.7 4.7 4.8 0.8 3.3 1.2 1.7 1.2 2.0 4.3 4.9 6.7 5.4 6.1 3.6 4.5 1.6 7.1 4.8 3.0 7.5 0.0 1.3 0.2 0.7 2.4 15.3 5.3 6.8 5.2 0.0 3.1 3.3 4.5 6.8 1.8 2.0 0.0 3.1 2.8 1.3 1.0 7.0 9.6 2.5 0.0 0.0 3.7 2.7 12.7 2.3 3.6 5.0 0.0 5.6 0.5 8.4 3.5 1.8 8.6 0.2 12.9 1.0 2.7 1.5 0.1 1.6 2.9 5.9 2.6 ZNF691 Zfp691 ENSG00000164011 "Zinc finger protein 691" Q5VV52 1 42846573-42852477 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062527 Approved Approved Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA062527: AB_2684791" "unprognostic (4.34e-2)" "unprognostic (4.05e-2)" "unprognostic (1.09e-1)" "unprognostic (4.32e-2)" "unprognostic (4.86e-2)" "unprognostic (5.50e-2)" "prognostic unfavorable (7.33e-6)" "unprognostic (1.40e-3)" "unprognostic (2.65e-3)" "unprognostic (5.12e-2)" "prognostic favorable (6.25e-5)" "unprognostic (1.24e-1)" "unprognostic (1.06e-2)" "unprognostic (1.41e-1)" "unprognostic (1.78e-1)" "unprognostic (1.00e-1)" "unprognostic (1.05e-1)" 7.8 14.6 13.6 11.2 15.5 2.9 15.6 10.8 14.4 12.9 12.6 18.3 14.1 8.8 16.9 21.8 9.1 14.2 8.4 11.4 11.9 9.8 14.2 24.1 9.9 16.0 12.2 12.1 18.6 13.4 19.2 17.3 12.7 12.3 16.8 10.2 12.3 15.2 18.5 10.9 12.8 10.6 13.5 11.9 17.7 10.8 13.9 14.8 17.9 19.3 6.4 16.8 11.8 10.0 20.5 12.5 18.2 11.2 18.4 19.3 12.8 4.5 6.3 12.8 10.5 11.6 8.9 1.6 5.4 6.5 8.8 8.8 4.4 6.6 11.1 8.4 5.0 4.4 8.0 12.3 7.1 7.6 19.8 12.4 11.6 17.3 7.9 8.6 4.4 2.5 7.7 8.7 11.0 9.1 10.8 8.9 11.0 11.2 4.8 8.6 3.6 13.2 5.9 19.1 4.9 4.7 9.0 16.1 7.6 8.2 4.3 9.2 9.2 5.5 10.0 9.3 20.0 5.5 15.2 4.6 8.8 9.3 4.9 5.8 11.7 9.2 3.2 6.2 5.4 7.4 18.2 11.2 16.0 12.2 9.7 15.7 15.9 16.4 16.4 11.1 20.5 15.8 15.7 6.3 18.4 10.0 12.5 19.3 12.8 13.6 15.5 10.8 14.4 11.9 9.8 12.2 12.1 12.3 14.8 6.0 2.4 3.0 2.1 1.5 2.4 5.7 5.1 4.0 2.3 5.2 3.9 5.4 6.6 3.9 3.0 3.6 1.7 0.0 3.3 4.4 4.0 2.4 4.7 6.4 6.4 1.6 2.9 6.2 3.3 2.5 6.6 3.5 1.7 3.6 2.7 5.2 2.4 2.9 6.7 6.8 4.2 0.0 3.9 9.1 6.4 0.6 2.7 6.4 2.3 1.0 ZNF692 "AREBP, FLJ20531, Zfp692" ENSG00000171163 "Zinc finger protein 692" Q9BU19 1 248850006-248859144 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059337, HPA062792" Uncertain Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA059337: AB_2683984, HPA062792: AB_2684869" "unprognostic (4.86e-2)" "unprognostic (9.51e-2)" "unprognostic (1.64e-3)" "unprognostic (1.05e-2)" "unprognostic (1.90e-1)" "unprognostic (6.72e-3)" "unprognostic (2.85e-3)" "unprognostic (5.66e-3)" "unprognostic (1.25e-1)" "unprognostic (4.50e-2)" "prognostic favorable (4.09e-4)" "unprognostic (5.65e-3)" "prognostic unfavorable (7.72e-9)" "unprognostic (5.32e-2)" "unprognostic (2.07e-2)" "unprognostic (1.59e-1)" "prognostic favorable (8.35e-5)" 5.6 8.7 15.3 7.9 25.0 11.1 10.7 27.7 22.3 11.6 8.1 16.5 17.8 8.3 13.6 15.1 9.7 13.1 9.4 7.4 20.1 11.6 9.7 8.6 6.9 9.8 30.4 14.3 17.2 12.2 18.4 13.8 8.1 21.2 14.9 7.0 7.7 21.9 11.1 11.5 19.6 8.9 9.2 18.3 10.0 8.7 22.9 25.7 6.6 11.3 9.2 7.8 9.1 8.8 4.6 4.4 4.8 2.1 10.6 6.4 2.8 4.8 5.1 4.3 10.7 3.7 1.9 18.7 4.1 1.4 4.7 3.0 5.8 7.0 6.0 8.5 2.0 1.9 7.0 6.5 6.2 3.4 8.9 4.4 7.1 10.9 1.6 2.8 7.9 5.7 2.4 8.0 4.8 12.8 4.7 4.3 8.0 14.6 4.4 2.1 3.4 4.0 16.3 8.8 12.4 11.1 13.7 2.8 12.0 9.0 3.6 8.5 6.3 4.5 7.8 8.4 1.7 9.5 13.0 3.0 2.1 3.5 2.3 5.6 12.4 7.8 3.8 4.6 10.5 3.5 0.0 2.1 1.9 5.7 1.6 4.9 4.6 4.5 6.0 4.4 3.8 6.4 4.6 4.8 10.6 1.4 3.5 4.7 2.8 15.3 25.0 27.7 22.3 20.1 11.6 30.4 14.3 21.2 25.7 8.9 7.5 8.0 10.6 8.5 14.0 3.0 10.2 8.1 2.3 10.4 21.6 10.2 5.0 6.3 8.0 6.3 8.8 23.3 3.4 9.1 6.6 13.7 5.7 5.9 5.7 11.1 7.9 1.8 6.9 5.8 9.5 5.4 15.1 6.4 9.4 8.4 6.1 5.8 6.7 3.1 13.8 0.0 4.9 31.1 15.6 6.9 5.1 10.2 11.7 8.5 ZNF696 FLJ14129 ENSG00000185730 "Zinc finger protein 696" Q9H7X3 8 143289676-143298061 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA057855, HPA072473" Uncertain Approved Nucleoplasm,Nucleoli No No Nucleoplasm Nucleoli "HPA057855: AB_2683545, HPA072473: AB_2686524" "unprognostic (3.23e-2)" "prognostic unfavorable (6.63e-5)" "unprognostic (3.62e-2)" "prognostic unfavorable (3.52e-5)" "unprognostic (2.58e-1)" "unprognostic (7.86e-2)" "unprognostic (2.76e-3)" "unprognostic (8.82e-2)" "unprognostic (3.16e-1)" "unprognostic (3.02e-1)" "prognostic favorable (1.41e-4)" "unprognostic (6.57e-2)" "unprognostic (8.22e-2)" "unprognostic (7.99e-2)" "unprognostic (2.86e-1)" "unprognostic (3.42e-3)" "unprognostic (8.09e-3)" 8.5 6.9 10.3 8.1 10.6 6.3 6.9 13.9 13.7 5.6 5.4 9.8 5.4 13.5 8.8 4.8 5.0 6.6 7.1 5.2 10.4 10.3 7.2 8.1 7.6 8.6 12.6 7.2 9.8 13.7 8.6 6.7 5.5 10.6 7.5 4.1 7.2 11.9 5.1 7.7 13.3 8.0 10.7 8.9 8.3 6.5 6.9 12.8 6.5 7.5 3.0 6.6 7.2 5.2 6.4 6.4 2.3 3.3 5.3 7.5 3.3 6.3 5.9 5.7 6.8 2.5 1.7 12.4 5.0 1.6 3.6 2.1 3.4 5.0 0.4 7.0 1.7 2.0 4.5 6.6 2.7 3.2 7.1 14.4 8.5 5.6 5.1 2.5 3.4 10.9 1.5 4.5 2.4 5.0 2.3 1.7 5.1 17.6 3.9 2.1 12.7 3.7 7.0 8.1 6.9 15.1 7.8 3.6 6.2 1.9 4.6 9.7 13.6 7.6 4.9 6.2 3.9 8.0 6.2 3.6 4.9 11.2 4.3 8.8 8.1 5.4 7.9 3.3 7.0 5.7 1.1 3.3 2.3 5.3 1.9 5.8 4.2 4.0 5.9 3.7 6.4 7.5 6.2 1.4 5.3 2.9 6.4 1.3 3.3 10.3 10.6 13.9 13.5 10.4 10.3 12.6 7.2 10.6 12.8 0.0 0.0 0.0 2.1 2.6 4.3 2.4 0.0 0.0 0.0 3.5 5.9 1.2 3.3 2.3 0.6 2.1 2.0 0.0 1.8 2.1 1.5 1.2 0.0 2.1 1.1 3.2 0.0 1.8 0.0 1.6 3.7 0.0 1.7 1.0 0.9 2.5 1.6 0.0 1.1 1.9 3.4 6.5 1.6 2.1 5.9 1.8 0.3 1.5 1.9 0.7 ZNF697 MGC45731 ENSG00000143067 "Zinc finger protein 697" Q5TEC3 1 119619422-119647773 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Syncytiotrophoblasts: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SK-MEL-30: 24.8;WM-115: 25.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049933 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA049933: AB_2680958" "unprognostic (2.57e-1)" "unprognostic (7.02e-3)" "unprognostic (4.32e-2)" "unprognostic (2.45e-2)" "unprognostic (3.38e-1)" "unprognostic (9.79e-3)" "unprognostic (1.20e-3)" "unprognostic (1.30e-3)" "unprognostic (2.82e-1)" "unprognostic (1.45e-1)" "unprognostic (5.09e-2)" "unprognostic (1.14e-1)" "prognostic favorable (6.20e-5)" "unprognostic (1.19e-2)" "unprognostic (6.48e-2)" "unprognostic (3.53e-2)" "unprognostic (3.36e-1)" 6.1 4.1 4.5 1.7 5.2 1.0 5.0 1.6 6.9 2.0 2.8 0.7 3.5 2.1 3.1 3.4 1.2 2.0 2.0 6.3 1.8 1.2 11.1 5.3 6.5 0.6 2.1 6.6 3.3 7.3 4.2 6.4 9.7 3.8 6.2 1.9 1.0 10.8 1.3 2.9 2.3 1.9 4.4 1.5 2.3 2.5 5.0 1.2 0.5 4.6 2.2 0.7 2.4 1.5 0.0 0.6 0.3 1.5 0.0 0.1 0.3 1.1 0.6 3.0 1.0 4.0 4.5 4.1 5.3 7.4 3.1 2.9 1.8 0.2 0.0 1.8 2.9 2.4 1.3 2.3 5.2 7.4 0.0 2.3 1.9 1.1 3.5 7.7 1.2 1.3 7.5 1.5 7.0 15.0 3.4 6.1 1.7 1.7 0.2 1.4 0.9 0.0 0.9 15.9 1.0 1.7 0.0 7.3 0.1 1.4 2.7 0.6 4.1 1.2 1.3 24.8 9.9 0.6 1.8 14.0 5.2 6.6 3.6 9.1 0.7 1.1 0.0 7.4 1.4 25.4 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 4.5 5.2 1.6 6.9 1.8 1.2 2.1 6.6 3.8 1.2 0.0 0.3 0.0 1.5 1.9 0.9 8.6 0.0 0.0 2.3 1.8 0.0 6.5 3.3 1.7 1.3 3.5 1.0 0.0 0.7 1.7 4.8 4.5 0.0 3.0 2.3 0.0 2.4 4.9 6.5 2.2 4.4 2.2 5.0 0.0 2.2 1.9 1.9 2.0 6.0 5.3 0.8 6.5 2.1 0.2 0.4 1.6 16.6 0.0 1.4 0.9 ZNF700 DKFZp434I1610 ENSG00000196757 "Zinc finger protein 700" Q9H0M5 19 11925068-11950773 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA047845 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA047845: AB_2680178" "unprognostic (1.92e-1)" "unprognostic (1.20e-2)" "unprognostic (3.99e-1)" "unprognostic (1.97e-1)" "unprognostic (1.51e-1)" "prognostic favorable (1.27e-4)" "unprognostic (8.63e-2)" "unprognostic (8.68e-2)" "prognostic unfavorable (2.58e-4)" "unprognostic (9.02e-2)" "unprognostic (7.44e-2)" "prognostic unfavorable (1.75e-4)" "prognostic unfavorable (2.01e-5)" "unprognostic (8.38e-2)" "unprognostic (2.24e-1)" "unprognostic (1.30e-1)" "prognostic favorable (2.53e-5)" 10.2 10.3 7.7 22.2 9.6 19.7 21.6 10.2 8.9 8.3 11.3 5.7 13.6 8.4 9.5 12.7 11.8 8.6 13.9 6.8 7.2 3.8 13.6 16.7 13.5 14.6 8.6 5.4 13.1 23.7 13.4 12.4 6.9 7.4 12.0 15.2 7.2 15.8 11.5 5.1 21.8 15.3 14.4 7.1 20.7 11.3 17.3 8.5 10.3 11.2 6.7 14.7 10.8 13.4 6.9 6.4 9.5 8.1 7.2 8.3 3.8 6.5 0.3 7.1 7.3 4.5 5.0 7.2 7.0 6.1 6.3 8.4 5.5 3.3 8.7 6.2 4.5 4.3 5.2 5.8 5.1 8.8 4.9 3.1 8.9 6.5 4.9 3.8 12.6 13.3 4.1 6.1 5.4 6.1 4.3 3.9 5.8 10.0 19.6 9.1 5.4 6.9 11.7 7.3 3.9 6.5 5.9 9.4 6.7 9.0 7.6 4.2 5.1 6.4 4.3 8.2 6.8 7.3 14.5 5.6 16.3 4.2 11.1 8.0 13.6 7.2 9.2 4.3 10.4 5.3 9.5 4.6 9.0 6.9 5.2 7.8 6.9 5.7 8.3 6.4 4.4 5.5 6.9 7.3 7.2 8.1 4.1 6.4 3.8 7.7 9.6 10.2 8.9 7.2 3.8 8.6 5.4 7.4 8.5 8.9 10.2 6.7 1.7 2.7 2.3 3.6 10.2 4.0 10.3 1.8 2.0 4.3 1.7 4.6 0.4 3.6 5.2 0.0 4.0 3.9 1.7 1.7 15.1 7.2 3.8 0.0 2.9 6.2 7.5 0.9 4.0 4.6 5.0 1.0 6.8 2.0 4.9 8.6 1.8 1.3 4.1 0.0 5.1 10.6 6.4 1.5 3.1 5.1 8.1 1.1 ZNF701 FLJ10891 ENSG00000167562 "Zinc finger protein 701" Q9NV72 19 52555457-52587174 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 23.4" HPA005532 Uncertain Approved "Nucleoplasm,Centriolar satellite" NA NA Nucleoplasm "Centriolar satellite" "HPA005532: AB_1080746" "unprognostic (1.21e-1)" "unprognostic (4.98e-3)" "unprognostic (5.58e-2)" "unprognostic (3.40e-1)" "unprognostic (7.74e-2)" "unprognostic (1.13e-2)" "unprognostic (8.86e-2)" "unprognostic (4.67e-2)" "unprognostic (5.46e-4)" "unprognostic (3.75e-1)" "unprognostic (2.86e-1)" "unprognostic (1.16e-2)" "unprognostic (8.17e-3)" "unprognostic (8.64e-2)" "unprognostic (2.54e-1)" "unprognostic (2.79e-1)" "prognostic favorable (4.89e-5)" 10.0 7.8 9.5 13.5 13.8 11.0 9.9 12.1 8.6 8.8 12.1 7.0 9.2 6.1 8.9 9.8 8.1 9.5 6.2 6.7 9.0 4.6 11.5 3.8 7.1 9.1 11.9 2.7 10.0 7.2 9.6 11.7 22.4 10.3 10.2 9.0 3.6 9.4 8.8 6.4 9.1 10.5 6.0 14.5 11.4 7.8 7.3 12.5 28.0 12.1 4.1 8.8 10.1 11.6 8.1 5.9 19.9 8.8 11.5 8.8 6.0 1.8 0.4 4.1 7.5 4.2 5.4 7.5 4.7 4.9 6.5 6.8 3.8 4.4 8.3 2.6 3.7 6.2 2.8 1.8 5.3 7.2 0.3 5.5 2.4 6.8 1.0 4.9 0.3 11.7 6.0 3.8 5.0 8.4 3.4 6.1 4.4 10.7 1.3 5.6 1.5 8.6 4.0 4.0 2.2 6.2 8.7 5.4 3.7 5.0 23.4 4.0 4.6 3.2 7.8 2.4 8.9 10.1 5.3 5.4 5.2 2.6 2.5 8.4 1.0 5.5 11.3 0.2 9.2 8.2 15.3 8.1 15.5 8.7 8.8 7.3 7.9 6.9 7.4 5.9 8.1 8.2 8.8 19.9 11.5 6.5 5.7 8.0 6.0 9.5 13.8 12.1 8.6 9.0 4.6 11.9 2.7 10.3 12.5 0.0 6.7 6.2 5.8 1.9 5.4 3.6 2.5 6.7 6.8 14.0 13.7 12.0 3.3 5.9 1.6 5.6 8.6 0.0 3.5 8.2 4.0 7.0 2.3 0.5 4.7 3.2 2.4 6.7 5.3 1.0 5.8 8.3 3.3 9.0 4.9 3.5 4.5 5.8 3.5 2.4 5.6 0.0 4.6 3.0 7.7 3.1 19.7 14.9 3.6 10.2 ZNF704 "FLJ16218, Gig1" ENSG00000164684 "Zinc finger protein 704" Q6ZNC4 8 80628451-80874781 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "non-classical monocyte: 1.6" "Lineage enriched" "Detected in single" 5 "monocytes: 1.6" "Cell line enhanced" "Detected in many" "HaCaT: 30.7;RH-30: 19.9;SH-SY5Y: 25.4;SK-BR-3: 31.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024285, HPA024302" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA024285: AB_2219847, HPA024302: AB_1859427" "unprognostic (5.23e-2)" "unprognostic (1.39e-1)" "unprognostic (2.27e-1)" "unprognostic (3.39e-3)" "unprognostic (6.86e-2)" "unprognostic (1.05e-1)" "unprognostic (1.81e-1)" "unprognostic (1.34e-1)" "unprognostic (2.80e-1)" "unprognostic (1.16e-1)" "unprognostic (7.02e-2)" "unprognostic (1.26e-1)" "prognostic favorable (4.02e-4)" "unprognostic (1.68e-2)" "unprognostic (1.62e-1)" "unprognostic (2.58e-1)" "unprognostic (9.90e-2)" 9.7 5.6 10.4 5.5 12.5 0.9 15.9 25.4 11.6 20.2 7.3 11.9 7.2 2.9 19.2 7.6 3.2 13.7 8.5 11.7 9.5 6.3 9.5 3.9 9.4 1.5 11.8 6.1 20.8 19.5 22.7 2.9 5.1 10.5 10.6 6.3 6.9 13.6 13.3 5.9 5.2 4.8 7.5 9.2 3.2 5.8 7.3 14.6 12.0 6.2 5.9 1.3 8.6 13.9 0.0 0.0 0.3 1.6 0.2 0.1 0.0 0.0 1.1 4.9 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.5 0.8 0.0 1.9 0.0 0.4 30.7 0.4 0.8 0.0 0.0 5.2 1.8 2.2 4.0 0.0 0.3 0.1 0.2 0.0 0.0 0.1 0.0 2.0 0.2 0.0 0.1 0.0 3.1 4.5 0.0 0.4 2.6 0.4 3.2 19.9 0.0 0.0 10.7 6.3 25.4 0.9 31.1 9.2 1.7 4.9 0.6 0.1 0.0 5.2 0.1 1.0 0.0 0.0 0.1 0.3 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 1.6 0.0 0.0 0.0 10.4 12.5 25.4 11.6 9.5 6.3 11.8 6.1 10.5 14.6 47.6 20.4 0.8 22.3 16.5 21.9 32.0 17.8 20.1 27.3 24.4 0.0 7.0 5.0 14.9 20.7 18.8 15.6 0.0 21.0 4.6 16.7 31.5 26.6 9.6 2.6 19.1 13.3 27.0 5.1 34.8 30.5 2.0 30.4 0.0 25.3 14.6 10.5 14.0 24.1 14.6 2.5 12.9 17.6 1.8 1.3 4.4 2.4 0.5 18.9 29.8 ZNF707 ENSG00000181135 "Zinc finger protein 707" Q96C28 8 143684452-143713898 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 14.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA044991 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA044991: AB_10961134" "unprognostic (5.12e-2)" "unprognostic (5.65e-2)" "unprognostic (3.86e-2)" "prognostic unfavorable (6.79e-4)" "unprognostic (1.73e-1)" "unprognostic (5.91e-2)" "unprognostic (2.94e-2)" "unprognostic (1.65e-1)" "unprognostic (8.66e-2)" "unprognostic (1.11e-1)" "unprognostic (6.98e-2)" "unprognostic (5.07e-2)" "unprognostic (2.30e-2)" "unprognostic (1.14e-2)" "unprognostic (5.23e-1)" "unprognostic (2.47e-2)" "unprognostic (4.08e-2)" 5.4 5.4 6.6 6.2 7.5 5.7 6.0 6.6 8.0 5.5 5.1 7.0 10.4 6.2 6.1 7.1 6.3 6.2 5.8 3.9 6.6 3.4 6.1 5.5 7.7 9.4 10.3 5.1 5.7 8.3 9.2 7.9 4.7 5.5 7.0 3.6 6.5 7.5 6.7 3.8 13.0 8.0 6.7 6.5 13.2 5.8 11.0 7.3 7.7 8.8 5.0 7.8 6.9 5.8 1.1 1.4 1.7 1.0 4.2 2.4 1.0 3.8 3.9 4.2 5.2 4.1 3.6 5.8 4.0 3.3 5.0 3.0 2.9 5.4 3.7 5.1 2.1 2.3 4.3 4.4 4.6 3.1 5.6 2.0 7.5 9.7 4.4 3.5 2.3 4.2 4.0 5.8 6.3 4.8 4.2 3.7 4.2 4.2 2.7 1.5 7.7 5.5 3.0 0.1 4.4 9.7 4.9 2.9 3.7 3.1 4.1 3.8 4.7 8.6 5.9 3.6 3.4 7.1 4.7 6.8 3.2 10.0 3.9 4.9 4.4 2.7 1.3 4.6 4.5 2.9 1.0 1.0 1.5 2.4 0.7 1.7 1.1 1.3 2.1 0.7 1.0 1.3 1.9 1.7 4.2 0.7 1.4 1.7 1.0 6.6 7.5 6.6 8.0 6.6 3.4 10.3 5.1 5.5 7.3 0.0 1.0 0.8 2.3 2.5 2.8 1.6 0.0 1.4 2.3 3.5 0.0 1.8 3.3 1.7 14.3 0.8 1.8 0.0 1.2 2.0 1.3 1.9 1.1 0.5 1.7 1.6 0.0 3.7 2.1 4.5 1.1 2.5 0.0 5.4 1.8 0.9 1.7 2.8 2.1 1.0 3.3 6.5 1.4 2.9 2.5 2.8 2.2 5.0 1.4 1.8 ZNF709 FLJ38281 ENSG00000242852 "Zinc finger protein 709" Q8N972 19 12461184-12513854 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 26.6" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 31.1;Late spermatids: 26.0;Spermatocytes: 7.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA045573, HPA053153" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA045573: AB_2679370, HPA053153: AB_2682060" "unprognostic (2.27e-1)" "unprognostic (7.40e-4)" "unprognostic (3.53e-2)" "unprognostic (3.01e-2)" "unprognostic (1.11e-1)" "unprognostic (1.24e-2)" "unprognostic (4.19e-3)" "unprognostic (2.58e-4)" "unprognostic (6.76e-2)" "unprognostic (1.22e-2)" "unprognostic (1.39e-3)" "unprognostic (1.93e-1)" "unprognostic (5.66e-3)" "unprognostic (1.71e-1)" "unprognostic (3.19e-2)" "unprognostic (2.13e-1)" "unprognostic (8.53e-5)" 3.4 3.0 7.8 4.8 8.4 2.0 5.1 12.7 7.3 5.0 2.7 3.2 5.6 0.7 5.5 5.3 2.4 6.6 2.4 3.6 6.2 5.4 5.4 2.0 3.0 2.7 3.8 4.6 8.4 4.1 6.2 8.0 3.5 4.9 5.7 2.1 3.3 3.4 4.5 2.5 2.8 2.7 5.1 5.5 4.0 2.6 26.6 5.0 7.2 8.5 0.0 4.0 4.1 4.5 2.0 1.3 3.5 1.1 5.5 4.4 1.0 1.9 0.0 6.3 7.7 1.2 1.8 1.0 1.9 2.2 2.1 2.3 1.7 0.2 1.8 1.3 2.0 0.6 1.3 3.4 1.3 2.4 0.3 0.9 1.6 1.1 1.2 2.5 0.4 2.7 1.0 0.6 1.2 0.0 3.0 1.4 2.4 1.0 0.2 2.7 3.5 4.0 2.2 2.1 0.7 2.0 2.2 6.1 5.7 2.2 3.0 2.9 4.0 0.0 0.3 0.8 2.9 1.5 1.0 0.0 3.3 0.7 1.4 1.3 3.4 4.8 2.6 0.0 0.0 1.5 3.5 0.4 0.1 2.0 0.1 3.1 1.7 3.3 2.1 0.9 2.0 4.4 3.1 0.1 5.5 1.1 1.3 1.8 1.0 7.8 8.4 12.7 7.3 6.2 5.4 3.8 4.6 4.9 5.0 0.0 0.3 0.0 0.1 0.3 0.5 0.3 0.0 0.0 1.2 1.8 0.0 0.4 0.0 0.4 31.1 0.1 0.0 0.0 0.3 0.2 0.4 0.4 0.0 0.0 0.4 0.0 0.0 1.3 1.0 26.0 0.9 0.2 0.0 0.0 0.6 1.5 0.2 0.0 0.7 0.7 2.1 6.5 0.3 7.2 1.7 0.5 0.2 0.0 0.0 0.1 ZNF71 "Cos26, EZFIT" ENSG00000197951 "Zinc finger protein 71" Q9NQZ8 19 56595264-56626481 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 20.3" "Low region specificity" "Detected in all" HPA018124 Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA018124: AB_1848339" "unprognostic (1.93e-2)" "unprognostic (7.95e-2)" "unprognostic (1.32e-1)" "unprognostic (1.96e-2)" "unprognostic (7.72e-2)" "unprognostic (5.03e-2)" "unprognostic (5.06e-3)" "unprognostic (1.27e-1)" "unprognostic (2.09e-1)" "unprognostic (1.39e-1)" "unprognostic (1.12e-3)" "unprognostic (1.90e-3)" "unprognostic (3.91e-2)" "unprognostic (4.34e-2)" "unprognostic (1.08e-1)" "unprognostic (2.05e-1)" "unprognostic (6.97e-3)" 11.8 6.4 12.9 6.9 8.7 3.5 11.7 12.0 12.5 7.9 9.9 10.2 6.5 6.7 12.3 6.6 8.6 8.7 7.0 10.5 9.3 8.0 6.4 3.4 9.6 10.6 7.7 10.2 12.3 8.8 7.6 8.5 8.0 9.3 8.7 5.0 6.4 8.9 10.5 10.6 7.4 6.0 16.6 8.5 10.2 7.0 8.7 8.2 9.8 7.5 5.9 6.2 10.0 10.7 7.0 4.9 6.8 4.2 9.0 8.3 4.2 3.4 6.6 9.8 8.1 4.1 3.6 6.3 4.0 3.8 2.8 4.0 1.2 1.0 2.9 3.7 3.4 3.3 1.2 2.2 3.1 2.4 0.0 20.3 4.4 0.9 2.6 3.4 5.5 4.3 4.1 3.3 2.8 1.8 4.3 4.5 7.3 2.6 0.0 3.0 0.0 11.3 2.1 7.6 0.0 6.5 4.2 6.1 2.4 2.0 3.9 8.7 10.6 2.8 3.7 4.0 4.0 2.1 5.7 5.9 9.4 5.3 2.2 6.4 2.8 3.5 4.5 3.1 3.3 2.5 2.9 3.2 6.8 7.7 2.0 8.3 6.5 6.4 7.3 4.9 7.0 7.2 7.4 1.3 9.0 4.2 3.7 6.6 4.2 12.9 8.7 12.0 12.5 9.3 8.0 7.7 10.2 9.3 8.2 3.0 1.7 2.2 2.5 2.6 7.8 3.2 2.5 0.0 1.2 7.0 3.9 4.5 3.3 8.7 2.2 6.0 0.7 0.0 4.3 5.2 5.3 1.9 0.0 0.6 5.1 11.1 2.4 3.1 1.6 3.1 5.8 3.9 3.3 5.4 1.7 3.2 5.5 2.3 5.3 4.6 7.7 0.0 4.1 2.1 8.0 3.8 1.3 5.4 2.4 1.0 ZNF710 "DKFZp547K1113, FLJ00306, FLJ37393" ENSG00000140548 "Zinc finger protein 710" Q8N1W2 15 90001392-90082206 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "pancreas: 79.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 7.9" "Group enriched" "Detected in many" 5 "dendritic cells: 2.3;granulocytes: 3.0;monocytes: 7.9" "Cell line enhanced" "Detected in all" "SK-BR-3: 29.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030226, HPA030227, HPA030228" Uncertain Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA030226: AB_2673384, HPA030227: AB_10599855, HPA030228: AB_10601899" "unprognostic (6.24e-2)" "unprognostic (7.07e-2)" "unprognostic (1.49e-2)" "unprognostic (2.40e-1)" "unprognostic (2.32e-1)" "unprognostic (1.36e-2)" "unprognostic (4.34e-2)" "unprognostic (8.45e-2)" "unprognostic (1.02e-1)" "unprognostic (1.49e-1)" "unprognostic (9.86e-2)" "unprognostic (1.57e-1)" "unprognostic (2.91e-3)" "unprognostic (1.03e-2)" "unprognostic (3.24e-2)" "unprognostic (1.65e-2)" "unprognostic (8.65e-2)" 2.6 2.1 5.6 8.7 6.7 4.3 3.2 2.9 5.0 3.1 4.3 6.6 1.7 5.3 3.3 4.1 9.5 2.9 4.8 5.9 3.9 3.5 2.7 3.4 6.4 7.9 4.0 4.1 3.4 79.6 1.5 2.5 3.2 5.0 4.2 4.0 3.5 5.2 2.6 18.3 6.7 4.5 4.3 6.3 8.6 5.9 2.4 4.1 11.7 3.5 5.2 7.0 4.4 4.9 0.3 2.3 3.0 7.9 0.4 0.8 0.9 5.8 6.9 13.3 5.0 1.8 2.7 7.0 6.1 5.7 4.5 5.8 4.9 5.4 6.0 2.9 5.9 4.2 4.0 3.4 8.7 2.5 3.8 6.3 10.9 2.8 8.2 3.7 3.1 17.0 4.4 4.8 9.6 5.3 2.1 7.7 6.6 3.6 4.1 1.7 15.1 7.0 8.8 10.4 7.2 4.5 8.6 3.0 6.5 1.8 7.3 12.2 8.3 8.2 29.5 4.2 3.6 6.4 10.9 11.0 9.3 4.6 2.8 4.7 3.3 1.7 5.8 7.1 9.4 4.8 0.0 2.6 1.8 0.4 5.7 0.3 0.2 0.2 0.3 1.9 0.3 0.8 0.8 3.0 0.4 7.9 2.3 0.7 0.9 5.6 6.7 2.9 4.3 3.9 3.5 4.0 4.1 5.0 4.1 3.0 8.0 1.5 3.9 4.7 1.8 7.6 7.6 1.4 6.8 10.4 2.0 2.0 0.0 2.9 0.6 2.9 3.5 0.0 5.3 2.6 2.7 5.9 1.1 1.0 10.4 3.2 4.6 8.0 13.9 2.9 2.3 12.8 1.7 9.0 8.1 0.9 8.0 10.5 2.8 0.7 0.8 6.5 2.3 0.2 1.9 6.6 1.9 2.9 5.8 12.9 ZNF711 "CMPX1, dJ75N13.1, MRX97, Zfp711, ZNF4, ZNF5, ZNF6" ENSG00000147180 "Zinc finger protein 711" Q9Y462 X 85244032-85273362 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 38.6" "Cell type enhanced" "Detected in many" 8 "Intestinal endocrine cells: 17.7;Spermatogonia: 25.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 2.6;naive B-cell: 3.6" "Group enriched" "Detected in many" 7 "B-cells: 3.6;T-cells: 1.3" "Cell line enhanced" "Detected in many" "AF22: 16.8;AN3-CA: 13.1;HAP1: 24.2;HEK 293: 22.3;Karpas-707: 14.9;RH-30: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030654 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA030654: AB_10670561" "unprognostic (2.04e-2)" "unprognostic (1.59e-1)" "unprognostic (8.07e-2)" "unprognostic (5.51e-3)" "unprognostic (1.75e-2)" "unprognostic (9.11e-3)" "unprognostic (7.40e-3)" "unprognostic (1.37e-2)" "unprognostic (2.96e-1)" "unprognostic (2.50e-3)" "unprognostic (3.25e-3)" "unprognostic (1.53e-1)" "unprognostic (1.86e-1)" "unprognostic (1.22e-1)" "unprognostic (1.28e-1)" "unprognostic (5.72e-2)" "unprognostic (6.62e-3)" 1.4 13.6 11.6 2.1 11.9 5.8 5.4 10.8 19.2 5.9 2.4 4.4 0.0 3.0 8.9 2.9 2.1 4.7 4.0 3.8 11.1 8.3 5.1 0.7 1.9 2.2 6.5 8.1 9.3 4.3 1.5 16.0 7.1 12.6 4.1 1.9 3.3 4.0 2.8 1.6 11.2 4.2 3.4 9.8 4.5 2.8 38.6 9.5 14.4 4.2 1.6 2.5 3.0 2.5 3.6 0.2 0.0 0.0 0.3 1.3 0.3 0.0 1.5 16.8 13.1 0.0 0.0 1.3 0.2 0.0 0.0 0.0 3.5 1.4 0.0 0.6 0.2 2.7 0.3 24.2 0.0 0.0 0.0 22.3 7.7 0.4 0.9 0.6 0.0 0.2 1.6 0.2 0.0 3.1 0.0 0.1 7.5 2.3 14.9 2.9 0.8 13.0 0.0 8.2 1.4 0.3 0.0 20.4 0.0 0.0 1.2 4.9 12.7 0.0 0.4 0.0 10.3 2.2 2.1 0.0 0.0 5.5 0.0 0.0 5.6 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.6 0.1 0.4 0.1 3.6 1.3 0.8 0.0 0.3 0.0 0.2 0.0 0.3 11.6 11.9 10.8 15.1 11.1 8.3 6.5 8.1 12.6 9.5 3.0 0.6 1.5 6.8 10.6 8.7 2.4 2.5 1.4 2.3 1.8 0.0 0.3 5.0 1.6 2.0 2.3 0.5 0.0 0.4 0.2 5.2 2.5 0.0 0.0 0.3 3.2 17.7 3.7 1.2 4.0 2.8 0.7 5.0 0.0 1.0 10.0 0.7 1.7 3.5 1.9 1.3 0.0 6.2 5.2 25.4 8.0 0.2 0.0 1.1 2.5 ZNF717 "X17, ZNF838" ENSG00000227124 "Zinc finger protein 717" 3 75709643-75785583 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 38.5" HPA044549 Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Nucleoplasm, Nuclear bodies" "Plasma membrane" "HPA044549: AB_10964630" "unprognostic (2.49e-1)" "unprognostic (4.44e-2)" "unprognostic (1.52e-1)" "unprognostic (2.49e-2)" "unprognostic (2.61e-1)" "unprognostic (1.00e-1)" "unprognostic (2.18e-1)" "unprognostic (3.80e-2)" "unprognostic (3.20e-1)" "unprognostic (2.16e-2)" "unprognostic (2.36e-1)" "unprognostic (1.45e-2)" "unprognostic (3.60e-6)" "unprognostic (3.88e-2)" "unprognostic (2.08e-2)" "unprognostic (1.00e-1)" "unprognostic (1.36e-1)" 8.1 8.6 11.9 7.2 14.4 4.6 11.2 12.1 12.4 7.7 6.7 11.7 7.3 6.9 11.0 24.6 7.7 11.3 8.1 8.2 10.9 8.3 13.4 10.5 6.8 6.2 16.2 7.1 12.6 12.7 14.7 22.8 7.3 12.6 9.4 8.9 10.8 9.9 9.6 6.1 13.7 7.3 10.9 15.6 10.1 10.1 11.2 13.6 8.4 16.2 5.3 8.4 8.6 7.8 9.5 6.2 6.8 5.3 4.0 10.2 3.2 7.4 4.7 4.5 2.7 4.9 6.9 2.7 2.5 4.9 3.1 3.9 6.3 6.4 4.0 4.3 4.6 4.9 3.7 7.1 5.3 2.8 0.4 6.8 7.8 7.1 0.7 9.6 0.3 6.9 6.7 4.4 7.5 11.4 3.2 0.6 0.8 38.5 9.5 4.1 2.4 0.8 10.3 5.1 5.5 8.3 5.9 4.3 21.9 5.0 3.6 3.7 17.4 2.1 4.3 9.2 7.3 15.3 3.5 0.9 7.9 10.8 6.5 1.1 11.4 13.9 4.7 4.3 0.8 4.8 1.5 4.0 6.8 3.6 5.3 1.8 7.6 5.1 3.4 4.1 9.5 10.2 6.2 1.0 4.0 4.9 6.2 1.9 3.2 11.9 14.4 12.1 12.4 10.9 8.3 16.2 7.1 12.6 13.6 3.0 1.9 3.0 3.6 2.9 8.3 5.3 10.2 5.3 3.4 7.0 2.0 3.3 10.0 4.0 2.6 4.5 2.6 0.0 3.8 1.6 4.3 4.9 9.2 6.6 6.1 9.5 5.1 6.7 3.8 1.3 2.3 3.8 1.7 5.4 7.2 5.7 3.8 0.0 2.8 12.5 8.0 0.0 3.8 9.5 7.4 3.9 2.9 2.6 5.5 3.9 ZNF720 ENSG00000197302 "Zinc finger protein 720" Q7Z2F6 16 31713229-31794869 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 59.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA041570 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA041570: AB_10795126" "unprognostic (5.52e-2)" "unprognostic (2.30e-1)" "unprognostic (1.84e-1)" "unprognostic (8.30e-2)" "unprognostic (2.58e-1)" "unprognostic (2.48e-1)" "unprognostic (2.30e-1)" "unprognostic (1.82e-3)" "unprognostic (8.72e-2)" "unprognostic (5.94e-2)" "unprognostic (1.54e-1)" "unprognostic (8.91e-3)" "unprognostic (5.47e-3)" "unprognostic (3.70e-2)" "unprognostic (9.62e-2)" "unprognostic (1.66e-1)" "unprognostic (3.91e-2)" 15.1 15.8 11.1 13.7 11.8 9.9 12.7 16.8 17.6 14.3 12.4 11.3 17.7 7.2 11.7 17.4 16.4 12.8 10.3 10.1 11.1 15.1 14.2 11.6 10.7 17.5 15.5 11.0 9.6 12.9 13.4 24.5 19.4 15.5 14.5 14.0 11.4 13.9 17.7 10.3 17.3 10.1 13.2 14.3 18.4 14.1 13.7 15.9 16.6 19.2 11.0 18.1 14.6 11.6 14.4 8.9 23.0 5.5 12.8 14.2 5.0 10.3 7.3 9.1 8.0 7.9 12.1 8.8 11.0 7.2 5.4 7.2 5.2 11.1 5.0 19.5 3.7 8.0 7.2 8.8 4.3 8.1 22.3 4.7 2.8 3.9 14.9 11.9 5.9 15.4 8.2 11.9 3.8 5.4 10.9 10.1 12.3 9.3 6.6 5.8 16.7 6.1 7.8 8.9 7.2 5.8 11.5 4.0 7.8 6.1 6.5 4.1 6.2 11.2 5.1 9.9 14.9 9.7 11.8 6.6 3.9 3.1 7.9 3.3 11.1 12.1 14.4 3.5 9.2 6.2 13.9 4.8 23.0 14.2 5.4 10.6 13.7 10.0 12.7 5.2 14.4 9.3 11.7 6.3 12.8 5.5 8.9 12.2 5.0 11.1 11.8 16.8 17.6 11.1 15.1 15.5 11.0 15.5 15.9 14.9 15.2 14.3 15.8 8.0 23.9 12.0 5.1 20.1 13.6 5.2 5.9 27.2 19.9 15.4 1.7 17.9 6.3 0.0 11.9 10.9 12.4 22.4 20.8 8.9 14.6 22.3 16.7 16.0 9.7 1.5 12.4 15.1 10.1 12.6 12.4 19.0 14.5 10.5 17.3 11.8 8.9 32.3 11.4 24.1 17.6 10.0 59.4 16.0 10.7 18.7 ZNF727 ZNF727P ENSG00000214652 "Zinc finger protein 727" A8MUV8 7 64045443-64078549 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 13.7" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 1.9;Distal tubular cells: 3.3;Early spermatids: 1.8;Horizontal cells: 1.6;Late spermatids: 1.7" "Cancer enhanced" "Detected in some" "testis cancer: 2.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "T-47d: 13.1" "HPA051027, HPA061215" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA051027: , HPA061215: AB_2684452" "unprognostic (5.87e-2)" "unprognostic (3.05e-1)" "unprognostic (1.28e-1)" "unprognostic (2.75e-3)" "unprognostic (1.36e-2)" "unprognostic (1.80e-1)" "unprognostic (3.86e-2)" "unprognostic (1.56e-1)" "unprognostic (1.16e-2)" "unprognostic (2.59e-1)" "unprognostic (1.69e-1)" "unprognostic (2.54e-1)" "unprognostic (4.04e-2)" "unprognostic (5.73e-4)" "unprognostic (8.70e-2)" "unprognostic (6.36e-2)" "unprognostic (8.61e-2)" 2.6 1.6 2.7 0.9 10.6 0.3 5.4 3.9 7.4 5.2 1.7 5.8 0.0 0.6 5.9 3.1 2.0 4.7 1.6 2.2 4.7 3.1 0.5 1.9 1.2 5.3 2.5 9.1 2.0 1.1 13.7 0.3 7.2 4.9 2.0 3.1 2.2 3.3 1.2 2.0 1.0 3.7 4.2 1.6 2.0 5.5 6.1 0.0 8.7 0.0 0.9 2.6 3.9 1.1 0.4 0.0 0.4 0.4 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.0 13.1 0.0 0.0 0.0 1.6 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.4 1.1 1.0 0.7 0.0 0.4 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 1.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.4 0.1 0.2 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 ZNF736 ENSG00000234444 "Zinc finger protein 736" B4DX44 7 64307459-64354860 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 36.3;Late spermatids: 47.2;Rod photoreceptor cells: 44.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA051027, HPA061215" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA051027: , HPA061215: AB_2684452" "unprognostic (2.41e-1)" "unprognostic (2.71e-2)" "unprognostic (1.17e-3)" "prognostic unfavorable (3.03e-4)" "unprognostic (4.14e-1)" "unprognostic (1.24e-1)" "unprognostic (1.20e-3)" "unprognostic (4.89e-2)" "unprognostic (2.51e-2)" "unprognostic (2.11e-2)" "unprognostic (2.01e-2)" "prognostic unfavorable (5.01e-4)" "unprognostic (2.26e-1)" "unprognostic (9.63e-2)" "unprognostic (5.28e-2)" "unprognostic (2.22e-3)" "prognostic favorable (8.65e-4)" 7.1 5.4 8.5 8.2 17.4 17.0 12.9 8.3 19.8 7.7 5.5 7.8 4.7 3.9 8.4 9.8 5.4 7.7 6.3 5.3 7.5 6.0 8.2 3.7 7.4 14.0 5.5 8.2 13.1 7.5 6.2 7.6 5.4 13.8 8.6 6.1 11.5 7.7 5.7 4.2 13.1 8.5 6.3 5.8 10.1 6.2 16.8 7.0 17.1 10.6 2.0 11.4 6.1 7.4 4.7 3.5 2.8 2.1 0.3 2.4 1.0 0.5 0.2 4.6 15.9 1.7 3.1 4.7 2.5 0.1 3.3 5.4 1.2 2.6 11.9 3.8 2.1 4.5 2.0 3.5 1.0 5.3 0.2 3.3 4.8 1.4 0.1 1.7 2.1 6.9 2.5 1.0 3.8 0.1 1.6 0.4 7.0 5.7 2.6 4.6 3.0 7.2 11.3 8.9 0.1 0.9 6.2 7.2 5.8 4.1 7.0 5.0 7.3 5.7 4.1 1.5 9.1 11.3 8.8 0.3 5.2 3.7 1.3 3.0 3.1 4.3 14.5 0.1 2.6 0.1 0.0 1.9 2.8 1.5 1.8 1.1 4.7 2.3 1.3 2.1 4.5 2.4 1.9 0.4 0.3 2.1 3.5 1.0 1.0 8.5 17.4 8.3 19.8 7.5 6.0 5.5 8.2 13.8 7.0 6.0 4.8 7.7 2.1 3.4 14.4 2.8 10.2 1.4 4.5 5.2 11.8 3.0 5.0 3.3 36.3 4.3 1.3 0.0 1.9 2.6 3.1 2.5 0.0 2.9 3.1 7.9 1.2 6.2 5.3 47.2 2.3 6.4 3.3 1.8 4.7 6.8 1.9 2.9 2.8 3.4 44.8 0.0 2.0 6.3 6.5 3.4 2.3 4.4 2.8 1.7 ZNF74 "Cos52, Zfp520, ZNF520" ENSG00000185252 "Zinc finger protein 74" Q16587 22 20394115-20408461 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 28.2" HPA003354 Approved Supported "Nucleoplasm,Actin filaments" NA NA Nucleoplasm "Actin filaments" "HPA003354: AB_1080747" "unprognostic (1.40e-1)" "unprognostic (2.36e-1)" "unprognostic (2.01e-1)" "unprognostic (1.12e-1)" "unprognostic (2.76e-2)" "unprognostic (1.02e-1)" "unprognostic (8.13e-3)" "unprognostic (1.76e-2)" "unprognostic (1.30e-1)" "unprognostic (2.15e-1)" "unprognostic (1.20e-3)" "unprognostic (3.80e-2)" "unprognostic (1.10e-1)" "unprognostic (5.58e-2)" "unprognostic (3.04e-1)" "unprognostic (7.91e-2)" "unprognostic (1.44e-3)" 3.7 4.3 6.1 3.1 7.7 1.3 5.9 9.5 11.1 7.0 6.3 8.0 5.8 2.9 7.7 5.8 4.6 7.5 3.8 4.0 6.5 6.2 4.2 3.2 5.0 3.3 7.9 7.0 11.5 6.9 7.0 7.2 3.9 6.2 6.6 4.0 3.8 7.5 8.2 9.7 4.2 3.6 6.4 5.2 3.5 4.1 2.3 6.9 4.3 5.1 3.0 3.1 6.6 6.8 2.3 3.5 1.6 2.0 6.5 5.3 3.3 2.5 2.9 7.2 10.5 2.1 2.1 5.2 2.7 2.1 3.6 3.3 3.2 1.3 0.0 3.4 2.2 1.1 3.5 5.5 3.5 1.9 1.8 10.9 2.7 1.3 4.9 3.5 6.9 3.4 2.0 6.1 2.6 2.7 2.6 3.4 6.3 28.2 0.0 2.4 3.7 6.4 2.8 7.1 6.0 3.4 8.8 4.0 1.1 2.1 3.0 14.2 8.9 2.8 5.0 6.4 3.8 1.8 2.9 2.6 2.5 5.8 4.0 2.0 2.6 3.8 0.0 0.7 3.0 2.3 0.0 1.8 1.6 4.1 2.0 3.2 2.3 2.9 5.3 3.5 1.8 3.9 3.1 0.0 6.5 1.3 2.5 2.5 3.3 6.1 7.7 9.5 11.1 6.5 6.2 7.9 7.0 6.2 6.9 3.0 1.3 0.0 1.7 1.3 5.4 2.5 2.5 0.0 3.4 0.0 2.0 2.7 3.3 3.2 0.5 0.7 1.1 0.0 2.1 3.8 2.7 2.0 0.0 0.8 1.9 3.2 4.1 3.7 0.0 0.0 6.6 0.1 0.0 1.8 1.9 2.3 2.6 0.0 4.6 1.3 1.8 6.5 2.1 2.8 1.3 0.9 0.9 1.5 2.8 0.9 ZNF740 Zfp740 ENSG00000139651 "Zinc finger protein 740" Q8NDX6 12 53180700-53195141 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035691 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA035691: AB_10669777" "unprognostic (2.31e-1)" "unprognostic (3.40e-1)" "unprognostic (1.61e-1)" "unprognostic (2.12e-3)" "unprognostic (2.86e-2)" "unprognostic (3.20e-2)" "unprognostic (4.19e-3)" "unprognostic (6.31e-2)" "prognostic unfavorable (4.55e-4)" "unprognostic (4.88e-2)" "unprognostic (2.36e-3)" "unprognostic (7.92e-2)" "unprognostic (8.89e-3)" "unprognostic (1.34e-1)" "unprognostic (1.20e-1)" "unprognostic (1.72e-1)" "unprognostic (2.30e-2)" 12.5 13.9 12.5 13.6 14.9 6.5 14.0 23.8 17.6 13.8 13.1 13.8 18.1 11.1 17.2 15.7 13.2 16.3 11.1 8.0 17.2 10.1 12.9 11.4 11.6 18.1 16.5 11.8 18.3 16.3 21.2 13.2 11.5 13.0 14.2 12.2 11.8 13.8 16.0 10.1 13.6 14.7 12.6 10.5 18.1 12.4 7.1 13.8 19.0 15.9 7.4 20.1 11.9 16.9 1.7 1.6 2.9 0.8 4.6 2.0 0.7 4.7 6.4 11.4 7.3 11.5 8.6 4.3 5.0 9.4 8.1 7.1 5.4 7.6 11.0 7.6 5.7 3.9 7.8 8.2 5.9 8.3 8.3 8.9 12.2 8.5 4.8 8.4 11.1 7.7 10.8 11.8 6.4 9.7 13.5 6.5 11.6 8.0 22.3 4.2 5.5 8.7 6.0 5.6 4.5 7.8 8.9 8.8 17.8 4.6 6.7 8.8 9.8 8.5 7.2 8.4 5.6 10.3 11.5 5.9 4.3 5.9 4.8 3.6 10.9 4.7 6.0 6.6 6.3 5.3 2.9 0.8 1.4 1.6 0.4 1.1 1.6 1.4 2.0 0.7 1.7 1.9 1.9 0.2 4.6 0.4 1.6 1.7 0.7 12.5 14.9 23.8 17.6 17.2 10.1 16.5 11.8 13.0 13.8 3.0 12.4 4.2 1.9 5.5 7.6 5.1 5.1 5.3 2.3 1.8 5.9 2.7 1.7 3.4 1.0 5.2 4.0 0.0 3.9 1.5 4.6 3.3 7.0 3.9 2.9 4.8 8.1 4.3 6.1 0.9 5.8 2.9 1.7 2.8 5.7 5.8 4.6 7.0 5.6 3.7 6.6 19.4 9.0 1.7 3.1 4.0 2.1 2.5 6.0 2.6 ZNF746 "FLJ31413, PARIS" ENSG00000181220 "Zinc finger protein 746" Q6NUN9 7 149472696-149497817 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 3.0;neutrophil: 10.4" "Lineage enriched" "Detected in many" 6 "granulocytes: 10.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020272 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA020272: AB_2670398" "unprognostic (2.66e-1)" "unprognostic (4.94e-2)" "unprognostic (4.27e-3)" "unprognostic (1.80e-2)" "unprognostic (2.10e-2)" "unprognostic (3.85e-1)" "prognostic unfavorable (2.32e-5)" "unprognostic (2.07e-1)" "unprognostic (1.79e-1)" "unprognostic (3.33e-1)" "prognostic favorable (4.22e-4)" "unprognostic (5.33e-2)" "prognostic unfavorable (7.47e-6)" "unprognostic (2.21e-2)" "unprognostic (2.09e-1)" "unprognostic (2.10e-1)" "unprognostic (2.06e-1)" 11.9 9.9 10.6 12.0 11.6 33.9 9.1 15.6 17.2 10.5 9.0 11.7 9.1 8.0 11.5 8.7 8.5 10.3 8.7 7.6 11.2 9.7 10.0 10.9 10.3 12.1 9.5 8.7 10.4 13.7 10.2 13.5 21.0 11.4 10.6 6.3 11.4 10.7 8.5 8.9 10.8 9.2 9.5 9.0 20.2 9.8 22.0 10.4 18.7 10.6 5.5 10.3 10.9 15.9 0.6 0.9 10.4 1.0 0.5 1.6 0.5 7.1 11.5 6.1 16.6 6.9 6.0 9.3 7.3 6.0 5.9 5.1 7.3 5.4 10.3 10.7 6.4 8.6 8.0 7.9 8.3 3.5 13.0 11.0 5.0 5.8 10.0 8.4 9.7 13.4 6.6 10.1 4.8 5.3 5.3 6.1 8.5 15.2 8.0 7.4 11.0 21.9 13.1 15.1 4.4 8.0 14.6 5.7 9.0 5.6 8.6 8.7 12.0 9.7 10.7 6.8 3.8 5.0 12.0 8.5 7.5 2.7 12.7 10.6 14.8 7.0 8.3 9.8 7.8 13.0 3.0 1.0 1.1 0.7 0.7 0.7 0.4 0.9 1.6 0.6 0.6 1.1 0.9 10.4 0.5 0.5 0.9 1.5 0.5 10.6 11.6 15.6 17.2 11.2 9.7 9.5 8.7 11.4 10.4 0.0 7.4 3.4 4.9 3.2 15.5 6.7 5.1 4.0 4.5 10.4 3.9 5.9 0.0 2.8 8.2 5.3 2.0 46.7 2.1 5.2 3.6 5.1 5.8 6.8 7.0 25.4 5.8 3.1 15.5 10.8 5.8 6.8 3.3 5.4 4.0 8.8 4.0 3.5 6.3 3.1 10.8 0.0 3.7 16.2 7.0 3.0 7.3 4.1 3.7 4.4 ZNF749 FLJ16360 ENSG00000186230 "Zinc finger protein 749" O43361 19 57435329-57445485 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Melanocytes: 21.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEK 293: 23.5" "HPA042082, HPA042091, HPA056001" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA042082: AB_10796572, HPA042091: AB_10793874, HPA056001: AB_2683005" "unprognostic (2.54e-1)" "unprognostic (1.55e-1)" "unprognostic (6.67e-2)" "unprognostic (9.92e-2)" "unprognostic (2.75e-1)" "unprognostic (9.95e-3)" "unprognostic (1.87e-1)" "unprognostic (8.23e-2)" "unprognostic (2.54e-1)" "unprognostic (1.07e-1)" "unprognostic (9.27e-3)" "unprognostic (2.76e-2)" "unprognostic (3.05e-5)" "unprognostic (1.35e-1)" "unprognostic (4.19e-1)" "unprognostic (1.06e-1)" "unprognostic (3.19e-1)" 5.8 5.6 7.2 7.6 8.0 5.0 8.4 12.4 10.7 6.3 8.1 5.2 7.5 6.6 6.3 5.1 7.4 7.9 8.3 5.1 6.4 6.0 5.3 12.4 5.4 7.5 9.0 7.7 8.2 7.0 11.4 7.2 6.3 6.0 6.2 4.5 8.5 12.8 10.8 6.2 9.7 7.1 5.9 5.3 6.7 5.5 6.2 6.8 7.8 6.7 12.1 8.0 6.0 6.1 2.9 3.2 0.2 2.7 1.9 4.1 2.8 2.7 6.4 5.7 5.8 1.5 1.5 2.3 1.7 1.4 2.8 5.1 2.6 2.0 5.3 1.5 1.6 1.9 2.0 5.4 4.3 4.2 2.3 23.5 4.7 6.7 3.0 1.8 5.2 3.1 1.8 4.8 3.6 7.7 2.8 1.5 5.7 4.5 6.3 2.1 1.1 6.4 1.8 5.4 2.0 8.9 6.7 8.2 3.9 1.3 6.5 5.6 4.6 3.2 1.9 1.3 4.7 2.8 1.7 1.6 5.2 3.8 1.6 4.7 4.8 6.2 5.5 2.9 2.2 3.1 0.1 1.2 0.2 2.1 2.7 3.4 2.7 3.5 3.1 3.2 2.9 4.1 3.0 0.2 1.9 1.2 1.6 2.6 2.8 7.2 8.0 12.4 10.7 6.4 6.0 9.0 7.7 6.0 6.8 3.0 0.6 0.8 0.6 2.2 0.8 0.4 5.1 2.7 3.4 0.0 0.0 0.9 3.3 0.9 0.6 1.6 1.3 0.0 0.3 0.7 0.8 0.7 0.0 2.9 0.8 3.2 2.9 1.3 0.3 0.0 0.6 1.0 21.9 1.0 0.7 0.4 0.8 0.0 0.0 3.1 0.9 6.5 1.2 0.7 1.7 2.8 0.7 2.1 0.9 0.9 ZNF75A FLJ31529 ENSG00000162086 "Zinc finger protein 75a" Q96N20 16 3305406-3318852 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA001665 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA001665: AB_1080751" "unprognostic (1.41e-1)" "unprognostic (9.81e-3)" "unprognostic (9.14e-2)" "unprognostic (2.16e-1)" "unprognostic (1.64e-1)" "unprognostic (7.79e-3)" "unprognostic (6.32e-2)" "unprognostic (4.45e-1)" "unprognostic (2.67e-2)" "unprognostic (5.93e-2)" "unprognostic (4.66e-3)" "unprognostic (2.75e-3)" "unprognostic (6.79e-3)" "unprognostic (4.71e-2)" "unprognostic (1.65e-1)" "unprognostic (3.47e-2)" "unprognostic (8.97e-3)" 10.0 11.4 13.6 14.8 15.7 9.0 15.0 19.6 15.4 10.6 10.1 17.2 14.4 8.0 12.4 26.1 9.5 14.1 9.0 9.0 13.2 12.2 12.7 16.2 10.4 18.1 12.8 14.4 19.3 13.6 32.1 23.5 12.7 17.7 16.2 15.1 10.1 10.6 15.4 10.4 13.8 12.8 10.8 10.3 15.6 10.1 13.5 15.9 15.8 17.9 7.7 18.0 10.2 8.6 25.2 13.8 15.2 9.1 17.8 23.0 3.3 4.5 6.8 12.7 6.4 6.0 5.5 10.8 7.3 3.0 6.9 8.2 0.1 5.9 7.3 5.0 5.3 8.5 3.4 7.6 4.4 10.4 3.1 10.2 15.6 7.9 0.6 4.3 9.9 15.8 7.5 4.6 7.3 5.5 6.8 6.2 7.1 8.8 12.1 9.6 6.3 15.1 6.8 19.6 4.4 4.7 31.5 6.2 8.8 7.4 7.5 11.5 8.2 11.5 4.6 4.5 18.2 14.9 12.7 7.2 5.1 13.0 4.9 5.8 8.4 7.4 21.0 1.7 11.3 7.9 13.3 6.7 15.2 13.0 6.2 16.0 16.8 14.8 13.3 5.2 25.2 23.0 17.2 4.8 17.8 9.1 13.8 11.9 3.3 13.6 15.7 19.6 15.4 13.2 12.2 12.8 14.4 17.7 15.9 20.8 9.4 33.5 23.3 3.7 39.7 10.6 10.2 9.4 14.8 15.7 31.4 15.0 5.0 18.8 2.1 11.8 12.0 0.0 8.9 8.4 8.8 17.0 12.8 7.8 9.0 46.1 5.8 12.9 9.5 1.9 21.6 13.3 8.5 17.2 7.9 32.0 10.4 9.5 25.1 6.3 63.2 25.8 9.5 37.6 26.6 3.0 13.2 34.9 11.5 14.6 ZNF75D "D8C6, ZKSCAN24, ZNF75, ZNF82, ZSCAN28" ENSG00000186376 "Zinc finger protein 75D" P51815 X 135248920-135344087 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 14 "Early spermatids: 162.9;Late spermatids: 247.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA004705 Supported Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA004705: AB_1080749" "unprognostic (1.56e-3)" "unprognostic (7.96e-3)" "unprognostic (3.07e-1)" "unprognostic (5.12e-2)" "unprognostic (1.30e-1)" "unprognostic (3.00e-2)" "unprognostic (7.92e-2)" "unprognostic (1.32e-3)" "unprognostic (9.17e-2)" "unprognostic (1.81e-1)" "unprognostic (1.15e-2)" "unprognostic (2.13e-2)" "prognostic favorable (1.31e-4)" "unprognostic (1.09e-2)" "unprognostic (1.96e-1)" "unprognostic (1.15e-1)" "prognostic favorable (7.42e-5)" 8.4 18.8 8.2 14.6 9.7 9.2 9.9 11.4 10.5 11.8 10.6 9.2 10.4 6.9 10.7 12.8 7.6 9.8 7.9 7.6 5.6 7.7 10.6 13.4 9.7 11.2 6.2 7.7 10.1 12.9 12.6 14.7 8.0 9.2 15.0 8.4 7.5 10.0 11.8 6.6 9.9 10.6 7.5 5.9 18.6 9.7 3.4 6.7 16.6 13.2 9.3 13.3 8.0 8.6 3.7 1.8 4.1 2.1 5.2 6.5 2.9 3.5 4.6 5.1 8.1 8.6 10.5 7.7 5.9 8.1 4.9 10.5 2.8 4.4 3.6 8.8 5.0 9.4 4.8 16.5 2.7 4.7 3.5 4.4 2.5 8.4 3.7 3.8 4.3 7.3 5.1 6.5 3.0 3.7 6.1 4.9 4.8 2.2 5.9 4.2 8.4 5.2 7.8 2.4 7.1 6.3 5.0 5.0 3.2 5.4 4.8 1.7 5.7 3.3 5.7 0.9 5.6 2.0 6.2 5.2 4.6 1.1 7.8 5.6 3.0 4.2 2.7 2.9 4.7 2.9 4.1 2.1 3.7 4.9 1.5 4.5 2.9 5.2 5.6 1.8 3.7 6.5 5.9 2.6 5.2 1.5 1.6 6.3 2.9 8.2 9.7 11.4 10.5 5.6 7.7 6.2 7.7 9.2 6.7 6.0 14.6 1.4 1.1 1.5 4.2 3.9 0.0 5.3 6.8 0.0 5.9 1.9 1.7 1.5 162.9 7.0 2.7 0.0 3.5 1.1 3.1 2.1 5.8 4.3 2.0 4.8 1.7 6.2 3.1 247.1 6.1 3.3 0.0 1.0 5.3 4.5 2.7 2.9 3.2 3.1 4.5 0.0 3.1 3.5 2.7 1.3 1.5 5.4 3.1 1.4 ZNF76 "D6S229E, Zfp523, ZNF523" ENSG00000065029 "Zinc finger protein 76" P36508 6 35258909-35295985 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030090, HPA030091" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030090: AB_10603334, HPA030091: AB_10602593" "unprognostic (8.29e-3)" "unprognostic (3.61e-2)" "unprognostic (7.71e-2)" "unprognostic (8.70e-3)" "unprognostic (2.76e-1)" "unprognostic (6.51e-2)" "unprognostic (1.40e-3)" "unprognostic (5.78e-2)" "unprognostic (1.23e-2)" "prognostic favorable (1.18e-4)" "prognostic favorable (5.09e-4)" "unprognostic (3.66e-3)" "unprognostic (1.20e-3)" "unprognostic (5.31e-3)" "unprognostic (1.14e-1)" "unprognostic (3.76e-1)" "unprognostic (1.20e-3)" 9.2 20.0 16.0 14.6 18.4 8.5 11.3 27.2 17.8 11.4 11.5 18.1 14.5 11.9 12.5 18.5 10.4 13.7 12.7 20.8 14.8 9.6 14.1 13.0 10.6 15.0 15.3 12.3 19.5 13.9 19.5 31.4 19.7 16.9 15.6 10.2 21.8 16.0 16.6 45.1 10.5 13.1 10.6 13.6 18.3 12.2 19.9 16.4 12.6 24.0 10.3 14.6 12.4 11.0 10.5 7.4 5.4 9.3 9.3 16.0 8.8 6.6 6.1 13.5 14.9 5.7 8.8 9.7 5.7 9.8 9.8 7.8 4.5 9.0 14.5 8.6 8.6 9.4 3.8 11.3 8.7 5.7 21.6 17.0 13.9 9.4 7.2 11.4 7.0 8.3 10.8 5.5 11.2 10.6 6.0 8.8 14.9 10.2 15.3 8.8 14.6 11.7 8.2 6.6 5.4 5.9 11.3 7.0 13.3 8.7 9.3 21.2 7.8 7.0 9.0 17.3 4.7 13.5 22.7 6.7 6.9 6.0 4.7 8.2 15.5 10.7 13.5 6.0 11.0 18.0 3.8 6.6 5.4 16.0 8.6 12.7 10.0 11.7 11.3 7.4 10.5 12.5 13.0 2.0 9.3 9.3 3.7 9.0 8.8 16.0 18.4 27.2 17.8 14.8 9.6 15.3 12.3 16.9 16.4 14.9 8.1 9.5 6.7 5.0 27.5 18.5 7.6 6.7 7.9 8.7 47.1 20.4 18.3 10.5 17.1 10.1 10.5 0.0 13.4 11.0 8.5 5.8 12.7 7.4 9.8 28.6 11.6 6.2 7.8 12.0 10.3 5.8 5.0 6.4 12.5 10.3 7.1 9.7 5.6 10.5 30.2 19.4 8.6 20.9 10.0 5.5 19.0 8.6 9.0 5.8 ZNF763 ZNF440L ENSG00000197054 "Zinc finger protein 763" Q0D2J5 19 11965037-11980381 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 9.8;Rod photoreceptor cells: 6.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 9.7" HPA047845 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA047845: AB_2680178" "unprognostic (4.09e-3)" "unprognostic (6.15e-4)" "unprognostic (1.28e-1)" "unprognostic (1.54e-2)" "unprognostic (6.15e-2)" "unprognostic (1.43e-4)" "unprognostic (1.43e-1)" "unprognostic (8.26e-3)" "unprognostic (9.36e-3)" "unprognostic (1.93e-2)" "unprognostic (1.17e-3)" "unprognostic (1.43e-1)" "unprognostic (6.07e-6)" "unprognostic (1.47e-1)" "unprognostic (3.08e-1)" "unprognostic (1.11e-1)" "unprognostic (8.89e-3)" 7.0 5.2 3.6 4.1 6.6 3.0 9.1 5.5 5.4 7.3 9.0 5.6 6.8 4.8 8.3 5.4 5.1 6.0 4.5 9.7 4.0 3.3 11.1 3.6 7.1 6.3 5.5 3.5 12.6 7.6 12.4 7.5 8.6 5.6 9.5 5.7 9.2 6.5 10.3 4.9 4.7 7.1 6.2 4.6 9.4 5.5 7.1 7.1 8.0 14.3 3.9 6.5 7.3 7.6 8.0 3.2 11.1 4.8 4.9 4.2 2.1 0.4 0.0 2.9 3.1 1.8 0.8 9.7 2.6 2.4 2.2 2.2 1.0 0.6 3.0 2.5 2.0 0.7 0.8 0.0 1.5 1.0 0.4 0.1 1.2 0.1 0.1 0.4 1.6 3.3 4.2 2.0 0.5 0.3 0.7 0.4 4.6 0.4 1.3 2.2 0.3 3.4 0.8 1.3 0.3 0.3 0.2 0.1 1.0 4.4 2.7 0.5 1.2 0.2 0.1 0.6 5.6 5.6 1.8 0.4 3.0 0.1 2.5 0.7 4.5 5.7 0.9 0.7 0.6 0.4 11.1 1.9 5.7 3.1 2.5 2.3 3.4 2.8 4.2 3.2 8.0 3.5 3.8 10.5 4.9 4.8 2.5 1.5 2.1 3.6 6.6 5.5 5.4 4.0 3.3 5.5 3.5 5.6 7.1 3.0 4.5 0.0 0.4 0.1 2.8 0.6 0.0 2.7 4.5 0.0 9.8 4.3 1.7 0.6 3.7 0.0 0.8 0.0 0.3 1.6 0.5 0.5 1.1 0.8 1.1 0.0 1.2 0.0 1.0 0.0 1.4 0.0 0.0 1.0 2.2 2.9 0.3 0.0 1.8 1.3 6.1 0.0 0.3 2.8 1.4 0.0 1.5 0.0 0.9 0.1 ZNF768 FLJ23436 ENSG00000169957 "Zinc finger protein 768" Q9H5H4 16 30524001-30526821 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024630, HPA066512" Supported Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA024630: AB_1859446, HPA066512: AB_2685683" "unprognostic (2.33e-1)" "unprognostic (6.16e-2)" "unprognostic (2.28e-2)" "unprognostic (1.20e-1)" "unprognostic (4.86e-2)" "unprognostic (1.73e-1)" "unprognostic (7.94e-3)" "unprognostic (1.61e-1)" "unprognostic (1.63e-1)" "unprognostic (1.11e-1)" "unprognostic (3.26e-2)" "unprognostic (2.74e-1)" "prognostic favorable (9.30e-6)" "unprognostic (4.49e-2)" "unprognostic (1.94e-1)" "unprognostic (3.13e-1)" "prognostic favorable (6.46e-4)" 11.7 9.2 12.7 12.0 15.6 8.0 17.8 11.1 12.2 11.4 26.0 13.9 11.5 20.4 13.1 7.4 12.6 13.1 11.2 26.2 11.1 9.3 18.9 14.4 8.6 4.7 13.5 6.0 15.9 14.3 25.4 11.5 10.1 11.5 14.2 12.1 13.9 17.5 16.0 56.6 11.2 31.6 16.0 12.8 13.1 11.7 14.0 14.4 3.8 10.1 14.2 7.8 14.1 24.5 3.7 1.8 3.1 1.9 1.8 0.5 0.6 10.1 12.7 14.5 14.0 7.0 8.2 11.4 7.7 8.7 12.8 11.2 8.1 14.2 6.4 11.9 5.4 10.3 13.6 9.6 9.2 7.7 14.3 20.3 15.1 8.5 11.2 17.8 10.0 47.8 7.2 20.5 9.8 12.7 11.9 8.5 2.6 17.5 10.9 6.6 28.0 3.6 24.2 13.5 8.3 10.5 19.0 9.6 15.8 9.4 5.3 17.2 19.1 4.4 23.3 29.3 6.5 23.1 25.2 5.7 13.5 10.3 7.6 8.5 16.2 11.8 7.9 11.3 15.7 13.6 0.2 1.4 3.1 0.1 1.9 0.4 3.7 0.5 0.2 1.8 1.4 0.4 0.1 1.7 1.8 0.3 1.7 0.1 0.6 12.7 15.6 11.1 12.2 11.1 9.3 13.5 6.0 11.5 14.4 8.9 3.4 0.5 6.1 4.8 13.0 7.0 17.8 1.4 4.5 15.7 2.0 6.1 10.0 10.4 6.4 7.7 34.2 0.0 13.9 6.8 6.5 6.6 3.5 14.3 10.7 20.6 17.3 13.5 5.7 6.1 10.0 5.6 5.0 7.2 27.7 12.9 10.6 39.1 12.4 13.5 9.2 6.5 7.6 12.7 5.3 5.0 3.0 1.9 24.7 4.8 ZNF77 pT1 ENSG00000175691 "Zinc finger protein 77" Q15935 19 2933218-2944971 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA023397 Uncertain Approved Nucleoplasm,Nucleoli No No Nucleoli Nucleoplasm "HPA023397: AB_1859447" "unprognostic (1.17e-2)" "prognostic favorable (8.49e-4)" "unprognostic (2.18e-1)" "prognostic favorable (6.65e-5)" "unprognostic (2.01e-3)" "unprognostic (1.58e-1)" "unprognostic (1.21e-1)" "prognostic favorable (6.79e-6)" "unprognostic (2.06e-1)" "unprognostic (5.03e-2)" "unprognostic (3.93e-3)" "unprognostic (2.65e-3)" "unprognostic (3.20e-3)" "unprognostic (2.33e-1)" "unprognostic (2.58e-1)" "unprognostic (1.84e-2)" "unprognostic (1.79e-3)" 6.3 6.6 6.6 5.4 8.9 5.6 13.2 18.2 9.8 8.4 6.1 8.4 9.9 4.1 8.5 8.5 7.5 7.3 4.2 7.4 5.9 5.8 6.4 6.3 12.7 6.6 7.0 7.8 9.7 8.2 8.2 8.2 8.2 6.5 6.9 6.4 8.9 11.4 6.7 6.1 8.3 6.1 8.7 5.5 6.8 8.1 8.3 4.3 9.6 8.8 4.0 9.3 6.4 6.7 5.5 3.7 1.3 3.1 3.9 6.2 3.3 4.7 2.2 10.8 6.3 2.3 3.0 4.9 2.9 4.3 5.8 6.9 7.3 1.9 5.3 2.4 3.2 3.2 3.8 7.0 4.7 9.8 0.4 5.1 6.4 3.4 8.1 5.7 0.2 5.3 4.6 6.5 4.5 6.7 7.2 8.0 10.5 8.4 0.0 3.9 5.2 7.8 4.6 2.4 4.1 3.1 8.9 8.3 3.7 4.6 7.4 4.4 8.3 4.4 4.2 5.0 5.5 4.0 11.1 3.8 2.4 3.1 6.8 5.2 5.5 5.3 2.5 6.2 0.1 4.4 0.0 2.7 1.3 5.5 2.6 6.2 5.5 5.8 5.9 3.7 5.3 4.5 6.2 0.2 3.9 3.1 3.0 2.8 3.3 6.6 8.9 18.2 9.8 5.9 5.8 7.0 7.8 6.5 4.3 3.0 3.8 0.0 4.2 10.3 2.8 2.0 0.0 2.7 4.5 1.8 2.0 2.9 0.0 1.8 1.6 2.1 1.3 0.0 1.5 2.6 2.2 2.0 2.3 1.5 1.5 0.0 6.9 3.1 0.6 0.0 2.6 1.6 1.7 0.0 2.2 3.0 2.0 1.9 1.4 1.0 5.5 0.0 2.1 10.0 7.3 9.5 5.1 1.9 3.1 1.8 ZNF771 DSC43 ENSG00000179965 "Zinc finger protein 771" Q7L3S4 16 30407297-30431108 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 27.0;REH: 17.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030730, HPA046672, HPA059398" Uncertain Enhanced Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA030730: AB_2673583, HPA046672: AB_2679745, HPA059398: AB_2684002" "unprognostic (8.21e-2)" "unprognostic (1.61e-1)" "unprognostic (9.21e-2)" "unprognostic (2.41e-1)" "unprognostic (1.09e-1)" "unprognostic (1.27e-1)" "unprognostic (1.45e-1)" "unprognostic (2.16e-1)" "unprognostic (1.94e-1)" "unprognostic (1.95e-2)" "unprognostic (3.12e-5)" "unprognostic (3.53e-2)" "unprognostic (3.44e-2)" "unprognostic (1.63e-1)" "unprognostic (2.38e-1)" "unprognostic (2.57e-1)" "unprognostic (9.99e-3)" 6.6 6.7 15.3 5.0 14.5 4.0 5.3 10.7 18.3 6.6 6.1 4.9 6.6 4.5 10.4 7.2 4.6 7.5 6.1 4.6 13.4 10.6 9.2 8.6 4.1 3.3 8.8 16.9 10.8 7.3 8.1 6.2 2.4 8.8 10.1 5.4 4.0 4.9 12.3 18.2 6.1 4.3 9.6 5.1 3.6 4.8 3.7 8.1 1.9 5.4 3.5 4.2 6.8 5.6 6.6 3.7 1.9 2.5 1.8 6.2 2.7 3.1 3.6 5.0 4.1 7.2 3.0 3.8 4.7 2.3 3.0 3.1 1.6 1.6 3.8 8.0 2.3 3.7 2.4 5.2 2.1 3.1 1.3 27.0 3.2 2.4 4.8 3.7 1.6 3.8 4.6 1.6 3.7 2.3 3.1 3.0 4.0 7.7 2.3 2.5 5.7 3.8 5.2 4.0 1.9 2.9 17.3 3.7 2.4 1.7 1.3 7.9 5.0 2.5 2.2 3.0 2.7 2.9 1.8 2.7 5.0 6.0 2.9 3.3 3.5 3.7 1.9 3.3 3.5 3.2 1.0 1.1 0.7 3.6 2.5 4.9 2.7 4.3 4.2 2.8 6.6 6.2 3.7 1.9 1.8 0.5 3.7 4.4 2.7 15.3 14.5 10.7 18.3 13.4 10.6 8.8 16.9 8.8 8.1 3.0 0.3 2.2 10.4 4.5 11.2 6.3 15.3 0.0 1.2 5.2 9.8 4.8 28.2 6.4 1.3 5.8 5.3 0.0 3.7 2.6 9.4 8.8 1.1 16.3 2.9 11.1 4.1 14.7 0.6 1.5 23.3 2.8 5.0 1.0 8.1 15.1 3.6 4.2 28.0 23.6 7.1 12.9 8.9 1.1 1.6 5.8 3.0 3.9 9.8 3.4 ZNF773 "MGC4728, ZNF419B" ENSG00000152439 "Zinc finger protein 773" Q6PK81 19 57499915-57518404 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Sertoli cells: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA003152 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA003152: AB_1080716" "unprognostic (6.53e-2)" "unprognostic (3.79e-3)" "unprognostic (2.09e-1)" "unprognostic (1.29e-1)" "unprognostic (6.06e-2)" "unprognostic (2.07e-1)" "unprognostic (3.21e-2)" "unprognostic (5.19e-2)" "unprognostic (1.30e-1)" "unprognostic (1.37e-1)" "unprognostic (9.50e-4)" "unprognostic (2.97e-2)" "unprognostic (3.56e-4)" "unprognostic (1.54e-1)" "unprognostic (2.69e-2)" "unprognostic (1.14e-1)" "unprognostic (3.71e-3)" 9.0 10.3 7.3 7.0 10.8 10.7 12.5 15.4 11.3 6.0 7.7 6.0 11.2 8.2 8.4 11.4 6.8 8.7 8.4 7.3 7.2 6.9 8.2 4.9 8.1 16.1 8.6 7.8 12.1 5.6 16.0 14.6 8.7 8.2 9.7 7.1 9.6 9.0 8.1 17.8 10.7 7.9 8.8 9.7 11.3 6.9 8.8 4.7 12.7 12.3 6.2 10.4 9.2 9.6 14.8 6.9 16.2 4.8 8.9 17.2 5.8 1.8 3.2 5.6 7.3 4.0 5.0 0.3 5.4 8.1 4.8 19.9 3.3 2.7 3.5 2.9 3.5 3.6 1.4 2.7 5.7 7.1 0.1 17.4 5.9 0.4 2.0 7.7 4.4 4.8 11.4 8.2 3.5 13.9 6.1 3.4 6.3 0.3 0.6 6.1 0.4 8.4 3.1 5.8 0.8 9.6 4.6 9.0 5.4 3.3 6.5 6.0 7.3 1.0 2.5 6.2 5.4 4.2 8.2 2.9 7.6 3.4 1.9 5.7 8.9 9.1 5.7 2.9 4.4 6.8 16.2 4.8 7.6 8.4 3.6 13.6 11.8 10.4 9.0 6.4 14.8 17.2 13.8 2.2 8.9 3.1 6.9 7.2 5.8 7.3 10.8 15.4 11.3 7.2 6.9 8.6 7.8 8.2 4.7 0.0 1.6 2.2 2.5 0.9 4.8 1.2 2.5 0.0 5.7 0.0 5.9 2.4 3.3 2.5 0.4 3.0 0.0 0.0 0.6 0.8 1.3 2.8 1.1 0.8 0.8 6.4 0.0 1.8 1.5 0.0 1.1 2.1 1.7 1.8 0.4 3.8 0.7 1.1 3.5 0.8 7.4 12.9 2.1 1.8 4.2 0.5 2.4 3.8 1.0 1.8 ZNF776 FLJ38288 ENSG00000152443 "Zinc finger protein 776" Q68DI1 19 57746796-57758159 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA046653, HPA068553" Uncertain Approved Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA046653: AB_10961126, HPA068553: AB_2686002" "unprognostic (6.73e-2)" "prognostic unfavorable (9.74e-4)" "unprognostic (3.99e-2)" "unprognostic (3.26e-1)" "unprognostic (6.35e-2)" "unprognostic (2.73e-2)" "unprognostic (1.62e-1)" "unprognostic (2.69e-2)" "unprognostic (2.96e-2)" "unprognostic (1.88e-1)" "unprognostic (7.00e-2)" "unprognostic (7.45e-3)" "unprognostic (1.71e-3)" "unprognostic (2.11e-1)" "unprognostic (1.89e-1)" "unprognostic (6.41e-2)" "unprognostic (6.86e-2)" 5.8 9.8 14.0 10.8 15.9 19.4 12.2 34.9 15.2 9.4 8.6 7.9 17.3 8.4 8.2 29.9 7.8 10.3 6.9 9.8 11.0 9.5 10.7 9.5 8.6 11.0 10.7 8.9 12.4 7.1 17.0 18.8 10.2 12.8 11.9 9.3 9.6 10.8 13.4 11.4 8.6 8.7 7.3 9.6 11.6 10.0 8.7 15.0 19.3 14.5 6.0 10.7 10.7 8.0 4.2 2.5 11.1 2.4 7.5 4.3 2.1 4.7 4.0 12.7 8.4 2.1 6.5 5.4 3.7 6.6 6.6 4.3 2.4 5.1 5.3 3.4 3.4 3.5 3.1 6.6 6.5 10.6 5.0 24.1 7.2 9.4 2.7 4.8 4.0 5.8 7.5 5.5 4.4 4.8 7.1 5.1 8.7 4.8 3.8 8.5 2.1 13.0 3.8 7.4 2.1 8.3 8.4 9.6 6.0 4.8 14.9 14.5 10.5 6.9 5.8 4.1 7.2 5.9 5.7 4.5 7.1 3.8 0.6 5.6 10.7 12.0 8.8 4.2 3.8 5.8 7.9 2.4 11.1 1.8 1.7 3.9 3.5 2.8 3.4 2.2 4.2 4.3 3.2 6.2 7.5 2.1 2.5 2.3 2.1 14.0 15.9 34.9 15.2 11.0 9.5 10.7 8.9 12.8 15.0 3.0 2.6 5.2 3.6 2.4 7.8 10.9 10.2 5.3 1.2 8.7 2.0 2.8 5.0 2.5 0.4 5.5 2.9 0.0 1.2 2.0 2.5 4.5 3.5 6.6 2.9 11.1 8.1 11.1 5.6 0.2 1.1 3.7 0.0 1.8 4.1 10.0 2.2 2.6 4.6 2.2 7.1 0.0 2.2 2.7 4.3 1.5 2.4 1.0 3.3 4.3 ZNF777 KIAA1285 ENSG00000196453 "Zinc finger protein 777" Q9ULD5 7 149431363-149461123 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "placenta: 65.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003252 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA003252: AB_1080755" "unprognostic (7.19e-2)" "unprognostic (1.06e-1)" "unprognostic (1.17e-2)" "unprognostic (3.37e-2)" "unprognostic (4.78e-2)" "unprognostic (6.64e-2)" "unprognostic (5.87e-3)" "unprognostic (4.52e-2)" "unprognostic (1.10e-1)" "unprognostic (6.15e-2)" "unprognostic (5.17e-3)" "unprognostic (2.64e-1)" "unprognostic (4.00e-2)" "unprognostic (6.33e-2)" "unprognostic (1.68e-1)" "unprognostic (8.23e-2)" "unprognostic (5.72e-2)" 5.0 4.3 5.5 4.1 8.8 6.9 4.9 7.1 9.3 5.2 5.2 5.4 3.5 4.5 7.3 3.5 4.1 6.5 3.5 4.7 5.3 5.1 3.8 4.4 4.4 4.7 4.3 5.3 9.1 6.6 6.6 5.9 65.7 6.6 5.8 3.3 5.0 7.3 5.8 10.6 7.3 4.4 5.4 6.2 6.0 4.9 4.2 3.5 3.5 5.2 4.8 3.9 6.2 5.0 0.4 0.2 0.6 0.3 0.1 1.5 0.1 10.2 12.7 8.6 12.4 6.4 5.2 11.0 6.6 7.0 9.0 7.8 7.9 6.6 6.5 13.4 7.5 5.6 6.8 8.3 10.1 5.0 10.5 12.7 6.4 3.6 7.8 10.9 9.0 9.3 6.1 11.6 7.3 10.7 4.8 4.8 8.9 20.5 0.0 5.1 13.2 18.9 12.3 10.4 4.6 7.5 15.7 4.4 13.6 5.6 8.0 9.3 13.1 11.4 11.8 11.0 3.3 5.5 15.1 7.5 7.6 3.0 14.9 10.8 6.2 5.4 3.0 5.7 6.2 9.7 0.0 0.3 0.0 0.5 0.3 0.1 0.3 0.4 0.4 0.0 0.4 0.1 1.5 0.6 0.1 0.1 0.2 0.0 0.1 5.5 8.8 7.1 9.3 5.3 5.1 4.3 5.3 6.6 3.5 0.0 1.7 1.5 1.4 1.0 6.9 2.3 2.5 1.4 0.0 1.8 5.9 1.8 0.0 0.7 2.1 1.6 1.5 0.0 0.9 2.8 1.1 2.0 0.0 5.0 1.3 1.6 1.7 2.5 2.8 2.5 2.6 1.1 0.0 0.0 3.1 4.9 1.0 2.9 3.2 1.4 5.4 0.0 1.4 0.6 4.7 1.6 3.2 2.2 2.6 0.9 ZNF778 FLJ31875 ENSG00000170100 "Zinc finger protein 778" Q96MU6 16 89217703-89237071 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 20.6;Late spermatids: 24.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 10.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA052057, HPA057151" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA052057: AB_2681710, HPA057151: AB_2683352" "unprognostic (3.63e-2)" "unprognostic (1.42e-1)" "unprognostic (4.75e-3)" "unprognostic (7.04e-2)" "unprognostic (2.43e-1)" "unprognostic (1.66e-3)" "unprognostic (5.34e-2)" "unprognostic (1.29e-2)" "unprognostic (1.91e-1)" "unprognostic (3.57e-1)" "unprognostic (3.53e-7)" "unprognostic (2.51e-1)" "unprognostic (2.85e-7)" "unprognostic (3.22e-2)" "unprognostic (3.67e-1)" "unprognostic (8.46e-2)" "unprognostic (3.63e-2)" 5.9 6.7 9.3 4.7 9.5 4.1 6.6 11.2 9.8 5.4 5.8 8.8 4.4 3.1 6.9 5.1 6.0 6.1 3.7 6.0 7.4 4.7 8.7 5.9 5.8 4.6 8.9 6.7 5.8 12.0 22.4 8.9 5.4 7.5 6.5 5.0 6.1 6.3 7.8 10.4 8.2 4.9 6.7 8.1 5.7 6.8 12.5 7.8 4.1 8.4 5.5 6.3 6.9 6.8 1.7 2.0 10.9 2.7 1.4 4.1 1.5 4.2 2.1 6.8 5.8 4.3 3.6 8.9 3.3 5.2 4.8 2.6 6.5 2.5 2.0 5.9 3.9 2.4 3.3 9.3 4.5 7.7 0.8 6.7 5.6 4.2 3.2 2.4 1.6 3.3 2.7 3.2 6.3 4.5 2.9 4.0 3.9 6.3 1.0 4.0 11.1 3.2 2.5 10.1 3.2 4.1 8.8 15.9 0.8 2.4 3.8 13.8 10.3 7.5 3.7 2.7 6.6 11.5 3.3 4.8 5.3 3.8 3.1 4.0 3.6 5.2 4.3 7.5 3.2 3.3 10.9 1.7 3.9 4.1 2.0 2.1 1.3 1.9 2.1 2.0 1.7 1.5 2.6 0.6 1.4 2.7 0.8 2.3 1.5 9.3 9.5 11.2 9.8 7.4 4.7 8.9 6.7 7.5 7.8 11.9 4.1 0.0 1.7 1.4 9.2 4.2 2.5 0.0 3.4 5.2 13.7 1.9 0.0 2.4 13.4 2.7 1.6 0.0 4.8 1.7 1.6 4.4 0.0 4.9 2.3 20.6 2.9 4.9 5.3 24.8 2.3 1.1 1.7 1.8 2.6 4.8 2.5 1.5 2.8 2.1 9.4 12.9 2.4 12.7 11.4 1.4 1.9 3.9 2.3 2.8 ZNF780A ZNF780 ENSG00000197782 "Zinc finger protein 780A" O75290 19 40069152-40090938 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Exocrine glandular cells: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003311 Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA003311: AB_1080757" "unprognostic (1.92e-1)" "unprognostic (9.25e-2)" "unprognostic (7.38e-2)" "unprognostic (2.27e-2)" "unprognostic (1.53e-2)" "unprognostic (8.95e-2)" "unprognostic (1.30e-1)" "unprognostic (1.10e-1)" "unprognostic (2.14e-2)" "unprognostic (1.46e-2)" "unprognostic (1.19e-2)" "unprognostic (2.17e-1)" "unprognostic (4.47e-3)" "unprognostic (1.13e-1)" "unprognostic (9.49e-2)" "unprognostic (4.91e-2)" "prognostic favorable (9.30e-4)" 6.9 9.2 11.1 8.6 8.5 4.1 7.7 12.8 10.8 8.7 6.6 5.8 13.9 5.7 8.2 10.8 10.4 7.8 7.8 6.7 7.1 6.1 7.9 11.8 7.0 11.3 10.5 8.9 8.6 11.0 15.8 14.1 7.0 6.8 7.9 6.0 6.8 10.0 11.4 4.5 8.0 9.1 6.0 10.4 12.0 8.2 7.9 9.7 7.8 11.2 5.3 11.3 8.8 7.9 3.9 4.6 8.4 7.7 3.3 5.9 2.5 4.9 9.4 6.2 5.7 5.6 5.2 4.4 5.8 4.7 4.7 7.2 6.1 3.4 4.4 3.8 2.8 4.7 4.2 3.9 3.3 5.3 7.5 5.3 6.9 7.8 5.8 5.0 7.2 5.8 5.3 3.7 4.8 4.0 6.4 4.9 5.0 7.8 7.5 4.0 2.9 2.9 2.4 4.9 4.8 2.9 2.3 10.9 2.6 3.9 10.2 3.8 7.3 8.6 3.3 3.8 5.7 4.1 8.7 3.6 5.8 7.7 5.3 4.6 7.4 6.5 4.4 3.7 5.0 3.9 2.7 5.4 8.4 3.9 4.9 5.1 3.7 4.2 3.5 4.6 3.9 5.9 5.1 4.7 3.3 7.7 3.6 4.5 2.5 11.1 8.5 12.8 10.8 7.1 6.1 10.5 8.9 6.8 9.7 8.9 12.2 4.4 3.5 3.4 5.7 3.7 7.6 8.1 9.1 8.7 2.0 5.0 8.3 11.9 17.3 7.7 7.4 0.0 42.0 6.3 5.5 3.0 16.1 33.6 13.1 4.8 3.4 11.6 25.0 1.1 4.0 17.9 11.8 8.2 7.2 3.5 24.5 8.6 4.9 13.3 6.6 6.5 6.2 5.8 2.5 2.3 4.9 11.5 6.6 2.7 ZNF780B ZNF779 ENSG00000128000 "Zinc finger protein 780B" Q9Y6R6 19 40028260-40056209 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 28.1;Cone photoreceptor cells: 31.4;Rod photoreceptor cells: 35.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA003311 Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA003311: AB_1080757" "unprognostic (3.28e-1)" "unprognostic (2.69e-1)" "unprognostic (1.92e-1)" "unprognostic (3.56e-3)" "unprognostic (5.54e-2)" "unprognostic (1.20e-2)" "unprognostic (1.27e-1)" "unprognostic (1.76e-2)" "unprognostic (1.24e-2)" "unprognostic (4.59e-3)" "unprognostic (1.83e-3)" "unprognostic (1.33e-2)" "unprognostic (4.89e-3)" "unprognostic (4.71e-2)" "unprognostic (1.70e-1)" "unprognostic (3.00e-1)" "unprognostic (1.56e-3)" 6.3 8.2 12.4 9.8 18.8 3.3 10.3 22.2 14.0 8.2 8.5 8.2 11.6 5.7 10.8 12.3 5.5 10.0 6.6 12.5 9.4 7.2 9.4 6.7 5.9 9.7 8.1 10.8 16.6 8.1 10.5 24.7 7.1 11.6 9.7 7.6 9.3 7.9 10.5 6.9 7.1 7.6 9.7 7.8 9.2 7.2 5.0 11.4 8.7 14.0 6.4 9.8 9.1 8.2 4.2 5.9 1.5 3.2 2.3 5.1 1.3 2.6 3.5 5.9 4.1 3.6 2.4 0.0 3.1 2.3 3.4 4.5 6.3 2.4 6.6 2.9 3.2 3.4 1.6 4.9 1.9 4.0 5.5 2.5 5.1 6.2 3.9 2.4 7.6 4.3 3.4 1.2 4.7 2.9 2.6 3.2 3.0 5.3 8.9 3.4 1.2 2.5 1.2 5.8 2.3 3.7 3.5 10.4 2.3 2.0 14.5 6.5 6.9 5.4 2.4 1.9 3.7 2.8 3.3 5.8 3.3 8.3 5.8 4.7 6.7 8.6 5.1 3.1 4.0 2.8 0.1 3.2 1.5 2.8 2.8 2.9 2.5 3.4 3.3 2.4 4.2 5.1 4.2 0.6 2.3 1.8 5.9 1.9 1.3 12.4 18.8 22.2 14.0 9.4 7.2 8.1 10.8 11.6 11.4 8.9 8.1 4.2 2.3 1.6 28.1 13.0 10.2 4.0 10.3 8.7 31.4 1.6 3.3 4.4 6.0 5.8 2.6 0.0 8.6 1.2 2.7 2.1 7.0 4.9 3.2 9.5 9.9 9.8 4.8 1.1 3.4 7.2 5.0 5.4 4.3 7.2 4.7 4.5 2.8 2.4 35.0 6.5 3.9 2.7 1.3 2.6 0.6 5.2 4.2 2.2 ZNF781 FLJ37549 ENSG00000196381 "Zinc finger protein 781" Q8N8C0 19 37667751-37692322 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 57.2;Late spermatids: 45.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 11 "B-cells: 1.0;T-cells: 3.2" "Cell line enhanced" "Detected in many" "AN3-CA: 4.7;ASC diff: 4.7;HSkMC: 4.6;SH-SY5Y: 4.6;U-266/84: 5.4" HPA062512 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA062512: AB_2684788" "unprognostic (3.01e-1)" "unprognostic (8.26e-2)" "unprognostic (3.03e-1)" "unprognostic (2.86e-2)" "unprognostic (1.90e-2)" "unprognostic (5.82e-2)" "unprognostic (1.76e-3)" "unprognostic (2.68e-2)" "unprognostic (1.58e-1)" "unprognostic (1.86e-1)" "unprognostic (1.84e-3)" "unprognostic (1.67e-1)" "unprognostic (1.23e-2)" "unprognostic (2.11e-2)" "unprognostic (8.12e-2)" "unprognostic (2.66e-2)" "unprognostic (1.04e-1)" 4.9 5.3 5.7 4.6 12.9 0.5 2.9 15.8 13.6 4.3 4.5 3.8 1.9 1.6 7.3 4.8 2.2 4.8 3.1 6.5 5.8 5.8 2.6 1.3 3.7 3.5 6.1 6.8 9.8 1.3 4.8 7.4 5.0 7.6 4.5 3.1 3.8 1.5 5.2 1.5 2.0 2.4 8.5 9.6 5.0 2.2 4.8 5.5 0.6 5.3 1.3 2.5 4.7 5.4 1.0 0.1 0.1 0.2 0.0 3.2 0.7 0.0 0.0 1.9 4.7 4.7 1.0 1.0 1.7 0.0 1.7 1.2 0.2 0.0 0.2 0.0 1.1 3.0 0.0 0.1 0.0 2.0 0.0 0.1 0.1 0.0 2.0 2.3 0.0 0.1 4.6 0.0 1.3 0.1 0.6 0.4 0.2 0.9 0.0 0.0 0.0 1.2 1.0 0.5 0.0 0.0 0.0 3.3 0.0 0.7 1.2 0.0 4.6 0.0 0.0 0.0 2.4 2.2 0.1 0.0 0.2 0.0 0.0 1.1 1.5 5.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 1.1 0.4 1.8 2.5 0.1 1.0 2.6 3.2 0.1 0.0 0.0 0.1 0.8 0.7 5.7 12.9 15.8 13.6 5.8 5.8 6.1 6.8 7.6 5.5 0.0 1.1 1.3 0.5 0.5 6.1 12.9 2.5 0.0 0.0 0.0 19.6 5.8 0.0 0.8 57.2 4.5 0.0 0.0 0.0 3.4 1.6 0.1 3.5 0.0 3.0 3.2 7.5 11.6 1.5 45.4 4.4 0.0 1.7 0.0 0.0 5.5 0.1 0.0 6.3 0.2 7.8 12.9 6.6 14.8 3.2 0.0 1.1 1.3 0.0 0.0 ZNF782 FLJ16636 ENSG00000196597 "Zinc finger protein 782" Q6ZMW2 9 96816472-96875623 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 8.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011013 Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA011013: AB_1080758" "unprognostic (5.51e-2)" "unprognostic (5.29e-2)" "unprognostic (1.43e-1)" "unprognostic (1.49e-2)" "unprognostic (1.99e-1)" "unprognostic (1.48e-2)" "unprognostic (2.82e-2)" "unprognostic (9.89e-3)" "unprognostic (2.38e-2)" "unprognostic (3.04e-2)" "unprognostic (4.68e-3)" "unprognostic (3.63e-3)" "unprognostic (4.84e-2)" "unprognostic (3.55e-1)" "unprognostic (4.95e-1)" "unprognostic (2.61e-2)" "unprognostic (4.39e-2)" 5.3 4.2 7.4 7.4 8.4 2.5 7.6 19.8 8.0 7.5 5.3 6.9 5.9 6.1 7.9 8.5 5.2 5.5 5.8 4.0 6.8 4.5 7.1 5.5 4.4 5.9 5.9 4.8 9.3 12.7 11.8 15.1 4.9 7.7 7.5 6.9 5.4 8.0 7.3 9.2 8.6 7.1 5.3 6.5 6.4 6.6 13.9 8.3 6.0 8.8 2.5 7.4 5.6 10.8 2.3 0.2 0.7 0.5 1.0 2.2 0.4 2.9 2.3 5.8 8.9 1.6 2.2 4.0 2.8 2.8 4.6 3.4 2.7 3.1 5.7 3.7 2.0 5.4 4.1 5.1 1.8 4.5 5.7 2.2 5.3 4.7 2.7 1.7 7.3 3.7 1.3 3.8 3.7 1.9 2.2 1.5 7.0 7.0 5.8 2.7 5.0 7.6 3.6 4.3 5.2 5.1 6.8 7.1 1.9 3.1 1.9 5.9 4.5 3.8 2.3 3.0 4.9 4.3 4.2 3.3 6.0 3.5 6.0 3.1 5.5 3.9 2.7 2.5 1.8 4.3 0.0 0.5 0.2 1.1 0.5 2.2 2.0 1.0 0.0 0.2 2.3 0.9 0.7 0.7 1.0 0.2 0.2 0.6 0.4 7.4 8.4 19.8 8.0 6.8 4.5 5.9 4.8 7.7 8.3 0.0 5.5 0.9 1.4 1.6 5.7 1.4 0.0 1.4 0.0 1.8 7.9 0.7 0.0 1.3 5.6 1.6 1.7 0.0 1.5 0.2 0.5 1.7 5.7 1.0 1.1 3.2 0.0 1.8 0.6 6.9 1.7 0.7 0.0 3.6 1.4 2.2 1.0 0.0 2.8 1.6 6.5 0.0 1.0 8.6 2.4 0.9 0.6 0.7 1.2 1.8 ZNF784 MGC75238 ENSG00000179922 "Zinc finger protein 784" Q8NCA9 19 55620742-55624601 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 39.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059676 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA059676: AB_2684102" "unprognostic (4.67e-2)" "unprognostic (8.13e-2)" "unprognostic (4.03e-1)" "unprognostic (6.46e-3)" "unprognostic (1.17e-1)" "unprognostic (2.63e-2)" "unprognostic (2.28e-1)" "unprognostic (9.44e-2)" "unprognostic (4.74e-1)" "unprognostic (1.26e-1)" "unprognostic (9.11e-3)" "unprognostic (4.86e-2)" "unprognostic (3.48e-3)" "unprognostic (3.87e-1)" "unprognostic (7.93e-2)" "unprognostic (5.10e-2)" "prognostic favorable (1.02e-4)" 5.9 5.6 2.9 7.4 3.2 5.7 4.9 5.2 5.0 7.5 9.3 3.3 4.1 8.6 7.9 8.0 4.9 6.7 7.0 9.1 2.8 2.3 5.8 7.3 10.4 3.5 2.7 3.2 9.7 15.0 6.0 5.5 4.9 3.9 7.9 3.8 5.8 5.9 5.8 39.1 4.9 11.2 10.4 2.6 6.5 5.8 3.6 2.6 3.2 7.3 16.1 6.1 6.7 4.5 1.4 1.6 2.9 2.0 1.4 1.3 0.6 4.5 6.4 6.1 3.2 2.3 3.2 5.7 4.8 3.0 2.8 3.7 3.3 5.1 5.5 4.2 3.4 2.1 2.5 1.7 4.2 2.0 3.0 17.1 5.2 5.0 4.0 4.7 4.2 5.5 4.3 4.6 2.3 3.0 4.4 1.8 7.9 6.0 5.7 4.2 4.4 3.2 4.8 5.9 3.5 14.2 6.1 4.1 6.1 5.0 11.7 6.8 9.1 7.9 3.7 2.1 4.2 4.0 7.5 5.5 3.2 3.0 1.9 3.9 6.6 2.7 3.2 4.9 3.2 2.7 0.0 2.0 2.9 0.8 1.8 0.6 1.0 0.8 0.8 1.6 1.4 0.8 1.3 1.1 1.4 1.5 1.2 0.1 0.6 2.9 3.2 5.2 5.0 2.8 2.3 2.7 3.2 3.9 2.6 0.0 9.0 3.2 3.6 0.8 5.4 11.3 5.1 2.7 2.3 0.0 2.0 4.3 3.3 3.2 1.9 2.0 9.3 0.0 3.6 2.3 1.0 2.0 2.3 5.4 3.0 7.9 5.2 1.8 1.9 0.0 3.7 1.3 0.0 4.6 5.1 4.1 4.0 7.0 2.5 4.3 9.5 12.9 2.0 0.7 1.9 1.1 8.5 2.1 5.2 3.4 ZNF786 DKFZp762I137 ENSG00000197362 "Zinc finger protein 786" Q8N393 7 149069643-149090782 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 17.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021518, HPA053459" Uncertain Approved "Nucleoplasm,Nuclear speckles,Nuclear bodies" NA NA "Nuclear speckles" "Nucleoplasm, Nuclear bodies" "HPA021518: AB_2670734, HPA053459: AB_2682159" "unprognostic (3.13e-2)" "unprognostic (2.72e-1)" "unprognostic (5.61e-2)" "unprognostic (5.39e-2)" "unprognostic (1.87e-1)" "unprognostic (2.84e-2)" "prognostic unfavorable (1.09e-4)" "unprognostic (5.62e-2)" "unprognostic (1.09e-3)" "unprognostic (8.85e-2)" "prognostic favorable (2.01e-4)" "unprognostic (3.97e-2)" "unprognostic (1.39e-2)" "unprognostic (8.86e-3)" "unprognostic (1.31e-1)" "unprognostic (3.44e-1)" "unprognostic (1.47e-2)" 3.9 4.3 8.7 6.1 9.6 3.3 5.1 10.4 15.2 6.0 5.1 4.2 6.4 4.6 6.9 6.1 6.8 6.7 4.8 3.2 6.4 6.1 4.5 5.4 7.3 8.2 4.8 5.8 8.3 6.0 7.6 8.5 3.8 4.0 6.8 3.4 5.4 5.3 5.8 4.1 13.0 5.1 6.6 3.4 7.7 5.1 2.9 4.2 8.4 6.1 5.8 6.5 6.2 6.1 7.2 4.5 2.9 5.0 8.4 12.1 5.3 4.5 8.2 6.6 11.1 4.0 1.7 9.4 2.7 2.9 3.1 2.5 4.3 4.3 6.4 6.8 1.9 5.4 5.2 4.0 3.8 2.0 7.0 6.1 3.2 4.8 5.4 3.4 6.2 4.3 2.3 4.3 3.9 2.8 3.2 2.9 4.7 5.6 3.7 2.9 14.1 10.5 10.6 12.0 4.3 6.2 7.9 3.2 4.2 2.5 6.3 7.8 12.4 6.9 6.5 5.1 4.3 4.2 2.9 3.7 3.7 2.1 6.3 4.0 13.4 9.9 3.5 6.1 4.0 4.0 1.7 3.7 2.9 12.1 5.0 9.8 7.2 8.5 10.7 4.5 7.1 11.3 9.5 1.1 8.4 3.9 3.9 5.1 5.3 8.7 9.6 10.4 15.2 6.4 6.1 4.8 5.8 4.0 4.2 0.0 0.6 2.4 2.1 2.4 9.4 2.5 0.0 2.7 0.0 3.5 2.0 2.1 3.3 3.7 0.3 1.5 1.3 0.0 1.3 1.9 1.9 1.2 4.6 2.1 1.9 17.5 4.6 2.5 1.2 0.0 2.8 2.0 0.0 2.8 1.0 2.7 1.8 2.9 3.9 1.8 5.7 0.0 1.9 3.1 8.3 1.5 1.6 4.9 2.6 1.7 ZNF787 ENSG00000142409 "Zinc finger protein 787" 19 56087366-56121280 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 52.1;Cone photoreceptor cells: 104.1;Rod photoreceptor cells: 60.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 43.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035140 Supported Approved Nucleoplasm,Nucleoli,Mitochondria NA NA Nucleoplasm "Nucleoli, Mitochondria" "HPA035140: AB_10602358" "unprognostic (1.97e-2)" "unprognostic (5.86e-2)" "unprognostic (8.77e-2)" "unprognostic (1.62e-1)" "unprognostic (1.08e-1)" "unprognostic (2.24e-1)" "unprognostic (1.46e-2)" "unprognostic (2.17e-1)" "unprognostic (3.19e-2)" "unprognostic (1.54e-1)" "unprognostic (4.83e-2)" "unprognostic (1.26e-1)" "unprognostic (1.27e-1)" "unprognostic (1.31e-2)" "unprognostic (1.86e-1)" "unprognostic (1.10e-1)" "unprognostic (1.96e-3)" 7.4 8.0 4.3 7.8 5.2 18.8 7.1 4.7 7.0 8.0 9.8 5.1 8.5 12.8 5.8 6.5 9.8 8.7 8.7 10.2 4.0 4.3 6.4 18.0 6.9 7.7 4.8 4.0 8.7 13.9 3.3 6.6 4.8 4.6 10.0 3.9 7.9 9.6 7.2 28.2 9.3 10.5 6.8 3.1 14.9 11.0 6.8 4.6 4.8 10.0 8.2 5.7 8.7 10.1 3.0 5.5 4.9 2.1 1.2 1.6 0.7 12.0 11.9 3.9 8.1 1.1 2.5 10.1 6.2 2.4 4.3 4.8 7.0 7.5 8.6 0.4 2.6 3.8 9.5 2.4 5.0 1.9 11.4 43.9 13.7 6.0 10.5 6.3 13.1 12.0 3.3 5.0 3.5 6.2 2.6 3.1 4.9 16.3 9.7 2.5 7.6 8.1 16.5 12.3 11.1 22.4 10.2 5.7 10.9 4.3 8.0 14.9 14.4 6.6 13.0 11.5 2.3 8.0 18.6 6.7 16.1 11.5 6.7 17.1 20.6 15.1 8.3 9.3 8.8 7.5 1.7 2.1 2.6 1.2 1.5 1.6 2.3 0.8 1.0 2.2 3.0 1.3 0.7 4.9 1.2 1.4 5.5 1.3 0.7 4.3 5.2 4.7 7.0 4.0 4.3 4.8 4.0 4.6 4.6 11.9 2.4 6.7 8.9 5.5 52.1 9.0 12.7 0.0 4.5 10.4 104.1 2.9 1.7 5.9 1.5 6.7 15.4 0.0 14.2 4.0 5.0 8.6 5.7 28.4 7.5 33.4 8.7 12.9 6.5 2.9 4.6 6.8 1.7 4.6 17.1 29.5 12.9 15.3 4.2 3.7 60.0 6.5 6.2 2.5 7.9 6.4 1.6 3.2 16.9 11.7 ZNF789 ENSG00000198556 "Zinc finger protein 789" Q5FWF6 7 99472841-99503650 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029500, HPA050793" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA029500: AB_10603009, HPA050793: AB_2681240" "unprognostic (6.84e-3)" "unprognostic (5.75e-2)" "unprognostic (5.71e-2)" "unprognostic (2.49e-2)" "unprognostic (3.08e-1)" "unprognostic (2.90e-2)" "unprognostic (1.25e-3)" "unprognostic (4.38e-3)" "unprognostic (5.16e-2)" "unprognostic (1.56e-1)" "prognostic favorable (7.14e-4)" "unprognostic (1.58e-2)" "prognostic unfavorable (3.56e-4)" "unprognostic (6.63e-2)" "unprognostic (2.03e-1)" "unprognostic (8.33e-2)" "prognostic favorable (5.31e-6)" 6.1 5.5 11.0 15.9 10.0 11.6 9.2 31.9 14.4 6.1 9.2 9.2 11.0 15.1 10.9 12.8 5.0 7.8 6.6 4.0 10.0 8.5 9.0 8.1 6.5 10.5 6.8 9.8 8.9 7.8 6.3 13.3 4.6 7.6 16.4 12.5 14.8 10.3 13.8 8.9 13.3 12.6 8.5 8.6 11.2 8.4 17.6 8.1 8.4 9.3 4.8 10.1 4.1 5.6 3.9 14.2 2.0 1.6 4.1 7.0 2.1 11.2 3.8 6.2 11.2 1.8 2.1 8.6 5.8 2.2 3.5 7.7 6.4 7.7 8.6 4.9 2.6 4.1 5.7 3.5 3.3 4.9 3.9 6.0 6.5 10.6 10.8 3.1 4.4 14.9 2.3 3.0 7.5 3.3 2.3 3.7 11.1 9.7 8.4 3.2 10.7 5.3 11.9 6.3 5.3 6.0 7.0 5.9 9.0 4.6 3.5 6.2 6.8 4.1 11.2 6.5 3.7 3.0 7.0 6.9 6.7 8.2 10.0 5.6 5.1 7.0 10.8 10.6 8.0 7.2 2.0 1.6 1.5 2.7 1.1 2.9 2.7 3.4 2.9 5.6 3.9 7.0 4.2 0.4 4.1 1.4 14.2 5.3 2.1 11.0 10.0 31.9 14.4 10.0 8.5 6.8 9.8 7.6 8.1 0.0 4.6 4.2 3.8 4.8 17.5 1.7 2.5 6.7 4.5 1.8 13.7 4.0 1.7 3.6 21.1 5.6 4.7 23.3 4.8 3.0 3.4 2.5 3.5 2.9 5.6 6.4 5.2 0.6 4.4 6.4 3.1 6.6 6.8 2.8 5.1 10.9 3.5 4.5 4.2 3.4 13.5 0.0 4.2 10.6 3.8 4.5 1.8 4.8 5.6 3.0 ZNF79 pT7 ENSG00000196152 "Zinc finger protein 79" Q15937 9 127424374-127445372 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 5.1;Spermatocytes: 5.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028977 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA028977: AB_10602359" "unprognostic (4.56e-2)" "unprognostic (3.59e-2)" "unprognostic (1.15e-1)" "prognostic favorable (6.83e-5)" "unprognostic (2.84e-2)" "unprognostic (2.45e-2)" "unprognostic (2.11e-1)" "prognostic favorable (5.96e-4)" "unprognostic (3.41e-1)" "unprognostic (1.13e-2)" "prognostic favorable (5.42e-5)" "unprognostic (4.53e-3)" "prognostic favorable (6.04e-7)" "unprognostic (6.09e-3)" "unprognostic (5.01e-1)" "unprognostic (5.23e-2)" "unprognostic (1.32e-1)" 9.9 11.0 7.6 6.7 7.8 6.7 8.1 18.3 8.5 9.2 9.6 10.3 6.9 5.6 12.9 10.4 7.0 9.4 5.6 6.8 6.8 5.3 6.8 9.5 6.8 8.3 7.5 5.2 9.1 9.5 13.2 11.8 8.1 8.4 11.2 8.2 10.7 12.2 8.3 13.2 8.7 7.7 8.3 6.1 10.2 8.8 21.1 8.6 12.8 8.5 4.8 10.5 13.3 9.9 8.5 7.5 7.4 6.0 9.4 11.8 4.9 2.3 4.6 6.2 3.6 6.9 4.1 17.2 5.7 6.9 6.8 7.9 4.9 2.1 4.9 2.3 4.2 9.1 7.1 4.6 6.9 5.4 4.9 3.0 3.4 7.4 5.4 8.1 8.0 5.4 4.1 7.8 8.4 6.9 4.4 7.1 5.7 5.7 7.4 6.4 5.0 6.2 3.0 4.9 5.7 5.9 5.2 8.5 7.0 2.9 3.3 7.0 4.7 10.8 5.6 3.2 5.5 7.4 4.6 4.9 4.4 4.0 4.3 4.4 9.9 21.2 6.3 5.6 2.5 7.2 3.3 4.9 7.4 9.3 6.0 10.6 7.4 6.4 11.8 7.0 8.5 8.4 9.1 6.5 9.4 4.0 7.5 7.9 4.9 7.6 7.8 18.3 8.5 6.8 5.3 7.5 5.2 8.4 8.6 0.0 0.3 0.0 1.0 1.3 0.8 1.6 5.1 0.0 2.3 0.0 0.0 1.8 1.7 1.7 2.1 0.7 0.6 0.0 0.5 0.6 1.1 0.5 0.0 1.0 1.7 1.6 0.0 1.3 0.6 3.7 0.6 0.9 0.0 0.0 0.6 1.3 0.4 0.0 1.8 0.7 1.4 0.0 1.2 5.1 1.3 0.9 2.2 0.8 0.9 0.7 ZNF791 FLJ90396 ENSG00000173875 "Zinc finger protein 791" Q3KP31 19 12610918-12633840 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021537 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA021537: AB_2670741" "unprognostic (1.95e-1)" "unprognostic (4.88e-3)" "unprognostic (1.73e-2)" "unprognostic (7.58e-2)" "unprognostic (2.30e-2)" "unprognostic (1.04e-3)" "unprognostic (6.86e-2)" "prognostic favorable (9.07e-4)" "unprognostic (1.88e-2)" "unprognostic (1.59e-2)" "unprognostic (3.38e-2)" "unprognostic (1.73e-2)" "unprognostic (2.57e-2)" "unprognostic (2.77e-2)" "unprognostic (1.39e-1)" "unprognostic (1.40e-2)" "prognostic favorable (1.39e-5)" 16.7 12.0 11.9 18.0 15.4 22.5 18.6 30.3 17.1 20.0 15.0 12.7 14.1 10.9 16.6 16.3 14.0 15.4 10.1 13.0 11.5 10.9 13.4 11.9 17.0 15.8 14.7 12.5 21.5 15.3 20.2 32.1 13.4 15.5 16.6 13.4 11.8 15.5 18.2 15.9 17.1 15.3 17.9 16.0 16.6 13.8 7.0 13.8 14.4 25.4 8.9 19.6 23.7 18.1 11.6 10.5 9.7 3.8 10.9 8.3 2.6 6.9 3.9 7.5 7.4 9.3 12.0 6.5 9.0 9.9 6.7 8.2 4.8 4.2 1.6 8.7 9.3 4.0 6.6 7.3 8.5 11.2 4.7 7.6 6.9 9.5 6.7 7.6 8.9 7.7 10.3 9.8 8.0 13.0 10.5 7.0 4.5 7.9 11.2 8.3 11.1 5.5 3.4 8.6 3.9 11.7 4.0 12.3 5.7 6.7 13.4 8.3 10.0 8.0 6.5 8.5 9.3 6.5 7.7 8.7 13.5 5.7 11.7 7.2 16.8 20.0 4.9 9.2 7.0 7.9 9.7 3.3 5.2 7.0 2.1 7.2 7.4 6.3 8.0 3.0 11.6 7.4 8.3 5.6 10.9 3.8 10.5 5.4 2.6 11.9 15.4 30.3 17.1 11.5 10.9 14.7 12.5 15.5 13.8 11.9 23.3 34.0 30.3 26.0 68.5 16.8 25.5 29.4 23.9 17.4 92.3 25.1 16.6 20.7 4.3 43.4 26.2 0.0 15.2 15.5 23.7 31.2 9.2 26.0 12.2 33.4 35.6 47.3 15.5 1.8 36.2 24.5 13.5 9.0 24.2 38.4 21.5 11.5 36.7 9.2 75.6 38.8 33.9 11.2 13.7 24.2 32.7 38.4 20.6 29.8 ZNF792 FLJ38451 ENSG00000180884 "Zinc finger protein 792" Q3KQV3 19 34956354-34964049 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Endothelial cells: 4.5;Ito cells: 8.6;T-cells: 4.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 12.0;HMC-1: 15.9;HUVEC TERT2: 10.7;SH-SY5Y: 10.3" "Low region specificity" "Detected in many" "HPA035157, HPA035158" Supported Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA035157: AB_2674497, HPA035158: AB_10603010" "unprognostic (1.31e-1)" "unprognostic (7.31e-2)" "prognostic favorable (2.72e-4)" "unprognostic (1.24e-1)" "unprognostic (2.15e-1)" "unprognostic (7.91e-2)" "unprognostic (2.41e-5)" "unprognostic (2.49e-2)" "unprognostic (4.30e-2)" "unprognostic (1.22e-1)" "unprognostic (1.49e-1)" "unprognostic (4.62e-1)" "unprognostic (6.88e-3)" "unprognostic (3.88e-1)" "unprognostic (2.48e-1)" "unprognostic (6.02e-2)" "unprognostic (2.77e-3)" 9.4 3.9 3.6 7.3 5.8 2.3 8.9 11.6 5.4 6.1 6.1 5.9 8.9 4.3 6.3 4.3 3.1 5.8 7.9 4.1 2.3 2.0 4.5 3.7 9.4 8.3 2.2 2.0 5.2 5.0 6.9 3.4 7.1 3.8 8.8 5.1 5.7 5.7 4.9 3.1 4.0 6.0 5.6 2.8 8.6 5.1 3.7 2.1 12.0 5.4 3.4 5.8 7.3 4.0 1.8 1.1 6.9 0.7 4.4 5.5 2.2 1.0 3.6 1.7 2.7 1.8 1.4 0.0 1.0 1.9 1.3 1.6 1.4 1.7 1.5 3.3 1.4 0.6 0.7 2.5 1.9 2.0 4.4 0.5 12.0 1.1 2.8 1.3 1.0 15.9 1.6 0.6 1.0 0.5 2.3 10.7 1.0 3.2 0.0 2.1 0.8 4.1 1.1 1.3 9.1 0.8 2.8 0.0 0.2 1.0 3.3 0.9 10.3 1.0 1.0 1.3 1.7 1.2 3.3 4.3 1.9 2.4 0.8 1.1 0.3 0.9 0.9 2.0 0.2 0.8 6.9 0.7 6.1 3.1 0.7 4.1 1.8 4.9 4.3 1.1 1.7 5.5 4.6 0.2 4.4 0.5 0.1 4.6 2.2 3.6 5.8 11.6 5.4 2.3 2.0 2.2 2.0 3.8 2.1 0.0 0.6 2.0 0.1 0.5 0.7 1.2 0.0 0.0 0.0 0.0 2.0 0.1 0.0 1.4 0.1 4.5 0.2 0.0 2.3 0.3 0.6 0.3 1.1 0.2 1.2 0.0 1.7 8.6 3.2 0.0 1.4 0.0 0.0 1.8 1.9 0.8 2.2 0.0 0.0 0.0 1.5 0.0 0.5 0.0 1.1 0.4 0.1 4.5 1.3 0.1 ZNF793 ENSG00000188227 "Zinc finger protein 793" Q6ZN11 19 37506939-37548762 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 29.5;Early spermatids: 32.2;Horizontal cells: 46.1;Rod photoreceptor cells: 33.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 11.5;RT4: 9.8;U-266/70: 17.0;U-266/84: 11.3" HPA034781 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA034781: AB_10602784" "unprognostic (4.80e-2)" "unprognostic (4.70e-2)" "unprognostic (3.26e-1)" "unprognostic (7.13e-2)" "unprognostic (4.08e-2)" "unprognostic (5.72e-2)" "unprognostic (1.05e-2)" "unprognostic (3.80e-2)" "unprognostic (2.22e-1)" "unprognostic (2.69e-3)" "unprognostic (4.16e-3)" "unprognostic (1.03e-4)" "unprognostic (4.94e-3)" "unprognostic (1.38e-1)" "unprognostic (4.62e-1)" "unprognostic (1.24e-2)" "unprognostic (8.12e-3)" 3.1 7.7 12.5 4.9 11.9 2.1 6.4 22.1 14.0 6.4 4.2 12.8 4.6 3.0 9.3 6.9 5.2 6.7 4.6 6.8 10.3 8.0 6.2 1.1 3.3 5.6 8.3 10.0 14.1 4.0 15.7 18.4 4.5 11.2 7.5 6.0 8.1 3.6 5.8 3.7 10.7 3.6 6.1 10.1 5.6 5.3 12.3 9.6 2.1 11.0 3.2 4.9 4.9 5.7 4.0 2.1 7.2 1.6 4.0 2.8 1.4 0.1 0.2 4.2 11.5 0.9 0.9 0.2 3.3 0.2 0.7 0.3 0.2 1.3 2.9 5.5 1.7 1.0 0.4 0.3 2.9 0.3 0.8 4.2 0.3 0.4 0.3 2.1 0.2 2.6 3.4 2.6 0.6 0.1 0.3 0.1 0.3 0.1 0.5 0.5 3.2 0.3 0.4 6.9 0.0 0.3 0.1 0.1 0.6 2.9 9.8 3.1 6.7 0.2 0.2 0.0 8.1 6.4 0.3 0.4 0.1 1.8 0.3 3.3 17.0 11.3 0.3 0.0 0.2 0.5 7.2 1.6 1.2 1.5 0.6 2.3 2.0 2.8 2.5 1.2 4.0 1.9 2.4 4.2 4.0 0.6 2.1 2.2 1.4 12.5 11.9 22.1 14.0 10.3 8.0 8.3 10.0 11.2 9.6 3.0 7.2 0.8 3.4 3.0 28.0 7.3 12.7 6.7 5.7 12.2 29.5 4.8 3.3 3.1 32.2 6.3 1.4 0.0 1.3 3.6 3.1 2.6 2.3 0.4 0.8 46.1 8.6 6.2 0.0 7.7 4.6 2.0 0.0 1.8 3.4 16.2 1.6 0.0 9.6 1.5 33.5 0.0 5.1 5.4 6.4 2.9 1.6 4.3 3.4 1.4 ZNF799 "HIT-40, MGC71805, ZNF842" ENSG00000196466 "Zinc finger protein 799" Q96GE5 19 12390016-12401271 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 13.2;Sertoli cells: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA003150, HPA018683" Approved Approved "Nucleoplasm,Centriolar satellite" NA NA Nucleoplasm "Centriolar satellite" "HPA003150: AB_1080725, HPA018683: AB_2669920" "unprognostic (2.96e-1)" "unprognostic (1.10e-1)" "unprognostic (8.84e-2)" "prognostic favorable (2.39e-4)" "unprognostic (3.63e-2)" "unprognostic (5.18e-3)" "unprognostic (3.02e-1)" "unprognostic (8.83e-3)" "unprognostic (4.47e-5)" "unprognostic (1.45e-1)" "unprognostic (5.56e-3)" "unprognostic (6.55e-2)" "unprognostic (1.41e-1)" "unprognostic (2.75e-1)" "unprognostic (2.04e-1)" "unprognostic (8.91e-3)" "unprognostic (1.23e-3)" 7.9 7.2 6.1 11.9 5.5 3.2 10.1 7.7 8.0 12.6 8.2 4.6 12.9 4.7 6.9 5.8 7.6 9.3 4.9 4.1 6.6 4.3 7.8 8.3 6.6 5.3 6.3 1.8 10.8 10.7 7.6 2.8 10.5 6.3 8.4 6.2 3.3 6.2 6.8 5.5 5.6 6.1 5.6 5.0 7.4 4.5 5.8 6.7 9.1 7.5 6.4 5.2 7.1 6.5 7.5 4.6 4.6 4.3 4.5 10.3 3.9 3.8 2.9 4.1 9.4 2.1 2.1 8.2 2.1 2.9 5.1 5.0 6.0 1.5 4.9 3.8 2.4 2.6 3.1 3.1 3.7 5.0 0.1 3.1 3.8 2.4 9.7 0.7 3.0 7.2 2.5 2.3 3.6 2.9 1.5 2.5 4.7 4.0 0.0 3.3 5.2 6.2 4.2 2.1 4.9 8.2 0.7 6.0 4.9 5.2 9.4 3.0 3.1 4.3 0.9 1.1 3.1 4.2 5.4 2.3 5.5 3.1 6.3 2.4 3.5 5.5 3.9 0.8 3.1 2.2 4.4 4.1 4.6 6.9 4.3 8.3 7.5 6.5 10.3 3.4 6.7 6.5 5.0 4.3 4.5 2.6 4.6 6.9 3.9 6.1 5.5 7.7 8.0 6.6 4.3 6.3 1.8 6.3 6.7 6.0 1.0 0.5 2.7 2.2 2.5 3.0 2.5 5.3 2.3 3.5 0.0 13.2 5.0 3.8 5.4 4.9 2.6 0.0 1.2 2.1 3.2 2.2 3.5 0.9 3.6 0.0 4.1 3.7 1.5 2.1 2.3 2.3 0.0 1.8 5.2 1.3 2.3 2.9 1.1 2.8 2.5 12.9 5.1 4.8 4.4 1.3 3.8 3.3 3.7 2.0 ZNF8 "HF.18, Zfp128" ENSG00000278129 "Zinc finger protein 8" P17098 19 58278951-58302805 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034797, HPA034798" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA034797: AB_10696364, HPA034798: AB_10602785" "unprognostic (1.41e-1)" "unprognostic (7.27e-2)" "unprognostic (6.66e-2)" "unprognostic (3.03e-2)" "unprognostic (1.52e-2)" "unprognostic (4.16e-3)" "unprognostic (1.09e-2)" "unprognostic (9.20e-2)" "unprognostic (2.45e-1)" "unprognostic (1.31e-1)" "unprognostic (4.14e-3)" "unprognostic (4.98e-2)" "unprognostic (7.16e-3)" "unprognostic (8.56e-2)" "unprognostic (7.65e-2)" "unprognostic (1.52e-1)" "unprognostic (1.28e-2)" 2.7 3.1 4.6 2.7 5.5 7.7 4.3 6.4 7.5 3.4 2.6 6.1 2.7 3.0 4.9 4.0 2.8 3.5 2.8 3.7 4.7 3.4 2.2 3.4 3.4 4.1 3.3 3.8 3.1 7.5 4.3 3.8 4.1 3.3 3.1 4.4 3.0 3.7 2.1 6.6 2.2 3.9 4.6 4.5 3.6 3.5 4.3 9.2 3.9 1.5 3.5 3.0 3.9 2.3 1.6 4.7 2.4 1.9 1.9 1.9 2.2 3.2 4.9 8.7 3.1 2.7 4.0 1.1 1.8 1.2 1.4 3.5 1.7 2.8 1.4 1.9 1.0 2.1 3.5 3.8 1.6 2.1 14.1 5.5 6.2 2.9 2.8 1.8 4.5 4.9 2.4 2.1 4.0 3.6 2.1 4.6 2.8 1.2 2.5 2.4 4.2 2.5 4.2 1.6 2.3 4.7 4.5 2.0 2.3 7.8 8.3 4.5 3.4 2.5 1.1 3.8 2.4 3.4 3.1 8.8 2.2 1.3 2.2 4.4 3.5 3.5 1.5 0.1 2.2 3.6 2.4 1.6 1.6 1.3 1.9 1.5 1.4 1.2 1.6 2.3 1.5 1.7 4.7 1.9 1.0 1.4 0.7 1.9 0.0 5.5 1.7 2.7 0.0 10.4 2.4 0.0 4.0 3.4 5.2 11.8 1.7 3.3 2.9 1.5 1.6 0.5 0.0 2.0 1.2 1.9 3.5 1.1 1.0 2.2 11.1 5.2 6.2 1.0 0.0 3.7 1.8 0.0 1.8 2.1 4.9 2.7 0.0 1.8 2.3 11.0 6.5 1.4 5.0 2.3 0.0 2.2 4.4 1.7 2.6 ZNF805 ENSG00000204524 "Zinc finger protein 805" Q5CZA5 19 57240685-57255135 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 7.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046330, HPA058895" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA046330: , HPA058895: AB_2683846" "unprognostic (2.18e-1)" "unprognostic (1.10e-1)" "unprognostic (8.98e-2)" "unprognostic (1.95e-1)" "unprognostic (1.22e-1)" "unprognostic (2.62e-3)" "unprognostic (2.07e-1)" "unprognostic (1.62e-1)" "unprognostic (1.29e-2)" "unprognostic (4.64e-2)" "unprognostic (2.20e-1)" "unprognostic (1.95e-1)" "unprognostic (1.58e-2)" "unprognostic (3.51e-1)" "unprognostic (3.68e-2)" "unprognostic (7.16e-3)" "unprognostic (1.64e-1)" 8.4 8.8 3.6 5.5 7.2 18.5 9.6 4.8 9.4 6.6 6.1 8.3 5.8 3.9 9.1 6.4 6.6 6.0 5.9 6.3 3.4 3.5 5.4 6.2 6.8 5.1 6.4 5.2 10.2 7.2 9.8 9.0 7.5 5.8 6.2 5.7 6.8 7.9 5.8 9.0 7.7 6.3 7.2 5.2 7.2 6.1 8.6 5.9 9.2 6.7 2.4 7.4 7.1 11.6 3.9 2.1 5.3 1.8 5.6 4.9 2.4 2.4 3.7 3.6 4.8 6.6 4.9 4.5 2.3 5.4 4.0 7.9 3.1 2.2 4.6 1.8 5.6 2.5 1.5 4.0 3.9 7.1 2.4 10.0 4.7 3.0 3.0 5.9 4.2 4.7 6.1 4.9 5.2 9.0 3.6 3.7 5.0 1.7 6.2 2.8 1.7 5.1 1.5 3.0 2.1 4.2 2.5 7.7 4.0 2.6 7.8 3.8 3.8 6.2 3.5 3.6 5.1 2.4 4.2 4.1 5.7 3.9 2.6 2.7 6.2 4.3 4.5 3.6 2.3 3.1 0.0 1.8 5.3 3.8 0.5 4.9 3.9 3.3 4.8 2.1 1.7 3.3 3.1 2.0 5.6 0.9 1.5 3.6 2.4 3.6 7.2 4.8 9.4 3.4 3.5 6.4 5.2 5.8 5.9 3.0 0.3 0.0 1.8 1.4 5.4 1.6 0.0 1.4 0.0 1.8 7.9 0.9 1.7 1.2 1.8 2.1 0.4 0.0 1.0 1.4 1.0 1.9 4.6 0.0 0.8 3.2 1.2 1.3 0.6 0.0 1.1 0.7 0.0 0.0 1.2 1.9 1.2 0.0 0.7 0.5 5.4 0.0 2.7 4.7 2.8 1.0 1.9 0.7 0.6 2.3 ZNF814 ENSG00000204514 "Zinc finger protein 814" B7Z6K7 19 57848731-57889074 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 21.5;U-266/84: 19.8" "HPA043800, HPA053762, HPA072145" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: " "unprognostic (3.74e-2)" "unprognostic (1.24e-1)" "unprognostic (4.53e-2)" "unprognostic (3.29e-2)" "unprognostic (6.01e-2)" "unprognostic (2.12e-2)" "unprognostic (1.03e-1)" "unprognostic (4.69e-2)" "unprognostic (6.78e-4)" "unprognostic (5.05e-3)" "unprognostic (2.41e-4)" "unprognostic (1.56e-2)" "unprognostic (4.99e-4)" "unprognostic (3.94e-1)" "unprognostic (2.33e-1)" "unprognostic (1.08e-1)" "unprognostic (1.54e-5)" 5.6 13.3 11.6 9.0 11.0 12.6 12.2 19.2 10.8 6.4 10.0 4.4 15.7 9.7 5.6 10.5 5.2 12.5 9.8 9.5 11.5 10.3 15.0 11.7 5.9 11.1 9.1 8.4 7.8 6.7 10.9 16.2 9.7 7.7 11.4 7.3 16.1 9.0 18.4 18.6 13.3 12.7 9.0 7.3 13.8 5.5 14.0 5.6 18.7 23.0 4.0 11.5 6.6 5.0 21.2 15.3 5.0 5.0 12.8 13.6 4.5 0.9 2.4 7.3 10.8 0.8 0.7 1.8 2.7 1.8 3.0 0.4 1.3 1.0 5.5 1.8 2.5 2.9 0.8 0.5 5.9 3.8 0.8 4.9 4.1 3.3 1.3 3.3 4.7 5.1 4.9 5.2 1.2 1.1 4.8 0.9 1.9 1.0 2.0 4.6 0.9 15.4 2.1 21.5 0.5 3.1 1.7 0.8 9.7 2.4 3.9 2.8 7.8 0.9 1.8 3.7 16.4 5.3 1.4 1.3 6.8 2.3 1.5 1.2 6.4 19.8 13.9 1.4 2.5 8.1 2.2 4.5 5.0 3.2 5.0 8.2 19.4 8.4 6.9 6.6 21.2 13.6 11.0 2.7 12.8 2.9 15.3 2.1 4.5 11.6 11.0 19.2 10.8 11.5 10.3 9.1 8.4 7.7 5.6 0.0 1.0 19.5 6.3 6.1 21.1 12.0 15.3 10.7 10.3 12.2 45.2 11.4 14.9 6.7 32.9 7.0 5.4 0.0 1.2 16.8 7.2 7.8 16.1 12.3 10.7 19.1 4.7 15.4 3.4 16.6 3.7 9.3 10.1 6.4 3.8 7.5 1.1 21.5 6.7 37.9 32.5 19.4 4.2 8.4 11.7 11.4 9.7 8.7 13.9 10.7 ZNF816-ZNF321P ZNF816-ZNF321 ENSG00000221874 "ZNF816-ZNF321P readthrough" 19 52928475-52962823 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 8.1;Syncytiotrophoblasts: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "NK-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 6 "RT4: 14.2" HPA051271 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA051271: AB_2681415" "unprognostic (4.18e-2)" 2.4 1.7 1.7 3.4 3.6 2.1 4.3 1.7 2.6 4.6 4.7 1.5 5.8 0.7 2.8 4.5 3.6 4.7 4.4 2.2 1.8 1.2 4.2 1.5 3.2 1.7 4.7 0.9 4.2 2.7 2.1 5.4 4.5 2.4 8.5 7.5 1.5 3.0 4.4 1.2 2.4 3.0 3.4 4.0 5.0 4.9 2.0 3.9 9.3 4.6 2.2 2.7 6.3 4.2 0.9 0.0 0.0 0.1 1.6 0.7 0.0 0.5 0.0 1.3 0.4 0.7 0.2 0.7 0.0 0.4 0.8 1.0 0.0 0.4 1.3 0.4 0.5 1.3 0.1 1.2 0.2 0.0 0.8 1.5 0.5 0.2 1.6 1.1 0.0 0.3 0.8 0.0 1.4 0.0 0.4 0.7 0.0 1.3 0.0 0.3 0.2 0.0 0.0 0.2 0.0 1.1 0.4 0.1 0.1 0.5 14.2 0.7 0.2 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.5 0.8 2.2 0.0 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.7 0.3 0.0 1.6 0.0 0.0 0.0 0.0 1.7 3.6 1.7 2.6 1.8 1.2 4.7 0.9 2.4 3.9 0.0 0.0 0.0 3.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 8.1 3.3 3.2 1.6 0.4 3.1 0.0 3.1 5.3 0.6 2.3 4.6 0.4 3.3 0.0 0.0 1.3 1.8 0.9 0.3 0.0 0.0 3.6 3.0 0.0 2.8 3.4 0.7 0.6 0.0 0.0 0.3 0.4 1.8 0.0 9.4 1.0 3.3 4.7 ZNF821 ENSG00000102984 "Zinc finger protein 821" O75541 16 71859680-71895336 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.9;testis: 23.7" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 108.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 9.3;naive B-cell: 11.5" "Group enriched" "Detected in many" 8 "B-cells: 11.5;T-cells: 5.1" "Cell line enhanced" "Detected in many" "AF22: 14.0;SCLC-21H: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036372, HPA042742" Enhanced Supported "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA036372: AB_10669790, HPA042742: AB_2678140" "unprognostic (3.16e-1)" "unprognostic (1.77e-1)" "unprognostic (6.50e-2)" "unprognostic (1.12e-2)" "prognostic favorable (1.20e-4)" "unprognostic (1.69e-2)" "unprognostic (2.28e-2)" "unprognostic (7.72e-2)" "unprognostic (5.25e-2)" "unprognostic (3.04e-2)" "prognostic favorable (4.27e-5)" "unprognostic (2.83e-2)" "prognostic favorable (6.32e-10)" "unprognostic (1.82e-2)" "unprognostic (1.79e-1)" "unprognostic (7.97e-2)" "unprognostic (1.02e-1)" 2.0 4.2 6.3 3.7 7.5 3.1 4.8 26.9 13.4 4.3 3.8 5.1 2.3 2.1 5.8 11.1 2.5 3.5 3.9 2.9 5.7 7.6 5.9 2.6 3.4 6.0 5.2 6.0 7.3 2.4 5.6 9.2 2.5 7.1 4.4 5.0 5.2 5.2 5.1 4.0 6.0 4.3 3.0 4.8 3.7 3.3 23.7 3.4 2.2 6.1 0.7 7.3 2.4 4.0 11.5 0.9 0.4 0.5 1.0 5.1 0.7 1.1 0.9 14.0 6.7 2.8 3.6 2.4 1.4 3.1 3.1 4.9 1.9 0.9 2.6 2.4 2.7 3.4 2.0 4.6 2.1 3.8 3.9 5.2 0.5 1.0 0.8 1.7 0.9 3.0 3.1 3.5 2.1 1.3 5.3 2.4 0.6 1.6 2.0 3.4 3.3 1.5 0.9 5.5 4.0 0.6 6.1 3.0 4.5 3.5 0.4 14.1 6.7 1.8 1.2 1.5 6.3 4.7 3.0 4.6 3.3 3.5 1.2 0.9 4.7 2.4 10.6 1.1 2.6 3.2 0.0 0.5 0.4 2.2 0.0 1.9 9.3 2.3 1.6 0.9 11.5 1.4 0.5 0.4 1.0 0.5 0.0 5.1 0.7 6.3 7.5 26.9 13.4 5.7 7.6 5.2 6.0 7.1 3.4 0.0 3.4 20.5 6.0 7.1 41.7 1.1 12.7 2.7 1.2 15.7 43.2 5.2 18.3 8.1 108.2 5.8 26.4 0.0 4.1 4.3 8.5 6.0 9.2 1.7 6.8 30.2 22.5 12.9 4.0 40.3 11.5 9.3 3.3 2.8 9.2 20.9 5.9 14.4 11.7 8.6 47.4 12.9 4.7 50.4 18.3 6.6 5.1 17.5 6.4 3.4 ZNF827 ENSG00000151612 "Zinc finger protein 827" Q17R98 4 145757627-145938635 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 12.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "TIME: 23.5;WM-115: 36.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021166 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA021166: AB_2670608" "unprognostic (2.75e-2)" "unprognostic (3.46e-3)" "unprognostic (2.79e-1)" "unprognostic (3.64e-1)" "unprognostic (3.90e-2)" "unprognostic (2.40e-2)" "unprognostic (3.77e-1)" "unprognostic (3.57e-1)" "unprognostic (1.57e-1)" "unprognostic (3.90e-2)" "unprognostic (7.64e-2)" "unprognostic (3.47e-1)" "unprognostic (1.64e-3)" "unprognostic (9.46e-2)" "unprognostic (7.85e-2)" "unprognostic (4.03e-2)" "unprognostic (1.88e-2)" 3.8 9.5 8.2 9.6 15.6 3.9 6.5 37.3 12.3 6.0 7.1 8.1 7.7 8.1 10.7 6.5 3.8 8.3 6.3 7.0 5.9 5.8 6.3 1.1 4.7 6.4 5.8 8.2 11.0 4.3 14.9 28.3 2.2 7.4 26.3 6.4 4.3 28.1 9.3 24.9 3.4 10.0 11.4 13.0 5.5 6.3 4.5 9.5 14.0 10.9 3.3 7.7 10.2 5.0 1.9 2.6 5.4 0.0 12.3 3.4 1.2 2.7 4.4 8.0 5.2 3.5 3.9 0.0 4.6 4.4 3.6 2.8 2.2 7.2 0.7 1.6 8.4 3.2 1.7 4.6 3.5 3.8 5.6 2.2 2.2 4.3 2.5 3.7 1.6 0.0 5.3 3.2 2.8 7.9 7.8 6.4 1.2 0.4 4.4 3.0 0.0 2.4 0.1 3.9 0.0 5.8 7.2 4.2 1.4 3.8 4.1 7.3 6.7 4.0 6.9 10.4 4.4 3.1 0.1 23.5 9.6 7.8 0.6 5.3 3.1 0.2 3.0 3.1 9.0 36.4 5.4 0.0 0.0 3.3 0.0 0.9 1.5 1.2 3.1 0.0 1.9 2.1 3.4 0.0 12.3 0.0 2.6 0.1 1.2 8.2 15.6 37.3 12.3 5.9 5.8 5.8 8.2 7.4 9.5 11.9 13.7 4.2 7.6 5.7 12.7 18.9 2.5 10.7 11.4 22.7 9.8 2.1 3.3 8.9 11.8 4.3 10.3 0.0 6.3 0.4 6.6 19.8 2.3 1.3 1.1 17.5 24.8 7.4 1.2 5.8 8.3 1.0 1.7 1.0 19.5 4.8 10.4 3.5 15.9 9.8 1.1 6.5 4.7 1.6 1.7 4.3 1.1 6.4 18.6 9.5 ZNF829 DKFZp779O175 ENSG00000185869 "Zinc finger protein 829" Q3KNS6 19 36888124-36916291 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 20.1" "Cell type enriched" "Detected in many" 8 "Early spermatids: 241.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 15.0" HPA073073 Approved "Nucleoplasm,Nuclear bodies" No No Nucleoplasm "Nuclear bodies" "HPA073073: AB_2686567" "unprognostic (4.55e-2)" "unprognostic (2.34e-1)" "unprognostic (5.63e-2)" "unprognostic (3.44e-4)" "unprognostic (1.32e-1)" "unprognostic (6.46e-2)" "unprognostic (8.20e-2)" "unprognostic (1.33e-2)" "unprognostic (9.35e-4)" "unprognostic (1.20e-2)" "unprognostic (3.57e-2)" "unprognostic (3.39e-2)" "unprognostic (3.48e-4)" "unprognostic (5.47e-3)" "unprognostic (1.64e-1)" "unprognostic (1.73e-1)" "unprognostic (8.92e-4)" 2.6 2.8 4.9 2.4 5.9 1.9 4.3 8.0 4.8 2.9 2.6 2.3 5.0 1.7 3.6 2.0 2.2 3.1 1.8 2.4 3.3 2.5 2.6 1.8 2.2 2.8 6.4 2.9 5.3 2.1 3.8 3.4 3.6 3.3 3.6 1.6 1.6 2.6 3.0 1.9 3.5 2.1 4.8 4.4 2.8 2.3 20.1 5.1 3.4 5.2 1.0 2.9 3.1 4.7 3.3 1.4 4.2 0.8 2.1 4.9 1.0 0.0 1.2 3.3 0.1 1.8 2.8 1.4 3.7 2.2 4.6 7.1 0.1 0.6 0.1 4.4 2.3 4.3 0.7 0.0 2.7 5.4 0.0 5.3 1.9 0.1 0.1 1.8 0.0 5.2 2.8 2.6 5.1 0.0 1.5 0.5 1.4 0.0 0.1 5.0 0.8 0.7 0.8 5.5 0.0 0.0 0.0 4.5 1.7 1.3 5.5 3.8 5.6 0.1 0.0 3.1 4.9 3.5 0.3 1.4 3.0 3.9 3.8 4.0 9.8 15.0 6.3 0.0 0.1 6.9 4.2 0.6 2.9 3.2 0.7 4.2 2.2 3.2 4.9 1.0 3.3 4.1 4.2 1.3 2.1 0.8 1.4 3.2 1.0 4.9 5.9 8.0 4.8 3.3 2.5 6.4 2.9 3.3 5.1 0.0 4.3 1.3 1.8 1.3 5.8 4.6 5.1 1.4 5.7 3.5 3.9 3.2 0.0 2.3 241.5 3.9 0.0 0.0 0.9 2.1 2.8 1.6 1.1 0.0 1.4 11.1 0.0 1.3 0.3 29.7 5.5 2.5 3.3 1.8 0.9 2.4 0.8 0.0 6.7 1.1 11.3 0.0 2.3 9.5 10.0 2.4 3.5 2.9 0.4 0.7 ZNF83 "FLJ11015, HPF1, ZNF816B" ENSG00000167766 "Zinc finger protein 83" P51522 19 52594060-52690496 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA025970 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA025970: AB_1859463" "unprognostic (6.38e-2)" "unprognostic (1.55e-1)" "unprognostic (1.73e-2)" "unprognostic (1.78e-1)" "unprognostic (1.18e-1)" "prognostic favorable (3.83e-4)" "unprognostic (3.38e-3)" "unprognostic (3.67e-1)" "prognostic unfavorable (9.20e-4)" "prognostic favorable (9.06e-4)" "unprognostic (6.08e-2)" "unprognostic (3.85e-3)" "prognostic unfavorable (3.13e-5)" "unprognostic (2.81e-2)" "unprognostic (1.14e-1)" "unprognostic (3.33e-1)" "prognostic favorable (6.92e-6)" 13.1 19.0 14.5 16.2 66.8 14.6 22.3 42.6 20.2 21.6 16.4 11.7 41.4 8.4 23.3 54.0 11.4 27.2 16.0 11.1 17.2 11.5 26.0 4.0 12.9 18.5 25.7 12.5 34.5 11.8 22.3 29.4 44.2 21.9 25.5 14.0 11.0 11.8 32.6 5.8 16.2 12.3 21.0 20.4 19.0 14.7 9.8 24.4 16.9 24.3 8.1 15.9 15.9 34.3 9.9 4.3 8.5 4.9 12.8 9.3 3.7 8.7 0.4 12.5 9.0 11.3 22.9 7.0 13.6 9.4 8.2 11.2 3.4 7.6 9.1 7.1 9.2 6.1 3.9 7.5 9.0 11.5 1.3 8.7 7.7 7.8 4.3 9.3 5.4 10.8 18.4 11.4 6.9 34.4 29.1 9.2 10.3 8.4 7.5 13.5 5.9 7.6 9.4 3.5 1.5 8.6 7.7 10.7 6.1 21.0 17.6 7.3 5.9 8.7 8.6 3.4 21.1 9.1 5.7 12.5 8.3 5.1 4.2 13.9 0.8 8.0 12.6 0.4 5.8 6.6 4.4 3.6 8.5 7.6 3.9 7.8 6.9 8.9 9.3 4.3 9.9 7.6 8.7 3.3 12.8 4.9 2.9 4.3 3.7 14.5 66.8 42.6 20.2 17.2 11.5 25.7 12.5 21.9 24.4 32.8 21.2 4.2 45.7 9.2 27.1 12.9 7.6 28.1 33.0 38.4 33.4 40.1 16.6 16.3 20.0 24.8 7.0 0.0 6.1 16.9 23.5 72.4 34.8 1.3 11.8 46.1 10.4 16.0 4.9 11.1 39.4 15.8 28.7 9.0 14.0 14.3 8.5 17.5 32.5 17.0 38.2 6.5 16.6 13.0 14.7 8.4 53.5 19.2 6.5 63.1 ZNF830 "CCDC16, MGC20398, OMCG1" ENSG00000198783 "Zinc finger protein 830" Q96NB3 17 34961530-34963775 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024754, HPA027211" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA024754: AB_1859464, HPA027211: AB_1859465" "unprognostic (2.87e-1)" "unprognostic (3.86e-2)" "unprognostic (2.47e-1)" "unprognostic (1.45e-1)" "unprognostic (1.14e-1)" "unprognostic (8.70e-2)" "unprognostic (2.37e-2)" "unprognostic (6.39e-2)" "unprognostic (6.39e-2)" "unprognostic (1.02e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (2.01e-4)" "unprognostic (2.01e-2)" "unprognostic (5.63e-2)" "unprognostic (1.55e-1)" "unprognostic (8.22e-2)" "unprognostic (8.63e-2)" 11.7 11.5 14.2 13.8 17.6 15.4 13.6 26.9 20.0 15.1 13.9 14.0 9.7 13.4 16.1 11.4 14.1 14.8 12.6 9.2 13.1 10.5 12.9 15.7 10.8 19.6 20.5 11.3 21.4 20.2 11.2 12.5 16.9 18.7 13.4 10.3 10.7 12.7 11.4 11.2 13.0 16.6 17.9 11.9 24.1 13.7 15.0 16.3 20.6 17.5 9.6 17.9 12.9 12.0 10.1 9.8 26.7 8.3 10.1 19.3 8.1 5.7 11.2 10.1 9.4 10.9 8.4 7.0 7.0 7.1 9.2 9.2 8.4 7.8 10.4 6.5 6.8 9.6 13.5 10.8 6.4 10.4 6.2 14.7 12.2 11.0 10.4 11.1 18.2 17.5 8.2 15.0 7.7 15.1 9.3 8.3 12.9 17.5 15.4 8.3 4.3 16.5 20.5 6.7 7.7 5.5 11.2 13.8 13.7 8.5 7.8 12.1 10.3 6.8 4.3 10.9 10.3 9.9 20.0 8.6 9.8 7.1 7.1 12.1 17.1 13.0 14.0 8.4 9.8 8.7 14.6 8.3 26.7 11.9 8.2 11.7 9.2 12.6 12.8 9.1 10.1 19.3 15.2 8.1 10.1 5.7 9.8 11.1 8.1 14.2 17.6 26.9 20.0 13.1 10.5 20.5 11.3 18.7 16.3 35.7 24.2 16.6 37.9 21.3 19.4 6.7 20.4 14.7 35.2 12.2 13.7 20.5 29.9 16.2 3.2 16.9 20.3 0.0 11.5 14.6 19.2 21.3 16.2 9.6 12.7 9.5 17.7 13.5 9.4 2.0 24.7 16.0 20.3 11.8 15.4 19.3 12.1 24.6 25.8 16.5 28.7 25.8 20.2 40.6 45.4 21.1 22.3 29.4 17.6 32.7 ZNF839 C14orf131 ENSG00000022976 "Zinc finger protein 839" A8K0R7 14 102317377-102342702 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020434 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA020434: AB_10669862" "unprognostic (7.83e-2)" "unprognostic (1.96e-1)" "unprognostic (2.28e-1)" "unprognostic (8.81e-2)" "unprognostic (1.49e-1)" "unprognostic (2.33e-1)" "unprognostic (6.73e-2)" "unprognostic (5.69e-2)" "unprognostic (1.85e-1)" "unprognostic (7.10e-3)" "prognostic favorable (4.57e-4)" "unprognostic (2.40e-2)" "prognostic favorable (5.00e-4)" "unprognostic (1.32e-1)" "unprognostic (2.17e-2)" "unprognostic (1.08e-1)" "unprognostic (8.21e-2)" 8.9 9.9 10.9 10.6 14.1 11.3 15.7 11.6 16.9 11.1 10.2 14.4 9.0 8.1 15.3 11.2 8.4 19.7 7.8 8.4 11.1 10.1 9.7 13.0 6.8 11.0 8.8 13.4 12.9 15.6 14.3 13.2 9.0 8.9 10.1 9.5 13.0 11.9 13.4 18.6 21.6 10.3 10.6 8.3 15.2 8.7 39.7 7.8 11.3 12.9 8.8 11.8 7.8 9.5 1.9 2.1 3.5 1.9 0.3 2.6 0.4 8.7 8.0 10.4 18.7 4.8 8.3 17.8 6.8 5.6 8.6 7.1 3.0 7.5 9.0 5.6 4.6 3.5 8.6 6.7 17.2 6.6 12.0 12.8 6.3 7.2 5.0 4.3 5.8 5.5 6.6 13.0 16.6 15.5 13.1 11.4 12.8 13.3 11.9 12.0 16.2 8.9 9.4 13.9 4.8 8.0 19.3 6.3 5.7 7.6 7.2 5.6 17.7 5.7 7.2 6.0 10.3 16.3 9.7 4.4 5.5 5.0 7.6 6.0 11.7 8.4 10.3 4.3 7.0 9.1 0.0 0.7 2.3 2.4 1.9 2.6 1.9 1.6 1.5 1.3 1.4 2.6 2.2 3.5 0.3 0.4 2.1 2.1 0.4 10.9 14.1 11.6 16.9 11.1 10.1 8.8 13.4 8.9 7.8 0.0 7.7 0.0 2.3 2.7 6.8 2.0 5.1 6.7 4.5 10.4 7.9 4.6 10.0 3.1 12.3 1.8 3.9 23.3 2.5 2.5 2.1 2.0 3.5 4.7 2.6 3.2 1.2 5.5 2.2 1.4 4.6 2.1 3.3 1.0 5.8 6.0 2.1 0.0 3.9 5.5 9.0 0.0 0.9 12.5 12.7 2.3 4.7 2.5 5.2 1.4 ZNF84 HPF2 ENSG00000198040 "Zinc finger protein 84" P51523 12 133037292-133063304 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA028860 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA028860: AB_10604102" "unprognostic (2.39e-1)" "unprognostic (5.11e-3)" "unprognostic (3.09e-2)" "unprognostic (8.66e-2)" "unprognostic (8.16e-2)" "unprognostic (3.63e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (5.96e-3)" "unprognostic (9.73e-3)" "unprognostic (2.67e-1)" "unprognostic (1.27e-2)" "unprognostic (3.24e-3)" "unprognostic (8.61e-3)" "unprognostic (1.15e-1)" "unprognostic (2.32e-1)" "unprognostic (3.48e-2)" "unprognostic (7.30e-3)" 9.7 9.6 19.6 10.0 22.2 8.1 18.6 26.1 21.6 16.3 11.3 16.9 11.8 7.8 20.1 25.3 7.8 17.7 12.1 10.0 17.9 15.9 12.1 11.0 11.5 13.3 25.2 17.9 23.6 11.7 18.3 31.5 12.4 20.6 16.3 13.6 9.8 10.4 15.1 8.8 13.3 10.1 19.6 21.0 12.7 10.6 12.2 23.2 12.4 20.0 11.1 14.8 13.8 10.8 9.6 7.4 4.3 4.9 9.1 12.5 4.9 8.7 7.1 21.6 12.9 8.6 14.4 16.5 8.2 7.6 6.7 6.1 4.3 2.6 10.7 7.8 7.5 8.0 4.2 8.2 6.6 9.6 3.0 13.3 16.1 8.6 6.3 10.5 17.8 7.1 10.1 8.9 9.3 10.4 22.6 10.0 8.2 7.9 5.0 16.4 5.5 11.9 17.3 25.3 3.4 6.6 16.4 10.0 7.2 9.3 19.4 17.3 19.0 16.3 4.6 6.7 12.8 15.9 11.7 13.2 7.4 7.6 6.6 5.8 2.8 0.0 23.8 4.5 13.9 8.2 1.4 3.8 4.3 8.4 4.9 12.3 9.6 9.2 10.7 5.8 8.4 12.5 10.2 0.8 9.1 3.4 7.4 4.9 4.9 19.6 22.2 26.1 21.6 17.9 15.9 25.2 17.9 20.6 23.2 8.9 11.1 9.4 11.6 2.7 18.2 22.9 7.6 28.1 12.5 15.7 5.9 8.4 3.3 10.9 11.7 15.3 3.3 0.0 6.2 5.0 9.7 9.1 12.8 6.7 9.0 19.1 9.2 13.5 7.3 10.4 12.4 7.1 1.7 2.8 9.1 15.2 9.0 8.2 14.2 9.2 16.6 12.9 7.8 9.0 21.6 2.4 5.4 6.9 6.9 8.0 ZNF843 MGC46336 ENSG00000176723 "Zinc finger protein 843" Q8N446 16 31432593-31443160 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 4.3;Cardiomyocytes: 4.8;Glandular cells: 3.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 5.9;EFO-21: 4.7;HMC-1: 4.3" "HPA030911, HPA030912, HPA077945" Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA030911: AB_2673656, HPA030912: AB_10670434, HPA077945: " "unprognostic (9.27e-2)" "unprognostic (1.32e-1)" "unprognostic (3.43e-3)" "unprognostic (9.24e-2)" "unprognostic (1.33e-1)" "unprognostic (6.25e-3)" "unprognostic (2.86e-1)" "unprognostic (8.30e-3)" "unprognostic (3.55e-1)" "unprognostic (1.22e-1)" "unprognostic (1.32e-3)" "unprognostic (2.93e-3)" "unprognostic (5.96e-3)" "unprognostic (1.23e-2)" "unprognostic (7.66e-2)" "unprognostic (1.28e-5)" "unprognostic (1.17e-1)" 1.2 1.4 3.5 2.5 3.4 0.8 1.7 3.9 5.4 3.5 1.2 2.3 1.9 0.6 2.8 5.6 1.2 3.3 2.0 7.4 3.0 3.2 1.8 0.9 2.4 0.8 2.5 2.3 10.6 5.0 3.1 5.7 2.2 1.9 3.2 0.4 3.9 7.5 3.2 5.1 2.5 1.3 1.9 1.9 1.1 0.9 1.2 1.7 0.1 2.6 2.8 0.6 1.0 1.3 1.0 0.9 2.5 0.6 4.8 2.3 2.2 0.3 0.7 0.7 3.2 5.9 1.7 0.2 0.6 0.5 0.0 0.3 0.4 0.9 0.1 4.7 0.8 0.2 0.3 0.3 0.3 0.3 0.5 0.0 0.2 0.6 0.2 1.7 0.5 4.3 3.1 0.8 0.0 0.3 2.0 0.0 0.5 0.5 0.7 1.6 2.1 0.2 1.0 1.7 0.2 0.2 0.4 0.0 0.1 0.4 0.2 0.1 1.8 1.9 0.3 0.8 0.6 0.4 0.6 0.1 0.7 0.5 2.0 0.1 0.7 0.4 0.3 0.2 0.3 1.0 2.3 0.6 0.6 2.2 0.4 1.3 0.6 0.8 2.3 0.3 1.0 0.6 1.6 2.5 4.8 0.4 0.9 0.4 2.2 3.5 3.4 3.9 3.5 3.0 3.2 2.5 2.3 1.9 1.7 0.0 0.3 0.0 4.3 0.7 2.4 4.8 0.0 0.0 1.2 0.0 2.0 0.2 0.0 0.2 0.1 0.9 0.0 0.0 0.2 0.1 0.9 3.2 1.1 0.0 0.5 0.0 1.2 1.3 0.8 0.0 1.4 0.2 0.0 0.0 0.0 1.1 0.1 0.0 1.4 0.4 1.9 0.0 1.4 0.5 0.9 1.3 0.2 0.0 0.0 2.0 ZNF85 "HPF4, HTF1" ENSG00000105750 "Zinc finger protein 85" Q03923 19 20923222-20950697 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 69.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA044760 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA044760: AB_10960412" "unprognostic (1.26e-2)" "unprognostic (1.92e-1)" "unprognostic (4.69e-2)" "prognostic unfavorable (5.20e-5)" "unprognostic (1.98e-2)" "unprognostic (4.27e-2)" "unprognostic (2.01e-2)" "unprognostic (1.31e-1)" "unprognostic (2.01e-4)" "prognostic favorable (6.45e-6)" "unprognostic (2.51e-1)" "unprognostic (1.01e-1)" "unprognostic (1.75e-2)" "unprognostic (2.05e-1)" "unprognostic (2.24e-1)" "unprognostic (3.90e-3)" "unprognostic (6.01e-2)" 5.2 8.4 4.3 7.0 7.0 7.7 8.4 24.7 7.1 5.3 3.4 3.3 7.8 1.0 5.5 3.4 4.8 4.3 3.4 4.9 4.3 3.6 4.9 1.9 3.4 7.8 3.9 5.4 8.9 13.1 6.3 3.5 6.5 5.2 4.7 4.6 3.4 5.1 6.8 1.7 5.4 4.0 4.9 6.3 6.9 7.8 22.8 5.0 15.4 11.7 4.4 8.7 4.7 4.5 8.5 3.2 4.4 3.9 7.6 4.6 2.3 0.8 0.4 9.7 8.3 3.8 3.4 7.6 7.1 2.5 9.6 9.9 0.0 4.3 8.7 8.2 1.7 3.9 0.8 0.1 5.4 10.6 0.3 4.4 2.4 0.9 0.6 0.7 0.1 1.8 1.5 1.8 4.6 6.5 1.7 2.9 9.4 0.1 3.6 5.5 2.9 13.6 5.4 7.2 0.0 8.0 7.6 14.8 4.1 3.4 8.2 6.3 4.8 0.1 0.3 1.3 9.1 4.2 7.1 2.0 4.6 1.3 12.3 7.6 4.6 11.1 9.7 0.2 0.1 3.9 0.8 1.2 4.4 3.4 3.9 2.8 8.5 3.8 2.6 2.7 6.8 4.6 3.8 4.0 7.6 2.5 3.2 4.3 2.3 4.3 7.0 24.7 7.1 4.3 3.6 3.9 5.4 5.2 5.0 3.0 1.7 9.5 2.8 0.7 4.5 3.1 0.0 4.0 2.3 5.2 0.0 7.6 1.7 5.2 69.1 6.9 0.1 0.0 5.4 11.6 3.1 2.0 11.5 0.0 7.1 3.2 0.0 3.7 0.6 10.5 2.8 5.9 5.0 7.2 2.4 3.2 4.1 2.3 3.5 1.7 1.9 19.4 1.4 16.9 13.6 1.3 6.3 5.2 1.5 1.8 ZNF850 ZNF850P ENSG00000267041 "Zinc finger protein 850" A8MQ14 19 36714383-36772825 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 17.9" "Cell type enhanced" "Detected in many" 5 "Ito cells: 8.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 14.7" HPA029299 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA029299: AB_2672987" "unprognostic (1.35e-2)" "unprognostic (5.54e-2)" "unprognostic (3.85e-2)" "unprognostic (1.38e-3)" "unprognostic (7.78e-2)" "unprognostic (6.63e-2)" "unprognostic (1.65e-3)" "unprognostic (1.68e-1)" "unprognostic (1.21e-2)" "unprognostic (1.25e-1)" "unprognostic (3.00e-2)" "unprognostic (5.56e-2)" "unprognostic (4.11e-3)" "unprognostic (1.77e-1)" "unprognostic (7.49e-2)" "unprognostic (4.49e-2)" "unprognostic (7.37e-3)" 4.0 3.4 2.6 3.0 4.2 11.5 3.3 8.7 3.1 5.1 2.4 3.4 1.6 1.9 5.6 2.6 2.8 2.9 3.2 4.6 2.5 1.7 2.0 2.8 3.0 4.0 5.9 0.7 5.9 4.1 3.2 6.4 17.9 3.2 3.4 2.9 3.0 2.3 2.2 1.9 3.2 2.9 2.3 3.5 3.6 2.7 6.7 3.8 7.0 2.6 1.0 2.9 5.0 4.4 6.8 3.5 6.0 3.8 3.8 6.0 5.1 0.3 1.7 3.7 5.8 0.8 0.3 7.2 2.4 1.3 1.4 2.1 1.3 0.4 1.2 5.1 0.4 7.8 0.8 2.6 0.5 2.7 0.6 2.1 14.7 0.2 1.1 1.0 1.8 8.4 1.1 0.1 2.4 0.0 0.5 1.4 1.8 3.8 0.8 3.7 0.8 2.6 1.8 10.8 0.6 1.0 1.6 7.3 0.9 0.6 7.4 2.5 4.0 3.8 0.2 0.6 5.4 1.5 3.3 3.0 3.7 5.8 2.1 3.6 1.5 2.6 3.2 0.0 0.8 5.7 4.2 3.4 2.4 3.9 3.6 5.0 6.8 4.8 3.2 3.2 5.4 5.7 6.0 6.0 3.8 3.8 3.5 3.2 5.1 2.6 4.2 8.7 3.1 2.5 1.7 5.9 0.7 3.2 3.8 0.0 0.0 0.9 1.1 1.9 1.1 2.4 2.5 0.0 0.0 3.5 0.0 3.0 0.0 1.1 6.1 2.1 0.0 0.0 0.6 3.8 2.6 0.5 0.0 1.8 1.1 4.8 0.0 8.6 2.7 3.6 1.1 1.1 3.3 0.0 2.9 1.3 0.5 0.0 0.4 0.4 0.0 0.0 1.4 2.6 2.5 3.0 2.4 0.9 0.6 0.9 ZNF860 ENSG00000197385 "Zinc finger protein 860" A6NHJ4 3 31981771-31991628 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.2" "Cell type enhanced" "Detected in some" 9 "B-cells: 3.4;Ciliated cells: 6.7;Club cells: 4.5;Intestinal endocrine cells: 3.4;Syncytiotrophoblasts: 3.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 61 "memory B-cell: 9.1;naive B-cell: 6.4" "Lineage enriched" "Detected in single" 71 "B-cells: 9.1" "Cell line enriched" "Detected in many" 4 "BEWO: 31.9" HPA063386 Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA063386: AB_2684999" "unprognostic (1.19e-1)" "unprognostic (2.46e-2)" "unprognostic (2.88e-1)" "unprognostic (1.64e-2)" "unprognostic (1.51e-1)" "unprognostic (8.01e-2)" "unprognostic (1.23e-2)" "unprognostic (1.94e-2)" "unprognostic (3.15e-1)" "unprognostic (4.15e-3)" "unprognostic (1.51e-2)" "unprognostic (6.38e-2)" "unprognostic (1.30e-4)" "unprognostic (9.51e-2)" "unprognostic (1.59e-1)" "unprognostic (8.74e-2)" "unprognostic (3.75e-3)" 2.0 1.0 0.7 11.2 1.0 0.1 2.8 0.8 1.5 4.3 1.1 0.0 1.7 0.3 4.1 4.9 6.2 1.9 3.6 1.3 0.6 1.6 7.2 0.4 3.7 8.3 1.6 0.6 1.8 0.6 0.1 5.5 8.1 1.1 6.0 1.6 1.6 5.6 2.6 0.4 2.3 3.7 6.7 0.5 9.6 1.1 2.2 0.0 0.5 1.8 4.2 20.2 6.4 3.6 9.1 0.0 0.1 0.0 0.0 0.0 0.2 2.1 0.7 0.0 1.6 0.0 0.0 31.9 0.2 0.1 0.2 0.2 2.1 2.5 2.3 2.3 0.0 1.0 1.9 0.7 3.1 0.2 0.0 0.3 0.0 3.2 1.0 0.0 0.0 0.0 0.1 1.4 0.2 6.1 0.2 0.6 0.0 0.0 0.0 0.3 1.8 0.0 0.0 0.8 5.6 3.4 0.0 0.0 0.1 7.2 0.9 0.2 0.0 0.5 3.8 0.0 1.6 2.9 0.0 1.2 0.2 2.6 0.0 0.2 0.0 0.0 3.6 0.3 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 1.0 0.8 1.5 0.6 1.6 1.6 0.6 1.1 0.0 0.0 0.0 3.4 0.4 0.8 0.2 0.6 0.0 6.7 4.5 0.0 0.0 1.4 0.0 0.0 0.0 1.1 0.0 0.0 0.5 3.0 0.5 0.9 0.0 0.0 0.3 0.0 3.4 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.9 0.2 0.0 0.4 1.1 0.0 0.0 0.3 0.1 0.1 0.3 3.5 0.0 0.3 0.6 ZNF865 ENSG00000261221 "Zinc finger protein 865" P0CJ78 19 55605405-55617269 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 56.2" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 18.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068079 Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA068079: AB_2685947" "unprognostic (3.98e-3)" "unprognostic (2.46e-1)" "unprognostic (4.72e-3)" "unprognostic (8.38e-2)" "unprognostic (1.60e-1)" "unprognostic (4.20e-2)" "unprognostic (3.22e-3)" "unprognostic (1.23e-1)" "unprognostic (1.16e-1)" "unprognostic (2.30e-2)" "unprognostic (1.05e-2)" "unprognostic (8.85e-2)" "unprognostic (1.40e-2)" "unprognostic (3.62e-2)" "unprognostic (2.12e-1)" "unprognostic (1.54e-1)" "unprognostic (9.41e-3)" 12.1 7.5 8.3 11.0 10.5 11.1 8.2 12.3 15.1 8.0 10.0 9.7 6.6 11.0 11.5 6.8 6.2 8.7 7.0 12.2 7.3 5.8 8.3 6.7 8.7 13.3 7.4 8.5 10.3 11.2 9.9 9.5 6.1 7.4 9.9 4.8 8.1 12.1 7.7 56.2 11.1 10.4 7.4 7.3 16.0 12.2 4.7 7.9 14.0 9.5 8.0 9.1 9.3 9.9 1.2 0.5 1.4 0.1 0.1 0.6 0.1 6.4 5.3 2.3 3.7 2.5 1.9 6.3 4.6 2.6 2.5 2.4 1.7 4.2 7.5 5.4 3.4 1.3 5.4 1.4 2.8 1.0 7.4 17.6 4.3 3.2 2.2 4.0 4.9 8.4 2.9 4.5 3.1 1.9 2.3 1.7 4.7 8.2 5.1 1.6 3.0 7.7 5.3 5.2 3.7 9.2 12.0 3.6 4.7 2.9 4.4 5.5 8.9 6.4 3.9 3.9 1.2 3.1 7.7 5.0 3.9 9.3 3.5 5.8 10.8 9.3 3.9 4.8 3.8 6.2 0.0 0.0 1.4 0.3 0.1 0.2 1.2 0.2 0.1 0.1 0.2 0.1 0.6 0.8 0.1 0.1 0.5 0.0 0.1 8.3 10.5 12.3 15.1 7.3 5.8 7.4 8.5 7.4 7.9 0.0 0.0 1.9 1.0 3.7 3.7 18.6 2.5 0.0 0.0 14.0 0.0 2.1 5.0 3.1 1.9 5.2 5.2 0.0 3.8 2.7 3.8 1.2 0.0 5.4 4.0 9.5 5.8 6.7 5.4 3.2 4.9 4.2 5.0 1.8 6.3 3.9 4.7 0.0 9.6 3.6 3.2 6.5 4.1 1.2 1.4 3.8 2.2 4.8 5.7 0.9 ZNF878 ENSG00000257446 "Zinc finger protein 878" C9JN71 19 12043805-12052939 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 12 "Cytotrophoblasts: 1.1;Spermatogonia: 1.5;Syncytiotrophoblasts: 1.0" "Cancer enriched" "Detected in single" 5 "testis cancer: 1.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "NK-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 6.4" HPA052735 Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA052735: AB_2681932" "unprognostic (3.27e-2)" "unprognostic (1.76e-1)" "unprognostic (2.62e-2)" "unprognostic (1.51e-1)" "unprognostic (2.79e-2)" "unprognostic (1.56e-2)" "unprognostic (3.00e-4)" "unprognostic (1.42e-1)" "unprognostic (7.43e-3)" "unprognostic (2.80e-1)" "unprognostic (6.67e-2)" "unprognostic (8.75e-2)" "unprognostic (3.02e-1)" "unprognostic (7.65e-3)" "unprognostic (6.82e-2)" "unprognostic (4.04e-1)" "unprognostic (3.62e-2)" 1.1 1.4 0.4 1.5 3.1 5.8 0.8 2.5 2.4 1.5 1.2 0.4 0.0 0.6 1.8 1.2 1.4 1.2 1.4 0.7 1.9 0.5 7.7 2.5 1.5 1.4 4.4 0.3 2.4 5.0 0.8 2.4 5.1 7.4 1.4 1.2 0.4 3.2 0.3 0.5 1.0 1.3 1.4 1.9 1.3 1.2 4.6 2.2 1.7 1.4 0.0 1.3 1.2 1.7 0.3 0.1 0.5 0.0 1.5 0.5 0.1 3.0 0.0 1.7 6.4 0.1 0.0 3.8 1.0 0.5 1.3 1.7 2.5 0.4 1.4 1.5 0.4 1.8 0.8 0.6 0.9 1.2 0.0 0.9 1.8 0.0 3.5 0.0 1.2 3.3 0.2 0.0 0.7 0.0 0.1 0.0 3.9 0.0 0.0 1.3 0.0 2.9 1.7 3.6 0.0 0.5 2.4 3.3 0.0 2.2 2.2 1.7 0.3 0.0 0.1 0.3 3.5 3.3 3.9 0.0 1.9 1.4 1.5 1.8 1.2 3.8 0.3 0.0 0.6 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.3 0.5 0.1 0.0 1.5 0.0 0.0 0.0 0.1 0.4 3.1 2.5 2.4 1.9 0.5 4.4 0.3 7.4 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 1.0 0.0 0.0 0.0 ZNF879 DKFZp686E2433 ENSG00000234284 "Zinc finger protein 879" B4DU55 5 179023752-179035064 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 11.8;Spermatocytes: 11.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 11.4;BEWO: 12.4" "Low region specificity" "Detected in all" HPA068608 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA068608: AB_2686010" "unprognostic (3.20e-2)" "unprognostic (5.24e-3)" "unprognostic (7.33e-2)" "unprognostic (1.49e-3)" "unprognostic (1.59e-1)" "unprognostic (1.61e-3)" "unprognostic (5.83e-2)" "unprognostic (8.80e-3)" "unprognostic (3.19e-3)" "unprognostic (6.04e-2)" "unprognostic (5.69e-4)" "unprognostic (1.07e-1)" "unprognostic (4.61e-2)" "unprognostic (2.10e-1)" "unprognostic (3.79e-1)" "unprognostic (4.72e-2)" "unprognostic (5.17e-3)" 5.9 4.0 5.5 5.3 7.2 1.9 6.6 13.5 8.0 6.1 5.8 6.3 4.9 2.9 7.3 5.5 5.0 6.2 4.0 6.3 7.4 4.7 5.9 3.6 4.7 7.2 7.0 5.7 10.2 4.9 8.4 7.6 6.7 6.1 7.7 3.0 4.4 5.2 8.1 7.9 8.2 5.2 5.6 6.9 7.1 4.6 14.5 10.7 12.1 9.1 2.5 7.9 6.2 5.0 5.4 4.4 13.1 4.9 6.0 9.1 3.7 0.0 4.1 3.7 11.4 3.6 2.8 12.4 2.0 3.0 5.0 6.2 3.8 2.1 3.0 2.9 1.9 5.7 1.7 0.0 2.3 4.0 0.0 0.3 0.0 2.6 0.7 5.9 0.0 5.8 2.7 2.2 2.8 1.4 2.3 1.7 3.0 0.6 0.0 4.0 2.0 3.4 1.2 4.2 1.5 1.0 3.1 1.3 0.4 3.7 3.3 1.6 3.8 3.9 0.6 5.3 5.9 5.6 3.4 1.6 2.3 4.3 2.6 0.5 0.0 0.0 4.7 0.0 0.0 3.0 13.1 4.9 4.7 6.3 4.1 6.5 5.2 5.8 5.3 4.4 5.4 9.1 7.1 0.1 6.0 3.9 2.8 6.7 3.7 5.5 7.2 13.5 8.0 7.4 4.7 7.0 5.7 6.1 10.7 6.0 0.6 0.0 1.3 0.5 8.0 1.6 2.5 1.4 0.0 5.2 11.8 2.9 5.0 1.5 2.2 2.2 0.8 0.0 0.7 1.5 1.3 1.4 2.3 0.9 1.9 9.5 1.2 1.8 2.6 2.0 1.4 1.5 0.0 0.0 0.1 4.5 0.8 0.0 2.1 1.1 5.3 6.5 1.2 11.3 8.5 1.0 3.5 1.3 0.6 1.0 ZNF880 ENSG00000221923 "Zinc finger protein 880" Q6PDB4 19 52369917-52385795 "Predicted intracellular proteins, Transcription factors" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 21.2;SuSa: 20.9" HPA077316 Approved "Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Intermediate filaments" "HPA077316: AB_2686833" "unprognostic (2.66e-3)" "unprognostic (2.19e-2)" "unprognostic (2.55e-1)" "unprognostic (3.99e-2)" "unprognostic (7.72e-2)" "unprognostic (1.54e-2)" "unprognostic (7.61e-2)" "unprognostic (2.00e-1)" "unprognostic (1.01e-2)" "unprognostic (1.26e-2)" "unprognostic (3.94e-2)" "unprognostic (2.52e-1)" "prognostic favorable (4.33e-8)" "unprognostic (4.14e-2)" "unprognostic (4.99e-1)" "unprognostic (1.77e-1)" "unprognostic (5.60e-3)" 14.7 12.7 12.4 12.2 21.8 17.3 16.3 22.9 14.6 16.5 13.0 13.6 10.8 6.9 16.0 20.3 13.3 14.7 12.5 20.1 13.9 10.5 13.0 4.4 13.3 15.9 12.2 7.4 22.7 9.4 4.0 18.2 12.4 14.3 20.8 10.8 18.1 12.9 16.8 11.3 12.6 11.6 16.8 13.4 16.1 11.6 11.2 13.3 24.5 22.2 12.1 16.5 27.9 11.4 25.4 20.3 27.7 7.2 12.1 20.4 8.7 0.1 0.8 10.7 8.3 5.8 16.5 11.6 7.0 7.6 4.9 9.8 0.2 4.7 0.1 2.5 12.2 10.3 1.6 0.0 6.4 8.3 0.1 12.6 0.3 0.5 0.0 6.9 0.2 8.8 12.3 8.1 9.2 0.0 0.6 7.8 0.9 0.8 0.3 9.4 0.6 1.1 0.7 14.4 0.0 1.7 0.7 21.2 0.7 13.8 11.0 7.9 10.0 0.0 2.0 3.0 20.9 0.4 2.1 6.2 0.3 0.2 2.1 6.4 0.4 3.9 0.3 0.2 0.2 13.6 27.7 6.6 15.1 13.3 6.2 17.3 23.2 16.9 14.6 10.2 25.4 20.4 17.8 2.7 12.1 7.2 20.3 17.2 8.7 12.4 21.8 22.9 14.6 13.9 10.5 12.2 7.4 14.3 13.3 11.9 3.8 10.7 13.7 5.3 16.5 11.7 7.6 10.7 18.2 19.2 11.8 8.8 24.9 14.7 10.6 10.8 2.1 0.0 12.9 12.5 7.8 21.9 9.3 1.0 5.9 22.3 0.0 9.8 5.9 3.1 12.7 11.0 8.5 16.2 5.1 11.3 17.7 7.0 6.0 6.3 15.7 19.4 13.0 3.3 7.9 6.1 12.0 12.5 3.1 22.2 ZNF891 ENSG00000214029 "Zinc finger protein 891" A8MT65 12 133106817-133130473 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 52.6;Horizontal cells: 38.1;Rod photoreceptor cells: 34.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040301 Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA040301: AB_10795380" "unprognostic (3.05e-1)" "unprognostic (9.12e-2)" "unprognostic (3.29e-1)" "unprognostic (3.72e-1)" "unprognostic (7.51e-3)" "unprognostic (5.98e-3)" "unprognostic (1.94e-2)" "unprognostic (7.90e-2)" "unprognostic (2.77e-2)" "unprognostic (1.47e-1)" "unprognostic (1.60e-2)" "unprognostic (6.09e-2)" "unprognostic (5.22e-2)" "unprognostic (1.14e-1)" "unprognostic (3.64e-1)" "unprognostic (2.07e-3)" "unprognostic (6.68e-2)" 3.6 5.3 7.0 4.0 9.3 4.2 5.4 13.2 7.2 4.6 4.4 3.6 2.6 3.4 5.5 4.6 2.9 4.0 2.9 3.5 7.9 3.3 3.4 2.9 2.9 4.3 7.8 2.7 6.4 3.8 4.9 8.8 3.0 6.6 3.8 3.5 2.3 4.5 4.0 4.3 6.9 3.3 4.5 7.0 4.5 4.0 14.0 8.9 4.2 5.6 2.9 3.8 4.3 4.5 2.9 1.6 2.3 1.2 2.4 2.7 0.7 1.5 1.7 4.6 0.3 1.9 2.2 3.0 0.8 0.9 1.2 1.0 1.3 0.7 0.3 1.3 1.0 2.0 2.1 2.4 1.2 1.3 0.1 2.3 3.8 5.0 1.7 0.9 3.4 2.7 1.6 1.2 1.9 1.6 2.3 1.0 4.1 2.3 0.8 1.6 1.0 3.8 4.1 2.9 1.2 1.9 3.5 2.6 1.5 1.0 2.7 4.6 2.9 3.0 1.1 1.0 2.9 3.1 1.4 1.8 2.4 2.4 2.1 1.3 0.5 0.2 3.1 0.6 1.3 1.8 2.0 1.2 1.4 1.8 0.7 1.6 1.9 1.7 1.7 0.6 2.9 2.7 2.3 2.3 2.4 0.8 1.6 1.1 0.7 7.0 9.3 13.2 7.2 7.9 3.3 7.8 2.7 6.6 8.9 3.0 4.0 2.7 5.5 1.5 30.2 4.4 2.5 16.0 10.3 10.4 27.5 3.1 0.0 3.5 52.6 3.9 1.4 0.0 1.7 1.9 3.1 2.9 1.1 1.9 1.6 38.1 6.4 4.3 1.0 4.2 4.9 3.2 1.7 0.0 2.4 10.9 1.6 2.5 5.6 1.3 34.9 19.4 5.2 14.0 14.6 1.5 1.9 5.0 3.1 2.3 ZNF90 HTF9 ENSG00000213988 "Zinc finger protein 90" Q03938 19 20077994-20127076 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 20.3;seminal vesicle: 36.4" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 192.8;Suprabasal keratinocytes: 245.0" "Cancer enhanced" "Detected in many" "testis cancer: 10.4" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 9.4;NTERA-2: 16.0;SuSa: 11.7;U-2197: 6.7" HPA003227 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA003227: AB_1859471" "unprognostic (4.52e-2)" "unprognostic (2.64e-3)" "unprognostic (3.93e-1)" "unprognostic (2.45e-2)" "unprognostic (2.42e-1)" "unprognostic (2.71e-3)" "unprognostic (1.50e-2)" "unprognostic (7.34e-3)" "unprognostic (4.95e-1)" "unprognostic (4.44e-3)" "unprognostic (2.28e-1)" "unprognostic (1.09e-1)" "unprognostic (1.18e-4)" "unprognostic (2.79e-2)" "unprognostic (1.13e-1)" "unprognostic (9.10e-2)" "unprognostic (2.60e-2)" 1.5 1.0 1.1 3.6 2.5 1.6 1.8 6.9 1.1 3.0 1.7 1.2 20.3 0.5 3.3 2.7 2.1 2.8 1.0 1.4 0.8 0.6 1.7 0.7 2.4 3.0 2.1 0.3 4.7 3.4 12.7 1.4 3.8 1.7 4.1 2.1 3.2 1.2 36.4 1.2 2.8 2.3 3.3 1.6 2.3 2.7 1.6 2.2 4.1 10.3 0.7 2.9 4.9 2.9 0.5 0.4 1.8 0.2 0.3 0.9 0.2 0.0 0.0 3.8 9.4 0.0 0.0 0.0 1.0 0.4 3.6 4.3 3.2 2.2 1.4 1.7 0.6 2.5 0.9 0.0 0.5 6.3 0.0 0.9 0.0 0.0 0.6 0.3 0.0 0.0 0.2 0.0 3.5 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 1.9 5.4 16.0 0.0 0.0 0.0 3.4 0.2 2.0 3.3 0.0 3.4 0.0 1.1 0.1 11.7 1.9 0.0 0.0 0.9 0.0 6.7 3.6 0.0 1.5 0.0 0.0 0.0 1.4 0.8 0.2 0.3 0.1 0.0 0.9 0.2 0.2 0.4 0.4 0.5 0.3 0.1 1.8 0.3 0.0 0.2 0.7 0.2 1.1 2.5 6.9 1.1 0.8 0.6 2.1 0.3 1.7 2.2 6.0 5.9 72.1 60.7 192.8 0.6 1.7 56.0 0.0 7.9 7.0 2.0 81.3 14.9 2.0 5.9 31.2 3.3 70.0 1.8 83.3 43.9 74.9 1.1 52.0 41.8 0.0 8.2 48.5 105.1 17.6 56.4 28.6 118.1 1.0 14.4 1.4 1.0 10.5 32.5 4.6 2.1 19.4 51.2 8.2 14.3 245.0 68.2 76.2 20.2 56.5 ZNF92 "HPF12, TF12" ENSG00000146757 "Zinc finger protein 92" Q03936 7 65373799-65401135 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "B-cells: 34.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003173 Approved Nucleoplasm NA NA Nucleoplasm "HPA003173: AB_1080744" "unprognostic (1.07e-1)" "unprognostic (1.36e-1)" "unprognostic (1.86e-1)" "unprognostic (2.13e-1)" "unprognostic (8.53e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (6.56e-4)" "unprognostic (5.48e-3)" "unprognostic (1.30e-2)" "unprognostic (3.86e-2)" "unprognostic (5.83e-2)" "unprognostic (1.40e-2)" "unprognostic (1.24e-1)" "unprognostic (9.65e-2)" "unprognostic (3.68e-1)" "unprognostic (1.59e-1)" "unprognostic (1.50e-3)" 6.7 9.3 9.6 13.7 13.0 20.8 16.3 24.4 11.9 8.3 6.2 5.0 6.1 6.1 5.7 7.2 11.2 5.4 6.3 4.6 9.6 8.9 7.9 5.6 5.7 14.8 12.1 8.6 8.8 6.9 7.7 13.4 5.7 12.6 6.6 7.0 2.5 6.9 6.6 4.7 4.9 10.1 3.9 18.5 14.8 7.6 7.6 15.7 26.0 9.4 5.1 14.0 8.3 5.7 10.7 2.3 5.6 2.7 9.4 6.0 2.2 4.5 3.1 13.7 13.5 3.5 4.2 6.5 3.8 2.8 4.2 6.1 5.7 6.8 17.7 7.4 2.1 6.3 4.5 10.6 2.6 6.9 6.6 7.1 7.9 1.7 5.6 1.2 9.5 7.6 3.6 2.3 3.8 2.9 5.7 5.1 9.4 10.3 7.3 6.0 1.3 14.0 10.8 18.5 4.8 4.2 12.8 8.0 6.0 4.6 9.2 11.7 8.9 5.8 9.1 4.3 13.9 6.5 13.0 3.7 4.9 4.4 2.9 5.4 4.6 4.1 25.7 3.2 7.7 4.3 5.6 1.6 4.0 2.7 2.1 5.7 10.7 4.2 4.1 2.3 9.2 5.1 5.2 1.3 9.4 2.7 2.2 6.0 2.2 9.6 13.0 24.4 11.9 9.6 8.9 12.1 8.6 12.6 15.7 8.9 0.6 34.0 6.2 4.9 7.6 3.4 5.1 1.4 7.9 5.2 0.0 5.3 10.0 6.3 1.0 5.8 2.6 0.0 4.2 4.4 5.1 6.3 11.5 2.1 3.7 4.8 6.9 6.2 5.4 1.7 6.6 6.8 5.0 9.0 7.2 7.7 6.3 7.0 6.0 3.5 4.8 0.0 5.7 19.6 24.5 3.3 4.1 7.9 4.7 7.0 ZNHIT1 "CG1I, H_DJ0747G18.14, ZNFN4A1" ENSG00000106400 "Zinc finger HIT-type containing 1" O43257 7 101217668-101224190 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Hepatocytes: 796.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019043 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA019043: AB_1859481" "unprognostic (1.16e-1)" "unprognostic (3.55e-1)" "unprognostic (3.52e-3)" "unprognostic (1.24e-1)" "unprognostic (4.26e-2)" "unprognostic (6.61e-2)" "unprognostic (3.49e-2)" "unprognostic (3.72e-2)" "unprognostic (2.39e-1)" "unprognostic (7.43e-2)" "unprognostic (1.05e-2)" "unprognostic (2.02e-2)" "unprognostic (2.10e-3)" "unprognostic (1.98e-1)" "unprognostic (2.01e-1)" "unprognostic (3.36e-1)" "unprognostic (7.24e-3)" 24.6 21.0 29.4 18.7 26.9 18.3 23.6 11.7 20.8 21.1 24.5 16.6 29.4 24.5 15.0 29.4 21.1 23.2 29.8 26.9 24.7 19.4 27.7 77.2 14.1 18.5 27.9 17.2 13.2 34.7 17.2 17.3 19.9 18.7 17.4 16.2 12.0 29.3 29.9 32.7 16.2 23.4 15.0 28.0 18.4 22.7 13.1 17.6 21.0 27.3 24.0 14.1 14.7 20.9 27.9 42.8 45.5 47.1 22.4 39.7 45.9 14.1 14.6 9.6 18.4 17.8 23.0 9.4 17.5 17.3 17.2 17.1 14.5 16.5 10.1 23.4 19.1 14.9 12.0 8.7 24.3 7.4 10.5 33.7 5.5 12.8 17.3 22.7 11.2 11.9 21.5 29.5 15.2 7.4 14.6 25.1 15.2 17.4 16.8 14.6 42.1 18.4 60.9 18.4 22.9 36.8 9.8 7.5 31.1 23.0 6.7 11.9 26.9 13.2 23.9 28.9 11.3 6.2 13.8 19.1 16.2 14.2 27.9 12.4 13.6 17.2 12.2 15.6 19.8 21.6 42.0 47.1 45.5 27.4 42.5 28.9 27.4 30.5 27.5 40.6 27.9 24.7 26.5 39.1 22.4 40.8 42.8 39.7 45.9 29.4 26.9 11.7 20.8 24.7 19.4 27.9 17.2 18.7 17.6 86.4 76.3 87.8 100.5 89.4 29.5 69.6 216.6 103.1 83.0 181.5 15.7 165.9 306.7 174.5 18.7 143.6 325.7 93.5 222.5 162.7 150.6 101.7 77.3 796.2 180.7 11.1 231.8 154.1 203.1 46.0 125.1 115.6 123.2 212.8 211.4 63.3 222.4 336.6 117.4 541.3 29.9 148.8 103.2 50.5 36.9 101.9 136.7 113.6 219.4 110.3 ZNRF2 RNF202 ENSG00000180233 "Zinc and ring finger 2" Q8NHG8 7 30284307-30367692 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 5.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072244 Approved Uncertain "Nucleoplasm,Nucleoli fibrillar center,Vesicles" NA NA "Nucleoplasm, Vesicles" "Nucleoli fibrillar center" "HPA072244: AB_2732197" "unprognostic (9.44e-2)" "unprognostic (2.38e-2)" "unprognostic (8.64e-2)" "prognostic unfavorable (7.68e-4)" "unprognostic (4.46e-2)" "unprognostic (1.24e-1)" "unprognostic (3.06e-1)" "unprognostic (6.10e-2)" "unprognostic (1.26e-1)" "unprognostic (1.67e-1)" "unprognostic (1.71e-1)" "unprognostic (5.93e-2)" "prognostic favorable (2.29e-4)" "unprognostic (1.51e-1)" "unprognostic (2.71e-1)" "prognostic favorable (8.71e-4)" "unprognostic (8.67e-2)" 7.8 8.0 10.0 9.3 10.6 9.7 16.2 12.8 10.0 5.8 16.1 10.5 7.6 11.3 7.7 9.7 14.2 5.2 8.7 8.4 9.6 6.1 19.3 24.0 7.9 12.0 10.0 7.4 5.8 14.0 8.0 9.9 9.6 11.0 7.0 14.3 5.8 10.5 13.7 17.5 11.5 12.7 8.3 10.5 9.2 12.4 20.6 9.1 7.9 13.3 9.8 10.9 9.4 11.8 1.3 5.8 1.4 1.1 0.7 2.4 0.5 6.7 2.5 2.0 1.8 2.3 1.6 10.7 2.6 2.7 2.9 3.9 1.2 11.3 7.1 6.8 2.1 7.5 6.6 6.7 4.4 3.1 6.9 6.1 4.4 5.2 3.3 1.2 3.4 8.4 2.5 7.5 2.0 4.9 3.0 2.4 5.5 5.4 14.2 3.1 2.6 6.9 9.0 4.7 6.7 3.1 6.0 4.4 12.1 8.7 14.6 7.0 6.6 5.2 22.0 4.3 12.4 5.9 13.8 2.7 2.8 4.8 2.7 5.4 24.3 20.8 9.3 3.1 7.4 4.1 0.5 0.9 1.1 1.0 0.9 1.5 1.3 1.2 1.4 0.8 0.8 0.7 1.1 1.4 0.7 1.1 5.8 2.4 0.5 10.0 10.6 12.8 10.0 9.6 6.1 10.0 7.4 11.0 9.1 8.9 6.7 5.2 5.8 14.2 11.0 3.2 17.8 2.7 4.5 15.7 39.3 7.5 6.6 4.9 4.3 4.5 42.5 0.0 8.9 8.0 4.4 5.5 3.5 33.4 9.4 1.6 30.1 9.2 18.9 7.6 2.6 11.2 11.8 9.0 14.5 4.3 6.7 14.4 2.1 26.0 5.7 6.5 7.2 20.9 7.9 16.6 9.6 8.7 19.6 10.8 ZPLD1 ENSG00000170044 "Zona pellucida like domain containing 1" Q8TCW7 3 102099244-102479841 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.0;gallbladder: 6.7;kidney: 2.6" "Cell type enhanced" "Detected in some" 18 "Cholangiocytes: 7.6;Ductal cells: 2.6;Late spermatids: 3.6;Muller glia cells: 11.4;Pancreatic endocrine cells: 3.1" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 8 "non-classical monocyte: 3.0" "Lineage enriched" "Detected in single" 11 "monocytes: 3.0" "Cell line enriched" "Detected in some" 8 "RPTEC TERT1: 12.4" "Region enriched" "Detected in single" 7 "olfactory region: 3.4" "Low region specificity" "Detected in all" HPA077519 Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA077519: AB_2732349" "unprognostic (2.49e-1)" "unprognostic (2.83e-3)" "unprognostic (6.38e-3)" "unprognostic (1.88e-1)" "unprognostic (5.02e-2)" "unprognostic (1.37e-2)" "unprognostic (2.68e-1)" "unprognostic (2.63e-1)" "unprognostic (4.63e-1)" "unprognostic (2.89e-4)" "unprognostic (4.59e-2)" "unprognostic (1.05e-3)" "unprognostic (1.97e-2)" "unprognostic (9.65e-2)" "unprognostic (1.41e-1)" "unprognostic (1.23e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.5 2.5 1.0 0.0 0.0 0.2 6.7 0.3 0.0 0.6 2.6 0.3 0.0 0.0 0.3 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.5 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.1 1.3 0.0 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 12.4 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.6 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 11.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 ZRANB1 TRABID ENSG00000019995 "Zinc finger RANBP2-type containing 1" Q9UGI0 10 124942123-124988189 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029239, HPA029240, HPA029241" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029239: AB_10599419, HPA029240: AB_10601450, HPA029241: AB_10602205" "unprognostic (2.06e-1)" "unprognostic (5.16e-2)" "unprognostic (6.96e-2)" "unprognostic (1.67e-1)" "unprognostic (1.40e-1)" "unprognostic (9.53e-3)" "unprognostic (4.16e-2)" "unprognostic (1.89e-1)" "unprognostic (1.71e-1)" "unprognostic (1.46e-1)" "unprognostic (4.20e-1)" "unprognostic (1.46e-1)" "unprognostic (1.22e-2)" "unprognostic (1.60e-1)" "unprognostic (2.76e-1)" "unprognostic (1.26e-1)" "unprognostic (1.47e-2)" 5.1 9.3 4.9 1.9 4.7 7.9 5.3 11.9 6.0 6.3 5.2 1.4 5.9 5.2 4.1 4.4 3.6 7.3 4.6 4.0 4.2 10.4 4.2 2.5 4.4 8.6 3.1 7.1 3.9 3.9 4.6 3.3 3.4 5.8 18.0 5.2 3.0 6.3 3.8 2.8 3.6 7.7 3.8 3.9 4.2 4.8 3.4 1.4 4.6 1.1 3.8 4.4 0.8 7.7 4.4 9.5 6.9 14.8 12.5 4.0 7.6 20.8 14.5 16.9 6.6 6.1 8.1 5.7 9.6 4.7 5.6 12.0 5.6 19.6 8.6 5.9 4.6 5.1 7.1 31.6 6.9 3.5 13.8 16.5 10.6 22.8 20.3 9.1 7.5 0.6 6.7 7.8 6.1 8.1 6.0 3.4 4.2 4.8 7.0 6.7 3.6 6.4 5.6 4.8 8.1 6.4 5.0 8.4 9.3 5.5 5.9 6.7 6.2 6.4 5.1 9.4 7.2 6.2 9.4 7.0 4.9 3.0 2.1 1.1 3.0 2.2 0.4 1.9 2.4 2.6 2.2 0.9 3.4 4.4 3.3 4.6 3.8 0.5 1.4 2.2 0.8 17.9 25.9 5.7 19.6 21.9 32.7 21.0 15.3 21.4 19.4 17.4 47.1 10.6 0.0 11.6 60.8 18.8 11.6 0.0 10.0 8.1 20.6 26.5 25.4 38.0 10.6 35.0 25.7 15.4 16.8 27.1 22.2 19.1 15.1 8.2 15.7 23.9 15.7 8.2 21.5 8.7 24.5 12.9 24.7 23.3 19.0 24.3 23.0 17.5 10.5 20.0 ZRANB2 "ZIS, ZIS1, ZIS2, ZNF265" ENSG00000132485 "Zinc finger RANBP2-type containing 2" O95218 1 71063291-71081297 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053960, HPA061949, HPA063298" Supported Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA053960: AB_2682323, HPA061949: AB_2684645, HPA063298: AB_2684979" "unprognostic (2.10e-1)" "unprognostic (7.54e-2)" "unprognostic (4.15e-3)" "unprognostic (8.11e-2)" "unprognostic (1.04e-2)" "unprognostic (2.66e-2)" "prognostic unfavorable (7.29e-5)" "unprognostic (4.25e-3)" "unprognostic (1.24e-2)" "unprognostic (7.79e-2)" "unprognostic (4.54e-2)" "prognostic unfavorable (5.70e-4)" "prognostic unfavorable (1.57e-8)" "unprognostic (3.96e-2)" "unprognostic (8.51e-2)" "unprognostic (1.40e-1)" "unprognostic (1.84e-3)" 26.4 27.4 39.8 31.1 42.2 35.1 34.4 54.1 48.6 39.3 28.8 19.6 33.3 23.4 48.3 45.6 20.2 30.6 20.3 27.5 33.5 30.6 20.1 19.5 26.7 37.8 34.1 40.5 39.5 23.9 23.1 77.5 24.6 32.0 30.5 29.3 17.5 25.1 33.2 54.4 27.9 24.9 35.1 42.2 26.2 23.6 31.6 38.0 40.0 32.8 24.3 30.9 32.8 25.6 31.4 34.0 32.1 16.3 20.9 30.8 13.8 23.7 8.6 35.6 20.5 13.9 24.0 20.3 29.1 16.0 25.6 32.7 16.1 15.4 49.3 25.8 17.9 24.1 15.0 30.1 18.1 38.4 34.8 21.7 42.8 33.8 13.4 20.7 46.6 17.5 18.2 22.7 24.9 21.5 29.0 21.5 25.5 44.7 26.4 19.5 8.1 38.1 15.1 36.3 14.2 16.9 43.4 26.6 28.9 16.5 20.3 26.5 16.8 24.8 16.7 24.8 19.4 20.5 20.5 28.8 18.9 18.1 14.8 28.7 21.8 27.0 54.2 27.9 43.5 26.5 32.1 16.3 14.2 22.2 15.0 25.1 30.6 23.6 21.3 12.4 31.4 30.8 24.2 14.6 20.9 14.8 34.0 22.0 13.8 39.8 42.2 54.1 48.6 33.5 30.6 34.1 40.5 32.0 38.0 92.3 128.7 70.6 66.5 45.0 171.8 89.9 58.6 91.0 72.8 47.1 121.7 45.9 41.4 45.1 111.6 51.1 53.4 23.3 58.7 46.6 56.3 44.1 84.4 36.4 38.8 201.8 70.2 51.0 27.2 20.7 171.7 52.0 45.5 50.5 41.0 144.1 55.6 45.6 108.5 30.6 205.0 116.4 59.5 149.3 96.0 40.7 53.1 60.9 36.0 49.3 ZRANB3 DKFZP434B1727 ENSG00000121988 "Zinc finger RANBP2-type containing 3" Q5FWF4 2 135136916-135531236 "Cancer-related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Endonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035234 Supported Nucleoplasm NA NA Nucleoplasm "HPA035234: AB_2674530" "unprognostic (6.98e-2)" "unprognostic (2.04e-1)" "unprognostic (1.01e-1)" "unprognostic (2.52e-3)" "unprognostic (4.09e-1)" "unprognostic (1.33e-1)" "unprognostic (1.09e-1)" "unprognostic (1.06e-1)" "unprognostic (3.53e-3)" "unprognostic (1.74e-1)" "unprognostic (3.58e-2)" "unprognostic (4.68e-2)" "unprognostic (2.77e-4)" "unprognostic (1.57e-1)" "unprognostic (1.29e-1)" "unprognostic (2.00e-2)" "unprognostic (9.88e-2)" 3.5 6.3 5.5 4.9 7.0 5.2 5.4 7.7 7.9 5.4 3.3 4.1 3.9 2.6 5.4 6.0 3.3 5.4 3.9 4.0 4.7 5.2 4.4 6.3 2.9 4.3 6.0 5.4 7.2 6.1 7.3 15.6 4.3 5.7 5.4 4.7 5.6 3.1 4.0 7.6 3.0 3.0 7.2 4.9 4.0 3.1 12.6 6.6 10.7 6.7 3.0 4.8 4.2 3.6 3.0 1.9 1.4 0.8 1.7 3.5 0.9 3.4 3.2 5.3 4.0 2.9 5.8 5.0 4.3 3.9 4.3 4.7 6.3 3.1 7.4 5.9 3.9 2.2 3.7 8.5 4.4 6.2 10.5 4.7 8.3 2.1 12.1 2.8 7.3 2.9 5.0 4.7 4.0 11.4 5.0 5.1 5.5 9.7 3.2 3.8 4.9 7.0 4.9 3.2 3.1 4.9 6.8 4.3 3.0 6.2 1.9 6.5 8.5 4.2 1.7 3.4 5.1 4.2 3.1 3.3 3.5 2.8 2.0 4.0 2.4 4.6 8.4 4.3 5.3 3.9 0.6 0.8 1.4 1.6 0.8 3.5 3.0 1.5 1.3 1.9 1.5 1.4 1.5 0.9 1.7 0.3 0.8 0.4 0.9 5.5 7.0 7.7 7.9 4.7 5.2 6.0 5.4 5.7 6.6 3.0 1.0 4.9 3.9 1.1 5.0 2.8 2.5 1.4 4.5 0.0 7.9 4.7 0.0 1.7 9.7 0.9 0.1 0.0 0.8 6.9 4.5 1.8 0.0 6.4 2.3 4.8 1.7 2.5 0.3 2.1 2.8 1.3 0.0 3.6 1.3 3.4 1.8 1.4 2.1 2.9 7.5 0.0 2.4 11.8 9.6 1.9 3.2 1.7 2.6 2.8 ZSCAN10 ZNF206 ENSG00000130182 "Zinc finger and SCAN domain containing 10" Q96SZ4 16 3088890-3099317 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 2.8;testis: 3.9" "Cell type enhanced" "Detected in single" 25 "Cytotrophoblasts: 1.5" "Cancer enriched" "Detected in single" 207 "testis cancer: 19.5" "Region enriched" "Detected in single" 7 "cerebellum: 2.7" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 9 "NTERA-2: 36.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA076826 Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA076826: " "unprognostic (4.37e-2)" "unprognostic (5.13e-2)" "unprognostic (9.15e-2)" "unprognostic (6.65e-3)" "unprognostic (6.24e-2)" "unprognostic (7.60e-2)" "unprognostic (3.24e-2)" "unprognostic (1.15e-1)" "unprognostic (1.72e-1)" "unprognostic (1.85e-11)" "unprognostic (5.98e-2)" "unprognostic (2.92e-2)" "unprognostic (1.79e-2)" 0.2 0.2 0.3 0.2 0.2 1.3 0.2 2.7 1.4 0.2 0.2 0.2 0.2 0.0 0.2 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.5 0.2 1.3 0.9 0.3 0.2 0.2 0.1 0.2 0.2 0.2 1.1 2.8 0.3 0.2 0.2 0.6 1.2 3.9 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.8 0.7 2.4 0.8 0.6 1.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 36.2 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.0 2.4 0.8 0.8 0.4 0.6 1.1 0.8 0.2 1.0 0.4 0.8 0.5 0.6 1.3 0.6 0.7 0.7 0.1 0.2 0.3 0.2 2.7 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 ZSCAN12 "dJ29K1.2, KIAA0426, ZFP96, ZNF29K1, ZNF305, ZNF96" ENSG00000158691 "Zinc finger and SCAN domain containing 12" O43309 6 28378955-28399734 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Club cells: 11.4;Early spermatids: 20.4;Spermatocytes: 11.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006637, HPA006732" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA006637: AB_1080646, HPA006732: " "unprognostic (1.44e-1)" "unprognostic (1.35e-1)" "unprognostic (2.22e-1)" "unprognostic (8.35e-4)" "unprognostic (1.51e-2)" "unprognostic (9.99e-2)" "unprognostic (1.00e-3)" "unprognostic (4.73e-2)" "unprognostic (9.96e-2)" "unprognostic (1.91e-2)" "unprognostic (2.35e-1)" "unprognostic (4.44e-2)" "unprognostic (1.71e-1)" "unprognostic (6.25e-3)" "unprognostic (2.69e-1)" "unprognostic (1.06e-1)" "unprognostic (8.71e-2)" 6.4 5.5 8.0 7.4 8.6 3.7 11.4 12.1 9.0 8.1 7.2 5.7 6.9 4.9 9.4 7.6 4.6 7.3 4.6 4.7 7.2 5.0 6.0 3.8 5.7 8.3 5.0 3.9 11.4 9.0 10.1 14.1 7.0 7.6 8.9 6.0 4.8 6.9 9.9 2.8 4.5 6.6 7.5 5.1 7.2 5.8 9.5 6.9 11.5 10.3 3.7 7.7 9.4 10.2 6.1 2.2 5.2 1.7 3.9 4.5 1.9 5.3 1.7 8.1 0.1 4.2 3.3 5.8 3.7 5.1 5.6 7.8 1.2 2.0 5.1 7.0 2.5 2.8 2.4 0.0 4.5 5.8 0.0 6.6 7.4 5.3 3.7 3.9 2.6 1.9 4.4 4.3 5.6 10.1 6.1 1.5 0.0 10.8 1.2 3.5 0.6 0.0 5.8 5.1 0.5 0.9 8.9 7.4 1.3 4.2 3.5 10.0 10.2 1.9 4.4 6.2 8.5 1.7 6.6 1.5 2.2 4.8 1.7 2.9 3.2 3.3 1.0 2.0 0.7 3.4 5.2 1.6 3.3 3.6 1.0 3.4 4.3 2.7 4.2 2.2 6.1 4.5 3.8 0.5 3.9 1.7 2.0 2.1 1.9 8.0 8.6 12.1 9.0 7.2 5.0 5.0 3.9 7.6 6.9 6.0 3.2 1.7 1.4 0.3 5.6 2.8 0.0 0.0 11.4 0.0 3.9 1.2 1.7 1.3 20.4 1.3 0.5 0.0 2.2 0.9 0.9 1.2 1.1 0.8 0.9 6.4 1.2 4.3 0.6 4.5 1.7 0.6 1.7 1.8 0.9 3.5 1.3 0.0 3.2 0.9 5.4 6.5 1.9 11.3 2.7 0.3 0.5 1.3 2.1 0.5 ZSCAN16 "dJ265C24.3, FLJ22191, ZNF392, ZNF435" ENSG00000196812 "Zinc finger and SCAN domain containing 16" Q9H4T2 6 28124560-28130082 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007290 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA007290: AB_1080721" "unprognostic (1.50e-1)" "prognostic favorable (5.73e-4)" "unprognostic (3.29e-2)" "unprognostic (8.93e-2)" "unprognostic (3.05e-3)" "unprognostic (1.00e-2)" "unprognostic (3.07e-2)" "prognostic favorable (3.19e-4)" "unprognostic (1.23e-2)" "prognostic favorable (1.14e-5)" "unprognostic (2.50e-1)" "unprognostic (1.98e-1)" "unprognostic (2.50e-1)" "unprognostic (1.55e-2)" "unprognostic (2.14e-1)" "unprognostic (3.37e-3)" "prognostic favorable (3.41e-5)" 5.3 6.7 7.6 7.8 8.9 3.5 9.3 26.4 7.7 5.4 9.0 5.5 12.7 11.0 6.0 9.6 6.1 5.4 6.3 3.7 6.9 5.4 9.5 6.9 6.2 11.3 8.0 5.9 4.6 8.3 11.2 11.9 2.8 7.8 7.5 12.0 4.3 10.4 9.9 5.1 8.8 13.0 6.2 10.1 13.4 9.1 3.2 9.3 11.7 7.5 4.2 11.2 7.2 5.4 10.0 11.0 30.5 6.3 9.9 10.7 4.8 0.0 7.2 9.3 6.8 2.6 0.6 7.6 2.5 5.3 6.6 7.1 5.0 4.7 7.1 6.7 2.3 4.6 5.6 6.4 3.6 6.2 10.2 8.9 7.4 5.8 6.9 4.1 5.4 6.3 0.8 6.1 5.5 3.0 7.0 12.0 0.2 1.0 6.1 1.7 7.9 0.0 8.6 1.9 6.0 4.4 8.8 7.1 9.8 7.7 10.2 12.6 13.9 1.2 7.7 8.7 6.3 10.1 2.6 3.7 2.5 5.7 3.7 6.4 3.1 9.8 1.9 1.1 2.7 1.3 30.5 4.9 5.4 8.1 6.3 10.7 10.0 7.2 6.2 5.0 8.1 8.8 7.1 8.9 9.9 6.1 11.0 7.7 4.8 7.6 8.9 26.4 7.7 6.9 5.4 8.0 5.9 7.8 9.3 6.0 1.6 1.4 0.6 1.5 3.8 1.4 5.1 9.4 4.5 7.0 3.9 2.0 5.0 10.1 2.5 3.5 5.6 0.0 11.1 1.0 0.7 0.9 2.3 1.8 1.8 1.6 1.7 3.1 4.6 0.9 0.6 4.0 1.7 5.4 4.7 3.1 8.2 6.8 3.2 5.8 5.5 0.0 1.1 0.7 5.1 1.1 1.5 8.2 7.7 0.6 ZSCAN18 "FLJ12895, ZNF447" ENSG00000121413 "Zinc finger and SCAN domain containing 18" Q8TBC5 19 58083838-58118427 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 49.8;SCLC-21H: 23.8" HPA024318 Supported Approved Nucleoplasm No No Nucleoplasm "HPA024318: AB_1859494" "unprognostic (1.85e-2)" "unprognostic (3.48e-2)" "unprognostic (7.07e-2)" "unprognostic (6.45e-3)" "unprognostic (1.28e-1)" "unprognostic (1.22e-2)" "unprognostic (1.54e-1)" "unprognostic (1.16e-1)" "unprognostic (2.24e-1)" "unprognostic (8.27e-2)" "unprognostic (2.59e-3)" "unprognostic (1.59e-1)" "prognostic favorable (3.95e-7)" "unprognostic (3.68e-2)" "unprognostic (7.23e-2)" "unprognostic (3.70e-1)" "unprognostic (9.04e-2)" 18.1 18.1 26.7 10.4 34.3 5.3 11.8 27.9 47.7 20.5 17.1 20.8 16.0 8.7 26.2 20.3 13.4 33.9 18.6 28.9 27.0 33.7 19.3 7.3 15.0 12.2 23.7 31.1 31.8 16.8 23.7 28.0 15.1 21.1 21.1 6.0 17.7 18.2 27.5 15.9 9.9 10.0 29.0 20.7 17.0 12.9 20.0 18.3 7.4 28.9 8.7 6.1 15.9 14.6 4.6 2.3 3.9 0.8 2.2 2.4 0.7 0.0 0.4 5.2 13.4 0.6 0.8 12.9 3.3 0.1 4.3 0.7 0.0 3.1 1.2 7.6 4.6 5.2 0.0 0.4 2.5 4.6 0.0 49.8 0.1 0.0 0.0 9.2 0.0 10.1 7.9 0.1 3.3 0.0 5.4 0.2 3.1 0.0 0.6 6.5 0.0 6.9 2.5 8.5 0.0 0.0 8.2 0.0 0.6 4.2 10.2 23.8 5.7 0.0 0.2 0.0 4.8 15.6 0.0 0.0 0.2 6.2 5.8 0.0 5.9 17.1 0.0 0.0 0.0 4.0 2.0 0.5 3.5 0.4 0.3 2.1 1.7 1.7 1.8 0.9 4.6 2.4 2.2 3.9 2.2 0.8 2.3 0.1 0.7 26.7 34.3 27.9 31.4 27.0 33.7 23.7 31.1 21.1 18.3 14.9 24.0 31.8 44.4 10.8 77.2 38.7 20.4 28.1 37.5 40.1 31.4 38.9 13.3 19.4 41.6 32.5 3.6 0.0 5.1 7.1 18.3 35.8 23.1 3.8 8.0 106.5 25.4 20.3 1.3 55.0 37.2 6.5 10.1 9.0 12.0 72.0 6.3 11.5 55.2 9.1 103.9 19.4 25.8 25.1 26.9 10.7 54.9 14.6 9.9 29.4 ZSCAN2 "FLJ20595, ZFP29, ZNF854" ENSG00000176371 "Zinc finger and SCAN domain containing 2" Q7Z7L9 15 84600986-84627796 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 36.9" "Cell type enhanced" "Detected in many" 4 "Proximal tubular cells: 14.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007296, HPA024331" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA007296: , HPA024331: AB_1859497" "unprognostic (4.05e-1)" "unprognostic (2.08e-1)" "unprognostic (9.49e-2)" "unprognostic (6.76e-2)" "unprognostic (7.84e-2)" "unprognostic (2.47e-2)" "unprognostic (3.58e-2)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (1.95e-1)" "prognostic favorable (3.52e-4)" "unprognostic (4.24e-1)" "prognostic favorable (7.46e-4)" "unprognostic (2.42e-2)" "unprognostic (3.53e-3)" "unprognostic (2.98e-1)" "prognostic favorable (4.16e-5)" 9.8 7.6 5.2 7.2 7.4 9.7 15.0 5.9 6.3 7.3 6.2 5.8 9.0 4.1 9.5 8.4 3.4 5.3 8.2 8.2 4.8 4.7 9.1 10.1 4.5 8.0 6.2 5.0 10.2 36.9 6.9 6.3 2.8 5.1 7.1 4.3 6.7 12.4 5.1 9.5 3.4 5.5 9.0 5.1 8.1 8.5 12.0 6.0 24.4 6.3 3.9 6.9 6.5 9.7 7.1 10.5 10.0 12.2 9.0 12.1 6.4 1.6 9.5 7.5 12.3 4.4 3.0 6.5 1.8 5.2 3.9 5.3 7.3 3.9 3.5 5.3 2.9 7.2 4.1 6.3 3.6 3.5 7.2 9.7 4.5 5.5 15.4 3.8 2.8 3.6 4.4 4.3 5.1 4.9 5.4 11.8 18.7 5.9 2.8 4.8 4.7 13.0 6.7 13.7 3.3 5.7 13.6 4.2 6.6 4.2 12.1 10.5 18.5 5.7 3.2 8.8 11.7 6.6 8.0 7.7 4.9 9.4 2.3 2.3 4.9 6.4 11.8 3.2 6.6 3.0 10.0 9.6 8.3 10.9 10.5 5.4 7.1 9.2 8.2 10.5 7.1 7.6 8.2 5.4 9.0 12.2 10.2 12.1 6.4 5.2 7.4 5.9 6.3 4.8 4.7 6.2 5.0 5.1 6.0 0.0 1.3 2.2 1.1 0.8 3.5 2.2 7.6 2.7 0.0 7.0 2.0 1.4 5.0 5.4 11.3 1.9 1.1 0.0 7.3 3.9 2.2 2.8 1.1 7.8 3.1 0.0 2.9 0.6 3.2 9.5 0.9 3.1 1.7 7.2 2.9 2.4 10.1 3.5 1.4 14.3 2.9 6.5 1.4 3.4 8.1 0.4 1.1 3.2 2.4 1.3 ZSCAN20 "KOX29, ZNF31, ZNF360" ENSG00000121903 "Zinc finger and SCAN domain containing 20" P17040 1 33472645-33496507 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 15.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017933 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA017933: AB_1859028" "unprognostic (1.52e-1)" "unprognostic (1.10e-2)" "unprognostic (1.27e-1)" "unprognostic (6.75e-3)" "unprognostic (9.28e-2)" "unprognostic (3.03e-3)" "unprognostic (1.77e-6)" "unprognostic (3.13e-1)" "unprognostic (6.94e-2)" "unprognostic (4.05e-2)" "unprognostic (2.96e-1)" "unprognostic (1.25e-1)" "unprognostic (1.53e-1)" "unprognostic (2.03e-1)" "unprognostic (2.92e-2)" "unprognostic (4.43e-2)" "unprognostic (1.74e-2)" 3.8 4.2 4.7 2.5 7.1 1.0 4.4 6.1 8.2 4.4 4.1 7.7 4.5 8.4 7.4 3.2 3.6 4.4 3.6 6.1 4.3 2.9 3.9 3.0 3.2 2.1 4.3 5.7 7.8 4.0 11.2 8.6 4.0 5.7 4.2 4.4 5.1 5.0 5.5 3.4 2.9 6.6 5.9 4.2 3.1 4.3 6.1 7.6 3.9 4.4 2.7 3.2 4.9 8.5 0.8 1.7 0.7 2.2 1.0 3.0 0.6 3.7 2.8 6.5 4.5 5.2 5.4 4.4 4.7 4.7 6.3 5.1 2.9 4.9 2.8 2.6 4.9 3.8 4.7 5.4 2.5 6.6 0.0 6.1 5.7 6.2 2.4 5.0 3.2 2.1 3.8 4.5 6.7 5.5 5.8 4.9 4.7 3.8 3.6 5.6 1.3 2.4 2.0 5.4 3.5 1.6 2.7 7.6 1.1 3.5 3.2 2.6 3.8 3.5 3.9 5.1 9.1 2.6 3.6 4.4 5.6 4.0 5.0 6.6 4.8 3.0 1.3 5.8 1.0 3.7 0.2 2.2 0.0 1.3 1.0 2.1 0.3 0.4 0.9 1.7 0.8 1.9 3.0 0.7 1.0 1.0 1.2 0.8 0.6 4.7 7.1 6.1 8.2 4.3 2.9 4.3 5.7 5.7 7.6 0.0 2.2 0.0 0.5 0.0 1.5 1.6 2.5 1.4 0.0 0.0 3.9 0.7 0.0 0.9 15.3 0.6 0.4 0.0 0.2 0.7 0.7 0.5 1.1 0.0 0.6 0.0 1.2 1.3 0.3 1.3 1.1 0.0 0.0 1.8 0.5 0.6 0.7 0.9 1.8 0.4 2.0 0.0 1.0 2.5 1.1 0.0 0.2 0.0 0.4 0.4 ZSCAN25 "FLJ32468, ZNF498" ENSG00000197037 "Zinc finger and SCAN domain containing 25" Q6NSZ9 7 99616946-99632407 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055127, HPA057173" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA055127: AB_2682706, HPA057173: AB_2683360" "unprognostic (2.21e-3)" "unprognostic (3.96e-2)" "unprognostic (4.45e-1)" "unprognostic (3.92e-2)" "unprognostic (5.89e-2)" "unprognostic (3.02e-2)" "unprognostic (1.08e-2)" "unprognostic (1.57e-3)" "unprognostic (3.97e-2)" "unprognostic (8.44e-2)" "unprognostic (3.82e-3)" "unprognostic (9.98e-2)" "unprognostic (1.10e-2)" "unprognostic (5.21e-2)" "unprognostic (2.12e-1)" "unprognostic (1.10e-1)" "unprognostic (7.19e-3)" 10.8 10.0 11.4 12.2 12.5 12.3 14.5 18.5 14.6 11.3 11.0 13.1 16.9 7.4 14.5 11.7 12.7 12.4 9.6 7.7 9.4 6.9 9.4 9.1 10.0 16.4 10.3 12.2 18.5 12.3 15.0 12.3 9.4 9.2 12.7 8.6 10.3 15.4 13.9 9.7 15.6 10.8 12.6 8.7 13.6 10.3 15.7 11.0 14.9 11.2 8.7 11.8 11.7 11.4 3.3 3.0 5.5 4.2 4.2 9.0 4.7 5.7 2.7 8.0 9.1 3.6 2.7 7.8 6.4 5.4 7.4 7.7 7.2 4.8 8.2 7.5 5.3 6.8 7.5 8.6 7.3 9.3 4.5 7.3 5.4 4.6 6.1 6.1 12.5 4.9 4.3 9.3 5.9 6.2 3.0 4.6 9.2 15.2 6.6 5.2 6.3 18.0 17.4 14.6 3.3 6.3 7.6 8.2 8.7 3.2 7.9 5.4 13.5 8.4 12.8 9.1 9.9 3.5 8.6 3.3 11.6 9.3 6.6 10.7 5.9 9.4 14.0 6.2 7.9 16.9 5.5 3.8 4.8 7.4 4.2 9.0 3.3 5.1 6.9 3.0 2.9 8.7 8.4 4.6 4.2 3.7 2.4 7.2 4.7 11.4 12.5 18.5 14.6 9.4 6.9 10.3 12.2 9.2 11.0 0.0 3.8 0.0 1.8 3.1 4.6 3.2 0.0 1.4 0.0 1.8 7.9 3.7 1.7 2.5 3.9 3.6 2.6 0.0 2.5 3.1 2.3 2.4 4.7 3.4 3.1 4.8 2.4 5.5 3.5 3.0 3.4 1.0 1.7 3.6 5.3 2.6 1.7 3.5 5.6 2.1 4.3 6.5 2.1 6.5 5.1 1.9 1.6 5.3 3.7 1.4 ZSCAN26 "SRE-ZBP, ZNF187" ENSG00000197062 "Zinc finger and SCAN domain containing 26" Q16670 6 28267010-28278224 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 19.4" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027521 Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA027521: AB_2672314" "unprognostic (1.07e-1)" "unprognostic (4.10e-1)" "unprognostic (1.95e-1)" "unprognostic (3.31e-2)" "unprognostic (1.38e-3)" "unprognostic (4.60e-3)" "prognostic unfavorable (7.81e-5)" "unprognostic (1.00e-2)" "unprognostic (1.16e-2)" "unprognostic (1.04e-2)" "unprognostic (2.49e-3)" "unprognostic (9.01e-2)" "prognostic unfavorable (6.79e-5)" "unprognostic (4.45e-2)" "unprognostic (1.44e-1)" "unprognostic (3.10e-1)" "prognostic favorable (1.68e-4)" 4.4 5.4 7.4 4.8 10.5 2.5 8.3 17.7 11.4 8.4 4.3 10.5 7.3 4.2 10.5 7.4 4.9 7.9 6.7 6.3 8.1 5.1 3.6 5.2 4.9 7.3 11.5 18.7 4.0 8.9 7.8 4.6 9.6 7.7 5.0 5.7 4.5 10.7 6.4 4.9 4.4 8.9 6.6 7.6 4.9 2.9 9.6 4.0 7.6 2.0 6.1 5.8 4.6 15.2 9.6 10.7 6.2 16.1 16.3 9.6 5.6 4.8 13.7 11.7 14.9 14.3 3.1 11.2 11.2 14.8 15.3 3.5 4.1 3.2 17.4 7.1 11.1 4.3 6.3 8.2 16.3 6.8 6.8 8.5 6.7 7.5 10.3 7.0 5.5 11.9 7.8 11.3 10.3 19.1 14.9 5.0 7.0 6.8 11.6 4.7 7.4 9.6 4.0 3.0 7.3 7.5 11.9 5.4 12.5 5.8 9.9 7.7 6.9 2.9 9.3 11.6 4.8 4.8 9.7 11.9 8.7 4.2 13.6 7.2 9.6 6.2 4.3 7.9 10.3 10.5 6.2 10.7 13.4 4.8 15.8 13.4 13.1 14.4 9.6 15.2 16.3 13.5 4.4 16.1 4.0 4.5 11.8 9.6 0.0 3.5 10.4 2.8 0.0 8.6 8.7 0.0 2.7 11.4 0.0 3.9 3.8 3.3 4.2 3.2 6.8 2.6 0.0 4.4 2.7 3.5 3.0 5.8 1.5 5.0 1.6 6.4 4.3 5.0 1.7 8.3 1.9 0.0 1.0 2.3 11.7 3.0 4.0 12.4 4.9 9.7 19.4 2.7 5.5 8.1 0.0 1.1 7.5 2.7 0.9 ZSCAN29 "FLJ35867, Zfp690, ZNF690" ENSG00000140265 "Zinc finger and SCAN domain containing 29" Q8IWY8 15 43358172-43371025 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 81.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 6.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007241, HPA011109" Enhanced Approved "Nucleoplasm,Plasma membrane,Actin filaments" NA NA Nucleoplasm "Plasma membrane, Actin filaments" "HPA007241: AB_10600420, HPA011109: AB_10611525" "unprognostic (3.90e-2)" "unprognostic (2.70e-1)" "unprognostic (1.15e-1)" "unprognostic (4.06e-2)" "unprognostic (2.21e-2)" "unprognostic (2.02e-2)" "unprognostic (1.57e-1)" "unprognostic (5.25e-1)" "unprognostic (2.12e-2)" "unprognostic (4.77e-3)" "unprognostic (1.64e-1)" "unprognostic (1.44e-3)" "unprognostic (9.61e-2)" "unprognostic (1.30e-1)" "unprognostic (1.31e-1)" "unprognostic (8.33e-2)" "unprognostic (3.43e-2)" 8.3 8.9 13.5 14.2 14.2 6.6 9.4 15.9 15.2 11.0 9.8 12.1 9.3 11.8 12.6 12.5 11.0 9.6 11.9 7.2 14.7 8.0 8.1 10.3 9.2 13.2 19.1 12.0 10.7 15.4 12.5 13.9 13.0 15.4 9.7 10.5 7.9 11.2 9.5 13.6 7.7 13.0 9.0 13.3 11.9 11.8 20.9 15.0 16.8 11.1 9.4 13.7 11.0 12.5 2.1 1.0 6.9 1.0 2.3 1.9 0.6 7.6 8.4 19.8 12.2 7.0 7.4 10.7 6.0 9.4 10.7 11.2 13.0 5.5 7.5 10.1 7.4 8.6 22.7 14.5 7.4 9.7 19.4 8.0 16.5 12.6 10.1 7.8 11.2 14.5 6.5 13.0 7.2 10.3 7.6 5.4 11.7 15.3 9.2 8.6 4.8 10.8 9.3 9.9 11.3 6.5 16.8 11.0 9.1 6.2 9.3 14.1 15.3 9.3 15.3 7.1 10.4 10.7 17.6 6.0 12.6 10.0 9.5 10.8 17.7 24.4 14.5 7.4 11.2 9.5 1.1 0.7 6.9 1.2 1.0 1.0 2.1 1.2 0.8 1.0 1.6 0.6 1.7 1.8 2.3 0.8 0.9 1.9 0.6 13.5 14.2 15.9 15.2 14.7 8.0 19.1 12.0 15.4 15.0 6.0 9.3 2.9 2.3 3.2 8.7 6.7 2.5 5.3 10.3 7.0 25.5 4.4 0.0 5.2 81.1 2.9 7.8 0.0 6.2 3.7 4.1 3.3 0.0 6.0 4.9 12.7 5.8 4.3 9.7 13.8 6.4 4.1 5.0 3.6 7.8 5.4 7.6 5.8 5.6 2.1 18.7 0.0 2.9 9.9 6.4 2.8 3.2 4.3 6.8 1.8 ZSCAN30 "ZNF397OS, ZNF917" ENSG00000186814 "Zinc finger and SCAN domain containing 30" Q86W11 18 35251058-35290245 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 28.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007289 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA007289: AB_1079726" "unprognostic (6.02e-3)" "unprognostic (1.15e-1)" "unprognostic (1.34e-1)" "unprognostic (1.18e-1)" "unprognostic (8.94e-2)" "unprognostic (3.56e-3)" "unprognostic (7.02e-3)" "unprognostic (3.05e-3)" "unprognostic (1.11e-1)" "unprognostic (1.39e-1)" "unprognostic (3.05e-3)" "unprognostic (2.78e-3)" "unprognostic (8.27e-3)" "unprognostic (1.15e-1)" "unprognostic (8.44e-3)" "unprognostic (8.75e-2)" "unprognostic (1.36e-1)" 9.4 14.4 11.8 9.2 19.1 7.9 12.2 23.0 19.9 9.4 8.9 20.9 9.8 10.1 14.2 13.9 6.7 10.3 10.4 16.4 12.2 10.6 12.1 8.7 10.3 12.4 11.8 12.8 10.7 9.7 19.8 27.3 9.6 14.7 11.1 8.4 12.8 9.2 9.4 15.4 11.7 12.8 9.4 15.0 12.1 10.0 10.5 15.0 13.0 15.2 6.8 9.4 8.6 8.2 7.7 5.4 4.8 1.9 4.0 5.6 2.5 4.4 1.2 10.1 13.3 6.8 13.5 6.9 8.6 11.5 5.0 9.9 3.6 5.5 8.0 5.7 9.1 8.5 3.1 4.7 9.0 13.6 8.0 2.7 5.2 5.7 2.5 7.1 4.4 5.2 8.7 7.1 13.5 11.4 13.2 9.1 11.4 8.3 9.6 13.1 2.0 6.4 7.3 6.5 1.3 4.2 9.5 3.3 5.8 7.6 3.0 14.2 7.4 8.5 2.7 3.6 10.8 4.2 5.9 11.4 18.1 3.9 2.8 3.4 17.1 7.3 7.1 13.7 4.9 10.2 2.4 1.3 4.4 4.6 1.6 3.0 5.3 4.2 2.7 2.2 7.7 5.0 5.6 4.8 4.0 1.9 5.4 3.7 2.5 11.8 19.1 23.0 19.9 12.2 10.6 11.8 12.8 14.7 15.0 8.9 5.4 1.5 1.7 1.5 28.2 11.2 7.6 6.7 13.6 1.8 19.6 2.9 5.0 3.4 8.3 6.7 3.2 0.0 3.0 1.2 3.1 2.1 8.1 4.3 2.2 19.1 6.9 9.8 4.8 6.5 5.5 2.0 0.0 1.0 3.6 13.6 3.2 4.2 7.4 3.8 18.6 0.0 2.4 10.7 5.2 0.9 1.5 4.9 3.6 1.7 ZSCAN31 "ZNF310P, ZNF323" ENSG00000235109 "Zinc finger and SCAN domain containing 31" Q96LW9 6 28324693-28356271 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 17 "Alveolar cells type 1: 26.8;Early spermatids: 114.2;Late spermatids: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 13.4" "Lineage enriched" "Detected in many" 6 "granulocytes: 13.4" "Cell line enhanced" "Detected in many" "CAPAN-2: 15.7;EFO-21: 21.8;TIME: 16.3;U-2 OS: 26.6" "Low region specificity" "Detected in all" HPA007124 Approved Approved Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA007124: AB_1080703" "unprognostic (1.11e-1)" "unprognostic (4.23e-2)" "unprognostic (3.54e-3)" "unprognostic (1.68e-1)" "unprognostic (2.45e-3)" "unprognostic (6.90e-2)" "unprognostic (2.77e-1)" "unprognostic (1.29e-2)" "unprognostic (2.41e-2)" "unprognostic (4.96e-2)" "unprognostic (6.07e-2)" "unprognostic (5.10e-2)" "prognostic favorable (2.19e-5)" "unprognostic (8.43e-3)" "unprognostic (6.22e-2)" "unprognostic (1.19e-1)" "unprognostic (5.64e-2)" 5.2 4.0 11.3 2.2 12.1 3.5 11.2 36.4 27.6 8.0 9.9 3.6 5.9 3.2 16.3 8.4 9.9 6.8 15.5 6.4 8.0 3.8 5.2 4.5 8.7 1.9 16.7 5.6 17.7 8.1 4.8 8.3 2.3 14.9 7.1 5.1 3.5 6.5 8.3 7.0 11.0 3.5 10.7 21.9 2.1 13.3 18.4 11.8 0.6 21.0 5.6 3.1 7.3 6.9 1.5 2.0 13.4 0.3 1.4 1.5 0.3 1.0 1.4 2.2 10.3 0.3 0.5 3.3 0.5 0.6 0.5 0.4 1.3 15.7 0.2 21.8 0.7 3.2 3.3 1.1 0.9 0.3 1.8 0.9 3.6 8.1 2.4 0.9 7.3 4.5 0.3 8.7 0.6 0.9 1.0 14.9 2.8 3.9 2.8 2.3 1.5 1.2 1.7 0.7 0.7 6.4 3.2 2.0 1.9 1.5 1.3 7.3 2.0 13.9 9.0 2.0 1.7 4.5 2.5 16.3 3.3 26.6 0.7 1.2 1.1 1.6 0.2 0.4 3.5 0.7 13.4 0.3 0.6 1.5 0.2 1.3 1.5 1.2 1.2 0.3 1.3 1.0 1.5 0.3 1.4 0.3 2.0 0.2 0.3 11.3 12.1 36.4 27.6 8.0 3.8 16.7 5.6 14.9 11.8 26.8 3.5 0.0 2.2 0.7 6.5 6.1 5.1 2.7 12.5 3.5 0.0 1.8 6.6 2.4 114.2 4.5 1.6 0.0 7.1 0.8 1.5 1.7 2.3 3.9 0.6 1.6 5.8 2.5 0.3 52.0 3.4 1.1 1.7 1.0 2.2 7.3 4.0 3.5 4.9 4.2 4.9 6.5 1.7 2.3 2.5 1.9 0.7 1.5 2.3 1.3 ZSCAN32 "FLJ20417, ZNF434" ENSG00000140987 "Zinc finger and SCAN domain containing 32" Q9NX65 16 3382081-3401065 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 17.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA005758 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005758: AB_1080720" "unprognostic (5.05e-2)" "unprognostic (2.64e-1)" "unprognostic (1.46e-2)" "unprognostic (6.04e-2)" "unprognostic (2.84e-2)" "unprognostic (2.38e-3)" "unprognostic (7.72e-2)" "unprognostic (9.40e-2)" "unprognostic (2.19e-1)" "unprognostic (4.73e-2)" "unprognostic (3.20e-1)" "unprognostic (1.54e-2)" "unprognostic (1.13e-3)" "unprognostic (6.04e-2)" "unprognostic (1.74e-1)" "unprognostic (1.18e-3)" "unprognostic (9.71e-2)" 7.4 10.0 12.0 11.1 19.7 4.7 9.2 12.0 11.9 9.5 9.0 12.5 5.5 11.6 10.8 7.2 7.5 10.6 9.9 8.0 11.5 10.3 9.3 8.3 9.2 11.2 19.3 7.3 12.4 9.8 14.3 13.2 8.0 14.1 9.5 9.0 8.3 7.2 11.7 5.6 8.3 12.4 9.1 14.1 10.1 8.7 11.1 16.1 13.9 10.9 5.9 13.7 8.9 7.0 8.2 5.1 6.9 12.2 16.3 10.4 6.0 4.7 7.4 10.9 12.9 8.6 8.7 7.7 6.1 10.7 8.7 8.3 3.6 6.7 15.6 6.5 8.6 4.8 4.3 8.6 8.8 9.9 9.9 6.3 13.9 6.5 5.4 11.1 9.4 10.1 8.5 14.6 8.1 14.7 9.0 8.1 17.1 13.1 5.7 11.5 5.4 12.3 6.4 11.2 8.3 4.3 13.1 11.7 13.4 7.5 5.2 8.7 6.8 11.5 7.7 5.0 6.6 8.2 11.2 10.6 6.5 6.8 5.7 7.0 10.1 11.4 19.3 2.4 7.5 10.6 4.9 4.9 6.9 10.4 4.3 8.8 8.2 7.2 6.6 4.6 7.4 9.8 8.8 6.0 16.3 12.2 5.1 9.4 6.0 12.0 19.7 12.0 11.9 11.5 10.3 19.3 7.3 14.1 16.1 17.9 4.0 4.4 1.9 2.1 4.5 0.8 7.6 1.4 9.1 1.8 7.9 3.6 10.0 4.3 1.4 2.7 2.5 0.0 5.3 2.5 2.3 3.2 4.7 3.0 2.5 7.9 0.0 2.5 3.5 0.7 4.0 2.2 1.7 5.4 3.0 4.8 4.9 2.9 4.9 4.1 4.4 0.0 1.9 7.1 13.4 2.5 2.2 7.5 2.5 1.3 ZSCAN9 "PRD51, ZNF193" ENSG00000137185 "Zinc finger and SCAN domain containing 9" O15535 6 28224886-28233482 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA054512, HPA059951" Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA054512: AB_2682511, HPA059951: AB_2684176" "unprognostic (1.67e-1)" "unprognostic (5.32e-2)" "unprognostic (2.68e-1)" "unprognostic (2.04e-1)" "unprognostic (1.32e-2)" "unprognostic (5.24e-3)" "prognostic unfavorable (3.49e-4)" "unprognostic (5.69e-2)" "unprognostic (4.53e-2)" "unprognostic (3.18e-2)" "unprognostic (1.55e-2)" "unprognostic (6.14e-3)" "prognostic unfavorable (1.21e-6)" "unprognostic (1.74e-2)" "unprognostic (1.51e-2)" "unprognostic (2.51e-1)" "prognostic favorable (1.16e-5)" 12.2 11.0 7.9 12.7 11.9 10.1 16.1 21.2 13.1 17.2 12.7 14.8 13.0 10.2 22.7 15.9 10.4 11.4 14.2 10.2 8.2 9.6 13.0 9.3 10.6 10.5 10.2 7.1 16.0 12.5 13.6 22.4 12.6 11.2 15.8 17.4 12.9 12.3 14.6 8.9 6.9 14.5 17.9 11.9 16.8 11.7 20.1 13.5 4.1 14.5 7.4 11.1 12.2 16.7 5.7 5.6 5.6 4.0 13.0 4.4 2.6 6.8 4.6 16.3 19.3 6.4 6.9 6.0 8.4 7.1 8.1 9.3 4.3 3.5 0.0 12.8 5.3 8.2 4.8 7.9 7.7 9.5 4.5 6.7 10.5 9.3 7.9 8.1 12.3 8.7 5.8 12.2 6.9 10.6 12.6 10.5 0.0 15.5 5.8 12.0 4.0 0.0 20.2 6.0 3.0 5.4 6.4 11.4 7.1 10.2 9.7 14.1 19.4 7.4 5.7 10.0 12.7 6.9 8.4 8.8 16.9 11.7 3.9 14.4 13.2 13.3 2.8 3.5 15.2 9.6 4.8 4.0 5.6 4.4 2.0 3.4 5.7 1.5 3.2 5.6 5.2 0.5 0.9 1.6 13.0 0.9 2.9 1.1 2.6 7.9 11.9 21.2 13.1 8.2 9.6 10.2 7.1 11.2 13.5 8.9 2.2 3.2 4.4 0.8 6.6 3.4 12.7 5.3 12.5 3.5 0.0 3.9 1.7 7.6 14.8 3.6 3.5 0.0 5.5 2.9 3.5 3.6 5.7 1.7 4.5 6.4 5.2 3.7 5.7 2.5 3.4 4.9 3.3 1.8 5.9 4.5 5.2 5.8 4.6 3.7 5.5 6.5 5.0 19.1 12.3 1.0 10.1 2.2 7.0 2.0 ZSWIM9 "C19orf68, LOC374920" ENSG00000185453 "Zinc finger SWIM-type containing 9" Q86XI8 19 48170692-48197620 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 5 "Alveolar cells type 2: 4.3;Cytotrophoblasts: 4.5;Exocrine glandular cells: 5.0;Hofbauer cells: 4.3;Pancreatic endocrine cells: 4.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061028 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA061028: AB_2684419" "unprognostic (1.59e-1)" "unprognostic (2.76e-1)" "unprognostic (5.79e-3)" "unprognostic (1.65e-1)" "unprognostic (8.49e-3)" "unprognostic (1.65e-2)" "prognostic unfavorable (2.35e-5)" "unprognostic (1.26e-1)" "unprognostic (2.93e-1)" "unprognostic (6.96e-2)" "unprognostic (3.19e-3)" "unprognostic (2.20e-2)" "prognostic favorable (2.44e-4)" "unprognostic (3.59e-1)" "unprognostic (2.64e-1)" "unprognostic (7.07e-2)" "unprognostic (1.03e-1)" 6.8 3.9 11.6 4.2 15.5 4.3 9.8 5.7 10.0 6.0 4.4 8.1 4.5 4.6 9.6 2.0 6.5 4.2 5.5 5.1 10.1 10.2 4.5 3.3 3.8 4.7 9.9 4.8 8.1 5.0 6.2 2.8 3.6 6.6 4.7 2.8 3.9 5.9 5.6 16.2 5.3 5.0 11.1 7.6 5.4 4.2 3.2 6.0 1.2 5.2 1.5 4.2 6.1 8.6 1.2 0.4 0.5 0.4 0.2 1.6 0.1 9.3 10.5 6.3 4.7 4.1 2.3 5.7 7.3 3.9 3.4 3.9 1.7 3.0 7.6 3.5 3.4 4.3 7.8 2.1 4.4 3.8 11.3 7.8 4.8 6.7 4.3 4.4 4.2 4.0 2.5 3.6 5.0 6.0 6.1 3.4 6.1 1.1 4.1 2.2 5.0 4.6 18.2 3.9 8.8 6.7 8.8 5.6 2.0 2.3 7.7 4.4 5.4 10.1 3.2 4.8 4.0 4.4 6.6 8.7 4.0 7.4 3.4 7.9 6.8 6.8 4.6 2.4 6.2 5.2 0.1 0.4 0.1 0.9 0.4 0.2 1.2 0.4 1.6 0.3 0.4 1.0 0.6 0.5 0.2 0.4 0.4 0.0 0.1 11.6 15.5 5.7 9.6 10.1 10.2 9.9 4.8 6.6 6.0 3.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 3.5 0.0 4.5 3.3 3.8 0.0 0.0 0.0 0.0 5.0 2.3 0.0 0.0 2.3 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.0 0.0 4.5 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 ZUFSP "C6orf113, dJ412I7.3" ENSG00000153975 "Zinc finger with UFM1 specific peptidase domain" Q96AP4 6 116635618-116668794 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044426 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044426: AB_10960887" "unprognostic (2.28e-3)" "unprognostic (2.45e-3)" "unprognostic (3.91e-2)" "unprognostic (2.17e-1)" "unprognostic (1.33e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (3.27e-1)" "unprognostic (5.88e-2)" "unprognostic (2.83e-1)" "unprognostic (1.95e-1)" "unprognostic (2.41e-1)" "unprognostic (1.90e-3)" "unprognostic (2.54e-2)" "unprognostic (1.48e-1)" "unprognostic (7.33e-2)" "unprognostic (7.92e-3)" 8.0 8.4 8.8 9.7 14.1 19.0 9.7 18.8 14.4 7.2 10.3 7.3 5.1 16.5 7.3 7.3 11.0 6.7 9.0 5.4 10.5 8.7 9.3 11.9 10.2 12.8 14.3 8.0 5.6 9.7 6.0 18.1 8.5 11.3 8.6 9.8 5.2 8.2 7.3 6.2 10.3 13.5 6.8 10.5 12.3 8.4 9.5 11.5 15.4 7.6 7.5 13.9 8.9 8.2 11.1 11.1 17.3 11.5 9.2 12.6 7.1 4.5 4.4 10.6 19.0 6.1 8.1 7.7 10.2 9.7 10.2 12.1 7.5 5.3 16.5 8.5 6.3 11.7 7.6 12.0 7.0 13.6 9.6 12.3 12.6 6.4 13.8 9.4 14.9 15.5 7.1 11.9 8.0 14.2 7.8 8.9 12.8 22.3 8.6 13.3 7.1 7.5 11.4 7.6 7.3 4.9 9.9 8.9 6.9 11.1 4.8 8.8 10.0 7.0 6.2 6.2 9.5 3.8 11.6 7.0 6.4 4.3 3.7 8.9 7.9 10.1 16.7 5.8 9.0 9.4 17.3 8.5 8.4 8.4 9.9 9.7 11.1 9.3 9.5 11.1 10.3 10.7 7.8 3.3 9.2 11.5 7.9 12.6 7.1 8.8 14.1 18.8 14.4 10.5 8.7 14.3 8.0 11.3 11.5 6.0 3.4 2.4 12.4 11.0 8.7 0.0 5.1 8.1 7.9 0.0 7.9 9.2 0.0 0.0 1.6 5.8 6.0 0.0 0.0 7.3 6.5 10.1 10.3 5.9 6.6 11.1 5.8 3.1 6.0 0.8 2.0 10.5 1.7 0.0 5.8 9.4 0.0 6.5 1.8 0.0 7.8 0.0 7.1 15.0 18.3 12.0 7.8 10.2 5.5 11.6 ZWINT "KNTC2AP, SIP30, Zwint1" ENSG00000122952 "ZW10 interacting kinetochore protein" O95229 10 56357228-56361275 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 35.6;testis: 37.1" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 87.4;Late spermatids: 149.1;Spermatocytes: 124.1;Spermatogonia: 125.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 15.2" "Lineage enriched" "Detected in many" 5 "T-cells: 15.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA005757, HPA022264" Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" No Yes "Nucleoplasm, Nuclear bodies" Cytosol "HPA005757: AB_10600224, HPA022264: AB_10600995" "unprognostic (5.59e-2)" "unprognostic (1.71e-2)" "unprognostic (2.33e-1)" "unprognostic (1.06e-2)" "unprognostic (9.38e-2)" "unprognostic (6.58e-2)" "prognostic unfavorable (1.77e-8)" "unprognostic (6.36e-3)" "unprognostic (5.88e-2)" "unprognostic (1.45e-2)" "unprognostic (1.58e-3)" "unprognostic (1.86e-2)" "prognostic unfavorable (3.72e-12)" "unprognostic (1.40e-2)" "unprognostic (1.48e-1)" "unprognostic (5.47e-2)" "unprognostic (3.46e-1)" 1.7 3.5 3.4 14.6 3.1 18.4 3.0 0.9 2.8 3.3 9.4 1.3 2.1 6.8 2.0 4.5 14.1 1.1 6.3 1.6 2.7 1.8 4.6 2.9 2.6 12.8 2.4 3.4 1.7 2.8 2.8 1.9 7.3 1.9 1.8 11.8 1.5 4.2 1.4 0.9 5.2 8.8 3.1 2.5 9.0 6.2 37.1 0.7 35.6 1.9 12.7 17.2 3.1 4.6 1.6 1.3 0.6 2.6 2.9 15.2 3.0 39.9 31.8 22.7 25.2 1.6 2.3 18.5 29.5 22.3 35.7 32.5 56.2 24.0 20.6 11.3 10.1 16.7 20.6 31.8 22.2 33.3 52.3 16.6 20.5 25.6 26.0 0.1 33.8 27.6 1.1 1.4 33.2 13.7 4.4 17.9 27.7 27.7 25.3 31.3 32.3 29.8 21.4 16.1 27.5 39.3 30.5 44.1 11.0 11.1 17.9 21.1 12.9 27.9 63.5 7.4 13.7 41.1 33.1 9.7 15.6 40.3 16.1 45.1 22.3 10.7 35.8 22.1 42.6 19.6 0.0 0.7 0.6 2.2 2.6 0.3 1.6 5.3 3.6 1.3 0.3 6.4 3.6 0.0 2.9 2.0 1.0 15.2 3.0 3.4 3.1 0.9 2.8 2.7 1.8 2.4 3.4 1.9 0.7 3.0 1.7 4.5 4.8 16.4 1.3 0.8 5.1 1.4 3.4 5.2 0.0 36.2 0.0 9.4 58.5 2.3 7.0 46.7 11.7 87.4 2.8 1.3 0.0 3.4 41.1 0.0 0.0 9.8 8.3 149.1 4.6 7.4 6.8 2.8 11.6 1.2 6.7 11.8 2.5 4.6 1.1 0.0 0.9 124.1 125.8 7.2 19.3 7.9 22.7 2.0 ZXDA ZNF896 ENSG00000198205 "Zinc finger, X-linked, duplicated A" P98168 X 57906708-57910820 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 8.2" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA043789 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA043789: AB_2678673" "unprognostic (1.53e-1)" "unprognostic (3.71e-1)" "unprognostic (1.01e-1)" "unprognostic (3.61e-3)" "unprognostic (1.65e-1)" "unprognostic (2.30e-1)" "unprognostic (1.42e-1)" "unprognostic (4.22e-3)" "unprognostic (1.05e-1)" "unprognostic (3.87e-1)" "unprognostic (6.85e-3)" "unprognostic (6.50e-2)" "prognostic favorable (8.55e-4)" "unprognostic (1.03e-1)" "unprognostic (1.94e-1)" "unprognostic (1.15e-1)" "unprognostic (3.27e-2)" 3.5 2.5 1.9 1.4 2.4 3.1 3.5 2.8 2.9 3.3 2.2 1.1 3.6 2.1 1.5 4.3 2.1 2.4 1.9 2.2 2.3 1.6 2.0 3.1 1.6 6.3 3.3 3.7 2.4 0.7 3.3 1.4 2.6 2.9 3.4 2.9 2.4 2.6 1.9 3.5 2.8 0.5 3.6 2.8 2.9 2.4 0.9 0.4 0.0 0.2 1.7 2.3 0.2 2.8 2.5 0.8 3.0 3.0 4.6 2.1 1.6 3.0 2.2 2.5 0.5 2.3 6.3 4.3 4.3 2.5 2.6 3.0 4.0 1.9 5.0 4.7 0.8 2.4 0.0 5.1 0.0 0.3 3.7 6.8 3.3 6.6 3.7 3.7 3.8 0.9 0.2 4.2 2.2 3.1 1.1 3.3 0.6 2.3 3.3 2.4 1.9 1.7 2.4 0.4 2.8 3.6 2.5 2.4 4.2 3.5 2.2 3.0 3.8 8.3 1.1 1.8 0.0 0.0 3.3 2.5 2.7 2.3 0.0 0.2 0.0 2.3 0.2 0.8 0.2 0.6 1.0 0.2 0.9 1.5 0.2 0.0 1.7 0.2 0.4 1.3 0.2 0.0 0.3 1.5 4.2 8.2 2.4 1.3 2.5 1.4 1.2 1.8 3.9 0.7 0.0 1.4 0.0 2.3 0.4 0.0 0.7 0.6 1.3 1.8 1.1 0.8 1.0 3.2 1.2 1.3 1.5 0.0 2.3 1.0 3.3 1.0 1.2 1.3 0.9 0.0 1.1 1.3 2.1 0.0 2.2 0.0 0.3 5.6 0.7 0.0 1.2 2.2 ZXDB ZNF905 ENSG00000198455 "Zinc finger, X-linked, duplicated B" P98169 X 57591652-57597545 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 28.2;Suprabasal keratinocytes: 33.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 24.7" HPA043789 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA043789: AB_2678673" "unprognostic (1.87e-1)" "unprognostic (3.22e-1)" "unprognostic (1.88e-1)" "unprognostic (8.61e-3)" "unprognostic (4.29e-2)" "unprognostic (2.80e-1)" "unprognostic (7.15e-2)" "unprognostic (1.98e-1)" "unprognostic (4.36e-1)" "unprognostic (9.04e-2)" "unprognostic (6.73e-2)" "unprognostic (2.16e-2)" "unprognostic (1.17e-3)" "unprognostic (1.43e-1)" "unprognostic (2.38e-1)" "unprognostic (4.02e-3)" "unprognostic (2.87e-3)" 2.6 2.1 2.4 1.9 3.0 5.1 3.4 6.3 3.4 3.5 2.5 1.6 4.0 2.0 2.1 4.1 2.8 2.3 2.4 3.2 2.4 11.2 2.3 2.9 2.3 4.5 4.3 5.3 1.9 1.4 3.6 2.5 2.8 3.1 3.6 3.9 2.9 4.2 2.4 2.9 3.2 0.5 3.8 2.9 4.1 2.3 1.3 1.3 0.0 0.6 0.5 2.4 0.3 3.7 4.4 2.9 3.9 5.0 4.9 4.0 2.7 3.3 2.2 2.3 1.8 2.7 3.2 4.0 4.8 3.6 4.2 8.3 14.2 4.3 8.0 4.5 1.8 5.8 5.0 6.4 3.0 2.0 4.3 24.7 5.6 15.3 4.8 6.6 3.6 2.0 3.5 5.9 2.6 2.6 2.5 11.6 1.5 5.6 3.4 10.6 1.8 3.0 6.0 2.4 4.6 5.4 3.9 4.1 6.8 4.0 3.4 5.7 4.8 9.5 4.1 2.7 0.0 1.4 4.4 3.4 2.6 2.2 0.0 0.3 0.0 1.5 0.5 1.3 1.3 1.1 2.4 0.4 1.2 2.1 1.1 0.0 0.5 0.6 1.3 0.9 0.3 6.0 1.6 5.2 9.6 28.2 3.9 5.3 10.2 2.7 3.4 1.8 0.0 1.9 3.3 2.4 0.0 3.6 2.3 0.0 3.0 1.2 5.0 10.9 0.0 11.4 1.0 6.4 0.0 3.7 2.7 0.0 4.6 1.5 6.8 1.8 6.1 1.2 3.1 0.0 5.3 2.8 2.9 0.0 3.8 0.0 0.0 33.2 2.4 2.2 3.7 12.4 ZYG11A ZYG11 ENSG00000203995 "Zyg-11 family member A, cell cycle regulator" Q6WRX3 1 52842511-52894998 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 21.2;thyroid gland: 8.1" "Cell type enhanced" "Detected in some" 18 "Glandular cells: 1.7;Spermatocytes: 3.4;Spermatogonia: 6.9" "Cancer enriched" "Detected in many" 7 "testis cancer: 11.1" "Region enhanced" "Detected in single" "pons and medulla: 2.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 10.6;hTEC/SVTERT24-B: 10.3;K-562: 9.9;SiHa: 10.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030378, HPA030379" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA030378: AB_10604159, HPA030379: AB_2673451" "unprognostic (7.94e-2)" "unprognostic (6.71e-3)" "unprognostic (1.04e-2)" "unprognostic (4.06e-3)" "unprognostic (1.59e-2)" "unprognostic (1.00e-4)" "unprognostic (1.87e-1)" "unprognostic (2.34e-1)" "unprognostic (4.56e-2)" "unprognostic (2.06e-2)" "unprognostic (4.01e-2)" "unprognostic (1.01e-1)" "unprognostic (6.15e-3)" "unprognostic (2.95e-1)" "unprognostic (1.21e-1)" "unprognostic (3.07e-1)" "unprognostic (1.02e-1)" 0.3 0.1 0.2 3.0 0.2 0.4 1.4 0.7 0.1 0.6 0.2 0.1 0.8 0.4 0.1 3.0 1.7 0.1 0.4 0.9 0.1 0.3 6.4 3.1 0.1 1.0 0.1 0.0 0.6 0.3 0.6 0.5 1.0 2.2 1.7 0.2 1.0 0.5 0.0 0.3 0.6 0.3 0.5 1.3 0.3 0.1 21.2 0.0 0.9 8.1 1.3 5.6 0.5 1.1 1.0 0.8 3.1 0.6 0.9 0.7 0.2 0.0 1.9 0.3 0.0 0.0 0.0 4.4 1.2 1.3 5.7 4.6 0.1 0.1 0.0 3.0 1.7 0.0 0.1 3.8 0.1 6.8 0.3 7.3 0.0 10.6 0.0 2.8 0.0 0.9 0.0 0.3 10.3 0.1 0.3 1.3 0.1 9.9 5.5 0.2 5.3 0.0 5.3 1.4 0.0 1.0 0.0 1.3 4.7 3.6 0.2 1.5 2.2 10.3 0.5 0.0 4.6 5.8 2.9 0.1 0.0 0.1 0.0 0.0 2.8 4.5 0.1 0.0 0.1 0.8 1.8 0.6 0.8 0.5 0.3 0.3 0.7 0.5 0.5 0.1 1.0 0.6 0.7 3.1 0.9 0.3 0.8 0.4 0.2 0.2 0.2 0.7 0.1 0.1 0.3 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.2 1.7 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 1.3 0.0 0.0 3.4 6.9 0.1 0.2 0.0 0.0 0.3 ZZEF1 "FLJ10821, KIAA0399, ZZZ4" ENSG00000074755 "Zinc finger ZZ-type and EF-hand domain containing 1" O43149 17 4004445-4143020 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 92.3;Enterocytes: 92.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031778, HPA031790" Uncertain Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA031778: AB_10599831, HPA031790: AB_10600999" "unprognostic (4.48e-2)" "unprognostic (7.59e-2)" "unprognostic (6.75e-2)" "unprognostic (2.39e-2)" "unprognostic (1.43e-1)" "prognostic favorable (1.02e-4)" "unprognostic (2.80e-1)" "unprognostic (1.44e-2)" "unprognostic (1.23e-1)" "unprognostic (2.21e-2)" "prognostic favorable (6.08e-4)" "unprognostic (1.54e-1)" "unprognostic (1.38e-3)" "unprognostic (6.09e-3)" "unprognostic (1.80e-1)" "unprognostic (9.43e-2)" "unprognostic (6.46e-2)" 11.3 11.7 8.0 13.5 10.2 21.1 10.5 14.4 14.3 11.3 23.8 17.5 9.2 17.7 11.6 11.0 12.8 9.9 11.1 10.7 7.7 7.7 8.8 9.6 12.1 15.6 8.3 8.4 12.0 15.3 18.0 12.6 13.1 11.3 11.4 17.3 17.6 10.1 11.8 37.7 13.9 42.4 10.9 7.5 16.1 12.8 8.1 9.7 22.5 12.1 6.5 14.2 12.4 9.8 1.5 1.8 3.8 3.4 1.1 4.2 1.5 10.5 16.5 6.0 8.1 15.0 8.5 7.2 9.2 11.6 10.8 10.5 8.1 3.7 10.1 6.2 12.3 7.2 12.1 12.0 6.3 11.0 11.7 12.5 9.6 13.3 5.3 10.2 8.1 19.2 10.9 8.5 10.6 12.5 5.6 13.8 10.2 7.0 10.3 6.7 7.2 10.1 4.8 3.6 10.2 6.4 11.3 7.3 4.3 6.1 10.9 4.7 7.0 10.4 6.5 8.9 6.2 6.4 6.2 16.2 9.5 4.8 11.8 12.0 4.5 2.4 5.2 9.5 7.3 8.8 2.8 2.3 2.3 3.2 3.2 4.2 1.5 2.2 2.0 1.8 1.3 1.5 2.5 3.8 1.1 3.4 1.7 1.4 1.5 8.0 10.2 14.4 14.3 7.7 7.7 8.3 8.4 11.3 9.7 53.6 63.9 15.9 4.6 6.4 30.7 15.7 20.4 26.8 45.5 8.7 92.3 6.0 0.0 6.4 43.0 14.8 92.3 0.0 9.7 5.4 7.4 9.7 24.4 11.5 10.5 38.1 12.7 24.5 24.0 17.3 13.8 14.5 11.8 7.2 30.4 16.0 11.9 29.4 9.2 4.1 53.7 6.5 10.3 10.4 11.3 8.8 7.4 20.8 24.7 7.6